#!genome-build Caribou1.2 #!genome-version Caribou1.2 #!genome-date 2021-08 #!genome-build-accession NCBI:PRJNA739179 #!genebuild-last-updated 2021-08 ##gff-version 3 scaffold1 indexed_genome mRNA 7894 8938 . - . ID=transcript_1;Q5VXT1 Q6ZWD4 Q765G8 Q765G9 Q8N679,Guanine nucleotide exchange factor DBS,DBL's big sister;MCF2-transforming sequence-like protein;, PF13716;PF00169;PF00621;PF07653;PF00435;, GO:0005737;GO:0005829;GO:0012505;GO:0005615;GO:0031234;GO:0005886;GO:0005085;GO:0035091;GO:0007186;GO:0035556;GO:0043065;GO:0035025;GO:0051056;, C:cytoplasm; C:cytosol; C:endomembrane system; C:extracellular space; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol binding;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; scaffold1 indexed_genome mRNA 44978 94074 . - . ID=transcript_2;P98196 Q5VXT2,Phospholipid-transporting ATPase IH,ATPase IS;ATPase class VI type 11A;P4-ATPase flippase complex alpha subunit ATP11A;, PF16212;PF16209;, GO:0005769;GO:0005783;GO:0005887;GO:0043231;GO:0005765;GO:0016020;GO:1990531;GO:0005886;GO:0055037;GO:0035579;GO:0070821;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0090555;GO:0140346;GO:0043312;GO:0045332;GO:0010831;, C:early endosome; C:endoplasmic reticulum; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:recycling endosome; C:specific granule membrane; C:tertiary granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylethanolamine flippase activity; F:phosphatidylserine flippase activity;, P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of myotube differentiation;|P98196 Q5VXT2,Phospholipid-transporting ATPase IH,ATPase IS;ATPase class VI type 11A;P4-ATPase flippase complex alpha subunit ATP11A;, PF16212;PF16209;, GO:0005769;GO:0005783;GO:0005887;GO:0043231;GO:0005765;GO:0016020;GO:1990531;GO:0005886;GO:0055037;GO:0035579;GO:0070821;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0090555;GO:0140346;GO:0043312;GO:0045332;GO:0010831;, C:early endosome; C:endoplasmic reticulum; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:recycling endosome; C:specific granule membrane; C:tertiary granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylethanolamine flippase activity; F:phosphatidylserine flippase activity;, P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of myotube differentiation;|P98196 Q5VXT2,Phospholipid-transporting ATPase IH,ATPase IS;ATPase class VI type 11A;P4-ATPase flippase complex alpha subunit ATP11A;, PF16212;PF16209;, GO:0005769;GO:0005783;GO:0005887;GO:0043231;GO:0005765;GO:0016020;GO:1990531;GO:0005886;GO:0055037;GO:0035579;GO:0070821;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0090555;GO:0140346;GO:0043312;GO:0045332;GO:0010831;, C:early endosome; C:endoplasmic reticulum; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:recycling endosome; C:specific granule membrane; C:tertiary granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylethanolamine flippase activity; F:phosphatidylserine flippase activity;, P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of myotube differentiation; scaffold1 indexed_genome mRNA 236005 237743 . + . ID=transcript_3;Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly; scaffold1 indexed_genome mRNA 876233 892396 . - . ID=transcript_4;Q15052 A6NMW9 A8K6S7 B1AL37 Q15396 Q5JQ66 Q7Z3W1 Q86XH0,Rho guanine nucleotide exchange factor 6,Alpha-Pix;COOL-2;PAK-interacting exchange factor alpha;Rac/Cdc42 guanine nucleotide exchange factor 6;, PF16523;PF00307;PF00169;PF00621;PF07653;, GO:0005829;GO:0030027;GO:0005096;GO:0005085;GO:0006915;GO:0007186;GO:0007254;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:lamellipodium;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:JNK cascade; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q14155 B1ALK6 B1ALK8 Q3LIA4 Q5W9H0 Q6P9G3 Q6PII2 Q86W63 Q8N3M1,Rho guanine nucleotide exchange factor 7,Beta-Pix;COOL-1;PAK-interacting exchange factor beta;p85;, PF00307;PF00169;PF00621;PF07653;, GO:0005938;GO:0005813;GO:0005829;GO:0005925;GO:0030027;GO:0097431;GO:0043005;GO:0043025;GO:0098794;GO:0032991;GO:0001726;GO:0043015;GO:0005085;GO:0019901;GO:0048013;GO:0048041;GO:0007186;GO:0007030;GO:0035556;GO:0030032;GO:0042059;GO:1905833;GO:0007399;GO:0043065;GO:0010763;GO:0043547;GO:2000394;GO:1900026;GO:1904424;GO:0051056;GO:0007165;, C:cell cortex; C:centrosome; C:cytosol; C:focal adhesion; C:lamellipodium; C:mitotic spindle pole; C:neuron projection; C:neuronal cell body; C:postsynapse; C:protein-containing complex; C:ruffle;, F:gamma-tubulin binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase binding;, P:ephrin receptor signaling pathway; P:focal adhesion assembly; P:G protein-coupled receptor signaling pathway; P:Golgi organization; P:intracellular signal transduction; P:lamellipodium assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of microtubule nucleation; P:nervous system development; P:positive regulation of apoptotic process; P:positive regulation of fibroblast migration; P:positive regulation of GTPase activity; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of GTP binding; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q14155 B1ALK6 B1ALK8 Q3LIA4 Q5W9H0 Q6P9G3 Q6PII2 Q86W63 Q8N3M1,Rho guanine nucleotide exchange factor 7,Beta-Pix;COOL-1;PAK-interacting exchange factor beta;p85;, PF00307;PF00169;PF00621;PF07653;, GO:0005938;GO:0005813;GO:0005829;GO:0005925;GO:0030027;GO:0097431;GO:0043005;GO:0043025;GO:0098794;GO:0032991;GO:0001726;GO:0043015;GO:0005085;GO:0019901;GO:0048013;GO:0048041;GO:0007186;GO:0007030;GO:0035556;GO:0030032;GO:0042059;GO:1905833;GO:0007399;GO:0043065;GO:0010763;GO:0043547;GO:2000394;GO:1900026;GO:1904424;GO:0051056;GO:0007165;, C:cell cortex; C:centrosome; C:cytosol; C:focal adhesion; C:lamellipodium; C:mitotic spindle pole; C:neuron projection; C:neuronal cell body; C:postsynapse; C:protein-containing complex; C:ruffle;, F:gamma-tubulin binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase binding;, P:ephrin receptor signaling pathway; P:focal adhesion assembly; P:G protein-coupled receptor signaling pathway; P:Golgi organization; P:intracellular signal transduction; P:lamellipodium assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of microtubule nucleation; P:nervous system development; P:positive regulation of apoptotic process; P:positive regulation of fibroblast migration; P:positive regulation of GTPase activity; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of GTP binding; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q14155 B1ALK6 B1ALK8 Q3LIA4 Q5W9H0 Q6P9G3 Q6PII2 Q86W63 Q8N3M1,Rho guanine nucleotide exchange factor 7,Beta-Pix;COOL-1;PAK-interacting exchange factor beta;p85;, PF00307;PF00169;PF00621;PF07653;, GO:0005938;GO:0005813;GO:0005829;GO:0005925;GO:0030027;GO:0097431;GO:0043005;GO:0043025;GO:0098794;GO:0032991;GO:0001726;GO:0043015;GO:0005085;GO:0019901;GO:0048013;GO:0048041;GO:0007186;GO:0007030;GO:0035556;GO:0030032;GO:0042059;GO:1905833;GO:0007399;GO:0043065;GO:0010763;GO:0043547;GO:2000394;GO:1900026;GO:1904424;GO:0051056;GO:0007165;, C:cell cortex; C:centrosome; C:cytosol; C:focal adhesion; C:lamellipodium; C:mitotic spindle pole; C:neuron projection; C:neuronal cell body; C:postsynapse; C:protein-containing complex; C:ruffle;, F:gamma-tubulin binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase binding;, P:ephrin receptor signaling pathway; P:focal adhesion assembly; P:G protein-coupled receptor signaling pathway; P:Golgi organization; P:intracellular signal transduction; P:lamellipodium assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of microtubule nucleation; P:nervous system development; P:positive regulation of apoptotic process; P:positive regulation of fibroblast migration; P:positive regulation of GTPase activity; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of GTP binding; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold1 indexed_genome mRNA 893688 895345 . - . ID=transcript_5;Q14155 B1ALK6 B1ALK8 Q3LIA4 Q5W9H0 Q6P9G3 Q6PII2 Q86W63 Q8N3M1,Rho guanine nucleotide exchange factor 7,Beta-Pix;COOL-1;PAK-interacting exchange factor beta;p85;, PF00307;PF00169;PF00621;PF07653;, GO:0005938;GO:0005813;GO:0005829;GO:0005925;GO:0030027;GO:0097431;GO:0043005;GO:0043025;GO:0098794;GO:0032991;GO:0001726;GO:0043015;GO:0005085;GO:0019901;GO:0048013;GO:0048041;GO:0007186;GO:0007030;GO:0035556;GO:0030032;GO:0042059;GO:1905833;GO:0007399;GO:0043065;GO:0010763;GO:0043547;GO:2000394;GO:1900026;GO:1904424;GO:0051056;GO:0007165;, C:cell cortex; C:centrosome; C:cytosol; C:focal adhesion; C:lamellipodium; C:mitotic spindle pole; C:neuron projection; C:neuronal cell body; C:postsynapse; C:protein-containing complex; C:ruffle;, F:gamma-tubulin binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase binding;, P:ephrin receptor signaling pathway; P:focal adhesion assembly; P:G protein-coupled receptor signaling pathway; P:Golgi organization; P:intracellular signal transduction; P:lamellipodium assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of microtubule nucleation; P:nervous system development; P:positive regulation of apoptotic process; P:positive regulation of fibroblast migration; P:positive regulation of GTPase activity; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of GTP binding; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold1 indexed_genome mRNA 1007275 1015943 . + . ID=transcript_6;Q9NXR5 Q5VW12 Q9BV12,Ankyrin repeat domain-containing protein 10,, PF12796; scaffold1 indexed_genome mRNA 1015979 1035652 . + . ID=transcript_7;Q9NXR5 Q5VW12 Q9BV12,Ankyrin repeat domain-containing protein 10,, PF12796;|Q9NXR5 Q5VW12 Q9BV12,Ankyrin repeat domain-containing protein 10,, PF12796;|Q9NXR5 Q5VW12 Q9BV12,Ankyrin repeat domain-containing protein 10,, PF12796; scaffold1 indexed_genome mRNA 1092622 1093318 . - . ID=transcript_8;Q9UK52,Inhibitor of growth protein 1,, PF12998;, GO:0005634;GO:0046872;GO:0035064;GO:0007049;GO:0030308;GO:0008285;GO:0045893;GO:0010941;, C:nucleus;, F:metal ion binding; F:methylated histone binding;, P:cell cycle; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:positive regulation of transcription, DNA-templated; P:regulation of cell death; scaffold1 indexed_genome mRNA 1096947 1118464 . + . ID=transcript_9;Q9HA77 Q8NI84 Q96IV4,Probable cysteine--tRNA ligase, mitochondrial,Cysteinyl-tRNA synthetase;, PF01406;, GO:0005737;GO:0005759;GO:0005524;GO:0004817;GO:0046872;GO:0006423;, C:cytoplasm; C:mitochondrial matrix;, F:ATP binding; F:cysteine-tRNA ligase activity; F:metal ion binding;, P:cysteinyl-tRNA aminoacylation;|Q9HA77 Q8NI84 Q96IV4,Probable cysteine--tRNA ligase, mitochondrial,Cysteinyl-tRNA synthetase;, PF01406;, GO:0005737;GO:0005759;GO:0005524;GO:0004817;GO:0046872;GO:0006423;, C:cytoplasm; C:mitochondrial matrix;, F:ATP binding; F:cysteine-tRNA ligase activity; F:metal ion binding;, P:cysteinyl-tRNA aminoacylation;|Q9HA77 Q8NI84 Q96IV4,Probable cysteine--tRNA ligase, mitochondrial,Cysteinyl-tRNA synthetase;, PF01406;, GO:0005737;GO:0005759;GO:0005524;GO:0004817;GO:0046872;GO:0006423;, C:cytoplasm; C:mitochondrial matrix;, F:ATP binding; F:cysteine-tRNA ligase activity; F:metal ion binding;, P:cysteinyl-tRNA aminoacylation;|Q9HA77 Q8NI84 Q96IV4,Probable cysteine--tRNA ligase, mitochondrial,Cysteinyl-tRNA synthetase;, PF01406;, GO:0005737;GO:0005759;GO:0005524;GO:0004817;GO:0046872;GO:0006423;, C:cytoplasm; C:mitochondrial matrix;, F:ATP binding; F:cysteine-tRNA ligase activity; F:metal ion binding;, P:cysteinyl-tRNA aminoacylation; scaffold1 indexed_genome mRNA 1118505 1129107 . + . ID=transcript_10;Q8IW45 B4DXT4 Q5T9X3 Q9H7W1 Q9NVF5,ATP-dependent (S)-NAD(P)H-hydrate dehydratase {ECO:0000255|HAMAP-Rule:MF_03157},ATP-dependent NAD(P)HX dehydratase {ECO:0000255|HAMAP-Rule:MF_03157};Carbohydrate kinase domain-containing protein {ECO:0000255|HAMAP-Rule:MF_03157};NAD(P)HX dehydratase {ECO:0000312|HGNC:HGNC:25576};, PF01256;, GO:0005759;GO:0052855;GO:0005524;GO:0047453;GO:0110051;GO:0034356;, C:mitochondrial matrix;, F:ADP-dependent NAD(P)H-hydrate dehydratase activity; F:ATP binding; F:ATP-dependent NAD(P)H-hydrate dehydratase activity;, P:metabolite repair; P:NAD biosynthesis via nicotinamide riboside salvage pathway;|Q8IW45 B4DXT4 Q5T9X3 Q9H7W1 Q9NVF5,ATP-dependent (S)-NAD(P)H-hydrate dehydratase {ECO:0000255|HAMAP-Rule:MF_03157},ATP-dependent NAD(P)HX dehydratase {ECO:0000255|HAMAP-Rule:MF_03157};Carbohydrate kinase domain-containing protein {ECO:0000255|HAMAP-Rule:MF_03157};NAD(P)HX dehydratase {ECO:0000312|HGNC:HGNC:25576};, PF01256;, GO:0005759;GO:0052855;GO:0005524;GO:0047453;GO:0110051;GO:0034356;, C:mitochondrial matrix;, F:ADP-dependent NAD(P)H-hydrate dehydratase activity; F:ATP binding; F:ATP-dependent NAD(P)H-hydrate dehydratase activity;, P:metabolite repair; P:NAD biosynthesis via nicotinamide riboside salvage pathway;|Q8IW45 B4DXT4 Q5T9X3 Q9H7W1 Q9NVF5,ATP-dependent (S)-NAD(P)H-hydrate dehydratase {ECO:0000255|HAMAP-Rule:MF_03157},ATP-dependent NAD(P)HX dehydratase {ECO:0000255|HAMAP-Rule:MF_03157};Carbohydrate kinase domain-containing protein {ECO:0000255|HAMAP-Rule:MF_03157};NAD(P)HX dehydratase {ECO:0000312|HGNC:HGNC:25576};, PF01256;, GO:0005759;GO:0052855;GO:0005524;GO:0047453;GO:0110051;GO:0034356;, C:mitochondrial matrix;, F:ADP-dependent NAD(P)H-hydrate dehydratase activity; F:ATP binding; F:ATP-dependent NAD(P)H-hydrate dehydratase activity;, P:metabolite repair; P:NAD biosynthesis via nicotinamide riboside salvage pathway;|Q8IW45 B4DXT4 Q5T9X3 Q9H7W1 Q9NVF5,ATP-dependent (S)-NAD(P)H-hydrate dehydratase {ECO:0000255|HAMAP-Rule:MF_03157},ATP-dependent NAD(P)HX dehydratase {ECO:0000255|HAMAP-Rule:MF_03157};Carbohydrate kinase domain-containing protein {ECO:0000255|HAMAP-Rule:MF_03157};NAD(P)HX dehydratase {ECO:0000312|HGNC:HGNC:25576};, PF01256;, GO:0005759;GO:0052855;GO:0005524;GO:0047453;GO:0110051;GO:0034356;, C:mitochondrial matrix;, F:ADP-dependent NAD(P)H-hydrate dehydratase activity; F:ATP binding; F:ATP-dependent NAD(P)H-hydrate dehydratase activity;, P:metabolite repair; P:NAD biosynthesis via nicotinamide riboside salvage pathway; scaffold1 indexed_genome mRNA 1160244 1190115 . + . ID=transcript_11;Q9NX57 Q5T9X5 Q9NX49,Ras-related protein Rab-20,, PF00071;, GO:0012505;GO:0005794;GO:0043231;GO:0045335;GO:0030670;GO:0005525;GO:0003924;GO:0071346;GO:0006886;GO:0090383;GO:0090385;, C:endomembrane system; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:phagocytic vesicle; C:phagocytic vesicle membrane;, F:GTP binding; F:GTPase activity;, P:cellular response to interferon-gamma; P:intracellular protein transport; P:phagosome acidification; P:phagosome-lysosome fusion; scaffold1 indexed_genome mRNA 1192600 1228052 . - . ID=transcript_12;P08572 Q14052 Q548C3 Q5VZA9 Q66K23,Collagen alpha-2(IV) chain,, PF01413;PF01391;, GO:0005587;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0007568;GO:0001525;GO:0071560;GO:0030199;GO:0038063;GO:0035987;GO:0030198;GO:0016525;GO:0014823;GO:0006351;, C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:aging; P:angiogenesis; P:cellular response to transforming growth factor beta stimulus; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:endodermal cell differentiation; P:extracellular matrix organization; P:negative regulation of angiogenesis; P:response to activity; P:transcription, DNA-templated;|P08572 Q14052 Q548C3 Q5VZA9 Q66K23,Collagen alpha-2(IV) chain,, PF01413;PF01391;, GO:0005587;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0007568;GO:0001525;GO:0071560;GO:0030199;GO:0038063;GO:0035987;GO:0030198;GO:0016525;GO:0014823;GO:0006351;, C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:aging; P:angiogenesis; P:cellular response to transforming growth factor beta stimulus; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:endodermal cell differentiation; P:extracellular matrix organization; P:negative regulation of angiogenesis; P:response to activity; P:transcription, DNA-templated;|P08572 Q14052 Q548C3 Q5VZA9 Q66K23,Collagen alpha-2(IV) chain,, PF01413;PF01391;, GO:0005587;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0007568;GO:0001525;GO:0071560;GO:0030199;GO:0038063;GO:0035987;GO:0030198;GO:0016525;GO:0014823;GO:0006351;, C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:aging; P:angiogenesis; P:cellular response to transforming growth factor beta stimulus; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:endodermal cell differentiation; P:extracellular matrix organization; P:negative regulation of angiogenesis; P:response to activity; P:transcription, DNA-templated;|P08572 Q14052 Q548C3 Q5VZA9 Q66K23,Collagen alpha-2(IV) chain,, PF01413;PF01391;, GO:0005587;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0007568;GO:0001525;GO:0071560;GO:0030199;GO:0038063;GO:0035987;GO:0030198;GO:0016525;GO:0014823;GO:0006351;, C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:aging; P:angiogenesis; P:cellular response to transforming growth factor beta stimulus; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:endodermal cell differentiation; P:extracellular matrix organization; P:negative regulation of angiogenesis; P:response to activity; P:transcription, DNA-templated; scaffold1 indexed_genome mRNA 1450077 1451883 . + . ID=transcript_13;P02462 A7E2W4 B1AM70 F5H5K0 Q1P9S9 Q5VWF6 Q86X41 Q8NF88 Q9NYC5,Collagen alpha-1(IV) chain,, PF01413;PF01391;, GO:0005604;GO:0005587;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0048407;GO:0071711;GO:0048514;GO:0007420;GO:0001569;GO:0071230;GO:0030199;GO:0038063;GO:0030855;GO:0030198;GO:0007528;GO:0061333;GO:0061304;, C:basement membrane; C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:platelet-derived growth factor binding;, P:basement membrane organization; P:blood vessel morphogenesis; P:brain development; P:branching involved in blood vessel morphogenesis; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:epithelial cell differentiation; P:extracellular matrix organization; P:neuromuscular junction development; P:renal tubule morphogenesis; P:retinal blood vessel morphogenesis; scaffold1 indexed_genome mRNA 1469707 1470418 . + . ID=transcript_14;P02462 A7E2W4 B1AM70 F5H5K0 Q1P9S9 Q5VWF6 Q86X41 Q8NF88 Q9NYC5,Collagen alpha-1(IV) chain,, PF01413;PF01391;, GO:0005604;GO:0005587;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0048407;GO:0071711;GO:0048514;GO:0007420;GO:0001569;GO:0071230;GO:0030199;GO:0038063;GO:0030855;GO:0030198;GO:0007528;GO:0061333;GO:0061304;, C:basement membrane; C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:platelet-derived growth factor binding;, P:basement membrane organization; P:blood vessel morphogenesis; P:brain development; P:branching involved in blood vessel morphogenesis; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:epithelial cell differentiation; P:extracellular matrix organization; P:neuromuscular junction development; P:renal tubule morphogenesis; P:retinal blood vessel morphogenesis; scaffold1 indexed_genome mRNA 1488850 1495111 . + . ID=transcript_15;P02462 A7E2W4 B1AM70 F5H5K0 Q1P9S9 Q5VWF6 Q86X41 Q8NF88 Q9NYC5,Collagen alpha-1(IV) chain,, PF01413;PF01391;, GO:0005604;GO:0005587;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0048407;GO:0071711;GO:0048514;GO:0007420;GO:0001569;GO:0071230;GO:0030199;GO:0038063;GO:0030855;GO:0030198;GO:0007528;GO:0061333;GO:0061304;, C:basement membrane; C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:platelet-derived growth factor binding;, P:basement membrane organization; P:blood vessel morphogenesis; P:brain development; P:branching involved in blood vessel morphogenesis; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:epithelial cell differentiation; P:extracellular matrix organization; P:neuromuscular junction development; P:renal tubule morphogenesis; P:retinal blood vessel morphogenesis; scaffold1 indexed_genome mRNA 2047353 2048682 . - . ID=transcript_16;Q9Y6X6 A6H8Y0 A8MTX3 Q5VYX4 Q5VYX5 Q5VYX6 Q6ZS13 Q8N3C2 Q8N948,Unconventional myosin-XVI,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3;Unconventional myosin-16;, PF12796;PF00063;PF15439;, GO:0005737;GO:0016459;GO:0005654;GO:0048471;GO:0005886;GO:0051015;GO:0005524;GO:0003774;GO:0019903;GO:0021549;GO:0008285;GO:2000134;GO:0048812;GO:0014065;, C:cytoplasm; C:myosin complex; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin filament binding; F:ATP binding; F:motor activity; F:protein phosphatase binding;, P:cerebellum development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling; scaffold1 indexed_genome mRNA 2075924 2082089 . - . ID=transcript_17;Q9Y6X6 A6H8Y0 A8MTX3 Q5VYX4 Q5VYX5 Q5VYX6 Q6ZS13 Q8N3C2 Q8N948,Unconventional myosin-XVI,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3;Unconventional myosin-16;, PF12796;PF00063;PF15439;, GO:0005737;GO:0016459;GO:0005654;GO:0048471;GO:0005886;GO:0051015;GO:0005524;GO:0003774;GO:0019903;GO:0021549;GO:0008285;GO:2000134;GO:0048812;GO:0014065;, C:cytoplasm; C:myosin complex; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin filament binding; F:ATP binding; F:motor activity; F:protein phosphatase binding;, P:cerebellum development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling;|Q9Y6X6 A6H8Y0 A8MTX3 Q5VYX4 Q5VYX5 Q5VYX6 Q6ZS13 Q8N3C2 Q8N948,Unconventional myosin-XVI,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3;Unconventional myosin-16;, PF12796;PF00063;PF15439;, GO:0005737;GO:0016459;GO:0005654;GO:0048471;GO:0005886;GO:0051015;GO:0005524;GO:0003774;GO:0019903;GO:0021549;GO:0008285;GO:2000134;GO:0048812;GO:0014065;, C:cytoplasm; C:myosin complex; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin filament binding; F:ATP binding; F:motor activity; F:protein phosphatase binding;, P:cerebellum development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling; scaffold1 indexed_genome mRNA 2121206 2309170 . - . ID=transcript_18;Q9Y6X6 A6H8Y0 A8MTX3 Q5VYX4 Q5VYX5 Q5VYX6 Q6ZS13 Q8N3C2 Q8N948,Unconventional myosin-XVI,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3;Unconventional myosin-16;, PF12796;PF00063;PF15439;, GO:0005737;GO:0016459;GO:0005654;GO:0048471;GO:0005886;GO:0051015;GO:0005524;GO:0003774;GO:0019903;GO:0021549;GO:0008285;GO:2000134;GO:0048812;GO:0014065;, C:cytoplasm; C:myosin complex; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin filament binding; F:ATP binding; F:motor activity; F:protein phosphatase binding;, P:cerebellum development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling; scaffold1 indexed_genome mRNA 2328277 2556877 . - . ID=transcript_19;Q9Y6X6 A6H8Y0 A8MTX3 Q5VYX4 Q5VYX5 Q5VYX6 Q6ZS13 Q8N3C2 Q8N948,Unconventional myosin-XVI,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3;Unconventional myosin-16;, PF12796;PF00063;PF15439;, GO:0005737;GO:0016459;GO:0005654;GO:0048471;GO:0005886;GO:0051015;GO:0005524;GO:0003774;GO:0019903;GO:0021549;GO:0008285;GO:2000134;GO:0048812;GO:0014065;, C:cytoplasm; C:myosin complex; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin filament binding; F:ATP binding; F:motor activity; F:protein phosphatase binding;, P:cerebellum development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling; scaffold1 indexed_genome mRNA 2657688 2688548 . - . ID=transcript_20;Q9Y275 E0ADT7 Q6FHD6 Q7Z5J2,Tumor necrosis factor ligand superfamily member 13B,B lymphocyte stimulator;B-cell-activating factor;BAFF;Dendritic cell-derived TNF-like molecule;TNF- and APOL-related leukocyte expressed ligand 1;, PF00229;, GO:0005737;GO:0005576;GO:0005615;GO:0005925;GO:0016021;GO:0043231;GO:0048471;GO:0005886;GO:0005125;GO:0048018;GO:0005102;GO:0005164;GO:0031296;GO:0001782;GO:0006955;GO:0030890;GO:0002636;GO:0042102;GO:0007165;GO:0031295;GO:0033209;, C:cytoplasm; C:extracellular region; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cytokine activity; F:receptor ligand activity; F:signaling receptor binding; F:tumor necrosis factor receptor binding;, P:B cell costimulation; P:B cell homeostasis; P:immune response; P:positive regulation of B cell proliferation; P:positive regulation of germinal center formation; P:positive regulation of T cell proliferation; P:signal transduction; P:T cell costimulation; P:tumor necrosis factor-mediated signaling pathway; scaffold1 indexed_genome mRNA 2704048 2707920 . - . ID=transcript_21;Q7L211 B3KWE7 Q8NBW1 Q96JX9,Protein ABHD13 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 13 {ECO:0000305};, PF12146;, GO:0032839;GO:0016021;GO:0016020;GO:0008474;GO:0002084;, C:dendrite cytoplasm; C:integral component of membrane; C:membrane;, F:palmitoyl-(protein) hydrolase activity;, P:protein depalmitoylation;|Q7L211 B3KWE7 Q8NBW1 Q96JX9,Protein ABHD13 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 13 {ECO:0000305};, PF12146;, GO:0032839;GO:0016021;GO:0016020;GO:0008474;GO:0002084;, C:dendrite cytoplasm; C:integral component of membrane; C:membrane;, F:palmitoyl-(protein) hydrolase activity;, P:protein depalmitoylation; scaffold1 indexed_genome mRNA 2736295 2738014 . + . ID=transcript_22;P49917 Q8IY66 Q8TEU5,DNA ligase 4,DNA ligase IV;Polydeoxyribonucleotide synthase [ATP] 4;, PF00533;PF04679;PF01068;PF04675;PF11411;, GO:0000781;GO:0000793;GO:0036464;GO:0032807;GO:0005958;GO:0070419;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0016874;GO:0046872;GO:0008022;GO:0007049;GO:0051301;GO:0008283;GO:0071479;GO:0071285;GO:0007417;GO:0051276;GO:0071897;GO:0006266;GO:0051102;GO:0051103;GO:0006260;GO:0006302;GO:0097680;GO:0006303;GO:0075713;GO:0033152;GO:0001701;GO:0045190;GO:0043524;GO:0051402;GO:0006297;GO:2001252;GO:0048146;GO:0050769;GO:0002328;GO:0010332;GO:0010165;GO:0000012;GO:0035019;GO:0033077;GO:0033153;GO:0033151;, C:chromosome, telomeric region; C:condensed chromosome; C:cytoplasmic ribonucleoprotein granule; C:DNA ligase IV complex; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:nonhomologous end joining complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:ligase activity; F:metal ion binding; F:protein C-terminus binding;, P:cell cycle; P:cell division; P:cell population proliferation; P:cellular response to ionizing radiation; P:cellular response to lithium ion; P:central nervous system development; P:chromosome organization; P:DNA biosynthetic process; P:DNA ligation; P:DNA ligation involved in DNA recombination; P:DNA ligation involved in DNA repair; P:DNA replication; P:double-strand break repair; P:double-strand break repair via classical nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:immunoglobulin V(D)J recombination; P:in utero embryonic development; P:isotype switching; P:negative regulation of neuron apoptotic process; P:neuron apoptotic process; P:nucleotide-excision repair, DNA gap filling; P:positive regulation of chromosome organization; P:positive regulation of fibroblast proliferation; P:positive regulation of neurogenesis; P:pro-B cell differentiation; P:response to gamma radiation; P:response to X-ray; P:single strand break repair; P:somatic stem cell population maintenance; P:T cell differentiation in thymus; P:T cell receptor V(D)J recombination; P:V(D)J recombination; scaffold1 indexed_genome mRNA 2738016 2740880 . - . ID=transcript_23;P49917 Q8IY66 Q8TEU5,DNA ligase 4,DNA ligase IV;Polydeoxyribonucleotide synthase [ATP] 4;, PF00533;PF04679;PF01068;PF04675;PF11411;, GO:0000781;GO:0000793;GO:0036464;GO:0032807;GO:0005958;GO:0070419;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0016874;GO:0046872;GO:0008022;GO:0007049;GO:0051301;GO:0008283;GO:0071479;GO:0071285;GO:0007417;GO:0051276;GO:0071897;GO:0006266;GO:0051102;GO:0051103;GO:0006260;GO:0006302;GO:0097680;GO:0006303;GO:0075713;GO:0033152;GO:0001701;GO:0045190;GO:0043524;GO:0051402;GO:0006297;GO:2001252;GO:0048146;GO:0050769;GO:0002328;GO:0010332;GO:0010165;GO:0000012;GO:0035019;GO:0033077;GO:0033153;GO:0033151;, C:chromosome, telomeric region; C:condensed chromosome; C:cytoplasmic ribonucleoprotein granule; C:DNA ligase IV complex; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:nonhomologous end joining complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:ligase activity; F:metal ion binding; F:protein C-terminus binding;, P:cell cycle; P:cell division; P:cell population proliferation; P:cellular response to ionizing radiation; P:cellular response to lithium ion; P:central nervous system development; P:chromosome organization; P:DNA biosynthetic process; P:DNA ligation; P:DNA ligation involved in DNA recombination; P:DNA ligation involved in DNA repair; P:DNA replication; P:double-strand break repair; P:double-strand break repair via classical nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:immunoglobulin V(D)J recombination; P:in utero embryonic development; P:isotype switching; P:negative regulation of neuron apoptotic process; P:neuron apoptotic process; P:nucleotide-excision repair, DNA gap filling; P:positive regulation of chromosome organization; P:positive regulation of fibroblast proliferation; P:positive regulation of neurogenesis; P:pro-B cell differentiation; P:response to gamma radiation; P:response to X-ray; P:single strand break repair; P:somatic stem cell population maintenance; P:T cell differentiation in thymus; P:T cell receptor V(D)J recombination; P:V(D)J recombination; scaffold1 indexed_genome mRNA 2905519 3480318 . + . ID=transcript_24;B1AL88 B2RUV1 B7Z334,Transmembrane protein FAM155A,, , GO:0016021;GO:0005886;GO:0098703;, C:integral component of membrane; C:plasma membrane;, , P:calcium ion import across plasma membrane; scaffold1 indexed_genome mRNA 3942576 3972392 . + . ID=transcript_25;Q9NWB6 B4E0Y3 Q5T257 Q6IQ34,Arginine and glutamate-rich protein 1,, PF15346;, GO:0005829;GO:0005739;GO:0005654;GO:0045296;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:cadherin binding;|Q9NWB6 B4E0Y3 Q5T257 Q6IQ34,Arginine and glutamate-rich protein 1,, PF15346;, GO:0005829;GO:0005739;GO:0005654;GO:0045296;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:cadherin binding; scaffold1 indexed_genome mRNA 4010366 4034237 . + . ID=transcript_26;P52799 Q5JV56,Ephrin-B2,EPH-related receptor tyrosine kinase ligand 5;HTK ligand;, PF00812;, GO:0005912;GO:0005925;GO:0098978;GO:0005887;GO:0099056;GO:0005886;GO:0046875;GO:0001618;GO:0009653;GO:0007411;GO:0048514;GO:0007155;GO:0002042;GO:0007267;GO:0048013;GO:0010977;GO:2000727;GO:0008284;GO:1901216;GO:0099054;GO:0050920;, C:adherens junction; C:focal adhesion; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane;, F:ephrin receptor binding; F:virus receptor activity;, P:anatomical structure morphogenesis; P:axon guidance; P:blood vessel morphogenesis; P:cell adhesion; P:cell migration involved in sprouting angiogenesis; P:cell-cell signaling; P:ephrin receptor signaling pathway; P:negative regulation of neuron projection development; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of neuron death; P:presynapse assembly; P:regulation of chemotaxis; scaffold1 indexed_genome mRNA 6989762 7006973 . - . ID=transcript_27;A6NDL7,Putative methyltransferase-like protein 21E pseudogene,, PF10294;, GO:0005737;GO:0005829;GO:0016279;GO:0018022;GO:0018023;, C:cytoplasm; C:cytosol;, F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine methylation; P:peptidyl-lysine trimethylation; scaffold1 indexed_genome mRNA 7011147 7033117 . - . ID=transcript_28;P28715 A6NGT4 Q5JUS4 Q5JUS5 Q7Z2V3 Q8IZL6 Q8N1B7 Q9HD59 Q9HD60,DNA repair protein complementing XP-G cells,DNA excision repair protein ERCC-5;Xeroderma pigmentosum group G-complementing protein;, PF00867;PF00752;, GO:0005654;GO:0000109;GO:0005634;GO:0032991;GO:0000405;GO:0003684;GO:0003690;GO:0004520;GO:0004519;GO:0008047;GO:0046872;GO:0042803;GO:0047485;GO:0044877;GO:0000993;GO:0003697;GO:0006285;GO:0000724;GO:0043066;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0050790;GO:0009411;GO:0010225;GO:0006283;GO:0009650;, C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleus; C:protein-containing complex;, F:bubble DNA binding; F:damaged DNA binding; F:double-stranded DNA binding; F:endodeoxyribonuclease activity; F:endonuclease activity; F:enzyme activator activity; F:metal ion binding; F:protein homodimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:RNA polymerase II complex binding; F:single-stranded DNA binding;, P:base-excision repair, AP site formation; P:double-strand break repair via homologous recombination; P:negative regulation of apoptotic process; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of catalytic activity; P:response to UV; P:response to UV-C; P:transcription-coupled nucleotide-excision repair; P:UV protection;|P28715 A6NGT4 Q5JUS4 Q5JUS5 Q7Z2V3 Q8IZL6 Q8N1B7 Q9HD59 Q9HD60,DNA repair protein complementing XP-G cells,DNA excision repair protein ERCC-5;Xeroderma pigmentosum group G-complementing protein;, PF00867;PF00752;, GO:0005654;GO:0000109;GO:0005634;GO:0032991;GO:0000405;GO:0003684;GO:0003690;GO:0004520;GO:0004519;GO:0008047;GO:0046872;GO:0042803;GO:0047485;GO:0044877;GO:0000993;GO:0003697;GO:0006285;GO:0000724;GO:0043066;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0050790;GO:0009411;GO:0010225;GO:0006283;GO:0009650;, C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleus; C:protein-containing complex;, F:bubble DNA binding; F:damaged DNA binding; F:double-stranded DNA binding; F:endodeoxyribonuclease activity; F:endonuclease activity; F:enzyme activator activity; F:metal ion binding; F:protein homodimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:RNA polymerase II complex binding; F:single-stranded DNA binding;, P:base-excision repair, AP site formation; P:double-strand break repair via homologous recombination; P:negative regulation of apoptotic process; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of catalytic activity; P:response to UV; P:response to UV-C; P:transcription-coupled nucleotide-excision repair; P:UV protection;|P28715 A6NGT4 Q5JUS4 Q5JUS5 Q7Z2V3 Q8IZL6 Q8N1B7 Q9HD59 Q9HD60,DNA repair protein complementing XP-G cells,DNA excision repair protein ERCC-5;Xeroderma pigmentosum group G-complementing protein;, PF00867;PF00752;, GO:0005654;GO:0000109;GO:0005634;GO:0032991;GO:0000405;GO:0003684;GO:0003690;GO:0004520;GO:0004519;GO:0008047;GO:0046872;GO:0042803;GO:0047485;GO:0044877;GO:0000993;GO:0003697;GO:0006285;GO:0000724;GO:0043066;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0050790;GO:0009411;GO:0010225;GO:0006283;GO:0009650;, C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleus; C:protein-containing complex;, F:bubble DNA binding; F:damaged DNA binding; F:double-stranded DNA binding; F:endodeoxyribonuclease activity; F:endonuclease activity; F:enzyme activator activity; F:metal ion binding; F:protein homodimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:RNA polymerase II complex binding; F:single-stranded DNA binding;, P:base-excision repair, AP site formation; P:double-strand break repair via homologous recombination; P:negative regulation of apoptotic process; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of catalytic activity; P:response to UV; P:response to UV-C; P:transcription-coupled nucleotide-excision repair; P:UV protection;|P28715 A6NGT4 Q5JUS4 Q5JUS5 Q7Z2V3 Q8IZL6 Q8N1B7 Q9HD59 Q9HD60,DNA repair protein complementing XP-G cells,DNA excision repair protein ERCC-5;Xeroderma pigmentosum group G-complementing protein;, PF00867;PF00752;, GO:0005654;GO:0000109;GO:0005634;GO:0032991;GO:0000405;GO:0003684;GO:0003690;GO:0004520;GO:0004519;GO:0008047;GO:0046872;GO:0042803;GO:0047485;GO:0044877;GO:0000993;GO:0003697;GO:0006285;GO:0000724;GO:0043066;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0050790;GO:0009411;GO:0010225;GO:0006283;GO:0009650;, C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleus; C:protein-containing complex;, F:bubble DNA binding; F:damaged DNA binding; F:double-stranded DNA binding; F:endodeoxyribonuclease activity; F:endonuclease activity; F:enzyme activator activity; F:metal ion binding; F:protein homodimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:RNA polymerase II complex binding; F:single-stranded DNA binding;, P:base-excision repair, AP site formation; P:double-strand break repair via homologous recombination; P:negative regulation of apoptotic process; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of catalytic activity; P:response to UV; P:response to UV-C; P:transcription-coupled nucleotide-excision repair; P:UV protection;|P28715 A6NGT4 Q5JUS4 Q5JUS5 Q7Z2V3 Q8IZL6 Q8N1B7 Q9HD59 Q9HD60,DNA repair protein complementing XP-G cells,DNA excision repair protein ERCC-5;Xeroderma pigmentosum group G-complementing protein;, PF00867;PF00752;, GO:0005654;GO:0000109;GO:0005634;GO:0032991;GO:0000405;GO:0003684;GO:0003690;GO:0004520;GO:0004519;GO:0008047;GO:0046872;GO:0042803;GO:0047485;GO:0044877;GO:0000993;GO:0003697;GO:0006285;GO:0000724;GO:0043066;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0050790;GO:0009411;GO:0010225;GO:0006283;GO:0009650;, C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleus; C:protein-containing complex;, F:bubble DNA binding; F:damaged DNA binding; F:double-stranded DNA binding; F:endodeoxyribonuclease activity; F:endonuclease activity; F:enzyme activator activity; F:metal ion binding; F:protein homodimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:RNA polymerase II complex binding; F:single-stranded DNA binding;, P:base-excision repair, AP site formation; P:double-strand break repair via homologous recombination; P:negative regulation of apoptotic process; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of catalytic activity; P:response to UV; P:response to UV-C; P:transcription-coupled nucleotide-excision repair; P:UV protection;|P28715 A6NGT4 Q5JUS4 Q5JUS5 Q7Z2V3 Q8IZL6 Q8N1B7 Q9HD59 Q9HD60,DNA repair protein complementing XP-G cells,DNA excision repair protein ERCC-5;Xeroderma pigmentosum group G-complementing protein;, PF00867;PF00752;, GO:0005654;GO:0000109;GO:0005634;GO:0032991;GO:0000405;GO:0003684;GO:0003690;GO:0004520;GO:0004519;GO:0008047;GO:0046872;GO:0042803;GO:0047485;GO:0044877;GO:0000993;GO:0003697;GO:0006285;GO:0000724;GO:0043066;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0050790;GO:0009411;GO:0010225;GO:0006283;GO:0009650;, C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleus; C:protein-containing complex;, F:bubble DNA binding; F:damaged DNA binding; F:double-stranded DNA binding; F:endodeoxyribonuclease activity; F:endonuclease activity; F:enzyme activator activity; F:metal ion binding; F:protein homodimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:RNA polymerase II complex binding; F:single-stranded DNA binding;, P:base-excision repair, AP site formation; P:double-strand break repair via homologous recombination; P:negative regulation of apoptotic process; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of catalytic activity; P:response to UV; P:response to UV-C; P:transcription-coupled nucleotide-excision repair; P:UV protection;|P28715 A6NGT4 Q5JUS4 Q5JUS5 Q7Z2V3 Q8IZL6 Q8N1B7 Q9HD59 Q9HD60,DNA repair protein complementing XP-G cells,DNA excision repair protein ERCC-5;Xeroderma pigmentosum group G-complementing protein;, PF00867;PF00752;, GO:0005654;GO:0000109;GO:0005634;GO:0032991;GO:0000405;GO:0003684;GO:0003690;GO:0004520;GO:0004519;GO:0008047;GO:0046872;GO:0042803;GO:0047485;GO:0044877;GO:0000993;GO:0003697;GO:0006285;GO:0000724;GO:0043066;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0050790;GO:0009411;GO:0010225;GO:0006283;GO:0009650;, C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleus; C:protein-containing complex;, F:bubble DNA binding; F:damaged DNA binding; F:double-stranded DNA binding; F:endodeoxyribonuclease activity; F:endonuclease activity; F:enzyme activator activity; F:metal ion binding; F:protein homodimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:RNA polymerase II complex binding; F:single-stranded DNA binding;, P:base-excision repair, AP site formation; P:double-strand break repair via homologous recombination; P:negative regulation of apoptotic process; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of catalytic activity; P:response to UV; P:response to UV-C; P:transcription-coupled nucleotide-excision repair; P:UV protection; scaffold1 indexed_genome mRNA 7036141 7038226 . - . ID=transcript_29;P28715 A6NGT4 Q5JUS4 Q5JUS5 Q7Z2V3 Q8IZL6 Q8N1B7 Q9HD59 Q9HD60,DNA repair protein complementing XP-G cells,DNA excision repair protein ERCC-5;Xeroderma pigmentosum group G-complementing protein;, PF00867;PF00752;, GO:0005654;GO:0000109;GO:0005634;GO:0032991;GO:0000405;GO:0003684;GO:0003690;GO:0004520;GO:0004519;GO:0008047;GO:0046872;GO:0042803;GO:0047485;GO:0044877;GO:0000993;GO:0003697;GO:0006285;GO:0000724;GO:0043066;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0050790;GO:0009411;GO:0010225;GO:0006283;GO:0009650;, C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleus; C:protein-containing complex;, F:bubble DNA binding; F:damaged DNA binding; F:double-stranded DNA binding; F:endodeoxyribonuclease activity; F:endonuclease activity; F:enzyme activator activity; F:metal ion binding; F:protein homodimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:RNA polymerase II complex binding; F:single-stranded DNA binding;, P:base-excision repair, AP site formation; P:double-strand break repair via homologous recombination; P:negative regulation of apoptotic process; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of catalytic activity; P:response to UV; P:response to UV-C; P:transcription-coupled nucleotide-excision repair; P:UV protection; scaffold1 indexed_genome mRNA 7042599 7064982 . - . ID=transcript_30;Q86UB2 Q2M1J2 Q9NXM4,Basic immunoglobulin-like variable motif-containing protein,, , GO:0005737;GO:0005615;GO:0005634;, C:cytoplasm; C:extracellular space; C:nucleus;|Q86UB2 Q2M1J2 Q9NXM4,Basic immunoglobulin-like variable motif-containing protein,, , GO:0005737;GO:0005615;GO:0005634;, C:cytoplasm; C:extracellular space; C:nucleus;|Q86UB2 Q2M1J2 Q9NXM4,Basic immunoglobulin-like variable motif-containing protein,, , GO:0005737;GO:0005615;GO:0005634;, C:cytoplasm; C:extracellular space; C:nucleus; scaffold1 indexed_genome mRNA 7075687 7087949 . + . ID=transcript_31;Q6UW63 Q53HL3 Q9BVD2,Protein O-glucosyltransferase 2 {ECO:0000305|PubMed:30127001},Endoplasmic reticulum resident protein 58;KDEL motif-containing protein 1 {ECO:0000312|HGNC:HGNC:19350};Protein O-xylosyltransferase POGLUT2 {ECO:0000305|PubMed:30127001};, PF00630;PF05686;, GO:0005829;GO:0012505;GO:0005788;GO:0005654;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0018242;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum lumen; C:nucleoplasm;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:protein O-linked glycosylation via serine;|Q6UW63 Q53HL3 Q9BVD2,Protein O-glucosyltransferase 2 {ECO:0000305|PubMed:30127001},Endoplasmic reticulum resident protein 58;KDEL motif-containing protein 1 {ECO:0000312|HGNC:HGNC:19350};Protein O-xylosyltransferase POGLUT2 {ECO:0000305|PubMed:30127001};, PF00630;PF05686;, GO:0005829;GO:0012505;GO:0005788;GO:0005654;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0018242;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum lumen; C:nucleoplasm;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:protein O-linked glycosylation via serine;|Q6UW63 Q53HL3 Q9BVD2,Protein O-glucosyltransferase 2 {ECO:0000305|PubMed:30127001},Endoplasmic reticulum resident protein 58;KDEL motif-containing protein 1 {ECO:0000312|HGNC:HGNC:19350};Protein O-xylosyltransferase POGLUT2 {ECO:0000305|PubMed:30127001};, PF00630;PF05686;, GO:0005829;GO:0012505;GO:0005788;GO:0005654;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0018242;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum lumen; C:nucleoplasm;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:protein O-linked glycosylation via serine; scaffold1 indexed_genome mRNA 7097667 7101219 . + . ID=transcript_32;Q5JUR7 Q5JUR8 Q96KZ8,Testis-expressed protein 30,, PF01738;, GO:0016787;, , F:hydrolase activity; scaffold1 indexed_genome mRNA 7138263 7139574 . + . ID=transcript_33;Q8NDH2 Q8N800,Coiled-coil domain-containing protein 168,, PF15804;|Q8NDH2 Q8N800,Coiled-coil domain-containing protein 168,, PF15804; scaffold1 indexed_genome mRNA 7183201 7185715 . + . ID=transcript_34;Q5VZV1,Protein-lysine methyltransferase METTL21C,Methyltransferase-like protein 21C;, PF10294;, GO:0005737;GO:0005829;GO:0005634;GO:0032991;GO:0031072;GO:0016279;GO:0018022;GO:0018023;GO:0006479;, C:cytoplasm; C:cytosol; C:nucleus; C:protein-containing complex;, F:heat shock protein binding; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine methylation; P:peptidyl-lysine trimethylation; P:protein methylation; scaffold1 indexed_genome mRNA 7190426 7233867 . - . ID=transcript_35;P29144 Q5VZU8,Tripeptidyl-peptidase 2,Tripeptidyl aminopeptidase;Tripeptidyl-peptidase II;, PF00082;PF12580;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0004177;GO:0004175;GO:0042802;GO:0004252;GO:0008240;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:aminopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:serine-type endopeptidase activity; F:tripeptidyl-peptidase activity;, P:protein polyubiquitination; P:proteolysis;|P29144 Q5VZU8,Tripeptidyl-peptidase 2,Tripeptidyl aminopeptidase;Tripeptidyl-peptidase II;, PF00082;PF12580;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0004177;GO:0004175;GO:0042802;GO:0004252;GO:0008240;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:aminopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:serine-type endopeptidase activity; F:tripeptidyl-peptidase activity;, P:protein polyubiquitination; P:proteolysis;|P29144 Q5VZU8,Tripeptidyl-peptidase 2,Tripeptidyl aminopeptidase;Tripeptidyl-peptidase II;, PF00082;PF12580;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0004177;GO:0004175;GO:0042802;GO:0004252;GO:0008240;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:aminopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:serine-type endopeptidase activity; F:tripeptidyl-peptidase activity;, P:protein polyubiquitination; P:proteolysis;|P29144 Q5VZU8,Tripeptidyl-peptidase 2,Tripeptidyl aminopeptidase;Tripeptidyl-peptidase II;, PF00082;PF12580;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0004177;GO:0004175;GO:0042802;GO:0004252;GO:0008240;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:aminopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:serine-type endopeptidase activity; F:tripeptidyl-peptidase activity;, P:protein polyubiquitination; P:proteolysis;|P29144 Q5VZU8,Tripeptidyl-peptidase 2,Tripeptidyl aminopeptidase;Tripeptidyl-peptidase II;, PF00082;PF12580;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0004177;GO:0004175;GO:0042802;GO:0004252;GO:0008240;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:aminopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:serine-type endopeptidase activity; F:tripeptidyl-peptidase activity;, P:protein polyubiquitination; P:proteolysis;|P29144 Q5VZU8,Tripeptidyl-peptidase 2,Tripeptidyl aminopeptidase;Tripeptidyl-peptidase II;, PF00082;PF12580;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0004177;GO:0004175;GO:0042802;GO:0004252;GO:0008240;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:aminopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:serine-type endopeptidase activity; F:tripeptidyl-peptidase activity;, P:protein polyubiquitination; P:proteolysis; scaffold1 indexed_genome mRNA 7330808 7934617 . + . ID=transcript_36;Q92915 Q86YN7 Q96QX6,Fibroblast growth factor 14,Fibroblast growth factor homologous factor 4;, PF00167;, GO:0005737;GO:0005576;GO:0005634;GO:0008083;GO:0008201;GO:0017080;GO:0007267;GO:0007254;GO:0007399;GO:1901843;GO:0060078;GO:0048167;GO:1903421;GO:1905150;GO:0007165;, C:cytoplasm; C:extracellular region; C:nucleus;, F:growth factor activity; F:heparin binding; F:sodium channel regulator activity;, P:cell-cell signaling; P:JNK cascade; P:nervous system development; P:positive regulation of high voltage-gated calcium channel activity; P:regulation of postsynaptic membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle recycling; P:regulation of voltage-gated sodium channel activity; P:signal transduction; scaffold1 indexed_genome mRNA 7936710 7967979 . + . ID=transcript_37;O95965 A8K5M5 B3KTP1 B4DQ02 Q8N172 Q9NPR0,Integrin beta-like protein 1,Osteoblast-specific cysteine-rich protein;Ten integrin EGF-like repeat domain-containing protein;, PF07974;, GO:0005576;GO:0005925;GO:0005886;GO:0005178;GO:0007155;GO:0033627;GO:0016477;GO:0007160;GO:0007229;, C:extracellular region; C:focal adhesion; C:plasma membrane;, F:integrin binding;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:integrin-mediated signaling pathway;|O95965 A8K5M5 B3KTP1 B4DQ02 Q8N172 Q9NPR0,Integrin beta-like protein 1,Osteoblast-specific cysteine-rich protein;Ten integrin EGF-like repeat domain-containing protein;, PF07974;, GO:0005576;GO:0005925;GO:0005886;GO:0005178;GO:0007155;GO:0033627;GO:0016477;GO:0007160;GO:0007229;, C:extracellular region; C:focal adhesion; C:plasma membrane;, F:integrin binding;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:integrin-mediated signaling pathway;|O95965 A8K5M5 B3KTP1 B4DQ02 Q8N172 Q9NPR0,Integrin beta-like protein 1,Osteoblast-specific cysteine-rich protein;Ten integrin EGF-like repeat domain-containing protein;, PF07974;, GO:0005576;GO:0005925;GO:0005886;GO:0005178;GO:0007155;GO:0033627;GO:0016477;GO:0007160;GO:0007229;, C:extracellular region; C:focal adhesion; C:plasma membrane;, F:integrin binding;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:integrin-mediated signaling pathway; scaffold1 indexed_genome mRNA 8040543 8158204 . - . ID=transcript_38;O95965 A8K5M5 B3KTP1 B4DQ02 Q8N172 Q9NPR0,Integrin beta-like protein 1,Osteoblast-specific cysteine-rich protein;Ten integrin EGF-like repeat domain-containing protein;, PF07974;, GO:0005576;GO:0005925;GO:0005886;GO:0005178;GO:0007155;GO:0033627;GO:0016477;GO:0007160;GO:0007229;, C:extracellular region; C:focal adhesion; C:plasma membrane;, F:integrin binding;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:integrin-mediated signaling pathway; scaffold1 indexed_genome mRNA 8203773 8270797 . + . ID=transcript_39;Q8IZF0 Q6P2S6 Q6ZMI7 Q8IZZ1 Q8TAH1,Sodium leak channel non-selective protein,CanIon;Voltage gated channel-like protein 1;, PF00520;, GO:0016021;GO:0005886;GO:0005261;GO:0022840;GO:0005272;GO:0005244;GO:0070588;GO:0034220;GO:0071805;GO:0034765;GO:0060075;GO:0035725;, C:integral component of membrane; C:plasma membrane;, F:cation channel activity; F:leak channel activity; F:sodium channel activity; F:voltage-gated ion channel activity;, P:calcium ion transmembrane transport; P:ion transmembrane transport; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of resting membrane potential; P:sodium ion transmembrane transport; scaffold1 indexed_genome mRNA 8300867 8463070 . + . ID=transcript_40;Q8IZF0 Q6P2S6 Q6ZMI7 Q8IZZ1 Q8TAH1,Sodium leak channel non-selective protein,CanIon;Voltage gated channel-like protein 1;, PF00520;, GO:0016021;GO:0005886;GO:0005261;GO:0022840;GO:0005272;GO:0005244;GO:0070588;GO:0034220;GO:0071805;GO:0034765;GO:0060075;GO:0035725;, C:integral component of membrane; C:plasma membrane;, F:cation channel activity; F:leak channel activity; F:sodium channel activity; F:voltage-gated ion channel activity;, P:calcium ion transmembrane transport; P:ion transmembrane transport; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of resting membrane potential; P:sodium ion transmembrane transport; scaffold1 indexed_genome mRNA 8743880 8793959 . + . ID=transcript_41;Q5T4D3 A6NLI7 B7Z666 Q5T4D4 Q5T4D5 Q5T4D6 Q8WV63 Q96SU8,Protein O-mannosyl-transferase TMTC4 {ECO:0000305},Transmembrane and TPR repeat-containing protein 4 {ECO:0000312|HGNC:HGNC:25904};, PF08409;PF13181;, GO:0005783;GO:0016021;GO:0051117;GO:0004169;GO:0000030;GO:0030968;GO:1905584;GO:0032470;GO:0035269;GO:0007605;, C:endoplasmic reticulum; C:integral component of membrane;, F:ATPase binding; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity;, P:endoplasmic reticulum unfolded protein response; P:outer hair cell apoptotic process; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:protein O-linked mannosylation; P:sensory perception of sound;|Q5T4D3 A6NLI7 B7Z666 Q5T4D4 Q5T4D5 Q5T4D6 Q8WV63 Q96SU8,Protein O-mannosyl-transferase TMTC4 {ECO:0000305},Transmembrane and TPR repeat-containing protein 4 {ECO:0000312|HGNC:HGNC:25904};, PF08409;PF13181;, GO:0005783;GO:0016021;GO:0051117;GO:0004169;GO:0000030;GO:0030968;GO:1905584;GO:0032470;GO:0035269;GO:0007605;, C:endoplasmic reticulum; C:integral component of membrane;, F:ATPase binding; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity;, P:endoplasmic reticulum unfolded protein response; P:outer hair cell apoptotic process; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:protein O-linked mannosylation; P:sensory perception of sound; scaffold1 indexed_genome mRNA 8804117 8850820 . + . ID=transcript_42;Q9BVM4 B3KTN1 Q9BT41,Gamma-glutamylaminecyclotransferase,AIG2-like domain-containing protein 1;Gamma-glutamylamine cyclotransferase;, PF06094;, GO:0005829;GO:0070062;GO:0061929;GO:0042219;, C:cytosol; C:extracellular exosome;, F:gamma-glutamylaminecyclotransferase activity;, P:cellular modified amino acid catabolic process; scaffold1 indexed_genome mRNA 8852018 9196709 . - . ID=transcript_43;P05165 B4DKY8 B4DPF9 C9JPQ8 Q15979 Q8WXQ7,Propionyl-CoA carboxylase alpha chain, mitochondrial {ECO:0000305|PubMed:2740237},Propanoyl-CoA:carbon dioxide ligase subunit alpha;, PF02785;PF00289;PF00364;PF02786;PF18140;, GO:0005829;GO:0005759;GO:0005739;GO:0005524;GO:0009374;GO:0016421;GO:0019899;GO:0046872;GO:0004658;GO:0006768;GO:0019626;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:biotin binding; F:CoA carboxylase activity; F:enzyme binding; F:metal ion binding; F:propionyl-CoA carboxylase activity;, P:biotin metabolic process; P:short-chain fatty acid catabolic process;|P05165 B4DKY8 B4DPF9 C9JPQ8 Q15979 Q8WXQ7,Propionyl-CoA carboxylase alpha chain, mitochondrial {ECO:0000305|PubMed:2740237},Propanoyl-CoA:carbon dioxide ligase subunit alpha;, PF02785;PF00289;PF00364;PF02786;PF18140;, GO:0005829;GO:0005759;GO:0005739;GO:0005524;GO:0009374;GO:0016421;GO:0019899;GO:0046872;GO:0004658;GO:0006768;GO:0019626;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:biotin binding; F:CoA carboxylase activity; F:enzyme binding; F:metal ion binding; F:propionyl-CoA carboxylase activity;, P:biotin metabolic process; P:short-chain fatty acid catabolic process; scaffold1 indexed_genome mRNA 9196780 9220885 . + . ID=transcript_44;Q549T9 Q96HD0,Asparagine synthetase [glutamine-hydrolyzing],Cell cycle control protein TS11;Glutamine-dependent asparagine synthetase;, PF00733;PF13537;, GO:0005829;GO:0004066;GO:0005524;GO:0042802;GO:0006529;GO:0009066;GO:0042149;GO:0032870;GO:0006541;GO:0070981;GO:0001889;GO:0043066;GO:0045931;GO:0043200;GO:0032354;GO:0009416;GO:0009612;GO:0031427;GO:0009636;, C:cytosol;, F:asparagine synthase (glutamine-hydrolyzing) activity; F:ATP binding; F:identical protein binding;, P:asparagine biosynthetic process; P:aspartate family amino acid metabolic process; P:cellular response to glucose starvation; P:cellular response to hormone stimulus; P:glutamine metabolic process; P:L-asparagine biosynthetic process; P:liver development; P:negative regulation of apoptotic process; P:positive regulation of mitotic cell cycle; P:response to amino acid; P:response to follicle-stimulating hormone; P:response to light stimulus; P:response to mechanical stimulus; P:response to methotrexate; P:response to toxic substance; scaffold1 indexed_genome mRNA 9274685 9275828 . + . ID=transcript_45;Q96T25 Q5VYB0,Zinc finger protein ZIC 5,Zinc finger protein of the cerebellum 5;, PF00096;PF18366;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0030154;GO:0007417;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:central nervous system development; P:regulation of transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 9344543 9378149 . - . ID=transcript_46;Q8N0X4 Q5W0F7 Q8TDH8,Citramalyl-CoA lyase, mitochondrial {ECO:0000303|PubMed:29056341},(3S)-malyl-CoA thioesterase {ECO:0000305|PubMed:29056341};Beta-methylmalate synthase;Citrate lyase subunit beta-like protein {ECO:0000305};Malate synthase;, PF03328;, GO:0005739;GO:0047777;GO:0016787;GO:0000287;GO:0004474;GO:0106121;GO:0070207;GO:0106064;, C:mitochondrion;, F:(S)-citramalyl-CoA lyase activity; F:hydrolase activity; F:magnesium ion binding; F:malate synthase activity;, P:positive regulation of cobalamin metabolic process; P:protein homotrimerization; P:regulation of cobalamin metabolic process;|Q8N0X4 Q5W0F7 Q8TDH8,Citramalyl-CoA lyase, mitochondrial {ECO:0000303|PubMed:29056341},(3S)-malyl-CoA thioesterase {ECO:0000305|PubMed:29056341};Beta-methylmalate synthase;Citrate lyase subunit beta-like protein {ECO:0000305};Malate synthase;, PF03328;, GO:0005739;GO:0047777;GO:0016787;GO:0000287;GO:0004474;GO:0106121;GO:0070207;GO:0106064;, C:mitochondrion;, F:(S)-citramalyl-CoA lyase activity; F:hydrolase activity; F:magnesium ion binding; F:malate synthase activity;, P:positive regulation of cobalamin metabolic process; P:protein homotrimerization; P:regulation of cobalamin metabolic process;|Q8N0X4 Q5W0F7 Q8TDH8,Citramalyl-CoA lyase, mitochondrial {ECO:0000303|PubMed:29056341},(3S)-malyl-CoA thioesterase {ECO:0000305|PubMed:29056341};Beta-methylmalate synthase;Citrate lyase subunit beta-like protein {ECO:0000305};Malate synthase;, PF03328;, GO:0005739;GO:0047777;GO:0016787;GO:0000287;GO:0004474;GO:0106121;GO:0070207;GO:0106064;, C:mitochondrion;, F:(S)-citramalyl-CoA lyase activity; F:hydrolase activity; F:magnesium ion binding; F:malate synthase activity;, P:positive regulation of cobalamin metabolic process; P:protein homotrimerization; P:regulation of cobalamin metabolic process;|Q8N0X4 Q5W0F7 Q8TDH8,Citramalyl-CoA lyase, mitochondrial {ECO:0000303|PubMed:29056341},(3S)-malyl-CoA thioesterase {ECO:0000305|PubMed:29056341};Beta-methylmalate synthase;Citrate lyase subunit beta-like protein {ECO:0000305};Malate synthase;, PF03328;, GO:0005739;GO:0047777;GO:0016787;GO:0000287;GO:0004474;GO:0106121;GO:0070207;GO:0106064;, C:mitochondrion;, F:(S)-citramalyl-CoA lyase activity; F:hydrolase activity; F:magnesium ion binding; F:malate synthase activity;, P:positive regulation of cobalamin metabolic process; P:protein homotrimerization; P:regulation of cobalamin metabolic process;|Q8N0X4 Q5W0F7 Q8TDH8,Citramalyl-CoA lyase, mitochondrial {ECO:0000303|PubMed:29056341},(3S)-malyl-CoA thioesterase {ECO:0000305|PubMed:29056341};Beta-methylmalate synthase;Citrate lyase subunit beta-like protein {ECO:0000305};Malate synthase;, PF03328;, GO:0005739;GO:0047777;GO:0016787;GO:0000287;GO:0004474;GO:0106121;GO:0070207;GO:0106064;, C:mitochondrion;, F:(S)-citramalyl-CoA lyase activity; F:hydrolase activity; F:magnesium ion binding; F:malate synthase activity;, P:positive regulation of cobalamin metabolic process; P:protein homotrimerization; P:regulation of cobalamin metabolic process;|Q8N0X4 Q5W0F7 Q8TDH8,Citramalyl-CoA lyase, mitochondrial {ECO:0000303|PubMed:29056341},(3S)-malyl-CoA thioesterase {ECO:0000305|PubMed:29056341};Beta-methylmalate synthase;Citrate lyase subunit beta-like protein {ECO:0000305};Malate synthase;, PF03328;, GO:0005739;GO:0047777;GO:0016787;GO:0000287;GO:0004474;GO:0106121;GO:0070207;GO:0106064;, C:mitochondrion;, F:(S)-citramalyl-CoA lyase activity; F:hydrolase activity; F:magnesium ion binding; F:malate synthase activity;, P:positive regulation of cobalamin metabolic process; P:protein homotrimerization; P:regulation of cobalamin metabolic process; scaffold1 indexed_genome mRNA 9593917 9646544 . + . ID=transcript_47;Q99805 A8K399 Q2TAY5,Transmembrane 9 superfamily member 2,p76;, PF02990;, GO:0005856;GO:0005768;GO:0010008;GO:0070062;GO:0005887;GO:0016020;GO:0150051;GO:0072657;, C:cytoskeleton; C:endosome; C:endosome membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:postsynaptic Golgi apparatus;, , P:protein localization to membrane;|Q99805 A8K399 Q2TAY5,Transmembrane 9 superfamily member 2,p76;, PF02990;, GO:0005856;GO:0005768;GO:0010008;GO:0070062;GO:0005887;GO:0016020;GO:0150051;GO:0072657;, C:cytoskeleton; C:endosome; C:endosome membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:postsynaptic Golgi apparatus;, , P:protein localization to membrane;|Q99805 A8K399 Q2TAY5,Transmembrane 9 superfamily member 2,p76;, PF02990;, GO:0005856;GO:0005768;GO:0010008;GO:0070062;GO:0005887;GO:0016020;GO:0150051;GO:0072657;, C:cytoskeleton; C:endosome; C:endosome membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:postsynaptic Golgi apparatus;, , P:protein localization to membrane;|Q99805 A8K399 Q2TAY5,Transmembrane 9 superfamily member 2,p76;, PF02990;, GO:0005856;GO:0005768;GO:0010008;GO:0070062;GO:0005887;GO:0016020;GO:0150051;GO:0072657;, C:cytoskeleton; C:endosome; C:endosome membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:postsynaptic Golgi apparatus;, , P:protein localization to membrane; scaffold1 indexed_genome mRNA 9733266 9903505 . + . ID=transcript_48;Q8NBM4 B3KNV7 Q0VAB5 Q5W0W6 Q5W0W9 Q6GQR2 Q6P4B0 Q8N2E8 Q96NW2,Ubiquitin-associated domain-containing protein 2,Phosphoglycerate dehydrogenase-like protein 1;, PF00627;, GO:0005783;GO:0005789;GO:0016021;GO:0090090;GO:1904153;GO:0070972;GO:0016055;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein localization to endoplasmic reticulum; P:Wnt signaling pathway;|Q8NBM4 B3KNV7 Q0VAB5 Q5W0W6 Q5W0W9 Q6GQR2 Q6P4B0 Q8N2E8 Q96NW2,Ubiquitin-associated domain-containing protein 2,Phosphoglycerate dehydrogenase-like protein 1;, PF00627;, GO:0005783;GO:0005789;GO:0016021;GO:0090090;GO:1904153;GO:0070972;GO:0016055;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein localization to endoplasmic reticulum; P:Wnt signaling pathway;|Q8NBM4 B3KNV7 Q0VAB5 Q5W0W6 Q5W0W9 Q6GQR2 Q6P4B0 Q8N2E8 Q96NW2,Ubiquitin-associated domain-containing protein 2,Phosphoglycerate dehydrogenase-like protein 1;, PF00627;, GO:0005783;GO:0005789;GO:0016021;GO:0090090;GO:1904153;GO:0070972;GO:0016055;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein localization to endoplasmic reticulum; P:Wnt signaling pathway;|P32249 B2R8N5 Q53F99 Q5JUH7,G-protein coupled receptor 183 {ECO:0000305},Epstein-Barr virus-induced G-protein coupled receptor 2 {ECO:0000303|PubMed:8383238};, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0008142;GO:0002250;GO:0002312;GO:0002407;GO:0036145;GO:0007186;GO:0006959;GO:0006955;GO:0030595;GO:0002313;GO:0030316;GO:0030890;GO:0070374;GO:2000458;GO:0010818;GO:0061470;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:oxysterol binding;, P:adaptive immune response; P:B cell activation involved in immune response; P:dendritic cell chemotaxis; P:dendritic cell homeostasis; P:G protein-coupled receptor signaling pathway; P:humoral immune response; P:immune response; P:leukocyte chemotaxis; P:mature B cell differentiation involved in immune response; P:osteoclast differentiation; P:positive regulation of B cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:regulation of astrocyte chemotaxis; P:T cell chemotaxis; P:T follicular helper cell differentiation;|Q14330 Q6GTM3 Q96HI6 Q9H2L2,N-arachidonyl glycine receptor,G-protein coupled receptor 18;, PF00001;, GO:0030659;GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0007186;GO:0051482;GO:0035025;, C:cytoplasmic vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of Rho protein signal transduction; scaffold1 indexed_genome mRNA 9940678 9942254 . + . ID=transcript_49;Q9Y3D5,28S ribosomal protein S18c, mitochondrial,28S ribosomal protein S18-1, mitochondrial;Mitochondrial small ribosomal subunit protein bS18c {ECO:0000303|PubMed:25838379};Mitochondrial small ribosomal subunit protein bS18m {ECO:0000303|PubMed:25838379};, PF01084;, GO:0005743;GO:0005763;GO:0070181;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit;, F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold1 indexed_genome mRNA 10107621 10253981 . + . ID=transcript_50;Q9BZ27 Q9BZ28 Q9UPU4,Dedicator of cytokinesis protein 9 {ECO:0000305},Cdc42 guanine nucleotide exchange factor zizimin-1 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0012505;GO:0016020;GO:0045296;GO:0005085;GO:0007596;GO:0043547;GO:0007264;, C:cytosol; C:endomembrane system; C:membrane;, F:cadherin binding; F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q9BZ27 Q9BZ28 Q9UPU4,Dedicator of cytokinesis protein 9 {ECO:0000305},Cdc42 guanine nucleotide exchange factor zizimin-1 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0012505;GO:0016020;GO:0045296;GO:0005085;GO:0007596;GO:0043547;GO:0007264;, C:cytosol; C:endomembrane system; C:membrane;, F:cadherin binding; F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q9BZ27 Q9BZ28 Q9UPU4,Dedicator of cytokinesis protein 9 {ECO:0000305},Cdc42 guanine nucleotide exchange factor zizimin-1 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0012505;GO:0016020;GO:0045296;GO:0005085;GO:0007596;GO:0043547;GO:0007264;, C:cytosol; C:endomembrane system; C:membrane;, F:cadherin binding; F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q5JSL3 A6NMF0 Q66M66 Q6ZUJ5 Q86VU8 Q96MN3,Dedicator of cytokinesis protein 11 {ECO:0000305},Activated Cdc42-associated guanine nucleotide exchange factor;Zizimin-2 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0005085;GO:0001782;GO:0007596;GO:0002315;GO:0051491;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:B cell homeostasis; P:blood coagulation; P:marginal zone B cell differentiation; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q9BZ27 Q9BZ28 Q9UPU4,Dedicator of cytokinesis protein 9 {ECO:0000305},Cdc42 guanine nucleotide exchange factor zizimin-1 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0012505;GO:0016020;GO:0045296;GO:0005085;GO:0007596;GO:0043547;GO:0007264;, C:cytosol; C:endomembrane system; C:membrane;, F:cadherin binding; F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q9BZ27 Q9BZ28 Q9UPU4,Dedicator of cytokinesis protein 9 {ECO:0000305},Cdc42 guanine nucleotide exchange factor zizimin-1 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0012505;GO:0016020;GO:0045296;GO:0005085;GO:0007596;GO:0043547;GO:0007264;, C:cytosol; C:endomembrane system; C:membrane;, F:cadherin binding; F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q9BZ27 Q9BZ28 Q9UPU4,Dedicator of cytokinesis protein 9 {ECO:0000305},Cdc42 guanine nucleotide exchange factor zizimin-1 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0012505;GO:0016020;GO:0045296;GO:0005085;GO:0007596;GO:0043547;GO:0007264;, C:cytosol; C:endomembrane system; C:membrane;, F:cadherin binding; F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q9BZ27 Q9BZ28 Q9UPU4,Dedicator of cytokinesis protein 9 {ECO:0000305},Cdc42 guanine nucleotide exchange factor zizimin-1 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0012505;GO:0016020;GO:0045296;GO:0005085;GO:0007596;GO:0043547;GO:0007264;, C:cytosol; C:endomembrane system; C:membrane;, F:cadherin binding; F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q9BZ27 Q9BZ28 Q9UPU4,Dedicator of cytokinesis protein 9 {ECO:0000305},Cdc42 guanine nucleotide exchange factor zizimin-1 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0012505;GO:0016020;GO:0045296;GO:0005085;GO:0007596;GO:0043547;GO:0007264;, C:cytosol; C:endomembrane system; C:membrane;, F:cadherin binding; F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction; scaffold1 indexed_genome mRNA 10292240 10341104 . + . ID=transcript_51;P46059 Q5VW82,Solute carrier family 15 member 1 {ECO:0000305},Intestinal H(+)/peptide cotransporter {ECO:0000303|PubMed:7896779};Oligopeptide transporter, small intestine isoform {ECO:0000303|PubMed:7896779};Peptide transporter 1 {ECO:0000303|PubMed:7896779};, PF00854;, GO:0016324;GO:0005903;GO:0005887;GO:0005886;GO:0089717;GO:0071916;GO:0015333;GO:0005427;GO:0042937;GO:0140206;GO:0006811;GO:0015031;GO:0140207;, C:apical plasma membrane; C:brush border; C:integral component of plasma membrane; C:plasma membrane; C:spanning component of membrane;, F:dipeptide transmembrane transporter activity; F:peptide:proton symporter activity; F:proton-dependent oligopeptide secondary active transmembrane transporter activity; F:tripeptide transmembrane transporter activity;, P:dipeptide import across plasma membrane; P:ion transport; P:protein transport; P:tripeptide import across plasma membrane; scaffold1 indexed_genome mRNA 10487786 10513112 . + . ID=transcript_52;Q9Y6E0 O14840 Q5JV92,Serine/threonine-protein kinase 24,Mammalian STE20-like protein kinase 3;STE20-like kinase MST3;, PF00069;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0045296;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0009267;GO:0097194;GO:0008631;GO:0030336;GO:0046777;GO:0006468;GO:0048679;GO:0042542;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cadherin binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to starvation; P:execution phase of apoptosis; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:negative regulation of cell migration; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axon regeneration; P:response to hydrogen peroxide; P:signal transduction; scaffold1 indexed_genome mRNA 10514312 10567515 . - . ID=transcript_53;Q9Y4F1 Q5JVI9 Q6IQ29,FERM, ARHGEF and pleckstrin domain-containing protein 1,Chondrocyte-derived ezrin-like protein;FERM, RhoGEF and pleckstrin domain-containing protein 1;Pleckstrin homology domain-containing family C member 2;, PF08736;PF09380;PF00373;PF09379;PF00169;PF00621;, GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0031234;GO:0030175;GO:0008092;GO:0005085;GO:0048813;GO:0010923;GO:0007416;, C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:filopodium;, F:cytoskeletal protein binding; F:guanyl-nucleotide exchange factor activity;, P:dendrite morphogenesis; P:negative regulation of phosphatase activity; P:synapse assembly;|Q9Y4F1 Q5JVI9 Q6IQ29,FERM, ARHGEF and pleckstrin domain-containing protein 1,Chondrocyte-derived ezrin-like protein;FERM, RhoGEF and pleckstrin domain-containing protein 1;Pleckstrin homology domain-containing family C member 2;, PF08736;PF09380;PF00373;PF09379;PF00169;PF00621;, GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0031234;GO:0030175;GO:0008092;GO:0005085;GO:0048813;GO:0010923;GO:0007416;, C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:filopodium;, F:cytoskeletal protein binding; F:guanyl-nucleotide exchange factor activity;, P:dendrite morphogenesis; P:negative regulation of phosphatase activity; P:synapse assembly;|Q9Y4F1 Q5JVI9 Q6IQ29,FERM, ARHGEF and pleckstrin domain-containing protein 1,Chondrocyte-derived ezrin-like protein;FERM, RhoGEF and pleckstrin domain-containing protein 1;Pleckstrin homology domain-containing family C member 2;, PF08736;PF09380;PF00373;PF09379;PF00169;PF00621;, GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0031234;GO:0030175;GO:0008092;GO:0005085;GO:0048813;GO:0010923;GO:0007416;, C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:filopodium;, F:cytoskeletal protein binding; F:guanyl-nucleotide exchange factor activity;, P:dendrite morphogenesis; P:negative regulation of phosphatase activity; P:synapse assembly; scaffold1 indexed_genome mRNA 10891430 10951427 . - . ID=transcript_54;O00410 B4DZA0 O15257 Q5T578 Q86XC7,Importin-5,Importin subunit beta-3;Karyopherin beta-3;Ran-binding protein 5;, PF02985;PF18808;PF18816;PF18829;, GO:0005737;GO:0016020;GO:0005643;GO:0005730;GO:0005634;GO:0005095;GO:0061608;GO:0008139;GO:0003723;GO:0031267;GO:0071230;GO:0045736;GO:0006607;GO:0042307;GO:0006606;GO:0006610;GO:0016032;, C:cytoplasm; C:membrane; C:nuclear pore; C:nucleolus; C:nucleus;, F:GTPase inhibitor activity; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:RNA binding; F:small GTPase binding;, P:cellular response to amino acid stimulus; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:NLS-bearing protein import into nucleus; P:positive regulation of protein import into nucleus; P:protein import into nucleus; P:ribosomal protein import into nucleus; P:viral process;|O00410 B4DZA0 O15257 Q5T578 Q86XC7,Importin-5,Importin subunit beta-3;Karyopherin beta-3;Ran-binding protein 5;, PF02985;PF18808;PF18816;PF18829;, GO:0005737;GO:0016020;GO:0005643;GO:0005730;GO:0005634;GO:0005095;GO:0061608;GO:0008139;GO:0003723;GO:0031267;GO:0071230;GO:0045736;GO:0006607;GO:0042307;GO:0006606;GO:0006610;GO:0016032;, C:cytoplasm; C:membrane; C:nuclear pore; C:nucleolus; C:nucleus;, F:GTPase inhibitor activity; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:RNA binding; F:small GTPase binding;, P:cellular response to amino acid stimulus; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:NLS-bearing protein import into nucleus; P:positive regulation of protein import into nucleus; P:protein import into nucleus; P:ribosomal protein import into nucleus; P:viral process;|O00410 B4DZA0 O15257 Q5T578 Q86XC7,Importin-5,Importin subunit beta-3;Karyopherin beta-3;Ran-binding protein 5;, PF02985;PF18808;PF18816;PF18829;, GO:0005737;GO:0016020;GO:0005643;GO:0005730;GO:0005634;GO:0005095;GO:0061608;GO:0008139;GO:0003723;GO:0031267;GO:0071230;GO:0045736;GO:0006607;GO:0042307;GO:0006606;GO:0006610;GO:0016032;, C:cytoplasm; C:membrane; C:nuclear pore; C:nucleolus; C:nucleus;, F:GTPase inhibitor activity; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:RNA binding; F:small GTPase binding;, P:cellular response to amino acid stimulus; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:NLS-bearing protein import into nucleus; P:positive regulation of protein import into nucleus; P:protein import into nucleus; P:ribosomal protein import into nucleus; P:viral process;|O00410 B4DZA0 O15257 Q5T578 Q86XC7,Importin-5,Importin subunit beta-3;Karyopherin beta-3;Ran-binding protein 5;, PF02985;PF18808;PF18816;PF18829;, GO:0005737;GO:0016020;GO:0005643;GO:0005730;GO:0005634;GO:0005095;GO:0061608;GO:0008139;GO:0003723;GO:0031267;GO:0071230;GO:0045736;GO:0006607;GO:0042307;GO:0006606;GO:0006610;GO:0016032;, C:cytoplasm; C:membrane; C:nuclear pore; C:nucleolus; C:nucleus;, F:GTPase inhibitor activity; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:RNA binding; F:small GTPase binding;, P:cellular response to amino acid stimulus; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:NLS-bearing protein import into nucleus; P:positive regulation of protein import into nucleus; P:protein import into nucleus; P:ribosomal protein import into nucleus; P:viral process; scaffold1 indexed_genome mRNA 11279868 11320031 . - . ID=transcript_55;P10114 B2RCJ1 Q5JSC1 Q5JSC2,Ras-related protein Rap-2a,RbBP-30;, PF00071;, GO:0005829;GO:0030496;GO:0005886;GO:0055037;GO:0055038;GO:0019003;GO:0005525;GO:0003924;GO:0000287;GO:0031532;GO:0034613;GO:0035690;GO:0045184;GO:0030033;GO:0030336;GO:0031954;GO:0001934;GO:0072659;GO:0032486;GO:0048814;GO:0046328;, C:cytosol; C:midbody; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:magnesium ion binding;, P:actin cytoskeleton reorganization; P:cellular protein localization; P:cellular response to drug; P:establishment of protein localization; P:microvillus assembly; P:negative regulation of cell migration; P:positive regulation of protein autophosphorylation; P:positive regulation of protein phosphorylation; P:protein localization to plasma membrane; P:Rap protein signal transduction; P:regulation of dendrite morphogenesis; P:regulation of JNK cascade; scaffold1 indexed_genome mRNA 11379461 11382283 . + . ID=transcript_56;Q5VZF2 Q3SXY5 Q58F19 Q8NEV3 Q8TD82,Muscleblind-like protein 2,Muscleblind-like protein 1;Muscleblind-like protein-like;Muscleblind-like protein-like 39;, PF00642;, GO:0005737;GO:0005654;GO:0046872;GO:0003723;GO:1990837;GO:0006397;GO:0000381;GO:0043484;GO:0008380;, C:cytoplasm; C:nucleoplasm;, F:metal ion binding; F:RNA binding; F:sequence-specific double-stranded DNA binding;, P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing; scaffold1 indexed_genome mRNA 11407512 11422854 . + . ID=transcript_57;Q5VZF2 Q3SXY5 Q58F19 Q8NEV3 Q8TD82,Muscleblind-like protein 2,Muscleblind-like protein 1;Muscleblind-like protein-like;Muscleblind-like protein-like 39;, PF00642;, GO:0005737;GO:0005654;GO:0046872;GO:0003723;GO:1990837;GO:0006397;GO:0000381;GO:0043484;GO:0008380;, C:cytoplasm; C:nucleoplasm;, F:metal ion binding; F:RNA binding; F:sequence-specific double-stranded DNA binding;, P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing;|Q5VZF2 Q3SXY5 Q58F19 Q8NEV3 Q8TD82,Muscleblind-like protein 2,Muscleblind-like protein 1;Muscleblind-like protein-like;Muscleblind-like protein-like 39;, PF00642;, GO:0005737;GO:0005654;GO:0046872;GO:0003723;GO:1990837;GO:0006397;GO:0000381;GO:0043484;GO:0008380;, C:cytoplasm; C:nucleoplasm;, F:metal ion binding; F:RNA binding; F:sequence-specific double-stranded DNA binding;, P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing; scaffold1 indexed_genome mRNA 12609266 12744486 . + . ID=transcript_58;Q9NYU1 A6NKL4 Q08AD0 Q5JQR8 Q8N5K0 Q9UFC4,UDP-glucose:glycoprotein glucosyltransferase 2,UDP--Glc:glycoprotein glucosyltransferase 2;UDP-glucose ceramide glucosyltransferase-like 1;, PF18404;PF18400;PF18401;PF18402;PF18403;PF06427;, GO:0005783;GO:0005788;GO:0044322;GO:0005793;GO:0032991;GO:0003980;GO:0051082;GO:1904380;GO:0071712;GO:0018279;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum-Golgi intermediate compartment; C:protein-containing complex;, F:UDP-glucose:glycoprotein glucosyltransferase activity; F:unfolded protein binding;, P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:protein N-linked glycosylation via asparagine;|Q9NYU1 A6NKL4 Q08AD0 Q5JQR8 Q8N5K0 Q9UFC4,UDP-glucose:glycoprotein glucosyltransferase 2,UDP--Glc:glycoprotein glucosyltransferase 2;UDP-glucose ceramide glucosyltransferase-like 1;, PF18404;PF18400;PF18401;PF18402;PF18403;PF06427;, GO:0005783;GO:0005788;GO:0044322;GO:0005793;GO:0032991;GO:0003980;GO:0051082;GO:1904380;GO:0071712;GO:0018279;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum-Golgi intermediate compartment; C:protein-containing complex;, F:UDP-glucose:glycoprotein glucosyltransferase activity; F:unfolded protein binding;, P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:protein N-linked glycosylation via asparagine; scaffold1 indexed_genome mRNA 12748202 12753851 . - . ID=transcript_59;Q13217 Q86WT9 Q8N4N2,DnaJ homolog subfamily C member 3,Endoplasmic reticulum DNA J domain-containing protein 6;Interferon-induced, double-stranded RNA-activated protein kinase inhibitor;Protein kinase inhibitor of 58 kDa;, PF00226;PF09976;PF13181;, GO:0035578;GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0070062;GO:0005576;GO:1903561;GO:0016020;GO:0005790;GO:0051087;GO:0051787;GO:0019901;GO:0004860;GO:0044267;GO:0070417;GO:0051607;GO:0036498;GO:0043066;GO:1903912;GO:0043312;GO:0036494;GO:0043687;GO:0034975;GO:0051603;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:membrane; C:smooth endoplasmic reticulum;, F:chaperone binding; F:misfolded protein binding; F:protein kinase binding; F:protein kinase inhibitor activity;, P:cellular protein metabolic process; P:cellular response to cold; P:defense response to virus; P:IRE1-mediated unfolded protein response; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:neutrophil degranulation; P:positive regulation of translation initiation in response to endoplasmic reticulum stress; P:post-translational protein modification; P:protein folding in endoplasmic reticulum; P:proteolysis involved in cellular protein catabolic process; scaffold1 indexed_genome mRNA 12754221 12816843 . - . ID=transcript_60;Q13217 Q86WT9 Q8N4N2,DnaJ homolog subfamily C member 3,Endoplasmic reticulum DNA J domain-containing protein 6;Interferon-induced, double-stranded RNA-activated protein kinase inhibitor;Protein kinase inhibitor of 58 kDa;, PF00226;PF09976;PF13181;, GO:0035578;GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0070062;GO:0005576;GO:1903561;GO:0016020;GO:0005790;GO:0051087;GO:0051787;GO:0019901;GO:0004860;GO:0044267;GO:0070417;GO:0051607;GO:0036498;GO:0043066;GO:1903912;GO:0043312;GO:0036494;GO:0043687;GO:0034975;GO:0051603;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:membrane; C:smooth endoplasmic reticulum;, F:chaperone binding; F:misfolded protein binding; F:protein kinase binding; F:protein kinase inhibitor activity;, P:cellular protein metabolic process; P:cellular response to cold; P:defense response to virus; P:IRE1-mediated unfolded protein response; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:neutrophil degranulation; P:positive regulation of translation initiation in response to endoplasmic reticulum stress; P:post-translational protein modification; P:protein folding in endoplasmic reticulum; P:proteolysis involved in cellular protein catabolic process; scaffold1 indexed_genome mRNA 12844956 12917449 . + . ID=transcript_61;Q86YF9 Q5W078 Q5W079 Q8WY45 Q8WY46 Q9UGA5 Q9Y2K0,Zinc finger protein DZIP1,DAZ-interacting protein 1/2;, PF13815;, GO:0034451;GO:0005814;GO:0036064;GO:0097539;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046872;GO:0060271;GO:0051220;GO:0045184;GO:0007281;GO:0007275;GO:0045724;GO:0061512;GO:0043393;GO:0007224;GO:0007283;, C:centriolar satellite; C:centriole; C:ciliary basal body; C:ciliary transition fiber; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:metal ion binding;, P:cilium assembly; P:cytoplasmic sequestering of protein; P:establishment of protein localization; P:germ cell development; P:multicellular organism development; P:positive regulation of cilium assembly; P:protein localization to cilium; P:regulation of protein binding; P:smoothened signaling pathway; P:spermatogenesis;|Q86YF9 Q5W078 Q5W079 Q8WY45 Q8WY46 Q9UGA5 Q9Y2K0,Zinc finger protein DZIP1,DAZ-interacting protein 1/2;, PF13815;, GO:0034451;GO:0005814;GO:0036064;GO:0097539;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046872;GO:0060271;GO:0051220;GO:0045184;GO:0007281;GO:0007275;GO:0045724;GO:0061512;GO:0043393;GO:0007224;GO:0007283;, C:centriolar satellite; C:centriole; C:ciliary basal body; C:ciliary transition fiber; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:metal ion binding;, P:cilium assembly; P:cytoplasmic sequestering of protein; P:establishment of protein localization; P:germ cell development; P:multicellular organism development; P:positive regulation of cilium assembly; P:protein localization to cilium; P:regulation of protein binding; P:smoothened signaling pathway; P:spermatogenesis;|Q86YF9 Q5W078 Q5W079 Q8WY45 Q8WY46 Q9UGA5 Q9Y2K0,Zinc finger protein DZIP1,DAZ-interacting protein 1/2;, PF13815;, GO:0034451;GO:0005814;GO:0036064;GO:0097539;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046872;GO:0060271;GO:0051220;GO:0045184;GO:0007281;GO:0007275;GO:0045724;GO:0061512;GO:0043393;GO:0007224;GO:0007283;, C:centriolar satellite; C:centriole; C:ciliary basal body; C:ciliary transition fiber; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:metal ion binding;, P:cilium assembly; P:cytoplasmic sequestering of protein; P:establishment of protein localization; P:germ cell development; P:multicellular organism development; P:positive regulation of cilium assembly; P:protein localization to cilium; P:regulation of protein binding; P:smoothened signaling pathway; P:spermatogenesis;|P78369 Q6IBF9 Q96N78,Claudin-10,Oligodendrocyte-specific protein-like;, PF00822;, GO:0005923;GO:0005737;GO:0016021;GO:0005886;GO:0042802;GO:0005198;GO:0070830;GO:0016338;GO:0007155;GO:0006811;GO:0043269;, C:bicellular tight junction; C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:structural molecule activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:ion transport; P:regulation of ion transport;|P78369 Q6IBF9 Q96N78,Claudin-10,Oligodendrocyte-specific protein-like;, PF00822;, GO:0005923;GO:0005737;GO:0016021;GO:0005886;GO:0042802;GO:0005198;GO:0070830;GO:0016338;GO:0007155;GO:0006811;GO:0043269;, C:bicellular tight junction; C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:structural molecule activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:ion transport; P:regulation of ion transport; scaffold1 indexed_genome mRNA 13057641 13086863 . + . ID=transcript_62;O15439 A9Z1Z7 B7Z3Q7 Q8IVZ4 Q8IZN6 Q8NEW8 Q9Y6J2,ATP-binding cassette sub-family C member 4,MRP/cMOAT-related ABC transporter;Multi-specific organic anion transporter B {ECO:0000303|PubMed:9661885};Multidrug resistance-associated protein 4;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0098591;GO:0016021;GO:0016020;GO:0005886;GO:0031088;GO:0016404;GO:0015432;GO:0015431;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0001409;GO:0015132;GO:0015216;GO:0015143;GO:0042910;GO:0015721;GO:0038183;GO:0070730;GO:0060271;GO:0140115;GO:0071716;GO:0002576;GO:0048661;GO:0032310;GO:0015732;GO:0042493;GO:0014070;GO:0010243;GO:0055085;GO:0150104;GO:0015747;, C:apical plasma membrane; C:basolateral plasma membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:platelet dense granule membrane;, F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:guanine nucleotide transmembrane transporter activity; F:prostaglandin transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cAMP transport; P:cilium assembly; P:export across plasma membrane; P:leukotriene transport; P:platelet degranulation; P:positive regulation of smooth muscle cell proliferation; P:prostaglandin secretion; P:prostaglandin transport; P:response to drug; P:response to organic cyclic compound; P:response to organonitrogen compound; P:transmembrane transport; P:transport across blood-brain barrier; P:urate transport; scaffold1 indexed_genome mRNA 13178370 13239895 . + . ID=transcript_63;O15439 A9Z1Z7 B7Z3Q7 Q8IVZ4 Q8IZN6 Q8NEW8 Q9Y6J2,ATP-binding cassette sub-family C member 4,MRP/cMOAT-related ABC transporter;Multi-specific organic anion transporter B {ECO:0000303|PubMed:9661885};Multidrug resistance-associated protein 4;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0098591;GO:0016021;GO:0016020;GO:0005886;GO:0031088;GO:0016404;GO:0015432;GO:0015431;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0001409;GO:0015132;GO:0015216;GO:0015143;GO:0042910;GO:0015721;GO:0038183;GO:0070730;GO:0060271;GO:0140115;GO:0071716;GO:0002576;GO:0048661;GO:0032310;GO:0015732;GO:0042493;GO:0014070;GO:0010243;GO:0055085;GO:0150104;GO:0015747;, C:apical plasma membrane; C:basolateral plasma membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:platelet dense granule membrane;, F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:guanine nucleotide transmembrane transporter activity; F:prostaglandin transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cAMP transport; P:cilium assembly; P:export across plasma membrane; P:leukotriene transport; P:platelet degranulation; P:positive regulation of smooth muscle cell proliferation; P:prostaglandin secretion; P:prostaglandin transport; P:response to drug; P:response to organic cyclic compound; P:response to organonitrogen compound; P:transmembrane transport; P:transport across blood-brain barrier; P:urate transport; scaffold1 indexed_genome mRNA 13651651 13652429 . - . ID=transcript_64;O15439 A9Z1Z7 B7Z3Q7 Q8IVZ4 Q8IZN6 Q8NEW8 Q9Y6J2,ATP-binding cassette sub-family C member 4,MRP/cMOAT-related ABC transporter;Multi-specific organic anion transporter B {ECO:0000303|PubMed:9661885};Multidrug resistance-associated protein 4;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0098591;GO:0016021;GO:0016020;GO:0005886;GO:0031088;GO:0016404;GO:0015432;GO:0015431;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0001409;GO:0015132;GO:0015216;GO:0015143;GO:0042910;GO:0015721;GO:0038183;GO:0070730;GO:0060271;GO:0140115;GO:0071716;GO:0002576;GO:0048661;GO:0032310;GO:0015732;GO:0042493;GO:0014070;GO:0010243;GO:0055085;GO:0150104;GO:0015747;, C:apical plasma membrane; C:basolateral plasma membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:platelet dense granule membrane;, F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:guanine nucleotide transmembrane transporter activity; F:prostaglandin transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cAMP transport; P:cilium assembly; P:export across plasma membrane; P:leukotriene transport; P:platelet degranulation; P:positive regulation of smooth muscle cell proliferation; P:prostaglandin secretion; P:prostaglandin transport; P:response to drug; P:response to organic cyclic compound; P:response to organonitrogen compound; P:transmembrane transport; P:transport across blood-brain barrier; P:urate transport; scaffold1 indexed_genome mRNA 14998386 15000302 . - . ID=transcript_65;Q13794 B2R4T7 Q8N589,Phorbol-12-myristate-13-acetate-induced protein 1,Immediate-early-response protein APR;Protein Noxa;, PF15150;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0006919;GO:0006915;GO:0006974;GO:0042149;GO:0071456;GO:0051607;GO:0097193;GO:0072332;GO:0010917;GO:0043065;GO:0043280;GO:0043517;GO:1902237;GO:1902043;GO:0010907;GO:2001244;GO:1900740;GO:0090200;GO:0010498;GO:0001844;GO:0072593;GO:0042981;GO:0046902;GO:0001836;GO:0043331;GO:0043029;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, , P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to glucose starvation; P:cellular response to hypoxia; P:defense response to virus; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of mitochondrial membrane potential; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of glucose metabolic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of release of cytochrome c from mitochondria; P:proteasomal protein catabolic process; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:reactive oxygen species metabolic process; P:regulation of apoptotic process; P:regulation of mitochondrial membrane permeability; P:release of cytochrome c from mitochondria; P:response to dsRNA; P:T cell homeostasis; scaffold1 indexed_genome mRNA 15646624 15694346 . + . ID=transcript_66;O15439 A9Z1Z7 B7Z3Q7 Q8IVZ4 Q8IZN6 Q8NEW8 Q9Y6J2,ATP-binding cassette sub-family C member 4,MRP/cMOAT-related ABC transporter;Multi-specific organic anion transporter B {ECO:0000303|PubMed:9661885};Multidrug resistance-associated protein 4;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0098591;GO:0016021;GO:0016020;GO:0005886;GO:0031088;GO:0016404;GO:0015432;GO:0015431;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0001409;GO:0015132;GO:0015216;GO:0015143;GO:0042910;GO:0015721;GO:0038183;GO:0070730;GO:0060271;GO:0140115;GO:0071716;GO:0002576;GO:0048661;GO:0032310;GO:0015732;GO:0042493;GO:0014070;GO:0010243;GO:0055085;GO:0150104;GO:0015747;, C:apical plasma membrane; C:basolateral plasma membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:platelet dense granule membrane;, F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:guanine nucleotide transmembrane transporter activity; F:prostaglandin transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cAMP transport; P:cilium assembly; P:export across plasma membrane; P:leukotriene transport; P:platelet degranulation; P:positive regulation of smooth muscle cell proliferation; P:prostaglandin secretion; P:prostaglandin transport; P:response to drug; P:response to organic cyclic compound; P:response to organonitrogen compound; P:transmembrane transport; P:transport across blood-brain barrier; P:urate transport; scaffold1 indexed_genome mRNA 15712882 15744710 . + . ID=transcript_67;O15439 A9Z1Z7 B7Z3Q7 Q8IVZ4 Q8IZN6 Q8NEW8 Q9Y6J2,ATP-binding cassette sub-family C member 4,MRP/cMOAT-related ABC transporter;Multi-specific organic anion transporter B {ECO:0000303|PubMed:9661885};Multidrug resistance-associated protein 4;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0098591;GO:0016021;GO:0016020;GO:0005886;GO:0031088;GO:0016404;GO:0015432;GO:0015431;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0001409;GO:0015132;GO:0015216;GO:0015143;GO:0042910;GO:0015721;GO:0038183;GO:0070730;GO:0060271;GO:0140115;GO:0071716;GO:0002576;GO:0048661;GO:0032310;GO:0015732;GO:0042493;GO:0014070;GO:0010243;GO:0055085;GO:0150104;GO:0015747;, C:apical plasma membrane; C:basolateral plasma membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:platelet dense granule membrane;, F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:guanine nucleotide transmembrane transporter activity; F:prostaglandin transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cAMP transport; P:cilium assembly; P:export across plasma membrane; P:leukotriene transport; P:platelet degranulation; P:positive regulation of smooth muscle cell proliferation; P:prostaglandin secretion; P:prostaglandin transport; P:response to drug; P:response to organic cyclic compound; P:response to organonitrogen compound; P:transmembrane transport; P:transport across blood-brain barrier; P:urate transport; scaffold1 indexed_genome mRNA 15744732 15801121 . + . ID=transcript_68;O15439 A9Z1Z7 B7Z3Q7 Q8IVZ4 Q8IZN6 Q8NEW8 Q9Y6J2,ATP-binding cassette sub-family C member 4,MRP/cMOAT-related ABC transporter;Multi-specific organic anion transporter B {ECO:0000303|PubMed:9661885};Multidrug resistance-associated protein 4;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0098591;GO:0016021;GO:0016020;GO:0005886;GO:0031088;GO:0016404;GO:0015432;GO:0015431;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0001409;GO:0015132;GO:0015216;GO:0015143;GO:0042910;GO:0015721;GO:0038183;GO:0070730;GO:0060271;GO:0140115;GO:0071716;GO:0002576;GO:0048661;GO:0032310;GO:0015732;GO:0042493;GO:0014070;GO:0010243;GO:0055085;GO:0150104;GO:0015747;, C:apical plasma membrane; C:basolateral plasma membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:platelet dense granule membrane;, F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:guanine nucleotide transmembrane transporter activity; F:prostaglandin transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cAMP transport; P:cilium assembly; P:export across plasma membrane; P:leukotriene transport; P:platelet degranulation; P:positive regulation of smooth muscle cell proliferation; P:prostaglandin secretion; P:prostaglandin transport; P:response to drug; P:response to organic cyclic compound; P:response to organonitrogen compound; P:transmembrane transport; P:transport across blood-brain barrier; P:urate transport; scaffold1 indexed_genome mRNA 15803343 15836400 . + . ID=transcript_69;O15439 A9Z1Z7 B7Z3Q7 Q8IVZ4 Q8IZN6 Q8NEW8 Q9Y6J2,ATP-binding cassette sub-family C member 4,MRP/cMOAT-related ABC transporter;Multi-specific organic anion transporter B {ECO:0000303|PubMed:9661885};Multidrug resistance-associated protein 4;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0098591;GO:0016021;GO:0016020;GO:0005886;GO:0031088;GO:0016404;GO:0015432;GO:0015431;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0001409;GO:0015132;GO:0015216;GO:0015143;GO:0042910;GO:0015721;GO:0038183;GO:0070730;GO:0060271;GO:0140115;GO:0071716;GO:0002576;GO:0048661;GO:0032310;GO:0015732;GO:0042493;GO:0014070;GO:0010243;GO:0055085;GO:0150104;GO:0015747;, C:apical plasma membrane; C:basolateral plasma membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:platelet dense granule membrane;, F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:guanine nucleotide transmembrane transporter activity; F:prostaglandin transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cAMP transport; P:cilium assembly; P:export across plasma membrane; P:leukotriene transport; P:platelet degranulation; P:positive regulation of smooth muscle cell proliferation; P:prostaglandin secretion; P:prostaglandin transport; P:response to drug; P:response to organic cyclic compound; P:response to organonitrogen compound; P:transmembrane transport; P:transport across blood-brain barrier; P:urate transport;|O15439 A9Z1Z7 B7Z3Q7 Q8IVZ4 Q8IZN6 Q8NEW8 Q9Y6J2,ATP-binding cassette sub-family C member 4,MRP/cMOAT-related ABC transporter;Multi-specific organic anion transporter B {ECO:0000303|PubMed:9661885};Multidrug resistance-associated protein 4;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0098591;GO:0016021;GO:0016020;GO:0005886;GO:0031088;GO:0016404;GO:0015432;GO:0015431;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0001409;GO:0015132;GO:0015216;GO:0015143;GO:0042910;GO:0015721;GO:0038183;GO:0070730;GO:0060271;GO:0140115;GO:0071716;GO:0002576;GO:0048661;GO:0032310;GO:0015732;GO:0042493;GO:0014070;GO:0010243;GO:0055085;GO:0150104;GO:0015747;, C:apical plasma membrane; C:basolateral plasma membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:platelet dense granule membrane;, F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:guanine nucleotide transmembrane transporter activity; F:prostaglandin transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cAMP transport; P:cilium assembly; P:export across plasma membrane; P:leukotriene transport; P:platelet degranulation; P:positive regulation of smooth muscle cell proliferation; P:prostaglandin secretion; P:prostaglandin transport; P:response to drug; P:response to organic cyclic compound; P:response to organonitrogen compound; P:transmembrane transport; P:transport across blood-brain barrier; P:urate transport; scaffold1 indexed_genome mRNA 16184428 16189980 . - . ID=transcript_70;Q86V85 A8K1D5,Integral membrane protein GPR180,Intimal thickness-related receptor;, PF10192;, GO:0016021;GO:0007186;GO:0019236;, C:integral component of membrane;, , P:G protein-coupled receptor signaling pathway; P:response to pheromone;|Q86V85 A8K1D5,Integral membrane protein GPR180,Intimal thickness-related receptor;, PF10192;, GO:0016021;GO:0007186;GO:0019236;, C:integral component of membrane;, , P:G protein-coupled receptor signaling pathway; P:response to pheromone;|Q86V85 A8K1D5,Integral membrane protein GPR180,Intimal thickness-related receptor;, PF10192;, GO:0016021;GO:0007186;GO:0019236;, C:integral component of membrane;, , P:G protein-coupled receptor signaling pathway; P:response to pheromone; scaffold1 indexed_genome mRNA 16193574 16211285 . - . ID=transcript_71;Q86V85 A8K1D5,Integral membrane protein GPR180,Intimal thickness-related receptor;, PF10192;, GO:0016021;GO:0007186;GO:0019236;, C:integral component of membrane;, , P:G protein-coupled receptor signaling pathway; P:response to pheromone;|Q86V85 A8K1D5,Integral membrane protein GPR180,Intimal thickness-related receptor;, PF10192;, GO:0016021;GO:0007186;GO:0019236;, C:integral component of membrane;, , P:G protein-coupled receptor signaling pathway; P:response to pheromone;|Q86V85 A8K1D5,Integral membrane protein GPR180,Intimal thickness-related receptor;, PF10192;, GO:0016021;GO:0007186;GO:0019236;, C:integral component of membrane;, , P:G protein-coupled receptor signaling pathway; P:response to pheromone; scaffold1 indexed_genome mRNA 16225116 16227980 . - . ID=transcript_72;O95455 Q05DQ3 Q2TU31 Q5T3Z2 Q9H1T9,dTDP-D-glucose 4,6-dehydratase,, PF16363;, GO:0008460;GO:0009225;, , F:dTDP-glucose 4,6-dehydratase activity;, P:nucleotide-sugar metabolic process;|O95455 Q05DQ3 Q2TU31 Q5T3Z2 Q9H1T9,dTDP-D-glucose 4,6-dehydratase,, PF16363;, GO:0008460;GO:0009225;, , F:dTDP-glucose 4,6-dehydratase activity;, P:nucleotide-sugar metabolic process; scaffold1 indexed_genome mRNA 16228496 16230419 . - . ID=transcript_73;O95455 Q05DQ3 Q2TU31 Q5T3Z2 Q9H1T9,dTDP-D-glucose 4,6-dehydratase,, PF16363;, GO:0008460;GO:0009225;, , F:dTDP-glucose 4,6-dehydratase activity;, P:nucleotide-sugar metabolic process; scaffold1 indexed_genome mRNA 16232430 16233684 . - . ID=transcript_74;O95455 Q05DQ3 Q2TU31 Q5T3Z2 Q9H1T9,dTDP-D-glucose 4,6-dehydratase,, PF16363;, GO:0008460;GO:0009225;, , F:dTDP-glucose 4,6-dehydratase activity;, P:nucleotide-sugar metabolic process; scaffold1 indexed_genome mRNA 22576006 22582588 . - . ID=transcript_75;O94991 B3KNB8 B4DSH5 Q5VT81,SLIT and NTRK-like protein 5,Leucine-rich repeat-containing protein 11;, PF13855;, GO:0016021;GO:0005886;GO:0043235;GO:0045202;GO:0030534;GO:0007409;GO:0007268;GO:0072359;GO:0048813;GO:0007625;GO:0051965;GO:1905606;GO:0009410;GO:0043588;GO:0021756;, C:integral component of membrane; C:plasma membrane; C:receptor complex; C:synapse;, , P:adult behavior; P:axonogenesis; P:chemical synaptic transmission; P:circulatory system development; P:dendrite morphogenesis; P:grooming behavior; P:positive regulation of synapse assembly; P:regulation of presynapse assembly; P:response to xenobiotic stimulus; P:skin development; P:striatum development; scaffold1 indexed_genome mRNA 23983585 23989906 . + . ID=transcript_76;Q9H5Y7 A8K9S8 Q495Q0 Q6AW93 Q9HAA8 Q9NT60,SLIT and NTRK-like protein 6,, PF13855;, GO:0009986;GO:0005887;GO:0005886;GO:0008344;GO:0031223;GO:0002093;GO:0007409;GO:0090102;GO:0060384;GO:0002088;GO:0060007;GO:0035264;GO:0051965;GO:1905606;GO:0007605;GO:0001964;GO:0007416;GO:0021562;GO:0007601;, C:cell surface; C:integral component of plasma membrane; C:plasma membrane;, , P:adult locomotory behavior; P:auditory behavior; P:auditory receptor cell morphogenesis; P:axonogenesis; P:cochlea development; P:innervation; P:lens development in camera-type eye; P:linear vestibuloocular reflex; P:multicellular organism growth; P:positive regulation of synapse assembly; P:regulation of presynapse assembly; P:sensory perception of sound; P:startle response; P:synapse assembly; P:vestibulocochlear nerve development; P:visual perception; scaffold1 indexed_genome mRNA 25716764 25721782 . + . ID=transcript_77;Q96PX8 Q5U5I6 Q96SF9,SLIT and NTRK-like protein 1,Leucine-rich repeat-containing protein 12;, PF13855;, GO:0005576;GO:0098982;GO:0098978;GO:0099061;GO:0005886;GO:0045202;GO:0030534;GO:0007409;GO:0042592;GO:0035264;GO:0050772;GO:0051965;GO:1905606;GO:0007416;GO:0099560;, C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:plasma membrane; C:synapse;, , P:adult behavior; P:axonogenesis; P:homeostatic process; P:multicellular organism growth; P:positive regulation of axonogenesis; P:positive regulation of synapse assembly; P:regulation of presynapse assembly; P:synapse assembly; P:synaptic membrane adhesion; scaffold1 indexed_genome mRNA 28847576 28851266 . - . ID=transcript_78;O43597 B2R9J9 Q5T6Z7,Protein sprouty homolog 2,, PF05210;, GO:0015629;GO:0005856;GO:0005829;GO:0016020;GO:0015630;GO:1990752;GO:0005634;GO:0005886;GO:0032587;GO:0019901;GO:0043539;GO:0030291;GO:0048513;GO:0060449;GO:0045165;GO:1990830;GO:0035924;GO:0000132;GO:0042472;GO:0060437;GO:0016525;GO:0043066;GO:0008285;GO:0031345;GO:0042059;GO:0010719;GO:0070373;GO:0040037;GO:0034260;GO:1902747;GO:0043407;GO:0051387;GO:0010801;GO:0031397;GO:0046580;GO:0030512;GO:1900747;GO:0030335;GO:0070374;GO:0010628;GO:0033138;GO:0051897;GO:0007605;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:membrane; C:microtubule cytoskeleton; C:microtubule end; C:nucleus; C:plasma membrane; C:ruffle membrane;, F:protein kinase binding; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase inhibitor activity;, P:animal organ development; P:bud elongation involved in lung branching; P:cell fate commitment; P:cellular response to leukemia inhibitory factor; P:cellular response to vascular endothelial growth factor stimulus; P:establishment of mitotic spindle orientation; P:inner ear morphogenesis; P:lung growth; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cell projection organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of GTPase activity; P:negative regulation of lens fiber cell differentiation; P:negative regulation of MAP kinase activity; P:negative regulation of neurotrophin TRK receptor signaling pathway; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein ubiquitination; P:negative regulation of Ras protein signal transduction; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:sensory perception of sound; scaffold1 indexed_genome mRNA 29498285 29505909 . + . ID=transcript_79;Q9NV92 Q7Z2H3 Q7Z428 Q8TAR3 Q9ULQ5,NEDD4 family-interacting protein 2,NEDD4 WW domain-binding protein 5A;Putative MAPK-activating protein PM04/PM05/PM06/PM07;Putative NF-kappa-B-activating protein 413;, , GO:0005737;GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005739;GO:0032585;GO:0048471;GO:0050699;GO:0030001;GO:0010629;GO:0051224;GO:0032410;GO:0043123;GO:0031398;GO:0006511;GO:0007034;, C:cytoplasm; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrion; C:multivesicular body membrane; C:perinuclear region of cytoplasm;, F:WW domain binding;, P:metal ion transport; P:negative regulation of gene expression; P:negative regulation of protein transport; P:negative regulation of transporter activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein ubiquitination; P:ubiquitin-dependent protein catabolic process; P:vacuolar transport; scaffold1 indexed_genome mRNA 29505944 29516697 . - . ID=transcript_80;Q9NV92 Q7Z2H3 Q7Z428 Q8TAR3 Q9ULQ5,NEDD4 family-interacting protein 2,NEDD4 WW domain-binding protein 5A;Putative MAPK-activating protein PM04/PM05/PM06/PM07;Putative NF-kappa-B-activating protein 413;, , GO:0005737;GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005739;GO:0032585;GO:0048471;GO:0050699;GO:0030001;GO:0010629;GO:0051224;GO:0032410;GO:0043123;GO:0031398;GO:0006511;GO:0007034;, C:cytoplasm; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrion; C:multivesicular body membrane; C:perinuclear region of cytoplasm;, F:WW domain binding;, P:metal ion transport; P:negative regulation of gene expression; P:negative regulation of protein transport; P:negative regulation of transporter activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein ubiquitination; P:ubiquitin-dependent protein catabolic process; P:vacuolar transport; scaffold1 indexed_genome mRNA 29633064 29719706 . + . ID=transcript_81;Q8N3H5 Q96K92 Q96SZ3 Q9H2F8 Q9H7F9 Q9P1G7,RNA-binding protein 26,CTCL tumor antigen se70-2;RNA-binding motif protein 26;, PF01480;, GO:0005634;GO:0046872;GO:0003723;GO:0006397;GO:0010923;, C:nucleus;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:negative regulation of phosphatase activity;|Q8N3H5 Q96K92 Q96SZ3 Q9H2F8 Q9H7F9 Q9P1G7,RNA-binding protein 26,CTCL tumor antigen se70-2;RNA-binding motif protein 26;, PF01480;, GO:0005634;GO:0046872;GO:0003723;GO:0006397;GO:0010923;, C:nucleus;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:negative regulation of phosphatase activity;|Q8N3H5 Q96K92 Q96SZ3 Q9H2F8 Q9H7F9 Q9P1G7,RNA-binding protein 26,CTCL tumor antigen se70-2;RNA-binding motif protein 26;, PF01480;, GO:0005634;GO:0046872;GO:0003723;GO:0006397;GO:0010923;, C:nucleus;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:negative regulation of phosphatase activity;|Q8N3H5 Q96K92 Q96SZ3 Q9H2F8 Q9H7F9 Q9P1G7,RNA-binding protein 26,CTCL tumor antigen se70-2;RNA-binding motif protein 26;, PF01480;, GO:0005634;GO:0046872;GO:0003723;GO:0006397;GO:0010923;, C:nucleus;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:negative regulation of phosphatase activity;|Q8N3H5 Q96K92 Q96SZ3 Q9H2F8 Q9H7F9 Q9P1G7,RNA-binding protein 26,CTCL tumor antigen se70-2;RNA-binding motif protein 26;, PF01480;, GO:0005634;GO:0046872;GO:0003723;GO:0006397;GO:0010923;, C:nucleus;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:negative regulation of phosphatase activity; scaffold1 indexed_genome mRNA 30346928 30379221 . + . ID=transcript_82;Q5W0B1 B2RN99 Q8TBY2 Q9H0T2 Q9H8M0,ORC ubiquitin ligase 1 {ECO:0000305},RING finger protein 219;, , GO:0000785;GO:0003682;GO:0046872;GO:0004842;GO:0051865;GO:0006513;GO:0006275;, C:chromatin;, F:chromatin binding; F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein autoubiquitination; P:protein monoubiquitination; P:regulation of DNA replication; scaffold1 indexed_genome mRNA 31039416 31068242 . + . ID=transcript_83;Q8NHM9 Q9UD23 Q9UQK3,Endothelin receptor type B {ECO:0000305},Endothelin receptor non-selective type;, PF00001;, GO:0005887;GO:0045121;GO:0031965;GO:0005886;GO:0004962;GO:0017046;GO:0031702;GO:0007568;GO:0019722;GO:0007166;GO:0071222;GO:0019934;GO:0086100;GO:0048484;GO:0035645;GO:0042045;GO:0007186;GO:0048246;GO:0030318;GO:0007194;GO:0043066;GO:0032269;GO:0014043;GO:0000122;GO:0007399;GO:0001755;GO:0007422;GO:0007200;GO:0008284;GO:0007204;GO:0060406;GO:0001934;GO:0035815;GO:0035810;GO:0007497;GO:0008217;GO:0050678;GO:0031620;GO:0006885;GO:0051930;GO:1990839;GO:0014070;GO:0048265;GO:0019233;GO:0042310;GO:0042311;GO:0014826;, C:integral component of plasma membrane; C:membrane raft; C:nuclear membrane; C:plasma membrane;, F:endothelin receptor activity; F:peptide hormone binding; F:type 1 angiotensin receptor binding;, P:aging; P:calcium-mediated signaling; P:cell surface receptor signaling pathway; P:cellular response to lipopolysaccharide; P:cGMP-mediated signaling; P:endothelin receptor signaling pathway; P:enteric nervous system development; P:enteric smooth muscle cell differentiation; P:epithelial fluid transport; P:G protein-coupled receptor signaling pathway; P:macrophage chemotaxis; P:melanocyte differentiation; P:negative regulation of adenylate cyclase activity; P:negative regulation of apoptotic process; P:negative regulation of cellular protein metabolic process; P:negative regulation of neuron maturation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neural crest cell migration; P:peripheral nervous system development; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of penile erection; P:positive regulation of protein phosphorylation; P:positive regulation of renal sodium excretion; P:positive regulation of urine volume; P:posterior midgut development; P:regulation of blood pressure; P:regulation of epithelial cell proliferation; P:regulation of fever generation; P:regulation of pH; P:regulation of sensory perception of pain; P:response to endothelin; P:response to organic cyclic compound; P:response to pain; P:sensory perception of pain; P:vasoconstriction; P:vasodilation; P:vein smooth muscle contraction;|Q8NHM9 Q9UD23 Q9UQK3,Endothelin receptor type B {ECO:0000305},Endothelin receptor non-selective type;, PF00001;, GO:0005887;GO:0045121;GO:0031965;GO:0005886;GO:0004962;GO:0017046;GO:0031702;GO:0007568;GO:0019722;GO:0007166;GO:0071222;GO:0019934;GO:0086100;GO:0048484;GO:0035645;GO:0042045;GO:0007186;GO:0048246;GO:0030318;GO:0007194;GO:0043066;GO:0032269;GO:0014043;GO:0000122;GO:0007399;GO:0001755;GO:0007422;GO:0007200;GO:0008284;GO:0007204;GO:0060406;GO:0001934;GO:0035815;GO:0035810;GO:0007497;GO:0008217;GO:0050678;GO:0031620;GO:0006885;GO:0051930;GO:1990839;GO:0014070;GO:0048265;GO:0019233;GO:0042310;GO:0042311;GO:0014826;, C:integral component of plasma membrane; C:membrane raft; C:nuclear membrane; C:plasma membrane;, F:endothelin receptor activity; F:peptide hormone binding; F:type 1 angiotensin receptor binding;, P:aging; P:calcium-mediated signaling; P:cell surface receptor signaling pathway; P:cellular response to lipopolysaccharide; P:cGMP-mediated signaling; P:endothelin receptor signaling pathway; P:enteric nervous system development; P:enteric smooth muscle cell differentiation; P:epithelial fluid transport; P:G protein-coupled receptor signaling pathway; P:macrophage chemotaxis; P:melanocyte differentiation; P:negative regulation of adenylate cyclase activity; P:negative regulation of apoptotic process; P:negative regulation of cellular protein metabolic process; P:negative regulation of neuron maturation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neural crest cell migration; P:peripheral nervous system development; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of penile erection; P:positive regulation of protein phosphorylation; P:positive regulation of renal sodium excretion; P:positive regulation of urine volume; P:posterior midgut development; P:regulation of blood pressure; P:regulation of epithelial cell proliferation; P:regulation of fever generation; P:regulation of pH; P:regulation of sensory perception of pain; P:response to endothelin; P:response to organic cyclic compound; P:response to pain; P:sensory perception of pain; P:vasoconstriction; P:vasodilation; P:vein smooth muscle contraction;|Q8NHM9 Q9UD23 Q9UQK3,Endothelin receptor type B {ECO:0000305},Endothelin receptor non-selective type;, PF00001;, GO:0005887;GO:0045121;GO:0031965;GO:0005886;GO:0004962;GO:0017046;GO:0031702;GO:0007568;GO:0019722;GO:0007166;GO:0071222;GO:0019934;GO:0086100;GO:0048484;GO:0035645;GO:0042045;GO:0007186;GO:0048246;GO:0030318;GO:0007194;GO:0043066;GO:0032269;GO:0014043;GO:0000122;GO:0007399;GO:0001755;GO:0007422;GO:0007200;GO:0008284;GO:0007204;GO:0060406;GO:0001934;GO:0035815;GO:0035810;GO:0007497;GO:0008217;GO:0050678;GO:0031620;GO:0006885;GO:0051930;GO:1990839;GO:0014070;GO:0048265;GO:0019233;GO:0042310;GO:0042311;GO:0014826;, C:integral component of plasma membrane; C:membrane raft; C:nuclear membrane; C:plasma membrane;, F:endothelin receptor activity; F:peptide hormone binding; F:type 1 angiotensin receptor binding;, P:aging; P:calcium-mediated signaling; P:cell surface receptor signaling pathway; P:cellular response to lipopolysaccharide; P:cGMP-mediated signaling; P:endothelin receptor signaling pathway; P:enteric nervous system development; P:enteric smooth muscle cell differentiation; P:epithelial fluid transport; P:G protein-coupled receptor signaling pathway; P:macrophage chemotaxis; P:melanocyte differentiation; P:negative regulation of adenylate cyclase activity; P:negative regulation of apoptotic process; P:negative regulation of cellular protein metabolic process; P:negative regulation of neuron maturation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neural crest cell migration; P:peripheral nervous system development; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of penile erection; P:positive regulation of protein phosphorylation; P:positive regulation of renal sodium excretion; P:positive regulation of urine volume; P:posterior midgut development; P:regulation of blood pressure; P:regulation of epithelial cell proliferation; P:regulation of fever generation; P:regulation of pH; P:regulation of sensory perception of pain; P:response to endothelin; P:response to organic cyclic compound; P:response to pain; P:sensory perception of pain; P:vasoconstriction; P:vasodilation; P:vein smooth muscle contraction; scaffold1 indexed_genome mRNA 31283496 31387150 . - . ID=transcript_84;O95171 B7Z797 F5H651 Q53H61 Q5W0S8 Q5W0S9 Q86X00,Sciellin,, , GO:0001533;GO:0005737;GO:0070062;GO:0048471;GO:0046872;GO:0009792;GO:0008544;GO:0030216;GO:0090263;GO:0009612;, C:cornified envelope; C:cytoplasm; C:extracellular exosome; C:perinuclear region of cytoplasm;, F:metal ion binding;, P:embryo development ending in birth or egg hatching; P:epidermis development; P:keratinocyte differentiation; P:positive regulation of canonical Wnt signaling pathway; P:response to mechanical stimulus; scaffold1 indexed_genome mRNA 31628145 31710556 . + . ID=transcript_85;O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization;|O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization;|O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization;|O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization; scaffold1 indexed_genome mRNA 31715184 31889091 . + . ID=transcript_86;O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization;|O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization;|O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization;|O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization;|O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization;|O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization;|O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization;|O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization; scaffold1 indexed_genome mRNA 31890165 31892525 . - . ID=transcript_87;O75592 A6NJC6 Q5JSX8 Q5VZN6 Q6PIB6 Q9UQ11 Q9Y6E4,E3 ubiquitin-protein ligase MYCBP2 {ECO:0000305},Myc-binding protein 2 {ECO:0000305};Protein associated with Myc {ECO:0000303|PubMed:9689053};, PF03256;PF08005;PF00415;PF08239;PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005634;GO:0005085;GO:0042802;GO:0031267;GO:0061630;GO:0008270;GO:0021785;GO:0021952;GO:0032922;GO:0042177;GO:0050905;GO:0031398;GO:0016567;GO:1902667;GO:0051493;GO:0032880;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:branchiomotor neuron axon guidance; P:central nervous system projection neuron axonogenesis; P:circadian regulation of gene expression; P:negative regulation of protein catabolic process; P:neuromuscular process; P:positive regulation of protein ubiquitination; P:protein ubiquitination; P:regulation of axon guidance; P:regulation of cytoskeleton organization; P:regulation of protein localization; scaffold1 indexed_genome mRNA 31903080 31922491 . + . ID=transcript_88;Q9UKT7 B2RB04 Q9P122,F-box/LRR-repeat protein 3,F-box and leucine-rich repeat protein 3A;F-box/LRR-repeat protein 3A;, PF12937;, GO:0005829;GO:0016604;GO:0005634;GO:0019005;GO:0000151;GO:0004842;GO:0043153;GO:0000086;GO:0043687;GO:0031648;GO:0000209;GO:0016567;GO:0051726;GO:0042752;GO:0048511;GO:0031146;, C:cytosol; C:nuclear body; C:nucleus; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:post-translational protein modification; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell cycle; P:regulation of circadian rhythm; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9UKT7 B2RB04 Q9P122,F-box/LRR-repeat protein 3,F-box and leucine-rich repeat protein 3A;F-box/LRR-repeat protein 3A;, PF12937;, GO:0005829;GO:0016604;GO:0005634;GO:0019005;GO:0000151;GO:0004842;GO:0043153;GO:0000086;GO:0043687;GO:0031648;GO:0000209;GO:0016567;GO:0051726;GO:0042752;GO:0048511;GO:0031146;, C:cytosol; C:nuclear body; C:nucleus; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:post-translational protein modification; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell cycle; P:regulation of circadian rhythm; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9UKT7 B2RB04 Q9P122,F-box/LRR-repeat protein 3,F-box and leucine-rich repeat protein 3A;F-box/LRR-repeat protein 3A;, PF12937;, GO:0005829;GO:0016604;GO:0005634;GO:0019005;GO:0000151;GO:0004842;GO:0043153;GO:0000086;GO:0043687;GO:0031648;GO:0000209;GO:0016567;GO:0051726;GO:0042752;GO:0048511;GO:0031146;, C:cytosol; C:nuclear body; C:nucleus; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:post-translational protein modification; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell cycle; P:regulation of circadian rhythm; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold1 indexed_genome mRNA 31923324 31930376 . - . ID=transcript_89;O75503 B3KQK7,Ceroid-lipofuscinosis neuronal protein 5,, PF15014;, GO:0005829;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0005765;GO:0005764;GO:0048471;GO:0016798;GO:0005537;GO:0007420;GO:0070085;GO:0007042;GO:0007040;GO:0022008;GO:0042551;GO:1904426;GO:0030163;GO:0042147;GO:0006465;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, F:hydrolase activity, acting on glycosyl bonds; F:mannose binding;, P:brain development; P:glycosylation; P:lysosomal lumen acidification; P:lysosome organization; P:neurogenesis; P:neuron maturation; P:positive regulation of GTP binding; P:protein catabolic process; P:retrograde transport, endosome to Golgi; P:signal peptide processing; scaffold1 indexed_genome mRNA 33070368 33285264 . - . ID=transcript_90;Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;|Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7,LIM domain only protein 7,F-box only protein 20;LOMP;, PF00307;PF15949;PF00412;PF00595;, GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling; scaffold1 indexed_genome mRNA 33314901 33365068 . - . ID=transcript_91;P15374 B2R970 Q5TBK8 Q6IBE9,Ubiquitin carboxyl-terminal hydrolase isozyme L3,Ubiquitin thioesterase L3;, PF01088;, GO:0005737;GO:0005829;GO:0005654;GO:0008234;GO:0008233;GO:0004843;GO:0043130;GO:0043687;GO:0030163;GO:0016579;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cysteine-type peptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding;, P:post-translational protein modification; P:protein catabolic process; P:protein deubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P15374 B2R970 Q5TBK8 Q6IBE9,Ubiquitin carboxyl-terminal hydrolase isozyme L3,Ubiquitin thioesterase L3;, PF01088;, GO:0005737;GO:0005829;GO:0005654;GO:0008234;GO:0008233;GO:0004843;GO:0043130;GO:0043687;GO:0030163;GO:0016579;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cysteine-type peptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding;, P:post-translational protein modification; P:protein catabolic process; P:protein deubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P15374 B2R970 Q5TBK8 Q6IBE9,Ubiquitin carboxyl-terminal hydrolase isozyme L3,Ubiquitin thioesterase L3;, PF01088;, GO:0005737;GO:0005829;GO:0005654;GO:0008234;GO:0008233;GO:0004843;GO:0043130;GO:0043687;GO:0030163;GO:0016579;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cysteine-type peptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding;, P:post-translational protein modification; P:protein catabolic process; P:protein deubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P15374 B2R970 Q5TBK8 Q6IBE9,Ubiquitin carboxyl-terminal hydrolase isozyme L3,Ubiquitin thioesterase L3;, PF01088;, GO:0005737;GO:0005829;GO:0005654;GO:0008234;GO:0008233;GO:0004843;GO:0043130;GO:0043687;GO:0030163;GO:0016579;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cysteine-type peptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding;, P:post-translational protein modification; P:protein catabolic process; P:protein deubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold1 indexed_genome mRNA 33370039 33391995 . + . ID=transcript_92;Q7Z4G1 A6NF28 B7ZLN0 Q5TBK4,COMM domain-containing protein 6,, PF07258;, GO:0005737;GO:0005634;GO:0051059;GO:0032088;, C:cytoplasm; C:nucleus;, F:NF-kappaB binding;, P:negative regulation of NF-kappaB transcription factor activity;|Q7Z4G1 A6NF28 B7ZLN0 Q5TBK4,COMM domain-containing protein 6,, PF07258;, GO:0005737;GO:0005634;GO:0051059;GO:0032088;, C:cytoplasm; C:nucleus;, F:NF-kappaB binding;, P:negative regulation of NF-kappaB transcription factor activity;|Q7Z4G1 A6NF28 B7ZLN0 Q5TBK4,COMM domain-containing protein 6,, PF07258;, GO:0005737;GO:0005634;GO:0051059;GO:0032088;, C:cytoplasm; C:nucleus;, F:NF-kappaB binding;, P:negative regulation of NF-kappaB transcription factor activity; scaffold1 indexed_genome mRNA 33552664 33639537 . + . ID=transcript_93;O60343 A7E2X8 B4DU25 B4E235 B6ETN8 B6ETN9 Q5W0B9 Q68D14,TBC1 domain family member 4,Akt substrate of 160 kDa;, PF11830;PF00640;PF00566;, GO:0005829;GO:0031982;GO:0005096;GO:0090630;GO:0032869;GO:0006886;GO:0031339;GO:0016192;, C:cytosol; C:vesicle;, F:GTPase activator activity;, P:activation of GTPase activity; P:cellular response to insulin stimulus; P:intracellular protein transport; P:negative regulation of vesicle fusion; P:vesicle-mediated transport;|O60343 A7E2X8 B4DU25 B4E235 B6ETN8 B6ETN9 Q5W0B9 Q68D14,TBC1 domain family member 4,Akt substrate of 160 kDa;, PF11830;PF00640;PF00566;, GO:0005829;GO:0031982;GO:0005096;GO:0090630;GO:0032869;GO:0006886;GO:0031339;GO:0016192;, C:cytosol; C:vesicle;, F:GTPase activator activity;, P:activation of GTPase activity; P:cellular response to insulin stimulus; P:intracellular protein transport; P:negative regulation of vesicle fusion; P:vesicle-mediated transport;|O60343 A7E2X8 B4DU25 B4E235 B6ETN8 B6ETN9 Q5W0B9 Q68D14,TBC1 domain family member 4,Akt substrate of 160 kDa;, PF11830;PF00640;PF00566;, GO:0005829;GO:0031982;GO:0005096;GO:0090630;GO:0032869;GO:0006886;GO:0031339;GO:0016192;, C:cytosol; C:vesicle;, F:GTPase activator activity;, P:activation of GTPase activity; P:cellular response to insulin stimulus; P:intracellular protein transport; P:negative regulation of vesicle fusion; P:vesicle-mediated transport; scaffold1 indexed_genome mRNA 35184010 35347174 . + . ID=transcript_94;Q9Y4X4 A8K5T2 L0R3J4 Q5VZM7 Q9UHZ0,Krueppel-like factor 12,Transcriptional repressor AP-2rep;, PF00096;, GO:0000785;GO:0005829;GO:0005654;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0000122;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 35999685 36028363 . - . ID=transcript_95;Q13887 A2TJX0 L0R3U5 L0R4T9 Q9UHP8,Krueppel-like factor 5,Basic transcription element-binding protein 2;Colon krueppel-like factor;GC-box-binding protein 2;Intestinal-enriched krueppel-like factor;Transcription factor BTEB2;, PF00096;, GO:0000785;GO:0005794;GO:0043231;GO:0005654;GO:0005667;GO:0001228;GO:0000981;GO:0046872;GO:0043426;GO:0000978;GO:1990837;GO:0001525;GO:0099156;GO:1990830;GO:0071407;GO:1901653;GO:0060576;GO:0030033;GO:0014908;GO:0000122;GO:0008284;GO:0045600;GO:1902895;GO:0045944;GO:0061586;GO:0032534;GO:0006357;GO:0014901;GO:0014816;, C:chromatin; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:MRF binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:cell-cell signaling via exosome; P:cellular response to leukemia inhibitory factor; P:cellular response to organic cyclic compound; P:cellular response to peptide; P:intestinal epithelial cell development; P:microvillus assembly; P:myotube differentiation involved in skeletal muscle regeneration; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by transcription factor localization; P:regulation of microvillus assembly; P:regulation of transcription by RNA polymerase II; P:satellite cell activation involved in skeletal muscle regeneration; P:skeletal muscle satellite cell differentiation; scaffold1 indexed_genome mRNA 36095963 36289811 . - . ID=transcript_96;Q8WXW3 O95664 Q6U9V2 Q6UG50 Q86V07 Q96SF4,Progesterone-induced-blocking factor 1,Centrosomal protein of 90 kDa;, , GO:0034451;GO:0005813;GO:0005737;GO:0005615;GO:0005634;GO:0005136;GO:0042976;GO:0060271;GO:0002376;GO:0007080;GO:0090307;GO:0032695;GO:0032815;GO:0031393;GO:0042532;GO:1905515;GO:0032733;GO:0042531;GO:0071539;, C:centriolar satellite; C:centrosome; C:cytoplasm; C:extracellular space; C:nucleus;, F:interleukin-4 receptor binding;, P:activation of Janus kinase activity; P:cilium assembly; P:immune system process; P:mitotic metaphase plate congression; P:mitotic spindle assembly; P:negative regulation of interleukin-12 production; P:negative regulation of natural killer cell activation; P:negative regulation of prostaglandin biosynthetic process; P:negative regulation of tyrosine phosphorylation of STAT protein; P:non-motile cilium assembly; P:positive regulation of interleukin-10 production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein localization to centrosome; scaffold1 indexed_genome mRNA 36290106 36317341 . + . ID=transcript_97;Q9Y2L1 A6NI21 B2RBL2 Q5W0P7 Q5W0P8 Q658Z7 Q7Z481 Q8WWI2 Q9UG36,Exosome complex exonuclease RRP44,Protein DIS3 homolog;Ribosomal RNA-processing protein 44;, PF17849;PF13638;PF00773;PF17216;PF17215;, GO:0000177;GO:0005829;GO:0000178;GO:0016020;GO:0000176;GO:0005654;GO:0000175;GO:0004519;GO:0005085;GO:0003723;GO:0071034;GO:0043928;GO:0043488;GO:0016075;GO:0006364;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:membrane; C:nuclear exosome (RNase complex); C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:endonuclease activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing;|Q9Y2L1 A6NI21 B2RBL2 Q5W0P7 Q5W0P8 Q658Z7 Q7Z481 Q8WWI2 Q9UG36,Exosome complex exonuclease RRP44,Protein DIS3 homolog;Ribosomal RNA-processing protein 44;, PF17849;PF13638;PF00773;PF17216;PF17215;, GO:0000177;GO:0005829;GO:0000178;GO:0016020;GO:0000176;GO:0005654;GO:0000175;GO:0004519;GO:0005085;GO:0003723;GO:0071034;GO:0043928;GO:0043488;GO:0016075;GO:0006364;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:membrane; C:nuclear exosome (RNase complex); C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:endonuclease activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing;|Q9Y2L1 A6NI21 B2RBL2 Q5W0P7 Q5W0P8 Q658Z7 Q7Z481 Q8WWI2 Q9UG36,Exosome complex exonuclease RRP44,Protein DIS3 homolog;Ribosomal RNA-processing protein 44;, PF17849;PF13638;PF00773;PF17216;PF17215;, GO:0000177;GO:0005829;GO:0000178;GO:0016020;GO:0000176;GO:0005654;GO:0000175;GO:0004519;GO:0005085;GO:0003723;GO:0071034;GO:0043928;GO:0043488;GO:0016075;GO:0006364;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:membrane; C:nuclear exosome (RNase complex); C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:endonuclease activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing;|Q9Y2L1 A6NI21 B2RBL2 Q5W0P7 Q5W0P8 Q658Z7 Q7Z481 Q8WWI2 Q9UG36,Exosome complex exonuclease RRP44,Protein DIS3 homolog;Ribosomal RNA-processing protein 44;, PF17849;PF13638;PF00773;PF17216;PF17215;, GO:0000177;GO:0005829;GO:0000178;GO:0016020;GO:0000176;GO:0005654;GO:0000175;GO:0004519;GO:0005085;GO:0003723;GO:0071034;GO:0043928;GO:0043488;GO:0016075;GO:0006364;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:membrane; C:nuclear exosome (RNase complex); C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:endonuclease activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing;|Q9Y2L1 A6NI21 B2RBL2 Q5W0P7 Q5W0P8 Q658Z7 Q7Z481 Q8WWI2 Q9UG36,Exosome complex exonuclease RRP44,Protein DIS3 homolog;Ribosomal RNA-processing protein 44;, PF17849;PF13638;PF00773;PF17216;PF17215;, GO:0000177;GO:0005829;GO:0000178;GO:0016020;GO:0000176;GO:0005654;GO:0000175;GO:0004519;GO:0005085;GO:0003723;GO:0071034;GO:0043928;GO:0043488;GO:0016075;GO:0006364;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:membrane; C:nuclear exosome (RNase complex); C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:endonuclease activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing;|Q9Y2L1 A6NI21 B2RBL2 Q5W0P7 Q5W0P8 Q658Z7 Q7Z481 Q8WWI2 Q9UG36,Exosome complex exonuclease RRP44,Protein DIS3 homolog;Ribosomal RNA-processing protein 44;, PF17849;PF13638;PF00773;PF17216;PF17215;, GO:0000177;GO:0005829;GO:0000178;GO:0016020;GO:0000176;GO:0005654;GO:0000175;GO:0004519;GO:0005085;GO:0003723;GO:0071034;GO:0043928;GO:0043488;GO:0016075;GO:0006364;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:membrane; C:nuclear exosome (RNase complex); C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:endonuclease activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing;|Q9Y2L1 A6NI21 B2RBL2 Q5W0P7 Q5W0P8 Q658Z7 Q7Z481 Q8WWI2 Q9UG36,Exosome complex exonuclease RRP44,Protein DIS3 homolog;Ribosomal RNA-processing protein 44;, PF17849;PF13638;PF00773;PF17216;PF17215;, GO:0000177;GO:0005829;GO:0000178;GO:0016020;GO:0000176;GO:0005654;GO:0000175;GO:0004519;GO:0005085;GO:0003723;GO:0071034;GO:0043928;GO:0043488;GO:0016075;GO:0006364;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:membrane; C:nuclear exosome (RNase complex); C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:endonuclease activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; scaffold1 indexed_genome mRNA 36318900 36327363 . - . ID=transcript_98;Q6PGQ7 B4DQ30 Q5W0P3 Q5W0P4 Q86YC6 Q96IW9 Q9H640,Protein aurora borealis,, PF15280;, GO:0005737;GO:0005829;GO:0005634;GO:0019901;GO:0032147;GO:0051301;GO:0000086;GO:0007088;GO:0060236;GO:0032880;, C:cytoplasm; C:cytosol; C:nucleus;, F:protein kinase binding;, P:activation of protein kinase activity; P:cell division; P:G2/M transition of mitotic cell cycle; P:regulation of mitotic nuclear division; P:regulation of mitotic spindle organization; P:regulation of protein localization; scaffold1 indexed_genome mRNA 36328515 36336890 . - . ID=transcript_99;Q6PGQ7 B4DQ30 Q5W0P3 Q5W0P4 Q86YC6 Q96IW9 Q9H640,Protein aurora borealis,, PF15280;, GO:0005737;GO:0005829;GO:0005634;GO:0019901;GO:0032147;GO:0051301;GO:0000086;GO:0007088;GO:0060236;GO:0032880;, C:cytoplasm; C:cytosol; C:nucleus;, F:protein kinase binding;, P:activation of protein kinase activity; P:cell division; P:G2/M transition of mitotic cell cycle; P:regulation of mitotic nuclear division; P:regulation of mitotic spindle organization; P:regulation of protein localization; scaffold1 indexed_genome mRNA 36341441 36357835 . - . ID=transcript_100;Q6PGQ7 B4DQ30 Q5W0P3 Q5W0P4 Q86YC6 Q96IW9 Q9H640,Protein aurora borealis,, PF15280;, GO:0005737;GO:0005829;GO:0005634;GO:0019901;GO:0032147;GO:0051301;GO:0000086;GO:0007088;GO:0060236;GO:0032880;, C:cytoplasm; C:cytosol; C:nucleus;, F:protein kinase binding;, P:activation of protein kinase activity; P:cell division; P:G2/M transition of mitotic cell cycle; P:regulation of mitotic nuclear division; P:regulation of mitotic spindle organization; P:regulation of protein localization;|Q08AG7 Q5W0P5,Mitotic-spindle organizing protein 1,Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 1;, PF12554;, GO:0005813;GO:0005829;GO:0008274;GO:0031021;GO:0005819;GO:0033566;GO:0051415;GO:0090307;, C:centrosome; C:cytosol; C:gamma-tubulin ring complex; C:interphase microtubule organizing center; C:spindle;, , P:gamma-tubulin complex localization; P:microtubule nucleation by interphase microtubule organizing center; P:mitotic spindle assembly;|Q08AG7 Q5W0P5,Mitotic-spindle organizing protein 1,Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 1;, PF12554;, GO:0005813;GO:0005829;GO:0008274;GO:0031021;GO:0005819;GO:0033566;GO:0051415;GO:0090307;, C:centrosome; C:cytosol; C:gamma-tubulin ring complex; C:interphase microtubule organizing center; C:spindle;, , P:gamma-tubulin complex localization; P:microtubule nucleation by interphase microtubule organizing center; P:mitotic spindle assembly; scaffold1 indexed_genome mRNA 37224248 37677416 . + . ID=transcript_101;Q96SG4 Q9H524 Q9UMH4,Dachshund homolog 1,, PF02437;, GO:0005737;GO:0005634;GO:0005667;GO:0000981;GO:0001227;GO:0000978;GO:0000977;GO:0008283;GO:0046545;GO:0030336;GO:0060244;GO:2000279;GO:0048147;GO:0010944;GO:0000122;GO:0045892;GO:0033262;GO:0006357;GO:0007585;GO:0001967;, C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell population proliferation; P:development of primary female sexual characteristics; P:negative regulation of cell migration; P:negative regulation of cell proliferation involved in contact inhibition; P:negative regulation of DNA biosynthetic process; P:negative regulation of fibroblast proliferation; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of nuclear cell cycle DNA replication; P:regulation of transcription by RNA polymerase II; P:respiratory gaseous exchange by respiratory system; P:suckling behavior; scaffold1 indexed_genome mRNA 42561970 43633124 . + . ID=transcript_102;Q9HC56 A2A6U1 Q5VT83 Q7Z3U0 Q8N3K7,Protocadherin-9,, PF00028;PF08266;PF08374;, GO:0044291;GO:0030426;GO:0005887;GO:0005509;GO:0007155;GO:0030900;GO:0007156;, C:cell-cell contact zone; C:growth cone; C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:forebrain development; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9HC56 A2A6U1 Q5VT83 Q7Z3U0 Q8N3K7,Protocadherin-9,, PF00028;PF08266;PF08374;, GO:0044291;GO:0030426;GO:0005887;GO:0005509;GO:0007155;GO:0030900;GO:0007156;, C:cell-cell contact zone; C:growth cone; C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:forebrain development; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold1 indexed_genome mRNA 46468813 46494383 . - . ID=transcript_103;Q9HC77 Q2KHM6 Q5JPD5 Q5T6R5 Q96KS5 Q9C067,Centromere protein J,Centrosomal P4.1-associated protein;LAG-3-associated protein;LYST-interacting protein 1;, PF07202;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0008275;GO:0005874;GO:0005654;GO:0005634;GO:0005886;GO:0043015;GO:0042802;GO:0019904;GO:0019901;GO:0003713;GO:0015631;GO:0030954;GO:0051301;GO:0061511;GO:0007099;GO:0097711;GO:0060271;GO:0000086;GO:0007020;GO:0046785;GO:1903724;GO:1904951;GO:0046427;GO:0046599;GO:0010389;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:gamma-tubulin small complex; C:microtubule; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:gamma-tubulin binding; F:identical protein binding; F:protein domain specific binding; F:protein kinase binding; F:transcription coactivator activity; F:tubulin binding;, P:astral microtubule nucleation; P:cell division; P:centriole elongation; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule nucleation; P:microtubule polymerization; P:positive regulation of centriole elongation; P:positive regulation of establishment of protein localization; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of centriole replication; P:regulation of G2/M transition of mitotic cell cycle;|Q9HC77 Q2KHM6 Q5JPD5 Q5T6R5 Q96KS5 Q9C067,Centromere protein J,Centrosomal P4.1-associated protein;LAG-3-associated protein;LYST-interacting protein 1;, PF07202;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0008275;GO:0005874;GO:0005654;GO:0005634;GO:0005886;GO:0043015;GO:0042802;GO:0019904;GO:0019901;GO:0003713;GO:0015631;GO:0030954;GO:0051301;GO:0061511;GO:0007099;GO:0097711;GO:0060271;GO:0000086;GO:0007020;GO:0046785;GO:1903724;GO:1904951;GO:0046427;GO:0046599;GO:0010389;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:gamma-tubulin small complex; C:microtubule; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:gamma-tubulin binding; F:identical protein binding; F:protein domain specific binding; F:protein kinase binding; F:transcription coactivator activity; F:tubulin binding;, P:astral microtubule nucleation; P:cell division; P:centriole elongation; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule nucleation; P:microtubule polymerization; P:positive regulation of centriole elongation; P:positive regulation of establishment of protein localization; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of centriole replication; P:regulation of G2/M transition of mitotic cell cycle; scaffold1 indexed_genome mRNA 46494392 46506057 . + . ID=transcript_104;Q9HC77 Q2KHM6 Q5JPD5 Q5T6R5 Q96KS5 Q9C067,Centromere protein J,Centrosomal P4.1-associated protein;LAG-3-associated protein;LYST-interacting protein 1;, PF07202;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0008275;GO:0005874;GO:0005654;GO:0005634;GO:0005886;GO:0043015;GO:0042802;GO:0019904;GO:0019901;GO:0003713;GO:0015631;GO:0030954;GO:0051301;GO:0061511;GO:0007099;GO:0097711;GO:0060271;GO:0000086;GO:0007020;GO:0046785;GO:1903724;GO:1904951;GO:0046427;GO:0046599;GO:0010389;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:gamma-tubulin small complex; C:microtubule; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:gamma-tubulin binding; F:identical protein binding; F:protein domain specific binding; F:protein kinase binding; F:transcription coactivator activity; F:tubulin binding;, P:astral microtubule nucleation; P:cell division; P:centriole elongation; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule nucleation; P:microtubule polymerization; P:positive regulation of centriole elongation; P:positive regulation of establishment of protein localization; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of centriole replication; P:regulation of G2/M transition of mitotic cell cycle;|Q9HC77 Q2KHM6 Q5JPD5 Q5T6R5 Q96KS5 Q9C067,Centromere protein J,Centrosomal P4.1-associated protein;LAG-3-associated protein;LYST-interacting protein 1;, PF07202;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0008275;GO:0005874;GO:0005654;GO:0005634;GO:0005886;GO:0043015;GO:0042802;GO:0019904;GO:0019901;GO:0003713;GO:0015631;GO:0030954;GO:0051301;GO:0061511;GO:0007099;GO:0097711;GO:0060271;GO:0000086;GO:0007020;GO:0046785;GO:1903724;GO:1904951;GO:0046427;GO:0046599;GO:0010389;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:gamma-tubulin small complex; C:microtubule; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:gamma-tubulin binding; F:identical protein binding; F:protein domain specific binding; F:protein kinase binding; F:transcription coactivator activity; F:tubulin binding;, P:astral microtubule nucleation; P:cell division; P:centriole elongation; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule nucleation; P:microtubule polymerization; P:positive regulation of centriole elongation; P:positive regulation of establishment of protein localization; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of centriole replication; P:regulation of G2/M transition of mitotic cell cycle; scaffold1 indexed_genome mRNA 46519184 46561852 . + . ID=transcript_105;Q9UKK3 O75903 Q14682 Q5QNZ9 Q9H1M6,Protein mono-ADP-ribosyltransferase PARP4 {ECO:0000305},193 kDa vault protein {ECO:0000303|PubMed:10477748};ADP-ribosyltransferase diphtheria toxin-like 4 {ECO:0000303|PubMed:20106667};PARP-related/IalphaI-related H5/proline-rich {ECO:0000303|PubMed:10100603};Poly [ADP-ribose] polymerase 4 {ECO:0000303|PubMed:20106667};Vault poly(ADP-ribose) polymerase {ECO:0000303|PubMed:10477748};, PF00533;PF00644;PF08487;PF00092;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:1990904;GO:0005876;GO:0003677;GO:0019899;GO:0003950;GO:1990404;GO:0008219;GO:0006464;GO:0006974;GO:0006281;GO:0006954;GO:0006471;GO:0140289;GO:0051972;GO:0042493;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus; C:ribonucleoprotein complex; C:spindle microtubule;, F:DNA binding; F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell death; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:DNA repair; P:inflammatory response; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:regulation of telomerase activity; P:response to drug;|Q9UKK3 O75903 Q14682 Q5QNZ9 Q9H1M6,Protein mono-ADP-ribosyltransferase PARP4 {ECO:0000305},193 kDa vault protein {ECO:0000303|PubMed:10477748};ADP-ribosyltransferase diphtheria toxin-like 4 {ECO:0000303|PubMed:20106667};PARP-related/IalphaI-related H5/proline-rich {ECO:0000303|PubMed:10100603};Poly [ADP-ribose] polymerase 4 {ECO:0000303|PubMed:20106667};Vault poly(ADP-ribose) polymerase {ECO:0000303|PubMed:10477748};, PF00533;PF00644;PF08487;PF00092;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:1990904;GO:0005876;GO:0003677;GO:0019899;GO:0003950;GO:1990404;GO:0008219;GO:0006464;GO:0006974;GO:0006281;GO:0006954;GO:0006471;GO:0140289;GO:0051972;GO:0042493;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus; C:ribonucleoprotein complex; C:spindle microtubule;, F:DNA binding; F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell death; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:DNA repair; P:inflammatory response; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:regulation of telomerase activity; P:response to drug;|Q9UKK3 O75903 Q14682 Q5QNZ9 Q9H1M6,Protein mono-ADP-ribosyltransferase PARP4 {ECO:0000305},193 kDa vault protein {ECO:0000303|PubMed:10477748};ADP-ribosyltransferase diphtheria toxin-like 4 {ECO:0000303|PubMed:20106667};PARP-related/IalphaI-related H5/proline-rich {ECO:0000303|PubMed:10100603};Poly [ADP-ribose] polymerase 4 {ECO:0000303|PubMed:20106667};Vault poly(ADP-ribose) polymerase {ECO:0000303|PubMed:10477748};, PF00533;PF00644;PF08487;PF00092;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:1990904;GO:0005876;GO:0003677;GO:0019899;GO:0003950;GO:1990404;GO:0008219;GO:0006464;GO:0006974;GO:0006281;GO:0006954;GO:0006471;GO:0140289;GO:0051972;GO:0042493;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus; C:ribonucleoprotein complex; C:spindle microtubule;, F:DNA binding; F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell death; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:DNA repair; P:inflammatory response; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:regulation of telomerase activity; P:response to drug; scaffold1 indexed_genome mRNA 46563689 46564391 . + . ID=transcript_106;Q9UKK3 O75903 Q14682 Q5QNZ9 Q9H1M6,Protein mono-ADP-ribosyltransferase PARP4 {ECO:0000305},193 kDa vault protein {ECO:0000303|PubMed:10477748};ADP-ribosyltransferase diphtheria toxin-like 4 {ECO:0000303|PubMed:20106667};PARP-related/IalphaI-related H5/proline-rich {ECO:0000303|PubMed:10100603};Poly [ADP-ribose] polymerase 4 {ECO:0000303|PubMed:20106667};Vault poly(ADP-ribose) polymerase {ECO:0000303|PubMed:10477748};, PF00533;PF00644;PF08487;PF00092;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:1990904;GO:0005876;GO:0003677;GO:0019899;GO:0003950;GO:1990404;GO:0008219;GO:0006464;GO:0006974;GO:0006281;GO:0006954;GO:0006471;GO:0140289;GO:0051972;GO:0042493;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus; C:ribonucleoprotein complex; C:spindle microtubule;, F:DNA binding; F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell death; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:DNA repair; P:inflammatory response; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:regulation of telomerase activity; P:response to drug; scaffold1 indexed_genome mRNA 46564483 46565793 . + . ID=transcript_107;Q9UKK3 O75903 Q14682 Q5QNZ9 Q9H1M6,Protein mono-ADP-ribosyltransferase PARP4 {ECO:0000305},193 kDa vault protein {ECO:0000303|PubMed:10477748};ADP-ribosyltransferase diphtheria toxin-like 4 {ECO:0000303|PubMed:20106667};PARP-related/IalphaI-related H5/proline-rich {ECO:0000303|PubMed:10100603};Poly [ADP-ribose] polymerase 4 {ECO:0000303|PubMed:20106667};Vault poly(ADP-ribose) polymerase {ECO:0000303|PubMed:10477748};, PF00533;PF00644;PF08487;PF00092;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:1990904;GO:0005876;GO:0003677;GO:0019899;GO:0003950;GO:1990404;GO:0008219;GO:0006464;GO:0006974;GO:0006281;GO:0006954;GO:0006471;GO:0140289;GO:0051972;GO:0042493;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus; C:ribonucleoprotein complex; C:spindle microtubule;, F:DNA binding; F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell death; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:DNA repair; P:inflammatory response; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:regulation of telomerase activity; P:response to drug; scaffold1 indexed_genome mRNA 46570937 46587058 . - . ID=transcript_108;Q9UKK3 O75903 Q14682 Q5QNZ9 Q9H1M6,Protein mono-ADP-ribosyltransferase PARP4 {ECO:0000305},193 kDa vault protein {ECO:0000303|PubMed:10477748};ADP-ribosyltransferase diphtheria toxin-like 4 {ECO:0000303|PubMed:20106667};PARP-related/IalphaI-related H5/proline-rich {ECO:0000303|PubMed:10100603};Poly [ADP-ribose] polymerase 4 {ECO:0000303|PubMed:20106667};Vault poly(ADP-ribose) polymerase {ECO:0000303|PubMed:10477748};, PF00533;PF00644;PF08487;PF00092;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:1990904;GO:0005876;GO:0003677;GO:0019899;GO:0003950;GO:1990404;GO:0008219;GO:0006464;GO:0006974;GO:0006281;GO:0006954;GO:0006471;GO:0140289;GO:0051972;GO:0042493;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus; C:ribonucleoprotein complex; C:spindle microtubule;, F:DNA binding; F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell death; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:DNA repair; P:inflammatory response; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:regulation of telomerase activity; P:response to drug;|Q9UKK3 O75903 Q14682 Q5QNZ9 Q9H1M6,Protein mono-ADP-ribosyltransferase PARP4 {ECO:0000305},193 kDa vault protein {ECO:0000303|PubMed:10477748};ADP-ribosyltransferase diphtheria toxin-like 4 {ECO:0000303|PubMed:20106667};PARP-related/IalphaI-related H5/proline-rich {ECO:0000303|PubMed:10100603};Poly [ADP-ribose] polymerase 4 {ECO:0000303|PubMed:20106667};Vault poly(ADP-ribose) polymerase {ECO:0000303|PubMed:10477748};, PF00533;PF00644;PF08487;PF00092;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:1990904;GO:0005876;GO:0003677;GO:0019899;GO:0003950;GO:1990404;GO:0008219;GO:0006464;GO:0006974;GO:0006281;GO:0006954;GO:0006471;GO:0140289;GO:0051972;GO:0042493;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus; C:ribonucleoprotein complex; C:spindle microtubule;, F:DNA binding; F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell death; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:DNA repair; P:inflammatory response; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:regulation of telomerase activity; P:response to drug; scaffold1 indexed_genome mRNA 46588269 46639473 . + . ID=transcript_109;Q99549 B7Z6F9 Q5JPE5 Q5JTQ0 Q86TK3 Q96MK4 Q9BTP1,M-phase phosphoprotein 8,Two hybrid-associated protein 3 with RanBPM {ECO:0000303|PubMed:12559565};, PF12796;PF00385;, GO:0005737;GO:0005829;GO:0000792;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005886;GO:0003682;GO:0035064;GO:0045814;GO:0045869;GO:0045892;GO:0090309;GO:0044030;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:plasma membrane;, F:chromatin binding; F:methylated histone binding;, P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:regulation of DNA methylation;|Q8TBQ9 Q0P692,Protein kish-A,Transmembrane protein 167;Transmembrane protein 167A;, PF06842;, GO:0005794;GO:0000139;GO:0016021;GO:0045054;GO:0046907;GO:0009306;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:constitutive secretory pathway; P:intracellular transport; P:protein secretion;|Q99549 B7Z6F9 Q5JPE5 Q5JTQ0 Q86TK3 Q96MK4 Q9BTP1,M-phase phosphoprotein 8,Two hybrid-associated protein 3 with RanBPM {ECO:0000303|PubMed:12559565};, PF12796;PF00385;, GO:0005737;GO:0005829;GO:0000792;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005886;GO:0003682;GO:0035064;GO:0045814;GO:0045869;GO:0045892;GO:0090309;GO:0044030;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:plasma membrane;, F:chromatin binding; F:methylated histone binding;, P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:regulation of DNA methylation;|Q99549 B7Z6F9 Q5JPE5 Q5JTQ0 Q86TK3 Q96MK4 Q9BTP1,M-phase phosphoprotein 8,Two hybrid-associated protein 3 with RanBPM {ECO:0000303|PubMed:12559565};, PF12796;PF00385;, GO:0005737;GO:0005829;GO:0000792;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005886;GO:0003682;GO:0035064;GO:0045814;GO:0045869;GO:0045892;GO:0090309;GO:0044030;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:plasma membrane;, F:chromatin binding; F:methylated histone binding;, P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:regulation of DNA methylation;|Q99549 B7Z6F9 Q5JPE5 Q5JTQ0 Q86TK3 Q96MK4 Q9BTP1,M-phase phosphoprotein 8,Two hybrid-associated protein 3 with RanBPM {ECO:0000303|PubMed:12559565};, PF12796;PF00385;, GO:0005737;GO:0005829;GO:0000792;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005886;GO:0003682;GO:0035064;GO:0045814;GO:0045869;GO:0045892;GO:0090309;GO:0044030;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:plasma membrane;, F:chromatin binding; F:methylated histone binding;, P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:regulation of DNA methylation;|Q99549 B7Z6F9 Q5JPE5 Q5JTQ0 Q86TK3 Q96MK4 Q9BTP1,M-phase phosphoprotein 8,Two hybrid-associated protein 3 with RanBPM {ECO:0000303|PubMed:12559565};, PF12796;PF00385;, GO:0005737;GO:0005829;GO:0000792;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005886;GO:0003682;GO:0035064;GO:0045814;GO:0045869;GO:0045892;GO:0090309;GO:0044030;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:plasma membrane;, F:chromatin binding; F:methylated histone binding;, P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:regulation of DNA methylation;|Q99549 B7Z6F9 Q5JPE5 Q5JTQ0 Q86TK3 Q96MK4 Q9BTP1,M-phase phosphoprotein 8,Two hybrid-associated protein 3 with RanBPM {ECO:0000303|PubMed:12559565};, PF12796;PF00385;, GO:0005737;GO:0005829;GO:0000792;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005886;GO:0003682;GO:0035064;GO:0045814;GO:0045869;GO:0045892;GO:0090309;GO:0044030;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:plasma membrane;, F:chromatin binding; F:methylated histone binding;, P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:regulation of DNA methylation; scaffold1 indexed_genome mRNA 46661286 46706947 . - . ID=transcript_110;Q8WXF1 Q5JTQ3 Q8NCZ9 Q8WXE8 Q9NV36,Paraspeckle component 1,Paraspeckle protein 1;, PF08075;PF00076;, GO:0005737;GO:0001650;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0003676;GO:0003723;GO:0000976;GO:0002218;GO:0045087;GO:0000398;GO:0045892;GO:0042752;GO:0006355;GO:0048511;, C:cytoplasm; C:fibrillar center; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:nucleic acid binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:innate immune response; P:mRNA splicing, via spliceosome; P:negative regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of transcription, DNA-templated; P:rhythmic process;|Q8WXF1 Q5JTQ3 Q8NCZ9 Q8WXE8 Q9NV36,Paraspeckle component 1,Paraspeckle protein 1;, PF08075;PF00076;, GO:0005737;GO:0001650;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0003676;GO:0003723;GO:0000976;GO:0002218;GO:0045087;GO:0000398;GO:0045892;GO:0042752;GO:0006355;GO:0048511;, C:cytoplasm; C:fibrillar center; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:nucleic acid binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:innate immune response; P:mRNA splicing, via spliceosome; P:negative regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of transcription, DNA-templated; P:rhythmic process;|Q04837,Single-stranded DNA-binding protein, mitochondrial,PWP1-interacting protein 17;, PF00436;, GO:0070062;GO:0005759;GO:0042645;GO:0005739;GO:0009295;GO:0005634;GO:0003682;GO:0042802;GO:0003723;GO:0003697;GO:0006268;GO:0006264;GO:0070584;GO:0007005;GO:1905776;GO:0051096;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoid; C:nucleus;, F:chromatin binding; F:identical protein binding; F:RNA binding; F:single-stranded DNA binding;, P:DNA unwinding involved in DNA replication; P:mitochondrial DNA replication; P:mitochondrion morphogenesis; P:mitochondrion organization; P:positive regulation of DNA helicase activity; P:positive regulation of helicase activity;|Q8WXF1 Q5JTQ3 Q8NCZ9 Q8WXE8 Q9NV36,Paraspeckle component 1,Paraspeckle protein 1;, PF08075;PF00076;, GO:0005737;GO:0001650;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0003676;GO:0003723;GO:0000976;GO:0002218;GO:0045087;GO:0000398;GO:0045892;GO:0042752;GO:0006355;GO:0048511;, C:cytoplasm; C:fibrillar center; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:nucleic acid binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:innate immune response; P:mRNA splicing, via spliceosome; P:negative regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of transcription, DNA-templated; P:rhythmic process; scaffold1 indexed_genome mRNA 46715521 46740074 . - . ID=transcript_111;Q9UJ78 B2R6V1 Q5T6E1 Q5T6E2 Q5T6E4 Q96IY6 Q9NZY5 Q9UBW0 Q9UJ77,Zinc finger MYM-type protein 5,Zinc finger protein 198-like 1;Zinc finger protein 237;, PF06467;, GO:0005634;GO:0008270;GO:0000122;, C:nucleus;, F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II;|Q9UJ78 B2R6V1 Q5T6E1 Q5T6E2 Q5T6E4 Q96IY6 Q9NZY5 Q9UBW0 Q9UJ77,Zinc finger MYM-type protein 5,Zinc finger protein 198-like 1;Zinc finger protein 237;, PF06467;, GO:0005634;GO:0008270;GO:0000122;, C:nucleus;, F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II;|Q8NE39 Q9H0V5 Q9H538 Q9UEU2,Zinc finger MYM-type protein 2,Fused in myeloproliferative disorders protein;Rearranged in atypical myeloproliferative disorder protein;Zinc finger protein 198;, PF12012;PF06467;, GO:0005829;GO:0016605;GO:0031624;GO:0008270;, C:cytosol; C:PML body;, F:ubiquitin conjugating enzyme binding; F:zinc ion binding;|Q9UJ78 B2R6V1 Q5T6E1 Q5T6E2 Q5T6E4 Q96IY6 Q9NZY5 Q9UBW0 Q9UJ77,Zinc finger MYM-type protein 5,Zinc finger protein 198-like 1;Zinc finger protein 237;, PF06467;, GO:0005634;GO:0008270;GO:0000122;, C:nucleus;, F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II;|Q9UJ78 B2R6V1 Q5T6E1 Q5T6E2 Q5T6E4 Q96IY6 Q9NZY5 Q9UBW0 Q9UJ77,Zinc finger MYM-type protein 5,Zinc finger protein 198-like 1;Zinc finger protein 237;, PF06467;, GO:0005634;GO:0008270;GO:0000122;, C:nucleus;, F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II;|Q9UJ78 B2R6V1 Q5T6E1 Q5T6E2 Q5T6E4 Q96IY6 Q9NZY5 Q9UBW0 Q9UJ77,Zinc finger MYM-type protein 5,Zinc finger protein 198-like 1;Zinc finger protein 237;, PF06467;, GO:0005634;GO:0008270;GO:0000122;, C:nucleus;, F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II;|Q8NE39 Q9H0V5 Q9H538 Q9UEU2,Zinc finger MYM-type protein 2,Fused in myeloproliferative disorders protein;Rearranged in atypical myeloproliferative disorder protein;Zinc finger protein 198;, PF12012;PF06467;, GO:0005829;GO:0016605;GO:0031624;GO:0008270;, C:cytosol; C:PML body;, F:ubiquitin conjugating enzyme binding; F:zinc ion binding;|Q8NE39 Q9H0V5 Q9H538 Q9UEU2,Zinc finger MYM-type protein 2,Fused in myeloproliferative disorders protein;Rearranged in atypical myeloproliferative disorder protein;Zinc finger protein 198;, PF12012;PF06467;, GO:0005829;GO:0016605;GO:0031624;GO:0008270;, C:cytosol; C:PML body;, F:ubiquitin conjugating enzyme binding; F:zinc ion binding;|Q8NE39 Q9H0V5 Q9H538 Q9UEU2,Zinc finger MYM-type protein 2,Fused in myeloproliferative disorders protein;Rearranged in atypical myeloproliferative disorder protein;Zinc finger protein 198;, PF12012;PF06467;, GO:0005829;GO:0016605;GO:0031624;GO:0008270;, C:cytosol; C:PML body;, F:ubiquitin conjugating enzyme binding; F:zinc ion binding; scaffold1 indexed_genome mRNA 46840505 46852365 . + . ID=transcript_112;Q8NE39 Q9H0V5 Q9H538 Q9UEU2,Zinc finger MYM-type protein 2,Fused in myeloproliferative disorders protein;Rearranged in atypical myeloproliferative disorder protein;Zinc finger protein 198;, PF12012;PF06467;, GO:0005829;GO:0016605;GO:0031624;GO:0008270;, C:cytosol; C:PML body;, F:ubiquitin conjugating enzyme binding; F:zinc ion binding;|Q8NE39 Q9H0V5 Q9H538 Q9UEU2,Zinc finger MYM-type protein 2,Fused in myeloproliferative disorders protein;Rearranged in atypical myeloproliferative disorder protein;Zinc finger protein 198;, PF12012;PF06467;, GO:0005829;GO:0016605;GO:0031624;GO:0008270;, C:cytosol; C:PML body;, F:ubiquitin conjugating enzyme binding; F:zinc ion binding;|Q8NE39 Q9H0V5 Q9H538 Q9UEU2,Zinc finger MYM-type protein 2,Fused in myeloproliferative disorders protein;Rearranged in atypical myeloproliferative disorder protein;Zinc finger protein 198;, PF12012;PF06467;, GO:0005829;GO:0016605;GO:0031624;GO:0008270;, C:cytosol; C:PML body;, F:ubiquitin conjugating enzyme binding; F:zinc ion binding;|Q8NE39 Q9H0V5 Q9H538 Q9UEU2,Zinc finger MYM-type protein 2,Fused in myeloproliferative disorders protein;Rearranged in atypical myeloproliferative disorder protein;Zinc finger protein 198;, PF12012;PF06467;, GO:0005829;GO:0016605;GO:0031624;GO:0008270;, C:cytosol; C:PML body;, F:ubiquitin conjugating enzyme binding; F:zinc ion binding; scaffold1 indexed_genome mRNA 46919808 46928480 . + . ID=transcript_113;O95452 B3KQN2 Q5Q1H9 Q5Q1I0 Q5Q1I1 Q5T5U0 Q8IUP0,Gap junction beta-6 protein,Connexin-30;, PF00029;, GO:0005884;GO:0016324;GO:0030054;GO:0005922;GO:0005829;GO:0005921;GO:0016021;GO:0051015;GO:0048487;GO:0005243;GO:1903763;GO:0008017;GO:0007568;GO:0006915;GO:0007267;GO:0071333;GO:0042471;GO:0016264;GO:1990349;GO:0048839;GO:0035633;GO:0008285;GO:0051602;GO:0032496;GO:0007605;GO:0055085;, C:actin filament; C:apical plasma membrane; C:cell junction; C:connexin complex; C:cytosol; C:gap junction; C:integral component of membrane;, F:actin filament binding; F:beta-tubulin binding; F:gap junction channel activity; F:gap junction channel activity involved in cell communication by electrical coupling; F:microtubule binding;, P:aging; P:apoptotic process; P:cell-cell signaling; P:cellular response to glucose stimulus; P:ear morphogenesis; P:gap junction assembly; P:gap junction-mediated intercellular transport; P:inner ear development; P:maintenance of blood-brain barrier; P:negative regulation of cell population proliferation; P:response to electrical stimulus; P:response to lipopolysaccharide; P:sensory perception of sound; P:transmembrane transport;|O95452 B3KQN2 Q5Q1H9 Q5Q1I0 Q5Q1I1 Q5T5U0 Q8IUP0,Gap junction beta-6 protein,Connexin-30;, PF00029;, GO:0005884;GO:0016324;GO:0030054;GO:0005922;GO:0005829;GO:0005921;GO:0016021;GO:0051015;GO:0048487;GO:0005243;GO:1903763;GO:0008017;GO:0007568;GO:0006915;GO:0007267;GO:0071333;GO:0042471;GO:0016264;GO:1990349;GO:0048839;GO:0035633;GO:0008285;GO:0051602;GO:0032496;GO:0007605;GO:0055085;, C:actin filament; C:apical plasma membrane; C:cell junction; C:connexin complex; C:cytosol; C:gap junction; C:integral component of membrane;, F:actin filament binding; F:beta-tubulin binding; F:gap junction channel activity; F:gap junction channel activity involved in cell communication by electrical coupling; F:microtubule binding;, P:aging; P:apoptotic process; P:cell-cell signaling; P:cellular response to glucose stimulus; P:ear morphogenesis; P:gap junction assembly; P:gap junction-mediated intercellular transport; P:inner ear development; P:maintenance of blood-brain barrier; P:negative regulation of cell population proliferation; P:response to electrical stimulus; P:response to lipopolysaccharide; P:sensory perception of sound; P:transmembrane transport; scaffold1 indexed_genome mRNA 46995437 47045938 . - . ID=transcript_114;Q9Y2S2 A0PJ43 B3KN92 Q0VDI1 Q7Z4Z9 Q9P0G7,Lambda-crystallin homolog,L-gulonate 3-dehydrogenase;, PF00725;PF02737;, GO:0005829;GO:0070062;GO:0050104;GO:0070403;GO:0016616;GO:0042803;GO:0006631;GO:0019640;, C:cytosol; C:extracellular exosome;, F:L-gulonate 3-dehydrogenase activity; F:NAD+ binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein homodimerization activity;, P:fatty acid metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate;|Q9Y2S2 A0PJ43 B3KN92 Q0VDI1 Q7Z4Z9 Q9P0G7,Lambda-crystallin homolog,L-gulonate 3-dehydrogenase;, PF00725;PF02737;, GO:0005829;GO:0070062;GO:0050104;GO:0070403;GO:0016616;GO:0042803;GO:0006631;GO:0019640;, C:cytosol; C:extracellular exosome;, F:L-gulonate 3-dehydrogenase activity; F:NAD+ binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein homodimerization activity;, P:fatty acid metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate;|Q9Y2S2 A0PJ43 B3KN92 Q0VDI1 Q7Z4Z9 Q9P0G7,Lambda-crystallin homolog,L-gulonate 3-dehydrogenase;, PF00725;PF02737;, GO:0005829;GO:0070062;GO:0050104;GO:0070403;GO:0016616;GO:0042803;GO:0006631;GO:0019640;, C:cytosol; C:extracellular exosome;, F:L-gulonate 3-dehydrogenase activity; F:NAD+ binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein homodimerization activity;, P:fatty acid metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate;|Q9Y2S2 A0PJ43 B3KN92 Q0VDI1 Q7Z4Z9 Q9P0G7,Lambda-crystallin homolog,L-gulonate 3-dehydrogenase;, PF00725;PF02737;, GO:0005829;GO:0070062;GO:0050104;GO:0070403;GO:0016616;GO:0042803;GO:0006631;GO:0019640;, C:cytosol; C:extracellular exosome;, F:L-gulonate 3-dehydrogenase activity; F:NAD+ binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein homodimerization activity;, P:fatty acid metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; scaffold1 indexed_genome mRNA 47070380 47135765 . + . ID=transcript_115;Q13099 A2A491 B4DUS2 Q5SZJ6 Q8N719,Intraflagellar transport protein 88 homolog,Recessive polycystic kidney disease protein Tg737 homolog;Tetratricopeptide repeat protein 10;, PF13174;PF13181;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0005829;GO:0030992;GO:0031514;GO:0097730;GO:0036126;GO:0019894;GO:0035973;GO:0060271;GO:0060122;GO:0042073;GO:0035735;GO:0001822;GO:1905515;GO:2000785;GO:1902017;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:cytosol; C:intraciliary transport particle B; C:motile cilium; C:non-motile cilium; C:sperm flagellum;, F:kinesin binding;, P:aggrephagy; P:cilium assembly; P:inner ear receptor cell stereocilium organization; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:non-motile cilium assembly; P:regulation of autophagosome assembly; P:regulation of cilium assembly;|Q13099 A2A491 B4DUS2 Q5SZJ6 Q8N719,Intraflagellar transport protein 88 homolog,Recessive polycystic kidney disease protein Tg737 homolog;Tetratricopeptide repeat protein 10;, PF13174;PF13181;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0005829;GO:0030992;GO:0031514;GO:0097730;GO:0036126;GO:0019894;GO:0035973;GO:0060271;GO:0060122;GO:0042073;GO:0035735;GO:0001822;GO:1905515;GO:2000785;GO:1902017;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:cytosol; C:intraciliary transport particle B; C:motile cilium; C:non-motile cilium; C:sperm flagellum;, F:kinesin binding;, P:aggrephagy; P:cilium assembly; P:inner ear receptor cell stereocilium organization; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:non-motile cilium assembly; P:regulation of autophagosome assembly; P:regulation of cilium assembly;|Q13099 A2A491 B4DUS2 Q5SZJ6 Q8N719,Intraflagellar transport protein 88 homolog,Recessive polycystic kidney disease protein Tg737 homolog;Tetratricopeptide repeat protein 10;, PF13174;PF13181;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0005829;GO:0030992;GO:0031514;GO:0097730;GO:0036126;GO:0019894;GO:0035973;GO:0060271;GO:0060122;GO:0042073;GO:0035735;GO:0001822;GO:1905515;GO:2000785;GO:1902017;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:cytosol; C:intraciliary transport particle B; C:motile cilium; C:non-motile cilium; C:sperm flagellum;, F:kinesin binding;, P:aggrephagy; P:cilium assembly; P:inner ear receptor cell stereocilium organization; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:non-motile cilium assembly; P:regulation of autophagosome assembly; P:regulation of cilium assembly;|Q13099 A2A491 B4DUS2 Q5SZJ6 Q8N719,Intraflagellar transport protein 88 homolog,Recessive polycystic kidney disease protein Tg737 homolog;Tetratricopeptide repeat protein 10;, PF13174;PF13181;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0005829;GO:0030992;GO:0031514;GO:0097730;GO:0036126;GO:0019894;GO:0035973;GO:0060271;GO:0060122;GO:0042073;GO:0035735;GO:0001822;GO:1905515;GO:2000785;GO:1902017;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:cytosol; C:intraciliary transport particle B; C:motile cilium; C:non-motile cilium; C:sperm flagellum;, F:kinesin binding;, P:aggrephagy; P:cilium assembly; P:inner ear receptor cell stereocilium organization; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:non-motile cilium assembly; P:regulation of autophagosome assembly; P:regulation of cilium assembly; scaffold1 indexed_genome mRNA 47171890 47177069 . - . ID=transcript_116;Q8WVE0 B5G4V1,EEF1A lysine methyltransferase 1 {ECO:0000255|HAMAP-Rule:MF_03187, ECO:0000312|HGNC:HGNC:27351},N(6)-adenine-specific DNA methyltransferase 2 {ECO:0000255|HAMAP-Rule:MF_03187};Protein-lysine N-methyltransferase N6AMT2 {ECO:0000255|HAMAP-Rule:MF_03187};, PF10237;, GO:0005829;GO:0008168;GO:0003676;GO:0016279;GO:0018022;GO:0006479;, C:cytosol;, F:methyltransferase activity; F:nucleic acid binding; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine methylation; P:protein methylation;|Q8WVE0 B5G4V1,EEF1A lysine methyltransferase 1 {ECO:0000255|HAMAP-Rule:MF_03187, ECO:0000312|HGNC:HGNC:27351},N(6)-adenine-specific DNA methyltransferase 2 {ECO:0000255|HAMAP-Rule:MF_03187};Protein-lysine N-methyltransferase N6AMT2 {ECO:0000255|HAMAP-Rule:MF_03187};, PF10237;, GO:0005829;GO:0008168;GO:0003676;GO:0016279;GO:0018022;GO:0006479;, C:cytosol;, F:methyltransferase activity; F:nucleic acid binding; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine methylation; P:protein methylation; scaffold1 indexed_genome mRNA 47184851 47192030 . + . ID=transcript_117;Q96IK5 Q9H826 Q9H8V7 Q9H927,Germ cell-less protein-like 1,Spermatogenesis-associated protein 29;, PF07707;PF00651;, GO:0016363;GO:0005634;GO:0042802;GO:0007281;GO:0007275;GO:0007283;, C:nuclear matrix; C:nucleus;, F:identical protein binding;, P:germ cell development; P:multicellular organism development; P:spermatogenesis; scaffold1 indexed_genome mRNA 47202574 47274313 . - . ID=transcript_118;Q9C0E2 Q5VUZ5 Q8N3V6 Q9H934,Exportin-4,, , GO:0005737;GO:0005829;GO:0005643;GO:0005654;GO:0005049;GO:0046827;GO:0006611;, C:cytoplasm; C:cytosol; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity;, P:positive regulation of protein export from nucleus; P:protein export from nucleus;|Q9C0E2 Q5VUZ5 Q8N3V6 Q9H934,Exportin-4,, , GO:0005737;GO:0005829;GO:0005643;GO:0005654;GO:0005049;GO:0046827;GO:0006611;, C:cytoplasm; C:cytosol; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity;, P:positive regulation of protein export from nucleus; P:protein export from nucleus;|Q9C0E2 Q5VUZ5 Q8N3V6 Q9H934,Exportin-4,, , GO:0005737;GO:0005829;GO:0005643;GO:0005654;GO:0005049;GO:0046827;GO:0006611;, C:cytoplasm; C:cytosol; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity;, P:positive regulation of protein export from nucleus; P:protein export from nucleus;|Q9C0E2 Q5VUZ5 Q8N3V6 Q9H934,Exportin-4,, , GO:0005737;GO:0005829;GO:0005643;GO:0005654;GO:0005049;GO:0046827;GO:0006611;, C:cytoplasm; C:cytosol; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity;, P:positive regulation of protein export from nucleus; P:protein export from nucleus;|Q9C0E2 Q5VUZ5 Q8N3V6 Q9H934,Exportin-4,, , GO:0005737;GO:0005829;GO:0005643;GO:0005654;GO:0005049;GO:0046827;GO:0006611;, C:cytoplasm; C:cytosol; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity;, P:positive regulation of protein export from nucleus; P:protein export from nucleus;|Q9C0E2 Q5VUZ5 Q8N3V6 Q9H934,Exportin-4,, , GO:0005737;GO:0005829;GO:0005643;GO:0005654;GO:0005049;GO:0046827;GO:0006611;, C:cytoplasm; C:cytosol; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity;, P:positive regulation of protein export from nucleus; P:protein export from nucleus; scaffold1 indexed_genome mRNA 47296616 47303488 . + . ID=transcript_119;Q9NZN6,CCR4-NOT transcription complex subunit 4,CCR4-associated factor 4;E3 ubiquitin-protein ligase CNOT4;Potential transcriptional repressor NOT4Hp;RING-type E3 ubiquitin transferase CNOT4 {ECO:0000305};, PF00076;, GO:0030014;GO:0005829;GO:0005634;GO:0046872;GO:0003723;GO:0004842;GO:0006977;GO:0000289;GO:0051865;GO:0016567;GO:0045652;GO:0006511;, C:CCR4-NOT complex; C:cytosol; C:nucleus;, F:metal ion binding; F:RNA binding; F:ubiquitin-protein transferase activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:nuclear-transcribed mRNA poly(A) tail shortening; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of megakaryocyte differentiation; P:ubiquitin-dependent protein catabolic process; scaffold1 indexed_genome mRNA 47304655 47307201 . - . ID=transcript_120;Q9NRM7 B1AM47 Q9P2X1,Serine/threonine-protein kinase LATS2,Kinase phosphorylated during mitosis protein;Large tumor suppressor homolog 2;Serine/threonine-protein kinase kpm;Warts-like kinase;, PF00069;PF00433;, GO:0034451;GO:0005829;GO:0005634;GO:0000922;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0000082;GO:0035329;GO:0009755;GO:0035556;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0006468;GO:0046620;GO:0017015;, C:centriolar satellite; C:cytosol; C:nucleus; C:spindle pole;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:G1/S transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:protein phosphorylation; P:regulation of organ growth; P:regulation of transforming growth factor beta receptor signaling pathway; scaffold1 indexed_genome mRNA 47308615 47312299 . - . ID=transcript_121;Q9NRM7 B1AM47 Q9P2X1,Serine/threonine-protein kinase LATS2,Kinase phosphorylated during mitosis protein;Large tumor suppressor homolog 2;Serine/threonine-protein kinase kpm;Warts-like kinase;, PF00069;PF00433;, GO:0034451;GO:0005829;GO:0005634;GO:0000922;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0000082;GO:0035329;GO:0009755;GO:0035556;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0006468;GO:0046620;GO:0017015;, C:centriolar satellite; C:cytosol; C:nucleus; C:spindle pole;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:G1/S transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:protein phosphorylation; P:regulation of organ growth; P:regulation of transforming growth factor beta receptor signaling pathway; scaffold1 indexed_genome mRNA 47313129 47313788 . + . ID=transcript_122;Q9NRM7 B1AM47 Q9P2X1,Serine/threonine-protein kinase LATS2,Kinase phosphorylated during mitosis protein;Large tumor suppressor homolog 2;Serine/threonine-protein kinase kpm;Warts-like kinase;, PF00069;PF00433;, GO:0034451;GO:0005829;GO:0005634;GO:0000922;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0000082;GO:0035329;GO:0009755;GO:0035556;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0006468;GO:0046620;GO:0017015;, C:centriolar satellite; C:cytosol; C:nucleus; C:spindle pole;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:G1/S transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:protein phosphorylation; P:regulation of organ growth; P:regulation of transforming growth factor beta receptor signaling pathway; scaffold1 indexed_genome mRNA 47316927 47329144 . - . ID=transcript_123;Q9NRM7 B1AM47 Q9P2X1,Serine/threonine-protein kinase LATS2,Kinase phosphorylated during mitosis protein;Large tumor suppressor homolog 2;Serine/threonine-protein kinase kpm;Warts-like kinase;, PF00069;PF00433;, GO:0034451;GO:0005829;GO:0005634;GO:0000922;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0000082;GO:0035329;GO:0009755;GO:0035556;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0006468;GO:0046620;GO:0017015;, C:centriolar satellite; C:cytosol; C:nucleus; C:spindle pole;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:G1/S transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:protein phosphorylation; P:regulation of organ growth; P:regulation of transforming growth factor beta receptor signaling pathway; scaffold1 indexed_genome mRNA 47377572 47380189 . + . ID=transcript_124;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold1 indexed_genome mRNA 47380451 47386455 . + . ID=transcript_125;O00422 B2R494 Q2TTR4 Q6IAW9 Q8N606 Q9UF14 X6RAL5,Histone deacetylase complex subunit SAP18,18 kDa Sin3-associated polypeptide;2HOR0202;Cell growth-inhibiting gene 38 protein;Sin3-associated polypeptide p18;, PF06487;, GO:0061574;GO:0005829;GO:0000118;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0003714;GO:0008134;GO:0006397;GO:0048025;GO:0045892;GO:0043065;GO:0000381;GO:0006357;GO:0008380;, C:ASAP complex; C:cytosol; C:histone deacetylase complex; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:mRNA processing; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of transcription by RNA polymerase II; P:RNA splicing; scaffold1 indexed_genome mRNA 47391105 47394582 . - . ID=transcript_126;Q8IX90 A2A330 A2A331 B2RBY2 Q5VZV5 Q86WR2 Q8NBG1 Q96D22,Spindle and kinetochore-associated protein 3,, , GO:0005813;GO:0000940;GO:0005829;GO:0000776;GO:0072686;GO:0005876;GO:0051301;GO:0007059;GO:0000278;GO:0031110;, C:centrosome; C:condensed chromosome outer kinetochore; C:cytosol; C:kinetochore; C:mitotic spindle; C:spindle microtubule;, , P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:regulation of microtubule polymerization or depolymerization;|Q8IX90 A2A330 A2A331 B2RBY2 Q5VZV5 Q86WR2 Q8NBG1 Q96D22,Spindle and kinetochore-associated protein 3,, , GO:0005813;GO:0000940;GO:0005829;GO:0000776;GO:0072686;GO:0005876;GO:0051301;GO:0007059;GO:0000278;GO:0031110;, C:centrosome; C:condensed chromosome outer kinetochore; C:cytosol; C:kinetochore; C:mitotic spindle; C:spindle microtubule;, , P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:regulation of microtubule polymerization or depolymerization;|Q8IX90 A2A330 A2A331 B2RBY2 Q5VZV5 Q86WR2 Q8NBG1 Q96D22,Spindle and kinetochore-associated protein 3,, , GO:0005813;GO:0000940;GO:0005829;GO:0000776;GO:0072686;GO:0005876;GO:0051301;GO:0007059;GO:0000278;GO:0031110;, C:centrosome; C:condensed chromosome outer kinetochore; C:cytosol; C:kinetochore; C:mitotic spindle; C:spindle microtubule;, , P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:regulation of microtubule polymerization or depolymerization; scaffold1 indexed_genome mRNA 47394602 47395595 . - . ID=transcript_127;Q8IX90 A2A330 A2A331 B2RBY2 Q5VZV5 Q86WR2 Q8NBG1 Q96D22,Spindle and kinetochore-associated protein 3,, , GO:0005813;GO:0000940;GO:0005829;GO:0000776;GO:0072686;GO:0005876;GO:0051301;GO:0007059;GO:0000278;GO:0031110;, C:centrosome; C:condensed chromosome outer kinetochore; C:cytosol; C:kinetochore; C:mitotic spindle; C:spindle microtubule;, , P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:regulation of microtubule polymerization or depolymerization; scaffold1 indexed_genome mRNA 47398510 47433694 . - . ID=transcript_128;Q8IX90 A2A330 A2A331 B2RBY2 Q5VZV5 Q86WR2 Q8NBG1 Q96D22,Spindle and kinetochore-associated protein 3,, , GO:0005813;GO:0000940;GO:0005829;GO:0000776;GO:0072686;GO:0005876;GO:0051301;GO:0007059;GO:0000278;GO:0031110;, C:centrosome; C:condensed chromosome outer kinetochore; C:cytosol; C:kinetochore; C:mitotic spindle; C:spindle microtubule;, , P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:regulation of microtubule polymerization or depolymerization;|Q9BQC6 A2A332,Ribosomal protein 63, mitochondrial,Mitochondrial large ribosomal subunit protein mL63 {ECO:0000303|PubMed:25278503};Mitochondrial ribosomal protein 63;Mitochondrial ribosomal protein L57;, PF14978;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003735;GO:0032543;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q5W0Z9 A8MTV9 C9JG20 I6L9D4 Q2TB82 Q6NVU8,Palmitoyltransferase ZDHHC20 {ECO:0000305|PubMed:27153536},Acyltransferase ZDHHC20 {ECO:0000305|PubMed:29326245};DHHC domain-containing cysteine-rich protein 20 {ECO:0000303|PubMed:27153536};Zinc finger DHHC domain-containing protein 20 {ECO:0000312|HGNC:HGNC:20749};, PF01529;, GO:0005783;GO:0005794;GO:0030173;GO:0043231;GO:0016020;GO:0048471;GO:0005886;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0008270;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:zinc ion binding;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane;|Q5W0Z9 A8MTV9 C9JG20 I6L9D4 Q2TB82 Q6NVU8,Palmitoyltransferase ZDHHC20 {ECO:0000305|PubMed:27153536},Acyltransferase ZDHHC20 {ECO:0000305|PubMed:29326245};DHHC domain-containing cysteine-rich protein 20 {ECO:0000303|PubMed:27153536};Zinc finger DHHC domain-containing protein 20 {ECO:0000312|HGNC:HGNC:20749};, PF01529;, GO:0005783;GO:0005794;GO:0030173;GO:0043231;GO:0016020;GO:0048471;GO:0005886;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0008270;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:zinc ion binding;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane;|Q5W0Z9 A8MTV9 C9JG20 I6L9D4 Q2TB82 Q6NVU8,Palmitoyltransferase ZDHHC20 {ECO:0000305|PubMed:27153536},Acyltransferase ZDHHC20 {ECO:0000305|PubMed:29326245};DHHC domain-containing cysteine-rich protein 20 {ECO:0000303|PubMed:27153536};Zinc finger DHHC domain-containing protein 20 {ECO:0000312|HGNC:HGNC:20749};, PF01529;, GO:0005783;GO:0005794;GO:0030173;GO:0043231;GO:0016020;GO:0048471;GO:0005886;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0008270;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:zinc ion binding;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane; scaffold1 indexed_genome mRNA 47435319 47440782 . - . ID=transcript_129;Q5W0Z9 A8MTV9 C9JG20 I6L9D4 Q2TB82 Q6NVU8,Palmitoyltransferase ZDHHC20 {ECO:0000305|PubMed:27153536},Acyltransferase ZDHHC20 {ECO:0000305|PubMed:29326245};DHHC domain-containing cysteine-rich protein 20 {ECO:0000303|PubMed:27153536};Zinc finger DHHC domain-containing protein 20 {ECO:0000312|HGNC:HGNC:20749};, PF01529;, GO:0005783;GO:0005794;GO:0030173;GO:0043231;GO:0016020;GO:0048471;GO:0005886;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0008270;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:zinc ion binding;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane; scaffold1 indexed_genome mRNA 47463283 47532302 . - . ID=transcript_130;Q8IYU8 Q8N0T6 Q8NAX8,Calcium uptake protein 2, mitochondrial,EF-hand domain-containing family member A1;, PF13833;, GO:0034704;GO:0005743;GO:0005758;GO:0005739;GO:1990246;GO:0005509;GO:0046982;GO:0036444;GO:0051560;GO:0006851;GO:0051562;GO:0051561;, C:calcium channel complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:uniplex complex;, F:calcium ion binding; F:protein heterodimerization activity;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial calcium ion concentration;|Q8IYU8 Q8N0T6 Q8NAX8,Calcium uptake protein 2, mitochondrial,EF-hand domain-containing family member A1;, PF13833;, GO:0034704;GO:0005743;GO:0005758;GO:0005739;GO:1990246;GO:0005509;GO:0046982;GO:0036444;GO:0051560;GO:0006851;GO:0051562;GO:0051561;, C:calcium channel complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:uniplex complex;, F:calcium ion binding; F:protein heterodimerization activity;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial calcium ion concentration;|Q8IYU8 Q8N0T6 Q8NAX8,Calcium uptake protein 2, mitochondrial,EF-hand domain-containing family member A1;, PF13833;, GO:0034704;GO:0005743;GO:0005758;GO:0005739;GO:1990246;GO:0005509;GO:0046982;GO:0036444;GO:0051560;GO:0006851;GO:0051562;GO:0051561;, C:calcium channel complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:uniplex complex;, F:calcium ion binding; F:protein heterodimerization activity;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial calcium ion concentration;|Q8IYU8 Q8N0T6 Q8NAX8,Calcium uptake protein 2, mitochondrial,EF-hand domain-containing family member A1;, PF13833;, GO:0034704;GO:0005743;GO:0005758;GO:0005739;GO:1990246;GO:0005509;GO:0046982;GO:0036444;GO:0051560;GO:0006851;GO:0051562;GO:0051561;, C:calcium channel complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:uniplex complex;, F:calcium ion binding; F:protein heterodimerization activity;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial calcium ion concentration;|Q8IYU8 Q8N0T6 Q8NAX8,Calcium uptake protein 2, mitochondrial,EF-hand domain-containing family member A1;, PF13833;, GO:0034704;GO:0005743;GO:0005758;GO:0005739;GO:1990246;GO:0005509;GO:0046982;GO:0036444;GO:0051560;GO:0006851;GO:0051562;GO:0051561;, C:calcium channel complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:uniplex complex;, F:calcium ion binding; F:protein heterodimerization activity;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial calcium ion concentration;|Q8IYU8 Q8N0T6 Q8NAX8,Calcium uptake protein 2, mitochondrial,EF-hand domain-containing family member A1;, PF13833;, GO:0034704;GO:0005743;GO:0005758;GO:0005739;GO:1990246;GO:0005509;GO:0046982;GO:0036444;GO:0051560;GO:0006851;GO:0051562;GO:0051561;, C:calcium channel complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:uniplex complex;, F:calcium ion binding; F:protein heterodimerization activity;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial calcium ion concentration; scaffold1 indexed_genome mRNA 47591806 47592383 . - . ID=transcript_131;P31371 A8K427 Q3SY32,Fibroblast growth factor 9,Glia-activating factor;Heparin-binding growth factor 9;, PF00167;, GO:0005604;GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0008201;GO:0009887;GO:0030154;GO:0007267;GO:0008543;GO:0030324;GO:0008584;GO:0000165;GO:1905931;GO:0051781;GO:0008284;GO:0050679;GO:0010628;GO:0043410;GO:0051897;GO:0001934;GO:1904754;GO:1904707;GO:0030334;GO:0007165;GO:0021762;, C:basement membrane; C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparin binding;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:fibroblast growth factor receptor signaling pathway; P:lung development; P:male gonad development; P:MAPK cascade; P:negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of MAPK cascade; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of cell migration; P:signal transduction; P:substantia nigra development; scaffold1 indexed_genome mRNA 47606513 47608573 . - . ID=transcript_132;P31371 A8K427 Q3SY32,Fibroblast growth factor 9,Glia-activating factor;Heparin-binding growth factor 9;, PF00167;, GO:0005604;GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0008201;GO:0009887;GO:0030154;GO:0007267;GO:0008543;GO:0030324;GO:0008584;GO:0000165;GO:1905931;GO:0051781;GO:0008284;GO:0050679;GO:0010628;GO:0043410;GO:0051897;GO:0001934;GO:1904754;GO:1904707;GO:0030334;GO:0007165;GO:0021762;, C:basement membrane; C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparin binding;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:fibroblast growth factor receptor signaling pathway; P:lung development; P:male gonad development; P:MAPK cascade; P:negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of MAPK cascade; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of cell migration; P:signal transduction; P:substantia nigra development; scaffold1 indexed_genome mRNA 48329632 48353687 . - . ID=transcript_133;Q9NZJ4 O94835 Q5T9J5 Q5T9J7 Q5T9J8 Q68DF5 Q6MZR4 Q8NBF9,Sacsin,DnaJ homolog subfamily C member 29;, PF05168;PF00240;, GO:0030424;GO:0070852;GO:0005737;GO:0030425;GO:0005739;GO:0005634;GO:0051087;GO:0030544;GO:0070628;GO:0090084;GO:0006457;, C:axon; C:cell body fiber; C:cytoplasm; C:dendrite; C:mitochondrion; C:nucleus;, F:chaperone binding; F:Hsp70 protein binding; F:proteasome binding;, P:negative regulation of inclusion body assembly; P:protein folding; scaffold1 indexed_genome mRNA 48353755 48354743 . - . ID=transcript_134;Q9NZJ4 O94835 Q5T9J5 Q5T9J7 Q5T9J8 Q68DF5 Q6MZR4 Q8NBF9,Sacsin,DnaJ homolog subfamily C member 29;, PF05168;PF00240;, GO:0030424;GO:0070852;GO:0005737;GO:0030425;GO:0005739;GO:0005634;GO:0051087;GO:0030544;GO:0070628;GO:0090084;GO:0006457;, C:axon; C:cell body fiber; C:cytoplasm; C:dendrite; C:mitochondrion; C:nucleus;, F:chaperone binding; F:Hsp70 protein binding; F:proteasome binding;, P:negative regulation of inclusion body assembly; P:protein folding; scaffold1 indexed_genome mRNA 48608334 48619775 . + . ID=transcript_135;Q99797 Q5JV15 Q5T9Q9 Q96G65,Mitochondrial intermediate peptidase,, PF01432;, GO:0005759;GO:0005739;GO:0046872;GO:0004222;GO:0006518;GO:0006627;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:metalloendopeptidase activity;, P:peptide metabolic process; P:protein processing involved in protein targeting to mitochondrion; P:proteolysis; scaffold1 indexed_genome mRNA 48658235 48659324 . + . ID=transcript_136;Q99797 Q5JV15 Q5T9Q9 Q96G65,Mitochondrial intermediate peptidase,, PF01432;, GO:0005759;GO:0005739;GO:0046872;GO:0004222;GO:0006518;GO:0006627;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:metalloendopeptidase activity;, P:peptide metabolic process; P:protein processing involved in protein targeting to mitochondrion; P:proteolysis; scaffold1 indexed_genome mRNA 48691678 48699547 . - . ID=transcript_137;P0C862 A2A3T6 Q0VGC5 Q5VX65 Q5VX66 Q8IUU4,Complement C1q and tumor necrosis factor-related protein 9A,Complement C1q and tumor necrosis factor-related protein 9;, PF00386;PF01391;, GO:0005581;GO:0005576;GO:0005179;GO:0042802;, C:collagen trimer; C:extracellular region;, F:hormone activity; F:identical protein binding; scaffold1 indexed_genome mRNA 48701577 48717711 . - . ID=transcript_138;Q6ZML1 Q8N873 Q8TEK6,Spermatogenesis-associated protein 13,APC-stimulated guanine nucleotide exchange factor 2;, PF00169;PF00621;PF00018;, GO:0005737;GO:0005829;GO:0030175;GO:0030027;GO:0005654;GO:0032587;GO:0005085;GO:0042802;GO:0016477;GO:0046847;GO:0030032;GO:0030334;, C:cytoplasm; C:cytosol; C:filopodium; C:lamellipodium; C:nucleoplasm; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:cell migration; P:filopodium assembly; P:lamellipodium assembly; P:regulation of cell migration; scaffold1 indexed_genome mRNA 49022042 49040674 . - . ID=transcript_139;Q9Y217 B2RBB5 B3KSB4 Q5JRG6 Q86TB7 Q86YH4 Q96P80,Myotubularin-related protein 6 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0005635;GO:0048471;GO:0032587;GO:0052629;GO:0106018;GO:0004438;GO:0004722;GO:0004725;GO:0006897;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:nuclear envelope; C:perinuclear region of cytoplasm; C:ruffle membrane;, F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,5-bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:endocytosis; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation;|Q9Y217 B2RBB5 B3KSB4 Q5JRG6 Q86TB7 Q86YH4 Q96P80,Myotubularin-related protein 6 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0005635;GO:0048471;GO:0032587;GO:0052629;GO:0106018;GO:0004438;GO:0004722;GO:0004725;GO:0006897;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:nuclear envelope; C:perinuclear region of cytoplasm; C:ruffle membrane;, F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,5-bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:endocytosis; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation;|Q9Y217 B2RBB5 B3KSB4 Q5JRG6 Q86TB7 Q86YH4 Q96P80,Myotubularin-related protein 6 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0005635;GO:0048471;GO:0032587;GO:0052629;GO:0106018;GO:0004438;GO:0004722;GO:0004725;GO:0006897;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:nuclear envelope; C:perinuclear region of cytoplasm; C:ruffle membrane;, F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,5-bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:endocytosis; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; scaffold1 indexed_genome mRNA 49052837 49083595 . + . ID=transcript_140;Q9BVL2 A6NI12 B4DZJ1 O43160 Q5JRG2 Q5JRG5,Nucleoporin p58/p45 {ECO:0000305},58 kDa nucleoporin {ECO:0000312|HGNC:HGNC:20261};Nucleoporin-like protein 1;, , GO:0043657;GO:0005635;GO:0031965;GO:0005643;GO:0042802;GO:0008139;GO:0044877;GO:0017056;GO:0075733;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0042306;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, F:identical protein binding; F:nuclear localization sequence binding; F:protein-containing complex binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of protein import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BVL2 A6NI12 B4DZJ1 O43160 Q5JRG2 Q5JRG5,Nucleoporin p58/p45 {ECO:0000305},58 kDa nucleoporin {ECO:0000312|HGNC:HGNC:20261};Nucleoporin-like protein 1;, , GO:0043657;GO:0005635;GO:0031965;GO:0005643;GO:0042802;GO:0008139;GO:0044877;GO:0017056;GO:0075733;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0042306;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, F:identical protein binding; F:nuclear localization sequence binding; F:protein-containing complex binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of protein import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BVL2 A6NI12 B4DZJ1 O43160 Q5JRG2 Q5JRG5,Nucleoporin p58/p45 {ECO:0000305},58 kDa nucleoporin {ECO:0000312|HGNC:HGNC:20261};Nucleoporin-like protein 1;, , GO:0043657;GO:0005635;GO:0031965;GO:0005643;GO:0042802;GO:0008139;GO:0044877;GO:0017056;GO:0075733;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0042306;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, F:identical protein binding; F:nuclear localization sequence binding; F:protein-containing complex binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of protein import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BVL2 A6NI12 B4DZJ1 O43160 Q5JRG2 Q5JRG5,Nucleoporin p58/p45 {ECO:0000305},58 kDa nucleoporin {ECO:0000312|HGNC:HGNC:20261};Nucleoporin-like protein 1;, , GO:0043657;GO:0005635;GO:0031965;GO:0005643;GO:0042802;GO:0008139;GO:0044877;GO:0017056;GO:0075733;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0042306;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, F:identical protein binding; F:nuclear localization sequence binding; F:protein-containing complex binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of protein import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BVL2 A6NI12 B4DZJ1 O43160 Q5JRG2 Q5JRG5,Nucleoporin p58/p45 {ECO:0000305},58 kDa nucleoporin {ECO:0000312|HGNC:HGNC:20261};Nucleoporin-like protein 1;, , GO:0043657;GO:0005635;GO:0031965;GO:0005643;GO:0042802;GO:0008139;GO:0044877;GO:0017056;GO:0075733;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0042306;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, F:identical protein binding; F:nuclear localization sequence binding; F:protein-containing complex binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of protein import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold1 indexed_genome mRNA 49167742 49551707 . + . ID=transcript_141;Q9NTI2 Q6ZSP3 Q9H527 Q9NPU6 Q9NTL2 Q9NYM3,Phospholipid-transporting ATPase IB {ECO:0000305},ATPase class I type 8A member 2;ML-1;P4-ATPase flippase complex alpha subunit ATP8A2;, PF16212;PF16209;, GO:0005768;GO:0005794;GO:0016021;GO:0005654;GO:0001750;GO:0005886;GO:0005524;GO:0016887;GO:0140326;GO:0000287;GO:0090555;GO:0140346;GO:0007568;GO:0140331;GO:0007409;GO:0050908;GO:0042755;GO:0042472;GO:0003011;GO:0008285;GO:0060052;GO:0050884;GO:0048666;GO:0045332;GO:0040018;GO:0010976;GO:0061092;GO:0010996;GO:0010842;GO:0043588;, C:endosome; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:photoreceptor outer segment; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylethanolamine flippase activity; F:phosphatidylserine flippase activity;, P:aging; P:aminophospholipid translocation; P:axonogenesis; P:detection of light stimulus involved in visual perception; P:eating behavior; P:inner ear morphogenesis; P:involuntary skeletal muscle contraction; P:negative regulation of cell population proliferation; P:neurofilament cytoskeleton organization; P:neuromuscular process controlling posture; P:neuron development; P:phospholipid translocation; P:positive regulation of multicellular organism growth; P:positive regulation of neuron projection development; P:positive regulation of phospholipid translocation; P:response to auditory stimulus; P:retina layer formation; P:skin development;|Q9NTI2 Q6ZSP3 Q9H527 Q9NPU6 Q9NTL2 Q9NYM3,Phospholipid-transporting ATPase IB {ECO:0000305},ATPase class I type 8A member 2;ML-1;P4-ATPase flippase complex alpha subunit ATP8A2;, PF16212;PF16209;, GO:0005768;GO:0005794;GO:0016021;GO:0005654;GO:0001750;GO:0005886;GO:0005524;GO:0016887;GO:0140326;GO:0000287;GO:0090555;GO:0140346;GO:0007568;GO:0140331;GO:0007409;GO:0050908;GO:0042755;GO:0042472;GO:0003011;GO:0008285;GO:0060052;GO:0050884;GO:0048666;GO:0045332;GO:0040018;GO:0010976;GO:0061092;GO:0010996;GO:0010842;GO:0043588;, C:endosome; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:photoreceptor outer segment; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylethanolamine flippase activity; F:phosphatidylserine flippase activity;, P:aging; P:aminophospholipid translocation; P:axonogenesis; P:detection of light stimulus involved in visual perception; P:eating behavior; P:inner ear morphogenesis; P:involuntary skeletal muscle contraction; P:negative regulation of cell population proliferation; P:neurofilament cytoskeleton organization; P:neuromuscular process controlling posture; P:neuron development; P:phospholipid translocation; P:positive regulation of multicellular organism growth; P:positive regulation of neuron projection development; P:positive regulation of phospholipid translocation; P:response to auditory stimulus; P:retina layer formation; P:skin development; scaffold1 indexed_genome mRNA 49735976 49746365 . - . ID=transcript_142;Q9Y252 B4DDP0 Q5W0H0 Q9BZP5 Q9UF41,E3 ubiquitin-protein ligase RNF6,RING-type E3 ubiquitin transferase RNF6 {ECO:0000305};, PF13639;, GO:0030424;GO:0005737;GO:0043231;GO:0031965;GO:0005654;GO:0005634;GO:0016605;GO:0050681;GO:0046872;GO:0061630;GO:0004842;GO:0030517;GO:0045893;GO:0044314;GO:0070936;GO:0085020;GO:0016567;GO:0060765;GO:0006355;GO:0006511;, C:axon; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:PML body;, F:androgen receptor binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of axon extension; P:positive regulation of transcription, DNA-templated; P:protein K27-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein ubiquitination; P:regulation of androgen receptor signaling pathway; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process; scaffold1 indexed_genome mRNA 49760231 49841162 . + . ID=transcript_143;P49336 Q5VUF3 Q6ISB5,Cyclin-dependent kinase 8,Cell division protein kinase 8;Mediator complex subunit CDK8;Mediator of RNA polymerase II transcription subunit CDK8;Protein kinase K35;, PF00069;, GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0008353;GO:0045944;GO:0006468;GO:0060260;, C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter;|P49336 Q5VUF3 Q6ISB5,Cyclin-dependent kinase 8,Cell division protein kinase 8;Mediator complex subunit CDK8;Mediator of RNA polymerase II transcription subunit CDK8;Protein kinase K35;, PF00069;, GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0008353;GO:0045944;GO:0006468;GO:0060260;, C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter;|P49336 Q5VUF3 Q6ISB5,Cyclin-dependent kinase 8,Cell division protein kinase 8;Mediator complex subunit CDK8;Mediator of RNA polymerase II transcription subunit CDK8;Protein kinase K35;, PF00069;, GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0008353;GO:0045944;GO:0006468;GO:0060260;, C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter;|P49336 Q5VUF3 Q6ISB5,Cyclin-dependent kinase 8,Cell division protein kinase 8;Mediator complex subunit CDK8;Mediator of RNA polymerase II transcription subunit CDK8;Protein kinase K35;, PF00069;, GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0008353;GO:0045944;GO:0006468;GO:0060260;, C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter;|P49336 Q5VUF3 Q6ISB5,Cyclin-dependent kinase 8,Cell division protein kinase 8;Mediator complex subunit CDK8;Mediator of RNA polymerase II transcription subunit CDK8;Protein kinase K35;, PF00069;, GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0008353;GO:0045944;GO:0006468;GO:0060260;, C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter;|P49336 Q5VUF3 Q6ISB5,Cyclin-dependent kinase 8,Cell division protein kinase 8;Mediator complex subunit CDK8;Mediator of RNA polymerase II transcription subunit CDK8;Protein kinase K35;, PF00069;, GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0008353;GO:0045944;GO:0006468;GO:0060260;, C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter;|P49336 Q5VUF3 Q6ISB5,Cyclin-dependent kinase 8,Cell division protein kinase 8;Mediator complex subunit CDK8;Mediator of RNA polymerase II transcription subunit CDK8;Protein kinase K35;, PF00069;, GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0008353;GO:0045944;GO:0006468;GO:0060260;, C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter; scaffold1 indexed_genome mRNA 49964209 50005876 . + . ID=transcript_144;Q9UPY6 O94974 Q86VQ2,Wiskott-Aldrich syndrome protein family member 3,Protein WAVE-3;Verprolin homology domain-containing protein 3;, PF02205;, GO:0005856;GO:0070062;GO:0098978;GO:0030027;GO:0098794;GO:0031209;GO:0003779;GO:0071933;GO:0034237;GO:0030036;GO:0030041;GO:0007010;GO:0030032;GO:0098885;GO:0014003;GO:2000601;GO:0031643;GO:0065003;GO:0008360;, C:cytoskeleton; C:extracellular exosome; C:glutamatergic synapse; C:lamellipodium; C:postsynapse; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cytoskeleton organization; P:lamellipodium assembly; P:modification of postsynaptic actin cytoskeleton; P:oligodendrocyte development; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of myelination; P:protein-containing complex assembly; P:regulation of cell shape;|Q9UPY6 O94974 Q86VQ2,Wiskott-Aldrich syndrome protein family member 3,Protein WAVE-3;Verprolin homology domain-containing protein 3;, PF02205;, GO:0005856;GO:0070062;GO:0098978;GO:0030027;GO:0098794;GO:0031209;GO:0003779;GO:0071933;GO:0034237;GO:0030036;GO:0030041;GO:0007010;GO:0030032;GO:0098885;GO:0014003;GO:2000601;GO:0031643;GO:0065003;GO:0008360;, C:cytoskeleton; C:extracellular exosome; C:glutamatergic synapse; C:lamellipodium; C:postsynapse; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cytoskeleton organization; P:lamellipodium assembly; P:modification of postsynaptic actin cytoskeleton; P:oligodendrocyte development; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of myelination; P:protein-containing complex assembly; P:regulation of cell shape;|Q9Y6W5 B4DZN0 O60794 Q9UDY7,Wiskott-Aldrich syndrome protein family member 2,Protein WAVE-2;Verprolin homology domain-containing protein 2;, PF02205;, GO:0015629;GO:0016323;GO:0005911;GO:0005829;GO:0005769;GO:0070062;GO:0030027;GO:0032991;GO:0001726;GO:0031209;GO:0045202;GO:0003779;GO:0071933;GO:0045296;GO:0051018;GO:0034237;GO:0017124;GO:0030036;GO:0030048;GO:0007188;GO:0001667;GO:0001525;GO:0006897;GO:0038096;GO:0030032;GO:0072673;GO:0035855;GO:0051497;GO:2000601;GO:0010592;GO:0098974;GO:0016601;GO:0048010;GO:0016032;, C:actin cytoskeleton; C:basolateral plasma membrane; C:cell-cell junction; C:cytosol; C:early endosome; C:extracellular exosome; C:lamellipodium; C:protein-containing complex; C:ruffle; C:SCAR complex; C:synapse;, F:actin binding; F:Arp2/3 complex binding; F:cadherin binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding; F:SH3 domain binding;, P:actin cytoskeleton organization; P:actin filament-based movement; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:ameboidal-type cell migration; P:angiogenesis; P:endocytosis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium assembly; P:lamellipodium morphogenesis; P:megakaryocyte development; P:negative regulation of stress fiber assembly; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:postsynaptic actin cytoskeleton organization; P:Rac protein signal transduction; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; scaffold1 indexed_genome mRNA 50005893 50012326 . + . ID=transcript_145;Q9UPY6 O94974 Q86VQ2,Wiskott-Aldrich syndrome protein family member 3,Protein WAVE-3;Verprolin homology domain-containing protein 3;, PF02205;, GO:0005856;GO:0070062;GO:0098978;GO:0030027;GO:0098794;GO:0031209;GO:0003779;GO:0071933;GO:0034237;GO:0030036;GO:0030041;GO:0007010;GO:0030032;GO:0098885;GO:0014003;GO:2000601;GO:0031643;GO:0065003;GO:0008360;, C:cytoskeleton; C:extracellular exosome; C:glutamatergic synapse; C:lamellipodium; C:postsynapse; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cytoskeleton organization; P:lamellipodium assembly; P:modification of postsynaptic actin cytoskeleton; P:oligodendrocyte development; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of myelination; P:protein-containing complex assembly; P:regulation of cell shape;|Q9UPY6 O94974 Q86VQ2,Wiskott-Aldrich syndrome protein family member 3,Protein WAVE-3;Verprolin homology domain-containing protein 3;, PF02205;, GO:0005856;GO:0070062;GO:0098978;GO:0030027;GO:0098794;GO:0031209;GO:0003779;GO:0071933;GO:0034237;GO:0030036;GO:0030041;GO:0007010;GO:0030032;GO:0098885;GO:0014003;GO:2000601;GO:0031643;GO:0065003;GO:0008360;, C:cytoskeleton; C:extracellular exosome; C:glutamatergic synapse; C:lamellipodium; C:postsynapse; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cytoskeleton organization; P:lamellipodium assembly; P:modification of postsynaptic actin cytoskeleton; P:oligodendrocyte development; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of myelination; P:protein-containing complex assembly; P:regulation of cell shape; scaffold1 indexed_genome mRNA 50051059 50052015 . + . ID=transcript_146;P47775 Q5T8P3,G-protein coupled receptor 12,, PF00001;, GO:0005737;GO:0005887;GO:0005886;GO:0004930;GO:0031210;GO:0007189;GO:0006874;GO:0007186;GO:0019222;, C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:phosphatidylcholine binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular calcium ion homeostasis; P:G protein-coupled receptor signaling pathway; P:regulation of metabolic process; scaffold1 indexed_genome mRNA 50207173 50214273 . - . ID=transcript_147;O75317 A8K0X0 Q5VZV3 Q8TC49,Ubiquitin carboxyl-terminal hydrolase 12,Deubiquitinating enzyme 12;Ubiquitin thioesterase 12;Ubiquitin-hydrolyzing enzyme 1;Ubiquitin-specific-processing protease 12;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0046872;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|P62068 B7Z3Y7 B7Z675 B7Z7S3 G8ACC7 Q80V95 Q9H7U4 Q9H9T8,Ubiquitin carboxyl-terminal hydrolase 46,Deubiquitinating enzyme 46;Ubiquitin thioesterase 46;Ubiquitin-specific-processing protease 46;, PF00443;, GO:0005829;GO:0098978;GO:0005634;GO:0004197;GO:0046872;GO:0004843;GO:0008343;GO:0001662;GO:0048149;GO:0016579;GO:0099149;GO:0032228;GO:0060013;GO:0006511;, C:cytosol; C:glutamatergic synapse; C:nucleus;, F:cysteine-type endopeptidase activity; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity;, P:adult feeding behavior; P:behavioral fear response; P:behavioral response to ethanol; P:protein deubiquitination; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of synaptic transmission, GABAergic; P:righting reflex; P:ubiquitin-dependent protein catabolic process;|O75317 A8K0X0 Q5VZV3 Q8TC49,Ubiquitin carboxyl-terminal hydrolase 12,Deubiquitinating enzyme 12;Ubiquitin thioesterase 12;Ubiquitin-hydrolyzing enzyme 1;Ubiquitin-specific-processing protease 12;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0046872;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold1 indexed_genome mRNA 50300283 50301881 . + . ID=transcript_148;P46778 Q16699,60S ribosomal protein L21,Large ribosomal subunit protein eL21 {ECO:0000303|PubMed:24524803};, PF01157;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold1 indexed_genome mRNA 50316428 50317848 . - . ID=transcript_149;Q6T310 B2RN97,Ras-like protein family member 11A,, PF00071;, GO:0016020;GO:0005730;GO:0005525;GO:0003924;GO:0045943;GO:0007165;, C:membrane; C:nucleolus;, F:GTP binding; F:GTPase activity;, P:positive regulation of transcription by RNA polymerase I; P:signal transduction;|Q6T310 B2RN97,Ras-like protein family member 11A,, PF00071;, GO:0016020;GO:0005730;GO:0005525;GO:0003924;GO:0045943;GO:0007165;, C:membrane; C:nucleolus;, F:GTP binding; F:GTPase activity;, P:positive regulation of transcription by RNA polymerase I; P:signal transduction; scaffold1 indexed_genome mRNA 50422821 50443544 . + . ID=transcript_150;Q92664 B7ZBK5 Q12963 Q13097,Transcription factor IIIA,, PF00096;, GO:0005654;GO:0005634;GO:0008097;GO:0003677;GO:0046872;GO:0042273;GO:0009303;GO:0006383;, C:nucleoplasm; C:nucleus;, F:5S rRNA binding; F:DNA binding; F:metal ion binding;, P:ribosomal large subunit biogenesis; P:rRNA transcription; P:transcription by RNA polymerase III;|Q92664 B7ZBK5 Q12963 Q13097,Transcription factor IIIA,, PF00096;, GO:0005654;GO:0005634;GO:0008097;GO:0003677;GO:0046872;GO:0042273;GO:0009303;GO:0006383;, C:nucleoplasm; C:nucleus;, F:5S rRNA binding; F:DNA binding; F:metal ion binding;, P:ribosomal large subunit biogenesis; P:rRNA transcription; P:transcription by RNA polymerase III;|Q92664 B7ZBK5 Q12963 Q13097,Transcription factor IIIA,, PF00096;, GO:0005654;GO:0005634;GO:0008097;GO:0003677;GO:0046872;GO:0042273;GO:0009303;GO:0006383;, C:nucleoplasm; C:nucleus;, F:5S rRNA binding; F:DNA binding; F:metal ion binding;, P:ribosomal large subunit biogenesis; P:rRNA transcription; P:transcription by RNA polymerase III;|Q92664 B7ZBK5 Q12963 Q13097,Transcription factor IIIA,, PF00096;, GO:0005654;GO:0005634;GO:0008097;GO:0003677;GO:0046872;GO:0042273;GO:0009303;GO:0006383;, C:nucleoplasm; C:nucleus;, F:5S rRNA binding; F:DNA binding; F:metal ion binding;, P:ribosomal large subunit biogenesis; P:rRNA transcription; P:transcription by RNA polymerase III;|Q9H2K0 Q05BL8 Q5W0V0 Q86X68,Translation initiation factor IF-3, mitochondrial,, PF05198;, GO:0005739;GO:0043024;GO:0043022;GO:0008135;GO:0003743;GO:0070124;GO:0032790;, C:mitochondrion;, F:ribosomal small subunit binding; F:ribosome binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:mitochondrial translational initiation; P:ribosome disassembly; scaffold1 indexed_genome mRNA 50507504 50550598 . - . ID=transcript_151;Q8N448 Q5W0P0 Q6ZMH2 Q96SH4,Ligand of Numb protein X 2,Numb-binding protein 2;PDZ domain-containing RING finger protein 1;, PF00595;, GO:0042802;GO:0046872;GO:0030165;, , F:identical protein binding; F:metal ion binding; F:PDZ domain binding;|Q8N448 Q5W0P0 Q6ZMH2 Q96SH4,Ligand of Numb protein X 2,Numb-binding protein 2;PDZ domain-containing RING finger protein 1;, PF00595;, GO:0042802;GO:0046872;GO:0030165;, , F:identical protein binding; F:metal ion binding; F:PDZ domain binding; scaffold1 indexed_genome mRNA 50609388 50610669 . + . ID=transcript_152;P0DPB6 Q5TBX2 Q96BR3 Q9Y2S0,DNA-directed RNA polymerases I and III subunit RPAC2,AC19;DNA-directed RNA polymerase I subunit D;RNA polymerase I 16 kDa subunit;RPC16;hRPA19;, PF13656;, GO:0005736;GO:0005666;GO:0003677;GO:0003899;GO:0046983;GO:0006351;, C:RNA polymerase I complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:protein dimerization activity;, P:transcription, DNA-templated; scaffold1 indexed_genome mRNA 50629389 50641746 . - . ID=transcript_153;P0DPB5 Q5TBX2 Q96BR3 Q9Y2S0,Protein POLR1D, isoform 2,, , GO:0005829;GO:0005654;GO:0045815;GO:0032481;GO:0006363;GO:0006361;, C:cytosol; C:nucleoplasm;, , P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter;|P0DPB5 Q5TBX2 Q96BR3 Q9Y2S0,Protein POLR1D, isoform 2,, , GO:0005829;GO:0005654;GO:0045815;GO:0032481;GO:0006363;GO:0006361;, C:cytosol; C:nucleoplasm;, , P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; scaffold1 indexed_genome mRNA 50869716 50873801 . - . ID=transcript_154;P36888 A0AVG9 B7ZLT7 B7ZLT8 F5H0A0 Q13414,Receptor-type tyrosine-protein kinase FLT3,FL cytokine receptor;Fetal liver kinase-2;Fms-like tyrosine kinase 3;Stem cell tyrosine kinase 1;, PF00047;PF07714;, GO:0005829;GO:0005783;GO:0005788;GO:0010008;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0004896;GO:0035259;GO:0019838;GO:0043621;GO:0044877;GO:0004714;GO:0005021;GO:0031100;GO:0030183;GO:0071345;GO:0071385;GO:0035726;GO:0019221;GO:0097028;GO:0030097;GO:0001776;GO:0046651;GO:0000165;GO:0007275;GO:0002318;GO:0018108;GO:0008284;GO:0033674;GO:0043406;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0042531;GO:0002328;GO:0046777;GO:0042981;GO:0010243;GO:0007169;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endosome membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:cytokine receptor activity; F:glucocorticoid receptor binding; F:growth factor binding; F:protein self-association; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor-activated receptor activity;, P:animal organ regeneration; P:B cell differentiation; P:cellular response to cytokine stimulus; P:cellular response to glucocorticoid stimulus; P:common myeloid progenitor cell proliferation; P:cytokine-mediated signaling pathway; P:dendritic cell differentiation; P:hemopoiesis; P:leukocyte homeostasis; P:lymphocyte proliferation; P:MAPK cascade; P:multicellular organism development; P:myeloid progenitor cell differentiation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:pro-B cell differentiation; P:protein autophosphorylation; P:regulation of apoptotic process; P:response to organonitrogen compound; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|P36888 A0AVG9 B7ZLT7 B7ZLT8 F5H0A0 Q13414,Receptor-type tyrosine-protein kinase FLT3,FL cytokine receptor;Fetal liver kinase-2;Fms-like tyrosine kinase 3;Stem cell tyrosine kinase 1;, PF00047;PF07714;, GO:0005829;GO:0005783;GO:0005788;GO:0010008;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0004896;GO:0035259;GO:0019838;GO:0043621;GO:0044877;GO:0004714;GO:0005021;GO:0031100;GO:0030183;GO:0071345;GO:0071385;GO:0035726;GO:0019221;GO:0097028;GO:0030097;GO:0001776;GO:0046651;GO:0000165;GO:0007275;GO:0002318;GO:0018108;GO:0008284;GO:0033674;GO:0043406;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0042531;GO:0002328;GO:0046777;GO:0042981;GO:0010243;GO:0007169;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endosome membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:cytokine receptor activity; F:glucocorticoid receptor binding; F:growth factor binding; F:protein self-association; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor-activated receptor activity;, P:animal organ regeneration; P:B cell differentiation; P:cellular response to cytokine stimulus; P:cellular response to glucocorticoid stimulus; P:common myeloid progenitor cell proliferation; P:cytokine-mediated signaling pathway; P:dendritic cell differentiation; P:hemopoiesis; P:leukocyte homeostasis; P:lymphocyte proliferation; P:MAPK cascade; P:multicellular organism development; P:myeloid progenitor cell differentiation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:pro-B cell differentiation; P:protein autophosphorylation; P:regulation of apoptotic process; P:response to organonitrogen compound; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process; scaffold1 indexed_genome mRNA 50875455 50883501 . - . ID=transcript_155;P36888 A0AVG9 B7ZLT7 B7ZLT8 F5H0A0 Q13414,Receptor-type tyrosine-protein kinase FLT3,FL cytokine receptor;Fetal liver kinase-2;Fms-like tyrosine kinase 3;Stem cell tyrosine kinase 1;, PF00047;PF07714;, GO:0005829;GO:0005783;GO:0005788;GO:0010008;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0004896;GO:0035259;GO:0019838;GO:0043621;GO:0044877;GO:0004714;GO:0005021;GO:0031100;GO:0030183;GO:0071345;GO:0071385;GO:0035726;GO:0019221;GO:0097028;GO:0030097;GO:0001776;GO:0046651;GO:0000165;GO:0007275;GO:0002318;GO:0018108;GO:0008284;GO:0033674;GO:0043406;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0042531;GO:0002328;GO:0046777;GO:0042981;GO:0010243;GO:0007169;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endosome membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:cytokine receptor activity; F:glucocorticoid receptor binding; F:growth factor binding; F:protein self-association; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor-activated receptor activity;, P:animal organ regeneration; P:B cell differentiation; P:cellular response to cytokine stimulus; P:cellular response to glucocorticoid stimulus; P:common myeloid progenitor cell proliferation; P:cytokine-mediated signaling pathway; P:dendritic cell differentiation; P:hemopoiesis; P:leukocyte homeostasis; P:lymphocyte proliferation; P:MAPK cascade; P:multicellular organism development; P:myeloid progenitor cell differentiation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:pro-B cell differentiation; P:protein autophosphorylation; P:regulation of apoptotic process; P:response to organonitrogen compound; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|P36888 A0AVG9 B7ZLT7 B7ZLT8 F5H0A0 Q13414,Receptor-type tyrosine-protein kinase FLT3,FL cytokine receptor;Fetal liver kinase-2;Fms-like tyrosine kinase 3;Stem cell tyrosine kinase 1;, PF00047;PF07714;, GO:0005829;GO:0005783;GO:0005788;GO:0010008;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0004896;GO:0035259;GO:0019838;GO:0043621;GO:0044877;GO:0004714;GO:0005021;GO:0031100;GO:0030183;GO:0071345;GO:0071385;GO:0035726;GO:0019221;GO:0097028;GO:0030097;GO:0001776;GO:0046651;GO:0000165;GO:0007275;GO:0002318;GO:0018108;GO:0008284;GO:0033674;GO:0043406;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0042531;GO:0002328;GO:0046777;GO:0042981;GO:0010243;GO:0007169;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endosome membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:cytokine receptor activity; F:glucocorticoid receptor binding; F:growth factor binding; F:protein self-association; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor-activated receptor activity;, P:animal organ regeneration; P:B cell differentiation; P:cellular response to cytokine stimulus; P:cellular response to glucocorticoid stimulus; P:common myeloid progenitor cell proliferation; P:cytokine-mediated signaling pathway; P:dendritic cell differentiation; P:hemopoiesis; P:leukocyte homeostasis; P:lymphocyte proliferation; P:MAPK cascade; P:multicellular organism development; P:myeloid progenitor cell differentiation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:pro-B cell differentiation; P:protein autophosphorylation; P:regulation of apoptotic process; P:response to organonitrogen compound; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process; scaffold1 indexed_genome mRNA 50884513 50923737 . - . ID=transcript_156;P36888 A0AVG9 B7ZLT7 B7ZLT8 F5H0A0 Q13414,Receptor-type tyrosine-protein kinase FLT3,FL cytokine receptor;Fetal liver kinase-2;Fms-like tyrosine kinase 3;Stem cell tyrosine kinase 1;, PF00047;PF07714;, GO:0005829;GO:0005783;GO:0005788;GO:0010008;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0004896;GO:0035259;GO:0019838;GO:0043621;GO:0044877;GO:0004714;GO:0005021;GO:0031100;GO:0030183;GO:0071345;GO:0071385;GO:0035726;GO:0019221;GO:0097028;GO:0030097;GO:0001776;GO:0046651;GO:0000165;GO:0007275;GO:0002318;GO:0018108;GO:0008284;GO:0033674;GO:0043406;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0042531;GO:0002328;GO:0046777;GO:0042981;GO:0010243;GO:0007169;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endosome membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:cytokine receptor activity; F:glucocorticoid receptor binding; F:growth factor binding; F:protein self-association; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor-activated receptor activity;, P:animal organ regeneration; P:B cell differentiation; P:cellular response to cytokine stimulus; P:cellular response to glucocorticoid stimulus; P:common myeloid progenitor cell proliferation; P:cytokine-mediated signaling pathway; P:dendritic cell differentiation; P:hemopoiesis; P:leukocyte homeostasis; P:lymphocyte proliferation; P:MAPK cascade; P:multicellular organism development; P:myeloid progenitor cell differentiation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:pro-B cell differentiation; P:protein autophosphorylation; P:regulation of apoptotic process; P:response to organonitrogen compound; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process; scaffold1 indexed_genome mRNA 51000730 51102387 . + . ID=transcript_157;Q5T516 Q5TBA0 Q76E13 Q8NBA6,PAN2-PAN3 deadenylation complex subunit PAN3 {ECO:0000255|HAMAP-Rule:MF_03181},PAB1P-dependent poly(A)-specific ribonuclease {ECO:0000255|HAMAP-Rule:MF_03181};Poly(A)-nuclease deadenylation complex subunit 3 {ECO:0000255|HAMAP-Rule:MF_03181};, PF18101;, GO:0005829;GO:0000932;GO:0031251;GO:0005524;GO:0046872;GO:0004672;GO:0003723;GO:0006397;GO:0000289;GO:0010606;GO:0090503;, C:cytosol; C:P-body; C:PAN complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:RNA binding;, P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:RNA phosphodiester bond hydrolysis, exonucleolytic;|Q02224 A6NKY9 A8K2U7 Q4LE75,Centromere-associated protein E,Centromere protein E;Kinesin-7 {ECO:0000303|PubMed:25908662};Kinesin-related protein CENPE;, PF00225;, GO:0005694;GO:0000775;GO:0000777;GO:0000779;GO:0005829;GO:0000776;GO:0005828;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0043515;GO:0008017;GO:0003777;GO:0019886;GO:0051315;GO:0051301;GO:0007059;GO:0051382;GO:0099607;GO:0051310;GO:0099606;GO:0007018;GO:0000278;GO:0007079;GO:0007080;GO:0007052;GO:0007275;GO:0045860;GO:0030071;GO:0006890;, C:chromosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:condensed chromosome, centromeric region; C:cytosol; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:kinetochore binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore assembly; P:lateral attachment of mitotic spindle microtubules to kinetochore; P:metaphase plate congression; P:microtubule plus-end directed mitotic chromosome migration; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:multicellular organism development; P:positive regulation of protein kinase activity; P:regulation of mitotic metaphase/anaphase transition; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q02224 A6NKY9 A8K2U7 Q4LE75,Centromere-associated protein E,Centromere protein E;Kinesin-7 {ECO:0000303|PubMed:25908662};Kinesin-related protein CENPE;, PF00225;, GO:0005694;GO:0000775;GO:0000777;GO:0000779;GO:0005829;GO:0000776;GO:0005828;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0043515;GO:0008017;GO:0003777;GO:0019886;GO:0051315;GO:0051301;GO:0007059;GO:0051382;GO:0099607;GO:0051310;GO:0099606;GO:0007018;GO:0000278;GO:0007079;GO:0007080;GO:0007052;GO:0007275;GO:0045860;GO:0030071;GO:0006890;, C:chromosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:condensed chromosome, centromeric region; C:cytosol; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:kinetochore binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore assembly; P:lateral attachment of mitotic spindle microtubules to kinetochore; P:metaphase plate congression; P:microtubule plus-end directed mitotic chromosome migration; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:multicellular organism development; P:positive regulation of protein kinase activity; P:regulation of mitotic metaphase/anaphase transition; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q02224 A6NKY9 A8K2U7 Q4LE75,Centromere-associated protein E,Centromere protein E;Kinesin-7 {ECO:0000303|PubMed:25908662};Kinesin-related protein CENPE;, PF00225;, GO:0005694;GO:0000775;GO:0000777;GO:0000779;GO:0005829;GO:0000776;GO:0005828;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0043515;GO:0008017;GO:0003777;GO:0019886;GO:0051315;GO:0051301;GO:0007059;GO:0051382;GO:0099607;GO:0051310;GO:0099606;GO:0007018;GO:0000278;GO:0007079;GO:0007080;GO:0007052;GO:0007275;GO:0045860;GO:0030071;GO:0006890;, C:chromosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:condensed chromosome, centromeric region; C:cytosol; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:kinetochore binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore assembly; P:lateral attachment of mitotic spindle microtubules to kinetochore; P:metaphase plate congression; P:microtubule plus-end directed mitotic chromosome migration; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:multicellular organism development; P:positive regulation of protein kinase activity; P:regulation of mitotic metaphase/anaphase transition; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q5T516 Q5TBA0 Q76E13 Q8NBA6,PAN2-PAN3 deadenylation complex subunit PAN3 {ECO:0000255|HAMAP-Rule:MF_03181},PAB1P-dependent poly(A)-specific ribonuclease {ECO:0000255|HAMAP-Rule:MF_03181};Poly(A)-nuclease deadenylation complex subunit 3 {ECO:0000255|HAMAP-Rule:MF_03181};, PF18101;, GO:0005829;GO:0000932;GO:0031251;GO:0005524;GO:0046872;GO:0004672;GO:0003723;GO:0006397;GO:0000289;GO:0010606;GO:0090503;, C:cytosol; C:P-body; C:PAN complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:RNA binding;, P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:RNA phosphodiester bond hydrolysis, exonucleolytic;|Q5T516 Q5TBA0 Q76E13 Q8NBA6,PAN2-PAN3 deadenylation complex subunit PAN3 {ECO:0000255|HAMAP-Rule:MF_03181},PAB1P-dependent poly(A)-specific ribonuclease {ECO:0000255|HAMAP-Rule:MF_03181};Poly(A)-nuclease deadenylation complex subunit 3 {ECO:0000255|HAMAP-Rule:MF_03181};, PF18101;, GO:0005829;GO:0000932;GO:0031251;GO:0005524;GO:0046872;GO:0004672;GO:0003723;GO:0006397;GO:0000289;GO:0010606;GO:0090503;, C:cytosol; C:P-body; C:PAN complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:RNA binding;, P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:RNA phosphodiester bond hydrolysis, exonucleolytic;|Q5T516 Q5TBA0 Q76E13 Q8NBA6,PAN2-PAN3 deadenylation complex subunit PAN3 {ECO:0000255|HAMAP-Rule:MF_03181},PAB1P-dependent poly(A)-specific ribonuclease {ECO:0000255|HAMAP-Rule:MF_03181};Poly(A)-nuclease deadenylation complex subunit 3 {ECO:0000255|HAMAP-Rule:MF_03181};, PF18101;, GO:0005829;GO:0000932;GO:0031251;GO:0005524;GO:0046872;GO:0004672;GO:0003723;GO:0006397;GO:0000289;GO:0010606;GO:0090503;, C:cytosol; C:P-body; C:PAN complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:RNA binding;, P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:RNA phosphodiester bond hydrolysis, exonucleolytic;|Q5T516 Q5TBA0 Q76E13 Q8NBA6,PAN2-PAN3 deadenylation complex subunit PAN3 {ECO:0000255|HAMAP-Rule:MF_03181},PAB1P-dependent poly(A)-specific ribonuclease {ECO:0000255|HAMAP-Rule:MF_03181};Poly(A)-nuclease deadenylation complex subunit 3 {ECO:0000255|HAMAP-Rule:MF_03181};, PF18101;, GO:0005829;GO:0000932;GO:0031251;GO:0005524;GO:0046872;GO:0004672;GO:0003723;GO:0006397;GO:0000289;GO:0010606;GO:0090503;, C:cytosol; C:P-body; C:PAN complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:RNA binding;, P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:RNA phosphodiester bond hydrolysis, exonucleolytic; scaffold1 indexed_genome mRNA 51111146 51309515 . - . ID=transcript_158;B5A923 F5H5L6 O60722 P16057 Q12954,Vascular endothelial growth factor receptor 1,Fms-like tyrosine kinase 1;Tyrosine-protein kinase FRT;Tyrosine-protein kinase receptor FLT;Vascular permeability factor receptor;, PF07679;PF00047;PF07714;PF17988;, GO:0015629;GO:0005768;GO:0005615;GO:0005925;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0036332;GO:0004714;GO:0005021;GO:0001525;GO:0048514;GO:0016477;GO:0035924;GO:0048598;GO:0002244;GO:1990384;GO:0002548;GO:0007275;GO:1905563;GO:0018108;GO:0045766;GO:0030335;GO:0008284;GO:0033674;GO:0043406;GO:0043410;GO:0043552;GO:0014068;GO:0010863;GO:0046777;GO:0007169;GO:0048010;GO:0036323;, C:actin cytoskeleton; C:endosome; C:extracellular space; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:placental growth factor-activated receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor-activated receptor activity;, P:angiogenesis; P:blood vessel morphogenesis; P:cell migration; P:cellular response to vascular endothelial growth factor stimulus; P:embryonic morphogenesis; P:hematopoietic progenitor cell differentiation; P:hyaloid vascular plexus regression; P:monocyte chemotaxis; P:multicellular organism development; P:negative regulation of vascular endothelial cell proliferation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:protein autophosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor receptor-1 signaling pathway;|B5A923 F5H5L6 O60722 P16057 Q12954,Vascular endothelial growth factor receptor 1,Fms-like tyrosine kinase 1;Tyrosine-protein kinase FRT;Tyrosine-protein kinase receptor FLT;Vascular permeability factor receptor;, PF07679;PF00047;PF07714;PF17988;, GO:0015629;GO:0005768;GO:0005615;GO:0005925;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0036332;GO:0004714;GO:0005021;GO:0001525;GO:0048514;GO:0016477;GO:0035924;GO:0048598;GO:0002244;GO:1990384;GO:0002548;GO:0007275;GO:1905563;GO:0018108;GO:0045766;GO:0030335;GO:0008284;GO:0033674;GO:0043406;GO:0043410;GO:0043552;GO:0014068;GO:0010863;GO:0046777;GO:0007169;GO:0048010;GO:0036323;, C:actin cytoskeleton; C:endosome; C:extracellular space; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:placental growth factor-activated receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor-activated receptor activity;, P:angiogenesis; P:blood vessel morphogenesis; P:cell migration; P:cellular response to vascular endothelial growth factor stimulus; P:embryonic morphogenesis; P:hematopoietic progenitor cell differentiation; P:hyaloid vascular plexus regression; P:monocyte chemotaxis; P:multicellular organism development; P:negative regulation of vascular endothelial cell proliferation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:protein autophosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor receptor-1 signaling pathway;|B5A923 F5H5L6 O60722 P16057 Q12954,Vascular endothelial growth factor receptor 1,Fms-like tyrosine kinase 1;Tyrosine-protein kinase FRT;Tyrosine-protein kinase receptor FLT;Vascular permeability factor receptor;, PF07679;PF00047;PF07714;PF17988;, GO:0015629;GO:0005768;GO:0005615;GO:0005925;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0036332;GO:0004714;GO:0005021;GO:0001525;GO:0048514;GO:0016477;GO:0035924;GO:0048598;GO:0002244;GO:1990384;GO:0002548;GO:0007275;GO:1905563;GO:0018108;GO:0045766;GO:0030335;GO:0008284;GO:0033674;GO:0043406;GO:0043410;GO:0043552;GO:0014068;GO:0010863;GO:0046777;GO:0007169;GO:0048010;GO:0036323;, C:actin cytoskeleton; C:endosome; C:extracellular space; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:placental growth factor-activated receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor-activated receptor activity;, P:angiogenesis; P:blood vessel morphogenesis; P:cell migration; P:cellular response to vascular endothelial growth factor stimulus; P:embryonic morphogenesis; P:hematopoietic progenitor cell differentiation; P:hyaloid vascular plexus regression; P:monocyte chemotaxis; P:multicellular organism development; P:negative regulation of vascular endothelial cell proliferation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:protein autophosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor receptor-1 signaling pathway; scaffold1 indexed_genome mRNA 51439836 51456321 . + . ID=transcript_159;Q9Y244 A5HKJ2 D6MXU3 Q9HB69,Proteasome maturation protein,Proteassemblin;Protein UMP1 homolog;Voltage-gated K channel beta subunit 4.1;, PF05348;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0016607;GO:0005634;GO:0043248;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane; C:nuclear speck; C:nucleus;, , P:proteasome assembly; scaffold1 indexed_genome mRNA 51466334 51492887 . - . ID=transcript_160;Q7Z3Q1 Q3ZCV8 Q6NUK5 Q6P9B3 Q6ZVG5 Q96QA1,Solute carrier family 46 member 3,, PF07690;, GO:0070062;GO:1905103;GO:0022857;GO:0034486;, C:extracellular exosome; C:integral component of lysosomal membrane;, F:transmembrane transporter activity;, P:vacuolar transmembrane transport; scaffold1 indexed_genome mRNA 51662997 51802332 . + . ID=transcript_161;Q5JR59 A7E292 B4DF81 O94872 Q08E97 Q5JQR3 Q8N5E2,Microtubule-associated tumor suppressor candidate 2,Cardiac zipper protein;Microtubule plus-end tracking protein TIP150;, , GO:0005737;GO:0005874;GO:0005634;GO:0008017;GO:0042803;, C:cytoplasm; C:microtubule; C:nucleus;, F:microtubule binding; F:protein homodimerization activity; scaffold1 indexed_genome mRNA 51850326 51914227 . + . ID=transcript_162;Q5JR59 A7E292 B4DF81 O94872 Q08E97 Q5JQR3 Q8N5E2,Microtubule-associated tumor suppressor candidate 2,Cardiac zipper protein;Microtubule plus-end tracking protein TIP150;, , GO:0005737;GO:0005874;GO:0005634;GO:0008017;GO:0042803;, C:cytoplasm; C:microtubule; C:nucleus;, F:microtubule binding; F:protein homodimerization activity;|Q5JR59 A7E292 B4DF81 O94872 Q08E97 Q5JQR3 Q8N5E2,Microtubule-associated tumor suppressor candidate 2,Cardiac zipper protein;Microtubule plus-end tracking protein TIP150;, , GO:0005737;GO:0005874;GO:0005634;GO:0008017;GO:0042803;, C:cytoplasm; C:microtubule; C:nucleus;, F:microtubule binding; F:protein homodimerization activity;|Q5JR59 A7E292 B4DF81 O94872 Q08E97 Q5JQR3 Q8N5E2,Microtubule-associated tumor suppressor candidate 2,Cardiac zipper protein;Microtubule plus-end tracking protein TIP150;, , GO:0005737;GO:0005874;GO:0005634;GO:0008017;GO:0042803;, C:cytoplasm; C:microtubule; C:nucleus;, F:microtubule binding; F:protein homodimerization activity; scaffold1 indexed_genome mRNA 52074962 52082275 . - . ID=transcript_163;O95164 B2R4J1 Q5RL72 Q5VZS0 Q6FIG8 Q96SG7,Ubiquitin-like protein 3,Membrane-anchored ubiquitin-fold protein;Protein HCG-1;, PF13881;, GO:0070062;GO:0005886;, C:extracellular exosome; C:plasma membrane;|O95164 B2R4J1 Q5RL72 Q5VZS0 Q6FIG8 Q96SG7,Ubiquitin-like protein 3,Membrane-anchored ubiquitin-fold protein;Protein HCG-1;, PF13881;, GO:0070062;GO:0005886;, C:extracellular exosome; C:plasma membrane; scaffold1 indexed_genome mRNA 52088379 52089420 . + . ID=transcript_164;O95164 B2R4J1 Q5RL72 Q5VZS0 Q6FIG8 Q96SG7,Ubiquitin-like protein 3,Membrane-anchored ubiquitin-fold protein;Protein HCG-1;, PF13881;, GO:0070062;GO:0005886;, C:extracellular exosome; C:plasma membrane; scaffold1 indexed_genome mRNA 52405878 52461716 . - . ID=transcript_165;Q9BW62 A8K5X4,Katanin p60 ATPase-containing subunit A-like 1 {ECO:0000255|HAMAP-Rule:MF_03024},p60 katanin-like 1 {ECO:0000255|HAMAP-Rule:MF_03024};, PF00004;PF17862;PF09336;, GO:0005813;GO:0005737;GO:0005874;GO:0015630;GO:0005634;GO:0005819;GO:0000922;GO:0005524;GO:0016887;GO:0042802;GO:0016853;GO:0008017;GO:0008568;GO:0031122;GO:0051013;GO:0007283;, C:centrosome; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:spindle; C:spindle pole;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity;, P:cytoplasmic microtubule organization; P:microtubule severing; P:spermatogenesis; scaffold1 indexed_genome mRNA 52726179 52752089 . + . ID=transcript_166;Q5W0Q7 Q14109 Q6AI45 Q8IY30 Q8IYE8,SUMO-specific isopeptidase USPL1,Ubiquitin-specific peptidase-like protein 1;, PF15509;PF15499;, GO:0015030;GO:0005615;GO:0032183;GO:0070140;GO:0030576;GO:0008283;GO:0016926;GO:0009301;, C:Cajal body; C:extracellular space;, F:SUMO binding; F:SUMO-specific isopeptidase activity;, P:Cajal body organization; P:cell population proliferation; P:protein desumoylation; P:snRNA transcription;|Q5W0Q7 Q14109 Q6AI45 Q8IY30 Q8IYE8,SUMO-specific isopeptidase USPL1,Ubiquitin-specific peptidase-like protein 1;, PF15509;PF15499;, GO:0015030;GO:0005615;GO:0032183;GO:0070140;GO:0030576;GO:0008283;GO:0016926;GO:0009301;, C:Cajal body; C:extracellular space;, F:SUMO binding; F:SUMO-specific isopeptidase activity;, P:Cajal body organization; P:cell population proliferation; P:protein desumoylation; P:snRNA transcription;|Q5W0Q7 Q14109 Q6AI45 Q8IY30 Q8IYE8,SUMO-specific isopeptidase USPL1,Ubiquitin-specific peptidase-like protein 1;, PF15509;PF15499;, GO:0015030;GO:0005615;GO:0032183;GO:0070140;GO:0030576;GO:0008283;GO:0016926;GO:0009301;, C:Cajal body; C:extracellular space;, F:SUMO binding; F:SUMO-specific isopeptidase activity;, P:Cajal body organization; P:cell population proliferation; P:protein desumoylation; P:snRNA transcription; scaffold1 indexed_genome mRNA 52752517 52753223 . + . ID=transcript_167;Q07020 F8VWC5 Q8WTZ6,60S ribosomal protein L18,Large ribosomal subunit protein eL18 {ECO:0000303|PubMed:24524803};, PF17135;, GO:0005829;GO:0022625;GO:0005783;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:0042788;GO:0005791;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:polysomal ribosome; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold1 indexed_genome mRNA 52799742 52828485 . + . ID=transcript_168;P20292 Q5VV04,Arachidonate 5-lipoxygenase-activating protein,FLAP;MK-886-binding protein;, PF01124;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005635;GO:0031965;GO:0050544;GO:0008047;GO:0004602;GO:0004364;GO:0004464;GO:0047485;GO:0071277;GO:0019370;GO:0006691;GO:2001301;GO:0019372;GO:0070207;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear membrane;, F:arachidonic acid binding; F:enzyme activator activity; F:glutathione peroxidase activity; F:glutathione transferase activity; F:leukotriene-C4 synthase activity; F:protein N-terminus binding;, P:cellular response to calcium ion; P:leukotriene biosynthetic process; P:leukotriene metabolic process; P:lipoxin biosynthetic process; P:lipoxygenase pathway; P:protein homotrimerization; scaffold1 indexed_genome mRNA 52926823 52943433 . + . ID=transcript_169;Q5VYS4 Q8IXF1 Q96K26 Q96NC8,Mesenteric estrogen-dependent adipogenesis protein,Activated in W/Wv mouse stomach 3 homolog;Mesenteric estrogen-dependent adipose 4;, , GO:0005737;GO:0045600;, C:cytoplasm;, , P:positive regulation of fat cell differentiation; scaffold1 indexed_genome mRNA 53119422 53142812 . - . ID=transcript_170;Q92598 B4DYH1 O95739 Q5TBM6 Q5TBM7 Q5TBM8 Q9UPC4,Heat shock protein 105 kDa,Antigen NY-CO-25;Heat shock 110 kDa protein;, PF00012;, GO:0005737;GO:0005829;GO:0071682;GO:0070062;GO:0005576;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0000774;GO:0043014;GO:0005524;GO:0016887;GO:0051085;GO:0045345;GO:0051135;GO:0006898;GO:1900034;GO:0006986;, C:cytoplasm; C:cytosol; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:adenyl-nucleotide exchange factor activity; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity;, P:chaperone cofactor-dependent protein refolding; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of NK T cell activation; P:receptor-mediated endocytosis; P:regulation of cellular response to heat; P:response to unfolded protein;|Q92598 B4DYH1 O95739 Q5TBM6 Q5TBM7 Q5TBM8 Q9UPC4,Heat shock protein 105 kDa,Antigen NY-CO-25;Heat shock 110 kDa protein;, PF00012;, GO:0005737;GO:0005829;GO:0071682;GO:0070062;GO:0005576;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0000774;GO:0043014;GO:0005524;GO:0016887;GO:0051085;GO:0045345;GO:0051135;GO:0006898;GO:1900034;GO:0006986;, C:cytoplasm; C:cytosol; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:adenyl-nucleotide exchange factor activity; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity;, P:chaperone cofactor-dependent protein refolding; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of NK T cell activation; P:receptor-mediated endocytosis; P:regulation of cellular response to heat; P:response to unfolded protein;|Q92598 B4DYH1 O95739 Q5TBM6 Q5TBM7 Q5TBM8 Q9UPC4,Heat shock protein 105 kDa,Antigen NY-CO-25;Heat shock 110 kDa protein;, PF00012;, GO:0005737;GO:0005829;GO:0071682;GO:0070062;GO:0005576;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0000774;GO:0043014;GO:0005524;GO:0016887;GO:0051085;GO:0045345;GO:0051135;GO:0006898;GO:1900034;GO:0006986;, C:cytoplasm; C:cytosol; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:adenyl-nucleotide exchange factor activity; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity;, P:chaperone cofactor-dependent protein refolding; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of NK T cell activation; P:receptor-mediated endocytosis; P:regulation of cellular response to heat; P:response to unfolded protein;|Q92598 B4DYH1 O95739 Q5TBM6 Q5TBM7 Q5TBM8 Q9UPC4,Heat shock protein 105 kDa,Antigen NY-CO-25;Heat shock 110 kDa protein;, PF00012;, GO:0005737;GO:0005829;GO:0071682;GO:0070062;GO:0005576;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0000774;GO:0043014;GO:0005524;GO:0016887;GO:0051085;GO:0045345;GO:0051135;GO:0006898;GO:1900034;GO:0006986;, C:cytoplasm; C:cytosol; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:adenyl-nucleotide exchange factor activity; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity;, P:chaperone cofactor-dependent protein refolding; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of NK T cell activation; P:receptor-mediated endocytosis; P:regulation of cellular response to heat; P:response to unfolded protein;|Q92598 B4DYH1 O95739 Q5TBM6 Q5TBM7 Q5TBM8 Q9UPC4,Heat shock protein 105 kDa,Antigen NY-CO-25;Heat shock 110 kDa protein;, PF00012;, GO:0005737;GO:0005829;GO:0071682;GO:0070062;GO:0005576;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0000774;GO:0043014;GO:0005524;GO:0016887;GO:0051085;GO:0045345;GO:0051135;GO:0006898;GO:1900034;GO:0006986;, C:cytoplasm; C:cytosol; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:adenyl-nucleotide exchange factor activity; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity;, P:chaperone cofactor-dependent protein refolding; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of NK T cell activation; P:receptor-mediated endocytosis; P:regulation of cellular response to heat; P:response to unfolded protein;|Q92598 B4DYH1 O95739 Q5TBM6 Q5TBM7 Q5TBM8 Q9UPC4,Heat shock protein 105 kDa,Antigen NY-CO-25;Heat shock 110 kDa protein;, PF00012;, GO:0005737;GO:0005829;GO:0071682;GO:0070062;GO:0005576;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0000774;GO:0043014;GO:0005524;GO:0016887;GO:0051085;GO:0045345;GO:0051135;GO:0006898;GO:1900034;GO:0006986;, C:cytoplasm; C:cytosol; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:adenyl-nucleotide exchange factor activity; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity;, P:chaperone cofactor-dependent protein refolding; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of NK T cell activation; P:receptor-mediated endocytosis; P:regulation of cellular response to heat; P:response to unfolded protein;|Q92598 B4DYH1 O95739 Q5TBM6 Q5TBM7 Q5TBM8 Q9UPC4,Heat shock protein 105 kDa,Antigen NY-CO-25;Heat shock 110 kDa protein;, PF00012;, GO:0005737;GO:0005829;GO:0071682;GO:0070062;GO:0005576;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0000774;GO:0043014;GO:0005524;GO:0016887;GO:0051085;GO:0045345;GO:0051135;GO:0006898;GO:1900034;GO:0006986;, C:cytoplasm; C:cytosol; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:adenyl-nucleotide exchange factor activity; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity;, P:chaperone cofactor-dependent protein refolding; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of NK T cell activation; P:receptor-mediated endocytosis; P:regulation of cellular response to heat; P:response to unfolded protein; scaffold1 indexed_genome mRNA 53197920 53295766 . + . ID=transcript_171;Q6Y288 A8K5F8 Q5W0H2 Q6NUI3,Beta-1,3-glucosyltransferase,Beta 3-glucosyltransferase {ECO:0000312|HGNC:HGNC:20207};Beta-3-glycosyltransferase-like;, PF02434;, GO:0005789;GO:0016021;GO:0008375;GO:0006004;GO:0036066;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:acetylglucosaminyltransferase activity;, P:fucose metabolic process; P:protein O-linked fucosylation;|Q6Y288 A8K5F8 Q5W0H2 Q6NUI3,Beta-1,3-glucosyltransferase,Beta 3-glucosyltransferase {ECO:0000312|HGNC:HGNC:20207};Beta-3-glycosyltransferase-like;, PF02434;, GO:0005789;GO:0016021;GO:0008375;GO:0006004;GO:0036066;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:acetylglucosaminyltransferase activity;, P:fucose metabolic process; P:protein O-linked fucosylation; scaffold1 indexed_genome mRNA 54078931 54149717 . - . ID=transcript_172;Q5TBA9 Q9Y3N6,Protein furry homolog,, PF14225;PF14228;PF14222;, GO:0005938;GO:0005815;GO:0030427;GO:0000922;GO:0000902;GO:0031175;, C:cell cortex; C:microtubule organizing center; C:site of polarized growth; C:spindle pole;, , P:cell morphogenesis; P:neuron projection development;|Q5TBA9 Q9Y3N6,Protein furry homolog,, PF14225;PF14228;PF14222;, GO:0005938;GO:0005815;GO:0030427;GO:0000922;GO:0000902;GO:0031175;, C:cell cortex; C:microtubule organizing center; C:site of polarized growth; C:spindle pole;, , P:cell morphogenesis; P:neuron projection development; scaffold1 indexed_genome mRNA 54152010 54234644 . + . ID=transcript_173;Q5TBA9 Q9Y3N6,Protein furry homolog,, PF14225;PF14228;PF14222;, GO:0005938;GO:0005815;GO:0030427;GO:0000922;GO:0000902;GO:0031175;, C:cell cortex; C:microtubule organizing center; C:site of polarized growth; C:spindle pole;, , P:cell morphogenesis; P:neuron projection development;|Q5TBA9 Q9Y3N6,Protein furry homolog,, PF14225;PF14228;PF14222;, GO:0005938;GO:0005815;GO:0030427;GO:0000922;GO:0000902;GO:0031175;, C:cell cortex; C:microtubule organizing center; C:site of polarized growth; C:spindle pole;, , P:cell morphogenesis; P:neuron projection development;|Q5TBA9 Q9Y3N6,Protein furry homolog,, PF14225;PF14228;PF14222;, GO:0005938;GO:0005815;GO:0030427;GO:0000922;GO:0000902;GO:0031175;, C:cell cortex; C:microtubule organizing center; C:site of polarized growth; C:spindle pole;, , P:cell morphogenesis; P:neuron projection development;|Q5TBA9 Q9Y3N6,Protein furry homolog,, PF14225;PF14228;PF14222;, GO:0005938;GO:0005815;GO:0030427;GO:0000922;GO:0000902;GO:0031175;, C:cell cortex; C:microtubule organizing center; C:site of polarized growth; C:spindle pole;, , P:cell morphogenesis; P:neuron projection development;|Q5TBA9 Q9Y3N6,Protein furry homolog,, PF14225;PF14228;PF14222;, GO:0005938;GO:0005815;GO:0030427;GO:0000922;GO:0000902;GO:0031175;, C:cell cortex; C:microtubule organizing center; C:site of polarized growth; C:spindle pole;, , P:cell morphogenesis; P:neuron projection development;|A6NP61 B2RV03 B7ZBU2,ZAR1-like protein,, PF13695;, GO:0005737;GO:1903231;GO:0006412;, C:cytoplasm;, F:mRNA binding involved in posttranscriptional gene silencing;, P:translation;|A6NP61 B2RV03 B7ZBU2,ZAR1-like protein,, PF13695;, GO:0005737;GO:1903231;GO:0006412;, C:cytoplasm;, F:mRNA binding involved in posttranscriptional gene silencing;, P:translation; scaffold1 indexed_genome mRNA 54265743 54267414 . + . ID=transcript_174;P51587 O00183 O15008 Q13879 Q5TBJ7,Breast cancer type 2 susceptibility protein {ECO:0000305},Fanconi anemia group D1 protein;, PF09169;PF09103;PF09104;PF00634;PF09121;, GO:0033593;GO:0005813;GO:0000781;GO:0005829;GO:0000800;GO:0005654;GO:0005634;GO:0032991;GO:0030141;GO:0043015;GO:0010484;GO:0010485;GO:0042802;GO:0002020;GO:0008022;GO:0003697;GO:0007420;GO:0007569;GO:0051298;GO:0006978;GO:0006302;GO:0000724;GO:0070200;GO:0008585;GO:0030097;GO:0043966;GO:0043967;GO:0001833;GO:0042771;GO:0007141;GO:1990426;GO:0033600;GO:0006289;GO:0001556;GO:0045931;GO:0045893;GO:0032465;GO:0006355;GO:0048478;GO:0010332;GO:0010225;GO:0010165;GO:0007283;GO:0000722;, C:BRCA2-MAGE-D1 complex; C:centrosome; C:chromosome, telomeric region; C:cytosol; C:lateral element; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:secretory granule;, F:gamma-tubulin binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:identical protein binding; F:protease binding; F:protein C-terminus binding; F:single-stranded DNA binding;, P:brain development; P:cell aging; P:centrosome duplication; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:establishment of protein localization to telomere; P:female gonad development; P:hemopoiesis; P:histone H3 acetylation; P:histone H4 acetylation; P:inner cell mass cell proliferation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:male meiosis I; P:mitotic recombination-dependent replication fork processing; P:negative regulation of mammary gland epithelial cell proliferation; P:nucleotide-excision repair; P:oocyte maturation; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:regulation of cytokinesis; P:regulation of transcription, DNA-templated; P:replication fork protection; P:response to gamma radiation; P:response to UV-C; P:response to X-ray; P:spermatogenesis; P:telomere maintenance via recombination; scaffold1 indexed_genome mRNA 54272127 54288581 . + . ID=transcript_175;P51587 O00183 O15008 Q13879 Q5TBJ7,Breast cancer type 2 susceptibility protein {ECO:0000305},Fanconi anemia group D1 protein;, PF09169;PF09103;PF09104;PF00634;PF09121;, GO:0033593;GO:0005813;GO:0000781;GO:0005829;GO:0000800;GO:0005654;GO:0005634;GO:0032991;GO:0030141;GO:0043015;GO:0010484;GO:0010485;GO:0042802;GO:0002020;GO:0008022;GO:0003697;GO:0007420;GO:0007569;GO:0051298;GO:0006978;GO:0006302;GO:0000724;GO:0070200;GO:0008585;GO:0030097;GO:0043966;GO:0043967;GO:0001833;GO:0042771;GO:0007141;GO:1990426;GO:0033600;GO:0006289;GO:0001556;GO:0045931;GO:0045893;GO:0032465;GO:0006355;GO:0048478;GO:0010332;GO:0010225;GO:0010165;GO:0007283;GO:0000722;, C:BRCA2-MAGE-D1 complex; C:centrosome; C:chromosome, telomeric region; C:cytosol; C:lateral element; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:secretory granule;, F:gamma-tubulin binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:identical protein binding; F:protease binding; F:protein C-terminus binding; F:single-stranded DNA binding;, P:brain development; P:cell aging; P:centrosome duplication; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:establishment of protein localization to telomere; P:female gonad development; P:hemopoiesis; P:histone H3 acetylation; P:histone H4 acetylation; P:inner cell mass cell proliferation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:male meiosis I; P:mitotic recombination-dependent replication fork processing; P:negative regulation of mammary gland epithelial cell proliferation; P:nucleotide-excision repair; P:oocyte maturation; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:regulation of cytokinesis; P:regulation of transcription, DNA-templated; P:replication fork protection; P:response to gamma radiation; P:response to UV-C; P:response to X-ray; P:spermatogenesis; P:telomere maintenance via recombination; scaffold1 indexed_genome mRNA 54288702 54312329 . - . ID=transcript_176;Q5TBK1 A4QN21 Q5TBK0,NEDD4-binding protein 2-like 1|Q5TBK1 A4QN21 Q5TBK0,NEDD4-binding protein 2-like 1|Q5TBK1 A4QN21 Q5TBK0,NEDD4-binding protein 2-like 1 scaffold1 indexed_genome mRNA 54317204 54378389 . - . ID=transcript_177;Q92802 A3KME8,NEDD4-binding protein 2-like 2,Phosphonoformate immuno-associated protein 5;, , GO:0070062;GO:0005634;GO:0017053;GO:0019899;GO:0003714;GO:1902037;GO:0000122;GO:1902035;, C:extracellular exosome; C:nucleus; C:transcription repressor complex;, F:enzyme binding; F:transcription corepressor activity;, P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hematopoietic stem cell proliferation;|Q92802 A3KME8,NEDD4-binding protein 2-like 2,Phosphonoformate immuno-associated protein 5;, , GO:0070062;GO:0005634;GO:0017053;GO:0019899;GO:0003714;GO:1902037;GO:0000122;GO:1902035;, C:extracellular exosome; C:nucleus; C:transcription repressor complex;, F:enzyme binding; F:transcription corepressor activity;, P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hematopoietic stem cell proliferation;|Q92802 A3KME8,NEDD4-binding protein 2-like 2,Phosphonoformate immuno-associated protein 5;, , GO:0070062;GO:0005634;GO:0017053;GO:0019899;GO:0003714;GO:1902037;GO:0000122;GO:1902035;, C:extracellular exosome; C:nucleus; C:transcription repressor complex;, F:enzyme binding; F:transcription corepressor activity;, P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hematopoietic stem cell proliferation;|Q92802 A3KME8,NEDD4-binding protein 2-like 2,Phosphonoformate immuno-associated protein 5;, , GO:0070062;GO:0005634;GO:0017053;GO:0019899;GO:0003714;GO:1902037;GO:0000122;GO:1902035;, C:extracellular exosome; C:nucleus; C:transcription repressor complex;, F:enzyme binding; F:transcription corepressor activity;, P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hematopoietic stem cell proliferation;|Q92802 A3KME8,NEDD4-binding protein 2-like 2,Phosphonoformate immuno-associated protein 5;, , GO:0070062;GO:0005634;GO:0017053;GO:0019899;GO:0003714;GO:1902037;GO:0000122;GO:1902035;, C:extracellular exosome; C:nucleus; C:transcription repressor complex;, F:enzyme binding; F:transcription corepressor activity;, P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hematopoietic stem cell proliferation;|Q92802 A3KME8,NEDD4-binding protein 2-like 2,Phosphonoformate immuno-associated protein 5;, , GO:0070062;GO:0005634;GO:0017053;GO:0019899;GO:0003714;GO:1902037;GO:0000122;GO:1902035;, C:extracellular exosome; C:nucleus; C:transcription repressor complex;, F:enzyme binding; F:transcription corepressor activity;, P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hematopoietic stem cell proliferation; scaffold1 indexed_genome mRNA 54412752 54579271 . + . ID=transcript_178;Q9NTI5 Q5R3S3 Q5W0K8 Q6NSC3 Q8IXT6 Q9H5N8 Q9Y2I5 Q9Y451,Sister chromatid cohesion protein PDS5 homolog B,Androgen-induced proliferation inhibitor;Androgen-induced prostate proliferative shutoff-associated protein AS3;, , GO:0000785;GO:0005694;GO:0000775;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0008283;GO:0006281;GO:0007064;GO:0008285;GO:0042127;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:cell population proliferation; P:DNA repair; P:mitotic sister chromatid cohesion; P:negative regulation of cell population proliferation; P:regulation of cell population proliferation;|Q9NTI5 Q5R3S3 Q5W0K8 Q6NSC3 Q8IXT6 Q9H5N8 Q9Y2I5 Q9Y451,Sister chromatid cohesion protein PDS5 homolog B,Androgen-induced proliferation inhibitor;Androgen-induced prostate proliferative shutoff-associated protein AS3;, , GO:0000785;GO:0005694;GO:0000775;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0008283;GO:0006281;GO:0007064;GO:0008285;GO:0042127;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:cell population proliferation; P:DNA repair; P:mitotic sister chromatid cohesion; P:negative regulation of cell population proliferation; P:regulation of cell population proliferation;|Q9NTI5 Q5R3S3 Q5W0K8 Q6NSC3 Q8IXT6 Q9H5N8 Q9Y2I5 Q9Y451,Sister chromatid cohesion protein PDS5 homolog B,Androgen-induced proliferation inhibitor;Androgen-induced prostate proliferative shutoff-associated protein AS3;, , GO:0000785;GO:0005694;GO:0000775;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0008283;GO:0006281;GO:0007064;GO:0008285;GO:0042127;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:cell population proliferation; P:DNA repair; P:mitotic sister chromatid cohesion; P:negative regulation of cell population proliferation; P:regulation of cell population proliferation;|Q9NTI5 Q5R3S3 Q5W0K8 Q6NSC3 Q8IXT6 Q9H5N8 Q9Y2I5 Q9Y451,Sister chromatid cohesion protein PDS5 homolog B,Androgen-induced proliferation inhibitor;Androgen-induced prostate proliferative shutoff-associated protein AS3;, , GO:0000785;GO:0005694;GO:0000775;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0008283;GO:0006281;GO:0007064;GO:0008285;GO:0042127;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:cell population proliferation; P:DNA repair; P:mitotic sister chromatid cohesion; P:negative regulation of cell population proliferation; P:regulation of cell population proliferation; scaffold1 indexed_genome mRNA 54856402 55298808 . + . ID=transcript_179;Q9Y3M8 A2A309 A2A310 Q5HYH1 Q5TAE3 Q6UN61 Q86TP6 Q86WQ3 Q86XT1,StAR-related lipid transfer protein 13,46H23.2;Deleted in liver cancer 2 protein;Rho GTPase-activating protein;START domain-containing protein 13;, PF00620;PF07647;PF01852;, GO:0005829;GO:0005811;GO:0031966;GO:0005096;GO:0008289;GO:0030036;GO:0043542;GO:0097498;GO:0090051;GO:0035023;GO:0051056;GO:0007165;, C:cytosol; C:lipid droplet; C:mitochondrial membrane;, F:GTPase activator activity; F:lipid binding;, P:actin cytoskeleton organization; P:endothelial cell migration; P:endothelial tube lumen extension; P:negative regulation of cell migration involved in sprouting angiogenesis; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9Y3M8 A2A309 A2A310 Q5HYH1 Q5TAE3 Q6UN61 Q86TP6 Q86WQ3 Q86XT1,StAR-related lipid transfer protein 13,46H23.2;Deleted in liver cancer 2 protein;Rho GTPase-activating protein;START domain-containing protein 13;, PF00620;PF07647;PF01852;, GO:0005829;GO:0005811;GO:0031966;GO:0005096;GO:0008289;GO:0030036;GO:0043542;GO:0097498;GO:0090051;GO:0035023;GO:0051056;GO:0007165;, C:cytosol; C:lipid droplet; C:mitochondrial membrane;, F:GTPase activator activity; F:lipid binding;, P:actin cytoskeleton organization; P:endothelial cell migration; P:endothelial tube lumen extension; P:negative regulation of cell migration involved in sprouting angiogenesis; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9Y3M8 A2A309 A2A310 Q5HYH1 Q5TAE3 Q6UN61 Q86TP6 Q86WQ3 Q86XT1,StAR-related lipid transfer protein 13,46H23.2;Deleted in liver cancer 2 protein;Rho GTPase-activating protein;START domain-containing protein 13;, PF00620;PF07647;PF01852;, GO:0005829;GO:0005811;GO:0031966;GO:0005096;GO:0008289;GO:0030036;GO:0043542;GO:0097498;GO:0090051;GO:0035023;GO:0051056;GO:0007165;, C:cytosol; C:lipid droplet; C:mitochondrial membrane;, F:GTPase activator activity; F:lipid binding;, P:actin cytoskeleton organization; P:endothelial cell migration; P:endothelial tube lumen extension; P:negative regulation of cell migration involved in sprouting angiogenesis; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9Y3M8 A2A309 A2A310 Q5HYH1 Q5TAE3 Q6UN61 Q86TP6 Q86WQ3 Q86XT1,StAR-related lipid transfer protein 13,46H23.2;Deleted in liver cancer 2 protein;Rho GTPase-activating protein;START domain-containing protein 13;, PF00620;PF07647;PF01852;, GO:0005829;GO:0005811;GO:0031966;GO:0005096;GO:0008289;GO:0030036;GO:0043542;GO:0097498;GO:0090051;GO:0035023;GO:0051056;GO:0007165;, C:cytosol; C:lipid droplet; C:mitochondrial membrane;, F:GTPase activator activity; F:lipid binding;, P:actin cytoskeleton organization; P:endothelial cell migration; P:endothelial tube lumen extension; P:negative regulation of cell migration involved in sprouting angiogenesis; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9Y3M8 A2A309 A2A310 Q5HYH1 Q5TAE3 Q6UN61 Q86TP6 Q86WQ3 Q86XT1,StAR-related lipid transfer protein 13,46H23.2;Deleted in liver cancer 2 protein;Rho GTPase-activating protein;START domain-containing protein 13;, PF00620;PF07647;PF01852;, GO:0005829;GO:0005811;GO:0031966;GO:0005096;GO:0008289;GO:0030036;GO:0043542;GO:0097498;GO:0090051;GO:0035023;GO:0051056;GO:0007165;, C:cytosol; C:lipid droplet; C:mitochondrial membrane;, F:GTPase activator activity; F:lipid binding;, P:actin cytoskeleton organization; P:endothelial cell migration; P:endothelial tube lumen extension; P:negative regulation of cell migration involved in sprouting angiogenesis; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9Y3M8 A2A309 A2A310 Q5HYH1 Q5TAE3 Q6UN61 Q86TP6 Q86WQ3 Q86XT1,StAR-related lipid transfer protein 13,46H23.2;Deleted in liver cancer 2 protein;Rho GTPase-activating protein;START domain-containing protein 13;, PF00620;PF07647;PF01852;, GO:0005829;GO:0005811;GO:0031966;GO:0005096;GO:0008289;GO:0030036;GO:0043542;GO:0097498;GO:0090051;GO:0035023;GO:0051056;GO:0007165;, C:cytosol; C:lipid droplet; C:mitochondrial membrane;, F:GTPase activator activity; F:lipid binding;, P:actin cytoskeleton organization; P:endothelial cell migration; P:endothelial tube lumen extension; P:negative regulation of cell migration involved in sprouting angiogenesis; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9Y3M8 A2A309 A2A310 Q5HYH1 Q5TAE3 Q6UN61 Q86TP6 Q86WQ3 Q86XT1,StAR-related lipid transfer protein 13,46H23.2;Deleted in liver cancer 2 protein;Rho GTPase-activating protein;START domain-containing protein 13;, PF00620;PF07647;PF01852;, GO:0005829;GO:0005811;GO:0031966;GO:0005096;GO:0008289;GO:0030036;GO:0043542;GO:0097498;GO:0090051;GO:0035023;GO:0051056;GO:0007165;, C:cytosol; C:lipid droplet; C:mitochondrial membrane;, F:GTPase activator activity; F:lipid binding;, P:actin cytoskeleton organization; P:endothelial cell migration; P:endothelial tube lumen extension; P:negative regulation of cell migration involved in sprouting angiogenesis; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold1 indexed_genome mRNA 56391256 56576024 . + . ID=transcript_180;Q8NFP9 B7Z2H9 Q5T320 Q9HCM8 Q9NSU1 Q9NW98 Q9Y6J1,Neurobeachin,Lysosomal-trafficking regulator 2;Protein BCL8B;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0005802;GO:0019901;GO:0008104;, C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:protein kinase binding;, P:protein localization;|Q8NFP9 B7Z2H9 Q5T320 Q9HCM8 Q9NSU1 Q9NW98 Q9Y6J1,Neurobeachin,Lysosomal-trafficking regulator 2;Protein BCL8B;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0005802;GO:0019901;GO:0008104;, C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:protein kinase binding;, P:protein localization;|Q8NFP9 B7Z2H9 Q5T320 Q9HCM8 Q9NSU1 Q9NW98 Q9Y6J1,Neurobeachin,Lysosomal-trafficking regulator 2;Protein BCL8B;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0005802;GO:0019901;GO:0008104;, C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:protein kinase binding;, P:protein localization;|Q8NFP9 B7Z2H9 Q5T320 Q9HCM8 Q9NSU1 Q9NW98 Q9Y6J1,Neurobeachin,Lysosomal-trafficking regulator 2;Protein BCL8B;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0005802;GO:0019901;GO:0008104;, C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:protein kinase binding;, P:protein localization;|Q8NFP9 B7Z2H9 Q5T320 Q9HCM8 Q9NSU1 Q9NW98 Q9Y6J1,Neurobeachin,Lysosomal-trafficking regulator 2;Protein BCL8B;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0005802;GO:0019901;GO:0008104;, C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:protein kinase binding;, P:protein localization; scaffold1 indexed_genome mRNA 56584802 57034708 . + . ID=transcript_181;Q8NFP9 B7Z2H9 Q5T320 Q9HCM8 Q9NSU1 Q9NW98 Q9Y6J1,Neurobeachin,Lysosomal-trafficking regulator 2;Protein BCL8B;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0005802;GO:0019901;GO:0008104;, C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:protein kinase binding;, P:protein localization;|Q8NFP9 B7Z2H9 Q5T320 Q9HCM8 Q9NSU1 Q9NW98 Q9Y6J1,Neurobeachin,Lysosomal-trafficking regulator 2;Protein BCL8B;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0005802;GO:0019901;GO:0008104;, C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:protein kinase binding;, P:protein localization;|Q8NFP9 B7Z2H9 Q5T320 Q9HCM8 Q9NSU1 Q9NW98 Q9Y6J1,Neurobeachin,Lysosomal-trafficking regulator 2;Protein BCL8B;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0005802;GO:0019901;GO:0008104;, C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:protein kinase binding;, P:protein localization;|Q8NFP9 B7Z2H9 Q5T320 Q9HCM8 Q9NSU1 Q9NW98 Q9Y6J1,Neurobeachin,Lysosomal-trafficking regulator 2;Protein BCL8B;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0005802;GO:0019901;GO:0008104;, C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:protein kinase binding;, P:protein localization;|Q13394 Q6I9T5,Putative nucleotidyltransferase MAB21L1 {ECO:0000305},Protein mab-21-like 1 {ECO:0000312|HGNC:HGNC:6757};, PF03281;, GO:0005634;GO:0005524;GO:0005525;GO:0046872;GO:0016779;GO:0009653;GO:0043010;GO:0001654;GO:0008284;, C:nucleus;, F:ATP binding; F:GTP binding; F:metal ion binding; F:nucleotidyltransferase activity;, P:anatomical structure morphogenesis; P:camera-type eye development; P:eye development; P:positive regulation of cell population proliferation;|Q13394 Q6I9T5,Putative nucleotidyltransferase MAB21L1 {ECO:0000305},Protein mab-21-like 1 {ECO:0000312|HGNC:HGNC:6757};, PF03281;, GO:0005634;GO:0005524;GO:0005525;GO:0046872;GO:0016779;GO:0009653;GO:0043010;GO:0001654;GO:0008284;, C:nucleus;, F:ATP binding; F:GTP binding; F:metal ion binding; F:nucleotidyltransferase activity;, P:anatomical structure morphogenesis; P:camera-type eye development; P:eye development; P:positive regulation of cell population proliferation;|Q8NFP9 B7Z2H9 Q5T320 Q9HCM8 Q9NSU1 Q9NW98 Q9Y6J1,Neurobeachin,Lysosomal-trafficking regulator 2;Protein BCL8B;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0005802;GO:0019901;GO:0008104;, C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:protein kinase binding;, P:protein localization; scaffold1 indexed_genome mRNA 57114700 57150406 . - . ID=transcript_182;O15075 B7Z3E9 Q5VZY8 Q5VZZ0 Q5VZZ1,Serine/threonine-protein kinase DCLK1,Doublecortin domain-containing protein 3A;Doublecortin-like and CAM kinase-like 1;Doublecortin-like kinase 1;, PF03607;PF00069;, GO:0005887;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0048675;GO:0007417;GO:0021952;GO:0048813;GO:0016197;GO:0030900;GO:0035556;GO:1900181;GO:0007399;GO:0001764;GO:0048812;GO:0018105;GO:0006468;GO:0009615;, C:integral component of plasma membrane; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:axon extension; P:central nervous system development; P:central nervous system projection neuron axonogenesis; P:dendrite morphogenesis; P:endosomal transport; P:forebrain development; P:intracellular signal transduction; P:negative regulation of protein localization to nucleus; P:nervous system development; P:neuron migration; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:response to virus; scaffold1 indexed_genome mRNA 57150502 57444457 . - . ID=transcript_183;O15075 B7Z3E9 Q5VZY8 Q5VZZ0 Q5VZZ1,Serine/threonine-protein kinase DCLK1,Doublecortin domain-containing protein 3A;Doublecortin-like and CAM kinase-like 1;Doublecortin-like kinase 1;, PF03607;PF00069;, GO:0005887;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0048675;GO:0007417;GO:0021952;GO:0048813;GO:0016197;GO:0030900;GO:0035556;GO:1900181;GO:0007399;GO:0001764;GO:0048812;GO:0018105;GO:0006468;GO:0009615;, C:integral component of plasma membrane; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:axon extension; P:central nervous system development; P:central nervous system projection neuron axonogenesis; P:dendrite morphogenesis; P:endosomal transport; P:forebrain development; P:intracellular signal transduction; P:negative regulation of protein localization to nucleus; P:nervous system development; P:neuron migration; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:response to virus;|O15075 B7Z3E9 Q5VZY8 Q5VZZ0 Q5VZZ1,Serine/threonine-protein kinase DCLK1,Doublecortin domain-containing protein 3A;Doublecortin-like and CAM kinase-like 1;Doublecortin-like kinase 1;, PF03607;PF00069;, GO:0005887;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0048675;GO:0007417;GO:0021952;GO:0048813;GO:0016197;GO:0030900;GO:0035556;GO:1900181;GO:0007399;GO:0001764;GO:0048812;GO:0018105;GO:0006468;GO:0009615;, C:integral component of plasma membrane; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:axon extension; P:central nervous system development; P:central nervous system projection neuron axonogenesis; P:dendrite morphogenesis; P:endosomal transport; P:forebrain development; P:intracellular signal transduction; P:negative regulation of protein localization to nucleus; P:nervous system development; P:neuron migration; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:response to virus;|O15075 B7Z3E9 Q5VZY8 Q5VZZ0 Q5VZZ1,Serine/threonine-protein kinase DCLK1,Doublecortin domain-containing protein 3A;Doublecortin-like and CAM kinase-like 1;Doublecortin-like kinase 1;, PF03607;PF00069;, GO:0005887;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0048675;GO:0007417;GO:0021952;GO:0048813;GO:0016197;GO:0030900;GO:0035556;GO:1900181;GO:0007399;GO:0001764;GO:0048812;GO:0018105;GO:0006468;GO:0009615;, C:integral component of plasma membrane; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:axon extension; P:central nervous system development; P:central nervous system projection neuron axonogenesis; P:dendrite morphogenesis; P:endosomal transport; P:forebrain development; P:intracellular signal transduction; P:negative regulation of protein localization to nucleus; P:nervous system development; P:neuron migration; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:response to virus;|O15075 B7Z3E9 Q5VZY8 Q5VZZ0 Q5VZZ1,Serine/threonine-protein kinase DCLK1,Doublecortin domain-containing protein 3A;Doublecortin-like and CAM kinase-like 1;Doublecortin-like kinase 1;, PF03607;PF00069;, GO:0005887;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0048675;GO:0007417;GO:0021952;GO:0048813;GO:0016197;GO:0030900;GO:0035556;GO:1900181;GO:0007399;GO:0001764;GO:0048812;GO:0018105;GO:0006468;GO:0009615;, C:integral component of plasma membrane; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:axon extension; P:central nervous system development; P:central nervous system projection neuron axonogenesis; P:dendrite morphogenesis; P:endosomal transport; P:forebrain development; P:intracellular signal transduction; P:negative regulation of protein localization to nucleus; P:nervous system development; P:neuron migration; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:response to virus; scaffold1 indexed_genome mRNA 57488551 57493859 . - . ID=transcript_184;Q9NX45 B4DX90 Q5EGC3 Q8TC74 Q96QX4,Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2,, PF00010;, GO:0000785;GO:0005737;GO:0005634;GO:0000981;GO:0046982;GO:0042803;GO:0000978;GO:1990837;GO:0030154;GO:0007275;GO:0009994;GO:0006357;GO:0007283;, C:chromatin; C:cytoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:multicellular organism development; P:oocyte differentiation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold1 indexed_genome mRNA 57585584 57605992 . - . ID=transcript_185;Q8N0X7 O60349 Q86Y67 Q9H1T2 Q9H1T3,Spartin {ECO:0000305},Spastic paraplegia 20 protein;Trans-activated by hepatitis C virus core protein 1;, PF06911;, GO:0005737;GO:0005829;GO:0005811;GO:0030496;GO:0005741;GO:0005886;GO:0045202;GO:0031625;GO:0009838;GO:0060612;GO:0051301;GO:0034389;GO:0030514;GO:0048698;GO:0050905;GO:0051881;, C:cytoplasm; C:cytosol; C:lipid droplet; C:midbody; C:mitochondrial outer membrane; C:plasma membrane; C:synapse;, F:ubiquitin protein ligase binding;, P:abscission; P:adipose tissue development; P:cell division; P:lipid droplet organization; P:negative regulation of BMP signaling pathway; P:negative regulation of collateral sprouting in absence of injury; P:neuromuscular process; P:regulation of mitochondrial membrane potential;|Q8N0X7 O60349 Q86Y67 Q9H1T2 Q9H1T3,Spartin {ECO:0000305},Spastic paraplegia 20 protein;Trans-activated by hepatitis C virus core protein 1;, PF06911;, GO:0005737;GO:0005829;GO:0005811;GO:0030496;GO:0005741;GO:0005886;GO:0045202;GO:0031625;GO:0009838;GO:0060612;GO:0051301;GO:0034389;GO:0030514;GO:0048698;GO:0050905;GO:0051881;, C:cytoplasm; C:cytosol; C:lipid droplet; C:midbody; C:mitochondrial outer membrane; C:plasma membrane; C:synapse;, F:ubiquitin protein ligase binding;, P:abscission; P:adipose tissue development; P:cell division; P:lipid droplet organization; P:negative regulation of BMP signaling pathway; P:negative regulation of collateral sprouting in absence of injury; P:neuromuscular process; P:regulation of mitochondrial membrane potential;|Q8N0X7 O60349 Q86Y67 Q9H1T2 Q9H1T3,Spartin {ECO:0000305},Spastic paraplegia 20 protein;Trans-activated by hepatitis C virus core protein 1;, PF06911;, GO:0005737;GO:0005829;GO:0005811;GO:0030496;GO:0005741;GO:0005886;GO:0045202;GO:0031625;GO:0009838;GO:0060612;GO:0051301;GO:0034389;GO:0030514;GO:0048698;GO:0050905;GO:0051881;, C:cytoplasm; C:cytosol; C:lipid droplet; C:midbody; C:mitochondrial outer membrane; C:plasma membrane; C:synapse;, F:ubiquitin protein ligase binding;, P:abscission; P:adipose tissue development; P:cell division; P:lipid droplet organization; P:negative regulation of BMP signaling pathway; P:negative regulation of collateral sprouting in absence of injury; P:neuromuscular process; P:regulation of mitochondrial membrane potential;|Q8N0X7 O60349 Q86Y67 Q9H1T2 Q9H1T3,Spartin {ECO:0000305},Spastic paraplegia 20 protein;Trans-activated by hepatitis C virus core protein 1;, PF06911;, GO:0005737;GO:0005829;GO:0005811;GO:0030496;GO:0005741;GO:0005886;GO:0045202;GO:0031625;GO:0009838;GO:0060612;GO:0051301;GO:0034389;GO:0030514;GO:0048698;GO:0050905;GO:0051881;, C:cytoplasm; C:cytosol; C:lipid droplet; C:midbody; C:mitochondrial outer membrane; C:plasma membrane; C:synapse;, F:ubiquitin protein ligase binding;, P:abscission; P:adipose tissue development; P:cell division; P:lipid droplet organization; P:negative regulation of BMP signaling pathway; P:negative regulation of collateral sprouting in absence of injury; P:neuromuscular process; P:regulation of mitochondrial membrane potential;|Q8N0X7 O60349 Q86Y67 Q9H1T2 Q9H1T3,Spartin {ECO:0000305},Spastic paraplegia 20 protein;Trans-activated by hepatitis C virus core protein 1;, PF06911;, GO:0005737;GO:0005829;GO:0005811;GO:0030496;GO:0005741;GO:0005886;GO:0045202;GO:0031625;GO:0009838;GO:0060612;GO:0051301;GO:0034389;GO:0030514;GO:0048698;GO:0050905;GO:0051881;, C:cytoplasm; C:cytosol; C:lipid droplet; C:midbody; C:mitochondrial outer membrane; C:plasma membrane; C:synapse;, F:ubiquitin protein ligase binding;, P:abscission; P:adipose tissue development; P:cell division; P:lipid droplet organization; P:negative regulation of BMP signaling pathway; P:negative regulation of collateral sprouting in absence of injury; P:neuromuscular process; P:regulation of mitochondrial membrane potential; scaffold1 indexed_genome mRNA 57693177 57696146 . + . ID=transcript_186;P78396 B7Z7E3 Q5T3V0 Q5U0G2 Q8IY91,Cyclin-A1,, PF02984;PF00134;, GO:0097123;GO:0097124;GO:0000307;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0016538;GO:0051301;GO:0007141;GO:0044772;GO:0016579;GO:0000079;GO:0000083;GO:0007283;, C:cyclin A1-CDK2 complex; C:cyclin A2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:male meiosis I; P:mitotic cell cycle phase transition; P:protein deubiquitination; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:spermatogenesis; scaffold1 indexed_genome mRNA 57868844 57894977 . - . ID=transcript_187;A2A2V5 Q8N469,Serine-rich and transmembrane domain-containing protein 1,, PF15872;, GO:0016021;GO:0043231;, C:integral component of membrane; C:intracellular membrane-bounded organelle; scaffold1 indexed_genome mRNA 57986007 57997371 . + . ID=transcript_188;O00287 B2R9T8 Q5VZM6 Q8TC40,Regulatory factor X-associated protein,RFX DNA-binding complex 36 kDa subunit;, PF15289;, GO:0016607;GO:0005634;GO:0090575;GO:0003677;GO:0045944;GO:0006357;, C:nuclear speck; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O00287 B2R9T8 Q5VZM6 Q8TC40,Regulatory factor X-associated protein,RFX DNA-binding complex 36 kDa subunit;, PF15289;, GO:0016607;GO:0005634;GO:0090575;GO:0003677;GO:0045944;GO:0006357;, C:nuclear speck; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 58003161 58028184 . - . ID=transcript_189;O15198 A2A2Y6 O14989 Q5TBA1,Mothers against decapentaplegic homolog 9,Madh6;SMAD family member 9;, PF03165;PF03166;, GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0071141;GO:0000981;GO:0070411;GO:0046872;GO:0000978;GO:0009653;GO:0030509;GO:0030154;GO:0071773;GO:0030514;GO:1901522;GO:0060395;GO:0007179;, C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:SMAD protein complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:BMP signaling pathway; P:cell differentiation; P:cellular response to BMP stimulus; P:negative regulation of BMP signaling pathway; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway;|Q15797 A8KAJ0 D3DNZ9 Q16636 Q9UFT8,Mothers against decapentaplegic homolog 1,JV4-1;Mad-related protein 1;SMAD family member 1;Transforming growth factor-beta-signaling protein 1;, PF03165;PF03166;, GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0016021;GO:0005637;GO:0005654;GO:0005634;GO:0032991;GO:0071141;GO:0070410;GO:0017151;GO:0001228;GO:0003700;GO:0000981;GO:0070411;GO:0042802;GO:0046872;GO:0070878;GO:0019901;GO:0000978;GO:0009653;GO:0030509;GO:0060348;GO:0060038;GO:0051216;GO:0030154;GO:0071407;GO:0009880;GO:0007276;GO:0030902;GO:0042592;GO:0006954;GO:0000165;GO:0001710;GO:0030901;GO:0030514;GO:0008285;GO:0002051;GO:0061036;GO:0010628;GO:0045669;GO:1902895;GO:1903672;GO:0045944;GO:1901522;GO:0031053;GO:0016579;GO:0006468;GO:0007165;GO:0007183;GO:0060395;GO:0007179;GO:0001657;, C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:integral component of membrane; C:nuclear inner membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SMAD protein complex;, F:co-SMAD binding; F:DEAD/H-box RNA helicase binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:identical protein binding; F:metal ion binding; F:primary miRNA binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:BMP signaling pathway; P:bone development; P:cardiac muscle cell proliferation; P:cartilage development; P:cell differentiation; P:cellular response to organic cyclic compound; P:embryonic pattern specification; P:gamete generation; P:hindbrain development; P:homeostatic process; P:inflammatory response; P:MAPK cascade; P:mesodermal cell fate commitment; P:midbrain development; P:negative regulation of BMP signaling pathway; P:negative regulation of cell population proliferation; P:osteoblast fate commitment; P:positive regulation of cartilage development; P:positive regulation of gene expression; P:positive regulation of osteoblast differentiation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:primary miRNA processing; P:protein deubiquitination; P:protein phosphorylation; P:signal transduction; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development;|O15198 A2A2Y6 O14989 Q5TBA1,Mothers against decapentaplegic homolog 9,Madh6;SMAD family member 9;, PF03165;PF03166;, GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0071141;GO:0000981;GO:0070411;GO:0046872;GO:0000978;GO:0009653;GO:0030509;GO:0030154;GO:0071773;GO:0030514;GO:1901522;GO:0060395;GO:0007179;, C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:SMAD protein complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:BMP signaling pathway; P:cell differentiation; P:cellular response to BMP stimulus; P:negative regulation of BMP signaling pathway; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; scaffold1 indexed_genome mRNA 58073291 58082844 . - . ID=transcript_190;Q9Y673 B4DR37 Q5TBA6,Dolichyl-phosphate beta-glucosyltransferase,Asparagine-linked glycosylation protein 5 homolog;, PF00535;, GO:0005789;GO:0016021;GO:0016020;GO:0004581;GO:0004576;GO:0007368;GO:0006486;GO:0006487;GO:0018279;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dolichyl-phosphate beta-glucosyltransferase activity; F:oligosaccharyl transferase activity;, P:determination of left/right symmetry; P:protein glycosylation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine;|Q9Y673 B4DR37 Q5TBA6,Dolichyl-phosphate beta-glucosyltransferase,Asparagine-linked glycosylation protein 5 homolog;, PF00535;, GO:0005789;GO:0016021;GO:0016020;GO:0004581;GO:0004576;GO:0007368;GO:0006486;GO:0006487;GO:0018279;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dolichyl-phosphate beta-glucosyltransferase activity; F:oligosaccharyl transferase activity;, P:determination of left/right symmetry; P:protein glycosylation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine;|Q9Y673 B4DR37 Q5TBA6,Dolichyl-phosphate beta-glucosyltransferase,Asparagine-linked glycosylation protein 5 homolog;, PF00535;, GO:0005789;GO:0016021;GO:0016020;GO:0004581;GO:0004576;GO:0007368;GO:0006486;GO:0006487;GO:0018279;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dolichyl-phosphate beta-glucosyltransferase activity; F:oligosaccharyl transferase activity;, P:determination of left/right symmetry; P:protein glycosylation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; scaffold1 indexed_genome mRNA 58082937 58109976 . - . ID=transcript_191;Q9Y673 B4DR37 Q5TBA6,Dolichyl-phosphate beta-glucosyltransferase,Asparagine-linked glycosylation protein 5 homolog;, PF00535;, GO:0005789;GO:0016021;GO:0016020;GO:0004581;GO:0004576;GO:0007368;GO:0006486;GO:0006487;GO:0018279;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dolichyl-phosphate beta-glucosyltransferase activity; F:oligosaccharyl transferase activity;, P:determination of left/right symmetry; P:protein glycosylation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; scaffold1 indexed_genome mRNA 58112115 58113670 . - . ID=transcript_192;Q96B26 O43480 Q5TBA5,Exosome complex component RRP43,Exosome component 8;Opa-interacting protein 2;Ribosomal RNA-processing protein 43;p9;, PF01138;PF03725;, GO:0005694;GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0001650;GO:0043231;GO:0000176;GO:0005654;GO:0005634;GO:0042802;GO:0035925;GO:0043928;GO:0000467;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0034427;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:chromosome; C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:fibrillar center; C:intracellular membrane-bounded organelle; C:nuclear exosome (RNase complex); C:nucleoplasm; C:nucleus;, F:identical protein binding; F:mRNA 3'-UTR AU-rich region binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing; scaffold1 indexed_genome mRNA 58113996 58130012 . + . ID=transcript_193;Q96B26 O43480 Q5TBA5,Exosome complex component RRP43,Exosome component 8;Opa-interacting protein 2;Ribosomal RNA-processing protein 43;p9;, PF01138;PF03725;, GO:0005694;GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0001650;GO:0043231;GO:0000176;GO:0005654;GO:0005634;GO:0042802;GO:0035925;GO:0043928;GO:0000467;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0034427;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:chromosome; C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:fibrillar center; C:intracellular membrane-bounded organelle; C:nuclear exosome (RNase complex); C:nucleoplasm; C:nucleus;, F:identical protein binding; F:mRNA 3'-UTR AU-rich region binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q96B26 O43480 Q5TBA5,Exosome complex component RRP43,Exosome component 8;Opa-interacting protein 2;Ribosomal RNA-processing protein 43;p9;, PF01138;PF03725;, GO:0005694;GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0001650;GO:0043231;GO:0000176;GO:0005654;GO:0005634;GO:0042802;GO:0035925;GO:0043928;GO:0000467;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0034427;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:chromosome; C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:fibrillar center; C:intracellular membrane-bounded organelle; C:nuclear exosome (RNase complex); C:nucleoplasm; C:nucleus;, F:identical protein binding; F:mRNA 3'-UTR AU-rich region binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q96B26 O43480 Q5TBA5,Exosome complex component RRP43,Exosome component 8;Opa-interacting protein 2;Ribosomal RNA-processing protein 43;p9;, PF01138;PF03725;, GO:0005694;GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0001650;GO:0043231;GO:0000176;GO:0005654;GO:0005634;GO:0042802;GO:0035925;GO:0043928;GO:0000467;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0034427;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:chromosome; C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:fibrillar center; C:intracellular membrane-bounded organelle; C:nuclear exosome (RNase complex); C:nucleoplasm; C:nucleus;, F:identical protein binding; F:mRNA 3'-UTR AU-rich region binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q8NEM7 E7ER46 Q71RF3 Q9Y6A6,Transcription factor SPT20 homolog,p38-interacting protein;, PF12090;, GO:0000124;GO:0070461;GO:0003712;GO:0006914;GO:0007369;GO:0006357;, C:SAGA complex; C:SAGA-type complex;, F:transcription coregulator activity;, P:autophagy; P:gastrulation; P:regulation of transcription by RNA polymerase II;|Q8NEM7 E7ER46 Q71RF3 Q9Y6A6,Transcription factor SPT20 homolog,p38-interacting protein;, PF12090;, GO:0000124;GO:0070461;GO:0003712;GO:0006914;GO:0007369;GO:0006357;, C:SAGA complex; C:SAGA-type complex;, F:transcription coregulator activity;, P:autophagy; P:gastrulation; P:regulation of transcription by RNA polymerase II;|Q8NEM7 E7ER46 Q71RF3 Q9Y6A6,Transcription factor SPT20 homolog,p38-interacting protein;, PF12090;, GO:0000124;GO:0070461;GO:0003712;GO:0006914;GO:0007369;GO:0006357;, C:SAGA complex; C:SAGA-type complex;, F:transcription coregulator activity;, P:autophagy; P:gastrulation; P:regulation of transcription by RNA polymerase II;|Q8NEM7 E7ER46 Q71RF3 Q9Y6A6,Transcription factor SPT20 homolog,p38-interacting protein;, PF12090;, GO:0000124;GO:0070461;GO:0003712;GO:0006914;GO:0007369;GO:0006357;, C:SAGA complex; C:SAGA-type complex;, F:transcription coregulator activity;, P:autophagy; P:gastrulation; P:regulation of transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 58130013 58133338 . - . ID=transcript_194;Q8NEM7 E7ER46 Q71RF3 Q9Y6A6,Transcription factor SPT20 homolog,p38-interacting protein;, PF12090;, GO:0000124;GO:0070461;GO:0003712;GO:0006914;GO:0007369;GO:0006357;, C:SAGA complex; C:SAGA-type complex;, F:transcription coregulator activity;, P:autophagy; P:gastrulation; P:regulation of transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 58133372 58154962 . - . ID=transcript_195;Q8NEM7 E7ER46 Q71RF3 Q9Y6A6,Transcription factor SPT20 homolog,p38-interacting protein;, PF12090;, GO:0000124;GO:0070461;GO:0003712;GO:0006914;GO:0007369;GO:0006357;, C:SAGA complex; C:SAGA-type complex;, F:transcription coregulator activity;, P:autophagy; P:gastrulation; P:regulation of transcription by RNA polymerase II;|Q8NEM7 E7ER46 Q71RF3 Q9Y6A6,Transcription factor SPT20 homolog,p38-interacting protein;, PF12090;, GO:0000124;GO:0070461;GO:0003712;GO:0006914;GO:0007369;GO:0006357;, C:SAGA complex; C:SAGA-type complex;, F:transcription coregulator activity;, P:autophagy; P:gastrulation; P:regulation of transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 58520362 58555449 . - . ID=transcript_196;Q3KPJ5 Q5VSY5 Q8IZF9,Periostin,Osteoblast-specific factor 2;, PF02469;, GO:0062023;GO:0031012;GO:0005615;GO:0031594;GO:0005802;GO:0050839;GO:0008201;GO:0046872;GO:1990523;GO:0007155;GO:0044344;GO:0071560;GO:0071356;GO:0071307;GO:0030198;GO:0001953;GO:1900025;GO:1990138;GO:2000343;GO:0014911;GO:0008593;GO:0003073;GO:0032355;GO:0001666;GO:0009612;GO:0014850;GO:0042060;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space; C:neuromuscular junction; C:trans-Golgi network;, F:cell adhesion molecule binding; F:heparin binding; F:metal ion binding;, P:bone regeneration; P:cell adhesion; P:cellular response to fibroblast growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:cellular response to vitamin K; P:extracellular matrix organization; P:negative regulation of cell-matrix adhesion; P:negative regulation of substrate adhesion-dependent cell spreading; P:neuron projection extension; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of smooth muscle cell migration; P:regulation of Notch signaling pathway; P:regulation of systemic arterial blood pressure; P:response to estradiol; P:response to hypoxia; P:response to mechanical stimulus; P:response to muscle activity; P:wound healing;|Q3KPJ5 Q5VSY5 Q8IZF9,Periostin,Osteoblast-specific factor 2;, PF02469;, GO:0062023;GO:0031012;GO:0005615;GO:0031594;GO:0005802;GO:0050839;GO:0008201;GO:0046872;GO:1990523;GO:0007155;GO:0044344;GO:0071560;GO:0071356;GO:0071307;GO:0030198;GO:0001953;GO:1900025;GO:1990138;GO:2000343;GO:0014911;GO:0008593;GO:0003073;GO:0032355;GO:0001666;GO:0009612;GO:0014850;GO:0042060;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space; C:neuromuscular junction; C:trans-Golgi network;, F:cell adhesion molecule binding; F:heparin binding; F:metal ion binding;, P:bone regeneration; P:cell adhesion; P:cellular response to fibroblast growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:cellular response to vitamin K; P:extracellular matrix organization; P:negative regulation of cell-matrix adhesion; P:negative regulation of substrate adhesion-dependent cell spreading; P:neuron projection extension; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of smooth muscle cell migration; P:regulation of Notch signaling pathway; P:regulation of systemic arterial blood pressure; P:response to estradiol; P:response to hypoxia; P:response to mechanical stimulus; P:response to muscle activity; P:wound healing;|Q3KPJ5 Q5VSY5 Q8IZF9,Periostin,Osteoblast-specific factor 2;, PF02469;, GO:0062023;GO:0031012;GO:0005615;GO:0031594;GO:0005802;GO:0050839;GO:0008201;GO:0046872;GO:1990523;GO:0007155;GO:0044344;GO:0071560;GO:0071356;GO:0071307;GO:0030198;GO:0001953;GO:1900025;GO:1990138;GO:2000343;GO:0014911;GO:0008593;GO:0003073;GO:0032355;GO:0001666;GO:0009612;GO:0014850;GO:0042060;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space; C:neuromuscular junction; C:trans-Golgi network;, F:cell adhesion molecule binding; F:heparin binding; F:metal ion binding;, P:bone regeneration; P:cell adhesion; P:cellular response to fibroblast growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:cellular response to vitamin K; P:extracellular matrix organization; P:negative regulation of cell-matrix adhesion; P:negative regulation of substrate adhesion-dependent cell spreading; P:neuron projection extension; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of smooth muscle cell migration; P:regulation of Notch signaling pathway; P:regulation of systemic arterial blood pressure; P:response to estradiol; P:response to hypoxia; P:response to mechanical stimulus; P:response to muscle activity; P:wound healing;|Q3KPJ5 Q5VSY5 Q8IZF9,Periostin,Osteoblast-specific factor 2;, PF02469;, GO:0062023;GO:0031012;GO:0005615;GO:0031594;GO:0005802;GO:0050839;GO:0008201;GO:0046872;GO:1990523;GO:0007155;GO:0044344;GO:0071560;GO:0071356;GO:0071307;GO:0030198;GO:0001953;GO:1900025;GO:1990138;GO:2000343;GO:0014911;GO:0008593;GO:0003073;GO:0032355;GO:0001666;GO:0009612;GO:0014850;GO:0042060;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space; C:neuromuscular junction; C:trans-Golgi network;, F:cell adhesion molecule binding; F:heparin binding; F:metal ion binding;, P:bone regeneration; P:cell adhesion; P:cellular response to fibroblast growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:cellular response to vitamin K; P:extracellular matrix organization; P:negative regulation of cell-matrix adhesion; P:negative regulation of substrate adhesion-dependent cell spreading; P:neuron projection extension; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of smooth muscle cell migration; P:regulation of Notch signaling pathway; P:regulation of systemic arterial blood pressure; P:response to estradiol; P:response to hypoxia; P:response to mechanical stimulus; P:response to muscle activity; P:wound healing;|Q3KPJ5 Q5VSY5 Q8IZF9,Periostin,Osteoblast-specific factor 2;, PF02469;, GO:0062023;GO:0031012;GO:0005615;GO:0031594;GO:0005802;GO:0050839;GO:0008201;GO:0046872;GO:1990523;GO:0007155;GO:0044344;GO:0071560;GO:0071356;GO:0071307;GO:0030198;GO:0001953;GO:1900025;GO:1990138;GO:2000343;GO:0014911;GO:0008593;GO:0003073;GO:0032355;GO:0001666;GO:0009612;GO:0014850;GO:0042060;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space; C:neuromuscular junction; C:trans-Golgi network;, F:cell adhesion molecule binding; F:heparin binding; F:metal ion binding;, P:bone regeneration; P:cell adhesion; P:cellular response to fibroblast growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:cellular response to vitamin K; P:extracellular matrix organization; P:negative regulation of cell-matrix adhesion; P:negative regulation of substrate adhesion-dependent cell spreading; P:neuron projection extension; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of smooth muscle cell migration; P:regulation of Notch signaling pathway; P:regulation of systemic arterial blood pressure; P:response to estradiol; P:response to hypoxia; P:response to mechanical stimulus; P:response to muscle activity; P:wound healing; scaffold1 indexed_genome mRNA 58592860 58608031 . - . ID=transcript_197;Q9UIB0 Q9UIB1 Q9UIB2,Short transient receptor potential channel 4,Trp-related protein 4;, PF00520;PF08344;, GO:0016323;GO:0034704;GO:0034703;GO:0005901;GO:0009986;GO:0030863;GO:0005887;GO:0005886;GO:0008013;GO:0045296;GO:0070679;GO:0015279;GO:0070509;GO:0070588;GO:0006816;GO:0014051;GO:0006828;GO:0048709;GO:0051480;, C:basolateral plasma membrane; C:calcium channel complex; C:cation channel complex; C:caveola; C:cell surface; C:cortical cytoskeleton; C:integral component of plasma membrane; C:plasma membrane;, F:beta-catenin binding; F:cadherin binding; F:inositol 1,4,5 trisphosphate binding; F:store-operated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:gamma-aminobutyric acid secretion; P:manganese ion transport; P:oligodendrocyte differentiation; P:regulation of cytosolic calcium ion concentration; scaffold1 indexed_genome mRNA 59048403 59059913 . + . ID=transcript_198;P61960 Q14346 Q5VXS0 Q6IAG6 Q9CPX2 Q9NZF2,Ubiquitin-fold modifier 1 {ECO:0000303|PubMed:15071506},, PF03671;, GO:0005737;GO:0005783;GO:0005634;GO:0007420;GO:0043066;GO:0042308;GO:1990592;GO:0071569;GO:0033146;GO:0034976;GO:0061709;, C:cytoplasm; C:endoplasmic reticulum; C:nucleus;, , P:brain development; P:negative regulation of apoptotic process; P:negative regulation of protein import into nucleus; P:protein K69-linked ufmylation; P:protein ufmylation; P:regulation of intracellular estrogen receptor signaling pathway; P:response to endoplasmic reticulum stress; P:reticulophagy;|P61960 Q14346 Q5VXS0 Q6IAG6 Q9CPX2 Q9NZF2,Ubiquitin-fold modifier 1 {ECO:0000303|PubMed:15071506},, PF03671;, GO:0005737;GO:0005783;GO:0005634;GO:0007420;GO:0043066;GO:0042308;GO:1990592;GO:0071569;GO:0033146;GO:0034976;GO:0061709;, C:cytoplasm; C:endoplasmic reticulum; C:nucleus;, , P:brain development; P:negative regulation of apoptotic process; P:negative regulation of protein import into nucleus; P:protein K69-linked ufmylation; P:protein ufmylation; P:regulation of intracellular estrogen receptor signaling pathway; P:response to endoplasmic reticulum stress; P:reticulophagy; scaffold1 indexed_genome mRNA 59440256 59441334 . + . ID=transcript_199;Q5SZK8 Q4QQG1 Q5H9N8 Q5T6Q1 Q6N057 Q6ZSB4 Q7Z305 Q7Z341,FRAS1-related extracellular matrix protein 2,ECM3 homolog;, PF03160;, GO:0005604;GO:0070062;GO:0016021;GO:0005886;GO:0046872;GO:0007155;GO:0007154;GO:0042733;GO:0001654;GO:0007507;GO:0048839;GO:0001822;GO:0002009;, C:basement membrane; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:metal ion binding;, P:cell adhesion; P:cell communication; P:embryonic digit morphogenesis; P:eye development; P:heart development; P:inner ear development; P:kidney development; P:morphogenesis of an epithelium; scaffold1 indexed_genome mRNA 59449875 59475034 . - . ID=transcript_200;Q8TAV4 B4E285 Q5JS35,Stomatin-like protein 3,, PF01145;, GO:0005929;GO:0016021;GO:0045121;GO:0005886;GO:0034220;GO:0007165;, C:cilium; C:integral component of membrane; C:membrane raft; C:plasma membrane;, , P:ion transmembrane transport; P:signal transduction; scaffold1 indexed_genome mRNA 59497891 59499086 . - . ID=transcript_201;Q86XN7 A6NJ97 Q6P2S2 Q7Z3X5 Q8N3D2 Q8N3P1 Q9H9M1,Proline and serine-rich protein 1,, PF14771; scaffold1 indexed_genome mRNA 59499102 59501723 . - . ID=transcript_202;Q86XN7 A6NJ97 Q6P2S2 Q7Z3X5 Q8N3D2 Q8N3P1 Q9H9M1,Proline and serine-rich protein 1,, PF14771; scaffold1 indexed_genome mRNA 59512951 59513638 . + . ID=transcript_203;Q5JS37 B2RTZ2 B4DTL0 Q69YI9,NHL repeat-containing protein 3,, PF01436;, GO:0035578;GO:0005576;GO:0061630;GO:0043312;GO:0043161;GO:0000209;, C:azurophil granule lumen; C:extracellular region;, F:ubiquitin protein ligase activity;, P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; scaffold1 indexed_genome mRNA 59513966 59514752 . + . ID=transcript_204;Q5JS37 B2RTZ2 B4DTL0 Q69YI9,NHL repeat-containing protein 3,, PF01436;, GO:0035578;GO:0005576;GO:0061630;GO:0043312;GO:0043161;GO:0000209;, C:azurophil granule lumen; C:extracellular region;, F:ubiquitin protein ligase activity;, P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; scaffold1 indexed_genome mRNA 59516135 59524258 . + . ID=transcript_205;Q5JS37 B2RTZ2 B4DTL0 Q69YI9,NHL repeat-containing protein 3,, PF01436;, GO:0035578;GO:0005576;GO:0061630;GO:0043312;GO:0043161;GO:0000209;, C:azurophil granule lumen; C:extracellular region;, F:ubiquitin protein ligase activity;, P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination;|Q5JS37 B2RTZ2 B4DTL0 Q69YI9,NHL repeat-containing protein 3,, PF01436;, GO:0035578;GO:0005576;GO:0061630;GO:0043312;GO:0043161;GO:0000209;, C:azurophil granule lumen; C:extracellular region;, F:ubiquitin protein ligase activity;, P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination;|Q5JS37 B2RTZ2 B4DTL0 Q69YI9,NHL repeat-containing protein 3,, PF01436;, GO:0035578;GO:0005576;GO:0061630;GO:0043312;GO:0043161;GO:0000209;, C:azurophil granule lumen; C:extracellular region;, F:ubiquitin protein ligase activity;, P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination;|Q5JS37 B2RTZ2 B4DTL0 Q69YI9,NHL repeat-containing protein 3,, PF01436;, GO:0035578;GO:0005576;GO:0061630;GO:0043312;GO:0043161;GO:0000209;, C:azurophil granule lumen; C:extracellular region;, F:ubiquitin protein ligase activity;, P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; scaffold1 indexed_genome mRNA 59968045 60007015 . + . ID=transcript_206;Q9Y2V7 Q5T0U1 Q6AI19 Q86V49 Q9ULT5,Conserved oligomeric Golgi complex subunit 6,Component of oligomeric Golgi complex 6;, PF06419;, GO:0000139;GO:0017119;GO:0032588;GO:0006888;GO:0070085;GO:0006891;GO:0015031;, C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:glycosylation; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q9Y2V7 Q5T0U1 Q6AI19 Q86V49 Q9ULT5,Conserved oligomeric Golgi complex subunit 6,Component of oligomeric Golgi complex 6;, PF06419;, GO:0000139;GO:0017119;GO:0032588;GO:0006888;GO:0070085;GO:0006891;GO:0015031;, C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:glycosylation; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q9Y2V7 Q5T0U1 Q6AI19 Q86V49 Q9ULT5,Conserved oligomeric Golgi complex subunit 6,Component of oligomeric Golgi complex 6;, PF06419;, GO:0000139;GO:0017119;GO:0032588;GO:0006888;GO:0070085;GO:0006891;GO:0015031;, C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:glycosylation; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q9Y2V7 Q5T0U1 Q6AI19 Q86V49 Q9ULT5,Conserved oligomeric Golgi complex subunit 6,Component of oligomeric Golgi complex 6;, PF06419;, GO:0000139;GO:0017119;GO:0032588;GO:0006888;GO:0070085;GO:0006891;GO:0015031;, C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:glycosylation; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold1 indexed_genome mRNA 60015402 60018822 . - . ID=transcript_207;Q9Y2V7 Q5T0U1 Q6AI19 Q86V49 Q9ULT5,Conserved oligomeric Golgi complex subunit 6,Component of oligomeric Golgi complex 6;, PF06419;, GO:0000139;GO:0017119;GO:0032588;GO:0006888;GO:0070085;GO:0006891;GO:0015031;, C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:glycosylation; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q9Y2V7 Q5T0U1 Q6AI19 Q86V49 Q9ULT5,Conserved oligomeric Golgi complex subunit 6,Component of oligomeric Golgi complex 6;, PF06419;, GO:0000139;GO:0017119;GO:0032588;GO:0006888;GO:0070085;GO:0006891;GO:0015031;, C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:glycosylation; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold1 indexed_genome mRNA 60706546 60710397 . - . ID=transcript_208;Q12778 O43523 Q5VYC7 Q6NSK6,Forkhead box protein O1,Forkhead box protein O1A;Forkhead in rhabdomyosarcoma;, PF00250;PF16676;PF16675;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0008013;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0051721;GO:0000978;GO:0043565;GO:0001223;GO:0031625;GO:0006915;GO:0006914;GO:0001678;GO:0070417;GO:0071549;GO:0006974;GO:0070301;GO:0071455;GO:0032869;GO:0071732;GO:0034599;GO:0009267;GO:0019221;GO:0070166;GO:0097009;GO:0045444;GO:0008286;GO:0043066;GO:1903243;GO:0045599;GO:0032873;GO:0045892;GO:0043065;GO:0010508;GO:0045732;GO:0045944;GO:0045893;GO:0006473;GO:0006357;GO:2000074;GO:0070542;GO:1902617;GO:0001659;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein phosphatase 2A binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:autophagy; P:cellular glucose homeostasis; P:cellular response to cold; P:cellular response to dexamethasone stimulus; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hyperoxia; P:cellular response to insulin stimulus; P:cellular response to nitric oxide; P:cellular response to oxidative stress; P:cellular response to starvation; P:cytokine-mediated signaling pathway; P:enamel mineralization; P:energy homeostasis; P:fat cell differentiation; P:insulin receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of fat cell differentiation; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein acetylation; P:regulation of transcription by RNA polymerase II; P:regulation of type B pancreatic cell development; P:response to fatty acid; P:response to fluoride; P:temperature homeostasis;|Q12778 O43523 Q5VYC7 Q6NSK6,Forkhead box protein O1,Forkhead box protein O1A;Forkhead in rhabdomyosarcoma;, PF00250;PF16676;PF16675;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0008013;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0051721;GO:0000978;GO:0043565;GO:0001223;GO:0031625;GO:0006915;GO:0006914;GO:0001678;GO:0070417;GO:0071549;GO:0006974;GO:0070301;GO:0071455;GO:0032869;GO:0071732;GO:0034599;GO:0009267;GO:0019221;GO:0070166;GO:0097009;GO:0045444;GO:0008286;GO:0043066;GO:1903243;GO:0045599;GO:0032873;GO:0045892;GO:0043065;GO:0010508;GO:0045732;GO:0045944;GO:0045893;GO:0006473;GO:0006357;GO:2000074;GO:0070542;GO:1902617;GO:0001659;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein phosphatase 2A binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:autophagy; P:cellular glucose homeostasis; P:cellular response to cold; P:cellular response to dexamethasone stimulus; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hyperoxia; P:cellular response to insulin stimulus; P:cellular response to nitric oxide; P:cellular response to oxidative stress; P:cellular response to starvation; P:cytokine-mediated signaling pathway; P:enamel mineralization; P:energy homeostasis; P:fat cell differentiation; P:insulin receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of fat cell differentiation; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein acetylation; P:regulation of transcription by RNA polymerase II; P:regulation of type B pancreatic cell development; P:response to fatty acid; P:response to fluoride; P:temperature homeostasis; scaffold1 indexed_genome mRNA 60850467 60854927 . + . ID=transcript_209;Q92665 B2RCS3 Q5VYC8 Q8WTV8,28S ribosomal protein S31, mitochondrial,Imogen 38;Mitochondrial small ribosomal subunit protein mS31 {ECO:0000303|PubMed:25838379};, PF15433;, GO:0005743;GO:0005763;GO:0005739;GO:0005730;GO:0019904;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleolus;, F:protein domain specific binding; F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold1 indexed_genome mRNA 60859242 60877887 . - . ID=transcript_210;Q92665 B2RCS3 Q5VYC8 Q8WTV8,28S ribosomal protein S31, mitochondrial,Imogen 38;Mitochondrial small ribosomal subunit protein mS31 {ECO:0000303|PubMed:25838379};, PF15433;, GO:0005743;GO:0005763;GO:0005739;GO:0005730;GO:0019904;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleolus;, F:protein domain specific binding; F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q92665 B2RCS3 Q5VYC8 Q8WTV8,28S ribosomal protein S31, mitochondrial,Imogen 38;Mitochondrial small ribosomal subunit protein mS31 {ECO:0000303|PubMed:25838379};, PF15433;, GO:0005743;GO:0005763;GO:0005739;GO:0005730;GO:0019904;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleolus;, F:protein domain specific binding; F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold1 indexed_genome mRNA 60899585 60936017 . + . ID=transcript_211;Q9Y619 Q5VZD8 Q9HC45,Mitochondrial ornithine transporter 1,Solute carrier family 25 member 15;, PF00153;, GO:0016021;GO:0005743;GO:0000064;GO:1990575;GO:0000050;, C:integral component of membrane; C:mitochondrial inner membrane;, F:L-ornithine transmembrane transporter activity;, P:mitochondrial L-ornithine transmembrane transport; P:urea cycle; scaffold1 indexed_genome mRNA 61034750 61060571 . - . ID=transcript_212;Q9NS62 A2A3J3 B2RCF5 Q6P3U1 Q6UXZ2,Thrombospondin type-1 domain-containing protein 1,Transmembrane molecule with thrombospondin module;, PF00090;, GO:0071944;GO:0005829;GO:0005768;GO:0010008;GO:0005576;GO:0005925;GO:0016021;GO:0050840;GO:0048041;, C:cell periphery; C:cytosol; C:endosome; C:endosome membrane; C:extracellular region; C:focal adhesion; C:integral component of membrane;, F:extracellular matrix binding;, P:focal adhesion assembly; scaffold1 indexed_genome mRNA 61066933 61086505 . - . ID=transcript_213;Q86VN1 A8K125 Q3ZCV7 Q5H9S1 Q5VXB6 Q9H8Z5 Q9Y3E3,Vacuolar protein-sorting-associated protein 36,ELL-associated protein of 45 kDa;ESCRT-II complex subunit VPS36;, PF04157;PF11605;, GO:0005829;GO:0005768;GO:0000814;GO:0070062;GO:0031902;GO:0005634;GO:0032266;GO:0008022;GO:0043130;GO:0016197;GO:0016236;GO:0036258;GO:0043328;, C:cytosol; C:endosome; C:ESCRT II complex; C:extracellular exosome; C:late endosome membrane; C:nucleus;, F:phosphatidylinositol-3-phosphate binding; F:protein C-terminus binding; F:ubiquitin binding;, P:endosomal transport; P:macroautophagy; P:multivesicular body assembly; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q86VN1 A8K125 Q3ZCV7 Q5H9S1 Q5VXB6 Q9H8Z5 Q9Y3E3,Vacuolar protein-sorting-associated protein 36,ELL-associated protein of 45 kDa;ESCRT-II complex subunit VPS36;, PF04157;PF11605;, GO:0005829;GO:0005768;GO:0000814;GO:0070062;GO:0031902;GO:0005634;GO:0032266;GO:0008022;GO:0043130;GO:0016197;GO:0016236;GO:0036258;GO:0043328;, C:cytosol; C:endosome; C:ESCRT II complex; C:extracellular exosome; C:late endosome membrane; C:nucleus;, F:phosphatidylinositol-3-phosphate binding; F:protein C-terminus binding; F:ubiquitin binding;, P:endosomal transport; P:macroautophagy; P:multivesicular body assembly; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q86VN1 A8K125 Q3ZCV7 Q5H9S1 Q5VXB6 Q9H8Z5 Q9Y3E3,Vacuolar protein-sorting-associated protein 36,ELL-associated protein of 45 kDa;ESCRT-II complex subunit VPS36;, PF04157;PF11605;, GO:0005829;GO:0005768;GO:0000814;GO:0070062;GO:0031902;GO:0005634;GO:0032266;GO:0008022;GO:0043130;GO:0016197;GO:0016236;GO:0036258;GO:0043328;, C:cytosol; C:endosome; C:ESCRT II complex; C:extracellular exosome; C:late endosome membrane; C:nucleus;, F:phosphatidylinositol-3-phosphate binding; F:protein C-terminus binding; F:ubiquitin binding;, P:endosomal transport; P:macroautophagy; P:multivesicular body assembly; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q86VN1 A8K125 Q3ZCV7 Q5H9S1 Q5VXB6 Q9H8Z5 Q9Y3E3,Vacuolar protein-sorting-associated protein 36,ELL-associated protein of 45 kDa;ESCRT-II complex subunit VPS36;, PF04157;PF11605;, GO:0005829;GO:0005768;GO:0000814;GO:0070062;GO:0031902;GO:0005634;GO:0032266;GO:0008022;GO:0043130;GO:0016197;GO:0016236;GO:0036258;GO:0043328;, C:cytosol; C:endosome; C:ESCRT II complex; C:extracellular exosome; C:late endosome membrane; C:nucleus;, F:phosphatidylinositol-3-phosphate binding; F:protein C-terminus binding; F:ubiquitin binding;, P:endosomal transport; P:macroautophagy; P:multivesicular body assembly; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold1 indexed_genome mRNA 61104896 61124219 . + . ID=transcript_214;Q96FH9 Q9H012 Q9H0D0 Q9H988 Q9HC49 Q9NVG4,Cytoskeleton-associated protein 2,CTCL tumor antigen se20-10;Tumor- and microtubule-associated protein;, PF15297;, GO:0005813;GO:0005829;GO:0005874;GO:0015630;GO:0000922;GO:0006915;GO:0000281;GO:0045944;, C:centrosome; C:cytosol; C:microtubule; C:microtubule cytoskeleton; C:spindle pole;, , P:apoptotic process; P:mitotic cytokinesis; P:positive regulation of transcription by RNA polymerase II;|Q96FH9 Q9H012 Q9H0D0 Q9H988 Q9HC49 Q9NVG4,Cytoskeleton-associated protein 2,CTCL tumor antigen se20-10;Tumor- and microtubule-associated protein;, PF15297;, GO:0005813;GO:0005829;GO:0005874;GO:0015630;GO:0000922;GO:0006915;GO:0000281;GO:0045944;, C:centrosome; C:cytosol; C:microtubule; C:microtubule cytoskeleton; C:spindle pole;, , P:apoptotic process; P:mitotic cytokinesis; P:positive regulation of transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 61124554 61126636 . - . ID=transcript_215;Q96FH9 Q9H012 Q9H0D0 Q9H988 Q9HC49 Q9NVG4,Cytoskeleton-associated protein 2,CTCL tumor antigen se20-10;Tumor- and microtubule-associated protein;, PF15297;, GO:0005813;GO:0005829;GO:0005874;GO:0015630;GO:0000922;GO:0006915;GO:0000281;GO:0045944;, C:centrosome; C:cytosol; C:microtubule; C:microtubule cytoskeleton; C:spindle pole;, , P:apoptotic process; P:mitotic cytokinesis; P:positive regulation of transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 61132900 61138920 . + . ID=transcript_216;P51956 A8K2J4 Q5TAP2 Q8J023 Q8WUN5,Serine/threonine-protein kinase Nek3,HSPK 36;Never in mitosis A-related kinase 3;, PF00069;, GO:0030424;GO:0005737;GO:0005634;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0000278;GO:0006468;, C:axon; C:cytoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:mitotic cell cycle; P:protein phosphorylation; scaffold1 indexed_genome mRNA 61140058 61151748 . + . ID=transcript_217;P51956 A8K2J4 Q5TAP2 Q8J023 Q8WUN5,Serine/threonine-protein kinase Nek3,HSPK 36;Never in mitosis A-related kinase 3;, PF00069;, GO:0030424;GO:0005737;GO:0005634;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0000278;GO:0006468;, C:axon; C:cytoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:mitotic cell cycle; P:protein phosphorylation; scaffold1 indexed_genome mRNA 61224855 61237357 . - . ID=transcript_218;Q2TAA5 A5PLP3 B4DKW9 Q5TAN9 Q6DKI6 Q96FI7,GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase,Asparagine-linked glycosylation protein 11 homolog;Glycolipid 2-alpha-mannosyltransferase;, PF15924;PF00534;, GO:0005789;GO:0016021;GO:0016020;GO:0004377;GO:0006490;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity;, P:oligosaccharide-lipid intermediate biosynthetic process; P:protein N-linked glycosylation;|Q2TAA5 A5PLP3 B4DKW9 Q5TAN9 Q6DKI6 Q96FI7,GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase,Asparagine-linked glycosylation protein 11 homolog;Glycolipid 2-alpha-mannosyltransferase;, PF15924;PF00534;, GO:0005789;GO:0016021;GO:0016020;GO:0004377;GO:0006490;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity;, P:oligosaccharide-lipid intermediate biosynthetic process; P:protein N-linked glycosylation; scaffold1 indexed_genome mRNA 61237726 61317005 . + . ID=transcript_219;P35670 Q16318 Q16319 Q4U3V3 Q59FJ9 Q5T7X7,Copper-transporting ATPase 2,Copper pump 2;Wilson disease-associated protein;, PF00403;, GO:0005794;GO:0000139;GO:0005887;GO:0005770;GO:0016020;GO:0005739;GO:0032588;GO:0005524;GO:0005507;GO:0005375;GO:0043682;GO:0006878;GO:0060003;GO:0015677;GO:0006825;GO:0034220;GO:0046688;GO:0051208;GO:1990961;, C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:late endosome; C:membrane; C:mitochondrion; C:trans-Golgi network membrane;, F:ATP binding; F:copper ion binding; F:copper ion transmembrane transporter activity; F:P-type divalent copper transporter activity;, P:cellular copper ion homeostasis; P:copper ion export; P:copper ion import; P:copper ion transport; P:ion transmembrane transport; P:response to copper ion; P:sequestering of calcium ion; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|P35670 Q16318 Q16319 Q4U3V3 Q59FJ9 Q5T7X7,Copper-transporting ATPase 2,Copper pump 2;Wilson disease-associated protein;, PF00403;, GO:0005794;GO:0000139;GO:0005887;GO:0005770;GO:0016020;GO:0005739;GO:0032588;GO:0005524;GO:0005507;GO:0005375;GO:0043682;GO:0006878;GO:0060003;GO:0015677;GO:0006825;GO:0034220;GO:0046688;GO:0051208;GO:1990961;, C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:late endosome; C:membrane; C:mitochondrion; C:trans-Golgi network membrane;, F:ATP binding; F:copper ion binding; F:copper ion transmembrane transporter activity; F:P-type divalent copper transporter activity;, P:cellular copper ion homeostasis; P:copper ion export; P:copper ion import; P:copper ion transport; P:ion transmembrane transport; P:response to copper ion; P:sequestering of calcium ion; P:xenobiotic detoxification by transmembrane export across the plasma membrane; scaffold1 indexed_genome mRNA 61430188 61432527 . - . ID=transcript_220;A0PJE2 Q96GB2 Q9H8H1,Dehydrogenase/reductase SDR family member 12,Short-chain dehydrogenase/reductase family 40C member 1 {ECO:0000303|PubMed:15489334};, PF00106;, GO:0016491;, , F:oxidoreductase activity;|A0PJE2 Q96GB2 Q9H8H1,Dehydrogenase/reductase SDR family member 12,Short-chain dehydrogenase/reductase family 40C member 1 {ECO:0000303|PubMed:15489334};, PF00106;, GO:0016491;, , F:oxidoreductase activity; scaffold1 indexed_genome mRNA 61458500 61637006 . + . ID=transcript_221;Q96P53 B1AL86 Q96CS1,WD repeat and FYVE domain-containing protein 2,Propeller-FYVE protein {ECO:0000303|PubMed:16792529};WD40- and FYVE domain-containing protein 2;Zinc finger FYVE domain-containing protein 22;, PF01363;PF00400;, GO:0005769;GO:0043231;GO:0031982;GO:0046872;GO:0045600;GO:0001934;, C:early endosome; C:intracellular membrane-bounded organelle; C:vesicle;, F:metal ion binding;, P:positive regulation of fat cell differentiation; P:positive regulation of protein phosphorylation;|Q96P53 B1AL86 Q96CS1,WD repeat and FYVE domain-containing protein 2,Propeller-FYVE protein {ECO:0000303|PubMed:16792529};WD40- and FYVE domain-containing protein 2;Zinc finger FYVE domain-containing protein 22;, PF01363;PF00400;, GO:0005769;GO:0043231;GO:0031982;GO:0046872;GO:0045600;GO:0001934;, C:early endosome; C:intracellular membrane-bounded organelle; C:vesicle;, F:metal ion binding;, P:positive regulation of fat cell differentiation; P:positive regulation of protein phosphorylation;|Q96P53 B1AL86 Q96CS1,WD repeat and FYVE domain-containing protein 2,Propeller-FYVE protein {ECO:0000303|PubMed:16792529};WD40- and FYVE domain-containing protein 2;Zinc finger FYVE domain-containing protein 22;, PF01363;PF00400;, GO:0005769;GO:0043231;GO:0031982;GO:0046872;GO:0045600;GO:0001934;, C:early endosome; C:intracellular membrane-bounded organelle; C:vesicle;, F:metal ion binding;, P:positive regulation of fat cell differentiation; P:positive regulation of protein phosphorylation;|Q96P53 B1AL86 Q96CS1,WD repeat and FYVE domain-containing protein 2,Propeller-FYVE protein {ECO:0000303|PubMed:16792529};WD40- and FYVE domain-containing protein 2;Zinc finger FYVE domain-containing protein 22;, PF01363;PF00400;, GO:0005769;GO:0043231;GO:0031982;GO:0046872;GO:0045600;GO:0001934;, C:early endosome; C:intracellular membrane-bounded organelle; C:vesicle;, F:metal ion binding;, P:positive regulation of fat cell differentiation; P:positive regulation of protein phosphorylation;|Q96P53 B1AL86 Q96CS1,WD repeat and FYVE domain-containing protein 2,Propeller-FYVE protein {ECO:0000303|PubMed:16792529};WD40- and FYVE domain-containing protein 2;Zinc finger FYVE domain-containing protein 22;, PF01363;PF00400;, GO:0005769;GO:0043231;GO:0031982;GO:0046872;GO:0045600;GO:0001934;, C:early endosome; C:intracellular membrane-bounded organelle; C:vesicle;, F:metal ion binding;, P:positive regulation of fat cell differentiation; P:positive regulation of protein phosphorylation; scaffold1 indexed_genome mRNA 61797001 61825291 . + . ID=transcript_222;Q9UL03 Q0P664 Q6PJP4 Q9UFK0 Q9Y5M9,Integrator complex subunit 6,DBI-1;Protein DDX26;Protein deleted in cancer 1;, PF15300;PF13519;, GO:0015629;GO:0032039;GO:0005654;GO:0005634;GO:0004888;GO:0034472;GO:0016180;GO:0042795;, C:actin cytoskeleton; C:integrator complex; C:nucleoplasm; C:nucleus;, F:transmembrane signaling receptor activity;, P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9UL03 Q0P664 Q6PJP4 Q9UFK0 Q9Y5M9,Integrator complex subunit 6,DBI-1;Protein DDX26;Protein deleted in cancer 1;, PF15300;PF13519;, GO:0015629;GO:0032039;GO:0005654;GO:0005634;GO:0004888;GO:0034472;GO:0016180;GO:0042795;, C:actin cytoskeleton; C:integrator complex; C:nucleoplasm; C:nucleus;, F:transmembrane signaling receptor activity;, P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9UL03 Q0P664 Q6PJP4 Q9UFK0 Q9Y5M9,Integrator complex subunit 6,DBI-1;Protein DDX26;Protein deleted in cancer 1;, PF15300;PF13519;, GO:0015629;GO:0032039;GO:0005654;GO:0005634;GO:0004888;GO:0034472;GO:0016180;GO:0042795;, C:actin cytoskeleton; C:integrator complex; C:nucleoplasm; C:nucleus;, F:transmembrane signaling receptor activity;, P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9UL03 Q0P664 Q6PJP4 Q9UFK0 Q9Y5M9,Integrator complex subunit 6,DBI-1;Protein DDX26;Protein deleted in cancer 1;, PF15300;PF13519;, GO:0015629;GO:0032039;GO:0005654;GO:0005634;GO:0004888;GO:0034472;GO:0016180;GO:0042795;, C:actin cytoskeleton; C:integrator complex; C:nucleoplasm; C:nucleus;, F:transmembrane signaling receptor activity;, P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9UL03 Q0P664 Q6PJP4 Q9UFK0 Q9Y5M9,Integrator complex subunit 6,DBI-1;Protein DDX26;Protein deleted in cancer 1;, PF15300;PF13519;, GO:0015629;GO:0032039;GO:0005654;GO:0005634;GO:0004888;GO:0034472;GO:0016180;GO:0042795;, C:actin cytoskeleton; C:integrator complex; C:nucleoplasm; C:nucleus;, F:transmembrane signaling receptor activity;, P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 61825303 61847598 . - . ID=transcript_223;A8MV23 B1V8P3,Serpin E3,, PF00079;, GO:0005615;GO:0004867;GO:0010951;, C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity;|A8MV23 B1V8P3,Serpin E3,, PF00079;, GO:0005615;GO:0004867;GO:0010951;, C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity; scaffold1 indexed_genome mRNA 61927607 61931000 . - . ID=transcript_224;Q86V42 A2A324 Q8N8P9 Q8NE66 Q96NJ9,Protein FAM124A,, PF15067; scaffold1 indexed_genome mRNA 61992106 61992800 . + . ID=transcript_225;Q86V42 A2A324 Q8N8P9 Q8NE66 Q96NJ9,Protein FAM124A,, PF15067; scaffold1 indexed_genome mRNA 62173088 62174689 . - . ID=transcript_226;O75343 Q9NZ64,Guanylate cyclase soluble subunit beta-2,, PF00211;PF07700;PF07701;, GO:0005737;GO:0005525;GO:0004383;GO:0020037;GO:0046872;GO:0019934;, C:cytoplasm;, F:GTP binding; F:guanylate cyclase activity; F:heme binding; F:metal ion binding;, P:cGMP-mediated signaling; scaffold1 indexed_genome mRNA 62218448 62282719 . - . ID=transcript_227;Q5TBB1 G3XAJ1 Q05DR2 Q6PK48 Q9HAF7,Ribonuclease H2 subunit B,Aicardi-Goutieres syndrome 2 protein;Deleted in lymphocytic leukemia 8;Ribonuclease HI subunit B;, PF09468;PF17745;, GO:0005654;GO:0032299;GO:0009259;GO:0006401;, C:nucleoplasm; C:ribonuclease H2 complex;, , P:ribonucleotide metabolic process; P:RNA catabolic process;|Q5TBB1 G3XAJ1 Q05DR2 Q6PK48 Q9HAF7,Ribonuclease H2 subunit B,Aicardi-Goutieres syndrome 2 protein;Deleted in lymphocytic leukemia 8;Ribonuclease HI subunit B;, PF09468;PF17745;, GO:0005654;GO:0032299;GO:0009259;GO:0006401;, C:nucleoplasm; C:ribonuclease H2 complex;, , P:ribonucleotide metabolic process; P:RNA catabolic process;|Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response;|Q5TBB1 G3XAJ1 Q05DR2 Q6PK48 Q9HAF7,Ribonuclease H2 subunit B,Aicardi-Goutieres syndrome 2 protein;Deleted in lymphocytic leukemia 8;Ribonuclease HI subunit B;, PF09468;PF17745;, GO:0005654;GO:0032299;GO:0009259;GO:0006401;, C:nucleoplasm; C:ribonuclease H2 complex;, , P:ribonucleotide metabolic process; P:RNA catabolic process; scaffold1 indexed_genome mRNA 63108907 63110856 . + . ID=transcript_228;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold1 indexed_genome mRNA 63140614 63142357 . + . ID=transcript_229;Q8N5I3 A2A2X9 Q0P6D0 Q8IU75 Q8N3Q9,Potassium channel regulatory protein,Protein CLLD4;, PF02214;, GO:0005783;GO:0042802;GO:1902260;GO:0051260;, C:endoplasmic reticulum;, F:identical protein binding;, P:negative regulation of delayed rectifier potassium channel activity; P:protein homooligomerization; scaffold1 indexed_genome mRNA 63142359 63143212 . + . ID=transcript_230;Q8N5I3 A2A2X9 Q0P6D0 Q8IU75 Q8N3Q9,Potassium channel regulatory protein,Protein CLLD4;, PF02214;, GO:0005783;GO:0042802;GO:1902260;GO:0051260;, C:endoplasmic reticulum;, F:identical protein binding;, P:negative regulation of delayed rectifier potassium channel activity; P:protein homooligomerization; scaffold1 indexed_genome mRNA 63144125 63147230 . + . ID=transcript_231;O60858 B2RB49 Q5UBW0 Q5W0U8 Q5W0U9 Q9BQ47 Q9C021,E3 ubiquitin-protein ligase TRIM13,B-cell chronic lymphocytic leukemia tumor suppressor Leu5;Leukemia-associated protein 5;Putative tumor suppressor RFP2;RING finger protein 77;RING-type E3 ubiquitin transferase TRIM13 {ECO:0000305};Ret finger protein 2;Tripartite motif-containing protein 13;, PF00643;PF13445;, GO:0005737;GO:0005789;GO:0044322;GO:0016021;GO:0097038;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0009653;GO:1904380;GO:0045087;GO:1902187;GO:0032897;GO:0010942;GO:0043123;GO:0016239;GO:0051092;GO:0043161;GO:0051865;GO:0016567;GO:0010332;GO:0030433;, C:cytoplasm; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:perinuclear endoplasmic reticulum;, F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:anatomical structure morphogenesis; P:endoplasmic reticulum mannose trimming; P:innate immune response; P:negative regulation of viral release from host cell; P:negative regulation of viral transcription; P:positive regulation of cell death; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of NF-kappaB transcription factor activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein ubiquitination; P:response to gamma radiation; P:ubiquitin-dependent ERAD pathway; scaffold1 indexed_genome mRNA 63187487 63205995 . + . ID=transcript_232;Q5W111 A8K3G1 O60648 Q8TBG8 Q96T69,SPRY domain-containing protein 7,Chronic lymphocytic leukemia deletion region gene 6 protein;, PF00622;|Q5W111 A8K3G1 O60648 Q8TBG8 Q96T69,SPRY domain-containing protein 7,Chronic lymphocytic leukemia deletion region gene 6 protein;, PF00622;|Q5W111 A8K3G1 O60648 Q8TBG8 Q96T69,SPRY domain-containing protein 7,Chronic lymphocytic leukemia deletion region gene 6 protein;, PF00622; scaffold1 indexed_genome mRNA 63343967 63370821 . + . ID=transcript_233;O00505 O00191 O43195 Q5JVM9 Q8IYQ9 Q96AA7,Importin subunit alpha-4,Importin alpha Q2;Karyopherin subunit alpha-3;SRP1-gamma;, PF00514;PF16186;PF01749;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0008022;GO:0019054;GO:0006607;GO:0065003;GO:0046718;GO:0075732;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:protein C-terminus binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:protein-containing complex assembly; P:viral entry into host cell; P:viral penetration into host nucleus;|O00505 O00191 O43195 Q5JVM9 Q8IYQ9 Q96AA7,Importin subunit alpha-4,Importin alpha Q2;Karyopherin subunit alpha-3;SRP1-gamma;, PF00514;PF16186;PF01749;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0008022;GO:0019054;GO:0006607;GO:0065003;GO:0046718;GO:0075732;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:protein C-terminus binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:protein-containing complex assembly; P:viral entry into host cell; P:viral penetration into host nucleus;|O00505 O00191 O43195 Q5JVM9 Q8IYQ9 Q96AA7,Importin subunit alpha-4,Importin alpha Q2;Karyopherin subunit alpha-3;SRP1-gamma;, PF00514;PF16186;PF01749;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0008022;GO:0019054;GO:0006607;GO:0065003;GO:0046718;GO:0075732;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:protein C-terminus binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:protein-containing complex assembly; P:viral entry into host cell; P:viral penetration into host nucleus;|O00505 O00191 O43195 Q5JVM9 Q8IYQ9 Q96AA7,Importin subunit alpha-4,Importin alpha Q2;Karyopherin subunit alpha-3;SRP1-gamma;, PF00514;PF16186;PF01749;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0008022;GO:0019054;GO:0006607;GO:0065003;GO:0046718;GO:0075732;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:protein C-terminus binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:protein-containing complex assembly; P:viral entry into host cell; P:viral penetration into host nucleus;|O00505 O00191 O43195 Q5JVM9 Q8IYQ9 Q96AA7,Importin subunit alpha-4,Importin alpha Q2;Karyopherin subunit alpha-3;SRP1-gamma;, PF00514;PF16186;PF01749;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0008022;GO:0019054;GO:0006607;GO:0065003;GO:0046718;GO:0075732;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:protein C-terminus binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:protein-containing complex assembly; P:viral entry into host cell; P:viral penetration into host nucleus; scaffold1 indexed_genome mRNA 63378752 63408807 . + . ID=transcript_234;Q9BY08 A6NJ59 Q569H7 Q5JVN2 Q5JVN3 Q5JVN4 Q5JVN5 Q5JVN6,Emopamil-binding protein-like,Emopamil-binding-related protein;, , GO:0005783;GO:0005789;GO:0016021;GO:0047750;GO:0016125;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cholestenol delta-isomerase activity;, P:sterol metabolic process; scaffold1 indexed_genome mRNA 63430681 63432133 . - . ID=transcript_235;Q969Q4,ADP-ribosylation factor-like protein 11,ADP-ribosylation factor-like tumor suppressor protein 1;, PF00025;, GO:0005886;GO:0005525;GO:0006886;GO:0016192;, C:plasma membrane;, F:GTP binding;, P:intracellular protein transport; P:vesicle-mediated transport; scaffold1 indexed_genome mRNA 63466630 63469007 . + . ID=transcript_236;Q8NDN9 Q8IY29 Q969U9,RCC1 and BTB domain-containing protein 1,Chronic lymphocytic leukemia deletion region gene 7 protein;Regulator of chromosome condensation and BTB domain-containing protein 1;, PF00651;PF00415;, GO:0005737;GO:0005634;GO:0007049;GO:0006325;, C:cytoplasm; C:nucleus;, , P:cell cycle; P:chromatin organization; scaffold1 indexed_genome mRNA 63475021 63499995 . + . ID=transcript_237;Q8NDN9 Q8IY29 Q969U9,RCC1 and BTB domain-containing protein 1,Chronic lymphocytic leukemia deletion region gene 7 protein;Regulator of chromosome condensation and BTB domain-containing protein 1;, PF00651;PF00415;, GO:0005737;GO:0005634;GO:0007049;GO:0006325;, C:cytoplasm; C:nucleus;, , P:cell cycle; P:chromatin organization;|Q8NDN9 Q8IY29 Q969U9,RCC1 and BTB domain-containing protein 1,Chronic lymphocytic leukemia deletion region gene 7 protein;Regulator of chromosome condensation and BTB domain-containing protein 1;, PF00651;PF00415;, GO:0005737;GO:0005634;GO:0007049;GO:0006325;, C:cytoplasm; C:nucleus;, , P:cell cycle; P:chromatin organization;|Q8NDN9 Q8IY29 Q969U9,RCC1 and BTB domain-containing protein 1,Chronic lymphocytic leukemia deletion region gene 7 protein;Regulator of chromosome condensation and BTB domain-containing protein 1;, PF00651;PF00415;, GO:0005737;GO:0005634;GO:0007049;GO:0006325;, C:cytoplasm; C:nucleus;, , P:cell cycle; P:chromatin organization;|Q8NDN9 Q8IY29 Q969U9,RCC1 and BTB domain-containing protein 1,Chronic lymphocytic leukemia deletion region gene 7 protein;Regulator of chromosome condensation and BTB domain-containing protein 1;, PF00651;PF00415;, GO:0005737;GO:0005634;GO:0007049;GO:0006325;, C:cytoplasm; C:nucleus;, , P:cell cycle; P:chromatin organization; scaffold1 indexed_genome mRNA 63508253 63544305 . - . ID=transcript_238;Q9UIL8 Q5W0A4 Q5W0A6 Q9Y5A2,PHD finger protein 11,BRCA1 C-terminus-associated protein;Renal carcinoma antigen NY-REN-34;, , GO:0031965;GO:0005654;GO:0005634;GO:0046872;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:metal ion binding;|Q9UIL8 Q5W0A4 Q5W0A6 Q9Y5A2,PHD finger protein 11,BRCA1 C-terminus-associated protein;Renal carcinoma antigen NY-REN-34;, , GO:0031965;GO:0005654;GO:0005634;GO:0046872;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:metal ion binding;|Q9UIL8 Q5W0A4 Q5W0A6 Q9Y5A2,PHD finger protein 11,BRCA1 C-terminus-associated protein;Renal carcinoma antigen NY-REN-34;, , GO:0031965;GO:0005654;GO:0005634;GO:0046872;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:metal ion binding;|Q9UIL8 Q5W0A4 Q5W0A6 Q9Y5A2,PHD finger protein 11,BRCA1 C-terminus-associated protein;Renal carcinoma antigen NY-REN-34;, , GO:0031965;GO:0005654;GO:0005634;GO:0046872;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:metal ion binding;|Q9UIL8 Q5W0A4 Q5W0A6 Q9Y5A2,PHD finger protein 11,BRCA1 C-terminus-associated protein;Renal carcinoma antigen NY-REN-34;, , GO:0031965;GO:0005654;GO:0005634;GO:0046872;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:metal ion binding;|Q9UIL8 Q5W0A4 Q5W0A6 Q9Y5A2,PHD finger protein 11,BRCA1 C-terminus-associated protein;Renal carcinoma antigen NY-REN-34;, , GO:0031965;GO:0005654;GO:0005634;GO:0046872;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:metal ion binding; scaffold1 indexed_genome mRNA 63554256 63594454 . - . ID=transcript_239;Q96T68 Q5TC65 Q5TC66 Q5W0A7 Q659A7 Q86UD6 Q96AI6,Histone-lysine N-methyltransferase SETDB2,Chronic lymphocytic leukemia deletion region gene 8 protein;Lysine N-methyltransferase 1F;SET domain bifurcated 2;, PF01429;PF05033;PF00856;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0046974;GO:0008270;GO:0051301;GO:0007059;GO:0001947;GO:0070828;GO:0051567;GO:0070986;GO:0000278;GO:0010629;GO:0045892;GO:0090309;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone methyltransferase activity (H3-K9 specific); F:zinc ion binding;, P:cell division; P:chromosome segregation; P:heart looping; P:heterochromatin organization; P:histone H3-K9 methylation; P:left/right axis specification; P:mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly;|Q96T68 Q5TC65 Q5TC66 Q5W0A7 Q659A7 Q86UD6 Q96AI6,Histone-lysine N-methyltransferase SETDB2,Chronic lymphocytic leukemia deletion region gene 8 protein;Lysine N-methyltransferase 1F;SET domain bifurcated 2;, PF01429;PF05033;PF00856;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0046974;GO:0008270;GO:0051301;GO:0007059;GO:0001947;GO:0070828;GO:0051567;GO:0070986;GO:0000278;GO:0010629;GO:0045892;GO:0090309;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone methyltransferase activity (H3-K9 specific); F:zinc ion binding;, P:cell division; P:chromosome segregation; P:heart looping; P:heterochromatin organization; P:histone H3-K9 methylation; P:left/right axis specification; P:mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly;|Q96T68 Q5TC65 Q5TC66 Q5W0A7 Q659A7 Q86UD6 Q96AI6,Histone-lysine N-methyltransferase SETDB2,Chronic lymphocytic leukemia deletion region gene 8 protein;Lysine N-methyltransferase 1F;SET domain bifurcated 2;, PF01429;PF05033;PF00856;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0046974;GO:0008270;GO:0051301;GO:0007059;GO:0001947;GO:0070828;GO:0051567;GO:0070986;GO:0000278;GO:0010629;GO:0045892;GO:0090309;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone methyltransferase activity (H3-K9 specific); F:zinc ion binding;, P:cell division; P:chromosome segregation; P:heart looping; P:heterochromatin organization; P:histone H3-K9 methylation; P:left/right axis specification; P:mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly;|Q96T68 Q5TC65 Q5TC66 Q5W0A7 Q659A7 Q86UD6 Q96AI6,Histone-lysine N-methyltransferase SETDB2,Chronic lymphocytic leukemia deletion region gene 8 protein;Lysine N-methyltransferase 1F;SET domain bifurcated 2;, PF01429;PF05033;PF00856;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0046974;GO:0008270;GO:0051301;GO:0007059;GO:0001947;GO:0070828;GO:0051567;GO:0070986;GO:0000278;GO:0010629;GO:0045892;GO:0090309;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone methyltransferase activity (H3-K9 specific); F:zinc ion binding;, P:cell division; P:chromosome segregation; P:heart looping; P:heterochromatin organization; P:histone H3-K9 methylation; P:left/right axis specification; P:mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; scaffold1 indexed_genome mRNA 63620407 63683272 . + . ID=transcript_240;Q9H9S4 Q5TAW6 Q6WG71 Q96FG1 Q9BZ33,Calcium-binding protein 39-like,Antigen MLAA-34;MO25beta;Mo25-like protein;, PF08569;, GO:0005829;GO:0043539;GO:0007050;GO:0035556;, C:cytosol;, F:protein serine/threonine kinase activator activity;, P:cell cycle arrest; P:intracellular signal transduction; scaffold1 indexed_genome mRNA 63708828 63741499 . - . ID=transcript_241;Q9BWV3 Q49A08 Q4G119 Q5TAW9 Q7Z764 Q9NT36,Cytidine and dCMP deaminase domain-containing protein 1,Cytidine deaminase {ECO:0000305};Testis development protein NYD-SP15;, PF00383;, GO:0005737;GO:0005634;GO:0004126;GO:0047844;GO:0061676;GO:0042803;GO:0008270;GO:0009972;GO:0070383;, C:cytoplasm; C:nucleus;, F:cytidine deaminase activity; F:deoxycytidine deaminase activity; F:importin-alpha family protein binding; F:protein homodimerization activity; F:zinc ion binding;, P:cytidine deamination; P:DNA cytosine deamination; scaffold1 indexed_genome mRNA 63767569 63858152 . - . ID=transcript_242;Q6ZME4 Q9H1W1,Fibronectin type-III domain-containing protein 3A,Human gene expressed in odontoblasts;, PF00041;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0003723;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:RNA binding;|Q6ZME4 Q9H1W1,Fibronectin type-III domain-containing protein 3A,Human gene expressed in odontoblasts;, PF00041;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0003723;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:RNA binding;|Q6ZME4 Q9H1W1,Fibronectin type-III domain-containing protein 3A,Human gene expressed in odontoblasts;, PF00041;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0003723;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:RNA binding;|Q6ZME4 Q9H1W1,Fibronectin type-III domain-containing protein 3A,Human gene expressed in odontoblasts;, PF00041;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0003723;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:RNA binding;|Q6ZME4 Q9H1W1,Fibronectin type-III domain-containing protein 3A,Human gene expressed in odontoblasts;, PF00041;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0003723;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:RNA binding;|Q6ZME4 Q9H1W1,Fibronectin type-III domain-containing protein 3A,Human gene expressed in odontoblasts;, PF00041;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0003723;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:RNA binding;|Q6ZME4 Q9H1W1,Fibronectin type-III domain-containing protein 3A,Human gene expressed in odontoblasts;, PF00041;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0003723;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:RNA binding;|Q6ZME4 Q9H1W1,Fibronectin type-III domain-containing protein 3A,Human gene expressed in odontoblasts;, PF00041;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0003723;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:RNA binding; scaffold1 indexed_genome mRNA 64154840 64160447 . - . ID=transcript_243;Q9NS75 Q9HCQ2,Cysteinyl leukotriene receptor 2,G-protein coupled receptor GPCR21;G-protein coupled receptor HG57;HPN321;, PF00001;, GO:0005887;GO:0005886;GO:0001631;GO:0008528;GO:0004974;GO:0071377;GO:0007186;GO:0006955;GO:0002862;GO:0007218;, C:integral component of plasma membrane; C:plasma membrane;, F:cysteinyl leukotriene receptor activity; F:G protein-coupled peptide receptor activity; F:leukotriene receptor activity;, P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:neuropeptide signaling pathway; scaffold1 indexed_genome mRNA 64939422 64956728 . + . ID=transcript_244;A2RU30 B4DPM3 B4E048 B7Z9K7 O94849 Q4G0P2 Q9P0C4,Protein TESPA1,Thymocyte-expressed positive selection-associated protein 1;, PF14722;, GO:0008180;GO:0005737;GO:0005789;GO:0005102;GO:0010387;GO:0033089;GO:0050862;, C:COP9 signalosome; C:cytoplasm; C:endoplasmic reticulum membrane;, F:signaling receptor binding;, P:COP9 signalosome assembly; P:positive regulation of T cell differentiation in thymus; P:positive regulation of T cell receptor signaling pathway; scaffold1 indexed_genome mRNA 64963648 64972350 . + . ID=transcript_245;A2RU30 B4DPM3 B4E048 B7Z9K7 O94849 Q4G0P2 Q9P0C4,Protein TESPA1,Thymocyte-expressed positive selection-associated protein 1;, PF14722;, GO:0008180;GO:0005737;GO:0005789;GO:0005102;GO:0010387;GO:0033089;GO:0050862;, C:COP9 signalosome; C:cytoplasm; C:endoplasmic reticulum membrane;, F:signaling receptor binding;, P:COP9 signalosome assembly; P:positive regulation of T cell differentiation in thymus; P:positive regulation of T cell receptor signaling pathway; scaffold1 indexed_genome mRNA 65048839 65171295 . - . ID=transcript_246;Q9HB63 B2RNC2 Q658K9 Q7L3F1 Q7L9D6 Q7Z5B6 Q9BZP1 Q9NT44 Q9P133,Netrin-4,Beta-netrin;Hepar-derived netrin-like protein;, PF00053;PF00055;PF01759;, GO:0005576;GO:0043256;GO:0005886;GO:0043237;GO:0009887;GO:0007411;GO:0070831;GO:0016477;GO:0016322;GO:0060668;GO:0034446;GO:0009888;, C:extracellular region; C:laminin complex; C:plasma membrane;, F:laminin-1 binding;, P:animal organ morphogenesis; P:axon guidance; P:basement membrane assembly; P:cell migration; P:neuron remodeling; P:regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling; P:substrate adhesion-dependent cell spreading; P:tissue development; scaffold1 indexed_genome mRNA 65222336 65240358 . + . ID=transcript_247;Q502W7 Q8N835,Coiled-coil domain-containing protein 38,, PF13863;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm;|P62306 A2VCR2 B2R498 Q15356 Q6IBQ1 Q6P4I0,Small nuclear ribonucleoprotein F,Sm protein F;, PF01423;, GO:0071013;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0034715;GO:0030532;GO:0034719;GO:0005681;GO:0005685;GO:0005689;GO:0071007;GO:0071005;GO:0005687;GO:0046540;GO:0005683;GO:0003723;GO:0008334;GO:0051170;GO:0000398;GO:0008380;GO:0000387;GO:0006369;, C:catalytic step 2 spliceosome; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U7 snRNP;, F:RNA binding;, P:histone mRNA metabolic process; P:import into nucleus; P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal snRNP assembly; P:termination of RNA polymerase II transcription;|Q502W7 Q8N835,Coiled-coil domain-containing protein 38,, PF13863;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm;|Q502W7 Q8N835,Coiled-coil domain-containing protein 38,, PF13863;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm;|Q502W7 Q8N835,Coiled-coil domain-containing protein 38,, PF13863;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm; scaffold1 indexed_genome mRNA 65247509 65268409 . - . ID=transcript_248;Q502W7 Q8N835,Coiled-coil domain-containing protein 38,, PF13863;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm;|Q502W7 Q8N835,Coiled-coil domain-containing protein 38,, PF13863;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm; scaffold1 indexed_genome mRNA 65268874 65288329 . + . ID=transcript_249;Q96NU7 A8K463 Q68CI8,Probable imidazolonepropionase,Amidohydrolase domain-containing protein 1;, PF01979;, GO:0005829;GO:0050480;GO:0046872;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:imidazolonepropionase activity; F:metal ion binding;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate;|Q9H7X2 B3KRN3 D3DTB2,Uncharacterized protein C1orf115,, PF15828;, GO:0097731;GO:0016021;, C:9+0 non-motile cilium; C:integral component of membrane;|Q96NU7 A8K463 Q68CI8,Probable imidazolonepropionase,Amidohydrolase domain-containing protein 1;, PF01979;, GO:0005829;GO:0050480;GO:0046872;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:imidazolonepropionase activity; F:metal ion binding;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate;|Q96NU7 A8K463 Q68CI8,Probable imidazolonepropionase,Amidohydrolase domain-containing protein 1;, PF01979;, GO:0005829;GO:0050480;GO:0046872;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:imidazolonepropionase activity; F:metal ion binding;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate;|Q96NU7 A8K463 Q68CI8,Probable imidazolonepropionase,Amidohydrolase domain-containing protein 1;, PF01979;, GO:0005829;GO:0050480;GO:0046872;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:imidazolonepropionase activity; F:metal ion binding;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate; scaffold1 indexed_genome mRNA 65290301 65316920 . - . ID=transcript_250;P42357 B4DQC1 B4E0V8 F5GXF2 F5H1U5 Q4VB92 Q4VB93,Histidine ammonia-lyase,, PF00221;PF12053;, GO:0005829;GO:0016841;GO:0004397;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:ammonia-lyase activity; F:histidine ammonia-lyase activity;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate;|P42357 B4DQC1 B4E0V8 F5GXF2 F5H1U5 Q4VB92 Q4VB93,Histidine ammonia-lyase,, PF00221;PF12053;, GO:0005829;GO:0016841;GO:0004397;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:ammonia-lyase activity; F:histidine ammonia-lyase activity;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate;|P42357 B4DQC1 B4E0V8 F5GXF2 F5H1U5 Q4VB92 Q4VB93,Histidine ammonia-lyase,, PF00221;PF12053;, GO:0005829;GO:0016841;GO:0004397;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:ammonia-lyase activity; F:histidine ammonia-lyase activity;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate; scaffold1 indexed_genome mRNA 65320904 65334085 . - . ID=transcript_251;P09960 B4DNQ9 F8VV40 Q6IAT6 Q9UCT7,Leukotriene A-4 hydrolase,Leukotriene A(4) hydrolase;Tripeptide aminopeptidase LTA4H {ECO:0000305};, PF09127;PF01433;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:1904724;GO:0004177;GO:0004301;GO:0004463;GO:0070006;GO:0008233;GO:0003723;GO:0045148;GO:0008270;GO:0044267;GO:0019370;GO:0006691;GO:0042759;GO:0043312;GO:0043171;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:tertiary granule lumen;, F:aminopeptidase activity; F:epoxide hydrolase activity; F:leukotriene-A4 hydrolase activity; F:metalloaminopeptidase activity; F:peptidase activity; F:RNA binding; F:tripeptide aminopeptidase activity; F:zinc ion binding;, P:cellular protein metabolic process; P:leukotriene biosynthetic process; P:leukotriene metabolic process; P:long-chain fatty acid biosynthetic process; P:neutrophil degranulation; P:peptide catabolic process; scaffold1 indexed_genome mRNA 65335062 65363846 . - . ID=transcript_252;P09960 B4DNQ9 F8VV40 Q6IAT6 Q9UCT7,Leukotriene A-4 hydrolase,Leukotriene A(4) hydrolase;Tripeptide aminopeptidase LTA4H {ECO:0000305};, PF09127;PF01433;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:1904724;GO:0004177;GO:0004301;GO:0004463;GO:0070006;GO:0008233;GO:0003723;GO:0045148;GO:0008270;GO:0044267;GO:0019370;GO:0006691;GO:0042759;GO:0043312;GO:0043171;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:tertiary granule lumen;, F:aminopeptidase activity; F:epoxide hydrolase activity; F:leukotriene-A4 hydrolase activity; F:metalloaminopeptidase activity; F:peptidase activity; F:RNA binding; F:tripeptide aminopeptidase activity; F:zinc ion binding;, P:cellular protein metabolic process; P:leukotriene biosynthetic process; P:leukotriene metabolic process; P:long-chain fatty acid biosynthetic process; P:neutrophil degranulation; P:peptide catabolic process; scaffold1 indexed_genome mRNA 65453366 65453916 . - . ID=transcript_253;Q16587 B5MCE3 B7Z5Y2 Q6IBV2 Q6PJP1 Q9UC04 Q9UF05 Q9UF06 Q9UF07,Zinc finger protein 74,Zinc finger protein 520;hZNF7;, PF01352;PF00096;, GO:0015629;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0003723;GO:0000978;GO:0007275;GO:0006357;GO:0006355;, C:actin cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold1 indexed_genome mRNA 65526877 65567499 . + . ID=transcript_254;P41970 B2R6S6 Q6FG57 Q6GU29 Q9UD17,ETS domain-containing protein Elk-3,ETS-related protein ERP;ETS-related protein NET;Serum response factor accessory protein 2;, PF00178;, GO:0000785;GO:0005739;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0032422;GO:0000978;GO:1990837;GO:0001525;GO:0030154;GO:0045892;GO:0045944;GO:0006357;GO:0007165;GO:0042060;, C:chromatin; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:purine-rich negative regulatory element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:wound healing;|P41970 B2R6S6 Q6FG57 Q6GU29 Q9UD17,ETS domain-containing protein Elk-3,ETS-related protein ERP;ETS-related protein NET;Serum response factor accessory protein 2;, PF00178;, GO:0000785;GO:0005739;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0032422;GO:0000978;GO:1990837;GO:0001525;GO:0030154;GO:0045892;GO:0045944;GO:0006357;GO:0007165;GO:0042060;, C:chromatin; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:purine-rich negative regulatory element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:wound healing; scaffold1 indexed_genome mRNA 65569251 65695962 . + . ID=transcript_255;Q00537 A8K1U6 B2RCQ2 Q8NEB8,Cyclin-dependent kinase 17,Cell division protein kinase 17;PCTAIRE-motif protein kinase 2;Serine/threonine-protein kinase PCTAIRE-2;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0006468;GO:0000083;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q00537 A8K1U6 B2RCQ2 Q8NEB8,Cyclin-dependent kinase 17,Cell division protein kinase 17;PCTAIRE-motif protein kinase 2;Serine/threonine-protein kinase PCTAIRE-2;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0006468;GO:0000083;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q00537 A8K1U6 B2RCQ2 Q8NEB8,Cyclin-dependent kinase 17,Cell division protein kinase 17;PCTAIRE-motif protein kinase 2;Serine/threonine-protein kinase PCTAIRE-2;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0006468;GO:0000083;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q00537 A8K1U6 B2RCQ2 Q8NEB8,Cyclin-dependent kinase 17,Cell division protein kinase 17;PCTAIRE-motif protein kinase 2;Serine/threonine-protein kinase PCTAIRE-2;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0006468;GO:0000083;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q00537 A8K1U6 B2RCQ2 Q8NEB8,Cyclin-dependent kinase 17,Cell division protein kinase 17;PCTAIRE-motif protein kinase 2;Serine/threonine-protein kinase PCTAIRE-2;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0006468;GO:0000083;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; scaffold1 indexed_genome mRNA 65810935 65820356 . + . ID=transcript_256;Q96N23 E9PJL5 Q6ZTY8,Cilia- and flagella-associated protein 54 {ECO:0000305},, PF14858;, GO:0005930;GO:0030154;GO:0060271;GO:0060294;GO:0007283;, C:axoneme;, , P:cell differentiation; P:cilium assembly; P:cilium movement involved in cell motility; P:spermatogenesis; scaffold1 indexed_genome mRNA 65882354 65909608 . + . ID=transcript_257;Q96N23 E9PJL5 Q6ZTY8,Cilia- and flagella-associated protein 54 {ECO:0000305},, PF14858;, GO:0005930;GO:0030154;GO:0060271;GO:0060294;GO:0007283;, C:axoneme;, , P:cell differentiation; P:cilium assembly; P:cilium movement involved in cell motility; P:spermatogenesis; scaffold1 indexed_genome mRNA 65929757 66062976 . + . ID=transcript_258;Q96N23 E9PJL5 Q6ZTY8,Cilia- and flagella-associated protein 54 {ECO:0000305},, PF14858;, GO:0005930;GO:0030154;GO:0060271;GO:0060294;GO:0007283;, C:axoneme;, , P:cell differentiation; P:cilium assembly; P:cilium movement involved in cell motility; P:spermatogenesis; scaffold1 indexed_genome mRNA 66111035 66155573 . + . ID=transcript_259;Q8NHV4 B0AZN0 B4E145 G3V3F1 Q8NA30,Protein NEDD1,Neural precursor cell expressed developmentally down-regulated protein 1;, PF00400;, GO:0045177;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0005654;GO:0000242;GO:0005886;GO:0000922;GO:0051301;GO:0097711;GO:0000086;GO:0071539;GO:0010389;, C:apical part of cell; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:nucleoplasm; C:pericentriolar material; C:plasma membrane; C:spindle pole;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q8NHV4 B0AZN0 B4E145 G3V3F1 Q8NA30,Protein NEDD1,Neural precursor cell expressed developmentally down-regulated protein 1;, PF00400;, GO:0045177;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0005654;GO:0000242;GO:0005886;GO:0000922;GO:0051301;GO:0097711;GO:0000086;GO:0071539;GO:0010389;, C:apical part of cell; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:nucleoplasm; C:pericentriolar material; C:plasma membrane; C:spindle pole;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q8NHV4 B0AZN0 B4E145 G3V3F1 Q8NA30,Protein NEDD1,Neural precursor cell expressed developmentally down-regulated protein 1;, PF00400;, GO:0045177;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0005654;GO:0000242;GO:0005886;GO:0000922;GO:0051301;GO:0097711;GO:0000086;GO:0071539;GO:0010389;, C:apical part of cell; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:nucleoplasm; C:pericentriolar material; C:plasma membrane; C:spindle pole;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; scaffold1 indexed_genome mRNA 67636706 67675391 . + . ID=transcript_260;P42167 A2T926 Q14861,Lamina-associated polypeptide 2, isoforms beta/gamma,Thymopoietin, isoforms beta/gamma;Thymopoietin-related peptide isoforms beta/gamma;, PF03020;PF08198;, GO:0005737;GO:0016021;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0005634;GO:0003677;GO:0005521;, C:cytoplasm; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nucleus;, F:DNA binding; F:lamin binding;|P42166 P08918 P08919 Q14860 Q16295,Lamina-associated polypeptide 2, isoform alpha,Thymopoietin isoform alpha;Thymopoietin-related peptide isoform alpha;, PF11560;PF03020;PF08198;, GO:0000785;GO:0005635;GO:0005634;GO:0045296;GO:0003677;GO:0005521;GO:0006355;, C:chromatin; C:nuclear envelope; C:nucleus;, F:cadherin binding; F:DNA binding; F:lamin binding;, P:regulation of transcription, DNA-templated;|P42167 A2T926 Q14861,Lamina-associated polypeptide 2, isoforms beta/gamma,Thymopoietin, isoforms beta/gamma;Thymopoietin-related peptide isoforms beta/gamma;, PF03020;PF08198;, GO:0005737;GO:0016021;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0005634;GO:0003677;GO:0005521;, C:cytoplasm; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nucleus;, F:DNA binding; F:lamin binding;|P42167 A2T926 Q14861,Lamina-associated polypeptide 2, isoforms beta/gamma,Thymopoietin, isoforms beta/gamma;Thymopoietin-related peptide isoforms beta/gamma;, PF03020;PF08198;, GO:0005737;GO:0016021;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0005634;GO:0003677;GO:0005521;, C:cytoplasm; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nucleus;, F:DNA binding; F:lamin binding;|P42167 A2T926 Q14861,Lamina-associated polypeptide 2, isoforms beta/gamma,Thymopoietin, isoforms beta/gamma;Thymopoietin-related peptide isoforms beta/gamma;, PF03020;PF08198;, GO:0005737;GO:0016021;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0005634;GO:0003677;GO:0005521;, C:cytoplasm; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nucleus;, F:DNA binding; F:lamin binding;|P42167 A2T926 Q14861,Lamina-associated polypeptide 2, isoforms beta/gamma,Thymopoietin, isoforms beta/gamma;Thymopoietin-related peptide isoforms beta/gamma;, PF03020;PF08198;, GO:0005737;GO:0016021;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0005634;GO:0003677;GO:0005521;, C:cytoplasm; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nucleus;, F:DNA binding; F:lamin binding; scaffold1 indexed_genome mRNA 67702065 67704135 . + . ID=transcript_261;Q00325 B3KS34 Q7Z7N7 Q96A03,Phosphate carrier protein, mitochondrial,Phosphate transport protein;Solute carrier family 25 member 3;, PF00153;, GO:0070062;GO:0031305;GO:0005887;GO:0016020;GO:0005743;GO:0005739;GO:0005315;GO:0015317;GO:0044877;GO:0035435;, C:extracellular exosome; C:integral component of mitochondrial inner membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:inorganic phosphate transmembrane transporter activity; F:phosphate:proton symporter activity; F:protein-containing complex binding;, P:phosphate ion transmembrane transport; scaffold1 indexed_genome mRNA 67704139 67715039 . - . ID=transcript_262;Q00325 B3KS34 Q7Z7N7 Q96A03,Phosphate carrier protein, mitochondrial,Phosphate transport protein;Solute carrier family 25 member 3;, PF00153;, GO:0070062;GO:0031305;GO:0005887;GO:0016020;GO:0005743;GO:0005739;GO:0005315;GO:0015317;GO:0044877;GO:0035435;, C:extracellular exosome; C:integral component of mitochondrial inner membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:inorganic phosphate transmembrane transporter activity; F:phosphate:proton symporter activity; F:protein-containing complex binding;, P:phosphate ion transmembrane transport;|Q00325 B3KS34 Q7Z7N7 Q96A03,Phosphate carrier protein, mitochondrial,Phosphate transport protein;Solute carrier family 25 member 3;, PF00153;, GO:0070062;GO:0031305;GO:0005887;GO:0016020;GO:0005743;GO:0005739;GO:0005315;GO:0015317;GO:0044877;GO:0035435;, C:extracellular exosome; C:integral component of mitochondrial inner membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:inorganic phosphate transmembrane transporter activity; F:phosphate:proton symporter activity; F:protein-containing complex binding;, P:phosphate ion transmembrane transport;|Q70UQ0 Q6ZWH4 Q70UP9 Q86V91 Q96ND2,Inhibitor of nuclear factor kappa-B kinase-interacting protein,, , GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0010165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:response to X-ray;|Q00325 B3KS34 Q7Z7N7 Q96A03,Phosphate carrier protein, mitochondrial,Phosphate transport protein;Solute carrier family 25 member 3;, PF00153;, GO:0070062;GO:0031305;GO:0005887;GO:0016020;GO:0005743;GO:0005739;GO:0005315;GO:0015317;GO:0044877;GO:0035435;, C:extracellular exosome; C:integral component of mitochondrial inner membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:inorganic phosphate transmembrane transporter activity; F:phosphate:proton symporter activity; F:protein-containing complex binding;, P:phosphate ion transmembrane transport;|Q70UQ0 Q6ZWH4 Q70UP9 Q86V91 Q96ND2,Inhibitor of nuclear factor kappa-B kinase-interacting protein,, , GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0010165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:response to X-ray; scaffold1 indexed_genome mRNA 67718051 67734180 . - . ID=transcript_263;Q70UQ0 Q6ZWH4 Q70UP9 Q86V91 Q96ND2,Inhibitor of nuclear factor kappa-B kinase-interacting protein,, , GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0010165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:response to X-ray; scaffold1 indexed_genome mRNA 67739697 67784009 . + . ID=transcript_264;Q9UJ67 Q9UNC9,Apoptotic protease-activating factor 1 {ECO:0000305},, PF17908;PF00619;PF00931;PF00400;, GO:0043293;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0032991;GO:0034774;GO:0043531;GO:0005524;GO:0008656;GO:0031072;GO:0042802;GO:0000166;GO:0006919;GO:0008635;GO:0007568;GO:0006915;GO:0010659;GO:0030154;GO:0071560;GO:0030900;GO:0097193;GO:0070059;GO:0001822;GO:0070317;GO:0007399;GO:0001843;GO:0051402;GO:0043312;GO:0043065;GO:2001235;GO:1902510;GO:0042981;GO:0072432;GO:0001666;GO:0007584;, C:apoptosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:protein-containing complex; C:secretory granule lumen;, F:ADP binding; F:ATP binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:heat shock protein binding; F:identical protein binding; F:nucleotide binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:aging; P:apoptotic process; P:cardiac muscle cell apoptotic process; P:cell differentiation; P:cellular response to transforming growth factor beta stimulus; P:forebrain development; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:negative regulation of G0 to G1 transition; P:nervous system development; P:neural tube closure; P:neuron apoptotic process; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:regulation of apoptotic DNA fragmentation; P:regulation of apoptotic process; P:response to G1 DNA damage checkpoint signaling; P:response to hypoxia; P:response to nutrient; scaffold1 indexed_genome mRNA 67786860 67787572 . + . ID=transcript_265;Q9H079 A8KAF6 Q2TAC0 Q9H670,KATNB1-like protein 1,Katanin p80 subunit B-like 1 {ECO:0000303|PubMed:26929214};, PF13925;, GO:0032154;GO:0005737;GO:0030496;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0005634;GO:0008017;GO:0051495;, C:cleavage furrow; C:cytoplasm; C:midbody; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:nucleus;, F:microtubule binding;, P:positive regulation of cytoskeleton organization; scaffold1 indexed_genome mRNA 67790853 67834737 . + . ID=transcript_266;Q9UJ67 Q9UNC9,Apoptotic protease-activating factor 1 {ECO:0000305},, PF17908;PF00619;PF00931;PF00400;, GO:0043293;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0032991;GO:0034774;GO:0043531;GO:0005524;GO:0008656;GO:0031072;GO:0042802;GO:0000166;GO:0006919;GO:0008635;GO:0007568;GO:0006915;GO:0010659;GO:0030154;GO:0071560;GO:0030900;GO:0097193;GO:0070059;GO:0001822;GO:0070317;GO:0007399;GO:0001843;GO:0051402;GO:0043312;GO:0043065;GO:2001235;GO:1902510;GO:0042981;GO:0072432;GO:0001666;GO:0007584;, C:apoptosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:protein-containing complex; C:secretory granule lumen;, F:ADP binding; F:ATP binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:heat shock protein binding; F:identical protein binding; F:nucleotide binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:aging; P:apoptotic process; P:cardiac muscle cell apoptotic process; P:cell differentiation; P:cellular response to transforming growth factor beta stimulus; P:forebrain development; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:negative regulation of G0 to G1 transition; P:nervous system development; P:neural tube closure; P:neuron apoptotic process; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:regulation of apoptotic DNA fragmentation; P:regulation of apoptotic process; P:response to G1 DNA damage checkpoint signaling; P:response to hypoxia; P:response to nutrient; scaffold1 indexed_genome mRNA 67855954 68797308 . - . ID=transcript_267;F8WC27 Q5XLJ0 Q6IVB5 Q6NUS4 Q7Z6G6 Q7Z6G7 Q8TAP3 Q9NRX7 Q9Y5K9,Ankyrin repeat and sterile alpha motif domain-containing protein 1B,Amyloid-beta protein intracellular domain-associated protein 1;E2A-PBX1-associated protein;, PF12796;PF00640;PF00536;, GO:0015030;GO:0005829;GO:0043197;GO:0043231;GO:0005886;GO:0014069;GO:0046875;GO:0048013;GO:1900383;, C:Cajal body; C:cytosol; C:dendritic spine; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:regulation of synaptic plasticity by receptor localization to synapse;|F8WC27 Q5XLJ0 Q6IVB5 Q6NUS4 Q7Z6G6 Q7Z6G7 Q8TAP3 Q9NRX7 Q9Y5K9,Ankyrin repeat and sterile alpha motif domain-containing protein 1B,Amyloid-beta protein intracellular domain-associated protein 1;E2A-PBX1-associated protein;, PF12796;PF00640;PF00536;, GO:0015030;GO:0005829;GO:0043197;GO:0043231;GO:0005886;GO:0014069;GO:0046875;GO:0048013;GO:1900383;, C:Cajal body; C:cytosol; C:dendritic spine; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:regulation of synaptic plasticity by receptor localization to synapse;|F8WC27 Q5XLJ0 Q6IVB5 Q6NUS4 Q7Z6G6 Q7Z6G7 Q8TAP3 Q9NRX7 Q9Y5K9,Ankyrin repeat and sterile alpha motif domain-containing protein 1B,Amyloid-beta protein intracellular domain-associated protein 1;E2A-PBX1-associated protein;, PF12796;PF00640;PF00536;, GO:0015030;GO:0005829;GO:0043197;GO:0043231;GO:0005886;GO:0014069;GO:0046875;GO:0048013;GO:1900383;, C:Cajal body; C:cytosol; C:dendritic spine; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:regulation of synaptic plasticity by receptor localization to synapse;|F8WC27 Q5XLJ0 Q6IVB5 Q6NUS4 Q7Z6G6 Q7Z6G7 Q8TAP3 Q9NRX7 Q9Y5K9,Ankyrin repeat and sterile alpha motif domain-containing protein 1B,Amyloid-beta protein intracellular domain-associated protein 1;E2A-PBX1-associated protein;, PF12796;PF00640;PF00536;, GO:0015030;GO:0005829;GO:0043197;GO:0043231;GO:0005886;GO:0014069;GO:0046875;GO:0048013;GO:1900383;, C:Cajal body; C:cytosol; C:dendritic spine; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:regulation of synaptic plasticity by receptor localization to synapse; scaffold1 indexed_genome mRNA 69032174 69055002 . + . ID=transcript_268;Q9GZN1 B3KW37 B4DLG9 Q53GH2 Q9BY39 Q9H8H6,Actin-related protein 6,hARPX;, PF00022;, GO:0005737;GO:0005856;GO:0005634;GO:0000812;GO:0031491;GO:0043486;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:Swr1 complex;, F:nucleosome binding;, P:histone exchange;|Q9GZN1 B3KW37 B4DLG9 Q53GH2 Q9BY39 Q9H8H6,Actin-related protein 6,hARPX;, PF00022;, GO:0005737;GO:0005856;GO:0005634;GO:0000812;GO:0031491;GO:0043486;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:Swr1 complex;, F:nucleosome binding;, P:histone exchange;|Q9GZN1 B3KW37 B4DLG9 Q53GH2 Q9BY39 Q9H8H6,Actin-related protein 6,hARPX;, PF00022;, GO:0005737;GO:0005856;GO:0005634;GO:0000812;GO:0031491;GO:0043486;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:Swr1 complex;, F:nucleosome binding;, P:histone exchange; scaffold1 indexed_genome mRNA 69086232 69144240 . + . ID=transcript_269;Q6P3W7 A8KAB5 Q96EF4 Q96ST4 Q9H7V5 Q9NVH3 Q9P2I7,SCY1-like protein 2 {ECO:0000305},Coated vesicle-associated kinase of 104 kDa {ECO:0000303|PubMed:15809293};, PF00069;, GO:0030136;GO:0010008;GO:0005794;GO:0005524;GO:0004672;GO:0005102;GO:0007420;GO:0008333;GO:0090090;GO:2000370;GO:0002092;GO:0021860;GO:2000286;, C:clathrin-coated vesicle; C:endosome membrane; C:Golgi apparatus;, F:ATP binding; F:protein kinase activity; F:signaling receptor binding;, P:brain development; P:endosome to lysosome transport; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of receptor internalization; P:pyramidal neuron development; P:receptor internalization involved in canonical Wnt signaling pathway;|Q6P3W7 A8KAB5 Q96EF4 Q96ST4 Q9H7V5 Q9NVH3 Q9P2I7,SCY1-like protein 2 {ECO:0000305},Coated vesicle-associated kinase of 104 kDa {ECO:0000303|PubMed:15809293};, PF00069;, GO:0030136;GO:0010008;GO:0005794;GO:0005524;GO:0004672;GO:0005102;GO:0007420;GO:0008333;GO:0090090;GO:2000370;GO:0002092;GO:0021860;GO:2000286;, C:clathrin-coated vesicle; C:endosome membrane; C:Golgi apparatus;, F:ATP binding; F:protein kinase activity; F:signaling receptor binding;, P:brain development; P:endosome to lysosome transport; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of receptor internalization; P:pyramidal neuron development; P:receptor internalization involved in canonical Wnt signaling pathway;|Q6P3W7 A8KAB5 Q96EF4 Q96ST4 Q9H7V5 Q9NVH3 Q9P2I7,SCY1-like protein 2 {ECO:0000305},Coated vesicle-associated kinase of 104 kDa {ECO:0000303|PubMed:15809293};, PF00069;, GO:0030136;GO:0010008;GO:0005794;GO:0005524;GO:0004672;GO:0005102;GO:0007420;GO:0008333;GO:0090090;GO:2000370;GO:0002092;GO:0021860;GO:2000286;, C:clathrin-coated vesicle; C:endosome membrane; C:Golgi apparatus;, F:ATP binding; F:protein kinase activity; F:signaling receptor binding;, P:brain development; P:endosome to lysosome transport; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of receptor internalization; P:pyramidal neuron development; P:receptor internalization involved in canonical Wnt signaling pathway; scaffold1 indexed_genome mRNA 69157076 69174099 . + . ID=transcript_270;Q8NDX2 B3KXZ6 B7ZKV4 Q17RQ8,Vesicular glutamate transporter 3,Solute carrier family 17 member 8;, PF07690;, GO:0097440;GO:0043679;GO:0097441;GO:0060076;GO:0097451;GO:0016021;GO:0030285;GO:0005771;GO:1990030;GO:0043204;GO:0030672;GO:0005313;GO:0005326;GO:0015293;GO:0022857;GO:0006820;GO:0007420;GO:0090102;GO:0006811;GO:0003407;GO:0098700;GO:0050803;GO:0007605;GO:0006814;GO:0035249;, C:apical dendrite; C:axon terminus; C:basal dendrite; C:excitatory synapse; C:glial limiting end-foot; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:multivesicular body; C:pericellular basket; C:perikaryon; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:symporter activity; F:transmembrane transporter activity;, P:anion transport; P:brain development; P:cochlea development; P:ion transport; P:neural retina development; P:neurotransmitter loading into synaptic vesicle; P:regulation of synapse structure or activity; P:sensory perception of sound; P:sodium ion transport; P:synaptic transmission, glutamatergic; scaffold1 indexed_genome mRNA 69180578 69186986 . + . ID=transcript_271;Q8NDX2 B3KXZ6 B7ZKV4 Q17RQ8,Vesicular glutamate transporter 3,Solute carrier family 17 member 8;, PF07690;, GO:0097440;GO:0043679;GO:0097441;GO:0060076;GO:0097451;GO:0016021;GO:0030285;GO:0005771;GO:1990030;GO:0043204;GO:0030672;GO:0005313;GO:0005326;GO:0015293;GO:0022857;GO:0006820;GO:0007420;GO:0090102;GO:0006811;GO:0003407;GO:0098700;GO:0050803;GO:0007605;GO:0006814;GO:0035249;, C:apical dendrite; C:axon terminus; C:basal dendrite; C:excitatory synapse; C:glial limiting end-foot; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:multivesicular body; C:pericellular basket; C:perikaryon; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:symporter activity; F:transmembrane transporter activity;, P:anion transport; P:brain development; P:cochlea development; P:ion transport; P:neural retina development; P:neurotransmitter loading into synaptic vesicle; P:regulation of synapse structure or activity; P:sensory perception of sound; P:sodium ion transport; P:synaptic transmission, glutamatergic;|Q8NDX2 B3KXZ6 B7ZKV4 Q17RQ8,Vesicular glutamate transporter 3,Solute carrier family 17 member 8;, PF07690;, GO:0097440;GO:0043679;GO:0097441;GO:0060076;GO:0097451;GO:0016021;GO:0030285;GO:0005771;GO:1990030;GO:0043204;GO:0030672;GO:0005313;GO:0005326;GO:0015293;GO:0022857;GO:0006820;GO:0007420;GO:0090102;GO:0006811;GO:0003407;GO:0098700;GO:0050803;GO:0007605;GO:0006814;GO:0035249;, C:apical dendrite; C:axon terminus; C:basal dendrite; C:excitatory synapse; C:glial limiting end-foot; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:multivesicular body; C:pericellular basket; C:perikaryon; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:symporter activity; F:transmembrane transporter activity;, P:anion transport; P:brain development; P:cochlea development; P:ion transport; P:neural retina development; P:neurotransmitter loading into synaptic vesicle; P:regulation of synapse structure or activity; P:sensory perception of sound; P:sodium ion transport; P:synaptic transmission, glutamatergic; scaffold1 indexed_genome mRNA 69193991 69197007 . - . ID=transcript_272;Q8NDX2 B3KXZ6 B7ZKV4 Q17RQ8,Vesicular glutamate transporter 3,Solute carrier family 17 member 8;, PF07690;, GO:0097440;GO:0043679;GO:0097441;GO:0060076;GO:0097451;GO:0016021;GO:0030285;GO:0005771;GO:1990030;GO:0043204;GO:0030672;GO:0005313;GO:0005326;GO:0015293;GO:0022857;GO:0006820;GO:0007420;GO:0090102;GO:0006811;GO:0003407;GO:0098700;GO:0050803;GO:0007605;GO:0006814;GO:0035249;, C:apical dendrite; C:axon terminus; C:basal dendrite; C:excitatory synapse; C:glial limiting end-foot; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:multivesicular body; C:pericellular basket; C:perikaryon; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:symporter activity; F:transmembrane transporter activity;, P:anion transport; P:brain development; P:cochlea development; P:ion transport; P:neural retina development; P:neurotransmitter loading into synaptic vesicle; P:regulation of synapse structure or activity; P:sensory perception of sound; P:sodium ion transport; P:synaptic transmission, glutamatergic; scaffold1 indexed_genome mRNA 69275742 69334517 . + . ID=transcript_273;Q96RI1 A1L4K5 B7Z412 B7ZM06 F8VYG8 Q8NFP5 Q8NFP6 Q92943,Bile acid receptor,Farnesoid X-activated receptor;Farnesol receptor HRR-1;Nuclear receptor subfamily 1 group H member 4;Retinoid X receptor-interacting protein 14;, PF00104;PF00105;, GO:0000785;GO:0000791;GO:0005654;GO:0043235;GO:0032052;GO:0038181;GO:1902122;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0016922;GO:0046965;GO:0000978;GO:0000977;GO:0043565;GO:0000976;GO:0008270;GO:0015721;GO:0008206;GO:0038183;GO:0030154;GO:0007043;GO:0001678;GO:1903413;GO:0071398;GO:0071222;GO:0071417;GO:0035356;GO:0042632;GO:0042742;GO:0055089;GO:0034971;GO:0006954;GO:0045087;GO:0038185;GO:0030522;GO:0043066;GO:0043124;GO:0050728;GO:0032689;GO:0032692;GO:0032703;GO:0032715;GO:0071638;GO:0032088;GO:0000122;GO:0032720;GO:0010804;GO:0010903;GO:0001080;GO:0007219;GO:1904179;GO:2001250;GO:2000213;GO:0046628;GO:0035774;GO:0032740;GO:1905695;GO:0045944;GO:0045893;GO:0070857;GO:0090181;GO:0061178;GO:0010988;GO:0006357;GO:0006355;GO:0034255;GO:0034142;GO:0034162;GO:0006367;, C:chromatin; C:euchromatin; C:nucleoplasm; C:receptor complex;, F:bile acid binding; F:bile acid receptor activity; F:chenodeoxycholic acid binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:nuclear receptor binding; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:bile acid signaling pathway; P:cell differentiation; P:cell-cell junction assembly; P:cellular glucose homeostasis; P:cellular response to bile acid; P:cellular response to fatty acid; P:cellular response to lipopolysaccharide; P:cellular response to organonitrogen compound; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:defense response to bacterium; P:fatty acid homeostasis; P:histone H3-R17 methylation; P:inflammatory response; P:innate immune response; P:intracellular bile acid receptor signaling pathway; P:intracellular receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 production; P:negative regulation of interleukin-2 production; P:negative regulation of interleukin-6 production; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:negative regulation of very-low-density lipoprotein particle remodeling; P:nitrogen catabolite activation of transcription from RNA polymerase II promoter; P:Notch signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of ammonia assimilation cycle; P:positive regulation of glutamate metabolic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of interleukin-17 production; P:positive regulation of phosphatidic acid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of bile acid biosynthetic process; P:regulation of cholesterol metabolic process; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of low-density lipoprotein particle clearance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of urea metabolic process; P:toll-like receptor 4 signaling pathway; P:toll-like receptor 9 signaling pathway; P:transcription initiation from RNA polymerase II promoter;|Q96RI1 A1L4K5 B7Z412 B7ZM06 F8VYG8 Q8NFP5 Q8NFP6 Q92943,Bile acid receptor,Farnesoid X-activated receptor;Farnesol receptor HRR-1;Nuclear receptor subfamily 1 group H member 4;Retinoid X receptor-interacting protein 14;, PF00104;PF00105;, GO:0000785;GO:0000791;GO:0005654;GO:0043235;GO:0032052;GO:0038181;GO:1902122;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0016922;GO:0046965;GO:0000978;GO:0000977;GO:0043565;GO:0000976;GO:0008270;GO:0015721;GO:0008206;GO:0038183;GO:0030154;GO:0007043;GO:0001678;GO:1903413;GO:0071398;GO:0071222;GO:0071417;GO:0035356;GO:0042632;GO:0042742;GO:0055089;GO:0034971;GO:0006954;GO:0045087;GO:0038185;GO:0030522;GO:0043066;GO:0043124;GO:0050728;GO:0032689;GO:0032692;GO:0032703;GO:0032715;GO:0071638;GO:0032088;GO:0000122;GO:0032720;GO:0010804;GO:0010903;GO:0001080;GO:0007219;GO:1904179;GO:2001250;GO:2000213;GO:0046628;GO:0035774;GO:0032740;GO:1905695;GO:0045944;GO:0045893;GO:0070857;GO:0090181;GO:0061178;GO:0010988;GO:0006357;GO:0006355;GO:0034255;GO:0034142;GO:0034162;GO:0006367;, C:chromatin; C:euchromatin; C:nucleoplasm; C:receptor complex;, F:bile acid binding; F:bile acid receptor activity; F:chenodeoxycholic acid binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:nuclear receptor binding; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:bile acid signaling pathway; P:cell differentiation; P:cell-cell junction assembly; P:cellular glucose homeostasis; P:cellular response to bile acid; P:cellular response to fatty acid; P:cellular response to lipopolysaccharide; P:cellular response to organonitrogen compound; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:defense response to bacterium; P:fatty acid homeostasis; P:histone H3-R17 methylation; P:inflammatory response; P:innate immune response; P:intracellular bile acid receptor signaling pathway; P:intracellular receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 production; P:negative regulation of interleukin-2 production; P:negative regulation of interleukin-6 production; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:negative regulation of very-low-density lipoprotein particle remodeling; P:nitrogen catabolite activation of transcription from RNA polymerase II promoter; P:Notch signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of ammonia assimilation cycle; P:positive regulation of glutamate metabolic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of interleukin-17 production; P:positive regulation of phosphatidic acid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of bile acid biosynthetic process; P:regulation of cholesterol metabolic process; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of low-density lipoprotein particle clearance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of urea metabolic process; P:toll-like receptor 4 signaling pathway; P:toll-like receptor 9 signaling pathway; P:transcription initiation from RNA polymerase II promoter; scaffold1 indexed_genome mRNA 69689217 69788804 . + . ID=transcript_274;Q32M45 Q8NAJ0 Q8NB39 Q8NB53,Anoctamin-4,Transmembrane protein 16D;, PF16178;PF04547;, GO:0016021;GO:0005886;GO:0005254;GO:0005229;GO:0046983;GO:0061588;GO:1902476;GO:0006821;GO:0034220;GO:0055085;, C:integral component of membrane; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:protein dimerization activity;, P:calcium activated phospholipid scrambling; P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:transmembrane transport; scaffold1 indexed_genome mRNA 69794192 69871642 . + . ID=transcript_275;Q32M45 Q8NAJ0 Q8NB39 Q8NB53,Anoctamin-4,Transmembrane protein 16D;, PF16178;PF04547;, GO:0016021;GO:0005886;GO:0005254;GO:0005229;GO:0046983;GO:0061588;GO:1902476;GO:0006821;GO:0034220;GO:0055085;, C:integral component of membrane; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:protein dimerization activity;, P:calcium activated phospholipid scrambling; P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:transmembrane transport;|Q32M45 Q8NAJ0 Q8NB39 Q8NB53,Anoctamin-4,Transmembrane protein 16D;, PF16178;PF04547;, GO:0016021;GO:0005886;GO:0005254;GO:0005229;GO:0046983;GO:0061588;GO:1902476;GO:0006821;GO:0034220;GO:0055085;, C:integral component of membrane; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:protein dimerization activity;, P:calcium activated phospholipid scrambling; P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:transmembrane transport; scaffold1 indexed_genome mRNA 70035822 70061917 . + . ID=transcript_276;O75691 Q9H3H4,Small subunit processome component 20 homolog,Down-regulated in metastasis protein;Novel nucleolar protein 73;Protein Key-1A6;, PF07539;, GO:0030686;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0030688;GO:0032040;GO:0003723;GO:0000480;GO:0000447;GO:0000472;GO:0008285;GO:0006364;, C:90S preribosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:preribosome, small subunit precursor; C:small-subunit processome;, F:RNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell population proliferation; P:rRNA processing; scaffold1 indexed_genome mRNA 70064987 70122621 . + . ID=transcript_277;O75691 Q9H3H4,Small subunit processome component 20 homolog,Down-regulated in metastasis protein;Novel nucleolar protein 73;Protein Key-1A6;, PF07539;, GO:0030686;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0030688;GO:0032040;GO:0003723;GO:0000480;GO:0000447;GO:0000472;GO:0008285;GO:0006364;, C:90S preribosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:preribosome, small subunit precursor; C:small-subunit processome;, F:RNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell population proliferation; P:rRNA processing;|O75691 Q9H3H4,Small subunit processome component 20 homolog,Down-regulated in metastasis protein;Novel nucleolar protein 73;Protein Key-1A6;, PF07539;, GO:0030686;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0030688;GO:0032040;GO:0003723;GO:0000480;GO:0000447;GO:0000472;GO:0008285;GO:0006364;, C:90S preribosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:preribosome, small subunit precursor; C:small-subunit processome;, F:RNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell population proliferation; P:rRNA processing;|O75691 Q9H3H4,Small subunit processome component 20 homolog,Down-regulated in metastasis protein;Novel nucleolar protein 73;Protein Key-1A6;, PF07539;, GO:0030686;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0030688;GO:0032040;GO:0003723;GO:0000480;GO:0000447;GO:0000472;GO:0008285;GO:0006364;, C:90S preribosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:preribosome, small subunit precursor; C:small-subunit processome;, F:RNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell population proliferation; P:rRNA processing;|O75691 Q9H3H4,Small subunit processome component 20 homolog,Down-regulated in metastasis protein;Novel nucleolar protein 73;Protein Key-1A6;, PF07539;, GO:0030686;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0030688;GO:0032040;GO:0003723;GO:0000480;GO:0000447;GO:0000472;GO:0008285;GO:0006364;, C:90S preribosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:preribosome, small subunit precursor; C:small-subunit processome;, F:RNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell population proliferation; P:rRNA processing;|O75691 Q9H3H4,Small subunit processome component 20 homolog,Down-regulated in metastasis protein;Novel nucleolar protein 73;Protein Key-1A6;, PF07539;, GO:0030686;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0030688;GO:0032040;GO:0003723;GO:0000480;GO:0000447;GO:0000472;GO:0008285;GO:0006364;, C:90S preribosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:preribosome, small subunit precursor; C:small-subunit processome;, F:RNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell population proliferation; P:rRNA processing;|O75691 Q9H3H4,Small subunit processome component 20 homolog,Down-regulated in metastasis protein;Novel nucleolar protein 73;Protein Key-1A6;, PF07539;, GO:0030686;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0030688;GO:0032040;GO:0003723;GO:0000480;GO:0000447;GO:0000472;GO:0008285;GO:0006364;, C:90S preribosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:preribosome, small subunit precursor; C:small-subunit processome;, F:RNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell population proliferation; P:rRNA processing;|O75691 Q9H3H4,Small subunit processome component 20 homolog,Down-regulated in metastasis protein;Novel nucleolar protein 73;Protein Key-1A6;, PF07539;, GO:0030686;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0030688;GO:0032040;GO:0003723;GO:0000480;GO:0000447;GO:0000472;GO:0008285;GO:0006364;, C:90S preribosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:preribosome, small subunit precursor; C:small-subunit processome;, F:RNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell population proliferation; P:rRNA processing;|O75691 Q9H3H4,Small subunit processome component 20 homolog,Down-regulated in metastasis protein;Novel nucleolar protein 73;Protein Key-1A6;, PF07539;, GO:0030686;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0030688;GO:0032040;GO:0003723;GO:0000480;GO:0000447;GO:0000472;GO:0008285;GO:0006364;, C:90S preribosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:preribosome, small subunit precursor; C:small-subunit processome;, F:RNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell population proliferation; P:rRNA processing; scaffold1 indexed_genome mRNA 70126687 70137990 . - . ID=transcript_278;P40616 B4DWW1 P80417 Q53XB1,ADP-ribosylation factor-like protein 1,, PF00025;, GO:0005737;GO:0005829;GO:0005794;GO:0005802;GO:0032588;GO:0008047;GO:0005525;GO:0003924;GO:0046872;GO:0019904;GO:0031584;GO:0007030;GO:0006886;GO:0034067;GO:0042147;GO:0009404;GO:0016192;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:trans-Golgi network; C:trans-Golgi network membrane;, F:enzyme activator activity; F:GTP binding; F:GTPase activity; F:metal ion binding; F:protein domain specific binding;, P:activation of phospholipase D activity; P:Golgi organization; P:intracellular protein transport; P:protein localization to Golgi apparatus; P:retrograde transport, endosome to Golgi; P:toxin metabolic process; P:vesicle-mediated transport;|P40616 B4DWW1 P80417 Q53XB1,ADP-ribosylation factor-like protein 1,, PF00025;, GO:0005737;GO:0005829;GO:0005794;GO:0005802;GO:0032588;GO:0008047;GO:0005525;GO:0003924;GO:0046872;GO:0019904;GO:0031584;GO:0007030;GO:0006886;GO:0034067;GO:0042147;GO:0009404;GO:0016192;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:trans-Golgi network; C:trans-Golgi network membrane;, F:enzyme activator activity; F:GTP binding; F:GTPase activity; F:metal ion binding; F:protein domain specific binding;, P:activation of phospholipase D activity; P:Golgi organization; P:intracellular protein transport; P:protein localization to Golgi apparatus; P:retrograde transport, endosome to Golgi; P:toxin metabolic process; P:vesicle-mediated transport; scaffold1 indexed_genome mRNA 70164294 70165114 . - . ID=transcript_279;P98169 A8K151 Q9UBB3,Zinc finger X-linked protein ZXDB,, PF00096;, GO:0005634;GO:0046872;GO:0003712;GO:0006357;, C:nucleus;, F:metal ion binding; F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 70184737 70192685 . + . ID=transcript_280;Q8N5J4,Transcription factor Spi-C,, PF00178;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0001824;GO:0030154;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:blastocyst development; P:cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 70284856 70344141 . + . ID=transcript_281;Q15497 Q17RR7 Q569K7 Q86T48 Q86TC8 Q8N3L2,Myosin-binding protein C, slow-type,C-protein, skeletal muscle slow isoform;, PF00041;PF07679;PF18362;, GO:0005829;GO:0030016;GO:0032982;GO:0003779;GO:0017022;GO:0008307;GO:0031432;GO:0007155;GO:0030049;, C:cytosol; C:myofibril; C:myosin filament;, F:actin binding; F:myosin binding; F:structural constituent of muscle; F:titin binding;, P:cell adhesion; P:muscle filament sliding;|Q15497 Q17RR7 Q569K7 Q86T48 Q86TC8 Q8N3L2,Myosin-binding protein C, slow-type,C-protein, skeletal muscle slow isoform;, PF00041;PF07679;PF18362;, GO:0005829;GO:0030016;GO:0032982;GO:0003779;GO:0017022;GO:0008307;GO:0031432;GO:0007155;GO:0030049;, C:cytosol; C:myofibril; C:myosin filament;, F:actin binding; F:myosin binding; F:structural constituent of muscle; F:titin binding;, P:cell adhesion; P:muscle filament sliding; scaffold1 indexed_genome mRNA 70367004 70396420 . + . ID=transcript_282;Q9NRQ7 Q9Y6M6,Cholinephosphotransferase 1 {ECO:0000305},AAPT1-like protein;Diacylglycerol cholinephosphotransferase 1;, PF01066;, GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0016020;GO:0019992;GO:0004142;GO:0046872;GO:0006657;GO:0006629;GO:0006656;GO:0006663;GO:0001558;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:diacylglycerol binding; F:diacylglycerol cholinephosphotransferase activity; F:metal ion binding;, P:CDP-choline pathway; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:platelet activating factor biosynthetic process; P:regulation of cell growth;|Q9NRQ7 Q9Y6M6,Cholinephosphotransferase 1 {ECO:0000305},AAPT1-like protein;Diacylglycerol cholinephosphotransferase 1;, PF01066;, GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0016020;GO:0019992;GO:0004142;GO:0046872;GO:0006657;GO:0006629;GO:0006656;GO:0006663;GO:0001558;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:diacylglycerol binding; F:diacylglycerol cholinephosphotransferase activity; F:metal ion binding;, P:CDP-choline pathway; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:platelet activating factor biosynthetic process; P:regulation of cell growth;|Q9NRQ7 Q9Y6M6,Cholinephosphotransferase 1 {ECO:0000305},AAPT1-like protein;Diacylglycerol cholinephosphotransferase 1;, PF01066;, GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0016020;GO:0019992;GO:0004142;GO:0046872;GO:0006657;GO:0006629;GO:0006656;GO:0006663;GO:0001558;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:diacylglycerol binding; F:diacylglycerol cholinephosphotransferase activity; F:metal ion binding;, P:CDP-choline pathway; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:platelet activating factor biosynthetic process; P:regulation of cell growth;|Q9NRQ7 Q9Y6M6,Cholinephosphotransferase 1 {ECO:0000305},AAPT1-like protein;Diacylglycerol cholinephosphotransferase 1;, PF01066;, GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0016020;GO:0019992;GO:0004142;GO:0046872;GO:0006657;GO:0006629;GO:0006656;GO:0006663;GO:0001558;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:diacylglycerol binding; F:diacylglycerol cholinephosphotransferase activity; F:metal ion binding;, P:CDP-choline pathway; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:platelet activating factor biosynthetic process; P:regulation of cell growth;|Q9NRQ7 Q9Y6M6,Cholinephosphotransferase 1 {ECO:0000305},AAPT1-like protein;Diacylglycerol cholinephosphotransferase 1;, PF01066;, GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0016020;GO:0019992;GO:0004142;GO:0046872;GO:0006657;GO:0006629;GO:0006656;GO:0006663;GO:0001558;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:diacylglycerol binding; F:diacylglycerol cholinephosphotransferase activity; F:metal ion binding;, P:CDP-choline pathway; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:platelet activating factor biosynthetic process; P:regulation of cell growth;|Q9NRQ7 Q9Y6M6,Cholinephosphotransferase 1 {ECO:0000305},AAPT1-like protein;Diacylglycerol cholinephosphotransferase 1;, PF01066;, GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0016020;GO:0019992;GO:0004142;GO:0046872;GO:0006657;GO:0006629;GO:0006656;GO:0006663;GO:0001558;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:diacylglycerol binding; F:diacylglycerol cholinephosphotransferase activity; F:metal ion binding;, P:CDP-choline pathway; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:platelet activating factor biosynthetic process; P:regulation of cell growth;|Q9NRQ7 Q9Y6M6,Cholinephosphotransferase 1 {ECO:0000305},AAPT1-like protein;Diacylglycerol cholinephosphotransferase 1;, PF01066;, GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0016020;GO:0019992;GO:0004142;GO:0046872;GO:0006657;GO:0006629;GO:0006656;GO:0006663;GO:0001558;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:diacylglycerol binding; F:diacylglycerol cholinephosphotransferase activity; F:metal ion binding;, P:CDP-choline pathway; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:platelet activating factor biosynthetic process; P:regulation of cell growth;|Q8IZU3,Synaptonemal complex protein 3,, PF04803;, GO:0000775;GO:0000800;GO:0005634;GO:0000795;GO:0003677;GO:0051301;GO:0007141;GO:0051321;GO:0007286;GO:0035093;, C:chromosome, centromeric region; C:lateral element; C:nucleus; C:synaptonemal complex;, F:DNA binding;, P:cell division; P:male meiosis I; P:meiotic cell cycle; P:spermatid development; P:spermatogenesis, exchange of chromosomal proteins;|Q8IZU3,Synaptonemal complex protein 3,, PF04803;, GO:0000775;GO:0000800;GO:0005634;GO:0000795;GO:0003677;GO:0051301;GO:0007141;GO:0051321;GO:0007286;GO:0035093;, C:chromosome, centromeric region; C:lateral element; C:nucleus; C:synaptonemal complex;, F:DNA binding;, P:cell division; P:male meiosis I; P:meiotic cell cycle; P:spermatid development; P:spermatogenesis, exchange of chromosomal proteins;|Q8IZU3,Synaptonemal complex protein 3,, PF04803;, GO:0000775;GO:0000800;GO:0005634;GO:0000795;GO:0003677;GO:0051301;GO:0007141;GO:0051321;GO:0007286;GO:0035093;, C:chromosome, centromeric region; C:lateral element; C:nucleus; C:synaptonemal complex;, F:DNA binding;, P:cell division; P:male meiosis I; P:meiotic cell cycle; P:spermatid development; P:spermatogenesis, exchange of chromosomal proteins; scaffold1 indexed_genome mRNA 70397482 70397991 . - . ID=transcript_283;P02792 B2R4B9 Q6IBT7 Q7Z2W1 Q86WI9 Q8WU07 Q96AU9 Q96CU0 Q9BTZ8,Ferritin light chain,, PF00210;, GO:0044754;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0008043;GO:0016020;GO:0008199;GO:0008198;GO:0042802;GO:0005506;GO:0006879;GO:0006880;GO:0055072;GO:0006826;GO:0043312;GO:0006892;, C:autolysosome; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular ferritin complex; C:membrane;, F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:iron ion binding;, P:cellular iron ion homeostasis; P:intracellular sequestering of iron ion; P:iron ion homeostasis; P:iron ion transport; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; scaffold1 indexed_genome mRNA 70413550 70493736 . - . ID=transcript_284;Q3T906 A2RRQ9 Q3ZQK2 Q6IPW5 Q86TQ2 Q96N13 Q9ULL2,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta,GlcNAc-1-phosphotransferase subunits alpha/beta;Stealth protein GNPTAB;UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta;, PF06464;PF18440;PF00066;PF17101;PF11380;PF17102;PF17103;, GO:0005794;GO:0000139;GO:0016021;GO:0005509;GO:0003976;GO:0046835;GO:0007040;GO:0016256;GO:0033299;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:carbohydrate phosphorylation; P:lysosome organization; P:N-glycan processing to lysosome; P:secretion of lysosomal enzymes;|Q3T906 A2RRQ9 Q3ZQK2 Q6IPW5 Q86TQ2 Q96N13 Q9ULL2,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta,GlcNAc-1-phosphotransferase subunits alpha/beta;Stealth protein GNPTAB;UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta;, PF06464;PF18440;PF00066;PF17101;PF11380;PF17102;PF17103;, GO:0005794;GO:0000139;GO:0016021;GO:0005509;GO:0003976;GO:0046835;GO:0007040;GO:0016256;GO:0033299;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:carbohydrate phosphorylation; P:lysosome organization; P:N-glycan processing to lysosome; P:secretion of lysosomal enzymes;|Q3T906 A2RRQ9 Q3ZQK2 Q6IPW5 Q86TQ2 Q96N13 Q9ULL2,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta,GlcNAc-1-phosphotransferase subunits alpha/beta;Stealth protein GNPTAB;UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta;, PF06464;PF18440;PF00066;PF17101;PF11380;PF17102;PF17103;, GO:0005794;GO:0000139;GO:0016021;GO:0005509;GO:0003976;GO:0046835;GO:0007040;GO:0016256;GO:0033299;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:carbohydrate phosphorylation; P:lysosome organization; P:N-glycan processing to lysosome; P:secretion of lysosomal enzymes;|Q3T906 A2RRQ9 Q3ZQK2 Q6IPW5 Q86TQ2 Q96N13 Q9ULL2,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta,GlcNAc-1-phosphotransferase subunits alpha/beta;Stealth protein GNPTAB;UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta;, PF06464;PF18440;PF00066;PF17101;PF11380;PF17102;PF17103;, GO:0005794;GO:0000139;GO:0016021;GO:0005509;GO:0003976;GO:0046835;GO:0007040;GO:0016256;GO:0033299;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:carbohydrate phosphorylation; P:lysosome organization; P:N-glycan processing to lysosome; P:secretion of lysosomal enzymes;|Q3T906 A2RRQ9 Q3ZQK2 Q6IPW5 Q86TQ2 Q96N13 Q9ULL2,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta,GlcNAc-1-phosphotransferase subunits alpha/beta;Stealth protein GNPTAB;UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta;, PF06464;PF18440;PF00066;PF17101;PF11380;PF17102;PF17103;, GO:0005794;GO:0000139;GO:0016021;GO:0005509;GO:0003976;GO:0046835;GO:0007040;GO:0016256;GO:0033299;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:carbohydrate phosphorylation; P:lysosome organization; P:N-glycan processing to lysosome; P:secretion of lysosomal enzymes;|Q3T906 A2RRQ9 Q3ZQK2 Q6IPW5 Q86TQ2 Q96N13 Q9ULL2,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta,GlcNAc-1-phosphotransferase subunits alpha/beta;Stealth protein GNPTAB;UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta;, PF06464;PF18440;PF00066;PF17101;PF11380;PF17102;PF17103;, GO:0005794;GO:0000139;GO:0016021;GO:0005509;GO:0003976;GO:0046835;GO:0007040;GO:0016256;GO:0033299;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:carbohydrate phosphorylation; P:lysosome organization; P:N-glycan processing to lysosome; P:secretion of lysosomal enzymes; scaffold1 indexed_genome mRNA 70551207 70584347 . + . ID=transcript_285;Q8N682 B7Z4T0 Q7L3E3 Q9NUN1,DNA damage-regulated autophagy modulator protein 1,Damage-regulated autophagy modulator;, PF10277;, GO:0005737;GO:0016021;GO:0005765;GO:0005764;GO:0006915;GO:0006914;GO:0010506;, C:cytoplasm; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, , P:apoptotic process; P:autophagy; P:regulation of autophagy; scaffold1 indexed_genome mRNA 70733117 70773509 . - . ID=transcript_286;Q8NFH4 Q9H644,Nucleoporin Nup37,Nup107-160 subcomplex subunit Nup37;, PF00400;, GO:0000777;GO:0005829;GO:0043657;GO:0005635;GO:0031080;GO:0005654;GO:0005634;GO:0051301;GO:0007059;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore outer ring; C:nucleoplasm; C:nucleus;, , P:cell division; P:chromosome segregation; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8NFH4 Q9H644,Nucleoporin Nup37,Nup107-160 subcomplex subunit Nup37;, PF00400;, GO:0000777;GO:0005829;GO:0043657;GO:0005635;GO:0031080;GO:0005654;GO:0005634;GO:0051301;GO:0007059;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore outer ring; C:nucleoplasm; C:nucleus;, , P:cell division; P:chromosome segregation; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8NFH4 Q9H644,Nucleoporin Nup37,Nup107-160 subcomplex subunit Nup37;, PF00400;, GO:0000777;GO:0005829;GO:0043657;GO:0005635;GO:0031080;GO:0005654;GO:0005634;GO:0051301;GO:0007059;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore outer ring; C:nucleoplasm; C:nucleus;, , P:cell division; P:chromosome segregation; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold1 indexed_genome mRNA 70833948 70834628 . - . ID=transcript_287;P20382 Q16044 Q8WVG0,Pro-MCH,, PF05824;, GO:0005576;GO:0005634;GO:0045202;GO:0030354;GO:0031777;GO:0030154;GO:0007268;GO:0007631;GO:0007186;GO:0007275;GO:0007218;GO:0007283;, C:extracellular region; C:nucleus; C:synapse;, F:melanin-concentrating hormone activity; F:type 1 melanin-concentrating hormone receptor binding;, P:cell differentiation; P:chemical synaptic transmission; P:feeding behavior; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:neuropeptide signaling pathway; P:spermatogenesis; scaffold1 indexed_genome mRNA 70999954 71075633 . - . ID=transcript_288;P05019 B2RWM7 E9PD02 P01343 Q14620,Insulin-like growth factor I,Mechano growth factor;Somatomedin-C;, PF00049;, GO:0035867;GO:0070382;GO:0005576;GO:0005615;GO:0016942;GO:0042567;GO:0031093;GO:0008083;GO:0005179;GO:0005158;GO:0005159;GO:0005178;GO:0000187;GO:0032148;GO:0035630;GO:0001775;GO:0008283;GO:0044267;GO:1904646;GO:0070371;GO:0009441;GO:0048009;GO:0014896;GO:0007517;GO:0045445;GO:0051450;GO:0014904;GO:1902430;GO:0043066;GO:2001237;GO:0010629;GO:0032691;GO:0150079;GO:0060283;GO:0090201;GO:0034392;GO:0032720;GO:1905460;GO:0014065;GO:0048015;GO:0002576;GO:0042104;GO:0070886;GO:0010613;GO:0061051;GO:0030335;GO:0008284;GO:0043388;GO:0050679;GO:0048146;GO:0010628;GO:0046326;GO:0045725;GO:0045821;GO:0010560;GO:0043568;GO:0043410;GO:0045840;GO:0045669;GO:0050731;GO:0014068;GO:0050714;GO:0046579;GO:0014911;GO:0048661;GO:0045944;GO:2000679;GO:0045893;GO:1904075;GO:0042531;GO:1904707;GO:0043491;GO:0050821;GO:0030166;GO:0007265;GO:0010468;GO:0040014;GO:0009408;GO:0007165;GO:0014834;GO:0001501;GO:0042060;, C:alphav-beta3 integrin-IGF-1-IGF1R complex; C:exocytic vesicle; C:extracellular region; C:extracellular space; C:insulin-like growth factor binding protein complex; C:insulin-like growth factor ternary complex; C:platelet alpha granule lumen;, F:growth factor activity; F:hormone activity; F:insulin receptor binding; F:insulin-like growth factor receptor binding; F:integrin binding;, P:activation of MAPK activity; P:activation of protein kinase B activity; P:bone mineralization involved in bone maturation; P:cell activation; P:cell population proliferation; P:cellular protein metabolic process; P:cellular response to amyloid-beta; P:ERK1 and ERK2 cascade; P:glycolate metabolic process; P:insulin-like growth factor receptor signaling pathway; P:muscle hypertrophy; P:muscle organ development; P:myoblast differentiation; P:myoblast proliferation; P:myotube cell development; P:negative regulation of amyloid-beta formation; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of gene expression; P:negative regulation of interleukin-1 beta production; P:negative regulation of neuroinflammatory response; P:negative regulation of oocyte development; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of smooth muscle cell apoptotic process; P:negative regulation of tumor necrosis factor production; P:negative regulation of vascular associated smooth muscle cell apoptotic process; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol-mediated signaling; P:platelet degranulation; P:positive regulation of activated T cell proliferation; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of DNA binding; P:positive regulation of epithelial cell proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of glycoprotein biosynthetic process; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of MAPK cascade; P:positive regulation of mitotic nuclear division; P:positive regulation of osteoblast differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein secretion; P:positive regulation of Ras protein signal transduction; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated; P:positive regulation of trophectodermal cell proliferation; P:positive regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein kinase B signaling; P:protein stabilization; P:proteoglycan biosynthetic process; P:Ras protein signal transduction; P:regulation of gene expression; P:regulation of multicellular organism growth; P:response to heat; P:signal transduction; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:skeletal system development; P:wound healing; scaffold1 indexed_genome mRNA 71407685 71497964 . - . ID=transcript_289;P00439 Q16717 Q8TC14,Phenylalanine-4-hydroxylase,Phe-4-monooxygenase;, PF01842;PF00351;, GO:0005829;GO:0005506;GO:0004505;GO:0042423;GO:0008652;GO:0006559;GO:0006558;GO:0042136;GO:0006571;, C:cytosol;, F:iron ion binding; F:phenylalanine 4-monooxygenase activity;, P:catecholamine biosynthetic process; P:cellular amino acid biosynthetic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:neurotransmitter biosynthetic process; P:tyrosine biosynthetic process;|P00439 Q16717 Q8TC14,Phenylalanine-4-hydroxylase,Phe-4-monooxygenase;, PF01842;PF00351;, GO:0005829;GO:0005506;GO:0004505;GO:0042423;GO:0008652;GO:0006559;GO:0006558;GO:0042136;GO:0006571;, C:cytosol;, F:iron ion binding; F:phenylalanine 4-monooxygenase activity;, P:catecholamine biosynthetic process; P:cellular amino acid biosynthetic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:neurotransmitter biosynthetic process; P:tyrosine biosynthetic process;|P00439 Q16717 Q8TC14,Phenylalanine-4-hydroxylase,Phe-4-monooxygenase;, PF01842;PF00351;, GO:0005829;GO:0005506;GO:0004505;GO:0042423;GO:0008652;GO:0006559;GO:0006558;GO:0042136;GO:0006571;, C:cytosol;, F:iron ion binding; F:phenylalanine 4-monooxygenase activity;, P:catecholamine biosynthetic process; P:cellular amino acid biosynthetic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:neurotransmitter biosynthetic process; P:tyrosine biosynthetic process;|P00439 Q16717 Q8TC14,Phenylalanine-4-hydroxylase,Phe-4-monooxygenase;, PF01842;PF00351;, GO:0005829;GO:0005506;GO:0004505;GO:0042423;GO:0008652;GO:0006559;GO:0006558;GO:0042136;GO:0006571;, C:cytosol;, F:iron ion binding; F:phenylalanine 4-monooxygenase activity;, P:catecholamine biosynthetic process; P:cellular amino acid biosynthetic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:neurotransmitter biosynthetic process; P:tyrosine biosynthetic process; scaffold1 indexed_genome mRNA 71525353 71527418 . + . ID=transcript_290;P50553 A8K3C4 Q9BQ30,Achaete-scute homolog 1 {ECO:0000303|PubMed:8390674},Class A basic helix-loop-helix protein 46 {ECO:0000312|HGNC:HGNC:738};, PF00010;, GO:0000785;GO:0043025;GO:0005634;GO:0090575;GO:0043425;GO:0003682;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0042802;GO:0046983;GO:0000978;GO:0000977;GO:1990837;GO:0061104;GO:0061103;GO:0048469;GO:0071259;GO:0021954;GO:0021987;GO:0021892;GO:0021902;GO:0007507;GO:0060487;GO:0061100;GO:0050883;GO:0043066;GO:0045665;GO:0000122;GO:0045892;GO:0007400;GO:0007405;GO:0022008;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0001764;GO:0003358;GO:0003359;GO:0007219;GO:0060166;GO:0014003;GO:0045787;GO:2000179;GO:0050769;GO:0043525;GO:0045666;GO:0045747;GO:0045944;GO:0030856;GO:0010468;GO:0007346;GO:0050767;GO:0060165;GO:0006357;GO:0070849;GO:0051593;GO:0010226;GO:0032526;GO:0007423;GO:0021527;GO:0021530;GO:0061102;GO:0060163;GO:0061549;GO:0048485;GO:0060579;GO:0021750;, C:chromatin; C:neuronal cell body; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:bHLH transcription factor binding; F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adrenal chromaffin cell differentiation; P:carotid body glomus cell differentiation; P:cell maturation; P:cellular response to magnetism; P:central nervous system neuron development; P:cerebral cortex development; P:cerebral cortex GABAergic interneuron differentiation; P:commitment of neuronal cell to specific neuron type in forebrain; P:heart development; P:lung epithelial cell differentiation; P:lung neuroendocrine cell differentiation; P:musculoskeletal movement, spinal reflex action; P:negative regulation of apoptotic process; P:negative regulation of neuron differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuroblast fate determination; P:neuroblast proliferation; P:neurogenesis; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:neuron migration; P:noradrenergic neuron development; P:noradrenergic neuron fate commitment; P:Notch signaling pathway; P:olfactory pit development; P:oligodendrocyte development; P:positive regulation of cell cycle; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neurogenesis; P:positive regulation of neuron apoptotic process; P:positive regulation of neuron differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of epithelial cell differentiation; P:regulation of gene expression; P:regulation of mitotic cell cycle; P:regulation of neurogenesis; P:regulation of timing of subpallium neuron differentiation; P:regulation of transcription by RNA polymerase II; P:response to epidermal growth factor; P:response to folic acid; P:response to lithium ion; P:response to retinoic acid; P:sensory organ development; P:spinal cord association neuron differentiation; P:spinal cord oligodendrocyte cell fate specification; P:stomach neuroendocrine cell differentiation; P:subpallium neuron fate commitment; P:sympathetic ganglion development; P:sympathetic nervous system development; P:ventral spinal cord interneuron fate commitment; P:vestibular nucleus development; scaffold1 indexed_genome mRNA 72043560 72209903 . + . ID=transcript_291;Q8WWQ8 Q6ZMK2 Q7Z5N9 Q86UR4 Q8IUG9 Q8TES1 Q9H7H7 Q9NRY3,Stabilin-2,FAS1 EGF-like and X-link domain-containing adhesion molecule 2;Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2;Hyaluronan receptor for endocytosis;, PF12947;PF02469;PF00193;, GO:0005829;GO:0030666;GO:0009897;GO:0005887;GO:0005886;GO:0005509;GO:0005540;GO:0030169;GO:0005041;GO:0015035;GO:0005044;GO:0001525;GO:0007155;GO:0042742;GO:0050830;GO:0006897;GO:0030214;GO:0006898;, C:cytosol; C:endocytic vesicle membrane; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:hyaluronic acid binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:protein disulfide oxidoreductase activity; F:scavenger receptor activity;, P:angiogenesis; P:cell adhesion; P:defense response to bacterium; P:defense response to Gram-positive bacterium; P:endocytosis; P:hyaluronan catabolic process; P:receptor-mediated endocytosis; scaffold1 indexed_genome mRNA 72211634 72283719 . - . ID=transcript_292;Q86UY8 Q9NUM7 Q9P2T2 Q9P2T3,5'-nucleotidase domain-containing protein 3,GRP94-neighboring nucleotidase;, PF05761;, GO:0043235;GO:0008253;GO:0046872;, C:receptor complex;, F:5'-nucleotidase activity; F:metal ion binding;|Q86UY8 Q9NUM7 Q9P2T2 Q9P2T3,5'-nucleotidase domain-containing protein 3,GRP94-neighboring nucleotidase;, PF05761;, GO:0043235;GO:0008253;GO:0046872;, C:receptor complex;, F:5'-nucleotidase activity; F:metal ion binding; scaffold1 indexed_genome mRNA 72303750 72342169 . - . ID=transcript_293;Q6P2S7 Q05DD4,Putative tetratricopeptide repeat protein 41 {ECO:0000250|UniProtKB:Q692V3},Grp94-neighboring nucleotidase {ECO:0000250|UniProtKB:Q692V3};, , GO:0005737;, C:cytoplasm;|Q6P2S7 Q05DD4,Putative tetratricopeptide repeat protein 41 {ECO:0000250|UniProtKB:Q692V3},Grp94-neighboring nucleotidase {ECO:0000250|UniProtKB:Q692V3};, , GO:0005737;, C:cytoplasm; scaffold1 indexed_genome mRNA 72342204 72375352 . - . ID=transcript_294;Q6P2S7 Q05DD4,Putative tetratricopeptide repeat protein 41 {ECO:0000250|UniProtKB:Q692V3},Grp94-neighboring nucleotidase {ECO:0000250|UniProtKB:Q692V3};, , GO:0005737;, C:cytoplasm;|Q6P2S7 Q05DD4,Putative tetratricopeptide repeat protein 41 {ECO:0000250|UniProtKB:Q692V3},Grp94-neighboring nucleotidase {ECO:0000250|UniProtKB:Q692V3};, , GO:0005737;, C:cytoplasm; scaffold1 indexed_genome mRNA 72376043 72403505 . + . ID=transcript_295;P14625 Q96A97,Endoplasmin,94 kDa glucose-regulated protein;Heat shock protein 90 kDa beta member 1;Tumor rejection antigen 1;gp96 homolog;, PF02518;PF00183;, GO:0062023;GO:0005829;GO:0071682;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005925;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:0048471;GO:0032991;GO:0033018;GO:0005524;GO:0016887;GO:0005509;GO:0050750;GO:0019903;GO:0003723;GO:0051082;GO:0031247;GO:0036500;GO:0044267;GO:0071318;GO:0019221;GO:0043066;GO:0043687;GO:0006457;GO:0034975;GO:0015031;GO:0006898;GO:0043666;GO:0034976;GO:0001666;GO:0030970;GO:0051208;GO:0002224;GO:0030433;, C:collagen-containing extracellular matrix; C:cytosol; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:melanosome; C:membrane; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:sarcoplasmic reticulum lumen;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:low-density lipoprotein particle receptor binding; F:protein phosphatase binding; F:RNA binding; F:unfolded protein binding;, P:actin rod assembly; P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cellular response to ATP; P:cytokine-mediated signaling pathway; P:negative regulation of apoptotic process; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein transport; P:receptor-mediated endocytosis; P:regulation of phosphoprotein phosphatase activity; P:response to endoplasmic reticulum stress; P:response to hypoxia; P:retrograde protein transport, ER to cytosol; P:sequestering of calcium ion; P:toll-like receptor signaling pathway; P:ubiquitin-dependent ERAD pathway;|P14625 Q96A97,Endoplasmin,94 kDa glucose-regulated protein;Heat shock protein 90 kDa beta member 1;Tumor rejection antigen 1;gp96 homolog;, PF02518;PF00183;, GO:0062023;GO:0005829;GO:0071682;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005925;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:0048471;GO:0032991;GO:0033018;GO:0005524;GO:0016887;GO:0005509;GO:0050750;GO:0019903;GO:0003723;GO:0051082;GO:0031247;GO:0036500;GO:0044267;GO:0071318;GO:0019221;GO:0043066;GO:0043687;GO:0006457;GO:0034975;GO:0015031;GO:0006898;GO:0043666;GO:0034976;GO:0001666;GO:0030970;GO:0051208;GO:0002224;GO:0030433;, C:collagen-containing extracellular matrix; C:cytosol; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:melanosome; C:membrane; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:sarcoplasmic reticulum lumen;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:low-density lipoprotein particle receptor binding; F:protein phosphatase binding; F:RNA binding; F:unfolded protein binding;, P:actin rod assembly; P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cellular response to ATP; P:cytokine-mediated signaling pathway; P:negative regulation of apoptotic process; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein transport; P:receptor-mediated endocytosis; P:regulation of phosphoprotein phosphatase activity; P:response to endoplasmic reticulum stress; P:response to hypoxia; P:retrograde protein transport, ER to cytosol; P:sequestering of calcium ion; P:toll-like receptor signaling pathway; P:ubiquitin-dependent ERAD pathway;|P14625 Q96A97,Endoplasmin,94 kDa glucose-regulated protein;Heat shock protein 90 kDa beta member 1;Tumor rejection antigen 1;gp96 homolog;, PF02518;PF00183;, GO:0062023;GO:0005829;GO:0071682;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005925;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:0048471;GO:0032991;GO:0033018;GO:0005524;GO:0016887;GO:0005509;GO:0050750;GO:0019903;GO:0003723;GO:0051082;GO:0031247;GO:0036500;GO:0044267;GO:0071318;GO:0019221;GO:0043066;GO:0043687;GO:0006457;GO:0034975;GO:0015031;GO:0006898;GO:0043666;GO:0034976;GO:0001666;GO:0030970;GO:0051208;GO:0002224;GO:0030433;, C:collagen-containing extracellular matrix; C:cytosol; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:melanosome; C:membrane; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:sarcoplasmic reticulum lumen;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:low-density lipoprotein particle receptor binding; F:protein phosphatase binding; F:RNA binding; F:unfolded protein binding;, P:actin rod assembly; P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cellular response to ATP; P:cytokine-mediated signaling pathway; P:negative regulation of apoptotic process; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein transport; P:receptor-mediated endocytosis; P:regulation of phosphoprotein phosphatase activity; P:response to endoplasmic reticulum stress; P:response to hypoxia; P:retrograde protein transport, ER to cytosol; P:sequestering of calcium ion; P:toll-like receptor signaling pathway; P:ubiquitin-dependent ERAD pathway;|P14625 Q96A97,Endoplasmin,94 kDa glucose-regulated protein;Heat shock protein 90 kDa beta member 1;Tumor rejection antigen 1;gp96 homolog;, PF02518;PF00183;, GO:0062023;GO:0005829;GO:0071682;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005925;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:0048471;GO:0032991;GO:0033018;GO:0005524;GO:0016887;GO:0005509;GO:0050750;GO:0019903;GO:0003723;GO:0051082;GO:0031247;GO:0036500;GO:0044267;GO:0071318;GO:0019221;GO:0043066;GO:0043687;GO:0006457;GO:0034975;GO:0015031;GO:0006898;GO:0043666;GO:0034976;GO:0001666;GO:0030970;GO:0051208;GO:0002224;GO:0030433;, C:collagen-containing extracellular matrix; C:cytosol; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:melanosome; C:membrane; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:sarcoplasmic reticulum lumen;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:low-density lipoprotein particle receptor binding; F:protein phosphatase binding; F:RNA binding; F:unfolded protein binding;, P:actin rod assembly; P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cellular response to ATP; P:cytokine-mediated signaling pathway; P:negative regulation of apoptotic process; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein transport; P:receptor-mediated endocytosis; P:regulation of phosphoprotein phosphatase activity; P:response to endoplasmic reticulum stress; P:response to hypoxia; P:retrograde protein transport, ER to cytosol; P:sequestering of calcium ion; P:toll-like receptor signaling pathway; P:ubiquitin-dependent ERAD pathway;|P14625 Q96A97,Endoplasmin,94 kDa glucose-regulated protein;Heat shock protein 90 kDa beta member 1;Tumor rejection antigen 1;gp96 homolog;, PF02518;PF00183;, GO:0062023;GO:0005829;GO:0071682;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005925;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:0048471;GO:0032991;GO:0033018;GO:0005524;GO:0016887;GO:0005509;GO:0050750;GO:0019903;GO:0003723;GO:0051082;GO:0031247;GO:0036500;GO:0044267;GO:0071318;GO:0019221;GO:0043066;GO:0043687;GO:0006457;GO:0034975;GO:0015031;GO:0006898;GO:0043666;GO:0034976;GO:0001666;GO:0030970;GO:0051208;GO:0002224;GO:0030433;, C:collagen-containing extracellular matrix; C:cytosol; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:melanosome; C:membrane; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:sarcoplasmic reticulum lumen;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:low-density lipoprotein particle receptor binding; F:protein phosphatase binding; F:RNA binding; F:unfolded protein binding;, P:actin rod assembly; P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cellular response to ATP; P:cytokine-mediated signaling pathway; P:negative regulation of apoptotic process; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein transport; P:receptor-mediated endocytosis; P:regulation of phosphoprotein phosphatase activity; P:response to endoplasmic reticulum stress; P:response to hypoxia; P:retrograde protein transport, ER to cytosol; P:sequestering of calcium ion; P:toll-like receptor signaling pathway; P:ubiquitin-dependent ERAD pathway;|P14625 Q96A97,Endoplasmin,94 kDa glucose-regulated protein;Heat shock protein 90 kDa beta member 1;Tumor rejection antigen 1;gp96 homolog;, PF02518;PF00183;, GO:0062023;GO:0005829;GO:0071682;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005925;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:0048471;GO:0032991;GO:0033018;GO:0005524;GO:0016887;GO:0005509;GO:0050750;GO:0019903;GO:0003723;GO:0051082;GO:0031247;GO:0036500;GO:0044267;GO:0071318;GO:0019221;GO:0043066;GO:0043687;GO:0006457;GO:0034975;GO:0015031;GO:0006898;GO:0043666;GO:0034976;GO:0001666;GO:0030970;GO:0051208;GO:0002224;GO:0030433;, C:collagen-containing extracellular matrix; C:cytosol; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:melanosome; C:membrane; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:sarcoplasmic reticulum lumen;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:low-density lipoprotein particle receptor binding; F:protein phosphatase binding; F:RNA binding; F:unfolded protein binding;, P:actin rod assembly; P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cellular response to ATP; P:cytokine-mediated signaling pathway; P:negative regulation of apoptotic process; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein transport; P:receptor-mediated endocytosis; P:regulation of phosphoprotein phosphatase activity; P:response to endoplasmic reticulum stress; P:response to hypoxia; P:retrograde protein transport, ER to cytosol; P:sequestering of calcium ion; P:toll-like receptor signaling pathway; P:ubiquitin-dependent ERAD pathway;|P14625 Q96A97,Endoplasmin,94 kDa glucose-regulated protein;Heat shock protein 90 kDa beta member 1;Tumor rejection antigen 1;gp96 homolog;, PF02518;PF00183;, GO:0062023;GO:0005829;GO:0071682;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005925;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:0048471;GO:0032991;GO:0033018;GO:0005524;GO:0016887;GO:0005509;GO:0050750;GO:0019903;GO:0003723;GO:0051082;GO:0031247;GO:0036500;GO:0044267;GO:0071318;GO:0019221;GO:0043066;GO:0043687;GO:0006457;GO:0034975;GO:0015031;GO:0006898;GO:0043666;GO:0034976;GO:0001666;GO:0030970;GO:0051208;GO:0002224;GO:0030433;, C:collagen-containing extracellular matrix; C:cytosol; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:melanosome; C:membrane; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:sarcoplasmic reticulum lumen;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:low-density lipoprotein particle receptor binding; F:protein phosphatase binding; F:RNA binding; F:unfolded protein binding;, P:actin rod assembly; P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cellular response to ATP; P:cytokine-mediated signaling pathway; P:negative regulation of apoptotic process; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein transport; P:receptor-mediated endocytosis; P:regulation of phosphoprotein phosphatase activity; P:response to endoplasmic reticulum stress; P:response to hypoxia; P:retrograde protein transport, ER to cytosol; P:sequestering of calcium ion; P:toll-like receptor signaling pathway; P:ubiquitin-dependent ERAD pathway;|Q69YU5,Protein BRAWNIN {ECO:0000303|PubMed:32161263},, PF14990;, GO:0016021;GO:0005743;GO:0005739;GO:0034551;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial respiratory chain complex III assembly; scaffold1 indexed_genome mRNA 72410851 72468079 . + . ID=transcript_296;Q9H1C3 Q96KA2,Glycosyltransferase 8 domain-containing protein 2,, PF01501;, GO:0005794;GO:0016021;GO:0016757;, C:Golgi apparatus; C:integral component of membrane;, F:transferase activity, transferring glycosyl groups;|Q13569 Q8IUZ6 Q8IZM3,G/T mismatch-specific thymine DNA glycosylase,Thymine-DNA glycosylase;, PF03167;, GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0031404;GO:0003684;GO:0003677;GO:0019104;GO:0003690;GO:0043739;GO:0000287;GO:0030983;GO:0019904;GO:0042803;GO:0043621;GO:0008263;GO:0031402;GO:0032183;GO:0008134;GO:0004844;GO:0006284;GO:0006285;GO:0006287;GO:0006325;GO:0045008;GO:0080111;GO:0006298;GO:0000122;GO:0035511;GO:1902544;GO:0045995;GO:0040029;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:chloride ion binding; F:damaged DNA binding; F:DNA binding; F:DNA N-glycosylase activity; F:double-stranded DNA binding; F:G/U mismatch-specific uracil-DNA glycosylase activity; F:magnesium ion binding; F:mismatched DNA binding; F:protein domain specific binding; F:protein homodimerization activity; F:protein self-association; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; F:sodium ion binding; F:SUMO binding; F:transcription factor binding; F:uracil DNA N-glycosylase activity;, P:base-excision repair; P:base-excision repair, AP site formation; P:base-excision repair, gap-filling; P:chromatin organization; P:depyrimidination; P:DNA demethylation; P:mismatch repair; P:negative regulation of transcription by RNA polymerase II; P:oxidative DNA demethylation; P:regulation of DNA N-glycosylase activity; P:regulation of embryonic development; P:regulation of gene expression, epigenetic;|Q13569 Q8IUZ6 Q8IZM3,G/T mismatch-specific thymine DNA glycosylase,Thymine-DNA glycosylase;, PF03167;, GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0031404;GO:0003684;GO:0003677;GO:0019104;GO:0003690;GO:0043739;GO:0000287;GO:0030983;GO:0019904;GO:0042803;GO:0043621;GO:0008263;GO:0031402;GO:0032183;GO:0008134;GO:0004844;GO:0006284;GO:0006285;GO:0006287;GO:0006325;GO:0045008;GO:0080111;GO:0006298;GO:0000122;GO:0035511;GO:1902544;GO:0045995;GO:0040029;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:chloride ion binding; F:damaged DNA binding; F:DNA binding; F:DNA N-glycosylase activity; F:double-stranded DNA binding; F:G/U mismatch-specific uracil-DNA glycosylase activity; F:magnesium ion binding; F:mismatched DNA binding; F:protein domain specific binding; F:protein homodimerization activity; F:protein self-association; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; F:sodium ion binding; F:SUMO binding; F:transcription factor binding; F:uracil DNA N-glycosylase activity;, P:base-excision repair; P:base-excision repair, AP site formation; P:base-excision repair, gap-filling; P:chromatin organization; P:depyrimidination; P:DNA demethylation; P:mismatch repair; P:negative regulation of transcription by RNA polymerase II; P:oxidative DNA demethylation; P:regulation of DNA N-glycosylase activity; P:regulation of embryonic development; P:regulation of gene expression, epigenetic;|Q13569 Q8IUZ6 Q8IZM3,G/T mismatch-specific thymine DNA glycosylase,Thymine-DNA glycosylase;, PF03167;, GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0031404;GO:0003684;GO:0003677;GO:0019104;GO:0003690;GO:0043739;GO:0000287;GO:0030983;GO:0019904;GO:0042803;GO:0043621;GO:0008263;GO:0031402;GO:0032183;GO:0008134;GO:0004844;GO:0006284;GO:0006285;GO:0006287;GO:0006325;GO:0045008;GO:0080111;GO:0006298;GO:0000122;GO:0035511;GO:1902544;GO:0045995;GO:0040029;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:chloride ion binding; F:damaged DNA binding; F:DNA binding; F:DNA N-glycosylase activity; F:double-stranded DNA binding; F:G/U mismatch-specific uracil-DNA glycosylase activity; F:magnesium ion binding; F:mismatched DNA binding; F:protein domain specific binding; F:protein homodimerization activity; F:protein self-association; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; F:sodium ion binding; F:SUMO binding; F:transcription factor binding; F:uracil DNA N-glycosylase activity;, P:base-excision repair; P:base-excision repair, AP site formation; P:base-excision repair, gap-filling; P:chromatin organization; P:depyrimidination; P:DNA demethylation; P:mismatch repair; P:negative regulation of transcription by RNA polymerase II; P:oxidative DNA demethylation; P:regulation of DNA N-glycosylase activity; P:regulation of embryonic development; P:regulation of gene expression, epigenetic; scaffold1 indexed_genome mRNA 72498814 72500329 . + . ID=transcript_297;Q9Y5Z7 B2R8Q5 C0H5X3,Host cell factor 2,C2 factor;, , GO:0005737;GO:0005829;GO:0035097;GO:0071339;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0003713;GO:0006338;GO:0000122;GO:0006357;GO:0006355;GO:0016032;, C:cytoplasm; C:cytosol; C:histone methyltransferase complex; C:MLL1 complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:transcription coactivator activity;, P:chromatin remodeling; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:viral process; scaffold1 indexed_genome mRNA 72500780 72501794 . + . ID=transcript_298;Q9Y5Z7 B2R8Q5 C0H5X3,Host cell factor 2,C2 factor;, , GO:0005737;GO:0005829;GO:0035097;GO:0071339;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0003713;GO:0006338;GO:0000122;GO:0006357;GO:0006355;GO:0016032;, C:cytoplasm; C:cytosol; C:histone methyltransferase complex; C:MLL1 complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:transcription coactivator activity;, P:chromatin remodeling; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:viral process; scaffold1 indexed_genome mRNA 72531499 72533631 . - . ID=transcript_299;P25208 A8K7B9 Q96IY8,Nuclear transcription factor Y subunit beta,CAAT box DNA-binding protein subunit B;Nuclear transcription factor Y subunit B;, PF00808;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0070491;GO:0000978;GO:0045944;GO:0019216;GO:0006357;GO:0006355;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold1 indexed_genome mRNA 72653337 72713622 . + . ID=transcript_300;Q7LA96 Q8WVC8 Q99475 Q9UES8 Q9UH79,Thioredoxin reductase 1, cytoplasmic,Gene associated with retinoic and interferon-induced mortality 12 protein;KM-102-derived reductase-like factor;Thioredoxin reductase TR1;, PF00462;PF07992;PF02852;, GO:0005737;GO:0005829;GO:0070062;GO:0001650;GO:0005739;GO:0005654;GO:0050660;GO:0015035;GO:0004791;GO:0008283;GO:0045454;GO:0034599;GO:0001707;GO:0015949;GO:0019222;GO:0001887;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:fibrillar center; C:mitochondrion; C:nucleoplasm;, F:flavin adenine dinucleotide binding; F:protein disulfide oxidoreductase activity; F:thioredoxin-disulfide reductase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:mesoderm formation; P:nucleobase-containing small molecule interconversion; P:regulation of metabolic process; P:selenium compound metabolic process; P:signal transduction;|Q8N140,EP300-interacting inhibitor of differentiation 3,E1A-like inhibitor of differentiation 3;EID-1-like inhibitor of differentiation 3;Non-structural maintenance of chromosomes element 4 homolog B;, PF15412;PF08743;, GO:0000781;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0030915;GO:0006310;GO:0006281;, C:chromosome, telomeric region; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, , P:DNA recombination; P:DNA repair;|Q7LA96 Q8WVC8 Q99475 Q9UES8 Q9UH79,Thioredoxin reductase 1, cytoplasmic,Gene associated with retinoic and interferon-induced mortality 12 protein;KM-102-derived reductase-like factor;Thioredoxin reductase TR1;, PF00462;PF07992;PF02852;, GO:0005737;GO:0005829;GO:0070062;GO:0001650;GO:0005739;GO:0005654;GO:0050660;GO:0015035;GO:0004791;GO:0008283;GO:0045454;GO:0034599;GO:0001707;GO:0015949;GO:0019222;GO:0001887;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:fibrillar center; C:mitochondrion; C:nucleoplasm;, F:flavin adenine dinucleotide binding; F:protein disulfide oxidoreductase activity; F:thioredoxin-disulfide reductase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:mesoderm formation; P:nucleobase-containing small molecule interconversion; P:regulation of metabolic process; P:selenium compound metabolic process; P:signal transduction;|Q7LA96 Q8WVC8 Q99475 Q9UES8 Q9UH79,Thioredoxin reductase 1, cytoplasmic,Gene associated with retinoic and interferon-induced mortality 12 protein;KM-102-derived reductase-like factor;Thioredoxin reductase TR1;, PF00462;PF07992;PF02852;, GO:0005737;GO:0005829;GO:0070062;GO:0001650;GO:0005739;GO:0005654;GO:0050660;GO:0015035;GO:0004791;GO:0008283;GO:0045454;GO:0034599;GO:0001707;GO:0015949;GO:0019222;GO:0001887;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:fibrillar center; C:mitochondrion; C:nucleoplasm;, F:flavin adenine dinucleotide binding; F:protein disulfide oxidoreductase activity; F:thioredoxin-disulfide reductase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:mesoderm formation; P:nucleobase-containing small molecule interconversion; P:regulation of metabolic process; P:selenium compound metabolic process; P:signal transduction;|Q7LA96 Q8WVC8 Q99475 Q9UES8 Q9UH79,Thioredoxin reductase 1, cytoplasmic,Gene associated with retinoic and interferon-induced mortality 12 protein;KM-102-derived reductase-like factor;Thioredoxin reductase TR1;, PF00462;PF07992;PF02852;, GO:0005737;GO:0005829;GO:0070062;GO:0001650;GO:0005739;GO:0005654;GO:0050660;GO:0015035;GO:0004791;GO:0008283;GO:0045454;GO:0034599;GO:0001707;GO:0015949;GO:0019222;GO:0001887;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:fibrillar center; C:mitochondrion; C:nucleoplasm;, F:flavin adenine dinucleotide binding; F:protein disulfide oxidoreductase activity; F:thioredoxin-disulfide reductase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:mesoderm formation; P:nucleobase-containing small molecule interconversion; P:regulation of metabolic process; P:selenium compound metabolic process; P:signal transduction; scaffold1 indexed_genome mRNA 73057923 73058646 . - . ID=transcript_301;Q9NPF2 A8K4F8 Q9NXY6 Q9NY36,Carbohydrate sulfotransferase 11,Chondroitin 4-O-sulfotransferase 1;Chondroitin 4-sulfotransferase 1;, PF03567;, GO:0000139;GO:0016021;GO:0016020;GO:0047756;GO:0001537;GO:0050659;GO:0008146;GO:0016051;GO:0002063;GO:0030206;GO:0048589;GO:0042733;GO:0048703;GO:0001701;GO:0043066;GO:0030512;GO:0033037;GO:0036342;GO:0009791;GO:0030166;GO:0042127;GO:0007585;, C:Golgi membrane; C:integral component of membrane; C:membrane;, F:chondroitin 4-sulfotransferase activity; F:N-acetylgalactosamine 4-O-sulfotransferase activity; F:N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity; F:sulfotransferase activity;, P:carbohydrate biosynthetic process; P:chondrocyte development; P:chondroitin sulfate biosynthetic process; P:developmental growth; P:embryonic digit morphogenesis; P:embryonic viscerocranium morphogenesis; P:in utero embryonic development; P:negative regulation of apoptotic process; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:polysaccharide localization; P:post-anal tail morphogenesis; P:post-embryonic development; P:proteoglycan biosynthetic process; P:regulation of cell population proliferation; P:respiratory gaseous exchange by respiratory system; scaffold1 indexed_genome mRNA 73106591 73206290 . - . ID=transcript_302;Q96JW4 Q3KP68 Q9H0E5,Solute carrier family 41 member 2,, PF01769;, GO:0016021;GO:0005886;GO:0022890;GO:0030001;, C:integral component of membrane; C:plasma membrane;, F:inorganic cation transmembrane transporter activity;, P:metal ion transport; scaffold1 indexed_genome mRNA 73279638 73281800 . + . ID=transcript_303;Q8N5I9,Uncharacterized protein C12orf45,, PF15370; scaffold1 indexed_genome mRNA 73289206 73343725 . - . ID=transcript_304;Q3SY69 Q3SY68 Q68D62 Q6AI55 Q8N922,Mitochondrial 10-formyltetrahydrofolate dehydrogenase,Aldehyde dehydrogenase family 1 member L2;, PF00171;PF02911;PF00551;PF00550;, GO:0070062;GO:0005759;GO:0005739;GO:0005654;GO:0004029;GO:0016155;GO:0016742;GO:0009258;GO:0009058;GO:0046655;GO:0006730;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:aldehyde dehydrogenase (NAD+) activity; F:formyltetrahydrofolate dehydrogenase activity; F:hydroxymethyl-, formyl- and related transferase activity;, P:10-formyltetrahydrofolate catabolic process; P:biosynthetic process; P:folic acid metabolic process; P:one-carbon metabolic process;|Q3SY69 Q3SY68 Q68D62 Q6AI55 Q8N922,Mitochondrial 10-formyltetrahydrofolate dehydrogenase,Aldehyde dehydrogenase family 1 member L2;, PF00171;PF02911;PF00551;PF00550;, GO:0070062;GO:0005759;GO:0005739;GO:0005654;GO:0004029;GO:0016155;GO:0016742;GO:0009258;GO:0009058;GO:0046655;GO:0006730;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:aldehyde dehydrogenase (NAD+) activity; F:formyltetrahydrofolate dehydrogenase activity; F:hydroxymethyl-, formyl- and related transferase activity;, P:10-formyltetrahydrofolate catabolic process; P:biosynthetic process; P:folic acid metabolic process; P:one-carbon metabolic process; scaffold1 indexed_genome mRNA 73366180 73475857 . - . ID=transcript_305;Q2M389 Q2NL83 Q8IW61 Q8N5W7 Q9NVD6 Q9UPW7,WASH complex subunit 4 {ECO:0000312|HGNC:HGNC:29174},Strumpellin and WASH-interacting protein {ECO:0000303|PubMed:21498477};WASH complex subunit SWIP {ECO:0000305};, PF14746;PF14744;PF14745;, GO:0005769;GO:0005768;GO:0005654;GO:0071203;GO:0016197;GO:0007032;GO:0015031;, C:early endosome; C:endosome; C:nucleoplasm; C:WASH complex;, , P:endosomal transport; P:endosome organization; P:protein transport;|Q8NEU8 B7Z411 B7Z4B0 F5GZG0 F8W1P5 Q8N4R7 Q9NVL2,DCC-interacting protein 13-beta {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 2 {ECO:0000305};, PF00169;PF00640;, GO:0031410;GO:0031901;GO:0032009;GO:0036186;GO:0005768;GO:0010008;GO:0070062;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0032587;GO:0031982;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0009631;GO:0002024;GO:0042593;GO:1900077;GO:1900016;GO:0046322;GO:0046325;GO:2000178;GO:0050768;GO:0120162;GO:1905451;GO:1905303;GO:0060100;GO:0051289;GO:0006606;GO:0010762;GO:2000045;GO:0045088;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasmic vesicle; C:early endosome membrane; C:early phagosome; C:early phagosome membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:ruffle membrane; C:vesicle;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:cold acclimation; P:diet induced thermogenesis; P:glucose homeostasis; P:negative regulation of cellular response to insulin stimulus; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fatty acid oxidation; P:negative regulation of glucose import; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neurogenesis; P:positive regulation of cold-induced thermogenesis; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of macropinocytosis; P:positive regulation of phagocytosis, engulfment; P:protein homotetramerization; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of innate immune response; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway;|Q8NEU8 B7Z411 B7Z4B0 F5GZG0 F8W1P5 Q8N4R7 Q9NVL2,DCC-interacting protein 13-beta {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 2 {ECO:0000305};, PF00169;PF00640;, GO:0031410;GO:0031901;GO:0032009;GO:0036186;GO:0005768;GO:0010008;GO:0070062;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0032587;GO:0031982;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0009631;GO:0002024;GO:0042593;GO:1900077;GO:1900016;GO:0046322;GO:0046325;GO:2000178;GO:0050768;GO:0120162;GO:1905451;GO:1905303;GO:0060100;GO:0051289;GO:0006606;GO:0010762;GO:2000045;GO:0045088;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasmic vesicle; C:early endosome membrane; C:early phagosome; C:early phagosome membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:ruffle membrane; C:vesicle;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:cold acclimation; P:diet induced thermogenesis; P:glucose homeostasis; P:negative regulation of cellular response to insulin stimulus; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fatty acid oxidation; P:negative regulation of glucose import; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neurogenesis; P:positive regulation of cold-induced thermogenesis; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of macropinocytosis; P:positive regulation of phagocytosis, engulfment; P:protein homotetramerization; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of innate immune response; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway;|Q8NEU8 B7Z411 B7Z4B0 F5GZG0 F8W1P5 Q8N4R7 Q9NVL2,DCC-interacting protein 13-beta {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 2 {ECO:0000305};, PF00169;PF00640;, GO:0031410;GO:0031901;GO:0032009;GO:0036186;GO:0005768;GO:0010008;GO:0070062;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0032587;GO:0031982;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0009631;GO:0002024;GO:0042593;GO:1900077;GO:1900016;GO:0046322;GO:0046325;GO:2000178;GO:0050768;GO:0120162;GO:1905451;GO:1905303;GO:0060100;GO:0051289;GO:0006606;GO:0010762;GO:2000045;GO:0045088;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasmic vesicle; C:early endosome membrane; C:early phagosome; C:early phagosome membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:ruffle membrane; C:vesicle;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:cold acclimation; P:diet induced thermogenesis; P:glucose homeostasis; P:negative regulation of cellular response to insulin stimulus; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fatty acid oxidation; P:negative regulation of glucose import; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neurogenesis; P:positive regulation of cold-induced thermogenesis; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of macropinocytosis; P:positive regulation of phagocytosis, engulfment; P:protein homotetramerization; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of innate immune response; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway;|Q8NEU8 B7Z411 B7Z4B0 F5GZG0 F8W1P5 Q8N4R7 Q9NVL2,DCC-interacting protein 13-beta {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 2 {ECO:0000305};, PF00169;PF00640;, GO:0031410;GO:0031901;GO:0032009;GO:0036186;GO:0005768;GO:0010008;GO:0070062;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0032587;GO:0031982;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0009631;GO:0002024;GO:0042593;GO:1900077;GO:1900016;GO:0046322;GO:0046325;GO:2000178;GO:0050768;GO:0120162;GO:1905451;GO:1905303;GO:0060100;GO:0051289;GO:0006606;GO:0010762;GO:2000045;GO:0045088;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasmic vesicle; C:early endosome membrane; C:early phagosome; C:early phagosome membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:ruffle membrane; C:vesicle;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:cold acclimation; P:diet induced thermogenesis; P:glucose homeostasis; P:negative regulation of cellular response to insulin stimulus; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fatty acid oxidation; P:negative regulation of glucose import; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neurogenesis; P:positive regulation of cold-induced thermogenesis; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of macropinocytosis; P:positive regulation of phagocytosis, engulfment; P:protein homotetramerization; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of innate immune response; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway;|Q8NEU8 B7Z411 B7Z4B0 F5GZG0 F8W1P5 Q8N4R7 Q9NVL2,DCC-interacting protein 13-beta {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 2 {ECO:0000305};, PF00169;PF00640;, GO:0031410;GO:0031901;GO:0032009;GO:0036186;GO:0005768;GO:0010008;GO:0070062;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0032587;GO:0031982;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0009631;GO:0002024;GO:0042593;GO:1900077;GO:1900016;GO:0046322;GO:0046325;GO:2000178;GO:0050768;GO:0120162;GO:1905451;GO:1905303;GO:0060100;GO:0051289;GO:0006606;GO:0010762;GO:2000045;GO:0045088;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasmic vesicle; C:early endosome membrane; C:early phagosome; C:early phagosome membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:ruffle membrane; C:vesicle;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:cold acclimation; P:diet induced thermogenesis; P:glucose homeostasis; P:negative regulation of cellular response to insulin stimulus; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fatty acid oxidation; P:negative regulation of glucose import; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neurogenesis; P:positive regulation of cold-induced thermogenesis; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of macropinocytosis; P:positive regulation of phagocytosis, engulfment; P:protein homotetramerization; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of innate immune response; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway; scaffold1 indexed_genome mRNA 73536533 73581325 . + . ID=transcript_306;Q8TAD7,Overexpressed in colon carcinoma 1 protein,AGD3;, PF15506; scaffold1 indexed_genome mRNA 74150087 74190410 . - . ID=transcript_307;O60285 A7MD39 Q96KA8,NUAK family SNF1-like kinase 1,AMPK-related protein kinase 5;Omphalocele kinase 1;, PF00069;, GO:0005737;GO:0001650;GO:0015630;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0007155;GO:0006974;GO:0042149;GO:0035556;GO:0006468;GO:0030155;GO:0042127;GO:2000772;GO:0035507;GO:1901796;, C:cytoplasm; C:fibrillar center; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell adhesion; P:cellular response to DNA damage stimulus; P:cellular response to glucose starvation; P:intracellular signal transduction; P:protein phosphorylation; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:regulation of cellular senescence; P:regulation of myosin-light-chain-phosphatase activity; P:regulation of signal transduction by p53 class mediator; scaffold1 indexed_genome mRNA 74345765 74383514 . + . ID=transcript_308;Q8N4U5 B2RA65 G3V1Y9,T-complex protein 11-like protein 2,, PF05794;, GO:0007165;, , , P:signal transduction;|Q8N4U5 B2RA65 G3V1Y9,T-complex protein 11-like protein 2,, PF05794;, GO:0007165;, , , P:signal transduction;|Q8N4U5 B2RA65 G3V1Y9,T-complex protein 11-like protein 2,, PF05794;, GO:0007165;, , , P:signal transduction;|Q8N4U5 B2RA65 G3V1Y9,T-complex protein 11-like protein 2,, PF05794;, GO:0007165;, , , P:signal transduction;|Q8N4U5 B2RA65 G3V1Y9,T-complex protein 11-like protein 2,, PF05794;, GO:0007165;, , , P:signal transduction; scaffold1 indexed_genome mRNA 74392029 74468256 . + . ID=transcript_309;Q9NW08 A8K6H0 B3KV73 F5H1E6 Q9NW59,DNA-directed RNA polymerase III subunit RPC2,C128;DNA-directed RNA polymerase III 127.6 kDa polypeptide;DNA-directed RNA polymerase III subunit B;, PF04563;PF04561;PF04565;PF04566;PF04567;PF00562;PF04560;, GO:0005829;GO:0005654;GO:0005666;GO:0003677;GO:0003899;GO:0046872;GO:0032549;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding; F:ribonucleoside binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:transcription, DNA-templated;|Q9NW08 A8K6H0 B3KV73 F5H1E6 Q9NW59,DNA-directed RNA polymerase III subunit RPC2,C128;DNA-directed RNA polymerase III 127.6 kDa polypeptide;DNA-directed RNA polymerase III subunit B;, PF04563;PF04561;PF04565;PF04566;PF04567;PF00562;PF04560;, GO:0005829;GO:0005654;GO:0005666;GO:0003677;GO:0003899;GO:0046872;GO:0032549;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding; F:ribonucleoside binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:transcription, DNA-templated;|Q9NW08 A8K6H0 B3KV73 F5H1E6 Q9NW59,DNA-directed RNA polymerase III subunit RPC2,C128;DNA-directed RNA polymerase III 127.6 kDa polypeptide;DNA-directed RNA polymerase III subunit B;, PF04563;PF04561;PF04565;PF04566;PF04567;PF00562;PF04560;, GO:0005829;GO:0005654;GO:0005666;GO:0003677;GO:0003899;GO:0046872;GO:0032549;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding; F:ribonucleoside binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:transcription, DNA-templated; scaffold1 indexed_genome mRNA 74488897 74501891 . + . ID=transcript_310;Q9NW08 A8K6H0 B3KV73 F5H1E6 Q9NW59,DNA-directed RNA polymerase III subunit RPC2,C128;DNA-directed RNA polymerase III 127.6 kDa polypeptide;DNA-directed RNA polymerase III subunit B;, PF04563;PF04561;PF04565;PF04566;PF04567;PF00562;PF04560;, GO:0005829;GO:0005654;GO:0005666;GO:0003677;GO:0003899;GO:0046872;GO:0032549;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding; F:ribonucleoside binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:transcription, DNA-templated; scaffold1 indexed_genome mRNA 74542456 74717527 . + . ID=transcript_311;Q8NDF9 Q8SNA1 Q96S80 Q9BXI0,Transcription factor RFX4,Regulatory factor X 4;Testis development protein NYD-SP10;, PF02257;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0060271;GO:0021914;GO:0045944;GO:0070613;GO:0006357;GO:0021537;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cilium assembly; P:negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning; P:positive regulation of transcription by RNA polymerase II; P:regulation of protein processing; P:regulation of transcription by RNA polymerase II; P:telencephalon development;|Q8NDF9 Q8SNA1 Q96S80 Q9BXI0,Transcription factor RFX4,Regulatory factor X 4;Testis development protein NYD-SP10;, PF02257;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0060271;GO:0021914;GO:0045944;GO:0070613;GO:0006357;GO:0021537;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cilium assembly; P:negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning; P:positive regulation of transcription by RNA polymerase II; P:regulation of protein processing; P:regulation of transcription by RNA polymerase II; P:telencephalon development;|Q8NDF9 Q8SNA1 Q96S80 Q9BXI0,Transcription factor RFX4,Regulatory factor X 4;Testis development protein NYD-SP10;, PF02257;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0060271;GO:0021914;GO:0045944;GO:0070613;GO:0006357;GO:0021537;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cilium assembly; P:negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning; P:positive regulation of transcription by RNA polymerase II; P:regulation of protein processing; P:regulation of transcription by RNA polymerase II; P:telencephalon development; scaffold1 indexed_genome mRNA 74729124 74791568 . + . ID=transcript_312;Q9NVN3 A2RTZ0 Q4G103 Q6ZRN4 Q86WD3,Synembryn-B,Brain synembryn;Protein Ric-8B;, PF10165;, GO:0005938;GO:0005737;GO:0005829;GO:0005886;GO:0001965;GO:0005096;GO:0005085;GO:0007186;GO:0008277;, C:cell cortex; C:cytoplasm; C:cytosol; C:plasma membrane;, F:G-protein alpha-subunit binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; scaffold1 indexed_genome mRNA 74802786 74832864 . + . ID=transcript_313;Q9NPQ8 Q0P508 Q2T9J1 Q7Z352 Q96EZ1 Q96SZ2 Q9H064 Q9H5H3 Q9H9E7,Synembryn-A,Protein Ric-8A;, PF10165;, GO:0005737;GO:0005886;GO:0001965;GO:0005096;GO:0005085;GO:0007193;GO:0071711;GO:0042074;GO:0070586;GO:0007186;GO:0001701;GO:0001944;GO:0008542;, C:cytoplasm; C:plasma membrane;, F:G-protein alpha-subunit binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:basement membrane organization; P:cell migration involved in gastrulation; P:cell-cell adhesion involved in gastrulation; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:vasculature development; P:visual learning;|Q9NVN3 A2RTZ0 Q4G103 Q6ZRN4 Q86WD3,Synembryn-B,Brain synembryn;Protein Ric-8B;, PF10165;, GO:0005938;GO:0005737;GO:0005829;GO:0005886;GO:0001965;GO:0005096;GO:0005085;GO:0007186;GO:0008277;, C:cell cortex; C:cytoplasm; C:cytosol; C:plasma membrane;, F:G-protein alpha-subunit binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; scaffold1 indexed_genome mRNA 74885581 74911960 . + . ID=transcript_314;Q8WUH6 B3KMN9,Transmembrane protein 263,, PF15475;, GO:0016021;, C:integral component of membrane;|Q8WUH6 B3KMN9,Transmembrane protein 263,, PF15475;, GO:0016021;, C:integral component of membrane;|Q49AM1 Q53HM2 Q9H4L6 Q9H7Y9,Transcription termination factor 2, mitochondrial,Mitochondrial transcription termination factor 2;Mitochondrial transcription termination factor-like protein;mTERF domain-containing protein 3, mitochondrial;, PF02536;, GO:0005759;GO:0042645;GO:0005739;GO:0003677;GO:0003690;GO:0003676;GO:0006355;GO:0006393;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:DNA binding; F:double-stranded DNA binding; F:nucleic acid binding;, P:regulation of transcription, DNA-templated; P:termination of mitochondrial transcription; scaffold1 indexed_genome mRNA 74915678 75004003 . - . ID=transcript_315;Q16526,Cryptochrome-1,, PF00875;PF03441;, GO:0005737;GO:0005739;GO:0005634;GO:0009882;GO:0003677;GO:0003690;GO:0070888;GO:0071949;GO:0042826;GO:0035257;GO:0019902;GO:0019901;GO:0009785;GO:0032922;GO:0007623;GO:0006975;GO:0043153;GO:0006094;GO:0042593;GO:0019915;GO:0042754;GO:0045744;GO:2000323;GO:2000850;GO:0045721;GO:0031397;GO:0000122;GO:0045892;GO:0031398;GO:0018298;GO:0042752;GO:2000001;GO:0014823;GO:0033762;GO:0032868;GO:0009416;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:blue light photoreceptor activity; F:DNA binding; F:double-stranded DNA binding; F:E-box binding; F:FAD binding; F:histone deacetylase binding; F:nuclear hormone receptor binding; F:phosphatase binding; F:protein kinase binding;, P:blue light signaling pathway; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA damage induced protein phosphorylation; P:entrainment of circadian clock by photoperiod; P:gluconeogenesis; P:glucose homeostasis; P:lipid storage; P:negative regulation of circadian rhythm; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of glucocorticoid secretion; P:negative regulation of gluconeogenesis; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein ubiquitination; P:protein-chromophore linkage; P:regulation of circadian rhythm; P:regulation of DNA damage checkpoint; P:response to activity; P:response to glucagon; P:response to insulin; P:response to light stimulus; scaffold1 indexed_genome mRNA 75479085 75513479 . + . ID=transcript_316;Q8N245,Ankyrin repeat and BTB/POZ domain-containing protein BTBD11,BTB/POZ domain-containing protein 11;, PF00023;PF12796;PF00651;, GO:0016021;GO:0046982;GO:0060395;, C:integral component of membrane;, F:protein heterodimerization activity;, P:SMAD protein signal transduction; scaffold1 indexed_genome mRNA 75544710 75552703 . + . ID=transcript_317;Q13610 A8K3R6 Q7Z3X9,Periodic tryptophan protein 1 homolog {ECO:0000312|HGNC:HGNC:17015},Keratinocyte protein IEF SSP 9502;, PF00400;, GO:0005694;GO:0005794;GO:0005730;GO:0005634;GO:1990889;GO:0034773;GO:0033140;GO:2000738;GO:1901838;GO:0006364;GO:0006351;, C:chromosome; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:H4K20me3 modified histone binding;, P:histone H4-K20 trimethylation; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:positive regulation of stem cell differentiation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing; P:transcription, DNA-templated;|Q13610 A8K3R6 Q7Z3X9,Periodic tryptophan protein 1 homolog {ECO:0000312|HGNC:HGNC:17015},Keratinocyte protein IEF SSP 9502;, PF00400;, GO:0005694;GO:0005794;GO:0005730;GO:0005634;GO:1990889;GO:0034773;GO:0033140;GO:2000738;GO:1901838;GO:0006364;GO:0006351;, C:chromosome; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:H4K20me3 modified histone binding;, P:histone H4-K20 trimethylation; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:positive regulation of stem cell differentiation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing; P:transcription, DNA-templated; scaffold1 indexed_genome mRNA 75554355 75565110 . + . ID=transcript_318;Q13610 A8K3R6 Q7Z3X9,Periodic tryptophan protein 1 homolog {ECO:0000312|HGNC:HGNC:17015},Keratinocyte protein IEF SSP 9502;, PF00400;, GO:0005694;GO:0005794;GO:0005730;GO:0005634;GO:1990889;GO:0034773;GO:0033140;GO:2000738;GO:1901838;GO:0006364;GO:0006351;, C:chromosome; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:H4K20me3 modified histone binding;, P:histone H4-K20 trimethylation; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:positive regulation of stem cell differentiation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing; P:transcription, DNA-templated;|Q13610 A8K3R6 Q7Z3X9,Periodic tryptophan protein 1 homolog {ECO:0000312|HGNC:HGNC:17015},Keratinocyte protein IEF SSP 9502;, PF00400;, GO:0005694;GO:0005794;GO:0005730;GO:0005634;GO:1990889;GO:0034773;GO:0033140;GO:2000738;GO:1901838;GO:0006364;GO:0006351;, C:chromosome; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:H4K20me3 modified histone binding;, P:histone H4-K20 trimethylation; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:positive regulation of stem cell differentiation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing; P:transcription, DNA-templated;|Q13610 A8K3R6 Q7Z3X9,Periodic tryptophan protein 1 homolog {ECO:0000312|HGNC:HGNC:17015},Keratinocyte protein IEF SSP 9502;, PF00400;, GO:0005694;GO:0005794;GO:0005730;GO:0005634;GO:1990889;GO:0034773;GO:0033140;GO:2000738;GO:1901838;GO:0006364;GO:0006351;, C:chromosome; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:H4K20me3 modified histone binding;, P:histone H4-K20 trimethylation; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:positive regulation of stem cell differentiation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing; P:transcription, DNA-templated; scaffold1 indexed_genome mRNA 75580356 75604270 . - . ID=transcript_319;Q9UKN5 Q9UFA6,PR domain zinc finger protein 4,PR domain-containing protein 4;, PF00096;PF18445;, GO:0005737;GO:0035097;GO:0005634;GO:0001228;GO:0000981;GO:1990226;GO:0046872;GO:0008168;GO:0000978;GO:1990837;GO:0043985;GO:0045944;GO:0010468;GO:0006366;, C:cytoplasm; C:histone methyltransferase complex; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone methyltransferase binding; F:metal ion binding; F:methyltransferase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:histone H4-R3 methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:transcription by RNA polymerase II;|Q9UKN5 Q9UFA6,PR domain zinc finger protein 4,PR domain-containing protein 4;, PF00096;PF18445;, GO:0005737;GO:0035097;GO:0005634;GO:0001228;GO:0000981;GO:1990226;GO:0046872;GO:0008168;GO:0000978;GO:1990837;GO:0043985;GO:0045944;GO:0010468;GO:0006366;, C:cytoplasm; C:histone methyltransferase complex; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone methyltransferase binding; F:metal ion binding; F:methyltransferase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:histone H4-R3 methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:transcription by RNA polymerase II; scaffold1 indexed_genome mRNA 75628051 75650559 . - . ID=transcript_320;Q9Y3I0 B2R6A8 Q6IAI0 Q9BWL4 Q9NTH1 Q9P037 Q9P0J3,RNA-splicing ligase RtcB homolog {ECO:0000255|HAMAP-Rule:MF_03144, ECO:0000305},3'-phosphate/5'-hydroxy nucleic acid ligase {ECO:0000255|HAMAP-Rule:MF_03144, ECO:0000305};, PF01139;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0072669;GO:0005525;GO:0046872;GO:0003723;GO:0003972;GO:0017166;GO:0000971;GO:0006388;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:tRNA-splicing ligase complex;, F:GTP binding; F:metal ion binding; F:RNA binding; F:RNA ligase (ATP) activity; F:vinculin binding;, P:tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q9Y3I0 B2R6A8 Q6IAI0 Q9BWL4 Q9NTH1 Q9P037 Q9P0J3,RNA-splicing ligase RtcB homolog {ECO:0000255|HAMAP-Rule:MF_03144, ECO:0000305},3'-phosphate/5'-hydroxy nucleic acid ligase {ECO:0000255|HAMAP-Rule:MF_03144, ECO:0000305};, PF01139;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0072669;GO:0005525;GO:0046872;GO:0003723;GO:0003972;GO:0017166;GO:0000971;GO:0006388;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:tRNA-splicing ligase complex;, F:GTP binding; F:metal ion binding; F:RNA binding; F:RNA ligase (ATP) activity; F:vinculin binding;, P:tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold1 indexed_genome mRNA 75715582 75745467 . + . ID=transcript_321;Q9Y3I1 B4DNB3 B4DWX5 Q5TGC4 Q5TI86 Q96HM6 Q9UF21 Q9UKT2,F-box only protein 7,, PF12937;PF11566;, GO:0097414;GO:0005737;GO:0005829;GO:0097409;GO:1990037;GO:1990038;GO:0097462;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0019005;GO:0000151;GO:0046982;GO:0019901;GO:0043130;GO:1990756;GO:0031625;GO:0004842;GO:0000422;GO:0045736;GO:2000134;GO:1903208;GO:0045620;GO:1903204;GO:1903599;GO:0043687;GO:0000209;GO:0006626;GO:0016567;GO:0040012;GO:0010975;GO:0031647;GO:0006511;, C:classical Lewy body; C:cytoplasm; C:cytosol; C:glial cytoplasmic inclusion; C:Lewy body core; C:Lewy body corona; C:Lewy neurite; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:protein heterodimerization activity; F:protein kinase binding; F:ubiquitin binding; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:autophagy of mitochondrion; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of lymphocyte differentiation; P:negative regulation of oxidative stress-induced neuron death; P:positive regulation of autophagy of mitochondrion; P:post-translational protein modification; P:protein polyubiquitination; P:protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of locomotion; P:regulation of neuron projection development; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y3I1 B4DNB3 B4DWX5 Q5TGC4 Q5TI86 Q96HM6 Q9UF21 Q9UKT2,F-box only protein 7,, PF12937;PF11566;, GO:0097414;GO:0005737;GO:0005829;GO:0097409;GO:1990037;GO:1990038;GO:0097462;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0019005;GO:0000151;GO:0046982;GO:0019901;GO:0043130;GO:1990756;GO:0031625;GO:0004842;GO:0000422;GO:0045736;GO:2000134;GO:1903208;GO:0045620;GO:1903204;GO:1903599;GO:0043687;GO:0000209;GO:0006626;GO:0016567;GO:0040012;GO:0010975;GO:0031647;GO:0006511;, C:classical Lewy body; C:cytoplasm; C:cytosol; C:glial cytoplasmic inclusion; C:Lewy body core; C:Lewy body corona; C:Lewy neurite; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:protein heterodimerization activity; F:protein kinase binding; F:ubiquitin binding; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:autophagy of mitochondrion; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of lymphocyte differentiation; P:negative regulation of oxidative stress-induced neuron death; P:positive regulation of autophagy of mitochondrion; P:post-translational protein modification; P:protein polyubiquitination; P:protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of locomotion; P:regulation of neuron projection development; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y3I1 B4DNB3 B4DWX5 Q5TGC4 Q5TI86 Q96HM6 Q9UF21 Q9UKT2,F-box only protein 7,, PF12937;PF11566;, GO:0097414;GO:0005737;GO:0005829;GO:0097409;GO:1990037;GO:1990038;GO:0097462;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0019005;GO:0000151;GO:0046982;GO:0019901;GO:0043130;GO:1990756;GO:0031625;GO:0004842;GO:0000422;GO:0045736;GO:2000134;GO:1903208;GO:0045620;GO:1903204;GO:1903599;GO:0043687;GO:0000209;GO:0006626;GO:0016567;GO:0040012;GO:0010975;GO:0031647;GO:0006511;, C:classical Lewy body; C:cytoplasm; C:cytosol; C:glial cytoplasmic inclusion; C:Lewy body core; C:Lewy body corona; C:Lewy neurite; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:protein heterodimerization activity; F:protein kinase binding; F:ubiquitin binding; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:autophagy of mitochondrion; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of lymphocyte differentiation; P:negative regulation of oxidative stress-induced neuron death; P:positive regulation of autophagy of mitochondrion; P:post-translational protein modification; P:protein polyubiquitination; P:protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of locomotion; P:regulation of neuron projection development; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y3I1 B4DNB3 B4DWX5 Q5TGC4 Q5TI86 Q96HM6 Q9UF21 Q9UKT2,F-box only protein 7,, PF12937;PF11566;, GO:0097414;GO:0005737;GO:0005829;GO:0097409;GO:1990037;GO:1990038;GO:0097462;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0019005;GO:0000151;GO:0046982;GO:0019901;GO:0043130;GO:1990756;GO:0031625;GO:0004842;GO:0000422;GO:0045736;GO:2000134;GO:1903208;GO:0045620;GO:1903204;GO:1903599;GO:0043687;GO:0000209;GO:0006626;GO:0016567;GO:0040012;GO:0010975;GO:0031647;GO:0006511;, C:classical Lewy body; C:cytoplasm; C:cytosol; C:glial cytoplasmic inclusion; C:Lewy body core; C:Lewy body corona; C:Lewy neurite; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:protein heterodimerization activity; F:protein kinase binding; F:ubiquitin binding; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:autophagy of mitochondrion; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of lymphocyte differentiation; P:negative regulation of oxidative stress-induced neuron death; P:positive regulation of autophagy of mitochondrion; P:post-translational protein modification; P:protein polyubiquitination; P:protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of locomotion; P:regulation of neuron projection development; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y3I1 B4DNB3 B4DWX5 Q5TGC4 Q5TI86 Q96HM6 Q9UF21 Q9UKT2,F-box only protein 7,, PF12937;PF11566;, GO:0097414;GO:0005737;GO:0005829;GO:0097409;GO:1990037;GO:1990038;GO:0097462;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0019005;GO:0000151;GO:0046982;GO:0019901;GO:0043130;GO:1990756;GO:0031625;GO:0004842;GO:0000422;GO:0045736;GO:2000134;GO:1903208;GO:0045620;GO:1903204;GO:1903599;GO:0043687;GO:0000209;GO:0006626;GO:0016567;GO:0040012;GO:0010975;GO:0031647;GO:0006511;, C:classical Lewy body; C:cytoplasm; C:cytosol; C:glial cytoplasmic inclusion; C:Lewy body core; C:Lewy body corona; C:Lewy neurite; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:protein heterodimerization activity; F:protein kinase binding; F:ubiquitin binding; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:autophagy of mitochondrion; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of lymphocyte differentiation; P:negative regulation of oxidative stress-induced neuron death; P:positive regulation of autophagy of mitochondrion; P:post-translational protein modification; P:protein polyubiquitination; P:protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of locomotion; P:regulation of neuron projection development; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y3I1 B4DNB3 B4DWX5 Q5TGC4 Q5TI86 Q96HM6 Q9UF21 Q9UKT2,F-box only protein 7,, PF12937;PF11566;, GO:0097414;GO:0005737;GO:0005829;GO:0097409;GO:1990037;GO:1990038;GO:0097462;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0019005;GO:0000151;GO:0046982;GO:0019901;GO:0043130;GO:1990756;GO:0031625;GO:0004842;GO:0000422;GO:0045736;GO:2000134;GO:1903208;GO:0045620;GO:1903204;GO:1903599;GO:0043687;GO:0000209;GO:0006626;GO:0016567;GO:0040012;GO:0010975;GO:0031647;GO:0006511;, C:classical Lewy body; C:cytoplasm; C:cytosol; C:glial cytoplasmic inclusion; C:Lewy body core; C:Lewy body corona; C:Lewy neurite; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:protein heterodimerization activity; F:protein kinase binding; F:ubiquitin binding; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:autophagy of mitochondrion; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of lymphocyte differentiation; P:negative regulation of oxidative stress-induced neuron death; P:positive regulation of autophagy of mitochondrion; P:post-translational protein modification; P:protein polyubiquitination; P:protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of locomotion; P:regulation of neuron projection development; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y3I1 B4DNB3 B4DWX5 Q5TGC4 Q5TI86 Q96HM6 Q9UF21 Q9UKT2,F-box only protein 7,, PF12937;PF11566;, GO:0097414;GO:0005737;GO:0005829;GO:0097409;GO:1990037;GO:1990038;GO:0097462;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0019005;GO:0000151;GO:0046982;GO:0019901;GO:0043130;GO:1990756;GO:0031625;GO:0004842;GO:0000422;GO:0045736;GO:2000134;GO:1903208;GO:0045620;GO:1903204;GO:1903599;GO:0043687;GO:0000209;GO:0006626;GO:0016567;GO:0040012;GO:0010975;GO:0031647;GO:0006511;, C:classical Lewy body; C:cytoplasm; C:cytosol; C:glial cytoplasmic inclusion; C:Lewy body core; C:Lewy body corona; C:Lewy neurite; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:protein heterodimerization activity; F:protein kinase binding; F:ubiquitin binding; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:autophagy of mitochondrion; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of lymphocyte differentiation; P:negative regulation of oxidative stress-induced neuron death; P:positive regulation of autophagy of mitochondrion; P:post-translational protein modification; P:protein polyubiquitination; P:protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of locomotion; P:regulation of neuron projection development; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process; scaffold1 indexed_genome mRNA 76000798 76059211 . + . ID=transcript_322;P35625 B2RBY9 Q5THV4 Q9UC74 Q9UGS2,Metalloproteinase inhibitor 3,Protein MIG-5;Tissue inhibitor of metalloproteinases 3;, PF00965;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0005634;GO:0031089;GO:0046872;GO:0008191;GO:0002020;GO:0010951;GO:0070373;GO:0051045;GO:1904684;GO:0002576;GO:1903984;GO:0034097;GO:0009725;GO:0010033;GO:0007601;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nucleus; C:platelet dense granule lumen;, F:metal ion binding; F:metalloendopeptidase inhibitor activity; F:protease binding;, P:negative regulation of endopeptidase activity; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of metalloendopeptidase activity; P:platelet degranulation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:response to cytokine; P:response to hormone; P:response to organic substance; P:visual perception;|P35625 B2RBY9 Q5THV4 Q9UC74 Q9UGS2,Metalloproteinase inhibitor 3,Protein MIG-5;Tissue inhibitor of metalloproteinases 3;, PF00965;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0005634;GO:0031089;GO:0046872;GO:0008191;GO:0002020;GO:0010951;GO:0070373;GO:0051045;GO:1904684;GO:0002576;GO:1903984;GO:0034097;GO:0009725;GO:0010033;GO:0007601;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nucleus; C:platelet dense granule lumen;, F:metal ion binding; F:metalloendopeptidase inhibitor activity; F:protease binding;, P:negative regulation of endopeptidase activity; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of metalloendopeptidase activity; P:platelet degranulation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:response to cytokine; P:response to hormone; P:response to organic substance; P:visual perception; scaffold1 indexed_genome mRNA 76118364 76173020 . - . ID=transcript_323;O14994 B1B1F9,Synapsin-3,Synapsin III;, PF02078;PF02750;PF10581;, GO:0098978;GO:0014069;GO:0008021;GO:0030672;GO:0005524;GO:0007269;GO:0032228;GO:0097091;, C:glutamatergic synapse; C:postsynaptic density; C:synaptic vesicle; C:synaptic vesicle membrane;, F:ATP binding;, P:neurotransmitter secretion; P:regulation of synaptic transmission, GABAergic; P:synaptic vesicle clustering; scaffold1 indexed_genome mRNA 76291231 76305773 . + . ID=transcript_324;P0C862 A2A3T6 Q0VGC5 Q5VX65 Q5VX66 Q8IUU4,Complement C1q and tumor necrosis factor-related protein 9A,Complement C1q and tumor necrosis factor-related protein 9;, PF00386;PF01391;, GO:0005581;GO:0005576;GO:0005179;GO:0042802;, C:collagen trimer; C:extracellular region;, F:hormone activity; F:identical protein binding; scaffold1 indexed_genome mRNA 76392346 76989479 . - . ID=transcript_325;O95461 B0QXZ7 O60348 Q17R80 Q9UGD1 Q9UGE7 Q9UGG3 Q9UGZ8 Q9UH22,LARGE xylosyl- and glucuronyltransferase 1 {ECO:0000312|HGNC:HGNC:6511},Acetylglucosaminyltransferase-like 1A;Glycosyltransferase-like protein;, PF01501;, GO:0005794;GO:0000139;GO:0030173;GO:0008375;GO:0015020;GO:0030145;GO:0016757;GO:0042285;GO:0009101;GO:0006688;GO:0046716;GO:0006044;GO:0006486;GO:0006493;GO:0035269;GO:0060538;GO:0043403;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane;, F:acetylglucosaminyltransferase activity; F:glucuronosyltransferase activity; F:manganese ion binding; F:transferase activity, transferring glycosyl groups; F:xylosyltransferase activity;, P:glycoprotein biosynthetic process; P:glycosphingolipid biosynthetic process; P:muscle cell cellular homeostasis; P:N-acetylglucosamine metabolic process; P:protein glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation; P:skeletal muscle organ development; P:skeletal muscle tissue regeneration; scaffold1 indexed_genome mRNA 78020958 78059531 . + . ID=transcript_326;Q9UGU5 O75672 O75673 Q9UMT5,HMG domain-containing protein 4,HMG box-containing protein 4;High mobility group protein 2-like 1;Protein HMGBCG;, PF13775;PF00505;, GO:0016589;GO:0003677;GO:0042802;GO:0008333;GO:0030178;GO:0016055;, C:NURF complex;, F:DNA binding; F:identical protein binding;, P:endosome to lysosome transport; P:negative regulation of Wnt signaling pathway; P:Wnt signaling pathway;|Q9UGU5 O75672 O75673 Q9UMT5,HMG domain-containing protein 4,HMG box-containing protein 4;High mobility group protein 2-like 1;Protein HMGBCG;, PF13775;PF00505;, GO:0016589;GO:0003677;GO:0042802;GO:0008333;GO:0030178;GO:0016055;, C:NURF complex;, F:DNA binding; F:identical protein binding;, P:endosome to lysosome transport; P:negative regulation of Wnt signaling pathway; P:Wnt signaling pathway; scaffold1 indexed_genome mRNA 78063285 78102045 . + . ID=transcript_327;O60784 B4DEL9 B4DNA1 Q5TIJ6 Q86X74,Target of Myb protein 1,, PF03127;PF00790;, GO:0035577;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0016020;GO:0005886;GO:0035579;GO:0030276;GO:0006897;GO:0016197;GO:0006886;GO:0043312;GO:0015031;GO:0007165;, C:azurophil granule membrane; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:membrane; C:plasma membrane; C:specific granule membrane;, F:clathrin binding;, P:endocytosis; P:endosomal transport; P:intracellular protein transport; P:neutrophil degranulation; P:protein transport; P:signal transduction;|O60784 B4DEL9 B4DNA1 Q5TIJ6 Q86X74,Target of Myb protein 1,, PF03127;PF00790;, GO:0035577;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0016020;GO:0005886;GO:0035579;GO:0030276;GO:0006897;GO:0016197;GO:0006886;GO:0043312;GO:0015031;GO:0007165;, C:azurophil granule membrane; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:membrane; C:plasma membrane; C:specific granule membrane;, F:clathrin binding;, P:endocytosis; P:endosomal transport; P:intracellular protein transport; P:neutrophil degranulation; P:protein transport; P:signal transduction; scaffold1 indexed_genome mRNA 78133319 78139708 . + . ID=transcript_328;P09601,Heme oxygenase 1,, PF01126;, GO:0005901;GO:0005829;GO:0005783;GO:0005789;GO:0005615;GO:0016020;GO:0005730;GO:0005634;GO:0048471;GO:0019899;GO:0020037;GO:0004392;GO:0042802;GO:0046872;GO:0004630;GO:0042803;GO:0005198;GO:0001525;GO:0008219;GO:0006879;GO:0071243;GO:0071276;GO:0072719;GO:0034605;GO:0071456;GO:0031670;GO:0019221;GO:0001935;GO:0034101;GO:0007588;GO:0042167;GO:0006788;GO:0035556;GO:0008630;GO:0055072;GO:0097421;GO:0034383;GO:0043392;GO:0043433;GO:1904036;GO:1902042;GO:0002686;GO:0016242;GO:0032764;GO:0043305;GO:0010656;GO:0043524;GO:0048662;GO:1904706;GO:0045766;GO:0043065;GO:1903589;GO:0090050;GO:0032722;GO:0043123;GO:0016239;GO:0048661;GO:0045048;GO:0045765;GO:0008217;GO:0051090;GO:0034395;GO:0043619;GO:0042493;GO:0043627;GO:0042542;GO:0035094;GO:0006979;GO:0007264;GO:0014806;GO:0002246;, C:caveola; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:membrane; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm;, F:enzyme binding; F:heme binding; F:heme oxygenase (decyclizing) activity; F:identical protein binding; F:metal ion binding; F:phospholipase D activity; F:protein homodimerization activity; F:structural molecule activity;, P:angiogenesis; P:cell death; P:cellular iron ion homeostasis; P:cellular response to arsenic-containing substance; P:cellular response to cadmium ion; P:cellular response to cisplatin; P:cellular response to heat; P:cellular response to hypoxia; P:cellular response to nutrient; P:cytokine-mediated signaling pathway; P:endothelial cell proliferation; P:erythrocyte homeostasis; P:excretion; P:heme catabolic process; P:heme oxidation; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:iron ion homeostasis; P:liver regeneration; P:low-density lipoprotein particle clearance; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of leukocyte migration; P:negative regulation of macroautophagy; P:negative regulation of mast cell cytokine production; P:negative regulation of mast cell degranulation; P:negative regulation of muscle cell apoptotic process; P:negative regulation of neuron apoptotic process; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of chemokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of smooth muscle cell proliferation; P:protein insertion into ER membrane; P:regulation of angiogenesis; P:regulation of blood pressure; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription from RNA polymerase II promoter in response to iron; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to drug; P:response to estrogen; P:response to hydrogen peroxide; P:response to nicotine; P:response to oxidative stress; P:small GTPase mediated signal transduction; P:smooth muscle hyperplasia; P:wound healing involved in inflammatory response;|P09601,Heme oxygenase 1,, PF01126;, GO:0005901;GO:0005829;GO:0005783;GO:0005789;GO:0005615;GO:0016020;GO:0005730;GO:0005634;GO:0048471;GO:0019899;GO:0020037;GO:0004392;GO:0042802;GO:0046872;GO:0004630;GO:0042803;GO:0005198;GO:0001525;GO:0008219;GO:0006879;GO:0071243;GO:0071276;GO:0072719;GO:0034605;GO:0071456;GO:0031670;GO:0019221;GO:0001935;GO:0034101;GO:0007588;GO:0042167;GO:0006788;GO:0035556;GO:0008630;GO:0055072;GO:0097421;GO:0034383;GO:0043392;GO:0043433;GO:1904036;GO:1902042;GO:0002686;GO:0016242;GO:0032764;GO:0043305;GO:0010656;GO:0043524;GO:0048662;GO:1904706;GO:0045766;GO:0043065;GO:1903589;GO:0090050;GO:0032722;GO:0043123;GO:0016239;GO:0048661;GO:0045048;GO:0045765;GO:0008217;GO:0051090;GO:0034395;GO:0043619;GO:0042493;GO:0043627;GO:0042542;GO:0035094;GO:0006979;GO:0007264;GO:0014806;GO:0002246;, C:caveola; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:membrane; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm;, F:enzyme binding; F:heme binding; F:heme oxygenase (decyclizing) activity; F:identical protein binding; F:metal ion binding; F:phospholipase D activity; F:protein homodimerization activity; F:structural molecule activity;, P:angiogenesis; P:cell death; P:cellular iron ion homeostasis; P:cellular response to arsenic-containing substance; P:cellular response to cadmium ion; P:cellular response to cisplatin; P:cellular response to heat; P:cellular response to hypoxia; P:cellular response to nutrient; P:cytokine-mediated signaling pathway; P:endothelial cell proliferation; P:erythrocyte homeostasis; P:excretion; P:heme catabolic process; P:heme oxidation; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:iron ion homeostasis; P:liver regeneration; P:low-density lipoprotein particle clearance; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of leukocyte migration; P:negative regulation of macroautophagy; P:negative regulation of mast cell cytokine production; P:negative regulation of mast cell degranulation; P:negative regulation of muscle cell apoptotic process; P:negative regulation of neuron apoptotic process; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of chemokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of smooth muscle cell proliferation; P:protein insertion into ER membrane; P:regulation of angiogenesis; P:regulation of blood pressure; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription from RNA polymerase II promoter in response to iron; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to drug; P:response to estrogen; P:response to hydrogen peroxide; P:response to nicotine; P:response to oxidative stress; P:small GTPase mediated signal transduction; P:smooth muscle hyperplasia; P:wound healing involved in inflammatory response; scaffold1 indexed_genome mRNA 78142211 78160545 . + . ID=transcript_329;P33992 O60785 Q14578 Q9BTJ4 Q9BWL8,DNA replication licensing factor MCM5 {ECO:0000303|Ref.3},CDC46 homolog {ECO:0000250|UniProtKB:P49718};P1-CDC46 {ECO:0000303|PubMed:8265339};, PF00493;PF17855;PF14551;PF17207;, GO:0000781;GO:0071162;GO:0005829;GO:0042555;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0003678;GO:0003688;GO:0003697;GO:0006260;GO:0006270;GO:0000727;GO:0036388;GO:0006267;, C:chromosome, telomeric region; C:CMG complex; C:cytosol; C:MCM complex; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA helicase activity; F:DNA replication origin binding; F:single-stranded DNA binding;, P:DNA replication; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; scaffold1 indexed_genome mRNA 78259658 78271581 . + . ID=transcript_330;Q96D21 O95520 Q5THY8,GTP-binding protein Rhes,Ras homolog enriched in striatum;Tumor endothelial marker 2;, PF00071;, GO:0005886;GO:0031681;GO:0005525;GO:0003924;GO:0043548;GO:0031624;GO:0007626;GO:0031397;GO:0051897;GO:0033235;GO:0043949;GO:0007165;, C:plasma membrane;, F:G-protein beta-subunit binding; F:GTP binding; F:GTPase activity; F:phosphatidylinositol 3-kinase binding; F:ubiquitin conjugating enzyme binding;, P:locomotory behavior; P:negative regulation of protein ubiquitination; P:positive regulation of protein kinase B signaling; P:positive regulation of protein sumoylation; P:regulation of cAMP-mediated signaling; P:signal transduction; scaffold1 indexed_genome mRNA 78321929 78326587 . - . ID=transcript_331;P02144 Q52H51 Q5THY7,Myoglobin,, PF00042;, GO:0005829;GO:0070062;GO:0020037;GO:0046872;GO:0019825;GO:0005344;GO:0015671;GO:0009725;GO:0042542;GO:0031444;, C:cytosol; C:extracellular exosome;, F:heme binding; F:metal ion binding; F:oxygen binding; F:oxygen carrier activity;, P:oxygen transport; P:response to hormone; P:response to hydrogen peroxide; P:slow-twitch skeletal muscle fiber contraction; scaffold1 indexed_genome mRNA 78406462 78420016 . - . ID=transcript_332;Q8TD00 Q8WYB1 Q96DZ6 Q96NL7 Q9UGW4 Q9UH33,RNA binding protein fox-1 homolog 2,Fox-1 homolog B;Hexaribonucleotide-binding protein 2;RNA-binding motif protein 9;RNA-binding protein 9;Repressor of tamoxifen transcriptional activity;, PF12414;PF00076;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003714;GO:0008134;GO:0048813;GO:0008543;GO:0030520;GO:0006397;GO:0045892;GO:0007399;GO:0050885;GO:0021942;GO:0000381;GO:0042127;GO:0010724;GO:0016070;GO:0008380;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:dendrite morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:mRNA processing; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neuromuscular process controlling balance; P:radial glia guided migration of Purkinje cell; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of cell population proliferation; P:regulation of definitive erythrocyte differentiation; P:RNA metabolic process; P:RNA splicing;|Q8TD00 Q8WYB1 Q96DZ6 Q96NL7 Q9UGW4 Q9UH33,RNA binding protein fox-1 homolog 2,Fox-1 homolog B;Hexaribonucleotide-binding protein 2;RNA-binding motif protein 9;RNA-binding protein 9;Repressor of tamoxifen transcriptional activity;, PF12414;PF00076;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003714;GO:0008134;GO:0048813;GO:0008543;GO:0030520;GO:0006397;GO:0045892;GO:0007399;GO:0050885;GO:0021942;GO:0000381;GO:0042127;GO:0010724;GO:0016070;GO:0008380;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:dendrite morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:mRNA processing; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neuromuscular process controlling balance; P:radial glia guided migration of Purkinje cell; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of cell population proliferation; P:regulation of definitive erythrocyte differentiation; P:RNA metabolic process; P:RNA splicing; scaffold1 indexed_genome mRNA 78424989 78470175 . - . ID=transcript_333;Q8TD00 Q8WYB1 Q96DZ6 Q96NL7 Q9UGW4 Q9UH33,RNA binding protein fox-1 homolog 2,Fox-1 homolog B;Hexaribonucleotide-binding protein 2;RNA-binding motif protein 9;RNA-binding protein 9;Repressor of tamoxifen transcriptional activity;, PF12414;PF00076;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003714;GO:0008134;GO:0048813;GO:0008543;GO:0030520;GO:0006397;GO:0045892;GO:0007399;GO:0050885;GO:0021942;GO:0000381;GO:0042127;GO:0010724;GO:0016070;GO:0008380;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:dendrite morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:mRNA processing; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neuromuscular process controlling balance; P:radial glia guided migration of Purkinje cell; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of cell population proliferation; P:regulation of definitive erythrocyte differentiation; P:RNA metabolic process; P:RNA splicing;|Q8TD00 Q8WYB1 Q96DZ6 Q96NL7 Q9UGW4 Q9UH33,RNA binding protein fox-1 homolog 2,Fox-1 homolog B;Hexaribonucleotide-binding protein 2;RNA-binding motif protein 9;RNA-binding protein 9;Repressor of tamoxifen transcriptional activity;, PF12414;PF00076;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003714;GO:0008134;GO:0048813;GO:0008543;GO:0030520;GO:0006397;GO:0045892;GO:0007399;GO:0050885;GO:0021942;GO:0000381;GO:0042127;GO:0010724;GO:0016070;GO:0008380;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:dendrite morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:mRNA processing; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neuromuscular process controlling balance; P:radial glia guided migration of Purkinje cell; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of cell population proliferation; P:regulation of definitive erythrocyte differentiation; P:RNA metabolic process; P:RNA splicing;|Q8TD00 Q8WYB1 Q96DZ6 Q96NL7 Q9UGW4 Q9UH33,RNA binding protein fox-1 homolog 2,Fox-1 homolog B;Hexaribonucleotide-binding protein 2;RNA-binding motif protein 9;RNA-binding protein 9;Repressor of tamoxifen transcriptional activity;, PF12414;PF00076;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003714;GO:0008134;GO:0048813;GO:0008543;GO:0030520;GO:0006397;GO:0045892;GO:0007399;GO:0050885;GO:0021942;GO:0000381;GO:0042127;GO:0010724;GO:0016070;GO:0008380;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:dendrite morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:mRNA processing; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neuromuscular process controlling balance; P:radial glia guided migration of Purkinje cell; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of cell population proliferation; P:regulation of definitive erythrocyte differentiation; P:RNA metabolic process; P:RNA splicing; scaffold2 indexed_genome mRNA 516012 524955 . - . ID=transcript_334;Q9ULF9,Transducin-like enhancer protein 4,Grg-4;Groucho-related protein 4;, PF03920;PF00400;, GO:1990907;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:1904837;GO:0090090;GO:0016055;, C:beta-catenin-TCF complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q9ULF9,Transducin-like enhancer protein 4,Grg-4;Groucho-related protein 4;, PF03920;PF00400;, GO:1990907;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:1904837;GO:0090090;GO:0016055;, C:beta-catenin-TCF complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q04724 A8K495 Q5T3G4 Q969V9,Transducin-like enhancer protein 1,E(Sp1) homolog;Enhancer of split groucho-like protein 1;, PF03920;PF00400;, GO:1990907;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0042802;GO:0070491;GO:0003714;GO:0008134;GO:0009887;GO:1904837;GO:0007275;GO:2000811;GO:0090090;GO:0043124;GO:0045892;GO:0030178;GO:0010628;GO:0007165;GO:0016055;, C:beta-catenin-TCF complex; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:multicellular organism development; P:negative regulation of anoikis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:positive regulation of gene expression; P:signal transduction; P:Wnt signaling pathway; scaffold2 indexed_genome mRNA 1870328 1896962 . - . ID=transcript_335;Q9Y617 Q5T7G5 Q5T7G6 Q96AW2 Q9BQ12,Phosphoserine aminotransferase,Phosphohydroxythreonine aminotransferase;, PF00266;, GO:0005737;GO:0005829;GO:0070062;GO:0042802;GO:0004648;GO:0030170;GO:0006564;GO:0008615;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:identical protein binding; F:O-phospho-L-serine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:L-serine biosynthetic process; P:pyridoxine biosynthetic process; scaffold2 indexed_genome mRNA 1931502 1936067 . - . ID=transcript_336;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold2 indexed_genome mRNA 1936082 1955271 . - . ID=transcript_337;Q5JTW2 A1A4S8 E9PHX5 Q5BJE3 Q5JTW0 Q5JTW1 Q9H9N3,Centrosomal protein of 78 kDa,, PF13516;, GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0097711;GO:0044782;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol;, , P:ciliary basal body-plasma membrane docking; P:cilium organization; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|Q5JTW2 A1A4S8 E9PHX5 Q5BJE3 Q5JTW0 Q5JTW1 Q9H9N3,Centrosomal protein of 78 kDa,, PF13516;, GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0097711;GO:0044782;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol;, , P:ciliary basal body-plasma membrane docking; P:cilium organization; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; scaffold2 indexed_genome mRNA 2427784 2617932 . + . ID=transcript_338;O95837 B1ALW3,Guanine nucleotide-binding protein subunit alpha-14,, PF00503;, GO:0070062;GO:0005834;GO:0005886;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007188;GO:0007186;GO:0060158;GO:0030168;GO:0007165;, C:extracellular exosome; C:heterotrimeric G-protein complex; C:plasma membrane;, F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;, P:action potential; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:phospholipase C-activating dopamine receptor signaling pathway; P:platelet activation; P:signal transduction; scaffold2 indexed_genome mRNA 2625975 2652542 . - . ID=transcript_339;Q9Y2J1,Vacuolar protein sorting-associated protein 13A,Chorea-acanthocytosis protein;Chorein;, PF09333;PF12624;PF06650;PF16908;PF16909;PF16910;, GO:0005829;GO:0005789;GO:0010008;GO:0019898;GO:0005794;GO:0005811;GO:0005765;GO:0031966;GO:0005741;GO:0099013;GO:0097225;GO:0006914;GO:0030317;GO:0006895;GO:0007626;GO:1905146;GO:0007399;GO:0008104;GO:0045053;GO:0006623;GO:0035176;GO:0030382;, C:cytosol; C:endoplasmic reticulum membrane; C:endosome membrane; C:extrinsic component of membrane; C:Golgi apparatus; C:lipid droplet; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:neuronal dense core vesicle lumen; C:sperm midpiece;, , P:autophagy; P:flagellated sperm motility; P:Golgi to endosome transport; P:locomotory behavior; P:lysosomal protein catabolic process; P:nervous system development; P:protein localization; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; P:social behavior; P:sperm mitochondrion organization;|Q9Y2J1,Vacuolar protein sorting-associated protein 13A,Chorea-acanthocytosis protein;Chorein;, PF09333;PF12624;PF06650;PF16908;PF16909;PF16910;, GO:0005829;GO:0005789;GO:0010008;GO:0019898;GO:0005794;GO:0005811;GO:0005765;GO:0031966;GO:0005741;GO:0099013;GO:0097225;GO:0006914;GO:0030317;GO:0006895;GO:0007626;GO:1905146;GO:0007399;GO:0008104;GO:0045053;GO:0006623;GO:0035176;GO:0030382;, C:cytosol; C:endoplasmic reticulum membrane; C:endosome membrane; C:extrinsic component of membrane; C:Golgi apparatus; C:lipid droplet; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:neuronal dense core vesicle lumen; C:sperm midpiece;, , P:autophagy; P:flagellated sperm motility; P:Golgi to endosome transport; P:locomotory behavior; P:lysosomal protein catabolic process; P:nervous system development; P:protein localization; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; P:social behavior; P:sperm mitochondrion organization; scaffold2 indexed_genome mRNA 2656585 2676752 . - . ID=transcript_340;Q9Y2J1,Vacuolar protein sorting-associated protein 13A,Chorea-acanthocytosis protein;Chorein;, PF09333;PF12624;PF06650;PF16908;PF16909;PF16910;, GO:0005829;GO:0005789;GO:0010008;GO:0019898;GO:0005794;GO:0005811;GO:0005765;GO:0031966;GO:0005741;GO:0099013;GO:0097225;GO:0006914;GO:0030317;GO:0006895;GO:0007626;GO:1905146;GO:0007399;GO:0008104;GO:0045053;GO:0006623;GO:0035176;GO:0030382;, C:cytosol; C:endoplasmic reticulum membrane; C:endosome membrane; C:extrinsic component of membrane; C:Golgi apparatus; C:lipid droplet; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:neuronal dense core vesicle lumen; C:sperm midpiece;, , P:autophagy; P:flagellated sperm motility; P:Golgi to endosome transport; P:locomotory behavior; P:lysosomal protein catabolic process; P:nervous system development; P:protein localization; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; P:social behavior; P:sperm mitochondrion organization; scaffold2 indexed_genome mRNA 2678124 2864691 . + . ID=transcript_341;Q9Y2J1,Vacuolar protein sorting-associated protein 13A,Chorea-acanthocytosis protein;Chorein;, PF09333;PF12624;PF06650;PF16908;PF16909;PF16910;, GO:0005829;GO:0005789;GO:0010008;GO:0019898;GO:0005794;GO:0005811;GO:0005765;GO:0031966;GO:0005741;GO:0099013;GO:0097225;GO:0006914;GO:0030317;GO:0006895;GO:0007626;GO:1905146;GO:0007399;GO:0008104;GO:0045053;GO:0006623;GO:0035176;GO:0030382;, C:cytosol; C:endoplasmic reticulum membrane; C:endosome membrane; C:extrinsic component of membrane; C:Golgi apparatus; C:lipid droplet; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:neuronal dense core vesicle lumen; C:sperm midpiece;, , P:autophagy; P:flagellated sperm motility; P:Golgi to endosome transport; P:locomotory behavior; P:lysosomal protein catabolic process; P:nervous system development; P:protein localization; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; P:social behavior; P:sperm mitochondrion organization;|Q9Y2J1,Vacuolar protein sorting-associated protein 13A,Chorea-acanthocytosis protein;Chorein;, PF09333;PF12624;PF06650;PF16908;PF16909;PF16910;, GO:0005829;GO:0005789;GO:0010008;GO:0019898;GO:0005794;GO:0005811;GO:0005765;GO:0031966;GO:0005741;GO:0099013;GO:0097225;GO:0006914;GO:0030317;GO:0006895;GO:0007626;GO:1905146;GO:0007399;GO:0008104;GO:0045053;GO:0006623;GO:0035176;GO:0030382;, C:cytosol; C:endoplasmic reticulum membrane; C:endosome membrane; C:extrinsic component of membrane; C:Golgi apparatus; C:lipid droplet; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:neuronal dense core vesicle lumen; C:sperm midpiece;, , P:autophagy; P:flagellated sperm motility; P:Golgi to endosome transport; P:locomotory behavior; P:lysosomal protein catabolic process; P:nervous system development; P:protein localization; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; P:social behavior; P:sperm mitochondrion organization; scaffold2 indexed_genome mRNA 3283266 3354495 . + . ID=transcript_342;Q6T2V7 Q8N665,Protein prune homolog 2,BNIP2 motif-containing molecule at the C-terminal region 1;, PF12496;PF13716;PF02833;, GO:0005737;GO:0004309;GO:0046872;GO:0006915;GO:0006798;, C:cytoplasm;, F:exopolyphosphatase activity; F:metal ion binding;, P:apoptotic process; P:polyphosphate catabolic process;|Q6T2V7 Q8N665,Protein prune homolog 2,BNIP2 motif-containing molecule at the C-terminal region 1;, PF12496;PF13716;PF02833;, GO:0005737;GO:0004309;GO:0046872;GO:0006915;GO:0006798;, C:cytoplasm;, F:exopolyphosphatase activity; F:metal ion binding;, P:apoptotic process; P:polyphosphate catabolic process;|Q6T2V7 Q8N665,Protein prune homolog 2,BNIP2 motif-containing molecule at the C-terminal region 1;, PF12496;PF13716;PF02833;, GO:0005737;GO:0004309;GO:0046872;GO:0006915;GO:0006798;, C:cytoplasm;, F:exopolyphosphatase activity; F:metal ion binding;, P:apoptotic process; P:polyphosphate catabolic process;|Q6T2V7 Q8N665,Protein prune homolog 2,BNIP2 motif-containing molecule at the C-terminal region 1;, PF12496;PF13716;PF02833;, GO:0005737;GO:0004309;GO:0046872;GO:0006915;GO:0006798;, C:cytoplasm;, F:exopolyphosphatase activity; F:metal ion binding;, P:apoptotic process; P:polyphosphate catabolic process; scaffold2 indexed_genome mRNA 3460634 3508706 . - . ID=transcript_343;Q02742 Q6DJZ4,Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase,Core 2-branching enzyme;Core2-GlcNAc-transferase;, PF02485;, GO:0005615;GO:0031985;GO:0000139;GO:0016021;GO:0005802;GO:0003829;GO:0060352;GO:0009101;GO:0060993;GO:0050901;GO:0016266;GO:0032868;GO:0048729;, C:extracellular space; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:trans-Golgi network;, F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity;, P:cell adhesion molecule production; P:glycoprotein biosynthetic process; P:kidney morphogenesis; P:leukocyte tethering or rolling; P:O-glycan processing; P:response to insulin; P:tissue morphogenesis; scaffold2 indexed_genome mRNA 3571374 3583041 . + . ID=transcript_344;Q969G6 Q5JSG9 Q9NUT7,Riboflavin kinase,ATP:riboflavin 5'-phosphotransferase;Flavokinase;, PF01687;, GO:0005737;GO:0005829;GO:0005739;GO:0005524;GO:0046872;GO:0008531;GO:0006915;GO:0009398;GO:0033864;GO:0072593;GO:0009231;GO:0006771;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:riboflavin kinase activity;, P:apoptotic process; P:FMN biosynthetic process; P:positive regulation of NAD(P)H oxidase activity; P:reactive oxygen species metabolic process; P:riboflavin biosynthetic process; P:riboflavin metabolic process;|Q969G6 Q5JSG9 Q9NUT7,Riboflavin kinase,ATP:riboflavin 5'-phosphotransferase;Flavokinase;, PF01687;, GO:0005737;GO:0005829;GO:0005739;GO:0005524;GO:0046872;GO:0008531;GO:0006915;GO:0009398;GO:0033864;GO:0072593;GO:0009231;GO:0006771;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:riboflavin kinase activity;, P:apoptotic process; P:FMN biosynthetic process; P:positive regulation of NAD(P)H oxidase activity; P:reactive oxygen species metabolic process; P:riboflavin biosynthetic process; P:riboflavin metabolic process;|Q969G6 Q5JSG9 Q9NUT7,Riboflavin kinase,ATP:riboflavin 5'-phosphotransferase;Flavokinase;, PF01687;, GO:0005737;GO:0005829;GO:0005739;GO:0005524;GO:0046872;GO:0008531;GO:0006915;GO:0009398;GO:0033864;GO:0072593;GO:0009231;GO:0006771;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:riboflavin kinase activity;, P:apoptotic process; P:FMN biosynthetic process; P:positive regulation of NAD(P)H oxidase activity; P:reactive oxygen species metabolic process; P:riboflavin biosynthetic process; P:riboflavin metabolic process; scaffold2 indexed_genome mRNA 3753522 4095527 . - . ID=transcript_345;Q92824 F5H2G7 Q13527 Q96EP4,Proprotein convertase subtilisin/kexin type 5,Proprotein convertase 5;Proprotein convertase 6;Subtilisin/kexin-like protease PC5;, PF14843;PF01483;PF00082;PF16470;, GO:0005576;GO:0005615;GO:0005794;GO:0005796;GO:0030173;GO:0016020;GO:0030141;GO:0005802;GO:0004175;GO:0008233;GO:0042277;GO:0004252;GO:0009952;GO:0007267;GO:0140447;GO:0007566;GO:0048566;GO:0048706;GO:0007507;GO:0001822;GO:0035108;GO:0032455;GO:0043043;GO:0016486;GO:0016485;GO:0051004;GO:0002001;GO:0030323;GO:0006465;GO:0019058;, C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi lumen; C:integral component of Golgi membrane; C:membrane; C:secretory granule; C:trans-Golgi network;, F:endopeptidase activity; F:peptidase activity; F:peptide binding; F:serine-type endopeptidase activity;, P:anterior/posterior pattern specification; P:cell-cell signaling; P:cytokine precursor processing; P:embryo implantation; P:embryonic digestive tract development; P:embryonic skeletal system development; P:heart development; P:kidney development; P:limb morphogenesis; P:nerve growth factor processing; P:peptide biosynthetic process; P:peptide hormone processing; P:protein processing; P:regulation of lipoprotein lipase activity; P:renin secretion into blood stream; P:respiratory tube development; P:signal peptide processing; P:viral life cycle; scaffold2 indexed_genome mRNA 4760816 4817626 . - . ID=transcript_346;Q92882 Q5W126 Q96IJ4,Osteoclast-stimulating factor 1,, PF12796;PF00018;, GO:0005576;GO:1904813;GO:0005622;GO:0034774;GO:0017124;GO:0043312;GO:0001503;GO:0007165;, C:extracellular region; C:ficolin-1-rich granule lumen; C:intracellular anatomical structure; C:secretory granule lumen;, F:SH3 domain binding;, P:neutrophil degranulation; P:ossification; P:signal transduction;|Q92882 Q5W126 Q96IJ4,Osteoclast-stimulating factor 1,, PF12796;PF00018;, GO:0005576;GO:1904813;GO:0005622;GO:0034774;GO:0017124;GO:0043312;GO:0001503;GO:0007165;, C:extracellular region; C:ficolin-1-rich granule lumen; C:intracellular anatomical structure; C:secretory granule lumen;, F:SH3 domain binding;, P:neutrophil degranulation; P:ossification; P:signal transduction;|Q92882 Q5W126 Q96IJ4,Osteoclast-stimulating factor 1,, PF12796;PF00018;, GO:0005576;GO:1904813;GO:0005622;GO:0034774;GO:0017124;GO:0043312;GO:0001503;GO:0007165;, C:extracellular region; C:ficolin-1-rich granule lumen; C:intracellular anatomical structure; C:secretory granule lumen;, F:SH3 domain binding;, P:neutrophil degranulation; P:ossification; P:signal transduction;|P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q92882 Q5W126 Q96IJ4,Osteoclast-stimulating factor 1,, PF12796;PF00018;, GO:0005576;GO:1904813;GO:0005622;GO:0034774;GO:0017124;GO:0043312;GO:0001503;GO:0007165;, C:extracellular region; C:ficolin-1-rich granule lumen; C:intracellular anatomical structure; C:secretory granule lumen;, F:SH3 domain binding;, P:neutrophil degranulation; P:ossification; P:signal transduction; scaffold2 indexed_genome mRNA 4852275 4854234 . + . ID=transcript_347;Q9NWW6 Q5W124 Q8N430,Nicotinamide riboside kinase 1,Nicotinic acid riboside kinase 1;Ribosylnicotinamide kinase 1;Ribosylnicotinic acid kinase 1;, , GO:0005829;GO:0005524;GO:0016301;GO:0046872;GO:0050262;GO:0061769;GO:0009435;GO:0019674;, C:cytosol;, F:ATP binding; F:kinase activity; F:metal ion binding; F:ribosylnicotinamide kinase activity; F:ribosylnicotinate kinase activity;, P:NAD biosynthetic process; P:NAD metabolic process; scaffold2 indexed_genome mRNA 4904043 4905323 . - . ID=transcript_348;Q8N4J0 Q7Z383 Q8N7C5,Carnosine N-methyltransferase {ECO:0000303|PubMed:26001783, ECO:0000312|HGNC:HGNC:23435},, PF07942;, GO:0005829;GO:0005634;GO:0030735;GO:0042803;GO:0008757;GO:0035498;GO:0006548;GO:0032259;, C:cytosol; C:nucleus;, F:carnosine N-methyltransferase activity; F:protein homodimerization activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:carnosine metabolic process; P:histidine catabolic process; P:methylation; scaffold2 indexed_genome mRNA 4906255 4907151 . - . ID=transcript_349;Q8N4J0 Q7Z383 Q8N7C5,Carnosine N-methyltransferase {ECO:0000303|PubMed:26001783, ECO:0000312|HGNC:HGNC:23435},, PF07942;, GO:0005829;GO:0005634;GO:0030735;GO:0042803;GO:0008757;GO:0035498;GO:0006548;GO:0032259;, C:cytosol; C:nucleus;, F:carnosine N-methyltransferase activity; F:protein homodimerization activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:carnosine metabolic process; P:histidine catabolic process; P:methylation; scaffold2 indexed_genome mRNA 4919877 4928136 . - . ID=transcript_350;Q8N4J0 Q7Z383 Q8N7C5,Carnosine N-methyltransferase {ECO:0000303|PubMed:26001783, ECO:0000312|HGNC:HGNC:23435},, PF07942;, GO:0005829;GO:0005634;GO:0030735;GO:0042803;GO:0008757;GO:0035498;GO:0006548;GO:0032259;, C:cytosol; C:nucleus;, F:carnosine N-methyltransferase activity; F:protein homodimerization activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:carnosine metabolic process; P:histidine catabolic process; P:methylation;|Q8N4J0 Q7Z383 Q8N7C5,Carnosine N-methyltransferase {ECO:0000303|PubMed:26001783, ECO:0000312|HGNC:HGNC:23435},, PF07942;, GO:0005829;GO:0005634;GO:0030735;GO:0042803;GO:0008757;GO:0035498;GO:0006548;GO:0032259;, C:cytosol; C:nucleus;, F:carnosine N-methyltransferase activity; F:protein homodimerization activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:carnosine metabolic process; P:histidine catabolic process; P:methylation; scaffold2 indexed_genome mRNA 4936096 4939528 . + . ID=transcript_351;Q8N4J0 Q7Z383 Q8N7C5,Carnosine N-methyltransferase {ECO:0000303|PubMed:26001783, ECO:0000312|HGNC:HGNC:23435},, PF07942;, GO:0005829;GO:0005634;GO:0030735;GO:0042803;GO:0008757;GO:0035498;GO:0006548;GO:0032259;, C:cytosol; C:nucleus;, F:carnosine N-methyltransferase activity; F:protein homodimerization activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:carnosine metabolic process; P:histidine catabolic process; P:methylation; scaffold2 indexed_genome mRNA 4942485 4948597 . + . ID=transcript_352;Q8IXQ3 Q9NWD3,Uncharacterized protein C9orf40,, PF15017;|Q8IXQ3 Q9NWD3,Uncharacterized protein C9orf40,, PF15017;|Q8IXQ3 Q9NWD3,Uncharacterized protein C9orf40,, PF15017; scaffold2 indexed_genome mRNA 5100863 5103374 . + . ID=transcript_353;Q9BX84 Q6VPR8 Q6VPR9 Q6VPS0 Q6VPS1 Q6VPS2,Transient receptor potential cation channel subfamily M member 6,Channel kinase 2;Melastatin-related TRP cation channel 6;, PF02816;PF00520;PF18139;PF16519;, GO:0016324;GO:0031526;GO:0005887;GO:0005886;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0106310;GO:0106311;GO:0070588;GO:0098655;GO:0030001;GO:0051262;GO:0009636;, C:apical plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:metal ion transport; P:protein tetramerization; P:response to toxic substance; scaffold2 indexed_genome mRNA 5105541 5114693 . + . ID=transcript_354;Q9BX84 Q6VPR8 Q6VPR9 Q6VPS0 Q6VPS1 Q6VPS2,Transient receptor potential cation channel subfamily M member 6,Channel kinase 2;Melastatin-related TRP cation channel 6;, PF02816;PF00520;PF18139;PF16519;, GO:0016324;GO:0031526;GO:0005887;GO:0005886;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0106310;GO:0106311;GO:0070588;GO:0098655;GO:0030001;GO:0051262;GO:0009636;, C:apical plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:metal ion transport; P:protein tetramerization; P:response to toxic substance; scaffold2 indexed_genome mRNA 5166883 5185125 . + . ID=transcript_355;Q92753 Q8WX73,Nuclear receptor ROR-beta,Nuclear receptor RZR-beta;Nuclear receptor subfamily 1 group F member 2;Retinoid-related orphan receptor-beta;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0008502;GO:0004879;GO:0000978;GO:1990837;GO:0008134;GO:0008270;GO:0035881;GO:0071300;GO:0042462;GO:0045668;GO:0045892;GO:0045944;GO:0045893;GO:0042752;GO:0006357;GO:0006355;GO:0060041;GO:0046549;GO:0046548;GO:0048511;GO:0006367;GO:0007601;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:melatonin receptor activity; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:zinc ion binding;, P:amacrine cell differentiation; P:cellular response to retinoic acid; P:eye photoreceptor cell development; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:retina development in camera-type eye; P:retinal cone cell development; P:retinal rod cell development; P:rhythmic process; P:transcription initiation from RNA polymerase II promoter; P:visual perception; scaffold2 indexed_genome mRNA 6469776 6489812 . - . ID=transcript_356;P04083 B5BU38,Annexin A1,Annexin I;Annexin-1;Calpactin II;Calpactin-2;Chromobindin-9;Lipocortin I {ECO:0000303|PubMed:1832554};Phospholipase A2 inhibitory protein;p35;, PF00191;, GO:0005912;GO:0016324;GO:0016323;GO:0009986;GO:0062023;GO:0001533;GO:0005737;GO:0030659;GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0005576;GO:0005615;GO:0031313;GO:0031232;GO:0019898;GO:0005925;GO:0016328;GO:0042629;GO:0031966;GO:0031514;GO:0005654;GO:0005634;GO:0001891;GO:0005886;GO:0032991;GO:0042383;GO:0097060;GO:0031982;GO:0098641;GO:0005509;GO:0005544;GO:0048306;GO:1990814;GO:0036121;GO:0042802;GO:0019834;GO:0005543;GO:0005102;GO:0003697;GO:0003727;GO:0031532;GO:0002250;GO:0046632;GO:0050482;GO:0007166;GO:0071385;GO:0070301;GO:0035924;GO:0019221;GO:0032508;GO:0031018;GO:0007186;GO:0007187;GO:0042063;GO:0071621;GO:0070365;GO:0006954;GO:0045087;GO:0030073;GO:0030216;GO:0002548;GO:0014839;GO:0043066;GO:0045920;GO:0032717;GO:1900138;GO:0050709;GO:0045629;GO:0097350;GO:0001780;GO:0018149;GO:0006909;GO:0090050;GO:1900087;GO:0032743;GO:0033031;GO:0031394;GO:0042102;GO:0045627;GO:0031340;GO:0090303;GO:0070459;GO:0030850;GO:0008360;GO:0046883;GO:0050727;GO:0032652;GO:0002685;GO:0042493;GO:0032355;GO:0070555;GO:0043434;GO:0010165;GO:0007165;, C:adherens junction; C:apical plasma membrane; C:basolateral plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cornified envelope; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of endosome membrane; C:extrinsic component of external side of plasma membrane; C:extrinsic component of membrane; C:focal adhesion; C:lateral plasma membrane; C:mast cell granule; C:mitochondrial membrane; C:motile cilium; C:nucleoplasm; C:nucleus; C:phagocytic cup; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:synaptic membrane; C:vesicle;, F:cadherin binding involved in cell-cell adhesion; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:DNA/DNA annealing activity; F:double-stranded DNA helicase activity; F:identical protein binding; F:phospholipase A2 inhibitor activity; F:phospholipid binding; F:signaling receptor binding; F:single-stranded DNA binding; F:single-stranded RNA binding;, P:actin cytoskeleton reorganization; P:adaptive immune response; P:alpha-beta T cell differentiation; P:arachidonic acid secretion; P:cell surface receptor signaling pathway; P:cellular response to glucocorticoid stimulus; P:cellular response to hydrogen peroxide; P:cellular response to vascular endothelial growth factor stimulus; P:cytokine-mediated signaling pathway; P:DNA duplex unwinding; P:endocrine pancreas development; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:gliogenesis; P:granulocyte chemotaxis; P:hepatocyte differentiation; P:inflammatory response; P:innate immune response; P:insulin secretion; P:keratinocyte differentiation; P:monocyte chemotaxis; P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of apoptotic process; P:negative regulation of exocytosis; P:negative regulation of interleukin-8 production; P:negative regulation of phospholipase A2 activity; P:negative regulation of protein secretion; P:negative regulation of T-helper 2 cell differentiation; P:neutrophil clearance; P:neutrophil homeostasis; P:peptide cross-linking; P:phagocytosis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of interleukin-2 production; P:positive regulation of neutrophil apoptotic process; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of T cell proliferation; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of vesicle fusion; P:positive regulation of wound healing; P:prolactin secretion; P:prostate gland development; P:regulation of cell shape; P:regulation of hormone secretion; P:regulation of inflammatory response; P:regulation of interleukin-1 production; P:regulation of leukocyte migration; P:response to drug; P:response to estradiol; P:response to interleukin-1; P:response to peptide hormone; P:response to X-ray; P:signal transduction;|P04083 B5BU38,Annexin A1,Annexin I;Annexin-1;Calpactin II;Calpactin-2;Chromobindin-9;Lipocortin I {ECO:0000303|PubMed:1832554};Phospholipase A2 inhibitory protein;p35;, PF00191;, GO:0005912;GO:0016324;GO:0016323;GO:0009986;GO:0062023;GO:0001533;GO:0005737;GO:0030659;GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0005576;GO:0005615;GO:0031313;GO:0031232;GO:0019898;GO:0005925;GO:0016328;GO:0042629;GO:0031966;GO:0031514;GO:0005654;GO:0005634;GO:0001891;GO:0005886;GO:0032991;GO:0042383;GO:0097060;GO:0031982;GO:0098641;GO:0005509;GO:0005544;GO:0048306;GO:1990814;GO:0036121;GO:0042802;GO:0019834;GO:0005543;GO:0005102;GO:0003697;GO:0003727;GO:0031532;GO:0002250;GO:0046632;GO:0050482;GO:0007166;GO:0071385;GO:0070301;GO:0035924;GO:0019221;GO:0032508;GO:0031018;GO:0007186;GO:0007187;GO:0042063;GO:0071621;GO:0070365;GO:0006954;GO:0045087;GO:0030073;GO:0030216;GO:0002548;GO:0014839;GO:0043066;GO:0045920;GO:0032717;GO:1900138;GO:0050709;GO:0045629;GO:0097350;GO:0001780;GO:0018149;GO:0006909;GO:0090050;GO:1900087;GO:0032743;GO:0033031;GO:0031394;GO:0042102;GO:0045627;GO:0031340;GO:0090303;GO:0070459;GO:0030850;GO:0008360;GO:0046883;GO:0050727;GO:0032652;GO:0002685;GO:0042493;GO:0032355;GO:0070555;GO:0043434;GO:0010165;GO:0007165;, C:adherens junction; C:apical plasma membrane; C:basolateral plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cornified envelope; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of endosome membrane; C:extrinsic component of external side of plasma membrane; C:extrinsic component of membrane; C:focal adhesion; C:lateral plasma membrane; C:mast cell granule; C:mitochondrial membrane; C:motile cilium; C:nucleoplasm; C:nucleus; C:phagocytic cup; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:synaptic membrane; C:vesicle;, F:cadherin binding involved in cell-cell adhesion; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:DNA/DNA annealing activity; F:double-stranded DNA helicase activity; F:identical protein binding; F:phospholipase A2 inhibitor activity; F:phospholipid binding; F:signaling receptor binding; F:single-stranded DNA binding; F:single-stranded RNA binding;, P:actin cytoskeleton reorganization; P:adaptive immune response; P:alpha-beta T cell differentiation; P:arachidonic acid secretion; P:cell surface receptor signaling pathway; P:cellular response to glucocorticoid stimulus; P:cellular response to hydrogen peroxide; P:cellular response to vascular endothelial growth factor stimulus; P:cytokine-mediated signaling pathway; P:DNA duplex unwinding; P:endocrine pancreas development; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:gliogenesis; P:granulocyte chemotaxis; P:hepatocyte differentiation; P:inflammatory response; P:innate immune response; P:insulin secretion; P:keratinocyte differentiation; P:monocyte chemotaxis; P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of apoptotic process; P:negative regulation of exocytosis; P:negative regulation of interleukin-8 production; P:negative regulation of phospholipase A2 activity; P:negative regulation of protein secretion; P:negative regulation of T-helper 2 cell differentiation; P:neutrophil clearance; P:neutrophil homeostasis; P:peptide cross-linking; P:phagocytosis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of interleukin-2 production; P:positive regulation of neutrophil apoptotic process; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of T cell proliferation; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of vesicle fusion; P:positive regulation of wound healing; P:prolactin secretion; P:prostate gland development; P:regulation of cell shape; P:regulation of hormone secretion; P:regulation of inflammatory response; P:regulation of interleukin-1 production; P:regulation of leukocyte migration; P:response to drug; P:response to estradiol; P:response to interleukin-1; P:response to peptide hormone; P:response to X-ray; P:signal transduction;|P04083 B5BU38,Annexin A1,Annexin I;Annexin-1;Calpactin II;Calpactin-2;Chromobindin-9;Lipocortin I {ECO:0000303|PubMed:1832554};Phospholipase A2 inhibitory protein;p35;, PF00191;, GO:0005912;GO:0016324;GO:0016323;GO:0009986;GO:0062023;GO:0001533;GO:0005737;GO:0030659;GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0005576;GO:0005615;GO:0031313;GO:0031232;GO:0019898;GO:0005925;GO:0016328;GO:0042629;GO:0031966;GO:0031514;GO:0005654;GO:0005634;GO:0001891;GO:0005886;GO:0032991;GO:0042383;GO:0097060;GO:0031982;GO:0098641;GO:0005509;GO:0005544;GO:0048306;GO:1990814;GO:0036121;GO:0042802;GO:0019834;GO:0005543;GO:0005102;GO:0003697;GO:0003727;GO:0031532;GO:0002250;GO:0046632;GO:0050482;GO:0007166;GO:0071385;GO:0070301;GO:0035924;GO:0019221;GO:0032508;GO:0031018;GO:0007186;GO:0007187;GO:0042063;GO:0071621;GO:0070365;GO:0006954;GO:0045087;GO:0030073;GO:0030216;GO:0002548;GO:0014839;GO:0043066;GO:0045920;GO:0032717;GO:1900138;GO:0050709;GO:0045629;GO:0097350;GO:0001780;GO:0018149;GO:0006909;GO:0090050;GO:1900087;GO:0032743;GO:0033031;GO:0031394;GO:0042102;GO:0045627;GO:0031340;GO:0090303;GO:0070459;GO:0030850;GO:0008360;GO:0046883;GO:0050727;GO:0032652;GO:0002685;GO:0042493;GO:0032355;GO:0070555;GO:0043434;GO:0010165;GO:0007165;, C:adherens junction; C:apical plasma membrane; C:basolateral plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cornified envelope; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of endosome membrane; C:extrinsic component of external side of plasma membrane; C:extrinsic component of membrane; C:focal adhesion; C:lateral plasma membrane; C:mast cell granule; C:mitochondrial membrane; C:motile cilium; C:nucleoplasm; C:nucleus; C:phagocytic cup; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:synaptic membrane; C:vesicle;, F:cadherin binding involved in cell-cell adhesion; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:DNA/DNA annealing activity; F:double-stranded DNA helicase activity; F:identical protein binding; F:phospholipase A2 inhibitor activity; F:phospholipid binding; F:signaling receptor binding; F:single-stranded DNA binding; F:single-stranded RNA binding;, P:actin cytoskeleton reorganization; P:adaptive immune response; P:alpha-beta T cell differentiation; P:arachidonic acid secretion; P:cell surface receptor signaling pathway; P:cellular response to glucocorticoid stimulus; P:cellular response to hydrogen peroxide; P:cellular response to vascular endothelial growth factor stimulus; P:cytokine-mediated signaling pathway; P:DNA duplex unwinding; P:endocrine pancreas development; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:gliogenesis; P:granulocyte chemotaxis; P:hepatocyte differentiation; P:inflammatory response; P:innate immune response; P:insulin secretion; P:keratinocyte differentiation; P:monocyte chemotaxis; P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of apoptotic process; P:negative regulation of exocytosis; P:negative regulation of interleukin-8 production; P:negative regulation of phospholipase A2 activity; P:negative regulation of protein secretion; P:negative regulation of T-helper 2 cell differentiation; P:neutrophil clearance; P:neutrophil homeostasis; P:peptide cross-linking; P:phagocytosis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of interleukin-2 production; P:positive regulation of neutrophil apoptotic process; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of T cell proliferation; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of vesicle fusion; P:positive regulation of wound healing; P:prolactin secretion; P:prostate gland development; P:regulation of cell shape; P:regulation of hormone secretion; P:regulation of inflammatory response; P:regulation of interleukin-1 production; P:regulation of leukocyte migration; P:response to drug; P:response to estradiol; P:response to interleukin-1; P:response to peptide hormone; P:response to X-ray; P:signal transduction;|P04083 B5BU38,Annexin A1,Annexin I;Annexin-1;Calpactin II;Calpactin-2;Chromobindin-9;Lipocortin I {ECO:0000303|PubMed:1832554};Phospholipase A2 inhibitory protein;p35;, PF00191;, GO:0005912;GO:0016324;GO:0016323;GO:0009986;GO:0062023;GO:0001533;GO:0005737;GO:0030659;GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0005576;GO:0005615;GO:0031313;GO:0031232;GO:0019898;GO:0005925;GO:0016328;GO:0042629;GO:0031966;GO:0031514;GO:0005654;GO:0005634;GO:0001891;GO:0005886;GO:0032991;GO:0042383;GO:0097060;GO:0031982;GO:0098641;GO:0005509;GO:0005544;GO:0048306;GO:1990814;GO:0036121;GO:0042802;GO:0019834;GO:0005543;GO:0005102;GO:0003697;GO:0003727;GO:0031532;GO:0002250;GO:0046632;GO:0050482;GO:0007166;GO:0071385;GO:0070301;GO:0035924;GO:0019221;GO:0032508;GO:0031018;GO:0007186;GO:0007187;GO:0042063;GO:0071621;GO:0070365;GO:0006954;GO:0045087;GO:0030073;GO:0030216;GO:0002548;GO:0014839;GO:0043066;GO:0045920;GO:0032717;GO:1900138;GO:0050709;GO:0045629;GO:0097350;GO:0001780;GO:0018149;GO:0006909;GO:0090050;GO:1900087;GO:0032743;GO:0033031;GO:0031394;GO:0042102;GO:0045627;GO:0031340;GO:0090303;GO:0070459;GO:0030850;GO:0008360;GO:0046883;GO:0050727;GO:0032652;GO:0002685;GO:0042493;GO:0032355;GO:0070555;GO:0043434;GO:0010165;GO:0007165;, C:adherens junction; C:apical plasma membrane; C:basolateral plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cornified envelope; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of endosome membrane; C:extrinsic component of external side of plasma membrane; C:extrinsic component of membrane; C:focal adhesion; C:lateral plasma membrane; C:mast cell granule; C:mitochondrial membrane; C:motile cilium; C:nucleoplasm; C:nucleus; C:phagocytic cup; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:synaptic membrane; C:vesicle;, F:cadherin binding involved in cell-cell adhesion; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:DNA/DNA annealing activity; F:double-stranded DNA helicase activity; F:identical protein binding; F:phospholipase A2 inhibitor activity; F:phospholipid binding; F:signaling receptor binding; F:single-stranded DNA binding; F:single-stranded RNA binding;, P:actin cytoskeleton reorganization; P:adaptive immune response; P:alpha-beta T cell differentiation; P:arachidonic acid secretion; P:cell surface receptor signaling pathway; P:cellular response to glucocorticoid stimulus; P:cellular response to hydrogen peroxide; P:cellular response to vascular endothelial growth factor stimulus; P:cytokine-mediated signaling pathway; P:DNA duplex unwinding; P:endocrine pancreas development; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:gliogenesis; P:granulocyte chemotaxis; P:hepatocyte differentiation; P:inflammatory response; P:innate immune response; P:insulin secretion; P:keratinocyte differentiation; P:monocyte chemotaxis; P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of apoptotic process; P:negative regulation of exocytosis; P:negative regulation of interleukin-8 production; P:negative regulation of phospholipase A2 activity; P:negative regulation of protein secretion; P:negative regulation of T-helper 2 cell differentiation; P:neutrophil clearance; P:neutrophil homeostasis; P:peptide cross-linking; P:phagocytosis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of interleukin-2 production; P:positive regulation of neutrophil apoptotic process; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of T cell proliferation; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of vesicle fusion; P:positive regulation of wound healing; P:prolactin secretion; P:prostate gland development; P:regulation of cell shape; P:regulation of hormone secretion; P:regulation of inflammatory response; P:regulation of interleukin-1 production; P:regulation of leukocyte migration; P:response to drug; P:response to estradiol; P:response to interleukin-1; P:response to peptide hormone; P:response to X-ray; P:signal transduction;|P04083 B5BU38,Annexin A1,Annexin I;Annexin-1;Calpactin II;Calpactin-2;Chromobindin-9;Lipocortin I {ECO:0000303|PubMed:1832554};Phospholipase A2 inhibitory protein;p35;, PF00191;, GO:0005912;GO:0016324;GO:0016323;GO:0009986;GO:0062023;GO:0001533;GO:0005737;GO:0030659;GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0005576;GO:0005615;GO:0031313;GO:0031232;GO:0019898;GO:0005925;GO:0016328;GO:0042629;GO:0031966;GO:0031514;GO:0005654;GO:0005634;GO:0001891;GO:0005886;GO:0032991;GO:0042383;GO:0097060;GO:0031982;GO:0098641;GO:0005509;GO:0005544;GO:0048306;GO:1990814;GO:0036121;GO:0042802;GO:0019834;GO:0005543;GO:0005102;GO:0003697;GO:0003727;GO:0031532;GO:0002250;GO:0046632;GO:0050482;GO:0007166;GO:0071385;GO:0070301;GO:0035924;GO:0019221;GO:0032508;GO:0031018;GO:0007186;GO:0007187;GO:0042063;GO:0071621;GO:0070365;GO:0006954;GO:0045087;GO:0030073;GO:0030216;GO:0002548;GO:0014839;GO:0043066;GO:0045920;GO:0032717;GO:1900138;GO:0050709;GO:0045629;GO:0097350;GO:0001780;GO:0018149;GO:0006909;GO:0090050;GO:1900087;GO:0032743;GO:0033031;GO:0031394;GO:0042102;GO:0045627;GO:0031340;GO:0090303;GO:0070459;GO:0030850;GO:0008360;GO:0046883;GO:0050727;GO:0032652;GO:0002685;GO:0042493;GO:0032355;GO:0070555;GO:0043434;GO:0010165;GO:0007165;, C:adherens junction; C:apical plasma membrane; C:basolateral plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cornified envelope; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of endosome membrane; C:extrinsic component of external side of plasma membrane; C:extrinsic component of membrane; C:focal adhesion; C:lateral plasma membrane; C:mast cell granule; C:mitochondrial membrane; C:motile cilium; C:nucleoplasm; C:nucleus; C:phagocytic cup; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:synaptic membrane; C:vesicle;, F:cadherin binding involved in cell-cell adhesion; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:DNA/DNA annealing activity; F:double-stranded DNA helicase activity; F:identical protein binding; F:phospholipase A2 inhibitor activity; F:phospholipid binding; F:signaling receptor binding; F:single-stranded DNA binding; F:single-stranded RNA binding;, P:actin cytoskeleton reorganization; P:adaptive immune response; P:alpha-beta T cell differentiation; P:arachidonic acid secretion; P:cell surface receptor signaling pathway; P:cellular response to glucocorticoid stimulus; P:cellular response to hydrogen peroxide; P:cellular response to vascular endothelial growth factor stimulus; P:cytokine-mediated signaling pathway; P:DNA duplex unwinding; P:endocrine pancreas development; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:gliogenesis; P:granulocyte chemotaxis; P:hepatocyte differentiation; P:inflammatory response; P:innate immune response; P:insulin secretion; P:keratinocyte differentiation; P:monocyte chemotaxis; P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of apoptotic process; P:negative regulation of exocytosis; P:negative regulation of interleukin-8 production; P:negative regulation of phospholipase A2 activity; P:negative regulation of protein secretion; P:negative regulation of T-helper 2 cell differentiation; P:neutrophil clearance; P:neutrophil homeostasis; P:peptide cross-linking; P:phagocytosis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of interleukin-2 production; P:positive regulation of neutrophil apoptotic process; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of T cell proliferation; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of vesicle fusion; P:positive regulation of wound healing; P:prolactin secretion; P:prostate gland development; P:regulation of cell shape; P:regulation of hormone secretion; P:regulation of inflammatory response; P:regulation of interleukin-1 production; P:regulation of leukocyte migration; P:response to drug; P:response to estradiol; P:response to interleukin-1; P:response to peptide hormone; P:response to X-ray; P:signal transduction; scaffold2 indexed_genome mRNA 6585714 6592750 . - . ID=transcript_357;P05177 Q16754 Q6NWU3 Q6NWU5 Q9BXX7 Q9UK49,Cytochrome P450 1A2 {ECO:0000303|PubMed:14725854},CYPIA2;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P(3)450;Cytochrome P450 4;Cytochrome P450-P3;Hydroperoxy icosatetraenoate dehydratase {ECO:0000305|PubMed:21068195};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0034875;GO:0032451;GO:0009055;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0106256;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0046222;GO:0009820;GO:0045333;GO:0071276;GO:0071280;GO:0008203;GO:0018894;GO:0042737;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046483;GO:0050665;GO:0042759;GO:0030324;GO:0032259;GO:0032787;GO:0016098;GO:0097267;GO:0070989;GO:0006778;GO:0009791;GO:0010468;GO:0032355;GO:0035902;GO:0032496;GO:0042572;GO:0006706;GO:0009403;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:caffeine oxidase activity; F:demethylase activity; F:electron transfer activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:hydroperoxy icosatetraenoate dehydratase activity; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;, P:aflatoxin metabolic process; P:alkaloid metabolic process; P:cellular respiration; P:cellular response to cadmium ion; P:cellular response to copper ion; P:cholesterol metabolic process; P:dibenzo-p-dioxin metabolic process; P:drug catabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:hydrogen peroxide biosynthetic process; P:long-chain fatty acid biosynthetic process; P:lung development; P:methylation; P:monocarboxylic acid metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:oxidative demethylation; P:porphyrin-containing compound metabolic process; P:post-embryonic development; P:regulation of gene expression; P:response to estradiol; P:response to immobilization stress; P:response to lipopolysaccharide; P:retinol metabolic process; P:steroid catabolic process; P:toxin biosynthetic process; P:xenobiotic metabolic process; scaffold2 indexed_genome mRNA 7005006 7029287 . + . ID=transcript_358;O76080 A8K484,AN1-type zinc finger protein 5,Zinc finger A20 domain-containing protein 2;Zinc finger protein 216;, PF01754;PF01428;, GO:0005737;GO:0003677;GO:0008270;GO:0060324;GO:0010761;GO:0001701;GO:0048008;GO:0003016;GO:0048705;GO:0048745;GO:0001944;, C:cytoplasm;, F:DNA binding; F:zinc ion binding;, P:face development; P:fibroblast migration; P:in utero embryonic development; P:platelet-derived growth factor receptor signaling pathway; P:respiratory system process; P:skeletal system morphogenesis; P:smooth muscle tissue development; P:vasculature development;|O76080 A8K484,AN1-type zinc finger protein 5,Zinc finger A20 domain-containing protein 2;Zinc finger protein 216;, PF01754;PF01428;, GO:0005737;GO:0003677;GO:0008270;GO:0060324;GO:0010761;GO:0001701;GO:0048008;GO:0003016;GO:0048705;GO:0048745;GO:0001944;, C:cytoplasm;, F:DNA binding; F:zinc ion binding;, P:face development; P:fibroblast migration; P:in utero embryonic development; P:platelet-derived growth factor receptor signaling pathway; P:respiratory system process; P:skeletal system morphogenesis; P:smooth muscle tissue development; P:vasculature development; scaffold2 indexed_genome mRNA 7124918 7138844 . - . ID=transcript_359;Q9Y2T3 B4DTY5 Q5SZC7 Q9H335 Q9ULG2,Guanine deaminase,Guanine aminohydrolase;p51-nedasin;, PF01979;, GO:0005829;GO:0005622;GO:0019239;GO:0008892;GO:0008270;GO:0046055;GO:0046038;GO:0006147;GO:0046098;GO:0007399;GO:0006139;GO:0006195;, C:cytosol; C:intracellular anatomical structure;, F:deaminase activity; F:guanine deaminase activity; F:zinc ion binding;, P:dGMP catabolic process; P:GMP catabolic process; P:guanine catabolic process; P:guanine metabolic process; P:nervous system development; P:nucleobase-containing compound metabolic process; P:purine nucleotide catabolic process; scaffold2 indexed_genome mRNA 7151448 7152085 . + . ID=transcript_360;Q9Y2T3 B4DTY5 Q5SZC7 Q9H335 Q9ULG2,Guanine deaminase,Guanine aminohydrolase;p51-nedasin;, PF01979;, GO:0005829;GO:0005622;GO:0019239;GO:0008892;GO:0008270;GO:0046055;GO:0046038;GO:0006147;GO:0046098;GO:0007399;GO:0006139;GO:0006195;, C:cytosol; C:intracellular anatomical structure;, F:deaminase activity; F:guanine deaminase activity; F:zinc ion binding;, P:dGMP catabolic process; P:GMP catabolic process; P:guanine catabolic process; P:guanine metabolic process; P:nervous system development; P:nucleobase-containing compound metabolic process; P:purine nucleotide catabolic process; scaffold2 indexed_genome mRNA 7394767 7458232 . - . ID=transcript_361;Q96MD7 Q5W0N1 Q5W0N3 Q6PJW9 Q86U95,Uncharacterized protein C9orf85,, PF10217; scaffold2 indexed_genome mRNA 7504442 7511927 . - . ID=transcript_362;Q5VST6 A8KAJ5 Q5VST7 Q86YB6 Q8IY03 Q9Y377,Alpha/beta hydrolase domain-containing protein 17B {ECO:0000305},, PF12146;, GO:0099031;GO:0099033;GO:0043197;GO:0010008;GO:0098978;GO:0016020;GO:0005886;GO:0055038;GO:0008474;GO:0000165;GO:1902817;GO:1905668;GO:0002084;GO:1902950;GO:0099175;GO:1902473;, C:anchored component of postsynaptic density membrane; C:anchored component of postsynaptic recycling endosome membrane; C:dendritic spine; C:endosome membrane; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:recycling endosome membrane;, F:palmitoyl-(protein) hydrolase activity;, P:MAPK cascade; P:negative regulation of protein localization to microtubule; P:positive regulation of protein localization to endosome; P:protein depalmitoylation; P:regulation of dendritic spine maintenance; P:regulation of postsynapse organization; P:regulation of protein localization to synapse;|Q5VST6 A8KAJ5 Q5VST7 Q86YB6 Q8IY03 Q9Y377,Alpha/beta hydrolase domain-containing protein 17B {ECO:0000305},, PF12146;, GO:0099031;GO:0099033;GO:0043197;GO:0010008;GO:0098978;GO:0016020;GO:0005886;GO:0055038;GO:0008474;GO:0000165;GO:1902817;GO:1905668;GO:0002084;GO:1902950;GO:0099175;GO:1902473;, C:anchored component of postsynaptic density membrane; C:anchored component of postsynaptic recycling endosome membrane; C:dendritic spine; C:endosome membrane; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:recycling endosome membrane;, F:palmitoyl-(protein) hydrolase activity;, P:MAPK cascade; P:negative regulation of protein localization to microtubule; P:positive regulation of protein localization to endosome; P:protein depalmitoylation; P:regulation of dendritic spine maintenance; P:regulation of postsynapse organization; P:regulation of protein localization to synapse; scaffold2 indexed_genome mRNA 7512094 7514120 . + . ID=transcript_363;Q5VST6 A8KAJ5 Q5VST7 Q86YB6 Q8IY03 Q9Y377,Alpha/beta hydrolase domain-containing protein 17B {ECO:0000305},, PF12146;, GO:0099031;GO:0099033;GO:0043197;GO:0010008;GO:0098978;GO:0016020;GO:0005886;GO:0055038;GO:0008474;GO:0000165;GO:1902817;GO:1905668;GO:0002084;GO:1902950;GO:0099175;GO:1902473;, C:anchored component of postsynaptic density membrane; C:anchored component of postsynaptic recycling endosome membrane; C:dendritic spine; C:endosome membrane; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:recycling endosome membrane;, F:palmitoyl-(protein) hydrolase activity;, P:MAPK cascade; P:negative regulation of protein localization to microtubule; P:positive regulation of protein localization to endosome; P:protein depalmitoylation; P:regulation of dendritic spine maintenance; P:regulation of postsynapse organization; P:regulation of protein localization to synapse; scaffold2 indexed_genome mRNA 7615555 7684704 . + . ID=transcript_364;Q9UHN6 A6H8W9 B2RTQ6 Q5T838 Q5T839 Q5T840 Q5T841 Q8NBP6 Q9P2D5,Cell surface hyaluronidase {ECO:0000303|PubMed:28246172},Cell migration-inducing hyaluronidase 2 {ECO:0000312|HGNC:HGNC:11869};Transmembrane protein 2 {ECO:0000303|PubMed:10767548};, PF10162;PF15711;, GO:0070062;GO:0016021;GO:0005887;GO:0043231;GO:0005886;GO:0045296;GO:0005509;GO:0004415;GO:0001525;GO:0030214;GO:1903670;, C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:cadherin binding; F:calcium ion binding; F:hyalurononglucosaminidase activity;, P:angiogenesis; P:hyaluronan catabolic process; P:regulation of sprouting angiogenesis; scaffold2 indexed_genome mRNA 7686531 7692248 . - . ID=transcript_365;Q9UHN6 A6H8W9 B2RTQ6 Q5T838 Q5T839 Q5T840 Q5T841 Q8NBP6 Q9P2D5,Cell surface hyaluronidase {ECO:0000303|PubMed:28246172},Cell migration-inducing hyaluronidase 2 {ECO:0000312|HGNC:HGNC:11869};Transmembrane protein 2 {ECO:0000303|PubMed:10767548};, PF10162;PF15711;, GO:0070062;GO:0016021;GO:0005887;GO:0043231;GO:0005886;GO:0045296;GO:0005509;GO:0004415;GO:0001525;GO:0030214;GO:1903670;, C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:cadherin binding; F:calcium ion binding; F:hyalurononglucosaminidase activity;, P:angiogenesis; P:hyaluronan catabolic process; P:regulation of sprouting angiogenesis;|Q9UHN6 A6H8W9 B2RTQ6 Q5T838 Q5T839 Q5T840 Q5T841 Q8NBP6 Q9P2D5,Cell surface hyaluronidase {ECO:0000303|PubMed:28246172},Cell migration-inducing hyaluronidase 2 {ECO:0000312|HGNC:HGNC:11869};Transmembrane protein 2 {ECO:0000303|PubMed:10767548};, PF10162;PF15711;, GO:0070062;GO:0016021;GO:0005887;GO:0043231;GO:0005886;GO:0045296;GO:0005509;GO:0004415;GO:0001525;GO:0030214;GO:1903670;, C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:cadherin binding; F:calcium ion binding; F:hyalurononglucosaminidase activity;, P:angiogenesis; P:hyaluronan catabolic process; P:regulation of sprouting angiogenesis;|Q9UHN6 A6H8W9 B2RTQ6 Q5T838 Q5T839 Q5T840 Q5T841 Q8NBP6 Q9P2D5,Cell surface hyaluronidase {ECO:0000303|PubMed:28246172},Cell migration-inducing hyaluronidase 2 {ECO:0000312|HGNC:HGNC:11869};Transmembrane protein 2 {ECO:0000303|PubMed:10767548};, PF10162;PF15711;, GO:0070062;GO:0016021;GO:0005887;GO:0043231;GO:0005886;GO:0045296;GO:0005509;GO:0004415;GO:0001525;GO:0030214;GO:1903670;, C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:cadherin binding; F:calcium ion binding; F:hyalurononglucosaminidase activity;, P:angiogenesis; P:hyaluronan catabolic process; P:regulation of sprouting angiogenesis; scaffold2 indexed_genome mRNA 8260984 8620644 . + . ID=transcript_366;Q86UL0 Q86WK1 Q86WK2 Q86WK3 Q86WK4 Q86YZ9 Q86Z00 Q86Z01 Q9H0X2,Transient receptor potential cation channel subfamily M member 3,Long transient receptor potential channel 3;Melastatin-2;, PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0005227;GO:0005262;GO:0005261;GO:0070588;GO:0098655;GO:0006812;GO:0016048;GO:0030001;GO:0051262;GO:0050951;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:calcium channel activity; F:cation channel activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:cation transport; P:detection of temperature stimulus; P:metal ion transport; P:protein tetramerization; P:sensory perception of temperature stimulus; scaffold2 indexed_genome mRNA 8735650 8738658 . + . ID=transcript_367;Q86UL0 Q86WK1 Q86WK2 Q86WK3 Q86WK4 Q86YZ9 Q86Z00 Q86Z01 Q9H0X2,Transient receptor potential cation channel subfamily M member 3,Long transient receptor potential channel 3;Melastatin-2;, PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0005227;GO:0005262;GO:0005261;GO:0070588;GO:0098655;GO:0006812;GO:0016048;GO:0030001;GO:0051262;GO:0050951;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:calcium channel activity; F:cation channel activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:cation transport; P:detection of temperature stimulus; P:metal ion transport; P:protein tetramerization; P:sensory perception of temperature stimulus; scaffold2 indexed_genome mRNA 8743865 8744654 . - . ID=transcript_368;Q86UL0 Q86WK1 Q86WK2 Q86WK3 Q86WK4 Q86YZ9 Q86Z00 Q86Z01 Q9H0X2,Transient receptor potential cation channel subfamily M member 3,Long transient receptor potential channel 3;Melastatin-2;, PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0005227;GO:0005262;GO:0005261;GO:0070588;GO:0098655;GO:0006812;GO:0016048;GO:0030001;GO:0051262;GO:0050951;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:calcium channel activity; F:cation channel activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:cation transport; P:detection of temperature stimulus; P:metal ion transport; P:protein tetramerization; P:sensory perception of temperature stimulus; scaffold2 indexed_genome mRNA 8751483 8850407 . + . ID=transcript_369;Q86UL0 Q86WK1 Q86WK2 Q86WK3 Q86WK4 Q86YZ9 Q86Z00 Q86Z01 Q9H0X2,Transient receptor potential cation channel subfamily M member 3,Long transient receptor potential channel 3;Melastatin-2;, PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0005227;GO:0005262;GO:0005261;GO:0070588;GO:0098655;GO:0006812;GO:0016048;GO:0030001;GO:0051262;GO:0050951;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:calcium channel activity; F:cation channel activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:cation transport; P:detection of temperature stimulus; P:metal ion transport; P:protein tetramerization; P:sensory perception of temperature stimulus; scaffold2 indexed_genome mRNA 8961547 8987629 . + . ID=transcript_370;Q13886 B2R943 Q16196,Krueppel-like factor 9,Basic transcription element-binding protein 1;GC-box-binding protein 1;Transcription factor BTEB1;, PF00096;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0071387;GO:0097067;GO:0007623;GO:0010839;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to cortisol stimulus; P:cellular response to thyroid hormone stimulus; P:circadian rhythm; P:negative regulation of keratinocyte proliferation; P:regulation of transcription by RNA polymerase II; scaffold2 indexed_genome mRNA 9045008 9059241 . - . ID=transcript_371;Q8IY18 A6NM81 O60335 Q05D92 Q5VZ60 Q96SB9,Structural maintenance of chromosomes protein 5,, PF02463;, GO:0030054;GO:0000775;GO:0000781;GO:0005737;GO:0035061;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0000803;GO:0035861;GO:0030915;GO:0005524;GO:0016887;GO:0051301;GO:0006974;GO:0090398;GO:0030261;GO:0000724;GO:0018393;GO:0044772;GO:0051984;GO:0034184;GO:0071459;GO:0007062;GO:0019827;GO:0000722;, C:cell junction; C:chromosome, centromeric region; C:chromosome, telomeric region; C:cytoplasm; C:interchromatin granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body; C:sex chromosome; C:site of double-strand break; C:Smc5-Smc6 complex;, F:ATP binding; F:ATPase activity;, P:cell division; P:cellular response to DNA damage stimulus; P:cellular senescence; P:chromosome condensation; P:double-strand break repair via homologous recombination; P:internal peptidyl-lysine acetylation; P:mitotic cell cycle phase transition; P:positive regulation of chromosome segregation; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:protein localization to chromosome, centromeric region; P:sister chromatid cohesion; P:stem cell population maintenance; P:telomere maintenance via recombination;|Q8IY18 A6NM81 O60335 Q05D92 Q5VZ60 Q96SB9,Structural maintenance of chromosomes protein 5,, PF02463;, GO:0030054;GO:0000775;GO:0000781;GO:0005737;GO:0035061;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0000803;GO:0035861;GO:0030915;GO:0005524;GO:0016887;GO:0051301;GO:0006974;GO:0090398;GO:0030261;GO:0000724;GO:0018393;GO:0044772;GO:0051984;GO:0034184;GO:0071459;GO:0007062;GO:0019827;GO:0000722;, C:cell junction; C:chromosome, centromeric region; C:chromosome, telomeric region; C:cytoplasm; C:interchromatin granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body; C:sex chromosome; C:site of double-strand break; C:Smc5-Smc6 complex;, F:ATP binding; F:ATPase activity;, P:cell division; P:cellular response to DNA damage stimulus; P:cellular senescence; P:chromosome condensation; P:double-strand break repair via homologous recombination; P:internal peptidyl-lysine acetylation; P:mitotic cell cycle phase transition; P:positive regulation of chromosome segregation; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:protein localization to chromosome, centromeric region; P:sister chromatid cohesion; P:stem cell population maintenance; P:telomere maintenance via recombination;|Q8IY18 A6NM81 O60335 Q05D92 Q5VZ60 Q96SB9,Structural maintenance of chromosomes protein 5,, PF02463;, GO:0030054;GO:0000775;GO:0000781;GO:0005737;GO:0035061;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0000803;GO:0035861;GO:0030915;GO:0005524;GO:0016887;GO:0051301;GO:0006974;GO:0090398;GO:0030261;GO:0000724;GO:0018393;GO:0044772;GO:0051984;GO:0034184;GO:0071459;GO:0007062;GO:0019827;GO:0000722;, C:cell junction; C:chromosome, centromeric region; C:chromosome, telomeric region; C:cytoplasm; C:interchromatin granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body; C:sex chromosome; C:site of double-strand break; C:Smc5-Smc6 complex;, F:ATP binding; F:ATPase activity;, P:cell division; P:cellular response to DNA damage stimulus; P:cellular senescence; P:chromosome condensation; P:double-strand break repair via homologous recombination; P:internal peptidyl-lysine acetylation; P:mitotic cell cycle phase transition; P:positive regulation of chromosome segregation; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:protein localization to chromosome, centromeric region; P:sister chromatid cohesion; P:stem cell population maintenance; P:telomere maintenance via recombination;|Q8IY18 A6NM81 O60335 Q05D92 Q5VZ60 Q96SB9,Structural maintenance of chromosomes protein 5,, PF02463;, GO:0030054;GO:0000775;GO:0000781;GO:0005737;GO:0035061;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0000803;GO:0035861;GO:0030915;GO:0005524;GO:0016887;GO:0051301;GO:0006974;GO:0090398;GO:0030261;GO:0000724;GO:0018393;GO:0044772;GO:0051984;GO:0034184;GO:0071459;GO:0007062;GO:0019827;GO:0000722;, C:cell junction; C:chromosome, centromeric region; C:chromosome, telomeric region; C:cytoplasm; C:interchromatin granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body; C:sex chromosome; C:site of double-strand break; C:Smc5-Smc6 complex;, F:ATP binding; F:ATPase activity;, P:cell division; P:cellular response to DNA damage stimulus; P:cellular senescence; P:chromosome condensation; P:double-strand break repair via homologous recombination; P:internal peptidyl-lysine acetylation; P:mitotic cell cycle phase transition; P:positive regulation of chromosome segregation; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:protein localization to chromosome, centromeric region; P:sister chromatid cohesion; P:stem cell population maintenance; P:telomere maintenance via recombination; scaffold2 indexed_genome mRNA 9059278 9150330 . - . ID=transcript_372;Q8IY18 A6NM81 O60335 Q05D92 Q5VZ60 Q96SB9,Structural maintenance of chromosomes protein 5,, PF02463;, GO:0030054;GO:0000775;GO:0000781;GO:0005737;GO:0035061;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0000803;GO:0035861;GO:0030915;GO:0005524;GO:0016887;GO:0051301;GO:0006974;GO:0090398;GO:0030261;GO:0000724;GO:0018393;GO:0044772;GO:0051984;GO:0034184;GO:0071459;GO:0007062;GO:0019827;GO:0000722;, C:cell junction; C:chromosome, centromeric region; C:chromosome, telomeric region; C:cytoplasm; C:interchromatin granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body; C:sex chromosome; C:site of double-strand break; C:Smc5-Smc6 complex;, F:ATP binding; F:ATPase activity;, P:cell division; P:cellular response to DNA damage stimulus; P:cellular senescence; P:chromosome condensation; P:double-strand break repair via homologous recombination; P:internal peptidyl-lysine acetylation; P:mitotic cell cycle phase transition; P:positive regulation of chromosome segregation; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:protein localization to chromosome, centromeric region; P:sister chromatid cohesion; P:stem cell population maintenance; P:telomere maintenance via recombination; scaffold2 indexed_genome mRNA 9162187 9314456 . - . ID=transcript_373;Q7Z304 Q5VW47 Q8WX43 Q96BM4,MAM domain-containing protein 2,MAM domain-containing proteoglycan;, PF00629;, GO:0005783;GO:0005576;GO:0016020;, C:endoplasmic reticulum; C:extracellular region; C:membrane;|Q7Z304 Q5VW47 Q8WX43 Q96BM4,MAM domain-containing protein 2,MAM domain-containing proteoglycan;, PF00629;, GO:0005783;GO:0005576;GO:0016020;, C:endoplasmic reticulum; C:extracellular region; C:membrane; scaffold2 indexed_genome mRNA 9626877 9668731 . + . ID=transcript_374;Q7Z6K3 Q5T7V5 Q5T7V6,Protein prenyltransferase alpha subunit repeat-containing protein 1,, PF01239;, GO:0005737;GO:0008318;GO:0018342;, C:cytoplasm;, F:protein prenyltransferase activity;, P:protein prenylation; scaffold2 indexed_genome mRNA 9894074 9934957 . + . ID=transcript_375;Q02410 O14914 O60570 Q5VYR8,Amyloid-beta A4 precursor protein-binding family A member 1,Adapter protein X11alpha;Neuron-specific X11 protein;Neuronal Munc18-1-interacting protein 1;, PF00595;PF00640;, GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0005794;GO:0005634;GO:0048471;GO:0005886;GO:0048787;GO:0098685;GO:0008021;GO:0001540;GO:0008088;GO:0007155;GO:0007268;GO:0014051;GO:0014047;GO:0001701;GO:0006886;GO:0007626;GO:0035264;GO:0007399;GO:0006836;GO:0065003;GO:0010468;GO:2000300;, C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:Golgi apparatus; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynaptic active zone membrane; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle;, F:amyloid-beta binding;, P:axo-dendritic transport; P:cell adhesion; P:chemical synaptic transmission; P:gamma-aminobutyric acid secretion; P:glutamate secretion; P:in utero embryonic development; P:intracellular protein transport; P:locomotory behavior; P:multicellular organism growth; P:nervous system development; P:neurotransmitter transport; P:protein-containing complex assembly; P:regulation of gene expression; P:regulation of synaptic vesicle exocytosis;|Q02410 O14914 O60570 Q5VYR8,Amyloid-beta A4 precursor protein-binding family A member 1,Adapter protein X11alpha;Neuron-specific X11 protein;Neuronal Munc18-1-interacting protein 1;, PF00595;PF00640;, GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0005794;GO:0005634;GO:0048471;GO:0005886;GO:0048787;GO:0098685;GO:0008021;GO:0001540;GO:0008088;GO:0007155;GO:0007268;GO:0014051;GO:0014047;GO:0001701;GO:0006886;GO:0007626;GO:0035264;GO:0007399;GO:0006836;GO:0065003;GO:0010468;GO:2000300;, C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:Golgi apparatus; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynaptic active zone membrane; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle;, F:amyloid-beta binding;, P:axo-dendritic transport; P:cell adhesion; P:chemical synaptic transmission; P:gamma-aminobutyric acid secretion; P:glutamate secretion; P:in utero embryonic development; P:intracellular protein transport; P:locomotory behavior; P:multicellular organism growth; P:nervous system development; P:neurotransmitter transport; P:protein-containing complex assembly; P:regulation of gene expression; P:regulation of synaptic vesicle exocytosis;|Q02410 O14914 O60570 Q5VYR8,Amyloid-beta A4 precursor protein-binding family A member 1,Adapter protein X11alpha;Neuron-specific X11 protein;Neuronal Munc18-1-interacting protein 1;, PF00595;PF00640;, GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0005794;GO:0005634;GO:0048471;GO:0005886;GO:0048787;GO:0098685;GO:0008021;GO:0001540;GO:0008088;GO:0007155;GO:0007268;GO:0014051;GO:0014047;GO:0001701;GO:0006886;GO:0007626;GO:0035264;GO:0007399;GO:0006836;GO:0065003;GO:0010468;GO:2000300;, C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:Golgi apparatus; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynaptic active zone membrane; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle;, F:amyloid-beta binding;, P:axo-dendritic transport; P:cell adhesion; P:chemical synaptic transmission; P:gamma-aminobutyric acid secretion; P:glutamate secretion; P:in utero embryonic development; P:intracellular protein transport; P:locomotory behavior; P:multicellular organism growth; P:nervous system development; P:neurotransmitter transport; P:protein-containing complex assembly; P:regulation of gene expression; P:regulation of synaptic vesicle exocytosis;|Q99767 E9PGI4 O60571 Q5XKC0,Amyloid-beta A4 precursor protein-binding family A member 2,Adapter protein X11beta;Neuron-specific X11L protein;Neuronal Munc18-1-interacting protein 2;, PF00595;PF00640;, GO:0005737;GO:0043197;GO:0005886;GO:0008021;GO:0001540;GO:0042802;GO:0007268;GO:0007399;GO:0015031;, C:cytoplasm; C:dendritic spine; C:plasma membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:identical protein binding;, P:chemical synaptic transmission; P:nervous system development; P:protein transport; scaffold2 indexed_genome mRNA 9963620 10033903 . - . ID=transcript_376;Q15884 Q14CN5 Q5T6C8 Q5T6C9 Q6ZTX4 Q96N10,Protein FAM189A2,Protein X123;, PF04103;, GO:0016021;, C:integral component of membrane;|Q15884 Q14CN5 Q5T6C8 Q5T6C9 Q6ZTX4 Q96N10,Protein FAM189A2,Protein X123;, PF04103;, GO:0016021;, C:integral component of membrane;|Q15884 Q14CN5 Q5T6C8 Q5T6C9 Q6ZTX4 Q96N10,Protein FAM189A2,Protein X123;, PF04103;, GO:0016021;, C:integral component of membrane; scaffold2 indexed_genome mRNA 10078061 10084850 . - . ID=transcript_377;Q8N756 Q8NI14 Q99839 Q9UDY0 Q9UDY1,Tight junction protein ZO-2,Tight junction protein 2;Zona occludens protein 2;Zonula occludens protein 2;, PF00625;PF00595;PF07653;, GO:0005912;GO:0005923;GO:0044291;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0050839;GO:0004385;GO:0019904;GO:1990782;GO:0030674;GO:0098609;GO:0045216;GO:0090557;GO:0035329;GO:0034109;GO:0050892;GO:0035633;GO:1905605;GO:0150105;GO:0090559;, C:adherens junction; C:bicellular tight junction; C:cell-cell contact zone; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:cell adhesion molecule binding; F:guanylate kinase activity; F:protein domain specific binding; F:protein tyrosine kinase binding; F:protein-macromolecule adaptor activity;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:homotypic cell-cell adhesion; P:intestinal absorption; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction; P:regulation of membrane permeability;|Q8N756 Q8NI14 Q99839 Q9UDY0 Q9UDY1,Tight junction protein ZO-2,Tight junction protein 2;Zona occludens protein 2;Zonula occludens protein 2;, PF00625;PF00595;PF07653;, GO:0005912;GO:0005923;GO:0044291;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0050839;GO:0004385;GO:0019904;GO:1990782;GO:0030674;GO:0098609;GO:0045216;GO:0090557;GO:0035329;GO:0034109;GO:0050892;GO:0035633;GO:1905605;GO:0150105;GO:0090559;, C:adherens junction; C:bicellular tight junction; C:cell-cell contact zone; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:cell adhesion molecule binding; F:guanylate kinase activity; F:protein domain specific binding; F:protein tyrosine kinase binding; F:protein-macromolecule adaptor activity;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:homotypic cell-cell adhesion; P:intestinal absorption; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction; P:regulation of membrane permeability;|Q8N756 Q8NI14 Q99839 Q9UDY0 Q9UDY1,Tight junction protein ZO-2,Tight junction protein 2;Zona occludens protein 2;Zonula occludens protein 2;, PF00625;PF00595;PF07653;, GO:0005912;GO:0005923;GO:0044291;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0050839;GO:0004385;GO:0019904;GO:1990782;GO:0030674;GO:0098609;GO:0045216;GO:0090557;GO:0035329;GO:0034109;GO:0050892;GO:0035633;GO:1905605;GO:0150105;GO:0090559;, C:adherens junction; C:bicellular tight junction; C:cell-cell contact zone; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:cell adhesion molecule binding; F:guanylate kinase activity; F:protein domain specific binding; F:protein tyrosine kinase binding; F:protein-macromolecule adaptor activity;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:homotypic cell-cell adhesion; P:intestinal absorption; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction; P:regulation of membrane permeability;|Q8N756 Q8NI14 Q99839 Q9UDY0 Q9UDY1,Tight junction protein ZO-2,Tight junction protein 2;Zona occludens protein 2;Zonula occludens protein 2;, PF00625;PF00595;PF07653;, GO:0005912;GO:0005923;GO:0044291;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0050839;GO:0004385;GO:0019904;GO:1990782;GO:0030674;GO:0098609;GO:0045216;GO:0090557;GO:0035329;GO:0034109;GO:0050892;GO:0035633;GO:1905605;GO:0150105;GO:0090559;, C:adherens junction; C:bicellular tight junction; C:cell-cell contact zone; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:cell adhesion molecule binding; F:guanylate kinase activity; F:protein domain specific binding; F:protein tyrosine kinase binding; F:protein-macromolecule adaptor activity;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:homotypic cell-cell adhesion; P:intestinal absorption; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction; P:regulation of membrane permeability;|Q8N756 Q8NI14 Q99839 Q9UDY0 Q9UDY1,Tight junction protein ZO-2,Tight junction protein 2;Zona occludens protein 2;Zonula occludens protein 2;, PF00625;PF00595;PF07653;, GO:0005912;GO:0005923;GO:0044291;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0050839;GO:0004385;GO:0019904;GO:1990782;GO:0030674;GO:0098609;GO:0045216;GO:0090557;GO:0035329;GO:0034109;GO:0050892;GO:0035633;GO:1905605;GO:0150105;GO:0090559;, C:adherens junction; C:bicellular tight junction; C:cell-cell contact zone; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:cell adhesion molecule binding; F:guanylate kinase activity; F:protein domain specific binding; F:protein tyrosine kinase binding; F:protein-macromolecule adaptor activity;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:homotypic cell-cell adhesion; P:intestinal absorption; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction; P:regulation of membrane permeability; scaffold2 indexed_genome mRNA 10084871 10203020 . - . ID=transcript_378;Q8N756 Q8NI14 Q99839 Q9UDY0 Q9UDY1,Tight junction protein ZO-2,Tight junction protein 2;Zona occludens protein 2;Zonula occludens protein 2;, PF00625;PF00595;PF07653;, GO:0005912;GO:0005923;GO:0044291;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0050839;GO:0004385;GO:0019904;GO:1990782;GO:0030674;GO:0098609;GO:0045216;GO:0090557;GO:0035329;GO:0034109;GO:0050892;GO:0035633;GO:1905605;GO:0150105;GO:0090559;, C:adherens junction; C:bicellular tight junction; C:cell-cell contact zone; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:cell adhesion molecule binding; F:guanylate kinase activity; F:protein domain specific binding; F:protein tyrosine kinase binding; F:protein-macromolecule adaptor activity;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:homotypic cell-cell adhesion; P:intestinal absorption; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction; P:regulation of membrane permeability;|Q8N756 Q8NI14 Q99839 Q9UDY0 Q9UDY1,Tight junction protein ZO-2,Tight junction protein 2;Zona occludens protein 2;Zonula occludens protein 2;, PF00625;PF00595;PF07653;, GO:0005912;GO:0005923;GO:0044291;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0050839;GO:0004385;GO:0019904;GO:1990782;GO:0030674;GO:0098609;GO:0045216;GO:0090557;GO:0035329;GO:0034109;GO:0050892;GO:0035633;GO:1905605;GO:0150105;GO:0090559;, C:adherens junction; C:bicellular tight junction; C:cell-cell contact zone; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:cell adhesion molecule binding; F:guanylate kinase activity; F:protein domain specific binding; F:protein tyrosine kinase binding; F:protein-macromolecule adaptor activity;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:homotypic cell-cell adhesion; P:intestinal absorption; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction; P:regulation of membrane permeability;|Q8N756 Q8NI14 Q99839 Q9UDY0 Q9UDY1,Tight junction protein ZO-2,Tight junction protein 2;Zona occludens protein 2;Zonula occludens protein 2;, PF00625;PF00595;PF07653;, GO:0005912;GO:0005923;GO:0044291;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0050839;GO:0004385;GO:0019904;GO:1990782;GO:0030674;GO:0098609;GO:0045216;GO:0090557;GO:0035329;GO:0034109;GO:0050892;GO:0035633;GO:1905605;GO:0150105;GO:0090559;, C:adherens junction; C:bicellular tight junction; C:cell-cell contact zone; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:cell adhesion molecule binding; F:guanylate kinase activity; F:protein domain specific binding; F:protein tyrosine kinase binding; F:protein-macromolecule adaptor activity;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:homotypic cell-cell adhesion; P:intestinal absorption; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction; P:regulation of membrane permeability; scaffold2 indexed_genome mRNA 10235289 10239440 . - . ID=transcript_379;Q16595 A8MXJ6 C9JJ89 O15545 O95656 Q15294 Q5VZ01,Frataxin, mitochondrial,Friedreich ataxia protein;, PF01491;, GO:0005829;GO:1990221;GO:0005759;GO:0005739;GO:0051537;GO:0008199;GO:0008198;GO:0004322;GO:0034986;GO:0007628;GO:0009060;GO:0006879;GO:0070301;GO:0009792;GO:0006783;GO:0006811;GO:0018283;GO:0016226;GO:0007005;GO:0043066;GO:0040015;GO:0046621;GO:0090201;GO:0006119;GO:1904234;GO:0043085;GO:0030307;GO:0008284;GO:0051349;GO:1904231;GO:0019230;GO:0016540;GO:0010722;GO:0010039;, C:cytosol; C:L-cysteine desulfurase complex; C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:ferric iron binding; F:ferrous iron binding; F:ferroxidase activity; F:iron chaperone activity;, P:adult walking behavior; P:aerobic respiration; P:cellular iron ion homeostasis; P:cellular response to hydrogen peroxide; P:embryo development ending in birth or egg hatching; P:heme biosynthetic process; P:ion transport; P:iron incorporation into metallo-sulfur cluster; P:iron-sulfur cluster assembly; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of multicellular organism growth; P:negative regulation of organ growth; P:negative regulation of release of cytochrome c from mitochondria; P:oxidative phosphorylation; P:positive regulation of aconitate hydratase activity; P:positive regulation of catalytic activity; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of lyase activity; P:positive regulation of succinate dehydrogenase activity; P:proprioception; P:protein autoprocessing; P:regulation of ferrochelatase activity; P:response to iron ion; scaffold2 indexed_genome mRNA 10240610 10252636 . - . ID=transcript_380;Q16595 A8MXJ6 C9JJ89 O15545 O95656 Q15294 Q5VZ01,Frataxin, mitochondrial,Friedreich ataxia protein;, PF01491;, GO:0005829;GO:1990221;GO:0005759;GO:0005739;GO:0051537;GO:0008199;GO:0008198;GO:0004322;GO:0034986;GO:0007628;GO:0009060;GO:0006879;GO:0070301;GO:0009792;GO:0006783;GO:0006811;GO:0018283;GO:0016226;GO:0007005;GO:0043066;GO:0040015;GO:0046621;GO:0090201;GO:0006119;GO:1904234;GO:0043085;GO:0030307;GO:0008284;GO:0051349;GO:1904231;GO:0019230;GO:0016540;GO:0010722;GO:0010039;, C:cytosol; C:L-cysteine desulfurase complex; C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:ferric iron binding; F:ferrous iron binding; F:ferroxidase activity; F:iron chaperone activity;, P:adult walking behavior; P:aerobic respiration; P:cellular iron ion homeostasis; P:cellular response to hydrogen peroxide; P:embryo development ending in birth or egg hatching; P:heme biosynthetic process; P:ion transport; P:iron incorporation into metallo-sulfur cluster; P:iron-sulfur cluster assembly; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of multicellular organism growth; P:negative regulation of organ growth; P:negative regulation of release of cytochrome c from mitochondria; P:oxidative phosphorylation; P:positive regulation of aconitate hydratase activity; P:positive regulation of catalytic activity; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of lyase activity; P:positive regulation of succinate dehydrogenase activity; P:proprioception; P:protein autoprocessing; P:regulation of ferrochelatase activity; P:response to iron ion;|Q16595 A8MXJ6 C9JJ89 O15545 O95656 Q15294 Q5VZ01,Frataxin, mitochondrial,Friedreich ataxia protein;, PF01491;, GO:0005829;GO:1990221;GO:0005759;GO:0005739;GO:0051537;GO:0008199;GO:0008198;GO:0004322;GO:0034986;GO:0007628;GO:0009060;GO:0006879;GO:0070301;GO:0009792;GO:0006783;GO:0006811;GO:0018283;GO:0016226;GO:0007005;GO:0043066;GO:0040015;GO:0046621;GO:0090201;GO:0006119;GO:1904234;GO:0043085;GO:0030307;GO:0008284;GO:0051349;GO:1904231;GO:0019230;GO:0016540;GO:0010722;GO:0010039;, C:cytosol; C:L-cysteine desulfurase complex; C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:ferric iron binding; F:ferrous iron binding; F:ferroxidase activity; F:iron chaperone activity;, P:adult walking behavior; P:aerobic respiration; P:cellular iron ion homeostasis; P:cellular response to hydrogen peroxide; P:embryo development ending in birth or egg hatching; P:heme biosynthetic process; P:ion transport; P:iron incorporation into metallo-sulfur cluster; P:iron-sulfur cluster assembly; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of multicellular organism growth; P:negative regulation of organ growth; P:negative regulation of release of cytochrome c from mitochondria; P:oxidative phosphorylation; P:positive regulation of aconitate hydratase activity; P:positive regulation of catalytic activity; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of lyase activity; P:positive regulation of succinate dehydrogenase activity; P:proprioception; P:protein autoprocessing; P:regulation of ferrochelatase activity; P:response to iron ion; scaffold2 indexed_genome mRNA 10320548 10540658 . - . ID=transcript_381;Q7KYT5 Q8NHQ5 Q92749,Phosphatidylinositol 4-phosphate 5-kinase type-1 beta {ECO:0000305|PubMed:8955136},Phosphatidylinositol 4-phosphate 5-kinase type I beta {ECO:0000305|PubMed:8955136};Protein STM-7 {ECO:0000303|PubMed:8841185};Type I phosphatidylinositol 4-phosphate 5-kinase beta {ECO:0000305|PubMed:8955136};, PF01504;, GO:0005829;GO:0012505;GO:0005886;GO:0001931;GO:0016308;GO:0005524;GO:0006661;GO:0014066;, C:cytosol; C:endomembrane system; C:plasma membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling;|Q7KYT5 Q8NHQ5 Q92749,Phosphatidylinositol 4-phosphate 5-kinase type-1 beta {ECO:0000305|PubMed:8955136},Phosphatidylinositol 4-phosphate 5-kinase type I beta {ECO:0000305|PubMed:8955136};Protein STM-7 {ECO:0000303|PubMed:8841185};Type I phosphatidylinositol 4-phosphate 5-kinase beta {ECO:0000305|PubMed:8955136};, PF01504;, GO:0005829;GO:0012505;GO:0005886;GO:0001931;GO:0016308;GO:0005524;GO:0006661;GO:0014066;, C:cytosol; C:endomembrane system; C:plasma membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling;|Q7KYT5 Q8NHQ5 Q92749,Phosphatidylinositol 4-phosphate 5-kinase type-1 beta {ECO:0000305|PubMed:8955136},Phosphatidylinositol 4-phosphate 5-kinase type I beta {ECO:0000305|PubMed:8955136};Protein STM-7 {ECO:0000303|PubMed:8841185};Type I phosphatidylinositol 4-phosphate 5-kinase beta {ECO:0000305|PubMed:8955136};, PF01504;, GO:0005829;GO:0012505;GO:0005886;GO:0001931;GO:0016308;GO:0005524;GO:0006661;GO:0014066;, C:cytosol; C:endomembrane system; C:plasma membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling; scaffold2 indexed_genome mRNA 10566146 10570892 . - . ID=transcript_382;Q96E09,PPP2R1A-PPP2R2A-interacting phosphatase regulator 1 {ECO:0000303|PubMed:33108758, ECO:0000312|HGNC:HGNC:23490},PABIR family member 1 {ECO:0000305};, , GO:0005737;GO:0005634;GO:0004865;GO:0044818;GO:0030307;GO:0032436;, C:cytoplasm; C:nucleus;, F:protein serine/threonine phosphatase inhibitor activity;, P:mitotic G2/M transition checkpoint; P:positive regulation of cell growth; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; scaffold2 indexed_genome mRNA 11161725 11383690 . + . ID=transcript_383;Q8WUY2 Q9BYJ5 Q9H1Q2 Q9H1Q3 Q9H308 Q9H7P2,Dedicator of cytokinesis protein 8,, PF06920;PF14429;PF11878;, GO:0005737;GO:0031258;GO:0031256;GO:0016020;GO:0005085;GO:1990869;GO:0036336;GO:0001771;GO:0061485;GO:0070233;GO:1903905;GO:0043547;GO:2000406;GO:0007264;, C:cytoplasm; C:lamellipodium membrane; C:leading edge membrane; C:membrane;, F:guanyl-nucleotide exchange factor activity;, P:cellular response to chemokine; P:dendritic cell migration; P:immunological synapse formation; P:memory T cell proliferation; P:negative regulation of T cell apoptotic process; P:positive regulation of establishment of T cell polarity; P:positive regulation of GTPase activity; P:positive regulation of T cell migration; P:small GTPase mediated signal transduction; scaffold2 indexed_genome mRNA 11605078 11622929 . + . ID=transcript_384;Q14678 A2A2W8 D3DRH3 Q5W0W0 Q8IY65 Q8WX74,KN motif and ankyrin repeat domain-containing protein 1,Ankyrin repeat domain-containing protein 15;Kidney ankyrin repeat-containing protein;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0005634;GO:0005886;GO:0032587;GO:0008013;GO:0030036;GO:0008283;GO:0090521;GO:0030837;GO:0030336;GO:0046627;GO:2000393;GO:0010977;GO:0035024;GO:1900028;GO:1900025;GO:0090263;GO:0030177;GO:0090303;GO:2000114;GO:0035023;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:plasma membrane; C:ruffle membrane;, F:beta-catenin binding;, P:actin cytoskeleton organization; P:cell population proliferation; P:glomerular visceral epithelial cell migration; P:negative regulation of actin filament polymerization; P:negative regulation of cell migration; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lamellipodium morphogenesis; P:negative regulation of neuron projection development; P:negative regulation of Rho protein signal transduction; P:negative regulation of ruffle assembly; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Wnt signaling pathway; P:positive regulation of wound healing; P:regulation of establishment of cell polarity; P:regulation of Rho protein signal transduction; scaffold2 indexed_genome mRNA 11625838 11633803 . + . ID=transcript_385;Q14678 A2A2W8 D3DRH3 Q5W0W0 Q8IY65 Q8WX74,KN motif and ankyrin repeat domain-containing protein 1,Ankyrin repeat domain-containing protein 15;Kidney ankyrin repeat-containing protein;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0005634;GO:0005886;GO:0032587;GO:0008013;GO:0030036;GO:0008283;GO:0090521;GO:0030837;GO:0030336;GO:0046627;GO:2000393;GO:0010977;GO:0035024;GO:1900028;GO:1900025;GO:0090263;GO:0030177;GO:0090303;GO:2000114;GO:0035023;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:plasma membrane; C:ruffle membrane;, F:beta-catenin binding;, P:actin cytoskeleton organization; P:cell population proliferation; P:glomerular visceral epithelial cell migration; P:negative regulation of actin filament polymerization; P:negative regulation of cell migration; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lamellipodium morphogenesis; P:negative regulation of neuron projection development; P:negative regulation of Rho protein signal transduction; P:negative regulation of ruffle assembly; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Wnt signaling pathway; P:positive regulation of wound healing; P:regulation of establishment of cell polarity; P:regulation of Rho protein signal transduction;|Q14678 A2A2W8 D3DRH3 Q5W0W0 Q8IY65 Q8WX74,KN motif and ankyrin repeat domain-containing protein 1,Ankyrin repeat domain-containing protein 15;Kidney ankyrin repeat-containing protein;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0005634;GO:0005886;GO:0032587;GO:0008013;GO:0030036;GO:0008283;GO:0090521;GO:0030837;GO:0030336;GO:0046627;GO:2000393;GO:0010977;GO:0035024;GO:1900028;GO:1900025;GO:0090263;GO:0030177;GO:0090303;GO:2000114;GO:0035023;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:plasma membrane; C:ruffle membrane;, F:beta-catenin binding;, P:actin cytoskeleton organization; P:cell population proliferation; P:glomerular visceral epithelial cell migration; P:negative regulation of actin filament polymerization; P:negative regulation of cell migration; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lamellipodium morphogenesis; P:negative regulation of neuron projection development; P:negative regulation of Rho protein signal transduction; P:negative regulation of ruffle assembly; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Wnt signaling pathway; P:positive regulation of wound healing; P:regulation of establishment of cell polarity; P:regulation of Rho protein signal transduction;|Q14678 A2A2W8 D3DRH3 Q5W0W0 Q8IY65 Q8WX74,KN motif and ankyrin repeat domain-containing protein 1,Ankyrin repeat domain-containing protein 15;Kidney ankyrin repeat-containing protein;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0005634;GO:0005886;GO:0032587;GO:0008013;GO:0030036;GO:0008283;GO:0090521;GO:0030837;GO:0030336;GO:0046627;GO:2000393;GO:0010977;GO:0035024;GO:1900028;GO:1900025;GO:0090263;GO:0030177;GO:0090303;GO:2000114;GO:0035023;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:plasma membrane; C:ruffle membrane;, F:beta-catenin binding;, P:actin cytoskeleton organization; P:cell population proliferation; P:glomerular visceral epithelial cell migration; P:negative regulation of actin filament polymerization; P:negative regulation of cell migration; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lamellipodium morphogenesis; P:negative regulation of neuron projection development; P:negative regulation of Rho protein signal transduction; P:negative regulation of ruffle assembly; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Wnt signaling pathway; P:positive regulation of wound healing; P:regulation of establishment of cell polarity; P:regulation of Rho protein signal transduction;|Q14678 A2A2W8 D3DRH3 Q5W0W0 Q8IY65 Q8WX74,KN motif and ankyrin repeat domain-containing protein 1,Ankyrin repeat domain-containing protein 15;Kidney ankyrin repeat-containing protein;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0005634;GO:0005886;GO:0032587;GO:0008013;GO:0030036;GO:0008283;GO:0090521;GO:0030837;GO:0030336;GO:0046627;GO:2000393;GO:0010977;GO:0035024;GO:1900028;GO:1900025;GO:0090263;GO:0030177;GO:0090303;GO:2000114;GO:0035023;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:plasma membrane; C:ruffle membrane;, F:beta-catenin binding;, P:actin cytoskeleton organization; P:cell population proliferation; P:glomerular visceral epithelial cell migration; P:negative regulation of actin filament polymerization; P:negative regulation of cell migration; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lamellipodium morphogenesis; P:negative regulation of neuron projection development; P:negative regulation of Rho protein signal transduction; P:negative regulation of ruffle assembly; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Wnt signaling pathway; P:positive regulation of wound healing; P:regulation of establishment of cell polarity; P:regulation of Rho protein signal transduction; scaffold2 indexed_genome mRNA 12940150 12941272 . + . ID=transcript_386;P51531 B1ALG3 B1ALG4 D3DRH4 D3DRH5,Probable global transcription activator SNF2L2,ATP-dependent helicase SMARCA2;BRG1-associated factor 190B;Protein brahma homolog;SNF2-alpha;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 {ECO:0000312|HGNC:HGNC:11098};, PF07533;PF00439;PF00271;PF07529;PF08880;PF14619;PF00176;, GO:0000785;GO:0045111;GO:0043231;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0005524;GO:0003682;GO:0003677;GO:0008094;GO:0004386;GO:0042393;GO:0070615;GO:0003713;GO:0000976;GO:0043044;GO:0006338;GO:0030308;GO:0008285;GO:0000122;GO:0045892;GO:0007399;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0007286;, C:chromatin; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:histone binding; F:nucleosome-dependent ATPase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatid development; scaffold2 indexed_genome mRNA 12949223 12950533 . + . ID=transcript_387;P51531 B1ALG3 B1ALG4 D3DRH4 D3DRH5,Probable global transcription activator SNF2L2,ATP-dependent helicase SMARCA2;BRG1-associated factor 190B;Protein brahma homolog;SNF2-alpha;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 {ECO:0000312|HGNC:HGNC:11098};, PF07533;PF00439;PF00271;PF07529;PF08880;PF14619;PF00176;, GO:0000785;GO:0045111;GO:0043231;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0005524;GO:0003682;GO:0003677;GO:0008094;GO:0004386;GO:0042393;GO:0070615;GO:0003713;GO:0000976;GO:0043044;GO:0006338;GO:0030308;GO:0008285;GO:0000122;GO:0045892;GO:0007399;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0007286;, C:chromatin; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:histone binding; F:nucleosome-dependent ATPase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatid development; scaffold2 indexed_genome mRNA 13243821 14635124 . - . ID=transcript_388;Q8NEA6 B1AL19 Q1PHK5,Zinc finger protein GLIS3,GLI-similar 3;Zinc finger protein 515;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0000122;GO:0045944;GO:0006357;GO:0006366;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|P98155 B2RMZ7 D3DRH6 Q5VVF6,Very low-density lipoprotein receptor,, PF07645;PF00057;PF00058;, GO:0005905;GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0043235;GO:0034361;GO:0034185;GO:0005509;GO:0048306;GO:0038024;GO:0005041;GO:0038025;GO:0034189;GO:0030229;GO:0007411;GO:0008203;GO:0048813;GO:0034436;GO:0006869;GO:0032802;GO:0007613;GO:0007399;GO:1900006;GO:0045860;GO:0006898;GO:0038026;GO:0007165;GO:0021517;GO:0034447;, C:clathrin-coated pit; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:receptor complex; C:very-low-density lipoprotein particle;, F:apolipoprotein binding; F:calcium ion binding; F:calcium-dependent protein binding; F:cargo receptor activity; F:low-density lipoprotein particle receptor activity; F:reelin receptor activity; F:very-low-density lipoprotein particle binding; F:very-low-density lipoprotein particle receptor activity;, P:axon guidance; P:cholesterol metabolic process; P:dendrite morphogenesis; P:glycoprotein transport; P:lipid transport; P:low-density lipoprotein particle receptor catabolic process; P:memory; P:nervous system development; P:positive regulation of dendrite development; P:positive regulation of protein kinase activity; P:receptor-mediated endocytosis; P:reelin-mediated signaling pathway; P:signal transduction; P:ventral spinal cord development; P:very-low-density lipoprotein particle clearance;|P98155 B2RMZ7 D3DRH6 Q5VVF6,Very low-density lipoprotein receptor,, PF07645;PF00057;PF00058;, GO:0005905;GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0043235;GO:0034361;GO:0034185;GO:0005509;GO:0048306;GO:0038024;GO:0005041;GO:0038025;GO:0034189;GO:0030229;GO:0007411;GO:0008203;GO:0048813;GO:0034436;GO:0006869;GO:0032802;GO:0007613;GO:0007399;GO:1900006;GO:0045860;GO:0006898;GO:0038026;GO:0007165;GO:0021517;GO:0034447;, C:clathrin-coated pit; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:receptor complex; C:very-low-density lipoprotein particle;, F:apolipoprotein binding; F:calcium ion binding; F:calcium-dependent protein binding; F:cargo receptor activity; F:low-density lipoprotein particle receptor activity; F:reelin receptor activity; F:very-low-density lipoprotein particle binding; F:very-low-density lipoprotein particle receptor activity;, P:axon guidance; P:cholesterol metabolic process; P:dendrite morphogenesis; P:glycoprotein transport; P:lipid transport; P:low-density lipoprotein particle receptor catabolic process; P:memory; P:nervous system development; P:positive regulation of dendrite development; P:positive regulation of protein kinase activity; P:receptor-mediated endocytosis; P:reelin-mediated signaling pathway; P:signal transduction; P:ventral spinal cord development; P:very-low-density lipoprotein particle clearance;|Q15397 A8K804 Q547G7 Q5SZY9 Q6IB47 Q96B27 Q96L78 Q96L79 Q96L80,Pumilio homolog 3 {ECO:0000305},HBV X-transactivated gene 5 protein;HBV XAg-transactivated protein 5;Minor histocompatibility antigen HA-8;, PF08144;, GO:0005694;GO:0005783;GO:0005730;GO:0005654;GO:0003677;GO:0003729;GO:0003723;GO:0010835;GO:0006417;, C:chromosome; C:endoplasmic reticulum; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:regulation of protein ADP-ribosylation; P:regulation of translation;|Q95HL6,Transcription factor RFX3,Regulatory factor X 3;, PF04589;PF02257;, GO:0000785;GO:0005576;GO:0005634;GO:0005667;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0048469;GO:0060271;GO:0060285;GO:0031018;GO:0060287;GO:0045892;GO:0045944;GO:0045893;GO:2000078;GO:0050796;GO:0006357;GO:0006355;GO:0006351;GO:0072560;, C:chromatin; C:extracellular region; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell maturation; P:cilium assembly; P:cilium-dependent cell motility; P:endocrine pancreas development; P:epithelial cilium movement involved in determination of left/right asymmetry; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type B pancreatic cell development; P:regulation of insulin secretion; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; P:type B pancreatic cell maturation; scaffold2 indexed_genome mRNA 15187196 15260339 . + . ID=transcript_389;P43005 O75587 Q5VZ24 Q8N199 Q9UEW2,Excitatory amino acid transporter 3,Excitatory amino-acid carrier 1;Neuronal and epithelial glutamate transporter;Sodium-dependent glutamate/aspartate transporter 3;Solute carrier family 1 member 1;, PF00375;, GO:0097440;GO:0016324;GO:0032279;GO:0030424;GO:0043679;GO:0071944;GO:0009986;GO:0030425;GO:0043198;GO:0043197;GO:0150002;GO:0031901;GO:0005783;GO:0070062;GO:0097386;GO:0016021;GO:0005887;GO:0031902;GO:0016020;GO:0045121;GO:0043025;GO:0043204;GO:0099544;GO:0005886;GO:0098793;GO:1990635;GO:0055038;GO:0043083;GO:0005253;GO:0015108;GO:0033229;GO:0140010;GO:0016595;GO:0015501;GO:0005314;GO:0042802;GO:0015183;GO:0005313;GO:0046872;GO:0006919;GO:0032148;GO:0001662;GO:0048514;GO:0071242;GO:0071288;GO:0071407;GO:0006882;GO:0007268;GO:1902476;GO:1990708;GO:0042883;GO:0070779;GO:0070777;GO:0042417;GO:0007212;GO:0010467;GO:0090461;GO:0007215;GO:0006750;GO:0007625;GO:0060047;GO:0006811;GO:0140009;GO:0070778;GO:0051938;GO:0098712;GO:0015813;GO:0007626;GO:0060291;GO:0035633;GO:0061744;GO:0097049;GO:0043524;GO:0022008;GO:0036475;GO:0098877;GO:0006836;GO:0018105;GO:0010460;GO:0090313;GO:0001975;GO:0072347;GO:0048678;GO:0036293;GO:0043278;GO:0010842;GO:0060013;GO:0070633;GO:0150104;, C:apical dendrite; C:apical plasma membrane; C:asymmetric synapse; C:axon; C:axon terminus; C:cell periphery; C:cell surface; C:dendrite; C:dendritic shaft; C:dendritic spine; C:distal dendrite; C:early endosome membrane; C:endoplasmic reticulum; C:extracellular exosome; C:glial cell projection; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:membrane; C:membrane raft; C:neuronal cell body; C:perikaryon; C:perisynaptic space; C:plasma membrane; C:presynapse; C:proximal dendrite; C:recycling endosome membrane; C:synaptic cleft;, F:anion channel activity; F:chloride transmembrane transporter activity; F:cysteine transmembrane transporter activity; F:D-aspartate transmembrane transporter activity; F:glutamate binding; F:glutamate:sodium symporter activity; F:high-affinity glutamate transmembrane transporter activity; F:identical protein binding; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:metal ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of protein kinase B activity; P:behavioral fear response; P:blood vessel morphogenesis; P:cellular response to ammonium ion; P:cellular response to mercury ion; P:cellular response to organic cyclic compound; P:cellular zinc ion homeostasis; P:chemical synaptic transmission; P:chloride transmembrane transport; P:conditioned place preference; P:cysteine transport; P:D-aspartate import across plasma membrane; P:D-aspartate transport; P:dopamine metabolic process; P:dopamine receptor signaling pathway; P:gene expression; P:glutamate homeostasis; P:glutamate receptor signaling pathway; P:glutathione biosynthetic process; P:grooming behavior; P:heart contraction; P:ion transport; P:L-aspartate import across plasma membrane; P:L-aspartate transmembrane transport; P:L-glutamate import; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:locomotory behavior; P:long-term synaptic potentiation; P:maintenance of blood-brain barrier; P:motor behavior; P:motor neuron apoptotic process; P:negative regulation of neuron apoptotic process; P:neurogenesis; P:neuron death in response to oxidative stress; P:neurotransmitter receptor transport to plasma membrane; P:neurotransmitter transport; P:peptidyl-serine phosphorylation; P:positive regulation of heart rate; P:regulation of protein targeting to membrane; P:response to amphetamine; P:response to anesthetic; P:response to axon injury; P:response to decreased oxygen levels; P:response to morphine; P:retina layer formation; P:righting reflex; P:transepithelial transport; P:transport across blood-brain barrier; scaffold2 indexed_genome mRNA 15273550 15354414 . - . ID=transcript_390;Q8N4H0 B4DIY4 Q5JVJ5 Q8IY90,Spermatogenesis associated 6-like protein,, PF14909;, GO:0097224;GO:0032027;GO:0007283;, C:sperm connecting piece;, F:myosin light chain binding;, P:spermatogenesis;|Q8IY26 B3KY05 Q5JVJ6 Q8NCK9,Phospholipid phosphatase 6 {ECO:0000312|HGNC:HGNC:23682},Phosphatidic acid phosphatase type 2 domain-containing protein 2;Presqualene diphosphate phosphatase;, PF01569;, GO:0016021;GO:0016020;GO:0005886;GO:0042577;GO:0042392;GO:0006695;GO:0046839;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:lipid phosphatase activity; F:sphingosine-1-phosphate phosphatase activity;, P:cholesterol biosynthetic process; P:phospholipid dephosphorylation; scaffold2 indexed_genome mRNA 15354477 15374952 . + . ID=transcript_391;Q7L3B6 B1AL70 Q9NWS3 Q9NX16,Hsp90 co-chaperone Cdc37-like 1,Hsp90-associating relative of Cdc37;, PF08565;, GO:0005737;GO:0005829;GO:0005576;GO:0031089;GO:0051087;GO:0031072;GO:0051082;GO:0002576;GO:0006457;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular region; C:platelet dense granule lumen;, F:chaperone binding; F:heat shock protein binding; F:unfolded protein binding;, P:platelet degranulation; P:protein folding; P:protein stabilization;|Q7L3B6 B1AL70 Q9NWS3 Q9NX16,Hsp90 co-chaperone Cdc37-like 1,Hsp90-associating relative of Cdc37;, PF08565;, GO:0005737;GO:0005829;GO:0005576;GO:0031089;GO:0051087;GO:0031072;GO:0051082;GO:0002576;GO:0006457;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular region; C:platelet dense granule lumen;, F:chaperone binding; F:heat shock protein binding; F:unfolded protein binding;, P:platelet degranulation; P:protein folding; P:protein stabilization;|Q7L3B6 B1AL70 Q9NWS3 Q9NX16,Hsp90 co-chaperone Cdc37-like 1,Hsp90-associating relative of Cdc37;, PF08565;, GO:0005737;GO:0005829;GO:0005576;GO:0031089;GO:0051087;GO:0031072;GO:0051082;GO:0002576;GO:0006457;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular region; C:platelet dense granule lumen;, F:chaperone binding; F:heat shock protein binding; F:unfolded protein binding;, P:platelet degranulation; P:protein folding; P:protein stabilization; scaffold2 indexed_genome mRNA 15375746 15396974 . - . ID=transcript_392;Q9UIJ7 B4DP58 D3DRI1 E7ET30 Q5VYW6 Q9H576 Q9HC01 Q9NPB4,GTP:AMP phosphotransferase AK3, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03169},Adenylate kinase 3 {ECO:0000255|HAMAP-Rule:MF_03169};Adenylate kinase 3 alpha-like 1 {ECO:0000255|HAMAP-Rule:MF_03169};, PF05191;, GO:0005737;GO:0005759;GO:0005739;GO:0005524;GO:0005525;GO:0046899;GO:0006172;GO:0046033;GO:0007596;GO:0046039;GO:0046041;GO:0046940;GO:0009142;GO:0046051;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:GTP binding; F:nucleoside triphosphate adenylate kinase activity;, P:ADP biosynthetic process; P:AMP metabolic process; P:blood coagulation; P:GTP metabolic process; P:ITP metabolic process; P:nucleoside monophosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:UTP metabolic process;|Q9UIJ7 B4DP58 D3DRI1 E7ET30 Q5VYW6 Q9H576 Q9HC01 Q9NPB4,GTP:AMP phosphotransferase AK3, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03169},Adenylate kinase 3 {ECO:0000255|HAMAP-Rule:MF_03169};Adenylate kinase 3 alpha-like 1 {ECO:0000255|HAMAP-Rule:MF_03169};, PF05191;, GO:0005737;GO:0005759;GO:0005739;GO:0005524;GO:0005525;GO:0046899;GO:0006172;GO:0046033;GO:0007596;GO:0046039;GO:0046041;GO:0046940;GO:0009142;GO:0046051;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:GTP binding; F:nucleoside triphosphate adenylate kinase activity;, P:ADP biosynthetic process; P:AMP metabolic process; P:blood coagulation; P:GTP metabolic process; P:ITP metabolic process; P:nucleoside monophosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:UTP metabolic process; scaffold2 indexed_genome mRNA 15449019 15513507 . + . ID=transcript_393;Q9Y2P8 D3DRI2 Q5VYW9 Q5VZU1 Q9H9D0 Q9NY00 Q9P044,RNA 3'-terminal phosphate cyclase-like protein,, PF01137;PF05189;, GO:0005730;GO:0005654;GO:0004521;GO:0000480;GO:0000447;GO:0000479;GO:0006364;, C:nucleolus; C:nucleoplasm;, F:endoribonuclease activity;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9Y2P8 D3DRI2 Q5VYW9 Q5VZU1 Q9H9D0 Q9NY00 Q9P044,RNA 3'-terminal phosphate cyclase-like protein,, PF01137;PF05189;, GO:0005730;GO:0005654;GO:0004521;GO:0000480;GO:0000447;GO:0000479;GO:0006364;, C:nucleolus; C:nucleoplasm;, F:endoribonuclease activity;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9Y2P8 D3DRI2 Q5VYW9 Q5VZU1 Q9H9D0 Q9NY00 Q9P044,RNA 3'-terminal phosphate cyclase-like protein,, PF01137;PF05189;, GO:0005730;GO:0005654;GO:0004521;GO:0000480;GO:0000447;GO:0000479;GO:0006364;, C:nucleolus; C:nucleoplasm;, F:endoribonuclease activity;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9Y2P8 D3DRI2 Q5VYW9 Q5VZU1 Q9H9D0 Q9NY00 Q9P044,RNA 3'-terminal phosphate cyclase-like protein,, PF01137;PF05189;, GO:0005730;GO:0005654;GO:0004521;GO:0000480;GO:0000447;GO:0000479;GO:0006364;, C:nucleolus; C:nucleoplasm;, F:endoribonuclease activity;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9Y2P8 D3DRI2 Q5VYW9 Q5VZU1 Q9H9D0 Q9NY00 Q9P044,RNA 3'-terminal phosphate cyclase-like protein,, PF01137;PF05189;, GO:0005730;GO:0005654;GO:0004521;GO:0000480;GO:0000447;GO:0000479;GO:0006364;, C:nucleolus; C:nucleoplasm;, F:endoribonuclease activity;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9Y2P8 D3DRI2 Q5VYW9 Q5VZU1 Q9H9D0 Q9NY00 Q9P044,RNA 3'-terminal phosphate cyclase-like protein,, PF01137;PF05189;, GO:0005730;GO:0005654;GO:0004521;GO:0000480;GO:0000447;GO:0000479;GO:0006364;, C:nucleolus; C:nucleoplasm;, F:endoribonuclease activity;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing; scaffold2 indexed_genome mRNA 15663162 15774814 . + . ID=transcript_394;O60674 O14636 O75297,Tyrosine-protein kinase JAK2 {ECO:0000305},Janus kinase 2;, PF18379;PF18377;PF17887;PF07714;PF00017;, GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0031904;GO:0000791;GO:0005925;GO:0098978;GO:0045121;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0098794;GO:0033130;GO:0005524;GO:0005131;GO:0020037;GO:0042393;GO:0035401;GO:0042802;GO:0043560;GO:0005143;GO:0046872;GO:0051428;GO:0043548;GO:0008022;GO:0004672;GO:0019901;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0031702;GO:0030041;GO:0006919;GO:0097296;GO:0042976;GO:0000186;GO:0002250;GO:0006915;GO:0031103;GO:0007596;GO:0030154;GO:0019221;GO:0007167;GO:0030218;GO:0097191;GO:0007186;GO:0060396;GO:0060397;GO:0035409;GO:0060333;GO:0035722;GO:0038155;GO:0070106;GO:0070757;GO:0070102;GO:0035556;GO:0008631;GO:0061180;GO:0000165;GO:0007498;GO:0001774;GO:0031959;GO:0050804;GO:0010667;GO:0008285;GO:0022408;GO:0043392;GO:0045822;GO:0043524;GO:0018108;GO:0048008;GO:0050867;GO:0045597;GO:0030335;GO:0010811;GO:0120162;GO:0007204;GO:0043388;GO:0051091;GO:1904037;GO:1902728;GO:0060399;GO:0050729;GO:0032024;GO:0032731;GO:0045348;GO:0045429;GO:0051770;GO:0050731;GO:0014068;GO:0032516;GO:0042307;GO:0046579;GO:2000273;GO:0060391;GO:0032760;GO:0042531;GO:1904707;GO:0099527;GO:0046777;GO:0006468;GO:0007259;GO:0042981;GO:0050727;GO:0060334;GO:0045428;GO:0046425;GO:0046677;GO:0033194;GO:0070671;GO:0032496;GO:0034612;GO:0007165;GO:0033209;GO:0007260;, C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome lumen; C:euchromatin; C:focal adhesion; C:glutamatergic synapse; C:membrane raft; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynapse;, F:acetylcholine receptor binding; F:ATP binding; F:growth hormone receptor binding; F:heme binding; F:histone binding; F:histone kinase activity (H3-Y41 specific); F:identical protein binding; F:insulin receptor substrate binding; F:interleukin-12 receptor binding; F:metal ion binding; F:peptide hormone receptor binding; F:phosphatidylinositol 3-kinase binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:type 1 angiotensin receptor binding;, P:actin filament polymerization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:activation of Janus kinase activity; P:activation of MAPKK activity; P:adaptive immune response; P:apoptotic process; P:axon regeneration; P:blood coagulation; P:cell differentiation; P:cytokine-mediated signaling pathway; P:enzyme linked receptor protein signaling pathway; P:erythrocyte differentiation; P:extrinsic apoptotic signaling pathway; P:G protein-coupled receptor signaling pathway; P:growth hormone receptor signaling pathway; P:growth hormone receptor signaling pathway via JAK-STAT; P:histone H3-Y41 phosphorylation; P:interferon-gamma-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:mammary gland epithelium development; P:MAPK cascade; P:mesoderm development; P:microglial cell activation; P:mineralocorticoid receptor signaling pathway; P:modulation of chemical synaptic transmission; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of DNA binding; P:negative regulation of heart contraction; P:negative regulation of neuron apoptotic process; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell activation; P:positive regulation of cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA binding; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of epithelial cell apoptotic process; P:positive regulation of growth factor dependent skeletal muscle satellite cell proliferation; P:positive regulation of growth hormone receptor signaling pathway; P:positive regulation of inflammatory response; P:positive regulation of insulin secretion; P:positive regulation of interleukin-1 beta production; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein import into nucleus; P:positive regulation of Ras protein signal transduction; P:positive regulation of signaling receptor activity; P:positive regulation of SMAD protein signal transduction; P:positive regulation of tumor necrosis factor production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of vascular associated smooth muscle cell proliferation; P:postsynapse to nucleus signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:receptor signaling pathway via JAK-STAT; P:regulation of apoptotic process; P:regulation of inflammatory response; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of nitric oxide biosynthetic process; P:regulation of receptor signaling pathway via JAK-STAT; P:response to antibiotic; P:response to hydroperoxide; P:response to interleukin-12; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; P:tyrosine phosphorylation of STAT protein;|O60674 O14636 O75297,Tyrosine-protein kinase JAK2 {ECO:0000305},Janus kinase 2;, PF18379;PF18377;PF17887;PF07714;PF00017;, GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0031904;GO:0000791;GO:0005925;GO:0098978;GO:0045121;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0098794;GO:0033130;GO:0005524;GO:0005131;GO:0020037;GO:0042393;GO:0035401;GO:0042802;GO:0043560;GO:0005143;GO:0046872;GO:0051428;GO:0043548;GO:0008022;GO:0004672;GO:0019901;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0031702;GO:0030041;GO:0006919;GO:0097296;GO:0042976;GO:0000186;GO:0002250;GO:0006915;GO:0031103;GO:0007596;GO:0030154;GO:0019221;GO:0007167;GO:0030218;GO:0097191;GO:0007186;GO:0060396;GO:0060397;GO:0035409;GO:0060333;GO:0035722;GO:0038155;GO:0070106;GO:0070757;GO:0070102;GO:0035556;GO:0008631;GO:0061180;GO:0000165;GO:0007498;GO:0001774;GO:0031959;GO:0050804;GO:0010667;GO:0008285;GO:0022408;GO:0043392;GO:0045822;GO:0043524;GO:0018108;GO:0048008;GO:0050867;GO:0045597;GO:0030335;GO:0010811;GO:0120162;GO:0007204;GO:0043388;GO:0051091;GO:1904037;GO:1902728;GO:0060399;GO:0050729;GO:0032024;GO:0032731;GO:0045348;GO:0045429;GO:0051770;GO:0050731;GO:0014068;GO:0032516;GO:0042307;GO:0046579;GO:2000273;GO:0060391;GO:0032760;GO:0042531;GO:1904707;GO:0099527;GO:0046777;GO:0006468;GO:0007259;GO:0042981;GO:0050727;GO:0060334;GO:0045428;GO:0046425;GO:0046677;GO:0033194;GO:0070671;GO:0032496;GO:0034612;GO:0007165;GO:0033209;GO:0007260;, C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome lumen; C:euchromatin; C:focal adhesion; C:glutamatergic synapse; C:membrane raft; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynapse;, F:acetylcholine receptor binding; F:ATP binding; F:growth hormone receptor binding; F:heme binding; F:histone binding; F:histone kinase activity (H3-Y41 specific); F:identical protein binding; F:insulin receptor substrate binding; F:interleukin-12 receptor binding; F:metal ion binding; F:peptide hormone receptor binding; F:phosphatidylinositol 3-kinase binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:type 1 angiotensin receptor binding;, P:actin filament polymerization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:activation of Janus kinase activity; P:activation of MAPKK activity; P:adaptive immune response; P:apoptotic process; P:axon regeneration; P:blood coagulation; P:cell differentiation; P:cytokine-mediated signaling pathway; P:enzyme linked receptor protein signaling pathway; P:erythrocyte differentiation; P:extrinsic apoptotic signaling pathway; P:G protein-coupled receptor signaling pathway; P:growth hormone receptor signaling pathway; P:growth hormone receptor signaling pathway via JAK-STAT; P:histone H3-Y41 phosphorylation; P:interferon-gamma-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:mammary gland epithelium development; P:MAPK cascade; P:mesoderm development; P:microglial cell activation; P:mineralocorticoid receptor signaling pathway; P:modulation of chemical synaptic transmission; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of DNA binding; P:negative regulation of heart contraction; P:negative regulation of neuron apoptotic process; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell activation; P:positive regulation of cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA binding; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of epithelial cell apoptotic process; P:positive regulation of growth factor dependent skeletal muscle satellite cell proliferation; P:positive regulation of growth hormone receptor signaling pathway; P:positive regulation of inflammatory response; P:positive regulation of insulin secretion; P:positive regulation of interleukin-1 beta production; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein import into nucleus; P:positive regulation of Ras protein signal transduction; P:positive regulation of signaling receptor activity; P:positive regulation of SMAD protein signal transduction; P:positive regulation of tumor necrosis factor production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of vascular associated smooth muscle cell proliferation; P:postsynapse to nucleus signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:receptor signaling pathway via JAK-STAT; P:regulation of apoptotic process; P:regulation of inflammatory response; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of nitric oxide biosynthetic process; P:regulation of receptor signaling pathway via JAK-STAT; P:response to antibiotic; P:response to hydroperoxide; P:response to interleukin-12; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; P:tyrosine phosphorylation of STAT protein; scaffold2 indexed_genome mRNA 15788546 15789697 . + . ID=transcript_395;P62333 B2R975 P49719 Q6IBU3 Q92524,26S proteasome regulatory subunit 10B,26S proteasome AAA-ATPase subunit RPT4;Proteasome 26S subunit ATPase 6;Proteasome subunit p42;, PF00004;PF17862;PF16450;, GO:0005829;GO:0031597;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0030674;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0030433;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity; F:protein-macromolecule adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold2 indexed_genome mRNA 15791914 15792976 . + . ID=transcript_396;Q9Y581 A0AVS0 Q9NS16,Insulin-like peptide INSL6,Relaxin/insulin-like factor 1;, PF00049;, GO:0005576;GO:0005179;, C:extracellular region;, F:hormone activity; scaffold2 indexed_genome mRNA 15824775 15865224 . - . ID=transcript_397;Q9HBL7 B2R6W0 Q9NZ44,Plasminogen receptor (KT),, PF10166;, GO:0005887;GO:0006935;GO:0006954;GO:0010756;, C:integral component of plasma membrane;, , P:chemotaxis; P:inflammatory response; P:positive regulation of plasminogen activation;|Q9HBL7 B2R6W0 Q9NZ44,Plasminogen receptor (KT),, PF10166;, GO:0005887;GO:0006935;GO:0006954;GO:0010756;, C:integral component of plasma membrane;, , P:chemotaxis; P:inflammatory response; P:positive regulation of plasminogen activation; scaffold2 indexed_genome mRNA 15881104 15897701 . + . ID=transcript_398;Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5,Programmed cell death 1 ligand 1 {ECO:0000303|PubMed:28813417},B7 homolog 1 {ECO:0000303|PubMed:10581077};, PF08205;PF07686;, GO:0015629;GO:0031901;GO:0009897;GO:0070062;GO:0016021;GO:0005654;GO:0005886;GO:0055038;GO:0002250;GO:0007166;GO:0071222;GO:0006955;GO:0046007;GO:2000562;GO:2001186;GO:0032689;GO:0032693;GO:0042130;GO:1903556;GO:1905404;GO:0030335;GO:0032733;GO:0042102;GO:0002845;GO:0034097;GO:0007165;GO:0031295;GO:1901998;, C:actin cytoskeleton; C:early endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:integral component of membrane; C:nucleoplasm; C:plasma membrane; C:recycling endosome membrane;, , P:adaptive immune response; P:cell surface receptor signaling pathway; P:cellular response to lipopolysaccharide; P:immune response; P:negative regulation of activated T cell proliferation; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of CD8-positive, alpha-beta T cell activation; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-10 production; P:negative regulation of T cell proliferation; P:negative regulation of tumor necrosis factor superfamily cytokine production; P:positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process; P:positive regulation of cell migration; P:positive regulation of interleukin-10 production; P:positive regulation of T cell proliferation; P:positive regulation of tolerance induction to tumor cell; P:response to cytokine; P:signal transduction; P:T cell costimulation; P:toxin transport; scaffold2 indexed_genome mRNA 15929659 15996398 . + . ID=transcript_399;Q9BQ51 Q14CN8 Q5T7Z6 Q6JXL8 Q6JXL9,Programmed cell death 1 ligand 2,Butyrophilin B7-DC;, PF08205;, GO:0012505;GO:0009897;GO:0005576;GO:0016021;GO:0005886;GO:0002250;GO:0007166;GO:0071222;GO:0006955;GO:0046007;GO:0032689;GO:0032693;GO:0042130;GO:0042102;GO:0031295;, C:endomembrane system; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane;, , P:adaptive immune response; P:cell surface receptor signaling pathway; P:cellular response to lipopolysaccharide; P:immune response; P:negative regulation of activated T cell proliferation; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-10 production; P:negative regulation of T cell proliferation; P:positive regulation of T cell proliferation; P:T cell costimulation; scaffold2 indexed_genome mRNA 16048678 16192196 . + . ID=transcript_400;Q9H0A5 Q9H9S1,Guanine nucleotide exchange factor subunit RIC1 {ECO:0000305},Connexin-43-interacting protein of 150 kDa {ECO:0000303|PubMed:16112082};Protein RIC1 homolog {ECO:0000250|UniProtKB:P40395};RAB6A-GEF complex partner protein 1 {ECO:0000312|HGNC:HGNC:17686};, PF07064;, GO:0005829;GO:0000139;GO:0016020;GO:0032991;GO:0034066;GO:0032588;GO:0005085;GO:0031267;GO:1904888;GO:0006886;GO:1903363;GO:0043547;GO:0003330;GO:0042147;, C:cytosol; C:Golgi membrane; C:membrane; C:protein-containing complex; C:RIC1-RGP1 guanyl-nucleotide exchange factor complex; C:trans-Golgi network membrane;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:cranial skeletal system development; P:intracellular protein transport; P:negative regulation of cellular protein catabolic process; P:positive regulation of GTPase activity; P:regulation of extracellular matrix constituent secretion; P:retrograde transport, endosome to Golgi;|Q9H0A5 Q9H9S1,Guanine nucleotide exchange factor subunit RIC1 {ECO:0000305},Connexin-43-interacting protein of 150 kDa {ECO:0000303|PubMed:16112082};Protein RIC1 homolog {ECO:0000250|UniProtKB:P40395};RAB6A-GEF complex partner protein 1 {ECO:0000312|HGNC:HGNC:17686};, PF07064;, GO:0005829;GO:0000139;GO:0016020;GO:0032991;GO:0034066;GO:0032588;GO:0005085;GO:0031267;GO:1904888;GO:0006886;GO:1903363;GO:0043547;GO:0003330;GO:0042147;, C:cytosol; C:Golgi membrane; C:membrane; C:protein-containing complex; C:RIC1-RGP1 guanyl-nucleotide exchange factor complex; C:trans-Golgi network membrane;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:cranial skeletal system development; P:intracellular protein transport; P:negative regulation of cellular protein catabolic process; P:positive regulation of GTPase activity; P:regulation of extracellular matrix constituent secretion; P:retrograde transport, endosome to Golgi;|Q9H0A5 Q9H9S1,Guanine nucleotide exchange factor subunit RIC1 {ECO:0000305},Connexin-43-interacting protein of 150 kDa {ECO:0000303|PubMed:16112082};Protein RIC1 homolog {ECO:0000250|UniProtKB:P40395};RAB6A-GEF complex partner protein 1 {ECO:0000312|HGNC:HGNC:17686};, PF07064;, GO:0005829;GO:0000139;GO:0016020;GO:0032991;GO:0034066;GO:0032588;GO:0005085;GO:0031267;GO:1904888;GO:0006886;GO:1903363;GO:0043547;GO:0003330;GO:0042147;, C:cytosol; C:Golgi membrane; C:membrane; C:protein-containing complex; C:RIC1-RGP1 guanyl-nucleotide exchange factor complex; C:trans-Golgi network membrane;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:cranial skeletal system development; P:intracellular protein transport; P:negative regulation of cellular protein catabolic process; P:positive regulation of GTPase activity; P:regulation of extracellular matrix constituent secretion; P:retrograde transport, endosome to Golgi;|Q9H0A5 Q9H9S1,Guanine nucleotide exchange factor subunit RIC1 {ECO:0000305},Connexin-43-interacting protein of 150 kDa {ECO:0000303|PubMed:16112082};Protein RIC1 homolog {ECO:0000250|UniProtKB:P40395};RAB6A-GEF complex partner protein 1 {ECO:0000312|HGNC:HGNC:17686};, PF07064;, GO:0005829;GO:0000139;GO:0016020;GO:0032991;GO:0034066;GO:0032588;GO:0005085;GO:0031267;GO:1904888;GO:0006886;GO:1903363;GO:0043547;GO:0003330;GO:0042147;, C:cytosol; C:Golgi membrane; C:membrane; C:protein-containing complex; C:RIC1-RGP1 guanyl-nucleotide exchange factor complex; C:trans-Golgi network membrane;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:cranial skeletal system development; P:intracellular protein transport; P:negative regulation of cellular protein catabolic process; P:positive regulation of GTPase activity; P:regulation of extracellular matrix constituent secretion; P:retrograde transport, endosome to Golgi; scaffold2 indexed_genome mRNA 16192837 16249974 . - . ID=transcript_401;Q7Z2K6 B2RNA4 B3KSB1 Q8N5T5 Q9H5M1,Endoplasmic reticulum metallopeptidase 1 {ECO:0000250|UniProtKB:Q6UPR8, ECO:0000312|HGNC:HGNC:23703},Felix-ina {ECO:0000250|UniProtKB:Q6UPR8};, PF04389;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0046872;GO:0008237;GO:0034599;GO:0030968;GO:0006508;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:metal ion binding; F:metallopeptidase activity;, P:cellular response to oxidative stress; P:endoplasmic reticulum unfolded protein response; P:proteolysis; scaffold2 indexed_genome mRNA 16310891 16324138 . + . ID=transcript_402;Q16655 Q6ICU4,Melanoma antigen recognized by T-cells 1,Antigen LB39-AA;Antigen SK29-AA;Protein Melan-A;, PF14991;, GO:0005789;GO:0005794;GO:0005887;GO:0042470;GO:0005802;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:melanosome; C:trans-Golgi network; scaffold2 indexed_genome mRNA 16336719 16444913 . - . ID=transcript_403;Q5HYC2 A8MTP2 B9EGW7 Q4VXA2 Q8IVE5,Uncharacterized protein KIAA2026|Q5HYC2 A8MTP2 B9EGW7 Q4VXA2 Q8IVE5,Uncharacterized protein KIAA2026|Q5HYC2 A8MTP2 B9EGW7 Q4VXA2 Q8IVE5,Uncharacterized protein KIAA2026|Q5HYC2 A8MTP2 B9EGW7 Q4VXA2 Q8IVE5,Uncharacterized protein KIAA2026 scaffold2 indexed_genome mRNA 16447823 16452424 . - . ID=transcript_404;O60518 Q5T7X4 Q7Z3V2 Q96E78,Ran-binding protein 6,, PF02985;PF18808;PF18829;, GO:0005737;GO:0005634;GO:0061608;GO:0008139;GO:0006606;, C:cytoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:protein import into nucleus; scaffold2 indexed_genome mRNA 16549344 16610833 . + . ID=transcript_405;O95760 B2R8L1 B4DJ35 B4E1Q9 D3DRI5 E7EAX4 Q2YEJ5,Interleukin-33,Interleukin-1 family member 11;Nuclear factor from high endothelial venules;, PF15095;, GO:0005694;GO:0005737;GO:0005576;GO:0005615;GO:0043231;GO:0005654;GO:0005634;GO:0030133;GO:0005125;GO:0002112;GO:0051607;GO:0097191;GO:0038172;GO:0002282;GO:0061518;GO:0002638;GO:0032689;GO:0002686;GO:0120042;GO:0002826;GO:0000122;GO:0150145;GO:0150142;GO:0010186;GO:0032722;GO:0001819;GO:0010628;GO:0002639;GO:0050729;GO:0032736;GO:0032753;GO:0032754;GO:0032755;GO:0043032;GO:0045345;GO:0045348;GO:0150078;GO:0051770;GO:0032436;GO:0045944;GO:0032760;GO:0002830;GO:0016579;, C:chromosome; C:cytoplasm; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:transport vesicle;, F:cytokine activity; F:interleukin-33 receptor binding;, P:defense response to virus; P:extrinsic apoptotic signaling pathway; P:interleukin-33-mediated signaling pathway; P:microglial cell activation involved in immune response; P:microglial cell proliferation; P:negative regulation of immunoglobulin production; P:negative regulation of interferon-gamma production; P:negative regulation of leukocyte migration; P:negative regulation of macrophage proliferation; P:negative regulation of T-helper 1 type immune response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of CD80 production; P:positive regulation of CD86 production; P:positive regulation of cellular defense response; P:positive regulation of chemokine production; P:positive regulation of cytokine production; P:positive regulation of gene expression; P:positive regulation of immunoglobulin production; P:positive regulation of inflammatory response; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage activation; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of neuroinflammatory response; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type 2 immune response; P:protein deubiquitination;|Q69384 Q8TD93 Q9UBU4 Q9YNA5 Q9YNA9,Endogenous retrovirus group K member 6 Env polyprotein,EnvK2 protein;Envelope polyprotein;HERV-K(C7) envelope protein;HERV-K(HML-2.HOM) envelope protein;HERV-K108 envelope protein;HERV-K_7p22.1 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity;|O95760 B2R8L1 B4DJ35 B4E1Q9 D3DRI5 E7EAX4 Q2YEJ5,Interleukin-33,Interleukin-1 family member 11;Nuclear factor from high endothelial venules;, PF15095;, GO:0005694;GO:0005737;GO:0005576;GO:0005615;GO:0043231;GO:0005654;GO:0005634;GO:0030133;GO:0005125;GO:0002112;GO:0051607;GO:0097191;GO:0038172;GO:0002282;GO:0061518;GO:0002638;GO:0032689;GO:0002686;GO:0120042;GO:0002826;GO:0000122;GO:0150145;GO:0150142;GO:0010186;GO:0032722;GO:0001819;GO:0010628;GO:0002639;GO:0050729;GO:0032736;GO:0032753;GO:0032754;GO:0032755;GO:0043032;GO:0045345;GO:0045348;GO:0150078;GO:0051770;GO:0032436;GO:0045944;GO:0032760;GO:0002830;GO:0016579;, C:chromosome; C:cytoplasm; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:transport vesicle;, F:cytokine activity; F:interleukin-33 receptor binding;, P:defense response to virus; P:extrinsic apoptotic signaling pathway; P:interleukin-33-mediated signaling pathway; P:microglial cell activation involved in immune response; P:microglial cell proliferation; P:negative regulation of immunoglobulin production; P:negative regulation of interferon-gamma production; P:negative regulation of leukocyte migration; P:negative regulation of macrophage proliferation; P:negative regulation of T-helper 1 type immune response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of CD80 production; P:positive regulation of CD86 production; P:positive regulation of cellular defense response; P:positive regulation of chemokine production; P:positive regulation of cytokine production; P:positive regulation of gene expression; P:positive regulation of immunoglobulin production; P:positive regulation of inflammatory response; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage activation; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of neuroinflammatory response; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type 2 immune response; P:protein deubiquitination;|O95760 B2R8L1 B4DJ35 B4E1Q9 D3DRI5 E7EAX4 Q2YEJ5,Interleukin-33,Interleukin-1 family member 11;Nuclear factor from high endothelial venules;, PF15095;, GO:0005694;GO:0005737;GO:0005576;GO:0005615;GO:0043231;GO:0005654;GO:0005634;GO:0030133;GO:0005125;GO:0002112;GO:0051607;GO:0097191;GO:0038172;GO:0002282;GO:0061518;GO:0002638;GO:0032689;GO:0002686;GO:0120042;GO:0002826;GO:0000122;GO:0150145;GO:0150142;GO:0010186;GO:0032722;GO:0001819;GO:0010628;GO:0002639;GO:0050729;GO:0032736;GO:0032753;GO:0032754;GO:0032755;GO:0043032;GO:0045345;GO:0045348;GO:0150078;GO:0051770;GO:0032436;GO:0045944;GO:0032760;GO:0002830;GO:0016579;, C:chromosome; C:cytoplasm; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:transport vesicle;, F:cytokine activity; F:interleukin-33 receptor binding;, P:defense response to virus; P:extrinsic apoptotic signaling pathway; P:interleukin-33-mediated signaling pathway; P:microglial cell activation involved in immune response; P:microglial cell proliferation; P:negative regulation of immunoglobulin production; P:negative regulation of interferon-gamma production; P:negative regulation of leukocyte migration; P:negative regulation of macrophage proliferation; P:negative regulation of T-helper 1 type immune response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of CD80 production; P:positive regulation of CD86 production; P:positive regulation of cellular defense response; P:positive regulation of chemokine production; P:positive regulation of cytokine production; P:positive regulation of gene expression; P:positive regulation of immunoglobulin production; P:positive regulation of inflammatory response; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage activation; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of neuroinflammatory response; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type 2 immune response; P:protein deubiquitination;|O95760 B2R8L1 B4DJ35 B4E1Q9 D3DRI5 E7EAX4 Q2YEJ5,Interleukin-33,Interleukin-1 family member 11;Nuclear factor from high endothelial venules;, PF15095;, GO:0005694;GO:0005737;GO:0005576;GO:0005615;GO:0043231;GO:0005654;GO:0005634;GO:0030133;GO:0005125;GO:0002112;GO:0051607;GO:0097191;GO:0038172;GO:0002282;GO:0061518;GO:0002638;GO:0032689;GO:0002686;GO:0120042;GO:0002826;GO:0000122;GO:0150145;GO:0150142;GO:0010186;GO:0032722;GO:0001819;GO:0010628;GO:0002639;GO:0050729;GO:0032736;GO:0032753;GO:0032754;GO:0032755;GO:0043032;GO:0045345;GO:0045348;GO:0150078;GO:0051770;GO:0032436;GO:0045944;GO:0032760;GO:0002830;GO:0016579;, C:chromosome; C:cytoplasm; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:transport vesicle;, F:cytokine activity; F:interleukin-33 receptor binding;, P:defense response to virus; P:extrinsic apoptotic signaling pathway; P:interleukin-33-mediated signaling pathway; P:microglial cell activation involved in immune response; P:microglial cell proliferation; P:negative regulation of immunoglobulin production; P:negative regulation of interferon-gamma production; P:negative regulation of leukocyte migration; P:negative regulation of macrophage proliferation; P:negative regulation of T-helper 1 type immune response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of CD80 production; P:positive regulation of CD86 production; P:positive regulation of cellular defense response; P:positive regulation of chemokine production; P:positive regulation of cytokine production; P:positive regulation of gene expression; P:positive regulation of immunoglobulin production; P:positive regulation of inflammatory response; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage activation; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of neuroinflammatory response; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type 2 immune response; P:protein deubiquitination; scaffold2 indexed_genome mRNA 16695979 16767496 . + . ID=transcript_406;Q96PU4 Q5VYR1 Q5VYR3 Q659C8 Q8TAG7,E3 ubiquitin-protein ligase UHRF2,Np95/ICBP90-like RING finger protein;Nuclear protein 97;Nuclear zinc finger protein Np97;RING finger protein 107;RING-type E3 ubiquitin transferase UHRF2;Ubiquitin-like PHD and RING finger domain-containing protein 2;Ubiquitin-like-containing PHD and RING finger domains protein 2;, PF00628;PF02182;PF12148;PF00240;, GO:0000792;GO:0005654;GO:0005634;GO:0005721;GO:0003677;GO:0042393;GO:0046872;GO:0008134;GO:0061630;GO:0004842;GO:0007049;GO:0030154;GO:0010216;GO:0071158;GO:0051865;GO:0016567;GO:0051726;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:DNA binding; F:histone binding; F:metal ion binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell cycle; P:cell differentiation; P:maintenance of DNA methylation; P:positive regulation of cell cycle arrest; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of cell cycle;|Q96PU4 Q5VYR1 Q5VYR3 Q659C8 Q8TAG7,E3 ubiquitin-protein ligase UHRF2,Np95/ICBP90-like RING finger protein;Nuclear protein 97;Nuclear zinc finger protein Np97;RING finger protein 107;RING-type E3 ubiquitin transferase UHRF2;Ubiquitin-like PHD and RING finger domain-containing protein 2;Ubiquitin-like-containing PHD and RING finger domains protein 2;, PF00628;PF02182;PF12148;PF00240;, GO:0000792;GO:0005654;GO:0005634;GO:0005721;GO:0003677;GO:0042393;GO:0046872;GO:0008134;GO:0061630;GO:0004842;GO:0007049;GO:0030154;GO:0010216;GO:0071158;GO:0051865;GO:0016567;GO:0051726;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:DNA binding; F:histone binding; F:metal ion binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell cycle; P:cell differentiation; P:maintenance of DNA methylation; P:positive regulation of cell cycle arrest; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of cell cycle;|Q96PU4 Q5VYR1 Q5VYR3 Q659C8 Q8TAG7,E3 ubiquitin-protein ligase UHRF2,Np95/ICBP90-like RING finger protein;Nuclear protein 97;Nuclear zinc finger protein Np97;RING finger protein 107;RING-type E3 ubiquitin transferase UHRF2;Ubiquitin-like PHD and RING finger domain-containing protein 2;Ubiquitin-like-containing PHD and RING finger domains protein 2;, PF00628;PF02182;PF12148;PF00240;, GO:0000792;GO:0005654;GO:0005634;GO:0005721;GO:0003677;GO:0042393;GO:0046872;GO:0008134;GO:0061630;GO:0004842;GO:0007049;GO:0030154;GO:0010216;GO:0071158;GO:0051865;GO:0016567;GO:0051726;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:DNA binding; F:histone binding; F:metal ion binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell cycle; P:cell differentiation; P:maintenance of DNA methylation; P:positive regulation of cell cycle arrest; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of cell cycle;|Q96PU4 Q5VYR1 Q5VYR3 Q659C8 Q8TAG7,E3 ubiquitin-protein ligase UHRF2,Np95/ICBP90-like RING finger protein;Nuclear protein 97;Nuclear zinc finger protein Np97;RING finger protein 107;RING-type E3 ubiquitin transferase UHRF2;Ubiquitin-like PHD and RING finger domain-containing protein 2;Ubiquitin-like-containing PHD and RING finger domains protein 2;, PF00628;PF02182;PF12148;PF00240;, GO:0000792;GO:0005654;GO:0005634;GO:0005721;GO:0003677;GO:0042393;GO:0046872;GO:0008134;GO:0061630;GO:0004842;GO:0007049;GO:0030154;GO:0010216;GO:0071158;GO:0051865;GO:0016567;GO:0051726;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:DNA binding; F:histone binding; F:metal ion binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell cycle; P:cell differentiation; P:maintenance of DNA methylation; P:positive regulation of cell cycle arrest; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of cell cycle; scaffold2 indexed_genome mRNA 16780253 16786682 . - . ID=transcript_407;P23378 Q2M2F8,Glycine dehydrogenase (decarboxylating), mitochondrial {ECO:0000303|PubMed:15489334},Glycine cleavage system P protein;Glycine decarboxylase {ECO:0000303|PubMed:1993704, ECO:0000303|PubMed:1996985};Glycine dehydrogenase (aminomethyl-transferring);, PF01212;PF02347;, GO:0005960;GO:0005759;GO:0005739;GO:0005654;GO:0005886;GO:0009055;GO:0019899;GO:0016594;GO:0004375;GO:0016829;GO:0042803;GO:0070280;GO:0030170;GO:0006546;GO:0019464;GO:0065003;GO:1903442;GO:0036255;, C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:electron transfer activity; F:enzyme binding; F:glycine binding; F:glycine dehydrogenase (decarboxylating) activity; F:lyase activity; F:protein homodimerization activity; F:pyridoxal binding; F:pyridoxal phosphate binding;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein-containing complex assembly; P:response to lipoic acid; P:response to methylamine;|P23378 Q2M2F8,Glycine dehydrogenase (decarboxylating), mitochondrial {ECO:0000303|PubMed:15489334},Glycine cleavage system P protein;Glycine decarboxylase {ECO:0000303|PubMed:1993704, ECO:0000303|PubMed:1996985};Glycine dehydrogenase (aminomethyl-transferring);, PF01212;PF02347;, GO:0005960;GO:0005759;GO:0005739;GO:0005654;GO:0005886;GO:0009055;GO:0019899;GO:0016594;GO:0004375;GO:0016829;GO:0042803;GO:0070280;GO:0030170;GO:0006546;GO:0019464;GO:0065003;GO:1903442;GO:0036255;, C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:electron transfer activity; F:enzyme binding; F:glycine binding; F:glycine dehydrogenase (decarboxylating) activity; F:lyase activity; F:protein homodimerization activity; F:pyridoxal binding; F:pyridoxal phosphate binding;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein-containing complex assembly; P:response to lipoic acid; P:response to methylamine; scaffold2 indexed_genome mRNA 16787490 16867491 . - . ID=transcript_408;P23378 Q2M2F8,Glycine dehydrogenase (decarboxylating), mitochondrial {ECO:0000303|PubMed:15489334},Glycine cleavage system P protein;Glycine decarboxylase {ECO:0000303|PubMed:1993704, ECO:0000303|PubMed:1996985};Glycine dehydrogenase (aminomethyl-transferring);, PF01212;PF02347;, GO:0005960;GO:0005759;GO:0005739;GO:0005654;GO:0005886;GO:0009055;GO:0019899;GO:0016594;GO:0004375;GO:0016829;GO:0042803;GO:0070280;GO:0030170;GO:0006546;GO:0019464;GO:0065003;GO:1903442;GO:0036255;, C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:electron transfer activity; F:enzyme binding; F:glycine binding; F:glycine dehydrogenase (decarboxylating) activity; F:lyase activity; F:protein homodimerization activity; F:pyridoxal binding; F:pyridoxal phosphate binding;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein-containing complex assembly; P:response to lipoic acid; P:response to methylamine;|P23378 Q2M2F8,Glycine dehydrogenase (decarboxylating), mitochondrial {ECO:0000303|PubMed:15489334},Glycine cleavage system P protein;Glycine decarboxylase {ECO:0000303|PubMed:1993704, ECO:0000303|PubMed:1996985};Glycine dehydrogenase (aminomethyl-transferring);, PF01212;PF02347;, GO:0005960;GO:0005759;GO:0005739;GO:0005654;GO:0005886;GO:0009055;GO:0019899;GO:0016594;GO:0004375;GO:0016829;GO:0042803;GO:0070280;GO:0030170;GO:0006546;GO:0019464;GO:0065003;GO:1903442;GO:0036255;, C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:electron transfer activity; F:enzyme binding; F:glycine binding; F:glycine dehydrogenase (decarboxylating) activity; F:lyase activity; F:protein homodimerization activity; F:pyridoxal binding; F:pyridoxal phosphate binding;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein-containing complex assembly; P:response to lipoic acid; P:response to methylamine;|P23378 Q2M2F8,Glycine dehydrogenase (decarboxylating), mitochondrial {ECO:0000303|PubMed:15489334},Glycine cleavage system P protein;Glycine decarboxylase {ECO:0000303|PubMed:1993704, ECO:0000303|PubMed:1996985};Glycine dehydrogenase (aminomethyl-transferring);, PF01212;PF02347;, GO:0005960;GO:0005759;GO:0005739;GO:0005654;GO:0005886;GO:0009055;GO:0019899;GO:0016594;GO:0004375;GO:0016829;GO:0042803;GO:0070280;GO:0030170;GO:0006546;GO:0019464;GO:0065003;GO:1903442;GO:0036255;, C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:electron transfer activity; F:enzyme binding; F:glycine binding; F:glycine dehydrogenase (decarboxylating) activity; F:lyase activity; F:protein homodimerization activity; F:pyridoxal binding; F:pyridoxal phosphate binding;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein-containing complex assembly; P:response to lipoic acid; P:response to methylamine;|P23378 Q2M2F8,Glycine dehydrogenase (decarboxylating), mitochondrial {ECO:0000303|PubMed:15489334},Glycine cleavage system P protein;Glycine decarboxylase {ECO:0000303|PubMed:1993704, ECO:0000303|PubMed:1996985};Glycine dehydrogenase (aminomethyl-transferring);, PF01212;PF02347;, GO:0005960;GO:0005759;GO:0005739;GO:0005654;GO:0005886;GO:0009055;GO:0019899;GO:0016594;GO:0004375;GO:0016829;GO:0042803;GO:0070280;GO:0030170;GO:0006546;GO:0019464;GO:0065003;GO:1903442;GO:0036255;, C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:electron transfer activity; F:enzyme binding; F:glycine binding; F:glycine dehydrogenase (decarboxylating) activity; F:lyase activity; F:protein homodimerization activity; F:pyridoxal binding; F:pyridoxal phosphate binding;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein-containing complex assembly; P:response to lipoic acid; P:response to methylamine; scaffold2 indexed_genome mRNA 16950564 17356011 . + . ID=transcript_409;Q5VYJ3,Lysine-specific demethylase 4C,Gene amplified in squamous cell carcinoma 1 protein;JmjC domain-containing histone demethylation protein 3C;Jumonji domain-containing protein 2C;[histone H3]-trimethyl-L-lysine(9) demethylase 4C {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0000785;GO:0035097;GO:0005654;GO:0050681;GO:0003682;GO:0019899;GO:0032452;GO:0051864;GO:0032454;GO:0008270;GO:0006338;GO:0070544;GO:0033169;GO:0008284;GO:0010628;GO:0045666;GO:0060765;GO:0006357;, C:chromatin; C:histone methyltransferase complex; C:nucleoplasm;, F:androgen receptor binding; F:chromatin binding; F:enzyme binding; F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:regulation of androgen receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q5VYJ3,Lysine-specific demethylase 4C,Gene amplified in squamous cell carcinoma 1 protein;JmjC domain-containing histone demethylation protein 3C;Jumonji domain-containing protein 2C;[histone H3]-trimethyl-L-lysine(9) demethylase 4C {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0000785;GO:0035097;GO:0005654;GO:0050681;GO:0003682;GO:0019899;GO:0032452;GO:0051864;GO:0032454;GO:0008270;GO:0006338;GO:0070544;GO:0033169;GO:0008284;GO:0010628;GO:0045666;GO:0060765;GO:0006357;, C:chromatin; C:histone methyltransferase complex; C:nucleoplasm;, F:androgen receptor binding; F:chromatin binding; F:enzyme binding; F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:regulation of androgen receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q5VYJ3,Lysine-specific demethylase 4C,Gene amplified in squamous cell carcinoma 1 protein;JmjC domain-containing histone demethylation protein 3C;Jumonji domain-containing protein 2C;[histone H3]-trimethyl-L-lysine(9) demethylase 4C {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0000785;GO:0035097;GO:0005654;GO:0050681;GO:0003682;GO:0019899;GO:0032452;GO:0051864;GO:0032454;GO:0008270;GO:0006338;GO:0070544;GO:0033169;GO:0008284;GO:0010628;GO:0045666;GO:0060765;GO:0006357;, C:chromatin; C:histone methyltransferase complex; C:nucleoplasm;, F:androgen receptor binding; F:chromatin binding; F:enzyme binding; F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:regulation of androgen receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q5VYJ3,Lysine-specific demethylase 4C,Gene amplified in squamous cell carcinoma 1 protein;JmjC domain-containing histone demethylation protein 3C;Jumonji domain-containing protein 2C;[histone H3]-trimethyl-L-lysine(9) demethylase 4C {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0000785;GO:0035097;GO:0005654;GO:0050681;GO:0003682;GO:0019899;GO:0032452;GO:0051864;GO:0032454;GO:0008270;GO:0006338;GO:0070544;GO:0033169;GO:0008284;GO:0010628;GO:0045666;GO:0060765;GO:0006357;, C:chromatin; C:histone methyltransferase complex; C:nucleoplasm;, F:androgen receptor binding; F:chromatin binding; F:enzyme binding; F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:regulation of androgen receptor signaling pathway; P:regulation of transcription by RNA polymerase II; scaffold2 indexed_genome mRNA 17936605 17939032 . - . ID=transcript_410;Q96GE9 A8K9B7 Q5T6Y9 Q9NT74,Distal membrane-arm assembly complex protein 1 {ECO:0000303|PubMed:27626371},Transmembrane protein 261 {ECO:0000305};, PF15055;, GO:0016021;GO:0005743;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:mitochondrial respiratory chain complex I assembly; scaffold2 indexed_genome mRNA 18415232 18635510 . - . ID=transcript_411;P23468 B1ALA0 F5GWT7 Q3KPJ0 Q3KPJ1 Q3KPJ2,Receptor-type tyrosine-protein phosphatase delta,, PF00041;PF07679;PF00102;, GO:0070062;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0005886;GO:0098685;GO:0050839;GO:0004725;GO:0005102;GO:0005001;GO:0007157;GO:0050804;GO:0046426;GO:0030182;GO:0006796;GO:0050775;GO:0051965;GO:0097105;GO:0006470;GO:0050776;GO:0099151;GO:1905606;GO:0099560;GO:0099545;GO:0007185;, C:extracellular exosome; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:modulation of chemical synaptic transmission; P:negative regulation of receptor signaling pathway via JAK-STAT; P:neuron differentiation; P:phosphate-containing compound metabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse assembly; P:presynaptic membrane assembly; P:protein dephosphorylation; P:regulation of immune response; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|P23468 B1ALA0 F5GWT7 Q3KPJ0 Q3KPJ1 Q3KPJ2,Receptor-type tyrosine-protein phosphatase delta,, PF00041;PF07679;PF00102;, GO:0070062;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0005886;GO:0098685;GO:0050839;GO:0004725;GO:0005102;GO:0005001;GO:0007157;GO:0050804;GO:0046426;GO:0030182;GO:0006796;GO:0050775;GO:0051965;GO:0097105;GO:0006470;GO:0050776;GO:0099151;GO:1905606;GO:0099560;GO:0099545;GO:0007185;, C:extracellular exosome; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:modulation of chemical synaptic transmission; P:negative regulation of receptor signaling pathway via JAK-STAT; P:neuron differentiation; P:phosphate-containing compound metabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse assembly; P:presynaptic membrane assembly; P:protein dephosphorylation; P:regulation of immune response; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7,Receptor-type tyrosine-protein phosphatase S,Receptor-type tyrosine-protein phosphatase sigma;, PF00041;PF07679;PF00102;, GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;, C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;, P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;|P23468 B1ALA0 F5GWT7 Q3KPJ0 Q3KPJ1 Q3KPJ2,Receptor-type tyrosine-protein phosphatase delta,, PF00041;PF07679;PF00102;, GO:0070062;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0005886;GO:0098685;GO:0050839;GO:0004725;GO:0005102;GO:0005001;GO:0007157;GO:0050804;GO:0046426;GO:0030182;GO:0006796;GO:0050775;GO:0051965;GO:0097105;GO:0006470;GO:0050776;GO:0099151;GO:1905606;GO:0099560;GO:0099545;GO:0007185;, C:extracellular exosome; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:modulation of chemical synaptic transmission; P:negative regulation of receptor signaling pathway via JAK-STAT; P:neuron differentiation; P:phosphate-containing compound metabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse assembly; P:presynaptic membrane assembly; P:protein dephosphorylation; P:regulation of immune response; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|P23468 B1ALA0 F5GWT7 Q3KPJ0 Q3KPJ1 Q3KPJ2,Receptor-type tyrosine-protein phosphatase delta,, PF00041;PF07679;PF00102;, GO:0070062;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0005886;GO:0098685;GO:0050839;GO:0004725;GO:0005102;GO:0005001;GO:0007157;GO:0050804;GO:0046426;GO:0030182;GO:0006796;GO:0050775;GO:0051965;GO:0097105;GO:0006470;GO:0050776;GO:0099151;GO:1905606;GO:0099560;GO:0099545;GO:0007185;, C:extracellular exosome; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:modulation of chemical synaptic transmission; P:negative regulation of receptor signaling pathway via JAK-STAT; P:neuron differentiation; P:phosphate-containing compound metabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse assembly; P:presynaptic membrane assembly; P:protein dephosphorylation; P:regulation of immune response; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|P23468 B1ALA0 F5GWT7 Q3KPJ0 Q3KPJ1 Q3KPJ2,Receptor-type tyrosine-protein phosphatase delta,, PF00041;PF07679;PF00102;, GO:0070062;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0005886;GO:0098685;GO:0050839;GO:0004725;GO:0005102;GO:0005001;GO:0007157;GO:0050804;GO:0046426;GO:0030182;GO:0006796;GO:0050775;GO:0051965;GO:0097105;GO:0006470;GO:0050776;GO:0099151;GO:1905606;GO:0099560;GO:0099545;GO:0007185;, C:extracellular exosome; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:modulation of chemical synaptic transmission; P:negative regulation of receptor signaling pathway via JAK-STAT; P:neuron differentiation; P:phosphate-containing compound metabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse assembly; P:presynaptic membrane assembly; P:protein dephosphorylation; P:regulation of immune response; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|P23468 B1ALA0 F5GWT7 Q3KPJ0 Q3KPJ1 Q3KPJ2,Receptor-type tyrosine-protein phosphatase delta,, PF00041;PF07679;PF00102;, GO:0070062;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0005886;GO:0098685;GO:0050839;GO:0004725;GO:0005102;GO:0005001;GO:0007157;GO:0050804;GO:0046426;GO:0030182;GO:0006796;GO:0050775;GO:0051965;GO:0097105;GO:0006470;GO:0050776;GO:0099151;GO:1905606;GO:0099560;GO:0099545;GO:0007185;, C:extracellular exosome; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:modulation of chemical synaptic transmission; P:negative regulation of receptor signaling pathway via JAK-STAT; P:neuron differentiation; P:phosphate-containing compound metabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse assembly; P:presynaptic membrane assembly; P:protein dephosphorylation; P:regulation of immune response; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|Q86UB2 Q2M1J2 Q9NXM4,Basic immunoglobulin-like variable motif-containing protein,, , GO:0005737;GO:0005615;GO:0005634;, C:cytoplasm; C:extracellular space; C:nucleus;|P23468 B1ALA0 F5GWT7 Q3KPJ0 Q3KPJ1 Q3KPJ2,Receptor-type tyrosine-protein phosphatase delta,, PF00041;PF07679;PF00102;, GO:0070062;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0005886;GO:0098685;GO:0050839;GO:0004725;GO:0005102;GO:0005001;GO:0007157;GO:0050804;GO:0046426;GO:0030182;GO:0006796;GO:0050775;GO:0051965;GO:0097105;GO:0006470;GO:0050776;GO:0099151;GO:1905606;GO:0099560;GO:0099545;GO:0007185;, C:extracellular exosome; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:modulation of chemical synaptic transmission; P:negative regulation of receptor signaling pathway via JAK-STAT; P:neuron differentiation; P:phosphate-containing compound metabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse assembly; P:presynaptic membrane assembly; P:protein dephosphorylation; P:regulation of immune response; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|P23468 B1ALA0 F5GWT7 Q3KPJ0 Q3KPJ1 Q3KPJ2,Receptor-type tyrosine-protein phosphatase delta,, PF00041;PF07679;PF00102;, GO:0070062;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0005886;GO:0098685;GO:0050839;GO:0004725;GO:0005102;GO:0005001;GO:0007157;GO:0050804;GO:0046426;GO:0030182;GO:0006796;GO:0050775;GO:0051965;GO:0097105;GO:0006470;GO:0050776;GO:0099151;GO:1905606;GO:0099560;GO:0099545;GO:0007185;, C:extracellular exosome; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:modulation of chemical synaptic transmission; P:negative regulation of receptor signaling pathway via JAK-STAT; P:neuron differentiation; P:phosphate-containing compound metabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse assembly; P:presynaptic membrane assembly; P:protein dephosphorylation; P:regulation of immune response; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|P23468 B1ALA0 F5GWT7 Q3KPJ0 Q3KPJ1 Q3KPJ2,Receptor-type tyrosine-protein phosphatase delta,, PF00041;PF07679;PF00102;, GO:0070062;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0005886;GO:0098685;GO:0050839;GO:0004725;GO:0005102;GO:0005001;GO:0007157;GO:0050804;GO:0046426;GO:0030182;GO:0006796;GO:0050775;GO:0051965;GO:0097105;GO:0006470;GO:0050776;GO:0099151;GO:1905606;GO:0099560;GO:0099545;GO:0007185;, C:extracellular exosome; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:modulation of chemical synaptic transmission; P:negative regulation of receptor signaling pathway via JAK-STAT; P:neuron differentiation; P:phosphate-containing compound metabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse assembly; P:presynaptic membrane assembly; P:protein dephosphorylation; P:regulation of immune response; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; scaffold2 indexed_genome mRNA 22785366 22800232 . + . ID=transcript_412;P17643 P78468 P78469 Q13721 Q15679,5,6-dihydroxyindole-2-carboxylic acid oxidase,Catalase B;Glycoprotein 75 {ECO:0000303|PubMed:1693779};Melanoma antigen gp75 {ECO:0000303|PubMed:2324688};Tyrosinase-related protein 1 {ECO:0000303|PubMed:9434945};, PF00264;, GO:0030669;GO:0005737;GO:0010008;GO:0016021;GO:0097708;GO:0042470;GO:0033162;GO:0046872;GO:0004503;GO:0042803;GO:0043438;GO:0042438;GO:0030318;GO:0032438;GO:0048023;, C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:endosome membrane; C:integral component of membrane; C:intracellular vesicle; C:melanosome; C:melanosome membrane;, F:metal ion binding; F:monophenol monooxygenase activity; F:protein homodimerization activity;, P:acetoacetic acid metabolic process; P:melanin biosynthetic process; P:melanocyte differentiation; P:melanosome organization; P:positive regulation of melanin biosynthetic process; scaffold2 indexed_genome mRNA 22874724 22921293 . + . ID=transcript_413;Q8IV03 Q5VZX7 Q8N923 Q8NCG2,Leucine rich adaptor protein 1-like,, PF14854;, GO:0043123;, , , P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold2 indexed_genome mRNA 23193836 23331590 . - . ID=transcript_414;Q5JTX7 Q5JUC3 Q5JUC4 Q5VZ62 Q8N790,Multiple PDZ domain protein,Multi-PDZ domain protein 1;, PF09045;PF16667;PF00595;, GO:0016324;GO:0016327;GO:0005923;GO:0005737;GO:0030425;GO:0014069;GO:0008022;GO:0016032;, C:apical plasma membrane; C:apicolateral plasma membrane; C:bicellular tight junction; C:cytoplasm; C:dendrite; C:postsynaptic density;, F:protein C-terminus binding;, P:viral process;|Q5JTX7 Q5JUC3 Q5JUC4 Q5VZ62 Q8N790,Multiple PDZ domain protein,Multi-PDZ domain protein 1;, PF09045;PF16667;PF00595;, GO:0016324;GO:0016327;GO:0005923;GO:0005737;GO:0030425;GO:0014069;GO:0008022;GO:0016032;, C:apical plasma membrane; C:apicolateral plasma membrane; C:bicellular tight junction; C:cytoplasm; C:dendrite; C:postsynaptic density;, F:protein C-terminus binding;, P:viral process;|Q5JTX7 Q5JUC3 Q5JUC4 Q5VZ62 Q8N790,Multiple PDZ domain protein,Multi-PDZ domain protein 1;, PF09045;PF16667;PF00595;, GO:0016324;GO:0016327;GO:0005923;GO:0005737;GO:0030425;GO:0014069;GO:0008022;GO:0016032;, C:apical plasma membrane; C:apicolateral plasma membrane; C:bicellular tight junction; C:cytoplasm; C:dendrite; C:postsynaptic density;, F:protein C-terminus binding;, P:viral process; scaffold2 indexed_genome mRNA 24569695 24639291 . - . ID=transcript_415;Q8IVQ6 A8KA95 D3DRI7 Q5VWG1,Palmitoyltransferase ZDHHC21 {ECO:0000305},DHHC domain-containing cysteine-rich protein 21 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 21 {ECO:0000312|HGNC:HGNC:20750};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0016409;GO:0019706;GO:0071875;GO:0001942;GO:0018230;GO:0018345;GO:0006612;GO:1903140;GO:1904997;GO:0050999;GO:0003056;GO:0048733;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:adrenergic receptor signaling pathway; P:hair follicle development; P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of establishment of endothelial barrier; P:regulation of leukocyte adhesion to arterial endothelial cell; P:regulation of nitric-oxide synthase activity; P:regulation of vascular associated smooth muscle contraction; P:sebaceous gland development;|Q8IVQ6 A8KA95 D3DRI7 Q5VWG1,Palmitoyltransferase ZDHHC21 {ECO:0000305},DHHC domain-containing cysteine-rich protein 21 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 21 {ECO:0000312|HGNC:HGNC:20750};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0016409;GO:0019706;GO:0071875;GO:0001942;GO:0018230;GO:0018345;GO:0006612;GO:1903140;GO:1904997;GO:0050999;GO:0003056;GO:0048733;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:adrenergic receptor signaling pathway; P:hair follicle development; P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of establishment of endothelial barrier; P:regulation of leukocyte adhesion to arterial endothelial cell; P:regulation of nitric-oxide synthase activity; P:regulation of vascular associated smooth muscle contraction; P:sebaceous gland development; scaffold2 indexed_genome mRNA 24674300 24719132 . - . ID=transcript_416;Q5H8C1 B7ZBX4 Q5VV00 Q5VV01 Q6MZI4 Q8NEG9 Q96LI3,FRAS1-related extracellular matrix protein 1 {ECO:0000305},Protein QBRICK;, PF03160;PF00059;, GO:0005604;GO:0005576;GO:0016021;GO:0030246;GO:0046872;GO:0007154;GO:0007160;GO:0097094;, C:basement membrane; C:extracellular region; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding;, P:cell communication; P:cell-matrix adhesion; P:craniofacial suture morphogenesis;|Q5H8C1 B7ZBX4 Q5VV00 Q5VV01 Q6MZI4 Q8NEG9 Q96LI3,FRAS1-related extracellular matrix protein 1 {ECO:0000305},Protein QBRICK;, PF03160;PF00059;, GO:0005604;GO:0005576;GO:0016021;GO:0030246;GO:0046872;GO:0007154;GO:0007160;GO:0097094;, C:basement membrane; C:extracellular region; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding;, P:cell communication; P:cell-matrix adhesion; P:craniofacial suture morphogenesis; scaffold2 indexed_genome mRNA 24989175 25132615 . - . ID=transcript_417;Q5VTQ0 A5PLN1 B4DQ10 B4DQX4 B4DW93 Q8IVR7 Q8IXZ6 Q8N267,Tetratricopeptide repeat protein 39B,, PF10300;PF13174;, GO:0042632;GO:0006629;GO:0010887;GO:0010874;GO:0090181;, , , P:cholesterol homeostasis; P:lipid metabolic process; P:negative regulation of cholesterol storage; P:regulation of cholesterol efflux; P:regulation of cholesterol metabolic process;|Q5VTQ0 A5PLN1 B4DQ10 B4DQX4 B4DW93 Q8IVR7 Q8IXZ6 Q8N267,Tetratricopeptide repeat protein 39B,, PF10300;PF13174;, GO:0042632;GO:0006629;GO:0010887;GO:0010874;GO:0090181;, , , P:cholesterol homeostasis; P:lipid metabolic process; P:negative regulation of cholesterol storage; P:regulation of cholesterol efflux; P:regulation of cholesterol metabolic process;|Q5VTQ0 A5PLN1 B4DQ10 B4DQX4 B4DW93 Q8IVR7 Q8IXZ6 Q8N267,Tetratricopeptide repeat protein 39B,, PF10300;PF13174;, GO:0042632;GO:0006629;GO:0010887;GO:0010874;GO:0090181;, , , P:cholesterol homeostasis; P:lipid metabolic process; P:negative regulation of cholesterol storage; P:regulation of cholesterol efflux; P:regulation of cholesterol metabolic process; scaffold2 indexed_genome mRNA 25203176 25242113 . + . ID=transcript_418;Q92966 D3DRI8 Q2VPI6 Q5T285,snRNA-activating protein complex subunit 3,Proximal sequence element-binding transcription factor subunit beta;Small nuclear RNA-activating complex polypeptide 3;snRNA-activating protein complex 50 kDa subunit;, PF12251;, GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0019185;GO:0003681;GO:0003677;GO:0000995;GO:0001006;GO:0009301;GO:0042795;GO:0042796;GO:0006366;GO:0006383;, C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:snRNA-activating protein complex;, F:bent DNA binding; F:DNA binding; F:RNA polymerase III general transcription initiation factor activity; F:RNA polymerase III type 3 promoter sequence-specific DNA binding;, P:snRNA transcription; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:transcription by RNA polymerase II; P:transcription by RNA polymerase III;|Q92966 D3DRI8 Q2VPI6 Q5T285,snRNA-activating protein complex subunit 3,Proximal sequence element-binding transcription factor subunit beta;Small nuclear RNA-activating complex polypeptide 3;snRNA-activating protein complex 50 kDa subunit;, PF12251;, GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0019185;GO:0003681;GO:0003677;GO:0000995;GO:0001006;GO:0009301;GO:0042795;GO:0042796;GO:0006366;GO:0006383;, C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:snRNA-activating protein complex;, F:bent DNA binding; F:DNA binding; F:RNA polymerase III general transcription initiation factor activity; F:RNA polymerase III type 3 promoter sequence-specific DNA binding;, P:snRNA transcription; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:transcription by RNA polymerase II; P:transcription by RNA polymerase III; scaffold2 indexed_genome mRNA 25244077 25282637 . - . ID=transcript_419;O75475 D3DRI9 O00256 O95368 Q6P391 Q86YB9 Q9NZI3 Q9UER6,PC4 and SFRS1-interacting protein,CLL-associated antigen KW-7;Dense fine speckles 70 kDa protein;Lens epithelium-derived growth factor;Transcriptional coactivator p75/p52;, PF11467;PF00855;, GO:0005829;GO:0000792;GO:0034399;GO:0005654;GO:0005634;GO:0035327;GO:0033613;GO:0003682;GO:0003690;GO:0003723;GO:0097100;GO:0003713;GO:0003712;GO:0075713;GO:0000395;GO:0051169;GO:0045944;GO:0006357;GO:0009408;GO:0006979;, C:cytosol; C:heterochromatin; C:nuclear periphery; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:activating transcription factor binding; F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:supercoiled DNA binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:establishment of integrated proviral latency; P:mRNA 5'-splice site recognition; P:nuclear transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to heat; P:response to oxidative stress;|O75475 D3DRI9 O00256 O95368 Q6P391 Q86YB9 Q9NZI3 Q9UER6,PC4 and SFRS1-interacting protein,CLL-associated antigen KW-7;Dense fine speckles 70 kDa protein;Lens epithelium-derived growth factor;Transcriptional coactivator p75/p52;, PF11467;PF00855;, GO:0005829;GO:0000792;GO:0034399;GO:0005654;GO:0005634;GO:0035327;GO:0033613;GO:0003682;GO:0003690;GO:0003723;GO:0097100;GO:0003713;GO:0003712;GO:0075713;GO:0000395;GO:0051169;GO:0045944;GO:0006357;GO:0009408;GO:0006979;, C:cytosol; C:heterochromatin; C:nuclear periphery; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:activating transcription factor binding; F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:supercoiled DNA binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:establishment of integrated proviral latency; P:mRNA 5'-splice site recognition; P:nuclear transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to heat; P:response to oxidative stress;|O75475 D3DRI9 O00256 O95368 Q6P391 Q86YB9 Q9NZI3 Q9UER6,PC4 and SFRS1-interacting protein,CLL-associated antigen KW-7;Dense fine speckles 70 kDa protein;Lens epithelium-derived growth factor;Transcriptional coactivator p75/p52;, PF11467;PF00855;, GO:0005829;GO:0000792;GO:0034399;GO:0005654;GO:0005634;GO:0035327;GO:0033613;GO:0003682;GO:0003690;GO:0003723;GO:0097100;GO:0003713;GO:0003712;GO:0075713;GO:0000395;GO:0051169;GO:0045944;GO:0006357;GO:0009408;GO:0006979;, C:cytosol; C:heterochromatin; C:nuclear periphery; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:activating transcription factor binding; F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:supercoiled DNA binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:establishment of integrated proviral latency; P:mRNA 5'-splice site recognition; P:nuclear transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to heat; P:response to oxidative stress;|O75475 D3DRI9 O00256 O95368 Q6P391 Q86YB9 Q9NZI3 Q9UER6,PC4 and SFRS1-interacting protein,CLL-associated antigen KW-7;Dense fine speckles 70 kDa protein;Lens epithelium-derived growth factor;Transcriptional coactivator p75/p52;, PF11467;PF00855;, GO:0005829;GO:0000792;GO:0034399;GO:0005654;GO:0005634;GO:0035327;GO:0033613;GO:0003682;GO:0003690;GO:0003723;GO:0097100;GO:0003713;GO:0003712;GO:0075713;GO:0000395;GO:0051169;GO:0045944;GO:0006357;GO:0009408;GO:0006979;, C:cytosol; C:heterochromatin; C:nuclear periphery; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:activating transcription factor binding; F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:supercoiled DNA binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:establishment of integrated proviral latency; P:mRNA 5'-splice site recognition; P:nuclear transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to heat; P:response to oxidative stress;|O75475 D3DRI9 O00256 O95368 Q6P391 Q86YB9 Q9NZI3 Q9UER6,PC4 and SFRS1-interacting protein,CLL-associated antigen KW-7;Dense fine speckles 70 kDa protein;Lens epithelium-derived growth factor;Transcriptional coactivator p75/p52;, PF11467;PF00855;, GO:0005829;GO:0000792;GO:0034399;GO:0005654;GO:0005634;GO:0035327;GO:0033613;GO:0003682;GO:0003690;GO:0003723;GO:0097100;GO:0003713;GO:0003712;GO:0075713;GO:0000395;GO:0051169;GO:0045944;GO:0006357;GO:0009408;GO:0006979;, C:cytosol; C:heterochromatin; C:nuclear periphery; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:activating transcription factor binding; F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:supercoiled DNA binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:establishment of integrated proviral latency; P:mRNA 5'-splice site recognition; P:nuclear transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to heat; P:response to oxidative stress;|O75475 D3DRI9 O00256 O95368 Q6P391 Q86YB9 Q9NZI3 Q9UER6,PC4 and SFRS1-interacting protein,CLL-associated antigen KW-7;Dense fine speckles 70 kDa protein;Lens epithelium-derived growth factor;Transcriptional coactivator p75/p52;, PF11467;PF00855;, GO:0005829;GO:0000792;GO:0034399;GO:0005654;GO:0005634;GO:0035327;GO:0033613;GO:0003682;GO:0003690;GO:0003723;GO:0097100;GO:0003713;GO:0003712;GO:0075713;GO:0000395;GO:0051169;GO:0045944;GO:0006357;GO:0009408;GO:0006979;, C:cytosol; C:heterochromatin; C:nuclear periphery; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:activating transcription factor binding; F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:supercoiled DNA binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:establishment of integrated proviral latency; P:mRNA 5'-splice site recognition; P:nuclear transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to heat; P:response to oxidative stress; scaffold2 indexed_genome mRNA 25319148 25362190 . + . ID=transcript_420;Q6TFL3 B7ZM22 Q5SU58 Q6P1W1 Q6ZR13 Q8N1Z4 Q8N8L3 Q8TBR2,Coiled-coil domain-containing protein 171 scaffold2 indexed_genome mRNA 25368487 25632242 . + . ID=transcript_421;Q6TFL3 B7ZM22 Q5SU58 Q6P1W1 Q6ZR13 Q8N1Z4 Q8N8L3 Q8TBR2,Coiled-coil domain-containing protein 171|Q6TFL3 B7ZM22 Q5SU58 Q6P1W1 Q6ZR13 Q8N1Z4 Q8N8L3 Q8TBR2,Coiled-coil domain-containing protein 171|Q6TFL3 B7ZM22 Q5SU58 Q6P1W1 Q6ZR13 Q8N1Z4 Q8N8L3 Q8TBR2,Coiled-coil domain-containing protein 171 scaffold2 indexed_genome mRNA 26101678 26102299 . + . ID=transcript_422;Q6ZN30 B1APG9 Q6T3A3 Q8NAR2 Q9H6J0 Q9NXV0,Zinc finger protein basonuclin-2,, PF00096;, GO:0005654;GO:0005634;GO:0046872;GO:0000976;GO:0003416;GO:0060485;GO:0006355;GO:0060021;GO:0043586;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:endochondral bone growth; P:mesenchyme development; P:regulation of transcription, DNA-templated; P:roof of mouth development; P:tongue development; scaffold2 indexed_genome mRNA 26762686 26859984 . + . ID=transcript_423;Q9NXG0 A5Z2X6 Q5VYJ0 Q8N1G9 Q9HAJ5,Centlein,Centrosomal protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0019904;GO:0019901;GO:0030674;GO:0010457;GO:0033365;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:protein domain specific binding; F:protein kinase binding; F:protein-macromolecule adaptor activity;, P:centriole-centriole cohesion; P:protein localization to organelle; scaffold2 indexed_genome mRNA 26904580 27086217 . + . ID=transcript_424;Q9NXG0 A5Z2X6 Q5VYJ0 Q8N1G9 Q9HAJ5,Centlein,Centrosomal protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0019904;GO:0019901;GO:0030674;GO:0010457;GO:0033365;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:protein domain specific binding; F:protein kinase binding; F:protein-macromolecule adaptor activity;, P:centriole-centriole cohesion; P:protein localization to organelle; scaffold2 indexed_genome mRNA 27362452 27371573 . + . ID=transcript_425;Q99962 B2R618 Q9NQK5,Endophilin-A1,EEN-B1;Endophilin-1;SH3 domain protein 2A;SH3 domain-containing GRB2-like protein 2;, PF03114;PF07653;, GO:0097441;GO:0030669;GO:0005829;GO:0005769;GO:0098978;GO:0000139;GO:0098686;GO:0043025;GO:0048471;GO:0005886;GO:0098685;GO:0030672;GO:0042802;GO:0008289;GO:0008022;GO:0019901;GO:0019886;GO:1990416;GO:0007417;GO:0097484;GO:0060988;GO:0097753;GO:0061024;GO:0097749;GO:1905604;GO:0042059;GO:0010629;GO:0001933;GO:0031175;GO:1903527;GO:0006892;GO:2000369;GO:0007165;GO:0048488;GO:0099050;, C:basal dendrite; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:early endosome; C:glutamatergic synapse; C:Golgi membrane; C:hippocampal mossy fiber to CA3 synapse; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle membrane;, F:identical protein binding; F:lipid binding; F:protein C-terminus binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular response to brain-derived neurotrophic factor stimulus; P:central nervous system development; P:dendrite extension; P:lipid tube assembly; P:membrane bending; P:membrane organization; P:membrane tubulation; P:negative regulation of blood-brain barrier permeability; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:neuron projection development; P:positive regulation of membrane tubulation; P:post-Golgi vesicle-mediated transport; P:regulation of clathrin-dependent endocytosis; P:signal transduction; P:synaptic vesicle endocytosis; P:vesicle scission; scaffold2 indexed_genome mRNA 27513949 28205360 . + . ID=transcript_426;Q9BXY3,ADAMTS-like protein 1,Punctin-1;, PF07679;PF08686;PF00090;, GO:0005788;GO:0031012;GO:0005576;GO:0004222;GO:0030198;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold2 indexed_genome mRNA 28456231 28555995 . + . ID=transcript_427;Q9BXY3,ADAMTS-like protein 1,Punctin-1;, PF07679;PF08686;PF00090;, GO:0005788;GO:0031012;GO:0005576;GO:0004222;GO:0030198;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold2 indexed_genome mRNA 28556693 28560996 . + . ID=transcript_428;Q9BXY3,ADAMTS-like protein 1,Punctin-1;, PF07679;PF08686;PF00090;, GO:0005788;GO:0031012;GO:0005576;GO:0004222;GO:0030198;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold2 indexed_genome mRNA 28701296 28711817 . - . ID=transcript_429;Q7L523 B2R7L1 O00290 Q15347,Ras-related GTP-binding protein A {ECO:0000305},Adenovirus E3 14.7 kDa-interacting protein 1 {ECO:0000303|PubMed:8995684};FIP-1 {ECO:0000303|PubMed:8995684};, PF04670;, GO:0005737;GO:0005829;GO:0034448;GO:1990131;GO:0005765;GO:0005764;GO:0005634;GO:0005525;GO:0003924;GO:0051219;GO:0046982;GO:0042803;GO:0031625;GO:0006915;GO:0007050;GO:0008219;GO:0034613;GO:0034198;GO:0071230;GO:0009267;GO:0019048;GO:0010507;GO:0032008;GO:1904263;GO:0016567;GO:0010506;GO:0016241;, C:cytoplasm; C:cytosol; C:EGO complex; C:Gtr1-Gtr2 GTPase complex; C:lysosomal membrane; C:lysosome; C:nucleus;, F:GTP binding; F:GTPase activity; F:phosphoprotein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell cycle arrest; P:cell death; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to starvation; P:modulation by virus of host process; P:negative regulation of autophagy; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:protein ubiquitination; P:regulation of autophagy; P:regulation of macroautophagy;|Q8IZQ4 Q96FN0 Q9H950 Q9H998 Q9HCJ8 Q9NXT8,HAUS augmin-like complex subunit 6,, PF14661;, GO:0034451;GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0016607;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centriolar satellite; C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule; C:nuclear speck;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold2 indexed_genome mRNA 28715392 28747435 . - . ID=transcript_430;Q8IZQ4 Q96FN0 Q9H950 Q9H998 Q9HCJ8 Q9NXT8,HAUS augmin-like complex subunit 6,, PF14661;, GO:0034451;GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0016607;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centriolar satellite; C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule; C:nuclear speck;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold2 indexed_genome mRNA 28758575 28766874 . - . ID=transcript_431;Q99541 Q9BSC3,Perilipin-2,Adipophilin;Adipose differentiation-related protein;, PF03036;, GO:0005829;GO:0005783;GO:0005576;GO:0005811;GO:0005634;GO:0005886;GO:0019915;GO:0015909;GO:0010890;GO:0019222;GO:0042493;GO:0014070;, C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:lipid droplet; C:nucleus; C:plasma membrane;, , P:lipid storage; P:long-chain fatty acid transport; P:positive regulation of sequestering of triglyceride; P:regulation of metabolic process; P:response to drug; P:response to organic cyclic compound; scaffold2 indexed_genome mRNA 28843514 28961943 . + . ID=transcript_432;Q9NUT1 Q9NWA5 Q9NWT3 R4GN35 R4GNB2,DENN domain-containing protein 4C,, PF03455;PF02141;PF03456;, GO:0031410;GO:0030659;GO:0005829;GO:0005794;GO:0032593;GO:0043231;GO:0005886;GO:0030904;GO:0005085;GO:0032869;GO:0072659;GO:0015031;GO:0032483;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:insulin-responsive compartment; C:intracellular membrane-bounded organelle; C:plasma membrane; C:retromer complex;, F:guanyl-nucleotide exchange factor activity;, P:cellular response to insulin stimulus; P:protein localization to plasma membrane; P:protein transport; P:regulation of Rab protein signal transduction;|Q9NUT1 Q9NWA5 Q9NWT3 R4GN35 R4GNB2,DENN domain-containing protein 4C,, PF03455;PF02141;PF03456;, GO:0031410;GO:0030659;GO:0005829;GO:0005794;GO:0032593;GO:0043231;GO:0005886;GO:0030904;GO:0005085;GO:0032869;GO:0072659;GO:0015031;GO:0032483;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:insulin-responsive compartment; C:intracellular membrane-bounded organelle; C:plasma membrane; C:retromer complex;, F:guanyl-nucleotide exchange factor activity;, P:cellular response to insulin stimulus; P:protein localization to plasma membrane; P:protein transport; P:regulation of Rab protein signal transduction;|Q9NUT1 Q9NWA5 Q9NWT3 R4GN35 R4GNB2,DENN domain-containing protein 4C,, PF03455;PF02141;PF03456;, GO:0031410;GO:0030659;GO:0005829;GO:0005794;GO:0032593;GO:0043231;GO:0005886;GO:0030904;GO:0005085;GO:0032869;GO:0072659;GO:0015031;GO:0032483;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:insulin-responsive compartment; C:intracellular membrane-bounded organelle; C:plasma membrane; C:retromer complex;, F:guanyl-nucleotide exchange factor activity;, P:cellular response to insulin stimulus; P:protein localization to plasma membrane; P:protein transport; P:regulation of Rab protein signal transduction;|Q9NUT1 Q9NWA5 Q9NWT3 R4GN35 R4GNB2,DENN domain-containing protein 4C,, PF03455;PF02141;PF03456;, GO:0031410;GO:0030659;GO:0005829;GO:0005794;GO:0032593;GO:0043231;GO:0005886;GO:0030904;GO:0005085;GO:0032869;GO:0072659;GO:0015031;GO:0032483;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:insulin-responsive compartment; C:intracellular membrane-bounded organelle; C:plasma membrane; C:retromer complex;, F:guanyl-nucleotide exchange factor activity;, P:cellular response to insulin stimulus; P:protein localization to plasma membrane; P:protein transport; P:regulation of Rab protein signal transduction;|Q9NUT1 Q9NWA5 Q9NWT3 R4GN35 R4GNB2,DENN domain-containing protein 4C,, PF03455;PF02141;PF03456;, GO:0031410;GO:0030659;GO:0005829;GO:0005794;GO:0032593;GO:0043231;GO:0005886;GO:0030904;GO:0005085;GO:0032869;GO:0072659;GO:0015031;GO:0032483;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:insulin-responsive compartment; C:intracellular membrane-bounded organelle; C:plasma membrane; C:retromer complex;, F:guanyl-nucleotide exchange factor activity;, P:cellular response to insulin stimulus; P:protein localization to plasma membrane; P:protein transport; P:regulation of Rab protein signal transduction;|Q9NUT1 Q9NWA5 Q9NWT3 R4GN35 R4GNB2,DENN domain-containing protein 4C,, PF03455;PF02141;PF03456;, GO:0031410;GO:0030659;GO:0005829;GO:0005794;GO:0032593;GO:0043231;GO:0005886;GO:0030904;GO:0005085;GO:0032869;GO:0072659;GO:0015031;GO:0032483;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:insulin-responsive compartment; C:intracellular membrane-bounded organelle; C:plasma membrane; C:retromer complex;, F:guanyl-nucleotide exchange factor activity;, P:cellular response to insulin stimulus; P:protein localization to plasma membrane; P:protein transport; P:regulation of Rab protein signal transduction;|Q9NUT1 Q9NWA5 Q9NWT3 R4GN35 R4GNB2,DENN domain-containing protein 4C,, PF03455;PF02141;PF03456;, GO:0031410;GO:0030659;GO:0005829;GO:0005794;GO:0032593;GO:0043231;GO:0005886;GO:0030904;GO:0005085;GO:0032869;GO:0072659;GO:0015031;GO:0032483;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:insulin-responsive compartment; C:intracellular membrane-bounded organelle; C:plasma membrane; C:retromer complex;, F:guanyl-nucleotide exchange factor activity;, P:cellular response to insulin stimulus; P:protein localization to plasma membrane; P:protein transport; P:regulation of Rab protein signal transduction;|P62753 P08227 P10660 Q4VBY7 Q8N6Z7,40S ribosomal protein S6 {ECO:0000303|PubMed:29563586},Phosphoprotein NP33;Small ribosomal subunit protein eS6 {ECO:0000303|PubMed:24524803};, PF01092;, GO:0044297;GO:0036464;GO:0005829;GO:0022627;GO:0030425;GO:0005783;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005844;GO:1990904;GO:0015935;GO:0019901;GO:0003723;GO:0003735;GO:0006924;GO:0048821;GO:0000082;GO:0007369;GO:0042593;GO:0022605;GO:0043066;GO:0000184;GO:0001890;GO:0043065;GO:0008284;GO:0042274;GO:0006364;GO:0006614;GO:0033077;GO:0002309;GO:0031929;GO:0006412;GO:0006413;GO:0019083;, C:cell body; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic small ribosomal subunit; C:dendrite; C:endoplasmic reticulum; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:small ribosomal subunit;, F:protein kinase binding; F:RNA binding; F:structural constituent of ribosome;, P:activation-induced cell death of T cells; P:erythrocyte development; P:G1/S transition of mitotic cell cycle; P:gastrulation; P:glucose homeostasis; P:mammalian oogenesis stage; P:negative regulation of apoptotic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:placenta development; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:T cell differentiation in thymus; P:T cell proliferation involved in immune response; P:TOR signaling; P:translation; P:translational initiation; P:viral transcription;|P62753 P08227 P10660 Q4VBY7 Q8N6Z7,40S ribosomal protein S6 {ECO:0000303|PubMed:29563586},Phosphoprotein NP33;Small ribosomal subunit protein eS6 {ECO:0000303|PubMed:24524803};, PF01092;, GO:0044297;GO:0036464;GO:0005829;GO:0022627;GO:0030425;GO:0005783;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005844;GO:1990904;GO:0015935;GO:0019901;GO:0003723;GO:0003735;GO:0006924;GO:0048821;GO:0000082;GO:0007369;GO:0042593;GO:0022605;GO:0043066;GO:0000184;GO:0001890;GO:0043065;GO:0008284;GO:0042274;GO:0006364;GO:0006614;GO:0033077;GO:0002309;GO:0031929;GO:0006412;GO:0006413;GO:0019083;, C:cell body; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic small ribosomal subunit; C:dendrite; C:endoplasmic reticulum; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:small ribosomal subunit;, F:protein kinase binding; F:RNA binding; F:structural constituent of ribosome;, P:activation-induced cell death of T cells; P:erythrocyte development; P:G1/S transition of mitotic cell cycle; P:gastrulation; P:glucose homeostasis; P:mammalian oogenesis stage; P:negative regulation of apoptotic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:placenta development; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:T cell differentiation in thymus; P:T cell proliferation involved in immune response; P:TOR signaling; P:translation; P:translational initiation; P:viral transcription; scaffold2 indexed_genome mRNA 28984948 29018352 . + . ID=transcript_433;Q5QJU3 A2A3R8 Q569G5 Q5VZR7 Q71RD2,Alkaline ceramidase 2 {ECO:0000305},Acylsphingosine deacylase 3-like;N-acylsphingosine amidohydrolase 3-like;, PF05875;, GO:0005794;GO:0000139;GO:0030173;GO:0102121;GO:0071633;GO:0046872;GO:0017040;GO:0006919;GO:0006974;GO:0035690;GO:0046514;GO:0030330;GO:0033629;GO:0001953;GO:0090285;GO:0010942;GO:0008284;GO:0042981;GO:0010506;GO:0032526;GO:0030148;GO:0046512;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane;, F:ceramidase activity; F:dihydroceramidase activity; F:metal ion binding; F:N-acylsphingosine amidohydrolase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:ceramide catabolic process; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell-matrix adhesion; P:negative regulation of protein glycosylation in Golgi; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:regulation of apoptotic process; P:regulation of autophagy; P:response to retinoic acid; P:sphingolipid biosynthetic process; P:sphingosine biosynthetic process;|Q5QJU3 A2A3R8 Q569G5 Q5VZR7 Q71RD2,Alkaline ceramidase 2 {ECO:0000305},Acylsphingosine deacylase 3-like;N-acylsphingosine amidohydrolase 3-like;, PF05875;, GO:0005794;GO:0000139;GO:0030173;GO:0102121;GO:0071633;GO:0046872;GO:0017040;GO:0006919;GO:0006974;GO:0035690;GO:0046514;GO:0030330;GO:0033629;GO:0001953;GO:0090285;GO:0010942;GO:0008284;GO:0042981;GO:0010506;GO:0032526;GO:0030148;GO:0046512;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane;, F:ceramidase activity; F:dihydroceramidase activity; F:metal ion binding; F:N-acylsphingosine amidohydrolase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:ceramide catabolic process; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell-matrix adhesion; P:negative regulation of protein glycosylation in Golgi; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:regulation of apoptotic process; P:regulation of autophagy; P:response to retinoic acid; P:sphingolipid biosynthetic process; P:sphingosine biosynthetic process; scaffold2 indexed_genome mRNA 29064804 29335386 . - . ID=transcript_434;Q9UI40 B7ZLL8 Q9NTN5 Q9NZQ4,Sodium/potassium/calcium exchanger 2,Na(+)/K(+)/Ca(2+)-exchange protein 2;Retinal cone Na-Ca+K exchanger;Solute carrier family 24 member 2;, PF01699;, GO:0005887;GO:0001917;GO:0005886;GO:0005262;GO:0008273;GO:0015293;GO:0098703;GO:0070588;GO:0006874;GO:0034220;GO:0006811;GO:0007612;GO:0060292;GO:0060291;GO:0007613;GO:0071805;GO:0065003;GO:0050896;GO:0035725;GO:0007601;, C:integral component of plasma membrane; C:photoreceptor inner segment; C:plasma membrane;, F:calcium channel activity; F:calcium, potassium:sodium antiporter activity; F:symporter activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:ion transport; P:learning; P:long-term synaptic depression; P:long-term synaptic potentiation; P:memory; P:potassium ion transmembrane transport; P:protein-containing complex assembly; P:response to stimulus; P:sodium ion transmembrane transport; P:visual perception; scaffold2 indexed_genome mRNA 30171665 30440012 . + . ID=transcript_435;Q5VW36 D3DRJ9 Q6ZME1 Q8IZG0 Q96JM8 Q96MS9 Q9BVF3 Q9NX87,Focadhesin,, PF12530;PF11229;, GO:0005925;GO:0016021;, C:focal adhesion; C:integral component of membrane;|Q5VW36 D3DRJ9 Q6ZME1 Q8IZG0 Q96JM8 Q96MS9 Q9BVF3 Q9NX87,Focadhesin,, PF12530;PF11229;, GO:0005925;GO:0016021;, C:focal adhesion; C:integral component of membrane; scaffold2 indexed_genome mRNA 30455136 30479653 . - . ID=transcript_436;Q5VWC8 Q7Z385,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 4 {ECO:0000303|PubMed:18554506};Protein-tyrosine phosphatase-like A domain-containing protein 2 {ECO:0000312|HGNC:HGNC:20920};, PF04387;, GO:0005783;GO:0030176;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0102158;GO:0030497;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:fatty acid elongation; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q5VWC8 Q7Z385,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 4 {ECO:0000303|PubMed:18554506};Protein-tyrosine phosphatase-like A domain-containing protein 2 {ECO:0000312|HGNC:HGNC:20920};, PF04387;, GO:0005783;GO:0030176;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0102158;GO:0030497;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:fatty acid elongation; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold2 indexed_genome mRNA 30844930 30849244 . + . ID=transcript_437;Q9P2J3 Q8TCQ2,Kelch-like protein 9,, PF07707;PF00651;PF01344;, GO:0031463;GO:0005829;GO:0030496;GO:0097602;GO:0007049;GO:0051301;GO:0043687;GO:0016567;GO:0032465;, C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:midbody;, F:cullin family protein binding;, P:cell cycle; P:cell division; P:post-translational protein modification; P:protein ubiquitination; P:regulation of cytokinesis; scaffold2 indexed_genome mRNA 30997649 30998678 . + . ID=transcript_438;P01569 Q52LX3,Interferon alpha-5,Interferon alpha-61;Interferon alpha-G;, PF00143;, GO:0005576;GO:0005615;GO:0005125;GO:0005126;GO:0005132;GO:0002250;GO:0030183;GO:0042100;GO:0007596;GO:0019221;GO:0051607;GO:0006959;GO:0002323;GO:0033141;GO:0043330;GO:0002286;GO:0060337;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:cytokine receptor binding; F:type I interferon receptor binding;, P:adaptive immune response; P:B cell differentiation; P:B cell proliferation; P:blood coagulation; P:cytokine-mediated signaling pathway; P:defense response to virus; P:humoral immune response; P:natural killer cell activation involved in immune response; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; P:response to exogenous dsRNA; P:T cell activation involved in immune response; P:type I interferon signaling pathway; scaffold2 indexed_genome mRNA 31013913 31017970 . + . ID=transcript_439;P05000 Q13168 Q5U802 Q5VWD0 Q7M4P5,Interferon omega-1,Interferon alpha-II-1;, PF00143;, GO:0005615;GO:0005125;GO:0005126;GO:0005132;GO:0002250;GO:0030183;GO:0042100;GO:0007050;GO:0019221;GO:0051607;GO:0006959;GO:0002323;GO:0033141;GO:0043330;GO:0009615;GO:0002286;, C:extracellular space;, F:cytokine activity; F:cytokine receptor binding; F:type I interferon receptor binding;, P:adaptive immune response; P:B cell differentiation; P:B cell proliferation; P:cell cycle arrest; P:cytokine-mediated signaling pathway; P:defense response to virus; P:humoral immune response; P:natural killer cell activation involved in immune response; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; P:response to exogenous dsRNA; P:response to virus; P:T cell activation involved in immune response; scaffold2 indexed_genome mRNA 31320792 31362802 . + . ID=transcript_440;Q13126 I2G7M5 I2G7M6 I2G7M7 I2G7M8 I2G7M9 I2G7N0 Q5T3P3 Q9H010,S-methyl-5'-thioadenosine phosphorylase {ECO:0000255|HAMAP-Rule:MF_03155},5'-methylthioadenosine phosphorylase {ECO:0000255|HAMAP-Rule:MF_03155};, PF01048;, GO:0005829;GO:0070062;GO:0005654;GO:0004645;GO:0017061;GO:0035722;GO:0019509;GO:0006139;GO:0006166;GO:0033574;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:1,4-alpha-oligoglucan phosphorylase activity; F:S-methyl-5-thioadenosine phosphorylase activity;, P:interleukin-12-mediated signaling pathway; P:L-methionine salvage from methylthioadenosine; P:nucleobase-containing compound metabolic process; P:purine ribonucleoside salvage; P:response to testosterone; scaffold2 indexed_genome mRNA 31430035 31455984 . + . ID=transcript_441;P42771 A5X2G7 D3DRK1 G3XAG3 O95440 Q15191 Q5VVJ5 Q96B52 Q9NP05,Cyclin-dependent kinase inhibitor 2A {ECO:0000312|HGNC:HGNC:1787},Cyclin-dependent kinase 4 inhibitor A;Multiple tumor suppressor 1;p16-INK4a;, , GO:0005737;GO:0005829;GO:0005634;GO:0035985;GO:0004861;GO:0051059;GO:0019901;GO:0003723;GO:0007050;GO:0090398;GO:0000082;GO:0030308;GO:0008285;GO:0001953;GO:0045736;GO:2000134;GO:0032088;GO:0042326;GO:0045892;GO:2000774;GO:2000111;GO:0034393;GO:0007265;GO:0060260;GO:0090399;GO:0035986;, C:cytoplasm; C:cytosol; C:nucleus; C:senescence-associated heterochromatin focus;, F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:NF-kappaB binding; F:protein kinase binding; F:RNA binding;, P:cell cycle arrest; P:cellular senescence; P:G1/S transition of mitotic cell cycle; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-matrix adhesion; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cellular senescence; P:positive regulation of macrophage apoptotic process; P:positive regulation of smooth muscle cell apoptotic process; P:Ras protein signal transduction; P:regulation of transcription initiation from RNA polymerase II promoter; P:replicative senescence; P:senescence-associated heterochromatin focus assembly; scaffold2 indexed_genome mRNA 31467222 31470276 . - . ID=transcript_442;P42772 O15125 Q6FI09,Cyclin-dependent kinase 4 inhibitor B,Multiple tumor suppressor 2;p14-INK4b;p15-INK4b;, , GO:0005737;GO:0005829;GO:0005634;GO:0004861;GO:0019901;GO:0007050;GO:0031668;GO:0031670;GO:0090398;GO:0000086;GO:0030219;GO:0008285;GO:0050680;GO:2000134;GO:0042326;GO:0045944;GO:0030511;GO:0000079;GO:0070316;GO:0048536;, C:cytoplasm; C:cytosol; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:protein kinase binding;, P:cell cycle arrest; P:cellular response to extracellular stimulus; P:cellular response to nutrient; P:cellular senescence; P:G2/M transition of mitotic cell cycle; P:megakaryocyte differentiation; P:negative regulation of cell population proliferation; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of G0 to G1 transition; P:spleen development;|P42772 O15125 Q6FI09,Cyclin-dependent kinase 4 inhibitor B,Multiple tumor suppressor 2;p14-INK4b;p15-INK4b;, , GO:0005737;GO:0005829;GO:0005634;GO:0004861;GO:0019901;GO:0007050;GO:0031668;GO:0031670;GO:0090398;GO:0000086;GO:0030219;GO:0008285;GO:0050680;GO:2000134;GO:0042326;GO:0045944;GO:0030511;GO:0000079;GO:0070316;GO:0048536;, C:cytoplasm; C:cytosol; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:protein kinase binding;, P:cell cycle arrest; P:cellular response to extracellular stimulus; P:cellular response to nutrient; P:cellular senescence; P:G2/M transition of mitotic cell cycle; P:megakaryocyte differentiation; P:negative regulation of cell population proliferation; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of G0 to G1 transition; P:spleen development; scaffold2 indexed_genome mRNA 31827803 31828582 . - . ID=transcript_443;Q5VZB9 A1L481 Q8N8Y9 Q9H4B9,Doublesex- and mab-3-related transcription factor A1,, PF00751;PF03474;, GO:0000785;GO:0005634;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0007281;GO:0060179;GO:0001541;GO:0006357;GO:0007548;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:germ cell development; P:male mating behavior; P:ovarian follicle development; P:regulation of transcription by RNA polymerase II; P:sex differentiation; scaffold2 indexed_genome mRNA 32996567 33076048 . - . ID=transcript_444;Q12926 D3DRK3 Q13235 Q59G15 Q8NEM4 Q9H1Q8,ELAV-like protein 2,ELAV-like neuronal protein 1;Hu-antigen B;Nervous system-specific RNA-binding protein Hel-N1;, PF00076;, GO:0005654;GO:1990904;GO:0003730;GO:0003723;GO:0000398;GO:0006355;, C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:regulation of transcription, DNA-templated; scaffold2 indexed_genome mRNA 34716814 34726339 . - . ID=transcript_445;Q9NRP0 A8MYS2 B2R5H1 D6RH22 Q9P075 Q9P1R4,Oligosaccharyltransferase complex subunit OSTC,Hydrophobic protein HSF-28;, PF04756;, GO:0016021;GO:0008250;GO:0018279;, C:integral component of membrane; C:oligosaccharyltransferase complex;, , P:protein N-linked glycosylation via asparagine; scaffold2 indexed_genome mRNA 34753275 34755094 . - . ID=transcript_446;P49207 Q6FG66 Q9BUZ2,60S ribosomal protein L34,Large ribosomal subunit protein eL34 {ECO:0000303|PubMed:24524803};, PF01199;, GO:0005829;GO:0022625;GO:0005783;GO:0070062;GO:0045296;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome;, F:cadherin binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold2 indexed_genome mRNA 35275817 35317637 . - . ID=transcript_447;Q16836 J3KQ17 O00324 O00397 O00753 Q4W5B4,Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial,Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase;Short-chain 3-hydroxyacyl-CoA dehydrogenase {ECO:0000303|PubMed:8687463};, PF00725;PF02737;, GO:0005737;GO:0005759;GO:0005739;GO:0005654;GO:0003857;GO:0042802;GO:0070403;GO:0016740;GO:0006635;GO:0120162;GO:0050796;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:identical protein binding; F:NAD+ binding; F:transferase activity;, P:fatty acid beta-oxidation; P:positive regulation of cold-induced thermogenesis; P:regulation of insulin secretion;|Q16836 J3KQ17 O00324 O00397 O00753 Q4W5B4,Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial,Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase;Short-chain 3-hydroxyacyl-CoA dehydrogenase {ECO:0000303|PubMed:8687463};, PF00725;PF02737;, GO:0005737;GO:0005759;GO:0005739;GO:0005654;GO:0003857;GO:0042802;GO:0070403;GO:0016740;GO:0006635;GO:0120162;GO:0050796;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:identical protein binding; F:NAD+ binding; F:transferase activity;, P:fatty acid beta-oxidation; P:positive regulation of cold-induced thermogenesis; P:regulation of insulin secretion;|Q16836 J3KQ17 O00324 O00397 O00753 Q4W5B4,Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial,Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase;Short-chain 3-hydroxyacyl-CoA dehydrogenase {ECO:0000303|PubMed:8687463};, PF00725;PF02737;, GO:0005737;GO:0005759;GO:0005739;GO:0005654;GO:0003857;GO:0042802;GO:0070403;GO:0016740;GO:0006635;GO:0120162;GO:0050796;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:identical protein binding; F:NAD+ binding; F:transferase activity;, P:fatty acid beta-oxidation; P:positive regulation of cold-induced thermogenesis; P:regulation of insulin secretion;|Q16836 J3KQ17 O00324 O00397 O00753 Q4W5B4,Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial,Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase;Short-chain 3-hydroxyacyl-CoA dehydrogenase {ECO:0000303|PubMed:8687463};, PF00725;PF02737;, GO:0005737;GO:0005759;GO:0005739;GO:0005654;GO:0003857;GO:0042802;GO:0070403;GO:0016740;GO:0006635;GO:0120162;GO:0050796;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:identical protein binding; F:NAD+ binding; F:transferase activity;, P:fatty acid beta-oxidation; P:positive regulation of cold-induced thermogenesis; P:regulation of insulin secretion; scaffold2 indexed_genome mRNA 35324241 35328290 . + . ID=transcript_448;Q7Z449 B2RMV7 Q96EQ6,Cytochrome P450 2U1 {ECO:0000303|PubMed:24563460},Long-chain fatty acid omega-monooxygenase {ECO:0000305|PubMed:24563460};, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0005743;GO:0052869;GO:0020037;GO:0005506;GO:0102033;GO:0016712;GO:0008395;GO:0042738;GO:0097267;GO:0006082;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane;, F:arachidonic acid omega-hydroxylase activity; F:heme binding; F:iron ion binding; F:long-chain fatty acid omega-hydroxylase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:exogenous drug catabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:xenobiotic metabolic process; scaffold2 indexed_genome mRNA 35331630 35333041 . - . ID=transcript_449;Q7Z449 B2RMV7 Q96EQ6,Cytochrome P450 2U1 {ECO:0000303|PubMed:24563460},Long-chain fatty acid omega-monooxygenase {ECO:0000305|PubMed:24563460};, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0005743;GO:0052869;GO:0020037;GO:0005506;GO:0102033;GO:0016712;GO:0008395;GO:0042738;GO:0097267;GO:0006082;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane;, F:arachidonic acid omega-hydroxylase activity; F:heme binding; F:iron ion binding; F:long-chain fatty acid omega-hydroxylase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:exogenous drug catabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:xenobiotic metabolic process; scaffold2 indexed_genome mRNA 35363844 35452495 . - . ID=transcript_450;Q8NHU3 A8K2S9 B2RA61,Phosphatidylcholine:ceramide cholinephosphotransferase 2,Sphingomyelin synthase 2 {ECO:0000303|PubMed:19233134};, PF14360;, GO:0005794;GO:0030176;GO:0030173;GO:0005887;GO:0005886;GO:0047493;GO:0002950;GO:0016301;GO:0033188;GO:0046513;GO:1905373;GO:0030500;GO:0030148;GO:0006686;, C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:integral component of plasma membrane; C:plasma membrane;, F:ceramide cholinephosphotransferase activity; F:ceramide phosphoethanolamine synthase activity; F:kinase activity; F:sphingomyelin synthase activity;, P:ceramide biosynthetic process; P:ceramide phosphoethanolamine biosynthetic process; P:regulation of bone mineralization; P:sphingolipid biosynthetic process; P:sphingomyelin biosynthetic process; scaffold2 indexed_genome mRNA 35544760 35654512 . + . ID=transcript_451;O43252 O43841 O75332 Q6IAX6 Q96FB1 Q96TF4 Q9P1P9 Q9UE98,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,Sulfurylase kinase 1;, PF01747;PF14306;, GO:0005829;GO:0004020;GO:0005524;GO:0016779;GO:0042803;GO:0004781;GO:0050428;GO:0001501;GO:0000103;, C:cytosol;, F:adenylylsulfate kinase activity; F:ATP binding; F:nucleotidyltransferase activity; F:protein homodimerization activity; F:sulfate adenylyltransferase (ATP) activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; P:skeletal system development; P:sulfate assimilation; scaffold2 indexed_genome mRNA 36151588 36274940 . + . ID=transcript_452;Q9UBU2 A0AVE9 B2R6S7 Q9UIU3,Dickkopf-related protein 2,, PF04706;, GO:0005615;GO:0039706;GO:0048019;GO:0007275;GO:0090090;GO:0090263;GO:0016055;, C:extracellular space;, F:co-receptor binding; F:receptor antagonist activity;, P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold2 indexed_genome mRNA 36806975 36845042 . - . ID=transcript_453;Q12904 B3KTR2 B4E1S7 Q6FG28 Q96CQ9,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1,Multisynthase complex auxiliary component p43;, PF01588;, GO:0017101;GO:0009986;GO:0005829;GO:0005783;GO:0005615;GO:0005794;GO:0016020;GO:0005634;GO:0005125;GO:0051020;GO:0042803;GO:0000049;GO:0001525;GO:0006915;GO:0007267;GO:0051607;GO:0006954;GO:0050900;GO:0001937;GO:0070094;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cell surface; C:cytosol; C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus; C:membrane; C:nucleus;, F:cytokine activity; F:GTPase binding; F:protein homodimerization activity; F:tRNA binding;, P:angiogenesis; P:apoptotic process; P:cell-cell signaling; P:defense response to virus; P:inflammatory response; P:leukocyte migration; P:negative regulation of endothelial cell proliferation; P:positive regulation of glucagon secretion; P:tRNA aminoacylation for protein translation;|Q12904 B3KTR2 B4E1S7 Q6FG28 Q96CQ9,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1,Multisynthase complex auxiliary component p43;, PF01588;, GO:0017101;GO:0009986;GO:0005829;GO:0005783;GO:0005615;GO:0005794;GO:0016020;GO:0005634;GO:0005125;GO:0051020;GO:0042803;GO:0000049;GO:0001525;GO:0006915;GO:0007267;GO:0051607;GO:0006954;GO:0050900;GO:0001937;GO:0070094;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cell surface; C:cytosol; C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus; C:membrane; C:nucleus;, F:cytokine activity; F:GTPase binding; F:protein homodimerization activity; F:tRNA binding;, P:angiogenesis; P:apoptotic process; P:cell-cell signaling; P:defense response to virus; P:inflammatory response; P:leukocyte migration; P:negative regulation of endothelial cell proliferation; P:positive regulation of glucagon secretion; P:tRNA aminoacylation for protein translation;|Q12904 B3KTR2 B4E1S7 Q6FG28 Q96CQ9,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1,Multisynthase complex auxiliary component p43;, PF01588;, GO:0017101;GO:0009986;GO:0005829;GO:0005783;GO:0005615;GO:0005794;GO:0016020;GO:0005634;GO:0005125;GO:0051020;GO:0042803;GO:0000049;GO:0001525;GO:0006915;GO:0007267;GO:0051607;GO:0006954;GO:0050900;GO:0001937;GO:0070094;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cell surface; C:cytosol; C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus; C:membrane; C:nucleus;, F:cytokine activity; F:GTPase binding; F:protein homodimerization activity; F:tRNA binding;, P:angiogenesis; P:apoptotic process; P:cell-cell signaling; P:defense response to virus; P:inflammatory response; P:leukocyte migration; P:negative regulation of endothelial cell proliferation; P:positive regulation of glucagon secretion; P:tRNA aminoacylation for protein translation; scaffold2 indexed_genome mRNA 36853527 37050850 . + . ID=transcript_454;Q8TEA7 B9A6J1 Q4W5B3 Q4W5E1 Q6NUP4 Q8N7M8 Q8WW57 Q96GV6 Q9P080,TBC domain-containing protein kinase-like protein,, PF00069;PF00566;PF00581;, GO:0005737;GO:0030496;GO:0072686;GO:0005524;GO:0005096;GO:0004672;GO:0030036;GO:0090630;GO:0008283;GO:0006886;GO:0032006;, C:cytoplasm; C:midbody; C:mitotic spindle;, F:ATP binding; F:GTPase activator activity; F:protein kinase activity;, P:actin cytoskeleton organization; P:activation of GTPase activity; P:cell population proliferation; P:intracellular protein transport; P:regulation of TOR signaling; scaffold2 indexed_genome mRNA 37128394 37204484 . - . ID=transcript_455;E9PCQ1 E9PE64 E9PF04,Nephronectin,Preosteoblast EGF-like repeat protein with MAM domain;Protein EGFL6-like;, PF07645;PF00629;, GO:0062023;GO:0070062;GO:0005576;GO:0016020;GO:0005509;GO:0005178;GO:0001658;GO:0030154;GO:0033631;GO:0007160;GO:0071356;GO:0030198;GO:0010811;GO:0070374;GO:0045669;GO:0001657;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:membrane;, F:calcium ion binding; F:integrin binding;, P:branching involved in ureteric bud morphogenesis; P:cell differentiation; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cellular response to tumor necrosis factor; P:extracellular matrix organization; P:positive regulation of cell-substrate adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of osteoblast differentiation; P:ureteric bud development; scaffold2 indexed_genome mRNA 37250937 37371670 . - . ID=transcript_456;Q8NEC7 A8K8J0 A8MVD3 H9KV97 Q9H8S3,Glutathione S-transferase C-terminal domain-containing protein,, PF13679;, GO:0005737;GO:0070062;, C:cytoplasm; C:extracellular exosome; scaffold2 indexed_genome mRNA 37385471 37416585 . + . ID=transcript_457;Q96CB8 B2RC48 Q3B6Z3 Q9HD71,Integrator complex subunit 12,PHD finger protein 22;, PF00628;, GO:0032039;GO:0005654;GO:0005634;GO:0046872;GO:0034472;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm; C:nucleus;, F:metal ion binding;, P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q96CB8 B2RC48 Q3B6Z3 Q9HD71,Integrator complex subunit 12,PHD finger protein 22;, PF00628;, GO:0032039;GO:0005654;GO:0005634;GO:0046872;GO:0034472;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm; C:nucleus;, F:metal ion binding;, P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold2 indexed_genome mRNA 37605731 37703012 . + . ID=transcript_458;Q9NX37 Q9P033 Q9ULX0,Inorganic pyrophosphatase 2, mitochondrial,Pyrophosphatase SID6-306;Pyrophosphate phospho-hydrolase 2;, PF00719;, GO:0005829;GO:0005759;GO:0004427;GO:0000287;GO:0004722;GO:0071344;GO:0006796;GO:0051881;GO:0006418;, C:cytosol; C:mitochondrial matrix;, F:inorganic diphosphatase activity; F:magnesium ion binding; F:protein serine/threonine phosphatase activity;, P:diphosphate metabolic process; P:phosphate-containing compound metabolic process; P:regulation of mitochondrial membrane potential; P:tRNA aminoacylation for protein translation;|P61956 B2R4I2 P55855 Q32Q42 Q6IPZ6 Q96HK1,Small ubiquitin-related modifier 2 {ECO:0000305},HSMT3 {ECO:0000303|PubMed:8630065};SMT3 homolog 2 {ECO:0000312|HGNC:HGNC:11125};SUMO-3 {ECO:0000303|PubMed:10692421};Sentrin-2 {ECO:0000303|PubMed:9556629};Ubiquitin-like protein SMT3B {ECO:0000305};, PF11976;, GO:0005654;GO:0005634;GO:0016605;GO:0031386;GO:0003723;GO:0031625;GO:0044389;GO:0032436;GO:0016925;, C:nucleoplasm; C:nucleus; C:PML body;, F:protein tag; F:RNA binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein sumoylation; scaffold2 indexed_genome mRNA 37788906 37824150 . - . ID=transcript_459;Q6N021 B5MDU0 Q2TB88 Q3LIB8 Q96JX5 Q9HCM6 Q9NXW0,Methylcytosine dioxygenase TET2,, PF12851;, GO:0005634;GO:0003677;GO:0008198;GO:0070579;GO:0008270;GO:0006211;GO:0007049;GO:0080111;GO:0080182;GO:0030099;GO:0070989;GO:0045944;GO:0006493;, C:nucleus;, F:DNA binding; F:ferrous iron binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:cell cycle; P:DNA demethylation; P:histone H3-K4 trimethylation; P:myeloid cell differentiation; P:oxidative demethylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation;|Q6N021 B5MDU0 Q2TB88 Q3LIB8 Q96JX5 Q9HCM6 Q9NXW0,Methylcytosine dioxygenase TET2,, PF12851;, GO:0005634;GO:0003677;GO:0008198;GO:0070579;GO:0008270;GO:0006211;GO:0007049;GO:0080111;GO:0080182;GO:0030099;GO:0070989;GO:0045944;GO:0006493;, C:nucleus;, F:DNA binding; F:ferrous iron binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:cell cycle; P:DNA demethylation; P:histone H3-K4 trimethylation; P:myeloid cell differentiation; P:oxidative demethylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation; scaffold2 indexed_genome mRNA 37824165 37825157 . + . ID=transcript_460;Q6N021 B5MDU0 Q2TB88 Q3LIB8 Q96JX5 Q9HCM6 Q9NXW0,Methylcytosine dioxygenase TET2,, PF12851;, GO:0005634;GO:0003677;GO:0008198;GO:0070579;GO:0008270;GO:0006211;GO:0007049;GO:0080111;GO:0080182;GO:0030099;GO:0070989;GO:0045944;GO:0006493;, C:nucleus;, F:DNA binding; F:ferrous iron binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:cell cycle; P:DNA demethylation; P:histone H3-K4 trimethylation; P:myeloid cell differentiation; P:oxidative demethylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation; scaffold2 indexed_genome mRNA 37825179 37831571 . - . ID=transcript_461;Q6N021 B5MDU0 Q2TB88 Q3LIB8 Q96JX5 Q9HCM6 Q9NXW0,Methylcytosine dioxygenase TET2,, PF12851;, GO:0005634;GO:0003677;GO:0008198;GO:0070579;GO:0008270;GO:0006211;GO:0007049;GO:0080111;GO:0080182;GO:0030099;GO:0070989;GO:0045944;GO:0006493;, C:nucleus;, F:DNA binding; F:ferrous iron binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:cell cycle; P:DNA demethylation; P:histone H3-K4 trimethylation; P:myeloid cell differentiation; P:oxidative demethylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation;|Q6N021 B5MDU0 Q2TB88 Q3LIB8 Q96JX5 Q9HCM6 Q9NXW0,Methylcytosine dioxygenase TET2,, PF12851;, GO:0005634;GO:0003677;GO:0008198;GO:0070579;GO:0008270;GO:0006211;GO:0007049;GO:0080111;GO:0080182;GO:0030099;GO:0070989;GO:0045944;GO:0006493;, C:nucleus;, F:DNA binding; F:ferrous iron binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:cell cycle; P:DNA demethylation; P:histone H3-K4 trimethylation; P:myeloid cell differentiation; P:oxidative demethylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation;|Q6N021 B5MDU0 Q2TB88 Q3LIB8 Q96JX5 Q9HCM6 Q9NXW0,Methylcytosine dioxygenase TET2,, PF12851;, GO:0005634;GO:0003677;GO:0008198;GO:0070579;GO:0008270;GO:0006211;GO:0007049;GO:0080111;GO:0080182;GO:0030099;GO:0070989;GO:0045944;GO:0006493;, C:nucleus;, F:DNA binding; F:ferrous iron binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:cell cycle; P:DNA demethylation; P:histone H3-K4 trimethylation; P:myeloid cell differentiation; P:oxidative demethylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation; scaffold2 indexed_genome mRNA 38527043 38547613 . + . ID=transcript_462;Q9H2H0,CXXC-type zinc finger protein 4,Inhibition of the Dvl and axin complex protein;, PF02008;, GO:0005737;GO:0031410;GO:0005634;GO:0008327;GO:0030165;GO:0008270;GO:0030178;GO:0016055;GO:0007352;, C:cytoplasm; C:cytoplasmic vesicle; C:nucleus;, F:methyl-CpG binding; F:PDZ domain binding; F:zinc ion binding;, P:negative regulation of Wnt signaling pathway; P:Wnt signaling pathway; P:zygotic specification of dorsal/ventral axis; scaffold2 indexed_genome mRNA 39476737 39490764 . + . ID=transcript_463;Q02224 A6NKY9 A8K2U7 Q4LE75,Centromere-associated protein E,Centromere protein E;Kinesin-7 {ECO:0000303|PubMed:25908662};Kinesin-related protein CENPE;, PF00225;, GO:0005694;GO:0000775;GO:0000777;GO:0000779;GO:0005829;GO:0000776;GO:0005828;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0043515;GO:0008017;GO:0003777;GO:0019886;GO:0051315;GO:0051301;GO:0007059;GO:0051382;GO:0099607;GO:0051310;GO:0099606;GO:0007018;GO:0000278;GO:0007079;GO:0007080;GO:0007052;GO:0007275;GO:0045860;GO:0030071;GO:0006890;, C:chromosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:condensed chromosome, centromeric region; C:cytosol; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:kinetochore binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore assembly; P:lateral attachment of mitotic spindle microtubules to kinetochore; P:metaphase plate congression; P:microtubule plus-end directed mitotic chromosome migration; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:multicellular organism development; P:positive regulation of protein kinase activity; P:regulation of mitotic metaphase/anaphase transition; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q02224 A6NKY9 A8K2U7 Q4LE75,Centromere-associated protein E,Centromere protein E;Kinesin-7 {ECO:0000303|PubMed:25908662};Kinesin-related protein CENPE;, PF00225;, GO:0005694;GO:0000775;GO:0000777;GO:0000779;GO:0005829;GO:0000776;GO:0005828;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0043515;GO:0008017;GO:0003777;GO:0019886;GO:0051315;GO:0051301;GO:0007059;GO:0051382;GO:0099607;GO:0051310;GO:0099606;GO:0007018;GO:0000278;GO:0007079;GO:0007080;GO:0007052;GO:0007275;GO:0045860;GO:0030071;GO:0006890;, C:chromosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:condensed chromosome, centromeric region; C:cytosol; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:kinetochore binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore assembly; P:lateral attachment of mitotic spindle microtubules to kinetochore; P:metaphase plate congression; P:microtubule plus-end directed mitotic chromosome migration; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:multicellular organism development; P:positive regulation of protein kinase activity; P:regulation of mitotic metaphase/anaphase transition; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold2 indexed_genome mRNA 39505293 39507932 . - . ID=transcript_464;Q02224 A6NKY9 A8K2U7 Q4LE75,Centromere-associated protein E,Centromere protein E;Kinesin-7 {ECO:0000303|PubMed:25908662};Kinesin-related protein CENPE;, PF00225;, GO:0005694;GO:0000775;GO:0000777;GO:0000779;GO:0005829;GO:0000776;GO:0005828;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0043515;GO:0008017;GO:0003777;GO:0019886;GO:0051315;GO:0051301;GO:0007059;GO:0051382;GO:0099607;GO:0051310;GO:0099606;GO:0007018;GO:0000278;GO:0007079;GO:0007080;GO:0007052;GO:0007275;GO:0045860;GO:0030071;GO:0006890;, C:chromosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:condensed chromosome, centromeric region; C:cytosol; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:kinetochore binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore assembly; P:lateral attachment of mitotic spindle microtubules to kinetochore; P:metaphase plate congression; P:microtubule plus-end directed mitotic chromosome migration; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:multicellular organism development; P:positive regulation of protein kinase activity; P:regulation of mitotic metaphase/anaphase transition; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold2 indexed_genome mRNA 39551840 39589161 . + . ID=transcript_465;Q96EY4 Q0P6E4 Q0P6J1 Q9NUR7,Translation machinery-associated protein 16,, PF11176;, GO:0005730;GO:0005654;GO:0005634;, C:nucleolus; C:nucleoplasm; C:nucleus;|Q96EY4 Q0P6E4 Q0P6J1 Q9NUR7,Translation machinery-associated protein 16,, PF11176;, GO:0005730;GO:0005654;GO:0005634;, C:nucleolus; C:nucleoplasm; C:nucleus;|Q96EY4 Q0P6E4 Q0P6J1 Q9NUR7,Translation machinery-associated protein 16,, PF11176;, GO:0005730;GO:0005654;GO:0005634;, C:nucleolus; C:nucleoplasm; C:nucleus;|Q96EY4 Q0P6E4 Q0P6J1 Q9NUR7,Translation machinery-associated protein 16,, PF11176;, GO:0005730;GO:0005654;GO:0005634;, C:nucleolus; C:nucleoplasm; C:nucleus; scaffold2 indexed_genome mRNA 39616368 39621788 . + . ID=transcript_466;Q9BUT1 A8K295 B4DUF6 Q503A0 Q6IA46 Q6UWD3 Q9H8S8 Q9NRX8,3-hydroxybutyrate dehydrogenase type 2,Dehydrogenase/reductase SDR family member 6;Oxidoreductase UCPA;R-beta-hydroxybutyrate dehydrogenase;Short chain dehydrogenase/reductase family 15C member 1;, , GO:0005737;GO:0005829;GO:0070062;GO:0003858;GO:0051287;GO:0016628;GO:0016616;GO:0030855;GO:0006635;GO:0042168;GO:0055072;GO:0046951;GO:0019290;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:3-hydroxybutyrate dehydrogenase activity; F:NAD binding; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:epithelial cell differentiation; P:fatty acid beta-oxidation; P:heme metabolic process; P:iron ion homeostasis; P:ketone body biosynthetic process; P:siderophore biosynthetic process; scaffold2 indexed_genome mRNA 39624353 39624911 . + . ID=transcript_467;Q9BUT1 A8K295 B4DUF6 Q503A0 Q6IA46 Q6UWD3 Q9H8S8 Q9NRX8,3-hydroxybutyrate dehydrogenase type 2,Dehydrogenase/reductase SDR family member 6;Oxidoreductase UCPA;R-beta-hydroxybutyrate dehydrogenase;Short chain dehydrogenase/reductase family 15C member 1;, , GO:0005737;GO:0005829;GO:0070062;GO:0003858;GO:0051287;GO:0016628;GO:0016616;GO:0030855;GO:0006635;GO:0042168;GO:0055072;GO:0046951;GO:0019290;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:3-hydroxybutyrate dehydrogenase activity; F:NAD binding; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:epithelial cell differentiation; P:fatty acid beta-oxidation; P:heme metabolic process; P:iron ion homeostasis; P:ketone body biosynthetic process; P:siderophore biosynthetic process; scaffold2 indexed_genome mRNA 39629453 39680746 . + . ID=transcript_468;Q86UD5 B5ME52 Q6ZMD8 Q96D95,Sodium/hydrogen exchanger 9B2,Na(+)/H(+) exchanger NHA2;Na(+)/H(+) exchanger-like domain-containing protein 2;Sodium/hydrogen exchanger-like domain-containing protein 2;Solute carrier family 9 subfamily B member 2;, PF00999;, GO:0016324;GO:0016323;GO:0010008;GO:0016021;GO:0005743;GO:0031966;GO:0005886;GO:0097228;GO:0030672;GO:0042802;GO:0010348;GO:0015385;GO:0072583;GO:0030317;GO:0098662;GO:0034220;GO:2001206;GO:0061178;GO:0006814;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:plasma membrane; C:sperm principal piece; C:synaptic vesicle membrane;, F:identical protein binding; F:lithium:proton antiporter activity; F:sodium:proton antiporter activity;, P:clathrin-dependent endocytosis; P:flagellated sperm motility; P:inorganic cation transmembrane transport; P:ion transmembrane transport; P:positive regulation of osteoclast development; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:sodium ion transport;|Q86UD5 B5ME52 Q6ZMD8 Q96D95,Sodium/hydrogen exchanger 9B2,Na(+)/H(+) exchanger NHA2;Na(+)/H(+) exchanger-like domain-containing protein 2;Sodium/hydrogen exchanger-like domain-containing protein 2;Solute carrier family 9 subfamily B member 2;, PF00999;, GO:0016324;GO:0016323;GO:0010008;GO:0016021;GO:0005743;GO:0031966;GO:0005886;GO:0097228;GO:0030672;GO:0042802;GO:0010348;GO:0015385;GO:0072583;GO:0030317;GO:0098662;GO:0034220;GO:2001206;GO:0061178;GO:0006814;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:plasma membrane; C:sperm principal piece; C:synaptic vesicle membrane;, F:identical protein binding; F:lithium:proton antiporter activity; F:sodium:proton antiporter activity;, P:clathrin-dependent endocytosis; P:flagellated sperm motility; P:inorganic cation transmembrane transport; P:ion transmembrane transport; P:positive regulation of osteoclast development; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:sodium ion transport; scaffold2 indexed_genome mRNA 39704133 39704854 . + . ID=transcript_469;Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold2 indexed_genome mRNA 39718238 39720243 . + . ID=transcript_470;Q4ZJI4 A1KXV1 B9EH04 C9JBP7 Q49A30 Q8NCV2 Q8WVZ0,Sodium/hydrogen exchanger 9B1,Na(+)/H(+) exchanger-like domain-containing protein 1;Sodium/hydrogen exchanger-like domain-containing protein 1 {ECO:0000303|PubMed:16850186};Solute carrier family 9, subfamily B member 1;, PF00999;, GO:0016021;GO:0005886;GO:0097228;GO:0015299;GO:0030317;GO:0098662;GO:0034220;GO:0051453;GO:0007338;GO:0006814;, C:integral component of membrane; C:plasma membrane; C:sperm principal piece;, F:solute:proton antiporter activity;, P:flagellated sperm motility; P:inorganic cation transmembrane transport; P:ion transmembrane transport; P:regulation of intracellular pH; P:single fertilization; P:sodium ion transport; scaffold2 indexed_genome mRNA 39758262 39765096 . + . ID=transcript_471;A6NJY1,Putative SLC9B1-like protein SLC9B1P1,Solute carrier family 9 subfamily B member 1 pseudogene 1;, PF00999;, GO:0016021;GO:0015299;GO:0098662;GO:0006814;, C:integral component of membrane;, F:solute:proton antiporter activity;, P:inorganic cation transmembrane transport; P:sodium ion transport; scaffold2 indexed_genome mRNA 39807751 39843743 . + . ID=transcript_472;Q8N5K1 Q7Z3D5,CDGSH iron-sulfur domain-containing protein 2,Endoplasmic reticulum intermembrane small protein;MitoNEET-related 1 protein;Nutrient-deprivation autophagy factor-1;, PF10660;PF09360;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0097038;GO:0032991;GO:0051537;GO:0046872;GO:0042803;GO:0003723;GO:0000422;GO:0010259;GO:0010506;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:perinuclear endoplasmic reticulum; C:protein-containing complex;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding; F:protein homodimerization activity; F:RNA binding;, P:autophagy of mitochondrion; P:multicellular organism aging; P:regulation of autophagy;|Q8N5K1 Q7Z3D5,CDGSH iron-sulfur domain-containing protein 2,Endoplasmic reticulum intermembrane small protein;MitoNEET-related 1 protein;Nutrient-deprivation autophagy factor-1;, PF10660;PF09360;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0097038;GO:0032991;GO:0051537;GO:0046872;GO:0042803;GO:0003723;GO:0000422;GO:0010259;GO:0010506;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:perinuclear endoplasmic reticulum; C:protein-containing complex;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding; F:protein homodimerization activity; F:RNA binding;, P:autophagy of mitochondrion; P:multicellular organism aging; P:regulation of autophagy;|Q8N5K1 Q7Z3D5,CDGSH iron-sulfur domain-containing protein 2,Endoplasmic reticulum intermembrane small protein;MitoNEET-related 1 protein;Nutrient-deprivation autophagy factor-1;, PF10660;PF09360;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0097038;GO:0032991;GO:0051537;GO:0046872;GO:0042803;GO:0003723;GO:0000422;GO:0010259;GO:0010506;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:perinuclear endoplasmic reticulum; C:protein-containing complex;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding; F:protein homodimerization activity; F:RNA binding;, P:autophagy of mitochondrion; P:multicellular organism aging; P:regulation of autophagy; scaffold2 indexed_genome mRNA 39859223 39889793 . - . ID=transcript_473;P61077 A6NJ93 A6NJB1 A6NM99 P47986 Q6IB88 Q6NXS4 Q8N924,Ubiquitin-conjugating enzyme E2 D3,(E3-independent) E2 ubiquitin-conjugating enzyme D3;E2 ubiquitin-conjugating enzyme D3;Ubiquitin carrier protein D3;Ubiquitin-conjugating enzyme E2(17)KB 3;Ubiquitin-conjugating enzyme E2-17 kDa 3;Ubiquitin-protein ligase D3;, PF00179;, GO:0005829;GO:0010008;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006915;GO:0006464;GO:0071276;GO:0071288;GO:0006281;GO:0002756;GO:0030514;GO:0000122;GO:1903955;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0008104;GO:0006513;GO:0000209;GO:0016567;GO:0035666;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cellular protein modification process; P:cellular response to cadmium ion; P:cellular response to mercury ion; P:DNA repair; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway;|P61077 A6NJ93 A6NJB1 A6NM99 P47986 Q6IB88 Q6NXS4 Q8N924,Ubiquitin-conjugating enzyme E2 D3,(E3-independent) E2 ubiquitin-conjugating enzyme D3;E2 ubiquitin-conjugating enzyme D3;Ubiquitin carrier protein D3;Ubiquitin-conjugating enzyme E2(17)KB 3;Ubiquitin-conjugating enzyme E2-17 kDa 3;Ubiquitin-protein ligase D3;, PF00179;, GO:0005829;GO:0010008;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006915;GO:0006464;GO:0071276;GO:0071288;GO:0006281;GO:0002756;GO:0030514;GO:0000122;GO:1903955;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0008104;GO:0006513;GO:0000209;GO:0016567;GO:0035666;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cellular protein modification process; P:cellular response to cadmium ion; P:cellular response to mercury ion; P:DNA repair; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway;|P61077 A6NJ93 A6NJB1 A6NM99 P47986 Q6IB88 Q6NXS4 Q8N924,Ubiquitin-conjugating enzyme E2 D3,(E3-independent) E2 ubiquitin-conjugating enzyme D3;E2 ubiquitin-conjugating enzyme D3;Ubiquitin carrier protein D3;Ubiquitin-conjugating enzyme E2(17)KB 3;Ubiquitin-conjugating enzyme E2-17 kDa 3;Ubiquitin-protein ligase D3;, PF00179;, GO:0005829;GO:0010008;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006915;GO:0006464;GO:0071276;GO:0071288;GO:0006281;GO:0002756;GO:0030514;GO:0000122;GO:1903955;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0008104;GO:0006513;GO:0000209;GO:0016567;GO:0035666;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cellular protein modification process; P:cellular response to cadmium ion; P:cellular response to mercury ion; P:DNA repair; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway;|P62837 D3DQC9 P51669 Q3MN78 Q96RP6,Ubiquitin-conjugating enzyme E2 D2,(E3-independent) E2 ubiquitin-conjugating enzyme D2;E2 ubiquitin-conjugating enzyme D2;Ubiquitin carrier protein D2;Ubiquitin-conjugating enzyme E2(17)KB 2;Ubiquitin-conjugating enzyme E2-17 kDa 2;Ubiquitin-protein ligase D2;p53-regulated ubiquitin-conjugating enzyme 1;, PF00179;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0000151;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006464;GO:0002756;GO:0051865;GO:0070936;GO:0008104;GO:0000209;GO:0016567;GO:0035666;GO:0006511;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:MyD88-independent toll-like receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|P62837 D3DQC9 P51669 Q3MN78 Q96RP6,Ubiquitin-conjugating enzyme E2 D2,(E3-independent) E2 ubiquitin-conjugating enzyme D2;E2 ubiquitin-conjugating enzyme D2;Ubiquitin carrier protein D2;Ubiquitin-conjugating enzyme E2(17)KB 2;Ubiquitin-conjugating enzyme E2-17 kDa 2;Ubiquitin-protein ligase D2;p53-regulated ubiquitin-conjugating enzyme 1;, PF00179;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0000151;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006464;GO:0002756;GO:0051865;GO:0070936;GO:0008104;GO:0000209;GO:0016567;GO:0035666;GO:0006511;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:MyD88-independent toll-like receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|P61077 A6NJ93 A6NJB1 A6NM99 P47986 Q6IB88 Q6NXS4 Q8N924,Ubiquitin-conjugating enzyme E2 D3,(E3-independent) E2 ubiquitin-conjugating enzyme D3;E2 ubiquitin-conjugating enzyme D3;Ubiquitin carrier protein D3;Ubiquitin-conjugating enzyme E2(17)KB 3;Ubiquitin-conjugating enzyme E2-17 kDa 3;Ubiquitin-protein ligase D3;, PF00179;, GO:0005829;GO:0010008;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006915;GO:0006464;GO:0071276;GO:0071288;GO:0006281;GO:0002756;GO:0030514;GO:0000122;GO:1903955;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0008104;GO:0006513;GO:0000209;GO:0016567;GO:0035666;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cellular protein modification process; P:cellular response to cadmium ion; P:cellular response to mercury ion; P:DNA repair; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway; scaffold2 indexed_genome mRNA 39907452 40034567 . + . ID=transcript_474;O00462 Q96BC3 Q9NYX9,Beta-mannosidase,Lysosomal beta A mannosidase;Mannanase;, PF02836;PF17753;PF17786;, GO:0035577;GO:0043202;GO:0005764;GO:0005886;GO:0004567;GO:0006464;GO:0006516;GO:0043312;GO:0009313;, C:azurophil granule membrane; C:lysosomal lumen; C:lysosome; C:plasma membrane;, F:beta-mannosidase activity;, P:cellular protein modification process; P:glycoprotein catabolic process; P:neutrophil degranulation; P:oligosaccharide catabolic process;|O00462 Q96BC3 Q9NYX9,Beta-mannosidase,Lysosomal beta A mannosidase;Mannanase;, PF02836;PF17753;PF17786;, GO:0035577;GO:0043202;GO:0005764;GO:0005886;GO:0004567;GO:0006464;GO:0006516;GO:0043312;GO:0009313;, C:azurophil granule membrane; C:lysosomal lumen; C:lysosome; C:plasma membrane;, F:beta-mannosidase activity;, P:cellular protein modification process; P:glycoprotein catabolic process; P:neutrophil degranulation; P:oligosaccharide catabolic process;|O00462 Q96BC3 Q9NYX9,Beta-mannosidase,Lysosomal beta A mannosidase;Mannanase;, PF02836;PF17753;PF17786;, GO:0035577;GO:0043202;GO:0005764;GO:0005886;GO:0004567;GO:0006464;GO:0006516;GO:0043312;GO:0009313;, C:azurophil granule membrane; C:lysosomal lumen; C:lysosome; C:plasma membrane;, F:beta-mannosidase activity;, P:cellular protein modification process; P:glycoprotein catabolic process; P:neutrophil degranulation; P:oligosaccharide catabolic process;|O00462 Q96BC3 Q9NYX9,Beta-mannosidase,Lysosomal beta A mannosidase;Mannanase;, PF02836;PF17753;PF17786;, GO:0035577;GO:0043202;GO:0005764;GO:0005886;GO:0004567;GO:0006464;GO:0006516;GO:0043312;GO:0009313;, C:azurophil granule membrane; C:lysosomal lumen; C:lysosome; C:plasma membrane;, F:beta-mannosidase activity;, P:cellular protein modification process; P:glycoprotein catabolic process; P:neutrophil degranulation; P:oligosaccharide catabolic process; scaffold2 indexed_genome mRNA 40049684 40064177 . - . ID=transcript_475;P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0,Nuclear factor NF-kappa-B p105 subunit,DNA-binding factor KBF1;EBP-1;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;, PF12796;PF00531;PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005576;GO:0033256;GO:0005739;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0042805;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0042802;GO:0000978;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0006915;GO:1904385;GO:0071359;GO:0071347;GO:0071354;GO:0071222;GO:0071260;GO:0071316;GO:0071356;GO:0038095;GO:0006954;GO:0070498;GO:0031293;GO:0043066;GO:0010956;GO:0032269;GO:0032375;GO:0010629;GO:0050728;GO:0032695;GO:0000122;GO:0010957;GO:0043312;GO:0090263;GO:1900127;GO:0010884;GO:0010744;GO:2000630;GO:0051092;GO:0045944;GO:0045893;GO:0032481;GO:0006357;GO:0060260;GO:0035994;GO:0002223;GO:0051403;GO:0050852;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular region; C:I-kappaB/NF-kappaB complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:actinin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to angiotensin; P:cellular response to dsRNA; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cellular response to tumor necrosis factor; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cellular protein metabolic process; P:negative regulation of cholesterol transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-12 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to muscle stretch; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transcription by RNA polymerase II;|P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0,Nuclear factor NF-kappa-B p105 subunit,DNA-binding factor KBF1;EBP-1;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;, PF12796;PF00531;PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005576;GO:0033256;GO:0005739;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0042805;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0042802;GO:0000978;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0006915;GO:1904385;GO:0071359;GO:0071347;GO:0071354;GO:0071222;GO:0071260;GO:0071316;GO:0071356;GO:0038095;GO:0006954;GO:0070498;GO:0031293;GO:0043066;GO:0010956;GO:0032269;GO:0032375;GO:0010629;GO:0050728;GO:0032695;GO:0000122;GO:0010957;GO:0043312;GO:0090263;GO:1900127;GO:0010884;GO:0010744;GO:2000630;GO:0051092;GO:0045944;GO:0045893;GO:0032481;GO:0006357;GO:0060260;GO:0035994;GO:0002223;GO:0051403;GO:0050852;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular region; C:I-kappaB/NF-kappaB complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:actinin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to angiotensin; P:cellular response to dsRNA; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cellular response to tumor necrosis factor; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cellular protein metabolic process; P:negative regulation of cholesterol transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-12 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to muscle stretch; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transcription by RNA polymerase II;|P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0,Nuclear factor NF-kappa-B p105 subunit,DNA-binding factor KBF1;EBP-1;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;, PF12796;PF00531;PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005576;GO:0033256;GO:0005739;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0042805;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0042802;GO:0000978;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0006915;GO:1904385;GO:0071359;GO:0071347;GO:0071354;GO:0071222;GO:0071260;GO:0071316;GO:0071356;GO:0038095;GO:0006954;GO:0070498;GO:0031293;GO:0043066;GO:0010956;GO:0032269;GO:0032375;GO:0010629;GO:0050728;GO:0032695;GO:0000122;GO:0010957;GO:0043312;GO:0090263;GO:1900127;GO:0010884;GO:0010744;GO:2000630;GO:0051092;GO:0045944;GO:0045893;GO:0032481;GO:0006357;GO:0060260;GO:0035994;GO:0002223;GO:0051403;GO:0050852;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular region; C:I-kappaB/NF-kappaB complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:actinin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to angiotensin; P:cellular response to dsRNA; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cellular response to tumor necrosis factor; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cellular protein metabolic process; P:negative regulation of cholesterol transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-12 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to muscle stretch; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transcription by RNA polymerase II;|P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0,Nuclear factor NF-kappa-B p105 subunit,DNA-binding factor KBF1;EBP-1;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;, PF12796;PF00531;PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005576;GO:0033256;GO:0005739;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0042805;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0042802;GO:0000978;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0006915;GO:1904385;GO:0071359;GO:0071347;GO:0071354;GO:0071222;GO:0071260;GO:0071316;GO:0071356;GO:0038095;GO:0006954;GO:0070498;GO:0031293;GO:0043066;GO:0010956;GO:0032269;GO:0032375;GO:0010629;GO:0050728;GO:0032695;GO:0000122;GO:0010957;GO:0043312;GO:0090263;GO:1900127;GO:0010884;GO:0010744;GO:2000630;GO:0051092;GO:0045944;GO:0045893;GO:0032481;GO:0006357;GO:0060260;GO:0035994;GO:0002223;GO:0051403;GO:0050852;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular region; C:I-kappaB/NF-kappaB complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:actinin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to angiotensin; P:cellular response to dsRNA; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cellular response to tumor necrosis factor; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cellular protein metabolic process; P:negative regulation of cholesterol transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-12 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to muscle stretch; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transcription by RNA polymerase II;|P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0,Nuclear factor NF-kappa-B p105 subunit,DNA-binding factor KBF1;EBP-1;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;, PF12796;PF00531;PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005576;GO:0033256;GO:0005739;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0042805;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0042802;GO:0000978;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0006915;GO:1904385;GO:0071359;GO:0071347;GO:0071354;GO:0071222;GO:0071260;GO:0071316;GO:0071356;GO:0038095;GO:0006954;GO:0070498;GO:0031293;GO:0043066;GO:0010956;GO:0032269;GO:0032375;GO:0010629;GO:0050728;GO:0032695;GO:0000122;GO:0010957;GO:0043312;GO:0090263;GO:1900127;GO:0010884;GO:0010744;GO:2000630;GO:0051092;GO:0045944;GO:0045893;GO:0032481;GO:0006357;GO:0060260;GO:0035994;GO:0002223;GO:0051403;GO:0050852;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular region; C:I-kappaB/NF-kappaB complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:actinin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to angiotensin; P:cellular response to dsRNA; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cellular response to tumor necrosis factor; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cellular protein metabolic process; P:negative regulation of cholesterol transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-12 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to muscle stretch; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transcription by RNA polymerase II;|P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0,Nuclear factor NF-kappa-B p105 subunit,DNA-binding factor KBF1;EBP-1;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;, PF12796;PF00531;PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005576;GO:0033256;GO:0005739;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0042805;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0042802;GO:0000978;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0006915;GO:1904385;GO:0071359;GO:0071347;GO:0071354;GO:0071222;GO:0071260;GO:0071316;GO:0071356;GO:0038095;GO:0006954;GO:0070498;GO:0031293;GO:0043066;GO:0010956;GO:0032269;GO:0032375;GO:0010629;GO:0050728;GO:0032695;GO:0000122;GO:0010957;GO:0043312;GO:0090263;GO:1900127;GO:0010884;GO:0010744;GO:2000630;GO:0051092;GO:0045944;GO:0045893;GO:0032481;GO:0006357;GO:0060260;GO:0035994;GO:0002223;GO:0051403;GO:0050852;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular region; C:I-kappaB/NF-kappaB complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:actinin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to angiotensin; P:cellular response to dsRNA; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cellular response to tumor necrosis factor; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cellular protein metabolic process; P:negative regulation of cholesterol transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-12 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to muscle stretch; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transcription by RNA polymerase II;|P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0,Nuclear factor NF-kappa-B p105 subunit,DNA-binding factor KBF1;EBP-1;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;, PF12796;PF00531;PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005576;GO:0033256;GO:0005739;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0042805;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0042802;GO:0000978;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0006915;GO:1904385;GO:0071359;GO:0071347;GO:0071354;GO:0071222;GO:0071260;GO:0071316;GO:0071356;GO:0038095;GO:0006954;GO:0070498;GO:0031293;GO:0043066;GO:0010956;GO:0032269;GO:0032375;GO:0010629;GO:0050728;GO:0032695;GO:0000122;GO:0010957;GO:0043312;GO:0090263;GO:1900127;GO:0010884;GO:0010744;GO:2000630;GO:0051092;GO:0045944;GO:0045893;GO:0032481;GO:0006357;GO:0060260;GO:0035994;GO:0002223;GO:0051403;GO:0050852;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular region; C:I-kappaB/NF-kappaB complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:actinin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to angiotensin; P:cellular response to dsRNA; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cellular response to tumor necrosis factor; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cellular protein metabolic process; P:negative regulation of cholesterol transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-12 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to muscle stretch; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transcription by RNA polymerase II; scaffold2 indexed_genome mRNA 40068235 40074160 . + . ID=transcript_476;P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0,Nuclear factor NF-kappa-B p105 subunit,DNA-binding factor KBF1;EBP-1;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;, PF12796;PF00531;PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005576;GO:0033256;GO:0005739;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0042805;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0042802;GO:0000978;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0006915;GO:1904385;GO:0071359;GO:0071347;GO:0071354;GO:0071222;GO:0071260;GO:0071316;GO:0071356;GO:0038095;GO:0006954;GO:0070498;GO:0031293;GO:0043066;GO:0010956;GO:0032269;GO:0032375;GO:0010629;GO:0050728;GO:0032695;GO:0000122;GO:0010957;GO:0043312;GO:0090263;GO:1900127;GO:0010884;GO:0010744;GO:2000630;GO:0051092;GO:0045944;GO:0045893;GO:0032481;GO:0006357;GO:0060260;GO:0035994;GO:0002223;GO:0051403;GO:0050852;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular region; C:I-kappaB/NF-kappaB complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:actinin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to angiotensin; P:cellular response to dsRNA; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cellular response to tumor necrosis factor; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cellular protein metabolic process; P:negative regulation of cholesterol transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-12 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to muscle stretch; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transcription by RNA polymerase II; scaffold2 indexed_genome mRNA 40076309 40079552 . + . ID=transcript_477;P19838 A8K5Y5 B3KVE8 Q68D84 Q86V43 Q8N4X7 Q9NZC0,Nuclear factor NF-kappa-B p105 subunit,DNA-binding factor KBF1;EBP-1;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;, PF12796;PF00531;PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005576;GO:0033256;GO:0005739;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0042805;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0042802;GO:0000978;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0006915;GO:1904385;GO:0071359;GO:0071347;GO:0071354;GO:0071222;GO:0071260;GO:0071316;GO:0071356;GO:0038095;GO:0006954;GO:0070498;GO:0031293;GO:0043066;GO:0010956;GO:0032269;GO:0032375;GO:0010629;GO:0050728;GO:0032695;GO:0000122;GO:0010957;GO:0043312;GO:0090263;GO:1900127;GO:0010884;GO:0010744;GO:2000630;GO:0051092;GO:0045944;GO:0045893;GO:0032481;GO:0006357;GO:0060260;GO:0035994;GO:0002223;GO:0051403;GO:0050852;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular region; C:I-kappaB/NF-kappaB complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:actinin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to angiotensin; P:cellular response to dsRNA; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cellular response to tumor necrosis factor; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cellular protein metabolic process; P:negative regulation of cholesterol transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-12 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to muscle stretch; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transcription by RNA polymerase II; scaffold2 indexed_genome mRNA 40284080 40368344 . + . ID=transcript_478;Q9C0K1 B4E2H3 Q96SM9 Q9BVC0 Q9NSA4,Metal cation symporter ZIP8 {ECO:0000305|PubMed:12504855},BCG-induced integral membrane protein in monocyte clone 103 protein {ECO:0000303|PubMed:12504855};LIV-1 subfamily of ZIP zinc transporter 6;Solute carrier family 39 member 8 {ECO:0000312|HGNC:HGNC:20862};Zrt- and Irt-like protein 8 {ECO:0000250|UniProtKB:Q91W10};, PF02535;, GO:0016324;GO:0016323;GO:0005887;GO:0005765;GO:0031090;GO:0005886;GO:0015296;GO:0015106;GO:0015086;GO:0015087;GO:0005381;GO:0005384;GO:0097079;GO:0005385;GO:0140412;GO:0006525;GO:0015701;GO:0070574;GO:1990079;GO:0006876;GO:0030026;GO:0006882;GO:0006824;GO:0030198;GO:0098711;GO:0061757;GO:0071421;GO:1990540;GO:0097080;GO:0006487;GO:0042391;GO:0006355;GO:0006351;GO:0071578;GO:0071577;GO:0006829;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:organelle membrane; C:plasma membrane;, F:anion:cation symporter activity; F:bicarbonate transmembrane transporter activity; F:cadmium ion transmembrane transporter activity; F:cobalt ion transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:selenite:proton symporter activity; F:zinc ion transmembrane transporter activity; F:zinc:bicarbonate symporter activity;, P:arginine metabolic process; P:bicarbonate transport; P:cadmium ion transmembrane transport; P:cartilage homeostasis; P:cellular cadmium ion homeostasis; P:cellular manganese ion homeostasis; P:cellular zinc ion homeostasis; P:cobalt ion transport; P:extracellular matrix organization; P:iron ion import across plasma membrane; P:leukocyte adhesion to arterial endothelial cell; P:manganese ion transmembrane transport; P:mitochondrial manganese ion transmembrane transport; P:plasma membrane selenite transport; P:protein N-linked glycosylation; P:regulation of membrane potential; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport; P:zinc ion transport; scaffold2 indexed_genome mRNA 40505374 40785107 . - . ID=transcript_479;Q8NDB2 A8K7W8 B0F3S2 Q8N5K8 Q8NB56 Q8WYN5 Q9NWP2,B-cell scaffold protein with ankyrin repeats,, PF14545;PF18567;, GO:1990782;GO:0005102;GO:0042113;GO:0050869;GO:0032715;GO:0051898;GO:0045947;GO:0043410;GO:0050731;GO:0009617;, , F:protein tyrosine kinase binding; F:signaling receptor binding;, P:B cell activation; P:negative regulation of B cell activation; P:negative regulation of interleukin-6 production; P:negative regulation of protein kinase B signaling; P:negative regulation of translational initiation; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:response to bacterium;|Q8NDB2 A8K7W8 B0F3S2 Q8N5K8 Q8NB56 Q8WYN5 Q9NWP2,B-cell scaffold protein with ankyrin repeats,, PF14545;PF18567;, GO:1990782;GO:0005102;GO:0042113;GO:0050869;GO:0032715;GO:0051898;GO:0045947;GO:0043410;GO:0050731;GO:0009617;, , F:protein tyrosine kinase binding; F:signaling receptor binding;, P:B cell activation; P:negative regulation of B cell activation; P:negative regulation of interleukin-6 production; P:negative regulation of protein kinase B signaling; P:negative regulation of translational initiation; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:response to bacterium; scaffold2 indexed_genome mRNA 41491275 41492154 . + . ID=transcript_480;P48454 B4DRT5 Q9BSS6 Q9H4M5,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,CAM-PRP catalytic subunit;Calcineurin, testis-specific catalytic subunit;Calmodulin-dependent calcineurin A subunit gamma isoform;, PF00149;, GO:0005955;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0098793;GO:0005516;GO:0033192;GO:0046872;GO:0106306;GO:0106307;GO:0007420;GO:0097720;GO:0033173;GO:1900740;GO:1900244;GO:0006470;, C:calcineurin complex; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion; C:presynapse;, F:calmodulin binding; F:calmodulin-dependent protein phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:brain development; P:calcineurin-mediated signaling; P:calcineurin-NFAT signaling cascade; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of synaptic vesicle endocytosis; P:protein dephosphorylation; scaffold2 indexed_genome mRNA 41517722 41521508 . - . ID=transcript_481;Q08209 A1A441 A8K3B7 A8W6Z7 A8W6Z8 B5BUA2 Q8TAW9,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,CAM-PRP catalytic subunit;Calmodulin-dependent calcineurin A subunit alpha isoform;, PF00149;, GO:0005955;GO:0005737;GO:0005829;GO:0043197;GO:0019897;GO:0098978;GO:0005739;GO:0005654;GO:0005886;GO:0042383;GO:0098685;GO:0036057;GO:0030018;GO:0051117;GO:0005509;GO:0005516;GO:0033192;GO:0016018;GO:0019899;GO:0046983;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0007568;GO:0007420;GO:0097720;GO:0033173;GO:0006816;GO:0014898;GO:0071333;GO:0016311;GO:0060079;GO:0038095;GO:0000082;GO:0033555;GO:0035562;GO:0050774;GO:0046676;GO:1903799;GO:0070262;GO:1903244;GO:0045785;GO:0030335;GO:1905205;GO:0051091;GO:0045807;GO:0045944;GO:0099170;GO:0006470;GO:0006606;GO:0001975;GO:0051592;GO:0048741;GO:0043403;GO:0042110;GO:0014883;GO:0007223;GO:0042060;, C:calcineurin complex; C:cytoplasm; C:cytosol; C:dendritic spine; C:extrinsic component of plasma membrane; C:glutamatergic synapse; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:sarcolemma; C:Schaffer collateral - CA1 synapse; C:slit diaphragm; C:Z disc;, F:ATPase binding; F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein phosphatase activity; F:cyclosporin A binding; F:enzyme binding; F:protein dimerization activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding;, P:aging; P:brain development; P:calcineurin-mediated signaling; P:calcineurin-NFAT signaling cascade; P:calcium ion transport; P:cardiac muscle hypertrophy in response to stress; P:cellular response to glucose stimulus; P:dephosphorylation; P:excitatory postsynaptic potential; P:Fc-epsilon receptor signaling pathway; P:G1/S transition of mitotic cell cycle; P:multicellular organismal response to stress; P:negative regulation of chromatin binding; P:negative regulation of dendrite morphogenesis; P:negative regulation of insulin secretion; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:peptidyl-serine dephosphorylation; P:positive regulation of cardiac muscle hypertrophy in response to stress; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of connective tissue replacement; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endocytosis; P:positive regulation of transcription by RNA polymerase II; P:postsynaptic modulation of chemical synaptic transmission; P:protein dephosphorylation; P:protein import into nucleus; P:response to amphetamine; P:response to calcium ion; P:skeletal muscle fiber development; P:skeletal muscle tissue regeneration; P:T cell activation; P:transition between fast and slow fiber; P:Wnt signaling pathway, calcium modulating pathway; P:wound healing; scaffold2 indexed_genome mRNA 41929486 42058988 . + . ID=transcript_482;Q9ULC0 A8K716 B4E347 Q8NEY5 Q8WWE7 Q9NRM8,Endomucin,Endomucin-2;Gastric cancer antigen Ga34;Mucin-14;, PF07010;, GO:0005576;GO:0016021;GO:0005886;GO:0061484;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, , P:hematopoietic stem cell homeostasis; scaffold2 indexed_genome mRNA 42242957 42246210 . - . ID=transcript_483;Q96D03 B2R7C3,DNA damage-inducible transcript 4-like protein,HIF-1 responsive protein RTP801-like;Protein regulated in development and DNA damage response 2;, PF07809;, GO:0005737;GO:0009968;, C:cytoplasm;, , P:negative regulation of signal transduction; scaffold2 indexed_genome mRNA 42442267 42444663 . + . ID=transcript_484;P0C0S5 B2RD56 P17317 Q6I9U0,Histone H2A.Z,, PF00125;PF16211;, GO:0000791;GO:0070062;GO:0000792;GO:0000786;GO:0005634;GO:0031490;GO:0003677;GO:0031492;GO:0046982;GO:0000978;GO:0000979;GO:0071392;GO:0006342;GO:0045944;, C:euchromatin; C:extracellular exosome; C:heterochromatin; C:nucleosome; C:nucleus;, F:chromatin DNA binding; F:DNA binding; F:nucleosomal DNA binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding;, P:cellular response to estradiol stimulus; P:chromatin silencing; P:positive regulation of transcription by RNA polymerase II;|P0C0S5 B2RD56 P17317 Q6I9U0,Histone H2A.Z,, PF00125;PF16211;, GO:0000791;GO:0070062;GO:0000792;GO:0000786;GO:0005634;GO:0031490;GO:0003677;GO:0031492;GO:0046982;GO:0000978;GO:0000979;GO:0071392;GO:0006342;GO:0045944;, C:euchromatin; C:extracellular exosome; C:heterochromatin; C:nucleosome; C:nucleus;, F:chromatin DNA binding; F:DNA binding; F:nucleosomal DNA binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding;, P:cellular response to estradiol stimulus; P:chromatin silencing; P:positive regulation of transcription by RNA polymerase II;|Q71UI9 A6NFA8 A6NKY0 A6NN01 A8MQC5 Q59GV8 Q6PK98,Histone H2A.V,H2A.F/Z;H2A.Z variant histone 2 {ECO:0000312|HGNC:HGNC:20664};, PF00125;PF16211;, GO:0070062;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006342;, C:extracellular exosome; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:chromatin silencing; scaffold2 indexed_genome mRNA 42461612 42487683 . + . ID=transcript_485;Q8TBM8 Q6UXN1 Q7Z3P0 Q86TA7 Q86TM0 Q9GZU9,DnaJ homolog subfamily B member 14 {ECO:0000312|HGNC:HGNC:25881},, PF00226;PF09320;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0031965;GO:0030544;GO:0034622;GO:0071218;GO:0051085;GO:0030433;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear membrane;, F:Hsp70 protein binding;, P:cellular protein-containing complex assembly; P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q8TBM8 Q6UXN1 Q7Z3P0 Q86TA7 Q86TM0 Q9GZU9,DnaJ homolog subfamily B member 14 {ECO:0000312|HGNC:HGNC:25881},, PF00226;PF09320;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0031965;GO:0030544;GO:0034622;GO:0071218;GO:0051085;GO:0030433;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear membrane;, F:Hsp70 protein binding;, P:cellular protein-containing complex assembly; P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q8TBM8 Q6UXN1 Q7Z3P0 Q86TA7 Q86TM0 Q9GZU9,DnaJ homolog subfamily B member 14 {ECO:0000312|HGNC:HGNC:25881},, PF00226;PF09320;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0031965;GO:0030544;GO:0034622;GO:0071218;GO:0051085;GO:0030433;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear membrane;, F:Hsp70 protein binding;, P:cellular protein-containing complex assembly; P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q8TBM8 Q6UXN1 Q7Z3P0 Q86TA7 Q86TM0 Q9GZU9,DnaJ homolog subfamily B member 14 {ECO:0000312|HGNC:HGNC:25881},, PF00226;PF09320;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0031965;GO:0030544;GO:0034622;GO:0071218;GO:0051085;GO:0030433;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear membrane;, F:Hsp70 protein binding;, P:cellular protein-containing complex assembly; P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q8TBM8 Q6UXN1 Q7Z3P0 Q86TA7 Q86TM0 Q9GZU9,DnaJ homolog subfamily B member 14 {ECO:0000312|HGNC:HGNC:25881},, PF00226;PF09320;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0031965;GO:0030544;GO:0034622;GO:0071218;GO:0051085;GO:0030433;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear membrane;, F:Hsp70 protein binding;, P:cellular protein-containing complex assembly; P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway; P:viral process; scaffold2 indexed_genome mRNA 42493404 42505310 . + . ID=transcript_486;Q9UHA4 B2R4A1 J3KMX4 Q9H364,Ragulator complex protein LAMTOR3,Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3;MEK-binding partner 1;Mitogen-activated protein kinase kinase 1-interacting protein 1;Mitogen-activated protein kinase scaffold protein 1;, PF08923;, GO:0010008;GO:0070062;GO:0005925;GO:0005765;GO:0005886;GO:0071986;GO:0035579;GO:0070821;GO:0019209;GO:0000186;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:0000165;GO:0043312;GO:0032008;GO:1902414;GO:0016241;, C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:lysosomal membrane; C:plasma membrane; C:Ragulator complex; C:specific granule membrane; C:tertiary granule membrane;, F:kinase activator activity;, P:activation of MAPKK activity; P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:MAPK cascade; P:neutrophil degranulation; P:positive regulation of TOR signaling; P:protein localization to cell junction; P:regulation of macroautophagy;|Q9UHA4 B2R4A1 J3KMX4 Q9H364,Ragulator complex protein LAMTOR3,Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3;MEK-binding partner 1;Mitogen-activated protein kinase kinase 1-interacting protein 1;Mitogen-activated protein kinase scaffold protein 1;, PF08923;, GO:0010008;GO:0070062;GO:0005925;GO:0005765;GO:0005886;GO:0071986;GO:0035579;GO:0070821;GO:0019209;GO:0000186;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:0000165;GO:0043312;GO:0032008;GO:1902414;GO:0016241;, C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:lysosomal membrane; C:plasma membrane; C:Ragulator complex; C:specific granule membrane; C:tertiary granule membrane;, F:kinase activator activity;, P:activation of MAPKK activity; P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:MAPK cascade; P:neutrophil degranulation; P:positive regulation of TOR signaling; P:protein localization to cell junction; P:regulation of macroautophagy;|Q9UHA4 B2R4A1 J3KMX4 Q9H364,Ragulator complex protein LAMTOR3,Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3;MEK-binding partner 1;Mitogen-activated protein kinase kinase 1-interacting protein 1;Mitogen-activated protein kinase scaffold protein 1;, PF08923;, GO:0010008;GO:0070062;GO:0005925;GO:0005765;GO:0005886;GO:0071986;GO:0035579;GO:0070821;GO:0019209;GO:0000186;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:0000165;GO:0043312;GO:0032008;GO:1902414;GO:0016241;, C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:lysosomal membrane; C:plasma membrane; C:Ragulator complex; C:specific granule membrane; C:tertiary granule membrane;, F:kinase activator activity;, P:activation of MAPKK activity; P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:MAPK cascade; P:neutrophil degranulation; P:positive regulation of TOR signaling; P:protein localization to cell junction; P:regulation of macroautophagy; scaffold2 indexed_genome mRNA 42508834 42564173 . - . ID=transcript_487;Q9UN19 Q8TCK5 Q9UHF2,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,B lymphocyte adapter protein Bam32;B-cell adapter molecule of 32 kDa;, PF00169;PF00017;, GO:0005829;GO:0005886;GO:0005547;GO:0043325;GO:0005543;GO:0006470;GO:0007165;, C:cytosol; C:plasma membrane;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phospholipid binding;, P:protein dephosphorylation; P:signal transduction; scaffold2 indexed_genome mRNA 42665957 42667630 . - . ID=transcript_488;D6RIA3,Uncharacterized protein C4orf54 {ECO:0000305},Familial obliterative portal venopathy {ECO:0000303|PubMed:28792652};, PF15232; scaffold2 indexed_genome mRNA 42668086 42681122 . + . ID=transcript_489;D6RIA3,Uncharacterized protein C4orf54 {ECO:0000305},Familial obliterative portal venopathy {ECO:0000303|PubMed:28792652};, PF15232;|D6RIA3,Uncharacterized protein C4orf54 {ECO:0000305},Familial obliterative portal venopathy {ECO:0000303|PubMed:28792652};, PF15232; scaffold2 indexed_genome mRNA 42691215 42746842 . - . ID=transcript_490;P55157 A8K428 Q08AM4 Q6P5T3,Microsomal triglyceride transfer protein large subunit,, PF01347;, GO:0016323;GO:0031526;GO:0005783;GO:0005788;GO:0005794;GO:0031528;GO:0043235;GO:0005791;GO:0031982;GO:0034185;GO:1902388;GO:0120020;GO:0008289;GO:0120019;GO:1904121;GO:0120014;GO:0005548;GO:0046982;GO:0044877;GO:0140344;GO:0042632;GO:0034378;GO:0007623;GO:0006629;GO:0042157;GO:0042953;GO:0034374;GO:0015914;GO:0034377;GO:0006497;GO:0009306;GO:0051592;GO:0006641;GO:0034197;GO:0034379;, C:basolateral plasma membrane; C:brush border membrane; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microvillus membrane; C:receptor complex; C:rough endoplasmic reticulum; C:vesicle;, F:apolipoprotein binding; F:ceramide 1-phosphate transfer activity; F:cholesterol transfer activity; F:lipid binding; F:phosphatidylcholine transfer activity; F:phosphatidylethanolamine transfer activity; F:phospholipid transfer activity; F:phospholipid transporter activity; F:protein heterodimerization activity; F:protein-containing complex binding; F:triglyceride transfer activity;, P:cholesterol homeostasis; P:chylomicron assembly; P:circadian rhythm; P:lipid metabolic process; P:lipoprotein metabolic process; P:lipoprotein transport; P:low-density lipoprotein particle remodeling; P:phospholipid transport; P:plasma lipoprotein particle assembly; P:protein lipidation; P:protein secretion; P:response to calcium ion; P:triglyceride metabolic process; P:triglyceride transport; P:very-low-density lipoprotein particle assembly; scaffold2 indexed_genome mRNA 42769475 42787594 . + . ID=transcript_491;Q8TBZ6 B2R8X7 Q9Y2T9,tRNA methyltransferase 10 homolog A,RNA (guanine-9-)-methyltransferase domain-containing protein 2;tRNA (guanine(9)-N(1))-methyltransferase TRMT10A;, PF01746;, GO:0015629;GO:0005829;GO:0070062;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0003723;GO:0052905;GO:0009019;GO:0000049;GO:0090646;GO:0030488;GO:0002939;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA binding; F:tRNA (guanine(9)-N(1))-methyltransferase activity; F:tRNA (guanine-N1-)-methyltransferase activity; F:tRNA binding;, P:mitochondrial tRNA processing; P:tRNA methylation; P:tRNA N1-guanine methylation; scaffold2 indexed_genome mRNA 42799378 42800722 . + . ID=transcript_492;Q53FE4 Q6FI84 Q6IS77 Q8NA78 Q9H0D9,Uncharacterized protein C4orf17,, PF15256; scaffold2 indexed_genome mRNA 42803291 42804044 . - . ID=transcript_493;Q53FE4 Q6FI84 Q6IS77 Q8NA78 Q9H0D9,Uncharacterized protein C4orf17,, PF15256; scaffold2 indexed_genome mRNA 42947784 42967091 . + . ID=transcript_494;P00325 A8MYN5 B4DRS9 B4DVC3 Q13711 Q4ZGI9 Q96KI7,All-trans-retinol dehydrogenase [NAD(+)] ADH1B {ECO:0000305},Alcohol dehydrogenase 1B;Alcohol dehydrogenase subunit beta;, PF08240;PF00107;, GO:0005829;GO:0005654;GO:0005886;GO:0004024;GO:0004745;GO:0008270;GO:0006069;GO:0042573;GO:0001523;GO:0042572;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:alcohol dehydrogenase activity, zinc-dependent; F:retinol dehydrogenase activity; F:zinc ion binding;, P:ethanol oxidation; P:retinoic acid metabolic process; P:retinoid metabolic process; P:retinol metabolic process; scaffold2 indexed_genome mRNA 43063127 43079744 . + . ID=transcript_495;P28332 A0A0A0MS56 B3KS45 Q58F53,Alcohol dehydrogenase 6,, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0004022;GO:0004024;GO:0004745;GO:0008270;GO:0006069;GO:0045471;GO:0042573;GO:0042572;, C:cytosol; C:extracellular exosome;, F:alcohol dehydrogenase (NAD+) activity; F:alcohol dehydrogenase activity, zinc-dependent; F:retinol dehydrogenase activity; F:zinc ion binding;, P:ethanol oxidation; P:response to ethanol; P:retinoic acid metabolic process; P:retinol metabolic process;|P28332 A0A0A0MS56 B3KS45 Q58F53,Alcohol dehydrogenase 6,, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0004022;GO:0004024;GO:0004745;GO:0008270;GO:0006069;GO:0045471;GO:0042573;GO:0042572;, C:cytosol; C:extracellular exosome;, F:alcohol dehydrogenase (NAD+) activity; F:alcohol dehydrogenase activity, zinc-dependent; F:retinol dehydrogenase activity; F:zinc ion binding;, P:ethanol oxidation; P:response to ethanol; P:retinoic acid metabolic process; P:retinol metabolic process;|P28332 A0A0A0MS56 B3KS45 Q58F53,Alcohol dehydrogenase 6,, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0004022;GO:0004024;GO:0004745;GO:0008270;GO:0006069;GO:0045471;GO:0042573;GO:0042572;, C:cytosol; C:extracellular exosome;, F:alcohol dehydrogenase (NAD+) activity; F:alcohol dehydrogenase activity, zinc-dependent; F:retinol dehydrogenase activity; F:zinc ion binding;, P:ethanol oxidation; P:response to ethanol; P:retinoic acid metabolic process; P:retinol metabolic process; scaffold2 indexed_genome mRNA 43119190 43155953 . + . ID=transcript_496;P08319 A8K470 B4DIE7 C9J4A9 Q8TCD7,All-trans-retinol dehydrogenase [NAD(+)] ADH4 {ECO:0000305},Alcohol dehydrogenase 4;Alcohol dehydrogenase class II pi chain;, PF08240;PF00107;, GO:0005829;GO:0005654;GO:0004022;GO:0004024;GO:0004032;GO:0005503;GO:0019115;GO:0035276;GO:0051287;GO:0003960;GO:0016620;GO:0019841;GO:0004745;GO:0051903;GO:0008270;GO:0046164;GO:0006066;GO:0006081;GO:0006069;GO:0010430;GO:0046294;GO:1901661;GO:0001523;GO:0042572;, C:cytosol; C:nucleoplasm;, F:alcohol dehydrogenase (NAD+) activity; F:alcohol dehydrogenase activity, zinc-dependent; F:alditol:NADP+ 1-oxidoreductase activity; F:all-trans retinal binding; F:benzaldehyde dehydrogenase [NAD(P)+] activity; F:ethanol binding; F:NAD binding; F:NADPH:quinone reductase activity; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; F:retinol binding; F:retinol dehydrogenase activity; F:S-(hydroxymethyl)glutathione dehydrogenase activity; F:zinc ion binding;, P:alcohol catabolic process; P:alcohol metabolic process; P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fatty acid omega-oxidation; P:formaldehyde catabolic process; P:quinone metabolic process; P:retinoid metabolic process; P:retinol metabolic process; scaffold2 indexed_genome mRNA 43180423 43195454 . + . ID=transcript_497;P11766 Q6FHR2,Alcohol dehydrogenase class-3 {ECO:0000305},Alcohol dehydrogenase 5;Alcohol dehydrogenase class chi chain;Alcohol dehydrogenase class-III;Glutathione-dependent formaldehyde dehydrogenase;S-(hydroxymethyl)glutathione dehydrogenase;, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0005739;GO:0004024;GO:0009055;GO:0005504;GO:0018467;GO:0042802;GO:0051903;GO:0106322;GO:0106321;GO:0008270;GO:0006069;GO:0010430;GO:0046294;GO:0018119;GO:0045777;GO:0003016;GO:0032496;GO:0051409;GO:0051775;GO:0001523;, C:cytosol; C:extracellular exosome; C:mitochondrion;, F:alcohol dehydrogenase activity, zinc-dependent; F:electron transfer activity; F:fatty acid binding; F:formaldehyde dehydrogenase activity; F:identical protein binding; F:S-(hydroxymethyl)glutathione dehydrogenase activity; F:S-(hydroxymethyl)glutathione dehydrogenase NAD activity; F:S-(hydroxymethyl)glutathione dehydrogenase NADP activity; F:zinc ion binding;, P:ethanol oxidation; P:fatty acid omega-oxidation; P:formaldehyde catabolic process; P:peptidyl-cysteine S-nitrosylation; P:positive regulation of blood pressure; P:respiratory system process; P:response to lipopolysaccharide; P:response to nitrosative stress; P:response to redox state; P:retinoid metabolic process;|P11766 Q6FHR2,Alcohol dehydrogenase class-3 {ECO:0000305},Alcohol dehydrogenase 5;Alcohol dehydrogenase class chi chain;Alcohol dehydrogenase class-III;Glutathione-dependent formaldehyde dehydrogenase;S-(hydroxymethyl)glutathione dehydrogenase;, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0005739;GO:0004024;GO:0009055;GO:0005504;GO:0018467;GO:0042802;GO:0051903;GO:0106322;GO:0106321;GO:0008270;GO:0006069;GO:0010430;GO:0046294;GO:0018119;GO:0045777;GO:0003016;GO:0032496;GO:0051409;GO:0051775;GO:0001523;, C:cytosol; C:extracellular exosome; C:mitochondrion;, F:alcohol dehydrogenase activity, zinc-dependent; F:electron transfer activity; F:fatty acid binding; F:formaldehyde dehydrogenase activity; F:identical protein binding; F:S-(hydroxymethyl)glutathione dehydrogenase activity; F:S-(hydroxymethyl)glutathione dehydrogenase NAD activity; F:S-(hydroxymethyl)glutathione dehydrogenase NADP activity; F:zinc ion binding;, P:ethanol oxidation; P:fatty acid omega-oxidation; P:formaldehyde catabolic process; P:peptidyl-cysteine S-nitrosylation; P:positive regulation of blood pressure; P:respiratory system process; P:response to lipopolysaccharide; P:response to nitrosative stress; P:response to redox state; P:retinoid metabolic process;|P11766 Q6FHR2,Alcohol dehydrogenase class-3 {ECO:0000305},Alcohol dehydrogenase 5;Alcohol dehydrogenase class chi chain;Alcohol dehydrogenase class-III;Glutathione-dependent formaldehyde dehydrogenase;S-(hydroxymethyl)glutathione dehydrogenase;, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0005739;GO:0004024;GO:0009055;GO:0005504;GO:0018467;GO:0042802;GO:0051903;GO:0106322;GO:0106321;GO:0008270;GO:0006069;GO:0010430;GO:0046294;GO:0018119;GO:0045777;GO:0003016;GO:0032496;GO:0051409;GO:0051775;GO:0001523;, C:cytosol; C:extracellular exosome; C:mitochondrion;, F:alcohol dehydrogenase activity, zinc-dependent; F:electron transfer activity; F:fatty acid binding; F:formaldehyde dehydrogenase activity; F:identical protein binding; F:S-(hydroxymethyl)glutathione dehydrogenase activity; F:S-(hydroxymethyl)glutathione dehydrogenase NAD activity; F:S-(hydroxymethyl)glutathione dehydrogenase NADP activity; F:zinc ion binding;, P:ethanol oxidation; P:fatty acid omega-oxidation; P:formaldehyde catabolic process; P:peptidyl-cysteine S-nitrosylation; P:positive regulation of blood pressure; P:respiratory system process; P:response to lipopolysaccharide; P:response to nitrosative stress; P:response to redox state; P:retinoid metabolic process; scaffold2 indexed_genome mRNA 43199319 43231815 . - . ID=transcript_498;P53582 B4E2E6,Methionine aminopeptidase 1 {ECO:0000255|HAMAP-Rule:MF_03174},Peptidase M 1 {ECO:0000255|HAMAP-Rule:MF_03174};, PF00557;PF15801;, GO:0005737;GO:0005829;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0031365;GO:0018206;GO:0070527;GO:0070084;GO:0022400;GO:0006417;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:platelet aggregation; P:protein initiator methionine removal; P:regulation of rhodopsin mediated signaling pathway; P:regulation of translation;|P53582 B4E2E6,Methionine aminopeptidase 1 {ECO:0000255|HAMAP-Rule:MF_03174},Peptidase M 1 {ECO:0000255|HAMAP-Rule:MF_03174};, PF00557;PF15801;, GO:0005737;GO:0005829;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0031365;GO:0018206;GO:0070527;GO:0070084;GO:0022400;GO:0006417;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:platelet aggregation; P:protein initiator methionine removal; P:regulation of rhodopsin mediated signaling pathway; P:regulation of translation; scaffold2 indexed_genome mRNA 43322088 43365327 . + . ID=transcript_499;P06730 B7Z6V1 D6RCQ6 Q96E95,Eukaryotic translation initiation factor 4E {ECO:0000303|PubMed:1993647},eIF-4F 25 kDa subunit;mRNA cap-binding protein {ECO:0000303|PubMed:3469651};, PF01652;, GO:0033391;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0016281;GO:0070062;GO:0098978;GO:0005845;GO:0005634;GO:0000932;GO:0048471;GO:0099524;GO:0016442;GO:0019899;GO:0031370;GO:0070491;GO:0000340;GO:0003723;GO:0000339;GO:0003743;GO:0001662;GO:0071549;GO:0000082;GO:0030324;GO:0006406;GO:0045665;GO:0017148;GO:0045931;GO:0006417;GO:0099578;GO:0006405;GO:0019827;GO:0006413;GO:0016032;, C:chromatoid body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:extracellular exosome; C:glutamatergic synapse; C:mRNA cap binding complex; C:nucleus; C:P-body; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:RISC complex;, F:enzyme binding; F:eukaryotic initiation factor 4G binding; F:repressing transcription factor binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation initiation factor activity;, P:behavioral fear response; P:cellular response to dexamethasone stimulus; P:G1/S transition of mitotic cell cycle; P:lung development; P:mRNA export from nucleus; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:positive regulation of mitotic cell cycle; P:regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:RNA export from nucleus; P:stem cell population maintenance; P:translational initiation; P:viral process;|P06730 B7Z6V1 D6RCQ6 Q96E95,Eukaryotic translation initiation factor 4E {ECO:0000303|PubMed:1993647},eIF-4F 25 kDa subunit;mRNA cap-binding protein {ECO:0000303|PubMed:3469651};, PF01652;, GO:0033391;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0016281;GO:0070062;GO:0098978;GO:0005845;GO:0005634;GO:0000932;GO:0048471;GO:0099524;GO:0016442;GO:0019899;GO:0031370;GO:0070491;GO:0000340;GO:0003723;GO:0000339;GO:0003743;GO:0001662;GO:0071549;GO:0000082;GO:0030324;GO:0006406;GO:0045665;GO:0017148;GO:0045931;GO:0006417;GO:0099578;GO:0006405;GO:0019827;GO:0006413;GO:0016032;, C:chromatoid body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:extracellular exosome; C:glutamatergic synapse; C:mRNA cap binding complex; C:nucleus; C:P-body; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:RISC complex;, F:enzyme binding; F:eukaryotic initiation factor 4G binding; F:repressing transcription factor binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation initiation factor activity;, P:behavioral fear response; P:cellular response to dexamethasone stimulus; P:G1/S transition of mitotic cell cycle; P:lung development; P:mRNA export from nucleus; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:positive regulation of mitotic cell cycle; P:regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:RNA export from nucleus; P:stem cell population maintenance; P:translational initiation; P:viral process;|P06730 B7Z6V1 D6RCQ6 Q96E95,Eukaryotic translation initiation factor 4E {ECO:0000303|PubMed:1993647},eIF-4F 25 kDa subunit;mRNA cap-binding protein {ECO:0000303|PubMed:3469651};, PF01652;, GO:0033391;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0016281;GO:0070062;GO:0098978;GO:0005845;GO:0005634;GO:0000932;GO:0048471;GO:0099524;GO:0016442;GO:0019899;GO:0031370;GO:0070491;GO:0000340;GO:0003723;GO:0000339;GO:0003743;GO:0001662;GO:0071549;GO:0000082;GO:0030324;GO:0006406;GO:0045665;GO:0017148;GO:0045931;GO:0006417;GO:0099578;GO:0006405;GO:0019827;GO:0006413;GO:0016032;, C:chromatoid body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:extracellular exosome; C:glutamatergic synapse; C:mRNA cap binding complex; C:nucleus; C:P-body; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:RISC complex;, F:enzyme binding; F:eukaryotic initiation factor 4G binding; F:repressing transcription factor binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation initiation factor activity;, P:behavioral fear response; P:cellular response to dexamethasone stimulus; P:G1/S transition of mitotic cell cycle; P:lung development; P:mRNA export from nucleus; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:positive regulation of mitotic cell cycle; P:regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:RNA export from nucleus; P:stem cell population maintenance; P:translational initiation; P:viral process;|P06730 B7Z6V1 D6RCQ6 Q96E95,Eukaryotic translation initiation factor 4E {ECO:0000303|PubMed:1993647},eIF-4F 25 kDa subunit;mRNA cap-binding protein {ECO:0000303|PubMed:3469651};, PF01652;, GO:0033391;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0016281;GO:0070062;GO:0098978;GO:0005845;GO:0005634;GO:0000932;GO:0048471;GO:0099524;GO:0016442;GO:0019899;GO:0031370;GO:0070491;GO:0000340;GO:0003723;GO:0000339;GO:0003743;GO:0001662;GO:0071549;GO:0000082;GO:0030324;GO:0006406;GO:0045665;GO:0017148;GO:0045931;GO:0006417;GO:0099578;GO:0006405;GO:0019827;GO:0006413;GO:0016032;, C:chromatoid body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:extracellular exosome; C:glutamatergic synapse; C:mRNA cap binding complex; C:nucleus; C:P-body; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:RISC complex;, F:enzyme binding; F:eukaryotic initiation factor 4G binding; F:repressing transcription factor binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation initiation factor activity;, P:behavioral fear response; P:cellular response to dexamethasone stimulus; P:G1/S transition of mitotic cell cycle; P:lung development; P:mRNA export from nucleus; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:positive regulation of mitotic cell cycle; P:regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:RNA export from nucleus; P:stem cell population maintenance; P:translational initiation; P:viral process;|P06730 B7Z6V1 D6RCQ6 Q96E95,Eukaryotic translation initiation factor 4E {ECO:0000303|PubMed:1993647},eIF-4F 25 kDa subunit;mRNA cap-binding protein {ECO:0000303|PubMed:3469651};, PF01652;, GO:0033391;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0016281;GO:0070062;GO:0098978;GO:0005845;GO:0005634;GO:0000932;GO:0048471;GO:0099524;GO:0016442;GO:0019899;GO:0031370;GO:0070491;GO:0000340;GO:0003723;GO:0000339;GO:0003743;GO:0001662;GO:0071549;GO:0000082;GO:0030324;GO:0006406;GO:0045665;GO:0017148;GO:0045931;GO:0006417;GO:0099578;GO:0006405;GO:0019827;GO:0006413;GO:0016032;, C:chromatoid body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:extracellular exosome; C:glutamatergic synapse; C:mRNA cap binding complex; C:nucleus; C:P-body; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:RISC complex;, F:enzyme binding; F:eukaryotic initiation factor 4G binding; F:repressing transcription factor binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation initiation factor activity;, P:behavioral fear response; P:cellular response to dexamethasone stimulus; P:G1/S transition of mitotic cell cycle; P:lung development; P:mRNA export from nucleus; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:positive regulation of mitotic cell cycle; P:regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:RNA export from nucleus; P:stem cell population maintenance; P:translational initiation; P:viral process; scaffold2 indexed_genome mRNA 43731323 43743710 . + . ID=transcript_500;P62079 B2RDY2 O60628 O60746 Q6FHE5 Q9JLY1,Tetraspanin-5,Tetraspan NET-4;Transmembrane 4 superfamily member 9;, PF00335;, GO:0005788;GO:0005887;GO:0005886;GO:0019899;GO:1990000;GO:0045747;GO:0072659;GO:0051604;, C:endoplasmic reticulum lumen; C:integral component of plasma membrane; C:plasma membrane;, F:enzyme binding;, P:amyloid fibril formation; P:positive regulation of Notch signaling pathway; P:protein localization to plasma membrane; P:protein maturation; scaffold2 indexed_genome mRNA 43762607 43912921 . - . ID=transcript_501;Q9NZA8,Rap1 GTPase-GDP dissociation stimulator 1 {ECO:0000305},Exchange factor smgGDS {ECO:0000303|PubMed:11948427};SMG GDS protein {ECO:0000303|PubMed:11948427};SMG P21 stimulatory GDP/GTP exchange protein {ECO:0000303|PubMed:1549351};, PF00514;, GO:0005829;GO:0005783;GO:0070062;GO:0005739;GO:0005096;GO:0031034;GO:0032471;GO:0043547;GO:0051561;GO:0014829;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrion;, F:GTPase activator activity;, P:myosin filament assembly; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of GTPase activity; P:positive regulation of mitochondrial calcium ion concentration; P:vascular associated smooth muscle contraction;|Q9NZA8,Rap1 GTPase-GDP dissociation stimulator 1 {ECO:0000305},Exchange factor smgGDS {ECO:0000303|PubMed:11948427};SMG GDS protein {ECO:0000303|PubMed:11948427};SMG P21 stimulatory GDP/GTP exchange protein {ECO:0000303|PubMed:1549351};, PF00514;, GO:0005829;GO:0005783;GO:0070062;GO:0005739;GO:0005096;GO:0031034;GO:0032471;GO:0043547;GO:0051561;GO:0014829;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrion;, F:GTPase activator activity;, P:myosin filament assembly; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of GTPase activity; P:positive regulation of mitochondrial calcium ion concentration; P:vascular associated smooth muscle contraction; scaffold2 indexed_genome mRNA 46386987 46786659 . + . ID=transcript_502;O95185 Q8IUT0,Netrin receptor UNC5C,Protein unc-5 homolog 3;Protein unc-5 homolog C;, PF00531;PF07679;PF00090;PF17217;PF00791;, GO:0009986;GO:0030425;GO:0030175;GO:0030426;GO:0016021;GO:0030027;GO:0043025;GO:0005886;GO:0045202;GO:0005042;GO:0005043;GO:0019901;GO:0015631;GO:0033564;GO:0006915;GO:0007411;GO:0007420;GO:0061643;GO:1990791;GO:0043065;GO:0030334;, C:cell surface; C:dendrite; C:filopodium; C:growth cone; C:integral component of membrane; C:lamellipodium; C:neuronal cell body; C:plasma membrane; C:synapse;, F:netrin receptor activity; F:netrin receptor activity involved in chemorepulsion; F:protein kinase binding; F:tubulin binding;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:brain development; P:chemorepulsion of axon; P:dorsal root ganglion development; P:positive regulation of apoptotic process; P:regulation of cell migration;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|O95185 Q8IUT0,Netrin receptor UNC5C,Protein unc-5 homolog 3;Protein unc-5 homolog C;, PF00531;PF07679;PF00090;PF17217;PF00791;, GO:0009986;GO:0030425;GO:0030175;GO:0030426;GO:0016021;GO:0030027;GO:0043025;GO:0005886;GO:0045202;GO:0005042;GO:0005043;GO:0019901;GO:0015631;GO:0033564;GO:0006915;GO:0007411;GO:0007420;GO:0061643;GO:1990791;GO:0043065;GO:0030334;, C:cell surface; C:dendrite; C:filopodium; C:growth cone; C:integral component of membrane; C:lamellipodium; C:neuronal cell body; C:plasma membrane; C:synapse;, F:netrin receptor activity; F:netrin receptor activity involved in chemorepulsion; F:protein kinase binding; F:tubulin binding;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:brain development; P:chemorepulsion of axon; P:dorsal root ganglion development; P:positive regulation of apoptotic process; P:regulation of cell migration;|O95185 Q8IUT0,Netrin receptor UNC5C,Protein unc-5 homolog 3;Protein unc-5 homolog C;, PF00531;PF07679;PF00090;PF17217;PF00791;, GO:0009986;GO:0030425;GO:0030175;GO:0030426;GO:0016021;GO:0030027;GO:0043025;GO:0005886;GO:0045202;GO:0005042;GO:0005043;GO:0019901;GO:0015631;GO:0033564;GO:0006915;GO:0007411;GO:0007420;GO:0061643;GO:1990791;GO:0043065;GO:0030334;, C:cell surface; C:dendrite; C:filopodium; C:growth cone; C:integral component of membrane; C:lamellipodium; C:neuronal cell body; C:plasma membrane; C:synapse;, F:netrin receptor activity; F:netrin receptor activity involved in chemorepulsion; F:protein kinase binding; F:tubulin binding;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:brain development; P:chemorepulsion of axon; P:dorsal root ganglion development; P:positive regulation of apoptotic process; P:regulation of cell migration;|O95185 Q8IUT0,Netrin receptor UNC5C,Protein unc-5 homolog 3;Protein unc-5 homolog C;, PF00531;PF07679;PF00090;PF17217;PF00791;, GO:0009986;GO:0030425;GO:0030175;GO:0030426;GO:0016021;GO:0030027;GO:0043025;GO:0005886;GO:0045202;GO:0005042;GO:0005043;GO:0019901;GO:0015631;GO:0033564;GO:0006915;GO:0007411;GO:0007420;GO:0061643;GO:1990791;GO:0043065;GO:0030334;, C:cell surface; C:dendrite; C:filopodium; C:growth cone; C:integral component of membrane; C:lamellipodium; C:neuronal cell body; C:plasma membrane; C:synapse;, F:netrin receptor activity; F:netrin receptor activity involved in chemorepulsion; F:protein kinase binding; F:tubulin binding;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:brain development; P:chemorepulsion of axon; P:dorsal root ganglion development; P:positive regulation of apoptotic process; P:regulation of cell migration;|O95185 Q8IUT0,Netrin receptor UNC5C,Protein unc-5 homolog 3;Protein unc-5 homolog C;, PF00531;PF07679;PF00090;PF17217;PF00791;, GO:0009986;GO:0030425;GO:0030175;GO:0030426;GO:0016021;GO:0030027;GO:0043025;GO:0005886;GO:0045202;GO:0005042;GO:0005043;GO:0019901;GO:0015631;GO:0033564;GO:0006915;GO:0007411;GO:0007420;GO:0061643;GO:1990791;GO:0043065;GO:0030334;, C:cell surface; C:dendrite; C:filopodium; C:growth cone; C:integral component of membrane; C:lamellipodium; C:neuronal cell body; C:plasma membrane; C:synapse;, F:netrin receptor activity; F:netrin receptor activity involved in chemorepulsion; F:protein kinase binding; F:tubulin binding;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:brain development; P:chemorepulsion of axon; P:dorsal root ganglion development; P:positive regulation of apoptotic process; P:regulation of cell migration;|O95185 Q8IUT0,Netrin receptor UNC5C,Protein unc-5 homolog 3;Protein unc-5 homolog C;, PF00531;PF07679;PF00090;PF17217;PF00791;, GO:0009986;GO:0030425;GO:0030175;GO:0030426;GO:0016021;GO:0030027;GO:0043025;GO:0005886;GO:0045202;GO:0005042;GO:0005043;GO:0019901;GO:0015631;GO:0033564;GO:0006915;GO:0007411;GO:0007420;GO:0061643;GO:1990791;GO:0043065;GO:0030334;, C:cell surface; C:dendrite; C:filopodium; C:growth cone; C:integral component of membrane; C:lamellipodium; C:neuronal cell body; C:plasma membrane; C:synapse;, F:netrin receptor activity; F:netrin receptor activity involved in chemorepulsion; F:protein kinase binding; F:tubulin binding;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:brain development; P:chemorepulsion of axon; P:dorsal root ganglion development; P:positive regulation of apoptotic process; P:regulation of cell migration; scaffold2 indexed_genome mRNA 46797180 46844369 . + . ID=transcript_503;O00238 B2R953 B4DSV1 P78366,Bone morphogenetic protein receptor type-1B,, PF01064;PF07714;PF08515;, GO:0030425;GO:1990712;GO:0005887;GO:0043025;GO:0005886;GO:0043235;GO:0005524;GO:0046872;GO:0004674;GO:0046332;GO:0005025;GO:0004675;GO:0030509;GO:0001502;GO:0071773;GO:0071363;GO:0002063;GO:0009953;GO:0060350;GO:0001654;GO:0006954;GO:0035108;GO:0030514;GO:1902731;GO:0001649;GO:0001550;GO:0042698;GO:0030513;GO:0030501;GO:0061036;GO:0045597;GO:0032332;GO:1902043;GO:0045669;GO:0045944;GO:0006468;GO:0030166;GO:0060041;GO:0031290;GO:0001501;, C:dendrite; C:HFE-transferrin receptor complex; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:receptor complex;, F:ATP binding; F:metal ion binding; F:protein serine/threonine kinase activity; F:SMAD binding; F:transforming growth factor beta receptor activity, type I; F:transmembrane receptor protein serine/threonine kinase activity;, P:BMP signaling pathway; P:cartilage condensation; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:chondrocyte development; P:dorsal/ventral pattern formation; P:endochondral bone morphogenesis; P:eye development; P:inflammatory response; P:limb morphogenesis; P:negative regulation of BMP signaling pathway; P:negative regulation of chondrocyte proliferation; P:osteoblast differentiation; P:ovarian cumulus expansion; P:ovulation cycle; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of cartilage development; P:positive regulation of cell differentiation; P:positive regulation of chondrocyte differentiation; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:proteoglycan biosynthetic process; P:retina development in camera-type eye; P:retinal ganglion cell axon guidance; P:skeletal system development;|O00238 B2R953 B4DSV1 P78366,Bone morphogenetic protein receptor type-1B,, PF01064;PF07714;PF08515;, GO:0030425;GO:1990712;GO:0005887;GO:0043025;GO:0005886;GO:0043235;GO:0005524;GO:0046872;GO:0004674;GO:0046332;GO:0005025;GO:0004675;GO:0030509;GO:0001502;GO:0071773;GO:0071363;GO:0002063;GO:0009953;GO:0060350;GO:0001654;GO:0006954;GO:0035108;GO:0030514;GO:1902731;GO:0001649;GO:0001550;GO:0042698;GO:0030513;GO:0030501;GO:0061036;GO:0045597;GO:0032332;GO:1902043;GO:0045669;GO:0045944;GO:0006468;GO:0030166;GO:0060041;GO:0031290;GO:0001501;, C:dendrite; C:HFE-transferrin receptor complex; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:receptor complex;, F:ATP binding; F:metal ion binding; F:protein serine/threonine kinase activity; F:SMAD binding; F:transforming growth factor beta receptor activity, type I; F:transmembrane receptor protein serine/threonine kinase activity;, P:BMP signaling pathway; P:cartilage condensation; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:chondrocyte development; P:dorsal/ventral pattern formation; P:endochondral bone morphogenesis; P:eye development; P:inflammatory response; P:limb morphogenesis; P:negative regulation of BMP signaling pathway; P:negative regulation of chondrocyte proliferation; P:osteoblast differentiation; P:ovarian cumulus expansion; P:ovulation cycle; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of cartilage development; P:positive regulation of cell differentiation; P:positive regulation of chondrocyte differentiation; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:proteoglycan biosynthetic process; P:retina development in camera-type eye; P:retinal ganglion cell axon guidance; P:skeletal system development; scaffold2 indexed_genome mRNA 47320209 47477050 . - . ID=transcript_504;Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly;|Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly;|Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly;|Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly;|Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly;|Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly;|Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly;|Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly;|Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly;|Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly; scaffold2 indexed_genome mRNA 47543706 47547260 . - . ID=transcript_505;Q96HC4 A8K6F9 D6RB78 E9PBF5 O60705 Q56VN4 Q5UW38 Q8WVK0,PDZ and LIM domain protein 5,Enigma homolog;Enigma-like PDZ and LIM domains protein;, PF15936;PF00412;PF00595;, GO:0015629;GO:0005912;GO:0042995;GO:0005829;GO:0031941;GO:0016020;GO:0014069;GO:0098793;GO:0001725;GO:0030018;GO:0003779;GO:0042805;GO:0098641;GO:0046872;GO:0051371;GO:0005080;GO:0047485;GO:0030036;GO:0061049;GO:0007507;GO:0061061;GO:0061001;GO:0051963;, C:actin cytoskeleton; C:adherens junction; C:cell projection; C:cytosol; C:filamentous actin; C:membrane; C:postsynaptic density; C:presynapse; C:stress fiber; C:Z disc;, F:actin binding; F:actinin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:actin cytoskeleton organization; P:cell growth involved in cardiac muscle cell development; P:heart development; P:muscle structure development; P:regulation of dendritic spine morphogenesis; P:regulation of synapse assembly; scaffold2 indexed_genome mRNA 47699390 47779336 . - . ID=transcript_506;Q9H4L7 B7Z799 Q05D56 Q96SX1 Q9H017 Q9H860 Q9NPU9 Q9ULU7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,ATP-dependent helicase 1;, PF00271;PF00176;, GO:0000792;GO:0043596;GO:0005654;GO:0005634;GO:0035861;GO:0005524;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0070615;GO:0043130;GO:0043044;GO:0006338;GO:0051304;GO:0000729;GO:0070932;GO:0070933;GO:0000018;, C:heterochromatin; C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:nucleosome-dependent ATPase activity; F:ubiquitin binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromosome separation; P:DNA double-strand break processing; P:histone H3 deacetylation; P:histone H4 deacetylation; P:regulation of DNA recombination;|Q9H4L7 B7Z799 Q05D56 Q96SX1 Q9H017 Q9H860 Q9NPU9 Q9ULU7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,ATP-dependent helicase 1;, PF00271;PF00176;, GO:0000792;GO:0043596;GO:0005654;GO:0005634;GO:0035861;GO:0005524;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0070615;GO:0043130;GO:0043044;GO:0006338;GO:0051304;GO:0000729;GO:0070932;GO:0070933;GO:0000018;, C:heterochromatin; C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:nucleosome-dependent ATPase activity; F:ubiquitin binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromosome separation; P:DNA double-strand break processing; P:histone H3 deacetylation; P:histone H4 deacetylation; P:regulation of DNA recombination;|Q9H4L7 B7Z799 Q05D56 Q96SX1 Q9H017 Q9H860 Q9NPU9 Q9ULU7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,ATP-dependent helicase 1;, PF00271;PF00176;, GO:0000792;GO:0043596;GO:0005654;GO:0005634;GO:0035861;GO:0005524;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0070615;GO:0043130;GO:0043044;GO:0006338;GO:0051304;GO:0000729;GO:0070932;GO:0070933;GO:0000018;, C:heterochromatin; C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:nucleosome-dependent ATPase activity; F:ubiquitin binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromosome separation; P:DNA double-strand break processing; P:histone H3 deacetylation; P:histone H4 deacetylation; P:regulation of DNA recombination;|Q9H4L7 B7Z799 Q05D56 Q96SX1 Q9H017 Q9H860 Q9NPU9 Q9ULU7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,ATP-dependent helicase 1;, PF00271;PF00176;, GO:0000792;GO:0043596;GO:0005654;GO:0005634;GO:0035861;GO:0005524;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0070615;GO:0043130;GO:0043044;GO:0006338;GO:0051304;GO:0000729;GO:0070932;GO:0070933;GO:0000018;, C:heterochromatin; C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:nucleosome-dependent ATPase activity; F:ubiquitin binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromosome separation; P:DNA double-strand break processing; P:histone H3 deacetylation; P:histone H4 deacetylation; P:regulation of DNA recombination;|Q9H4L7 B7Z799 Q05D56 Q96SX1 Q9H017 Q9H860 Q9NPU9 Q9ULU7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,ATP-dependent helicase 1;, PF00271;PF00176;, GO:0000792;GO:0043596;GO:0005654;GO:0005634;GO:0035861;GO:0005524;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0070615;GO:0043130;GO:0043044;GO:0006338;GO:0051304;GO:0000729;GO:0070932;GO:0070933;GO:0000018;, C:heterochromatin; C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:nucleosome-dependent ATPase activity; F:ubiquitin binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromosome separation; P:DNA double-strand break processing; P:histone H3 deacetylation; P:histone H4 deacetylation; P:regulation of DNA recombination;|Q9H4L7 B7Z799 Q05D56 Q96SX1 Q9H017 Q9H860 Q9NPU9 Q9ULU7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,ATP-dependent helicase 1;, PF00271;PF00176;, GO:0000792;GO:0043596;GO:0005654;GO:0005634;GO:0035861;GO:0005524;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0070615;GO:0043130;GO:0043044;GO:0006338;GO:0051304;GO:0000729;GO:0070932;GO:0070933;GO:0000018;, C:heterochromatin; C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:nucleosome-dependent ATPase activity; F:ubiquitin binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromosome separation; P:DNA double-strand break processing; P:histone H3 deacetylation; P:histone H4 deacetylation; P:regulation of DNA recombination; scaffold2 indexed_genome mRNA 48110255 48114140 . + . ID=transcript_507;O43424 E9PH24 Q4KKU8 Q4KKU9 Q4KKV0 Q59FZ1,Glutamate receptor ionotropic, delta-2,, PF01094;PF00060;PF10613;, GO:0043197;GO:0098978;GO:0005887;GO:0099061;GO:0008328;GO:0098688;GO:0005886;GO:0045211;GO:0045202;GO:0008066;GO:0004970;GO:0015276;GO:0030165;GO:0097110;GO:0038023;GO:1904315;GO:0034613;GO:0021707;GO:0060079;GO:1904861;GO:0007215;GO:0007157;GO:0050804;GO:1900454;GO:0051965;GO:0060134;GO:0043523;GO:0010975;GO:0099151;GO:0035249;, C:dendritic spine; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:ionotropic glutamate receptor complex; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:glutamate receptor activity; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:PDZ domain binding; F:scaffold protein binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular protein localization; P:cerebellar granule cell differentiation; P:excitatory postsynaptic potential; P:excitatory synapse assembly; P:glutamate receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:modulation of chemical synaptic transmission; P:positive regulation of long-term synaptic depression; P:positive regulation of synapse assembly; P:prepulse inhibition; P:regulation of neuron apoptotic process; P:regulation of neuron projection development; P:regulation of postsynaptic density assembly; P:synaptic transmission, glutamatergic; scaffold2 indexed_genome mRNA 49071395 49071971 . - . ID=transcript_508;Q96H96 O95331 Q1JQ78 Q684R2,4-hydroxybenzoate polyprenyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03189},4-hydroxybenzoate decaprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};COQ2 homolog;Para-hydroxybenzoate--polyprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};, PF01040;, GO:0031305;GO:0005743;GO:0002083;GO:0047293;GO:0004659;GO:0016765;GO:0006071;GO:0008299;GO:0006744;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane;, F:4-hydroxybenzoate decaprenyltransferase activity; F:4-hydroxybenzoate nonaprenyltransferase activity; F:prenyltransferase activity; F:transferase activity, transferring alkyl or aryl (other than methyl) groups;, P:glycerol metabolic process; P:isoprenoid biosynthetic process; P:ubiquinone biosynthetic process; scaffold2 indexed_genome mRNA 49305927 49307119 . - . ID=transcript_509;P03915 Q34773 Q8WCY3,NADH-ubiquinone oxidoreductase chain 5,NADH dehydrogenase subunit 5;, PF06455;PF00361;PF00662;, GO:0016021;GO:0005743;GO:0005747;GO:0043005;GO:0008137;GO:0003954;GO:0015990;GO:0006120;GO:0032981;GO:0042542;GO:0001666;GO:0010243;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:neuron projection;, F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity;, P:electron transport coupled proton transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to hydrogen peroxide; P:response to hypoxia; P:response to organonitrogen compound; scaffold2 indexed_genome mRNA 50797325 51591117 . - . ID=transcript_510;Q9C0I3 Q4W5M0 Q86V57,Serine-rich coiled-coil domain-containing protein 1,Coiled-coil serine-rich protein 1; scaffold2 indexed_genome mRNA 51764821 51807023 . - . ID=transcript_511;Q13201 Q4W5L1 Q6P3T8 Q6ZUL9,Multimerin-1,EMILIN-4;Elastin microfibril interface located protein 4;Endothelial cell multimerin;, PF00386;PF00008;PF07546;, GO:0062023;GO:0005576;GO:0031093;GO:0005509;GO:0007596;GO:0007155;GO:0002576;, C:collagen-containing extracellular matrix; C:extracellular region; C:platelet alpha granule lumen;, F:calcium ion binding;, P:blood coagulation; P:cell adhesion; P:platelet degranulation; scaffold2 indexed_genome mRNA 51904696 52051975 . + . ID=transcript_512;P37840 A8K2A4 Q13701 Q4JHI3 Q6IAU6,Alpha-synuclein,Non-A beta component of AD amyloid;Non-A4 component of amyloid precursor;, PF01387;, GO:0015629;GO:0030424;GO:0043679;GO:0005938;GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0030426;GO:0016234;GO:0005764;GO:0016020;GO:0005739;GO:0043025;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0099512;GO:0003779;GO:0043014;GO:0005509;GO:0005507;GO:1903136;GO:0043027;GO:0070840;GO:0008198;GO:0042393;GO:0030544;GO:0042802;GO:0019894;GO:0000287;GO:0016491;GO:0005543;GO:0051219;GO:0004860;GO:0000149;GO:0048156;GO:0000976;GO:0008270;GO:0006919;GO:1990000;GO:0071280;GO:0071872;GO:0034599;GO:0007268;GO:0042416;GO:0051583;GO:0001774;GO:0043066;GO:1904715;GO:0043154;GO:0051585;GO:0045920;GO:0035067;GO:0031115;GO:1902957;GO:0032769;GO:1901215;GO:0051622;GO:0010642;GO:0006469;GO:0051612;GO:0070495;GO:0000122;GO:0032410;GO:0043065;GO:0045807;GO:0045921;GO:1903284;GO:1903285;GO:0050729;GO:0060732;GO:1901216;GO:0033138;GO:0071902;GO:0001921;GO:0051281;GO:0035543;GO:0031648;GO:0051262;GO:0031623;GO:0014059;GO:1901214;GO:0051621;GO:0010517;GO:1905606;GO:1903426;GO:1903421;GO:0022898;GO:0034341;GO:0070555;GO:0010040;GO:0032496;GO:0032026;GO:0035493;GO:0097435;GO:0050808;GO:0048488;GO:0016079;GO:0016082;, C:actin cytoskeleton; C:axon; C:axon terminus; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:growth cone; C:inclusion body; C:lysosome; C:membrane; C:mitochondrion; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:supramolecular fiber;, F:actin binding; F:alpha-tubulin binding; F:calcium ion binding; F:copper ion binding; F:cuprous ion binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:dynein complex binding; F:ferrous iron binding; F:histone binding; F:Hsp70 protein binding; F:identical protein binding; F:kinesin binding; F:magnesium ion binding; F:oxidoreductase activity; F:phospholipid binding; F:phosphoprotein binding; F:protein kinase inhibitor activity; F:SNARE binding; F:tau protein binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:amyloid fibril formation; P:cellular response to copper ion; P:cellular response to epinephrine stimulus; P:cellular response to oxidative stress; P:chemical synaptic transmission; P:dopamine biosynthetic process; P:dopamine uptake involved in synaptic transmission; P:microglial cell activation; P:negative regulation of apoptotic process; P:negative regulation of chaperone-mediated autophagy; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dopamine uptake involved in synaptic transmission; P:negative regulation of exocytosis; P:negative regulation of histone acetylation; P:negative regulation of microtubule polymerization; P:negative regulation of mitochondrial electron transport, NADH to ubiquinone; P:negative regulation of monooxygenase activity; P:negative regulation of neuron death; P:negative regulation of norepinephrine uptake; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of protein kinase activity; P:negative regulation of serotonin uptake; P:negative regulation of thrombin-activated receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transporter activity; P:positive regulation of apoptotic process; P:positive regulation of endocytosis; P:positive regulation of exocytosis; P:positive regulation of glutathione peroxidase activity; P:positive regulation of hydrogen peroxide catabolic process; P:positive regulation of inflammatory response; P:positive regulation of inositol phosphate biosynthetic process; P:positive regulation of neuron death; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of receptor recycling; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of SNARE complex assembly; P:protein destabilization; P:protein tetramerization; P:receptor internalization; P:regulation of dopamine secretion; P:regulation of neuron death; P:regulation of norepinephrine uptake; P:regulation of phospholipase activity; P:regulation of presynapse assembly; P:regulation of reactive oxygen species biosynthetic process; P:regulation of synaptic vesicle recycling; P:regulation of transmembrane transporter activity; P:response to interferon-gamma; P:response to interleukin-1; P:response to iron(II) ion; P:response to lipopolysaccharide; P:response to magnesium ion; P:SNARE complex assembly; P:supramolecular fiber organization; P:synapse organization; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis; P:synaptic vesicle priming;|P37840 A8K2A4 Q13701 Q4JHI3 Q6IAU6,Alpha-synuclein,Non-A beta component of AD amyloid;Non-A4 component of amyloid precursor;, PF01387;, GO:0015629;GO:0030424;GO:0043679;GO:0005938;GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0030426;GO:0016234;GO:0005764;GO:0016020;GO:0005739;GO:0043025;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0099512;GO:0003779;GO:0043014;GO:0005509;GO:0005507;GO:1903136;GO:0043027;GO:0070840;GO:0008198;GO:0042393;GO:0030544;GO:0042802;GO:0019894;GO:0000287;GO:0016491;GO:0005543;GO:0051219;GO:0004860;GO:0000149;GO:0048156;GO:0000976;GO:0008270;GO:0006919;GO:1990000;GO:0071280;GO:0071872;GO:0034599;GO:0007268;GO:0042416;GO:0051583;GO:0001774;GO:0043066;GO:1904715;GO:0043154;GO:0051585;GO:0045920;GO:0035067;GO:0031115;GO:1902957;GO:0032769;GO:1901215;GO:0051622;GO:0010642;GO:0006469;GO:0051612;GO:0070495;GO:0000122;GO:0032410;GO:0043065;GO:0045807;GO:0045921;GO:1903284;GO:1903285;GO:0050729;GO:0060732;GO:1901216;GO:0033138;GO:0071902;GO:0001921;GO:0051281;GO:0035543;GO:0031648;GO:0051262;GO:0031623;GO:0014059;GO:1901214;GO:0051621;GO:0010517;GO:1905606;GO:1903426;GO:1903421;GO:0022898;GO:0034341;GO:0070555;GO:0010040;GO:0032496;GO:0032026;GO:0035493;GO:0097435;GO:0050808;GO:0048488;GO:0016079;GO:0016082;, C:actin cytoskeleton; C:axon; C:axon terminus; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:growth cone; C:inclusion body; C:lysosome; C:membrane; C:mitochondrion; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:supramolecular fiber;, F:actin binding; F:alpha-tubulin binding; F:calcium ion binding; F:copper ion binding; F:cuprous ion binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:dynein complex binding; F:ferrous iron binding; F:histone binding; F:Hsp70 protein binding; F:identical protein binding; F:kinesin binding; F:magnesium ion binding; F:oxidoreductase activity; F:phospholipid binding; F:phosphoprotein binding; F:protein kinase inhibitor activity; F:SNARE binding; F:tau protein binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:amyloid fibril formation; P:cellular response to copper ion; P:cellular response to epinephrine stimulus; P:cellular response to oxidative stress; P:chemical synaptic transmission; P:dopamine biosynthetic process; P:dopamine uptake involved in synaptic transmission; P:microglial cell activation; P:negative regulation of apoptotic process; P:negative regulation of chaperone-mediated autophagy; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dopamine uptake involved in synaptic transmission; P:negative regulation of exocytosis; P:negative regulation of histone acetylation; P:negative regulation of microtubule polymerization; P:negative regulation of mitochondrial electron transport, NADH to ubiquinone; P:negative regulation of monooxygenase activity; P:negative regulation of neuron death; P:negative regulation of norepinephrine uptake; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of protein kinase activity; P:negative regulation of serotonin uptake; P:negative regulation of thrombin-activated receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transporter activity; P:positive regulation of apoptotic process; P:positive regulation of endocytosis; P:positive regulation of exocytosis; P:positive regulation of glutathione peroxidase activity; P:positive regulation of hydrogen peroxide catabolic process; P:positive regulation of inflammatory response; P:positive regulation of inositol phosphate biosynthetic process; P:positive regulation of neuron death; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of receptor recycling; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of SNARE complex assembly; P:protein destabilization; P:protein tetramerization; P:receptor internalization; P:regulation of dopamine secretion; P:regulation of neuron death; P:regulation of norepinephrine uptake; P:regulation of phospholipase activity; P:regulation of presynapse assembly; P:regulation of reactive oxygen species biosynthetic process; P:regulation of synaptic vesicle recycling; P:regulation of transmembrane transporter activity; P:response to interferon-gamma; P:response to interleukin-1; P:response to iron(II) ion; P:response to lipopolysaccharide; P:response to magnesium ion; P:SNARE complex assembly; P:supramolecular fiber organization; P:synapse organization; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis; P:synaptic vesicle priming; scaffold2 indexed_genome mRNA 52497937 52566612 . + . ID=transcript_513;Q6ZVF9 Q8IVE4,G protein-regulated inducer of neurite outgrowth 3,, PF15235;, GO:0005886;GO:0031175;, C:plasma membrane;, , P:neuron projection development;|Q6ZVF9 Q8IVE4,G protein-regulated inducer of neurite outgrowth 3,, PF15235;, GO:0005886;GO:0031175;, C:plasma membrane;, , P:neuron projection development; scaffold2 indexed_genome mRNA 52566622 52568934 . + . ID=transcript_514;Q6ZVF9 Q8IVE4,G protein-regulated inducer of neurite outgrowth 3,, PF15235;, GO:0005886;GO:0031175;, C:plasma membrane;, , P:neuron projection development; scaffold2 indexed_genome mRNA 52732213 52813730 . + . ID=transcript_515;O94988 B4DLC1 Q24JP0 Q5PR21 Q8NBA3,Protein FAM13A,, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold2 indexed_genome mRNA 52914653 53017958 . + . ID=transcript_516;O94988 B4DLC1 Q24JP0 Q5PR21 Q8NBA3,Protein FAM13A,, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|O94988 B4DLC1 Q24JP0 Q5PR21 Q8NBA3,Protein FAM13A,, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|O94988 B4DLC1 Q24JP0 Q5PR21 Q8NBA3,Protein FAM13A,, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|O94988 B4DLC1 Q24JP0 Q5PR21 Q8NBA3,Protein FAM13A,, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|O94988 B4DLC1 Q24JP0 Q5PR21 Q8NBA3,Protein FAM13A,, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|O94988 B4DLC1 Q24JP0 Q5PR21 Q8NBA3,Protein FAM13A,, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold2 indexed_genome mRNA 53037099 53186090 . - . ID=transcript_517;Q15034 A8K1S5 Q8IXX3,Probable E3 ubiquitin-protein ligase HERC3,HECT domain and RCC1-like domain-containing protein 3;HECT-type E3 ubiquitin transferase HERC3;, PF00632;PF00415;, GO:0031410;GO:0005829;GO:0004842;, C:cytoplasmic vesicle; C:cytosol;, F:ubiquitin-protein transferase activity;|Q15034 A8K1S5 Q8IXX3,Probable E3 ubiquitin-protein ligase HERC3,HECT domain and RCC1-like domain-containing protein 3;HECT-type E3 ubiquitin transferase HERC3;, PF00632;PF00415;, GO:0031410;GO:0005829;GO:0004842;, C:cytoplasmic vesicle; C:cytosol;, F:ubiquitin-protein transferase activity;|Q15034 A8K1S5 Q8IXX3,Probable E3 ubiquitin-protein ligase HERC3,HECT domain and RCC1-like domain-containing protein 3;HECT-type E3 ubiquitin transferase HERC3;, PF00632;PF00415;, GO:0031410;GO:0005829;GO:0004842;, C:cytoplasmic vesicle; C:cytosol;, F:ubiquitin-protein transferase activity;|Q96NT1,Nucleosome assembly protein 1-like 5,Down-regulated in liver malignancy;, PF00956;, GO:0000785;GO:0005634;GO:0003682;GO:0042393;GO:0006334;, C:chromatin; C:nucleus;, F:chromatin binding; F:histone binding;, P:nucleosome assembly;|Q15034 A8K1S5 Q8IXX3,Probable E3 ubiquitin-protein ligase HERC3,HECT domain and RCC1-like domain-containing protein 3;HECT-type E3 ubiquitin transferase HERC3;, PF00632;PF00415;, GO:0031410;GO:0005829;GO:0004842;, C:cytoplasmic vesicle; C:cytosol;, F:ubiquitin-protein transferase activity; scaffold2 indexed_genome mRNA 53233264 53236334 . - . ID=transcript_518;Q3MUY2,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Y {ECO:0000305},Phosphatidylinositol-glycan biosynthesis class Y protein;, PF15159;, GO:0005789;GO:0000506;GO:0016021;GO:0005886;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane; C:plasma membrane;, , P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold2 indexed_genome mRNA 53238027 53268542 . - . ID=transcript_519;Q9UII4 B2RTQ1 Q69G20,E3 ISG15--protein ligase HERC5,Cyclin-E-binding protein 1;HECT domain and RCC1-like domain-containing protein 5;, PF00632;PF00415;, GO:0005737;GO:0005829;GO:0048471;GO:0042296;GO:0003723;GO:0061630;GO:0051607;GO:0045087;GO:0032020;GO:0032480;GO:0000209;GO:0016567;GO:0000079;GO:0050688;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ISG15 transferase activity; F:RNA binding; F:ubiquitin protein ligase activity;, P:defense response to virus; P:innate immune response; P:ISG15-protein conjugation; P:negative regulation of type I interferon production; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of defense response to virus;|Q9UII4 B2RTQ1 Q69G20,E3 ISG15--protein ligase HERC5,Cyclin-E-binding protein 1;HECT domain and RCC1-like domain-containing protein 5;, PF00632;PF00415;, GO:0005737;GO:0005829;GO:0048471;GO:0042296;GO:0003723;GO:0061630;GO:0051607;GO:0045087;GO:0032020;GO:0032480;GO:0000209;GO:0016567;GO:0000079;GO:0050688;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ISG15 transferase activity; F:RNA binding; F:ubiquitin protein ligase activity;, P:defense response to virus; P:innate immune response; P:ISG15-protein conjugation; P:negative regulation of type I interferon production; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of defense response to virus;|Q9UII4 B2RTQ1 Q69G20,E3 ISG15--protein ligase HERC5,Cyclin-E-binding protein 1;HECT domain and RCC1-like domain-containing protein 5;, PF00632;PF00415;, GO:0005737;GO:0005829;GO:0048471;GO:0042296;GO:0003723;GO:0061630;GO:0051607;GO:0045087;GO:0032020;GO:0032480;GO:0000209;GO:0016567;GO:0000079;GO:0050688;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ISG15 transferase activity; F:RNA binding; F:ubiquitin protein ligase activity;, P:defense response to virus; P:innate immune response; P:ISG15-protein conjugation; P:negative regulation of type I interferon production; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of defense response to virus;|Q8IVU3 B4DIY5 Q5GC90 Q5GRH3 Q5HYM6 Q5JPB6 Q6PIF4 Q8NAN3 Q9NWS4,Probable E3 ubiquitin-protein ligase HERC6,HECT domain and RCC1-like domain-containing protein 6;HECT-type E3 ubiquitin transferase HERC6;, PF00632;PF00415;, GO:0005829;GO:0005654;GO:0004842;GO:0000209;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q9UII4 B2RTQ1 Q69G20,E3 ISG15--protein ligase HERC5,Cyclin-E-binding protein 1;HECT domain and RCC1-like domain-containing protein 5;, PF00632;PF00415;, GO:0005737;GO:0005829;GO:0048471;GO:0042296;GO:0003723;GO:0061630;GO:0051607;GO:0045087;GO:0032020;GO:0032480;GO:0000209;GO:0016567;GO:0000079;GO:0050688;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ISG15 transferase activity; F:RNA binding; F:ubiquitin protein ligase activity;, P:defense response to virus; P:innate immune response; P:ISG15-protein conjugation; P:negative regulation of type I interferon production; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of defense response to virus;|Q9UII4 B2RTQ1 Q69G20,E3 ISG15--protein ligase HERC5,Cyclin-E-binding protein 1;HECT domain and RCC1-like domain-containing protein 5;, PF00632;PF00415;, GO:0005737;GO:0005829;GO:0048471;GO:0042296;GO:0003723;GO:0061630;GO:0051607;GO:0045087;GO:0032020;GO:0032480;GO:0000209;GO:0016567;GO:0000079;GO:0050688;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ISG15 transferase activity; F:RNA binding; F:ubiquitin protein ligase activity;, P:defense response to virus; P:innate immune response; P:ISG15-protein conjugation; P:negative regulation of type I interferon production; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of defense response to virus; scaffold2 indexed_genome mRNA 53270352 53270913 . + . ID=transcript_520;Q9UII4 B2RTQ1 Q69G20,E3 ISG15--protein ligase HERC5,Cyclin-E-binding protein 1;HECT domain and RCC1-like domain-containing protein 5;, PF00632;PF00415;, GO:0005737;GO:0005829;GO:0048471;GO:0042296;GO:0003723;GO:0061630;GO:0051607;GO:0045087;GO:0032020;GO:0032480;GO:0000209;GO:0016567;GO:0000079;GO:0050688;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ISG15 transferase activity; F:RNA binding; F:ubiquitin protein ligase activity;, P:defense response to virus; P:innate immune response; P:ISG15-protein conjugation; P:negative regulation of type I interferon production; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of defense response to virus; scaffold2 indexed_genome mRNA 53272884 53287202 . - . ID=transcript_521;Q9UII4 B2RTQ1 Q69G20,E3 ISG15--protein ligase HERC5,Cyclin-E-binding protein 1;HECT domain and RCC1-like domain-containing protein 5;, PF00632;PF00415;, GO:0005737;GO:0005829;GO:0048471;GO:0042296;GO:0003723;GO:0061630;GO:0051607;GO:0045087;GO:0032020;GO:0032480;GO:0000209;GO:0016567;GO:0000079;GO:0050688;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ISG15 transferase activity; F:RNA binding; F:ubiquitin protein ligase activity;, P:defense response to virus; P:innate immune response; P:ISG15-protein conjugation; P:negative regulation of type I interferon production; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of defense response to virus;|Q9UII4 B2RTQ1 Q69G20,E3 ISG15--protein ligase HERC5,Cyclin-E-binding protein 1;HECT domain and RCC1-like domain-containing protein 5;, PF00632;PF00415;, GO:0005737;GO:0005829;GO:0048471;GO:0042296;GO:0003723;GO:0061630;GO:0051607;GO:0045087;GO:0032020;GO:0032480;GO:0000209;GO:0016567;GO:0000079;GO:0050688;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ISG15 transferase activity; F:RNA binding; F:ubiquitin protein ligase activity;, P:defense response to virus; P:innate immune response; P:ISG15-protein conjugation; P:negative regulation of type I interferon production; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of defense response to virus;|Q9UII4 B2RTQ1 Q69G20,E3 ISG15--protein ligase HERC5,Cyclin-E-binding protein 1;HECT domain and RCC1-like domain-containing protein 5;, PF00632;PF00415;, GO:0005737;GO:0005829;GO:0048471;GO:0042296;GO:0003723;GO:0061630;GO:0051607;GO:0045087;GO:0032020;GO:0032480;GO:0000209;GO:0016567;GO:0000079;GO:0050688;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ISG15 transferase activity; F:RNA binding; F:ubiquitin protein ligase activity;, P:defense response to virus; P:innate immune response; P:ISG15-protein conjugation; P:negative regulation of type I interferon production; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of defense response to virus; scaffold2 indexed_genome mRNA 53294248 53347066 . - . ID=transcript_522;Q8IVU3 B4DIY5 Q5GC90 Q5GRH3 Q5HYM6 Q5JPB6 Q6PIF4 Q8NAN3 Q9NWS4,Probable E3 ubiquitin-protein ligase HERC6,HECT domain and RCC1-like domain-containing protein 6;HECT-type E3 ubiquitin transferase HERC6;, PF00632;PF00415;, GO:0005829;GO:0005654;GO:0004842;GO:0000209;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q8IVU3 B4DIY5 Q5GC90 Q5GRH3 Q5HYM6 Q5JPB6 Q6PIF4 Q8NAN3 Q9NWS4,Probable E3 ubiquitin-protein ligase HERC6,HECT domain and RCC1-like domain-containing protein 6;HECT-type E3 ubiquitin transferase HERC6;, PF00632;PF00415;, GO:0005829;GO:0005654;GO:0004842;GO:0000209;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q8IVU3 B4DIY5 Q5GC90 Q5GRH3 Q5HYM6 Q5JPB6 Q6PIF4 Q8NAN3 Q9NWS4,Probable E3 ubiquitin-protein ligase HERC6,HECT domain and RCC1-like domain-containing protein 6;HECT-type E3 ubiquitin transferase HERC6;, PF00632;PF00415;, GO:0005829;GO:0005654;GO:0004842;GO:0000209;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q8IVU3 B4DIY5 Q5GC90 Q5GRH3 Q5HYM6 Q5JPB6 Q6PIF4 Q8NAN3 Q9NWS4,Probable E3 ubiquitin-protein ligase HERC6,HECT domain and RCC1-like domain-containing protein 6;HECT-type E3 ubiquitin transferase HERC6;, PF00632;PF00415;, GO:0005829;GO:0005654;GO:0004842;GO:0000209;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q8IVU3 B4DIY5 Q5GC90 Q5GRH3 Q5HYM6 Q5JPB6 Q6PIF4 Q8NAN3 Q9NWS4,Probable E3 ubiquitin-protein ligase HERC6,HECT domain and RCC1-like domain-containing protein 6;HECT-type E3 ubiquitin transferase HERC6;, PF00632;PF00415;, GO:0005829;GO:0005654;GO:0004842;GO:0000209;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q8IVU3 B4DIY5 Q5GC90 Q5GRH3 Q5HYM6 Q5JPB6 Q6PIF4 Q8NAN3 Q9NWS4,Probable E3 ubiquitin-protein ligase HERC6,HECT domain and RCC1-like domain-containing protein 6;HECT-type E3 ubiquitin transferase HERC6;, PF00632;PF00415;, GO:0005829;GO:0005654;GO:0004842;GO:0000209;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination; scaffold2 indexed_genome mRNA 53418061 53440042 . + . ID=transcript_523;Q96NT4,Protein phosphatase 1K, mitochondrial,PP2C domain-containing protein phosphatase 1K;PP2C-like mitochondrial protein;PP2C-type mitochondrial phosphoprotein phosphatase;Protein phosphatase 2C isoform kappa;, PF00481;, GO:0005759;GO:0005739;GO:0046872;GO:0106306;GO:0106307;GO:0045764;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:positive regulation of cellular amino acid metabolic process;|Q96NT4,Protein phosphatase 1K, mitochondrial,PP2C domain-containing protein phosphatase 1K;PP2C-like mitochondrial protein;PP2C-type mitochondrial phosphoprotein phosphatase;Protein phosphatase 2C isoform kappa;, PF00481;, GO:0005759;GO:0005739;GO:0046872;GO:0106306;GO:0106307;GO:0045764;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:positive regulation of cellular amino acid metabolic process;|Q96NT4,Protein phosphatase 1K, mitochondrial,PP2C domain-containing protein phosphatase 1K;PP2C-like mitochondrial protein;PP2C-type mitochondrial phosphoprotein phosphatase;Protein phosphatase 2C isoform kappa;, PF00481;, GO:0005759;GO:0005739;GO:0046872;GO:0106306;GO:0106307;GO:0045764;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:positive regulation of cellular amino acid metabolic process; scaffold2 indexed_genome mRNA 53457029 53577555 . + . ID=transcript_524;Q8IX16 Q96LD6 Q96TA8 Q9BY73 Q9NUS0,Broad substrate specificity ATP-binding cassette transporter ABCG2 {ECO:0000305},ATP-binding cassette sub-family G member 2;Breast cancer resistance protein;CDw338;Mitoxantrone resistance-associated protein;Placenta-specific ATP-binding cassette transporter;Urate exporter;, PF01061;PF19055;PF00005;, GO:0016324;GO:0031526;GO:0098591;GO:0016021;GO:0045121;GO:0031966;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0042626;GO:0015225;GO:0015562;GO:0042802;GO:0008514;GO:0042803;GO:0032217;GO:0015143;GO:0042910;GO:0015878;GO:1990748;GO:0006879;GO:0140115;GO:0006783;GO:0042167;GO:0015711;GO:0032218;GO:0070633;GO:0055085;GO:0150104;GO:0046415;GO:0097744;GO:1990962;, C:apical plasma membrane; C:brush border membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane raft; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:identical protein binding; F:organic anion transmembrane transporter activity; F:protein homodimerization activity; F:riboflavin transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:biotin transport; P:cellular detoxification; P:cellular iron ion homeostasis; P:export across plasma membrane; P:heme biosynthetic process; P:heme catabolic process; P:organic anion transport; P:riboflavin transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:urate metabolic process; P:urate salt excretion; P:xenobiotic transport across blood-brain barrier;|Q8IX16 Q96LD6 Q96TA8 Q9BY73 Q9NUS0,Broad substrate specificity ATP-binding cassette transporter ABCG2 {ECO:0000305},ATP-binding cassette sub-family G member 2;Breast cancer resistance protein;CDw338;Mitoxantrone resistance-associated protein;Placenta-specific ATP-binding cassette transporter;Urate exporter;, PF01061;PF19055;PF00005;, GO:0016324;GO:0031526;GO:0098591;GO:0016021;GO:0045121;GO:0031966;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0042626;GO:0015225;GO:0015562;GO:0042802;GO:0008514;GO:0042803;GO:0032217;GO:0015143;GO:0042910;GO:0015878;GO:1990748;GO:0006879;GO:0140115;GO:0006783;GO:0042167;GO:0015711;GO:0032218;GO:0070633;GO:0055085;GO:0150104;GO:0046415;GO:0097744;GO:1990962;, C:apical plasma membrane; C:brush border membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane raft; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:identical protein binding; F:organic anion transmembrane transporter activity; F:protein homodimerization activity; F:riboflavin transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:biotin transport; P:cellular detoxification; P:cellular iron ion homeostasis; P:export across plasma membrane; P:heme biosynthetic process; P:heme catabolic process; P:organic anion transport; P:riboflavin transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:urate metabolic process; P:urate salt excretion; P:xenobiotic transport across blood-brain barrier;|Q8IX16 Q96LD6 Q96TA8 Q9BY73 Q9NUS0,Broad substrate specificity ATP-binding cassette transporter ABCG2 {ECO:0000305},ATP-binding cassette sub-family G member 2;Breast cancer resistance protein;CDw338;Mitoxantrone resistance-associated protein;Placenta-specific ATP-binding cassette transporter;Urate exporter;, PF01061;PF19055;PF00005;, GO:0016324;GO:0031526;GO:0098591;GO:0016021;GO:0045121;GO:0031966;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0042626;GO:0015225;GO:0015562;GO:0042802;GO:0008514;GO:0042803;GO:0032217;GO:0015143;GO:0042910;GO:0015878;GO:1990748;GO:0006879;GO:0140115;GO:0006783;GO:0042167;GO:0015711;GO:0032218;GO:0070633;GO:0055085;GO:0150104;GO:0046415;GO:0097744;GO:1990962;, C:apical plasma membrane; C:brush border membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane raft; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:identical protein binding; F:organic anion transmembrane transporter activity; F:protein homodimerization activity; F:riboflavin transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:biotin transport; P:cellular detoxification; P:cellular iron ion homeostasis; P:export across plasma membrane; P:heme biosynthetic process; P:heme catabolic process; P:organic anion transport; P:riboflavin transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:urate metabolic process; P:urate salt excretion; P:xenobiotic transport across blood-brain barrier;|Q8IX16 Q96LD6 Q96TA8 Q9BY73 Q9NUS0,Broad substrate specificity ATP-binding cassette transporter ABCG2 {ECO:0000305},ATP-binding cassette sub-family G member 2;Breast cancer resistance protein;CDw338;Mitoxantrone resistance-associated protein;Placenta-specific ATP-binding cassette transporter;Urate exporter;, PF01061;PF19055;PF00005;, GO:0016324;GO:0031526;GO:0098591;GO:0016021;GO:0045121;GO:0031966;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0042626;GO:0015225;GO:0015562;GO:0042802;GO:0008514;GO:0042803;GO:0032217;GO:0015143;GO:0042910;GO:0015878;GO:1990748;GO:0006879;GO:0140115;GO:0006783;GO:0042167;GO:0015711;GO:0032218;GO:0070633;GO:0055085;GO:0150104;GO:0046415;GO:0097744;GO:1990962;, C:apical plasma membrane; C:brush border membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane raft; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:identical protein binding; F:organic anion transmembrane transporter activity; F:protein homodimerization activity; F:riboflavin transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:biotin transport; P:cellular detoxification; P:cellular iron ion homeostasis; P:export across plasma membrane; P:heme biosynthetic process; P:heme catabolic process; P:organic anion transport; P:riboflavin transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:urate metabolic process; P:urate salt excretion; P:xenobiotic transport across blood-brain barrier;|Q8IX16 Q96LD6 Q96TA8 Q9BY73 Q9NUS0,Broad substrate specificity ATP-binding cassette transporter ABCG2 {ECO:0000305},ATP-binding cassette sub-family G member 2;Breast cancer resistance protein;CDw338;Mitoxantrone resistance-associated protein;Placenta-specific ATP-binding cassette transporter;Urate exporter;, PF01061;PF19055;PF00005;, GO:0016324;GO:0031526;GO:0098591;GO:0016021;GO:0045121;GO:0031966;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0042626;GO:0015225;GO:0015562;GO:0042802;GO:0008514;GO:0042803;GO:0032217;GO:0015143;GO:0042910;GO:0015878;GO:1990748;GO:0006879;GO:0140115;GO:0006783;GO:0042167;GO:0015711;GO:0032218;GO:0070633;GO:0055085;GO:0150104;GO:0046415;GO:0097744;GO:1990962;, C:apical plasma membrane; C:brush border membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane raft; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:identical protein binding; F:organic anion transmembrane transporter activity; F:protein homodimerization activity; F:riboflavin transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:biotin transport; P:cellular detoxification; P:cellular iron ion homeostasis; P:export across plasma membrane; P:heme biosynthetic process; P:heme catabolic process; P:organic anion transport; P:riboflavin transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:urate metabolic process; P:urate salt excretion; P:xenobiotic transport across blood-brain barrier;|Q8IX16 Q96LD6 Q96TA8 Q9BY73 Q9NUS0,Broad substrate specificity ATP-binding cassette transporter ABCG2 {ECO:0000305},ATP-binding cassette sub-family G member 2;Breast cancer resistance protein;CDw338;Mitoxantrone resistance-associated protein;Placenta-specific ATP-binding cassette transporter;Urate exporter;, PF01061;PF19055;PF00005;, GO:0016324;GO:0031526;GO:0098591;GO:0016021;GO:0045121;GO:0031966;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0042626;GO:0015225;GO:0015562;GO:0042802;GO:0008514;GO:0042803;GO:0032217;GO:0015143;GO:0042910;GO:0015878;GO:1990748;GO:0006879;GO:0140115;GO:0006783;GO:0042167;GO:0015711;GO:0032218;GO:0070633;GO:0055085;GO:0150104;GO:0046415;GO:0097744;GO:1990962;, C:apical plasma membrane; C:brush border membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane raft; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:identical protein binding; F:organic anion transmembrane transporter activity; F:protein homodimerization activity; F:riboflavin transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:biotin transport; P:cellular detoxification; P:cellular iron ion homeostasis; P:export across plasma membrane; P:heme biosynthetic process; P:heme catabolic process; P:organic anion transport; P:riboflavin transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:urate metabolic process; P:urate salt excretion; P:xenobiotic transport across blood-brain barrier;|Q8IX16 Q96LD6 Q96TA8 Q9BY73 Q9NUS0,Broad substrate specificity ATP-binding cassette transporter ABCG2 {ECO:0000305},ATP-binding cassette sub-family G member 2;Breast cancer resistance protein;CDw338;Mitoxantrone resistance-associated protein;Placenta-specific ATP-binding cassette transporter;Urate exporter;, PF01061;PF19055;PF00005;, GO:0016324;GO:0031526;GO:0098591;GO:0016021;GO:0045121;GO:0031966;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0042626;GO:0015225;GO:0015562;GO:0042802;GO:0008514;GO:0042803;GO:0032217;GO:0015143;GO:0042910;GO:0015878;GO:1990748;GO:0006879;GO:0140115;GO:0006783;GO:0042167;GO:0015711;GO:0032218;GO:0070633;GO:0055085;GO:0150104;GO:0046415;GO:0097744;GO:1990962;, C:apical plasma membrane; C:brush border membrane; C:external side of apical plasma membrane; C:integral component of membrane; C:membrane raft; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:identical protein binding; F:organic anion transmembrane transporter activity; F:protein homodimerization activity; F:riboflavin transmembrane transporter activity; F:urate transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:biotin transport; P:cellular detoxification; P:cellular iron ion homeostasis; P:export across plasma membrane; P:heme biosynthetic process; P:heme catabolic process; P:organic anion transport; P:riboflavin transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:urate metabolic process; P:urate salt excretion; P:xenobiotic transport across blood-brain barrier; scaffold2 indexed_genome mRNA 53584965 53587936 . - . ID=transcript_525;Q13563 O60441 Q15764 Q2M1Q3 Q2M1Q5,Polycystin-2 {ECO:0000305},Autosomal dominant polycystic kidney disease type II protein;Polycystic kidney disease 2 protein;Polycystwin {ECO:0000303|PubMed:8954772};R48321;Transient receptor potential cation channel subfamily P member 2 {ECO:0000303|PubMed:19556541, ECO:0000312|HGNC:HGNC:9009};, PF08016;, GO:0045180;GO:0009925;GO:0034703;GO:0005911;GO:0036064;GO:0060170;GO:0005929;GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0071458;GO:0071556;GO:0005887;GO:0030027;GO:0016020;GO:0072686;GO:0031514;GO:0097730;GO:0005886;GO:0002133;GO:0042805;GO:0051117;GO:0005509;GO:0048763;GO:0005261;GO:0008092;GO:0043398;GO:0042802;GO:0044325;GO:0051371;GO:0015271;GO:0051219;GO:0005267;GO:0042803;GO:0005102;GO:0005245;GO:0022843;GO:0005244;GO:0005249;GO:0005248;GO:0035904;GO:0001658;GO:0070588;GO:0006816;GO:0007050;GO:0198738;GO:0071277;GO:0071320;GO:0071498;GO:0071464;GO:0071470;GO:0034614;GO:0051298;GO:0044782;GO:0042994;GO:0050982;GO:0003127;GO:0007368;GO:0071910;GO:0001892;GO:0007507;GO:0001947;GO:0098662;GO:0001889;GO:0072177;GO:0072164;GO:0072218;GO:0072214;GO:0072219;GO:0072235;GO:0072075;GO:0035502;GO:0072284;GO:0072208;GO:0008285;GO:2000134;GO:0060315;GO:0021915;GO:0060674;GO:0071158;GO:0045737;GO:0031587;GO:0045429;GO:0045944;GO:0071805;GO:0051290;GO:0051289;GO:0051262;GO:0007259;GO:0090279;GO:0042127;GO:0051209;GO:0061441;GO:0061333;GO:0035725;GO:0021510;GO:0016055;, C:basal cortex; C:basal plasma membrane; C:cation channel complex; C:cell-cell junction; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:lamellipodium; C:membrane; C:mitotic spindle; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:polycystin complex;, F:actinin binding; F:ATPase binding; F:calcium ion binding; F:calcium-induced calcium release activity; F:cation channel activity; F:cytoskeletal protein binding; F:HLH domain binding; F:identical protein binding; F:ion channel binding; F:muscle alpha-actinin binding; F:outward rectifier potassium channel activity; F:phosphoprotein binding; F:potassium channel activity; F:protein homodimerization activity; F:signaling receptor binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity; F:voltage-gated ion channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:aorta development; P:branching involved in ureteric bud morphogenesis; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to fluid shear stress; P:cellular response to hydrostatic pressure; P:cellular response to osmotic stress; P:cellular response to reactive oxygen species; P:centrosome duplication; P:cilium organization; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:detection of nodal flow; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:embryonic placenta development; P:heart development; P:heart looping; P:inorganic cation transmembrane transport; P:liver development; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric cortex development; P:metanephric cortical collecting duct development; P:metanephric distal tubule development; P:metanephric mesenchyme development; P:metanephric part of ureteric bud development; P:metanephric S-shaped body morphogenesis; P:metanephric smooth muscle tissue development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:neural tube development; P:placenta blood vessel development; P:positive regulation of cell cycle arrest; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:potassium ion transmembrane transport; P:protein heterotetramerization; P:protein homotetramerization; P:protein tetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of calcium ion import; P:regulation of cell population proliferation; P:release of sequestered calcium ion into cytosol; P:renal artery morphogenesis; P:renal tubule morphogenesis; P:sodium ion transmembrane transport; P:spinal cord development; P:Wnt signaling pathway;|Q13563 O60441 Q15764 Q2M1Q3 Q2M1Q5,Polycystin-2 {ECO:0000305},Autosomal dominant polycystic kidney disease type II protein;Polycystic kidney disease 2 protein;Polycystwin {ECO:0000303|PubMed:8954772};R48321;Transient receptor potential cation channel subfamily P member 2 {ECO:0000303|PubMed:19556541, ECO:0000312|HGNC:HGNC:9009};, PF08016;, GO:0045180;GO:0009925;GO:0034703;GO:0005911;GO:0036064;GO:0060170;GO:0005929;GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0071458;GO:0071556;GO:0005887;GO:0030027;GO:0016020;GO:0072686;GO:0031514;GO:0097730;GO:0005886;GO:0002133;GO:0042805;GO:0051117;GO:0005509;GO:0048763;GO:0005261;GO:0008092;GO:0043398;GO:0042802;GO:0044325;GO:0051371;GO:0015271;GO:0051219;GO:0005267;GO:0042803;GO:0005102;GO:0005245;GO:0022843;GO:0005244;GO:0005249;GO:0005248;GO:0035904;GO:0001658;GO:0070588;GO:0006816;GO:0007050;GO:0198738;GO:0071277;GO:0071320;GO:0071498;GO:0071464;GO:0071470;GO:0034614;GO:0051298;GO:0044782;GO:0042994;GO:0050982;GO:0003127;GO:0007368;GO:0071910;GO:0001892;GO:0007507;GO:0001947;GO:0098662;GO:0001889;GO:0072177;GO:0072164;GO:0072218;GO:0072214;GO:0072219;GO:0072235;GO:0072075;GO:0035502;GO:0072284;GO:0072208;GO:0008285;GO:2000134;GO:0060315;GO:0021915;GO:0060674;GO:0071158;GO:0045737;GO:0031587;GO:0045429;GO:0045944;GO:0071805;GO:0051290;GO:0051289;GO:0051262;GO:0007259;GO:0090279;GO:0042127;GO:0051209;GO:0061441;GO:0061333;GO:0035725;GO:0021510;GO:0016055;, C:basal cortex; C:basal plasma membrane; C:cation channel complex; C:cell-cell junction; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:lamellipodium; C:membrane; C:mitotic spindle; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:polycystin complex;, F:actinin binding; F:ATPase binding; F:calcium ion binding; F:calcium-induced calcium release activity; F:cation channel activity; F:cytoskeletal protein binding; F:HLH domain binding; F:identical protein binding; F:ion channel binding; F:muscle alpha-actinin binding; F:outward rectifier potassium channel activity; F:phosphoprotein binding; F:potassium channel activity; F:protein homodimerization activity; F:signaling receptor binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity; F:voltage-gated ion channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:aorta development; P:branching involved in ureteric bud morphogenesis; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to fluid shear stress; P:cellular response to hydrostatic pressure; P:cellular response to osmotic stress; P:cellular response to reactive oxygen species; P:centrosome duplication; P:cilium organization; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:detection of nodal flow; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:embryonic placenta development; P:heart development; P:heart looping; P:inorganic cation transmembrane transport; P:liver development; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric cortex development; P:metanephric cortical collecting duct development; P:metanephric distal tubule development; P:metanephric mesenchyme development; P:metanephric part of ureteric bud development; P:metanephric S-shaped body morphogenesis; P:metanephric smooth muscle tissue development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:neural tube development; P:placenta blood vessel development; P:positive regulation of cell cycle arrest; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:potassium ion transmembrane transport; P:protein heterotetramerization; P:protein homotetramerization; P:protein tetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of calcium ion import; P:regulation of cell population proliferation; P:release of sequestered calcium ion into cytosol; P:renal artery morphogenesis; P:renal tubule morphogenesis; P:sodium ion transmembrane transport; P:spinal cord development; P:Wnt signaling pathway; scaffold2 indexed_genome mRNA 53587980 53640492 . - . ID=transcript_526;Q13563 O60441 Q15764 Q2M1Q3 Q2M1Q5,Polycystin-2 {ECO:0000305},Autosomal dominant polycystic kidney disease type II protein;Polycystic kidney disease 2 protein;Polycystwin {ECO:0000303|PubMed:8954772};R48321;Transient receptor potential cation channel subfamily P member 2 {ECO:0000303|PubMed:19556541, ECO:0000312|HGNC:HGNC:9009};, PF08016;, GO:0045180;GO:0009925;GO:0034703;GO:0005911;GO:0036064;GO:0060170;GO:0005929;GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0071458;GO:0071556;GO:0005887;GO:0030027;GO:0016020;GO:0072686;GO:0031514;GO:0097730;GO:0005886;GO:0002133;GO:0042805;GO:0051117;GO:0005509;GO:0048763;GO:0005261;GO:0008092;GO:0043398;GO:0042802;GO:0044325;GO:0051371;GO:0015271;GO:0051219;GO:0005267;GO:0042803;GO:0005102;GO:0005245;GO:0022843;GO:0005244;GO:0005249;GO:0005248;GO:0035904;GO:0001658;GO:0070588;GO:0006816;GO:0007050;GO:0198738;GO:0071277;GO:0071320;GO:0071498;GO:0071464;GO:0071470;GO:0034614;GO:0051298;GO:0044782;GO:0042994;GO:0050982;GO:0003127;GO:0007368;GO:0071910;GO:0001892;GO:0007507;GO:0001947;GO:0098662;GO:0001889;GO:0072177;GO:0072164;GO:0072218;GO:0072214;GO:0072219;GO:0072235;GO:0072075;GO:0035502;GO:0072284;GO:0072208;GO:0008285;GO:2000134;GO:0060315;GO:0021915;GO:0060674;GO:0071158;GO:0045737;GO:0031587;GO:0045429;GO:0045944;GO:0071805;GO:0051290;GO:0051289;GO:0051262;GO:0007259;GO:0090279;GO:0042127;GO:0051209;GO:0061441;GO:0061333;GO:0035725;GO:0021510;GO:0016055;, C:basal cortex; C:basal plasma membrane; C:cation channel complex; C:cell-cell junction; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:lamellipodium; C:membrane; C:mitotic spindle; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:polycystin complex;, F:actinin binding; F:ATPase binding; F:calcium ion binding; F:calcium-induced calcium release activity; F:cation channel activity; F:cytoskeletal protein binding; F:HLH domain binding; F:identical protein binding; F:ion channel binding; F:muscle alpha-actinin binding; F:outward rectifier potassium channel activity; F:phosphoprotein binding; F:potassium channel activity; F:protein homodimerization activity; F:signaling receptor binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity; F:voltage-gated ion channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:aorta development; P:branching involved in ureteric bud morphogenesis; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to fluid shear stress; P:cellular response to hydrostatic pressure; P:cellular response to osmotic stress; P:cellular response to reactive oxygen species; P:centrosome duplication; P:cilium organization; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:detection of nodal flow; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:embryonic placenta development; P:heart development; P:heart looping; P:inorganic cation transmembrane transport; P:liver development; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric cortex development; P:metanephric cortical collecting duct development; P:metanephric distal tubule development; P:metanephric mesenchyme development; P:metanephric part of ureteric bud development; P:metanephric S-shaped body morphogenesis; P:metanephric smooth muscle tissue development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:neural tube development; P:placenta blood vessel development; P:positive regulation of cell cycle arrest; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:potassium ion transmembrane transport; P:protein heterotetramerization; P:protein homotetramerization; P:protein tetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of calcium ion import; P:regulation of cell population proliferation; P:release of sequestered calcium ion into cytosol; P:renal artery morphogenesis; P:renal tubule morphogenesis; P:sodium ion transmembrane transport; P:spinal cord development; P:Wnt signaling pathway;|Q13563 O60441 Q15764 Q2M1Q3 Q2M1Q5,Polycystin-2 {ECO:0000305},Autosomal dominant polycystic kidney disease type II protein;Polycystic kidney disease 2 protein;Polycystwin {ECO:0000303|PubMed:8954772};R48321;Transient receptor potential cation channel subfamily P member 2 {ECO:0000303|PubMed:19556541, ECO:0000312|HGNC:HGNC:9009};, PF08016;, GO:0045180;GO:0009925;GO:0034703;GO:0005911;GO:0036064;GO:0060170;GO:0005929;GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0071458;GO:0071556;GO:0005887;GO:0030027;GO:0016020;GO:0072686;GO:0031514;GO:0097730;GO:0005886;GO:0002133;GO:0042805;GO:0051117;GO:0005509;GO:0048763;GO:0005261;GO:0008092;GO:0043398;GO:0042802;GO:0044325;GO:0051371;GO:0015271;GO:0051219;GO:0005267;GO:0042803;GO:0005102;GO:0005245;GO:0022843;GO:0005244;GO:0005249;GO:0005248;GO:0035904;GO:0001658;GO:0070588;GO:0006816;GO:0007050;GO:0198738;GO:0071277;GO:0071320;GO:0071498;GO:0071464;GO:0071470;GO:0034614;GO:0051298;GO:0044782;GO:0042994;GO:0050982;GO:0003127;GO:0007368;GO:0071910;GO:0001892;GO:0007507;GO:0001947;GO:0098662;GO:0001889;GO:0072177;GO:0072164;GO:0072218;GO:0072214;GO:0072219;GO:0072235;GO:0072075;GO:0035502;GO:0072284;GO:0072208;GO:0008285;GO:2000134;GO:0060315;GO:0021915;GO:0060674;GO:0071158;GO:0045737;GO:0031587;GO:0045429;GO:0045944;GO:0071805;GO:0051290;GO:0051289;GO:0051262;GO:0007259;GO:0090279;GO:0042127;GO:0051209;GO:0061441;GO:0061333;GO:0035725;GO:0021510;GO:0016055;, C:basal cortex; C:basal plasma membrane; C:cation channel complex; C:cell-cell junction; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:lamellipodium; C:membrane; C:mitotic spindle; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:polycystin complex;, F:actinin binding; F:ATPase binding; F:calcium ion binding; F:calcium-induced calcium release activity; F:cation channel activity; F:cytoskeletal protein binding; F:HLH domain binding; F:identical protein binding; F:ion channel binding; F:muscle alpha-actinin binding; F:outward rectifier potassium channel activity; F:phosphoprotein binding; F:potassium channel activity; F:protein homodimerization activity; F:signaling receptor binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity; F:voltage-gated ion channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:aorta development; P:branching involved in ureteric bud morphogenesis; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to fluid shear stress; P:cellular response to hydrostatic pressure; P:cellular response to osmotic stress; P:cellular response to reactive oxygen species; P:centrosome duplication; P:cilium organization; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:detection of nodal flow; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:embryonic placenta development; P:heart development; P:heart looping; P:inorganic cation transmembrane transport; P:liver development; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric cortex development; P:metanephric cortical collecting duct development; P:metanephric distal tubule development; P:metanephric mesenchyme development; P:metanephric part of ureteric bud development; P:metanephric S-shaped body morphogenesis; P:metanephric smooth muscle tissue development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:neural tube development; P:placenta blood vessel development; P:positive regulation of cell cycle arrest; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:potassium ion transmembrane transport; P:protein heterotetramerization; P:protein homotetramerization; P:protein tetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of calcium ion import; P:regulation of cell population proliferation; P:release of sequestered calcium ion into cytosol; P:renal artery morphogenesis; P:renal tubule morphogenesis; P:sodium ion transmembrane transport; P:spinal cord development; P:Wnt signaling pathway;|Q13563 O60441 Q15764 Q2M1Q3 Q2M1Q5,Polycystin-2 {ECO:0000305},Autosomal dominant polycystic kidney disease type II protein;Polycystic kidney disease 2 protein;Polycystwin {ECO:0000303|PubMed:8954772};R48321;Transient receptor potential cation channel subfamily P member 2 {ECO:0000303|PubMed:19556541, ECO:0000312|HGNC:HGNC:9009};, PF08016;, GO:0045180;GO:0009925;GO:0034703;GO:0005911;GO:0036064;GO:0060170;GO:0005929;GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0071458;GO:0071556;GO:0005887;GO:0030027;GO:0016020;GO:0072686;GO:0031514;GO:0097730;GO:0005886;GO:0002133;GO:0042805;GO:0051117;GO:0005509;GO:0048763;GO:0005261;GO:0008092;GO:0043398;GO:0042802;GO:0044325;GO:0051371;GO:0015271;GO:0051219;GO:0005267;GO:0042803;GO:0005102;GO:0005245;GO:0022843;GO:0005244;GO:0005249;GO:0005248;GO:0035904;GO:0001658;GO:0070588;GO:0006816;GO:0007050;GO:0198738;GO:0071277;GO:0071320;GO:0071498;GO:0071464;GO:0071470;GO:0034614;GO:0051298;GO:0044782;GO:0042994;GO:0050982;GO:0003127;GO:0007368;GO:0071910;GO:0001892;GO:0007507;GO:0001947;GO:0098662;GO:0001889;GO:0072177;GO:0072164;GO:0072218;GO:0072214;GO:0072219;GO:0072235;GO:0072075;GO:0035502;GO:0072284;GO:0072208;GO:0008285;GO:2000134;GO:0060315;GO:0021915;GO:0060674;GO:0071158;GO:0045737;GO:0031587;GO:0045429;GO:0045944;GO:0071805;GO:0051290;GO:0051289;GO:0051262;GO:0007259;GO:0090279;GO:0042127;GO:0051209;GO:0061441;GO:0061333;GO:0035725;GO:0021510;GO:0016055;, C:basal cortex; C:basal plasma membrane; C:cation channel complex; C:cell-cell junction; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:lamellipodium; C:membrane; C:mitotic spindle; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:polycystin complex;, F:actinin binding; F:ATPase binding; F:calcium ion binding; F:calcium-induced calcium release activity; F:cation channel activity; F:cytoskeletal protein binding; F:HLH domain binding; F:identical protein binding; F:ion channel binding; F:muscle alpha-actinin binding; F:outward rectifier potassium channel activity; F:phosphoprotein binding; F:potassium channel activity; F:protein homodimerization activity; F:signaling receptor binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity; F:voltage-gated ion channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:aorta development; P:branching involved in ureteric bud morphogenesis; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to fluid shear stress; P:cellular response to hydrostatic pressure; P:cellular response to osmotic stress; P:cellular response to reactive oxygen species; P:centrosome duplication; P:cilium organization; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:detection of nodal flow; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:embryonic placenta development; P:heart development; P:heart looping; P:inorganic cation transmembrane transport; P:liver development; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric cortex development; P:metanephric cortical collecting duct development; P:metanephric distal tubule development; P:metanephric mesenchyme development; P:metanephric part of ureteric bud development; P:metanephric S-shaped body morphogenesis; P:metanephric smooth muscle tissue development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:neural tube development; P:placenta blood vessel development; P:positive regulation of cell cycle arrest; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:potassium ion transmembrane transport; P:protein heterotetramerization; P:protein homotetramerization; P:protein tetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of calcium ion import; P:regulation of cell population proliferation; P:release of sequestered calcium ion into cytosol; P:renal artery morphogenesis; P:renal tubule morphogenesis; P:sodium ion transmembrane transport; P:spinal cord development; P:Wnt signaling pathway;|Q13563 O60441 Q15764 Q2M1Q3 Q2M1Q5,Polycystin-2 {ECO:0000305},Autosomal dominant polycystic kidney disease type II protein;Polycystic kidney disease 2 protein;Polycystwin {ECO:0000303|PubMed:8954772};R48321;Transient receptor potential cation channel subfamily P member 2 {ECO:0000303|PubMed:19556541, ECO:0000312|HGNC:HGNC:9009};, PF08016;, GO:0045180;GO:0009925;GO:0034703;GO:0005911;GO:0036064;GO:0060170;GO:0005929;GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0071458;GO:0071556;GO:0005887;GO:0030027;GO:0016020;GO:0072686;GO:0031514;GO:0097730;GO:0005886;GO:0002133;GO:0042805;GO:0051117;GO:0005509;GO:0048763;GO:0005261;GO:0008092;GO:0043398;GO:0042802;GO:0044325;GO:0051371;GO:0015271;GO:0051219;GO:0005267;GO:0042803;GO:0005102;GO:0005245;GO:0022843;GO:0005244;GO:0005249;GO:0005248;GO:0035904;GO:0001658;GO:0070588;GO:0006816;GO:0007050;GO:0198738;GO:0071277;GO:0071320;GO:0071498;GO:0071464;GO:0071470;GO:0034614;GO:0051298;GO:0044782;GO:0042994;GO:0050982;GO:0003127;GO:0007368;GO:0071910;GO:0001892;GO:0007507;GO:0001947;GO:0098662;GO:0001889;GO:0072177;GO:0072164;GO:0072218;GO:0072214;GO:0072219;GO:0072235;GO:0072075;GO:0035502;GO:0072284;GO:0072208;GO:0008285;GO:2000134;GO:0060315;GO:0021915;GO:0060674;GO:0071158;GO:0045737;GO:0031587;GO:0045429;GO:0045944;GO:0071805;GO:0051290;GO:0051289;GO:0051262;GO:0007259;GO:0090279;GO:0042127;GO:0051209;GO:0061441;GO:0061333;GO:0035725;GO:0021510;GO:0016055;, C:basal cortex; C:basal plasma membrane; C:cation channel complex; C:cell-cell junction; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:lamellipodium; C:membrane; C:mitotic spindle; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:polycystin complex;, F:actinin binding; F:ATPase binding; F:calcium ion binding; F:calcium-induced calcium release activity; F:cation channel activity; F:cytoskeletal protein binding; F:HLH domain binding; F:identical protein binding; F:ion channel binding; F:muscle alpha-actinin binding; F:outward rectifier potassium channel activity; F:phosphoprotein binding; F:potassium channel activity; F:protein homodimerization activity; F:signaling receptor binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity; F:voltage-gated ion channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:aorta development; P:branching involved in ureteric bud morphogenesis; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to fluid shear stress; P:cellular response to hydrostatic pressure; P:cellular response to osmotic stress; P:cellular response to reactive oxygen species; P:centrosome duplication; P:cilium organization; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:detection of nodal flow; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:embryonic placenta development; P:heart development; P:heart looping; P:inorganic cation transmembrane transport; P:liver development; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric cortex development; P:metanephric cortical collecting duct development; P:metanephric distal tubule development; P:metanephric mesenchyme development; P:metanephric part of ureteric bud development; P:metanephric S-shaped body morphogenesis; P:metanephric smooth muscle tissue development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:neural tube development; P:placenta blood vessel development; P:positive regulation of cell cycle arrest; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:potassium ion transmembrane transport; P:protein heterotetramerization; P:protein homotetramerization; P:protein tetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of calcium ion import; P:regulation of cell population proliferation; P:release of sequestered calcium ion into cytosol; P:renal artery morphogenesis; P:renal tubule morphogenesis; P:sodium ion transmembrane transport; P:spinal cord development; P:Wnt signaling pathway; scaffold2 indexed_genome mRNA 53666256 53673395 . - . ID=transcript_527;P10451 B2RDA1 Q15681 Q15682 Q15683 Q4W597 Q567T5 Q8NBK2 Q96IZ1,Osteopontin {ECO:0000303|PubMed:1974876, ECO:0000303|PubMed:2726470},Bone sialoprotein 1;Nephropontin;Secreted phosphoprotein 1;Urinary stone protein {ECO:0000303|PubMed:1729712};Uropontin {ECO:0000303|PubMed:1729712};, PF00865;, GO:0042995;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0048471;GO:0005125;GO:0050840;GO:0005178;GO:0006710;GO:0031214;GO:0007155;GO:0044267;GO:0071394;GO:0046697;GO:0007566;GO:0030198;GO:0006954;GO:0048685;GO:0001649;GO:0045780;GO:2000866;GO:0045893;GO:0043687;GO:0048545;GO:0033280;, C:cell projection; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:cytokine activity; F:extracellular matrix binding; F:integrin binding;, P:androgen catabolic process; P:biomineral tissue development; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to testosterone stimulus; P:decidualization; P:embryo implantation; P:extracellular matrix organization; P:inflammatory response; P:negative regulation of collateral sprouting of intact axon in response to injury; P:osteoblast differentiation; P:positive regulation of bone resorption; P:positive regulation of estradiol secretion; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:response to steroid hormone; P:response to vitamin D;|P10451 B2RDA1 Q15681 Q15682 Q15683 Q4W597 Q567T5 Q8NBK2 Q96IZ1,Osteopontin {ECO:0000303|PubMed:1974876, ECO:0000303|PubMed:2726470},Bone sialoprotein 1;Nephropontin;Secreted phosphoprotein 1;Urinary stone protein {ECO:0000303|PubMed:1729712};Uropontin {ECO:0000303|PubMed:1729712};, PF00865;, GO:0042995;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0048471;GO:0005125;GO:0050840;GO:0005178;GO:0006710;GO:0031214;GO:0007155;GO:0044267;GO:0071394;GO:0046697;GO:0007566;GO:0030198;GO:0006954;GO:0048685;GO:0001649;GO:0045780;GO:2000866;GO:0045893;GO:0043687;GO:0048545;GO:0033280;, C:cell projection; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:cytokine activity; F:extracellular matrix binding; F:integrin binding;, P:androgen catabolic process; P:biomineral tissue development; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to testosterone stimulus; P:decidualization; P:embryo implantation; P:extracellular matrix organization; P:inflammatory response; P:negative regulation of collateral sprouting of intact axon in response to injury; P:osteoblast differentiation; P:positive regulation of bone resorption; P:positive regulation of estradiol secretion; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:response to steroid hormone; P:response to vitamin D;|P10451 B2RDA1 Q15681 Q15682 Q15683 Q4W597 Q567T5 Q8NBK2 Q96IZ1,Osteopontin {ECO:0000303|PubMed:1974876, ECO:0000303|PubMed:2726470},Bone sialoprotein 1;Nephropontin;Secreted phosphoprotein 1;Urinary stone protein {ECO:0000303|PubMed:1729712};Uropontin {ECO:0000303|PubMed:1729712};, PF00865;, GO:0042995;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0048471;GO:0005125;GO:0050840;GO:0005178;GO:0006710;GO:0031214;GO:0007155;GO:0044267;GO:0071394;GO:0046697;GO:0007566;GO:0030198;GO:0006954;GO:0048685;GO:0001649;GO:0045780;GO:2000866;GO:0045893;GO:0043687;GO:0048545;GO:0033280;, C:cell projection; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:cytokine activity; F:extracellular matrix binding; F:integrin binding;, P:androgen catabolic process; P:biomineral tissue development; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to testosterone stimulus; P:decidualization; P:embryo implantation; P:extracellular matrix organization; P:inflammatory response; P:negative regulation of collateral sprouting of intact axon in response to injury; P:osteoblast differentiation; P:positive regulation of bone resorption; P:positive regulation of estradiol secretion; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:response to steroid hormone; P:response to vitamin D; scaffold2 indexed_genome mRNA 54090430 54115994 . + . ID=transcript_528;P28838 B3KMQ3 Q6IAM6 Q6P0L6 Q9UQE3,Cytosol aminopeptidase {ECO:0000305},Cysteinylglycine-S-conjugate dipeptidase {ECO:0000250|UniProtKB:P00727};Leucine aminopeptidase 3 {ECO:0000312|HGNC:HGNC:18449};Leucyl aminopeptidase {ECO:0000250|UniProtKB:P00727};Peptidase S {ECO:0000312|HGNC:HGNC:18449};Proline aminopeptidase {ECO:0000250|UniProtKB:P28839};Prolyl aminopeptidase {ECO:0000303|PubMed:1908238};, PF00883;PF02789;, GO:0005829;GO:0070062;GO:0005925;GO:0030496;GO:0005654;GO:0005634;GO:0005802;GO:0004177;GO:0004180;GO:0030145;GO:0070006;GO:0008235;GO:0006508;, C:cytosol; C:extracellular exosome; C:focal adhesion; C:midbody; C:nucleoplasm; C:nucleus; C:trans-Golgi network;, F:aminopeptidase activity; F:carboxypeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:proteolysis;|P28838 B3KMQ3 Q6IAM6 Q6P0L6 Q9UQE3,Cytosol aminopeptidase {ECO:0000305},Cysteinylglycine-S-conjugate dipeptidase {ECO:0000250|UniProtKB:P00727};Leucine aminopeptidase 3 {ECO:0000312|HGNC:HGNC:18449};Leucyl aminopeptidase {ECO:0000250|UniProtKB:P00727};Peptidase S {ECO:0000312|HGNC:HGNC:18449};Proline aminopeptidase {ECO:0000250|UniProtKB:P28839};Prolyl aminopeptidase {ECO:0000303|PubMed:1908238};, PF00883;PF02789;, GO:0005829;GO:0070062;GO:0005925;GO:0030496;GO:0005654;GO:0005634;GO:0005802;GO:0004177;GO:0004180;GO:0030145;GO:0070006;GO:0008235;GO:0006508;, C:cytosol; C:extracellular exosome; C:focal adhesion; C:midbody; C:nucleoplasm; C:nucleus; C:trans-Golgi network;, F:aminopeptidase activity; F:carboxypeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:proteolysis;|P28838 B3KMQ3 Q6IAM6 Q6P0L6 Q9UQE3,Cytosol aminopeptidase {ECO:0000305},Cysteinylglycine-S-conjugate dipeptidase {ECO:0000250|UniProtKB:P00727};Leucine aminopeptidase 3 {ECO:0000312|HGNC:HGNC:18449};Leucyl aminopeptidase {ECO:0000250|UniProtKB:P00727};Peptidase S {ECO:0000312|HGNC:HGNC:18449};Proline aminopeptidase {ECO:0000250|UniProtKB:P28839};Prolyl aminopeptidase {ECO:0000303|PubMed:1908238};, PF00883;PF02789;, GO:0005829;GO:0070062;GO:0005925;GO:0030496;GO:0005654;GO:0005634;GO:0005802;GO:0004177;GO:0004180;GO:0030145;GO:0070006;GO:0008235;GO:0006508;, C:cytosol; C:extracellular exosome; C:focal adhesion; C:midbody; C:nucleoplasm; C:nucleus; C:trans-Golgi network;, F:aminopeptidase activity; F:carboxypeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:proteolysis;|P28838 B3KMQ3 Q6IAM6 Q6P0L6 Q9UQE3,Cytosol aminopeptidase {ECO:0000305},Cysteinylglycine-S-conjugate dipeptidase {ECO:0000250|UniProtKB:P00727};Leucine aminopeptidase 3 {ECO:0000312|HGNC:HGNC:18449};Leucyl aminopeptidase {ECO:0000250|UniProtKB:P00727};Peptidase S {ECO:0000312|HGNC:HGNC:18449};Proline aminopeptidase {ECO:0000250|UniProtKB:P28839};Prolyl aminopeptidase {ECO:0000303|PubMed:1908238};, PF00883;PF02789;, GO:0005829;GO:0070062;GO:0005925;GO:0030496;GO:0005654;GO:0005634;GO:0005802;GO:0004177;GO:0004180;GO:0030145;GO:0070006;GO:0008235;GO:0006508;, C:cytosol; C:extracellular exosome; C:focal adhesion; C:midbody; C:nucleoplasm; C:nucleus; C:trans-Golgi network;, F:aminopeptidase activity; F:carboxypeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:proteolysis;|P28838 B3KMQ3 Q6IAM6 Q6P0L6 Q9UQE3,Cytosol aminopeptidase {ECO:0000305},Cysteinylglycine-S-conjugate dipeptidase {ECO:0000250|UniProtKB:P00727};Leucine aminopeptidase 3 {ECO:0000312|HGNC:HGNC:18449};Leucyl aminopeptidase {ECO:0000250|UniProtKB:P00727};Peptidase S {ECO:0000312|HGNC:HGNC:18449};Proline aminopeptidase {ECO:0000250|UniProtKB:P28839};Prolyl aminopeptidase {ECO:0000303|PubMed:1908238};, PF00883;PF02789;, GO:0005829;GO:0070062;GO:0005925;GO:0030496;GO:0005654;GO:0005634;GO:0005802;GO:0004177;GO:0004180;GO:0030145;GO:0070006;GO:0008235;GO:0006508;, C:cytosol; C:extracellular exosome; C:focal adhesion; C:midbody; C:nucleoplasm; C:nucleus; C:trans-Golgi network;, F:aminopeptidase activity; F:carboxypeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:proteolysis;|P28838 B3KMQ3 Q6IAM6 Q6P0L6 Q9UQE3,Cytosol aminopeptidase {ECO:0000305},Cysteinylglycine-S-conjugate dipeptidase {ECO:0000250|UniProtKB:P00727};Leucine aminopeptidase 3 {ECO:0000312|HGNC:HGNC:18449};Leucyl aminopeptidase {ECO:0000250|UniProtKB:P00727};Peptidase S {ECO:0000312|HGNC:HGNC:18449};Proline aminopeptidase {ECO:0000250|UniProtKB:P28839};Prolyl aminopeptidase {ECO:0000303|PubMed:1908238};, PF00883;PF02789;, GO:0005829;GO:0070062;GO:0005925;GO:0030496;GO:0005654;GO:0005634;GO:0005802;GO:0004177;GO:0004180;GO:0030145;GO:0070006;GO:0008235;GO:0006508;, C:cytosol; C:extracellular exosome; C:focal adhesion; C:midbody; C:nucleoplasm; C:nucleus; C:trans-Golgi network;, F:aminopeptidase activity; F:carboxypeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:proteolysis;|P28838 B3KMQ3 Q6IAM6 Q6P0L6 Q9UQE3,Cytosol aminopeptidase {ECO:0000305},Cysteinylglycine-S-conjugate dipeptidase {ECO:0000250|UniProtKB:P00727};Leucine aminopeptidase 3 {ECO:0000312|HGNC:HGNC:18449};Leucyl aminopeptidase {ECO:0000250|UniProtKB:P00727};Peptidase S {ECO:0000312|HGNC:HGNC:18449};Proline aminopeptidase {ECO:0000250|UniProtKB:P28839};Prolyl aminopeptidase {ECO:0000303|PubMed:1908238};, PF00883;PF02789;, GO:0005829;GO:0070062;GO:0005925;GO:0030496;GO:0005654;GO:0005634;GO:0005802;GO:0004177;GO:0004180;GO:0030145;GO:0070006;GO:0008235;GO:0006508;, C:cytosol; C:extracellular exosome; C:focal adhesion; C:midbody; C:nucleoplasm; C:nucleus; C:trans-Golgi network;, F:aminopeptidase activity; F:carboxypeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:proteolysis; scaffold2 indexed_genome mRNA 54117362 54139235 . + . ID=transcript_529;Q9H204 Q9BZJ5,Mediator of RNA polymerase II transcription subunit 28,Endothelial-derived protein 1;Mediator complex subunit 28;Merlin and Grb2-interacting cytoskeletal protein;Tumor angiogenesis marker EG-1;, , GO:0030864;GO:0016592;GO:0016020;GO:0005654;GO:0003779;GO:0051151;GO:0019827;, C:cortical actin cytoskeleton; C:mediator complex; C:membrane; C:nucleoplasm;, F:actin binding;, P:negative regulation of smooth muscle cell differentiation; P:stem cell population maintenance;|Q9ULE4,Protein FAM184B,, PF15665; scaffold2 indexed_genome mRNA 54142119 54159452 . - . ID=transcript_530;Q9ULE4,Protein FAM184B,, PF15665; scaffold2 indexed_genome mRNA 54184533 54186165 . - . ID=transcript_531;Q9ULE4,Protein FAM184B,, PF15665; scaffold2 indexed_genome mRNA 54264116 54268730 . + . ID=transcript_532;Q9NXF7 B3KPB7,DDB1- and CUL4-associated factor 16 {ECO:0000305},, PF15349;, GO:0080008;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination; scaffold2 indexed_genome mRNA 54276357 54278479 . + . ID=transcript_533;Q9BPX3 Q3MJE0 Q96SV9 Q9BUR3 Q9BVY1 Q9H914 Q9H9Z6 Q9HBI9,Condensin complex subunit 3,Chromosome-associated protein G;Condensin subunit CAP-G;Melanoma antigen NY-MEL-3;Non-SMC condensin I complex subunit G;XCAP-G homolog;, PF12719;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0051301;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, , P:cell division; P:mitotic chromosome condensation; scaffold2 indexed_genome mRNA 54305647 54346317 . + . ID=transcript_534;Q9BPX3 Q3MJE0 Q96SV9 Q9BUR3 Q9BVY1 Q9H914 Q9H9Z6 Q9HBI9,Condensin complex subunit 3,Chromosome-associated protein G;Condensin subunit CAP-G;Melanoma antigen NY-MEL-3;Non-SMC condensin I complex subunit G;XCAP-G homolog;, PF12719;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0051301;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, , P:cell division; P:mitotic chromosome condensation;|Q9BPX3 Q3MJE0 Q96SV9 Q9BUR3 Q9BVY1 Q9H914 Q9H9Z6 Q9HBI9,Condensin complex subunit 3,Chromosome-associated protein G;Condensin subunit CAP-G;Melanoma antigen NY-MEL-3;Non-SMC condensin I complex subunit G;XCAP-G homolog;, PF12719;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0051301;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, , P:cell division; P:mitotic chromosome condensation;|A8MVM7,Putative uncharacterized protein ENSP00000382790,, PF15090; scaffold2 indexed_genome mRNA 54348239 54489124 . - . ID=transcript_535;Q8N3X6 Q96NK1,Ligand-dependent nuclear receptor corepressor-like protein,, PF05225;, GO:0005634;GO:0003677;GO:1990226;GO:0006357;, C:nucleus;, F:DNA binding; F:histone methyltransferase binding;, P:regulation of transcription by RNA polymerase II;|Q8N3X6 Q96NK1,Ligand-dependent nuclear receptor corepressor-like protein,, PF05225;, GO:0005634;GO:0003677;GO:1990226;GO:0006357;, C:nucleus;, F:DNA binding; F:histone methyltransferase binding;, P:regulation of transcription by RNA polymerase II; scaffold2 indexed_genome mRNA 56792948 56883830 . + . ID=transcript_536;O94813 A0A0A6YYB8 B7ZLR5 O95710 Q17RU3 Q9Y5Q7,Slit homolog 2 protein,, PF00008;PF12661;PF00054;PF13855;PF01463;PF01462;, GO:0009986;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005509;GO:0005095;GO:0008201;GO:0042802;GO:0043237;GO:0042803;GO:0043394;GO:0048495;GO:0003180;GO:0061364;GO:0048846;GO:0007411;GO:0048754;GO:0002042;GO:0071504;GO:0032870;GO:0021836;GO:0021972;GO:0050929;GO:0008045;GO:0050919;GO:0030837;GO:0030308;GO:0030336;GO:0090288;GO:0070100;GO:0010596;GO:0010593;GO:0002689;GO:0090027;GO:0071676;GO:0090024;GO:0001933;GO:0090260;GO:0051058;GO:0071672;GO:0014912;GO:0043116;GO:0043065;GO:0050772;GO:0003184;GO:0051414;GO:0031290;GO:0035385;GO:0001657;GO:0060412;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane;, F:calcium ion binding; F:GTPase inhibitor activity; F:heparin binding; F:identical protein binding; F:laminin-1 binding; F:protein homodimerization activity; F:proteoglycan binding; F:Roundabout binding;, P:aortic valve morphogenesis; P:apoptotic process involved in luteolysis; P:axon extension involved in axon guidance; P:axon guidance; P:branching morphogenesis of an epithelial tube; P:cell migration involved in sprouting angiogenesis; P:cellular response to heparin; P:cellular response to hormone stimulus; P:chemorepulsion involved in postnatal olfactory bulb interneuron migration; P:corticospinal neuron axon guidance through spinal cord; P:induction of negative chemotaxis; P:motor neuron axon guidance; P:negative chemotaxis; P:negative regulation of actin filament polymerization; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cellular response to growth factor stimulus; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of endothelial cell migration; P:negative regulation of lamellipodium assembly; P:negative regulation of leukocyte chemotaxis; P:negative regulation of monocyte chemotaxis; P:negative regulation of mononuclear cell migration; P:negative regulation of neutrophil chemotaxis; P:negative regulation of protein phosphorylation; P:negative regulation of retinal ganglion cell axon guidance; P:negative regulation of small GTPase mediated signal transduction; P:negative regulation of smooth muscle cell chemotaxis; P:negative regulation of smooth muscle cell migration; P:negative regulation of vascular permeability; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:pulmonary valve morphogenesis; P:response to cortisol; P:retinal ganglion cell axon guidance; P:Roundabout signaling pathway; P:ureteric bud development; P:ventricular septum morphogenesis; scaffold2 indexed_genome mRNA 56928014 56944280 . + . ID=transcript_537;Q8N7B6 B2RDB9 B4DFF8 B4DMN7 Q8TBA8,PACRG-like protein,, PF10274; scaffold2 indexed_genome mRNA 56945897 56968573 . - . ID=transcript_538;Q9H294 Q9H2A4,Kv channel-interacting protein 4,A-type potassium channel modulatory protein 4;Calsenilin-like protein {ECO:0000303|PubMed:11847232};Potassium channel-interacting protein 4;, PF13499;PF13833;, GO:0005737;GO:0005829;GO:0005783;GO:0005886;GO:0008076;GO:0005509;GO:0005267;GO:0015459;GO:0005244;GO:0061337;GO:0072659;GO:1901379;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calcium ion binding; F:potassium channel activity; F:potassium channel regulator activity; F:voltage-gated ion channel activity;, P:cardiac conduction; P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport; scaffold2 indexed_genome mRNA 57051586 58155677 . - . ID=transcript_539;Q9H294 Q9H2A4,Kv channel-interacting protein 4,A-type potassium channel modulatory protein 4;Calsenilin-like protein {ECO:0000303|PubMed:11847232};Potassium channel-interacting protein 4;, PF13499;PF13833;, GO:0005737;GO:0005829;GO:0005783;GO:0005886;GO:0008076;GO:0005509;GO:0005267;GO:0015459;GO:0005244;GO:0061337;GO:0072659;GO:1901379;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calcium ion binding; F:potassium channel activity; F:potassium channel regulator activity; F:voltage-gated ion channel activity;, P:cardiac conduction; P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport; scaffold2 indexed_genome mRNA 58554262 58679966 . - . ID=transcript_540;Q8IWK6 Q6UXK9 Q86SQ5 Q8TC55,Adhesion G protein-coupled receptor A3 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 125;, PF00002;PF01825;PF07679;PF13855;, GO:0009897;GO:0016021;GO:0005886;GO:0004930;GO:0007166;GO:0007186;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway;|Q8IWK6 Q6UXK9 Q86SQ5 Q8TC55,Adhesion G protein-coupled receptor A3 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 125;, PF00002;PF01825;PF07679;PF13855;, GO:0009897;GO:0016021;GO:0005886;GO:0004930;GO:0007166;GO:0007186;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway;|Q8IWK6 Q6UXK9 Q86SQ5 Q8TC55,Adhesion G protein-coupled receptor A3 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 125;, PF00002;PF01825;PF07679;PF13855;, GO:0009897;GO:0016021;GO:0005886;GO:0004930;GO:0007166;GO:0007186;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold2 indexed_genome mRNA 58870663 58946222 . + . ID=transcript_541;Q9H227 Q32LY7 Q3MIH4 Q53GG8 Q6NSF4 Q8NHT8 Q9H3T4 Q9H4C6,Cytosolic beta-glucosidase {ECO:0000305|PubMed:11389701},Cytosolic beta-glucosidase-like protein 1;Cytosolic glycosylceramidase {ECO:0000303|PubMed:17595169};Glucosidase beta acid 3 {ECO:0000312|HGNC:HGNC:19069};Glucosylceramidase beta 3 {ECO:0000312|HGNC:HGNC:19069};Klotho-related protein {ECO:0000303|PubMed:17595169};, PF00232;, GO:1902494;GO:0005829;GO:0004565;GO:0008422;GO:0004336;GO:0004348;GO:0017042;GO:0102483;GO:1901805;GO:0051692;GO:0006683;GO:0006680;GO:0016139;GO:0006687;GO:0046477;GO:1903017;GO:0050821;, C:catalytic complex; C:cytosol;, F:beta-galactosidase activity; F:beta-glucosidase activity; F:galactosylceramidase activity; F:glucosylceramidase activity; F:glycosylceramidase activity; F:scopolin beta-glucosidase activity;, P:beta-glucoside catabolic process; P:cellular oligosaccharide catabolic process; P:galactosylceramide catabolic process; P:glucosylceramide catabolic process; P:glycoside catabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide catabolic process; P:positive regulation of exo-alpha-sialidase activity; P:protein stabilization; scaffold2 indexed_genome mRNA 59848455 59950972 . - . ID=transcript_542;Q4W5M7 Q9UN32,Peroxisome proliferator-activated receptor gamma coactivator 1-alpha,Ligand effect modulator 6;, PF00076;, GO:0097440;GO:0000785;GO:0022626;GO:1990844;GO:0043231;GO:0043025;GO:0005654;GO:0005634;GO:0016605;GO:1990843;GO:0043014;GO:0031490;GO:0003677;GO:0030331;GO:0016922;GO:0030374;GO:0042975;GO:1990841;GO:0003723;GO:0043565;GO:0003713;GO:0003712;GO:0008134;GO:0031625;GO:1990845;GO:0060612;GO:0007568;GO:0008209;GO:0000422;GO:0050873;GO:0001678;GO:0045333;GO:0071313;GO:0071392;GO:0071372;GO:0071332;GO:0071333;GO:0071456;GO:0071354;GO:1904637;GO:0071222;GO:0071250;GO:0034599;GO:0035865;GO:1904639;GO:0097067;GO:0071560;GO:0071356;GO:0021549;GO:0032922;GO:0007623;GO:0007586;GO:0097009;GO:0019395;GO:0051552;GO:0030900;GO:0006012;GO:0006094;GO:0007005;GO:0006397;GO:0045820;GO:0090258;GO:0043524;GO:1901215;GO:0001933;GO:2000272;GO:0014912;GO:0048662;GO:2001171;GO:1901857;GO:0120162;GO:0051091;GO:0046321;GO:0010628;GO:1904635;GO:0045722;GO:0035066;GO:1901860;GO:0010822;GO:1901863;GO:2000184;GO:0048661;GO:0045944;GO:0045893;GO:0050821;GO:0065003;GO:0042752;GO:2000310;GO:0006355;GO:0022904;GO:0009409;GO:0002021;GO:0042493;GO:0014878;GO:0071871;GO:0002931;GO:0043201;GO:1901558;GO:1904640;GO:0014850;GO:0071873;GO:0000302;GO:0042594;GO:0008380;GO:0014732;GO:0001659;GO:0006367;, C:apical dendrite; C:chromatin; C:cytosolic ribosome; C:interfibrillar mitochondrion; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:PML body; C:subsarcolemmal mitochondrion;, F:alpha-tubulin binding; F:chromatin DNA binding; F:DNA binding; F:estrogen receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:promoter-specific chromatin binding; F:RNA binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:adaptive thermogenesis; P:adipose tissue development; P:aging; P:androgen metabolic process; P:autophagy of mitochondrion; P:brown fat cell differentiation; P:cellular glucose homeostasis; P:cellular respiration; P:cellular response to caffeine; P:cellular response to estradiol stimulus; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to fructose stimulus; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:cellular response to interleukin-6; P:cellular response to ionomycin; P:cellular response to lipopolysaccharide; P:cellular response to nitrite; P:cellular response to oxidative stress; P:cellular response to potassium ion; P:cellular response to resveratrol; P:cellular response to thyroid hormone stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:cerebellum development; P:circadian regulation of gene expression; P:circadian rhythm; P:digestion; P:energy homeostasis; P:fatty acid oxidation; P:flavone metabolic process; P:forebrain development; P:galactose metabolic process; P:gluconeogenesis; P:mitochondrion organization; P:mRNA processing; P:negative regulation of glycolytic process; P:negative regulation of mitochondrial fission; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of protein phosphorylation; P:negative regulation of signaling receptor activity; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of ATP biosynthetic process; P:positive regulation of cellular respiration; P:positive regulation of cold-induced thermogenesis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of fatty acid oxidation; P:positive regulation of gene expression; P:positive regulation of glomerular visceral epithelial cell apoptotic process; P:positive regulation of gluconeogenesis; P:positive regulation of histone acetylation; P:positive regulation of mitochondrial DNA metabolic process; P:positive regulation of mitochondrion organization; P:positive regulation of muscle tissue development; P:positive regulation of progesterone biosynthetic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:protein-containing complex assembly; P:regulation of circadian rhythm; P:regulation of NMDA receptor activity; P:regulation of transcription, DNA-templated; P:respiratory electron transport chain; P:response to cold; P:response to dietary excess; P:response to drug; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to epinephrine; P:response to ischemia; P:response to leucine; P:response to metformin; P:response to methionine; P:response to muscle activity; P:response to norepinephrine; P:response to reactive oxygen species; P:response to starvation; P:RNA splicing; P:skeletal muscle atrophy; P:temperature homeostasis; P:transcription initiation from RNA polymerase II promoter;|Q4W5M7 Q9UN32,Peroxisome proliferator-activated receptor gamma coactivator 1-alpha,Ligand effect modulator 6;, PF00076;, GO:0097440;GO:0000785;GO:0022626;GO:1990844;GO:0043231;GO:0043025;GO:0005654;GO:0005634;GO:0016605;GO:1990843;GO:0043014;GO:0031490;GO:0003677;GO:0030331;GO:0016922;GO:0030374;GO:0042975;GO:1990841;GO:0003723;GO:0043565;GO:0003713;GO:0003712;GO:0008134;GO:0031625;GO:1990845;GO:0060612;GO:0007568;GO:0008209;GO:0000422;GO:0050873;GO:0001678;GO:0045333;GO:0071313;GO:0071392;GO:0071372;GO:0071332;GO:0071333;GO:0071456;GO:0071354;GO:1904637;GO:0071222;GO:0071250;GO:0034599;GO:0035865;GO:1904639;GO:0097067;GO:0071560;GO:0071356;GO:0021549;GO:0032922;GO:0007623;GO:0007586;GO:0097009;GO:0019395;GO:0051552;GO:0030900;GO:0006012;GO:0006094;GO:0007005;GO:0006397;GO:0045820;GO:0090258;GO:0043524;GO:1901215;GO:0001933;GO:2000272;GO:0014912;GO:0048662;GO:2001171;GO:1901857;GO:0120162;GO:0051091;GO:0046321;GO:0010628;GO:1904635;GO:0045722;GO:0035066;GO:1901860;GO:0010822;GO:1901863;GO:2000184;GO:0048661;GO:0045944;GO:0045893;GO:0050821;GO:0065003;GO:0042752;GO:2000310;GO:0006355;GO:0022904;GO:0009409;GO:0002021;GO:0042493;GO:0014878;GO:0071871;GO:0002931;GO:0043201;GO:1901558;GO:1904640;GO:0014850;GO:0071873;GO:0000302;GO:0042594;GO:0008380;GO:0014732;GO:0001659;GO:0006367;, C:apical dendrite; C:chromatin; C:cytosolic ribosome; C:interfibrillar mitochondrion; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:PML body; C:subsarcolemmal mitochondrion;, F:alpha-tubulin binding; F:chromatin DNA binding; F:DNA binding; F:estrogen receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:promoter-specific chromatin binding; F:RNA binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:adaptive thermogenesis; P:adipose tissue development; P:aging; P:androgen metabolic process; P:autophagy of mitochondrion; P:brown fat cell differentiation; P:cellular glucose homeostasis; P:cellular respiration; P:cellular response to caffeine; P:cellular response to estradiol stimulus; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to fructose stimulus; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:cellular response to interleukin-6; P:cellular response to ionomycin; P:cellular response to lipopolysaccharide; P:cellular response to nitrite; P:cellular response to oxidative stress; P:cellular response to potassium ion; P:cellular response to resveratrol; P:cellular response to thyroid hormone stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:cerebellum development; P:circadian regulation of gene expression; P:circadian rhythm; P:digestion; P:energy homeostasis; P:fatty acid oxidation; P:flavone metabolic process; P:forebrain development; P:galactose metabolic process; P:gluconeogenesis; P:mitochondrion organization; P:mRNA processing; P:negative regulation of glycolytic process; P:negative regulation of mitochondrial fission; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of protein phosphorylation; P:negative regulation of signaling receptor activity; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of ATP biosynthetic process; P:positive regulation of cellular respiration; P:positive regulation of cold-induced thermogenesis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of fatty acid oxidation; P:positive regulation of gene expression; P:positive regulation of glomerular visceral epithelial cell apoptotic process; P:positive regulation of gluconeogenesis; P:positive regulation of histone acetylation; P:positive regulation of mitochondrial DNA metabolic process; P:positive regulation of mitochondrion organization; P:positive regulation of muscle tissue development; P:positive regulation of progesterone biosynthetic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:protein-containing complex assembly; P:regulation of circadian rhythm; P:regulation of NMDA receptor activity; P:regulation of transcription, DNA-templated; P:respiratory electron transport chain; P:response to cold; P:response to dietary excess; P:response to drug; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to epinephrine; P:response to ischemia; P:response to leucine; P:response to metformin; P:response to methionine; P:response to muscle activity; P:response to norepinephrine; P:response to reactive oxygen species; P:response to starvation; P:RNA splicing; P:skeletal muscle atrophy; P:temperature homeostasis; P:transcription initiation from RNA polymerase II promoter; scaffold2 indexed_genome mRNA 60585223 60639831 . - . ID=transcript_543;O43143 Q9NQT7,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15,ATP-dependent RNA helicase #46;DEAH box protein 15;, PF00270;PF04408;PF00271;PF07717;, GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005681;GO:0005689;GO:0005524;GO:0003725;GO:0003723;GO:0003724;GO:0006397;GO:0000398;GO:0043279;GO:0009636;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U12-type spliceosomal complex;, F:ATP binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:response to alkaloid; P:response to toxic substance; P:RNA splicing;|O43143 Q9NQT7,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15,ATP-dependent RNA helicase #46;DEAH box protein 15;, PF00270;PF04408;PF00271;PF07717;, GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005681;GO:0005689;GO:0005524;GO:0003725;GO:0003723;GO:0003724;GO:0006397;GO:0000398;GO:0043279;GO:0009636;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U12-type spliceosomal complex;, F:ATP binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:response to alkaloid; P:response to toxic substance; P:RNA splicing;|O43143 Q9NQT7,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15,ATP-dependent RNA helicase #46;DEAH box protein 15;, PF00270;PF04408;PF00271;PF07717;, GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005681;GO:0005689;GO:0005524;GO:0003725;GO:0003723;GO:0003724;GO:0006397;GO:0000398;GO:0043279;GO:0009636;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U12-type spliceosomal complex;, F:ATP binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:response to alkaloid; P:response to toxic substance; P:RNA splicing; scaffold2 indexed_genome mRNA 60829869 60836248 . + . ID=transcript_544;P08294 Q5U781 Q6FHA2,Extracellular superoxide dismutase [Cu-Zn],, PF00080;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0005634;GO:0005507;GO:0008201;GO:0004784;GO:0034599;GO:0019430;GO:0046688;GO:0001666;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:nucleus;, F:copper ion binding; F:heparin binding; F:superoxide dismutase activity;, P:cellular response to oxidative stress; P:removal of superoxide radicals; P:response to copper ion; P:response to hypoxia; scaffold2 indexed_genome mRNA 60844480 60916346 . - . ID=transcript_545;Q6ZUS6 A6NJE7 B4DK90 B4DZG3 G5EA04 Q6NW41 Q8N3K8,Coiled-coil domain-containing protein 149,, PF09789;|Q6ZUS6 A6NJE7 B4DK90 B4DZG3 G5EA04 Q6NW41 Q8N3K8,Coiled-coil domain-containing protein 149,, PF09789;|Q6ZUS6 A6NJE7 B4DK90 B4DZG3 G5EA04 Q6NW41 Q8N3K8,Coiled-coil domain-containing protein 149,, PF09789; scaffold2 indexed_genome mRNA 61033328 61061670 . - . ID=transcript_546;Q8N0V4 Q3MIN2 Q8NDW6 Q96PX2 Q9NVK4,Leucine-rich repeat LGI family member 2,LGI1-like protein 2;Leucine-rich glioma-inactivated protein 2;, PF03736;PF13855;, GO:0005576;GO:1904862;, C:extracellular region;, , P:inhibitory synapse assembly; scaffold2 indexed_genome mRNA 61143583 61184132 . - . ID=transcript_547;Q9HD40 A8K8W1 Q0D2P3 Q17RT1 Q9NXZ5 Q9UGM9 Q9Y353,O-phosphoseryl-tRNA(Sec) selenium transferase,Liver-pancreas antigen;SLA-p35;SLA/LP autoantigen;Selenocysteine synthase;Selenocysteinyl-tRNA(Sec) synthase;Sep-tRNA:Sec-tRNA synthase;Soluble liver antigen;UGA suppressor tRNA-associated protein;tRNA(Ser/Sec)-associated antigenic protein;, PF05889;, GO:0005737;GO:0005829;GO:0005634;GO:0016785;GO:0000049;GO:0001514;GO:0016259;GO:0097056;, C:cytoplasm; C:cytosol; C:nucleus;, F:transferase activity, transferring selenium-containing groups; F:tRNA binding;, P:selenocysteine incorporation; P:selenocysteine metabolic process; P:selenocysteinyl-tRNA(Sec) biosynthetic process;|Q9HD40 A8K8W1 Q0D2P3 Q17RT1 Q9NXZ5 Q9UGM9 Q9Y353,O-phosphoseryl-tRNA(Sec) selenium transferase,Liver-pancreas antigen;SLA-p35;SLA/LP autoantigen;Selenocysteine synthase;Selenocysteinyl-tRNA(Sec) synthase;Sep-tRNA:Sec-tRNA synthase;Soluble liver antigen;UGA suppressor tRNA-associated protein;tRNA(Ser/Sec)-associated antigenic protein;, PF05889;, GO:0005737;GO:0005829;GO:0005634;GO:0016785;GO:0000049;GO:0001514;GO:0016259;GO:0097056;, C:cytoplasm; C:cytosol; C:nucleus;, F:transferase activity, transferring selenium-containing groups; F:tRNA binding;, P:selenocysteine incorporation; P:selenocysteine metabolic process; P:selenocysteinyl-tRNA(Sec) biosynthetic process;|Q9HD40 A8K8W1 Q0D2P3 Q17RT1 Q9NXZ5 Q9UGM9 Q9Y353,O-phosphoseryl-tRNA(Sec) selenium transferase,Liver-pancreas antigen;SLA-p35;SLA/LP autoantigen;Selenocysteine synthase;Selenocysteinyl-tRNA(Sec) synthase;Sep-tRNA:Sec-tRNA synthase;Soluble liver antigen;UGA suppressor tRNA-associated protein;tRNA(Ser/Sec)-associated antigenic protein;, PF05889;, GO:0005737;GO:0005829;GO:0005634;GO:0016785;GO:0000049;GO:0001514;GO:0016259;GO:0097056;, C:cytoplasm; C:cytosol; C:nucleus;, F:transferase activity, transferring selenium-containing groups; F:tRNA binding;, P:selenocysteine incorporation; P:selenocysteine metabolic process; P:selenocysteinyl-tRNA(Sec) biosynthetic process;|Q9HD40 A8K8W1 Q0D2P3 Q17RT1 Q9NXZ5 Q9UGM9 Q9Y353,O-phosphoseryl-tRNA(Sec) selenium transferase,Liver-pancreas antigen;SLA-p35;SLA/LP autoantigen;Selenocysteine synthase;Selenocysteinyl-tRNA(Sec) synthase;Sep-tRNA:Sec-tRNA synthase;Soluble liver antigen;UGA suppressor tRNA-associated protein;tRNA(Ser/Sec)-associated antigenic protein;, PF05889;, GO:0005737;GO:0005829;GO:0005634;GO:0016785;GO:0000049;GO:0001514;GO:0016259;GO:0097056;, C:cytoplasm; C:cytosol; C:nucleus;, F:transferase activity, transferring selenium-containing groups; F:tRNA binding;, P:selenocysteine incorporation; P:selenocysteine metabolic process; P:selenocysteinyl-tRNA(Sec) biosynthetic process; scaffold2 indexed_genome mRNA 61249282 61260388 . + . ID=transcript_548;Q8TCG2 Q9NUW2,Phosphatidylinositol 4-kinase type 2-beta,Phosphatidylinositol 4-kinase type II-beta;, PF00454;, GO:0005829;GO:0005768;GO:0016020;GO:0005886;GO:0005802;GO:0004430;GO:0005524;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytosol; C:endosome; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation;|Q8TCG2 Q9NUW2,Phosphatidylinositol 4-kinase type 2-beta,Phosphatidylinositol 4-kinase type II-beta;, PF00454;, GO:0005829;GO:0005768;GO:0016020;GO:0005886;GO:0005802;GO:0004430;GO:0005524;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytosol; C:endosome; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation;|Q8TCG2 Q9NUW2,Phosphatidylinositol 4-kinase type 2-beta,Phosphatidylinositol 4-kinase type II-beta;, PF00454;, GO:0005829;GO:0005768;GO:0016020;GO:0005886;GO:0005802;GO:0004430;GO:0005524;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytosol; C:endosome; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; scaffold2 indexed_genome mRNA 61260676 61269151 . + . ID=transcript_549;Q8TCG2 Q9NUW2,Phosphatidylinositol 4-kinase type 2-beta,Phosphatidylinositol 4-kinase type II-beta;, PF00454;, GO:0005829;GO:0005768;GO:0016020;GO:0005886;GO:0005802;GO:0004430;GO:0005524;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytosol; C:endosome; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation;|Q8TCG2 Q9NUW2,Phosphatidylinositol 4-kinase type 2-beta,Phosphatidylinositol 4-kinase type II-beta;, PF00454;, GO:0005829;GO:0005768;GO:0016020;GO:0005886;GO:0005802;GO:0004430;GO:0005524;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytosol; C:endosome; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation;|Q8TCG2 Q9NUW2,Phosphatidylinositol 4-kinase type 2-beta,Phosphatidylinositol 4-kinase type II-beta;, PF00454;, GO:0005829;GO:0005768;GO:0016020;GO:0005886;GO:0005802;GO:0004430;GO:0005524;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytosol; C:endosome; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; scaffold2 indexed_genome mRNA 61270090 61273977 . - . ID=transcript_550;Q8TCG2 Q9NUW2,Phosphatidylinositol 4-kinase type 2-beta,Phosphatidylinositol 4-kinase type II-beta;, PF00454;, GO:0005829;GO:0005768;GO:0016020;GO:0005886;GO:0005802;GO:0004430;GO:0005524;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytosol; C:endosome; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation;|Q8TCG2 Q9NUW2,Phosphatidylinositol 4-kinase type 2-beta,Phosphatidylinositol 4-kinase type II-beta;, PF00454;, GO:0005829;GO:0005768;GO:0016020;GO:0005886;GO:0005802;GO:0004430;GO:0005524;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytosol; C:endosome; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; scaffold2 indexed_genome mRNA 61294004 61350890 . + . ID=transcript_551;Q9H5U6 B2RXF6 B4DRD8 B7ZW20 Q5IW78 Q96AN7,rRNA N6-adenosine-methyltransferase ZCCHC4 {ECO:0000305},Zinc finger CCHC domain-containing protein 4 {ECO:0000305};, PF10237;PF06839;, GO:0005737;GO:0005730;GO:0003676;GO:0008988;GO:1904047;GO:0008270;GO:0045727;GO:0031167;, C:cytoplasm; C:nucleolus;, F:nucleic acid binding; F:rRNA (adenine-N6-)-methyltransferase activity; F:S-adenosyl-L-methionine binding; F:zinc ion binding;, P:positive regulation of translation; P:rRNA methylation; scaffold2 indexed_genome mRNA 61360871 61395269 . + . ID=transcript_552;Q9UJX5 A8K8H1 E9PCR4 Q6PCC6 Q9NSH6,Anaphase-promoting complex subunit 4,Cyclosome subunit 4;, PF12896;PF12894;, GO:0005680;GO:0005829;GO:0034399;GO:0005654;GO:0005634;GO:0019903;GO:0004842;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:protein phosphatase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX5 A8K8H1 E9PCR4 Q6PCC6 Q9NSH6,Anaphase-promoting complex subunit 4,Cyclosome subunit 4;, PF12896;PF12894;, GO:0005680;GO:0005829;GO:0034399;GO:0005654;GO:0005634;GO:0019903;GO:0004842;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:protein phosphatase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX5 A8K8H1 E9PCR4 Q6PCC6 Q9NSH6,Anaphase-promoting complex subunit 4,Cyclosome subunit 4;, PF12896;PF12894;, GO:0005680;GO:0005829;GO:0034399;GO:0005654;GO:0005634;GO:0019903;GO:0004842;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:protein phosphatase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX5 A8K8H1 E9PCR4 Q6PCC6 Q9NSH6,Anaphase-promoting complex subunit 4,Cyclosome subunit 4;, PF12896;PF12894;, GO:0005680;GO:0005829;GO:0034399;GO:0005654;GO:0005634;GO:0019903;GO:0004842;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:protein phosphatase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX5 A8K8H1 E9PCR4 Q6PCC6 Q9NSH6,Anaphase-promoting complex subunit 4,Cyclosome subunit 4;, PF12896;PF12894;, GO:0005680;GO:0005829;GO:0034399;GO:0005654;GO:0005634;GO:0019903;GO:0004842;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:protein phosphatase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX5 A8K8H1 E9PCR4 Q6PCC6 Q9NSH6,Anaphase-promoting complex subunit 4,Cyclosome subunit 4;, PF12896;PF12894;, GO:0005680;GO:0005829;GO:0034399;GO:0005654;GO:0005634;GO:0019903;GO:0004842;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:protein phosphatase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX5 A8K8H1 E9PCR4 Q6PCC6 Q9NSH6,Anaphase-promoting complex subunit 4,Cyclosome subunit 4;, PF12896;PF12894;, GO:0005680;GO:0005829;GO:0034399;GO:0005654;GO:0005634;GO:0019903;GO:0004842;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:protein phosphatase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX5 A8K8H1 E9PCR4 Q6PCC6 Q9NSH6,Anaphase-promoting complex subunit 4,Cyclosome subunit 4;, PF12896;PF12894;, GO:0005680;GO:0005829;GO:0034399;GO:0005654;GO:0005634;GO:0019903;GO:0004842;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:protein phosphatase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold2 indexed_genome mRNA 61575607 61588055 . + . ID=transcript_553;O95436 A5PL17 Q8N2K2 Q8WYA9 Q9P0V7,Sodium-dependent phosphate transport protein 2B,Na(+)-dependent phosphate cotransporter 2B;NaPi3b;Sodium/phosphate cotransporter 2B;Solute carrier family 34 member 2;, PF02690;, GO:0016324;GO:0005903;GO:0031526;GO:0016021;GO:0005887;GO:0005886;GO:0031982;GO:0042301;GO:0031402;GO:0005436;GO:0030643;GO:0044267;GO:0001701;GO:0006817;GO:0043627;GO:0044341;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:vesicle;, F:phosphate ion binding; F:sodium ion binding; F:sodium:phosphate symporter activity;, P:cellular phosphate ion homeostasis; P:cellular protein metabolic process; P:in utero embryonic development; P:phosphate ion transport; P:response to estrogen; P:sodium-dependent phosphate transport;|O95436 A5PL17 Q8N2K2 Q8WYA9 Q9P0V7,Sodium-dependent phosphate transport protein 2B,Na(+)-dependent phosphate cotransporter 2B;NaPi3b;Sodium/phosphate cotransporter 2B;Solute carrier family 34 member 2;, PF02690;, GO:0016324;GO:0005903;GO:0031526;GO:0016021;GO:0005887;GO:0005886;GO:0031982;GO:0042301;GO:0031402;GO:0005436;GO:0030643;GO:0044267;GO:0001701;GO:0006817;GO:0043627;GO:0044341;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:vesicle;, F:phosphate ion binding; F:sodium ion binding; F:sodium:phosphate symporter activity;, P:cellular phosphate ion homeostasis; P:cellular protein metabolic process; P:in utero embryonic development; P:phosphate ion transport; P:response to estrogen; P:sodium-dependent phosphate transport;|O95436 A5PL17 Q8N2K2 Q8WYA9 Q9P0V7,Sodium-dependent phosphate transport protein 2B,Na(+)-dependent phosphate cotransporter 2B;NaPi3b;Sodium/phosphate cotransporter 2B;Solute carrier family 34 member 2;, PF02690;, GO:0016324;GO:0005903;GO:0031526;GO:0016021;GO:0005887;GO:0005886;GO:0031982;GO:0042301;GO:0031402;GO:0005436;GO:0030643;GO:0044267;GO:0001701;GO:0006817;GO:0043627;GO:0044341;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:vesicle;, F:phosphate ion binding; F:sodium ion binding; F:sodium:phosphate symporter activity;, P:cellular phosphate ion homeostasis; P:cellular protein metabolic process; P:in utero embryonic development; P:phosphate ion transport; P:response to estrogen; P:sodium-dependent phosphate transport;|O95436 A5PL17 Q8N2K2 Q8WYA9 Q9P0V7,Sodium-dependent phosphate transport protein 2B,Na(+)-dependent phosphate cotransporter 2B;NaPi3b;Sodium/phosphate cotransporter 2B;Solute carrier family 34 member 2;, PF02690;, GO:0016324;GO:0005903;GO:0031526;GO:0016021;GO:0005887;GO:0005886;GO:0031982;GO:0042301;GO:0031402;GO:0005436;GO:0030643;GO:0044267;GO:0001701;GO:0006817;GO:0043627;GO:0044341;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:vesicle;, F:phosphate ion binding; F:sodium ion binding; F:sodium:phosphate symporter activity;, P:cellular phosphate ion homeostasis; P:cellular protein metabolic process; P:in utero embryonic development; P:phosphate ion transport; P:response to estrogen; P:sodium-dependent phosphate transport;|O95436 A5PL17 Q8N2K2 Q8WYA9 Q9P0V7,Sodium-dependent phosphate transport protein 2B,Na(+)-dependent phosphate cotransporter 2B;NaPi3b;Sodium/phosphate cotransporter 2B;Solute carrier family 34 member 2;, PF02690;, GO:0016324;GO:0005903;GO:0031526;GO:0016021;GO:0005887;GO:0005886;GO:0031982;GO:0042301;GO:0031402;GO:0005436;GO:0030643;GO:0044267;GO:0001701;GO:0006817;GO:0043627;GO:0044341;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:vesicle;, F:phosphate ion binding; F:sodium ion binding; F:sodium:phosphate symporter activity;, P:cellular phosphate ion homeostasis; P:cellular protein metabolic process; P:in utero embryonic development; P:phosphate ion transport; P:response to estrogen; P:sodium-dependent phosphate transport; scaffold2 indexed_genome mRNA 61636508 61706229 . - . ID=transcript_554;Q68CR1 A0PJH6 A8K0X2 O94847 Q6P999 Q96G59,Protein sel-1 homolog 3,Suppressor of lin-12-like protein 3;, PF08238;, GO:0016021;GO:0005654;, C:integral component of membrane; C:nucleoplasm;|Q68CR1 A0PJH6 A8K0X2 O94847 Q6P999 Q96G59,Protein sel-1 homolog 3,Suppressor of lin-12-like protein 3;, PF08238;, GO:0016021;GO:0005654;, C:integral component of membrane; C:nucleoplasm;|Q68CR1 A0PJH6 A8K0X2 O94847 Q6P999 Q96G59,Protein sel-1 homolog 3,Suppressor of lin-12-like protein 3;, PF08238;, GO:0016021;GO:0005654;, C:integral component of membrane; C:nucleoplasm;|Q68CR1 A0PJH6 A8K0X2 O94847 Q6P999 Q96G59,Protein sel-1 homolog 3,Suppressor of lin-12-like protein 3;, PF08238;, GO:0016021;GO:0005654;, C:integral component of membrane; C:nucleoplasm;|Q68CR1 A0PJH6 A8K0X2 O94847 Q6P999 Q96G59,Protein sel-1 homolog 3,Suppressor of lin-12-like protein 3;, PF08238;, GO:0016021;GO:0005654;, C:integral component of membrane; C:nucleoplasm; scaffold2 indexed_genome mRNA 61713585 61720908 . - . ID=transcript_555;Q68CR1 A0PJH6 A8K0X2 O94847 Q6P999 Q96G59,Protein sel-1 homolog 3,Suppressor of lin-12-like protein 3;, PF08238;, GO:0016021;GO:0005654;, C:integral component of membrane; C:nucleoplasm; scaffold2 indexed_genome mRNA 61721148 61734717 . - . ID=transcript_556;Q68CR1 A0PJH6 A8K0X2 O94847 Q6P999 Q96G59,Protein sel-1 homolog 3,Suppressor of lin-12-like protein 3;, PF08238;, GO:0016021;GO:0005654;, C:integral component of membrane; C:nucleoplasm; scaffold2 indexed_genome mRNA 61789854 61802548 . - . ID=transcript_557;Q8N5G0 C9JYT8 Q9BRT5,Small integral membrane protein 20,Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 7 kDa {ECO:0000303|PubMed:26321642};, PF15061;, GO:0005576;GO:0016021;GO:0005743;GO:0033617;, C:extracellular region; C:integral component of membrane; C:mitochondrial inner membrane;, , P:mitochondrial cytochrome c oxidase assembly; scaffold2 indexed_genome mRNA 62208627 62256221 . + . ID=transcript_558;Q06330 B4DY22 Q5XKH9 Q6P1N3,Recombining binding protein suppressor of hairless,CBF-1;J kappa-recombination signal-binding protein;RBP-J kappa;Renal carcinoma antigen NY-REN-30;, PF09270;PF09271;, GO:0000785;GO:0005737;GO:0002193;GO:0005730;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0047485;GO:0070491;GO:0000978;GO:0001103;GO:0043565;GO:0008134;GO:0001525;GO:0003176;GO:0060844;GO:0036302;GO:0009912;GO:0030183;GO:0097101;GO:0072554;GO:0001974;GO:0003214;GO:0060486;GO:0042742;GO:0035912;GO:0003160;GO:0009957;GO:0001837;GO:0003198;GO:0048820;GO:0006959;GO:0002437;GO:0030216;GO:0060716;GO:0043011;GO:0045596;GO:0008285;GO:0120163;GO:0030279;GO:0000122;GO:0045892;GO:0061314;GO:0007219;GO:0003151;GO:0021983;GO:0030513;GO:1901297;GO:0060045;GO:2000138;GO:1901189;GO:1901186;GO:0010628;GO:0045747;GO:0045944;GO:0061419;GO:0007221;GO:0003177;GO:0048505;GO:0003256;GO:0048733;GO:0003139;GO:0035019;GO:0001756;GO:0006367;GO:0060412;GO:0003222;, C:chromatin; C:cytoplasm; C:MAML1-RBP-Jkappa- ICN1 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein N-terminus binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:angiogenesis; P:aortic valve development; P:arterial endothelial cell fate commitment; P:atrioventricular canal development; P:auditory receptor cell fate commitment; P:B cell differentiation; P:blood vessel endothelial cell fate specification; P:blood vessel lumenization; P:blood vessel remodeling; P:cardiac left ventricle morphogenesis; P:club cell differentiation; P:defense response to bacterium; P:dorsal aorta morphogenesis; P:endocardium morphogenesis; P:epidermal cell fate specification; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:hair follicle maturation; P:humoral immune response; P:inflammatory response to antigenic stimulus; P:keratinocyte differentiation; P:labyrinthine layer blood vessel development; P:myeloid dendritic cell differentiation; P:negative regulation of cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ossification; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:outflow tract morphogenesis; P:pituitary gland development; P:positive regulation of BMP signaling pathway; P:positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell proliferation involved in heart morphogenesis; P:positive regulation of ephrin receptor signaling pathway; P:positive regulation of ERBB signaling pathway; P:positive regulation of gene expression; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription of Notch receptor target; P:pulmonary valve development; P:regulation of timing of cell differentiation; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:sebaceous gland development; P:secondary heart field specification; P:somatic stem cell population maintenance; P:somitogenesis; P:transcription initiation from RNA polymerase II promoter; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis;|Q06330 B4DY22 Q5XKH9 Q6P1N3,Recombining binding protein suppressor of hairless,CBF-1;J kappa-recombination signal-binding protein;RBP-J kappa;Renal carcinoma antigen NY-REN-30;, PF09270;PF09271;, GO:0000785;GO:0005737;GO:0002193;GO:0005730;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0047485;GO:0070491;GO:0000978;GO:0001103;GO:0043565;GO:0008134;GO:0001525;GO:0003176;GO:0060844;GO:0036302;GO:0009912;GO:0030183;GO:0097101;GO:0072554;GO:0001974;GO:0003214;GO:0060486;GO:0042742;GO:0035912;GO:0003160;GO:0009957;GO:0001837;GO:0003198;GO:0048820;GO:0006959;GO:0002437;GO:0030216;GO:0060716;GO:0043011;GO:0045596;GO:0008285;GO:0120163;GO:0030279;GO:0000122;GO:0045892;GO:0061314;GO:0007219;GO:0003151;GO:0021983;GO:0030513;GO:1901297;GO:0060045;GO:2000138;GO:1901189;GO:1901186;GO:0010628;GO:0045747;GO:0045944;GO:0061419;GO:0007221;GO:0003177;GO:0048505;GO:0003256;GO:0048733;GO:0003139;GO:0035019;GO:0001756;GO:0006367;GO:0060412;GO:0003222;, C:chromatin; C:cytoplasm; C:MAML1-RBP-Jkappa- ICN1 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein N-terminus binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:angiogenesis; P:aortic valve development; P:arterial endothelial cell fate commitment; P:atrioventricular canal development; P:auditory receptor cell fate commitment; P:B cell differentiation; P:blood vessel endothelial cell fate specification; P:blood vessel lumenization; P:blood vessel remodeling; P:cardiac left ventricle morphogenesis; P:club cell differentiation; P:defense response to bacterium; P:dorsal aorta morphogenesis; P:endocardium morphogenesis; P:epidermal cell fate specification; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:hair follicle maturation; P:humoral immune response; P:inflammatory response to antigenic stimulus; P:keratinocyte differentiation; P:labyrinthine layer blood vessel development; P:myeloid dendritic cell differentiation; P:negative regulation of cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ossification; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:outflow tract morphogenesis; P:pituitary gland development; P:positive regulation of BMP signaling pathway; P:positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell proliferation involved in heart morphogenesis; P:positive regulation of ephrin receptor signaling pathway; P:positive regulation of ERBB signaling pathway; P:positive regulation of gene expression; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription of Notch receptor target; P:pulmonary valve development; P:regulation of timing of cell differentiation; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:sebaceous gland development; P:secondary heart field specification; P:somatic stem cell population maintenance; P:somitogenesis; P:transcription initiation from RNA polymerase II promoter; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis; scaffold2 indexed_genome mRNA 62381387 62521266 . + . ID=transcript_559;Q8N5T2 B9A6M0 Q9NUX1,TBC1 domain family member 19,, PF00566;, GO:0005096;, , F:GTPase activator activity;|Q8N5T2 B9A6M0 Q9NUX1,TBC1 domain family member 19,, PF00566;, GO:0005096;, , F:GTPase activator activity;|Q8N5T2 B9A6M0 Q9NUX1,TBC1 domain family member 19,, PF00566;, GO:0005096;, , F:GTPase activator activity; scaffold2 indexed_genome mRNA 62757619 62759136 . + . ID=transcript_560;Q9P246 A6H8L7 B7ZVY0 Q96BF1 Q9BQH2 Q9H8R1,Stromal interaction molecule 2,, PF07647;PF16533;, GO:0005783;GO:0005789;GO:0016021;GO:0005886;GO:0005246;GO:0005509;GO:0015279;GO:0032237;GO:0006874;GO:0051928;GO:0002115;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:calcium channel regulator activity; F:calcium ion binding; F:store-operated calcium channel activity;, P:activation of store-operated calcium channel activity; P:cellular calcium ion homeostasis; P:positive regulation of calcium ion transport; P:store-operated calcium entry; scaffold2 indexed_genome mRNA 62760718 62762790 . + . ID=transcript_561;Q9P246 A6H8L7 B7ZVY0 Q96BF1 Q9BQH2 Q9H8R1,Stromal interaction molecule 2,, PF07647;PF16533;, GO:0005783;GO:0005789;GO:0016021;GO:0005886;GO:0005246;GO:0005509;GO:0015279;GO:0032237;GO:0006874;GO:0051928;GO:0002115;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:calcium channel regulator activity; F:calcium ion binding; F:store-operated calcium channel activity;, P:activation of store-operated calcium channel activity; P:cellular calcium ion homeostasis; P:positive regulation of calcium ion transport; P:store-operated calcium entry;|Q9P246 A6H8L7 B7ZVY0 Q96BF1 Q9BQH2 Q9H8R1,Stromal interaction molecule 2,, PF07647;PF16533;, GO:0005783;GO:0005789;GO:0016021;GO:0005886;GO:0005246;GO:0005509;GO:0015279;GO:0032237;GO:0006874;GO:0051928;GO:0002115;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:calcium channel regulator activity; F:calcium ion binding; F:store-operated calcium channel activity;, P:activation of store-operated calcium channel activity; P:cellular calcium ion homeostasis; P:positive regulation of calcium ion transport; P:store-operated calcium entry; scaffold2 indexed_genome mRNA 62764476 62787566 . + . ID=transcript_562;Q9P246 A6H8L7 B7ZVY0 Q96BF1 Q9BQH2 Q9H8R1,Stromal interaction molecule 2,, PF07647;PF16533;, GO:0005783;GO:0005789;GO:0016021;GO:0005886;GO:0005246;GO:0005509;GO:0015279;GO:0032237;GO:0006874;GO:0051928;GO:0002115;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:calcium channel regulator activity; F:calcium ion binding; F:store-operated calcium channel activity;, P:activation of store-operated calcium channel activity; P:cellular calcium ion homeostasis; P:positive regulation of calcium ion transport; P:store-operated calcium entry;|Q9P246 A6H8L7 B7ZVY0 Q96BF1 Q9BQH2 Q9H8R1,Stromal interaction molecule 2,, PF07647;PF16533;, GO:0005783;GO:0005789;GO:0016021;GO:0005886;GO:0005246;GO:0005509;GO:0015279;GO:0032237;GO:0006874;GO:0051928;GO:0002115;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:calcium channel regulator activity; F:calcium ion binding; F:store-operated calcium channel activity;, P:activation of store-operated calcium channel activity; P:cellular calcium ion homeostasis; P:positive regulation of calcium ion transport; P:store-operated calcium entry; scaffold2 indexed_genome mRNA 65955002 65955746 . - . ID=transcript_563;O60245 O60246 O60247 Q4W5C4,Protocadherin-7,Brain-heart protocadherin;, PF00028;PF08266;PF08374;, GO:0005887;GO:0005886;GO:0031092;GO:0005509;GO:0007155;GO:0007156;GO:0002576;, C:integral component of plasma membrane; C:plasma membrane; C:platelet alpha granule membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:platelet degranulation; scaffold2 indexed_genome mRNA 66023591 66025412 . - . ID=transcript_564;O60245 O60246 O60247 Q4W5C4,Protocadherin-7,Brain-heart protocadherin;, PF00028;PF08266;PF08374;, GO:0005887;GO:0005886;GO:0031092;GO:0005509;GO:0007155;GO:0007156;GO:0002576;, C:integral component of plasma membrane; C:plasma membrane; C:platelet alpha granule membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:platelet degranulation; scaffold2 indexed_genome mRNA 66393575 66398096 . - . ID=transcript_565;O60245 O60246 O60247 Q4W5C4,Protocadherin-7,Brain-heart protocadherin;, PF00028;PF08266;PF08374;, GO:0005887;GO:0005886;GO:0031092;GO:0005509;GO:0007155;GO:0007156;GO:0002576;, C:integral component of plasma membrane; C:plasma membrane; C:platelet alpha granule membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:platelet degranulation; scaffold2 indexed_genome mRNA 70835294 71021920 . - . ID=transcript_566;Q8WZ64 Q4W5D2 Q7Z2L5 Q96L70 Q96P49 Q9Y4E4,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2,Centaurin-delta-1;Protein PARX;, PF01412;PF00169;PF00788;PF00620;PF00536;, GO:0005829;GO:0005096;GO:0046872;GO:0005547;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold2 indexed_genome mRNA 71059927 71089820 . + . ID=transcript_567;Q6ZMT9 B2RXK4 B4E2N7,Death domain-containing protein 1,, PF00531;, GO:0007165;, , , P:signal transduction;|Q6ZMT9 B2RXK4 B4E2N7,Death domain-containing protein 1,, PF00531;, GO:0007165;, , , P:signal transduction; scaffold2 indexed_genome mRNA 71099270 71140770 . + . ID=transcript_568;Q6ZMT9 B2RXK4 B4E2N7,Death domain-containing protein 1,, PF00531;, GO:0007165;, , , P:signal transduction; scaffold2 indexed_genome mRNA 71985155 72091456 . - . ID=transcript_569;Q9ULI1 A8MRU1,NACHT and WD repeat domain-containing protein 2,Leucine-rich repeat and WD repeat-containing protein KIAA1239;, PF05729; scaffold2 indexed_genome mRNA 72102580 72170086 . + . ID=transcript_570;Q8IY42 Q9NV03,Uncharacterized protein C4orf19,, PF15770;, GO:0030054;GO:0005654;, C:cell junction; C:nucleoplasm;|Q8N5K1 Q7Z3D5,CDGSH iron-sulfur domain-containing protein 2,Endoplasmic reticulum intermembrane small protein;MitoNEET-related 1 protein;Nutrient-deprivation autophagy factor-1;, PF10660;PF09360;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0097038;GO:0032991;GO:0051537;GO:0046872;GO:0042803;GO:0003723;GO:0000422;GO:0010259;GO:0010506;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:perinuclear endoplasmic reticulum; C:protein-containing complex;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding; F:protein homodimerization activity; F:RNA binding;, P:autophagy of mitochondrion; P:multicellular organism aging; P:regulation of autophagy; scaffold2 indexed_genome mRNA 72195851 72268366 . + . ID=transcript_571;Q8IUW5 Q8NBK1,RELT-like protein 1,, PF12606;, GO:0016021;GO:0015630;GO:0005886;GO:1900745;, C:integral component of membrane; C:microtubule cytoskeleton; C:plasma membrane;, , P:positive regulation of p38MAPK cascade;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold2 indexed_genome mRNA 72379853 72415710 . + . ID=transcript_572;Q96G03 B4E0G8 Q53FP5 Q5QTR0 Q9H0P9 Q9NV22,Phosphoglucomutase-2,Glucose phosphomutase 2;Phosphodeoxyribomutase;Phosphopentomutase;, PF02878;PF02879;PF02880;PF00408;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0034774;GO:0000287;GO:0004614;GO:0008973;GO:0046386;GO:0019388;GO:0006006;GO:0005978;GO:0005980;GO:0043312;GO:0006098;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen;, F:magnesium ion binding; F:phosphoglucomutase activity; F:phosphopentomutase activity;, P:deoxyribose phosphate catabolic process; P:galactose catabolic process; P:glucose metabolic process; P:glycogen biosynthetic process; P:glycogen catabolic process; P:neutrophil degranulation; P:pentose-phosphate shunt; scaffold2 indexed_genome mRNA 72554787 72641129 . + . ID=transcript_573;Q86TI0 B7Z3D9 E9PGH8 Q96K82 Q9UPP4,TBC1 domain family member 1,, PF11830;PF00640;PF00566;, GO:0005634;GO:0005096;GO:0090630;GO:0006886;GO:0032880;, C:nucleus;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of protein localization;|Q86TI0 B7Z3D9 E9PGH8 Q96K82 Q9UPP4,TBC1 domain family member 1,, PF11830;PF00640;PF00566;, GO:0005634;GO:0005096;GO:0090630;GO:0006886;GO:0032880;, C:nucleus;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of protein localization;|Q86TI0 B7Z3D9 E9PGH8 Q96K82 Q9UPP4,TBC1 domain family member 1,, PF11830;PF00640;PF00566;, GO:0005634;GO:0005096;GO:0090630;GO:0006886;GO:0032880;, C:nucleus;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of protein localization; scaffold2 indexed_genome mRNA 72644280 72682932 . + . ID=transcript_574;Q86TI0 B7Z3D9 E9PGH8 Q96K82 Q9UPP4,TBC1 domain family member 1,, PF11830;PF00640;PF00566;, GO:0005634;GO:0005096;GO:0090630;GO:0006886;GO:0032880;, C:nucleus;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of protein localization;|Q86TI0 B7Z3D9 E9PGH8 Q96K82 Q9UPP4,TBC1 domain family member 1,, PF11830;PF00640;PF00566;, GO:0005634;GO:0005096;GO:0090630;GO:0006886;GO:0032880;, C:nucleus;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of protein localization; scaffold2 indexed_genome mRNA 73207955 73221102 . + . ID=transcript_575;P57682 Q6PIR1 Q86TN0 Q9P2X6,Krueppel-like factor 3,Basic krueppel-like factor;CACCC-box-binding protein BKLF;TEF-2;, PF00096;, GO:0000785;GO:0005654;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:1901653;GO:0007275;GO:0000122;GO:0006357;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to peptide; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P57682 Q6PIR1 Q86TN0 Q9P2X6,Krueppel-like factor 3,Basic krueppel-like factor;CACCC-box-binding protein BKLF;TEF-2;, PF00096;, GO:0000785;GO:0005654;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:1901653;GO:0007275;GO:0000122;GO:0006357;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to peptide; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold2 indexed_genome mRNA 73276396 73278290 . - . ID=transcript_576;Q9BXR5 A8K7L1 B3Y668 D1CS21 D1CS22 Q32MI7 Q32MI8 Q5FWG4 Q6UXL3,Toll-like receptor 10,, PF00560;PF13855;PF01582;, GO:0005887;GO:0016020;GO:0005886;GO:0042802;GO:0050135;GO:0061809;GO:0038023;GO:0004888;GO:0006955;GO:0006954;GO:0045087;GO:0002755;GO:0050729;GO:0001817;GO:0034166;GO:0002224;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:identical protein binding; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:immune response; P:inflammatory response; P:innate immune response; P:MyD88-dependent toll-like receptor signaling pathway; P:positive regulation of inflammatory response; P:regulation of cytokine production; P:toll-like receptor 10 signaling pathway; P:toll-like receptor signaling pathway; scaffold2 indexed_genome mRNA 73278302 73279422 . + . ID=transcript_577;Q9BXR5 A8K7L1 B3Y668 D1CS21 D1CS22 Q32MI7 Q32MI8 Q5FWG4 Q6UXL3,Toll-like receptor 10,, PF00560;PF13855;PF01582;, GO:0005887;GO:0016020;GO:0005886;GO:0042802;GO:0050135;GO:0061809;GO:0038023;GO:0004888;GO:0006955;GO:0006954;GO:0045087;GO:0002755;GO:0050729;GO:0001817;GO:0034166;GO:0002224;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:identical protein binding; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:immune response; P:inflammatory response; P:innate immune response; P:MyD88-dependent toll-like receptor signaling pathway; P:positive regulation of inflammatory response; P:regulation of cytokine production; P:toll-like receptor 10 signaling pathway; P:toll-like receptor signaling pathway; scaffold2 indexed_genome mRNA 73287265 73287893 . - . ID=transcript_578;A6NJG6,Arginine-fifty homeobox,, PF00046;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold2 indexed_genome mRNA 73294705 73295247 . + . ID=transcript_579;Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3,Toll-like receptor 6,, PF13855;PF01463;PF01582;, GO:0005794;GO:0005887;GO:0045121;GO:0030670;GO:0005886;GO:0043235;GO:0035355;GO:0001540;GO:0042802;GO:0071723;GO:0050135;GO:0061809;GO:0046982;GO:0038023;GO:0005102;GO:0035663;GO:0004888;GO:0007250;GO:0001775;GO:1904646;GO:0071221;GO:0071726;GO:0140052;GO:0042742;GO:0042496;GO:0006955;GO:0006954;GO:0045087;GO:0001774;GO:0002755;GO:0032717;GO:0034136;GO:0046209;GO:1900017;GO:0010628;GO:0043123;GO:0032731;GO:0032755;GO:0043507;GO:0043032;GO:0051092;GO:0045429;GO:1900227;GO:1903223;GO:1903428;GO:0007165;GO:0034150;GO:0002224;GO:0038124;GO:0035666;, C:Golgi apparatus; C:integral component of plasma membrane; C:membrane raft; C:phagocytic vesicle membrane; C:plasma membrane; C:receptor complex; C:Toll-like receptor 2-Toll-like receptor 6 protein complex;, F:amyloid-beta binding; F:identical protein binding; F:lipopeptide binding; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:protein heterodimerization activity; F:signaling receptor activity; F:signaling receptor binding; F:Toll-like receptor 2 binding; F:transmembrane signaling receptor activity;, P:activation of NF-kappaB-inducing kinase activity; P:cell activation; P:cellular response to amyloid-beta; P:cellular response to bacterial lipopeptide; P:cellular response to diacyl bacterial lipopeptide; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:defense response to bacterium; P:detection of diacyl bacterial lipopeptide; P:immune response; P:inflammatory response; P:innate immune response; P:microglial cell activation; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of interleukin-8 production; P:negative regulation of toll-like receptor 2 signaling pathway; P:nitric oxide metabolic process; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of JUN kinase activity; P:positive regulation of macrophage activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of oxidative stress-induced neuron death; P:positive regulation of reactive oxygen species biosynthetic process; P:signal transduction; P:toll-like receptor 6 signaling pathway; P:toll-like receptor signaling pathway; P:toll-like receptor TLR6:TLR2 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; scaffold2 indexed_genome mRNA 73311581 73382232 . + . ID=transcript_580;Q8IWE2 A8K9W6 Q6MZV4 Q9BVL6,Protein NOXP20,Nervous system overexpressed protein 20;Protein FAM114A1;, PF05334;, GO:0005829;GO:0005794;GO:0005654;, C:cytosol; C:Golgi apparatus; C:nucleoplasm; scaffold2 indexed_genome mRNA 73417027 73439168 . - . ID=transcript_581;Q8N614 Q9H5N9,Transmembrane protein 156,, PF15106;, GO:0016021;, C:integral component of membrane; scaffold2 indexed_genome mRNA 73485403 73546505 . + . ID=transcript_582;Q9NV27 Q9NVA9 Q9Y2X2,Kelch-like protein 5,, PF07707;PF00651;PF01344;, GO:0005737;GO:0005856;GO:0005829;GO:0003779;GO:0043687;, C:cytoplasm; C:cytoskeleton; C:cytosol;, F:actin binding;, P:post-translational protein modification; scaffold2 indexed_genome mRNA 73592965 73593894 . - . ID=transcript_583;Q8NEZ3 B5MEF2 Q8N5B4 Q9H5S0 Q9HCD4,WD repeat-containing protein 19 {ECO:0000305},Intraflagellar transport 144 homolog;, PF15911;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0031514;GO:0097730;GO:0032391;GO:0001750;GO:0000902;GO:0060830;GO:0060271;GO:0055123;GO:0042471;GO:0031076;GO:0048701;GO:0030326;GO:0008406;GO:0001701;GO:0035721;GO:0035735;GO:0061055;GO:0050877;GO:1903441;GO:0065003;GO:0060831;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A; C:motile cilium; C:non-motile cilium; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cell morphogenesis; P:ciliary receptor clustering involved in smoothened signaling pathway; P:cilium assembly; P:digestive system development; P:ear morphogenesis; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic limb morphogenesis; P:gonad development; P:in utero embryonic development; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:myotome development; P:nervous system process; P:protein localization to ciliary membrane; P:protein-containing complex assembly; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; scaffold2 indexed_genome mRNA 73597587 73598977 . - . ID=transcript_584;Q8NEZ3 B5MEF2 Q8N5B4 Q9H5S0 Q9HCD4,WD repeat-containing protein 19 {ECO:0000305},Intraflagellar transport 144 homolog;, PF15911;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0031514;GO:0097730;GO:0032391;GO:0001750;GO:0000902;GO:0060830;GO:0060271;GO:0055123;GO:0042471;GO:0031076;GO:0048701;GO:0030326;GO:0008406;GO:0001701;GO:0035721;GO:0035735;GO:0061055;GO:0050877;GO:1903441;GO:0065003;GO:0060831;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A; C:motile cilium; C:non-motile cilium; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cell morphogenesis; P:ciliary receptor clustering involved in smoothened signaling pathway; P:cilium assembly; P:digestive system development; P:ear morphogenesis; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic limb morphogenesis; P:gonad development; P:in utero embryonic development; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:myotome development; P:nervous system process; P:protein localization to ciliary membrane; P:protein-containing complex assembly; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; scaffold2 indexed_genome mRNA 73607261 73634521 . + . ID=transcript_585;Q8NEZ3 B5MEF2 Q8N5B4 Q9H5S0 Q9HCD4,WD repeat-containing protein 19 {ECO:0000305},Intraflagellar transport 144 homolog;, PF15911;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0031514;GO:0097730;GO:0032391;GO:0001750;GO:0000902;GO:0060830;GO:0060271;GO:0055123;GO:0042471;GO:0031076;GO:0048701;GO:0030326;GO:0008406;GO:0001701;GO:0035721;GO:0035735;GO:0061055;GO:0050877;GO:1903441;GO:0065003;GO:0060831;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A; C:motile cilium; C:non-motile cilium; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cell morphogenesis; P:ciliary receptor clustering involved in smoothened signaling pathway; P:cilium assembly; P:digestive system development; P:ear morphogenesis; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic limb morphogenesis; P:gonad development; P:in utero embryonic development; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:myotome development; P:nervous system process; P:protein localization to ciliary membrane; P:protein-containing complex assembly; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning;|Q8NEZ3 B5MEF2 Q8N5B4 Q9H5S0 Q9HCD4,WD repeat-containing protein 19 {ECO:0000305},Intraflagellar transport 144 homolog;, PF15911;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0031514;GO:0097730;GO:0032391;GO:0001750;GO:0000902;GO:0060830;GO:0060271;GO:0055123;GO:0042471;GO:0031076;GO:0048701;GO:0030326;GO:0008406;GO:0001701;GO:0035721;GO:0035735;GO:0061055;GO:0050877;GO:1903441;GO:0065003;GO:0060831;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A; C:motile cilium; C:non-motile cilium; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cell morphogenesis; P:ciliary receptor clustering involved in smoothened signaling pathway; P:cilium assembly; P:digestive system development; P:ear morphogenesis; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic limb morphogenesis; P:gonad development; P:in utero embryonic development; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:myotome development; P:nervous system process; P:protein localization to ciliary membrane; P:protein-containing complex assembly; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning;|Q8NEZ3 B5MEF2 Q8N5B4 Q9H5S0 Q9HCD4,WD repeat-containing protein 19 {ECO:0000305},Intraflagellar transport 144 homolog;, PF15911;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0031514;GO:0097730;GO:0032391;GO:0001750;GO:0000902;GO:0060830;GO:0060271;GO:0055123;GO:0042471;GO:0031076;GO:0048701;GO:0030326;GO:0008406;GO:0001701;GO:0035721;GO:0035735;GO:0061055;GO:0050877;GO:1903441;GO:0065003;GO:0060831;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A; C:motile cilium; C:non-motile cilium; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cell morphogenesis; P:ciliary receptor clustering involved in smoothened signaling pathway; P:cilium assembly; P:digestive system development; P:ear morphogenesis; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic limb morphogenesis; P:gonad development; P:in utero embryonic development; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:myotome development; P:nervous system process; P:protein localization to ciliary membrane; P:protein-containing complex assembly; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning;|Q8NEZ3 B5MEF2 Q8N5B4 Q9H5S0 Q9HCD4,WD repeat-containing protein 19 {ECO:0000305},Intraflagellar transport 144 homolog;, PF15911;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0031514;GO:0097730;GO:0032391;GO:0001750;GO:0000902;GO:0060830;GO:0060271;GO:0055123;GO:0042471;GO:0031076;GO:0048701;GO:0030326;GO:0008406;GO:0001701;GO:0035721;GO:0035735;GO:0061055;GO:0050877;GO:1903441;GO:0065003;GO:0060831;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A; C:motile cilium; C:non-motile cilium; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cell morphogenesis; P:ciliary receptor clustering involved in smoothened signaling pathway; P:cilium assembly; P:digestive system development; P:ear morphogenesis; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic limb morphogenesis; P:gonad development; P:in utero embryonic development; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:myotome development; P:nervous system process; P:protein localization to ciliary membrane; P:protein-containing complex assembly; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning;|Q8NEZ3 B5MEF2 Q8N5B4 Q9H5S0 Q9HCD4,WD repeat-containing protein 19 {ECO:0000305},Intraflagellar transport 144 homolog;, PF15911;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0031514;GO:0097730;GO:0032391;GO:0001750;GO:0000902;GO:0060830;GO:0060271;GO:0055123;GO:0042471;GO:0031076;GO:0048701;GO:0030326;GO:0008406;GO:0001701;GO:0035721;GO:0035735;GO:0061055;GO:0050877;GO:1903441;GO:0065003;GO:0060831;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A; C:motile cilium; C:non-motile cilium; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cell morphogenesis; P:ciliary receptor clustering involved in smoothened signaling pathway; P:cilium assembly; P:digestive system development; P:ear morphogenesis; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic limb morphogenesis; P:gonad development; P:in utero embryonic development; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:myotome development; P:nervous system process; P:protein localization to ciliary membrane; P:protein-containing complex assembly; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; scaffold2 indexed_genome mRNA 73635466 73706064 . - . ID=transcript_586;P35251 A8K6E7 Q5XKF5 Q6PKU0 Q86V41 Q86V46,Replication factor C subunit 1,Activator 1 140 kDa subunit;Activator 1 large subunit;Activator 1 subunit 1;DNA-binding protein PO-GA;Replication factor C 140 kDa subunit;Replication factor C large subunit;, PF00004;PF00533;PF08519;, GO:0005737;GO:0005663;GO:0031391;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003689;GO:0061860;GO:0003690;GO:0008047;GO:0019904;GO:0043565;GO:0006287;GO:0090618;GO:0042769;GO:0006261;GO:0070987;GO:0042276;GO:0000122;GO:0006297;GO:0033683;GO:0006296;GO:0045893;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:cytoplasm; C:DNA replication factor C complex; C:Elg1 RFC-like complex; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp loader activity; F:DNA clamp unloader activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein domain specific binding; F:sequence-specific DNA binding;, P:base-excision repair, gap-filling; P:DNA clamp unloading; P:DNA damage response, detection of DNA damage; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of transcription, DNA-templated; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P35251 A8K6E7 Q5XKF5 Q6PKU0 Q86V41 Q86V46,Replication factor C subunit 1,Activator 1 140 kDa subunit;Activator 1 large subunit;Activator 1 subunit 1;DNA-binding protein PO-GA;Replication factor C 140 kDa subunit;Replication factor C large subunit;, PF00004;PF00533;PF08519;, GO:0005737;GO:0005663;GO:0031391;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003689;GO:0061860;GO:0003690;GO:0008047;GO:0019904;GO:0043565;GO:0006287;GO:0090618;GO:0042769;GO:0006261;GO:0070987;GO:0042276;GO:0000122;GO:0006297;GO:0033683;GO:0006296;GO:0045893;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:cytoplasm; C:DNA replication factor C complex; C:Elg1 RFC-like complex; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp loader activity; F:DNA clamp unloader activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein domain specific binding; F:sequence-specific DNA binding;, P:base-excision repair, gap-filling; P:DNA clamp unloading; P:DNA damage response, detection of DNA damage; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of transcription, DNA-templated; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P35251 A8K6E7 Q5XKF5 Q6PKU0 Q86V41 Q86V46,Replication factor C subunit 1,Activator 1 140 kDa subunit;Activator 1 large subunit;Activator 1 subunit 1;DNA-binding protein PO-GA;Replication factor C 140 kDa subunit;Replication factor C large subunit;, PF00004;PF00533;PF08519;, GO:0005737;GO:0005663;GO:0031391;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003689;GO:0061860;GO:0003690;GO:0008047;GO:0019904;GO:0043565;GO:0006287;GO:0090618;GO:0042769;GO:0006261;GO:0070987;GO:0042276;GO:0000122;GO:0006297;GO:0033683;GO:0006296;GO:0045893;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:cytoplasm; C:DNA replication factor C complex; C:Elg1 RFC-like complex; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp loader activity; F:DNA clamp unloader activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein domain specific binding; F:sequence-specific DNA binding;, P:base-excision repair, gap-filling; P:DNA clamp unloading; P:DNA damage response, detection of DNA damage; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of transcription, DNA-templated; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P35251 A8K6E7 Q5XKF5 Q6PKU0 Q86V41 Q86V46,Replication factor C subunit 1,Activator 1 140 kDa subunit;Activator 1 large subunit;Activator 1 subunit 1;DNA-binding protein PO-GA;Replication factor C 140 kDa subunit;Replication factor C large subunit;, PF00004;PF00533;PF08519;, GO:0005737;GO:0005663;GO:0031391;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003689;GO:0061860;GO:0003690;GO:0008047;GO:0019904;GO:0043565;GO:0006287;GO:0090618;GO:0042769;GO:0006261;GO:0070987;GO:0042276;GO:0000122;GO:0006297;GO:0033683;GO:0006296;GO:0045893;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:cytoplasm; C:DNA replication factor C complex; C:Elg1 RFC-like complex; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp loader activity; F:DNA clamp unloader activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein domain specific binding; F:sequence-specific DNA binding;, P:base-excision repair, gap-filling; P:DNA clamp unloading; P:DNA damage response, detection of DNA damage; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of transcription, DNA-templated; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P35251 A8K6E7 Q5XKF5 Q6PKU0 Q86V41 Q86V46,Replication factor C subunit 1,Activator 1 140 kDa subunit;Activator 1 large subunit;Activator 1 subunit 1;DNA-binding protein PO-GA;Replication factor C 140 kDa subunit;Replication factor C large subunit;, PF00004;PF00533;PF08519;, GO:0005737;GO:0005663;GO:0031391;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003689;GO:0061860;GO:0003690;GO:0008047;GO:0019904;GO:0043565;GO:0006287;GO:0090618;GO:0042769;GO:0006261;GO:0070987;GO:0042276;GO:0000122;GO:0006297;GO:0033683;GO:0006296;GO:0045893;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:cytoplasm; C:DNA replication factor C complex; C:Elg1 RFC-like complex; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp loader activity; F:DNA clamp unloader activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein domain specific binding; F:sequence-specific DNA binding;, P:base-excision repair, gap-filling; P:DNA clamp unloading; P:DNA damage response, detection of DNA damage; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of transcription, DNA-templated; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P35251 A8K6E7 Q5XKF5 Q6PKU0 Q86V41 Q86V46,Replication factor C subunit 1,Activator 1 140 kDa subunit;Activator 1 large subunit;Activator 1 subunit 1;DNA-binding protein PO-GA;Replication factor C 140 kDa subunit;Replication factor C large subunit;, PF00004;PF00533;PF08519;, GO:0005737;GO:0005663;GO:0031391;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003689;GO:0061860;GO:0003690;GO:0008047;GO:0019904;GO:0043565;GO:0006287;GO:0090618;GO:0042769;GO:0006261;GO:0070987;GO:0042276;GO:0000122;GO:0006297;GO:0033683;GO:0006296;GO:0045893;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:cytoplasm; C:DNA replication factor C complex; C:Elg1 RFC-like complex; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp loader activity; F:DNA clamp unloader activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein domain specific binding; F:sequence-specific DNA binding;, P:base-excision repair, gap-filling; P:DNA clamp unloading; P:DNA damage response, detection of DNA damage; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of transcription, DNA-templated; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P35251 A8K6E7 Q5XKF5 Q6PKU0 Q86V41 Q86V46,Replication factor C subunit 1,Activator 1 140 kDa subunit;Activator 1 large subunit;Activator 1 subunit 1;DNA-binding protein PO-GA;Replication factor C 140 kDa subunit;Replication factor C large subunit;, PF00004;PF00533;PF08519;, GO:0005737;GO:0005663;GO:0031391;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003689;GO:0061860;GO:0003690;GO:0008047;GO:0019904;GO:0043565;GO:0006287;GO:0090618;GO:0042769;GO:0006261;GO:0070987;GO:0042276;GO:0000122;GO:0006297;GO:0033683;GO:0006296;GO:0045893;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:cytoplasm; C:DNA replication factor C complex; C:Elg1 RFC-like complex; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp loader activity; F:DNA clamp unloader activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein domain specific binding; F:sequence-specific DNA binding;, P:base-excision repair, gap-filling; P:DNA clamp unloading; P:DNA damage response, detection of DNA damage; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of transcription, DNA-templated; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold2 indexed_genome mRNA 73725457 73754365 . + . ID=transcript_587;Q86Z14 Q2M3K8,Beta-klotho,Klotho beta-like protein;, PF00232;, GO:0005783;GO:0016021;GO:0005886;GO:0017134;GO:0005104;GO:0004553;GO:0005975;GO:0008543;GO:0000165;GO:0008284;GO:0090080;GO:0051897;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, F:fibroblast growth factor binding; F:fibroblast growth factor receptor binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds;, P:carbohydrate metabolic process; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:positive regulation of cell population proliferation; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; P:positive regulation of protein kinase B signaling; scaffold2 indexed_genome mRNA 73754559 73759553 . + . ID=transcript_588;Q86Z14 Q2M3K8,Beta-klotho,Klotho beta-like protein;, PF00232;, GO:0005783;GO:0016021;GO:0005886;GO:0017134;GO:0005104;GO:0004553;GO:0005975;GO:0008543;GO:0000165;GO:0008284;GO:0090080;GO:0051897;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, F:fibroblast growth factor binding; F:fibroblast growth factor receptor binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds;, P:carbohydrate metabolic process; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:positive regulation of cell population proliferation; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; P:positive regulation of protein kinase B signaling; scaffold2 indexed_genome mRNA 73759647 73764026 . - . ID=transcript_589;P32969,60S ribosomal protein L9,Large ribosomal subunit protein uL6 {ECO:0000303|PubMed:24524803};, PF00347;, GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005634;GO:0005840;GO:0003723;GO:0019843;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleus; C:ribosome;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P32969,60S ribosomal protein L9,Large ribosomal subunit protein uL6 {ECO:0000303|PubMed:24524803};, PF00347;, GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005634;GO:0005840;GO:0003723;GO:0019843;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleus; C:ribosome;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold2 indexed_genome mRNA 73764788 73776548 . + . ID=transcript_590;O43766 A8K873 C9JCF6 Q8IV62,Lipoyl synthase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03123},Lipoate synthase {ECO:0000255|HAMAP-Rule:MF_03123};Lipoic acid synthase {ECO:0000255|HAMAP-Rule:MF_03123};, PF16881;PF04055;, GO:0005759;GO:0005739;GO:0051539;GO:0016992;GO:0102552;GO:0102553;GO:0046872;GO:0019752;GO:0006954;GO:0009107;GO:0001843;GO:0009249;GO:0032496;GO:0006979;, C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:lipoate synthase activity; F:lipoyl synthase activity (acting on glycine-cleavage complex H protein; F:lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein); F:metal ion binding;, P:carboxylic acid metabolic process; P:inflammatory response; P:lipoate biosynthetic process; P:neural tube closure; P:protein lipoylation; P:response to lipopolysaccharide; P:response to oxidative stress;|O43766 A8K873 C9JCF6 Q8IV62,Lipoyl synthase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03123},Lipoate synthase {ECO:0000255|HAMAP-Rule:MF_03123};Lipoic acid synthase {ECO:0000255|HAMAP-Rule:MF_03123};, PF16881;PF04055;, GO:0005759;GO:0005739;GO:0051539;GO:0016992;GO:0102552;GO:0102553;GO:0046872;GO:0019752;GO:0006954;GO:0009107;GO:0001843;GO:0009249;GO:0032496;GO:0006979;, C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:lipoate synthase activity; F:lipoyl synthase activity (acting on glycine-cleavage complex H protein; F:lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein); F:metal ion binding;, P:carboxylic acid metabolic process; P:inflammatory response; P:lipoate biosynthetic process; P:neural tube closure; P:protein lipoylation; P:response to lipopolysaccharide; P:response to oxidative stress;|O43766 A8K873 C9JCF6 Q8IV62,Lipoyl synthase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03123},Lipoate synthase {ECO:0000255|HAMAP-Rule:MF_03123};Lipoic acid synthase {ECO:0000255|HAMAP-Rule:MF_03123};, PF16881;PF04055;, GO:0005759;GO:0005739;GO:0051539;GO:0016992;GO:0102552;GO:0102553;GO:0046872;GO:0019752;GO:0006954;GO:0009107;GO:0001843;GO:0009249;GO:0032496;GO:0006979;, C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:lipoate synthase activity; F:lipoyl synthase activity (acting on glycine-cleavage complex H protein; F:lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein); F:metal ion binding;, P:carboxylic acid metabolic process; P:inflammatory response; P:lipoate biosynthetic process; P:neural tube closure; P:protein lipoylation; P:response to lipopolysaccharide; P:response to oxidative stress;|O43766 A8K873 C9JCF6 Q8IV62,Lipoyl synthase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03123},Lipoate synthase {ECO:0000255|HAMAP-Rule:MF_03123};Lipoic acid synthase {ECO:0000255|HAMAP-Rule:MF_03123};, PF16881;PF04055;, GO:0005759;GO:0005739;GO:0051539;GO:0016992;GO:0102552;GO:0102553;GO:0046872;GO:0019752;GO:0006954;GO:0009107;GO:0001843;GO:0009249;GO:0032496;GO:0006979;, C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:lipoate synthase activity; F:lipoyl synthase activity (acting on glycine-cleavage complex H protein; F:lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein); F:metal ion binding;, P:carboxylic acid metabolic process; P:inflammatory response; P:lipoate biosynthetic process; P:neural tube closure; P:protein lipoylation; P:response to lipopolysaccharide; P:response to oxidative stress;|O43766 A8K873 C9JCF6 Q8IV62,Lipoyl synthase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03123},Lipoate synthase {ECO:0000255|HAMAP-Rule:MF_03123};Lipoic acid synthase {ECO:0000255|HAMAP-Rule:MF_03123};, PF16881;PF04055;, GO:0005759;GO:0005739;GO:0051539;GO:0016992;GO:0102552;GO:0102553;GO:0046872;GO:0019752;GO:0006954;GO:0009107;GO:0001843;GO:0009249;GO:0032496;GO:0006979;, C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:lipoate synthase activity; F:lipoyl synthase activity (acting on glycine-cleavage complex H protein; F:lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein); F:metal ion binding;, P:carboxylic acid metabolic process; P:inflammatory response; P:lipoate biosynthetic process; P:neural tube closure; P:protein lipoylation; P:response to lipopolysaccharide; P:response to oxidative stress;|O43766 A8K873 C9JCF6 Q8IV62,Lipoyl synthase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03123},Lipoate synthase {ECO:0000255|HAMAP-Rule:MF_03123};Lipoic acid synthase {ECO:0000255|HAMAP-Rule:MF_03123};, PF16881;PF04055;, GO:0005759;GO:0005739;GO:0051539;GO:0016992;GO:0102552;GO:0102553;GO:0046872;GO:0019752;GO:0006954;GO:0009107;GO:0001843;GO:0009249;GO:0032496;GO:0006979;, C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:lipoate synthase activity; F:lipoyl synthase activity (acting on glycine-cleavage complex H protein; F:lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein); F:metal ion binding;, P:carboxylic acid metabolic process; P:inflammatory response; P:lipoate biosynthetic process; P:neural tube closure; P:protein lipoylation; P:response to lipopolysaccharide; P:response to oxidative stress;|O43766 A8K873 C9JCF6 Q8IV62,Lipoyl synthase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03123},Lipoate synthase {ECO:0000255|HAMAP-Rule:MF_03123};Lipoic acid synthase {ECO:0000255|HAMAP-Rule:MF_03123};, PF16881;PF04055;, GO:0005759;GO:0005739;GO:0051539;GO:0016992;GO:0102552;GO:0102553;GO:0046872;GO:0019752;GO:0006954;GO:0009107;GO:0001843;GO:0009249;GO:0032496;GO:0006979;, C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:lipoate synthase activity; F:lipoyl synthase activity (acting on glycine-cleavage complex H protein; F:lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein); F:metal ion binding;, P:carboxylic acid metabolic process; P:inflammatory response; P:lipoate biosynthetic process; P:neural tube closure; P:protein lipoylation; P:response to lipopolysaccharide; P:response to oxidative stress; scaffold2 indexed_genome mRNA 73782287 73816121 . - . ID=transcript_591;O60701 B3KUU2 B4DN25 O60589,UDP-glucose 6-dehydrogenase,, PF00984;PF03720;PF03721;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0042802;GO:0051287;GO:0003979;GO:0005975;GO:0030206;GO:0001702;GO:0006024;GO:0015012;GO:0048666;GO:0034214;GO:0006065;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:NAD binding; F:UDP-glucose 6-dehydrogenase activity;, P:carbohydrate metabolic process; P:chondroitin sulfate biosynthetic process; P:gastrulation with mouth forming second; P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process; P:neuron development; P:protein hexamerization; P:UDP-glucuronate biosynthetic process;|O60701 B3KUU2 B4DN25 O60589,UDP-glucose 6-dehydrogenase,, PF00984;PF03720;PF03721;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0042802;GO:0051287;GO:0003979;GO:0005975;GO:0030206;GO:0001702;GO:0006024;GO:0015012;GO:0048666;GO:0034214;GO:0006065;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:NAD binding; F:UDP-glucose 6-dehydrogenase activity;, P:carbohydrate metabolic process; P:chondroitin sulfate biosynthetic process; P:gastrulation with mouth forming second; P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process; P:neuron development; P:protein hexamerization; P:UDP-glucuronate biosynthetic process;|O60701 B3KUU2 B4DN25 O60589,UDP-glucose 6-dehydrogenase,, PF00984;PF03720;PF03721;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0042802;GO:0051287;GO:0003979;GO:0005975;GO:0030206;GO:0001702;GO:0006024;GO:0015012;GO:0048666;GO:0034214;GO:0006065;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:NAD binding; F:UDP-glucose 6-dehydrogenase activity;, P:carbohydrate metabolic process; P:chondroitin sulfate biosynthetic process; P:gastrulation with mouth forming second; P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process; P:neuron development; P:protein hexamerization; P:UDP-glucuronate biosynthetic process;|O60701 B3KUU2 B4DN25 O60589,UDP-glucose 6-dehydrogenase,, PF00984;PF03720;PF03721;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0042802;GO:0051287;GO:0003979;GO:0005975;GO:0030206;GO:0001702;GO:0006024;GO:0015012;GO:0048666;GO:0034214;GO:0006065;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:NAD binding; F:UDP-glucose 6-dehydrogenase activity;, P:carbohydrate metabolic process; P:chondroitin sulfate biosynthetic process; P:gastrulation with mouth forming second; P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process; P:neuron development; P:protein hexamerization; P:UDP-glucuronate biosynthetic process; scaffold2 indexed_genome mRNA 73825547 73881896 . - . ID=transcript_592;Q96QK8,Small integral membrane protein 14,, PF11027;, GO:0005783;GO:0005789;GO:0016021;GO:0001835;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:blastocyst hatching;|Q96QK8,Small integral membrane protein 14,, PF11027;, GO:0005783;GO:0005789;GO:0016021;GO:0001835;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:blastocyst hatching; scaffold2 indexed_genome mRNA 73954479 74019689 . + . ID=transcript_593;Q9Y2D3,Ubiquitin-conjugating enzyme E2 K,E2 ubiquitin-conjugating enzyme K;Huntingtin-interacting protein 2;Ubiquitin carrier protein;Ubiquitin-conjugating enzyme E2-25 kDa;Ubiquitin-protein ligase;, PF00627;PF00179;, GO:0005829;GO:0032433;GO:0005634;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0034450;GO:0035458;GO:0010994;GO:0070059;GO:0010800;GO:1903265;GO:0060340;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0032434;GO:0006511;, C:cytosol; C:filopodium tip; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:ubiquitin-ubiquitin ligase activity;, P:cellular response to interferon-beta; P:free ubiquitin chain polymerization; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of type I interferon-mediated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9Y2D3,Ubiquitin-conjugating enzyme E2 K,E2 ubiquitin-conjugating enzyme K;Huntingtin-interacting protein 2;Ubiquitin carrier protein;Ubiquitin-conjugating enzyme E2-25 kDa;Ubiquitin-protein ligase;, PF00627;PF00179;, GO:0005829;GO:0032433;GO:0005634;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0034450;GO:0035458;GO:0010994;GO:0070059;GO:0010800;GO:1903265;GO:0060340;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0032434;GO:0006511;, C:cytosol; C:filopodium tip; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:ubiquitin-ubiquitin ligase activity;, P:cellular response to interferon-beta; P:free ubiquitin chain polymerization; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of type I interferon-mediated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process; scaffold2 indexed_genome mRNA 74020190 74025246 . + . ID=transcript_594;Q9Y2D3,Ubiquitin-conjugating enzyme E2 K,E2 ubiquitin-conjugating enzyme K;Huntingtin-interacting protein 2;Ubiquitin carrier protein;Ubiquitin-conjugating enzyme E2-25 kDa;Ubiquitin-protein ligase;, PF00627;PF00179;, GO:0005829;GO:0032433;GO:0005634;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0034450;GO:0035458;GO:0010994;GO:0070059;GO:0010800;GO:1903265;GO:0060340;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0032434;GO:0006511;, C:cytosol; C:filopodium tip; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:ubiquitin-ubiquitin ligase activity;, P:cellular response to interferon-beta; P:free ubiquitin chain polymerization; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of type I interferon-mediated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process; scaffold2 indexed_genome mRNA 74058540 74176358 . - . ID=transcript_595;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q29RF7 Q2TTR5 Q68DF7 Q8N7J4 Q8NG14 Q9Y4D4,Sister chromatid cohesion protein PDS5 homolog A,Cell proliferation-inducing gene 54 protein;Sister chromatid cohesion protein 112;, , GO:0000785;GO:0005694;GO:0000775;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0051301;GO:0006281;GO:0007064;GO:0008156;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, , P:cell division; P:DNA repair; P:mitotic sister chromatid cohesion; P:negative regulation of DNA replication;|Q29RF7 Q2TTR5 Q68DF7 Q8N7J4 Q8NG14 Q9Y4D4,Sister chromatid cohesion protein PDS5 homolog A,Cell proliferation-inducing gene 54 protein;Sister chromatid cohesion protein 112;, , GO:0000785;GO:0005694;GO:0000775;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0051301;GO:0006281;GO:0007064;GO:0008156;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, , P:cell division; P:DNA repair; P:mitotic sister chromatid cohesion; P:negative regulation of DNA replication; scaffold2 indexed_genome mRNA 74262312 74321101 . + . ID=transcript_596;Q86UW6 A0AVR3 Q9NVK2 Q9P2D4,NEDD4-binding protein 2,BCL-3-binding protein;, PF08590;PF01713;, GO:0005829;GO:0005524;GO:0046404;GO:0004519;GO:0043130;, C:cytosol;, F:ATP binding; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; F:endonuclease activity; F:ubiquitin binding;|Q86UW6 A0AVR3 Q9NVK2 Q9P2D4,NEDD4-binding protein 2,BCL-3-binding protein;, PF08590;PF01713;, GO:0005829;GO:0005524;GO:0046404;GO:0004519;GO:0043130;, C:cytosol;, F:ATP binding; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; F:endonuclease activity; F:ubiquitin binding;|Q86UW6 A0AVR3 Q9NVK2 Q9P2D4,NEDD4-binding protein 2,BCL-3-binding protein;, PF08590;PF01713;, GO:0005829;GO:0005524;GO:0046404;GO:0004519;GO:0043130;, C:cytosol;, F:ATP binding; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; F:endonuclease activity; F:ubiquitin binding; scaffold2 indexed_genome mRNA 74367233 74407046 . + . ID=transcript_597;Q15669,Rho-related GTP-binding protein RhoH,GTP-binding protein TTF;Translocation three four protein;, PF00071;, GO:0005938;GO:0042995;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0001772;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0005095;GO:0019210;GO:0019901;GO:0031267;GO:0007015;GO:0030031;GO:0030865;GO:0043652;GO:0007163;GO:0045576;GO:0008045;GO:0043124;GO:0045582;GO:0016601;GO:0032956;GO:0008360;GO:1902622;GO:0051056;GO:0006355;GO:0030217;, C:cell cortex; C:cell projection; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:immunological synapse; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:GTPase inhibitor activity; F:kinase inhibitor activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell projection assembly; P:cortical cytoskeleton organization; P:engulfment of apoptotic cell; P:establishment or maintenance of cell polarity; P:mast cell activation; P:motor neuron axon guidance; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of T cell differentiation; P:Rac protein signal transduction; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of neutrophil migration; P:regulation of small GTPase mediated signal transduction; P:regulation of transcription, DNA-templated; P:T cell differentiation; scaffold2 indexed_genome mRNA 74407062 74409224 . + . ID=transcript_598;Q15669,Rho-related GTP-binding protein RhoH,GTP-binding protein TTF;Translocation three four protein;, PF00071;, GO:0005938;GO:0042995;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0001772;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0005095;GO:0019210;GO:0019901;GO:0031267;GO:0007015;GO:0030031;GO:0030865;GO:0043652;GO:0007163;GO:0045576;GO:0008045;GO:0043124;GO:0045582;GO:0016601;GO:0032956;GO:0008360;GO:1902622;GO:0051056;GO:0006355;GO:0030217;, C:cell cortex; C:cell projection; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:immunological synapse; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:GTPase inhibitor activity; F:kinase inhibitor activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell projection assembly; P:cortical cytoskeleton organization; P:engulfment of apoptotic cell; P:establishment or maintenance of cell polarity; P:mast cell activation; P:motor neuron axon guidance; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of T cell differentiation; P:Rac protein signal transduction; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of neutrophil migration; P:regulation of small GTPase mediated signal transduction; P:regulation of transcription, DNA-templated; P:T cell differentiation; scaffold2 indexed_genome mRNA 74538937 74712119 . - . ID=transcript_599;A0AV96 A0PJK2 B5MED4 Q8NI52 Q8NI53 Q9NXG3,RNA-binding protein 47,RNA-binding motif protein 47;, PF00076;, GO:0005634;GO:0003729;GO:0003723;GO:0016554;GO:0002244;, C:nucleus;, F:mRNA binding; F:RNA binding;, P:cytidine to uridine editing; P:hematopoietic progenitor cell differentiation;|A0AV96 A0PJK2 B5MED4 Q8NI52 Q8NI53 Q9NXG3,RNA-binding protein 47,RNA-binding motif protein 47;, PF00076;, GO:0005634;GO:0003729;GO:0003723;GO:0016554;GO:0002244;, C:nucleus;, F:mRNA binding; F:RNA binding;, P:cytidine to uridine editing; P:hematopoietic progenitor cell differentiation; scaffold3 indexed_genome mRNA 287693 371247 . + . ID=transcript_600;Q13884 A8K9E0 O14912 Q4KMG8,Beta-1-syntrophin,59 kDa dystrophin-associated protein A1 basic component 1;BSYN2;Syntrophin-2;Tax interaction protein 43;, PF00595;PF00169;PF18012;, GO:0005737;GO:0005856;GO:0016010;GO:0005925;GO:0032991;GO:0042383;GO:0045202;GO:0003779;GO:0005516;GO:0030165;GO:0005198;GO:0006936;, C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:focal adhesion; C:protein-containing complex; C:sarcolemma; C:synapse;, F:actin binding; F:calmodulin binding; F:PDZ domain binding; F:structural molecule activity;, P:muscle contraction; scaffold3 indexed_genome mRNA 373735 379808 . - . ID=transcript_601;Q96DY7 B4DUR5 Q9HA89,Mdm2-binding protein,, PF14920;PF14919;PF14918;, GO:0000785;GO:0000776;GO:0007050;GO:0008285;GO:0045839;GO:0034501;GO:0031396;GO:0007089;, C:chromatin; C:kinetochore;, , P:cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of mitotic nuclear division; P:protein localization to kinetochore; P:regulation of protein ubiquitination; P:traversing start control point of mitotic cell cycle;|Q96DY7 B4DUR5 Q9HA89,Mdm2-binding protein,, PF14920;PF14919;PF14918;, GO:0000785;GO:0000776;GO:0007050;GO:0008285;GO:0045839;GO:0034501;GO:0031396;GO:0007089;, C:chromatin; C:kinetochore;, , P:cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of mitotic nuclear division; P:protein localization to kinetochore; P:regulation of protein ubiquitination; P:traversing start control point of mitotic cell cycle; scaffold3 indexed_genome mRNA 380028 446644 . - . ID=transcript_602;Q96DY7 B4DUR5 Q9HA89,Mdm2-binding protein,, PF14920;PF14919;PF14918;, GO:0000785;GO:0000776;GO:0007050;GO:0008285;GO:0045839;GO:0034501;GO:0031396;GO:0007089;, C:chromatin; C:kinetochore;, , P:cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of mitotic nuclear division; P:protein localization to kinetochore; P:regulation of protein ubiquitination; P:traversing start control point of mitotic cell cycle;|Q96DY7 B4DUR5 Q9HA89,Mdm2-binding protein,, PF14920;PF14919;PF14918;, GO:0000785;GO:0000776;GO:0007050;GO:0008285;GO:0045839;GO:0034501;GO:0031396;GO:0007089;, C:chromatin; C:kinetochore;, , P:cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of mitotic nuclear division; P:protein localization to kinetochore; P:regulation of protein ubiquitination; P:traversing start control point of mitotic cell cycle;|Q96DY7 B4DUR5 Q9HA89,Mdm2-binding protein,, PF14920;PF14919;PF14918;, GO:0000785;GO:0000776;GO:0007050;GO:0008285;GO:0045839;GO:0034501;GO:0031396;GO:0007089;, C:chromatin; C:kinetochore;, , P:cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of mitotic nuclear division; P:protein localization to kinetochore; P:regulation of protein ubiquitination; P:traversing start control point of mitotic cell cycle; scaffold3 indexed_genome mRNA 455081 460558 . + . ID=transcript_603;Q9BYD1 B2R4R8 Q9UI04,39S ribosomal protein L13, mitochondrial,Mitochondrial large ribosomal subunit protein uL13m {ECO:0000303|PubMed:25278503};, PF00572;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0005840;GO:0003729;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0017148;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion; C:ribosome;, F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:negative regulation of translation; P:translation; scaffold3 indexed_genome mRNA 499106 713347 . - . ID=transcript_604;Q05707 B2RU07 O00260 O00261 O00262 Q05708 Q5XJ18 Q96C67 Q9UDF6,Collagen alpha-1(XIV) chain,Undulin;, PF01391;PF00041;PF00092;, GO:0005581;GO:0005596;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005614;GO:0005518;GO:0005201;GO:0030020;GO:0030674;GO:0003723;GO:0098609;GO:0030199;GO:0030198;, C:collagen trimer; C:collagen type XIV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:interstitial matrix;, F:collagen binding; F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:protein-macromolecule adaptor activity; F:RNA binding;, P:cell-cell adhesion; P:collagen fibril organization; P:extracellular matrix organization;|Q05707 B2RU07 O00260 O00261 O00262 Q05708 Q5XJ18 Q96C67 Q9UDF6,Collagen alpha-1(XIV) chain,Undulin;, PF01391;PF00041;PF00092;, GO:0005581;GO:0005596;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005614;GO:0005518;GO:0005201;GO:0030020;GO:0030674;GO:0003723;GO:0098609;GO:0030199;GO:0030198;, C:collagen trimer; C:collagen type XIV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:interstitial matrix;, F:collagen binding; F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:protein-macromolecule adaptor activity; F:RNA binding;, P:cell-cell adhesion; P:collagen fibril organization; P:extracellular matrix organization;|Q05707 B2RU07 O00260 O00261 O00262 Q05708 Q5XJ18 Q96C67 Q9UDF6,Collagen alpha-1(XIV) chain,Undulin;, PF01391;PF00041;PF00092;, GO:0005581;GO:0005596;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005614;GO:0005518;GO:0005201;GO:0030020;GO:0030674;GO:0003723;GO:0098609;GO:0030199;GO:0030198;, C:collagen trimer; C:collagen type XIV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:interstitial matrix;, F:collagen binding; F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:protein-macromolecule adaptor activity; F:RNA binding;, P:cell-cell adhesion; P:collagen fibril organization; P:extracellular matrix organization; scaffold3 indexed_genome mRNA 827533 828159 . + . ID=transcript_605;Q8TB45 B2RCL9 B4DN97 E7EV87 Q96EQ1 Q9H0R7 Q9H894 Q9HA07,DEP domain-containing mTOR-interacting protein,DEP domain-containing protein 6;, PF00610;, GO:0035556;GO:0045792;GO:0006469;GO:0032007;GO:2001236;, , , P:intracellular signal transduction; P:negative regulation of cell size; P:negative regulation of protein kinase activity; P:negative regulation of TOR signaling; P:regulation of extrinsic apoptotic signaling pathway; scaffold3 indexed_genome mRNA 966008 970561 . + . ID=transcript_606;Q9BVC3 Q969N5,Sister chromatid cohesion protein DCC1,Defective in sister chromatid cohesion protein 1 homolog;, PF09724;, GO:0000785;GO:0000775;GO:0031390;GO:0005654;GO:0005634;GO:0003677;GO:0032508;GO:0034088;GO:1900264;GO:0034421;GO:0006275;GO:0032201;, C:chromatin; C:chromosome, centromeric region; C:Ctf18 RFC-like complex; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:DNA duplex unwinding; P:maintenance of mitotic sister chromatid cohesion; P:positive regulation of DNA-directed DNA polymerase activity; P:post-translational protein acetylation; P:regulation of DNA replication; P:telomere maintenance via semi-conservative replication;|Q9BVC3 Q969N5,Sister chromatid cohesion protein DCC1,Defective in sister chromatid cohesion protein 1 homolog;, PF09724;, GO:0000785;GO:0000775;GO:0031390;GO:0005654;GO:0005634;GO:0003677;GO:0032508;GO:0034088;GO:1900264;GO:0034421;GO:0006275;GO:0032201;, C:chromatin; C:chromosome, centromeric region; C:Ctf18 RFC-like complex; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:DNA duplex unwinding; P:maintenance of mitotic sister chromatid cohesion; P:positive regulation of DNA-directed DNA polymerase activity; P:post-translational protein acetylation; P:regulation of DNA replication; P:telomere maintenance via semi-conservative replication; scaffold3 indexed_genome mRNA 973941 1035156 . + . ID=transcript_607;Q6P1X5 B2RE82 O43487 O43604 O60668 Q86WW7 Q8IWK4,Transcription initiation factor TFIID subunit 2,150 kDa cofactor of initiator function;RNA polymerase II TBP-associated factor subunit B;TBP-associated factor 150 kDa;Transcription initiation factor TFIID 150 kDa subunit;, , GO:0005654;GO:0005669;GO:0033276;GO:0003682;GO:0016251;GO:0000976;GO:0000086;GO:1901796;GO:0014070;GO:0006366;GO:0006367;, C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:chromatin binding; F:RNA polymerase II general transcription initiation factor activity; F:transcription regulatory region sequence-specific DNA binding;, P:G2/M transition of mitotic cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to organic cyclic compound; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q6P1X5 B2RE82 O43487 O43604 O60668 Q86WW7 Q8IWK4,Transcription initiation factor TFIID subunit 2,150 kDa cofactor of initiator function;RNA polymerase II TBP-associated factor subunit B;TBP-associated factor 150 kDa;Transcription initiation factor TFIID 150 kDa subunit;, , GO:0005654;GO:0005669;GO:0033276;GO:0003682;GO:0016251;GO:0000976;GO:0000086;GO:1901796;GO:0014070;GO:0006366;GO:0006367;, C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:chromatin binding; F:RNA polymerase II general transcription initiation factor activity; F:transcription regulatory region sequence-specific DNA binding;, P:G2/M transition of mitotic cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to organic cyclic compound; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q6P1X5 B2RE82 O43487 O43604 O60668 Q86WW7 Q8IWK4,Transcription initiation factor TFIID subunit 2,150 kDa cofactor of initiator function;RNA polymerase II TBP-associated factor subunit B;TBP-associated factor 150 kDa;Transcription initiation factor TFIID 150 kDa subunit;, , GO:0005654;GO:0005669;GO:0033276;GO:0003682;GO:0016251;GO:0000976;GO:0000086;GO:1901796;GO:0014070;GO:0006366;GO:0006367;, C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:chromatin binding; F:RNA polymerase II general transcription initiation factor activity; F:transcription regulatory region sequence-specific DNA binding;, P:G2/M transition of mitotic cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to organic cyclic compound; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q6P1X5 B2RE82 O43487 O43604 O60668 Q86WW7 Q8IWK4,Transcription initiation factor TFIID subunit 2,150 kDa cofactor of initiator function;RNA polymerase II TBP-associated factor subunit B;TBP-associated factor 150 kDa;Transcription initiation factor TFIID 150 kDa subunit;, , GO:0005654;GO:0005669;GO:0033276;GO:0003682;GO:0016251;GO:0000976;GO:0000086;GO:1901796;GO:0014070;GO:0006366;GO:0006367;, C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:chromatin binding; F:RNA polymerase II general transcription initiation factor activity; F:transcription regulatory region sequence-specific DNA binding;, P:G2/M transition of mitotic cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to organic cyclic compound; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q6P1X5 B2RE82 O43487 O43604 O60668 Q86WW7 Q8IWK4,Transcription initiation factor TFIID subunit 2,150 kDa cofactor of initiator function;RNA polymerase II TBP-associated factor subunit B;TBP-associated factor 150 kDa;Transcription initiation factor TFIID 150 kDa subunit;, , GO:0005654;GO:0005669;GO:0033276;GO:0003682;GO:0016251;GO:0000976;GO:0000086;GO:1901796;GO:0014070;GO:0006366;GO:0006367;, C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:chromatin binding; F:RNA polymerase II general transcription initiation factor activity; F:transcription regulatory region sequence-specific DNA binding;, P:G2/M transition of mitotic cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to organic cyclic compound; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q6P1X5 B2RE82 O43487 O43604 O60668 Q86WW7 Q8IWK4,Transcription initiation factor TFIID subunit 2,150 kDa cofactor of initiator function;RNA polymerase II TBP-associated factor subunit B;TBP-associated factor 150 kDa;Transcription initiation factor TFIID 150 kDa subunit;, , GO:0005654;GO:0005669;GO:0033276;GO:0003682;GO:0016251;GO:0000976;GO:0000086;GO:1901796;GO:0014070;GO:0006366;GO:0006367;, C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:chromatin binding; F:RNA polymerase II general transcription initiation factor activity; F:transcription regulatory region sequence-specific DNA binding;, P:G2/M transition of mitotic cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to organic cyclic compound; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold3 indexed_genome mRNA 1102039 1235782 . + . ID=transcript_608;Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process;|Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process;|Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process;|Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process;|Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process;|Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process;|Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process;|Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process;|Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process;|Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process;|Q9UCR2 Q9UCR3 Q9UCR4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Autotaxin {ECO:0000303|PubMed:12176993, ECO:0000303|PubMed:7982964};Extracellular lysophospholipase D;, PF01223;PF01663;PF01033;, GO:0005615;GO:0005886;GO:0047391;GO:0005509;GO:0016787;GO:0004622;GO:0003676;GO:0004551;GO:0004528;GO:0030247;GO:0005044;GO:0008134;GO:0008270;GO:0048870;GO:0006935;GO:0006955;GO:0034638;GO:0009395;GO:0010634;GO:2000394;GO:0050731;GO:0045765;GO:0030334;GO:0030149;, C:extracellular space; C:plasma membrane;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:calcium ion binding; F:hydrolase activity; F:lysophospholipase activity; F:nucleic acid binding; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:scavenger receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell motility; P:chemotaxis; P:immune response; P:phosphatidylcholine catabolic process; P:phospholipid catabolic process; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of angiogenesis; P:regulation of cell migration; P:sphingolipid catabolic process; scaffold3 indexed_genome mRNA 1293599 1323096 . - . ID=transcript_609;P29218 B2R733 B4DLN3 B7Z6Q4 J3KQT7 Q9UK71,Inositol monophosphatase 1,D-galactose 1-phosphate phosphatase {ECO:0000303|PubMed:9462881};Inositol-1(or 4)-monophosphatase 1;Lithium-sensitive myo-inositol monophosphatase A1;, PF00459;, GO:0005737;GO:0005829;GO:0042802;GO:0008934;GO:0052832;GO:0052833;GO:0052834;GO:0031403;GO:0000287;GO:0030145;GO:0042803;GO:0006021;GO:0006020;GO:0046855;GO:0043647;GO:0006796;GO:0006661;GO:0046854;GO:0007165;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:inositol monophosphate phosphatase activity; F:lithium ion binding; F:magnesium ion binding; F:manganese ion binding; F:protein homodimerization activity;, P:inositol biosynthetic process; P:inositol metabolic process; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphate-containing compound metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:signal transduction;|P29218 B2R733 B4DLN3 B7Z6Q4 J3KQT7 Q9UK71,Inositol monophosphatase 1,D-galactose 1-phosphate phosphatase {ECO:0000303|PubMed:9462881};Inositol-1(or 4)-monophosphatase 1;Lithium-sensitive myo-inositol monophosphatase A1;, PF00459;, GO:0005737;GO:0005829;GO:0042802;GO:0008934;GO:0052832;GO:0052833;GO:0052834;GO:0031403;GO:0000287;GO:0030145;GO:0042803;GO:0006021;GO:0006020;GO:0046855;GO:0043647;GO:0006796;GO:0006661;GO:0046854;GO:0007165;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:inositol monophosphate phosphatase activity; F:lithium ion binding; F:magnesium ion binding; F:manganese ion binding; F:protein homodimerization activity;, P:inositol biosynthetic process; P:inositol metabolic process; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphate-containing compound metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:signal transduction; scaffold3 indexed_genome mRNA 1325230 1346203 . - . ID=transcript_610;Q5PT55 B2RN26,Sodium/bile acid cotransporter 5,Na(+)/bile acid cotransporter 5;Solute carrier family 10 member 5;, PF01758;, GO:0016021;GO:0008508;GO:0015721;, C:integral component of membrane;, F:bile acid:sodium symporter activity;, P:bile acid and bile salt transport;|Q8TCF1 E5RIG0 E5RJ99 Q658R7 Q6IA32 Q6PGQ6 Q9H810,AN1-type zinc finger protein 1 {ECO:0000305},Zinc finger AN1-type-containing protein 1 {ECO:0000305};, PF01428;, GO:0010494;GO:0070628;GO:0008270;GO:1903843;GO:0090316;GO:0035617;, C:cytoplasmic stress granule;, F:proteasome binding; F:zinc ion binding;, P:cellular response to arsenite ion; P:positive regulation of intracellular protein transport; P:stress granule disassembly;|Q8TCF1 E5RIG0 E5RJ99 Q658R7 Q6IA32 Q6PGQ6 Q9H810,AN1-type zinc finger protein 1 {ECO:0000305},Zinc finger AN1-type-containing protein 1 {ECO:0000305};, PF01428;, GO:0010494;GO:0070628;GO:0008270;GO:1903843;GO:0090316;GO:0035617;, C:cytoplasmic stress granule;, F:proteasome binding; F:zinc ion binding;, P:cellular response to arsenite ion; P:positive regulation of intracellular protein transport; P:stress granule disassembly;|Q8TCF1 E5RIG0 E5RJ99 Q658R7 Q6IA32 Q6PGQ6 Q9H810,AN1-type zinc finger protein 1 {ECO:0000305},Zinc finger AN1-type-containing protein 1 {ECO:0000305};, PF01428;, GO:0010494;GO:0070628;GO:0008270;GO:1903843;GO:0090316;GO:0035617;, C:cytoplasmic stress granule;, F:proteasome binding; F:zinc ion binding;, P:cellular response to arsenite ion; P:positive regulation of intracellular protein transport; P:stress granule disassembly;|Q8TCF1 E5RIG0 E5RJ99 Q658R7 Q6IA32 Q6PGQ6 Q9H810,AN1-type zinc finger protein 1 {ECO:0000305},Zinc finger AN1-type-containing protein 1 {ECO:0000305};, PF01428;, GO:0010494;GO:0070628;GO:0008270;GO:1903843;GO:0090316;GO:0035617;, C:cytoplasmic stress granule;, F:proteasome binding; F:zinc ion binding;, P:cellular response to arsenite ion; P:positive regulation of intracellular protein transport; P:stress granule disassembly; scaffold3 indexed_genome mRNA 1370998 1400043 . + . ID=transcript_611;Q96CF2 B2RBZ1,Charged multivesicular body protein 4c,Chromatin-modifying protein 4c;SNF7 homolog associated with Alix 3;SNF7-3 {ECO:0000303|PubMed:14583093};Vacuolar protein sorting-associated protein 32-3;, PF03357;, GO:0009898;GO:0005829;GO:0000815;GO:0090543;GO:0031902;GO:0030496;GO:0005771;GO:0042803;GO:0009838;GO:0016197;GO:0032511;GO:0016236;GO:0061952;GO:0044878;GO:0007080;GO:0007084;GO:0036258;GO:0032466;GO:0006997;GO:1902188;GO:0015031;GO:0010824;GO:1901673;GO:0050792;GO:0090611;GO:0006900;GO:0039702;GO:0019058;, C:cytoplasmic side of plasma membrane; C:cytosol; C:ESCRT III complex; C:Flemming body; C:late endosome membrane; C:midbody; C:multivesicular body;, F:protein homodimerization activity;, P:abscission; P:endosomal transport; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:macroautophagy; P:midbody abscission; P:mitotic cytokinesis checkpoint; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of cytokinesis; P:nucleus organization; P:positive regulation of viral release from host cell; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:vesicle budding from membrane; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold3 indexed_genome mRNA 1427522 1463850 . + . ID=transcript_612;P57768 A8K4D8 Q658L0 Q8N4U3,Sorting nexin-16,, PF00787;, GO:0005829;GO:0005769;GO:0031901;GO:0031313;GO:0043231;GO:0005770;GO:0031902;GO:0005764;GO:0042802;GO:0035091;GO:0045022;GO:0008333;GO:0006622;, C:cytosol; C:early endosome; C:early endosome membrane; C:extrinsic component of endosome membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosome;, F:identical protein binding; F:phosphatidylinositol binding;, P:early endosome to late endosome transport; P:endosome to lysosome transport; P:protein targeting to lysosome;|P57768 A8K4D8 Q658L0 Q8N4U3,Sorting nexin-16,, PF00787;, GO:0005829;GO:0005769;GO:0031901;GO:0031313;GO:0043231;GO:0005770;GO:0031902;GO:0005764;GO:0042802;GO:0035091;GO:0045022;GO:0008333;GO:0006622;, C:cytosol; C:early endosome; C:early endosome membrane; C:extrinsic component of endosome membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosome;, F:identical protein binding; F:phosphatidylinositol binding;, P:early endosome to late endosome transport; P:endosome to lysosome transport; P:protein targeting to lysosome;|P57768 A8K4D8 Q658L0 Q8N4U3,Sorting nexin-16,, PF00787;, GO:0005829;GO:0005769;GO:0031901;GO:0031313;GO:0043231;GO:0005770;GO:0031902;GO:0005764;GO:0042802;GO:0035091;GO:0045022;GO:0008333;GO:0006622;, C:cytosol; C:early endosome; C:early endosome membrane; C:extrinsic component of endosome membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosome;, F:identical protein binding; F:phosphatidylinositol binding;, P:early endosome to late endosome transport; P:endosome to lysosome transport; P:protein targeting to lysosome;|P57768 A8K4D8 Q658L0 Q8N4U3,Sorting nexin-16,, PF00787;, GO:0005829;GO:0005769;GO:0031901;GO:0031313;GO:0043231;GO:0005770;GO:0031902;GO:0005764;GO:0042802;GO:0035091;GO:0045022;GO:0008333;GO:0006622;, C:cytosol; C:early endosome; C:early endosome membrane; C:extrinsic component of endosome membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosome;, F:identical protein binding; F:phosphatidylinositol binding;, P:early endosome to late endosome transport; P:endosome to lysosome transport; P:protein targeting to lysosome;|P57768 A8K4D8 Q658L0 Q8N4U3,Sorting nexin-16,, PF00787;, GO:0005829;GO:0005769;GO:0031901;GO:0031313;GO:0043231;GO:0005770;GO:0031902;GO:0005764;GO:0042802;GO:0035091;GO:0045022;GO:0008333;GO:0006622;, C:cytosol; C:early endosome; C:early endosome membrane; C:extrinsic component of endosome membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosome;, F:identical protein binding; F:phosphatidylinositol binding;, P:early endosome to late endosome transport; P:endosome to lysosome transport; P:protein targeting to lysosome; scaffold3 indexed_genome mRNA 3512580 4259897 . + . ID=transcript_613;Q86SE5 B3KTH2 G3V129 Q6ZW87 Q8N1C2,RNA-binding Raly-like protein,Heterogeneous nuclear ribonucleoprotein C-like 3;, PF00076;, GO:0005654;GO:0005634;GO:0042802;GO:0003723;, C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; scaffold3 indexed_genome mRNA 4291399 4294297 . - . ID=transcript_614;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold3 indexed_genome mRNA 4475223 4520551 . + . ID=transcript_615;Q9C099 B4DYX6 B5RI11 Q8N768 Q96DK7 Q96N01,Leucine-rich repeat and coiled-coil domain-containing protein 1,Centrosomal leucine-rich repeat and coiled-coil domain-containing protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0007049;GO:0051301;, C:centriole; C:centrosome; C:cytoplasm;, , P:cell cycle; P:cell division;|Q9C099 B4DYX6 B5RI11 Q8N768 Q96DK7 Q96N01,Leucine-rich repeat and coiled-coil domain-containing protein 1,Centrosomal leucine-rich repeat and coiled-coil domain-containing protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0007049;GO:0051301;, C:centriole; C:centrosome; C:cytoplasm;, , P:cell cycle; P:cell division;|Q9C099 B4DYX6 B5RI11 Q8N768 Q96DK7 Q96N01,Leucine-rich repeat and coiled-coil domain-containing protein 1,Centrosomal leucine-rich repeat and coiled-coil domain-containing protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0007049;GO:0051301;, C:centriole; C:centrosome; C:cytoplasm;, , P:cell cycle; P:cell division;|Q9C099 B4DYX6 B5RI11 Q8N768 Q96DK7 Q96N01,Leucine-rich repeat and coiled-coil domain-containing protein 1,Centrosomal leucine-rich repeat and coiled-coil domain-containing protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0007049;GO:0051301;, C:centriole; C:centrosome; C:cytoplasm;, , P:cell cycle; P:cell division;|Q9C099 B4DYX6 B5RI11 Q8N768 Q96DK7 Q96N01,Leucine-rich repeat and coiled-coil domain-containing protein 1,Centrosomal leucine-rich repeat and coiled-coil domain-containing protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0007049;GO:0051301;, C:centriole; C:centrosome; C:cytoplasm;, , P:cell cycle; P:cell division;|Q9C099 B4DYX6 B5RI11 Q8N768 Q96DK7 Q96N01,Leucine-rich repeat and coiled-coil domain-containing protein 1,Centrosomal leucine-rich repeat and coiled-coil domain-containing protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0007049;GO:0051301;, C:centriole; C:centrosome; C:cytoplasm;, , P:cell cycle; P:cell division;|Q9C099 B4DYX6 B5RI11 Q8N768 Q96DK7 Q96N01,Leucine-rich repeat and coiled-coil domain-containing protein 1,Centrosomal leucine-rich repeat and coiled-coil domain-containing protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0007049;GO:0051301;, C:centriole; C:centrosome; C:cytoplasm;, , P:cell cycle; P:cell division;|Q9C099 B4DYX6 B5RI11 Q8N768 Q96DK7 Q96N01,Leucine-rich repeat and coiled-coil domain-containing protein 1,Centrosomal leucine-rich repeat and coiled-coil domain-containing protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0007049;GO:0051301;, C:centriole; C:centrosome; C:cytoplasm;, , P:cell cycle; P:cell division;|Q9C099 B4DYX6 B5RI11 Q8N768 Q96DK7 Q96N01,Leucine-rich repeat and coiled-coil domain-containing protein 1,Centrosomal leucine-rich repeat and coiled-coil domain-containing protein;, , GO:0005814;GO:0005813;GO:0005737;GO:0007049;GO:0051301;, C:centriole; C:centrosome; C:cytoplasm;, , P:cell cycle; P:cell division; scaffold3 indexed_genome mRNA 4547089 4565684 . - . ID=transcript_616;Q15329 E9PBN9 Q16601 Q92756,Transcription factor E2F5,, PF16421;PF02319;, GO:0000785;GO:0001650;GO:0043231;GO:0005730;GO:0005654;GO:0090575;GO:0001216;GO:0003700;GO:0000981;GO:0046983;GO:0000978;GO:0008134;GO:0030030;GO:0045944;GO:0051726;GO:0006357;, C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:cell projection organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II;|Q15329 E9PBN9 Q16601 Q92756,Transcription factor E2F5,, PF16421;PF02319;, GO:0000785;GO:0001650;GO:0043231;GO:0005730;GO:0005654;GO:0090575;GO:0001216;GO:0003700;GO:0000981;GO:0046983;GO:0000978;GO:0008134;GO:0030030;GO:0045944;GO:0051726;GO:0006357;, C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:cell projection organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II;|Q15329 E9PBN9 Q16601 Q92756,Transcription factor E2F5,, PF16421;PF02319;, GO:0000785;GO:0001650;GO:0043231;GO:0005730;GO:0005654;GO:0090575;GO:0001216;GO:0003700;GO:0000981;GO:0046983;GO:0000978;GO:0008134;GO:0030030;GO:0045944;GO:0051726;GO:0006357;, C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:cell projection organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II;|Q15329 E9PBN9 Q16601 Q92756,Transcription factor E2F5,, PF16421;PF02319;, GO:0000785;GO:0001650;GO:0043231;GO:0005730;GO:0005654;GO:0090575;GO:0001216;GO:0003700;GO:0000981;GO:0046983;GO:0000978;GO:0008134;GO:0030030;GO:0045944;GO:0051726;GO:0006357;, C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:cell projection organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II;|Q8N0T1 B2RXE7 E5RFW5,Ribosomal biogenesis factor {ECO:0000305},, PF15679;, GO:0005829;GO:0005730;GO:0005654;GO:0042254;, C:cytosol; C:nucleolus; C:nucleoplasm;, , P:ribosome biogenesis;|Q8N0T1 B2RXE7 E5RFW5,Ribosomal biogenesis factor {ECO:0000305},, PF15679;, GO:0005829;GO:0005730;GO:0005654;GO:0042254;, C:cytosol; C:nucleolus; C:nucleoplasm;, , P:ribosome biogenesis; scaffold3 indexed_genome mRNA 4573274 4574422 . - . ID=transcript_617;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold3 indexed_genome mRNA 4581585 4621332 . + . ID=transcript_618;Q8N1Q1,Carbonic anhydrase 13,Carbonate dehydratase XIII;Carbonic anhydrase XIII;, PF00194;, GO:0005737;GO:0005829;GO:0043231;GO:0043209;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:myelin sheath;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process; scaffold3 indexed_genome mRNA 4674753 4684715 . - . ID=transcript_619;P00915,Carbonic anhydrase 1,Carbonate dehydratase I;Carbonic anhydrase B;Carbonic anhydrase I;, PF00194;, GO:0005737;GO:0005829;GO:0070062;GO:0004064;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0035722;GO:0006730;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:arylesterase activity; F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:interleukin-12-mediated signaling pathway; P:one-carbon metabolic process; scaffold3 indexed_genome mRNA 4781421 4787639 . + . ID=transcript_620;P07451 B2R867 B3KUC8 O60842,Carbonic anhydrase 3,Carbonate dehydratase III;Carbonic anhydrase III;, PF00194;, GO:0005829;GO:0004089;GO:0016836;GO:0016151;GO:0016791;GO:0008270;GO:0015701;GO:0006730;GO:0009617;GO:0045471;GO:0006979;, C:cytosol;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:nickel cation binding; F:phosphatase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process; P:response to bacterium; P:response to ethanol; P:response to oxidative stress; scaffold3 indexed_genome mRNA 4805208 4820855 . + . ID=transcript_621;P00918 B2R7G8 Q6FI12 Q96ET9,Carbonic anhydrase 2,Carbonate dehydratase II;Carbonic anhydrase C;Carbonic anhydrase II;, PF00194;, GO:0045177;GO:0030424;GO:0016323;GO:0005737;GO:0005829;GO:0070062;GO:0005902;GO:0005886;GO:0004064;GO:0004089;GO:0016836;GO:0008270;GO:0038166;GO:0015701;GO:0015670;GO:0071498;GO:0001822;GO:0042475;GO:0006730;GO:0045780;GO:0032849;GO:2001150;GO:0045672;GO:0044070;GO:0051453;GO:0043627;GO:0009268;GO:0048545;GO:0010043;, C:apical part of cell; C:axon; C:basolateral plasma membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microvillus; C:plasma membrane;, F:arylesterase activity; F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:angiotensin-activated signaling pathway; P:bicarbonate transport; P:carbon dioxide transport; P:cellular response to fluid shear stress; P:kidney development; P:odontogenesis of dentin-containing tooth; P:one-carbon metabolic process; P:positive regulation of bone resorption; P:positive regulation of cellular pH reduction; P:positive regulation of dipeptide transmembrane transport; P:positive regulation of osteoclast differentiation; P:regulation of anion transport; P:regulation of intracellular pH; P:response to estrogen; P:response to pH; P:response to steroid hormone; P:response to zinc ion;|P00918 B2R7G8 Q6FI12 Q96ET9,Carbonic anhydrase 2,Carbonate dehydratase II;Carbonic anhydrase C;Carbonic anhydrase II;, PF00194;, GO:0045177;GO:0030424;GO:0016323;GO:0005737;GO:0005829;GO:0070062;GO:0005902;GO:0005886;GO:0004064;GO:0004089;GO:0016836;GO:0008270;GO:0038166;GO:0015701;GO:0015670;GO:0071498;GO:0001822;GO:0042475;GO:0006730;GO:0045780;GO:0032849;GO:2001150;GO:0045672;GO:0044070;GO:0051453;GO:0043627;GO:0009268;GO:0048545;GO:0010043;, C:apical part of cell; C:axon; C:basolateral plasma membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microvillus; C:plasma membrane;, F:arylesterase activity; F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:angiotensin-activated signaling pathway; P:bicarbonate transport; P:carbon dioxide transport; P:cellular response to fluid shear stress; P:kidney development; P:odontogenesis of dentin-containing tooth; P:one-carbon metabolic process; P:positive regulation of bone resorption; P:positive regulation of cellular pH reduction; P:positive regulation of dipeptide transmembrane transport; P:positive regulation of osteoclast differentiation; P:regulation of anion transport; P:regulation of intracellular pH; P:response to estrogen; P:response to pH; P:response to steroid hormone; P:response to zinc ion;|P00918 B2R7G8 Q6FI12 Q96ET9,Carbonic anhydrase 2,Carbonate dehydratase II;Carbonic anhydrase C;Carbonic anhydrase II;, PF00194;, GO:0045177;GO:0030424;GO:0016323;GO:0005737;GO:0005829;GO:0070062;GO:0005902;GO:0005886;GO:0004064;GO:0004089;GO:0016836;GO:0008270;GO:0038166;GO:0015701;GO:0015670;GO:0071498;GO:0001822;GO:0042475;GO:0006730;GO:0045780;GO:0032849;GO:2001150;GO:0045672;GO:0044070;GO:0051453;GO:0043627;GO:0009268;GO:0048545;GO:0010043;, C:apical part of cell; C:axon; C:basolateral plasma membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microvillus; C:plasma membrane;, F:arylesterase activity; F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:angiotensin-activated signaling pathway; P:bicarbonate transport; P:carbon dioxide transport; P:cellular response to fluid shear stress; P:kidney development; P:odontogenesis of dentin-containing tooth; P:one-carbon metabolic process; P:positive regulation of bone resorption; P:positive regulation of cellular pH reduction; P:positive regulation of dipeptide transmembrane transport; P:positive regulation of osteoclast differentiation; P:regulation of anion transport; P:regulation of intracellular pH; P:response to estrogen; P:response to pH; P:response to steroid hormone; P:response to zinc ion; scaffold3 indexed_genome mRNA 5213025 5261260 . + . ID=transcript_622;Q8N8Y2,V-type proton ATPase subunit d 2,Vacuolar proton pump subunit d 2;, PF01992;, GO:0016324;GO:0005769;GO:0010008;GO:0070062;GO:0005765;GO:0016020;GO:0030670;GO:0033181;GO:0033179;GO:0016471;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;GO:0007035;GO:0007034;, C:apical plasma membrane; C:early endosome; C:endosome membrane; C:extracellular exosome; C:lysosomal membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane proton-transporting V-type ATPase complex; C:proton-transporting V-type ATPase, V0 domain; C:vacuolar proton-transporting V-type ATPase complex;, F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification; P:vacuolar transport; scaffold3 indexed_genome mRNA 5453870 5599834 . + . ID=transcript_623;Q9H0M0 O00307 Q5YLC1 Q96BP4,NEDD4-like E3 ubiquitin-protein ligase WWP1,Atrophin-1-interacting protein 5;HECT-type E3 ubiquitin transferase WWP1;TGIF-interacting ubiquitin ligase 1;WW domain-containing protein 1;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0000151;GO:0061630;GO:0004842;GO:0007417;GO:0034220;GO:0045892;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0007165;GO:0046718;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:central nervous system development; P:ion transmembrane transport; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:signal transduction; P:viral entry into host cell;|Q9H0M0 O00307 Q5YLC1 Q96BP4,NEDD4-like E3 ubiquitin-protein ligase WWP1,Atrophin-1-interacting protein 5;HECT-type E3 ubiquitin transferase WWP1;TGIF-interacting ubiquitin ligase 1;WW domain-containing protein 1;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0000151;GO:0061630;GO:0004842;GO:0007417;GO:0034220;GO:0045892;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0007165;GO:0046718;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:central nervous system development; P:ion transmembrane transport; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:signal transduction; P:viral entry into host cell;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q96DB5 A9UMZ8 B4DNF5 B4DZW6 B5MC61 C9JSC6 E7EVI2 Q9Y398,Regulator of microtubule dynamics protein 1,Protein FAM82B;, , GO:0005737;GO:0097431;GO:0005876;GO:0008017;GO:0051315;GO:0007052;, C:cytoplasm; C:mitotic spindle pole; C:spindle microtubule;, F:microtubule binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:mitotic spindle organization;|Q96DB5 A9UMZ8 B4DNF5 B4DZW6 B5MC61 C9JSC6 E7EVI2 Q9Y398,Regulator of microtubule dynamics protein 1,Protein FAM82B;, , GO:0005737;GO:0097431;GO:0005876;GO:0008017;GO:0051315;GO:0007052;, C:cytoplasm; C:mitotic spindle pole; C:spindle microtubule;, F:microtubule binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:mitotic spindle organization; scaffold3 indexed_genome mRNA 5626731 5657404 . + . ID=transcript_624;O75131 A8KA47 Q8IYA1,Copine-3 {ECO:0000305},Copine III {ECO:0000303|PubMed:11041869, ECO:0000312|HGNC:HGNC:2316};, PF00168;PF07002;, GO:0035577;GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005544;GO:0048306;GO:0046872;GO:0004674;GO:0030971;GO:0003723;GO:0071277;GO:0071363;GO:0038128;GO:0046474;GO:0043312;GO:0030335;, C:azurophil granule membrane; C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:metal ion binding; F:protein serine/threonine kinase activity; F:receptor tyrosine kinase binding; F:RNA binding;, P:cellular response to calcium ion; P:cellular response to growth factor stimulus; P:ERBB2 signaling pathway; P:glycerophospholipid biosynthetic process; P:neutrophil degranulation; P:positive regulation of cell migration;|O75131 A8KA47 Q8IYA1,Copine-3 {ECO:0000305},Copine III {ECO:0000303|PubMed:11041869, ECO:0000312|HGNC:HGNC:2316};, PF00168;PF07002;, GO:0035577;GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005544;GO:0048306;GO:0046872;GO:0004674;GO:0030971;GO:0003723;GO:0071277;GO:0071363;GO:0038128;GO:0046474;GO:0043312;GO:0030335;, C:azurophil granule membrane; C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:metal ion binding; F:protein serine/threonine kinase activity; F:receptor tyrosine kinase binding; F:RNA binding;, P:cellular response to calcium ion; P:cellular response to growth factor stimulus; P:ERBB2 signaling pathway; P:glycerophospholipid biosynthetic process; P:neutrophil degranulation; P:positive regulation of cell migration; scaffold3 indexed_genome mRNA 5659078 5660867 . + . ID=transcript_625;O75131 A8KA47 Q8IYA1,Copine-3 {ECO:0000305},Copine III {ECO:0000303|PubMed:11041869, ECO:0000312|HGNC:HGNC:2316};, PF00168;PF07002;, GO:0035577;GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005544;GO:0048306;GO:0046872;GO:0004674;GO:0030971;GO:0003723;GO:0071277;GO:0071363;GO:0038128;GO:0046474;GO:0043312;GO:0030335;, C:azurophil granule membrane; C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:metal ion binding; F:protein serine/threonine kinase activity; F:receptor tyrosine kinase binding; F:RNA binding;, P:cellular response to calcium ion; P:cellular response to growth factor stimulus; P:ERBB2 signaling pathway; P:glycerophospholipid biosynthetic process; P:neutrophil degranulation; P:positive regulation of cell migration;|O75131 A8KA47 Q8IYA1,Copine-3 {ECO:0000305},Copine III {ECO:0000303|PubMed:11041869, ECO:0000312|HGNC:HGNC:2316};, PF00168;PF07002;, GO:0035577;GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005544;GO:0048306;GO:0046872;GO:0004674;GO:0030971;GO:0003723;GO:0071277;GO:0071363;GO:0038128;GO:0046474;GO:0043312;GO:0030335;, C:azurophil granule membrane; C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:metal ion binding; F:protein serine/threonine kinase activity; F:receptor tyrosine kinase binding; F:RNA binding;, P:cellular response to calcium ion; P:cellular response to growth factor stimulus; P:ERBB2 signaling pathway; P:glycerophospholipid biosynthetic process; P:neutrophil degranulation; P:positive regulation of cell migration; scaffold3 indexed_genome mRNA 6920200 7287084 . - . ID=transcript_626;P51512 B2RAN7 Q14824 Q52H48,Matrix metalloproteinase-16,MMP-X2;Membrane-type matrix metalloproteinase 3;Membrane-type-3 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0009986;GO:0031012;GO:0005576;GO:0005796;GO:0005887;GO:0005886;GO:0008047;GO:0070006;GO:0004222;GO:0008270;GO:0035988;GO:0030574;GO:0097094;GO:0048701;GO:0001958;GO:0022617;GO:0030198;GO:0016485;GO:0006508;GO:0001501;, C:cell surface; C:extracellular matrix; C:extracellular region; C:Golgi lumen; C:integral component of plasma membrane; C:plasma membrane;, F:enzyme activator activity; F:metalloaminopeptidase activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:chondrocyte proliferation; P:collagen catabolic process; P:craniofacial suture morphogenesis; P:embryonic cranial skeleton morphogenesis; P:endochondral ossification; P:extracellular matrix disassembly; P:extracellular matrix organization; P:protein processing; P:proteolysis; P:skeletal system development; scaffold3 indexed_genome mRNA 7679832 7719969 . + . ID=transcript_627;O43353 B7Z748 Q6UWF0,Receptor-interacting serine/threonine-protein kinase 2,CARD-containing interleukin-1 beta-converting enzyme-associated kinase;RIP-like-interacting CLARP kinase;Receptor-interacting protein 2;Tyrosine-protein kinase RIPK2;, PF00619;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0032991;GO:0031982;GO:0005524;GO:0050700;GO:0089720;GO:0042802;GO:0004706;GO:0030274;GO:0004715;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0005102;GO:0004714;GO:0097202;GO:0007257;GO:0000187;GO:0002250;GO:0006915;GO:0071223;GO:0071225;GO:0071224;GO:0050830;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0007254;GO:0031663;GO:0043066;GO:0070427;GO:0070431;GO:0070423;GO:0046641;GO:0043065;GO:0010942;GO:0032722;GO:0001961;GO:0070374;GO:0043123;GO:0033091;GO:0032727;GO:0032728;GO:0032729;GO:0032731;GO:0032735;GO:0032743;GO:0032755;GO:0046330;GO:0051092;GO:0033138;GO:0010800;GO:0050731;GO:0032092;GO:0031398;GO:0045627;GO:0002827;GO:0045944;GO:0032760;GO:1904417;GO:0043330;GO:0070671;GO:0070673;GO:0007165;GO:0042098;GO:0050852;GO:0034134;GO:0034142;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:protein-containing complex; C:vesicle;, F:ATP binding; F:CARD domain binding; F:caspase binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:LIM domain binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of cysteine-type endopeptidase activity; P:activation of JUN kinase activity; P:activation of MAPK activity; P:adaptive immune response; P:apoptotic process; P:cellular response to lipoteichoic acid; P:cellular response to muramyl dipeptide; P:cellular response to peptidoglycan; P:defense response to Gram-positive bacterium; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nucleotide-binding oligomerization domain containing 1 signaling pathway; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of chemokine production; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of immature T cell proliferation; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of T-helper 1 type immune response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of xenophagy; P:response to exogenous dsRNA; P:response to interleukin-12; P:response to interleukin-18; P:signal transduction; P:T cell proliferation; P:T cell receptor signaling pathway; P:toll-like receptor 2 signaling pathway; P:toll-like receptor 4 signaling pathway;|O43353 B7Z748 Q6UWF0,Receptor-interacting serine/threonine-protein kinase 2,CARD-containing interleukin-1 beta-converting enzyme-associated kinase;RIP-like-interacting CLARP kinase;Receptor-interacting protein 2;Tyrosine-protein kinase RIPK2;, PF00619;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0032991;GO:0031982;GO:0005524;GO:0050700;GO:0089720;GO:0042802;GO:0004706;GO:0030274;GO:0004715;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0005102;GO:0004714;GO:0097202;GO:0007257;GO:0000187;GO:0002250;GO:0006915;GO:0071223;GO:0071225;GO:0071224;GO:0050830;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0007254;GO:0031663;GO:0043066;GO:0070427;GO:0070431;GO:0070423;GO:0046641;GO:0043065;GO:0010942;GO:0032722;GO:0001961;GO:0070374;GO:0043123;GO:0033091;GO:0032727;GO:0032728;GO:0032729;GO:0032731;GO:0032735;GO:0032743;GO:0032755;GO:0046330;GO:0051092;GO:0033138;GO:0010800;GO:0050731;GO:0032092;GO:0031398;GO:0045627;GO:0002827;GO:0045944;GO:0032760;GO:1904417;GO:0043330;GO:0070671;GO:0070673;GO:0007165;GO:0042098;GO:0050852;GO:0034134;GO:0034142;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:protein-containing complex; C:vesicle;, F:ATP binding; F:CARD domain binding; F:caspase binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:LIM domain binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of cysteine-type endopeptidase activity; P:activation of JUN kinase activity; P:activation of MAPK activity; P:adaptive immune response; P:apoptotic process; P:cellular response to lipoteichoic acid; P:cellular response to muramyl dipeptide; P:cellular response to peptidoglycan; P:defense response to Gram-positive bacterium; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nucleotide-binding oligomerization domain containing 1 signaling pathway; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of chemokine production; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of immature T cell proliferation; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of T-helper 1 type immune response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of xenophagy; P:response to exogenous dsRNA; P:response to interleukin-12; P:response to interleukin-18; P:signal transduction; P:T cell proliferation; P:T cell receptor signaling pathway; P:toll-like receptor 2 signaling pathway; P:toll-like receptor 4 signaling pathway;|O43353 B7Z748 Q6UWF0,Receptor-interacting serine/threonine-protein kinase 2,CARD-containing interleukin-1 beta-converting enzyme-associated kinase;RIP-like-interacting CLARP kinase;Receptor-interacting protein 2;Tyrosine-protein kinase RIPK2;, PF00619;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0032991;GO:0031982;GO:0005524;GO:0050700;GO:0089720;GO:0042802;GO:0004706;GO:0030274;GO:0004715;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0005102;GO:0004714;GO:0097202;GO:0007257;GO:0000187;GO:0002250;GO:0006915;GO:0071223;GO:0071225;GO:0071224;GO:0050830;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0007254;GO:0031663;GO:0043066;GO:0070427;GO:0070431;GO:0070423;GO:0046641;GO:0043065;GO:0010942;GO:0032722;GO:0001961;GO:0070374;GO:0043123;GO:0033091;GO:0032727;GO:0032728;GO:0032729;GO:0032731;GO:0032735;GO:0032743;GO:0032755;GO:0046330;GO:0051092;GO:0033138;GO:0010800;GO:0050731;GO:0032092;GO:0031398;GO:0045627;GO:0002827;GO:0045944;GO:0032760;GO:1904417;GO:0043330;GO:0070671;GO:0070673;GO:0007165;GO:0042098;GO:0050852;GO:0034134;GO:0034142;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:protein-containing complex; C:vesicle;, F:ATP binding; F:CARD domain binding; F:caspase binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:LIM domain binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of cysteine-type endopeptidase activity; P:activation of JUN kinase activity; P:activation of MAPK activity; P:adaptive immune response; P:apoptotic process; P:cellular response to lipoteichoic acid; P:cellular response to muramyl dipeptide; P:cellular response to peptidoglycan; P:defense response to Gram-positive bacterium; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nucleotide-binding oligomerization domain containing 1 signaling pathway; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of chemokine production; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of immature T cell proliferation; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of T-helper 1 type immune response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of xenophagy; P:response to exogenous dsRNA; P:response to interleukin-12; P:response to interleukin-18; P:signal transduction; P:T cell proliferation; P:T cell receptor signaling pathway; P:toll-like receptor 2 signaling pathway; P:toll-like receptor 4 signaling pathway;|O43353 B7Z748 Q6UWF0,Receptor-interacting serine/threonine-protein kinase 2,CARD-containing interleukin-1 beta-converting enzyme-associated kinase;RIP-like-interacting CLARP kinase;Receptor-interacting protein 2;Tyrosine-protein kinase RIPK2;, PF00619;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0032991;GO:0031982;GO:0005524;GO:0050700;GO:0089720;GO:0042802;GO:0004706;GO:0030274;GO:0004715;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0005102;GO:0004714;GO:0097202;GO:0007257;GO:0000187;GO:0002250;GO:0006915;GO:0071223;GO:0071225;GO:0071224;GO:0050830;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0007254;GO:0031663;GO:0043066;GO:0070427;GO:0070431;GO:0070423;GO:0046641;GO:0043065;GO:0010942;GO:0032722;GO:0001961;GO:0070374;GO:0043123;GO:0033091;GO:0032727;GO:0032728;GO:0032729;GO:0032731;GO:0032735;GO:0032743;GO:0032755;GO:0046330;GO:0051092;GO:0033138;GO:0010800;GO:0050731;GO:0032092;GO:0031398;GO:0045627;GO:0002827;GO:0045944;GO:0032760;GO:1904417;GO:0043330;GO:0070671;GO:0070673;GO:0007165;GO:0042098;GO:0050852;GO:0034134;GO:0034142;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:protein-containing complex; C:vesicle;, F:ATP binding; F:CARD domain binding; F:caspase binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:LIM domain binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of cysteine-type endopeptidase activity; P:activation of JUN kinase activity; P:activation of MAPK activity; P:adaptive immune response; P:apoptotic process; P:cellular response to lipoteichoic acid; P:cellular response to muramyl dipeptide; P:cellular response to peptidoglycan; P:defense response to Gram-positive bacterium; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nucleotide-binding oligomerization domain containing 1 signaling pathway; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of chemokine production; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of immature T cell proliferation; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of T-helper 1 type immune response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of xenophagy; P:response to exogenous dsRNA; P:response to interleukin-12; P:response to interleukin-18; P:signal transduction; P:T cell proliferation; P:T cell receptor signaling pathway; P:toll-like receptor 2 signaling pathway; P:toll-like receptor 4 signaling pathway; scaffold3 indexed_genome mRNA 7791182 7808925 . + . ID=transcript_628;Q9Y236,Oxidative stress-induced growth inhibitor 2,hT41;, , GO:0008083;GO:0051321;GO:0030308;, , F:growth factor activity;, P:meiotic cell cycle; P:negative regulation of cell growth;|Q9Y236,Oxidative stress-induced growth inhibitor 2,hT41;, , GO:0008083;GO:0051321;GO:0030308;, , F:growth factor activity;, P:meiotic cell cycle; P:negative regulation of cell growth;|Q9Y236,Oxidative stress-induced growth inhibitor 2,hT41;, , GO:0008083;GO:0051321;GO:0030308;, , F:growth factor activity;, P:meiotic cell cycle; P:negative regulation of cell growth;|Q9Y236,Oxidative stress-induced growth inhibitor 2,hT41;, , GO:0008083;GO:0051321;GO:0030308;, , F:growth factor activity;, P:meiotic cell cycle; P:negative regulation of cell growth; scaffold3 indexed_genome mRNA 7814841 7872292 . - . ID=transcript_629;O60934 B2R626 B2RNC5 O60672 Q32NF7 Q53FM6 Q63HR6 Q7LDM2,Nibrin,Cell cycle regulatory protein p95;Nijmegen breakage syndrome protein 1;, PF00498;PF08599;PF16508;, GO:0000781;GO:0005829;GO:0030870;GO:0042405;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0005657;GO:0035861;GO:0003684;GO:0047485;GO:0008134;GO:0001832;GO:0007050;GO:0008283;GO:0000077;GO:0030330;GO:0000729;GO:0032508;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097193;GO:0045190;GO:0051321;GO:0007095;GO:1904354;GO:0050885;GO:0033674;GO:0031954;GO:0032206;GO:0030174;GO:1901796;GO:0042770;GO:0090656;GO:0000723;GO:0090737;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:cytosol; C:Mre11 complex; C:nuclear inclusion body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:protein N-terminus binding; F:transcription factor binding;, P:blastocyst growth; P:cell cycle arrest; P:cell population proliferation; P:DNA damage checkpoint; P:DNA damage response, signal transduction by p53 class mediator; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:intrinsic apoptotic signaling pathway; P:isotype switching; P:meiotic cell cycle; P:mitotic G2 DNA damage checkpoint; P:negative regulation of telomere capping; P:neuromuscular process controlling balance; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:regulation of DNA-dependent DNA replication initiation; P:regulation of signal transduction by p53 class mediator; P:signal transduction in response to DNA damage; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via telomere trimming; P:telomeric 3' overhang formation; P:viral process;|O60934 B2R626 B2RNC5 O60672 Q32NF7 Q53FM6 Q63HR6 Q7LDM2,Nibrin,Cell cycle regulatory protein p95;Nijmegen breakage syndrome protein 1;, PF00498;PF08599;PF16508;, GO:0000781;GO:0005829;GO:0030870;GO:0042405;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0005657;GO:0035861;GO:0003684;GO:0047485;GO:0008134;GO:0001832;GO:0007050;GO:0008283;GO:0000077;GO:0030330;GO:0000729;GO:0032508;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097193;GO:0045190;GO:0051321;GO:0007095;GO:1904354;GO:0050885;GO:0033674;GO:0031954;GO:0032206;GO:0030174;GO:1901796;GO:0042770;GO:0090656;GO:0000723;GO:0090737;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:cytosol; C:Mre11 complex; C:nuclear inclusion body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:protein N-terminus binding; F:transcription factor binding;, P:blastocyst growth; P:cell cycle arrest; P:cell population proliferation; P:DNA damage checkpoint; P:DNA damage response, signal transduction by p53 class mediator; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:intrinsic apoptotic signaling pathway; P:isotype switching; P:meiotic cell cycle; P:mitotic G2 DNA damage checkpoint; P:negative regulation of telomere capping; P:neuromuscular process controlling balance; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:regulation of DNA-dependent DNA replication initiation; P:regulation of signal transduction by p53 class mediator; P:signal transduction in response to DNA damage; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via telomere trimming; P:telomeric 3' overhang formation; P:viral process;|O60934 B2R626 B2RNC5 O60672 Q32NF7 Q53FM6 Q63HR6 Q7LDM2,Nibrin,Cell cycle regulatory protein p95;Nijmegen breakage syndrome protein 1;, PF00498;PF08599;PF16508;, GO:0000781;GO:0005829;GO:0030870;GO:0042405;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0005657;GO:0035861;GO:0003684;GO:0047485;GO:0008134;GO:0001832;GO:0007050;GO:0008283;GO:0000077;GO:0030330;GO:0000729;GO:0032508;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097193;GO:0045190;GO:0051321;GO:0007095;GO:1904354;GO:0050885;GO:0033674;GO:0031954;GO:0032206;GO:0030174;GO:1901796;GO:0042770;GO:0090656;GO:0000723;GO:0090737;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:cytosol; C:Mre11 complex; C:nuclear inclusion body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:protein N-terminus binding; F:transcription factor binding;, P:blastocyst growth; P:cell cycle arrest; P:cell population proliferation; P:DNA damage checkpoint; P:DNA damage response, signal transduction by p53 class mediator; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:intrinsic apoptotic signaling pathway; P:isotype switching; P:meiotic cell cycle; P:mitotic G2 DNA damage checkpoint; P:negative regulation of telomere capping; P:neuromuscular process controlling balance; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:regulation of DNA-dependent DNA replication initiation; P:regulation of signal transduction by p53 class mediator; P:signal transduction in response to DNA damage; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via telomere trimming; P:telomeric 3' overhang formation; P:viral process;|O60934 B2R626 B2RNC5 O60672 Q32NF7 Q53FM6 Q63HR6 Q7LDM2,Nibrin,Cell cycle regulatory protein p95;Nijmegen breakage syndrome protein 1;, PF00498;PF08599;PF16508;, GO:0000781;GO:0005829;GO:0030870;GO:0042405;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0005657;GO:0035861;GO:0003684;GO:0047485;GO:0008134;GO:0001832;GO:0007050;GO:0008283;GO:0000077;GO:0030330;GO:0000729;GO:0032508;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097193;GO:0045190;GO:0051321;GO:0007095;GO:1904354;GO:0050885;GO:0033674;GO:0031954;GO:0032206;GO:0030174;GO:1901796;GO:0042770;GO:0090656;GO:0000723;GO:0090737;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:cytosol; C:Mre11 complex; C:nuclear inclusion body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:protein N-terminus binding; F:transcription factor binding;, P:blastocyst growth; P:cell cycle arrest; P:cell population proliferation; P:DNA damage checkpoint; P:DNA damage response, signal transduction by p53 class mediator; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:intrinsic apoptotic signaling pathway; P:isotype switching; P:meiotic cell cycle; P:mitotic G2 DNA damage checkpoint; P:negative regulation of telomere capping; P:neuromuscular process controlling balance; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:regulation of DNA-dependent DNA replication initiation; P:regulation of signal transduction by p53 class mediator; P:signal transduction in response to DNA damage; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via telomere trimming; P:telomeric 3' overhang formation; P:viral process; scaffold3 indexed_genome mRNA 7896423 7943837 . + . ID=transcript_630;Q16698 B7Z6B8 Q2M304 Q93085,2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial,2,4-dienoyl-CoA reductase [NADPH];Short chain dehydrogenase/reductase family 18C member 1;, , GO:1902494;GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0008670;GO:0042802;GO:0070402;GO:0006635;GO:0120162;, C:catalytic complex; C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:2,4-dienoyl-CoA reductase (NADPH) activity; F:identical protein binding; F:NADPH binding;, P:fatty acid beta-oxidation; P:positive regulation of cold-induced thermogenesis;|Q16698 B7Z6B8 Q2M304 Q93085,2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial,2,4-dienoyl-CoA reductase [NADPH];Short chain dehydrogenase/reductase family 18C member 1;, , GO:1902494;GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0008670;GO:0042802;GO:0070402;GO:0006635;GO:0120162;, C:catalytic complex; C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:2,4-dienoyl-CoA reductase (NADPH) activity; F:identical protein binding; F:NADPH binding;, P:fatty acid beta-oxidation; P:positive regulation of cold-induced thermogenesis; scaffold3 indexed_genome mRNA 7953044 7974765 . - . ID=transcript_631;P05937 B2R696 B7Z9J4,Calbindin,Calbindin D28;D-28K;Vitamin D-dependent calcium-binding protein, avian-type;, PF00036;PF13499;, GO:0030424;GO:0044305;GO:0032437;GO:0005829;GO:0030425;GO:0043197;GO:0070062;GO:0098982;GO:0098978;GO:0098686;GO:0043005;GO:0043025;GO:0005634;GO:0099524;GO:0099523;GO:0032420;GO:0045202;GO:0043195;GO:0005509;GO:0099567;GO:0099534;GO:0005499;GO:0008270;GO:1990000;GO:0071310;GO:0090102;GO:0007626;GO:0007616;GO:0072205;GO:0072286;GO:0072221;GO:0035502;GO:0051480;GO:1900271;GO:0099509;GO:0010842;GO:0007614;, C:axon; C:calyx of Held; C:cuticular plate; C:cytosol; C:dendrite; C:dendritic spine; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:neuron projection; C:neuronal cell body; C:nucleus; C:postsynaptic cytosol; C:presynaptic cytosol; C:stereocilium; C:synapse; C:terminal bouton;, F:calcium ion binding; F:calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration; F:vitamin D binding; F:zinc ion binding;, P:amyloid fibril formation; P:cellular response to organic substance; P:cochlea development; P:locomotory behavior; P:long-term memory; P:metanephric collecting duct development; P:metanephric connecting tubule development; P:metanephric distal convoluted tubule development; P:metanephric part of ureteric bud development; P:regulation of cytosolic calcium ion concentration; P:regulation of long-term synaptic potentiation; P:regulation of presynaptic cytosolic calcium ion concentration; P:retina layer formation; P:short-term memory;|P05937 B2R696 B7Z9J4,Calbindin,Calbindin D28;D-28K;Vitamin D-dependent calcium-binding protein, avian-type;, PF00036;PF13499;, GO:0030424;GO:0044305;GO:0032437;GO:0005829;GO:0030425;GO:0043197;GO:0070062;GO:0098982;GO:0098978;GO:0098686;GO:0043005;GO:0043025;GO:0005634;GO:0099524;GO:0099523;GO:0032420;GO:0045202;GO:0043195;GO:0005509;GO:0099567;GO:0099534;GO:0005499;GO:0008270;GO:1990000;GO:0071310;GO:0090102;GO:0007626;GO:0007616;GO:0072205;GO:0072286;GO:0072221;GO:0035502;GO:0051480;GO:1900271;GO:0099509;GO:0010842;GO:0007614;, C:axon; C:calyx of Held; C:cuticular plate; C:cytosol; C:dendrite; C:dendritic spine; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:neuron projection; C:neuronal cell body; C:nucleus; C:postsynaptic cytosol; C:presynaptic cytosol; C:stereocilium; C:synapse; C:terminal bouton;, F:calcium ion binding; F:calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration; F:vitamin D binding; F:zinc ion binding;, P:amyloid fibril formation; P:cellular response to organic substance; P:cochlea development; P:locomotory behavior; P:long-term memory; P:metanephric collecting duct development; P:metanephric connecting tubule development; P:metanephric distal convoluted tubule development; P:metanephric part of ureteric bud development; P:regulation of cytosolic calcium ion concentration; P:regulation of long-term synaptic potentiation; P:regulation of presynaptic cytosolic calcium ion concentration; P:retina layer formation; P:short-term memory;|P05937 B2R696 B7Z9J4,Calbindin,Calbindin D28;D-28K;Vitamin D-dependent calcium-binding protein, avian-type;, PF00036;PF13499;, GO:0030424;GO:0044305;GO:0032437;GO:0005829;GO:0030425;GO:0043197;GO:0070062;GO:0098982;GO:0098978;GO:0098686;GO:0043005;GO:0043025;GO:0005634;GO:0099524;GO:0099523;GO:0032420;GO:0045202;GO:0043195;GO:0005509;GO:0099567;GO:0099534;GO:0005499;GO:0008270;GO:1990000;GO:0071310;GO:0090102;GO:0007626;GO:0007616;GO:0072205;GO:0072286;GO:0072221;GO:0035502;GO:0051480;GO:1900271;GO:0099509;GO:0010842;GO:0007614;, C:axon; C:calyx of Held; C:cuticular plate; C:cytosol; C:dendrite; C:dendritic spine; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:neuron projection; C:neuronal cell body; C:nucleus; C:postsynaptic cytosol; C:presynaptic cytosol; C:stereocilium; C:synapse; C:terminal bouton;, F:calcium ion binding; F:calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration; F:vitamin D binding; F:zinc ion binding;, P:amyloid fibril formation; P:cellular response to organic substance; P:cochlea development; P:locomotory behavior; P:long-term memory; P:metanephric collecting duct development; P:metanephric connecting tubule development; P:metanephric distal convoluted tubule development; P:metanephric part of ureteric bud development; P:regulation of cytosolic calcium ion concentration; P:regulation of long-term synaptic potentiation; P:regulation of presynaptic cytosolic calcium ion concentration; P:retina layer formation; P:short-term memory; scaffold3 indexed_genome mRNA 8120168 8149598 . - . ID=transcript_632;P0DMB2,Uncharacterized protein C8orf88,, , GO:0005737;GO:0008190;GO:0045947;, C:cytoplasm;, F:eukaryotic initiation factor 4E binding;, P:negative regulation of translational initiation; scaffold3 indexed_genome mRNA 8162523 8228086 . - . ID=transcript_633;Q8N4L2 B2R9H4 Q68CU2,Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase,PtdIns-4,5-P2 4-Ptase II;Transmembrane protein 55A;, PF09788;, GO:0016021;GO:0031902;GO:0005765;GO:0030670;GO:0005886;GO:0034597;GO:0050765;GO:0046856;, C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:phagocytic vesicle membrane; C:plasma membrane;, F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:negative regulation of phagocytosis; P:phosphatidylinositol dephosphorylation; scaffold3 indexed_genome mRNA 8259185 8344182 . + . ID=transcript_634;Q8N6M0 A8K6I1 B4DEY0 Q9NTA4 Q9Y387,Deubiquitinase OTUD6B {ECO:0000305},DUBA-5;OTU domain-containing protein 6B {ECO:0000312|HGNC:HGNC:24281};, PF02338;, GO:0008234;GO:0004843;GO:0008283;GO:0017148;GO:0045727;GO:0043248;GO:0016579;, , F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:negative regulation of translation; P:positive regulation of translation; P:proteasome assembly; P:protein deubiquitination;|Q8N6M0 A8K6I1 B4DEY0 Q9NTA4 Q9Y387,Deubiquitinase OTUD6B {ECO:0000305},DUBA-5;OTU domain-containing protein 6B {ECO:0000312|HGNC:HGNC:24281};, PF02338;, GO:0008234;GO:0004843;GO:0008283;GO:0017148;GO:0045727;GO:0043248;GO:0016579;, , F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:negative regulation of translation; P:positive regulation of translation; P:proteasome assembly; P:protein deubiquitination;|Q8N6M0 A8K6I1 B4DEY0 Q9NTA4 Q9Y387,Deubiquitinase OTUD6B {ECO:0000305},DUBA-5;OTU domain-containing protein 6B {ECO:0000312|HGNC:HGNC:24281};, PF02338;, GO:0008234;GO:0004843;GO:0008283;GO:0017148;GO:0045727;GO:0043248;GO:0016579;, , F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:negative regulation of translation; P:positive regulation of translation; P:proteasome assembly; P:protein deubiquitination;|Q6ZNQ3,Leucine-rich repeat-containing protein 69,, PF13855;, GO:0007165;, , , P:signal transduction; scaffold3 indexed_genome mRNA 8470707 8514182 . + . ID=transcript_635;Q8TE54 Q24JS8 Q8TE53 Q96RN2,Anion exchange transporter,Solute carrier family 26 member 7;, PF01740;PF00916;, GO:0016323;GO:0005737;GO:0005768;GO:0005887;GO:0005886;GO:0055038;GO:0015301;GO:0015106;GO:0005254;GO:0015108;GO:0019531;GO:0008271;GO:0015116;GO:0006820;GO:0015701;GO:0006821;GO:0001696;GO:0006811;GO:0019532;GO:0008272;, C:basolateral plasma membrane; C:cytoplasm; C:endosome; C:integral component of plasma membrane; C:plasma membrane; C:recycling endosome membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride channel activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:anion transport; P:bicarbonate transport; P:chloride transport; P:gastric acid secretion; P:ion transport; P:oxalate transport; P:sulfate transport; scaffold3 indexed_genome mRNA 9049251 9109633 . - . ID=transcript_636;Q6IBL1 Q6NXH1 Q7Z4J5 Q92479 Q9BRZ0,Protein CBFA2T1,Cyclin-D-related protein;Eight twenty one protein;Protein ETO;Protein MTG8;Zinc finger MYND domain-containing protein 2;, PF08788;PF07531;PF01753;, GO:0016363;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003714;GO:0045599;GO:0045892;GO:0006351;, C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription corepressor activity;, P:negative regulation of fat cell differentiation; P:negative regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q6IBL1 Q6NXH1 Q7Z4J5 Q92479 Q9BRZ0,Protein CBFA2T1,Cyclin-D-related protein;Eight twenty one protein;Protein ETO;Protein MTG8;Zinc finger MYND domain-containing protein 2;, PF08788;PF07531;PF01753;, GO:0016363;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003714;GO:0045599;GO:0045892;GO:0006351;, C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription corepressor activity;, P:negative regulation of fat cell differentiation; P:negative regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q6IBL1 Q6NXH1 Q7Z4J5 Q92479 Q9BRZ0,Protein CBFA2T1,Cyclin-D-related protein;Eight twenty one protein;Protein ETO;Protein MTG8;Zinc finger MYND domain-containing protein 2;, PF08788;PF07531;PF01753;, GO:0016363;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003714;GO:0045599;GO:0045892;GO:0006351;, C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription corepressor activity;, P:negative regulation of fat cell differentiation; P:negative regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q6IBL1 Q6NXH1 Q7Z4J5 Q92479 Q9BRZ0,Protein CBFA2T1,Cyclin-D-related protein;Eight twenty one protein;Protein ETO;Protein MTG8;Zinc finger MYND domain-containing protein 2;, PF08788;PF07531;PF01753;, GO:0016363;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003714;GO:0045599;GO:0045892;GO:0006351;, C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription corepressor activity;, P:negative regulation of fat cell differentiation; P:negative regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q6IBL1 Q6NXH1 Q7Z4J5 Q92479 Q9BRZ0,Protein CBFA2T1,Cyclin-D-related protein;Eight twenty one protein;Protein ETO;Protein MTG8;Zinc finger MYND domain-containing protein 2;, PF08788;PF07531;PF01753;, GO:0016363;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003714;GO:0045599;GO:0045892;GO:0006351;, C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription corepressor activity;, P:negative regulation of fat cell differentiation; P:negative regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q6IBL1 Q6NXH1 Q7Z4J5 Q92479 Q9BRZ0,Protein CBFA2T1,Cyclin-D-related protein;Eight twenty one protein;Protein ETO;Protein MTG8;Zinc finger MYND domain-containing protein 2;, PF08788;PF07531;PF01753;, GO:0016363;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003714;GO:0045599;GO:0045892;GO:0006351;, C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription corepressor activity;, P:negative regulation of fat cell differentiation; P:negative regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q6IBL1 Q6NXH1 Q7Z4J5 Q92479 Q9BRZ0,Protein CBFA2T1,Cyclin-D-related protein;Eight twenty one protein;Protein ETO;Protein MTG8;Zinc finger MYND domain-containing protein 2;, PF08788;PF07531;PF01753;, GO:0016363;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003714;GO:0045599;GO:0045892;GO:0006351;, C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription corepressor activity;, P:negative regulation of fat cell differentiation; P:negative regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q6IBL1 Q6NXH1 Q7Z4J5 Q92479 Q9BRZ0,Protein CBFA2T1,Cyclin-D-related protein;Eight twenty one protein;Protein ETO;Protein MTG8;Zinc finger MYND domain-containing protein 2;, PF08788;PF07531;PF01753;, GO:0016363;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003714;GO:0045599;GO:0045892;GO:0006351;, C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription corepressor activity;, P:negative regulation of fat cell differentiation; P:negative regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold3 indexed_genome mRNA 10002674 10011417 . - . ID=transcript_637;Q629K1,Triple QxxK/R motif-containing protein,Triple repetitive-sequence of QXXK/R protein homolog;, PF15168;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane; scaffold3 indexed_genome mRNA 10787225 10819357 . + . ID=transcript_638;A1XBS5 A1XBS4 Q32ND3 Q6AHW7 Q8N8R1 Q96L09,Protein FAM92A,, PF06730;, GO:0005814;GO:0036064;GO:0097546;GO:0035869;GO:0005737;GO:0005743;GO:0005634;GO:0005543;GO:0060271;GO:0007007;GO:0035108;GO:0061024;GO:0045880;, C:centriole; C:ciliary basal body; C:ciliary base; C:ciliary transition zone; C:cytoplasm; C:mitochondrial inner membrane; C:nucleus;, F:phospholipid binding;, P:cilium assembly; P:inner mitochondrial membrane organization; P:limb morphogenesis; P:membrane organization; P:positive regulation of smoothened signaling pathway;|A1XBS5 A1XBS4 Q32ND3 Q6AHW7 Q8N8R1 Q96L09,Protein FAM92A,, PF06730;, GO:0005814;GO:0036064;GO:0097546;GO:0035869;GO:0005737;GO:0005743;GO:0005634;GO:0005543;GO:0060271;GO:0007007;GO:0035108;GO:0061024;GO:0045880;, C:centriole; C:ciliary basal body; C:ciliary base; C:ciliary transition zone; C:cytoplasm; C:mitochondrial inner membrane; C:nucleus;, F:phospholipid binding;, P:cilium assembly; P:inner mitochondrial membrane organization; P:limb morphogenesis; P:membrane organization; P:positive regulation of smoothened signaling pathway;|A1XBS5 A1XBS4 Q32ND3 Q6AHW7 Q8N8R1 Q96L09,Protein FAM92A,, PF06730;, GO:0005814;GO:0036064;GO:0097546;GO:0035869;GO:0005737;GO:0005743;GO:0005634;GO:0005543;GO:0060271;GO:0007007;GO:0035108;GO:0061024;GO:0045880;, C:centriole; C:ciliary basal body; C:ciliary base; C:ciliary transition zone; C:cytoplasm; C:mitochondrial inner membrane; C:nucleus;, F:phospholipid binding;, P:cilium assembly; P:inner mitochondrial membrane organization; P:limb morphogenesis; P:membrane organization; P:positive regulation of smoothened signaling pathway;|A1XBS5 A1XBS4 Q32ND3 Q6AHW7 Q8N8R1 Q96L09,Protein FAM92A,, PF06730;, GO:0005814;GO:0036064;GO:0097546;GO:0035869;GO:0005737;GO:0005743;GO:0005634;GO:0005543;GO:0060271;GO:0007007;GO:0035108;GO:0061024;GO:0045880;, C:centriole; C:ciliary basal body; C:ciliary base; C:ciliary transition zone; C:cytoplasm; C:mitochondrial inner membrane; C:nucleus;, F:phospholipid binding;, P:cilium assembly; P:inner mitochondrial membrane organization; P:limb morphogenesis; P:membrane organization; P:positive regulation of smoothened signaling pathway;|Q8IXT5 A8MYB5,RNA-binding protein 12B,RNA-binding motif protein 12B;, PF00076;, GO:0005654;GO:1990904;GO:0003723;GO:0043484;, C:nucleoplasm; C:ribonucleoprotein complex;, F:RNA binding;, P:regulation of RNA splicing; scaffold3 indexed_genome mRNA 10819362 10824769 . + . ID=transcript_639;Q8IXT5 A8MYB5,RNA-binding protein 12B,RNA-binding motif protein 12B;, PF00076;, GO:0005654;GO:1990904;GO:0003723;GO:0043484;, C:nucleoplasm; C:ribonucleoprotein complex;, F:RNA binding;, P:regulation of RNA splicing; scaffold3 indexed_genome mRNA 10855013 10897420 . + . ID=transcript_640;Q5HYA8 B3KRU5 B3KT47 G5E9H2 Q3ZCX3 Q7Z5T8 Q8IZ06,Meckelin,Meckel syndrome type 3 protein;Transmembrane protein 67;, PF09773;, GO:0005813;GO:0060170;GO:0035869;GO:0030659;GO:0005789;GO:0016021;GO:0036038;GO:0031005;GO:0051082;GO:0097711;GO:0060271;GO:0010826;GO:0030433;, C:centrosome; C:ciliary membrane; C:ciliary transition zone; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:MKS complex;, F:filamin binding; F:unfolded protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:negative regulation of centrosome duplication; P:ubiquitin-dependent ERAD pathway;|Q5HYA8 B3KRU5 B3KT47 G5E9H2 Q3ZCX3 Q7Z5T8 Q8IZ06,Meckelin,Meckel syndrome type 3 protein;Transmembrane protein 67;, PF09773;, GO:0005813;GO:0060170;GO:0035869;GO:0030659;GO:0005789;GO:0016021;GO:0036038;GO:0031005;GO:0051082;GO:0097711;GO:0060271;GO:0010826;GO:0030433;, C:centrosome; C:ciliary membrane; C:ciliary transition zone; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:MKS complex;, F:filamin binding; F:unfolded protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:negative regulation of centrosome duplication; P:ubiquitin-dependent ERAD pathway;|Q5HYA8 B3KRU5 B3KT47 G5E9H2 Q3ZCX3 Q7Z5T8 Q8IZ06,Meckelin,Meckel syndrome type 3 protein;Transmembrane protein 67;, PF09773;, GO:0005813;GO:0060170;GO:0035869;GO:0030659;GO:0005789;GO:0016021;GO:0036038;GO:0031005;GO:0051082;GO:0097711;GO:0060271;GO:0010826;GO:0030433;, C:centrosome; C:ciliary membrane; C:ciliary transition zone; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:MKS complex;, F:filamin binding; F:unfolded protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:negative regulation of centrosome duplication; P:ubiquitin-dependent ERAD pathway;|Q5HYA8 B3KRU5 B3KT47 G5E9H2 Q3ZCX3 Q7Z5T8 Q8IZ06,Meckelin,Meckel syndrome type 3 protein;Transmembrane protein 67;, PF09773;, GO:0005813;GO:0060170;GO:0035869;GO:0030659;GO:0005789;GO:0016021;GO:0036038;GO:0031005;GO:0051082;GO:0097711;GO:0060271;GO:0010826;GO:0030433;, C:centrosome; C:ciliary membrane; C:ciliary transition zone; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:MKS complex;, F:filamin binding; F:unfolded protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:negative regulation of centrosome duplication; P:ubiquitin-dependent ERAD pathway;|Q5HYA8 B3KRU5 B3KT47 G5E9H2 Q3ZCX3 Q7Z5T8 Q8IZ06,Meckelin,Meckel syndrome type 3 protein;Transmembrane protein 67;, PF09773;, GO:0005813;GO:0060170;GO:0035869;GO:0030659;GO:0005789;GO:0016021;GO:0036038;GO:0031005;GO:0051082;GO:0097711;GO:0060271;GO:0010826;GO:0030433;, C:centrosome; C:ciliary membrane; C:ciliary transition zone; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:MKS complex;, F:filamin binding; F:unfolded protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:negative regulation of centrosome duplication; P:ubiquitin-dependent ERAD pathway;|Q5HYA8 B3KRU5 B3KT47 G5E9H2 Q3ZCX3 Q7Z5T8 Q8IZ06,Meckelin,Meckel syndrome type 3 protein;Transmembrane protein 67;, PF09773;, GO:0005813;GO:0060170;GO:0035869;GO:0030659;GO:0005789;GO:0016021;GO:0036038;GO:0031005;GO:0051082;GO:0097711;GO:0060271;GO:0010826;GO:0030433;, C:centrosome; C:ciliary membrane; C:ciliary transition zone; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:MKS complex;, F:filamin binding; F:unfolded protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:negative regulation of centrosome duplication; P:ubiquitin-dependent ERAD pathway;|Q5HYA8 B3KRU5 B3KT47 G5E9H2 Q3ZCX3 Q7Z5T8 Q8IZ06,Meckelin,Meckel syndrome type 3 protein;Transmembrane protein 67;, PF09773;, GO:0005813;GO:0060170;GO:0035869;GO:0030659;GO:0005789;GO:0016021;GO:0036038;GO:0031005;GO:0051082;GO:0097711;GO:0060271;GO:0010826;GO:0030433;, C:centrosome; C:ciliary membrane; C:ciliary transition zone; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:MKS complex;, F:filamin binding; F:unfolded protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:negative regulation of centrosome duplication; P:ubiquitin-dependent ERAD pathway;|Q5HYA8 B3KRU5 B3KT47 G5E9H2 Q3ZCX3 Q7Z5T8 Q8IZ06,Meckelin,Meckel syndrome type 3 protein;Transmembrane protein 67;, PF09773;, GO:0005813;GO:0060170;GO:0035869;GO:0030659;GO:0005789;GO:0016021;GO:0036038;GO:0031005;GO:0051082;GO:0097711;GO:0060271;GO:0010826;GO:0030433;, C:centrosome; C:ciliary membrane; C:ciliary transition zone; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:MKS complex;, F:filamin binding; F:unfolded protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:negative regulation of centrosome duplication; P:ubiquitin-dependent ERAD pathway;|Q5HYA8 B3KRU5 B3KT47 G5E9H2 Q3ZCX3 Q7Z5T8 Q8IZ06,Meckelin,Meckel syndrome type 3 protein;Transmembrane protein 67;, PF09773;, GO:0005813;GO:0060170;GO:0035869;GO:0030659;GO:0005789;GO:0016021;GO:0036038;GO:0031005;GO:0051082;GO:0097711;GO:0060271;GO:0010826;GO:0030433;, C:centrosome; C:ciliary membrane; C:ciliary transition zone; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:MKS complex;, F:filamin binding; F:unfolded protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:negative regulation of centrosome duplication; P:ubiquitin-dependent ERAD pathway; scaffold3 indexed_genome mRNA 10988322 10989969 . + . ID=transcript_641;Q9P0J1 B3KX71 J3KPU0 Q5U5K1,[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial,Protein phosphatase 2C;Pyruvate dehydrogenase phosphatase catalytic subunit 1;, PF00481;, GO:0005759;GO:0005739;GO:0004741;GO:0004724;GO:0046872;GO:0004722;GO:0035970;GO:1904184;GO:0006470;GO:0010510;, C:mitochondrial matrix; C:mitochondrion;, F:[pyruvate dehydrogenase (lipoamide)] phosphatase activity; F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:protein serine/threonine phosphatase activity;, P:peptidyl-threonine dephosphorylation; P:positive regulation of pyruvate dehydrogenase activity; P:protein dephosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; scaffold3 indexed_genome mRNA 11254894 11268010 . - . ID=transcript_642;P55040 B2RA31,GTP-binding protein GEM,GTP-binding mitogen-induced T-cell protein;RAS-like protein KIR;, PF00071;, GO:0009898;GO:0030496;GO:0072686;GO:0005634;GO:0005886;GO:0051233;GO:0005246;GO:0005516;GO:0019003;GO:0005525;GO:0003924;GO:0000287;GO:0007166;GO:0051276;GO:0006955;GO:0051310;GO:0000278;GO:1901842;GO:0007165;, C:cytoplasmic side of plasma membrane; C:midbody; C:mitotic spindle; C:nucleus; C:plasma membrane; C:spindle midzone;, F:calcium channel regulator activity; F:calmodulin binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:magnesium ion binding;, P:cell surface receptor signaling pathway; P:chromosome organization; P:immune response; P:metaphase plate congression; P:mitotic cell cycle; P:negative regulation of high voltage-gated calcium channel activity; P:signal transduction;|P55040 B2RA31,GTP-binding protein GEM,GTP-binding mitogen-induced T-cell protein;RAS-like protein KIR;, PF00071;, GO:0009898;GO:0030496;GO:0072686;GO:0005634;GO:0005886;GO:0051233;GO:0005246;GO:0005516;GO:0019003;GO:0005525;GO:0003924;GO:0000287;GO:0007166;GO:0051276;GO:0006955;GO:0051310;GO:0000278;GO:1901842;GO:0007165;, C:cytoplasmic side of plasma membrane; C:midbody; C:mitotic spindle; C:nucleus; C:plasma membrane; C:spindle midzone;, F:calcium channel regulator activity; F:calmodulin binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:magnesium ion binding;, P:cell surface receptor signaling pathway; P:chromosome organization; P:immune response; P:metaphase plate congression; P:mitotic cell cycle; P:negative regulation of high voltage-gated calcium channel activity; P:signal transduction; scaffold3 indexed_genome mRNA 11361475 11413242 . - . ID=transcript_643;Q9Y620 F6WBS8,DNA repair and recombination protein RAD54B,RAD54 homolog B;, PF00271;PF00176;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0015616;GO:0070615;GO:0003724;GO:0008340;GO:0000724;GO:0006312;GO:0007131;GO:0042493;GO:0010212;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:nucleosome-dependent ATPase activity; F:RNA helicase activity;, P:determination of adult lifespan; P:double-strand break repair via homologous recombination; P:mitotic recombination; P:reciprocal meiotic recombination; P:response to drug; P:response to ionizing radiation; scaffold3 indexed_genome mRNA 11429323 11434945 . - . ID=transcript_644;O95073 Q8N4S5,Fibrinogen silencer-binding protein,, PF13873;, GO:0005654;GO:0005634;GO:0042802;, C:nucleoplasm; C:nucleus;, F:identical protein binding; scaffold3 indexed_genome mRNA 11484203 11547309 . - . ID=transcript_645;Q9P2B8 Q9UFW1,Protein virilizer homolog {ECO:0000305},, PF15912;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0036396;GO:0003723;GO:0110104;GO:0080009;GO:0006397;GO:0007275;GO:0008380;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:RNA binding;, P:mRNA alternative polyadenylation; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:RNA splicing;|Q9P2B8 Q9UFW1,Protein virilizer homolog {ECO:0000305},, PF15912;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0036396;GO:0003723;GO:0110104;GO:0080009;GO:0006397;GO:0007275;GO:0008380;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:RNA binding;, P:mRNA alternative polyadenylation; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:RNA splicing;|Q9P2B8 Q9UFW1,Protein virilizer homolog {ECO:0000305},, PF15912;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0036396;GO:0003723;GO:0110104;GO:0080009;GO:0006397;GO:0007275;GO:0008380;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:RNA binding;, P:mRNA alternative polyadenylation; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:RNA splicing;|Q9P2B8 Q9UFW1,Protein virilizer homolog {ECO:0000305},, PF15912;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0036396;GO:0003723;GO:0110104;GO:0080009;GO:0006397;GO:0007275;GO:0008380;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:RNA binding;, P:mRNA alternative polyadenylation; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:RNA splicing;|Q9P2B8 Q9UFW1,Protein virilizer homolog {ECO:0000305},, PF15912;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0036396;GO:0003723;GO:0110104;GO:0080009;GO:0006397;GO:0007275;GO:0008380;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:RNA binding;, P:mRNA alternative polyadenylation; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:RNA splicing;|Q9P2B8 Q9UFW1,Protein virilizer homolog {ECO:0000305},, PF15912;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0036396;GO:0003723;GO:0110104;GO:0080009;GO:0006397;GO:0007275;GO:0008380;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:RNA binding;, P:mRNA alternative polyadenylation; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:RNA splicing;|Q9P2B8 Q9UFW1,Protein virilizer homolog {ECO:0000305},, PF15912;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0036396;GO:0003723;GO:0110104;GO:0080009;GO:0006397;GO:0007275;GO:0008380;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:RNA binding;, P:mRNA alternative polyadenylation; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:RNA splicing;|Q9P2B8 Q9UFW1,Protein virilizer homolog {ECO:0000305},, PF15912;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0036396;GO:0003723;GO:0110104;GO:0080009;GO:0006397;GO:0007275;GO:0008380;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:RNA binding;, P:mRNA alternative polyadenylation; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:RNA splicing;|Q9P2B8 Q9UFW1,Protein virilizer homolog {ECO:0000305},, PF15912;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0036396;GO:0003723;GO:0110104;GO:0080009;GO:0006397;GO:0007275;GO:0008380;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:RNA binding;, P:mRNA alternative polyadenylation; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:RNA splicing;|Q9P2B8 Q9UFW1,Protein virilizer homolog {ECO:0000305},, PF15912;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0036396;GO:0003723;GO:0110104;GO:0080009;GO:0006397;GO:0007275;GO:0008380;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:RNA binding;, P:mRNA alternative polyadenylation; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:RNA splicing; scaffold3 indexed_genome mRNA 11636021 11693453 . - . ID=transcript_646;Q6NXG1 A6NHA8 A8MPX1 E9PB47 Q2M2B0 Q499G3 Q6PJ86 Q9NXL8,Epithelial splicing regulatory protein 1,RNA-binding motif protein 35A;RNA-binding protein 35A;, , GO:0016604;GO:0005654;GO:0005634;GO:1990904;GO:0003729;GO:0003723;GO:0008543;GO:0006397;GO:0042669;GO:0043484;GO:0008380;, C:nuclear body; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding;, P:fibroblast growth factor receptor signaling pathway; P:mRNA processing; P:regulation of inner ear auditory receptor cell fate specification; P:regulation of RNA splicing; P:RNA splicing; scaffold3 indexed_genome mRNA 11712195 11774626 . + . ID=transcript_647;Q7Z388 Q6ZW32 Q6ZW42 Q7Z329,Probable C-mannosyltransferase DPY19L4,Dpy-19-like protein 4;Protein dpy-19 homolog 4;, PF10034;, GO:0016021;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;|Q7Z388 Q6ZW32 Q6ZW42 Q7Z329,Probable C-mannosyltransferase DPY19L4,Dpy-19-like protein 4;Protein dpy-19 homolog 4;, PF10034;, GO:0016021;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;|Q7Z388 Q6ZW32 Q6ZW42 Q7Z329,Probable C-mannosyltransferase DPY19L4,Dpy-19-like protein 4;Protein dpy-19 homolog 4;, PF10034;, GO:0016021;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan; scaffold3 indexed_genome mRNA 11791383 11845995 . + . ID=transcript_648;Q75QN2 B2RN92 Q5RKZ3 Q6P1R5 Q7Z314 Q9NVS6 Q9NWY7,Integrator complex subunit 8,Protein kaonashi-1;, , GO:0032039;GO:0005654;GO:0034472;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q75QN2 B2RN92 Q5RKZ3 Q6P1R5 Q7Z314 Q9NVS6 Q9NWY7,Integrator complex subunit 8,Protein kaonashi-1;, , GO:0032039;GO:0005654;GO:0034472;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q75QN2 B2RN92 Q5RKZ3 Q6P1R5 Q7Z314 Q9NVS6 Q9NWY7,Integrator complex subunit 8,Protein kaonashi-1;, , GO:0032039;GO:0005654;GO:0034472;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q75QN2 B2RN92 Q5RKZ3 Q6P1R5 Q7Z314 Q9NVS6 Q9NWY7,Integrator complex subunit 8,Protein kaonashi-1;, , GO:0032039;GO:0005654;GO:0034472;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q75QN2 B2RN92 Q5RKZ3 Q6P1R5 Q7Z314 Q9NVS6 Q9NWY7,Integrator complex subunit 8,Protein kaonashi-1;, , GO:0032039;GO:0005654;GO:0034472;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q75QN2 B2RN92 Q5RKZ3 Q6P1R5 Q7Z314 Q9NVS6 Q9NWY7,Integrator complex subunit 8,Protein kaonashi-1;, , GO:0032039;GO:0005654;GO:0034472;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q75QN2 B2RN92 Q5RKZ3 Q6P1R5 Q7Z314 Q9NVS6 Q9NWY7,Integrator complex subunit 8,Protein kaonashi-1;, , GO:0032039;GO:0005654;GO:0034472;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|O96020 O95439,G1/S-specific cyclin-E2,, PF02984;PF00134;, GO:0005813;GO:0097134;GO:0097135;GO:0000307;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0006270;GO:0000082;GO:0007129;GO:0044772;GO:1903827;GO:0000079;GO:0000723;, C:centrosome; C:cyclin E1-CDK2 complex; C:cyclin E2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:homologous chromosome pairing at meiosis; P:mitotic cell cycle phase transition; P:regulation of cellular protein localization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:telomere maintenance;|O96020 O95439,G1/S-specific cyclin-E2,, PF02984;PF00134;, GO:0005813;GO:0097134;GO:0097135;GO:0000307;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0006270;GO:0000082;GO:0007129;GO:0044772;GO:1903827;GO:0000079;GO:0000723;, C:centrosome; C:cyclin E1-CDK2 complex; C:cyclin E2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:homologous chromosome pairing at meiosis; P:mitotic cell cycle phase transition; P:regulation of cellular protein localization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:telomere maintenance;|O96020 O95439,G1/S-specific cyclin-E2,, PF02984;PF00134;, GO:0005813;GO:0097134;GO:0097135;GO:0000307;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0006270;GO:0000082;GO:0007129;GO:0044772;GO:1903827;GO:0000079;GO:0000723;, C:centrosome; C:cyclin E1-CDK2 complex; C:cyclin E2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:homologous chromosome pairing at meiosis; P:mitotic cell cycle phase transition; P:regulation of cellular protein localization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:telomere maintenance;|O96020 O95439,G1/S-specific cyclin-E2,, PF02984;PF00134;, GO:0005813;GO:0097134;GO:0097135;GO:0000307;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0006270;GO:0000082;GO:0007129;GO:0044772;GO:1903827;GO:0000079;GO:0000723;, C:centrosome; C:cyclin E1-CDK2 complex; C:cyclin E2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:homologous chromosome pairing at meiosis; P:mitotic cell cycle phase transition; P:regulation of cellular protein localization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:telomere maintenance;|O96020 O95439,G1/S-specific cyclin-E2,, PF02984;PF00134;, GO:0005813;GO:0097134;GO:0097135;GO:0000307;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0006270;GO:0000082;GO:0007129;GO:0044772;GO:1903827;GO:0000079;GO:0000723;, C:centrosome; C:cyclin E1-CDK2 complex; C:cyclin E2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:homologous chromosome pairing at meiosis; P:mitotic cell cycle phase transition; P:regulation of cellular protein localization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:telomere maintenance;|O96020 O95439,G1/S-specific cyclin-E2,, PF02984;PF00134;, GO:0005813;GO:0097134;GO:0097135;GO:0000307;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0006270;GO:0000082;GO:0007129;GO:0044772;GO:1903827;GO:0000079;GO:0000723;, C:centrosome; C:cyclin E1-CDK2 complex; C:cyclin E2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:homologous chromosome pairing at meiosis; P:mitotic cell cycle phase transition; P:regulation of cellular protein localization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:telomere maintenance;|O96020 O95439,G1/S-specific cyclin-E2,, PF02984;PF00134;, GO:0005813;GO:0097134;GO:0097135;GO:0000307;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0006270;GO:0000082;GO:0007129;GO:0044772;GO:1903827;GO:0000079;GO:0000723;, C:centrosome; C:cyclin E1-CDK2 complex; C:cyclin E2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:homologous chromosome pairing at meiosis; P:mitotic cell cycle phase transition; P:regulation of cellular protein localization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:telomere maintenance; scaffold3 indexed_genome mRNA 11886792 11899266 . - . ID=transcript_649;Q96A56 B2RCE5 Q969R9,Tumor protein p53-inducible nuclear protein 1,Stress-induced protein;p53-dependent damage-inducible nuclear protein 1;, PF14839;, GO:0005776;GO:0031410;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0016209;GO:0006915;GO:0048102;GO:0000045;GO:0007050;GO:0071361;GO:0071447;GO:0072703;GO:0034644;GO:0030336;GO:0008285;GO:0048147;GO:0010629;GO:1904761;GO:0043065;GO:0010508;GO:0045893;GO:0042981;GO:1901796;GO:0009408;, C:autophagosome; C:cytoplasmic vesicle; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body;, F:antioxidant activity;, P:apoptotic process; P:autophagic cell death; P:autophagosome assembly; P:cell cycle arrest; P:cellular response to ethanol; P:cellular response to hydroperoxide; P:cellular response to methyl methanesulfonate; P:cellular response to UV; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of gene expression; P:negative regulation of myofibroblast differentiation; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of transcription, DNA-templated; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator; P:response to heat; scaffold3 indexed_genome mRNA 11997123 12037009 . + . ID=transcript_650;Q330K2 A8MT28 A8MWF0 B4DQ45 Q8N6U6,NADH dehydrogenase (ubiquinone) complex I, assembly factor 6,Putative phytoene synthase;, , GO:0005737;GO:0005743;GO:0005739;GO:0005634;GO:0032981;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, , P:mitochondrial respiratory chain complex I assembly;|Q330K2 A8MT28 A8MWF0 B4DQ45 Q8N6U6,NADH dehydrogenase (ubiquinone) complex I, assembly factor 6,Putative phytoene synthase;, , GO:0005737;GO:0005743;GO:0005739;GO:0005634;GO:0032981;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, , P:mitochondrial respiratory chain complex I assembly;|Q330K2 A8MT28 A8MWF0 B4DQ45 Q8N6U6,NADH dehydrogenase (ubiquinone) complex I, assembly factor 6,Putative phytoene synthase;, , GO:0005737;GO:0005743;GO:0005739;GO:0005634;GO:0032981;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, , P:mitochondrial respiratory chain complex I assembly;|Q330K2 A8MT28 A8MWF0 B4DQ45 Q8N6U6,NADH dehydrogenase (ubiquinone) complex I, assembly factor 6,Putative phytoene synthase;, , GO:0005737;GO:0005743;GO:0005739;GO:0005634;GO:0032981;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, , P:mitochondrial respiratory chain complex I assembly; scaffold3 indexed_genome mRNA 12131955 12136267 . - . ID=transcript_651;Q9H8W4,Pleckstrin homology domain-containing family F member 2,Endoplasmic reticulum-associated apoptosis-involved protein containing PH and FYVE domains;PH and FYVE domain-containing protein 2;Phafin-2;Zinc finger FYVE domain-containing protein 18;, PF01363;PF00169;, GO:0031901;GO:0005783;GO:0030133;GO:0046872;GO:0035091;GO:0015031;, C:early endosome membrane; C:endoplasmic reticulum; C:transport vesicle;, F:metal ion binding; F:phosphatidylinositol binding;, P:protein transport;|Q9H8W4,Pleckstrin homology domain-containing family F member 2,Endoplasmic reticulum-associated apoptosis-involved protein containing PH and FYVE domains;PH and FYVE domain-containing protein 2;Phafin-2;Zinc finger FYVE domain-containing protein 18;, PF01363;PF00169;, GO:0031901;GO:0005783;GO:0030133;GO:0046872;GO:0035091;GO:0015031;, C:early endosome membrane; C:endoplasmic reticulum; C:transport vesicle;, F:metal ion binding; F:phosphatidylinositol binding;, P:protein transport; scaffold3 indexed_genome mRNA 12227477 12253805 . - . ID=transcript_652;Q96NL8 F4Y588,Protein C8orf37,, PF14996;, GO:0030054;GO:0097546;GO:0005737;GO:0005829;GO:0001917;GO:0005886;GO:0008594;, C:cell junction; C:ciliary base; C:cytoplasm; C:cytosol; C:photoreceptor inner segment; C:plasma membrane;, , P:photoreceptor cell morphogenesis; scaffold3 indexed_genome mRNA 13261361 13264826 . + . ID=transcript_653;P14927 E5RJU0 Q6FGD1,Cytochrome b-c1 complex subunit 7,Complex III subunit 7;Complex III subunit VII;QP-C;Ubiquinol-cytochrome c reductase complex 14 kDa protein;, PF02271;, GO:0005743;GO:0005746;GO:0005750;GO:0009060;GO:0006122;GO:0006119;, C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex III;, , P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; scaffold3 indexed_genome mRNA 13269590 13286928 . - . ID=transcript_654;Q96E29 B3KMG6 G3V130 Q9Y301,Transcription termination factor 3, mitochondrial,Mitochondrial transcription termination factor 3;mTERF domain-containing protein 1, mitochondrial;, PF02536;, GO:0005829;GO:0005741;GO:0005739;GO:0000976;GO:0016236;GO:0061668;GO:0045892;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:transcription regulatory region sequence-specific DNA binding;, P:macroautophagy; P:mitochondrial ribosome assembly; P:negative regulation of transcription, DNA-templated;|Q96E29 B3KMG6 G3V130 Q9Y301,Transcription termination factor 3, mitochondrial,Mitochondrial transcription termination factor 3;mTERF domain-containing protein 1, mitochondrial;, PF02536;, GO:0005829;GO:0005741;GO:0005739;GO:0000976;GO:0016236;GO:0061668;GO:0045892;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:transcription regulatory region sequence-specific DNA binding;, P:macroautophagy; P:mitochondrial ribosome assembly; P:negative regulation of transcription, DNA-templated;|Q96E29 B3KMG6 G3V130 Q9Y301,Transcription termination factor 3, mitochondrial,Mitochondrial transcription termination factor 3;mTERF domain-containing protein 1, mitochondrial;, PF02536;, GO:0005829;GO:0005741;GO:0005739;GO:0000976;GO:0016236;GO:0061668;GO:0045892;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:transcription regulatory region sequence-specific DNA binding;, P:macroautophagy; P:mitochondrial ribosome assembly; P:negative regulation of transcription, DNA-templated; scaffold3 indexed_genome mRNA 13319622 13360823 . + . ID=transcript_655;P48651 B4DE85 E5RFC5 Q9BUQ5,Phosphatidylserine synthase 1,Serine-exchange enzyme I;, PF03034;, GO:0005789;GO:0016021;GO:0016020;GO:0106258;GO:0106245;GO:0006659;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:L-serine-phosphatidylcholine phosphatidyltransferase activity; F:L-serine-phosphatidylethanolamine phosphatidyltransferase activity;, P:phosphatidylserine biosynthetic process; scaffold3 indexed_genome mRNA 13524256 13645647 . + . ID=transcript_656;P34741 B3KQA3 Q6PIS6 Q9H6V1,Syndecan-2,Fibroglycan;Heparan sulfate proteoglycan core protein;, PF01034;, GO:0009986;GO:0062023;GO:0005788;GO:0005796;GO:0016021;GO:0043202;GO:0005886;GO:0042802;GO:0030165;GO:0016477;GO:0044267;GO:0048813;GO:0048013;GO:0006024;GO:0006027;GO:0050900;GO:0043687;GO:0048814;GO:0001523;, C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:plasma membrane;, F:identical protein binding; F:PDZ domain binding;, P:cell migration; P:cellular protein metabolic process; P:dendrite morphogenesis; P:ephrin receptor signaling pathway; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:leukocyte migration; P:post-translational protein modification; P:regulation of dendrite morphogenesis; P:retinoid metabolic process;|P34741 B3KQA3 Q6PIS6 Q9H6V1,Syndecan-2,Fibroglycan;Heparan sulfate proteoglycan core protein;, PF01034;, GO:0009986;GO:0062023;GO:0005788;GO:0005796;GO:0016021;GO:0043202;GO:0005886;GO:0042802;GO:0030165;GO:0016477;GO:0044267;GO:0048813;GO:0048013;GO:0006024;GO:0006027;GO:0050900;GO:0043687;GO:0048814;GO:0001523;, C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:plasma membrane;, F:identical protein binding; F:PDZ domain binding;, P:cell migration; P:cellular protein metabolic process; P:dendrite morphogenesis; P:ephrin receptor signaling pathway; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:leukocyte migration; P:post-translational protein modification; P:regulation of dendrite morphogenesis; P:retinoid metabolic process;|P34741 B3KQA3 Q6PIS6 Q9H6V1,Syndecan-2,Fibroglycan;Heparan sulfate proteoglycan core protein;, PF01034;, GO:0009986;GO:0062023;GO:0005788;GO:0005796;GO:0016021;GO:0043202;GO:0005886;GO:0042802;GO:0030165;GO:0016477;GO:0044267;GO:0048813;GO:0048013;GO:0006024;GO:0006027;GO:0050900;GO:0043687;GO:0048814;GO:0001523;, C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:plasma membrane;, F:identical protein binding; F:PDZ domain binding;, P:cell migration; P:cellular protein metabolic process; P:dendrite morphogenesis; P:ephrin receptor signaling pathway; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:leukocyte migration; P:post-translational protein modification; P:regulation of dendrite morphogenesis; P:retinoid metabolic process; scaffold3 indexed_genome mRNA 13800984 14212715 . + . ID=transcript_657;Q9Y646 B2RD88 Q8NBZ1 Q9UNM8 Q9Y5X6,Carboxypeptidase Q,Lysosomal dipeptidase;Plasma glutamate carboxypeptidase;, PF04389;, GO:0005737;GO:0005783;GO:0070062;GO:0005615;GO:0005794;GO:0043231;GO:0005764;GO:0004180;GO:0046872;GO:0070573;GO:0042803;GO:0043171;GO:0006508;GO:0006590;GO:0042246;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome;, F:carboxypeptidase activity; F:metal ion binding; F:metallodipeptidase activity; F:protein homodimerization activity;, P:peptide catabolic process; P:proteolysis; P:thyroid hormone generation; P:tissue regeneration; scaffold3 indexed_genome mRNA 14322524 14325549 . + . ID=transcript_658;Q86VY4 B3KRF0 Q9C0B3,Testis-specific Y-encoded-like protein 5,, PF00956;, GO:0000785;GO:0005634;GO:0003682;GO:0042393;GO:0071480;GO:0006334;GO:0008284;GO:0051897;GO:0031398;GO:0040008;, C:chromatin; C:nucleus;, F:chromatin binding; F:histone binding;, P:cellular response to gamma radiation; P:nucleosome assembly; P:positive regulation of cell population proliferation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein ubiquitination; P:regulation of growth; scaffold3 indexed_genome mRNA 14325585 14326376 . - . ID=transcript_659;Q86VY4 B3KRF0 Q9C0B3,Testis-specific Y-encoded-like protein 5,, PF00956;, GO:0000785;GO:0005634;GO:0003682;GO:0042393;GO:0071480;GO:0006334;GO:0008284;GO:0051897;GO:0031398;GO:0040008;, C:chromatin; C:nucleus;, F:chromatin binding; F:histone binding;, P:cellular response to gamma radiation; P:nucleosome assembly; P:positive regulation of cell population proliferation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein ubiquitination; P:regulation of growth; scaffold3 indexed_genome mRNA 14611184 14612122 . + . ID=transcript_660;P54849 B2R5N1 B4DRR1 O00681 Q13481 Q13834,Epithelial membrane protein 1,CL-20;Protein B4B;Tumor-associated membrane protein;, PF00822;, GO:0016021;GO:0005886;GO:0032060;GO:0008219;GO:0008544;, C:integral component of membrane; C:plasma membrane;, , P:bleb assembly; P:cell death; P:epidermis development; scaffold3 indexed_genome mRNA 14643134 14700698 . + . ID=transcript_661;Q86UE4 Q05DH2 Q52QU9 Q6PK07 Q8TCX3,Protein LYRIC,3D3/LYRIC;Astrocyte elevated gene-1 protein;Lysine-rich CEACAM1 co-isolated protein;Metadherin;Metastasis adhesion protein;, PF15686;, GO:0016324;GO:0005923;GO:0005737;GO:0005783;GO:0005789;GO:0001650;GO:0016021;GO:0046581;GO:0016604;GO:0031965;GO:0005634;GO:0048471;GO:0003725;GO:0051059;GO:0003723;GO:0001085;GO:0003713;GO:0003712;GO:0070830;GO:0031663;GO:0043066;GO:0000122;GO:0045766;GO:0010508;GO:0043123;GO:0051092;GO:0051897;GO:0006357;, C:apical plasma membrane; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:fibrillar center; C:integral component of membrane; C:intercellular canaliculus; C:nuclear body; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:double-stranded RNA binding; F:NF-kappaB binding; F:RNA binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:bicellular tight junction assembly; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase B signaling; P:regulation of transcription by RNA polymerase II;|Q86UE4 Q05DH2 Q52QU9 Q6PK07 Q8TCX3,Protein LYRIC,3D3/LYRIC;Astrocyte elevated gene-1 protein;Lysine-rich CEACAM1 co-isolated protein;Metadherin;Metastasis adhesion protein;, PF15686;, GO:0016324;GO:0005923;GO:0005737;GO:0005783;GO:0005789;GO:0001650;GO:0016021;GO:0046581;GO:0016604;GO:0031965;GO:0005634;GO:0048471;GO:0003725;GO:0051059;GO:0003723;GO:0001085;GO:0003713;GO:0003712;GO:0070830;GO:0031663;GO:0043066;GO:0000122;GO:0045766;GO:0010508;GO:0043123;GO:0051092;GO:0051897;GO:0006357;, C:apical plasma membrane; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:fibrillar center; C:integral component of membrane; C:intercellular canaliculus; C:nuclear body; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:double-stranded RNA binding; F:NF-kappaB binding; F:RNA binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:bicellular tight junction assembly; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase B signaling; P:regulation of transcription by RNA polymerase II;|Q86UE4 Q05DH2 Q52QU9 Q6PK07 Q8TCX3,Protein LYRIC,3D3/LYRIC;Astrocyte elevated gene-1 protein;Lysine-rich CEACAM1 co-isolated protein;Metadherin;Metastasis adhesion protein;, PF15686;, GO:0016324;GO:0005923;GO:0005737;GO:0005783;GO:0005789;GO:0001650;GO:0016021;GO:0046581;GO:0016604;GO:0031965;GO:0005634;GO:0048471;GO:0003725;GO:0051059;GO:0003723;GO:0001085;GO:0003713;GO:0003712;GO:0070830;GO:0031663;GO:0043066;GO:0000122;GO:0045766;GO:0010508;GO:0043123;GO:0051092;GO:0051897;GO:0006357;, C:apical plasma membrane; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:fibrillar center; C:integral component of membrane; C:intercellular canaliculus; C:nuclear body; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:double-stranded RNA binding; F:NF-kappaB binding; F:RNA binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:bicellular tight junction assembly; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase B signaling; P:regulation of transcription by RNA polymerase II;|Q86UE4 Q05DH2 Q52QU9 Q6PK07 Q8TCX3,Protein LYRIC,3D3/LYRIC;Astrocyte elevated gene-1 protein;Lysine-rich CEACAM1 co-isolated protein;Metadherin;Metastasis adhesion protein;, PF15686;, GO:0016324;GO:0005923;GO:0005737;GO:0005783;GO:0005789;GO:0001650;GO:0016021;GO:0046581;GO:0016604;GO:0031965;GO:0005634;GO:0048471;GO:0003725;GO:0051059;GO:0003723;GO:0001085;GO:0003713;GO:0003712;GO:0070830;GO:0031663;GO:0043066;GO:0000122;GO:0045766;GO:0010508;GO:0043123;GO:0051092;GO:0051897;GO:0006357;, C:apical plasma membrane; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:fibrillar center; C:integral component of membrane; C:intercellular canaliculus; C:nuclear body; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:double-stranded RNA binding; F:NF-kappaB binding; F:RNA binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:bicellular tight junction assembly; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase B signaling; P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 14774902 14807509 . + . ID=transcript_662;Q86VI4 Q3ZCV5 Q7L909 Q86VH8 Q9H060,Lysosomal-associated transmembrane protein 4B {ECO:0000305},Lysosome-associated transmembrane protein 4-beta {ECO:0000303|PubMed:12902989};, PF03821;, GO:0042995;GO:0005769;GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0032585;GO:0097487;GO:0005886;GO:0097001;GO:0019900;GO:1902936;GO:0031625;GO:0007032;GO:0032509;GO:1905166;GO:0032911;GO:0097213;GO:1905671;, C:cell projection; C:early endosome; C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:multivesicular body membrane; C:multivesicular body, internal vesicle; C:plasma membrane;, F:ceramide binding; F:kinase binding; F:phosphatidylinositol bisphosphate binding; F:ubiquitin protein ligase binding;, P:endosome organization; P:endosome transport via multivesicular body sorting pathway; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of transforming growth factor beta1 production; P:regulation of lysosomal membrane permeability; P:regulation of lysosome organization; scaffold3 indexed_genome mRNA 14809459 14836635 . + . ID=transcript_663;Q86VI4 Q3ZCV5 Q7L909 Q86VH8 Q9H060,Lysosomal-associated transmembrane protein 4B {ECO:0000305},Lysosome-associated transmembrane protein 4-beta {ECO:0000303|PubMed:12902989};, PF03821;, GO:0042995;GO:0005769;GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0032585;GO:0097487;GO:0005886;GO:0097001;GO:0019900;GO:1902936;GO:0031625;GO:0007032;GO:0032509;GO:1905166;GO:0032911;GO:0097213;GO:1905671;, C:cell projection; C:early endosome; C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:multivesicular body membrane; C:multivesicular body, internal vesicle; C:plasma membrane;, F:ceramide binding; F:kinase binding; F:phosphatidylinositol bisphosphate binding; F:ubiquitin protein ligase binding;, P:endosome organization; P:endosome transport via multivesicular body sorting pathway; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of transforming growth factor beta1 production; P:regulation of lysosomal membrane permeability; P:regulation of lysosome organization;|Q86VI4 Q3ZCV5 Q7L909 Q86VH8 Q9H060,Lysosomal-associated transmembrane protein 4B {ECO:0000305},Lysosome-associated transmembrane protein 4-beta {ECO:0000303|PubMed:12902989};, PF03821;, GO:0042995;GO:0005769;GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0032585;GO:0097487;GO:0005886;GO:0097001;GO:0019900;GO:1902936;GO:0031625;GO:0007032;GO:0032509;GO:1905166;GO:0032911;GO:0097213;GO:1905671;, C:cell projection; C:early endosome; C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:multivesicular body membrane; C:multivesicular body, internal vesicle; C:plasma membrane;, F:ceramide binding; F:kinase binding; F:phosphatidylinositol bisphosphate binding; F:ubiquitin protein ligase binding;, P:endosome organization; P:endosome transport via multivesicular body sorting pathway; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of transforming growth factor beta1 production; P:regulation of lysosomal membrane permeability; P:regulation of lysosome organization;|Q86VI4 Q3ZCV5 Q7L909 Q86VH8 Q9H060,Lysosomal-associated transmembrane protein 4B {ECO:0000305},Lysosome-associated transmembrane protein 4-beta {ECO:0000303|PubMed:12902989};, PF03821;, GO:0042995;GO:0005769;GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0032585;GO:0097487;GO:0005886;GO:0097001;GO:0019900;GO:1902936;GO:0031625;GO:0007032;GO:0032509;GO:1905166;GO:0032911;GO:0097213;GO:1905671;, C:cell projection; C:early endosome; C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:multivesicular body membrane; C:multivesicular body, internal vesicle; C:plasma membrane;, F:ceramide binding; F:kinase binding; F:phosphatidylinositol bisphosphate binding; F:ubiquitin protein ligase binding;, P:endosome organization; P:endosome transport via multivesicular body sorting pathway; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of transforming growth factor beta1 production; P:regulation of lysosomal membrane permeability; P:regulation of lysosome organization;|Q86VI4 Q3ZCV5 Q7L909 Q86VH8 Q9H060,Lysosomal-associated transmembrane protein 4B {ECO:0000305},Lysosome-associated transmembrane protein 4-beta {ECO:0000303|PubMed:12902989};, PF03821;, GO:0042995;GO:0005769;GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0032585;GO:0097487;GO:0005886;GO:0097001;GO:0019900;GO:1902936;GO:0031625;GO:0007032;GO:0032509;GO:1905166;GO:0032911;GO:0097213;GO:1905671;, C:cell projection; C:early endosome; C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:multivesicular body membrane; C:multivesicular body, internal vesicle; C:plasma membrane;, F:ceramide binding; F:kinase binding; F:phosphatidylinositol bisphosphate binding; F:ubiquitin protein ligase binding;, P:endosome organization; P:endosome transport via multivesicular body sorting pathway; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of transforming growth factor beta1 production; P:regulation of lysosomal membrane permeability; P:regulation of lysosome organization; scaffold3 indexed_genome mRNA 14867799 15014396 . + . ID=transcript_664;Q9NSZ1,Matrilin-2,, PF12662;PF07645;PF10393;PF00092;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;|Q9NSZ1,Matrilin-2,, PF12662;PF07645;PF10393;PF00092;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;|Q9NSZ1,Matrilin-2,, PF12662;PF07645;PF10393;PF00092;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent; scaffold3 indexed_genome mRNA 15022268 15024719 . - . ID=transcript_665;P62888 B2R591 P04645 Q502Z6,60S ribosomal protein L30,Large ribosomal subunit protein eL30 {ECO:0000303|PubMed:24524803};, PF01248;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0014069;GO:0003723;GO:0035368;GO:0003735;GO:0061844;GO:0002181;GO:0050829;GO:0031640;GO:0097421;GO:0000184;GO:1904571;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome; C:postsynaptic density;, F:RNA binding; F:selenocysteine insertion sequence binding; F:structural constituent of ribosome;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cytoplasmic translation; P:defense response to Gram-negative bacterium; P:killing of cells of other organism; P:liver regeneration; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of selenocysteine incorporation; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62888 B2R591 P04645 Q502Z6,60S ribosomal protein L30,Large ribosomal subunit protein eL30 {ECO:0000303|PubMed:24524803};, PF01248;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0014069;GO:0003723;GO:0035368;GO:0003735;GO:0061844;GO:0002181;GO:0050829;GO:0031640;GO:0097421;GO:0000184;GO:1904571;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome; C:postsynaptic density;, F:RNA binding; F:selenocysteine insertion sequence binding; F:structural constituent of ribosome;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cytoplasmic translation; P:defense response to Gram-negative bacterium; P:killing of cells of other organism; P:liver regeneration; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of selenocysteine incorporation; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62888 B2R591 P04645 Q502Z6,60S ribosomal protein L30,Large ribosomal subunit protein eL30 {ECO:0000303|PubMed:24524803};, PF01248;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0014069;GO:0003723;GO:0035368;GO:0003735;GO:0061844;GO:0002181;GO:0050829;GO:0031640;GO:0097421;GO:0000184;GO:1904571;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome; C:postsynaptic density;, F:RNA binding; F:selenocysteine insertion sequence binding; F:structural constituent of ribosome;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cytoplasmic translation; P:defense response to Gram-negative bacterium; P:killing of cells of other organism; P:liver regeneration; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of selenocysteine incorporation; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold3 indexed_genome mRNA 15054963 15058379 . + . ID=transcript_666;Q6P6B1 G3V1K4 Q8N1L8,Glutamate-rich protein 5,, PF15140; scaffold3 indexed_genome mRNA 15066747 15079423 . - . ID=transcript_667;P52758 Q6FHU9 Q6IBG0,2-iminobutanoate/2-iminopropanoate deaminase {ECO:0000305|PubMed:22094463},14.5 kDa translational inhibitor protein {ECO:0000303|PubMed:8973653};Heat-responsive protein 12 {ECO:0000312|HGNC:HGNC:16897};Reactive intermediate imine deaminase A homolog {ECO:0000312|HGNC:HGNC:16897};Translation inhibitor L-PSP ribonuclease {ECO:0000250|UniProtKB:P52759};UK114 antigen homolog {ECO:0000305|PubMed:20817725};, PF01042;, GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0005777;GO:0120242;GO:0120243;GO:0019239;GO:0016892;GO:0003729;GO:0003723;GO:0019518;GO:0006402;GO:0061157;GO:0017148;GO:1901565;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:peroxisome;, F:2-iminobutanoate deaminase activity; F:2-iminopropanoate deaminase activity; F:deaminase activity; F:endoribonuclease activity, producing 3'-phosphomonoesters; F:mRNA binding; F:RNA binding;, P:L-threonine catabolic process to glycine; P:mRNA catabolic process; P:mRNA destabilization; P:negative regulation of translation; P:organonitrogen compound catabolic process;|P52758 Q6FHU9 Q6IBG0,2-iminobutanoate/2-iminopropanoate deaminase {ECO:0000305|PubMed:22094463},14.5 kDa translational inhibitor protein {ECO:0000303|PubMed:8973653};Heat-responsive protein 12 {ECO:0000312|HGNC:HGNC:16897};Reactive intermediate imine deaminase A homolog {ECO:0000312|HGNC:HGNC:16897};Translation inhibitor L-PSP ribonuclease {ECO:0000250|UniProtKB:P52759};UK114 antigen homolog {ECO:0000305|PubMed:20817725};, PF01042;, GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0005777;GO:0120242;GO:0120243;GO:0019239;GO:0016892;GO:0003729;GO:0003723;GO:0019518;GO:0006402;GO:0061157;GO:0017148;GO:1901565;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:peroxisome;, F:2-iminobutanoate deaminase activity; F:2-iminopropanoate deaminase activity; F:deaminase activity; F:endoribonuclease activity, producing 3'-phosphomonoesters; F:mRNA binding; F:RNA binding;, P:L-threonine catabolic process to glycine; P:mRNA catabolic process; P:mRNA destabilization; P:negative regulation of translation; P:organonitrogen compound catabolic process;|P52758 Q6FHU9 Q6IBG0,2-iminobutanoate/2-iminopropanoate deaminase {ECO:0000305|PubMed:22094463},14.5 kDa translational inhibitor protein {ECO:0000303|PubMed:8973653};Heat-responsive protein 12 {ECO:0000312|HGNC:HGNC:16897};Reactive intermediate imine deaminase A homolog {ECO:0000312|HGNC:HGNC:16897};Translation inhibitor L-PSP ribonuclease {ECO:0000250|UniProtKB:P52759};UK114 antigen homolog {ECO:0000305|PubMed:20817725};, PF01042;, GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0005777;GO:0120242;GO:0120243;GO:0019239;GO:0016892;GO:0003729;GO:0003723;GO:0019518;GO:0006402;GO:0061157;GO:0017148;GO:1901565;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:peroxisome;, F:2-iminobutanoate deaminase activity; F:2-iminopropanoate deaminase activity; F:deaminase activity; F:endoribonuclease activity, producing 3'-phosphomonoesters; F:mRNA binding; F:RNA binding;, P:L-threonine catabolic process to glycine; P:mRNA catabolic process; P:mRNA destabilization; P:negative regulation of translation; P:organonitrogen compound catabolic process; scaffold3 indexed_genome mRNA 15079643 15116852 . + . ID=transcript_668;Q99575 A8K5W9 Q15037,Ribonucleases P/MRP protein subunit POP1,, PF06978;PF08170;, GO:0005615;GO:0030681;GO:0005655;GO:0005730;GO:0005654;GO:0000172;GO:0004526;GO:0033204;GO:0003723;GO:0090502;GO:0001682;GO:0016078;GO:0008033;, C:extracellular space; C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleolus; C:nucleoplasm; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding; F:RNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:tRNA 5'-leader removal; P:tRNA catabolic process; P:tRNA processing; scaffold3 indexed_genome mRNA 15149412 15225919 . - . ID=transcript_669;Q9H841 A2RTY8,NIPA-like protein 2,, PF05653;, GO:0016021;GO:0016020;GO:0015095;GO:0015693;, C:integral component of membrane; C:membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport; scaffold3 indexed_genome mRNA 15385248 15631747 . - . ID=transcript_670;Q13188 A8K722 B3KYA7 Q15445 Q15801 Q96FM6,Serine/threonine-protein kinase 3,Mammalian STE20-like protein kinase 2;STE20-like kinase MST2;Serine/threonine-protein kinase Krs-1;, PF11629;PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0032991;GO:0005524;GO:0042802;GO:0000287;GO:0004672;GO:0106310;GO:0043539;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0060706;GO:0007417;GO:0003157;GO:0097284;GO:0035329;GO:0035556;GO:0090090;GO:0008285;GO:0046621;GO:0001841;GO:0043065;GO:0051091;GO:1902043;GO:0045600;GO:0046330;GO:0032092;GO:0051897;GO:0060215;GO:0006468;GO:0050821;GO:0060800;GO:0007165;GO:0031098;, C:cytoplasm; C:cytosol; C:nucleus; C:protein-containing complex;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cell differentiation involved in embryonic placenta development; P:central nervous system development; P:endocardium development; P:hepatocyte apoptotic process; P:hippo signaling; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of organ growth; P:neural tube formation; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of fat cell differentiation; P:positive regulation of JNK cascade; P:positive regulation of protein binding; P:positive regulation of protein kinase B signaling; P:primitive hemopoiesis; P:protein phosphorylation; P:protein stabilization; P:regulation of cell differentiation involved in embryonic placenta development; P:signal transduction; P:stress-activated protein kinase signaling cascade; scaffold3 indexed_genome mRNA 15826698 15829206 . + . ID=transcript_671;Q8N2R0 A8K626 B4E3B7 Q96AM6 Q96LB6 Q96LB7,Protein odd-skipped-related 2,, PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0043565;GO:1990837;GO:0060349;GO:0030154;GO:0002062;GO:0009792;GO:0042733;GO:0035115;GO:0035116;GO:0072498;GO:0060272;GO:0036023;GO:0048704;GO:0061029;GO:0060322;GO:0001823;GO:0001656;GO:0042474;GO:0000122;GO:0042476;GO:0033687;GO:0030501;GO:0008284;GO:0050679;GO:0010628;GO:0045944;GO:0045893;GO:0006357;GO:0060021;GO:0001655;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:bone morphogenesis; P:cell differentiation; P:chondrocyte differentiation; P:embryo development ending in birth or egg hatching; P:embryonic digit morphogenesis; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:embryonic skeletal joint development; P:embryonic skeletal joint morphogenesis; P:embryonic skeletal limb joint morphogenesis; P:embryonic skeletal system morphogenesis; P:eyelid development in camera-type eye; P:head development; P:mesonephros development; P:metanephros development; P:middle ear morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis; P:osteoblast proliferation; P:positive regulation of bone mineralization; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; P:urogenital system development; scaffold3 indexed_genome mRNA 15901601 16019676 . + . ID=transcript_672;Q9NWV1 Q9Y4E7,Vacuolar protein sorting-associated protein 13B,Cohen syndrome protein 1;, PF12624;PF06650;PF16909;, GO:0015031;, , , P:protein transport; scaffold3 indexed_genome mRNA 16049728 16073726 . + . ID=transcript_673;Q9NWV1 Q9Y4E7,Vacuolar protein sorting-associated protein 13B,Cohen syndrome protein 1;, PF12624;PF06650;PF16909;, GO:0015031;, , , P:protein transport; scaffold3 indexed_genome mRNA 16125060 16677122 . + . ID=transcript_674;Q9NWV1 Q9Y4E7,Vacuolar protein sorting-associated protein 13B,Cohen syndrome protein 1;, PF12624;PF06650;PF16909;, GO:0015031;, , , P:protein transport;|Q9NWV1 Q9Y4E7,Vacuolar protein sorting-associated protein 13B,Cohen syndrome protein 1;, PF12624;PF06650;PF16909;, GO:0015031;, , , P:protein transport;|Q9NWV1 Q9Y4E7,Vacuolar protein sorting-associated protein 13B,Cohen syndrome protein 1;, PF12624;PF06650;PF16909;, GO:0015031;, , , P:protein transport;|Q9NWV1 Q9Y4E7,Vacuolar protein sorting-associated protein 13B,Cohen syndrome protein 1;, PF12624;PF06650;PF16909;, GO:0015031;, , , P:protein transport;|Q9NWV1 Q9Y4E7,Vacuolar protein sorting-associated protein 13B,Cohen syndrome protein 1;, PF12624;PF06650;PF16909;, GO:0015031;, , , P:protein transport; scaffold3 indexed_genome mRNA 16931260 16935911 . + . ID=transcript_675;P53803 Q6IBD4,DNA-directed RNA polymerases I, II, and III subunit RPABC4,ABC10-alpha;DNA-directed RNA polymerase II subunit K;RNA polymerase II 7.0 kDa subunit;RPB10alpha;, PF03604;, GO:0005829;GO:0005654;GO:0005634;GO:0005736;GO:0005665;GO:0005666;GO:0003677;GO:0003899;GO:0008270;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0006356;GO:0016070;GO:0042795;GO:0006363;GO:0006366;GO:0006383;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:zinc ion binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:regulation of transcription by RNA polymerase I; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription by RNA polymerase III; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; scaffold3 indexed_genome mRNA 16936675 17024065 . + . ID=transcript_676;Q07617 A6NP70 B3KQ58 G3XAM3 Q7Z5G1,Sperm-associated antigen 1,HSD-3.8;Infertility-related sperm protein Spag-1;, PF13877;PF00515;PF13181;, GO:0005737;GO:0005829;GO:0005525;GO:0016787;GO:0070286;GO:0007338;, C:cytoplasm; C:cytosol;, F:GTP binding; F:hydrolase activity;, P:axonemal dynein complex assembly; P:single fertilization;|Q07617 A6NP70 B3KQ58 G3XAM3 Q7Z5G1,Sperm-associated antigen 1,HSD-3.8;Infertility-related sperm protein Spag-1;, PF13877;PF00515;PF13181;, GO:0005737;GO:0005829;GO:0005525;GO:0016787;GO:0070286;GO:0007338;, C:cytoplasm; C:cytosol;, F:GTP binding; F:hydrolase activity;, P:axonemal dynein complex assembly; P:single fertilization; scaffold3 indexed_genome mRNA 17043385 17071004 . - . ID=transcript_677;Q9NV58 A3KCU9 Q52LG1 Q9H5H9 Q9H8M8 Q9UFG0 Q9UFX6 Q9Y4Y1,E3 ubiquitin-protein ligase RNF19A,Double ring-finger protein;RING finger protein 19A;p38;, PF01485;, GO:0005813;GO:0005737;GO:0005829;GO:0098978;GO:0098686;GO:0016021;GO:0098794;GO:0000151;GO:0046872;GO:0008134;GO:0031624;GO:0061630;GO:0000226;GO:0032436;GO:0000209;GO:0099576;GO:0006511;, C:centrosome; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:postsynapse; C:ubiquitin ligase complex;, F:metal ion binding; F:transcription factor binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:microtubule cytoskeleton organization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:ubiquitin-dependent protein catabolic process;|Q9NV58 A3KCU9 Q52LG1 Q9H5H9 Q9H8M8 Q9UFG0 Q9UFX6 Q9Y4Y1,E3 ubiquitin-protein ligase RNF19A,Double ring-finger protein;RING finger protein 19A;p38;, PF01485;, GO:0005813;GO:0005737;GO:0005829;GO:0098978;GO:0098686;GO:0016021;GO:0098794;GO:0000151;GO:0046872;GO:0008134;GO:0031624;GO:0061630;GO:0000226;GO:0032436;GO:0000209;GO:0099576;GO:0006511;, C:centrosome; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:postsynapse; C:ubiquitin ligase complex;, F:metal ion binding; F:transcription factor binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:microtubule cytoskeleton organization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:ubiquitin-dependent protein catabolic process;|Q9NV58 A3KCU9 Q52LG1 Q9H5H9 Q9H8M8 Q9UFG0 Q9UFX6 Q9Y4Y1,E3 ubiquitin-protein ligase RNF19A,Double ring-finger protein;RING finger protein 19A;p38;, PF01485;, GO:0005813;GO:0005737;GO:0005829;GO:0098978;GO:0098686;GO:0016021;GO:0098794;GO:0000151;GO:0046872;GO:0008134;GO:0031624;GO:0061630;GO:0000226;GO:0032436;GO:0000209;GO:0099576;GO:0006511;, C:centrosome; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:postsynapse; C:ubiquitin ligase complex;, F:metal ion binding; F:transcription factor binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:microtubule cytoskeleton organization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:ubiquitin-dependent protein catabolic process;|Q9NV58 A3KCU9 Q52LG1 Q9H5H9 Q9H8M8 Q9UFG0 Q9UFX6 Q9Y4Y1,E3 ubiquitin-protein ligase RNF19A,Double ring-finger protein;RING finger protein 19A;p38;, PF01485;, GO:0005813;GO:0005737;GO:0005829;GO:0098978;GO:0098686;GO:0016021;GO:0098794;GO:0000151;GO:0046872;GO:0008134;GO:0031624;GO:0061630;GO:0000226;GO:0032436;GO:0000209;GO:0099576;GO:0006511;, C:centrosome; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:postsynapse; C:ubiquitin ligase complex;, F:metal ion binding; F:transcription factor binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:microtubule cytoskeleton organization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:ubiquitin-dependent protein catabolic process;|Q9NV58 A3KCU9 Q52LG1 Q9H5H9 Q9H8M8 Q9UFG0 Q9UFX6 Q9Y4Y1,E3 ubiquitin-protein ligase RNF19A,Double ring-finger protein;RING finger protein 19A;p38;, PF01485;, GO:0005813;GO:0005737;GO:0005829;GO:0098978;GO:0098686;GO:0016021;GO:0098794;GO:0000151;GO:0046872;GO:0008134;GO:0031624;GO:0061630;GO:0000226;GO:0032436;GO:0000209;GO:0099576;GO:0006511;, C:centrosome; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:postsynapse; C:ubiquitin ligase complex;, F:metal ion binding; F:transcription factor binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:microtubule cytoskeleton organization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:ubiquitin-dependent protein catabolic process; scaffold3 indexed_genome mRNA 17312045 17349477 . - . ID=transcript_678;Q86W74 Q6P9B7,Ankyrin repeat domain-containing protein 46,Ankyrin repeat small protein;, PF12796;, GO:0016021;, C:integral component of membrane; scaffold3 indexed_genome mRNA 17509112 17523121 . - . ID=transcript_679;P11940 Q15097 Q93004,Polyadenylate-binding protein 1,, PF00658;PF00076;, GO:0071013;GO:0031252;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0070062;GO:0005925;GO:0030027;GO:0016020;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0008022;GO:0003723;GO:0008494;GO:0031047;GO:0006378;GO:0000398;GO:0048255;GO:2000623;GO:0000184;GO:1900153;GO:0060213;GO:0045070;GO:0043488;GO:0006413;, C:catalytic step 2 spliceosome; C:cell leading edge; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:protein C-terminus binding; F:RNA binding; F:translation activator activity;, P:gene silencing by RNA; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of viral genome replication; P:regulation of mRNA stability; P:translational initiation;|Q9H361 Q8NHV0 Q9H086,Polyadenylate-binding protein 3,Testis-specific poly(A)-binding protein;, PF00658;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0070062;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0016071;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:mRNA metabolic process;|P11940 Q15097 Q93004,Polyadenylate-binding protein 1,, PF00658;PF00076;, GO:0071013;GO:0031252;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0070062;GO:0005925;GO:0030027;GO:0016020;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0008022;GO:0003723;GO:0008494;GO:0031047;GO:0006378;GO:0000398;GO:0048255;GO:2000623;GO:0000184;GO:1900153;GO:0060213;GO:0045070;GO:0043488;GO:0006413;, C:catalytic step 2 spliceosome; C:cell leading edge; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:protein C-terminus binding; F:RNA binding; F:translation activator activity;, P:gene silencing by RNA; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of viral genome replication; P:regulation of mRNA stability; P:translational initiation; scaffold3 indexed_genome mRNA 17714989 17756070 . - . ID=transcript_680;Q6NUR9 Q6P3U9 Q86V33,14-3-3 protein zeta/delta,Protein kinase C inhibitor protein 1;, PF00244;, GO:0072562;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0005925;GO:0098978;GO:0042470;GO:0005739;GO:0005654;GO:0005634;GO:0031982;GO:0045296;GO:0042802;GO:0044325;GO:0019901;GO:0003723;GO:0008134;GO:0031625;GO:0002250;GO:0019221;GO:0051683;GO:0090168;GO:0043066;GO:0030168;GO:1900740;GO:0006468;GO:0070372;GO:0043488;GO:0090128;GO:0007165;, C:blood microparticle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:glutamatergic synapse; C:melanosome; C:mitochondrion; C:nucleoplasm; C:nucleus; C:vesicle;, F:cadherin binding; F:identical protein binding; F:ion channel binding; F:protein kinase binding; F:RNA binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:adaptive immune response; P:cytokine-mediated signaling pathway; P:establishment of Golgi localization; P:Golgi reassembly; P:negative regulation of apoptotic process; P:platelet activation; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein phosphorylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of mRNA stability; P:regulation of synapse maturation; P:signal transduction;|Q6NUR9 Q6P3U9 Q86V33,14-3-3 protein zeta/delta,Protein kinase C inhibitor protein 1;, PF00244;, GO:0072562;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0005925;GO:0098978;GO:0042470;GO:0005739;GO:0005654;GO:0005634;GO:0031982;GO:0045296;GO:0042802;GO:0044325;GO:0019901;GO:0003723;GO:0008134;GO:0031625;GO:0002250;GO:0019221;GO:0051683;GO:0090168;GO:0043066;GO:0030168;GO:1900740;GO:0006468;GO:0070372;GO:0043488;GO:0090128;GO:0007165;, C:blood microparticle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:glutamatergic synapse; C:melanosome; C:mitochondrion; C:nucleoplasm; C:nucleus; C:vesicle;, F:cadherin binding; F:identical protein binding; F:ion channel binding; F:protein kinase binding; F:RNA binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:adaptive immune response; P:cytokine-mediated signaling pathway; P:establishment of Golgi localization; P:Golgi reassembly; P:negative regulation of apoptotic process; P:platelet activation; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein phosphorylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of mRNA stability; P:regulation of synapse maturation; P:signal transduction;|Q6NUR9 Q6P3U9 Q86V33,14-3-3 protein zeta/delta,Protein kinase C inhibitor protein 1;, PF00244;, GO:0072562;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0005925;GO:0098978;GO:0042470;GO:0005739;GO:0005654;GO:0005634;GO:0031982;GO:0045296;GO:0042802;GO:0044325;GO:0019901;GO:0003723;GO:0008134;GO:0031625;GO:0002250;GO:0019221;GO:0051683;GO:0090168;GO:0043066;GO:0030168;GO:1900740;GO:0006468;GO:0070372;GO:0043488;GO:0090128;GO:0007165;, C:blood microparticle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:glutamatergic synapse; C:melanosome; C:mitochondrion; C:nucleoplasm; C:nucleus; C:vesicle;, F:cadherin binding; F:identical protein binding; F:ion channel binding; F:protein kinase binding; F:RNA binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:adaptive immune response; P:cytokine-mediated signaling pathway; P:establishment of Golgi localization; P:Golgi reassembly; P:negative regulation of apoptotic process; P:platelet activation; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein phosphorylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of mRNA stability; P:regulation of synapse maturation; P:signal transduction; scaffold3 indexed_genome mRNA 17879042 17879928 . + . ID=transcript_681;Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold3 indexed_genome mRNA 17983147 17986906 . - . ID=transcript_682;Q9Y5V0 A8K362,Zinc finger protein 706 {ECO:0000305},, PF04419;, GO:0005737;GO:0005634;GO:0046872;GO:1902455;GO:0045892;GO:0006417;, C:cytoplasm; C:nucleus;, F:metal ion binding;, P:negative regulation of stem cell population maintenance; P:negative regulation of transcription, DNA-templated; P:regulation of translation;|Q9Y5V0 A8K362,Zinc finger protein 706 {ECO:0000305},, PF04419;, GO:0005737;GO:0005634;GO:0046872;GO:1902455;GO:0045892;GO:0006417;, C:cytoplasm; C:nucleus;, F:metal ion binding;, P:negative regulation of stem cell population maintenance; P:negative regulation of transcription, DNA-templated; P:regulation of translation; scaffold3 indexed_genome mRNA 18348499 18351557 . + . ID=transcript_683;Q6ISB3 A1L303 Q6NT03 Q9H8B8,Grainyhead-like protein 2 homolog,Brother of mammalian grainyhead;Transcription factor CP2-like 3;, PF04516;, GO:0005911;GO:0000785;GO:0016020;GO:0005654;GO:0005634;GO:0031490;GO:0001228;GO:0003700;GO:0000981;GO:0001161;GO:0000978;GO:0043565;GO:0061713;GO:0070830;GO:0007420;GO:0043010;GO:0003208;GO:0007155;GO:0034329;GO:0008283;GO:0048701;GO:0042733;GO:0008544;GO:0003382;GO:0060672;GO:0090132;GO:0060324;GO:0060487;GO:0060463;GO:0035264;GO:0045617;GO:0001843;GO:0021915;GO:0051973;GO:0045944;GO:0044030;GO:0006357;, C:cell-cell junction; C:chromatin; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:intronic transcription regulatory region sequence-specific DNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:anterior neural tube closure; P:bicellular tight junction assembly; P:brain development; P:camera-type eye development; P:cardiac ventricle morphogenesis; P:cell adhesion; P:cell junction assembly; P:cell population proliferation; P:embryonic cranial skeleton morphogenesis; P:embryonic digit morphogenesis; P:epidermis development; P:epithelial cell morphogenesis; P:epithelial cell morphogenesis involved in placental branching; P:epithelium migration; P:face development; P:lung epithelial cell differentiation; P:lung lobe morphogenesis; P:multicellular organism growth; P:negative regulation of keratinocyte differentiation; P:neural tube closure; P:neural tube development; P:positive regulation of telomerase activity; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA methylation; P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 18359039 18535150 . - . ID=transcript_684;P61601 P29554 Q8IYC3 Q9H0W2,Neurocalcin-delta,, PF13499;PF13833;, GO:0030130;GO:0005829;GO:0003779;GO:0005509;GO:0030276;GO:0015631;GO:0016192;, C:clathrin coat of trans-Golgi network vesicle; C:cytosol;, F:actin binding; F:calcium ion binding; F:clathrin binding; F:tubulin binding;, P:vesicle-mediated transport; scaffold3 indexed_genome mRNA 18865238 18907712 . - . ID=transcript_685;Q9NTD8 Q9NUW3,Ribonucleoside-diphosphate reductase subunit M2 B,TP53-inducible ribonucleotide reductase M2 B;p53-inducible ribonucleotide reductase small subunit 2-like protein;, PF00268;, GO:0005829;GO:0005654;GO:0042802;GO:0046872;GO:0004748;GO:0009263;GO:0006281;GO:0006260;GO:0015949;, C:cytosol; C:nucleoplasm;, F:identical protein binding; F:metal ion binding; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor;, P:deoxyribonucleotide biosynthetic process; P:DNA repair; P:DNA replication; P:nucleobase-containing small molecule interconversion; scaffold3 indexed_genome mRNA 18916250 19013407 . - . ID=transcript_686;O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process;|O95071 B2RP24 J3KMW7 O94970 Q9NPL3,E3 ubiquitin-protein ligase UBR5,E3 ubiquitin-protein ligase, HECT domain-containing 1;HECT-type E3 ubiquitin transferase UBR5;Hyperplastic discs protein homolog;Progestin-induced protein;, PF11547;PF00632;PF00658;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003723;GO:0043130;GO:0061630;GO:0034450;GO:0008270;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0090263;GO:0010628;GO:0042307;GO:0050847;GO:0070936;GO:0000209;GO:2000779;GO:0016032;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:RNA binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of protein import into nucleus; P:progesterone receptor signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:viral process; scaffold3 indexed_genome mRNA 19285739 19289739 . - . ID=transcript_687;Q13118 A8MVH0 B2R794 L0R4P6 L0R679 O75411 Q503B2,Krueppel-like factor 10,EGR-alpha;Transforming growth factor-beta-inducible early growth response protein 1;, PF00096;, GO:0000785;GO:0005634;GO:0001046;GO:0001228;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0030282;GO:0007267;GO:1901653;GO:0009267;GO:0007623;GO:0008285;GO:0000122;GO:0045892;GO:0045672;GO:0045944;GO:0042752;GO:0006357;GO:0035019;, C:chromatin; C:nucleus;, F:core promoter sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:bone mineralization; P:cell-cell signaling; P:cellular response to peptide; P:cellular response to starvation; P:circadian rhythm; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of osteoclast differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II; P:somatic stem cell population maintenance;|Q13118 A8MVH0 B2R794 L0R4P6 L0R679 O75411 Q503B2,Krueppel-like factor 10,EGR-alpha;Transforming growth factor-beta-inducible early growth response protein 1;, PF00096;, GO:0000785;GO:0005634;GO:0001046;GO:0001228;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0030282;GO:0007267;GO:1901653;GO:0009267;GO:0007623;GO:0008285;GO:0000122;GO:0045892;GO:0045672;GO:0045944;GO:0042752;GO:0006357;GO:0035019;, C:chromatin; C:nucleus;, F:core promoter sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:bone mineralization; P:cell-cell signaling; P:cellular response to peptide; P:cellular response to starvation; P:circadian rhythm; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of osteoclast differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II; P:somatic stem cell population maintenance; scaffold3 indexed_genome mRNA 19440518 19500670 . - . ID=transcript_688;O14977 A6NCD5 Q6IBQ7 Q96D20,Antizyme inhibitor 1,Ornithine decarboxylase antizyme inhibitor;, PF02784;PF00278;, GO:0005737;GO:0005829;GO:0005634;GO:0042978;GO:0004586;GO:0042177;GO:1902269;GO:0033387;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase activator activity; F:ornithine decarboxylase activity;, P:negative regulation of protein catabolic process; P:positive regulation of polyamine transmembrane transport; P:putrescine biosynthetic process from ornithine; P:regulation of cellular amino acid metabolic process;|O14977 A6NCD5 Q6IBQ7 Q96D20,Antizyme inhibitor 1,Ornithine decarboxylase antizyme inhibitor;, PF02784;PF00278;, GO:0005737;GO:0005829;GO:0005634;GO:0042978;GO:0004586;GO:0042177;GO:1902269;GO:0033387;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase activator activity; F:ornithine decarboxylase activity;, P:negative regulation of protein catabolic process; P:positive regulation of polyamine transmembrane transport; P:putrescine biosynthetic process from ornithine; P:regulation of cellular amino acid metabolic process;|O14977 A6NCD5 Q6IBQ7 Q96D20,Antizyme inhibitor 1,Ornithine decarboxylase antizyme inhibitor;, PF02784;PF00278;, GO:0005737;GO:0005829;GO:0005634;GO:0042978;GO:0004586;GO:0042177;GO:1902269;GO:0033387;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase activator activity; F:ornithine decarboxylase activity;, P:negative regulation of protein catabolic process; P:positive regulation of polyamine transmembrane transport; P:putrescine biosynthetic process from ornithine; P:regulation of cellular amino acid metabolic process;|O14977 A6NCD5 Q6IBQ7 Q96D20,Antizyme inhibitor 1,Ornithine decarboxylase antizyme inhibitor;, PF02784;PF00278;, GO:0005737;GO:0005829;GO:0005634;GO:0042978;GO:0004586;GO:0042177;GO:1902269;GO:0033387;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase activator activity; F:ornithine decarboxylase activity;, P:negative regulation of protein catabolic process; P:positive regulation of polyamine transmembrane transport; P:putrescine biosynthetic process from ornithine; P:regulation of cellular amino acid metabolic process;|O14977 A6NCD5 Q6IBQ7 Q96D20,Antizyme inhibitor 1,Ornithine decarboxylase antizyme inhibitor;, PF02784;PF00278;, GO:0005737;GO:0005829;GO:0005634;GO:0042978;GO:0004586;GO:0042177;GO:1902269;GO:0033387;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase activator activity; F:ornithine decarboxylase activity;, P:negative regulation of protein catabolic process; P:positive regulation of polyamine transmembrane transport; P:putrescine biosynthetic process from ornithine; P:regulation of cellular amino acid metabolic process;|O14977 A6NCD5 Q6IBQ7 Q96D20,Antizyme inhibitor 1,Ornithine decarboxylase antizyme inhibitor;, PF02784;PF00278;, GO:0005737;GO:0005829;GO:0005634;GO:0042978;GO:0004586;GO:0042177;GO:1902269;GO:0033387;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase activator activity; F:ornithine decarboxylase activity;, P:negative regulation of protein catabolic process; P:positive regulation of polyamine transmembrane transport; P:putrescine biosynthetic process from ornithine; P:regulation of cellular amino acid metabolic process;|O14977 A6NCD5 Q6IBQ7 Q96D20,Antizyme inhibitor 1,Ornithine decarboxylase antizyme inhibitor;, PF02784;PF00278;, GO:0005737;GO:0005829;GO:0005634;GO:0042978;GO:0004586;GO:0042177;GO:1902269;GO:0033387;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase activator activity; F:ornithine decarboxylase activity;, P:negative regulation of protein catabolic process; P:positive regulation of polyamine transmembrane transport; P:putrescine biosynthetic process from ornithine; P:regulation of cellular amino acid metabolic process; scaffold3 indexed_genome mRNA 19603114 19645293 . + . ID=transcript_689;P21283,V-type proton ATPase subunit C 1,Vacuolar proton pump subunit C 1;, PF03223;, GO:0045177;GO:0031410;GO:0005829;GO:0070062;GO:0005765;GO:0005886;GO:0016469;GO:0000221;GO:0046961;GO:0005215;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical part of cell; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:plasma membrane; C:proton-transporting two-sector ATPase complex; C:vacuolar proton-transporting V-type ATPase, V1 domain;, F:proton-transporting ATPase activity, rotational mechanism; F:transporter activity;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P21283,V-type proton ATPase subunit C 1,Vacuolar proton pump subunit C 1;, PF03223;, GO:0045177;GO:0031410;GO:0005829;GO:0070062;GO:0005765;GO:0005886;GO:0016469;GO:0000221;GO:0046961;GO:0005215;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical part of cell; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:plasma membrane; C:proton-transporting two-sector ATPase complex; C:vacuolar proton-transporting V-type ATPase, V1 domain;, F:proton-transporting ATPase activity, rotational mechanism; F:transporter activity;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P21283,V-type proton ATPase subunit C 1,Vacuolar proton pump subunit C 1;, PF03223;, GO:0045177;GO:0031410;GO:0005829;GO:0070062;GO:0005765;GO:0005886;GO:0016469;GO:0000221;GO:0046961;GO:0005215;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical part of cell; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:plasma membrane; C:proton-transporting two-sector ATPase complex; C:vacuolar proton-transporting V-type ATPase, V1 domain;, F:proton-transporting ATPase activity, rotational mechanism; F:transporter activity;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P21283,V-type proton ATPase subunit C 1,Vacuolar proton pump subunit C 1;, PF03223;, GO:0045177;GO:0031410;GO:0005829;GO:0070062;GO:0005765;GO:0005886;GO:0016469;GO:0000221;GO:0046961;GO:0005215;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical part of cell; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:plasma membrane; C:proton-transporting two-sector ATPase complex; C:vacuolar proton-transporting V-type ATPase, V1 domain;, F:proton-transporting ATPase activity, rotational mechanism; F:transporter activity;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P21283,V-type proton ATPase subunit C 1,Vacuolar proton pump subunit C 1;, PF03223;, GO:0045177;GO:0031410;GO:0005829;GO:0070062;GO:0005765;GO:0005886;GO:0016469;GO:0000221;GO:0046961;GO:0005215;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical part of cell; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:plasma membrane; C:proton-transporting two-sector ATPase complex; C:vacuolar proton-transporting V-type ATPase, V1 domain;, F:proton-transporting ATPase activity, rotational mechanism; F:transporter activity;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; scaffold3 indexed_genome mRNA 19705654 19793459 . + . ID=transcript_690;Q8WXS3 Q8WTP6 Q8WXS0 Q8WXS1 Q8WXS2 Q9HA93,Brain and acute leukemia cytoplasmic protein {ECO:0000303|PubMed:11707601},, PF06989;, GO:0005737;GO:0005829;GO:0045121;GO:0043005;GO:0005654;GO:0014069;, C:cytoplasm; C:cytosol; C:membrane raft; C:neuron projection; C:nucleoplasm; C:postsynaptic density; scaffold3 indexed_genome mRNA 19848039 19883977 . + . ID=transcript_691;O60353 B4DRN0 Q6N0A5 Q6P9C3 Q8WXR9,Frizzled-6,, PF01534;PF01392;, GO:0016324;GO:0016327;GO:0009986;GO:0030659;GO:0005789;GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0031625;GO:0042813;GO:0017147;GO:0060070;GO:0033278;GO:0035880;GO:0048105;GO:0001942;GO:0042472;GO:1904693;GO:0090090;GO:0043433;GO:0001843;GO:0035567;GO:0030168;GO:0007223;GO:0060071;, C:apical plasma membrane; C:apicolateral plasma membrane; C:cell surface; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:ubiquitin protein ligase binding; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:cell proliferation in midbrain; P:embryonic nail plate morphogenesis; P:establishment of body hair planar orientation; P:hair follicle development; P:inner ear morphogenesis; P:midbrain morphogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:neural tube closure; P:non-canonical Wnt signaling pathway; P:platelet activation; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway;|O60353 B4DRN0 Q6N0A5 Q6P9C3 Q8WXR9,Frizzled-6,, PF01534;PF01392;, GO:0016324;GO:0016327;GO:0009986;GO:0030659;GO:0005789;GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0031625;GO:0042813;GO:0017147;GO:0060070;GO:0033278;GO:0035880;GO:0048105;GO:0001942;GO:0042472;GO:1904693;GO:0090090;GO:0043433;GO:0001843;GO:0035567;GO:0030168;GO:0007223;GO:0060071;, C:apical plasma membrane; C:apicolateral plasma membrane; C:cell surface; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:ubiquitin protein ligase binding; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:cell proliferation in midbrain; P:embryonic nail plate morphogenesis; P:establishment of body hair planar orientation; P:hair follicle development; P:inner ear morphogenesis; P:midbrain morphogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:neural tube closure; P:non-canonical Wnt signaling pathway; P:platelet activation; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway;|O60353 B4DRN0 Q6N0A5 Q6P9C3 Q8WXR9,Frizzled-6,, PF01534;PF01392;, GO:0016324;GO:0016327;GO:0009986;GO:0030659;GO:0005789;GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0031625;GO:0042813;GO:0017147;GO:0060070;GO:0033278;GO:0035880;GO:0048105;GO:0001942;GO:0042472;GO:1904693;GO:0090090;GO:0043433;GO:0001843;GO:0035567;GO:0030168;GO:0007223;GO:0060071;, C:apical plasma membrane; C:apicolateral plasma membrane; C:cell surface; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:ubiquitin protein ligase binding; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:cell proliferation in midbrain; P:embryonic nail plate morphogenesis; P:establishment of body hair planar orientation; P:hair follicle development; P:inner ear morphogenesis; P:midbrain morphogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:neural tube closure; P:non-canonical Wnt signaling pathway; P:platelet activation; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway;|O60353 B4DRN0 Q6N0A5 Q6P9C3 Q8WXR9,Frizzled-6,, PF01534;PF01392;, GO:0016324;GO:0016327;GO:0009986;GO:0030659;GO:0005789;GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0031625;GO:0042813;GO:0017147;GO:0060070;GO:0033278;GO:0035880;GO:0048105;GO:0001942;GO:0042472;GO:1904693;GO:0090090;GO:0043433;GO:0001843;GO:0035567;GO:0030168;GO:0007223;GO:0060071;, C:apical plasma membrane; C:apicolateral plasma membrane; C:cell surface; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:ubiquitin protein ligase binding; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:cell proliferation in midbrain; P:embryonic nail plate morphogenesis; P:establishment of body hair planar orientation; P:hair follicle development; P:inner ear morphogenesis; P:midbrain morphogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:neural tube closure; P:non-canonical Wnt signaling pathway; P:platelet activation; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold3 indexed_genome mRNA 19915812 19925412 . + . ID=transcript_692;Q96CG8 G3V141 Q6UW91 Q8IX63,Collagen triple helix repeat-containing protein 1,, , GO:0005581;GO:0062023;GO:0005737;GO:0005576;GO:0005615;GO:0005109;GO:0017147;GO:0016477;GO:0090103;GO:0090177;GO:0060122;GO:0090090;GO:0043932;GO:0045669;GO:0033690;GO:0032092;GO:0060071;, C:collagen trimer; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular region; C:extracellular space;, F:frizzled binding; F:Wnt-protein binding;, P:cell migration; P:cochlea morphogenesis; P:establishment of planar polarity involved in neural tube closure; P:inner ear receptor cell stereocilium organization; P:negative regulation of canonical Wnt signaling pathway; P:ossification involved in bone remodeling; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of protein binding; P:Wnt signaling pathway, planar cell polarity pathway; scaffold3 indexed_genome mRNA 19943734 19968304 . - . ID=transcript_693;Q9H2D1 A0A024R9D0 Q96JZ6 Q96SU7,Mitochondrial folate transporter/carrier,Solute carrier family 25 member 32;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015230;GO:0008517;GO:1904947;GO:0046655;GO:0015884;GO:1990548;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:FAD transmembrane transporter activity; F:folic acid transmembrane transporter activity;, P:folate import into mitochondrion; P:folic acid metabolic process; P:folic acid transport; P:mitochondrial FAD transmembrane transport;|Q9H2D1 A0A024R9D0 Q96JZ6 Q96SU7,Mitochondrial folate transporter/carrier,Solute carrier family 25 member 32;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015230;GO:0008517;GO:1904947;GO:0046655;GO:0015884;GO:1990548;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:FAD transmembrane transporter activity; F:folic acid transmembrane transporter activity;, P:folate import into mitochondrion; P:folic acid metabolic process; P:folic acid transport; P:mitochondrial FAD transmembrane transport; scaffold3 indexed_genome mRNA 19968409 19996363 . + . ID=transcript_694;Q9NV06 Q3MII9 Q8NCH8 Q8TC51 Q96JY7 Q9NZX3,DDB1- and CUL4-associated factor 13,WD repeat and SOF domain-containing protein 1;, PF08662;PF04158;PF00400;, GO:0030054;GO:0005813;GO:0080008;GO:0005829;GO:0005730;GO:0005654;GO:0032040;GO:0030331;GO:0003723;GO:0000462;GO:0043687;GO:0016567;GO:0006364;, C:cell junction; C:centrosome; C:Cul4-RING E3 ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:estrogen receptor binding; F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:post-translational protein modification; P:protein ubiquitination; P:rRNA processing;|Q9NV06 Q3MII9 Q8NCH8 Q8TC51 Q96JY7 Q9NZX3,DDB1- and CUL4-associated factor 13,WD repeat and SOF domain-containing protein 1;, PF08662;PF04158;PF00400;, GO:0030054;GO:0005813;GO:0080008;GO:0005829;GO:0005730;GO:0005654;GO:0032040;GO:0030331;GO:0003723;GO:0000462;GO:0043687;GO:0016567;GO:0006364;, C:cell junction; C:centrosome; C:Cul4-RING E3 ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:estrogen receptor binding; F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:post-translational protein modification; P:protein ubiquitination; P:rRNA processing;|Q9NV06 Q3MII9 Q8NCH8 Q8TC51 Q96JY7 Q9NZX3,DDB1- and CUL4-associated factor 13,WD repeat and SOF domain-containing protein 1;, PF08662;PF04158;PF00400;, GO:0030054;GO:0005813;GO:0080008;GO:0005829;GO:0005730;GO:0005654;GO:0032040;GO:0030331;GO:0003723;GO:0000462;GO:0043687;GO:0016567;GO:0006364;, C:cell junction; C:centrosome; C:Cul4-RING E3 ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:estrogen receptor binding; F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:post-translational protein modification; P:protein ubiquitination; P:rRNA processing;|Q9NV06 Q3MII9 Q8NCH8 Q8TC51 Q96JY7 Q9NZX3,DDB1- and CUL4-associated factor 13,WD repeat and SOF domain-containing protein 1;, PF08662;PF04158;PF00400;, GO:0030054;GO:0005813;GO:0080008;GO:0005829;GO:0005730;GO:0005654;GO:0032040;GO:0030331;GO:0003723;GO:0000462;GO:0043687;GO:0016567;GO:0006364;, C:cell junction; C:centrosome; C:Cul4-RING E3 ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:estrogen receptor binding; F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:post-translational protein modification; P:protein ubiquitination; P:rRNA processing;|Q9NV06 Q3MII9 Q8NCH8 Q8TC51 Q96JY7 Q9NZX3,DDB1- and CUL4-associated factor 13,WD repeat and SOF domain-containing protein 1;, PF08662;PF04158;PF00400;, GO:0030054;GO:0005813;GO:0080008;GO:0005829;GO:0005730;GO:0005654;GO:0032040;GO:0030331;GO:0003723;GO:0000462;GO:0043687;GO:0016567;GO:0006364;, C:cell junction; C:centrosome; C:Cul4-RING E3 ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:estrogen receptor binding; F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:post-translational protein modification; P:protein ubiquitination; P:rRNA processing; scaffold3 indexed_genome mRNA 20520138 20649711 . + . ID=transcript_695;Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9UQ26 B3KX91 F8WD47 O43413 Q86XL9 Q8IWV9 Q8IWW1,Regulating synaptic membrane exocytosis protein 2,Rab-3-interacting molecule 2;Rab-3-interacting protein 3;, PF00168;PF02318;PF17820;, GO:0042995;GO:0048788;GO:0070062;GO:0048786;GO:0042734;GO:0044325;GO:0046872;GO:0031267;GO:0048791;GO:0017156;GO:0019933;GO:0030154;GO:0030073;GO:0006886;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0017157;GO:0042391;GO:0048167;GO:2000300;GO:0061669;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:presynaptic active zone; C:presynaptic membrane;, F:ion channel binding; F:metal ion binding; F:small GTPase binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:cell differentiation; P:insulin secretion; P:intracellular protein transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:regulation of exocytosis; P:regulation of membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:spontaneous neurotransmitter secretion;|Q9UQ26 B3KX91 F8WD47 O43413 Q86XL9 Q8IWV9 Q8IWW1,Regulating synaptic membrane exocytosis protein 2,Rab-3-interacting molecule 2;Rab-3-interacting protein 3;, PF00168;PF02318;PF17820;, GO:0042995;GO:0048788;GO:0070062;GO:0048786;GO:0042734;GO:0044325;GO:0046872;GO:0031267;GO:0048791;GO:0017156;GO:0019933;GO:0030154;GO:0030073;GO:0006886;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0017157;GO:0042391;GO:0048167;GO:2000300;GO:0061669;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:presynaptic active zone; C:presynaptic membrane;, F:ion channel binding; F:metal ion binding; F:small GTPase binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:cell differentiation; P:insulin secretion; P:intracellular protein transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:regulation of exocytosis; P:regulation of membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:spontaneous neurotransmitter secretion;|Q9UQ26 B3KX91 F8WD47 O43413 Q86XL9 Q8IWV9 Q8IWW1,Regulating synaptic membrane exocytosis protein 2,Rab-3-interacting molecule 2;Rab-3-interacting protein 3;, PF00168;PF02318;PF17820;, GO:0042995;GO:0048788;GO:0070062;GO:0048786;GO:0042734;GO:0044325;GO:0046872;GO:0031267;GO:0048791;GO:0017156;GO:0019933;GO:0030154;GO:0030073;GO:0006886;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0017157;GO:0042391;GO:0048167;GO:2000300;GO:0061669;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:presynaptic active zone; C:presynaptic membrane;, F:ion channel binding; F:metal ion binding; F:small GTPase binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:cell differentiation; P:insulin secretion; P:intracellular protein transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:regulation of exocytosis; P:regulation of membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:spontaneous neurotransmitter secretion;|Q9UQ26 B3KX91 F8WD47 O43413 Q86XL9 Q8IWV9 Q8IWW1,Regulating synaptic membrane exocytosis protein 2,Rab-3-interacting molecule 2;Rab-3-interacting protein 3;, PF00168;PF02318;PF17820;, GO:0042995;GO:0048788;GO:0070062;GO:0048786;GO:0042734;GO:0044325;GO:0046872;GO:0031267;GO:0048791;GO:0017156;GO:0019933;GO:0030154;GO:0030073;GO:0006886;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0017157;GO:0042391;GO:0048167;GO:2000300;GO:0061669;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:presynaptic active zone; C:presynaptic membrane;, F:ion channel binding; F:metal ion binding; F:small GTPase binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:cell differentiation; P:insulin secretion; P:intracellular protein transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:regulation of exocytosis; P:regulation of membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:spontaneous neurotransmitter secretion; scaffold3 indexed_genome mRNA 20725734 20726416 . - . ID=transcript_696;Q9H295 B7ZVW2 E7ESG0 Q2M2D5,Dendritic cell-specific transmembrane protein,Dendrocyte-expressed seven transmembrane protein;IL-four-induced protein;Transmembrane 7 superfamily member 4;, PF07782;, GO:0009986;GO:0005789;GO:0033116;GO:0010008;GO:0030176;GO:0016021;GO:0005886;GO:0071353;GO:0036006;GO:0071356;GO:0061025;GO:0043011;GO:0030308;GO:0030316;GO:0072675;GO:0045780;GO:0034241;GO:0045657;, C:cell surface; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:endosome membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, , P:cellular response to interleukin-4; P:cellular response to macrophage colony-stimulating factor stimulus; P:cellular response to tumor necrosis factor; P:membrane fusion; P:myeloid dendritic cell differentiation; P:negative regulation of cell growth; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of bone resorption; P:positive regulation of macrophage fusion; P:positive regulation of monocyte differentiation; scaffold3 indexed_genome mRNA 20726730 20733827 . + . ID=transcript_697;Q9H295 B7ZVW2 E7ESG0 Q2M2D5,Dendritic cell-specific transmembrane protein,Dendrocyte-expressed seven transmembrane protein;IL-four-induced protein;Transmembrane 7 superfamily member 4;, PF07782;, GO:0009986;GO:0005789;GO:0033116;GO:0010008;GO:0030176;GO:0016021;GO:0005886;GO:0071353;GO:0036006;GO:0071356;GO:0061025;GO:0043011;GO:0030308;GO:0030316;GO:0072675;GO:0045780;GO:0034241;GO:0045657;, C:cell surface; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:endosome membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, , P:cellular response to interleukin-4; P:cellular response to macrophage colony-stimulating factor stimulus; P:cellular response to tumor necrosis factor; P:membrane fusion; P:myeloid dendritic cell differentiation; P:negative regulation of cell growth; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of bone resorption; P:positive regulation of macrophage fusion; P:positive regulation of monocyte differentiation; scaffold3 indexed_genome mRNA 20758346 20854614 . - . ID=transcript_698;Q14117,Dihydropyrimidinase,Dihydropyrimidine amidohydrolase;Hydantoinase;, PF01979;, GO:0005829;GO:0070062;GO:0032991;GO:0016597;GO:0004157;GO:0042802;GO:0051219;GO:0002059;GO:0002058;GO:0008270;GO:0019482;GO:0006248;GO:0006249;GO:0046079;GO:0006208;GO:0046135;GO:0006210;GO:0046050;GO:0006212;, C:cytosol; C:extracellular exosome; C:protein-containing complex;, F:amino acid binding; F:dihydropyrimidinase activity; F:identical protein binding; F:phosphoprotein binding; F:thymine binding; F:uracil binding; F:zinc ion binding;, P:beta-alanine metabolic process; P:CMP catabolic process; P:dCMP catabolic process; P:dUMP catabolic process; P:pyrimidine nucleobase catabolic process; P:pyrimidine nucleoside catabolic process; P:thymine catabolic process; P:UMP catabolic process; P:uracil catabolic process; scaffold3 indexed_genome mRNA 20873865 20882881 . - . ID=transcript_699;Q9Y561 A8K137 B4DRQ2,Low-density lipoprotein receptor-related protein 12,Suppressor of tumorigenicity 7 protein;, PF00431;PF00057;, GO:0005905;GO:0016021;GO:0005887;GO:0005041;GO:0006897;GO:0001764;GO:0031175;GO:0040008;GO:0007165;, C:clathrin-coated pit; C:integral component of membrane; C:integral component of plasma membrane;, F:low-density lipoprotein particle receptor activity;, P:endocytosis; P:neuron migration; P:neuron projection development; P:regulation of growth; P:signal transduction; scaffold3 indexed_genome mRNA 20884296 20885129 . + . ID=transcript_700;Q9Y561 A8K137 B4DRQ2,Low-density lipoprotein receptor-related protein 12,Suppressor of tumorigenicity 7 protein;, PF00431;PF00057;, GO:0005905;GO:0016021;GO:0005887;GO:0005041;GO:0006897;GO:0001764;GO:0031175;GO:0040008;GO:0007165;, C:clathrin-coated pit; C:integral component of membrane; C:integral component of plasma membrane;, F:low-density lipoprotein particle receptor activity;, P:endocytosis; P:neuron migration; P:neuron projection development; P:regulation of growth; P:signal transduction; scaffold3 indexed_genome mRNA 22083150 22093349 . - . ID=transcript_701;Q8WW38 Q32MA6 Q9NPL7 Q9NPS4 Q9UNI5,Zinc finger protein ZFPM2,Friend of GATA protein 2;Zinc finger protein 89B;Zinc finger protein multitype 2;, , GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:0007596;GO:0030154;GO:0048568;GO:0007506;GO:0007507;GO:0001701;GO:0030324;GO:0060548;GO:0045599;GO:2000195;GO:0000122;GO:0045892;GO:0003148;GO:0060045;GO:2000020;GO:0045944;GO:0003221;GO:0001570;GO:0060412;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:blood coagulation; P:cell differentiation; P:embryonic organ development; P:gonadal mesoderm development; P:heart development; P:in utero embryonic development; P:lung development; P:negative regulation of cell death; P:negative regulation of fat cell differentiation; P:negative regulation of female gonad development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:outflow tract septum morphogenesis; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of male gonad development; P:positive regulation of transcription by RNA polymerase II; P:right ventricular cardiac muscle tissue morphogenesis; P:vasculogenesis; P:ventricular septum morphogenesis;|Q8WW38 Q32MA6 Q9NPL7 Q9NPS4 Q9UNI5,Zinc finger protein ZFPM2,Friend of GATA protein 2;Zinc finger protein 89B;Zinc finger protein multitype 2;, , GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:0007596;GO:0030154;GO:0048568;GO:0007506;GO:0007507;GO:0001701;GO:0030324;GO:0060548;GO:0045599;GO:2000195;GO:0000122;GO:0045892;GO:0003148;GO:0060045;GO:2000020;GO:0045944;GO:0003221;GO:0001570;GO:0060412;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:blood coagulation; P:cell differentiation; P:embryonic organ development; P:gonadal mesoderm development; P:heart development; P:in utero embryonic development; P:lung development; P:negative regulation of cell death; P:negative regulation of fat cell differentiation; P:negative regulation of female gonad development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:outflow tract septum morphogenesis; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of male gonad development; P:positive regulation of transcription by RNA polymerase II; P:right ventricular cardiac muscle tissue morphogenesis; P:vasculogenesis; P:ventricular septum morphogenesis;|Q8WW38 Q32MA6 Q9NPL7 Q9NPS4 Q9UNI5,Zinc finger protein ZFPM2,Friend of GATA protein 2;Zinc finger protein 89B;Zinc finger protein multitype 2;, , GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:0007596;GO:0030154;GO:0048568;GO:0007506;GO:0007507;GO:0001701;GO:0030324;GO:0060548;GO:0045599;GO:2000195;GO:0000122;GO:0045892;GO:0003148;GO:0060045;GO:2000020;GO:0045944;GO:0003221;GO:0001570;GO:0060412;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:blood coagulation; P:cell differentiation; P:embryonic organ development; P:gonadal mesoderm development; P:heart development; P:in utero embryonic development; P:lung development; P:negative regulation of cell death; P:negative regulation of fat cell differentiation; P:negative regulation of female gonad development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:outflow tract septum morphogenesis; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of male gonad development; P:positive regulation of transcription by RNA polymerase II; P:right ventricular cardiac muscle tissue morphogenesis; P:vasculogenesis; P:ventricular septum morphogenesis; scaffold3 indexed_genome mRNA 22812264 22994346 . + . ID=transcript_702;Q8N8V0 Q9H266 Q9NWC7,Oxidation resistance protein 1,, PF01476;PF07534;, GO:0005739;GO:0005730;GO:0005634;GO:0016491;GO:0007628;GO:0071447;GO:1900408;GO:0043524;GO:1903204;GO:1902083;GO:0051402;GO:0006979;, C:mitochondrion; C:nucleolus; C:nucleus;, F:oxidoreductase activity;, P:adult walking behavior; P:cellular response to hydroperoxide; P:negative regulation of cellular response to oxidative stress; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:neuron apoptotic process; P:response to oxidative stress;|Q8N8V0 Q9H266 Q9NWC7,Oxidation resistance protein 1,, PF01476;PF07534;, GO:0005739;GO:0005730;GO:0005634;GO:0016491;GO:0007628;GO:0071447;GO:1900408;GO:0043524;GO:1903204;GO:1902083;GO:0051402;GO:0006979;, C:mitochondrion; C:nucleolus; C:nucleus;, F:oxidoreductase activity;, P:adult walking behavior; P:cellular response to hydroperoxide; P:negative regulation of cellular response to oxidative stress; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:neuron apoptotic process; P:response to oxidative stress;|Q8N8V0 Q9H266 Q9NWC7,Oxidation resistance protein 1,, PF01476;PF07534;, GO:0005739;GO:0005730;GO:0005634;GO:0016491;GO:0007628;GO:0071447;GO:1900408;GO:0043524;GO:1903204;GO:1902083;GO:0051402;GO:0006979;, C:mitochondrion; C:nucleolus; C:nucleus;, F:oxidoreductase activity;, P:adult walking behavior; P:cellular response to hydroperoxide; P:negative regulation of cellular response to oxidative stress; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:neuron apoptotic process; P:response to oxidative stress;|Q8N8V0 Q9H266 Q9NWC7,Oxidation resistance protein 1,, PF01476;PF07534;, GO:0005739;GO:0005730;GO:0005634;GO:0016491;GO:0007628;GO:0071447;GO:1900408;GO:0043524;GO:1903204;GO:1902083;GO:0051402;GO:0006979;, C:mitochondrion; C:nucleolus; C:nucleus;, F:oxidoreductase activity;, P:adult walking behavior; P:cellular response to hydroperoxide; P:negative regulation of cellular response to oxidative stress; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:neuron apoptotic process; P:response to oxidative stress;|Q8N8V0 Q9H266 Q9NWC7,Oxidation resistance protein 1,, PF01476;PF07534;, GO:0005739;GO:0005730;GO:0005634;GO:0016491;GO:0007628;GO:0071447;GO:1900408;GO:0043524;GO:1903204;GO:1902083;GO:0051402;GO:0006979;, C:mitochondrion; C:nucleolus; C:nucleus;, F:oxidoreductase activity;, P:adult walking behavior; P:cellular response to hydroperoxide; P:negative regulation of cellular response to oxidative stress; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:neuron apoptotic process; P:response to oxidative stress;|Q8N8V0 Q9H266 Q9NWC7,Oxidation resistance protein 1,, PF01476;PF07534;, GO:0005739;GO:0005730;GO:0005634;GO:0016491;GO:0007628;GO:0071447;GO:1900408;GO:0043524;GO:1903204;GO:1902083;GO:0051402;GO:0006979;, C:mitochondrion; C:nucleolus; C:nucleus;, F:oxidoreductase activity;, P:adult walking behavior; P:cellular response to hydroperoxide; P:negative regulation of cellular response to oxidative stress; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:neuron apoptotic process; P:response to oxidative stress;|Q8N8V0 Q9H266 Q9NWC7,Oxidation resistance protein 1,, PF01476;PF07534;, GO:0005739;GO:0005730;GO:0005634;GO:0016491;GO:0007628;GO:0071447;GO:1900408;GO:0043524;GO:1903204;GO:1902083;GO:0051402;GO:0006979;, C:mitochondrion; C:nucleolus; C:nucleus;, F:oxidoreductase activity;, P:adult walking behavior; P:cellular response to hydroperoxide; P:negative regulation of cellular response to oxidative stress; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:neuron apoptotic process; P:response to oxidative stress; scaffold3 indexed_genome mRNA 23008851 23009551 . - . ID=transcript_703;Q8N0Z2,Actin-binding Rho-activating protein,Striated muscle activator of Rho-dependent signaling;, PF14705;, GO:0015629;GO:0005886;GO:0030017;GO:0003779;GO:0051091;GO:0035025;GO:0045944;GO:0006606;, C:actin cytoskeleton; C:plasma membrane; C:sarcomere;, F:actin binding;, P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of Rho protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:protein import into nucleus; scaffold3 indexed_genome mRNA 23017304 23017961 . - . ID=transcript_704;Q8N0Z2,Actin-binding Rho-activating protein,Striated muscle activator of Rho-dependent signaling;, PF14705;, GO:0015629;GO:0005886;GO:0030017;GO:0003779;GO:0051091;GO:0035025;GO:0045944;GO:0006606;, C:actin cytoskeleton; C:plasma membrane; C:sarcomere;, F:actin binding;, P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of Rho protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:protein import into nucleus; scaffold3 indexed_genome mRNA 23514314 23801583 . - . ID=transcript_705;Q15389 Q5HYA0,Angiopoietin-1,, PF00147;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0045121;GO:0005902;GO:0005886;GO:0030971;GO:0005102;GO:0007171;GO:0001525;GO:0030154;GO:0031589;GO:0072012;GO:0030097;GO:0030210;GO:0001701;GO:0050900;GO:0000165;GO:0043066;GO:0007162;GO:0002719;GO:2000352;GO:0043524;GO:0042308;GO:0001933;GO:0043116;GO:0050918;GO:0043536;GO:1905605;GO:0045785;GO:0010595;GO:0070374;GO:0010628;GO:0033138;GO:0050731;GO:0014068;GO:0051897;GO:0001934;GO:0031398;GO:0002092;GO:0034394;GO:0043122;GO:2000446;GO:0043393;GO:0014842;GO:0032680;GO:0002040;GO:0048014;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane raft; C:microvillus; C:plasma membrane;, F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:activation of transmembrane receptor protein tyrosine kinase activity; P:angiogenesis; P:cell differentiation; P:cell-substrate adhesion; P:glomerulus vasculature development; P:hemopoiesis; P:heparin biosynthetic process; P:in utero embryonic development; P:leukocyte migration; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cytokine production involved in immune response; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:negative regulation of protein import into nucleus; P:negative regulation of protein phosphorylation; P:negative regulation of vascular permeability; P:positive chemotaxis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of blood-brain barrier permeability; P:positive regulation of cell adhesion; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of receptor internalization; P:protein localization to cell surface; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of macrophage migration inhibitory factor signaling pathway; P:regulation of protein binding; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of tumor necrosis factor production; P:sprouting angiogenesis; P:Tie signaling pathway; scaffold3 indexed_genome mRNA 24228248 24391069 . - . ID=transcript_706;Q6UXX9 B3KVP0 Q4G0U4 Q8N6X6,R-spondin-2,Roof plate-specific spondin-2;, PF15913;, GO:0009986;GO:0005576;GO:0008201;GO:0005102;GO:0030282;GO:0071542;GO:0035115;GO:0035116;GO:0060441;GO:0060173;GO:0060437;GO:0042489;GO:0001649;GO:0090263;GO:0030177;GO:0060535;GO:0016055;, C:cell surface; C:extracellular region;, F:heparin binding; F:signaling receptor binding;, P:bone mineralization; P:dopaminergic neuron differentiation; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:epithelial tube branching involved in lung morphogenesis; P:limb development; P:lung growth; P:negative regulation of odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Wnt signaling pathway; P:trachea cartilage morphogenesis; P:Wnt signaling pathway; scaffold3 indexed_genome mRNA 24472749 24524621 . - . ID=transcript_707;P60228 O43902 Q64058 Q64059 Q64252 Q6FG33 Q8WVK4,Eukaryotic translation initiation factor 3 subunit E {ECO:0000255|HAMAP-Rule:MF_03004},Eukaryotic translation initiation factor 3 subunit 6 {ECO:0000255|HAMAP-Rule:MF_03004};Viral integration site protein INT-6 homolog;eIF-3 p48 {ECO:0000255|HAMAP-Rule:MF_03004};, PF09440;PF01399;, GO:0005737;GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071540;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0016605;GO:0045296;GO:0047485;GO:0003723;GO:0003743;GO:0001732;GO:0045947;GO:0000184;GO:1902416;GO:0045727;GO:0006446;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:PML body;, F:cadherin binding; F:protein N-terminus binding; F:RNA binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:negative regulation of translational initiation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA binding; P:positive regulation of translation; P:regulation of translational initiation; P:translational initiation; scaffold3 indexed_genome mRNA 24753261 24804388 . + . ID=transcript_708;Q15006 Q8WUE1,ER membrane protein complex subunit 2 {ECO:0000305},Tetratricopeptide repeat protein 35 {ECO:0000312|HGNC:HGNC:28963};, , GO:0005737;GO:0072546;GO:0005783;GO:0005789;GO:0042406;GO:0045050;GO:0071816;, C:cytoplasm; C:EMC complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of endoplasmic reticulum membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q15006 Q8WUE1,ER membrane protein complex subunit 2 {ECO:0000305},Tetratricopeptide repeat protein 35 {ECO:0000312|HGNC:HGNC:28963};, , GO:0005737;GO:0072546;GO:0005783;GO:0005789;GO:0042406;GO:0045050;GO:0071816;, C:cytoplasm; C:EMC complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of endoplasmic reticulum membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q15006 Q8WUE1,ER membrane protein complex subunit 2 {ECO:0000305},Tetratricopeptide repeat protein 35 {ECO:0000312|HGNC:HGNC:28963};, , GO:0005737;GO:0072546;GO:0005783;GO:0005789;GO:0042406;GO:0045050;GO:0071816;, C:cytoplasm; C:EMC complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of endoplasmic reticulum membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q15006 Q8WUE1,ER membrane protein complex subunit 2 {ECO:0000305},Tetratricopeptide repeat protein 35 {ECO:0000312|HGNC:HGNC:28963};, , GO:0005737;GO:0072546;GO:0005783;GO:0005789;GO:0042406;GO:0045050;GO:0071816;, C:cytoplasm; C:EMC complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of endoplasmic reticulum membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane; scaffold3 indexed_genome mRNA 25104527 25113476 . - . ID=transcript_709;Q96NL1,Transmembrane protein 74,, , GO:0000421;GO:0031410;GO:0016021;GO:0005765;GO:0016236;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:lysosomal membrane;, , P:macroautophagy; scaffold3 indexed_genome mRNA 25496714 25568938 . - . ID=transcript_710;Q96RS6 B4DVX6 Q4G130 Q8NDQ5 Q8NG18 Q96SI4 Q9BVR5,NudC domain-containing protein 1,Chronic myelogenous leukemia tumor antigen 66;Tumor antigen CML66;, PF04969;, GO:0005829;GO:0005654;GO:0002376;, C:cytosol; C:nucleoplasm;, , P:immune system process; scaffold3 indexed_genome mRNA 25602630 25612380 . + . ID=transcript_711;Q9NPA8 B2RE52 G3V117,Transcription and mRNA export factor ENY2 {ECO:0000255|HAMAP-Rule:MF_03046},Enhancer of yellow 2 transcription factor homolog {ECO:0000255|HAMAP-Rule:MF_03046};, PF10163;, GO:0071819;GO:0005739;GO:0044615;GO:0005654;GO:0000124;GO:0070390;GO:0003682;GO:0030374;GO:0003713;GO:0016578;GO:0061179;GO:0016973;GO:0045893;GO:0006357;GO:0006368;, C:DUBm complex; C:mitochondrion; C:nuclear pore nuclear basket; C:nucleoplasm; C:SAGA complex; C:transcription export complex 2;, F:chromatin binding; F:nuclear receptor coactivator activity; F:transcription coactivator activity;, P:histone deubiquitination; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; P:poly(A)+ mRNA export from nucleus; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9NPA8 B2RE52 G3V117,Transcription and mRNA export factor ENY2 {ECO:0000255|HAMAP-Rule:MF_03046},Enhancer of yellow 2 transcription factor homolog {ECO:0000255|HAMAP-Rule:MF_03046};, PF10163;, GO:0071819;GO:0005739;GO:0044615;GO:0005654;GO:0000124;GO:0070390;GO:0003682;GO:0030374;GO:0003713;GO:0016578;GO:0061179;GO:0016973;GO:0045893;GO:0006357;GO:0006368;, C:DUBm complex; C:mitochondrion; C:nuclear pore nuclear basket; C:nucleoplasm; C:SAGA complex; C:transcription export complex 2;, F:chromatin binding; F:nuclear receptor coactivator activity; F:transcription coactivator activity;, P:histone deubiquitination; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; P:poly(A)+ mRNA export from nucleus; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold3 indexed_genome mRNA 25815259 25829269 . + . ID=transcript_712;O00559 A8K3N6 Q5Y8C7 Q6IB20 Q9BS76,Receptor-binding cancer antigen expressed on SiSo cells,Cancer-associated surface antigen RCAS1;Estrogen receptor-binding fragment-associated gene 9 protein;, , GO:0000139;GO:0016021;GO:0030141;GO:0016505;GO:0001558;, C:Golgi membrane; C:integral component of membrane; C:secretory granule;, F:peptidase activator activity involved in apoptotic process;, P:regulation of cell growth; scaffold3 indexed_genome mRNA 25831537 25834399 . + . ID=transcript_713;O00559 A8K3N6 Q5Y8C7 Q6IB20 Q9BS76,Receptor-binding cancer antigen expressed on SiSo cells,Cancer-associated surface antigen RCAS1;Estrogen receptor-binding fragment-associated gene 9 protein;, , GO:0000139;GO:0016021;GO:0030141;GO:0016505;GO:0001558;, C:Golgi membrane; C:integral component of membrane; C:secretory granule;, F:peptidase activator activity involved in apoptotic process;, P:regulation of cell growth; scaffold3 indexed_genome mRNA 25842690 25920364 . - . ID=transcript_714;Q8TCR6 Q96D80 Q9P256,Syntabulin,Golgi-localized syntaphilin-related protein;Syntaxin-1-binding protein;, PF15290;, GO:1904115;GO:0005881;GO:0031410;GO:0000139;GO:0016021;GO:0043231;GO:0019894;GO:0008017;GO:0017075;GO:0019896;GO:0060074;, C:axon cytoplasm; C:cytoplasmic microtubule; C:cytoplasmic vesicle; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:kinesin binding; F:microtubule binding; F:syntaxin-1 binding;, P:axonal transport of mitochondrion; P:synapse maturation;|Q8TCR6 Q96D80 Q9P256,Syntabulin,Golgi-localized syntaphilin-related protein;Syntaxin-1-binding protein;, PF15290;, GO:1904115;GO:0005881;GO:0031410;GO:0000139;GO:0016021;GO:0043231;GO:0019894;GO:0008017;GO:0017075;GO:0019896;GO:0060074;, C:axon cytoplasm; C:cytoplasmic microtubule; C:cytoplasmic vesicle; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:kinesin binding; F:microtubule binding; F:syntaxin-1 binding;, P:axonal transport of mitochondrion; P:synapse maturation;|Q8TCR6 Q96D80 Q9P256,Syntabulin,Golgi-localized syntaphilin-related protein;Syntaxin-1-binding protein;, PF15290;, GO:1904115;GO:0005881;GO:0031410;GO:0000139;GO:0016021;GO:0043231;GO:0019894;GO:0008017;GO:0017075;GO:0019896;GO:0060074;, C:axon cytoplasm; C:cytoplasmic microtubule; C:cytoplasmic vesicle; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:kinesin binding; F:microtubule binding; F:syntaxin-1 binding;, P:axonal transport of mitochondrion; P:synapse maturation;|P15880 B2R5G0 D3DU82 Q3MIB1,40S ribosomal protein S2,40S ribosomal protein S4;Protein LLRep3;Small ribosomal subunit protein uS5 {ECO:0000303|PubMed:24524803};, PF00333;PF03719;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0045296;GO:0019899;GO:0017134;GO:0003729;GO:0003723;GO:0003735;GO:0000184;GO:0051443;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus;, F:cadherin binding; F:enzyme binding; F:fibroblast growth factor binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of ubiquitin-protein transferase activity; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold3 indexed_genome mRNA 28153675 28479330 . - . ID=transcript_715;Q7Z407 Q96PZ3,CUB and sushi domain-containing protein 3,CUB and sushi multiple domains protein 3;, PF00431;PF00084;, GO:0016021;GO:0005886;GO:0050773;, C:integral component of membrane; C:plasma membrane;, , P:regulation of dendrite development;|Q7Z407 Q96PZ3,CUB and sushi domain-containing protein 3,CUB and sushi multiple domains protein 3;, PF00431;PF00084;, GO:0016021;GO:0005886;GO:0050773;, C:integral component of membrane; C:plasma membrane;, , P:regulation of dendrite development;|Q7Z407 Q96PZ3,CUB and sushi domain-containing protein 3,CUB and sushi multiple domains protein 3;, PF00431;PF00084;, GO:0016021;GO:0005886;GO:0050773;, C:integral component of membrane; C:plasma membrane;, , P:regulation of dendrite development; scaffold3 indexed_genome mRNA 28737906 28914463 . - . ID=transcript_716;Q7Z407 Q96PZ3,CUB and sushi domain-containing protein 3,CUB and sushi multiple domains protein 3;, PF00431;PF00084;, GO:0016021;GO:0005886;GO:0050773;, C:integral component of membrane; C:plasma membrane;, , P:regulation of dendrite development; scaffold3 indexed_genome mRNA 28992305 29316305 . - . ID=transcript_717;Q7Z407 Q96PZ3,CUB and sushi domain-containing protein 3,CUB and sushi multiple domains protein 3;, PF00431;PF00084;, GO:0016021;GO:0005886;GO:0050773;, C:integral component of membrane; C:plasma membrane;, , P:regulation of dendrite development; scaffold3 indexed_genome mRNA 31164467 31377935 . - . ID=transcript_718;Q9UHF7 B4E1Z5 Q08AU2 Q9NWE1 Q9UHH6,Zinc finger transcription factor Trps1,Tricho-rhino-phalangeal syndrome type I protein;Zinc finger protein GC79;, PF00320;, GO:0000785;GO:0005654;GO:0005634;GO:0032991;GO:0003700;GO:0001227;GO:0019904;GO:0000977;GO:0008270;GO:0000122;GO:0032330;GO:0006357;GO:0001501;, C:chromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of chondrocyte differentiation; P:regulation of transcription by RNA polymerase II; P:skeletal system development; scaffold3 indexed_genome mRNA 32344195 32348189 . - . ID=transcript_719;O15372,Eukaryotic translation initiation factor 3 subunit H {ECO:0000255|HAMAP-Rule:MF_03007},Eukaryotic translation initiation factor 3 subunit 3 {ECO:0000255|HAMAP-Rule:MF_03007};eIF-3-gamma;eIF3 p40 subunit {ECO:0000255|HAMAP-Rule:MF_03007};, PF01398;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0070062;GO:0016020;GO:0042788;GO:0070122;GO:0008237;GO:0003723;GO:0003743;GO:0101005;GO:0001732;GO:0032435;GO:0006446;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:extracellular exosome; C:membrane; C:polysomal ribosome;, F:isopeptidase activity; F:metallopeptidase activity; F:RNA binding; F:translation initiation factor activity; F:ubiquitinyl hydrolase activity;, P:formation of cytoplasmic translation initiation complex; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of translational initiation; P:translational initiation; scaffold3 indexed_genome mRNA 32454677 32456968 . + . ID=transcript_720;Q9BRU9 B2RE25 Q96NJ8,rRNA-processing protein UTP23 homolog,, PF04900;, GO:0005730;GO:0032040;GO:0003730;GO:0048027;GO:0003723;GO:0070181;GO:0000480;, C:nucleolus; C:small-subunit processome;, F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:RNA binding; F:small ribosomal subunit rRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q9BRU9 B2RE25 Q96NJ8,rRNA-processing protein UTP23 homolog,, PF04900;, GO:0005730;GO:0032040;GO:0003730;GO:0048027;GO:0003723;GO:0070181;GO:0000480;, C:nucleolus; C:small-subunit processome;, F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:RNA binding; F:small ribosomal subunit rRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q9BRU9 B2RE25 Q96NJ8,rRNA-processing protein UTP23 homolog,, PF04900;, GO:0005730;GO:0032040;GO:0003730;GO:0048027;GO:0003723;GO:0070181;GO:0000480;, C:nucleolus; C:small-subunit processome;, F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:RNA binding; F:small ribosomal subunit rRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); scaffold3 indexed_genome mRNA 32562182 32588211 . - . ID=transcript_721;O60216 A8K0E0 Q15001 Q99568,Double-strand-break repair protein rad21 homolog,Nuclear matrix protein 1 {ECO:0000303|PubMed:10623634};SCC1 homolog;, PF04824;PF04825;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0016020;GO:0016363;GO:0034991;GO:0034990;GO:0005654;GO:0000922;GO:0000795;GO:0003682;GO:0006915;GO:0051301;GO:0006310;GO:0006302;GO:0007064;GO:0007275;GO:0010972;GO:0045841;GO:0045876;GO:0071168;GO:0007131;GO:0006357;GO:1990414;GO:0007130;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:membrane; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleoplasm; C:spindle pole; C:synaptonemal complex;, F:chromatin binding;, P:apoptotic process; P:cell division; P:DNA recombination; P:double-strand break repair; P:mitotic sister chromatid cohesion; P:multicellular organism development; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of mitotic metaphase/anaphase transition; P:positive regulation of sister chromatid cohesion; P:protein localization to chromatin; P:reciprocal meiotic recombination; P:regulation of transcription by RNA polymerase II; P:replication-born double-strand break repair via sister chromatid exchange; P:synaptonemal complex assembly;|O60216 A8K0E0 Q15001 Q99568,Double-strand-break repair protein rad21 homolog,Nuclear matrix protein 1 {ECO:0000303|PubMed:10623634};SCC1 homolog;, PF04824;PF04825;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0016020;GO:0016363;GO:0034991;GO:0034990;GO:0005654;GO:0000922;GO:0000795;GO:0003682;GO:0006915;GO:0051301;GO:0006310;GO:0006302;GO:0007064;GO:0007275;GO:0010972;GO:0045841;GO:0045876;GO:0071168;GO:0007131;GO:0006357;GO:1990414;GO:0007130;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:membrane; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleoplasm; C:spindle pole; C:synaptonemal complex;, F:chromatin binding;, P:apoptotic process; P:cell division; P:DNA recombination; P:double-strand break repair; P:mitotic sister chromatid cohesion; P:multicellular organism development; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of mitotic metaphase/anaphase transition; P:positive regulation of sister chromatid cohesion; P:protein localization to chromatin; P:reciprocal meiotic recombination; P:regulation of transcription by RNA polymerase II; P:replication-born double-strand break repair via sister chromatid exchange; P:synaptonemal complex assembly;|O60216 A8K0E0 Q15001 Q99568,Double-strand-break repair protein rad21 homolog,Nuclear matrix protein 1 {ECO:0000303|PubMed:10623634};SCC1 homolog;, PF04824;PF04825;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0016020;GO:0016363;GO:0034991;GO:0034990;GO:0005654;GO:0000922;GO:0000795;GO:0003682;GO:0006915;GO:0051301;GO:0006310;GO:0006302;GO:0007064;GO:0007275;GO:0010972;GO:0045841;GO:0045876;GO:0071168;GO:0007131;GO:0006357;GO:1990414;GO:0007130;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:membrane; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleoplasm; C:spindle pole; C:synaptonemal complex;, F:chromatin binding;, P:apoptotic process; P:cell division; P:DNA recombination; P:double-strand break repair; P:mitotic sister chromatid cohesion; P:multicellular organism development; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of mitotic metaphase/anaphase transition; P:positive regulation of sister chromatid cohesion; P:protein localization to chromatin; P:reciprocal meiotic recombination; P:regulation of transcription by RNA polymerase II; P:replication-born double-strand break repair via sister chromatid exchange; P:synaptonemal complex assembly;|O60216 A8K0E0 Q15001 Q99568,Double-strand-break repair protein rad21 homolog,Nuclear matrix protein 1 {ECO:0000303|PubMed:10623634};SCC1 homolog;, PF04824;PF04825;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0016020;GO:0016363;GO:0034991;GO:0034990;GO:0005654;GO:0000922;GO:0000795;GO:0003682;GO:0006915;GO:0051301;GO:0006310;GO:0006302;GO:0007064;GO:0007275;GO:0010972;GO:0045841;GO:0045876;GO:0071168;GO:0007131;GO:0006357;GO:1990414;GO:0007130;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:membrane; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleoplasm; C:spindle pole; C:synaptonemal complex;, F:chromatin binding;, P:apoptotic process; P:cell division; P:DNA recombination; P:double-strand break repair; P:mitotic sister chromatid cohesion; P:multicellular organism development; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of mitotic metaphase/anaphase transition; P:positive regulation of sister chromatid cohesion; P:protein localization to chromatin; P:reciprocal meiotic recombination; P:regulation of transcription by RNA polymerase II; P:replication-born double-strand break repair via sister chromatid exchange; P:synaptonemal complex assembly;|O60216 A8K0E0 Q15001 Q99568,Double-strand-break repair protein rad21 homolog,Nuclear matrix protein 1 {ECO:0000303|PubMed:10623634};SCC1 homolog;, PF04824;PF04825;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0016020;GO:0016363;GO:0034991;GO:0034990;GO:0005654;GO:0000922;GO:0000795;GO:0003682;GO:0006915;GO:0051301;GO:0006310;GO:0006302;GO:0007064;GO:0007275;GO:0010972;GO:0045841;GO:0045876;GO:0071168;GO:0007131;GO:0006357;GO:1990414;GO:0007130;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:membrane; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleoplasm; C:spindle pole; C:synaptonemal complex;, F:chromatin binding;, P:apoptotic process; P:cell division; P:DNA recombination; P:double-strand break repair; P:mitotic sister chromatid cohesion; P:multicellular organism development; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of mitotic metaphase/anaphase transition; P:positive regulation of sister chromatid cohesion; P:protein localization to chromatin; P:reciprocal meiotic recombination; P:regulation of transcription by RNA polymerase II; P:replication-born double-strand break repair via sister chromatid exchange; P:synaptonemal complex assembly;|O60216 A8K0E0 Q15001 Q99568,Double-strand-break repair protein rad21 homolog,Nuclear matrix protein 1 {ECO:0000303|PubMed:10623634};SCC1 homolog;, PF04824;PF04825;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0016020;GO:0016363;GO:0034991;GO:0034990;GO:0005654;GO:0000922;GO:0000795;GO:0003682;GO:0006915;GO:0051301;GO:0006310;GO:0006302;GO:0007064;GO:0007275;GO:0010972;GO:0045841;GO:0045876;GO:0071168;GO:0007131;GO:0006357;GO:1990414;GO:0007130;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:membrane; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleoplasm; C:spindle pole; C:synaptonemal complex;, F:chromatin binding;, P:apoptotic process; P:cell division; P:DNA recombination; P:double-strand break repair; P:mitotic sister chromatid cohesion; P:multicellular organism development; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of mitotic metaphase/anaphase transition; P:positive regulation of sister chromatid cohesion; P:protein localization to chromatin; P:reciprocal meiotic recombination; P:regulation of transcription by RNA polymerase II; P:replication-born double-strand break repair via sister chromatid exchange; P:synaptonemal complex assembly;|O60216 A8K0E0 Q15001 Q99568,Double-strand-break repair protein rad21 homolog,Nuclear matrix protein 1 {ECO:0000303|PubMed:10623634};SCC1 homolog;, PF04824;PF04825;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0016020;GO:0016363;GO:0034991;GO:0034990;GO:0005654;GO:0000922;GO:0000795;GO:0003682;GO:0006915;GO:0051301;GO:0006310;GO:0006302;GO:0007064;GO:0007275;GO:0010972;GO:0045841;GO:0045876;GO:0071168;GO:0007131;GO:0006357;GO:1990414;GO:0007130;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:membrane; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleoplasm; C:spindle pole; C:synaptonemal complex;, F:chromatin binding;, P:apoptotic process; P:cell division; P:DNA recombination; P:double-strand break repair; P:mitotic sister chromatid cohesion; P:multicellular organism development; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of mitotic metaphase/anaphase transition; P:positive regulation of sister chromatid cohesion; P:protein localization to chromatin; P:reciprocal meiotic recombination; P:regulation of transcription by RNA polymerase II; P:replication-born double-strand break repair via sister chromatid exchange; P:synaptonemal complex assembly;|O60216 A8K0E0 Q15001 Q99568,Double-strand-break repair protein rad21 homolog,Nuclear matrix protein 1 {ECO:0000303|PubMed:10623634};SCC1 homolog;, PF04824;PF04825;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0016020;GO:0016363;GO:0034991;GO:0034990;GO:0005654;GO:0000922;GO:0000795;GO:0003682;GO:0006915;GO:0051301;GO:0006310;GO:0006302;GO:0007064;GO:0007275;GO:0010972;GO:0045841;GO:0045876;GO:0071168;GO:0007131;GO:0006357;GO:1990414;GO:0007130;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:membrane; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleoplasm; C:spindle pole; C:synaptonemal complex;, F:chromatin binding;, P:apoptotic process; P:cell division; P:DNA recombination; P:double-strand break repair; P:mitotic sister chromatid cohesion; P:multicellular organism development; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of mitotic metaphase/anaphase transition; P:positive regulation of sister chromatid cohesion; P:protein localization to chromatin; P:reciprocal meiotic recombination; P:regulation of transcription by RNA polymerase II; P:replication-born double-strand break repair via sister chromatid exchange; P:synaptonemal complex assembly; scaffold3 indexed_genome mRNA 33173242 33192459 . + . ID=transcript_722;Q96HR3 C6GKU9,Mediator of RNA polymerase II transcription subunit 30,Mediator complex subunit 30;TRAP/Mediator complex component TRAP25;Thyroid hormone receptor-associated protein 6;Thyroid hormone receptor-associated protein complex 25 kDa component;, PF11315;, GO:0016592;GO:0005654;GO:0005634;GO:0000151;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0061630;GO:0042809;GO:0060261;GO:0045893;GO:0060260;GO:0019827;, C:mediator complex; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription initiation from RNA polymerase II promoter; P:stem cell population maintenance; scaffold3 indexed_genome mRNA 33497497 33805565 . - . ID=transcript_723;Q16394 B2R7V2 Q9BVI9,Exostosin-1,Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Multiple exostoses protein 1;Putative tumor suppressor protein EXT1;, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0030176;GO:0016021;GO:0045202;GO:0008375;GO:0050508;GO:0015020;GO:0042328;GO:0046872;GO:0050509;GO:0046982;GO:0042803;GO:0016757;GO:0019882;GO:0007411;GO:0071711;GO:0001974;GO:0030509;GO:0045453;GO:0060070;GO:0060351;GO:0033627;GO:0045165;GO:0033692;GO:0002062;GO:0035988;GO:0030204;GO:0030199;GO:1904888;GO:0070593;GO:0036336;GO:0060560;GO:0072498;GO:0003416;GO:0001958;GO:0007492;GO:0060441;GO:0042596;GO:0008543;GO:0042044;GO:0007369;GO:0010467;GO:0002067;GO:0032836;GO:0072112;GO:0006024;GO:0060047;GO:0003128;GO:0060218;GO:0061484;GO:0097241;GO:0015012;GO:0015014;GO:0030210;GO:0002524;GO:0050901;GO:0036022;GO:0036339;GO:0097021;GO:1901706;GO:0007498;GO:0061744;GO:0050891;GO:0014033;GO:0021772;GO:0021554;GO:0001503;GO:0043931;GO:0061974;GO:0030163;GO:0006486;GO:0065003;GO:0008217;GO:0071503;GO:1990823;GO:0009642;GO:0009615;GO:0007165;GO:0001501;GO:0060506;GO:0035176;GO:0055078;GO:0017145;GO:0062094;GO:0051923;GO:0035249;GO:0120193;GO:0071847;GO:0007033;GO:0042311;GO:0071625;GO:0042060;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:synapse;, F:acetylglucosaminyltransferase activity; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronosyltransferase activity; F:heparan sulfate N-acetylglucosaminyltransferase activity; F:metal ion binding; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferase activity, transferring glycosyl groups;, P:antigen processing and presentation; P:axon guidance; P:basement membrane organization; P:blood vessel remodeling; P:BMP signaling pathway; P:bone resorption; P:canonical Wnt signaling pathway; P:cartilage development involved in endochondral bone morphogenesis; P:cell adhesion mediated by integrin; P:cell fate commitment; P:cellular polysaccharide biosynthetic process; P:chondrocyte differentiation; P:chondrocyte proliferation; P:chondroitin sulfate metabolic process; P:collagen fibril organization; P:cranial skeletal system development; P:dendrite self-avoidance; P:dendritic cell migration; P:developmental growth involved in morphogenesis; P:embryonic skeletal joint development; P:endochondral bone growth; P:endochondral ossification; P:endoderm development; P:epithelial tube branching involved in lung morphogenesis; P:fear response; P:fibroblast growth factor receptor signaling pathway; P:fluid transport; P:gastrulation; P:gene expression; P:glandular epithelial cell differentiation; P:glomerular basement membrane development; P:glomerular visceral epithelial cell differentiation; P:glycosaminoglycan biosynthetic process; P:heart contraction; P:heart field specification; P:hematopoietic stem cell differentiation; P:hematopoietic stem cell homeostasis; P:hematopoietic stem cell migration to bone marrow; P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:hypersensitivity; P:leukocyte tethering or rolling; P:limb joint morphogenesis; P:lymphocyte adhesion to endothelial cell of high endothelial venule; P:lymphocyte migration into lymphoid organs; P:mesenchymal cell differentiation involved in bone development; P:mesoderm development; P:motor behavior; P:multicellular organismal water homeostasis; P:neural crest cell differentiation; P:olfactory bulb development; P:optic nerve development; P:ossification; P:ossification involved in bone maturation; P:perichondral bone morphogenesis; P:protein catabolic process; P:protein glycosylation; P:protein-containing complex assembly; P:regulation of blood pressure; P:response to heparin; P:response to leukemia inhibitory factor; P:response to light intensity; P:response to virus; P:signal transduction; P:skeletal system development; P:smoothened signaling pathway involved in lung development; P:social behavior; P:sodium ion homeostasis; P:stem cell division; P:stomach development; P:sulfation; P:synaptic transmission, glutamatergic; P:tight junction organization; P:TNFSF11-mediated signaling pathway; P:vacuole organization; P:vasodilation; P:vocalization behavior; P:wound healing;|Q16394 B2R7V2 Q9BVI9,Exostosin-1,Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Multiple exostoses protein 1;Putative tumor suppressor protein EXT1;, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0030176;GO:0016021;GO:0045202;GO:0008375;GO:0050508;GO:0015020;GO:0042328;GO:0046872;GO:0050509;GO:0046982;GO:0042803;GO:0016757;GO:0019882;GO:0007411;GO:0071711;GO:0001974;GO:0030509;GO:0045453;GO:0060070;GO:0060351;GO:0033627;GO:0045165;GO:0033692;GO:0002062;GO:0035988;GO:0030204;GO:0030199;GO:1904888;GO:0070593;GO:0036336;GO:0060560;GO:0072498;GO:0003416;GO:0001958;GO:0007492;GO:0060441;GO:0042596;GO:0008543;GO:0042044;GO:0007369;GO:0010467;GO:0002067;GO:0032836;GO:0072112;GO:0006024;GO:0060047;GO:0003128;GO:0060218;GO:0061484;GO:0097241;GO:0015012;GO:0015014;GO:0030210;GO:0002524;GO:0050901;GO:0036022;GO:0036339;GO:0097021;GO:1901706;GO:0007498;GO:0061744;GO:0050891;GO:0014033;GO:0021772;GO:0021554;GO:0001503;GO:0043931;GO:0061974;GO:0030163;GO:0006486;GO:0065003;GO:0008217;GO:0071503;GO:1990823;GO:0009642;GO:0009615;GO:0007165;GO:0001501;GO:0060506;GO:0035176;GO:0055078;GO:0017145;GO:0062094;GO:0051923;GO:0035249;GO:0120193;GO:0071847;GO:0007033;GO:0042311;GO:0071625;GO:0042060;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:synapse;, F:acetylglucosaminyltransferase activity; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronosyltransferase activity; F:heparan sulfate N-acetylglucosaminyltransferase activity; F:metal ion binding; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferase activity, transferring glycosyl groups;, P:antigen processing and presentation; P:axon guidance; P:basement membrane organization; P:blood vessel remodeling; P:BMP signaling pathway; P:bone resorption; P:canonical Wnt signaling pathway; P:cartilage development involved in endochondral bone morphogenesis; P:cell adhesion mediated by integrin; P:cell fate commitment; P:cellular polysaccharide biosynthetic process; P:chondrocyte differentiation; P:chondrocyte proliferation; P:chondroitin sulfate metabolic process; P:collagen fibril organization; P:cranial skeletal system development; P:dendrite self-avoidance; P:dendritic cell migration; P:developmental growth involved in morphogenesis; P:embryonic skeletal joint development; P:endochondral bone growth; P:endochondral ossification; P:endoderm development; P:epithelial tube branching involved in lung morphogenesis; P:fear response; P:fibroblast growth factor receptor signaling pathway; P:fluid transport; P:gastrulation; P:gene expression; P:glandular epithelial cell differentiation; P:glomerular basement membrane development; P:glomerular visceral epithelial cell differentiation; P:glycosaminoglycan biosynthetic process; P:heart contraction; P:heart field specification; P:hematopoietic stem cell differentiation; P:hematopoietic stem cell homeostasis; P:hematopoietic stem cell migration to bone marrow; P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:hypersensitivity; P:leukocyte tethering or rolling; P:limb joint morphogenesis; P:lymphocyte adhesion to endothelial cell of high endothelial venule; P:lymphocyte migration into lymphoid organs; P:mesenchymal cell differentiation involved in bone development; P:mesoderm development; P:motor behavior; P:multicellular organismal water homeostasis; P:neural crest cell differentiation; P:olfactory bulb development; P:optic nerve development; P:ossification; P:ossification involved in bone maturation; P:perichondral bone morphogenesis; P:protein catabolic process; P:protein glycosylation; P:protein-containing complex assembly; P:regulation of blood pressure; P:response to heparin; P:response to leukemia inhibitory factor; P:response to light intensity; P:response to virus; P:signal transduction; P:skeletal system development; P:smoothened signaling pathway involved in lung development; P:social behavior; P:sodium ion homeostasis; P:stem cell division; P:stomach development; P:sulfation; P:synaptic transmission, glutamatergic; P:tight junction organization; P:TNFSF11-mediated signaling pathway; P:vacuole organization; P:vasodilation; P:vocalization behavior; P:wound healing;|Q16394 B2R7V2 Q9BVI9,Exostosin-1,Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Multiple exostoses protein 1;Putative tumor suppressor protein EXT1;, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0030176;GO:0016021;GO:0045202;GO:0008375;GO:0050508;GO:0015020;GO:0042328;GO:0046872;GO:0050509;GO:0046982;GO:0042803;GO:0016757;GO:0019882;GO:0007411;GO:0071711;GO:0001974;GO:0030509;GO:0045453;GO:0060070;GO:0060351;GO:0033627;GO:0045165;GO:0033692;GO:0002062;GO:0035988;GO:0030204;GO:0030199;GO:1904888;GO:0070593;GO:0036336;GO:0060560;GO:0072498;GO:0003416;GO:0001958;GO:0007492;GO:0060441;GO:0042596;GO:0008543;GO:0042044;GO:0007369;GO:0010467;GO:0002067;GO:0032836;GO:0072112;GO:0006024;GO:0060047;GO:0003128;GO:0060218;GO:0061484;GO:0097241;GO:0015012;GO:0015014;GO:0030210;GO:0002524;GO:0050901;GO:0036022;GO:0036339;GO:0097021;GO:1901706;GO:0007498;GO:0061744;GO:0050891;GO:0014033;GO:0021772;GO:0021554;GO:0001503;GO:0043931;GO:0061974;GO:0030163;GO:0006486;GO:0065003;GO:0008217;GO:0071503;GO:1990823;GO:0009642;GO:0009615;GO:0007165;GO:0001501;GO:0060506;GO:0035176;GO:0055078;GO:0017145;GO:0062094;GO:0051923;GO:0035249;GO:0120193;GO:0071847;GO:0007033;GO:0042311;GO:0071625;GO:0042060;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:synapse;, F:acetylglucosaminyltransferase activity; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronosyltransferase activity; F:heparan sulfate N-acetylglucosaminyltransferase activity; F:metal ion binding; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferase activity, transferring glycosyl groups;, P:antigen processing and presentation; P:axon guidance; P:basement membrane organization; P:blood vessel remodeling; P:BMP signaling pathway; P:bone resorption; P:canonical Wnt signaling pathway; P:cartilage development involved in endochondral bone morphogenesis; P:cell adhesion mediated by integrin; P:cell fate commitment; P:cellular polysaccharide biosynthetic process; P:chondrocyte differentiation; P:chondrocyte proliferation; P:chondroitin sulfate metabolic process; P:collagen fibril organization; P:cranial skeletal system development; P:dendrite self-avoidance; P:dendritic cell migration; P:developmental growth involved in morphogenesis; P:embryonic skeletal joint development; P:endochondral bone growth; P:endochondral ossification; P:endoderm development; P:epithelial tube branching involved in lung morphogenesis; P:fear response; P:fibroblast growth factor receptor signaling pathway; P:fluid transport; P:gastrulation; P:gene expression; P:glandular epithelial cell differentiation; P:glomerular basement membrane development; P:glomerular visceral epithelial cell differentiation; P:glycosaminoglycan biosynthetic process; P:heart contraction; P:heart field specification; P:hematopoietic stem cell differentiation; P:hematopoietic stem cell homeostasis; P:hematopoietic stem cell migration to bone marrow; P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:hypersensitivity; P:leukocyte tethering or rolling; P:limb joint morphogenesis; P:lymphocyte adhesion to endothelial cell of high endothelial venule; P:lymphocyte migration into lymphoid organs; P:mesenchymal cell differentiation involved in bone development; P:mesoderm development; P:motor behavior; P:multicellular organismal water homeostasis; P:neural crest cell differentiation; P:olfactory bulb development; P:optic nerve development; P:ossification; P:ossification involved in bone maturation; P:perichondral bone morphogenesis; P:protein catabolic process; P:protein glycosylation; P:protein-containing complex assembly; P:regulation of blood pressure; P:response to heparin; P:response to leukemia inhibitory factor; P:response to light intensity; P:response to virus; P:signal transduction; P:skeletal system development; P:smoothened signaling pathway involved in lung development; P:social behavior; P:sodium ion homeostasis; P:stem cell division; P:stomach development; P:sulfation; P:synaptic transmission, glutamatergic; P:tight junction organization; P:TNFSF11-mediated signaling pathway; P:vacuole organization; P:vasodilation; P:vocalization behavior; P:wound healing;|Q16394 B2R7V2 Q9BVI9,Exostosin-1,Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Multiple exostoses protein 1;Putative tumor suppressor protein EXT1;, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0030176;GO:0016021;GO:0045202;GO:0008375;GO:0050508;GO:0015020;GO:0042328;GO:0046872;GO:0050509;GO:0046982;GO:0042803;GO:0016757;GO:0019882;GO:0007411;GO:0071711;GO:0001974;GO:0030509;GO:0045453;GO:0060070;GO:0060351;GO:0033627;GO:0045165;GO:0033692;GO:0002062;GO:0035988;GO:0030204;GO:0030199;GO:1904888;GO:0070593;GO:0036336;GO:0060560;GO:0072498;GO:0003416;GO:0001958;GO:0007492;GO:0060441;GO:0042596;GO:0008543;GO:0042044;GO:0007369;GO:0010467;GO:0002067;GO:0032836;GO:0072112;GO:0006024;GO:0060047;GO:0003128;GO:0060218;GO:0061484;GO:0097241;GO:0015012;GO:0015014;GO:0030210;GO:0002524;GO:0050901;GO:0036022;GO:0036339;GO:0097021;GO:1901706;GO:0007498;GO:0061744;GO:0050891;GO:0014033;GO:0021772;GO:0021554;GO:0001503;GO:0043931;GO:0061974;GO:0030163;GO:0006486;GO:0065003;GO:0008217;GO:0071503;GO:1990823;GO:0009642;GO:0009615;GO:0007165;GO:0001501;GO:0060506;GO:0035176;GO:0055078;GO:0017145;GO:0062094;GO:0051923;GO:0035249;GO:0120193;GO:0071847;GO:0007033;GO:0042311;GO:0071625;GO:0042060;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:synapse;, F:acetylglucosaminyltransferase activity; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronosyltransferase activity; F:heparan sulfate N-acetylglucosaminyltransferase activity; F:metal ion binding; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferase activity, transferring glycosyl groups;, P:antigen processing and presentation; P:axon guidance; P:basement membrane organization; P:blood vessel remodeling; P:BMP signaling pathway; P:bone resorption; P:canonical Wnt signaling pathway; P:cartilage development involved in endochondral bone morphogenesis; P:cell adhesion mediated by integrin; P:cell fate commitment; P:cellular polysaccharide biosynthetic process; P:chondrocyte differentiation; P:chondrocyte proliferation; P:chondroitin sulfate metabolic process; P:collagen fibril organization; P:cranial skeletal system development; P:dendrite self-avoidance; P:dendritic cell migration; P:developmental growth involved in morphogenesis; P:embryonic skeletal joint development; P:endochondral bone growth; P:endochondral ossification; P:endoderm development; P:epithelial tube branching involved in lung morphogenesis; P:fear response; P:fibroblast growth factor receptor signaling pathway; P:fluid transport; P:gastrulation; P:gene expression; P:glandular epithelial cell differentiation; P:glomerular basement membrane development; P:glomerular visceral epithelial cell differentiation; P:glycosaminoglycan biosynthetic process; P:heart contraction; P:heart field specification; P:hematopoietic stem cell differentiation; P:hematopoietic stem cell homeostasis; P:hematopoietic stem cell migration to bone marrow; P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:hypersensitivity; P:leukocyte tethering or rolling; P:limb joint morphogenesis; P:lymphocyte adhesion to endothelial cell of high endothelial venule; P:lymphocyte migration into lymphoid organs; P:mesenchymal cell differentiation involved in bone development; P:mesoderm development; P:motor behavior; P:multicellular organismal water homeostasis; P:neural crest cell differentiation; P:olfactory bulb development; P:optic nerve development; P:ossification; P:ossification involved in bone maturation; P:perichondral bone morphogenesis; P:protein catabolic process; P:protein glycosylation; P:protein-containing complex assembly; P:regulation of blood pressure; P:response to heparin; P:response to leukemia inhibitory factor; P:response to light intensity; P:response to virus; P:signal transduction; P:skeletal system development; P:smoothened signaling pathway involved in lung development; P:social behavior; P:sodium ion homeostasis; P:stem cell division; P:stomach development; P:sulfation; P:synaptic transmission, glutamatergic; P:tight junction organization; P:TNFSF11-mediated signaling pathway; P:vacuole organization; P:vasodilation; P:vocalization behavior; P:wound healing; scaffold3 indexed_genome mRNA 33900687 34080751 . - . ID=transcript_724;Q8N8I0 Q0P502,Sterile alpha motif domain-containing protein 12,, PF07647; scaffold3 indexed_genome mRNA 34616738 34817508 . - . ID=transcript_725;O00300 B2R9A8 O60236 Q53FX6 Q9UHP4,Tumor necrosis factor receptor superfamily member 11B,Osteoclastogenesis inhibitory factor;Osteoprotegerin;, PF00531;PF00020;, GO:0031012;GO:0005576;GO:0005615;GO:0005886;GO:0005125;GO:0038023;GO:0006915;GO:0030198;GO:0045779;GO:0042489;GO:0046685;GO:0042493;GO:0043627;GO:0032026;GO:0007584;GO:0007165;GO:0001501;GO:0033209;, C:extracellular matrix; C:extracellular region; C:extracellular space; C:plasma membrane;, F:cytokine activity; F:signaling receptor activity;, P:apoptotic process; P:extracellular matrix organization; P:negative regulation of bone resorption; P:negative regulation of odontogenesis of dentin-containing tooth; P:response to arsenic-containing substance; P:response to drug; P:response to estrogen; P:response to magnesium ion; P:response to nutrient; P:signal transduction; P:skeletal system development; P:tumor necrosis factor-mediated signaling pathway;|O00300 B2R9A8 O60236 Q53FX6 Q9UHP4,Tumor necrosis factor receptor superfamily member 11B,Osteoclastogenesis inhibitory factor;Osteoprotegerin;, PF00531;PF00020;, GO:0031012;GO:0005576;GO:0005615;GO:0005886;GO:0005125;GO:0038023;GO:0006915;GO:0030198;GO:0045779;GO:0042489;GO:0046685;GO:0042493;GO:0043627;GO:0032026;GO:0007584;GO:0007165;GO:0001501;GO:0033209;, C:extracellular matrix; C:extracellular region; C:extracellular space; C:plasma membrane;, F:cytokine activity; F:signaling receptor activity;, P:apoptotic process; P:extracellular matrix organization; P:negative regulation of bone resorption; P:negative regulation of odontogenesis of dentin-containing tooth; P:response to arsenic-containing substance; P:response to drug; P:response to estrogen; P:response to magnesium ion; P:response to nutrient; P:signal transduction; P:skeletal system development; P:tumor necrosis factor-mediated signaling pathway;|O00300 B2R9A8 O60236 Q53FX6 Q9UHP4,Tumor necrosis factor receptor superfamily member 11B,Osteoclastogenesis inhibitory factor;Osteoprotegerin;, PF00531;PF00020;, GO:0031012;GO:0005576;GO:0005615;GO:0005886;GO:0005125;GO:0038023;GO:0006915;GO:0030198;GO:0045779;GO:0042489;GO:0046685;GO:0042493;GO:0043627;GO:0032026;GO:0007584;GO:0007165;GO:0001501;GO:0033209;, C:extracellular matrix; C:extracellular region; C:extracellular space; C:plasma membrane;, F:cytokine activity; F:signaling receptor activity;, P:apoptotic process; P:extracellular matrix organization; P:negative regulation of bone resorption; P:negative regulation of odontogenesis of dentin-containing tooth; P:response to arsenic-containing substance; P:response to drug; P:response to estrogen; P:response to magnesium ion; P:response to nutrient; P:signal transduction; P:skeletal system development; P:tumor necrosis factor-mediated signaling pathway;|O00300 B2R9A8 O60236 Q53FX6 Q9UHP4,Tumor necrosis factor receptor superfamily member 11B,Osteoclastogenesis inhibitory factor;Osteoprotegerin;, PF00531;PF00020;, GO:0031012;GO:0005576;GO:0005615;GO:0005886;GO:0005125;GO:0038023;GO:0006915;GO:0030198;GO:0045779;GO:0042489;GO:0046685;GO:0042493;GO:0043627;GO:0032026;GO:0007584;GO:0007165;GO:0001501;GO:0033209;, C:extracellular matrix; C:extracellular region; C:extracellular space; C:plasma membrane;, F:cytokine activity; F:signaling receptor activity;, P:apoptotic process; P:extracellular matrix organization; P:negative regulation of bone resorption; P:negative regulation of odontogenesis of dentin-containing tooth; P:response to arsenic-containing substance; P:response to drug; P:response to estrogen; P:response to magnesium ion; P:response to nutrient; P:signal transduction; P:skeletal system development; P:tumor necrosis factor-mediated signaling pathway;|Q9Y6Z7 Q3SYH6 Q6UW19,Collectin-10,Collectin liver protein 1;Collectin-34;, PF01391;PF00059;, GO:0005581;GO:0005737;GO:0005576;GO:0005615;GO:0005794;GO:0042056;GO:0005537;GO:0006956;GO:0001867;GO:1904888;, C:collagen trimer; C:cytoplasm; C:extracellular region; C:extracellular space; C:Golgi apparatus;, F:chemoattractant activity; F:mannose binding;, P:complement activation; P:complement activation, lectin pathway; P:cranial skeletal system development;|Q9Y6Z7 Q3SYH6 Q6UW19,Collectin-10,Collectin liver protein 1;Collectin-34;, PF01391;PF00059;, GO:0005581;GO:0005737;GO:0005576;GO:0005615;GO:0005794;GO:0042056;GO:0005537;GO:0006956;GO:0001867;GO:1904888;, C:collagen trimer; C:cytoplasm; C:extracellular region; C:extracellular space; C:Golgi apparatus;, F:chemoattractant activity; F:mannose binding;, P:complement activation; P:complement activation, lectin pathway; P:cranial skeletal system development; scaffold3 indexed_genome mRNA 34928410 34933918 . - . ID=transcript_726;Q969L2 B2R520 Q6ZMD9,Protein MAL2,, PF01284;, GO:0016324;GO:0012505;GO:0070062;GO:0016021;GO:0045121;GO:0048471;GO:0019911;GO:0042552;GO:0045056;, C:apical plasma membrane; C:endomembrane system; C:extracellular exosome; C:integral component of membrane; C:membrane raft; C:perinuclear region of cytoplasm;, F:structural constituent of myelin sheath;, P:myelination; P:transcytosis;|Q969L2 B2R520 Q6ZMD9,Protein MAL2,, PF01284;, GO:0016324;GO:0012505;GO:0070062;GO:0016021;GO:0045121;GO:0048471;GO:0019911;GO:0042552;GO:0045056;, C:apical plasma membrane; C:endomembrane system; C:extracellular exosome; C:integral component of membrane; C:membrane raft; C:perinuclear region of cytoplasm;, F:structural constituent of myelin sheath;, P:myelination; P:transcytosis; scaffold3 indexed_genome mRNA 35052977 35061483 . + . ID=transcript_727;P48745 B2R5X7 Q6I9S3 Q96BY5 Q9UDE4,CCN family member 3 {ECO:0000305},Cellular communication network factor 3 {ECO:0000312|HGNC:HGNC:7885};Insulin-like growth factor-binding protein 9;Nephro blastoma-overexpressed gene protein homolog;Protein NOV homolog;, PF00007;PF00219;PF19035;PF00093;, GO:0030424;GO:0062023;GO:0005737;GO:0030425;GO:0031012;GO:0005576;GO:0005921;GO:0043231;GO:0043025;GO:0008083;GO:0008201;GO:0005520;GO:0005178;GO:0005112;GO:0001525;GO:1990523;GO:0007155;GO:0033627;GO:0060326;GO:0002062;GO:0035767;GO:0071603;GO:0010761;GO:0061484;GO:0060548;GO:0030308;GO:1902731;GO:0050728;GO:0046676;GO:0090027;GO:0010832;GO:1901223;GO:1904057;GO:0060392;GO:0045747;GO:0010468;GO:0007165;GO:0014909;GO:0048659;GO:0044342;, C:axon; C:collagen-containing extracellular matrix; C:cytoplasm; C:dendrite; C:extracellular matrix; C:extracellular region; C:gap junction; C:intracellular membrane-bounded organelle; C:neuronal cell body;, F:growth factor activity; F:heparin binding; F:insulin-like growth factor binding; F:integrin binding; F:Notch binding;, P:angiogenesis; P:bone regeneration; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell chemotaxis; P:chondrocyte differentiation; P:endothelial cell chemotaxis; P:endothelial cell-cell adhesion; P:fibroblast migration; P:hematopoietic stem cell homeostasis; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of chondrocyte proliferation; P:negative regulation of inflammatory response; P:negative regulation of insulin secretion; P:negative regulation of monocyte chemotaxis; P:negative regulation of myotube differentiation; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of sensory perception of pain; P:negative regulation of SMAD protein signal transduction; P:positive regulation of Notch signaling pathway; P:regulation of gene expression; P:signal transduction; P:smooth muscle cell migration; P:smooth muscle cell proliferation; P:type B pancreatic cell proliferation;|P48745 B2R5X7 Q6I9S3 Q96BY5 Q9UDE4,CCN family member 3 {ECO:0000305},Cellular communication network factor 3 {ECO:0000312|HGNC:HGNC:7885};Insulin-like growth factor-binding protein 9;Nephro blastoma-overexpressed gene protein homolog;Protein NOV homolog;, PF00007;PF00219;PF19035;PF00093;, GO:0030424;GO:0062023;GO:0005737;GO:0030425;GO:0031012;GO:0005576;GO:0005921;GO:0043231;GO:0043025;GO:0008083;GO:0008201;GO:0005520;GO:0005178;GO:0005112;GO:0001525;GO:1990523;GO:0007155;GO:0033627;GO:0060326;GO:0002062;GO:0035767;GO:0071603;GO:0010761;GO:0061484;GO:0060548;GO:0030308;GO:1902731;GO:0050728;GO:0046676;GO:0090027;GO:0010832;GO:1901223;GO:1904057;GO:0060392;GO:0045747;GO:0010468;GO:0007165;GO:0014909;GO:0048659;GO:0044342;, C:axon; C:collagen-containing extracellular matrix; C:cytoplasm; C:dendrite; C:extracellular matrix; C:extracellular region; C:gap junction; C:intracellular membrane-bounded organelle; C:neuronal cell body;, F:growth factor activity; F:heparin binding; F:insulin-like growth factor binding; F:integrin binding; F:Notch binding;, P:angiogenesis; P:bone regeneration; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell chemotaxis; P:chondrocyte differentiation; P:endothelial cell chemotaxis; P:endothelial cell-cell adhesion; P:fibroblast migration; P:hematopoietic stem cell homeostasis; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of chondrocyte proliferation; P:negative regulation of inflammatory response; P:negative regulation of insulin secretion; P:negative regulation of monocyte chemotaxis; P:negative regulation of myotube differentiation; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of sensory perception of pain; P:negative regulation of SMAD protein signal transduction; P:positive regulation of Notch signaling pathway; P:regulation of gene expression; P:signal transduction; P:smooth muscle cell migration; P:smooth muscle cell proliferation; P:type B pancreatic cell proliferation;|P48745 B2R5X7 Q6I9S3 Q96BY5 Q9UDE4,CCN family member 3 {ECO:0000305},Cellular communication network factor 3 {ECO:0000312|HGNC:HGNC:7885};Insulin-like growth factor-binding protein 9;Nephro blastoma-overexpressed gene protein homolog;Protein NOV homolog;, PF00007;PF00219;PF19035;PF00093;, GO:0030424;GO:0062023;GO:0005737;GO:0030425;GO:0031012;GO:0005576;GO:0005921;GO:0043231;GO:0043025;GO:0008083;GO:0008201;GO:0005520;GO:0005178;GO:0005112;GO:0001525;GO:1990523;GO:0007155;GO:0033627;GO:0060326;GO:0002062;GO:0035767;GO:0071603;GO:0010761;GO:0061484;GO:0060548;GO:0030308;GO:1902731;GO:0050728;GO:0046676;GO:0090027;GO:0010832;GO:1901223;GO:1904057;GO:0060392;GO:0045747;GO:0010468;GO:0007165;GO:0014909;GO:0048659;GO:0044342;, C:axon; C:collagen-containing extracellular matrix; C:cytoplasm; C:dendrite; C:extracellular matrix; C:extracellular region; C:gap junction; C:intracellular membrane-bounded organelle; C:neuronal cell body;, F:growth factor activity; F:heparin binding; F:insulin-like growth factor binding; F:integrin binding; F:Notch binding;, P:angiogenesis; P:bone regeneration; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell chemotaxis; P:chondrocyte differentiation; P:endothelial cell chemotaxis; P:endothelial cell-cell adhesion; P:fibroblast migration; P:hematopoietic stem cell homeostasis; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of chondrocyte proliferation; P:negative regulation of inflammatory response; P:negative regulation of insulin secretion; P:negative regulation of monocyte chemotaxis; P:negative regulation of myotube differentiation; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of sensory perception of pain; P:negative regulation of SMAD protein signal transduction; P:positive regulation of Notch signaling pathway; P:regulation of gene expression; P:signal transduction; P:smooth muscle cell migration; P:smooth muscle cell proliferation; P:type B pancreatic cell proliferation;|P48745 B2R5X7 Q6I9S3 Q96BY5 Q9UDE4,CCN family member 3 {ECO:0000305},Cellular communication network factor 3 {ECO:0000312|HGNC:HGNC:7885};Insulin-like growth factor-binding protein 9;Nephro blastoma-overexpressed gene protein homolog;Protein NOV homolog;, PF00007;PF00219;PF19035;PF00093;, GO:0030424;GO:0062023;GO:0005737;GO:0030425;GO:0031012;GO:0005576;GO:0005921;GO:0043231;GO:0043025;GO:0008083;GO:0008201;GO:0005520;GO:0005178;GO:0005112;GO:0001525;GO:1990523;GO:0007155;GO:0033627;GO:0060326;GO:0002062;GO:0035767;GO:0071603;GO:0010761;GO:0061484;GO:0060548;GO:0030308;GO:1902731;GO:0050728;GO:0046676;GO:0090027;GO:0010832;GO:1901223;GO:1904057;GO:0060392;GO:0045747;GO:0010468;GO:0007165;GO:0014909;GO:0048659;GO:0044342;, C:axon; C:collagen-containing extracellular matrix; C:cytoplasm; C:dendrite; C:extracellular matrix; C:extracellular region; C:gap junction; C:intracellular membrane-bounded organelle; C:neuronal cell body;, F:growth factor activity; F:heparin binding; F:insulin-like growth factor binding; F:integrin binding; F:Notch binding;, P:angiogenesis; P:bone regeneration; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell chemotaxis; P:chondrocyte differentiation; P:endothelial cell chemotaxis; P:endothelial cell-cell adhesion; P:fibroblast migration; P:hematopoietic stem cell homeostasis; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of chondrocyte proliferation; P:negative regulation of inflammatory response; P:negative regulation of insulin secretion; P:negative regulation of monocyte chemotaxis; P:negative regulation of myotube differentiation; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of sensory perception of pain; P:negative regulation of SMAD protein signal transduction; P:positive regulation of Notch signaling pathway; P:regulation of gene expression; P:signal transduction; P:smooth muscle cell migration; P:smooth muscle cell proliferation; P:type B pancreatic cell proliferation; scaffold3 indexed_genome mRNA 35200466 35201332 . + . ID=transcript_728;P15090 Q6IBA1,Fatty acid-binding protein, adipocyte,Adipocyte lipid-binding protein;Adipocyte-type fatty acid-binding protein;Fatty acid-binding protein 4;, PF00061;, GO:0005737;GO:0005829;GO:0070062;GO:0005811;GO:0005634;GO:0005504;GO:0051427;GO:0036041;GO:0005324;GO:0050873;GO:0071285;GO:0071356;GO:0042632;GO:0015909;GO:0006469;GO:0045892;GO:0120162;GO:0050729;GO:0009617;GO:0019433;GO:0050872;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:lipid droplet; C:nucleus;, F:fatty acid binding; F:hormone receptor binding; F:long-chain fatty acid binding; F:long-chain fatty acid transporter activity;, P:brown fat cell differentiation; P:cellular response to lithium ion; P:cellular response to tumor necrosis factor; P:cholesterol homeostasis; P:long-chain fatty acid transport; P:negative regulation of protein kinase activity; P:negative regulation of transcription, DNA-templated; P:positive regulation of cold-induced thermogenesis; P:positive regulation of inflammatory response; P:response to bacterium; P:triglyceride catabolic process; P:white fat cell differentiation; scaffold3 indexed_genome mRNA 35203329 35205523 . - . ID=transcript_729;P15090 Q6IBA1,Fatty acid-binding protein, adipocyte,Adipocyte lipid-binding protein;Adipocyte-type fatty acid-binding protein;Fatty acid-binding protein 4;, PF00061;, GO:0005737;GO:0005829;GO:0070062;GO:0005811;GO:0005634;GO:0005504;GO:0051427;GO:0036041;GO:0005324;GO:0050873;GO:0071285;GO:0071356;GO:0042632;GO:0015909;GO:0006469;GO:0045892;GO:0120162;GO:0050729;GO:0009617;GO:0019433;GO:0050872;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:lipid droplet; C:nucleus;, F:fatty acid binding; F:hormone receptor binding; F:long-chain fatty acid binding; F:long-chain fatty acid transporter activity;, P:brown fat cell differentiation; P:cellular response to lithium ion; P:cellular response to tumor necrosis factor; P:cholesterol homeostasis; P:long-chain fatty acid transport; P:negative regulation of protein kinase activity; P:negative regulation of transcription, DNA-templated; P:positive regulation of cold-induced thermogenesis; P:positive regulation of inflammatory response; P:response to bacterium; P:triglyceride catabolic process; P:white fat cell differentiation;|P15090 Q6IBA1,Fatty acid-binding protein, adipocyte,Adipocyte lipid-binding protein;Adipocyte-type fatty acid-binding protein;Fatty acid-binding protein 4;, PF00061;, GO:0005737;GO:0005829;GO:0070062;GO:0005811;GO:0005634;GO:0005504;GO:0051427;GO:0036041;GO:0005324;GO:0050873;GO:0071285;GO:0071356;GO:0042632;GO:0015909;GO:0006469;GO:0045892;GO:0120162;GO:0050729;GO:0009617;GO:0019433;GO:0050872;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:lipid droplet; C:nucleus;, F:fatty acid binding; F:hormone receptor binding; F:long-chain fatty acid binding; F:long-chain fatty acid transporter activity;, P:brown fat cell differentiation; P:cellular response to lithium ion; P:cellular response to tumor necrosis factor; P:cholesterol homeostasis; P:long-chain fatty acid transport; P:negative regulation of protein kinase activity; P:negative regulation of transcription, DNA-templated; P:positive regulation of cold-induced thermogenesis; P:positive regulation of inflammatory response; P:response to bacterium; P:triglyceride catabolic process; P:white fat cell differentiation; scaffold3 indexed_genome mRNA 35230674 35238164 . + . ID=transcript_730;P02689 Q6FHL4,Myelin P2 protein,Peripheral myelin protein 2;, PF00061;, GO:0005737;GO:0070062;GO:0043209;GO:0015485;GO:0005504;GO:0061024;, C:cytoplasm; C:extracellular exosome; C:myelin sheath;, F:cholesterol binding; F:fatty acid binding;, P:membrane organization; scaffold3 indexed_genome mRNA 35357883 35363363 . - . ID=transcript_731;Q01469 B2R4K0,Fatty acid-binding protein 5 {ECO:0000305},Epidermal-type fatty acid-binding protein {ECO:0000303|PubMed:8092987};Fatty acid-binding protein, epidermal;Psoriasis-associated fatty acid-binding protein homolog;, PF00061;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0030667;GO:0045202;GO:0005504;GO:0042802;GO:0008289;GO:0005324;GO:0001972;GO:0008544;GO:0042593;GO:0006006;GO:0006629;GO:1990379;GO:0015909;GO:0010829;GO:0043312;GO:0006656;GO:0120162;GO:0035360;GO:0031392;GO:0099178;GO:0051930;GO:0019433;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:secretory granule membrane; C:synapse;, F:fatty acid binding; F:identical protein binding; F:lipid binding; F:long-chain fatty acid transporter activity; F:retinoic acid binding;, P:epidermis development; P:glucose homeostasis; P:glucose metabolic process; P:lipid metabolic process; P:lipid transport across blood-brain barrier; P:long-chain fatty acid transport; P:negative regulation of glucose transmembrane transport; P:neutrophil degranulation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; P:regulation of prostaglandin biosynthetic process; P:regulation of retrograde trans-synaptic signaling by endocanabinoid; P:regulation of sensory perception of pain; P:triglyceride catabolic process;|Q01469 B2R4K0,Fatty acid-binding protein 5 {ECO:0000305},Epidermal-type fatty acid-binding protein {ECO:0000303|PubMed:8092987};Fatty acid-binding protein, epidermal;Psoriasis-associated fatty acid-binding protein homolog;, PF00061;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0030667;GO:0045202;GO:0005504;GO:0042802;GO:0008289;GO:0005324;GO:0001972;GO:0008544;GO:0042593;GO:0006006;GO:0006629;GO:1990379;GO:0015909;GO:0010829;GO:0043312;GO:0006656;GO:0120162;GO:0035360;GO:0031392;GO:0099178;GO:0051930;GO:0019433;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:secretory granule membrane; C:synapse;, F:fatty acid binding; F:identical protein binding; F:lipid binding; F:long-chain fatty acid transporter activity; F:retinoic acid binding;, P:epidermis development; P:glucose homeostasis; P:glucose metabolic process; P:lipid metabolic process; P:lipid transport across blood-brain barrier; P:long-chain fatty acid transport; P:negative regulation of glucose transmembrane transport; P:neutrophil degranulation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; P:regulation of prostaglandin biosynthetic process; P:regulation of retrograde trans-synaptic signaling by endocanabinoid; P:regulation of sensory perception of pain; P:triglyceride catabolic process; scaffold3 indexed_genome mRNA 35521340 35686838 . + . ID=transcript_732;Q9NWQ8 A8K1A3 Q2M1Z9 Q5BKU4 Q9NYK0,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Csk-binding protein;Transmembrane adapter protein PAG;Transmembrane phosphoprotein Cbp;, PF15347;, GO:0016021;GO:0045121;GO:0005886;GO:0042169;GO:0035591;GO:0002250;GO:0035556;GO:0050868;GO:0050863;GO:0007165;GO:0050852;, C:integral component of membrane; C:membrane raft; C:plasma membrane;, F:SH2 domain binding; F:signaling adaptor activity;, P:adaptive immune response; P:intracellular signal transduction; P:negative regulation of T cell activation; P:regulation of T cell activation; P:signal transduction; P:T cell receptor signaling pathway; scaffold3 indexed_genome mRNA 36157242 36180650 . + . ID=transcript_733;Q96DT7 A4FVD0 Q86W96 Q8IXI9 Q96MH9,Zinc finger and BTB domain-containing protein 10,Zinc finger protein RIN ZF;, PF00651;, GO:0005654;GO:0005634;GO:0046872;GO:0000977;GO:0006357;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q96DT7 A4FVD0 Q86W96 Q8IXI9 Q96MH9,Zinc finger and BTB domain-containing protein 10,Zinc finger protein RIN ZF;, PF00651;, GO:0005654;GO:0005634;GO:0046872;GO:0000977;GO:0006357;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 36478529 36609458 . + . ID=transcript_734;Q13056 Q53EK8 Q6FGP3 Q6FGS3 Q86YZ2 Q9UCX8,Tumor protein D52,Protein N8;, PF04201;, GO:0005737;GO:0005783;GO:0048471;GO:0005509;GO:0042803;GO:0009653;GO:0030183;GO:0046903;, C:cytoplasm; C:endoplasmic reticulum; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:protein homodimerization activity;, P:anatomical structure morphogenesis; P:B cell differentiation; P:secretion;|Q13056 Q53EK8 Q6FGP3 Q6FGS3 Q86YZ2 Q9UCX8,Tumor protein D52,Protein N8;, PF04201;, GO:0005737;GO:0005783;GO:0048471;GO:0005509;GO:0042803;GO:0009653;GO:0030183;GO:0046903;, C:cytoplasm; C:endoplasmic reticulum; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:protein homodimerization activity;, P:anatomical structure morphogenesis; P:B cell differentiation; P:secretion;|Q13056 Q53EK8 Q6FGP3 Q6FGS3 Q86YZ2 Q9UCX8,Tumor protein D52,Protein N8;, PF04201;, GO:0005737;GO:0005783;GO:0048471;GO:0005509;GO:0042803;GO:0009653;GO:0030183;GO:0046903;, C:cytoplasm; C:endoplasmic reticulum; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:protein homodimerization activity;, P:anatomical structure morphogenesis; P:B cell differentiation; P:secretion;|Q13056 Q53EK8 Q6FGP3 Q6FGS3 Q86YZ2 Q9UCX8,Tumor protein D52,Protein N8;, PF04201;, GO:0005737;GO:0005783;GO:0048471;GO:0005509;GO:0042803;GO:0009653;GO:0030183;GO:0046903;, C:cytoplasm; C:endoplasmic reticulum; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:protein homodimerization activity;, P:anatomical structure morphogenesis; P:B cell differentiation; P:secretion;|Q13056 Q53EK8 Q6FGP3 Q6FGS3 Q86YZ2 Q9UCX8,Tumor protein D52,Protein N8;, PF04201;, GO:0005737;GO:0005783;GO:0048471;GO:0005509;GO:0042803;GO:0009653;GO:0030183;GO:0046903;, C:cytoplasm; C:endoplasmic reticulum; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:protein homodimerization activity;, P:anatomical structure morphogenesis; P:B cell differentiation; P:secretion; scaffold3 indexed_genome mRNA 36614548 36709414 . + . ID=transcript_735;Q9Y2Q9 B2RDZ7 Q96Q21,28S ribosomal protein S28, mitochondrial,28S ribosomal protein S35, mitochondrial;Mitochondrial small ribosomal subunit protein bS1m {ECO:0000303|PubMed:25838379};, PF10246;, GO:0005743;GO:0005763;GO:0005739;GO:0003723;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:RNA binding;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold3 indexed_genome mRNA 36865631 36868373 . + . ID=transcript_736;Q9Y5J3 B2R883 Q5TZS3 Q8NAM2 Q9NYP4,Hairy/enhancer-of-split related with YRPW motif protein 1,Cardiovascular helix-loop-helix factor 2;Class B basic helix-loop-helix protein 31;HES-related repressor protein 1;Hairy and enhancer of split-related protein 1;Hairy-related transcription factor 1;, PF07527;PF00010;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:1990837;GO:0008134;GO:0001525;GO:0009952;GO:0003180;GO:0060842;GO:0003190;GO:0060317;GO:0060411;GO:0003208;GO:0071385;GO:0072359;GO:0035912;GO:0003203;GO:0060347;GO:0060716;GO:0070168;GO:0045665;GO:0045746;GO:0000122;GO:2000820;GO:2000678;GO:0045892;GO:0061314;GO:0007219;GO:0010628;GO:0045944;GO:0045893;GO:0003184;GO:0050767;GO:0006357;GO:2001212;GO:0036304;GO:0060412;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:angiogenesis; P:anterior/posterior pattern specification; P:aortic valve morphogenesis; P:arterial endothelial cell differentiation; P:atrioventricular valve formation; P:cardiac epithelial to mesenchymal transition; P:cardiac septum morphogenesis; P:cardiac ventricle morphogenesis; P:cellular response to glucocorticoid stimulus; P:circulatory system development; P:dorsal aorta morphogenesis; P:endocardial cushion morphogenesis; P:heart trabecula formation; P:labyrinthine layer blood vessel development; P:negative regulation of biomineral tissue development; P:negative regulation of neuron differentiation; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:pulmonary valve morphogenesis; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of vasculogenesis; P:umbilical cord morphogenesis; P:ventricular septum morphogenesis; scaffold3 indexed_genome mRNA 36960811 37016885 . - . ID=transcript_737;Q93045 A8K9M2 G3V110 O14952 Q6PK68,Stathmin-2,Superior cervical ganglion-10 protein;, PF00836;, GO:0005737;GO:0005768;GO:0005794;GO:0030426;GO:0030027;GO:0016020;GO:0043005;GO:0043025;GO:0048471;GO:0048306;GO:0015631;GO:1990090;GO:0007019;GO:0007026;GO:0031115;GO:0010977;GO:0031175;GO:0031117;GO:0010976;GO:0031110;, C:cytoplasm; C:endosome; C:Golgi apparatus; C:growth cone; C:lamellipodium; C:membrane; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm;, F:calcium-dependent protein binding; F:tubulin binding;, P:cellular response to nerve growth factor stimulus; P:microtubule depolymerization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization; P:negative regulation of neuron projection development; P:neuron projection development; P:positive regulation of microtubule depolymerization; P:positive regulation of neuron projection development; P:regulation of microtubule polymerization or depolymerization; scaffold3 indexed_genome mRNA 37746202 37799572 . + . ID=transcript_738;P13232 A0N0L3 Q5FBY5 Q5FBY9,Interleukin-7,, PF01415;, GO:0062023;GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005139;GO:0009887;GO:0045453;GO:0007267;GO:0019221;GO:0048873;GO:0006959;GO:0038111;GO:0043066;GO:0043086;GO:2001240;GO:0045579;GO:0030890;GO:0008284;GO:0032722;GO:0001961;GO:0046622;GO:0045582;GO:0050730;GO:0002360;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:interleukin-7 receptor binding;, P:animal organ morphogenesis; P:bone resorption; P:cell-cell signaling; P:cytokine-mediated signaling pathway; P:homeostasis of number of cells within a tissue; P:humoral immune response; P:interleukin-7-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of B cell differentiation; P:positive regulation of B cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of chemokine production; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of organ growth; P:positive regulation of T cell differentiation; P:regulation of peptidyl-tyrosine phosphorylation; P:T cell lineage commitment; scaffold3 indexed_genome mRNA 37811803 37818177 . - . ID=transcript_739;Q96GY0 Q9Y372,Zinc finger C2HC domain-containing protein 1A,, , GO:0046872;, , F:metal ion binding;|Q96GY0 Q9Y372,Zinc finger C2HC domain-containing protein 1A,, , GO:0046872;, , F:metal ion binding; scaffold3 indexed_genome mRNA 37830723 37831394 . - . ID=transcript_740;Q96GY0 Q9Y372,Zinc finger C2HC domain-containing protein 1A,, , GO:0046872;, , F:metal ion binding; scaffold3 indexed_genome mRNA 37831438 37832547 . - . ID=transcript_741;Q96GY0 Q9Y372,Zinc finger C2HC domain-containing protein 1A,, , GO:0046872;, , F:metal ion binding; scaffold3 indexed_genome mRNA 37836285 37837065 . - . ID=transcript_742;Q96GY0 Q9Y372,Zinc finger C2HC domain-containing protein 1A,, , GO:0046872;, , F:metal ion binding; scaffold3 indexed_genome mRNA 37907224 38009919 . - . ID=transcript_743;P61925 P04541 Q6IAV2,cAMP-dependent protein kinase inhibitor alpha,cAMP-dependent protein kinase inhibitor, muscle/brain isoform;, PF02827;, GO:0005737;GO:0005634;GO:0004862;GO:0034236;GO:2000480;GO:0042308;GO:0000122;GO:0010389;, C:cytoplasm; C:nucleus;, F:cAMP-dependent protein kinase inhibitor activity; F:protein kinase A catalytic subunit binding;, P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of protein import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:regulation of G2/M transition of mitotic cell cycle; scaffold3 indexed_genome mRNA 39452571 39456666 . - . ID=transcript_744;P28328 Q567S6 Q9BW41,Peroxisome biogenesis factor 2,35 kDa peroxisomal membrane protein;Peroxin-2;Peroxisomal membrane protein 3;Peroxisome assembly factor 1;RING finger protein 72;, PF04757;PF00097;, GO:0016593;GO:0005829;GO:0005779;GO:0016020;GO:0005778;GO:0046872;GO:0006635;GO:0050680;GO:0048147;GO:0000122;GO:0007031;GO:0031648;GO:0016558;GO:0045046;GO:0008104;GO:0016567;GO:0000038;, C:Cdc73/Paf1 complex; C:cytosol; C:integral component of peroxisomal membrane; C:membrane; C:peroxisomal membrane;, F:metal ion binding;, P:fatty acid beta-oxidation; P:negative regulation of epithelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of transcription by RNA polymerase II; P:peroxisome organization; P:protein destabilization; P:protein import into peroxisome matrix; P:protein import into peroxisome membrane; P:protein localization; P:protein ubiquitination; P:very long-chain fatty acid metabolic process; scaffold3 indexed_genome mRNA 39573646 39584628 . - . ID=transcript_745;Q86UP3 G3V138 Q18PS0 Q6ZN20,Zinc finger homeobox protein 4,Zinc finger homeodomain protein 4;, PF00046;PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 39584871 39585826 . + . ID=transcript_746;Q86UP3 G3V138 Q18PS0 Q6ZN20,Zinc finger homeobox protein 4,Zinc finger homeodomain protein 4;, PF00046;PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 39586235 39586813 . - . ID=transcript_747;Q86UP3 G3V138 Q18PS0 Q6ZN20,Zinc finger homeobox protein 4,Zinc finger homeodomain protein 4;, PF00046;PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 39587220 39587795 . - . ID=transcript_748;Q86UP3 G3V138 Q18PS0 Q6ZN20,Zinc finger homeobox protein 4,Zinc finger homeodomain protein 4;, PF00046;PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 39588781 39590851 . - . ID=transcript_749;Q86UP3 G3V138 Q18PS0 Q6ZN20,Zinc finger homeobox protein 4,Zinc finger homeodomain protein 4;, PF00046;PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 40726795 40856173 . - . ID=transcript_750;Q14541 Q7Z2V9 Q9UH81 Q9UIS6,Hepatocyte nuclear factor 4-gamma,Nuclear receptor subfamily 2 group A member 2;, PF00104;PF00105;, GO:0000785;GO:0005829;GO:0045171;GO:0072686;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0000978;GO:0008270;GO:0048856;GO:0030154;GO:0045944;GO:0006357;GO:0006367;, C:chromatin; C:cytosol; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold3 indexed_genome mRNA 41173628 41225072 . - . ID=transcript_751;Q9H336 B2RA60 B7Z929,Cysteine-rich secretory protein LCCL domain-containing 1,CocoaCrisp;Cysteine-rich secretory protein 10;LCCL domain-containing cysteine-rich secretory protein 1;Trypsin inhibitor Hl;, PF00188;PF03815;, GO:0070062;GO:0005615;GO:0060325;, C:extracellular exosome; C:extracellular space;, , P:face morphogenesis; scaffold3 indexed_genome mRNA 41805494 41823533 . - . ID=transcript_752;Q8TB36 A8K957 E7FJF3 E7FJF4,Ganglioside-induced differentiation-associated protein 1,, PF13417;, GO:0005829;GO:0031307;GO:0016020;GO:0005739;GO:0005634;GO:0005778;GO:0006749;GO:0000266;GO:0008053;GO:0045046;GO:0006626;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, , P:glutathione metabolic process; P:mitochondrial fission; P:mitochondrial fusion; P:protein import into peroxisome membrane; P:protein targeting to mitochondrion;|Q8TB36 A8K957 E7FJF3 E7FJF4,Ganglioside-induced differentiation-associated protein 1,, PF13417;, GO:0005829;GO:0031307;GO:0016020;GO:0005739;GO:0005634;GO:0005778;GO:0006749;GO:0000266;GO:0008053;GO:0045046;GO:0006626;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, , P:glutathione metabolic process; P:mitochondrial fission; P:mitochondrial fusion; P:protein import into peroxisome membrane; P:protein targeting to mitochondrion;|Q8TB36 A8K957 E7FJF3 E7FJF4,Ganglioside-induced differentiation-associated protein 1,, PF13417;, GO:0005829;GO:0031307;GO:0016020;GO:0005739;GO:0005634;GO:0005778;GO:0006749;GO:0000266;GO:0008053;GO:0045046;GO:0006626;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, , P:glutathione metabolic process; P:mitochondrial fission; P:mitochondrial fusion; P:protein import into peroxisome membrane; P:protein targeting to mitochondrion;|Q8TB36 A8K957 E7FJF3 E7FJF4,Ganglioside-induced differentiation-associated protein 1,, PF13417;, GO:0005829;GO:0031307;GO:0016020;GO:0005739;GO:0005634;GO:0005778;GO:0006749;GO:0000266;GO:0008053;GO:0045046;GO:0006626;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, , P:glutathione metabolic process; P:mitochondrial fission; P:mitochondrial fusion; P:protein import into peroxisome membrane; P:protein targeting to mitochondrion;|Q8TB36 A8K957 E7FJF3 E7FJF4,Ganglioside-induced differentiation-associated protein 1,, PF13417;, GO:0005829;GO:0031307;GO:0016020;GO:0005739;GO:0005634;GO:0005778;GO:0006749;GO:0000266;GO:0008053;GO:0045046;GO:0006626;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, , P:glutathione metabolic process; P:mitochondrial fission; P:mitochondrial fusion; P:protein import into peroxisome membrane; P:protein targeting to mitochondrion; scaffold3 indexed_genome mRNA 41852660 41942045 . + . ID=transcript_753;Q9HDC5 B2RTZ0,Junctophilin-1,Junctophilin type 1;, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005654;GO:0005886;GO:0016529;GO:0030018;GO:0008307;GO:0060402;GO:0007517;GO:0060314;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:nucleoplasm; C:plasma membrane; C:sarcoplasmic reticulum; C:Z disc;, F:structural constituent of muscle;, P:calcium ion transport into cytosol; P:muscle organ development; P:regulation of ryanodine-sensitive calcium-release channel activity;|Q9HDC5 B2RTZ0,Junctophilin-1,Junctophilin type 1;, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005654;GO:0005886;GO:0016529;GO:0030018;GO:0008307;GO:0060402;GO:0007517;GO:0060314;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:nucleoplasm; C:plasma membrane; C:sarcoplasmic reticulum; C:Z disc;, F:structural constituent of muscle;, P:calcium ion transport into cytosol; P:muscle organ development; P:regulation of ryanodine-sensitive calcium-release channel activity; scaffold3 indexed_genome mRNA 42156436 42196834 . - . ID=transcript_754;Q9Y6Y9 B3Y6A5 E5RJJ7,Lymphocyte antigen 96,ESOP-1 {ECO:0000303|PubMed:10891475};Protein MD-2 {ECO:0000303|PubMed:10359581};, , GO:0010008;GO:0005615;GO:0031226;GO:0046696;GO:0005886;GO:0015026;GO:0001530;GO:0001875;GO:0035662;GO:0097190;GO:0007166;GO:0006968;GO:0071222;GO:0032497;GO:0007249;GO:0006954;GO:0045087;GO:0002755;GO:0002756;GO:0070266;GO:0034128;GO:0031666;GO:0032760;GO:0032496;GO:0034142;GO:0002224;GO:0035666;, C:endosome membrane; C:extracellular space; C:intrinsic component of plasma membrane; C:lipopolysaccharide receptor complex; C:plasma membrane;, F:coreceptor activity; F:lipopolysaccharide binding; F:lipopolysaccharide immune receptor activity; F:Toll-like receptor 4 binding;, P:apoptotic signaling pathway; P:cell surface receptor signaling pathway; P:cellular defense response; P:cellular response to lipopolysaccharide; P:detection of lipopolysaccharide; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:negative regulation of MyD88-independent toll-like receptor signaling pathway; P:positive regulation of lipopolysaccharide-mediated signaling pathway; P:positive regulation of tumor necrosis factor production; P:response to lipopolysaccharide; P:toll-like receptor 4 signaling pathway; P:toll-like receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; scaffold3 indexed_genome mRNA 42203926 42210754 . - . ID=transcript_755;Q9BUB7 E9PDY9 Q9NWY5,Transmembrane protein 70, mitochondrial,, PF06979;, GO:0032592;GO:0005743;GO:0005739;GO:0005654;GO:0033615;, C:integral component of mitochondrial membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm;, , P:mitochondrial proton-transporting ATP synthase complex assembly; scaffold3 indexed_genome mRNA 42219131 42242512 . + . ID=transcript_756;Q15369 E5RGD9 Q567Q6,Elongin-C,Elongin 15 kDa subunit;RNA polymerase II transcription factor SIII subunit C;SIII p15;Transcription elongation factor B polypeptide 1;, PF03931;, GO:0031462;GO:0005829;GO:0070449;GO:0005654;GO:0030891;GO:0044877;GO:0032968;GO:0043687;GO:0016567;GO:0006357;GO:0061418;GO:0006366;GO:0006368;GO:0006511;GO:0016032;, C:Cul2-RING ubiquitin ligase complex; C:cytosol; C:elongin complex; C:nucleoplasm; C:VCB complex;, F:protein-containing complex binding;, P:positive regulation of transcription elongation from RNA polymerase II promoter; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q15369 E5RGD9 Q567Q6,Elongin-C,Elongin 15 kDa subunit;RNA polymerase II transcription factor SIII subunit C;SIII p15;Transcription elongation factor B polypeptide 1;, PF03931;, GO:0031462;GO:0005829;GO:0070449;GO:0005654;GO:0030891;GO:0044877;GO:0032968;GO:0043687;GO:0016567;GO:0006357;GO:0061418;GO:0006366;GO:0006368;GO:0006511;GO:0016032;, C:Cul2-RING ubiquitin ligase complex; C:cytosol; C:elongin complex; C:nucleoplasm; C:VCB complex;, F:protein-containing complex binding;, P:positive regulation of transcription elongation from RNA polymerase II promoter; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q15369 E5RGD9 Q567Q6,Elongin-C,Elongin 15 kDa subunit;RNA polymerase II transcription factor SIII subunit C;SIII p15;Transcription elongation factor B polypeptide 1;, PF03931;, GO:0031462;GO:0005829;GO:0070449;GO:0005654;GO:0030891;GO:0044877;GO:0032968;GO:0043687;GO:0016567;GO:0006357;GO:0061418;GO:0006366;GO:0006368;GO:0006511;GO:0016032;, C:Cul2-RING ubiquitin ligase complex; C:cytosol; C:elongin complex; C:nucleoplasm; C:VCB complex;, F:protein-containing complex binding;, P:positive regulation of transcription elongation from RNA polymerase II promoter; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold3 indexed_genome mRNA 42269533 42327630 . + . ID=transcript_757;Q96B02 B4DIV1 Q1XBE0 Q9H823 Q9HAG6 Q9NV07,Ubiquitin-conjugating enzyme E2 W,E2 ubiquitin-conjugating enzyme W;N-terminal E2 ubiquitin-conjugating enzyme;N-terminus-conjugating E2;Ubiquitin carrier protein W;Ubiquitin-conjugating enzyme 16;Ubiquitin-protein ligase W;, PF00179;, GO:0005654;GO:0005634;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0071218;GO:0006281;GO:0043161;GO:0070979;GO:0006513;GO:0000209;GO:0006515;GO:0016567;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to misfolded protein; P:DNA repair; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K11-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein ubiquitination; scaffold3 indexed_genome mRNA 42419773 42675615 . + . ID=transcript_758;Q6AHY7 Q96HM0 Q96HM1 Q9NVI5 Q9UGG6,Double-stranded RNA-binding protein Staufen homolog 2,, PF00035;PF16482;, GO:0005783;GO:0016020;GO:0005874;GO:0005730;GO:0003725;GO:0003723;, C:endoplasmic reticulum; C:membrane; C:microtubule; C:nucleolus;, F:double-stranded RNA binding; F:RNA binding;|Q6AHY7 Q96HM0 Q96HM1 Q9NVI5 Q9UGG6,Double-stranded RNA-binding protein Staufen homolog 2,, PF00035;PF16482;, GO:0005783;GO:0016020;GO:0005874;GO:0005730;GO:0003725;GO:0003723;, C:endoplasmic reticulum; C:membrane; C:microtubule; C:nucleolus;, F:double-stranded RNA binding; F:RNA binding;|Q6AHY7 Q96HM0 Q96HM1 Q9NVI5 Q9UGG6,Double-stranded RNA-binding protein Staufen homolog 2,, PF00035;PF16482;, GO:0005783;GO:0016020;GO:0005874;GO:0005730;GO:0003725;GO:0003723;, C:endoplasmic reticulum; C:membrane; C:microtubule; C:nucleolus;, F:double-stranded RNA binding; F:RNA binding;|Q6AHY7 Q96HM0 Q96HM1 Q9NVI5 Q9UGG6,Double-stranded RNA-binding protein Staufen homolog 2,, PF00035;PF16482;, GO:0005783;GO:0016020;GO:0005874;GO:0005730;GO:0003725;GO:0003723;, C:endoplasmic reticulum; C:membrane; C:microtubule; C:nucleolus;, F:double-stranded RNA binding; F:RNA binding; scaffold3 indexed_genome mRNA 42776442 42803528 . - . ID=transcript_759;Q8IZV5,Retinol dehydrogenase 10,Short chain dehydrogenase/reductase family 16C member 4;, PF00106;, GO:0005737;GO:0005789;GO:0016021;GO:0005811;GO:0052650;GO:0016616;GO:0004745;GO:0060449;GO:0043583;GO:0031076;GO:0035115;GO:0048703;GO:0008406;GO:0001701;GO:0001656;GO:0014032;GO:0043584;GO:1900054;GO:0060431;GO:0042574;GO:0002138;GO:0001523;GO:0042572;GO:0007601;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:NADP-retinol dehydrogenase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:retinol dehydrogenase activity;, P:bud elongation involved in lung branching; P:ear development; P:embryonic camera-type eye development; P:embryonic forelimb morphogenesis; P:embryonic viscerocranium morphogenesis; P:gonad development; P:in utero embryonic development; P:metanephros development; P:neural crest cell development; P:nose development; P:positive regulation of retinoic acid biosynthetic process; P:primary lung bud formation; P:retinal metabolic process; P:retinoic acid biosynthetic process; P:retinoid metabolic process; P:retinol metabolic process; P:visual perception;|Q8IZV5,Retinol dehydrogenase 10,Short chain dehydrogenase/reductase family 16C member 4;, PF00106;, GO:0005737;GO:0005789;GO:0016021;GO:0005811;GO:0052650;GO:0016616;GO:0004745;GO:0060449;GO:0043583;GO:0031076;GO:0035115;GO:0048703;GO:0008406;GO:0001701;GO:0001656;GO:0014032;GO:0043584;GO:1900054;GO:0060431;GO:0042574;GO:0002138;GO:0001523;GO:0042572;GO:0007601;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:NADP-retinol dehydrogenase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:retinol dehydrogenase activity;, P:bud elongation involved in lung branching; P:ear development; P:embryonic camera-type eye development; P:embryonic forelimb morphogenesis; P:embryonic viscerocranium morphogenesis; P:gonad development; P:in utero embryonic development; P:metanephros development; P:neural crest cell development; P:nose development; P:positive regulation of retinoic acid biosynthetic process; P:primary lung bud formation; P:retinal metabolic process; P:retinoic acid biosynthetic process; P:retinoid metabolic process; P:retinol metabolic process; P:visual perception;|Q8IZV5,Retinol dehydrogenase 10,Short chain dehydrogenase/reductase family 16C member 4;, PF00106;, GO:0005737;GO:0005789;GO:0016021;GO:0005811;GO:0052650;GO:0016616;GO:0004745;GO:0060449;GO:0043583;GO:0031076;GO:0035115;GO:0048703;GO:0008406;GO:0001701;GO:0001656;GO:0014032;GO:0043584;GO:1900054;GO:0060431;GO:0042574;GO:0002138;GO:0001523;GO:0042572;GO:0007601;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:NADP-retinol dehydrogenase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:retinol dehydrogenase activity;, P:bud elongation involved in lung branching; P:ear development; P:embryonic camera-type eye development; P:embryonic forelimb morphogenesis; P:embryonic viscerocranium morphogenesis; P:gonad development; P:in utero embryonic development; P:metanephros development; P:neural crest cell development; P:nose development; P:positive regulation of retinoic acid biosynthetic process; P:primary lung bud formation; P:retinal metabolic process; P:retinoic acid biosynthetic process; P:retinoid metabolic process; P:retinol metabolic process; P:visual perception; scaffold3 indexed_genome mRNA 42805513 42807887 . + . ID=transcript_760;P18124 A8K504 Q15289 Q3KQU0 Q5I0X1 Q6IBM9,60S ribosomal protein L7,Large ribosomal subunit protein uL30 {ECO:0000303|PubMed:24524803};, PF00327;PF08079;, GO:0005737;GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:0014069;GO:1990904;GO:0003677;GO:0042802;GO:0003729;GO:0003723;GO:0003735;GO:0000463;GO:0000184;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:postsynaptic density; C:ribonucleoprotein complex;, F:DNA binding; F:identical protein binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P18124 A8K504 Q15289 Q3KQU0 Q5I0X1 Q6IBM9,60S ribosomal protein L7,Large ribosomal subunit protein uL30 {ECO:0000303|PubMed:24524803};, PF00327;PF08079;, GO:0005737;GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:0014069;GO:1990904;GO:0003677;GO:0042802;GO:0003729;GO:0003723;GO:0003735;GO:0000463;GO:0000184;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:postsynaptic density; C:ribonucleoprotein complex;, F:DNA binding; F:identical protein binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold3 indexed_genome mRNA 42828370 42839865 . + . ID=transcript_761;P0DMQ9,Putative uncharacterized protein C8orf89 {ECO:0000305},, PF17690; scaffold3 indexed_genome mRNA 42955044 42986939 . + . ID=transcript_762;Q8IVN8 A8KAA5 Q96J64,Somatomedin-B and thrombospondin type-1 domain-containing protein,RPE-spondin;, PF19028;, GO:0062023;GO:0005576;, C:collagen-containing extracellular matrix; C:extracellular region; scaffold3 indexed_genome mRNA 42995708 43035095 . - . ID=transcript_763;P54274 A7XP29 Q15553 Q8NHT6 Q93029,Telomeric repeat-binding factor 1,NIMA-interacting protein 2;TTAGGG repeat-binding factor 1;Telomeric protein Pin2/TRF1;, PF00249;PF08558;, GO:0000781;GO:0005737;GO:0001650;GO:0016604;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0070187;GO:0005819;GO:0071532;GO:0003677;GO:0008301;GO:0003691;GO:0098505;GO:0042802;GO:0008017;GO:0008022;GO:0042803;GO:0042162;GO:0051301;GO:0045007;GO:0048239;GO:0008156;GO:1904850;GO:1904914;GO:1904911;GO:1905778;GO:0051974;GO:0032214;GO:0032211;GO:1904357;GO:1905839;GO:1900051;GO:1904792;GO:0090656;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0061820;, C:chromosome, telomeric region; C:cytoplasm; C:fibrillar center; C:nuclear body; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:shelterin complex; C:spindle;, F:ankyrin repeat binding; F:DNA binding; F:DNA binding, bending; F:double-stranded telomeric DNA binding; F:G-rich strand telomeric DNA binding; F:identical protein binding; F:microtubule binding; F:protein C-terminus binding; F:protein homodimerization activity; F:telomeric DNA binding;, P:cell division; P:depurination; P:negative regulation of DNA recombination at telomere; P:negative regulation of DNA replication; P:negative regulation of establishment of protein localization to telomere; P:negative regulation of establishment of protein-containing complex localization to telomere; P:negative regulation of establishment of RNA localization to telomere; P:negative regulation of exonuclease activity; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via semi-conservative replication; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of telomeric D-loop disassembly; P:positive regulation of histone exchange; P:positive regulation of shelterin complex assembly; P:t-circle formation; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomeric D-loop disassembly;|P54274 A7XP29 Q15553 Q8NHT6 Q93029,Telomeric repeat-binding factor 1,NIMA-interacting protein 2;TTAGGG repeat-binding factor 1;Telomeric protein Pin2/TRF1;, PF00249;PF08558;, GO:0000781;GO:0005737;GO:0001650;GO:0016604;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0070187;GO:0005819;GO:0071532;GO:0003677;GO:0008301;GO:0003691;GO:0098505;GO:0042802;GO:0008017;GO:0008022;GO:0042803;GO:0042162;GO:0051301;GO:0045007;GO:0048239;GO:0008156;GO:1904850;GO:1904914;GO:1904911;GO:1905778;GO:0051974;GO:0032214;GO:0032211;GO:1904357;GO:1905839;GO:1900051;GO:1904792;GO:0090656;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0061820;, C:chromosome, telomeric region; C:cytoplasm; C:fibrillar center; C:nuclear body; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:shelterin complex; C:spindle;, F:ankyrin repeat binding; F:DNA binding; F:DNA binding, bending; F:double-stranded telomeric DNA binding; F:G-rich strand telomeric DNA binding; F:identical protein binding; F:microtubule binding; F:protein C-terminus binding; F:protein homodimerization activity; F:telomeric DNA binding;, P:cell division; P:depurination; P:negative regulation of DNA recombination at telomere; P:negative regulation of DNA replication; P:negative regulation of establishment of protein localization to telomere; P:negative regulation of establishment of protein-containing complex localization to telomere; P:negative regulation of establishment of RNA localization to telomere; P:negative regulation of exonuclease activity; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via semi-conservative replication; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of telomeric D-loop disassembly; P:positive regulation of histone exchange; P:positive regulation of shelterin complex assembly; P:t-circle formation; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomeric D-loop disassembly;|P54274 A7XP29 Q15553 Q8NHT6 Q93029,Telomeric repeat-binding factor 1,NIMA-interacting protein 2;TTAGGG repeat-binding factor 1;Telomeric protein Pin2/TRF1;, PF00249;PF08558;, GO:0000781;GO:0005737;GO:0001650;GO:0016604;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0070187;GO:0005819;GO:0071532;GO:0003677;GO:0008301;GO:0003691;GO:0098505;GO:0042802;GO:0008017;GO:0008022;GO:0042803;GO:0042162;GO:0051301;GO:0045007;GO:0048239;GO:0008156;GO:1904850;GO:1904914;GO:1904911;GO:1905778;GO:0051974;GO:0032214;GO:0032211;GO:1904357;GO:1905839;GO:1900051;GO:1904792;GO:0090656;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0061820;, C:chromosome, telomeric region; C:cytoplasm; C:fibrillar center; C:nuclear body; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:shelterin complex; C:spindle;, F:ankyrin repeat binding; F:DNA binding; F:DNA binding, bending; F:double-stranded telomeric DNA binding; F:G-rich strand telomeric DNA binding; F:identical protein binding; F:microtubule binding; F:protein C-terminus binding; F:protein homodimerization activity; F:telomeric DNA binding;, P:cell division; P:depurination; P:negative regulation of DNA recombination at telomere; P:negative regulation of DNA replication; P:negative regulation of establishment of protein localization to telomere; P:negative regulation of establishment of protein-containing complex localization to telomere; P:negative regulation of establishment of RNA localization to telomere; P:negative regulation of exonuclease activity; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via semi-conservative replication; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of telomeric D-loop disassembly; P:positive regulation of histone exchange; P:positive regulation of shelterin complex assembly; P:t-circle formation; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomeric D-loop disassembly; scaffold3 indexed_genome mRNA 43927690 43929762 . - . ID=transcript_764;O60682 O75946 Q53XZ2 Q9BRE7,Musculin,Activated B-cell factor 1;Class A basic helix-loop-helix protein 22;, PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:0000977;GO:1990837;GO:0014707;GO:1990830;GO:0032502;GO:0060539;GO:0006357;GO:0006355;GO:0060021;GO:0007519;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:branchiomeric skeletal muscle development; P:cellular response to leukemia inhibitory factor; P:developmental process; P:diaphragm development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:roof of mouth development; P:skeletal muscle tissue development; scaffold3 indexed_genome mRNA 44418928 44554451 . + . ID=transcript_765;Q99502 A6NHQ0 G5E9R4 Q0P516 Q8WX80,Eyes absent homolog 1,, , GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0046872;GO:0106306;GO:0106307;GO:0004725;GO:0048856;GO:0009653;GO:0030154;GO:0006302;GO:0042471;GO:0016576;GO:2001240;GO:0045739;GO:0016925;GO:0010212;GO:0007605;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:anatomical structure development; P:anatomical structure morphogenesis; P:cell differentiation; P:double-strand break repair; P:ear morphogenesis; P:histone dephosphorylation; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:protein sumoylation; P:response to ionizing radiation; P:sensory perception of sound; scaffold3 indexed_genome mRNA 44927801 44956053 . - . ID=transcript_766;Q5GH70 B2RNS9 B9EH74,XK-related protein 9,, PF09815;, GO:0016021;GO:0016020;GO:0005886;GO:1902742;GO:0043652;GO:0070782;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:apoptotic process involved in development; P:engulfment of apoptotic cell; P:phosphatidylserine exposure on apoptotic cell surface;|Q5GH70 B2RNS9 B9EH74,XK-related protein 9,, PF09815;, GO:0016021;GO:0016020;GO:0005886;GO:1902742;GO:0043652;GO:0070782;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:apoptotic process involved in development; P:engulfment of apoptotic cell; P:phosphatidylserine exposure on apoptotic cell surface; scaffold3 indexed_genome mRNA 44956244 44985827 . + . ID=transcript_767;Q53H82 A8K2D6 Q9Y392,Endoribonuclease LACTB2 {ECO:0000303|PubMed:26826708},Beta-lactamase-like protein 2;, PF17778;PF00753;, GO:0005759;GO:0004521;GO:0003727;GO:0008270;GO:0090502;, C:mitochondrial matrix;, F:endoribonuclease activity; F:single-stranded RNA binding; F:zinc ion binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic;|Q53H82 A8K2D6 Q9Y392,Endoribonuclease LACTB2 {ECO:0000303|PubMed:26826708},Beta-lactamase-like protein 2;, PF17778;PF00753;, GO:0005759;GO:0004521;GO:0003727;GO:0008270;GO:0090502;, C:mitochondrial matrix;, F:endoribonuclease activity; F:single-stranded RNA binding; F:zinc ion binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic;|Q53H82 A8K2D6 Q9Y392,Endoribonuclease LACTB2 {ECO:0000303|PubMed:26826708},Beta-lactamase-like protein 2;, PF17778;PF00753;, GO:0005759;GO:0004521;GO:0003727;GO:0008270;GO:0090502;, C:mitochondrial matrix;, F:endoribonuclease activity; F:single-stranded RNA binding; F:zinc ion binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic;|Q53H82 A8K2D6 Q9Y392,Endoribonuclease LACTB2 {ECO:0000303|PubMed:26826708},Beta-lactamase-like protein 2;, PF17778;PF00753;, GO:0005759;GO:0004521;GO:0003727;GO:0008270;GO:0090502;, C:mitochondrial matrix;, F:endoribonuclease activity; F:single-stranded RNA binding; F:zinc ion binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold3 indexed_genome mRNA 45016925 45040283 . + . ID=transcript_768;Q15629 B4E0K2,Translocating chain-associated membrane protein 1,, PF08390;PF03798;, GO:0005783;GO:0030176;GO:0016021;GO:0038023;GO:0006613;GO:0045048;GO:0006616;GO:0016032;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:signaling receptor activity;, P:cotranslational protein targeting to membrane; P:protein insertion into ER membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:viral process;|Q15629 B4E0K2,Translocating chain-associated membrane protein 1,, PF08390;PF03798;, GO:0005783;GO:0030176;GO:0016021;GO:0038023;GO:0006613;GO:0045048;GO:0006616;GO:0016032;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:signaling receptor activity;, P:cotranslational protein targeting to membrane; P:protein insertion into ER membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:viral process;|Q15629 B4E0K2,Translocating chain-associated membrane protein 1,, PF08390;PF03798;, GO:0005783;GO:0030176;GO:0016021;GO:0038023;GO:0006613;GO:0045048;GO:0006616;GO:0016032;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:signaling receptor activity;, P:cotranslational protein targeting to membrane; P:protein insertion into ER membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:viral process;|Q15629 B4E0K2,Translocating chain-associated membrane protein 1,, PF08390;PF03798;, GO:0005783;GO:0030176;GO:0016021;GO:0038023;GO:0006613;GO:0045048;GO:0006616;GO:0016032;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:signaling receptor activity;, P:cotranslational protein targeting to membrane; P:protein insertion into ER membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:viral process;|Q15629 B4E0K2,Translocating chain-associated membrane protein 1,, PF08390;PF03798;, GO:0005783;GO:0030176;GO:0016021;GO:0038023;GO:0006613;GO:0045048;GO:0006616;GO:0016032;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:signaling receptor activity;, P:cotranslational protein targeting to membrane; P:protein insertion into ER membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:viral process;|Q15629 B4E0K2,Translocating chain-associated membrane protein 1,, PF08390;PF03798;, GO:0005783;GO:0030176;GO:0016021;GO:0038023;GO:0006613;GO:0045048;GO:0006616;GO:0016032;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:signaling receptor activity;, P:cotranslational protein targeting to membrane; P:protein insertion into ER membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:viral process;|Q15629 B4E0K2,Translocating chain-associated membrane protein 1,, PF08390;PF03798;, GO:0005783;GO:0030176;GO:0016021;GO:0038023;GO:0006613;GO:0045048;GO:0006616;GO:0016032;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:signaling receptor activity;, P:cotranslational protein targeting to membrane; P:protein insertion into ER membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:viral process;|Q15629 B4E0K2,Translocating chain-associated membrane protein 1,, PF08390;PF03798;, GO:0005783;GO:0030176;GO:0016021;GO:0038023;GO:0006613;GO:0045048;GO:0006616;GO:0016032;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:signaling receptor activity;, P:cotranslational protein targeting to membrane; P:protein insertion into ER membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:viral process; scaffold3 indexed_genome mRNA 45385983 45479338 . + . ID=transcript_769;Q15596 Q14CD2,Nuclear receptor coactivator 2,Class E basic helix-loop-helix protein 75;Transcriptional intermediary factor 2;, PF07469;PF16279;PF08815;PF00989;PF08832;, GO:0000785;GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0017162;GO:0003682;GO:0035257;GO:0016922;GO:0030374;GO:0046983;GO:0019904;GO:0000978;GO:0001162;GO:0003713;GO:0015721;GO:0032870;GO:1904017;GO:0032922;GO:0045475;GO:0000122;GO:0045944;GO:0060765;GO:0010906;GO:0019216;GO:0006355;GO:0032570;, C:chromatin; C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:aryl hydrocarbon receptor binding; F:chromatin binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein dimerization activity; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:bile acid and bile salt transport; P:cellular response to hormone stimulus; P:cellular response to Thyroglobulin triiodothyronine; P:circadian regulation of gene expression; P:locomotor rhythm; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of androgen receptor signaling pathway; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:regulation of transcription, DNA-templated; P:response to progesterone;|Q15596 Q14CD2,Nuclear receptor coactivator 2,Class E basic helix-loop-helix protein 75;Transcriptional intermediary factor 2;, PF07469;PF16279;PF08815;PF00989;PF08832;, GO:0000785;GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0017162;GO:0003682;GO:0035257;GO:0016922;GO:0030374;GO:0046983;GO:0019904;GO:0000978;GO:0001162;GO:0003713;GO:0015721;GO:0032870;GO:1904017;GO:0032922;GO:0045475;GO:0000122;GO:0045944;GO:0060765;GO:0010906;GO:0019216;GO:0006355;GO:0032570;, C:chromatin; C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:aryl hydrocarbon receptor binding; F:chromatin binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein dimerization activity; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:bile acid and bile salt transport; P:cellular response to hormone stimulus; P:cellular response to Thyroglobulin triiodothyronine; P:circadian regulation of gene expression; P:locomotor rhythm; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of androgen receptor signaling pathway; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:regulation of transcription, DNA-templated; P:response to progesterone; scaffold3 indexed_genome mRNA 45839926 45896026 . - . ID=transcript_770;Q8IWU6 Q86YV8 Q8NCA2 Q9UPS5,Extracellular sulfatase Sulf-1,, PF12548;PF00884;, GO:0009986;GO:0005783;GO:0005615;GO:0005794;GO:0005795;GO:0045121;GO:0005886;GO:0004065;GO:0005509;GO:0005539;GO:0008449;GO:0006915;GO:0060348;GO:0051216;GO:0002063;GO:0048706;GO:0014846;GO:0035860;GO:0032836;GO:0003094;GO:0030201;GO:0060384;GO:0001822;GO:0016525;GO:0030336;GO:0001937;GO:0040037;GO:0060686;GO:0030513;GO:0010575;GO:0030177;GO:0040036;GO:0048010;, C:cell surface; C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus; C:Golgi stack; C:membrane raft; C:plasma membrane;, F:arylsulfatase activity; F:calcium ion binding; F:glycosaminoglycan binding; F:N-acetylglucosamine-6-sulfatase activity;, P:apoptotic process; P:bone development; P:cartilage development; P:chondrocyte development; P:embryonic skeletal system development; P:esophagus smooth muscle contraction; P:glial cell-derived neurotrophic factor receptor signaling pathway; P:glomerular basement membrane development; P:glomerular filtration; P:heparan sulfate proteoglycan metabolic process; P:innervation; P:kidney development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of prostatic bud formation; P:positive regulation of BMP signaling pathway; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of Wnt signaling pathway; P:regulation of fibroblast growth factor receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold3 indexed_genome mRNA 45896045 45923163 . - . ID=transcript_771;Q8IWU6 Q86YV8 Q8NCA2 Q9UPS5,Extracellular sulfatase Sulf-1,, PF12548;PF00884;, GO:0009986;GO:0005783;GO:0005615;GO:0005794;GO:0005795;GO:0045121;GO:0005886;GO:0004065;GO:0005509;GO:0005539;GO:0008449;GO:0006915;GO:0060348;GO:0051216;GO:0002063;GO:0048706;GO:0014846;GO:0035860;GO:0032836;GO:0003094;GO:0030201;GO:0060384;GO:0001822;GO:0016525;GO:0030336;GO:0001937;GO:0040037;GO:0060686;GO:0030513;GO:0010575;GO:0030177;GO:0040036;GO:0048010;, C:cell surface; C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus; C:Golgi stack; C:membrane raft; C:plasma membrane;, F:arylsulfatase activity; F:calcium ion binding; F:glycosaminoglycan binding; F:N-acetylglucosamine-6-sulfatase activity;, P:apoptotic process; P:bone development; P:cartilage development; P:chondrocyte development; P:embryonic skeletal system development; P:esophagus smooth muscle contraction; P:glial cell-derived neurotrophic factor receptor signaling pathway; P:glomerular basement membrane development; P:glomerular filtration; P:heparan sulfate proteoglycan metabolic process; P:innervation; P:kidney development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of prostatic bud formation; P:positive regulation of BMP signaling pathway; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of Wnt signaling pathway; P:regulation of fibroblast growth factor receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold3 indexed_genome mRNA 46524993 46862936 . - . ID=transcript_772;Q49A92 A0A0C4DFS7 A8K5X1 G3XAM6 Q8N1X0 Q8N9M7 Q8ND19 Q96Q28,Uncharacterized protein C8orf34,Protein VEST-1;, PF17824; scaffold3 indexed_genome mRNA 46966170 47251952 . - . ID=transcript_773;Q70Z35 B4DFX0 Q32KL0 Q32KL1 Q6R7Q3 Q6R7Q4 Q9H805 Q9H961,Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein {ECO:0000305},DEP domain-containing protein 2;, PF00610;PF00169;PF00621;, GO:0005829;GO:0005886;GO:0005096;GO:0005085;GO:0008344;GO:0048813;GO:0007186;GO:0014065;, C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:adult locomotory behavior; P:dendrite morphogenesis; P:G protein-coupled receptor signaling pathway; P:phosphatidylinositol 3-kinase signaling;|Q70Z35 B4DFX0 Q32KL0 Q32KL1 Q6R7Q3 Q6R7Q4 Q9H805 Q9H961,Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein {ECO:0000305},DEP domain-containing protein 2;, PF00610;PF00169;PF00621;, GO:0005829;GO:0005886;GO:0005096;GO:0005085;GO:0008344;GO:0048813;GO:0007186;GO:0014065;, C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:adult locomotory behavior; P:dendrite morphogenesis; P:G protein-coupled receptor signaling pathway; P:phosphatidylinositol 3-kinase signaling; scaffold3 indexed_genome mRNA 47743457 47875035 . + . ID=transcript_774;Q9Y6D6 Q9NV46 Q9UFV2 Q9UNL0,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,ADP-ribosylation factor guanine nucleotide-exchange factor 1;p200 ARF guanine nucleotide exchange factor;p200 ARF-GEP1;, PF16213;PF09324;PF01369;PF12783;, GO:0005829;GO:0005794;GO:0000139;GO:0016363;GO:0005730;GO:0005654;GO:0048471;GO:0030532;GO:0005802;GO:0005085;GO:0017022;GO:0034237;GO:0010256;GO:0006887;GO:0007030;GO:0030837;GO:0034260;GO:0031175;GO:0043547;GO:0090284;GO:0051897;GO:0090303;GO:0015031;GO:0032012;GO:2000114;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:small nuclear ribonucleoprotein complex; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:myosin binding; F:protein kinase A regulatory subunit binding;, P:endomembrane system organization; P:exocytosis; P:Golgi organization; P:negative regulation of actin filament polymerization; P:negative regulation of GTPase activity; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of protein glycosylation in Golgi; P:positive regulation of protein kinase B signaling; P:positive regulation of wound healing; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of establishment of cell polarity;|Q9Y6D6 Q9NV46 Q9UFV2 Q9UNL0,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,ADP-ribosylation factor guanine nucleotide-exchange factor 1;p200 ARF guanine nucleotide exchange factor;p200 ARF-GEP1;, PF16213;PF09324;PF01369;PF12783;, GO:0005829;GO:0005794;GO:0000139;GO:0016363;GO:0005730;GO:0005654;GO:0048471;GO:0030532;GO:0005802;GO:0005085;GO:0017022;GO:0034237;GO:0010256;GO:0006887;GO:0007030;GO:0030837;GO:0034260;GO:0031175;GO:0043547;GO:0090284;GO:0051897;GO:0090303;GO:0015031;GO:0032012;GO:2000114;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:small nuclear ribonucleoprotein complex; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:myosin binding; F:protein kinase A regulatory subunit binding;, P:endomembrane system organization; P:exocytosis; P:Golgi organization; P:negative regulation of actin filament polymerization; P:negative regulation of GTPase activity; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of protein glycosylation in Golgi; P:positive regulation of protein kinase B signaling; P:positive regulation of wound healing; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of establishment of cell polarity;|Q9Y6D6 Q9NV46 Q9UFV2 Q9UNL0,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,ADP-ribosylation factor guanine nucleotide-exchange factor 1;p200 ARF guanine nucleotide exchange factor;p200 ARF-GEP1;, PF16213;PF09324;PF01369;PF12783;, GO:0005829;GO:0005794;GO:0000139;GO:0016363;GO:0005730;GO:0005654;GO:0048471;GO:0030532;GO:0005802;GO:0005085;GO:0017022;GO:0034237;GO:0010256;GO:0006887;GO:0007030;GO:0030837;GO:0034260;GO:0031175;GO:0043547;GO:0090284;GO:0051897;GO:0090303;GO:0015031;GO:0032012;GO:2000114;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:small nuclear ribonucleoprotein complex; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:myosin binding; F:protein kinase A regulatory subunit binding;, P:endomembrane system organization; P:exocytosis; P:Golgi organization; P:negative regulation of actin filament polymerization; P:negative regulation of GTPase activity; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of protein glycosylation in Golgi; P:positive regulation of protein kinase B signaling; P:positive regulation of wound healing; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of establishment of cell polarity;|Q9Y6D6 Q9NV46 Q9UFV2 Q9UNL0,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,ADP-ribosylation factor guanine nucleotide-exchange factor 1;p200 ARF guanine nucleotide exchange factor;p200 ARF-GEP1;, PF16213;PF09324;PF01369;PF12783;, GO:0005829;GO:0005794;GO:0000139;GO:0016363;GO:0005730;GO:0005654;GO:0048471;GO:0030532;GO:0005802;GO:0005085;GO:0017022;GO:0034237;GO:0010256;GO:0006887;GO:0007030;GO:0030837;GO:0034260;GO:0031175;GO:0043547;GO:0090284;GO:0051897;GO:0090303;GO:0015031;GO:0032012;GO:2000114;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:small nuclear ribonucleoprotein complex; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:myosin binding; F:protein kinase A regulatory subunit binding;, P:endomembrane system organization; P:exocytosis; P:Golgi organization; P:negative regulation of actin filament polymerization; P:negative regulation of GTPase activity; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of protein glycosylation in Golgi; P:positive regulation of protein kinase B signaling; P:positive regulation of wound healing; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of establishment of cell polarity;|Q9Y6D6 Q9NV46 Q9UFV2 Q9UNL0,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,ADP-ribosylation factor guanine nucleotide-exchange factor 1;p200 ARF guanine nucleotide exchange factor;p200 ARF-GEP1;, PF16213;PF09324;PF01369;PF12783;, GO:0005829;GO:0005794;GO:0000139;GO:0016363;GO:0005730;GO:0005654;GO:0048471;GO:0030532;GO:0005802;GO:0005085;GO:0017022;GO:0034237;GO:0010256;GO:0006887;GO:0007030;GO:0030837;GO:0034260;GO:0031175;GO:0043547;GO:0090284;GO:0051897;GO:0090303;GO:0015031;GO:0032012;GO:2000114;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:small nuclear ribonucleoprotein complex; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:myosin binding; F:protein kinase A regulatory subunit binding;, P:endomembrane system organization; P:exocytosis; P:Golgi organization; P:negative regulation of actin filament polymerization; P:negative regulation of GTPase activity; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of protein glycosylation in Golgi; P:positive regulation of protein kinase B signaling; P:positive regulation of wound healing; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of establishment of cell polarity;|Q9Y6D6 Q9NV46 Q9UFV2 Q9UNL0,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,ADP-ribosylation factor guanine nucleotide-exchange factor 1;p200 ARF guanine nucleotide exchange factor;p200 ARF-GEP1;, PF16213;PF09324;PF01369;PF12783;, GO:0005829;GO:0005794;GO:0000139;GO:0016363;GO:0005730;GO:0005654;GO:0048471;GO:0030532;GO:0005802;GO:0005085;GO:0017022;GO:0034237;GO:0010256;GO:0006887;GO:0007030;GO:0030837;GO:0034260;GO:0031175;GO:0043547;GO:0090284;GO:0051897;GO:0090303;GO:0015031;GO:0032012;GO:2000114;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:small nuclear ribonucleoprotein complex; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:myosin binding; F:protein kinase A regulatory subunit binding;, P:endomembrane system organization; P:exocytosis; P:Golgi organization; P:negative regulation of actin filament polymerization; P:negative regulation of GTPase activity; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of protein glycosylation in Golgi; P:positive regulation of protein kinase B signaling; P:positive regulation of wound healing; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of establishment of cell polarity; scaffold3 indexed_genome mRNA 47876049 47989236 . - . ID=transcript_775;Q1MSJ5 A6ND63 Q70F00 Q8TBC1,Centrosome and spindle pole-associated protein 1,, , GO:0005813;GO:0005737;GO:0005874;GO:0005819;GO:0000922;GO:0051781;GO:0032467;, C:centrosome; C:cytoplasm; C:microtubule; C:spindle; C:spindle pole;, , P:positive regulation of cell division; P:positive regulation of cytokinesis;|Q1MSJ5 A6ND63 Q70F00 Q8TBC1,Centrosome and spindle pole-associated protein 1,, , GO:0005813;GO:0005737;GO:0005874;GO:0005819;GO:0000922;GO:0051781;GO:0032467;, C:centrosome; C:cytoplasm; C:microtubule; C:spindle; C:spindle pole;, , P:positive regulation of cell division; P:positive regulation of cytokinesis;|Q1MSJ5 A6ND63 Q70F00 Q8TBC1,Centrosome and spindle pole-associated protein 1,, , GO:0005813;GO:0005737;GO:0005874;GO:0005819;GO:0000922;GO:0051781;GO:0032467;, C:centrosome; C:cytoplasm; C:microtubule; C:spindle; C:spindle pole;, , P:positive regulation of cell division; P:positive regulation of cytokinesis;|Q1MSJ5 A6ND63 Q70F00 Q8TBC1,Centrosome and spindle pole-associated protein 1,, , GO:0005813;GO:0005737;GO:0005874;GO:0005819;GO:0000922;GO:0051781;GO:0032467;, C:centrosome; C:cytoplasm; C:microtubule; C:spindle; C:spindle pole;, , P:positive regulation of cell division; P:positive regulation of cytokinesis;|Q1MSJ5 A6ND63 Q70F00 Q8TBC1,Centrosome and spindle pole-associated protein 1,, , GO:0005813;GO:0005737;GO:0005874;GO:0005819;GO:0000922;GO:0051781;GO:0032467;, C:centrosome; C:cytoplasm; C:microtubule; C:spindle; C:spindle pole;, , P:positive regulation of cell division; P:positive regulation of cytokinesis;|Q1MSJ5 A6ND63 Q70F00 Q8TBC1,Centrosome and spindle pole-associated protein 1,, , GO:0005813;GO:0005737;GO:0005874;GO:0005819;GO:0000922;GO:0051781;GO:0032467;, C:centrosome; C:cytoplasm; C:microtubule; C:spindle; C:spindle pole;, , P:positive regulation of cell division; P:positive regulation of cytokinesis;|Q1MSJ5 A6ND63 Q70F00 Q8TBC1,Centrosome and spindle pole-associated protein 1,, , GO:0005813;GO:0005737;GO:0005874;GO:0005819;GO:0000922;GO:0051781;GO:0032467;, C:centrosome; C:cytoplasm; C:microtubule; C:spindle; C:spindle pole;, , P:positive regulation of cell division; P:positive regulation of cytokinesis; scaffold3 indexed_genome mRNA 48000299 48015093 . + . ID=transcript_776;Q92905 O15386 Q6AW95 Q86WQ4 Q9BQ17,COP9 signalosome complex subunit 5,Jun activation domain-binding protein 1;, PF18323;PF01398;, GO:0008180;GO:0005737;GO:0005829;GO:0005852;GO:0005654;GO:0005634;GO:0048471;GO:0008021;GO:0019899;GO:0070122;GO:0035718;GO:0046872;GO:0004222;GO:0008237;GO:0019784;GO:0004843;GO:0003713;GO:0003743;GO:1990182;GO:0043066;GO:0000715;GO:0051091;GO:0045944;GO:0043687;GO:0000338;GO:0016579;GO:0051726;GO:1903894;GO:0046328;GO:0006283;GO:0006412;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 3 complex; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synaptic vesicle;, F:enzyme binding; F:isopeptidase activity; F:macrophage migration inhibitory factor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:translation initiation factor activity;, P:exosomal secretion; P:negative regulation of apoptotic process; P:nucleotide-excision repair, DNA damage recognition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein deneddylation; P:protein deubiquitination; P:regulation of cell cycle; P:regulation of IRE1-mediated unfolded protein response; P:regulation of JNK cascade; P:transcription-coupled nucleotide-excision repair; P:translation;|Q92905 O15386 Q6AW95 Q86WQ4 Q9BQ17,COP9 signalosome complex subunit 5,Jun activation domain-binding protein 1;, PF18323;PF01398;, GO:0008180;GO:0005737;GO:0005829;GO:0005852;GO:0005654;GO:0005634;GO:0048471;GO:0008021;GO:0019899;GO:0070122;GO:0035718;GO:0046872;GO:0004222;GO:0008237;GO:0019784;GO:0004843;GO:0003713;GO:0003743;GO:1990182;GO:0043066;GO:0000715;GO:0051091;GO:0045944;GO:0043687;GO:0000338;GO:0016579;GO:0051726;GO:1903894;GO:0046328;GO:0006283;GO:0006412;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 3 complex; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synaptic vesicle;, F:enzyme binding; F:isopeptidase activity; F:macrophage migration inhibitory factor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:translation initiation factor activity;, P:exosomal secretion; P:negative regulation of apoptotic process; P:nucleotide-excision repair, DNA damage recognition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein deneddylation; P:protein deubiquitination; P:regulation of cell cycle; P:regulation of IRE1-mediated unfolded protein response; P:regulation of JNK cascade; P:transcription-coupled nucleotide-excision repair; P:translation;|Q92905 O15386 Q6AW95 Q86WQ4 Q9BQ17,COP9 signalosome complex subunit 5,Jun activation domain-binding protein 1;, PF18323;PF01398;, GO:0008180;GO:0005737;GO:0005829;GO:0005852;GO:0005654;GO:0005634;GO:0048471;GO:0008021;GO:0019899;GO:0070122;GO:0035718;GO:0046872;GO:0004222;GO:0008237;GO:0019784;GO:0004843;GO:0003713;GO:0003743;GO:1990182;GO:0043066;GO:0000715;GO:0051091;GO:0045944;GO:0043687;GO:0000338;GO:0016579;GO:0051726;GO:1903894;GO:0046328;GO:0006283;GO:0006412;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 3 complex; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synaptic vesicle;, F:enzyme binding; F:isopeptidase activity; F:macrophage migration inhibitory factor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:translation initiation factor activity;, P:exosomal secretion; P:negative regulation of apoptotic process; P:nucleotide-excision repair, DNA damage recognition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein deneddylation; P:protein deubiquitination; P:regulation of cell cycle; P:regulation of IRE1-mediated unfolded protein response; P:regulation of JNK cascade; P:transcription-coupled nucleotide-excision repair; P:translation;|Q92905 O15386 Q6AW95 Q86WQ4 Q9BQ17,COP9 signalosome complex subunit 5,Jun activation domain-binding protein 1;, PF18323;PF01398;, GO:0008180;GO:0005737;GO:0005829;GO:0005852;GO:0005654;GO:0005634;GO:0048471;GO:0008021;GO:0019899;GO:0070122;GO:0035718;GO:0046872;GO:0004222;GO:0008237;GO:0019784;GO:0004843;GO:0003713;GO:0003743;GO:1990182;GO:0043066;GO:0000715;GO:0051091;GO:0045944;GO:0043687;GO:0000338;GO:0016579;GO:0051726;GO:1903894;GO:0046328;GO:0006283;GO:0006412;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 3 complex; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synaptic vesicle;, F:enzyme binding; F:isopeptidase activity; F:macrophage migration inhibitory factor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:translation initiation factor activity;, P:exosomal secretion; P:negative regulation of apoptotic process; P:nucleotide-excision repair, DNA damage recognition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein deneddylation; P:protein deubiquitination; P:regulation of cell cycle; P:regulation of IRE1-mediated unfolded protein response; P:regulation of JNK cascade; P:transcription-coupled nucleotide-excision repair; P:translation;|Q92905 O15386 Q6AW95 Q86WQ4 Q9BQ17,COP9 signalosome complex subunit 5,Jun activation domain-binding protein 1;, PF18323;PF01398;, GO:0008180;GO:0005737;GO:0005829;GO:0005852;GO:0005654;GO:0005634;GO:0048471;GO:0008021;GO:0019899;GO:0070122;GO:0035718;GO:0046872;GO:0004222;GO:0008237;GO:0019784;GO:0004843;GO:0003713;GO:0003743;GO:1990182;GO:0043066;GO:0000715;GO:0051091;GO:0045944;GO:0043687;GO:0000338;GO:0016579;GO:0051726;GO:1903894;GO:0046328;GO:0006283;GO:0006412;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 3 complex; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synaptic vesicle;, F:enzyme binding; F:isopeptidase activity; F:macrophage migration inhibitory factor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:translation initiation factor activity;, P:exosomal secretion; P:negative regulation of apoptotic process; P:nucleotide-excision repair, DNA damage recognition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein deneddylation; P:protein deubiquitination; P:regulation of cell cycle; P:regulation of IRE1-mediated unfolded protein response; P:regulation of JNK cascade; P:transcription-coupled nucleotide-excision repair; P:translation; scaffold3 indexed_genome mRNA 48038854 48051443 . + . ID=transcript_777;Q7Z4L9 G3V118,Protein phosphatase 1 regulatory subunit 42 {ECO:0000305},Leucine-rich repeat-containing protein 67 {ECO:0000305};, PF12799;, GO:0005813;GO:0005737;GO:0002177;GO:0015630;GO:0005815;GO:0003779;GO:0070840;GO:0015631;GO:0010921;, C:centrosome; C:cytoplasm; C:manchette; C:microtubule cytoskeleton; C:microtubule organizing center;, F:actin binding; F:dynein complex binding; F:tubulin binding;, P:regulation of phosphatase activity; scaffold3 indexed_genome mRNA 48158973 48159605 . - . ID=transcript_778;Q96BR1 A8K5W3 B3KQC2 Q9P1Q7 Q9UKG5,Serine/threonine-protein kinase Sgk3,Cytokine-independent survival kinase;Serum/glucocorticoid-regulated kinase 3;Serum/glucocorticoid-regulated kinase-like;, PF00069;PF00433;PF00787;, GO:0005829;GO:0005769;GO:0043231;GO:0005654;GO:0055037;GO:0005524;GO:0005246;GO:0017081;GO:0035091;GO:0015459;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0017080;GO:0035556;GO:0034220;GO:0018105;GO:0006468;GO:0001558;GO:0030334;GO:0042127;GO:0051090;, C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:recycling endosome;, F:ATP binding; F:calcium channel regulator activity; F:chloride channel regulator activity; F:phosphatidylinositol binding; F:potassium channel regulator activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:intracellular signal transduction; P:ion transmembrane transport; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of cell growth; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; scaffold3 indexed_genome mRNA 48298206 48322789 . + . ID=transcript_779;Q96JH7 Q504T4 Q86T93 Q86W01 Q8N3A9 Q9H5R8,Deubiquitinating protein VCPIP1 {ECO:0000305},Valosin-containing protein p97/p47 complex-interacting protein 1 {ECO:0000305};Valosin-containing protein p97/p47 complex-interacting protein p135 {ECO:0000250|UniProtKB:Q8CF97};, PF02338;, GO:0005737;GO:0005788;GO:0005795;GO:0005634;GO:0008234;GO:0004843;GO:0006974;GO:0016320;GO:0090168;GO:0000278;GO:0016579;GO:0035871;GO:0071108;GO:0016567;GO:0106300;GO:1905634;, C:cytoplasm; C:endoplasmic reticulum lumen; C:Golgi stack; C:nucleus;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular response to DNA damage stimulus; P:endoplasmic reticulum membrane fusion; P:Golgi reassembly; P:mitotic cell cycle; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein ubiquitination; P:protein-DNA covalent cross-linking repair; P:regulation of protein localization to chromatin; scaffold3 indexed_genome mRNA 48343209 48353137 . + . ID=transcript_780;P10243 E7EW29 Q495F9,Myb-related protein A {ECO:0000303|PubMed:7987850, ECO:0000303|PubMed:8058310},Myb-like protein 1;, PF09316;PF07988;PF00249;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0030154;GO:0007141;GO:0000278;GO:0010529;GO:1990511;GO:0045944;GO:0045893;GO:0006355;GO:0007283;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell differentiation; P:male meiosis I; P:mitotic cell cycle; P:negative regulation of transposition; P:piRNA biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:spermatogenesis; scaffold3 indexed_genome mRNA 48358240 48365085 . + . ID=transcript_781;P10243 E7EW29 Q495F9,Myb-related protein A {ECO:0000303|PubMed:7987850, ECO:0000303|PubMed:8058310},Myb-like protein 1;, PF09316;PF07988;PF00249;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0030154;GO:0007141;GO:0000278;GO:0010529;GO:1990511;GO:0045944;GO:0045893;GO:0006355;GO:0007283;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell differentiation; P:male meiosis I; P:mitotic cell cycle; P:negative regulation of transposition; P:piRNA biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:spermatogenesis; scaffold3 indexed_genome mRNA 48365197 48368412 . + . ID=transcript_782;P10243 E7EW29 Q495F9,Myb-related protein A {ECO:0000303|PubMed:7987850, ECO:0000303|PubMed:8058310},Myb-like protein 1;, PF09316;PF07988;PF00249;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0030154;GO:0007141;GO:0000278;GO:0010529;GO:1990511;GO:0045944;GO:0045893;GO:0006355;GO:0007283;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell differentiation; P:male meiosis I; P:mitotic cell cycle; P:negative regulation of transposition; P:piRNA biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:spermatogenesis; scaffold3 indexed_genome mRNA 48410406 48436321 . - . ID=transcript_783;Q8TAG6 B2RDC3 B4DFU4 C9J814 C9JCS3,Vexin {ECO:0000250|UniProtKB:Q8BG31},, PF15505;, GO:0005634;GO:0005886;GO:0022008;GO:0030182;, C:nucleus; C:plasma membrane;, , P:neurogenesis; P:neuron differentiation; scaffold3 indexed_genome mRNA 48458652 48491144 . - . ID=transcript_784;Q8IWW8 B4DTJ8 Q49A19 Q68CI7 Q6P2B6 Q96MF9,Hydroxyacid-oxoacid transhydrogenase, mitochondrial,Alcohol dehydrogenase iron-containing protein 1;Fe-containing alcohol dehydrogenase;, PF00465;, GO:0005759;GO:0005739;GO:0004022;GO:0047988;GO:0046872;GO:0006103;GO:0006539;, C:mitochondrial matrix; C:mitochondrion;, F:alcohol dehydrogenase (NAD+) activity; F:hydroxyacid-oxoacid transhydrogenase activity; F:metal ion binding;, P:2-oxoglutarate metabolic process; P:glutamate catabolic process via 2-oxoglutarate;|Q8IWW8 B4DTJ8 Q49A19 Q68CI7 Q6P2B6 Q96MF9,Hydroxyacid-oxoacid transhydrogenase, mitochondrial,Alcohol dehydrogenase iron-containing protein 1;Fe-containing alcohol dehydrogenase;, PF00465;, GO:0005759;GO:0005739;GO:0004022;GO:0047988;GO:0046872;GO:0006103;GO:0006539;, C:mitochondrial matrix; C:mitochondrion;, F:alcohol dehydrogenase (NAD+) activity; F:hydroxyacid-oxoacid transhydrogenase activity; F:metal ion binding;, P:2-oxoglutarate metabolic process; P:glutamate catabolic process via 2-oxoglutarate;|Q8IWW8 B4DTJ8 Q49A19 Q68CI7 Q6P2B6 Q96MF9,Hydroxyacid-oxoacid transhydrogenase, mitochondrial,Alcohol dehydrogenase iron-containing protein 1;Fe-containing alcohol dehydrogenase;, PF00465;, GO:0005759;GO:0005739;GO:0004022;GO:0047988;GO:0046872;GO:0006103;GO:0006539;, C:mitochondrial matrix; C:mitochondrion;, F:alcohol dehydrogenase (NAD+) activity; F:hydroxyacid-oxoacid transhydrogenase activity; F:metal ion binding;, P:2-oxoglutarate metabolic process; P:glutamate catabolic process via 2-oxoglutarate;|Q8IWW8 B4DTJ8 Q49A19 Q68CI7 Q6P2B6 Q96MF9,Hydroxyacid-oxoacid transhydrogenase, mitochondrial,Alcohol dehydrogenase iron-containing protein 1;Fe-containing alcohol dehydrogenase;, PF00465;, GO:0005759;GO:0005739;GO:0004022;GO:0047988;GO:0046872;GO:0006103;GO:0006539;, C:mitochondrial matrix; C:mitochondrion;, F:alcohol dehydrogenase (NAD+) activity; F:hydroxyacid-oxoacid transhydrogenase activity; F:metal ion binding;, P:2-oxoglutarate metabolic process; P:glutamate catabolic process via 2-oxoglutarate; scaffold3 indexed_genome mRNA 48491672 48494437 . - . ID=transcript_785;Q15050 Q9BUX8,Ribosome biogenesis regulatory protein homolog,, PF04939;, GO:0000794;GO:0005730;GO:0005654;GO:0030687;GO:0008097;GO:0003723;GO:0000447;GO:0007080;GO:1902570;GO:1901796;GO:0000027;GO:0042273;GO:0000055;, C:condensed nuclear chromosome; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:5S rRNA binding; F:RNA binding;, P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:mitotic metaphase plate congression; P:protein localization to nucleolus; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosomal large subunit biogenesis; P:ribosomal large subunit export from nucleus; scaffold3 indexed_genome mRNA 48651249 48663414 . + . ID=transcript_786;Q9BYV6 B3KRC0 B3KRJ3 Q53XX3 Q8IUD9 Q8IUE4 Q96DV2 Q96DV3 Q9BYV5,Tripartite motif-containing protein 55,Muscle-specific RING finger protein 2;RING finger protein 29;, PF00643;PF13445;, GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0061630;GO:0008270;GO:0050904;GO:0002523;GO:1905517;GO:0016567;GO:0007165;, C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:diapedesis; P:leukocyte migration involved in inflammatory response; P:macrophage migration; P:protein ubiquitination; P:signal transduction; scaffold3 indexed_genome mRNA 48668794 48699014 . - . ID=transcript_787;Q9BYV6 B3KRC0 B3KRJ3 Q53XX3 Q8IUD9 Q8IUE4 Q96DV2 Q96DV3 Q9BYV5,Tripartite motif-containing protein 55,Muscle-specific RING finger protein 2;RING finger protein 29;, PF00643;PF13445;, GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0061630;GO:0008270;GO:0050904;GO:0002523;GO:1905517;GO:0016567;GO:0007165;, C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:diapedesis; P:leukocyte migration involved in inflammatory response; P:macrophage migration; P:protein ubiquitination; P:signal transduction;|Q9BYV6 B3KRC0 B3KRJ3 Q53XX3 Q8IUD9 Q8IUE4 Q96DV2 Q96DV3 Q9BYV5,Tripartite motif-containing protein 55,Muscle-specific RING finger protein 2;RING finger protein 29;, PF00643;PF13445;, GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0061630;GO:0008270;GO:0050904;GO:0002523;GO:1905517;GO:0016567;GO:0007165;, C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:diapedesis; P:leukocyte migration involved in inflammatory response; P:macrophage migration; P:protein ubiquitination; P:signal transduction; scaffold3 indexed_genome mRNA 49046539 49062487 . + . ID=transcript_788;Q13946 A0AVH6 A8K436 A8K9G5 O15380 Q96T72,High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A,HCP1;TM22;, PF00233;, GO:0005829;GO:0004115;GO:0004114;GO:0046872;GO:0006198;GO:0019933;GO:0007186;GO:0007165;, C:cytosol;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:cAMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:signal transduction;|Q13946 A0AVH6 A8K436 A8K9G5 O15380 Q96T72,High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A,HCP1;TM22;, PF00233;, GO:0005829;GO:0004115;GO:0004114;GO:0046872;GO:0006198;GO:0019933;GO:0007186;GO:0007165;, C:cytosol;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:cAMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:signal transduction;|Q13946 A0AVH6 A8K436 A8K9G5 O15380 Q96T72,High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A,HCP1;TM22;, PF00233;, GO:0005829;GO:0004115;GO:0004114;GO:0046872;GO:0006198;GO:0019933;GO:0007186;GO:0007165;, C:cytosol;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:cAMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:signal transduction;|Q13946 A0AVH6 A8K436 A8K9G5 O15380 Q96T72,High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A,HCP1;TM22;, PF00233;, GO:0005829;GO:0004115;GO:0004114;GO:0046872;GO:0006198;GO:0019933;GO:0007186;GO:0007165;, C:cytosol;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:cAMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:signal transduction; scaffold3 indexed_genome mRNA 49069503 49113149 . - . ID=transcript_789;Q15390 E7EP84 Q6IB94 Q7Z669 Q86XH5 Q8IVD7,Mitochondrial fission regulator 1,Chondrocyte protein with a poly-proline region;, PF05308;, GO:0005829;GO:0005739;GO:0005886;GO:0009060;GO:0000266;GO:0007005;, C:cytosol; C:mitochondrion; C:plasma membrane;, , P:aerobic respiration; P:mitochondrial fission; P:mitochondrion organization;|Q15390 E7EP84 Q6IB94 Q7Z669 Q86XH5 Q8IVD7,Mitochondrial fission regulator 1,Chondrocyte protein with a poly-proline region;, PF05308;, GO:0005829;GO:0005739;GO:0005886;GO:0009060;GO:0000266;GO:0007005;, C:cytosol; C:mitochondrion; C:plasma membrane;, , P:aerobic respiration; P:mitochondrial fission; P:mitochondrion organization; scaffold3 indexed_genome mRNA 49154592 49156663 . + . ID=transcript_790;Q9NVT9 B4E2W7 Q9H018 Q9H820,Armadillo repeat-containing protein 1,, PF00514;, GO:0005829;GO:0005741;GO:0005739;GO:0046872;GO:0048312;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:metal ion binding;, P:intracellular distribution of mitochondria;|Q9NVT9 B4E2W7 Q9H018 Q9H820,Armadillo repeat-containing protein 1,, PF00514;, GO:0005829;GO:0005741;GO:0005739;GO:0046872;GO:0048312;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:metal ion binding;, P:intracellular distribution of mitochondria; scaffold3 indexed_genome mRNA 49680990 49851768 . + . ID=transcript_791;O75881 B2RN07 Q9UNF5,Cytochrome P450 7B1,24-hydroxycholesterol 7-alpha-hydroxylase {ECO:0000250|UniProtKB:Q60991};25/26-hydroxycholesterol 7-alpha-hydroxylase {ECO:0000305|PubMed:10588945};3-hydroxysteroid 7-alpha hydroxylase {ECO:0000303|PubMed:24491228};Oxysterol 7-alpha-hydroxylase {ECO:0000303|PubMed:10588945};, PF00067;, GO:0005789;GO:0016021;GO:0033783;GO:0047092;GO:0020037;GO:0005506;GO:0008396;GO:0008395;GO:0035754;GO:0006699;GO:0042632;GO:0008203;GO:0033147;GO:0050679;GO:0060740;GO:0016125;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:25-hydroxycholesterol 7alpha-hydroxylase activity; F:27-hydroxycholesterol 7-alpha-monooxygenase activity; F:heme binding; F:iron ion binding; F:oxysterol 7-alpha-hydroxylase activity; F:steroid hydroxylase activity;, P:B cell chemotaxis; P:bile acid biosynthetic process; P:cholesterol homeostasis; P:cholesterol metabolic process; P:negative regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of epithelial cell proliferation; P:prostate gland epithelium morphogenesis; P:sterol metabolic process; scaffold3 indexed_genome mRNA 50902862 50941172 . - . ID=transcript_792;Q7Z739 B3KXL4 Q63Z37 Q659A3,YTH domain-containing family protein 3 {ECO:0000305},, PF04146;, GO:0005737;GO:0010494;GO:0005829;GO:0000932;GO:0003729;GO:1990247;GO:0043022;GO:0003723;GO:0061157;GO:0060339;GO:0070925;GO:0045727;GO:0045948;GO:0043488;GO:1901163;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:P-body;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:ribosome binding; F:RNA binding;, P:mRNA destabilization; P:negative regulation of type I interferon-mediated signaling pathway; P:organelle assembly; P:positive regulation of translation; P:positive regulation of translational initiation; P:regulation of mRNA stability; P:regulation of trophoblast cell migration; P:stress granule assembly;|Q7Z739 B3KXL4 Q63Z37 Q659A3,YTH domain-containing family protein 3 {ECO:0000305},, PF04146;, GO:0005737;GO:0010494;GO:0005829;GO:0000932;GO:0003729;GO:1990247;GO:0043022;GO:0003723;GO:0061157;GO:0060339;GO:0070925;GO:0045727;GO:0045948;GO:0043488;GO:1901163;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:P-body;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:ribosome binding; F:RNA binding;, P:mRNA destabilization; P:negative regulation of type I interferon-mediated signaling pathway; P:organelle assembly; P:positive regulation of translation; P:positive regulation of translational initiation; P:regulation of mRNA stability; P:regulation of trophoblast cell migration; P:stress granule assembly;|Q7Z739 B3KXL4 Q63Z37 Q659A3,YTH domain-containing family protein 3 {ECO:0000305},, PF04146;, GO:0005737;GO:0010494;GO:0005829;GO:0000932;GO:0003729;GO:1990247;GO:0043022;GO:0003723;GO:0061157;GO:0060339;GO:0070925;GO:0045727;GO:0045948;GO:0043488;GO:1901163;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:P-body;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:ribosome binding; F:RNA binding;, P:mRNA destabilization; P:negative regulation of type I interferon-mediated signaling pathway; P:organelle assembly; P:positive regulation of translation; P:positive regulation of translational initiation; P:regulation of mRNA stability; P:regulation of trophoblast cell migration; P:stress granule assembly; scaffold3 indexed_genome mRNA 50999952 51026828 . + . ID=transcript_793;Q92820,Gamma-glutamyl hydrolase,Conjugase;GH;Gamma-Glu-X carboxypeptidase;, PF07722;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0042470;GO:0005634;GO:0035580;GO:1904724;GO:0005773;GO:0008238;GO:0034722;GO:0008242;GO:0043312;GO:0042493;GO:0045471;GO:0032868;GO:0010043;GO:0046900;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:melanosome; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:vacuole;, F:exopeptidase activity; F:gamma-glutamyl-peptidase activity; F:omega peptidase activity;, P:neutrophil degranulation; P:response to drug; P:response to ethanol; P:response to insulin; P:response to zinc ion; P:tetrahydrofolylpolyglutamate metabolic process;|Q92820,Gamma-glutamyl hydrolase,Conjugase;GH;Gamma-Glu-X carboxypeptidase;, PF07722;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0042470;GO:0005634;GO:0035580;GO:1904724;GO:0005773;GO:0008238;GO:0034722;GO:0008242;GO:0043312;GO:0042493;GO:0045471;GO:0032868;GO:0010043;GO:0046900;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:melanosome; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:vacuole;, F:exopeptidase activity; F:gamma-glutamyl-peptidase activity; F:omega peptidase activity;, P:neutrophil degranulation; P:response to drug; P:response to ethanol; P:response to insulin; P:response to zinc ion; P:tetrahydrofolylpolyglutamate metabolic process;|Q92820,Gamma-glutamyl hydrolase,Conjugase;GH;Gamma-Glu-X carboxypeptidase;, PF07722;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0042470;GO:0005634;GO:0035580;GO:1904724;GO:0005773;GO:0008238;GO:0034722;GO:0008242;GO:0043312;GO:0042493;GO:0045471;GO:0032868;GO:0010043;GO:0046900;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:melanosome; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:vacuole;, F:exopeptidase activity; F:gamma-glutamyl-peptidase activity; F:omega peptidase activity;, P:neutrophil degranulation; P:response to drug; P:response to ethanol; P:response to insulin; P:response to zinc ion; P:tetrahydrofolylpolyglutamate metabolic process;|Q92820,Gamma-glutamyl hydrolase,Conjugase;GH;Gamma-Glu-X carboxypeptidase;, PF07722;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0042470;GO:0005634;GO:0035580;GO:1904724;GO:0005773;GO:0008238;GO:0034722;GO:0008242;GO:0043312;GO:0042493;GO:0045471;GO:0032868;GO:0010043;GO:0046900;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:melanosome; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:vacuole;, F:exopeptidase activity; F:gamma-glutamyl-peptidase activity; F:omega peptidase activity;, P:neutrophil degranulation; P:response to drug; P:response to ethanol; P:response to insulin; P:response to zinc ion; P:tetrahydrofolylpolyglutamate metabolic process;|Q92820,Gamma-glutamyl hydrolase,Conjugase;GH;Gamma-Glu-X carboxypeptidase;, PF07722;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0042470;GO:0005634;GO:0035580;GO:1904724;GO:0005773;GO:0008238;GO:0034722;GO:0008242;GO:0043312;GO:0042493;GO:0045471;GO:0032868;GO:0010043;GO:0046900;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:melanosome; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:vacuole;, F:exopeptidase activity; F:gamma-glutamyl-peptidase activity; F:omega peptidase activity;, P:neutrophil degranulation; P:response to drug; P:response to ethanol; P:response to insulin; P:response to zinc ion; P:tetrahydrofolylpolyglutamate metabolic process; scaffold3 indexed_genome mRNA 51060015 51579332 . - . ID=transcript_794;Q8N8D7,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3,Protein FAM77D;, PF05640;, GO:0016021;GO:0005886;GO:0002028;, C:integral component of membrane; C:plasma membrane;, , P:regulation of sodium ion transport; scaffold3 indexed_genome mRNA 51858784 52011563 . + . ID=transcript_795;Q6NXR7 Q8TB28 Q9H291 Q9H2C4 Q9NRI0 Q9NRI1 Q9Y4J0,Aspartyl/asparaginyl beta-hydroxylase,Aspartate beta-hydroxylase;Peptide-aspartate beta-dioxygenase;, PF05279;PF05118;, GO:0034704;GO:0032541;GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0014701;GO:0005886;GO:0033018;GO:0033017;GO:0005509;GO:0009055;GO:0044325;GO:0004597;GO:0062101;GO:0008307;GO:0005198;GO:0097202;GO:0032237;GO:0055074;GO:0070588;GO:0071277;GO:0005513;GO:0034220;GO:0006936;GO:0042264;GO:0010524;GO:0090316;GO:0045862;GO:0060316;GO:0045893;GO:1903779;GO:0010881;GO:0010649;GO:0031585;GO:0010880;GO:0060314;GO:0033198;, C:calcium channel complex; C:cortical endoplasmic reticulum; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:calcium ion binding; F:electron transfer activity; F:ion channel binding; F:peptide-aspartate beta-dioxygenase activity; F:peptidyl-aspartic acid 3-dioxygenase activity; F:structural constituent of muscle; F:structural molecule activity;, P:activation of cysteine-type endopeptidase activity; P:activation of store-operated calcium channel activity; P:calcium ion homeostasis; P:calcium ion transmembrane transport; P:cellular response to calcium ion; P:detection of calcium ion; P:ion transmembrane transport; P:muscle contraction; P:peptidyl-aspartic acid hydroxylation; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of intracellular protein transport; P:positive regulation of proteolysis; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of transcription, DNA-templated; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:response to ATP;|Q6NXR7 Q8TB28 Q9H291 Q9H2C4 Q9NRI0 Q9NRI1 Q9Y4J0,Aspartyl/asparaginyl beta-hydroxylase,Aspartate beta-hydroxylase;Peptide-aspartate beta-dioxygenase;, PF05279;PF05118;, GO:0034704;GO:0032541;GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0014701;GO:0005886;GO:0033018;GO:0033017;GO:0005509;GO:0009055;GO:0044325;GO:0004597;GO:0062101;GO:0008307;GO:0005198;GO:0097202;GO:0032237;GO:0055074;GO:0070588;GO:0071277;GO:0005513;GO:0034220;GO:0006936;GO:0042264;GO:0010524;GO:0090316;GO:0045862;GO:0060316;GO:0045893;GO:1903779;GO:0010881;GO:0010649;GO:0031585;GO:0010880;GO:0060314;GO:0033198;, C:calcium channel complex; C:cortical endoplasmic reticulum; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:calcium ion binding; F:electron transfer activity; F:ion channel binding; F:peptide-aspartate beta-dioxygenase activity; F:peptidyl-aspartic acid 3-dioxygenase activity; F:structural constituent of muscle; F:structural molecule activity;, P:activation of cysteine-type endopeptidase activity; P:activation of store-operated calcium channel activity; P:calcium ion homeostasis; P:calcium ion transmembrane transport; P:cellular response to calcium ion; P:detection of calcium ion; P:ion transmembrane transport; P:muscle contraction; P:peptidyl-aspartic acid hydroxylation; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of intracellular protein transport; P:positive regulation of proteolysis; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of transcription, DNA-templated; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:response to ATP;|Q6NXR7 Q8TB28 Q9H291 Q9H2C4 Q9NRI0 Q9NRI1 Q9Y4J0,Aspartyl/asparaginyl beta-hydroxylase,Aspartate beta-hydroxylase;Peptide-aspartate beta-dioxygenase;, PF05279;PF05118;, GO:0034704;GO:0032541;GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0014701;GO:0005886;GO:0033018;GO:0033017;GO:0005509;GO:0009055;GO:0044325;GO:0004597;GO:0062101;GO:0008307;GO:0005198;GO:0097202;GO:0032237;GO:0055074;GO:0070588;GO:0071277;GO:0005513;GO:0034220;GO:0006936;GO:0042264;GO:0010524;GO:0090316;GO:0045862;GO:0060316;GO:0045893;GO:1903779;GO:0010881;GO:0010649;GO:0031585;GO:0010880;GO:0060314;GO:0033198;, C:calcium channel complex; C:cortical endoplasmic reticulum; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:calcium ion binding; F:electron transfer activity; F:ion channel binding; F:peptide-aspartate beta-dioxygenase activity; F:peptidyl-aspartic acid 3-dioxygenase activity; F:structural constituent of muscle; F:structural molecule activity;, P:activation of cysteine-type endopeptidase activity; P:activation of store-operated calcium channel activity; P:calcium ion homeostasis; P:calcium ion transmembrane transport; P:cellular response to calcium ion; P:detection of calcium ion; P:ion transmembrane transport; P:muscle contraction; P:peptidyl-aspartic acid hydroxylation; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of intracellular protein transport; P:positive regulation of proteolysis; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of transcription, DNA-templated; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:response to ATP;|Q6NXR7 Q8TB28 Q9H291 Q9H2C4 Q9NRI0 Q9NRI1 Q9Y4J0,Aspartyl/asparaginyl beta-hydroxylase,Aspartate beta-hydroxylase;Peptide-aspartate beta-dioxygenase;, PF05279;PF05118;, GO:0034704;GO:0032541;GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0014701;GO:0005886;GO:0033018;GO:0033017;GO:0005509;GO:0009055;GO:0044325;GO:0004597;GO:0062101;GO:0008307;GO:0005198;GO:0097202;GO:0032237;GO:0055074;GO:0070588;GO:0071277;GO:0005513;GO:0034220;GO:0006936;GO:0042264;GO:0010524;GO:0090316;GO:0045862;GO:0060316;GO:0045893;GO:1903779;GO:0010881;GO:0010649;GO:0031585;GO:0010880;GO:0060314;GO:0033198;, C:calcium channel complex; C:cortical endoplasmic reticulum; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:calcium ion binding; F:electron transfer activity; F:ion channel binding; F:peptide-aspartate beta-dioxygenase activity; F:peptidyl-aspartic acid 3-dioxygenase activity; F:structural constituent of muscle; F:structural molecule activity;, P:activation of cysteine-type endopeptidase activity; P:activation of store-operated calcium channel activity; P:calcium ion homeostasis; P:calcium ion transmembrane transport; P:cellular response to calcium ion; P:detection of calcium ion; P:ion transmembrane transport; P:muscle contraction; P:peptidyl-aspartic acid hydroxylation; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of intracellular protein transport; P:positive regulation of proteolysis; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of transcription, DNA-templated; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:response to ATP;|Q8IUQ0 B2R7M5 C8UZT3 Q8NB32,Clavesin-1,Cellular retinaldehyde-binding protein-like;Retinaldehyde-binding protein 1-like 1;clathrin vesicle-associated Sec14 protein 1 {ECO:0000303|PubMed:19651769};, PF00650;PF03765;, GO:0030136;GO:0031901;GO:0005768;GO:0005802;GO:0032588;GO:1902936;GO:0080025;GO:0007040;GO:0006892;, C:clathrin-coated vesicle; C:early endosome membrane; C:endosome; C:trans-Golgi network; C:trans-Golgi network membrane;, F:phosphatidylinositol bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:lysosome organization; P:post-Golgi vesicle-mediated transport; scaffold3 indexed_genome mRNA 52035702 52176630 . - . ID=transcript_796;Q8IUQ0 B2R7M5 C8UZT3 Q8NB32,Clavesin-1,Cellular retinaldehyde-binding protein-like;Retinaldehyde-binding protein 1-like 1;clathrin vesicle-associated Sec14 protein 1 {ECO:0000303|PubMed:19651769};, PF00650;PF03765;, GO:0030136;GO:0031901;GO:0005768;GO:0005802;GO:0032588;GO:1902936;GO:0080025;GO:0007040;GO:0006892;, C:clathrin-coated vesicle; C:early endosome membrane; C:endosome; C:trans-Golgi network; C:trans-Golgi network membrane;, F:phosphatidylinositol bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:lysosome organization; P:post-Golgi vesicle-mediated transport; scaffold3 indexed_genome mRNA 52514945 52644794 . - . ID=transcript_797;Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis;|Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis;|Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis;|Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis;|Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis;|Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis;|Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis;|Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis;|Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis;|Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis;|Q9NXA3,Chromodomain-helicase-DNA-binding protein 7,ATP-dependent helicase CHD7;, PF07533;PF00385;PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0070615;GO:1990841;GO:0000978;GO:0007512;GO:0007628;GO:0035909;GO:0036302;GO:0008015;GO:0001974;GO:0060411;GO:0007417;GO:0006338;GO:0050890;GO:0021545;GO:0035116;GO:0060429;GO:0060324;GO:0030540;GO:0048806;GO:0003007;GO:0001701;GO:0042472;GO:0060384;GO:0060173;GO:0043584;GO:0042048;GO:0021772;GO:0021553;GO:0040018;GO:0045944;GO:0060123;GO:0050767;GO:0010880;GO:0006355;GO:0009617;GO:0060041;GO:0003226;GO:0006364;GO:0062009;GO:0048752;GO:0007605;GO:0001501;GO:0030217;GO:0003222;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adult heart development; P:adult walking behavior; P:aorta morphogenesis; P:atrioventricular canal development; P:blood circulation; P:blood vessel remodeling; P:cardiac septum morphogenesis; P:central nervous system development; P:chromatin remodeling; P:cognition; P:cranial nerve development; P:embryonic hindlimb morphogenesis; P:epithelium development; P:face development; P:female genitalia development; P:genitalia development; P:heart morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:innervation; P:limb development; P:nose development; P:olfactory behavior; P:olfactory bulb development; P:olfactory nerve development; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth hormone secretion; P:regulation of neurogenesis; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of transcription, DNA-templated; P:response to bacterium; P:retina development in camera-type eye; P:right ventricular compact myocardium morphogenesis; P:rRNA processing; P:secondary palate development; P:semicircular canal morphogenesis; P:sensory perception of sound; P:skeletal system development; P:T cell differentiation; P:ventricular trabecula myocardium morphogenesis; scaffold3 indexed_genome mRNA 52749278 52784561 . - . ID=transcript_798;P61019 B2R5W8 B4DMQ5 P08886,Ras-related protein Rab-2A,, PF00071;, GO:0005829;GO:0005789;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0005765;GO:0042470;GO:0005634;GO:0019003;GO:0005525;GO:0003924;GO:0006888;GO:0007030;GO:0043687;GO:0015031;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:melanosome; C:nucleus;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:post-translational protein modification; P:protein transport;|P61019 B2R5W8 B4DMQ5 P08886,Ras-related protein Rab-2A,, PF00071;, GO:0005829;GO:0005789;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0005765;GO:0042470;GO:0005634;GO:0019003;GO:0005525;GO:0003924;GO:0006888;GO:0007030;GO:0043687;GO:0015031;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:melanosome; C:nucleus;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:post-translational protein modification; P:protein transport;|P61019 B2R5W8 B4DMQ5 P08886,Ras-related protein Rab-2A,, PF00071;, GO:0005829;GO:0005789;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0005765;GO:0042470;GO:0005634;GO:0019003;GO:0005525;GO:0003924;GO:0006888;GO:0007030;GO:0043687;GO:0015031;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:melanosome; C:nucleus;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:post-translational protein modification; P:protein transport;|P61019 B2R5W8 B4DMQ5 P08886,Ras-related protein Rab-2A,, PF00071;, GO:0005829;GO:0005789;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0005765;GO:0042470;GO:0005634;GO:0019003;GO:0005525;GO:0003924;GO:0006888;GO:0007030;GO:0043687;GO:0015031;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:melanosome; C:nucleus;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:post-translational protein modification; P:protein transport; scaffold3 indexed_genome mRNA 52826410 52827429 . + . ID=transcript_799;P13639 B2RMP5 D6W618 Q58J86,Elongation factor 2,, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0016235;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0045121;GO:0005634;GO:0005886;GO:0042788;GO:1990904;GO:0034774;GO:0045202;GO:0008097;GO:0051015;GO:0045296;GO:0005525;GO:0003924;GO:0002039;GO:0019901;GO:0043022;GO:0003723;GO:0003746;GO:0007568;GO:1990416;GO:0014009;GO:0002244;GO:0043312;GO:2000767;GO:0045727;GO:0042493;GO:0034976;GO:0032355;GO:0045471;GO:0051593;GO:0042542;GO:0002931;GO:0035914;GO:0003009;GO:0006414;, C:aggresome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:polysomal ribosome; C:ribonucleoprotein complex; C:secretory granule lumen; C:synapse;, F:5S rRNA binding; F:actin filament binding; F:cadherin binding; F:GTP binding; F:GTPase activity; F:p53 binding; F:protein kinase binding; F:ribosome binding; F:RNA binding; F:translation elongation factor activity;, P:aging; P:cellular response to brain-derived neurotrophic factor stimulus; P:glial cell proliferation; P:hematopoietic progenitor cell differentiation; P:neutrophil degranulation; P:positive regulation of cytoplasmic translation; P:positive regulation of translation; P:response to drug; P:response to endoplasmic reticulum stress; P:response to estradiol; P:response to ethanol; P:response to folic acid; P:response to hydrogen peroxide; P:response to ischemia; P:skeletal muscle cell differentiation; P:skeletal muscle contraction; P:translational elongation; scaffold3 indexed_genome mRNA 52962399 53050054 . + . ID=transcript_800;P35219 A8K0A5 B3KQZ7 Q32MY2,Carbonic anhydrase-related protein,Carbonic anhydrase VIII;, PF00194;, GO:0005737;GO:0004089;GO:0016836;GO:0008270;GO:0006730;GO:0048015;, C:cytoplasm;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:one-carbon metabolic process; P:phosphatidylinositol-mediated signaling;|P35219 A8K0A5 B3KQZ7 Q32MY2,Carbonic anhydrase-related protein,Carbonic anhydrase VIII;, PF00194;, GO:0005737;GO:0004089;GO:0016836;GO:0008270;GO:0006730;GO:0048015;, C:cytoplasm;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:one-carbon metabolic process; P:phosphatidylinositol-mediated signaling; scaffold3 indexed_genome mRNA 54144394 54191530 . + . ID=transcript_801;Q92636 B4DFB0 E9PCH0 Q8IW26,Protein FAN,Factor associated with neutral sphingomyelinase activation;, PF02138;PF02893;PF00400;, GO:0005737;GO:0005829;GO:0016230;GO:0006672;GO:0043065;GO:2000304;GO:0007165;, C:cytoplasm; C:cytosol;, F:sphingomyelin phosphodiesterase activator activity;, P:ceramide metabolic process; P:positive regulation of apoptotic process; P:positive regulation of ceramide biosynthetic process; P:signal transduction;|Q92636 B4DFB0 E9PCH0 Q8IW26,Protein FAN,Factor associated with neutral sphingomyelinase activation;, PF02138;PF02893;PF00400;, GO:0005737;GO:0005829;GO:0016230;GO:0006672;GO:0043065;GO:2000304;GO:0007165;, C:cytoplasm; C:cytosol;, F:sphingomyelin phosphodiesterase activator activity;, P:ceramide metabolic process; P:positive regulation of apoptotic process; P:positive regulation of ceramide biosynthetic process; P:signal transduction;|Q92636 B4DFB0 E9PCH0 Q8IW26,Protein FAN,Factor associated with neutral sphingomyelinase activation;, PF02138;PF02893;PF00400;, GO:0005737;GO:0005829;GO:0016230;GO:0006672;GO:0043065;GO:2000304;GO:0007165;, C:cytoplasm; C:cytosol;, F:sphingomyelin phosphodiesterase activator activity;, P:ceramide metabolic process; P:positive regulation of apoptotic process; P:positive regulation of ceramide biosynthetic process; P:signal transduction;|Q92636 B4DFB0 E9PCH0 Q8IW26,Protein FAN,Factor associated with neutral sphingomyelinase activation;, PF02138;PF02893;PF00400;, GO:0005737;GO:0005829;GO:0016230;GO:0006672;GO:0043065;GO:2000304;GO:0007165;, C:cytoplasm; C:cytosol;, F:sphingomyelin phosphodiesterase activator activity;, P:ceramide metabolic process; P:positive regulation of apoptotic process; P:positive regulation of ceramide biosynthetic process; P:signal transduction;|Q92636 B4DFB0 E9PCH0 Q8IW26,Protein FAN,Factor associated with neutral sphingomyelinase activation;, PF02138;PF02893;PF00400;, GO:0005737;GO:0005829;GO:0016230;GO:0006672;GO:0043065;GO:2000304;GO:0007165;, C:cytoplasm; C:cytosol;, F:sphingomyelin phosphodiesterase activator activity;, P:ceramide metabolic process; P:positive regulation of apoptotic process; P:positive regulation of ceramide biosynthetic process; P:signal transduction;|Q92636 B4DFB0 E9PCH0 Q8IW26,Protein FAN,Factor associated with neutral sphingomyelinase activation;, PF02138;PF02893;PF00400;, GO:0005737;GO:0005829;GO:0016230;GO:0006672;GO:0043065;GO:2000304;GO:0007165;, C:cytoplasm; C:cytosol;, F:sphingomyelin phosphodiesterase activator activity;, P:ceramide metabolic process; P:positive regulation of apoptotic process; P:positive regulation of ceramide biosynthetic process; P:signal transduction;|Q92636 B4DFB0 E9PCH0 Q8IW26,Protein FAN,Factor associated with neutral sphingomyelinase activation;, PF02138;PF02893;PF00400;, GO:0005737;GO:0005829;GO:0016230;GO:0006672;GO:0043065;GO:2000304;GO:0007165;, C:cytoplasm; C:cytosol;, F:sphingomyelin phosphodiesterase activator activity;, P:ceramide metabolic process; P:positive regulation of apoptotic process; P:positive regulation of ceramide biosynthetic process; P:signal transduction; scaffold3 indexed_genome mRNA 54191944 54224788 . - . ID=transcript_802;O00560 B2R5Q7 B4DUH3 B7ZLN2 O00173 O43391 Q14CP2,Syntenin-1,Melanoma differentiation-associated protein 9;Pro-TGF-alpha cytoplasmic domain-interacting protein 18;Scaffold protein Pbp1;Syndecan-binding protein 1;, PF00595;, GO:0005912;GO:0035578;GO:0072562;GO:0005737;GO:0005856;GO:0005829;GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005925;GO:0005895;GO:0042470;GO:0016020;GO:0045121;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0008093;GO:0005109;GO:0042802;GO:0005137;GO:0005546;GO:0046982;GO:0047485;GO:0045545;GO:0030036;GO:0007268;GO:0048013;GO:0035556;GO:0032435;GO:0002091;GO:0043312;GO:0030307;GO:0030335;GO:0008284;GO:0010718;GO:1903543;GO:1903553;GO:0046330;GO:0010862;GO:0042327;GO:0030511;GO:0006612;GO:0007346;GO:0060544;GO:0006930;, C:adherens junction; C:azurophil granule lumen; C:blood microparticle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:focal adhesion; C:interleukin-5 receptor complex; C:melanosome; C:membrane; C:membrane raft; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:cytoskeletal anchor activity; F:frizzled binding; F:identical protein binding; F:interleukin-5 receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein N-terminus binding; F:syndecan binding;, P:actin cytoskeleton organization; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of receptor internalization; P:neutrophil degranulation; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:positive regulation of JNK cascade; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of phosphorylation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein targeting to membrane; P:regulation of mitotic cell cycle; P:regulation of necroptotic process; P:substrate-dependent cell migration, cell extension;|O00560 B2R5Q7 B4DUH3 B7ZLN2 O00173 O43391 Q14CP2,Syntenin-1,Melanoma differentiation-associated protein 9;Pro-TGF-alpha cytoplasmic domain-interacting protein 18;Scaffold protein Pbp1;Syndecan-binding protein 1;, PF00595;, GO:0005912;GO:0035578;GO:0072562;GO:0005737;GO:0005856;GO:0005829;GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005925;GO:0005895;GO:0042470;GO:0016020;GO:0045121;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0008093;GO:0005109;GO:0042802;GO:0005137;GO:0005546;GO:0046982;GO:0047485;GO:0045545;GO:0030036;GO:0007268;GO:0048013;GO:0035556;GO:0032435;GO:0002091;GO:0043312;GO:0030307;GO:0030335;GO:0008284;GO:0010718;GO:1903543;GO:1903553;GO:0046330;GO:0010862;GO:0042327;GO:0030511;GO:0006612;GO:0007346;GO:0060544;GO:0006930;, C:adherens junction; C:azurophil granule lumen; C:blood microparticle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:focal adhesion; C:interleukin-5 receptor complex; C:melanosome; C:membrane; C:membrane raft; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:cytoskeletal anchor activity; F:frizzled binding; F:identical protein binding; F:interleukin-5 receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein N-terminus binding; F:syndecan binding;, P:actin cytoskeleton organization; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of receptor internalization; P:neutrophil degranulation; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:positive regulation of JNK cascade; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of phosphorylation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein targeting to membrane; P:regulation of mitotic cell cycle; P:regulation of necroptotic process; P:substrate-dependent cell migration, cell extension;|O00560 B2R5Q7 B4DUH3 B7ZLN2 O00173 O43391 Q14CP2,Syntenin-1,Melanoma differentiation-associated protein 9;Pro-TGF-alpha cytoplasmic domain-interacting protein 18;Scaffold protein Pbp1;Syndecan-binding protein 1;, PF00595;, GO:0005912;GO:0035578;GO:0072562;GO:0005737;GO:0005856;GO:0005829;GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005925;GO:0005895;GO:0042470;GO:0016020;GO:0045121;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0008093;GO:0005109;GO:0042802;GO:0005137;GO:0005546;GO:0046982;GO:0047485;GO:0045545;GO:0030036;GO:0007268;GO:0048013;GO:0035556;GO:0032435;GO:0002091;GO:0043312;GO:0030307;GO:0030335;GO:0008284;GO:0010718;GO:1903543;GO:1903553;GO:0046330;GO:0010862;GO:0042327;GO:0030511;GO:0006612;GO:0007346;GO:0060544;GO:0006930;, C:adherens junction; C:azurophil granule lumen; C:blood microparticle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:focal adhesion; C:interleukin-5 receptor complex; C:melanosome; C:membrane; C:membrane raft; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:cytoskeletal anchor activity; F:frizzled binding; F:identical protein binding; F:interleukin-5 receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein N-terminus binding; F:syndecan binding;, P:actin cytoskeleton organization; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of receptor internalization; P:neutrophil degranulation; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:positive regulation of JNK cascade; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of phosphorylation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein targeting to membrane; P:regulation of mitotic cell cycle; P:regulation of necroptotic process; P:substrate-dependent cell migration, cell extension;|O00560 B2R5Q7 B4DUH3 B7ZLN2 O00173 O43391 Q14CP2,Syntenin-1,Melanoma differentiation-associated protein 9;Pro-TGF-alpha cytoplasmic domain-interacting protein 18;Scaffold protein Pbp1;Syndecan-binding protein 1;, PF00595;, GO:0005912;GO:0035578;GO:0072562;GO:0005737;GO:0005856;GO:0005829;GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005925;GO:0005895;GO:0042470;GO:0016020;GO:0045121;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0008093;GO:0005109;GO:0042802;GO:0005137;GO:0005546;GO:0046982;GO:0047485;GO:0045545;GO:0030036;GO:0007268;GO:0048013;GO:0035556;GO:0032435;GO:0002091;GO:0043312;GO:0030307;GO:0030335;GO:0008284;GO:0010718;GO:1903543;GO:1903553;GO:0046330;GO:0010862;GO:0042327;GO:0030511;GO:0006612;GO:0007346;GO:0060544;GO:0006930;, C:adherens junction; C:azurophil granule lumen; C:blood microparticle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:focal adhesion; C:interleukin-5 receptor complex; C:melanosome; C:membrane; C:membrane raft; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:cytoskeletal anchor activity; F:frizzled binding; F:identical protein binding; F:interleukin-5 receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein N-terminus binding; F:syndecan binding;, P:actin cytoskeleton organization; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of receptor internalization; P:neutrophil degranulation; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:positive regulation of JNK cascade; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of phosphorylation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein targeting to membrane; P:regulation of mitotic cell cycle; P:regulation of necroptotic process; P:substrate-dependent cell migration, cell extension; scaffold3 indexed_genome mRNA 54280797 54291528 . + . ID=transcript_803;P22680 P78454 Q3MIL8 Q7KZ19,Cytochrome P450 7A1 {ECO:0000303|PubMed:21813643},24-hydroxycholesterol 7-alpha-hydroxylase {ECO:0000305|PubMed:11013305};CYPVII;Cholesterol 7-alpha-hydroxylase {ECO:0000303|PubMed:11013305};Cholesterol 7-alpha-monooxygenase;, PF00067;, GO:0005789;GO:0016021;GO:0043231;GO:0033782;GO:0008123;GO:0020037;GO:0005506;GO:0008395;GO:0015721;GO:0006699;GO:0038183;GO:0071397;GO:0071333;GO:0006707;GO:0042632;GO:0032966;GO:0045717;GO:0045542;GO:0070857;GO:0010468;GO:0019222;GO:0045471;GO:0016125;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:24-hydroxycholesterol 7alpha-hydroxylase activity; F:cholesterol 7-alpha-monooxygenase activity; F:heme binding; F:iron ion binding; F:steroid hydroxylase activity;, P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:bile acid signaling pathway; P:cellular response to cholesterol; P:cellular response to glucose stimulus; P:cholesterol catabolic process; P:cholesterol homeostasis; P:negative regulation of collagen biosynthetic process; P:negative regulation of fatty acid biosynthetic process; P:positive regulation of cholesterol biosynthetic process; P:regulation of bile acid biosynthetic process; P:regulation of gene expression; P:regulation of metabolic process; P:response to ethanol; P:sterol metabolic process; scaffold3 indexed_genome mRNA 54327499 54353766 . - . ID=transcript_804;Q14CS0 B3KWZ3,UBX domain-containing protein 2B,NSFL1 cofactor p37;p97 cofactor p37;, PF08059;PF00789;, GO:0005829;GO:0005783;GO:0005794;GO:0005634;GO:0031616;GO:0043130;GO:0000045;GO:0000132;GO:0007030;GO:0061025;GO:1904780;GO:0031468;GO:0046604;GO:0043161;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleus; C:spindle pole centrosome;, F:ubiquitin binding;, P:autophagosome assembly; P:establishment of mitotic spindle orientation; P:Golgi organization; P:membrane fusion; P:negative regulation of protein localization to centrosome; P:nuclear envelope reassembly; P:positive regulation of mitotic centrosome separation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; scaffold3 indexed_genome mRNA 55036506 55056001 . + . ID=transcript_805;Q9NX62 Q6NVY7,Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase {ECO:0000250|UniProtKB:Q80V26},3'(2'), 5'-bisphosphate nucleotidase 2 {ECO:0000312|HGNC:HGNC:26019};Inositol monophosphatase domain-containing protein 1 {ECO:0000250|UniProtKB:Q80V26};Myo-inositol monophosphatase A3 {ECO:0000303|Ref.1};Phosphoadenosine phosphate 3'-nucleotidase {ECO:0000250|UniProtKB:Q80V26};, PF00459;, GO:0005829;GO:0012505;GO:0005794;GO:0005796;GO:0016021;GO:0016020;GO:0016604;GO:0005654;GO:0032588;GO:0008441;GO:0097657;GO:0008254;GO:0046872;GO:0050427;GO:0002063;GO:0030204;GO:0042733;GO:0001958;GO:0046855;GO:0046854;GO:0009791;GO:0001501;, C:cytosol; C:endomembrane system; C:Golgi apparatus; C:Golgi lumen; C:integral component of membrane; C:membrane; C:nuclear body; C:nucleoplasm; C:trans-Golgi network membrane;, F:3'(2'),5'-bisphosphate nucleotidase activity; F:3',5'-nucleotide bisphosphate phosphatase activity; F:3'-nucleotidase activity; F:metal ion binding;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:chondrocyte development; P:chondroitin sulfate metabolic process; P:embryonic digit morphogenesis; P:endochondral ossification; P:inositol phosphate dephosphorylation; P:phosphatidylinositol phosphorylation; P:post-embryonic development; P:skeletal system development;|Q9NX62 Q6NVY7,Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase {ECO:0000250|UniProtKB:Q80V26},3'(2'), 5'-bisphosphate nucleotidase 2 {ECO:0000312|HGNC:HGNC:26019};Inositol monophosphatase domain-containing protein 1 {ECO:0000250|UniProtKB:Q80V26};Myo-inositol monophosphatase A3 {ECO:0000303|Ref.1};Phosphoadenosine phosphate 3'-nucleotidase {ECO:0000250|UniProtKB:Q80V26};, PF00459;, GO:0005829;GO:0012505;GO:0005794;GO:0005796;GO:0016021;GO:0016020;GO:0016604;GO:0005654;GO:0032588;GO:0008441;GO:0097657;GO:0008254;GO:0046872;GO:0050427;GO:0002063;GO:0030204;GO:0042733;GO:0001958;GO:0046855;GO:0046854;GO:0009791;GO:0001501;, C:cytosol; C:endomembrane system; C:Golgi apparatus; C:Golgi lumen; C:integral component of membrane; C:membrane; C:nuclear body; C:nucleoplasm; C:trans-Golgi network membrane;, F:3'(2'),5'-bisphosphate nucleotidase activity; F:3',5'-nucleotide bisphosphate phosphatase activity; F:3'-nucleotidase activity; F:metal ion binding;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:chondrocyte development; P:chondroitin sulfate metabolic process; P:embryonic digit morphogenesis; P:endochondral ossification; P:inositol phosphate dephosphorylation; P:phosphatidylinositol phosphorylation; P:post-embryonic development; P:skeletal system development; scaffold3 indexed_genome mRNA 55458284 55473900 . + . ID=transcript_806;Q8N3Y7 B4DGK2 Q330K3 Q8TDV9 Q96LX1,Epidermal retinol dehydrogenase 2,Retinal short-chain dehydrogenase reductase 2;Short-chain dehydrogenase/reductase family 16C member 5;, PF00106;, GO:0005789;GO:0016021;GO:0005811;GO:0005634;GO:0017053;GO:0033613;GO:0016616;GO:0004745;GO:0003714;GO:0008134;GO:0043616;GO:0035067;GO:0000122;GO:0031065;GO:0042574;GO:0042572;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:nucleus; C:transcription repressor complex;, F:activating transcription factor binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:retinol dehydrogenase activity; F:transcription corepressor activity; F:transcription factor binding;, P:keratinocyte proliferation; P:negative regulation of histone acetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone deacetylation; P:retinal metabolic process; P:retinol metabolic process; scaffold3 indexed_genome mRNA 55516607 55523391 . - . ID=transcript_807;Q9BUK0 A8K223 E9PBH3 J3KNE9 Q7Z588,Coiled-coil-helix-coiled-coil-helix domain-containing protein 7,, , GO:0005758;, C:mitochondrial intermembrane space;|Q9BUK0 A8K223 E9PBH3 J3KNE9 Q7Z588,Coiled-coil-helix-coiled-coil-helix domain-containing protein 7,, , GO:0005758;, C:mitochondrial intermembrane space;|Q9BUK0 A8K223 E9PBH3 J3KNE9 Q7Z588,Coiled-coil-helix-coiled-coil-helix domain-containing protein 7,, , GO:0005758;, C:mitochondrial intermembrane space; scaffold3 indexed_genome mRNA 55561759 55627003 . + . ID=transcript_808;P60866 B2R4F4 B4DW28 P17075 Q5M8S9,40S ribosomal protein S20,Small ribosomal subunit protein uS10 {ECO:0000303|PubMed:24524803};, PF00338;, GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0015935;GO:0003723;GO:0003735;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P60866 B2R4F4 B4DW28 P17075 Q5M8S9,40S ribosomal protein S20,Small ribosomal subunit protein uS10 {ECO:0000303|PubMed:24524803};, PF00338;, GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0015935;GO:0003723;GO:0003735;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold3 indexed_genome mRNA 55655812 55768160 . - . ID=transcript_809;P07948 A0AVQ5,Tyrosine-protein kinase Lyn,Lck/Yes-related novel protein tyrosine kinase;V-yes-1 Yamaguchi sarcoma viral related oncogene homolog;p53Lyn;p56Lyn;, PF07714;PF00017;PF00018;, GO:0005912;GO:0005737;GO:0005829;GO:0070062;GO:0031234;GO:0098978;GO:0005794;GO:0034666;GO:0043231;GO:0045121;GO:0030061;GO:0005758;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0099091;GO:0005524;GO:0019899;GO:0046875;GO:0043015;GO:0043208;GO:0005178;GO:0044325;GO:0016301;GO:0004715;GO:0051219;GO:0140031;GO:0005161;GO:0004713;GO:0017124;GO:0005102;GO:0004714;GO:0031625;GO:0002250;GO:0001782;GO:0050853;GO:0007596;GO:0030154;GO:0006974;GO:0031668;GO:0034605;GO:0071300;GO:0097028;GO:0048013;GO:0030218;GO:0002774;GO:0002431;GO:0038095;GO:0038096;GO:0060397;GO:0002553;GO:0002768;GO:0045087;GO:0035556;GO:0050900;GO:0031663;GO:0030889;GO:0008285;GO:0070373;GO:0050777;GO:0002862;GO:1902532;GO:0043407;GO:0070667;GO:0002762;GO:0001933;GO:0034136;GO:0034144;GO:0031175;GO:0014003;GO:0018108;GO:0030168;GO:0002576;GO:1902961;GO:0030335;GO:0008284;GO:0051272;GO:2000670;GO:0060369;GO:0060252;GO:0070668;GO:0010976;GO:0070447;GO:0043552;GO:0014068;GO:0001934;GO:0046579;GO:0070304;GO:0042531;GO:0046777;GO:0006468;GO:0002902;GO:0050855;GO:0033628;GO:0001817;GO:0070372;GO:0045646;GO:0033003;GO:0043304;GO:0090025;GO:0090330;GO:0001932;GO:0051279;GO:0043200;GO:0048678;GO:0009743;GO:0042493;GO:0009725;GO:0032868;GO:0014070;GO:0006991;GO:0009636;GO:0007165;GO:0002223;GO:0031295;GO:0002513;GO:0034142;GO:0007169;GO:0016032;, C:adherens junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:Golgi apparatus; C:integrin alpha2-beta1 complex; C:intracellular membrane-bounded organelle; C:membrane raft; C:mitochondrial crista; C:mitochondrial intermembrane space; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization, intracellular component;, F:ATP binding; F:enzyme binding; F:ephrin receptor binding; F:gamma-tubulin binding; F:glycosphingolipid binding; F:integrin binding; F:ion channel binding; F:kinase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphoprotein binding; F:phosphorylation-dependent protein binding; F:platelet-derived growth factor receptor binding; F:protein tyrosine kinase activity; F:SH3 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:adaptive immune response; P:B cell homeostasis; P:B cell receptor signaling pathway; P:blood coagulation; P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to extracellular stimulus; P:cellular response to heat; P:cellular response to retinoic acid; P:dendritic cell differentiation; P:ephrin receptor signaling pathway; P:erythrocyte differentiation; P:Fc receptor mediated inhibitory signaling pathway; P:Fc receptor mediated stimulatory signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway via JAK-STAT; P:histamine secretion by mast cell; P:immune response-regulating cell surface receptor signaling pathway; P:innate immune response; P:intracellular signal transduction; P:leukocyte migration; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of B cell proliferation; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of intracellular signal transduction; P:negative regulation of MAP kinase activity; P:negative regulation of mast cell proliferation; P:negative regulation of myeloid leukocyte differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor 2 signaling pathway; P:negative regulation of toll-like receptor 4 signaling pathway; P:neuron projection development; P:oligodendrocyte development; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:platelet degranulation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of Fc receptor mediated stimulatory signaling pathway; P:positive regulation of glial cell proliferation; P:positive regulation of mast cell proliferation; P:positive regulation of neuron projection development; P:positive regulation of oligodendrocyte progenitor proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of stress-activated protein kinase signaling cascade; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of B cell apoptotic process; P:regulation of B cell receptor signaling pathway; P:regulation of cell adhesion mediated by integrin; P:regulation of cytokine production; P:regulation of ERK1 and ERK2 cascade; P:regulation of erythrocyte differentiation; P:regulation of mast cell activation; P:regulation of mast cell degranulation; P:regulation of monocyte chemotaxis; P:regulation of platelet aggregation; P:regulation of protein phosphorylation; P:regulation of release of sequestered calcium ion into cytosol; P:response to amino acid; P:response to axon injury; P:response to carbohydrate; P:response to drug; P:response to hormone; P:response to insulin; P:response to organic cyclic compound; P:response to sterol depletion; P:response to toxic substance; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:tolerance induction to self antigen; P:toll-like receptor 4 signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|P07948 A0AVQ5,Tyrosine-protein kinase Lyn,Lck/Yes-related novel protein tyrosine kinase;V-yes-1 Yamaguchi sarcoma viral related oncogene homolog;p53Lyn;p56Lyn;, PF07714;PF00017;PF00018;, GO:0005912;GO:0005737;GO:0005829;GO:0070062;GO:0031234;GO:0098978;GO:0005794;GO:0034666;GO:0043231;GO:0045121;GO:0030061;GO:0005758;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0099091;GO:0005524;GO:0019899;GO:0046875;GO:0043015;GO:0043208;GO:0005178;GO:0044325;GO:0016301;GO:0004715;GO:0051219;GO:0140031;GO:0005161;GO:0004713;GO:0017124;GO:0005102;GO:0004714;GO:0031625;GO:0002250;GO:0001782;GO:0050853;GO:0007596;GO:0030154;GO:0006974;GO:0031668;GO:0034605;GO:0071300;GO:0097028;GO:0048013;GO:0030218;GO:0002774;GO:0002431;GO:0038095;GO:0038096;GO:0060397;GO:0002553;GO:0002768;GO:0045087;GO:0035556;GO:0050900;GO:0031663;GO:0030889;GO:0008285;GO:0070373;GO:0050777;GO:0002862;GO:1902532;GO:0043407;GO:0070667;GO:0002762;GO:0001933;GO:0034136;GO:0034144;GO:0031175;GO:0014003;GO:0018108;GO:0030168;GO:0002576;GO:1902961;GO:0030335;GO:0008284;GO:0051272;GO:2000670;GO:0060369;GO:0060252;GO:0070668;GO:0010976;GO:0070447;GO:0043552;GO:0014068;GO:0001934;GO:0046579;GO:0070304;GO:0042531;GO:0046777;GO:0006468;GO:0002902;GO:0050855;GO:0033628;GO:0001817;GO:0070372;GO:0045646;GO:0033003;GO:0043304;GO:0090025;GO:0090330;GO:0001932;GO:0051279;GO:0043200;GO:0048678;GO:0009743;GO:0042493;GO:0009725;GO:0032868;GO:0014070;GO:0006991;GO:0009636;GO:0007165;GO:0002223;GO:0031295;GO:0002513;GO:0034142;GO:0007169;GO:0016032;, C:adherens junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:Golgi apparatus; C:integrin alpha2-beta1 complex; C:intracellular membrane-bounded organelle; C:membrane raft; C:mitochondrial crista; C:mitochondrial intermembrane space; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization, intracellular component;, F:ATP binding; F:enzyme binding; F:ephrin receptor binding; F:gamma-tubulin binding; F:glycosphingolipid binding; F:integrin binding; F:ion channel binding; F:kinase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphoprotein binding; F:phosphorylation-dependent protein binding; F:platelet-derived growth factor receptor binding; F:protein tyrosine kinase activity; F:SH3 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:adaptive immune response; P:B cell homeostasis; P:B cell receptor signaling pathway; P:blood coagulation; P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to extracellular stimulus; P:cellular response to heat; P:cellular response to retinoic acid; P:dendritic cell differentiation; P:ephrin receptor signaling pathway; P:erythrocyte differentiation; P:Fc receptor mediated inhibitory signaling pathway; P:Fc receptor mediated stimulatory signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway via JAK-STAT; P:histamine secretion by mast cell; P:immune response-regulating cell surface receptor signaling pathway; P:innate immune response; P:intracellular signal transduction; P:leukocyte migration; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of B cell proliferation; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of intracellular signal transduction; P:negative regulation of MAP kinase activity; P:negative regulation of mast cell proliferation; P:negative regulation of myeloid leukocyte differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor 2 signaling pathway; P:negative regulation of toll-like receptor 4 signaling pathway; P:neuron projection development; P:oligodendrocyte development; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:platelet degranulation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of Fc receptor mediated stimulatory signaling pathway; P:positive regulation of glial cell proliferation; P:positive regulation of mast cell proliferation; P:positive regulation of neuron projection development; P:positive regulation of oligodendrocyte progenitor proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of stress-activated protein kinase signaling cascade; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of B cell apoptotic process; P:regulation of B cell receptor signaling pathway; P:regulation of cell adhesion mediated by integrin; P:regulation of cytokine production; P:regulation of ERK1 and ERK2 cascade; P:regulation of erythrocyte differentiation; P:regulation of mast cell activation; P:regulation of mast cell degranulation; P:regulation of monocyte chemotaxis; P:regulation of platelet aggregation; P:regulation of protein phosphorylation; P:regulation of release of sequestered calcium ion into cytosol; P:response to amino acid; P:response to axon injury; P:response to carbohydrate; P:response to drug; P:response to hormone; P:response to insulin; P:response to organic cyclic compound; P:response to sterol depletion; P:response to toxic substance; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:tolerance induction to self antigen; P:toll-like receptor 4 signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|P07948 A0AVQ5,Tyrosine-protein kinase Lyn,Lck/Yes-related novel protein tyrosine kinase;V-yes-1 Yamaguchi sarcoma viral related oncogene homolog;p53Lyn;p56Lyn;, PF07714;PF00017;PF00018;, GO:0005912;GO:0005737;GO:0005829;GO:0070062;GO:0031234;GO:0098978;GO:0005794;GO:0034666;GO:0043231;GO:0045121;GO:0030061;GO:0005758;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0099091;GO:0005524;GO:0019899;GO:0046875;GO:0043015;GO:0043208;GO:0005178;GO:0044325;GO:0016301;GO:0004715;GO:0051219;GO:0140031;GO:0005161;GO:0004713;GO:0017124;GO:0005102;GO:0004714;GO:0031625;GO:0002250;GO:0001782;GO:0050853;GO:0007596;GO:0030154;GO:0006974;GO:0031668;GO:0034605;GO:0071300;GO:0097028;GO:0048013;GO:0030218;GO:0002774;GO:0002431;GO:0038095;GO:0038096;GO:0060397;GO:0002553;GO:0002768;GO:0045087;GO:0035556;GO:0050900;GO:0031663;GO:0030889;GO:0008285;GO:0070373;GO:0050777;GO:0002862;GO:1902532;GO:0043407;GO:0070667;GO:0002762;GO:0001933;GO:0034136;GO:0034144;GO:0031175;GO:0014003;GO:0018108;GO:0030168;GO:0002576;GO:1902961;GO:0030335;GO:0008284;GO:0051272;GO:2000670;GO:0060369;GO:0060252;GO:0070668;GO:0010976;GO:0070447;GO:0043552;GO:0014068;GO:0001934;GO:0046579;GO:0070304;GO:0042531;GO:0046777;GO:0006468;GO:0002902;GO:0050855;GO:0033628;GO:0001817;GO:0070372;GO:0045646;GO:0033003;GO:0043304;GO:0090025;GO:0090330;GO:0001932;GO:0051279;GO:0043200;GO:0048678;GO:0009743;GO:0042493;GO:0009725;GO:0032868;GO:0014070;GO:0006991;GO:0009636;GO:0007165;GO:0002223;GO:0031295;GO:0002513;GO:0034142;GO:0007169;GO:0016032;, C:adherens junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:Golgi apparatus; C:integrin alpha2-beta1 complex; C:intracellular membrane-bounded organelle; C:membrane raft; C:mitochondrial crista; C:mitochondrial intermembrane space; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization, intracellular component;, F:ATP binding; F:enzyme binding; F:ephrin receptor binding; F:gamma-tubulin binding; F:glycosphingolipid binding; F:integrin binding; F:ion channel binding; F:kinase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphoprotein binding; F:phosphorylation-dependent protein binding; F:platelet-derived growth factor receptor binding; F:protein tyrosine kinase activity; F:SH3 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:adaptive immune response; P:B cell homeostasis; P:B cell receptor signaling pathway; P:blood coagulation; P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to extracellular stimulus; P:cellular response to heat; P:cellular response to retinoic acid; P:dendritic cell differentiation; P:ephrin receptor signaling pathway; P:erythrocyte differentiation; P:Fc receptor mediated inhibitory signaling pathway; P:Fc receptor mediated stimulatory signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway via JAK-STAT; P:histamine secretion by mast cell; P:immune response-regulating cell surface receptor signaling pathway; P:innate immune response; P:intracellular signal transduction; P:leukocyte migration; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of B cell proliferation; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of intracellular signal transduction; P:negative regulation of MAP kinase activity; P:negative regulation of mast cell proliferation; P:negative regulation of myeloid leukocyte differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor 2 signaling pathway; P:negative regulation of toll-like receptor 4 signaling pathway; P:neuron projection development; P:oligodendrocyte development; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:platelet degranulation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of Fc receptor mediated stimulatory signaling pathway; P:positive regulation of glial cell proliferation; P:positive regulation of mast cell proliferation; P:positive regulation of neuron projection development; P:positive regulation of oligodendrocyte progenitor proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of stress-activated protein kinase signaling cascade; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of B cell apoptotic process; P:regulation of B cell receptor signaling pathway; P:regulation of cell adhesion mediated by integrin; P:regulation of cytokine production; P:regulation of ERK1 and ERK2 cascade; P:regulation of erythrocyte differentiation; P:regulation of mast cell activation; P:regulation of mast cell degranulation; P:regulation of monocyte chemotaxis; P:regulation of platelet aggregation; P:regulation of protein phosphorylation; P:regulation of release of sequestered calcium ion into cytosol; P:response to amino acid; P:response to axon injury; P:response to carbohydrate; P:response to drug; P:response to hormone; P:response to insulin; P:response to organic cyclic compound; P:response to sterol depletion; P:response to toxic substance; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:tolerance induction to self antigen; P:toll-like receptor 4 signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|P07948 A0AVQ5,Tyrosine-protein kinase Lyn,Lck/Yes-related novel protein tyrosine kinase;V-yes-1 Yamaguchi sarcoma viral related oncogene homolog;p53Lyn;p56Lyn;, PF07714;PF00017;PF00018;, GO:0005912;GO:0005737;GO:0005829;GO:0070062;GO:0031234;GO:0098978;GO:0005794;GO:0034666;GO:0043231;GO:0045121;GO:0030061;GO:0005758;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0099091;GO:0005524;GO:0019899;GO:0046875;GO:0043015;GO:0043208;GO:0005178;GO:0044325;GO:0016301;GO:0004715;GO:0051219;GO:0140031;GO:0005161;GO:0004713;GO:0017124;GO:0005102;GO:0004714;GO:0031625;GO:0002250;GO:0001782;GO:0050853;GO:0007596;GO:0030154;GO:0006974;GO:0031668;GO:0034605;GO:0071300;GO:0097028;GO:0048013;GO:0030218;GO:0002774;GO:0002431;GO:0038095;GO:0038096;GO:0060397;GO:0002553;GO:0002768;GO:0045087;GO:0035556;GO:0050900;GO:0031663;GO:0030889;GO:0008285;GO:0070373;GO:0050777;GO:0002862;GO:1902532;GO:0043407;GO:0070667;GO:0002762;GO:0001933;GO:0034136;GO:0034144;GO:0031175;GO:0014003;GO:0018108;GO:0030168;GO:0002576;GO:1902961;GO:0030335;GO:0008284;GO:0051272;GO:2000670;GO:0060369;GO:0060252;GO:0070668;GO:0010976;GO:0070447;GO:0043552;GO:0014068;GO:0001934;GO:0046579;GO:0070304;GO:0042531;GO:0046777;GO:0006468;GO:0002902;GO:0050855;GO:0033628;GO:0001817;GO:0070372;GO:0045646;GO:0033003;GO:0043304;GO:0090025;GO:0090330;GO:0001932;GO:0051279;GO:0043200;GO:0048678;GO:0009743;GO:0042493;GO:0009725;GO:0032868;GO:0014070;GO:0006991;GO:0009636;GO:0007165;GO:0002223;GO:0031295;GO:0002513;GO:0034142;GO:0007169;GO:0016032;, C:adherens junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:Golgi apparatus; C:integrin alpha2-beta1 complex; C:intracellular membrane-bounded organelle; C:membrane raft; C:mitochondrial crista; C:mitochondrial intermembrane space; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization, intracellular component;, F:ATP binding; F:enzyme binding; F:ephrin receptor binding; F:gamma-tubulin binding; F:glycosphingolipid binding; F:integrin binding; F:ion channel binding; F:kinase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphoprotein binding; F:phosphorylation-dependent protein binding; F:platelet-derived growth factor receptor binding; F:protein tyrosine kinase activity; F:SH3 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:adaptive immune response; P:B cell homeostasis; P:B cell receptor signaling pathway; P:blood coagulation; P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to extracellular stimulus; P:cellular response to heat; P:cellular response to retinoic acid; P:dendritic cell differentiation; P:ephrin receptor signaling pathway; P:erythrocyte differentiation; P:Fc receptor mediated inhibitory signaling pathway; P:Fc receptor mediated stimulatory signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway via JAK-STAT; P:histamine secretion by mast cell; P:immune response-regulating cell surface receptor signaling pathway; P:innate immune response; P:intracellular signal transduction; P:leukocyte migration; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of B cell proliferation; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of intracellular signal transduction; P:negative regulation of MAP kinase activity; P:negative regulation of mast cell proliferation; P:negative regulation of myeloid leukocyte differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor 2 signaling pathway; P:negative regulation of toll-like receptor 4 signaling pathway; P:neuron projection development; P:oligodendrocyte development; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:platelet degranulation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of Fc receptor mediated stimulatory signaling pathway; P:positive regulation of glial cell proliferation; P:positive regulation of mast cell proliferation; P:positive regulation of neuron projection development; P:positive regulation of oligodendrocyte progenitor proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of stress-activated protein kinase signaling cascade; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of B cell apoptotic process; P:regulation of B cell receptor signaling pathway; P:regulation of cell adhesion mediated by integrin; P:regulation of cytokine production; P:regulation of ERK1 and ERK2 cascade; P:regulation of erythrocyte differentiation; P:regulation of mast cell activation; P:regulation of mast cell degranulation; P:regulation of monocyte chemotaxis; P:regulation of platelet aggregation; P:regulation of protein phosphorylation; P:regulation of release of sequestered calcium ion into cytosol; P:response to amino acid; P:response to axon injury; P:response to carbohydrate; P:response to drug; P:response to hormone; P:response to insulin; P:response to organic cyclic compound; P:response to sterol depletion; P:response to toxic substance; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:tolerance induction to self antigen; P:toll-like receptor 4 signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|P07948 A0AVQ5,Tyrosine-protein kinase Lyn,Lck/Yes-related novel protein tyrosine kinase;V-yes-1 Yamaguchi sarcoma viral related oncogene homolog;p53Lyn;p56Lyn;, PF07714;PF00017;PF00018;, GO:0005912;GO:0005737;GO:0005829;GO:0070062;GO:0031234;GO:0098978;GO:0005794;GO:0034666;GO:0043231;GO:0045121;GO:0030061;GO:0005758;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0099091;GO:0005524;GO:0019899;GO:0046875;GO:0043015;GO:0043208;GO:0005178;GO:0044325;GO:0016301;GO:0004715;GO:0051219;GO:0140031;GO:0005161;GO:0004713;GO:0017124;GO:0005102;GO:0004714;GO:0031625;GO:0002250;GO:0001782;GO:0050853;GO:0007596;GO:0030154;GO:0006974;GO:0031668;GO:0034605;GO:0071300;GO:0097028;GO:0048013;GO:0030218;GO:0002774;GO:0002431;GO:0038095;GO:0038096;GO:0060397;GO:0002553;GO:0002768;GO:0045087;GO:0035556;GO:0050900;GO:0031663;GO:0030889;GO:0008285;GO:0070373;GO:0050777;GO:0002862;GO:1902532;GO:0043407;GO:0070667;GO:0002762;GO:0001933;GO:0034136;GO:0034144;GO:0031175;GO:0014003;GO:0018108;GO:0030168;GO:0002576;GO:1902961;GO:0030335;GO:0008284;GO:0051272;GO:2000670;GO:0060369;GO:0060252;GO:0070668;GO:0010976;GO:0070447;GO:0043552;GO:0014068;GO:0001934;GO:0046579;GO:0070304;GO:0042531;GO:0046777;GO:0006468;GO:0002902;GO:0050855;GO:0033628;GO:0001817;GO:0070372;GO:0045646;GO:0033003;GO:0043304;GO:0090025;GO:0090330;GO:0001932;GO:0051279;GO:0043200;GO:0048678;GO:0009743;GO:0042493;GO:0009725;GO:0032868;GO:0014070;GO:0006991;GO:0009636;GO:0007165;GO:0002223;GO:0031295;GO:0002513;GO:0034142;GO:0007169;GO:0016032;, C:adherens junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:Golgi apparatus; C:integrin alpha2-beta1 complex; C:intracellular membrane-bounded organelle; C:membrane raft; C:mitochondrial crista; C:mitochondrial intermembrane space; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization, intracellular component;, F:ATP binding; F:enzyme binding; F:ephrin receptor binding; F:gamma-tubulin binding; F:glycosphingolipid binding; F:integrin binding; F:ion channel binding; F:kinase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphoprotein binding; F:phosphorylation-dependent protein binding; F:platelet-derived growth factor receptor binding; F:protein tyrosine kinase activity; F:SH3 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:adaptive immune response; P:B cell homeostasis; P:B cell receptor signaling pathway; P:blood coagulation; P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to extracellular stimulus; P:cellular response to heat; P:cellular response to retinoic acid; P:dendritic cell differentiation; P:ephrin receptor signaling pathway; P:erythrocyte differentiation; P:Fc receptor mediated inhibitory signaling pathway; P:Fc receptor mediated stimulatory signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway via JAK-STAT; P:histamine secretion by mast cell; P:immune response-regulating cell surface receptor signaling pathway; P:innate immune response; P:intracellular signal transduction; P:leukocyte migration; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of B cell proliferation; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of intracellular signal transduction; P:negative regulation of MAP kinase activity; P:negative regulation of mast cell proliferation; P:negative regulation of myeloid leukocyte differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor 2 signaling pathway; P:negative regulation of toll-like receptor 4 signaling pathway; P:neuron projection development; P:oligodendrocyte development; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:platelet degranulation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of Fc receptor mediated stimulatory signaling pathway; P:positive regulation of glial cell proliferation; P:positive regulation of mast cell proliferation; P:positive regulation of neuron projection development; P:positive regulation of oligodendrocyte progenitor proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of stress-activated protein kinase signaling cascade; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of B cell apoptotic process; P:regulation of B cell receptor signaling pathway; P:regulation of cell adhesion mediated by integrin; P:regulation of cytokine production; P:regulation of ERK1 and ERK2 cascade; P:regulation of erythrocyte differentiation; P:regulation of mast cell activation; P:regulation of mast cell degranulation; P:regulation of monocyte chemotaxis; P:regulation of platelet aggregation; P:regulation of protein phosphorylation; P:regulation of release of sequestered calcium ion into cytosol; P:response to amino acid; P:response to axon injury; P:response to carbohydrate; P:response to drug; P:response to hormone; P:response to insulin; P:response to organic cyclic compound; P:response to sterol depletion; P:response to toxic substance; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:tolerance induction to self antigen; P:toll-like receptor 4 signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|Q9BX73 B2RBK4 D3DSX8 Q8N0X9,TM2 domain-containing protein 2,Beta-amyloid-binding protein-like protein 1;, PF05154;, GO:0016021;, C:integral component of membrane; scaffold3 indexed_genome mRNA 55807049 55833106 . + . ID=transcript_810;Q96RS0 A6NJQ5 Q5GH23 Q8TDG9 Q96QU3 Q9H5V3,Trimethylguanosine synthase,CLL-associated antigen KW-2;Cap-specific guanine-N2 methyltransferase;Hepatocellular carcinoma-associated antigen 137;Nuclear receptor coactivator 6-interacting protein;PRIP-interacting protein with methyltransferase motif;, PF09445;, GO:0015030;GO:0005737;GO:0005829;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0030532;GO:0071164;GO:0036261;GO:0009452;GO:0019216;GO:0022613;GO:0000387;, C:Cajal body; C:cytoplasm; C:cytosol; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex;, F:RNA trimethylguanosine synthase activity;, P:7-methylguanosine cap hypermethylation; P:7-methylguanosine RNA capping; P:regulation of lipid metabolic process; P:ribonucleoprotein complex biogenesis; P:spliceosomal snRNP assembly;|Q96RS0 A6NJQ5 Q5GH23 Q8TDG9 Q96QU3 Q9H5V3,Trimethylguanosine synthase,CLL-associated antigen KW-2;Cap-specific guanine-N2 methyltransferase;Hepatocellular carcinoma-associated antigen 137;Nuclear receptor coactivator 6-interacting protein;PRIP-interacting protein with methyltransferase motif;, PF09445;, GO:0015030;GO:0005737;GO:0005829;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0030532;GO:0071164;GO:0036261;GO:0009452;GO:0019216;GO:0022613;GO:0000387;, C:Cajal body; C:cytoplasm; C:cytosol; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex;, F:RNA trimethylguanosine synthase activity;, P:7-methylguanosine cap hypermethylation; P:7-methylguanosine RNA capping; P:regulation of lipid metabolic process; P:ribonucleoprotein complex biogenesis; P:spliceosomal snRNP assembly;|Q96RS0 A6NJQ5 Q5GH23 Q8TDG9 Q96QU3 Q9H5V3,Trimethylguanosine synthase,CLL-associated antigen KW-2;Cap-specific guanine-N2 methyltransferase;Hepatocellular carcinoma-associated antigen 137;Nuclear receptor coactivator 6-interacting protein;PRIP-interacting protein with methyltransferase motif;, PF09445;, GO:0015030;GO:0005737;GO:0005829;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0030532;GO:0071164;GO:0036261;GO:0009452;GO:0019216;GO:0022613;GO:0000387;, C:Cajal body; C:cytoplasm; C:cytosol; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex;, F:RNA trimethylguanosine synthase activity;, P:7-methylguanosine cap hypermethylation; P:7-methylguanosine RNA capping; P:regulation of lipid metabolic process; P:ribonucleoprotein complex biogenesis; P:spliceosomal snRNP assembly;|Q96RS0 A6NJQ5 Q5GH23 Q8TDG9 Q96QU3 Q9H5V3,Trimethylguanosine synthase,CLL-associated antigen KW-2;Cap-specific guanine-N2 methyltransferase;Hepatocellular carcinoma-associated antigen 137;Nuclear receptor coactivator 6-interacting protein;PRIP-interacting protein with methyltransferase motif;, PF09445;, GO:0015030;GO:0005737;GO:0005829;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0030532;GO:0071164;GO:0036261;GO:0009452;GO:0019216;GO:0022613;GO:0000387;, C:Cajal body; C:cytoplasm; C:cytosol; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex;, F:RNA trimethylguanosine synthase activity;, P:7-methylguanosine cap hypermethylation; P:7-methylguanosine RNA capping; P:regulation of lipid metabolic process; P:ribonucleoprotein complex biogenesis; P:spliceosomal snRNP assembly; scaffold3 indexed_genome mRNA 55833178 55865560 . + . ID=transcript_811;Q96MH6 Q658X6 Q8WUD2,Transmembrane protein 68,, PF01553;, GO:0016021;GO:0016746;, C:integral component of membrane;, F:transferase activity, transferring acyl groups;|Q96MH6 Q658X6 Q8WUD2,Transmembrane protein 68,, PF01553;, GO:0016021;GO:0016746;, C:integral component of membrane;, F:transferase activity, transferring acyl groups;|Q96MH6 Q658X6 Q8WUD2,Transmembrane protein 68,, PF01553;, GO:0016021;GO:0016746;, C:integral component of membrane;, F:transferase activity, transferring acyl groups;|Q96MH6 Q658X6 Q8WUD2,Transmembrane protein 68,, PF01553;, GO:0016021;GO:0016746;, C:integral component of membrane;, F:transferase activity, transferring acyl groups; scaffold3 indexed_genome mRNA 55865595 55867210 . + . ID=transcript_812;Q96MH6 Q658X6 Q8WUD2,Transmembrane protein 68,, PF01553;, GO:0016021;GO:0016746;, C:integral component of membrane;, F:transferase activity, transferring acyl groups; scaffold3 indexed_genome mRNA 55939260 55939792 . - . ID=transcript_813;Q5GH76 Q96PZ8,XK-related protein 4,, PF09815;, GO:0016021;GO:0016020;GO:0005886;GO:1902742;GO:0043652;GO:0070782;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:apoptotic process involved in development; P:engulfment of apoptotic cell; P:phosphatidylserine exposure on apoptotic cell surface; scaffold3 indexed_genome mRNA 55963033 55971860 . + . ID=transcript_814;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold3 indexed_genome mRNA 56785968 56791598 . - . ID=transcript_815;Q9P015 Q96Q54 Q9H0Y1,39S ribosomal protein L15, mitochondrial,Mitochondrial large ribosomal subunit protein uL15m {ECO:0000303|PubMed:25278503};, PF00828;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:1990830;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:cellular response to leukemia inhibitory factor; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold3 indexed_genome mRNA 56797892 56822056 . + . ID=transcript_816;O75608 O43202 Q9UQF9,Acyl-protein thioesterase 1,Lysophospholipase 1;Lysophospholipase I;, PF02230;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0031965;GO:0005886;GO:0052689;GO:0016298;GO:0004622;GO:0008474;GO:0004620;GO:0006631;GO:0000165;GO:0042997;GO:0002084;GO:0050999;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:nuclear membrane; C:plasma membrane;, F:carboxylic ester hydrolase activity; F:lipase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:fatty acid metabolic process; P:MAPK cascade; P:negative regulation of Golgi to plasma membrane protein transport; P:protein depalmitoylation; P:regulation of nitric-oxide synthase activity;|O75608 O43202 Q9UQF9,Acyl-protein thioesterase 1,Lysophospholipase 1;Lysophospholipase I;, PF02230;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0031965;GO:0005886;GO:0052689;GO:0016298;GO:0004622;GO:0008474;GO:0004620;GO:0006631;GO:0000165;GO:0042997;GO:0002084;GO:0050999;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:nuclear membrane; C:plasma membrane;, F:carboxylic ester hydrolase activity; F:lipase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:fatty acid metabolic process; P:MAPK cascade; P:negative regulation of Golgi to plasma membrane protein transport; P:protein depalmitoylation; P:regulation of nitric-oxide synthase activity;|O75608 O43202 Q9UQF9,Acyl-protein thioesterase 1,Lysophospholipase 1;Lysophospholipase I;, PF02230;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0031965;GO:0005886;GO:0052689;GO:0016298;GO:0004622;GO:0008474;GO:0004620;GO:0006631;GO:0000165;GO:0042997;GO:0002084;GO:0050999;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:nuclear membrane; C:plasma membrane;, F:carboxylic ester hydrolase activity; F:lipase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:fatty acid metabolic process; P:MAPK cascade; P:negative regulation of Golgi to plasma membrane protein transport; P:protein depalmitoylation; P:regulation of nitric-oxide synthase activity;|O75608 O43202 Q9UQF9,Acyl-protein thioesterase 1,Lysophospholipase 1;Lysophospholipase I;, PF02230;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0031965;GO:0005886;GO:0052689;GO:0016298;GO:0004622;GO:0008474;GO:0004620;GO:0006631;GO:0000165;GO:0042997;GO:0002084;GO:0050999;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:nuclear membrane; C:plasma membrane;, F:carboxylic ester hydrolase activity; F:lipase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:fatty acid metabolic process; P:MAPK cascade; P:negative regulation of Golgi to plasma membrane protein transport; P:protein depalmitoylation; P:regulation of nitric-oxide synthase activity;|O75608 O43202 Q9UQF9,Acyl-protein thioesterase 1,Lysophospholipase 1;Lysophospholipase I;, PF02230;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0031965;GO:0005886;GO:0052689;GO:0016298;GO:0004622;GO:0008474;GO:0004620;GO:0006631;GO:0000165;GO:0042997;GO:0002084;GO:0050999;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:nuclear membrane; C:plasma membrane;, F:carboxylic ester hydrolase activity; F:lipase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:fatty acid metabolic process; P:MAPK cascade; P:negative regulation of Golgi to plasma membrane protein transport; P:protein depalmitoylation; P:regulation of nitric-oxide synthase activity; scaffold3 indexed_genome mRNA 56840568 56857023 . + . ID=transcript_817;P23193 A6NF25 A8K339 Q15563 Q6FG87,Transcription elongation factor A protein 1,Transcription elongation factor S-II protein 1;Transcription elongation factor TFIIS.o;, PF08711;PF01096;PF07500;, GO:0005730;GO:0005654;GO:0005669;GO:0003677;GO:0008270;GO:1901919;GO:0045944;GO:0006366;GO:0006368;GO:0006283;, C:nucleolus; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:zinc ion binding;, P:positive regulation of exoribonuclease activity; P:positive regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P23193 A6NF25 A8K339 Q15563 Q6FG87,Transcription elongation factor A protein 1,Transcription elongation factor S-II protein 1;Transcription elongation factor TFIIS.o;, PF08711;PF01096;PF07500;, GO:0005730;GO:0005654;GO:0005669;GO:0003677;GO:0008270;GO:1901919;GO:0045944;GO:0006366;GO:0006368;GO:0006283;, C:nucleolus; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:zinc ion binding;, P:positive regulation of exoribonuclease activity; P:positive regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P23193 A6NF25 A8K339 Q15563 Q6FG87,Transcription elongation factor A protein 1,Transcription elongation factor S-II protein 1;Transcription elongation factor TFIIS.o;, PF08711;PF01096;PF07500;, GO:0005730;GO:0005654;GO:0005669;GO:0003677;GO:0008270;GO:1901919;GO:0045944;GO:0006366;GO:0006368;GO:0006283;, C:nucleolus; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:zinc ion binding;, P:positive regulation of exoribonuclease activity; P:positive regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P23193 A6NF25 A8K339 Q15563 Q6FG87,Transcription elongation factor A protein 1,Transcription elongation factor S-II protein 1;Transcription elongation factor TFIIS.o;, PF08711;PF01096;PF07500;, GO:0005730;GO:0005654;GO:0005669;GO:0003677;GO:0008270;GO:1901919;GO:0045944;GO:0006366;GO:0006368;GO:0006283;, C:nucleolus; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:zinc ion binding;, P:positive regulation of exoribonuclease activity; P:positive regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P23193 A6NF25 A8K339 Q15563 Q6FG87,Transcription elongation factor A protein 1,Transcription elongation factor S-II protein 1;Transcription elongation factor TFIIS.o;, PF08711;PF01096;PF07500;, GO:0005730;GO:0005654;GO:0005669;GO:0003677;GO:0008270;GO:1901919;GO:0045944;GO:0006366;GO:0006368;GO:0006283;, C:nucleolus; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:zinc ion binding;, P:positive regulation of exoribonuclease activity; P:positive regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P23193 A6NF25 A8K339 Q15563 Q6FG87,Transcription elongation factor A protein 1,Transcription elongation factor S-II protein 1;Transcription elongation factor TFIIS.o;, PF08711;PF01096;PF07500;, GO:0005730;GO:0005654;GO:0005669;GO:0003677;GO:0008270;GO:1901919;GO:0045944;GO:0006366;GO:0006368;GO:0006283;, C:nucleolus; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:zinc ion binding;, P:positive regulation of exoribonuclease activity; P:positive regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P23193 A6NF25 A8K339 Q15563 Q6FG87,Transcription elongation factor A protein 1,Transcription elongation factor S-II protein 1;Transcription elongation factor TFIIS.o;, PF08711;PF01096;PF07500;, GO:0005730;GO:0005654;GO:0005669;GO:0003677;GO:0008270;GO:1901919;GO:0045944;GO:0006366;GO:0006368;GO:0006283;, C:nucleolus; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:zinc ion binding;, P:positive regulation of exoribonuclease activity; P:positive regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; scaffold3 indexed_genome mRNA 56861802 56868484 . - . ID=transcript_818;O76081 Q96BG9,Regulator of G-protein signaling 20,Gz-selective GTPase-activating protein;Regulator of G-protein signaling Z1;Regulator of Gz-selective protein signaling 1;, PF00615;, GO:0005737;GO:0005634;GO:0005886;GO:0005802;GO:0005096;GO:0007186;GO:0009968;GO:0008277;, C:cytoplasm; C:nucleus; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway; scaffold3 indexed_genome mRNA 56923229 56926181 . + . ID=transcript_819;Q9UI12 B3KMR0 Q6PK44 Q9H3E3 Q9Y300,V-type proton ATPase subunit H,Nef-binding protein 1;Protein VMA13 homolog;V-ATPase 50/57 kDa subunits;Vacuolar proton pump subunit H;Vacuolar proton pump subunit SFD;, PF11698;PF03224;, GO:0005829;GO:0070062;GO:0005765;GO:0005886;GO:0000221;GO:0030234;GO:0046961;GO:0034198;GO:0006897;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0050690;GO:0016241;GO:0033572;GO:0007035;, C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:plasma membrane; C:vacuolar proton-transporting V-type ATPase, V1 domain;, F:enzyme regulator activity; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:endocytosis; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of defense response to virus by virus; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification; scaffold3 indexed_genome mRNA 57277431 57302767 . + . ID=transcript_820;Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy;|Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy;|Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy; scaffold3 indexed_genome mRNA 57303490 57327290 . + . ID=transcript_821;Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy;|Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy;|Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy;|Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy;|Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy;|Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy;|Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy;|Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy;|Q8TDY2 Q86YR4 Q8WVU9 Q92601,RB1-inducible coiled-coil protein 1 {ECO:0000305},FAK family kinase-interacting protein of 200 kDa;, PF10377;, GO:1990316;GO:0000421;GO:0005829;GO:0005789;GO:0019898;GO:0005764;GO:0031965;GO:0000407;GO:0034045;GO:0060090;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0030242;GO:0007049;GO:0061723;GO:0007507;GO:0001889;GO:0016236;GO:2001237;GO:0034727;GO:0045793;GO:0046330;GO:0001934;GO:0016241;GO:0061709;, C:Atg1/ULK1 kinase complex; C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lysosome; C:nuclear membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:molecular adaptor activity; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of peroxisome; P:cell cycle; P:glycophagy; P:heart development; P:liver development; P:macroautophagy; P:negative regulation of extrinsic apoptotic signaling pathway; P:piecemeal microautophagy of the nucleus; P:positive regulation of cell size; P:positive regulation of JNK cascade; P:positive regulation of protein phosphorylation; P:regulation of macroautophagy; P:reticulophagy; scaffold3 indexed_genome mRNA 57529329 57651999 . + . ID=transcript_822;O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway;|O60284 Q17RY1,Suppression of tumorigenicity 18 protein,Zinc finger protein 387;, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0032993;GO:0000981;GO:0000978;GO:0008270;GO:0070498;GO:0070102;GO:0008285;GO:2001269;GO:0045944;GO:0006357;GO:0033209;, C:chromatin; C:nucleus; C:protein-DNA complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:interleukin-1-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:negative regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:tumor necrosis factor-mediated signaling pathway; scaffold3 indexed_genome mRNA 57756139 57789765 . + . ID=transcript_823;Q96MG8 Q96FK9,Protein-L-isoaspartate O-methyltransferase domain-containing protein 1,, , GO:0005737;GO:0016020;GO:0004719;, C:cytoplasm; C:membrane;, F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;|Q96MG8 Q96FK9,Protein-L-isoaspartate O-methyltransferase domain-containing protein 1,, , GO:0005737;GO:0016020;GO:0004719;, C:cytoplasm; C:membrane;, F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;|Q96MG8 Q96FK9,Protein-L-isoaspartate O-methyltransferase domain-containing protein 1,, , GO:0005737;GO:0016020;GO:0004719;, C:cytoplasm; C:membrane;, F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;|Q96MG8 Q96FK9,Protein-L-isoaspartate O-methyltransferase domain-containing protein 1,, , GO:0005737;GO:0016020;GO:0004719;, C:cytoplasm; C:membrane;, F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity; scaffold3 indexed_genome mRNA 58748134 58751248 . - . ID=transcript_824;Q8WWR9 G3V137 Q8WVI1,Pancreatic progenitor cell differentiation and proliferation factor-like protein,Exocrine differentiation and proliferation factor-like protein;, PF15060;, GO:0030154;GO:0007275;, , , P:cell differentiation; P:multicellular organism development; scaffold3 indexed_genome mRNA 58786191 58789692 . + . ID=transcript_825;O43623 B2R6P6 Q53FC1,Zinc finger protein SNAI2,Neural crest transcription factor Slug;Protein snail homolog 2;, PF00096;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0070888;GO:0046872;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0003180;GO:0003273;GO:0071364;GO:0035921;GO:0001837;GO:0003198;GO:0060429;GO:2000811;GO:0090090;GO:0033629;GO:0032331;GO:0043518;GO:2001240;GO:1902230;GO:0010839;GO:0000122;GO:0010957;GO:0070563;GO:0014032;GO:0061314;GO:0007219;GO:0001649;GO:0043473;GO:0030335;GO:2000810;GO:0032642;GO:0045667;GO:0006355;GO:0007605;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:aortic valve morphogenesis; P:cell migration involved in endocardial cushion formation; P:cellular response to epidermal growth factor stimulus; P:desmosome disassembly; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:epithelium development; P:negative regulation of anoikis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of chondrocyte differentiation; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:negative regulation of vitamin D receptor signaling pathway; P:neural crest cell development; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:osteoblast differentiation; P:pigmentation; P:positive regulation of cell migration; P:regulation of bicellular tight junction assembly; P:regulation of chemokine production; P:regulation of osteoblast differentiation; P:regulation of transcription, DNA-templated; P:sensory perception of sound; scaffold3 indexed_genome mRNA 59076331 59100650 . - . ID=transcript_826;Q15819,Ubiquitin-conjugating enzyme E2 variant 2,DDVit 1;Enterocyte differentiation-associated factor 1;Enterocyte differentiation-promoting factor 1;MMS2 homolog;Vitamin D3-inducible protein;, PF00179;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0031372;GO:0000729;GO:0006302;GO:0006303;GO:0042275;GO:0043524;GO:0045739;GO:0010976;GO:0032436;GO:0051965;GO:0006301;GO:0070534;GO:0000209;GO:0016567;GO:0006282;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:UBC13-MMS2 complex;, , P:DNA double-strand break processing; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:error-free postreplication DNA repair; P:negative regulation of neuron apoptotic process; P:positive regulation of DNA repair; P:positive regulation of neuron projection development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of synapse assembly; P:postreplication repair; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of DNA repair;|Q15819,Ubiquitin-conjugating enzyme E2 variant 2,DDVit 1;Enterocyte differentiation-associated factor 1;Enterocyte differentiation-promoting factor 1;MMS2 homolog;Vitamin D3-inducible protein;, PF00179;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0031372;GO:0000729;GO:0006302;GO:0006303;GO:0042275;GO:0043524;GO:0045739;GO:0010976;GO:0032436;GO:0051965;GO:0006301;GO:0070534;GO:0000209;GO:0016567;GO:0006282;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:UBC13-MMS2 complex;, , P:DNA double-strand break processing; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:error-free postreplication DNA repair; P:negative regulation of neuron apoptotic process; P:positive regulation of DNA repair; P:positive regulation of neuron projection development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of synapse assembly; P:postreplication repair; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of DNA repair;|Q15819,Ubiquitin-conjugating enzyme E2 variant 2,DDVit 1;Enterocyte differentiation-associated factor 1;Enterocyte differentiation-promoting factor 1;MMS2 homolog;Vitamin D3-inducible protein;, PF00179;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0031372;GO:0000729;GO:0006302;GO:0006303;GO:0042275;GO:0043524;GO:0045739;GO:0010976;GO:0032436;GO:0051965;GO:0006301;GO:0070534;GO:0000209;GO:0016567;GO:0006282;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:UBC13-MMS2 complex;, , P:DNA double-strand break processing; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:error-free postreplication DNA repair; P:negative regulation of neuron apoptotic process; P:positive regulation of DNA repair; P:positive regulation of neuron projection development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of synapse assembly; P:postreplication repair; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of DNA repair; scaffold3 indexed_genome mRNA 59134809 59145595 . - . ID=transcript_827;P33991 Q8NEH1 Q99658,DNA replication licensing factor MCM4,CDC21 homolog;P1-CDC21;, PF00493;PF17855;PF14551;PF17207;, GO:0000781;GO:0071162;GO:0042555;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0003678;GO:0003688;GO:0003697;GO:0006260;GO:0006270;GO:0006271;GO:0006268;GO:0000727;GO:1902975;GO:0036388;GO:0006267;, C:chromosome, telomeric region; C:CMG complex; C:MCM complex; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA helicase activity; F:DNA replication origin binding; F:single-stranded DNA binding;, P:DNA replication; P:DNA replication initiation; P:DNA strand elongation involved in DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via break-induced replication; P:mitotic DNA replication initiation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; scaffold3 indexed_genome mRNA 59156210 59194172 . + . ID=transcript_828;P78527 P78528 Q13327 Q13337 Q14175 Q59H99 Q7Z611 Q96SE6 Q9UME3,DNA-dependent protein kinase catalytic subunit,DNPK1;p460;, PF02259;PF02260;PF08163;PF00454;, GO:0000781;GO:0005829;GO:0005958;GO:0016020;GO:0070419;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0032040;GO:0005667;GO:0005524;GO:0004677;GO:0003690;GO:0019899;GO:0019904;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0008134;GO:0034511;GO:0002218;GO:0002326;GO:0007420;GO:0006464;GO:0006974;GO:0032869;GO:0006302;GO:0097681;GO:0006303;GO:0035234;GO:0007507;GO:0033152;GO:0045087;GO:0008630;GO:0000460;GO:0043066;GO:2000773;GO:0002638;GO:0001933;GO:2001229;GO:0018105;GO:0018107;GO:0043065;GO:0048639;GO:2001034;GO:0045648;GO:0048146;GO:0045621;GO:1905221;GO:0045944;GO:0045727;GO:0032481;GO:0002328;GO:0031648;GO:0006468;GO:0016567;GO:0042752;GO:0050678;GO:1902036;GO:0048660;GO:0014823;GO:0010332;GO:0048511;GO:0072431;GO:0034462;GO:0001756;GO:0048536;GO:0033077;GO:0002360;GO:0033153;GO:0016233;GO:0000723;GO:0048538;, C:chromosome, telomeric region; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:membrane; C:nonhomologous end joining complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:small-subunit processome; C:transcription regulator complex;, F:ATP binding; F:DNA-dependent protein kinase activity; F:double-stranded DNA binding; F:enzyme binding; F:protein domain specific binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transcription factor binding; F:U3 snoRNA binding;, P:activation of innate immune response; P:B cell lineage commitment; P:brain development; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:ectopic germ cell programmed cell death; P:heart development; P:immunoglobulin V(D)J recombination; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:maturation of 5.8S rRNA; P:negative regulation of apoptotic process; P:negative regulation of cellular senescence; P:negative regulation of immunoglobulin production; P:negative regulation of protein phosphorylation; P:negative regulation of response to gamma radiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of developmental growth; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of erythrocyte differentiation; P:positive regulation of fibroblast proliferation; P:positive regulation of lymphocyte differentiation; P:positive regulation of platelet formation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of type I interferon production; P:pro-B cell differentiation; P:protein destabilization; P:protein phosphorylation; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of epithelial cell proliferation; P:regulation of hematopoietic stem cell differentiation; P:regulation of smooth muscle cell proliferation; P:response to activity; P:response to gamma radiation; P:rhythmic process; P:signal transduction involved in mitotic G1 DNA damage checkpoint; P:small-subunit processome assembly; P:somitogenesis; P:spleen development; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell receptor V(D)J recombination; P:telomere capping; P:telomere maintenance; P:thymus development;|P78527 P78528 Q13327 Q13337 Q14175 Q59H99 Q7Z611 Q96SE6 Q9UME3,DNA-dependent protein kinase catalytic subunit,DNPK1;p460;, PF02259;PF02260;PF08163;PF00454;, GO:0000781;GO:0005829;GO:0005958;GO:0016020;GO:0070419;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0032040;GO:0005667;GO:0005524;GO:0004677;GO:0003690;GO:0019899;GO:0019904;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0008134;GO:0034511;GO:0002218;GO:0002326;GO:0007420;GO:0006464;GO:0006974;GO:0032869;GO:0006302;GO:0097681;GO:0006303;GO:0035234;GO:0007507;GO:0033152;GO:0045087;GO:0008630;GO:0000460;GO:0043066;GO:2000773;GO:0002638;GO:0001933;GO:2001229;GO:0018105;GO:0018107;GO:0043065;GO:0048639;GO:2001034;GO:0045648;GO:0048146;GO:0045621;GO:1905221;GO:0045944;GO:0045727;GO:0032481;GO:0002328;GO:0031648;GO:0006468;GO:0016567;GO:0042752;GO:0050678;GO:1902036;GO:0048660;GO:0014823;GO:0010332;GO:0048511;GO:0072431;GO:0034462;GO:0001756;GO:0048536;GO:0033077;GO:0002360;GO:0033153;GO:0016233;GO:0000723;GO:0048538;, C:chromosome, telomeric region; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:membrane; C:nonhomologous end joining complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:small-subunit processome; C:transcription regulator complex;, F:ATP binding; F:DNA-dependent protein kinase activity; F:double-stranded DNA binding; F:enzyme binding; F:protein domain specific binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transcription factor binding; F:U3 snoRNA binding;, P:activation of innate immune response; P:B cell lineage commitment; P:brain development; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:ectopic germ cell programmed cell death; P:heart development; P:immunoglobulin V(D)J recombination; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:maturation of 5.8S rRNA; P:negative regulation of apoptotic process; P:negative regulation of cellular senescence; P:negative regulation of immunoglobulin production; P:negative regulation of protein phosphorylation; P:negative regulation of response to gamma radiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of developmental growth; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of erythrocyte differentiation; P:positive regulation of fibroblast proliferation; P:positive regulation of lymphocyte differentiation; P:positive regulation of platelet formation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of type I interferon production; P:pro-B cell differentiation; P:protein destabilization; P:protein phosphorylation; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of epithelial cell proliferation; P:regulation of hematopoietic stem cell differentiation; P:regulation of smooth muscle cell proliferation; P:response to activity; P:response to gamma radiation; P:rhythmic process; P:signal transduction involved in mitotic G1 DNA damage checkpoint; P:small-subunit processome assembly; P:somitogenesis; P:spleen development; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell receptor V(D)J recombination; P:telomere capping; P:telomere maintenance; P:thymus development; scaffold3 indexed_genome mRNA 59195611 59196244 . - . ID=transcript_829;P78527 P78528 Q13327 Q13337 Q14175 Q59H99 Q7Z611 Q96SE6 Q9UME3,DNA-dependent protein kinase catalytic subunit,DNPK1;p460;, PF02259;PF02260;PF08163;PF00454;, GO:0000781;GO:0005829;GO:0005958;GO:0016020;GO:0070419;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0032040;GO:0005667;GO:0005524;GO:0004677;GO:0003690;GO:0019899;GO:0019904;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0008134;GO:0034511;GO:0002218;GO:0002326;GO:0007420;GO:0006464;GO:0006974;GO:0032869;GO:0006302;GO:0097681;GO:0006303;GO:0035234;GO:0007507;GO:0033152;GO:0045087;GO:0008630;GO:0000460;GO:0043066;GO:2000773;GO:0002638;GO:0001933;GO:2001229;GO:0018105;GO:0018107;GO:0043065;GO:0048639;GO:2001034;GO:0045648;GO:0048146;GO:0045621;GO:1905221;GO:0045944;GO:0045727;GO:0032481;GO:0002328;GO:0031648;GO:0006468;GO:0016567;GO:0042752;GO:0050678;GO:1902036;GO:0048660;GO:0014823;GO:0010332;GO:0048511;GO:0072431;GO:0034462;GO:0001756;GO:0048536;GO:0033077;GO:0002360;GO:0033153;GO:0016233;GO:0000723;GO:0048538;, C:chromosome, telomeric region; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:membrane; C:nonhomologous end joining complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:small-subunit processome; C:transcription regulator complex;, F:ATP binding; F:DNA-dependent protein kinase activity; F:double-stranded DNA binding; F:enzyme binding; F:protein domain specific binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transcription factor binding; F:U3 snoRNA binding;, P:activation of innate immune response; P:B cell lineage commitment; P:brain development; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:ectopic germ cell programmed cell death; P:heart development; P:immunoglobulin V(D)J recombination; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:maturation of 5.8S rRNA; P:negative regulation of apoptotic process; P:negative regulation of cellular senescence; P:negative regulation of immunoglobulin production; P:negative regulation of protein phosphorylation; P:negative regulation of response to gamma radiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of developmental growth; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of erythrocyte differentiation; P:positive regulation of fibroblast proliferation; P:positive regulation of lymphocyte differentiation; P:positive regulation of platelet formation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of type I interferon production; P:pro-B cell differentiation; P:protein destabilization; P:protein phosphorylation; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of epithelial cell proliferation; P:regulation of hematopoietic stem cell differentiation; P:regulation of smooth muscle cell proliferation; P:response to activity; P:response to gamma radiation; P:rhythmic process; P:signal transduction involved in mitotic G1 DNA damage checkpoint; P:small-subunit processome assembly; P:somitogenesis; P:spleen development; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell receptor V(D)J recombination; P:telomere capping; P:telomere maintenance; P:thymus development; scaffold3 indexed_genome mRNA 59197708 59293325 . + . ID=transcript_830;P78527 P78528 Q13327 Q13337 Q14175 Q59H99 Q7Z611 Q96SE6 Q9UME3,DNA-dependent protein kinase catalytic subunit,DNPK1;p460;, PF02259;PF02260;PF08163;PF00454;, GO:0000781;GO:0005829;GO:0005958;GO:0016020;GO:0070419;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0032040;GO:0005667;GO:0005524;GO:0004677;GO:0003690;GO:0019899;GO:0019904;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0008134;GO:0034511;GO:0002218;GO:0002326;GO:0007420;GO:0006464;GO:0006974;GO:0032869;GO:0006302;GO:0097681;GO:0006303;GO:0035234;GO:0007507;GO:0033152;GO:0045087;GO:0008630;GO:0000460;GO:0043066;GO:2000773;GO:0002638;GO:0001933;GO:2001229;GO:0018105;GO:0018107;GO:0043065;GO:0048639;GO:2001034;GO:0045648;GO:0048146;GO:0045621;GO:1905221;GO:0045944;GO:0045727;GO:0032481;GO:0002328;GO:0031648;GO:0006468;GO:0016567;GO:0042752;GO:0050678;GO:1902036;GO:0048660;GO:0014823;GO:0010332;GO:0048511;GO:0072431;GO:0034462;GO:0001756;GO:0048536;GO:0033077;GO:0002360;GO:0033153;GO:0016233;GO:0000723;GO:0048538;, C:chromosome, telomeric region; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:membrane; C:nonhomologous end joining complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:small-subunit processome; C:transcription regulator complex;, F:ATP binding; F:DNA-dependent protein kinase activity; F:double-stranded DNA binding; F:enzyme binding; F:protein domain specific binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transcription factor binding; F:U3 snoRNA binding;, P:activation of innate immune response; P:B cell lineage commitment; P:brain development; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:ectopic germ cell programmed cell death; P:heart development; P:immunoglobulin V(D)J recombination; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:maturation of 5.8S rRNA; P:negative regulation of apoptotic process; P:negative regulation of cellular senescence; P:negative regulation of immunoglobulin production; P:negative regulation of protein phosphorylation; P:negative regulation of response to gamma radiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of developmental growth; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of erythrocyte differentiation; P:positive regulation of fibroblast proliferation; P:positive regulation of lymphocyte differentiation; P:positive regulation of platelet formation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of type I interferon production; P:pro-B cell differentiation; P:protein destabilization; P:protein phosphorylation; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of epithelial cell proliferation; P:regulation of hematopoietic stem cell differentiation; P:regulation of smooth muscle cell proliferation; P:response to activity; P:response to gamma radiation; P:rhythmic process; P:signal transduction involved in mitotic G1 DNA damage checkpoint; P:small-subunit processome assembly; P:somitogenesis; P:spleen development; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell receptor V(D)J recombination; P:telomere capping; P:telomere maintenance; P:thymus development;|P78527 P78528 Q13327 Q13337 Q14175 Q59H99 Q7Z611 Q96SE6 Q9UME3,DNA-dependent protein kinase catalytic subunit,DNPK1;p460;, PF02259;PF02260;PF08163;PF00454;, GO:0000781;GO:0005829;GO:0005958;GO:0016020;GO:0070419;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0032040;GO:0005667;GO:0005524;GO:0004677;GO:0003690;GO:0019899;GO:0019904;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0008134;GO:0034511;GO:0002218;GO:0002326;GO:0007420;GO:0006464;GO:0006974;GO:0032869;GO:0006302;GO:0097681;GO:0006303;GO:0035234;GO:0007507;GO:0033152;GO:0045087;GO:0008630;GO:0000460;GO:0043066;GO:2000773;GO:0002638;GO:0001933;GO:2001229;GO:0018105;GO:0018107;GO:0043065;GO:0048639;GO:2001034;GO:0045648;GO:0048146;GO:0045621;GO:1905221;GO:0045944;GO:0045727;GO:0032481;GO:0002328;GO:0031648;GO:0006468;GO:0016567;GO:0042752;GO:0050678;GO:1902036;GO:0048660;GO:0014823;GO:0010332;GO:0048511;GO:0072431;GO:0034462;GO:0001756;GO:0048536;GO:0033077;GO:0002360;GO:0033153;GO:0016233;GO:0000723;GO:0048538;, C:chromosome, telomeric region; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:membrane; C:nonhomologous end joining complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:small-subunit processome; C:transcription regulator complex;, F:ATP binding; F:DNA-dependent protein kinase activity; F:double-stranded DNA binding; F:enzyme binding; F:protein domain specific binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transcription factor binding; F:U3 snoRNA binding;, P:activation of innate immune response; P:B cell lineage commitment; P:brain development; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:ectopic germ cell programmed cell death; P:heart development; P:immunoglobulin V(D)J recombination; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:maturation of 5.8S rRNA; P:negative regulation of apoptotic process; P:negative regulation of cellular senescence; P:negative regulation of immunoglobulin production; P:negative regulation of protein phosphorylation; P:negative regulation of response to gamma radiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of developmental growth; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of erythrocyte differentiation; P:positive regulation of fibroblast proliferation; P:positive regulation of lymphocyte differentiation; P:positive regulation of platelet formation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of type I interferon production; P:pro-B cell differentiation; P:protein destabilization; P:protein phosphorylation; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of epithelial cell proliferation; P:regulation of hematopoietic stem cell differentiation; P:regulation of smooth muscle cell proliferation; P:response to activity; P:response to gamma radiation; P:rhythmic process; P:signal transduction involved in mitotic G1 DNA damage checkpoint; P:small-subunit processome assembly; P:somitogenesis; P:spleen development; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell receptor V(D)J recombination; P:telomere capping; P:telomere maintenance; P:thymus development;|P78527 P78528 Q13327 Q13337 Q14175 Q59H99 Q7Z611 Q96SE6 Q9UME3,DNA-dependent protein kinase catalytic subunit,DNPK1;p460;, PF02259;PF02260;PF08163;PF00454;, GO:0000781;GO:0005829;GO:0005958;GO:0016020;GO:0070419;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0032040;GO:0005667;GO:0005524;GO:0004677;GO:0003690;GO:0019899;GO:0019904;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0008134;GO:0034511;GO:0002218;GO:0002326;GO:0007420;GO:0006464;GO:0006974;GO:0032869;GO:0006302;GO:0097681;GO:0006303;GO:0035234;GO:0007507;GO:0033152;GO:0045087;GO:0008630;GO:0000460;GO:0043066;GO:2000773;GO:0002638;GO:0001933;GO:2001229;GO:0018105;GO:0018107;GO:0043065;GO:0048639;GO:2001034;GO:0045648;GO:0048146;GO:0045621;GO:1905221;GO:0045944;GO:0045727;GO:0032481;GO:0002328;GO:0031648;GO:0006468;GO:0016567;GO:0042752;GO:0050678;GO:1902036;GO:0048660;GO:0014823;GO:0010332;GO:0048511;GO:0072431;GO:0034462;GO:0001756;GO:0048536;GO:0033077;GO:0002360;GO:0033153;GO:0016233;GO:0000723;GO:0048538;, C:chromosome, telomeric region; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:membrane; C:nonhomologous end joining complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:small-subunit processome; C:transcription regulator complex;, F:ATP binding; F:DNA-dependent protein kinase activity; F:double-stranded DNA binding; F:enzyme binding; F:protein domain specific binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transcription factor binding; F:U3 snoRNA binding;, P:activation of innate immune response; P:B cell lineage commitment; P:brain development; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:ectopic germ cell programmed cell death; P:heart development; P:immunoglobulin V(D)J recombination; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:maturation of 5.8S rRNA; P:negative regulation of apoptotic process; P:negative regulation of cellular senescence; P:negative regulation of immunoglobulin production; P:negative regulation of protein phosphorylation; P:negative regulation of response to gamma radiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of developmental growth; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of erythrocyte differentiation; P:positive regulation of fibroblast proliferation; P:positive regulation of lymphocyte differentiation; P:positive regulation of platelet formation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of type I interferon production; P:pro-B cell differentiation; P:protein destabilization; P:protein phosphorylation; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of epithelial cell proliferation; P:regulation of hematopoietic stem cell differentiation; P:regulation of smooth muscle cell proliferation; P:response to activity; P:response to gamma radiation; P:rhythmic process; P:signal transduction involved in mitotic G1 DNA damage checkpoint; P:small-subunit processome assembly; P:somitogenesis; P:spleen development; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell receptor V(D)J recombination; P:telomere capping; P:telomere maintenance; P:thymus development; scaffold3 indexed_genome mRNA 59339788 59566750 . + . ID=transcript_831;Q14159 B4DFV2 B4E0Y6 Q96BI5,DNA repair-scaffolding protein,Scaffolding protein involved in DNA repair;, PF14950;PF14951;, GO:0000228;GO:0005654;GO:0072757;GO:0006974;GO:0072711;GO:0071479;GO:0000724;GO:2000781;GO:0031334;GO:0010569;GO:0070202;, C:nuclear chromosome; C:nucleoplasm;, , P:cellular response to camptothecin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to ionizing radiation; P:double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair; P:positive regulation of protein-containing complex assembly; P:regulation of double-strand break repair via homologous recombination; P:regulation of establishment of protein localization to chromosome;|Q14159 B4DFV2 B4E0Y6 Q96BI5,DNA repair-scaffolding protein,Scaffolding protein involved in DNA repair;, PF14950;PF14951;, GO:0000228;GO:0005654;GO:0072757;GO:0006974;GO:0072711;GO:0071479;GO:0000724;GO:2000781;GO:0031334;GO:0010569;GO:0070202;, C:nuclear chromosome; C:nucleoplasm;, , P:cellular response to camptothecin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to ionizing radiation; P:double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair; P:positive regulation of protein-containing complex assembly; P:regulation of double-strand break repair via homologous recombination; P:regulation of establishment of protein localization to chromosome;|Q14159 B4DFV2 B4E0Y6 Q96BI5,DNA repair-scaffolding protein,Scaffolding protein involved in DNA repair;, PF14950;PF14951;, GO:0000228;GO:0005654;GO:0072757;GO:0006974;GO:0072711;GO:0071479;GO:0000724;GO:2000781;GO:0031334;GO:0010569;GO:0070202;, C:nuclear chromosome; C:nucleoplasm;, , P:cellular response to camptothecin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to ionizing radiation; P:double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair; P:positive regulation of protein-containing complex assembly; P:regulation of double-strand break repair via homologous recombination; P:regulation of establishment of protein localization to chromosome;|Q14159 B4DFV2 B4E0Y6 Q96BI5,DNA repair-scaffolding protein,Scaffolding protein involved in DNA repair;, PF14950;PF14951;, GO:0000228;GO:0005654;GO:0072757;GO:0006974;GO:0072711;GO:0071479;GO:0000724;GO:2000781;GO:0031334;GO:0010569;GO:0070202;, C:nuclear chromosome; C:nucleoplasm;, , P:cellular response to camptothecin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to ionizing radiation; P:double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair; P:positive regulation of protein-containing complex assembly; P:regulation of double-strand break repair via homologous recombination; P:regulation of establishment of protein localization to chromosome; scaffold3 indexed_genome mRNA 60515610 60516180 . - . ID=transcript_832;Q92819 Q32MM3,Hyaluronan synthase 2,Hyaluronate synthase 2;Hyaluronic acid synthase 2;, , GO:0031410;GO:0005887;GO:0044853;GO:0050501;GO:0036302;GO:0060349;GO:0071498;GO:0071347;GO:0036120;GO:0071356;GO:0090500;GO:0044849;GO:0085029;GO:0045226;GO:0030213;GO:0001822;GO:0030335;GO:0008284;GO:1900127;GO:0051549;GO:0010838;GO:1900625;GO:0014911;GO:1900026;GO:0035810;GO:1901201;GO:0070295;GO:0001570;, C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane raft;, F:hyaluronan synthase activity;, P:atrioventricular canal development; P:bone morphogenesis; P:cellular response to fluid shear stress; P:cellular response to interleukin-1; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to tumor necrosis factor; P:endocardial cushion to mesenchymal transition; P:estrous cycle; P:extracellular matrix assembly; P:extracellular polysaccharide biosynthetic process; P:hyaluronan biosynthetic process; P:kidney development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of keratinocyte migration; P:positive regulation of keratinocyte proliferation; P:positive regulation of monocyte aggregation; P:positive regulation of smooth muscle cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of urine volume; P:regulation of extracellular matrix assembly; P:renal water absorption; P:vasculogenesis; scaffold3 indexed_genome mRNA 61756101 61774993 . - . ID=transcript_833;Q9Y6X8,Zinc fingers and homeoboxes protein 2,Alpha-fetoprotein regulator 1;Regulator of AFP;Zinc finger and homeodomain protein 2;, PF00046;PF18387;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0042802;GO:0046872;GO:0046982;GO:0042803;GO:0006402;GO:0045665;GO:0000122;GO:0045892;GO:0006357;GO:0060040;GO:0035019;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:mRNA catabolic process; P:negative regulation of neuron differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:retinal bipolar neuron differentiation; P:somatic stem cell population maintenance;|Q9Y6X8,Zinc fingers and homeoboxes protein 2,Alpha-fetoprotein regulator 1;Regulator of AFP;Zinc finger and homeodomain protein 2;, PF00046;PF18387;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0042802;GO:0046872;GO:0046982;GO:0042803;GO:0006402;GO:0045665;GO:0000122;GO:0045892;GO:0006357;GO:0060040;GO:0035019;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:mRNA catabolic process; P:negative regulation of neuron differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:retinal bipolar neuron differentiation; P:somatic stem cell population maintenance; scaffold3 indexed_genome mRNA 61806246 61833149 . - . ID=transcript_834;Q9BUN8 B3KW41 E9PH19,Derlin-1 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 1;Der1-like protein 1 {ECO:0000303|PubMed:15215855};, PF04511;, GO:0036513;GO:0036502;GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0016021;GO:0005770;GO:0016020;GO:0051117;GO:0042802;GO:0042288;GO:0051787;GO:0002020;GO:0044877;GO:0005047;GO:0038023;GO:0031625;GO:1990381;GO:0030968;GO:0071712;GO:0036503;GO:0045184;GO:0032092;GO:0031398;GO:0031648;GO:0006457;GO:0016567;GO:0006986;GO:0030970;GO:0055085;GO:0030433;GO:0016032;, C:Derlin-1 retrotranslocation complex; C:Derlin-1-VIMP complex; C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:membrane;, F:ATPase binding; F:identical protein binding; F:MHC class I protein binding; F:misfolded protein binding; F:protease binding; F:protein-containing complex binding; F:signal recognition particle binding; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:establishment of protein localization; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein folding; P:protein ubiquitination; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9BUN8 B3KW41 E9PH19,Derlin-1 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 1;Der1-like protein 1 {ECO:0000303|PubMed:15215855};, PF04511;, GO:0036513;GO:0036502;GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0016021;GO:0005770;GO:0016020;GO:0051117;GO:0042802;GO:0042288;GO:0051787;GO:0002020;GO:0044877;GO:0005047;GO:0038023;GO:0031625;GO:1990381;GO:0030968;GO:0071712;GO:0036503;GO:0045184;GO:0032092;GO:0031398;GO:0031648;GO:0006457;GO:0016567;GO:0006986;GO:0030970;GO:0055085;GO:0030433;GO:0016032;, C:Derlin-1 retrotranslocation complex; C:Derlin-1-VIMP complex; C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:membrane;, F:ATPase binding; F:identical protein binding; F:MHC class I protein binding; F:misfolded protein binding; F:protease binding; F:protein-containing complex binding; F:signal recognition particle binding; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:establishment of protein localization; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein folding; P:protein ubiquitination; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9BUN8 B3KW41 E9PH19,Derlin-1 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 1;Der1-like protein 1 {ECO:0000303|PubMed:15215855};, PF04511;, GO:0036513;GO:0036502;GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0016021;GO:0005770;GO:0016020;GO:0051117;GO:0042802;GO:0042288;GO:0051787;GO:0002020;GO:0044877;GO:0005047;GO:0038023;GO:0031625;GO:1990381;GO:0030968;GO:0071712;GO:0036503;GO:0045184;GO:0032092;GO:0031398;GO:0031648;GO:0006457;GO:0016567;GO:0006986;GO:0030970;GO:0055085;GO:0030433;GO:0016032;, C:Derlin-1 retrotranslocation complex; C:Derlin-1-VIMP complex; C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:membrane;, F:ATPase binding; F:identical protein binding; F:MHC class I protein binding; F:misfolded protein binding; F:protease binding; F:protein-containing complex binding; F:signal recognition particle binding; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:establishment of protein localization; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein folding; P:protein ubiquitination; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9BUN8 B3KW41 E9PH19,Derlin-1 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 1;Der1-like protein 1 {ECO:0000303|PubMed:15215855};, PF04511;, GO:0036513;GO:0036502;GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0016021;GO:0005770;GO:0016020;GO:0051117;GO:0042802;GO:0042288;GO:0051787;GO:0002020;GO:0044877;GO:0005047;GO:0038023;GO:0031625;GO:1990381;GO:0030968;GO:0071712;GO:0036503;GO:0045184;GO:0032092;GO:0031398;GO:0031648;GO:0006457;GO:0016567;GO:0006986;GO:0030970;GO:0055085;GO:0030433;GO:0016032;, C:Derlin-1 retrotranslocation complex; C:Derlin-1-VIMP complex; C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:membrane;, F:ATPase binding; F:identical protein binding; F:MHC class I protein binding; F:misfolded protein binding; F:protease binding; F:protein-containing complex binding; F:signal recognition particle binding; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:establishment of protein localization; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein folding; P:protein ubiquitination; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:viral process; scaffold3 indexed_genome mRNA 61846023 61909643 . + . ID=transcript_835;Q96DN5 B7ZL19 Q2M2J9 Q3MIR6 Q8TBP9,TBC1 domain family member 31,WD repeat-containing protein 67;, PF00566;, GO:0005813;, C:centrosome;|Q96DN5 B7ZL19 Q2M2J9 Q3MIR6 Q8TBP9,TBC1 domain family member 31,WD repeat-containing protein 67;, PF00566;, GO:0005813;, C:centrosome;|Q96DN5 B7ZL19 Q2M2J9 Q3MIR6 Q8TBP9,TBC1 domain family member 31,WD repeat-containing protein 67;, PF00566;, GO:0005813;, C:centrosome; scaffold3 indexed_genome mRNA 61966193 61981837 . - . ID=transcript_836;Q96K31 Q53HC1,Uncharacterized protein C8orf76,, PF17826;|Q96EF9,Zinc fingers and homeoboxes protein 1, isoform 2,ZHX1-C8orf76 readthrough transcript protein;, PF17826; scaffold3 indexed_genome mRNA 61994378 62007687 . - . ID=transcript_837;Q9UKY1 Q8IWD8,Zinc fingers and homeoboxes protein 1,, PF00046;PF11569;PF18387;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0046872;GO:0046982;GO:0030154;GO:0000122;GO:0045892;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein heterodimerization activity;, P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 62031346 62066378 . - . ID=transcript_838;Q6PL18 Q14CR1 Q658P2 Q68CQ0 Q6PJV6 Q8N890 Q9UHS5,ATPase family AAA domain-containing protein 2,AAA nuclear coregulator cancer-associated protein;, PF00004;PF17862;PF00439;, GO:0070062;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0042393;GO:0006325;GO:0031936;GO:0045944;GO:0045893;GO:0006357;, C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:histone binding;, P:chromatin organization; P:negative regulation of chromatin silencing; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q6PL18 Q14CR1 Q658P2 Q68CQ0 Q6PJV6 Q8N890 Q9UHS5,ATPase family AAA domain-containing protein 2,AAA nuclear coregulator cancer-associated protein;, PF00004;PF17862;PF00439;, GO:0070062;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0042393;GO:0006325;GO:0031936;GO:0045944;GO:0045893;GO:0006357;, C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:histone binding;, P:chromatin organization; P:negative regulation of chromatin silencing; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 62071102 62078902 . - . ID=transcript_839;Q6PL18 Q14CR1 Q658P2 Q68CQ0 Q6PJV6 Q8N890 Q9UHS5,ATPase family AAA domain-containing protein 2,AAA nuclear coregulator cancer-associated protein;, PF00004;PF17862;PF00439;, GO:0070062;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0042393;GO:0006325;GO:0031936;GO:0045944;GO:0045893;GO:0006357;, C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:histone binding;, P:chromatin organization; P:negative regulation of chromatin silencing; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 62110496 62129623 . + . ID=transcript_840;Q96HA8 B4DE68 Q9NW95,Protein N-terminal glutamine amidohydrolase {ECO:0000305},Protein NH2-terminal glutamine deamidase;WDYHV motif-containing protein 1;, PF09764;, GO:0005829;GO:0005634;GO:0008418;GO:0070773;GO:0006464;, C:cytosol; C:nucleus;, F:protein-N-terminal asparagine amidohydrolase activity; F:protein-N-terminal glutamine amidohydrolase activity;, P:cellular protein modification process;|Q96HA8 B4DE68 Q9NW95,Protein N-terminal glutamine amidohydrolase {ECO:0000305},Protein NH2-terminal glutamine deamidase;WDYHV motif-containing protein 1;, PF09764;, GO:0005829;GO:0005634;GO:0008418;GO:0070773;GO:0006464;, C:cytosol; C:nucleus;, F:protein-N-terminal asparagine amidohydrolase activity; F:protein-N-terminal glutamine amidohydrolase activity;, P:cellular protein modification process;|Q96HA8 B4DE68 Q9NW95,Protein N-terminal glutamine amidohydrolase {ECO:0000305},Protein NH2-terminal glutamine deamidase;WDYHV motif-containing protein 1;, PF09764;, GO:0005829;GO:0005634;GO:0008418;GO:0070773;GO:0006464;, C:cytosol; C:nucleus;, F:protein-N-terminal asparagine amidohydrolase activity; F:protein-N-terminal glutamine amidohydrolase activity;, P:cellular protein modification process; scaffold3 indexed_genome mRNA 62183524 62221142 . - . ID=transcript_841;Q969P5 A4KYM0,F-box only protein 32,Atrogin-1;Muscle atrophy F-box protein;, , GO:0005737;GO:0005829;GO:0005654;GO:0019005;GO:0030018;GO:0071549;GO:0043687;GO:0000209;GO:0016567;GO:0014894;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex; C:Z disc;, , P:cellular response to dexamethasone stimulus; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:response to denervation involved in regulation of muscle adaptation;|Q969P5 A4KYM0,F-box only protein 32,Atrogin-1;Muscle atrophy F-box protein;, , GO:0005737;GO:0005829;GO:0005654;GO:0019005;GO:0030018;GO:0071549;GO:0043687;GO:0000209;GO:0016567;GO:0014894;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex; C:Z disc;, , P:cellular response to dexamethasone stimulus; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:response to denervation involved in regulation of muscle adaptation; scaffold3 indexed_genome mRNA 62306057 62317167 . - . ID=transcript_842;Q2WGJ6 A0PK12,Kelch-like protein 38,, PF07707;PF00651;PF01344; scaffold3 indexed_genome mRNA 62346101 62377993 . - . ID=transcript_843;P27216 Q9BQR5,Annexin A13,Annexin XIII;Annexin-13;Intestine-specific annexin {ECO:0000303|PubMed:1530946};, PF00191;, GO:0016324;GO:0016323;GO:0005737;GO:0031410;GO:0070382;GO:0070062;GO:0005615;GO:0019898;GO:0045121;GO:0005654;GO:0005886;GO:0005509;GO:0005544;GO:1901611;GO:0001786;GO:0030154;GO:0042997;GO:0042998;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:cytoplasmic vesicle; C:exocytic vesicle; C:extracellular exosome; C:extracellular space; C:extrinsic component of membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phosphatidylglycerol binding; F:phosphatidylserine binding;, P:cell differentiation; P:negative regulation of Golgi to plasma membrane protein transport; P:positive regulation of Golgi to plasma membrane protein transport; scaffold3 indexed_genome mRNA 62428290 62469506 . + . ID=transcript_844;Q658Y4 B6YY23 Q658T5 Q8TE89,Protein FAM91A1,, PF14648;PF14647;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi;|Q658Y4 B6YY23 Q658T5 Q8TE89,Protein FAM91A1,, PF14648;PF14647;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi;|Q658Y4 B6YY23 Q658T5 Q8TE89,Protein FAM91A1,, PF14648;PF14647;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi;|Q658Y4 B6YY23 Q658T5 Q8TE89,Protein FAM91A1,, PF14648;PF14647;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi;|Q658Y4 B6YY23 Q658T5 Q8TE89,Protein FAM91A1,, PF14648;PF14647;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi;|Q658Y4 B6YY23 Q658T5 Q8TE89,Protein FAM91A1,, PF14648;PF14647;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi; scaffold3 indexed_genome mRNA 62905982 62910453 . + . ID=transcript_845;Q53H54 Q6PKB9 Q96F21 Q9NWK6,tRNA wybutosine-synthesizing protein 2 homolog,tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase;, PF02475;, GO:0005737;GO:0102522;GO:0008175;GO:0030488;, C:cytoplasm;, F:tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity; F:tRNA methyltransferase activity;, P:tRNA methylation;|Q53H54 Q6PKB9 Q96F21 Q9NWK6,tRNA wybutosine-synthesizing protein 2 homolog,tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase;, PF02475;, GO:0005737;GO:0102522;GO:0008175;GO:0030488;, C:cytoplasm;, F:tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity; F:tRNA methyltransferase activity;, P:tRNA methylation; scaffold3 indexed_genome mRNA 62926848 62973288 . + . ID=transcript_846;Q8WU17 B3KMD5 O75485 Q7LDL3,E3 ubiquitin-protein ligase RNF139,RING finger protein 139;RING-type E3 ubiquitin transferase RNF139 {ECO:0000305};Translocation in renal carcinoma on chromosome 8 protein;, PF13705;PF13639;, GO:0036513;GO:0012505;GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0002020;GO:0038023;GO:0061630;GO:0019787;GO:0004842;GO:0008270;GO:1904380;GO:0036503;GO:0008285;GO:0017148;GO:2000060;GO:0031648;GO:0016567;GO:0060628;GO:0070613;, C:Derlin-1 retrotranslocation complex; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane;, F:protease binding; F:signaling receptor activity; F:ubiquitin protein ligase activity; F:ubiquitin-like protein transferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:negative regulation of cell population proliferation; P:negative regulation of translation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein ubiquitination; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of protein processing;|Q8WU17 B3KMD5 O75485 Q7LDL3,E3 ubiquitin-protein ligase RNF139,RING finger protein 139;RING-type E3 ubiquitin transferase RNF139 {ECO:0000305};Translocation in renal carcinoma on chromosome 8 protein;, PF13705;PF13639;, GO:0036513;GO:0012505;GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0002020;GO:0038023;GO:0061630;GO:0019787;GO:0004842;GO:0008270;GO:1904380;GO:0036503;GO:0008285;GO:0017148;GO:2000060;GO:0031648;GO:0016567;GO:0060628;GO:0070613;, C:Derlin-1 retrotranslocation complex; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane;, F:protease binding; F:signaling receptor activity; F:ubiquitin protein ligase activity; F:ubiquitin-like protein transferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:negative regulation of cell population proliferation; P:negative regulation of translation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein ubiquitination; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of protein processing;|Q6P1N9 B2R5J0 Q8TD02 Q9BY40,Putative deoxyribonuclease TATDN1,Hepatocarcinoma high expression protein;, PF01026;, GO:0005654;GO:0008296;GO:0016888;GO:0046872;, C:nucleoplasm;, F:3'-5'-exodeoxyribonuclease activity; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:metal ion binding;|Q6P1N9 B2R5J0 Q8TD02 Q9BY40,Putative deoxyribonuclease TATDN1,Hepatocarcinoma high expression protein;, PF01026;, GO:0005654;GO:0008296;GO:0016888;GO:0046872;, C:nucleoplasm;, F:3'-5'-exodeoxyribonuclease activity; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:metal ion binding;|Q6P1N9 B2R5J0 Q8TD02 Q9BY40,Putative deoxyribonuclease TATDN1,Hepatocarcinoma high expression protein;, PF01026;, GO:0005654;GO:0008296;GO:0016888;GO:0046872;, C:nucleoplasm;, F:3'-5'-exodeoxyribonuclease activity; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:metal ion binding;|Q6P1N9 B2R5J0 Q8TD02 Q9BY40,Putative deoxyribonuclease TATDN1,Hepatocarcinoma high expression protein;, PF01026;, GO:0005654;GO:0008296;GO:0016888;GO:0046872;, C:nucleoplasm;, F:3'-5'-exodeoxyribonuclease activity; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:metal ion binding;|Q6P1N9 B2R5J0 Q8TD02 Q9BY40,Putative deoxyribonuclease TATDN1,Hepatocarcinoma high expression protein;, PF01026;, GO:0005654;GO:0008296;GO:0016888;GO:0046872;, C:nucleoplasm;, F:3'-5'-exodeoxyribonuclease activity; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:metal ion binding;|Q6P1N9 B2R5J0 Q8TD02 Q9BY40,Putative deoxyribonuclease TATDN1,Hepatocarcinoma high expression protein;, PF01026;, GO:0005654;GO:0008296;GO:0016888;GO:0046872;, C:nucleoplasm;, F:3'-5'-exodeoxyribonuclease activity; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:metal ion binding; scaffold3 indexed_genome mRNA 62973323 62981047 . + . ID=transcript_847;Q9Y6M9 B2R8M6 Q9UQE8,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9,Complex I-B22;LYR motif-containing protein 3;NADH-ubiquinone oxidoreductase B22 subunit;, PF05347;, GO:0005743;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;GO:0007605;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:sensory perception of sound; scaffold3 indexed_genome mRNA 62981052 62988012 . - . ID=transcript_848;O43312 J3KNK6 Q8TCA2 Q96RX2,Protein MTSS 1 {ECO:0000305},Metastasis suppressor YGL-1;Metastasis suppressor protein 1;Missing in metastasis protein;, PF08397;PF02205;, GO:0015629;GO:0005737;GO:0030139;GO:0001726;GO:0003785;GO:0042802;GO:0005102;GO:0030036;GO:0007155;GO:0071498;GO:2001013;GO:0072102;GO:0030035;GO:0050680;GO:0072160;GO:0007009;GO:0061333;GO:0007169;, C:actin cytoskeleton; C:cytoplasm; C:endocytic vesicle; C:ruffle;, F:actin monomer binding; F:identical protein binding; F:signaling receptor binding;, P:actin cytoskeleton organization; P:cell adhesion; P:cellular response to fluid shear stress; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:glomerulus morphogenesis; P:microspike assembly; P:negative regulation of epithelial cell proliferation; P:nephron tubule epithelial cell differentiation; P:plasma membrane organization; P:renal tubule morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|O43312 J3KNK6 Q8TCA2 Q96RX2,Protein MTSS 1 {ECO:0000305},Metastasis suppressor YGL-1;Metastasis suppressor protein 1;Missing in metastasis protein;, PF08397;PF02205;, GO:0015629;GO:0005737;GO:0030139;GO:0001726;GO:0003785;GO:0042802;GO:0005102;GO:0030036;GO:0007155;GO:0071498;GO:2001013;GO:0072102;GO:0030035;GO:0050680;GO:0072160;GO:0007009;GO:0061333;GO:0007169;, C:actin cytoskeleton; C:cytoplasm; C:endocytic vesicle; C:ruffle;, F:actin monomer binding; F:identical protein binding; F:signaling receptor binding;, P:actin cytoskeleton organization; P:cell adhesion; P:cellular response to fluid shear stress; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:glomerulus morphogenesis; P:microspike assembly; P:negative regulation of epithelial cell proliferation; P:nephron tubule epithelial cell differentiation; P:plasma membrane organization; P:renal tubule morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|O43312 J3KNK6 Q8TCA2 Q96RX2,Protein MTSS 1 {ECO:0000305},Metastasis suppressor YGL-1;Metastasis suppressor protein 1;Missing in metastasis protein;, PF08397;PF02205;, GO:0015629;GO:0005737;GO:0030139;GO:0001726;GO:0003785;GO:0042802;GO:0005102;GO:0030036;GO:0007155;GO:0071498;GO:2001013;GO:0072102;GO:0030035;GO:0050680;GO:0072160;GO:0007009;GO:0061333;GO:0007169;, C:actin cytoskeleton; C:cytoplasm; C:endocytic vesicle; C:ruffle;, F:actin monomer binding; F:identical protein binding; F:signaling receptor binding;, P:actin cytoskeleton organization; P:cell adhesion; P:cellular response to fluid shear stress; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:glomerulus morphogenesis; P:microspike assembly; P:negative regulation of epithelial cell proliferation; P:nephron tubule epithelial cell differentiation; P:plasma membrane organization; P:renal tubule morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold3 indexed_genome mRNA 62988062 62999915 . - . ID=transcript_849;O43312 J3KNK6 Q8TCA2 Q96RX2,Protein MTSS 1 {ECO:0000305},Metastasis suppressor YGL-1;Metastasis suppressor protein 1;Missing in metastasis protein;, PF08397;PF02205;, GO:0015629;GO:0005737;GO:0030139;GO:0001726;GO:0003785;GO:0042802;GO:0005102;GO:0030036;GO:0007155;GO:0071498;GO:2001013;GO:0072102;GO:0030035;GO:0050680;GO:0072160;GO:0007009;GO:0061333;GO:0007169;, C:actin cytoskeleton; C:cytoplasm; C:endocytic vesicle; C:ruffle;, F:actin monomer binding; F:identical protein binding; F:signaling receptor binding;, P:actin cytoskeleton organization; P:cell adhesion; P:cellular response to fluid shear stress; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:glomerulus morphogenesis; P:microspike assembly; P:negative regulation of epithelial cell proliferation; P:nephron tubule epithelial cell differentiation; P:plasma membrane organization; P:renal tubule morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|O43312 J3KNK6 Q8TCA2 Q96RX2,Protein MTSS 1 {ECO:0000305},Metastasis suppressor YGL-1;Metastasis suppressor protein 1;Missing in metastasis protein;, PF08397;PF02205;, GO:0015629;GO:0005737;GO:0030139;GO:0001726;GO:0003785;GO:0042802;GO:0005102;GO:0030036;GO:0007155;GO:0071498;GO:2001013;GO:0072102;GO:0030035;GO:0050680;GO:0072160;GO:0007009;GO:0061333;GO:0007169;, C:actin cytoskeleton; C:cytoplasm; C:endocytic vesicle; C:ruffle;, F:actin monomer binding; F:identical protein binding; F:signaling receptor binding;, P:actin cytoskeleton organization; P:cell adhesion; P:cellular response to fluid shear stress; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:glomerulus morphogenesis; P:microspike assembly; P:negative regulation of epithelial cell proliferation; P:nephron tubule epithelial cell differentiation; P:plasma membrane organization; P:renal tubule morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold3 indexed_genome mRNA 63013446 63141551 . - . ID=transcript_850;O43312 J3KNK6 Q8TCA2 Q96RX2,Protein MTSS 1 {ECO:0000305},Metastasis suppressor YGL-1;Metastasis suppressor protein 1;Missing in metastasis protein;, PF08397;PF02205;, GO:0015629;GO:0005737;GO:0030139;GO:0001726;GO:0003785;GO:0042802;GO:0005102;GO:0030036;GO:0007155;GO:0071498;GO:2001013;GO:0072102;GO:0030035;GO:0050680;GO:0072160;GO:0007009;GO:0061333;GO:0007169;, C:actin cytoskeleton; C:cytoplasm; C:endocytic vesicle; C:ruffle;, F:actin monomer binding; F:identical protein binding; F:signaling receptor binding;, P:actin cytoskeleton organization; P:cell adhesion; P:cellular response to fluid shear stress; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:glomerulus morphogenesis; P:microspike assembly; P:negative regulation of epithelial cell proliferation; P:nephron tubule epithelial cell differentiation; P:plasma membrane organization; P:renal tubule morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold3 indexed_genome mRNA 63360658 63365432 . - . ID=transcript_851;Q7Z3I7 A1L4E9 A1L4F1 Q8N1Q0,Zinc finger protein 572,, PF00096;, GO:0005654;GO:0005634;GO:0001227;GO:0042802;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold3 indexed_genome mRNA 63377371 63399280 . + . ID=transcript_852;Q14534 Q9UEK6 Q9UNR6,Squalene monooxygenase,Squalene epoxidase {ECO:0000303|PubMed:9286711};, PF08491;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0071949;GO:0004506;GO:0006725;GO:0006695;GO:0008203;GO:0140042;GO:0042127;GO:0019216;GO:0010033;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:FAD binding; F:squalene monooxygenase activity;, P:cellular aromatic compound metabolic process; P:cholesterol biosynthetic process; P:cholesterol metabolic process; P:lipid droplet formation; P:regulation of cell population proliferation; P:regulation of lipid metabolic process; P:response to organic substance; P:sterol biosynthetic process;|Q14534 Q9UEK6 Q9UNR6,Squalene monooxygenase,Squalene epoxidase {ECO:0000303|PubMed:9286711};, PF08491;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0071949;GO:0004506;GO:0006725;GO:0006695;GO:0008203;GO:0140042;GO:0042127;GO:0019216;GO:0010033;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:FAD binding; F:squalene monooxygenase activity;, P:cellular aromatic compound metabolic process; P:cholesterol biosynthetic process; P:cholesterol metabolic process; P:lipid droplet formation; P:regulation of cell population proliferation; P:regulation of lipid metabolic process; P:response to organic substance; P:sterol biosynthetic process;|Q14534 Q9UEK6 Q9UNR6,Squalene monooxygenase,Squalene epoxidase {ECO:0000303|PubMed:9286711};, PF08491;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0071949;GO:0004506;GO:0006725;GO:0006695;GO:0008203;GO:0140042;GO:0042127;GO:0019216;GO:0010033;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:FAD binding; F:squalene monooxygenase activity;, P:cellular aromatic compound metabolic process; P:cholesterol biosynthetic process; P:cholesterol metabolic process; P:lipid droplet formation; P:regulation of cell population proliferation; P:regulation of lipid metabolic process; P:response to organic substance; P:sterol biosynthetic process;|Q14534 Q9UEK6 Q9UNR6,Squalene monooxygenase,Squalene epoxidase {ECO:0000303|PubMed:9286711};, PF08491;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0071949;GO:0004506;GO:0006725;GO:0006695;GO:0008203;GO:0140042;GO:0042127;GO:0019216;GO:0010033;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:FAD binding; F:squalene monooxygenase activity;, P:cellular aromatic compound metabolic process; P:cholesterol biosynthetic process; P:cholesterol metabolic process; P:lipid droplet formation; P:regulation of cell population proliferation; P:regulation of lipid metabolic process; P:response to organic substance; P:sterol biosynthetic process; scaffold3 indexed_genome mRNA 63403146 63459408 . - . ID=transcript_853;Q12768 A8K4R7 Q3KQX5 Q8TBQ2,WASH complex subunit 5 {ECO:0000312|HGNC:HGNC:28984},Strumpellin;WASH complex subunit strumpellin {ECO:0000305};, PF10266;, GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0043005;GO:0043025;GO:0005654;GO:0071203;GO:0030041;GO:0034629;GO:0016197;GO:0140285;GO:0007032;GO:0007040;GO:0001556;GO:0040038;GO:0010976;GO:0015031;GO:0051125;GO:0097494;GO:0090306;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:WASH complex;, , P:actin filament polymerization; P:cellular protein-containing complex localization; P:endosomal transport; P:endosome fission; P:endosome organization; P:lysosome organization; P:oocyte maturation; P:polar body extrusion after meiotic divisions; P:positive regulation of neuron projection development; P:protein transport; P:regulation of actin nucleation; P:regulation of vesicle size; P:spindle assembly involved in meiosis;|Q12768 A8K4R7 Q3KQX5 Q8TBQ2,WASH complex subunit 5 {ECO:0000312|HGNC:HGNC:28984},Strumpellin;WASH complex subunit strumpellin {ECO:0000305};, PF10266;, GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0043005;GO:0043025;GO:0005654;GO:0071203;GO:0030041;GO:0034629;GO:0016197;GO:0140285;GO:0007032;GO:0007040;GO:0001556;GO:0040038;GO:0010976;GO:0015031;GO:0051125;GO:0097494;GO:0090306;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:WASH complex;, , P:actin filament polymerization; P:cellular protein-containing complex localization; P:endosomal transport; P:endosome fission; P:endosome organization; P:lysosome organization; P:oocyte maturation; P:polar body extrusion after meiotic divisions; P:positive regulation of neuron projection development; P:protein transport; P:regulation of actin nucleation; P:regulation of vesicle size; P:spindle assembly involved in meiosis;|Q12768 A8K4R7 Q3KQX5 Q8TBQ2,WASH complex subunit 5 {ECO:0000312|HGNC:HGNC:28984},Strumpellin;WASH complex subunit strumpellin {ECO:0000305};, PF10266;, GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0043005;GO:0043025;GO:0005654;GO:0071203;GO:0030041;GO:0034629;GO:0016197;GO:0140285;GO:0007032;GO:0007040;GO:0001556;GO:0040038;GO:0010976;GO:0015031;GO:0051125;GO:0097494;GO:0090306;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:WASH complex;, , P:actin filament polymerization; P:cellular protein-containing complex localization; P:endosomal transport; P:endosome fission; P:endosome organization; P:lysosome organization; P:oocyte maturation; P:polar body extrusion after meiotic divisions; P:positive regulation of neuron projection development; P:protein transport; P:regulation of actin nucleation; P:regulation of vesicle size; P:spindle assembly involved in meiosis;|Q12768 A8K4R7 Q3KQX5 Q8TBQ2,WASH complex subunit 5 {ECO:0000312|HGNC:HGNC:28984},Strumpellin;WASH complex subunit strumpellin {ECO:0000305};, PF10266;, GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0043005;GO:0043025;GO:0005654;GO:0071203;GO:0030041;GO:0034629;GO:0016197;GO:0140285;GO:0007032;GO:0007040;GO:0001556;GO:0040038;GO:0010976;GO:0015031;GO:0051125;GO:0097494;GO:0090306;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:WASH complex;, , P:actin filament polymerization; P:cellular protein-containing complex localization; P:endosomal transport; P:endosome fission; P:endosome organization; P:lysosome organization; P:oocyte maturation; P:polar body extrusion after meiotic divisions; P:positive regulation of neuron projection development; P:protein transport; P:regulation of actin nucleation; P:regulation of vesicle size; P:spindle assembly involved in meiosis;|Q12768 A8K4R7 Q3KQX5 Q8TBQ2,WASH complex subunit 5 {ECO:0000312|HGNC:HGNC:28984},Strumpellin;WASH complex subunit strumpellin {ECO:0000305};, PF10266;, GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0043005;GO:0043025;GO:0005654;GO:0071203;GO:0030041;GO:0034629;GO:0016197;GO:0140285;GO:0007032;GO:0007040;GO:0001556;GO:0040038;GO:0010976;GO:0015031;GO:0051125;GO:0097494;GO:0090306;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:WASH complex;, , P:actin filament polymerization; P:cellular protein-containing complex localization; P:endosomal transport; P:endosome fission; P:endosome organization; P:lysosome organization; P:oocyte maturation; P:polar body extrusion after meiotic divisions; P:positive regulation of neuron projection development; P:protein transport; P:regulation of actin nucleation; P:regulation of vesicle size; P:spindle assembly involved in meiosis;|Q12768 A8K4R7 Q3KQX5 Q8TBQ2,WASH complex subunit 5 {ECO:0000312|HGNC:HGNC:28984},Strumpellin;WASH complex subunit strumpellin {ECO:0000305};, PF10266;, GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0043005;GO:0043025;GO:0005654;GO:0071203;GO:0030041;GO:0034629;GO:0016197;GO:0140285;GO:0007032;GO:0007040;GO:0001556;GO:0040038;GO:0010976;GO:0015031;GO:0051125;GO:0097494;GO:0090306;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:WASH complex;, , P:actin filament polymerization; P:cellular protein-containing complex localization; P:endosomal transport; P:endosome fission; P:endosome organization; P:lysosome organization; P:oocyte maturation; P:polar body extrusion after meiotic divisions; P:positive regulation of neuron projection development; P:protein transport; P:regulation of actin nucleation; P:regulation of vesicle size; P:spindle assembly involved in meiosis; scaffold3 indexed_genome mRNA 63459482 63688866 . + . ID=transcript_854;Q96MF7 Q8N549,E3 SUMO-protein ligase NSE2,E3 SUMO-protein transferase NSE2 {ECO:0000305};MMS21 homolog;Non-structural maintenance of chromosomes element 2 homolog;, PF11789;, GO:0000781;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0030915;GO:0061665;GO:0019789;GO:0008270;GO:0007049;GO:0051301;GO:0090398;GO:0000724;GO:0034184;GO:0045842;GO:0016925;GO:0000722;, C:chromosome, telomeric region; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:Smc5-Smc6 complex;, F:SUMO ligase activity; F:SUMO transferase activity; F:zinc ion binding;, P:cell cycle; P:cell division; P:cellular senescence; P:double-strand break repair via homologous recombination; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of mitotic metaphase/anaphase transition; P:protein sumoylation; P:telomere maintenance via recombination;|Q96MF7 Q8N549,E3 SUMO-protein ligase NSE2,E3 SUMO-protein transferase NSE2 {ECO:0000305};MMS21 homolog;Non-structural maintenance of chromosomes element 2 homolog;, PF11789;, GO:0000781;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0030915;GO:0061665;GO:0019789;GO:0008270;GO:0007049;GO:0051301;GO:0090398;GO:0000724;GO:0034184;GO:0045842;GO:0016925;GO:0000722;, C:chromosome, telomeric region; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:Smc5-Smc6 complex;, F:SUMO ligase activity; F:SUMO transferase activity; F:zinc ion binding;, P:cell cycle; P:cell division; P:cellular senescence; P:double-strand break repair via homologous recombination; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of mitotic metaphase/anaphase transition; P:protein sumoylation; P:telomere maintenance via recombination; scaffold3 indexed_genome mRNA 63758186 63761660 . - . ID=transcript_855;Q96RU8 B4DMM6 C5HU08 O15180 Q9H2Y8,Tribbles homolog 1,G-protein-coupled receptor-induced gene 2 protein;SKIP1;, PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0031434;GO:0004860;GO:0008134;GO:0031625;GO:0055106;GO:0007254;GO:0043433;GO:0031665;GO:0045659;GO:0006469;GO:0014912;GO:0048662;GO:0045645;GO:0045651;GO:0032436;GO:0006468;GO:0043405;GO:0032496;, C:cytoplasm; C:cytosol; C:nucleus;, F:mitogen-activated protein kinase kinase binding; F:protein kinase inhibitor activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase regulator activity;, P:JNK cascade; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of neutrophil differentiation; P:negative regulation of protein kinase activity; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of eosinophil differentiation; P:positive regulation of macrophage differentiation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein phosphorylation; P:regulation of MAP kinase activity; P:response to lipopolysaccharide; scaffold3 indexed_genome mRNA 64604928 64608098 . + . ID=transcript_856;Q96KN1,Protein LRATD2 {ECO:0000305},Breast cancer membrane protein 101;LRAT domain-containing 2 {ECO:0000312|HGNC:HGNC:24166};Protein FAM84B {ECO:0000305};Protein NSE2;, PF04970;, GO:0005737;GO:0005886;, C:cytoplasm; C:plasma membrane;|Q96KN1,Protein LRATD2 {ECO:0000305},Breast cancer membrane protein 101;LRAT domain-containing 2 {ECO:0000312|HGNC:HGNC:24166};Protein FAM84B {ECO:0000305};Protein NSE2;, PF04970;, GO:0005737;GO:0005886;, C:cytoplasm; C:plasma membrane; scaffold4 indexed_genome mRNA 1086 1725 . - . ID=transcript_857;Q504T8 Q96BW8,Midnolin,Midbrain nucleolar protein;, PF00240;, GO:0005737;GO:0005829;GO:0005730;GO:0005634;GO:0019900;GO:0033132;GO:0046676;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleus;, F:kinase binding;, P:negative regulation of glucokinase activity; P:negative regulation of insulin secretion; scaffold4 indexed_genome mRNA 13062 14416 . - . ID=transcript_858;Q14011 B3KT17 B4E2X2,Cold-inducible RNA-binding protein,A18 hnRNP;Glycine-rich RNA-binding protein CIRP;, PF00076;, GO:0005737;GO:0010494;GO:0005654;GO:0005634;GO:0005681;GO:0003730;GO:0003723;GO:0070181;GO:0030371;GO:0048255;GO:0048026;GO:0045727;GO:0009409;GO:0009411;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:mRNA 3'-UTR binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:translation repressor activity;, P:mRNA stabilization; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of translation; P:response to cold; P:response to UV; P:stress granule assembly; scaffold4 indexed_genome mRNA 19188 20094 . + . ID=transcript_859;Q9BVV8 Q9NWS2,Protein FAM174C {ECO:0000305},, PF06679;, GO:0005737;GO:0005576;GO:0016021;, C:cytoplasm; C:extracellular region; C:integral component of membrane; scaffold4 indexed_genome mRNA 36756 42766 . + . ID=transcript_860;O43921 O76020,Ephrin-A2,EPH-related receptor tyrosine kinase ligand 6;HEK7 ligand;, PF00812;, GO:0031225;GO:0031594;GO:0043204;GO:0005886;GO:0046875;GO:0007411;GO:0046849;GO:0007267;GO:0048013;GO:0021772;GO:0030316;, C:anchored component of membrane; C:neuromuscular junction; C:perikaryon; C:plasma membrane;, F:ephrin receptor binding;, P:axon guidance; P:bone remodeling; P:cell-cell signaling; P:ephrin receptor signaling pathway; P:olfactory bulb development; P:osteoclast differentiation;|O43921 O76020,Ephrin-A2,EPH-related receptor tyrosine kinase ligand 6;HEK7 ligand;, PF00812;, GO:0031225;GO:0031594;GO:0043204;GO:0005886;GO:0046875;GO:0007411;GO:0046849;GO:0007267;GO:0048013;GO:0021772;GO:0030316;, C:anchored component of membrane; C:neuromuscular junction; C:perikaryon; C:plasma membrane;, F:ephrin receptor binding;, P:axon guidance; P:bone remodeling; P:cell-cell signaling; P:ephrin receptor signaling pathway; P:olfactory bulb development; P:osteoclast differentiation;|O43921 O76020,Ephrin-A2,EPH-related receptor tyrosine kinase ligand 6;HEK7 ligand;, PF00812;, GO:0031225;GO:0031594;GO:0043204;GO:0005886;GO:0046875;GO:0007411;GO:0046849;GO:0007267;GO:0048013;GO:0021772;GO:0030316;, C:anchored component of membrane; C:neuromuscular junction; C:perikaryon; C:plasma membrane;, F:ephrin receptor binding;, P:axon guidance; P:bone remodeling; P:cell-cell signaling; P:ephrin receptor signaling pathway; P:olfactory bulb development; P:osteoclast differentiation; scaffold4 indexed_genome mRNA 92200 97679 . + . ID=transcript_861;Q2TAK8 A1L489 B5ME02 B7ZLY8 J3KQD6 Q13109 Q5XKB9 Q8N2I4 Q96A67,PWWP domain-containing DNA repair factor 3A {ECO:0000305},Mutated melanoma-associated antigen 1;PWWP domain-containing protein MUM1;Protein expandere;, , GO:0005829;GO:0005654;GO:0005634;GO:0031491;GO:0006325;GO:0006281;, C:cytosol; C:nucleoplasm; C:nucleus;, F:nucleosome binding;, P:chromatin organization; P:DNA repair; scaffold4 indexed_genome mRNA 98326 109709 . + . ID=transcript_862;Q2TAK8 A1L489 B5ME02 B7ZLY8 J3KQD6 Q13109 Q5XKB9 Q8N2I4 Q96A67,PWWP domain-containing DNA repair factor 3A {ECO:0000305},Mutated melanoma-associated antigen 1;PWWP domain-containing protein MUM1;Protein expandere;, , GO:0005829;GO:0005654;GO:0005634;GO:0031491;GO:0006325;GO:0006281;, C:cytosol; C:nucleoplasm; C:nucleus;, F:nucleosome binding;, P:chromatin organization; P:DNA repair;|Q2TAK8 A1L489 B5ME02 B7ZLY8 J3KQD6 Q13109 Q5XKB9 Q8N2I4 Q96A67,PWWP domain-containing DNA repair factor 3A {ECO:0000305},Mutated melanoma-associated antigen 1;PWWP domain-containing protein MUM1;Protein expandere;, , GO:0005829;GO:0005654;GO:0005634;GO:0031491;GO:0006325;GO:0006281;, C:cytosol; C:nucleoplasm; C:nucleus;, F:nucleosome binding;, P:chromatin organization; P:DNA repair;|Q2TAK8 A1L489 B5ME02 B7ZLY8 J3KQD6 Q13109 Q5XKB9 Q8N2I4 Q96A67,PWWP domain-containing DNA repair factor 3A {ECO:0000305},Mutated melanoma-associated antigen 1;PWWP domain-containing protein MUM1;Protein expandere;, , GO:0005829;GO:0005654;GO:0005634;GO:0031491;GO:0006325;GO:0006281;, C:cytosol; C:nucleoplasm; C:nucleus;, F:nucleosome binding;, P:chromatin organization; P:DNA repair;|Q2TAK8 A1L489 B5ME02 B7ZLY8 J3KQD6 Q13109 Q5XKB9 Q8N2I4 Q96A67,PWWP domain-containing DNA repair factor 3A {ECO:0000305},Mutated melanoma-associated antigen 1;PWWP domain-containing protein MUM1;Protein expandere;, , GO:0005829;GO:0005654;GO:0005634;GO:0031491;GO:0006325;GO:0006281;, C:cytosol; C:nucleoplasm; C:nucleus;, F:nucleosome binding;, P:chromatin organization; P:DNA repair;|Q2TAK8 A1L489 B5ME02 B7ZLY8 J3KQD6 Q13109 Q5XKB9 Q8N2I4 Q96A67,PWWP domain-containing DNA repair factor 3A {ECO:0000305},Mutated melanoma-associated antigen 1;PWWP domain-containing protein MUM1;Protein expandere;, , GO:0005829;GO:0005654;GO:0005634;GO:0031491;GO:0006325;GO:0006281;, C:cytosol; C:nucleoplasm; C:nucleus;, F:nucleosome binding;, P:chromatin organization; P:DNA repair; scaffold4 indexed_genome mRNA 112704 119147 . + . ID=transcript_863;O75251 B3KRI2 Q2T9H7 Q9BV17,NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial,Complex I-20kD;NADH-ubiquinone oxidoreductase 20 kDa subunit;PSST subunit {ECO:0000303|PubMed:8938450};, PF01058;, GO:0005759;GO:0005747;GO:0051539;GO:0046872;GO:0008137;GO:0016655;GO:0048038;GO:0009060;GO:0015990;GO:0006120;GO:0032981;, C:mitochondrial matrix; C:mitochondrial respiratory chain complex I;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:quinone binding;, P:aerobic respiration; P:electron transport coupled proton transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O75251 B3KRI2 Q2T9H7 Q9BV17,NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial,Complex I-20kD;NADH-ubiquinone oxidoreductase 20 kDa subunit;PSST subunit {ECO:0000303|PubMed:8938450};, PF01058;, GO:0005759;GO:0005747;GO:0051539;GO:0046872;GO:0008137;GO:0016655;GO:0048038;GO:0009060;GO:0015990;GO:0006120;GO:0032981;, C:mitochondrial matrix; C:mitochondrial respiratory chain complex I;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:quinone binding;, P:aerobic respiration; P:electron transport coupled proton transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O75251 B3KRI2 Q2T9H7 Q9BV17,NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial,Complex I-20kD;NADH-ubiquinone oxidoreductase 20 kDa subunit;PSST subunit {ECO:0000303|PubMed:8938450};, PF01058;, GO:0005759;GO:0005747;GO:0051539;GO:0046872;GO:0008137;GO:0016655;GO:0048038;GO:0009060;GO:0015990;GO:0006120;GO:0032981;, C:mitochondrial matrix; C:mitochondrial respiratory chain complex I;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:quinone binding;, P:aerobic respiration; P:electron transport coupled proton transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold4 indexed_genome mRNA 119316 122291 . - . ID=transcript_864;Q14353 A8K0A0 Q53Y34 Q8WVJ1,Guanidinoacetate N-methyltransferase,, , GO:0005737;GO:0005829;GO:0005634;GO:0030731;GO:0008168;GO:0008757;GO:0009887;GO:0006601;GO:0006600;GO:0032259;GO:0006936;GO:0040014;GO:0007283;, C:cytoplasm; C:cytosol; C:nucleus;, F:guanidinoacetate N-methyltransferase activity; F:methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:animal organ morphogenesis; P:creatine biosynthetic process; P:creatine metabolic process; P:methylation; P:muscle contraction; P:regulation of multicellular organism growth; P:spermatogenesis;|Q14353 A8K0A0 Q53Y34 Q8WVJ1,Guanidinoacetate N-methyltransferase,, , GO:0005737;GO:0005829;GO:0005634;GO:0030731;GO:0008168;GO:0008757;GO:0009887;GO:0006601;GO:0006600;GO:0032259;GO:0006936;GO:0040014;GO:0007283;, C:cytoplasm; C:cytosol; C:nucleus;, F:guanidinoacetate N-methyltransferase activity; F:methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:animal organ morphogenesis; P:creatine biosynthetic process; P:creatine metabolic process; P:methylation; P:muscle contraction; P:regulation of multicellular organism growth; P:spermatogenesis; scaffold4 indexed_genome mRNA 136460 148437 . + . ID=transcript_865;Q96EP5 Q96MJ3 Q9NRR9,DAZ-associated protein 1,Deleted in azoospermia-associated protein 1;, PF00076;, GO:0005829;GO:0005654;GO:0032991;GO:1990904;GO:0003730;GO:0034046;GO:0008266;GO:0003723;GO:0035613;GO:0030154;GO:0008283;GO:0001893;GO:0048026;GO:0007283;, C:cytosol; C:nucleoplasm; C:protein-containing complex; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(G) binding; F:poly(U) RNA binding; F:RNA binding; F:RNA stem-loop binding;, P:cell differentiation; P:cell population proliferation; P:maternal placenta development; P:positive regulation of mRNA splicing, via spliceosome; P:spermatogenesis;|Q96EP5 Q96MJ3 Q9NRR9,DAZ-associated protein 1,Deleted in azoospermia-associated protein 1;, PF00076;, GO:0005829;GO:0005654;GO:0032991;GO:1990904;GO:0003730;GO:0034046;GO:0008266;GO:0003723;GO:0035613;GO:0030154;GO:0008283;GO:0001893;GO:0048026;GO:0007283;, C:cytosol; C:nucleoplasm; C:protein-containing complex; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(G) binding; F:poly(U) RNA binding; F:RNA binding; F:RNA stem-loop binding;, P:cell differentiation; P:cell population proliferation; P:maternal placenta development; P:positive regulation of mRNA splicing, via spliceosome; P:spermatogenesis;|Q96EP5 Q96MJ3 Q9NRR9,DAZ-associated protein 1,Deleted in azoospermia-associated protein 1;, PF00076;, GO:0005829;GO:0005654;GO:0032991;GO:1990904;GO:0003730;GO:0034046;GO:0008266;GO:0003723;GO:0035613;GO:0030154;GO:0008283;GO:0001893;GO:0048026;GO:0007283;, C:cytosol; C:nucleoplasm; C:protein-containing complex; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(G) binding; F:poly(U) RNA binding; F:RNA binding; F:RNA stem-loop binding;, P:cell differentiation; P:cell population proliferation; P:maternal placenta development; P:positive regulation of mRNA splicing, via spliceosome; P:spermatogenesis;|Q96EP5 Q96MJ3 Q9NRR9,DAZ-associated protein 1,Deleted in azoospermia-associated protein 1;, PF00076;, GO:0005829;GO:0005654;GO:0032991;GO:1990904;GO:0003730;GO:0034046;GO:0008266;GO:0003723;GO:0035613;GO:0030154;GO:0008283;GO:0001893;GO:0048026;GO:0007283;, C:cytosol; C:nucleoplasm; C:protein-containing complex; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(G) binding; F:poly(U) RNA binding; F:RNA binding; F:RNA stem-loop binding;, P:cell differentiation; P:cell population proliferation; P:maternal placenta development; P:positive regulation of mRNA splicing, via spliceosome; P:spermatogenesis;|Q96EP5 Q96MJ3 Q9NRR9,DAZ-associated protein 1,Deleted in azoospermia-associated protein 1;, PF00076;, GO:0005829;GO:0005654;GO:0032991;GO:1990904;GO:0003730;GO:0034046;GO:0008266;GO:0003723;GO:0035613;GO:0030154;GO:0008283;GO:0001893;GO:0048026;GO:0007283;, C:cytosol; C:nucleoplasm; C:protein-containing complex; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(G) binding; F:poly(U) RNA binding; F:RNA binding; F:RNA stem-loop binding;, P:cell differentiation; P:cell population proliferation; P:maternal placenta development; P:positive regulation of mRNA splicing, via spliceosome; P:spermatogenesis; scaffold4 indexed_genome mRNA 151106 152895 . + . ID=transcript_866;P62841 A5D8V9 P11174 Q3KRA1 Q9UDC2,40S ribosomal protein S15,RIG protein;Small ribosomal subunit protein uS19 {ECO:0000303|PubMed:24524803};, PF00203;, GO:0005829;GO:0022627;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0003735;GO:0000184;GO:0001649;GO:0000028;GO:0042274;GO:0000056;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:osteoblast differentiation; P:ribosomal small subunit assembly; P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold4 indexed_genome mRNA 162495 168181 . + . ID=transcript_867;O95996 Q05BW4 Q9UBZ1 Q9UEM8 Q9UQJ8 Q9UQJ9 Q9Y632,Adenomatous polyposis coli protein 2 {ECO:0000305},Adenomatous polyposis coli protein-like;, PF05956;PF16689;PF05923;PF18797;PF00514;PF05924;, GO:0005884;GO:0030877;GO:0016342;GO:0005737;GO:0005829;GO:0005794;GO:0045171;GO:0031258;GO:0005874;GO:0015630;GO:0030496;GO:0048471;GO:0098794;GO:0008013;GO:0045295;GO:0008017;GO:0090630;GO:0001708;GO:0016477;GO:0000226;GO:0090090;GO:0007026;GO:0007399;GO:0007389;GO:0045732;GO:0045595;GO:0016055;, C:actin filament; C:beta-catenin destruction complex; C:catenin complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercellular bridge; C:lamellipodium membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:perinuclear region of cytoplasm; C:postsynapse;, F:beta-catenin binding; F:gamma-catenin binding; F:microtubule binding;, P:activation of GTPase activity; P:cell fate specification; P:cell migration; P:microtubule cytoskeleton organization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of protein catabolic process; P:regulation of cell differentiation; P:Wnt signaling pathway;|O95996 Q05BW4 Q9UBZ1 Q9UEM8 Q9UQJ8 Q9UQJ9 Q9Y632,Adenomatous polyposis coli protein 2 {ECO:0000305},Adenomatous polyposis coli protein-like;, PF05956;PF16689;PF05923;PF18797;PF00514;PF05924;, GO:0005884;GO:0030877;GO:0016342;GO:0005737;GO:0005829;GO:0005794;GO:0045171;GO:0031258;GO:0005874;GO:0015630;GO:0030496;GO:0048471;GO:0098794;GO:0008013;GO:0045295;GO:0008017;GO:0090630;GO:0001708;GO:0016477;GO:0000226;GO:0090090;GO:0007026;GO:0007399;GO:0007389;GO:0045732;GO:0045595;GO:0016055;, C:actin filament; C:beta-catenin destruction complex; C:catenin complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercellular bridge; C:lamellipodium membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:perinuclear region of cytoplasm; C:postsynapse;, F:beta-catenin binding; F:gamma-catenin binding; F:microtubule binding;, P:activation of GTPase activity; P:cell fate specification; P:cell migration; P:microtubule cytoskeleton organization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of protein catabolic process; P:regulation of cell differentiation; P:Wnt signaling pathway;|O95996 Q05BW4 Q9UBZ1 Q9UEM8 Q9UQJ8 Q9UQJ9 Q9Y632,Adenomatous polyposis coli protein 2 {ECO:0000305},Adenomatous polyposis coli protein-like;, PF05956;PF16689;PF05923;PF18797;PF00514;PF05924;, GO:0005884;GO:0030877;GO:0016342;GO:0005737;GO:0005829;GO:0005794;GO:0045171;GO:0031258;GO:0005874;GO:0015630;GO:0030496;GO:0048471;GO:0098794;GO:0008013;GO:0045295;GO:0008017;GO:0090630;GO:0001708;GO:0016477;GO:0000226;GO:0090090;GO:0007026;GO:0007399;GO:0007389;GO:0045732;GO:0045595;GO:0016055;, C:actin filament; C:beta-catenin destruction complex; C:catenin complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercellular bridge; C:lamellipodium membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:perinuclear region of cytoplasm; C:postsynapse;, F:beta-catenin binding; F:gamma-catenin binding; F:microtubule binding;, P:activation of GTPase activity; P:cell fate specification; P:cell migration; P:microtubule cytoskeleton organization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of protein catabolic process; P:regulation of cell differentiation; P:Wnt signaling pathway; scaffold4 indexed_genome mRNA 169760 170556 . - . ID=transcript_868;O95996 Q05BW4 Q9UBZ1 Q9UEM8 Q9UQJ8 Q9UQJ9 Q9Y632,Adenomatous polyposis coli protein 2 {ECO:0000305},Adenomatous polyposis coli protein-like;, PF05956;PF16689;PF05923;PF18797;PF00514;PF05924;, GO:0005884;GO:0030877;GO:0016342;GO:0005737;GO:0005829;GO:0005794;GO:0045171;GO:0031258;GO:0005874;GO:0015630;GO:0030496;GO:0048471;GO:0098794;GO:0008013;GO:0045295;GO:0008017;GO:0090630;GO:0001708;GO:0016477;GO:0000226;GO:0090090;GO:0007026;GO:0007399;GO:0007389;GO:0045732;GO:0045595;GO:0016055;, C:actin filament; C:beta-catenin destruction complex; C:catenin complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercellular bridge; C:lamellipodium membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:perinuclear region of cytoplasm; C:postsynapse;, F:beta-catenin binding; F:gamma-catenin binding; F:microtubule binding;, P:activation of GTPase activity; P:cell fate specification; P:cell migration; P:microtubule cytoskeleton organization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of protein catabolic process; P:regulation of cell differentiation; P:Wnt signaling pathway; scaffold4 indexed_genome mRNA 171831 173318 . + . ID=transcript_869;O95996 Q05BW4 Q9UBZ1 Q9UEM8 Q9UQJ8 Q9UQJ9 Q9Y632,Adenomatous polyposis coli protein 2 {ECO:0000305},Adenomatous polyposis coli protein-like;, PF05956;PF16689;PF05923;PF18797;PF00514;PF05924;, GO:0005884;GO:0030877;GO:0016342;GO:0005737;GO:0005829;GO:0005794;GO:0045171;GO:0031258;GO:0005874;GO:0015630;GO:0030496;GO:0048471;GO:0098794;GO:0008013;GO:0045295;GO:0008017;GO:0090630;GO:0001708;GO:0016477;GO:0000226;GO:0090090;GO:0007026;GO:0007399;GO:0007389;GO:0045732;GO:0045595;GO:0016055;, C:actin filament; C:beta-catenin destruction complex; C:catenin complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercellular bridge; C:lamellipodium membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:perinuclear region of cytoplasm; C:postsynapse;, F:beta-catenin binding; F:gamma-catenin binding; F:microtubule binding;, P:activation of GTPase activity; P:cell fate specification; P:cell migration; P:microtubule cytoskeleton organization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of protein catabolic process; P:regulation of cell differentiation; P:Wnt signaling pathway; scaffold4 indexed_genome mRNA 190868 196958 . - . ID=transcript_870;Q6UW60 Q8IY88 Q9UF79,Proprotein convertase subtilisin/kexin type 4,Proprotein convertase 4;, PF01483;PF00082;PF16470;, GO:0002080;GO:0001669;GO:0030173;GO:0016020;GO:0005802;GO:0004252;GO:0007340;GO:0007339;GO:0009566;GO:0016486;GO:0016485;GO:0022414;GO:0048240;, C:acrosomal membrane; C:acrosomal vesicle; C:integral component of Golgi membrane; C:membrane; C:trans-Golgi network;, F:serine-type endopeptidase activity;, P:acrosome reaction; P:binding of sperm to zona pellucida; P:fertilization; P:peptide hormone processing; P:protein processing; P:reproductive process; P:sperm capacitation; scaffold4 indexed_genome mRNA 198389 205108 . + . ID=transcript_871;Q96HR9 A0A1L5BXV3 B2RE01 D6W5Z0 Q96LM0,Receptor expression-enhancing protein 6,Polyposis locus protein 1-like 1;, PF03134;, GO:0030665;GO:0005783;GO:0005789;GO:0016021;GO:0005634;GO:0001917;GO:0050908;GO:0007029;GO:0032386;, C:clathrin-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus; C:photoreceptor inner segment;, , P:detection of light stimulus involved in visual perception; P:endoplasmic reticulum organization; P:regulation of intracellular transport; scaffold4 indexed_genome mRNA 210715 222803 . + . ID=transcript_872;Q6ZMM2 B4DXK7 Q8IW95,ADAMTS-like protein 5,Thrombospondin type-1 domain-containing protein 6;, PF05986;PF01759;PF00090;, GO:0031012;GO:0005576;GO:0001527;GO:0008201;GO:0004222;GO:0050436;GO:0030198;, C:extracellular matrix; C:extracellular region; C:microfibril;, F:heparin binding; F:metalloendopeptidase activity; F:microfibril binding;, P:extracellular matrix organization;|Q6ZMM2 B4DXK7 Q8IW95,ADAMTS-like protein 5,Thrombospondin type-1 domain-containing protein 6;, PF05986;PF01759;PF00090;, GO:0031012;GO:0005576;GO:0001527;GO:0008201;GO:0004222;GO:0050436;GO:0030198;, C:extracellular matrix; C:extracellular region; C:microfibril;, F:heparin binding; F:metalloendopeptidase activity; F:microfibril binding;, P:extracellular matrix organization;|Q6ZMM2 B4DXK7 Q8IW95,ADAMTS-like protein 5,Thrombospondin type-1 domain-containing protein 6;, PF05986;PF01759;PF00090;, GO:0031012;GO:0005576;GO:0001527;GO:0008201;GO:0004222;GO:0050436;GO:0030198;, C:extracellular matrix; C:extracellular region; C:microfibril;, F:heparin binding; F:metalloendopeptidase activity; F:microfibril binding;, P:extracellular matrix organization;|Q6ZMM2 B4DXK7 Q8IW95,ADAMTS-like protein 5,Thrombospondin type-1 domain-containing protein 6;, PF05986;PF01759;PF00090;, GO:0031012;GO:0005576;GO:0001527;GO:0008201;GO:0004222;GO:0050436;GO:0030198;, C:extracellular matrix; C:extracellular region; C:microfibril;, F:heparin binding; F:metalloendopeptidase activity; F:microfibril binding;, P:extracellular matrix organization;|Q6ZMM2 B4DXK7 Q8IW95,ADAMTS-like protein 5,Thrombospondin type-1 domain-containing protein 6;, PF05986;PF01759;PF00090;, GO:0031012;GO:0005576;GO:0001527;GO:0008201;GO:0004222;GO:0050436;GO:0030198;, C:extracellular matrix; C:extracellular region; C:microfibril;, F:heparin binding; F:metalloendopeptidase activity; F:microfibril binding;, P:extracellular matrix organization;|Q6ZMM2 B4DXK7 Q8IW95,ADAMTS-like protein 5,Thrombospondin type-1 domain-containing protein 6;, PF05986;PF01759;PF00090;, GO:0031012;GO:0005576;GO:0001527;GO:0008201;GO:0004222;GO:0050436;GO:0030198;, C:extracellular matrix; C:extracellular region; C:microfibril;, F:heparin binding; F:metalloendopeptidase activity; F:microfibril binding;, P:extracellular matrix organization; scaffold4 indexed_genome mRNA 229962 243434 . + . ID=transcript_873;Q9NYY3 O60679 Q96CV7 Q9UE61,Serine/threonine-protein kinase PLK2,Polo-like kinase 2;Serine/threonine-protein kinase SNK;Serum-inducible kinase;, PF00069;PF00659;, GO:0005814;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0030425;GO:0005634;GO:0000922;GO:0005524;GO:0043008;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0006977;GO:0000082;GO:0060292;GO:0060291;GO:0007613;GO:0000278;GO:0007093;GO:0007052;GO:0016525;GO:0043066;GO:0071866;GO:2000773;GO:0061000;GO:0002862;GO:0018105;GO:0010508;GO:0090050;GO:0043123;GO:0032436;GO:0032092;GO:0045732;GO:0006468;GO:0032486;GO:0007265;GO:0046599;GO:0032465;GO:0048167;, C:centriole; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:dendrite; C:nucleus; C:spindle pole;, F:ATP binding; F:ATP-dependent protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:long-term synaptic depression; P:long-term synaptic potentiation; P:memory; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle organization; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic process in bone marrow cell; P:negative regulation of cellular senescence; P:negative regulation of dendritic spine development; P:negative regulation of inflammatory response to antigenic stimulus; P:peptidyl-serine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:protein phosphorylation; P:Rap protein signal transduction; P:Ras protein signal transduction; P:regulation of centriole replication; P:regulation of cytokinesis; P:regulation of synaptic plasticity;|Q9NYY3 O60679 Q96CV7 Q9UE61,Serine/threonine-protein kinase PLK2,Polo-like kinase 2;Serine/threonine-protein kinase SNK;Serum-inducible kinase;, PF00069;PF00659;, GO:0005814;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0030425;GO:0005634;GO:0000922;GO:0005524;GO:0043008;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0006977;GO:0000082;GO:0060292;GO:0060291;GO:0007613;GO:0000278;GO:0007093;GO:0007052;GO:0016525;GO:0043066;GO:0071866;GO:2000773;GO:0061000;GO:0002862;GO:0018105;GO:0010508;GO:0090050;GO:0043123;GO:0032436;GO:0032092;GO:0045732;GO:0006468;GO:0032486;GO:0007265;GO:0046599;GO:0032465;GO:0048167;, C:centriole; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:dendrite; C:nucleus; C:spindle pole;, F:ATP binding; F:ATP-dependent protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:long-term synaptic depression; P:long-term synaptic potentiation; P:memory; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle organization; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic process in bone marrow cell; P:negative regulation of cellular senescence; P:negative regulation of dendritic spine development; P:negative regulation of inflammatory response to antigenic stimulus; P:peptidyl-serine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:protein phosphorylation; P:Rap protein signal transduction; P:Ras protein signal transduction; P:regulation of centriole replication; P:regulation of cytokinesis; P:regulation of synaptic plasticity;|Q9NYY3 O60679 Q96CV7 Q9UE61,Serine/threonine-protein kinase PLK2,Polo-like kinase 2;Serine/threonine-protein kinase SNK;Serum-inducible kinase;, PF00069;PF00659;, GO:0005814;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0030425;GO:0005634;GO:0000922;GO:0005524;GO:0043008;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0006977;GO:0000082;GO:0060292;GO:0060291;GO:0007613;GO:0000278;GO:0007093;GO:0007052;GO:0016525;GO:0043066;GO:0071866;GO:2000773;GO:0061000;GO:0002862;GO:0018105;GO:0010508;GO:0090050;GO:0043123;GO:0032436;GO:0032092;GO:0045732;GO:0006468;GO:0032486;GO:0007265;GO:0046599;GO:0032465;GO:0048167;, C:centriole; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:dendrite; C:nucleus; C:spindle pole;, F:ATP binding; F:ATP-dependent protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:long-term synaptic depression; P:long-term synaptic potentiation; P:memory; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle organization; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic process in bone marrow cell; P:negative regulation of cellular senescence; P:negative regulation of dendritic spine development; P:negative regulation of inflammatory response to antigenic stimulus; P:peptidyl-serine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:protein phosphorylation; P:Rap protein signal transduction; P:Ras protein signal transduction; P:regulation of centriole replication; P:regulation of cytokinesis; P:regulation of synaptic plasticity;|Q9NYY3 O60679 Q96CV7 Q9UE61,Serine/threonine-protein kinase PLK2,Polo-like kinase 2;Serine/threonine-protein kinase SNK;Serum-inducible kinase;, PF00069;PF00659;, GO:0005814;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0030425;GO:0005634;GO:0000922;GO:0005524;GO:0043008;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0006977;GO:0000082;GO:0060292;GO:0060291;GO:0007613;GO:0000278;GO:0007093;GO:0007052;GO:0016525;GO:0043066;GO:0071866;GO:2000773;GO:0061000;GO:0002862;GO:0018105;GO:0010508;GO:0090050;GO:0043123;GO:0032436;GO:0032092;GO:0045732;GO:0006468;GO:0032486;GO:0007265;GO:0046599;GO:0032465;GO:0048167;, C:centriole; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:dendrite; C:nucleus; C:spindle pole;, F:ATP binding; F:ATP-dependent protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:long-term synaptic depression; P:long-term synaptic potentiation; P:memory; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle organization; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic process in bone marrow cell; P:negative regulation of cellular senescence; P:negative regulation of dendritic spine development; P:negative regulation of inflammatory response to antigenic stimulus; P:peptidyl-serine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:protein phosphorylation; P:Rap protein signal transduction; P:Ras protein signal transduction; P:regulation of centriole replication; P:regulation of cytokinesis; P:regulation of synaptic plasticity;|Q496M5 B3KNR4 Q1ZYM0,Inactive serine/threonine-protein kinase PLK5,Polo-like kinase 5;, , GO:0005813;GO:0005737;GO:0005730;GO:0005634;GO:0000922;GO:0005524;GO:0004672;GO:0030154;GO:0051301;GO:0006974;GO:0071363;GO:0002357;GO:0090166;GO:0000278;GO:0044819;GO:0010976;GO:0042981;GO:0032465;GO:2000045;, C:centrosome; C:cytoplasm; C:nucleolus; C:nucleus; C:spindle pole;, F:ATP binding; F:protein kinase activity;, P:cell differentiation; P:cell division; P:cellular response to DNA damage stimulus; P:cellular response to growth factor stimulus; P:defense response to tumor cell; P:Golgi disassembly; P:mitotic cell cycle; P:mitotic G1/S transition checkpoint; P:positive regulation of neuron projection development; P:regulation of apoptotic process; P:regulation of cytokinesis; P:regulation of G1/S transition of mitotic cell cycle; scaffold4 indexed_genome mRNA 253421 259939 . + . ID=transcript_874;Q86XN8 A0PJL8 A1L023 E9PAL6 Q71M49,RNA-binding protein MEX3D,RING finger and KH domain-containing protein 1;RING finger protein 193;TINO;, PF00013;, GO:0005634;GO:0048471;GO:0046872;GO:0035925;GO:0003723;GO:0061157;GO:0010609;, C:nucleus; C:perinuclear region of cytoplasm;, F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding;, P:mRNA destabilization; P:mRNA localization resulting in posttranscriptional regulation of gene expression; scaffold4 indexed_genome mRNA 277465 278983 . + . ID=transcript_875;O95983 A8K4B7 D6W5Z2 Q6PIL9 Q6PJZ9 Q86XF4,Methyl-CpG-binding domain protein 3,Methyl-CpG-binding protein MBD3;, PF01429;PF14048;PF16564;, GO:0000785;GO:0005737;GO:0000792;GO:0005654;GO:0016581;GO:0032991;GO:0003682;GO:0003677;GO:0008327;GO:0007568;GO:0043044;GO:0007420;GO:0006346;GO:0048568;GO:0007507;GO:0016573;GO:0001701;GO:0000122;GO:0044030;GO:1901796;GO:0032355;GO:0031667;GO:0009888;, C:chromatin; C:cytoplasm; C:heterochromatin; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:methyl-CpG binding;, P:aging; P:ATP-dependent chromatin remodeling; P:brain development; P:DNA methylation-dependent heterochromatin assembly; P:embryonic organ development; P:heart development; P:histone acetylation; P:in utero embryonic development; P:negative regulation of transcription by RNA polymerase II; P:regulation of DNA methylation; P:regulation of signal transduction by p53 class mediator; P:response to estradiol; P:response to nutrient levels; P:tissue development; scaffold4 indexed_genome mRNA 279562 280471 . - . ID=transcript_876;O95983 A8K4B7 D6W5Z2 Q6PIL9 Q6PJZ9 Q86XF4,Methyl-CpG-binding domain protein 3,Methyl-CpG-binding protein MBD3;, PF01429;PF14048;PF16564;, GO:0000785;GO:0005737;GO:0000792;GO:0005654;GO:0016581;GO:0032991;GO:0003682;GO:0003677;GO:0008327;GO:0007568;GO:0043044;GO:0007420;GO:0006346;GO:0048568;GO:0007507;GO:0016573;GO:0001701;GO:0000122;GO:0044030;GO:1901796;GO:0032355;GO:0031667;GO:0009888;, C:chromatin; C:cytoplasm; C:heterochromatin; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:methyl-CpG binding;, P:aging; P:ATP-dependent chromatin remodeling; P:brain development; P:DNA methylation-dependent heterochromatin assembly; P:embryonic organ development; P:heart development; P:histone acetylation; P:in utero embryonic development; P:negative regulation of transcription by RNA polymerase II; P:regulation of DNA methylation; P:regulation of signal transduction by p53 class mediator; P:response to estradiol; P:response to nutrient levels; P:tissue development; scaffold4 indexed_genome mRNA 299911 339291 . - . ID=transcript_877;O14957 B2R542 D6W5Z4 Q9UEA3 Q9UPK4,Cytochrome b-c1 complex subunit 10,Complex III subunit 10;Complex III subunit XI;Ubiquinol-cytochrome c reductase complex 6.4 kDa protein;, PF08997;, GO:0016021;GO:0005743;GO:0070469;GO:0009055;GO:0008121;GO:0006091;GO:0006122;, C:integral component of membrane; C:mitochondrial inner membrane; C:respirasome;, F:electron transfer activity; F:ubiquinol-cytochrome-c reductase activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, ubiquinol to cytochrome c;|P15923 P15883 Q14208 Q14635 Q14636 Q2TB39 Q2TB40 Q9UPI9,Transcription factor E2-alpha,Class B basic helix-loop-helix protein 21;Immunoglobulin enhancer-binding factor E12/E47;Immunoglobulin transcription factor 1;Kappa-E2-binding factor;Transcription factor 3;Transcription factor ITF-1;, PF00010;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0031435;GO:0046982;GO:0042803;GO:0070491;GO:0001102;GO:0000978;GO:0008134;GO:0070644;GO:0030183;GO:0002326;GO:0033152;GO:0000122;GO:0007399;GO:0030890;GO:0045787;GO:0051091;GO:0051149;GO:0045666;GO:0045944;GO:0045893;GO:2000045;GO:1902036;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:vitamin D response element binding;, P:B cell differentiation; P:B cell lineage commitment; P:immunoglobulin V(D)J recombination; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of B cell proliferation; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P15923 P15883 Q14208 Q14635 Q14636 Q2TB39 Q2TB40 Q9UPI9,Transcription factor E2-alpha,Class B basic helix-loop-helix protein 21;Immunoglobulin enhancer-binding factor E12/E47;Immunoglobulin transcription factor 1;Kappa-E2-binding factor;Transcription factor 3;Transcription factor ITF-1;, PF00010;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0031435;GO:0046982;GO:0042803;GO:0070491;GO:0001102;GO:0000978;GO:0008134;GO:0070644;GO:0030183;GO:0002326;GO:0033152;GO:0000122;GO:0007399;GO:0030890;GO:0045787;GO:0051091;GO:0051149;GO:0045666;GO:0045944;GO:0045893;GO:2000045;GO:1902036;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:vitamin D response element binding;, P:B cell differentiation; P:B cell lineage commitment; P:immunoglobulin V(D)J recombination; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of B cell proliferation; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P15923 P15883 Q14208 Q14635 Q14636 Q2TB39 Q2TB40 Q9UPI9,Transcription factor E2-alpha,Class B basic helix-loop-helix protein 21;Immunoglobulin enhancer-binding factor E12/E47;Immunoglobulin transcription factor 1;Kappa-E2-binding factor;Transcription factor 3;Transcription factor ITF-1;, PF00010;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0031435;GO:0046982;GO:0042803;GO:0070491;GO:0001102;GO:0000978;GO:0008134;GO:0070644;GO:0030183;GO:0002326;GO:0033152;GO:0000122;GO:0007399;GO:0030890;GO:0045787;GO:0051091;GO:0051149;GO:0045666;GO:0045944;GO:0045893;GO:2000045;GO:1902036;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:vitamin D response element binding;, P:B cell differentiation; P:B cell lineage commitment; P:immunoglobulin V(D)J recombination; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of B cell proliferation; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P15923 P15883 Q14208 Q14635 Q14636 Q2TB39 Q2TB40 Q9UPI9,Transcription factor E2-alpha,Class B basic helix-loop-helix protein 21;Immunoglobulin enhancer-binding factor E12/E47;Immunoglobulin transcription factor 1;Kappa-E2-binding factor;Transcription factor 3;Transcription factor ITF-1;, PF00010;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0031435;GO:0046982;GO:0042803;GO:0070491;GO:0001102;GO:0000978;GO:0008134;GO:0070644;GO:0030183;GO:0002326;GO:0033152;GO:0000122;GO:0007399;GO:0030890;GO:0045787;GO:0051091;GO:0051149;GO:0045666;GO:0045944;GO:0045893;GO:2000045;GO:1902036;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:vitamin D response element binding;, P:B cell differentiation; P:B cell lineage commitment; P:immunoglobulin V(D)J recombination; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of B cell proliferation; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P15923 P15883 Q14208 Q14635 Q14636 Q2TB39 Q2TB40 Q9UPI9,Transcription factor E2-alpha,Class B basic helix-loop-helix protein 21;Immunoglobulin enhancer-binding factor E12/E47;Immunoglobulin transcription factor 1;Kappa-E2-binding factor;Transcription factor 3;Transcription factor ITF-1;, PF00010;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0031435;GO:0046982;GO:0042803;GO:0070491;GO:0001102;GO:0000978;GO:0008134;GO:0070644;GO:0030183;GO:0002326;GO:0033152;GO:0000122;GO:0007399;GO:0030890;GO:0045787;GO:0051091;GO:0051149;GO:0045666;GO:0045944;GO:0045893;GO:2000045;GO:1902036;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:vitamin D response element binding;, P:B cell differentiation; P:B cell lineage commitment; P:immunoglobulin V(D)J recombination; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of B cell proliferation; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P15923 P15883 Q14208 Q14635 Q14636 Q2TB39 Q2TB40 Q9UPI9,Transcription factor E2-alpha,Class B basic helix-loop-helix protein 21;Immunoglobulin enhancer-binding factor E12/E47;Immunoglobulin transcription factor 1;Kappa-E2-binding factor;Transcription factor 3;Transcription factor ITF-1;, PF00010;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0031435;GO:0046982;GO:0042803;GO:0070491;GO:0001102;GO:0000978;GO:0008134;GO:0070644;GO:0030183;GO:0002326;GO:0033152;GO:0000122;GO:0007399;GO:0030890;GO:0045787;GO:0051091;GO:0051149;GO:0045666;GO:0045944;GO:0045893;GO:2000045;GO:1902036;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:vitamin D response element binding;, P:B cell differentiation; P:B cell lineage commitment; P:immunoglobulin V(D)J recombination; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of B cell proliferation; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P15923 P15883 Q14208 Q14635 Q14636 Q2TB39 Q2TB40 Q9UPI9,Transcription factor E2-alpha,Class B basic helix-loop-helix protein 21;Immunoglobulin enhancer-binding factor E12/E47;Immunoglobulin transcription factor 1;Kappa-E2-binding factor;Transcription factor 3;Transcription factor ITF-1;, PF00010;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0031435;GO:0046982;GO:0042803;GO:0070491;GO:0001102;GO:0000978;GO:0008134;GO:0070644;GO:0030183;GO:0002326;GO:0033152;GO:0000122;GO:0007399;GO:0030890;GO:0045787;GO:0051091;GO:0051149;GO:0045666;GO:0045944;GO:0045893;GO:2000045;GO:1902036;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:vitamin D response element binding;, P:B cell differentiation; P:B cell lineage commitment; P:immunoglobulin V(D)J recombination; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of B cell proliferation; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P15923 P15883 Q14208 Q14635 Q14636 Q2TB39 Q2TB40 Q9UPI9,Transcription factor E2-alpha,Class B basic helix-loop-helix protein 21;Immunoglobulin enhancer-binding factor E12/E47;Immunoglobulin transcription factor 1;Kappa-E2-binding factor;Transcription factor 3;Transcription factor ITF-1;, PF00010;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0031435;GO:0046982;GO:0042803;GO:0070491;GO:0001102;GO:0000978;GO:0008134;GO:0070644;GO:0030183;GO:0002326;GO:0033152;GO:0000122;GO:0007399;GO:0030890;GO:0045787;GO:0051091;GO:0051149;GO:0045666;GO:0045944;GO:0045893;GO:2000045;GO:1902036;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:vitamin D response element binding;, P:B cell differentiation; P:B cell lineage commitment; P:immunoglobulin V(D)J recombination; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of B cell proliferation; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P15923 P15883 Q14208 Q14635 Q14636 Q2TB39 Q2TB40 Q9UPI9,Transcription factor E2-alpha,Class B basic helix-loop-helix protein 21;Immunoglobulin enhancer-binding factor E12/E47;Immunoglobulin transcription factor 1;Kappa-E2-binding factor;Transcription factor 3;Transcription factor ITF-1;, PF00010;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0031435;GO:0046982;GO:0042803;GO:0070491;GO:0001102;GO:0000978;GO:0008134;GO:0070644;GO:0030183;GO:0002326;GO:0033152;GO:0000122;GO:0007399;GO:0030890;GO:0045787;GO:0051091;GO:0051149;GO:0045666;GO:0045944;GO:0045893;GO:2000045;GO:1902036;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:vitamin D response element binding;, P:B cell differentiation; P:B cell lineage commitment; P:immunoglobulin V(D)J recombination; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of B cell proliferation; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P15923 P15883 Q14208 Q14635 Q14636 Q2TB39 Q2TB40 Q9UPI9,Transcription factor E2-alpha,Class B basic helix-loop-helix protein 21;Immunoglobulin enhancer-binding factor E12/E47;Immunoglobulin transcription factor 1;Kappa-E2-binding factor;Transcription factor 3;Transcription factor ITF-1;, PF00010;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0031435;GO:0046982;GO:0042803;GO:0070491;GO:0001102;GO:0000978;GO:0008134;GO:0070644;GO:0030183;GO:0002326;GO:0033152;GO:0000122;GO:0007399;GO:0030890;GO:0045787;GO:0051091;GO:0051149;GO:0045666;GO:0045944;GO:0045893;GO:2000045;GO:1902036;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:vitamin D response element binding;, P:B cell differentiation; P:B cell lineage commitment; P:immunoglobulin V(D)J recombination; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of B cell proliferation; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold4 indexed_genome mRNA 450016 450798 . - . ID=transcript_878;O60423 Q7Z485 Q8IVB8 Q8N4Y8 Q96M22,Phospholipid-transporting ATPase IK {ECO:0000305},ATPase class I type 8B member 3;, PF16212;PF16209;, GO:0002080;GO:0005789;GO:0016021;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0007339;GO:0007030;GO:0045332;, C:acrosomal membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:binding of sperm to zona pellucida; P:Golgi organization; P:phospholipid translocation; scaffold4 indexed_genome mRNA 474545 493858 . - . ID=transcript_879;Q8N1G1 Q9ULT2,RNA exonuclease 1 homolog,Elongin-A-binding protein 1;Transcription elongation factor B polypeptide 3-binding protein 1;, PF15870;, GO:0016604;GO:0005654;GO:0005634;GO:0004527;GO:0003676;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:exonuclease activity; F:nucleic acid binding;|Q8N1G1 Q9ULT2,RNA exonuclease 1 homolog,Elongin-A-binding protein 1;Transcription elongation factor B polypeptide 3-binding protein 1;, PF15870;, GO:0016604;GO:0005654;GO:0005634;GO:0004527;GO:0003676;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:exonuclease activity; F:nucleic acid binding;|Q8N1G1 Q9ULT2,RNA exonuclease 1 homolog,Elongin-A-binding protein 1;Transcription elongation factor B polypeptide 3-binding protein 1;, PF15870;, GO:0016604;GO:0005654;GO:0005634;GO:0004527;GO:0003676;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:exonuclease activity; F:nucleic acid binding; scaffold4 indexed_genome mRNA 499376 500424 . - . ID=transcript_880;Q9BXK1,Krueppel-like factor 16,Basic transcription element-binding protein 4;Novel Sp1-like zinc finger transcription factor 2;Transcription factor BTEB4;Transcription factor NSLP2;, PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0007212;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:dopamine receptor signaling pathway; P:regulation of transcription by RNA polymerase II; scaffold4 indexed_genome mRNA 516159 521215 . - . ID=transcript_881;Q96GS6 A8K0G8 D6W5Z9 Q6PJU2 Q8WUH9 Q9BWL0 Q9H7Q9,Alpha/beta hydrolase domain-containing protein 17A {ECO:0000305},, PF12146;, GO:0099031;GO:0099033;GO:0043197;GO:0010008;GO:0098978;GO:0043231;GO:0016020;GO:0016607;GO:0005886;GO:0055038;GO:0008474;GO:0000165;GO:1902817;GO:1905668;GO:0002084;GO:0072657;GO:0099175;, C:anchored component of postsynaptic density membrane; C:anchored component of postsynaptic recycling endosome membrane; C:dendritic spine; C:endosome membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:plasma membrane; C:recycling endosome membrane;, F:palmitoyl-(protein) hydrolase activity;, P:MAPK cascade; P:negative regulation of protein localization to microtubule; P:positive regulation of protein localization to endosome; P:protein depalmitoylation; P:protein localization to membrane; P:regulation of postsynapse organization;|Q96GS6 A8K0G8 D6W5Z9 Q6PJU2 Q8WUH9 Q9BWL0 Q9H7Q9,Alpha/beta hydrolase domain-containing protein 17A {ECO:0000305},, PF12146;, GO:0099031;GO:0099033;GO:0043197;GO:0010008;GO:0098978;GO:0043231;GO:0016020;GO:0016607;GO:0005886;GO:0055038;GO:0008474;GO:0000165;GO:1902817;GO:1905668;GO:0002084;GO:0072657;GO:0099175;, C:anchored component of postsynaptic density membrane; C:anchored component of postsynaptic recycling endosome membrane; C:dendritic spine; C:endosome membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:plasma membrane; C:recycling endosome membrane;, F:palmitoyl-(protein) hydrolase activity;, P:MAPK cascade; P:negative regulation of protein localization to microtubule; P:positive regulation of protein localization to endosome; P:protein depalmitoylation; P:protein localization to membrane; P:regulation of postsynapse organization; scaffold4 indexed_genome mRNA 551272 573111 . + . ID=transcript_882;Q969E2 Q8N2N1 Q8NAV0,Secretory carrier-associated membrane protein 4,, PF04144;, GO:0016021;GO:0055038;GO:0032588;GO:0015031;, C:integral component of membrane; C:recycling endosome membrane; C:trans-Golgi network membrane;, , P:protein transport;|Q96EY9,Probable inactive tRNA-specific adenosine deaminase-like protein 3,tRNA-specific adenosine-34 deaminase subunit ADAT3;, PF00383;, GO:0005654;GO:0003824;GO:0046872;GO:0006400;, C:nucleoplasm;, F:catalytic activity; F:metal ion binding;, P:tRNA modification;|Q96EY9,Probable inactive tRNA-specific adenosine deaminase-like protein 3,tRNA-specific adenosine-34 deaminase subunit ADAT3;, PF00383;, GO:0005654;GO:0003824;GO:0046872;GO:0006400;, C:nucleoplasm;, F:catalytic activity; F:metal ion binding;, P:tRNA modification;|Q969E2 Q8N2N1 Q8NAV0,Secretory carrier-associated membrane protein 4,, PF04144;, GO:0016021;GO:0055038;GO:0032588;GO:0015031;, C:integral component of membrane; C:recycling endosome membrane; C:trans-Golgi network membrane;, , P:protein transport; scaffold4 indexed_genome mRNA 593526 602726 . + . ID=transcript_883;P78368 B5BU42 O00704 Q8WUB1,Casein kinase I isoform gamma-2,, PF12605;PF00069;, GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006897;GO:0018105;GO:0090263;GO:0046777;GO:0006468;GO:0007165;GO:0030148;GO:0016055;, C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:endocytosis; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:signal transduction; P:sphingolipid biosynthetic process; P:Wnt signaling pathway;|P78368 B5BU42 O00704 Q8WUB1,Casein kinase I isoform gamma-2,, PF12605;PF00069;, GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006897;GO:0018105;GO:0090263;GO:0046777;GO:0006468;GO:0007165;GO:0030148;GO:0016055;, C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:endocytosis; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:signal transduction; P:sphingolipid biosynthetic process; P:Wnt signaling pathway; scaffold4 indexed_genome mRNA 613171 615087 . - . ID=transcript_884;Q9BX70 O60418 O75248 Q4VBZ1 Q6IAC5 Q7Z5W0 Q96SX8 Q9NPS1 Q9NX81,BTB/POZ domain-containing protein 2,, PF07707;PF00651;PF08005;, GO:0005829;GO:0000932;GO:0022008;, C:cytosol; C:P-body;, , P:neurogenesis;|Q9BX70 O60418 O75248 Q4VBZ1 Q6IAC5 Q7Z5W0 Q96SX8 Q9NPS1 Q9NX81,BTB/POZ domain-containing protein 2,, PF07707;PF00651;PF08005;, GO:0005829;GO:0000932;GO:0022008;, C:cytosol; C:P-body;, , P:neurogenesis; scaffold4 indexed_genome mRNA 615246 617574 . - . ID=transcript_885;Q9BX70 O60418 O75248 Q4VBZ1 Q6IAC5 Q7Z5W0 Q96SX8 Q9NPS1 Q9NX81,BTB/POZ domain-containing protein 2,, PF07707;PF00651;PF08005;, GO:0005829;GO:0000932;GO:0022008;, C:cytosol; C:P-body;, , P:neurogenesis; scaffold4 indexed_genome mRNA 622097 622960 . + . ID=transcript_886;Q9BX70 O60418 O75248 Q4VBZ1 Q6IAC5 Q7Z5W0 Q96SX8 Q9NPS1 Q9NX81,BTB/POZ domain-containing protein 2,, PF07707;PF00651;PF08005;, GO:0005829;GO:0000932;GO:0022008;, C:cytosol; C:P-body;, , P:neurogenesis; scaffold4 indexed_genome mRNA 745631 748160 . - . ID=transcript_887;Q2M3G4 B7WP40 B7ZL01 Q8TDP0 Q8TF41,Protein Shroom1,Apical protein 2;, PF08688;PF08687;, GO:0005912;GO:0043296;GO:0016324;GO:0030864;GO:0005874;GO:0051015;GO:0045159;GO:0051017;GO:0007015;GO:0000902;, C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:cortical actin cytoskeleton; C:microtubule;, F:actin filament binding; F:myosin II binding;, P:actin filament bundle assembly; P:actin filament organization; P:cell morphogenesis; scaffold4 indexed_genome mRNA 773132 778440 . + . ID=transcript_888;O14949 Q5FVE2 Q9BV88 Q9T2V7,Cytochrome b-c1 complex subunit 8,Complex III subunit 8;Complex III subunit VIII;Ubiquinol-cytochrome c reductase complex 9.5 kDa protein;Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C;, PF02939;, GO:0016021;GO:0005743;GO:0005750;GO:0005739;GO:0008121;GO:0021680;GO:0021766;GO:0021854;GO:0030901;GO:0006122;GO:0021548;GO:0021860;GO:0021539;GO:0021794;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:ubiquinol-cytochrome-c reductase activity;, P:cerebellar Purkinje cell layer development; P:hippocampus development; P:hypothalamus development; P:midbrain development; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:pons development; P:pyramidal neuron development; P:subthalamus development; P:thalamus development;|O14949 Q5FVE2 Q9BV88 Q9T2V7,Cytochrome b-c1 complex subunit 8,Complex III subunit 8;Complex III subunit VIII;Ubiquinol-cytochrome c reductase complex 9.5 kDa protein;Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C;, PF02939;, GO:0016021;GO:0005743;GO:0005750;GO:0005739;GO:0008121;GO:0021680;GO:0021766;GO:0021854;GO:0030901;GO:0006122;GO:0021548;GO:0021860;GO:0021539;GO:0021794;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:ubiquinol-cytochrome-c reductase activity;, P:cerebellar Purkinje cell layer development; P:hippocampus development; P:hypothalamus development; P:midbrain development; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:pons development; P:pyramidal neuron development; P:subthalamus development; P:thalamus development; scaffold4 indexed_genome mRNA 782079 790195 . + . ID=transcript_889;Q969E1 D3DQ91,Liver-expressed antimicrobial peptide 2,, PF07359;, GO:0005576;GO:0061844;GO:0019730;GO:0042742;GO:0050832;, C:extracellular region;, , P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:antimicrobial humoral response; P:defense response to bacterium; P:defense response to fungus; scaffold4 indexed_genome mRNA 790319 791848 . + . ID=transcript_890;Q9UHB7 B2RP19 B7WPD2 Q498B2 Q59FB3 Q6P592 Q8TDR1 Q9P0E4,AF4/FMR2 family member 4,ALL1-fused gene from chromosome 5q31 protein;Major CDK9 elongation factor-associated protein;, PF18876;PF18875;, GO:0001650;GO:0005654;GO:0032783;GO:0008023;GO:0035327;GO:0010468;GO:0007286;GO:0006366;GO:0006368;, C:fibrillar center; C:nucleoplasm; C:super elongation complex; C:transcription elongation factor complex; C:transcriptionally active chromatin;, , P:regulation of gene expression; P:spermatid development; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold4 indexed_genome mRNA 791896 861618 . - . ID=transcript_891;Q9UHB7 B2RP19 B7WPD2 Q498B2 Q59FB3 Q6P592 Q8TDR1 Q9P0E4,AF4/FMR2 family member 4,ALL1-fused gene from chromosome 5q31 protein;Major CDK9 elongation factor-associated protein;, PF18876;PF18875;, GO:0001650;GO:0005654;GO:0032783;GO:0008023;GO:0035327;GO:0010468;GO:0007286;GO:0006366;GO:0006368;, C:fibrillar center; C:nucleoplasm; C:super elongation complex; C:transcription elongation factor complex; C:transcriptionally active chromatin;, , P:regulation of gene expression; P:spermatid development; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9UHB7 B2RP19 B7WPD2 Q498B2 Q59FB3 Q6P592 Q8TDR1 Q9P0E4,AF4/FMR2 family member 4,ALL1-fused gene from chromosome 5q31 protein;Major CDK9 elongation factor-associated protein;, PF18876;PF18875;, GO:0001650;GO:0005654;GO:0032783;GO:0008023;GO:0035327;GO:0010468;GO:0007286;GO:0006366;GO:0006368;, C:fibrillar center; C:nucleoplasm; C:super elongation complex; C:transcription elongation factor complex; C:transcriptionally active chromatin;, , P:regulation of gene expression; P:spermatid development; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9UHB7 B2RP19 B7WPD2 Q498B2 Q59FB3 Q6P592 Q8TDR1 Q9P0E4,AF4/FMR2 family member 4,ALL1-fused gene from chromosome 5q31 protein;Major CDK9 elongation factor-associated protein;, PF18876;PF18875;, GO:0001650;GO:0005654;GO:0032783;GO:0008023;GO:0035327;GO:0010468;GO:0007286;GO:0006366;GO:0006368;, C:fibrillar center; C:nucleoplasm; C:super elongation complex; C:transcription elongation factor complex; C:transcriptionally active chromatin;, , P:regulation of gene expression; P:spermatid development; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold4 indexed_genome mRNA 921897 971870 . + . ID=transcript_892;P34932 O95756 Q2TAL4 Q9BUK9,Heat shock 70 kDa protein 4,HSP70RY;Heat shock 70-related protein APG-2;, PF00012;, GO:0005829;GO:0070062;GO:0005739;GO:0005634;GO:0005524;GO:0016887;GO:0051131;GO:0045040;GO:0006986;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleus;, F:ATP binding; F:ATPase activity;, P:chaperone-mediated protein complex assembly; P:protein insertion into mitochondrial outer membrane; P:response to unfolded protein;|P34932 O95756 Q2TAL4 Q9BUK9,Heat shock 70 kDa protein 4,HSP70RY;Heat shock 70-related protein APG-2;, PF00012;, GO:0005829;GO:0070062;GO:0005739;GO:0005634;GO:0005524;GO:0016887;GO:0051131;GO:0045040;GO:0006986;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleus;, F:ATP binding; F:ATPase activity;, P:chaperone-mediated protein complex assembly; P:protein insertion into mitochondrial outer membrane; P:response to unfolded protein;|P34932 O95756 Q2TAL4 Q9BUK9,Heat shock 70 kDa protein 4,HSP70RY;Heat shock 70-related protein APG-2;, PF00012;, GO:0005829;GO:0070062;GO:0005739;GO:0005634;GO:0005524;GO:0016887;GO:0051131;GO:0045040;GO:0006986;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleus;, F:ATP binding; F:ATPase activity;, P:chaperone-mediated protein complex assembly; P:protein insertion into mitochondrial outer membrane; P:response to unfolded protein;|P34932 O95756 Q2TAL4 Q9BUK9,Heat shock 70 kDa protein 4,HSP70RY;Heat shock 70-related protein APG-2;, PF00012;, GO:0005829;GO:0070062;GO:0005739;GO:0005634;GO:0005524;GO:0016887;GO:0051131;GO:0045040;GO:0006986;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleus;, F:ATP binding; F:ATPase activity;, P:chaperone-mediated protein complex assembly; P:protein insertion into mitochondrial outer membrane; P:response to unfolded protein;|P34932 O95756 Q2TAL4 Q9BUK9,Heat shock 70 kDa protein 4,HSP70RY;Heat shock 70-related protein APG-2;, PF00012;, GO:0005829;GO:0070062;GO:0005739;GO:0005634;GO:0005524;GO:0016887;GO:0051131;GO:0045040;GO:0006986;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleus;, F:ATP binding; F:ATPase activity;, P:chaperone-mediated protein complex assembly; P:protein insertion into mitochondrial outer membrane; P:response to unfolded protein; scaffold4 indexed_genome mRNA 1124550 1546318 . - . ID=transcript_893;Q6MZW2 Q8TBU0 Q9UPU1,Follistatin-related protein 4,Follistatin-like protein 4;, PF07648;, GO:0005576;GO:0030141;GO:0048403;GO:0005509;GO:0030154;GO:0007275;GO:0031549;GO:0048671;GO:0061000;, C:extracellular region; C:secretory granule;, F:brain-derived neurotrophic factor binding; F:calcium ion binding;, P:cell differentiation; P:multicellular organism development; P:negative regulation of brain-derived neurotrophic factor receptor signaling pathway; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; scaffold4 indexed_genome mRNA 1919438 1922430 . - . ID=transcript_894;Q8NC54 B2RD10 D3DQ92 Q9NRG2,Keratinocyte-associated transmembrane protein 2,, , GO:0016021;, C:integral component of membrane; scaffold4 indexed_genome mRNA 1922727 1925458 . + . ID=transcript_895;Q8NC54 B2RD10 D3DQ92 Q9NRG2,Keratinocyte-associated transmembrane protein 2,, , GO:0016021;, C:integral component of membrane; scaffold4 indexed_genome mRNA 1934488 1965758 . - . ID=transcript_896;P21796 B3KVK4 D3DQ93 Q5FVE7 Q9UIQ5 Q9UPL0,Voltage-dependent anion-selective channel protein 1,Outer mitochondrial membrane protein porin 1;Plasmalemmal porin;Porin 31HL;Porin 31HM;, PF01459;, GO:0070062;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005757;GO:0005739;GO:0005634;GO:0005886;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0042802;GO:0044325;GO:0031210;GO:0015288;GO:0019901;GO:0044877;GO:0008308;GO:0006820;GO:0006915;GO:0001662;GO:0030855;GO:0007612;GO:0016236;GO:0006851;GO:0043066;GO:0110099;GO:2000378;GO:0007270;GO:1901526;GO:0006090;GO:1903146;GO:0016032;, C:extracellular exosome; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nucleus; C:plasma membrane; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:identical protein binding; F:ion channel binding; F:phosphatidylcholine binding; F:porin activity; F:protein kinase binding; F:protein-containing complex binding; F:voltage-gated anion channel activity;, P:anion transport; P:apoptotic process; P:behavioral fear response; P:epithelial cell differentiation; P:learning; P:macroautophagy; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of apoptotic process; P:negative regulation of calcium import into the mitochondrion; P:negative regulation of reactive oxygen species metabolic process; P:neuron-neuron synaptic transmission; P:positive regulation of mitophagy; P:pyruvate metabolic process; P:regulation of autophagy of mitochondrion; P:viral process;|P21796 B3KVK4 D3DQ93 Q5FVE7 Q9UIQ5 Q9UPL0,Voltage-dependent anion-selective channel protein 1,Outer mitochondrial membrane protein porin 1;Plasmalemmal porin;Porin 31HL;Porin 31HM;, PF01459;, GO:0070062;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005757;GO:0005739;GO:0005634;GO:0005886;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0042802;GO:0044325;GO:0031210;GO:0015288;GO:0019901;GO:0044877;GO:0008308;GO:0006820;GO:0006915;GO:0001662;GO:0030855;GO:0007612;GO:0016236;GO:0006851;GO:0043066;GO:0110099;GO:2000378;GO:0007270;GO:1901526;GO:0006090;GO:1903146;GO:0016032;, C:extracellular exosome; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nucleus; C:plasma membrane; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:identical protein binding; F:ion channel binding; F:phosphatidylcholine binding; F:porin activity; F:protein kinase binding; F:protein-containing complex binding; F:voltage-gated anion channel activity;, P:anion transport; P:apoptotic process; P:behavioral fear response; P:epithelial cell differentiation; P:learning; P:macroautophagy; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of apoptotic process; P:negative regulation of calcium import into the mitochondrion; P:negative regulation of reactive oxygen species metabolic process; P:neuron-neuron synaptic transmission; P:positive regulation of mitophagy; P:pyruvate metabolic process; P:regulation of autophagy of mitochondrion; P:viral process;|P21796 B3KVK4 D3DQ93 Q5FVE7 Q9UIQ5 Q9UPL0,Voltage-dependent anion-selective channel protein 1,Outer mitochondrial membrane protein porin 1;Plasmalemmal porin;Porin 31HL;Porin 31HM;, PF01459;, GO:0070062;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005757;GO:0005739;GO:0005634;GO:0005886;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0042802;GO:0044325;GO:0031210;GO:0015288;GO:0019901;GO:0044877;GO:0008308;GO:0006820;GO:0006915;GO:0001662;GO:0030855;GO:0007612;GO:0016236;GO:0006851;GO:0043066;GO:0110099;GO:2000378;GO:0007270;GO:1901526;GO:0006090;GO:1903146;GO:0016032;, C:extracellular exosome; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nucleus; C:plasma membrane; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:identical protein binding; F:ion channel binding; F:phosphatidylcholine binding; F:porin activity; F:protein kinase binding; F:protein-containing complex binding; F:voltage-gated anion channel activity;, P:anion transport; P:apoptotic process; P:behavioral fear response; P:epithelial cell differentiation; P:learning; P:macroautophagy; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of apoptotic process; P:negative regulation of calcium import into the mitochondrion; P:negative regulation of reactive oxygen species metabolic process; P:neuron-neuron synaptic transmission; P:positive regulation of mitophagy; P:pyruvate metabolic process; P:regulation of autophagy of mitochondrion; P:viral process;|P21796 B3KVK4 D3DQ93 Q5FVE7 Q9UIQ5 Q9UPL0,Voltage-dependent anion-selective channel protein 1,Outer mitochondrial membrane protein porin 1;Plasmalemmal porin;Porin 31HL;Porin 31HM;, PF01459;, GO:0070062;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005757;GO:0005739;GO:0005634;GO:0005886;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0042802;GO:0044325;GO:0031210;GO:0015288;GO:0019901;GO:0044877;GO:0008308;GO:0006820;GO:0006915;GO:0001662;GO:0030855;GO:0007612;GO:0016236;GO:0006851;GO:0043066;GO:0110099;GO:2000378;GO:0007270;GO:1901526;GO:0006090;GO:1903146;GO:0016032;, C:extracellular exosome; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nucleus; C:plasma membrane; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:identical protein binding; F:ion channel binding; F:phosphatidylcholine binding; F:porin activity; F:protein kinase binding; F:protein-containing complex binding; F:voltage-gated anion channel activity;, P:anion transport; P:apoptotic process; P:behavioral fear response; P:epithelial cell differentiation; P:learning; P:macroautophagy; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of apoptotic process; P:negative regulation of calcium import into the mitochondrion; P:negative regulation of reactive oxygen species metabolic process; P:neuron-neuron synaptic transmission; P:positive regulation of mitophagy; P:pyruvate metabolic process; P:regulation of autophagy of mitochondrion; P:viral process;|P21796 B3KVK4 D3DQ93 Q5FVE7 Q9UIQ5 Q9UPL0,Voltage-dependent anion-selective channel protein 1,Outer mitochondrial membrane protein porin 1;Plasmalemmal porin;Porin 31HL;Porin 31HM;, PF01459;, GO:0070062;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005757;GO:0005739;GO:0005634;GO:0005886;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0042802;GO:0044325;GO:0031210;GO:0015288;GO:0019901;GO:0044877;GO:0008308;GO:0006820;GO:0006915;GO:0001662;GO:0030855;GO:0007612;GO:0016236;GO:0006851;GO:0043066;GO:0110099;GO:2000378;GO:0007270;GO:1901526;GO:0006090;GO:1903146;GO:0016032;, C:extracellular exosome; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nucleus; C:plasma membrane; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:identical protein binding; F:ion channel binding; F:phosphatidylcholine binding; F:porin activity; F:protein kinase binding; F:protein-containing complex binding; F:voltage-gated anion channel activity;, P:anion transport; P:apoptotic process; P:behavioral fear response; P:epithelial cell differentiation; P:learning; P:macroautophagy; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of apoptotic process; P:negative regulation of calcium import into the mitochondrion; P:negative regulation of reactive oxygen species metabolic process; P:neuron-neuron synaptic transmission; P:positive regulation of mitophagy; P:pyruvate metabolic process; P:regulation of autophagy of mitochondrion; P:viral process;|P21796 B3KVK4 D3DQ93 Q5FVE7 Q9UIQ5 Q9UPL0,Voltage-dependent anion-selective channel protein 1,Outer mitochondrial membrane protein porin 1;Plasmalemmal porin;Porin 31HL;Porin 31HM;, PF01459;, GO:0070062;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005757;GO:0005739;GO:0005634;GO:0005886;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0042802;GO:0044325;GO:0031210;GO:0015288;GO:0019901;GO:0044877;GO:0008308;GO:0006820;GO:0006915;GO:0001662;GO:0030855;GO:0007612;GO:0016236;GO:0006851;GO:0043066;GO:0110099;GO:2000378;GO:0007270;GO:1901526;GO:0006090;GO:1903146;GO:0016032;, C:extracellular exosome; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nucleus; C:plasma membrane; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:identical protein binding; F:ion channel binding; F:phosphatidylcholine binding; F:porin activity; F:protein kinase binding; F:protein-containing complex binding; F:voltage-gated anion channel activity;, P:anion transport; P:apoptotic process; P:behavioral fear response; P:epithelial cell differentiation; P:learning; P:macroautophagy; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of apoptotic process; P:negative regulation of calcium import into the mitochondrion; P:negative regulation of reactive oxygen species metabolic process; P:neuron-neuron synaptic transmission; P:positive regulation of mitophagy; P:pyruvate metabolic process; P:regulation of autophagy of mitochondrion; P:viral process; scaffold4 indexed_genome mRNA 2085045 2089353 . - . ID=transcript_897;P63208 D3DQ97 D3DQ98 P34991 Q8TAY2,S-phase kinase-associated protein 1,Cyclin-A/CDK2-associated protein p19;Organ of Corti protein 2;Organ of Corti protein II;RNA polymerase II elongation factor-like protein;SIII;Transcription elongation factor B polypeptide 1-like;p19skp1;, PF01466;PF03931;, GO:0005813;GO:0031467;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0008013;GO:0097602;GO:1990444;GO:0019904;GO:1990756;GO:0006879;GO:0038095;GO:0000086;GO:0035518;GO:0070498;GO:0051457;GO:0010972;GO:0038061;GO:1904668;GO:0043687;GO:0070936;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:cullin family protein binding; F:F-box domain binding; F:protein domain specific binding; F:ubiquitin ligase-substrate adaptor activity;, P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:histone H2A monoubiquitination; P:interleukin-1-mediated signaling pathway; P:maintenance of protein location in nucleus; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway;|P63208 D3DQ97 D3DQ98 P34991 Q8TAY2,S-phase kinase-associated protein 1,Cyclin-A/CDK2-associated protein p19;Organ of Corti protein 2;Organ of Corti protein II;RNA polymerase II elongation factor-like protein;SIII;Transcription elongation factor B polypeptide 1-like;p19skp1;, PF01466;PF03931;, GO:0005813;GO:0031467;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0008013;GO:0097602;GO:1990444;GO:0019904;GO:1990756;GO:0006879;GO:0038095;GO:0000086;GO:0035518;GO:0070498;GO:0051457;GO:0010972;GO:0038061;GO:1904668;GO:0043687;GO:0070936;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:cullin family protein binding; F:F-box domain binding; F:protein domain specific binding; F:ubiquitin ligase-substrate adaptor activity;, P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:histone H2A monoubiquitination; P:interleukin-1-mediated signaling pathway; P:maintenance of protein location in nucleus; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway;|P63208 D3DQ97 D3DQ98 P34991 Q8TAY2,S-phase kinase-associated protein 1,Cyclin-A/CDK2-associated protein p19;Organ of Corti protein 2;Organ of Corti protein II;RNA polymerase II elongation factor-like protein;SIII;Transcription elongation factor B polypeptide 1-like;p19skp1;, PF01466;PF03931;, GO:0005813;GO:0031467;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0008013;GO:0097602;GO:1990444;GO:0019904;GO:1990756;GO:0006879;GO:0038095;GO:0000086;GO:0035518;GO:0070498;GO:0051457;GO:0010972;GO:0038061;GO:1904668;GO:0043687;GO:0070936;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:cullin family protein binding; F:F-box domain binding; F:protein domain specific binding; F:ubiquitin ligase-substrate adaptor activity;, P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:histone H2A monoubiquitination; P:interleukin-1-mediated signaling pathway; P:maintenance of protein location in nucleus; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway; scaffold4 indexed_genome mRNA 2120646 2206686 . - . ID=transcript_898;P67775 P05323 P13197,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,Replication protein C;, PF00149;, GO:0000775;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0015630;GO:0005739;GO:0005634;GO:0005886;GO:0000159;GO:0000922;GO:0045202;GO:0050811;GO:0046872;GO:0004721;GO:0008022;GO:0046982;GO:0106306;GO:0004722;GO:0106307;GO:0048156;GO:0006915;GO:0006672;GO:0000188;GO:0051321;GO:0007498;GO:0007084;GO:0030308;GO:0010719;GO:0042532;GO:0000184;GO:0070262;GO:0035970;GO:1904528;GO:0071902;GO:0006470;GO:0030155;GO:0045595;GO:0006275;GO:0040008;GO:1904526;GO:0001932;GO:0006355;GO:0030111;GO:0010288;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:plasma membrane; C:protein phosphatase type 2A complex; C:spindle pole; C:synapse;, F:GABA receptor binding; F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:tau protein binding;, P:apoptotic process; P:ceramide metabolic process; P:inactivation of MAPK activity; P:meiotic cell cycle; P:mesoderm development; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of microtubule binding; P:positive regulation of protein serine/threonine kinase activity; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of growth; P:regulation of microtubule binding; P:regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to lead ion; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling;|P67775 P05323 P13197,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,Replication protein C;, PF00149;, GO:0000775;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0015630;GO:0005739;GO:0005634;GO:0005886;GO:0000159;GO:0000922;GO:0045202;GO:0050811;GO:0046872;GO:0004721;GO:0008022;GO:0046982;GO:0106306;GO:0004722;GO:0106307;GO:0048156;GO:0006915;GO:0006672;GO:0000188;GO:0051321;GO:0007498;GO:0007084;GO:0030308;GO:0010719;GO:0042532;GO:0000184;GO:0070262;GO:0035970;GO:1904528;GO:0071902;GO:0006470;GO:0030155;GO:0045595;GO:0006275;GO:0040008;GO:1904526;GO:0001932;GO:0006355;GO:0030111;GO:0010288;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:plasma membrane; C:protein phosphatase type 2A complex; C:spindle pole; C:synapse;, F:GABA receptor binding; F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:tau protein binding;, P:apoptotic process; P:ceramide metabolic process; P:inactivation of MAPK activity; P:meiotic cell cycle; P:mesoderm development; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of microtubule binding; P:positive regulation of protein serine/threonine kinase activity; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of growth; P:regulation of microtubule binding; P:regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to lead ion; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling; scaffold4 indexed_genome mRNA 2226423 2246052 . + . ID=transcript_899;P63146 B2R503 D3DQA2 P23567 Q4PJ15 Q9D0J6,Ubiquitin-conjugating enzyme E2 B,E2 ubiquitin-conjugating enzyme B;RAD6 homolog B;Ubiquitin carrier protein B;Ubiquitin-conjugating enzyme E2-17 kDa;Ubiquitin-protein ligase B;, PF00179;, GO:0000785;GO:0005737;GO:0033503;GO:0005654;GO:0005634;GO:0005886;GO:0005657;GO:0001741;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0006974;GO:0051026;GO:0042769;GO:0006281;GO:0070829;GO:0033522;GO:0070076;GO:0016574;GO:0001701;GO:0045141;GO:0043066;GO:0043951;GO:0033128;GO:0090263;GO:0010845;GO:0006301;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0070534;GO:0006513;GO:0000209;GO:0050821;GO:0016567;GO:0042493;GO:0009411;GO:0007288;GO:0007283;GO:0070193;GO:0006511;, C:chromatin; C:cytoplasm; C:HULC complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:replication fork; C:XY body;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:chiasma assembly; P:DNA damage response, detection of DNA damage; P:DNA repair; P:heterochromatin maintenance; P:histone H2A ubiquitination; P:histone lysine demethylation; P:histone ubiquitination; P:in utero embryonic development; P:meiotic telomere clustering; P:negative regulation of apoptotic process; P:negative regulation of cAMP-mediated signaling; P:negative regulation of histone phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of reciprocal meiotic recombination; P:postreplication repair; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:response to drug; P:response to UV; P:sperm axoneme assembly; P:spermatogenesis; P:synaptonemal complex organization; P:ubiquitin-dependent protein catabolic process;|P63146 B2R503 D3DQA2 P23567 Q4PJ15 Q9D0J6,Ubiquitin-conjugating enzyme E2 B,E2 ubiquitin-conjugating enzyme B;RAD6 homolog B;Ubiquitin carrier protein B;Ubiquitin-conjugating enzyme E2-17 kDa;Ubiquitin-protein ligase B;, PF00179;, GO:0000785;GO:0005737;GO:0033503;GO:0005654;GO:0005634;GO:0005886;GO:0005657;GO:0001741;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0006974;GO:0051026;GO:0042769;GO:0006281;GO:0070829;GO:0033522;GO:0070076;GO:0016574;GO:0001701;GO:0045141;GO:0043066;GO:0043951;GO:0033128;GO:0090263;GO:0010845;GO:0006301;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0070534;GO:0006513;GO:0000209;GO:0050821;GO:0016567;GO:0042493;GO:0009411;GO:0007288;GO:0007283;GO:0070193;GO:0006511;, C:chromatin; C:cytoplasm; C:HULC complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:replication fork; C:XY body;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:chiasma assembly; P:DNA damage response, detection of DNA damage; P:DNA repair; P:heterochromatin maintenance; P:histone H2A ubiquitination; P:histone lysine demethylation; P:histone ubiquitination; P:in utero embryonic development; P:meiotic telomere clustering; P:negative regulation of apoptotic process; P:negative regulation of cAMP-mediated signaling; P:negative regulation of histone phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of reciprocal meiotic recombination; P:postreplication repair; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:response to drug; P:response to UV; P:sperm axoneme assembly; P:spermatogenesis; P:synaptonemal complex organization; P:ubiquitin-dependent protein catabolic process;|P63146 B2R503 D3DQA2 P23567 Q4PJ15 Q9D0J6,Ubiquitin-conjugating enzyme E2 B,E2 ubiquitin-conjugating enzyme B;RAD6 homolog B;Ubiquitin carrier protein B;Ubiquitin-conjugating enzyme E2-17 kDa;Ubiquitin-protein ligase B;, PF00179;, GO:0000785;GO:0005737;GO:0033503;GO:0005654;GO:0005634;GO:0005886;GO:0005657;GO:0001741;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0006974;GO:0051026;GO:0042769;GO:0006281;GO:0070829;GO:0033522;GO:0070076;GO:0016574;GO:0001701;GO:0045141;GO:0043066;GO:0043951;GO:0033128;GO:0090263;GO:0010845;GO:0006301;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0070534;GO:0006513;GO:0000209;GO:0050821;GO:0016567;GO:0042493;GO:0009411;GO:0007288;GO:0007283;GO:0070193;GO:0006511;, C:chromatin; C:cytoplasm; C:HULC complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:replication fork; C:XY body;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:chiasma assembly; P:DNA damage response, detection of DNA damage; P:DNA repair; P:heterochromatin maintenance; P:histone H2A ubiquitination; P:histone lysine demethylation; P:histone ubiquitination; P:in utero embryonic development; P:meiotic telomere clustering; P:negative regulation of apoptotic process; P:negative regulation of cAMP-mediated signaling; P:negative regulation of histone phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of reciprocal meiotic recombination; P:postreplication repair; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:response to drug; P:response to UV; P:sperm axoneme assembly; P:spermatogenesis; P:synaptonemal complex organization; P:ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 2250094 2256501 . - . ID=transcript_900;Q96HQ2 Q8WVE3,CDKN2AIP N-terminal-like protein,CDKN2A-interacting protein N-terminal-like protein;, PF11952;, GO:0005730;GO:0005654;, C:nucleolus; C:nucleoplasm;|Q96HQ2 Q8WVE3,CDKN2AIP N-terminal-like protein,CDKN2A-interacting protein N-terminal-like protein;, PF11952;, GO:0005730;GO:0005654;, C:nucleolus; C:nucleoplasm;|Q96HQ2 Q8WVE3,CDKN2AIP N-terminal-like protein,CDKN2A-interacting protein N-terminal-like protein;, PF11952;, GO:0005730;GO:0005654;, C:nucleolus; C:nucleoplasm; scaffold4 indexed_genome mRNA 2343720 2392452 . - . ID=transcript_901;Q99798 O75809 Q5JZ41 Q6FHX0 Q8TAQ6,Aconitate hydratase, mitochondrial,Citrate hydro-lyase;, PF00330;PF00694;, GO:0005829;GO:0005759;GO:0005739;GO:0051539;GO:0003994;GO:0047780;GO:0005506;GO:0006101;GO:0006091;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron ion binding;, P:citrate metabolic process; P:generation of precursor metabolites and energy; P:tricarboxylic acid cycle;|Q9NQC1 D3DQA3 Q6IE80 Q8TEK0 Q92513 Q96GQ6,E3 ubiquitin-protein ligase Jade-2 {ECO:0000303|PubMed:25018020},Jade family PHD finger protein 2;PHD finger protein 15;, PF10513;, GO:0070062;GO:0000123;GO:0005654;GO:0046872;GO:0016740;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0016567;, C:extracellular exosome; C:histone acetyltransferase complex; C:nucleoplasm;, F:metal ion binding; F:transferase activity;, P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:protein ubiquitination;|Q9NQC1 D3DQA3 Q6IE80 Q8TEK0 Q92513 Q96GQ6,E3 ubiquitin-protein ligase Jade-2 {ECO:0000303|PubMed:25018020},Jade family PHD finger protein 2;PHD finger protein 15;, PF10513;, GO:0070062;GO:0000123;GO:0005654;GO:0046872;GO:0016740;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0016567;, C:extracellular exosome; C:histone acetyltransferase complex; C:nucleoplasm;, F:metal ion binding; F:transferase activity;, P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:protein ubiquitination;|Q9NQC1 D3DQA3 Q6IE80 Q8TEK0 Q92513 Q96GQ6,E3 ubiquitin-protein ligase Jade-2 {ECO:0000303|PubMed:25018020},Jade family PHD finger protein 2;PHD finger protein 15;, PF10513;, GO:0070062;GO:0000123;GO:0005654;GO:0046872;GO:0016740;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0016567;, C:extracellular exosome; C:histone acetyltransferase complex; C:nucleoplasm;, F:metal ion binding; F:transferase activity;, P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:protein ubiquitination; scaffold4 indexed_genome mRNA 2402809 2432173 . + . ID=transcript_902;Q9Y6B6 D3DQA4 Q567T4,GTP-binding protein SAR1b,GTP-binding protein B;, PF00025;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0032580;GO:0005525;GO:0003924;GO:0046872;GO:0019886;GO:0002474;GO:0048208;GO:0006888;GO:0006886;GO:0061024;GO:0070863;GO:0003400;GO:0016050;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi cisterna membrane;, F:GTP binding; F:GTPase activity; F:metal ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane organization; P:positive regulation of protein exit from endoplasmic reticulum; P:regulation of COPII vesicle coating; P:vesicle organization;|Q9Y6B6 D3DQA4 Q567T4,GTP-binding protein SAR1b,GTP-binding protein B;, PF00025;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0032580;GO:0005525;GO:0003924;GO:0046872;GO:0019886;GO:0002474;GO:0048208;GO:0006888;GO:0006886;GO:0061024;GO:0070863;GO:0003400;GO:0016050;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi cisterna membrane;, F:GTP binding; F:GTPase activity; F:metal ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane organization; P:positive regulation of protein exit from endoplasmic reticulum; P:regulation of COPII vesicle coating; P:vesicle organization;|Q9Y6B6 D3DQA4 Q567T4,GTP-binding protein SAR1b,GTP-binding protein B;, PF00025;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0032580;GO:0005525;GO:0003924;GO:0046872;GO:0019886;GO:0002474;GO:0048208;GO:0006888;GO:0006886;GO:0061024;GO:0070863;GO:0003400;GO:0016050;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi cisterna membrane;, F:GTP binding; F:GTPase activity; F:metal ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane organization; P:positive regulation of protein exit from endoplasmic reticulum; P:regulation of COPII vesicle coating; P:vesicle organization;|Q9Y6B6 D3DQA4 Q567T4,GTP-binding protein SAR1b,GTP-binding protein B;, PF00025;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0032580;GO:0005525;GO:0003924;GO:0046872;GO:0019886;GO:0002474;GO:0048208;GO:0006888;GO:0006886;GO:0061024;GO:0070863;GO:0003400;GO:0016050;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi cisterna membrane;, F:GTP binding; F:GTPase activity; F:metal ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane organization; P:positive regulation of protein exit from endoplasmic reticulum; P:regulation of COPII vesicle coating; P:vesicle organization; scaffold4 indexed_genome mRNA 2439686 2505708 . + . ID=transcript_903;O95486 A8MVW3 Q8WUV2 Q96GP7,Protein transport protein Sec24A {ECO:0000305},SEC24-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|O95486 A8MVW3 Q8WUV2 Q96GP7,Protein transport protein Sec24A {ECO:0000305},SEC24-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|O95486 A8MVW3 Q8WUV2 Q96GP7,Protein transport protein Sec24A {ECO:0000305},SEC24-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|O95486 A8MVW3 Q8WUV2 Q96GP7,Protein transport protein Sec24A {ECO:0000305},SEC24-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|O95486 A8MVW3 Q8WUV2 Q96GP7,Protein transport protein Sec24A {ECO:0000305},SEC24-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|O95486 A8MVW3 Q8WUV2 Q96GP7,Protein transport protein Sec24A {ECO:0000305},SEC24-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|O95486 A8MVW3 Q8WUV2 Q96GP7,Protein transport protein Sec24A {ECO:0000305},SEC24-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|O95486 A8MVW3 Q8WUV2 Q96GP7,Protein transport protein Sec24A {ECO:0000305},SEC24-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; scaffold4 indexed_genome mRNA 2513182 2521136 . - . ID=transcript_904;P49069 A1L3Y3,Calcium signal-modulating cyclophilin ligand,, PF14963;, GO:0005737;GO:0005783;GO:0043529;GO:0016021;GO:0016020;GO:0050839;GO:0031625;GO:0001782;GO:0006952;GO:0032435;GO:0031397;GO:0050821;GO:0007165;GO:0071816;GO:0016032;, C:cytoplasm; C:endoplasmic reticulum; C:GET complex; C:integral component of membrane; C:membrane;, F:cell adhesion molecule binding; F:ubiquitin protein ligase binding;, P:B cell homeostasis; P:defense response; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:protein stabilization; P:signal transduction; P:tail-anchored membrane protein insertion into ER membrane; P:viral process;|P49069 A1L3Y3,Calcium signal-modulating cyclophilin ligand,, PF14963;, GO:0005737;GO:0005783;GO:0043529;GO:0016021;GO:0016020;GO:0050839;GO:0031625;GO:0001782;GO:0006952;GO:0032435;GO:0031397;GO:0050821;GO:0007165;GO:0071816;GO:0016032;, C:cytoplasm; C:endoplasmic reticulum; C:GET complex; C:integral component of membrane; C:membrane;, F:cell adhesion molecule binding; F:ubiquitin protein ligase binding;, P:B cell homeostasis; P:defense response; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:protein stabilization; P:signal transduction; P:tail-anchored membrane protein insertion into ER membrane; P:viral process;|P49069 A1L3Y3,Calcium signal-modulating cyclophilin ligand,, PF14963;, GO:0005737;GO:0005783;GO:0043529;GO:0016021;GO:0016020;GO:0050839;GO:0031625;GO:0001782;GO:0006952;GO:0032435;GO:0031397;GO:0050821;GO:0007165;GO:0071816;GO:0016032;, C:cytoplasm; C:endoplasmic reticulum; C:GET complex; C:integral component of membrane; C:membrane;, F:cell adhesion molecule binding; F:ubiquitin protein ligase binding;, P:B cell homeostasis; P:defense response; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:protein stabilization; P:signal transduction; P:tail-anchored membrane protein insertion into ER membrane; P:viral process; scaffold4 indexed_genome mRNA 2529214 2579545 . + . ID=transcript_905;Q7L014 O94894 Q96EI0 Q9Y658,Probable ATP-dependent RNA helicase DDX46,DEAD box protein 46;PRP5 homolog;, PF00270;PF00271;, GO:0015030;GO:0001650;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0000398;, C:Cajal body; C:fibrillar center; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome;|Q7L014 O94894 Q96EI0 Q9Y658,Probable ATP-dependent RNA helicase DDX46,DEAD box protein 46;PRP5 homolog;, PF00270;PF00271;, GO:0015030;GO:0001650;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0000398;, C:Cajal body; C:fibrillar center; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome;|Q7L014 O94894 Q96EI0 Q9Y658,Probable ATP-dependent RNA helicase DDX46,DEAD box protein 46;PRP5 homolog;, PF00270;PF00271;, GO:0015030;GO:0001650;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0000398;, C:Cajal body; C:fibrillar center; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome;|Q7L014 O94894 Q96EI0 Q9Y658,Probable ATP-dependent RNA helicase DDX46,DEAD box protein 46;PRP5 homolog;, PF00270;PF00271;, GO:0015030;GO:0001650;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0000398;, C:Cajal body; C:fibrillar center; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome;|Q7L014 O94894 Q96EI0 Q9Y658,Probable ATP-dependent RNA helicase DDX46,DEAD box protein 46;PRP5 homolog;, PF00270;PF00271;, GO:0015030;GO:0001650;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0000398;, C:Cajal body; C:fibrillar center; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; scaffold4 indexed_genome mRNA 2583284 2594577 . + . ID=transcript_906;Q7Z6I8 D3DQA7 Q86Y53 Q8N1T9,UPF0461 protein C5orf24,, PF17724; scaffold4 indexed_genome mRNA 2612994 2629163 . + . ID=transcript_907;Q96J42 D3DQA9 Q96MT2 Q9H639,Thioredoxin domain-containing protein 15,, PF00085;, GO:0060170;GO:0005929;GO:0016021;GO:0060271;GO:0045880;, C:ciliary membrane; C:cilium; C:integral component of membrane;, , P:cilium assembly; P:positive regulation of smoothened signaling pathway;|Q96J42 D3DQA9 Q96MT2 Q9H639,Thioredoxin domain-containing protein 15,, PF00085;, GO:0060170;GO:0005929;GO:0016021;GO:0060271;GO:0045880;, C:ciliary membrane; C:cilium; C:integral component of membrane;, , P:cilium assembly; P:positive regulation of smoothened signaling pathway;|Q96J42 D3DQA9 Q96MT2 Q9H639,Thioredoxin domain-containing protein 15,, PF00085;, GO:0060170;GO:0005929;GO:0016021;GO:0060271;GO:0045880;, C:ciliary membrane; C:cilium; C:integral component of membrane;, , P:cilium assembly; P:positive regulation of smoothened signaling pathway;|Q96J42 D3DQA9 Q96MT2 Q9H639,Thioredoxin domain-containing protein 15,, PF00085;, GO:0060170;GO:0005929;GO:0016021;GO:0060271;GO:0045880;, C:ciliary membrane; C:cilium; C:integral component of membrane;, , P:cilium assembly; P:positive regulation of smoothened signaling pathway; scaffold4 indexed_genome mRNA 2634834 2679194 . + . ID=transcript_908;Q9H0N5 Q8TD40,Pterin-4-alpha-carbinolamine dehydratase 2,4-alpha-hydroxy-tetrahydropterin dehydratase 2;DcoH-like protein DCoHm;Dimerization cofactor of hepatocyte nuclear factor 1 from muscle;HNF-1-alpha dimerization cofactor;, PF01329;, GO:0005634;GO:0008124;GO:0042802;GO:0004505;GO:0045893;GO:0006729;, C:nucleus;, F:4-alpha-hydroxytetrahydrobiopterin dehydratase activity; F:identical protein binding; F:phenylalanine 4-monooxygenase activity;, P:positive regulation of transcription, DNA-templated; P:tetrahydrobiopterin biosynthetic process;|Q9H0N5 Q8TD40,Pterin-4-alpha-carbinolamine dehydratase 2,4-alpha-hydroxy-tetrahydropterin dehydratase 2;DcoH-like protein DCoHm;Dimerization cofactor of hepatocyte nuclear factor 1 from muscle;HNF-1-alpha dimerization cofactor;, PF01329;, GO:0005634;GO:0008124;GO:0042802;GO:0004505;GO:0045893;GO:0006729;, C:nucleus;, F:4-alpha-hydroxytetrahydrobiopterin dehydratase activity; F:identical protein binding; F:phenylalanine 4-monooxygenase activity;, P:positive regulation of transcription, DNA-templated; P:tetrahydrobiopterin biosynthetic process; scaffold4 indexed_genome mRNA 2709526 2713356 . + . ID=transcript_909;Q86XQ3 Q86XS6,Cation channel sperm-associated protein 3,Ca(v)-like protein;One-repeat calcium channel-like protein;, PF00520;, GO:0001669;GO:0036128;GO:0005783;GO:0031514;GO:0005886;GO:0005245;GO:0030317;GO:0007275;GO:0034765;GO:0032570;GO:0006814;GO:0048240;GO:0035036;, C:acrosomal vesicle; C:CatSper complex; C:endoplasmic reticulum; C:motile cilium; C:plasma membrane;, F:voltage-gated calcium channel activity;, P:flagellated sperm motility; P:multicellular organism development; P:regulation of ion transmembrane transport; P:response to progesterone; P:sodium ion transport; P:sperm capacitation; P:sperm-egg recognition; scaffold4 indexed_genome mRNA 3046883 3051427 . - . ID=transcript_910;O75367 O75377 Q503A8 Q7Z5E3 Q96D41 Q9H8P3 Q9UP96,Core histone macro-H2A.1,Histone H2A.y;Medulloblastoma antigen MU-MB-50.205;, PF00125;PF16211;PF01661;, GO:0001740;GO:0000785;GO:0000781;GO:0000793;GO:0070062;GO:0000228;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005721;GO:0001739;GO:0031490;GO:0003677;GO:0010385;GO:0019899;GO:0031492;GO:1990841;GO:0046982;GO:0019901;GO:0030291;GO:0000182;GO:0000979;GO:0000977;GO:0000976;GO:0006342;GO:0007549;GO:0071169;GO:1902750;GO:0045814;GO:0061086;GO:0051572;GO:0033128;GO:1904815;GO:0071901;GO:1902883;GO:0000122;GO:1901837;GO:0006334;GO:1903226;GO:0045815;GO:0045618;GO:0034184;GO:1902884;GO:0040029;GO:0019216;GO:1902882;, C:Barr body; C:chromatin; C:chromosome, telomeric region; C:condensed chromosome; C:extracellular exosome; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:pericentric heterochromatin; C:sex chromatin;, F:chromatin DNA binding; F:DNA binding; F:double-stranded methylated DNA binding; F:enzyme binding; F:nucleosomal DNA binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; F:rDNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin silencing; P:dosage compensation; P:establishment of protein localization to chromatin; P:negative regulation of cell cycle G2/M phase transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone phosphorylation; P:negative regulation of protein localization to chromosome, telomeric region; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of response to oxidative stress; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:nucleosome assembly; P:positive regulation of endodermal cell differentiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of keratinocyte differentiation; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of response to oxidative stress; P:regulation of gene expression, epigenetic; P:regulation of lipid metabolic process; P:regulation of response to oxidative stress; scaffold4 indexed_genome mRNA 3054108 3135513 . - . ID=transcript_911;O75367 O75377 Q503A8 Q7Z5E3 Q96D41 Q9H8P3 Q9UP96,Core histone macro-H2A.1,Histone H2A.y;Medulloblastoma antigen MU-MB-50.205;, PF00125;PF16211;PF01661;, GO:0001740;GO:0000785;GO:0000781;GO:0000793;GO:0070062;GO:0000228;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005721;GO:0001739;GO:0031490;GO:0003677;GO:0010385;GO:0019899;GO:0031492;GO:1990841;GO:0046982;GO:0019901;GO:0030291;GO:0000182;GO:0000979;GO:0000977;GO:0000976;GO:0006342;GO:0007549;GO:0071169;GO:1902750;GO:0045814;GO:0061086;GO:0051572;GO:0033128;GO:1904815;GO:0071901;GO:1902883;GO:0000122;GO:1901837;GO:0006334;GO:1903226;GO:0045815;GO:0045618;GO:0034184;GO:1902884;GO:0040029;GO:0019216;GO:1902882;, C:Barr body; C:chromatin; C:chromosome, telomeric region; C:condensed chromosome; C:extracellular exosome; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:pericentric heterochromatin; C:sex chromatin;, F:chromatin DNA binding; F:DNA binding; F:double-stranded methylated DNA binding; F:enzyme binding; F:nucleosomal DNA binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; F:rDNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin silencing; P:dosage compensation; P:establishment of protein localization to chromatin; P:negative regulation of cell cycle G2/M phase transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone phosphorylation; P:negative regulation of protein localization to chromosome, telomeric region; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of response to oxidative stress; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:nucleosome assembly; P:positive regulation of endodermal cell differentiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of keratinocyte differentiation; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of response to oxidative stress; P:regulation of gene expression, epigenetic; P:regulation of lipid metabolic process; P:regulation of response to oxidative stress;|O75367 O75377 Q503A8 Q7Z5E3 Q96D41 Q9H8P3 Q9UP96,Core histone macro-H2A.1,Histone H2A.y;Medulloblastoma antigen MU-MB-50.205;, PF00125;PF16211;PF01661;, GO:0001740;GO:0000785;GO:0000781;GO:0000793;GO:0070062;GO:0000228;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005721;GO:0001739;GO:0031490;GO:0003677;GO:0010385;GO:0019899;GO:0031492;GO:1990841;GO:0046982;GO:0019901;GO:0030291;GO:0000182;GO:0000979;GO:0000977;GO:0000976;GO:0006342;GO:0007549;GO:0071169;GO:1902750;GO:0045814;GO:0061086;GO:0051572;GO:0033128;GO:1904815;GO:0071901;GO:1902883;GO:0000122;GO:1901837;GO:0006334;GO:1903226;GO:0045815;GO:0045618;GO:0034184;GO:1902884;GO:0040029;GO:0019216;GO:1902882;, C:Barr body; C:chromatin; C:chromosome, telomeric region; C:condensed chromosome; C:extracellular exosome; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:pericentric heterochromatin; C:sex chromatin;, F:chromatin DNA binding; F:DNA binding; F:double-stranded methylated DNA binding; F:enzyme binding; F:nucleosomal DNA binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; F:rDNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin silencing; P:dosage compensation; P:establishment of protein localization to chromatin; P:negative regulation of cell cycle G2/M phase transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone phosphorylation; P:negative regulation of protein localization to chromosome, telomeric region; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of response to oxidative stress; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:nucleosome assembly; P:positive regulation of endodermal cell differentiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of keratinocyte differentiation; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of response to oxidative stress; P:regulation of gene expression, epigenetic; P:regulation of lipid metabolic process; P:regulation of response to oxidative stress;|O75367 O75377 Q503A8 Q7Z5E3 Q96D41 Q9H8P3 Q9UP96,Core histone macro-H2A.1,Histone H2A.y;Medulloblastoma antigen MU-MB-50.205;, PF00125;PF16211;PF01661;, GO:0001740;GO:0000785;GO:0000781;GO:0000793;GO:0070062;GO:0000228;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005721;GO:0001739;GO:0031490;GO:0003677;GO:0010385;GO:0019899;GO:0031492;GO:1990841;GO:0046982;GO:0019901;GO:0030291;GO:0000182;GO:0000979;GO:0000977;GO:0000976;GO:0006342;GO:0007549;GO:0071169;GO:1902750;GO:0045814;GO:0061086;GO:0051572;GO:0033128;GO:1904815;GO:0071901;GO:1902883;GO:0000122;GO:1901837;GO:0006334;GO:1903226;GO:0045815;GO:0045618;GO:0034184;GO:1902884;GO:0040029;GO:0019216;GO:1902882;, C:Barr body; C:chromatin; C:chromosome, telomeric region; C:condensed chromosome; C:extracellular exosome; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:pericentric heterochromatin; C:sex chromatin;, F:chromatin DNA binding; F:DNA binding; F:double-stranded methylated DNA binding; F:enzyme binding; F:nucleosomal DNA binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; F:rDNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin silencing; P:dosage compensation; P:establishment of protein localization to chromatin; P:negative regulation of cell cycle G2/M phase transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone phosphorylation; P:negative regulation of protein localization to chromosome, telomeric region; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of response to oxidative stress; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:nucleosome assembly; P:positive regulation of endodermal cell differentiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of keratinocyte differentiation; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of response to oxidative stress; P:regulation of gene expression, epigenetic; P:regulation of lipid metabolic process; P:regulation of response to oxidative stress;|O75367 O75377 Q503A8 Q7Z5E3 Q96D41 Q9H8P3 Q9UP96,Core histone macro-H2A.1,Histone H2A.y;Medulloblastoma antigen MU-MB-50.205;, PF00125;PF16211;PF01661;, GO:0001740;GO:0000785;GO:0000781;GO:0000793;GO:0070062;GO:0000228;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005721;GO:0001739;GO:0031490;GO:0003677;GO:0010385;GO:0019899;GO:0031492;GO:1990841;GO:0046982;GO:0019901;GO:0030291;GO:0000182;GO:0000979;GO:0000977;GO:0000976;GO:0006342;GO:0007549;GO:0071169;GO:1902750;GO:0045814;GO:0061086;GO:0051572;GO:0033128;GO:1904815;GO:0071901;GO:1902883;GO:0000122;GO:1901837;GO:0006334;GO:1903226;GO:0045815;GO:0045618;GO:0034184;GO:1902884;GO:0040029;GO:0019216;GO:1902882;, C:Barr body; C:chromatin; C:chromosome, telomeric region; C:condensed chromosome; C:extracellular exosome; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:pericentric heterochromatin; C:sex chromatin;, F:chromatin DNA binding; F:DNA binding; F:double-stranded methylated DNA binding; F:enzyme binding; F:nucleosomal DNA binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; F:rDNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin silencing; P:dosage compensation; P:establishment of protein localization to chromatin; P:negative regulation of cell cycle G2/M phase transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone phosphorylation; P:negative regulation of protein localization to chromosome, telomeric region; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of response to oxidative stress; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:nucleosome assembly; P:positive regulation of endodermal cell differentiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of keratinocyte differentiation; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of response to oxidative stress; P:regulation of gene expression, epigenetic; P:regulation of lipid metabolic process; P:regulation of response to oxidative stress; scaffold4 indexed_genome mRNA 3312698 3320294 . - . ID=transcript_912;O95715 B3KQU8 Q6UW97 Q86U69 Q9BTR1 Q9NS21,C-X-C motif chemokine 14,Chemokine BRAK;MIP-2G;Small-inducible cytokine B14;, PF00048;, GO:0005615;GO:0005794;GO:0008009;GO:0061844;GO:0007267;GO:0006935;GO:0048839;GO:0031640;GO:0045662;GO:2000503;GO:0007165;, C:extracellular space; C:Golgi apparatus;, F:chemokine activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell-cell signaling; P:chemotaxis; P:inner ear development; P:killing of cells of other organism; P:negative regulation of myoblast differentiation; P:positive regulation of natural killer cell chemotaxis; P:signal transduction; scaffold4 indexed_genome mRNA 3616498 3625087 . + . ID=transcript_913;Q9UKT6,Putative F-box/LRR-repeat protein 21,F-box and leucine-rich repeat protein 21;F-box and leucine-rich repeat protein 3B;F-box/LRR-repeat protein 3B;, PF12937;, GO:0005829;GO:0005634;GO:0019005;GO:0000151;GO:0004842;GO:0043153;GO:0000086;GO:0043687;GO:0000209;GO:0016567;GO:0051726;GO:0048511;GO:0031146;, C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell cycle; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9UKT6,Putative F-box/LRR-repeat protein 21,F-box and leucine-rich repeat protein 21;F-box and leucine-rich repeat protein 3B;F-box/LRR-repeat protein 3B;, PF12937;, GO:0005829;GO:0005634;GO:0019005;GO:0000151;GO:0004842;GO:0043153;GO:0000086;GO:0043687;GO:0000209;GO:0016567;GO:0051726;GO:0048511;GO:0031146;, C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell cycle; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 3628107 3640846 . - . ID=transcript_914;O14960 B2RA90 O14565 Q52M49,Leukocyte cell-derived chemotaxin-2,, PF01551;, GO:0005737;GO:0005829;GO:0005615;GO:0043231;GO:0042802;GO:0046872;GO:0006935;GO:0001501;, C:cytoplasm; C:cytosol; C:extracellular space; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:metal ion binding;, P:chemotaxis; P:skeletal system development;|O14960 B2RA90 O14565 Q52M49,Leukocyte cell-derived chemotaxin-2,, PF01551;, GO:0005737;GO:0005829;GO:0005615;GO:0043231;GO:0042802;GO:0046872;GO:0006935;GO:0001501;, C:cytoplasm; C:cytosol; C:extracellular space; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:metal ion binding;, P:chemotaxis; P:skeletal system development;|O14960 B2RA90 O14565 Q52M49,Leukocyte cell-derived chemotaxin-2,, PF01551;, GO:0005737;GO:0005829;GO:0005615;GO:0043231;GO:0042802;GO:0046872;GO:0006935;GO:0001501;, C:cytoplasm; C:cytosol; C:extracellular space; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:metal ion binding;, P:chemotaxis; P:skeletal system development; scaffold4 indexed_genome mRNA 3705190 3738715 . + . ID=transcript_915;Q53XM1,Transforming growth factor-beta-induced protein ig-h3,Kerato-epithelin;RGD-containing collagen-associated protein;, PF02469;, GO:0005604;GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005886;GO:0005802;GO:0050839;GO:0005518;GO:0050840;GO:0005201;GO:0042802;GO:0005178;GO:1990000;GO:0001525;GO:0007155;GO:0008283;GO:0002062;GO:0030198;GO:0007162;GO:0050896;GO:0007601;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:plasma membrane; C:trans-Golgi network;, F:cell adhesion molecule binding; F:collagen binding; F:extracellular matrix binding; F:extracellular matrix structural constituent; F:identical protein binding; F:integrin binding;, P:amyloid fibril formation; P:angiogenesis; P:cell adhesion; P:cell population proliferation; P:chondrocyte differentiation; P:extracellular matrix organization; P:negative regulation of cell adhesion; P:response to stimulus; P:visual perception; scaffold4 indexed_genome mRNA 3796166 3855757 . + . ID=transcript_916;Q99717 O14688 Q15798 Q9UQA1,Mothers against decapentaplegic homolog 5,JV5-1;SMAD family member 5;, PF03165;PF03166;, GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0032991;GO:0071141;GO:0017151;GO:0000981;GO:0001227;GO:0070411;GO:0046872;GO:0000978;GO:1990837;GO:0031625;GO:0009653;GO:0030509;GO:0060348;GO:0060048;GO:0051216;GO:0030154;GO:0071407;GO:0009880;GO:0030218;GO:0007281;GO:0001880;GO:0030514;GO:0002051;GO:0045669;GO:1901522;GO:0045893;GO:0006468;GO:0007165;GO:0060395;GO:0007179;GO:0001657;, C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SMAD protein complex;, F:DEAD/H-box RNA helicase binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:I-SMAD binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:ubiquitin protein ligase binding;, P:anatomical structure morphogenesis; P:BMP signaling pathway; P:bone development; P:cardiac muscle contraction; P:cartilage development; P:cell differentiation; P:cellular response to organic cyclic compound; P:embryonic pattern specification; P:erythrocyte differentiation; P:germ cell development; P:Mullerian duct regression; P:negative regulation of BMP signaling pathway; P:osteoblast fate commitment; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:signal transduction; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development;|Q99717 O14688 Q15798 Q9UQA1,Mothers against decapentaplegic homolog 5,JV5-1;SMAD family member 5;, PF03165;PF03166;, GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0032991;GO:0071141;GO:0017151;GO:0000981;GO:0001227;GO:0070411;GO:0046872;GO:0000978;GO:1990837;GO:0031625;GO:0009653;GO:0030509;GO:0060348;GO:0060048;GO:0051216;GO:0030154;GO:0071407;GO:0009880;GO:0030218;GO:0007281;GO:0001880;GO:0030514;GO:0002051;GO:0045669;GO:1901522;GO:0045893;GO:0006468;GO:0007165;GO:0060395;GO:0007179;GO:0001657;, C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SMAD protein complex;, F:DEAD/H-box RNA helicase binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:I-SMAD binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:ubiquitin protein ligase binding;, P:anatomical structure morphogenesis; P:BMP signaling pathway; P:bone development; P:cardiac muscle contraction; P:cartilage development; P:cell differentiation; P:cellular response to organic cyclic compound; P:embryonic pattern specification; P:erythrocyte differentiation; P:germ cell development; P:Mullerian duct regression; P:negative regulation of BMP signaling pathway; P:osteoblast fate commitment; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:signal transduction; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development;|Q99717 O14688 Q15798 Q9UQA1,Mothers against decapentaplegic homolog 5,JV5-1;SMAD family member 5;, PF03165;PF03166;, GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0032991;GO:0071141;GO:0017151;GO:0000981;GO:0001227;GO:0070411;GO:0046872;GO:0000978;GO:1990837;GO:0031625;GO:0009653;GO:0030509;GO:0060348;GO:0060048;GO:0051216;GO:0030154;GO:0071407;GO:0009880;GO:0030218;GO:0007281;GO:0001880;GO:0030514;GO:0002051;GO:0045669;GO:1901522;GO:0045893;GO:0006468;GO:0007165;GO:0060395;GO:0007179;GO:0001657;, C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SMAD protein complex;, F:DEAD/H-box RNA helicase binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:I-SMAD binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:ubiquitin protein ligase binding;, P:anatomical structure morphogenesis; P:BMP signaling pathway; P:bone development; P:cardiac muscle contraction; P:cartilage development; P:cell differentiation; P:cellular response to organic cyclic compound; P:embryonic pattern specification; P:erythrocyte differentiation; P:germ cell development; P:Mullerian duct regression; P:negative regulation of BMP signaling pathway; P:osteoblast fate commitment; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:signal transduction; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development; scaffold4 indexed_genome mRNA 4569376 4704127 . + . ID=transcript_917;Q08629 B3KSW3 Q59EW0 Q8N630 Q9UCL8,Testican-1,Protein SPOCK;, PF07648;PF10591;PF00086;, GO:0005737;GO:0005615;GO:0031594;GO:0033268;GO:0014069;GO:0016528;GO:0005509;GO:0004869;GO:0008191;GO:0004867;GO:0007155;GO:0021953;GO:0010812;GO:0010951;GO:0010977;GO:0007399;GO:0022008;GO:0001764;GO:0001558;, C:cytoplasm; C:extracellular space; C:neuromuscular junction; C:node of Ranvier; C:postsynaptic density; C:sarcoplasm;, F:calcium ion binding; F:cysteine-type endopeptidase inhibitor activity; F:metalloendopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:central nervous system neuron differentiation; P:negative regulation of cell-substrate adhesion; P:negative regulation of endopeptidase activity; P:negative regulation of neuron projection development; P:nervous system development; P:neurogenesis; P:neuron migration; P:regulation of cell growth; scaffold4 indexed_genome mRNA 5262428 5346046 . - . ID=transcript_918;Q9UH77 B2RBK7 Q9UH75 Q9UH76 Q9ULU0 Q9Y6V6,Kelch-like protein 3,, PF07707;PF00651;PF01344;, GO:0031463;GO:0005856;GO:0005829;GO:0003779;GO:0097602;GO:0005198;GO:0072156;GO:0050801;GO:0043687;GO:0070936;GO:0016567;GO:0070294;GO:0061912;GO:0006511;, C:Cul3-RING ubiquitin ligase complex; C:cytoskeleton; C:cytosol;, F:actin binding; F:cullin family protein binding; F:structural molecule activity;, P:distal tubule morphogenesis; P:ion homeostasis; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:renal sodium ion absorption; P:selective autophagy; P:ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 5408545 5410350 . + . ID=transcript_919;Q13151 Q6IB18,Heterogeneous nuclear ribonucleoprotein A0,, PF00076;, GO:0005654;GO:0005634;GO:0035925;GO:0003729;GO:0019901;GO:0003723;GO:0070935;GO:0006954;GO:0006397;GO:0000398;GO:0032496;GO:0016070;, C:nucleoplasm; C:nucleus;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA binding; F:protein kinase binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:inflammatory response; P:mRNA processing; P:mRNA splicing, via spliceosome; P:response to lipopolysaccharide; P:RNA metabolic process; scaffold4 indexed_genome mRNA 5530149 5547038 . + . ID=transcript_920;Q9UBF9 A0A4R6 B4DT79,Myotilin,57 kDa cytoskeletal protein;Myofibrillar titin-like Ig domains protein;Titin immunoglobulin domain protein;, PF07679;, GO:0015629;GO:0030424;GO:0043025;GO:0005886;GO:0042383;GO:0030018;GO:0003779;GO:0051393;GO:0008046;GO:0008307;GO:0007156;GO:0006936;GO:0050808;, C:actin cytoskeleton; C:axon; C:neuronal cell body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:actin binding; F:alpha-actinin binding; F:axon guidance receptor activity; F:structural constituent of muscle;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:muscle contraction; P:synapse organization;|Q9UBF9 A0A4R6 B4DT79,Myotilin,57 kDa cytoskeletal protein;Myofibrillar titin-like Ig domains protein;Titin immunoglobulin domain protein;, PF07679;, GO:0015629;GO:0030424;GO:0043025;GO:0005886;GO:0042383;GO:0030018;GO:0003779;GO:0051393;GO:0008046;GO:0008307;GO:0007156;GO:0006936;GO:0050808;, C:actin cytoskeleton; C:axon; C:neuronal cell body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:actin binding; F:alpha-actinin binding; F:axon guidance receptor activity; F:structural constituent of muscle;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:muscle contraction; P:synapse organization;|Q9UBF9 A0A4R6 B4DT79,Myotilin,57 kDa cytoskeletal protein;Myofibrillar titin-like Ig domains protein;Titin immunoglobulin domain protein;, PF07679;, GO:0015629;GO:0030424;GO:0043025;GO:0005886;GO:0042383;GO:0030018;GO:0003779;GO:0051393;GO:0008046;GO:0008307;GO:0007156;GO:0006936;GO:0050808;, C:actin cytoskeleton; C:axon; C:neuronal cell body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:actin binding; F:alpha-actinin binding; F:axon guidance receptor activity; F:structural constituent of muscle;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:muscle contraction; P:synapse organization; scaffold4 indexed_genome mRNA 5574262 5576916 . - . ID=transcript_921;Q9NZM6 A6NK98 B4DXD2 E9PC91 E9PDG4 Q86YB4 Q9UNJ0,Polycystic kidney disease 2-like 2 protein,Polycystin-2L2;Polycystin-L2;, PF08016;, GO:0016021;GO:0016020;GO:0005262;GO:0005509;GO:0050982;, C:integral component of membrane; C:membrane;, F:calcium channel activity; F:calcium ion binding;, P:detection of mechanical stimulus; scaffold4 indexed_genome mRNA 5576937 5578633 . - . ID=transcript_922;Q9NZM6 A6NK98 B4DXD2 E9PC91 E9PDG4 Q86YB4 Q9UNJ0,Polycystic kidney disease 2-like 2 protein,Polycystin-2L2;Polycystin-L2;, PF08016;, GO:0016021;GO:0016020;GO:0005262;GO:0005509;GO:0050982;, C:integral component of membrane; C:membrane;, F:calcium channel activity; F:calcium ion binding;, P:detection of mechanical stimulus; scaffold4 indexed_genome mRNA 5584312 5588388 . - . ID=transcript_923;Q9NZM6 A6NK98 B4DXD2 E9PC91 E9PDG4 Q86YB4 Q9UNJ0,Polycystic kidney disease 2-like 2 protein,Polycystin-2L2;Polycystin-L2;, PF08016;, GO:0016021;GO:0016020;GO:0005262;GO:0005509;GO:0050982;, C:integral component of membrane; C:membrane;, F:calcium channel activity; F:calcium ion binding;, P:detection of mechanical stimulus; scaffold4 indexed_genome mRNA 5588417 5595310 . - . ID=transcript_924;Q9NYF5 D3DQB5 G3V0H9 Q3ZCR0 Q6PGQ2 Q9P0I7,Protein FAM13B,GAP-like protein N61;, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9NYF5 D3DQB5 G3V0H9 Q3ZCR0 Q6PGQ2 Q9P0I7,Protein FAM13B,GAP-like protein N61;, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold4 indexed_genome mRNA 5596462 5668403 . - . ID=transcript_925;Q9NYF5 D3DQB5 G3V0H9 Q3ZCR0 Q6PGQ2 Q9P0I7,Protein FAM13B,GAP-like protein N61;, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9NYF5 D3DQB5 G3V0H9 Q3ZCR0 Q6PGQ2 Q9P0I7,Protein FAM13B,GAP-like protein N61;, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9NYF5 D3DQB5 G3V0H9 Q3ZCR0 Q6PGQ2 Q9P0I7,Protein FAM13B,GAP-like protein N61;, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9NYF5 D3DQB5 G3V0H9 Q3ZCR0 Q6PGQ2 Q9P0I7,Protein FAM13B,GAP-like protein N61;, PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold4 indexed_genome mRNA 5748917 5767437 . - . ID=transcript_926;P56597 B2R5G7,Nucleoside diphosphate kinase homolog 5,Inhibitor of p53-induced apoptosis-beta;Testis-specific nm23 homolog;nm23-H5;, PF05186;PF00334;, GO:0005929;GO:0005576;GO:0036126;GO:0004550;GO:0060271;GO:0006241;GO:0003351;GO:0006183;GO:1902176;GO:0009116;GO:0007286;GO:0007283;GO:0006228;GO:0021591;, C:cilium; C:extracellular region; C:sperm flagellum;, F:nucleoside diphosphate kinase activity;, P:cilium assembly; P:CTP biosynthetic process; P:epithelial cilium movement involved in extracellular fluid movement; P:GTP biosynthetic process; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:nucleoside metabolic process; P:spermatid development; P:spermatogenesis; P:UTP biosynthetic process; P:ventricular system development;|P56597 B2R5G7,Nucleoside diphosphate kinase homolog 5,Inhibitor of p53-induced apoptosis-beta;Testis-specific nm23 homolog;nm23-H5;, PF05186;PF00334;, GO:0005929;GO:0005576;GO:0036126;GO:0004550;GO:0060271;GO:0006241;GO:0003351;GO:0006183;GO:1902176;GO:0009116;GO:0007286;GO:0007283;GO:0006228;GO:0021591;, C:cilium; C:extracellular region; C:sperm flagellum;, F:nucleoside diphosphate kinase activity;, P:cilium assembly; P:CTP biosynthetic process; P:epithelial cilium movement involved in extracellular fluid movement; P:GTP biosynthetic process; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:nucleoside metabolic process; P:spermatid development; P:spermatogenesis; P:UTP biosynthetic process; P:ventricular system development;|P56597 B2R5G7,Nucleoside diphosphate kinase homolog 5,Inhibitor of p53-induced apoptosis-beta;Testis-specific nm23 homolog;nm23-H5;, PF05186;PF00334;, GO:0005929;GO:0005576;GO:0036126;GO:0004550;GO:0060271;GO:0006241;GO:0003351;GO:0006183;GO:1902176;GO:0009116;GO:0007286;GO:0007283;GO:0006228;GO:0021591;, C:cilium; C:extracellular region; C:sperm flagellum;, F:nucleoside diphosphate kinase activity;, P:cilium assembly; P:CTP biosynthetic process; P:epithelial cilium movement involved in extracellular fluid movement; P:GTP biosynthetic process; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:nucleoside metabolic process; P:spermatid development; P:spermatogenesis; P:UTP biosynthetic process; P:ventricular system development;|P07900 A8K500 B3KPJ9 Q2PP14 Q5CAQ6 Q5CAQ7 Q9BVQ5,Heat shock protein HSP 90-alpha {ECO:0000305},Heat shock 86 kDa;Lipopolysaccharide-associated protein 2;Renal carcinoma antigen NY-REN-38;, PF02518;PF00183;, GO:0044295;GO:0005737;GO:0005829;GO:0044294;GO:0071682;GO:0070062;GO:0005576;GO:1904813;GO:0043202;GO:0042470;GO:0016020;GO:0005739;GO:0043209;GO:0043025;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0034774;GO:0005524;GO:0016887;GO:0097718;GO:0070182;GO:0051020;GO:0042826;GO:0042802;GO:0023026;GO:0030235;GO:0044183;GO:0042803;GO:1990782;GO:0003723;GO:0097110;GO:0048156;GO:0030911;GO:0031625;GO:0051082;GO:0002218;GO:0048675;GO:0034605;GO:0098586;GO:0021955;GO:0061684;GO:0051131;GO:0097711;GO:0019221;GO:0038128;GO:0030010;GO:0038096;GO:0000086;GO:0006839;GO:0043312;GO:1903364;GO:0002230;GO:0032728;GO:0045429;GO:0033138;GO:0051897;GO:0001934;GO:0032273;GO:1902949;GO:0051973;GO:0006457;GO:0045040;GO:0042026;GO:0050821;GO:0043335;GO:0006898;GO:0042981;GO:1903827;GO:1900034;GO:0010389;GO:0060544;GO:0050999;GO:0031396;GO:0043254;GO:0046677;GO:0009409;GO:0009408;GO:0006986;GO:1905323;GO:0007004;GO:0046146;GO:0048010;GO:0016032;, C:axonal growth cone; C:cytoplasm; C:cytosol; C:dendritic growth cone; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:melanosome; C:membrane; C:mitochondrion; C:myelin sheath; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:disordered domain specific binding; F:DNA polymerase binding; F:GTPase binding; F:histone deacetylase binding; F:identical protein binding; F:MHC class II protein complex binding; F:nitric-oxide synthase regulator activity; F:protein folding chaperone; F:protein homodimerization activity; F:protein tyrosine kinase binding; F:RNA binding; F:scaffold protein binding; F:tau protein binding; F:TPR domain binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:activation of innate immune response; P:axon extension; P:cellular response to heat; P:cellular response to virus; P:central nervous system neuron axonogenesis; P:chaperone-mediated autophagy; P:chaperone-mediated protein complex assembly; P:ciliary basal body-plasma membrane docking; P:cytokine-mediated signaling pathway; P:ERBB2 signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G2/M transition of mitotic cell cycle; P:mitochondrial transport; P:neutrophil degranulation; P:positive regulation of cellular protein catabolic process; P:positive regulation of defense response to virus by host; P:positive regulation of interferon-beta production; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein polymerization; P:positive regulation of tau-protein kinase activity; P:positive regulation of telomerase activity; P:protein folding; P:protein insertion into mitochondrial outer membrane; P:protein refolding; P:protein stabilization; P:protein unfolding; P:receptor-mediated endocytosis; P:regulation of apoptotic process; P:regulation of cellular protein localization; P:regulation of cellular response to heat; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of necroptotic process; P:regulation of nitric-oxide synthase activity; P:regulation of protein ubiquitination; P:regulation of protein-containing complex assembly; P:response to antibiotic; P:response to cold; P:response to heat; P:response to unfolded protein; P:telomerase holoenzyme complex assembly; P:telomere maintenance via telomerase; P:tetrahydrobiopterin metabolic process; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; scaffold4 indexed_genome mRNA 5784646 5805660 . - . ID=transcript_927;Q9H0E9 O43178 Q15355 Q58AB0 Q59GN0 Q969M9,Bromodomain-containing protein 8,Skeletal muscle abundant protein;Skeletal muscle abundant protein 2;Thyroid hormone receptor coactivating protein of 120 kDa;p120;, PF00439;, GO:0005739;GO:0035267;GO:0005654;GO:0000812;GO:0030374;GO:0046966;GO:0007166;GO:0097067;GO:0016573;GO:0043968;GO:0043967;GO:0045944;GO:0040008;, C:mitochondrion; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:Swr1 complex;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding;, P:cell surface receptor signaling pathway; P:cellular response to thyroid hormone stimulus; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9H0E9 O43178 Q15355 Q58AB0 Q59GN0 Q969M9,Bromodomain-containing protein 8,Skeletal muscle abundant protein;Skeletal muscle abundant protein 2;Thyroid hormone receptor coactivating protein of 120 kDa;p120;, PF00439;, GO:0005739;GO:0035267;GO:0005654;GO:0000812;GO:0030374;GO:0046966;GO:0007166;GO:0097067;GO:0016573;GO:0043968;GO:0043967;GO:0045944;GO:0040008;, C:mitochondrion; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:Swr1 complex;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding;, P:cell surface receptor signaling pathway; P:cellular response to thyroid hormone stimulus; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth;|Q9H0E9 O43178 Q15355 Q58AB0 Q59GN0 Q969M9,Bromodomain-containing protein 8,Skeletal muscle abundant protein;Skeletal muscle abundant protein 2;Thyroid hormone receptor coactivating protein of 120 kDa;p120;, PF00439;, GO:0005739;GO:0035267;GO:0005654;GO:0000812;GO:0030374;GO:0046966;GO:0007166;GO:0097067;GO:0016573;GO:0043968;GO:0043967;GO:0045944;GO:0040008;, C:mitochondrion; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:Swr1 complex;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding;, P:cell surface receptor signaling pathway; P:cellular response to thyroid hormone stimulus; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth;|Q9H0E9 O43178 Q15355 Q58AB0 Q59GN0 Q969M9,Bromodomain-containing protein 8,Skeletal muscle abundant protein;Skeletal muscle abundant protein 2;Thyroid hormone receptor coactivating protein of 120 kDa;p120;, PF00439;, GO:0005739;GO:0035267;GO:0005654;GO:0000812;GO:0030374;GO:0046966;GO:0007166;GO:0097067;GO:0016573;GO:0043968;GO:0043967;GO:0045944;GO:0040008;, C:mitochondrion; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:Swr1 complex;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding;, P:cell surface receptor signaling pathway; P:cellular response to thyroid hormone stimulus; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth;|Q9H0E9 O43178 Q15355 Q58AB0 Q59GN0 Q969M9,Bromodomain-containing protein 8,Skeletal muscle abundant protein;Skeletal muscle abundant protein 2;Thyroid hormone receptor coactivating protein of 120 kDa;p120;, PF00439;, GO:0005739;GO:0035267;GO:0005654;GO:0000812;GO:0030374;GO:0046966;GO:0007166;GO:0097067;GO:0016573;GO:0043968;GO:0043967;GO:0045944;GO:0040008;, C:mitochondrion; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:Swr1 complex;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding;, P:cell surface receptor signaling pathway; P:cellular response to thyroid hormone stimulus; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth;|Q9H0E9 O43178 Q15355 Q58AB0 Q59GN0 Q969M9,Bromodomain-containing protein 8,Skeletal muscle abundant protein;Skeletal muscle abundant protein 2;Thyroid hormone receptor coactivating protein of 120 kDa;p120;, PF00439;, GO:0005739;GO:0035267;GO:0005654;GO:0000812;GO:0030374;GO:0046966;GO:0007166;GO:0097067;GO:0016573;GO:0043968;GO:0043967;GO:0045944;GO:0040008;, C:mitochondrion; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:Swr1 complex;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding;, P:cell surface receptor signaling pathway; P:cellular response to thyroid hormone stimulus; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth; scaffold4 indexed_genome mRNA 5808229 5810589 . + . ID=transcript_928;O95235 B4DL79 D3DQB6,Kinesin-like protein KIF20A,GG10_2;Mitotic kinesin-like protein 2;Rab6-interacting kinesin-like protein;Rabkinesin-6;, PF00225;, GO:0032154;GO:0005794;GO:0045171;GO:0005871;GO:0005874;GO:0030496;GO:0005654;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0019901;GO:0001578;GO:0007018;GO:0061952;GO:0000281;GO:0015031;GO:0032465;, C:cleavage furrow; C:Golgi apparatus; C:intercellular bridge; C:kinesin complex; C:microtubule; C:midbody; C:nucleoplasm; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein kinase binding;, P:microtubule bundle formation; P:microtubule-based movement; P:midbody abscission; P:mitotic cytokinesis; P:protein transport; P:regulation of cytokinesis; scaffold4 indexed_genome mRNA 5810854 5812110 . + . ID=transcript_929;O95235 B4DL79 D3DQB6,Kinesin-like protein KIF20A,GG10_2;Mitotic kinesin-like protein 2;Rab6-interacting kinesin-like protein;Rabkinesin-6;, PF00225;, GO:0032154;GO:0005794;GO:0045171;GO:0005871;GO:0005874;GO:0030496;GO:0005654;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0019901;GO:0001578;GO:0007018;GO:0061952;GO:0000281;GO:0015031;GO:0032465;, C:cleavage furrow; C:Golgi apparatus; C:intercellular bridge; C:kinesin complex; C:microtubule; C:midbody; C:nucleoplasm; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein kinase binding;, P:microtubule bundle formation; P:microtubule-based movement; P:midbody abscission; P:mitotic cytokinesis; P:protein transport; P:regulation of cytokinesis; scaffold4 indexed_genome mRNA 5812235 5827615 . + . ID=transcript_930;O95235 B4DL79 D3DQB6,Kinesin-like protein KIF20A,GG10_2;Mitotic kinesin-like protein 2;Rab6-interacting kinesin-like protein;Rabkinesin-6;, PF00225;, GO:0032154;GO:0005794;GO:0045171;GO:0005871;GO:0005874;GO:0030496;GO:0005654;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0019901;GO:0001578;GO:0007018;GO:0061952;GO:0000281;GO:0015031;GO:0032465;, C:cleavage furrow; C:Golgi apparatus; C:intercellular bridge; C:kinesin complex; C:microtubule; C:midbody; C:nucleoplasm; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein kinase binding;, P:microtubule bundle formation; P:microtubule-based movement; P:midbody abscission; P:mitotic cytokinesis; P:protein transport; P:regulation of cytokinesis;|Q9UJX2 A8K6E5 B4E3A2 B7WP05 D3DQB7 O75433 Q53FN2 Q9BS73,Cell division cycle protein 23 homolog,Anaphase-promoting complex subunit 8;Cyclosome subunit 8;, PF04049;PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0005654;GO:0004842;GO:0031145;GO:0051301;GO:0007091;GO:0000278;GO:0007080;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0030071;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic metaphase/anaphase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX2 A8K6E5 B4E3A2 B7WP05 D3DQB7 O75433 Q53FN2 Q9BS73,Cell division cycle protein 23 homolog,Anaphase-promoting complex subunit 8;Cyclosome subunit 8;, PF04049;PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0005654;GO:0004842;GO:0031145;GO:0051301;GO:0007091;GO:0000278;GO:0007080;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0030071;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic metaphase/anaphase transition; P:ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 5827873 5830626 . + . ID=transcript_931;Q9UJX2 A8K6E5 B4E3A2 B7WP05 D3DQB7 O75433 Q53FN2 Q9BS73,Cell division cycle protein 23 homolog,Anaphase-promoting complex subunit 8;Cyclosome subunit 8;, PF04049;PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0005654;GO:0004842;GO:0031145;GO:0051301;GO:0007091;GO:0000278;GO:0007080;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0030071;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic metaphase/anaphase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX2 A8K6E5 B4E3A2 B7WP05 D3DQB7 O75433 Q53FN2 Q9BS73,Cell division cycle protein 23 homolog,Anaphase-promoting complex subunit 8;Cyclosome subunit 8;, PF04049;PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0005654;GO:0004842;GO:0031145;GO:0051301;GO:0007091;GO:0000278;GO:0007080;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0030071;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic metaphase/anaphase transition; P:ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 5865680 5885151 . - . ID=transcript_932;O60609 B2RA36 B4DMY9 Q6UW20 Q8IUZ2,GDNF family receptor alpha-3,, PF02351;, GO:0031225;GO:0005829;GO:0009897;GO:0019898;GO:0005886;GO:0043235;GO:0008046;GO:0016167;GO:0038023;GO:0005102;GO:0007411;GO:0000165;GO:0007399;GO:0001764;GO:0007422;GO:0007165;GO:0048485;, C:anchored component of membrane; C:cytosol; C:external side of plasma membrane; C:extrinsic component of membrane; C:plasma membrane; C:receptor complex;, F:axon guidance receptor activity; F:glial cell-derived neurotrophic factor receptor activity; F:signaling receptor activity; F:signaling receptor binding;, P:axon guidance; P:MAPK cascade; P:nervous system development; P:neuron migration; P:peripheral nervous system development; P:signal transduction; P:sympathetic nervous system development; scaffold4 indexed_genome mRNA 5890104 5892772 . - . ID=transcript_933;P30307 D3DQB8 Q96PL3 Q9H168 Q9H2E8 Q9H2E9 Q9H2F1,M-phase inducer phosphatase 3,Dual specificity phosphatase Cdc25C;, PF06617;PF00581;, GO:0005737;GO:0005829;GO:0005758;GO:0016607;GO:0005654;GO:0005634;GO:0048471;GO:0019901;GO:0004725;GO:0050699;GO:0051301;GO:0008283;GO:0006977;GO:0000086;GO:0010971;GO:0110032;GO:0000079;GO:0007088;GO:0007283;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:protein kinase binding; F:protein tyrosine phosphatase activity; F:WW domain binding;, P:cell division; P:cell population proliferation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G2/M transition of mitotic cell cycle; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of G2/MI transition of meiotic cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of mitotic nuclear division; P:spermatogenesis; P:viral process; scaffold4 indexed_genome mRNA 5894900 5922330 . - . ID=transcript_934;P30307 D3DQB8 Q96PL3 Q9H168 Q9H2E8 Q9H2E9 Q9H2F1,M-phase inducer phosphatase 3,Dual specificity phosphatase Cdc25C;, PF06617;PF00581;, GO:0005737;GO:0005829;GO:0005758;GO:0016607;GO:0005654;GO:0005634;GO:0048471;GO:0019901;GO:0004725;GO:0050699;GO:0051301;GO:0008283;GO:0006977;GO:0000086;GO:0010971;GO:0110032;GO:0000079;GO:0007088;GO:0007283;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:protein kinase binding; F:protein tyrosine phosphatase activity; F:WW domain binding;, P:cell division; P:cell population proliferation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G2/M transition of mitotic cell cycle; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of G2/MI transition of meiotic cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of mitotic nuclear division; P:spermatogenesis; P:viral process; scaffold4 indexed_genome mRNA 5934337 5938698 . + . ID=transcript_935;Q9NYF3 B2RDJ5 D3DQB9,Protein FAM53C {ECO:0000305},, PF15242;, GO:0005634;GO:0006606;, C:nucleus;, , P:protein import into nucleus;|Q9NYF3 B2RDJ5 D3DQB9,Protein FAM53C {ECO:0000305},, PF15242;, GO:0005634;GO:0006606;, C:nucleus;, , P:protein import into nucleus;|Q9NYF3 B2RDJ5 D3DQB9,Protein FAM53C {ECO:0000305},, PF15242;, GO:0005634;GO:0006606;, C:nucleus;, , P:protein import into nucleus;|Q9NYF3 B2RDJ5 D3DQB9,Protein FAM53C {ECO:0000305},, PF15242;, GO:0005634;GO:0006606;, C:nucleus;, , P:protein import into nucleus;|Q9NYF3 B2RDJ5 D3DQB9,Protein FAM53C {ECO:0000305},, PF15242;, GO:0005634;GO:0006606;, C:nucleus;, , P:protein import into nucleus; scaffold4 indexed_genome mRNA 5956270 5999461 . + . ID=transcript_936;Q7LBC6 A6H8X7 Q9BVH6 Q9BW93 Q9BZ52 Q9NYF4 Q9UPS0,Lysine-specific demethylase 3B,JmjC domain-containing histone demethylation protein 2B;Jumonji domain-containing protein 1B;Nuclear protein 5qNCA;[histone H3]-dimethyl-L-lysine(9) demethylase 3B {ECO:0000305};, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0016209;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0003712;GO:0033169;GO:0006357;GO:0072718;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:antioxidant activity; F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:transcription coregulator activity;, P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:response to cisplatin;|Q7LBC6 A6H8X7 Q9BVH6 Q9BW93 Q9BZ52 Q9NYF4 Q9UPS0,Lysine-specific demethylase 3B,JmjC domain-containing histone demethylation protein 2B;Jumonji domain-containing protein 1B;Nuclear protein 5qNCA;[histone H3]-dimethyl-L-lysine(9) demethylase 3B {ECO:0000305};, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0016209;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0003712;GO:0033169;GO:0006357;GO:0072718;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:antioxidant activity; F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:transcription coregulator activity;, P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:response to cisplatin;|Q7LBC6 A6H8X7 Q9BVH6 Q9BW93 Q9BZ52 Q9NYF4 Q9UPS0,Lysine-specific demethylase 3B,JmjC domain-containing histone demethylation protein 2B;Jumonji domain-containing protein 1B;Nuclear protein 5qNCA;[histone H3]-dimethyl-L-lysine(9) demethylase 3B {ECO:0000305};, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0016209;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0003712;GO:0033169;GO:0006357;GO:0072718;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:antioxidant activity; F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:transcription coregulator activity;, P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:response to cisplatin;|Q7LBC6 A6H8X7 Q9BVH6 Q9BW93 Q9BZ52 Q9NYF4 Q9UPS0,Lysine-specific demethylase 3B,JmjC domain-containing histone demethylation protein 2B;Jumonji domain-containing protein 1B;Nuclear protein 5qNCA;[histone H3]-dimethyl-L-lysine(9) demethylase 3B {ECO:0000305};, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0016209;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0003712;GO:0033169;GO:0006357;GO:0072718;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:antioxidant activity; F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:transcription coregulator activity;, P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:response to cisplatin;|Q7LBC6 A6H8X7 Q9BVH6 Q9BW93 Q9BZ52 Q9NYF4 Q9UPS0,Lysine-specific demethylase 3B,JmjC domain-containing histone demethylation protein 2B;Jumonji domain-containing protein 1B;Nuclear protein 5qNCA;[histone H3]-dimethyl-L-lysine(9) demethylase 3B {ECO:0000305};, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0016209;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0003712;GO:0033169;GO:0006357;GO:0072718;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:antioxidant activity; F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:transcription coregulator activity;, P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:response to cisplatin; scaffold4 indexed_genome mRNA 6001636 6008311 . + . ID=transcript_937;Q9BRK0 Q53EM8 Q9NYF2,Receptor expression-enhancing protein 2,, PF03134;, GO:0005881;GO:0005783;GO:0005789;GO:0071782;GO:0005887;GO:0016020;GO:0008017;GO:0031883;GO:0071786;GO:0032596;GO:0032386;GO:0050913;GO:0050916;, C:cytoplasmic microtubule; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of plasma membrane; C:membrane;, F:microtubule binding; F:taste receptor binding;, P:endoplasmic reticulum tubular network organization; P:protein transport into membrane raft; P:regulation of intracellular transport; P:sensory perception of bitter taste; P:sensory perception of sweet taste;|Q9BRK0 Q53EM8 Q9NYF2,Receptor expression-enhancing protein 2,, PF03134;, GO:0005881;GO:0005783;GO:0005789;GO:0071782;GO:0005887;GO:0016020;GO:0008017;GO:0031883;GO:0071786;GO:0032596;GO:0032386;GO:0050913;GO:0050916;, C:cytoplasmic microtubule; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of plasma membrane; C:membrane;, F:microtubule binding; F:taste receptor binding;, P:endoplasmic reticulum tubular network organization; P:protein transport into membrane raft; P:regulation of intracellular transport; P:sensory perception of bitter taste; P:sensory perception of sweet taste;|Q9BRK0 Q53EM8 Q9NYF2,Receptor expression-enhancing protein 2,, PF03134;, GO:0005881;GO:0005783;GO:0005789;GO:0071782;GO:0005887;GO:0016020;GO:0008017;GO:0031883;GO:0071786;GO:0032596;GO:0032386;GO:0050913;GO:0050916;, C:cytoplasmic microtubule; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of plasma membrane; C:membrane;, F:microtubule binding; F:taste receptor binding;, P:endoplasmic reticulum tubular network organization; P:protein transport into membrane raft; P:regulation of intracellular transport; P:sensory perception of bitter taste; P:sensory perception of sweet taste; scaffold4 indexed_genome mRNA 6019897 6023820 . - . ID=transcript_938;P18146,Early growth response protein 1 {ECO:0000303|PubMed:2377485},AT225;Nerve growth factor-induced protein A;Transcription factor ETR103;Transcription factor Zif268;Zinc finger protein 225 {ECO:0000303|PubMed:2110381};Zinc finger protein Krox-24;, PF11914;PF11928;PF00096;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0010385;GO:0044729;GO:0035035;GO:1990841;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0000976;GO:0008270;GO:0030509;GO:0071480;GO:0071504;GO:0098759;GO:0071506;GO:0032922;GO:0060086;GO:0044849;GO:0072110;GO:0070498;GO:0045475;GO:0090090;GO:0000122;GO:0032722;GO:0010628;GO:0072303;GO:0046886;GO:0032731;GO:1901216;GO:1902895;GO:1902949;GO:0045944;GO:0045893;GO:0042981;GO:2000182;GO:0033233;GO:0006357;GO:0061418;GO:0009749;GO:0001666;GO:0032868;GO:0002931;GO:0035914;GO:0030217;GO:0060337;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded methylated DNA binding; F:hemi-methylated DNA-binding; F:histone acetyltransferase binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:BMP signaling pathway; P:cellular response to gamma radiation; P:cellular response to heparin; P:cellular response to interleukin-8; P:cellular response to mycophenolic acid; P:circadian regulation of gene expression; P:circadian temperature homeostasis; P:estrous cycle; P:glomerular mesangial cell proliferation; P:interleukin-1-mediated signaling pathway; P:locomotor rhythm; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chemokine production; P:positive regulation of gene expression; P:positive regulation of glomerular metanephric mesangial cell proliferation; P:positive regulation of hormone biosynthetic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of neuron death; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of tau-protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of apoptotic process; P:regulation of progesterone biosynthetic process; P:regulation of protein sumoylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to glucose; P:response to hypoxia; P:response to insulin; P:response to ischemia; P:skeletal muscle cell differentiation; P:T cell differentiation; P:type I interferon signaling pathway;|P18146,Early growth response protein 1 {ECO:0000303|PubMed:2377485},AT225;Nerve growth factor-induced protein A;Transcription factor ETR103;Transcription factor Zif268;Zinc finger protein 225 {ECO:0000303|PubMed:2110381};Zinc finger protein Krox-24;, PF11914;PF11928;PF00096;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0010385;GO:0044729;GO:0035035;GO:1990841;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0000976;GO:0008270;GO:0030509;GO:0071480;GO:0071504;GO:0098759;GO:0071506;GO:0032922;GO:0060086;GO:0044849;GO:0072110;GO:0070498;GO:0045475;GO:0090090;GO:0000122;GO:0032722;GO:0010628;GO:0072303;GO:0046886;GO:0032731;GO:1901216;GO:1902895;GO:1902949;GO:0045944;GO:0045893;GO:0042981;GO:2000182;GO:0033233;GO:0006357;GO:0061418;GO:0009749;GO:0001666;GO:0032868;GO:0002931;GO:0035914;GO:0030217;GO:0060337;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded methylated DNA binding; F:hemi-methylated DNA-binding; F:histone acetyltransferase binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:BMP signaling pathway; P:cellular response to gamma radiation; P:cellular response to heparin; P:cellular response to interleukin-8; P:cellular response to mycophenolic acid; P:circadian regulation of gene expression; P:circadian temperature homeostasis; P:estrous cycle; P:glomerular mesangial cell proliferation; P:interleukin-1-mediated signaling pathway; P:locomotor rhythm; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chemokine production; P:positive regulation of gene expression; P:positive regulation of glomerular metanephric mesangial cell proliferation; P:positive regulation of hormone biosynthetic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of neuron death; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of tau-protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of apoptotic process; P:regulation of progesterone biosynthetic process; P:regulation of protein sumoylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to glucose; P:response to hypoxia; P:response to insulin; P:response to ischemia; P:skeletal muscle cell differentiation; P:T cell differentiation; P:type I interferon signaling pathway; scaffold4 indexed_genome mRNA 6051460 6076519 . - . ID=transcript_939;P62495 B2R6B4 D3DQC1 P46055 Q5M7Z7 Q96CG1,Eukaryotic peptide chain release factor subunit 1,Protein Cl1;TB3-1;, PF03463;PF03464;PF03465;, GO:0005737;GO:0005829;GO:0018444;GO:0043022;GO:0003723;GO:1990825;GO:0003747;GO:0016149;GO:0008079;GO:0002184;GO:0000184;GO:0006479;GO:0006449;GO:0006415;, C:cytoplasm; C:cytosol; C:translation release factor complex;, F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding; F:translation release factor activity; F:translation release factor activity, codon specific; F:translation termination factor activity;, P:cytoplasmic translational termination; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translational termination;|P62495 B2R6B4 D3DQC1 P46055 Q5M7Z7 Q96CG1,Eukaryotic peptide chain release factor subunit 1,Protein Cl1;TB3-1;, PF03463;PF03464;PF03465;, GO:0005737;GO:0005829;GO:0018444;GO:0043022;GO:0003723;GO:1990825;GO:0003747;GO:0016149;GO:0008079;GO:0002184;GO:0000184;GO:0006479;GO:0006449;GO:0006415;, C:cytoplasm; C:cytosol; C:translation release factor complex;, F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding; F:translation release factor activity; F:translation release factor activity, codon specific; F:translation termination factor activity;, P:cytoplasmic translational termination; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translational termination;|P62495 B2R6B4 D3DQC1 P46055 Q5M7Z7 Q96CG1,Eukaryotic peptide chain release factor subunit 1,Protein Cl1;TB3-1;, PF03463;PF03464;PF03465;, GO:0005737;GO:0005829;GO:0018444;GO:0043022;GO:0003723;GO:1990825;GO:0003747;GO:0016149;GO:0008079;GO:0002184;GO:0000184;GO:0006479;GO:0006449;GO:0006415;, C:cytoplasm; C:cytosol; C:translation release factor complex;, F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding; F:translation release factor activity; F:translation release factor activity, codon specific; F:translation termination factor activity;, P:cytoplasmic translational termination; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translational termination;|P62495 B2R6B4 D3DQC1 P46055 Q5M7Z7 Q96CG1,Eukaryotic peptide chain release factor subunit 1,Protein Cl1;TB3-1;, PF03463;PF03464;PF03465;, GO:0005737;GO:0005829;GO:0018444;GO:0043022;GO:0003723;GO:1990825;GO:0003747;GO:0016149;GO:0008079;GO:0002184;GO:0000184;GO:0006479;GO:0006449;GO:0006415;, C:cytoplasm; C:cytosol; C:translation release factor complex;, F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding; F:translation release factor activity; F:translation release factor activity, codon specific; F:translation termination factor activity;, P:cytoplasmic translational termination; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translational termination;|P62495 B2R6B4 D3DQC1 P46055 Q5M7Z7 Q96CG1,Eukaryotic peptide chain release factor subunit 1,Protein Cl1;TB3-1;, PF03463;PF03464;PF03465;, GO:0005737;GO:0005829;GO:0018444;GO:0043022;GO:0003723;GO:1990825;GO:0003747;GO:0016149;GO:0008079;GO:0002184;GO:0000184;GO:0006479;GO:0006449;GO:0006415;, C:cytoplasm; C:cytosol; C:translation release factor complex;, F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding; F:translation release factor activity; F:translation release factor activity, codon specific; F:translation termination factor activity;, P:cytoplasmic translational termination; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translational termination;|P62495 B2R6B4 D3DQC1 P46055 Q5M7Z7 Q96CG1,Eukaryotic peptide chain release factor subunit 1,Protein Cl1;TB3-1;, PF03463;PF03464;PF03465;, GO:0005737;GO:0005829;GO:0018444;GO:0043022;GO:0003723;GO:1990825;GO:0003747;GO:0016149;GO:0008079;GO:0002184;GO:0000184;GO:0006479;GO:0006449;GO:0006415;, C:cytoplasm; C:cytosol; C:translation release factor complex;, F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding; F:translation release factor activity; F:translation release factor activity, codon specific; F:translation termination factor activity;, P:cytoplasmic translational termination; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translational termination;|P62495 B2R6B4 D3DQC1 P46055 Q5M7Z7 Q96CG1,Eukaryotic peptide chain release factor subunit 1,Protein Cl1;TB3-1;, PF03463;PF03464;PF03465;, GO:0005737;GO:0005829;GO:0018444;GO:0043022;GO:0003723;GO:1990825;GO:0003747;GO:0016149;GO:0008079;GO:0002184;GO:0000184;GO:0006479;GO:0006449;GO:0006415;, C:cytoplasm; C:cytosol; C:translation release factor complex;, F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding; F:translation release factor activity; F:translation release factor activity, codon specific; F:translation termination factor activity;, P:cytoplasmic translational termination; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translational termination; scaffold4 indexed_genome mRNA 6081436 6104548 . - . ID=transcript_940;P38646 B2RCM1 P30036 P31932 Q1HB43 Q53H23 Q6GU03 Q9BWB7 Q9UC56,Stress-70 protein, mitochondrial,75 kDa glucose-regulated protein;Heat shock 70 kDa protein 9;Mortalin;Peptide-binding protein 74;, PF00012;, GO:0005737;GO:0070062;GO:0005925;GO:0140275;GO:0005759;GO:0042645;GO:0005739;GO:0005730;GO:0001401;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0034620;GO:0051085;GO:0030218;GO:0007007;GO:0035722;GO:0016226;GO:0043066;GO:0045647;GO:1902037;GO:1903707;GO:0006611;GO:0042026;GO:0045646;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:MIB complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleolus; C:SAM complex;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:erythrocyte differentiation; P:inner mitochondrial membrane organization; P:interleukin-12-mediated signaling pathway; P:iron-sulfur cluster assembly; P:negative regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of hemopoiesis; P:protein export from nucleus; P:protein refolding; P:regulation of erythrocyte differentiation;|P38646 B2RCM1 P30036 P31932 Q1HB43 Q53H23 Q6GU03 Q9BWB7 Q9UC56,Stress-70 protein, mitochondrial,75 kDa glucose-regulated protein;Heat shock 70 kDa protein 9;Mortalin;Peptide-binding protein 74;, PF00012;, GO:0005737;GO:0070062;GO:0005925;GO:0140275;GO:0005759;GO:0042645;GO:0005739;GO:0005730;GO:0001401;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0034620;GO:0051085;GO:0030218;GO:0007007;GO:0035722;GO:0016226;GO:0043066;GO:0045647;GO:1902037;GO:1903707;GO:0006611;GO:0042026;GO:0045646;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:MIB complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleolus; C:SAM complex;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:erythrocyte differentiation; P:inner mitochondrial membrane organization; P:interleukin-12-mediated signaling pathway; P:iron-sulfur cluster assembly; P:negative regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of hemopoiesis; P:protein export from nucleus; P:protein refolding; P:regulation of erythrocyte differentiation;|P38646 B2RCM1 P30036 P31932 Q1HB43 Q53H23 Q6GU03 Q9BWB7 Q9UC56,Stress-70 protein, mitochondrial,75 kDa glucose-regulated protein;Heat shock 70 kDa protein 9;Mortalin;Peptide-binding protein 74;, PF00012;, GO:0005737;GO:0070062;GO:0005925;GO:0140275;GO:0005759;GO:0042645;GO:0005739;GO:0005730;GO:0001401;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0034620;GO:0051085;GO:0030218;GO:0007007;GO:0035722;GO:0016226;GO:0043066;GO:0045647;GO:1902037;GO:1903707;GO:0006611;GO:0042026;GO:0045646;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:MIB complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleolus; C:SAM complex;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:erythrocyte differentiation; P:inner mitochondrial membrane organization; P:interleukin-12-mediated signaling pathway; P:iron-sulfur cluster assembly; P:negative regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of hemopoiesis; P:protein export from nucleus; P:protein refolding; P:regulation of erythrocyte differentiation;|P38646 B2RCM1 P30036 P31932 Q1HB43 Q53H23 Q6GU03 Q9BWB7 Q9UC56,Stress-70 protein, mitochondrial,75 kDa glucose-regulated protein;Heat shock 70 kDa protein 9;Mortalin;Peptide-binding protein 74;, PF00012;, GO:0005737;GO:0070062;GO:0005925;GO:0140275;GO:0005759;GO:0042645;GO:0005739;GO:0005730;GO:0001401;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0034620;GO:0051085;GO:0030218;GO:0007007;GO:0035722;GO:0016226;GO:0043066;GO:0045647;GO:1902037;GO:1903707;GO:0006611;GO:0042026;GO:0045646;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:MIB complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleolus; C:SAM complex;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:erythrocyte differentiation; P:inner mitochondrial membrane organization; P:interleukin-12-mediated signaling pathway; P:iron-sulfur cluster assembly; P:negative regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of hemopoiesis; P:protein export from nucleus; P:protein refolding; P:regulation of erythrocyte differentiation; scaffold4 indexed_genome mRNA 6262698 6436242 . + . ID=transcript_941;P35221 Q12795 Q8N1C0,Catenin alpha-1,Alpha E-catenin;Cadherin-associated protein;Renal carcinoma antigen NY-REN-13;, PF01044;, GO:0001669;GO:0015629;GO:0016342;GO:0030054;GO:0005911;GO:0005829;GO:0016600;GO:0005925;GO:0014704;GO:0043231;GO:0030027;GO:0005886;GO:0005915;GO:0051015;GO:0008013;GO:0045296;GO:0045295;GO:0042802;GO:0003723;GO:0005198;GO:0017166;GO:0007015;GO:0034332;GO:0007568;GO:0043297;GO:0031103;GO:0007155;GO:0034613;GO:0071681;GO:0090136;GO:0007163;GO:0016264;GO:0008584;GO:2000146;GO:2001240;GO:2001045;GO:0007406;GO:1900181;GO:0042475;GO:0001541;GO:2001241;GO:0051149;GO:0045880;GO:0043627;, C:acrosomal vesicle; C:actin cytoskeleton; C:catenin complex; C:cell junction; C:cell-cell junction; C:cytosol; C:flotillin complex; C:focal adhesion; C:intercalated disc; C:intracellular membrane-bounded organelle; C:lamellipodium; C:plasma membrane; C:zonula adherens;, F:actin filament binding; F:beta-catenin binding; F:cadherin binding; F:gamma-catenin binding; F:identical protein binding; F:RNA binding; F:structural molecule activity; F:vinculin binding;, P:actin filament organization; P:adherens junction organization; P:aging; P:apical junction assembly; P:axon regeneration; P:cell adhesion; P:cellular protein localization; P:cellular response to indole-3-methanol; P:epithelial cell-cell adhesion; P:establishment or maintenance of cell polarity; P:gap junction assembly; P:male gonad development; P:negative regulation of cell motility; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of integrin-mediated signaling pathway; P:negative regulation of neuroblast proliferation; P:negative regulation of protein localization to nucleus; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of muscle cell differentiation; P:positive regulation of smoothened signaling pathway; P:response to estrogen;|O43300 A0AVL3 A8K4U9 B7ZLN8 Q7L770,Leucine-rich repeat transmembrane neuronal protein 2,Leucine-rich repeat neuronal 2 protein;, PF13855;, GO:0060076;GO:0005615;GO:0098982;GO:0098978;GO:0098686;GO:0099061;GO:0099060;GO:0098685;GO:0042043;GO:0060291;GO:0002091;GO:0051965;GO:0099151;GO:0050808;, C:excitatory synapse; C:extracellular space; C:GABA-ergic synapse; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of postsynaptic density membrane; C:integral component of postsynaptic specialization membrane; C:Schaffer collateral - CA1 synapse;, F:neurexin family protein binding;, P:long-term synaptic potentiation; P:negative regulation of receptor internalization; P:positive regulation of synapse assembly; P:regulation of postsynaptic density assembly; P:synapse organization;|P35221 Q12795 Q8N1C0,Catenin alpha-1,Alpha E-catenin;Cadherin-associated protein;Renal carcinoma antigen NY-REN-13;, PF01044;, GO:0001669;GO:0015629;GO:0016342;GO:0030054;GO:0005911;GO:0005829;GO:0016600;GO:0005925;GO:0014704;GO:0043231;GO:0030027;GO:0005886;GO:0005915;GO:0051015;GO:0008013;GO:0045296;GO:0045295;GO:0042802;GO:0003723;GO:0005198;GO:0017166;GO:0007015;GO:0034332;GO:0007568;GO:0043297;GO:0031103;GO:0007155;GO:0034613;GO:0071681;GO:0090136;GO:0007163;GO:0016264;GO:0008584;GO:2000146;GO:2001240;GO:2001045;GO:0007406;GO:1900181;GO:0042475;GO:0001541;GO:2001241;GO:0051149;GO:0045880;GO:0043627;, C:acrosomal vesicle; C:actin cytoskeleton; C:catenin complex; C:cell junction; C:cell-cell junction; C:cytosol; C:flotillin complex; C:focal adhesion; C:intercalated disc; C:intracellular membrane-bounded organelle; C:lamellipodium; C:plasma membrane; C:zonula adherens;, F:actin filament binding; F:beta-catenin binding; F:cadherin binding; F:gamma-catenin binding; F:identical protein binding; F:RNA binding; F:structural molecule activity; F:vinculin binding;, P:actin filament organization; P:adherens junction organization; P:aging; P:apical junction assembly; P:axon regeneration; P:cell adhesion; P:cellular protein localization; P:cellular response to indole-3-methanol; P:epithelial cell-cell adhesion; P:establishment or maintenance of cell polarity; P:gap junction assembly; P:male gonad development; P:negative regulation of cell motility; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of integrin-mediated signaling pathway; P:negative regulation of neuroblast proliferation; P:negative regulation of protein localization to nucleus; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of muscle cell differentiation; P:positive regulation of smoothened signaling pathway; P:response to estrogen;|P35221 Q12795 Q8N1C0,Catenin alpha-1,Alpha E-catenin;Cadherin-associated protein;Renal carcinoma antigen NY-REN-13;, PF01044;, GO:0001669;GO:0015629;GO:0016342;GO:0030054;GO:0005911;GO:0005829;GO:0016600;GO:0005925;GO:0014704;GO:0043231;GO:0030027;GO:0005886;GO:0005915;GO:0051015;GO:0008013;GO:0045296;GO:0045295;GO:0042802;GO:0003723;GO:0005198;GO:0017166;GO:0007015;GO:0034332;GO:0007568;GO:0043297;GO:0031103;GO:0007155;GO:0034613;GO:0071681;GO:0090136;GO:0007163;GO:0016264;GO:0008584;GO:2000146;GO:2001240;GO:2001045;GO:0007406;GO:1900181;GO:0042475;GO:0001541;GO:2001241;GO:0051149;GO:0045880;GO:0043627;, C:acrosomal vesicle; C:actin cytoskeleton; C:catenin complex; C:cell junction; C:cell-cell junction; C:cytosol; C:flotillin complex; C:focal adhesion; C:intercalated disc; C:intracellular membrane-bounded organelle; C:lamellipodium; C:plasma membrane; C:zonula adherens;, F:actin filament binding; F:beta-catenin binding; F:cadherin binding; F:gamma-catenin binding; F:identical protein binding; F:RNA binding; F:structural molecule activity; F:vinculin binding;, P:actin filament organization; P:adherens junction organization; P:aging; P:apical junction assembly; P:axon regeneration; P:cell adhesion; P:cellular protein localization; P:cellular response to indole-3-methanol; P:epithelial cell-cell adhesion; P:establishment or maintenance of cell polarity; P:gap junction assembly; P:male gonad development; P:negative regulation of cell motility; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of integrin-mediated signaling pathway; P:negative regulation of neuroblast proliferation; P:negative regulation of protein localization to nucleus; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of muscle cell differentiation; P:positive regulation of smoothened signaling pathway; P:response to estrogen;|P35221 Q12795 Q8N1C0,Catenin alpha-1,Alpha E-catenin;Cadherin-associated protein;Renal carcinoma antigen NY-REN-13;, PF01044;, GO:0001669;GO:0015629;GO:0016342;GO:0030054;GO:0005911;GO:0005829;GO:0016600;GO:0005925;GO:0014704;GO:0043231;GO:0030027;GO:0005886;GO:0005915;GO:0051015;GO:0008013;GO:0045296;GO:0045295;GO:0042802;GO:0003723;GO:0005198;GO:0017166;GO:0007015;GO:0034332;GO:0007568;GO:0043297;GO:0031103;GO:0007155;GO:0034613;GO:0071681;GO:0090136;GO:0007163;GO:0016264;GO:0008584;GO:2000146;GO:2001240;GO:2001045;GO:0007406;GO:1900181;GO:0042475;GO:0001541;GO:2001241;GO:0051149;GO:0045880;GO:0043627;, C:acrosomal vesicle; C:actin cytoskeleton; C:catenin complex; C:cell junction; C:cell-cell junction; C:cytosol; C:flotillin complex; C:focal adhesion; C:intercalated disc; C:intracellular membrane-bounded organelle; C:lamellipodium; C:plasma membrane; C:zonula adherens;, F:actin filament binding; F:beta-catenin binding; F:cadherin binding; F:gamma-catenin binding; F:identical protein binding; F:RNA binding; F:structural molecule activity; F:vinculin binding;, P:actin filament organization; P:adherens junction organization; P:aging; P:apical junction assembly; P:axon regeneration; P:cell adhesion; P:cellular protein localization; P:cellular response to indole-3-methanol; P:epithelial cell-cell adhesion; P:establishment or maintenance of cell polarity; P:gap junction assembly; P:male gonad development; P:negative regulation of cell motility; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of integrin-mediated signaling pathway; P:negative regulation of neuroblast proliferation; P:negative regulation of protein localization to nucleus; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of muscle cell differentiation; P:positive regulation of smoothened signaling pathway; P:response to estrogen;|P35221 Q12795 Q8N1C0,Catenin alpha-1,Alpha E-catenin;Cadherin-associated protein;Renal carcinoma antigen NY-REN-13;, PF01044;, GO:0001669;GO:0015629;GO:0016342;GO:0030054;GO:0005911;GO:0005829;GO:0016600;GO:0005925;GO:0014704;GO:0043231;GO:0030027;GO:0005886;GO:0005915;GO:0051015;GO:0008013;GO:0045296;GO:0045295;GO:0042802;GO:0003723;GO:0005198;GO:0017166;GO:0007015;GO:0034332;GO:0007568;GO:0043297;GO:0031103;GO:0007155;GO:0034613;GO:0071681;GO:0090136;GO:0007163;GO:0016264;GO:0008584;GO:2000146;GO:2001240;GO:2001045;GO:0007406;GO:1900181;GO:0042475;GO:0001541;GO:2001241;GO:0051149;GO:0045880;GO:0043627;, C:acrosomal vesicle; C:actin cytoskeleton; C:catenin complex; C:cell junction; C:cell-cell junction; C:cytosol; C:flotillin complex; C:focal adhesion; C:intercalated disc; C:intracellular membrane-bounded organelle; C:lamellipodium; C:plasma membrane; C:zonula adherens;, F:actin filament binding; F:beta-catenin binding; F:cadherin binding; F:gamma-catenin binding; F:identical protein binding; F:RNA binding; F:structural molecule activity; F:vinculin binding;, P:actin filament organization; P:adherens junction organization; P:aging; P:apical junction assembly; P:axon regeneration; P:cell adhesion; P:cellular protein localization; P:cellular response to indole-3-methanol; P:epithelial cell-cell adhesion; P:establishment or maintenance of cell polarity; P:gap junction assembly; P:male gonad development; P:negative regulation of cell motility; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of integrin-mediated signaling pathway; P:negative regulation of neuroblast proliferation; P:negative regulation of protein localization to nucleus; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of muscle cell differentiation; P:positive regulation of smoothened signaling pathway; P:response to estrogen;|P35221 Q12795 Q8N1C0,Catenin alpha-1,Alpha E-catenin;Cadherin-associated protein;Renal carcinoma antigen NY-REN-13;, PF01044;, GO:0001669;GO:0015629;GO:0016342;GO:0030054;GO:0005911;GO:0005829;GO:0016600;GO:0005925;GO:0014704;GO:0043231;GO:0030027;GO:0005886;GO:0005915;GO:0051015;GO:0008013;GO:0045296;GO:0045295;GO:0042802;GO:0003723;GO:0005198;GO:0017166;GO:0007015;GO:0034332;GO:0007568;GO:0043297;GO:0031103;GO:0007155;GO:0034613;GO:0071681;GO:0090136;GO:0007163;GO:0016264;GO:0008584;GO:2000146;GO:2001240;GO:2001045;GO:0007406;GO:1900181;GO:0042475;GO:0001541;GO:2001241;GO:0051149;GO:0045880;GO:0043627;, C:acrosomal vesicle; C:actin cytoskeleton; C:catenin complex; C:cell junction; C:cell-cell junction; C:cytosol; C:flotillin complex; C:focal adhesion; C:intercalated disc; C:intracellular membrane-bounded organelle; C:lamellipodium; C:plasma membrane; C:zonula adherens;, F:actin filament binding; F:beta-catenin binding; F:cadherin binding; F:gamma-catenin binding; F:identical protein binding; F:RNA binding; F:structural molecule activity; F:vinculin binding;, P:actin filament organization; P:adherens junction organization; P:aging; P:apical junction assembly; P:axon regeneration; P:cell adhesion; P:cellular protein localization; P:cellular response to indole-3-methanol; P:epithelial cell-cell adhesion; P:establishment or maintenance of cell polarity; P:gap junction assembly; P:male gonad development; P:negative regulation of cell motility; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of integrin-mediated signaling pathway; P:negative regulation of neuroblast proliferation; P:negative regulation of protein localization to nucleus; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of muscle cell differentiation; P:positive regulation of smoothened signaling pathway; P:response to estrogen; scaffold4 indexed_genome mRNA 6438189 6619676 . - . ID=transcript_942;Q9H173 D3DQC2 Q8N2L3,Nucleotide exchange factor SIL1,BiP-associated protein;, , GO:0005783;GO:0005788;GO:0005615;GO:0000774;GO:0051082;GO:0006613;GO:0006886;GO:0006457;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space;, F:adenyl-nucleotide exchange factor activity; F:unfolded protein binding;, P:cotranslational protein targeting to membrane; P:intracellular protein transport; P:protein folding; scaffold4 indexed_genome mRNA 6747535 6774800 . + . ID=transcript_943;P43243 B7ZAV5 D3DQC3 Q9UHW0 Q9UQ27,Matrin-3,, , GO:0016020;GO:0005637;GO:0016363;GO:0005634;GO:0042802;GO:0035198;GO:0003723;GO:0005198;GO:0008270;GO:0002218;GO:0003170;GO:0045087;GO:0010608;GO:0003281;, C:membrane; C:nuclear inner membrane; C:nuclear matrix; C:nucleus;, F:identical protein binding; F:miRNA binding; F:RNA binding; F:structural molecule activity; F:zinc ion binding;, P:activation of innate immune response; P:heart valve development; P:innate immune response; P:posttranscriptional regulation of gene expression; P:ventricular septum development;|P43243 B7ZAV5 D3DQC3 Q9UHW0 Q9UQ27,Matrin-3,, , GO:0016020;GO:0005637;GO:0016363;GO:0005634;GO:0042802;GO:0035198;GO:0003723;GO:0005198;GO:0008270;GO:0002218;GO:0003170;GO:0045087;GO:0010608;GO:0003281;, C:membrane; C:nuclear inner membrane; C:nuclear matrix; C:nucleus;, F:identical protein binding; F:miRNA binding; F:RNA binding; F:structural molecule activity; F:zinc ion binding;, P:activation of innate immune response; P:heart valve development; P:innate immune response; P:posttranscriptional regulation of gene expression; P:ventricular septum development;|P43243 B7ZAV5 D3DQC3 Q9UHW0 Q9UQ27,Matrin-3,, , GO:0016020;GO:0005637;GO:0016363;GO:0005634;GO:0042802;GO:0035198;GO:0003723;GO:0005198;GO:0008270;GO:0002218;GO:0003170;GO:0045087;GO:0010608;GO:0003281;, C:membrane; C:nuclear inner membrane; C:nuclear matrix; C:nucleus;, F:identical protein binding; F:miRNA binding; F:RNA binding; F:structural molecule activity; F:zinc ion binding;, P:activation of innate immune response; P:heart valve development; P:innate immune response; P:posttranscriptional regulation of gene expression; P:ventricular septum development;|P43243 B7ZAV5 D3DQC3 Q9UHW0 Q9UQ27,Matrin-3,, , GO:0016020;GO:0005637;GO:0016363;GO:0005634;GO:0042802;GO:0035198;GO:0003723;GO:0005198;GO:0008270;GO:0002218;GO:0003170;GO:0045087;GO:0010608;GO:0003281;, C:membrane; C:nuclear inner membrane; C:nuclear matrix; C:nucleus;, F:identical protein binding; F:miRNA binding; F:RNA binding; F:structural molecule activity; F:zinc ion binding;, P:activation of innate immune response; P:heart valve development; P:innate immune response; P:posttranscriptional regulation of gene expression; P:ventricular septum development;|P43243 B7ZAV5 D3DQC3 Q9UHW0 Q9UQ27,Matrin-3,, , GO:0016020;GO:0005637;GO:0016363;GO:0005634;GO:0042802;GO:0035198;GO:0003723;GO:0005198;GO:0008270;GO:0002218;GO:0003170;GO:0045087;GO:0010608;GO:0003281;, C:membrane; C:nuclear inner membrane; C:nuclear matrix; C:nucleus;, F:identical protein binding; F:miRNA binding; F:RNA binding; F:structural molecule activity; F:zinc ion binding;, P:activation of innate immune response; P:heart valve development; P:innate immune response; P:posttranscriptional regulation of gene expression; P:ventricular septum development; scaffold4 indexed_genome mRNA 6793854 6799874 . + . ID=transcript_944;Q9BPZ3 B2RBI1 D3DQC6 Q49A06 Q9H0Y5 Q9P0Q8,Polyadenylate-binding protein-interacting protein 2,, PF07145;, GO:0005737;GO:0003729;GO:0030371;GO:0000900;GO:0007613;GO:0017148;GO:0045947;GO:1900271;GO:0007283;, C:cytoplasm;, F:mRNA binding; F:translation repressor activity; F:translation repressor activity, mRNA regulatory element binding;, P:memory; P:negative regulation of translation; P:negative regulation of translational initiation; P:regulation of long-term synaptic potentiation; P:spermatogenesis;|Q9BPZ3 B2RBI1 D3DQC6 Q49A06 Q9H0Y5 Q9P0Q8,Polyadenylate-binding protein-interacting protein 2,, PF07145;, GO:0005737;GO:0003729;GO:0030371;GO:0000900;GO:0007613;GO:0017148;GO:0045947;GO:1900271;GO:0007283;, C:cytoplasm;, F:mRNA binding; F:translation repressor activity; F:translation repressor activity, mRNA regulatory element binding;, P:memory; P:negative regulation of translation; P:negative regulation of translational initiation; P:regulation of long-term synaptic potentiation; P:spermatogenesis; scaffold4 indexed_genome mRNA 6800962 6810723 . - . ID=transcript_945;Q9UHI7 O95191 Q8WWB6 Q9UGH4 Q9UI39,Solute carrier family 23 member 1,Na(+)/L-ascorbic acid transporter 1;Sodium-dependent vitamin C transporter 1;Yolk sac permease-like molecule 3;, PF00860;, GO:0016324;GO:0009925;GO:0005737;GO:0070062;GO:0005887;GO:0043229;GO:0005886;GO:0033300;GO:0008520;GO:0015229;GO:0015205;GO:0015081;GO:0007420;GO:0070837;GO:0019852;GO:0015882;GO:0030324;GO:0015851;GO:0009636;GO:0006814;GO:0070904;, C:apical plasma membrane; C:basal plasma membrane; C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular organelle; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:L-ascorbate:sodium symporter activity; F:L-ascorbic acid transmembrane transporter activity; F:nucleobase transmembrane transporter activity; F:sodium ion transmembrane transporter activity;, P:brain development; P:dehydroascorbic acid transport; P:L-ascorbic acid metabolic process; P:L-ascorbic acid transmembrane transport; P:lung development; P:nucleobase transport; P:response to toxic substance; P:sodium ion transport; P:transepithelial L-ascorbic acid transport; scaffold4 indexed_genome mRNA 6811946 6816434 . - . ID=transcript_946;Q8WU39 D2IYS0 Q7Z6N2 Q96RL5 Q9P0T3,Marginal zone B- and B1-cell-specific protein,Mesenteric estrogen-dependent adipose 7;Plasma cell-induced resident endoplasmic reticulum protein;Proapoptotic caspase adapter protein;, PF11938;, GO:0005737;GO:0034663;GO:0005788;GO:0005576;GO:0006915;GO:0033622;GO:0008284;GO:0002639;GO:0030888;GO:0042127;GO:0046626;, C:cytoplasm; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:extracellular region;, , P:apoptotic process; P:integrin activation; P:positive regulation of cell population proliferation; P:positive regulation of immunoglobulin production; P:regulation of B cell proliferation; P:regulation of cell population proliferation; P:regulation of insulin receptor signaling pathway;|Q8WU39 D2IYS0 Q7Z6N2 Q96RL5 Q9P0T3,Marginal zone B- and B1-cell-specific protein,Mesenteric estrogen-dependent adipose 7;Plasma cell-induced resident endoplasmic reticulum protein;Proapoptotic caspase adapter protein;, PF11938;, GO:0005737;GO:0034663;GO:0005788;GO:0005576;GO:0006915;GO:0033622;GO:0008284;GO:0002639;GO:0030888;GO:0042127;GO:0046626;, C:cytoplasm; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:extracellular region;, , P:apoptotic process; P:integrin activation; P:positive regulation of cell population proliferation; P:positive regulation of immunoglobulin production; P:regulation of B cell proliferation; P:regulation of cell population proliferation; P:regulation of insulin receptor signaling pathway;|Q8WU39 D2IYS0 Q7Z6N2 Q96RL5 Q9P0T3,Marginal zone B- and B1-cell-specific protein,Mesenteric estrogen-dependent adipose 7;Plasma cell-induced resident endoplasmic reticulum protein;Proapoptotic caspase adapter protein;, PF11938;, GO:0005737;GO:0034663;GO:0005788;GO:0005576;GO:0006915;GO:0033622;GO:0008284;GO:0002639;GO:0030888;GO:0042127;GO:0046626;, C:cytoplasm; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:extracellular region;, , P:apoptotic process; P:integrin activation; P:positive regulation of cell population proliferation; P:positive regulation of immunoglobulin production; P:regulation of B cell proliferation; P:regulation of cell population proliferation; P:regulation of insulin receptor signaling pathway; scaffold4 indexed_genome mRNA 6816452 6819639 . - . ID=transcript_947;E7EW31 B4E007,Proline-rich basic protein 1,, PF15232;, GO:0005654;, C:nucleoplasm; scaffold4 indexed_genome mRNA 6820867 6828820 . - . ID=transcript_948;Q86W54,Spermatogenesis-associated protein 24,Testis protein T6441 homolog;, PF15175;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0030154;GO:0007275;GO:0007283;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell differentiation; P:multicellular organism development; P:spermatogenesis;|Q86W54,Spermatogenesis-associated protein 24,Testis protein T6441 homolog;, PF15175;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0030154;GO:0007275;GO:0007283;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell differentiation; P:multicellular organism development; P:spermatogenesis;|Q86W54,Spermatogenesis-associated protein 24,Testis protein T6441 homolog;, PF15175;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0030154;GO:0007275;GO:0007283;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell differentiation; P:multicellular organism development; P:spermatogenesis; scaffold4 indexed_genome mRNA 6830660 6844533 . + . ID=transcript_949;Q9H819,DnaJ homolog subfamily C member 18,, PF00226;PF09320;, GO:0005789;GO:0016021;GO:0030544;GO:0071218;GO:0051085;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:Hsp70 protein binding;, P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway;|Q9H819,DnaJ homolog subfamily C member 18,, PF00226;PF09320;, GO:0005789;GO:0016021;GO:0030544;GO:0071218;GO:0051085;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:Hsp70 protein binding;, P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway;|Q9H819,DnaJ homolog subfamily C member 18,, PF00226;PF09320;, GO:0005789;GO:0016021;GO:0030544;GO:0071218;GO:0051085;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:Hsp70 protein binding;, P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway;|Q9H819,DnaJ homolog subfamily C member 18,, PF00226;PF09320;, GO:0005789;GO:0016021;GO:0030544;GO:0071218;GO:0051085;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:Hsp70 protein binding;, P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway;|Q9H819,DnaJ homolog subfamily C member 18,, PF00226;PF09320;, GO:0005789;GO:0016021;GO:0030544;GO:0071218;GO:0051085;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:Hsp70 protein binding;, P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway; scaffold4 indexed_genome mRNA 6845352 6846872 . + . ID=transcript_950;Q9H819,DnaJ homolog subfamily C member 18,, PF00226;PF09320;, GO:0005789;GO:0016021;GO:0030544;GO:0071218;GO:0051085;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:Hsp70 protein binding;, P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway; scaffold4 indexed_genome mRNA 6857280 6857892 . + . ID=transcript_951;Q9H819,DnaJ homolog subfamily C member 18,, PF00226;PF09320;, GO:0005789;GO:0016021;GO:0030544;GO:0071218;GO:0051085;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:Hsp70 protein binding;, P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ubiquitin-dependent ERAD pathway; scaffold4 indexed_genome mRNA 6867850 6875843 . - . ID=transcript_952;Q19T08 B4E3H7 C3RSF2,Endothelial cell-specific chemotaxis regulator,Apoptosis regulator through modulating IAP expression;Endothelial cell-specific molecule 2;, PF15820;, GO:0005829;GO:0016021;GO:0043231;GO:0005654;GO:0005886;GO:0001525;GO:0006915;GO:0030154;GO:0006935;GO:0016525;GO:2000353;GO:1901800;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, , P:angiogenesis; P:apoptotic process; P:cell differentiation; P:chemotaxis; P:negative regulation of angiogenesis; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of proteasomal protein catabolic process;|Q19T08 B4E3H7 C3RSF2,Endothelial cell-specific chemotaxis regulator,Apoptosis regulator through modulating IAP expression;Endothelial cell-specific molecule 2;, PF15820;, GO:0005829;GO:0016021;GO:0043231;GO:0005654;GO:0005886;GO:0001525;GO:0006915;GO:0030154;GO:0006935;GO:0016525;GO:2000353;GO:1901800;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, , P:angiogenesis; P:apoptotic process; P:cell differentiation; P:chemotaxis; P:negative regulation of angiogenesis; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of proteasomal protein catabolic process; scaffold4 indexed_genome mRNA 6882699 6888392 . - . ID=transcript_953;Q86WV6 A8K3P6 B6EB35 D6RBX0 D6RE01 D6RID9,Stimulator of interferon genes protein {ECO:0000303|PubMed:18724357},Endoplasmic reticulum interferon stimulator {ECO:0000303|PubMed:19433799};Mediator of IRF3 activation {ECO:0000303|PubMed:18818105, ECO:0000303|PubMed:19285439};Transmembrane protein 173 {ECO:0000305};, PF15009;, GO:0005776;GO:0000421;GO:0030659;GO:0005829;GO:0005789;GO:0005768;GO:0005794;GO:0030176;GO:1990701;GO:0005741;GO:0005654;GO:0048471;GO:0005777;GO:0005886;GO:0030667;GO:0035438;GO:0061507;GO:0042802;GO:0042803;GO:0019901;GO:0008134;GO:0031625;GO:0002218;GO:0000045;GO:0071360;GO:0035458;GO:0071407;GO:0051607;GO:0045087;GO:0043312;GO:0002230;GO:0051091;GO:0032728;GO:0016239;GO:0032092;GO:0045944;GO:0032481;GO:0051259;GO:0050727;GO:0032479;GO:0061709;GO:0016032;, C:autophagosome; C:autophagosome membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:endoplasmic reticulum membrane; C:endosome; C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane; C:mitochondrial outer membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:peroxisome; C:plasma membrane; C:secretory granule membrane;, F:cyclic-di-GMP binding; F:cyclic-GMP-AMP binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:activation of innate immune response; P:autophagosome assembly; P:cellular response to exogenous dsRNA; P:cellular response to interferon-beta; P:cellular response to organic cyclic compound; P:defense response to virus; P:innate immune response; P:neutrophil degranulation; P:positive regulation of defense response to virus by host; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of interferon-beta production; P:positive regulation of macroautophagy; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:protein complex oligomerization; P:regulation of inflammatory response; P:regulation of type I interferon production; P:reticulophagy; P:viral process;|Q86WV6 A8K3P6 B6EB35 D6RBX0 D6RE01 D6RID9,Stimulator of interferon genes protein {ECO:0000303|PubMed:18724357},Endoplasmic reticulum interferon stimulator {ECO:0000303|PubMed:19433799};Mediator of IRF3 activation {ECO:0000303|PubMed:18818105, ECO:0000303|PubMed:19285439};Transmembrane protein 173 {ECO:0000305};, PF15009;, GO:0005776;GO:0000421;GO:0030659;GO:0005829;GO:0005789;GO:0005768;GO:0005794;GO:0030176;GO:1990701;GO:0005741;GO:0005654;GO:0048471;GO:0005777;GO:0005886;GO:0030667;GO:0035438;GO:0061507;GO:0042802;GO:0042803;GO:0019901;GO:0008134;GO:0031625;GO:0002218;GO:0000045;GO:0071360;GO:0035458;GO:0071407;GO:0051607;GO:0045087;GO:0043312;GO:0002230;GO:0051091;GO:0032728;GO:0016239;GO:0032092;GO:0045944;GO:0032481;GO:0051259;GO:0050727;GO:0032479;GO:0061709;GO:0016032;, C:autophagosome; C:autophagosome membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:endoplasmic reticulum membrane; C:endosome; C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane; C:mitochondrial outer membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:peroxisome; C:plasma membrane; C:secretory granule membrane;, F:cyclic-di-GMP binding; F:cyclic-GMP-AMP binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:activation of innate immune response; P:autophagosome assembly; P:cellular response to exogenous dsRNA; P:cellular response to interferon-beta; P:cellular response to organic cyclic compound; P:defense response to virus; P:innate immune response; P:neutrophil degranulation; P:positive regulation of defense response to virus by host; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of interferon-beta production; P:positive regulation of macroautophagy; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:protein complex oligomerization; P:regulation of inflammatory response; P:regulation of type I interferon production; P:reticulophagy; P:viral process; scaffold4 indexed_genome mRNA 6964992 6966253 . + . ID=transcript_954;P62837 D3DQC9 P51669 Q3MN78 Q96RP6,Ubiquitin-conjugating enzyme E2 D2,(E3-independent) E2 ubiquitin-conjugating enzyme D2;E2 ubiquitin-conjugating enzyme D2;Ubiquitin carrier protein D2;Ubiquitin-conjugating enzyme E2(17)KB 2;Ubiquitin-conjugating enzyme E2-17 kDa 2;Ubiquitin-protein ligase D2;p53-regulated ubiquitin-conjugating enzyme 1;, PF00179;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0000151;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006464;GO:0002756;GO:0051865;GO:0070936;GO:0008104;GO:0000209;GO:0016567;GO:0035666;GO:0006511;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:MyD88-independent toll-like receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 6966543 6969929 . + . ID=transcript_955;P62837 D3DQC9 P51669 Q3MN78 Q96RP6,Ubiquitin-conjugating enzyme E2 D2,(E3-independent) E2 ubiquitin-conjugating enzyme D2;E2 ubiquitin-conjugating enzyme D2;Ubiquitin carrier protein D2;Ubiquitin-conjugating enzyme E2(17)KB 2;Ubiquitin-conjugating enzyme E2-17 kDa 2;Ubiquitin-protein ligase D2;p53-regulated ubiquitin-conjugating enzyme 1;, PF00179;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0000151;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006464;GO:0002756;GO:0051865;GO:0070936;GO:0008104;GO:0000209;GO:0016567;GO:0035666;GO:0006511;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:MyD88-independent toll-like receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 6973148 6977105 . + . ID=transcript_956;P62837 D3DQC9 P51669 Q3MN78 Q96RP6,Ubiquitin-conjugating enzyme E2 D2,(E3-independent) E2 ubiquitin-conjugating enzyme D2;E2 ubiquitin-conjugating enzyme D2;Ubiquitin carrier protein D2;Ubiquitin-conjugating enzyme E2(17)KB 2;Ubiquitin-conjugating enzyme E2-17 kDa 2;Ubiquitin-protein ligase D2;p53-regulated ubiquitin-conjugating enzyme 1;, PF00179;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0000151;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006464;GO:0002756;GO:0051865;GO:0070936;GO:0008104;GO:0000209;GO:0016567;GO:0035666;GO:0006511;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:MyD88-independent toll-like receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 7028856 7032425 . - . ID=transcript_957;Q7LFL8 B3KND0 C8CBA8 Q8TB79 Q9NV51 Q9P0S8,CXXC-type zinc finger protein 5,Putative MAPK-activating protein PM08;Putative NF-kappa-B-activating protein 102;Retinoid-inducible nuclear factor;, PF02008;, GO:0005829;GO:0005654;GO:0005634;GO:0008327;GO:0043565;GO:0008134;GO:0008270;GO:0000122;GO:0043123;, C:cytosol; C:nucleoplasm; C:nucleus;, F:methyl-CpG binding; F:sequence-specific DNA binding; F:transcription factor binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold4 indexed_genome mRNA 7134214 7173535 . + . ID=transcript_958;Q9BQI7 D3DQD3 Q8N3J8,PH and SEC7 domain-containing protein 2,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 C;Pleckstrin homology and SEC7 domain-containing protein 2;, PF15410;PF01369;, GO:0032154;GO:0030425;GO:0098978;GO:0016021;GO:0043025;GO:0098794;GO:0032587;GO:0005085;GO:0005543;GO:0032012;, C:cleavage furrow; C:dendrite; C:glutamatergic synapse; C:integral component of membrane; C:neuronal cell body; C:postsynapse; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:regulation of ARF protein signal transduction;|Q9BQI7 D3DQD3 Q8N3J8,PH and SEC7 domain-containing protein 2,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 C;Pleckstrin homology and SEC7 domain-containing protein 2;, PF15410;PF01369;, GO:0032154;GO:0030425;GO:0098978;GO:0016021;GO:0043025;GO:0098794;GO:0032587;GO:0005085;GO:0005543;GO:0032012;, C:cleavage furrow; C:dendrite; C:glutamatergic synapse; C:integral component of membrane; C:neuronal cell body; C:postsynapse; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:regulation of ARF protein signal transduction;|Q9BQI7 D3DQD3 Q8N3J8,PH and SEC7 domain-containing protein 2,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 C;Pleckstrin homology and SEC7 domain-containing protein 2;, PF15410;PF01369;, GO:0032154;GO:0030425;GO:0098978;GO:0016021;GO:0043025;GO:0098794;GO:0032587;GO:0005085;GO:0005543;GO:0032012;, C:cleavage furrow; C:dendrite; C:glutamatergic synapse; C:integral component of membrane; C:neuronal cell body; C:postsynapse; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:regulation of ARF protein signal transduction; scaffold4 indexed_genome mRNA 7183277 7362841 . - . ID=transcript_959;O14511,Pro-neuregulin-2, membrane-bound isoform,, PF07679;PF02158;, GO:0005576;GO:0005615;GO:0016021;GO:0005886;GO:0008083;GO:0005102;GO:0048513;GO:0038128;GO:0035556;GO:0000165;GO:0007399;GO:0051897;GO:2000145;GO:0007165;, C:extracellular region; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:growth factor activity; F:signaling receptor binding;, P:animal organ development; P:ERBB2 signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:nervous system development; P:positive regulation of protein kinase B signaling; P:regulation of cell motility; P:signal transduction;|O14511,Pro-neuregulin-2, membrane-bound isoform,, PF07679;PF02158;, GO:0005576;GO:0005615;GO:0016021;GO:0005886;GO:0008083;GO:0005102;GO:0048513;GO:0038128;GO:0035556;GO:0000165;GO:0007399;GO:0051897;GO:2000145;GO:0007165;, C:extracellular region; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:growth factor activity; F:signaling receptor binding;, P:animal organ development; P:ERBB2 signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:nervous system development; P:positive regulation of protein kinase B signaling; P:regulation of cell motility; P:signal transduction; scaffold4 indexed_genome mRNA 7391326 7393012 . + . ID=transcript_960;Q96DA6 B2R4B1 C9JBV1,Mitochondrial import inner membrane translocase subunit TIM14,DnaJ homolog subfamily C member 19;, PF00226;, GO:0098800;GO:0016021;GO:0099617;GO:0005743;GO:0005739;GO:0001405;GO:0032991;GO:0001671;GO:0048806;GO:0006457;GO:0030150;GO:0006626;GO:1900208;GO:0007601;, C:inner mitochondrial membrane protein complex; C:integral component of membrane; C:matrix side of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:PAM complex, Tim23 associated import motor; C:protein-containing complex;, F:ATPase activator activity;, P:genitalia development; P:protein folding; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:regulation of cardiolipin metabolic process; P:visual perception; scaffold4 indexed_genome mRNA 7441770 7445866 . - . ID=transcript_961;Q00577,Transcriptional activator protein Pur-alpha,Purine-rich single-stranded DNA-binding protein alpha;, PF04845;, GO:0000781;GO:0032839;GO:0098978;GO:0043025;GO:0005634;GO:0098794;GO:0000981;GO:0003691;GO:0032422;GO:0003723;GO:0000977;GO:0003697;GO:0046332;GO:0008134;GO:0000900;GO:0030154;GO:0098963;GO:0006270;GO:0006268;GO:0050673;GO:0046651;GO:0000122;GO:0007399;GO:0008284;GO:0006357;, C:chromosome, telomeric region; C:dendrite cytoplasm; C:glutamatergic synapse; C:neuronal cell body; C:nucleus; C:postsynapse;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded telomeric DNA binding; F:purine-rich negative regulatory element binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:SMAD binding; F:transcription factor binding; F:translation repressor activity, mRNA regulatory element binding;, P:cell differentiation; P:dendritic transport of messenger ribonucleoprotein complex; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:epithelial cell proliferation; P:lymphocyte proliferation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; scaffold4 indexed_genome mRNA 7453416 7456282 . - . ID=transcript_962;A6NJ69,IgA-inducing protein homolog,, , GO:0005576;, C:extracellular region; scaffold4 indexed_genome mRNA 7529535 7575136 . + . ID=transcript_963;Q9H1C7 Q8TBA5,Cysteine-rich and transmembrane domain-containing protein 1,, PF12734;, GO:0070062;GO:0016021;GO:0005886;GO:0070821;GO:0043312;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane; C:tertiary granule membrane;, , P:neutrophil degranulation; scaffold4 indexed_genome mRNA 7575936 7653529 . - . ID=transcript_964;O60925 B2RD02 Q53F95 Q96EX6,Prefoldin subunit 1,, PF01920;, GO:0005737;GO:0016272;GO:0001540;GO:0044183;GO:0051082;GO:1905907;GO:0006457;, C:cytoplasm; C:prefoldin complex;, F:amyloid-beta binding; F:protein folding chaperone; F:unfolded protein binding;, P:negative regulation of amyloid fibril formation; P:protein folding; scaffold4 indexed_genome mRNA 7676038 7688334 . - . ID=transcript_965;Q99075 B2R821,Proheparin-binding EGF-like growth factor,, PF00008;, GO:0009986;GO:0030669;GO:0030666;GO:0005576;GO:0005615;GO:0005887;GO:0005886;GO:0005154;GO:0008083;GO:0008201;GO:0060326;GO:0007173;GO:0038128;GO:0000165;GO:0061024;GO:0007517;GO:0051545;GO:0042059;GO:0030307;GO:0030335;GO:0008284;GO:0045741;GO:0051549;GO:0051897;GO:0048661;GO:0090303;GO:2000145;GO:0008016;GO:0007165;GO:0035313;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:epidermal growth factor receptor binding; F:growth factor activity; F:heparin binding;, P:cell chemotaxis; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:MAPK cascade; P:membrane organization; P:muscle organ development; P:negative regulation of elastin biosynthetic process; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of keratinocyte migration; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of wound healing; P:regulation of cell motility; P:regulation of heart contraction; P:signal transduction; P:wound healing, spreading of epidermal cells;|Q99075 B2R821,Proheparin-binding EGF-like growth factor,, PF00008;, GO:0009986;GO:0030669;GO:0030666;GO:0005576;GO:0005615;GO:0005887;GO:0005886;GO:0005154;GO:0008083;GO:0008201;GO:0060326;GO:0007173;GO:0038128;GO:0000165;GO:0061024;GO:0007517;GO:0051545;GO:0042059;GO:0030307;GO:0030335;GO:0008284;GO:0045741;GO:0051549;GO:0051897;GO:0048661;GO:0090303;GO:2000145;GO:0008016;GO:0007165;GO:0035313;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:epidermal growth factor receptor binding; F:growth factor activity; F:heparin binding;, P:cell chemotaxis; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:MAPK cascade; P:membrane organization; P:muscle organ development; P:negative regulation of elastin biosynthetic process; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of keratinocyte migration; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of wound healing; P:regulation of cell motility; P:regulation of heart contraction; P:signal transduction; P:wound healing, spreading of epidermal cells;|Q99075 B2R821,Proheparin-binding EGF-like growth factor,, PF00008;, GO:0009986;GO:0030669;GO:0030666;GO:0005576;GO:0005615;GO:0005887;GO:0005886;GO:0005154;GO:0008083;GO:0008201;GO:0060326;GO:0007173;GO:0038128;GO:0000165;GO:0061024;GO:0007517;GO:0051545;GO:0042059;GO:0030307;GO:0030335;GO:0008284;GO:0045741;GO:0051549;GO:0051897;GO:0048661;GO:0090303;GO:2000145;GO:0008016;GO:0007165;GO:0035313;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:epidermal growth factor receptor binding; F:growth factor activity; F:heparin binding;, P:cell chemotaxis; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:MAPK cascade; P:membrane organization; P:muscle organ development; P:negative regulation of elastin biosynthetic process; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of keratinocyte migration; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of wound healing; P:regulation of cell motility; P:regulation of heart contraction; P:signal transduction; P:wound healing, spreading of epidermal cells;|Q99075 B2R821,Proheparin-binding EGF-like growth factor,, PF00008;, GO:0009986;GO:0030669;GO:0030666;GO:0005576;GO:0005615;GO:0005887;GO:0005886;GO:0005154;GO:0008083;GO:0008201;GO:0060326;GO:0007173;GO:0038128;GO:0000165;GO:0061024;GO:0007517;GO:0051545;GO:0042059;GO:0030307;GO:0030335;GO:0008284;GO:0045741;GO:0051549;GO:0051897;GO:0048661;GO:0090303;GO:2000145;GO:0008016;GO:0007165;GO:0035313;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:epidermal growth factor receptor binding; F:growth factor activity; F:heparin binding;, P:cell chemotaxis; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:MAPK cascade; P:membrane organization; P:muscle organ development; P:negative regulation of elastin biosynthetic process; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of keratinocyte migration; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of wound healing; P:regulation of cell motility; P:regulation of heart contraction; P:signal transduction; P:wound healing, spreading of epidermal cells;|Q99075 B2R821,Proheparin-binding EGF-like growth factor,, PF00008;, GO:0009986;GO:0030669;GO:0030666;GO:0005576;GO:0005615;GO:0005887;GO:0005886;GO:0005154;GO:0008083;GO:0008201;GO:0060326;GO:0007173;GO:0038128;GO:0000165;GO:0061024;GO:0007517;GO:0051545;GO:0042059;GO:0030307;GO:0030335;GO:0008284;GO:0045741;GO:0051549;GO:0051897;GO:0048661;GO:0090303;GO:2000145;GO:0008016;GO:0007165;GO:0035313;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:epidermal growth factor receptor binding; F:growth factor activity; F:heparin binding;, P:cell chemotaxis; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:MAPK cascade; P:membrane organization; P:muscle organ development; P:negative regulation of elastin biosynthetic process; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of keratinocyte migration; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of wound healing; P:regulation of cell motility; P:regulation of heart contraction; P:signal transduction; P:wound healing, spreading of epidermal cells; scaffold4 indexed_genome mRNA 7709747 7710933 . - . ID=transcript_966;Q96Q91 B7ZL63 D3DQD4 D3DQD5 D3DQD6 E9PDK1 Q96RM5 Q9BXF2 Q9BXN3,Anion exchange protein 4,Sodium bicarbonate cotransporter 5;Solute carrier family 4 member 9;, PF07565;PF00955;, GO:0045177;GO:0016323;GO:0016021;GO:0005886;GO:0015301;GO:0005452;GO:0008510;GO:0022857;GO:0015701;GO:0050801;GO:0051453;GO:0055085;, C:apical part of cell; C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport; scaffold4 indexed_genome mRNA 7711869 7712729 . - . ID=transcript_967;Q96Q91 B7ZL63 D3DQD4 D3DQD5 D3DQD6 E9PDK1 Q96RM5 Q9BXF2 Q9BXN3,Anion exchange protein 4,Sodium bicarbonate cotransporter 5;Solute carrier family 4 member 9;, PF07565;PF00955;, GO:0045177;GO:0016323;GO:0016021;GO:0005886;GO:0015301;GO:0005452;GO:0008510;GO:0022857;GO:0015701;GO:0050801;GO:0051453;GO:0055085;, C:apical part of cell; C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport; scaffold4 indexed_genome mRNA 7712923 7713678 . - . ID=transcript_968;Q9BY07 Q32MA7 Q59EQ9 Q8WXD3 Q8WXD7 Q96DS7 Q96DS8 Q9HBU5,Electrogenic sodium bicarbonate cotransporter 4,NBCe2;Solute carrier family 4 member 5;, PF07565;PF00955;, GO:0016324;GO:0016021;GO:0005886;GO:0015301;GO:0005452;GO:0008510;GO:0022857;GO:0015701;GO:0033326;GO:0002064;GO:0050801;GO:0048311;GO:0010468;GO:0051453;GO:0003073;GO:0003014;GO:0060041;GO:0055085;, C:apical plasma membrane; C:integral component of membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:cerebrospinal fluid secretion; P:epithelial cell development; P:ion homeostasis; P:mitochondrion distribution; P:regulation of gene expression; P:regulation of intracellular pH; P:regulation of systemic arterial blood pressure; P:renal system process; P:retina development in camera-type eye; P:transmembrane transport; scaffold4 indexed_genome mRNA 7752163 7856915 . + . ID=transcript_969;Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response;|Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response;|Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response;|Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response;|Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response;|Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response;|Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response;|Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response;|Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response;|Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response; scaffold4 indexed_genome mRNA 7857013 7879045 . + . ID=transcript_970;Q9NWG4 Q9UPR7,Ankyrin repeat and KH domain-containing protein 1,HIV-1 Vpr-binding ankyrin repeat protein;Multiple ankyrin repeats single KH domain;, PF12796;PF00013;, GO:0005737;GO:0003723;GO:0045087;, C:cytoplasm;, F:RNA binding;, P:innate immune response;|Q9HD15 Q6NVU9 Q8IXM1 Q9HD13 Q9HD14,Steroid receptor RNA activator 1,Steroid receptor RNA activator protein;, PF07304;, GO:0031252;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0005886;GO:1990904;GO:0031209;GO:0005667;GO:0003677;GO:0030374;GO:0002153;GO:0003713;GO:0006915;GO:0030154;GO:0071391;GO:0045662;GO:0042981;GO:0007346;, C:cell leading edge; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ribonucleoprotein complex; C:SCAR complex; C:transcription regulator complex;, F:DNA binding; F:nuclear receptor coactivator activity; F:steroid receptor RNA activator RNA binding; F:transcription coactivator activity;, P:apoptotic process; P:cell differentiation; P:cellular response to estrogen stimulus; P:negative regulation of myoblast differentiation; P:regulation of apoptotic process; P:regulation of mitotic cell cycle;|O60516,Eukaryotic translation initiation factor 4E-binding protein 3,, PF05456;, GO:0005737;GO:0016281;GO:0016020;GO:0008190;GO:0030371;GO:0045947;, C:cytoplasm; C:eukaryotic translation initiation factor 4F complex; C:membrane;, F:eukaryotic initiation factor 4E binding; F:translation repressor activity;, P:negative regulation of translational initiation;|Q9HD15 Q6NVU9 Q8IXM1 Q9HD13 Q9HD14,Steroid receptor RNA activator 1,Steroid receptor RNA activator protein;, PF07304;, GO:0031252;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0005886;GO:1990904;GO:0031209;GO:0005667;GO:0003677;GO:0030374;GO:0002153;GO:0003713;GO:0006915;GO:0030154;GO:0071391;GO:0045662;GO:0042981;GO:0007346;, C:cell leading edge; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ribonucleoprotein complex; C:SCAR complex; C:transcription regulator complex;, F:DNA binding; F:nuclear receptor coactivator activity; F:steroid receptor RNA activator RNA binding; F:transcription coactivator activity;, P:apoptotic process; P:cell differentiation; P:cellular response to estrogen stimulus; P:negative regulation of myoblast differentiation; P:regulation of apoptotic process; P:regulation of mitotic cell cycle;|O95704 B3KQN9 Q08AG4 Q96Q18 Q9BYD4 Q9NYX6 Q9NYX7 Q9NYX8,Amyloid-beta A4 precursor protein-binding family B member 3,Protein Fe65-like 2;, PF00640;, GO:0015629;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0001540;GO:0050750;GO:0008134;GO:0050714;GO:0006355;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:amyloid-beta binding; F:low-density lipoprotein particle receptor binding; F:transcription factor binding;, P:positive regulation of protein secretion; P:regulation of transcription, DNA-templated;|O95704 B3KQN9 Q08AG4 Q96Q18 Q9BYD4 Q9NYX6 Q9NYX7 Q9NYX8,Amyloid-beta A4 precursor protein-binding family B member 3,Protein Fe65-like 2;, PF00640;, GO:0015629;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0001540;GO:0050750;GO:0008134;GO:0050714;GO:0006355;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:amyloid-beta binding; F:low-density lipoprotein particle receptor binding; F:transcription factor binding;, P:positive regulation of protein secretion; P:regulation of transcription, DNA-templated;|O95704 B3KQN9 Q08AG4 Q96Q18 Q9BYD4 Q9NYX6 Q9NYX7 Q9NYX8,Amyloid-beta A4 precursor protein-binding family B member 3,Protein Fe65-like 2;, PF00640;, GO:0015629;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0001540;GO:0050750;GO:0008134;GO:0050714;GO:0006355;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:amyloid-beta binding; F:low-density lipoprotein particle receptor binding; F:transcription factor binding;, P:positive regulation of protein secretion; P:regulation of transcription, DNA-templated;|O95704 B3KQN9 Q08AG4 Q96Q18 Q9BYD4 Q9NYX6 Q9NYX7 Q9NYX8,Amyloid-beta A4 precursor protein-binding family B member 3,Protein Fe65-like 2;, PF00640;, GO:0015629;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0001540;GO:0050750;GO:0008134;GO:0050714;GO:0006355;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:amyloid-beta binding; F:low-density lipoprotein particle receptor binding; F:transcription factor binding;, P:positive regulation of protein secretion; P:regulation of transcription, DNA-templated;|O95704 B3KQN9 Q08AG4 Q96Q18 Q9BYD4 Q9NYX6 Q9NYX7 Q9NYX8,Amyloid-beta A4 precursor protein-binding family B member 3,Protein Fe65-like 2;, PF00640;, GO:0015629;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0001540;GO:0050750;GO:0008134;GO:0050714;GO:0006355;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:amyloid-beta binding; F:low-density lipoprotein particle receptor binding; F:transcription factor binding;, P:positive regulation of protein secretion; P:regulation of transcription, DNA-templated; scaffold4 indexed_genome mRNA 7879194 7883940 . + . ID=transcript_971;Q96G79 A8K013,Probable UDP-sugar transporter protein SLC35A4 {ECO:0000305},Solute carrier family 35 member A4 {ECO:0000312|HGNC:HGNC:20753};, PF04142;, GO:0005794;GO:0030173;GO:0015165;GO:0008643;, C:Golgi apparatus; C:integral component of Golgi membrane;, F:pyrimidine nucleotide-sugar transmembrane transporter activity;, P:carbohydrate transport; scaffold4 indexed_genome mRNA 7900526 7904257 . - . ID=transcript_972;P08571 Q53XT5 Q96FR6 Q96L99 Q9UNS3,Monocyte differentiation antigen CD14 {ECO:0000303|PubMed:3385210},Myeloid cell-specific leucine-rich glycoprotein;, , GO:0031362;GO:0010008;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0046696;GO:0045121;GO:0005886;GO:0030667;GO:0071723;GO:0001530;GO:0070891;GO:0001847;GO:0016019;GO:0006915;GO:0097190;GO:0007166;GO:0071726;GO:0071222;GO:0071223;GO:0071219;GO:0071727;GO:0007249;GO:0006954;GO:0045087;GO:0031663;GO:0002755;GO:0002756;GO:0070266;GO:0034128;GO:0043312;GO:0006909;GO:0045807;GO:0032729;GO:0032757;GO:1901224;GO:0032760;GO:0032481;GO:0006898;GO:0051602;GO:0045471;GO:0009408;GO:0032026;GO:0034612;GO:0034142;GO:0002224;GO:0038123;GO:0038124;GO:0035666;, C:anchored component of external side of plasma membrane; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:lipopolysaccharide receptor complex; C:membrane raft; C:plasma membrane; C:secretory granule membrane;, F:lipopeptide binding; F:lipopolysaccharide binding; F:lipoteichoic acid binding; F:opsonin receptor activity; F:peptidoglycan immune receptor activity;, P:apoptotic process; P:apoptotic signaling pathway; P:cell surface receptor signaling pathway; P:cellular response to diacyl bacterial lipopeptide; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to molecule of bacterial origin; P:cellular response to triacyl bacterial lipopeptide; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:negative regulation of MyD88-independent toll-like receptor signaling pathway; P:neutrophil degranulation; P:phagocytosis; P:positive regulation of endocytosis; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-8 production; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:receptor-mediated endocytosis; P:response to electrical stimulus; P:response to ethanol; P:response to heat; P:response to magnesium ion; P:response to tumor necrosis factor; P:toll-like receptor 4 signaling pathway; P:toll-like receptor signaling pathway; P:toll-like receptor TLR1:TLR2 signaling pathway; P:toll-like receptor TLR6:TLR2 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; scaffold4 indexed_genome mRNA 7910660 7918547 . + . ID=transcript_973;Q96DC7 Q9BUU0 Q9P198,Transmembrane and coiled-coil domain-containing protein 6,, , GO:0016021;GO:0061608;GO:0006606;, C:integral component of membrane;, F:nuclear import signal receptor activity;, P:protein import into nucleus;|Q96DC7 Q9BUU0 Q9P198,Transmembrane and coiled-coil domain-containing protein 6,, , GO:0016021;GO:0061608;GO:0006606;, C:integral component of membrane;, F:nuclear import signal receptor activity;, P:protein import into nucleus;|Q96DC7 Q9BUU0 Q9P198,Transmembrane and coiled-coil domain-containing protein 6,, , GO:0016021;GO:0061608;GO:0006606;, C:integral component of membrane;, F:nuclear import signal receptor activity;, P:protein import into nucleus;|Q96DC7 Q9BUU0 Q9P198,Transmembrane and coiled-coil domain-containing protein 6,, , GO:0016021;GO:0061608;GO:0006606;, C:integral component of membrane;, F:nuclear import signal receptor activity;, P:protein import into nucleus;|Q96DC7 Q9BUU0 Q9P198,Transmembrane and coiled-coil domain-containing protein 6,, , GO:0016021;GO:0061608;GO:0006606;, C:integral component of membrane;, F:nuclear import signal receptor activity;, P:protein import into nucleus;|Q96DC7 Q9BUU0 Q9P198,Transmembrane and coiled-coil domain-containing protein 6,, , GO:0016021;GO:0061608;GO:0006606;, C:integral component of membrane;, F:nuclear import signal receptor activity;, P:protein import into nucleus;|O43678 D6RJD6 Q6IAY8,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2,Complex I-B8;NADH-ubiquinone oxidoreductase B8 subunit;, PF05047;, GO:0005743;GO:0031966;GO:0005747;GO:0008137;GO:0001835;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:blastocyst hatching; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O43678 D6RJD6 Q6IAY8,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2,Complex I-B8;NADH-ubiquinone oxidoreductase B8 subunit;, PF05047;, GO:0005743;GO:0031966;GO:0005747;GO:0008137;GO:0001835;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:blastocyst hatching; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold4 indexed_genome mRNA 7918712 7930807 . + . ID=transcript_974;Q13123 Q6IPD8,Protein Red {ECO:0000303|PubMed:10216252},Cytokine IK {ECO:0000303|PubMed:7970704};IK factor {ECO:0000303|PubMed:7970704};Protein RER;, PF07807;PF07808;, GO:0005694;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0000922;GO:0071005;GO:0042802;GO:0000278;GO:0007094;GO:0000398;GO:0034501;GO:0016032;, C:chromosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spindle pole; C:U2-type precatalytic spliceosome;, F:identical protein binding;, P:mitotic cell cycle; P:mitotic spindle assembly checkpoint; P:mRNA splicing, via spliceosome; P:protein localization to kinetochore; P:viral process;|Q13123 Q6IPD8,Protein Red {ECO:0000303|PubMed:10216252},Cytokine IK {ECO:0000303|PubMed:7970704};IK factor {ECO:0000303|PubMed:7970704};Protein RER;, PF07807;PF07808;, GO:0005694;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0000922;GO:0071005;GO:0042802;GO:0000278;GO:0007094;GO:0000398;GO:0034501;GO:0016032;, C:chromosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spindle pole; C:U2-type precatalytic spliceosome;, F:identical protein binding;, P:mitotic cell cycle; P:mitotic spindle assembly checkpoint; P:mRNA splicing, via spliceosome; P:protein localization to kinetochore; P:viral process;|Q13123 Q6IPD8,Protein Red {ECO:0000303|PubMed:10216252},Cytokine IK {ECO:0000303|PubMed:7970704};IK factor {ECO:0000303|PubMed:7970704};Protein RER;, PF07807;PF07808;, GO:0005694;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0000922;GO:0071005;GO:0042802;GO:0000278;GO:0007094;GO:0000398;GO:0034501;GO:0016032;, C:chromosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spindle pole; C:U2-type precatalytic spliceosome;, F:identical protein binding;, P:mitotic cell cycle; P:mitotic spindle assembly checkpoint; P:mRNA splicing, via spliceosome; P:protein localization to kinetochore; P:viral process; scaffold4 indexed_genome mRNA 7933796 7954244 . + . ID=transcript_975;Q9H6Y2 Q9NXK4,WD repeat-containing protein 55,, PF12894;PF00400;, GO:0005737;GO:0005730;GO:0005654;GO:0006364;, C:cytoplasm; C:nucleolus; C:nucleoplasm;, , P:rRNA processing;|Q9H6Y2 Q9NXK4,WD repeat-containing protein 55,, PF12894;PF00400;, GO:0005737;GO:0005730;GO:0005654;GO:0006364;, C:cytoplasm; C:nucleolus; C:nucleoplasm;, , P:rRNA processing;|Q9H6Y2 Q9NXK4,WD repeat-containing protein 55,, PF12894;PF00400;, GO:0005737;GO:0005730;GO:0005654;GO:0006364;, C:cytoplasm; C:nucleolus; C:nucleoplasm;, , P:rRNA processing;|P12081 B4DHQ1 B4DY73 D6REN6 J3KNE5,Histidine--tRNA ligase, cytoplasmic,Histidyl-tRNA synthetase;, PF03129;PF13393;PF00458;, GO:0005737;GO:0005829;GO:0005739;GO:0005524;GO:0004821;GO:0042802;GO:0042803;GO:0006427;GO:0032543;GO:0006412;GO:0006418;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:ATP binding; F:histidine-tRNA ligase activity; F:identical protein binding; F:protein homodimerization activity;, P:histidyl-tRNA aminoacylation; P:mitochondrial translation; P:translation; P:tRNA aminoacylation for protein translation;|P12081 B4DHQ1 B4DY73 D6REN6 J3KNE5,Histidine--tRNA ligase, cytoplasmic,Histidyl-tRNA synthetase;, PF03129;PF13393;PF00458;, GO:0005737;GO:0005829;GO:0005739;GO:0005524;GO:0004821;GO:0042802;GO:0042803;GO:0006427;GO:0032543;GO:0006412;GO:0006418;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:ATP binding; F:histidine-tRNA ligase activity; F:identical protein binding; F:protein homodimerization activity;, P:histidyl-tRNA aminoacylation; P:mitochondrial translation; P:translation; P:tRNA aminoacylation for protein translation; scaffold4 indexed_genome mRNA 7954468 7961358 . - . ID=transcript_976;P49590 B4DDY8,Histidine--tRNA ligase, mitochondrial,Histidine--tRNA ligase-like;Histidyl-tRNA synthetase;, PF03129;PF13393;, GO:0005829;GO:0005759;GO:0005739;GO:0005524;GO:0004821;GO:0042802;GO:0003723;GO:0006427;GO:0006412;GO:0006418;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:histidine-tRNA ligase activity; F:identical protein binding; F:RNA binding;, P:histidyl-tRNA aminoacylation; P:translation; P:tRNA aminoacylation for protein translation;|P49590 B4DDY8,Histidine--tRNA ligase, mitochondrial,Histidine--tRNA ligase-like;Histidyl-tRNA synthetase;, PF03129;PF13393;, GO:0005829;GO:0005759;GO:0005739;GO:0005524;GO:0004821;GO:0042802;GO:0003723;GO:0006427;GO:0006412;GO:0006418;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:histidine-tRNA ligase activity; F:identical protein binding; F:RNA binding;, P:histidyl-tRNA aminoacylation; P:translation; P:tRNA aminoacylation for protein translation;|P49590 B4DDY8,Histidine--tRNA ligase, mitochondrial,Histidine--tRNA ligase-like;Histidyl-tRNA synthetase;, PF03129;PF13393;, GO:0005829;GO:0005759;GO:0005739;GO:0005524;GO:0004821;GO:0042802;GO:0003723;GO:0006427;GO:0006412;GO:0006418;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:histidine-tRNA ligase activity; F:identical protein binding; F:RNA binding;, P:histidyl-tRNA aminoacylation; P:translation; P:tRNA aminoacylation for protein translation; scaffold4 indexed_genome mRNA 7962454 7969181 . + . ID=transcript_977;Q96NC0,Zinc finger matrin-type protein 2,, PF12171;, GO:0005634;GO:0071005;GO:0046540;GO:0003677;GO:0008270;GO:0000398;, C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:DNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome;|Q96NC0,Zinc finger matrin-type protein 2,, PF12171;, GO:0005634;GO:0071005;GO:0046540;GO:0003677;GO:0008270;GO:0000398;, C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:DNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome;|Q96NC0,Zinc finger matrin-type protein 2,, PF12171;, GO:0005634;GO:0071005;GO:0046540;GO:0003677;GO:0008270;GO:0000398;, C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:DNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; scaffold4 indexed_genome mRNA 8035791 8036501 . - . ID=transcript_978;Q9UN74 O75285 Q2M253,Protocadherin alpha-4 {ECO:0000305},, PF00028;PF08266;PF15974;, GO:0005887;GO:0005509;GO:0042802;GO:0007155;GO:0007156;GO:0007399;, C:integral component of plasma membrane;, F:calcium ion binding; F:identical protein binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; scaffold4 indexed_genome mRNA 8036568 8037551 . - . ID=transcript_979;Q9Y5H7 O75284 Q8N4R3,Protocadherin alpha-5,, PF00028;PF08266;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0007399;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; scaffold4 indexed_genome mRNA 8071193 8071888 . - . ID=transcript_980;Q9UN72 O75282,Protocadherin alpha-7 {ECO:0000305},, PF00028;PF08266;PF15974;, GO:0005887;GO:0005509;GO:0042802;GO:0007155;GO:0009988;GO:0007156;GO:0007399;, C:integral component of plasma membrane;, F:calcium ion binding; F:identical protein binding;, P:cell adhesion; P:cell-cell recognition; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; scaffold4 indexed_genome mRNA 8130279 8131020 . - . ID=transcript_981;Q9H158 Q9Y5F5 Q9Y5I5,Protocadherin alpha-C1,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0007399;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; scaffold4 indexed_genome mRNA 8167526 8170352 . + . ID=transcript_982;Q9Y5I4 Q2M3V1 Q9Y5F4,Protocadherin alpha-C2,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0007399;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; scaffold4 indexed_genome mRNA 8181905 8216226 . + . ID=transcript_983;Q9Y5H9 O75287 Q9BTV3,Protocadherin alpha-2,, PF00028;PF08266;PF15974;, GO:0005783;GO:0005887;GO:0005634;GO:0005509;GO:0007155;GO:0007156;GO:0007399;, C:endoplasmic reticulum; C:integral component of plasma membrane; C:nucleus;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; scaffold4 indexed_genome mRNA 8219694 8283491 . + . ID=transcript_984;Q9Y5F3 Q2M257,Protocadherin beta-1,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5F3 Q2M257,Protocadherin beta-1,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5F3 Q2M257,Protocadherin beta-1,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 8329523 8446377 . - . ID=transcript_985;Q9Y5F0 A8K9V6,Protocadherin beta-13,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse assembly;|Q9Y5E7 Q4KMU1,Protocadherin beta-2,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007399;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; P:synapse assembly;|Q9Y5E5 Q4V761,Protocadherin beta-4,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007399;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; P:synapse assembly;|Q9Y5F2 B4DSF7 Q2M223,Protocadherin beta-11,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007399;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; P:synapse assembly;|Q9Y5E5 Q4V761,Protocadherin beta-4,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007399;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; P:synapse assembly;|Q9Y5E3 B2R8R9,Protocadherin beta-6 {ECO:0000305},, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0042802;GO:0016339;GO:0007155;GO:0009988;GO:0007268;GO:0007156;GO:0007399;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding; F:identical protein binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:cell-cell recognition; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; P:synapse assembly;|Q9Y5E2 A1L3Y8,Protocadherin beta-7,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5F1 B4DDU1,Protocadherin beta-12,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0007399;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development;|Q9Y5E9 B4DPE2 Q4FZA4 Q4KN11,Protocadherin beta-14,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse assembly;|Q9Y5E9 B4DPE2 Q4FZA4 Q4KN11,Protocadherin beta-14,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse assembly;|Q9Y5F2 B4DSF7 Q2M223,Protocadherin beta-11,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007399;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; P:synapse assembly;|Q96TA0 B3KTF8,Putative protocadherin beta-18,PCDH-psi2;, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 8446382 8450551 . - . ID=transcript_986;Q3KP31 B7Z586 Q8NC99,Zinc finger protein 791,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold4 indexed_genome mRNA 8487993 8490346 . + . ID=transcript_987;Q15545 B2RBV9 Q13036,Transcription initiation factor TFIID subunit 7,RNA polymerase II TBP-associated factor subunit F;Transcription initiation factor TFIID 55 kDa subunit;, PF04658;, GO:0005737;GO:0071339;GO:0005654;GO:0005669;GO:0033276;GO:0005667;GO:0035035;GO:0106140;GO:0046982;GO:0016251;GO:0001097;GO:0046966;GO:0008134;GO:0000976;GO:0042809;GO:0006352;GO:0030520;GO:0035067;GO:0090241;GO:0045344;GO:0045347;GO:0006469;GO:0000122;GO:0045892;GO:0045944;GO:1901796;GO:0006357;GO:0051123;GO:0000296;GO:0006366;GO:0006367;, C:cytoplasm; C:MLL1 complex; C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex; C:transcription regulator complex;, F:histone acetyltransferase binding; F:P-TEFb complex binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:TFIIH-class transcription factor complex binding; F:thyroid hormone receptor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:vitamin D receptor binding;, P:DNA-templated transcription, initiation; P:intracellular estrogen receptor signaling pathway; P:negative regulation of histone acetylation; P:negative regulation of histone H4 acetylation; P:negative regulation of MHC class I biosynthetic process; P:negative regulation of MHC class II biosynthetic process; P:negative regulation of protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:RNA polymerase II preinitiation complex assembly; P:spermine transport; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold4 indexed_genome mRNA 8503100 8505418 . - . ID=transcript_988;Q9Y5H4 Q2M273 Q9Y5D6,Protocadherin gamma-A1,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 8507650 8508219 . - . ID=transcript_989;Q9Y3B9,RRP15-like protein,Ribosomal RNA-processing protein 15;, PF07890;, GO:0030687;GO:0000460;GO:0000470;, C:preribosome, large subunit precursor;, , P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; scaffold4 indexed_genome mRNA 8509531 8513659 . + . ID=transcript_990;Q9Y5H1 Q52LL6 Q9Y5D5,Protocadherin gamma-A2,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5H4 Q2M273 Q9Y5D6,Protocadherin gamma-A1,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 8524318 8526315 . - . ID=transcript_991;Q9Y5G9 A0A087WT05 A0A087WTI2 Q9Y5D3,Protocadherin gamma-A4,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0007283;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:spermatogenesis; scaffold4 indexed_genome mRNA 8533486 8535956 . + . ID=transcript_992;Q9Y5G8 Q2M3F5 Q9Y5D2,Protocadherin gamma-A5,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5H0 Q9Y5D4,Protocadherin gamma-A3,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0008333;GO:0007156;GO:0060989;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:endosome to lysosome transport; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:lipid tube assembly involved in organelle fusion; scaffold4 indexed_genome mRNA 8542844 8544347 . - . ID=transcript_993;Q9Y5G7 A6H8K7 B2RN55 Q9Y5D1,Protocadherin gamma-A6,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 8547743 8549397 . + . ID=transcript_994;Q9Y5G0 Q52LK8 Q9Y5C6,Protocadherin gamma-B5,, PF00028;PF08266;PF16492;PF15974;, GO:0070062;GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:extracellular exosome; C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9UN71 O15099 Q2M267 Q9UN64,Protocadherin gamma-B4,Cadherin-20;Fibroblast cadherin-2;, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0016020;GO:0005509;GO:0016339;GO:0007155;GO:0007156;, C:integral component of plasma membrane; C:membrane;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 8555034 8555622 . - . ID=transcript_995;Q9Y5G5 A7MCZ4 O15039,Protocadherin gamma-A8,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 8558182 8559376 . - . ID=transcript_996;Q9Y5G0 Q52LK8 Q9Y5C6,Protocadherin gamma-B5,, PF00028;PF08266;PF16492;PF15974;, GO:0070062;GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:extracellular exosome; C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 8564670 8565248 . - . ID=transcript_997;Q9Y5H3 Q9Y5E0,Protocadherin gamma-A10,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 8570536 8675164 . - . ID=transcript_998;Q9Y5H3 Q9Y5E0,Protocadherin gamma-A10,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5H3 Q9Y5E0,Protocadherin gamma-A10,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5H2 B7ZVY8 Q9Y5D8 Q9Y5D9,Protocadherin gamma-A11,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5G2 Q3MIJ3 Q9UN65,Protocadherin gamma-B2,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|O60330 O15100 Q6UW70 Q9Y5D7,Protocadherin gamma-A12,Cadherin-21;Fibroblast cadherin-3;, PF00028;PF08266;PF16492;PF15974;, GO:0005911;GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:cell-cell junction; C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9UN70 O60622 Q08192 Q9Y5C4,Protocadherin gamma-C3,Protocadherin-2;Protocadherin-43;, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0016020;GO:0005509;GO:0016339;GO:0007155;GO:0007156;GO:0050808;, C:integral component of plasma membrane; C:membrane;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse organization;|Q9Y5H3 Q9Y5E0,Protocadherin gamma-A10,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5F7 Q495T2 Q9Y5C3,Protocadherin gamma-C4,, PF00028;PF08266;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0050808;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse organization;|Q9Y5F7 Q495T2 Q9Y5C3,Protocadherin gamma-C4,, PF00028;PF08266;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0050808;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse organization;|Q9Y5F6 Q9Y5C2,Protocadherin gamma-C5,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0050808;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse organization;|Q9Y5F6 Q9Y5C2,Protocadherin gamma-C5,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0050808;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse organization;|Q9UN71 O15099 Q2M267 Q9UN64,Protocadherin gamma-B4,Cadherin-20;Fibroblast cadherin-2;, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0016020;GO:0005509;GO:0016339;GO:0007155;GO:0007156;, C:integral component of plasma membrane; C:membrane;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5F9 Q9Y5C5,Protocadherin gamma-B6,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5H1 Q52LL6 Q9Y5D5,Protocadherin gamma-A2,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5H1 Q52LL6 Q9Y5D5,Protocadherin gamma-A2,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 8676765 8741701 . + . ID=transcript_999;O60610 A6NF18 B7ZKW2 E9PEZ2 Q17RN4 Q59FH8 Q9UC76,Protein diaphanous homolog 1,Diaphanous-related formin-1;, PF06345;PF06367;PF06371;PF02181;, GO:0005737;GO:0005829;GO:0101003;GO:0005815;GO:0072686;GO:0005634;GO:0005886;GO:0032587;GO:0030667;GO:0003779;GO:0044325;GO:0003723;GO:0005102;GO:0031267;GO:0030036;GO:0030041;GO:0071420;GO:0007010;GO:0043312;GO:0035372;GO:2000145;GO:0008360;GO:0051493;GO:0032886;GO:0051279;GO:0007605;, C:cytoplasm; C:cytosol; C:ficolin-1-rich granule membrane; C:microtubule organizing center; C:mitotic spindle; C:nucleus; C:plasma membrane; C:ruffle membrane; C:secretory granule membrane;, F:actin binding; F:ion channel binding; F:RNA binding; F:signaling receptor binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to histamine; P:cytoskeleton organization; P:neutrophil degranulation; P:protein localization to microtubule; P:regulation of cell motility; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of microtubule-based process; P:regulation of release of sequestered calcium ion into cytosol; P:sensory perception of sound;|O60610 A6NF18 B7ZKW2 E9PEZ2 Q17RN4 Q59FH8 Q9UC76,Protein diaphanous homolog 1,Diaphanous-related formin-1;, PF06345;PF06367;PF06371;PF02181;, GO:0005737;GO:0005829;GO:0101003;GO:0005815;GO:0072686;GO:0005634;GO:0005886;GO:0032587;GO:0030667;GO:0003779;GO:0044325;GO:0003723;GO:0005102;GO:0031267;GO:0030036;GO:0030041;GO:0071420;GO:0007010;GO:0043312;GO:0035372;GO:2000145;GO:0008360;GO:0051493;GO:0032886;GO:0051279;GO:0007605;, C:cytoplasm; C:cytosol; C:ficolin-1-rich granule membrane; C:microtubule organizing center; C:mitotic spindle; C:nucleus; C:plasma membrane; C:ruffle membrane; C:secretory granule membrane;, F:actin binding; F:ion channel binding; F:RNA binding; F:signaling receptor binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to histamine; P:cytoskeleton organization; P:neutrophil degranulation; P:protein localization to microtubule; P:regulation of cell motility; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of microtubule-based process; P:regulation of release of sequestered calcium ion into cytosol; P:sensory perception of sound; scaffold4 indexed_genome mRNA 8741736 8785315 . - . ID=transcript_1000;O60610 A6NF18 B7ZKW2 E9PEZ2 Q17RN4 Q59FH8 Q9UC76,Protein diaphanous homolog 1,Diaphanous-related formin-1;, PF06345;PF06367;PF06371;PF02181;, GO:0005737;GO:0005829;GO:0101003;GO:0005815;GO:0072686;GO:0005634;GO:0005886;GO:0032587;GO:0030667;GO:0003779;GO:0044325;GO:0003723;GO:0005102;GO:0031267;GO:0030036;GO:0030041;GO:0071420;GO:0007010;GO:0043312;GO:0035372;GO:2000145;GO:0008360;GO:0051493;GO:0032886;GO:0051279;GO:0007605;, C:cytoplasm; C:cytosol; C:ficolin-1-rich granule membrane; C:microtubule organizing center; C:mitotic spindle; C:nucleus; C:plasma membrane; C:ruffle membrane; C:secretory granule membrane;, F:actin binding; F:ion channel binding; F:RNA binding; F:signaling receptor binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to histamine; P:cytoskeleton organization; P:neutrophil degranulation; P:protein localization to microtubule; P:regulation of cell motility; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of microtubule-based process; P:regulation of release of sequestered calcium ion into cytosol; P:sensory perception of sound; scaffold4 indexed_genome mRNA 8787375 8792870 . - . ID=transcript_1001;O15379 D3DQE1 O43268 Q9UEI5 Q9UEV0,Histone deacetylase 3,RPD3-2;SMAP45;, PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0005886;GO:0017053;GO:0003682;GO:0030332;GO:0019899;GO:0004407;GO:0042826;GO:0032041;GO:0051059;GO:0033558;GO:0001226;GO:0003714;GO:0008134;GO:0071498;GO:0006325;GO:0032922;GO:0007623;GO:0070932;GO:0070933;GO:0030522;GO:0043066;GO:0046329;GO:0000122;GO:0045892;GO:0120162;GO:0042307;GO:0001934;GO:0031398;GO:0032008;GO:0045944;GO:0006476;GO:0042752;GO:0019216;GO:0031647;GO:0051225;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:transcription repressor complex;, F:chromatin binding; F:cyclin binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:protein deacetylase activity; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:cellular response to fluid shear stress; P:chromatin organization; P:circadian regulation of gene expression; P:circadian rhythm; P:histone H3 deacetylation; P:histone H4 deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein import into nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of TOR signaling; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of circadian rhythm; P:regulation of lipid metabolic process; P:regulation of protein stability; P:spindle assembly; P:transcription initiation from RNA polymerase II promoter;|O15379 D3DQE1 O43268 Q9UEI5 Q9UEV0,Histone deacetylase 3,RPD3-2;SMAP45;, PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0005886;GO:0017053;GO:0003682;GO:0030332;GO:0019899;GO:0004407;GO:0042826;GO:0032041;GO:0051059;GO:0033558;GO:0001226;GO:0003714;GO:0008134;GO:0071498;GO:0006325;GO:0032922;GO:0007623;GO:0070932;GO:0070933;GO:0030522;GO:0043066;GO:0046329;GO:0000122;GO:0045892;GO:0120162;GO:0042307;GO:0001934;GO:0031398;GO:0032008;GO:0045944;GO:0006476;GO:0042752;GO:0019216;GO:0031647;GO:0051225;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:transcription repressor complex;, F:chromatin binding; F:cyclin binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:protein deacetylase activity; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:cellular response to fluid shear stress; P:chromatin organization; P:circadian regulation of gene expression; P:circadian rhythm; P:histone H3 deacetylation; P:histone H4 deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein import into nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of TOR signaling; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of circadian rhythm; P:regulation of lipid metabolic process; P:regulation of protein stability; P:spindle assembly; P:transcription initiation from RNA polymerase II promoter;|O15379 D3DQE1 O43268 Q9UEI5 Q9UEV0,Histone deacetylase 3,RPD3-2;SMAP45;, PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0005886;GO:0017053;GO:0003682;GO:0030332;GO:0019899;GO:0004407;GO:0042826;GO:0032041;GO:0051059;GO:0033558;GO:0001226;GO:0003714;GO:0008134;GO:0071498;GO:0006325;GO:0032922;GO:0007623;GO:0070932;GO:0070933;GO:0030522;GO:0043066;GO:0046329;GO:0000122;GO:0045892;GO:0120162;GO:0042307;GO:0001934;GO:0031398;GO:0032008;GO:0045944;GO:0006476;GO:0042752;GO:0019216;GO:0031647;GO:0051225;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:transcription repressor complex;, F:chromatin binding; F:cyclin binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:protein deacetylase activity; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:cellular response to fluid shear stress; P:chromatin organization; P:circadian regulation of gene expression; P:circadian rhythm; P:histone H3 deacetylation; P:histone H4 deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein import into nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of TOR signaling; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of circadian rhythm; P:regulation of lipid metabolic process; P:regulation of protein stability; P:spindle assembly; P:transcription initiation from RNA polymerase II promoter; scaffold4 indexed_genome mRNA 8794881 8815561 . - . ID=transcript_1002;O15379 D3DQE1 O43268 Q9UEI5 Q9UEV0,Histone deacetylase 3,RPD3-2;SMAP45;, PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0005886;GO:0017053;GO:0003682;GO:0030332;GO:0019899;GO:0004407;GO:0042826;GO:0032041;GO:0051059;GO:0033558;GO:0001226;GO:0003714;GO:0008134;GO:0071498;GO:0006325;GO:0032922;GO:0007623;GO:0070932;GO:0070933;GO:0030522;GO:0043066;GO:0046329;GO:0000122;GO:0045892;GO:0120162;GO:0042307;GO:0001934;GO:0031398;GO:0032008;GO:0045944;GO:0006476;GO:0042752;GO:0019216;GO:0031647;GO:0051225;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:transcription repressor complex;, F:chromatin binding; F:cyclin binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:protein deacetylase activity; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:cellular response to fluid shear stress; P:chromatin organization; P:circadian regulation of gene expression; P:circadian rhythm; P:histone H3 deacetylation; P:histone H4 deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein import into nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of TOR signaling; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of circadian rhythm; P:regulation of lipid metabolic process; P:regulation of protein stability; P:spindle assembly; P:transcription initiation from RNA polymerase II promoter;|Q92769 B3KRS5 B4DL58 E1P561 Q5SRI8 Q5SZ86 Q8NEH4,Histone deacetylase 2 {ECO:0000305},, PF00850;, GO:0000785;GO:0005737;GO:0035098;GO:0000118;GO:0005654;GO:0005634;GO:0016581;GO:0032991;GO:0016580;GO:0003682;GO:0019213;GO:0019899;GO:0031072;GO:0004407;GO:0042826;GO:0032041;GO:0051059;GO:1990841;GO:0033558;GO:0003723;GO:0001103;GO:0043565;GO:0008134;GO:0043044;GO:0048149;GO:0007596;GO:0003300;GO:1903351;GO:0034605;GO:0070301;GO:0071300;GO:0071560;GO:0006338;GO:0032922;GO:0016358;GO:0042733;GO:0009913;GO:0061029;GO:0061198;GO:0060789;GO:0070829;GO:0016575;GO:0070932;GO:0070933;GO:0043066;GO:0061000;GO:0043392;GO:0043433;GO:0045347;GO:0010977;GO:2000757;GO:0000122;GO:0045892;GO:0042475;GO:0008284;GO:0032967;GO:0010718;GO:0032732;GO:1902437;GO:0048714;GO:0045862;GO:2000273;GO:0045944;GO:0045893;GO:0032760;GO:0042531;GO:1901796;GO:0001975;GO:0031000;GO:0042220;GO:0042493;GO:0055093;GO:0032496;GO:0035094;, C:chromatin; C:cytoplasm; C:ESC/E(Z) complex; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:NuRD complex; C:protein-containing complex; C:Sin3 complex;, F:chromatin binding; F:deacetylase activity; F:enzyme binding; F:heat shock protein binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:RNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:behavioral response to ethanol; P:blood coagulation; P:cardiac muscle hypertrophy; P:cellular response to dopamine; P:cellular response to heat; P:cellular response to hydrogen peroxide; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:chromatin remodeling; P:circadian regulation of gene expression; P:dendrite development; P:embryonic digit morphogenesis; P:epidermal cell differentiation; P:eyelid development in camera-type eye; P:fungiform papilla formation; P:hair follicle placode formation; P:heterochromatin maintenance; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation of apoptotic process; P:negative regulation of dendritic spine development; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of MHC class II biosynthetic process; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of interleukin-1 production; P:positive regulation of male mating behavior; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of proteolysis; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of signal transduction by p53 class mediator; P:response to amphetamine; P:response to caffeine; P:response to cocaine; P:response to drug; P:response to hyperoxia; P:response to lipopolysaccharide; P:response to nicotine;|Q86WN1 Q6UX75 Q86Y77 Q9NXX8,F-BAR and double SH3 domains protein 1,Protein nervous wreck 2 {ECO:0000250|UniProtKB:Q6PFY1};, PF00611;PF14604;, GO:0042995;GO:0032437;GO:0031594;GO:0043204;GO:0055037;GO:0008289;GO:0044803;GO:0007274;GO:0030838;GO:0030833;, C:cell projection; C:cuticular plate; C:neuromuscular junction; C:perikaryon; C:recycling endosome;, F:lipid binding;, P:multi-organism membrane organization; P:neuromuscular synaptic transmission; P:positive regulation of actin filament polymerization; P:regulation of actin filament polymerization;|Q86WN1 Q6UX75 Q86Y77 Q9NXX8,F-BAR and double SH3 domains protein 1,Protein nervous wreck 2 {ECO:0000250|UniProtKB:Q6PFY1};, PF00611;PF14604;, GO:0042995;GO:0032437;GO:0031594;GO:0043204;GO:0055037;GO:0008289;GO:0044803;GO:0007274;GO:0030838;GO:0030833;, C:cell projection; C:cuticular plate; C:neuromuscular junction; C:perikaryon; C:recycling endosome;, F:lipid binding;, P:multi-organism membrane organization; P:neuromuscular synaptic transmission; P:positive regulation of actin filament polymerization; P:regulation of actin filament polymerization; scaffold4 indexed_genome mRNA 8818325 8844464 . - . ID=transcript_1003;Q8WWN8 B4DIT1 D3DQE3,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3,Centaurin-delta-3;, PF01412;PF00169;PF00788;PF00620;PF07647;, GO:0005856;GO:0005829;GO:0030027;GO:0005886;GO:0001726;GO:0005096;GO:0046872;GO:0005547;GO:0043325;GO:0007010;GO:0051056;GO:0007165;GO:0016192;, C:cytoskeleton; C:cytosol; C:lamellipodium; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:vesicle-mediated transport;|Q8WWN8 B4DIT1 D3DQE3,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3,Centaurin-delta-3;, PF01412;PF00169;PF00788;PF00620;PF07647;, GO:0005856;GO:0005829;GO:0030027;GO:0005886;GO:0001726;GO:0005096;GO:0046872;GO:0005547;GO:0043325;GO:0007010;GO:0051056;GO:0007165;GO:0016192;, C:cytoskeleton; C:cytosol; C:lamellipodium; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:vesicle-mediated transport;|Q8WWN8 B4DIT1 D3DQE3,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3,Centaurin-delta-3;, PF01412;PF00169;PF00788;PF00620;PF07647;, GO:0005856;GO:0005829;GO:0030027;GO:0005886;GO:0001726;GO:0005096;GO:0046872;GO:0005547;GO:0043325;GO:0007010;GO:0051056;GO:0007165;GO:0016192;, C:cytoskeleton; C:cytosol; C:lamellipodium; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:vesicle-mediated transport;|Q8WWN8 B4DIT1 D3DQE3,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3,Centaurin-delta-3;, PF01412;PF00169;PF00788;PF00620;PF07647;, GO:0005856;GO:0005829;GO:0030027;GO:0005886;GO:0001726;GO:0005096;GO:0046872;GO:0005547;GO:0043325;GO:0007010;GO:0051056;GO:0007165;GO:0016192;, C:cytoskeleton; C:cytosol; C:lamellipodium; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:vesicle-mediated transport;|Q8WWN8 B4DIT1 D3DQE3,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3,Centaurin-delta-3;, PF01412;PF00169;PF00788;PF00620;PF07647;, GO:0005856;GO:0005829;GO:0030027;GO:0005886;GO:0001726;GO:0005096;GO:0046872;GO:0005547;GO:0043325;GO:0007010;GO:0051056;GO:0007165;GO:0016192;, C:cytoskeleton; C:cytosol; C:lamellipodium; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:vesicle-mediated transport; scaffold4 indexed_genome mRNA 9002232 9011161 . - . ID=transcript_1004;Q9HC56 A2A6U1 Q5VT83 Q7Z3U0 Q8N3K7,Protocadherin-9,, PF00028;PF08266;PF08374;, GO:0044291;GO:0030426;GO:0005887;GO:0005509;GO:0007155;GO:0030900;GO:0007156;, C:cell-cell contact zone; C:growth cone; C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:forebrain development; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 9012686 9019214 . - . ID=transcript_1005;Q08174 Q8IUP2,Protocadherin-1,Cadherin-like protein 1;Protocadherin-42;, PF00028;PF08266;PF08374;, GO:0030054;GO:0005911;GO:0005887;GO:0043231;GO:0005730;GO:0005654;GO:0005886;GO:0005509;GO:0007155;GO:0007267;GO:0007156;GO:0007399;, C:cell junction; C:cell-cell junction; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:cell-cell signaling; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; scaffold4 indexed_genome mRNA 9063196 9077158 . + . ID=transcript_1006;Q14154 Q969R4 Q96EU9,DAP3-binding cell death enhancer 1 {ECO:0000305},DAP3-binding cell death enhancer 1, long form {ECO:0000303|PubMed:32132707};Death ligand signal enhancer {ECO:0000303|PubMed:20563667};, PF08238;, GO:0005829;GO:0005743;GO:0005739;GO:0019901;GO:0043539;GO:0008625;GO:0140468;GO:0140467;GO:0043281;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrion;, F:protein kinase binding; F:protein serine/threonine kinase activator activity;, P:extrinsic apoptotic signaling pathway via death domain receptors; P:HRI-mediated signaling; P:integrated stress response signaling; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process;|Q14154 Q969R4 Q96EU9,DAP3-binding cell death enhancer 1 {ECO:0000305},DAP3-binding cell death enhancer 1, long form {ECO:0000303|PubMed:32132707};Death ligand signal enhancer {ECO:0000303|PubMed:20563667};, PF08238;, GO:0005829;GO:0005743;GO:0005739;GO:0019901;GO:0043539;GO:0008625;GO:0140468;GO:0140467;GO:0043281;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrion;, F:protein kinase binding; F:protein serine/threonine kinase activator activity;, P:extrinsic apoptotic signaling pathway via death domain receptors; P:HRI-mediated signaling; P:integrated stress response signaling; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; scaffold4 indexed_genome mRNA 9082556 9095278 . + . ID=transcript_1007;Q9NPG4 Q6UXB6 Q96KB8 Q9H7Y6 Q9H8E0,Protocadherin-12 {ECO:0000305},Vascular cadherin-2 {ECO:0000303|PubMed:11063261};Vascular endothelial cadherin-2 {ECO:0000303|PubMed:11063261};, PF00028;PF08266;, GO:0005911;GO:0070062;GO:0005887;GO:0005886;GO:0005509;GO:0016339;GO:0007155;GO:0005977;GO:0007156;GO:0060711;GO:0008038;, C:cell-cell junction; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:glycogen metabolic process; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:labyrinthine layer development; P:neuron recognition; scaffold4 indexed_genome mRNA 9105759 9123186 . + . ID=transcript_1008;Q9UBS8 A0AV26 A6NMR2 A8MTW5 B3KN72 B7ZLV2 D3DQE4 O94793 Q6IBV0,E3 ubiquitin-protein ligase RNF14,Androgen receptor-associated protein 54;HFB30;RING finger protein 14;Triad2 protein;, PF01485;PF05773;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0050681;GO:0046872;GO:0003713;GO:0031624;GO:0061630;GO:0019787;GO:0030521;GO:0032436;GO:0045893;GO:0000209;GO:0016567;GO:0060765;GO:0006357;GO:0006355;GO:0007165;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:androgen receptor binding; F:metal ion binding; F:transcription coactivator activity; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein transferase activity;, P:androgen receptor signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of androgen receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:signal transduction; P:ubiquitin-dependent protein catabolic process;|Q9UBS8 A0AV26 A6NMR2 A8MTW5 B3KN72 B7ZLV2 D3DQE4 O94793 Q6IBV0,E3 ubiquitin-protein ligase RNF14,Androgen receptor-associated protein 54;HFB30;RING finger protein 14;Triad2 protein;, PF01485;PF05773;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0050681;GO:0046872;GO:0003713;GO:0031624;GO:0061630;GO:0019787;GO:0030521;GO:0032436;GO:0045893;GO:0000209;GO:0016567;GO:0060765;GO:0006357;GO:0006355;GO:0007165;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:androgen receptor binding; F:metal ion binding; F:transcription coactivator activity; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein transferase activity;, P:androgen receptor signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of androgen receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:signal transduction; P:ubiquitin-dependent protein catabolic process;|Q9UBS8 A0AV26 A6NMR2 A8MTW5 B3KN72 B7ZLV2 D3DQE4 O94793 Q6IBV0,E3 ubiquitin-protein ligase RNF14,Androgen receptor-associated protein 54;HFB30;RING finger protein 14;Triad2 protein;, PF01485;PF05773;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0050681;GO:0046872;GO:0003713;GO:0031624;GO:0061630;GO:0019787;GO:0030521;GO:0032436;GO:0045893;GO:0000209;GO:0016567;GO:0060765;GO:0006357;GO:0006355;GO:0007165;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:androgen receptor binding; F:metal ion binding; F:transcription coactivator activity; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein transferase activity;, P:androgen receptor signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of androgen receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:signal transduction; P:ubiquitin-dependent protein catabolic process;|Q9UBS8 A0AV26 A6NMR2 A8MTW5 B3KN72 B7ZLV2 D3DQE4 O94793 Q6IBV0,E3 ubiquitin-protein ligase RNF14,Androgen receptor-associated protein 54;HFB30;RING finger protein 14;Triad2 protein;, PF01485;PF05773;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0050681;GO:0046872;GO:0003713;GO:0031624;GO:0061630;GO:0019787;GO:0030521;GO:0032436;GO:0045893;GO:0000209;GO:0016567;GO:0060765;GO:0006357;GO:0006355;GO:0007165;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:androgen receptor binding; F:metal ion binding; F:transcription coactivator activity; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein transferase activity;, P:androgen receptor signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of androgen receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:signal transduction; P:ubiquitin-dependent protein catabolic process;|Q9UBS8 A0AV26 A6NMR2 A8MTW5 B3KN72 B7ZLV2 D3DQE4 O94793 Q6IBV0,E3 ubiquitin-protein ligase RNF14,Androgen receptor-associated protein 54;HFB30;RING finger protein 14;Triad2 protein;, PF01485;PF05773;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0050681;GO:0046872;GO:0003713;GO:0031624;GO:0061630;GO:0019787;GO:0030521;GO:0032436;GO:0045893;GO:0000209;GO:0016567;GO:0060765;GO:0006357;GO:0006355;GO:0007165;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:androgen receptor binding; F:metal ion binding; F:transcription coactivator activity; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein transferase activity;, P:androgen receptor signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of androgen receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:signal transduction; P:ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 9134170 9146926 . - . ID=transcript_1009;P46926 B7Z3X4 D3DQE7,Glucosamine-6-phosphate isomerase 1,Glucosamine-6-phosphate deaminase 1;Oscillin;, PF01182;, GO:0005737;GO:0005829;GO:0070062;GO:0004342;GO:0042802;GO:0005975;GO:0006091;GO:0006043;GO:0006046;GO:0019262;GO:0007338;GO:0006048;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glucosamine-6-phosphate deaminase activity; F:identical protein binding;, P:carbohydrate metabolic process; P:generation of precursor metabolites and energy; P:glucosamine catabolic process; P:N-acetylglucosamine catabolic process; P:N-acetylneuraminate catabolic process; P:single fertilization; P:UDP-N-acetylglucosamine biosynthetic process;|P46926 B7Z3X4 D3DQE7,Glucosamine-6-phosphate isomerase 1,Glucosamine-6-phosphate deaminase 1;Oscillin;, PF01182;, GO:0005737;GO:0005829;GO:0070062;GO:0004342;GO:0042802;GO:0005975;GO:0006091;GO:0006043;GO:0006046;GO:0019262;GO:0007338;GO:0006048;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glucosamine-6-phosphate deaminase activity; F:identical protein binding;, P:carbohydrate metabolic process; P:generation of precursor metabolites and energy; P:glucosamine catabolic process; P:N-acetylglucosamine catabolic process; P:N-acetylneuraminate catabolic process; P:single fertilization; P:UDP-N-acetylglucosamine biosynthetic process;|P46926 B7Z3X4 D3DQE7,Glucosamine-6-phosphate isomerase 1,Glucosamine-6-phosphate deaminase 1;Oscillin;, PF01182;, GO:0005737;GO:0005829;GO:0070062;GO:0004342;GO:0042802;GO:0005975;GO:0006091;GO:0006043;GO:0006046;GO:0019262;GO:0007338;GO:0006048;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glucosamine-6-phosphate deaminase activity; F:identical protein binding;, P:carbohydrate metabolic process; P:generation of precursor metabolites and energy; P:glucosamine catabolic process; P:N-acetylglucosamine catabolic process; P:N-acetylneuraminate catabolic process; P:single fertilization; P:UDP-N-acetylglucosamine biosynthetic process;|P46926 B7Z3X4 D3DQE7,Glucosamine-6-phosphate isomerase 1,Glucosamine-6-phosphate deaminase 1;Oscillin;, PF01182;, GO:0005737;GO:0005829;GO:0070062;GO:0004342;GO:0042802;GO:0005975;GO:0006091;GO:0006043;GO:0006046;GO:0019262;GO:0007338;GO:0006048;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glucosamine-6-phosphate deaminase activity; F:identical protein binding;, P:carbohydrate metabolic process; P:generation of precursor metabolites and energy; P:glucosamine catabolic process; P:N-acetylglucosamine catabolic process; P:N-acetylneuraminate catabolic process; P:single fertilization; P:UDP-N-acetylglucosamine biosynthetic process;|P46926 B7Z3X4 D3DQE7,Glucosamine-6-phosphate isomerase 1,Glucosamine-6-phosphate deaminase 1;Oscillin;, PF01182;, GO:0005737;GO:0005829;GO:0070062;GO:0004342;GO:0042802;GO:0005975;GO:0006091;GO:0006043;GO:0006046;GO:0019262;GO:0007338;GO:0006048;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glucosamine-6-phosphate deaminase activity; F:identical protein binding;, P:carbohydrate metabolic process; P:generation of precursor metabolites and energy; P:glucosamine catabolic process; P:N-acetylglucosamine catabolic process; P:N-acetylneuraminate catabolic process; P:single fertilization; P:UDP-N-acetylglucosamine biosynthetic process; scaffold4 indexed_genome mRNA 9251115 9252170 . + . ID=transcript_1010;Q9BT67 B2RDB8 D3DQF0 Q658T8 Q8N2E3 Q8N2F9,NEDD4 family-interacting protein 1,Breast cancer-associated protein SGA-1M;NEDD4 WW domain-binding protein 5;Putative MAPK-activating protein PM13;Putative NF-kappa-B-activating protein 164;Putative NFKB and MAPK-activating protein;, PF10176;, GO:0005938;GO:0030425;GO:0005783;GO:0010008;GO:0005576;GO:0005794;GO:0000139;GO:0016021;GO:0048471;GO:0045202;GO:0050699;GO:0006879;GO:0030001;GO:0010629;GO:0050728;GO:0032713;GO:0048294;GO:0051224;GO:0042130;GO:0032410;GO:0002829;GO:0043123;GO:0045732;GO:0031398;GO:0048302;GO:0045619;GO:0002761;GO:0006511;GO:0007034;, C:cell cortex; C:dendrite; C:endoplasmic reticulum; C:endosome membrane; C:extracellular region; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:synapse;, F:WW domain binding;, P:cellular iron ion homeostasis; P:metal ion transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-4 production; P:negative regulation of isotype switching to IgE isotypes; P:negative regulation of protein transport; P:negative regulation of T cell proliferation; P:negative regulation of transporter activity; P:negative regulation of type 2 immune response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein catabolic process; P:positive regulation of protein ubiquitination; P:regulation of isotype switching to IgG isotypes; P:regulation of lymphocyte differentiation; P:regulation of myeloid leukocyte differentiation; P:ubiquitin-dependent protein catabolic process; P:vacuolar transport; scaffold4 indexed_genome mRNA 9252374 9263996 . - . ID=transcript_1011;Q9BT67 B2RDB8 D3DQF0 Q658T8 Q8N2E3 Q8N2F9,NEDD4 family-interacting protein 1,Breast cancer-associated protein SGA-1M;NEDD4 WW domain-binding protein 5;Putative MAPK-activating protein PM13;Putative NF-kappa-B-activating protein 164;Putative NFKB and MAPK-activating protein;, PF10176;, GO:0005938;GO:0030425;GO:0005783;GO:0010008;GO:0005576;GO:0005794;GO:0000139;GO:0016021;GO:0048471;GO:0045202;GO:0050699;GO:0006879;GO:0030001;GO:0010629;GO:0050728;GO:0032713;GO:0048294;GO:0051224;GO:0042130;GO:0032410;GO:0002829;GO:0043123;GO:0045732;GO:0031398;GO:0048302;GO:0045619;GO:0002761;GO:0006511;GO:0007034;, C:cell cortex; C:dendrite; C:endoplasmic reticulum; C:endosome membrane; C:extracellular region; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:synapse;, F:WW domain binding;, P:cellular iron ion homeostasis; P:metal ion transport; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of interleukin-4 production; P:negative regulation of isotype switching to IgE isotypes; P:negative regulation of protein transport; P:negative regulation of T cell proliferation; P:negative regulation of transporter activity; P:negative regulation of type 2 immune response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein catabolic process; P:positive regulation of protein ubiquitination; P:regulation of isotype switching to IgG isotypes; P:regulation of lymphocyte differentiation; P:regulation of myeloid leukocyte differentiation; P:ubiquitin-dependent protein catabolic process; P:vacuolar transport; scaffold4 indexed_genome mRNA 9398502 9401502 . - . ID=transcript_1012;Q9C004 A4FVB2 A4FVB3 Q6QIX2 Q9C003,Protein sprouty homolog 4,, PF05210;, GO:0005737;GO:0005829;GO:0005925;GO:0032587;GO:0004860;GO:0048513;GO:0070373;GO:0040037;GO:0043407;GO:0046580;GO:1900025;, C:cytoplasm; C:cytosol; C:focal adhesion; C:ruffle membrane;, F:protein kinase inhibitor activity;, P:animal organ development; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of Ras protein signal transduction; P:negative regulation of substrate adhesion-dependent cell spreading; scaffold4 indexed_genome mRNA 9678593 9788005 . - . ID=transcript_1013;P05230 B2R5T0 D3DQF2 P07502 Q16588,Fibroblast growth factor 1,Acidic fibroblast growth factor;Endothelial cell growth factor;Heparin-binding growth factor 1;, PF00167;, GO:0005938;GO:0005737;GO:0005829;GO:0031012;GO:0005576;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0005104;GO:0008083;GO:0008201;GO:0030544;GO:0005178;GO:0044548;GO:0000187;GO:0032148;GO:0009653;GO:0001525;GO:0009887;GO:0060681;GO:0030154;GO:0034605;GO:0008543;GO:0030324;GO:0000165;GO:0072163;GO:0007275;GO:0001759;GO:0045766;GO:0051781;GO:0030335;GO:0008284;GO:0045542;GO:0010595;GO:0050679;GO:0010628;GO:2000347;GO:1902533;GO:0043406;GO:0051897;GO:0001934;GO:1903672;GO:0045944;GO:0030334;GO:2000544;GO:1901509;GO:0007165;GO:0042060;, C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus;, F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparin binding; F:Hsp70 protein binding; F:integrin binding; F:S100 protein binding;, P:activation of MAPK activity; P:activation of protein kinase B activity; P:anatomical structure morphogenesis; P:angiogenesis; P:animal organ morphogenesis; P:branch elongation involved in ureteric bud branching; P:cell differentiation; P:cellular response to heat; P:fibroblast growth factor receptor signaling pathway; P:lung development; P:MAPK cascade; P:mesonephric epithelium development; P:multicellular organism development; P:organ induction; P:positive regulation of angiogenesis; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of endothelial cell migration; P:positive regulation of epithelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of hepatocyte proliferation; P:positive regulation of intracellular signal transduction; P:positive regulation of MAP kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell migration; P:regulation of endothelial cell chemotaxis to fibroblast growth factor; P:regulation of endothelial tube morphogenesis; P:signal transduction; P:wound healing; scaffold4 indexed_genome mRNA 9865533 10331516 . + . ID=transcript_1014;Q9UNA1 O75117 Q5D035 Q9BYS6 Q9BYS7 Q9UJ00,Rho GTPase-activating protein 26,GTPase regulator associated with focal adhesion kinase;Oligophrenin-1-like protein;Rho-type GTPase-activating protein 26;, PF00169;PF00620;PF14604;, GO:0005856;GO:0005829;GO:0005925;GO:0005096;GO:0005543;GO:0030036;GO:0007399;GO:0051056;GO:0007165;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:GTPase activator activity; F:phospholipid binding;, P:actin cytoskeleton organization; P:nervous system development; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9UNA1 O75117 Q5D035 Q9BYS6 Q9BYS7 Q9UJ00,Rho GTPase-activating protein 26,GTPase regulator associated with focal adhesion kinase;Oligophrenin-1-like protein;Rho-type GTPase-activating protein 26;, PF00169;PF00620;PF14604;, GO:0005856;GO:0005829;GO:0005925;GO:0005096;GO:0005543;GO:0030036;GO:0007399;GO:0051056;GO:0007165;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:GTPase activator activity; F:phospholipid binding;, P:actin cytoskeleton organization; P:nervous system development; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9UNA1 O75117 Q5D035 Q9BYS6 Q9BYS7 Q9UJ00,Rho GTPase-activating protein 26,GTPase regulator associated with focal adhesion kinase;Oligophrenin-1-like protein;Rho-type GTPase-activating protein 26;, PF00169;PF00620;PF14604;, GO:0005856;GO:0005829;GO:0005925;GO:0005096;GO:0005543;GO:0030036;GO:0007399;GO:0051056;GO:0007165;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:GTPase activator activity; F:phospholipid binding;, P:actin cytoskeleton organization; P:nervous system development; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold4 indexed_genome mRNA 10391785 10397695 . - . ID=transcript_1015;P04150 A0ZXF9 B0LPG8 D3DQF4 F5ATB7 P04151 Q53EP5 Q6N0A4,Glucocorticoid receptor,Nuclear receptor subfamily 3 group C member 1;, PF02155;PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005815;GO:0005759;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0001046;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0004883;GO:0051879;GO:0004879;GO:0019901;GO:0003723;GO:0000978;GO:0000977;GO:1990837;GO:0005496;GO:1990239;GO:0008270;GO:0006915;GO:0007049;GO:0051301;GO:0071549;GO:0071385;GO:0071383;GO:0071560;GO:0006325;GO:0007059;GO:0030518;GO:0000122;GO:0045892;GO:1902895;GO:0045944;GO:0006357;GO:0006355;GO:0007165;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:microtubule organizing center; C:mitochondrial matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle;, F:core promoter sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:glucocorticoid receptor activity; F:Hsp90 protein binding; F:nuclear receptor activity; F:protein kinase binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid binding; F:steroid hormone binding; F:zinc ion binding;, P:apoptotic process; P:cell cycle; P:cell division; P:cellular response to dexamethasone stimulus; P:cellular response to glucocorticoid stimulus; P:cellular response to steroid hormone stimulus; P:cellular response to transforming growth factor beta stimulus; P:chromatin organization; P:chromosome segregation; P:intracellular steroid hormone receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:signal transduction; P:transcription initiation from RNA polymerase II promoter;|P04150 A0ZXF9 B0LPG8 D3DQF4 F5ATB7 P04151 Q53EP5 Q6N0A4,Glucocorticoid receptor,Nuclear receptor subfamily 3 group C member 1;, PF02155;PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005815;GO:0005759;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0001046;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0004883;GO:0051879;GO:0004879;GO:0019901;GO:0003723;GO:0000978;GO:0000977;GO:1990837;GO:0005496;GO:1990239;GO:0008270;GO:0006915;GO:0007049;GO:0051301;GO:0071549;GO:0071385;GO:0071383;GO:0071560;GO:0006325;GO:0007059;GO:0030518;GO:0000122;GO:0045892;GO:1902895;GO:0045944;GO:0006357;GO:0006355;GO:0007165;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:microtubule organizing center; C:mitochondrial matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle;, F:core promoter sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:glucocorticoid receptor activity; F:Hsp90 protein binding; F:nuclear receptor activity; F:protein kinase binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid binding; F:steroid hormone binding; F:zinc ion binding;, P:apoptotic process; P:cell cycle; P:cell division; P:cellular response to dexamethasone stimulus; P:cellular response to glucocorticoid stimulus; P:cellular response to steroid hormone stimulus; P:cellular response to transforming growth factor beta stimulus; P:chromatin organization; P:chromosome segregation; P:intracellular steroid hormone receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; scaffold4 indexed_genome mRNA 10406722 10410806 . - . ID=transcript_1016;P04150 A0ZXF9 B0LPG8 D3DQF4 F5ATB7 P04151 Q53EP5 Q6N0A4,Glucocorticoid receptor,Nuclear receptor subfamily 3 group C member 1;, PF02155;PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005815;GO:0005759;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0001046;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0004883;GO:0051879;GO:0004879;GO:0019901;GO:0003723;GO:0000978;GO:0000977;GO:1990837;GO:0005496;GO:1990239;GO:0008270;GO:0006915;GO:0007049;GO:0051301;GO:0071549;GO:0071385;GO:0071383;GO:0071560;GO:0006325;GO:0007059;GO:0030518;GO:0000122;GO:0045892;GO:1902895;GO:0045944;GO:0006357;GO:0006355;GO:0007165;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:microtubule organizing center; C:mitochondrial matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle;, F:core promoter sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:glucocorticoid receptor activity; F:Hsp90 protein binding; F:nuclear receptor activity; F:protein kinase binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid binding; F:steroid hormone binding; F:zinc ion binding;, P:apoptotic process; P:cell cycle; P:cell division; P:cellular response to dexamethasone stimulus; P:cellular response to glucocorticoid stimulus; P:cellular response to steroid hormone stimulus; P:cellular response to transforming growth factor beta stimulus; P:chromatin organization; P:chromosome segregation; P:intracellular steroid hormone receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; scaffold4 indexed_genome mRNA 11302787 11319654 . - . ID=transcript_1017;Q969M3 D3DQF5 Q4VSN6 Q53EX4 Q8NHE5 Q9H338 Q9H3U4,Protein YIPF5,Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 5;Smooth muscle cell-associated protein 5;YIP1 family member 5;YPT-interacting protein 1 A;, , GO:0030134;GO:0005783;GO:0070971;GO:0005789;GO:0005794;GO:0016021;GO:0043231;GO:0005654;GO:0015031;GO:0060628;GO:0016192;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:protein transport; P:regulation of ER to Golgi vesicle-mediated transport; P:vesicle-mediated transport;|Q969M3 D3DQF5 Q4VSN6 Q53EX4 Q8NHE5 Q9H338 Q9H3U4,Protein YIPF5,Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 5;Smooth muscle cell-associated protein 5;YIP1 family member 5;YPT-interacting protein 1 A;, , GO:0030134;GO:0005783;GO:0070971;GO:0005789;GO:0005794;GO:0016021;GO:0043231;GO:0005654;GO:0015031;GO:0060628;GO:0016192;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:protein transport; P:regulation of ER to Golgi vesicle-mediated transport; P:vesicle-mediated transport;|Q969M3 D3DQF5 Q4VSN6 Q53EX4 Q8NHE5 Q9H338 Q9H3U4,Protein YIPF5,Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 5;Smooth muscle cell-associated protein 5;YIP1 family member 5;YPT-interacting protein 1 A;, , GO:0030134;GO:0005783;GO:0070971;GO:0005789;GO:0005794;GO:0016021;GO:0043231;GO:0005654;GO:0015031;GO:0060628;GO:0016192;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:protein transport; P:regulation of ER to Golgi vesicle-mediated transport; P:vesicle-mediated transport; scaffold4 indexed_genome mRNA 12948216 13034977 . - . ID=transcript_1018;Q8N945 G5EA01 Q96EQ3,PRELI domain-containing protein 2,, PF04707;, GO:0005758;GO:1990050;GO:0015914;, C:mitochondrial intermembrane space;, F:phosphatidic acid transfer activity;, P:phospholipid transport; scaffold4 indexed_genome mRNA 13069834 13071734 . - . ID=transcript_1019;A6NFK2,Glutaredoxin domain-containing cysteine-rich protein 2,GRXCR1-like protein;Glutaredoxin domain-containing cysteine-rich protein 1-like protein;, , GO:0005902;GO:0120044;GO:0120043;GO:0060088;GO:0033365;GO:0007605;, C:microvillus; C:stereocilium base; C:stereocilium shaft;, , P:auditory receptor cell stereocilium organization; P:protein localization to organelle; P:sensory perception of sound; scaffold4 indexed_genome mRNA 13146070 13269715 . + . ID=transcript_1020;Q8TEC5 A8K961 Q08AM9 Q6GMR9 Q8N5S8 Q96LP8,E3 ubiquitin-protein ligase SH3RF2,Heart protein phosphatase 1-binding protein;POSH-eliminating RING protein {ECO:0000303|PubMed:22128169};Protein phosphatase 1 regulatory subunit 39;RING finger protein 158;RING-type E3 ubiquitin transferase SH3RF2 {ECO:0000305};SH3 domain-containing RING finger protein 2;, PF00018;PF07653;PF14604;PF13445;, GO:0005654;GO:0005634;GO:0046872;GO:0019902;GO:0008157;GO:0004864;GO:0061630;GO:0043066;GO:0046329;GO:0010923;GO:0031397;GO:0030335;GO:0046330;GO:0032436;GO:0051865;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:phosphatase binding; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity; F:ubiquitin protein ligase activity;, P:negative regulation of apoptotic process; P:negative regulation of JNK cascade; P:negative regulation of phosphatase activity; P:negative regulation of protein ubiquitination; P:positive regulation of cell migration; P:positive regulation of JNK cascade; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein autoubiquitination;|Q8TEC5 A8K961 Q08AM9 Q6GMR9 Q8N5S8 Q96LP8,E3 ubiquitin-protein ligase SH3RF2,Heart protein phosphatase 1-binding protein;POSH-eliminating RING protein {ECO:0000303|PubMed:22128169};Protein phosphatase 1 regulatory subunit 39;RING finger protein 158;RING-type E3 ubiquitin transferase SH3RF2 {ECO:0000305};SH3 domain-containing RING finger protein 2;, PF00018;PF07653;PF14604;PF13445;, GO:0005654;GO:0005634;GO:0046872;GO:0019902;GO:0008157;GO:0004864;GO:0061630;GO:0043066;GO:0046329;GO:0010923;GO:0031397;GO:0030335;GO:0046330;GO:0032436;GO:0051865;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:phosphatase binding; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity; F:ubiquitin protein ligase activity;, P:negative regulation of apoptotic process; P:negative regulation of JNK cascade; P:negative regulation of phosphatase activity; P:negative regulation of protein ubiquitination; P:positive regulation of cell migration; P:positive regulation of JNK cascade; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein autoubiquitination;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold4 indexed_genome mRNA 13294188 13295445 . - . ID=transcript_1021;A1L4L8,PLAC8-like protein 1,, PF04749; scaffold4 indexed_genome mRNA 13316668 13387099 . - . ID=transcript_1022;Q9P2J5 A2RRR4 A7E266 B4DJ10 Q2TU79 Q9NSE1,Leucine--tRNA ligase, cytoplasmic,Leucyl-tRNA synthetase;, PF08264;PF00133;, GO:0017101;GO:0005737;GO:0005829;GO:0012505;GO:0005783;GO:0005764;GO:0016604;GO:0002161;GO:0005524;GO:0004819;GO:0005096;GO:0004823;GO:0034198;GO:0071230;GO:0071233;GO:1990253;GO:0006425;GO:0006429;GO:0043547;GO:0032008;GO:1904263;GO:0008361;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:endomembrane system; C:endoplasmic reticulum; C:lysosome; C:nuclear body;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:glutamine-tRNA ligase activity; F:GTPase activator activity; F:leucine-tRNA ligase activity;, P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to leucine; P:cellular response to leucine starvation; P:glutaminyl-tRNA aminoacylation; P:leucyl-tRNA aminoacylation; P:positive regulation of GTPase activity; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:regulation of cell size; P:tRNA aminoacylation for protein translation; scaffold4 indexed_genome mRNA 13403419 13458892 . + . ID=transcript_1023;Q9P2N5 Q8IYW9,RNA-binding protein 27,RNA-binding motif protein 27;, PF01480;PF00076;PF00642;, GO:0005737;GO:0016607;GO:0005634;GO:0046872;GO:0003723;GO:0006397;, C:cytoplasm; C:nuclear speck; C:nucleus;, F:metal ion binding; F:RNA binding;, P:mRNA processing; scaffold4 indexed_genome mRNA 13524542 13526808 . - . ID=transcript_1024;Q86U42 D3DS49 O43484,Polyadenylate-binding protein 2,Nuclear poly(A)-binding protein 1;Poly(A)-binding protein II;Polyadenylate-binding nuclear protein 1;, PF00076;, GO:0005737;GO:0042405;GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0003723;GO:0070063;GO:0071222;GO:0000165;GO:0046778;GO:0031124;GO:0000398;GO:0006936;GO:0016973;GO:1904247;GO:0006396;GO:0006369;, C:cytoplasm; C:nuclear inclusion body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:RNA binding; F:RNA polymerase binding;, P:cellular response to lipopolysaccharide; P:MAPK cascade; P:modification by virus of host mRNA processing; P:mRNA 3'-end processing; P:mRNA splicing, via spliceosome; P:muscle contraction; P:poly(A)+ mRNA export from nucleus; P:positive regulation of polynucleotide adenylyltransferase activity; P:RNA processing; P:termination of RNA polymerase II transcription; scaffold4 indexed_genome mRNA 13610312 13652294 . + . ID=transcript_1025;O14776 Q2NKN2 Q59EA1,Transcription elongation regulator 1,TATA box-binding protein-associated factor 2S;Transcription factor CA150;, PF01846;PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0070063;GO:0001103;GO:0003713;GO:0003712;GO:0003714;GO:0003711;GO:0044390;GO:0006397;GO:0000122;GO:0034244;GO:0045944;GO:0032968;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:RNA polymerase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription elongation regulator activity; F:ubiquitin-like protein conjugating enzyme binding;, P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:RNA splicing;|O14776 Q2NKN2 Q59EA1,Transcription elongation regulator 1,TATA box-binding protein-associated factor 2S;Transcription factor CA150;, PF01846;PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0070063;GO:0001103;GO:0003713;GO:0003712;GO:0003714;GO:0003711;GO:0044390;GO:0006397;GO:0000122;GO:0034244;GO:0045944;GO:0032968;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:RNA polymerase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription elongation regulator activity; F:ubiquitin-like protein conjugating enzyme binding;, P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:RNA splicing;|O14776 Q2NKN2 Q59EA1,Transcription elongation regulator 1,TATA box-binding protein-associated factor 2S;Transcription factor CA150;, PF01846;PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0070063;GO:0001103;GO:0003713;GO:0003712;GO:0003714;GO:0003711;GO:0044390;GO:0006397;GO:0000122;GO:0034244;GO:0045944;GO:0032968;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:RNA polymerase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription elongation regulator activity; F:ubiquitin-like protein conjugating enzyme binding;, P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:RNA splicing;|O14776 Q2NKN2 Q59EA1,Transcription elongation regulator 1,TATA box-binding protein-associated factor 2S;Transcription factor CA150;, PF01846;PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0070063;GO:0001103;GO:0003713;GO:0003712;GO:0003714;GO:0003711;GO:0044390;GO:0006397;GO:0000122;GO:0034244;GO:0045944;GO:0032968;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:RNA polymerase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription elongation regulator activity; F:ubiquitin-like protein conjugating enzyme binding;, P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:RNA splicing; scaffold4 indexed_genome mRNA 13655562 13665336 . + . ID=transcript_1026;O14776 Q2NKN2 Q59EA1,Transcription elongation regulator 1,TATA box-binding protein-associated factor 2S;Transcription factor CA150;, PF01846;PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0070063;GO:0001103;GO:0003713;GO:0003712;GO:0003714;GO:0003711;GO:0044390;GO:0006397;GO:0000122;GO:0034244;GO:0045944;GO:0032968;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:RNA polymerase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription elongation regulator activity; F:ubiquitin-like protein conjugating enzyme binding;, P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:RNA splicing;|O14776 Q2NKN2 Q59EA1,Transcription elongation regulator 1,TATA box-binding protein-associated factor 2S;Transcription factor CA150;, PF01846;PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0070063;GO:0001103;GO:0003713;GO:0003712;GO:0003714;GO:0003711;GO:0044390;GO:0006397;GO:0000122;GO:0034244;GO:0045944;GO:0032968;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:RNA polymerase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription elongation regulator activity; F:ubiquitin-like protein conjugating enzyme binding;, P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:RNA splicing;|O14776 Q2NKN2 Q59EA1,Transcription elongation regulator 1,TATA box-binding protein-associated factor 2S;Transcription factor CA150;, PF01846;PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0070063;GO:0001103;GO:0003713;GO:0003712;GO:0003714;GO:0003711;GO:0044390;GO:0006397;GO:0000122;GO:0034244;GO:0045944;GO:0032968;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:RNA polymerase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription elongation regulator activity; F:ubiquitin-like protein conjugating enzyme binding;, P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:RNA splicing; scaffold4 indexed_genome mRNA 13759554 14233386 . - . ID=transcript_1027;Q00005 A6NEJ2 A8K102 B3KPD0 B7Z2F2 B7Z304 D3DQF7 D3DQF8 G3V149,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform,PP2A subunit B isoform B55-beta;PP2A subunit B isoform PR55-beta;PP2A subunit B isoform R2-beta;PP2A subunit B isoform beta;, , GO:0005856;GO:0005829;GO:0005741;GO:0005739;GO:0000159;GO:0019888;GO:0006915;GO:0070262;, C:cytoskeleton; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:protein phosphatase type 2A complex;, F:protein phosphatase regulator activity;, P:apoptotic process; P:peptidyl-serine dephosphorylation;|Q9UQR0 Q5JXE6 Q86U98 Q8IWD0 Q8NDP2 Q9UGC5,Sex comb on midleg-like protein 2,, PF02820;PF17208;PF00536;PF12140;, GO:0005634;GO:0031519;GO:0003682;GO:0042393;GO:0009653;GO:0045892;, C:nucleus; C:PcG protein complex;, F:chromatin binding; F:histone binding;, P:anatomical structure morphogenesis; P:negative regulation of transcription, DNA-templated; scaffold4 indexed_genome mRNA 14394917 14536109 . + . ID=transcript_1028;Q8WU08 B3KSY0,Serine/threonine-protein kinase 32A,Yet another novel kinase 1;, PF00069;, GO:0005886;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;, C:plasma membrane;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation;|Q8WU08 B3KSY0,Serine/threonine-protein kinase 32A,Yet another novel kinase 1;, PF00069;, GO:0005886;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;, C:plasma membrane;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; scaffold4 indexed_genome mRNA 14541282 14656958 . - . ID=transcript_1029;Q14195 B3SXQ8 Q93012,Dihydropyrimidinase-related protein 3,Collapsin response mediator protein 4;Unc-33-like phosphoprotein 1;, PF01979;, GO:0044297;GO:0005829;GO:0070382;GO:0005615;GO:0031941;GO:0030426;GO:0030027;GO:0045202;GO:0035374;GO:0031005;GO:0016810;GO:0042802;GO:0017124;GO:0051764;GO:0051017;GO:0071345;GO:0030336;GO:0010977;GO:0048666;GO:0051491;GO:0010976;GO:0048678;, C:cell body; C:cytosol; C:exocytic vesicle; C:extracellular space; C:filamentous actin; C:growth cone; C:lamellipodium; C:synapse;, F:chondroitin sulfate binding; F:filamin binding; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:identical protein binding; F:SH3 domain binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:cellular response to cytokine stimulus; P:negative regulation of cell migration; P:negative regulation of neuron projection development; P:neuron development; P:positive regulation of filopodium assembly; P:positive regulation of neuron projection development; P:response to axon injury; scaffold4 indexed_genome mRNA 14754958 14807064 . - . ID=transcript_1030;Q96AA8 A4ZZA7 A8K5G5 B4DSG0 G5E9Y0 O60302 Q548S1,Janus kinase and microtubule-interacting protein 2,CTCL tumor antigen HD-CL-04;Neuroendocrine long coiled-coil protein 1;, PF16034;, GO:0005794;GO:0019900;GO:0008017;, C:Golgi apparatus;, F:kinase binding; F:microtubule binding; scaffold4 indexed_genome mRNA 15035310 15038232 . + . ID=transcript_1031;Q96PL1,Secretoglobin family 3A member 2,Pneumo secretory protein 1;Uteroglobin-related protein 1;, PF01099;, GO:0071682;GO:0005576;GO:0005615;GO:0006898;, C:endocytic vesicle lumen; C:extracellular region; C:extracellular space;, , P:receptor-mediated endocytosis; scaffold4 indexed_genome mRNA 15354625 15360263 . + . ID=transcript_1032;Q6UWN8 E0X656 Q8N5P0,Serine protease inhibitor Kazal-type 6,Kallikrein inhibitor;, PF00050;, GO:0005576;GO:0004867;GO:0030154;GO:0007417;GO:0070268;GO:0007275;GO:1900004;GO:1902572;, C:extracellular region;, F:serine-type endopeptidase inhibitor activity;, P:cell differentiation; P:central nervous system development; P:cornification; P:multicellular organism development; P:negative regulation of serine-type endopeptidase activity; P:negative regulation of serine-type peptidase activity; scaffold4 indexed_genome mRNA 15743390 15772075 . + . ID=transcript_1033;Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 15783912 15802694 . + . ID=transcript_1034;Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q6PIJ6 Q6PK72 Q7Z2U0 Q86VN3 Q9BXY6 Q9H837 Q9HC40,F-box only protein 38 {ECO:0000305},, PF00646;, GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0002250;GO:0010976;GO:0002842;GO:0070936;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:adaptive immune response; P:positive regulation of neuron projection development; P:positive regulation of T cell mediated immune response to tumor cell; P:protein K48-linked ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 16149395 16152929 . + . ID=transcript_1035;Q9UHA1 Q9UMZ5,Beta-2 adrenergic receptor,Beta-2 adrenoreceptor;, PF00001;, GO:0016324;GO:0030669;GO:0005769;GO:0005768;GO:0010008;GO:0005794;GO:0005887;GO:0005764;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0008179;GO:0001540;GO:0004941;GO:0004930;GO:0042802;GO:0051380;GO:0015459;GO:0042803;GO:0044877;GO:0007190;GO:0007171;GO:0071880;GO:0007188;GO:0071875;GO:0045453;GO:0050873;GO:0007166;GO:1904646;GO:0002032;GO:0002024;GO:0008333;GO:0007186;GO:0031649;GO:0061024;GO:0002862;GO:0040015;GO:0045986;GO:0002025;GO:2000969;GO:1901098;GO:0030501;GO:2000481;GO:0120162;GO:1904504;GO:0043410;GO:0061885;GO:0010739;GO:0071902;GO:0045944;GO:0016579;GO:0006898;GO:0002028;GO:0009409;GO:1990911;, C:apical plasma membrane; C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endosome; C:endosome membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:lysosome; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:adenylate cyclase binding; F:amyloid-beta binding; F:beta2-adrenergic receptor activity; F:G protein-coupled receptor activity; F:identical protein binding; F:norepinephrine binding; F:potassium channel regulator activity; F:protein homodimerization activity; F:protein-containing complex binding;, P:activation of adenylate cyclase activity; P:activation of transmembrane receptor protein tyrosine kinase activity; P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:adrenergic receptor signaling pathway; P:bone resorption; P:brown fat cell differentiation; P:cell surface receptor signaling pathway; P:cellular response to amyloid-beta; P:desensitization of G protein-coupled receptor signaling pathway by arrestin; P:diet induced thermogenesis; P:endosome to lysosome transport; P:G protein-coupled receptor signaling pathway; P:heat generation; P:membrane organization; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of multicellular organism growth; P:negative regulation of smooth muscle contraction; P:norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure; P:positive regulation of AMPA receptor activity; P:positive regulation of autophagosome maturation; P:positive regulation of bone mineralization; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cold-induced thermogenesis; P:positive regulation of lipophagy; P:positive regulation of MAPK cascade; P:positive regulation of mini excitatory postsynaptic potential; P:positive regulation of protein kinase A signaling; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:receptor-mediated endocytosis; P:regulation of sodium ion transport; P:response to cold; P:response to psychosocial stress; scaffold4 indexed_genome mRNA 16314393 16353588 . - . ID=transcript_1036;Q8TF17 B3KWE5 Q14CC0 Q14CF5 Q9H8I5,SH3 domain and tetratricopeptide repeat-containing protein 2,, PF00018;, GO:0031410;GO:0005886;GO:0032287;GO:1901184;GO:0033157;, C:cytoplasmic vesicle; C:plasma membrane;, , P:peripheral nervous system myelin maintenance; P:regulation of ERBB signaling pathway; P:regulation of intracellular protein transport;|Q8TF17 B3KWE5 Q14CC0 Q14CF5 Q9H8I5,SH3 domain and tetratricopeptide repeat-containing protein 2,, PF00018;, GO:0031410;GO:0005886;GO:0032287;GO:1901184;GO:0033157;, C:cytoplasmic vesicle; C:plasma membrane;, , P:peripheral nervous system myelin maintenance; P:regulation of ERBB signaling pathway; P:regulation of intracellular protein transport; scaffold4 indexed_genome mRNA 16426374 16554735 . + . ID=transcript_1037;O94929 A8K121 Q19VH3 Q658S1 Q68CI5 Q9BV32,Actin-binding LIM protein 3,Actin-binding LIM protein family member 3;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0098978;GO:0030027;GO:0001725;GO:0051015;GO:0046872;GO:0030036;GO:0060271;GO:0030032;GO:1903955;GO:0045944;GO:0006351;, C:actin cytoskeleton; C:cytoplasm; C:glutamatergic synapse; C:lamellipodium; C:stress fiber;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:cilium assembly; P:lamellipodium assembly; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated;|O94929 A8K121 Q19VH3 Q658S1 Q68CI5 Q9BV32,Actin-binding LIM protein 3,Actin-binding LIM protein family member 3;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0098978;GO:0030027;GO:0001725;GO:0051015;GO:0046872;GO:0030036;GO:0060271;GO:0030032;GO:1903955;GO:0045944;GO:0006351;, C:actin cytoskeleton; C:cytoplasm; C:glutamatergic synapse; C:lamellipodium; C:stress fiber;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:cilium assembly; P:lamellipodium assembly; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated;|O94929 A8K121 Q19VH3 Q658S1 Q68CI5 Q9BV32,Actin-binding LIM protein 3,Actin-binding LIM protein family member 3;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0098978;GO:0030027;GO:0001725;GO:0051015;GO:0046872;GO:0030036;GO:0060271;GO:0030032;GO:1903955;GO:0045944;GO:0006351;, C:actin cytoskeleton; C:cytoplasm; C:glutamatergic synapse; C:lamellipodium; C:stress fiber;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:cilium assembly; P:lamellipodium assembly; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated;|O94929 A8K121 Q19VH3 Q658S1 Q68CI5 Q9BV32,Actin-binding LIM protein 3,Actin-binding LIM protein family member 3;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0098978;GO:0030027;GO:0001725;GO:0051015;GO:0046872;GO:0030036;GO:0060271;GO:0030032;GO:1903955;GO:0045944;GO:0006351;, C:actin cytoskeleton; C:cytoplasm; C:glutamatergic synapse; C:lamellipodium; C:stress fiber;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:cilium assembly; P:lamellipodium assembly; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated;|O94929 A8K121 Q19VH3 Q658S1 Q68CI5 Q9BV32,Actin-binding LIM protein 3,Actin-binding LIM protein family member 3;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0098978;GO:0030027;GO:0001725;GO:0051015;GO:0046872;GO:0030036;GO:0060271;GO:0030032;GO:1903955;GO:0045944;GO:0006351;, C:actin cytoskeleton; C:cytoplasm; C:glutamatergic synapse; C:lamellipodium; C:stress fiber;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:cilium assembly; P:lamellipodium assembly; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated;|O94929 A8K121 Q19VH3 Q658S1 Q68CI5 Q9BV32,Actin-binding LIM protein 3,Actin-binding LIM protein family member 3;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0098978;GO:0030027;GO:0001725;GO:0051015;GO:0046872;GO:0030036;GO:0060271;GO:0030032;GO:1903955;GO:0045944;GO:0006351;, C:actin cytoskeleton; C:cytoplasm; C:glutamatergic synapse; C:lamellipodium; C:stress fiber;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:cilium assembly; P:lamellipodium assembly; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated;|O94929 A8K121 Q19VH3 Q658S1 Q68CI5 Q9BV32,Actin-binding LIM protein 3,Actin-binding LIM protein family member 3;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0098978;GO:0030027;GO:0001725;GO:0051015;GO:0046872;GO:0030036;GO:0060271;GO:0030032;GO:1903955;GO:0045944;GO:0006351;, C:actin cytoskeleton; C:cytoplasm; C:glutamatergic synapse; C:lamellipodium; C:stress fiber;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:cilium assembly; P:lamellipodium assembly; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold4 indexed_genome mRNA 16577731 16646185 . + . ID=transcript_1038;Q8TED9 Q08AN4 Q08AN5 Q8IW82 Q8N8Z5 Q8N9Q4,Actin filament-associated protein 1-like 1,, PF00169;, GO:0030054;GO:0042995;GO:0005829;GO:0002102;GO:0017124;, C:cell junction; C:cell projection; C:cytosol; C:podosome;, F:SH3 domain binding; scaffold4 indexed_genome mRNA 16651657 16658577 . - . ID=transcript_1039;Q8TAA5 B4DFA6 Q49AJ6,GrpE protein homolog 2, mitochondrial,Mt-GrpE#2;, PF01025;, GO:0005739;GO:0001405;GO:0000774;GO:0051087;GO:0042803;GO:0051082;GO:0006457;GO:0030150;, C:mitochondrion; C:PAM complex, Tim23 associated import motor;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:protein homodimerization activity; F:unfolded protein binding;, P:protein folding; P:protein import into mitochondrial matrix;|Q8TAA5 B4DFA6 Q49AJ6,GrpE protein homolog 2, mitochondrial,Mt-GrpE#2;, PF01025;, GO:0005739;GO:0001405;GO:0000774;GO:0051087;GO:0042803;GO:0051082;GO:0006457;GO:0030150;, C:mitochondrion; C:PAM complex, Tim23 associated import motor;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:protein homodimerization activity; F:unfolded protein binding;, P:protein folding; P:protein import into mitochondrial matrix;|Q8TAA5 B4DFA6 Q49AJ6,GrpE protein homolog 2, mitochondrial,Mt-GrpE#2;, PF01025;, GO:0005739;GO:0001405;GO:0000774;GO:0051087;GO:0042803;GO:0051082;GO:0006457;GO:0030150;, C:mitochondrion; C:PAM complex, Tim23 associated import motor;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:protein homodimerization activity; F:unfolded protein binding;, P:protein folding; P:protein import into mitochondrial matrix; scaffold4 indexed_genome mRNA 16661177 16678679 . + . ID=transcript_1040;Q8NBM8 Q7Z4S2 Q8NCY5 Q8NF69 Q9BTE8 Q9BWS3,Prenylcysteine oxidase-like,, PF07156;, GO:0005576;GO:0016020;GO:0031093;GO:0001735;GO:0002576;GO:0030327;GO:0030328;, C:extracellular region; C:membrane; C:platelet alpha granule lumen;, F:prenylcysteine oxidase activity;, P:platelet degranulation; P:prenylated protein catabolic process; P:prenylcysteine catabolic process;|Q8NBM8 Q7Z4S2 Q8NCY5 Q8NF69 Q9BTE8 Q9BWS3,Prenylcysteine oxidase-like,, PF07156;, GO:0005576;GO:0016020;GO:0031093;GO:0001735;GO:0002576;GO:0030327;GO:0030328;, C:extracellular region; C:membrane; C:platelet alpha granule lumen;, F:prenylcysteine oxidase activity;, P:platelet degranulation; P:prenylated protein catabolic process; P:prenylcysteine catabolic process;|Q8NBM8 Q7Z4S2 Q8NCY5 Q8NF69 Q9BTE8 Q9BWS3,Prenylcysteine oxidase-like,, PF07156;, GO:0005576;GO:0016020;GO:0031093;GO:0001735;GO:0002576;GO:0030327;GO:0030328;, C:extracellular region; C:membrane; C:platelet alpha granule lumen;, F:prenylcysteine oxidase activity;, P:platelet degranulation; P:prenylated protein catabolic process; P:prenylcysteine catabolic process; scaffold4 indexed_genome mRNA 16769882 16820226 . - . ID=transcript_1041;Q9UDK3,Casein kinase I isoform alpha,CK1;, PF00069;, GO:0030877;GO:0005813;GO:0036064;GO:0005929;GO:0000777;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:1904885;GO:1904886;GO:0007049;GO:0051301;GO:0007166;GO:0007030;GO:0045104;GO:0090090;GO:0018105;GO:0032436;GO:0006468;GO:1904424;GO:0007165;GO:0016055;, C:beta-catenin destruction complex; C:centrosome; C:ciliary basal body; C:cilium; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cell cycle; P:cell division; P:cell surface receptor signaling pathway; P:Golgi organization; P:intermediate filament cytoskeleton organization; P:negative regulation of canonical Wnt signaling pathway; P:peptidyl-serine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein phosphorylation; P:regulation of GTP binding; P:signal transduction; P:Wnt signaling pathway;|Q9UDK3,Casein kinase I isoform alpha,CK1;, PF00069;, GO:0030877;GO:0005813;GO:0036064;GO:0005929;GO:0000777;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:1904885;GO:1904886;GO:0007049;GO:0051301;GO:0007166;GO:0007030;GO:0045104;GO:0090090;GO:0018105;GO:0032436;GO:0006468;GO:1904424;GO:0007165;GO:0016055;, C:beta-catenin destruction complex; C:centrosome; C:ciliary basal body; C:cilium; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cell cycle; P:cell division; P:cell surface receptor signaling pathway; P:Golgi organization; P:intermediate filament cytoskeleton organization; P:negative regulation of canonical Wnt signaling pathway; P:peptidyl-serine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein phosphorylation; P:regulation of GTP binding; P:signal transduction; P:Wnt signaling pathway;|Q9UDK3,Casein kinase I isoform alpha,CK1;, PF00069;, GO:0030877;GO:0005813;GO:0036064;GO:0005929;GO:0000777;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:1904885;GO:1904886;GO:0007049;GO:0051301;GO:0007166;GO:0007030;GO:0045104;GO:0090090;GO:0018105;GO:0032436;GO:0006468;GO:1904424;GO:0007165;GO:0016055;, C:beta-catenin destruction complex; C:centrosome; C:ciliary basal body; C:cilium; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cell cycle; P:cell division; P:cell surface receptor signaling pathway; P:Golgi organization; P:intermediate filament cytoskeleton organization; P:negative regulation of canonical Wnt signaling pathway; P:peptidyl-serine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein phosphorylation; P:regulation of GTP binding; P:signal transduction; P:Wnt signaling pathway; scaffold4 indexed_genome mRNA 16841358 16898829 . + . ID=transcript_1042;A1IGU5 Q6ZW51,Rho guanine nucleotide exchange factor 37,, PF00621;PF00018;PF07653;, GO:0005737;GO:0005085;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity;|A1IGU5 Q6ZW51,Rho guanine nucleotide exchange factor 37,, PF00621;PF00018;PF07653;, GO:0005737;GO:0005085;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity;|A1IGU5 Q6ZW51,Rho guanine nucleotide exchange factor 37,, PF00621;PF00018;PF07653;, GO:0005737;GO:0005085;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity;|A1IGU5 Q6ZW51,Rho guanine nucleotide exchange factor 37,, PF00621;PF00018;PF07653;, GO:0005737;GO:0005085;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity;|A1IGU5 Q6ZW51,Rho guanine nucleotide exchange factor 37,, PF00621;PF00018;PF07653;, GO:0005737;GO:0005085;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity;|A1IGU5 Q6ZW51,Rho guanine nucleotide exchange factor 37,, PF00621;PF00018;PF07653;, GO:0005737;GO:0005085;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity; scaffold4 indexed_genome mRNA 17068087 17099963 . + . ID=transcript_1043;Q8TDE5,Peroxisome proliferator-activated receptor gamma coactivator 1-beta,PGC-1-related estrogen receptor alpha coactivator;, PF00076;, GO:0005829;GO:0016592;GO:0005739;GO:0005654;GO:0005634;GO:0050682;GO:0030331;GO:0030374;GO:0003723;GO:0003712;GO:0008134;GO:0007015;GO:0060346;GO:0034614;GO:0030520;GO:0006390;GO:0045892;GO:0001503;GO:0010694;GO:0045780;GO:0120162;GO:0051091;GO:0045672;GO:0042327;GO:0045944;GO:0006355;GO:0051591;GO:0051384;, C:cytosol; C:mediator complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:AF-2 domain binding; F:estrogen receptor binding; F:nuclear receptor coactivator activity; F:RNA binding; F:transcription coregulator activity; F:transcription factor binding;, P:actin filament organization; P:bone trabecula formation; P:cellular response to reactive oxygen species; P:intracellular estrogen receptor signaling pathway; P:mitochondrial transcription; P:negative regulation of transcription, DNA-templated; P:ossification; P:positive regulation of alkaline phosphatase activity; P:positive regulation of bone resorption; P:positive regulation of cold-induced thermogenesis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of osteoclast differentiation; P:positive regulation of phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to cAMP; P:response to glucocorticoid; scaffold4 indexed_genome mRNA 17191922 17212414 . + . ID=transcript_1044;P50443 A8K2U3 B2R6J1 Q6N051,Sulfate transporter,Diastrophic dysplasia protein;Solute carrier family 26 member 2;, PF01740;PF00916;, GO:0016324;GO:0070062;GO:0005887;GO:0016020;GO:0031528;GO:0005886;GO:0015301;GO:0015106;GO:0015108;GO:0019531;GO:0008271;GO:0015116;GO:0050428;GO:0006811;GO:0001503;GO:1902358;, C:apical plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:microvillus membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; P:ion transport; P:ossification; P:sulfate transmembrane transport; scaffold4 indexed_genome mRNA 17225101 17249331 . + . ID=transcript_1045;Q12766 G5E9Y4 Q86UG3 Q9UMF4,HMG domain-containing protein 3,HMG box-containing protein 3;Protein SMF;, PF18717;PF09011;, GO:0005634;GO:0003677;, C:nucleus;, F:DNA binding; scaffold4 indexed_genome mRNA 17250934 17251623 . - . ID=transcript_1046;Q15014 B3KP92 D3DXA5 Q567V0 Q8J026,Mortality factor 4-like protein 2,MORF-related gene X protein;Protein MSL3-2;Transcription factor-like protein MRGX;, PF05712;, GO:0000123;GO:0035267;GO:0005730;GO:0005654;GO:0005886;GO:0006342;GO:0006281;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0051155;GO:0045944;GO:0040008;, C:histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm; C:plasma membrane;, , P:chromatin silencing; P:DNA repair; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of striated muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth; scaffold4 indexed_genome mRNA 17252022 17322068 . + . ID=transcript_1047;Q12766 G5E9Y4 Q86UG3 Q9UMF4,HMG domain-containing protein 3,HMG box-containing protein 3;Protein SMF;, PF18717;PF09011;, GO:0005634;GO:0003677;, C:nucleus;, F:DNA binding;|P07333 B5A955 D3DQG2 Q6LDW5 Q6LDY4 Q86VW7,Macrophage colony-stimulating factor 1 receptor,CSF-1 receptor;Proto-oncogene c-Fms;, PF00047;PF07714;, GO:0009986;GO:1990682;GO:0005887;GO:0043231;GO:0005654;GO:0005886;GO:0043235;GO:0005524;GO:0019955;GO:0005011;GO:0042803;GO:0019903;GO:0004713;GO:0004714;GO:0007411;GO:0008283;GO:0045217;GO:0071345;GO:0036006;GO:0019221;GO:0021879;GO:0002244;GO:0030097;GO:0006954;GO:0045087;GO:0038145;GO:0030225;GO:0060603;GO:0061518;GO:0030224;GO:0007275;GO:0043066;GO:0008285;GO:0021772;GO:0030316;GO:0018108;GO:0046488;GO:0048015;GO:0044794;GO:0030335;GO:2000147;GO:0008284;GO:0032722;GO:0070374;GO:0033674;GO:0010759;GO:0120041;GO:0001934;GO:0071902;GO:0061098;GO:0042531;GO:0046777;GO:2000249;GO:0045124;GO:0008360;GO:0060260;GO:0002931;GO:0031529;GO:0007165;GO:0007169;, C:cell surface; C:CSF1-CSF1R complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:ATP binding; F:cytokine binding; F:macrophage colony-stimulating factor receptor activity; F:protein homodimerization activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:axon guidance; P:cell population proliferation; P:cell-cell junction maintenance; P:cellular response to cytokine stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cytokine-mediated signaling pathway; P:forebrain neuron differentiation; P:hematopoietic progenitor cell differentiation; P:hemopoiesis; P:inflammatory response; P:innate immune response; P:macrophage colony-stimulating factor signaling pathway; P:macrophage differentiation; P:mammary gland duct morphogenesis; P:microglial cell proliferation; P:monocyte differentiation; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:olfactory bulb development; P:osteoclast differentiation; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:positive regulation by host of viral process; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of chemokine production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:regulation of actin cytoskeleton reorganization; P:regulation of bone resorption; P:regulation of cell shape; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to ischemia; P:ruffle organization; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q12766 G5E9Y4 Q86UG3 Q9UMF4,HMG domain-containing protein 3,HMG box-containing protein 3;Protein SMF;, PF18717;PF09011;, GO:0005634;GO:0003677;, C:nucleus;, F:DNA binding;|P07333 B5A955 D3DQG2 Q6LDW5 Q6LDY4 Q86VW7,Macrophage colony-stimulating factor 1 receptor,CSF-1 receptor;Proto-oncogene c-Fms;, PF00047;PF07714;, GO:0009986;GO:1990682;GO:0005887;GO:0043231;GO:0005654;GO:0005886;GO:0043235;GO:0005524;GO:0019955;GO:0005011;GO:0042803;GO:0019903;GO:0004713;GO:0004714;GO:0007411;GO:0008283;GO:0045217;GO:0071345;GO:0036006;GO:0019221;GO:0021879;GO:0002244;GO:0030097;GO:0006954;GO:0045087;GO:0038145;GO:0030225;GO:0060603;GO:0061518;GO:0030224;GO:0007275;GO:0043066;GO:0008285;GO:0021772;GO:0030316;GO:0018108;GO:0046488;GO:0048015;GO:0044794;GO:0030335;GO:2000147;GO:0008284;GO:0032722;GO:0070374;GO:0033674;GO:0010759;GO:0120041;GO:0001934;GO:0071902;GO:0061098;GO:0042531;GO:0046777;GO:2000249;GO:0045124;GO:0008360;GO:0060260;GO:0002931;GO:0031529;GO:0007165;GO:0007169;, C:cell surface; C:CSF1-CSF1R complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:ATP binding; F:cytokine binding; F:macrophage colony-stimulating factor receptor activity; F:protein homodimerization activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:axon guidance; P:cell population proliferation; P:cell-cell junction maintenance; P:cellular response to cytokine stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cytokine-mediated signaling pathway; P:forebrain neuron differentiation; P:hematopoietic progenitor cell differentiation; P:hemopoiesis; P:inflammatory response; P:innate immune response; P:macrophage colony-stimulating factor signaling pathway; P:macrophage differentiation; P:mammary gland duct morphogenesis; P:microglial cell proliferation; P:monocyte differentiation; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:olfactory bulb development; P:osteoclast differentiation; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:positive regulation by host of viral process; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of chemokine production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:regulation of actin cytoskeleton reorganization; P:regulation of bone resorption; P:regulation of cell shape; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to ischemia; P:ruffle organization; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P07333 B5A955 D3DQG2 Q6LDW5 Q6LDY4 Q86VW7,Macrophage colony-stimulating factor 1 receptor,CSF-1 receptor;Proto-oncogene c-Fms;, PF00047;PF07714;, GO:0009986;GO:1990682;GO:0005887;GO:0043231;GO:0005654;GO:0005886;GO:0043235;GO:0005524;GO:0019955;GO:0005011;GO:0042803;GO:0019903;GO:0004713;GO:0004714;GO:0007411;GO:0008283;GO:0045217;GO:0071345;GO:0036006;GO:0019221;GO:0021879;GO:0002244;GO:0030097;GO:0006954;GO:0045087;GO:0038145;GO:0030225;GO:0060603;GO:0061518;GO:0030224;GO:0007275;GO:0043066;GO:0008285;GO:0021772;GO:0030316;GO:0018108;GO:0046488;GO:0048015;GO:0044794;GO:0030335;GO:2000147;GO:0008284;GO:0032722;GO:0070374;GO:0033674;GO:0010759;GO:0120041;GO:0001934;GO:0071902;GO:0061098;GO:0042531;GO:0046777;GO:2000249;GO:0045124;GO:0008360;GO:0060260;GO:0002931;GO:0031529;GO:0007165;GO:0007169;, C:cell surface; C:CSF1-CSF1R complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:ATP binding; F:cytokine binding; F:macrophage colony-stimulating factor receptor activity; F:protein homodimerization activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:axon guidance; P:cell population proliferation; P:cell-cell junction maintenance; P:cellular response to cytokine stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cytokine-mediated signaling pathway; P:forebrain neuron differentiation; P:hematopoietic progenitor cell differentiation; P:hemopoiesis; P:inflammatory response; P:innate immune response; P:macrophage colony-stimulating factor signaling pathway; P:macrophage differentiation; P:mammary gland duct morphogenesis; P:microglial cell proliferation; P:monocyte differentiation; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:olfactory bulb development; P:osteoclast differentiation; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:positive regulation by host of viral process; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of chemokine production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:regulation of actin cytoskeleton reorganization; P:regulation of bone resorption; P:regulation of cell shape; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to ischemia; P:ruffle organization; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P07333 B5A955 D3DQG2 Q6LDW5 Q6LDY4 Q86VW7,Macrophage colony-stimulating factor 1 receptor,CSF-1 receptor;Proto-oncogene c-Fms;, PF00047;PF07714;, GO:0009986;GO:1990682;GO:0005887;GO:0043231;GO:0005654;GO:0005886;GO:0043235;GO:0005524;GO:0019955;GO:0005011;GO:0042803;GO:0019903;GO:0004713;GO:0004714;GO:0007411;GO:0008283;GO:0045217;GO:0071345;GO:0036006;GO:0019221;GO:0021879;GO:0002244;GO:0030097;GO:0006954;GO:0045087;GO:0038145;GO:0030225;GO:0060603;GO:0061518;GO:0030224;GO:0007275;GO:0043066;GO:0008285;GO:0021772;GO:0030316;GO:0018108;GO:0046488;GO:0048015;GO:0044794;GO:0030335;GO:2000147;GO:0008284;GO:0032722;GO:0070374;GO:0033674;GO:0010759;GO:0120041;GO:0001934;GO:0071902;GO:0061098;GO:0042531;GO:0046777;GO:2000249;GO:0045124;GO:0008360;GO:0060260;GO:0002931;GO:0031529;GO:0007165;GO:0007169;, C:cell surface; C:CSF1-CSF1R complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:ATP binding; F:cytokine binding; F:macrophage colony-stimulating factor receptor activity; F:protein homodimerization activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:axon guidance; P:cell population proliferation; P:cell-cell junction maintenance; P:cellular response to cytokine stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cytokine-mediated signaling pathway; P:forebrain neuron differentiation; P:hematopoietic progenitor cell differentiation; P:hemopoiesis; P:inflammatory response; P:innate immune response; P:macrophage colony-stimulating factor signaling pathway; P:macrophage differentiation; P:mammary gland duct morphogenesis; P:microglial cell proliferation; P:monocyte differentiation; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:olfactory bulb development; P:osteoclast differentiation; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:positive regulation by host of viral process; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of chemokine production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:regulation of actin cytoskeleton reorganization; P:regulation of bone resorption; P:regulation of cell shape; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to ischemia; P:ruffle organization; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold4 indexed_genome mRNA 17364494 17385649 . - . ID=transcript_1048;P09619 B5A957 Q8N5L4,Platelet-derived growth factor receptor beta,Beta platelet-derived growth factor receptor;Beta-type platelet-derived growth factor receptor;CD140 antigen-like family member B;Platelet-derived growth factor receptor 1;, PF07679;PF00047;PF07714;, GO:0016324;GO:0009986;GO:0005737;GO:0031410;GO:0005925;GO:0005794;GO:0005887;GO:0043231;GO:0031226;GO:0043202;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0019899;GO:0019838;GO:0043548;GO:0004992;GO:0005019;GO:0048407;GO:0005161;GO:0005017;GO:0019901;GO:0004713;GO:0005102;GO:0004714;GO:0038085;GO:0007568;GO:0035909;GO:0055003;GO:0060326;GO:0016477;GO:0060981;GO:0035441;GO:0006024;GO:0048839;GO:0060437;GO:0008584;GO:0000165;GO:0072278;GO:0072277;GO:0072262;GO:0035789;GO:0072075;GO:0072284;GO:0007275;GO:0043066;GO:0018108;GO:0046488;GO:0048015;GO:0048008;GO:0035791;GO:0043065;GO:0090280;GO:0030335;GO:0008284;GO:0038091;GO:0050921;GO:0032967;GO:2000573;GO:0070374;GO:0048146;GO:2000491;GO:0033674;GO:0043406;GO:0035793;GO:0045840;GO:0043552;GO:0014068;GO:0010863;GO:0032516;GO:0051897;GO:2000379;GO:0035025;GO:0014911;GO:0048661;GO:0046777;GO:0032956;GO:0032355;GO:0043627;GO:0034405;GO:0042542;GO:0055093;GO:0032526;GO:0009636;GO:0061298;GO:0007165;GO:0071670;GO:0007169;GO:0042060;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of plasma membrane; C:lysosomal lumen; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:enzyme binding; F:growth factor binding; F:phosphatidylinositol 3-kinase binding; F:platelet activating factor receptor activity; F:platelet-derived growth factor beta-receptor activity; F:platelet-derived growth factor binding; F:platelet-derived growth factor receptor binding; F:platelet-derived growth factor-activated receptor activity; F:protein kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor binding;, P:aging; P:aorta morphogenesis; P:cardiac myofibril assembly; P:cell chemotaxis; P:cell migration; P:cell migration involved in coronary angiogenesis; P:cell migration involved in vasculogenesis; P:glycosaminoglycan biosynthetic process; P:inner ear development; P:lung growth; P:male gonad development; P:MAPK cascade; P:metanephric comma-shaped body morphogenesis; P:metanephric glomerular capillary formation; P:metanephric glomerular mesangial cell proliferation involved in metanephros development; P:metanephric mesenchymal cell migration; P:metanephric mesenchyme development; P:metanephric S-shaped body morphogenesis; P:multicellular organism development; P:negative regulation of apoptotic process; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:platelet-derived growth factor receptor signaling pathway; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of calcium ion import; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; P:positive regulation of chemotaxis; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of hepatic stellate cell activation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:protein autophosphorylation; P:regulation of actin cytoskeleton organization; P:response to estradiol; P:response to estrogen; P:response to fluid shear stress; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to retinoic acid; P:response to toxic substance; P:retina vasculature development in camera-type eye; P:signal transduction; P:smooth muscle cell chemotaxis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing;|P09619 B5A957 Q8N5L4,Platelet-derived growth factor receptor beta,Beta platelet-derived growth factor receptor;Beta-type platelet-derived growth factor receptor;CD140 antigen-like family member B;Platelet-derived growth factor receptor 1;, PF07679;PF00047;PF07714;, GO:0016324;GO:0009986;GO:0005737;GO:0031410;GO:0005925;GO:0005794;GO:0005887;GO:0043231;GO:0031226;GO:0043202;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0019899;GO:0019838;GO:0043548;GO:0004992;GO:0005019;GO:0048407;GO:0005161;GO:0005017;GO:0019901;GO:0004713;GO:0005102;GO:0004714;GO:0038085;GO:0007568;GO:0035909;GO:0055003;GO:0060326;GO:0016477;GO:0060981;GO:0035441;GO:0006024;GO:0048839;GO:0060437;GO:0008584;GO:0000165;GO:0072278;GO:0072277;GO:0072262;GO:0035789;GO:0072075;GO:0072284;GO:0007275;GO:0043066;GO:0018108;GO:0046488;GO:0048015;GO:0048008;GO:0035791;GO:0043065;GO:0090280;GO:0030335;GO:0008284;GO:0038091;GO:0050921;GO:0032967;GO:2000573;GO:0070374;GO:0048146;GO:2000491;GO:0033674;GO:0043406;GO:0035793;GO:0045840;GO:0043552;GO:0014068;GO:0010863;GO:0032516;GO:0051897;GO:2000379;GO:0035025;GO:0014911;GO:0048661;GO:0046777;GO:0032956;GO:0032355;GO:0043627;GO:0034405;GO:0042542;GO:0055093;GO:0032526;GO:0009636;GO:0061298;GO:0007165;GO:0071670;GO:0007169;GO:0042060;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of plasma membrane; C:lysosomal lumen; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:enzyme binding; F:growth factor binding; F:phosphatidylinositol 3-kinase binding; F:platelet activating factor receptor activity; F:platelet-derived growth factor beta-receptor activity; F:platelet-derived growth factor binding; F:platelet-derived growth factor receptor binding; F:platelet-derived growth factor-activated receptor activity; F:protein kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor binding;, P:aging; P:aorta morphogenesis; P:cardiac myofibril assembly; P:cell chemotaxis; P:cell migration; P:cell migration involved in coronary angiogenesis; P:cell migration involved in vasculogenesis; P:glycosaminoglycan biosynthetic process; P:inner ear development; P:lung growth; P:male gonad development; P:MAPK cascade; P:metanephric comma-shaped body morphogenesis; P:metanephric glomerular capillary formation; P:metanephric glomerular mesangial cell proliferation involved in metanephros development; P:metanephric mesenchymal cell migration; P:metanephric mesenchyme development; P:metanephric S-shaped body morphogenesis; P:multicellular organism development; P:negative regulation of apoptotic process; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:platelet-derived growth factor receptor signaling pathway; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of calcium ion import; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; P:positive regulation of chemotaxis; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of hepatic stellate cell activation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:protein autophosphorylation; P:regulation of actin cytoskeleton organization; P:response to estradiol; P:response to estrogen; P:response to fluid shear stress; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to retinoic acid; P:response to toxic substance; P:retina vasculature development in camera-type eye; P:signal transduction; P:smooth muscle cell chemotaxis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing;|P09619 B5A957 Q8N5L4,Platelet-derived growth factor receptor beta,Beta platelet-derived growth factor receptor;Beta-type platelet-derived growth factor receptor;CD140 antigen-like family member B;Platelet-derived growth factor receptor 1;, PF07679;PF00047;PF07714;, GO:0016324;GO:0009986;GO:0005737;GO:0031410;GO:0005925;GO:0005794;GO:0005887;GO:0043231;GO:0031226;GO:0043202;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0019899;GO:0019838;GO:0043548;GO:0004992;GO:0005019;GO:0048407;GO:0005161;GO:0005017;GO:0019901;GO:0004713;GO:0005102;GO:0004714;GO:0038085;GO:0007568;GO:0035909;GO:0055003;GO:0060326;GO:0016477;GO:0060981;GO:0035441;GO:0006024;GO:0048839;GO:0060437;GO:0008584;GO:0000165;GO:0072278;GO:0072277;GO:0072262;GO:0035789;GO:0072075;GO:0072284;GO:0007275;GO:0043066;GO:0018108;GO:0046488;GO:0048015;GO:0048008;GO:0035791;GO:0043065;GO:0090280;GO:0030335;GO:0008284;GO:0038091;GO:0050921;GO:0032967;GO:2000573;GO:0070374;GO:0048146;GO:2000491;GO:0033674;GO:0043406;GO:0035793;GO:0045840;GO:0043552;GO:0014068;GO:0010863;GO:0032516;GO:0051897;GO:2000379;GO:0035025;GO:0014911;GO:0048661;GO:0046777;GO:0032956;GO:0032355;GO:0043627;GO:0034405;GO:0042542;GO:0055093;GO:0032526;GO:0009636;GO:0061298;GO:0007165;GO:0071670;GO:0007169;GO:0042060;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of plasma membrane; C:lysosomal lumen; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:enzyme binding; F:growth factor binding; F:phosphatidylinositol 3-kinase binding; F:platelet activating factor receptor activity; F:platelet-derived growth factor beta-receptor activity; F:platelet-derived growth factor binding; F:platelet-derived growth factor receptor binding; F:platelet-derived growth factor-activated receptor activity; F:protein kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor binding;, P:aging; P:aorta morphogenesis; P:cardiac myofibril assembly; P:cell chemotaxis; P:cell migration; P:cell migration involved in coronary angiogenesis; P:cell migration involved in vasculogenesis; P:glycosaminoglycan biosynthetic process; P:inner ear development; P:lung growth; P:male gonad development; P:MAPK cascade; P:metanephric comma-shaped body morphogenesis; P:metanephric glomerular capillary formation; P:metanephric glomerular mesangial cell proliferation involved in metanephros development; P:metanephric mesenchymal cell migration; P:metanephric mesenchyme development; P:metanephric S-shaped body morphogenesis; P:multicellular organism development; P:negative regulation of apoptotic process; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:platelet-derived growth factor receptor signaling pathway; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of calcium ion import; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; P:positive regulation of chemotaxis; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of hepatic stellate cell activation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:protein autophosphorylation; P:regulation of actin cytoskeleton organization; P:response to estradiol; P:response to estrogen; P:response to fluid shear stress; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to retinoic acid; P:response to toxic substance; P:retina vasculature development in camera-type eye; P:signal transduction; P:smooth muscle cell chemotaxis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing;|P09619 B5A957 Q8N5L4,Platelet-derived growth factor receptor beta,Beta platelet-derived growth factor receptor;Beta-type platelet-derived growth factor receptor;CD140 antigen-like family member B;Platelet-derived growth factor receptor 1;, PF07679;PF00047;PF07714;, GO:0016324;GO:0009986;GO:0005737;GO:0031410;GO:0005925;GO:0005794;GO:0005887;GO:0043231;GO:0031226;GO:0043202;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0019899;GO:0019838;GO:0043548;GO:0004992;GO:0005019;GO:0048407;GO:0005161;GO:0005017;GO:0019901;GO:0004713;GO:0005102;GO:0004714;GO:0038085;GO:0007568;GO:0035909;GO:0055003;GO:0060326;GO:0016477;GO:0060981;GO:0035441;GO:0006024;GO:0048839;GO:0060437;GO:0008584;GO:0000165;GO:0072278;GO:0072277;GO:0072262;GO:0035789;GO:0072075;GO:0072284;GO:0007275;GO:0043066;GO:0018108;GO:0046488;GO:0048015;GO:0048008;GO:0035791;GO:0043065;GO:0090280;GO:0030335;GO:0008284;GO:0038091;GO:0050921;GO:0032967;GO:2000573;GO:0070374;GO:0048146;GO:2000491;GO:0033674;GO:0043406;GO:0035793;GO:0045840;GO:0043552;GO:0014068;GO:0010863;GO:0032516;GO:0051897;GO:2000379;GO:0035025;GO:0014911;GO:0048661;GO:0046777;GO:0032956;GO:0032355;GO:0043627;GO:0034405;GO:0042542;GO:0055093;GO:0032526;GO:0009636;GO:0061298;GO:0007165;GO:0071670;GO:0007169;GO:0042060;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of plasma membrane; C:lysosomal lumen; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:enzyme binding; F:growth factor binding; F:phosphatidylinositol 3-kinase binding; F:platelet activating factor receptor activity; F:platelet-derived growth factor beta-receptor activity; F:platelet-derived growth factor binding; F:platelet-derived growth factor receptor binding; F:platelet-derived growth factor-activated receptor activity; F:protein kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor binding;, P:aging; P:aorta morphogenesis; P:cardiac myofibril assembly; P:cell chemotaxis; P:cell migration; P:cell migration involved in coronary angiogenesis; P:cell migration involved in vasculogenesis; P:glycosaminoglycan biosynthetic process; P:inner ear development; P:lung growth; P:male gonad development; P:MAPK cascade; P:metanephric comma-shaped body morphogenesis; P:metanephric glomerular capillary formation; P:metanephric glomerular mesangial cell proliferation involved in metanephros development; P:metanephric mesenchymal cell migration; P:metanephric mesenchyme development; P:metanephric S-shaped body morphogenesis; P:multicellular organism development; P:negative regulation of apoptotic process; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:platelet-derived growth factor receptor signaling pathway; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of calcium ion import; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; P:positive regulation of chemotaxis; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of hepatic stellate cell activation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:protein autophosphorylation; P:regulation of actin cytoskeleton organization; P:response to estradiol; P:response to estrogen; P:response to fluid shear stress; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to retinoic acid; P:response to toxic substance; P:retina vasculature development in camera-type eye; P:signal transduction; P:smooth muscle cell chemotaxis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing;|P09619 B5A957 Q8N5L4,Platelet-derived growth factor receptor beta,Beta platelet-derived growth factor receptor;Beta-type platelet-derived growth factor receptor;CD140 antigen-like family member B;Platelet-derived growth factor receptor 1;, PF07679;PF00047;PF07714;, GO:0016324;GO:0009986;GO:0005737;GO:0031410;GO:0005925;GO:0005794;GO:0005887;GO:0043231;GO:0031226;GO:0043202;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0019899;GO:0019838;GO:0043548;GO:0004992;GO:0005019;GO:0048407;GO:0005161;GO:0005017;GO:0019901;GO:0004713;GO:0005102;GO:0004714;GO:0038085;GO:0007568;GO:0035909;GO:0055003;GO:0060326;GO:0016477;GO:0060981;GO:0035441;GO:0006024;GO:0048839;GO:0060437;GO:0008584;GO:0000165;GO:0072278;GO:0072277;GO:0072262;GO:0035789;GO:0072075;GO:0072284;GO:0007275;GO:0043066;GO:0018108;GO:0046488;GO:0048015;GO:0048008;GO:0035791;GO:0043065;GO:0090280;GO:0030335;GO:0008284;GO:0038091;GO:0050921;GO:0032967;GO:2000573;GO:0070374;GO:0048146;GO:2000491;GO:0033674;GO:0043406;GO:0035793;GO:0045840;GO:0043552;GO:0014068;GO:0010863;GO:0032516;GO:0051897;GO:2000379;GO:0035025;GO:0014911;GO:0048661;GO:0046777;GO:0032956;GO:0032355;GO:0043627;GO:0034405;GO:0042542;GO:0055093;GO:0032526;GO:0009636;GO:0061298;GO:0007165;GO:0071670;GO:0007169;GO:0042060;, C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of plasma membrane; C:lysosomal lumen; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:enzyme binding; F:growth factor binding; F:phosphatidylinositol 3-kinase binding; F:platelet activating factor receptor activity; F:platelet-derived growth factor beta-receptor activity; F:platelet-derived growth factor binding; F:platelet-derived growth factor receptor binding; F:platelet-derived growth factor-activated receptor activity; F:protein kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor binding;, P:aging; P:aorta morphogenesis; P:cardiac myofibril assembly; P:cell chemotaxis; P:cell migration; P:cell migration involved in coronary angiogenesis; P:cell migration involved in vasculogenesis; P:glycosaminoglycan biosynthetic process; P:inner ear development; P:lung growth; P:male gonad development; P:MAPK cascade; P:metanephric comma-shaped body morphogenesis; P:metanephric glomerular capillary formation; P:metanephric glomerular mesangial cell proliferation involved in metanephros development; P:metanephric mesenchymal cell migration; P:metanephric mesenchyme development; P:metanephric S-shaped body morphogenesis; P:multicellular organism development; P:negative regulation of apoptotic process; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:platelet-derived growth factor receptor signaling pathway; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of calcium ion import; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; P:positive regulation of chemotaxis; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of hepatic stellate cell activation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:protein autophosphorylation; P:regulation of actin cytoskeleton organization; P:response to estradiol; P:response to estrogen; P:response to fluid shear stress; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to retinoic acid; P:response to toxic substance; P:retina vasculature development in camera-type eye; P:signal transduction; P:smooth muscle cell chemotaxis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing; scaffold4 indexed_genome mRNA 17435850 17455763 . + . ID=transcript_1049;Q99884 Q0VG81 Q52LU6,Sodium-dependent proline transporter,Solute carrier family 6 member 7;, PF00209;, GO:0005887;GO:0016020;GO:0005886;GO:0015193;GO:0015293;GO:0006836;GO:0015824;GO:0035725;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:L-proline transmembrane transporter activity; F:symporter activity;, P:neurotransmitter transport; P:proline transport; P:sodium ion transmembrane transport;|Q99884 Q0VG81 Q52LU6,Sodium-dependent proline transporter,Solute carrier family 6 member 7;, PF00209;, GO:0005887;GO:0016020;GO:0005886;GO:0015193;GO:0015293;GO:0006836;GO:0015824;GO:0035725;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:L-proline transmembrane transporter activity; F:symporter activity;, P:neurotransmitter transport; P:proline transport; P:sodium ion transmembrane transport;|Q99884 Q0VG81 Q52LU6,Sodium-dependent proline transporter,Solute carrier family 6 member 7;, PF00209;, GO:0005887;GO:0016020;GO:0005886;GO:0015193;GO:0015293;GO:0006836;GO:0015824;GO:0035725;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:L-proline transmembrane transporter activity; F:symporter activity;, P:neurotransmitter transport; P:proline transport; P:sodium ion transmembrane transport;|Q99884 Q0VG81 Q52LU6,Sodium-dependent proline transporter,Solute carrier family 6 member 7;, PF00209;, GO:0005887;GO:0016020;GO:0005886;GO:0015193;GO:0015293;GO:0006836;GO:0015824;GO:0035725;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:L-proline transmembrane transporter activity; F:symporter activity;, P:neurotransmitter transport; P:proline transport; P:sodium ion transmembrane transport;|Q99884 Q0VG81 Q52LU6,Sodium-dependent proline transporter,Solute carrier family 6 member 7;, PF00209;, GO:0005887;GO:0016020;GO:0005886;GO:0015193;GO:0015293;GO:0006836;GO:0015824;GO:0035725;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:L-proline transmembrane transporter activity; F:symporter activity;, P:neurotransmitter transport; P:proline transport; P:sodium ion transmembrane transport;|Q99884 Q0VG81 Q52LU6,Sodium-dependent proline transporter,Solute carrier family 6 member 7;, PF00209;, GO:0005887;GO:0016020;GO:0005886;GO:0015193;GO:0015293;GO:0006836;GO:0015824;GO:0035725;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:L-proline transmembrane transporter activity; F:symporter activity;, P:neurotransmitter transport; P:proline transport; P:sodium ion transmembrane transport; scaffold4 indexed_genome mRNA 17465911 17528006 . - . ID=transcript_1050;Q9UQM7 Q9UL21 Q9Y2H4 Q9Y352,Calcium/calmodulin-dependent protein kinase type II subunit alpha,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0043197;GO:0030666;GO:0005739;GO:0043005;GO:0005654;GO:0005634;GO:0014069;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0035254;GO:0042802;GO:0016301;GO:0046872;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0038166;GO:0006816;GO:0060996;GO:0000082;GO:0060333;GO:0000165;GO:0051346;GO:0018105;GO:1990443;GO:0051928;GO:0010666;GO:0051092;GO:0046777;GO:0006468;GO:1900034;GO:2000124;GO:1902108;GO:2001222;GO:0048168;GO:0046928;GO:2000310;GO:0002931;GO:0007223;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:dendritic spine; C:endocytic vesicle membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:glutamate receptor binding; F:identical protein binding; F:kinase activity; F:metal ion binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:angiotensin-activated signaling pathway; P:calcium ion transport; P:dendritic spine development; P:G1/S transition of mitotic cell cycle; P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:negative regulation of hydrolase activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine autophosphorylation; P:positive regulation of calcium ion transport; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cellular response to heat; P:regulation of endocannabinoid signaling pathway; P:regulation of mitochondrial membrane permeability involved in apoptotic process; P:regulation of neuron migration; P:regulation of neuronal synaptic plasticity; P:regulation of neurotransmitter secretion; P:regulation of NMDA receptor activity; P:response to ischemia; P:Wnt signaling pathway, calcium modulating pathway;|Q9UQM7 Q9UL21 Q9Y2H4 Q9Y352,Calcium/calmodulin-dependent protein kinase type II subunit alpha,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0043197;GO:0030666;GO:0005739;GO:0043005;GO:0005654;GO:0005634;GO:0014069;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0035254;GO:0042802;GO:0016301;GO:0046872;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0038166;GO:0006816;GO:0060996;GO:0000082;GO:0060333;GO:0000165;GO:0051346;GO:0018105;GO:1990443;GO:0051928;GO:0010666;GO:0051092;GO:0046777;GO:0006468;GO:1900034;GO:2000124;GO:1902108;GO:2001222;GO:0048168;GO:0046928;GO:2000310;GO:0002931;GO:0007223;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:dendritic spine; C:endocytic vesicle membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:glutamate receptor binding; F:identical protein binding; F:kinase activity; F:metal ion binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:angiotensin-activated signaling pathway; P:calcium ion transport; P:dendritic spine development; P:G1/S transition of mitotic cell cycle; P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:negative regulation of hydrolase activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine autophosphorylation; P:positive regulation of calcium ion transport; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cellular response to heat; P:regulation of endocannabinoid signaling pathway; P:regulation of mitochondrial membrane permeability involved in apoptotic process; P:regulation of neuron migration; P:regulation of neuronal synaptic plasticity; P:regulation of neurotransmitter secretion; P:regulation of NMDA receptor activity; P:response to ischemia; P:Wnt signaling pathway, calcium modulating pathway; scaffold4 indexed_genome mRNA 17535158 17540603 . - . ID=transcript_1051;Q5FYB1 A1L3B0 B3KV22 B7XD03,Arylsulfatase I,, PF00884;, GO:0005788;GO:0005576;GO:0004065;GO:0046872;, C:endoplasmic reticulum lumen; C:extracellular region;, F:arylsulfatase activity; F:metal ion binding; scaffold4 indexed_genome mRNA 17600649 17636645 . + . ID=transcript_1052;Q13428 A0JLU0 B4E111 Q6SC72 Q7Z5W9 Q96A52 Q99408 Q99860,Treacle protein,Treacher Collins syndrome protein;, PF03546;, GO:0005829;GO:0001650;GO:0005730;GO:0005654;GO:0046982;GO:0030674;GO:0003723;GO:0097110;GO:0005215;GO:0014032;GO:0014029;GO:0042790;GO:0006417;GO:0001501;, C:cytosol; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:protein heterodimerization activity; F:protein-macromolecule adaptor activity; F:RNA binding; F:scaffold protein binding; F:transporter activity;, P:neural crest cell development; P:neural crest formation; P:nucleolar large rRNA transcription by RNA polymerase I; P:regulation of translation; P:skeletal system development;|Q13428 A0JLU0 B4E111 Q6SC72 Q7Z5W9 Q96A52 Q99408 Q99860,Treacle protein,Treacher Collins syndrome protein;, PF03546;, GO:0005829;GO:0001650;GO:0005730;GO:0005654;GO:0046982;GO:0030674;GO:0003723;GO:0097110;GO:0005215;GO:0014032;GO:0014029;GO:0042790;GO:0006417;GO:0001501;, C:cytosol; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:protein heterodimerization activity; F:protein-macromolecule adaptor activity; F:RNA binding; F:scaffold protein binding; F:transporter activity;, P:neural crest cell development; P:neural crest formation; P:nucleolar large rRNA transcription by RNA polymerase I; P:regulation of translation; P:skeletal system development; scaffold4 indexed_genome mRNA 17639684 17647394 . - . ID=transcript_1053;Q8WLP6,HLA class II histocompatibility antigen gamma chain {ECO:0000305},HLA-DR antigens-associated invariant chain;Ia antigen-associated invariant chain;, PF09307;PF08831;PF00086;, GO:0009986;GO:0030669;GO:0005737;GO:0030666;GO:0012507;GO:0009897;GO:0070062;GO:0000139;GO:0071556;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0035692;GO:0016020;GO:0042613;GO:0005771;GO:0035693;GO:0005634;GO:0005886;GO:0032991;GO:0032588;GO:0030658;GO:0005773;GO:0001540;GO:0042609;GO:0019955;GO:0004896;GO:0042802;GO:0035718;GO:0042289;GO:0042658;GO:0023026;GO:0050998;GO:0044183;GO:0000187;GO:0019882;GO:0019883;GO:0019886;GO:0008283;GO:0051085;GO:0016064;GO:0006886;GO:0050900;GO:0035691;GO:0043066;GO:0030336;GO:0043518;GO:1902166;GO:0002906;GO:0002792;GO:0045581;GO:0046597;GO:0045060;GO:0030890;GO:2000343;GO:0032722;GO:0001961;GO:0002606;GO:0070374;GO:0048146;GO:0010628;GO:0043123;GO:0032755;GO:0032757;GO:0033674;GO:0060907;GO:2000448;GO:0043410;GO:0045657;GO:0090023;GO:0050731;GO:0031394;GO:0001934;GO:0045582;GO:0045893;GO:0002830;GO:0046598;GO:0045059;GO:0001516;GO:0050821;GO:0070206;GO:0065003;GO:0043030;GO:0034341;GO:0002286;GO:0045058;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:endocytic vesicle membrane; C:ER to Golgi transport vesicle membrane; C:external side of plasma membrane; C:extracellular exosome; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:macrophage migration inhibitory factor receptor complex; C:membrane; C:MHC class II protein complex; C:multivesicular body; C:NOS2-CD74 complex; C:nucleus; C:plasma membrane; C:protein-containing complex; C:trans-Golgi network membrane; C:transport vesicle membrane; C:vacuole;, F:amyloid-beta binding; F:CD4 receptor binding; F:cytokine binding; F:cytokine receptor activity; F:identical protein binding; F:macrophage migration inhibitory factor binding; F:MHC class II protein binding; F:MHC class II protein binding, via antigen binding groove; F:MHC class II protein complex binding; F:nitric-oxide synthase binding; F:protein folding chaperone;, P:activation of MAPK activity; P:antigen processing and presentation; P:antigen processing and presentation of endogenous antigen; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell population proliferation; P:chaperone cofactor-dependent protein refolding; P:immunoglobulin mediated immune response; P:intracellular protein transport; P:leukocyte migration; P:macrophage migration inhibitory factor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell migration; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of mature B cell apoptotic process; P:negative regulation of peptide secretion; P:negative regulation of T cell differentiation; P:negative regulation of viral entry into host cell; P:negative thymic T cell selection; P:positive regulation of B cell proliferation; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of chemokine production; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of kinase activity; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage migration inhibitory factor signaling pathway; P:positive regulation of MAPK cascade; P:positive regulation of monocyte differentiation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of protein phosphorylation; P:positive regulation of T cell differentiation; P:positive regulation of transcription, DNA-templated; P:positive regulation of type 2 immune response; P:positive regulation of viral entry into host cell; P:positive thymic T cell selection; P:prostaglandin biosynthetic process; P:protein stabilization; P:protein trimerization; P:protein-containing complex assembly; P:regulation of macrophage activation; P:response to interferon-gamma; P:T cell activation involved in immune response; P:T cell selection;|Q8WLP6,HLA class II histocompatibility antigen gamma chain {ECO:0000305},HLA-DR antigens-associated invariant chain;Ia antigen-associated invariant chain;, PF09307;PF08831;PF00086;, GO:0009986;GO:0030669;GO:0005737;GO:0030666;GO:0012507;GO:0009897;GO:0070062;GO:0000139;GO:0071556;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0035692;GO:0016020;GO:0042613;GO:0005771;GO:0035693;GO:0005634;GO:0005886;GO:0032991;GO:0032588;GO:0030658;GO:0005773;GO:0001540;GO:0042609;GO:0019955;GO:0004896;GO:0042802;GO:0035718;GO:0042289;GO:0042658;GO:0023026;GO:0050998;GO:0044183;GO:0000187;GO:0019882;GO:0019883;GO:0019886;GO:0008283;GO:0051085;GO:0016064;GO:0006886;GO:0050900;GO:0035691;GO:0043066;GO:0030336;GO:0043518;GO:1902166;GO:0002906;GO:0002792;GO:0045581;GO:0046597;GO:0045060;GO:0030890;GO:2000343;GO:0032722;GO:0001961;GO:0002606;GO:0070374;GO:0048146;GO:0010628;GO:0043123;GO:0032755;GO:0032757;GO:0033674;GO:0060907;GO:2000448;GO:0043410;GO:0045657;GO:0090023;GO:0050731;GO:0031394;GO:0001934;GO:0045582;GO:0045893;GO:0002830;GO:0046598;GO:0045059;GO:0001516;GO:0050821;GO:0070206;GO:0065003;GO:0043030;GO:0034341;GO:0002286;GO:0045058;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:endocytic vesicle membrane; C:ER to Golgi transport vesicle membrane; C:external side of plasma membrane; C:extracellular exosome; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:macrophage migration inhibitory factor receptor complex; C:membrane; C:MHC class II protein complex; C:multivesicular body; C:NOS2-CD74 complex; C:nucleus; C:plasma membrane; C:protein-containing complex; C:trans-Golgi network membrane; C:transport vesicle membrane; C:vacuole;, F:amyloid-beta binding; F:CD4 receptor binding; F:cytokine binding; F:cytokine receptor activity; F:identical protein binding; F:macrophage migration inhibitory factor binding; F:MHC class II protein binding; F:MHC class II protein binding, via antigen binding groove; F:MHC class II protein complex binding; F:nitric-oxide synthase binding; F:protein folding chaperone;, P:activation of MAPK activity; P:antigen processing and presentation; P:antigen processing and presentation of endogenous antigen; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell population proliferation; P:chaperone cofactor-dependent protein refolding; P:immunoglobulin mediated immune response; P:intracellular protein transport; P:leukocyte migration; P:macrophage migration inhibitory factor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell migration; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of mature B cell apoptotic process; P:negative regulation of peptide secretion; P:negative regulation of T cell differentiation; P:negative regulation of viral entry into host cell; P:negative thymic T cell selection; P:positive regulation of B cell proliferation; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of chemokine production; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of kinase activity; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage migration inhibitory factor signaling pathway; P:positive regulation of MAPK cascade; P:positive regulation of monocyte differentiation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of protein phosphorylation; P:positive regulation of T cell differentiation; P:positive regulation of transcription, DNA-templated; P:positive regulation of type 2 immune response; P:positive regulation of viral entry into host cell; P:positive thymic T cell selection; P:prostaglandin biosynthetic process; P:protein stabilization; P:protein trimerization; P:protein-containing complex assembly; P:regulation of macrophage activation; P:response to interferon-gamma; P:T cell activation involved in immune response; P:T cell selection;|Q8WLP6,HLA class II histocompatibility antigen gamma chain {ECO:0000305},HLA-DR antigens-associated invariant chain;Ia antigen-associated invariant chain;, PF09307;PF08831;PF00086;, GO:0009986;GO:0030669;GO:0005737;GO:0030666;GO:0012507;GO:0009897;GO:0070062;GO:0000139;GO:0071556;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0035692;GO:0016020;GO:0042613;GO:0005771;GO:0035693;GO:0005634;GO:0005886;GO:0032991;GO:0032588;GO:0030658;GO:0005773;GO:0001540;GO:0042609;GO:0019955;GO:0004896;GO:0042802;GO:0035718;GO:0042289;GO:0042658;GO:0023026;GO:0050998;GO:0044183;GO:0000187;GO:0019882;GO:0019883;GO:0019886;GO:0008283;GO:0051085;GO:0016064;GO:0006886;GO:0050900;GO:0035691;GO:0043066;GO:0030336;GO:0043518;GO:1902166;GO:0002906;GO:0002792;GO:0045581;GO:0046597;GO:0045060;GO:0030890;GO:2000343;GO:0032722;GO:0001961;GO:0002606;GO:0070374;GO:0048146;GO:0010628;GO:0043123;GO:0032755;GO:0032757;GO:0033674;GO:0060907;GO:2000448;GO:0043410;GO:0045657;GO:0090023;GO:0050731;GO:0031394;GO:0001934;GO:0045582;GO:0045893;GO:0002830;GO:0046598;GO:0045059;GO:0001516;GO:0050821;GO:0070206;GO:0065003;GO:0043030;GO:0034341;GO:0002286;GO:0045058;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:endocytic vesicle membrane; C:ER to Golgi transport vesicle membrane; C:external side of plasma membrane; C:extracellular exosome; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:macrophage migration inhibitory factor receptor complex; C:membrane; C:MHC class II protein complex; C:multivesicular body; C:NOS2-CD74 complex; C:nucleus; C:plasma membrane; C:protein-containing complex; C:trans-Golgi network membrane; C:transport vesicle membrane; C:vacuole;, F:amyloid-beta binding; F:CD4 receptor binding; F:cytokine binding; F:cytokine receptor activity; F:identical protein binding; F:macrophage migration inhibitory factor binding; F:MHC class II protein binding; F:MHC class II protein binding, via antigen binding groove; F:MHC class II protein complex binding; F:nitric-oxide synthase binding; F:protein folding chaperone;, P:activation of MAPK activity; P:antigen processing and presentation; P:antigen processing and presentation of endogenous antigen; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell population proliferation; P:chaperone cofactor-dependent protein refolding; P:immunoglobulin mediated immune response; P:intracellular protein transport; P:leukocyte migration; P:macrophage migration inhibitory factor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell migration; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of mature B cell apoptotic process; P:negative regulation of peptide secretion; P:negative regulation of T cell differentiation; P:negative regulation of viral entry into host cell; P:negative thymic T cell selection; P:positive regulation of B cell proliferation; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of chemokine production; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of kinase activity; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage migration inhibitory factor signaling pathway; P:positive regulation of MAPK cascade; P:positive regulation of monocyte differentiation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of protein phosphorylation; P:positive regulation of T cell differentiation; P:positive regulation of transcription, DNA-templated; P:positive regulation of type 2 immune response; P:positive regulation of viral entry into host cell; P:positive thymic T cell selection; P:prostaglandin biosynthetic process; P:protein stabilization; P:protein trimerization; P:protein-containing complex assembly; P:regulation of macrophage activation; P:response to interferon-gamma; P:T cell activation involved in immune response; P:T cell selection;|Q8WLP6,HLA class II histocompatibility antigen gamma chain {ECO:0000305},HLA-DR antigens-associated invariant chain;Ia antigen-associated invariant chain;, PF09307;PF08831;PF00086;, GO:0009986;GO:0030669;GO:0005737;GO:0030666;GO:0012507;GO:0009897;GO:0070062;GO:0000139;GO:0071556;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0035692;GO:0016020;GO:0042613;GO:0005771;GO:0035693;GO:0005634;GO:0005886;GO:0032991;GO:0032588;GO:0030658;GO:0005773;GO:0001540;GO:0042609;GO:0019955;GO:0004896;GO:0042802;GO:0035718;GO:0042289;GO:0042658;GO:0023026;GO:0050998;GO:0044183;GO:0000187;GO:0019882;GO:0019883;GO:0019886;GO:0008283;GO:0051085;GO:0016064;GO:0006886;GO:0050900;GO:0035691;GO:0043066;GO:0030336;GO:0043518;GO:1902166;GO:0002906;GO:0002792;GO:0045581;GO:0046597;GO:0045060;GO:0030890;GO:2000343;GO:0032722;GO:0001961;GO:0002606;GO:0070374;GO:0048146;GO:0010628;GO:0043123;GO:0032755;GO:0032757;GO:0033674;GO:0060907;GO:2000448;GO:0043410;GO:0045657;GO:0090023;GO:0050731;GO:0031394;GO:0001934;GO:0045582;GO:0045893;GO:0002830;GO:0046598;GO:0045059;GO:0001516;GO:0050821;GO:0070206;GO:0065003;GO:0043030;GO:0034341;GO:0002286;GO:0045058;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:endocytic vesicle membrane; C:ER to Golgi transport vesicle membrane; C:external side of plasma membrane; C:extracellular exosome; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:macrophage migration inhibitory factor receptor complex; C:membrane; C:MHC class II protein complex; C:multivesicular body; C:NOS2-CD74 complex; C:nucleus; C:plasma membrane; C:protein-containing complex; C:trans-Golgi network membrane; C:transport vesicle membrane; C:vacuole;, F:amyloid-beta binding; F:CD4 receptor binding; F:cytokine binding; F:cytokine receptor activity; F:identical protein binding; F:macrophage migration inhibitory factor binding; F:MHC class II protein binding; F:MHC class II protein binding, via antigen binding groove; F:MHC class II protein complex binding; F:nitric-oxide synthase binding; F:protein folding chaperone;, P:activation of MAPK activity; P:antigen processing and presentation; P:antigen processing and presentation of endogenous antigen; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell population proliferation; P:chaperone cofactor-dependent protein refolding; P:immunoglobulin mediated immune response; P:intracellular protein transport; P:leukocyte migration; P:macrophage migration inhibitory factor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell migration; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of mature B cell apoptotic process; P:negative regulation of peptide secretion; P:negative regulation of T cell differentiation; P:negative regulation of viral entry into host cell; P:negative thymic T cell selection; P:positive regulation of B cell proliferation; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of chemokine production; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of kinase activity; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage migration inhibitory factor signaling pathway; P:positive regulation of MAPK cascade; P:positive regulation of monocyte differentiation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of protein phosphorylation; P:positive regulation of T cell differentiation; P:positive regulation of transcription, DNA-templated; P:positive regulation of type 2 immune response; P:positive regulation of viral entry into host cell; P:positive thymic T cell selection; P:prostaglandin biosynthetic process; P:protein stabilization; P:protein trimerization; P:protein-containing complex assembly; P:regulation of macrophage activation; P:response to interferon-gamma; P:T cell activation involved in immune response; P:T cell selection;|Q8WLP6,HLA class II histocompatibility antigen gamma chain {ECO:0000305},HLA-DR antigens-associated invariant chain;Ia antigen-associated invariant chain;, PF09307;PF08831;PF00086;, GO:0009986;GO:0030669;GO:0005737;GO:0030666;GO:0012507;GO:0009897;GO:0070062;GO:0000139;GO:0071556;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0035692;GO:0016020;GO:0042613;GO:0005771;GO:0035693;GO:0005634;GO:0005886;GO:0032991;GO:0032588;GO:0030658;GO:0005773;GO:0001540;GO:0042609;GO:0019955;GO:0004896;GO:0042802;GO:0035718;GO:0042289;GO:0042658;GO:0023026;GO:0050998;GO:0044183;GO:0000187;GO:0019882;GO:0019883;GO:0019886;GO:0008283;GO:0051085;GO:0016064;GO:0006886;GO:0050900;GO:0035691;GO:0043066;GO:0030336;GO:0043518;GO:1902166;GO:0002906;GO:0002792;GO:0045581;GO:0046597;GO:0045060;GO:0030890;GO:2000343;GO:0032722;GO:0001961;GO:0002606;GO:0070374;GO:0048146;GO:0010628;GO:0043123;GO:0032755;GO:0032757;GO:0033674;GO:0060907;GO:2000448;GO:0043410;GO:0045657;GO:0090023;GO:0050731;GO:0031394;GO:0001934;GO:0045582;GO:0045893;GO:0002830;GO:0046598;GO:0045059;GO:0001516;GO:0050821;GO:0070206;GO:0065003;GO:0043030;GO:0034341;GO:0002286;GO:0045058;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:endocytic vesicle membrane; C:ER to Golgi transport vesicle membrane; C:external side of plasma membrane; C:extracellular exosome; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:macrophage migration inhibitory factor receptor complex; C:membrane; C:MHC class II protein complex; C:multivesicular body; C:NOS2-CD74 complex; C:nucleus; C:plasma membrane; C:protein-containing complex; C:trans-Golgi network membrane; C:transport vesicle membrane; C:vacuole;, F:amyloid-beta binding; F:CD4 receptor binding; F:cytokine binding; F:cytokine receptor activity; F:identical protein binding; F:macrophage migration inhibitory factor binding; F:MHC class II protein binding; F:MHC class II protein binding, via antigen binding groove; F:MHC class II protein complex binding; F:nitric-oxide synthase binding; F:protein folding chaperone;, P:activation of MAPK activity; P:antigen processing and presentation; P:antigen processing and presentation of endogenous antigen; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell population proliferation; P:chaperone cofactor-dependent protein refolding; P:immunoglobulin mediated immune response; P:intracellular protein transport; P:leukocyte migration; P:macrophage migration inhibitory factor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell migration; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of mature B cell apoptotic process; P:negative regulation of peptide secretion; P:negative regulation of T cell differentiation; P:negative regulation of viral entry into host cell; P:negative thymic T cell selection; P:positive regulation of B cell proliferation; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of chemokine production; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of kinase activity; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage migration inhibitory factor signaling pathway; P:positive regulation of MAPK cascade; P:positive regulation of monocyte differentiation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of protein phosphorylation; P:positive regulation of T cell differentiation; P:positive regulation of transcription, DNA-templated; P:positive regulation of type 2 immune response; P:positive regulation of viral entry into host cell; P:positive thymic T cell selection; P:prostaglandin biosynthetic process; P:protein stabilization; P:protein trimerization; P:protein-containing complex assembly; P:regulation of macrophage activation; P:response to interferon-gamma; P:T cell activation involved in immune response; P:T cell selection; scaffold4 indexed_genome mRNA 17665777 17669565 . - . ID=transcript_1054;P62263 B2R5G5 D3DQG5 P06366 Q5BJI0,40S ribosomal protein S14,Small ribosomal subunit protein uS11 {ECO:0000303|PubMed:24524803};, PF00411;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0014069;GO:0048027;GO:0003723;GO:0070181;GO:0003735;GO:0045182;GO:0030218;GO:0030490;GO:0000462;GO:0000122;GO:0000184;GO:0000028;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:postsynaptic density;, F:mRNA 5'-UTR binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:erythrocyte differentiation; P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62263 B2R5G5 D3DQG5 P06366 Q5BJI0,40S ribosomal protein S14,Small ribosomal subunit protein uS11 {ECO:0000303|PubMed:24524803};, PF00411;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0014069;GO:0048027;GO:0003723;GO:0070181;GO:0003735;GO:0045182;GO:0030218;GO:0030490;GO:0000462;GO:0000122;GO:0000184;GO:0000028;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:postsynaptic density;, F:mRNA 5'-UTR binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:erythrocyte differentiation; P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62263 B2R5G5 D3DQG5 P06366 Q5BJI0,40S ribosomal protein S14,Small ribosomal subunit protein uS11 {ECO:0000303|PubMed:24524803};, PF00411;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0014069;GO:0048027;GO:0003723;GO:0070181;GO:0003735;GO:0045182;GO:0030218;GO:0030490;GO:0000462;GO:0000122;GO:0000184;GO:0000028;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:postsynaptic density;, F:mRNA 5'-UTR binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:erythrocyte differentiation; P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold4 indexed_genome mRNA 17703748 17791018 . + . ID=transcript_1055;P52848 Q96E57,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,Glucosaminyl N-deacetylase/N-sulfotransferase 1;N-heparan sulfate sulfotransferase 1;[Heparan sulfate]-glucosamine N-sulfotransferase 1;, PF12062;PF00685;, GO:0005794;GO:0000139;GO:0016021;GO:0015016;GO:0019213;GO:0102140;GO:0035904;GO:0003279;GO:0008283;GO:0060976;GO:0048702;GO:0048703;GO:0008543;GO:0030900;GO:0006024;GO:0015014;GO:0030210;GO:0006954;GO:0030901;GO:0043410;GO:0045880;GO:0006477;GO:0007585;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:[heparan sulfate]-glucosamine N-sulfotransferase activity; F:deacetylase activity; F:heparan sulfate N-deacetylase activity;, P:aorta development; P:cardiac septum development; P:cell population proliferation; P:coronary vasculature development; P:embryonic neurocranium morphogenesis; P:embryonic viscerocranium morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:forebrain development; P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:inflammatory response; P:midbrain development; P:positive regulation of MAPK cascade; P:positive regulation of smoothened signaling pathway; P:protein sulfation; P:respiratory gaseous exchange by respiratory system;|P52848 Q96E57,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,Glucosaminyl N-deacetylase/N-sulfotransferase 1;N-heparan sulfate sulfotransferase 1;[Heparan sulfate]-glucosamine N-sulfotransferase 1;, PF12062;PF00685;, GO:0005794;GO:0000139;GO:0016021;GO:0015016;GO:0019213;GO:0102140;GO:0035904;GO:0003279;GO:0008283;GO:0060976;GO:0048702;GO:0048703;GO:0008543;GO:0030900;GO:0006024;GO:0015014;GO:0030210;GO:0006954;GO:0030901;GO:0043410;GO:0045880;GO:0006477;GO:0007585;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:[heparan sulfate]-glucosamine N-sulfotransferase activity; F:deacetylase activity; F:heparan sulfate N-deacetylase activity;, P:aorta development; P:cardiac septum development; P:cell population proliferation; P:coronary vasculature development; P:embryonic neurocranium morphogenesis; P:embryonic viscerocranium morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:forebrain development; P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:inflammatory response; P:midbrain development; P:positive regulation of MAPK cascade; P:positive regulation of smoothened signaling pathway; P:protein sulfation; P:respiratory gaseous exchange by respiratory system; scaffold4 indexed_genome mRNA 17902870 17913371 . + . ID=transcript_1056;Q8N3V7 A5PKZ8 D3DQG8 O15271 Q9UPX1,Synaptopodin,, , GO:0015629;GO:0005923;GO:0005829;GO:0043197;GO:0005634;GO:0043204;GO:0014069;GO:0097444;GO:0001725;GO:0030018;GO:0003779;GO:0098886;GO:0032233;GO:0051492;GO:1905355;, C:actin cytoskeleton; C:bicellular tight junction; C:cytosol; C:dendritic spine; C:nucleus; C:perikaryon; C:postsynaptic density; C:spine apparatus; C:stress fiber; C:Z disc;, F:actin binding;, P:modification of dendritic spine; P:positive regulation of actin filament bundle assembly; P:regulation of stress fiber assembly; P:spine apparatus assembly; scaffold4 indexed_genome mRNA 17920510 17941755 . + . ID=transcript_1057;Q8TDC0 B2R9Q4 D3DQG9 Q8IVM1 Q8IVN1,Myozenin-3,Calsarcin-3;FATZ-related protein 3;, PF05556;, GO:0015629;GO:0030018;GO:0003779;GO:0051373;GO:0031433;, C:actin cytoskeleton; C:Z disc;, F:actin binding; F:FATZ binding; F:telethonin binding;|Q8TDC0 B2R9Q4 D3DQG9 Q8IVM1 Q8IVN1,Myozenin-3,Calsarcin-3;FATZ-related protein 3;, PF05556;, GO:0015629;GO:0030018;GO:0003779;GO:0051373;GO:0031433;, C:actin cytoskeleton; C:Z disc;, F:actin binding; F:FATZ binding; F:telethonin binding; scaffold4 indexed_genome mRNA 17943788 17945127 . - . ID=transcript_1058;Q9NW64 A6NDM5 B4DLI9 O95607,Pre-mRNA-splicing factor RBM22,RNA-binding motif protein 22;Zinc finger CCCH domain-containing protein 16;, PF00076;, GO:0071013;GO:0005737;GO:0005654;GO:0005634;GO:0000974;GO:0071006;GO:0071007;GO:0048306;GO:0046872;GO:0036002;GO:0003723;GO:0017070;GO:0035690;GO:0045292;GO:0000398;GO:0046827;GO:0042307;GO:0033120;, C:catalytic step 2 spliceosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome;, F:calcium-dependent protein binding; F:metal ion binding; F:pre-mRNA binding; F:RNA binding; F:U6 snRNA binding;, P:cellular response to drug; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:positive regulation of protein export from nucleus; P:positive regulation of protein import into nucleus; P:positive regulation of RNA splicing;|Q9NW64 A6NDM5 B4DLI9 O95607,Pre-mRNA-splicing factor RBM22,RNA-binding motif protein 22;Zinc finger CCCH domain-containing protein 16;, PF00076;, GO:0071013;GO:0005737;GO:0005654;GO:0005634;GO:0000974;GO:0071006;GO:0071007;GO:0048306;GO:0046872;GO:0036002;GO:0003723;GO:0017070;GO:0035690;GO:0045292;GO:0000398;GO:0046827;GO:0042307;GO:0033120;, C:catalytic step 2 spliceosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome;, F:calcium-dependent protein binding; F:metal ion binding; F:pre-mRNA binding; F:RNA binding; F:U6 snRNA binding;, P:cellular response to drug; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:positive regulation of protein export from nucleus; P:positive regulation of protein import into nucleus; P:positive regulation of RNA splicing; scaffold4 indexed_genome mRNA 17961515 17994250 . - . ID=transcript_1059;Q9UJW0 B3KWW0 D3DQH0 E5RGT5 Q8TAN8,Dynactin subunit 4,Dynactin subunit p62;, PF05502;, GO:0005938;GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005869;GO:0005925;GO:0000776;GO:0005634;GO:0030017;GO:0000922;GO:0001725;GO:0047485;GO:0019886;GO:0006888;, C:cell cortex; C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:dynactin complex; C:focal adhesion; C:kinetochore; C:nucleus; C:sarcomere; C:spindle pole; C:stress fiber;, F:protein N-terminus binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q9UJW0 B3KWW0 D3DQH0 E5RGT5 Q8TAN8,Dynactin subunit 4,Dynactin subunit p62;, PF05502;, GO:0005938;GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005869;GO:0005925;GO:0000776;GO:0005634;GO:0030017;GO:0000922;GO:0001725;GO:0047485;GO:0019886;GO:0006888;, C:cell cortex; C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:dynactin complex; C:focal adhesion; C:kinetochore; C:nucleus; C:sarcomere; C:spindle pole; C:stress fiber;, F:protein N-terminus binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q9UJW0 B3KWW0 D3DQH0 E5RGT5 Q8TAN8,Dynactin subunit 4,Dynactin subunit p62;, PF05502;, GO:0005938;GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005869;GO:0005925;GO:0000776;GO:0005634;GO:0030017;GO:0000922;GO:0001725;GO:0047485;GO:0019886;GO:0006888;, C:cell cortex; C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:dynactin complex; C:focal adhesion; C:kinetochore; C:nucleus; C:sarcomere; C:spindle pole; C:stress fiber;, F:protein N-terminus binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q9UJW0 B3KWW0 D3DQH0 E5RGT5 Q8TAN8,Dynactin subunit 4,Dynactin subunit p62;, PF05502;, GO:0005938;GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005869;GO:0005925;GO:0000776;GO:0005634;GO:0030017;GO:0000922;GO:0001725;GO:0047485;GO:0019886;GO:0006888;, C:cell cortex; C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:dynactin complex; C:focal adhesion; C:kinetochore; C:nucleus; C:sarcomere; C:spindle pole; C:stress fiber;, F:protein N-terminus binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q9UJW0 B3KWW0 D3DQH0 E5RGT5 Q8TAN8,Dynactin subunit 4,Dynactin subunit p62;, PF05502;, GO:0005938;GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005869;GO:0005925;GO:0000776;GO:0005634;GO:0030017;GO:0000922;GO:0001725;GO:0047485;GO:0019886;GO:0006888;, C:cell cortex; C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:dynactin complex; C:focal adhesion; C:kinetochore; C:nucleus; C:sarcomere; C:spindle pole; C:stress fiber;, F:protein N-terminus binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q9UJW0 B3KWW0 D3DQH0 E5RGT5 Q8TAN8,Dynactin subunit 4,Dynactin subunit p62;, PF05502;, GO:0005938;GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005869;GO:0005925;GO:0000776;GO:0005634;GO:0030017;GO:0000922;GO:0001725;GO:0047485;GO:0019886;GO:0006888;, C:cell cortex; C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:dynactin complex; C:focal adhesion; C:kinetochore; C:nucleus; C:sarcomere; C:spindle pole; C:stress fiber;, F:protein N-terminus binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport; scaffold4 indexed_genome mRNA 18018022 18039014 . + . ID=transcript_1060;Q9BZL3 Q3MIG3 Q6ZUV4,Small integral membrane protein 3,NGF-induced differentiation clone 67 protein;Small membrane protein NID67;, PF17307;, GO:0016021;GO:0042802;, C:integral component of membrane;, F:identical protein binding; scaffold4 indexed_genome mRNA 18116618 18130075 . - . ID=transcript_1061;Q96RE9 A8MY91 B3KU35 B4DU78 F5GWS1 Q06DQ3 Q17RP3 Q5H9N5,Zinc finger protein 300,, PF01352;PF00096;, GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:0045944;GO:0006357;, C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96RE9 A8MY91 B3KU35 B4DU78 F5GWS1 Q06DQ3 Q17RP3 Q5H9N5,Zinc finger protein 300,, PF01352;PF00096;, GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:0045944;GO:0006357;, C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96RE9 A8MY91 B3KU35 B4DU78 F5GWS1 Q06DQ3 Q17RP3 Q5H9N5,Zinc finger protein 300,, PF01352;PF00096;, GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:0045944;GO:0006357;, C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold4 indexed_genome mRNA 18168239 18176772 . + . ID=transcript_1062;P22352 O43787 Q86W78 Q9NZ74 Q9UEL1,Glutathione peroxidase 3,Extracellular glutathione peroxidase;Plasma glutathione peroxidase;, PF00255;, GO:0070062;GO:0005576;GO:0005615;GO:0004602;GO:0042802;GO:0004601;GO:0008430;GO:0008134;GO:0034599;GO:0042744;GO:0006982;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:glutathione peroxidase activity; F:identical protein binding; F:peroxidase activity; F:selenium binding; F:transcription factor binding;, P:cellular response to oxidative stress; P:hydrogen peroxide catabolic process; P:response to lipid hydroperoxide;|P22352 O43787 Q86W78 Q9NZ74 Q9UEL1,Glutathione peroxidase 3,Extracellular glutathione peroxidase;Plasma glutathione peroxidase;, PF00255;, GO:0070062;GO:0005576;GO:0005615;GO:0004602;GO:0042802;GO:0004601;GO:0008430;GO:0008134;GO:0034599;GO:0042744;GO:0006982;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:glutathione peroxidase activity; F:identical protein binding; F:peroxidase activity; F:selenium binding; F:transcription factor binding;, P:cellular response to oxidative stress; P:hydrogen peroxide catabolic process; P:response to lipid hydroperoxide;|P22352 O43787 Q86W78 Q9NZ74 Q9UEL1,Glutathione peroxidase 3,Extracellular glutathione peroxidase;Plasma glutathione peroxidase;, PF00255;, GO:0070062;GO:0005576;GO:0005615;GO:0004602;GO:0042802;GO:0004601;GO:0008430;GO:0008134;GO:0034599;GO:0042744;GO:0006982;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:glutathione peroxidase activity; F:identical protein binding; F:peroxidase activity; F:selenium binding; F:transcription factor binding;, P:cellular response to oxidative stress; P:hydrogen peroxide catabolic process; P:response to lipid hydroperoxide; scaffold4 indexed_genome mRNA 18176851 18206160 . - . ID=transcript_1063;Q9H1J3,TNFAIP3-interacting protein 1,A20-binding inhibitor of NF-kappa-B activation 1;HIV-1 Nef-interacting protein;Nef-associated factor 1;Nip40-1;Virion-associated nuclear shuttling protein;, , GO:0005829;GO:0005654;GO:0042802;GO:0051019;GO:0031593;GO:0006952;GO:0009101;GO:0006954;GO:0007159;GO:0085032;GO:0002755;GO:0070373;GO:0043124;GO:0045071;GO:0050729;GO:1903003;GO:0045944;GO:0016579;GO:0006412;, C:cytosol; C:nucleoplasm;, F:identical protein binding; F:mitogen-activated protein kinase binding; F:polyubiquitin modification-dependent protein binding;, P:defense response; P:glycoprotein biosynthetic process; P:inflammatory response; P:leukocyte cell-cell adhesion; P:modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of viral genome replication; P:positive regulation of inflammatory response; P:positive regulation of protein deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:translation;|Q9H1J3,TNFAIP3-interacting protein 1,A20-binding inhibitor of NF-kappa-B activation 1;HIV-1 Nef-interacting protein;Nef-associated factor 1;Nip40-1;Virion-associated nuclear shuttling protein;, , GO:0005829;GO:0005654;GO:0042802;GO:0051019;GO:0031593;GO:0006952;GO:0009101;GO:0006954;GO:0007159;GO:0085032;GO:0002755;GO:0070373;GO:0043124;GO:0045071;GO:0050729;GO:1903003;GO:0045944;GO:0016579;GO:0006412;, C:cytosol; C:nucleoplasm;, F:identical protein binding; F:mitogen-activated protein kinase binding; F:polyubiquitin modification-dependent protein binding;, P:defense response; P:glycoprotein biosynthetic process; P:inflammatory response; P:leukocyte cell-cell adhesion; P:modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of viral genome replication; P:positive regulation of inflammatory response; P:positive regulation of protein deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:translation;|Q9H1J3,TNFAIP3-interacting protein 1,A20-binding inhibitor of NF-kappa-B activation 1;HIV-1 Nef-interacting protein;Nef-associated factor 1;Nip40-1;Virion-associated nuclear shuttling protein;, , GO:0005829;GO:0005654;GO:0042802;GO:0051019;GO:0031593;GO:0006952;GO:0009101;GO:0006954;GO:0007159;GO:0085032;GO:0002755;GO:0070373;GO:0043124;GO:0045071;GO:0050729;GO:1903003;GO:0045944;GO:0016579;GO:0006412;, C:cytosol; C:nucleoplasm;, F:identical protein binding; F:mitogen-activated protein kinase binding; F:polyubiquitin modification-dependent protein binding;, P:defense response; P:glycoprotein biosynthetic process; P:inflammatory response; P:leukocyte cell-cell adhesion; P:modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of viral genome replication; P:positive regulation of inflammatory response; P:positive regulation of protein deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:translation;|Q9H1J3,TNFAIP3-interacting protein 1,A20-binding inhibitor of NF-kappa-B activation 1;HIV-1 Nef-interacting protein;Nef-associated factor 1;Nip40-1;Virion-associated nuclear shuttling protein;, , GO:0005829;GO:0005654;GO:0042802;GO:0051019;GO:0031593;GO:0006952;GO:0009101;GO:0006954;GO:0007159;GO:0085032;GO:0002755;GO:0070373;GO:0043124;GO:0045071;GO:0050729;GO:1903003;GO:0045944;GO:0016579;GO:0006412;, C:cytosol; C:nucleoplasm;, F:identical protein binding; F:mitogen-activated protein kinase binding; F:polyubiquitin modification-dependent protein binding;, P:defense response; P:glycoprotein biosynthetic process; P:inflammatory response; P:leukocyte cell-cell adhesion; P:modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of viral genome replication; P:positive regulation of inflammatory response; P:positive regulation of protein deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:translation; scaffold4 indexed_genome mRNA 18238098 18287643 . - . ID=transcript_1064;P08133 B7Z8A7 D3DQH4 E9PGK1 Q6ZT79,Annexin A6,67 kDa calelectrin;Annexin VI;Annexin-6;Calphobindin-II;Chromobindin-20;Lipocortin VI;Protein III;p68;p70;, PF00191;, GO:0062023;GO:0005737;GO:0070062;GO:0005925;GO:0031902;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0048471;GO:0051015;GO:0005262;GO:0005509;GO:0005544;GO:0048306;GO:0015485;GO:0035374;GO:0005525;GO:0042802;GO:0015276;GO:0008289;GO:0001786;GO:0097190;GO:0003418;GO:0034220;GO:0051560;GO:0051283;GO:0001755;GO:0001778;GO:0006937;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:late endosome membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:perinuclear region of cytoplasm;, F:actin filament binding; F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:cholesterol binding; F:chondroitin sulfate binding; F:GTP binding; F:identical protein binding; F:ligand-gated ion channel activity; F:lipid binding; F:phosphatidylserine binding;, P:apoptotic signaling pathway; P:growth plate cartilage chondrocyte differentiation; P:ion transmembrane transport; P:mitochondrial calcium ion homeostasis; P:negative regulation of sequestering of calcium ion; P:neural crest cell migration; P:plasma membrane repair; P:regulation of muscle contraction;|P08133 B7Z8A7 D3DQH4 E9PGK1 Q6ZT79,Annexin A6,67 kDa calelectrin;Annexin VI;Annexin-6;Calphobindin-II;Chromobindin-20;Lipocortin VI;Protein III;p68;p70;, PF00191;, GO:0062023;GO:0005737;GO:0070062;GO:0005925;GO:0031902;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0048471;GO:0051015;GO:0005262;GO:0005509;GO:0005544;GO:0048306;GO:0015485;GO:0035374;GO:0005525;GO:0042802;GO:0015276;GO:0008289;GO:0001786;GO:0097190;GO:0003418;GO:0034220;GO:0051560;GO:0051283;GO:0001755;GO:0001778;GO:0006937;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:late endosome membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:perinuclear region of cytoplasm;, F:actin filament binding; F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:cholesterol binding; F:chondroitin sulfate binding; F:GTP binding; F:identical protein binding; F:ligand-gated ion channel activity; F:lipid binding; F:phosphatidylserine binding;, P:apoptotic signaling pathway; P:growth plate cartilage chondrocyte differentiation; P:ion transmembrane transport; P:mitochondrial calcium ion homeostasis; P:negative regulation of sequestering of calcium ion; P:neural crest cell migration; P:plasma membrane repair; P:regulation of muscle contraction;|P08133 B7Z8A7 D3DQH4 E9PGK1 Q6ZT79,Annexin A6,67 kDa calelectrin;Annexin VI;Annexin-6;Calphobindin-II;Chromobindin-20;Lipocortin VI;Protein III;p68;p70;, PF00191;, GO:0062023;GO:0005737;GO:0070062;GO:0005925;GO:0031902;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0048471;GO:0051015;GO:0005262;GO:0005509;GO:0005544;GO:0048306;GO:0015485;GO:0035374;GO:0005525;GO:0042802;GO:0015276;GO:0008289;GO:0001786;GO:0097190;GO:0003418;GO:0034220;GO:0051560;GO:0051283;GO:0001755;GO:0001778;GO:0006937;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:late endosome membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:perinuclear region of cytoplasm;, F:actin filament binding; F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:cholesterol binding; F:chondroitin sulfate binding; F:GTP binding; F:identical protein binding; F:ligand-gated ion channel activity; F:lipid binding; F:phosphatidylserine binding;, P:apoptotic signaling pathway; P:growth plate cartilage chondrocyte differentiation; P:ion transmembrane transport; P:mitochondrial calcium ion homeostasis; P:negative regulation of sequestering of calcium ion; P:neural crest cell migration; P:plasma membrane repair; P:regulation of muscle contraction;|P08133 B7Z8A7 D3DQH4 E9PGK1 Q6ZT79,Annexin A6,67 kDa calelectrin;Annexin VI;Annexin-6;Calphobindin-II;Chromobindin-20;Lipocortin VI;Protein III;p68;p70;, PF00191;, GO:0062023;GO:0005737;GO:0070062;GO:0005925;GO:0031902;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0048471;GO:0051015;GO:0005262;GO:0005509;GO:0005544;GO:0048306;GO:0015485;GO:0035374;GO:0005525;GO:0042802;GO:0015276;GO:0008289;GO:0001786;GO:0097190;GO:0003418;GO:0034220;GO:0051560;GO:0051283;GO:0001755;GO:0001778;GO:0006937;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:late endosome membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:perinuclear region of cytoplasm;, F:actin filament binding; F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:cholesterol binding; F:chondroitin sulfate binding; F:GTP binding; F:identical protein binding; F:ligand-gated ion channel activity; F:lipid binding; F:phosphatidylserine binding;, P:apoptotic signaling pathway; P:growth plate cartilage chondrocyte differentiation; P:ion transmembrane transport; P:mitochondrial calcium ion homeostasis; P:negative regulation of sequestering of calcium ion; P:neural crest cell migration; P:plasma membrane repair; P:regulation of muscle contraction; scaffold4 indexed_genome mRNA 18316462 18351666 . - . ID=transcript_1065;A6NI79 A8K9X6,Coiled-coil domain-containing protein 69 {ECO:0000305},, , GO:0005737;GO:0030496;GO:0005634;GO:0051233;GO:0008017;GO:0051255;, C:cytoplasm; C:midbody; C:nucleus; C:spindle midzone;, F:microtubule binding;, P:spindle midzone assembly; scaffold4 indexed_genome mRNA 18379638 18395727 . + . ID=transcript_1066;P17900 B2R699 D3DQH6 Q14426 Q14428 Q6LBL5,Ganglioside GM2 activator {ECO:0000305},Cerebroside sulfate activator protein;GM2-AP;Sphingolipid activator protein 3;, PF02221;, GO:0016324;GO:0035578;GO:0016323;GO:0009898;GO:0005829;GO:0070062;GO:0005576;GO:0043231;GO:0043202;GO:0032428;GO:0005319;GO:0016004;GO:0006689;GO:0006687;GO:0007611;GO:0019915;GO:0006869;GO:0050885;GO:0043312;GO:0009313;GO:0051345;, C:apical plasma membrane; C:azurophil granule lumen; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular membrane-bounded organelle; C:lysosomal lumen;, F:beta-N-acetylgalactosaminidase activity; F:lipid transporter activity; F:phospholipase activator activity;, P:ganglioside catabolic process; P:glycosphingolipid metabolic process; P:learning or memory; P:lipid storage; P:lipid transport; P:neuromuscular process controlling balance; P:neutrophil degranulation; P:oligosaccharide catabolic process; P:positive regulation of hydrolase activity; scaffold4 indexed_genome mRNA 18545949 18578460 . + . ID=transcript_1067;Q7Z2H8 C9JI34 Q1LZ56 Q7Z7C0 Q86YK4 Q96M74,Proton-coupled amino acid transporter 1,Solute carrier family 36 member 1;, PF01490;, GO:0005783;GO:0016021;GO:0005765;GO:0005886;GO:0022858;GO:0015171;GO:0005280;GO:0015187;GO:0015180;GO:0015193;GO:0005368;GO:0032328;GO:0089718;GO:0003333;GO:0006865;GO:0015816;GO:0006811;GO:0015808;GO:0035524;GO:0015824;GO:1902600;GO:0015734;, C:endoplasmic reticulum; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane;, F:alanine transmembrane transporter activity; F:amino acid transmembrane transporter activity; F:amino acid:proton symporter activity; F:glycine transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:taurine transmembrane transporter activity;, P:alanine transport; P:amino acid import across plasma membrane; P:amino acid transmembrane transport; P:amino acid transport; P:glycine transport; P:ion transport; P:L-alanine transport; P:proline transmembrane transport; P:proline transport; P:proton transmembrane transport; P:taurine transport;|Q7Z2H8 C9JI34 Q1LZ56 Q7Z7C0 Q86YK4 Q96M74,Proton-coupled amino acid transporter 1,Solute carrier family 36 member 1;, PF01490;, GO:0005783;GO:0016021;GO:0005765;GO:0005886;GO:0022858;GO:0015171;GO:0005280;GO:0015187;GO:0015180;GO:0015193;GO:0005368;GO:0032328;GO:0089718;GO:0003333;GO:0006865;GO:0015816;GO:0006811;GO:0015808;GO:0035524;GO:0015824;GO:1902600;GO:0015734;, C:endoplasmic reticulum; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane;, F:alanine transmembrane transporter activity; F:amino acid transmembrane transporter activity; F:amino acid:proton symporter activity; F:glycine transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:taurine transmembrane transporter activity;, P:alanine transport; P:amino acid import across plasma membrane; P:amino acid transmembrane transport; P:amino acid transport; P:glycine transport; P:ion transport; P:L-alanine transport; P:proline transmembrane transport; P:proline transport; P:proton transmembrane transport; P:taurine transport;|Q7Z2H8 C9JI34 Q1LZ56 Q7Z7C0 Q86YK4 Q96M74,Proton-coupled amino acid transporter 1,Solute carrier family 36 member 1;, PF01490;, GO:0005783;GO:0016021;GO:0005765;GO:0005886;GO:0022858;GO:0015171;GO:0005280;GO:0015187;GO:0015180;GO:0015193;GO:0005368;GO:0032328;GO:0089718;GO:0003333;GO:0006865;GO:0015816;GO:0006811;GO:0015808;GO:0035524;GO:0015824;GO:1902600;GO:0015734;, C:endoplasmic reticulum; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane;, F:alanine transmembrane transporter activity; F:amino acid transmembrane transporter activity; F:amino acid:proton symporter activity; F:glycine transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:taurine transmembrane transporter activity;, P:alanine transport; P:amino acid import across plasma membrane; P:amino acid transmembrane transport; P:amino acid transport; P:glycine transport; P:ion transport; P:L-alanine transport; P:proline transmembrane transport; P:proline transport; P:proton transmembrane transport; P:taurine transport; scaffold4 indexed_genome mRNA 18583155 18591389 . + . ID=transcript_1068;Q7Z2H8 C9JI34 Q1LZ56 Q7Z7C0 Q86YK4 Q96M74,Proton-coupled amino acid transporter 1,Solute carrier family 36 member 1;, PF01490;, GO:0005783;GO:0016021;GO:0005765;GO:0005886;GO:0022858;GO:0015171;GO:0005280;GO:0015187;GO:0015180;GO:0015193;GO:0005368;GO:0032328;GO:0089718;GO:0003333;GO:0006865;GO:0015816;GO:0006811;GO:0015808;GO:0035524;GO:0015824;GO:1902600;GO:0015734;, C:endoplasmic reticulum; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane;, F:alanine transmembrane transporter activity; F:amino acid transmembrane transporter activity; F:amino acid:proton symporter activity; F:glycine transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:taurine transmembrane transporter activity;, P:alanine transport; P:amino acid import across plasma membrane; P:amino acid transmembrane transport; P:amino acid transport; P:glycine transport; P:ion transport; P:L-alanine transport; P:proline transmembrane transport; P:proline transport; P:proton transmembrane transport; P:taurine transport; scaffold4 indexed_genome mRNA 18616500 18677066 . - . ID=transcript_1069;Q9NYQ8 O75091 Q9NSR7,Protocadherin Fat 2,Cadherin family member 8;Multiple epidermal growth factor-like domains protein 1;, PF00028;PF00008;PF02210;, GO:0005912;GO:0070062;GO:0005794;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0031589;GO:0010631;GO:0007156;, C:adherens junction; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:epithelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9NYQ8 O75091 Q9NSR7,Protocadherin Fat 2,Cadherin family member 8;Multiple epidermal growth factor-like domains protein 1;, PF00028;PF00008;PF02210;, GO:0005912;GO:0070062;GO:0005794;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0031589;GO:0010631;GO:0007156;, C:adherens junction; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:epithelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9NYQ8 O75091 Q9NSR7,Protocadherin Fat 2,Cadherin family member 8;Multiple epidermal growth factor-like domains protein 1;, PF00028;PF00008;PF02210;, GO:0005912;GO:0070062;GO:0005794;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0031589;GO:0010631;GO:0007156;, C:adherens junction; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:epithelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9NYQ8 O75091 Q9NSR7,Protocadherin Fat 2,Cadherin family member 8;Multiple epidermal growth factor-like domains protein 1;, PF00028;PF00008;PF02210;, GO:0005912;GO:0070062;GO:0005794;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0031589;GO:0010631;GO:0007156;, C:adherens junction; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:epithelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9NYQ8 O75091 Q9NSR7,Protocadherin Fat 2,Cadherin family member 8;Multiple epidermal growth factor-like domains protein 1;, PF00028;PF00008;PF02210;, GO:0005912;GO:0070062;GO:0005794;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0031589;GO:0010631;GO:0007156;, C:adherens junction; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:epithelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9NYQ8 O75091 Q9NSR7,Protocadherin Fat 2,Cadherin family member 8;Multiple epidermal growth factor-like domains protein 1;, PF00028;PF00008;PF02210;, GO:0005912;GO:0070062;GO:0005794;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0031589;GO:0010631;GO:0007156;, C:adherens junction; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:epithelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9NYQ8 O75091 Q9NSR7,Protocadherin Fat 2,Cadherin family member 8;Multiple epidermal growth factor-like domains protein 1;, PF00028;PF00008;PF02210;, GO:0005912;GO:0070062;GO:0005794;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0031589;GO:0010631;GO:0007156;, C:adherens junction; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:epithelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9NYQ8 O75091 Q9NSR7,Protocadherin Fat 2,Cadherin family member 8;Multiple epidermal growth factor-like domains protein 1;, PF00028;PF00008;PF02210;, GO:0005912;GO:0070062;GO:0005794;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0031589;GO:0010631;GO:0007156;, C:adherens junction; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:epithelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9NYQ8 O75091 Q9NSR7,Protocadherin Fat 2,Cadherin family member 8;Multiple epidermal growth factor-like domains protein 1;, PF00028;PF00008;PF02210;, GO:0005912;GO:0070062;GO:0005794;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0031589;GO:0010631;GO:0007156;, C:adherens junction; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:epithelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold4 indexed_genome mRNA 18769160 18781376 . - . ID=transcript_1070;P09486 D3DQH9 Q6IBK4,SPARC,Basement-membrane protein 40;Osteonectin;Secreted protein acidic and rich in cysteine;, PF09289;PF00050;PF10591;, GO:0005604;GO:0009986;GO:0062023;GO:0005737;GO:0071682;GO:0005576;GO:0005615;GO:0098978;GO:0043231;GO:0016363;GO:0005886;GO:0031091;GO:0031093;GO:0031092;GO:0005509;GO:0005518;GO:0050840;GO:0048856;GO:0030198;GO:0007507;GO:0048839;GO:0030324;GO:0016525;GO:0001937;GO:0001503;GO:0002576;GO:0010595;GO:0006898;GO:0022604;GO:0050807;GO:0046686;GO:0051592;GO:0051591;GO:0034097;GO:0045471;GO:0051384;GO:0009629;GO:0033591;GO:0010288;GO:0032496;GO:0043434;GO:0042060;, C:basement membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:endocytic vesicle lumen; C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen; C:platelet alpha granule membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix binding;, P:anatomical structure development; P:extracellular matrix organization; P:heart development; P:inner ear development; P:lung development; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell proliferation; P:ossification; P:platelet degranulation; P:positive regulation of endothelial cell migration; P:receptor-mediated endocytosis; P:regulation of cell morphogenesis; P:regulation of synapse organization; P:response to cadmium ion; P:response to calcium ion; P:response to cAMP; P:response to cytokine; P:response to ethanol; P:response to glucocorticoid; P:response to gravity; P:response to L-ascorbic acid; P:response to lead ion; P:response to lipopolysaccharide; P:response to peptide hormone; P:wound healing;|P09486 D3DQH9 Q6IBK4,SPARC,Basement-membrane protein 40;Osteonectin;Secreted protein acidic and rich in cysteine;, PF09289;PF00050;PF10591;, GO:0005604;GO:0009986;GO:0062023;GO:0005737;GO:0071682;GO:0005576;GO:0005615;GO:0098978;GO:0043231;GO:0016363;GO:0005886;GO:0031091;GO:0031093;GO:0031092;GO:0005509;GO:0005518;GO:0050840;GO:0048856;GO:0030198;GO:0007507;GO:0048839;GO:0030324;GO:0016525;GO:0001937;GO:0001503;GO:0002576;GO:0010595;GO:0006898;GO:0022604;GO:0050807;GO:0046686;GO:0051592;GO:0051591;GO:0034097;GO:0045471;GO:0051384;GO:0009629;GO:0033591;GO:0010288;GO:0032496;GO:0043434;GO:0042060;, C:basement membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:endocytic vesicle lumen; C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen; C:platelet alpha granule membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix binding;, P:anatomical structure development; P:extracellular matrix organization; P:heart development; P:inner ear development; P:lung development; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell proliferation; P:ossification; P:platelet degranulation; P:positive regulation of endothelial cell migration; P:receptor-mediated endocytosis; P:regulation of cell morphogenesis; P:regulation of synapse organization; P:response to cadmium ion; P:response to calcium ion; P:response to cAMP; P:response to cytokine; P:response to ethanol; P:response to glucocorticoid; P:response to gravity; P:response to L-ascorbic acid; P:response to lead ion; P:response to lipopolysaccharide; P:response to peptide hormone; P:wound healing; scaffold4 indexed_genome mRNA 18834291 18850191 . - . ID=transcript_1071;O00244 A8KAJ8 D3DQI2 Q2M1R6 Q56AP3,Copper transport protein ATOX1,Metal transport protein ATX1;, PF00403;, GO:0005829;GO:0016531;GO:0005507;GO:0032767;GO:1903136;GO:0016530;GO:0006878;GO:0006825;GO:0006979;, C:cytosol;, F:copper chaperone activity; F:copper ion binding; F:copper-dependent protein binding; F:cuprous ion binding; F:metallochaperone activity;, P:cellular copper ion homeostasis; P:copper ion transport; P:response to oxidative stress; scaffold4 indexed_genome mRNA 18887495 18904955 . + . ID=transcript_1072;Q13283 Q5HYE9,Ras GTPase-activating protein-binding protein 1,ATP-dependent DNA helicase VIII;GAP SH3 domain-binding protein 1;, PF02136;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005925;GO:0005634;GO:0043204;GO:1990904;GO:0005524;GO:0003677;GO:0003678;GO:0033677;GO:0004519;GO:0003729;GO:0003723;GO:0003724;GO:0051607;GO:0045087;GO:0062029;GO:0032481;GO:0007265;GO:0034063;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:focal adhesion; C:nucleus; C:perikaryon; C:ribonucleoprotein complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA/RNA helicase activity; F:endonuclease activity; F:mRNA binding; F:RNA binding; F:RNA helicase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of stress granule assembly; P:positive regulation of type I interferon production; P:Ras protein signal transduction; P:stress granule assembly; P:viral process;|Q13283 Q5HYE9,Ras GTPase-activating protein-binding protein 1,ATP-dependent DNA helicase VIII;GAP SH3 domain-binding protein 1;, PF02136;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005925;GO:0005634;GO:0043204;GO:1990904;GO:0005524;GO:0003677;GO:0003678;GO:0033677;GO:0004519;GO:0003729;GO:0003723;GO:0003724;GO:0051607;GO:0045087;GO:0062029;GO:0032481;GO:0007265;GO:0034063;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:focal adhesion; C:nucleus; C:perikaryon; C:ribonucleoprotein complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA/RNA helicase activity; F:endonuclease activity; F:mRNA binding; F:RNA binding; F:RNA helicase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of stress granule assembly; P:positive regulation of type I interferon production; P:Ras protein signal transduction; P:stress granule assembly; P:viral process;|Q13283 Q5HYE9,Ras GTPase-activating protein-binding protein 1,ATP-dependent DNA helicase VIII;GAP SH3 domain-binding protein 1;, PF02136;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005925;GO:0005634;GO:0043204;GO:1990904;GO:0005524;GO:0003677;GO:0003678;GO:0033677;GO:0004519;GO:0003729;GO:0003723;GO:0003724;GO:0051607;GO:0045087;GO:0062029;GO:0032481;GO:0007265;GO:0034063;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:focal adhesion; C:nucleus; C:perikaryon; C:ribonucleoprotein complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA/RNA helicase activity; F:endonuclease activity; F:mRNA binding; F:RNA binding; F:RNA helicase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of stress granule assembly; P:positive regulation of type I interferon production; P:Ras protein signal transduction; P:stress granule assembly; P:viral process;|Q9UN86 A8K6X1 O60606 O75149 Q9UPA1,Ras GTPase-activating protein-binding protein 2,GAP SH3 domain-binding protein 2;, PF02136;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:1990904;GO:0003729;GO:0003723;GO:0030159;GO:0007253;GO:0045087;GO:0051028;GO:0062029;GO:0051260;GO:0007265;GO:0034063;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding; F:signaling receptor complex adaptor activity;, P:cytoplasmic sequestering of NF-kappaB; P:innate immune response; P:mRNA transport; P:positive regulation of stress granule assembly; P:protein homooligomerization; P:Ras protein signal transduction; P:stress granule assembly; P:viral process;|Q13283 Q5HYE9,Ras GTPase-activating protein-binding protein 1,ATP-dependent DNA helicase VIII;GAP SH3 domain-binding protein 1;, PF02136;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005925;GO:0005634;GO:0043204;GO:1990904;GO:0005524;GO:0003677;GO:0003678;GO:0033677;GO:0004519;GO:0003729;GO:0003723;GO:0003724;GO:0051607;GO:0045087;GO:0062029;GO:0032481;GO:0007265;GO:0034063;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:focal adhesion; C:nucleus; C:perikaryon; C:ribonucleoprotein complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA/RNA helicase activity; F:endonuclease activity; F:mRNA binding; F:RNA binding; F:RNA helicase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of stress granule assembly; P:positive regulation of type I interferon production; P:Ras protein signal transduction; P:stress granule assembly; P:viral process; scaffold4 indexed_genome mRNA 20573845 20906411 . + . ID=transcript_1073;P42261 B7Z2S0 B7Z2W8 B7Z3F6 B7Z9G9 D3DQI4 E7ESV8 Q2NKM6,Glutamate receptor 1,AMPA-selective glutamate receptor 1;GluR-A;GluR-K1;Glutamate receptor ionotropic, AMPA 1;, PF01094;PF00060;PF10613;, GO:0032281;GO:0044308;GO:0009986;GO:0030425;GO:0043197;GO:0032591;GO:0031901;GO:0030666;GO:0005789;GO:0033116;GO:0012507;GO:0060076;GO:0098978;GO:0099061;GO:0044309;GO:0043025;GO:0099544;GO:0005886;GO:0014069;GO:0055037;GO:0055038;GO:0097060;GO:0030672;GO:0004971;GO:0001540;GO:0008066;GO:0015276;GO:0099583;GO:0030165;GO:0038023;GO:1904315;GO:0071242;GO:0007268;GO:0048208;GO:0006888;GO:0007616;GO:0060292;GO:0031623;GO:2000310;GO:0007165;, C:AMPA glutamate receptor complex; C:axonal spine; C:cell surface; C:dendrite; C:dendritic spine; C:dendritic spine membrane; C:early endosome membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:excitatory synapse; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:neuron spine; C:neuronal cell body; C:perisynaptic space; C:plasma membrane; C:postsynaptic density; C:recycling endosome; C:recycling endosome membrane; C:synaptic membrane; C:synaptic vesicle membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:glutamate receptor activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to ammonium ion; P:chemical synaptic transmission; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:long-term memory; P:long-term synaptic depression; P:receptor internalization; P:regulation of NMDA receptor activity; P:signal transduction;|P42261 B7Z2S0 B7Z2W8 B7Z3F6 B7Z9G9 D3DQI4 E7ESV8 Q2NKM6,Glutamate receptor 1,AMPA-selective glutamate receptor 1;GluR-A;GluR-K1;Glutamate receptor ionotropic, AMPA 1;, PF01094;PF00060;PF10613;, GO:0032281;GO:0044308;GO:0009986;GO:0030425;GO:0043197;GO:0032591;GO:0031901;GO:0030666;GO:0005789;GO:0033116;GO:0012507;GO:0060076;GO:0098978;GO:0099061;GO:0044309;GO:0043025;GO:0099544;GO:0005886;GO:0014069;GO:0055037;GO:0055038;GO:0097060;GO:0030672;GO:0004971;GO:0001540;GO:0008066;GO:0015276;GO:0099583;GO:0030165;GO:0038023;GO:1904315;GO:0071242;GO:0007268;GO:0048208;GO:0006888;GO:0007616;GO:0060292;GO:0031623;GO:2000310;GO:0007165;, C:AMPA glutamate receptor complex; C:axonal spine; C:cell surface; C:dendrite; C:dendritic spine; C:dendritic spine membrane; C:early endosome membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:excitatory synapse; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:neuron spine; C:neuronal cell body; C:perisynaptic space; C:plasma membrane; C:postsynaptic density; C:recycling endosome; C:recycling endosome membrane; C:synaptic membrane; C:synaptic vesicle membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:glutamate receptor activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to ammonium ion; P:chemical synaptic transmission; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:long-term memory; P:long-term synaptic depression; P:receptor internalization; P:regulation of NMDA receptor activity; P:signal transduction;|P42261 B7Z2S0 B7Z2W8 B7Z3F6 B7Z9G9 D3DQI4 E7ESV8 Q2NKM6,Glutamate receptor 1,AMPA-selective glutamate receptor 1;GluR-A;GluR-K1;Glutamate receptor ionotropic, AMPA 1;, PF01094;PF00060;PF10613;, GO:0032281;GO:0044308;GO:0009986;GO:0030425;GO:0043197;GO:0032591;GO:0031901;GO:0030666;GO:0005789;GO:0033116;GO:0012507;GO:0060076;GO:0098978;GO:0099061;GO:0044309;GO:0043025;GO:0099544;GO:0005886;GO:0014069;GO:0055037;GO:0055038;GO:0097060;GO:0030672;GO:0004971;GO:0001540;GO:0008066;GO:0015276;GO:0099583;GO:0030165;GO:0038023;GO:1904315;GO:0071242;GO:0007268;GO:0048208;GO:0006888;GO:0007616;GO:0060292;GO:0031623;GO:2000310;GO:0007165;, C:AMPA glutamate receptor complex; C:axonal spine; C:cell surface; C:dendrite; C:dendritic spine; C:dendritic spine membrane; C:early endosome membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:excitatory synapse; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:neuron spine; C:neuronal cell body; C:perisynaptic space; C:plasma membrane; C:postsynaptic density; C:recycling endosome; C:recycling endosome membrane; C:synaptic membrane; C:synaptic vesicle membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:glutamate receptor activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to ammonium ion; P:chemical synaptic transmission; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:long-term memory; P:long-term synaptic depression; P:receptor internalization; P:regulation of NMDA receptor activity; P:signal transduction;|P48058 Q86XE8,Glutamate receptor 4,AMPA-selective glutamate receptor 4;GluR-D;Glutamate receptor ionotropic, AMPA 4;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:1903561;GO:0043025;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:extracellular vesicle; C:neuronal cell body; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P42262 A8MT92 I6L997 Q96FP6,Glutamate receptor 2 {ECO:0000305},AMPA-selective glutamate receptor 2;GluR-B;GluR-K2;Glutamate receptor ionotropic, AMPA 2;, PF01094;PF00060;PF10613;, GO:0032281;GO:0032279;GO:0030425;GO:0043197;GO:0030666;GO:0005789;GO:0060076;GO:0009897;GO:0005887;GO:0043025;GO:0005886;GO:0098794;GO:0014069;GO:0098839;GO:0098843;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0035235;GO:2000310;GO:0007165;GO:0035249;, C:AMPA glutamate receptor complex; C:asymmetric synapse; C:dendrite; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:excitatory synapse; C:external side of plasma membrane; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic endocytic zone;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:ionotropic glutamate receptor signaling pathway; P:regulation of NMDA receptor activity; P:signal transduction; P:synaptic transmission, glutamatergic; scaffold4 indexed_genome mRNA 20912891 20917421 . + . ID=transcript_1074;P42261 B7Z2S0 B7Z2W8 B7Z3F6 B7Z9G9 D3DQI4 E7ESV8 Q2NKM6,Glutamate receptor 1,AMPA-selective glutamate receptor 1;GluR-A;GluR-K1;Glutamate receptor ionotropic, AMPA 1;, PF01094;PF00060;PF10613;, GO:0032281;GO:0044308;GO:0009986;GO:0030425;GO:0043197;GO:0032591;GO:0031901;GO:0030666;GO:0005789;GO:0033116;GO:0012507;GO:0060076;GO:0098978;GO:0099061;GO:0044309;GO:0043025;GO:0099544;GO:0005886;GO:0014069;GO:0055037;GO:0055038;GO:0097060;GO:0030672;GO:0004971;GO:0001540;GO:0008066;GO:0015276;GO:0099583;GO:0030165;GO:0038023;GO:1904315;GO:0071242;GO:0007268;GO:0048208;GO:0006888;GO:0007616;GO:0060292;GO:0031623;GO:2000310;GO:0007165;, C:AMPA glutamate receptor complex; C:axonal spine; C:cell surface; C:dendrite; C:dendritic spine; C:dendritic spine membrane; C:early endosome membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:excitatory synapse; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:neuron spine; C:neuronal cell body; C:perisynaptic space; C:plasma membrane; C:postsynaptic density; C:recycling endosome; C:recycling endosome membrane; C:synaptic membrane; C:synaptic vesicle membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:glutamate receptor activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to ammonium ion; P:chemical synaptic transmission; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:long-term memory; P:long-term synaptic depression; P:receptor internalization; P:regulation of NMDA receptor activity; P:signal transduction;|P42261 B7Z2S0 B7Z2W8 B7Z3F6 B7Z9G9 D3DQI4 E7ESV8 Q2NKM6,Glutamate receptor 1,AMPA-selective glutamate receptor 1;GluR-A;GluR-K1;Glutamate receptor ionotropic, AMPA 1;, PF01094;PF00060;PF10613;, GO:0032281;GO:0044308;GO:0009986;GO:0030425;GO:0043197;GO:0032591;GO:0031901;GO:0030666;GO:0005789;GO:0033116;GO:0012507;GO:0060076;GO:0098978;GO:0099061;GO:0044309;GO:0043025;GO:0099544;GO:0005886;GO:0014069;GO:0055037;GO:0055038;GO:0097060;GO:0030672;GO:0004971;GO:0001540;GO:0008066;GO:0015276;GO:0099583;GO:0030165;GO:0038023;GO:1904315;GO:0071242;GO:0007268;GO:0048208;GO:0006888;GO:0007616;GO:0060292;GO:0031623;GO:2000310;GO:0007165;, C:AMPA glutamate receptor complex; C:axonal spine; C:cell surface; C:dendrite; C:dendritic spine; C:dendritic spine membrane; C:early endosome membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:excitatory synapse; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:neuron spine; C:neuronal cell body; C:perisynaptic space; C:plasma membrane; C:postsynaptic density; C:recycling endosome; C:recycling endosome membrane; C:synaptic membrane; C:synaptic vesicle membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:glutamate receptor activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to ammonium ion; P:chemical synaptic transmission; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:long-term memory; P:long-term synaptic depression; P:receptor internalization; P:regulation of NMDA receptor activity; P:signal transduction; scaffold4 indexed_genome mRNA 21082433 21114760 . - . ID=transcript_1075;Q9NRY5 B2R8D8 Q9H7E0,Protein FAM114A2,, PF05334;, GO:0017076;, , F:purine nucleotide binding;|Q96SI9 Q32NB9 Q9BUE1 Q9BXG4 Q9H0B4 Q9H7V1 Q9NUK4,Spermatid perinuclear RNA-binding protein,, PF00035;PF07528;, GO:0005737;GO:0002177;GO:0005634;GO:0003677;GO:0003725;GO:0008017;GO:0003723;GO:0003727;GO:0007638;GO:0007275;GO:0007286;, C:cytoplasm; C:manchette; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:microtubule binding; F:RNA binding; F:single-stranded RNA binding;, P:mechanosensory behavior; P:multicellular organism development; P:spermatid development; scaffold4 indexed_genome mRNA 21119991 21120797 . - . ID=transcript_1076;O00515 O95614 Q96GD8,Ladinin-1,Linear IgA disease antigen;, , GO:0015629;GO:0005604;GO:0070062;GO:0045296;GO:0005198;, C:actin cytoskeleton; C:basement membrane; C:extracellular exosome;, F:cadherin binding; F:structural molecule activity; scaffold4 indexed_genome mRNA 21129929 21137795 . + . ID=transcript_1077;P55082 B2RDK0 B4DKA1 Q9NXA7,Microfibril-associated glycoprotein 3,, PF00047;, GO:0005737;GO:0005576;GO:0016021;GO:0005634;GO:0005886;, C:cytoplasm; C:extracellular region; C:integral component of membrane; C:nucleus; C:plasma membrane; scaffold4 indexed_genome mRNA 21432037 21472713 . + . ID=transcript_1078;Q86SR1 B3KXC9 Q6IN56 Q86VP8 Q8IXJ2 Q8TEJ2 Q96IV2 Q9H8E1 Q9Y4M4,Polypeptide N-acetylgalactosaminyltransferase 10,Polypeptide GalNAc transferase 10;Protein-UDP acetylgalactosaminyltransferase 10;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;GO:0006493;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation; scaffold4 indexed_genome mRNA 21492198 21501843 . + . ID=transcript_1079;Q9HAJ7 E9PAU7 E9PAY2,Histone deacetylase complex subunit SAP30L,HCV non-structural protein 4A-transactivated protein 2;Sin3 corepressor complex subunit SAP30L;Sin3-associated protein p30-like;, PF13867;PF13866;, GO:0001650;GO:0000118;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0044378;GO:0031491;GO:0032266;GO:0070273;GO:0010314;GO:0003712;GO:0008270;GO:0000122;GO:0006355;, C:fibrillar center; C:histone deacetylase complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:non-sequence-specific DNA binding, bending; F:nucleosome binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:transcription coregulator activity; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9HAJ7 E9PAU7 E9PAY2,Histone deacetylase complex subunit SAP30L,HCV non-structural protein 4A-transactivated protein 2;Sin3 corepressor complex subunit SAP30L;Sin3-associated protein p30-like;, PF13867;PF13866;, GO:0001650;GO:0000118;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0044378;GO:0031491;GO:0032266;GO:0070273;GO:0010314;GO:0003712;GO:0008270;GO:0000122;GO:0006355;, C:fibrillar center; C:histone deacetylase complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:non-sequence-specific DNA binding, bending; F:nucleosome binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:transcription coregulator activity; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9HAJ7 E9PAU7 E9PAY2,Histone deacetylase complex subunit SAP30L,HCV non-structural protein 4A-transactivated protein 2;Sin3 corepressor complex subunit SAP30L;Sin3-associated protein p30-like;, PF13867;PF13866;, GO:0001650;GO:0000118;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0044378;GO:0031491;GO:0032266;GO:0070273;GO:0010314;GO:0003712;GO:0008270;GO:0000122;GO:0006355;, C:fibrillar center; C:histone deacetylase complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:non-sequence-specific DNA binding, bending; F:nucleosome binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:transcription coregulator activity; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9HAJ7 E9PAU7 E9PAY2,Histone deacetylase complex subunit SAP30L,HCV non-structural protein 4A-transactivated protein 2;Sin3 corepressor complex subunit SAP30L;Sin3-associated protein p30-like;, PF13867;PF13866;, GO:0001650;GO:0000118;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0044378;GO:0031491;GO:0032266;GO:0070273;GO:0010314;GO:0003712;GO:0008270;GO:0000122;GO:0006355;, C:fibrillar center; C:histone deacetylase complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:non-sequence-specific DNA binding, bending; F:nucleosome binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:transcription coregulator activity; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold4 indexed_genome mRNA 21518716 21521985 . - . ID=transcript_1080;O96004,Heart- and neural crest derivatives-expressed protein 1,Class A basic helix-loop-helix protein 27;Extraembryonic tissues, heart, autonomic nervous system and neural crest derivatives-expressed protein 1;, PF00010;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0090575;GO:0043425;GO:0001228;GO:0000981;GO:0001227;GO:0019899;GO:0042802;GO:0042803;GO:0000978;GO:0000977;GO:0001221;GO:0008134;GO:0001525;GO:0001824;GO:0003218;GO:0003219;GO:0060411;GO:0060536;GO:0032502;GO:0035050;GO:0003144;GO:0007507;GO:0001947;GO:0060485;GO:0001707;GO:0043433;GO:1903026;GO:0000122;GO:0045892;GO:0042475;GO:0045944;GO:0006357;GO:0001829;GO:0060707;GO:0055010;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:bHLH transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coregulator binding; F:transcription factor binding;, P:angiogenesis; P:blastocyst development; P:cardiac left ventricle formation; P:cardiac right ventricle formation; P:cardiac septum morphogenesis; P:cartilage morphogenesis; P:developmental process; P:embryonic heart tube development; P:embryonic heart tube formation; P:heart development; P:heart looping; P:mesenchyme development; P:mesoderm formation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:odontogenesis of dentin-containing tooth; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:trophectodermal cell differentiation; P:trophoblast giant cell differentiation; P:ventricular cardiac muscle tissue morphogenesis; scaffold4 indexed_genome mRNA 21752983 21774388 . + . ID=transcript_1081;Q6PKG0 O94836 Q8N4M2 Q8NB73 Q9UFD7,La-related protein 1,La ribonucleoprotein domain family member 1;, PF05383;, GO:0005737;GO:0010494;GO:0016020;GO:0045296;GO:0008190;GO:0003730;GO:0048027;GO:0043024;GO:0000340;GO:0003723;GO:0000339;GO:0008494;GO:0031369;GO:0008283;GO:0072752;GO:0048255;GO:0017148;GO:0045947;GO:0016239;GO:0045948;GO:0045070;GO:0010608;GO:1990928;GO:0031929;GO:0038202;GO:0006413;, C:cytoplasm; C:cytoplasmic stress granule; C:membrane;, F:cadherin binding; F:eukaryotic initiation factor 4E binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:ribosomal small subunit binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation activator activity; F:translation initiation factor binding;, P:cell population proliferation; P:cellular response to rapamycin; P:mRNA stabilization; P:negative regulation of translation; P:negative regulation of translational initiation; P:positive regulation of macroautophagy; P:positive regulation of translational initiation; P:positive regulation of viral genome replication; P:posttranscriptional regulation of gene expression; P:response to amino acid starvation; P:TOR signaling; P:TORC1 signaling; P:translational initiation;|Q6PKG0 O94836 Q8N4M2 Q8NB73 Q9UFD7,La-related protein 1,La ribonucleoprotein domain family member 1;, PF05383;, GO:0005737;GO:0010494;GO:0016020;GO:0045296;GO:0008190;GO:0003730;GO:0048027;GO:0043024;GO:0000340;GO:0003723;GO:0000339;GO:0008494;GO:0031369;GO:0008283;GO:0072752;GO:0048255;GO:0017148;GO:0045947;GO:0016239;GO:0045948;GO:0045070;GO:0010608;GO:1990928;GO:0031929;GO:0038202;GO:0006413;, C:cytoplasm; C:cytoplasmic stress granule; C:membrane;, F:cadherin binding; F:eukaryotic initiation factor 4E binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:ribosomal small subunit binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation activator activity; F:translation initiation factor binding;, P:cell population proliferation; P:cellular response to rapamycin; P:mRNA stabilization; P:negative regulation of translation; P:negative regulation of translational initiation; P:positive regulation of macroautophagy; P:positive regulation of translational initiation; P:positive regulation of viral genome replication; P:posttranscriptional regulation of gene expression; P:response to amino acid starvation; P:TOR signaling; P:TORC1 signaling; P:translational initiation;|Q6PKG0 O94836 Q8N4M2 Q8NB73 Q9UFD7,La-related protein 1,La ribonucleoprotein domain family member 1;, PF05383;, GO:0005737;GO:0010494;GO:0016020;GO:0045296;GO:0008190;GO:0003730;GO:0048027;GO:0043024;GO:0000340;GO:0003723;GO:0000339;GO:0008494;GO:0031369;GO:0008283;GO:0072752;GO:0048255;GO:0017148;GO:0045947;GO:0016239;GO:0045948;GO:0045070;GO:0010608;GO:1990928;GO:0031929;GO:0038202;GO:0006413;, C:cytoplasm; C:cytoplasmic stress granule; C:membrane;, F:cadherin binding; F:eukaryotic initiation factor 4E binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:ribosomal small subunit binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation activator activity; F:translation initiation factor binding;, P:cell population proliferation; P:cellular response to rapamycin; P:mRNA stabilization; P:negative regulation of translation; P:negative regulation of translational initiation; P:positive regulation of macroautophagy; P:positive regulation of translational initiation; P:positive regulation of viral genome replication; P:posttranscriptional regulation of gene expression; P:response to amino acid starvation; P:TOR signaling; P:TORC1 signaling; P:translational initiation;|Q6PKG0 O94836 Q8N4M2 Q8NB73 Q9UFD7,La-related protein 1,La ribonucleoprotein domain family member 1;, PF05383;, GO:0005737;GO:0010494;GO:0016020;GO:0045296;GO:0008190;GO:0003730;GO:0048027;GO:0043024;GO:0000340;GO:0003723;GO:0000339;GO:0008494;GO:0031369;GO:0008283;GO:0072752;GO:0048255;GO:0017148;GO:0045947;GO:0016239;GO:0045948;GO:0045070;GO:0010608;GO:1990928;GO:0031929;GO:0038202;GO:0006413;, C:cytoplasm; C:cytoplasmic stress granule; C:membrane;, F:cadherin binding; F:eukaryotic initiation factor 4E binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:ribosomal small subunit binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation activator activity; F:translation initiation factor binding;, P:cell population proliferation; P:cellular response to rapamycin; P:mRNA stabilization; P:negative regulation of translation; P:negative regulation of translational initiation; P:positive regulation of macroautophagy; P:positive regulation of translational initiation; P:positive regulation of viral genome replication; P:posttranscriptional regulation of gene expression; P:response to amino acid starvation; P:TOR signaling; P:TORC1 signaling; P:translational initiation;|Q6PKG0 O94836 Q8N4M2 Q8NB73 Q9UFD7,La-related protein 1,La ribonucleoprotein domain family member 1;, PF05383;, GO:0005737;GO:0010494;GO:0016020;GO:0045296;GO:0008190;GO:0003730;GO:0048027;GO:0043024;GO:0000340;GO:0003723;GO:0000339;GO:0008494;GO:0031369;GO:0008283;GO:0072752;GO:0048255;GO:0017148;GO:0045947;GO:0016239;GO:0045948;GO:0045070;GO:0010608;GO:1990928;GO:0031929;GO:0038202;GO:0006413;, C:cytoplasm; C:cytoplasmic stress granule; C:membrane;, F:cadherin binding; F:eukaryotic initiation factor 4E binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:ribosomal small subunit binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation activator activity; F:translation initiation factor binding;, P:cell population proliferation; P:cellular response to rapamycin; P:mRNA stabilization; P:negative regulation of translation; P:negative regulation of translational initiation; P:positive regulation of macroautophagy; P:positive regulation of translational initiation; P:positive regulation of viral genome replication; P:posttranscriptional regulation of gene expression; P:response to amino acid starvation; P:TOR signaling; P:TORC1 signaling; P:translational initiation; scaffold4 indexed_genome mRNA 21802512 21812617 . + . ID=transcript_1082;Q9UFF9 B0AZS3 B2RAR8 B7Z8R1 D3DQI8 O95709 Q7Z521 Q9H6Y1,CCR4-NOT transcription complex subunit 8,CAF1-like protein;CAF2;CCR4-associated factor 8;Caf1b;, PF04857;, GO:0030014;GO:0030015;GO:0005829;GO:0005634;GO:0000932;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0006977;GO:0043928;GO:0035195;GO:0017148;GO:0000289;GO:0008284;GO:0061014;GO:0006351;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:nucleus; C:P-body;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:exonucleolytic catabolism of deadenylated mRNA; P:gene silencing by miRNA; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cell population proliferation; P:positive regulation of mRNA catabolic process; P:transcription, DNA-templated; scaffold4 indexed_genome mRNA 21812961 21819479 . + . ID=transcript_1083;Q9UFF9 B0AZS3 B2RAR8 B7Z8R1 D3DQI8 O95709 Q7Z521 Q9H6Y1,CCR4-NOT transcription complex subunit 8,CAF1-like protein;CAF2;CCR4-associated factor 8;Caf1b;, PF04857;, GO:0030014;GO:0030015;GO:0005829;GO:0005634;GO:0000932;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0006977;GO:0043928;GO:0035195;GO:0017148;GO:0000289;GO:0008284;GO:0061014;GO:0006351;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:nucleus; C:P-body;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:exonucleolytic catabolism of deadenylated mRNA; P:gene silencing by miRNA; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cell population proliferation; P:positive regulation of mRNA catabolic process; P:transcription, DNA-templated;|Q9UFF9 B0AZS3 B2RAR8 B7Z8R1 D3DQI8 O95709 Q7Z521 Q9H6Y1,CCR4-NOT transcription complex subunit 8,CAF1-like protein;CAF2;CCR4-associated factor 8;Caf1b;, PF04857;, GO:0030014;GO:0030015;GO:0005829;GO:0005634;GO:0000932;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0006977;GO:0043928;GO:0035195;GO:0017148;GO:0000289;GO:0008284;GO:0061014;GO:0006351;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:nucleus; C:P-body;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:exonucleolytic catabolism of deadenylated mRNA; P:gene silencing by miRNA; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cell population proliferation; P:positive regulation of mRNA catabolic process; P:transcription, DNA-templated; scaffold4 indexed_genome mRNA 21823680 21865332 . - . ID=transcript_1084;Q8TEQ6 Q14CV0 Q8WWV4 Q969W4 Q9H9K3 Q9UFI5,Gem-associated protein 5,, PF12894;PF00400;, GO:0005737;GO:0005829;GO:0097504;GO:0016020;GO:0016604;GO:0005654;GO:0032797;GO:0034718;GO:0034719;GO:0003730;GO:0043022;GO:0000340;GO:0003723;GO:0017069;GO:0030619;GO:0030621;GO:0030622;GO:0051170;GO:0000398;GO:0065003;GO:0006417;GO:0000387;GO:0006412;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nuclear body; C:nucleoplasm; C:SMN complex; C:SMN-Gemin2 complex; C:SMN-Sm protein complex;, F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding; F:U4 snRNA binding; F:U4atac snRNA binding;, P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein-containing complex assembly; P:regulation of translation; P:spliceosomal snRNP assembly; P:translation;|Q8TEQ6 Q14CV0 Q8WWV4 Q969W4 Q9H9K3 Q9UFI5,Gem-associated protein 5,, PF12894;PF00400;, GO:0005737;GO:0005829;GO:0097504;GO:0016020;GO:0016604;GO:0005654;GO:0032797;GO:0034718;GO:0034719;GO:0003730;GO:0043022;GO:0000340;GO:0003723;GO:0017069;GO:0030619;GO:0030621;GO:0030622;GO:0051170;GO:0000398;GO:0065003;GO:0006417;GO:0000387;GO:0006412;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nuclear body; C:nucleoplasm; C:SMN complex; C:SMN-Gemin2 complex; C:SMN-Sm protein complex;, F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding; F:U4 snRNA binding; F:U4atac snRNA binding;, P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein-containing complex assembly; P:regulation of translation; P:spliceosomal snRNP assembly; P:translation;|Q8TEQ6 Q14CV0 Q8WWV4 Q969W4 Q9H9K3 Q9UFI5,Gem-associated protein 5,, PF12894;PF00400;, GO:0005737;GO:0005829;GO:0097504;GO:0016020;GO:0016604;GO:0005654;GO:0032797;GO:0034718;GO:0034719;GO:0003730;GO:0043022;GO:0000340;GO:0003723;GO:0017069;GO:0030619;GO:0030621;GO:0030622;GO:0051170;GO:0000398;GO:0065003;GO:0006417;GO:0000387;GO:0006412;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nuclear body; C:nucleoplasm; C:SMN complex; C:SMN-Gemin2 complex; C:SMN-Sm protein complex;, F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding; F:U4 snRNA binding; F:U4atac snRNA binding;, P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein-containing complex assembly; P:regulation of translation; P:spliceosomal snRNP assembly; P:translation;|Q8TEQ6 Q14CV0 Q8WWV4 Q969W4 Q9H9K3 Q9UFI5,Gem-associated protein 5,, PF12894;PF00400;, GO:0005737;GO:0005829;GO:0097504;GO:0016020;GO:0016604;GO:0005654;GO:0032797;GO:0034718;GO:0034719;GO:0003730;GO:0043022;GO:0000340;GO:0003723;GO:0017069;GO:0030619;GO:0030621;GO:0030622;GO:0051170;GO:0000398;GO:0065003;GO:0006417;GO:0000387;GO:0006412;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nuclear body; C:nucleoplasm; C:SMN complex; C:SMN-Gemin2 complex; C:SMN-Sm protein complex;, F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding; F:U4 snRNA binding; F:U4atac snRNA binding;, P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein-containing complex assembly; P:regulation of translation; P:spliceosomal snRNP assembly; P:translation;|Q8TEQ6 Q14CV0 Q8WWV4 Q969W4 Q9H9K3 Q9UFI5,Gem-associated protein 5,, PF12894;PF00400;, GO:0005737;GO:0005829;GO:0097504;GO:0016020;GO:0016604;GO:0005654;GO:0032797;GO:0034718;GO:0034719;GO:0003730;GO:0043022;GO:0000340;GO:0003723;GO:0017069;GO:0030619;GO:0030621;GO:0030622;GO:0051170;GO:0000398;GO:0065003;GO:0006417;GO:0000387;GO:0006412;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nuclear body; C:nucleoplasm; C:SMN complex; C:SMN-Gemin2 complex; C:SMN-Sm protein complex;, F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding; F:U4 snRNA binding; F:U4atac snRNA binding;, P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein-containing complex assembly; P:regulation of translation; P:spliceosomal snRNP assembly; P:translation;|Q8TEQ6 Q14CV0 Q8WWV4 Q969W4 Q9H9K3 Q9UFI5,Gem-associated protein 5,, PF12894;PF00400;, GO:0005737;GO:0005829;GO:0097504;GO:0016020;GO:0016604;GO:0005654;GO:0032797;GO:0034718;GO:0034719;GO:0003730;GO:0043022;GO:0000340;GO:0003723;GO:0017069;GO:0030619;GO:0030621;GO:0030622;GO:0051170;GO:0000398;GO:0065003;GO:0006417;GO:0000387;GO:0006412;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nuclear body; C:nucleoplasm; C:SMN complex; C:SMN-Gemin2 complex; C:SMN-Sm protein complex;, F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding; F:U4 snRNA binding; F:U4atac snRNA binding;, P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein-containing complex assembly; P:regulation of translation; P:spliceosomal snRNP assembly; P:translation;|Q8TEQ6 Q14CV0 Q8WWV4 Q969W4 Q9H9K3 Q9UFI5,Gem-associated protein 5,, PF12894;PF00400;, GO:0005737;GO:0005829;GO:0097504;GO:0016020;GO:0016604;GO:0005654;GO:0032797;GO:0034718;GO:0034719;GO:0003730;GO:0043022;GO:0000340;GO:0003723;GO:0017069;GO:0030619;GO:0030621;GO:0030622;GO:0051170;GO:0000398;GO:0065003;GO:0006417;GO:0000387;GO:0006412;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nuclear body; C:nucleoplasm; C:SMN complex; C:SMN-Gemin2 complex; C:SMN-Sm protein complex;, F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding; F:U4 snRNA binding; F:U4atac snRNA binding;, P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein-containing complex assembly; P:regulation of translation; P:spliceosomal snRNP assembly; P:translation; scaffold4 indexed_genome mRNA 21892141 21907865 . - . ID=transcript_1085;Q9NWU5 A6NGJ8 Q5H9Q1 Q96Q51 Q9P006,39S ribosomal protein L22, mitochondrial,39S ribosomal protein L25, mitochondrial;Mitochondrial large ribosomal subunit protein uL22m {ECO:0000303|PubMed:25278503};, PF00237;, GO:0015934;GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0042255;, C:large ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosome assembly;|Q9NWU5 A6NGJ8 Q5H9Q1 Q96Q51 Q9P006,39S ribosomal protein L22, mitochondrial,39S ribosomal protein L25, mitochondrial;Mitochondrial large ribosomal subunit protein uL22m {ECO:0000303|PubMed:25278503};, PF00237;, GO:0015934;GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0042255;, C:large ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosome assembly;|Q9NWU5 A6NGJ8 Q5H9Q1 Q96Q51 Q9P006,39S ribosomal protein L22, mitochondrial,39S ribosomal protein L25, mitochondrial;Mitochondrial large ribosomal subunit protein uL22m {ECO:0000303|PubMed:25278503};, PF00237;, GO:0015934;GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0042255;, C:large ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosome assembly;|Q9NWU5 A6NGJ8 Q5H9Q1 Q96Q51 Q9P006,39S ribosomal protein L22, mitochondrial,39S ribosomal protein L25, mitochondrial;Mitochondrial large ribosomal subunit protein uL22m {ECO:0000303|PubMed:25278503};, PF00237;, GO:0015934;GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0042255;, C:large ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosome assembly; scaffold4 indexed_genome mRNA 23504895 23667464 . + . ID=transcript_1086;Q92629 A8K9S9 Q53XA5 Q99644,Delta-sarcoglycan,35 kDa dystrophin-associated glycoprotein;, PF04790;, GO:0005737;GO:0005856;GO:0016010;GO:0016021;GO:0005886;GO:0016012;GO:0042383;GO:0048738;GO:0060047;GO:0007517;, C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:integral component of membrane; C:plasma membrane; C:sarcoglycan complex; C:sarcolemma;, , P:cardiac muscle tissue development; P:heart contraction; P:muscle organ development; scaffold4 indexed_genome mRNA 23823982 23851370 . - . ID=transcript_1087;Q96H15 B5MCL9,T-cell immunoglobulin and mucin domain-containing protein 4,T-cell immunoglobulin mucin receptor 4;T-cell membrane protein 4;, PF07686;, GO:0016021;, C:integral component of membrane; scaffold4 indexed_genome mRNA 23968807 23977541 . - . ID=transcript_1088;Q96D42 O43656,Hepatitis A virus cellular receptor 1,Kidney injury molecule 1;T-cell immunoglobulin and mucin domain-containing protein 1;T-cell immunoglobulin mucin receptor 1;T-cell membrane protein 1;, PF07686;, GO:0009986;GO:0016021;GO:0031514;GO:0001786;GO:0001618;GO:0006911;GO:0033005;, C:cell surface; C:integral component of membrane; C:motile cilium;, F:phosphatidylserine binding; F:virus receptor activity;, P:phagocytosis, engulfment; P:positive regulation of mast cell activation; scaffold4 indexed_genome mRNA 24197074 24210212 . - . ID=transcript_1089;Q96D42 O43656,Hepatitis A virus cellular receptor 1,Kidney injury molecule 1;T-cell immunoglobulin and mucin domain-containing protein 1;T-cell immunoglobulin mucin receptor 1;T-cell membrane protein 1;, PF07686;, GO:0009986;GO:0016021;GO:0031514;GO:0001786;GO:0001618;GO:0006911;GO:0033005;, C:cell surface; C:integral component of membrane; C:motile cilium;, F:phosphatidylserine binding; F:virus receptor activity;, P:phagocytosis, engulfment; P:positive regulation of mast cell activation; scaffold4 indexed_genome mRNA 24241585 24260338 . + . ID=transcript_1090;Q8TDQ0 B2RAY2 Q8WW60 Q96K94,Hepatitis A virus cellular receptor 2,T-cell immunoglobulin and mucin domain-containing protein 3;T-cell immunoglobulin mucin receptor 3;T-cell membrane protein 3;, PF07686;, GO:0030054;GO:0009986;GO:0005769;GO:0001772;GO:0016021;GO:0046872;GO:0002250;GO:0071222;GO:0050830;GO:0006954;GO:0045087;GO:0002281;GO:0060135;GO:0002519;GO:1900425;GO:0010629;GO:0071656;GO:2000521;GO:0032687;GO:0032689;GO:0032703;GO:0032712;GO:0032715;GO:0030886;GO:0032815;GO:0002859;GO:0032088;GO:2001189;GO:0042130;GO:0002826;GO:0032720;GO:0032722;GO:1900426;GO:0070374;GO:0045089;GO:0032729;GO:0032732;GO:0032753;GO:0043032;GO:1901224;GO:0042102;GO:0032760;GO:0002652;GO:0034138;GO:0034154;GO:0034162;, C:cell junction; C:cell surface; C:early endosome; C:immunological synapse; C:integral component of membrane;, F:metal ion binding;, P:adaptive immune response; P:cellular response to lipopolysaccharide; P:defense response to Gram-positive bacterium; P:inflammatory response; P:innate immune response; P:macrophage activation involved in immune response; P:maternal process involved in female pregnancy; P:natural killer cell tolerance induction; P:negative regulation of defense response to bacterium; P:negative regulation of gene expression; P:negative regulation of granulocyte colony-stimulating factor production; P:negative regulation of immunological synapse formation; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-2 production; P:negative regulation of interleukin-3 production; P:negative regulation of interleukin-6 production; P:negative regulation of myeloid dendritic cell activation; P:negative regulation of natural killer cell activation; P:negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:negative regulation of T cell proliferation; P:negative regulation of T-helper 1 type immune response; P:negative regulation of tumor necrosis factor production; P:positive regulation of chemokine production; P:positive regulation of defense response to bacterium; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of innate immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 production; P:positive regulation of interleukin-4 production; P:positive regulation of macrophage activation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:regulation of tolerance induction dependent upon immune response; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway;|Q8TDQ0 B2RAY2 Q8WW60 Q96K94,Hepatitis A virus cellular receptor 2,T-cell immunoglobulin and mucin domain-containing protein 3;T-cell immunoglobulin mucin receptor 3;T-cell membrane protein 3;, PF07686;, GO:0030054;GO:0009986;GO:0005769;GO:0001772;GO:0016021;GO:0046872;GO:0002250;GO:0071222;GO:0050830;GO:0006954;GO:0045087;GO:0002281;GO:0060135;GO:0002519;GO:1900425;GO:0010629;GO:0071656;GO:2000521;GO:0032687;GO:0032689;GO:0032703;GO:0032712;GO:0032715;GO:0030886;GO:0032815;GO:0002859;GO:0032088;GO:2001189;GO:0042130;GO:0002826;GO:0032720;GO:0032722;GO:1900426;GO:0070374;GO:0045089;GO:0032729;GO:0032732;GO:0032753;GO:0043032;GO:1901224;GO:0042102;GO:0032760;GO:0002652;GO:0034138;GO:0034154;GO:0034162;, C:cell junction; C:cell surface; C:early endosome; C:immunological synapse; C:integral component of membrane;, F:metal ion binding;, P:adaptive immune response; P:cellular response to lipopolysaccharide; P:defense response to Gram-positive bacterium; P:inflammatory response; P:innate immune response; P:macrophage activation involved in immune response; P:maternal process involved in female pregnancy; P:natural killer cell tolerance induction; P:negative regulation of defense response to bacterium; P:negative regulation of gene expression; P:negative regulation of granulocyte colony-stimulating factor production; P:negative regulation of immunological synapse formation; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-2 production; P:negative regulation of interleukin-3 production; P:negative regulation of interleukin-6 production; P:negative regulation of myeloid dendritic cell activation; P:negative regulation of natural killer cell activation; P:negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:negative regulation of T cell proliferation; P:negative regulation of T-helper 1 type immune response; P:negative regulation of tumor necrosis factor production; P:positive regulation of chemokine production; P:positive regulation of defense response to bacterium; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of innate immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 production; P:positive regulation of interleukin-4 production; P:positive regulation of macrophage activation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:regulation of tolerance induction dependent upon immune response; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway;|Q8TDQ0 B2RAY2 Q8WW60 Q96K94,Hepatitis A virus cellular receptor 2,T-cell immunoglobulin and mucin domain-containing protein 3;T-cell immunoglobulin mucin receptor 3;T-cell membrane protein 3;, PF07686;, GO:0030054;GO:0009986;GO:0005769;GO:0001772;GO:0016021;GO:0046872;GO:0002250;GO:0071222;GO:0050830;GO:0006954;GO:0045087;GO:0002281;GO:0060135;GO:0002519;GO:1900425;GO:0010629;GO:0071656;GO:2000521;GO:0032687;GO:0032689;GO:0032703;GO:0032712;GO:0032715;GO:0030886;GO:0032815;GO:0002859;GO:0032088;GO:2001189;GO:0042130;GO:0002826;GO:0032720;GO:0032722;GO:1900426;GO:0070374;GO:0045089;GO:0032729;GO:0032732;GO:0032753;GO:0043032;GO:1901224;GO:0042102;GO:0032760;GO:0002652;GO:0034138;GO:0034154;GO:0034162;, C:cell junction; C:cell surface; C:early endosome; C:immunological synapse; C:integral component of membrane;, F:metal ion binding;, P:adaptive immune response; P:cellular response to lipopolysaccharide; P:defense response to Gram-positive bacterium; P:inflammatory response; P:innate immune response; P:macrophage activation involved in immune response; P:maternal process involved in female pregnancy; P:natural killer cell tolerance induction; P:negative regulation of defense response to bacterium; P:negative regulation of gene expression; P:negative regulation of granulocyte colony-stimulating factor production; P:negative regulation of immunological synapse formation; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-2 production; P:negative regulation of interleukin-3 production; P:negative regulation of interleukin-6 production; P:negative regulation of myeloid dendritic cell activation; P:negative regulation of natural killer cell activation; P:negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:negative regulation of T cell proliferation; P:negative regulation of T-helper 1 type immune response; P:negative regulation of tumor necrosis factor production; P:positive regulation of chemokine production; P:positive regulation of defense response to bacterium; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of innate immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 production; P:positive regulation of interleukin-4 production; P:positive regulation of macrophage activation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:regulation of tolerance induction dependent upon immune response; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; scaffold4 indexed_genome mRNA 24260363 24263129 . - . ID=transcript_1091;Q8TDQ0 B2RAY2 Q8WW60 Q96K94,Hepatitis A virus cellular receptor 2,T-cell immunoglobulin and mucin domain-containing protein 3;T-cell immunoglobulin mucin receptor 3;T-cell membrane protein 3;, PF07686;, GO:0030054;GO:0009986;GO:0005769;GO:0001772;GO:0016021;GO:0046872;GO:0002250;GO:0071222;GO:0050830;GO:0006954;GO:0045087;GO:0002281;GO:0060135;GO:0002519;GO:1900425;GO:0010629;GO:0071656;GO:2000521;GO:0032687;GO:0032689;GO:0032703;GO:0032712;GO:0032715;GO:0030886;GO:0032815;GO:0002859;GO:0032088;GO:2001189;GO:0042130;GO:0002826;GO:0032720;GO:0032722;GO:1900426;GO:0070374;GO:0045089;GO:0032729;GO:0032732;GO:0032753;GO:0043032;GO:1901224;GO:0042102;GO:0032760;GO:0002652;GO:0034138;GO:0034154;GO:0034162;, C:cell junction; C:cell surface; C:early endosome; C:immunological synapse; C:integral component of membrane;, F:metal ion binding;, P:adaptive immune response; P:cellular response to lipopolysaccharide; P:defense response to Gram-positive bacterium; P:inflammatory response; P:innate immune response; P:macrophage activation involved in immune response; P:maternal process involved in female pregnancy; P:natural killer cell tolerance induction; P:negative regulation of defense response to bacterium; P:negative regulation of gene expression; P:negative regulation of granulocyte colony-stimulating factor production; P:negative regulation of immunological synapse formation; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-2 production; P:negative regulation of interleukin-3 production; P:negative regulation of interleukin-6 production; P:negative regulation of myeloid dendritic cell activation; P:negative regulation of natural killer cell activation; P:negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:negative regulation of T cell proliferation; P:negative regulation of T-helper 1 type immune response; P:negative regulation of tumor necrosis factor production; P:positive regulation of chemokine production; P:positive regulation of defense response to bacterium; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of innate immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 production; P:positive regulation of interleukin-4 production; P:positive regulation of macrophage activation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:regulation of tolerance induction dependent upon immune response; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; scaffold4 indexed_genome mRNA 24281186 24282909 . + . ID=transcript_1092;O43513,Mediator of RNA polymerase II transcription subunit 7,Activator-recruited cofactor 34 kDa component;Cofactor required for Sp1 transcriptional activation subunit 9;Mediator complex subunit 7;RNA polymerase transcriptional regulation mediator subunit 7 homolog;Transcriptional coactivator CRSP33;, PF05983;, GO:0016592;GO:0016604;GO:0005654;GO:0005667;GO:0000151;GO:0003713;GO:0061630;GO:0006357;GO:0060260;GO:0019827;GO:0006367;, C:mediator complex; C:nuclear body; C:nucleoplasm; C:transcription regulator complex; C:ubiquitin ligase complex;, F:transcription coactivator activity; F:ubiquitin protein ligase activity;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:stem cell population maintenance; P:transcription initiation from RNA polymerase II promoter; scaffold4 indexed_genome mRNA 24380218 24410538 . + . ID=transcript_1093;Q08881 B2R752 Q32ML7,Tyrosine-protein kinase ITK/TSK,Interleukin-2-inducible T-cell kinase;Kinase EMT;T-cell-specific kinase;Tyrosine-protein kinase Lyk;, PF00779;PF00169;PF07714;PF00017;PF00018;, GO:0005911;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0046872;GO:0004715;GO:0004713;GO:0004714;GO:0007202;GO:0002250;GO:0050853;GO:0006968;GO:0038095;GO:0046629;GO:0035556;GO:0001865;GO:0038083;GO:0001819;GO:0007165;GO:0042110;GO:0050852;, C:cell-cell junction; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of phospholipase C activity; P:adaptive immune response; P:B cell receptor signaling pathway; P:cellular defense response; P:Fc-epsilon receptor signaling pathway; P:gamma-delta T cell activation; P:intracellular signal transduction; P:NK T cell differentiation; P:peptidyl-tyrosine autophosphorylation; P:positive regulation of cytokine production; P:signal transduction; P:T cell activation; P:T cell receptor signaling pathway;|Q08881 B2R752 Q32ML7,Tyrosine-protein kinase ITK/TSK,Interleukin-2-inducible T-cell kinase;Kinase EMT;T-cell-specific kinase;Tyrosine-protein kinase Lyk;, PF00779;PF00169;PF07714;PF00017;PF00018;, GO:0005911;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0046872;GO:0004715;GO:0004713;GO:0004714;GO:0007202;GO:0002250;GO:0050853;GO:0006968;GO:0038095;GO:0046629;GO:0035556;GO:0001865;GO:0038083;GO:0001819;GO:0007165;GO:0042110;GO:0050852;, C:cell-cell junction; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of phospholipase C activity; P:adaptive immune response; P:B cell receptor signaling pathway; P:cellular defense response; P:Fc-epsilon receptor signaling pathway; P:gamma-delta T cell activation; P:intracellular signal transduction; P:NK T cell differentiation; P:peptidyl-tyrosine autophosphorylation; P:positive regulation of cytokine production; P:signal transduction; P:T cell activation; P:T cell receptor signaling pathway; scaffold4 indexed_genome mRNA 24419646 24552653 . + . ID=transcript_1094;Q96F07 A6NLT2 D3DQJ3 Q53EN5 Q9NTK4 Q9ULQ2 Q9UN29,Cytoplasmic FMR1-interacting protein 2,p53-inducible protein 121;, PF07159;PF05994;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0031209;GO:0045202;GO:0031267;GO:0097202;GO:0006915;GO:0000902;GO:0098609;GO:0038096;GO:0045862;GO:0030833;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:SCAR complex; C:synapse;, F:small GTPase binding;, P:activation of cysteine-type endopeptidase activity; P:apoptotic process; P:cell morphogenesis; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of proteolysis; P:regulation of actin filament polymerization; P:vascular endothelial growth factor receptor signaling pathway;|Q96F07 A6NLT2 D3DQJ3 Q53EN5 Q9NTK4 Q9ULQ2 Q9UN29,Cytoplasmic FMR1-interacting protein 2,p53-inducible protein 121;, PF07159;PF05994;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0031209;GO:0045202;GO:0031267;GO:0097202;GO:0006915;GO:0000902;GO:0098609;GO:0038096;GO:0045862;GO:0030833;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:SCAR complex; C:synapse;, F:small GTPase binding;, P:activation of cysteine-type endopeptidase activity; P:apoptotic process; P:cell morphogenesis; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of proteolysis; P:regulation of actin filament polymerization; P:vascular endothelial growth factor receptor signaling pathway;|Q96F07 A6NLT2 D3DQJ3 Q53EN5 Q9NTK4 Q9ULQ2 Q9UN29,Cytoplasmic FMR1-interacting protein 2,p53-inducible protein 121;, PF07159;PF05994;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0031209;GO:0045202;GO:0031267;GO:0097202;GO:0006915;GO:0000902;GO:0098609;GO:0038096;GO:0045862;GO:0030833;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:SCAR complex; C:synapse;, F:small GTPase binding;, P:activation of cysteine-type endopeptidase activity; P:apoptotic process; P:cell morphogenesis; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of proteolysis; P:regulation of actin filament polymerization; P:vascular endothelial growth factor receptor signaling pathway;|Q96F07 A6NLT2 D3DQJ3 Q53EN5 Q9NTK4 Q9ULQ2 Q9UN29,Cytoplasmic FMR1-interacting protein 2,p53-inducible protein 121;, PF07159;PF05994;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0031209;GO:0045202;GO:0031267;GO:0097202;GO:0006915;GO:0000902;GO:0098609;GO:0038096;GO:0045862;GO:0030833;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:SCAR complex; C:synapse;, F:small GTPase binding;, P:activation of cysteine-type endopeptidase activity; P:apoptotic process; P:cell morphogenesis; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of proteolysis; P:regulation of actin filament polymerization; P:vascular endothelial growth factor receptor signaling pathway;|Q96F07 A6NLT2 D3DQJ3 Q53EN5 Q9NTK4 Q9ULQ2 Q9UN29,Cytoplasmic FMR1-interacting protein 2,p53-inducible protein 121;, PF07159;PF05994;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0031209;GO:0045202;GO:0031267;GO:0097202;GO:0006915;GO:0000902;GO:0098609;GO:0038096;GO:0045862;GO:0030833;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:SCAR complex; C:synapse;, F:small GTPase binding;, P:activation of cysteine-type endopeptidase activity; P:apoptotic process; P:cell morphogenesis; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of proteolysis; P:regulation of actin filament polymerization; P:vascular endothelial growth factor receptor signaling pathway;|Q96F07 A6NLT2 D3DQJ3 Q53EN5 Q9NTK4 Q9ULQ2 Q9UN29,Cytoplasmic FMR1-interacting protein 2,p53-inducible protein 121;, PF07159;PF05994;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0031209;GO:0045202;GO:0031267;GO:0097202;GO:0006915;GO:0000902;GO:0098609;GO:0038096;GO:0045862;GO:0030833;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:SCAR complex; C:synapse;, F:small GTPase binding;, P:activation of cysteine-type endopeptidase activity; P:apoptotic process; P:cell morphogenesis; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of proteolysis; P:regulation of actin filament polymerization; P:vascular endothelial growth factor receptor signaling pathway; scaffold4 indexed_genome mRNA 24586665 24587178 . - . ID=transcript_1095;Q0D2K0 A8S6F1 A8S6F5 A8S6F8 B4DLF3 Q0D2J8 Q0D2J9,Magnesium transporter NIPA4,Ichthyin;NIPA-like protein 4;Non-imprinted in Prader-Willi/Angelman syndrome region protein 4;, PF05653;, GO:0016021;GO:0016020;GO:0015095;GO:0015693;, C:integral component of membrane; C:membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport; scaffold4 indexed_genome mRNA 24592413 24594866 . + . ID=transcript_1096;Q0D2K0 A8S6F1 A8S6F5 A8S6F8 B4DLF3 Q0D2J8 Q0D2J9,Magnesium transporter NIPA4,Ichthyin;NIPA-like protein 4;Non-imprinted in Prader-Willi/Angelman syndrome region protein 4;, PF05653;, GO:0016021;GO:0016020;GO:0015095;GO:0015693;, C:integral component of membrane; C:membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport; scaffold4 indexed_genome mRNA 24595461 24681898 . - . ID=transcript_1097;Q9H013 Q9BZL5 Q9UHP2,Disintegrin and metalloproteinase domain-containing protein 19,Meltrin-beta;Metalloprotease and disintegrin dendritic antigen marker;, PF08516;PF00200;PF01562;PF01421;, GO:0062023;GO:0005794;GO:0016021;GO:0005634;GO:0005886;GO:0046872;GO:0004222;GO:1902945;GO:0017124;GO:0042987;GO:0030198;GO:0006509;GO:0001890;GO:2000049;GO:0010628;GO:0016485;, C:collagen-containing extracellular matrix; C:Golgi apparatus; C:integral component of membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:extracellular matrix organization; P:membrane protein ectodomain proteolysis; P:placenta development; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of gene expression; P:protein processing;|Q9H013 Q9BZL5 Q9UHP2,Disintegrin and metalloproteinase domain-containing protein 19,Meltrin-beta;Metalloprotease and disintegrin dendritic antigen marker;, PF08516;PF00200;PF01562;PF01421;, GO:0062023;GO:0005794;GO:0016021;GO:0005634;GO:0005886;GO:0046872;GO:0004222;GO:1902945;GO:0017124;GO:0042987;GO:0030198;GO:0006509;GO:0001890;GO:2000049;GO:0010628;GO:0016485;, C:collagen-containing extracellular matrix; C:Golgi apparatus; C:integral component of membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:extracellular matrix organization; P:membrane protein ectodomain proteolysis; P:placenta development; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of gene expression; P:protein processing;|Q9H013 Q9BZL5 Q9UHP2,Disintegrin and metalloproteinase domain-containing protein 19,Meltrin-beta;Metalloprotease and disintegrin dendritic antigen marker;, PF08516;PF00200;PF01562;PF01421;, GO:0062023;GO:0005794;GO:0016021;GO:0005634;GO:0005886;GO:0046872;GO:0004222;GO:1902945;GO:0017124;GO:0042987;GO:0030198;GO:0006509;GO:0001890;GO:2000049;GO:0010628;GO:0016485;, C:collagen-containing extracellular matrix; C:Golgi apparatus; C:integral component of membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:extracellular matrix organization; P:membrane protein ectodomain proteolysis; P:placenta development; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of gene expression; P:protein processing;|Q9H013 Q9BZL5 Q9UHP2,Disintegrin and metalloproteinase domain-containing protein 19,Meltrin-beta;Metalloprotease and disintegrin dendritic antigen marker;, PF08516;PF00200;PF01562;PF01421;, GO:0062023;GO:0005794;GO:0016021;GO:0005634;GO:0005886;GO:0046872;GO:0004222;GO:1902945;GO:0017124;GO:0042987;GO:0030198;GO:0006509;GO:0001890;GO:2000049;GO:0010628;GO:0016485;, C:collagen-containing extracellular matrix; C:Golgi apparatus; C:integral component of membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:extracellular matrix organization; P:membrane protein ectodomain proteolysis; P:placenta development; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of gene expression; P:protein processing;|Q9H013 Q9BZL5 Q9UHP2,Disintegrin and metalloproteinase domain-containing protein 19,Meltrin-beta;Metalloprotease and disintegrin dendritic antigen marker;, PF08516;PF00200;PF01562;PF01421;, GO:0062023;GO:0005794;GO:0016021;GO:0005634;GO:0005886;GO:0046872;GO:0004222;GO:1902945;GO:0017124;GO:0042987;GO:0030198;GO:0006509;GO:0001890;GO:2000049;GO:0010628;GO:0016485;, C:collagen-containing extracellular matrix; C:Golgi apparatus; C:integral component of membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:extracellular matrix organization; P:membrane protein ectodomain proteolysis; P:placenta development; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of gene expression; P:protein processing; scaffold4 indexed_genome mRNA 24792116 24799465 . + . ID=transcript_1098;Q9NWX6 D3DQJ5 Q53G12 Q7L5R3 Q9H0S2,Probable tRNA(His) guanylyltransferase,Induced in high glucose-1 {ECO:0000303|PubMed:25008184};Interphase cytoplasmic foci protein 45;tRNA-histidine guanylyltransferase;, PF04446;PF14413;, GO:0005829;GO:0005741;GO:0005739;GO:1990234;GO:0005524;GO:0005525;GO:0005085;GO:0042802;GO:0000287;GO:0016779;GO:0000049;GO:0008193;GO:0008053;GO:0051289;GO:0006979;GO:1990046;GO:0006400;GO:0008033;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:transferase complex;, F:ATP binding; F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:magnesium ion binding; F:nucleotidyltransferase activity; F:tRNA binding; F:tRNA guanylyltransferase activity;, P:mitochondrial fusion; P:protein homotetramerization; P:response to oxidative stress; P:stress-induced mitochondrial fusion; P:tRNA modification; P:tRNA processing;|Q9NWX6 D3DQJ5 Q53G12 Q7L5R3 Q9H0S2,Probable tRNA(His) guanylyltransferase,Induced in high glucose-1 {ECO:0000303|PubMed:25008184};Interphase cytoplasmic foci protein 45;tRNA-histidine guanylyltransferase;, PF04446;PF14413;, GO:0005829;GO:0005741;GO:0005739;GO:1990234;GO:0005524;GO:0005525;GO:0005085;GO:0042802;GO:0000287;GO:0016779;GO:0000049;GO:0008193;GO:0008053;GO:0051289;GO:0006979;GO:1990046;GO:0006400;GO:0008033;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:transferase complex;, F:ATP binding; F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:magnesium ion binding; F:nucleotidyltransferase activity; F:tRNA binding; F:tRNA guanylyltransferase activity;, P:mitochondrial fusion; P:protein homotetramerization; P:response to oxidative stress; P:stress-induced mitochondrial fusion; P:tRNA modification; P:tRNA processing;|Q9NWX6 D3DQJ5 Q53G12 Q7L5R3 Q9H0S2,Probable tRNA(His) guanylyltransferase,Induced in high glucose-1 {ECO:0000303|PubMed:25008184};Interphase cytoplasmic foci protein 45;tRNA-histidine guanylyltransferase;, PF04446;PF14413;, GO:0005829;GO:0005741;GO:0005739;GO:1990234;GO:0005524;GO:0005525;GO:0005085;GO:0042802;GO:0000287;GO:0016779;GO:0000049;GO:0008193;GO:0008053;GO:0051289;GO:0006979;GO:1990046;GO:0006400;GO:0008033;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:transferase complex;, F:ATP binding; F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:magnesium ion binding; F:nucleotidyltransferase activity; F:tRNA binding; F:tRNA guanylyltransferase activity;, P:mitochondrial fusion; P:protein homotetramerization; P:response to oxidative stress; P:stress-induced mitochondrial fusion; P:tRNA modification; P:tRNA processing;|Q9NWX6 D3DQJ5 Q53G12 Q7L5R3 Q9H0S2,Probable tRNA(His) guanylyltransferase,Induced in high glucose-1 {ECO:0000303|PubMed:25008184};Interphase cytoplasmic foci protein 45;tRNA-histidine guanylyltransferase;, PF04446;PF14413;, GO:0005829;GO:0005741;GO:0005739;GO:1990234;GO:0005524;GO:0005525;GO:0005085;GO:0042802;GO:0000287;GO:0016779;GO:0000049;GO:0008193;GO:0008053;GO:0051289;GO:0006979;GO:1990046;GO:0006400;GO:0008033;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:transferase complex;, F:ATP binding; F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:magnesium ion binding; F:nucleotidyltransferase activity; F:tRNA binding; F:tRNA guanylyltransferase activity;, P:mitochondrial fusion; P:protein homotetramerization; P:response to oxidative stress; P:stress-induced mitochondrial fusion; P:tRNA modification; P:tRNA processing; scaffold4 indexed_genome mRNA 24810797 24823125 . + . ID=transcript_1099;P83369 A0AVQ1 Q7Z7P0 Q8N975,U7 snRNA-associated Sm-like protein LSm11,, , GO:0071204;GO:0016604;GO:0005654;GO:0005634;GO:0005697;GO:0005683;GO:0071209;GO:0008334;GO:0006398;GO:1900087;GO:0006369;, C:histone pre-mRNA 3'end processing complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex; C:U7 snRNP;, F:U7 snRNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:positive regulation of G1/S transition of mitotic cell cycle; P:termination of RNA polymerase II transcription; scaffold4 indexed_genome mRNA 24858563 24917410 . - . ID=transcript_1100;Q14677 B7Z6F8 D3DQJ6 Q8NAF1 Q96E05,Clathrin interactor 1,Clathrin-interacting protein localized in the trans-Golgi region;Enthoprotin;Epsin-4;Epsin-related protein;, PF01417;, GO:0030125;GO:0005829;GO:0005768;GO:0005794;GO:0043231;GO:0016020;GO:0005654;GO:0048471;GO:0005886;GO:0045296;GO:0030276;GO:0005543;GO:0048268;GO:0006897;GO:0006892;, C:clathrin vesicle coat; C:cytosol; C:endosome; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cadherin binding; F:clathrin binding; F:phospholipid binding;, P:clathrin coat assembly; P:endocytosis; P:post-Golgi vesicle-mediated transport; scaffold4 indexed_genome mRNA 25710107 26111197 . - . ID=transcript_1101;Q9UH73 Q8IW11,Transcription factor COE1,Early B-cell factor;, PF16422;PF16423;PF01833;, GO:0000785;GO:0005634;GO:0070742;GO:0000981;GO:0046872;GO:0046983;GO:0000978;GO:0007275;GO:0006357;, C:chromatin; C:nucleus;, F:C2H2 zinc finger domain binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; scaffold4 indexed_genome mRNA 26154596 26212532 . - . ID=transcript_1102;Q96MT1 B7Z903 B7Z949 E7EVI7 Q8IVP7,RING finger protein 145 {ECO:0000305},, PF13705;PF13639;, GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0061630;GO:0008270;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:ubiquitin protein ligase activity; F:zinc ion binding;|Q96MT1 B7Z903 B7Z949 E7EVI7 Q8IVP7,RING finger protein 145 {ECO:0000305},, PF13705;PF13639;, GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0061630;GO:0008270;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:ubiquitin protein ligase activity; F:zinc ion binding; scaffold4 indexed_genome mRNA 26275633 26277053 . + . ID=transcript_1103;Q8WVY7 D3DQJ7 Q96DK5,Ubiquitin-like domain-containing CTD phosphatase 1,Nuclear proteasome inhibitor UBLCP1;, PF03031;PF00240;, GO:0005730;GO:0005654;GO:0005634;GO:0106306;GO:0004722;GO:0106307;GO:0006470;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation; scaffold4 indexed_genome mRNA 26277904 26279863 . + . ID=transcript_1104;Q8WVY7 D3DQJ7 Q96DK5,Ubiquitin-like domain-containing CTD phosphatase 1,Nuclear proteasome inhibitor UBLCP1;, PF03031;PF00240;, GO:0005730;GO:0005654;GO:0005634;GO:0106306;GO:0004722;GO:0106307;GO:0006470;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation; scaffold4 indexed_genome mRNA 26280273 26284730 . + . ID=transcript_1105;Q8WVY7 D3DQJ7 Q96DK5,Ubiquitin-like domain-containing CTD phosphatase 1,Nuclear proteasome inhibitor UBLCP1;, PF03031;PF00240;, GO:0005730;GO:0005654;GO:0005634;GO:0106306;GO:0004722;GO:0106307;GO:0006470;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation;|Q8WVY7 D3DQJ7 Q96DK5,Ubiquitin-like domain-containing CTD phosphatase 1,Nuclear proteasome inhibitor UBLCP1;, PF03031;PF00240;, GO:0005730;GO:0005654;GO:0005634;GO:0106306;GO:0004722;GO:0106307;GO:0006470;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation; scaffold4 indexed_genome mRNA 26898882 26958385 . + . ID=transcript_1106;P35368 B0LPE1,Alpha-1B adrenergic receptor,Alpha-1B adrenoreceptor;, PF00001;, GO:0005901;GO:0005737;GO:0005887;GO:0031965;GO:0005634;GO:0005886;GO:0004937;GO:0004930;GO:0046982;GO:0071880;GO:0007188;GO:0007267;GO:0007186;GO:0035556;GO:0150099;GO:0007200;GO:0007204;GO:0001996;GO:0043410;GO:0045907;GO:0055117;, C:caveola; C:cytoplasm; C:integral component of plasma membrane; C:nuclear membrane; C:nucleus; C:plasma membrane;, F:alpha1-adrenergic receptor activity; F:G protein-coupled receptor activity; F:protein heterodimerization activity;, P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:neuron-glial cell signaling; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of heart rate by epinephrine-norepinephrine; P:positive regulation of MAPK cascade; P:positive regulation of vasoconstriction; P:regulation of cardiac muscle contraction; scaffold4 indexed_genome mRNA 27023183 27049812 . + . ID=transcript_1107;Q99614 B2RCT2 D3DQJ8 Q9BVT3,Tetratricopeptide repeat protein 1,, PF00515;PF13181;, GO:0005829;GO:0005778;GO:0051082;GO:0006457;, C:cytosol; C:peroxisomal membrane;, F:unfolded protein binding;, P:protein folding;|Q99614 B2RCT2 D3DQJ8 Q9BVT3,Tetratricopeptide repeat protein 1,, PF00515;PF13181;, GO:0005829;GO:0005778;GO:0051082;GO:0006457;, C:cytosol; C:peroxisomal membrane;, F:unfolded protein binding;, P:protein folding;|Q99614 B2RCT2 D3DQJ8 Q9BVT3,Tetratricopeptide repeat protein 1,, PF00515;PF13181;, GO:0005829;GO:0005778;GO:0051082;GO:0006457;, C:cytosol; C:peroxisomal membrane;, F:unfolded protein binding;, P:protein folding;|Q99614 B2RCT2 D3DQJ8 Q9BVT3,Tetratricopeptide repeat protein 1,, PF00515;PF13181;, GO:0005829;GO:0005778;GO:0051082;GO:0006457;, C:cytosol; C:peroxisomal membrane;, F:unfolded protein binding;, P:protein folding;|Q99614 B2RCT2 D3DQJ8 Q9BVT3,Tetratricopeptide repeat protein 1,, PF00515;PF13181;, GO:0005829;GO:0005778;GO:0051082;GO:0006457;, C:cytosol; C:peroxisomal membrane;, F:unfolded protein binding;, P:protein folding;|Q99614 B2RCT2 D3DQJ8 Q9BVT3,Tetratricopeptide repeat protein 1,, PF00515;PF13181;, GO:0005829;GO:0005778;GO:0051082;GO:0006457;, C:cytosol; C:peroxisomal membrane;, F:unfolded protein binding;, P:protein folding; scaffold4 indexed_genome mRNA 27052763 27072394 . - . ID=transcript_1108;Q96N64 G5EA07 Q2HJJ2 Q8IYR3 Q96PV3,PWWP domain-containing protein 2A,, PF00855;, GO:0005634;GO:0003682;GO:0042393;, C:nucleus;, F:chromatin binding; F:histone binding;|Q96N64 G5EA07 Q2HJJ2 Q8IYR3 Q96PV3,PWWP domain-containing protein 2A,, PF00855;, GO:0005634;GO:0003682;GO:0042393;, C:nucleus;, F:chromatin binding; F:histone binding;|Q96N64 G5EA07 Q2HJJ2 Q8IYR3 Q96PV3,PWWP domain-containing protein 2A,, PF00855;, GO:0005634;GO:0003682;GO:0042393;, C:nucleus;, F:chromatin binding; F:histone binding;|Q96N64 G5EA07 Q2HJJ2 Q8IYR3 Q96PV3,PWWP domain-containing protein 2A,, PF00855;, GO:0005634;GO:0003682;GO:0042393;, C:nucleus;, F:chromatin binding; F:histone binding; scaffold4 indexed_genome mRNA 27206690 27210630 . - . ID=transcript_1109;Q8IV13 Q6ZN43 Q9H7W8,Cyclin-J-like protein,, PF02984;PF00134;, GO:0005813;GO:0000307;GO:0005737;GO:0005634;GO:0016538;GO:0044772;GO:0000079;, C:centrosome; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold4 indexed_genome mRNA 27311974 27334961 . - . ID=transcript_1110;Q9BXJ5,Complement C1q tumor necrosis factor-related protein 2,, PF00386;PF01391;, GO:0005581;GO:0005576;GO:0019216;, C:collagen trimer; C:extracellular region;, , P:regulation of lipid metabolic process; scaffold4 indexed_genome mRNA 27359532 27365211 . - . ID=transcript_1111;Q8IZ13 D3DQJ9 Q9H5S8 Q9UH87,Protein ZBED8,Transposon-derived Buster3 transposase-like protein;Zinc finger BED domain-containing protein 8;, PF14291;, GO:0005654;, C:nucleoplasm; scaffold4 indexed_genome mRNA 27366947 27382198 . - . ID=transcript_1112;O95391 D3DQK2 Q3LUJ0 Q3LUJ1 Q6RXQ5 Q96FM9,Pre-mRNA-splicing factor SLU7,, PF11708;, GO:0071013;GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0030532;GO:0005681;GO:0030628;GO:0000386;GO:0008270;GO:0000380;GO:0034605;GO:0006886;GO:0031124;GO:0000389;GO:0006406;GO:0000398;GO:0006405;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex; C:spliceosomal complex;, F:pre-mRNA 3'-splice site binding; F:second spliceosomal transesterification activity; F:zinc ion binding;, P:alternative mRNA splicing, via spliceosome; P:cellular response to heat; P:intracellular protein transport; P:mRNA 3'-end processing; P:mRNA 3'-splice site recognition; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; P:RNA splicing, via transesterification reactions;|O95391 D3DQK2 Q3LUJ0 Q3LUJ1 Q6RXQ5 Q96FM9,Pre-mRNA-splicing factor SLU7,, PF11708;, GO:0071013;GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0030532;GO:0005681;GO:0030628;GO:0000386;GO:0008270;GO:0000380;GO:0034605;GO:0006886;GO:0031124;GO:0000389;GO:0006406;GO:0000398;GO:0006405;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex; C:spliceosomal complex;, F:pre-mRNA 3'-splice site binding; F:second spliceosomal transesterification activity; F:zinc ion binding;, P:alternative mRNA splicing, via spliceosome; P:cellular response to heat; P:intracellular protein transport; P:mRNA 3'-end processing; P:mRNA 3'-splice site recognition; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; P:RNA splicing, via transesterification reactions;|O95391 D3DQK2 Q3LUJ0 Q3LUJ1 Q6RXQ5 Q96FM9,Pre-mRNA-splicing factor SLU7,, PF11708;, GO:0071013;GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0030532;GO:0005681;GO:0030628;GO:0000386;GO:0008270;GO:0000380;GO:0034605;GO:0006886;GO:0031124;GO:0000389;GO:0006406;GO:0000398;GO:0006405;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex; C:spliceosomal complex;, F:pre-mRNA 3'-splice site binding; F:second spliceosomal transesterification activity; F:zinc ion binding;, P:alternative mRNA splicing, via spliceosome; P:cellular response to heat; P:intracellular protein transport; P:mRNA 3'-end processing; P:mRNA 3'-splice site recognition; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold4 indexed_genome mRNA 27386499 27394007 . + . ID=transcript_1113;O95997,Securin,Esp1-associated protein;Pituitary tumor-transforming gene 1 protein;, PF04856;, GO:0005737;GO:0005829;GO:0005634;GO:0004869;GO:0017124;GO:0031145;GO:0051301;GO:0051276;GO:0006281;GO:0045143;GO:2000816;GO:0007283;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleus;, F:cysteine-type endopeptidase inhibitor activity; F:SH3 domain binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:chromosome organization; P:DNA repair; P:homologous chromosome segregation; P:negative regulation of mitotic sister chromatid separation; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 27577077 27612883 . - . ID=transcript_1114;O94823 Q9H725,Phospholipid-transporting ATPase VB,ATPase class V type 10B;P4-ATPase flippase complex alpha subunit ATP10B;, PF16212;PF16209;, GO:0005783;GO:0005789;GO:1905103;GO:0031902;GO:1990531;GO:0005886;GO:0005524;GO:0140326;GO:0140351;GO:0000287;GO:0140345;GO:0097212;GO:0045332;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of lysosomal membrane; C:late endosome membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:glycosylceramide flippase activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:lysosomal membrane organization; P:phospholipid translocation; scaffold4 indexed_genome mRNA 27612951 27628543 . - . ID=transcript_1115;O94823 Q9H725,Phospholipid-transporting ATPase VB,ATPase class V type 10B;P4-ATPase flippase complex alpha subunit ATP10B;, PF16212;PF16209;, GO:0005783;GO:0005789;GO:1905103;GO:0031902;GO:1990531;GO:0005886;GO:0005524;GO:0140326;GO:0140351;GO:0000287;GO:0140345;GO:0097212;GO:0045332;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of lysosomal membrane; C:late endosome membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:glycosylceramide flippase activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:lysosomal membrane organization; P:phospholipid translocation; scaffold4 indexed_genome mRNA 27665330 27716733 . - . ID=transcript_1116;O94823 Q9H725,Phospholipid-transporting ATPase VB,ATPase class V type 10B;P4-ATPase flippase complex alpha subunit ATP10B;, PF16212;PF16209;, GO:0005783;GO:0005789;GO:1905103;GO:0031902;GO:1990531;GO:0005886;GO:0005524;GO:0140326;GO:0140351;GO:0000287;GO:0140345;GO:0097212;GO:0045332;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of lysosomal membrane; C:late endosome membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:glycosylceramide flippase activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:lysosomal membrane organization; P:phospholipid translocation; scaffold4 indexed_genome mRNA 28296813 28561737 . - . ID=transcript_1117;P47870 A8K115 A8K1A0 D1LYT0 D1LYT1 Q16323 Q4FZB2,Gamma-aminobutyric acid receptor subunit beta-2,GABA(A) receptor subunit beta-2;, PF02931;PF02932;, GO:0034707;GO:0030659;GO:0005829;GO:0070062;GO:1902711;GO:0098982;GO:0005887;GO:0099060;GO:0043005;GO:0005886;GO:0045202;GO:0005254;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0071420;GO:0007268;GO:1902476;GO:0090102;GO:0007214;GO:1904862;GO:0060119;GO:0060384;GO:0034220;GO:0043524;GO:0050877;GO:0042391;GO:0007605;GO:0007165;GO:0051932;, C:chloride channel complex; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuron projection; C:plasma membrane; C:synapse;, F:chloride channel activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to histamine; P:chemical synaptic transmission; P:chloride transmembrane transport; P:cochlea development; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:inner ear receptor cell development; P:innervation; P:ion transmembrane transport; P:negative regulation of neuron apoptotic process; P:nervous system process; P:regulation of membrane potential; P:sensory perception of sound; P:signal transduction; P:synaptic transmission, GABAergic;|P47870 A8K115 A8K1A0 D1LYT0 D1LYT1 Q16323 Q4FZB2,Gamma-aminobutyric acid receptor subunit beta-2,GABA(A) receptor subunit beta-2;, PF02931;PF02932;, GO:0034707;GO:0030659;GO:0005829;GO:0070062;GO:1902711;GO:0098982;GO:0005887;GO:0099060;GO:0043005;GO:0005886;GO:0045202;GO:0005254;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0071420;GO:0007268;GO:1902476;GO:0090102;GO:0007214;GO:1904862;GO:0060119;GO:0060384;GO:0034220;GO:0043524;GO:0050877;GO:0042391;GO:0007605;GO:0007165;GO:0051932;, C:chloride channel complex; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuron projection; C:plasma membrane; C:synapse;, F:chloride channel activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to histamine; P:chemical synaptic transmission; P:chloride transmembrane transport; P:cochlea development; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:inner ear receptor cell development; P:innervation; P:ion transmembrane transport; P:negative regulation of neuron apoptotic process; P:nervous system process; P:regulation of membrane potential; P:sensory perception of sound; P:signal transduction; P:synaptic transmission, GABAergic;|P47870 A8K115 A8K1A0 D1LYT0 D1LYT1 Q16323 Q4FZB2,Gamma-aminobutyric acid receptor subunit beta-2,GABA(A) receptor subunit beta-2;, PF02931;PF02932;, GO:0034707;GO:0030659;GO:0005829;GO:0070062;GO:1902711;GO:0098982;GO:0005887;GO:0099060;GO:0043005;GO:0005886;GO:0045202;GO:0005254;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0071420;GO:0007268;GO:1902476;GO:0090102;GO:0007214;GO:1904862;GO:0060119;GO:0060384;GO:0034220;GO:0043524;GO:0050877;GO:0042391;GO:0007605;GO:0007165;GO:0051932;, C:chloride channel complex; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuron projection; C:plasma membrane; C:synapse;, F:chloride channel activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to histamine; P:chemical synaptic transmission; P:chloride transmembrane transport; P:cochlea development; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:inner ear receptor cell development; P:innervation; P:ion transmembrane transport; P:negative regulation of neuron apoptotic process; P:nervous system process; P:regulation of membrane potential; P:sensory perception of sound; P:signal transduction; P:synaptic transmission, GABAergic; scaffold4 indexed_genome mRNA 28685979 28693129 . + . ID=transcript_1118;Q16445 A8K096 Q4VAV2,Gamma-aminobutyric acid receptor subunit alpha-6,GABA(A) receptor subunit alpha-6;, PF02931;PF02932;, GO:0099192;GO:0034707;GO:0032590;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:cerebellar Golgi cell to granule cell synapse; C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|Q16445 A8K096 Q4VAV2,Gamma-aminobutyric acid receptor subunit alpha-6,GABA(A) receptor subunit alpha-6;, PF02931;PF02932;, GO:0099192;GO:0034707;GO:0032590;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:cerebellar Golgi cell to granule cell synapse; C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|Q16445 A8K096 Q4VAV2,Gamma-aminobutyric acid receptor subunit alpha-6,GABA(A) receptor subunit alpha-6;, PF02931;PF02932;, GO:0099192;GO:0034707;GO:0032590;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:cerebellar Golgi cell to granule cell synapse; C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|Q16445 A8K096 Q4VAV2,Gamma-aminobutyric acid receptor subunit alpha-6,GABA(A) receptor subunit alpha-6;, PF02931;PF02932;, GO:0099192;GO:0034707;GO:0032590;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:cerebellar Golgi cell to granule cell synapse; C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold4 indexed_genome mRNA 28698665 28704017 . - . ID=transcript_1119;Q16445 A8K096 Q4VAV2,Gamma-aminobutyric acid receptor subunit alpha-6,GABA(A) receptor subunit alpha-6;, PF02931;PF02932;, GO:0099192;GO:0034707;GO:0032590;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:cerebellar Golgi cell to granule cell synapse; C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold4 indexed_genome mRNA 28840497 28897771 . + . ID=transcript_1120;P14867 D3DQK6 Q8N629,Gamma-aminobutyric acid receptor subunit alpha-1,GABA(A) receptor subunit alpha-1;, PF02931;PF02932;, GO:0034707;GO:0030659;GO:0032590;GO:1902710;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008144;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:cytoplasmic vesicle membrane; C:dendrite membrane; C:GABA receptor complex; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:drug binding; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|P14867 D3DQK6 Q8N629,Gamma-aminobutyric acid receptor subunit alpha-1,GABA(A) receptor subunit alpha-1;, PF02931;PF02932;, GO:0034707;GO:0030659;GO:0032590;GO:1902710;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008144;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:cytoplasmic vesicle membrane; C:dendrite membrane; C:GABA receptor complex; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:drug binding; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|P14867 D3DQK6 Q8N629,Gamma-aminobutyric acid receptor subunit alpha-1,GABA(A) receptor subunit alpha-1;, PF02931;PF02932;, GO:0034707;GO:0030659;GO:0032590;GO:1902710;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008144;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:cytoplasmic vesicle membrane; C:dendrite membrane; C:GABA receptor complex; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:drug binding; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|P34903 Q8TAF9,Gamma-aminobutyric acid receptor subunit alpha-3,GABA(A) receptor subunit alpha-3;, PF02931;PF02932;, GO:0034707;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0099060;GO:0043005;GO:0005886;GO:0098794;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|P14867 D3DQK6 Q8N629,Gamma-aminobutyric acid receptor subunit alpha-1,GABA(A) receptor subunit alpha-1;, PF02931;PF02932;, GO:0034707;GO:0030659;GO:0032590;GO:1902710;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008144;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:cytoplasmic vesicle membrane; C:dendrite membrane; C:GABA receptor complex; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:drug binding; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold4 indexed_genome mRNA 29021908 29136252 . + . ID=transcript_1121;P18507 F5HB82 Q6GRL6 Q6PCC3 Q9UDB3 Q9UN15,Gamma-aminobutyric acid receptor subunit gamma-2,GABA(A) receptor subunit gamma-2;, PF02931;PF02932;, GO:0030424;GO:0034707;GO:0030659;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0005254;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0030534;GO:0071420;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0009791;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:axon; C:chloride channel complex; C:cytoplasmic vesicle membrane; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:chloride channel activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:adult behavior; P:cellular response to histamine; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:post-embryonic development; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|P18507 F5HB82 Q6GRL6 Q6PCC3 Q9UDB3 Q9UN15,Gamma-aminobutyric acid receptor subunit gamma-2,GABA(A) receptor subunit gamma-2;, PF02931;PF02932;, GO:0030424;GO:0034707;GO:0030659;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0005254;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0030534;GO:0071420;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0009791;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:axon; C:chloride channel complex; C:cytoplasmic vesicle membrane; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:chloride channel activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:adult behavior; P:cellular response to histamine; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:post-embryonic development; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|P18507 F5HB82 Q6GRL6 Q6PCC3 Q9UDB3 Q9UN15,Gamma-aminobutyric acid receptor subunit gamma-2,GABA(A) receptor subunit gamma-2;, PF02931;PF02932;, GO:0030424;GO:0034707;GO:0030659;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0005254;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0030534;GO:0071420;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0009791;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:axon; C:chloride channel complex; C:cytoplasmic vesicle membrane; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:chloride channel activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:adult behavior; P:cellular response to histamine; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:post-embryonic development; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|P18507 F5HB82 Q6GRL6 Q6PCC3 Q9UDB3 Q9UN15,Gamma-aminobutyric acid receptor subunit gamma-2,GABA(A) receptor subunit gamma-2;, PF02931;PF02932;, GO:0030424;GO:0034707;GO:0030659;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0005254;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0030534;GO:0071420;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0009791;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:axon; C:chloride channel complex; C:cytoplasmic vesicle membrane; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:chloride channel activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:adult behavior; P:cellular response to histamine; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:post-embryonic development; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold4 indexed_genome mRNA 29136279 29138783 . - . ID=transcript_1122;P18507 F5HB82 Q6GRL6 Q6PCC3 Q9UDB3 Q9UN15,Gamma-aminobutyric acid receptor subunit gamma-2,GABA(A) receptor subunit gamma-2;, PF02931;PF02932;, GO:0030424;GO:0034707;GO:0030659;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0005254;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0030534;GO:0071420;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0009791;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:axon; C:chloride channel complex; C:cytoplasmic vesicle membrane; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:chloride channel activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:adult behavior; P:cellular response to histamine; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:post-embryonic development; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold4 indexed_genome mRNA 30265374 30274134 . + . ID=transcript_1123;P51959 B2R7B2 B4DLW7 D3DQK7 Q15757 Q96L32,Cyclin-G1,, PF00134;, GO:0000307;GO:0005737;GO:0005654;GO:0005634;GO:0016538;GO:0051301;GO:0044772;GO:0000079;GO:1901796;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of signal transduction by p53 class mediator;|P51959 B2R7B2 B4DLW7 D3DQK7 Q15757 Q96L32,Cyclin-G1,, PF00134;, GO:0000307;GO:0005737;GO:0005654;GO:0005634;GO:0016538;GO:0051301;GO:0044772;GO:0000079;GO:1901796;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of signal transduction by p53 class mediator; scaffold4 indexed_genome mRNA 30280559 30286589 . - . ID=transcript_1124;Q8WVJ2 B2R4V0,NudC domain-containing protein 2,, PF04969;, GO:0000777;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0005815;GO:0072686;GO:0000922;GO:0051082;GO:0006457;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:microtubule organizing center; C:mitotic spindle; C:spindle pole;, F:unfolded protein binding;, P:protein folding;|Q8WVJ2 B2R4V0,NudC domain-containing protein 2,, PF04969;, GO:0000777;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0005815;GO:0072686;GO:0000922;GO:0051082;GO:0006457;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:microtubule organizing center; C:mitotic spindle; C:spindle pole;, F:unfolded protein binding;, P:protein folding;|Q8WVJ2 B2R4V0,NudC domain-containing protein 2,, PF04969;, GO:0000777;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0005815;GO:0072686;GO:0000922;GO:0051082;GO:0006457;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:microtubule organizing center; C:mitotic spindle; C:spindle pole;, F:unfolded protein binding;, P:protein folding; scaffold4 indexed_genome mRNA 30298246 30324986 . + . ID=transcript_1125;O75330 A8K3G2 B4E114 D3DQK9 D3DQL0 E9PCS0 Q32N02 Q92767,Hyaluronan mediated motility receptor,Intracellular hyaluronic acid-binding protein;Receptor for hyaluronan-mediated motility;, PF15908;PF15905;, GO:0009986;GO:0005813;GO:0005829;GO:0016020;GO:0015630;GO:0005886;GO:0005540;GO:0030214;GO:0010389;, C:cell surface; C:centrosome; C:cytosol; C:membrane; C:microtubule cytoskeleton; C:plasma membrane;, F:hyaluronic acid binding;, P:hyaluronan catabolic process; P:regulation of G2/M transition of mitotic cell cycle; scaffold4 indexed_genome mRNA 30336143 30353187 . + . ID=transcript_1126;Q9UJ54,Methionine adenosyltransferase 2 subunit beta,Methionine adenosyltransferase II beta;Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase;, PF04321;, GO:0005829;GO:0070062;GO:0048269;GO:0005634;GO:0019899;GO:0048270;GO:0032259;GO:0006730;GO:0006556;, C:cytosol; C:extracellular exosome; C:methionine adenosyltransferase complex; C:nucleus;, F:enzyme binding; F:methionine adenosyltransferase regulator activity;, P:methylation; P:one-carbon metabolic process; P:S-adenosylmethionine biosynthetic process;|Q9UJ54,Methionine adenosyltransferase 2 subunit beta,Methionine adenosyltransferase II beta;Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase;, PF04321;, GO:0005829;GO:0070062;GO:0048269;GO:0005634;GO:0019899;GO:0048270;GO:0032259;GO:0006730;GO:0006556;, C:cytosol; C:extracellular exosome; C:methionine adenosyltransferase complex; C:nucleus;, F:enzyme binding; F:methionine adenosyltransferase regulator activity;, P:methylation; P:one-carbon metabolic process; P:S-adenosylmethionine biosynthetic process; scaffold4 indexed_genome mRNA 35017929 35048422 . + . ID=transcript_1127;Q9NT68 Q9ULU2,Teneurin-2,Protein Odd Oz/ten-m homolog 2;Tenascin-M2;Teneurin transmembrane protein 2;, PF06484;PF15636;, GO:0030054;GO:0005911;GO:0030425;GO:0043197;GO:0005783;GO:0030175;GO:0005794;GO:0030426;GO:0005887;GO:0043005;GO:0005634;GO:0005886;GO:0016605;GO:0045211;GO:0045202;GO:0005509;GO:0050839;GO:0046982;GO:0042803;GO:0005102;GO:0007411;GO:0035584;GO:0098609;GO:0007157;GO:0000122;GO:0048666;GO:0051491;GO:0098942;GO:0007165;, C:cell junction; C:cell-cell junction; C:dendrite; C:dendritic spine; C:endoplasmic reticulum; C:filopodium; C:Golgi apparatus; C:growth cone; C:integral component of plasma membrane; C:neuron projection; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic membrane; C:synapse;, F:calcium ion binding; F:cell adhesion molecule binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:signaling receptor binding;, P:axon guidance; P:calcium-mediated signaling using intracellular calcium source; P:cell-cell adhesion; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:negative regulation of transcription by RNA polymerase II; P:neuron development; P:positive regulation of filopodium assembly; P:retrograde trans-synaptic signaling by trans-synaptic protein complex; P:signal transduction; scaffold4 indexed_genome mRNA 35066252 35067570 . + . ID=transcript_1128;Q9NT68 Q9ULU2,Teneurin-2,Protein Odd Oz/ten-m homolog 2;Tenascin-M2;Teneurin transmembrane protein 2;, PF06484;PF15636;, GO:0030054;GO:0005911;GO:0030425;GO:0043197;GO:0005783;GO:0030175;GO:0005794;GO:0030426;GO:0005887;GO:0043005;GO:0005634;GO:0005886;GO:0016605;GO:0045211;GO:0045202;GO:0005509;GO:0050839;GO:0046982;GO:0042803;GO:0005102;GO:0007411;GO:0035584;GO:0098609;GO:0007157;GO:0000122;GO:0048666;GO:0051491;GO:0098942;GO:0007165;, C:cell junction; C:cell-cell junction; C:dendrite; C:dendritic spine; C:endoplasmic reticulum; C:filopodium; C:Golgi apparatus; C:growth cone; C:integral component of plasma membrane; C:neuron projection; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic membrane; C:synapse;, F:calcium ion binding; F:cell adhesion molecule binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:signaling receptor binding;, P:axon guidance; P:calcium-mediated signaling using intracellular calcium source; P:cell-cell adhesion; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:negative regulation of transcription by RNA polymerase II; P:neuron development; P:positive regulation of filopodium assembly; P:retrograde trans-synaptic signaling by trans-synaptic protein complex; P:signal transduction; scaffold4 indexed_genome mRNA 35098883 35254690 . + . ID=transcript_1129;Q8IX03 B4DK05 O94946 Q6MZX4 Q6Y2F8 Q7Z4G8 Q8WVM4 Q9BT29,Protein KIBRA,HBeAg-binding protein 3;Kidney and brain protein;WW domain-containing protein 1;, PF00397;, GO:0005737;GO:0005829;GO:0005634;GO:0048471;GO:0032991;GO:0032587;GO:0019900;GO:0060090;GO:0003713;GO:0016477;GO:0030010;GO:0035329;GO:0035331;GO:0046621;GO:0000122;GO:0043410;GO:0007221;GO:0035330;GO:0032386;, C:cytoplasm; C:cytosol; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:kinase binding; F:molecular adaptor activity; F:transcription coactivator activity;, P:cell migration; P:establishment of cell polarity; P:hippo signaling; P:negative regulation of hippo signaling; P:negative regulation of organ growth; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of MAPK cascade; P:positive regulation of transcription of Notch receptor target; P:regulation of hippo signaling; P:regulation of intracellular transport;|Q9P0U1 O95939,Mitochondrial import receptor subunit TOM7 homolog,Translocase of outer membrane 7 kDa subunit homolog;, PF08038;, GO:0016021;GO:0005741;GO:0005742;GO:0005739;GO:0008320;GO:0016236;GO:0098779;GO:1903955;GO:0030150;GO:0006626;GO:0031647;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:protein transmembrane transporter activity;, P:macroautophagy; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein targeting to mitochondrion; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:regulation of protein stability;|Q8IX03 B4DK05 O94946 Q6MZX4 Q6Y2F8 Q7Z4G8 Q8WVM4 Q9BT29,Protein KIBRA,HBeAg-binding protein 3;Kidney and brain protein;WW domain-containing protein 1;, PF00397;, GO:0005737;GO:0005829;GO:0005634;GO:0048471;GO:0032991;GO:0032587;GO:0019900;GO:0060090;GO:0003713;GO:0016477;GO:0030010;GO:0035329;GO:0035331;GO:0046621;GO:0000122;GO:0043410;GO:0007221;GO:0035330;GO:0032386;, C:cytoplasm; C:cytosol; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:kinase binding; F:molecular adaptor activity; F:transcription coactivator activity;, P:cell migration; P:establishment of cell polarity; P:hippo signaling; P:negative regulation of hippo signaling; P:negative regulation of organ growth; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of MAPK cascade; P:positive regulation of transcription of Notch receptor target; P:regulation of hippo signaling; P:regulation of intracellular transport; scaffold4 indexed_genome mRNA 35264065 35290803 . + . ID=transcript_1130;P54136 B2RBS9 Q53GY4 Q9BWA1,Arginine--tRNA ligase, cytoplasmic,Arginyl-tRNA synthetase;, PF03485;PF05746;PF00750;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0034618;GO:0004814;GO:0005524;GO:0045296;GO:0000049;GO:0006420;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus;, F:arginine binding; F:arginine-tRNA ligase activity; F:ATP binding; F:cadherin binding; F:tRNA binding;, P:arginyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P54136 B2RBS9 Q53GY4 Q9BWA1,Arginine--tRNA ligase, cytoplasmic,Arginyl-tRNA synthetase;, PF03485;PF05746;PF00750;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0034618;GO:0004814;GO:0005524;GO:0045296;GO:0000049;GO:0006420;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus;, F:arginine binding; F:arginine-tRNA ligase activity; F:ATP binding; F:cadherin binding; F:tRNA binding;, P:arginyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P54136 B2RBS9 Q53GY4 Q9BWA1,Arginine--tRNA ligase, cytoplasmic,Arginyl-tRNA synthetase;, PF03485;PF05746;PF00750;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0034618;GO:0004814;GO:0005524;GO:0045296;GO:0000049;GO:0006420;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus;, F:arginine binding; F:arginine-tRNA ligase activity; F:ATP binding; F:cadherin binding; F:tRNA binding;, P:arginyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P54136 B2RBS9 Q53GY4 Q9BWA1,Arginine--tRNA ligase, cytoplasmic,Arginyl-tRNA synthetase;, PF03485;PF05746;PF00750;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0034618;GO:0004814;GO:0005524;GO:0045296;GO:0000049;GO:0006420;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus;, F:arginine binding; F:arginine-tRNA ligase activity; F:ATP binding; F:cadherin binding; F:tRNA binding;, P:arginyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; scaffold4 indexed_genome mRNA 35331411 35363777 . + . ID=transcript_1131;Q7Z3T8 O15023 Q5H9U2 Q7LAU7 Q86T69 Q8N5L3 Q8NEK3,Zinc finger FYVE domain-containing protein 16,Endofin;Endosome-associated FYVE domain protein;, PF11979;PF01363;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005545;GO:0046872;GO:0005547;GO:0030509;GO:0016197;GO:0006622;GO:0030100;GO:0007165;GO:0016050;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle;, F:1-phosphatidylinositol binding; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:BMP signaling pathway; P:endosomal transport; P:protein targeting to lysosome; P:regulation of endocytosis; P:signal transduction; P:vesicle organization;|Q7Z3T8 O15023 Q5H9U2 Q7LAU7 Q86T69 Q8N5L3 Q8NEK3,Zinc finger FYVE domain-containing protein 16,Endofin;Endosome-associated FYVE domain protein;, PF11979;PF01363;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005545;GO:0046872;GO:0005547;GO:0030509;GO:0016197;GO:0006622;GO:0030100;GO:0007165;GO:0016050;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle;, F:1-phosphatidylinositol binding; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:BMP signaling pathway; P:endosomal transport; P:protein targeting to lysosome; P:regulation of endocytosis; P:signal transduction; P:vesicle organization;|Q7Z3T8 O15023 Q5H9U2 Q7LAU7 Q86T69 Q8N5L3 Q8NEK3,Zinc finger FYVE domain-containing protein 16,Endofin;Endosome-associated FYVE domain protein;, PF11979;PF01363;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005545;GO:0046872;GO:0005547;GO:0030509;GO:0016197;GO:0006622;GO:0030100;GO:0007165;GO:0016050;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle;, F:1-phosphatidylinositol binding; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:BMP signaling pathway; P:endosomal transport; P:protein targeting to lysosome; P:regulation of endocytosis; P:signal transduction; P:vesicle organization;|Q7Z3T8 O15023 Q5H9U2 Q7LAU7 Q86T69 Q8N5L3 Q8NEK3,Zinc finger FYVE domain-containing protein 16,Endofin;Endosome-associated FYVE domain protein;, PF11979;PF01363;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005545;GO:0046872;GO:0005547;GO:0030509;GO:0016197;GO:0006622;GO:0030100;GO:0007165;GO:0016050;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle;, F:1-phosphatidylinositol binding; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:BMP signaling pathway; P:endosomal transport; P:protein targeting to lysosome; P:regulation of endocytosis; P:signal transduction; P:vesicle organization; scaffold4 indexed_genome mRNA 35363919 35392325 . + . ID=transcript_1132;Q7Z3T8 O15023 Q5H9U2 Q7LAU7 Q86T69 Q8N5L3 Q8NEK3,Zinc finger FYVE domain-containing protein 16,Endofin;Endosome-associated FYVE domain protein;, PF11979;PF01363;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005545;GO:0046872;GO:0005547;GO:0030509;GO:0016197;GO:0006622;GO:0030100;GO:0007165;GO:0016050;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle;, F:1-phosphatidylinositol binding; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:BMP signaling pathway; P:endosomal transport; P:protein targeting to lysosome; P:regulation of endocytosis; P:signal transduction; P:vesicle organization;|Q7Z3T8 O15023 Q5H9U2 Q7LAU7 Q86T69 Q8N5L3 Q8NEK3,Zinc finger FYVE domain-containing protein 16,Endofin;Endosome-associated FYVE domain protein;, PF11979;PF01363;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005545;GO:0046872;GO:0005547;GO:0030509;GO:0016197;GO:0006622;GO:0030100;GO:0007165;GO:0016050;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle;, F:1-phosphatidylinositol binding; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:BMP signaling pathway; P:endosomal transport; P:protein targeting to lysosome; P:regulation of endocytosis; P:signal transduction; P:vesicle organization;|Q7Z3T8 O15023 Q5H9U2 Q7LAU7 Q86T69 Q8N5L3 Q8NEK3,Zinc finger FYVE domain-containing protein 16,Endofin;Endosome-associated FYVE domain protein;, PF11979;PF01363;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005545;GO:0046872;GO:0005547;GO:0030509;GO:0016197;GO:0006622;GO:0030100;GO:0007165;GO:0016050;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle;, F:1-phosphatidylinositol binding; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:BMP signaling pathway; P:endosomal transport; P:protein targeting to lysosome; P:regulation of endocytosis; P:signal transduction; P:vesicle organization; scaffold4 indexed_genome mRNA 35395350 35425696 . + . ID=transcript_1133;Q6UXP7 A2RRE4,Protein FAM151B,, PF10223;|Q6UXP7 A2RRE4,Protein FAM151B,, PF10223; scaffold4 indexed_genome mRNA 35435323 35447877 . - . ID=transcript_1134;A5PLL1 B2RPH1 Q68D79,Ankyrin repeat domain-containing protein 34B,, PF12796;, GO:0005737;GO:0005634;, C:cytoplasm; C:nucleus; scaffold4 indexed_genome mRNA 35485959 35503133 . - . ID=transcript_1135;P00374 B4DDD2 Q14130 Q6IRW8,Dihydrofolate reductase,, PF00186;, GO:0005829;GO:0005739;GO:0004146;GO:0008144;GO:0005542;GO:0051870;GO:0003729;GO:0050661;GO:0070402;GO:1990825;GO:0000900;GO:0031103;GO:0046452;GO:0046655;GO:0006545;GO:0017148;GO:0006730;GO:0051000;GO:2000121;GO:0000083;GO:0031427;GO:0006729;GO:0046654;GO:0046653;, C:cytosol; C:mitochondrion;, F:dihydrofolate reductase activity; F:drug binding; F:folic acid binding; F:methotrexate binding; F:mRNA binding; F:NADP binding; F:NADPH binding; F:sequence-specific mRNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:axon regeneration; P:dihydrofolate metabolic process; P:folic acid metabolic process; P:glycine biosynthetic process; P:negative regulation of translation; P:one-carbon metabolic process; P:positive regulation of nitric-oxide synthase activity; P:regulation of removal of superoxide radicals; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:response to methotrexate; P:tetrahydrobiopterin biosynthetic process; P:tetrahydrofolate biosynthetic process; P:tetrahydrofolate metabolic process;|P00374 B4DDD2 Q14130 Q6IRW8,Dihydrofolate reductase,, PF00186;, GO:0005829;GO:0005739;GO:0004146;GO:0008144;GO:0005542;GO:0051870;GO:0003729;GO:0050661;GO:0070402;GO:1990825;GO:0000900;GO:0031103;GO:0046452;GO:0046655;GO:0006545;GO:0017148;GO:0006730;GO:0051000;GO:2000121;GO:0000083;GO:0031427;GO:0006729;GO:0046654;GO:0046653;, C:cytosol; C:mitochondrion;, F:dihydrofolate reductase activity; F:drug binding; F:folic acid binding; F:methotrexate binding; F:mRNA binding; F:NADP binding; F:NADPH binding; F:sequence-specific mRNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:axon regeneration; P:dihydrofolate metabolic process; P:folic acid metabolic process; P:glycine biosynthetic process; P:negative regulation of translation; P:one-carbon metabolic process; P:positive regulation of nitric-oxide synthase activity; P:regulation of removal of superoxide radicals; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:response to methotrexate; P:tetrahydrobiopterin biosynthetic process; P:tetrahydrofolate biosynthetic process; P:tetrahydrofolate metabolic process; scaffold4 indexed_genome mRNA 35503198 35672224 . + . ID=transcript_1136;P20585 A1L480 A1L482 A6NMM6 Q6PJT5 Q86UQ6 Q92867,DNA mismatch repair protein Msh3,Divergent upstream protein;Mismatch repair protein 1;, PF01624;PF05188;PF05192;PF00488;, GO:0016020;GO:0032300;GO:0032302;GO:0005654;GO:0005634;GO:0005524;GO:0032135;GO:0008094;GO:0019899;GO:0006281;GO:0043570;GO:0000710;GO:0006298;GO:0006312;GO:0045910;GO:0051096;GO:0007131;GO:0000735;GO:0043111;GO:0016447;, C:membrane; C:mismatch repair complex; C:MutSbeta complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA insertion or deletion binding; F:DNA-dependent ATPase activity; F:enzyme binding;, P:DNA repair; P:maintenance of DNA repeat elements; P:meiotic mismatch repair; P:mismatch repair; P:mitotic recombination; P:negative regulation of DNA recombination; P:positive regulation of helicase activity; P:reciprocal meiotic recombination; P:removal of nonhomologous ends; P:replication fork arrest; P:somatic recombination of immunoglobulin gene segments;|P20585 A1L480 A1L482 A6NMM6 Q6PJT5 Q86UQ6 Q92867,DNA mismatch repair protein Msh3,Divergent upstream protein;Mismatch repair protein 1;, PF01624;PF05188;PF05192;PF00488;, GO:0016020;GO:0032300;GO:0032302;GO:0005654;GO:0005634;GO:0005524;GO:0032135;GO:0008094;GO:0019899;GO:0006281;GO:0043570;GO:0000710;GO:0006298;GO:0006312;GO:0045910;GO:0051096;GO:0007131;GO:0000735;GO:0043111;GO:0016447;, C:membrane; C:mismatch repair complex; C:MutSbeta complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA insertion or deletion binding; F:DNA-dependent ATPase activity; F:enzyme binding;, P:DNA repair; P:maintenance of DNA repeat elements; P:meiotic mismatch repair; P:mismatch repair; P:mitotic recombination; P:negative regulation of DNA recombination; P:positive regulation of helicase activity; P:reciprocal meiotic recombination; P:removal of nonhomologous ends; P:replication fork arrest; P:somatic recombination of immunoglobulin gene segments; scaffold4 indexed_genome mRNA 35716388 35861604 . + . ID=transcript_1137;O14827 B9EG89 Q9UK56,Ras-specific guanine nucleotide-releasing factor 2,Ras guanine nucleotide exchange factor 2;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0005783;GO:0005789;GO:0005886;GO:0005516;GO:0005085;GO:0007186;GO:0060291;GO:0000165;GO:0043065;GO:2000310;GO:0035023;GO:0051056;GO:0034976;GO:0007264;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:plasma membrane;, F:calmodulin binding; F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:long-term synaptic potentiation; P:MAPK cascade; P:positive regulation of apoptotic process; P:regulation of NMDA receptor activity; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:response to endoplasmic reticulum stress; P:small GTPase mediated signal transduction; scaffold4 indexed_genome mRNA 35922122 35970393 . + . ID=transcript_1138;O14827 B9EG89 Q9UK56,Ras-specific guanine nucleotide-releasing factor 2,Ras guanine nucleotide exchange factor 2;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0005783;GO:0005789;GO:0005886;GO:0005516;GO:0005085;GO:0007186;GO:0060291;GO:0000165;GO:0043065;GO:2000310;GO:0035023;GO:0051056;GO:0034976;GO:0007264;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:plasma membrane;, F:calmodulin binding; F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:long-term synaptic potentiation; P:MAPK cascade; P:positive regulation of apoptotic process; P:regulation of NMDA receptor activity; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:response to endoplasmic reticulum stress; P:small GTPase mediated signal transduction; scaffold4 indexed_genome mRNA 35977333 36003264 . + . ID=transcript_1139;P17540 Q6ICS8 Q8N1E1,Creatine kinase S-type, mitochondrial,Basic-type mitochondrial creatine kinase;Sarcomeric mitochondrial creatine kinase;, PF00217;PF02807;, GO:0005743;GO:0005739;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0006936;GO:0046314;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:muscle contraction; P:phosphocreatine biosynthetic process;|P17540 Q6ICS8 Q8N1E1,Creatine kinase S-type, mitochondrial,Basic-type mitochondrial creatine kinase;Sarcomeric mitochondrial creatine kinase;, PF00217;PF02807;, GO:0005743;GO:0005739;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0006936;GO:0046314;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:muscle contraction; P:phosphocreatine biosynthetic process;|P17540 Q6ICS8 Q8N1E1,Creatine kinase S-type, mitochondrial,Basic-type mitochondrial creatine kinase;Sarcomeric mitochondrial creatine kinase;, PF00217;PF02807;, GO:0005743;GO:0005739;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0006936;GO:0046314;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:muscle contraction; P:phosphocreatine biosynthetic process;|P17540 Q6ICS8 Q8N1E1,Creatine kinase S-type, mitochondrial,Basic-type mitochondrial creatine kinase;Sarcomeric mitochondrial creatine kinase;, PF00217;PF02807;, GO:0005743;GO:0005739;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0006936;GO:0046314;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:muscle contraction; P:phosphocreatine biosynthetic process; scaffold4 indexed_genome mRNA 36022656 36031018 . + . ID=transcript_1140;Q8N567 B2RAE7 Q9H027,Zinc finger CCHC domain-containing protein 9,, PF00098;, GO:0005730;GO:0005654;GO:0003723;GO:0008270;GO:0010923;, C:nucleolus; C:nucleoplasm;, F:RNA binding; F:zinc ion binding;, P:negative regulation of phosphatase activity;|Q8N567 B2RAE7 Q9H027,Zinc finger CCHC domain-containing protein 9,, PF00098;, GO:0005730;GO:0005654;GO:0003723;GO:0008270;GO:0010923;, C:nucleolus; C:nucleoplasm;, F:RNA binding; F:zinc ion binding;, P:negative regulation of phosphatase activity;|Q8N567 B2RAE7 Q9H027,Zinc finger CCHC domain-containing protein 9,, PF00098;, GO:0005730;GO:0005654;GO:0003723;GO:0008270;GO:0010923;, C:nucleolus; C:nucleoplasm;, F:RNA binding; F:zinc ion binding;, P:negative regulation of phosphatase activity;|Q8N567 B2RAE7 Q9H027,Zinc finger CCHC domain-containing protein 9,, PF00098;, GO:0005730;GO:0005654;GO:0003723;GO:0008270;GO:0010923;, C:nucleolus; C:nucleoplasm;, F:RNA binding; F:zinc ion binding;, P:negative regulation of phosphatase activity; scaffold4 indexed_genome mRNA 36031026 36069918 . - . ID=transcript_1141;Q8WYK0 B3KVK9 Q5FWE9,Acetyl-coenzyme A thioesterase {ECO:0000305},Acyl-CoA thioester hydrolase 12;Acyl-coenzyme A thioesterase 12;Cytoplasmic acetyl-CoA hydrolase 1;START domain-containing protein 15;, PF03061;PF01852;, GO:0005829;GO:0003986;GO:0047617;GO:0005524;GO:0052689;GO:0042802;GO:0008289;GO:0036042;GO:0006084;GO:0006637;GO:0006631;, C:cytosol;, F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:ATP binding; F:carboxylic ester hydrolase activity; F:identical protein binding; F:lipid binding; F:long-chain fatty acyl-CoA binding;, P:acetyl-CoA metabolic process; P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q8WYK0 B3KVK9 Q5FWE9,Acetyl-coenzyme A thioesterase {ECO:0000305},Acyl-CoA thioester hydrolase 12;Acyl-coenzyme A thioesterase 12;Cytoplasmic acetyl-CoA hydrolase 1;START domain-containing protein 15;, PF03061;PF01852;, GO:0005829;GO:0003986;GO:0047617;GO:0005524;GO:0052689;GO:0042802;GO:0008289;GO:0036042;GO:0006084;GO:0006637;GO:0006631;, C:cytosol;, F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:ATP binding; F:carboxylic ester hydrolase activity; F:identical protein binding; F:lipid binding; F:long-chain fatty acyl-CoA binding;, P:acetyl-CoA metabolic process; P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q8WYK0 B3KVK9 Q5FWE9,Acetyl-coenzyme A thioesterase {ECO:0000305},Acyl-CoA thioester hydrolase 12;Acyl-coenzyme A thioesterase 12;Cytoplasmic acetyl-CoA hydrolase 1;START domain-containing protein 15;, PF03061;PF01852;, GO:0005829;GO:0003986;GO:0047617;GO:0005524;GO:0052689;GO:0042802;GO:0008289;GO:0036042;GO:0006084;GO:0006637;GO:0006631;, C:cytosol;, F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:ATP binding; F:carboxylic ester hydrolase activity; F:identical protein binding; F:lipid binding; F:long-chain fatty acyl-CoA binding;, P:acetyl-CoA metabolic process; P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q8WYK0 B3KVK9 Q5FWE9,Acetyl-coenzyme A thioesterase {ECO:0000305},Acyl-CoA thioester hydrolase 12;Acyl-coenzyme A thioesterase 12;Cytoplasmic acetyl-CoA hydrolase 1;START domain-containing protein 15;, PF03061;PF01852;, GO:0005829;GO:0003986;GO:0047617;GO:0005524;GO:0052689;GO:0042802;GO:0008289;GO:0036042;GO:0006084;GO:0006637;GO:0006631;, C:cytosol;, F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:ATP binding; F:carboxylic ester hydrolase activity; F:identical protein binding; F:lipid binding; F:long-chain fatty acyl-CoA binding;, P:acetyl-CoA metabolic process; P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q8WYK0 B3KVK9 Q5FWE9,Acetyl-coenzyme A thioesterase {ECO:0000305},Acyl-CoA thioester hydrolase 12;Acyl-coenzyme A thioesterase 12;Cytoplasmic acetyl-CoA hydrolase 1;START domain-containing protein 15;, PF03061;PF01852;, GO:0005829;GO:0003986;GO:0047617;GO:0005524;GO:0052689;GO:0042802;GO:0008289;GO:0036042;GO:0006084;GO:0006637;GO:0006631;, C:cytosol;, F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:ATP binding; F:carboxylic ester hydrolase activity; F:identical protein binding; F:lipid binding; F:long-chain fatty acyl-CoA binding;, P:acetyl-CoA metabolic process; P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q8WYK0 B3KVK9 Q5FWE9,Acetyl-coenzyme A thioesterase {ECO:0000305},Acyl-CoA thioester hydrolase 12;Acyl-coenzyme A thioesterase 12;Cytoplasmic acetyl-CoA hydrolase 1;START domain-containing protein 15;, PF03061;PF01852;, GO:0005829;GO:0003986;GO:0047617;GO:0005524;GO:0052689;GO:0042802;GO:0008289;GO:0036042;GO:0006084;GO:0006637;GO:0006631;, C:cytosol;, F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:ATP binding; F:carboxylic ester hydrolase activity; F:identical protein binding; F:lipid binding; F:long-chain fatty acyl-CoA binding;, P:acetyl-CoA metabolic process; P:acyl-CoA metabolic process; P:fatty acid metabolic process; scaffold4 indexed_genome mRNA 36115068 36316975 . - . ID=transcript_1142;Q9BWW6 Q9Y4T7,Single-stranded DNA-binding protein 2,Sequence-specific single-stranded-DNA-binding protein 2;, , GO:0005737;GO:0005634;GO:0003697;GO:0045944;GO:0006355;, C:cytoplasm; C:nucleus;, F:single-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold4 indexed_genome mRNA 36647046 36825100 . + . ID=transcript_1143;Q9H0Y0 B2RE09 Q6PIX1 Q9H842,Ubiquitin-like-conjugating enzyme ATG10,Autophagy-related protein 10;, PF03987;, GO:0005829;GO:0019777;GO:0006914;GO:0006983;GO:0016236;GO:0031401;GO:0006497;GO:0032446;GO:0015031;, C:cytosol;, F:Atg12 transferase activity;, P:autophagy; P:ER overload response; P:macroautophagy; P:positive regulation of protein modification process; P:protein lipidation; P:protein modification by small protein conjugation; P:protein transport; scaffold4 indexed_genome mRNA 36901838 36904986 . + . ID=transcript_1144;P62266 P39028 Q6IB08,40S ribosomal protein S23,Small ribosomal subunit protein uS12 {ECO:0000303|PubMed:24524803};, PF00164;, GO:0005829;GO:0022627;GO:0005783;GO:0016020;GO:0005654;GO:0042788;GO:0005840;GO:0005791;GO:0003723;GO:0003735;GO:0002181;GO:1990145;GO:0000184;GO:0006614;GO:0034063;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:membrane; C:nucleoplasm; C:polysomal ribosome; C:ribosome; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:maintenance of translational fidelity; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:stress granule assembly; P:translation; P:translational initiation; P:viral transcription; scaffold4 indexed_genome mRNA 36908275 36910504 . - . ID=transcript_1145;P62266 P39028 Q6IB08,40S ribosomal protein S23,Small ribosomal subunit protein uS12 {ECO:0000303|PubMed:24524803};, PF00164;, GO:0005829;GO:0022627;GO:0005783;GO:0016020;GO:0005654;GO:0042788;GO:0005840;GO:0005791;GO:0003723;GO:0003735;GO:0002181;GO:1990145;GO:0000184;GO:0006614;GO:0034063;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:membrane; C:nucleoplasm; C:polysomal ribosome; C:ribosome; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:maintenance of translational fidelity; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:stress granule assembly; P:translation; P:translational initiation; P:viral transcription;|P62266 P39028 Q6IB08,40S ribosomal protein S23,Small ribosomal subunit protein uS12 {ECO:0000303|PubMed:24524803};, PF00164;, GO:0005829;GO:0022627;GO:0005783;GO:0016020;GO:0005654;GO:0042788;GO:0005840;GO:0005791;GO:0003723;GO:0003735;GO:0002181;GO:1990145;GO:0000184;GO:0006614;GO:0034063;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:membrane; C:nucleoplasm; C:polysomal ribosome; C:ribosome; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:maintenance of translational fidelity; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:stress granule assembly; P:translation; P:translational initiation; P:viral transcription;|P62266 P39028 Q6IB08,40S ribosomal protein S23,Small ribosomal subunit protein uS12 {ECO:0000303|PubMed:24524803};, PF00164;, GO:0005829;GO:0022627;GO:0005783;GO:0016020;GO:0005654;GO:0042788;GO:0005840;GO:0005791;GO:0003723;GO:0003735;GO:0002181;GO:1990145;GO:0000184;GO:0006614;GO:0034063;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:membrane; C:nucleoplasm; C:polysomal ribosome; C:ribosome; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:maintenance of translational fidelity; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:stress granule assembly; P:translation; P:translational initiation; P:viral transcription; scaffold4 indexed_genome mRNA 36934617 36947424 . + . ID=transcript_1146;Q52LC2,V-type proton ATPase subunit S1-like protein,Vacuolar proton pump subunit S1-like protein;, PF05827;, GO:0016021;GO:0033181;GO:0033180;GO:1902600;GO:0030641;, C:integral component of membrane; C:plasma membrane proton-transporting V-type ATPase complex; C:proton-transporting V-type ATPase, V1 domain;, , P:proton transmembrane transport; P:regulation of cellular pH; scaffold4 indexed_genome mRNA 37536239 37577410 . - . ID=transcript_1147;Q8TBQ9 Q0P692,Protein kish-A,Transmembrane protein 167;Transmembrane protein 167A;, PF06842;, GO:0005794;GO:0000139;GO:0016021;GO:0045054;GO:0046907;GO:0009306;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:constitutive secretory pathway; P:intracellular transport; P:protein secretion; scaffold4 indexed_genome mRNA 37606146 37854681 . + . ID=transcript_1148;Q13426 A8K3X4 Q9BS72 Q9UP94,DNA repair protein XRCC4,X-ray repair cross-complementing protein 4;, PF06632;, GO:0005829;GO:0032807;GO:0005958;GO:0070419;GO:0005654;GO:0005634;GO:0035861;GO:0042802;GO:0008022;GO:0071285;GO:0051103;GO:0006302;GO:0006303;GO:0075713;GO:0033152;GO:0051351;GO:1990166;GO:0010165;, C:cytosol; C:DNA ligase IV complex; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:nonhomologous end joining complex; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:identical protein binding; F:protein C-terminus binding;, P:cellular response to lithium ion; P:DNA ligation involved in DNA repair; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:immunoglobulin V(D)J recombination; P:positive regulation of ligase activity; P:protein localization to site of double-strand break; P:response to X-ray; scaffold4 indexed_genome mRNA 37996818 38071446 . + . ID=transcript_1149;P13611 P20754 Q13010 Q13189 Q15123 Q9UCL9 Q9UNW5,Versican core protein,Chondroitin sulfate proteoglycan core protein 2;Glial hyaluronate-binding protein;Large fibroblast proteoglycan;PG-M;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0033165;GO:0043202;GO:0016020;GO:0001750;GO:0005509;GO:0030246;GO:0030021;GO:0005539;GO:0005540;GO:0007155;GO:0008037;GO:0044267;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0008347;GO:0007275;GO:0001649;GO:0043687;GO:0001501;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:interphotoreceptor matrix; C:lysosomal lumen; C:membrane; C:photoreceptor outer segment;, F:calcium ion binding; F:carbohydrate binding; F:extracellular matrix structural constituent conferring compression resistance; F:glycosaminoglycan binding; F:hyaluronic acid binding;, P:cell adhesion; P:cell recognition; P:cellular protein metabolic process; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:glial cell migration; P:multicellular organism development; P:osteoblast differentiation; P:post-translational protein modification; P:skeletal system development;|P13611 P20754 Q13010 Q13189 Q15123 Q9UCL9 Q9UNW5,Versican core protein,Chondroitin sulfate proteoglycan core protein 2;Glial hyaluronate-binding protein;Large fibroblast proteoglycan;PG-M;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0033165;GO:0043202;GO:0016020;GO:0001750;GO:0005509;GO:0030246;GO:0030021;GO:0005539;GO:0005540;GO:0007155;GO:0008037;GO:0044267;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0008347;GO:0007275;GO:0001649;GO:0043687;GO:0001501;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:interphotoreceptor matrix; C:lysosomal lumen; C:membrane; C:photoreceptor outer segment;, F:calcium ion binding; F:carbohydrate binding; F:extracellular matrix structural constituent conferring compression resistance; F:glycosaminoglycan binding; F:hyaluronic acid binding;, P:cell adhesion; P:cell recognition; P:cellular protein metabolic process; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:glial cell migration; P:multicellular organism development; P:osteoblast differentiation; P:post-translational protein modification; P:skeletal system development;|P13611 P20754 Q13010 Q13189 Q15123 Q9UCL9 Q9UNW5,Versican core protein,Chondroitin sulfate proteoglycan core protein 2;Glial hyaluronate-binding protein;Large fibroblast proteoglycan;PG-M;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0033165;GO:0043202;GO:0016020;GO:0001750;GO:0005509;GO:0030246;GO:0030021;GO:0005539;GO:0005540;GO:0007155;GO:0008037;GO:0044267;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0008347;GO:0007275;GO:0001649;GO:0043687;GO:0001501;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:interphotoreceptor matrix; C:lysosomal lumen; C:membrane; C:photoreceptor outer segment;, F:calcium ion binding; F:carbohydrate binding; F:extracellular matrix structural constituent conferring compression resistance; F:glycosaminoglycan binding; F:hyaluronic acid binding;, P:cell adhesion; P:cell recognition; P:cellular protein metabolic process; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:glial cell migration; P:multicellular organism development; P:osteoblast differentiation; P:post-translational protein modification; P:skeletal system development;|P13611 P20754 Q13010 Q13189 Q15123 Q9UCL9 Q9UNW5,Versican core protein,Chondroitin sulfate proteoglycan core protein 2;Glial hyaluronate-binding protein;Large fibroblast proteoglycan;PG-M;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0033165;GO:0043202;GO:0016020;GO:0001750;GO:0005509;GO:0030246;GO:0030021;GO:0005539;GO:0005540;GO:0007155;GO:0008037;GO:0044267;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0008347;GO:0007275;GO:0001649;GO:0043687;GO:0001501;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:interphotoreceptor matrix; C:lysosomal lumen; C:membrane; C:photoreceptor outer segment;, F:calcium ion binding; F:carbohydrate binding; F:extracellular matrix structural constituent conferring compression resistance; F:glycosaminoglycan binding; F:hyaluronic acid binding;, P:cell adhesion; P:cell recognition; P:cellular protein metabolic process; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:glial cell migration; P:multicellular organism development; P:osteoblast differentiation; P:post-translational protein modification; P:skeletal system development;|P13611 P20754 Q13010 Q13189 Q15123 Q9UCL9 Q9UNW5,Versican core protein,Chondroitin sulfate proteoglycan core protein 2;Glial hyaluronate-binding protein;Large fibroblast proteoglycan;PG-M;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0033165;GO:0043202;GO:0016020;GO:0001750;GO:0005509;GO:0030246;GO:0030021;GO:0005539;GO:0005540;GO:0007155;GO:0008037;GO:0044267;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0008347;GO:0007275;GO:0001649;GO:0043687;GO:0001501;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:interphotoreceptor matrix; C:lysosomal lumen; C:membrane; C:photoreceptor outer segment;, F:calcium ion binding; F:carbohydrate binding; F:extracellular matrix structural constituent conferring compression resistance; F:glycosaminoglycan binding; F:hyaluronic acid binding;, P:cell adhesion; P:cell recognition; P:cellular protein metabolic process; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:glial cell migration; P:multicellular organism development; P:osteoblast differentiation; P:post-translational protein modification; P:skeletal system development; scaffold4 indexed_genome mRNA 38125095 38139016 . - . ID=transcript_1150;P10915 B2R9A9,Hyaluronan and proteoglycan link protein 1,Cartilage-linking protein 1;Proteoglycan link protein;, PF07686;PF00193;, GO:0062023;GO:0031012;GO:0005576;GO:0045202;GO:0005540;GO:0007155;GO:0007417;GO:0030198;GO:0001501;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:synapse;, F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:extracellular matrix organization; P:skeletal system development; scaffold4 indexed_genome mRNA 38415466 38622064 . - . ID=transcript_1151;O43854 B2R763 O43855 Q5D094 Q8N610,EGF-like repeat and discoidin I-like domain-containing protein 3,Developmentally-regulated endothelial cell locus 1 protein;Integrin-binding protein DEL1;, PF00008;PF00754;PF12661;, GO:0062023;GO:0070062;GO:1903561;GO:0005509;GO:0005178;GO:0007155;GO:0007275;GO:0010811;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular vesicle;, F:calcium ion binding; F:integrin binding;, P:cell adhesion; P:multicellular organism development; P:positive regulation of cell-substrate adhesion; scaffold4 indexed_genome mRNA 41328169 41437555 . + . ID=transcript_1152;P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;|P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;|P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;|P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;|P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;|P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;|P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;|P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;|P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;|P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1,Ras GTPase-activating protein 1,Ras p21 protein activator;p120GAP;, PF00168;PF00169;PF00616;PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;, C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;, F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;, P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis; scaffold4 indexed_genome mRNA 41440025 41464726 . - . ID=transcript_1153;P51946 Q53X72 Q8TBL9,Cyclin-H,MO15-associated protein;p34;p37;, PF16899;PF00134;, GO:0070516;GO:0019907;GO:0005654;GO:0005634;GO:0000439;GO:0005675;GO:0070985;GO:0016538;GO:0006370;GO:0000082;GO:0000086;GO:0006294;GO:0070816;GO:0050821;GO:0000079;GO:0006357;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:CAK-ERCC2 complex; C:cyclin-dependent protein kinase activating kinase holoenzyme complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex; C:transcription factor TFIIK complex;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:7-methylguanosine mRNA capping; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:nucleotide-excision repair, preincision complex assembly; P:phosphorylation of RNA polymerase II C-terminal domain; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P51946 Q53X72 Q8TBL9,Cyclin-H,MO15-associated protein;p34;p37;, PF16899;PF00134;, GO:0070516;GO:0019907;GO:0005654;GO:0005634;GO:0000439;GO:0005675;GO:0070985;GO:0016538;GO:0006370;GO:0000082;GO:0000086;GO:0006294;GO:0070816;GO:0050821;GO:0000079;GO:0006357;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:CAK-ERCC2 complex; C:cyclin-dependent protein kinase activating kinase holoenzyme complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex; C:transcription factor TFIIK complex;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:7-methylguanosine mRNA capping; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:nucleotide-excision repair, preincision complex assembly; P:phosphorylation of RNA polymerase II C-terminal domain; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; scaffold4 indexed_genome mRNA 42103591 42178845 . - . ID=transcript_1154;Q8NDZ6 Q5CZH7 Q6UWQ6,Transmembrane protein 161B,, PF10268;, GO:0016021;, C:integral component of membrane;|Q8NDZ6 Q5CZH7 Q6UWQ6,Transmembrane protein 161B,, PF10268;, GO:0016021;, C:integral component of membrane;|Q8NDZ6 Q5CZH7 Q6UWQ6,Transmembrane protein 161B,, PF10268;, GO:0016021;, C:integral component of membrane;|Q8NDZ6 Q5CZH7 Q6UWQ6,Transmembrane protein 161B,, PF10268;, GO:0016021;, C:integral component of membrane;|Q8NDZ6 Q5CZH7 Q6UWQ6,Transmembrane protein 161B,, PF10268;, GO:0016021;, C:integral component of membrane; scaffold4 indexed_genome mRNA 42602360 42634321 . - . ID=transcript_1155;Q06413 C9JMZ0 D7F7N5 F8W7V7,Myocyte-specific enhancer factor 2C {ECO:0000305},Myocyte enhancer factor 2C {ECO:0000312|HGNC:HGNC:6996};, PF12347;PF00319;, GO:0000785;GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0098794;GO:0032991;GO:0016528;GO:0033613;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0003680;GO:0046982;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0006915;GO:0001782;GO:0042100;GO:0050853;GO:0001568;GO:0001974;GO:0003211;GO:0030154;GO:0048667;GO:0071277;GO:0035690;GO:0071498;GO:0071222;GO:0071374;GO:0071560;GO:0035984;GO:0002062;GO:0001958;GO:2001013;GO:0060079;GO:0002467;GO:0072102;GO:0007507;GO:0001947;GO:0006959;GO:0007611;GO:0000165;GO:0030318;GO:0007521;GO:0007517;GO:0014902;GO:0043537;GO:0010629;GO:0043524;GO:0030279;GO:0000122;GO:1904753;GO:1904706;GO:1905563;GO:0072160;GO:0007399;GO:0014033;GO:0048666;GO:0030182;GO:0001764;GO:0001649;GO:0003151;GO:0030220;GO:0010694;GO:0030890;GO:2000987;GO:0030501;GO:2000727;GO:0060045;GO:0010628;GO:2000111;GO:0043406;GO:0051149;GO:0045663;GO:0045666;GO:0045669;GO:2001016;GO:0048643;GO:0045944;GO:0045893;GO:0003138;GO:2000311;GO:0060998;GO:0002634;GO:0045652;GO:0043523;GO:0046928;GO:2000310;GO:0051963;GO:0060025;GO:0048167;GO:0051966;GO:0006357;GO:0006355;GO:0061333;GO:0002931;GO:0003139;GO:0003185;GO:0007519;GO:0051145;GO:0055012;, C:chromatin; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:postsynapse; C:protein-containing complex; C:sarcoplasm;, F:activating transcription factor binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:B cell homeostasis; P:B cell proliferation; P:B cell receptor signaling pathway; P:blood vessel development; P:blood vessel remodeling; P:cardiac ventricle formation; P:cell differentiation; P:cell morphogenesis involved in neuron differentiation; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to parathyroid hormone stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to trichostatin A; P:chondrocyte differentiation; P:endochondral ossification; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:excitatory postsynaptic potential; P:germinal center formation; P:glomerulus morphogenesis; P:heart development; P:heart looping; P:humoral immune response; P:learning or memory; P:MAPK cascade; P:melanocyte differentiation; P:muscle cell fate determination; P:muscle organ development; P:myotube differentiation; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of ossification; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of vascular endothelial cell proliferation; P:nephron tubule epithelial cell differentiation; P:nervous system development; P:neural crest cell differentiation; P:neuron development; P:neuron differentiation; P:neuron migration; P:osteoblast differentiation; P:outflow tract morphogenesis; P:platelet formation; P:positive regulation of alkaline phosphatase activity; P:positive regulation of B cell proliferation; P:positive regulation of behavioral fear response; P:positive regulation of bone mineralization; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of gene expression; P:positive regulation of macrophage apoptotic process; P:positive regulation of MAP kinase activity; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of neuron differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of skeletal muscle tissue development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:primary heart field specification; P:regulation of AMPA receptor activity; P:regulation of dendritic spine development; P:regulation of germinal center formation; P:regulation of megakaryocyte differentiation; P:regulation of neuron apoptotic process; P:regulation of neurotransmitter secretion; P:regulation of NMDA receptor activity; P:regulation of synapse assembly; P:regulation of synaptic activity; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, glutamatergic; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal tubule morphogenesis; P:response to ischemia; P:secondary heart field specification; P:sinoatrial valve morphogenesis; P:skeletal muscle tissue development; P:smooth muscle cell differentiation; P:ventricular cardiac muscle cell differentiation;|Q06413 C9JMZ0 D7F7N5 F8W7V7,Myocyte-specific enhancer factor 2C {ECO:0000305},Myocyte enhancer factor 2C {ECO:0000312|HGNC:HGNC:6996};, PF12347;PF00319;, GO:0000785;GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0098794;GO:0032991;GO:0016528;GO:0033613;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0003680;GO:0046982;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0006915;GO:0001782;GO:0042100;GO:0050853;GO:0001568;GO:0001974;GO:0003211;GO:0030154;GO:0048667;GO:0071277;GO:0035690;GO:0071498;GO:0071222;GO:0071374;GO:0071560;GO:0035984;GO:0002062;GO:0001958;GO:2001013;GO:0060079;GO:0002467;GO:0072102;GO:0007507;GO:0001947;GO:0006959;GO:0007611;GO:0000165;GO:0030318;GO:0007521;GO:0007517;GO:0014902;GO:0043537;GO:0010629;GO:0043524;GO:0030279;GO:0000122;GO:1904753;GO:1904706;GO:1905563;GO:0072160;GO:0007399;GO:0014033;GO:0048666;GO:0030182;GO:0001764;GO:0001649;GO:0003151;GO:0030220;GO:0010694;GO:0030890;GO:2000987;GO:0030501;GO:2000727;GO:0060045;GO:0010628;GO:2000111;GO:0043406;GO:0051149;GO:0045663;GO:0045666;GO:0045669;GO:2001016;GO:0048643;GO:0045944;GO:0045893;GO:0003138;GO:2000311;GO:0060998;GO:0002634;GO:0045652;GO:0043523;GO:0046928;GO:2000310;GO:0051963;GO:0060025;GO:0048167;GO:0051966;GO:0006357;GO:0006355;GO:0061333;GO:0002931;GO:0003139;GO:0003185;GO:0007519;GO:0051145;GO:0055012;, C:chromatin; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:postsynapse; C:protein-containing complex; C:sarcoplasm;, F:activating transcription factor binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:B cell homeostasis; P:B cell proliferation; P:B cell receptor signaling pathway; P:blood vessel development; P:blood vessel remodeling; P:cardiac ventricle formation; P:cell differentiation; P:cell morphogenesis involved in neuron differentiation; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to parathyroid hormone stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to trichostatin A; P:chondrocyte differentiation; P:endochondral ossification; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:excitatory postsynaptic potential; P:germinal center formation; P:glomerulus morphogenesis; P:heart development; P:heart looping; P:humoral immune response; P:learning or memory; P:MAPK cascade; P:melanocyte differentiation; P:muscle cell fate determination; P:muscle organ development; P:myotube differentiation; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of ossification; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of vascular endothelial cell proliferation; P:nephron tubule epithelial cell differentiation; P:nervous system development; P:neural crest cell differentiation; P:neuron development; P:neuron differentiation; P:neuron migration; P:osteoblast differentiation; P:outflow tract morphogenesis; P:platelet formation; P:positive regulation of alkaline phosphatase activity; P:positive regulation of B cell proliferation; P:positive regulation of behavioral fear response; P:positive regulation of bone mineralization; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of gene expression; P:positive regulation of macrophage apoptotic process; P:positive regulation of MAP kinase activity; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of neuron differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of skeletal muscle tissue development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:primary heart field specification; P:regulation of AMPA receptor activity; P:regulation of dendritic spine development; P:regulation of germinal center formation; P:regulation of megakaryocyte differentiation; P:regulation of neuron apoptotic process; P:regulation of neurotransmitter secretion; P:regulation of NMDA receptor activity; P:regulation of synapse assembly; P:regulation of synaptic activity; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, glutamatergic; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal tubule morphogenesis; P:response to ischemia; P:secondary heart field specification; P:sinoatrial valve morphogenesis; P:skeletal muscle tissue development; P:smooth muscle cell differentiation; P:ventricular cardiac muscle cell differentiation; scaffold4 indexed_genome mRNA 44189580 44206758 . - . ID=transcript_1156;O15182 Q53YD2 Q9BS23,Centrin-3,, PF13499;, GO:0005814;GO:0005813;GO:0005737;GO:0005815;GO:0044615;GO:0005730;GO:0070390;GO:0005509;GO:0008017;GO:0051301;GO:0007098;GO:0051028;GO:0015031;, C:centriole; C:centrosome; C:cytoplasm; C:microtubule organizing center; C:nuclear pore nuclear basket; C:nucleolus; C:transcription export complex 2;, F:calcium ion binding; F:microtubule binding;, P:cell division; P:centrosome cycle; P:mRNA transport; P:protein transport; scaffold4 indexed_genome mRNA 44255047 44275490 . - . ID=transcript_1157;Q68D91 D6RJI1 Q8IY16 Q8N8D8,Metallo-beta-lactamase domain-containing protein 2,, PF00753;, GO:0070062;GO:0016787;GO:0046872;, C:extracellular exosome;, F:hydrolase activity; F:metal ion binding;|Q68D91 D6RJI1 Q8IY16 Q8N8D8,Metallo-beta-lactamase domain-containing protein 2,, PF00753;, GO:0070062;GO:0016787;GO:0046872;, C:extracellular exosome;, F:hydrolase activity; F:metal ion binding; scaffold4 indexed_genome mRNA 44275629 44299179 . + . ID=transcript_1158;O15318 A8MTH0,DNA-directed RNA polymerase III subunit RPC7,DNA-directed RNA polymerase III subunit G;RNA polymerase III 32 kDa apha subunit;RNA polymerase III 32 kDa subunit;, PF11705;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005666;GO:0003682;GO:0003899;GO:0008283;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006383;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:RNA polymerase III complex;, F:chromatin binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:cell population proliferation; P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription by RNA polymerase III; scaffold4 indexed_genome mRNA 44319926 44331828 . - . ID=transcript_1159;Q7Z3D4 Q5H9U0 Q6PEK0 Q9NTE9,LysM and putative peptidoglycan-binding domain-containing protein 3,, PF01476;, GO:0005794;GO:0016021;GO:0005886;GO:0007030;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:Golgi organization;|Q7Z3D4 Q5H9U0 Q6PEK0 Q9NTE9,LysM and putative peptidoglycan-binding domain-containing protein 3,, PF01476;, GO:0005794;GO:0016021;GO:0005886;GO:0007030;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:Golgi organization;|Q7Z3D4 Q5H9U0 Q6PEK0 Q9NTE9,LysM and putative peptidoglycan-binding domain-containing protein 3,, PF01476;, GO:0005794;GO:0016021;GO:0005886;GO:0007030;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:Golgi organization; scaffold4 indexed_genome mRNA 44576204 44581200 . + . ID=transcript_1160;Q8WXG9 O75171 Q8TF58 Q9H0X5 Q9UL61,Adhesion G-protein coupled receptor V1 {ECO:0000305},G-protein coupled receptor 98;Monogenic audiogenic seizure susceptibility protein 1 homolog;Usher syndrome type-2C protein;Very large G-protein coupled receptor 1;, PF00002;PF03160;PF03736;, GO:0009986;GO:0005737;GO:0070062;GO:0016021;GO:0016020;GO:1990075;GO:0001917;GO:0005886;GO:0043235;GO:0002141;GO:0002142;GO:0060171;GO:0045202;GO:1990696;GO:0010855;GO:0005509;GO:0004930;GO:0001965;GO:0016787;GO:0007166;GO:0098609;GO:0071277;GO:0050910;GO:0045184;GO:0007186;GO:0048839;GO:0060122;GO:0048496;GO:0007194;GO:0007399;GO:0050877;GO:0045494;GO:0030501;GO:0010739;GO:0090037;GO:0031647;GO:0097264;GO:0050953;GO:0007605;GO:0007601;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:integral component of membrane; C:membrane; C:periciliary membrane compartment; C:photoreceptor inner segment; C:plasma membrane; C:receptor complex; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium membrane; C:synapse; C:USH2 complex;, F:adenylate cyclase inhibitor activity; F:calcium ion binding; F:G protein-coupled receptor activity; F:G-protein alpha-subunit binding; F:hydrolase activity;, P:cell surface receptor signaling pathway; P:cell-cell adhesion; P:cellular response to calcium ion; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:G protein-coupled receptor signaling pathway; P:inner ear development; P:inner ear receptor cell stereocilium organization; P:maintenance of animal organ identity; P:negative regulation of adenylate cyclase activity; P:nervous system development; P:nervous system process; P:photoreceptor cell maintenance; P:positive regulation of bone mineralization; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase C signaling; P:regulation of protein stability; P:self proteolysis; P:sensory perception of light stimulus; P:sensory perception of sound; P:visual perception; scaffold4 indexed_genome mRNA 44595019 44912842 . + . ID=transcript_1161;Q8WXG9 O75171 Q8TF58 Q9H0X5 Q9UL61,Adhesion G-protein coupled receptor V1 {ECO:0000305},G-protein coupled receptor 98;Monogenic audiogenic seizure susceptibility protein 1 homolog;Usher syndrome type-2C protein;Very large G-protein coupled receptor 1;, PF00002;PF03160;PF03736;, GO:0009986;GO:0005737;GO:0070062;GO:0016021;GO:0016020;GO:1990075;GO:0001917;GO:0005886;GO:0043235;GO:0002141;GO:0002142;GO:0060171;GO:0045202;GO:1990696;GO:0010855;GO:0005509;GO:0004930;GO:0001965;GO:0016787;GO:0007166;GO:0098609;GO:0071277;GO:0050910;GO:0045184;GO:0007186;GO:0048839;GO:0060122;GO:0048496;GO:0007194;GO:0007399;GO:0050877;GO:0045494;GO:0030501;GO:0010739;GO:0090037;GO:0031647;GO:0097264;GO:0050953;GO:0007605;GO:0007601;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:integral component of membrane; C:membrane; C:periciliary membrane compartment; C:photoreceptor inner segment; C:plasma membrane; C:receptor complex; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium membrane; C:synapse; C:USH2 complex;, F:adenylate cyclase inhibitor activity; F:calcium ion binding; F:G protein-coupled receptor activity; F:G-protein alpha-subunit binding; F:hydrolase activity;, P:cell surface receptor signaling pathway; P:cell-cell adhesion; P:cellular response to calcium ion; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:G protein-coupled receptor signaling pathway; P:inner ear development; P:inner ear receptor cell stereocilium organization; P:maintenance of animal organ identity; P:negative regulation of adenylate cyclase activity; P:nervous system development; P:nervous system process; P:photoreceptor cell maintenance; P:positive regulation of bone mineralization; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase C signaling; P:regulation of protein stability; P:self proteolysis; P:sensory perception of light stimulus; P:sensory perception of sound; P:visual perception; scaffold4 indexed_genome mRNA 45308592 45309196 . - . ID=transcript_1162;Q6ZU80 B9EK52 Q86X97 Q96ML4,Centrosomal protein of 128 kDa,, , GO:0120103;GO:0005814;GO:0005737;GO:0000922;GO:0008104;, C:centriolar subdistal appendage; C:centriole; C:cytoplasm; C:spindle pole;, , P:protein localization; scaffold4 indexed_genome mRNA 47065429 47070110 . - . ID=transcript_1163;P24468 B4DQJ2 B6ZGU1 Q03754 Q3KQR7,COUP transcription factor 2,Apolipoprotein A-I regulatory protein 1;COUP transcription factor II;Nuclear receptor subfamily 2 group F member 2;, PF00104;PF00105;, GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0004879;GO:0042803;GO:0001972;GO:0000978;GO:0043565;GO:0008270;GO:0048856;GO:0009952;GO:0048514;GO:0030154;GO:0008585;GO:0009566;GO:0030900;GO:0060173;GO:0060838;GO:0001893;GO:0045736;GO:0010596;GO:0001937;GO:0000122;GO:0045892;GO:0001764;GO:0060674;GO:0003084;GO:0045944;GO:0045893;GO:0009956;GO:0006357;GO:0032355;GO:0007519;GO:0060707;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:nuclear receptor activity; F:protein homodimerization activity; F:retinoic acid binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:anterior/posterior pattern specification; P:blood vessel morphogenesis; P:cell differentiation; P:female gonad development; P:fertilization; P:forebrain development; P:limb development; P:lymphatic endothelial cell fate commitment; P:maternal placenta development; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron migration; P:placenta blood vessel development; P:positive regulation of systemic arterial blood pressure; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:radial pattern formation; P:regulation of transcription by RNA polymerase II; P:response to estradiol; P:skeletal muscle tissue development; P:trophoblast giant cell differentiation; scaffold4 indexed_genome mRNA 47519039 47711620 . - . ID=transcript_1164;Q8IV33 A0A088AWM3 O94914 Q6ZNN2,Uncharacterized protein KIAA0825,, PF14906; scaffold4 indexed_genome mRNA 47715879 47763880 . - . ID=transcript_1165;Q8IV33 A0A088AWM3 O94914 Q6ZNN2,Uncharacterized protein KIAA0825,, PF14906; scaffold4 indexed_genome mRNA 47799624 47852134 . - . ID=transcript_1166;Q8IV33 A0A088AWM3 O94914 Q6ZNN2,Uncharacterized protein KIAA0825,, PF14906; scaffold4 indexed_genome mRNA 47942049 48001896 . + . ID=transcript_1167;Q9BQI6 B4DMG4 Q3B7K4 Q6NSA5 Q6PHW9 Q9Y402,SMC5-SMC6 complex localization factor protein 1 {ECO:0000312|HGNC:HGNC:25408},Ankyrin repeat domain-containing protein 32;BRCT domain-containing protein 1;Smc5/6 localization factor 1 {ECO:0000303|PubMed:25931565};, PF12796;PF16770;, GO:0005813;GO:0005737;GO:0042405;GO:0005654;GO:0000786;GO:0005634;GO:0035861;GO:0044877;GO:0031625;GO:0006974;GO:0006281;GO:2000781;GO:0034184;GO:0031334;GO:1990166;, C:centrosome; C:cytoplasm; C:nuclear inclusion body; C:nucleoplasm; C:nucleosome; C:nucleus; C:site of double-strand break;, F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:positive regulation of double-strand break repair; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of protein-containing complex assembly; P:protein localization to site of double-strand break; scaffold4 indexed_genome mRNA 48009160 48244540 . - . ID=transcript_1168;Q6DN14 Q6DN13 Q8N2W1 Q8NBA2 Q96LX0 Q9H6E8,Multiple C2 and transmembrane domain-containing protein 1,, PF00168;PF08372;, GO:0005789;GO:0016021;GO:0055037;GO:0030672;GO:0005509;GO:0019722;GO:0030336;GO:0045806;GO:1902883;GO:0048168;GO:0046928;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:recycling endosome; C:synaptic vesicle membrane;, F:calcium ion binding;, P:calcium-mediated signaling; P:negative regulation of cell migration; P:negative regulation of endocytosis; P:negative regulation of response to oxidative stress; P:regulation of neuronal synaptic plasticity; P:regulation of neurotransmitter secretion;|Q6DN14 Q6DN13 Q8N2W1 Q8NBA2 Q96LX0 Q9H6E8,Multiple C2 and transmembrane domain-containing protein 1,, PF00168;PF08372;, GO:0005789;GO:0016021;GO:0055037;GO:0030672;GO:0005509;GO:0019722;GO:0030336;GO:0045806;GO:1902883;GO:0048168;GO:0046928;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:recycling endosome; C:synaptic vesicle membrane;, F:calcium ion binding;, P:calcium-mediated signaling; P:negative regulation of cell migration; P:negative regulation of endocytosis; P:negative regulation of response to oxidative stress; P:regulation of neuronal synaptic plasticity; P:regulation of neurotransmitter secretion;|Q6DN14 Q6DN13 Q8N2W1 Q8NBA2 Q96LX0 Q9H6E8,Multiple C2 and transmembrane domain-containing protein 1,, PF00168;PF08372;, GO:0005789;GO:0016021;GO:0055037;GO:0030672;GO:0005509;GO:0019722;GO:0030336;GO:0045806;GO:1902883;GO:0048168;GO:0046928;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:recycling endosome; C:synaptic vesicle membrane;, F:calcium ion binding;, P:calcium-mediated signaling; P:negative regulation of cell migration; P:negative regulation of endocytosis; P:negative regulation of response to oxidative stress; P:regulation of neuronal synaptic plasticity; P:regulation of neurotransmitter secretion; scaffold4 indexed_genome mRNA 48713629 48757172 . - . ID=transcript_1169;Q6PGP7 O15077 Q6PJI3,Tetratricopeptide repeat protein 37,SKI3 homolog;Tricho-hepatic-enteric syndrome protein;, PF13181;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0034427;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';|Q6PGP7 O15077 Q6PJI3,Tetratricopeptide repeat protein 37,SKI3 homolog;Tricho-hepatic-enteric syndrome protein;, PF13181;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0034427;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';|Q6PGP7 O15077 Q6PJI3,Tetratricopeptide repeat protein 37,SKI3 homolog;Tricho-hepatic-enteric syndrome protein;, PF13181;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0034427;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; scaffold4 indexed_genome mRNA 48758044 48800321 . - . ID=transcript_1170;Q6PGP7 O15077 Q6PJI3,Tetratricopeptide repeat protein 37,SKI3 homolog;Tricho-hepatic-enteric syndrome protein;, PF13181;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0034427;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';|Q6PGP7 O15077 Q6PJI3,Tetratricopeptide repeat protein 37,SKI3 homolog;Tricho-hepatic-enteric syndrome protein;, PF13181;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0034427;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';|Q6PGP7 O15077 Q6PJI3,Tetratricopeptide repeat protein 37,SKI3 homolog;Tricho-hepatic-enteric syndrome protein;, PF13181;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0034427;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; scaffold4 indexed_genome mRNA 48808815 48866399 . + . ID=transcript_1171;Q6UWY0 A2BDE3 B4E1I4 Q3ZCW3 Q8N3Q8,Arylsulfatase K,Telethon sulfatase;, PF00884;, GO:0005788;GO:0005576;GO:0004065;GO:0046872;, C:endoplasmic reticulum lumen; C:extracellular region;, F:arylsulfatase activity; F:metal ion binding; scaffold4 indexed_genome mRNA 48925098 48925785 . + . ID=transcript_1172;Q8TAC1 J3KPH1,Rieske domain-containing protein,, PF00355;, GO:0051537;GO:0046872;, , F:2 iron, 2 sulfur cluster binding; F:metal ion binding; scaffold4 indexed_genome mRNA 48926343 48944550 . - . ID=transcript_1173;Q9BWV2 A8K8H3 Q4G122 Q86X33 Q8NA28,Spermatogenesis-associated protein 9,Testis development protein NYD-SP16;, PF15824;, GO:0016021;GO:0030154;GO:0007275;GO:0007283;, C:integral component of membrane;, , P:cell differentiation; P:multicellular organism development; P:spermatogenesis; scaffold4 indexed_genome mRNA 48981850 49050710 . + . ID=transcript_1174;O94955 A0PJA4 A8K1W9 Q8IW06,Rho-related BTB domain-containing protein 3,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0032588;GO:0005524;GO:0016887;GO:0005525;GO:0003924;GO:0019901;GO:0031267;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0008584;GO:0032956;GO:0008360;GO:0042147;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase activity; F:GTP binding; F:GTPase activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:male gonad development; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:retrograde transport, endosome to Golgi;|O94955 A0PJA4 A8K1W9 Q8IW06,Rho-related BTB domain-containing protein 3,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0032588;GO:0005524;GO:0016887;GO:0005525;GO:0003924;GO:0019901;GO:0031267;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0008584;GO:0032956;GO:0008360;GO:0042147;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase activity; F:GTP binding; F:GTPase activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:male gonad development; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:retrograde transport, endosome to Golgi;|O94955 A0PJA4 A8K1W9 Q8IW06,Rho-related BTB domain-containing protein 3,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0032588;GO:0005524;GO:0016887;GO:0005525;GO:0003924;GO:0019901;GO:0031267;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0008584;GO:0032956;GO:0008360;GO:0042147;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase activity; F:GTP binding; F:GTPase activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:male gonad development; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:retrograde transport, endosome to Golgi;|O94955 A0PJA4 A8K1W9 Q8IW06,Rho-related BTB domain-containing protein 3,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0032588;GO:0005524;GO:0016887;GO:0005525;GO:0003924;GO:0019901;GO:0031267;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0008584;GO:0032956;GO:0008360;GO:0042147;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase activity; F:GTP binding; F:GTPase activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:male gonad development; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:retrograde transport, endosome to Golgi;|O94955 A0PJA4 A8K1W9 Q8IW06,Rho-related BTB domain-containing protein 3,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0032588;GO:0005524;GO:0016887;GO:0005525;GO:0003924;GO:0019901;GO:0031267;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0008584;GO:0032956;GO:0008360;GO:0042147;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase activity; F:GTP binding; F:GTPase activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:male gonad development; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:retrograde transport, endosome to Golgi;|O94955 A0PJA4 A8K1W9 Q8IW06,Rho-related BTB domain-containing protein 3,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0032588;GO:0005524;GO:0016887;GO:0005525;GO:0003924;GO:0019901;GO:0031267;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0008584;GO:0032956;GO:0008360;GO:0042147;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase activity; F:GTP binding; F:GTPase activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:male gonad development; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:retrograde transport, endosome to Golgi;|O94955 A0PJA4 A8K1W9 Q8IW06,Rho-related BTB domain-containing protein 3,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0032588;GO:0005524;GO:0016887;GO:0005525;GO:0003924;GO:0019901;GO:0031267;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0008584;GO:0032956;GO:0008360;GO:0042147;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase activity; F:GTP binding; F:GTPase activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:male gonad development; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:retrograde transport, endosome to Golgi;|O94955 A0PJA4 A8K1W9 Q8IW06,Rho-related BTB domain-containing protein 3,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0032588;GO:0005524;GO:0016887;GO:0005525;GO:0003924;GO:0019901;GO:0031267;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0008584;GO:0032956;GO:0008360;GO:0042147;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase activity; F:GTP binding; F:GTPase activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:male gonad development; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:retrograde transport, endosome to Golgi;|O94955 A0PJA4 A8K1W9 Q8IW06,Rho-related BTB domain-containing protein 3,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0032588;GO:0005524;GO:0016887;GO:0005525;GO:0003924;GO:0019901;GO:0031267;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0008584;GO:0032956;GO:0008360;GO:0042147;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase activity; F:GTP binding; F:GTPase activity; F:protein kinase binding; F:small GTPase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:male gonad development; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:retrograde transport, endosome to Golgi; scaffold4 indexed_genome mRNA 49080422 49090674 . - . ID=transcript_1175;P35754 B2R4L2 Q3KQS1 Q6ICT1,Glutaredoxin-1,Thioltransferase-1;, PF00462;, GO:0005829;GO:0070062;GO:0005634;GO:0009055;GO:0015038;GO:0097573;GO:0047485;GO:0015949;GO:0045838;GO:2000651;GO:0080058;, C:cytosol; C:extracellular exosome; C:nucleus;, F:electron transfer activity; F:glutathione disulfide oxidoreductase activity; F:glutathione oxidoreductase activity; F:protein N-terminus binding;, P:nucleobase-containing small molecule interconversion; P:positive regulation of membrane potential; P:positive regulation of sodium ion transmembrane transporter activity; P:protein deglutathionylation;|P35754 B2R4L2 Q3KQS1 Q6ICT1,Glutaredoxin-1,Thioltransferase-1;, PF00462;, GO:0005829;GO:0070062;GO:0005634;GO:0009055;GO:0015038;GO:0097573;GO:0047485;GO:0015949;GO:0045838;GO:2000651;GO:0080058;, C:cytosol; C:extracellular exosome; C:nucleus;, F:electron transfer activity; F:glutathione disulfide oxidoreductase activity; F:glutathione oxidoreductase activity; F:protein N-terminus binding;, P:nucleobase-containing small molecule interconversion; P:positive regulation of membrane potential; P:positive regulation of sodium ion transmembrane transporter activity; P:protein deglutathionylation; scaffold4 indexed_genome mRNA 49158785 49207936 . - . ID=transcript_1176;O00472 B4DNK7,RNA polymerase II elongation factor ELL2,, PF10390;PF07303;, GO:0005654;GO:0008023;GO:0042795;GO:0006368;, C:nucleoplasm; C:transcription elongation factor complex;, , P:snRNA transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O00472 B4DNK7,RNA polymerase II elongation factor ELL2,, PF10390;PF07303;, GO:0005654;GO:0008023;GO:0042795;GO:0006368;, C:nucleoplasm; C:transcription elongation factor complex;, , P:snRNA transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O00472 B4DNK7,RNA polymerase II elongation factor ELL2,, PF10390;PF07303;, GO:0005654;GO:0008023;GO:0042795;GO:0006368;, C:nucleoplasm; C:transcription elongation factor complex;, , P:snRNA transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O00472 B4DNK7,RNA polymerase II elongation factor ELL2,, PF10390;PF07303;, GO:0005654;GO:0008023;GO:0042795;GO:0006368;, C:nucleoplasm; C:transcription elongation factor complex;, , P:snRNA transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold4 indexed_genome mRNA 49667240 49680368 . - . ID=transcript_1177;P29120 B7Z8T7 E9PHA1 P78478 Q92532,Neuroendocrine convertase 1,Prohormone convertase 1;Proprotein convertase 1;, PF01483;PF00082;PF12177;PF16470;, GO:0005615;GO:0016020;GO:0043005;GO:0034774;GO:0030133;GO:0042802;GO:0004252;GO:0007267;GO:0043043;GO:0016486;GO:0016485;GO:0006508;, C:extracellular space; C:membrane; C:neuron projection; C:secretory granule lumen; C:transport vesicle;, F:identical protein binding; F:serine-type endopeptidase activity;, P:cell-cell signaling; P:peptide biosynthetic process; P:peptide hormone processing; P:protein processing; P:proteolysis; scaffold4 indexed_genome mRNA 49914878 50046710 . + . ID=transcript_1178;P20810 B7Z468 G5E946 G5E9D3 O95360 Q05DE8 Q7Z4K0 Q96D08 Q9H1Z5,Calpastatin,Calpain inhibitor;Sperm BS-17 component;, PF00748;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0045296;GO:0010859;GO:0004866;GO:0003723;GO:0097340;GO:2000675;GO:1990709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane;, F:cadherin binding; F:calcium-dependent cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:RNA binding;, P:inhibition of cysteine-type endopeptidase activity; P:negative regulation of type B pancreatic cell apoptotic process; P:presynaptic active zone organization;|P20810 B7Z468 G5E946 G5E9D3 O95360 Q05DE8 Q7Z4K0 Q96D08 Q9H1Z5,Calpastatin,Calpain inhibitor;Sperm BS-17 component;, PF00748;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0045296;GO:0010859;GO:0004866;GO:0003723;GO:0097340;GO:2000675;GO:1990709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane;, F:cadherin binding; F:calcium-dependent cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:RNA binding;, P:inhibition of cysteine-type endopeptidase activity; P:negative regulation of type B pancreatic cell apoptotic process; P:presynaptic active zone organization;|P20810 B7Z468 G5E946 G5E9D3 O95360 Q05DE8 Q7Z4K0 Q96D08 Q9H1Z5,Calpastatin,Calpain inhibitor;Sperm BS-17 component;, PF00748;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0045296;GO:0010859;GO:0004866;GO:0003723;GO:0097340;GO:2000675;GO:1990709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane;, F:cadherin binding; F:calcium-dependent cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:RNA binding;, P:inhibition of cysteine-type endopeptidase activity; P:negative regulation of type B pancreatic cell apoptotic process; P:presynaptic active zone organization;|P20810 B7Z468 G5E946 G5E9D3 O95360 Q05DE8 Q7Z4K0 Q96D08 Q9H1Z5,Calpastatin,Calpain inhibitor;Sperm BS-17 component;, PF00748;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0045296;GO:0010859;GO:0004866;GO:0003723;GO:0097340;GO:2000675;GO:1990709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane;, F:cadherin binding; F:calcium-dependent cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:RNA binding;, P:inhibition of cysteine-type endopeptidase activity; P:negative regulation of type B pancreatic cell apoptotic process; P:presynaptic active zone organization;|P20810 B7Z468 G5E946 G5E9D3 O95360 Q05DE8 Q7Z4K0 Q96D08 Q9H1Z5,Calpastatin,Calpain inhibitor;Sperm BS-17 component;, PF00748;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0045296;GO:0010859;GO:0004866;GO:0003723;GO:0097340;GO:2000675;GO:1990709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane;, F:cadherin binding; F:calcium-dependent cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:RNA binding;, P:inhibition of cysteine-type endopeptidase activity; P:negative regulation of type B pancreatic cell apoptotic process; P:presynaptic active zone organization;|P20810 B7Z468 G5E946 G5E9D3 O95360 Q05DE8 Q7Z4K0 Q96D08 Q9H1Z5,Calpastatin,Calpain inhibitor;Sperm BS-17 component;, PF00748;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0045296;GO:0010859;GO:0004866;GO:0003723;GO:0097340;GO:2000675;GO:1990709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane;, F:cadherin binding; F:calcium-dependent cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:RNA binding;, P:inhibition of cysteine-type endopeptidase activity; P:negative regulation of type B pancreatic cell apoptotic process; P:presynaptic active zone organization;|Q9NZ08 O60278 Q6UWY6 Q8NEL4 Q8TAD0 Q9UHF8 Q9UKY2,Endoplasmic reticulum aminopeptidase 1,ARTS-1;Adipocyte-derived leucine aminopeptidase;Aminopeptidase PILS;Puromycin-insensitive leucyl-specific aminopeptidase;Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0004177;GO:0005151;GO:0005138;GO:0070006;GO:0008235;GO:0042277;GO:0008270;GO:0002250;GO:0001525;GO:0019885;GO:0002474;GO:0045444;GO:0006509;GO:0043171;GO:0006508;GO:0008217;GO:0045088;GO:0009617;GO:0007165;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:aminopeptidase activity; F:interleukin-1, type II receptor binding; F:interleukin-6 receptor binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:peptide binding; F:zinc ion binding;, P:adaptive immune response; P:angiogenesis; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:antigen processing and presentation of peptide antigen via MHC class I; P:fat cell differentiation; P:membrane protein ectodomain proteolysis; P:peptide catabolic process; P:proteolysis; P:regulation of blood pressure; P:regulation of innate immune response; P:response to bacterium; P:signal transduction; scaffold4 indexed_genome mRNA 50049001 50080087 . + . ID=transcript_1179;Q9NZ08 O60278 Q6UWY6 Q8NEL4 Q8TAD0 Q9UHF8 Q9UKY2,Endoplasmic reticulum aminopeptidase 1,ARTS-1;Adipocyte-derived leucine aminopeptidase;Aminopeptidase PILS;Puromycin-insensitive leucyl-specific aminopeptidase;Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0004177;GO:0005151;GO:0005138;GO:0070006;GO:0008235;GO:0042277;GO:0008270;GO:0002250;GO:0001525;GO:0019885;GO:0002474;GO:0045444;GO:0006509;GO:0043171;GO:0006508;GO:0008217;GO:0045088;GO:0009617;GO:0007165;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:aminopeptidase activity; F:interleukin-1, type II receptor binding; F:interleukin-6 receptor binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:peptide binding; F:zinc ion binding;, P:adaptive immune response; P:angiogenesis; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:antigen processing and presentation of peptide antigen via MHC class I; P:fat cell differentiation; P:membrane protein ectodomain proteolysis; P:peptide catabolic process; P:proteolysis; P:regulation of blood pressure; P:regulation of innate immune response; P:response to bacterium; P:signal transduction;|Q9NZ08 O60278 Q6UWY6 Q8NEL4 Q8TAD0 Q9UHF8 Q9UKY2,Endoplasmic reticulum aminopeptidase 1,ARTS-1;Adipocyte-derived leucine aminopeptidase;Aminopeptidase PILS;Puromycin-insensitive leucyl-specific aminopeptidase;Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0004177;GO:0005151;GO:0005138;GO:0070006;GO:0008235;GO:0042277;GO:0008270;GO:0002250;GO:0001525;GO:0019885;GO:0002474;GO:0045444;GO:0006509;GO:0043171;GO:0006508;GO:0008217;GO:0045088;GO:0009617;GO:0007165;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:aminopeptidase activity; F:interleukin-1, type II receptor binding; F:interleukin-6 receptor binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:peptide binding; F:zinc ion binding;, P:adaptive immune response; P:angiogenesis; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:antigen processing and presentation of peptide antigen via MHC class I; P:fat cell differentiation; P:membrane protein ectodomain proteolysis; P:peptide catabolic process; P:proteolysis; P:regulation of blood pressure; P:regulation of innate immune response; P:response to bacterium; P:signal transduction; scaffold4 indexed_genome mRNA 50177187 50220853 . + . ID=transcript_1180;Q6P179 Q7Z5K1 Q8TD32 Q8WVJ4 Q9HBX2,Endoplasmic reticulum aminopeptidase 2,Leukocyte-derived arginine aminopeptidase;, PF11838;PF01433;, GO:0005737;GO:0005788;GO:0005789;GO:0016021;GO:0005886;GO:0004177;GO:0070006;GO:0008237;GO:0042277;GO:0008270;GO:0002250;GO:0019885;GO:0002474;GO:0043171;GO:0006508;GO:0008217;GO:0007165;, C:cytoplasm; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:metallopeptidase activity; F:peptide binding; F:zinc ion binding;, P:adaptive immune response; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:antigen processing and presentation of peptide antigen via MHC class I; P:peptide catabolic process; P:proteolysis; P:regulation of blood pressure; P:signal transduction; scaffold4 indexed_genome mRNA 50243069 50337013 . + . ID=transcript_1181;Q9UIQ6 O00769 Q15145 Q59H76 Q9TNQ2 Q9TNQ3 Q9UIQ7,Leucyl-cystinyl aminopeptidase,Insulin-regulated membrane aminopeptidase;Insulin-responsive aminopeptidase;Oxytocinase;Placental leucine aminopeptidase;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0031905;GO:0005576;GO:0005887;GO:0005765;GO:0016020;GO:0005886;GO:0004177;GO:0070006;GO:0008237;GO:0042277;GO:0008270;GO:0002480;GO:0007267;GO:0007565;GO:0120163;GO:0043171;GO:0000209;GO:0006508;GO:0008217;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome lumen; C:extracellular region; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:metallopeptidase activity; F:peptide binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; P:cell-cell signaling; P:female pregnancy; P:negative regulation of cold-induced thermogenesis; P:peptide catabolic process; P:protein polyubiquitination; P:proteolysis; P:regulation of blood pressure; P:signal transduction; scaffold4 indexed_genome mRNA 50385953 50395115 . + . ID=transcript_1182;Q16701 Q1PG42 Q3ZM01 Q53GC5 Q53YA4 Q6A1Z3 Q6IPC6 Q6P7N9 Q96J61,2'-5'-oligoadenylate synthase 1,E18/E16;p46/p42 OAS;, PF01909;PF10421;, GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0001730;GO:0005524;GO:0003725;GO:0046872;GO:0035457;GO:0051607;GO:0042593;GO:0006006;GO:0060333;GO:0045071;GO:0051259;GO:0006164;GO:0060700;GO:0009615;GO:0060337;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:2'-5'-oligoadenylate synthetase activity; F:ATP binding; F:double-stranded RNA binding; F:metal ion binding;, P:cellular response to interferon-alpha; P:defense response to virus; P:glucose homeostasis; P:glucose metabolic process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral genome replication; P:protein complex oligomerization; P:purine nucleotide biosynthetic process; P:regulation of ribonuclease activity; P:response to virus; P:type I interferon signaling pathway; scaffold4 indexed_genome mRNA 50467302 50485413 . - . ID=transcript_1183;Q9BVS4 D6RDI3 Q9NUT0,Serine/threonine-protein kinase RIO2,RIO kinase 2;, PF09202;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0030688;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0007049;GO:0030490;GO:2000208;GO:2000234;GO:0046777;GO:0030071;GO:0042274;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:preribosome, small subunit precursor;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:maturation of SSU-rRNA; P:positive regulation of ribosomal small subunit export from nucleus; P:positive regulation of rRNA processing; P:protein autophosphorylation; P:regulation of mitotic metaphase/anaphase transition; P:ribosomal small subunit biogenesis;|Q9BVS4 D6RDI3 Q9NUT0,Serine/threonine-protein kinase RIO2,RIO kinase 2;, PF09202;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0030688;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0007049;GO:0030490;GO:2000208;GO:2000234;GO:0046777;GO:0030071;GO:0042274;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:preribosome, small subunit precursor;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:maturation of SSU-rRNA; P:positive regulation of ribosomal small subunit export from nucleus; P:positive regulation of rRNA processing; P:protein autophosphorylation; P:regulation of mitotic metaphase/anaphase transition; P:ribosomal small subunit biogenesis; scaffold4 indexed_genome mRNA 51762247 51815562 . - . ID=transcript_1184;O14646 Q17RZ3,Chromodomain-helicase-DNA-binding protein 1,ATP-dependent helicase CHD1;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0035064;GO:0070615;GO:0016569;GO:0043923;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:covalent chromatin modification; P:positive regulation by host of viral transcription; P:regulation of transcription by RNA polymerase II;|O14646 Q17RZ3,Chromodomain-helicase-DNA-binding protein 1,ATP-dependent helicase CHD1;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0035064;GO:0070615;GO:0016569;GO:0043923;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:covalent chromatin modification; P:positive regulation by host of viral transcription; P:regulation of transcription by RNA polymerase II;|O14646 Q17RZ3,Chromodomain-helicase-DNA-binding protein 1,ATP-dependent helicase CHD1;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0035064;GO:0070615;GO:0016569;GO:0043923;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:covalent chromatin modification; P:positive regulation by host of viral transcription; P:regulation of transcription by RNA polymerase II;|O14646 Q17RZ3,Chromodomain-helicase-DNA-binding protein 1,ATP-dependent helicase CHD1;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0035064;GO:0070615;GO:0016569;GO:0043923;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:covalent chromatin modification; P:positive regulation by host of viral transcription; P:regulation of transcription by RNA polymerase II;|O14646 Q17RZ3,Chromodomain-helicase-DNA-binding protein 1,ATP-dependent helicase CHD1;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0035064;GO:0070615;GO:0016569;GO:0043923;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:covalent chromatin modification; P:positive regulation by host of viral transcription; P:regulation of transcription by RNA polymerase II;|O14646 Q17RZ3,Chromodomain-helicase-DNA-binding protein 1,ATP-dependent helicase CHD1;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0035064;GO:0070615;GO:0016569;GO:0043923;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:covalent chromatin modification; P:positive regulation by host of viral transcription; P:regulation of transcription by RNA polymerase II;|O14646 Q17RZ3,Chromodomain-helicase-DNA-binding protein 1,ATP-dependent helicase CHD1;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0035064;GO:0070615;GO:0016569;GO:0043923;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:covalent chromatin modification; P:positive regulation by host of viral transcription; P:regulation of transcription by RNA polymerase II; scaffold4 indexed_genome mRNA 53333702 53335629 . - . ID=transcript_1185;Q8TBP5 A8K0H4,Membrane protein FAM174A,Hepatitis C virus NS5A-transactivated protein 6;Transmembrane protein 157;, PF06679;, GO:0016021;, C:integral component of membrane; scaffold4 indexed_genome mRNA 53543097 53638892 . - . ID=transcript_1186;Q92187 A8KA07 G3V104 Q8N1F4 Q92693,CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase,Alpha-2,8-sialyltransferase 8D;Polysialyltransferase-1;Sialyltransferase 8D;Sialyltransferase St8Sia IV;, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0033691;GO:0006464;GO:0001574;GO:0006491;GO:0007399;GO:0009311;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:sialic acid binding;, P:cellular protein modification process; P:ganglioside biosynthetic process; P:N-glycan processing; P:nervous system development; P:oligosaccharide metabolic process; P:protein glycosylation; scaffold4 indexed_genome mRNA 54682354 54700628 . - . ID=transcript_1187;Q6ZQN7 Q86UG5,Solute carrier organic anion transporter family member 4C1,OATP-H;Organic anion transporter M1;Solute carrier family 21 member 20;, PF07648;PF03137;, GO:0035577;GO:0016323;GO:0070062;GO:0005887;GO:0005886;GO:0035579;GO:0015347;GO:0030154;GO:0007275;GO:0043312;GO:0043252;GO:0007283;, C:azurophil granule membrane; C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:specific granule membrane;, F:sodium-independent organic anion transmembrane transporter activity;, P:cell differentiation; P:multicellular organism development; P:neutrophil degranulation; P:sodium-independent organic anion transport; P:spermatogenesis; scaffold4 indexed_genome mRNA 55270640 55442244 . + . ID=transcript_1188;Q8WVC7 Q9UCG0,Peptidyl-glycine alpha-amidating monooxygenase {ECO:0000303|PubMed:12699694},, PF03712;PF01082;PF01436;, GO:0009986;GO:0070062;GO:0005576;GO:0016021;GO:0016020;GO:0043005;GO:0043204;GO:0048471;GO:0005886;GO:0030667;GO:0005802;GO:0030658;GO:0005509;GO:0005507;GO:0042802;GO:0031418;GO:0004598;GO:0004504;GO:0019901;GO:0008270;GO:0007417;GO:0062112;GO:0007507;GO:0007595;GO:0060173;GO:0001676;GO:0060135;GO:0042476;GO:0022602;GO:0001519;GO:0018032;GO:0032956;GO:0050708;GO:0006357;GO:0046688;GO:0042493;GO:0032355;GO:0051384;GO:0001666;GO:0009268;GO:0010043;GO:0009404;, C:cell surface; C:extracellular exosome; C:extracellular region; C:integral component of membrane; C:membrane; C:neuron projection; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:calcium ion binding; F:copper ion binding; F:identical protein binding; F:L-ascorbic acid binding; F:peptidylamidoglycolate lyase activity; F:peptidylglycine monooxygenase activity; F:protein kinase binding; F:zinc ion binding;, P:central nervous system development; P:fatty acid primary amide biosynthetic process; P:heart development; P:lactation; P:limb development; P:long-chain fatty acid metabolic process; P:maternal process involved in female pregnancy; P:odontogenesis; P:ovulation cycle process; P:peptide amidation; P:protein amidation; P:regulation of actin cytoskeleton organization; P:regulation of protein secretion; P:regulation of transcription by RNA polymerase II; P:response to copper ion; P:response to drug; P:response to estradiol; P:response to glucocorticoid; P:response to hypoxia; P:response to pH; P:response to zinc ion; P:toxin metabolic process; scaffold4 indexed_genome mRNA 55468059 55491192 . - . ID=transcript_1189;Q9NXP7 B2RXF7 B4DIV4 Q6AI03 Q96BR2,Gypsy retrotransposon integrase-like protein 1,Ty3/Gypsy integrase 1;Zinc finger H2C2 domain-containing protein;, PF17921;, GO:0003676;GO:0015074;, , F:nucleic acid binding;, P:DNA integration;|Q9NXP7 B2RXF7 B4DIV4 Q6AI03 Q96BR2,Gypsy retrotransposon integrase-like protein 1,Ty3/Gypsy integrase 1;Zinc finger H2C2 domain-containing protein;, PF17921;, GO:0003676;GO:0015074;, , F:nucleic acid binding;, P:DNA integration; scaffold4 indexed_genome mRNA 55500733 55578187 . + . ID=transcript_1190;O43314 A1NI53 A6NGS8 Q8TB50,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,Diphosphoinositol pentakisphosphate kinase 2;Histidine acid phosphatase domain-containing protein 1;InsP6 and PP-IP5 kinase 2;VIP1 homolog 2;, PF00328;PF18086;, GO:0005829;GO:0102092;GO:0005524;GO:0033857;GO:0000829;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0006020;GO:0032958;GO:0043647;GO:0007605;, C:cytosol;, F:5-diphosphoinositol pentakisphosphate 3-kinase activity; F:ATP binding; F:diphosphoinositol-pentakisphosphate kinase activity; F:inositol heptakisphosphate kinase activity; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity;, P:inositol metabolic process; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:sensory perception of sound;|O43314 A1NI53 A6NGS8 Q8TB50,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,Diphosphoinositol pentakisphosphate kinase 2;Histidine acid phosphatase domain-containing protein 1;InsP6 and PP-IP5 kinase 2;VIP1 homolog 2;, PF00328;PF18086;, GO:0005829;GO:0102092;GO:0005524;GO:0033857;GO:0000829;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0006020;GO:0032958;GO:0043647;GO:0007605;, C:cytosol;, F:5-diphosphoinositol pentakisphosphate 3-kinase activity; F:ATP binding; F:diphosphoinositol-pentakisphosphate kinase activity; F:inositol heptakisphosphate kinase activity; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity;, P:inositol metabolic process; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:sensory perception of sound;|O43314 A1NI53 A6NGS8 Q8TB50,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,Diphosphoinositol pentakisphosphate kinase 2;Histidine acid phosphatase domain-containing protein 1;InsP6 and PP-IP5 kinase 2;VIP1 homolog 2;, PF00328;PF18086;, GO:0005829;GO:0102092;GO:0005524;GO:0033857;GO:0000829;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0006020;GO:0032958;GO:0043647;GO:0007605;, C:cytosol;, F:5-diphosphoinositol pentakisphosphate 3-kinase activity; F:ATP binding; F:diphosphoinositol-pentakisphosphate kinase activity; F:inositol heptakisphosphate kinase activity; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity;, P:inositol metabolic process; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:sensory perception of sound;|O43314 A1NI53 A6NGS8 Q8TB50,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,Diphosphoinositol pentakisphosphate kinase 2;Histidine acid phosphatase domain-containing protein 1;InsP6 and PP-IP5 kinase 2;VIP1 homolog 2;, PF00328;PF18086;, GO:0005829;GO:0102092;GO:0005524;GO:0033857;GO:0000829;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0006020;GO:0032958;GO:0043647;GO:0007605;, C:cytosol;, F:5-diphosphoinositol pentakisphosphate 3-kinase activity; F:ATP binding; F:diphosphoinositol-pentakisphosphate kinase activity; F:inositol heptakisphosphate kinase activity; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity;, P:inositol metabolic process; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:sensory perception of sound;|O43314 A1NI53 A6NGS8 Q8TB50,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,Diphosphoinositol pentakisphosphate kinase 2;Histidine acid phosphatase domain-containing protein 1;InsP6 and PP-IP5 kinase 2;VIP1 homolog 2;, PF00328;PF18086;, GO:0005829;GO:0102092;GO:0005524;GO:0033857;GO:0000829;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0006020;GO:0032958;GO:0043647;GO:0007605;, C:cytosol;, F:5-diphosphoinositol pentakisphosphate 3-kinase activity; F:ATP binding; F:diphosphoinositol-pentakisphosphate kinase activity; F:inositol heptakisphosphate kinase activity; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity;, P:inositol metabolic process; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:sensory perception of sound;|O43314 A1NI53 A6NGS8 Q8TB50,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,Diphosphoinositol pentakisphosphate kinase 2;Histidine acid phosphatase domain-containing protein 1;InsP6 and PP-IP5 kinase 2;VIP1 homolog 2;, PF00328;PF18086;, GO:0005829;GO:0102092;GO:0005524;GO:0033857;GO:0000829;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0006020;GO:0032958;GO:0043647;GO:0007605;, C:cytosol;, F:5-diphosphoinositol pentakisphosphate 3-kinase activity; F:ATP binding; F:diphosphoinositol-pentakisphosphate kinase activity; F:inositol heptakisphosphate kinase activity; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity;, P:inositol metabolic process; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:sensory perception of sound;|O43314 A1NI53 A6NGS8 Q8TB50,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,Diphosphoinositol pentakisphosphate kinase 2;Histidine acid phosphatase domain-containing protein 1;InsP6 and PP-IP5 kinase 2;VIP1 homolog 2;, PF00328;PF18086;, GO:0005829;GO:0102092;GO:0005524;GO:0033857;GO:0000829;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0006020;GO:0032958;GO:0043647;GO:0007605;, C:cytosol;, F:5-diphosphoinositol pentakisphosphate 3-kinase activity; F:ATP binding; F:diphosphoinositol-pentakisphosphate kinase activity; F:inositol heptakisphosphate kinase activity; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity;, P:inositol metabolic process; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:sensory perception of sound; scaffold4 indexed_genome mRNA 55634523 55648291 . + . ID=transcript_1191;Q96GV9,Macrophage immunometabolism regulator,, PF15435;, GO:0035869;GO:0005737;GO:0060271;GO:0006954;GO:1900016;GO:0010764;GO:0050728;GO:0015031;, C:ciliary transition zone; C:cytoplasm;, , P:cilium assembly; P:inflammatory response; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fibroblast migration; P:negative regulation of inflammatory response; P:protein transport;|Q96GV9,Macrophage immunometabolism regulator,, PF15435;, GO:0035869;GO:0005737;GO:0060271;GO:0006954;GO:1900016;GO:0010764;GO:0050728;GO:0015031;, C:ciliary transition zone; C:cytoplasm;, , P:cilium assembly; P:inflammatory response; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fibroblast migration; P:negative regulation of inflammatory response; P:protein transport;|Q96GV9,Macrophage immunometabolism regulator,, PF15435;, GO:0035869;GO:0005737;GO:0060271;GO:0006954;GO:1900016;GO:0010764;GO:0050728;GO:0015031;, C:ciliary transition zone; C:cytoplasm;, , P:cilium assembly; P:inflammatory response; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fibroblast migration; P:negative regulation of inflammatory response; P:protein transport; scaffold4 indexed_genome mRNA 55813117 55904688 . - . ID=transcript_1192;Q9BVR4 Q9C0H7 Q9H924 Q9NVK8,Pleckstrin homology domain-containing family A member 5,Phosphoinositol 3-phosphate-binding protein 2;, PF00169;PF00397;, GO:0005829;GO:0098978;GO:0016020;GO:0005654;GO:0014069;GO:0080025;GO:0032266;GO:0070273;GO:0010314;GO:0061458;, C:cytosol; C:glutamatergic synapse; C:membrane; C:nucleoplasm; C:postsynaptic density;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:reproductive system development; scaffold4 indexed_genome mRNA 55944242 55956822 . - . ID=transcript_1193;Q9BQG2 B3KUW2 B4E1W3 Q8TAL7,NAD-capped RNA hydrolase NUDT12 {ECO:0000305},NADH pyrophosphatase NUDT12 {ECO:0000305};Nucleoside diphosphate-linked moiety X motif 12 {ECO:0000305};, PF12796;PF00293;PF09296;PF09297;, GO:0005737;GO:0005829;GO:0005634;GO:0005782;GO:0005777;GO:0000287;GO:0000210;GO:0035529;GO:0110153;GO:0008270;GO:0006402;GO:0034356;GO:0019677;GO:0110155;GO:0006734;GO:0006742;, C:cytoplasm; C:cytosol; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:magnesium ion binding; F:NAD+ diphosphatase activity; F:NADH pyrophosphatase activity; F:RNA NAD-cap (NMN-forming) hydrolase activity; F:zinc ion binding;, P:mRNA catabolic process; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:NAD catabolic process; P:NAD-cap decapping; P:NADH metabolic process; P:NADP catabolic process;|Q9BQG2 B3KUW2 B4E1W3 Q8TAL7,NAD-capped RNA hydrolase NUDT12 {ECO:0000305},NADH pyrophosphatase NUDT12 {ECO:0000305};Nucleoside diphosphate-linked moiety X motif 12 {ECO:0000305};, PF12796;PF00293;PF09296;PF09297;, GO:0005737;GO:0005829;GO:0005634;GO:0005782;GO:0005777;GO:0000287;GO:0000210;GO:0035529;GO:0110153;GO:0008270;GO:0006402;GO:0034356;GO:0019677;GO:0110155;GO:0006734;GO:0006742;, C:cytoplasm; C:cytosol; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:magnesium ion binding; F:NAD+ diphosphatase activity; F:NADH pyrophosphatase activity; F:RNA NAD-cap (NMN-forming) hydrolase activity; F:zinc ion binding;, P:mRNA catabolic process; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:NAD catabolic process; P:NAD-cap decapping; P:NADH metabolic process; P:NADP catabolic process;|Q9BQG2 B3KUW2 B4E1W3 Q8TAL7,NAD-capped RNA hydrolase NUDT12 {ECO:0000305},NADH pyrophosphatase NUDT12 {ECO:0000305};Nucleoside diphosphate-linked moiety X motif 12 {ECO:0000305};, PF12796;PF00293;PF09296;PF09297;, GO:0005737;GO:0005829;GO:0005634;GO:0005782;GO:0005777;GO:0000287;GO:0000210;GO:0035529;GO:0110153;GO:0008270;GO:0006402;GO:0034356;GO:0019677;GO:0110155;GO:0006734;GO:0006742;, C:cytoplasm; C:cytosol; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:magnesium ion binding; F:NAD+ diphosphatase activity; F:NADH pyrophosphatase activity; F:RNA NAD-cap (NMN-forming) hydrolase activity; F:zinc ion binding;, P:mRNA catabolic process; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:NAD catabolic process; P:NAD-cap decapping; P:NADH metabolic process; P:NADP catabolic process;|Q9BQG2 B3KUW2 B4E1W3 Q8TAL7,NAD-capped RNA hydrolase NUDT12 {ECO:0000305},NADH pyrophosphatase NUDT12 {ECO:0000305};Nucleoside diphosphate-linked moiety X motif 12 {ECO:0000305};, PF12796;PF00293;PF09296;PF09297;, GO:0005737;GO:0005829;GO:0005634;GO:0005782;GO:0005777;GO:0000287;GO:0000210;GO:0035529;GO:0110153;GO:0008270;GO:0006402;GO:0034356;GO:0019677;GO:0110155;GO:0006734;GO:0006742;, C:cytoplasm; C:cytosol; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:magnesium ion binding; F:NAD+ diphosphatase activity; F:NADH pyrophosphatase activity; F:RNA NAD-cap (NMN-forming) hydrolase activity; F:zinc ion binding;, P:mRNA catabolic process; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:NAD catabolic process; P:NAD-cap decapping; P:NADH metabolic process; P:NADP catabolic process; scaffold4 indexed_genome mRNA 60434914 60436343 . + . ID=transcript_1194;Q9UF56 A1A4E3,F-box/LRR-repeat protein 17 {ECO:0000303|PubMed:24035498},F-box and leucine-rich repeat protein 17 {ECO:0000305};F-box only protein 13 {ECO:0000250|UniProtKB:Q9QZN1};, PF12937;PF13516;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0043153;GO:0000086;GO:0007399;GO:0014033;GO:0043161;GO:0000209;GO:0006515;GO:0016567;GO:0051726;GO:0008589;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, , P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:nervous system development; P:neural crest cell differentiation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein ubiquitination; P:regulation of cell cycle; P:regulation of smoothened signaling pathway; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold4 indexed_genome mRNA 60437705 60482612 . - . ID=transcript_1195;Q9UF56 A1A4E3,F-box/LRR-repeat protein 17 {ECO:0000303|PubMed:24035498},F-box and leucine-rich repeat protein 17 {ECO:0000305};F-box only protein 13 {ECO:0000250|UniProtKB:Q9QZN1};, PF12937;PF13516;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0043153;GO:0000086;GO:0007399;GO:0014033;GO:0043161;GO:0000209;GO:0006515;GO:0016567;GO:0051726;GO:0008589;GO:0031146;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, , P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:nervous system development; P:neural crest cell differentiation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein ubiquitination; P:regulation of cell cycle; P:regulation of smoothened signaling pathway; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|P00395 Q34770,Cytochrome c oxidase subunit 1,Cytochrome c oxidase polypeptide I;, PF00115;, GO:0016021;GO:0005743;GO:0005750;GO:0005751;GO:0045277;GO:0004129;GO:0020037;GO:0046872;GO:0009060;GO:0007568;GO:0021549;GO:0015990;GO:0006123;GO:0022904;GO:0046688;GO:0051602;GO:0006979;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:heme binding; F:metal ion binding;, P:aerobic respiration; P:aging; P:cerebellum development; P:electron transport coupled proton transport; P:mitochondrial electron transport, cytochrome c to oxygen; P:respiratory electron transport chain; P:response to copper ion; P:response to electrical stimulus; P:response to oxidative stress; scaffold4 indexed_genome mRNA 60898381 61267897 . + . ID=transcript_1196;P16591 B2RCR4 B4DSQ2 H2FLB8,Tyrosine-protein kinase Fer,Feline encephalitis virus-related kinase FER;Fujinami poultry sarcoma/Feline sarcoma-related protein Fer;Proto-oncogene c-Fer;Tyrosine kinase 3;p94-Fer;, PF00611;PF07714;PF00017;, GO:0005938;GO:0030054;GO:0042995;GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0005634;GO:0005524;GO:0005154;GO:0008289;GO:0004715;GO:0008157;GO:0004713;GO:0005102;GO:0004714;GO:0031532;GO:0007155;GO:0030154;GO:0008283;GO:0044331;GO:0032869;GO:0036006;GO:0034614;GO:0006935;GO:0019221;GO:0050904;GO:0035426;GO:0038095;GO:0045087;GO:0038028;GO:0070102;GO:0035556;GO:0038109;GO:0000226;GO:0033007;GO:0018108;GO:0048008;GO:0030838;GO:0030335;GO:0008284;GO:0051092;GO:0046777;GO:0006468;GO:0042058;GO:0010762;GO:0010591;GO:0043304;GO:0001932;GO:0032496;GO:0036119;GO:0034446;GO:0007169;GO:0007260;, C:cell cortex; C:cell junction; C:cell projection; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleus;, F:ATP binding; F:epidermal growth factor receptor binding; F:lipid binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase 1 binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton reorganization; P:cell adhesion; P:cell differentiation; P:cell population proliferation; P:cell-cell adhesion mediated by cadherin; P:cellular response to insulin stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cellular response to reactive oxygen species; P:chemotaxis; P:cytokine-mediated signaling pathway; P:diapedesis; P:extracellular matrix-cell signaling; P:Fc-epsilon receptor signaling pathway; P:innate immune response; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:interleukin-6-mediated signaling pathway; P:intracellular signal transduction; P:Kit signaling pathway; P:microtubule cytoskeleton organization; P:negative regulation of mast cell activation involved in immune response; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of fibroblast migration; P:regulation of lamellipodium assembly; P:regulation of mast cell degranulation; P:regulation of protein phosphorylation; P:response to lipopolysaccharide; P:response to platelet-derived growth factor; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:tyrosine phosphorylation of STAT protein; scaffold4 indexed_genome mRNA 61387444 61437580 . - . ID=transcript_1197;O43164 A8K6U4 D3DSZ5 Q68D49 Q8N1G5,E3 ubiquitin-protein ligase Praja-2,RING finger protein 131;RING-type E3 ubiquitin transferase Praja-2 {ECO:0000305};, PF13639;, GO:0005737;GO:0005789;GO:0000139;GO:0045111;GO:0005886;GO:0014069;GO:0046872;GO:0034236;GO:0034237;GO:0004842;GO:0035329;GO:0006954;GO:0045087;GO:0007616;GO:0046330;GO:1900745;GO:0034137;GO:0016567;GO:0043030;GO:0010738;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intermediate filament cytoskeleton; C:plasma membrane; C:postsynaptic density;, F:metal ion binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:ubiquitin-protein transferase activity;, P:hippo signaling; P:inflammatory response; P:innate immune response; P:long-term memory; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:positive regulation of toll-like receptor 2 signaling pathway; P:protein ubiquitination; P:regulation of macrophage activation; P:regulation of protein kinase A signaling;|O43164 A8K6U4 D3DSZ5 Q68D49 Q8N1G5,E3 ubiquitin-protein ligase Praja-2,RING finger protein 131;RING-type E3 ubiquitin transferase Praja-2 {ECO:0000305};, PF13639;, GO:0005737;GO:0005789;GO:0000139;GO:0045111;GO:0005886;GO:0014069;GO:0046872;GO:0034236;GO:0034237;GO:0004842;GO:0035329;GO:0006954;GO:0045087;GO:0007616;GO:0046330;GO:1900745;GO:0034137;GO:0016567;GO:0043030;GO:0010738;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intermediate filament cytoskeleton; C:plasma membrane; C:postsynaptic density;, F:metal ion binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:ubiquitin-protein transferase activity;, P:hippo signaling; P:inflammatory response; P:innate immune response; P:long-term memory; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:positive regulation of toll-like receptor 2 signaling pathway; P:protein ubiquitination; P:regulation of macrophage activation; P:regulation of protein kinase A signaling; scaffold4 indexed_genome mRNA 61926178 61926731 . + . ID=transcript_1198;Q16706 Q16767,Alpha-mannosidase 2,Golgi alpha-mannosidase II;Mannosidase alpha class 2A member 1;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0005801;GO:0070062;GO:0005797;GO:0000139;GO:0016021;GO:0016020;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0042803;GO:0001701;GO:0001889;GO:0048286;GO:0006013;GO:0007005;GO:0006491;GO:0050769;GO:0006517;GO:0006486;GO:0007585;GO:0060042;GO:0007033;GO:0019082;, C:cis-Golgi network; C:extracellular exosome; C:Golgi medial cisterna; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding; F:protein homodimerization activity;, P:in utero embryonic development; P:liver development; P:lung alveolus development; P:mannose metabolic process; P:mitochondrion organization; P:N-glycan processing; P:positive regulation of neurogenesis; P:protein deglycosylation; P:protein glycosylation; P:respiratory gaseous exchange by respiratory system; P:retina morphogenesis in camera-type eye; P:vacuole organization; P:viral protein processing; scaffold4 indexed_genome mRNA 61941570 61944143 . - . ID=transcript_1199;Q16706 Q16767,Alpha-mannosidase 2,Golgi alpha-mannosidase II;Mannosidase alpha class 2A member 1;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0005801;GO:0070062;GO:0005797;GO:0000139;GO:0016021;GO:0016020;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0042803;GO:0001701;GO:0001889;GO:0048286;GO:0006013;GO:0007005;GO:0006491;GO:0050769;GO:0006517;GO:0006486;GO:0007585;GO:0060042;GO:0007033;GO:0019082;, C:cis-Golgi network; C:extracellular exosome; C:Golgi medial cisterna; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding; F:protein homodimerization activity;, P:in utero embryonic development; P:liver development; P:lung alveolus development; P:mannose metabolic process; P:mitochondrion organization; P:N-glycan processing; P:positive regulation of neurogenesis; P:protein deglycosylation; P:protein glycosylation; P:respiratory gaseous exchange by respiratory system; P:retina morphogenesis in camera-type eye; P:vacuole organization; P:viral protein processing; scaffold4 indexed_genome mRNA 61944237 61945576 . + . ID=transcript_1200;Q16706 Q16767,Alpha-mannosidase 2,Golgi alpha-mannosidase II;Mannosidase alpha class 2A member 1;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0005801;GO:0070062;GO:0005797;GO:0000139;GO:0016021;GO:0016020;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0042803;GO:0001701;GO:0001889;GO:0048286;GO:0006013;GO:0007005;GO:0006491;GO:0050769;GO:0006517;GO:0006486;GO:0007585;GO:0060042;GO:0007033;GO:0019082;, C:cis-Golgi network; C:extracellular exosome; C:Golgi medial cisterna; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding; F:protein homodimerization activity;, P:in utero embryonic development; P:liver development; P:lung alveolus development; P:mannose metabolic process; P:mitochondrion organization; P:N-glycan processing; P:positive regulation of neurogenesis; P:protein deglycosylation; P:protein glycosylation; P:respiratory gaseous exchange by respiratory system; P:retina morphogenesis in camera-type eye; P:vacuole organization; P:viral protein processing; scaffold4 indexed_genome mRNA 61946448 61949074 . - . ID=transcript_1201;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold4 indexed_genome mRNA 62674244 62697302 . + . ID=transcript_1202;Q96AG3 A8K2F2 B3KRE6 B4DTA3 D3DSZ6 D6R9W7 Q04197,Solute carrier family 25 member 46,, PF00153;, GO:0016021;GO:0005741;GO:0005739;GO:0090149;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, , P:mitochondrial membrane fission;|Q96AG3 A8K2F2 B3KRE6 B4DTA3 D3DSZ6 D6R9W7 Q04197,Solute carrier family 25 member 46,, PF00153;, GO:0016021;GO:0005741;GO:0005739;GO:0090149;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, , P:mitochondrial membrane fission;|Q96AG3 A8K2F2 B3KRE6 B4DTA3 D3DSZ6 D6R9W7 Q04197,Solute carrier family 25 member 46,, PF00153;, GO:0016021;GO:0005741;GO:0005739;GO:0090149;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, , P:mitochondrial membrane fission; scaffold4 indexed_genome mRNA 63073987 63508067 . - . ID=transcript_1203;Q96DR4 Q86TN9,StAR-related lipid transfer protein 4,START domain-containing protein 4;, PF01852;, GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0015485;GO:0120020;GO:0070508;GO:0010879;GO:0032367;GO:0070859;GO:0010873;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum;, F:cholesterol binding; F:cholesterol transfer activity;, P:cholesterol import; P:cholesterol transport involved in cholesterol storage; P:intracellular cholesterol transport; P:positive regulation of bile acid biosynthetic process; P:positive regulation of cholesterol esterification;|Q8NI36 A2RUS4 Q68E02 Q8N1Q2,WD repeat-containing protein 36,T-cell activation WD repeat-containing protein;, PF12894;PF04192;PF00400;, GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0003723;GO:0050896;GO:0006364;GO:0007601;, C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:response to stimulus; P:rRNA processing; P:visual perception;|Q8NI36 A2RUS4 Q68E02 Q8N1Q2,WD repeat-containing protein 36,T-cell activation WD repeat-containing protein;, PF12894;PF04192;PF00400;, GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0003723;GO:0050896;GO:0006364;GO:0007601;, C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:response to stimulus; P:rRNA processing; P:visual perception;|Q8NI36 A2RUS4 Q68E02 Q8N1Q2,WD repeat-containing protein 36,T-cell activation WD repeat-containing protein;, PF12894;PF04192;PF00400;, GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0003723;GO:0050896;GO:0006364;GO:0007601;, C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:response to stimulus; P:rRNA processing; P:visual perception;|Q16566 D3DSZ7,Calcium/calmodulin-dependent protein kinase type IV,CaM kinase-GR;, PF00069;, GO:0005737;GO:0070062;GO:0001650;GO:0098978;GO:0005654;GO:0005634;GO:0098794;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0002250;GO:0007268;GO:0006954;GO:0035556;GO:0007616;GO:0043011;GO:0018105;GO:0045893;GO:0046777;GO:0006468;GO:0045670;GO:0033081;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:fibrillar center; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynapse;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:adaptive immune response; P:chemical synaptic transmission; P:inflammatory response; P:intracellular signal transduction; P:long-term memory; P:myeloid dendritic cell differentiation; P:peptidyl-serine phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of osteoclast differentiation; P:regulation of T cell differentiation in thymus; P:signal transduction;|Q16566 D3DSZ7,Calcium/calmodulin-dependent protein kinase type IV,CaM kinase-GR;, PF00069;, GO:0005737;GO:0070062;GO:0001650;GO:0098978;GO:0005654;GO:0005634;GO:0098794;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0002250;GO:0007268;GO:0006954;GO:0035556;GO:0007616;GO:0043011;GO:0018105;GO:0045893;GO:0046777;GO:0006468;GO:0045670;GO:0033081;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:fibrillar center; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynapse;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:adaptive immune response; P:chemical synaptic transmission; P:inflammatory response; P:intracellular signal transduction; P:long-term memory; P:myeloid dendritic cell differentiation; P:peptidyl-serine phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of osteoclast differentiation; P:regulation of T cell differentiation in thymus; P:signal transduction;|Q16566 D3DSZ7,Calcium/calmodulin-dependent protein kinase type IV,CaM kinase-GR;, PF00069;, GO:0005737;GO:0070062;GO:0001650;GO:0098978;GO:0005654;GO:0005634;GO:0098794;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0002250;GO:0007268;GO:0006954;GO:0035556;GO:0007616;GO:0043011;GO:0018105;GO:0045893;GO:0046777;GO:0006468;GO:0045670;GO:0033081;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:fibrillar center; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynapse;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:adaptive immune response; P:chemical synaptic transmission; P:inflammatory response; P:intracellular signal transduction; P:long-term memory; P:myeloid dendritic cell differentiation; P:peptidyl-serine phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of osteoclast differentiation; P:regulation of T cell differentiation in thymus; P:signal transduction; scaffold5 indexed_genome mRNA 149178 172326 . + . ID=transcript_1204;Q8N118 G3V1U1 Q5VVE5 Q6ZN67 Q8NAZ3,Cytochrome P450 4X1 {ECO:0000303|PubMed:18549450},CYPIVX1;, PF00067;, GO:0005789;GO:0016021;GO:0062189;GO:0020037;GO:0005506;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:anandamide 14,15 epoxidase activity; F:heme binding; F:iron ion binding; scaffold5 indexed_genome mRNA 225647 228948 . - . ID=transcript_1205;P17542 D3DQ24,T-cell acute lymphocytic leukemia protein 1,Class A basic helix-loop-helix protein 17;Stem cell protein;T-cell leukemia/lymphoma protein 5;, PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0003700;GO:0000981;GO:0070888;GO:0019899;GO:0042826;GO:0046983;GO:0000978;GO:0001085;GO:0000976;GO:0001525;GO:0060018;GO:0030221;GO:0045165;GO:0060216;GO:0035162;GO:0030218;GO:0043249;GO:0060217;GO:0060218;GO:0030097;GO:0007626;GO:0035855;GO:0030219;GO:0000122;GO:0030220;GO:0051781;GO:0045799;GO:0045648;GO:0045931;GO:0031334;GO:0045944;GO:0045893;GO:0042127;GO:1902036;GO:0060375;GO:2000036;GO:0006357;GO:0021527;GO:0006366;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:enzyme binding; F:histone deacetylase binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:astrocyte fate commitment; P:basophil differentiation; P:cell fate commitment; P:definitive hemopoiesis; P:embryonic hemopoiesis; P:erythrocyte differentiation; P:erythrocyte maturation; P:hemangioblast cell differentiation; P:hematopoietic stem cell differentiation; P:hemopoiesis; P:locomotory behavior; P:megakaryocyte development; P:megakaryocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:platelet formation; P:positive regulation of cell division; P:positive regulation of chromatin assembly or disassembly; P:positive regulation of erythrocyte differentiation; P:positive regulation of mitotic cell cycle; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell population proliferation; P:regulation of hematopoietic stem cell differentiation; P:regulation of mast cell differentiation; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:spinal cord association neuron differentiation; P:transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 228969 229752 . + . ID=transcript_1206;P17542 D3DQ24,T-cell acute lymphocytic leukemia protein 1,Class A basic helix-loop-helix protein 17;Stem cell protein;T-cell leukemia/lymphoma protein 5;, PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0003700;GO:0000981;GO:0070888;GO:0019899;GO:0042826;GO:0046983;GO:0000978;GO:0001085;GO:0000976;GO:0001525;GO:0060018;GO:0030221;GO:0045165;GO:0060216;GO:0035162;GO:0030218;GO:0043249;GO:0060217;GO:0060218;GO:0030097;GO:0007626;GO:0035855;GO:0030219;GO:0000122;GO:0030220;GO:0051781;GO:0045799;GO:0045648;GO:0045931;GO:0031334;GO:0045944;GO:0045893;GO:0042127;GO:1902036;GO:0060375;GO:2000036;GO:0006357;GO:0021527;GO:0006366;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:enzyme binding; F:histone deacetylase binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:astrocyte fate commitment; P:basophil differentiation; P:cell fate commitment; P:definitive hemopoiesis; P:embryonic hemopoiesis; P:erythrocyte differentiation; P:erythrocyte maturation; P:hemangioblast cell differentiation; P:hematopoietic stem cell differentiation; P:hemopoiesis; P:locomotory behavior; P:megakaryocyte development; P:megakaryocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:platelet formation; P:positive regulation of cell division; P:positive regulation of chromatin assembly or disassembly; P:positive regulation of erythrocyte differentiation; P:positive regulation of mitotic cell cycle; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell population proliferation; P:regulation of hematopoietic stem cell differentiation; P:regulation of mast cell differentiation; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:spinal cord association neuron differentiation; P:transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 261669 262570 . - . ID=transcript_1207;Q15468 Q5T0C5 Q68CN9,SCL-interrupting locus protein,TAL-1-interrupting locus protein;, PF15253;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0042802;GO:0051298;GO:0007368;GO:0000578;GO:0033504;GO:0030900;GO:0001947;GO:0001701;GO:0007052;GO:0035264;GO:0043066;GO:0001843;GO:0021915;GO:0030903;GO:0071539;GO:0046599;GO:0007224;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol;, F:identical protein binding;, P:centrosome duplication; P:determination of left/right symmetry; P:embryonic axis specification; P:floor plate development; P:forebrain development; P:heart looping; P:in utero embryonic development; P:mitotic spindle organization; P:multicellular organism growth; P:negative regulation of apoptotic process; P:neural tube closure; P:neural tube development; P:notochord development; P:protein localization to centrosome; P:regulation of centriole replication; P:smoothened signaling pathway; scaffold5 indexed_genome mRNA 262605 283278 . - . ID=transcript_1208;Q15468 Q5T0C5 Q68CN9,SCL-interrupting locus protein,TAL-1-interrupting locus protein;, PF15253;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0042802;GO:0051298;GO:0007368;GO:0000578;GO:0033504;GO:0030900;GO:0001947;GO:0001701;GO:0007052;GO:0035264;GO:0043066;GO:0001843;GO:0021915;GO:0030903;GO:0071539;GO:0046599;GO:0007224;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol;, F:identical protein binding;, P:centrosome duplication; P:determination of left/right symmetry; P:embryonic axis specification; P:floor plate development; P:forebrain development; P:heart looping; P:in utero embryonic development; P:mitotic spindle organization; P:multicellular organism growth; P:negative regulation of apoptotic process; P:neural tube closure; P:neural tube development; P:notochord development; P:protein localization to centrosome; P:regulation of centriole replication; P:smoothened signaling pathway; scaffold5 indexed_genome mRNA 297894 302029 . - . ID=transcript_1209;Q15468 Q5T0C5 Q68CN9,SCL-interrupting locus protein,TAL-1-interrupting locus protein;, PF15253;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0042802;GO:0051298;GO:0007368;GO:0000578;GO:0033504;GO:0030900;GO:0001947;GO:0001701;GO:0007052;GO:0035264;GO:0043066;GO:0001843;GO:0021915;GO:0030903;GO:0071539;GO:0046599;GO:0007224;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol;, F:identical protein binding;, P:centrosome duplication; P:determination of left/right symmetry; P:embryonic axis specification; P:floor plate development; P:forebrain development; P:heart looping; P:in utero embryonic development; P:mitotic spindle organization; P:multicellular organism growth; P:negative regulation of apoptotic process; P:neural tube closure; P:neural tube development; P:notochord development; P:protein localization to centrosome; P:regulation of centriole replication; P:smoothened signaling pathway; scaffold5 indexed_genome mRNA 331430 365553 . + . ID=transcript_1210;P30085 B2R6S5 B4DPU7 E9PGI8 Q53GB7 Q5SVZ0 Q96C07 Q9UBQ8 Q9UIA2,UMP-CMP kinase {ECO:0000255|HAMAP-Rule:MF_03172},Deoxycytidylate kinase {ECO:0000255|HAMAP-Rule:MF_03172};Nucleoside-diphosphate kinase {ECO:0000255|HAMAP-Rule:MF_03172};Uridine monophosphate/cytidine monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03172};, , GO:0005737;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0036430;GO:0004127;GO:0036431;GO:0004550;GO:0033862;GO:0004849;GO:0006207;GO:0046705;GO:0015949;GO:0006165;GO:0009142;GO:0009220;GO:0006225;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:CMP kinase activity; F:cytidylate kinase activity; F:dCMP kinase activity; F:nucleoside diphosphate kinase activity; F:UMP kinase activity; F:uridine kinase activity;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:CDP biosynthetic process; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:pyrimidine ribonucleotide biosynthetic process; P:UDP biosynthetic process;|P30085 B2R6S5 B4DPU7 E9PGI8 Q53GB7 Q5SVZ0 Q96C07 Q9UBQ8 Q9UIA2,UMP-CMP kinase {ECO:0000255|HAMAP-Rule:MF_03172},Deoxycytidylate kinase {ECO:0000255|HAMAP-Rule:MF_03172};Nucleoside-diphosphate kinase {ECO:0000255|HAMAP-Rule:MF_03172};Uridine monophosphate/cytidine monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03172};, , GO:0005737;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0036430;GO:0004127;GO:0036431;GO:0004550;GO:0033862;GO:0004849;GO:0006207;GO:0046705;GO:0015949;GO:0006165;GO:0009142;GO:0009220;GO:0006225;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:CMP kinase activity; F:cytidylate kinase activity; F:dCMP kinase activity; F:nucleoside diphosphate kinase activity; F:UMP kinase activity; F:uridine kinase activity;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:CDP biosynthetic process; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:pyrimidine ribonucleotide biosynthetic process; P:UDP biosynthetic process; scaffold5 indexed_genome mRNA 756441 792212 . - . ID=transcript_1211;A6NFA1 I6U4Y0,Metalloprotease TIKI2,Heart, kidney and adipose-enriched transmembrane protein homolog;TRAB domain-containing protein 2B;, PF01963;, GO:0031301;GO:0005887;GO:0016020;GO:0046872;GO:0004222;GO:0017147;GO:0030178;GO:1904808;GO:0031334;GO:0006508;GO:0016055;, C:integral component of organelle membrane; C:integral component of plasma membrane; C:membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:Wnt-protein binding;, P:negative regulation of Wnt signaling pathway; P:positive regulation of protein oxidation; P:positive regulation of protein-containing complex assembly; P:proteolysis; P:Wnt signaling pathway; scaffold5 indexed_genome mRNA 1296686 1449134 . - . ID=transcript_1212;Q9NWH7 Q5T3N7 Q8WUE6,Spermatogenesis-associated protein 6,, PF14909;, GO:0005576;GO:0097224;GO:0032027;GO:0030154;GO:0044458;GO:0007275;GO:0007283;, C:extracellular region; C:sperm connecting piece;, F:myosin light chain binding;, P:cell differentiation; P:motile cilium assembly; P:multicellular organism development; P:spermatogenesis; scaffold5 indexed_genome mRNA 1701245 1703267 . - . ID=transcript_1213;Q7L4P6 D3DQ27 Q96A62 Q9HAI3,BEN domain-containing protein 5,, PF10523;, GO:0005794;GO:0003677;GO:0045892;, C:Golgi apparatus;, F:DNA binding;, P:negative regulation of transcription, DNA-templated;|Q7L4P6 D3DQ27 Q96A62 Q9HAI3,BEN domain-containing protein 5,, PF10523;, GO:0005794;GO:0003677;GO:0045892;, C:Golgi apparatus;, F:DNA binding;, P:negative regulation of transcription, DNA-templated; scaffold5 indexed_genome mRNA 2994522 3080089 . + . ID=transcript_1214;P26378 B1APY6 B1APY7 B1APY8 B7Z4G7 Q8IYD4 Q96J74 Q96J75 Q9UD24,ELAV-like protein 4,Hu-antigen D;Paraneoplastic encephalomyelitis antigen HuD;, PF00076;, GO:0030424;GO:0005737;GO:0030425;GO:0030426;GO:0043204;GO:1990904;GO:0035925;GO:0003730;GO:0008143;GO:0097158;GO:0070935;GO:0006397;GO:1905870;GO:0006396;GO:0008380;, C:axon; C:cytoplasm; C:dendrite; C:growth cone; C:perikaryon; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:poly(A) binding; F:pre-mRNA intronic pyrimidine-rich binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA processing; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:RNA processing; P:RNA splicing;|P26378 B1APY6 B1APY7 B1APY8 B7Z4G7 Q8IYD4 Q96J74 Q96J75 Q9UD24,ELAV-like protein 4,Hu-antigen D;Paraneoplastic encephalomyelitis antigen HuD;, PF00076;, GO:0030424;GO:0005737;GO:0030425;GO:0030426;GO:0043204;GO:1990904;GO:0035925;GO:0003730;GO:0008143;GO:0097158;GO:0070935;GO:0006397;GO:1905870;GO:0006396;GO:0008380;, C:axon; C:cytoplasm; C:dendrite; C:growth cone; C:perikaryon; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:poly(A) binding; F:pre-mRNA intronic pyrimidine-rich binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA processing; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:RNA processing; P:RNA splicing; scaffold5 indexed_genome mRNA 3286469 3647325 . - . ID=transcript_1215;Q9UNN5 Q549F0 Q9UF34 Q9UNT3 Q9Y2Z3,FAS-associated factor 1,UBX domain-containing protein 12;UBX domain-containing protein 3A;, PF00789;, GO:0031265;GO:0005829;GO:0005635;GO:0005654;GO:0005634;GO:0048471;GO:0034098;GO:0031072;GO:0051059;GO:0019904;GO:0019901;GO:0019887;GO:0043130;GO:0031625;GO:0006915;GO:0008219;GO:0007253;GO:0043065;GO:0010942;GO:1903364;GO:0045740;GO:1902043;GO:0031334;GO:0043161;GO:0030155;GO:0042176;, C:CD95 death-inducing signaling complex; C:cytosol; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:heat shock protein binding; F:NF-kappaB binding; F:protein domain specific binding; F:protein kinase binding; F:protein kinase regulator activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell death; P:cytoplasmic sequestering of NF-kappaB; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of cellular protein catabolic process; P:positive regulation of DNA replication; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of protein-containing complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell adhesion; P:regulation of protein catabolic process;|Q9UNN5 Q549F0 Q9UF34 Q9UNT3 Q9Y2Z3,FAS-associated factor 1,UBX domain-containing protein 12;UBX domain-containing protein 3A;, PF00789;, GO:0031265;GO:0005829;GO:0005635;GO:0005654;GO:0005634;GO:0048471;GO:0034098;GO:0031072;GO:0051059;GO:0019904;GO:0019901;GO:0019887;GO:0043130;GO:0031625;GO:0006915;GO:0008219;GO:0007253;GO:0043065;GO:0010942;GO:1903364;GO:0045740;GO:1902043;GO:0031334;GO:0043161;GO:0030155;GO:0042176;, C:CD95 death-inducing signaling complex; C:cytosol; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:heat shock protein binding; F:NF-kappaB binding; F:protein domain specific binding; F:protein kinase binding; F:protein kinase regulator activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell death; P:cytoplasmic sequestering of NF-kappaB; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of cellular protein catabolic process; P:positive regulation of DNA replication; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of protein-containing complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell adhesion; P:regulation of protein catabolic process; scaffold5 indexed_genome mRNA 3732167 3790795 . - . ID=transcript_1216;Q9UNN5 Q549F0 Q9UF34 Q9UNT3 Q9Y2Z3,FAS-associated factor 1,UBX domain-containing protein 12;UBX domain-containing protein 3A;, PF00789;, GO:0031265;GO:0005829;GO:0005635;GO:0005654;GO:0005634;GO:0048471;GO:0034098;GO:0031072;GO:0051059;GO:0019904;GO:0019901;GO:0019887;GO:0043130;GO:0031625;GO:0006915;GO:0008219;GO:0007253;GO:0043065;GO:0010942;GO:1903364;GO:0045740;GO:1902043;GO:0031334;GO:0043161;GO:0030155;GO:0042176;, C:CD95 death-inducing signaling complex; C:cytosol; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:heat shock protein binding; F:NF-kappaB binding; F:protein domain specific binding; F:protein kinase binding; F:protein kinase regulator activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell death; P:cytoplasmic sequestering of NF-kappaB; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of cellular protein catabolic process; P:positive regulation of DNA replication; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of protein-containing complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell adhesion; P:regulation of protein catabolic process; scaffold5 indexed_genome mRNA 3790926 3796887 . + . ID=transcript_1217;P42773 Q8TB83,Cyclin-dependent kinase 4 inhibitor C,Cyclin-dependent kinase 6 inhibitor;p18-INK4c;p18-INK6;, , GO:0005737;GO:0005829;GO:0005634;GO:0004861;GO:0019901;GO:0007050;GO:0000082;GO:0030308;GO:0008285;GO:2000134;GO:0042326;GO:0048709;GO:0000079;, C:cytoplasm; C:cytosol; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:protein kinase binding;, P:cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of phosphorylation; P:oligodendrocyte differentiation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold5 indexed_genome mRNA 4033792 4077510 . + . ID=transcript_1218;Q9Y3C5 A8KAI2 Q5T7R8,RING finger protein 11,, PF13639;, GO:0005769;GO:0070062;GO:0005634;GO:0055037;GO:0000151;GO:0003677;GO:0061630;GO:0008270;GO:0051865;GO:0006511;, C:early endosome; C:extracellular exosome; C:nucleus; C:recycling endosome; C:ubiquitin ligase complex;, F:DNA binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:protein autoubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold5 indexed_genome mRNA 4082095 4124607 . - . ID=transcript_1219;Q5SRH8 Q5SRI0 Q5SRI1 Q5SRI2 Q5T7S1 Q6PIU8 Q9BT24,Tetratricopeptide repeat protein 39A,Differentially expressed in MCF7 with estradiol protein 6;, PF10300;, GO:0005813;, C:centrosome;|Q5SRH8 Q5SRI0 Q5SRI1 Q5SRI2 Q5T7S1 Q6PIU8 Q9BT24,Tetratricopeptide repeat protein 39A,Differentially expressed in MCF7 with estradiol protein 6;, PF10300;, GO:0005813;, C:centrosome; scaffold5 indexed_genome mRNA 4146090 4288422 . - . ID=transcript_1220;P42566 B2R8J7 D3DPJ2 Q5SRH4,Epidermal growth factor receptor substrate 15,Protein AF-1p;, PF12763;, GO:0016235;GO:0016324;GO:0009925;GO:0030132;GO:0005905;GO:0005829;GO:0031901;GO:0098978;GO:0043231;GO:0016020;GO:0005886;GO:0098794;GO:0045296;GO:0005509;GO:0031593;GO:0017124;GO:0048268;GO:0032456;GO:0006897;GO:0016197;GO:0006895;GO:0061024;GO:0042059;GO:0001921;GO:0098884;GO:0019065;GO:0042127;GO:0016050;GO:0046718;, C:aggresome; C:apical plasma membrane; C:basal plasma membrane; C:clathrin coat of coated pit; C:clathrin-coated pit; C:cytosol; C:early endosome membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:postsynapse;, F:cadherin binding; F:calcium ion binding; F:polyubiquitin modification-dependent protein binding; F:SH3 domain binding;, P:clathrin coat assembly; P:endocytic recycling; P:endocytosis; P:endosomal transport; P:Golgi to endosome transport; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of receptor recycling; P:postsynaptic neurotransmitter receptor internalization; P:receptor-mediated endocytosis of virus by host cell; P:regulation of cell population proliferation; P:vesicle organization; P:viral entry into host cell;|P42566 B2R8J7 D3DPJ2 Q5SRH4,Epidermal growth factor receptor substrate 15,Protein AF-1p;, PF12763;, GO:0016235;GO:0016324;GO:0009925;GO:0030132;GO:0005905;GO:0005829;GO:0031901;GO:0098978;GO:0043231;GO:0016020;GO:0005886;GO:0098794;GO:0045296;GO:0005509;GO:0031593;GO:0017124;GO:0048268;GO:0032456;GO:0006897;GO:0016197;GO:0006895;GO:0061024;GO:0042059;GO:0001921;GO:0098884;GO:0019065;GO:0042127;GO:0016050;GO:0046718;, C:aggresome; C:apical plasma membrane; C:basal plasma membrane; C:clathrin coat of coated pit; C:clathrin-coated pit; C:cytosol; C:early endosome membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:postsynapse;, F:cadherin binding; F:calcium ion binding; F:polyubiquitin modification-dependent protein binding; F:SH3 domain binding;, P:clathrin coat assembly; P:endocytic recycling; P:endocytosis; P:endosomal transport; P:Golgi to endosome transport; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of receptor recycling; P:postsynaptic neurotransmitter receptor internalization; P:receptor-mediated endocytosis of virus by host cell; P:regulation of cell population proliferation; P:vesicle organization; P:viral entry into host cell;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold5 indexed_genome mRNA 4385923 4683309 . + . ID=transcript_1221;Q96SK4 Q9H9X2,Oxysterol-binding protein-related protein 9,, PF01237;PF00169;, GO:0005829;GO:0005794;GO:0043231;GO:0031902;GO:0016020;GO:0032934;GO:0015248;GO:0006699;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:membrane;, F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process;|Q96SK4 Q9H9X2,Oxysterol-binding protein-related protein 9,, PF01237;PF00169;, GO:0005829;GO:0005794;GO:0043231;GO:0031902;GO:0016020;GO:0032934;GO:0015248;GO:0006699;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:membrane;, F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process;|Q96SK4 Q9H9X2,Oxysterol-binding protein-related protein 9,, PF01237;PF00169;, GO:0005829;GO:0005794;GO:0043231;GO:0031902;GO:0016020;GO:0032934;GO:0015248;GO:0006699;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:membrane;, F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process;|Q96SK4 Q9H9X2,Oxysterol-binding protein-related protein 9,, PF01237;PF00169;, GO:0005829;GO:0005794;GO:0043231;GO:0031902;GO:0016020;GO:0032934;GO:0015248;GO:0006699;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:membrane;, F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process;|Q96SK4 Q9H9X2,Oxysterol-binding protein-related protein 9,, PF01237;PF00169;, GO:0005829;GO:0005794;GO:0043231;GO:0031902;GO:0016020;GO:0032934;GO:0015248;GO:0006699;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:membrane;, F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process;|O43847 A6NI41 O15241 O15242 Q5VUL0 Q96HB2 Q9NU57,Nardilysin,N-arginine dibasic convertase;Nardilysin convertase {ECO:0000312|HGNC:HGNC:7995};, PF00675;PF05193;PF16187;, GO:0009986;GO:0005829;GO:0005739;GO:0048408;GO:0046872;GO:0004222;GO:0120163;GO:0051044;GO:0052548;, C:cell surface; C:cytosol; C:mitochondrion;, F:epidermal growth factor binding; F:metal ion binding; F:metalloendopeptidase activity;, P:negative regulation of cold-induced thermogenesis; P:positive regulation of membrane protein ectodomain proteolysis; P:regulation of endopeptidase activity;|O43847 A6NI41 O15241 O15242 Q5VUL0 Q96HB2 Q9NU57,Nardilysin,N-arginine dibasic convertase;Nardilysin convertase {ECO:0000312|HGNC:HGNC:7995};, PF00675;PF05193;PF16187;, GO:0009986;GO:0005829;GO:0005739;GO:0048408;GO:0046872;GO:0004222;GO:0120163;GO:0051044;GO:0052548;, C:cell surface; C:cytosol; C:mitochondrion;, F:epidermal growth factor binding; F:metal ion binding; F:metalloendopeptidase activity;, P:negative regulation of cold-induced thermogenesis; P:positive regulation of membrane protein ectodomain proteolysis; P:regulation of endopeptidase activity;|O43847 A6NI41 O15241 O15242 Q5VUL0 Q96HB2 Q9NU57,Nardilysin,N-arginine dibasic convertase;Nardilysin convertase {ECO:0000312|HGNC:HGNC:7995};, PF00675;PF05193;PF16187;, GO:0009986;GO:0005829;GO:0005739;GO:0048408;GO:0046872;GO:0004222;GO:0120163;GO:0051044;GO:0052548;, C:cell surface; C:cytosol; C:mitochondrion;, F:epidermal growth factor binding; F:metal ion binding; F:metalloendopeptidase activity;, P:negative regulation of cold-induced thermogenesis; P:positive regulation of membrane protein ectodomain proteolysis; P:regulation of endopeptidase activity;|O43847 A6NI41 O15241 O15242 Q5VUL0 Q96HB2 Q9NU57,Nardilysin,N-arginine dibasic convertase;Nardilysin convertase {ECO:0000312|HGNC:HGNC:7995};, PF00675;PF05193;PF16187;, GO:0009986;GO:0005829;GO:0005739;GO:0048408;GO:0046872;GO:0004222;GO:0120163;GO:0051044;GO:0052548;, C:cell surface; C:cytosol; C:mitochondrion;, F:epidermal growth factor binding; F:metal ion binding; F:metalloendopeptidase activity;, P:negative regulation of cold-induced thermogenesis; P:positive regulation of membrane protein ectodomain proteolysis; P:regulation of endopeptidase activity;|O43847 A6NI41 O15241 O15242 Q5VUL0 Q96HB2 Q9NU57,Nardilysin,N-arginine dibasic convertase;Nardilysin convertase {ECO:0000312|HGNC:HGNC:7995};, PF00675;PF05193;PF16187;, GO:0009986;GO:0005829;GO:0005739;GO:0048408;GO:0046872;GO:0004222;GO:0120163;GO:0051044;GO:0052548;, C:cell surface; C:cytosol; C:mitochondrion;, F:epidermal growth factor binding; F:metal ion binding; F:metalloendopeptidase activity;, P:negative regulation of cold-induced thermogenesis; P:positive regulation of membrane protein ectodomain proteolysis; P:regulation of endopeptidase activity;|O43847 A6NI41 O15241 O15242 Q5VUL0 Q96HB2 Q9NU57,Nardilysin,N-arginine dibasic convertase;Nardilysin convertase {ECO:0000312|HGNC:HGNC:7995};, PF00675;PF05193;PF16187;, GO:0009986;GO:0005829;GO:0005739;GO:0048408;GO:0046872;GO:0004222;GO:0120163;GO:0051044;GO:0052548;, C:cell surface; C:cytosol; C:mitochondrion;, F:epidermal growth factor binding; F:metal ion binding; F:metalloendopeptidase activity;, P:negative regulation of cold-induced thermogenesis; P:positive regulation of membrane protein ectodomain proteolysis; P:regulation of endopeptidase activity;|O43847 A6NI41 O15241 O15242 Q5VUL0 Q96HB2 Q9NU57,Nardilysin,N-arginine dibasic convertase;Nardilysin convertase {ECO:0000312|HGNC:HGNC:7995};, PF00675;PF05193;PF16187;, GO:0009986;GO:0005829;GO:0005739;GO:0048408;GO:0046872;GO:0004222;GO:0120163;GO:0051044;GO:0052548;, C:cell surface; C:cytosol; C:mitochondrion;, F:epidermal growth factor binding; F:metal ion binding; F:metalloendopeptidase activity;, P:negative regulation of cold-induced thermogenesis; P:positive regulation of membrane protein ectodomain proteolysis; P:regulation of endopeptidase activity; scaffold5 indexed_genome mRNA 4716623 4773970 . - . ID=transcript_1222;P20337 Q5VUL2 Q9BSI1,Ras-related protein Rab-3B,, PF00071;, GO:0098993;GO:0005737;GO:0005829;GO:0098691;GO:0005768;GO:0070062;GO:0005794;GO:0048471;GO:0005886;GO:0008021;GO:0031982;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019882;GO:0051586;GO:0072659;GO:0009306;GO:0017157;GO:0098693;GO:0097494;GO:0006904;, C:anchored component of synaptic vesicle membrane; C:cytoplasm; C:cytosol; C:dopaminergic synapse; C:endosome; C:extracellular exosome; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:plasma membrane; C:synaptic vesicle; C:vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding;, P:antigen processing and presentation; P:positive regulation of dopamine uptake involved in synaptic transmission; P:protein localization to plasma membrane; P:protein secretion; P:regulation of exocytosis; P:regulation of synaptic vesicle cycle; P:regulation of vesicle size; P:vesicle docking involved in exocytosis; scaffold5 indexed_genome mRNA 4805009 4837957 . - . ID=transcript_1223;O95881 B3KQS0 Q5T1T4 Q96H50,Thioredoxin domain-containing protein 12,Endoplasmic reticulum resident protein 18;Endoplasmic reticulum resident protein 19;Thioredoxin-like protein p19;hTLP19;, , GO:0005783;GO:0005788;GO:0015037;GO:0019153;GO:0060548;GO:1902236;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:peptide disulfide oxidoreductase activity; F:protein-disulfide reductase (glutathione) activity;, P:negative regulation of cell death; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;|O95881 B3KQS0 Q5T1T4 Q96H50,Thioredoxin domain-containing protein 12,Endoplasmic reticulum resident protein 18;Endoplasmic reticulum resident protein 19;Thioredoxin-like protein p19;hTLP19;, , GO:0005783;GO:0005788;GO:0015037;GO:0019153;GO:0060548;GO:1902236;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:peptide disulfide oxidoreductase activity; F:protein-disulfide reductase (glutathione) activity;, P:negative regulation of cell death; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;|Q96EK9,Protein KTI12 homolog,, PF08433;, GO:0033588;GO:0005524;GO:0006357;GO:0002098;, C:elongator holoenzyme complex;, F:ATP binding;, P:regulation of transcription by RNA polymerase II; P:tRNA wobble uridine modification; scaffold5 indexed_genome mRNA 4839137 4864798 . + . ID=transcript_1224;Q96K17 B3KNJ1 D3DQ32 G3V1C6,Transcription factor BTF3 homolog 4,Basic transcription factor 3-like 4;, PF01849;|Q96K17 B3KNJ1 D3DQ32 G3V1C6,Transcription factor BTF3 homolog 4,Basic transcription factor 3-like 4;, PF01849; scaffold5 indexed_genome mRNA 4982592 5095632 . + . ID=transcript_1225;O95405 Q5T0F6 Q5T0F7 Q9UNE1 Q9Y5R7,Zinc finger FYVE domain-containing protein 9,Mothers against decapentaplegic homolog-interacting protein;Novel serine protease;Receptor activation anchor;Smad anchor for receptor activation;, PF11979;PF01363;PF11409;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0032991;GO:0005545;GO:0046872;GO:0019904;GO:0006897;GO:0016197;GO:0007179;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:protein-containing complex;, F:1-phosphatidylinositol binding; F:metal ion binding; F:protein domain specific binding;, P:endocytosis; P:endosomal transport; P:transforming growth factor beta receptor signaling pathway; scaffold5 indexed_genome mRNA 5095840 5114875 . - . ID=transcript_1226;Q5T0F9 Q49AE8 Q5T0F8 Q5T0G0 Q6ZNQ1 Q96AP3 Q96I04 Q96JJ1,Coiled-coil and C2 domain-containing protein 1B,Five prime repressor element under dual repression-binding protein 2;, PF00168;, GO:0043231;GO:0005635;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0007084;GO:0006357;, C:intracellular membrane-bounded organelle; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:mitotic nuclear envelope reassembly; P:regulation of transcription by RNA polymerase II;|Q5T0F9 Q49AE8 Q5T0F8 Q5T0G0 Q6ZNQ1 Q96AP3 Q96I04 Q96JJ1,Coiled-coil and C2 domain-containing protein 1B,Five prime repressor element under dual repression-binding protein 2;, PF00168;, GO:0043231;GO:0005635;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0007084;GO:0006357;, C:intracellular membrane-bounded organelle; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:mitotic nuclear envelope reassembly; P:regulation of transcription by RNA polymerase II;|Q5T0F9 Q49AE8 Q5T0F8 Q5T0G0 Q6ZNQ1 Q96AP3 Q96I04 Q96JJ1,Coiled-coil and C2 domain-containing protein 1B,Five prime repressor element under dual repression-binding protein 2;, PF00168;, GO:0043231;GO:0005635;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0007084;GO:0006357;, C:intracellular membrane-bounded organelle; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:mitotic nuclear envelope reassembly; P:regulation of transcription by RNA polymerase II;|Q5T0F9 Q49AE8 Q5T0F8 Q5T0G0 Q6ZNQ1 Q96AP3 Q96I04 Q96JJ1,Coiled-coil and C2 domain-containing protein 1B,Five prime repressor element under dual repression-binding protein 2;, PF00168;, GO:0043231;GO:0005635;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0007084;GO:0006357;, C:intracellular membrane-bounded organelle; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:mitotic nuclear envelope reassembly; P:regulation of transcription by RNA polymerase II;|Q6P1N0 Q7Z435 Q86XV0 Q8NF89 Q9H603 Q9NXI1,Coiled-coil and C2 domain-containing protein 1A,Akt kinase-interacting protein 1;Five prime repressor element under dual repression-binding protein 1;Putative NF-kappa-B-activating protein 023N;, PF00168;, GO:0005829;GO:0070062;GO:0001650;GO:0016020;GO:0005815;GO:0005634;GO:0005886;GO:0045296;GO:0000981;GO:0001227;GO:0000978;GO:1905381;GO:0043123;GO:0006357;, C:cytosol; C:extracellular exosome; C:fibrillar center; C:membrane; C:microtubule organizing center; C:nucleus; C:plasma membrane;, F:cadherin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of snRNA transcription by RNA polymerase II; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of transcription by RNA polymerase II;|Q5T0F9 Q49AE8 Q5T0F8 Q5T0G0 Q6ZNQ1 Q96AP3 Q96I04 Q96JJ1,Coiled-coil and C2 domain-containing protein 1B,Five prime repressor element under dual repression-binding protein 2;, PF00168;, GO:0043231;GO:0005635;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0007084;GO:0006357;, C:intracellular membrane-bounded organelle; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:mitotic nuclear envelope reassembly; P:regulation of transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 5152853 5172470 . + . ID=transcript_1227;Q8NAV1 Q96JW1 Q9BVZ8,Pre-mRNA-splicing factor 38A,, PF03371;PF12871;, GO:0005654;GO:0005634;GO:0071011;GO:0071005;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA splicing, via spliceosome; scaffold5 indexed_genome mRNA 5183832 5307846 . - . ID=transcript_1228;Q5TAX3 A2RRP0 B7Z8J5 D3DQ35 Q12764 Q5TAX2 Q5TAX4 Q86XZ3,Terminal uridylyltransferase 4 {ECO:0000305},Zinc finger CCHC domain-containing protein 11;, PF03828;PF00098;, GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0005615;GO:0005730;GO:0005634;GO:0035198;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0008270;GO:0010587;GO:0010586;GO:0006378;GO:0006397;GO:0010526;GO:0000289;GO:0001556;GO:1990074;GO:0031054;GO:0071076;GO:0031123;GO:0019827;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extracellular space; C:nucleolus; C:nucleus;, F:miRNA binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:zinc ion binding;, P:miRNA catabolic process; P:miRNA metabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of transposition, RNA-mediated; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oocyte maturation; P:polyuridylation-dependent mRNA catabolic process; P:pre-miRNA processing; P:RNA 3' uridylation; P:RNA 3'-end processing; P:stem cell population maintenance;|Q5TAX3 A2RRP0 B7Z8J5 D3DQ35 Q12764 Q5TAX2 Q5TAX4 Q86XZ3,Terminal uridylyltransferase 4 {ECO:0000305},Zinc finger CCHC domain-containing protein 11;, PF03828;PF00098;, GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0005615;GO:0005730;GO:0005634;GO:0035198;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0008270;GO:0010587;GO:0010586;GO:0006378;GO:0006397;GO:0010526;GO:0000289;GO:0001556;GO:1990074;GO:0031054;GO:0071076;GO:0031123;GO:0019827;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extracellular space; C:nucleolus; C:nucleus;, F:miRNA binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:zinc ion binding;, P:miRNA catabolic process; P:miRNA metabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of transposition, RNA-mediated; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oocyte maturation; P:polyuridylation-dependent mRNA catabolic process; P:pre-miRNA processing; P:RNA 3' uridylation; P:RNA 3'-end processing; P:stem cell population maintenance;|Q5TAX3 A2RRP0 B7Z8J5 D3DQ35 Q12764 Q5TAX2 Q5TAX4 Q86XZ3,Terminal uridylyltransferase 4 {ECO:0000305},Zinc finger CCHC domain-containing protein 11;, PF03828;PF00098;, GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0005615;GO:0005730;GO:0005634;GO:0035198;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0008270;GO:0010587;GO:0010586;GO:0006378;GO:0006397;GO:0010526;GO:0000289;GO:0001556;GO:1990074;GO:0031054;GO:0071076;GO:0031123;GO:0019827;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extracellular space; C:nucleolus; C:nucleus;, F:miRNA binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:zinc ion binding;, P:miRNA catabolic process; P:miRNA metabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of transposition, RNA-mediated; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oocyte maturation; P:polyuridylation-dependent mRNA catabolic process; P:pre-miRNA processing; P:RNA 3' uridylation; P:RNA 3'-end processing; P:stem cell population maintenance;|Q5TAX3 A2RRP0 B7Z8J5 D3DQ35 Q12764 Q5TAX2 Q5TAX4 Q86XZ3,Terminal uridylyltransferase 4 {ECO:0000305},Zinc finger CCHC domain-containing protein 11;, PF03828;PF00098;, GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0005615;GO:0005730;GO:0005634;GO:0035198;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0008270;GO:0010587;GO:0010586;GO:0006378;GO:0006397;GO:0010526;GO:0000289;GO:0001556;GO:1990074;GO:0031054;GO:0071076;GO:0031123;GO:0019827;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extracellular space; C:nucleolus; C:nucleus;, F:miRNA binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:zinc ion binding;, P:miRNA catabolic process; P:miRNA metabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of transposition, RNA-mediated; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oocyte maturation; P:polyuridylation-dependent mRNA catabolic process; P:pre-miRNA processing; P:RNA 3' uridylation; P:RNA 3'-end processing; P:stem cell population maintenance;|Q5TAX3 A2RRP0 B7Z8J5 D3DQ35 Q12764 Q5TAX2 Q5TAX4 Q86XZ3,Terminal uridylyltransferase 4 {ECO:0000305},Zinc finger CCHC domain-containing protein 11;, PF03828;PF00098;, GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0005615;GO:0005730;GO:0005634;GO:0035198;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0008270;GO:0010587;GO:0010586;GO:0006378;GO:0006397;GO:0010526;GO:0000289;GO:0001556;GO:1990074;GO:0031054;GO:0071076;GO:0031123;GO:0019827;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extracellular space; C:nucleolus; C:nucleus;, F:miRNA binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:zinc ion binding;, P:miRNA catabolic process; P:miRNA metabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of transposition, RNA-mediated; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oocyte maturation; P:polyuridylation-dependent mRNA catabolic process; P:pre-miRNA processing; P:RNA 3' uridylation; P:RNA 3'-end processing; P:stem cell population maintenance; scaffold5 indexed_genome mRNA 5366460 5369221 . + . ID=transcript_1229;Q96SL4 O95337 Q5T501,Glutathione peroxidase 7,CL683;, PF00255;, GO:0005783;GO:0005788;GO:0005576;GO:0004096;GO:0004602;GO:0004601;GO:0034599;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular region;, F:catalase activity; F:glutathione peroxidase activity; F:peroxidase activity;, P:cellular response to oxidative stress; scaffold5 indexed_genome mRNA 5432698 5459155 . - . ID=transcript_1230;Q96BR5 Q0P6I7 Q9H9Z9,Cytochrome c oxidase assembly factor 7,Beta-lactamase hcp-like protein;Respiratory chain assembly factor 1;Sel1 repeat-containing protein 1;, PF08238;, GO:0005758;GO:0005739;GO:0005654;, C:mitochondrial intermembrane space; C:mitochondrion; C:nucleoplasm; scaffold5 indexed_genome mRNA 5486485 5551870 . + . ID=transcript_1231;Q9C0D3 Q8N2X3 Q9H8L8,Protein zyg-11 homolog B {ECO:0000305},, , GO:0031462;GO:0032436;GO:0006515;, C:Cul2-RING ubiquitin ligase complex;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein quality control for misfolded or incompletely synthesized proteins; scaffold5 indexed_genome mRNA 5560892 5567310 . + . ID=transcript_1232;Q9C0D3 Q8N2X3 Q9H8L8,Protein zyg-11 homolog B {ECO:0000305},, , GO:0031462;GO:0032436;GO:0006515;, C:Cul2-RING ubiquitin ligase complex;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein quality control for misfolded or incompletely synthesized proteins;|Q9C0D3 Q8N2X3 Q9H8L8,Protein zyg-11 homolog B {ECO:0000305},, , GO:0031462;GO:0032436;GO:0006515;, C:Cul2-RING ubiquitin ligase complex;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein quality control for misfolded or incompletely synthesized proteins; scaffold5 indexed_genome mRNA 5641731 5794767 . - . ID=transcript_1233;Q6WRX3 A6NCK5,Protein zyg-11 homolog A,, , GO:0031462;, C:Cul2-RING ubiquitin ligase complex;|Q6WRX3 A6NCK5,Protein zyg-11 homolog A,, , GO:0031462;, C:Cul2-RING ubiquitin ligase complex;|Q86YB7 D3DQ36 Q9NV38,Enoyl-CoA hydratase domain-containing protein 2, mitochondrial,, PF00378;, GO:0005739;GO:0004300;GO:0006635;, C:mitochondrion;, F:enoyl-CoA hydratase activity;, P:fatty acid beta-oxidation;|Q16622 Q5VVZ1 Q6NXF4 Q99430,Sterol carrier protein 2,Acetyl-CoA C-myristoyltransferase;Non-specific lipid-transfer protein {ECO:0000305};Propanoyl-CoA C-acyltransferase;SCP-2/3-oxoacyl-CoA thiolase;SCP-2/thiolase;SCP-chi;SCPX;Sterol carrier protein X;Straight-chain acyl-CoA oxidase;, PF02036;PF02803;PF00108;, GO:0005737;GO:0005829;GO:0005783;GO:0043231;GO:0016020;GO:0005739;GO:0005654;GO:0005782;GO:0005777;GO:0032991;GO:0003988;GO:0050633;GO:0015485;GO:0120020;GO:0000062;GO:0036042;GO:0070538;GO:0120019;GO:0008526;GO:0033814;GO:0050632;GO:0005102;GO:0032934;GO:0036109;GO:0006699;GO:0008206;GO:0006635;GO:0033540;GO:0032959;GO:0032367;GO:1901373;GO:0007031;GO:0015914;GO:0032385;GO:0045940;GO:0006701;GO:0008104;GO:0072659;GO:0071071;GO:0006694;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nucleoplasm; C:peroxisomal matrix; C:peroxisome; C:protein-containing complex;, F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:cholesterol binding; F:cholesterol transfer activity; F:fatty-acyl-CoA binding; F:long-chain fatty acyl-CoA binding; F:oleic acid binding; F:phosphatidylcholine transfer activity; F:phosphatidylinositol transfer activity; F:propanoyl-CoA C-acyltransferase activity; F:propionyl-CoA C2-trimethyltridecanoyltransferase activity; F:signaling receptor binding; F:sterol binding;, P:alpha-linolenic acid metabolic process; P:bile acid biosynthetic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:inositol trisphosphate biosynthetic process; P:intracellular cholesterol transport; P:lipid hydroperoxide transport; P:peroxisome organization; P:phospholipid transport; P:positive regulation of intracellular cholesterol transport; P:positive regulation of steroid metabolic process; P:progesterone biosynthetic process; P:protein localization; P:protein localization to plasma membrane; P:regulation of phospholipid biosynthetic process; P:steroid biosynthetic process;|Q16622 Q5VVZ1 Q6NXF4 Q99430,Sterol carrier protein 2,Acetyl-CoA C-myristoyltransferase;Non-specific lipid-transfer protein {ECO:0000305};Propanoyl-CoA C-acyltransferase;SCP-2/3-oxoacyl-CoA thiolase;SCP-2/thiolase;SCP-chi;SCPX;Sterol carrier protein X;Straight-chain acyl-CoA oxidase;, PF02036;PF02803;PF00108;, GO:0005737;GO:0005829;GO:0005783;GO:0043231;GO:0016020;GO:0005739;GO:0005654;GO:0005782;GO:0005777;GO:0032991;GO:0003988;GO:0050633;GO:0015485;GO:0120020;GO:0000062;GO:0036042;GO:0070538;GO:0120019;GO:0008526;GO:0033814;GO:0050632;GO:0005102;GO:0032934;GO:0036109;GO:0006699;GO:0008206;GO:0006635;GO:0033540;GO:0032959;GO:0032367;GO:1901373;GO:0007031;GO:0015914;GO:0032385;GO:0045940;GO:0006701;GO:0008104;GO:0072659;GO:0071071;GO:0006694;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nucleoplasm; C:peroxisomal matrix; C:peroxisome; C:protein-containing complex;, F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:cholesterol binding; F:cholesterol transfer activity; F:fatty-acyl-CoA binding; F:long-chain fatty acyl-CoA binding; F:oleic acid binding; F:phosphatidylcholine transfer activity; F:phosphatidylinositol transfer activity; F:propanoyl-CoA C-acyltransferase activity; F:propionyl-CoA C2-trimethyltridecanoyltransferase activity; F:signaling receptor binding; F:sterol binding;, P:alpha-linolenic acid metabolic process; P:bile acid biosynthetic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:inositol trisphosphate biosynthetic process; P:intracellular cholesterol transport; P:lipid hydroperoxide transport; P:peroxisome organization; P:phospholipid transport; P:positive regulation of intracellular cholesterol transport; P:positive regulation of steroid metabolic process; P:progesterone biosynthetic process; P:protein localization; P:protein localization to plasma membrane; P:regulation of phospholipid biosynthetic process; P:steroid biosynthetic process;|Q16622 Q5VVZ1 Q6NXF4 Q99430,Sterol carrier protein 2,Acetyl-CoA C-myristoyltransferase;Non-specific lipid-transfer protein {ECO:0000305};Propanoyl-CoA C-acyltransferase;SCP-2/3-oxoacyl-CoA thiolase;SCP-2/thiolase;SCP-chi;SCPX;Sterol carrier protein X;Straight-chain acyl-CoA oxidase;, PF02036;PF02803;PF00108;, GO:0005737;GO:0005829;GO:0005783;GO:0043231;GO:0016020;GO:0005739;GO:0005654;GO:0005782;GO:0005777;GO:0032991;GO:0003988;GO:0050633;GO:0015485;GO:0120020;GO:0000062;GO:0036042;GO:0070538;GO:0120019;GO:0008526;GO:0033814;GO:0050632;GO:0005102;GO:0032934;GO:0036109;GO:0006699;GO:0008206;GO:0006635;GO:0033540;GO:0032959;GO:0032367;GO:1901373;GO:0007031;GO:0015914;GO:0032385;GO:0045940;GO:0006701;GO:0008104;GO:0072659;GO:0071071;GO:0006694;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nucleoplasm; C:peroxisomal matrix; C:peroxisome; C:protein-containing complex;, F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:cholesterol binding; F:cholesterol transfer activity; F:fatty-acyl-CoA binding; F:long-chain fatty acyl-CoA binding; F:oleic acid binding; F:phosphatidylcholine transfer activity; F:phosphatidylinositol transfer activity; F:propanoyl-CoA C-acyltransferase activity; F:propionyl-CoA C2-trimethyltridecanoyltransferase activity; F:signaling receptor binding; F:sterol binding;, P:alpha-linolenic acid metabolic process; P:bile acid biosynthetic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:inositol trisphosphate biosynthetic process; P:intracellular cholesterol transport; P:lipid hydroperoxide transport; P:peroxisome organization; P:phospholipid transport; P:positive regulation of intracellular cholesterol transport; P:positive regulation of steroid metabolic process; P:progesterone biosynthetic process; P:protein localization; P:protein localization to plasma membrane; P:regulation of phospholipid biosynthetic process; P:steroid biosynthetic process;|Q16622 Q5VVZ1 Q6NXF4 Q99430,Sterol carrier protein 2,Acetyl-CoA C-myristoyltransferase;Non-specific lipid-transfer protein {ECO:0000305};Propanoyl-CoA C-acyltransferase;SCP-2/3-oxoacyl-CoA thiolase;SCP-2/thiolase;SCP-chi;SCPX;Sterol carrier protein X;Straight-chain acyl-CoA oxidase;, PF02036;PF02803;PF00108;, GO:0005737;GO:0005829;GO:0005783;GO:0043231;GO:0016020;GO:0005739;GO:0005654;GO:0005782;GO:0005777;GO:0032991;GO:0003988;GO:0050633;GO:0015485;GO:0120020;GO:0000062;GO:0036042;GO:0070538;GO:0120019;GO:0008526;GO:0033814;GO:0050632;GO:0005102;GO:0032934;GO:0036109;GO:0006699;GO:0008206;GO:0006635;GO:0033540;GO:0032959;GO:0032367;GO:1901373;GO:0007031;GO:0015914;GO:0032385;GO:0045940;GO:0006701;GO:0008104;GO:0072659;GO:0071071;GO:0006694;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nucleoplasm; C:peroxisomal matrix; C:peroxisome; C:protein-containing complex;, F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:cholesterol binding; F:cholesterol transfer activity; F:fatty-acyl-CoA binding; F:long-chain fatty acyl-CoA binding; F:oleic acid binding; F:phosphatidylcholine transfer activity; F:phosphatidylinositol transfer activity; F:propanoyl-CoA C-acyltransferase activity; F:propionyl-CoA C2-trimethyltridecanoyltransferase activity; F:signaling receptor binding; F:sterol binding;, P:alpha-linolenic acid metabolic process; P:bile acid biosynthetic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:inositol trisphosphate biosynthetic process; P:intracellular cholesterol transport; P:lipid hydroperoxide transport; P:peroxisome organization; P:phospholipid transport; P:positive regulation of intracellular cholesterol transport; P:positive regulation of steroid metabolic process; P:progesterone biosynthetic process; P:protein localization; P:protein localization to plasma membrane; P:regulation of phospholipid biosynthetic process; P:steroid biosynthetic process; scaffold5 indexed_genome mRNA 5839720 5845460 . + . ID=transcript_1234;P60866 B2R4F4 B4DW28 P17075 Q5M8S9,40S ribosomal protein S20,Small ribosomal subunit protein uS10 {ECO:0000303|PubMed:24524803};, PF00338;, GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0015935;GO:0003723;GO:0003735;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold5 indexed_genome mRNA 5845493 5848358 . + . ID=transcript_1235;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold5 indexed_genome mRNA 5867182 5869659 . - . ID=transcript_1236;Q16622 Q5VVZ1 Q6NXF4 Q99430,Sterol carrier protein 2,Acetyl-CoA C-myristoyltransferase;Non-specific lipid-transfer protein {ECO:0000305};Propanoyl-CoA C-acyltransferase;SCP-2/3-oxoacyl-CoA thiolase;SCP-2/thiolase;SCP-chi;SCPX;Sterol carrier protein X;Straight-chain acyl-CoA oxidase;, PF02036;PF02803;PF00108;, GO:0005737;GO:0005829;GO:0005783;GO:0043231;GO:0016020;GO:0005739;GO:0005654;GO:0005782;GO:0005777;GO:0032991;GO:0003988;GO:0050633;GO:0015485;GO:0120020;GO:0000062;GO:0036042;GO:0070538;GO:0120019;GO:0008526;GO:0033814;GO:0050632;GO:0005102;GO:0032934;GO:0036109;GO:0006699;GO:0008206;GO:0006635;GO:0033540;GO:0032959;GO:0032367;GO:1901373;GO:0007031;GO:0015914;GO:0032385;GO:0045940;GO:0006701;GO:0008104;GO:0072659;GO:0071071;GO:0006694;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nucleoplasm; C:peroxisomal matrix; C:peroxisome; C:protein-containing complex;, F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:cholesterol binding; F:cholesterol transfer activity; F:fatty-acyl-CoA binding; F:long-chain fatty acyl-CoA binding; F:oleic acid binding; F:phosphatidylcholine transfer activity; F:phosphatidylinositol transfer activity; F:propanoyl-CoA C-acyltransferase activity; F:propionyl-CoA C2-trimethyltridecanoyltransferase activity; F:signaling receptor binding; F:sterol binding;, P:alpha-linolenic acid metabolic process; P:bile acid biosynthetic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:inositol trisphosphate biosynthetic process; P:intracellular cholesterol transport; P:lipid hydroperoxide transport; P:peroxisome organization; P:phospholipid transport; P:positive regulation of intracellular cholesterol transport; P:positive regulation of steroid metabolic process; P:progesterone biosynthetic process; P:protein localization; P:protein localization to plasma membrane; P:regulation of phospholipid biosynthetic process; P:steroid biosynthetic process; scaffold5 indexed_genome mRNA 5880408 5903611 . + . ID=transcript_1237;Q7Z5L7 B4DKN5 B4E373 Q5VVZ2 Q5VVZ3 Q6PIR3 Q6UXL8 Q8N641,Podocan,, PF13306;PF13855;, GO:0062023;GO:0005737;GO:0005615;GO:0005518;GO:0030336;GO:0008285;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular space;, F:collagen binding;, P:negative regulation of cell migration; P:negative regulation of cell population proliferation; scaffold5 indexed_genome mRNA 5908533 5911451 . - . ID=transcript_1238;O00341 Q5VVZ0 Q969Z8 Q9BW45,Excitatory amino acid transporter 5,Retinal glutamate transporter;Solute carrier family 1 member 7;, PF00375;, GO:0016021;GO:0005886;GO:0098793;GO:0005313;GO:0015293;GO:0006835;GO:0006811;GO:0098810;GO:0006836;GO:0001504;, C:integral component of membrane; C:plasma membrane; C:presynapse;, F:L-glutamate transmembrane transporter activity; F:symporter activity;, P:dicarboxylic acid transport; P:ion transport; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; scaffold5 indexed_genome mRNA 5911466 5912167 . - . ID=transcript_1239;O00341 Q5VVZ0 Q969Z8 Q9BW45,Excitatory amino acid transporter 5,Retinal glutamate transporter;Solute carrier family 1 member 7;, PF00375;, GO:0016021;GO:0005886;GO:0098793;GO:0005313;GO:0015293;GO:0006835;GO:0006811;GO:0098810;GO:0006836;GO:0001504;, C:integral component of membrane; C:plasma membrane; C:presynapse;, F:L-glutamate transmembrane transporter activity; F:symporter activity;, P:dicarboxylic acid transport; P:ion transport; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; scaffold5 indexed_genome mRNA 6019940 6034166 . + . ID=transcript_1240;P23786 B2R6S0 Q5SW68 Q9BQ26,Carnitine O-palmitoyltransferase 2, mitochondrial {ECO:0000305},Carnitine palmitoyltransferase II;, PF00755;, GO:0005743;GO:0005739;GO:0005730;GO:0005654;GO:0008458;GO:0004095;GO:0016746;GO:0009437;GO:0006853;GO:0006635;GO:0001676;GO:0120162;GO:0019222;, C:mitochondrial inner membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:carnitine O-octanoyltransferase activity; F:carnitine O-palmitoyltransferase activity; F:transferase activity, transferring acyl groups;, P:carnitine metabolic process; P:carnitine shuttle; P:fatty acid beta-oxidation; P:long-chain fatty acid metabolic process; P:positive regulation of cold-induced thermogenesis; P:regulation of metabolic process; scaffold5 indexed_genome mRNA 6046580 6064795 . - . ID=transcript_1241;Q9NWV4,CXXC motif containing zinc binding protein {ECO:0000305},UPF0587 protein C1orf123;, PF05907;, GO:0008270;, , F:zinc ion binding;|Q9NWV4,CXXC motif containing zinc binding protein {ECO:0000305},UPF0587 protein C1orf123;, PF05907;, GO:0008270;, , F:zinc ion binding;|Q9NWV4,CXXC motif containing zinc binding protein {ECO:0000305},UPF0587 protein C1orf123;, PF05907;, GO:0008270;, , F:zinc ion binding;|P61326 B1ARP8 B2R5A2 O35169 P50606 Q5SW69,Protein mago nashi homolog,, PF02792;, GO:0071013;GO:0005737;GO:0035145;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0000381;GO:0006417;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:cytoplasm; C:exon-exon junction complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of translation; P:RNA export from nucleus; P:RNA splicing;|Q96A72,Protein mago nashi homolog 2,, PF02792;, GO:0071013;GO:0035145;GO:0043025;GO:0005654;GO:0005634;GO:0071006;GO:0071005;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:exon-exon junction complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:RNA export from nucleus; P:RNA splicing;|P61326 B1ARP8 B2R5A2 O35169 P50606 Q5SW69,Protein mago nashi homolog,, PF02792;, GO:0071013;GO:0005737;GO:0035145;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0000381;GO:0006417;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:cytoplasm; C:exon-exon junction complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of translation; P:RNA export from nucleus; P:RNA splicing;|P61326 B1ARP8 B2R5A2 O35169 P50606 Q5SW69,Protein mago nashi homolog,, PF02792;, GO:0071013;GO:0005737;GO:0035145;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0000381;GO:0006417;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:cytoplasm; C:exon-exon junction complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of translation; P:RNA export from nucleus; P:RNA splicing; scaffold5 indexed_genome mRNA 6072235 6077053 . - . ID=transcript_1242;Q14114 B1AMT6 B1AMT7 B1AMT8 O14968 Q86V27 Q99876 Q9BR78,Low-density lipoprotein receptor-related protein 8,Apolipoprotein E receptor 2;, PF00057;PF00058;, GO:0030424;GO:0005901;GO:0009986;GO:0030425;GO:0005615;GO:0016021;GO:0016020;GO:0005875;GO:0043025;GO:0005886;GO:0014069;GO:0043235;GO:0001540;GO:0034185;GO:0005509;GO:0048306;GO:0038024;GO:0008035;GO:0019894;GO:0005041;GO:0047485;GO:0038025;GO:0004888;GO:0030229;GO:0021541;GO:0071397;GO:0071363;GO:0007268;GO:0019221;GO:0048813;GO:0006897;GO:0021819;GO:0006629;GO:0050804;GO:0032793;GO:1900006;GO:0061003;GO:0050731;GO:0061098;GO:0006508;GO:0038026;GO:0042981;GO:0045088;GO:0042493;GO:0001523;GO:0007165;GO:0021517;, C:axon; C:caveola; C:cell surface; C:dendrite; C:extracellular space; C:integral component of membrane; C:membrane; C:microtubule associated complex; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:receptor complex;, F:amyloid-beta binding; F:apolipoprotein binding; F:calcium ion binding; F:calcium-dependent protein binding; F:cargo receptor activity; F:high-density lipoprotein particle binding; F:kinesin binding; F:low-density lipoprotein particle receptor activity; F:protein N-terminus binding; F:reelin receptor activity; F:transmembrane signaling receptor activity; F:very-low-density lipoprotein particle receptor activity;, P:ammon gyrus development; P:cellular response to cholesterol; P:cellular response to growth factor stimulus; P:chemical synaptic transmission; P:cytokine-mediated signaling pathway; P:dendrite morphogenesis; P:endocytosis; P:layer formation in cerebral cortex; P:lipid metabolic process; P:modulation of chemical synaptic transmission; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:proteolysis; P:reelin-mediated signaling pathway; P:regulation of apoptotic process; P:regulation of innate immune response; P:response to drug; P:retinoid metabolic process; P:signal transduction; P:ventral spinal cord development; scaffold5 indexed_genome mRNA 6085208 6099530 . - . ID=transcript_1243;Q14114 B1AMT6 B1AMT7 B1AMT8 O14968 Q86V27 Q99876 Q9BR78,Low-density lipoprotein receptor-related protein 8,Apolipoprotein E receptor 2;, PF00057;PF00058;, GO:0030424;GO:0005901;GO:0009986;GO:0030425;GO:0005615;GO:0016021;GO:0016020;GO:0005875;GO:0043025;GO:0005886;GO:0014069;GO:0043235;GO:0001540;GO:0034185;GO:0005509;GO:0048306;GO:0038024;GO:0008035;GO:0019894;GO:0005041;GO:0047485;GO:0038025;GO:0004888;GO:0030229;GO:0021541;GO:0071397;GO:0071363;GO:0007268;GO:0019221;GO:0048813;GO:0006897;GO:0021819;GO:0006629;GO:0050804;GO:0032793;GO:1900006;GO:0061003;GO:0050731;GO:0061098;GO:0006508;GO:0038026;GO:0042981;GO:0045088;GO:0042493;GO:0001523;GO:0007165;GO:0021517;, C:axon; C:caveola; C:cell surface; C:dendrite; C:extracellular space; C:integral component of membrane; C:membrane; C:microtubule associated complex; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:receptor complex;, F:amyloid-beta binding; F:apolipoprotein binding; F:calcium ion binding; F:calcium-dependent protein binding; F:cargo receptor activity; F:high-density lipoprotein particle binding; F:kinesin binding; F:low-density lipoprotein particle receptor activity; F:protein N-terminus binding; F:reelin receptor activity; F:transmembrane signaling receptor activity; F:very-low-density lipoprotein particle receptor activity;, P:ammon gyrus development; P:cellular response to cholesterol; P:cellular response to growth factor stimulus; P:chemical synaptic transmission; P:cytokine-mediated signaling pathway; P:dendrite morphogenesis; P:endocytosis; P:layer formation in cerebral cortex; P:lipid metabolic process; P:modulation of chemical synaptic transmission; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:proteolysis; P:reelin-mediated signaling pathway; P:regulation of apoptotic process; P:regulation of innate immune response; P:response to drug; P:retinoid metabolic process; P:signal transduction; P:ventral spinal cord development;|Q14114 B1AMT6 B1AMT7 B1AMT8 O14968 Q86V27 Q99876 Q9BR78,Low-density lipoprotein receptor-related protein 8,Apolipoprotein E receptor 2;, PF00057;PF00058;, GO:0030424;GO:0005901;GO:0009986;GO:0030425;GO:0005615;GO:0016021;GO:0016020;GO:0005875;GO:0043025;GO:0005886;GO:0014069;GO:0043235;GO:0001540;GO:0034185;GO:0005509;GO:0048306;GO:0038024;GO:0008035;GO:0019894;GO:0005041;GO:0047485;GO:0038025;GO:0004888;GO:0030229;GO:0021541;GO:0071397;GO:0071363;GO:0007268;GO:0019221;GO:0048813;GO:0006897;GO:0021819;GO:0006629;GO:0050804;GO:0032793;GO:1900006;GO:0061003;GO:0050731;GO:0061098;GO:0006508;GO:0038026;GO:0042981;GO:0045088;GO:0042493;GO:0001523;GO:0007165;GO:0021517;, C:axon; C:caveola; C:cell surface; C:dendrite; C:extracellular space; C:integral component of membrane; C:membrane; C:microtubule associated complex; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:receptor complex;, F:amyloid-beta binding; F:apolipoprotein binding; F:calcium ion binding; F:calcium-dependent protein binding; F:cargo receptor activity; F:high-density lipoprotein particle binding; F:kinesin binding; F:low-density lipoprotein particle receptor activity; F:protein N-terminus binding; F:reelin receptor activity; F:transmembrane signaling receptor activity; F:very-low-density lipoprotein particle receptor activity;, P:ammon gyrus development; P:cellular response to cholesterol; P:cellular response to growth factor stimulus; P:chemical synaptic transmission; P:cytokine-mediated signaling pathway; P:dendrite morphogenesis; P:endocytosis; P:layer formation in cerebral cortex; P:lipid metabolic process; P:modulation of chemical synaptic transmission; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:proteolysis; P:reelin-mediated signaling pathway; P:regulation of apoptotic process; P:regulation of innate immune response; P:response to drug; P:retinoid metabolic process; P:signal transduction; P:ventral spinal cord development;|Q14114 B1AMT6 B1AMT7 B1AMT8 O14968 Q86V27 Q99876 Q9BR78,Low-density lipoprotein receptor-related protein 8,Apolipoprotein E receptor 2;, PF00057;PF00058;, GO:0030424;GO:0005901;GO:0009986;GO:0030425;GO:0005615;GO:0016021;GO:0016020;GO:0005875;GO:0043025;GO:0005886;GO:0014069;GO:0043235;GO:0001540;GO:0034185;GO:0005509;GO:0048306;GO:0038024;GO:0008035;GO:0019894;GO:0005041;GO:0047485;GO:0038025;GO:0004888;GO:0030229;GO:0021541;GO:0071397;GO:0071363;GO:0007268;GO:0019221;GO:0048813;GO:0006897;GO:0021819;GO:0006629;GO:0050804;GO:0032793;GO:1900006;GO:0061003;GO:0050731;GO:0061098;GO:0006508;GO:0038026;GO:0042981;GO:0045088;GO:0042493;GO:0001523;GO:0007165;GO:0021517;, C:axon; C:caveola; C:cell surface; C:dendrite; C:extracellular space; C:integral component of membrane; C:membrane; C:microtubule associated complex; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:receptor complex;, F:amyloid-beta binding; F:apolipoprotein binding; F:calcium ion binding; F:calcium-dependent protein binding; F:cargo receptor activity; F:high-density lipoprotein particle binding; F:kinesin binding; F:low-density lipoprotein particle receptor activity; F:protein N-terminus binding; F:reelin receptor activity; F:transmembrane signaling receptor activity; F:very-low-density lipoprotein particle receptor activity;, P:ammon gyrus development; P:cellular response to cholesterol; P:cellular response to growth factor stimulus; P:chemical synaptic transmission; P:cytokine-mediated signaling pathway; P:dendrite morphogenesis; P:endocytosis; P:layer formation in cerebral cortex; P:lipid metabolic process; P:modulation of chemical synaptic transmission; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:proteolysis; P:reelin-mediated signaling pathway; P:regulation of apoptotic process; P:regulation of innate immune response; P:response to drug; P:retinoid metabolic process; P:signal transduction; P:ventral spinal cord development;|Q14114 B1AMT6 B1AMT7 B1AMT8 O14968 Q86V27 Q99876 Q9BR78,Low-density lipoprotein receptor-related protein 8,Apolipoprotein E receptor 2;, PF00057;PF00058;, GO:0030424;GO:0005901;GO:0009986;GO:0030425;GO:0005615;GO:0016021;GO:0016020;GO:0005875;GO:0043025;GO:0005886;GO:0014069;GO:0043235;GO:0001540;GO:0034185;GO:0005509;GO:0048306;GO:0038024;GO:0008035;GO:0019894;GO:0005041;GO:0047485;GO:0038025;GO:0004888;GO:0030229;GO:0021541;GO:0071397;GO:0071363;GO:0007268;GO:0019221;GO:0048813;GO:0006897;GO:0021819;GO:0006629;GO:0050804;GO:0032793;GO:1900006;GO:0061003;GO:0050731;GO:0061098;GO:0006508;GO:0038026;GO:0042981;GO:0045088;GO:0042493;GO:0001523;GO:0007165;GO:0021517;, C:axon; C:caveola; C:cell surface; C:dendrite; C:extracellular space; C:integral component of membrane; C:membrane; C:microtubule associated complex; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:receptor complex;, F:amyloid-beta binding; F:apolipoprotein binding; F:calcium ion binding; F:calcium-dependent protein binding; F:cargo receptor activity; F:high-density lipoprotein particle binding; F:kinesin binding; F:low-density lipoprotein particle receptor activity; F:protein N-terminus binding; F:reelin receptor activity; F:transmembrane signaling receptor activity; F:very-low-density lipoprotein particle receptor activity;, P:ammon gyrus development; P:cellular response to cholesterol; P:cellular response to growth factor stimulus; P:chemical synaptic transmission; P:cytokine-mediated signaling pathway; P:dendrite morphogenesis; P:endocytosis; P:layer formation in cerebral cortex; P:lipid metabolic process; P:modulation of chemical synaptic transmission; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:proteolysis; P:reelin-mediated signaling pathway; P:regulation of apoptotic process; P:regulation of innate immune response; P:response to drug; P:retinoid metabolic process; P:signal transduction; P:ventral spinal cord development; scaffold5 indexed_genome mRNA 6592642 6647594 . - . ID=transcript_1244;Q9BTX1 B4DHA3 B4DQQ5 G3XA81 Q8NB76 Q9H9T6 Q9NSG3 Q9NSG4 Q9NVZ7,Nucleoporin NDC1,Transmembrane protein 48;, PF09531;, GO:0015629;GO:0005737;GO:0043657;GO:0016021;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0070762;GO:0005886;GO:0017056;GO:0007129;GO:0075733;GO:0007084;GO:0006406;GO:0051292;GO:0051664;GO:0006999;GO:0016925;GO:0015031;GO:1900034;GO:0060964;GO:0006110;GO:0007283;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:actin cytoskeleton; C:cytoplasm; C:host cell; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore transmembrane ring; C:plasma membrane;, F:structural constituent of nuclear pore;, P:homologous chromosome pairing at meiosis; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear pore complex assembly; P:nuclear pore localization; P:nuclear pore organization; P:protein sumoylation; P:protein transport; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:spermatogenesis; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold5 indexed_genome mRNA 6661559 6695606 . - . ID=transcript_1245;Q9Y548 B2RCM7 D3DQ40 Q9NWJ1,Protein YIPF1,YIP1 family member 1;, PF04893;, GO:0005794;GO:0005797;GO:0000138;GO:0016021;GO:0031902;GO:0005654;GO:0005886;GO:0005802;GO:0030133;GO:0031267;GO:0016192;, C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi trans cisterna; C:integral component of membrane; C:late endosome membrane; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network; C:transport vesicle;, F:small GTPase binding;, P:vesicle-mediated transport; scaffold5 indexed_genome mRNA 6708744 6724374 . + . ID=transcript_1246;Q6Q4C7 Q6Q4C9 Q8WWC6,Type I iodothyronine deiodinase,5DI;DIOI;Type 1 DI;Type-I 5'-deiodinase;, PF00837;, GO:0005789;GO:0016021;GO:0005886;GO:0008430;GO:0004800;GO:0006520;GO:0042446;GO:0006590;GO:0042403;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:selenium binding; F:thyroxine 5'-deiodinase activity;, P:cellular amino acid metabolic process; P:hormone biosynthetic process; P:thyroid hormone generation; P:thyroid hormone metabolic process; scaffold5 indexed_genome mRNA 6738503 6771711 . - . ID=transcript_1247;Q9Y547 A6NG57 D3DQ45 Q9Y684,Intraflagellar transport protein 25 homolog,Heat shock protein beta-11;Placental protein 25;, PF00754;, GO:0005813;GO:0097542;GO:0005929;GO:0030992;GO:0046872;GO:0030154;GO:0035735;GO:0001822;GO:0007283;, C:centrosome; C:ciliary tip; C:cilium; C:intraciliary transport particle B;, F:metal ion binding;, P:cell differentiation; P:intraciliary transport involved in cilium assembly; P:kidney development; P:spermatogenesis;|Q9Y547 A6NG57 D3DQ45 Q9Y684,Intraflagellar transport protein 25 homolog,Heat shock protein beta-11;Placental protein 25;, PF00754;, GO:0005813;GO:0097542;GO:0005929;GO:0030992;GO:0046872;GO:0030154;GO:0035735;GO:0001822;GO:0007283;, C:centrosome; C:ciliary tip; C:cilium; C:intraciliary transport particle B;, F:metal ion binding;, P:cell differentiation; P:intraciliary transport involved in cilium assembly; P:kidney development; P:spermatogenesis;|Q9Y547 A6NG57 D3DQ45 Q9Y684,Intraflagellar transport protein 25 homolog,Heat shock protein beta-11;Placental protein 25;, PF00754;, GO:0005813;GO:0097542;GO:0005929;GO:0030992;GO:0046872;GO:0030154;GO:0035735;GO:0001822;GO:0007283;, C:centrosome; C:ciliary tip; C:cilium; C:intraciliary transport particle B;, F:metal ion binding;, P:cell differentiation; P:intraciliary transport involved in cilium assembly; P:kidney development; P:spermatogenesis;|Q9Y547 A6NG57 D3DQ45 Q9Y684,Intraflagellar transport protein 25 homolog,Heat shock protein beta-11;Placental protein 25;, PF00754;, GO:0005813;GO:0097542;GO:0005929;GO:0030992;GO:0046872;GO:0030154;GO:0035735;GO:0001822;GO:0007283;, C:centrosome; C:ciliary tip; C:cilium; C:intraciliary transport particle B;, F:metal ion binding;, P:cell differentiation; P:intraciliary transport involved in cilium assembly; P:kidney development; P:spermatogenesis; scaffold5 indexed_genome mRNA 6772426 6796707 . + . ID=transcript_1248;Q9Y546 D3DQ46 Q8N2Q8,Leucine-rich repeat-containing protein 42,, PF13516;|Q9Y546 D3DQ46 Q8N2Q8,Leucine-rich repeat-containing protein 42,, PF13516;|Q9Y546 D3DQ46 Q8N2Q8,Leucine-rich repeat-containing protein 42,, PF13516;|Q9Y546 D3DQ46 Q8N2Q8,Leucine-rich repeat-containing protein 42,, PF13516;|Q9Y546 D3DQ46 Q8N2Q8,Leucine-rich repeat-containing protein 42,, PF13516;|Q9Y546 D3DQ46 Q8N2Q8,Leucine-rich repeat-containing protein 42,, PF13516; scaffold5 indexed_genome mRNA 6810841 6813957 . - . ID=transcript_1249;Q5T700 A0PJY0 B7ZME3 Q5T6Z9,Low-density lipoprotein receptor class A domain-containing protein 1,, PF00057;, GO:0016021;, C:integral component of membrane; scaffold5 indexed_genome mRNA 6827062 6854162 . - . ID=transcript_1250;Q9BXS4 B3KQL7 O75393 Q4VBP9 Q5T705 Q96KX7,Transmembrane protein 59,Liver membrane-bound protein;, PF12280;, GO:0070062;GO:0000137;GO:0005797;GO:0000139;GO:0000138;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005886;GO:0004175;GO:0006914;GO:0090285;GO:1903077;GO:0010955;GO:0010508;, C:extracellular exosome; C:Golgi cis cisterna; C:Golgi medial cisterna; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:endopeptidase activity;, P:autophagy; P:negative regulation of protein glycosylation in Golgi; P:negative regulation of protein localization to plasma membrane; P:negative regulation of protein processing; P:positive regulation of autophagy;|Q9BXS4 B3KQL7 O75393 Q4VBP9 Q5T705 Q96KX7,Transmembrane protein 59,Liver membrane-bound protein;, PF12280;, GO:0070062;GO:0000137;GO:0005797;GO:0000139;GO:0000138;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005886;GO:0004175;GO:0006914;GO:0090285;GO:1903077;GO:0010955;GO:0010508;, C:extracellular exosome; C:Golgi cis cisterna; C:Golgi medial cisterna; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:endopeptidase activity;, P:autophagy; P:negative regulation of protein glycosylation in Golgi; P:negative regulation of protein localization to plasma membrane; P:negative regulation of protein processing; P:positive regulation of autophagy;|Q9BXS4 B3KQL7 O75393 Q4VBP9 Q5T705 Q96KX7,Transmembrane protein 59,Liver membrane-bound protein;, PF12280;, GO:0070062;GO:0000137;GO:0005797;GO:0000139;GO:0000138;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005886;GO:0004175;GO:0006914;GO:0090285;GO:1903077;GO:0010955;GO:0010508;, C:extracellular exosome; C:Golgi cis cisterna; C:Golgi medial cisterna; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:endopeptidase activity;, P:autophagy; P:negative regulation of protein glycosylation in Golgi; P:negative regulation of protein localization to plasma membrane; P:negative regulation of protein processing; P:positive regulation of autophagy;|Q9BXS4 B3KQL7 O75393 Q4VBP9 Q5T705 Q96KX7,Transmembrane protein 59,Liver membrane-bound protein;, PF12280;, GO:0070062;GO:0000137;GO:0005797;GO:0000139;GO:0000138;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005886;GO:0004175;GO:0006914;GO:0090285;GO:1903077;GO:0010955;GO:0010508;, C:extracellular exosome; C:Golgi cis cisterna; C:Golgi medial cisterna; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:endopeptidase activity;, P:autophagy; P:negative regulation of protein glycosylation in Golgi; P:negative regulation of protein localization to plasma membrane; P:negative regulation of protein processing; P:positive regulation of autophagy;|Q9BXS4 B3KQL7 O75393 Q4VBP9 Q5T705 Q96KX7,Transmembrane protein 59,Liver membrane-bound protein;, PF12280;, GO:0070062;GO:0000137;GO:0005797;GO:0000139;GO:0000138;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005886;GO:0004175;GO:0006914;GO:0090285;GO:1903077;GO:0010955;GO:0010508;, C:extracellular exosome; C:Golgi cis cisterna; C:Golgi medial cisterna; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:endopeptidase activity;, P:autophagy; P:negative regulation of protein glycosylation in Golgi; P:negative regulation of protein localization to plasma membrane; P:negative regulation of protein processing; P:positive regulation of autophagy; scaffold5 indexed_genome mRNA 6854716 6897180 . + . ID=transcript_1251;Q96MN5 Q5T702 Q8N8N2,Transcription elongation factor A N-terminal and central domain-containing protein 2,, PF08711;, GO:0005634;GO:0006351;, C:nucleus;, , P:transcription, DNA-templated; scaffold5 indexed_genome mRNA 6965582 6983630 . - . ID=transcript_1252;Q6IPT4 B7ZBS4 Q8NF25,NADH-cytochrome b5 reductase-like,, PF00970;PF00175;PF09791;, GO:0005789;GO:0005654;GO:0004128;GO:0015701;, C:endoplasmic reticulum membrane; C:nucleoplasm;, F:cytochrome-b5 reductase activity, acting on NAD(P)H;, P:bicarbonate transport; scaffold5 indexed_genome mRNA 6988480 7007018 . + . ID=transcript_1253;Q9BZE1 Q96Q67 Q9BWR1 Q9P0P3,39S ribosomal protein L37, mitochondrial,39S ribosomal protein L2, mitochondrial;Mitochondrial large ribosomal subunit protein mL37 {ECO:0000303|PubMed:25278503};, PF07147;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9BZE1 Q96Q67 Q9BWR1 Q9P0P3,39S ribosomal protein L37, mitochondrial,39S ribosomal protein L2, mitochondrial;Mitochondrial large ribosomal subunit protein mL37 {ECO:0000303|PubMed:25278503};, PF07147;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9BZE1 Q96Q67 Q9BWR1 Q9P0P3,39S ribosomal protein L37, mitochondrial,39S ribosomal protein L2, mitochondrial;Mitochondrial large ribosomal subunit protein mL37 {ECO:0000303|PubMed:25278503};, PF07147;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold5 indexed_genome mRNA 7015716 7178859 . - . ID=transcript_1254;Q9BWW4 A8K0A9 Q5T860 Q5T861 Q9BTM0 Q9BWW3,Single-stranded DNA-binding protein 3,Sequence-specific single-stranded-DNA-binding protein;, , GO:0005634;GO:0003697;GO:0045944;, C:nucleus;, F:single-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II;|Q9BWW4 A8K0A9 Q5T860 Q5T861 Q9BTM0 Q9BWW3,Single-stranded DNA-binding protein 3,Sequence-specific single-stranded-DNA-binding protein;, , GO:0005634;GO:0003697;GO:0045944;, C:nucleus;, F:single-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II;|Q9BWW4 A8K0A9 Q5T860 Q5T861 Q9BTM0 Q9BWW3,Single-stranded DNA-binding protein 3,Sequence-specific single-stranded-DNA-binding protein;, , GO:0005634;GO:0003697;GO:0045944;, C:nucleus;, F:single-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II;|Q9BWW4 A8K0A9 Q5T860 Q5T861 Q9BTM0 Q9BWW3,Single-stranded DNA-binding protein 3,Sequence-specific single-stranded-DNA-binding protein;, , GO:0005634;GO:0003697;GO:0045944;, C:nucleus;, F:single-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II;|Q9BWW4 A8K0A9 Q5T860 Q5T861 Q9BTM0 Q9BWW3,Single-stranded DNA-binding protein 3,Sequence-specific single-stranded-DNA-binding protein;, , GO:0005634;GO:0003697;GO:0045944;, C:nucleus;, F:single-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 7308880 7339263 . + . ID=transcript_1255;Q8WXI4 B1AQ22 D3DQ50 O75187 Q52LP1 Q53ER9 Q96DI1 Q9H883,Acyl-coenzyme A thioesterase 11 {ECO:0000305|PubMed:22897136},Acyl-CoA thioester hydrolase 11;Adipose-associated thioesterase;Brown fat-inducible thioesterase;Palmitoyl-coenzyme A thioesterase {ECO:0000305|PubMed:22897136};, PF03061;PF01852;, GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0047617;GO:0052689;GO:0008289;GO:0052816;GO:0036042;GO:0102991;GO:0016290;GO:0006637;GO:0006631;GO:0035556;GO:0120163;GO:0009409;GO:0009266;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:lipid binding; F:long-chain acyl-CoA hydrolase activity; F:long-chain fatty acyl-CoA binding; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process; P:intracellular signal transduction; P:negative regulation of cold-induced thermogenesis; P:response to cold; P:response to temperature stimulus;|Q8WXI4 B1AQ22 D3DQ50 O75187 Q52LP1 Q53ER9 Q96DI1 Q9H883,Acyl-coenzyme A thioesterase 11 {ECO:0000305|PubMed:22897136},Acyl-CoA thioester hydrolase 11;Adipose-associated thioesterase;Brown fat-inducible thioesterase;Palmitoyl-coenzyme A thioesterase {ECO:0000305|PubMed:22897136};, PF03061;PF01852;, GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0047617;GO:0052689;GO:0008289;GO:0052816;GO:0036042;GO:0102991;GO:0016290;GO:0006637;GO:0006631;GO:0035556;GO:0120163;GO:0009409;GO:0009266;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:lipid binding; F:long-chain acyl-CoA hydrolase activity; F:long-chain fatty acyl-CoA binding; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process; P:intracellular signal transduction; P:negative regulation of cold-induced thermogenesis; P:response to cold; P:response to temperature stimulus;|Q8WXI4 B1AQ22 D3DQ50 O75187 Q52LP1 Q53ER9 Q96DI1 Q9H883,Acyl-coenzyme A thioesterase 11 {ECO:0000305|PubMed:22897136},Acyl-CoA thioester hydrolase 11;Adipose-associated thioesterase;Brown fat-inducible thioesterase;Palmitoyl-coenzyme A thioesterase {ECO:0000305|PubMed:22897136};, PF03061;PF01852;, GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0047617;GO:0052689;GO:0008289;GO:0052816;GO:0036042;GO:0102991;GO:0016290;GO:0006637;GO:0006631;GO:0035556;GO:0120163;GO:0009409;GO:0009266;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:lipid binding; F:long-chain acyl-CoA hydrolase activity; F:long-chain fatty acyl-CoA binding; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process; P:intracellular signal transduction; P:negative regulation of cold-induced thermogenesis; P:response to cold; P:response to temperature stimulus; scaffold5 indexed_genome mRNA 7437488 7469373 . + . ID=transcript_1256;O95801 Q53Y95 Q5TA96 Q9H3I2,Tetratricopeptide repeat protein 4,, PF18972;, GO:0005737;GO:0005654;GO:0005634;GO:0051879;GO:0051607;GO:0045087;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:Hsp90 protein binding;, P:defense response to virus; P:innate immune response;|O95801 Q53Y95 Q5TA96 Q9H3I2,Tetratricopeptide repeat protein 4,, PF18972;, GO:0005737;GO:0005654;GO:0005634;GO:0051879;GO:0051607;GO:0045087;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:Hsp90 protein binding;, P:defense response to virus; P:innate immune response;|O95801 Q53Y95 Q5TA96 Q9H3I2,Tetratricopeptide repeat protein 4,, PF18972;, GO:0005737;GO:0005654;GO:0005634;GO:0051879;GO:0051607;GO:0045087;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:Hsp90 protein binding;, P:defense response to virus; P:innate immune response;|O95801 Q53Y95 Q5TA96 Q9H3I2,Tetratricopeptide repeat protein 4,, PF18972;, GO:0005737;GO:0005654;GO:0005634;GO:0051879;GO:0051607;GO:0045087;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:Hsp90 protein binding;, P:defense response to virus; P:innate immune response; scaffold5 indexed_genome mRNA 7472932 7478827 . - . ID=transcript_1257;Q7L3T8 A8K0W4 Q9H6S5 Q9UFT1,Probable proline--tRNA ligase, mitochondrial,Prolyl-tRNA synthetase;, PF03129;PF00587;, GO:0005759;GO:0005739;GO:0005524;GO:0004827;GO:0006433;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:proline-tRNA ligase activity;, P:prolyl-tRNA aminoacylation; scaffold5 indexed_genome mRNA 7492768 7516106 . - . ID=transcript_1258;Q5TAA0 Q9NWT4,Tetratricopeptide repeat protein 22 scaffold5 indexed_genome mRNA 7558666 7590832 . - . ID=transcript_1259;Q15392 B7Z817 D3DQ51 Q9HBA8,Delta(24)-sterol reductase,24-dehydrocholesterol reductase;3-beta-hydroxysterol Delta-24-reductase;Diminuto/dwarf1 homolog;Seladin-1 {ECO:0000303|PubMed:11007892};, PF01565;, GO:0005737;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0016020;GO:0005634;GO:0000246;GO:0050614;GO:0019899;GO:0071949;GO:0016628;GO:0042605;GO:0006915;GO:0007050;GO:0006695;GO:0033489;GO:0033490;GO:0043066;GO:0043154;GO:1901214;GO:0006979;GO:0043588;GO:0008202;GO:0009888;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nucleus;, F:delta24(24-1) sterol reductase activity; F:delta24-sterol reductase activity; F:enzyme binding; F:FAD binding; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; F:peptide antigen binding;, P:apoptotic process; P:cell cycle arrest; P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of neuron death; P:response to oxidative stress; P:skin development; P:steroid metabolic process; P:tissue development;|Q15392 B7Z817 D3DQ51 Q9HBA8,Delta(24)-sterol reductase,24-dehydrocholesterol reductase;3-beta-hydroxysterol Delta-24-reductase;Diminuto/dwarf1 homolog;Seladin-1 {ECO:0000303|PubMed:11007892};, PF01565;, GO:0005737;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0016020;GO:0005634;GO:0000246;GO:0050614;GO:0019899;GO:0071949;GO:0016628;GO:0042605;GO:0006915;GO:0007050;GO:0006695;GO:0033489;GO:0033490;GO:0043066;GO:0043154;GO:1901214;GO:0006979;GO:0043588;GO:0008202;GO:0009888;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nucleus;, F:delta24(24-1) sterol reductase activity; F:delta24-sterol reductase activity; F:enzyme binding; F:FAD binding; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; F:peptide antigen binding;, P:apoptotic process; P:cell cycle arrest; P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of neuron death; P:response to oxidative stress; P:skin development; P:steroid metabolic process; P:tissue development;|Q15392 B7Z817 D3DQ51 Q9HBA8,Delta(24)-sterol reductase,24-dehydrocholesterol reductase;3-beta-hydroxysterol Delta-24-reductase;Diminuto/dwarf1 homolog;Seladin-1 {ECO:0000303|PubMed:11007892};, PF01565;, GO:0005737;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0016020;GO:0005634;GO:0000246;GO:0050614;GO:0019899;GO:0071949;GO:0016628;GO:0042605;GO:0006915;GO:0007050;GO:0006695;GO:0033489;GO:0033490;GO:0043066;GO:0043154;GO:1901214;GO:0006979;GO:0043588;GO:0008202;GO:0009888;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nucleus;, F:delta24(24-1) sterol reductase activity; F:delta24-sterol reductase activity; F:enzyme binding; F:FAD binding; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; F:peptide antigen binding;, P:apoptotic process; P:cell cycle arrest; P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of neuron death; P:response to oxidative stress; P:skin development; P:steroid metabolic process; P:tissue development;|Q15392 B7Z817 D3DQ51 Q9HBA8,Delta(24)-sterol reductase,24-dehydrocholesterol reductase;3-beta-hydroxysterol Delta-24-reductase;Diminuto/dwarf1 homolog;Seladin-1 {ECO:0000303|PubMed:11007892};, PF01565;, GO:0005737;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0016020;GO:0005634;GO:0000246;GO:0050614;GO:0019899;GO:0071949;GO:0016628;GO:0042605;GO:0006915;GO:0007050;GO:0006695;GO:0033489;GO:0033490;GO:0043066;GO:0043154;GO:1901214;GO:0006979;GO:0043588;GO:0008202;GO:0009888;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nucleus;, F:delta24(24-1) sterol reductase activity; F:delta24-sterol reductase activity; F:enzyme binding; F:FAD binding; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; F:peptide antigen binding;, P:apoptotic process; P:cell cycle arrest; P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of neuron death; P:response to oxidative stress; P:skin development; P:steroid metabolic process; P:tissue development; scaffold5 indexed_genome mRNA 7622585 7635610 . + . ID=transcript_1260;Q8N0U2,Transmembrane protein 61,, PF15105;, GO:0016021;, C:integral component of membrane; scaffold5 indexed_genome mRNA 7680130 7788950 . - . ID=transcript_1261;Q9UPU5 Q6ZSY2 Q8N2Y4 Q9NXD1,Ubiquitin carboxyl-terminal hydrolase 24,Deubiquitinating enzyme 24;Ubiquitin thioesterase 24;Ubiquitin-specific-processing protease 24;, PF12030;PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9UPU5 Q6ZSY2 Q8N2Y4 Q9NXD1,Ubiquitin carboxyl-terminal hydrolase 24,Deubiquitinating enzyme 24;Ubiquitin thioesterase 24;Ubiquitin-specific-processing protease 24;, PF12030;PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9UPU5 Q6ZSY2 Q8N2Y4 Q9NXD1,Ubiquitin carboxyl-terminal hydrolase 24,Deubiquitinating enzyme 24;Ubiquitin thioesterase 24;Ubiquitin-specific-processing protease 24;, PF12030;PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9UPU5 Q6ZSY2 Q8N2Y4 Q9NXD1,Ubiquitin carboxyl-terminal hydrolase 24,Deubiquitinating enzyme 24;Ubiquitin thioesterase 24;Ubiquitin-specific-processing protease 24;, PF12030;PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9UPU5 Q6ZSY2 Q8N2Y4 Q9NXD1,Ubiquitin carboxyl-terminal hydrolase 24,Deubiquitinating enzyme 24;Ubiquitin thioesterase 24;Ubiquitin-specific-processing protease 24;, PF12030;PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold5 indexed_genome mRNA 9181396 9269986 . - . ID=transcript_1262;O14495 B2R651 D3DQ52 Q5U0F7 Q96GW0 Q99782,Phospholipid phosphatase 3 {ECO:0000305},Lipid phosphate phosphohydrolase 3;PAP2-beta;Phosphatidate phosphohydrolase type 2b;Phosphatidic acid phosphatase 2b;Vascular endothelial growth factor and type I collagen-inducible protein {ECO:0000303|PubMed:12660161};, PF01569;, GO:0005912;GO:0016323;GO:0070971;GO:0005789;GO:0033116;GO:0005794;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0005802;GO:0106235;GO:0005178;GO:0042577;GO:0008195;GO:0042392;GO:0060070;GO:0044329;GO:0044328;GO:0044330;GO:0033631;GO:0006672;GO:0034109;GO:0007229;GO:0001933;GO:0046839;GO:0006644;GO:0051091;GO:0050821;GO:0030111;GO:0006890;GO:0007165;GO:0030148;GO:0006670;, C:adherens junction; C:basolateral plasma membrane; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane; C:trans-Golgi network;, F:ceramide-1-phosphate phosphatase activity; F:integrin binding; F:lipid phosphatase activity; F:phosphatidate phosphatase activity; F:sphingosine-1-phosphate phosphatase activity;, P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion; P:canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration; P:canonical Wnt signaling pathway involved in positive regulation of wound healing; P:cell-cell adhesion mediated by integrin; P:ceramide metabolic process; P:homotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:negative regulation of protein phosphorylation; P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:positive regulation of DNA-binding transcription factor activity; P:protein stabilization; P:regulation of Wnt signaling pathway; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:signal transduction; P:sphingolipid biosynthetic process; P:sphingosine metabolic process; scaffold5 indexed_genome mRNA 9353919 9520569 . + . ID=transcript_1263;P54646 Q9H1E8 Q9UD43,5'-AMP-activated protein kinase catalytic subunit alpha-2,Acetyl-CoA carboxylase kinase;Hydroxymethylglutaryl-CoA reductase kinase;, PF16579;PF00069;, GO:0030424;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0005794;GO:0043025;GO:0016607;GO:0005654;GO:0005634;GO:0050405;GO:0047322;GO:0004679;GO:0005524;GO:0003682;GO:0035174;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0006853;GO:0007050;GO:0071277;GO:0035690;GO:0042149;GO:0071333;GO:0031669;GO:0034599;GO:0071380;GO:0006695;GO:0097009;GO:0006633;GO:0055089;GO:0042593;GO:0035556;GO:0008610;GO:0016236;GO:0043066;GO:0010629;GO:0032007;GO:1904428;GO:0010508;GO:1903829;GO:0045821;GO:0016239;GO:2000758;GO:0006468;GO:0042752;GO:0042304;GO:0016241;GO:0070507;GO:1901796;GO:0062028;GO:0014850;GO:0048511;GO:0007165;GO:0016055;, C:axon; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:Golgi apparatus; C:neuronal cell body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:[acetyl-CoA carboxylase] kinase activity; F:[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; F:AMP-activated protein kinase activity; F:ATP binding; F:chromatin binding; F:histone serine kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:carnitine shuttle; P:cell cycle arrest; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to nutrient levels; P:cellular response to oxidative stress; P:cellular response to prostaglandin E stimulus; P:cholesterol biosynthetic process; P:energy homeostasis; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:glucose homeostasis; P:intracellular signal transduction; P:lipid biosynthetic process; P:macroautophagy; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of TOR signaling; P:negative regulation of tubulin deacetylation; P:positive regulation of autophagy; P:positive regulation of cellular protein localization; P:positive regulation of glycolytic process; P:positive regulation of macroautophagy; P:positive regulation of peptidyl-lysine acetylation; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of fatty acid biosynthetic process; P:regulation of macroautophagy; P:regulation of microtubule cytoskeleton organization; P:regulation of signal transduction by p53 class mediator; P:regulation of stress granule assembly; P:response to muscle activity; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway;|P54646 Q9H1E8 Q9UD43,5'-AMP-activated protein kinase catalytic subunit alpha-2,Acetyl-CoA carboxylase kinase;Hydroxymethylglutaryl-CoA reductase kinase;, PF16579;PF00069;, GO:0030424;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0005794;GO:0043025;GO:0016607;GO:0005654;GO:0005634;GO:0050405;GO:0047322;GO:0004679;GO:0005524;GO:0003682;GO:0035174;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0006853;GO:0007050;GO:0071277;GO:0035690;GO:0042149;GO:0071333;GO:0031669;GO:0034599;GO:0071380;GO:0006695;GO:0097009;GO:0006633;GO:0055089;GO:0042593;GO:0035556;GO:0008610;GO:0016236;GO:0043066;GO:0010629;GO:0032007;GO:1904428;GO:0010508;GO:1903829;GO:0045821;GO:0016239;GO:2000758;GO:0006468;GO:0042752;GO:0042304;GO:0016241;GO:0070507;GO:1901796;GO:0062028;GO:0014850;GO:0048511;GO:0007165;GO:0016055;, C:axon; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:Golgi apparatus; C:neuronal cell body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:[acetyl-CoA carboxylase] kinase activity; F:[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; F:AMP-activated protein kinase activity; F:ATP binding; F:chromatin binding; F:histone serine kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:carnitine shuttle; P:cell cycle arrest; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to nutrient levels; P:cellular response to oxidative stress; P:cellular response to prostaglandin E stimulus; P:cholesterol biosynthetic process; P:energy homeostasis; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:glucose homeostasis; P:intracellular signal transduction; P:lipid biosynthetic process; P:macroautophagy; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of TOR signaling; P:negative regulation of tubulin deacetylation; P:positive regulation of autophagy; P:positive regulation of cellular protein localization; P:positive regulation of glycolytic process; P:positive regulation of macroautophagy; P:positive regulation of peptidyl-lysine acetylation; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of fatty acid biosynthetic process; P:regulation of macroautophagy; P:regulation of microtubule cytoskeleton organization; P:regulation of signal transduction by p53 class mediator; P:regulation of stress granule assembly; P:response to muscle activity; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway;|Q5VWT5 Q63HM3 Q6ZUY6,FYN-binding protein 2 {ECO:0000312|HGNC:HGNC:27295},Activation-dependent, raft-recruited ADAP-like phosphoprotein {ECO:0000303|PubMed:27335501};, PF14603;, GO:0001772;GO:0045121;GO:0005886;GO:0033627;GO:0007229;GO:0072659;GO:0050852;, C:immunological synapse; C:membrane raft; C:plasma membrane;, , P:cell adhesion mediated by integrin; P:integrin-mediated signaling pathway; P:protein localization to plasma membrane; P:T cell receptor signaling pathway;|Q5VWT5 Q63HM3 Q6ZUY6,FYN-binding protein 2 {ECO:0000312|HGNC:HGNC:27295},Activation-dependent, raft-recruited ADAP-like phosphoprotein {ECO:0000303|PubMed:27335501};, PF14603;, GO:0001772;GO:0045121;GO:0005886;GO:0033627;GO:0007229;GO:0072659;GO:0050852;, C:immunological synapse; C:membrane raft; C:plasma membrane;, , P:cell adhesion mediated by integrin; P:integrin-mediated signaling pathway; P:protein localization to plasma membrane; P:T cell receptor signaling pathway;|Q5VWT5 Q63HM3 Q6ZUY6,FYN-binding protein 2 {ECO:0000312|HGNC:HGNC:27295},Activation-dependent, raft-recruited ADAP-like phosphoprotein {ECO:0000303|PubMed:27335501};, PF14603;, GO:0001772;GO:0045121;GO:0005886;GO:0033627;GO:0007229;GO:0072659;GO:0050852;, C:immunological synapse; C:membrane raft; C:plasma membrane;, , P:cell adhesion mediated by integrin; P:integrin-mediated signaling pathway; P:protein localization to plasma membrane; P:T cell receptor signaling pathway; scaffold5 indexed_genome mRNA 9581285 9635813 . + . ID=transcript_1264;P07357 A2RUI4 A2RUI5 Q13668 Q9H130,Complement component C8 alpha chain,Complement component 8 subunit alpha;, PF00057;PF01823;PF00090;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005579;GO:0001848;GO:0044877;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0006955;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:membrane attack complex;, F:complement binding; F:protein-containing complex binding;, P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:immune response; P:regulation of complement activation;|P07357 A2RUI4 A2RUI5 Q13668 Q9H130,Complement component C8 alpha chain,Complement component 8 subunit alpha;, PF00057;PF01823;PF00090;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005579;GO:0001848;GO:0044877;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0006955;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:membrane attack complex;, F:complement binding; F:protein-containing complex binding;, P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:immune response; P:regulation of complement activation;|P07357 A2RUI4 A2RUI5 Q13668 Q9H130,Complement component C8 alpha chain,Complement component 8 subunit alpha;, PF00057;PF01823;PF00090;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005579;GO:0001848;GO:0044877;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0006955;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:membrane attack complex;, F:complement binding; F:protein-containing complex binding;, P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:immune response; P:regulation of complement activation; scaffold5 indexed_genome mRNA 9641760 9686044 . - . ID=transcript_1265;P07358 A1L4K7,Complement component C8 beta chain,Complement component 8 subunit beta;, PF00057;PF01823;PF00090;, GO:0070062;GO:0005576;GO:1903561;GO:0016020;GO:0005579;GO:0044877;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0006955;GO:0030449;, C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:membrane; C:membrane attack complex;, F:protein-containing complex binding;, P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:immune response; P:regulation of complement activation; scaffold5 indexed_genome mRNA 11246358 11297057 . - . ID=transcript_1266;Q96E52 D3DQ54 Q5T3G6 Q5T3G7 Q5T3G8 Q5T3G9 Q5T3H0 Q8NBB3,Metalloendopeptidase OMA1, mitochondrial {ECO:0000305},Metalloprotease-related protein 1 {ECO:0000303|PubMed:12886954};Overlapping with the m-AAA protease 1 homolog {ECO:0000303|PubMed:20038677};, PF01435;, GO:0016021;GO:0005743;GO:0031966;GO:0008289;GO:0046872;GO:0004222;GO:0002024;GO:0097009;GO:0006006;GO:0140468;GO:0140467;GO:0006629;GO:0034982;GO:0033108;GO:0010637;GO:0043065;GO:0120162;GO:0016540;GO:0006515;GO:0042981;GO:1903850;GO:0031638;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane;, F:lipid binding; F:metal ion binding; F:metalloendopeptidase activity;, P:diet induced thermogenesis; P:energy homeostasis; P:glucose metabolic process; P:HRI-mediated signaling; P:integrated stress response signaling; P:lipid metabolic process; P:mitochondrial protein processing; P:mitochondrial respiratory chain complex assembly; P:negative regulation of mitochondrial fusion; P:positive regulation of apoptotic process; P:positive regulation of cold-induced thermogenesis; P:protein autoprocessing; P:protein quality control for misfolded or incompletely synthesized proteins; P:regulation of apoptotic process; P:regulation of cristae formation; P:zymogen activation;|Q96E52 D3DQ54 Q5T3G6 Q5T3G7 Q5T3G8 Q5T3G9 Q5T3H0 Q8NBB3,Metalloendopeptidase OMA1, mitochondrial {ECO:0000305},Metalloprotease-related protein 1 {ECO:0000303|PubMed:12886954};Overlapping with the m-AAA protease 1 homolog {ECO:0000303|PubMed:20038677};, PF01435;, GO:0016021;GO:0005743;GO:0031966;GO:0008289;GO:0046872;GO:0004222;GO:0002024;GO:0097009;GO:0006006;GO:0140468;GO:0140467;GO:0006629;GO:0034982;GO:0033108;GO:0010637;GO:0043065;GO:0120162;GO:0016540;GO:0006515;GO:0042981;GO:1903850;GO:0031638;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane;, F:lipid binding; F:metal ion binding; F:metalloendopeptidase activity;, P:diet induced thermogenesis; P:energy homeostasis; P:glucose metabolic process; P:HRI-mediated signaling; P:integrated stress response signaling; P:lipid metabolic process; P:mitochondrial protein processing; P:mitochondrial respiratory chain complex assembly; P:negative regulation of mitochondrial fusion; P:positive regulation of apoptotic process; P:positive regulation of cold-induced thermogenesis; P:protein autoprocessing; P:protein quality control for misfolded or incompletely synthesized proteins; P:regulation of apoptotic process; P:regulation of cristae formation; P:zymogen activation;|Q96E52 D3DQ54 Q5T3G6 Q5T3G7 Q5T3G8 Q5T3G9 Q5T3H0 Q8NBB3,Metalloendopeptidase OMA1, mitochondrial {ECO:0000305},Metalloprotease-related protein 1 {ECO:0000303|PubMed:12886954};Overlapping with the m-AAA protease 1 homolog {ECO:0000303|PubMed:20038677};, PF01435;, GO:0016021;GO:0005743;GO:0031966;GO:0008289;GO:0046872;GO:0004222;GO:0002024;GO:0097009;GO:0006006;GO:0140468;GO:0140467;GO:0006629;GO:0034982;GO:0033108;GO:0010637;GO:0043065;GO:0120162;GO:0016540;GO:0006515;GO:0042981;GO:1903850;GO:0031638;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane;, F:lipid binding; F:metal ion binding; F:metalloendopeptidase activity;, P:diet induced thermogenesis; P:energy homeostasis; P:glucose metabolic process; P:HRI-mediated signaling; P:integrated stress response signaling; P:lipid metabolic process; P:mitochondrial protein processing; P:mitochondrial respiratory chain complex assembly; P:negative regulation of mitochondrial fusion; P:positive regulation of apoptotic process; P:positive regulation of cold-induced thermogenesis; P:protein autoprocessing; P:protein quality control for misfolded or incompletely synthesized proteins; P:regulation of apoptotic process; P:regulation of cristae formation; P:zymogen activation;|Q96E52 D3DQ54 Q5T3G6 Q5T3G7 Q5T3G8 Q5T3G9 Q5T3H0 Q8NBB3,Metalloendopeptidase OMA1, mitochondrial {ECO:0000305},Metalloprotease-related protein 1 {ECO:0000303|PubMed:12886954};Overlapping with the m-AAA protease 1 homolog {ECO:0000303|PubMed:20038677};, PF01435;, GO:0016021;GO:0005743;GO:0031966;GO:0008289;GO:0046872;GO:0004222;GO:0002024;GO:0097009;GO:0006006;GO:0140468;GO:0140467;GO:0006629;GO:0034982;GO:0033108;GO:0010637;GO:0043065;GO:0120162;GO:0016540;GO:0006515;GO:0042981;GO:1903850;GO:0031638;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane;, F:lipid binding; F:metal ion binding; F:metalloendopeptidase activity;, P:diet induced thermogenesis; P:energy homeostasis; P:glucose metabolic process; P:HRI-mediated signaling; P:integrated stress response signaling; P:lipid metabolic process; P:mitochondrial protein processing; P:mitochondrial respiratory chain complex assembly; P:negative regulation of mitochondrial fusion; P:positive regulation of apoptotic process; P:positive regulation of cold-induced thermogenesis; P:protein autoprocessing; P:protein quality control for misfolded or incompletely synthesized proteins; P:regulation of apoptotic process; P:regulation of cristae formation; P:zymogen activation; scaffold5 indexed_genome mRNA 11325967 11327973 . + . ID=transcript_1267;P09758 Q15658 Q6FG48 Q7Z7Q4 Q96QD2,Tumor-associated calcium signal transducer 2,Cell surface glycoprotein Trop-2;Membrane component chromosome 1 surface marker 1;Pancreatic carcinoma marker protein GA733-1;, PF00086;, GO:0009925;GO:0005829;GO:0070062;GO:0005615;GO:0016021;GO:0016328;GO:0016020;GO:0005634;GO:0090191;GO:2000146;GO:0010633;GO:1900028;GO:0051497;GO:1900025;GO:2000738;GO:0050896;GO:0007601;, C:basal plasma membrane; C:cytosol; C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:lateral plasma membrane; C:membrane; C:nucleus;, , P:negative regulation of branching involved in ureteric bud morphogenesis; P:negative regulation of cell motility; P:negative regulation of epithelial cell migration; P:negative regulation of ruffle assembly; P:negative regulation of stress fiber assembly; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of stem cell differentiation; P:response to stimulus; P:visual perception; scaffold5 indexed_genome mRNA 11395252 11435084 . - . ID=transcript_1268;Q5VVJ2 A8KA54 B3KX65 Q68DD3 Q6AI53 Q7Z3G8 Q96PX3,Deubiquitinase MYSM1,Myb-like, SWIRM and MPN domain-containing protein 1;, PF01398;PF00249;PF04433;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042393;GO:0070122;GO:0046872;GO:0008237;GO:0004843;GO:0003713;GO:0006338;GO:0002376;GO:0035522;GO:0045944;GO:0016579;GO:1903706;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:histone binding; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:chromatin remodeling; P:immune system process; P:monoubiquitinated histone H2A deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of hemopoiesis;|Q5VVJ2 A8KA54 B3KX65 Q68DD3 Q6AI53 Q7Z3G8 Q96PX3,Deubiquitinase MYSM1,Myb-like, SWIRM and MPN domain-containing protein 1;, PF01398;PF00249;PF04433;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042393;GO:0070122;GO:0046872;GO:0008237;GO:0004843;GO:0003713;GO:0006338;GO:0002376;GO:0035522;GO:0045944;GO:0016579;GO:1903706;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:histone binding; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:chromatin remodeling; P:immune system process; P:monoubiquitinated histone H2A deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of hemopoiesis;|Q5VVJ2 A8KA54 B3KX65 Q68DD3 Q6AI53 Q7Z3G8 Q96PX3,Deubiquitinase MYSM1,Myb-like, SWIRM and MPN domain-containing protein 1;, PF01398;PF00249;PF04433;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042393;GO:0070122;GO:0046872;GO:0008237;GO:0004843;GO:0003713;GO:0006338;GO:0002376;GO:0035522;GO:0045944;GO:0016579;GO:1903706;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:histone binding; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:chromatin remodeling; P:immune system process; P:monoubiquitinated histone H2A deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of hemopoiesis;|Q5VVJ2 A8KA54 B3KX65 Q68DD3 Q6AI53 Q7Z3G8 Q96PX3,Deubiquitinase MYSM1,Myb-like, SWIRM and MPN domain-containing protein 1;, PF01398;PF00249;PF04433;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042393;GO:0070122;GO:0046872;GO:0008237;GO:0004843;GO:0003713;GO:0006338;GO:0002376;GO:0035522;GO:0045944;GO:0016579;GO:1903706;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:histone binding; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:chromatin remodeling; P:immune system process; P:monoubiquitinated histone H2A deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of hemopoiesis; scaffold5 indexed_genome mRNA 12077653 12543931 . + . ID=transcript_1269;Q96C11 B1AK92 B1AK93 B1AK94 B2RDR8 D3DQ56 Q9HA63 Q9NV20,FGGY carbohydrate kinase domain-containing protein,, PF02782;PF00370;, GO:0019150;GO:0046835;GO:0070050;GO:0019321;, , F:D-ribulokinase activity;, P:carbohydrate phosphorylation; P:neuron cellular homeostasis; P:pentose metabolic process; scaffold5 indexed_genome mRNA 12584572 12656365 . + . ID=transcript_1270;Q9UJC3 A8K8E9 A8MU44 B4DX15 O60561 Q5TG44,Protein Hook homolog 1,, PF05622;PF19047;, GO:0005813;GO:0005737;GO:0005829;GO:0070695;GO:0005874;GO:0003779;GO:0051959;GO:0042802;GO:0008017;GO:0031122;GO:0030705;GO:0045022;GO:0007032;GO:0008333;GO:0007030;GO:0007040;GO:1905198;GO:0007275;GO:0015031;, C:centrosome; C:cytoplasm; C:cytosol; C:FHF complex; C:microtubule;, F:actin binding; F:dynein light intermediate chain binding; F:identical protein binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:Golgi organization; P:lysosome organization; P:manchette assembly; P:multicellular organism development; P:protein transport;|Q9UJC3 A8K8E9 A8MU44 B4DX15 O60561 Q5TG44,Protein Hook homolog 1,, PF05622;PF19047;, GO:0005813;GO:0005737;GO:0005829;GO:0070695;GO:0005874;GO:0003779;GO:0051959;GO:0042802;GO:0008017;GO:0031122;GO:0030705;GO:0045022;GO:0007032;GO:0008333;GO:0007030;GO:0007040;GO:1905198;GO:0007275;GO:0015031;, C:centrosome; C:cytoplasm; C:cytosol; C:FHF complex; C:microtubule;, F:actin binding; F:dynein light intermediate chain binding; F:identical protein binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:Golgi organization; P:lysosome organization; P:manchette assembly; P:multicellular organism development; P:protein transport;|Q9UJC3 A8K8E9 A8MU44 B4DX15 O60561 Q5TG44,Protein Hook homolog 1,, PF05622;PF19047;, GO:0005813;GO:0005737;GO:0005829;GO:0070695;GO:0005874;GO:0003779;GO:0051959;GO:0042802;GO:0008017;GO:0031122;GO:0030705;GO:0045022;GO:0007032;GO:0008333;GO:0007030;GO:0007040;GO:1905198;GO:0007275;GO:0015031;, C:centrosome; C:cytoplasm; C:cytosol; C:FHF complex; C:microtubule;, F:actin binding; F:dynein light intermediate chain binding; F:identical protein binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:Golgi organization; P:lysosome organization; P:manchette assembly; P:multicellular organism development; P:protein transport;|Q9UJC3 A8K8E9 A8MU44 B4DX15 O60561 Q5TG44,Protein Hook homolog 1,, PF05622;PF19047;, GO:0005813;GO:0005737;GO:0005829;GO:0070695;GO:0005874;GO:0003779;GO:0051959;GO:0042802;GO:0008017;GO:0031122;GO:0030705;GO:0045022;GO:0007032;GO:0008333;GO:0007030;GO:0007040;GO:1905198;GO:0007275;GO:0015031;, C:centrosome; C:cytoplasm; C:cytosol; C:FHF complex; C:microtubule;, F:actin binding; F:dynein light intermediate chain binding; F:identical protein binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:Golgi organization; P:lysosome organization; P:manchette assembly; P:multicellular organism development; P:protein transport; scaffold5 indexed_genome mRNA 12660181 12694548 . - . ID=transcript_1271;P51589 B2RD33 Q8TF13,Cytochrome P450 2J2,Albendazole monooxygenase (hydroxylating) {ECO:0000305};Albendazole monooxygenase (sulfoxide-forming) {ECO:0000305};Arachidonic acid epoxygenase {ECO:0000303|PubMed:8631948};CYPIIJ2;Hydroperoxy icosatetraenoate isomerase {ECO:0000303|PubMed:19737933};, PF00067;, GO:0005737;GO:0005789;GO:0070062;GO:0043231;GO:0008405;GO:0008404;GO:0106301;GO:0008392;GO:0020037;GO:0106255;GO:0005506;GO:0016853;GO:0071614;GO:0016712;GO:0008395;GO:0019373;GO:0042738;GO:0006631;GO:0006690;GO:0043651;GO:0006082;GO:0008016;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle;, F:arachidonic acid 11,12-epoxygenase activity; F:arachidonic acid 14,15-epoxygenase activity; F:arachidonic acid 5,6-epoxygenase activity; F:arachidonic acid epoxygenase activity; F:heme binding; F:hydroperoxy icosatetraenoate isomerase activity; F:iron ion binding; F:isomerase activity; F:linoleic acid epoxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:fatty acid metabolic process; P:icosanoid metabolic process; P:linoleic acid metabolic process; P:organic acid metabolic process; P:regulation of heart contraction; P:xenobiotic metabolic process; scaffold5 indexed_genome mRNA 12716245 12731608 . + . ID=transcript_1272;P51589 B2RD33 Q8TF13,Cytochrome P450 2J2,Albendazole monooxygenase (hydroxylating) {ECO:0000305};Albendazole monooxygenase (sulfoxide-forming) {ECO:0000305};Arachidonic acid epoxygenase {ECO:0000303|PubMed:8631948};CYPIIJ2;Hydroperoxy icosatetraenoate isomerase {ECO:0000303|PubMed:19737933};, PF00067;, GO:0005737;GO:0005789;GO:0070062;GO:0043231;GO:0008405;GO:0008404;GO:0106301;GO:0008392;GO:0020037;GO:0106255;GO:0005506;GO:0016853;GO:0071614;GO:0016712;GO:0008395;GO:0019373;GO:0042738;GO:0006631;GO:0006690;GO:0043651;GO:0006082;GO:0008016;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle;, F:arachidonic acid 11,12-epoxygenase activity; F:arachidonic acid 14,15-epoxygenase activity; F:arachidonic acid 5,6-epoxygenase activity; F:arachidonic acid epoxygenase activity; F:heme binding; F:hydroperoxy icosatetraenoate isomerase activity; F:iron ion binding; F:isomerase activity; F:linoleic acid epoxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:fatty acid metabolic process; P:icosanoid metabolic process; P:linoleic acid metabolic process; P:organic acid metabolic process; P:regulation of heart contraction; P:xenobiotic metabolic process;|P51589 B2RD33 Q8TF13,Cytochrome P450 2J2,Albendazole monooxygenase (hydroxylating) {ECO:0000305};Albendazole monooxygenase (sulfoxide-forming) {ECO:0000305};Arachidonic acid epoxygenase {ECO:0000303|PubMed:8631948};CYPIIJ2;Hydroperoxy icosatetraenoate isomerase {ECO:0000303|PubMed:19737933};, PF00067;, GO:0005737;GO:0005789;GO:0070062;GO:0043231;GO:0008405;GO:0008404;GO:0106301;GO:0008392;GO:0020037;GO:0106255;GO:0005506;GO:0016853;GO:0071614;GO:0016712;GO:0008395;GO:0019373;GO:0042738;GO:0006631;GO:0006690;GO:0043651;GO:0006082;GO:0008016;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle;, F:arachidonic acid 11,12-epoxygenase activity; F:arachidonic acid 14,15-epoxygenase activity; F:arachidonic acid 5,6-epoxygenase activity; F:arachidonic acid epoxygenase activity; F:heme binding; F:hydroperoxy icosatetraenoate isomerase activity; F:iron ion binding; F:isomerase activity; F:linoleic acid epoxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:fatty acid metabolic process; P:icosanoid metabolic process; P:linoleic acid metabolic process; P:organic acid metabolic process; P:regulation of heart contraction; P:xenobiotic metabolic process; scaffold5 indexed_genome mRNA 12851480 12888310 . - . ID=transcript_1273;P51589 B2RD33 Q8TF13,Cytochrome P450 2J2,Albendazole monooxygenase (hydroxylating) {ECO:0000305};Albendazole monooxygenase (sulfoxide-forming) {ECO:0000305};Arachidonic acid epoxygenase {ECO:0000303|PubMed:8631948};CYPIIJ2;Hydroperoxy icosatetraenoate isomerase {ECO:0000303|PubMed:19737933};, PF00067;, GO:0005737;GO:0005789;GO:0070062;GO:0043231;GO:0008405;GO:0008404;GO:0106301;GO:0008392;GO:0020037;GO:0106255;GO:0005506;GO:0016853;GO:0071614;GO:0016712;GO:0008395;GO:0019373;GO:0042738;GO:0006631;GO:0006690;GO:0043651;GO:0006082;GO:0008016;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle;, F:arachidonic acid 11,12-epoxygenase activity; F:arachidonic acid 14,15-epoxygenase activity; F:arachidonic acid 5,6-epoxygenase activity; F:arachidonic acid epoxygenase activity; F:heme binding; F:hydroperoxy icosatetraenoate isomerase activity; F:iron ion binding; F:isomerase activity; F:linoleic acid epoxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:fatty acid metabolic process; P:icosanoid metabolic process; P:linoleic acid metabolic process; P:organic acid metabolic process; P:regulation of heart contraction; P:xenobiotic metabolic process; scaffold5 indexed_genome mRNA 14056052 14440757 . + . ID=transcript_1274;Q12857 B4DRJ3 B4DS53 F5H0R0 F8W8W3 Q8TA97 Q9H3X9 Q9P2A9,Nuclear factor 1 A-type,CCAAT-box-binding transcription factor;Nuclear factor I/A;TGGCA-binding protein;, PF00859;PF03165;PF10524;, GO:0030054;GO:0000785;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0008134;GO:0006260;GO:0045944;GO:0006357;GO:0006355;GO:0060074;GO:0072189;GO:0019079;, C:cell junction; C:chromatin; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:DNA replication; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:synapse maturation; P:ureter development; P:viral genome replication; scaffold5 indexed_genome mRNA 14624913 14671034 . - . ID=transcript_1275;Q9BX74 A6NDA8,TM2 domain-containing protein 1,Amyloid-beta-binding protein;, PF05154;, GO:0016021;GO:0001540;GO:0004930;GO:0097190;, C:integral component of membrane;, F:amyloid-beta binding; F:G protein-coupled receptor activity;, P:apoptotic signaling pathway; scaffold5 indexed_genome mRNA 14696585 15047048 . + . ID=transcript_1276;Q5VUB0 Q8WU78 Q9H3N9,InaD-like protein {ECO:0000303|PubMed:9280290},Channel-interacting PDZ domain-containing protein {ECO:0000250|UniProtKB:Q63ZW7};Pals1-associated tight junction protein {ECO:0000303|PubMed:11927608};Protein associated to tight junctions {ECO:0000303|PubMed:11964389};, PF09045;PF00595;, GO:0016324;GO:0005923;GO:0030054;GO:0034451;GO:0005829;GO:0070062;GO:0048471;GO:0005886;GO:0070830;GO:0035089;GO:0035556;GO:0120192;, C:apical plasma membrane; C:bicellular tight junction; C:cell junction; C:centriolar satellite; C:cytosol; C:extracellular exosome; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:bicellular tight junction assembly; P:establishment of apical/basal cell polarity; P:intracellular signal transduction; P:tight junction assembly;|Q5VUB0 Q8WU78 Q9H3N9,InaD-like protein {ECO:0000303|PubMed:9280290},Channel-interacting PDZ domain-containing protein {ECO:0000250|UniProtKB:Q63ZW7};Pals1-associated tight junction protein {ECO:0000303|PubMed:11927608};Protein associated to tight junctions {ECO:0000303|PubMed:11964389};, PF09045;PF00595;, GO:0016324;GO:0005923;GO:0030054;GO:0034451;GO:0005829;GO:0070062;GO:0048471;GO:0005886;GO:0070830;GO:0035089;GO:0035556;GO:0120192;, C:apical plasma membrane; C:bicellular tight junction; C:cell junction; C:centriolar satellite; C:cytosol; C:extracellular exosome; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:bicellular tight junction assembly; P:establishment of apical/basal cell polarity; P:intracellular signal transduction; P:tight junction assembly;|Q5VUB0 Q8WU78 Q9H3N9,InaD-like protein {ECO:0000303|PubMed:9280290},Channel-interacting PDZ domain-containing protein {ECO:0000250|UniProtKB:Q63ZW7};Pals1-associated tight junction protein {ECO:0000303|PubMed:11927608};Protein associated to tight junctions {ECO:0000303|PubMed:11964389};, PF09045;PF00595;, GO:0016324;GO:0005923;GO:0030054;GO:0034451;GO:0005829;GO:0070062;GO:0048471;GO:0005886;GO:0070830;GO:0035089;GO:0035556;GO:0120192;, C:apical plasma membrane; C:bicellular tight junction; C:cell junction; C:centriolar satellite; C:cytosol; C:extracellular exosome; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:bicellular tight junction assembly; P:establishment of apical/basal cell polarity; P:intracellular signal transduction; P:tight junction assembly;|Q5VUB0 Q8WU78 Q9H3N9,InaD-like protein {ECO:0000303|PubMed:9280290},Channel-interacting PDZ domain-containing protein {ECO:0000250|UniProtKB:Q63ZW7};Pals1-associated tight junction protein {ECO:0000303|PubMed:11927608};Protein associated to tight junctions {ECO:0000303|PubMed:11964389};, PF09045;PF00595;, GO:0016324;GO:0005923;GO:0030054;GO:0034451;GO:0005829;GO:0070062;GO:0048471;GO:0005886;GO:0070830;GO:0035089;GO:0035556;GO:0120192;, C:apical plasma membrane; C:bicellular tight junction; C:cell junction; C:centriolar satellite; C:cytosol; C:extracellular exosome; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:bicellular tight junction assembly; P:establishment of apical/basal cell polarity; P:intracellular signal transduction; P:tight junction assembly; scaffold5 indexed_genome mRNA 15294010 15318215 . - . ID=transcript_1277;Q5T7N3 B1ALP7 Q6P9A0 Q86T71 Q86VE6 Q8NAX3,KN motif and ankyrin repeat domain-containing protein 4,Ankyrin repeat domain-containing protein 38;, PF00023;PF12075;, GO:0005737;GO:0005856;GO:0005829;GO:0015630;GO:0030837;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:microtubule cytoskeleton;, , P:negative regulation of actin filament polymerization;|Q5T7N3 B1ALP7 Q6P9A0 Q86T71 Q86VE6 Q8NAX3,KN motif and ankyrin repeat domain-containing protein 4,Ankyrin repeat domain-containing protein 38;, PF00023;PF12075;, GO:0005737;GO:0005856;GO:0005829;GO:0015630;GO:0030837;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:microtubule cytoskeleton;, , P:negative regulation of actin filament polymerization; scaffold5 indexed_genome mRNA 15318319 15331115 . - . ID=transcript_1278;Q5T7N3 B1ALP7 Q6P9A0 Q86T71 Q86VE6 Q8NAX3,KN motif and ankyrin repeat domain-containing protein 4,Ankyrin repeat domain-containing protein 38;, PF00023;PF12075;, GO:0005737;GO:0005856;GO:0005829;GO:0015630;GO:0030837;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:microtubule cytoskeleton;, , P:negative regulation of actin filament polymerization; scaffold5 indexed_genome mRNA 15497141 15534383 . + . ID=transcript_1279;O94782 A0PJ95 D3DQ57 Q05BX7 Q59H66 Q9UFR0 Q9UNJ3,Ubiquitin carboxyl-terminal hydrolase 1,Deubiquitinating enzyme 1;Ubiquitin thioesterase 1;Ubiquitin-specific-processing protease 1;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0008233;GO:0004843;GO:0042769;GO:0036297;GO:0035520;GO:0016579;GO:0006282;GO:0009411;GO:0001501;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA damage response, detection of DNA damage; P:interstrand cross-link repair; P:monoubiquitinated protein deubiquitination; P:protein deubiquitination; P:regulation of DNA repair; P:response to UV; P:skeletal system development; P:ubiquitin-dependent protein catabolic process;|O94782 A0PJ95 D3DQ57 Q05BX7 Q59H66 Q9UFR0 Q9UNJ3,Ubiquitin carboxyl-terminal hydrolase 1,Deubiquitinating enzyme 1;Ubiquitin thioesterase 1;Ubiquitin-specific-processing protease 1;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0008233;GO:0004843;GO:0042769;GO:0036297;GO:0035520;GO:0016579;GO:0006282;GO:0009411;GO:0001501;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA damage response, detection of DNA damage; P:interstrand cross-link repair; P:monoubiquitinated protein deubiquitination; P:protein deubiquitination; P:regulation of DNA repair; P:response to UV; P:skeletal system development; P:ubiquitin-dependent protein catabolic process;|O94782 A0PJ95 D3DQ57 Q05BX7 Q59H66 Q9UFR0 Q9UNJ3,Ubiquitin carboxyl-terminal hydrolase 1,Deubiquitinating enzyme 1;Ubiquitin thioesterase 1;Ubiquitin-specific-processing protease 1;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0008233;GO:0004843;GO:0042769;GO:0036297;GO:0035520;GO:0016579;GO:0006282;GO:0009411;GO:0001501;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA damage response, detection of DNA damage; P:interstrand cross-link repair; P:monoubiquitinated protein deubiquitination; P:protein deubiquitination; P:regulation of DNA repair; P:response to UV; P:skeletal system development; P:ubiquitin-dependent protein catabolic process;|Q96NG6 Q96NI0 Q9C092,Dedicator of cytokinesis protein 7,, PF06920;PF14429;PF11878;, GO:0030424;GO:0045178;GO:0005925;GO:0030426;GO:0043005;GO:0005085;GO:0031267;GO:0090630;GO:0007409;GO:0045200;GO:0022027;GO:0000226;GO:0120163;GO:0031175;GO:0033138;GO:1904754;GO:0050767;GO:0007264;, C:axon; C:basal part of cell; C:focal adhesion; C:growth cone; C:neuron projection;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:activation of GTPase activity; P:axonogenesis; P:establishment of neuroblast polarity; P:interkinetic nuclear migration; P:microtubule cytoskeleton organization; P:negative regulation of cold-induced thermogenesis; P:neuron projection development; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of neurogenesis; P:small GTPase mediated signal transduction;|O94782 A0PJ95 D3DQ57 Q05BX7 Q59H66 Q9UFR0 Q9UNJ3,Ubiquitin carboxyl-terminal hydrolase 1,Deubiquitinating enzyme 1;Ubiquitin thioesterase 1;Ubiquitin-specific-processing protease 1;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0008233;GO:0004843;GO:0042769;GO:0036297;GO:0035520;GO:0016579;GO:0006282;GO:0009411;GO:0001501;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA damage response, detection of DNA damage; P:interstrand cross-link repair; P:monoubiquitinated protein deubiquitination; P:protein deubiquitination; P:regulation of DNA repair; P:response to UV; P:skeletal system development; P:ubiquitin-dependent protein catabolic process;|O94782 A0PJ95 D3DQ57 Q05BX7 Q59H66 Q9UFR0 Q9UNJ3,Ubiquitin carboxyl-terminal hydrolase 1,Deubiquitinating enzyme 1;Ubiquitin thioesterase 1;Ubiquitin-specific-processing protease 1;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0008233;GO:0004843;GO:0042769;GO:0036297;GO:0035520;GO:0016579;GO:0006282;GO:0009411;GO:0001501;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA damage response, detection of DNA damage; P:interstrand cross-link repair; P:monoubiquitinated protein deubiquitination; P:protein deubiquitination; P:regulation of DNA repair; P:response to UV; P:skeletal system development; P:ubiquitin-dependent protein catabolic process;|O94782 A0PJ95 D3DQ57 Q05BX7 Q59H66 Q9UFR0 Q9UNJ3,Ubiquitin carboxyl-terminal hydrolase 1,Deubiquitinating enzyme 1;Ubiquitin thioesterase 1;Ubiquitin-specific-processing protease 1;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0008233;GO:0004843;GO:0042769;GO:0036297;GO:0035520;GO:0016579;GO:0006282;GO:0009411;GO:0001501;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA damage response, detection of DNA damage; P:interstrand cross-link repair; P:monoubiquitinated protein deubiquitination; P:protein deubiquitination; P:regulation of DNA repair; P:response to UV; P:skeletal system development; P:ubiquitin-dependent protein catabolic process;|Q96NG6 Q96NI0 Q9C092,Dedicator of cytokinesis protein 7,, PF06920;PF14429;PF11878;, GO:0030424;GO:0045178;GO:0005925;GO:0030426;GO:0043005;GO:0005085;GO:0031267;GO:0090630;GO:0007409;GO:0045200;GO:0022027;GO:0000226;GO:0120163;GO:0031175;GO:0033138;GO:1904754;GO:0050767;GO:0007264;, C:axon; C:basal part of cell; C:focal adhesion; C:growth cone; C:neuron projection;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:activation of GTPase activity; P:axonogenesis; P:establishment of neuroblast polarity; P:interkinetic nuclear migration; P:microtubule cytoskeleton organization; P:negative regulation of cold-induced thermogenesis; P:neuron projection development; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of neurogenesis; P:small GTPase mediated signal transduction; scaffold5 indexed_genome mRNA 15534652 15671829 . - . ID=transcript_1280;Q96NG6 Q96NI0 Q9C092,Dedicator of cytokinesis protein 7,, PF06920;PF14429;PF11878;, GO:0030424;GO:0045178;GO:0005925;GO:0030426;GO:0043005;GO:0005085;GO:0031267;GO:0090630;GO:0007409;GO:0045200;GO:0022027;GO:0000226;GO:0120163;GO:0031175;GO:0033138;GO:1904754;GO:0050767;GO:0007264;, C:axon; C:basal part of cell; C:focal adhesion; C:growth cone; C:neuron projection;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:activation of GTPase activity; P:axonogenesis; P:establishment of neuroblast polarity; P:interkinetic nuclear migration; P:microtubule cytoskeleton organization; P:negative regulation of cold-induced thermogenesis; P:neuron projection development; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of neurogenesis; P:small GTPase mediated signal transduction;|Q96NG6 Q96NI0 Q9C092,Dedicator of cytokinesis protein 7,, PF06920;PF14429;PF11878;, GO:0030424;GO:0045178;GO:0005925;GO:0030426;GO:0043005;GO:0005085;GO:0031267;GO:0090630;GO:0007409;GO:0045200;GO:0022027;GO:0000226;GO:0120163;GO:0031175;GO:0033138;GO:1904754;GO:0050767;GO:0007264;, C:axon; C:basal part of cell; C:focal adhesion; C:growth cone; C:neuron projection;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:activation of GTPase activity; P:axonogenesis; P:establishment of neuroblast polarity; P:interkinetic nuclear migration; P:microtubule cytoskeleton organization; P:negative regulation of cold-induced thermogenesis; P:neuron projection development; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of neurogenesis; P:small GTPase mediated signal transduction;|Q96NG6 Q96NI0 Q9C092,Dedicator of cytokinesis protein 7,, PF06920;PF14429;PF11878;, GO:0030424;GO:0045178;GO:0005925;GO:0030426;GO:0043005;GO:0005085;GO:0031267;GO:0090630;GO:0007409;GO:0045200;GO:0022027;GO:0000226;GO:0120163;GO:0031175;GO:0033138;GO:1904754;GO:0050767;GO:0007264;, C:axon; C:basal part of cell; C:focal adhesion; C:growth cone; C:neuron projection;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:activation of GTPase activity; P:axonogenesis; P:establishment of neuroblast polarity; P:interkinetic nuclear migration; P:microtubule cytoskeleton organization; P:negative regulation of cold-induced thermogenesis; P:neuron projection development; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of neurogenesis; P:small GTPase mediated signal transduction;|Q9Y5C1 A0JLS0 B1ALJ0 B2RCW1,Angiopoietin-related protein 3,Angiopoietin-5;Angiopoietin-like protein 3;, PF00147;, GO:0009986;GO:0062023;GO:0005769;GO:0005576;GO:0005615;GO:0005794;GO:0030027;GO:0004857;GO:0008083;GO:0008201;GO:0005178;GO:0004859;GO:0005102;GO:0055090;GO:0001525;GO:0048844;GO:0007160;GO:0042632;GO:0008203;GO:0006631;GO:0006071;GO:0007229;GO:0030522;GO:0055088;GO:0019915;GO:0051005;GO:0010519;GO:0009395;GO:0055091;GO:0006644;GO:0045766;GO:0030335;GO:0050996;GO:0051004;GO:0009725;GO:0007165;GO:0070328;, C:cell surface; C:collagen-containing extracellular matrix; C:early endosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:lamellipodium;, F:enzyme inhibitor activity; F:growth factor activity; F:heparin binding; F:integrin binding; F:phospholipase inhibitor activity; F:signaling receptor binding;, P:acylglycerol homeostasis; P:angiogenesis; P:artery morphogenesis; P:cell-matrix adhesion; P:cholesterol homeostasis; P:cholesterol metabolic process; P:fatty acid metabolic process; P:glycerol metabolic process; P:integrin-mediated signaling pathway; P:intracellular receptor signaling pathway; P:lipid homeostasis; P:lipid storage; P:negative regulation of lipoprotein lipase activity; P:negative regulation of phospholipase activity; P:phospholipid catabolic process; P:phospholipid homeostasis; P:phospholipid metabolic process; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of lipid catabolic process; P:regulation of lipoprotein lipase activity; P:response to hormone; P:signal transduction; P:triglyceride homeostasis;|Q9Y5C1 A0JLS0 B1ALJ0 B2RCW1,Angiopoietin-related protein 3,Angiopoietin-5;Angiopoietin-like protein 3;, PF00147;, GO:0009986;GO:0062023;GO:0005769;GO:0005576;GO:0005615;GO:0005794;GO:0030027;GO:0004857;GO:0008083;GO:0008201;GO:0005178;GO:0004859;GO:0005102;GO:0055090;GO:0001525;GO:0048844;GO:0007160;GO:0042632;GO:0008203;GO:0006631;GO:0006071;GO:0007229;GO:0030522;GO:0055088;GO:0019915;GO:0051005;GO:0010519;GO:0009395;GO:0055091;GO:0006644;GO:0045766;GO:0030335;GO:0050996;GO:0051004;GO:0009725;GO:0007165;GO:0070328;, C:cell surface; C:collagen-containing extracellular matrix; C:early endosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:lamellipodium;, F:enzyme inhibitor activity; F:growth factor activity; F:heparin binding; F:integrin binding; F:phospholipase inhibitor activity; F:signaling receptor binding;, P:acylglycerol homeostasis; P:angiogenesis; P:artery morphogenesis; P:cell-matrix adhesion; P:cholesterol homeostasis; P:cholesterol metabolic process; P:fatty acid metabolic process; P:glycerol metabolic process; P:integrin-mediated signaling pathway; P:intracellular receptor signaling pathway; P:lipid homeostasis; P:lipid storage; P:negative regulation of lipoprotein lipase activity; P:negative regulation of phospholipase activity; P:phospholipid catabolic process; P:phospholipid homeostasis; P:phospholipid metabolic process; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of lipid catabolic process; P:regulation of lipoprotein lipase activity; P:response to hormone; P:signal transduction; P:triglyceride homeostasis;|Q9Y5C1 A0JLS0 B1ALJ0 B2RCW1,Angiopoietin-related protein 3,Angiopoietin-5;Angiopoietin-like protein 3;, PF00147;, GO:0009986;GO:0062023;GO:0005769;GO:0005576;GO:0005615;GO:0005794;GO:0030027;GO:0004857;GO:0008083;GO:0008201;GO:0005178;GO:0004859;GO:0005102;GO:0055090;GO:0001525;GO:0048844;GO:0007160;GO:0042632;GO:0008203;GO:0006631;GO:0006071;GO:0007229;GO:0030522;GO:0055088;GO:0019915;GO:0051005;GO:0010519;GO:0009395;GO:0055091;GO:0006644;GO:0045766;GO:0030335;GO:0050996;GO:0051004;GO:0009725;GO:0007165;GO:0070328;, C:cell surface; C:collagen-containing extracellular matrix; C:early endosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:lamellipodium;, F:enzyme inhibitor activity; F:growth factor activity; F:heparin binding; F:integrin binding; F:phospholipase inhibitor activity; F:signaling receptor binding;, P:acylglycerol homeostasis; P:angiogenesis; P:artery morphogenesis; P:cell-matrix adhesion; P:cholesterol homeostasis; P:cholesterol metabolic process; P:fatty acid metabolic process; P:glycerol metabolic process; P:integrin-mediated signaling pathway; P:intracellular receptor signaling pathway; P:lipid homeostasis; P:lipid storage; P:negative regulation of lipoprotein lipase activity; P:negative regulation of phospholipase activity; P:phospholipid catabolic process; P:phospholipid homeostasis; P:phospholipid metabolic process; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of lipid catabolic process; P:regulation of lipoprotein lipase activity; P:response to hormone; P:signal transduction; P:triglyceride homeostasis; scaffold5 indexed_genome mRNA 15818628 15850630 . + . ID=transcript_1281;Q96DT6 A6NLR8 D3DQ58 Q96K04,Cysteine protease ATG4C,AUT-like 3 cysteine endopeptidase;Autophagin-3;Autophagy-related cysteine endopeptidase 3;Autophagy-related protein 4 homolog C;, PF03416;, GO:0005737;GO:0004197;GO:0008234;GO:0006914;GO:0015031;GO:0006508;, C:cytoplasm;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:autophagy; P:protein transport; P:proteolysis;|Q96DT6 A6NLR8 D3DQ58 Q96K04,Cysteine protease ATG4C,AUT-like 3 cysteine endopeptidase;Autophagin-3;Autophagy-related cysteine endopeptidase 3;Autophagy-related protein 4 homolog C;, PF03416;, GO:0005737;GO:0004197;GO:0008234;GO:0006914;GO:0015031;GO:0006508;, C:cytoplasm;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:autophagy; P:protein transport; P:proteolysis; scaffold5 indexed_genome mRNA 15874771 15876562 . + . ID=transcript_1282;Q96DT6 A6NLR8 D3DQ58 Q96K04,Cysteine protease ATG4C,AUT-like 3 cysteine endopeptidase;Autophagin-3;Autophagy-related cysteine endopeptidase 3;Autophagy-related protein 4 homolog C;, PF03416;, GO:0005737;GO:0004197;GO:0008234;GO:0006914;GO:0015031;GO:0006508;, C:cytoplasm;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:autophagy; P:protein transport; P:proteolysis;|Q96DT6 A6NLR8 D3DQ58 Q96K04,Cysteine protease ATG4C,AUT-like 3 cysteine endopeptidase;Autophagin-3;Autophagy-related cysteine endopeptidase 3;Autophagy-related protein 4 homolog C;, PF03416;, GO:0005737;GO:0004197;GO:0008234;GO:0006914;GO:0015031;GO:0006508;, C:cytoplasm;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:autophagy; P:protein transport; P:proteolysis; scaffold5 indexed_genome mRNA 16390421 16418716 . + . ID=transcript_1283;Q9Y672 B3KMU2 Q5SXR9 Q9H3I0,Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase,Asparagine-linked glycosylation protein 6 homolog;Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase;Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase;, PF03155;, GO:0005789;GO:0016021;GO:0016020;GO:0042281;GO:0046527;GO:0006488;GO:0006490;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; F:glucosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide-lipid intermediate biosynthetic process; P:protein N-linked glycosylation;|Q9Y672 B3KMU2 Q5SXR9 Q9H3I0,Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase,Asparagine-linked glycosylation protein 6 homolog;Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase;Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase;, PF03155;, GO:0005789;GO:0016021;GO:0016020;GO:0042281;GO:0046527;GO:0006488;GO:0006490;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; F:glucosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide-lipid intermediate biosynthetic process; P:protein N-linked glycosylation; scaffold5 indexed_genome mRNA 16421578 16423628 . + . ID=transcript_1284;Q9Y672 B3KMU2 Q5SXR9 Q9H3I0,Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase,Asparagine-linked glycosylation protein 6 homolog;Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase;Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase;, PF03155;, GO:0005789;GO:0016021;GO:0016020;GO:0042281;GO:0046527;GO:0006488;GO:0006490;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; F:glucosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide-lipid intermediate biosynthetic process; P:protein N-linked glycosylation; scaffold5 indexed_genome mRNA 16423850 16519991 . + . ID=transcript_1285;Q9Y672 B3KMU2 Q5SXR9 Q9H3I0,Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase,Asparagine-linked glycosylation protein 6 homolog;Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase;Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase;, PF03155;, GO:0005789;GO:0016021;GO:0016020;GO:0042281;GO:0046527;GO:0006488;GO:0006490;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; F:glucosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide-lipid intermediate biosynthetic process; P:protein N-linked glycosylation;|Q9Y672 B3KMU2 Q5SXR9 Q9H3I0,Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase,Asparagine-linked glycosylation protein 6 homolog;Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase;Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase;, PF03155;, GO:0005789;GO:0016021;GO:0016020;GO:0042281;GO:0046527;GO:0006488;GO:0006490;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; F:glucosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide-lipid intermediate biosynthetic process; P:protein N-linked glycosylation;|Q9Y672 B3KMU2 Q5SXR9 Q9H3I0,Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase,Asparagine-linked glycosylation protein 6 homolog;Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase;Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase;, PF03155;, GO:0005789;GO:0016021;GO:0016020;GO:0042281;GO:0046527;GO:0006488;GO:0006490;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; F:glucosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide-lipid intermediate biosynthetic process; P:protein N-linked glycosylation;|Q13352 B2R7D8 Q13353 Q5RJ42 Q5RJ44 Q5RJ45 Q7KYX2 Q96CD5 Q9UKB6,Centromere protein R,Beta-3-endonexin;Integrin beta-3-binding protein;Nuclear receptor-interacting factor 3;, PF06729;, GO:0000777;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0008022;GO:0006915;GO:0007155;GO:0051301;GO:0034080;GO:0007052;GO:0043065;GO:0006355;GO:0007165;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:protein C-terminus binding;, P:apoptotic process; P:cell adhesion; P:cell division; P:CENP-A containing nucleosome assembly; P:mitotic spindle organization; P:positive regulation of apoptotic process; P:regulation of transcription, DNA-templated; P:signal transduction;|Q13352 B2R7D8 Q13353 Q5RJ42 Q5RJ44 Q5RJ45 Q7KYX2 Q96CD5 Q9UKB6,Centromere protein R,Beta-3-endonexin;Integrin beta-3-binding protein;Nuclear receptor-interacting factor 3;, PF06729;, GO:0000777;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0008022;GO:0006915;GO:0007155;GO:0051301;GO:0034080;GO:0007052;GO:0043065;GO:0006355;GO:0007165;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:protein C-terminus binding;, P:apoptotic process; P:cell adhesion; P:cell division; P:CENP-A containing nucleosome assembly; P:mitotic spindle organization; P:positive regulation of apoptotic process; P:regulation of transcription, DNA-templated; P:signal transduction; scaffold5 indexed_genome mRNA 16520194 16553165 . + . ID=transcript_1286;A8K855 Q658P0 Q96B95 Q96JM6,EF-hand calcium-binding domain-containing protein 7,, PF13499;, GO:0060170;GO:0005929;GO:0019898;GO:0098797;GO:0005509;GO:0042307;GO:1903569;GO:0045944;, C:ciliary membrane; C:cilium; C:extrinsic component of membrane; C:plasma membrane protein complex;, F:calcium ion binding;, P:positive regulation of protein import into nucleus; P:positive regulation of protein localization to ciliary membrane; P:positive regulation of transcription by RNA polymerase II;|A8K855 Q658P0 Q96B95 Q96JM6,EF-hand calcium-binding domain-containing protein 7,, PF13499;, GO:0060170;GO:0005929;GO:0019898;GO:0098797;GO:0005509;GO:0042307;GO:1903569;GO:0045944;, C:ciliary membrane; C:cilium; C:extrinsic component of membrane; C:plasma membrane protein complex;, F:calcium ion binding;, P:positive regulation of protein import into nucleus; P:positive regulation of protein localization to ciliary membrane; P:positive regulation of transcription by RNA polymerase II;|A8K855 Q658P0 Q96B95 Q96JM6,EF-hand calcium-binding domain-containing protein 7,, PF13499;, GO:0060170;GO:0005929;GO:0019898;GO:0098797;GO:0005509;GO:0042307;GO:1903569;GO:0045944;, C:ciliary membrane; C:cilium; C:extrinsic component of membrane; C:plasma membrane protein complex;, F:calcium ion binding;, P:positive regulation of protein import into nucleus; P:positive regulation of protein localization to ciliary membrane; P:positive regulation of transcription by RNA polymerase II;|A8K855 Q658P0 Q96B95 Q96JM6,EF-hand calcium-binding domain-containing protein 7,, PF13499;, GO:0060170;GO:0005929;GO:0019898;GO:0098797;GO:0005509;GO:0042307;GO:1903569;GO:0045944;, C:ciliary membrane; C:cilium; C:extrinsic component of membrane; C:plasma membrane protein complex;, F:calcium ion binding;, P:positive regulation of protein import into nucleus; P:positive regulation of protein localization to ciliary membrane; P:positive regulation of transcription by RNA polymerase II;|A8K855 Q658P0 Q96B95 Q96JM6,EF-hand calcium-binding domain-containing protein 7,, PF13499;, GO:0060170;GO:0005929;GO:0019898;GO:0098797;GO:0005509;GO:0042307;GO:1903569;GO:0045944;, C:ciliary membrane; C:cilium; C:extrinsic component of membrane; C:plasma membrane protein complex;, F:calcium ion binding;, P:positive regulation of protein import into nucleus; P:positive regulation of protein localization to ciliary membrane; P:positive regulation of transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 16553363 16573581 . - . ID=transcript_1287;A8K855 Q658P0 Q96B95 Q96JM6,EF-hand calcium-binding domain-containing protein 7,, PF13499;, GO:0060170;GO:0005929;GO:0019898;GO:0098797;GO:0005509;GO:0042307;GO:1903569;GO:0045944;, C:ciliary membrane; C:cilium; C:extrinsic component of membrane; C:plasma membrane protein complex;, F:calcium ion binding;, P:positive regulation of protein import into nucleus; P:positive regulation of protein localization to ciliary membrane; P:positive regulation of transcription by RNA polymerase II;|A8K855 Q658P0 Q96B95 Q96JM6,EF-hand calcium-binding domain-containing protein 7,, PF13499;, GO:0060170;GO:0005929;GO:0019898;GO:0098797;GO:0005509;GO:0042307;GO:1903569;GO:0045944;, C:ciliary membrane; C:cilium; C:extrinsic component of membrane; C:plasma membrane protein complex;, F:calcium ion binding;, P:positive regulation of protein import into nucleus; P:positive regulation of protein localization to ciliary membrane; P:positive regulation of transcription by RNA polymerase II;|A8K855 Q658P0 Q96B95 Q96JM6,EF-hand calcium-binding domain-containing protein 7,, PF13499;, GO:0060170;GO:0005929;GO:0019898;GO:0098797;GO:0005509;GO:0042307;GO:1903569;GO:0045944;, C:ciliary membrane; C:cilium; C:extrinsic component of membrane; C:plasma membrane protein complex;, F:calcium ion binding;, P:positive regulation of protein import into nucleus; P:positive regulation of protein localization to ciliary membrane; P:positive regulation of transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 16574077 16574987 . + . ID=transcript_1288;Q9NZC3 O43334 Q6PKF7 Q7KYR4,Glycerophosphodiester phosphodiesterase 1 {ECO:0000305},Glycerophosphoinositol glycerophosphodiesterase GDE1 {ECO:0000305};Lysophospholipase D GDE1 {ECO:0000305};Membrane-interacting protein of RGS16 {ECO:0000303|PubMed:10760272};RGS16-interacting membrane protein;, PF03009;, GO:0030659;GO:0016021;GO:0005886;GO:0008889;GO:0047395;GO:0004622;GO:0046872;GO:0006580;GO:0046475;GO:0006629;GO:0070291;GO:0006644;, C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:glycerophosphodiester phosphodiesterase activity; F:glycerophosphoinositol glycerophosphodiesterase activity; F:lysophospholipase activity; F:metal ion binding;, P:ethanolamine metabolic process; P:glycerophospholipid catabolic process; P:lipid metabolic process; P:N-acylethanolamine metabolic process; P:phospholipid metabolic process; scaffold5 indexed_genome mRNA 16599666 16664786 . + . ID=transcript_1289;Q9NTY4,Phosphoglucomutase-1,Glucose phosphomutase 1;, PF02878;PF02879;PF02880;PF00408;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:1904724;GO:0000287;GO:0004614;GO:0005975;GO:0006094;GO:0006006;GO:0005978;GO:0006096;GO:0043312;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:tertiary granule lumen;, F:magnesium ion binding; F:phosphoglucomutase activity;, P:carbohydrate metabolic process; P:gluconeogenesis; P:glucose metabolic process; P:glycogen biosynthetic process; P:glycolytic process; P:neutrophil degranulation;|Q15124 B1AM46 B4DLQ6 Q5VYV3 Q8N527 Q9UDH4,Phosphoglucomutase-like protein 5,Aciculin;Phosphoglucomutase-related protein;, PF02878;PF02879;PF02880;, GO:0005912;GO:0030055;GO:0043034;GO:0009898;GO:0005829;GO:0016010;GO:0005925;GO:0014704;GO:0042383;GO:0005914;GO:0001725;GO:0030018;GO:0016868;GO:0000287;GO:0005198;GO:0005975;GO:0007155;GO:0006006;GO:0030239;GO:0014706;, C:adherens junction; C:cell-substrate junction; C:costamere; C:cytoplasmic side of plasma membrane; C:cytosol; C:dystrophin-associated glycoprotein complex; C:focal adhesion; C:intercalated disc; C:sarcolemma; C:spot adherens junction; C:stress fiber; C:Z disc;, F:intramolecular transferase activity, phosphotransferases; F:magnesium ion binding; F:structural molecule activity;, P:carbohydrate metabolic process; P:cell adhesion; P:glucose metabolic process; P:myofibril assembly; P:striated muscle tissue development;|Q9NTY4,Phosphoglucomutase-1,Glucose phosphomutase 1;, PF02878;PF02879;PF02880;PF00408;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:1904724;GO:0000287;GO:0004614;GO:0005975;GO:0006094;GO:0006006;GO:0005978;GO:0006096;GO:0043312;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:tertiary granule lumen;, F:magnesium ion binding; F:phosphoglucomutase activity;, P:carbohydrate metabolic process; P:gluconeogenesis; P:glucose metabolic process; P:glycogen biosynthetic process; P:glycolytic process; P:neutrophil degranulation;|Q9NTY4,Phosphoglucomutase-1,Glucose phosphomutase 1;, PF02878;PF02879;PF02880;PF00408;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:1904724;GO:0000287;GO:0004614;GO:0005975;GO:0006094;GO:0006006;GO:0005978;GO:0006096;GO:0043312;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:tertiary granule lumen;, F:magnesium ion binding; F:phosphoglucomutase activity;, P:carbohydrate metabolic process; P:gluconeogenesis; P:glucose metabolic process; P:glycogen biosynthetic process; P:glycolytic process; P:neutrophil degranulation; scaffold5 indexed_genome mRNA 16761500 17218861 . + . ID=transcript_1290;Q01973 Q5VVX6 Q66K77 Q92776,Inactive tyrosine-protein kinase transmembrane receptor ROR1 {ECO:0000305},Neurotrophic tyrosine kinase, receptor-related 1;, PF01392;PF07679;PF00051;PF07714;, GO:0043679;GO:0009986;GO:0005737;GO:0005887;GO:0005886;GO:0043235;GO:0001725;GO:0005524;GO:1904929;GO:0004714;GO:0042813;GO:0017147;GO:0014002;GO:0048839;GO:0007275;GO:0043123;GO:0033674;GO:0043410;GO:0010976;GO:0051092;GO:0014068;GO:0007605;GO:0007169;, C:axon terminus; C:cell surface; C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:stress fiber;, F:ATP binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:transmembrane receptor protein tyrosine kinase activity; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:astrocyte development; P:inner ear development; P:multicellular organism development; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:sensory perception of sound; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q01973 Q5VVX6 Q66K77 Q92776,Inactive tyrosine-protein kinase transmembrane receptor ROR1 {ECO:0000305},Neurotrophic tyrosine kinase, receptor-related 1;, PF01392;PF07679;PF00051;PF07714;, GO:0043679;GO:0009986;GO:0005737;GO:0005887;GO:0005886;GO:0043235;GO:0001725;GO:0005524;GO:1904929;GO:0004714;GO:0042813;GO:0017147;GO:0014002;GO:0048839;GO:0007275;GO:0043123;GO:0033674;GO:0043410;GO:0010976;GO:0051092;GO:0014068;GO:0007605;GO:0007169;, C:axon terminus; C:cell surface; C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:stress fiber;, F:ATP binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:transmembrane receptor protein tyrosine kinase activity; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:astrocyte development; P:inner ear development; P:multicellular organism development; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:sensory perception of sound; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q01973 Q5VVX6 Q66K77 Q92776,Inactive tyrosine-protein kinase transmembrane receptor ROR1 {ECO:0000305},Neurotrophic tyrosine kinase, receptor-related 1;, PF01392;PF07679;PF00051;PF07714;, GO:0043679;GO:0009986;GO:0005737;GO:0005887;GO:0005886;GO:0043235;GO:0001725;GO:0005524;GO:1904929;GO:0004714;GO:0042813;GO:0017147;GO:0014002;GO:0048839;GO:0007275;GO:0043123;GO:0033674;GO:0043410;GO:0010976;GO:0051092;GO:0014068;GO:0007605;GO:0007169;, C:axon terminus; C:cell surface; C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:stress fiber;, F:ATP binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:transmembrane receptor protein tyrosine kinase activity; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:astrocyte development; P:inner ear development; P:multicellular organism development; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:sensory perception of sound; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold5 indexed_genome mRNA 17679872 17745759 . + . ID=transcript_1291;Q5VU97 Q49AE9 Q658T4 Q7Z3P2 Q9H7W4 Q9H9W3 Q9HCJ9,VWFA and cache domain-containing protein 1,, PF00092;PF08399;, GO:0005891;GO:0005245;, C:voltage-gated calcium channel complex;, F:voltage-gated calcium channel activity;|Q5VU97 Q49AE9 Q658T4 Q7Z3P2 Q9H7W4 Q9H9W3 Q9HCJ9,VWFA and cache domain-containing protein 1,, PF00092;PF08399;, GO:0005891;GO:0005245;, C:voltage-gated calcium channel complex;, F:voltage-gated calcium channel activity; scaffold5 indexed_genome mRNA 17852128 17942238 . + . ID=transcript_1292;Q9HCJ3 Q6P141 Q9NPV7,Ribonucleoprotein PTB-binding 2,Protein raver-2;, PF00076;, GO:0005737;GO:0005634;GO:0003676;GO:0003723;GO:0000398;, C:cytoplasm; C:nucleus;, F:nucleic acid binding; F:RNA binding;, P:mRNA splicing, via spliceosome;|P23458 Q59GQ2 Q9UD26,Tyrosine-protein kinase JAK1,Janus kinase 1;, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0005925;GO:0016020;GO:0005634;GO:0005524;GO:0031730;GO:0005131;GO:0046872;GO:0004715;GO:0019903;GO:0004713;GO:0004714;GO:0031625;GO:0019221;GO:0060333;GO:0035722;GO:0035723;GO:0038110;GO:0038114;GO:0070106;GO:0070757;GO:0070102;GO:0038111;GO:0038113;GO:0035556;GO:0000165;GO:0034112;GO:1903672;GO:0150105;GO:0006468;GO:0060334;GO:0046677;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:focal adhesion; C:membrane; C:nucleus;, F:ATP binding; F:CCR5 chemokine receptor binding; F:growth hormone receptor binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of sprouting angiogenesis; P:protein localization to cell-cell junction; P:protein phosphorylation; P:regulation of interferon-gamma-mediated signaling pathway; P:response to antibiotic; P:type I interferon signaling pathway;|P23458 Q59GQ2 Q9UD26,Tyrosine-protein kinase JAK1,Janus kinase 1;, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0005925;GO:0016020;GO:0005634;GO:0005524;GO:0031730;GO:0005131;GO:0046872;GO:0004715;GO:0019903;GO:0004713;GO:0004714;GO:0031625;GO:0019221;GO:0060333;GO:0035722;GO:0035723;GO:0038110;GO:0038114;GO:0070106;GO:0070757;GO:0070102;GO:0038111;GO:0038113;GO:0035556;GO:0000165;GO:0034112;GO:1903672;GO:0150105;GO:0006468;GO:0060334;GO:0046677;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:focal adhesion; C:membrane; C:nucleus;, F:ATP binding; F:CCR5 chemokine receptor binding; F:growth hormone receptor binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of sprouting angiogenesis; P:protein localization to cell-cell junction; P:protein phosphorylation; P:regulation of interferon-gamma-mediated signaling pathway; P:response to antibiotic; P:type I interferon signaling pathway;|P23458 Q59GQ2 Q9UD26,Tyrosine-protein kinase JAK1,Janus kinase 1;, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0005925;GO:0016020;GO:0005634;GO:0005524;GO:0031730;GO:0005131;GO:0046872;GO:0004715;GO:0019903;GO:0004713;GO:0004714;GO:0031625;GO:0019221;GO:0060333;GO:0035722;GO:0035723;GO:0038110;GO:0038114;GO:0070106;GO:0070757;GO:0070102;GO:0038111;GO:0038113;GO:0035556;GO:0000165;GO:0034112;GO:1903672;GO:0150105;GO:0006468;GO:0060334;GO:0046677;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:focal adhesion; C:membrane; C:nucleus;, F:ATP binding; F:CCR5 chemokine receptor binding; F:growth hormone receptor binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of sprouting angiogenesis; P:protein localization to cell-cell junction; P:protein phosphorylation; P:regulation of interferon-gamma-mediated signaling pathway; P:response to antibiotic; P:type I interferon signaling pathway; scaffold5 indexed_genome mRNA 17963157 17963822 . + . ID=transcript_1293;P23458 Q59GQ2 Q9UD26,Tyrosine-protein kinase JAK1,Janus kinase 1;, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0005925;GO:0016020;GO:0005634;GO:0005524;GO:0031730;GO:0005131;GO:0046872;GO:0004715;GO:0019903;GO:0004713;GO:0004714;GO:0031625;GO:0019221;GO:0060333;GO:0035722;GO:0035723;GO:0038110;GO:0038114;GO:0070106;GO:0070757;GO:0070102;GO:0038111;GO:0038113;GO:0035556;GO:0000165;GO:0034112;GO:1903672;GO:0150105;GO:0006468;GO:0060334;GO:0046677;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:focal adhesion; C:membrane; C:nucleus;, F:ATP binding; F:CCR5 chemokine receptor binding; F:growth hormone receptor binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of sprouting angiogenesis; P:protein localization to cell-cell junction; P:protein phosphorylation; P:regulation of interferon-gamma-mediated signaling pathway; P:response to antibiotic; P:type I interferon signaling pathway; scaffold5 indexed_genome mRNA 18344683 18354052 . + . ID=transcript_1294;P27144 B2R927 D3DQ62 Q6IBH4 Q6NXQ5 Q8IUU9,Adenylate kinase 4, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03170},Adenylate kinase 3-like {ECO:0000255|HAMAP-Rule:MF_03170};GTP:AMP phosphotransferase AK4 {ECO:0000255|HAMAP-Rule:MF_03170};, PF05191;, GO:0005737;GO:0005759;GO:0005739;GO:0004017;GO:0005524;GO:0005525;GO:0004550;GO:0046899;GO:0006172;GO:0046033;GO:0046034;GO:0007420;GO:0071456;GO:0046039;GO:0001889;GO:0015949;GO:0006165;GO:0009142;GO:2001169;GO:0002082;GO:0042493;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:adenylate kinase activity; F:ATP binding; F:GTP binding; F:nucleoside diphosphate kinase activity; F:nucleoside triphosphate adenylate kinase activity;, P:ADP biosynthetic process; P:AMP metabolic process; P:ATP metabolic process; P:brain development; P:cellular response to hypoxia; P:GTP metabolic process; P:liver development; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:regulation of ATP biosynthetic process; P:regulation of oxidative phosphorylation; P:response to drug; scaffold5 indexed_genome mRNA 18385560 18559029 . + . ID=transcript_1295;O75061 B7Z3V8 D3DQ65 D3DQ66 Q32M66 Q4G0K1 Q5T614 Q5T615,Putative tyrosine-protein phosphatase auxilin {ECO:0000305},DnaJ homolog subfamily C member 6 {ECO:0000312|HGNC:HGNC:15469};, PF00226;PF10409;, GO:0005737;GO:0005829;GO:0043231;GO:0014069;GO:0098793;GO:0031982;GO:0030276;GO:0004725;GO:0017124;GO:0072318;GO:0072583;GO:0061024;GO:0006892;GO:2000369;GO:0016191;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:postsynaptic density; C:presynapse; C:vesicle;, F:clathrin binding; F:protein tyrosine phosphatase activity; F:SH3 domain binding;, P:clathrin coat disassembly; P:clathrin-dependent endocytosis; P:membrane organization; P:post-Golgi vesicle-mediated transport; P:regulation of clathrin-dependent endocytosis; P:synaptic vesicle uncoating;|O75061 B7Z3V8 D3DQ65 D3DQ66 Q32M66 Q4G0K1 Q5T614 Q5T615,Putative tyrosine-protein phosphatase auxilin {ECO:0000305},DnaJ homolog subfamily C member 6 {ECO:0000312|HGNC:HGNC:15469};, PF00226;PF10409;, GO:0005737;GO:0005829;GO:0043231;GO:0014069;GO:0098793;GO:0031982;GO:0030276;GO:0004725;GO:0017124;GO:0072318;GO:0072583;GO:0061024;GO:0006892;GO:2000369;GO:0016191;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:postsynaptic density; C:presynapse; C:vesicle;, F:clathrin binding; F:protein tyrosine phosphatase activity; F:SH3 domain binding;, P:clathrin coat disassembly; P:clathrin-dependent endocytosis; P:membrane organization; P:post-Golgi vesicle-mediated transport; P:regulation of clathrin-dependent endocytosis; P:synaptic vesicle uncoating;|O75061 B7Z3V8 D3DQ65 D3DQ66 Q32M66 Q4G0K1 Q5T614 Q5T615,Putative tyrosine-protein phosphatase auxilin {ECO:0000305},DnaJ homolog subfamily C member 6 {ECO:0000312|HGNC:HGNC:15469};, PF00226;PF10409;, GO:0005737;GO:0005829;GO:0043231;GO:0014069;GO:0098793;GO:0031982;GO:0030276;GO:0004725;GO:0017124;GO:0072318;GO:0072583;GO:0061024;GO:0006892;GO:2000369;GO:0016191;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:postsynaptic density; C:presynapse; C:vesicle;, F:clathrin binding; F:protein tyrosine phosphatase activity; F:SH3 domain binding;, P:clathrin coat disassembly; P:clathrin-dependent endocytosis; P:membrane organization; P:post-Golgi vesicle-mediated transport; P:regulation of clathrin-dependent endocytosis; P:synaptic vesicle uncoating;|O75061 B7Z3V8 D3DQ65 D3DQ66 Q32M66 Q4G0K1 Q5T614 Q5T615,Putative tyrosine-protein phosphatase auxilin {ECO:0000305},DnaJ homolog subfamily C member 6 {ECO:0000312|HGNC:HGNC:15469};, PF00226;PF10409;, GO:0005737;GO:0005829;GO:0043231;GO:0014069;GO:0098793;GO:0031982;GO:0030276;GO:0004725;GO:0017124;GO:0072318;GO:0072583;GO:0061024;GO:0006892;GO:2000369;GO:0016191;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:postsynaptic density; C:presynapse; C:vesicle;, F:clathrin binding; F:protein tyrosine phosphatase activity; F:SH3 domain binding;, P:clathrin coat disassembly; P:clathrin-dependent endocytosis; P:membrane organization; P:post-Golgi vesicle-mediated transport; P:regulation of clathrin-dependent endocytosis; P:synaptic vesicle uncoating;|O75061 B7Z3V8 D3DQ65 D3DQ66 Q32M66 Q4G0K1 Q5T614 Q5T615,Putative tyrosine-protein phosphatase auxilin {ECO:0000305},DnaJ homolog subfamily C member 6 {ECO:0000312|HGNC:HGNC:15469};, PF00226;PF10409;, GO:0005737;GO:0005829;GO:0043231;GO:0014069;GO:0098793;GO:0031982;GO:0030276;GO:0004725;GO:0017124;GO:0072318;GO:0072583;GO:0061024;GO:0006892;GO:2000369;GO:0016191;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:postsynaptic density; C:presynapse; C:vesicle;, F:clathrin binding; F:protein tyrosine phosphatase activity; F:SH3 domain binding;, P:clathrin coat disassembly; P:clathrin-dependent endocytosis; P:membrane organization; P:post-Golgi vesicle-mediated transport; P:regulation of clathrin-dependent endocytosis; P:synaptic vesicle uncoating; scaffold5 indexed_genome mRNA 18565445 18573228 . + . ID=transcript_1296;O15243 Q6FHL5,Leptin receptor gene-related protein,Endospanin-1;Leptin receptor overlapping transcript protein;OB-R gene-related protein;, PF04133;, GO:0005768;GO:0010008;GO:0005794;GO:0000139;GO:0016021;GO:0005102;GO:0032511;GO:0060400;GO:2000009;GO:0046426;GO:1903955;, C:endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:signaling receptor binding;, P:late endosome to vacuole transport via multivesicular body sorting pathway; P:negative regulation of growth hormone receptor signaling pathway; P:negative regulation of protein localization to cell surface; P:negative regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of protein targeting to mitochondrion;|O15243 Q6FHL5,Leptin receptor gene-related protein,Endospanin-1;Leptin receptor overlapping transcript protein;OB-R gene-related protein;, PF04133;, GO:0005768;GO:0010008;GO:0005794;GO:0000139;GO:0016021;GO:0005102;GO:0032511;GO:0060400;GO:2000009;GO:0046426;GO:1903955;, C:endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:signaling receptor binding;, P:late endosome to vacuole transport via multivesicular body sorting pathway; P:negative regulation of growth hormone receptor signaling pathway; P:negative regulation of protein localization to cell surface; P:negative regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of protein targeting to mitochondrion; scaffold5 indexed_genome mRNA 18655227 18743452 . + . ID=transcript_1297;P48357 Q13592 Q13593 Q13594 Q92919 Q92920 Q92921,Leptin receptor,HuB219;OB receptor;, PF06328;PF18589;, GO:0016323;GO:0009897;GO:0005576;GO:0016021;GO:0043235;GO:0019955;GO:0004896;GO:0042802;GO:0038021;GO:0017046;GO:0004888;GO:0001525;GO:0098868;GO:0007166;GO:0008203;GO:0019221;GO:0097009;GO:0006112;GO:0014009;GO:0042593;GO:0005977;GO:0033210;GO:0007275;GO:0010507;GO:0045721;GO:0051346;GO:0006909;GO:0120162;GO:0001934;GO:0046850;GO:0060259;GO:0051049;GO:0044321;GO:0019953;GO:0030217;GO:0150104;, C:basolateral plasma membrane; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:identical protein binding; F:leptin receptor activity; F:peptide hormone binding; F:transmembrane signaling receptor activity;, P:angiogenesis; P:bone growth; P:cell surface receptor signaling pathway; P:cholesterol metabolic process; P:cytokine-mediated signaling pathway; P:energy homeostasis; P:energy reserve metabolic process; P:glial cell proliferation; P:glucose homeostasis; P:glycogen metabolic process; P:leptin-mediated signaling pathway; P:multicellular organism development; P:negative regulation of autophagy; P:negative regulation of gluconeogenesis; P:negative regulation of hydrolase activity; P:phagocytosis; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein phosphorylation; P:regulation of bone remodeling; P:regulation of feeding behavior; P:regulation of transport; P:response to leptin; P:sexual reproduction; P:T cell differentiation; P:transport across blood-brain barrier;|P48357 Q13592 Q13593 Q13594 Q92919 Q92920 Q92921,Leptin receptor,HuB219;OB receptor;, PF06328;PF18589;, GO:0016323;GO:0009897;GO:0005576;GO:0016021;GO:0043235;GO:0019955;GO:0004896;GO:0042802;GO:0038021;GO:0017046;GO:0004888;GO:0001525;GO:0098868;GO:0007166;GO:0008203;GO:0019221;GO:0097009;GO:0006112;GO:0014009;GO:0042593;GO:0005977;GO:0033210;GO:0007275;GO:0010507;GO:0045721;GO:0051346;GO:0006909;GO:0120162;GO:0001934;GO:0046850;GO:0060259;GO:0051049;GO:0044321;GO:0019953;GO:0030217;GO:0150104;, C:basolateral plasma membrane; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:identical protein binding; F:leptin receptor activity; F:peptide hormone binding; F:transmembrane signaling receptor activity;, P:angiogenesis; P:bone growth; P:cell surface receptor signaling pathway; P:cholesterol metabolic process; P:cytokine-mediated signaling pathway; P:energy homeostasis; P:energy reserve metabolic process; P:glial cell proliferation; P:glucose homeostasis; P:glycogen metabolic process; P:leptin-mediated signaling pathway; P:multicellular organism development; P:negative regulation of autophagy; P:negative regulation of gluconeogenesis; P:negative regulation of hydrolase activity; P:phagocytosis; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein phosphorylation; P:regulation of bone remodeling; P:regulation of feeding behavior; P:regulation of transport; P:response to leptin; P:sexual reproduction; P:T cell differentiation; P:transport across blood-brain barrier; scaffold5 indexed_genome mRNA 18744248 18745723 . - . ID=transcript_1298;P48357 Q13592 Q13593 Q13594 Q92919 Q92920 Q92921,Leptin receptor,HuB219;OB receptor;, PF06328;PF18589;, GO:0016323;GO:0009897;GO:0005576;GO:0016021;GO:0043235;GO:0019955;GO:0004896;GO:0042802;GO:0038021;GO:0017046;GO:0004888;GO:0001525;GO:0098868;GO:0007166;GO:0008203;GO:0019221;GO:0097009;GO:0006112;GO:0014009;GO:0042593;GO:0005977;GO:0033210;GO:0007275;GO:0010507;GO:0045721;GO:0051346;GO:0006909;GO:0120162;GO:0001934;GO:0046850;GO:0060259;GO:0051049;GO:0044321;GO:0019953;GO:0030217;GO:0150104;, C:basolateral plasma membrane; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:identical protein binding; F:leptin receptor activity; F:peptide hormone binding; F:transmembrane signaling receptor activity;, P:angiogenesis; P:bone growth; P:cell surface receptor signaling pathway; P:cholesterol metabolic process; P:cytokine-mediated signaling pathway; P:energy homeostasis; P:energy reserve metabolic process; P:glial cell proliferation; P:glucose homeostasis; P:glycogen metabolic process; P:leptin-mediated signaling pathway; P:multicellular organism development; P:negative regulation of autophagy; P:negative regulation of gluconeogenesis; P:negative regulation of hydrolase activity; P:phagocytosis; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein phosphorylation; P:regulation of bone remodeling; P:regulation of feeding behavior; P:regulation of transport; P:response to leptin; P:sexual reproduction; P:T cell differentiation; P:transport across blood-brain barrier; scaffold5 indexed_genome mRNA 19441290 19485476 . + . ID=transcript_1299;Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6,cAMP-specific 3',5'-cyclic phosphodiesterase 4B,DPDE4;PDE32;, PF18100;PF00233;, GO:0005813;GO:0005829;GO:0043197;GO:0060076;GO:0000930;GO:0005634;GO:0048471;GO:0014069;GO:0008021;GO:0005891;GO:0030018;GO:0004115;GO:0004114;GO:0030552;GO:0043015;GO:0044325;GO:0046872;GO:0006198;GO:0035690;GO:0071872;GO:0071222;GO:0050900;GO:0140199;GO:1901898;GO:0030593;GO:0001780;GO:0032729;GO:0032743;GO:0086004;GO:1901841;GO:0007165;GO:0050852;, C:centrosome; C:cytosol; C:dendritic spine; C:excitatory synapse; C:gamma-tubulin complex; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synaptic vesicle; C:voltage-gated calcium channel complex; C:Z disc;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:gamma-tubulin binding; F:ion channel binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to drug; P:cellular response to epinephrine stimulus; P:cellular response to lipopolysaccharide; P:leukocyte migration; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:negative regulation of relaxation of cardiac muscle; P:neutrophil chemotaxis; P:neutrophil homeostasis; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:regulation of cardiac muscle cell contraction; P:regulation of high voltage-gated calcium channel activity; P:signal transduction; P:T cell receptor signaling pathway; scaffold5 indexed_genome mRNA 19616670 19718639 . + . ID=transcript_1300;Q8IWC2,SH3-containing GRB2-like protein 3-interacting protein 1,Endophilin-3-interacting protein;, PF10291;, GO:0030122;GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008017;GO:0005543;GO:0017124;GO:0048268;GO:0072583;GO:0097009;GO:0061024;GO:2000253;GO:0048260;GO:0002021;, C:AP-2 adaptor complex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:microtubule binding; F:phospholipid binding; F:SH3 domain binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:energy homeostasis; P:membrane organization; P:positive regulation of feeding behavior; P:positive regulation of receptor-mediated endocytosis; P:response to dietary excess; scaffold5 indexed_genome mRNA 19760088 19841828 . + . ID=transcript_1301;Q8IWC2,SH3-containing GRB2-like protein 3-interacting protein 1,Endophilin-3-interacting protein;, PF10291;, GO:0030122;GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008017;GO:0005543;GO:0017124;GO:0048268;GO:0072583;GO:0097009;GO:0061024;GO:2000253;GO:0048260;GO:0002021;, C:AP-2 adaptor complex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:microtubule binding; F:phospholipid binding; F:SH3 domain binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:energy homeostasis; P:membrane organization; P:positive regulation of feeding behavior; P:positive regulation of receptor-mediated endocytosis; P:response to dietary excess;|Q8IWC2,SH3-containing GRB2-like protein 3-interacting protein 1,Endophilin-3-interacting protein;, PF10291;, GO:0030122;GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008017;GO:0005543;GO:0017124;GO:0048268;GO:0072583;GO:0097009;GO:0061024;GO:2000253;GO:0048260;GO:0002021;, C:AP-2 adaptor complex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:microtubule binding; F:phospholipid binding; F:SH3 domain binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:energy homeostasis; P:membrane organization; P:positive regulation of feeding behavior; P:positive regulation of receptor-mediated endocytosis; P:response to dietary excess;|Q8IWC2,SH3-containing GRB2-like protein 3-interacting protein 1,Endophilin-3-interacting protein;, PF10291;, GO:0030122;GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008017;GO:0005543;GO:0017124;GO:0048268;GO:0072583;GO:0097009;GO:0061024;GO:2000253;GO:0048260;GO:0002021;, C:AP-2 adaptor complex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:microtubule binding; F:phospholipid binding; F:SH3 domain binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:energy homeostasis; P:membrane organization; P:positive regulation of feeding behavior; P:positive regulation of receptor-mediated endocytosis; P:response to dietary excess; scaffold5 indexed_genome mRNA 19870985 19875710 . + . ID=transcript_1302;Q8N7M0 Q06YR9 Q5VYE1,Dynein light chain Tctex-type 5,Tctex1 domain-containing protein 1;, PF03645; scaffold5 indexed_genome mRNA 19907204 19921121 . - . ID=transcript_1303;Q5VTH9 A8K9W5 B5MDT3 H7BY80 Q5VTI0 Q8N5G5 Q9H5R9 Q9UF44,Dynein intermediate chain 4, axonemal {ECO:0000305},Dynein axonemal intermediate chain 4;WD repeat-containing protein 78;, PF00400;, GO:0005858;GO:0005930;GO:0031514;GO:0045504;GO:0045503;GO:0070286;GO:0003341;GO:0002244;GO:0007018;, C:axonemal dynein complex; C:axoneme; C:motile cilium;, F:dynein heavy chain binding; F:dynein light chain binding;, P:axonemal dynein complex assembly; P:cilium movement; P:hematopoietic progenitor cell differentiation; P:microtubule-based movement; scaffold5 indexed_genome mRNA 20014580 20079775 . + . ID=transcript_1304;Q9HCG2,Mesoderm induction early response protein 1,, PF01448;PF00249;, GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0017053;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;GO:0031937;GO:0043123;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription repressor complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chromatin silencing; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q9HCG2,Mesoderm induction early response protein 1,, PF01448;PF00249;, GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0017053;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;GO:0031937;GO:0043123;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription repressor complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chromatin silencing; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q9HCG2,Mesoderm induction early response protein 1,, PF01448;PF00249;, GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0017053;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;GO:0031937;GO:0043123;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription repressor complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chromatin silencing; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q9HCG2,Mesoderm induction early response protein 1,, PF01448;PF00249;, GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0017053;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;GO:0031937;GO:0043123;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription repressor complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chromatin silencing; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q9HCG2,Mesoderm induction early response protein 1,, PF01448;PF00249;, GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0017053;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;GO:0031937;GO:0043123;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription repressor complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chromatin silencing; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q9HCG2,Mesoderm induction early response protein 1,, PF01448;PF00249;, GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0017053;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;GO:0031937;GO:0043123;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription repressor complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chromatin silencing; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold5 indexed_genome mRNA 20093888 20141411 . - . ID=transcript_1305;Q9NTN3 A8K185 B7Z3X2 Q52LU5 Q92548,UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter,Solute carrier family 35 member D1;UDP-galactose transporter-related protein 7;, PF03151;, GO:0005789;GO:0005794;GO:0016021;GO:0015297;GO:0005461;GO:0005463;GO:0005462;GO:0008643;GO:0006065;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity; F:UDP-glucuronic acid transmembrane transporter activity; F:UDP-N-acetylgalactosamine transmembrane transporter activity; F:UDP-N-acetylglucosamine transmembrane transporter activity;, P:carbohydrate transport; P:UDP-glucuronate biosynthetic process;|Q9NTN3 A8K185 B7Z3X2 Q52LU5 Q92548,UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter,Solute carrier family 35 member D1;UDP-galactose transporter-related protein 7;, PF03151;, GO:0005789;GO:0005794;GO:0016021;GO:0015297;GO:0005461;GO:0005463;GO:0005462;GO:0008643;GO:0006065;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity; F:UDP-glucuronic acid transmembrane transporter activity; F:UDP-N-acetylgalactosamine transmembrane transporter activity; F:UDP-N-acetylglucosamine transmembrane transporter activity;, P:carbohydrate transport; P:UDP-glucuronate biosynthetic process; scaffold5 indexed_genome mRNA 20444065 20445792 . - . ID=transcript_1306;Q99665 B1AN98 B7ZKL9 F5H7L6 Q2M3V3,Interleukin-12 receptor subunit beta-2,, PF00041;PF06328;, GO:0009897;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0007166;GO:0019221;GO:0035722;GO:0070757;GO:0008284;GO:0032729;, C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of interferon-gamma production; scaffold5 indexed_genome mRNA 20450486 20470101 . - . ID=transcript_1307;Q9Y4S3,Plasminogen activator inhibitor 1 RNA-binding protein {ECO:0000305},PAI1 RNA-binding protein 1;SERPINE1 mRNA-binding protein 1;, PF04774;PF16174;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0045296;GO:0003730;GO:0003723;GO:0032183;GO:0030578;GO:0042981;GO:0043488;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cadherin binding; F:mRNA 3'-UTR binding; F:RNA binding; F:SUMO binding;, P:PML body organization; P:regulation of apoptotic process; P:regulation of mRNA stability; scaffold5 indexed_genome mRNA 20716122 20719113 . - . ID=transcript_1308;P24522 Q5TCA7 Q5TCA8,Growth arrest and DNA damage-inducible protein GADD45 alpha,DNA damage-inducible transcript 1 protein;, PF01248;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0019900;GO:1990841;GO:0046982;GO:0042803;GO:0047485;GO:0000185;GO:0006915;GO:0007050;GO:0071479;GO:0071260;GO:0007098;GO:0006977;GO:0006281;GO:0071850;GO:0016525;GO:0043537;GO:0033140;GO:0071901;GO:0000122;GO:0043065;GO:0046330;GO:1900745;GO:2000379;GO:0051726;GO:0000079;GO:0042770;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:kinase binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein N-terminus binding;, P:activation of MAPKKK activity; P:apoptotic process; P:cell cycle arrest; P:cellular response to ionizing radiation; P:cellular response to mechanical stimulus; P:centrosome cycle; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA repair; P:mitotic cell cycle arrest; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:positive regulation of reactive oxygen species metabolic process; P:regulation of cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:signal transduction in response to DNA damage;|P24522 Q5TCA7 Q5TCA8,Growth arrest and DNA damage-inducible protein GADD45 alpha,DNA damage-inducible transcript 1 protein;, PF01248;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0019900;GO:1990841;GO:0046982;GO:0042803;GO:0047485;GO:0000185;GO:0006915;GO:0007050;GO:0071479;GO:0071260;GO:0007098;GO:0006977;GO:0006281;GO:0071850;GO:0016525;GO:0043537;GO:0033140;GO:0071901;GO:0000122;GO:0043065;GO:0046330;GO:1900745;GO:2000379;GO:0051726;GO:0000079;GO:0042770;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:kinase binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein N-terminus binding;, P:activation of MAPKKK activity; P:apoptotic process; P:cell cycle arrest; P:cellular response to ionizing radiation; P:cellular response to mechanical stimulus; P:centrosome cycle; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA repair; P:mitotic cell cycle arrest; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:positive regulation of reactive oxygen species metabolic process; P:regulation of cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:signal transduction in response to DNA damage;|P24522 Q5TCA7 Q5TCA8,Growth arrest and DNA damage-inducible protein GADD45 alpha,DNA damage-inducible transcript 1 protein;, PF01248;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0019900;GO:1990841;GO:0046982;GO:0042803;GO:0047485;GO:0000185;GO:0006915;GO:0007050;GO:0071479;GO:0071260;GO:0007098;GO:0006977;GO:0006281;GO:0071850;GO:0016525;GO:0043537;GO:0033140;GO:0071901;GO:0000122;GO:0043065;GO:0046330;GO:1900745;GO:2000379;GO:0051726;GO:0000079;GO:0042770;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:kinase binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein N-terminus binding;, P:activation of MAPKKK activity; P:apoptotic process; P:cell cycle arrest; P:cellular response to ionizing radiation; P:cellular response to mechanical stimulus; P:centrosome cycle; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA repair; P:mitotic cell cycle arrest; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:positive regulation of reactive oxygen species metabolic process; P:regulation of cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:signal transduction in response to DNA damage; scaffold5 indexed_genome mRNA 20733944 20740092 . - . ID=transcript_1309;Q9UBI6 Q69YP5 Q9BRV5,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12,, PF00631;, GO:0005884;GO:0070062;GO:0031680;GO:0005834;GO:0005886;GO:0031681;GO:0030165;GO:0042301;GO:0021987;GO:0007186;GO:0032496;GO:0007165;, C:actin filament; C:extracellular exosome; C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:plasma membrane;, F:G-protein beta-subunit binding; F:PDZ domain binding; F:phosphate ion binding;, P:cerebral cortex development; P:G protein-coupled receptor signaling pathway; P:response to lipopolysaccharide; P:signal transduction; scaffold5 indexed_genome mRNA 21101372 21103802 . - . ID=transcript_1310;O95661 B3KMP3,GTP-binding protein Di-Ras3,Distinct subgroup of the Ras family member 3;Rho-related GTP-binding protein RhoI;, PF00071;, GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0000079;GO:0006349;GO:0007264;, C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of gene expression by genetic imprinting; P:small GTPase mediated signal transduction; scaffold5 indexed_genome mRNA 21160476 21273767 . - . ID=transcript_1311;Q5T9L3 B2RNT2 Q5JRS7 Q7Z2Z9 Q8NC43,Protein wntless homolog,Integral membrane protein GPR177;Protein evenness interrupted homolog;Putative NF-kappa-B-activating protein 373;, , GO:0031410;GO:0005829;GO:0032839;GO:0032590;GO:0005769;GO:0031901;GO:0030666;GO:0012505;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0031301;GO:0005886;GO:0005802;GO:0042802;GO:0031852;GO:0017147;GO:0009948;GO:0006886;GO:0090263;GO:0043123;GO:0061357;GO:0030177;GO:0061355;GO:0016055;, C:cytoplasmic vesicle; C:cytosol; C:dendrite cytoplasm; C:dendrite membrane; C:early endosome; C:early endosome membrane; C:endocytic vesicle membrane; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of organelle membrane; C:plasma membrane; C:trans-Golgi network;, F:identical protein binding; F:mu-type opioid receptor binding; F:Wnt-protein binding;, P:anterior/posterior axis specification; P:intracellular protein transport; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of Wnt protein secretion; P:positive regulation of Wnt signaling pathway; P:Wnt protein secretion; P:Wnt signaling pathway; scaffold5 indexed_genome mRNA 22986606 22987342 . - . ID=transcript_1312;Q96NW7 Q5VXC2 Q5VXC3 Q68D07 Q86VE8 Q8WX20 Q9P2I2,Leucine-rich repeat-containing protein 7,Densin-180;Protein LAP1;, PF13855;PF00595;, GO:0043194;GO:0016323;GO:0030054;GO:0005813;GO:0005829;GO:0005576;GO:0005654;GO:0005886;GO:0014069;GO:0035580;GO:0098609;GO:0045197;GO:0000165;GO:0043312;GO:0010976;GO:0043113;GO:0097120;GO:2000310;, C:axon initial segment; C:basolateral plasma membrane; C:cell junction; C:centrosome; C:cytosol; C:extracellular region; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:specific granule lumen;, , P:cell-cell adhesion; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:neutrophil degranulation; P:positive regulation of neuron projection development; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity; scaffold5 indexed_genome mRNA 23003453 23080756 . + . ID=transcript_1313;Q96NW7 Q5VXC2 Q5VXC3 Q68D07 Q86VE8 Q8WX20 Q9P2I2,Leucine-rich repeat-containing protein 7,Densin-180;Protein LAP1;, PF13855;PF00595;, GO:0043194;GO:0016323;GO:0030054;GO:0005813;GO:0005829;GO:0005576;GO:0005654;GO:0005886;GO:0014069;GO:0035580;GO:0098609;GO:0045197;GO:0000165;GO:0043312;GO:0010976;GO:0043113;GO:0097120;GO:2000310;, C:axon initial segment; C:basolateral plasma membrane; C:cell junction; C:centrosome; C:cytosol; C:extracellular region; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:specific granule lumen;, , P:cell-cell adhesion; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:neutrophil degranulation; P:positive regulation of neuron projection development; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity; scaffold5 indexed_genome mRNA 23100136 23132612 . - . ID=transcript_1314;Q9H9A6 Q9BTR7 Q9NSK1 Q9NXC1,Leucine-rich repeat-containing protein 40,, PF13855;, GO:0005737;GO:0043231;GO:0016020;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane;, F:protein serine/threonine phosphatase activity;, P:signal transduction;|Q9H9A6 Q9BTR7 Q9NSK1 Q9NXC1,Leucine-rich repeat-containing protein 40,, PF13855;, GO:0005737;GO:0043231;GO:0016020;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane;, F:protein serine/threonine phosphatase activity;, P:signal transduction;|Q9H9A6 Q9BTR7 Q9NSK1 Q9NXC1,Leucine-rich repeat-containing protein 40,, PF13855;, GO:0005737;GO:0043231;GO:0016020;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane;, F:protein serine/threonine phosphatase activity;, P:signal transduction; scaffold5 indexed_genome mRNA 23133617 23140683 . - . ID=transcript_1315;Q9H9A6 Q9BTR7 Q9NSK1 Q9NXC1,Leucine-rich repeat-containing protein 40,, PF13855;, GO:0005737;GO:0043231;GO:0016020;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane;, F:protein serine/threonine phosphatase activity;, P:signal transduction; scaffold5 indexed_genome mRNA 23153931 23159626 . + . ID=transcript_1316;Q05519 Q5T758 Q8IWE6,Serine/arginine-rich splicing factor 11,Arginine-rich 54 kDa nuclear protein;Splicing factor, arginine/serine-rich 11;, PF00076;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0006405;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; scaffold5 indexed_genome mRNA 23161549 23292098 . - . ID=transcript_1317;Q8N6S4 B3KQ97 Q5VYH4 Q5VYH5 Q6PJE4 Q9H0N9,Ankyrin repeat domain-containing protein 13C,, PF12796;PF11904;, GO:0005737;GO:0005783;GO:0005789;GO:0048471;GO:0005102;GO:0006621;GO:2000209;GO:0010469;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:signaling receptor binding;, P:protein retention in ER lumen; P:regulation of anoikis; P:regulation of signaling receptor activity;|Q8N6S4 B3KQ97 Q5VYH4 Q5VYH5 Q6PJE4 Q9H0N9,Ankyrin repeat domain-containing protein 13C,, PF12796;PF11904;, GO:0005737;GO:0005783;GO:0005789;GO:0048471;GO:0005102;GO:0006621;GO:2000209;GO:0010469;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:signaling receptor binding;, P:protein retention in ER lumen; P:regulation of anoikis; P:regulation of signaling receptor activity; scaffold5 indexed_genome mRNA 23338395 23367843 . + . ID=transcript_1318;P32929 B4E1R2 E9PDV0 Q53FB3 Q53Y79 Q9H4W7 Q9H4W8,Cystathionine gamma-lyase,Cysteine-protein sulfhydrase;Gamma-cystathionase;, PF01053;, GO:0005737;GO:0005829;GO:0070062;GO:0005516;GO:0016846;GO:0004123;GO:0042802;GO:0080146;GO:0044540;GO:0030170;GO:1990830;GO:0019344;GO:0019343;GO:0006534;GO:0030968;GO:0070814;GO:2001234;GO:1904831;GO:0043123;GO:0051092;GO:0051289;GO:0044524;GO:0018272;GO:0000098;GO:0019346;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:calmodulin binding; F:carbon-sulfur lyase activity; F:cystathionine gamma-lyase activity; F:identical protein binding; F:L-cysteine desulfhydrase activity; F:L-cystine L-cysteine-lyase (deaminating); F:pyridoxal phosphate binding;, P:cellular response to leukemia inhibitory factor; P:cysteine biosynthetic process; P:cysteine biosynthetic process via cystathionine; P:cysteine metabolic process; P:endoplasmic reticulum unfolded protein response; P:hydrogen sulfide biosynthetic process; P:negative regulation of apoptotic signaling pathway; P:positive regulation of aortic smooth muscle cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein homotetramerization; P:protein sulfhydration; P:protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine; P:sulfur amino acid catabolic process; P:transsulfuration;|P32929 B4E1R2 E9PDV0 Q53FB3 Q53Y79 Q9H4W7 Q9H4W8,Cystathionine gamma-lyase,Cysteine-protein sulfhydrase;Gamma-cystathionase;, PF01053;, GO:0005737;GO:0005829;GO:0070062;GO:0005516;GO:0016846;GO:0004123;GO:0042802;GO:0080146;GO:0044540;GO:0030170;GO:1990830;GO:0019344;GO:0019343;GO:0006534;GO:0030968;GO:0070814;GO:2001234;GO:1904831;GO:0043123;GO:0051092;GO:0051289;GO:0044524;GO:0018272;GO:0000098;GO:0019346;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:calmodulin binding; F:carbon-sulfur lyase activity; F:cystathionine gamma-lyase activity; F:identical protein binding; F:L-cysteine desulfhydrase activity; F:L-cystine L-cysteine-lyase (deaminating); F:pyridoxal phosphate binding;, P:cellular response to leukemia inhibitory factor; P:cysteine biosynthetic process; P:cysteine biosynthetic process via cystathionine; P:cysteine metabolic process; P:endoplasmic reticulum unfolded protein response; P:hydrogen sulfide biosynthetic process; P:negative regulation of apoptotic signaling pathway; P:positive regulation of aortic smooth muscle cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein homotetramerization; P:protein sulfhydration; P:protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine; P:sulfur amino acid catabolic process; P:transsulfuration;|P32929 B4E1R2 E9PDV0 Q53FB3 Q53Y79 Q9H4W7 Q9H4W8,Cystathionine gamma-lyase,Cysteine-protein sulfhydrase;Gamma-cystathionase;, PF01053;, GO:0005737;GO:0005829;GO:0070062;GO:0005516;GO:0016846;GO:0004123;GO:0042802;GO:0080146;GO:0044540;GO:0030170;GO:1990830;GO:0019344;GO:0019343;GO:0006534;GO:0030968;GO:0070814;GO:2001234;GO:1904831;GO:0043123;GO:0051092;GO:0051289;GO:0044524;GO:0018272;GO:0000098;GO:0019346;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:calmodulin binding; F:carbon-sulfur lyase activity; F:cystathionine gamma-lyase activity; F:identical protein binding; F:L-cysteine desulfhydrase activity; F:L-cystine L-cysteine-lyase (deaminating); F:pyridoxal phosphate binding;, P:cellular response to leukemia inhibitory factor; P:cysteine biosynthetic process; P:cysteine biosynthetic process via cystathionine; P:cysteine metabolic process; P:endoplasmic reticulum unfolded protein response; P:hydrogen sulfide biosynthetic process; P:negative regulation of apoptotic signaling pathway; P:positive regulation of aortic smooth muscle cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein homotetramerization; P:protein sulfhydration; P:protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine; P:sulfur amino acid catabolic process; P:transsulfuration;|P32929 B4E1R2 E9PDV0 Q53FB3 Q53Y79 Q9H4W7 Q9H4W8,Cystathionine gamma-lyase,Cysteine-protein sulfhydrase;Gamma-cystathionase;, PF01053;, GO:0005737;GO:0005829;GO:0070062;GO:0005516;GO:0016846;GO:0004123;GO:0042802;GO:0080146;GO:0044540;GO:0030170;GO:1990830;GO:0019344;GO:0019343;GO:0006534;GO:0030968;GO:0070814;GO:2001234;GO:1904831;GO:0043123;GO:0051092;GO:0051289;GO:0044524;GO:0018272;GO:0000098;GO:0019346;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:calmodulin binding; F:carbon-sulfur lyase activity; F:cystathionine gamma-lyase activity; F:identical protein binding; F:L-cysteine desulfhydrase activity; F:L-cystine L-cysteine-lyase (deaminating); F:pyridoxal phosphate binding;, P:cellular response to leukemia inhibitory factor; P:cysteine biosynthetic process; P:cysteine biosynthetic process via cystathionine; P:cysteine metabolic process; P:endoplasmic reticulum unfolded protein response; P:hydrogen sulfide biosynthetic process; P:negative regulation of apoptotic signaling pathway; P:positive regulation of aortic smooth muscle cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein homotetramerization; P:protein sulfhydration; P:protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine; P:sulfur amino acid catabolic process; P:transsulfuration;|P32929 B4E1R2 E9PDV0 Q53FB3 Q53Y79 Q9H4W7 Q9H4W8,Cystathionine gamma-lyase,Cysteine-protein sulfhydrase;Gamma-cystathionase;, PF01053;, GO:0005737;GO:0005829;GO:0070062;GO:0005516;GO:0016846;GO:0004123;GO:0042802;GO:0080146;GO:0044540;GO:0030170;GO:1990830;GO:0019344;GO:0019343;GO:0006534;GO:0030968;GO:0070814;GO:2001234;GO:1904831;GO:0043123;GO:0051092;GO:0051289;GO:0044524;GO:0018272;GO:0000098;GO:0019346;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:calmodulin binding; F:carbon-sulfur lyase activity; F:cystathionine gamma-lyase activity; F:identical protein binding; F:L-cysteine desulfhydrase activity; F:L-cystine L-cysteine-lyase (deaminating); F:pyridoxal phosphate binding;, P:cellular response to leukemia inhibitory factor; P:cysteine biosynthetic process; P:cysteine biosynthetic process via cystathionine; P:cysteine metabolic process; P:endoplasmic reticulum unfolded protein response; P:hydrogen sulfide biosynthetic process; P:negative regulation of apoptotic signaling pathway; P:positive regulation of aortic smooth muscle cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein homotetramerization; P:protein sulfhydration; P:protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine; P:sulfur amino acid catabolic process; P:transsulfuration; scaffold5 indexed_genome mRNA 23686876 23894609 . - . ID=transcript_1319;Q16546 Q5CZ59 Q5CZ61 Q5CZ62 Q5CZ63 Q5CZ64,Prostaglandin E2 receptor EP3 subtype,PGE2-R;Prostanoid EP3 receptor;, PF00001;, GO:0016021;GO:0005887;GO:0005635;GO:0005886;GO:0004957;GO:0007189;GO:0008219;GO:0007186;GO:0006954;GO:0014827;GO:0060455;GO:0007200;GO:0007204;GO:0031622;, C:integral component of membrane; C:integral component of plasma membrane; C:nuclear envelope; C:plasma membrane;, F:prostaglandin E receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell death; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:intestine smooth muscle contraction; P:negative regulation of gastric acid secretion; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of fever generation;|Q16546 Q5CZ59 Q5CZ61 Q5CZ62 Q5CZ63 Q5CZ64,Prostaglandin E2 receptor EP3 subtype,PGE2-R;Prostanoid EP3 receptor;, PF00001;, GO:0016021;GO:0005887;GO:0005635;GO:0005886;GO:0004957;GO:0007189;GO:0008219;GO:0007186;GO:0006954;GO:0014827;GO:0060455;GO:0007200;GO:0007204;GO:0031622;, C:integral component of membrane; C:integral component of plasma membrane; C:nuclear envelope; C:plasma membrane;, F:prostaglandin E receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell death; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:intestine smooth muscle contraction; P:negative regulation of gastric acid secretion; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of fever generation;|Q16546 Q5CZ59 Q5CZ61 Q5CZ62 Q5CZ63 Q5CZ64,Prostaglandin E2 receptor EP3 subtype,PGE2-R;Prostanoid EP3 receptor;, PF00001;, GO:0016021;GO:0005887;GO:0005635;GO:0005886;GO:0004957;GO:0007189;GO:0008219;GO:0007186;GO:0006954;GO:0014827;GO:0060455;GO:0007200;GO:0007204;GO:0031622;, C:integral component of membrane; C:integral component of plasma membrane; C:nuclear envelope; C:plasma membrane;, F:prostaglandin E receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell death; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:intestine smooth muscle contraction; P:negative regulation of gastric acid secretion; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of fever generation; scaffold5 indexed_genome mRNA 23919547 23930710 . - . ID=transcript_1320;O95218 D3DQ75 Q53GS3 Q59F92 Q5VV33 Q5VV34 Q8IXN6 Q9UP63,Zinc finger Ran-binding domain-containing protein 2,Zinc finger protein 265;Zinc finger, splicing;, PF00641;, GO:0005654;GO:0001530;GO:0046872;GO:0003723;GO:0006397;GO:0008380;, C:nucleoplasm;, F:lipopolysaccharide binding; F:metal ion binding; F:RNA binding;, P:mRNA processing; P:RNA splicing;|O95218 D3DQ75 Q53GS3 Q59F92 Q5VV33 Q5VV34 Q8IXN6 Q9UP63,Zinc finger Ran-binding domain-containing protein 2,Zinc finger protein 265;Zinc finger, splicing;, PF00641;, GO:0005654;GO:0001530;GO:0046872;GO:0003723;GO:0006397;GO:0008380;, C:nucleoplasm;, F:lipopolysaccharide binding; F:metal ion binding; F:RNA binding;, P:mRNA processing; P:RNA splicing; scaffold5 indexed_genome mRNA 24218480 24539865 . - . ID=transcript_1321;Q7Z3B1 Q5VT21 Q6UY06 Q8N440 Q8NAQ3,Neuronal growth regulator 1,IgLON family member 4;, PF07679;, GO:0031225;GO:0005576;GO:0005886;GO:0098609;GO:0007631;GO:0007626;GO:0010976;, C:anchored component of membrane; C:extracellular region; C:plasma membrane;, , P:cell-cell adhesion; P:feeding behavior; P:locomotory behavior; P:positive regulation of neuron projection development; scaffold5 indexed_genome mRNA 27149159 27149899 . + . ID=transcript_1322;A6PVS8 A6PVS9 Q6P5P7 Q6ZMV4 Q8WUE0,Leucine-rich repeat and IQ domain-containing protein 3,Leucine-rich repeat-containing protein 44;, PF12799; scaffold5 indexed_genome mRNA 27151309 27174278 . - . ID=transcript_1323;A6PVS8 A6PVS9 Q6P5P7 Q6ZMV4 Q8WUE0,Leucine-rich repeat and IQ domain-containing protein 3,Leucine-rich repeat-containing protein 44;, PF12799; scaffold5 indexed_genome mRNA 27174370 27183184 . + . ID=transcript_1324;O14772 A0A0A0MRP2 A6NMH3 B4DRX2 B4E2Y7 E9PNQ2 Q8N5J7,Fucose-1-phosphate guanylyltransferase,GDP-L-fucose diphosphorylase;GDP-L-fucose pyrophosphorylase;, PF07959;, GO:0005737;GO:0005829;GO:0003824;GO:0047341;GO:0005525;GO:0006004;, C:cytoplasm; C:cytosol;, F:catalytic activity; F:fucose-1-phosphate guanylyltransferase activity; F:GTP binding;, P:fucose metabolic process; scaffold5 indexed_genome mRNA 27224928 27502668 . + . ID=transcript_1325;Q59H18 Q17RN0 Q49AR1 Q6MZS9 Q9Y2V6,Serine/threonine-protein kinase TNNI3K,Cardiac ankyrin repeat kinase;Cardiac troponin I-interacting kinase;TNNI3-interacting kinase;, PF12796;PF07714;, GO:0005737;GO:0005634;GO:0005524;GO:0046872;GO:0008022;GO:0004672;GO:0106310;GO:0106311;GO:0031013;GO:0086069;GO:0006468;GO:1903779;GO:0055117;GO:0002027;, C:cytoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein C-terminus binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:troponin I binding;, P:bundle of His cell to Purkinje myocyte communication; P:protein phosphorylation; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of heart rate;|Q59H18 Q17RN0 Q49AR1 Q6MZS9 Q9Y2V6,Serine/threonine-protein kinase TNNI3K,Cardiac ankyrin repeat kinase;Cardiac troponin I-interacting kinase;TNNI3-interacting kinase;, PF12796;PF07714;, GO:0005737;GO:0005634;GO:0005524;GO:0046872;GO:0008022;GO:0004672;GO:0106310;GO:0106311;GO:0031013;GO:0086069;GO:0006468;GO:1903779;GO:0055117;GO:0002027;, C:cytoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein C-terminus binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:troponin I binding;, P:bundle of His cell to Purkinje myocyte communication; P:protein phosphorylation; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of heart rate; scaffold5 indexed_genome mRNA 27533643 27649120 . + . ID=transcript_1326;Q5RHP9 Q68DL8 Q6GMR8 Q6ZSF9 Q8ND41,Glutamate-rich protein 3,, PF15257; scaffold5 indexed_genome mRNA 27687978 27717851 . - . ID=transcript_1327;Q08257 A6NN60 D3DQ76 Q53FT0 Q59EU7 Q5HYE7 Q6NSK9,Quinone oxidoreductase,NADPH:quinone reductase;Zeta-crystallin;, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0042802;GO:0003730;GO:0070402;GO:0003960;GO:0008270;GO:0051289;GO:0007601;GO:0042178;, C:cytosol; C:extracellular exosome;, F:identical protein binding; F:mRNA 3'-UTR binding; F:NADPH binding; F:NADPH:quinone reductase activity; F:zinc ion binding;, P:protein homotetramerization; P:visual perception; P:xenobiotic catabolic process; scaffold5 indexed_genome mRNA 27717925 27739575 . + . ID=transcript_1328;Q6IPR3 B4DSP9 E9PGR7 Q5HYJ0 Q8N7L1,tRNA wybutosine-synthesizing protein 3 homolog,tRNA(Phe) 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase;, PF02676;, GO:0005737;GO:0008175;GO:0030488;, C:cytoplasm;, F:tRNA methyltransferase activity;, P:tRNA methylation; scaffold5 indexed_genome mRNA 28115986 28145619 . + . ID=transcript_1329;Q658S8 Q6UX89 Q8TEW4 Q96C58 Q96K59 Q9Y332,Choline transporter-like protein 4 {ECO:0000303|PubMed:23651124},Solute carrier family 44 member 4 {ECO:0000312|HGNC:HGNC:13941};Thiamine pyrophosphate transporter 1 {ECO:0000303|PubMed:24379411};, PF04515;, GO:0016324;GO:0070062;GO:0016021;GO:0016020;GO:0005886;GO:0015220;GO:0090422;GO:0022857;GO:0008292;GO:0061526;GO:0015871;GO:0035675;GO:0032475;GO:0006656;GO:0030307;GO:0030974;GO:0055085;, C:apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:choline transmembrane transporter activity; F:thiamine pyrophosphate transmembrane transporter activity; F:transmembrane transporter activity;, P:acetylcholine biosynthetic process; P:acetylcholine secretion; P:choline transport; P:neuromast hair cell development; P:otolith formation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cell growth; P:thiamine pyrophosphate transmembrane transport; P:transmembrane transport;|Q8NCS7 A0A0A0MRP1 B5MCU3 Q4G0K0 Q8NA44 Q8NB86,Choline transporter-like protein 5,Solute carrier family 44 member 5;, PF04515;, GO:0016021;GO:0016020;GO:0005886;GO:0022857;GO:0006656;GO:0055085;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:transmembrane transporter activity;, P:phosphatidylcholine biosynthetic process; P:transmembrane transport;|Q8NCS7 A0A0A0MRP1 B5MCU3 Q4G0K0 Q8NA44 Q8NB86,Choline transporter-like protein 5,Solute carrier family 44 member 5;, PF04515;, GO:0016021;GO:0016020;GO:0005886;GO:0022857;GO:0006656;GO:0055085;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:transmembrane transporter activity;, P:phosphatidylcholine biosynthetic process; P:transmembrane transport; scaffold5 indexed_genome mRNA 28145625 28166348 . - . ID=transcript_1330;Q8NCS7 A0A0A0MRP1 B5MCU3 Q4G0K0 Q8NA44 Q8NB86,Choline transporter-like protein 5,Solute carrier family 44 member 5;, PF04515;, GO:0016021;GO:0016020;GO:0005886;GO:0022857;GO:0006656;GO:0055085;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:transmembrane transporter activity;, P:phosphatidylcholine biosynthetic process; P:transmembrane transport;|Q8NCS7 A0A0A0MRP1 B5MCU3 Q4G0K0 Q8NA44 Q8NB86,Choline transporter-like protein 5,Solute carrier family 44 member 5;, PF04515;, GO:0016021;GO:0016020;GO:0005886;GO:0022857;GO:0006656;GO:0055085;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:transmembrane transporter activity;, P:phosphatidylcholine biosynthetic process; P:transmembrane transport;|Q8NCS7 A0A0A0MRP1 B5MCU3 Q4G0K0 Q8NA44 Q8NB86,Choline transporter-like protein 5,Solute carrier family 44 member 5;, PF04515;, GO:0016021;GO:0016020;GO:0005886;GO:0022857;GO:0006656;GO:0055085;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:transmembrane transporter activity;, P:phosphatidylcholine biosynthetic process; P:transmembrane transport;|Q8NCS7 A0A0A0MRP1 B5MCU3 Q4G0K0 Q8NA44 Q8NB86,Choline transporter-like protein 5,Solute carrier family 44 member 5;, PF04515;, GO:0016021;GO:0016020;GO:0005886;GO:0022857;GO:0006656;GO:0055085;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:transmembrane transporter activity;, P:phosphatidylcholine biosynthetic process; P:transmembrane transport; scaffold5 indexed_genome mRNA 28232266 28538841 . - . ID=transcript_1331;Q8NCS7 A0A0A0MRP1 B5MCU3 Q4G0K0 Q8NA44 Q8NB86,Choline transporter-like protein 5,Solute carrier family 44 member 5;, PF04515;, GO:0016021;GO:0016020;GO:0005886;GO:0022857;GO:0006656;GO:0055085;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:transmembrane transporter activity;, P:phosphatidylcholine biosynthetic process; P:transmembrane transport; scaffold5 indexed_genome mRNA 28579682 28614456 . + . ID=transcript_1332;P11310 Q5T4U4 Q9NYF1,Medium-chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:3035565},Medium chain acyl-CoA dehydrogenase {ECO:0000303|PubMed:8823175};, PF00441;PF02770;PF02771;, GO:0030424;GO:0005759;GO:0031966;GO:0005739;GO:0005634;GO:0003995;GO:0050660;GO:0042802;GO:0070991;GO:0045329;GO:0019254;GO:0006635;GO:0033539;GO:0051793;GO:0051791;GO:0019222;, C:axon; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:medium-chain-acyl-CoA dehydrogenase activity;, P:carnitine biosynthetic process; P:carnitine metabolic process, CoA-linked; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:medium-chain fatty acid catabolic process; P:medium-chain fatty acid metabolic process; P:regulation of metabolic process;|P11310 Q5T4U4 Q9NYF1,Medium-chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:3035565},Medium chain acyl-CoA dehydrogenase {ECO:0000303|PubMed:8823175};, PF00441;PF02770;PF02771;, GO:0030424;GO:0005759;GO:0031966;GO:0005739;GO:0005634;GO:0003995;GO:0050660;GO:0042802;GO:0070991;GO:0045329;GO:0019254;GO:0006635;GO:0033539;GO:0051793;GO:0051791;GO:0019222;, C:axon; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:medium-chain-acyl-CoA dehydrogenase activity;, P:carnitine biosynthetic process; P:carnitine metabolic process, CoA-linked; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:medium-chain fatty acid catabolic process; P:medium-chain fatty acid metabolic process; P:regulation of metabolic process;|P11310 Q5T4U4 Q9NYF1,Medium-chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:3035565},Medium chain acyl-CoA dehydrogenase {ECO:0000303|PubMed:8823175};, PF00441;PF02770;PF02771;, GO:0030424;GO:0005759;GO:0031966;GO:0005739;GO:0005634;GO:0003995;GO:0050660;GO:0042802;GO:0070991;GO:0045329;GO:0019254;GO:0006635;GO:0033539;GO:0051793;GO:0051791;GO:0019222;, C:axon; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:medium-chain-acyl-CoA dehydrogenase activity;, P:carnitine biosynthetic process; P:carnitine metabolic process, CoA-linked; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:medium-chain fatty acid catabolic process; P:medium-chain fatty acid metabolic process; P:regulation of metabolic process;|P11310 Q5T4U4 Q9NYF1,Medium-chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:3035565},Medium chain acyl-CoA dehydrogenase {ECO:0000303|PubMed:8823175};, PF00441;PF02770;PF02771;, GO:0030424;GO:0005759;GO:0031966;GO:0005739;GO:0005634;GO:0003995;GO:0050660;GO:0042802;GO:0070991;GO:0045329;GO:0019254;GO:0006635;GO:0033539;GO:0051793;GO:0051791;GO:0019222;, C:axon; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:medium-chain-acyl-CoA dehydrogenase activity;, P:carnitine biosynthetic process; P:carnitine metabolic process, CoA-linked; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:medium-chain fatty acid catabolic process; P:medium-chain fatty acid metabolic process; P:regulation of metabolic process; scaffold5 indexed_genome mRNA 28633561 28635571 . - . ID=transcript_1333;P53611 Q92697,Geranylgeranyl transferase type-2 subunit beta,Geranylgeranyl transferase type II subunit beta;Rab geranyl-geranyltransferase subunit beta;Rab geranylgeranyltransferase subunit beta;Type II protein geranyl-geranyltransferase subunit beta;, PF00432;, GO:0005829;GO:0005886;GO:0005968;GO:0004663;GO:0031267;GO:0008270;GO:0006464;GO:0043687;GO:0018344;GO:0018342;GO:0042981;GO:0007601;, C:cytosol; C:plasma membrane; C:Rab-protein geranylgeranyltransferase complex;, F:Rab geranylgeranyltransferase activity; F:small GTPase binding; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein geranylgeranylation; P:protein prenylation; P:regulation of apoptotic process; P:visual perception;|P53611 Q92697,Geranylgeranyl transferase type-2 subunit beta,Geranylgeranyl transferase type II subunit beta;Rab geranyl-geranyltransferase subunit beta;Rab geranylgeranyltransferase subunit beta;Type II protein geranyl-geranyltransferase subunit beta;, PF00432;, GO:0005829;GO:0005886;GO:0005968;GO:0004663;GO:0031267;GO:0008270;GO:0006464;GO:0043687;GO:0018344;GO:0018342;GO:0042981;GO:0007601;, C:cytosol; C:plasma membrane; C:Rab-protein geranylgeranyltransferase complex;, F:Rab geranylgeranyltransferase activity; F:small GTPase binding; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein geranylgeranylation; P:protein prenylation; P:regulation of apoptotic process; P:visual perception; scaffold5 indexed_genome mRNA 28636276 28637419 . - . ID=transcript_1334;P53611 Q92697,Geranylgeranyl transferase type-2 subunit beta,Geranylgeranyl transferase type II subunit beta;Rab geranyl-geranyltransferase subunit beta;Rab geranylgeranyltransferase subunit beta;Type II protein geranyl-geranyltransferase subunit beta;, PF00432;, GO:0005829;GO:0005886;GO:0005968;GO:0004663;GO:0031267;GO:0008270;GO:0006464;GO:0043687;GO:0018344;GO:0018342;GO:0042981;GO:0007601;, C:cytosol; C:plasma membrane; C:Rab-protein geranylgeranyltransferase complex;, F:Rab geranylgeranyltransferase activity; F:small GTPase binding; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein geranylgeranylation; P:protein prenylation; P:regulation of apoptotic process; P:visual perception; scaffold5 indexed_genome mRNA 28637425 28639028 . + . ID=transcript_1335;P53611 Q92697,Geranylgeranyl transferase type-2 subunit beta,Geranylgeranyl transferase type II subunit beta;Rab geranyl-geranyltransferase subunit beta;Rab geranylgeranyltransferase subunit beta;Type II protein geranyl-geranyltransferase subunit beta;, PF00432;, GO:0005829;GO:0005886;GO:0005968;GO:0004663;GO:0031267;GO:0008270;GO:0006464;GO:0043687;GO:0018344;GO:0018342;GO:0042981;GO:0007601;, C:cytosol; C:plasma membrane; C:Rab-protein geranylgeranyltransferase complex;, F:Rab geranylgeranyltransferase activity; F:small GTPase binding; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein geranylgeranylation; P:protein prenylation; P:regulation of apoptotic process; P:visual perception;|P53611 Q92697,Geranylgeranyl transferase type-2 subunit beta,Geranylgeranyl transferase type II subunit beta;Rab geranyl-geranyltransferase subunit beta;Rab geranylgeranyltransferase subunit beta;Type II protein geranyl-geranyltransferase subunit beta;, PF00432;, GO:0005829;GO:0005886;GO:0005968;GO:0004663;GO:0031267;GO:0008270;GO:0006464;GO:0043687;GO:0018344;GO:0018342;GO:0042981;GO:0007601;, C:cytosol; C:plasma membrane; C:Rab-protein geranylgeranyltransferase complex;, F:Rab geranylgeranyltransferase activity; F:small GTPase binding; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein geranylgeranylation; P:protein prenylation; P:regulation of apoptotic process; P:visual perception; scaffold5 indexed_genome mRNA 28697084 28707446 . - . ID=transcript_1336;O15457 Q5T4U6 Q8NEB3 Q9UNP8,MutS protein homolog 4,, PF05188;PF05192;PF05190;PF00488;, GO:0005694;GO:0005634;GO:0005713;GO:0000795;GO:0005524;GO:0003677;GO:0008094;GO:0030983;GO:0007292;GO:0007129;GO:0000710;GO:0001541;GO:0007131;GO:0000712;GO:0007283;, C:chromosome; C:nucleus; C:recombination nodule; C:synaptonemal complex;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:mismatched DNA binding;, P:female gamete generation; P:homologous chromosome pairing at meiosis; P:meiotic mismatch repair; P:ovarian follicle development; P:reciprocal meiotic recombination; P:resolution of meiotic recombination intermediates; P:spermatogenesis;|O15457 Q5T4U6 Q8NEB3 Q9UNP8,MutS protein homolog 4,, PF05188;PF05192;PF05190;PF00488;, GO:0005694;GO:0005634;GO:0005713;GO:0000795;GO:0005524;GO:0003677;GO:0008094;GO:0030983;GO:0007292;GO:0007129;GO:0000710;GO:0001541;GO:0007131;GO:0000712;GO:0007283;, C:chromosome; C:nucleus; C:recombination nodule; C:synaptonemal complex;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:mismatched DNA binding;, P:female gamete generation; P:homologous chromosome pairing at meiosis; P:meiotic mismatch repair; P:ovarian follicle development; P:reciprocal meiotic recombination; P:resolution of meiotic recombination intermediates; P:spermatogenesis; scaffold5 indexed_genome mRNA 28719178 28730405 . + . ID=transcript_1337;O15457 Q5T4U6 Q8NEB3 Q9UNP8,MutS protein homolog 4,, PF05188;PF05192;PF05190;PF00488;, GO:0005694;GO:0005634;GO:0005713;GO:0000795;GO:0005524;GO:0003677;GO:0008094;GO:0030983;GO:0007292;GO:0007129;GO:0000710;GO:0001541;GO:0007131;GO:0000712;GO:0007283;, C:chromosome; C:nucleus; C:recombination nodule; C:synaptonemal complex;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:mismatched DNA binding;, P:female gamete generation; P:homologous chromosome pairing at meiosis; P:meiotic mismatch repair; P:ovarian follicle development; P:reciprocal meiotic recombination; P:resolution of meiotic recombination intermediates; P:spermatogenesis; scaffold5 indexed_genome mRNA 28968877 29322172 . + . ID=transcript_1338;Q8NDV1 Q6PCE0 Q6UX29 Q8N259,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3,GalNAc alpha-2,6-sialyltransferase III;ST6GalNAc III {ECO:0000303|PubMed:16169874, ECO:0000303|PubMed:17123352};STY;Sialyltransferase 7C;, PF00777;, GO:0000139;GO:0016021;GO:0005654;GO:0047290;GO:0001665;GO:0008373;GO:0001574;GO:0009100;GO:0006687;GO:0006677;GO:0009311;GO:0006486;GO:0019082;, C:Golgi membrane; C:integral component of membrane; C:nucleoplasm;, F:(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity; F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide metabolic process; P:oligosaccharide metabolic process; P:protein glycosylation; P:viral protein processing; scaffold5 indexed_genome mRNA 29558318 29561738 . + . ID=transcript_1339;Q8NDV1 Q6PCE0 Q6UX29 Q8N259,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3,GalNAc alpha-2,6-sialyltransferase III;ST6GalNAc III {ECO:0000303|PubMed:16169874, ECO:0000303|PubMed:17123352};STY;Sialyltransferase 7C;, PF00777;, GO:0000139;GO:0016021;GO:0005654;GO:0047290;GO:0001665;GO:0008373;GO:0001574;GO:0009100;GO:0006687;GO:0006677;GO:0009311;GO:0006486;GO:0019082;, C:Golgi membrane; C:integral component of membrane; C:nucleoplasm;, F:(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity; F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide metabolic process; P:oligosaccharide metabolic process; P:protein glycosylation; P:viral protein processing; scaffold5 indexed_genome mRNA 29817537 30020823 . + . ID=transcript_1340;Q9BVH7 B1AK82,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5,GD1 alpha synthase;GalNAc alpha-2,6-sialyltransferase V;ST6GalNAc V {ECO:0000303|PubMed:12668675};Sialyltransferase 7E;, PF00777;, GO:0000139;GO:0016021;GO:0001665;GO:0008373;GO:0001574;GO:0006688;GO:0009312;GO:0009311;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:ganglioside biosynthetic process; P:glycosphingolipid biosynthetic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation; scaffold5 indexed_genome mRNA 30049053 30185576 . - . ID=transcript_1341;Q92643 B2R7K3 B4E2M3 O14822 Q5TG77,GPI-anchor transamidase,GPI8 homolog;Phosphatidylinositol-glycan biosynthesis class K protein;, PF01650;, GO:0005789;GO:0042765;GO:0016020;GO:0003923;GO:0003756;GO:0016255;GO:0034394;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane;, F:GPI-anchor transamidase activity; F:protein disulfide isomerase activity;, P:attachment of GPI anchor to protein; P:protein localization to cell surface; scaffold5 indexed_genome mRNA 30252593 30258313 . + . ID=transcript_1342;Q9Y6K8 Q5U622 Q6FH66 Q7Z4T5 Q86YS0 Q8N464 Q96EC9,Adenylate kinase isoenzyme 5,ATP-AMP transphosphorylase 5;, , GO:0034451;GO:0005737;GO:0005829;GO:0004017;GO:0005524;GO:0004550;GO:0006172;GO:0046034;GO:0006173;GO:0015949;GO:0006165;GO:0009142;GO:0009220;, C:centriolar satellite; C:cytoplasm; C:cytosol;, F:adenylate kinase activity; F:ATP binding; F:nucleoside diphosphate kinase activity;, P:ADP biosynthetic process; P:ATP metabolic process; P:dADP biosynthetic process; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:pyrimidine ribonucleotide biosynthetic process; scaffold5 indexed_genome mRNA 30268592 30489356 . + . ID=transcript_1343;Q9Y6K8 Q5U622 Q6FH66 Q7Z4T5 Q86YS0 Q8N464 Q96EC9,Adenylate kinase isoenzyme 5,ATP-AMP transphosphorylase 5;, , GO:0034451;GO:0005737;GO:0005829;GO:0004017;GO:0005524;GO:0004550;GO:0006172;GO:0046034;GO:0006173;GO:0015949;GO:0006165;GO:0009142;GO:0009220;, C:centriolar satellite; C:cytoplasm; C:cytosol;, F:adenylate kinase activity; F:ATP binding; F:nucleoside diphosphate kinase activity;, P:ADP biosynthetic process; P:ATP metabolic process; P:dADP biosynthetic process; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:pyrimidine ribonucleotide biosynthetic process; scaffold5 indexed_genome mRNA 30492190 30523001 . + . ID=transcript_1344;Q9Y6K8 Q5U622 Q6FH66 Q7Z4T5 Q86YS0 Q8N464 Q96EC9,Adenylate kinase isoenzyme 5,ATP-AMP transphosphorylase 5;, , GO:0034451;GO:0005737;GO:0005829;GO:0004017;GO:0005524;GO:0004550;GO:0006172;GO:0046034;GO:0006173;GO:0015949;GO:0006165;GO:0009142;GO:0009220;, C:centriolar satellite; C:cytoplasm; C:cytosol;, F:adenylate kinase activity; F:ATP binding; F:nucleoside diphosphate kinase activity;, P:ADP biosynthetic process; P:ATP metabolic process; P:dADP biosynthetic process; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:pyrimidine ribonucleotide biosynthetic process; scaffold5 indexed_genome mRNA 30527580 30541135 . - . ID=transcript_1345;Q8IYH5 B7WPC6 Q6N004 Q6N070 Q8IYP0 Q8IYR1 Q8TEK4 Q9Y4U0,ZZ-type zinc finger-containing protein 3,, PF00249;PF00569;, GO:0005671;GO:0005730;GO:0005654;GO:0003677;GO:0008270;GO:0043967;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:histone H4 acetylation; scaffold5 indexed_genome mRNA 30541151 30643007 . - . ID=transcript_1346;Q8IYH5 B7WPC6 Q6N004 Q6N070 Q8IYP0 Q8IYR1 Q8TEK4 Q9Y4U0,ZZ-type zinc finger-containing protein 3,, PF00249;PF00569;, GO:0005671;GO:0005730;GO:0005654;GO:0003677;GO:0008270;GO:0043967;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:histone H4 acetylation;|Q8IYH5 B7WPC6 Q6N004 Q6N070 Q8IYP0 Q8IYR1 Q8TEK4 Q9Y4U0,ZZ-type zinc finger-containing protein 3,, PF00249;PF00569;, GO:0005671;GO:0005730;GO:0005654;GO:0003677;GO:0008270;GO:0043967;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:histone H4 acetylation;|Q8IYH5 B7WPC6 Q6N004 Q6N070 Q8IYP0 Q8IYR1 Q8TEK4 Q9Y4U0,ZZ-type zinc finger-containing protein 3,, PF00249;PF00569;, GO:0005671;GO:0005730;GO:0005654;GO:0003677;GO:0008270;GO:0043967;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:histone H4 acetylation; scaffold5 indexed_genome mRNA 30668837 30727274 . - . ID=transcript_1347;Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q8TEY7 Q8TEY6 Q96AV6 Q9H9F0 Q9UPQ5,Ubiquitin carboxyl-terminal hydrolase 33,Deubiquitinating enzyme 33;Ubiquitin thioesterase 33;Ubiquitin-specific-processing protease 33;VHL-interacting deubiquitinating enzyme 1;, PF06337;PF00443;PF02148;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0005654;GO:0048471;GO:0030891;GO:0004197;GO:0001664;GO:0031267;GO:0004843;GO:0008270;GO:0007411;GO:0016477;GO:0009267;GO:0051298;GO:0006897;GO:0032091;GO:0032092;GO:0016579;GO:0071108;GO:0070536;GO:0050821;GO:0010506;GO:0008277;GO:0006511;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:VCB complex;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:small GTPase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:axon guidance; P:cell migration; P:cellular response to starvation; P:centrosome duplication; P:endocytosis; P:negative regulation of protein binding; P:positive regulation of protein binding; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold5 indexed_genome mRNA 30746076 30820354 . + . ID=transcript_1348;Q8NAN2 Q6MZG0,Mitoguardin 1 {ECO:0000303|PubMed:26711011},Protein FAM73A {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0005739;GO:0046982;GO:0042803;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:mitochondrial fusion;|Q8NAN2 Q6MZG0,Mitoguardin 1 {ECO:0000303|PubMed:26711011},Protein FAM73A {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0005739;GO:0046982;GO:0042803;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:mitochondrial fusion;|Q8NAN2 Q6MZG0,Mitoguardin 1 {ECO:0000303|PubMed:26711011},Protein FAM73A {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0005739;GO:0046982;GO:0042803;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:mitochondrial fusion;|Q8NAN2 Q6MZG0,Mitoguardin 1 {ECO:0000303|PubMed:26711011},Protein FAM73A {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0005739;GO:0046982;GO:0042803;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:mitochondrial fusion;|Q8NAN2 Q6MZG0,Mitoguardin 1 {ECO:0000303|PubMed:26711011},Protein FAM73A {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0005739;GO:0046982;GO:0042803;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:mitochondrial fusion;|Q8NAN2 Q6MZG0,Mitoguardin 1 {ECO:0000303|PubMed:26711011},Protein FAM73A {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0005739;GO:0046982;GO:0042803;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:mitochondrial fusion;|Q8NAN2 Q6MZG0,Mitoguardin 1 {ECO:0000303|PubMed:26711011},Protein FAM73A {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0005739;GO:0046982;GO:0042803;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:mitochondrial fusion; scaffold5 indexed_genome mRNA 30827862 30912862 . + . ID=transcript_1349;Q9Y2V1,Nexilin,F-actin-binding protein;Nelin;, PF07679;, GO:0015629;GO:0005912;GO:0030424;GO:0005925;GO:0005886;GO:0030018;GO:0051015;GO:0098632;GO:0008307;GO:0007411;GO:0070593;GO:0007156;GO:0030334;GO:0051493;, C:actin cytoskeleton; C:adherens junction; C:axon; C:focal adhesion; C:plasma membrane; C:Z disc;, F:actin filament binding; F:cell-cell adhesion mediator activity; F:structural constituent of muscle;, P:axon guidance; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:regulation of cell migration; P:regulation of cytoskeleton organization;|Q9Y2V1,Nexilin,F-actin-binding protein;Nelin;, PF07679;, GO:0015629;GO:0005912;GO:0030424;GO:0005925;GO:0005886;GO:0030018;GO:0051015;GO:0098632;GO:0008307;GO:0007411;GO:0070593;GO:0007156;GO:0030334;GO:0051493;, C:actin cytoskeleton; C:adherens junction; C:axon; C:focal adhesion; C:plasma membrane; C:Z disc;, F:actin filament binding; F:cell-cell adhesion mediator activity; F:structural constituent of muscle;, P:axon guidance; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:regulation of cell migration; P:regulation of cytoskeleton organization;|Q9Y2V1,Nexilin,F-actin-binding protein;Nelin;, PF07679;, GO:0015629;GO:0005912;GO:0030424;GO:0005925;GO:0005886;GO:0030018;GO:0051015;GO:0098632;GO:0008307;GO:0007411;GO:0070593;GO:0007156;GO:0030334;GO:0051493;, C:actin cytoskeleton; C:adherens junction; C:axon; C:focal adhesion; C:plasma membrane; C:Z disc;, F:actin filament binding; F:cell-cell adhesion mediator activity; F:structural constituent of muscle;, P:axon guidance; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:regulation of cell migration; P:regulation of cytoskeleton organization;|Q9Y2V1,Nexilin,F-actin-binding protein;Nelin;, PF07679;, GO:0015629;GO:0005912;GO:0030424;GO:0005925;GO:0005886;GO:0030018;GO:0051015;GO:0098632;GO:0008307;GO:0007411;GO:0070593;GO:0007156;GO:0030334;GO:0051493;, C:actin cytoskeleton; C:adherens junction; C:axon; C:focal adhesion; C:plasma membrane; C:Z disc;, F:actin filament binding; F:cell-cell adhesion mediator activity; F:structural constituent of muscle;, P:axon guidance; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:regulation of cell migration; P:regulation of cytoskeleton organization;|Q96AE4 Q12828,Far upstream element-binding protein 1,DNA helicase V;, PF09005;PF00013;, GO:0005737;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0010468;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:regulation of gene expression;|Q96AE4 Q12828,Far upstream element-binding protein 1,DNA helicase V;, PF09005;PF00013;, GO:0005737;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0010468;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:regulation of gene expression;|Q96AE4 Q12828,Far upstream element-binding protein 1,DNA helicase V;, PF09005;PF00013;, GO:0005737;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0010468;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:regulation of gene expression;|Q96AE4 Q12828,Far upstream element-binding protein 1,DNA helicase V;, PF09005;PF00013;, GO:0005737;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0010468;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:regulation of gene expression; scaffold5 indexed_genome mRNA 30912906 30920234 . - . ID=transcript_1350;Q96AE4 Q12828,Far upstream element-binding protein 1,DNA helicase V;, PF09005;PF00013;, GO:0005737;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0010468;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:regulation of gene expression; scaffold5 indexed_genome mRNA 30951725 30965283 . - . ID=transcript_1351;Q9UDY4 B2R824 Q13431,DnaJ homolog subfamily B member 4,Heat shock 40 kDa protein 1 homolog;Human liver DnaJ-like protein;, PF00226;PF01556;, GO:0005829;GO:0005654;GO:0005886;GO:0001671;GO:0051087;GO:0051082;GO:0051085;GO:0009408;GO:0006986;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:ATPase activator activity; F:chaperone binding; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:response to heat; P:response to unfolded protein;|Q9UDY4 B2R824 Q13431,DnaJ homolog subfamily B member 4,Heat shock 40 kDa protein 1 homolog;Human liver DnaJ-like protein;, PF00226;PF01556;, GO:0005829;GO:0005654;GO:0005886;GO:0001671;GO:0051087;GO:0051082;GO:0051085;GO:0009408;GO:0006986;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:ATPase activator activity; F:chaperone binding; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:response to heat; P:response to unfolded protein;|Q9UDY4 B2R824 Q13431,DnaJ homolog subfamily B member 4,Heat shock 40 kDa protein 1 homolog;Human liver DnaJ-like protein;, PF00226;PF01556;, GO:0005829;GO:0005654;GO:0005886;GO:0001671;GO:0051087;GO:0051082;GO:0051085;GO:0009408;GO:0006986;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:ATPase activator activity; F:chaperone binding; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:response to heat; P:response to unfolded protein; scaffold5 indexed_genome mRNA 30989306 31082298 . + . ID=transcript_1352;Q8TF65 Q8IYD3 Q9NXS7,PDZ domain-containing protein GIPC2,, PF00595;, GO:0005737;GO:0070062;GO:0042802;, C:cytoplasm; C:extracellular exosome;, F:identical protein binding; scaffold5 indexed_genome mRNA 31413282 31465720 . + . ID=transcript_1353;P43088 A8K9Y0 Q2KHP3 Q6RYQ6 Q9P1X4,Prostaglandin F2-alpha receptor,Prostanoid FP receptor;, PF00001;, GO:0005737;GO:0005576;GO:0005887;GO:0005886;GO:0004958;GO:0007189;GO:0035584;GO:0071799;GO:0007186;GO:0006954;GO:0043066;GO:0007567;GO:0008284;GO:0007204;GO:0010628;GO:0032355;GO:0032496;, C:cytoplasm; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:prostaglandin F receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cellular response to prostaglandin D stimulus; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of apoptotic process; P:parturition; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of gene expression; P:response to estradiol; P:response to lipopolysaccharide; scaffold5 indexed_genome mRNA 31529473 31539014 . + . ID=transcript_1354;Q53G44 Q86TE1 Q96B64 Q99984,Interferon-induced protein 44-like,, PF01926;, GO:0005737;GO:0005525;GO:0051607;GO:0006955;, C:cytoplasm;, F:GTP binding;, P:defense response to virus; P:immune response; scaffold5 indexed_genome mRNA 31561700 31564293 . + . ID=transcript_1355;Q8TCB0 B7ZAG3 D3DQ80 Q14496,Interferon-induced protein 44,Microtubule-associated protein 44;, PF07534;, GO:0005737;GO:0006955;GO:0009617;GO:0009615;, C:cytoplasm;, , P:immune response; P:response to bacterium; P:response to virus; scaffold5 indexed_genome mRNA 31750392 31905073 . - . ID=transcript_1356;Q9HBW9 B1AR71 Q5KU34,Adhesion G protein-coupled receptor L4 {ECO:0000303|PubMed:25713288},EGF, latrophilin and seven transmembrane domain-containing protein 1;EGF-TM7-latrophilin-related protein;, PF00002;PF07645;PF16489;PF01825;, GO:0031410;GO:0016021;GO:0005887;GO:0005886;GO:0005509;GO:0004930;GO:0007189;GO:0007166;GO:0007186;GO:0065003;, C:cytoplasmic vesicle; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:protein-containing complex assembly;|Q9HBW9 B1AR71 Q5KU34,Adhesion G protein-coupled receptor L4 {ECO:0000303|PubMed:25713288},EGF, latrophilin and seven transmembrane domain-containing protein 1;EGF-TM7-latrophilin-related protein;, PF00002;PF07645;PF16489;PF01825;, GO:0031410;GO:0016021;GO:0005887;GO:0005886;GO:0005509;GO:0004930;GO:0007189;GO:0007166;GO:0007186;GO:0065003;, C:cytoplasmic vesicle; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:protein-containing complex assembly; scaffold5 indexed_genome mRNA 34695175 34888225 . + . ID=transcript_1357;O94882 Q5VX76 Q9UKY5 Q9UKY6,Adhesion G protein-coupled receptor L2 {ECO:0000303|PubMed:25713288},Calcium-independent alpha-latrotoxin receptor 2;Latrophilin homolog 1;Latrophilin-2;Lectomedin-1;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0098978;GO:0016021;GO:0005887;GO:0099055;GO:0043005;GO:0030246;GO:0004930;GO:0016524;GO:0007189;GO:0007420;GO:0007166;GO:0007186;GO:0051965;GO:0009617;GO:0050808;, C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:neuron projection;, F:carbohydrate binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:brain development; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:positive regulation of synapse assembly; P:response to bacterium; P:synapse organization; scaffold5 indexed_genome mRNA 34890255 34894995 . + . ID=transcript_1358;O94882 Q5VX76 Q9UKY5 Q9UKY6,Adhesion G protein-coupled receptor L2 {ECO:0000303|PubMed:25713288},Calcium-independent alpha-latrotoxin receptor 2;Latrophilin homolog 1;Latrophilin-2;Lectomedin-1;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0098978;GO:0016021;GO:0005887;GO:0099055;GO:0043005;GO:0030246;GO:0004930;GO:0016524;GO:0007189;GO:0007420;GO:0007166;GO:0007186;GO:0051965;GO:0009617;GO:0050808;, C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:neuron projection;, F:carbohydrate binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:brain development; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:positive regulation of synapse assembly; P:response to bacterium; P:synapse organization; scaffold5 indexed_genome mRNA 36885380 37044756 . + . ID=transcript_1359;Q6ZT98 Q5TAX8 Q5TAX9 Q6P990 Q86YS1 Q9H5U4,Tubulin polyglutamylase TTLL7 {ECO:0000305},Testis development protein NYD-SP30 {ECO:0000303|Ref.1};Tubulin--tyrosine ligase-like protein 7 {ECO:0000305};, PF03133;, GO:0005929;GO:0005829;GO:0030425;GO:0005874;GO:0043204;GO:0043014;GO:0005524;GO:0048487;GO:0015631;GO:0070740;GO:0030154;GO:0000226;GO:0007399;GO:0018095;, C:cilium; C:cytosol; C:dendrite; C:microtubule; C:perikaryon;, F:alpha-tubulin binding; F:ATP binding; F:beta-tubulin binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:cell differentiation; P:microtubule cytoskeleton organization; P:nervous system development; P:protein polyglutamylation;|Q6ZT98 Q5TAX8 Q5TAX9 Q6P990 Q86YS1 Q9H5U4,Tubulin polyglutamylase TTLL7 {ECO:0000305},Testis development protein NYD-SP30 {ECO:0000303|Ref.1};Tubulin--tyrosine ligase-like protein 7 {ECO:0000305};, PF03133;, GO:0005929;GO:0005829;GO:0030425;GO:0005874;GO:0043204;GO:0043014;GO:0005524;GO:0048487;GO:0015631;GO:0070740;GO:0030154;GO:0000226;GO:0007399;GO:0018095;, C:cilium; C:cytosol; C:dendrite; C:microtubule; C:perikaryon;, F:alpha-tubulin binding; F:ATP binding; F:beta-tubulin binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:cell differentiation; P:microtubule cytoskeleton organization; P:nervous system development; P:protein polyglutamylation;|Q6ZT98 Q5TAX8 Q5TAX9 Q6P990 Q86YS1 Q9H5U4,Tubulin polyglutamylase TTLL7 {ECO:0000305},Testis development protein NYD-SP30 {ECO:0000303|Ref.1};Tubulin--tyrosine ligase-like protein 7 {ECO:0000305};, PF03133;, GO:0005929;GO:0005829;GO:0030425;GO:0005874;GO:0043204;GO:0043014;GO:0005524;GO:0048487;GO:0015631;GO:0070740;GO:0030154;GO:0000226;GO:0007399;GO:0018095;, C:cilium; C:cytosol; C:dendrite; C:microtubule; C:perikaryon;, F:alpha-tubulin binding; F:ATP binding; F:beta-tubulin binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:cell differentiation; P:microtubule cytoskeleton organization; P:nervous system development; P:protein polyglutamylation;|Q6ZT98 Q5TAX8 Q5TAX9 Q6P990 Q86YS1 Q9H5U4,Tubulin polyglutamylase TTLL7 {ECO:0000305},Testis development protein NYD-SP30 {ECO:0000303|Ref.1};Tubulin--tyrosine ligase-like protein 7 {ECO:0000305};, PF03133;, GO:0005929;GO:0005829;GO:0030425;GO:0005874;GO:0043204;GO:0043014;GO:0005524;GO:0048487;GO:0015631;GO:0070740;GO:0030154;GO:0000226;GO:0007399;GO:0018095;, C:cilium; C:cytosol; C:dendrite; C:microtubule; C:perikaryon;, F:alpha-tubulin binding; F:ATP binding; F:beta-tubulin binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:cell differentiation; P:microtubule cytoskeleton organization; P:nervous system development; P:protein polyglutamylation;|Q6ZT98 Q5TAX8 Q5TAX9 Q6P990 Q86YS1 Q9H5U4,Tubulin polyglutamylase TTLL7 {ECO:0000305},Testis development protein NYD-SP30 {ECO:0000303|Ref.1};Tubulin--tyrosine ligase-like protein 7 {ECO:0000305};, PF03133;, GO:0005929;GO:0005829;GO:0030425;GO:0005874;GO:0043204;GO:0043014;GO:0005524;GO:0048487;GO:0015631;GO:0070740;GO:0030154;GO:0000226;GO:0007399;GO:0018095;, C:cilium; C:cytosol; C:dendrite; C:microtubule; C:perikaryon;, F:alpha-tubulin binding; F:ATP binding; F:beta-tubulin binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:cell differentiation; P:microtubule cytoskeleton organization; P:nervous system development; P:protein polyglutamylation; scaffold5 indexed_genome mRNA 37190753 37278805 . + . ID=transcript_1360;Q5BNF2 Q5BNF3 Q5CZ92 Q5T1K3 Q7Z3M1 Q8IYR5 Q8IZQ0 Q96B09,cAMP-dependent protein kinase catalytic subunit beta,, PF00069;, GO:0005952;GO:0005813;GO:0097546;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0004679;GO:0005524;GO:0004691;GO:0000287;GO:0106310;GO:0106311;GO:0031625;GO:0034199;GO:0002250;GO:0007188;GO:0007596;GO:0071377;GO:0007268;GO:0034380;GO:0002862;GO:0051447;GO:1901621;GO:0001843;GO:0010737;GO:0006468;GO:0070613;GO:0003091;GO:0097338;GO:0007165;GO:0002223;, C:cAMP-dependent protein kinase complex; C:centrosome; C:ciliary base; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase activity; F:magnesium ion binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:ubiquitin protein ligase binding;, P:activation of protein kinase A activity; P:adaptive immune response; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:blood coagulation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:high-density lipoprotein particle assembly; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of meiotic cell cycle; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:neural tube closure; P:protein kinase A signaling; P:protein phosphorylation; P:regulation of protein processing; P:renal water homeostasis; P:response to clozapine; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway;|Q5BNF2 Q5BNF3 Q5CZ92 Q5T1K3 Q7Z3M1 Q8IYR5 Q8IZQ0 Q96B09,cAMP-dependent protein kinase catalytic subunit beta,, PF00069;, GO:0005952;GO:0005813;GO:0097546;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0004679;GO:0005524;GO:0004691;GO:0000287;GO:0106310;GO:0106311;GO:0031625;GO:0034199;GO:0002250;GO:0007188;GO:0007596;GO:0071377;GO:0007268;GO:0034380;GO:0002862;GO:0051447;GO:1901621;GO:0001843;GO:0010737;GO:0006468;GO:0070613;GO:0003091;GO:0097338;GO:0007165;GO:0002223;, C:cAMP-dependent protein kinase complex; C:centrosome; C:ciliary base; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase activity; F:magnesium ion binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:ubiquitin protein ligase binding;, P:activation of protein kinase A activity; P:adaptive immune response; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:blood coagulation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:high-density lipoprotein particle assembly; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of meiotic cell cycle; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:neural tube closure; P:protein kinase A signaling; P:protein phosphorylation; P:regulation of protein processing; P:renal water homeostasis; P:response to clozapine; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway;|Q5BNF2 Q5BNF3 Q5CZ92 Q5T1K3 Q7Z3M1 Q8IYR5 Q8IZQ0 Q96B09,cAMP-dependent protein kinase catalytic subunit beta,, PF00069;, GO:0005952;GO:0005813;GO:0097546;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0004679;GO:0005524;GO:0004691;GO:0000287;GO:0106310;GO:0106311;GO:0031625;GO:0034199;GO:0002250;GO:0007188;GO:0007596;GO:0071377;GO:0007268;GO:0034380;GO:0002862;GO:0051447;GO:1901621;GO:0001843;GO:0010737;GO:0006468;GO:0070613;GO:0003091;GO:0097338;GO:0007165;GO:0002223;, C:cAMP-dependent protein kinase complex; C:centrosome; C:ciliary base; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase activity; F:magnesium ion binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:ubiquitin protein ligase binding;, P:activation of protein kinase A activity; P:adaptive immune response; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:blood coagulation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:high-density lipoprotein particle assembly; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of meiotic cell cycle; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:neural tube closure; P:protein kinase A signaling; P:protein phosphorylation; P:regulation of protein processing; P:renal water homeostasis; P:response to clozapine; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; scaffold5 indexed_genome mRNA 37341840 37387988 . + . ID=transcript_1361;Q5VXD3 B3KPW8 D3DT11 Q53AI4 Q5VXD2 Q5VXD4,Sterile alpha motif domain-containing protein 13,, PF00536;, GO:0005634;GO:0003682;GO:0042393;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding;, P:negative regulation of transcription, DNA-templated;|Q5VXD3 B3KPW8 D3DT11 Q53AI4 Q5VXD2 Q5VXD4,Sterile alpha motif domain-containing protein 13,, PF00536;, GO:0005634;GO:0003682;GO:0042393;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding;, P:negative regulation of transcription, DNA-templated;|Q8WWF6,DnaJ homolog subfamily B member 3,, PF00226; scaffold5 indexed_genome mRNA 37540790 37564418 . - . ID=transcript_1362;Q9H9Y2 Q5VSK7 Q6AHX1 Q8WXZ8,Ribosome production factor 1,Brix domain-containing protein 5;Ribosome biogenesis protein RPF1;, PF04427;, GO:0005730;GO:0030687;GO:0003723;GO:0042134;GO:0000460;GO:0000470;GO:0006364;, C:nucleolus; C:preribosome, large subunit precursor;, F:RNA binding; F:rRNA primary transcript binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing;|Q9H9Y2 Q5VSK7 Q6AHX1 Q8WXZ8,Ribosome production factor 1,Brix domain-containing protein 5;Ribosome biogenesis protein RPF1;, PF04427;, GO:0005730;GO:0030687;GO:0003723;GO:0042134;GO:0000460;GO:0000470;GO:0006364;, C:nucleolus; C:preribosome, large subunit precursor;, F:RNA binding; F:rRNA primary transcript binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing;|Q9H9Y2 Q5VSK7 Q6AHX1 Q8WXZ8,Ribosome production factor 1,Brix domain-containing protein 5;Ribosome biogenesis protein RPF1;, PF04427;, GO:0005730;GO:0030687;GO:0003723;GO:0042134;GO:0000460;GO:0000470;GO:0006364;, C:nucleolus; C:preribosome, large subunit precursor;, F:RNA binding; F:rRNA primary transcript binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing;|Q9H9Y2 Q5VSK7 Q6AHX1 Q8WXZ8,Ribosome production factor 1,Brix domain-containing protein 5;Ribosome biogenesis protein RPF1;, PF04427;, GO:0005730;GO:0030687;GO:0003723;GO:0042134;GO:0000460;GO:0000470;GO:0006364;, C:nucleolus; C:preribosome, large subunit precursor;, F:RNA binding; F:rRNA primary transcript binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing;|P63218 B2R5A0 P30670 Q5VX54 Q61015,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5,, PF00631;, GO:0070062;GO:0031680;GO:0005834;GO:0016020;GO:0005886;GO:0031681;GO:0003924;GO:0030165;GO:0007186;GO:0007165;, C:extracellular exosome; C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:membrane; C:plasma membrane;, F:G-protein beta-subunit binding; F:GTPase activity; F:PDZ domain binding;, P:G protein-coupled receptor signaling pathway; P:signal transduction;|P63218 B2R5A0 P30670 Q5VX54 Q61015,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5,, PF00631;, GO:0070062;GO:0031680;GO:0005834;GO:0016020;GO:0005886;GO:0031681;GO:0003924;GO:0030165;GO:0007186;GO:0007165;, C:extracellular exosome; C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:membrane; C:plasma membrane;, F:G-protein beta-subunit binding; F:GTPase activity; F:PDZ domain binding;, P:G protein-coupled receptor signaling pathway; P:signal transduction; scaffold5 indexed_genome mRNA 37629699 37636796 . - . ID=transcript_1363;Q01459 Q5VX50,Di-N-acetylchitobiase,, PF00704;, GO:0005615;GO:0005764;GO:0008061;GO:0004568;GO:0006032;GO:0009313;, C:extracellular space; C:lysosome;, F:chitin binding; F:chitinase activity;, P:chitin catabolic process; P:oligosaccharide catabolic process; scaffold5 indexed_genome mRNA 37706356 37733834 . - . ID=transcript_1364;Q9Y2D8 A8K8W0 B4DFE3 D3DT13 J3KR02 Q6P2P8 Q6ULS1 Q7L168 Q9UIX0,Afadin- and alpha-actinin-binding protein,Afadin DIL domain-interacting protein;SSX2-interacting protein;, PF11559;, GO:0005912;GO:0031252;GO:0034451;GO:0036064;GO:0005737;GO:0005634;GO:0032991;GO:0019904;GO:0007155;GO:0007098;GO:0060271;GO:0035735;GO:2000145;GO:0035020;, C:adherens junction; C:cell leading edge; C:centriolar satellite; C:ciliary basal body; C:cytoplasm; C:nucleus; C:protein-containing complex;, F:protein domain specific binding;, P:cell adhesion; P:centrosome cycle; P:cilium assembly; P:intraciliary transport involved in cilium assembly; P:regulation of cell motility; P:regulation of Rac protein signal transduction;|Q9Y2D8 A8K8W0 B4DFE3 D3DT13 J3KR02 Q6P2P8 Q6ULS1 Q7L168 Q9UIX0,Afadin- and alpha-actinin-binding protein,Afadin DIL domain-interacting protein;SSX2-interacting protein;, PF11559;, GO:0005912;GO:0031252;GO:0034451;GO:0036064;GO:0005737;GO:0005634;GO:0032991;GO:0019904;GO:0007155;GO:0007098;GO:0060271;GO:0035735;GO:2000145;GO:0035020;, C:adherens junction; C:cell leading edge; C:centriolar satellite; C:ciliary basal body; C:cytoplasm; C:nucleus; C:protein-containing complex;, F:protein domain specific binding;, P:cell adhesion; P:centrosome cycle; P:cilium assembly; P:intraciliary transport involved in cilium assembly; P:regulation of cell motility; P:regulation of Rac protein signal transduction; scaffold5 indexed_genome mRNA 37888364 37979417 . - . ID=transcript_1365;Q9UBY5 A0AVA3,Lysophosphatidic acid receptor 3,Lysophosphatidic acid receptor Edg-7;, PF00001;, GO:0030424;GO:0005737;GO:0005887;GO:0005886;GO:0045202;GO:0004930;GO:0001965;GO:0008289;GO:0070915;GO:0005543;GO:0000187;GO:0007189;GO:0032060;GO:0007268;GO:0007186;GO:0007187;GO:0051928;GO:0048672;GO:0007204;GO:0051482;GO:0019222;, C:axon; C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:G protein-coupled receptor activity; F:G-protein alpha-subunit binding; F:lipid binding; F:lysophosphatidic acid receptor activity; F:phospholipid binding;, P:activation of MAPK activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:bleb assembly; P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:positive regulation of calcium ion transport; P:positive regulation of collateral sprouting; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:regulation of metabolic process; scaffold5 indexed_genome mRNA 38005221 38023018 . - . ID=transcript_1366;Q8IZK6 A6NI99 Q2M3I6 Q5TAG5 Q8N9R3,Mucolipin-2,Transient receptor potential channel mucolipin 2;, PF08016;, GO:0016021;GO:0031902;GO:0005764;GO:0016020;GO:0005886;GO:0055038;GO:0042802;GO:0072345;GO:0002250;GO:0070588;GO:0045087;GO:1905517;GO:1990266;GO:0071651;GO:2000343;GO:0071642;GO:0071639;GO:0015031;, C:integral component of membrane; C:late endosome membrane; C:lysosome; C:membrane; C:plasma membrane; C:recycling endosome membrane;, F:identical protein binding; F:NAADP-sensitive calcium-release channel activity;, P:adaptive immune response; P:calcium ion transmembrane transport; P:innate immune response; P:macrophage migration; P:neutrophil migration; P:positive regulation of chemokine (C-C motif) ligand 5 production; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of macrophage inflammatory protein 1 alpha production; P:positive regulation of monocyte chemotactic protein-1 production; P:protein transport; scaffold5 indexed_genome mRNA 38028432 38048833 . - . ID=transcript_1367;Q8IZK6 A6NI99 Q2M3I6 Q5TAG5 Q8N9R3,Mucolipin-2,Transient receptor potential channel mucolipin 2;, PF08016;, GO:0016021;GO:0031902;GO:0005764;GO:0016020;GO:0005886;GO:0055038;GO:0042802;GO:0072345;GO:0002250;GO:0070588;GO:0045087;GO:1905517;GO:1990266;GO:0071651;GO:2000343;GO:0071642;GO:0071639;GO:0015031;, C:integral component of membrane; C:late endosome membrane; C:lysosome; C:membrane; C:plasma membrane; C:recycling endosome membrane;, F:identical protein binding; F:NAADP-sensitive calcium-release channel activity;, P:adaptive immune response; P:calcium ion transmembrane transport; P:innate immune response; P:macrophage migration; P:neutrophil migration; P:positive regulation of chemokine (C-C motif) ligand 5 production; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of macrophage inflammatory protein 1 alpha production; P:positive regulation of monocyte chemotactic protein-1 production; P:protein transport; scaffold5 indexed_genome mRNA 38119126 38140236 . + . ID=transcript_1368;Q8IWG1 A8K988 Q96L72 Q96NU4,Dynein intermediate chain 3, axonemal {ECO:0000305},Dynein axonemal intermediate chain 3;Testis development protein NYD-SP29;WD repeat-containing protein 63;, , GO:0005858;GO:0005737;GO:0036156;GO:0071933;GO:0045504;GO:0045503;GO:0060294;GO:0036159;GO:0007018;GO:0034316;GO:0030336;GO:0045669;, C:axonemal dynein complex; C:cytoplasm; C:inner dynein arm;, F:Arp2/3 complex binding; F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium movement involved in cell motility; P:inner dynein arm assembly; P:microtubule-based movement; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:negative regulation of cell migration; P:positive regulation of osteoblast differentiation; scaffold5 indexed_genome mRNA 38149058 38165723 . + . ID=transcript_1369;Q8IWG1 A8K988 Q96L72 Q96NU4,Dynein intermediate chain 3, axonemal {ECO:0000305},Dynein axonemal intermediate chain 3;Testis development protein NYD-SP29;WD repeat-containing protein 63;, , GO:0005858;GO:0005737;GO:0036156;GO:0071933;GO:0045504;GO:0045503;GO:0060294;GO:0036159;GO:0007018;GO:0034316;GO:0030336;GO:0045669;, C:axonemal dynein complex; C:cytoplasm; C:inner dynein arm;, F:Arp2/3 complex binding; F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium movement involved in cell motility; P:inner dynein arm assembly; P:microtubule-based movement; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:negative regulation of cell migration; P:positive regulation of osteoblast differentiation; scaffold5 indexed_genome mRNA 38175653 38207429 . + . ID=transcript_1370;Q8IWG1 A8K988 Q96L72 Q96NU4,Dynein intermediate chain 3, axonemal {ECO:0000305},Dynein axonemal intermediate chain 3;Testis development protein NYD-SP29;WD repeat-containing protein 63;, , GO:0005858;GO:0005737;GO:0036156;GO:0071933;GO:0045504;GO:0045503;GO:0060294;GO:0036159;GO:0007018;GO:0034316;GO:0030336;GO:0045669;, C:axonemal dynein complex; C:cytoplasm; C:inner dynein arm;, F:Arp2/3 complex binding; F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium movement involved in cell motility; P:inner dynein arm assembly; P:microtubule-based movement; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:negative regulation of cell migration; P:positive regulation of osteoblast differentiation; scaffold5 indexed_genome mRNA 38229386 38251912 . - . ID=transcript_1371;Q5VT97 Q5VT96 Q8NDB8 Q9H8A6,Rho GTPase-activating protein SYDE2,Synapse defective protein 1 homolog 2;, PF00620;, GO:0005829;GO:0005096;GO:0090630;GO:0016477;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:activation of GTPase activity; P:cell migration; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold5 indexed_genome mRNA 38311310 38318712 . + . ID=transcript_1372;Q8N6N3 B3KX89 Q8TDK5 Q8TDK6,UPF0690 protein C1orf52,BCL10-associated gene protein;, PF15559;, GO:0005654;GO:0003723;, C:nucleoplasm;, F:RNA binding;|Q8N6N3 B3KX89 Q8TDK5 Q8TDK6,UPF0690 protein C1orf52,BCL10-associated gene protein;, PF15559;, GO:0005654;GO:0003723;, C:nucleoplasm;, F:RNA binding; scaffold5 indexed_genome mRNA 38326988 38331868 . - . ID=transcript_1373;O95999 Q5VUF1,B-cell lymphoma/leukemia 10,B-cell CLL/lymphoma 10;CARD-containing molecule enhancing NF-kappa-B;CARD-like apoptotic protein;CED-3/ICH-1 prodomain homologous E10-like regulator;Cellular homolog of vCARMEN;Cellular-E10;Mammalian CARD-containing adapter molecule E10;, PF00619;, GO:0032449;GO:0005737;GO:0005881;GO:0005829;GO:0001772;GO:0005764;GO:0045121;GO:0005634;GO:0048471;GO:0002096;GO:0032991;GO:0050700;GO:0019899;GO:0042802;GO:0019900;GO:0051059;GO:0002020;GO:0008022;GO:0043422;GO:0019901;GO:0043621;GO:0044877;GO:0003713;GO:0008134;GO:0031625;GO:0002250;GO:0001783;GO:0008219;GO:0006968;GO:0071222;GO:0071260;GO:0038095;GO:0007249;GO:0016064;GO:0045087;GO:0031663;GO:0002906;GO:0001843;GO:0043065;GO:0043280;GO:2001238;GO:0043123;GO:0032755;GO:0032757;GO:0033674;GO:0032761;GO:0032765;GO:0051092;GO:0042327;GO:0031398;GO:0050870;GO:0045893;GO:0016567;GO:0050856;GO:0032094;GO:0009620;GO:0002223;GO:0070231;GO:0050852;GO:0002224;, C:CBM complex; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:immunological synapse; C:lysosome; C:membrane raft; C:nucleus; C:perinuclear region of cytoplasm; C:polkadots; C:protein-containing complex;, F:CARD domain binding; F:enzyme binding; F:identical protein binding; F:kinase binding; F:NF-kappaB binding; F:protease binding; F:protein C-terminus binding; F:protein kinase B binding; F:protein kinase binding; F:protein self-association; F:protein-containing complex binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:adaptive immune response; P:B cell apoptotic process; P:cell death; P:cellular defense response; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:immunoglobulin mediated immune response; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of mature B cell apoptotic process; P:neural tube closure; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of kinase activity; P:positive regulation of lymphotoxin A production; P:positive regulation of mast cell cytokine production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of T cell activation; P:positive regulation of transcription, DNA-templated; P:protein ubiquitination; P:regulation of T cell receptor signaling pathway; P:response to food; P:response to fungus; P:stimulatory C-type lectin receptor signaling pathway; P:T cell apoptotic process; P:T cell receptor signaling pathway; P:toll-like receptor signaling pathway; scaffold5 indexed_genome mRNA 38380863 38526822 . - . ID=transcript_1374;O94760 Q5HYC8 Q86XK5,N(G),N(G)-dimethylarginine dimethylaminohydrolase 1,DDAHI;Dimethylargininase-1;, , GO:0005829;GO:0070062;GO:0016597;GO:0003824;GO:0016403;GO:0046872;GO:0006527;GO:0006525;GO:0000052;GO:0008285;GO:1900038;GO:0043116;GO:0007263;GO:0045766;GO:0045429;GO:0050999;GO:0003073;, C:cytosol; C:extracellular exosome;, F:amino acid binding; F:catalytic activity; F:dimethylargininase activity; F:metal ion binding;, P:arginine catabolic process; P:arginine metabolic process; P:citrulline metabolic process; P:negative regulation of cell population proliferation; P:negative regulation of cellular response to hypoxia; P:negative regulation of vascular permeability; P:nitric oxide mediated signal transduction; P:positive regulation of angiogenesis; P:positive regulation of nitric oxide biosynthetic process; P:regulation of nitric-oxide synthase activity; P:regulation of systemic arterial blood pressure; scaffold5 indexed_genome mRNA 38669204 38672173 . - . ID=transcript_1375;O00622 O14934 O43775 Q9BZL7,CCN family member 1 {ECO:0000305},Cellular communication network factor 1 {ECO:0000312|HGNC:HGNC:2654};Cysteine-rich angiogenic inducer 61;Insulin-like growth factor-binding protein 10;Protein CYR61;Protein GIG1;, PF00007;PF00219;PF19035;PF00093;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0050840;GO:0008201;GO:0005520;GO:0005178;GO:0003278;GO:0060413;GO:0003181;GO:0007155;GO:0044267;GO:0006935;GO:0060591;GO:0060710;GO:0030198;GO:0002041;GO:0060716;GO:0043066;GO:0060548;GO:0001649;GO:0043065;GO:0030513;GO:0030501;GO:0061036;GO:0030335;GO:0010811;GO:2000304;GO:0043280;GO:0045669;GO:0033690;GO:0010518;GO:0045860;GO:0001934;GO:0045944;GO:0043687;GO:0072593;GO:0070372;GO:0007165;GO:0003281;GO:0044319;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:extracellular matrix binding; F:heparin binding; F:insulin-like growth factor binding; F:integrin binding;, P:apoptotic process involved in heart morphogenesis; P:atrial septum morphogenesis; P:atrioventricular valve morphogenesis; P:cell adhesion; P:cellular protein metabolic process; P:chemotaxis; P:chondroblast differentiation; P:chorio-allantoic fusion; P:extracellular matrix organization; P:intussusceptive angiogenesis; P:labyrinthine layer blood vessel development; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:osteoblast differentiation; P:positive regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of cartilage development; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of ceramide biosynthetic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase activity; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:reactive oxygen species metabolic process; P:regulation of ERK1 and ERK2 cascade; P:signal transduction; P:ventricular septum development; P:wound healing, spreading of cells; scaffold5 indexed_genome mRNA 38723262 38784677 . - . ID=transcript_1376;Q9NWK9 B2RBA1 B4DP13 D3DT20 Q9H278 Q9H3X3 Q9NWN0,Box C/D snoRNA protein 1,Serologically defined breast cancer antigen NY-BR-75;Zinc finger HIT domain-containing protein 6;, PF04438;, GO:0070062;GO:0005634;GO:0070761;GO:0051117;GO:0019899;GO:0042802;GO:0046872;GO:0001094;GO:0000492;GO:0000463;GO:0051259;GO:0048254;, C:extracellular exosome; C:nucleus; C:pre-snoRNP complex;, F:ATPase binding; F:enzyme binding; F:identical protein binding; F:metal ion binding; F:TFIID-class transcription factor complex binding;, P:box C/D snoRNP assembly; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:protein complex oligomerization; P:snoRNA localization; scaffold5 indexed_genome mRNA 38864164 38876050 . - . ID=transcript_1377;Q17RW2 C9J1X6 Q14BD7 Q59EX5 Q5VY50 Q7Z5L5,Collagen alpha-1(XXIV) chain,, PF01410;PF01391;, GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030199;GO:0030198;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:collagen fibril organization; P:extracellular matrix organization; scaffold5 indexed_genome mRNA 38876052 38905756 . - . ID=transcript_1378;Q17RW2 C9J1X6 Q14BD7 Q59EX5 Q5VY50 Q7Z5L5,Collagen alpha-1(XXIV) chain,, PF01410;PF01391;, GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030199;GO:0030198;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:collagen fibril organization; P:extracellular matrix organization; scaffold5 indexed_genome mRNA 38945606 38966028 . - . ID=transcript_1379;Q17RW2 C9J1X6 Q14BD7 Q59EX5 Q5VY50 Q7Z5L5,Collagen alpha-1(XXIV) chain,, PF01410;PF01391;, GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030199;GO:0030198;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:collagen fibril organization; P:extracellular matrix organization; scaffold5 indexed_genome mRNA 39001960 39156734 . - . ID=transcript_1380;Q17RW2 C9J1X6 Q14BD7 Q59EX5 Q5VY50 Q7Z5L5,Collagen alpha-1(XXIV) chain,, PF01410;PF01391;, GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030199;GO:0030198;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:collagen fibril organization; P:extracellular matrix organization;|Q17RW2 C9J1X6 Q14BD7 Q59EX5 Q5VY50 Q7Z5L5,Collagen alpha-1(XXIV) chain,, PF01410;PF01391;, GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030199;GO:0030198;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:collagen fibril organization; P:extracellular matrix organization; scaffold5 indexed_genome mRNA 39191947 39192518 . - . ID=transcript_1381;Q17RW2 C9J1X6 Q14BD7 Q59EX5 Q5VY50 Q7Z5L5,Collagen alpha-1(XXIV) chain,, PF01410;PF01391;, GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030199;GO:0030198;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:collagen fibril organization; P:extracellular matrix organization; scaffold5 indexed_genome mRNA 39412483 39442210 . - . ID=transcript_1382;Q9ULJ1 A8MU56 B4E037 Q05C40 Q5BJG5 Q5TBX3 Q5TBX4 Q86X31,Protein BCAP {ECO:0000305},Basal body centriole-associated protein {ECO:0000303|PubMed:17485331};Outer dense fiber protein 2-like;, , GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0030030;GO:1902018;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm;, , P:cell projection organization; P:negative regulation of cilium assembly;|Q9ULJ1 A8MU56 B4E037 Q05C40 Q5BJG5 Q5TBX3 Q5TBX4 Q86X31,Protein BCAP {ECO:0000305},Basal body centriole-associated protein {ECO:0000303|PubMed:17485331};Outer dense fiber protein 2-like;, , GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0030030;GO:1902018;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm;, , P:cell projection organization; P:negative regulation of cilium assembly; scaffold5 indexed_genome mRNA 39478123 39517789 . + . ID=transcript_1383;Q9UQC9 A8K2T3 Q9Y6N2,Calcium-activated chloride channel regulator 2,Calcium-activated chloride channel family member 2;Calcium-activated chloride channel protein 3;, PF08434;, GO:0009925;GO:0030054;GO:0005829;GO:0005576;GO:0005887;GO:0031965;GO:0005654;GO:0005886;GO:0005254;GO:0005229;GO:0015276;GO:0046872;GO:0008237;GO:0007155;GO:0034220;, C:basal plasma membrane; C:cell junction; C:cytosol; C:extracellular region; C:integral component of plasma membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:ligand-gated ion channel activity; F:metal ion binding; F:metallopeptidase activity;, P:cell adhesion; P:ion transmembrane transport;|Q9UQC9 A8K2T3 Q9Y6N2,Calcium-activated chloride channel regulator 2,Calcium-activated chloride channel family member 2;Calcium-activated chloride channel protein 3;, PF08434;, GO:0009925;GO:0030054;GO:0005829;GO:0005576;GO:0005887;GO:0031965;GO:0005654;GO:0005886;GO:0005254;GO:0005229;GO:0015276;GO:0046872;GO:0008237;GO:0007155;GO:0034220;, C:basal plasma membrane; C:cell junction; C:cytosol; C:extracellular region; C:integral component of plasma membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:ligand-gated ion channel activity; F:metal ion binding; F:metallopeptidase activity;, P:cell adhesion; P:ion transmembrane transport; scaffold5 indexed_genome mRNA 39698340 39707639 . + . ID=transcript_1384;A8K7I4 B2RAV5 O95151 Q5TDF4 Q9UNF6 Q9UPC6,Calcium-activated chloride channel regulator 1,Calcium-activated chloride channel family member 1;Calcium-activated chloride channel protein 1;, PF08434;PF13519;, GO:0005615;GO:0005887;GO:0005902;GO:0005886;GO:0042589;GO:0005254;GO:0005229;GO:0046872;GO:0008237;GO:0006816;GO:0071456;GO:0034220;, C:extracellular space; C:integral component of plasma membrane; C:microvillus; C:plasma membrane; C:zymogen granule membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:metal ion binding; F:metallopeptidase activity;, P:calcium ion transport; P:cellular response to hypoxia; P:ion transmembrane transport; scaffold5 indexed_genome mRNA 39707997 39717043 . + . ID=transcript_1385;Q14CN2 A8MQC9 B7Z1Q5 Q6UX81 Q9UNF7,Calcium-activated chloride channel regulator 4,Calcium-activated chloride channel family member 4;Calcium-activated chloride channel protein 2;Chloride channel accessory 4;, PF08434;PF00092;, GO:0016324;GO:0005576;GO:0005887;GO:0005886;GO:0005254;GO:0005229;GO:0046872;GO:0008237;GO:0034220;, C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:metal ion binding; F:metallopeptidase activity;, P:ion transmembrane transport; scaffold5 indexed_genome mRNA 39763311 39763882 . - . ID=transcript_1386;Q9Y6N3,Calcium-activated chloride channel regulator family member 3,, PF08434;, GO:0034707;GO:0005615;GO:0005886;GO:0005262;GO:0005254;GO:0005215;GO:0005244;GO:0034220;GO:0034765;, C:chloride channel complex; C:extracellular space; C:plasma membrane;, F:calcium channel activity; F:chloride channel activity; F:transporter activity; F:voltage-gated ion channel activity;, P:ion transmembrane transport; P:regulation of ion transmembrane transport; scaffold5 indexed_genome mRNA 39820165 39863254 . + . ID=transcript_1387;Q9Y371 B4E182 Q5H8U5 Q9H3Z0 Q9NR47 Q9NYA9,Endophilin-B1,Bax-interacting factor 1;SH3 domain-containing GRB2-like protein B1;, PF03114;PF14604;, GO:0000421;GO:0005737;GO:0031410;GO:0005829;GO:0000139;GO:0030496;GO:0005741;GO:0032991;GO:0045296;GO:0042802;GO:0008289;GO:0042803;GO:0006915;GO:0048102;GO:0006914;GO:0034198;GO:0042149;GO:0090148;GO:2000786;GO:0010508;GO:1903527;GO:1903955;GO:0031334;GO:1903778;GO:0032801;GO:0032465;GO:0016241;GO:0031647;, C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi membrane; C:midbody; C:mitochondrial outer membrane; C:protein-containing complex;, F:cadherin binding; F:identical protein binding; F:lipid binding; F:protein homodimerization activity;, P:apoptotic process; P:autophagic cell death; P:autophagy; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:membrane fission; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:positive regulation of membrane tubulation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein-containing complex assembly; P:protein localization to vacuolar membrane; P:receptor catabolic process; P:regulation of cytokinesis; P:regulation of macroautophagy; P:regulation of protein stability;|Q9Y371 B4E182 Q5H8U5 Q9H3Z0 Q9NR47 Q9NYA9,Endophilin-B1,Bax-interacting factor 1;SH3 domain-containing GRB2-like protein B1;, PF03114;PF14604;, GO:0000421;GO:0005737;GO:0031410;GO:0005829;GO:0000139;GO:0030496;GO:0005741;GO:0032991;GO:0045296;GO:0042802;GO:0008289;GO:0042803;GO:0006915;GO:0048102;GO:0006914;GO:0034198;GO:0042149;GO:0090148;GO:2000786;GO:0010508;GO:1903527;GO:1903955;GO:0031334;GO:1903778;GO:0032801;GO:0032465;GO:0016241;GO:0031647;, C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi membrane; C:midbody; C:mitochondrial outer membrane; C:protein-containing complex;, F:cadherin binding; F:identical protein binding; F:lipid binding; F:protein homodimerization activity;, P:apoptotic process; P:autophagic cell death; P:autophagy; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:membrane fission; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:positive regulation of membrane tubulation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein-containing complex assembly; P:protein localization to vacuolar membrane; P:receptor catabolic process; P:regulation of cytokinesis; P:regulation of macroautophagy; P:regulation of protein stability;|Q9Y371 B4E182 Q5H8U5 Q9H3Z0 Q9NR47 Q9NYA9,Endophilin-B1,Bax-interacting factor 1;SH3 domain-containing GRB2-like protein B1;, PF03114;PF14604;, GO:0000421;GO:0005737;GO:0031410;GO:0005829;GO:0000139;GO:0030496;GO:0005741;GO:0032991;GO:0045296;GO:0042802;GO:0008289;GO:0042803;GO:0006915;GO:0048102;GO:0006914;GO:0034198;GO:0042149;GO:0090148;GO:2000786;GO:0010508;GO:1903527;GO:1903955;GO:0031334;GO:1903778;GO:0032801;GO:0032465;GO:0016241;GO:0031647;, C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi membrane; C:midbody; C:mitochondrial outer membrane; C:protein-containing complex;, F:cadherin binding; F:identical protein binding; F:lipid binding; F:protein homodimerization activity;, P:apoptotic process; P:autophagic cell death; P:autophagy; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:membrane fission; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:positive regulation of membrane tubulation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein-containing complex assembly; P:protein localization to vacuolar membrane; P:receptor catabolic process; P:regulation of cytokinesis; P:regulation of macroautophagy; P:regulation of protein stability;|Q9Y371 B4E182 Q5H8U5 Q9H3Z0 Q9NR47 Q9NYA9,Endophilin-B1,Bax-interacting factor 1;SH3 domain-containing GRB2-like protein B1;, PF03114;PF14604;, GO:0000421;GO:0005737;GO:0031410;GO:0005829;GO:0000139;GO:0030496;GO:0005741;GO:0032991;GO:0045296;GO:0042802;GO:0008289;GO:0042803;GO:0006915;GO:0048102;GO:0006914;GO:0034198;GO:0042149;GO:0090148;GO:2000786;GO:0010508;GO:1903527;GO:1903955;GO:0031334;GO:1903778;GO:0032801;GO:0032465;GO:0016241;GO:0031647;, C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi membrane; C:midbody; C:mitochondrial outer membrane; C:protein-containing complex;, F:cadherin binding; F:identical protein binding; F:lipid binding; F:protein homodimerization activity;, P:apoptotic process; P:autophagic cell death; P:autophagy; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:membrane fission; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:positive regulation of membrane tubulation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein-containing complex assembly; P:protein localization to vacuolar membrane; P:receptor catabolic process; P:regulation of cytokinesis; P:regulation of macroautophagy; P:regulation of protein stability;|Q9Y371 B4E182 Q5H8U5 Q9H3Z0 Q9NR47 Q9NYA9,Endophilin-B1,Bax-interacting factor 1;SH3 domain-containing GRB2-like protein B1;, PF03114;PF14604;, GO:0000421;GO:0005737;GO:0031410;GO:0005829;GO:0000139;GO:0030496;GO:0005741;GO:0032991;GO:0045296;GO:0042802;GO:0008289;GO:0042803;GO:0006915;GO:0048102;GO:0006914;GO:0034198;GO:0042149;GO:0090148;GO:2000786;GO:0010508;GO:1903527;GO:1903955;GO:0031334;GO:1903778;GO:0032801;GO:0032465;GO:0016241;GO:0031647;, C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi membrane; C:midbody; C:mitochondrial outer membrane; C:protein-containing complex;, F:cadherin binding; F:identical protein binding; F:lipid binding; F:protein homodimerization activity;, P:apoptotic process; P:autophagic cell death; P:autophagy; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:membrane fission; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:positive regulation of membrane tubulation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein-containing complex assembly; P:protein localization to vacuolar membrane; P:receptor catabolic process; P:regulation of cytokinesis; P:regulation of macroautophagy; P:regulation of protein stability; scaffold5 indexed_genome mRNA 39931589 39970691 . - . ID=transcript_1388;O60613 A0A0B4J1S4 Q4GZG7 Q8WU00 Q9BS64 Q9GZW0 Q9NR01,Selenoprotein F {ECO:0000303|PubMed:27645994},15 kDa selenoprotein {ECO:0000303|PubMed:9535873};, PF08806;, GO:0005788;GO:0016491;GO:0051084;, C:endoplasmic reticulum lumen;, F:oxidoreductase activity;, P:'de novo' posttranslational protein folding;|O60613 A0A0B4J1S4 Q4GZG7 Q8WU00 Q9BS64 Q9GZW0 Q9NR01,Selenoprotein F {ECO:0000303|PubMed:27645994},15 kDa selenoprotein {ECO:0000303|PubMed:9535873};, PF08806;, GO:0005788;GO:0016491;GO:0051084;, C:endoplasmic reticulum lumen;, F:oxidoreductase activity;, P:'de novo' posttranslational protein folding; scaffold5 indexed_genome mRNA 40108813 40147503 . + . ID=transcript_1389;Q7LGA3 D3DT22 O75036 Q32NB5 Q8TAC5 Q9H441 Q9NUJ9,Heparan sulfate 2-O-sulfotransferase 1,, PF03567;, GO:0000139;GO:0016021;GO:0016020;GO:0004394;GO:0008146;GO:0006024;GO:0015015;GO:0015014;, C:Golgi membrane; C:integral component of membrane; C:membrane;, F:heparan sulfate 2-O-sulfotransferase activity; F:sulfotransferase activity;, P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process;|Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation; scaffold5 indexed_genome mRNA 40402975 40417273 . + . ID=transcript_1390;P61968 D3DT23 O00158 O88894,LIM domain transcription factor LMO4,Breast tumor autoantigen;LIM domain only protein 4;, PF00412;, GO:0031252;GO:0090575;GO:0005667;GO:0046872;GO:0008134;GO:0031333;GO:0001843;GO:0033674;GO:0045944;GO:0050865;GO:0042659;GO:0030334;GO:0021527;GO:0021522;GO:0048538;GO:0021514;GO:0003281;, C:cell leading edge; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:metal ion binding; F:transcription factor binding;, P:negative regulation of protein-containing complex assembly; P:neural tube closure; P:positive regulation of kinase activity; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell activation; P:regulation of cell fate specification; P:regulation of cell migration; P:spinal cord association neuron differentiation; P:spinal cord motor neuron differentiation; P:thymus development; P:ventral spinal cord interneuron differentiation; P:ventricular septum development;|P61968 D3DT23 O00158 O88894,LIM domain transcription factor LMO4,Breast tumor autoantigen;LIM domain only protein 4;, PF00412;, GO:0031252;GO:0090575;GO:0005667;GO:0046872;GO:0008134;GO:0031333;GO:0001843;GO:0033674;GO:0045944;GO:0050865;GO:0042659;GO:0030334;GO:0021527;GO:0021522;GO:0048538;GO:0021514;GO:0003281;, C:cell leading edge; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:metal ion binding; F:transcription factor binding;, P:negative regulation of protein-containing complex assembly; P:neural tube closure; P:positive regulation of kinase activity; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell activation; P:regulation of cell fate specification; P:regulation of cell migration; P:spinal cord association neuron differentiation; P:spinal cord motor neuron differentiation; P:thymus development; P:ventral spinal cord interneuron differentiation; P:ventricular septum development; scaffold5 indexed_genome mRNA 41815044 41941783 . + . ID=transcript_1391;Q16513 B4DQ21 B4DTP5 B4DVG1 D3DT24 Q08AF4 Q9H1W4,Serine/threonine-protein kinase N2,PKN gamma;Protein kinase C-like 2;Protein-kinase C-related kinase 2;, PF02185;PF00069;PF00433;, GO:0043296;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0045111;GO:0030027;GO:0030496;GO:0016604;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005524;GO:0045296;GO:0004698;GO:0042826;GO:0016301;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0070063;GO:0031267;GO:0043297;GO:0006915;GO:0007155;GO:0007049;GO:0051301;GO:0030030;GO:0010631;GO:0035556;GO:0018105;GO:0032467;GO:0045931;GO:0045070;GO:0006468;GO:2000145;GO:0007165;GO:0016032;, C:apical junction complex; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:lamellipodium; C:midbody; C:nuclear body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:ATP binding; F:cadherin binding; F:calcium-dependent protein kinase C activity; F:histone deacetylase binding; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase binding; F:small GTPase binding;, P:apical junction assembly; P:apoptotic process; P:cell adhesion; P:cell cycle; P:cell division; P:cell projection organization; P:epithelial cell migration; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:positive regulation of cytokinesis; P:positive regulation of mitotic cell cycle; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of cell motility; P:signal transduction; P:viral process;|Q16513 B4DQ21 B4DTP5 B4DVG1 D3DT24 Q08AF4 Q9H1W4,Serine/threonine-protein kinase N2,PKN gamma;Protein kinase C-like 2;Protein-kinase C-related kinase 2;, PF02185;PF00069;PF00433;, GO:0043296;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0045111;GO:0030027;GO:0030496;GO:0016604;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005524;GO:0045296;GO:0004698;GO:0042826;GO:0016301;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0070063;GO:0031267;GO:0043297;GO:0006915;GO:0007155;GO:0007049;GO:0051301;GO:0030030;GO:0010631;GO:0035556;GO:0018105;GO:0032467;GO:0045931;GO:0045070;GO:0006468;GO:2000145;GO:0007165;GO:0016032;, C:apical junction complex; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:lamellipodium; C:midbody; C:nuclear body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:ATP binding; F:cadherin binding; F:calcium-dependent protein kinase C activity; F:histone deacetylase binding; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase binding; F:small GTPase binding;, P:apical junction assembly; P:apoptotic process; P:cell adhesion; P:cell cycle; P:cell division; P:cell projection organization; P:epithelial cell migration; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:positive regulation of cytokinesis; P:positive regulation of mitotic cell cycle; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of cell motility; P:signal transduction; P:viral process; scaffold5 indexed_genome mRNA 41945770 41962963 . + . ID=transcript_1392;Q16513 B4DQ21 B4DTP5 B4DVG1 D3DT24 Q08AF4 Q9H1W4,Serine/threonine-protein kinase N2,PKN gamma;Protein kinase C-like 2;Protein-kinase C-related kinase 2;, PF02185;PF00069;PF00433;, GO:0043296;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0045111;GO:0030027;GO:0030496;GO:0016604;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005524;GO:0045296;GO:0004698;GO:0042826;GO:0016301;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0070063;GO:0031267;GO:0043297;GO:0006915;GO:0007155;GO:0007049;GO:0051301;GO:0030030;GO:0010631;GO:0035556;GO:0018105;GO:0032467;GO:0045931;GO:0045070;GO:0006468;GO:2000145;GO:0007165;GO:0016032;, C:apical junction complex; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:lamellipodium; C:midbody; C:nuclear body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:ATP binding; F:cadherin binding; F:calcium-dependent protein kinase C activity; F:histone deacetylase binding; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase binding; F:small GTPase binding;, P:apical junction assembly; P:apoptotic process; P:cell adhesion; P:cell cycle; P:cell division; P:cell projection organization; P:epithelial cell migration; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:positive regulation of cytokinesis; P:positive regulation of mitotic cell cycle; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of cell motility; P:signal transduction; P:viral process;|Q16513 B4DQ21 B4DTP5 B4DVG1 D3DT24 Q08AF4 Q9H1W4,Serine/threonine-protein kinase N2,PKN gamma;Protein kinase C-like 2;Protein-kinase C-related kinase 2;, PF02185;PF00069;PF00433;, GO:0043296;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0045111;GO:0030027;GO:0030496;GO:0016604;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005524;GO:0045296;GO:0004698;GO:0042826;GO:0016301;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0070063;GO:0031267;GO:0043297;GO:0006915;GO:0007155;GO:0007049;GO:0051301;GO:0030030;GO:0010631;GO:0035556;GO:0018105;GO:0032467;GO:0045931;GO:0045070;GO:0006468;GO:2000145;GO:0007165;GO:0016032;, C:apical junction complex; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:lamellipodium; C:midbody; C:nuclear body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:ATP binding; F:cadherin binding; F:calcium-dependent protein kinase C activity; F:histone deacetylase binding; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase binding; F:small GTPase binding;, P:apical junction assembly; P:apoptotic process; P:cell adhesion; P:cell cycle; P:cell division; P:cell projection organization; P:epithelial cell migration; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:positive regulation of cytokinesis; P:positive regulation of mitotic cell cycle; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of cell motility; P:signal transduction; P:viral process;|Q16513 B4DQ21 B4DTP5 B4DVG1 D3DT24 Q08AF4 Q9H1W4,Serine/threonine-protein kinase N2,PKN gamma;Protein kinase C-like 2;Protein-kinase C-related kinase 2;, PF02185;PF00069;PF00433;, GO:0043296;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0045111;GO:0030027;GO:0030496;GO:0016604;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005524;GO:0045296;GO:0004698;GO:0042826;GO:0016301;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0070063;GO:0031267;GO:0043297;GO:0006915;GO:0007155;GO:0007049;GO:0051301;GO:0030030;GO:0010631;GO:0035556;GO:0018105;GO:0032467;GO:0045931;GO:0045070;GO:0006468;GO:2000145;GO:0007165;GO:0016032;, C:apical junction complex; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:lamellipodium; C:midbody; C:nuclear body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:ATP binding; F:cadherin binding; F:calcium-dependent protein kinase C activity; F:histone deacetylase binding; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase binding; F:small GTPase binding;, P:apical junction assembly; P:apoptotic process; P:cell adhesion; P:cell cycle; P:cell division; P:cell projection organization; P:epithelial cell migration; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:positive regulation of cytokinesis; P:positive regulation of mitotic cell cycle; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of cell motility; P:signal transduction; P:viral process;|Q16513 B4DQ21 B4DTP5 B4DVG1 D3DT24 Q08AF4 Q9H1W4,Serine/threonine-protein kinase N2,PKN gamma;Protein kinase C-like 2;Protein-kinase C-related kinase 2;, PF02185;PF00069;PF00433;, GO:0043296;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0045111;GO:0030027;GO:0030496;GO:0016604;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005524;GO:0045296;GO:0004698;GO:0042826;GO:0016301;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0070063;GO:0031267;GO:0043297;GO:0006915;GO:0007155;GO:0007049;GO:0051301;GO:0030030;GO:0010631;GO:0035556;GO:0018105;GO:0032467;GO:0045931;GO:0045070;GO:0006468;GO:2000145;GO:0007165;GO:0016032;, C:apical junction complex; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:lamellipodium; C:midbody; C:nuclear body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:ATP binding; F:cadherin binding; F:calcium-dependent protein kinase C activity; F:histone deacetylase binding; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase binding; F:small GTPase binding;, P:apical junction assembly; P:apoptotic process; P:cell adhesion; P:cell cycle; P:cell division; P:cell projection organization; P:epithelial cell migration; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:positive regulation of cytokinesis; P:positive regulation of mitotic cell cycle; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of cell motility; P:signal transduction; P:viral process; scaffold5 indexed_genome mRNA 41976402 42004402 . - . ID=transcript_1393;Q00403 A8K1A7 Q5JS30,Transcription initiation factor IIB {ECO:0000303|PubMed:1876184},General transcription factor TFIIB {ECO:0000303|PubMed:1946368};S300-II {ECO:0000303|PubMed:1517211};, PF08271;PF00382;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0005669;GO:0097550;GO:0016407;GO:0004402;GO:1990841;GO:0000993;GO:0000979;GO:0016251;GO:0017025;GO:0046966;GO:0008134;GO:0008270;GO:0006352;GO:1904798;GO:0006473;GO:1990114;GO:0051123;GO:0042795;GO:0006366;GO:0006367;GO:0001174;GO:0019083;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:acetyltransferase activity; F:histone acetyltransferase activity; F:promoter-specific chromatin binding; F:RNA polymerase II complex binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:TBP-class protein binding; F:thyroid hormone receptor binding; F:transcription factor binding; F:zinc ion binding;, P:DNA-templated transcription, initiation; P:positive regulation of core promoter binding; P:protein acetylation; P:RNA polymerase II core complex assembly; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:transcriptional start site selection at RNA polymerase II promoter; P:viral transcription;|Q00403 A8K1A7 Q5JS30,Transcription initiation factor IIB {ECO:0000303|PubMed:1876184},General transcription factor TFIIB {ECO:0000303|PubMed:1946368};S300-II {ECO:0000303|PubMed:1517211};, PF08271;PF00382;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0005669;GO:0097550;GO:0016407;GO:0004402;GO:1990841;GO:0000993;GO:0000979;GO:0016251;GO:0017025;GO:0046966;GO:0008134;GO:0008270;GO:0006352;GO:1904798;GO:0006473;GO:1990114;GO:0051123;GO:0042795;GO:0006366;GO:0006367;GO:0001174;GO:0019083;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:acetyltransferase activity; F:histone acetyltransferase activity; F:promoter-specific chromatin binding; F:RNA polymerase II complex binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:TBP-class protein binding; F:thyroid hormone receptor binding; F:transcription factor binding; F:zinc ion binding;, P:DNA-templated transcription, initiation; P:positive regulation of core promoter binding; P:protein acetylation; P:RNA polymerase II core complex assembly; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:transcriptional start site selection at RNA polymerase II promoter; P:viral transcription;|Q00403 A8K1A7 Q5JS30,Transcription initiation factor IIB {ECO:0000303|PubMed:1876184},General transcription factor TFIIB {ECO:0000303|PubMed:1946368};S300-II {ECO:0000303|PubMed:1517211};, PF08271;PF00382;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0005669;GO:0097550;GO:0016407;GO:0004402;GO:1990841;GO:0000993;GO:0000979;GO:0016251;GO:0017025;GO:0046966;GO:0008134;GO:0008270;GO:0006352;GO:1904798;GO:0006473;GO:1990114;GO:0051123;GO:0042795;GO:0006366;GO:0006367;GO:0001174;GO:0019083;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:acetyltransferase activity; F:histone acetyltransferase activity; F:promoter-specific chromatin binding; F:RNA polymerase II complex binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:TBP-class protein binding; F:thyroid hormone receptor binding; F:transcription factor binding; F:zinc ion binding;, P:DNA-templated transcription, initiation; P:positive regulation of core promoter binding; P:protein acetylation; P:RNA polymerase II core complex assembly; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:transcriptional start site selection at RNA polymerase II promoter; P:viral transcription;|Q00403 A8K1A7 Q5JS30,Transcription initiation factor IIB {ECO:0000303|PubMed:1876184},General transcription factor TFIIB {ECO:0000303|PubMed:1946368};S300-II {ECO:0000303|PubMed:1517211};, PF08271;PF00382;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0005669;GO:0097550;GO:0016407;GO:0004402;GO:1990841;GO:0000993;GO:0000979;GO:0016251;GO:0017025;GO:0046966;GO:0008134;GO:0008270;GO:0006352;GO:1904798;GO:0006473;GO:1990114;GO:0051123;GO:0042795;GO:0006366;GO:0006367;GO:0001174;GO:0019083;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:acetyltransferase activity; F:histone acetyltransferase activity; F:promoter-specific chromatin binding; F:RNA polymerase II complex binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:TBP-class protein binding; F:thyroid hormone receptor binding; F:transcription factor binding; F:zinc ion binding;, P:DNA-templated transcription, initiation; P:positive regulation of core promoter binding; P:protein acetylation; P:RNA polymerase II core complex assembly; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:transcriptional start site selection at RNA polymerase II promoter; P:viral transcription; scaffold5 indexed_genome mRNA 42034546 42054804 . - . ID=transcript_1394;Q6YP21 B3KQ13 O95335 Q5JS27 Q5T9T7 Q5T9T8 Q6AI27 Q6ICW1 Q9BVY5,Kynurenine--oxoglutarate transaminase 3 {ECO:0000250|UniProtKB:Q71RI9},Cysteine-S-conjugate beta-lyase 2 {ECO:0000250|UniProtKB:Q71RI9};Kynurenine aminotransferase 3 {ECO:0000312|HGNC:HGNC:33238};Kynurenine aminotransferase III;Kynurenine--glyoxylate transaminase {ECO:0000250|UniProtKB:Q71RI9};Kynurenine--oxoglutarate transaminase III;, PF00155;, GO:0005737;GO:0005739;GO:0047804;GO:0047315;GO:0016212;GO:0042803;GO:0030170;GO:0003723;GO:0006103;GO:0009058;GO:0006520;GO:0070189;GO:0097053;, C:cytoplasm; C:mitochondrion;, F:cysteine-S-conjugate beta-lyase activity; F:kynurenine-glyoxylate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:RNA binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:cellular amino acid metabolic process; P:kynurenine metabolic process; P:L-kynurenine catabolic process;|Q5T5Y3 A1L4L2 B2REB2 B2REB3 Q70W33 Q8NCY0 Q96E80 Q96FM3 Q9UFJ5,Calmodulin-regulated spectrin-associated protein 1,, PF17095;PF11971;PF08683;, GO:0005737;GO:0005874;GO:0005516;GO:0008017;GO:0051011;GO:0030507;GO:0031122;GO:0007010;GO:0000226;GO:0007026;GO:0031175;GO:0022604;GO:0031113;, C:cytoplasm; C:microtubule;, F:calmodulin binding; F:microtubule binding; F:microtubule minus-end binding; F:spectrin binding;, P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:neuron projection development; P:regulation of cell morphogenesis; P:regulation of microtubule polymerization; scaffold5 indexed_genome mRNA 42057944 42100631 . - . ID=transcript_1395;Q6YP21 B3KQ13 O95335 Q5JS27 Q5T9T7 Q5T9T8 Q6AI27 Q6ICW1 Q9BVY5,Kynurenine--oxoglutarate transaminase 3 {ECO:0000250|UniProtKB:Q71RI9},Cysteine-S-conjugate beta-lyase 2 {ECO:0000250|UniProtKB:Q71RI9};Kynurenine aminotransferase 3 {ECO:0000312|HGNC:HGNC:33238};Kynurenine aminotransferase III;Kynurenine--glyoxylate transaminase {ECO:0000250|UniProtKB:Q71RI9};Kynurenine--oxoglutarate transaminase III;, PF00155;, GO:0005737;GO:0005739;GO:0047804;GO:0047315;GO:0016212;GO:0042803;GO:0030170;GO:0003723;GO:0006103;GO:0009058;GO:0006520;GO:0070189;GO:0097053;, C:cytoplasm; C:mitochondrion;, F:cysteine-S-conjugate beta-lyase activity; F:kynurenine-glyoxylate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:RNA binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:cellular amino acid metabolic process; P:kynurenine metabolic process; P:L-kynurenine catabolic process; scaffold5 indexed_genome mRNA 42113216 42126840 . - . ID=transcript_1396;P32455 D3DT26 Q5T8M1,Guanylate-binding protein 1,GTP-binding protein 1;Guanine nucleotide-binding protein 1;Interferon-induced guanylate-binding protein 1;, PF02263;PF02841;, GO:0015629;GO:0005737;GO:0031410;GO:0005829;GO:0005576;GO:0005794;GO:0000139;GO:0005886;GO:0012506;GO:0003779;GO:0019955;GO:0019899;GO:0019003;GO:0005525;GO:0003924;GO:0051879;GO:0042802;GO:0042803;GO:0030507;GO:0071346;GO:0071347;GO:0071356;GO:0051607;GO:0060333;GO:0070373;GO:0032703;GO:1903077;GO:1900025;GO:0050860;GO:0072665;GO:0050848;GO:1903076;, C:actin cytoskeleton; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane; C:vesicle membrane;, F:actin binding; F:cytokine binding; F:enzyme binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:Hsp90 protein binding; F:identical protein binding; F:protein homodimerization activity; F:spectrin binding;, P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:defense response to virus; P:interferon-gamma-mediated signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-2 production; P:negative regulation of protein localization to plasma membrane; P:negative regulation of substrate adhesion-dependent cell spreading; P:negative regulation of T cell receptor signaling pathway; P:protein localization to vacuole; P:regulation of calcium-mediated signaling; P:regulation of protein localization to plasma membrane;|P32455 D3DT26 Q5T8M1,Guanylate-binding protein 1,GTP-binding protein 1;Guanine nucleotide-binding protein 1;Interferon-induced guanylate-binding protein 1;, PF02263;PF02841;, GO:0015629;GO:0005737;GO:0031410;GO:0005829;GO:0005576;GO:0005794;GO:0000139;GO:0005886;GO:0012506;GO:0003779;GO:0019955;GO:0019899;GO:0019003;GO:0005525;GO:0003924;GO:0051879;GO:0042802;GO:0042803;GO:0030507;GO:0071346;GO:0071347;GO:0071356;GO:0051607;GO:0060333;GO:0070373;GO:0032703;GO:1903077;GO:1900025;GO:0050860;GO:0072665;GO:0050848;GO:1903076;, C:actin cytoskeleton; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane; C:vesicle membrane;, F:actin binding; F:cytokine binding; F:enzyme binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:Hsp90 protein binding; F:identical protein binding; F:protein homodimerization activity; F:spectrin binding;, P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:defense response to virus; P:interferon-gamma-mediated signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-2 production; P:negative regulation of protein localization to plasma membrane; P:negative regulation of substrate adhesion-dependent cell spreading; P:negative regulation of T cell receptor signaling pathway; P:protein localization to vacuole; P:regulation of calcium-mediated signaling; P:regulation of protein localization to plasma membrane;|P32455 D3DT26 Q5T8M1,Guanylate-binding protein 1,GTP-binding protein 1;Guanine nucleotide-binding protein 1;Interferon-induced guanylate-binding protein 1;, PF02263;PF02841;, GO:0015629;GO:0005737;GO:0031410;GO:0005829;GO:0005576;GO:0005794;GO:0000139;GO:0005886;GO:0012506;GO:0003779;GO:0019955;GO:0019899;GO:0019003;GO:0005525;GO:0003924;GO:0051879;GO:0042802;GO:0042803;GO:0030507;GO:0071346;GO:0071347;GO:0071356;GO:0051607;GO:0060333;GO:0070373;GO:0032703;GO:1903077;GO:1900025;GO:0050860;GO:0072665;GO:0050848;GO:1903076;, C:actin cytoskeleton; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane; C:vesicle membrane;, F:actin binding; F:cytokine binding; F:enzyme binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:Hsp90 protein binding; F:identical protein binding; F:protein homodimerization activity; F:spectrin binding;, P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:defense response to virus; P:interferon-gamma-mediated signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-2 production; P:negative regulation of protein localization to plasma membrane; P:negative regulation of substrate adhesion-dependent cell spreading; P:negative regulation of T cell receptor signaling pathway; P:protein localization to vacuole; P:regulation of calcium-mediated signaling; P:regulation of protein localization to plasma membrane; scaffold5 indexed_genome mRNA 42160593 42181235 . - . ID=transcript_1397;Q96PP9 B2R630 Q05D63 Q6NSL0 Q86T99,Guanylate-binding protein 4,GTP-binding protein 4;Guanine nucleotide-binding protein 4;, PF02263;PF02841;, GO:0031410;GO:0005829;GO:0005794;GO:0000139;GO:0005634;GO:0048471;GO:0005886;GO:0005525;GO:0003924;GO:0042802;GO:0042803;GO:0071346;GO:0050830;GO:0042832;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:protein homodimerization activity;, P:cellular response to interferon-gamma; P:defense response to Gram-positive bacterium; P:defense response to protozoan; scaffold5 indexed_genome mRNA 42242325 42271096 . - . ID=transcript_1398;Q96PP9 B2R630 Q05D63 Q6NSL0 Q86T99,Guanylate-binding protein 4,GTP-binding protein 4;Guanine nucleotide-binding protein 4;, PF02263;PF02841;, GO:0031410;GO:0005829;GO:0005794;GO:0000139;GO:0005634;GO:0048471;GO:0005886;GO:0005525;GO:0003924;GO:0042802;GO:0042803;GO:0071346;GO:0050830;GO:0042832;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:protein homodimerization activity;, P:cellular response to interferon-gamma; P:defense response to Gram-positive bacterium; P:defense response to protozoan; scaffold5 indexed_genome mRNA 42280358 42301546 . - . ID=transcript_1399;P32456 Q6GPH0 Q6IAU2 Q86TB0,Guanylate-binding protein 2,GTP-binding protein 2;Guanine nucleotide-binding protein 2;Interferon-induced guanylate-binding protein 2;, PF02263;PF02841;, GO:0005737;GO:0031410;GO:0005829;GO:0005794;GO:0000139;GO:0005654;GO:0005634;GO:0048471;GO:0005525;GO:0003924;GO:0042802;GO:0042803;GO:0071346;GO:0071347;GO:0071356;GO:0050830;GO:0042832;GO:0006955;GO:0060333;GO:0034504;GO:0060337;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:protein homodimerization activity;, P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:defense response to Gram-positive bacterium; P:defense response to protozoan; P:immune response; P:interferon-gamma-mediated signaling pathway; P:protein localization to nucleus; P:type I interferon signaling pathway; scaffold5 indexed_genome mRNA 42459959 42487326 . - . ID=transcript_1400;Q6ZN66 A2RRM3 Q6ZN86 Q7Z3F0,Guanylate-binding protein 6,GTP-binding protein 6;Guanine nucleotide-binding protein 6;, PF02263;PF02841;, GO:0031410;GO:0070062;GO:0005525;GO:0003924;GO:0071346;GO:0042742;GO:0050830;GO:0042832;GO:0006955;, C:cytoplasmic vesicle; C:extracellular exosome;, F:GTP binding; F:GTPase activity;, P:cellular response to interferon-gamma; P:defense response to bacterium; P:defense response to Gram-positive bacterium; P:defense response to protozoan; P:immune response; scaffold5 indexed_genome mRNA 42628051 42642936 . + . ID=transcript_1401;Q6P9F7 D3DT28 Q6UY21 Q8N106 Q92627,Volume-regulated anion channel subunit LRRC8B {ECO:0000305},Leucine-rich repeat-containing protein 8B {ECO:0000303|PubMed:22532330};T-cell activation leucine repeat-rich protein {ECO:0000303|Ref.1};, PF13306;PF13855;PF12534;, GO:0005737;GO:0005789;GO:0005887;GO:0034702;GO:0005886;GO:0098656;GO:0015698;GO:0055085;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:ion channel complex; C:plasma membrane;, , P:anion transmembrane transport; P:inorganic anion transport; P:transmembrane transport; scaffold5 indexed_genome mRNA 42681975 42771252 . + . ID=transcript_1402;Q8TDW0 B3KXS9 Q29RV6 Q9H075,Volume-regulated anion channel subunit LRRC8C {ECO:0000305},Factor for adipocyte differentiation 158 {ECO:0000303|PubMed:15564382};Leucine-rich repeat-containing protein 8C {ECO:0000303|PubMed:22532330};, PF13306;PF13855;PF12534;, GO:0005737;GO:0005789;GO:0005887;GO:0034702;GO:0016020;GO:0005886;GO:0005225;GO:0098656;GO:0015810;GO:0071470;GO:0140361;GO:0034214;GO:0015734;GO:0055085;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:ion channel complex; C:membrane; C:plasma membrane;, F:volume-sensitive anion channel activity;, P:anion transmembrane transport; P:aspartate transmembrane transport; P:cellular response to osmotic stress; P:cyclic-GMP-AMP transmembrane import across plasma membrane; P:protein hexamerization; P:taurine transport; P:transmembrane transport;|Q8TDW0 B3KXS9 Q29RV6 Q9H075,Volume-regulated anion channel subunit LRRC8C {ECO:0000305},Factor for adipocyte differentiation 158 {ECO:0000303|PubMed:15564382};Leucine-rich repeat-containing protein 8C {ECO:0000303|PubMed:22532330};, PF13306;PF13855;PF12534;, GO:0005737;GO:0005789;GO:0005887;GO:0034702;GO:0016020;GO:0005886;GO:0005225;GO:0098656;GO:0015810;GO:0071470;GO:0140361;GO:0034214;GO:0015734;GO:0055085;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:ion channel complex; C:membrane; C:plasma membrane;, F:volume-sensitive anion channel activity;, P:anion transmembrane transport; P:aspartate transmembrane transport; P:cellular response to osmotic stress; P:cyclic-GMP-AMP transmembrane import across plasma membrane; P:protein hexamerization; P:taurine transport; P:transmembrane transport; scaffold5 indexed_genome mRNA 43010266 43013644 . + . ID=transcript_1403;Q7L1W4 D3DT29 Q6UWB2 Q9NVW3,Volume-regulated anion channel subunit LRRC8D {ECO:0000305},Leucine-rich repeat-containing protein 5 {ECO:0000312|HGNC:HGNC:16992};Leucine-rich repeat-containing protein 8D {ECO:0000303|PubMed:22532330};, PF13855;PF12534;, GO:0005737;GO:0005789;GO:0016021;GO:0005887;GO:0034702;GO:0016020;GO:0005886;GO:0005225;GO:0098656;GO:0015810;GO:0001678;GO:0071470;GO:0034214;GO:0015734;GO:0055085;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:ion channel complex; C:membrane; C:plasma membrane;, F:volume-sensitive anion channel activity;, P:anion transmembrane transport; P:aspartate transmembrane transport; P:cellular glucose homeostasis; P:cellular response to osmotic stress; P:protein hexamerization; P:taurine transport; P:transmembrane transport; scaffold5 indexed_genome mRNA 43068011 43089005 . + . ID=transcript_1404;Q7Z638 Q7Z6C2,DBIRD complex subunit ZNF326,Zinc finger protein 326;Zinc finger protein interacting with mRNPs and DBC1;, PF04988;, GO:0044609;GO:0043231;GO:0016363;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003723;GO:0000993;GO:0006397;GO:0032784;GO:0043484;GO:0008380;, C:DBIRD complex; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:RNA binding; F:RNA polymerase II complex binding;, P:mRNA processing; P:regulation of DNA-templated transcription, elongation; P:regulation of RNA splicing; P:RNA splicing; scaffold5 indexed_genome mRNA 43092677 43109548 . + . ID=transcript_1405;Q7Z638 Q7Z6C2,DBIRD complex subunit ZNF326,Zinc finger protein 326;Zinc finger protein interacting with mRNPs and DBC1;, PF04988;, GO:0044609;GO:0043231;GO:0016363;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003723;GO:0000993;GO:0006397;GO:0032784;GO:0043484;GO:0008380;, C:DBIRD complex; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:RNA binding; F:RNA polymerase II complex binding;, P:mRNA processing; P:regulation of DNA-templated transcription, elongation; P:regulation of RNA splicing; P:RNA splicing; scaffold5 indexed_genome mRNA 43785636 43796287 . - . ID=transcript_1406;Q9NY43 A0AVP2 Q7Z4N7,BarH-like 2 homeobox protein,, PF00046;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000977;GO:1990837;GO:0001709;GO:0030182;GO:0001764;GO:0045727;GO:0030516;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell fate determination; P:neuron differentiation; P:neuron migration; P:positive regulation of translation; P:regulation of axon extension; P:regulation of transcription by RNA polymerase II;|Q9NY43 A0AVP2 Q7Z4N7,BarH-like 2 homeobox protein,, PF00046;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000977;GO:1990837;GO:0001709;GO:0030182;GO:0001764;GO:0045727;GO:0030516;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell fate determination; P:neuron differentiation; P:neuron migration; P:positive regulation of translation; P:regulation of axon extension; P:regulation of transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 43971323 44036363 . - . ID=transcript_1407;Q9H582 A2RU71 Q2TAM0 Q5TCC0 Q6BEP7 Q6P446 Q6PI06 Q7LG67 Q9ULJ9,Zinc finger protein 644,Zinc finger motif enhancer-binding protein 2;, , GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0001226;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding;, P:regulation of transcription by RNA polymerase II;|Q9H582 A2RU71 Q2TAM0 Q5TCC0 Q6BEP7 Q6P446 Q6PI06 Q7LG67 Q9ULJ9,Zinc finger protein 644,Zinc finger motif enhancer-binding protein 2;, , GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0001226;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding;, P:regulation of transcription by RNA polymerase II;|Q9H582 A2RU71 Q2TAM0 Q5TCC0 Q6BEP7 Q6P446 Q6PI06 Q7LG67 Q9ULJ9,Zinc finger protein 644,Zinc finger motif enhancer-binding protein 2;, , GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0001226;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding;, P:regulation of transcription by RNA polymerase II;|Q9H582 A2RU71 Q2TAM0 Q5TCC0 Q6BEP7 Q6P446 Q6PI06 Q7LG67 Q9ULJ9,Zinc finger protein 644,Zinc finger motif enhancer-binding protein 2;, , GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0001226;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding;, P:regulation of transcription by RNA polymerase II;|Q9H582 A2RU71 Q2TAM0 Q5TCC0 Q6BEP7 Q6P446 Q6PI06 Q7LG67 Q9ULJ9,Zinc finger protein 644,Zinc finger motif enhancer-binding protein 2;, , GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0001226;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding;, P:regulation of transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 44262402 44283706 . - . ID=transcript_1408;A2PYH4 B1B0B6 Q8N9Q0,Probable ATP-dependent DNA helicase HFM1,SEC63 domain-containing protein 1;, PF00270;PF00271;PF02889;, GO:0005634;GO:0005524;GO:0003678;GO:0003676;GO:0000712;, C:nucleus;, F:ATP binding; F:DNA helicase activity; F:nucleic acid binding;, P:resolution of meiotic recombination intermediates; scaffold5 indexed_genome mRNA 44421638 44447982 . + . ID=transcript_1409;O00311 D3DT31 O00558 Q5T5U5,Cell division cycle 7-related protein kinase,, PF00069;, GO:0005737;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0005524;GO:0016301;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044770;GO:0051301;GO:0006260;GO:0006270;GO:0000727;GO:0000082;GO:0070317;GO:0018105;GO:0008284;GO:0010971;GO:0010571;, C:cytoplasm; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication;|O00311 D3DT31 O00558 Q5T5U5,Cell division cycle 7-related protein kinase,, PF00069;, GO:0005737;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0005524;GO:0016301;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044770;GO:0051301;GO:0006260;GO:0006270;GO:0000727;GO:0000082;GO:0070317;GO:0018105;GO:0008284;GO:0010971;GO:0010571;, C:cytoplasm; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication;|O00311 D3DT31 O00558 Q5T5U5,Cell division cycle 7-related protein kinase,, PF00069;, GO:0005737;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0005524;GO:0016301;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044770;GO:0051301;GO:0006260;GO:0006270;GO:0000727;GO:0000082;GO:0070317;GO:0018105;GO:0008284;GO:0010971;GO:0010571;, C:cytoplasm; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication;|O00311 D3DT31 O00558 Q5T5U5,Cell division cycle 7-related protein kinase,, PF00069;, GO:0005737;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0005524;GO:0016301;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044770;GO:0051301;GO:0006260;GO:0006270;GO:0000727;GO:0000082;GO:0070317;GO:0018105;GO:0008284;GO:0010971;GO:0010571;, C:cytoplasm; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication;|O00311 D3DT31 O00558 Q5T5U5,Cell division cycle 7-related protein kinase,, PF00069;, GO:0005737;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0005524;GO:0016301;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044770;GO:0051301;GO:0006260;GO:0006270;GO:0000727;GO:0000082;GO:0070317;GO:0018105;GO:0008284;GO:0010971;GO:0010571;, C:cytoplasm; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication;|O00311 D3DT31 O00558 Q5T5U5,Cell division cycle 7-related protein kinase,, PF00069;, GO:0005737;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0005524;GO:0016301;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044770;GO:0051301;GO:0006260;GO:0006270;GO:0000727;GO:0000082;GO:0070317;GO:0018105;GO:0008284;GO:0010971;GO:0010571;, C:cytoplasm; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication;|O00311 D3DT31 O00558 Q5T5U5,Cell division cycle 7-related protein kinase,, PF00069;, GO:0005737;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0005524;GO:0016301;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044770;GO:0051301;GO:0006260;GO:0006270;GO:0000727;GO:0000082;GO:0070317;GO:0018105;GO:0008284;GO:0010971;GO:0010571;, C:cytoplasm; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication; scaffold5 indexed_genome mRNA 44584447 44659153 . - . ID=transcript_1410;Q03167 A0AUW8 A8K5N0 B9EG88 Q5T2T4 Q5U731 Q9UGI2,Transforming growth factor beta receptor type 3,Betaglycan;Transforming growth factor beta receptor III;, PF00100;, GO:0009986;GO:0005737;GO:0009897;GO:0070062;GO:0031012;GO:0005615;GO:0034673;GO:0005887;GO:0043235;GO:0048185;GO:0015026;GO:0017134;GO:0005539;GO:0008201;GO:0030165;GO:0046332;GO:0050431;GO:0070123;GO:0005160;GO:0005024;GO:0005114;GO:0001525;GO:0031100;GO:0030509;GO:0060317;GO:0060038;GO:0016477;GO:0060318;GO:0060216;GO:0060939;GO:0001837;GO:0003007;GO:0060347;GO:0061384;GO:0006955;GO:0035556;GO:0001889;GO:0003150;GO:0051271;GO:0050680;GO:0030512;GO:0003151;GO:0060389;GO:0060045;GO:0030511;GO:0043393;GO:0017015;GO:0032354;GO:0001666;GO:0034699;GO:0034695;GO:0062009;GO:0007181;GO:0007179;GO:0001570;GO:0060979;GO:0055010;GO:0003223;GO:0060412;, C:cell surface; C:cytoplasm; C:external side of plasma membrane; C:extracellular exosome; C:extracellular matrix; C:extracellular space; C:inhibin-betaglycan-ActRII complex; C:integral component of plasma membrane; C:receptor complex;, F:activin binding; F:coreceptor activity; F:fibroblast growth factor binding; F:glycosaminoglycan binding; F:heparin binding; F:PDZ domain binding; F:SMAD binding; F:transforming growth factor beta binding; F:transforming growth factor beta receptor activity, type III; F:transforming growth factor beta receptor binding; F:transforming growth factor beta-activated receptor activity; F:type II transforming growth factor beta receptor binding;, P:angiogenesis; P:animal organ regeneration; P:BMP signaling pathway; P:cardiac epithelial to mesenchymal transition; P:cardiac muscle cell proliferation; P:cell migration; P:definitive erythrocyte differentiation; P:definitive hemopoiesis; P:epicardium-derived cardiac fibroblast cell development; P:epithelial to mesenchymal transition; P:heart morphogenesis; P:heart trabecula formation; P:heart trabecula morphogenesis; P:immune response; P:intracellular signal transduction; P:liver development; P:muscular septum morphogenesis; P:negative regulation of cellular component movement; P:negative regulation of epithelial cell proliferation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:outflow tract morphogenesis; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of protein binding; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to follicle-stimulating hormone; P:response to hypoxia; P:response to luteinizing hormone; P:response to prostaglandin E; P:secondary palate development; P:transforming growth factor beta receptor complex assembly; P:transforming growth factor beta receptor signaling pathway; P:vasculogenesis; P:vasculogenesis involved in coronary vascular morphogenesis; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular compact myocardium morphogenesis; P:ventricular septum morphogenesis; scaffold5 indexed_genome mRNA 44885088 44885706 . + . ID=transcript_1411;Q7Z4A6 Q8IWI6,Bromodomain testis-specific protein,Cancer/testis antigen 9;RING3-like protein;, PF17035;PF17105;PF00439;, GO:0005634;GO:0042393;GO:0070577;GO:0003713;GO:0030154;GO:0006338;GO:0001207;GO:0007141;GO:0007140;GO:0006397;GO:0051039;GO:0043484;GO:0006355;GO:0008380;GO:0007283;, C:nucleus;, F:histone binding; F:lysine-acetylated histone binding; F:transcription coactivator activity;, P:cell differentiation; P:chromatin remodeling; P:histone displacement; P:male meiosis I; P:male meiotic nuclear division; P:mRNA processing; P:positive regulation of transcription involved in meiotic cell cycle; P:regulation of RNA splicing; P:regulation of transcription, DNA-templated; P:RNA splicing; P:spermatogenesis; scaffold5 indexed_genome mRNA 44899042 44930583 . + . ID=transcript_1412;Q8IUS5 Q8NCC6,Epoxide hydrolase 4,Abhydrolase domain-containing protein 7;Epoxide hydrolase-related protein;, PF00561;, GO:0016021;GO:0016787;, C:integral component of membrane;, F:hydrolase activity;|Q8IUS5 Q8NCC6,Epoxide hydrolase 4,Abhydrolase domain-containing protein 7;Epoxide hydrolase-related protein;, PF00561;, GO:0016021;GO:0016787;, C:integral component of membrane;, F:hydrolase activity; scaffold5 indexed_genome mRNA 44946950 44955875 . + . ID=transcript_1413;Q5XKL5 Q6V9S5,BTB/POZ domain-containing protein 8,, PF00651;, GO:0005654;, C:nucleoplasm; scaffold5 indexed_genome mRNA 44970329 45021410 . + . ID=transcript_1414;Q5XKL5 Q6V9S5,BTB/POZ domain-containing protein 8,, PF00651;, GO:0005654;, C:nucleoplasm; scaffold5 indexed_genome mRNA 45023086 45037664 . + . ID=transcript_1415;Q9UPP5 A0A1B0GWG1 O14767 Q8N3X7,AP2-interacting clathrin-endocytosis protein {ECO:0000303|PubMed:29262337},, PF15363;, GO:0030424;GO:0044297;GO:0030136;GO:0044306;GO:0098793;GO:0008021;GO:0150007;GO:0031175;GO:0036466;, C:axon; C:cell body; C:clathrin-coated vesicle; C:neuron projection terminus; C:presynapse; C:synaptic vesicle;, , P:clathrin-dependent synaptic vesicle endocytosis; P:neuron projection development; P:synaptic vesicle recycling via endosome;|Q9UPP5 A0A1B0GWG1 O14767 Q8N3X7,AP2-interacting clathrin-endocytosis protein {ECO:0000303|PubMed:29262337},, PF15363;, GO:0030424;GO:0044297;GO:0030136;GO:0044306;GO:0098793;GO:0008021;GO:0150007;GO:0031175;GO:0036466;, C:axon; C:cell body; C:clathrin-coated vesicle; C:neuron projection terminus; C:presynapse; C:synaptic vesicle;, , P:clathrin-dependent synaptic vesicle endocytosis; P:neuron projection development; P:synaptic vesicle recycling via endosome;|Q9UPP5 A0A1B0GWG1 O14767 Q8N3X7,AP2-interacting clathrin-endocytosis protein {ECO:0000303|PubMed:29262337},, PF15363;, GO:0030424;GO:0044297;GO:0030136;GO:0044306;GO:0098793;GO:0008021;GO:0150007;GO:0031175;GO:0036466;, C:axon; C:cell body; C:clathrin-coated vesicle; C:neuron projection terminus; C:presynapse; C:synaptic vesicle;, , P:clathrin-dependent synaptic vesicle endocytosis; P:neuron projection development; P:synaptic vesicle recycling via endosome; scaffold5 indexed_genome mRNA 45081918 45082495 . - . ID=transcript_1416;Q5VVC0 Q5VVC4,Protein SPO16 homolog {ECO:0000250|UniProtKB:Q3KQP7},Synaptonemal complex reinforcing element {ECO:0000250|UniProtKB:Q3KQP7};, PF15162;, GO:0005694;GO:0007131;GO:0007130;, C:chromosome;, , P:reciprocal meiotic recombination; P:synaptonemal complex assembly; scaffold5 indexed_genome mRNA 45082549 45130988 . - . ID=transcript_1417;Q92990 Q5VVC3 Q9BVE8,Glomulin,FK506-binding protein-associated protein;FKBP-associated protein;, PF08568;, GO:0031462;GO:0031463;GO:0031464;GO:0031461;GO:0005737;GO:0005171;GO:0005102;GO:0031625;GO:0055105;GO:0007166;GO:0042692;GO:0008285;GO:0042130;GO:0001843;GO:0001819;GO:0032743;GO:0042327;GO:0040029;GO:0032434;GO:0001570;, C:Cul2-RING ubiquitin ligase complex; C:Cul3-RING ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm;, F:hepatocyte growth factor receptor binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase inhibitor activity;, P:cell surface receptor signaling pathway; P:muscle cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of T cell proliferation; P:neural tube closure; P:positive regulation of cytokine production; P:positive regulation of interleukin-2 production; P:positive regulation of phosphorylation; P:regulation of gene expression, epigenetic; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:vasculogenesis;|Q92990 Q5VVC3 Q9BVE8,Glomulin,FK506-binding protein-associated protein;FKBP-associated protein;, PF08568;, GO:0031462;GO:0031463;GO:0031464;GO:0031461;GO:0005737;GO:0005171;GO:0005102;GO:0031625;GO:0055105;GO:0007166;GO:0042692;GO:0008285;GO:0042130;GO:0001843;GO:0001819;GO:0032743;GO:0042327;GO:0040029;GO:0032434;GO:0001570;, C:Cul2-RING ubiquitin ligase complex; C:Cul3-RING ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm;, F:hepatocyte growth factor receptor binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase inhibitor activity;, P:cell surface receptor signaling pathway; P:muscle cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of T cell proliferation; P:neural tube closure; P:positive regulation of cytokine production; P:positive regulation of interleukin-2 production; P:positive regulation of phosphorylation; P:regulation of gene expression, epigenetic; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:vasculogenesis;|Q92990 Q5VVC3 Q9BVE8,Glomulin,FK506-binding protein-associated protein;FKBP-associated protein;, PF08568;, GO:0031462;GO:0031463;GO:0031464;GO:0031461;GO:0005737;GO:0005171;GO:0005102;GO:0031625;GO:0055105;GO:0007166;GO:0042692;GO:0008285;GO:0042130;GO:0001843;GO:0001819;GO:0032743;GO:0042327;GO:0040029;GO:0032434;GO:0001570;, C:Cul2-RING ubiquitin ligase complex; C:Cul3-RING ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm;, F:hepatocyte growth factor receptor binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase inhibitor activity;, P:cell surface receptor signaling pathway; P:muscle cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of T cell proliferation; P:neural tube closure; P:positive regulation of cytokine production; P:positive regulation of interleukin-2 production; P:positive regulation of phosphorylation; P:regulation of gene expression, epigenetic; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:vasculogenesis; scaffold5 indexed_genome mRNA 45136940 45150142 . + . ID=transcript_1418;Q8IXW5 C9JKB5 Q49AS7 Q9H8Y2,Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2,RNA polymerase II-associated protein 2;, PF04181;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0016591;GO:0046872;GO:0106306;GO:0106307;GO:0043175;GO:0008420;GO:0070940;GO:0009301;GO:0042795;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase core enzyme binding; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:snRNA transcription; P:snRNA transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 45161527 45178047 . + . ID=transcript_1419;Q8IXW5 C9JKB5 Q49AS7 Q9H8Y2,Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2,RNA polymerase II-associated protein 2;, PF04181;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0016591;GO:0046872;GO:0106306;GO:0106307;GO:0043175;GO:0008420;GO:0070940;GO:0009301;GO:0042795;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase core enzyme binding; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:snRNA transcription; P:snRNA transcription by RNA polymerase II;|Q8IXW5 C9JKB5 Q49AS7 Q9H8Y2,Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2,RNA polymerase II-associated protein 2;, PF04181;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0016591;GO:0046872;GO:0106306;GO:0106307;GO:0043175;GO:0008420;GO:0070940;GO:0009301;GO:0042795;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase core enzyme binding; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:snRNA transcription; P:snRNA transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 45219925 45223059 . + . ID=transcript_1420;Q8IXW5 C9JKB5 Q49AS7 Q9H8Y2,Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2,RNA polymerase II-associated protein 2;, PF04181;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0016591;GO:0046872;GO:0106306;GO:0106307;GO:0043175;GO:0008420;GO:0070940;GO:0009301;GO:0042795;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase core enzyme binding; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:snRNA transcription; P:snRNA transcription by RNA polymerase II; scaffold5 indexed_genome mRNA 45314358 45319647 . - . ID=transcript_1421;Q99684 Q8N564,Zinc finger protein Gfi-1,Growth factor independent protein 1;Zinc finger protein 163;, PF00096;, GO:0016604;GO:0016363;GO:0005634;GO:0017053;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0000976;GO:0071222;GO:0030097;GO:0010956;GO:0010977;GO:0032088;GO:0000122;GO:0045892;GO:0010957;GO:0070105;GO:0051569;GO:0034121;GO:0006357;GO:0000083;GO:0016032;, C:nuclear body; C:nuclear matrix; C:nucleus; C:transcription repressor complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to lipopolysaccharide; P:hemopoiesis; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of neuron projection development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of vitamin D biosynthetic process; P:positive regulation of interleukin-6-mediated signaling pathway; P:regulation of histone H3-K4 methylation; P:regulation of toll-like receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:viral process; scaffold5 indexed_genome mRNA 45340152 45374656 . + . ID=transcript_1422;O60447 A6NKX8 B9A6J0 Q9H1Y9,Ecotropic viral integration site 5 protein homolog,Neuroblastoma stage 4S gene protein;, PF00566;, GO:0005829;GO:0005815;GO:0005634;GO:0005819;GO:0005096;GO:0031267;GO:0090630;GO:0007049;GO:0051301;GO:0006886;GO:0043547;GO:0042147;, C:cytosol; C:microtubule organizing center; C:nucleus; C:spindle;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:cell cycle; P:cell division; P:intracellular protein transport; P:positive regulation of GTPase activity; P:retrograde transport, endosome to Golgi; scaffold5 indexed_genome mRNA 45405519 45591389 . - . ID=transcript_1423;Q96CN4 B9A6I9,EVI5-like protein,Ecotropic viral integration site 5-like protein;, PF00566;, GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:1902018;GO:0043547;, , F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:negative regulation of cilium assembly; P:positive regulation of GTPase activity; scaffold5 indexed_genome mRNA 45630651 45637913 . + . ID=transcript_1424;P46777 Q32LZ3 Q53HH6 Q9H3F4,60S ribosomal protein L5,Large ribosomal subunit protein uL18 {ECO:0000303|PubMed:24524803};, PF14204;PF17144;, GO:0005737;GO:0005829;GO:0022625;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0008097;GO:0003730;GO:0048027;GO:0003723;GO:0003735;GO:1990948;GO:0031625;GO:2000435;GO:1904667;GO:2000059;GO:0000184;GO:0010628;GO:0045727;GO:0050821;GO:1901796;GO:0000027;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:5S rRNA binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:RNA binding; F:structural constituent of ribosome; F:ubiquitin ligase inhibitor activity; F:ubiquitin protein ligase binding;, P:negative regulation of protein neddylation; P:negative regulation of ubiquitin protein ligase activity; P:negative regulation of ubiquitin-dependent protein catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of gene expression; P:positive regulation of translation; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P46777 Q32LZ3 Q53HH6 Q9H3F4,60S ribosomal protein L5,Large ribosomal subunit protein uL18 {ECO:0000303|PubMed:24524803};, PF14204;PF17144;, GO:0005737;GO:0005829;GO:0022625;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0008097;GO:0003730;GO:0048027;GO:0003723;GO:0003735;GO:1990948;GO:0031625;GO:2000435;GO:1904667;GO:2000059;GO:0000184;GO:0010628;GO:0045727;GO:0050821;GO:1901796;GO:0000027;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:5S rRNA binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:RNA binding; F:structural constituent of ribosome; F:ubiquitin ligase inhibitor activity; F:ubiquitin protein ligase binding;, P:negative regulation of protein neddylation; P:negative regulation of ubiquitin protein ligase activity; P:negative regulation of ubiquitin-dependent protein catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of gene expression; P:positive regulation of translation; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P46777 Q32LZ3 Q53HH6 Q9H3F4,60S ribosomal protein L5,Large ribosomal subunit protein uL18 {ECO:0000303|PubMed:24524803};, PF14204;PF17144;, GO:0005737;GO:0005829;GO:0022625;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0008097;GO:0003730;GO:0048027;GO:0003723;GO:0003735;GO:1990948;GO:0031625;GO:2000435;GO:1904667;GO:2000059;GO:0000184;GO:0010628;GO:0045727;GO:0050821;GO:1901796;GO:0000027;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:5S rRNA binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:RNA binding; F:structural constituent of ribosome; F:ubiquitin ligase inhibitor activity; F:ubiquitin protein ligase binding;, P:negative regulation of protein neddylation; P:negative regulation of ubiquitin protein ligase activity; P:negative regulation of ubiquitin-dependent protein catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of gene expression; P:positive regulation of translation; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P46777 Q32LZ3 Q53HH6 Q9H3F4,60S ribosomal protein L5,Large ribosomal subunit protein uL18 {ECO:0000303|PubMed:24524803};, PF14204;PF17144;, GO:0005737;GO:0005829;GO:0022625;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0008097;GO:0003730;GO:0048027;GO:0003723;GO:0003735;GO:1990948;GO:0031625;GO:2000435;GO:1904667;GO:2000059;GO:0000184;GO:0010628;GO:0045727;GO:0050821;GO:1901796;GO:0000027;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:5S rRNA binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:RNA binding; F:structural constituent of ribosome; F:ubiquitin ligase inhibitor activity; F:ubiquitin protein ligase binding;, P:negative regulation of protein neddylation; P:negative regulation of ubiquitin protein ligase activity; P:negative regulation of ubiquitin-dependent protein catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of gene expression; P:positive regulation of translation; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold5 indexed_genome mRNA 45638899 45681514 . - . ID=transcript_1425;Q5T7M9 Q6IRV2,Divergent protein kinase domain 1A {ECO:0000305},Protein FAM69A;, PF12260;PF14875;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane;|Q5T7M9 Q6IRV2,Divergent protein kinase domain 1A {ECO:0000305},Protein FAM69A;, PF12260;PF14875;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane; scaffold5 indexed_genome mRNA 45859324 45929167 . + . ID=transcript_1426;Q9Y483 A6NGQ9 A8K2Q3 B1AKT5 B1AKT6 Q96G26 Q9UES9 Q9UP40,Metal-response element-binding transcription factor 2,Metal regulatory transcription factor 2;Metal-response element DNA-binding protein M96;Polycomb-like protein 2;, PF14061;PF00628;PF18104;, GO:0005737;GO:0035098;GO:0005925;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0001226;GO:0000977;GO:1990830;GO:0006325;GO:0045814;GO:0061086;GO:0000122;GO:0061087;GO:0045944;GO:0006355;GO:0007379;GO:0048863;GO:0019827;, C:cytoplasm; C:ESC/E(Z) complex; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H3-K27 methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:segment specification; P:stem cell differentiation; P:stem cell population maintenance;|Q9Y483 A6NGQ9 A8K2Q3 B1AKT5 B1AKT6 Q96G26 Q9UES9 Q9UP40,Metal-response element-binding transcription factor 2,Metal regulatory transcription factor 2;Metal-response element DNA-binding protein M96;Polycomb-like protein 2;, PF14061;PF00628;PF18104;, GO:0005737;GO:0035098;GO:0005925;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0001226;GO:0000977;GO:1990830;GO:0006325;GO:0045814;GO:0061086;GO:0000122;GO:0061087;GO:0045944;GO:0006355;GO:0007379;GO:0048863;GO:0019827;, C:cytoplasm; C:ESC/E(Z) complex; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H3-K27 methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:segment specification; P:stem cell differentiation; P:stem cell population maintenance;|Q9Y483 A6NGQ9 A8K2Q3 B1AKT5 B1AKT6 Q96G26 Q9UES9 Q9UP40,Metal-response element-binding transcription factor 2,Metal regulatory transcription factor 2;Metal-response element DNA-binding protein M96;Polycomb-like protein 2;, PF14061;PF00628;PF18104;, GO:0005737;GO:0035098;GO:0005925;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0001226;GO:0000977;GO:1990830;GO:0006325;GO:0045814;GO:0061086;GO:0000122;GO:0061087;GO:0045944;GO:0006355;GO:0007379;GO:0048863;GO:0019827;, C:cytoplasm; C:ESC/E(Z) complex; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H3-K27 methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:segment specification; P:stem cell differentiation; P:stem cell population maintenance;|Q9Y483 A6NGQ9 A8K2Q3 B1AKT5 B1AKT6 Q96G26 Q9UES9 Q9UP40,Metal-response element-binding transcription factor 2,Metal regulatory transcription factor 2;Metal-response element DNA-binding protein M96;Polycomb-like protein 2;, PF14061;PF00628;PF18104;, GO:0005737;GO:0035098;GO:0005925;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0001226;GO:0000977;GO:1990830;GO:0006325;GO:0045814;GO:0061086;GO:0000122;GO:0061087;GO:0045944;GO:0006355;GO:0007379;GO:0048863;GO:0019827;, C:cytoplasm; C:ESC/E(Z) complex; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H3-K27 methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:segment specification; P:stem cell differentiation; P:stem cell population maintenance;|Q9Y483 A6NGQ9 A8K2Q3 B1AKT5 B1AKT6 Q96G26 Q9UES9 Q9UP40,Metal-response element-binding transcription factor 2,Metal regulatory transcription factor 2;Metal-response element DNA-binding protein M96;Polycomb-like protein 2;, PF14061;PF00628;PF18104;, GO:0005737;GO:0035098;GO:0005925;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0001226;GO:0000977;GO:1990830;GO:0006325;GO:0045814;GO:0061086;GO:0000122;GO:0061087;GO:0045944;GO:0006355;GO:0007379;GO:0048863;GO:0019827;, C:cytoplasm; C:ESC/E(Z) complex; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H3-K27 methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:segment specification; P:stem cell differentiation; P:stem cell population maintenance; scaffold5 indexed_genome mRNA 45947801 45969196 . - . ID=transcript_1427;Q9Y3A6 B1AKT4 B2R703 D3DT38 Q96AX8,Transmembrane emp24 domain-containing protein 5,p24 family protein gamma-2;p28;, PF01105;, GO:0005801;GO:0030134;GO:0005783;GO:0070971;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0006888;GO:0007030;GO:0090161;GO:0006886;, C:cis-Golgi network; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi ribbon formation; P:intracellular protein transport;|Q9Y3A6 B1AKT4 B2R703 D3DT38 Q96AX8,Transmembrane emp24 domain-containing protein 5,p24 family protein gamma-2;p28;, PF01105;, GO:0005801;GO:0030134;GO:0005783;GO:0070971;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0006888;GO:0007030;GO:0090161;GO:0006886;, C:cis-Golgi network; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi ribbon formation; P:intracellular protein transport; scaffold5 indexed_genome mRNA 45970127 45972817 . + . ID=transcript_1428;Q5T9S5 Q6ZU17,Coiled-coil domain-containing protein 18,Sarcoma antigen NY-SAR-24;|Q5T9S5 Q6ZU17,Coiled-coil domain-containing protein 18,Sarcoma antigen NY-SAR-24; scaffold5 indexed_genome mRNA 45974936 46069021 . + . ID=transcript_1429;Q5T9S5 Q6ZU17,Coiled-coil domain-containing protein 18,Sarcoma antigen NY-SAR-24;|Q5T9S5 Q6ZU17,Coiled-coil domain-containing protein 18,Sarcoma antigen NY-SAR-24; scaffold5 indexed_genome mRNA 46144889 46165724 . + . ID=transcript_1430;Q01658,Protein Dr1,Down-regulator of transcription 1;Negative cofactor 2-beta;TATA-binding protein-associated phosphoprotein;, PF00808;, GO:0005671;GO:0017054;GO:0005654;GO:0090575;GO:0001046;GO:0046982;GO:0016251;GO:0017025;GO:0003714;GO:0006338;GO:0043966;GO:0000122;GO:0045944;GO:0051123;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:negative cofactor 2 complex; C:nucleoplasm; C:RNA polymerase II transcription regulator complex;, F:core promoter sequence-specific DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:TBP-class protein binding; F:transcription corepressor activity;, P:chromatin remodeling; P:histone H3 acetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:RNA polymerase II preinitiation complex assembly;|Q01658,Protein Dr1,Down-regulator of transcription 1;Negative cofactor 2-beta;TATA-binding protein-associated phosphoprotein;, PF00808;, GO:0005671;GO:0017054;GO:0005654;GO:0090575;GO:0001046;GO:0046982;GO:0016251;GO:0017025;GO:0003714;GO:0006338;GO:0043966;GO:0000122;GO:0045944;GO:0051123;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:negative cofactor 2 complex; C:nucleoplasm; C:RNA polymerase II transcription regulator complex;, F:core promoter sequence-specific DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:TBP-class protein binding; F:transcription corepressor activity;, P:chromatin remodeling; P:histone H3 acetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:RNA polymerase II preinitiation complex assembly; scaffold5 indexed_genome mRNA 46203207 46316466 . + . ID=transcript_1431;Q5T0N5 J3QSS4 Q5T0N6 Q6B097 Q6P653 Q6R4Q4 Q9NXG1,Formin-binding protein 1-like,Transducer of Cdc42-dependent actin assembly protein 1;, PF00611;PF00018;, GO:0005938;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005886;GO:0045296;GO:0051020;GO:0008289;GO:0006914;GO:0060271;GO:0072583;GO:0010324;GO:0061024;GO:0097320;GO:0051491;GO:0007165;GO:0006900;GO:0016050;GO:0030050;, C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cadherin binding; F:GTPase binding; F:lipid binding;, P:autophagy; P:cilium assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:plasma membrane tubulation; P:positive regulation of filopodium assembly; P:signal transduction; P:vesicle budding from membrane; P:vesicle organization; P:vesicle transport along actin filament;|Q5T0N5 J3QSS4 Q5T0N6 Q6B097 Q6P653 Q6R4Q4 Q9NXG1,Formin-binding protein 1-like,Transducer of Cdc42-dependent actin assembly protein 1;, PF00611;PF00018;, GO:0005938;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005886;GO:0045296;GO:0051020;GO:0008289;GO:0006914;GO:0060271;GO:0072583;GO:0010324;GO:0061024;GO:0097320;GO:0051491;GO:0007165;GO:0006900;GO:0016050;GO:0030050;, C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cadherin binding; F:GTPase binding; F:lipid binding;, P:autophagy; P:cilium assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:plasma membrane tubulation; P:positive regulation of filopodium assembly; P:signal transduction; P:vesicle budding from membrane; P:vesicle organization; P:vesicle transport along actin filament;|Q5T0N5 J3QSS4 Q5T0N6 Q6B097 Q6P653 Q6R4Q4 Q9NXG1,Formin-binding protein 1-like,Transducer of Cdc42-dependent actin assembly protein 1;, PF00611;PF00018;, GO:0005938;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005886;GO:0045296;GO:0051020;GO:0008289;GO:0006914;GO:0060271;GO:0072583;GO:0010324;GO:0061024;GO:0097320;GO:0051491;GO:0007165;GO:0006900;GO:0016050;GO:0030050;, C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cadherin binding; F:GTPase binding; F:lipid binding;, P:autophagy; P:cilium assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:plasma membrane tubulation; P:positive regulation of filopodium assembly; P:signal transduction; P:vesicle budding from membrane; P:vesicle organization; P:vesicle transport along actin filament;|Q5T0N5 J3QSS4 Q5T0N6 Q6B097 Q6P653 Q6R4Q4 Q9NXG1,Formin-binding protein 1-like,Transducer of Cdc42-dependent actin assembly protein 1;, PF00611;PF00018;, GO:0005938;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005886;GO:0045296;GO:0051020;GO:0008289;GO:0006914;GO:0060271;GO:0072583;GO:0010324;GO:0061024;GO:0097320;GO:0051491;GO:0007165;GO:0006900;GO:0016050;GO:0030050;, C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cadherin binding; F:GTPase binding; F:lipid binding;, P:autophagy; P:cilium assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:plasma membrane tubulation; P:positive regulation of filopodium assembly; P:signal transduction; P:vesicle budding from membrane; P:vesicle organization; P:vesicle transport along actin filament;|Q5T0N5 J3QSS4 Q5T0N6 Q6B097 Q6P653 Q6R4Q4 Q9NXG1,Formin-binding protein 1-like,Transducer of Cdc42-dependent actin assembly protein 1;, PF00611;PF00018;, GO:0005938;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005886;GO:0045296;GO:0051020;GO:0008289;GO:0006914;GO:0060271;GO:0072583;GO:0010324;GO:0061024;GO:0097320;GO:0051491;GO:0007165;GO:0006900;GO:0016050;GO:0030050;, C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cadherin binding; F:GTPase binding; F:lipid binding;, P:autophagy; P:cilium assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:plasma membrane tubulation; P:positive regulation of filopodium assembly; P:signal transduction; P:vesicle budding from membrane; P:vesicle organization; P:vesicle transport along actin filament;|Q5T0N5 J3QSS4 Q5T0N6 Q6B097 Q6P653 Q6R4Q4 Q9NXG1,Formin-binding protein 1-like,Transducer of Cdc42-dependent actin assembly protein 1;, PF00611;PF00018;, GO:0005938;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005886;GO:0045296;GO:0051020;GO:0008289;GO:0006914;GO:0060271;GO:0072583;GO:0010324;GO:0061024;GO:0097320;GO:0051491;GO:0007165;GO:0006900;GO:0016050;GO:0030050;, C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cadherin binding; F:GTPase binding; F:lipid binding;, P:autophagy; P:cilium assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:plasma membrane tubulation; P:positive regulation of filopodium assembly; P:signal transduction; P:vesicle budding from membrane; P:vesicle organization; P:vesicle transport along actin filament; scaffold5 indexed_genome mRNA 46316684 46317905 . + . ID=transcript_1432;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold5 indexed_genome mRNA 46330044 46359471 . - . ID=transcript_1433;O75815 D3DT43 Q5TEW3 Q6UW40 Q9BR50,Breast cancer anti-estrogen resistance protein 3,Novel SH2-containing protein 2;SH2 domain-containing protein 3B;, PF00617;PF00017;, GO:0005737;GO:0005925;GO:0016020;GO:0005085;GO:0019900;GO:0001784;GO:0086100;GO:0008286;GO:0002089;GO:0045740;GO:0045742;GO:0043547;GO:0043410;GO:0033138;GO:0042493;GO:0007165;GO:0007264;, C:cytoplasm; C:focal adhesion; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:phosphotyrosine residue binding;, P:endothelin receptor signaling pathway; P:insulin receptor signaling pathway; P:lens morphogenesis in camera-type eye; P:positive regulation of DNA replication; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of GTPase activity; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:response to drug; P:signal transduction; P:small GTPase mediated signal transduction;|O75815 D3DT43 Q5TEW3 Q6UW40 Q9BR50,Breast cancer anti-estrogen resistance protein 3,Novel SH2-containing protein 2;SH2 domain-containing protein 3B;, PF00617;PF00017;, GO:0005737;GO:0005925;GO:0016020;GO:0005085;GO:0019900;GO:0001784;GO:0086100;GO:0008286;GO:0002089;GO:0045740;GO:0045742;GO:0043547;GO:0043410;GO:0033138;GO:0042493;GO:0007165;GO:0007264;, C:cytoplasm; C:focal adhesion; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:phosphotyrosine residue binding;, P:endothelin receptor signaling pathway; P:insulin receptor signaling pathway; P:lens morphogenesis in camera-type eye; P:positive regulation of DNA replication; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of GTPase activity; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:response to drug; P:signal transduction; P:small GTPase mediated signal transduction; scaffold5 indexed_genome mRNA 46363770 46456711 . - . ID=transcript_1434;O75815 D3DT43 Q5TEW3 Q6UW40 Q9BR50,Breast cancer anti-estrogen resistance protein 3,Novel SH2-containing protein 2;SH2 domain-containing protein 3B;, PF00617;PF00017;, GO:0005737;GO:0005925;GO:0016020;GO:0005085;GO:0019900;GO:0001784;GO:0086100;GO:0008286;GO:0002089;GO:0045740;GO:0045742;GO:0043547;GO:0043410;GO:0033138;GO:0042493;GO:0007165;GO:0007264;, C:cytoplasm; C:focal adhesion; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:phosphotyrosine residue binding;, P:endothelin receptor signaling pathway; P:insulin receptor signaling pathway; P:lens morphogenesis in camera-type eye; P:positive regulation of DNA replication; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of GTPase activity; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:response to drug; P:signal transduction; P:small GTPase mediated signal transduction; scaffold5 indexed_genome mRNA 46620272 46634390 . - . ID=transcript_1435;Q5QJE6 Q12987 Q53H59 Q5TFJ4 Q6TLI0 Q76MJ8 Q86WX9,Deoxynucleotidyltransferase terminal-interacting protein 2,Estrogen receptor-binding protein;LPTS-interacting protein 2;Terminal deoxynucleotidyltransferase-interacting factor 2;, PF08698;, GO:0005694;GO:0005730;GO:0005654;GO:0003723;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:RNA binding;|Q5QJE6 Q12987 Q53H59 Q5TFJ4 Q6TLI0 Q76MJ8 Q86WX9,Deoxynucleotidyltransferase terminal-interacting protein 2,Estrogen receptor-binding protein;LPTS-interacting protein 2;Terminal deoxynucleotidyltransferase-interacting factor 2;, PF08698;, GO:0005694;GO:0005730;GO:0005654;GO:0003723;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:RNA binding;|Q5QJE6 Q12987 Q53H59 Q5TFJ4 Q6TLI0 Q76MJ8 Q86WX9,Deoxynucleotidyltransferase terminal-interacting protein 2,Estrogen receptor-binding protein;LPTS-interacting protein 2;Terminal deoxynucleotidyltransferase-interacting factor 2;, PF08698;, GO:0005694;GO:0005730;GO:0005654;GO:0003723;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:RNA binding;|Q5QJE6 Q12987 Q53H59 Q5TFJ4 Q6TLI0 Q76MJ8 Q86WX9,Deoxynucleotidyltransferase terminal-interacting protein 2,Estrogen receptor-binding protein;LPTS-interacting protein 2;Terminal deoxynucleotidyltransferase-interacting factor 2;, PF08698;, GO:0005694;GO:0005730;GO:0005654;GO:0003723;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:RNA binding; scaffold5 indexed_genome mRNA 46640708 46646268 . + . ID=transcript_1436;P48507 A8K334 D3DT45 M5A959 Q6FHC1 Q9NPX9 Q9NU74,Glutamate--cysteine ligase regulatory subunit,GCS light chain;Gamma-ECS regulatory subunit;Gamma-glutamylcysteine synthetase regulatory subunit;Glutamate--cysteine ligase modifier subunit;, PF00248;, GO:0005829;GO:0017109;GO:0047834;GO:0030234;GO:0004357;GO:0035226;GO:0044877;GO:0007568;GO:0008637;GO:0097746;GO:0044344;GO:0071372;GO:0071333;GO:0035729;GO:1990830;GO:0097069;GO:0006534;GO:0006536;GO:0006750;GO:0035733;GO:2001237;GO:0043524;GO:0035229;GO:0051900;GO:0014823;GO:0042493;GO:0044752;GO:0051409;GO:0007584;GO:0006979;, C:cytosol; C:glutamate-cysteine ligase complex;, F:D-threo-aldose 1-dehydrogenase activity; F:enzyme regulator activity; F:glutamate-cysteine ligase activity; F:glutamate-cysteine ligase catalytic subunit binding; F:protein-containing complex binding;, P:aging; P:apoptotic mitochondrial changes; P:blood vessel diameter maintenance; P:cellular response to fibroblast growth factor stimulus; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to glucose stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to thyroxine stimulus; P:cysteine metabolic process; P:glutamate metabolic process; P:glutathione biosynthetic process; P:hepatic stellate cell activation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:positive regulation of glutamate-cysteine ligase activity; P:regulation of mitochondrial depolarization; P:response to activity; P:response to drug; P:response to human chorionic gonadotropin; P:response to nitrosative stress; P:response to nutrient; P:response to oxidative stress; scaffold5 indexed_genome mRNA 46656059 46656650 . - . ID=transcript_1437;P48507 A8K334 D3DT45 M5A959 Q6FHC1 Q9NPX9 Q9NU74,Glutamate--cysteine ligase regulatory subunit,GCS light chain;Gamma-ECS regulatory subunit;Gamma-glutamylcysteine synthetase regulatory subunit;Glutamate--cysteine ligase modifier subunit;, PF00248;, GO:0005829;GO:0017109;GO:0047834;GO:0030234;GO:0004357;GO:0035226;GO:0044877;GO:0007568;GO:0008637;GO:0097746;GO:0044344;GO:0071372;GO:0071333;GO:0035729;GO:1990830;GO:0097069;GO:0006534;GO:0006536;GO:0006750;GO:0035733;GO:2001237;GO:0043524;GO:0035229;GO:0051900;GO:0014823;GO:0042493;GO:0044752;GO:0051409;GO:0007584;GO:0006979;, C:cytosol; C:glutamate-cysteine ligase complex;, F:D-threo-aldose 1-dehydrogenase activity; F:enzyme regulator activity; F:glutamate-cysteine ligase activity; F:glutamate-cysteine ligase catalytic subunit binding; F:protein-containing complex binding;, P:aging; P:apoptotic mitochondrial changes; P:blood vessel diameter maintenance; P:cellular response to fibroblast growth factor stimulus; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to glucose stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to thyroxine stimulus; P:cysteine metabolic process; P:glutamate metabolic process; P:glutathione biosynthetic process; P:hepatic stellate cell activation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:positive regulation of glutamate-cysteine ligase activity; P:regulation of mitochondrial depolarization; P:response to activity; P:response to drug; P:response to human chorionic gonadotropin; P:response to nitrosative stress; P:response to nutrient; P:response to oxidative stress; scaffold5 indexed_genome mRNA 46912958 46968190 . - . ID=transcript_1438;Q52LW3 O15463 Q59H86 Q5VYZ0 Q6NVX2 Q8TBI6,Rho GTPase-activating protein 29,PTPL1-associated RhoGAP protein 1;Rho-type GTPase-activating protein 29;, PF00130;PF00620;, GO:0005737;GO:0005829;GO:0032991;GO:0005096;GO:0046872;GO:0030165;GO:0090630;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:protein-containing complex;, F:GTPase activator activity; F:metal ion binding; F:PDZ domain binding;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q52LW3 O15463 Q59H86 Q5VYZ0 Q6NVX2 Q8TBI6,Rho GTPase-activating protein 29,PTPL1-associated RhoGAP protein 1;Rho-type GTPase-activating protein 29;, PF00130;PF00620;, GO:0005737;GO:0005829;GO:0032991;GO:0005096;GO:0046872;GO:0030165;GO:0090630;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:protein-containing complex;, F:GTPase activator activity; F:metal ion binding; F:PDZ domain binding;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold5 indexed_genome mRNA 47184686 47260881 . + . ID=transcript_1439;P28288 D3DT46 Q15271 Q6NUN5 Q96DA3 Q9H529,ATP-binding cassette sub-family D member 3,70 kDa peroxisomal membrane protein;, PF06472;PF00005;, GO:0005829;GO:0016021;GO:0043231;GO:0016020;GO:0005739;GO:0005782;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:0042803;GO:0043621;GO:0006635;GO:0006633;GO:0006869;GO:0015910;GO:0007031;GO:0045046;GO:0042493;GO:0014070;GO:0042760;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:protein homodimerization activity; F:protein self-association;, P:fatty acid beta-oxidation; P:fatty acid biosynthetic process; P:lipid transport; P:long-chain fatty acid import into peroxisome; P:peroxisome organization; P:protein import into peroxisome membrane; P:response to drug; P:response to organic cyclic compound; P:very long-chain fatty acid catabolic process;|P28288 D3DT46 Q15271 Q6NUN5 Q96DA3 Q9H529,ATP-binding cassette sub-family D member 3,70 kDa peroxisomal membrane protein;, PF06472;PF00005;, GO:0005829;GO:0016021;GO:0043231;GO:0016020;GO:0005739;GO:0005782;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:0042803;GO:0043621;GO:0006635;GO:0006633;GO:0006869;GO:0015910;GO:0007031;GO:0045046;GO:0042493;GO:0014070;GO:0042760;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:protein homodimerization activity; F:protein self-association;, P:fatty acid beta-oxidation; P:fatty acid biosynthetic process; P:lipid transport; P:long-chain fatty acid import into peroxisome; P:peroxisome organization; P:protein import into peroxisome membrane; P:response to drug; P:response to organic cyclic compound; P:very long-chain fatty acid catabolic process; scaffold5 indexed_genome mRNA 47276568 47288020 . - . ID=transcript_1440;P13726 D3DT47 Q6FHG2 Q86WH4,Tissue factor,Coagulation factor III;Thromboplastin;, PF09294;PF01108;, GO:0009986;GO:0062023;GO:0005615;GO:0016021;GO:0031233;GO:0005886;GO:1905286;GO:0004896;GO:0005543;GO:0002020;GO:0002543;GO:0006919;GO:0002541;GO:0007596;GO:0007598;GO:0019221;GO:2000264;GO:0045766;GO:0030335;GO:0001938;GO:0010628;GO:0032757;GO:0010641;GO:0050927;GO:0051897;GO:0016485;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular space; C:integral component of membrane; C:intrinsic component of external side of plasma membrane; C:plasma membrane; C:serine-type peptidase complex;, F:cytokine receptor activity; F:phospholipid binding; F:protease binding;, P:activation of blood coagulation via clotting cascade; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of plasma proteins involved in acute inflammatory response; P:blood coagulation; P:blood coagulation, extrinsic pathway; P:cytokine-mediated signaling pathway; P:negative regulation of blood coagulation, extrinsic pathway; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of interleukin-8 production; P:positive regulation of platelet-derived growth factor receptor signaling pathway; P:positive regulation of positive chemotaxis; P:positive regulation of protein kinase B signaling; P:protein processing;|P13726 D3DT47 Q6FHG2 Q86WH4,Tissue factor,Coagulation factor III;Thromboplastin;, PF09294;PF01108;, GO:0009986;GO:0062023;GO:0005615;GO:0016021;GO:0031233;GO:0005886;GO:1905286;GO:0004896;GO:0005543;GO:0002020;GO:0002543;GO:0006919;GO:0002541;GO:0007596;GO:0007598;GO:0019221;GO:2000264;GO:0045766;GO:0030335;GO:0001938;GO:0010628;GO:0032757;GO:0010641;GO:0050927;GO:0051897;GO:0016485;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular space; C:integral component of membrane; C:intrinsic component of external side of plasma membrane; C:plasma membrane; C:serine-type peptidase complex;, F:cytokine receptor activity; F:phospholipid binding; F:protease binding;, P:activation of blood coagulation via clotting cascade; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of plasma proteins involved in acute inflammatory response; P:blood coagulation; P:blood coagulation, extrinsic pathway; P:cytokine-mediated signaling pathway; P:negative regulation of blood coagulation, extrinsic pathway; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of interleukin-8 production; P:positive regulation of platelet-derived growth factor receptor signaling pathway; P:positive regulation of positive chemotaxis; P:positive regulation of protein kinase B signaling; P:protein processing;|P13726 D3DT47 Q6FHG2 Q86WH4,Tissue factor,Coagulation factor III;Thromboplastin;, PF09294;PF01108;, GO:0009986;GO:0062023;GO:0005615;GO:0016021;GO:0031233;GO:0005886;GO:1905286;GO:0004896;GO:0005543;GO:0002020;GO:0002543;GO:0006919;GO:0002541;GO:0007596;GO:0007598;GO:0019221;GO:2000264;GO:0045766;GO:0030335;GO:0001938;GO:0010628;GO:0032757;GO:0010641;GO:0050927;GO:0051897;GO:0016485;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular space; C:integral component of membrane; C:intrinsic component of external side of plasma membrane; C:plasma membrane; C:serine-type peptidase complex;, F:cytokine receptor activity; F:phospholipid binding; F:protease binding;, P:activation of blood coagulation via clotting cascade; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of plasma proteins involved in acute inflammatory response; P:blood coagulation; P:blood coagulation, extrinsic pathway; P:cytokine-mediated signaling pathway; P:negative regulation of blood coagulation, extrinsic pathway; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of interleukin-8 production; P:positive regulation of platelet-derived growth factor receptor signaling pathway; P:positive regulation of positive chemotaxis; P:positive regulation of protein kinase B signaling; P:protein processing;|P13726 D3DT47 Q6FHG2 Q86WH4,Tissue factor,Coagulation factor III;Thromboplastin;, PF09294;PF01108;, GO:0009986;GO:0062023;GO:0005615;GO:0016021;GO:0031233;GO:0005886;GO:1905286;GO:0004896;GO:0005543;GO:0002020;GO:0002543;GO:0006919;GO:0002541;GO:0007596;GO:0007598;GO:0019221;GO:2000264;GO:0045766;GO:0030335;GO:0001938;GO:0010628;GO:0032757;GO:0010641;GO:0050927;GO:0051897;GO:0016485;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular space; C:integral component of membrane; C:intrinsic component of external side of plasma membrane; C:plasma membrane; C:serine-type peptidase complex;, F:cytokine receptor activity; F:phospholipid binding; F:protease binding;, P:activation of blood coagulation via clotting cascade; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of plasma proteins involved in acute inflammatory response; P:blood coagulation; P:blood coagulation, extrinsic pathway; P:cytokine-mediated signaling pathway; P:negative regulation of blood coagulation, extrinsic pathway; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of interleukin-8 production; P:positive regulation of platelet-derived growth factor receptor signaling pathway; P:positive regulation of positive chemotaxis; P:positive regulation of protein kinase B signaling; P:protein processing; scaffold5 indexed_genome mRNA 47541657 47623423 . + . ID=transcript_1441;Q8N4M1 B4DVY4 B4E1M4 B7ZA08 E9PJH2 E9PJY8 Q6UWT1 Q7Z6C5 Q9BWY7,Choline transporter-like protein 3,Solute carrier family 44 member 3;, PF04515;, GO:0016021;GO:0016020;GO:0005886;GO:0022857;GO:0006656;GO:0055085;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:transmembrane transporter activity;, P:phosphatidylcholine biosynthetic process; P:transmembrane transport; scaffold5 indexed_genome mRNA 47624832 47653308 . - . ID=transcript_1442;Q15417 B4DFK6 B4DP09 F8WA86 Q6FHA7,Calponin-3,Calponin, acidic isoform;, PF00402;PF00307;, GO:0015629;GO:0005912;GO:0005829;GO:0043197;GO:0005925;GO:0043025;GO:0014069;GO:0003779;GO:0098641;GO:0005516;GO:0008017;GO:0031032;GO:0030855;GO:0032780;, C:actin cytoskeleton; C:adherens junction; C:cytosol; C:dendritic spine; C:focal adhesion; C:neuronal cell body; C:postsynaptic density;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:calmodulin binding; F:microtubule binding;, P:actomyosin structure organization; P:epithelial cell differentiation; P:negative regulation of ATPase activity;|Q15417 B4DFK6 B4DP09 F8WA86 Q6FHA7,Calponin-3,Calponin, acidic isoform;, PF00402;PF00307;, GO:0015629;GO:0005912;GO:0005829;GO:0043197;GO:0005925;GO:0043025;GO:0014069;GO:0003779;GO:0098641;GO:0005516;GO:0008017;GO:0031032;GO:0030855;GO:0032780;, C:actin cytoskeleton; C:adherens junction; C:cytosol; C:dendritic spine; C:focal adhesion; C:neuronal cell body; C:postsynaptic density;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:calmodulin binding; F:microtubule binding;, P:actomyosin structure organization; P:epithelial cell differentiation; P:negative regulation of ATPase activity;|Q15417 B4DFK6 B4DP09 F8WA86 Q6FHA7,Calponin-3,Calponin, acidic isoform;, PF00402;PF00307;, GO:0015629;GO:0005912;GO:0005829;GO:0043197;GO:0005925;GO:0043025;GO:0014069;GO:0003779;GO:0098641;GO:0005516;GO:0008017;GO:0031032;GO:0030855;GO:0032780;, C:actin cytoskeleton; C:adherens junction; C:cytosol; C:dendritic spine; C:focal adhesion; C:neuronal cell body; C:postsynaptic density;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:calmodulin binding; F:microtubule binding;, P:actomyosin structure organization; P:epithelial cell differentiation; P:negative regulation of ATPase activity;|Q15417 B4DFK6 B4DP09 F8WA86 Q6FHA7,Calponin-3,Calponin, acidic isoform;, PF00402;PF00307;, GO:0015629;GO:0005912;GO:0005829;GO:0043197;GO:0005925;GO:0043025;GO:0014069;GO:0003779;GO:0098641;GO:0005516;GO:0008017;GO:0031032;GO:0030855;GO:0032780;, C:actin cytoskeleton; C:adherens junction; C:cytosol; C:dendritic spine; C:focal adhesion; C:neuronal cell body; C:postsynaptic density;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:calmodulin binding; F:microtubule binding;, P:actomyosin structure organization; P:epithelial cell differentiation; P:negative regulation of ATPase activity; scaffold5 indexed_genome mRNA 47713621 47775515 . - . ID=transcript_1443;Q96F25 A8K030,UDP-N-acetylglucosamine transferase subunit ALG14 homolog,, PF08660;, GO:0005789;GO:0016021;GO:0031965;GO:0043541;GO:0006488;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane; C:UDP-N-acetylglucosamine transferase complex;, , P:dolichol-linked oligosaccharide biosynthetic process; scaffold5 indexed_genome mRNA 47879964 47922561 . + . ID=transcript_1444;Q96MV1 B2RPI2 D3DT48,TLC domain-containing protein 4 {ECO:0000305},Transmembrane protein 56;, PF03798;, GO:0005783;GO:0016021;GO:0055088;, C:endoplasmic reticulum; C:integral component of membrane;, , P:lipid homeostasis;|Q96MV1 B2RPI2 D3DT48,TLC domain-containing protein 4 {ECO:0000305},Transmembrane protein 56;, PF03798;, GO:0005783;GO:0016021;GO:0055088;, C:endoplasmic reticulum; C:integral component of membrane;, , P:lipid homeostasis;|Q96MV1 B2RPI2 D3DT48,TLC domain-containing protein 4 {ECO:0000305},Transmembrane protein 56;, PF03798;, GO:0005783;GO:0016021;GO:0055088;, C:endoplasmic reticulum; C:integral component of membrane;, , P:lipid homeostasis; scaffold5 indexed_genome mRNA 47969881 47974786 . + . ID=transcript_1445;Q9Y3V2 A6NP44 A8K9F0 C9J9L7 C9JI45 Q08AJ7 Q6FID3 Q9BX35,RWD domain-containing protein 3,RWD domain-containing sumoylation enhancer;, PF05773;, GO:0005737;GO:0005634;GO:0032088;GO:1902073;GO:0033235;, C:cytoplasm; C:nucleus;, , P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of hypoxia-inducible factor-1alpha signaling pathway; P:positive regulation of protein sumoylation;|Q9Y3V2 A6NP44 A8K9F0 C9J9L7 C9JI45 Q08AJ7 Q6FID3 Q9BX35,RWD domain-containing protein 3,RWD domain-containing sumoylation enhancer;, PF05773;, GO:0005737;GO:0005634;GO:0032088;GO:1902073;GO:0033235;, C:cytoplasm; C:nucleus;, , P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of hypoxia-inducible factor-1alpha signaling pathway; P:positive regulation of protein sumoylation;|Q9Y3V2 A6NP44 A8K9F0 C9J9L7 C9JI45 Q08AJ7 Q6FID3 Q9BX35,RWD domain-containing protein 3,RWD domain-containing sumoylation enhancer;, PF05773;, GO:0005737;GO:0005634;GO:0032088;GO:1902073;GO:0033235;, C:cytoplasm; C:nucleus;, , P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of hypoxia-inducible factor-1alpha signaling pathway; P:positive regulation of protein sumoylation; scaffold5 indexed_genome mRNA 48511939 48512483 . + . ID=transcript_1446;Q9UQF0 B2RPD4 O95244 O95245 Q8NHY7 Q9NRZ2 Q9NZG3,Syncytin-1,Endogenous retrovirus group W member 1;Env-W;Envelope polyprotein gPr73;Enverin;HERV-7q Envelope protein;HERV-W envelope protein;HERV-W_7q21.2 provirus ancestral Env polyprotein;Syncytin;, PF00429;, GO:0016021;GO:0005886;GO:0009653;GO:0007520;GO:0006949;GO:0000768;, C:integral component of membrane; C:plasma membrane;, , P:anatomical structure morphogenesis; P:myoblast fusion; P:syncytium formation; P:syncytium formation by plasma membrane fusion; scaffold5 indexed_genome mRNA 49332355 49388164 . + . ID=transcript_1447;Q9UKA9 Q8N0Z1 Q8N160 Q8NFB0 Q8NFB1 Q969N9 Q96Q76,Polypyrimidine tract-binding protein 2,Neural polypyrimidine tract-binding protein;Neurally-enriched homolog of PTB;PTB-like protein;, PF00076;PF11835;, GO:0030426;GO:0043025;GO:0005634;GO:0005681;GO:0003729;GO:0003723;GO:0021549;GO:0006376;GO:0033119;GO:2000177;GO:0043484;GO:0021510;, C:growth cone; C:neuronal cell body; C:nucleus; C:spliceosomal complex;, F:mRNA binding; F:RNA binding;, P:cerebellum development; P:mRNA splice site selection; P:negative regulation of RNA splicing; P:regulation of neural precursor cell proliferation; P:regulation of RNA splicing; P:spinal cord development;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9UKA9 Q8N0Z1 Q8N160 Q8NFB0 Q8NFB1 Q969N9 Q96Q76,Polypyrimidine tract-binding protein 2,Neural polypyrimidine tract-binding protein;Neurally-enriched homolog of PTB;PTB-like protein;, PF00076;PF11835;, GO:0030426;GO:0043025;GO:0005634;GO:0005681;GO:0003729;GO:0003723;GO:0021549;GO:0006376;GO:0033119;GO:2000177;GO:0043484;GO:0021510;, C:growth cone; C:neuronal cell body; C:nucleus; C:spliceosomal complex;, F:mRNA binding; F:RNA binding;, P:cerebellum development; P:mRNA splice site selection; P:negative regulation of RNA splicing; P:regulation of neural precursor cell proliferation; P:regulation of RNA splicing; P:spinal cord development; scaffold5 indexed_genome mRNA 49397090 49413725 . + . ID=transcript_1448;Q9UKA9 Q8N0Z1 Q8N160 Q8NFB0 Q8NFB1 Q969N9 Q96Q76,Polypyrimidine tract-binding protein 2,Neural polypyrimidine tract-binding protein;Neurally-enriched homolog of PTB;PTB-like protein;, PF00076;PF11835;, GO:0030426;GO:0043025;GO:0005634;GO:0005681;GO:0003729;GO:0003723;GO:0021549;GO:0006376;GO:0033119;GO:2000177;GO:0043484;GO:0021510;, C:growth cone; C:neuronal cell body; C:nucleus; C:spliceosomal complex;, F:mRNA binding; F:RNA binding;, P:cerebellum development; P:mRNA splice site selection; P:negative regulation of RNA splicing; P:regulation of neural precursor cell proliferation; P:regulation of RNA splicing; P:spinal cord development;|Q9UKA9 Q8N0Z1 Q8N160 Q8NFB0 Q8NFB1 Q969N9 Q96Q76,Polypyrimidine tract-binding protein 2,Neural polypyrimidine tract-binding protein;Neurally-enriched homolog of PTB;PTB-like protein;, PF00076;PF11835;, GO:0030426;GO:0043025;GO:0005634;GO:0005681;GO:0003729;GO:0003723;GO:0021549;GO:0006376;GO:0033119;GO:2000177;GO:0043484;GO:0021510;, C:growth cone; C:neuronal cell body; C:nucleus; C:spliceosomal complex;, F:mRNA binding; F:RNA binding;, P:cerebellum development; P:mRNA splice site selection; P:negative regulation of RNA splicing; P:regulation of neural precursor cell proliferation; P:regulation of RNA splicing; P:spinal cord development;|Q9UKA9 Q8N0Z1 Q8N160 Q8NFB0 Q8NFB1 Q969N9 Q96Q76,Polypyrimidine tract-binding protein 2,Neural polypyrimidine tract-binding protein;Neurally-enriched homolog of PTB;PTB-like protein;, PF00076;PF11835;, GO:0030426;GO:0043025;GO:0005634;GO:0005681;GO:0003729;GO:0003723;GO:0021549;GO:0006376;GO:0033119;GO:2000177;GO:0043484;GO:0021510;, C:growth cone; C:neuronal cell body; C:nucleus; C:spliceosomal complex;, F:mRNA binding; F:RNA binding;, P:cerebellum development; P:mRNA splice site selection; P:negative regulation of RNA splicing; P:regulation of neural precursor cell proliferation; P:regulation of RNA splicing; P:spinal cord development;|Q9UKA9 Q8N0Z1 Q8N160 Q8NFB0 Q8NFB1 Q969N9 Q96Q76,Polypyrimidine tract-binding protein 2,Neural polypyrimidine tract-binding protein;Neurally-enriched homolog of PTB;PTB-like protein;, PF00076;PF11835;, GO:0030426;GO:0043025;GO:0005634;GO:0005681;GO:0003729;GO:0003723;GO:0021549;GO:0006376;GO:0033119;GO:2000177;GO:0043484;GO:0021510;, C:growth cone; C:neuronal cell body; C:nucleus; C:spliceosomal complex;, F:mRNA binding; F:RNA binding;, P:cerebellum development; P:mRNA splice site selection; P:negative regulation of RNA splicing; P:regulation of neural precursor cell proliferation; P:regulation of RNA splicing; P:spinal cord development; scaffold5 indexed_genome mRNA 49691716 50584644 . - . ID=transcript_1449;Q32NB0 Q96HL6 Q96TH1,Dihydropyrimidine dehydrogenase [NADP(+)],Dihydrothymine dehydrogenase;Dihydrouracil dehydrogenase;, PF01180;PF14691;PF07992;, GO:0005737;GO:0005829;GO:0051539;GO:0017113;GO:0050660;GO:0051536;GO:0046872;GO:0050661;GO:0042803;GO:0002058;GO:0019483;GO:0006248;GO:0006249;GO:0046079;GO:0006145;GO:0006208;GO:0046135;GO:0006214;GO:0006210;GO:0046050;GO:0006212;, C:cytoplasm; C:cytosol;, F:4 iron, 4 sulfur cluster binding; F:dihydropyrimidine dehydrogenase (NADP+) activity; F:flavin adenine dinucleotide binding; F:iron-sulfur cluster binding; F:metal ion binding; F:NADP binding; F:protein homodimerization activity; F:uracil binding;, P:beta-alanine biosynthetic process; P:CMP catabolic process; P:dCMP catabolic process; P:dUMP catabolic process; P:purine nucleobase catabolic process; P:pyrimidine nucleobase catabolic process; P:pyrimidine nucleoside catabolic process; P:thymidine catabolic process; P:thymine catabolic process; P:UMP catabolic process; P:uracil catabolic process; scaffold5 indexed_genome mRNA 51321132 51423437 . + . ID=transcript_1450;Q9Y3Z7,Sorting nexin-7,, PF00787;, GO:0030659;GO:0035091;GO:0015031;, C:cytoplasmic vesicle membrane;, F:phosphatidylinositol binding;, P:protein transport;|Q9Y3Z7,Sorting nexin-7,, PF00787;, GO:0030659;GO:0035091;GO:0015031;, C:cytoplasmic vesicle membrane;, F:phosphatidylinositol binding;, P:protein transport;|Q9Y3Z7,Sorting nexin-7,, PF00787;, GO:0030659;GO:0035091;GO:0015031;, C:cytoplasmic vesicle membrane;, F:phosphatidylinositol binding;, P:protein transport; scaffold5 indexed_genome mRNA 51556022 51634885 . - . ID=transcript_1451;Q32ZL2 A8MPX4 B7UCH3 Q32ZD0 Q3ZCU7,Phospholipid phosphatase-related protein type 5 {ECO:0000305},Lipid phosphate phosphatase-related protein type 5 {ECO:0000305};Phosphatidic acid phosphatase type 2d {ECO:0000305|PubMed:16010976};Plasticity-related gene 5 protein {ECO:0000305|PubMed:20032306};, PF01569;, GO:0005887;GO:0005886;GO:0042577;GO:0008195;GO:0046839;GO:0006644;GO:0051491;GO:0010976;GO:0007165;, C:integral component of plasma membrane; C:plasma membrane;, F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:positive regulation of filopodium assembly; P:positive regulation of neuron projection development; P:signal transduction; scaffold5 indexed_genome mRNA 51953785 51954840 . - . ID=transcript_1452;Q7Z2D5 E7EPS1 O75043 Q5T9R9 Q86XQ5 Q8N3F1 Q96MP0,2-lysophosphatidate phosphatase PLPPR4 {ECO:0000250|UniProtKB:Q7TMB7},Brain-specific phosphatidic acid phosphatase-like protein 1 {ECO:0000303|Ref.7};Lipid phosphate phosphatase-related protein type 4 {ECO:0000303|Ref.2};Phospholipid phosphatase-related protein type 4 {ECO:0000305};Plasticity-related gene 1 protein {ECO:0000305|PubMed:12730698};, PF01569;, GO:0098978;GO:0005887;GO:0099061;GO:0005886;GO:0042577;GO:0008195;GO:0007409;GO:0007186;GO:0048839;GO:0046839;GO:0006644;GO:0007165;, C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:axonogenesis; P:G protein-coupled receptor signaling pathway; P:inner ear development; P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:signal transduction; scaffold5 indexed_genome mRNA 51954981 51955955 . + . ID=transcript_1453;Q7Z2D5 E7EPS1 O75043 Q5T9R9 Q86XQ5 Q8N3F1 Q96MP0,2-lysophosphatidate phosphatase PLPPR4 {ECO:0000250|UniProtKB:Q7TMB7},Brain-specific phosphatidic acid phosphatase-like protein 1 {ECO:0000303|Ref.7};Lipid phosphate phosphatase-related protein type 4 {ECO:0000303|Ref.2};Phospholipid phosphatase-related protein type 4 {ECO:0000305};Plasticity-related gene 1 protein {ECO:0000305|PubMed:12730698};, PF01569;, GO:0098978;GO:0005887;GO:0099061;GO:0005886;GO:0042577;GO:0008195;GO:0007409;GO:0007186;GO:0048839;GO:0046839;GO:0006644;GO:0007165;, C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:axonogenesis; P:G protein-coupled receptor signaling pathway; P:inner ear development; P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:signal transduction; scaffold5 indexed_genome mRNA 52260979 52323742 . + . ID=transcript_1454;Q9NP74 Q9H7E6 Q9NPM5 Q9NPM6 Q9NPS0,Palmdelphin,Paralemmin-like protein;, PF03285;, GO:0005737;GO:0043197;GO:0016020;GO:0008360;, C:cytoplasm; C:dendritic spine; C:membrane;, , P:regulation of cell shape;|Q9NP74 Q9H7E6 Q9NPM5 Q9NPM6 Q9NPS0,Palmdelphin,Paralemmin-like protein;, PF03285;, GO:0005737;GO:0043197;GO:0016020;GO:0008360;, C:cytoplasm; C:dendritic spine; C:membrane;, , P:regulation of cell shape; scaffold5 indexed_genome mRNA 52333012 52373683 . - . ID=transcript_1455;Q6ZNA5 A6NLN7,Ferric-chelate reductase 1,Stromal cell-derived receptor 2;, PF03351;PF02014;, GO:0016021;GO:0046872;GO:0016722;GO:0006879;, C:integral component of membrane;, F:metal ion binding; F:oxidoreductase activity, oxidizing metal ions;, P:cellular iron ion homeostasis; scaffold5 indexed_genome mRNA 52426686 52505718 . + . ID=transcript_1456;P35573 A6NCX7 A6NEK2 D3DT51 P78354 P78544 Q59H92 Q6AZ90 Q9UF08,Glycogen debranching enzyme,Glycogen debrancher;, PF06202;PF14701;PF14702;PF14699;, GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0016234;GO:0043033;GO:0005634;GO:0016529;GO:0034774;GO:0004134;GO:0004135;GO:0102500;GO:0004133;GO:0030247;GO:0031593;GO:0005978;GO:0005980;GO:0043312;GO:0051384;GO:0007584;, C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:inclusion body; C:isoamylase complex; C:nucleus; C:sarcoplasmic reticulum; C:secretory granule lumen;, F:4-alpha-glucanotransferase activity; F:amylo-alpha-1,6-glucosidase activity; F:beta-maltose 4-alpha-glucanotransferase activity; F:glycogen debranching enzyme activity; F:polysaccharide binding; F:polyubiquitin modification-dependent protein binding;, P:glycogen biosynthetic process; P:glycogen catabolic process; P:neutrophil degranulation; P:response to glucocorticoid; P:response to nutrient;|P35573 A6NCX7 A6NEK2 D3DT51 P78354 P78544 Q59H92 Q6AZ90 Q9UF08,Glycogen debranching enzyme,Glycogen debrancher;, PF06202;PF14701;PF14702;PF14699;, GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0016234;GO:0043033;GO:0005634;GO:0016529;GO:0034774;GO:0004134;GO:0004135;GO:0102500;GO:0004133;GO:0030247;GO:0031593;GO:0005978;GO:0005980;GO:0043312;GO:0051384;GO:0007584;, C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:inclusion body; C:isoamylase complex; C:nucleus; C:sarcoplasmic reticulum; C:secretory granule lumen;, F:4-alpha-glucanotransferase activity; F:amylo-alpha-1,6-glucosidase activity; F:beta-maltose 4-alpha-glucanotransferase activity; F:glycogen debranching enzyme activity; F:polysaccharide binding; F:polyubiquitin modification-dependent protein binding;, P:glycogen biosynthetic process; P:glycogen catabolic process; P:neutrophil degranulation; P:response to glucocorticoid; P:response to nutrient; scaffold5 indexed_genome mRNA 52556147 52595817 . + . ID=transcript_1457;Q9Y2D2 A8K3F8 D3DT54 Q68CR2 Q9BSB7,UDP-N-acetylglucosamine transporter,Golgi UDP-GlcNAc transporter;Solute carrier family 35 member A3;, PF04142;, GO:0005794;GO:0000139;GO:0030173;GO:0005459;GO:0005462;GO:0008643;GO:0006047;GO:1990569;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane;, F:UDP-galactose transmembrane transporter activity; F:UDP-N-acetylglucosamine transmembrane transporter activity;, P:carbohydrate transport; P:UDP-N-acetylglucosamine metabolic process; P:UDP-N-acetylglucosamine transmembrane transport;|Q9Y2D2 A8K3F8 D3DT54 Q68CR2 Q9BSB7,UDP-N-acetylglucosamine transporter,Golgi UDP-GlcNAc transporter;Solute carrier family 35 member A3;, PF04142;, GO:0005794;GO:0000139;GO:0030173;GO:0005459;GO:0005462;GO:0008643;GO:0006047;GO:1990569;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane;, F:UDP-galactose transmembrane transporter activity; F:UDP-N-acetylglucosamine transmembrane transporter activity;, P:carbohydrate transport; P:UDP-N-acetylglucosamine metabolic process; P:UDP-N-acetylglucosamine transmembrane transport; scaffold5 indexed_genome mRNA 52639622 52640956 . + . ID=transcript_1458;Q96MC6 Q6P2N7 Q8N8K2 Q8NBV3 Q96NY0 Q9NT25,Hippocampus abundant transcript 1 protein {ECO:0000312|HGNC:HGNC:23363},Major facilitator superfamily domain-containing 14A {ECO:0000312|HGNC:HGNC:23363};Putative tetracycline transporter-like protein;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold5 indexed_genome mRNA 52648708 52654682 . + . ID=transcript_1459;Q96MC6 Q6P2N7 Q8N8K2 Q8NBV3 Q96NY0 Q9NT25,Hippocampus abundant transcript 1 protein {ECO:0000312|HGNC:HGNC:23363},Major facilitator superfamily domain-containing 14A {ECO:0000312|HGNC:HGNC:23363};Putative tetracycline transporter-like protein;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q96MC6 Q6P2N7 Q8N8K2 Q8NBV3 Q96NY0 Q9NT25,Hippocampus abundant transcript 1 protein {ECO:0000312|HGNC:HGNC:23363},Major facilitator superfamily domain-containing 14A {ECO:0000312|HGNC:HGNC:23363};Putative tetracycline transporter-like protein;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold5 indexed_genome mRNA 52654683 52666779 . - . ID=transcript_1460;Q6UVJ0 D3DT55 Q8N3K0,Spindle assembly abnormal protein 6 homolog {ECO:0000305},, PF16531;PF18594;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0098536;GO:0007099;GO:0051298;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:deuterosome;, , P:centriole replication; P:centrosome duplication;|Q6UVJ0 D3DT55 Q8N3K0,Spindle assembly abnormal protein 6 homolog {ECO:0000305},, PF16531;PF18594;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0098536;GO:0007099;GO:0051298;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:deuterosome;, , P:centriole replication; P:centrosome duplication;|Q6UVJ0 D3DT55 Q8N3K0,Spindle assembly abnormal protein 6 homolog {ECO:0000305},, PF16531;PF18594;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0098536;GO:0007099;GO:0051298;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:deuterosome;, , P:centriole replication; P:centrosome duplication; scaffold5 indexed_genome mRNA 52667922 52692643 . - . ID=transcript_1461;Q6UVJ0 D3DT55 Q8N3K0,Spindle assembly abnormal protein 6 homolog {ECO:0000305},, PF16531;PF18594;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0098536;GO:0007099;GO:0051298;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:deuterosome;, , P:centriole replication; P:centrosome duplication;|Q6UVJ0 D3DT55 Q8N3K0,Spindle assembly abnormal protein 6 homolog {ECO:0000305},, PF16531;PF18594;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0098536;GO:0007099;GO:0051298;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:deuterosome;, , P:centriole replication; P:centrosome duplication; scaffold5 indexed_genome mRNA 52692757 52696255 . + . ID=transcript_1462;Q9NUP7 Q5VVL0 Q9NW65,tRNA:m(4)X modification enzyme TRM13 homolog,Coiled-coil domain-containing protein 76;, PF05206;PF11722;PF05253;, GO:0046872;GO:0106050;GO:0008175;GO:0030488;, , F:metal ion binding; F:tRNA 2'-O-methyltransferase activity; F:tRNA methyltransferase activity;, P:tRNA methylation; scaffold5 indexed_genome mRNA 52700385 52701321 . + . ID=transcript_1463;Q9NUP7 Q5VVL0 Q9NW65,tRNA:m(4)X modification enzyme TRM13 homolog,Coiled-coil domain-containing protein 76;, PF05206;PF11722;PF05253;, GO:0046872;GO:0106050;GO:0008175;GO:0030488;, , F:metal ion binding; F:tRNA 2'-O-methyltransferase activity; F:tRNA methyltransferase activity;, P:tRNA methylation; scaffold5 indexed_genome mRNA 52709154 52732177 . - . ID=transcript_1464;Q9NUP7 Q5VVL0 Q9NW65,tRNA:m(4)X modification enzyme TRM13 homolog,Coiled-coil domain-containing protein 76;, PF05206;PF11722;PF05253;, GO:0046872;GO:0106050;GO:0008175;GO:0030488;, , F:metal ion binding; F:tRNA 2'-O-methyltransferase activity; F:tRNA methyltransferase activity;, P:tRNA methylation;|Q9NUP7 Q5VVL0 Q9NW65,tRNA:m(4)X modification enzyme TRM13 homolog,Coiled-coil domain-containing protein 76;, PF05206;PF11722;PF05253;, GO:0046872;GO:0106050;GO:0008175;GO:0030488;, , F:metal ion binding; F:tRNA 2'-O-methyltransferase activity; F:tRNA methyltransferase activity;, P:tRNA methylation;|Q9NUP7 Q5VVL0 Q9NW65,tRNA:m(4)X modification enzyme TRM13 homolog,Coiled-coil domain-containing protein 76;, PF05206;PF11722;PF05253;, GO:0046872;GO:0106050;GO:0008175;GO:0030488;, , F:metal ion binding; F:tRNA 2'-O-methyltransferase activity; F:tRNA methyltransferase activity;, P:tRNA methylation;|Q96DD0 B3KUD2 D3DT56 Q5VVK7,Leucine-rich repeat-containing protein 39 {ECO:0000305},Myosin-interacting M-band-associated stress-responsive protein {ECO:0000303|PubMed:20847312};, PF13855;, GO:0005737;GO:0043231;GO:0031430;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:M band;, F:protein serine/threonine phosphatase activity;, P:signal transduction;|Q96DD0 B3KUD2 D3DT56 Q5VVK7,Leucine-rich repeat-containing protein 39 {ECO:0000305},Myosin-interacting M-band-associated stress-responsive protein {ECO:0000303|PubMed:20847312};, PF13855;, GO:0005737;GO:0043231;GO:0031430;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:M band;, F:protein serine/threonine phosphatase activity;, P:signal transduction;|Q96DD0 B3KUD2 D3DT56 Q5VVK7,Leucine-rich repeat-containing protein 39 {ECO:0000305},Myosin-interacting M-band-associated stress-responsive protein {ECO:0000303|PubMed:20847312};, PF13855;, GO:0005737;GO:0043231;GO:0031430;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:M band;, F:protein serine/threonine phosphatase activity;, P:signal transduction;|Q96DD0 B3KUD2 D3DT56 Q5VVK7,Leucine-rich repeat-containing protein 39 {ECO:0000305},Myosin-interacting M-band-associated stress-responsive protein {ECO:0000303|PubMed:20847312};, PF13855;, GO:0005737;GO:0043231;GO:0031430;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:M band;, F:protein serine/threonine phosphatase activity;, P:signal transduction;|Q96DD0 B3KUD2 D3DT56 Q5VVK7,Leucine-rich repeat-containing protein 39 {ECO:0000305},Myosin-interacting M-band-associated stress-responsive protein {ECO:0000303|PubMed:20847312};, PF13855;, GO:0005737;GO:0043231;GO:0031430;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:M band;, F:protein serine/threonine phosphatase activity;, P:signal transduction; scaffold5 indexed_genome mRNA 52754611 52760578 . - . ID=transcript_1465;P11182 B2R811 Q5VVL8,Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial,52 kDa mitochondrial autoantigen of primary biliary cirrhosis {ECO:0000303|PubMed:2908870};Branched chain 2-oxo-acid dehydrogenase complex component E2 {ECO:0000303|PubMed:7543435, ECO:0000303|PubMed:9141421};Branched-chain alpha-keto acid dehydrogenase complex component E2;Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex;Dihydrolipoamide branched chain transacylase;Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase;, PF00198;PF00364;PF02817;, GO:0005737;GO:0005829;GO:0015630;GO:0005947;GO:0005759;GO:0042645;GO:0005739;GO:0016407;GO:0043754;GO:0031405;GO:0031625;GO:0009083;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:acetyltransferase activity; F:dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity; F:lipoic acid binding; F:ubiquitin protein ligase binding;, P:branched-chain amino acid catabolic process;|P11182 B2R811 Q5VVL8,Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial,52 kDa mitochondrial autoantigen of primary biliary cirrhosis {ECO:0000303|PubMed:2908870};Branched chain 2-oxo-acid dehydrogenase complex component E2 {ECO:0000303|PubMed:7543435, ECO:0000303|PubMed:9141421};Branched-chain alpha-keto acid dehydrogenase complex component E2;Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex;Dihydrolipoamide branched chain transacylase;Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase;, PF00198;PF00364;PF02817;, GO:0005737;GO:0005829;GO:0015630;GO:0005947;GO:0005759;GO:0042645;GO:0005739;GO:0016407;GO:0043754;GO:0031405;GO:0031625;GO:0009083;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:acetyltransferase activity; F:dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity; F:lipoic acid binding; F:ubiquitin protein ligase binding;, P:branched-chain amino acid catabolic process; scaffold5 indexed_genome mRNA 52760594 52791179 . - . ID=transcript_1466;P11182 B2R811 Q5VVL8,Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial,52 kDa mitochondrial autoantigen of primary biliary cirrhosis {ECO:0000303|PubMed:2908870};Branched chain 2-oxo-acid dehydrogenase complex component E2 {ECO:0000303|PubMed:7543435, ECO:0000303|PubMed:9141421};Branched-chain alpha-keto acid dehydrogenase complex component E2;Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex;Dihydrolipoamide branched chain transacylase;Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase;, PF00198;PF00364;PF02817;, GO:0005737;GO:0005829;GO:0015630;GO:0005947;GO:0005759;GO:0042645;GO:0005739;GO:0016407;GO:0043754;GO:0031405;GO:0031625;GO:0009083;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:acetyltransferase activity; F:dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity; F:lipoic acid binding; F:ubiquitin protein ligase binding;, P:branched-chain amino acid catabolic process;|P11182 B2R811 Q5VVL8,Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial,52 kDa mitochondrial autoantigen of primary biliary cirrhosis {ECO:0000303|PubMed:2908870};Branched chain 2-oxo-acid dehydrogenase complex component E2 {ECO:0000303|PubMed:7543435, ECO:0000303|PubMed:9141421};Branched-chain alpha-keto acid dehydrogenase complex component E2;Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex;Dihydrolipoamide branched chain transacylase;Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase;, PF00198;PF00364;PF02817;, GO:0005737;GO:0005829;GO:0015630;GO:0005947;GO:0005759;GO:0042645;GO:0005739;GO:0016407;GO:0043754;GO:0031405;GO:0031625;GO:0009083;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:acetyltransferase activity; F:dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity; F:lipoic acid binding; F:ubiquitin protein ligase binding;, P:branched-chain amino acid catabolic process;|P11182 B2R811 Q5VVL8,Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial,52 kDa mitochondrial autoantigen of primary biliary cirrhosis {ECO:0000303|PubMed:2908870};Branched chain 2-oxo-acid dehydrogenase complex component E2 {ECO:0000303|PubMed:7543435, ECO:0000303|PubMed:9141421};Branched-chain alpha-keto acid dehydrogenase complex component E2;Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex;Dihydrolipoamide branched chain transacylase;Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase;, PF00198;PF00364;PF02817;, GO:0005737;GO:0005829;GO:0015630;GO:0005947;GO:0005759;GO:0042645;GO:0005739;GO:0016407;GO:0043754;GO:0031405;GO:0031625;GO:0009083;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:acetyltransferase activity; F:dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity; F:lipoic acid binding; F:ubiquitin protein ligase binding;, P:branched-chain amino acid catabolic process; scaffold5 indexed_genome mRNA 52795926 52826482 . + . ID=transcript_1467;O00442 Q5VVL5 Q5VVL6 Q96E99,RNA 3'-terminal phosphate cyclase,RNA terminal phosphate cyclase domain-containing protein 1;, PF01137;PF05189;, GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003963;GO:0006396;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA-3'-phosphate cyclase activity;, P:RNA processing;|O00442 Q5VVL5 Q5VVL6 Q96E99,RNA 3'-terminal phosphate cyclase,RNA terminal phosphate cyclase domain-containing protein 1;, PF01137;PF05189;, GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003963;GO:0006396;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA-3'-phosphate cyclase activity;, P:RNA processing;|O00442 Q5VVL5 Q5VVL6 Q96E99,RNA 3'-terminal phosphate cyclase,RNA terminal phosphate cyclase domain-containing protein 1;, PF01137;PF05189;, GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003963;GO:0006396;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA-3'-phosphate cyclase activity;, P:RNA processing;|O00442 Q5VVL5 Q5VVL6 Q96E99,RNA 3'-terminal phosphate cyclase,RNA terminal phosphate cyclase domain-containing protein 1;, PF01137;PF05189;, GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003963;GO:0006396;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA-3'-phosphate cyclase activity;, P:RNA processing;|O00442 Q5VVL5 Q5VVL6 Q96E99,RNA 3'-terminal phosphate cyclase,RNA terminal phosphate cyclase domain-containing protein 1;, PF01137;PF05189;, GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003963;GO:0006396;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA-3'-phosphate cyclase activity;, P:RNA processing; scaffold5 indexed_genome mRNA 52872337 53038002 . + . ID=transcript_1468;Q9UNH5 A6MA65 B1AQ14 B1AQ15 O43171 O60727 O60728 Q52LH9 Q8IXX0,Dual specificity protein phosphatase CDC14A,CDC14 cell division cycle 14 homolog A;, PF14671;, GO:0005813;GO:0005737;GO:0005829;GO:1902636;GO:0060091;GO:0072686;GO:0016604;GO:0005730;GO:0005654;GO:0000922;GO:0032426;GO:0106306;GO:0004722;GO:0106307;GO:0004725;GO:0008138;GO:0051301;GO:0060271;GO:0000226;GO:0000278;GO:0071850;GO:0032467;GO:0007096;GO:0007605;, C:centrosome; C:cytoplasm; C:cytosol; C:kinociliary basal body; C:kinocilium; C:mitotic spindle; C:nuclear body; C:nucleolus; C:nucleoplasm; C:spindle pole; C:stereocilium tip;, F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cell division; P:cilium assembly; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:mitotic cell cycle arrest; P:positive regulation of cytokinesis; P:regulation of exit from mitosis; P:sensory perception of sound; scaffold5 indexed_genome mRNA 53077220 53079353 . + . ID=transcript_1469;Q9GZN0 Q29S24 Q6VN48,Probable G-protein coupled receptor 88,Striatum-specific G-protein coupled receptor;, PF00001;, GO:0005929;GO:0005737;GO:0005887;GO:0005634;GO:0005886;GO:0008020;GO:0003774;GO:0071482;GO:0007186;GO:0007626;GO:0061743;GO:0050885;GO:0019228;GO:0007602;, C:cilium; C:cytoplasm; C:integral component of plasma membrane; C:nucleus; C:plasma membrane;, F:G protein-coupled photoreceptor activity; F:motor activity;, P:cellular response to light stimulus; P:G protein-coupled receptor signaling pathway; P:locomotory behavior; P:motor learning; P:neuromuscular process controlling balance; P:neuronal action potential; P:phototransduction; scaffold5 indexed_genome mRNA 53217678 53221391 . + . ID=transcript_1470;P19320 A8K6R7 B4DKS4 E9PDD1 Q6NUP8,Vascular cell adhesion protein 1,INCAM-100;, PF05790;PF07679;PF00047;, GO:0071065;GO:0045177;GO:0009986;GO:0005769;GO:0005783;GO:0009897;GO:0070062;GO:0005615;GO:0030175;GO:0005794;GO:0005887;GO:0005902;GO:0005886;GO:0002102;GO:0042383;GO:0050839;GO:0005178;GO:0008131;GO:0002526;GO:0007568;GO:0009308;GO:0030183;GO:0035584;GO:0060945;GO:0007155;GO:0060326;GO:0140039;GO:0007160;GO:1904646;GO:0071356;GO:0035924;GO:0002544;GO:0019221;GO:0030198;GO:0007157;GO:0034113;GO:0060384;GO:0060333;GO:0007159;GO:0050901;GO:0022614;GO:0042102;GO:0050776;GO:0045471;GO:0001666;GO:0010212;GO:0032496;GO:0035094;GO:0007584;GO:0010043;, C:alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex; C:apical part of cell; C:cell surface; C:early endosome; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:filopodium; C:Golgi apparatus; C:integral component of plasma membrane; C:microvillus; C:plasma membrane; C:podosome; C:sarcolemma;, F:cell adhesion molecule binding; F:integrin binding; F:primary amine oxidase activity;, P:acute inflammatory response; P:aging; P:amine metabolic process; P:B cell differentiation; P:calcium-mediated signaling using intracellular calcium source; P:cardiac neuron differentiation; P:cell adhesion; P:cell chemotaxis; P:cell-cell adhesion in response to extracellular stimulus; P:cell-matrix adhesion; P:cellular response to amyloid-beta; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:chronic inflammatory response; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:heterotypic cell-cell adhesion; P:innervation; P:interferon-gamma-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte tethering or rolling; P:membrane to membrane docking; P:positive regulation of T cell proliferation; P:regulation of immune response; P:response to ethanol; P:response to hypoxia; P:response to ionizing radiation; P:response to lipopolysaccharide; P:response to nicotine; P:response to nutrient; P:response to zinc ion; scaffold5 indexed_genome mRNA 53223150 53237683 . + . ID=transcript_1471;P19320 A8K6R7 B4DKS4 E9PDD1 Q6NUP8,Vascular cell adhesion protein 1,INCAM-100;, PF05790;PF07679;PF00047;, GO:0071065;GO:0045177;GO:0009986;GO:0005769;GO:0005783;GO:0009897;GO:0070062;GO:0005615;GO:0030175;GO:0005794;GO:0005887;GO:0005902;GO:0005886;GO:0002102;GO:0042383;GO:0050839;GO:0005178;GO:0008131;GO:0002526;GO:0007568;GO:0009308;GO:0030183;GO:0035584;GO:0060945;GO:0007155;GO:0060326;GO:0140039;GO:0007160;GO:1904646;GO:0071356;GO:0035924;GO:0002544;GO:0019221;GO:0030198;GO:0007157;GO:0034113;GO:0060384;GO:0060333;GO:0007159;GO:0050901;GO:0022614;GO:0042102;GO:0050776;GO:0045471;GO:0001666;GO:0010212;GO:0032496;GO:0035094;GO:0007584;GO:0010043;, C:alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex; C:apical part of cell; C:cell surface; C:early endosome; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:filopodium; C:Golgi apparatus; C:integral component of plasma membrane; C:microvillus; C:plasma membrane; C:podosome; C:sarcolemma;, F:cell adhesion molecule binding; F:integrin binding; F:primary amine oxidase activity;, P:acute inflammatory response; P:aging; P:amine metabolic process; P:B cell differentiation; P:calcium-mediated signaling using intracellular calcium source; P:cardiac neuron differentiation; P:cell adhesion; P:cell chemotaxis; P:cell-cell adhesion in response to extracellular stimulus; P:cell-matrix adhesion; P:cellular response to amyloid-beta; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:chronic inflammatory response; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:heterotypic cell-cell adhesion; P:innervation; P:interferon-gamma-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte tethering or rolling; P:membrane to membrane docking; P:positive regulation of T cell proliferation; P:regulation of immune response; P:response to ethanol; P:response to hypoxia; P:response to ionizing radiation; P:response to lipopolysaccharide; P:response to nicotine; P:response to nutrient; P:response to zinc ion; scaffold5 indexed_genome mRNA 53255615 53277773 . + . ID=transcript_1472;P19320 A8K6R7 B4DKS4 E9PDD1 Q6NUP8,Vascular cell adhesion protein 1,INCAM-100;, PF05790;PF07679;PF00047;, GO:0071065;GO:0045177;GO:0009986;GO:0005769;GO:0005783;GO:0009897;GO:0070062;GO:0005615;GO:0030175;GO:0005794;GO:0005887;GO:0005902;GO:0005886;GO:0002102;GO:0042383;GO:0050839;GO:0005178;GO:0008131;GO:0002526;GO:0007568;GO:0009308;GO:0030183;GO:0035584;GO:0060945;GO:0007155;GO:0060326;GO:0140039;GO:0007160;GO:1904646;GO:0071356;GO:0035924;GO:0002544;GO:0019221;GO:0030198;GO:0007157;GO:0034113;GO:0060384;GO:0060333;GO:0007159;GO:0050901;GO:0022614;GO:0042102;GO:0050776;GO:0045471;GO:0001666;GO:0010212;GO:0032496;GO:0035094;GO:0007584;GO:0010043;, C:alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex; C:apical part of cell; C:cell surface; C:early endosome; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:filopodium; C:Golgi apparatus; C:integral component of plasma membrane; C:microvillus; C:plasma membrane; C:podosome; C:sarcolemma;, F:cell adhesion molecule binding; F:integrin binding; F:primary amine oxidase activity;, P:acute inflammatory response; P:aging; P:amine metabolic process; P:B cell differentiation; P:calcium-mediated signaling using intracellular calcium source; P:cardiac neuron differentiation; P:cell adhesion; P:cell chemotaxis; P:cell-cell adhesion in response to extracellular stimulus; P:cell-matrix adhesion; P:cellular response to amyloid-beta; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:chronic inflammatory response; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:heterotypic cell-cell adhesion; P:innervation; P:interferon-gamma-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte tethering or rolling; P:membrane to membrane docking; P:positive regulation of T cell proliferation; P:regulation of immune response; P:response to ethanol; P:response to hypoxia; P:response to ionizing radiation; P:response to lipopolysaccharide; P:response to nicotine; P:response to nutrient; P:response to zinc ion; scaffold5 indexed_genome mRNA 53393128 53411907 . - . ID=transcript_1473;Q9UBQ6 B2R795 D3DT60,Exostosin-like 2,Alpha-1,4-N-acetylhexosaminyltransferase EXTL2;Alpha-GalNAcT EXTL2;EXT-related protein 2;Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;, PF09258;, GO:0005829;GO:0005783;GO:0005789;GO:0005576;GO:0016021;GO:0005654;GO:0035248;GO:0001888;GO:0047237;GO:0005539;GO:0030145;GO:0015012;GO:0036498;GO:0006044;GO:0006486;GO:0019276;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:integral component of membrane; C:nucleoplasm;, F:alpha-1,4-N-acetylgalactosaminyltransferase activity; F:glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:glycosaminoglycan binding; F:manganese ion binding;, P:heparan sulfate proteoglycan biosynthetic process; P:IRE1-mediated unfolded protein response; P:N-acetylglucosamine metabolic process; P:protein glycosylation; P:UDP-N-acetylgalactosamine metabolic process;|Q9UBQ6 B2R795 D3DT60,Exostosin-like 2,Alpha-1,4-N-acetylhexosaminyltransferase EXTL2;Alpha-GalNAcT EXTL2;EXT-related protein 2;Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;, PF09258;, GO:0005829;GO:0005783;GO:0005789;GO:0005576;GO:0016021;GO:0005654;GO:0035248;GO:0001888;GO:0047237;GO:0005539;GO:0030145;GO:0015012;GO:0036498;GO:0006044;GO:0006486;GO:0019276;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:integral component of membrane; C:nucleoplasm;, F:alpha-1,4-N-acetylgalactosaminyltransferase activity; F:glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:glycosaminoglycan binding; F:manganese ion binding;, P:heparan sulfate proteoglycan biosynthetic process; P:IRE1-mediated unfolded protein response; P:N-acetylglucosamine metabolic process; P:protein glycosylation; P:UDP-N-acetylgalactosamine metabolic process;|Q9UBQ6 B2R795 D3DT60,Exostosin-like 2,Alpha-1,4-N-acetylhexosaminyltransferase EXTL2;Alpha-GalNAcT EXTL2;EXT-related protein 2;Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;, PF09258;, GO:0005829;GO:0005783;GO:0005789;GO:0005576;GO:0016021;GO:0005654;GO:0035248;GO:0001888;GO:0047237;GO:0005539;GO:0030145;GO:0015012;GO:0036498;GO:0006044;GO:0006486;GO:0019276;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:integral component of membrane; C:nucleoplasm;, F:alpha-1,4-N-acetylgalactosaminyltransferase activity; F:glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:glycosaminoglycan binding; F:manganese ion binding;, P:heparan sulfate proteoglycan biosynthetic process; P:IRE1-mediated unfolded protein response; P:N-acetylglucosamine metabolic process; P:protein glycosylation; P:UDP-N-acetylgalactosamine metabolic process; scaffold5 indexed_genome mRNA 53412044 53499669 . + . ID=transcript_1474;Q8NEW0 B2R949 D3DT61 Q8TCH2,Zinc transporter 7,Solute carrier family 30 member 7;Znt-like transporter 2;, PF01545;, GO:0005737;GO:0031410;GO:0005794;GO:0016021;GO:0048471;GO:0031982;GO:0008324;GO:0032119;GO:0006829;, C:cytoplasm; C:cytoplasmic vesicle; C:Golgi apparatus; C:integral component of membrane; C:perinuclear region of cytoplasm; C:vesicle;, F:cation transmembrane transporter activity;, P:sequestering of zinc ion; P:zinc ion transport; scaffold5 indexed_genome mRNA 53518554 53547885 . - . ID=transcript_1475;Q9H2P9 A8JZY6 D3DT62 Q9P017 Q9P0I4 Q9Y319,Diphthine methyl ester synthase,Diphthamide biosynthesis methyltransferase;, PF00590;, GO:0005829;GO:0004164;GO:0032259;GO:0017183;, C:cytosol;, F:diphthine synthase activity;, P:methylation; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|Q9H2P9 A8JZY6 D3DT62 Q9P017 Q9P0I4 Q9Y319,Diphthine methyl ester synthase,Diphthamide biosynthesis methyltransferase;, PF00590;, GO:0005829;GO:0004164;GO:0032259;GO:0017183;, C:cytosol;, F:diphthine synthase activity;, P:methylation; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|Q9H2P9 A8JZY6 D3DT62 Q9P017 Q9P0I4 Q9Y319,Diphthine methyl ester synthase,Diphthamide biosynthesis methyltransferase;, PF00590;, GO:0005829;GO:0004164;GO:0032259;GO:0017183;, C:cytosol;, F:diphthine synthase activity;, P:methylation; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|Q9H2P9 A8JZY6 D3DT62 Q9P017 Q9P0I4 Q9Y319,Diphthine methyl ester synthase,Diphthamide biosynthesis methyltransferase;, PF00590;, GO:0005829;GO:0004164;GO:0032259;GO:0017183;, C:cytosol;, F:diphthine synthase activity;, P:methylation; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; scaffold5 indexed_genome mRNA 53760995 53765711 . + . ID=transcript_1476;P21453 D3DT66 Q9BYY4 Q9NYN8,Sphingosine 1-phosphate receptor 1,Endothelial differentiation G-protein coupled receptor 1;Sphingosine 1-phosphate receptor Edg-1;, PF00001;, GO:0005737;GO:0005768;GO:0009897;GO:0016021;GO:0043231;GO:0031226;GO:0045121;GO:0005654;GO:0005886;GO:0004930;GO:0001664;GO:0046625;GO:0038036;GO:0031532;GO:0007189;GO:0007193;GO:0001525;GO:0001955;GO:0007420;GO:0003245;GO:0007155;GO:0016477;GO:0006935;GO:0019221;GO:0045446;GO:0007186;GO:0061384;GO:0030032;GO:0030595;GO:0051497;GO:0030182;GO:0030335;GO:0051482;GO:0043547;GO:0050927;GO:0048661;GO:0045944;GO:0030500;GO:0045124;GO:0030155;GO:0019222;GO:0003376;GO:0072678;GO:0019226;, C:cytoplasm; C:endosome; C:external side of plasma membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of plasma membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:G protein-coupled receptor activity; F:G protein-coupled receptor binding; F:sphingolipid binding; F:sphingosine-1-phosphate receptor activity;, P:actin cytoskeleton reorganization; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:angiogenesis; P:blood vessel maturation; P:brain development; P:cardiac muscle tissue growth involved in heart morphogenesis; P:cell adhesion; P:cell migration; P:chemotaxis; P:cytokine-mediated signaling pathway; P:endothelial cell differentiation; P:G protein-coupled receptor signaling pathway; P:heart trabecula morphogenesis; P:lamellipodium assembly; P:leukocyte chemotaxis; P:negative regulation of stress fiber assembly; P:neuron differentiation; P:positive regulation of cell migration; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of GTPase activity; P:positive regulation of positive chemotaxis; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of bone mineralization; P:regulation of bone resorption; P:regulation of cell adhesion; P:regulation of metabolic process; P:sphingosine-1-phosphate receptor signaling pathway; P:T cell migration; P:transmission of nerve impulse; scaffold5 indexed_genome mRNA 54281965 54484340 . - . ID=transcript_1477;Q96PB4 Q96PB5 Q96PB6,Noelin-3,Olfactomedin-3;Optimedin;, PF12308;PF02191;, GO:0032281;GO:0005615;GO:0005794;GO:0045202;GO:0042462;, C:AMPA glutamate receptor complex; C:extracellular space; C:Golgi apparatus; C:synapse;, , P:eye photoreceptor cell development; scaffold5 indexed_genome mRNA 55195378 55378401 . - . ID=transcript_1478;P12107 B1ASK7 D3DT73 E9PCU0 Q14034 Q149N0 Q9UIT4 Q9UIT5 Q9UIT6,Collagen alpha-1(XI) chain,, PF01410;PF01391;PF02210;, GO:0005592;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0050840;GO:0005201;GO:1904399;GO:0008201;GO:0046872;GO:0030674;GO:0001502;GO:0002063;GO:0030199;GO:0050910;GO:0048704;GO:0035987;GO:0030198;GO:0042472;GO:0001503;GO:0006029;GO:0007605;GO:0035989;GO:0055010;GO:0007601;, C:collagen type XI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix binding; F:extracellular matrix structural constituent; F:heparan sulfate binding; F:heparin binding; F:metal ion binding; F:protein-macromolecule adaptor activity;, P:cartilage condensation; P:chondrocyte development; P:collagen fibril organization; P:detection of mechanical stimulus involved in sensory perception of sound; P:embryonic skeletal system morphogenesis; P:endodermal cell differentiation; P:extracellular matrix organization; P:inner ear morphogenesis; P:ossification; P:proteoglycan metabolic process; P:sensory perception of sound; P:tendon development; P:ventricular cardiac muscle tissue morphogenesis; P:visual perception; scaffold5 indexed_genome mRNA 55771041 55804200 . + . ID=transcript_1479;Q96LT9 A8K1C9 D3DT74 Q5TZ87 Q96FK7 Q96JI8 Q9NSU7 Q9NXX2,RNA-binding region-containing protein 3,RNA-binding motif protein 40;U11/U12 small nuclear ribonucleoprotein 65 kDa protein;, PF00076;, GO:0005654;GO:0005634;GO:0005689;GO:0097157;GO:0030626;GO:0000398;GO:0008380;, C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex;, F:pre-mRNA intronic binding; F:U12 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA splicing;|Q96LT9 A8K1C9 D3DT74 Q5TZ87 Q96FK7 Q96JI8 Q9NSU7 Q9NXX2,RNA-binding region-containing protein 3,RNA-binding motif protein 40;U11/U12 small nuclear ribonucleoprotein 65 kDa protein;, PF00076;, GO:0005654;GO:0005634;GO:0005689;GO:0097157;GO:0030626;GO:0000398;GO:0008380;, C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex;, F:pre-mRNA intronic binding; F:U12 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA splicing;|Q96LT9 A8K1C9 D3DT74 Q5TZ87 Q96FK7 Q96JI8 Q9NSU7 Q9NXX2,RNA-binding region-containing protein 3,RNA-binding motif protein 40;U11/U12 small nuclear ribonucleoprotein 65 kDa protein;, PF00076;, GO:0005654;GO:0005634;GO:0005689;GO:0097157;GO:0030626;GO:0000398;GO:0008380;, C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex;, F:pre-mRNA intronic binding; F:U12 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA splicing;|Q96LT9 A8K1C9 D3DT74 Q5TZ87 Q96FK7 Q96JI8 Q9NSU7 Q9NXX2,RNA-binding region-containing protein 3,RNA-binding motif protein 40;U11/U12 small nuclear ribonucleoprotein 65 kDa protein;, PF00076;, GO:0005654;GO:0005634;GO:0005689;GO:0097157;GO:0030626;GO:0000398;GO:0008380;, C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex;, F:pre-mRNA intronic binding; F:U12 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; scaffold5 indexed_genome mRNA 55833362 55842761 . + . ID=transcript_1480;P19961 B3KTI1 B3KXB7 D3DT76 Q9UBH3,Alpha-amylase 2B,1,4-alpha-D-glucan glucanohydrolase 2B;Carcinoid alpha-amylase;, PF00128;PF02806;, GO:0070062;GO:0004556;GO:0103025;GO:0046872;GO:0005975;, C:extracellular exosome;, F:alpha-amylase activity; F:alpha-amylase activity (releasing maltohexaose); F:metal ion binding;, P:carbohydrate metabolic process;|P19961 B3KTI1 B3KXB7 D3DT76 Q9UBH3,Alpha-amylase 2B,1,4-alpha-D-glucan glucanohydrolase 2B;Carcinoid alpha-amylase;, PF00128;PF02806;, GO:0070062;GO:0004556;GO:0103025;GO:0046872;GO:0005975;, C:extracellular exosome;, F:alpha-amylase activity; F:alpha-amylase activity (releasing maltohexaose); F:metal ion binding;, P:carbohydrate metabolic process; scaffold5 indexed_genome mRNA 55843164 55873545 . - . ID=transcript_1481;P19961 B3KTI1 B3KXB7 D3DT76 Q9UBH3,Alpha-amylase 2B,1,4-alpha-D-glucan glucanohydrolase 2B;Carcinoid alpha-amylase;, PF00128;PF02806;, GO:0070062;GO:0004556;GO:0103025;GO:0046872;GO:0005975;, C:extracellular exosome;, F:alpha-amylase activity; F:alpha-amylase activity (releasing maltohexaose); F:metal ion binding;, P:carbohydrate metabolic process;|P0DTE7 A6NJS5 A8K8H6 P04745 Q13763 Q5T083,Alpha-amylase 1B,, PF00128;PF02806;, GO:0070062;GO:0005615;GO:0004556;GO:0103025;GO:0005509;GO:0031404;GO:0009311;, C:extracellular exosome; C:extracellular space;, F:alpha-amylase activity; F:alpha-amylase activity (releasing maltohexaose); F:calcium ion binding; F:chloride ion binding;, P:oligosaccharide metabolic process;|P0DTE7 A6NJS5 A8K8H6 P04745 Q13763 Q5T083,Alpha-amylase 1B,, PF00128;PF02806;, GO:0070062;GO:0005615;GO:0004556;GO:0103025;GO:0005509;GO:0031404;GO:0009311;, C:extracellular exosome; C:extracellular space;, F:alpha-amylase activity; F:alpha-amylase activity (releasing maltohexaose); F:calcium ion binding; F:chloride ion binding;, P:oligosaccharide metabolic process;|P04746 B9EJG1 Q9UBH3,Pancreatic alpha-amylase,1,4-alpha-D-glucan glucanohydrolase;, PF00128;PF02806;, GO:0070062;GO:0005576;GO:0005615;GO:0004556;GO:0103025;GO:0005509;GO:0031404;GO:0016052;GO:0005975;GO:0044245;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:alpha-amylase activity; F:alpha-amylase activity (releasing maltohexaose); F:calcium ion binding; F:chloride ion binding;, P:carbohydrate catabolic process; P:carbohydrate metabolic process; P:polysaccharide digestion;|P19961 B3KTI1 B3KXB7 D3DT76 Q9UBH3,Alpha-amylase 2B,1,4-alpha-D-glucan glucanohydrolase 2B;Carcinoid alpha-amylase;, PF00128;PF02806;, GO:0070062;GO:0004556;GO:0103025;GO:0046872;GO:0005975;, C:extracellular exosome;, F:alpha-amylase activity; F:alpha-amylase activity (releasing maltohexaose); F:metal ion binding;, P:carbohydrate metabolic process; scaffold5 indexed_genome mRNA 55878822 55986120 . + . ID=transcript_1482;P19961 B3KTI1 B3KXB7 D3DT76 Q9UBH3,Alpha-amylase 2B,1,4-alpha-D-glucan glucanohydrolase 2B;Carcinoid alpha-amylase;, PF00128;PF02806;, GO:0070062;GO:0004556;GO:0103025;GO:0046872;GO:0005975;, C:extracellular exosome;, F:alpha-amylase activity; F:alpha-amylase activity (releasing maltohexaose); F:metal ion binding;, P:carbohydrate metabolic process; scaffold5 indexed_genome mRNA 58985406 58987039 . - . ID=transcript_1483;Q96LA8 A3KME1 B4DID8 Q5T5Y5 Q6DKI4 Q9NVR8,Protein arginine N-methyltransferase 6,Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 6;Histone-arginine N-methyltransferase PRMT6;, PF13649;, GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0042054;GO:0070612;GO:0070611;GO:0044020;GO:0008469;GO:0016274;GO:0035242;GO:0035241;GO:0006284;GO:0090398;GO:0034970;GO:0016571;GO:0031064;GO:0051572;GO:0000122;GO:0045892;GO:0019919;GO:0045652;GO:0010821;GO:1901796;GO:0016032;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H2A-R3 specific); F:histone methyltransferase activity (H3-R2 specific); F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity;, P:base-excision repair; P:cellular senescence; P:histone H3-R2 methylation; P:histone methylation; P:negative regulation of histone deacetylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:viral process; scaffold5 indexed_genome mRNA 59074963 59263481 . + . ID=transcript_1484;Q9Y2I2 Q5VU86 Q5VU87 Q5VU89 Q5VU90 Q5VU91 Q7Z2Y3 Q8N633,Netrin-G1,Laminet-1;, PF00053;PF00055;, GO:0046658;GO:0099029;GO:0005576;GO:0098978;GO:0043256;GO:0005886;GO:0098685;GO:0050839;GO:0098632;GO:0009887;GO:0007409;GO:0070831;GO:0016477;GO:0050804;GO:2001222;GO:0150011;GO:0010975;GO:0034446;GO:0099560;GO:0009888;, C:anchored component of plasma membrane; C:anchored component of presynaptic active zone membrane; C:extracellular region; C:glutamatergic synapse; C:laminin complex; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:cell-cell adhesion mediator activity;, P:animal organ morphogenesis; P:axonogenesis; P:basement membrane assembly; P:cell migration; P:modulation of chemical synaptic transmission; P:regulation of neuron migration; P:regulation of neuron projection arborization; P:regulation of neuron projection development; P:substrate adhesion-dependent cell spreading; P:synaptic membrane adhesion; P:tissue development; scaffold5 indexed_genome mRNA 59370232 59433631 . + . ID=transcript_1485;Q9Y2I2 Q5VU86 Q5VU87 Q5VU89 Q5VU90 Q5VU91 Q7Z2Y3 Q8N633,Netrin-G1,Laminet-1;, PF00053;PF00055;, GO:0046658;GO:0099029;GO:0005576;GO:0098978;GO:0043256;GO:0005886;GO:0098685;GO:0050839;GO:0098632;GO:0009887;GO:0007409;GO:0070831;GO:0016477;GO:0050804;GO:2001222;GO:0150011;GO:0010975;GO:0034446;GO:0099560;GO:0009888;, C:anchored component of plasma membrane; C:anchored component of presynaptic active zone membrane; C:extracellular region; C:glutamatergic synapse; C:laminin complex; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:cell-cell adhesion mediator activity;, P:animal organ morphogenesis; P:axonogenesis; P:basement membrane assembly; P:cell migration; P:modulation of chemical synaptic transmission; P:regulation of neuron migration; P:regulation of neuron projection arborization; P:regulation of neuron projection development; P:substrate adhesion-dependent cell spreading; P:synaptic membrane adhesion; P:tissue development; scaffold5 indexed_genome mRNA 59536101 59760582 . - . ID=transcript_1486;Q9UKW4 B1AMM0 B1APV5 B4E232 B7ZLR1 E9PQ97 O60498 O95230 Q9Y5X8,Guanine nucleotide exchange factor VAV3,, PF00130;PF11971;PF00169;PF00621;PF00017;PF07653;, GO:0005829;GO:0001772;GO:0005154;GO:0005096;GO:0005085;GO:0046872;GO:0001525;GO:0050853;GO:0006974;GO:0048013;GO:0038095;GO:0038096;GO:0007186;GO:0007229;GO:0030032;GO:0030593;GO:0030168;GO:0043065;GO:0030890;GO:0045785;GO:0043552;GO:0008361;GO:0043087;GO:0051056;GO:0042493;GO:0007264;GO:0048010;GO:0006906;, C:cytosol; C:immunological synapse;, F:epidermal growth factor receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:metal ion binding;, P:angiogenesis; P:B cell receptor signaling pathway; P:cellular response to DNA damage stimulus; P:ephrin receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:integrin-mediated signaling pathway; P:lamellipodium assembly; P:neutrophil chemotaxis; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of cell adhesion; P:positive regulation of phosphatidylinositol 3-kinase activity; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:response to drug; P:small GTPase mediated signal transduction; P:vascular endothelial growth factor receptor signaling pathway; P:vesicle fusion; scaffold5 indexed_genome mRNA 60162873 60228283 . - . ID=transcript_1487;Q6NUK1 B7ZAI9 Q5T331 Q5T485 Q6PJJ9 Q705K4 Q9P129,Calcium-binding mitochondrial carrier protein SCaMC-1,Mitochondrial ATP-Mg/Pi carrier protein 1;Mitochondrial Ca(2+)-dependent solute carrier protein 1;Small calcium-binding mitochondrial carrier protein 1;Solute carrier family 25 member 24;, PF13499;PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005347;GO:0005509;GO:0015867;GO:0071277;GO:0034599;GO:0006839;GO:0010941;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:ATP transport; P:cellular response to calcium ion; P:cellular response to oxidative stress; P:mitochondrial transport; P:regulation of cell death;|Q6NUK1 B7ZAI9 Q5T331 Q5T485 Q6PJJ9 Q705K4 Q9P129,Calcium-binding mitochondrial carrier protein SCaMC-1,Mitochondrial ATP-Mg/Pi carrier protein 1;Mitochondrial Ca(2+)-dependent solute carrier protein 1;Small calcium-binding mitochondrial carrier protein 1;Solute carrier family 25 member 24;, PF13499;PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005347;GO:0005509;GO:0015867;GO:0071277;GO:0034599;GO:0006839;GO:0010941;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:ATP transport; P:cellular response to calcium ion; P:cellular response to oxidative stress; P:mitochondrial transport; P:regulation of cell death; scaffold5 indexed_genome mRNA 60236174 60236812 . + . ID=transcript_1488;Q9BV35 B4DGB6 Q4LBC2 Q705K3 Q86Y43 Q8N2N4 Q96NQ4,Calcium-binding mitochondrial carrier protein SCaMC-3,Mitochondrial ATP-Mg/Pi carrier protein 2;Mitochondrial Ca(2+)-dependent solute carrier protein 2;Small calcium-binding mitochondrial carrier protein 3;Solute carrier family 25 member 23;, PF13202;PF13499;PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005347;GO:0005509;GO:0036444;GO:0071277;GO:0006851;GO:0051561;GO:1900069;GO:0043457;GO:0002082;GO:0051282;GO:0097274;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:calcium import into the mitochondrion; P:cellular response to calcium ion; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration; P:regulation of cellular hyperosmotic salinity response; P:regulation of cellular respiration; P:regulation of oxidative phosphorylation; P:regulation of sequestering of calcium ion; P:urea homeostasis; scaffold5 indexed_genome mRNA 60430853 60503379 . + . ID=transcript_1489;Q5T8I3 A1L1A1 B0QZ46 B0QZ47 Q68DH7,Protein FAM102B,, PF10358; scaffold5 indexed_genome mRNA 60511140 60520877 . - . ID=transcript_1490;Q5T8I9 A8MRR6 B1AM16 B1AM17 Q96EJ7 Q96NN0,Small RNA 2'-O-methyltransferase,HEN1 methyltransferase homolog 1;, , GO:0005737;GO:0005634;GO:0043186;GO:0046872;GO:0008171;GO:0003723;GO:0008173;GO:0090486;GO:0034587;GO:0030422;GO:0001510;, C:cytoplasm; C:nucleus; C:P granule;, F:metal ion binding; F:O-methyltransferase activity; F:RNA binding; F:RNA methyltransferase activity; F:small RNA 2'-O-methyltransferase;, P:piRNA metabolic process; P:production of siRNA involved in RNA interference; P:RNA methylation;|Q5T8I9 A8MRR6 B1AM16 B1AM17 Q96EJ7 Q96NN0,Small RNA 2'-O-methyltransferase,HEN1 methyltransferase homolog 1;, , GO:0005737;GO:0005634;GO:0043186;GO:0046872;GO:0008171;GO:0003723;GO:0008173;GO:0090486;GO:0034587;GO:0030422;GO:0001510;, C:cytoplasm; C:nucleus; C:P granule;, F:metal ion binding; F:O-methyltransferase activity; F:RNA binding; F:RNA methyltransferase activity; F:small RNA 2'-O-methyltransferase;, P:piRNA metabolic process; P:production of siRNA involved in RNA interference; P:RNA methylation; scaffold5 indexed_genome mRNA 60538536 60548778 . + . ID=transcript_1491;Q5VTL8 Q05DD6 Q32Q58 Q5VTL9 Q6PK39 Q7Z6E2 Q86WF3 Q8IWG9 Q9NW40,Pre-mRNA-splicing factor 38B,Sarcoma antigen NY-SAR-27;, PF03371;, GO:0071011;GO:0003723;GO:0006397;GO:0008380;, C:precatalytic spliceosome;, F:RNA binding;, P:mRNA processing; P:RNA splicing;|Q5VTL8 Q05DD6 Q32Q58 Q5VTL9 Q6PK39 Q7Z6E2 Q86WF3 Q8IWG9 Q9NW40,Pre-mRNA-splicing factor 38B,Sarcoma antigen NY-SAR-27;, PF03371;, GO:0071011;GO:0003723;GO:0006397;GO:0008380;, C:precatalytic spliceosome;, F:RNA binding;, P:mRNA processing; P:RNA splicing;|Q5VTL8 Q05DD6 Q32Q58 Q5VTL9 Q6PK39 Q7Z6E2 Q86WF3 Q8IWG9 Q9NW40,Pre-mRNA-splicing factor 38B,Sarcoma antigen NY-SAR-27;, PF03371;, GO:0071011;GO:0003723;GO:0006397;GO:0008380;, C:precatalytic spliceosome;, F:RNA binding;, P:mRNA processing; P:RNA splicing;|Q5VTL8 Q05DD6 Q32Q58 Q5VTL9 Q6PK39 Q7Z6E2 Q86WF3 Q8IWG9 Q9NW40,Pre-mRNA-splicing factor 38B,Sarcoma antigen NY-SAR-27;, PF03371;, GO:0071011;GO:0003723;GO:0006397;GO:0008380;, C:precatalytic spliceosome;, F:RNA binding;, P:mRNA processing; P:RNA splicing; scaffold5 indexed_genome mRNA 60562069 60579881 . + . ID=transcript_1492;Q5VTL7 A1L468 E9PAZ5 Q6PF16 Q8NA51,Fibronectin type III domain-containing protein 7,, , GO:0005576;, C:extracellular region;|Q5VTL7 A1L468 E9PAZ5 Q6PF16 Q8NA51,Fibronectin type III domain-containing protein 7,, , GO:0005576;, C:extracellular region;|Q5VTL7 A1L468 E9PAZ5 Q6PF16 Q8NA51,Fibronectin type III domain-containing protein 7,, , GO:0005576;, C:extracellular region; scaffold5 indexed_genome mRNA 60597148 60628229 . + . ID=transcript_1493;O00186 A8K269 A8K5K7 Q53FW1 Q86YJ3 Q9UPD7,Syntaxin-binding protein 3,Platelet Sec1 protein;Protein unc-18 homolog 3;Protein unc-18 homolog C;, PF00995;, GO:0016324;GO:0016323;GO:0005829;GO:0070062;GO:0045335;GO:0005886;GO:0031091;GO:0098793;GO:0030141;GO:0042581;GO:0070820;GO:0044877;GO:0019905;GO:0017075;GO:0007420;GO:0001678;GO:0071346;GO:0030073;GO:0006886;GO:0045955;GO:0046325;GO:0007269;GO:0043312;GO:0070527;GO:0022615;GO:0032868;GO:0006904;GO:0016192;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytosol; C:extracellular exosome; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule; C:presynapse; C:secretory granule; C:specific granule; C:tertiary granule;, F:protein-containing complex binding; F:syntaxin binding; F:syntaxin-1 binding;, P:brain development; P:cellular glucose homeostasis; P:cellular response to interferon-gamma; P:insulin secretion; P:intracellular protein transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of glucose import; P:neurotransmitter secretion; P:neutrophil degranulation; P:platelet aggregation; P:protein to membrane docking; P:response to insulin; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport; scaffold5 indexed_genome mRNA 60628521 60651329 . + . ID=transcript_1494;O00186 A8K269 A8K5K7 Q53FW1 Q86YJ3 Q9UPD7,Syntaxin-binding protein 3,Platelet Sec1 protein;Protein unc-18 homolog 3;Protein unc-18 homolog C;, PF00995;, GO:0016324;GO:0016323;GO:0005829;GO:0070062;GO:0045335;GO:0005886;GO:0031091;GO:0098793;GO:0030141;GO:0042581;GO:0070820;GO:0044877;GO:0019905;GO:0017075;GO:0007420;GO:0001678;GO:0071346;GO:0030073;GO:0006886;GO:0045955;GO:0046325;GO:0007269;GO:0043312;GO:0070527;GO:0022615;GO:0032868;GO:0006904;GO:0016192;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytosol; C:extracellular exosome; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule; C:presynapse; C:secretory granule; C:specific granule; C:tertiary granule;, F:protein-containing complex binding; F:syntaxin binding; F:syntaxin-1 binding;, P:brain development; P:cellular glucose homeostasis; P:cellular response to interferon-gamma; P:insulin secretion; P:intracellular protein transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of glucose import; P:neurotransmitter secretion; P:neutrophil degranulation; P:platelet aggregation; P:protein to membrane docking; P:response to insulin; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|O00186 A8K269 A8K5K7 Q53FW1 Q86YJ3 Q9UPD7,Syntaxin-binding protein 3,Platelet Sec1 protein;Protein unc-18 homolog 3;Protein unc-18 homolog C;, PF00995;, GO:0016324;GO:0016323;GO:0005829;GO:0070062;GO:0045335;GO:0005886;GO:0031091;GO:0098793;GO:0030141;GO:0042581;GO:0070820;GO:0044877;GO:0019905;GO:0017075;GO:0007420;GO:0001678;GO:0071346;GO:0030073;GO:0006886;GO:0045955;GO:0046325;GO:0007269;GO:0043312;GO:0070527;GO:0022615;GO:0032868;GO:0006904;GO:0016192;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytosol; C:extracellular exosome; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule; C:presynapse; C:secretory granule; C:specific granule; C:tertiary granule;, F:protein-containing complex binding; F:syntaxin binding; F:syntaxin-1 binding;, P:brain development; P:cellular glucose homeostasis; P:cellular response to interferon-gamma; P:insulin secretion; P:intracellular protein transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of glucose import; P:neurotransmitter secretion; P:neutrophil degranulation; P:platelet aggregation; P:protein to membrane docking; P:response to insulin; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|O00186 A8K269 A8K5K7 Q53FW1 Q86YJ3 Q9UPD7,Syntaxin-binding protein 3,Platelet Sec1 protein;Protein unc-18 homolog 3;Protein unc-18 homolog C;, PF00995;, GO:0016324;GO:0016323;GO:0005829;GO:0070062;GO:0045335;GO:0005886;GO:0031091;GO:0098793;GO:0030141;GO:0042581;GO:0070820;GO:0044877;GO:0019905;GO:0017075;GO:0007420;GO:0001678;GO:0071346;GO:0030073;GO:0006886;GO:0045955;GO:0046325;GO:0007269;GO:0043312;GO:0070527;GO:0022615;GO:0032868;GO:0006904;GO:0016192;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytosol; C:extracellular exosome; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule; C:presynapse; C:secretory granule; C:specific granule; C:tertiary granule;, F:protein-containing complex binding; F:syntaxin binding; F:syntaxin-1 binding;, P:brain development; P:cellular glucose homeostasis; P:cellular response to interferon-gamma; P:insulin secretion; P:intracellular protein transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of glucose import; P:neurotransmitter secretion; P:neutrophil degranulation; P:platelet aggregation; P:protein to membrane docking; P:response to insulin; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport; scaffold5 indexed_genome mRNA 60729646 60780375 . + . ID=transcript_1495;P81274 Q5T1N8 Q6IBL7 Q8N0Z5,G-protein-signaling modulator 2,Mosaic protein LGN {ECO:0000303|PubMed:8973305};, PF02188;PF13176;PF13181;, GO:0005938;GO:0099738;GO:0005813;GO:0005737;GO:0005829;GO:0097575;GO:0016328;GO:0097431;GO:0032991;GO:0070840;GO:0005092;GO:0042802;GO:0000166;GO:0008022;GO:0019904;GO:0043621;GO:0051301;GO:0000132;GO:0007186;GO:0051661;GO:0007052;GO:1904778;GO:1905832;GO:0031291;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:cytoplasm; C:cytosol; C:lateral cell cortex; C:lateral plasma membrane; C:mitotic spindle pole; C:protein-containing complex;, F:dynein complex binding; F:GDP-dissociation inhibitor activity; F:identical protein binding; F:nucleotide binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein self-association;, P:cell division; P:establishment of mitotic spindle orientation; P:G protein-coupled receptor signaling pathway; P:maintenance of centrosome location; P:mitotic spindle organization; P:positive regulation of protein localization to cell cortex; P:positive regulation of spindle assembly; P:Ran protein signal transduction; P:regulation of mitotic spindle organization;|P81274 Q5T1N8 Q6IBL7 Q8N0Z5,G-protein-signaling modulator 2,Mosaic protein LGN {ECO:0000303|PubMed:8973305};, PF02188;PF13176;PF13181;, GO:0005938;GO:0099738;GO:0005813;GO:0005737;GO:0005829;GO:0097575;GO:0016328;GO:0097431;GO:0032991;GO:0070840;GO:0005092;GO:0042802;GO:0000166;GO:0008022;GO:0019904;GO:0043621;GO:0051301;GO:0000132;GO:0007186;GO:0051661;GO:0007052;GO:1904778;GO:1905832;GO:0031291;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:cytoplasm; C:cytosol; C:lateral cell cortex; C:lateral plasma membrane; C:mitotic spindle pole; C:protein-containing complex;, F:dynein complex binding; F:GDP-dissociation inhibitor activity; F:identical protein binding; F:nucleotide binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein self-association;, P:cell division; P:establishment of mitotic spindle orientation; P:G protein-coupled receptor signaling pathway; P:maintenance of centrosome location; P:mitotic spindle organization; P:positive regulation of protein localization to cell cortex; P:positive regulation of spindle assembly; P:Ran protein signal transduction; P:regulation of mitotic spindle organization;|P81274 Q5T1N8 Q6IBL7 Q8N0Z5,G-protein-signaling modulator 2,Mosaic protein LGN {ECO:0000303|PubMed:8973305};, PF02188;PF13176;PF13181;, GO:0005938;GO:0099738;GO:0005813;GO:0005737;GO:0005829;GO:0097575;GO:0016328;GO:0097431;GO:0032991;GO:0070840;GO:0005092;GO:0042802;GO:0000166;GO:0008022;GO:0019904;GO:0043621;GO:0051301;GO:0000132;GO:0007186;GO:0051661;GO:0007052;GO:1904778;GO:1905832;GO:0031291;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:cytoplasm; C:cytosol; C:lateral cell cortex; C:lateral plasma membrane; C:mitotic spindle pole; C:protein-containing complex;, F:dynein complex binding; F:GDP-dissociation inhibitor activity; F:identical protein binding; F:nucleotide binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein self-association;, P:cell division; P:establishment of mitotic spindle orientation; P:G protein-coupled receptor signaling pathway; P:maintenance of centrosome location; P:mitotic spindle organization; P:positive regulation of protein localization to cell cortex; P:positive regulation of spindle assembly; P:Ran protein signal transduction; P:regulation of mitotic spindle organization;|P81274 Q5T1N8 Q6IBL7 Q8N0Z5,G-protein-signaling modulator 2,Mosaic protein LGN {ECO:0000303|PubMed:8973305};, PF02188;PF13176;PF13181;, GO:0005938;GO:0099738;GO:0005813;GO:0005737;GO:0005829;GO:0097575;GO:0016328;GO:0097431;GO:0032991;GO:0070840;GO:0005092;GO:0042802;GO:0000166;GO:0008022;GO:0019904;GO:0043621;GO:0051301;GO:0000132;GO:0007186;GO:0051661;GO:0007052;GO:1904778;GO:1905832;GO:0031291;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:cytoplasm; C:cytosol; C:lateral cell cortex; C:lateral plasma membrane; C:mitotic spindle pole; C:protein-containing complex;, F:dynein complex binding; F:GDP-dissociation inhibitor activity; F:identical protein binding; F:nucleotide binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein self-association;, P:cell division; P:establishment of mitotic spindle orientation; P:G protein-coupled receptor signaling pathway; P:maintenance of centrosome location; P:mitotic spindle organization; P:positive regulation of protein localization to cell cortex; P:positive regulation of spindle assembly; P:Ran protein signal transduction; P:regulation of mitotic spindle organization;|P81274 Q5T1N8 Q6IBL7 Q8N0Z5,G-protein-signaling modulator 2,Mosaic protein LGN {ECO:0000303|PubMed:8973305};, PF02188;PF13176;PF13181;, GO:0005938;GO:0099738;GO:0005813;GO:0005737;GO:0005829;GO:0097575;GO:0016328;GO:0097431;GO:0032991;GO:0070840;GO:0005092;GO:0042802;GO:0000166;GO:0008022;GO:0019904;GO:0043621;GO:0051301;GO:0000132;GO:0007186;GO:0051661;GO:0007052;GO:1904778;GO:1905832;GO:0031291;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:cytoplasm; C:cytosol; C:lateral cell cortex; C:lateral plasma membrane; C:mitotic spindle pole; C:protein-containing complex;, F:dynein complex binding; F:GDP-dissociation inhibitor activity; F:identical protein binding; F:nucleotide binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein self-association;, P:cell division; P:establishment of mitotic spindle orientation; P:G protein-coupled receptor signaling pathway; P:maintenance of centrosome location; P:mitotic spindle organization; P:positive regulation of protein localization to cell cortex; P:positive regulation of spindle assembly; P:Ran protein signal transduction; P:regulation of mitotic spindle organization;|P81274 Q5T1N8 Q6IBL7 Q8N0Z5,G-protein-signaling modulator 2,Mosaic protein LGN {ECO:0000303|PubMed:8973305};, PF02188;PF13176;PF13181;, GO:0005938;GO:0099738;GO:0005813;GO:0005737;GO:0005829;GO:0097575;GO:0016328;GO:0097431;GO:0032991;GO:0070840;GO:0005092;GO:0042802;GO:0000166;GO:0008022;GO:0019904;GO:0043621;GO:0051301;GO:0000132;GO:0007186;GO:0051661;GO:0007052;GO:1904778;GO:1905832;GO:0031291;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:cytoplasm; C:cytosol; C:lateral cell cortex; C:lateral plasma membrane; C:mitotic spindle pole; C:protein-containing complex;, F:dynein complex binding; F:GDP-dissociation inhibitor activity; F:identical protein binding; F:nucleotide binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein self-association;, P:cell division; P:establishment of mitotic spindle orientation; P:G protein-coupled receptor signaling pathway; P:maintenance of centrosome location; P:mitotic spindle organization; P:positive regulation of protein localization to cell cortex; P:positive regulation of spindle assembly; P:Ran protein signal transduction; P:regulation of mitotic spindle organization;|P81274 Q5T1N8 Q6IBL7 Q8N0Z5,G-protein-signaling modulator 2,Mosaic protein LGN {ECO:0000303|PubMed:8973305};, PF02188;PF13176;PF13181;, GO:0005938;GO:0099738;GO:0005813;GO:0005737;GO:0005829;GO:0097575;GO:0016328;GO:0097431;GO:0032991;GO:0070840;GO:0005092;GO:0042802;GO:0000166;GO:0008022;GO:0019904;GO:0043621;GO:0051301;GO:0000132;GO:0007186;GO:0051661;GO:0007052;GO:1904778;GO:1905832;GO:0031291;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:cytoplasm; C:cytosol; C:lateral cell cortex; C:lateral plasma membrane; C:mitotic spindle pole; C:protein-containing complex;, F:dynein complex binding; F:GDP-dissociation inhibitor activity; F:identical protein binding; F:nucleotide binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein self-association;, P:cell division; P:establishment of mitotic spindle orientation; P:G protein-coupled receptor signaling pathway; P:maintenance of centrosome location; P:mitotic spindle organization; P:positive regulation of protein localization to cell cortex; P:positive regulation of spindle assembly; P:Ran protein signal transduction; P:regulation of mitotic spindle organization;|P81274 Q5T1N8 Q6IBL7 Q8N0Z5,G-protein-signaling modulator 2,Mosaic protein LGN {ECO:0000303|PubMed:8973305};, PF02188;PF13176;PF13181;, GO:0005938;GO:0099738;GO:0005813;GO:0005737;GO:0005829;GO:0097575;GO:0016328;GO:0097431;GO:0032991;GO:0070840;GO:0005092;GO:0042802;GO:0000166;GO:0008022;GO:0019904;GO:0043621;GO:0051301;GO:0000132;GO:0007186;GO:0051661;GO:0007052;GO:1904778;GO:1905832;GO:0031291;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:cytoplasm; C:cytosol; C:lateral cell cortex; C:lateral plasma membrane; C:mitotic spindle pole; C:protein-containing complex;, F:dynein complex binding; F:GDP-dissociation inhibitor activity; F:identical protein binding; F:nucleotide binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein self-association;, P:cell division; P:establishment of mitotic spindle orientation; P:G protein-coupled receptor signaling pathway; P:maintenance of centrosome location; P:mitotic spindle organization; P:positive regulation of protein localization to cell cortex; P:positive regulation of spindle assembly; P:Ran protein signal transduction; P:regulation of mitotic spindle organization; scaffold5 indexed_genome mRNA 60781902 60797723 . - . ID=transcript_1496;Q96S66 O94861 Q8WYP8 Q8WYP9 Q9BU25,Chloride channel CLIC-like protein 1,Mid-1-related chloride channel protein 1;, PF05934;, GO:0034707;GO:0005783;GO:0005789;GO:0000139;GO:0043231;GO:0016020;GO:0044233;GO:0031965;GO:0005254;, C:chloride channel complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:nuclear membrane;, F:chloride channel activity;|Q96S66 O94861 Q8WYP8 Q8WYP9 Q9BU25,Chloride channel CLIC-like protein 1,Mid-1-related chloride channel protein 1;, PF05934;, GO:0034707;GO:0005783;GO:0005789;GO:0000139;GO:0043231;GO:0016020;GO:0044233;GO:0031965;GO:0005254;, C:chloride channel complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:nuclear membrane;, F:chloride channel activity;|Q96S66 O94861 Q8WYP8 Q8WYP9 Q9BU25,Chloride channel CLIC-like protein 1,Mid-1-related chloride channel protein 1;, PF05934;, GO:0034707;GO:0005783;GO:0005789;GO:0000139;GO:0043231;GO:0016020;GO:0044233;GO:0031965;GO:0005254;, C:chloride channel complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:nuclear membrane;, F:chloride channel activity;|Q96S66 O94861 Q8WYP8 Q8WYP9 Q9BU25,Chloride channel CLIC-like protein 1,Mid-1-related chloride channel protein 1;, PF05934;, GO:0034707;GO:0005783;GO:0005789;GO:0000139;GO:0043231;GO:0016020;GO:0044233;GO:0031965;GO:0005254;, C:chloride channel complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:nuclear membrane;, F:chloride channel activity; scaffold5 indexed_genome mRNA 60813039 60875431 . - . ID=transcript_1497;O94967 A8MX09 Q5TYV7 Q5TYV8 Q5TYV9 Q8IXT7 Q8IYU9,WD repeat-containing protein 47,Neuronal enriched MAP-interacting protein;, PF12894;PF00400;, GO:0005737;GO:0005874;GO:0007275;, C:cytoplasm; C:microtubule;, , P:multicellular organism development;|O94967 A8MX09 Q5TYV7 Q5TYV8 Q5TYV9 Q8IXT7 Q8IYU9,WD repeat-containing protein 47,Neuronal enriched MAP-interacting protein;, PF12894;PF00400;, GO:0005737;GO:0005874;GO:0007275;, C:cytoplasm; C:microtubule;, , P:multicellular organism development;|O94967 A8MX09 Q5TYV7 Q5TYV8 Q5TYV9 Q8IXT7 Q8IYU9,WD repeat-containing protein 47,Neuronal enriched MAP-interacting protein;, PF12894;PF00400;, GO:0005737;GO:0005874;GO:0007275;, C:cytoplasm; C:microtubule;, , P:multicellular organism development;|O94967 A8MX09 Q5TYV7 Q5TYV8 Q5TYV9 Q8IXT7 Q8IYU9,WD repeat-containing protein 47,Neuronal enriched MAP-interacting protein;, PF12894;PF00400;, GO:0005737;GO:0005874;GO:0007275;, C:cytoplasm; C:microtubule;, , P:multicellular organism development;|O94967 A8MX09 Q5TYV7 Q5TYV8 Q5TYV9 Q8IXT7 Q8IYU9,WD repeat-containing protein 47,Neuronal enriched MAP-interacting protein;, PF12894;PF00400;, GO:0005737;GO:0005874;GO:0007275;, C:cytoplasm; C:microtubule;, , P:multicellular organism development;|O94967 A8MX09 Q5TYV7 Q5TYV8 Q5TYV9 Q8IXT7 Q8IYU9,WD repeat-containing protein 47,Neuronal enriched MAP-interacting protein;, PF12894;PF00400;, GO:0005737;GO:0005874;GO:0007275;, C:cytoplasm; C:microtubule;, , P:multicellular organism development;|O94967 A8MX09 Q5TYV7 Q5TYV8 Q5TYV9 Q8IXT7 Q8IYU9,WD repeat-containing protein 47,Neuronal enriched MAP-interacting protein;, PF12894;PF00400;, GO:0005737;GO:0005874;GO:0007275;, C:cytoplasm; C:microtubule;, , P:multicellular organism development; scaffold5 indexed_genome mRNA 60892661 60894275 . + . ID=transcript_1498;Q15543 B2R5E5 Q5TYV6,Transcription initiation factor TFIID subunit 13 {ECO:0000305},Transcription initiation factor TFIID 18 kDa subunit {ECO:0000303|PubMed:7729427};, PF02269;, GO:0005730;GO:0005654;GO:0005669;GO:0003677;GO:0008022;GO:0046982;GO:0016251;GO:0017025;GO:0006352;GO:1901796;GO:0042795;GO:0006366;GO:0006367;, C:nucleolus; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:TBP-class protein binding;, P:DNA-templated transcription, initiation; P:regulation of signal transduction by p53 class mediator; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold5 indexed_genome mRNA 60915541 60918819 . + . ID=transcript_1499;Q9NRX6 B2RUU9,Protein kish-B,Transmembrane protein 167B;, PF06842;, GO:0005794;GO:0000139;GO:0016021;GO:0045054;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:constitutive secretory pathway;|Q9NRX6 B2RUU9,Protein kish-B,Transmembrane protein 167B;, PF06842;, GO:0005794;GO:0000139;GO:0016021;GO:0045054;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:constitutive secretory pathway; scaffold5 indexed_genome mRNA 60926082 60927922 . - . ID=transcript_1500;Q5T5A4 Q5T5A3,Protein C1orf194,, PF12494;, GO:0005737;GO:0005856;GO:0020037;GO:0015232;GO:0097037;, C:cytoplasm; C:cytoskeleton;, F:heme binding; F:heme transmembrane transporter activity;, P:heme export; scaffold5 indexed_genome mRNA 60964605 61003303 . + . ID=transcript_1501;Q6UXG2 Q08AE6 Q5T5C9 Q5T5D0 Q5T5D1 Q9P2M2,Endosome/lysosome-associated apoptosis and autophagy regulator 1 {ECO:0000305},Estrogen-induced gene 121 protein {ECO:0000303|PubMed:16322283};, , GO:0005789;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005886;GO:0003723;GO:0000045;GO:0009267;GO:2000786;GO:0044090;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:RNA binding;, P:autophagosome assembly; P:cellular response to starvation; P:positive regulation of autophagosome assembly; P:positive regulation of vacuole organization;|Q6UXG2 Q08AE6 Q5T5C9 Q5T5D0 Q5T5D1 Q9P2M2,Endosome/lysosome-associated apoptosis and autophagy regulator 1 {ECO:0000305},Estrogen-induced gene 121 protein {ECO:0000303|PubMed:16322283};, , GO:0005789;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005886;GO:0003723;GO:0000045;GO:0009267;GO:2000786;GO:0044090;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:RNA binding;, P:autophagosome assembly; P:cellular response to starvation; P:positive regulation of autophagosome assembly; P:positive regulation of vacuole organization;|Q6UXG2 Q08AE6 Q5T5C9 Q5T5D0 Q5T5D1 Q9P2M2,Endosome/lysosome-associated apoptosis and autophagy regulator 1 {ECO:0000305},Estrogen-induced gene 121 protein {ECO:0000303|PubMed:16322283};, , GO:0005789;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005886;GO:0003723;GO:0000045;GO:0009267;GO:2000786;GO:0044090;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:RNA binding;, P:autophagosome assembly; P:cellular response to starvation; P:positive regulation of autophagosome assembly; P:positive regulation of vacuole organization; scaffold5 indexed_genome mRNA 61013485 61034202 . + . ID=transcript_1502;P49591 B2R6Y9 Q5T5C8 Q9NSE3,Serine--tRNA ligase, cytoplasmic,Seryl-tRNA synthetase;Seryl-tRNA(Ser/Sec) synthetase;, PF02403;PF00587;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0005524;GO:0019899;GO:0042803;GO:0003723;GO:0000978;GO:0004828;GO:0000049;GO:0016525;GO:0000122;GO:1904046;GO:0016259;GO:0097056;GO:0006434;GO:0006412;GO:0006418;GO:0008033;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:ATP binding; F:enzyme binding; F:protein homodimerization activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:serine-tRNA ligase activity; F:tRNA binding;, P:negative regulation of angiogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular endothelial growth factor production; P:selenocysteine metabolic process; P:selenocysteinyl-tRNA(Sec) biosynthetic process; P:seryl-tRNA aminoacylation; P:translation; P:tRNA aminoacylation for protein translation; P:tRNA processing;|P49591 B2R6Y9 Q5T5C8 Q9NSE3,Serine--tRNA ligase, cytoplasmic,Seryl-tRNA synthetase;Seryl-tRNA(Ser/Sec) synthetase;, PF02403;PF00587;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0005524;GO:0019899;GO:0042803;GO:0003723;GO:0000978;GO:0004828;GO:0000049;GO:0016525;GO:0000122;GO:1904046;GO:0016259;GO:0097056;GO:0006434;GO:0006412;GO:0006418;GO:0008033;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:ATP binding; F:enzyme binding; F:protein homodimerization activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:serine-tRNA ligase activity; F:tRNA binding;, P:negative regulation of angiogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular endothelial growth factor production; P:selenocysteine metabolic process; P:selenocysteinyl-tRNA(Sec) biosynthetic process; P:seryl-tRNA aminoacylation; P:translation; P:tRNA aminoacylation for protein translation; P:tRNA processing;|P49591 B2R6Y9 Q5T5C8 Q9NSE3,Serine--tRNA ligase, cytoplasmic,Seryl-tRNA synthetase;Seryl-tRNA(Ser/Sec) synthetase;, PF02403;PF00587;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0005524;GO:0019899;GO:0042803;GO:0003723;GO:0000978;GO:0004828;GO:0000049;GO:0016525;GO:0000122;GO:1904046;GO:0016259;GO:0097056;GO:0006434;GO:0006412;GO:0006418;GO:0008033;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:ATP binding; F:enzyme binding; F:protein homodimerization activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:serine-tRNA ligase activity; F:tRNA binding;, P:negative regulation of angiogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular endothelial growth factor production; P:selenocysteine metabolic process; P:selenocysteinyl-tRNA(Sec) biosynthetic process; P:seryl-tRNA aminoacylation; P:translation; P:tRNA aminoacylation for protein translation; P:tRNA processing;|P49591 B2R6Y9 Q5T5C8 Q9NSE3,Serine--tRNA ligase, cytoplasmic,Seryl-tRNA synthetase;Seryl-tRNA(Ser/Sec) synthetase;, PF02403;PF00587;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0005524;GO:0019899;GO:0042803;GO:0003723;GO:0000978;GO:0004828;GO:0000049;GO:0016525;GO:0000122;GO:1904046;GO:0016259;GO:0097056;GO:0006434;GO:0006412;GO:0006418;GO:0008033;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:ATP binding; F:enzyme binding; F:protein homodimerization activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:serine-tRNA ligase activity; F:tRNA binding;, P:negative regulation of angiogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular endothelial growth factor production; P:selenocysteine metabolic process; P:selenocysteinyl-tRNA(Sec) biosynthetic process; P:seryl-tRNA aminoacylation; P:translation; P:tRNA aminoacylation for protein translation; P:tRNA processing; scaffold5 indexed_genome mRNA 61050874 61076332 . + . ID=transcript_1503;Q9HCU4 Q5T2Y7 Q92566,Cadherin EGF LAG seven-pass G-type receptor 2 {ECO:0000305},Cadherin family member 10;Epidermal growth factor-like protein 2;Flamingo homolog 3;Multiple epidermal growth factor-like domains protein 3;, PF00002;PF00028;PF00008;PF16489;PF01825;PF12661;PF00053;PF02210;, GO:0005737;GO:0016021;GO:0005886;GO:0005509;GO:0004930;GO:0098609;GO:0033326;GO:0060271;GO:0003341;GO:0048813;GO:0007186;GO:0007156;GO:0021999;GO:0001764;GO:0022407;GO:0032880;GO:0006355;GO:0021591;GO:0016055;GO:0060071;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:cell-cell adhesion; P:cerebrospinal fluid secretion; P:cilium assembly; P:cilium movement; P:dendrite morphogenesis; P:G protein-coupled receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neural plate anterior/posterior regionalization; P:neuron migration; P:regulation of cell-cell adhesion; P:regulation of protein localization; P:regulation of transcription, DNA-templated; P:ventricular system development; P:Wnt signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HCU4 Q5T2Y7 Q92566,Cadherin EGF LAG seven-pass G-type receptor 2 {ECO:0000305},Cadherin family member 10;Epidermal growth factor-like protein 2;Flamingo homolog 3;Multiple epidermal growth factor-like domains protein 3;, PF00002;PF00028;PF00008;PF16489;PF01825;PF12661;PF00053;PF02210;, GO:0005737;GO:0016021;GO:0005886;GO:0005509;GO:0004930;GO:0098609;GO:0033326;GO:0060271;GO:0003341;GO:0048813;GO:0007186;GO:0007156;GO:0021999;GO:0001764;GO:0022407;GO:0032880;GO:0006355;GO:0021591;GO:0016055;GO:0060071;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:cell-cell adhesion; P:cerebrospinal fluid secretion; P:cilium assembly; P:cilium movement; P:dendrite morphogenesis; P:G protein-coupled receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neural plate anterior/posterior regionalization; P:neuron migration; P:regulation of cell-cell adhesion; P:regulation of protein localization; P:regulation of transcription, DNA-templated; P:ventricular system development; P:Wnt signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HCU4 Q5T2Y7 Q92566,Cadherin EGF LAG seven-pass G-type receptor 2 {ECO:0000305},Cadherin family member 10;Epidermal growth factor-like protein 2;Flamingo homolog 3;Multiple epidermal growth factor-like domains protein 3;, PF00002;PF00028;PF00008;PF16489;PF01825;PF12661;PF00053;PF02210;, GO:0005737;GO:0016021;GO:0005886;GO:0005509;GO:0004930;GO:0098609;GO:0033326;GO:0060271;GO:0003341;GO:0048813;GO:0007186;GO:0007156;GO:0021999;GO:0001764;GO:0022407;GO:0032880;GO:0006355;GO:0021591;GO:0016055;GO:0060071;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:cell-cell adhesion; P:cerebrospinal fluid secretion; P:cilium assembly; P:cilium movement; P:dendrite morphogenesis; P:G protein-coupled receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neural plate anterior/posterior regionalization; P:neuron migration; P:regulation of cell-cell adhesion; P:regulation of protein localization; P:regulation of transcription, DNA-templated; P:ventricular system development; P:Wnt signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold5 indexed_genome mRNA 61078467 61082070 . - . ID=transcript_1504;Q6PGN9 Q5T2Z3 Q6ZTI8 Q71MG3 Q9BV77,Proline/serine-rich coiled-coil protein 1,, PF15259;, GO:0005737;GO:0005829;GO:0015630;GO:0030496;GO:0005654;GO:0005819;GO:0000922;GO:0008017;GO:0051301;GO:0001578;GO:0007080;GO:0030308;GO:0045737;GO:0031116;GO:0045893;GO:0060236;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:midbody; C:nucleoplasm; C:spindle; C:spindle pole;, F:microtubule binding;, P:cell division; P:microtubule bundle formation; P:mitotic metaphase plate congression; P:negative regulation of cell growth; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of transcription, DNA-templated; P:regulation of mitotic spindle organization; scaffold5 indexed_genome mRNA 61085494 61090370 . - . ID=transcript_1505;A2RUH7 B7ZME5 Q5T2Z7,Myosin-binding protein H-like {ECO:0000305},, PF00041;PF07679;, GO:0036379;GO:0030017;GO:0001701;, C:myofilament; C:sarcomere;, , P:in utero embryonic development;|P84243 P06351 P33155 Q5VV55 Q5VV56 Q66I33 Q9V3W4,Histone H3.3,, PF00125;, GO:0001740;GO:0000781;GO:0070062;GO:0005576;GO:0000228;GO:0005654;GO:0000786;GO:0005634;GO:0032991;GO:0031492;GO:0046982;GO:0000978;GO:0000979;GO:1990000;GO:0007596;GO:0008283;GO:0006336;GO:0007566;GO:0008584;GO:0035264;GO:0042692;GO:1902340;GO:0045814;GO:0006334;GO:0006997;GO:0048477;GO:0001649;GO:0031508;GO:0030307;GO:1900051;GO:0000183;GO:0060765;GO:0090230;GO:0060964;GO:0045652;GO:0007338;GO:0007286;GO:0031509;GO:0032200;, C:Barr body; C:chromosome, telomeric region; C:extracellular exosome; C:extracellular region; C:nuclear chromosome; C:nucleoplasm; C:nucleosome; C:nucleus; C:protein-containing complex;, F:nucleosomal DNA binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding;, P:amyloid fibril formation; P:blood coagulation; P:cell population proliferation; P:DNA replication-independent nucleosome assembly; P:embryo implantation; P:male gonad development; P:multicellular organism growth; P:muscle cell differentiation; P:negative regulation of chromosome condensation; P:negative regulation of gene expression, epigenetic; P:nucleosome assembly; P:nucleus organization; P:oogenesis; P:osteoblast differentiation; P:pericentric heterochromatin assembly; P:positive regulation of cell growth; P:positive regulation of histone exchange; P:rDNA heterochromatin assembly; P:regulation of androgen receptor signaling pathway; P:regulation of centromere complex assembly; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:single fertilization; P:spermatid development; P:subtelomeric heterochromatin assembly; P:telomere organization; scaffold5 indexed_genome mRNA 61102606 61144441 . - . ID=transcript_1506;Q99523 B4DWI3 C0JYZ0 Q8IZ49,Sortilin {ECO:0000305},100 kDa NT receptor;Glycoprotein 95;Neurotensin receptor 3;, PF15902;PF15901;, GO:0009986;GO:0005905;GO:0030136;GO:0031410;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005789;GO:0010008;GO:0005794;GO:0032580;GO:0016021;GO:0005765;GO:0005764;GO:0043025;GO:0031965;GO:0048471;GO:0005886;GO:0030140;GO:0019899;GO:0048406;GO:0010465;GO:0030379;GO:1905394;GO:0006897;GO:0008333;GO:0032509;GO:0008625;GO:0007186;GO:0046323;GO:0006895;GO:0090160;GO:0007275;GO:0014902;GO:0045599;GO:0051005;GO:0007218;GO:0048011;GO:0001503;GO:0048227;GO:1904037;GO:0006892;GO:0006622;GO:0010468;GO:0032868;GO:0016050;, C:cell surface; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network transport vesicle;, F:enzyme binding; F:nerve growth factor binding; F:nerve growth factor receptor activity; F:neurotensin receptor activity, non-G protein-coupled; F:retromer complex binding;, P:endocytosis; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:G protein-coupled receptor signaling pathway; P:glucose import; P:Golgi to endosome transport; P:Golgi to lysosome transport; P:multicellular organism development; P:myotube differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of lipoprotein lipase activity; P:neuropeptide signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:ossification; P:plasma membrane to endosome transport; P:positive regulation of epithelial cell apoptotic process; P:post-Golgi vesicle-mediated transport; P:protein targeting to lysosome; P:regulation of gene expression; P:response to insulin; P:vesicle organization;|Q99523 B4DWI3 C0JYZ0 Q8IZ49,Sortilin {ECO:0000305},100 kDa NT receptor;Glycoprotein 95;Neurotensin receptor 3;, PF15902;PF15901;, GO:0009986;GO:0005905;GO:0030136;GO:0031410;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005789;GO:0010008;GO:0005794;GO:0032580;GO:0016021;GO:0005765;GO:0005764;GO:0043025;GO:0031965;GO:0048471;GO:0005886;GO:0030140;GO:0019899;GO:0048406;GO:0010465;GO:0030379;GO:1905394;GO:0006897;GO:0008333;GO:0032509;GO:0008625;GO:0007186;GO:0046323;GO:0006895;GO:0090160;GO:0007275;GO:0014902;GO:0045599;GO:0051005;GO:0007218;GO:0048011;GO:0001503;GO:0048227;GO:1904037;GO:0006892;GO:0006622;GO:0010468;GO:0032868;GO:0016050;, C:cell surface; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network transport vesicle;, F:enzyme binding; F:nerve growth factor binding; F:nerve growth factor receptor activity; F:neurotensin receptor activity, non-G protein-coupled; F:retromer complex binding;, P:endocytosis; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:G protein-coupled receptor signaling pathway; P:glucose import; P:Golgi to endosome transport; P:Golgi to lysosome transport; P:multicellular organism development; P:myotube differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of lipoprotein lipase activity; P:neuropeptide signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:ossification; P:plasma membrane to endosome transport; P:positive regulation of epithelial cell apoptotic process; P:post-Golgi vesicle-mediated transport; P:protein targeting to lysosome; P:regulation of gene expression; P:response to insulin; P:vesicle organization;|Q99523 B4DWI3 C0JYZ0 Q8IZ49,Sortilin {ECO:0000305},100 kDa NT receptor;Glycoprotein 95;Neurotensin receptor 3;, PF15902;PF15901;, GO:0009986;GO:0005905;GO:0030136;GO:0031410;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005789;GO:0010008;GO:0005794;GO:0032580;GO:0016021;GO:0005765;GO:0005764;GO:0043025;GO:0031965;GO:0048471;GO:0005886;GO:0030140;GO:0019899;GO:0048406;GO:0010465;GO:0030379;GO:1905394;GO:0006897;GO:0008333;GO:0032509;GO:0008625;GO:0007186;GO:0046323;GO:0006895;GO:0090160;GO:0007275;GO:0014902;GO:0045599;GO:0051005;GO:0007218;GO:0048011;GO:0001503;GO:0048227;GO:1904037;GO:0006892;GO:0006622;GO:0010468;GO:0032868;GO:0016050;, C:cell surface; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network transport vesicle;, F:enzyme binding; F:nerve growth factor binding; F:nerve growth factor receptor activity; F:neurotensin receptor activity, non-G protein-coupled; F:retromer complex binding;, P:endocytosis; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:G protein-coupled receptor signaling pathway; P:glucose import; P:Golgi to endosome transport; P:Golgi to lysosome transport; P:multicellular organism development; P:myotube differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of lipoprotein lipase activity; P:neuropeptide signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:ossification; P:plasma membrane to endosome transport; P:positive regulation of epithelial cell apoptotic process; P:post-Golgi vesicle-mediated transport; P:protein targeting to lysosome; P:regulation of gene expression; P:response to insulin; P:vesicle organization;|Q99523 B4DWI3 C0JYZ0 Q8IZ49,Sortilin {ECO:0000305},100 kDa NT receptor;Glycoprotein 95;Neurotensin receptor 3;, PF15902;PF15901;, GO:0009986;GO:0005905;GO:0030136;GO:0031410;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005789;GO:0010008;GO:0005794;GO:0032580;GO:0016021;GO:0005765;GO:0005764;GO:0043025;GO:0031965;GO:0048471;GO:0005886;GO:0030140;GO:0019899;GO:0048406;GO:0010465;GO:0030379;GO:1905394;GO:0006897;GO:0008333;GO:0032509;GO:0008625;GO:0007186;GO:0046323;GO:0006895;GO:0090160;GO:0007275;GO:0014902;GO:0045599;GO:0051005;GO:0007218;GO:0048011;GO:0001503;GO:0048227;GO:1904037;GO:0006892;GO:0006622;GO:0010468;GO:0032868;GO:0016050;, C:cell surface; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network transport vesicle;, F:enzyme binding; F:nerve growth factor binding; F:nerve growth factor receptor activity; F:neurotensin receptor activity, non-G protein-coupled; F:retromer complex binding;, P:endocytosis; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:G protein-coupled receptor signaling pathway; P:glucose import; P:Golgi to endosome transport; P:Golgi to lysosome transport; P:multicellular organism development; P:myotube differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of lipoprotein lipase activity; P:neuropeptide signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:ossification; P:plasma membrane to endosome transport; P:positive regulation of epithelial cell apoptotic process; P:post-Golgi vesicle-mediated transport; P:protein targeting to lysosome; P:regulation of gene expression; P:response to insulin; P:vesicle organization;|Q99523 B4DWI3 C0JYZ0 Q8IZ49,Sortilin {ECO:0000305},100 kDa NT receptor;Glycoprotein 95;Neurotensin receptor 3;, PF15902;PF15901;, GO:0009986;GO:0005905;GO:0030136;GO:0031410;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005789;GO:0010008;GO:0005794;GO:0032580;GO:0016021;GO:0005765;GO:0005764;GO:0043025;GO:0031965;GO:0048471;GO:0005886;GO:0030140;GO:0019899;GO:0048406;GO:0010465;GO:0030379;GO:1905394;GO:0006897;GO:0008333;GO:0032509;GO:0008625;GO:0007186;GO:0046323;GO:0006895;GO:0090160;GO:0007275;GO:0014902;GO:0045599;GO:0051005;GO:0007218;GO:0048011;GO:0001503;GO:0048227;GO:1904037;GO:0006892;GO:0006622;GO:0010468;GO:0032868;GO:0016050;, C:cell surface; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network transport vesicle;, F:enzyme binding; F:nerve growth factor binding; F:nerve growth factor receptor activity; F:neurotensin receptor activity, non-G protein-coupled; F:retromer complex binding;, P:endocytosis; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:G protein-coupled receptor signaling pathway; P:glucose import; P:Golgi to endosome transport; P:Golgi to lysosome transport; P:multicellular organism development; P:myotube differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of lipoprotein lipase activity; P:neuropeptide signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:ossification; P:plasma membrane to endosome transport; P:positive regulation of epithelial cell apoptotic process; P:post-Golgi vesicle-mediated transport; P:protein targeting to lysosome; P:regulation of gene expression; P:response to insulin; P:vesicle organization;|Q99523 B4DWI3 C0JYZ0 Q8IZ49,Sortilin {ECO:0000305},100 kDa NT receptor;Glycoprotein 95;Neurotensin receptor 3;, PF15902;PF15901;, GO:0009986;GO:0005905;GO:0030136;GO:0031410;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005789;GO:0010008;GO:0005794;GO:0032580;GO:0016021;GO:0005765;GO:0005764;GO:0043025;GO:0031965;GO:0048471;GO:0005886;GO:0030140;GO:0019899;GO:0048406;GO:0010465;GO:0030379;GO:1905394;GO:0006897;GO:0008333;GO:0032509;GO:0008625;GO:0007186;GO:0046323;GO:0006895;GO:0090160;GO:0007275;GO:0014902;GO:0045599;GO:0051005;GO:0007218;GO:0048011;GO:0001503;GO:0048227;GO:1904037;GO:0006892;GO:0006622;GO:0010468;GO:0032868;GO:0016050;, C:cell surface; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network transport vesicle;, F:enzyme binding; F:nerve growth factor binding; F:nerve growth factor receptor activity; F:neurotensin receptor activity, non-G protein-coupled; F:retromer complex binding;, P:endocytosis; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:G protein-coupled receptor signaling pathway; P:glucose import; P:Golgi to endosome transport; P:Golgi to lysosome transport; P:multicellular organism development; P:myotube differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of lipoprotein lipase activity; P:neuropeptide signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:ossification; P:plasma membrane to endosome transport; P:positive regulation of epithelial cell apoptotic process; P:post-Golgi vesicle-mediated transport; P:protein targeting to lysosome; P:regulation of gene expression; P:response to insulin; P:vesicle organization;|Q99523 B4DWI3 C0JYZ0 Q8IZ49,Sortilin {ECO:0000305},100 kDa NT receptor;Glycoprotein 95;Neurotensin receptor 3;, PF15902;PF15901;, GO:0009986;GO:0005905;GO:0030136;GO:0031410;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005789;GO:0010008;GO:0005794;GO:0032580;GO:0016021;GO:0005765;GO:0005764;GO:0043025;GO:0031965;GO:0048471;GO:0005886;GO:0030140;GO:0019899;GO:0048406;GO:0010465;GO:0030379;GO:1905394;GO:0006897;GO:0008333;GO:0032509;GO:0008625;GO:0007186;GO:0046323;GO:0006895;GO:0090160;GO:0007275;GO:0014902;GO:0045599;GO:0051005;GO:0007218;GO:0048011;GO:0001503;GO:0048227;GO:1904037;GO:0006892;GO:0006622;GO:0010468;GO:0032868;GO:0016050;, C:cell surface; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network transport vesicle;, F:enzyme binding; F:nerve growth factor binding; F:nerve growth factor receptor activity; F:neurotensin receptor activity, non-G protein-coupled; F:retromer complex binding;, P:endocytosis; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:G protein-coupled receptor signaling pathway; P:glucose import; P:Golgi to endosome transport; P:Golgi to lysosome transport; P:multicellular organism development; P:myotube differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of lipoprotein lipase activity; P:neuropeptide signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:ossification; P:plasma membrane to endosome transport; P:positive regulation of epithelial cell apoptotic process; P:post-Golgi vesicle-mediated transport; P:protein targeting to lysosome; P:regulation of gene expression; P:response to insulin; P:vesicle organization;|Q3ZAQ7 A6NKV7 B3KUA9,Vacuolar ATPase assembly integral membrane protein VMA21 {ECO:0000255|HAMAP-Rule:MF_03058},Myopathy with excessive autophagy protein;, PF09446;, GO:0005789;GO:0033116;GO:0012507;GO:0016021;GO:0005764;GO:0005773;GO:0043462;GO:0070072;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:integral component of membrane; C:lysosome; C:vacuole;, , P:regulation of ATPase activity; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q99523 B4DWI3 C0JYZ0 Q8IZ49,Sortilin {ECO:0000305},100 kDa NT receptor;Glycoprotein 95;Neurotensin receptor 3;, PF15902;PF15901;, GO:0009986;GO:0005905;GO:0030136;GO:0031410;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005789;GO:0010008;GO:0005794;GO:0032580;GO:0016021;GO:0005765;GO:0005764;GO:0043025;GO:0031965;GO:0048471;GO:0005886;GO:0030140;GO:0019899;GO:0048406;GO:0010465;GO:0030379;GO:1905394;GO:0006897;GO:0008333;GO:0032509;GO:0008625;GO:0007186;GO:0046323;GO:0006895;GO:0090160;GO:0007275;GO:0014902;GO:0045599;GO:0051005;GO:0007218;GO:0048011;GO:0001503;GO:0048227;GO:1904037;GO:0006892;GO:0006622;GO:0010468;GO:0032868;GO:0016050;, C:cell surface; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network transport vesicle;, F:enzyme binding; F:nerve growth factor binding; F:nerve growth factor receptor activity; F:neurotensin receptor activity, non-G protein-coupled; F:retromer complex binding;, P:endocytosis; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:G protein-coupled receptor signaling pathway; P:glucose import; P:Golgi to endosome transport; P:Golgi to lysosome transport; P:multicellular organism development; P:myotube differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of lipoprotein lipase activity; P:neuropeptide signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:ossification; P:plasma membrane to endosome transport; P:positive regulation of epithelial cell apoptotic process; P:post-Golgi vesicle-mediated transport; P:protein targeting to lysosome; P:regulation of gene expression; P:response to insulin; P:vesicle organization; scaffold5 indexed_genome mRNA 61174465 61195202 . + . ID=transcript_1507;P28066 B2R8F6 B4E2V4 Q3T1C1 Q6IBF7,Proteasome subunit alpha type-5,Macropain zeta chain;Multicatalytic endopeptidase complex zeta chain;Proteasome zeta chain;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0034774;GO:0004175;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:secretory granule lumen;, F:endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P28066 B2R8F6 B4E2V4 Q3T1C1 Q6IBF7,Proteasome subunit alpha type-5,Macropain zeta chain;Multicatalytic endopeptidase complex zeta chain;Proteasome zeta chain;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0034774;GO:0004175;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:secretory granule lumen;, F:endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P28066 B2R8F6 B4E2V4 Q3T1C1 Q6IBF7,Proteasome subunit alpha type-5,Macropain zeta chain;Multicatalytic endopeptidase complex zeta chain;Proteasome zeta chain;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0034774;GO:0004175;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:secretory granule lumen;, F:endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P28066 B2R8F6 B4E2V4 Q3T1C1 Q6IBF7,Proteasome subunit alpha type-5,Macropain zeta chain;Multicatalytic endopeptidase complex zeta chain;Proteasome zeta chain;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0034774;GO:0004175;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:secretory granule lumen;, F:endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P28066 B2R8F6 B4E2V4 Q3T1C1 Q6IBF7,Proteasome subunit alpha type-5,Macropain zeta chain;Multicatalytic endopeptidase complex zeta chain;Proteasome zeta chain;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0034774;GO:0004175;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:secretory granule lumen;, F:endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P28066 B2R8F6 B4E2V4 Q3T1C1 Q6IBF7,Proteasome subunit alpha type-5,Macropain zeta chain;Multicatalytic endopeptidase complex zeta chain;Proteasome zeta chain;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0034774;GO:0004175;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:secretory granule lumen;, F:endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold5 indexed_genome mRNA 61226256 61240760 . + . ID=transcript_1508;Q5VXT5 A8K0E8 A8KAL7 I0IT67 Q6ZMX1,Synaptophysin-like protein 2,, PF01284;, GO:0016021;GO:0030672;GO:0017075;GO:0006874;GO:0007507;GO:0021762;GO:0033292;, C:integral component of membrane; C:synaptic vesicle membrane;, F:syntaxin-1 binding;, P:cellular calcium ion homeostasis; P:heart development; P:substantia nigra development; P:T-tubule organization; scaffold5 indexed_genome mRNA 61242447 61251213 . - . ID=transcript_1509;Q5T6C5,Ataxin-7-like protein 2,, PF08313;|Q5T6C5,Ataxin-7-like protein 2,, PF08313;|Q5T6C5,Ataxin-7-like protein 2,, PF08313;|Q5T6C5,Ataxin-7-like protein 2,, PF08313;|Q5T6C5,Ataxin-7-like protein 2,, PF08313; scaffold5 indexed_genome mRNA 61251247 61267170 . + . ID=transcript_1510;Q8N8Q1 B4DH97 E9PCM8 Q52M36 Q5T6C2 Q5T6C3,Cytochrome b561 domain-containing protein 1,, PF03188;, GO:0016021;GO:0020037;GO:0046872;GO:0016491;, C:integral component of membrane;, F:heme binding; F:metal ion binding; F:oxidoreductase activity;|Q86WK6 B4DIM3 Q8IW71 Q9ULQ7,Amphoterin-induced protein 1,AMIGO-1;Alivin-2;, PF07679;PF13855;, GO:0030425;GO:0016021;GO:0032809;GO:1990030;GO:0043204;GO:0008076;GO:0015459;GO:0007413;GO:0007409;GO:0007420;GO:1905232;GO:0007157;GO:0007156;GO:0042552;GO:0050772;GO:0010976;GO:1901381;GO:0051965;GO:1903818;, C:dendrite; C:integral component of membrane; C:neuronal cell body membrane; C:pericellular basket; C:perikaryon; C:voltage-gated potassium channel complex;, F:potassium channel regulator activity;, P:axonal fasciculation; P:axonogenesis; P:brain development; P:cellular response to L-glutamate; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:myelination; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of synapse assembly; P:positive regulation of voltage-gated potassium channel activity; scaffold5 indexed_genome mRNA 61296997 61302661 . + . ID=transcript_1511;Q9BZJ8 A8K1W2 Q6NWS0 Q8TDV4 Q96PR4,G-protein coupled receptor 61 {ECO:0000305},Biogenic amine receptor-like G-protein coupled receptor {ECO:0000303|PubMed:11690637};, PF00001;, GO:0005768;GO:0010008;GO:0016021;GO:0005886;GO:0043235;GO:1990763;GO:0004930;GO:0007186;GO:0043950;, C:endosome; C:endosome membrane; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:arrestin family protein binding; F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of cAMP-mediated signaling; scaffold5 indexed_genome mRNA 61306502 61347405 . + . ID=transcript_1512;P08754 P17539 Q5TZX1,Guanine nucleotide-binding protein G(i) subunit alpha-3,G(i) alpha-3;, PF00503;, GO:0005813;GO:0005737;GO:0070062;GO:0005794;GO:0005834;GO:0005765;GO:0016020;GO:0045121;GO:0030496;GO:0005886;GO:0042588;GO:0001664;GO:0031821;GO:0031683;GO:0019003;GO:0005525;GO:0032794;GO:0003924;GO:0046872;GO:0019904;GO:0007193;GO:0007188;GO:0007420;GO:0007049;GO:0051301;GO:0007212;GO:0007186;GO:0046039;GO:0007194;GO:2001234;GO:0030168;GO:0016239;GO:0033864;GO:0032930;GO:1904707;GO:0006457;GO:0006906;, C:centrosome; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:membrane raft; C:midbody; C:plasma membrane; C:zymogen granule;, F:G protein-coupled receptor binding; F:G protein-coupled serotonin receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GDP binding; F:GTP binding; F:GTPase activating protein binding; F:GTPase activity; F:metal ion binding; F:protein domain specific binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:brain development; P:cell cycle; P:cell division; P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:GTP metabolic process; P:negative regulation of adenylate cyclase activity; P:negative regulation of apoptotic signaling pathway; P:platelet activation; P:positive regulation of macroautophagy; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of superoxide anion generation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein folding; P:vesicle fusion;|P08754 P17539 Q5TZX1,Guanine nucleotide-binding protein G(i) subunit alpha-3,G(i) alpha-3;, PF00503;, GO:0005813;GO:0005737;GO:0070062;GO:0005794;GO:0005834;GO:0005765;GO:0016020;GO:0045121;GO:0030496;GO:0005886;GO:0042588;GO:0001664;GO:0031821;GO:0031683;GO:0019003;GO:0005525;GO:0032794;GO:0003924;GO:0046872;GO:0019904;GO:0007193;GO:0007188;GO:0007420;GO:0007049;GO:0051301;GO:0007212;GO:0007186;GO:0046039;GO:0007194;GO:2001234;GO:0030168;GO:0016239;GO:0033864;GO:0032930;GO:1904707;GO:0006457;GO:0006906;, C:centrosome; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:membrane raft; C:midbody; C:plasma membrane; C:zymogen granule;, F:G protein-coupled receptor binding; F:G protein-coupled serotonin receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GDP binding; F:GTP binding; F:GTPase activating protein binding; F:GTPase activity; F:metal ion binding; F:protein domain specific binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:brain development; P:cell cycle; P:cell division; P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:GTP metabolic process; P:negative regulation of adenylate cyclase activity; P:negative regulation of apoptotic signaling pathway; P:platelet activation; P:positive regulation of macroautophagy; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of superoxide anion generation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein folding; P:vesicle fusion;|P08754 P17539 Q5TZX1,Guanine nucleotide-binding protein G(i) subunit alpha-3,G(i) alpha-3;, PF00503;, GO:0005813;GO:0005737;GO:0070062;GO:0005794;GO:0005834;GO:0005765;GO:0016020;GO:0045121;GO:0030496;GO:0005886;GO:0042588;GO:0001664;GO:0031821;GO:0031683;GO:0019003;GO:0005525;GO:0032794;GO:0003924;GO:0046872;GO:0019904;GO:0007193;GO:0007188;GO:0007420;GO:0007049;GO:0051301;GO:0007212;GO:0007186;GO:0046039;GO:0007194;GO:2001234;GO:0030168;GO:0016239;GO:0033864;GO:0032930;GO:1904707;GO:0006457;GO:0006906;, C:centrosome; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:membrane raft; C:midbody; C:plasma membrane; C:zymogen granule;, F:G protein-coupled receptor binding; F:G protein-coupled serotonin receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GDP binding; F:GTP binding; F:GTPase activating protein binding; F:GTPase activity; F:metal ion binding; F:protein domain specific binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:brain development; P:cell cycle; P:cell division; P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:GTP metabolic process; P:negative regulation of adenylate cyclase activity; P:negative regulation of apoptotic signaling pathway; P:platelet activation; P:positive regulation of macroautophagy; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of superoxide anion generation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein folding; P:vesicle fusion; scaffold5 indexed_genome mRNA 61356672 61360654 . - . ID=transcript_1513;P19087,Guanine nucleotide-binding protein G(t) subunit alpha-2,Transducin alpha-2 chain;, PF00503;, GO:0005834;GO:0001917;GO:0001750;GO:0042622;GO:0005886;GO:0008020;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007188;GO:0001580;GO:0050908;GO:0007186;GO:0007602;GO:0006457;GO:0007601;GO:0007223;, C:heterotrimeric G-protein complex; C:photoreceptor inner segment; C:photoreceptor outer segment; C:photoreceptor outer segment membrane; C:plasma membrane;, F:G protein-coupled photoreceptor activity; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:detection of light stimulus involved in visual perception; P:G protein-coupled receptor signaling pathway; P:phototransduction; P:protein folding; P:visual perception; P:Wnt signaling pathway, calcium modulating pathway; scaffold5 indexed_genome mRNA 61361480 61362039 . - . ID=transcript_1514;P19087,Guanine nucleotide-binding protein G(t) subunit alpha-2,Transducin alpha-2 chain;, PF00503;, GO:0005834;GO:0001917;GO:0001750;GO:0042622;GO:0005886;GO:0008020;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007188;GO:0001580;GO:0050908;GO:0007186;GO:0007602;GO:0006457;GO:0007601;GO:0007223;, C:heterotrimeric G-protein complex; C:photoreceptor inner segment; C:photoreceptor outer segment; C:photoreceptor outer segment membrane; C:plasma membrane;, F:G protein-coupled photoreceptor activity; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:detection of light stimulus involved in visual perception; P:G protein-coupled receptor signaling pathway; P:phototransduction; P:protein folding; P:visual perception; P:Wnt signaling pathway, calcium modulating pathway; scaffold5 indexed_genome mRNA 61362541 61363215 . - . ID=transcript_1515;P19087,Guanine nucleotide-binding protein G(t) subunit alpha-2,Transducin alpha-2 chain;, PF00503;, GO:0005834;GO:0001917;GO:0001750;GO:0042622;GO:0005886;GO:0008020;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007188;GO:0001580;GO:0050908;GO:0007186;GO:0007602;GO:0006457;GO:0007601;GO:0007223;, C:heterotrimeric G-protein complex; C:photoreceptor inner segment; C:photoreceptor outer segment; C:photoreceptor outer segment membrane; C:plasma membrane;, F:G protein-coupled photoreceptor activity; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:detection of light stimulus involved in visual perception; P:G protein-coupled receptor signaling pathway; P:phototransduction; P:protein folding; P:visual perception; P:Wnt signaling pathway, calcium modulating pathway; scaffold5 indexed_genome mRNA 61364390 61365817 . - . ID=transcript_1516;P19087,Guanine nucleotide-binding protein G(t) subunit alpha-2,Transducin alpha-2 chain;, PF00503;, GO:0005834;GO:0001917;GO:0001750;GO:0042622;GO:0005886;GO:0008020;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007188;GO:0001580;GO:0050908;GO:0007186;GO:0007602;GO:0006457;GO:0007601;GO:0007223;, C:heterotrimeric G-protein complex; C:photoreceptor inner segment; C:photoreceptor outer segment; C:photoreceptor outer segment membrane; C:plasma membrane;, F:G protein-coupled photoreceptor activity; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:detection of light stimulus involved in visual perception; P:G protein-coupled receptor signaling pathway; P:phototransduction; P:protein folding; P:visual perception; P:Wnt signaling pathway, calcium modulating pathway; scaffold5 indexed_genome mRNA 61372133 61385407 . + . ID=transcript_1517;Q16729 Q5T693 Q5T695 Q96IA1 Q9UDX8 Q9UDX9 Q9UMU4,AMP deaminase 2,AMP deaminase isoform L;, PF00962;, GO:0005829;GO:0003876;GO:0042802;GO:0046872;GO:0046033;GO:0052652;GO:0097009;GO:0006188;GO:0032264;GO:0043101;, C:cytosol;, F:AMP deaminase activity; F:identical protein binding; F:metal ion binding;, P:AMP metabolic process; P:cyclic purine nucleotide metabolic process; P:energy homeostasis; P:IMP biosynthetic process; P:IMP salvage; P:purine-containing compound salvage;|Q16729 Q5T693 Q5T695 Q96IA1 Q9UDX8 Q9UDX9 Q9UMU4,AMP deaminase 2,AMP deaminase isoform L;, PF00962;, GO:0005829;GO:0003876;GO:0042802;GO:0046872;GO:0046033;GO:0052652;GO:0097009;GO:0006188;GO:0032264;GO:0043101;, C:cytosol;, F:AMP deaminase activity; F:identical protein binding; F:metal ion binding;, P:AMP metabolic process; P:cyclic purine nucleotide metabolic process; P:energy homeostasis; P:IMP biosynthetic process; P:IMP salvage; P:purine-containing compound salvage;|Q16729 Q5T693 Q5T695 Q96IA1 Q9UDX8 Q9UDX9 Q9UMU4,AMP deaminase 2,AMP deaminase isoform L;, PF00962;, GO:0005829;GO:0003876;GO:0042802;GO:0046872;GO:0046033;GO:0052652;GO:0097009;GO:0006188;GO:0032264;GO:0043101;, C:cytosol;, F:AMP deaminase activity; F:identical protein binding; F:metal ion binding;, P:AMP metabolic process; P:cyclic purine nucleotide metabolic process; P:energy homeostasis; P:IMP biosynthetic process; P:IMP salvage; P:purine-containing compound salvage;|Q16729 Q5T693 Q5T695 Q96IA1 Q9UDX8 Q9UDX9 Q9UMU4,AMP deaminase 2,AMP deaminase isoform L;, PF00962;, GO:0005829;GO:0003876;GO:0042802;GO:0046872;GO:0046033;GO:0052652;GO:0097009;GO:0006188;GO:0032264;GO:0043101;, C:cytosol;, F:AMP deaminase activity; F:identical protein binding; F:metal ion binding;, P:AMP metabolic process; P:cyclic purine nucleotide metabolic process; P:energy homeostasis; P:IMP biosynthetic process; P:IMP salvage; P:purine-containing compound salvage;|Q16729 Q5T693 Q5T695 Q96IA1 Q9UDX8 Q9UDX9 Q9UMU4,AMP deaminase 2,AMP deaminase isoform L;, PF00962;, GO:0005829;GO:0003876;GO:0042802;GO:0046872;GO:0046033;GO:0052652;GO:0097009;GO:0006188;GO:0032264;GO:0043101;, C:cytosol;, F:AMP deaminase activity; F:identical protein binding; F:metal ion binding;, P:AMP metabolic process; P:cyclic purine nucleotide metabolic process; P:energy homeostasis; P:IMP biosynthetic process; P:IMP salvage; P:purine-containing compound salvage; scaffold5 indexed_genome mRNA 61436833 61442879 . + . ID=transcript_1518;P46439 A8K0V8 Q6PD78,Glutathione S-transferase Mu 5,GST class-mu 5;GSTM5-5;, PF00043;PF02798;, GO:0005829;GO:0045171;GO:0004364;GO:0042802;GO:1901687;GO:0006749;, C:cytosol; C:intercellular bridge;, F:glutathione transferase activity; F:identical protein binding;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process;|P09488 Q5GHG0 Q6FH88 Q8TC98 Q9UC96,Glutathione S-transferase Mu 1 {ECO:0000305},GST HB subunit 4;GST class-mu 1;GSTM1-1;GSTM1a-1a;GSTM1b-1b;GTH4;, PF14497;PF02798;, GO:0005737;GO:0005829;GO:0045171;GO:0019899;GO:0043295;GO:0004364;GO:0042803;GO:0070458;GO:1901687;GO:0006749;GO:0051122;GO:0018916;GO:0006693;GO:0042178;, C:cytoplasm; C:cytosol; C:intercellular bridge;, F:enzyme binding; F:glutathione binding; F:glutathione transferase activity; F:protein homodimerization activity;, P:cellular detoxification of nitrogen compound; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:hepoxilin biosynthetic process; P:nitrobenzene metabolic process; P:prostaglandin metabolic process; P:xenobiotic catabolic process; scaffold5 indexed_genome mRNA 61506654 61528795 . + . ID=transcript_1519;Q03013 A8K765 Q05465 Q32NC1 Q4JNT8 Q6FH87,Glutathione S-transferase Mu 4,GST class-mu 4;GST-Mu2;GSTM4-4;Leukotriene C4 synthase GSTM4;, PF14497;PF02798;, GO:0005737;GO:0005829;GO:0045171;GO:0019899;GO:0043295;GO:0004364;GO:0004464;GO:0042803;GO:1901687;GO:0006749;GO:0042759;GO:0018916;GO:0042178;, C:cytoplasm; C:cytosol; C:intercellular bridge;, F:enzyme binding; F:glutathione binding; F:glutathione transferase activity; F:leukotriene-C4 synthase activity; F:protein homodimerization activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:long-chain fatty acid biosynthetic process; P:nitrobenzene metabolic process; P:xenobiotic catabolic process;|Q03013 A8K765 Q05465 Q32NC1 Q4JNT8 Q6FH87,Glutathione S-transferase Mu 4,GST class-mu 4;GST-Mu2;GSTM4-4;Leukotriene C4 synthase GSTM4;, PF14497;PF02798;, GO:0005737;GO:0005829;GO:0045171;GO:0019899;GO:0043295;GO:0004364;GO:0004464;GO:0042803;GO:1901687;GO:0006749;GO:0042759;GO:0018916;GO:0042178;, C:cytoplasm; C:cytosol; C:intercellular bridge;, F:enzyme binding; F:glutathione binding; F:glutathione transferase activity; F:leukotriene-C4 synthase activity; F:protein homodimerization activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:long-chain fatty acid biosynthetic process; P:nitrobenzene metabolic process; P:xenobiotic catabolic process; scaffold5 indexed_genome mRNA 61538576 61541853 . - . ID=transcript_1520;P21266 O60550 Q96HA3,Glutathione S-transferase Mu 3,GST class-mu 3;GSTM3-3;, PF00043;PF02798;, GO:0005737;GO:0005829;GO:0070062;GO:0045171;GO:0005634;GO:0035686;GO:0019899;GO:0043295;GO:0004364;GO:0042802;GO:0042803;GO:0070458;GO:0008065;GO:1901687;GO:0006749;GO:0018916;GO:0043627;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercellular bridge; C:nucleus; C:sperm fibrous sheath;, F:enzyme binding; F:glutathione binding; F:glutathione transferase activity; F:identical protein binding; F:protein homodimerization activity;, P:cellular detoxification of nitrogen compound; P:establishment of blood-nerve barrier; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:nitrobenzene metabolic process; P:response to estrogen; P:xenobiotic catabolic process;|P21266 O60550 Q96HA3,Glutathione S-transferase Mu 3,GST class-mu 3;GSTM3-3;, PF00043;PF02798;, GO:0005737;GO:0005829;GO:0070062;GO:0045171;GO:0005634;GO:0035686;GO:0019899;GO:0043295;GO:0004364;GO:0042802;GO:0042803;GO:0070458;GO:0008065;GO:1901687;GO:0006749;GO:0018916;GO:0043627;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercellular bridge; C:nucleus; C:sperm fibrous sheath;, F:enzyme binding; F:glutathione binding; F:glutathione transferase activity; F:identical protein binding; F:protein homodimerization activity;, P:cellular detoxification of nitrogen compound; P:establishment of blood-nerve barrier; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:nitrobenzene metabolic process; P:response to estrogen; P:xenobiotic catabolic process;|P21266 O60550 Q96HA3,Glutathione S-transferase Mu 3,GST class-mu 3;GSTM3-3;, PF00043;PF02798;, GO:0005737;GO:0005829;GO:0070062;GO:0045171;GO:0005634;GO:0035686;GO:0019899;GO:0043295;GO:0004364;GO:0042802;GO:0042803;GO:0070458;GO:0008065;GO:1901687;GO:0006749;GO:0018916;GO:0043627;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercellular bridge; C:nucleus; C:sperm fibrous sheath;, F:enzyme binding; F:glutathione binding; F:glutathione transferase activity; F:identical protein binding; F:protein homodimerization activity;, P:cellular detoxification of nitrogen compound; P:establishment of blood-nerve barrier; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:nitrobenzene metabolic process; P:response to estrogen; P:xenobiotic catabolic process; scaffold5 indexed_genome mRNA 61678786 61701462 . + . ID=transcript_1521;P09603 A8K6J5 Q13130 Q14086 Q14806 Q5VVF3 Q5VVF4 Q9UQR8,Macrophage colony-stimulating factor 1,Lanimostim;, PF05337;, GO:1990682;GO:0005788;GO:0005576;GO:0005615;GO:0016021;GO:0016020;GO:0016604;GO:0048471;GO:0005886;GO:0005125;GO:0008083;GO:0042802;GO:0005157;GO:0042803;GO:0060444;GO:0044267;GO:0019221;GO:0003006;GO:0048873;GO:0006954;GO:0045087;GO:0038145;GO:0030225;GO:0060763;GO:0060611;GO:0061518;GO:0042117;GO:1901215;GO:0030316;GO:0002158;GO:0030335;GO:0008284;GO:0001954;GO:0032270;GO:0010628;GO:0010759;GO:1902228;GO:0010744;GO:0045651;GO:1904141;GO:0045657;GO:0032946;GO:0040018;GO:0042488;GO:0045672;GO:0045860;GO:0046579;GO:0043687;GO:0010743;GO:0030278;GO:0002931;GO:0007169;, C:CSF1-CSF1R complex; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane; C:nuclear body; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cytokine activity; F:growth factor activity; F:identical protein binding; F:macrophage colony-stimulating factor receptor binding; F:protein homodimerization activity;, P:branching involved in mammary gland duct morphogenesis; P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:developmental process involved in reproduction; P:homeostasis of number of cells within a tissue; P:inflammatory response; P:innate immune response; P:macrophage colony-stimulating factor signaling pathway; P:macrophage differentiation; P:mammary duct terminal end bud growth; P:mammary gland fat development; P:microglial cell proliferation; P:monocyte activation; P:negative regulation of neuron death; P:osteoclast differentiation; P:osteoclast proliferation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of cellular protein metabolic process; P:positive regulation of gene expression; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage colony-stimulating factor signaling pathway; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of macrophage differentiation; P:positive regulation of microglial cell migration; P:positive regulation of monocyte differentiation; P:positive regulation of mononuclear cell proliferation; P:positive regulation of multicellular organism growth; P:positive regulation of odontogenesis of dentin-containing tooth; P:positive regulation of osteoclast differentiation; P:positive regulation of protein kinase activity; P:positive regulation of Ras protein signal transduction; P:post-translational protein modification; P:regulation of macrophage derived foam cell differentiation; P:regulation of ossification; P:response to ischemia; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold5 indexed_genome mRNA 61747372 61790153 . + . ID=transcript_1522;O43865 B4E168 Q2TAJ6 Q502W8 Q5VSM0 Q6P171 Q96PK4 Q9UG84,S-adenosylhomocysteine hydrolase-like protein 1 {ECO:0000312|HGNC:HGNC:344},DC-expressed AHCY-like molecule;IP(3)Rs binding protein released with IP(3);Putative adenosylhomocysteinase 2;S-adenosyl-L-homocysteine hydrolase 2;, PF05221;PF00670;, GO:0016324;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0044233;GO:0042802;GO:0003723;GO:0038166;GO:0006915;GO:0042045;GO:1990456;GO:0006378;GO:0006730;GO:0010765;GO:0006611;GO:0044070;GO:1903779;GO:0032412;GO:0031440;GO:0051592;GO:0033353;, C:apical plasma membrane; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:mitochondria-associated endoplasmic reticulum membrane;, F:identical protein binding; F:RNA binding;, P:angiotensin-activated signaling pathway; P:apoptotic process; P:epithelial fluid transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:mRNA polyadenylation; P:one-carbon metabolic process; P:positive regulation of sodium ion transport; P:protein export from nucleus; P:regulation of anion transport; P:regulation of cardiac conduction; P:regulation of ion transmembrane transporter activity; P:regulation of mRNA 3'-end processing; P:response to calcium ion; P:S-adenosylmethionine cycle;|Q96HN2 B4DIZ5 D9N155 O94917,Adenosylhomocysteinase 3,IP(3)Rs binding protein released with IP(3) 2;Long-IRBIT {ECO:0000303|PubMed:19220705};S-adenosyl-L-homocysteine hydrolase 3;S-adenosylhomocysteine hydrolase-like protein 2;, PF05221;PF00670;, GO:0005829;GO:0005783;GO:0043005;GO:0016787;GO:0006730;GO:0033353;, C:cytosol; C:endoplasmic reticulum; C:neuron projection;, F:hydrolase activity;, P:one-carbon metabolic process; P:S-adenosylmethionine cycle;|Q96HN2 B4DIZ5 D9N155 O94917,Adenosylhomocysteinase 3,IP(3)Rs binding protein released with IP(3) 2;Long-IRBIT {ECO:0000303|PubMed:19220705};S-adenosyl-L-homocysteine hydrolase 3;S-adenosylhomocysteine hydrolase-like protein 2;, PF05221;PF00670;, GO:0005829;GO:0005783;GO:0043005;GO:0016787;GO:0006730;GO:0033353;, C:cytosol; C:endoplasmic reticulum; C:neuron projection;, F:hydrolase activity;, P:one-carbon metabolic process; P:S-adenosylmethionine cycle;|O43865 B4E168 Q2TAJ6 Q502W8 Q5VSM0 Q6P171 Q96PK4 Q9UG84,S-adenosylhomocysteine hydrolase-like protein 1 {ECO:0000312|HGNC:HGNC:344},DC-expressed AHCY-like molecule;IP(3)Rs binding protein released with IP(3);Putative adenosylhomocysteinase 2;S-adenosyl-L-homocysteine hydrolase 2;, PF05221;PF00670;, GO:0016324;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0044233;GO:0042802;GO:0003723;GO:0038166;GO:0006915;GO:0042045;GO:1990456;GO:0006378;GO:0006730;GO:0010765;GO:0006611;GO:0044070;GO:1903779;GO:0032412;GO:0031440;GO:0051592;GO:0033353;, C:apical plasma membrane; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:mitochondria-associated endoplasmic reticulum membrane;, F:identical protein binding; F:RNA binding;, P:angiotensin-activated signaling pathway; P:apoptotic process; P:epithelial fluid transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:mRNA polyadenylation; P:one-carbon metabolic process; P:positive regulation of sodium ion transport; P:protein export from nucleus; P:regulation of anion transport; P:regulation of cardiac conduction; P:regulation of ion transmembrane transporter activity; P:regulation of mRNA 3'-end processing; P:response to calcium ion; P:S-adenosylmethionine cycle;|O43865 B4E168 Q2TAJ6 Q502W8 Q5VSM0 Q6P171 Q96PK4 Q9UG84,S-adenosylhomocysteine hydrolase-like protein 1 {ECO:0000312|HGNC:HGNC:344},DC-expressed AHCY-like molecule;IP(3)Rs binding protein released with IP(3);Putative adenosylhomocysteinase 2;S-adenosyl-L-homocysteine hydrolase 2;, PF05221;PF00670;, GO:0016324;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0044233;GO:0042802;GO:0003723;GO:0038166;GO:0006915;GO:0042045;GO:1990456;GO:0006378;GO:0006730;GO:0010765;GO:0006611;GO:0044070;GO:1903779;GO:0032412;GO:0031440;GO:0051592;GO:0033353;, C:apical plasma membrane; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:mitochondria-associated endoplasmic reticulum membrane;, F:identical protein binding; F:RNA binding;, P:angiotensin-activated signaling pathway; P:apoptotic process; P:epithelial fluid transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:mRNA polyadenylation; P:one-carbon metabolic process; P:positive regulation of sodium ion transport; P:protein export from nucleus; P:regulation of anion transport; P:regulation of cardiac conduction; P:regulation of ion transmembrane transporter activity; P:regulation of mRNA 3'-end processing; P:response to calcium ion; P:S-adenosylmethionine cycle; scaffold5 indexed_genome mRNA 61801484 61819471 . + . ID=transcript_1523;Q5VSL9 Q0V925 Q5VSL8 Q658K2 Q6ZV31 Q8N598 Q96SN2 Q9C0A2,Striatin-interacting protein 1,Protein FAM40A;, PF11882;PF07923;, GO:0005829;GO:0070062;GO:0005634;GO:0019901;GO:0031267;GO:0030866;GO:0007010;GO:0022604;, C:cytosol; C:extracellular exosome; C:nucleus;, F:protein kinase binding; F:small GTPase binding;, P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell morphogenesis;|Q5VSL9 Q0V925 Q5VSL8 Q658K2 Q6ZV31 Q8N598 Q96SN2 Q9C0A2,Striatin-interacting protein 1,Protein FAM40A;, PF11882;PF07923;, GO:0005829;GO:0070062;GO:0005634;GO:0019901;GO:0031267;GO:0030866;GO:0007010;GO:0022604;, C:cytosol; C:extracellular exosome; C:nucleus;, F:protein kinase binding; F:small GTPase binding;, P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell morphogenesis;|Q5VSL9 Q0V925 Q5VSL8 Q658K2 Q6ZV31 Q8N598 Q96SN2 Q9C0A2,Striatin-interacting protein 1,Protein FAM40A;, PF11882;PF07923;, GO:0005829;GO:0070062;GO:0005634;GO:0019901;GO:0031267;GO:0030866;GO:0007010;GO:0022604;, C:cytosol; C:extracellular exosome; C:nucleus;, F:protein kinase binding; F:small GTPase binding;, P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell morphogenesis; scaffold5 indexed_genome mRNA 61908256 61962232 . + . ID=transcript_1524;Q9H1V8 A6NEA8 A8K1R7 B9EIR5 Q5T5Q9,Sodium-dependent neutral amino acid transporter SLC6A17,Sodium-dependent neurotransmitter transporter NTT4;Solute carrier family 6 member 17;, PF00209;, GO:0042995;GO:0098982;GO:0098978;GO:0005887;GO:0030285;GO:0098794;GO:0008021;GO:0015293;GO:0032328;GO:0007420;GO:0015816;GO:0015820;GO:0006836;GO:0015804;GO:0015824;GO:0035725;GO:0150104;, C:cell projection; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:postsynapse; C:synaptic vesicle;, F:symporter activity;, P:alanine transport; P:brain development; P:glycine transport; P:leucine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:proline transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier;|Q9H1V8 A6NEA8 A8K1R7 B9EIR5 Q5T5Q9,Sodium-dependent neutral amino acid transporter SLC6A17,Sodium-dependent neurotransmitter transporter NTT4;Solute carrier family 6 member 17;, PF00209;, GO:0042995;GO:0098982;GO:0098978;GO:0005887;GO:0030285;GO:0098794;GO:0008021;GO:0015293;GO:0032328;GO:0007420;GO:0015816;GO:0015820;GO:0006836;GO:0015804;GO:0015824;GO:0035725;GO:0150104;, C:cell projection; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:postsynapse; C:synaptic vesicle;, F:symporter activity;, P:alanine transport; P:brain development; P:glycine transport; P:leucine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:proline transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier;|Q9H1V8 A6NEA8 A8K1R7 B9EIR5 Q5T5Q9,Sodium-dependent neutral amino acid transporter SLC6A17,Sodium-dependent neurotransmitter transporter NTT4;Solute carrier family 6 member 17;, PF00209;, GO:0042995;GO:0098982;GO:0098978;GO:0005887;GO:0030285;GO:0098794;GO:0008021;GO:0015293;GO:0032328;GO:0007420;GO:0015816;GO:0015820;GO:0006836;GO:0015804;GO:0015824;GO:0035725;GO:0150104;, C:cell projection; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:postsynapse; C:synaptic vesicle;, F:symporter activity;, P:alanine transport; P:brain development; P:glycine transport; P:leucine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:proline transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier;|Q9H1V8 A6NEA8 A8K1R7 B9EIR5 Q5T5Q9,Sodium-dependent neutral amino acid transporter SLC6A17,Sodium-dependent neurotransmitter transporter NTT4;Solute carrier family 6 member 17;, PF00209;, GO:0042995;GO:0098982;GO:0098978;GO:0005887;GO:0030285;GO:0098794;GO:0008021;GO:0015293;GO:0032328;GO:0007420;GO:0015816;GO:0015820;GO:0006836;GO:0015804;GO:0015824;GO:0035725;GO:0150104;, C:cell projection; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:postsynapse; C:synaptic vesicle;, F:symporter activity;, P:alanine transport; P:brain development; P:glycine transport; P:leucine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:proline transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier; scaffold5 indexed_genome mRNA 61969988 61987437 . + . ID=transcript_1525;Q03721 Q3MIM4 Q5TBI6,Potassium voltage-gated channel subfamily C member 4,KSHIIIC;Voltage-gated potassium channel subunit Kv3.4;, PF02214;PF00520;PF11404;, GO:0030424;GO:0032590;GO:0016021;GO:0032809;GO:0005886;GO:0045202;GO:0008076;GO:0005251;GO:0005267;GO:0005249;GO:0007268;GO:0071805;GO:0006813;GO:0051260;GO:0034765;, C:axon; C:dendrite membrane; C:integral component of membrane; C:neuronal cell body membrane; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:potassium channel activity; F:voltage-gated potassium channel activity;, P:chemical synaptic transmission; P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:regulation of ion transmembrane transport; scaffold5 indexed_genome mRNA 62086307 62093650 . + . ID=transcript_1526;Q96SC6 Q96SC9 Q96SD0 Q96T38 Q9BRA5 Q9H6R8 Q9H9Y0,RNA-binding protein 15 {ECO:0000305},One-twenty two protein 1 {ECO:0000303|PubMed:16129689};RNA-binding motif protein 15 {ECO:0000303|PubMed:11431691};, PF00076;PF07744;, GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0036396;GO:0003729;GO:0003676;GO:0003723;GO:0001569;GO:0009048;GO:0000398;GO:0045638;GO:0060674;GO:0007221;GO:0000381;GO:0045652;GO:0001510;GO:0048536;GO:0038163;GO:0060412;GO:0016032;, C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:mRNA binding; F:nucleic acid binding; F:RNA binding;, P:branching involved in blood vessel morphogenesis; P:dosage compensation by inactivation of X chromosome; P:mRNA splicing, via spliceosome; P:negative regulation of myeloid cell differentiation; P:placenta blood vessel development; P:positive regulation of transcription of Notch receptor target; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of megakaryocyte differentiation; P:RNA methylation; P:spleen development; P:thrombopoietin-mediated signaling pathway; P:ventricular septum morphogenesis; P:viral process; scaffold5 indexed_genome mRNA 62105529 62135156 . - . ID=transcript_1527;O15374 A8K3V5 B2R9C9 B4DJ67 B4DPX7 E7EPY8 G3V175 Q5T612 Q8WU09,Monocarboxylate transporter 5,Monocarboxylate transporter 4;Solute carrier family 16 member 4;, PF07690;, GO:0016021;GO:0005887;GO:0016020;GO:0008028;GO:0015293;GO:0015718;, C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport;|O15374 A8K3V5 B2R9C9 B4DJ67 B4DPX7 E7EPY8 G3V175 Q5T612 Q8WU09,Monocarboxylate transporter 5,Monocarboxylate transporter 4;Solute carrier family 16 member 4;, PF07690;, GO:0016021;GO:0005887;GO:0016020;GO:0008028;GO:0015293;GO:0015718;, C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport;|O15374 A8K3V5 B2R9C9 B4DJ67 B4DPX7 E7EPY8 G3V175 Q5T612 Q8WU09,Monocarboxylate transporter 5,Monocarboxylate transporter 4;Solute carrier family 16 member 4;, PF07690;, GO:0016021;GO:0005887;GO:0016020;GO:0008028;GO:0015293;GO:0015718;, C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport; scaffold5 indexed_genome mRNA 62144135 62149638 . - . ID=transcript_1528;O43504 Q6IBD8,Ragulator complex protein LAMTOR5,Hepatitis B virus X-interacting protein {ECO:0000303|PubMed:9499022, ECO:0000303|Ref.2};Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5;, PF16672;, GO:0005829;GO:0005765;GO:0005764;GO:0032991;GO:0071986;GO:0007050;GO:0034198;GO:0071230;GO:0043154;GO:0010628;GO:0043123;GO:0032757;GO:0051092;GO:1900182;GO:1905636;GO:0032008;GO:1904263;GO:0061462;GO:0008361;GO:0016241;GO:0009615;GO:0019079;, C:cytosol; C:lysosomal membrane; C:lysosome; C:protein-containing complex; C:Ragulator complex;, , P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-8 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein localization to nucleus; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:protein localization to lysosome; P:regulation of cell size; P:regulation of macroautophagy; P:response to virus; P:viral genome replication;|O43504 Q6IBD8,Ragulator complex protein LAMTOR5,Hepatitis B virus X-interacting protein {ECO:0000303|PubMed:9499022, ECO:0000303|Ref.2};Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5;, PF16672;, GO:0005829;GO:0005765;GO:0005764;GO:0032991;GO:0071986;GO:0007050;GO:0034198;GO:0071230;GO:0043154;GO:0010628;GO:0043123;GO:0032757;GO:0051092;GO:1900182;GO:1905636;GO:0032008;GO:1904263;GO:0061462;GO:0008361;GO:0016241;GO:0009615;GO:0019079;, C:cytosol; C:lysosomal membrane; C:lysosome; C:protein-containing complex; C:Ragulator complex;, , P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-8 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein localization to nucleus; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:protein localization to lysosome; P:regulation of cell size; P:regulation of macroautophagy; P:response to virus; P:viral genome replication; scaffold5 indexed_genome mRNA 62332211 62338482 . - . ID=transcript_1529;P16389 A0A024R0D3 A8K1Z6 Q86XG6,Potassium voltage-gated channel subfamily A member 2,NGK1;Voltage-gated K(+) channel HuKIV {ECO:0000303|PubMed:19912772};Voltage-gated potassium channel HBK5;Voltage-gated potassium channel subunit Kv1.2;, PF02214;PF00520;, GO:0030424;GO:0043679;GO:0030425;GO:0005789;GO:0016021;GO:0005887;GO:0044224;GO:0030027;GO:0031258;GO:0032809;GO:0033010;GO:0043204;GO:0005886;GO:0042734;GO:0008076;GO:0005251;GO:0005267;GO:0005249;GO:0019228;GO:0071805;GO:0006813;GO:0051260;GO:0014059;GO:0034765;GO:0019233;, C:axon; C:axon terminus; C:dendrite; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:juxtaparanode region of axon; C:lamellipodium; C:lamellipodium membrane; C:neuronal cell body membrane; C:paranodal junction; C:perikaryon; C:plasma membrane; C:presynaptic membrane; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:potassium channel activity; F:voltage-gated potassium channel activity;, P:neuronal action potential; P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:regulation of dopamine secretion; P:regulation of ion transmembrane transport; P:sensory perception of pain; scaffold5 indexed_genome mRNA 62650507 62678457 . + . ID=transcript_1530;P19397 B2R905 Q5U0D6,Leukocyte surface antigen CD53,Cell surface glycoprotein CD53;Tetraspanin-25;, PF00335;, GO:0009986;GO:0005911;GO:0070062;GO:0001772;GO:0005887;GO:0005886;GO:0035579;GO:0070821;GO:0042802;GO:0043312;GO:1901741;GO:0007165;, C:cell surface; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:integral component of plasma membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:identical protein binding;, P:neutrophil degranulation; P:positive regulation of myoblast fusion; P:signal transduction;|P19397 B2R905 Q5U0D6,Leukocyte surface antigen CD53,Cell surface glycoprotein CD53;Tetraspanin-25;, PF00335;, GO:0009986;GO:0005911;GO:0070062;GO:0001772;GO:0005887;GO:0005886;GO:0035579;GO:0070821;GO:0042802;GO:0043312;GO:1901741;GO:0007165;, C:cell surface; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:integral component of plasma membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:identical protein binding;, P:neutrophil degranulation; P:positive regulation of myoblast fusion; P:signal transduction; scaffold5 indexed_genome mRNA 62741301 62760534 . - . ID=transcript_1531;Q5T3J3 Q86XS4 Q8N3B6 Q96HT4 Q9NUM5 Q9NV32,Ligand-dependent nuclear receptor-interacting factor 1 {ECO:0000305},HP1-binding protein enriched in inactive X chromosome protein 1 {ECO:0000303|PubMed:23542155};Receptor-interacting factor 1 {ECO:0000303|PubMed:17455211};, PF15741;, GO:0001740;GO:0034451;GO:0016363;GO:0005654;GO:0042974;GO:0009048;GO:0006355;, C:Barr body; C:centriolar satellite; C:nuclear matrix; C:nucleoplasm;, F:retinoic acid receptor binding;, P:dosage compensation by inactivation of X chromosome; P:regulation of transcription, DNA-templated;|Q5T3J3 Q86XS4 Q8N3B6 Q96HT4 Q9NUM5 Q9NV32,Ligand-dependent nuclear receptor-interacting factor 1 {ECO:0000305},HP1-binding protein enriched in inactive X chromosome protein 1 {ECO:0000303|PubMed:23542155};Receptor-interacting factor 1 {ECO:0000303|PubMed:17455211};, PF15741;, GO:0001740;GO:0034451;GO:0016363;GO:0005654;GO:0042974;GO:0009048;GO:0006355;, C:Barr body; C:centriolar satellite; C:nuclear matrix; C:nucleoplasm;, F:retinoic acid receptor binding;, P:dosage compensation by inactivation of X chromosome; P:regulation of transcription, DNA-templated; scaffold5 indexed_genome mRNA 62871101 62871646 . - . ID=transcript_1532;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold5 indexed_genome mRNA 62878960 62961277 . - . ID=transcript_1533;Q6UX65 B3SUG9 Q4VWF6 Q86VD3 Q8NBQ4,DNA damage-regulated autophagy modulator protein 2,Transmembrane protein 77;, PF10277;, GO:0016324;GO:0005737;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0005764;GO:0001917;GO:0006915;GO:0006914;GO:0045494;GO:0010506;GO:0007601;, C:apical plasma membrane; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:photoreceptor inner segment;, , P:apoptotic process; P:autophagy; P:photoreceptor cell maintenance; P:regulation of autophagy; P:visual perception;|Q6UX65 B3SUG9 Q4VWF6 Q86VD3 Q8NBQ4,DNA damage-regulated autophagy modulator protein 2,Transmembrane protein 77;, PF10277;, GO:0016324;GO:0005737;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0005764;GO:0001917;GO:0006915;GO:0006914;GO:0045494;GO:0010506;GO:0007601;, C:apical plasma membrane; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:photoreceptor inner segment;, , P:apoptotic process; P:autophagy; P:photoreceptor cell maintenance; P:regulation of autophagy; P:visual perception;|Q6UX65 B3SUG9 Q4VWF6 Q86VD3 Q8NBQ4,DNA damage-regulated autophagy modulator protein 2,Transmembrane protein 77;, PF10277;, GO:0016324;GO:0005737;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0005764;GO:0001917;GO:0006915;GO:0006914;GO:0045494;GO:0010506;GO:0007601;, C:apical plasma membrane; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:photoreceptor inner segment;, , P:apoptotic process; P:autophagy; P:photoreceptor cell maintenance; P:regulation of autophagy; P:visual perception;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9H6A0 Q5T5V6 Q9BSU0,DENN domain-containing protein 2D,, PF03455;PF02141;PF03456;, GO:0005829;GO:0005654;GO:0005085;, C:cytosol; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;|Q9Y6K0 Q69YJ9 Q9P0Y8,Choline/ethanolaminephosphotransferase 1 {ECO:0000305},, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0031965;GO:0004142;GO:0004307;GO:0046872;GO:0006629;GO:0006656;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:nuclear membrane;, F:diacylglycerol cholinephosphotransferase activity; F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process;|Q9Y6K0 Q69YJ9 Q9P0Y8,Choline/ethanolaminephosphotransferase 1 {ECO:0000305},, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0031965;GO:0004142;GO:0004307;GO:0046872;GO:0006629;GO:0006656;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:nuclear membrane;, F:diacylglycerol cholinephosphotransferase activity; F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process;|Q9Y6K0 Q69YJ9 Q9P0Y8,Choline/ethanolaminephosphotransferase 1 {ECO:0000305},, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0031965;GO:0004142;GO:0004307;GO:0046872;GO:0006629;GO:0006656;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:nuclear membrane;, F:diacylglycerol cholinephosphotransferase activity; F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process;|Q9Y6K0 Q69YJ9 Q9P0Y8,Choline/ethanolaminephosphotransferase 1 {ECO:0000305},, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0031965;GO:0004142;GO:0004307;GO:0046872;GO:0006629;GO:0006656;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:nuclear membrane;, F:diacylglycerol cholinephosphotransferase activity; F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process;|Q9Y6K0 Q69YJ9 Q9P0Y8,Choline/ethanolaminephosphotransferase 1 {ECO:0000305},, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0031965;GO:0004142;GO:0004307;GO:0046872;GO:0006629;GO:0006656;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:nuclear membrane;, F:diacylglycerol cholinephosphotransferase activity; F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; scaffold5 indexed_genome mRNA 62995468 63011241 . + . ID=transcript_1534;Q15782 A6NNY3 B4DPR7 Q15749 Q15783 Q5VUV7 Q96F97,Chitinase-3-like protein 2,Chondrocyte protein 39;YKL-39;, PF00704;, GO:0005576;GO:0005615;GO:0030246;GO:0008061;GO:0016787;GO:0005975;GO:0006032;, C:extracellular region; C:extracellular space;, F:carbohydrate binding; F:chitin binding; F:hydrolase activity;, P:carbohydrate metabolic process; P:chitin catabolic process; scaffold5 indexed_genome mRNA 63104741 63110177 . + . ID=transcript_1535;Q8TCI5 D9J0A2 D9J0A3 Q4G0K4 Q52LJ6 Q5T5D5 Q5T5D6 Q8N310,Protein pitchfork,, , GO:0036064;GO:0031410;GO:0005634;GO:0005802;GO:0048487;GO:0008092;GO:0043015;GO:0019894;GO:0019901;GO:0031267;GO:0044782;GO:0060971;GO:0033674;GO:0031344;, C:ciliary basal body; C:cytoplasmic vesicle; C:nucleus; C:trans-Golgi network;, F:beta-tubulin binding; F:cytoskeletal protein binding; F:gamma-tubulin binding; F:kinesin binding; F:protein kinase binding; F:small GTPase binding;, P:cilium organization; P:embryonic heart tube left/right pattern formation; P:positive regulation of kinase activity; P:regulation of cell projection organization; scaffold6 indexed_genome mRNA 14869 39788 . + . ID=transcript_1536;Q96LZ3 Q5VTR4 Q7Z4V8 Q8WYJ4,Calcineurin subunit B type 2,Calcineurin B-like protein;Calcineurin BII;PPP3R1-like;Protein phosphatase 2B regulatory subunit 2;Protein phosphatase 3 regulatory subunit B beta isoform;, PF13499;, GO:0005509;GO:0008597;, , F:calcium ion binding; F:calcium-dependent protein serine/threonine phosphatase regulator activity;|P63098 B2RC10 B5MDU4 P06705 P15117 Q08044 Q53SL0,Calcineurin subunit B type 1,Protein phosphatase 2B regulatory subunit 1;Protein phosphatase 3 regulatory subunit B alpha isoform 1;, PF13499;, GO:0005955;GO:0005829;GO:0005739;GO:0005654;GO:0042383;GO:0005509;GO:0004723;GO:0008597;GO:0005516;GO:0016018;GO:0019902;GO:0019904;GO:0033173;GO:0038095;GO:1900740;GO:0045944;GO:0007223;, C:calcineurin complex; C:cytosol; C:mitochondrion; C:nucleoplasm; C:sarcolemma;, F:calcium ion binding; F:calcium-dependent protein serine/threonine phosphatase activity; F:calcium-dependent protein serine/threonine phosphatase regulator activity; F:calmodulin binding; F:cyclosporin A binding; F:phosphatase binding; F:protein domain specific binding;, P:calcineurin-NFAT signaling cascade; P:Fc-epsilon receptor signaling pathway; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:Wnt signaling pathway, calcium modulating pathway;|P63098 B2RC10 B5MDU4 P06705 P15117 Q08044 Q53SL0,Calcineurin subunit B type 1,Protein phosphatase 2B regulatory subunit 1;Protein phosphatase 3 regulatory subunit B alpha isoform 1;, PF13499;, GO:0005955;GO:0005829;GO:0005739;GO:0005654;GO:0042383;GO:0005509;GO:0004723;GO:0008597;GO:0005516;GO:0016018;GO:0019902;GO:0019904;GO:0033173;GO:0038095;GO:1900740;GO:0045944;GO:0007223;, C:calcineurin complex; C:cytosol; C:mitochondrion; C:nucleoplasm; C:sarcolemma;, F:calcium ion binding; F:calcium-dependent protein serine/threonine phosphatase activity; F:calcium-dependent protein serine/threonine phosphatase regulator activity; F:calmodulin binding; F:cyclosporin A binding; F:phosphatase binding; F:protein domain specific binding;, P:calcineurin-NFAT signaling cascade; P:Fc-epsilon receptor signaling pathway; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:Wnt signaling pathway, calcium modulating pathway;|P63098 B2RC10 B5MDU4 P06705 P15117 Q08044 Q53SL0,Calcineurin subunit B type 1,Protein phosphatase 2B regulatory subunit 1;Protein phosphatase 3 regulatory subunit B alpha isoform 1;, PF13499;, GO:0005955;GO:0005829;GO:0005739;GO:0005654;GO:0042383;GO:0005509;GO:0004723;GO:0008597;GO:0005516;GO:0016018;GO:0019902;GO:0019904;GO:0033173;GO:0038095;GO:1900740;GO:0045944;GO:0007223;, C:calcineurin complex; C:cytosol; C:mitochondrion; C:nucleoplasm; C:sarcolemma;, F:calcium ion binding; F:calcium-dependent protein serine/threonine phosphatase activity; F:calcium-dependent protein serine/threonine phosphatase regulator activity; F:calmodulin binding; F:cyclosporin A binding; F:phosphatase binding; F:protein domain specific binding;, P:calcineurin-NFAT signaling cascade; P:Fc-epsilon receptor signaling pathway; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:Wnt signaling pathway, calcium modulating pathway; scaffold6 indexed_genome mRNA 45281 47606 . - . ID=transcript_1537;Q9NRX1 A8K6Q0 Q53G13 Q8WVB8,RNA-binding protein PNO1,Partner of NOB1 {ECO:0000303|PubMed:15497447};, , GO:0005829;GO:0005730;GO:0005654;GO:0003723;, C:cytosol; C:nucleolus; C:nucleoplasm;, F:RNA binding; scaffold6 indexed_genome mRNA 50548 54480 . - . ID=transcript_1538;Q9NRX1 A8K6Q0 Q53G13 Q8WVB8,RNA-binding protein PNO1,Partner of NOB1 {ECO:0000303|PubMed:15497447};, , GO:0005829;GO:0005730;GO:0005654;GO:0003723;, C:cytosol; C:nucleolus; C:nucleoplasm;, F:RNA binding; scaffold6 indexed_genome mRNA 54801 81678 . - . ID=transcript_1539;Q96MX6 Q96CR6,WD repeat-containing protein 92,WD repeat-containing protein Monad;, PF00400;, GO:0043130;GO:0006915;, , F:ubiquitin binding;, P:apoptotic process;|Q96MX6 Q96CR6,WD repeat-containing protein 92,WD repeat-containing protein Monad;, PF00400;, GO:0043130;GO:0006915;, , F:ubiquitin binding;, P:apoptotic process;|Q96MX6 Q96CR6,WD repeat-containing protein 92,WD repeat-containing protein Monad;, PF00400;, GO:0043130;GO:0006915;, , F:ubiquitin binding;, P:apoptotic process; scaffold6 indexed_genome mRNA 84917 147287 . - . ID=transcript_1540;Q13901 A8K336 D6W5F8 Q05D64,Nuclear nucleic acid-binding protein C1D,, PF04000;, GO:0005737;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0006915;GO:0000460;GO:0010468;GO:0006364;, C:cytoplasm; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:maturation of 5.8S rRNA; P:regulation of gene expression; P:rRNA processing;|Q13901 A8K336 D6W5F8 Q05D64,Nuclear nucleic acid-binding protein C1D,, PF04000;, GO:0005737;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0006915;GO:0000460;GO:0010468;GO:0006364;, C:cytoplasm; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:maturation of 5.8S rRNA; P:regulation of gene expression; P:rRNA processing;|Q13901 A8K336 D6W5F8 Q05D64,Nuclear nucleic acid-binding protein C1D,, PF04000;, GO:0005737;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0006915;GO:0000460;GO:0010468;GO:0006364;, C:cytoplasm; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:maturation of 5.8S rRNA; P:regulation of gene expression; P:rRNA processing; scaffold6 indexed_genome mRNA 762367 779486 . - . ID=transcript_1541;Q9NY74 Q05BT7 Q53SC4,Ewing's tumor-associated antigen 1 {ECO:0000312|HGNC:HGNC:24648},Ewing's tumor-associated antigen 16 {ECO:0000303|PubMed:16003559};, PF15350;, GO:0005829;GO:0043596;GO:0005654;GO:0043539;GO:0006974;GO:0006281;GO:0071902;GO:2000001;GO:0031297;, C:cytosol; C:nuclear replication fork; C:nucleoplasm;, F:protein serine/threonine kinase activator activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:positive regulation of protein serine/threonine kinase activity; P:regulation of DNA damage checkpoint; P:replication fork processing; scaffold6 indexed_genome mRNA 1605458 1747881 . - . ID=transcript_1542;Q9NRS2 Q9NRS3,Homeobox protein Meis2,Meis1-related protein 1;, PF05920;PF16493;, GO:0000785;GO:0005634;GO:0048471;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0009887;GO:0007420;GO:0009880;GO:0001654;GO:0045638;GO:0000122;GO:0031016;GO:0110024;GO:0008284;GO:0045931;GO:0045944;GO:0006357;GO:0070848;GO:0009612;GO:0008542;, C:chromatin; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:animal organ morphogenesis; P:brain development; P:embryonic pattern specification; P:eye development; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:pancreas development; P:positive regulation of cardiac muscle myoblast proliferation; P:positive regulation of cell population proliferation; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to growth factor; P:response to mechanical stimulus; P:visual learning;|Q9NRS2 Q9NRS3,Homeobox protein Meis2,Meis1-related protein 1;, PF05920;PF16493;, GO:0000785;GO:0005634;GO:0048471;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0009887;GO:0007420;GO:0009880;GO:0001654;GO:0045638;GO:0000122;GO:0031016;GO:0110024;GO:0008284;GO:0045931;GO:0045944;GO:0006357;GO:0070848;GO:0009612;GO:0008542;, C:chromatin; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:animal organ morphogenesis; P:brain development; P:embryonic pattern specification; P:eye development; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:pancreas development; P:positive regulation of cardiac muscle myoblast proliferation; P:positive regulation of cell population proliferation; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to growth factor; P:response to mechanical stimulus; P:visual learning;|O00470 A8MV50,Homeobox protein Meis1,, PF05920;PF16493;, GO:0000785;GO:0005634;GO:0005667;GO:0003682;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0001525;GO:0009887;GO:0007420;GO:0060216;GO:0009880;GO:0001654;GO:0030097;GO:0002089;GO:0007626;GO:0035855;GO:0060044;GO:0045638;GO:0045665;GO:0008284;GO:0045944;GO:0006357;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:animal organ morphogenesis; P:brain development; P:definitive hemopoiesis; P:embryonic pattern specification; P:eye development; P:hemopoiesis; P:lens morphogenesis in camera-type eye; P:locomotory behavior; P:megakaryocyte development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of myeloid cell differentiation; P:negative regulation of neuron differentiation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9NRS2 Q9NRS3,Homeobox protein Meis2,Meis1-related protein 1;, PF05920;PF16493;, GO:0000785;GO:0005634;GO:0048471;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0009887;GO:0007420;GO:0009880;GO:0001654;GO:0045638;GO:0000122;GO:0031016;GO:0110024;GO:0008284;GO:0045931;GO:0045944;GO:0006357;GO:0070848;GO:0009612;GO:0008542;, C:chromatin; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:animal organ morphogenesis; P:brain development; P:embryonic pattern specification; P:eye development; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:pancreas development; P:positive regulation of cardiac muscle myoblast proliferation; P:positive regulation of cell population proliferation; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to growth factor; P:response to mechanical stimulus; P:visual learning;|O00470 A8MV50,Homeobox protein Meis1,, PF05920;PF16493;, GO:0000785;GO:0005634;GO:0005667;GO:0003682;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0001525;GO:0009887;GO:0007420;GO:0060216;GO:0009880;GO:0001654;GO:0030097;GO:0002089;GO:0007626;GO:0035855;GO:0060044;GO:0045638;GO:0045665;GO:0008284;GO:0045944;GO:0006357;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:animal organ morphogenesis; P:brain development; P:definitive hemopoiesis; P:embryonic pattern specification; P:eye development; P:hemopoiesis; P:lens morphogenesis in camera-type eye; P:locomotory behavior; P:megakaryocyte development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of myeloid cell differentiation; P:negative regulation of neuron differentiation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold6 indexed_genome mRNA 2727859 2854717 . + . ID=transcript_1543;Q7Z698 A1L3V4 B7Z5K7 D6W5F7 E9PEP0 Q2NKX6,Sprouty-related, EVH1 domain-containing protein 2,, PF05210;PF00568;, GO:0005829;GO:0005886;GO:0030658;GO:0019901;GO:0030291;GO:0005173;GO:0008543;GO:0000188;GO:0007275;GO:0010719;GO:0070373;GO:1902747;GO:0010801;GO:0030512;GO:0043517;GO:0090311;, C:cytosol; C:plasma membrane; C:transport vesicle membrane;, F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; F:stem cell factor receptor binding;, P:fibroblast growth factor receptor signaling pathway; P:inactivation of MAPK activity; P:multicellular organism development; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of lens fiber cell differentiation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of protein deacetylation; scaffold6 indexed_genome mRNA 2900082 2938205 . - . ID=transcript_1544;P61160 B2RCP5 D6W5F4 E9PF41 O15142 Q96C82,Actin-related protein 2,Actin-like protein 2;, PF00022;, GO:0030478;GO:0015629;GO:0005885;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0030027;GO:0016020;GO:0005634;GO:0061825;GO:0014069;GO:0035861;GO:0003779;GO:0005524;GO:0005200;GO:0034314;GO:0008306;GO:0008356;GO:0071346;GO:0035984;GO:0060271;GO:0016482;GO:0048013;GO:0007163;GO:0038096;GO:0016344;GO:0033206;GO:0061024;GO:0043312;GO:0061003;GO:1905168;GO:0010592;GO:0045944;GO:0045471;GO:0035902;GO:0051653;, C:actin cap; C:actin cytoskeleton; C:Arp2/3 protein complex; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleus; C:podosome core; C:postsynaptic density; C:site of double-strand break;, F:actin binding; F:ATP binding; F:structural constituent of cytoskeleton;, P:Arp2/3 complex-mediated actin nucleation; P:associative learning; P:asymmetric cell division; P:cellular response to interferon-gamma; P:cellular response to trichostatin A; P:cilium assembly; P:cytosolic transport; P:ephrin receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:meiotic chromosome movement towards spindle pole; P:meiotic cytokinesis; P:membrane organization; P:neutrophil degranulation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of lamellipodium assembly; P:positive regulation of transcription by RNA polymerase II; P:response to ethanol; P:response to immobilization stress; P:spindle localization;|P61160 B2RCP5 D6W5F4 E9PF41 O15142 Q96C82,Actin-related protein 2,Actin-like protein 2;, PF00022;, GO:0030478;GO:0015629;GO:0005885;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0030027;GO:0016020;GO:0005634;GO:0061825;GO:0014069;GO:0035861;GO:0003779;GO:0005524;GO:0005200;GO:0034314;GO:0008306;GO:0008356;GO:0071346;GO:0035984;GO:0060271;GO:0016482;GO:0048013;GO:0007163;GO:0038096;GO:0016344;GO:0033206;GO:0061024;GO:0043312;GO:0061003;GO:1905168;GO:0010592;GO:0045944;GO:0045471;GO:0035902;GO:0051653;, C:actin cap; C:actin cytoskeleton; C:Arp2/3 protein complex; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleus; C:podosome core; C:postsynaptic density; C:site of double-strand break;, F:actin binding; F:ATP binding; F:structural constituent of cytoskeleton;, P:Arp2/3 complex-mediated actin nucleation; P:associative learning; P:asymmetric cell division; P:cellular response to interferon-gamma; P:cellular response to trichostatin A; P:cilium assembly; P:cytosolic transport; P:ephrin receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:meiotic chromosome movement towards spindle pole; P:meiotic cytokinesis; P:membrane organization; P:neutrophil degranulation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of lamellipodium assembly; P:positive regulation of transcription by RNA polymerase II; P:response to ethanol; P:response to immobilization stress; P:spindle localization;|P61160 B2RCP5 D6W5F4 E9PF41 O15142 Q96C82,Actin-related protein 2,Actin-like protein 2;, PF00022;, GO:0030478;GO:0015629;GO:0005885;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0030027;GO:0016020;GO:0005634;GO:0061825;GO:0014069;GO:0035861;GO:0003779;GO:0005524;GO:0005200;GO:0034314;GO:0008306;GO:0008356;GO:0071346;GO:0035984;GO:0060271;GO:0016482;GO:0048013;GO:0007163;GO:0038096;GO:0016344;GO:0033206;GO:0061024;GO:0043312;GO:0061003;GO:1905168;GO:0010592;GO:0045944;GO:0045471;GO:0035902;GO:0051653;, C:actin cap; C:actin cytoskeleton; C:Arp2/3 protein complex; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleus; C:podosome core; C:postsynaptic density; C:site of double-strand break;, F:actin binding; F:ATP binding; F:structural constituent of cytoskeleton;, P:Arp2/3 complex-mediated actin nucleation; P:associative learning; P:asymmetric cell division; P:cellular response to interferon-gamma; P:cellular response to trichostatin A; P:cilium assembly; P:cytosolic transport; P:ephrin receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:meiotic chromosome movement towards spindle pole; P:meiotic cytokinesis; P:membrane organization; P:neutrophil degranulation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of lamellipodium assembly; P:positive regulation of transcription by RNA polymerase II; P:response to ethanol; P:response to immobilization stress; P:spindle localization;|P61160 B2RCP5 D6W5F4 E9PF41 O15142 Q96C82,Actin-related protein 2,Actin-like protein 2;, PF00022;, GO:0030478;GO:0015629;GO:0005885;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0030027;GO:0016020;GO:0005634;GO:0061825;GO:0014069;GO:0035861;GO:0003779;GO:0005524;GO:0005200;GO:0034314;GO:0008306;GO:0008356;GO:0071346;GO:0035984;GO:0060271;GO:0016482;GO:0048013;GO:0007163;GO:0038096;GO:0016344;GO:0033206;GO:0061024;GO:0043312;GO:0061003;GO:1905168;GO:0010592;GO:0045944;GO:0045471;GO:0035902;GO:0051653;, C:actin cap; C:actin cytoskeleton; C:Arp2/3 protein complex; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleus; C:podosome core; C:postsynaptic density; C:site of double-strand break;, F:actin binding; F:ATP binding; F:structural constituent of cytoskeleton;, P:Arp2/3 complex-mediated actin nucleation; P:associative learning; P:asymmetric cell division; P:cellular response to interferon-gamma; P:cellular response to trichostatin A; P:cilium assembly; P:cytosolic transport; P:ephrin receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:meiotic chromosome movement towards spindle pole; P:meiotic cytokinesis; P:membrane organization; P:neutrophil degranulation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of lamellipodium assembly; P:positive regulation of transcription by RNA polymerase II; P:response to ethanol; P:response to immobilization stress; P:spindle localization; scaffold6 indexed_genome mRNA 3012439 3066761 . + . ID=transcript_1545;P62820 P11476 Q6FIE7 Q96N61 Q9Y3T2,Ras-related protein Rab-1A,YPT1-related protein;, PF00071;, GO:0005829;GO:0005769;GO:0012505;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0042470;GO:0030658;GO:0045296;GO:0005525;GO:0003924;GO:0000045;GO:0006914;GO:0016477;GO:0048208;GO:0090110;GO:0042742;GO:0006897;GO:0006888;GO:0007030;GO:0030252;GO:0006886;GO:0032402;GO:1903020;GO:0032757;GO:1904668;GO:0043687;GO:0006890;GO:0034446;GO:0047496;GO:0016192;GO:0019068;, C:cytosol; C:early endosome; C:endomembrane system; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:melanosome; C:transport vesicle membrane;, F:cadherin binding; F:GTP binding; F:GTPase activity;, P:autophagosome assembly; P:autophagy; P:cell migration; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:defense response to bacterium; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:growth hormone secretion; P:intracellular protein transport; P:melanosome transport; P:positive regulation of glycoprotein metabolic process; P:positive regulation of interleukin-8 production; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:substrate adhesion-dependent cell spreading; P:vesicle transport along microtubule; P:vesicle-mediated transport; P:virion assembly;|P62820 P11476 Q6FIE7 Q96N61 Q9Y3T2,Ras-related protein Rab-1A,YPT1-related protein;, PF00071;, GO:0005829;GO:0005769;GO:0012505;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0042470;GO:0030658;GO:0045296;GO:0005525;GO:0003924;GO:0000045;GO:0006914;GO:0016477;GO:0048208;GO:0090110;GO:0042742;GO:0006897;GO:0006888;GO:0007030;GO:0030252;GO:0006886;GO:0032402;GO:1903020;GO:0032757;GO:1904668;GO:0043687;GO:0006890;GO:0034446;GO:0047496;GO:0016192;GO:0019068;, C:cytosol; C:early endosome; C:endomembrane system; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:melanosome; C:transport vesicle membrane;, F:cadherin binding; F:GTP binding; F:GTPase activity;, P:autophagosome assembly; P:autophagy; P:cell migration; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:defense response to bacterium; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:growth hormone secretion; P:intracellular protein transport; P:melanosome transport; P:positive regulation of glycoprotein metabolic process; P:positive regulation of interleukin-8 production; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:substrate adhesion-dependent cell spreading; P:vesicle transport along microtubule; P:vesicle-mediated transport; P:virion assembly;|P62820 P11476 Q6FIE7 Q96N61 Q9Y3T2,Ras-related protein Rab-1A,YPT1-related protein;, PF00071;, GO:0005829;GO:0005769;GO:0012505;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0042470;GO:0030658;GO:0045296;GO:0005525;GO:0003924;GO:0000045;GO:0006914;GO:0016477;GO:0048208;GO:0090110;GO:0042742;GO:0006897;GO:0006888;GO:0007030;GO:0030252;GO:0006886;GO:0032402;GO:1903020;GO:0032757;GO:1904668;GO:0043687;GO:0006890;GO:0034446;GO:0047496;GO:0016192;GO:0019068;, C:cytosol; C:early endosome; C:endomembrane system; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:melanosome; C:transport vesicle membrane;, F:cadherin binding; F:GTP binding; F:GTPase activity;, P:autophagosome assembly; P:autophagy; P:cell migration; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:defense response to bacterium; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:growth hormone secretion; P:intracellular protein transport; P:melanosome transport; P:positive regulation of glycoprotein metabolic process; P:positive regulation of interleukin-8 production; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:substrate adhesion-dependent cell spreading; P:vesicle transport along microtubule; P:vesicle-mediated transport; P:virion assembly;|P62820 P11476 Q6FIE7 Q96N61 Q9Y3T2,Ras-related protein Rab-1A,YPT1-related protein;, PF00071;, GO:0005829;GO:0005769;GO:0012505;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0042470;GO:0030658;GO:0045296;GO:0005525;GO:0003924;GO:0000045;GO:0006914;GO:0016477;GO:0048208;GO:0090110;GO:0042742;GO:0006897;GO:0006888;GO:0007030;GO:0030252;GO:0006886;GO:0032402;GO:1903020;GO:0032757;GO:1904668;GO:0043687;GO:0006890;GO:0034446;GO:0047496;GO:0016192;GO:0019068;, C:cytosol; C:early endosome; C:endomembrane system; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:melanosome; C:transport vesicle membrane;, F:cadherin binding; F:GTP binding; F:GTPase activity;, P:autophagosome assembly; P:autophagy; P:cell migration; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:defense response to bacterium; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:growth hormone secretion; P:intracellular protein transport; P:melanosome transport; P:positive regulation of glycoprotein metabolic process; P:positive regulation of interleukin-8 production; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:substrate adhesion-dependent cell spreading; P:vesicle transport along microtubule; P:vesicle-mediated transport; P:virion assembly;|Q76N32 B4DRQ1 D6W5F1 D6W5F2 O60326 Q9BQ18 Q9UDM9,Centrosomal protein of 68 kDa,, , GO:0030054;GO:0034451;GO:0005813;GO:0005829;GO:0005654;GO:0019904;GO:0019901;GO:0010457;GO:0007098;GO:0033365;, C:cell junction; C:centriolar satellite; C:centrosome; C:cytosol; C:nucleoplasm;, F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:centrosome cycle; P:protein localization to organelle;|Q76N32 B4DRQ1 D6W5F1 D6W5F2 O60326 Q9BQ18 Q9UDM9,Centrosomal protein of 68 kDa,, , GO:0030054;GO:0034451;GO:0005813;GO:0005829;GO:0005654;GO:0019904;GO:0019901;GO:0010457;GO:0007098;GO:0033365;, C:cell junction; C:centriolar satellite; C:centrosome; C:cytosol; C:nucleoplasm;, F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:centrosome cycle; P:protein localization to organelle;|Q76N32 B4DRQ1 D6W5F1 D6W5F2 O60326 Q9BQ18 Q9UDM9,Centrosomal protein of 68 kDa,, , GO:0030054;GO:0034451;GO:0005813;GO:0005829;GO:0005654;GO:0019904;GO:0019901;GO:0010457;GO:0007098;GO:0033365;, C:cell junction; C:centriolar satellite; C:centrosome; C:cytosol; C:nucleoplasm;, F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:centrosome cycle; P:protein localization to organelle; scaffold6 indexed_genome mRNA 3095844 3128518 . - . ID=transcript_1546;P43007 B7Z3C0 D6W5F0,Neutral amino acid transporter A,Alanine/serine/cysteine/threonine transporter 1;SATT;Solute carrier family 1 member 4;, PF00375;, GO:0009986;GO:0005813;GO:0030425;GO:0070062;GO:0016021;GO:0005887;GO:0005882;GO:0042470;GO:0016020;GO:0043025;GO:0005886;GO:0045202;GO:0005254;GO:0015180;GO:0015183;GO:0015184;GO:0015186;GO:0034590;GO:0015193;GO:0015194;GO:0015195;GO:0015293;GO:0006865;GO:0050890;GO:0006868;GO:0034589;GO:1904273;GO:0015808;GO:0140009;GO:0015811;GO:1903812;GO:0015825;GO:0015824;GO:0035249;GO:0015826;GO:0150104;, C:cell surface; C:centrosome; C:dendrite; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intermediate filament; C:melanosome; C:membrane; C:neuronal cell body; C:plasma membrane; C:synapse;, F:chloride channel activity; F:L-alanine transmembrane transporter activity; F:L-aspartate transmembrane transporter activity; F:L-cystine transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-hydroxyproline transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:L-threonine transmembrane transporter activity; F:symporter activity;, P:amino acid transport; P:cognition; P:glutamine transport; P:hydroxyproline transport; P:L-alanine import across plasma membrane; P:L-alanine transport; P:L-aspartate import across plasma membrane; P:L-cystine transport; P:L-serine import across plasma membrane; P:L-serine transport; P:proline transport; P:synaptic transmission, glutamatergic; P:threonine transport; P:transport across blood-brain barrier; scaffold6 indexed_genome mRNA 3439203 3459403 . + . ID=transcript_1547;Q14140 Q53TS2,SERTA domain-containing protein 2,Transcriptional regulator interacting with the PHD-bromodomain 2;, PF06031;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003713;GO:0048096;GO:0030308;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity;, P:chromatin-mediated maintenance of transcription; P:negative regulation of cell growth;|Q14140 Q53TS2,SERTA domain-containing protein 2,Transcriptional regulator interacting with the PHD-bromodomain 2;, PF06031;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003713;GO:0048096;GO:0030308;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity;, P:chromatin-mediated maintenance of transcription; P:negative regulation of cell growth; scaffold6 indexed_genome mRNA 3503181 3511557 . - . ID=transcript_1548;Q6ULP2 D6W5E9 Q6ZM66 Q86VW3 Q8TCF3 Q9H7E3 Q9HAB9 Q9NXS4,Aftiphilin,, PF15045;, GO:0030121;GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0032588;GO:0030276;GO:0046907;GO:0015031;, C:AP-1 adaptor complex; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:trans-Golgi network membrane;, F:clathrin binding;, P:intracellular transport; P:protein transport; scaffold6 indexed_genome mRNA 3515225 3574370 . - . ID=transcript_1549;Q6ULP2 D6W5E9 Q6ZM66 Q86VW3 Q8TCF3 Q9H7E3 Q9HAB9 Q9NXS4,Aftiphilin,, PF15045;, GO:0030121;GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0032588;GO:0030276;GO:0046907;GO:0015031;, C:AP-1 adaptor complex; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:trans-Golgi network membrane;, F:clathrin binding;, P:intracellular transport; P:protein transport;|Q6ULP2 D6W5E9 Q6ZM66 Q86VW3 Q8TCF3 Q9H7E3 Q9HAB9 Q9NXS4,Aftiphilin,, PF15045;, GO:0030121;GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0032588;GO:0030276;GO:0046907;GO:0015031;, C:AP-1 adaptor complex; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:trans-Golgi network membrane;, F:clathrin binding;, P:intracellular transport; P:protein transport; scaffold6 indexed_genome mRNA 3954812 3959672 . - . ID=transcript_1550;Q96FA3 Q96SM0 Q9GZY5 Q9HCX0,E3 ubiquitin-protein ligase pellino homolog 1,Pellino-related intracellular-signaling molecule;RING-type E3 ubiquitin transferase pellino homolog 1 {ECO:0000305};, PF04710;, GO:0000778;GO:0005829;GO:0061630;GO:0070498;GO:0060546;GO:0032088;GO:0042130;GO:0030890;GO:0001819;GO:0043123;GO:0031398;GO:0034141;GO:0034145;GO:0043161;GO:0070936;GO:0070534;GO:0000209;GO:0060544;GO:0008592;GO:0043331;GO:0032496;GO:0008063;, C:condensed nuclear chromosome kinetochore; C:cytosol;, F:ubiquitin protein ligase activity;, P:interleukin-1-mediated signaling pathway; P:negative regulation of necroptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell proliferation; P:positive regulation of B cell proliferation; P:positive regulation of cytokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein ubiquitination; P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of toll-like receptor 4 signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of necroptotic process; P:regulation of Toll signaling pathway; P:response to dsRNA; P:response to lipopolysaccharide; P:Toll signaling pathway;|Q96FA3 Q96SM0 Q9GZY5 Q9HCX0,E3 ubiquitin-protein ligase pellino homolog 1,Pellino-related intracellular-signaling molecule;RING-type E3 ubiquitin transferase pellino homolog 1 {ECO:0000305};, PF04710;, GO:0000778;GO:0005829;GO:0061630;GO:0070498;GO:0060546;GO:0032088;GO:0042130;GO:0030890;GO:0001819;GO:0043123;GO:0031398;GO:0034141;GO:0034145;GO:0043161;GO:0070936;GO:0070534;GO:0000209;GO:0060544;GO:0008592;GO:0043331;GO:0032496;GO:0008063;, C:condensed nuclear chromosome kinetochore; C:cytosol;, F:ubiquitin protein ligase activity;, P:interleukin-1-mediated signaling pathway; P:negative regulation of necroptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell proliferation; P:positive regulation of B cell proliferation; P:positive regulation of cytokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein ubiquitination; P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of toll-like receptor 4 signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of necroptotic process; P:regulation of Toll signaling pathway; P:response to dsRNA; P:response to lipopolysaccharide; P:Toll signaling pathway; scaffold6 indexed_genome mRNA 4022204 4114918 . + . ID=transcript_1551;Q9P1Q0 Q5VIR5 Q86YF7 Q8N6G3 Q9NPV0 Q9NT07 Q9NUJ0,Vacuolar protein sorting-associated protein 54,Hepatocellular carcinoma protein 8;Tumor antigen HOM-HCC-8;Tumor antigen SLP-8p;, PF07928;PF10475;, GO:0005829;GO:0000938;GO:0005794;GO:0016020;GO:0005654;GO:0048471;GO:0005802;GO:0032588;GO:0019905;GO:0006896;GO:0048873;GO:0007041;GO:0050881;GO:0060052;GO:0015031;GO:0040008;GO:0042147;, C:cytosol; C:GARP complex; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:trans-Golgi network; C:trans-Golgi network membrane;, F:syntaxin binding;, P:Golgi to vacuole transport; P:homeostasis of number of cells within a tissue; P:lysosomal transport; P:musculoskeletal movement; P:neurofilament cytoskeleton organization; P:protein transport; P:regulation of growth; P:retrograde transport, endosome to Golgi;|Q9P1Q0 Q5VIR5 Q86YF7 Q8N6G3 Q9NPV0 Q9NT07 Q9NUJ0,Vacuolar protein sorting-associated protein 54,Hepatocellular carcinoma protein 8;Tumor antigen HOM-HCC-8;Tumor antigen SLP-8p;, PF07928;PF10475;, GO:0005829;GO:0000938;GO:0005794;GO:0016020;GO:0005654;GO:0048471;GO:0005802;GO:0032588;GO:0019905;GO:0006896;GO:0048873;GO:0007041;GO:0050881;GO:0060052;GO:0015031;GO:0040008;GO:0042147;, C:cytosol; C:GARP complex; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:trans-Golgi network; C:trans-Golgi network membrane;, F:syntaxin binding;, P:Golgi to vacuole transport; P:homeostasis of number of cells within a tissue; P:lysosomal transport; P:musculoskeletal movement; P:neurofilament cytoskeleton organization; P:protein transport; P:regulation of growth; P:retrograde transport, endosome to Golgi;|Q9P1Q0 Q5VIR5 Q86YF7 Q8N6G3 Q9NPV0 Q9NT07 Q9NUJ0,Vacuolar protein sorting-associated protein 54,Hepatocellular carcinoma protein 8;Tumor antigen HOM-HCC-8;Tumor antigen SLP-8p;, PF07928;PF10475;, GO:0005829;GO:0000938;GO:0005794;GO:0016020;GO:0005654;GO:0048471;GO:0005802;GO:0032588;GO:0019905;GO:0006896;GO:0048873;GO:0007041;GO:0050881;GO:0060052;GO:0015031;GO:0040008;GO:0042147;, C:cytosol; C:GARP complex; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:trans-Golgi network; C:trans-Golgi network membrane;, F:syntaxin binding;, P:Golgi to vacuole transport; P:homeostasis of number of cells within a tissue; P:lysosomal transport; P:musculoskeletal movement; P:neurofilament cytoskeleton organization; P:protein transport; P:regulation of growth; P:retrograde transport, endosome to Golgi;|Q9P1Q0 Q5VIR5 Q86YF7 Q8N6G3 Q9NPV0 Q9NT07 Q9NUJ0,Vacuolar protein sorting-associated protein 54,Hepatocellular carcinoma protein 8;Tumor antigen HOM-HCC-8;Tumor antigen SLP-8p;, PF07928;PF10475;, GO:0005829;GO:0000938;GO:0005794;GO:0016020;GO:0005654;GO:0048471;GO:0005802;GO:0032588;GO:0019905;GO:0006896;GO:0048873;GO:0007041;GO:0050881;GO:0060052;GO:0015031;GO:0040008;GO:0042147;, C:cytosol; C:GARP complex; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:trans-Golgi network; C:trans-Golgi network membrane;, F:syntaxin binding;, P:Golgi to vacuole transport; P:homeostasis of number of cells within a tissue; P:lysosomal transport; P:musculoskeletal movement; P:neurofilament cytoskeleton organization; P:protein transport; P:regulation of growth; P:retrograde transport, endosome to Golgi;|Q9P1Q0 Q5VIR5 Q86YF7 Q8N6G3 Q9NPV0 Q9NT07 Q9NUJ0,Vacuolar protein sorting-associated protein 54,Hepatocellular carcinoma protein 8;Tumor antigen HOM-HCC-8;Tumor antigen SLP-8p;, PF07928;PF10475;, GO:0005829;GO:0000938;GO:0005794;GO:0016020;GO:0005654;GO:0048471;GO:0005802;GO:0032588;GO:0019905;GO:0006896;GO:0048873;GO:0007041;GO:0050881;GO:0060052;GO:0015031;GO:0040008;GO:0042147;, C:cytosol; C:GARP complex; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:trans-Golgi network; C:trans-Golgi network membrane;, F:syntaxin binding;, P:Golgi to vacuole transport; P:homeostasis of number of cells within a tissue; P:lysosomal transport; P:musculoskeletal movement; P:neurofilament cytoskeleton organization; P:protein transport; P:regulation of growth; P:retrograde transport, endosome to Golgi; scaffold6 indexed_genome mRNA 4120756 4177093 . + . ID=transcript_1552;Q9P1Q0 Q5VIR5 Q86YF7 Q8N6G3 Q9NPV0 Q9NT07 Q9NUJ0,Vacuolar protein sorting-associated protein 54,Hepatocellular carcinoma protein 8;Tumor antigen HOM-HCC-8;Tumor antigen SLP-8p;, PF07928;PF10475;, GO:0005829;GO:0000938;GO:0005794;GO:0016020;GO:0005654;GO:0048471;GO:0005802;GO:0032588;GO:0019905;GO:0006896;GO:0048873;GO:0007041;GO:0050881;GO:0060052;GO:0015031;GO:0040008;GO:0042147;, C:cytosol; C:GARP complex; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:trans-Golgi network; C:trans-Golgi network membrane;, F:syntaxin binding;, P:Golgi to vacuole transport; P:homeostasis of number of cells within a tissue; P:lysosomal transport; P:musculoskeletal movement; P:neurofilament cytoskeleton organization; P:protein transport; P:regulation of growth; P:retrograde transport, endosome to Golgi;|Q16851 Q07131 Q0P6K2 Q86Y81 Q9BU15,UTP--glucose-1-phosphate uridylyltransferase {ECO:0000305|PubMed:8354390},UDP-glucose pyrophosphorylase;, PF01704;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0042802;GO:0046872;GO:0003983;GO:0007420;GO:0005978;GO:0005977;GO:0006011;GO:0006065;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:identical protein binding; F:metal ion binding; F:UTP:glucose-1-phosphate uridylyltransferase activity;, F:UTP:glucose-1-phosphate uridylyltransferase activity; P:brain development; P:glycogen biosynthetic process; P:glycogen metabolic process; P:UDP-glucose metabolic process; P:UDP-glucuronate biosynthetic process;|Q16851 Q07131 Q0P6K2 Q86Y81 Q9BU15,UTP--glucose-1-phosphate uridylyltransferase {ECO:0000305|PubMed:8354390},UDP-glucose pyrophosphorylase;, PF01704;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0042802;GO:0046872;GO:0003983;GO:0007420;GO:0005978;GO:0005977;GO:0006011;GO:0006065;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:identical protein binding; F:metal ion binding; F:UTP:glucose-1-phosphate uridylyltransferase activity;, F:UTP:glucose-1-phosphate uridylyltransferase activity; P:brain development; P:glycogen biosynthetic process; P:glycogen metabolic process; P:UDP-glucose metabolic process; P:UDP-glucuronate biosynthetic process;|Q16851 Q07131 Q0P6K2 Q86Y81 Q9BU15,UTP--glucose-1-phosphate uridylyltransferase {ECO:0000305|PubMed:8354390},UDP-glucose pyrophosphorylase;, PF01704;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0042802;GO:0046872;GO:0003983;GO:0007420;GO:0005978;GO:0005977;GO:0006011;GO:0006065;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:identical protein binding; F:metal ion binding; F:UTP:glucose-1-phosphate uridylyltransferase activity;, F:UTP:glucose-1-phosphate uridylyltransferase activity; P:brain development; P:glycogen biosynthetic process; P:glycogen metabolic process; P:UDP-glucose metabolic process; P:UDP-glucuronate biosynthetic process;|Q16851 Q07131 Q0P6K2 Q86Y81 Q9BU15,UTP--glucose-1-phosphate uridylyltransferase {ECO:0000305|PubMed:8354390},UDP-glucose pyrophosphorylase;, PF01704;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0042802;GO:0046872;GO:0003983;GO:0007420;GO:0005978;GO:0005977;GO:0006011;GO:0006065;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:identical protein binding; F:metal ion binding; F:UTP:glucose-1-phosphate uridylyltransferase activity;, F:UTP:glucose-1-phosphate uridylyltransferase activity; P:brain development; P:glycogen biosynthetic process; P:glycogen metabolic process; P:UDP-glucose metabolic process; P:UDP-glucuronate biosynthetic process; scaffold6 indexed_genome mRNA 4416119 4633300 . - . ID=transcript_1553;P40925 B2R5V5 B4DUN2 B7Z3I7 F5H098 Q6I9V0,Malate dehydrogenase, cytoplasmic {ECO:0000305},Cytosolic malate dehydrogenase;Diiodophenylpyruvate reductase;, PF02866;PF00056;, GO:0005813;GO:0005829;GO:0070062;GO:0005615;GO:0047860;GO:0030060;GO:0004470;GO:0006094;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular space;, F:diiodophenylpyruvate reductase activity; F:L-malate dehydrogenase activity; F:malic enzyme activity;, P:gluconeogenesis; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|P40925 B2R5V5 B4DUN2 B7Z3I7 F5H098 Q6I9V0,Malate dehydrogenase, cytoplasmic {ECO:0000305},Cytosolic malate dehydrogenase;Diiodophenylpyruvate reductase;, PF02866;PF00056;, GO:0005813;GO:0005829;GO:0070062;GO:0005615;GO:0047860;GO:0030060;GO:0004470;GO:0006094;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular space;, F:diiodophenylpyruvate reductase activity; F:L-malate dehydrogenase activity; F:malic enzyme activity;, P:gluconeogenesis; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|P40925 B2R5V5 B4DUN2 B7Z3I7 F5H098 Q6I9V0,Malate dehydrogenase, cytoplasmic {ECO:0000305},Cytosolic malate dehydrogenase;Diiodophenylpyruvate reductase;, PF02866;PF00056;, GO:0005813;GO:0005829;GO:0070062;GO:0005615;GO:0047860;GO:0030060;GO:0004470;GO:0006094;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular space;, F:diiodophenylpyruvate reductase activity; F:L-malate dehydrogenase activity; F:malic enzyme activity;, P:gluconeogenesis; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|P40925 B2R5V5 B4DUN2 B7Z3I7 F5H098 Q6I9V0,Malate dehydrogenase, cytoplasmic {ECO:0000305},Cytosolic malate dehydrogenase;Diiodophenylpyruvate reductase;, PF02866;PF00056;, GO:0005813;GO:0005829;GO:0070062;GO:0005615;GO:0047860;GO:0030060;GO:0004470;GO:0006094;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular space;, F:diiodophenylpyruvate reductase activity; F:L-malate dehydrogenase activity; F:malic enzyme activity;, P:gluconeogenesis; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|P40925 B2R5V5 B4DUN2 B7Z3I7 F5H098 Q6I9V0,Malate dehydrogenase, cytoplasmic {ECO:0000305},Cytosolic malate dehydrogenase;Diiodophenylpyruvate reductase;, PF02866;PF00056;, GO:0005813;GO:0005829;GO:0070062;GO:0005615;GO:0047860;GO:0030060;GO:0004470;GO:0006094;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular space;, F:diiodophenylpyruvate reductase activity; F:L-malate dehydrogenase activity; F:malic enzyme activity;, P:gluconeogenesis; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|P40925 B2R5V5 B4DUN2 B7Z3I7 F5H098 Q6I9V0,Malate dehydrogenase, cytoplasmic {ECO:0000305},Cytosolic malate dehydrogenase;Diiodophenylpyruvate reductase;, PF02866;PF00056;, GO:0005813;GO:0005829;GO:0070062;GO:0005615;GO:0047860;GO:0030060;GO:0004470;GO:0006094;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular space;, F:diiodophenylpyruvate reductase activity; F:L-malate dehydrogenase activity; F:malic enzyme activity;, P:gluconeogenesis; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|P40925 B2R5V5 B4DUN2 B7Z3I7 F5H098 Q6I9V0,Malate dehydrogenase, cytoplasmic {ECO:0000305},Cytosolic malate dehydrogenase;Diiodophenylpyruvate reductase;, PF02866;PF00056;, GO:0005813;GO:0005829;GO:0070062;GO:0005615;GO:0047860;GO:0030060;GO:0004470;GO:0006094;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular space;, F:diiodophenylpyruvate reductase activity; F:L-malate dehydrogenase activity; F:malic enzyme activity;, P:gluconeogenesis; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|P40925 B2R5V5 B4DUN2 B7Z3I7 F5H098 Q6I9V0,Malate dehydrogenase, cytoplasmic {ECO:0000305},Cytosolic malate dehydrogenase;Diiodophenylpyruvate reductase;, PF02866;PF00056;, GO:0005813;GO:0005829;GO:0070062;GO:0005615;GO:0047860;GO:0030060;GO:0004470;GO:0006094;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular space;, F:diiodophenylpyruvate reductase activity; F:L-malate dehydrogenase activity; F:malic enzyme activity;, P:gluconeogenesis; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|O95876 Q53RW4 Q7Z2Z3,WD repeat-containing and planar cell polarity effector protein fritz homolog,Bardet-Biedl syndrome 15 protein;WD repeat-containing and planar cell polarity effector protein;, PF11768;, GO:0097541;GO:0005930;GO:0005886;GO:0002093;GO:0043010;GO:0060271;GO:0044782;GO:0072359;GO:0055123;GO:0042733;GO:0045184;GO:0090521;GO:0001822;GO:0007399;GO:0016476;GO:2000114;GO:0010762;GO:0051893;GO:0032880;GO:1900027;GO:0060541;GO:0060021;GO:0032185;GO:0007224;GO:0043587;, C:axonemal basal plate; C:axoneme; C:plasma membrane;, , P:auditory receptor cell morphogenesis; P:camera-type eye development; P:cilium assembly; P:cilium organization; P:circulatory system development; P:digestive system development; P:embryonic digit morphogenesis; P:establishment of protein localization; P:glomerular visceral epithelial cell migration; P:kidney development; P:nervous system development; P:regulation of embryonic cell shape; P:regulation of establishment of cell polarity; P:regulation of fibroblast migration; P:regulation of focal adhesion assembly; P:regulation of protein localization; P:regulation of ruffle assembly; P:respiratory system development; P:roof of mouth development; P:septin cytoskeleton organization; P:smoothened signaling pathway; P:tongue morphogenesis; scaffold6 indexed_genome mRNA 4698419 4718851 . + . ID=transcript_1554;O95876 Q53RW4 Q7Z2Z3,WD repeat-containing and planar cell polarity effector protein fritz homolog,Bardet-Biedl syndrome 15 protein;WD repeat-containing and planar cell polarity effector protein;, PF11768;, GO:0097541;GO:0005930;GO:0005886;GO:0002093;GO:0043010;GO:0060271;GO:0044782;GO:0072359;GO:0055123;GO:0042733;GO:0045184;GO:0090521;GO:0001822;GO:0007399;GO:0016476;GO:2000114;GO:0010762;GO:0051893;GO:0032880;GO:1900027;GO:0060541;GO:0060021;GO:0032185;GO:0007224;GO:0043587;, C:axonemal basal plate; C:axoneme; C:plasma membrane;, , P:auditory receptor cell morphogenesis; P:camera-type eye development; P:cilium assembly; P:cilium organization; P:circulatory system development; P:digestive system development; P:embryonic digit morphogenesis; P:establishment of protein localization; P:glomerular visceral epithelial cell migration; P:kidney development; P:nervous system development; P:regulation of embryonic cell shape; P:regulation of establishment of cell polarity; P:regulation of fibroblast migration; P:regulation of focal adhesion assembly; P:regulation of protein localization; P:regulation of ruffle assembly; P:respiratory system development; P:roof of mouth development; P:septin cytoskeleton organization; P:smoothened signaling pathway; P:tongue morphogenesis; scaffold6 indexed_genome mRNA 4898965 5248865 . - . ID=transcript_1555;Q8NDI1 O94977 Q53TG7 Q53TV6 Q580X2 Q6NX72 Q6PIT3 Q6QNV2 Q9NWI9,EH domain-binding protein 1,, PF00307;PF12130;PF10358;, GO:0005829;GO:0005768;GO:0031941;GO:0005815;GO:0005654;GO:0005886;GO:0030036;GO:0006897;GO:0015031;, C:cytosol; C:endosome; C:filamentous actin; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, , P:actin cytoskeleton organization; P:endocytosis; P:protein transport;|Q8NDI1 O94977 Q53TG7 Q53TV6 Q580X2 Q6NX72 Q6PIT3 Q6QNV2 Q9NWI9,EH domain-binding protein 1,, PF00307;PF12130;PF10358;, GO:0005829;GO:0005768;GO:0031941;GO:0005815;GO:0005654;GO:0005886;GO:0030036;GO:0006897;GO:0015031;, C:cytosol; C:endosome; C:filamentous actin; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, , P:actin cytoskeleton organization; P:endocytosis; P:protein transport;|Q8NDI1 O94977 Q53TG7 Q53TV6 Q580X2 Q6NX72 Q6PIT3 Q6QNV2 Q9NWI9,EH domain-binding protein 1,, PF00307;PF12130;PF10358;, GO:0005829;GO:0005768;GO:0031941;GO:0005815;GO:0005654;GO:0005886;GO:0030036;GO:0006897;GO:0015031;, C:cytosol; C:endosome; C:filamentous actin; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, , P:actin cytoskeleton organization; P:endocytosis; P:protein transport;|Q8NDI1 O94977 Q53TG7 Q53TV6 Q580X2 Q6NX72 Q6PIT3 Q6QNV2 Q9NWI9,EH domain-binding protein 1,, PF00307;PF12130;PF10358;, GO:0005829;GO:0005768;GO:0031941;GO:0005815;GO:0005654;GO:0005886;GO:0030036;GO:0006897;GO:0015031;, C:cytosol; C:endosome; C:filamentous actin; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, , P:actin cytoskeleton organization; P:endocytosis; P:protein transport; scaffold6 indexed_genome mRNA 5415526 5423393 . + . ID=transcript_1556;Q86X19 Q53QP7 Q53R98,Transmembrane protein 17,, PF09799;, GO:0060170;GO:0035869;GO:0016021;GO:0036038;GO:0060271;GO:1905515;GO:0007224;, C:ciliary membrane; C:ciliary transition zone; C:integral component of membrane; C:MKS complex;, , P:cilium assembly; P:non-motile cilium assembly; P:smoothened signaling pathway;|Q86X19 Q53QP7 Q53R98,Transmembrane protein 17,, PF09799;, GO:0060170;GO:0035869;GO:0016021;GO:0036038;GO:0060271;GO:1905515;GO:0007224;, C:ciliary membrane; C:ciliary transition zone; C:integral component of membrane; C:MKS complex;, , P:cilium assembly; P:non-motile cilium assembly; P:smoothened signaling pathway;|Q86X19 Q53QP7 Q53R98,Transmembrane protein 17,, PF09799;, GO:0060170;GO:0035869;GO:0016021;GO:0036038;GO:0060271;GO:1905515;GO:0007224;, C:ciliary membrane; C:ciliary transition zone; C:integral component of membrane; C:MKS complex;, , P:cilium assembly; P:non-motile cilium assembly; P:smoothened signaling pathway; scaffold6 indexed_genome mRNA 5744619 5938145 . - . ID=transcript_1557;Q8N668 B4DFQ4 Q96GS0,COMM domain-containing protein 1,Protein Murr1;, PF07258;PF17221;, GO:0031462;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0005654;GO:0005634;GO:0055037;GO:0005507;GO:0042802;GO:0070300;GO:0005547;GO:0043325;GO:0080025;GO:0005546;GO:0042803;GO:0019871;GO:0055070;GO:0006893;GO:0032088;GO:2000009;GO:1902306;GO:0006289;GO:0048227;GO:0031398;GO:0043687;GO:0015031;GO:0016567;GO:0032434;, C:Cul2-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:nucleoplasm; C:nucleus; C:recycling endosome;, F:copper ion binding; F:identical protein binding; F:phosphatidic acid binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein homodimerization activity; F:sodium channel inhibitor activity;, P:copper ion homeostasis; P:Golgi to plasma membrane transport; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:nucleotide-excision repair; P:plasma membrane to endosome transport; P:positive regulation of protein ubiquitination; P:post-translational protein modification; P:protein transport; P:protein ubiquitination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; scaffold6 indexed_genome mRNA 5961213 5974144 . + . ID=transcript_1558;P50991 B2R6I3 B7Z8B1 F5H5W3 O14870 Q53QP9 Q96C51,T-complex protein 1 subunit delta,CCT-delta;Stimulator of TAR RNA-binding;, PF00118;, GO:0044297;GO:0042995;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0042470;GO:0005874;GO:0005654;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:cell body; C:cell projection; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:melanosome; C:microtubule; C:nucleoplasm; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport;|P50991 B2R6I3 B7Z8B1 F5H5W3 O14870 Q53QP9 Q96C51,T-complex protein 1 subunit delta,CCT-delta;Stimulator of TAR RNA-binding;, PF00118;, GO:0044297;GO:0042995;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0042470;GO:0005874;GO:0005654;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:cell body; C:cell projection; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:melanosome; C:microtubule; C:nucleoplasm; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport;|P50991 B2R6I3 B7Z8B1 F5H5W3 O14870 Q53QP9 Q96C51,T-complex protein 1 subunit delta,CCT-delta;Stimulator of TAR RNA-binding;, PF00118;, GO:0044297;GO:0042995;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0042470;GO:0005874;GO:0005654;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:cell body; C:cell projection; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:melanosome; C:microtubule; C:nucleoplasm; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport;|P50991 B2R6I3 B7Z8B1 F5H5W3 O14870 Q53QP9 Q96C51,T-complex protein 1 subunit delta,CCT-delta;Stimulator of TAR RNA-binding;, PF00118;, GO:0044297;GO:0042995;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0042470;GO:0005874;GO:0005654;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:cell body; C:cell projection; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:melanosome; C:microtubule; C:nucleoplasm; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport;|P50991 B2R6I3 B7Z8B1 F5H5W3 O14870 Q53QP9 Q96C51,T-complex protein 1 subunit delta,CCT-delta;Stimulator of TAR RNA-binding;, PF00118;, GO:0044297;GO:0042995;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0042470;GO:0005874;GO:0005654;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:cell body; C:cell projection; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:melanosome; C:microtubule; C:nucleoplasm; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport;|P50991 B2R6I3 B7Z8B1 F5H5W3 O14870 Q53QP9 Q96C51,T-complex protein 1 subunit delta,CCT-delta;Stimulator of TAR RNA-binding;, PF00118;, GO:0044297;GO:0042995;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0042470;GO:0005874;GO:0005654;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:cell body; C:cell projection; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:melanosome; C:microtubule; C:nucleoplasm; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport; scaffold6 indexed_genome mRNA 5985360 5985887 . - . ID=transcript_1559;Q9HCI6 A8K4M3 Q8IW25,E3 SUMO-protein ligase KIAA1586 {ECO:0000305},E3 SUMO-protein transferase KIAA1586 {ECO:0000305};, , GO:0061665;GO:0016925;, , F:SUMO ligase activity;, P:protein sumoylation; scaffold6 indexed_genome mRNA 5988078 6017024 . + . ID=transcript_1560;Q3B820 B4DJV7 Q9H8R2,Protein FAM161A,, PF10595;, GO:0000235;GO:0005813;GO:0036064;GO:0072686;GO:0097431;GO:0032391;GO:0001917;GO:0005876;GO:0042802;GO:0008017;GO:0060271;GO:0044782;GO:1901985;GO:0050896;GO:0007601;, C:astral microtubule; C:centrosome; C:ciliary basal body; C:mitotic spindle; C:mitotic spindle pole; C:photoreceptor connecting cilium; C:photoreceptor inner segment; C:spindle microtubule;, F:identical protein binding; F:microtubule binding;, P:cilium assembly; P:cilium organization; P:positive regulation of protein acetylation; P:response to stimulus; P:visual perception;|Q3B820 B4DJV7 Q9H8R2,Protein FAM161A,, PF10595;, GO:0000235;GO:0005813;GO:0036064;GO:0072686;GO:0097431;GO:0032391;GO:0001917;GO:0005876;GO:0042802;GO:0008017;GO:0060271;GO:0044782;GO:1901985;GO:0050896;GO:0007601;, C:astral microtubule; C:centrosome; C:ciliary basal body; C:mitotic spindle; C:mitotic spindle pole; C:photoreceptor connecting cilium; C:photoreceptor inner segment; C:spindle microtubule;, F:identical protein binding; F:microtubule binding;, P:cilium assembly; P:cilium organization; P:positive regulation of protein acetylation; P:response to stimulus; P:visual perception;|Q3B820 B4DJV7 Q9H8R2,Protein FAM161A,, PF10595;, GO:0000235;GO:0005813;GO:0036064;GO:0072686;GO:0097431;GO:0032391;GO:0001917;GO:0005876;GO:0042802;GO:0008017;GO:0060271;GO:0044782;GO:1901985;GO:0050896;GO:0007601;, C:astral microtubule; C:centrosome; C:ciliary basal body; C:mitotic spindle; C:mitotic spindle pole; C:photoreceptor connecting cilium; C:photoreceptor inner segment; C:spindle microtubule;, F:identical protein binding; F:microtubule binding;, P:cilium assembly; P:cilium organization; P:positive regulation of protein acetylation; P:response to stimulus; P:visual perception; scaffold6 indexed_genome mRNA 6100656 6117346 . - . ID=transcript_1561;P62854 P02383 P70394 Q06722 Q3MHD8 Q6IRY4,40S ribosomal protein S26,Small ribosomal subunit protein eS26 {ECO:0000303|PubMed:24524803};, PF01283;, GO:0098556;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0042788;GO:0015935;GO:0045296;GO:0003729;GO:0003723;GO:0003735;GO:0002181;GO:0033119;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic side of rough endoplasmic reticulum membrane; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:polysomal ribosome; C:small ribosomal subunit;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:negative regulation of RNA splicing; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold6 indexed_genome mRNA 6278831 6315800 . + . ID=transcript_1562;O14980 A6NL14 A8K1K5 D6W5E2 Q63HP8 Q68CP3 Q99433,Exportin-1,Chromosome region maintenance 1 protein homolog;, PF08767;PF18777;PF18784;PF18787;PF03810;PF08389;, GO:0005642;GO:0015030;GO:0005737;GO:0005829;GO:0043657;GO:0043231;GO:0000776;GO:0016020;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005049;GO:0003723;GO:0031267;GO:0075733;GO:0007052;GO:0051028;GO:0006913;GO:0006611;GO:0043488;GO:0032434;GO:0000055;GO:0000056;GO:0000054;GO:0042254;GO:0016032;, C:annulate lamellae; C:Cajal body; C:cytoplasm; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:kinetochore; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:nuclear export signal receptor activity; F:RNA binding; F:small GTPase binding;, P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA transport; P:nucleocytoplasmic transport; P:protein export from nucleus; P:regulation of mRNA stability; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:ribosome biogenesis; P:viral process;|O14980 A6NL14 A8K1K5 D6W5E2 Q63HP8 Q68CP3 Q99433,Exportin-1,Chromosome region maintenance 1 protein homolog;, PF08767;PF18777;PF18784;PF18787;PF03810;PF08389;, GO:0005642;GO:0015030;GO:0005737;GO:0005829;GO:0043657;GO:0043231;GO:0000776;GO:0016020;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005049;GO:0003723;GO:0031267;GO:0075733;GO:0007052;GO:0051028;GO:0006913;GO:0006611;GO:0043488;GO:0032434;GO:0000055;GO:0000056;GO:0000054;GO:0042254;GO:0016032;, C:annulate lamellae; C:Cajal body; C:cytoplasm; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:kinetochore; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:nuclear export signal receptor activity; F:RNA binding; F:small GTPase binding;, P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA transport; P:nucleocytoplasmic transport; P:protein export from nucleus; P:regulation of mRNA stability; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:ribosome biogenesis; P:viral process;|O14980 A6NL14 A8K1K5 D6W5E2 Q63HP8 Q68CP3 Q99433,Exportin-1,Chromosome region maintenance 1 protein homolog;, PF08767;PF18777;PF18784;PF18787;PF03810;PF08389;, GO:0005642;GO:0015030;GO:0005737;GO:0005829;GO:0043657;GO:0043231;GO:0000776;GO:0016020;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005049;GO:0003723;GO:0031267;GO:0075733;GO:0007052;GO:0051028;GO:0006913;GO:0006611;GO:0043488;GO:0032434;GO:0000055;GO:0000056;GO:0000054;GO:0042254;GO:0016032;, C:annulate lamellae; C:Cajal body; C:cytoplasm; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:kinetochore; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:nuclear export signal receptor activity; F:RNA binding; F:small GTPase binding;, P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA transport; P:nucleocytoplasmic transport; P:protein export from nucleus; P:regulation of mRNA stability; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:ribosome biogenesis; P:viral process;|O14980 A6NL14 A8K1K5 D6W5E2 Q63HP8 Q68CP3 Q99433,Exportin-1,Chromosome region maintenance 1 protein homolog;, PF08767;PF18777;PF18784;PF18787;PF03810;PF08389;, GO:0005642;GO:0015030;GO:0005737;GO:0005829;GO:0043657;GO:0043231;GO:0000776;GO:0016020;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005049;GO:0003723;GO:0031267;GO:0075733;GO:0007052;GO:0051028;GO:0006913;GO:0006611;GO:0043488;GO:0032434;GO:0000055;GO:0000056;GO:0000054;GO:0042254;GO:0016032;, C:annulate lamellae; C:Cajal body; C:cytoplasm; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:kinetochore; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:nuclear export signal receptor activity; F:RNA binding; F:small GTPase binding;, P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA transport; P:nucleocytoplasmic transport; P:protein export from nucleus; P:regulation of mRNA stability; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:ribosome biogenesis; P:viral process;|O14980 A6NL14 A8K1K5 D6W5E2 Q63HP8 Q68CP3 Q99433,Exportin-1,Chromosome region maintenance 1 protein homolog;, PF08767;PF18777;PF18784;PF18787;PF03810;PF08389;, GO:0005642;GO:0015030;GO:0005737;GO:0005829;GO:0043657;GO:0043231;GO:0000776;GO:0016020;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005049;GO:0003723;GO:0031267;GO:0075733;GO:0007052;GO:0051028;GO:0006913;GO:0006611;GO:0043488;GO:0032434;GO:0000055;GO:0000056;GO:0000054;GO:0042254;GO:0016032;, C:annulate lamellae; C:Cajal body; C:cytoplasm; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:kinetochore; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:nuclear export signal receptor activity; F:RNA binding; F:small GTPase binding;, P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA transport; P:nucleocytoplasmic transport; P:protein export from nucleus; P:regulation of mRNA stability; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:ribosome biogenesis; P:viral process;|O14980 A6NL14 A8K1K5 D6W5E2 Q63HP8 Q68CP3 Q99433,Exportin-1,Chromosome region maintenance 1 protein homolog;, PF08767;PF18777;PF18784;PF18787;PF03810;PF08389;, GO:0005642;GO:0015030;GO:0005737;GO:0005829;GO:0043657;GO:0043231;GO:0000776;GO:0016020;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005049;GO:0003723;GO:0031267;GO:0075733;GO:0007052;GO:0051028;GO:0006913;GO:0006611;GO:0043488;GO:0032434;GO:0000055;GO:0000056;GO:0000054;GO:0042254;GO:0016032;, C:annulate lamellae; C:Cajal body; C:cytoplasm; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:kinetochore; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:nuclear export signal receptor activity; F:RNA binding; F:small GTPase binding;, P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA transport; P:nucleocytoplasmic transport; P:protein export from nucleus; P:regulation of mRNA stability; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:ribosome biogenesis; P:viral process;|O14980 A6NL14 A8K1K5 D6W5E2 Q63HP8 Q68CP3 Q99433,Exportin-1,Chromosome region maintenance 1 protein homolog;, PF08767;PF18777;PF18784;PF18787;PF03810;PF08389;, GO:0005642;GO:0015030;GO:0005737;GO:0005829;GO:0043657;GO:0043231;GO:0000776;GO:0016020;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005049;GO:0003723;GO:0031267;GO:0075733;GO:0007052;GO:0051028;GO:0006913;GO:0006611;GO:0043488;GO:0032434;GO:0000055;GO:0000056;GO:0000054;GO:0042254;GO:0016032;, C:annulate lamellae; C:Cajal body; C:cytoplasm; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:kinetochore; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:nuclear export signal receptor activity; F:RNA binding; F:small GTPase binding;, P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA transport; P:nucleocytoplasmic transport; P:protein export from nucleus; P:regulation of mRNA stability; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:ribosome biogenesis; P:viral process; scaffold6 indexed_genome mRNA 6349944 6573048 . + . ID=transcript_1563;Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway; scaffold6 indexed_genome mRNA 6573061 6594050 . - . ID=transcript_1564;Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q719I0 B3KS51 D6W5E0 Q8NDU5,Putative activator of 90 kDa heat shock protein ATPase homolog 2 {ECO:0000305},Activator of HSP90 ATPase homolog 2 pseudogene {ECO:0000312|HGNC:HGNC:20437};, PF09229;, GO:0005829;GO:0001671;GO:0051087;GO:0051879;GO:0032781;GO:0006457;, C:cytosol;, F:ATPase activator activity; F:chaperone binding; F:Hsp90 protein binding;, P:positive regulation of ATPase activity; P:protein folding;|Q719I0 B3KS51 D6W5E0 Q8NDU5,Putative activator of 90 kDa heat shock protein ATPase homolog 2 {ECO:0000305},Activator of HSP90 ATPase homolog 2 pseudogene {ECO:0000312|HGNC:HGNC:20437};, PF09229;, GO:0005829;GO:0001671;GO:0051087;GO:0051879;GO:0032781;GO:0006457;, C:cytosol;, F:ATPase activator activity; F:chaperone binding; F:Hsp90 protein binding;, P:positive regulation of ATPase activity; P:protein folding; scaffold6 indexed_genome mRNA 7848277 7849285 . - . ID=transcript_1565;Q86VH4 Q4FZ98 Q6UXJ7,Leucine-rich repeat transmembrane neuronal protein 4,, PF00560;PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0045211;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:postsynaptic membrane; scaffold6 indexed_genome mRNA 7849291 7852032 . - . ID=transcript_1566;Q86VH4 Q4FZ98 Q6UXJ7,Leucine-rich repeat transmembrane neuronal protein 4,, PF00560;PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0045211;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:postsynaptic membrane; scaffold6 indexed_genome mRNA 10129095 10130036 . - . ID=transcript_1567;P03915 Q34773 Q8WCY3,NADH-ubiquinone oxidoreductase chain 5,NADH dehydrogenase subunit 5;, PF06455;PF00361;PF00662;, GO:0016021;GO:0005743;GO:0005747;GO:0043005;GO:0008137;GO:0003954;GO:0015990;GO:0006120;GO:0032981;GO:0042542;GO:0001666;GO:0010243;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:neuron projection;, F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity;, P:electron transport coupled proton transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to hydrogen peroxide; P:response to hypoxia; P:response to organonitrogen compound; scaffold6 indexed_genome mRNA 10137336 10142322 . + . ID=transcript_1568;P03886 C0JKH6 Q37523,NADH-ubiquinone oxidoreductase chain 1,NADH dehydrogenase subunit 1;, PF00146;, GO:0030425;GO:0016021;GO:0005743;GO:0031966;GO:0005747;GO:0043025;GO:0008137;GO:0009060;GO:0006120;GO:0032981;GO:0042493;GO:0033194;GO:0014070;, C:dendrite; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:neuronal cell body;, F:NADH dehydrogenase (ubiquinone) activity;, P:aerobic respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to drug; P:response to hydroperoxide; P:response to organic cyclic compound; scaffold6 indexed_genome mRNA 10386005 11259805 . + . ID=transcript_1569;Q53T71 Q53TM8 Q7Z3L1 Q7Z3Y0,Catenin alpha-2,Alpha N-catenin;Alpha-catenin-related protein;, PF01044;, GO:0015629;GO:0005912;GO:0030424;GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0051015;GO:0045296;GO:0005200;GO:0007409;GO:0048854;GO:0098609;GO:0048813;GO:0034316;GO:0051149;GO:0060134;GO:0021942;GO:2001222;GO:0010975;GO:0051823;, C:actin cytoskeleton; C:adherens junction; C:axon; C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;, F:actin filament binding; F:cadherin binding; F:structural constituent of cytoskeleton;, P:axonogenesis; P:brain morphogenesis; P:cell-cell adhesion; P:dendrite morphogenesis; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of muscle cell differentiation; P:prepulse inhibition; P:radial glia guided migration of Purkinje cell; P:regulation of neuron migration; P:regulation of neuron projection development; P:regulation of synapse structural plasticity;|Q86UE6 A8K397 D6W5K1 Q96DN1,Leucine-rich repeat transmembrane neuronal protein 1,, PF13855;, GO:0030424;GO:0005783;GO:0060076;GO:0031012;GO:0005615;GO:0098982;GO:0098978;GO:0030426;GO:0099060;GO:0099151;GO:1905606;GO:0050808;, C:axon; C:endoplasmic reticulum; C:excitatory synapse; C:extracellular matrix; C:extracellular space; C:GABA-ergic synapse; C:glutamatergic synapse; C:growth cone; C:integral component of postsynaptic specialization membrane;, , P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synapse organization; scaffold6 indexed_genome mRNA 15095648 15133044 . - . ID=transcript_1570;P53597 Q9BWB0 Q9UNP6,Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03222},Succinyl-CoA synthetase subunit alpha {ECO:0000255|HAMAP-Rule:MF_03222};, PF02629;PF00549;, GO:0005759;GO:0005739;GO:0009361;GO:0000166;GO:0003723;GO:0004775;GO:0004776;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:succinate-CoA ligase complex (ADP-forming);, F:nucleotide binding; F:RNA binding; F:succinate-CoA ligase (ADP-forming) activity; F:succinate-CoA ligase (GDP-forming) activity;, P:tricarboxylic acid cycle;|P53597 Q9BWB0 Q9UNP6,Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03222},Succinyl-CoA synthetase subunit alpha {ECO:0000255|HAMAP-Rule:MF_03222};, PF02629;PF00549;, GO:0005759;GO:0005739;GO:0009361;GO:0000166;GO:0003723;GO:0004775;GO:0004776;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:succinate-CoA ligase complex (ADP-forming);, F:nucleotide binding; F:RNA binding; F:succinate-CoA ligase (ADP-forming) activity; F:succinate-CoA ligase (GDP-forming) activity;, P:tricarboxylic acid cycle; scaffold6 indexed_genome mRNA 15548061 15549310 . + . ID=transcript_1571;P63313 P13472 Q596K9,Thymosin beta-10,, PF01290;, GO:0005737;GO:0005856;GO:0003785;GO:0007015;GO:0030334;GO:0042989;, C:cytoplasm; C:cytoskeleton;, F:actin monomer binding;, P:actin filament organization; P:regulation of cell migration; P:sequestering of actin monomers; scaffold6 indexed_genome mRNA 15616306 15711405 . - . ID=transcript_1572;Q9P0J7 Q4ZG04 Q53SC7 Q9BWK2 Q9H8P5 Q9UFE8,E3 ubiquitin-protein ligase KCMF1,FGF-induced in gastric cancer;Potassium channel modulatory factor;RING-type E3 ubiquitin transferase KCMF1 {ECO:0000305};ZZ-type zinc finger-containing protein 1;, PF05605;PF00569;, GO:0005829;GO:0005576;GO:1904813;GO:0005886;GO:0045202;GO:0061630;GO:0008270;GO:0043312;GO:0099536;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:plasma membrane; C:synapse;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:neutrophil degranulation; P:synaptic signaling;|Q9P0J7 Q4ZG04 Q53SC7 Q9BWK2 Q9H8P5 Q9UFE8,E3 ubiquitin-protein ligase KCMF1,FGF-induced in gastric cancer;Potassium channel modulatory factor;RING-type E3 ubiquitin transferase KCMF1 {ECO:0000305};ZZ-type zinc finger-containing protein 1;, PF05605;PF00569;, GO:0005829;GO:0005576;GO:1904813;GO:0005886;GO:0045202;GO:0061630;GO:0008270;GO:0043312;GO:0099536;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:plasma membrane; C:synapse;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:neutrophil degranulation; P:synaptic signaling; scaffold6 indexed_genome mRNA 15953497 15956839 . + . ID=transcript_1573;Q9HCS4 Q53R97 Q6PD70 Q9NP00,Transcription factor 7-like 1,HMG box transcription factor 3;, PF08347;PF00505;, GO:1990907;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:1904837;GO:0060070;GO:0006325;GO:0006357;GO:0006355;GO:0030111;, C:beta-catenin-TCF complex; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:beta-catenin-TCF complex assembly; P:canonical Wnt signaling pathway; P:chromatin organization; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; scaffold6 indexed_genome mRNA 15959236 15960586 . + . ID=transcript_1574;Q9HCS4 Q53R97 Q6PD70 Q9NP00,Transcription factor 7-like 1,HMG box transcription factor 3;, PF08347;PF00505;, GO:1990907;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:1904837;GO:0060070;GO:0006325;GO:0006357;GO:0006355;GO:0030111;, C:beta-catenin-TCF complex; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:beta-catenin-TCF complex assembly; P:canonical Wnt signaling pathway; P:chromatin organization; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; scaffold6 indexed_genome mRNA 15969151 15979265 . - . ID=transcript_1575;Q96QL2,Trans-Golgi network integral membrane protein 2 {ECO:0000305},Trans-Golgi network glycoprotein 46 {ECO:0000303|PubMed:9422759};Trans-Golgi network glycoprotein 48 {ECO:0000303|PubMed:9422759};Trans-Golgi network glycoprotein 51 {ECO:0000303|PubMed:9422759};Trans-Golgi network protein 2 {ECO:0000312|HGNC:HGNC:15450};, , GO:0030669;GO:0005788;GO:0005768;GO:0005794;GO:0016021;GO:0005654;GO:0005886;GO:0005802;GO:0030140;GO:0030133;GO:0044267;GO:0061024;GO:0043687;, C:clathrin-coated endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle; C:transport vesicle;, , P:cellular protein metabolic process; P:membrane organization; P:post-translational protein modification; scaffold6 indexed_genome mRNA 15979464 15982629 . - . ID=transcript_1576;Q6NUM9 A6NIK3 Q53R95 Q53SA9 Q6UX05 Q8N2H5 Q96FA4 Q9NXE5,All-trans-retinol 13,14-reductase,All-trans-13,14-dihydroretinol saturase;PPAR-alpha-regulated and starvation-induced gene protein;, , GO:0005789;GO:0016020;GO:0031965;GO:0005640;GO:0051786;GO:0042572;, C:endoplasmic reticulum membrane; C:membrane; C:nuclear membrane; C:nuclear outer membrane;, F:all-trans-retinol 13,14-reductase activity;, P:retinol metabolic process; scaffold6 indexed_genome mRNA 15983165 15995757 . - . ID=transcript_1577;Q6NUM9 A6NIK3 Q53R95 Q53SA9 Q6UX05 Q8N2H5 Q96FA4 Q9NXE5,All-trans-retinol 13,14-reductase,All-trans-13,14-dihydroretinol saturase;PPAR-alpha-regulated and starvation-induced gene protein;, , GO:0005789;GO:0016020;GO:0031965;GO:0005640;GO:0051786;GO:0042572;, C:endoplasmic reticulum membrane; C:membrane; C:nuclear membrane; C:nuclear outer membrane;, F:all-trans-retinol 13,14-reductase activity;, P:retinol metabolic process; scaffold6 indexed_genome mRNA 15995795 16016638 . + . ID=transcript_1578;Q8WY75 Q9H6Q8,ELMO domain-containing protein 3,RNA-binding motif and ELMO domain-containing protein 1;RNA-binding motif protein 29;RNA-binding protein 29;, PF04727;, GO:0005737;GO:0005856;GO:0060091;GO:0005886;GO:0032420;GO:0043547;, C:cytoplasm; C:cytoskeleton; C:kinocilium; C:plasma membrane; C:stereocilium;, , P:positive regulation of GTPase activity;|Q8WY75 Q9H6Q8,ELMO domain-containing protein 3,RNA-binding motif and ELMO domain-containing protein 1;RNA-binding motif protein 29;RNA-binding protein 29;, PF04727;, GO:0005737;GO:0005856;GO:0060091;GO:0005886;GO:0032420;GO:0043547;, C:cytoplasm; C:cytoskeleton; C:kinocilium; C:plasma membrane; C:stereocilium;, , P:positive regulation of GTPase activity; scaffold6 indexed_genome mRNA 16020052 16028842 . + . ID=transcript_1579;Q8WY75 Q9H6Q8,ELMO domain-containing protein 3,RNA-binding motif and ELMO domain-containing protein 1;RNA-binding motif protein 29;RNA-binding protein 29;, PF04727;, GO:0005737;GO:0005856;GO:0060091;GO:0005886;GO:0032420;GO:0043547;, C:cytoplasm; C:cytoskeleton; C:kinocilium; C:plasma membrane; C:stereocilium;, , P:positive regulation of GTPase activity;|Q8WY75 Q9H6Q8,ELMO domain-containing protein 3,RNA-binding motif and ELMO domain-containing protein 1;RNA-binding motif protein 29;RNA-binding protein 29;, PF04727;, GO:0005737;GO:0005856;GO:0060091;GO:0005886;GO:0032420;GO:0043547;, C:cytoplasm; C:cytoskeleton; C:kinocilium; C:plasma membrane; C:stereocilium;, , P:positive regulation of GTPase activity; scaffold6 indexed_genome mRNA 16028869 16040341 . + . ID=transcript_1580;P40121 B8ZZS7 D6W5K8 Q53SA7,Macrophage-capping protein,Actin regulatory protein CAP-G;, PF00626;, GO:0015629;GO:0005814;GO:0005737;GO:0070062;GO:0005615;GO:0008290;GO:0090543;GO:0030027;GO:0042470;GO:0072686;GO:0005730;GO:0005654;GO:0005634;GO:0001726;GO:0051015;GO:0045296;GO:0005546;GO:0019904;GO:0044877;GO:0051014;GO:0008154;GO:0051016;GO:0030031;GO:0007417;GO:0065003;, C:actin cytoskeleton; C:centriole; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:F-actin capping protein complex; C:Flemming body; C:lamellipodium; C:melanosome; C:mitotic spindle; C:nucleolus; C:nucleoplasm; C:nucleus; C:ruffle;, F:actin filament binding; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein domain specific binding; F:protein-containing complex binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cell projection assembly; P:central nervous system development; P:protein-containing complex assembly;|P40121 B8ZZS7 D6W5K8 Q53SA7,Macrophage-capping protein,Actin regulatory protein CAP-G;, PF00626;, GO:0015629;GO:0005814;GO:0005737;GO:0070062;GO:0005615;GO:0008290;GO:0090543;GO:0030027;GO:0042470;GO:0072686;GO:0005730;GO:0005654;GO:0005634;GO:0001726;GO:0051015;GO:0045296;GO:0005546;GO:0019904;GO:0044877;GO:0051014;GO:0008154;GO:0051016;GO:0030031;GO:0007417;GO:0065003;, C:actin cytoskeleton; C:centriole; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:F-actin capping protein complex; C:Flemming body; C:lamellipodium; C:melanosome; C:mitotic spindle; C:nucleolus; C:nucleoplasm; C:nucleus; C:ruffle;, F:actin filament binding; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein domain specific binding; F:protein-containing complex binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cell projection assembly; P:central nervous system development; P:protein-containing complex assembly;|P40121 B8ZZS7 D6W5K8 Q53SA7,Macrophage-capping protein,Actin regulatory protein CAP-G;, PF00626;, GO:0015629;GO:0005814;GO:0005737;GO:0070062;GO:0005615;GO:0008290;GO:0090543;GO:0030027;GO:0042470;GO:0072686;GO:0005730;GO:0005654;GO:0005634;GO:0001726;GO:0051015;GO:0045296;GO:0005546;GO:0019904;GO:0044877;GO:0051014;GO:0008154;GO:0051016;GO:0030031;GO:0007417;GO:0065003;, C:actin cytoskeleton; C:centriole; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:F-actin capping protein complex; C:Flemming body; C:lamellipodium; C:melanosome; C:mitotic spindle; C:nucleolus; C:nucleoplasm; C:nucleus; C:ruffle;, F:actin filament binding; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein domain specific binding; F:protein-containing complex binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cell projection assembly; P:central nervous system development; P:protein-containing complex assembly;|P40121 B8ZZS7 D6W5K8 Q53SA7,Macrophage-capping protein,Actin regulatory protein CAP-G;, PF00626;, GO:0015629;GO:0005814;GO:0005737;GO:0070062;GO:0005615;GO:0008290;GO:0090543;GO:0030027;GO:0042470;GO:0072686;GO:0005730;GO:0005654;GO:0005634;GO:0001726;GO:0051015;GO:0045296;GO:0005546;GO:0019904;GO:0044877;GO:0051014;GO:0008154;GO:0051016;GO:0030031;GO:0007417;GO:0065003;, C:actin cytoskeleton; C:centriole; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:F-actin capping protein complex; C:Flemming body; C:lamellipodium; C:melanosome; C:mitotic spindle; C:nucleolus; C:nucleoplasm; C:nucleus; C:ruffle;, F:actin filament binding; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein domain specific binding; F:protein-containing complex binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cell projection assembly; P:central nervous system development; P:protein-containing complex assembly; scaffold6 indexed_genome mRNA 16074712 16076853 . + . ID=transcript_1581;Q7Z4S9 A6ND14 Q6R306,SH2 domain-containing protein 6,, PF00017;, GO:0005737;GO:0035556;GO:0007169;, C:cytoplasm;, , P:intracellular signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold6 indexed_genome mRNA 16158107 16180227 . + . ID=transcript_1582;P31153 A8K511 B4DN45 D6W5L1 Q53SP5,S-adenosylmethionine synthase isoform type-2,Methionine adenosyltransferase 2;Methionine adenosyltransferase II;, PF02773;PF02772;PF00438;, GO:0005829;GO:0048269;GO:0005524;GO:0042802;GO:0046872;GO:0004478;GO:1990830;GO:0032259;GO:0006730;GO:0051291;GO:0034214;GO:0006556;, C:cytosol; C:methionine adenosyltransferase complex;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:methionine adenosyltransferase activity;, P:cellular response to leukemia inhibitory factor; P:methylation; P:one-carbon metabolic process; P:protein heterooligomerization; P:protein hexamerization; P:S-adenosylmethionine biosynthetic process;|P31153 A8K511 B4DN45 D6W5L1 Q53SP5,S-adenosylmethionine synthase isoform type-2,Methionine adenosyltransferase 2;Methionine adenosyltransferase II;, PF02773;PF02772;PF00438;, GO:0005829;GO:0048269;GO:0005524;GO:0042802;GO:0046872;GO:0004478;GO:1990830;GO:0032259;GO:0006730;GO:0051291;GO:0034214;GO:0006556;, C:cytosol; C:methionine adenosyltransferase complex;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:methionine adenosyltransferase activity;, P:cellular response to leukemia inhibitory factor; P:methylation; P:one-carbon metabolic process; P:protein heterooligomerization; P:protein hexamerization; P:S-adenosylmethionine biosynthetic process;|P31153 A8K511 B4DN45 D6W5L1 Q53SP5,S-adenosylmethionine synthase isoform type-2,Methionine adenosyltransferase 2;Methionine adenosyltransferase II;, PF02773;PF02772;PF00438;, GO:0005829;GO:0048269;GO:0005524;GO:0042802;GO:0046872;GO:0004478;GO:1990830;GO:0032259;GO:0006730;GO:0051291;GO:0034214;GO:0006556;, C:cytosol; C:methionine adenosyltransferase complex;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:methionine adenosyltransferase activity;, P:cellular response to leukemia inhibitory factor; P:methylation; P:one-carbon metabolic process; P:protein heterooligomerization; P:protein hexamerization; P:S-adenosylmethionine biosynthetic process;|P38435 B4DMC5 E9PEE1 Q14415 Q6GU45,Vitamin K-dependent gamma-carboxylase,Gamma-glutamyl carboxylase;Peptidyl-glutamate 4-carboxylase;Vitamin K gamma glutamyl carboxylase;, PF05090;, GO:0005789;GO:0016021;GO:0016020;GO:0008488;GO:0019842;GO:0007596;GO:0006464;GO:0017187;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:gamma-glutamyl carboxylase activity; F:vitamin binding;, P:blood coagulation; P:cellular protein modification process; P:peptidyl-glutamic acid carboxylation;|P38435 B4DMC5 E9PEE1 Q14415 Q6GU45,Vitamin K-dependent gamma-carboxylase,Gamma-glutamyl carboxylase;Peptidyl-glutamate 4-carboxylase;Vitamin K gamma glutamyl carboxylase;, PF05090;, GO:0005789;GO:0016021;GO:0016020;GO:0008488;GO:0019842;GO:0007596;GO:0006464;GO:0017187;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:gamma-glutamyl carboxylase activity; F:vitamin binding;, P:blood coagulation; P:cellular protein modification process; P:peptidyl-glutamic acid carboxylation;|P38435 B4DMC5 E9PEE1 Q14415 Q6GU45,Vitamin K-dependent gamma-carboxylase,Gamma-glutamyl carboxylase;Peptidyl-glutamate 4-carboxylase;Vitamin K gamma glutamyl carboxylase;, PF05090;, GO:0005789;GO:0016021;GO:0016020;GO:0008488;GO:0019842;GO:0007596;GO:0006464;GO:0017187;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:gamma-glutamyl carboxylase activity; F:vitamin binding;, P:blood coagulation; P:cellular protein modification process; P:peptidyl-glutamic acid carboxylation;|P38435 B4DMC5 E9PEE1 Q14415 Q6GU45,Vitamin K-dependent gamma-carboxylase,Gamma-glutamyl carboxylase;Peptidyl-glutamate 4-carboxylase;Vitamin K gamma glutamyl carboxylase;, PF05090;, GO:0005789;GO:0016021;GO:0016020;GO:0008488;GO:0019842;GO:0007596;GO:0006464;GO:0017187;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:gamma-glutamyl carboxylase activity; F:vitamin binding;, P:blood coagulation; P:cellular protein modification process; P:peptidyl-glutamic acid carboxylation;|P38435 B4DMC5 E9PEE1 Q14415 Q6GU45,Vitamin K-dependent gamma-carboxylase,Gamma-glutamyl carboxylase;Peptidyl-glutamate 4-carboxylase;Vitamin K gamma glutamyl carboxylase;, PF05090;, GO:0005789;GO:0016021;GO:0016020;GO:0008488;GO:0019842;GO:0007596;GO:0006464;GO:0017187;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:gamma-glutamyl carboxylase activity; F:vitamin binding;, P:blood coagulation; P:cellular protein modification process; P:peptidyl-glutamic acid carboxylation;|P38435 B4DMC5 E9PEE1 Q14415 Q6GU45,Vitamin K-dependent gamma-carboxylase,Gamma-glutamyl carboxylase;Peptidyl-glutamate 4-carboxylase;Vitamin K gamma glutamyl carboxylase;, PF05090;, GO:0005789;GO:0016021;GO:0016020;GO:0008488;GO:0019842;GO:0007596;GO:0006464;GO:0017187;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:gamma-glutamyl carboxylase activity; F:vitamin binding;, P:blood coagulation; P:cellular protein modification process; P:peptidyl-glutamic acid carboxylation; scaffold6 indexed_genome mRNA 16198974 16201800 . - . ID=transcript_1583;Q9BV40 O60625 Q53SP9 Q6IB09,Vesicle-associated membrane protein 8 {ECO:0000303|PubMed:12130530},Endobrevin {ECO:0000303|PubMed:9614193};, PF00957;, GO:0035577;GO:0030669;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0070062;GO:0016021;GO:0031902;GO:0005765;GO:0016020;GO:0098594;GO:0048471;GO:0030670;GO:0005886;GO:0055037;GO:0055038;GO:0030667;GO:0031201;GO:0035579;GO:0070821;GO:0031982;GO:0019869;GO:0005484;GO:0019905;GO:0002479;GO:0097352;GO:0016240;GO:0051607;GO:0061024;GO:0070254;GO:1903531;GO:0043312;GO:1903595;GO:0006892;GO:0015031;GO:1903076;GO:0035493;GO:0006906;GO:0046718;, C:azurophil granule membrane; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:mucin granule; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:secretory granule membrane; C:SNARE complex; C:specific granule membrane; C:tertiary granule membrane; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:syntaxin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:autophagosome maturation; P:autophagosome membrane docking; P:defense response to virus; P:membrane organization; P:mucus secretion; P:negative regulation of secretion by cell; P:neutrophil degranulation; P:positive regulation of histamine secretion by mast cell; P:post-Golgi vesicle-mediated transport; P:protein transport; P:regulation of protein localization to plasma membrane; P:SNARE complex assembly; P:vesicle fusion; P:viral entry into host cell;|Q9BV40 O60625 Q53SP9 Q6IB09,Vesicle-associated membrane protein 8 {ECO:0000303|PubMed:12130530},Endobrevin {ECO:0000303|PubMed:9614193};, PF00957;, GO:0035577;GO:0030669;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0070062;GO:0016021;GO:0031902;GO:0005765;GO:0016020;GO:0098594;GO:0048471;GO:0030670;GO:0005886;GO:0055037;GO:0055038;GO:0030667;GO:0031201;GO:0035579;GO:0070821;GO:0031982;GO:0019869;GO:0005484;GO:0019905;GO:0002479;GO:0097352;GO:0016240;GO:0051607;GO:0061024;GO:0070254;GO:1903531;GO:0043312;GO:1903595;GO:0006892;GO:0015031;GO:1903076;GO:0035493;GO:0006906;GO:0046718;, C:azurophil granule membrane; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:mucin granule; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:secretory granule membrane; C:SNARE complex; C:specific granule membrane; C:tertiary granule membrane; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:syntaxin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:autophagosome maturation; P:autophagosome membrane docking; P:defense response to virus; P:membrane organization; P:mucus secretion; P:negative regulation of secretion by cell; P:neutrophil degranulation; P:positive regulation of histamine secretion by mast cell; P:post-Golgi vesicle-mediated transport; P:protein transport; P:regulation of protein localization to plasma membrane; P:SNARE complex assembly; P:vesicle fusion; P:viral entry into host cell; scaffold6 indexed_genome mRNA 16206887 16212262 . - . ID=transcript_1584;O95183 Q9P0T2,Vesicle-associated membrane protein 5,Myobrevin;, PF00957;, GO:0009986;GO:0030659;GO:0070062;GO:0005794;GO:0031301;GO:0005887;GO:0014704;GO:0005770;GO:0048471;GO:0005886;GO:0030154;GO:0043001;GO:0007517;GO:0007519;, C:cell surface; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of organelle membrane; C:integral component of plasma membrane; C:intercalated disc; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:cell differentiation; P:Golgi to plasma membrane protein transport; P:muscle organ development; P:skeletal muscle tissue development;|O95183 Q9P0T2,Vesicle-associated membrane protein 5,Myobrevin;, PF00957;, GO:0009986;GO:0030659;GO:0070062;GO:0005794;GO:0031301;GO:0005887;GO:0014704;GO:0005770;GO:0048471;GO:0005886;GO:0030154;GO:0043001;GO:0007517;GO:0007519;, C:cell surface; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of organelle membrane; C:integral component of plasma membrane; C:intercalated disc; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:cell differentiation; P:Golgi to plasma membrane protein transport; P:muscle organ development; P:skeletal muscle tissue development; scaffold6 indexed_genome mRNA 16215358 16221365 . + . ID=transcript_1585;Q9P0P0 Q53H81,E3 ubiquitin-protein ligase RNF181,RING finger protein 181;RING-type E3 ubiquitin transferase RNF181 {ECO:0000305};, PF13639;, GO:0005737;GO:0046872;GO:0061630;GO:0004842;GO:0051865;GO:0016567;, C:cytoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein autoubiquitination; P:protein ubiquitination;|Q9P0P0 Q53H81,E3 ubiquitin-protein ligase RNF181,RING finger protein 181;RING-type E3 ubiquitin transferase RNF181 {ECO:0000305};, PF13639;, GO:0005737;GO:0046872;GO:0061630;GO:0004842;GO:0051865;GO:0016567;, C:cytoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein autoubiquitination; P:protein ubiquitination;|Q86TG1 A8K764 B7WPQ9 D6W5L2 Q8N2R6,Transmembrane protein 150A,Transmembrane protein 150;, PF10277;, GO:0005887;GO:0005764;GO:0009056;GO:0046854;GO:0072659;GO:0010506;, C:integral component of plasma membrane; C:lysosome;, , P:catabolic process; P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane; P:regulation of autophagy;|Q86TG1 A8K764 B7WPQ9 D6W5L2 Q8N2R6,Transmembrane protein 150A,Transmembrane protein 150;, PF10277;, GO:0005887;GO:0005764;GO:0009056;GO:0046854;GO:0072659;GO:0010506;, C:integral component of plasma membrane; C:lysosome;, , P:catabolic process; P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane; P:regulation of autophagy;|Q86TG1 A8K764 B7WPQ9 D6W5L2 Q8N2R6,Transmembrane protein 150A,Transmembrane protein 150;, PF10277;, GO:0005887;GO:0005764;GO:0009056;GO:0046854;GO:0072659;GO:0010506;, C:integral component of plasma membrane; C:lysosome;, , P:catabolic process; P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane; P:regulation of autophagy;|Q86TG1 A8K764 B7WPQ9 D6W5L2 Q8N2R6,Transmembrane protein 150A,Transmembrane protein 150;, PF10277;, GO:0005887;GO:0005764;GO:0009056;GO:0046854;GO:0072659;GO:0010506;, C:integral component of plasma membrane; C:lysosome;, , P:catabolic process; P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane; P:regulation of autophagy; scaffold6 indexed_genome mRNA 16223967 16230995 . - . ID=transcript_1586;Q2NKX9 B4DT10 Q4G0J7 Q6ZVA6,UPF0561 protein C2orf68,, PF10573; scaffold6 indexed_genome mRNA 16234703 16269932 . + . ID=transcript_1587;Q9H381 Q9P050 Q9Y310,U4/U6.U5 tri-snRNP-associated protein 2,Inactive ubiquitin-specific peptidase 39 {ECO:0000303|PubMed:18728397};SAD1 homolog {ECO:0000303|PubMed:11350945};U4/U6.U5 tri-snRNP-associated 65 kDa protein {ECO:0000303|PubMed:11350945};, PF00443;PF02148;, GO:0005654;GO:0005634;GO:0005681;GO:0046540;GO:0008270;GO:0007049;GO:0051301;GO:0006397;GO:0000398;GO:0016579;GO:0018215;GO:0008380;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U4/U6 x U5 tri-snRNP complex;, F:zinc ion binding;, P:cell cycle; P:cell division; P:mRNA processing; P:mRNA splicing, via spliceosome; P:protein deubiquitination; P:protein phosphopantetheinylation; P:RNA splicing; P:spliceosomal complex assembly;|Q9H381 Q9P050 Q9Y310,U4/U6.U5 tri-snRNP-associated protein 2,Inactive ubiquitin-specific peptidase 39 {ECO:0000303|PubMed:18728397};SAD1 homolog {ECO:0000303|PubMed:11350945};U4/U6.U5 tri-snRNP-associated 65 kDa protein {ECO:0000303|PubMed:11350945};, PF00443;PF02148;, GO:0005654;GO:0005634;GO:0005681;GO:0046540;GO:0008270;GO:0007049;GO:0051301;GO:0006397;GO:0000398;GO:0016579;GO:0018215;GO:0008380;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U4/U6 x U5 tri-snRNP complex;, F:zinc ion binding;, P:cell cycle; P:cell division; P:mRNA processing; P:mRNA splicing, via spliceosome; P:protein deubiquitination; P:protein phosphopantetheinylation; P:RNA splicing; P:spliceosomal complex assembly;|Q9H381 Q9P050 Q9Y310,U4/U6.U5 tri-snRNP-associated protein 2,Inactive ubiquitin-specific peptidase 39 {ECO:0000303|PubMed:18728397};SAD1 homolog {ECO:0000303|PubMed:11350945};U4/U6.U5 tri-snRNP-associated 65 kDa protein {ECO:0000303|PubMed:11350945};, PF00443;PF02148;, GO:0005654;GO:0005634;GO:0005681;GO:0046540;GO:0008270;GO:0007049;GO:0051301;GO:0006397;GO:0000398;GO:0016579;GO:0018215;GO:0008380;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U4/U6 x U5 tri-snRNP complex;, F:zinc ion binding;, P:cell cycle; P:cell division; P:mRNA processing; P:mRNA splicing, via spliceosome; P:protein deubiquitination; P:protein phosphopantetheinylation; P:RNA splicing; P:spliceosomal complex assembly;|Q9H381 Q9P050 Q9Y310,U4/U6.U5 tri-snRNP-associated protein 2,Inactive ubiquitin-specific peptidase 39 {ECO:0000303|PubMed:18728397};SAD1 homolog {ECO:0000303|PubMed:11350945};U4/U6.U5 tri-snRNP-associated 65 kDa protein {ECO:0000303|PubMed:11350945};, PF00443;PF02148;, GO:0005654;GO:0005634;GO:0005681;GO:0046540;GO:0008270;GO:0007049;GO:0051301;GO:0006397;GO:0000398;GO:0016579;GO:0018215;GO:0008380;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U4/U6 x U5 tri-snRNP complex;, F:zinc ion binding;, P:cell cycle; P:cell division; P:mRNA processing; P:mRNA splicing, via spliceosome; P:protein deubiquitination; P:protein phosphopantetheinylation; P:RNA splicing; P:spliceosomal complex assembly;|Q9H381 Q9P050 Q9Y310,U4/U6.U5 tri-snRNP-associated protein 2,Inactive ubiquitin-specific peptidase 39 {ECO:0000303|PubMed:18728397};SAD1 homolog {ECO:0000303|PubMed:11350945};U4/U6.U5 tri-snRNP-associated 65 kDa protein {ECO:0000303|PubMed:11350945};, PF00443;PF02148;, GO:0005654;GO:0005634;GO:0005681;GO:0046540;GO:0008270;GO:0007049;GO:0051301;GO:0006397;GO:0000398;GO:0016579;GO:0018215;GO:0008380;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U4/U6 x U5 tri-snRNP complex;, F:zinc ion binding;, P:cell cycle; P:cell division; P:mRNA processing; P:mRNA splicing, via spliceosome; P:protein deubiquitination; P:protein phosphopantetheinylation; P:RNA splicing; P:spliceosomal complex assembly; scaffold6 indexed_genome mRNA 16271117 16276375 . + . ID=transcript_1588;Q6ZN92,Putative inactive deoxyuridine 5'-triphosphate nucleotidohydrolase-like protein FLJ16323,, PF00692;, GO:0004170;GO:0000287;GO:0006226;GO:0046081;, , F:dUTP diphosphatase activity; F:magnesium ion binding;, P:dUMP biosynthetic process; P:dUTP catabolic process; scaffold6 indexed_genome mRNA 16285103 16286812 . - . ID=transcript_1589;P07988 Q96R04,Pulmonary surfactant-associated protein B,18 kDa pulmonary-surfactant protein;6 kDa protein;Pulmonary surfactant-associated proteolipid SPL(Phe);, PF02199;PF05184;PF03489;, GO:0097208;GO:0045334;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0005764;GO:0005771;GO:0097486;GO:0009887;GO:0044267;GO:0007585;GO:0006665;, C:alveolar lamellar body; C:clathrin-coated endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body; C:lysosome; C:multivesicular body; C:multivesicular body lumen;, , P:animal organ morphogenesis; P:cellular protein metabolic process; P:respiratory gaseous exchange by respiratory system; P:sphingolipid metabolic process; scaffold6 indexed_genome mRNA 16287006 16288536 . - . ID=transcript_1590;P07988 Q96R04,Pulmonary surfactant-associated protein B,18 kDa pulmonary-surfactant protein;6 kDa protein;Pulmonary surfactant-associated proteolipid SPL(Phe);, PF02199;PF05184;PF03489;, GO:0097208;GO:0045334;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0005764;GO:0005771;GO:0097486;GO:0009887;GO:0044267;GO:0007585;GO:0006665;, C:alveolar lamellar body; C:clathrin-coated endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body; C:lysosome; C:multivesicular body; C:multivesicular body lumen;, , P:animal organ morphogenesis; P:cellular protein metabolic process; P:respiratory gaseous exchange by respiratory system; P:sphingolipid metabolic process; scaffold6 indexed_genome mRNA 16288567 16293336 . + . ID=transcript_1591;P07988 Q96R04,Pulmonary surfactant-associated protein B,18 kDa pulmonary-surfactant protein;6 kDa protein;Pulmonary surfactant-associated proteolipid SPL(Phe);, PF02199;PF05184;PF03489;, GO:0097208;GO:0045334;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0005764;GO:0005771;GO:0097486;GO:0009887;GO:0044267;GO:0007585;GO:0006665;, C:alveolar lamellar body; C:clathrin-coated endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body; C:lysosome; C:multivesicular body; C:multivesicular body lumen;, , P:animal organ morphogenesis; P:cellular protein metabolic process; P:respiratory gaseous exchange by respiratory system; P:sphingolipid metabolic process;|P07988 Q96R04,Pulmonary surfactant-associated protein B,18 kDa pulmonary-surfactant protein;6 kDa protein;Pulmonary surfactant-associated proteolipid SPL(Phe);, PF02199;PF05184;PF03489;, GO:0097208;GO:0045334;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0005764;GO:0005771;GO:0097486;GO:0009887;GO:0044267;GO:0007585;GO:0006665;, C:alveolar lamellar body; C:clathrin-coated endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body; C:lysosome; C:multivesicular body; C:multivesicular body lumen;, , P:animal organ morphogenesis; P:cellular protein metabolic process; P:respiratory gaseous exchange by respiratory system; P:sphingolipid metabolic process; scaffold6 indexed_genome mRNA 16359785 16362257 . + . ID=transcript_1592;P22749 P09325 Q6GU08,Granulysin,Lymphokine LAG-2;Protein NKG5;T-cell activation protein 519;, , GO:0005576;GO:0005615;GO:0097013;GO:0061844;GO:0019730;GO:0006968;GO:0042742;GO:0050832;GO:0031640;, C:extracellular region; C:extracellular space; C:phagocytic vesicle lumen;, , P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:antimicrobial humoral response; P:cellular defense response; P:defense response to bacterium; P:defense response to fungus; P:killing of cells of other organism; scaffold6 indexed_genome mRNA 16519191 16580066 . - . ID=transcript_1593;Q9UNP4 B3KM82 D6W5L9 O94902 Q53QU1 Q6NZX4 Q6YFL1,Lactosylceramide alpha-2,3-sialyltransferase,CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase;GM3 synthase {ECO:0000303|PubMed:16934889};Ganglioside GM3 synthase {ECO:0000303|PubMed:9822625};ST3Gal V;Sialyltransferase 9;, PF00777;, GO:0000139;GO:0016021;GO:0005887;GO:0047291;GO:0004513;GO:0008373;GO:0005975;GO:0001574;GO:0006688;GO:0006486;, C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:lactosylceramide alpha-2,3-sialyltransferase activity; F:neolactotetraosylceramide alpha-2,3-sialyltransferase activity; F:sialyltransferase activity;, P:carbohydrate metabolic process; P:ganglioside biosynthetic process; P:glycosphingolipid biosynthetic process; P:protein glycosylation; scaffold6 indexed_genome mRNA 16720421 16802719 . - . ID=transcript_1594;O95602 B7Z7T0 D6W5M0 Q0VG05 Q9UEH0 Q9UFT9,DNA-directed RNA polymerase I subunit RPA1,A190;DNA-directed RNA polymerase I largest subunit;DNA-directed RNA polymerase I subunit A;RNA polymerase I 194 kDa subunit;, PF04997;PF00623;PF04983;PF05000;PF04998;, GO:0005694;GO:0005654;GO:0005736;GO:0003682;GO:0003677;GO:0001054;GO:0008270;GO:1904750;GO:0045815;GO:0006363;GO:0006361;, C:chromosome; C:nucleoplasm; C:RNA polymerase I complex;, F:chromatin binding; F:DNA binding; F:RNA polymerase I activity; F:zinc ion binding;, P:negative regulation of protein localization to nucleolus; P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter;|O95602 B7Z7T0 D6W5M0 Q0VG05 Q9UEH0 Q9UFT9,DNA-directed RNA polymerase I subunit RPA1,A190;DNA-directed RNA polymerase I largest subunit;DNA-directed RNA polymerase I subunit A;RNA polymerase I 194 kDa subunit;, PF04997;PF00623;PF04983;PF05000;PF04998;, GO:0005694;GO:0005654;GO:0005736;GO:0003682;GO:0003677;GO:0001054;GO:0008270;GO:1904750;GO:0045815;GO:0006363;GO:0006361;, C:chromosome; C:nucleoplasm; C:RNA polymerase I complex;, F:chromatin binding; F:DNA binding; F:RNA polymerase I activity; F:zinc ion binding;, P:negative regulation of protein localization to nucleolus; P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter;|O95602 B7Z7T0 D6W5M0 Q0VG05 Q9UEH0 Q9UFT9,DNA-directed RNA polymerase I subunit RPA1,A190;DNA-directed RNA polymerase I largest subunit;DNA-directed RNA polymerase I subunit A;RNA polymerase I 194 kDa subunit;, PF04997;PF00623;PF04983;PF05000;PF04998;, GO:0005694;GO:0005654;GO:0005736;GO:0003682;GO:0003677;GO:0001054;GO:0008270;GO:1904750;GO:0045815;GO:0006363;GO:0006361;, C:chromosome; C:nucleoplasm; C:RNA polymerase I complex;, F:chromatin binding; F:DNA binding; F:RNA polymerase I activity; F:zinc ion binding;, P:negative regulation of protein localization to nucleolus; P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter;|O95602 B7Z7T0 D6W5M0 Q0VG05 Q9UEH0 Q9UFT9,DNA-directed RNA polymerase I subunit RPA1,A190;DNA-directed RNA polymerase I largest subunit;DNA-directed RNA polymerase I subunit A;RNA polymerase I 194 kDa subunit;, PF04997;PF00623;PF04983;PF05000;PF04998;, GO:0005694;GO:0005654;GO:0005736;GO:0003682;GO:0003677;GO:0001054;GO:0008270;GO:1904750;GO:0045815;GO:0006363;GO:0006361;, C:chromosome; C:nucleoplasm; C:RNA polymerase I complex;, F:chromatin binding; F:DNA binding; F:RNA polymerase I activity; F:zinc ion binding;, P:negative regulation of protein localization to nucleolus; P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter;|O95602 B7Z7T0 D6W5M0 Q0VG05 Q9UEH0 Q9UFT9,DNA-directed RNA polymerase I subunit RPA1,A190;DNA-directed RNA polymerase I largest subunit;DNA-directed RNA polymerase I subunit A;RNA polymerase I 194 kDa subunit;, PF04997;PF00623;PF04983;PF05000;PF04998;, GO:0005694;GO:0005654;GO:0005736;GO:0003682;GO:0003677;GO:0001054;GO:0008270;GO:1904750;GO:0045815;GO:0006363;GO:0006361;, C:chromosome; C:nucleoplasm; C:RNA polymerase I complex;, F:chromatin binding; F:DNA binding; F:RNA polymerase I activity; F:zinc ion binding;, P:negative regulation of protein localization to nucleolus; P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter;|O95602 B7Z7T0 D6W5M0 Q0VG05 Q9UEH0 Q9UFT9,DNA-directed RNA polymerase I subunit RPA1,A190;DNA-directed RNA polymerase I largest subunit;DNA-directed RNA polymerase I subunit A;RNA polymerase I 194 kDa subunit;, PF04997;PF00623;PF04983;PF05000;PF04998;, GO:0005694;GO:0005654;GO:0005736;GO:0003682;GO:0003677;GO:0001054;GO:0008270;GO:1904750;GO:0045815;GO:0006363;GO:0006361;, C:chromosome; C:nucleoplasm; C:RNA polymerase I complex;, F:chromatin binding; F:DNA binding; F:RNA polymerase I activity; F:zinc ion binding;, P:negative regulation of protein localization to nucleolus; P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; scaffold6 indexed_genome mRNA 16803081 16830530 . + . ID=transcript_1595;Q96EY7 A6NHD2 D6W5M1 Q597H0 Q658Y9 Q9BUZ8 Q9NWL0,Pentatricopeptide repeat domain-containing protein 3, mitochondrial,28S ribosomal protein S39, mitochondrial;Mitochondrial small ribosomal subunit protein mS39 {ECO:0000303|PubMed:25838379};Transformation-related gene 15 protein;, PF13041;PF13812;, GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005886;GO:0005840;GO:0043024;GO:0003723;GO:0019843;GO:0032543;GO:0070125;GO:0070126;GO:0006417;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:ribosome;, F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:regulation of translation;|Q96EY7 A6NHD2 D6W5M1 Q597H0 Q658Y9 Q9BUZ8 Q9NWL0,Pentatricopeptide repeat domain-containing protein 3, mitochondrial,28S ribosomal protein S39, mitochondrial;Mitochondrial small ribosomal subunit protein mS39 {ECO:0000303|PubMed:25838379};Transformation-related gene 15 protein;, PF13041;PF13812;, GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005886;GO:0005840;GO:0043024;GO:0003723;GO:0019843;GO:0032543;GO:0070125;GO:0070126;GO:0006417;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:ribosome;, F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:regulation of translation;|Q96EY7 A6NHD2 D6W5M1 Q597H0 Q658Y9 Q9BUZ8 Q9NWL0,Pentatricopeptide repeat domain-containing protein 3, mitochondrial,28S ribosomal protein S39, mitochondrial;Mitochondrial small ribosomal subunit protein mS39 {ECO:0000303|PubMed:25838379};Transformation-related gene 15 protein;, PF13041;PF13812;, GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005886;GO:0005840;GO:0043024;GO:0003723;GO:0019843;GO:0032543;GO:0070125;GO:0070126;GO:0006417;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:ribosome;, F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:regulation of translation;|Q96EY7 A6NHD2 D6W5M1 Q597H0 Q658Y9 Q9BUZ8 Q9NWL0,Pentatricopeptide repeat domain-containing protein 3, mitochondrial,28S ribosomal protein S39, mitochondrial;Mitochondrial small ribosomal subunit protein mS39 {ECO:0000303|PubMed:25838379};Transformation-related gene 15 protein;, PF13041;PF13812;, GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005886;GO:0005840;GO:0043024;GO:0003723;GO:0019843;GO:0032543;GO:0070125;GO:0070126;GO:0006417;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:ribosome;, F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:regulation of translation;|Q96EY7 A6NHD2 D6W5M1 Q597H0 Q658Y9 Q9BUZ8 Q9NWL0,Pentatricopeptide repeat domain-containing protein 3, mitochondrial,28S ribosomal protein S39, mitochondrial;Mitochondrial small ribosomal subunit protein mS39 {ECO:0000303|PubMed:25838379};Transformation-related gene 15 protein;, PF13041;PF13812;, GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005886;GO:0005840;GO:0043024;GO:0003723;GO:0019843;GO:0032543;GO:0070125;GO:0070126;GO:0006417;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:ribosome;, F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:regulation of translation;|Q96EY7 A6NHD2 D6W5M1 Q597H0 Q658Y9 Q9BUZ8 Q9NWL0,Pentatricopeptide repeat domain-containing protein 3, mitochondrial,28S ribosomal protein S39, mitochondrial;Mitochondrial small ribosomal subunit protein mS39 {ECO:0000303|PubMed:25838379};Transformation-related gene 15 protein;, PF13041;PF13812;, GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005886;GO:0005840;GO:0043024;GO:0003723;GO:0019843;GO:0032543;GO:0070125;GO:0070126;GO:0006417;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:ribosome;, F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:regulation of translation;|Q96EY7 A6NHD2 D6W5M1 Q597H0 Q658Y9 Q9BUZ8 Q9NWL0,Pentatricopeptide repeat domain-containing protein 3, mitochondrial,28S ribosomal protein S39, mitochondrial;Mitochondrial small ribosomal subunit protein mS39 {ECO:0000303|PubMed:25838379};Transformation-related gene 15 protein;, PF13041;PF13812;, GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005886;GO:0005840;GO:0043024;GO:0003723;GO:0019843;GO:0032543;GO:0070125;GO:0070126;GO:0006417;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:ribosome;, F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:regulation of translation;|Q96EY7 A6NHD2 D6W5M1 Q597H0 Q658Y9 Q9BUZ8 Q9NWL0,Pentatricopeptide repeat domain-containing protein 3, mitochondrial,28S ribosomal protein S39, mitochondrial;Mitochondrial small ribosomal subunit protein mS39 {ECO:0000303|PubMed:25838379};Transformation-related gene 15 protein;, PF13041;PF13812;, GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005886;GO:0005840;GO:0043024;GO:0003723;GO:0019843;GO:0032543;GO:0070125;GO:0070126;GO:0006417;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:ribosome;, F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:regulation of translation; scaffold6 indexed_genome mRNA 16836110 16853177 . - . ID=transcript_1596;Q8TAJ5 Q9P0V2,MICOS complex subunit MIC60,Cell proliferation-inducing gene 4/52 protein;Mitochondrial inner membrane protein;Mitofilin;p87/89;, PF09731;, GO:0016020;GO:0140275;GO:0061617;GO:0005743;GO:0005758;GO:0005739;GO:0001401;GO:0003723;GO:0042407;GO:0007007;GO:0051560;, C:membrane; C:MIB complex; C:MICOS complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:SAM complex;, F:RNA binding;, P:cristae formation; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis;|Q8TAJ5 Q9P0V2,MICOS complex subunit MIC60,Cell proliferation-inducing gene 4/52 protein;Mitochondrial inner membrane protein;Mitofilin;p87/89;, PF09731;, GO:0016020;GO:0140275;GO:0061617;GO:0005743;GO:0005758;GO:0005739;GO:0001401;GO:0003723;GO:0042407;GO:0007007;GO:0051560;, C:membrane; C:MIB complex; C:MICOS complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:SAM complex;, F:RNA binding;, P:cristae formation; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis;|Q8TAJ5 Q9P0V2,MICOS complex subunit MIC60,Cell proliferation-inducing gene 4/52 protein;Mitochondrial inner membrane protein;Mitofilin;p87/89;, PF09731;, GO:0016020;GO:0140275;GO:0061617;GO:0005743;GO:0005758;GO:0005739;GO:0001401;GO:0003723;GO:0042407;GO:0007007;GO:0051560;, C:membrane; C:MIB complex; C:MICOS complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:SAM complex;, F:RNA binding;, P:cristae formation; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis; scaffold6 indexed_genome mRNA 16855218 16875834 . - . ID=transcript_1597;Q8TAJ5 Q9P0V2,MICOS complex subunit MIC60,Cell proliferation-inducing gene 4/52 protein;Mitochondrial inner membrane protein;Mitofilin;p87/89;, PF09731;, GO:0016020;GO:0140275;GO:0061617;GO:0005743;GO:0005758;GO:0005739;GO:0001401;GO:0003723;GO:0042407;GO:0007007;GO:0051560;, C:membrane; C:MIB complex; C:MICOS complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:SAM complex;, F:RNA binding;, P:cristae formation; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis;|Q8TAJ5 Q9P0V2,MICOS complex subunit MIC60,Cell proliferation-inducing gene 4/52 protein;Mitochondrial inner membrane protein;Mitofilin;p87/89;, PF09731;, GO:0016020;GO:0140275;GO:0061617;GO:0005743;GO:0005758;GO:0005739;GO:0001401;GO:0003723;GO:0042407;GO:0007007;GO:0051560;, C:membrane; C:MIB complex; C:MICOS complex; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:SAM complex;, F:RNA binding;, P:cristae formation; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis; scaffold6 indexed_genome mRNA 16884221 16892237 . + . ID=transcript_1598;Q9NZE8 A6NKV6 B2RB93 Q658U7 Q8WWA2,39S ribosomal protein L35, mitochondrial,Mitochondrial large ribosomal subunit protein bL35m {ECO:0000303|PubMed:25278503};, PF01632;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9NZE8 A6NKV6 B2RB93 Q658U7 Q8WWA2,39S ribosomal protein L35, mitochondrial,Mitochondrial large ribosomal subunit protein bL35m {ECO:0000303|PubMed:25278503};, PF01632;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9NZE8 A6NKV6 B2RB93 Q658U7 Q8WWA2,39S ribosomal protein L35, mitochondrial,Mitochondrial large ribosomal subunit protein bL35m {ECO:0000303|PubMed:25278503};, PF01632;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold6 indexed_genome mRNA 17103416 17171129 . + . ID=transcript_1599;Q9Y4C1 D6W5M3 Q53S72 Q68D47 Q68UT9 Q6N050 Q8IY08,Lysine-specific demethylase 3A,JmjC domain-containing histone demethylation protein 2A;Jumonji domain-containing protein 1A;[histone H3]-dimethyl-L-lysine(9) demethylase 3A {ECO:0000305};, PF02373;, GO:0000785;GO:0005737;GO:0000118;GO:0016020;GO:0005654;GO:0005634;GO:0050681;GO:0031490;GO:0051213;GO:0032454;GO:0005506;GO:0003712;GO:0030521;GO:1990830;GO:0046293;GO:0033169;GO:0036123;GO:0009755;GO:0030522;GO:0051573;GO:0120162;GO:0045944;GO:0045893;GO:2000736;GO:2000036;GO:0006357;GO:0007290;, C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:membrane; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:iron ion binding; F:transcription coregulator activity;, P:androgen receptor signaling pathway; P:cellular response to leukemia inhibitory factor; P:formaldehyde biosynthetic process; P:histone H3-K9 demethylation; P:histone H3-K9 dimethylation; P:hormone-mediated signaling pathway; P:intracellular receptor signaling pathway; P:negative regulation of histone H3-K9 methylation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of stem cell differentiation; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:spermatid nucleus elongation;|Q9Y4C1 D6W5M3 Q53S72 Q68D47 Q68UT9 Q6N050 Q8IY08,Lysine-specific demethylase 3A,JmjC domain-containing histone demethylation protein 2A;Jumonji domain-containing protein 1A;[histone H3]-dimethyl-L-lysine(9) demethylase 3A {ECO:0000305};, PF02373;, GO:0000785;GO:0005737;GO:0000118;GO:0016020;GO:0005654;GO:0005634;GO:0050681;GO:0031490;GO:0051213;GO:0032454;GO:0005506;GO:0003712;GO:0030521;GO:1990830;GO:0046293;GO:0033169;GO:0036123;GO:0009755;GO:0030522;GO:0051573;GO:0120162;GO:0045944;GO:0045893;GO:2000736;GO:2000036;GO:0006357;GO:0007290;, C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:membrane; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:iron ion binding; F:transcription coregulator activity;, P:androgen receptor signaling pathway; P:cellular response to leukemia inhibitory factor; P:formaldehyde biosynthetic process; P:histone H3-K9 demethylation; P:histone H3-K9 dimethylation; P:hormone-mediated signaling pathway; P:intracellular receptor signaling pathway; P:negative regulation of histone H3-K9 methylation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of stem cell differentiation; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:spermatid nucleus elongation;|Q9Y4C1 D6W5M3 Q53S72 Q68D47 Q68UT9 Q6N050 Q8IY08,Lysine-specific demethylase 3A,JmjC domain-containing histone demethylation protein 2A;Jumonji domain-containing protein 1A;[histone H3]-dimethyl-L-lysine(9) demethylase 3A {ECO:0000305};, PF02373;, GO:0000785;GO:0005737;GO:0000118;GO:0016020;GO:0005654;GO:0005634;GO:0050681;GO:0031490;GO:0051213;GO:0032454;GO:0005506;GO:0003712;GO:0030521;GO:1990830;GO:0046293;GO:0033169;GO:0036123;GO:0009755;GO:0030522;GO:0051573;GO:0120162;GO:0045944;GO:0045893;GO:2000736;GO:2000036;GO:0006357;GO:0007290;, C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:membrane; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:iron ion binding; F:transcription coregulator activity;, P:androgen receptor signaling pathway; P:cellular response to leukemia inhibitory factor; P:formaldehyde biosynthetic process; P:histone H3-K9 demethylation; P:histone H3-K9 dimethylation; P:hormone-mediated signaling pathway; P:intracellular receptor signaling pathway; P:negative regulation of histone H3-K9 methylation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of stem cell differentiation; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:spermatid nucleus elongation;|P27635 A3KQT0 D3DWW6 Q16470 Q2HXT7 Q53FH7 Q6FGN8 Q8TDA5,60S ribosomal protein L10 {ECO:0000305},Laminin receptor homolog;Large ribosomal subunit protein uL16 {ECO:0000303|PubMed:24524803};Protein QM;Ribosomal protein L10 {ECO:0000312|HGNC:HGNC:10298};Tumor suppressor QM;, PF00252;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0005634;GO:0032991;GO:0003723;GO:0003735;GO:0045182;GO:1990403;GO:0043066;GO:0000122;GO:0000184;GO:0006417;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane; C:nucleus; C:protein-containing complex;, F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:embryonic brain development; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold6 indexed_genome mRNA 17175877 17176903 . - . ID=transcript_1600;Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold6 indexed_genome mRNA 17181500 17223523 . - . ID=transcript_1601;Q9Y3E7 A8K3W0 B4DG34 B8ZZM0 B8ZZX5 Q3ZTS9 Q53S71 Q53SU5 Q9NZ51,Charged multivesicular body protein 3,Chromatin-modifying protein 3;Neuroendocrine differentiation factor;Vacuolar protein sorting-associated protein 24;, PF03357;, GO:0031410;GO:0005829;GO:0000815;GO:0070062;GO:0005770;GO:0031902;GO:0005771;GO:0005886;GO:0042802;GO:0031210;GO:1990381;GO:0006915;GO:0097352;GO:0016197;GO:0032509;GO:0045324;GO:0016236;GO:0061952;GO:0007084;GO:0036258;GO:0071985;GO:0061763;GO:1902187;GO:1902188;GO:0051258;GO:0015031;GO:0010824;GO:2000641;GO:0050792;GO:0039702;GO:0019058;, C:cytoplasmic vesicle; C:cytosol; C:ESCRT III complex; C:extracellular exosome; C:late endosome; C:late endosome membrane; C:multivesicular body; C:plasma membrane;, F:identical protein binding; F:phosphatidylcholine binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:autophagosome maturation; P:endosomal transport; P:endosome transport via multivesicular body sorting pathway; P:late endosome to vacuole transport; P:macroautophagy; P:midbody abscission; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:multivesicular body-lysosome fusion; P:negative regulation of viral release from host cell; P:positive regulation of viral release from host cell; P:protein polymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of early endosome to late endosome transport; P:regulation of viral process; P:viral budding via host ESCRT complex; P:viral life cycle;|Q9Y3E7 A8K3W0 B4DG34 B8ZZM0 B8ZZX5 Q3ZTS9 Q53S71 Q53SU5 Q9NZ51,Charged multivesicular body protein 3,Chromatin-modifying protein 3;Neuroendocrine differentiation factor;Vacuolar protein sorting-associated protein 24;, PF03357;, GO:0031410;GO:0005829;GO:0000815;GO:0070062;GO:0005770;GO:0031902;GO:0005771;GO:0005886;GO:0042802;GO:0031210;GO:1990381;GO:0006915;GO:0097352;GO:0016197;GO:0032509;GO:0045324;GO:0016236;GO:0061952;GO:0007084;GO:0036258;GO:0071985;GO:0061763;GO:1902187;GO:1902188;GO:0051258;GO:0015031;GO:0010824;GO:2000641;GO:0050792;GO:0039702;GO:0019058;, C:cytoplasmic vesicle; C:cytosol; C:ESCRT III complex; C:extracellular exosome; C:late endosome; C:late endosome membrane; C:multivesicular body; C:plasma membrane;, F:identical protein binding; F:phosphatidylcholine binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:autophagosome maturation; P:endosomal transport; P:endosome transport via multivesicular body sorting pathway; P:late endosome to vacuole transport; P:macroautophagy; P:midbody abscission; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:multivesicular body-lysosome fusion; P:negative regulation of viral release from host cell; P:positive regulation of viral release from host cell; P:protein polymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of early endosome to late endosome transport; P:regulation of viral process; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold6 indexed_genome mRNA 17238130 17263111 . + . ID=transcript_1602;O00237 A6NFV6 B2RAG4 Q53SU6 Q8IVB9,E3 ubiquitin-protein ligase RNF103,KF-1;RING finger protein 103;RING-type E3 ubiquitin transferase RNF103 {ECO:0000305};Zinc finger protein 103 homolog;, PF13639;, GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0046872;GO:0004842;GO:0007417;GO:1904380;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:central nervous system development; P:endoplasmic reticulum mannose trimming; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O00237 A6NFV6 B2RAG4 Q53SU6 Q8IVB9,E3 ubiquitin-protein ligase RNF103,KF-1;RING finger protein 103;RING-type E3 ubiquitin transferase RNF103 {ECO:0000305};Zinc finger protein 103 homolog;, PF13639;, GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0046872;GO:0004842;GO:0007417;GO:1904380;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:central nervous system development; P:endoplasmic reticulum mannose trimming; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O00237 A6NFV6 B2RAG4 Q53SU6 Q8IVB9,E3 ubiquitin-protein ligase RNF103,KF-1;RING finger protein 103;RING-type E3 ubiquitin transferase RNF103 {ECO:0000305};Zinc finger protein 103 homolog;, PF13639;, GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0046872;GO:0004842;GO:0007417;GO:1904380;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:central nervous system development; P:endoplasmic reticulum mannose trimming; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O00237 A6NFV6 B2RAG4 Q53SU6 Q8IVB9,E3 ubiquitin-protein ligase RNF103,KF-1;RING finger protein 103;RING-type E3 ubiquitin transferase RNF103 {ECO:0000305};Zinc finger protein 103 homolog;, PF13639;, GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0046872;GO:0004842;GO:0007417;GO:1904380;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:central nervous system development; P:endoplasmic reticulum mannose trimming; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O00237 A6NFV6 B2RAG4 Q53SU6 Q8IVB9,E3 ubiquitin-protein ligase RNF103,KF-1;RING finger protein 103;RING-type E3 ubiquitin transferase RNF103 {ECO:0000305};Zinc finger protein 103 homolog;, PF13639;, GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0046872;GO:0004842;GO:0007417;GO:1904380;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:central nervous system development; P:endoplasmic reticulum mannose trimming; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O00237 A6NFV6 B2RAG4 Q53SU6 Q8IVB9,E3 ubiquitin-protein ligase RNF103,KF-1;RING finger protein 103;RING-type E3 ubiquitin transferase RNF103 {ECO:0000305};Zinc finger protein 103 homolog;, PF13639;, GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0046872;GO:0004842;GO:0007417;GO:1904380;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:central nervous system development; P:endoplasmic reticulum mannose trimming; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway; scaffold6 indexed_genome mRNA 17363587 17423134 . + . ID=transcript_1603;Q9H871 D6W5M6 Q6NTF0 Q9H6W5 Q9H9H2,E3 ubiquitin-protein transferase RMND5A,P44CTLH {ECO:0000303|PubMed:17467196};Protein RMD5 homolog A;, PF10607;, GO:0005737;GO:0034657;GO:0005654;GO:0005634;GO:0000151;GO:0046872;GO:0061630;GO:0004842;GO:0043161;GO:0000209;, C:cytoplasm; C:GID complex; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination;|Q9H871 D6W5M6 Q6NTF0 Q9H6W5 Q9H9H2,E3 ubiquitin-protein transferase RMND5A,P44CTLH {ECO:0000303|PubMed:17467196};Protein RMD5 homolog A;, PF10607;, GO:0005737;GO:0034657;GO:0005654;GO:0005634;GO:0000151;GO:0046872;GO:0061630;GO:0004842;GO:0043161;GO:0000209;, C:cytoplasm; C:GID complex; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination;|Q9H871 D6W5M6 Q6NTF0 Q9H6W5 Q9H9H2,E3 ubiquitin-protein transferase RMND5A,P44CTLH {ECO:0000303|PubMed:17467196};Protein RMD5 homolog A;, PF10607;, GO:0005737;GO:0034657;GO:0005654;GO:0005634;GO:0000151;GO:0046872;GO:0061630;GO:0004842;GO:0043161;GO:0000209;, C:cytoplasm; C:GID complex; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; scaffold6 indexed_genome mRNA 17433977 17441357 . - . ID=transcript_1604;P01732 B4DT80 D6W5M8 Q13970 Q4ZG17,T-cell surface glycoprotein CD8 alpha chain,T-lymphocyte differentiation antigen T8/Leu-2;, PF07686;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0044853;GO:0042101;GO:0015026;GO:0042288;GO:0023024;GO:0019882;GO:0007166;GO:0045065;GO:0006955;GO:0050776;GO:0042110;GO:0002456;GO:0007169;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:plasma membrane raft; C:T cell receptor complex;, F:coreceptor activity; F:MHC class I protein binding; F:MHC class I protein complex binding;, P:antigen processing and presentation; P:cell surface receptor signaling pathway; P:cytotoxic T cell differentiation; P:immune response; P:regulation of immune response; P:T cell activation; P:T cell mediated immunity; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold6 indexed_genome mRNA 17495138 17510096 . - . ID=transcript_1605;Q9UDB6 Q9UDB7 Q9UDB8 Q9UDB9 Q9UDC0 Q9UQ55,T-cell surface glycoprotein CD8 beta chain,, PF07686;, GO:0009986;GO:0031901;GO:0005576;GO:0005887;GO:0005886;GO:0042101;GO:0015026;GO:0042288;GO:0002250;GO:0006955;GO:0050690;GO:0050776;GO:0042110;GO:0007169;, C:cell surface; C:early endosome membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:T cell receptor complex;, F:coreceptor activity; F:MHC class I protein binding;, P:adaptive immune response; P:immune response; P:regulation of defense response to virus by virus; P:regulation of immune response; P:T cell activation; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold6 indexed_genome mRNA 17558908 17573187 . - . ID=transcript_1606;Q9NPI7 Q3B7J7,Lysine-rich coiled-coil protein 1,Cryptogenic hepatitis-binding protein 2; scaffold6 indexed_genome mRNA 17636161 17641990 . - . ID=transcript_1607;P07148,Fatty acid-binding protein, liver,Fatty acid-binding protein 1;Liver-type fatty acid-binding protein;, , GO:0045179;GO:0005829;GO:0070062;GO:0005654;GO:0005782;GO:0032991;GO:0016209;GO:0032052;GO:0003682;GO:0008144;GO:0005504;GO:0005324;GO:0005543;GO:0070301;GO:0071456;GO:0042167;GO:0050892;GO:0043066;GO:0043154;GO:0032000;GO:0051345;GO:0019216;GO:0019222;GO:0019433;, C:apical cortex; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:peroxisomal matrix; C:protein-containing complex;, F:antioxidant activity; F:bile acid binding; F:chromatin binding; F:drug binding; F:fatty acid binding; F:long-chain fatty acid transporter activity; F:phospholipid binding;, P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:heme catabolic process; P:intestinal absorption; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of hydrolase activity; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:triglyceride catabolic process; scaffold6 indexed_genome mRNA 17681166 17697563 . + . ID=transcript_1608;Q86YJ6 B3KTB1 B5MDX8 B7WPF8 D9ZZB8 Q6P2M7 Q6PI27 Q9NV54,Threonine synthase-like 2,Secreted osteoclastogenic factor of activated T-cells;, PF00291;PF14821;, GO:0005615;GO:0005125;GO:0016829;GO:0030170;GO:0070905;GO:0046360;GO:0016311;GO:0009071;, C:extracellular space;, F:cytokine activity; F:lyase activity; F:pyridoxal phosphate binding; F:serine binding;, P:2-oxobutyrate biosynthetic process; P:dephosphorylation; P:serine family amino acid catabolic process; scaffold6 indexed_genome mRNA 17808778 17810239 . + . ID=transcript_1609;O75529 Q5TDI5 Q5TDI6 Q8IW31,TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L {ECO:0000305},PCAF-associated factor 65 beta;, PF04494;PF00400;, GO:0036464;GO:0016607;GO:0005634;GO:0030914;GO:0033276;GO:0003713;GO:0043966;GO:1904672;GO:0006355;GO:0006366;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of somatic stem cell population maintenance; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; scaffold6 indexed_genome mRNA 18045617 18129538 . - . ID=transcript_1610;Q9NZJ5 A0AVH1 A0AVH2 B2RCU9 O95846 Q53QY0 Q53SB1,Eukaryotic translation initiation factor 2-alpha kinase 3,PRKR-like endoplasmic reticulum kinase;Pancreatic eIF2-alpha kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0048471;GO:0005524;GO:0019899;GO:0004694;GO:0051879;GO:0042802;GO:0004672;GO:0019903;GO:0106310;GO:0004674;GO:0106311;GO:0006919;GO:0001525;GO:0030282;GO:0019722;GO:0034198;GO:0070417;GO:0042149;GO:0002063;GO:0036492;GO:0031018;GO:0007029;GO:0030968;GO:0006983;GO:0048009;GO:0031642;GO:0017148;GO:0032057;GO:0001503;GO:0018105;GO:0036499;GO:0010628;GO:1900182;GO:0045943;GO:0010575;GO:0046777;GO:0006468;GO:0060734;GO:1902235;GO:0010998;GO:0034976;GO:1990737;GO:0001501;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:perinuclear region of cytoplasm;, F:ATP binding; F:enzyme binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:Hsp90 protein binding; F:identical protein binding; F:protein kinase activity; F:protein phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:angiogenesis; P:bone mineralization; P:calcium-mediated signaling; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to glucose starvation; P:chondrocyte development; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:endocrine pancreas development; P:endoplasmic reticulum organization; P:endoplasmic reticulum unfolded protein response; P:ER overload response; P:insulin-like growth factor receptor signaling pathway; P:negative regulation of myelination; P:negative regulation of translation; P:negative regulation of translational initiation in response to stress; P:ossification; P:peptidyl-serine phosphorylation; P:PERK-mediated unfolded protein response; P:positive regulation of gene expression; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of vascular endothelial growth factor production; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:response to endoplasmic reticulum stress; P:response to manganese-induced endoplasmic reticulum stress; P:skeletal system development; scaffold6 indexed_genome mRNA 18174131 18206448 . + . ID=transcript_1611;P49247 Q541P9 Q96BJ6,Ribose-5-phosphate isomerase,Phosphoriboisomerase;, PF06026;, GO:0005829;GO:0043231;GO:0042802;GO:0048029;GO:0004751;GO:0006014;GO:0006098;GO:0009052;GO:0019693;, C:cytosol; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:monosaccharide binding; F:ribose-5-phosphate isomerase activity;, P:D-ribose metabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:ribose phosphate metabolic process;|P49247 Q541P9 Q96BJ6,Ribose-5-phosphate isomerase,Phosphoriboisomerase;, PF06026;, GO:0005829;GO:0043231;GO:0042802;GO:0048029;GO:0004751;GO:0006014;GO:0006098;GO:0009052;GO:0019693;, C:cytosol; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:monosaccharide binding; F:ribose-5-phosphate isomerase activity;, P:D-ribose metabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:ribose phosphate metabolic process;|P49247 Q541P9 Q96BJ6,Ribose-5-phosphate isomerase,Phosphoriboisomerase;, PF06026;, GO:0005829;GO:0043231;GO:0042802;GO:0048029;GO:0004751;GO:0006014;GO:0006098;GO:0009052;GO:0019693;, C:cytosol; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:monosaccharide binding; F:ribose-5-phosphate isomerase activity;, P:D-ribose metabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:ribose phosphate metabolic process;|P49247 Q541P9 Q96BJ6,Ribose-5-phosphate isomerase,Phosphoriboisomerase;, PF06026;, GO:0005829;GO:0043231;GO:0042802;GO:0048029;GO:0004751;GO:0006014;GO:0006098;GO:0009052;GO:0019693;, C:cytosol; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:monosaccharide binding; F:ribose-5-phosphate isomerase activity;, P:D-ribose metabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:ribose phosphate metabolic process; scaffold6 indexed_genome mRNA 18253578 18254104 . - . ID=transcript_1612;P01834 A0A075B6H6 A0A087X130,Immunoglobulin kappa constant {ECO:0000303|PubMed:11549845, ECO:0000303|Ref.13},Ig kappa chain C region {ECO:0000305};Ig kappa chain C region AG {ECO:0000305|PubMed:4893682};Ig kappa chain C region CUM {ECO:0000305|PubMed:5586923};Ig kappa chain C region EU {ECO:0000305|PubMed:5489770};Ig kappa chain C region OU {ECO:0000305|PubMed:5447531};Ig kappa chain C region ROY {ECO:0000305|Ref.3};Ig kappa chain C region TI {ECO:0000305|PubMed:5027703};, PF07654;, GO:0072562;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0042571;GO:0005886;GO:0003823;GO:0034987;GO:0050853;GO:0006956;GO:0006958;GO:0042742;GO:0038095;GO:0038096;GO:0006955;GO:0045087;GO:0050900;GO:0002862;GO:0008228;GO:0018149;GO:0006911;GO:0006910;GO:0050871;GO:0006898;GO:0030449;GO:0050776;GO:0001895;, C:blood microparticle; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:immunoglobulin complex, circulating; C:plasma membrane;, F:antigen binding; F:immunoglobulin receptor binding;, P:B cell receptor signaling pathway; P:complement activation; P:complement activation, classical pathway; P:defense response to bacterium; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:immune response; P:innate immune response; P:leukocyte migration; P:negative regulation of inflammatory response to antigenic stimulus; P:opsonization; P:peptide cross-linking; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; P:receptor-mediated endocytosis; P:regulation of complement activation; P:regulation of immune response; P:retina homeostasis; scaffold6 indexed_genome mRNA 18599314 18616547 . + . ID=transcript_1613;Q06710 Q09155 Q16337 Q16338 Q16339 Q4ZG35 Q96J49,Paired box protein Pax-8,, PF00292;PF12403;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0004996;GO:0000976;GO:0048856;GO:0009653;GO:0001658;GO:0071371;GO:0007417;GO:0042472;GO:0001822;GO:0003337;GO:0001823;GO:0072278;GO:0072221;GO:0072207;GO:0072289;GO:0072284;GO:1900215;GO:1900218;GO:0072305;GO:1900212;GO:0071599;GO:0090190;GO:0072108;GO:2000594;GO:2000611;GO:0045944;GO:0045893;GO:0039003;GO:0048793;GO:0042981;GO:0072307;GO:2000612;GO:0006357;GO:0030878;GO:0006351;GO:0001655;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:thyroid-stimulating hormone receptor activity; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure development; P:anatomical structure morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cellular response to gonadotropin stimulus; P:central nervous system development; P:inner ear morphogenesis; P:kidney development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; P:mesonephros development; P:metanephric comma-shaped body morphogenesis; P:metanephric distal convoluted tubule development; P:metanephric epithelium development; P:metanephric nephron tubule formation; P:metanephric S-shaped body morphogenesis; P:negative regulation of apoptotic process involved in metanephric collecting duct development; P:negative regulation of apoptotic process involved in metanephric nephron tubule development; P:negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis; P:negative regulation of mesenchymal cell apoptotic process involved in metanephros development; P:otic vesicle development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; P:positive regulation of metanephric DCT cell differentiation; P:positive regulation of thyroid hormone generation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:pronephric field specification; P:pronephros development; P:regulation of apoptotic process; P:regulation of metanephric nephron tubule epithelial cell differentiation; P:regulation of thyroid-stimulating hormone secretion; P:regulation of transcription by RNA polymerase II; P:thyroid gland development; P:transcription, DNA-templated; P:urogenital system development; scaffold6 indexed_genome mRNA 18629788 18648702 . - . ID=transcript_1614;Q8NDX1 A6NEG7 A8K1Y0 O95621 Q4ZG34 Q6GPH8 Q8IYP4,PH and SEC7 domain-containing protein 4,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B;Pleckstrin homology and SEC7 domain-containing protein 4;Telomeric of interleukin-1 cluster protein;, PF15410;PF01369;, GO:0016020;GO:0032587;GO:0005085;GO:0005543;GO:0032012;, C:membrane; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:regulation of ARF protein signal transduction; scaffold6 indexed_genome mRNA 18699053 18704191 . - . ID=transcript_1615;P18510 A8K4G1 Q14628 Q53SC2 Q7RTZ4 Q96GD6 Q9UPC0,Interleukin-1 receptor antagonist protein,ICIL-1RA;IL1 inhibitor;, PF00340;, GO:0005737;GO:0070062;GO:0005615;GO:0005886;GO:0005125;GO:0005152;GO:0005149;GO:0045352;GO:0045353;GO:0005150;GO:0005151;GO:0006953;GO:0019221;GO:0006955;GO:0006954;GO:0002437;GO:0030073;GO:0070498;GO:0006629;GO:0034115;GO:2000660;GO:0051384;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:cytokine activity; F:interleukin-1 receptor antagonist activity; F:interleukin-1 receptor binding; F:interleukin-1 type I receptor antagonist activity; F:interleukin-1 type II receptor antagonist activity; F:interleukin-1, type I receptor binding; F:interleukin-1, type II receptor binding;, P:acute-phase response; P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:inflammatory response to antigenic stimulus; P:insulin secretion; P:interleukin-1-mediated signaling pathway; P:lipid metabolic process; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of interleukin-1-mediated signaling pathway; P:response to glucocorticoid;|P18510 A8K4G1 Q14628 Q53SC2 Q7RTZ4 Q96GD6 Q9UPC0,Interleukin-1 receptor antagonist protein,ICIL-1RA;IL1 inhibitor;, PF00340;, GO:0005737;GO:0070062;GO:0005615;GO:0005886;GO:0005125;GO:0005152;GO:0005149;GO:0045352;GO:0045353;GO:0005150;GO:0005151;GO:0006953;GO:0019221;GO:0006955;GO:0006954;GO:0002437;GO:0030073;GO:0070498;GO:0006629;GO:0034115;GO:2000660;GO:0051384;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:cytokine activity; F:interleukin-1 receptor antagonist activity; F:interleukin-1 receptor binding; F:interleukin-1 type I receptor antagonist activity; F:interleukin-1 type II receptor antagonist activity; F:interleukin-1, type I receptor binding; F:interleukin-1, type II receptor binding;, P:acute-phase response; P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:inflammatory response to antigenic stimulus; P:insulin secretion; P:interleukin-1-mediated signaling pathway; P:lipid metabolic process; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of interleukin-1-mediated signaling pathway; P:response to glucocorticoid;|P18510 A8K4G1 Q14628 Q53SC2 Q7RTZ4 Q96GD6 Q9UPC0,Interleukin-1 receptor antagonist protein,ICIL-1RA;IL1 inhibitor;, PF00340;, GO:0005737;GO:0070062;GO:0005615;GO:0005886;GO:0005125;GO:0005152;GO:0005149;GO:0045352;GO:0045353;GO:0005150;GO:0005151;GO:0006953;GO:0019221;GO:0006955;GO:0006954;GO:0002437;GO:0030073;GO:0070498;GO:0006629;GO:0034115;GO:2000660;GO:0051384;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:cytokine activity; F:interleukin-1 receptor antagonist activity; F:interleukin-1 receptor binding; F:interleukin-1 type I receptor antagonist activity; F:interleukin-1 type II receptor antagonist activity; F:interleukin-1, type I receptor binding; F:interleukin-1, type II receptor binding;, P:acute-phase response; P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:inflammatory response to antigenic stimulus; P:insulin secretion; P:interleukin-1-mediated signaling pathway; P:lipid metabolic process; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of interleukin-1-mediated signaling pathway; P:response to glucocorticoid; scaffold6 indexed_genome mRNA 18986651 18995125 . + . ID=transcript_1616;P01584 Q53X59 Q53XX2 Q7M4S7 Q7RU01 Q96HE5 Q9UCT6,Interleukin-1 beta {ECO:0000303|PubMed:1919436},Catabolin;, PF00340;PF02394;, GO:0005829;GO:0005576;GO:0005615;GO:0005764;GO:0005125;GO:0005178;GO:0005149;GO:0019904;GO:0000187;GO:0006915;GO:0007267;GO:0035690;GO:0071222;GO:0071260;GO:0071407;GO:0071310;GO:0019221;GO:0007566;GO:0001660;GO:0030213;GO:0006955;GO:0006954;GO:0070498;GO:0031663;GO:0000165;GO:0070487;GO:0070164;GO:0008285;GO:2001240;GO:1903597;GO:0010829;GO:0046627;GO:0050995;GO:0045833;GO:0043407;GO:0050768;GO:0050805;GO:0045766;GO:0060559;GO:0060355;GO:0051781;GO:0030335;GO:0008284;GO:0045917;GO:0051091;GO:0010718;GO:0031622;GO:0010628;GO:0060252;GO:0032725;GO:0034116;GO:0035066;GO:0033129;GO:0033092;GO:0050729;GO:0032729;GO:0032743;GO:0032755;GO:0032757;GO:0046330;GO:0050996;GO:0051044;GO:0045840;GO:0071639;GO:0035505;GO:0150078;GO:0051092;GO:1901224;GO:0045429;GO:1900745;GO:0050766;GO:0031394;GO:0032308;GO:0046827;GO:0001934;GO:1902680;GO:0002711;GO:0042102;GO:2000556;GO:0045893;GO:0010575;GO:0030949;GO:0043491;GO:0035590;GO:0070372;GO:1903140;GO:0043122;GO:0050796;GO:0050767;GO:0050999;GO:0070555;GO:0032496;GO:0030730;GO:0007165;GO:0014805;GO:0010573;, C:cytosol; C:extracellular region; C:extracellular space; C:lysosome;, F:cytokine activity; F:integrin binding; F:interleukin-1 receptor binding; F:protein domain specific binding;, P:activation of MAPK activity; P:apoptotic process; P:cell-cell signaling; P:cellular response to drug; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to organic cyclic compound; P:cellular response to organic substance; P:cytokine-mediated signaling pathway; P:embryo implantation; P:fever generation; P:hyaluronan biosynthetic process; P:immune response; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:MAPK cascade; P:monocyte aggregation; P:negative regulation of adiponectin secretion; P:negative regulation of cell population proliferation; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of gap junction assembly; P:negative regulation of glucose transmembrane transport; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lipid catabolic process; P:negative regulation of lipid metabolic process; P:negative regulation of MAP kinase activity; P:negative regulation of neurogenesis; P:negative regulation of synaptic transmission; P:positive regulation of angiogenesis; P:positive regulation of calcidiol 1-monooxygenase activity; P:positive regulation of cell adhesion molecule production; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of complement activation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of fever generation; P:positive regulation of gene expression; P:positive regulation of glial cell proliferation; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of immature T cell proliferation in thymus; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of lipid catabolic process; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of mitotic nuclear division; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of myosin light chain kinase activity; P:positive regulation of neuroinflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of p38MAPK cascade; P:positive regulation of phagocytosis; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of prostaglandin secretion; P:positive regulation of protein export from nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of RNA biosynthetic process; P:positive regulation of T cell mediated immunity; P:positive regulation of T cell proliferation; P:positive regulation of T-helper 1 cell cytokine production; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:protein kinase B signaling; P:purinergic nucleotide receptor signaling pathway; P:regulation of ERK1 and ERK2 cascade; P:regulation of establishment of endothelial barrier; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of nitric-oxide synthase activity; P:response to interleukin-1; P:response to lipopolysaccharide; P:sequestering of triglyceride; P:signal transduction; P:smooth muscle adaptation; P:vascular endothelial growth factor production; scaffold6 indexed_genome mRNA 19044648 19055553 . + . ID=transcript_1617;P01583 Q53QF9 Q7RU02,Interleukin-1 alpha,Hematopoietin-1;, PF00340;PF02394;, GO:0005829;GO:0005576;GO:0005615;GO:0005507;GO:0005125;GO:0005149;GO:0006915;GO:0034605;GO:0071222;GO:0006883;GO:0002248;GO:0019221;GO:0035234;GO:0097192;GO:0001660;GO:0006955;GO:0006954;GO:0070498;GO:0008285;GO:2001240;GO:0045766;GO:0051781;GO:0001819;GO:0010628;GO:0033092;GO:0032743;GO:0032755;GO:0045840;GO:0050714;GO:0045944;GO:0032760;GO:0010575;GO:0050999;GO:0046688;, C:cytosol; C:extracellular region; C:extracellular space;, F:copper ion binding; F:cytokine activity; F:interleukin-1 receptor binding;, P:apoptotic process; P:cellular response to heat; P:cellular response to lipopolysaccharide; P:cellular sodium ion homeostasis; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:ectopic germ cell programmed cell death; P:extrinsic apoptotic signaling pathway in absence of ligand; P:fever generation; P:immune response; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of angiogenesis; P:positive regulation of cell division; P:positive regulation of cytokine production; P:positive regulation of gene expression; P:positive regulation of immature T cell proliferation in thymus; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of mitotic nuclear division; P:positive regulation of protein secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of vascular endothelial growth factor production; P:regulation of nitric-oxide synthase activity; P:response to copper ion;|P01583 Q53QF9 Q7RU02,Interleukin-1 alpha,Hematopoietin-1;, PF00340;PF02394;, GO:0005829;GO:0005576;GO:0005615;GO:0005507;GO:0005125;GO:0005149;GO:0006915;GO:0034605;GO:0071222;GO:0006883;GO:0002248;GO:0019221;GO:0035234;GO:0097192;GO:0001660;GO:0006955;GO:0006954;GO:0070498;GO:0008285;GO:2001240;GO:0045766;GO:0051781;GO:0001819;GO:0010628;GO:0033092;GO:0032743;GO:0032755;GO:0045840;GO:0050714;GO:0045944;GO:0032760;GO:0010575;GO:0050999;GO:0046688;, C:cytosol; C:extracellular region; C:extracellular space;, F:copper ion binding; F:cytokine activity; F:interleukin-1 receptor binding;, P:apoptotic process; P:cellular response to heat; P:cellular response to lipopolysaccharide; P:cellular sodium ion homeostasis; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:ectopic germ cell programmed cell death; P:extrinsic apoptotic signaling pathway in absence of ligand; P:fever generation; P:immune response; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of angiogenesis; P:positive regulation of cell division; P:positive regulation of cytokine production; P:positive regulation of gene expression; P:positive regulation of immature T cell proliferation in thymus; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of mitotic nuclear division; P:positive regulation of protein secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of vascular endothelial growth factor production; P:regulation of nitric-oxide synthase activity; P:response to copper ion;|P01583 Q53QF9 Q7RU02,Interleukin-1 alpha,Hematopoietin-1;, PF00340;PF02394;, GO:0005829;GO:0005576;GO:0005615;GO:0005507;GO:0005125;GO:0005149;GO:0006915;GO:0034605;GO:0071222;GO:0006883;GO:0002248;GO:0019221;GO:0035234;GO:0097192;GO:0001660;GO:0006955;GO:0006954;GO:0070498;GO:0008285;GO:2001240;GO:0045766;GO:0051781;GO:0001819;GO:0010628;GO:0033092;GO:0032743;GO:0032755;GO:0045840;GO:0050714;GO:0045944;GO:0032760;GO:0010575;GO:0050999;GO:0046688;, C:cytosol; C:extracellular region; C:extracellular space;, F:copper ion binding; F:cytokine activity; F:interleukin-1 receptor binding;, P:apoptotic process; P:cellular response to heat; P:cellular response to lipopolysaccharide; P:cellular sodium ion homeostasis; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:ectopic germ cell programmed cell death; P:extrinsic apoptotic signaling pathway in absence of ligand; P:fever generation; P:immune response; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of angiogenesis; P:positive regulation of cell division; P:positive regulation of cytokine production; P:positive regulation of gene expression; P:positive regulation of immature T cell proliferation in thymus; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of mitotic nuclear division; P:positive regulation of protein secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of vascular endothelial growth factor production; P:regulation of nitric-oxide synthase activity; P:response to copper ion; scaffold6 indexed_genome mRNA 19069048 19076907 . + . ID=transcript_1618;Q8IYA6 A8K915 B4DZE3 B7ZAC6 F5H0M5 Q53QF8 Q53RS8 Q8N1J8,Cytoskeleton-associated protein 2-like,Radial fiber and mitotic spindle protein;, PF15297;, GO:0005813;GO:0005829;GO:0072686;GO:0000922;, C:centrosome; C:cytosol; C:mitotic spindle; C:spindle pole; scaffold6 indexed_genome mRNA 19165857 19186110 . - . ID=transcript_1619;Q8WUM9 Q08344 Q6DHX8 Q9UQ82,Sodium-dependent phosphate transporter 1,Gibbon ape leukemia virus receptor 1;Leukemia virus receptor 1 homolog;Phosphate transporter 1;Solute carrier family 20 member 1;, PF01384;, GO:0005887;GO:0016020;GO:0005886;GO:0005316;GO:0005315;GO:0038023;GO:0005436;GO:0031214;GO:0006811;GO:0035435;GO:0006796;GO:0043123;GO:0016032;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:high-affinity inorganic phosphate:sodium symporter activity; F:inorganic phosphate transmembrane transporter activity; F:signaling receptor activity; F:sodium:phosphate symporter activity;, P:biomineral tissue development; P:ion transport; P:phosphate ion transmembrane transport; P:phosphate-containing compound metabolic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:viral process;|Q8WUM9 Q08344 Q6DHX8 Q9UQ82,Sodium-dependent phosphate transporter 1,Gibbon ape leukemia virus receptor 1;Leukemia virus receptor 1 homolog;Phosphate transporter 1;Solute carrier family 20 member 1;, PF01384;, GO:0005887;GO:0016020;GO:0005886;GO:0005316;GO:0005315;GO:0038023;GO:0005436;GO:0031214;GO:0006811;GO:0035435;GO:0006796;GO:0043123;GO:0016032;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:high-affinity inorganic phosphate:sodium symporter activity; F:inorganic phosphate transmembrane transporter activity; F:signaling receptor activity; F:sodium:phosphate symporter activity;, P:biomineral tissue development; P:ion transport; P:phosphate ion transmembrane transport; P:phosphate-containing compound metabolic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:viral process;|Q8WUM9 Q08344 Q6DHX8 Q9UQ82,Sodium-dependent phosphate transporter 1,Gibbon ape leukemia virus receptor 1;Leukemia virus receptor 1 homolog;Phosphate transporter 1;Solute carrier family 20 member 1;, PF01384;, GO:0005887;GO:0016020;GO:0005886;GO:0005316;GO:0005315;GO:0038023;GO:0005436;GO:0031214;GO:0006811;GO:0035435;GO:0006796;GO:0043123;GO:0016032;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:high-affinity inorganic phosphate:sodium symporter activity; F:inorganic phosphate transmembrane transporter activity; F:signaling receptor activity; F:sodium:phosphate symporter activity;, P:biomineral tissue development; P:ion transport; P:phosphate ion transmembrane transport; P:phosphate-containing compound metabolic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:viral process;|Q8WUM9 Q08344 Q6DHX8 Q9UQ82,Sodium-dependent phosphate transporter 1,Gibbon ape leukemia virus receptor 1;Leukemia virus receptor 1 homolog;Phosphate transporter 1;Solute carrier family 20 member 1;, PF01384;, GO:0005887;GO:0016020;GO:0005886;GO:0005316;GO:0005315;GO:0038023;GO:0005436;GO:0031214;GO:0006811;GO:0035435;GO:0006796;GO:0043123;GO:0016032;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:high-affinity inorganic phosphate:sodium symporter activity; F:inorganic phosphate transmembrane transporter activity; F:signaling receptor activity; F:sodium:phosphate symporter activity;, P:biomineral tissue development; P:ion transport; P:phosphate ion transmembrane transport; P:phosphate-containing compound metabolic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:viral process; scaffold6 indexed_genome mRNA 19241976 19286382 . - . ID=transcript_1620;Q9H9Y6 B7Z6Y7 B7Z823 F5GZX4 F8W898 Q2TAM4 Q585T5 Q6ZRR2 Q9H9D3,DNA-directed RNA polymerase I subunit RPA2,DNA-directed RNA polymerase I 135 kDa polypeptide;, PF06883;PF04563;PF04561;PF04565;PF00562;PF04560;, GO:0005694;GO:0005829;GO:0005730;GO:0005654;GO:0005736;GO:0003677;GO:0003899;GO:0046872;GO:0032549;GO:0007566;GO:0017126;GO:0045815;GO:0009303;GO:0006363;GO:0006361;, C:chromosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:RNA polymerase I complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding; F:ribonucleoside binding;, P:embryo implantation; P:nucleologenesis; P:positive regulation of gene expression, epigenetic; P:rRNA transcription; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter;|Q9BSY4 Q585T4 Q8N8C4,Coiled-coil-helix-coiled-coil-helix domain-containing protein 5,, PF16860;, GO:0005758;GO:0005739;, C:mitochondrial intermembrane space; C:mitochondrion; scaffold6 indexed_genome mRNA 19296052 19326096 . - . ID=transcript_1621;Q8NG68 Q585T3 Q7Z302 Q8N426,Tubulin--tyrosine ligase,, PF03133;, GO:0005876;GO:0005524;GO:0004835;GO:0018166;GO:0000226;GO:0045931;GO:0030516;GO:0090235;, C:spindle microtubule;, F:ATP binding; F:tubulin-tyrosine ligase activity;, P:C-terminal protein-tyrosinylation; P:microtubule cytoskeleton organization; P:positive regulation of mitotic cell cycle; P:regulation of axon extension; P:regulation of metaphase plate congression; scaffold6 indexed_genome mRNA 19613382 19661620 . + . ID=transcript_1622;O43639 D3DVK1 Q9BWN9 Q9UIC3,Cytoplasmic protein NCK2,Growth factor receptor-bound protein 4;NCK adaptor protein 2;SH2/SH3 adaptor protein NCK-beta;, PF00017;PF00018;PF14604;, GO:0005737;GO:0005829;GO:0005783;GO:0014069;GO:0012506;GO:0008093;GO:0001784;GO:0044877;GO:0097110;GO:0035591;GO:0030159;GO:0007015;GO:0016477;GO:0060996;GO:0048013;GO:0007173;GO:0001771;GO:0030032;GO:0008285;GO:1903912;GO:0033137;GO:1903898;GO:1990441;GO:0030838;GO:1902237;GO:0042102;GO:0045944;GO:0036493;GO:0007176;GO:0007172;GO:0007165;GO:0042110;GO:0048010;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:postsynaptic density; C:vesicle membrane;, F:cytoskeletal anchor activity; F:phosphotyrosine residue binding; F:protein-containing complex binding; F:scaffold protein binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity;, P:actin filament organization; P:cell migration; P:dendritic spine development; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:immunological synapse formation; P:lamellipodium assembly; P:negative regulation of cell population proliferation; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of actin filament polymerization; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of epidermal growth factor-activated receptor activity; P:signal complex assembly; P:signal transduction; P:T cell activation; P:vascular endothelial growth factor receptor signaling pathway;|O43639 D3DVK1 Q9BWN9 Q9UIC3,Cytoplasmic protein NCK2,Growth factor receptor-bound protein 4;NCK adaptor protein 2;SH2/SH3 adaptor protein NCK-beta;, PF00017;PF00018;PF14604;, GO:0005737;GO:0005829;GO:0005783;GO:0014069;GO:0012506;GO:0008093;GO:0001784;GO:0044877;GO:0097110;GO:0035591;GO:0030159;GO:0007015;GO:0016477;GO:0060996;GO:0048013;GO:0007173;GO:0001771;GO:0030032;GO:0008285;GO:1903912;GO:0033137;GO:1903898;GO:1990441;GO:0030838;GO:1902237;GO:0042102;GO:0045944;GO:0036493;GO:0007176;GO:0007172;GO:0007165;GO:0042110;GO:0048010;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:postsynaptic density; C:vesicle membrane;, F:cytoskeletal anchor activity; F:phosphotyrosine residue binding; F:protein-containing complex binding; F:scaffold protein binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity;, P:actin filament organization; P:cell migration; P:dendritic spine development; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:immunological synapse formation; P:lamellipodium assembly; P:negative regulation of cell population proliferation; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of actin filament polymerization; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of epidermal growth factor-activated receptor activity; P:signal complex assembly; P:signal transduction; P:T cell activation; P:vascular endothelial growth factor receptor signaling pathway;|O43639 D3DVK1 Q9BWN9 Q9UIC3,Cytoplasmic protein NCK2,Growth factor receptor-bound protein 4;NCK adaptor protein 2;SH2/SH3 adaptor protein NCK-beta;, PF00017;PF00018;PF14604;, GO:0005737;GO:0005829;GO:0005783;GO:0014069;GO:0012506;GO:0008093;GO:0001784;GO:0044877;GO:0097110;GO:0035591;GO:0030159;GO:0007015;GO:0016477;GO:0060996;GO:0048013;GO:0007173;GO:0001771;GO:0030032;GO:0008285;GO:1903912;GO:0033137;GO:1903898;GO:1990441;GO:0030838;GO:1902237;GO:0042102;GO:0045944;GO:0036493;GO:0007176;GO:0007172;GO:0007165;GO:0042110;GO:0048010;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:postsynaptic density; C:vesicle membrane;, F:cytoskeletal anchor activity; F:phosphotyrosine residue binding; F:protein-containing complex binding; F:scaffold protein binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity;, P:actin filament organization; P:cell migration; P:dendritic spine development; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:immunological synapse formation; P:lamellipodium assembly; P:negative regulation of cell population proliferation; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of actin filament polymerization; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of epidermal growth factor-activated receptor activity; P:signal complex assembly; P:signal transduction; P:T cell activation; P:vascular endothelial growth factor receptor signaling pathway; scaffold6 indexed_genome mRNA 19741145 19751118 . + . ID=transcript_1623;Q9H1Z8 D3DVK2,Augurin {ECO:0000305},Esophageal cancer-related gene 4 protein {ECO:0000303|Ref.1};, PF15187;, GO:0016324;GO:0005737;GO:0031045;GO:0005615;GO:0005184;GO:0031145;GO:0090398;GO:0007417;GO:0070314;GO:0008285;GO:0007218;GO:2000854;GO:0051461;GO:0051466;GO:0042127;GO:0009611;GO:0030103;, C:apical plasma membrane; C:cytoplasm; C:dense core granule; C:extracellular space;, F:neuropeptide hormone activity;, P:anaphase-promoting complex-dependent catabolic process; P:cellular senescence; P:central nervous system development; P:G1 to G0 transition; P:negative regulation of cell population proliferation; P:neuropeptide signaling pathway; P:positive regulation of corticosterone secretion; P:positive regulation of corticotropin secretion; P:positive regulation of corticotropin-releasing hormone secretion; P:regulation of cell population proliferation; P:response to wounding; P:vasopressin secretion; scaffold6 indexed_genome mRNA 19791741 19833937 . - . ID=transcript_1624;Q8NBZ7 Q8NBX3 Q9H5C2,UDP-glucuronic acid decarboxylase 1,UDP-glucuronate decarboxylase 1;, PF16363;PF11803;, GO:1902494;GO:0005737;GO:0070062;GO:0032580;GO:0016021;GO:0042802;GO:0070403;GO:0042803;GO:0048040;GO:0033320;, C:catalytic complex; C:cytoplasm; C:extracellular exosome; C:Golgi cisterna membrane; C:integral component of membrane;, F:identical protein binding; F:NAD+ binding; F:protein homodimerization activity; F:UDP-glucuronate decarboxylase activity;, P:UDP-D-xylose biosynthetic process;|Q8NBZ7 Q8NBX3 Q9H5C2,UDP-glucuronic acid decarboxylase 1,UDP-glucuronate decarboxylase 1;, PF16363;PF11803;, GO:1902494;GO:0005737;GO:0070062;GO:0032580;GO:0016021;GO:0042802;GO:0070403;GO:0042803;GO:0048040;GO:0033320;, C:catalytic complex; C:cytoplasm; C:extracellular exosome; C:Golgi cisterna membrane; C:integral component of membrane;, F:identical protein binding; F:NAD+ binding; F:protein homodimerization activity; F:UDP-glucuronate decarboxylase activity;, P:UDP-D-xylose biosynthetic process;|Q8NBZ7 Q8NBX3 Q9H5C2,UDP-glucuronic acid decarboxylase 1,UDP-glucuronate decarboxylase 1;, PF16363;PF11803;, GO:1902494;GO:0005737;GO:0070062;GO:0032580;GO:0016021;GO:0042802;GO:0070403;GO:0042803;GO:0048040;GO:0033320;, C:catalytic complex; C:cytoplasm; C:extracellular exosome; C:Golgi cisterna membrane; C:integral component of membrane;, F:identical protein binding; F:NAD+ binding; F:protein homodimerization activity; F:UDP-glucuronate decarboxylase activity;, P:UDP-D-xylose biosynthetic process;|Q8NBZ7 Q8NBX3 Q9H5C2,UDP-glucuronic acid decarboxylase 1,UDP-glucuronate decarboxylase 1;, PF16363;PF11803;, GO:1902494;GO:0005737;GO:0070062;GO:0032580;GO:0016021;GO:0042802;GO:0070403;GO:0042803;GO:0048040;GO:0033320;, C:catalytic complex; C:cytoplasm; C:extracellular exosome; C:Golgi cisterna membrane; C:integral component of membrane;, F:identical protein binding; F:NAD+ binding; F:protein homodimerization activity; F:UDP-glucuronate decarboxylase activity;, P:UDP-D-xylose biosynthetic process;|Q8NBZ7 Q8NBX3 Q9H5C2,UDP-glucuronic acid decarboxylase 1,UDP-glucuronate decarboxylase 1;, PF16363;PF11803;, GO:1902494;GO:0005737;GO:0070062;GO:0032580;GO:0016021;GO:0042802;GO:0070403;GO:0042803;GO:0048040;GO:0033320;, C:catalytic complex; C:cytoplasm; C:extracellular exosome; C:Golgi cisterna membrane; C:integral component of membrane;, F:identical protein binding; F:NAD+ binding; F:protein homodimerization activity; F:UDP-glucuronate decarboxylase activity;, P:UDP-D-xylose biosynthetic process; scaffold6 indexed_genome mRNA 20684097 20689476 . + . ID=transcript_1625;O75897 Q069I8 Q08AS5 Q53S63,Sulfotransferase 1C4,Sulfotransferase 1C2;, PF00685;, GO:0005737;GO:0005829;GO:0004062;GO:0008146;GO:0050427;GO:0006068;GO:0051923;, C:cytoplasm; C:cytosol;, F:aryl sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:ethanol catabolic process; P:sulfation; scaffold6 indexed_genome mRNA 20689512 20692952 . + . ID=transcript_1626;O75897 Q069I8 Q08AS5 Q53S63,Sulfotransferase 1C4,Sulfotransferase 1C2;, PF00685;, GO:0005737;GO:0005829;GO:0004062;GO:0008146;GO:0050427;GO:0006068;GO:0051923;, C:cytoplasm; C:cytosol;, F:aryl sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:ethanol catabolic process; P:sulfation;|O75897 Q069I8 Q08AS5 Q53S63,Sulfotransferase 1C4,Sulfotransferase 1C2;, PF00685;, GO:0005737;GO:0005829;GO:0004062;GO:0008146;GO:0050427;GO:0006068;GO:0051923;, C:cytoplasm; C:cytosol;, F:aryl sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:ethanol catabolic process; P:sulfation; scaffold6 indexed_genome mRNA 20706093 20737270 . + . ID=transcript_1627;Q8IWJ2 A6H8X8 O15045 Q4ZG46 Q8TDH3 Q9H2G8,GRIP and coiled-coil domain-containing protein 2,185 kDa Golgi coiled-coil protein;CLL-associated antigen KW-11;CTCL tumor antigen se1-1;Ran-binding protein 2-like 4;Renal carcinoma antigen NY-REN-53;, PF01465;PF16704;, GO:0005829;GO:0005794;GO:0016020;GO:0005654;GO:0005802;GO:0042802;GO:0031267;GO:0090161;GO:0034499;GO:0034453;GO:0031023;GO:0034067;GO:0006622;GO:0071955;GO:0070861;GO:0042147;, C:cytosol; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:trans-Golgi network;, F:identical protein binding; F:small GTPase binding;, P:Golgi ribbon formation; P:late endosome to Golgi transport; P:microtubule anchoring; P:microtubule organizing center organization; P:protein localization to Golgi apparatus; P:protein targeting to lysosome; P:recycling endosome to Golgi transport; P:regulation of protein exit from endoplasmic reticulum; P:retrograde transport, endosome to Golgi;|Q8IWJ2 A6H8X8 O15045 Q4ZG46 Q8TDH3 Q9H2G8,GRIP and coiled-coil domain-containing protein 2,185 kDa Golgi coiled-coil protein;CLL-associated antigen KW-11;CTCL tumor antigen se1-1;Ran-binding protein 2-like 4;Renal carcinoma antigen NY-REN-53;, PF01465;PF16704;, GO:0005829;GO:0005794;GO:0016020;GO:0005654;GO:0005802;GO:0042802;GO:0031267;GO:0090161;GO:0034499;GO:0034453;GO:0031023;GO:0034067;GO:0006622;GO:0071955;GO:0070861;GO:0042147;, C:cytosol; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:trans-Golgi network;, F:identical protein binding; F:small GTPase binding;, P:Golgi ribbon formation; P:late endosome to Golgi transport; P:microtubule anchoring; P:microtubule organizing center organization; P:protein localization to Golgi apparatus; P:protein targeting to lysosome; P:recycling endosome to Golgi transport; P:regulation of protein exit from endoplasmic reticulum; P:retrograde transport, endosome to Golgi; scaffold6 indexed_genome mRNA 20737282 20741740 . + . ID=transcript_1628;Q8IWJ2 A6H8X8 O15045 Q4ZG46 Q8TDH3 Q9H2G8,GRIP and coiled-coil domain-containing protein 2,185 kDa Golgi coiled-coil protein;CLL-associated antigen KW-11;CTCL tumor antigen se1-1;Ran-binding protein 2-like 4;Renal carcinoma antigen NY-REN-53;, PF01465;PF16704;, GO:0005829;GO:0005794;GO:0016020;GO:0005654;GO:0005802;GO:0042802;GO:0031267;GO:0090161;GO:0034499;GO:0034453;GO:0031023;GO:0034067;GO:0006622;GO:0071955;GO:0070861;GO:0042147;, C:cytosol; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:trans-Golgi network;, F:identical protein binding; F:small GTPase binding;, P:Golgi ribbon formation; P:late endosome to Golgi transport; P:microtubule anchoring; P:microtubule organizing center organization; P:protein localization to Golgi apparatus; P:protein targeting to lysosome; P:recycling endosome to Golgi transport; P:regulation of protein exit from endoplasmic reticulum; P:retrograde transport, endosome to Golgi; scaffold6 indexed_genome mRNA 20790003 20814388 . + . ID=transcript_1629;P49792 Q13074 Q15280 Q53TE2 Q59FH7,E3 SUMO-protein ligase RanBP2,358 kDa nucleoporin;Nuclear pore complex protein Nup358;Nucleoporin Nup358;Ran-binding protein 2;p270;, PF12185;PF00160;PF00638;PF00641;, GO:0005642;GO:0005737;GO:1990723;GO:0005829;GO:0043657;GO:0043231;GO:0016020;GO:0005739;GO:0005635;GO:0042405;GO:0031965;GO:0005643;GO:0044614;GO:0044615;GO:0005654;GO:0046872;GO:0044877;GO:0003723;GO:0031267;GO:0019789;GO:0051642;GO:0075733;GO:0007052;GO:0006406;GO:0006607;GO:0033133;GO:0043547;GO:0006457;GO:0000413;GO:0016925;GO:1900034;GO:0060964;GO:0006111;GO:0006110;GO:0001975;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:annulate lamellae; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nuclear pore nuclear basket; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding; F:RNA binding; F:small GTPase binding; F:SUMO transferase activity;, P:centrosome localization; P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:positive regulation of glucokinase activity; P:positive regulation of GTPase activity; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:response to amphetamine; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P49792 Q13074 Q15280 Q53TE2 Q59FH7,E3 SUMO-protein ligase RanBP2,358 kDa nucleoporin;Nuclear pore complex protein Nup358;Nucleoporin Nup358;Ran-binding protein 2;p270;, PF12185;PF00160;PF00638;PF00641;, GO:0005642;GO:0005737;GO:1990723;GO:0005829;GO:0043657;GO:0043231;GO:0016020;GO:0005739;GO:0005635;GO:0042405;GO:0031965;GO:0005643;GO:0044614;GO:0044615;GO:0005654;GO:0046872;GO:0044877;GO:0003723;GO:0031267;GO:0019789;GO:0051642;GO:0075733;GO:0007052;GO:0006406;GO:0006607;GO:0033133;GO:0043547;GO:0006457;GO:0000413;GO:0016925;GO:1900034;GO:0060964;GO:0006111;GO:0006110;GO:0001975;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:annulate lamellae; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nuclear pore nuclear basket; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding; F:RNA binding; F:small GTPase binding; F:SUMO transferase activity;, P:centrosome localization; P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:positive regulation of glucokinase activity; P:positive regulation of GTPase activity; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:response to amphetamine; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P49792 Q13074 Q15280 Q53TE2 Q59FH7,E3 SUMO-protein ligase RanBP2,358 kDa nucleoporin;Nuclear pore complex protein Nup358;Nucleoporin Nup358;Ran-binding protein 2;p270;, PF12185;PF00160;PF00638;PF00641;, GO:0005642;GO:0005737;GO:1990723;GO:0005829;GO:0043657;GO:0043231;GO:0016020;GO:0005739;GO:0005635;GO:0042405;GO:0031965;GO:0005643;GO:0044614;GO:0044615;GO:0005654;GO:0046872;GO:0044877;GO:0003723;GO:0031267;GO:0019789;GO:0051642;GO:0075733;GO:0007052;GO:0006406;GO:0006607;GO:0033133;GO:0043547;GO:0006457;GO:0000413;GO:0016925;GO:1900034;GO:0060964;GO:0006111;GO:0006110;GO:0001975;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:annulate lamellae; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nuclear pore nuclear basket; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding; F:RNA binding; F:small GTPase binding; F:SUMO transferase activity;, P:centrosome localization; P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:positive regulation of glucokinase activity; P:positive regulation of GTPase activity; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:response to amphetamine; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P49792 Q13074 Q15280 Q53TE2 Q59FH7,E3 SUMO-protein ligase RanBP2,358 kDa nucleoporin;Nuclear pore complex protein Nup358;Nucleoporin Nup358;Ran-binding protein 2;p270;, PF12185;PF00160;PF00638;PF00641;, GO:0005642;GO:0005737;GO:1990723;GO:0005829;GO:0043657;GO:0043231;GO:0016020;GO:0005739;GO:0005635;GO:0042405;GO:0031965;GO:0005643;GO:0044614;GO:0044615;GO:0005654;GO:0046872;GO:0044877;GO:0003723;GO:0031267;GO:0019789;GO:0051642;GO:0075733;GO:0007052;GO:0006406;GO:0006607;GO:0033133;GO:0043547;GO:0006457;GO:0000413;GO:0016925;GO:1900034;GO:0060964;GO:0006111;GO:0006110;GO:0001975;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:annulate lamellae; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nuclear pore nuclear basket; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding; F:RNA binding; F:small GTPase binding; F:SUMO transferase activity;, P:centrosome localization; P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:positive regulation of glucokinase activity; P:positive regulation of GTPase activity; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:response to amphetamine; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold6 indexed_genome mRNA 20815598 20819300 . + . ID=transcript_1630;P49792 Q13074 Q15280 Q53TE2 Q59FH7,E3 SUMO-protein ligase RanBP2,358 kDa nucleoporin;Nuclear pore complex protein Nup358;Nucleoporin Nup358;Ran-binding protein 2;p270;, PF12185;PF00160;PF00638;PF00641;, GO:0005642;GO:0005737;GO:1990723;GO:0005829;GO:0043657;GO:0043231;GO:0016020;GO:0005739;GO:0005635;GO:0042405;GO:0031965;GO:0005643;GO:0044614;GO:0044615;GO:0005654;GO:0046872;GO:0044877;GO:0003723;GO:0031267;GO:0019789;GO:0051642;GO:0075733;GO:0007052;GO:0006406;GO:0006607;GO:0033133;GO:0043547;GO:0006457;GO:0000413;GO:0016925;GO:1900034;GO:0060964;GO:0006111;GO:0006110;GO:0001975;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:annulate lamellae; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nuclear pore nuclear basket; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding; F:RNA binding; F:small GTPase binding; F:SUMO transferase activity;, P:centrosome localization; P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:positive regulation of glucokinase activity; P:positive regulation of GTPase activity; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:response to amphetamine; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P49792 Q13074 Q15280 Q53TE2 Q59FH7,E3 SUMO-protein ligase RanBP2,358 kDa nucleoporin;Nuclear pore complex protein Nup358;Nucleoporin Nup358;Ran-binding protein 2;p270;, PF12185;PF00160;PF00638;PF00641;, GO:0005642;GO:0005737;GO:1990723;GO:0005829;GO:0043657;GO:0043231;GO:0016020;GO:0005739;GO:0005635;GO:0042405;GO:0031965;GO:0005643;GO:0044614;GO:0044615;GO:0005654;GO:0046872;GO:0044877;GO:0003723;GO:0031267;GO:0019789;GO:0051642;GO:0075733;GO:0007052;GO:0006406;GO:0006607;GO:0033133;GO:0043547;GO:0006457;GO:0000413;GO:0016925;GO:1900034;GO:0060964;GO:0006111;GO:0006110;GO:0001975;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:annulate lamellae; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nuclear pore nuclear basket; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding; F:RNA binding; F:small GTPase binding; F:SUMO transferase activity;, P:centrosome localization; P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:positive regulation of glucokinase activity; P:positive regulation of GTPase activity; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:response to amphetamine; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P49792 Q13074 Q15280 Q53TE2 Q59FH7,E3 SUMO-protein ligase RanBP2,358 kDa nucleoporin;Nuclear pore complex protein Nup358;Nucleoporin Nup358;Ran-binding protein 2;p270;, PF12185;PF00160;PF00638;PF00641;, GO:0005642;GO:0005737;GO:1990723;GO:0005829;GO:0043657;GO:0043231;GO:0016020;GO:0005739;GO:0005635;GO:0042405;GO:0031965;GO:0005643;GO:0044614;GO:0044615;GO:0005654;GO:0046872;GO:0044877;GO:0003723;GO:0031267;GO:0019789;GO:0051642;GO:0075733;GO:0007052;GO:0006406;GO:0006607;GO:0033133;GO:0043547;GO:0006457;GO:0000413;GO:0016925;GO:1900034;GO:0060964;GO:0006111;GO:0006110;GO:0001975;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:annulate lamellae; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nuclear pore nuclear basket; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding; F:RNA binding; F:small GTPase binding; F:SUMO transferase activity;, P:centrosome localization; P:intracellular transport of virus; P:mitotic spindle organization; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:positive regulation of glucokinase activity; P:positive regulation of GTPase activity; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:response to amphetamine; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold6 indexed_genome mRNA 20820222 20843458 . + . ID=transcript_1631;Q96M89 Q05DF1 Q4ZG07 Q53TE1 Q6ZUY5 Q86VL7,Coiled-coil domain-containing protein 138|Q96M89 Q05DF1 Q4ZG07 Q53TE1 Q6ZUY5 Q86VL7,Coiled-coil domain-containing protein 138|Q96M89 Q05DF1 Q4ZG07 Q53TE1 Q6ZUY5 Q86VL7,Coiled-coil domain-containing protein 138|Q96M89 Q05DF1 Q4ZG07 Q53TE1 Q6ZUY5 Q86VL7,Coiled-coil domain-containing protein 138 scaffold6 indexed_genome mRNA 20847157 20849766 . + . ID=transcript_1632;Q96M89 Q05DF1 Q4ZG07 Q53TE1 Q6ZUY5 Q86VL7,Coiled-coil domain-containing protein 138|Q96M89 Q05DF1 Q4ZG07 Q53TE1 Q6ZUY5 Q86VL7,Coiled-coil domain-containing protein 138 scaffold6 indexed_genome mRNA 21113170 21115095 . - . ID=transcript_1633;Q8TEJ3 A0SDZ7 A8MPR1 Q8NDU1,E3 ubiquitin-protein ligase SH3RF3,Plenty of SH3s 2;SH3 domain-containing RING finger protein 3;SH3 multiple domains protein 4;, PF00018;PF14604;PF00097;, GO:0046872;GO:0061630;GO:0006915;GO:0046330;GO:0051865;, , F:metal ion binding; F:ubiquitin protein ligase activity;, P:apoptotic process; P:positive regulation of JNK cascade; P:protein autoubiquitination; scaffold6 indexed_genome mRNA 21130832 21177543 . - . ID=transcript_1634;Q9P0V9 B3KRQ9 Q86VP5 Q9HAH6,Septin-10,, PF00735;, GO:0032153;GO:0015630;GO:0031105;GO:0005940;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;, C:cell division site; C:microtubule cytoskeleton; C:septin complex; C:septin ring;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis;|Q9P0V9 B3KRQ9 Q86VP5 Q9HAH6,Septin-10,, PF00735;, GO:0032153;GO:0015630;GO:0031105;GO:0005940;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;, C:cell division site; C:microtubule cytoskeleton; C:septin complex; C:septin ring;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis;|Q9P0V9 B3KRQ9 Q86VP5 Q9HAH6,Septin-10,, PF00735;, GO:0032153;GO:0015630;GO:0031105;GO:0005940;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;, C:cell division site; C:microtubule cytoskeleton; C:septin complex; C:septin ring;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis;|Q9P0V9 B3KRQ9 Q86VP5 Q9HAH6,Septin-10,, PF00735;, GO:0032153;GO:0015630;GO:0031105;GO:0005940;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;, C:cell division site; C:microtubule cytoskeleton; C:septin complex; C:septin ring;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; scaffold6 indexed_genome mRNA 21265878 21338937 . - . ID=transcript_1635;Q9H8M9 D6W5J3 Q9HC41,Protein eva-1 homolog A,Protein FAM176A;Transmembrane protein 166;, PF14851;, GO:0005788;GO:0005789;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0006915;GO:0006914;GO:0044267;GO:0043687;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane;, , P:apoptotic process; P:autophagy; P:cellular protein metabolic process; P:post-translational protein modification; scaffold6 indexed_genome mRNA 21394291 21408311 . + . ID=transcript_1636;P49406 Q53TX9 Q96Q52,39S ribosomal protein L19, mitochondrial,39S ribosomal protein L15, mitochondrial;Mitochondrial large ribosomal subunit protein bL19m {ECO:0000303|PubMed:25278503};, PF01245;, GO:0005743;GO:0005762;GO:0005739;GO:0031965;GO:0005634;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion; C:nuclear membrane; C:nucleus;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|P49406 Q53TX9 Q96Q52,39S ribosomal protein L19, mitochondrial,39S ribosomal protein L15, mitochondrial;Mitochondrial large ribosomal subunit protein bL19m {ECO:0000303|PubMed:25278503};, PF01245;, GO:0005743;GO:0005762;GO:0005739;GO:0031965;GO:0005634;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion; C:nuclear membrane; C:nucleus;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|P49406 Q53TX9 Q96Q52,39S ribosomal protein L19, mitochondrial,39S ribosomal protein L15, mitochondrial;Mitochondrial large ribosomal subunit protein bL19m {ECO:0000303|PubMed:25278503};, PF01245;, GO:0005743;GO:0005762;GO:0005739;GO:0031965;GO:0005634;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion; C:nuclear membrane; C:nucleus;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold6 indexed_genome mRNA 21432324 21472607 . - . ID=transcript_1637;P16383 A4UHQ8 A4UHQ9 O95032 Q53TY0 Q6P2F2,Intron Large complex component GCFC2 {ECO:0000305},GC-rich sequence DNA-binding factor;GC-rich sequence DNA-binding factor 2;Transcription factor 9;, PF07842;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0071008;GO:0003677;GO:0000398;GO:0045892;GO:0006355;GO:0000245;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:U2-type post-mRNA release spliceosomal complex;, F:DNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:spliceosomal complex assembly;|P16383 A4UHQ8 A4UHQ9 O95032 Q53TY0 Q6P2F2,Intron Large complex component GCFC2 {ECO:0000305},GC-rich sequence DNA-binding factor;GC-rich sequence DNA-binding factor 2;Transcription factor 9;, PF07842;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0071008;GO:0003677;GO:0000398;GO:0045892;GO:0006355;GO:0000245;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:U2-type post-mRNA release spliceosomal complex;, F:DNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:spliceosomal complex assembly;|P16383 A4UHQ8 A4UHQ9 O95032 Q53TY0 Q6P2F2,Intron Large complex component GCFC2 {ECO:0000305},GC-rich sequence DNA-binding factor;GC-rich sequence DNA-binding factor 2;Transcription factor 9;, PF07842;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0071008;GO:0003677;GO:0000398;GO:0045892;GO:0006355;GO:0000245;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:U2-type post-mRNA release spliceosomal complex;, F:DNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:spliceosomal complex assembly;|P16383 A4UHQ8 A4UHQ9 O95032 Q53TY0 Q6P2F2,Intron Large complex component GCFC2 {ECO:0000305},GC-rich sequence DNA-binding factor;GC-rich sequence DNA-binding factor 2;Transcription factor 9;, PF07842;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0071008;GO:0003677;GO:0000398;GO:0045892;GO:0006355;GO:0000245;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:U2-type post-mRNA release spliceosomal complex;, F:DNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:spliceosomal complex assembly;|P16383 A4UHQ8 A4UHQ9 O95032 Q53TY0 Q6P2F2,Intron Large complex component GCFC2 {ECO:0000305},GC-rich sequence DNA-binding factor;GC-rich sequence DNA-binding factor 2;Transcription factor 9;, PF07842;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0071008;GO:0003677;GO:0000398;GO:0045892;GO:0006355;GO:0000245;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:U2-type post-mRNA release spliceosomal complex;, F:DNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:spliceosomal complex assembly; scaffold6 indexed_genome mRNA 21552027 21606651 . - . ID=transcript_1638;Q6NSI8 Q49AF0 Q6ZND0 Q96JI6,Uncharacterized protein KIAA1841,, PF11822;|Q6NSI8 Q49AF0 Q6ZND0 Q96JI6,Uncharacterized protein KIAA1841,, PF11822;|Q6NSI8 Q49AF0 Q6ZND0 Q96JI6,Uncharacterized protein KIAA1841,, PF11822; scaffold6 indexed_genome mRNA 21626314 21660237 . - . ID=transcript_1639;Q92968 B2RCS1,Peroxisomal membrane protein PEX13,Peroxin-13;, PF04088;PF14604;, GO:0005829;GO:0005779;GO:0016020;GO:1990429;GO:0005778;GO:0005777;GO:0021795;GO:0001561;GO:0007626;GO:0060152;GO:0001764;GO:0016560;GO:0045046;GO:0008104;GO:0016567;GO:0001967;, C:cytosol; C:integral component of peroxisomal membrane; C:membrane; C:peroxisomal importomer complex; C:peroxisomal membrane; C:peroxisome;, , P:cerebral cortex cell migration; P:fatty acid alpha-oxidation; P:locomotory behavior; P:microtubule-based peroxisome localization; P:neuron migration; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome membrane; P:protein localization; P:protein ubiquitination; P:suckling behavior; scaffold6 indexed_genome mRNA 21660659 21735240 . + . ID=transcript_1640;Q3MIT2 Q5JPJ5 Q96MI8,tRNA pseudouridine synthase Pus10,Coiled-coil domain-containing protein 139 {ECO:0000312|HGNC:HGNC:26505};tRNA pseudouridine 55 synthase;tRNA pseudouridylate synthase;tRNA-uridine isomerase;, , GO:0005737;GO:0005739;GO:0005634;GO:0046872;GO:0070878;GO:0009982;GO:0106029;GO:0031053;GO:0031119;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:metal ion binding; F:primary miRNA binding; F:pseudouridine synthase activity; F:tRNA pseudouridine synthase activity;, P:primary miRNA processing; P:tRNA pseudouridine synthesis;|Q3MIT2 Q5JPJ5 Q96MI8,tRNA pseudouridine synthase Pus10,Coiled-coil domain-containing protein 139 {ECO:0000312|HGNC:HGNC:26505};tRNA pseudouridine 55 synthase;tRNA pseudouridylate synthase;tRNA-uridine isomerase;, , GO:0005737;GO:0005739;GO:0005634;GO:0046872;GO:0070878;GO:0009982;GO:0106029;GO:0031053;GO:0031119;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:metal ion binding; F:primary miRNA binding; F:pseudouridine synthase activity; F:tRNA pseudouridine synthase activity;, P:primary miRNA processing; P:tRNA pseudouridine synthesis;|Q3MIT2 Q5JPJ5 Q96MI8,tRNA pseudouridine synthase Pus10,Coiled-coil domain-containing protein 139 {ECO:0000312|HGNC:HGNC:26505};tRNA pseudouridine 55 synthase;tRNA pseudouridylate synthase;tRNA-uridine isomerase;, , GO:0005737;GO:0005739;GO:0005634;GO:0046872;GO:0070878;GO:0009982;GO:0106029;GO:0031053;GO:0031119;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:metal ion binding; F:primary miRNA binding; F:pseudouridine synthase activity; F:tRNA pseudouridine synthase activity;, P:primary miRNA processing; P:tRNA pseudouridine synthesis;|Q3MIT2 Q5JPJ5 Q96MI8,tRNA pseudouridine synthase Pus10,Coiled-coil domain-containing protein 139 {ECO:0000312|HGNC:HGNC:26505};tRNA pseudouridine 55 synthase;tRNA pseudouridylate synthase;tRNA-uridine isomerase;, , GO:0005737;GO:0005739;GO:0005634;GO:0046872;GO:0070878;GO:0009982;GO:0106029;GO:0031053;GO:0031119;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:metal ion binding; F:primary miRNA binding; F:pseudouridine synthase activity; F:tRNA pseudouridine synthase activity;, P:primary miRNA processing; P:tRNA pseudouridine synthesis;|Q3MIT2 Q5JPJ5 Q96MI8,tRNA pseudouridine synthase Pus10,Coiled-coil domain-containing protein 139 {ECO:0000312|HGNC:HGNC:26505};tRNA pseudouridine 55 synthase;tRNA pseudouridylate synthase;tRNA-uridine isomerase;, , GO:0005737;GO:0005739;GO:0005634;GO:0046872;GO:0070878;GO:0009982;GO:0106029;GO:0031053;GO:0031119;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:metal ion binding; F:primary miRNA binding; F:pseudouridine synthase activity; F:tRNA pseudouridine synthase activity;, P:primary miRNA processing; P:tRNA pseudouridine synthesis;|Q3MIT2 Q5JPJ5 Q96MI8,tRNA pseudouridine synthase Pus10,Coiled-coil domain-containing protein 139 {ECO:0000312|HGNC:HGNC:26505};tRNA pseudouridine 55 synthase;tRNA pseudouridylate synthase;tRNA-uridine isomerase;, , GO:0005737;GO:0005739;GO:0005634;GO:0046872;GO:0070878;GO:0009982;GO:0106029;GO:0031053;GO:0031119;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:metal ion binding; F:primary miRNA binding; F:pseudouridine synthase activity; F:tRNA pseudouridine synthase activity;, P:primary miRNA processing; P:tRNA pseudouridine synthesis;|Q3MIT2 Q5JPJ5 Q96MI8,tRNA pseudouridine synthase Pus10,Coiled-coil domain-containing protein 139 {ECO:0000312|HGNC:HGNC:26505};tRNA pseudouridine 55 synthase;tRNA pseudouridylate synthase;tRNA-uridine isomerase;, , GO:0005737;GO:0005739;GO:0005634;GO:0046872;GO:0070878;GO:0009982;GO:0106029;GO:0031053;GO:0031119;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:metal ion binding; F:primary miRNA binding; F:pseudouridine synthase activity; F:tRNA pseudouridine synthase activity;, P:primary miRNA processing; P:tRNA pseudouridine synthesis; scaffold6 indexed_genome mRNA 21746903 21749458 . - . ID=transcript_1641;Q04864 Q17RU2 Q2PNZ7 Q6LDY0,Proto-oncogene c-Rel,, PF16179;PF00554;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0007249;GO:0006954;GO:0045087;GO:0010629;GO:0032688;GO:1901215;GO:0038061;GO:0043123;GO:0045944;GO:0006357;GO:0034097;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:negative regulation of gene expression; P:negative regulation of interferon-beta production; P:negative regulation of neuron death; P:NIK/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to cytokine; scaffold6 indexed_genome mRNA 21749506 21750974 . - . ID=transcript_1642;Q04864 Q17RU2 Q2PNZ7 Q6LDY0,Proto-oncogene c-Rel,, PF16179;PF00554;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0007249;GO:0006954;GO:0045087;GO:0010629;GO:0032688;GO:1901215;GO:0038061;GO:0043123;GO:0045944;GO:0006357;GO:0034097;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:negative regulation of gene expression; P:negative regulation of interferon-beta production; P:negative regulation of neuron death; P:NIK/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to cytokine; scaffold6 indexed_genome mRNA 21866197 21891813 . - . ID=transcript_1643;Q9BWT3 B2RBH4 Q59G05 Q969N1 Q9H8L2 Q9HAD0,Poly(A) polymerase gamma,Neo-poly(A) polymerase;Polynucleotide adenylyltransferase gamma;SRP RNA 3'-adenylating enzyme;Signal recognition particle RNA-adenylating enzyme;, PF01909;PF04928;PF04926;, GO:0005829;GO:0016020;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0004652;GO:0003723;GO:0006378;GO:0043631;, C:cytosol; C:membrane; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA polyadenylation; P:RNA polyadenylation;|Q9BWT3 B2RBH4 Q59G05 Q969N1 Q9H8L2 Q9HAD0,Poly(A) polymerase gamma,Neo-poly(A) polymerase;Polynucleotide adenylyltransferase gamma;SRP RNA 3'-adenylating enzyme;Signal recognition particle RNA-adenylating enzyme;, PF01909;PF04928;PF04926;, GO:0005829;GO:0016020;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0004652;GO:0003723;GO:0006378;GO:0043631;, C:cytosol; C:membrane; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA polyadenylation; P:RNA polyadenylation;|Q9BWT3 B2RBH4 Q59G05 Q969N1 Q9H8L2 Q9HAD0,Poly(A) polymerase gamma,Neo-poly(A) polymerase;Polynucleotide adenylyltransferase gamma;SRP RNA 3'-adenylating enzyme;Signal recognition particle RNA-adenylating enzyme;, PF01909;PF04928;PF04926;, GO:0005829;GO:0016020;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0004652;GO:0003723;GO:0006378;GO:0043631;, C:cytosol; C:membrane; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA polyadenylation; P:RNA polyadenylation;|Q9BWT3 B2RBH4 Q59G05 Q969N1 Q9H8L2 Q9HAD0,Poly(A) polymerase gamma,Neo-poly(A) polymerase;Polynucleotide adenylyltransferase gamma;SRP RNA 3'-adenylating enzyme;Signal recognition particle RNA-adenylating enzyme;, PF01909;PF04928;PF04926;, GO:0005829;GO:0016020;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0004652;GO:0003723;GO:0006378;GO:0043631;, C:cytosol; C:membrane; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA polyadenylation; P:RNA polyadenylation;|Q9BWT3 B2RBH4 Q59G05 Q969N1 Q9H8L2 Q9HAD0,Poly(A) polymerase gamma,Neo-poly(A) polymerase;Polynucleotide adenylyltransferase gamma;SRP RNA 3'-adenylating enzyme;Signal recognition particle RNA-adenylating enzyme;, PF01909;PF04928;PF04926;, GO:0005829;GO:0016020;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0004652;GO:0003723;GO:0006378;GO:0043631;, C:cytosol; C:membrane; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA polyadenylation; P:RNA polyadenylation;|Q9BWT3 B2RBH4 Q59G05 Q969N1 Q9H8L2 Q9HAD0,Poly(A) polymerase gamma,Neo-poly(A) polymerase;Polynucleotide adenylyltransferase gamma;SRP RNA 3'-adenylating enzyme;Signal recognition particle RNA-adenylating enzyme;, PF01909;PF04928;PF04926;, GO:0005829;GO:0016020;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0004652;GO:0003723;GO:0006378;GO:0043631;, C:cytosol; C:membrane; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA polyadenylation; P:RNA polyadenylation; scaffold6 indexed_genome mRNA 21892141 21894985 . - . ID=transcript_1644;Q9BWT3 B2RBH4 Q59G05 Q969N1 Q9H8L2 Q9HAD0,Poly(A) polymerase gamma,Neo-poly(A) polymerase;Polynucleotide adenylyltransferase gamma;SRP RNA 3'-adenylating enzyme;Signal recognition particle RNA-adenylating enzyme;, PF01909;PF04928;PF04926;, GO:0005829;GO:0016020;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0004652;GO:0003723;GO:0006378;GO:0043631;, C:cytosol; C:membrane; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA polyadenylation; P:RNA polyadenylation; scaffold6 indexed_genome mRNA 22078105 22178167 . + . ID=transcript_1645;Q9NWA7,B-cell lymphoma/leukemia 11A {ECO:0000303|PubMed:11719382},B-cell CLL/lymphoma 11A;COUP-TF-interacting protein 1;Ecotropic viral integration site 9 protein homolog;Zinc finger protein 856;, PF00096;, GO:0005737;GO:0005654;GO:0005634;GO:0014069;GO:0003700;GO:0001227;GO:0046872;GO:0046982;GO:0042803;GO:0019901;GO:0001067;GO:0000978;GO:0003712;GO:1905232;GO:0030517;GO:2000173;GO:0048671;GO:2000171;GO:1903860;GO:0010977;GO:1904800;GO:0032463;GO:0000122;GO:0048672;GO:0010628;GO:0010976;GO:0045944;GO:0016925;GO:0050773;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:regulatory region nucleic acid binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coregulator activity;, P:cellular response to L-glutamate; P:negative regulation of axon extension; P:negative regulation of branching morphogenesis of a nerve; P:negative regulation of collateral sprouting; P:negative regulation of dendrite development; P:negative regulation of dendrite extension; P:negative regulation of neuron projection development; P:negative regulation of neuron remodeling; P:negative regulation of protein homooligomerization; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of collateral sprouting; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of transcription by RNA polymerase II; P:protein sumoylation; P:regulation of dendrite development; P:regulation of transcription by RNA polymerase II; scaffold6 indexed_genome mRNA 24455541 24618146 . + . ID=transcript_1646;Q9NW38 Q6GU60,E3 ubiquitin-protein ligase FANCL,Fanconi anemia group L protein;Fanconi anemia-associated polypeptide of 43 kDa;RING-type E3 ubiquitin transferase FANCL {ECO:0000305};, PF11793;PF09765;PF18890;PF18891;, GO:0005737;GO:0043240;GO:0043231;GO:0016604;GO:0005635;GO:0005654;GO:0005634;GO:0046872;GO:0061630;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0007276;GO:0036297;GO:0006513;GO:0042127;, C:cytoplasm; C:Fanconi anaemia nuclear complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:gamete generation; P:interstrand cross-link repair; P:protein monoubiquitination; P:regulation of cell population proliferation;|Q9NW38 Q6GU60,E3 ubiquitin-protein ligase FANCL,Fanconi anemia group L protein;Fanconi anemia-associated polypeptide of 43 kDa;RING-type E3 ubiquitin transferase FANCL {ECO:0000305};, PF11793;PF09765;PF18890;PF18891;, GO:0005737;GO:0043240;GO:0043231;GO:0016604;GO:0005635;GO:0005654;GO:0005634;GO:0046872;GO:0061630;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0007276;GO:0036297;GO:0006513;GO:0042127;, C:cytoplasm; C:Fanconi anaemia nuclear complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:gamete generation; P:interstrand cross-link repair; P:protein monoubiquitination; P:regulation of cell population proliferation;|Q9NW38 Q6GU60,E3 ubiquitin-protein ligase FANCL,Fanconi anemia group L protein;Fanconi anemia-associated polypeptide of 43 kDa;RING-type E3 ubiquitin transferase FANCL {ECO:0000305};, PF11793;PF09765;PF18890;PF18891;, GO:0005737;GO:0043240;GO:0043231;GO:0016604;GO:0005635;GO:0005654;GO:0005634;GO:0046872;GO:0061630;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0007276;GO:0036297;GO:0006513;GO:0042127;, C:cytoplasm; C:Fanconi anaemia nuclear complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:gamete generation; P:interstrand cross-link repair; P:protein monoubiquitination; P:regulation of cell population proliferation;|Q9NW38 Q6GU60,E3 ubiquitin-protein ligase FANCL,Fanconi anemia group L protein;Fanconi anemia-associated polypeptide of 43 kDa;RING-type E3 ubiquitin transferase FANCL {ECO:0000305};, PF11793;PF09765;PF18890;PF18891;, GO:0005737;GO:0043240;GO:0043231;GO:0016604;GO:0005635;GO:0005654;GO:0005634;GO:0046872;GO:0061630;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0007276;GO:0036297;GO:0006513;GO:0042127;, C:cytoplasm; C:Fanconi anaemia nuclear complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:gamete generation; P:interstrand cross-link repair; P:protein monoubiquitination; P:regulation of cell population proliferation;|Q9NW38 Q6GU60,E3 ubiquitin-protein ligase FANCL,Fanconi anemia group L protein;Fanconi anemia-associated polypeptide of 43 kDa;RING-type E3 ubiquitin transferase FANCL {ECO:0000305};, PF11793;PF09765;PF18890;PF18891;, GO:0005737;GO:0043240;GO:0043231;GO:0016604;GO:0005635;GO:0005654;GO:0005634;GO:0046872;GO:0061630;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0007276;GO:0036297;GO:0006513;GO:0042127;, C:cytoplasm; C:Fanconi anaemia nuclear complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:gamete generation; P:interstrand cross-link repair; P:protein monoubiquitination; P:regulation of cell population proliferation;|Q86Y08 Q86Y09 Q86Y10 Q86Y11 Q86Y12 Q8IXI5 Q99987,Serine/threonine-protein kinase VRK2,Vaccinia-related kinase 2;, PF00069;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0031966;GO:0005635;GO:0005634;GO:0032991;GO:0005524;GO:0019904;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0034599;GO:0018105;GO:0046777;GO:0006468;GO:2000659;GO:0043408;GO:0016032;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial membrane; C:nuclear envelope; C:nucleus; C:protein-containing complex;, F:ATP binding; F:protein domain specific binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to oxidative stress; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of interleukin-1-mediated signaling pathway; P:regulation of MAPK cascade; P:viral process;|Q86Y08 Q86Y09 Q86Y10 Q86Y11 Q86Y12 Q8IXI5 Q99987,Serine/threonine-protein kinase VRK2,Vaccinia-related kinase 2;, PF00069;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0031966;GO:0005635;GO:0005634;GO:0032991;GO:0005524;GO:0019904;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0034599;GO:0018105;GO:0046777;GO:0006468;GO:2000659;GO:0043408;GO:0016032;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial membrane; C:nuclear envelope; C:nucleus; C:protein-containing complex;, F:ATP binding; F:protein domain specific binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to oxidative stress; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of interleukin-1-mediated signaling pathway; P:regulation of MAPK cascade; P:viral process; scaffold6 indexed_genome mRNA 25457330 27469436 . - . ID=transcript_1647;Q9H3I3 Q9UQ42 Q9Y293 Q9Y2Y7 Q9Y5U6,Reticulon-4 {ECO:0000305},Foocen;Neurite outgrowth inhibitor;Neuroendocrine-specific protein;Neuroendocrine-specific protein C homolog;RTN-x;Reticulon-5;, PF02453;, GO:0030054;GO:0042995;GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0030176;GO:0043025;GO:0005635;GO:0005886;GO:0014069;GO:0045296;GO:0042803;GO:0003723;GO:0031625;GO:0006915;GO:0007413;GO:0001825;GO:0060317;GO:0120078;GO:0035441;GO:0071456;GO:0090156;GO:0022009;GO:0021801;GO:0007029;GO:0071787;GO:1990809;GO:0071786;GO:0002523;GO:1902430;GO:0030517;GO:0050771;GO:0030308;GO:2001213;GO:0051292;GO:0045766;GO:1905653;GO:0010634;GO:1905580;GO:2000347;GO:0060907;GO:1905523;GO:0033601;GO:1902624;GO:0051897;GO:1905552;GO:0035022;GO:0034165;GO:0061462;GO:0050821;GO:0042981;GO:2000172;GO:0030334;, C:cell junction; C:cell projection; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:integral component of endoplasmic reticulum membrane; C:neuronal cell body; C:nuclear envelope; C:plasma membrane; C:postsynaptic density;, F:cadherin binding; F:protein homodimerization activity; F:RNA binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:axonal fasciculation; P:blastocyst formation; P:cardiac epithelial to mesenchymal transition; P:cell adhesion involved in sprouting angiogenesis; P:cell migration involved in vasculogenesis; P:cellular response to hypoxia; P:cellular sphingolipid homeostasis; P:central nervous system vasculogenesis; P:cerebral cortex radial glia guided migration; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network membrane organization; P:endoplasmic reticulum tubular network organization; P:leukocyte migration involved in inflammatory response; P:negative regulation of amyloid-beta formation; P:negative regulation of axon extension; P:negative regulation of axonogenesis; P:negative regulation of cell growth; P:negative regulation of vasculogenesis; P:nuclear pore complex assembly; P:positive regulation of angiogenesis; P:positive regulation of artery morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of ERBB3 signaling pathway; P:positive regulation of hepatocyte proliferation; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage migration; P:positive regulation of mammary gland epithelial cell proliferation; P:positive regulation of neutrophil migration; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to endoplasmic reticulum; P:positive regulation of Rac protein signal transduction; P:positive regulation of toll-like receptor 9 signaling pathway; P:protein localization to lysosome; P:protein stabilization; P:regulation of apoptotic process; P:regulation of branching morphogenesis of a nerve; P:regulation of cell migration;|Q96PX6,Coiled-coil domain-containing protein 85A,, PF10226;, GO:0005912;, C:adherens junction;|Q12805 A8K3I4 B4DW75 D6W5D2 Q541U7,EGF-containing fibulin-like extracellular matrix protein 1,Extracellular protein S1-5;Fibrillin-like protein;Fibulin-3;, PF12662;PF07645;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005509;GO:0005154;GO:0005006;GO:0008083;GO:0043010;GO:0048048;GO:0007173;GO:0032331;GO:0018108;GO:0048050;GO:0006355;GO:0007601;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:epidermal growth factor receptor binding; F:epidermal growth factor-activated receptor activity; F:growth factor activity;, P:camera-type eye development; P:embryonic eye morphogenesis; P:epidermal growth factor receptor signaling pathway; P:negative regulation of chondrocyte differentiation; P:peptidyl-tyrosine phosphorylation; P:post-embryonic eye morphogenesis; P:regulation of transcription, DNA-templated; P:visual perception;|Q12805 A8K3I4 B4DW75 D6W5D2 Q541U7,EGF-containing fibulin-like extracellular matrix protein 1,Extracellular protein S1-5;Fibrillin-like protein;Fibulin-3;, PF12662;PF07645;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005509;GO:0005154;GO:0005006;GO:0008083;GO:0043010;GO:0048048;GO:0007173;GO:0032331;GO:0018108;GO:0048050;GO:0006355;GO:0007601;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:epidermal growth factor receptor binding; F:epidermal growth factor-activated receptor activity; F:growth factor activity;, P:camera-type eye development; P:embryonic eye morphogenesis; P:epidermal growth factor receptor signaling pathway; P:negative regulation of chondrocyte differentiation; P:peptidyl-tyrosine phosphorylation; P:post-embryonic eye morphogenesis; P:regulation of transcription, DNA-templated; P:visual perception;|Q8TCS8 Q53SU0 Q68CN1 Q7Z7D1 Q8IWX1 Q96T05 Q9BRU3 Q9BVX0,Polyribonucleotide nucleotidyltransferase 1, mitochondrial,3'-5' RNA exonuclease OLD35;PNPase old-35;Polynucleotide phosphorylase 1;Polynucleotide phosphorylase-like protein;, PF00013;PF03726;PF01138;PF03725;PF00575;, GO:0005737;GO:0005829;GO:0005789;GO:0045025;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0042788;GO:0000175;GO:0035198;GO:0034046;GO:0008266;GO:0004654;GO:0003723;GO:0035458;GO:0034599;GO:0097421;GO:0000958;GO:0097222;GO:0000965;GO:0000964;GO:0000957;GO:0070584;GO:0071850;GO:0006402;GO:0045926;GO:0071042;GO:2000627;GO:0000962;GO:0061014;GO:0051260;GO:0070207;GO:0043457;GO:2000772;GO:0051591;GO:0060416;GO:0006401;GO:0035927;GO:0043631;GO:0035928;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial degradosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:polysomal ribosome;, F:3'-5'-exoribonuclease activity; F:miRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:polyribonucleotide nucleotidyltransferase activity; F:RNA binding;, P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:liver regeneration; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA polyadenylation; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA 5'-end processing; P:mitochondrial RNA catabolic process; P:mitochondrion morphogenesis; P:mitotic cell cycle arrest; P:mRNA catabolic process; P:negative regulation of growth; P:nuclear polyadenylation-dependent mRNA catabolic process; P:positive regulation of miRNA catabolic process; P:positive regulation of mitochondrial RNA catabolic process; P:positive regulation of mRNA catabolic process; P:protein homooligomerization; P:protein homotrimerization; P:regulation of cellular respiration; P:regulation of cellular senescence; P:response to cAMP; P:response to growth hormone; P:RNA catabolic process; P:RNA import into mitochondrion; P:RNA polyadenylation; P:rRNA import into mitochondrion;|Q8TCS8 Q53SU0 Q68CN1 Q7Z7D1 Q8IWX1 Q96T05 Q9BRU3 Q9BVX0,Polyribonucleotide nucleotidyltransferase 1, mitochondrial,3'-5' RNA exonuclease OLD35;PNPase old-35;Polynucleotide phosphorylase 1;Polynucleotide phosphorylase-like protein;, PF00013;PF03726;PF01138;PF03725;PF00575;, GO:0005737;GO:0005829;GO:0005789;GO:0045025;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0042788;GO:0000175;GO:0035198;GO:0034046;GO:0008266;GO:0004654;GO:0003723;GO:0035458;GO:0034599;GO:0097421;GO:0000958;GO:0097222;GO:0000965;GO:0000964;GO:0000957;GO:0070584;GO:0071850;GO:0006402;GO:0045926;GO:0071042;GO:2000627;GO:0000962;GO:0061014;GO:0051260;GO:0070207;GO:0043457;GO:2000772;GO:0051591;GO:0060416;GO:0006401;GO:0035927;GO:0043631;GO:0035928;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial degradosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:polysomal ribosome;, F:3'-5'-exoribonuclease activity; F:miRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:polyribonucleotide nucleotidyltransferase activity; F:RNA binding;, P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:liver regeneration; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA polyadenylation; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA 5'-end processing; P:mitochondrial RNA catabolic process; P:mitochondrion morphogenesis; P:mitotic cell cycle arrest; P:mRNA catabolic process; P:negative regulation of growth; P:nuclear polyadenylation-dependent mRNA catabolic process; P:positive regulation of miRNA catabolic process; P:positive regulation of mitochondrial RNA catabolic process; P:positive regulation of mRNA catabolic process; P:protein homooligomerization; P:protein homotrimerization; P:regulation of cellular respiration; P:regulation of cellular senescence; P:response to cAMP; P:response to growth hormone; P:RNA catabolic process; P:RNA import into mitochondrion; P:RNA polyadenylation; P:rRNA import into mitochondrion;|Q8TCS8 Q53SU0 Q68CN1 Q7Z7D1 Q8IWX1 Q96T05 Q9BRU3 Q9BVX0,Polyribonucleotide nucleotidyltransferase 1, mitochondrial,3'-5' RNA exonuclease OLD35;PNPase old-35;Polynucleotide phosphorylase 1;Polynucleotide phosphorylase-like protein;, PF00013;PF03726;PF01138;PF03725;PF00575;, GO:0005737;GO:0005829;GO:0005789;GO:0045025;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0042788;GO:0000175;GO:0035198;GO:0034046;GO:0008266;GO:0004654;GO:0003723;GO:0035458;GO:0034599;GO:0097421;GO:0000958;GO:0097222;GO:0000965;GO:0000964;GO:0000957;GO:0070584;GO:0071850;GO:0006402;GO:0045926;GO:0071042;GO:2000627;GO:0000962;GO:0061014;GO:0051260;GO:0070207;GO:0043457;GO:2000772;GO:0051591;GO:0060416;GO:0006401;GO:0035927;GO:0043631;GO:0035928;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial degradosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:polysomal ribosome;, F:3'-5'-exoribonuclease activity; F:miRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:polyribonucleotide nucleotidyltransferase activity; F:RNA binding;, P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:liver regeneration; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA polyadenylation; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA 5'-end processing; P:mitochondrial RNA catabolic process; P:mitochondrion morphogenesis; P:mitotic cell cycle arrest; P:mRNA catabolic process; P:negative regulation of growth; P:nuclear polyadenylation-dependent mRNA catabolic process; P:positive regulation of miRNA catabolic process; P:positive regulation of mitochondrial RNA catabolic process; P:positive regulation of mRNA catabolic process; P:protein homooligomerization; P:protein homotrimerization; P:regulation of cellular respiration; P:regulation of cellular senescence; P:response to cAMP; P:response to growth hormone; P:RNA catabolic process; P:RNA import into mitochondrion; P:RNA polyadenylation; P:rRNA import into mitochondrion;|Q8TCS8 Q53SU0 Q68CN1 Q7Z7D1 Q8IWX1 Q96T05 Q9BRU3 Q9BVX0,Polyribonucleotide nucleotidyltransferase 1, mitochondrial,3'-5' RNA exonuclease OLD35;PNPase old-35;Polynucleotide phosphorylase 1;Polynucleotide phosphorylase-like protein;, PF00013;PF03726;PF01138;PF03725;PF00575;, GO:0005737;GO:0005829;GO:0005789;GO:0045025;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0042788;GO:0000175;GO:0035198;GO:0034046;GO:0008266;GO:0004654;GO:0003723;GO:0035458;GO:0034599;GO:0097421;GO:0000958;GO:0097222;GO:0000965;GO:0000964;GO:0000957;GO:0070584;GO:0071850;GO:0006402;GO:0045926;GO:0071042;GO:2000627;GO:0000962;GO:0061014;GO:0051260;GO:0070207;GO:0043457;GO:2000772;GO:0051591;GO:0060416;GO:0006401;GO:0035927;GO:0043631;GO:0035928;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial degradosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:polysomal ribosome;, F:3'-5'-exoribonuclease activity; F:miRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:polyribonucleotide nucleotidyltransferase activity; F:RNA binding;, P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:liver regeneration; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA polyadenylation; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA 5'-end processing; P:mitochondrial RNA catabolic process; P:mitochondrion morphogenesis; P:mitotic cell cycle arrest; P:mRNA catabolic process; P:negative regulation of growth; P:nuclear polyadenylation-dependent mRNA catabolic process; P:positive regulation of miRNA catabolic process; P:positive regulation of mitochondrial RNA catabolic process; P:positive regulation of mRNA catabolic process; P:protein homooligomerization; P:protein homotrimerization; P:regulation of cellular respiration; P:regulation of cellular senescence; P:response to cAMP; P:response to growth hormone; P:RNA catabolic process; P:RNA import into mitochondrion; P:RNA polyadenylation; P:rRNA import into mitochondrion;|Q8TCS8 Q53SU0 Q68CN1 Q7Z7D1 Q8IWX1 Q96T05 Q9BRU3 Q9BVX0,Polyribonucleotide nucleotidyltransferase 1, mitochondrial,3'-5' RNA exonuclease OLD35;PNPase old-35;Polynucleotide phosphorylase 1;Polynucleotide phosphorylase-like protein;, PF00013;PF03726;PF01138;PF03725;PF00575;, GO:0005737;GO:0005829;GO:0005789;GO:0045025;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0042788;GO:0000175;GO:0035198;GO:0034046;GO:0008266;GO:0004654;GO:0003723;GO:0035458;GO:0034599;GO:0097421;GO:0000958;GO:0097222;GO:0000965;GO:0000964;GO:0000957;GO:0070584;GO:0071850;GO:0006402;GO:0045926;GO:0071042;GO:2000627;GO:0000962;GO:0061014;GO:0051260;GO:0070207;GO:0043457;GO:2000772;GO:0051591;GO:0060416;GO:0006401;GO:0035927;GO:0043631;GO:0035928;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial degradosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:polysomal ribosome;, F:3'-5'-exoribonuclease activity; F:miRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:polyribonucleotide nucleotidyltransferase activity; F:RNA binding;, P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:liver regeneration; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA polyadenylation; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA 5'-end processing; P:mitochondrial RNA catabolic process; P:mitochondrion morphogenesis; P:mitotic cell cycle arrest; P:mRNA catabolic process; P:negative regulation of growth; P:nuclear polyadenylation-dependent mRNA catabolic process; P:positive regulation of miRNA catabolic process; P:positive regulation of mitochondrial RNA catabolic process; P:positive regulation of mRNA catabolic process; P:protein homooligomerization; P:protein homotrimerization; P:regulation of cellular respiration; P:regulation of cellular senescence; P:response to cAMP; P:response to growth hormone; P:RNA catabolic process; P:RNA import into mitochondrion; P:RNA polyadenylation; P:rRNA import into mitochondrion;|Q8TCS8 Q53SU0 Q68CN1 Q7Z7D1 Q8IWX1 Q96T05 Q9BRU3 Q9BVX0,Polyribonucleotide nucleotidyltransferase 1, mitochondrial,3'-5' RNA exonuclease OLD35;PNPase old-35;Polynucleotide phosphorylase 1;Polynucleotide phosphorylase-like protein;, PF00013;PF03726;PF01138;PF03725;PF00575;, GO:0005737;GO:0005829;GO:0005789;GO:0045025;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0042788;GO:0000175;GO:0035198;GO:0034046;GO:0008266;GO:0004654;GO:0003723;GO:0035458;GO:0034599;GO:0097421;GO:0000958;GO:0097222;GO:0000965;GO:0000964;GO:0000957;GO:0070584;GO:0071850;GO:0006402;GO:0045926;GO:0071042;GO:2000627;GO:0000962;GO:0061014;GO:0051260;GO:0070207;GO:0043457;GO:2000772;GO:0051591;GO:0060416;GO:0006401;GO:0035927;GO:0043631;GO:0035928;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial degradosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:polysomal ribosome;, F:3'-5'-exoribonuclease activity; F:miRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:polyribonucleotide nucleotidyltransferase activity; F:RNA binding;, P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:liver regeneration; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA polyadenylation; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA 5'-end processing; P:mitochondrial RNA catabolic process; P:mitochondrion morphogenesis; P:mitotic cell cycle arrest; P:mRNA catabolic process; P:negative regulation of growth; P:nuclear polyadenylation-dependent mRNA catabolic process; P:positive regulation of miRNA catabolic process; P:positive regulation of mitochondrial RNA catabolic process; P:positive regulation of mRNA catabolic process; P:protein homooligomerization; P:protein homotrimerization; P:regulation of cellular respiration; P:regulation of cellular senescence; P:response to cAMP; P:response to growth hormone; P:RNA catabolic process; P:RNA import into mitochondrion; P:RNA polyadenylation; P:rRNA import into mitochondrion;|Q8TCS8 Q53SU0 Q68CN1 Q7Z7D1 Q8IWX1 Q96T05 Q9BRU3 Q9BVX0,Polyribonucleotide nucleotidyltransferase 1, mitochondrial,3'-5' RNA exonuclease OLD35;PNPase old-35;Polynucleotide phosphorylase 1;Polynucleotide phosphorylase-like protein;, PF00013;PF03726;PF01138;PF03725;PF00575;, GO:0005737;GO:0005829;GO:0005789;GO:0045025;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0042788;GO:0000175;GO:0035198;GO:0034046;GO:0008266;GO:0004654;GO:0003723;GO:0035458;GO:0034599;GO:0097421;GO:0000958;GO:0097222;GO:0000965;GO:0000964;GO:0000957;GO:0070584;GO:0071850;GO:0006402;GO:0045926;GO:0071042;GO:2000627;GO:0000962;GO:0061014;GO:0051260;GO:0070207;GO:0043457;GO:2000772;GO:0051591;GO:0060416;GO:0006401;GO:0035927;GO:0043631;GO:0035928;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial degradosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:polysomal ribosome;, F:3'-5'-exoribonuclease activity; F:miRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:polyribonucleotide nucleotidyltransferase activity; F:RNA binding;, P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:liver regeneration; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA polyadenylation; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA 5'-end processing; P:mitochondrial RNA catabolic process; P:mitochondrion morphogenesis; P:mitotic cell cycle arrest; P:mRNA catabolic process; P:negative regulation of growth; P:nuclear polyadenylation-dependent mRNA catabolic process; P:positive regulation of miRNA catabolic process; P:positive regulation of mitochondrial RNA catabolic process; P:positive regulation of mRNA catabolic process; P:protein homooligomerization; P:protein homotrimerization; P:regulation of cellular respiration; P:regulation of cellular senescence; P:response to cAMP; P:response to growth hormone; P:RNA catabolic process; P:RNA import into mitochondrion; P:RNA polyadenylation; P:rRNA import into mitochondrion;|Q8TCS8 Q53SU0 Q68CN1 Q7Z7D1 Q8IWX1 Q96T05 Q9BRU3 Q9BVX0,Polyribonucleotide nucleotidyltransferase 1, mitochondrial,3'-5' RNA exonuclease OLD35;PNPase old-35;Polynucleotide phosphorylase 1;Polynucleotide phosphorylase-like protein;, PF00013;PF03726;PF01138;PF03725;PF00575;, GO:0005737;GO:0005829;GO:0005789;GO:0045025;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0042788;GO:0000175;GO:0035198;GO:0034046;GO:0008266;GO:0004654;GO:0003723;GO:0035458;GO:0034599;GO:0097421;GO:0000958;GO:0097222;GO:0000965;GO:0000964;GO:0000957;GO:0070584;GO:0071850;GO:0006402;GO:0045926;GO:0071042;GO:2000627;GO:0000962;GO:0061014;GO:0051260;GO:0070207;GO:0043457;GO:2000772;GO:0051591;GO:0060416;GO:0006401;GO:0035927;GO:0043631;GO:0035928;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial degradosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:polysomal ribosome;, F:3'-5'-exoribonuclease activity; F:miRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:polyribonucleotide nucleotidyltransferase activity; F:RNA binding;, P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:liver regeneration; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA polyadenylation; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA 5'-end processing; P:mitochondrial RNA catabolic process; P:mitochondrion morphogenesis; P:mitotic cell cycle arrest; P:mRNA catabolic process; P:negative regulation of growth; P:nuclear polyadenylation-dependent mRNA catabolic process; P:positive regulation of miRNA catabolic process; P:positive regulation of mitochondrial RNA catabolic process; P:positive regulation of mRNA catabolic process; P:protein homooligomerization; P:protein homotrimerization; P:regulation of cellular respiration; P:regulation of cellular senescence; P:response to cAMP; P:response to growth hormone; P:RNA catabolic process; P:RNA import into mitochondrion; P:RNA polyadenylation; P:rRNA import into mitochondrion;|Q8TCS8 Q53SU0 Q68CN1 Q7Z7D1 Q8IWX1 Q96T05 Q9BRU3 Q9BVX0,Polyribonucleotide nucleotidyltransferase 1, mitochondrial,3'-5' RNA exonuclease OLD35;PNPase old-35;Polynucleotide phosphorylase 1;Polynucleotide phosphorylase-like protein;, PF00013;PF03726;PF01138;PF03725;PF00575;, GO:0005737;GO:0005829;GO:0005789;GO:0045025;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0042788;GO:0000175;GO:0035198;GO:0034046;GO:0008266;GO:0004654;GO:0003723;GO:0035458;GO:0034599;GO:0097421;GO:0000958;GO:0097222;GO:0000965;GO:0000964;GO:0000957;GO:0070584;GO:0071850;GO:0006402;GO:0045926;GO:0071042;GO:2000627;GO:0000962;GO:0061014;GO:0051260;GO:0070207;GO:0043457;GO:2000772;GO:0051591;GO:0060416;GO:0006401;GO:0035927;GO:0043631;GO:0035928;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial degradosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:polysomal ribosome;, F:3'-5'-exoribonuclease activity; F:miRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:polyribonucleotide nucleotidyltransferase activity; F:RNA binding;, P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:liver regeneration; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA polyadenylation; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA 5'-end processing; P:mitochondrial RNA catabolic process; P:mitochondrion morphogenesis; P:mitotic cell cycle arrest; P:mRNA catabolic process; P:negative regulation of growth; P:nuclear polyadenylation-dependent mRNA catabolic process; P:positive regulation of miRNA catabolic process; P:positive regulation of mitochondrial RNA catabolic process; P:positive regulation of mRNA catabolic process; P:protein homooligomerization; P:protein homotrimerization; P:regulation of cellular respiration; P:regulation of cellular senescence; P:response to cAMP; P:response to growth hormone; P:RNA catabolic process; P:RNA import into mitochondrion; P:RNA polyadenylation; P:rRNA import into mitochondrion;|Q8TCS8 Q53SU0 Q68CN1 Q7Z7D1 Q8IWX1 Q96T05 Q9BRU3 Q9BVX0,Polyribonucleotide nucleotidyltransferase 1, mitochondrial,3'-5' RNA exonuclease OLD35;PNPase old-35;Polynucleotide phosphorylase 1;Polynucleotide phosphorylase-like protein;, PF00013;PF03726;PF01138;PF03725;PF00575;, GO:0005737;GO:0005829;GO:0005789;GO:0045025;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0042788;GO:0000175;GO:0035198;GO:0034046;GO:0008266;GO:0004654;GO:0003723;GO:0035458;GO:0034599;GO:0097421;GO:0000958;GO:0097222;GO:0000965;GO:0000964;GO:0000957;GO:0070584;GO:0071850;GO:0006402;GO:0045926;GO:0071042;GO:2000627;GO:0000962;GO:0061014;GO:0051260;GO:0070207;GO:0043457;GO:2000772;GO:0051591;GO:0060416;GO:0006401;GO:0035927;GO:0043631;GO:0035928;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial degradosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:polysomal ribosome;, F:3'-5'-exoribonuclease activity; F:miRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:polyribonucleotide nucleotidyltransferase activity; F:RNA binding;, P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:liver regeneration; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA polyadenylation; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA 5'-end processing; P:mitochondrial RNA catabolic process; P:mitochondrion morphogenesis; P:mitotic cell cycle arrest; P:mRNA catabolic process; P:negative regulation of growth; P:nuclear polyadenylation-dependent mRNA catabolic process; P:positive regulation of miRNA catabolic process; P:positive regulation of mitochondrial RNA catabolic process; P:positive regulation of mRNA catabolic process; P:protein homooligomerization; P:protein homotrimerization; P:regulation of cellular respiration; P:regulation of cellular senescence; P:response to cAMP; P:response to growth hormone; P:RNA catabolic process; P:RNA import into mitochondrion; P:RNA polyadenylation; P:rRNA import into mitochondrion;|Q5MIZ7 Q6P9B0 Q86XB8 Q9BQJ0 Q9BRK2 Q9H913 Q9P2G0,Serine/threonine-protein phosphatase 4 regulatory subunit 3B,SMEK homolog 2;, PF04802;, GO:0005813;GO:0005737;GO:0016607;GO:0005654;GO:0030289;GO:0045722;GO:0006470;GO:0019216;, C:centrosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:protein phosphatase 4 complex;, , P:positive regulation of gluconeogenesis; P:protein dephosphorylation; P:regulation of lipid metabolic process;|Q5MIZ7 Q6P9B0 Q86XB8 Q9BQJ0 Q9BRK2 Q9H913 Q9P2G0,Serine/threonine-protein phosphatase 4 regulatory subunit 3B,SMEK homolog 2;, PF04802;, GO:0005813;GO:0005737;GO:0016607;GO:0005654;GO:0030289;GO:0045722;GO:0006470;GO:0019216;, C:centrosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:protein phosphatase 4 complex;, , P:positive regulation of gluconeogenesis; P:protein dephosphorylation; P:regulation of lipid metabolic process;|Q96G28 Q53SF0 Q53ST9 Q6UY34,Cilia- and flagella-associated protein 36 {ECO:0000312|HGNC:HGNC:30540},Coiled-coil domain-containing protein 104 {ECO:0000312|HGNC:HGNC:30540};, PF11527;, GO:0005930;GO:0097546;GO:0035869;GO:0031514;GO:0005634;GO:0047485;, C:axoneme; C:ciliary base; C:ciliary transition zone; C:motile cilium; C:nucleus;, F:protein N-terminus binding;|Q3V6T2 A1IGE7 B7ZM78 C9JG83 Q53SF1 Q581G3 Q5HYD0 Q7Z339 Q7Z3C5,Girdin,Akt phosphorylation enhancer;Coiled-coil domain-containing protein 88A;G alpha-interacting vesicle-associated protein;Girders of actin filament;Hook-related protein 1;, PF19047;, GO:0005814;GO:0005813;GO:0036064;GO:0030142;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005794;GO:0030027;GO:0016020;GO:0005886;GO:0003779;GO:0051959;GO:0005154;GO:0001965;GO:0031682;GO:0005092;GO:0005085;GO:0005158;GO:0008017;GO:0035091;GO:0042803;GO:0043422;GO:0005080;GO:0042169;GO:0043184;GO:0032147;GO:0032148;GO:0016477;GO:0031122;GO:0030705;GO:0006260;GO:0030032;GO:0072660;GO:0061024;GO:0007399;GO:0045724;GO:0045742;GO:1903566;GO:0051496;GO:0032956;GO:0042127;GO:0006275;GO:0010975;GO:0001932;GO:0007264;GO:0031929;, C:centriole; C:centrosome; C:ciliary basal body; C:COPI-coated Golgi to ER transport vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:membrane; C:plasma membrane;, F:actin binding; F:dynein light intermediate chain binding; F:epidermal growth factor receptor binding; F:G-protein alpha-subunit binding; F:G-protein gamma-subunit binding; F:GDP-dissociation inhibitor activity; F:guanyl-nucleotide exchange factor activity; F:insulin receptor binding; F:microtubule binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein kinase C binding; F:SH2 domain binding; F:vascular endothelial growth factor receptor 2 binding;, P:activation of protein kinase activity; P:activation of protein kinase B activity; P:cell migration; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:DNA replication; P:lamellipodium assembly; P:maintenance of protein location in plasma membrane; P:membrane organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of protein localization to cilium; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell population proliferation; P:regulation of DNA replication; P:regulation of neuron projection development; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:TOR signaling;|Q3V6T2 A1IGE7 B7ZM78 C9JG83 Q53SF1 Q581G3 Q5HYD0 Q7Z339 Q7Z3C5,Girdin,Akt phosphorylation enhancer;Coiled-coil domain-containing protein 88A;G alpha-interacting vesicle-associated protein;Girders of actin filament;Hook-related protein 1;, PF19047;, GO:0005814;GO:0005813;GO:0036064;GO:0030142;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005794;GO:0030027;GO:0016020;GO:0005886;GO:0003779;GO:0051959;GO:0005154;GO:0001965;GO:0031682;GO:0005092;GO:0005085;GO:0005158;GO:0008017;GO:0035091;GO:0042803;GO:0043422;GO:0005080;GO:0042169;GO:0043184;GO:0032147;GO:0032148;GO:0016477;GO:0031122;GO:0030705;GO:0006260;GO:0030032;GO:0072660;GO:0061024;GO:0007399;GO:0045724;GO:0045742;GO:1903566;GO:0051496;GO:0032956;GO:0042127;GO:0006275;GO:0010975;GO:0001932;GO:0007264;GO:0031929;, C:centriole; C:centrosome; C:ciliary basal body; C:COPI-coated Golgi to ER transport vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:membrane; C:plasma membrane;, F:actin binding; F:dynein light intermediate chain binding; F:epidermal growth factor receptor binding; F:G-protein alpha-subunit binding; F:G-protein gamma-subunit binding; F:GDP-dissociation inhibitor activity; F:guanyl-nucleotide exchange factor activity; F:insulin receptor binding; F:microtubule binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein kinase C binding; F:SH2 domain binding; F:vascular endothelial growth factor receptor 2 binding;, P:activation of protein kinase activity; P:activation of protein kinase B activity; P:cell migration; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:DNA replication; P:lamellipodium assembly; P:maintenance of protein location in plasma membrane; P:membrane organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of protein localization to cilium; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell population proliferation; P:regulation of DNA replication; P:regulation of neuron projection development; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:TOR signaling;|Q3V6T2 A1IGE7 B7ZM78 C9JG83 Q53SF1 Q581G3 Q5HYD0 Q7Z339 Q7Z3C5,Girdin,Akt phosphorylation enhancer;Coiled-coil domain-containing protein 88A;G alpha-interacting vesicle-associated protein;Girders of actin filament;Hook-related protein 1;, PF19047;, GO:0005814;GO:0005813;GO:0036064;GO:0030142;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005794;GO:0030027;GO:0016020;GO:0005886;GO:0003779;GO:0051959;GO:0005154;GO:0001965;GO:0031682;GO:0005092;GO:0005085;GO:0005158;GO:0008017;GO:0035091;GO:0042803;GO:0043422;GO:0005080;GO:0042169;GO:0043184;GO:0032147;GO:0032148;GO:0016477;GO:0031122;GO:0030705;GO:0006260;GO:0030032;GO:0072660;GO:0061024;GO:0007399;GO:0045724;GO:0045742;GO:1903566;GO:0051496;GO:0032956;GO:0042127;GO:0006275;GO:0010975;GO:0001932;GO:0007264;GO:0031929;, C:centriole; C:centrosome; C:ciliary basal body; C:COPI-coated Golgi to ER transport vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:membrane; C:plasma membrane;, F:actin binding; F:dynein light intermediate chain binding; F:epidermal growth factor receptor binding; F:G-protein alpha-subunit binding; F:G-protein gamma-subunit binding; F:GDP-dissociation inhibitor activity; F:guanyl-nucleotide exchange factor activity; F:insulin receptor binding; F:microtubule binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein kinase C binding; F:SH2 domain binding; F:vascular endothelial growth factor receptor 2 binding;, P:activation of protein kinase activity; P:activation of protein kinase B activity; P:cell migration; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:DNA replication; P:lamellipodium assembly; P:maintenance of protein location in plasma membrane; P:membrane organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of protein localization to cilium; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell population proliferation; P:regulation of DNA replication; P:regulation of neuron projection development; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:TOR signaling;|Q3V6T2 A1IGE7 B7ZM78 C9JG83 Q53SF1 Q581G3 Q5HYD0 Q7Z339 Q7Z3C5,Girdin,Akt phosphorylation enhancer;Coiled-coil domain-containing protein 88A;G alpha-interacting vesicle-associated protein;Girders of actin filament;Hook-related protein 1;, PF19047;, GO:0005814;GO:0005813;GO:0036064;GO:0030142;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005794;GO:0030027;GO:0016020;GO:0005886;GO:0003779;GO:0051959;GO:0005154;GO:0001965;GO:0031682;GO:0005092;GO:0005085;GO:0005158;GO:0008017;GO:0035091;GO:0042803;GO:0043422;GO:0005080;GO:0042169;GO:0043184;GO:0032147;GO:0032148;GO:0016477;GO:0031122;GO:0030705;GO:0006260;GO:0030032;GO:0072660;GO:0061024;GO:0007399;GO:0045724;GO:0045742;GO:1903566;GO:0051496;GO:0032956;GO:0042127;GO:0006275;GO:0010975;GO:0001932;GO:0007264;GO:0031929;, C:centriole; C:centrosome; C:ciliary basal body; C:COPI-coated Golgi to ER transport vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:membrane; C:plasma membrane;, F:actin binding; F:dynein light intermediate chain binding; F:epidermal growth factor receptor binding; F:G-protein alpha-subunit binding; F:G-protein gamma-subunit binding; F:GDP-dissociation inhibitor activity; F:guanyl-nucleotide exchange factor activity; F:insulin receptor binding; F:microtubule binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein kinase C binding; F:SH2 domain binding; F:vascular endothelial growth factor receptor 2 binding;, P:activation of protein kinase activity; P:activation of protein kinase B activity; P:cell migration; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:DNA replication; P:lamellipodium assembly; P:maintenance of protein location in plasma membrane; P:membrane organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of protein localization to cilium; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell population proliferation; P:regulation of DNA replication; P:regulation of neuron projection development; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:TOR signaling;|Q3V6T2 A1IGE7 B7ZM78 C9JG83 Q53SF1 Q581G3 Q5HYD0 Q7Z339 Q7Z3C5,Girdin,Akt phosphorylation enhancer;Coiled-coil domain-containing protein 88A;G alpha-interacting vesicle-associated protein;Girders of actin filament;Hook-related protein 1;, PF19047;, GO:0005814;GO:0005813;GO:0036064;GO:0030142;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005794;GO:0030027;GO:0016020;GO:0005886;GO:0003779;GO:0051959;GO:0005154;GO:0001965;GO:0031682;GO:0005092;GO:0005085;GO:0005158;GO:0008017;GO:0035091;GO:0042803;GO:0043422;GO:0005080;GO:0042169;GO:0043184;GO:0032147;GO:0032148;GO:0016477;GO:0031122;GO:0030705;GO:0006260;GO:0030032;GO:0072660;GO:0061024;GO:0007399;GO:0045724;GO:0045742;GO:1903566;GO:0051496;GO:0032956;GO:0042127;GO:0006275;GO:0010975;GO:0001932;GO:0007264;GO:0031929;, C:centriole; C:centrosome; C:ciliary basal body; C:COPI-coated Golgi to ER transport vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:membrane; C:plasma membrane;, F:actin binding; F:dynein light intermediate chain binding; F:epidermal growth factor receptor binding; F:G-protein alpha-subunit binding; F:G-protein gamma-subunit binding; F:GDP-dissociation inhibitor activity; F:guanyl-nucleotide exchange factor activity; F:insulin receptor binding; F:microtubule binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein kinase C binding; F:SH2 domain binding; F:vascular endothelial growth factor receptor 2 binding;, P:activation of protein kinase activity; P:activation of protein kinase B activity; P:cell migration; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:DNA replication; P:lamellipodium assembly; P:maintenance of protein location in plasma membrane; P:membrane organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of protein localization to cilium; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell population proliferation; P:regulation of DNA replication; P:regulation of neuron projection development; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:TOR signaling;|Q3V6T2 A1IGE7 B7ZM78 C9JG83 Q53SF1 Q581G3 Q5HYD0 Q7Z339 Q7Z3C5,Girdin,Akt phosphorylation enhancer;Coiled-coil domain-containing protein 88A;G alpha-interacting vesicle-associated protein;Girders of actin filament;Hook-related protein 1;, PF19047;, GO:0005814;GO:0005813;GO:0036064;GO:0030142;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005794;GO:0030027;GO:0016020;GO:0005886;GO:0003779;GO:0051959;GO:0005154;GO:0001965;GO:0031682;GO:0005092;GO:0005085;GO:0005158;GO:0008017;GO:0035091;GO:0042803;GO:0043422;GO:0005080;GO:0042169;GO:0043184;GO:0032147;GO:0032148;GO:0016477;GO:0031122;GO:0030705;GO:0006260;GO:0030032;GO:0072660;GO:0061024;GO:0007399;GO:0045724;GO:0045742;GO:1903566;GO:0051496;GO:0032956;GO:0042127;GO:0006275;GO:0010975;GO:0001932;GO:0007264;GO:0031929;, C:centriole; C:centrosome; C:ciliary basal body; C:COPI-coated Golgi to ER transport vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:membrane; C:plasma membrane;, F:actin binding; F:dynein light intermediate chain binding; F:epidermal growth factor receptor binding; F:G-protein alpha-subunit binding; F:G-protein gamma-subunit binding; F:GDP-dissociation inhibitor activity; F:guanyl-nucleotide exchange factor activity; F:insulin receptor binding; F:microtubule binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein kinase C binding; F:SH2 domain binding; F:vascular endothelial growth factor receptor 2 binding;, P:activation of protein kinase activity; P:activation of protein kinase B activity; P:cell migration; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:DNA replication; P:lamellipodium assembly; P:maintenance of protein location in plasma membrane; P:membrane organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of protein localization to cilium; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell population proliferation; P:regulation of DNA replication; P:regulation of neuron projection development; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:TOR signaling;|Q3V6T2 A1IGE7 B7ZM78 C9JG83 Q53SF1 Q581G3 Q5HYD0 Q7Z339 Q7Z3C5,Girdin,Akt phosphorylation enhancer;Coiled-coil domain-containing protein 88A;G alpha-interacting vesicle-associated protein;Girders of actin filament;Hook-related protein 1;, PF19047;, GO:0005814;GO:0005813;GO:0036064;GO:0030142;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005794;GO:0030027;GO:0016020;GO:0005886;GO:0003779;GO:0051959;GO:0005154;GO:0001965;GO:0031682;GO:0005092;GO:0005085;GO:0005158;GO:0008017;GO:0035091;GO:0042803;GO:0043422;GO:0005080;GO:0042169;GO:0043184;GO:0032147;GO:0032148;GO:0016477;GO:0031122;GO:0030705;GO:0006260;GO:0030032;GO:0072660;GO:0061024;GO:0007399;GO:0045724;GO:0045742;GO:1903566;GO:0051496;GO:0032956;GO:0042127;GO:0006275;GO:0010975;GO:0001932;GO:0007264;GO:0031929;, C:centriole; C:centrosome; C:ciliary basal body; C:COPI-coated Golgi to ER transport vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:membrane; C:plasma membrane;, F:actin binding; F:dynein light intermediate chain binding; F:epidermal growth factor receptor binding; F:G-protein alpha-subunit binding; F:G-protein gamma-subunit binding; F:GDP-dissociation inhibitor activity; F:guanyl-nucleotide exchange factor activity; F:insulin receptor binding; F:microtubule binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein kinase C binding; F:SH2 domain binding; F:vascular endothelial growth factor receptor 2 binding;, P:activation of protein kinase activity; P:activation of protein kinase B activity; P:cell migration; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:DNA replication; P:lamellipodium assembly; P:maintenance of protein location in plasma membrane; P:membrane organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of protein localization to cilium; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell population proliferation; P:regulation of DNA replication; P:regulation of neuron projection development; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:TOR signaling;|Q3V6T2 A1IGE7 B7ZM78 C9JG83 Q53SF1 Q581G3 Q5HYD0 Q7Z339 Q7Z3C5,Girdin,Akt phosphorylation enhancer;Coiled-coil domain-containing protein 88A;G alpha-interacting vesicle-associated protein;Girders of actin filament;Hook-related protein 1;, PF19047;, GO:0005814;GO:0005813;GO:0036064;GO:0030142;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005794;GO:0030027;GO:0016020;GO:0005886;GO:0003779;GO:0051959;GO:0005154;GO:0001965;GO:0031682;GO:0005092;GO:0005085;GO:0005158;GO:0008017;GO:0035091;GO:0042803;GO:0043422;GO:0005080;GO:0042169;GO:0043184;GO:0032147;GO:0032148;GO:0016477;GO:0031122;GO:0030705;GO:0006260;GO:0030032;GO:0072660;GO:0061024;GO:0007399;GO:0045724;GO:0045742;GO:1903566;GO:0051496;GO:0032956;GO:0042127;GO:0006275;GO:0010975;GO:0001932;GO:0007264;GO:0031929;, C:centriole; C:centrosome; C:ciliary basal body; C:COPI-coated Golgi to ER transport vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:membrane; C:plasma membrane;, F:actin binding; F:dynein light intermediate chain binding; F:epidermal growth factor receptor binding; F:G-protein alpha-subunit binding; F:G-protein gamma-subunit binding; F:GDP-dissociation inhibitor activity; F:guanyl-nucleotide exchange factor activity; F:insulin receptor binding; F:microtubule binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein kinase C binding; F:SH2 domain binding; F:vascular endothelial growth factor receptor 2 binding;, P:activation of protein kinase activity; P:activation of protein kinase B activity; P:cell migration; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:DNA replication; P:lamellipodium assembly; P:maintenance of protein location in plasma membrane; P:membrane organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of protein localization to cilium; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell population proliferation; P:regulation of DNA replication; P:regulation of neuron projection development; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:TOR signaling;|Q3V6T2 A1IGE7 B7ZM78 C9JG83 Q53SF1 Q581G3 Q5HYD0 Q7Z339 Q7Z3C5,Girdin,Akt phosphorylation enhancer;Coiled-coil domain-containing protein 88A;G alpha-interacting vesicle-associated protein;Girders of actin filament;Hook-related protein 1;, PF19047;, GO:0005814;GO:0005813;GO:0036064;GO:0030142;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005794;GO:0030027;GO:0016020;GO:0005886;GO:0003779;GO:0051959;GO:0005154;GO:0001965;GO:0031682;GO:0005092;GO:0005085;GO:0005158;GO:0008017;GO:0035091;GO:0042803;GO:0043422;GO:0005080;GO:0042169;GO:0043184;GO:0032147;GO:0032148;GO:0016477;GO:0031122;GO:0030705;GO:0006260;GO:0030032;GO:0072660;GO:0061024;GO:0007399;GO:0045724;GO:0045742;GO:1903566;GO:0051496;GO:0032956;GO:0042127;GO:0006275;GO:0010975;GO:0001932;GO:0007264;GO:0031929;, C:centriole; C:centrosome; C:ciliary basal body; C:COPI-coated Golgi to ER transport vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:membrane; C:plasma membrane;, F:actin binding; F:dynein light intermediate chain binding; F:epidermal growth factor receptor binding; F:G-protein alpha-subunit binding; F:G-protein gamma-subunit binding; F:GDP-dissociation inhibitor activity; F:guanyl-nucleotide exchange factor activity; F:insulin receptor binding; F:microtubule binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein kinase C binding; F:SH2 domain binding; F:vascular endothelial growth factor receptor 2 binding;, P:activation of protein kinase activity; P:activation of protein kinase B activity; P:cell migration; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:DNA replication; P:lamellipodium assembly; P:maintenance of protein location in plasma membrane; P:membrane organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of protein localization to cilium; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell population proliferation; P:regulation of DNA replication; P:regulation of neuron projection development; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:TOR signaling;|A6NEY8,Putative prolyl-tRNA synthetase associated domain-containing protein 1,PrdX deacylase domain-containing protein 1;Prolyl-tRNA synthetase associated domain-containing protein 1 pseudogene;, PF04073;, GO:0002161;, , F:aminoacyl-tRNA editing activity;|P46199 D6W5D0,Translation initiation factor IF-2, mitochondrial,, PF00009;PF11987;, GO:0005739;GO:0005654;GO:0005525;GO:0003924;GO:0043024;GO:0003723;GO:0008135;GO:0003743;GO:0070124;GO:0006446;GO:0032790;, C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:GTPase activity; F:ribosomal small subunit binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:mitochondrial translational initiation; P:regulation of translational initiation; P:ribosome disassembly;|P46199 D6W5D0,Translation initiation factor IF-2, mitochondrial,, PF00009;PF11987;, GO:0005739;GO:0005654;GO:0005525;GO:0003924;GO:0043024;GO:0003723;GO:0008135;GO:0003743;GO:0070124;GO:0006446;GO:0032790;, C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:GTPase activity; F:ribosomal small subunit binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:mitochondrial translational initiation; P:regulation of translational initiation; P:ribosome disassembly;|P46199 D6W5D0,Translation initiation factor IF-2, mitochondrial,, PF00009;PF11987;, GO:0005739;GO:0005654;GO:0005525;GO:0003924;GO:0043024;GO:0003723;GO:0008135;GO:0003743;GO:0070124;GO:0006446;GO:0032790;, C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:GTPase activity; F:ribosomal small subunit binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:mitochondrial translational initiation; P:regulation of translational initiation; P:ribosome disassembly;|P46199 D6W5D0,Translation initiation factor IF-2, mitochondrial,, PF00009;PF11987;, GO:0005739;GO:0005654;GO:0005525;GO:0003924;GO:0043024;GO:0003723;GO:0008135;GO:0003743;GO:0070124;GO:0006446;GO:0032790;, C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:GTPase activity; F:ribosomal small subunit binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:mitochondrial translational initiation; P:regulation of translational initiation; P:ribosome disassembly;|P46199 D6W5D0,Translation initiation factor IF-2, mitochondrial,, PF00009;PF11987;, GO:0005739;GO:0005654;GO:0005525;GO:0003924;GO:0043024;GO:0003723;GO:0008135;GO:0003743;GO:0070124;GO:0006446;GO:0032790;, C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:GTPase activity; F:ribosomal small subunit binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:mitochondrial translational initiation; P:regulation of translational initiation; P:ribosome disassembly;|P46199 D6W5D0,Translation initiation factor IF-2, mitochondrial,, PF00009;PF11987;, GO:0005739;GO:0005654;GO:0005525;GO:0003924;GO:0043024;GO:0003723;GO:0008135;GO:0003743;GO:0070124;GO:0006446;GO:0032790;, C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:GTPase activity; F:ribosomal small subunit binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:mitochondrial translational initiation; P:regulation of translational initiation; P:ribosome disassembly;|P46199 D6W5D0,Translation initiation factor IF-2, mitochondrial,, PF00009;PF11987;, GO:0005739;GO:0005654;GO:0005525;GO:0003924;GO:0043024;GO:0003723;GO:0008135;GO:0003743;GO:0070124;GO:0006446;GO:0032790;, C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:GTPase activity; F:ribosomal small subunit binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:mitochondrial translational initiation; P:regulation of translational initiation; P:ribosome disassembly;|Q9UPK7,Ubiquitin-40S ribosomal protein S27a,Ubiquitin carboxyl extension protein 80;, PF01599;PF00240;, GO:0005737;GO:0005829;GO:0022627;GO:0030666;GO:0005789;GO:0010008;GO:0070062;GO:0005615;GO:0043657;GO:0016020;GO:0005741;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0015935;GO:0031982;GO:0046872;GO:0031386;GO:0003723;GO:0003735;GO:0031625;GO:0000187;GO:0035973;GO:1990000;GO:0031145;GO:0019221;GO:0002753;GO:0042769;GO:1904380;GO:0016197;GO:0070987;GO:0042276;GO:0070911;GO:0007249;GO:0070498;GO:0036297;GO:0075733;GO:0007254;GO:0061024;GO:0019941;GO:0052031;GO:0002755;GO:0002756;GO:0043066;GO:0000122;GO:0030512;GO:0000184;GO:0070423;GO:0000715;GO:0000717;GO:0006297;GO:0033683;GO:0006296;GO:0006294;GO:0043065;GO:0051092;GO:0045944;GO:0036388;GO:0016579;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:0043488;GO:0061418;GO:0006614;GO:0051403;GO:0006283;GO:0007179;GO:0006412;GO:0006413;GO:0019985;GO:0055085;GO:0035666;GO:0019058;GO:0019083;GO:0019081;GO:0019068;GO:0016055;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:host cell; C:membrane; C:mitochondrial outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:small ribosomal subunit; C:vesicle;, F:metal ion binding; F:protein tag; F:RNA binding; F:structural constituent of ribosome; F:ubiquitin protein ligase binding;, P:activation of MAPK activity; P:aggrephagy; P:amyloid fibril formation; P:anaphase-promoting complex-dependent catabolic process; P:cytokine-mediated signaling pathway; P:cytoplasmic pattern recognition receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:endoplasmic reticulum mannose trimming; P:endosomal transport; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:global genome nucleotide-excision repair; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:interstrand cross-link repair; P:intracellular transport of virus; P:JNK cascade; P:membrane organization; P:modification-dependent protein catabolic process; P:modulation by symbiont of host defense response; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nucleotide-binding oligomerization domain containing signaling pathway; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly; P:protein deubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SRP-dependent cotranslational protein targeting to membrane; P:stress-activated MAPK cascade; P:transcription-coupled nucleotide-excision repair; P:transforming growth factor beta receptor signaling pathway; P:translation; P:translational initiation; P:translesion synthesis; P:transmembrane transport; P:TRIF-dependent toll-like receptor signaling pathway; P:viral life cycle; P:viral transcription; P:viral translation; P:virion assembly; P:Wnt signaling pathway;|Q8WYN8 Q91887 Q91888 Q9BWD6 Q9BX98 Q9UEF2 Q9UEG1 Q9UEK8 Q9UPK7,Ubiquitin-60S ribosomal protein L40,CEP52;Ubiquitin A-52 residue ribosomal protein fusion product 1;, PF01020;PF00240;, GO:0005737;GO:0005829;GO:0022625;GO:0022627;GO:0030666;GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005615;GO:0043657;GO:0005765;GO:0005741;GO:0005654;GO:0005634;GO:0005886;GO:0031982;GO:0031386;GO:0003735;GO:0031625;GO:0000187;GO:0035973;GO:1990000;GO:0031145;GO:0006464;GO:0019221;GO:0002753;GO:0042769;GO:1904380;GO:0016197;GO:0070987;GO:0042276;GO:0070911;GO:0007249;GO:0070498;GO:0036297;GO:0075733;GO:0007254;GO:0061024;GO:0019941;GO:0052031;GO:0002755;GO:0002756;GO:0043066;GO:0000122;GO:0030512;GO:0000184;GO:0070423;GO:0000715;GO:0000717;GO:0006297;GO:0033683;GO:0006296;GO:0006294;GO:0043065;GO:0051092;GO:0045944;GO:0036388;GO:0016579;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:0043488;GO:0061418;GO:0006364;GO:0006614;GO:0051403;GO:0006283;GO:0007179;GO:0006412;GO:0006413;GO:0019985;GO:0055085;GO:0035666;GO:0019058;GO:0019083;GO:0019081;GO:0019068;GO:0016055;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:cytosolic small ribosomal subunit; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:host cell; C:lysosomal membrane; C:mitochondrial outer membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle;, F:protein tag; F:structural constituent of ribosome; F:ubiquitin protein ligase binding;, P:activation of MAPK activity; P:aggrephagy; P:amyloid fibril formation; P:anaphase-promoting complex-dependent catabolic process; P:cellular protein modification process; P:cytokine-mediated signaling pathway; P:cytoplasmic pattern recognition receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:endoplasmic reticulum mannose trimming; P:endosomal transport; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:global genome nucleotide-excision repair; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:interstrand cross-link repair; P:intracellular transport of virus; P:JNK cascade; P:membrane organization; P:modification-dependent protein catabolic process; P:modulation by symbiont of host defense response; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nucleotide-binding oligomerization domain containing signaling pathway; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly; P:protein deubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:stress-activated MAPK cascade; P:transcription-coupled nucleotide-excision repair; P:transforming growth factor beta receptor signaling pathway; P:translation; P:translational initiation; P:translesion synthesis; P:transmembrane transport; P:TRIF-dependent toll-like receptor signaling pathway; P:viral life cycle; P:viral transcription; P:viral translation; P:virion assembly; P:Wnt signaling pathway;|Q8NHS4 B2RDV1 Q53R93 Q8N403,Clathrin heavy chain linker domain-containing protein 1,, PF15739;|Q8NHS4 B2RDV1 Q53R93 Q8N403,Clathrin heavy chain linker domain-containing protein 1,, PF15739;|Q6ZMW3 A8MUB5 B6ZDG7,Echinoderm microtubule-associated protein-like 6,Echinoderm microtubule-associated protein-like 5-like;, PF12894;PF03451;PF00400;, GO:0005737;GO:0005874;GO:0008017;, C:cytoplasm; C:microtubule;, F:microtubule binding;|Q9H3I3 Q9UQ42 Q9Y293 Q9Y2Y7 Q9Y5U6,Reticulon-4 {ECO:0000305},Foocen;Neurite outgrowth inhibitor;Neuroendocrine-specific protein;Neuroendocrine-specific protein C homolog;RTN-x;Reticulon-5;, PF02453;, GO:0030054;GO:0042995;GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0030176;GO:0043025;GO:0005635;GO:0005886;GO:0014069;GO:0045296;GO:0042803;GO:0003723;GO:0031625;GO:0006915;GO:0007413;GO:0001825;GO:0060317;GO:0120078;GO:0035441;GO:0071456;GO:0090156;GO:0022009;GO:0021801;GO:0007029;GO:0071787;GO:1990809;GO:0071786;GO:0002523;GO:1902430;GO:0030517;GO:0050771;GO:0030308;GO:2001213;GO:0051292;GO:0045766;GO:1905653;GO:0010634;GO:1905580;GO:2000347;GO:0060907;GO:1905523;GO:0033601;GO:1902624;GO:0051897;GO:1905552;GO:0035022;GO:0034165;GO:0061462;GO:0050821;GO:0042981;GO:2000172;GO:0030334;, C:cell junction; C:cell projection; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:integral component of endoplasmic reticulum membrane; C:neuronal cell body; C:nuclear envelope; C:plasma membrane; C:postsynaptic density;, F:cadherin binding; F:protein homodimerization activity; F:RNA binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:axonal fasciculation; P:blastocyst formation; P:cardiac epithelial to mesenchymal transition; P:cell adhesion involved in sprouting angiogenesis; P:cell migration involved in vasculogenesis; P:cellular response to hypoxia; P:cellular sphingolipid homeostasis; P:central nervous system vasculogenesis; P:cerebral cortex radial glia guided migration; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network membrane organization; P:endoplasmic reticulum tubular network organization; P:leukocyte migration involved in inflammatory response; P:negative regulation of amyloid-beta formation; P:negative regulation of axon extension; P:negative regulation of axonogenesis; P:negative regulation of cell growth; P:negative regulation of vasculogenesis; P:nuclear pore complex assembly; P:positive regulation of angiogenesis; P:positive regulation of artery morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of ERBB3 signaling pathway; P:positive regulation of hepatocyte proliferation; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage migration; P:positive regulation of mammary gland epithelial cell proliferation; P:positive regulation of neutrophil migration; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to endoplasmic reticulum; P:positive regulation of Rac protein signal transduction; P:positive regulation of toll-like receptor 9 signaling pathway; P:protein localization to lysosome; P:protein stabilization; P:regulation of apoptotic process; P:regulation of branching morphogenesis of a nerve; P:regulation of cell migration;|Q9H3I3 Q9UQ42 Q9Y293 Q9Y2Y7 Q9Y5U6,Reticulon-4 {ECO:0000305},Foocen;Neurite outgrowth inhibitor;Neuroendocrine-specific protein;Neuroendocrine-specific protein C homolog;RTN-x;Reticulon-5;, PF02453;, GO:0030054;GO:0042995;GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0030176;GO:0043025;GO:0005635;GO:0005886;GO:0014069;GO:0045296;GO:0042803;GO:0003723;GO:0031625;GO:0006915;GO:0007413;GO:0001825;GO:0060317;GO:0120078;GO:0035441;GO:0071456;GO:0090156;GO:0022009;GO:0021801;GO:0007029;GO:0071787;GO:1990809;GO:0071786;GO:0002523;GO:1902430;GO:0030517;GO:0050771;GO:0030308;GO:2001213;GO:0051292;GO:0045766;GO:1905653;GO:0010634;GO:1905580;GO:2000347;GO:0060907;GO:1905523;GO:0033601;GO:1902624;GO:0051897;GO:1905552;GO:0035022;GO:0034165;GO:0061462;GO:0050821;GO:0042981;GO:2000172;GO:0030334;, C:cell junction; C:cell projection; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:integral component of endoplasmic reticulum membrane; C:neuronal cell body; C:nuclear envelope; C:plasma membrane; C:postsynaptic density;, F:cadherin binding; F:protein homodimerization activity; F:RNA binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:axonal fasciculation; P:blastocyst formation; P:cardiac epithelial to mesenchymal transition; P:cell adhesion involved in sprouting angiogenesis; P:cell migration involved in vasculogenesis; P:cellular response to hypoxia; P:cellular sphingolipid homeostasis; P:central nervous system vasculogenesis; P:cerebral cortex radial glia guided migration; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network membrane organization; P:endoplasmic reticulum tubular network organization; P:leukocyte migration involved in inflammatory response; P:negative regulation of amyloid-beta formation; P:negative regulation of axon extension; P:negative regulation of axonogenesis; P:negative regulation of cell growth; P:negative regulation of vasculogenesis; P:nuclear pore complex assembly; P:positive regulation of angiogenesis; P:positive regulation of artery morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of ERBB3 signaling pathway; P:positive regulation of hepatocyte proliferation; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage migration; P:positive regulation of mammary gland epithelial cell proliferation; P:positive regulation of neutrophil migration; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to endoplasmic reticulum; P:positive regulation of Rac protein signal transduction; P:positive regulation of toll-like receptor 9 signaling pathway; P:protein localization to lysosome; P:protein stabilization; P:regulation of apoptotic process; P:regulation of branching morphogenesis of a nerve; P:regulation of cell migration;|Q9H3I3 Q9UQ42 Q9Y293 Q9Y2Y7 Q9Y5U6,Reticulon-4 {ECO:0000305},Foocen;Neurite outgrowth inhibitor;Neuroendocrine-specific protein;Neuroendocrine-specific protein C homolog;RTN-x;Reticulon-5;, PF02453;, GO:0030054;GO:0042995;GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0030176;GO:0043025;GO:0005635;GO:0005886;GO:0014069;GO:0045296;GO:0042803;GO:0003723;GO:0031625;GO:0006915;GO:0007413;GO:0001825;GO:0060317;GO:0120078;GO:0035441;GO:0071456;GO:0090156;GO:0022009;GO:0021801;GO:0007029;GO:0071787;GO:1990809;GO:0071786;GO:0002523;GO:1902430;GO:0030517;GO:0050771;GO:0030308;GO:2001213;GO:0051292;GO:0045766;GO:1905653;GO:0010634;GO:1905580;GO:2000347;GO:0060907;GO:1905523;GO:0033601;GO:1902624;GO:0051897;GO:1905552;GO:0035022;GO:0034165;GO:0061462;GO:0050821;GO:0042981;GO:2000172;GO:0030334;, C:cell junction; C:cell projection; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:integral component of endoplasmic reticulum membrane; C:neuronal cell body; C:nuclear envelope; C:plasma membrane; C:postsynaptic density;, F:cadherin binding; F:protein homodimerization activity; F:RNA binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:axonal fasciculation; P:blastocyst formation; P:cardiac epithelial to mesenchymal transition; P:cell adhesion involved in sprouting angiogenesis; P:cell migration involved in vasculogenesis; P:cellular response to hypoxia; P:cellular sphingolipid homeostasis; P:central nervous system vasculogenesis; P:cerebral cortex radial glia guided migration; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network membrane organization; P:endoplasmic reticulum tubular network organization; P:leukocyte migration involved in inflammatory response; P:negative regulation of amyloid-beta formation; P:negative regulation of axon extension; P:negative regulation of axonogenesis; P:negative regulation of cell growth; P:negative regulation of vasculogenesis; P:nuclear pore complex assembly; P:positive regulation of angiogenesis; P:positive regulation of artery morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of ERBB3 signaling pathway; P:positive regulation of hepatocyte proliferation; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage migration; P:positive regulation of mammary gland epithelial cell proliferation; P:positive regulation of neutrophil migration; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to endoplasmic reticulum; P:positive regulation of Rac protein signal transduction; P:positive regulation of toll-like receptor 9 signaling pathway; P:protein localization to lysosome; P:protein stabilization; P:regulation of apoptotic process; P:regulation of branching morphogenesis of a nerve; P:regulation of cell migration;|Q6ZMW3 A8MUB5 B6ZDG7,Echinoderm microtubule-associated protein-like 6,Echinoderm microtubule-associated protein-like 5-like;, PF12894;PF03451;PF00400;, GO:0005737;GO:0005874;GO:0008017;, C:cytoplasm; C:microtubule;, F:microtubule binding;|Q6ZMW3 A8MUB5 B6ZDG7,Echinoderm microtubule-associated protein-like 6,Echinoderm microtubule-associated protein-like 5-like;, PF12894;PF03451;PF00400;, GO:0005737;GO:0005874;GO:0008017;, C:cytoplasm; C:microtubule;, F:microtubule binding;|Q6ZMW3 A8MUB5 B6ZDG7,Echinoderm microtubule-associated protein-like 6,Echinoderm microtubule-associated protein-like 5-like;, PF12894;PF03451;PF00400;, GO:0005737;GO:0005874;GO:0008017;, C:cytoplasm; C:microtubule;, F:microtubule binding;|Q6ZMW3 A8MUB5 B6ZDG7,Echinoderm microtubule-associated protein-like 6,Echinoderm microtubule-associated protein-like 5-like;, PF12894;PF03451;PF00400;, GO:0005737;GO:0005874;GO:0008017;, C:cytoplasm; C:microtubule;, F:microtubule binding;|Q6ZMW3 A8MUB5 B6ZDG7,Echinoderm microtubule-associated protein-like 6,Echinoderm microtubule-associated protein-like 5-like;, PF12894;PF03451;PF00400;, GO:0005737;GO:0005874;GO:0008017;, C:cytoplasm; C:microtubule;, F:microtubule binding; scaffold6 indexed_genome mRNA 27469956 27691213 . - . ID=transcript_1648;Q6ZMW3 A8MUB5 B6ZDG7,Echinoderm microtubule-associated protein-like 6,Echinoderm microtubule-associated protein-like 5-like;, PF12894;PF03451;PF00400;, GO:0005737;GO:0005874;GO:0008017;, C:cytoplasm; C:microtubule;, F:microtubule binding;|Q6ZMW3 A8MUB5 B6ZDG7,Echinoderm microtubule-associated protein-like 6,Echinoderm microtubule-associated protein-like 5-like;, PF12894;PF03451;PF00400;, GO:0005737;GO:0005874;GO:0008017;, C:cytoplasm; C:microtubule;, F:microtubule binding;|Q6ZMW3 A8MUB5 B6ZDG7,Echinoderm microtubule-associated protein-like 6,Echinoderm microtubule-associated protein-like 5-like;, PF12894;PF03451;PF00400;, GO:0005737;GO:0005874;GO:0008017;, C:cytoplasm; C:microtubule;, F:microtubule binding; scaffold6 indexed_genome mRNA 27738718 27793759 . - . ID=transcript_1649;Q01082 B2RP63 O60837 Q16057 Q53R99 Q59ER3 Q8IX99,Spectrin beta chain, non-erythrocytic 1,Beta-II spectrin;Fodrin beta chain;Spectrin, non-erythroid beta chain 1;, PF00307;PF15410;PF00435;, GO:0030673;GO:0005737;GO:0005829;GO:0070062;GO:0031430;GO:0005730;GO:0008091;GO:0014731;GO:0003779;GO:0030506;GO:0045296;GO:0005516;GO:0051020;GO:0005543;GO:0003723;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0043001;GO:0000165;GO:0071709;GO:0000281;GO:0007009;GO:0032743;GO:1903078;GO:0072659;GO:1903076;, C:axolemma; C:cytoplasm; C:cytosol; C:extracellular exosome; C:M band; C:nucleolus; C:spectrin; C:spectrin-associated cytoskeleton;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:calmodulin binding; F:GTPase binding; F:phospholipid binding; F:RNA binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to plasma membrane protein transport; P:MAPK cascade; P:membrane assembly; P:mitotic cytokinesis; P:plasma membrane organization; P:positive regulation of interleukin-2 production; P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:regulation of protein localization to plasma membrane;|Q01082 B2RP63 O60837 Q16057 Q53R99 Q59ER3 Q8IX99,Spectrin beta chain, non-erythrocytic 1,Beta-II spectrin;Fodrin beta chain;Spectrin, non-erythroid beta chain 1;, PF00307;PF15410;PF00435;, GO:0030673;GO:0005737;GO:0005829;GO:0070062;GO:0031430;GO:0005730;GO:0008091;GO:0014731;GO:0003779;GO:0030506;GO:0045296;GO:0005516;GO:0051020;GO:0005543;GO:0003723;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0043001;GO:0000165;GO:0071709;GO:0000281;GO:0007009;GO:0032743;GO:1903078;GO:0072659;GO:1903076;, C:axolemma; C:cytoplasm; C:cytosol; C:extracellular exosome; C:M band; C:nucleolus; C:spectrin; C:spectrin-associated cytoskeleton;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:calmodulin binding; F:GTPase binding; F:phospholipid binding; F:RNA binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to plasma membrane protein transport; P:MAPK cascade; P:membrane assembly; P:mitotic cytokinesis; P:plasma membrane organization; P:positive regulation of interleukin-2 production; P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:regulation of protein localization to plasma membrane;|Q01082 B2RP63 O60837 Q16057 Q53R99 Q59ER3 Q8IX99,Spectrin beta chain, non-erythrocytic 1,Beta-II spectrin;Fodrin beta chain;Spectrin, non-erythroid beta chain 1;, PF00307;PF15410;PF00435;, GO:0030673;GO:0005737;GO:0005829;GO:0070062;GO:0031430;GO:0005730;GO:0008091;GO:0014731;GO:0003779;GO:0030506;GO:0045296;GO:0005516;GO:0051020;GO:0005543;GO:0003723;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0043001;GO:0000165;GO:0071709;GO:0000281;GO:0007009;GO:0032743;GO:1903078;GO:0072659;GO:1903076;, C:axolemma; C:cytoplasm; C:cytosol; C:extracellular exosome; C:M band; C:nucleolus; C:spectrin; C:spectrin-associated cytoskeleton;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:calmodulin binding; F:GTPase binding; F:phospholipid binding; F:RNA binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to plasma membrane protein transport; P:MAPK cascade; P:membrane assembly; P:mitotic cytokinesis; P:plasma membrane organization; P:positive regulation of interleukin-2 production; P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:regulation of protein localization to plasma membrane; scaffold6 indexed_genome mRNA 28049428 28057052 . - . ID=transcript_1650;Q8N5S3 A0AV79 A0AV81 Q8N7V4,Uncharacterized protein C2orf73,, PF15667; scaffold6 indexed_genome mRNA 28096956 28271910 . - . ID=transcript_1651;P14621,Acylphosphatase-2,Acylphosphatase, muscle type isozyme;Acylphosphate phosphohydrolase 2;, PF00708;, GO:0003998;GO:0042802;GO:0006796;, , F:acylphosphatase activity; F:identical protein binding;, P:phosphate-containing compound metabolic process;|P14621,Acylphosphatase-2,Acylphosphatase, muscle type isozyme;Acylphosphate phosphohydrolase 2;, PF00708;, GO:0003998;GO:0042802;GO:0006796;, , F:acylphosphatase activity; F:identical protein binding;, P:phosphate-containing compound metabolic process; scaffold6 indexed_genome mRNA 28424053 28508220 . + . ID=transcript_1652;Q14997 Q1XBG4 Q1XBG5 Q1XBG6 Q2M1Z0 Q6IPR2 Q86XF8,Proteasome activator complex subunit 4,Proteasome activator PA200;, PF16507;PF11919;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:1990111;GO:0070577;GO:0016504;GO:0070628;GO:0031145;GO:0002479;GO:0006974;GO:0006281;GO:0038095;GO:0070498;GO:0000165;GO:0007275;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0035093;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spermatoproteasome complex;, F:lysine-acetylated histone binding; F:peptidase activator activity; F:proteasome binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to DNA damage stimulus; P:DNA repair; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis, exchange of chromosomal proteins; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q14997 Q1XBG4 Q1XBG5 Q1XBG6 Q2M1Z0 Q6IPR2 Q86XF8,Proteasome activator complex subunit 4,Proteasome activator PA200;, PF16507;PF11919;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:1990111;GO:0070577;GO:0016504;GO:0070628;GO:0031145;GO:0002479;GO:0006974;GO:0006281;GO:0038095;GO:0070498;GO:0000165;GO:0007275;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0035093;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spermatoproteasome complex;, F:lysine-acetylated histone binding; F:peptidase activator activity; F:proteasome binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to DNA damage stimulus; P:DNA repair; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis, exchange of chromosomal proteins; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q14997 Q1XBG4 Q1XBG5 Q1XBG6 Q2M1Z0 Q6IPR2 Q86XF8,Proteasome activator complex subunit 4,Proteasome activator PA200;, PF16507;PF11919;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:1990111;GO:0070577;GO:0016504;GO:0070628;GO:0031145;GO:0002479;GO:0006974;GO:0006281;GO:0038095;GO:0070498;GO:0000165;GO:0007275;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0035093;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spermatoproteasome complex;, F:lysine-acetylated histone binding; F:peptidase activator activity; F:proteasome binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to DNA damage stimulus; P:DNA repair; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis, exchange of chromosomal proteins; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q14997 Q1XBG4 Q1XBG5 Q1XBG6 Q2M1Z0 Q6IPR2 Q86XF8,Proteasome activator complex subunit 4,Proteasome activator PA200;, PF16507;PF11919;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:1990111;GO:0070577;GO:0016504;GO:0070628;GO:0031145;GO:0002479;GO:0006974;GO:0006281;GO:0038095;GO:0070498;GO:0000165;GO:0007275;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0035093;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spermatoproteasome complex;, F:lysine-acetylated histone binding; F:peptidase activator activity; F:proteasome binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to DNA damage stimulus; P:DNA repair; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis, exchange of chromosomal proteins; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold6 indexed_genome mRNA 28508231 28516812 . + . ID=transcript_1653;Q14997 Q1XBG4 Q1XBG5 Q1XBG6 Q2M1Z0 Q6IPR2 Q86XF8,Proteasome activator complex subunit 4,Proteasome activator PA200;, PF16507;PF11919;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:1990111;GO:0070577;GO:0016504;GO:0070628;GO:0031145;GO:0002479;GO:0006974;GO:0006281;GO:0038095;GO:0070498;GO:0000165;GO:0007275;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0035093;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spermatoproteasome complex;, F:lysine-acetylated histone binding; F:peptidase activator activity; F:proteasome binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to DNA damage stimulus; P:DNA repair; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis, exchange of chromosomal proteins; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q14997 Q1XBG4 Q1XBG5 Q1XBG6 Q2M1Z0 Q6IPR2 Q86XF8,Proteasome activator complex subunit 4,Proteasome activator PA200;, PF16507;PF11919;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:1990111;GO:0070577;GO:0016504;GO:0070628;GO:0031145;GO:0002479;GO:0006974;GO:0006281;GO:0038095;GO:0070498;GO:0000165;GO:0007275;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0035093;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spermatoproteasome complex;, F:lysine-acetylated histone binding; F:peptidase activator activity; F:proteasome binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to DNA damage stimulus; P:DNA repair; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis, exchange of chromosomal proteins; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q14997 Q1XBG4 Q1XBG5 Q1XBG6 Q2M1Z0 Q6IPR2 Q86XF8,Proteasome activator complex subunit 4,Proteasome activator PA200;, PF16507;PF11919;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:1990111;GO:0070577;GO:0016504;GO:0070628;GO:0031145;GO:0002479;GO:0006974;GO:0006281;GO:0038095;GO:0070498;GO:0000165;GO:0007275;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0035093;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spermatoproteasome complex;, F:lysine-acetylated histone binding; F:peptidase activator activity; F:proteasome binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to DNA damage stimulus; P:DNA repair; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis, exchange of chromosomal proteins; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold6 indexed_genome mRNA 28527245 28530609 . - . ID=transcript_1654;O95800 B2RC02 Q6NWR2,Probable G-protein coupled receptor 75,, PF00001;, GO:0005887;GO:0005886;GO:0016493;GO:0004930;GO:0070098;GO:0007186;GO:1901214;, C:integral component of plasma membrane; C:plasma membrane;, F:C-C chemokine receptor activity; F:G protein-coupled receptor activity;, P:chemokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:regulation of neuron death; scaffold6 indexed_genome mRNA 28543330 28572191 . - . ID=transcript_1655;Q96DZ1 B2RDB4 B5MC72 O95901 Q6UWN7 Q9NUY7 Q9UQL4,Endoplasmic reticulum lectin 1,ER lectin;XTP3-transactivated gene B protein;, PF07915;, GO:0005788;GO:0044322;GO:0051082;GO:0036503;GO:1904153;GO:0055085;GO:0030433;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment;, F:unfolded protein binding;, P:ERAD pathway; P:negative regulation of retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|Q96DZ1 B2RDB4 B5MC72 O95901 Q6UWN7 Q9NUY7 Q9UQL4,Endoplasmic reticulum lectin 1,ER lectin;XTP3-transactivated gene B protein;, PF07915;, GO:0005788;GO:0044322;GO:0051082;GO:0036503;GO:1904153;GO:0055085;GO:0030433;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment;, F:unfolded protein binding;, P:ERAD pathway; P:negative regulation of retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|Q96DZ1 B2RDB4 B5MC72 O95901 Q6UWN7 Q9NUY7 Q9UQL4,Endoplasmic reticulum lectin 1,ER lectin;XTP3-transactivated gene B protein;, PF07915;, GO:0005788;GO:0044322;GO:0051082;GO:0036503;GO:1904153;GO:0055085;GO:0030433;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment;, F:unfolded protein binding;, P:ERAD pathway; P:negative regulation of retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|Q96DZ1 B2RDB4 B5MC72 O95901 Q6UWN7 Q9NUY7 Q9UQL4,Endoplasmic reticulum lectin 1,ER lectin;XTP3-transactivated gene B protein;, PF07915;, GO:0005788;GO:0044322;GO:0051082;GO:0036503;GO:1904153;GO:0055085;GO:0030433;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment;, F:unfolded protein binding;, P:ERAD pathway; P:negative regulation of retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|Q96DZ1 B2RDB4 B5MC72 O95901 Q6UWN7 Q9NUY7 Q9UQL4,Endoplasmic reticulum lectin 1,ER lectin;XTP3-transactivated gene B protein;, PF07915;, GO:0005788;GO:0044322;GO:0051082;GO:0036503;GO:1904153;GO:0055085;GO:0030433;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment;, F:unfolded protein binding;, P:ERAD pathway; P:negative regulation of retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|Q96DZ1 B2RDB4 B5MC72 O95901 Q6UWN7 Q9NUY7 Q9UQL4,Endoplasmic reticulum lectin 1,ER lectin;XTP3-transactivated gene B protein;, PF07915;, GO:0005788;GO:0044322;GO:0051082;GO:0036503;GO:1904153;GO:0055085;GO:0030433;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment;, F:unfolded protein binding;, P:ERAD pathway; P:negative regulation of retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|Q96DZ1 B2RDB4 B5MC72 O95901 Q6UWN7 Q9NUY7 Q9UQL4,Endoplasmic reticulum lectin 1,ER lectin;XTP3-transactivated gene B protein;, PF07915;, GO:0005788;GO:0044322;GO:0051082;GO:0036503;GO:1904153;GO:0055085;GO:0030433;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment;, F:unfolded protein binding;, P:ERAD pathway; P:negative regulation of retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; scaffold6 indexed_genome mRNA 28572248 28684850 . + . ID=transcript_1656;Q9Y575 B3KPA3 D6W5B4 D6W5B5 G8JLA9 Q2TAI4 Q53TN0 Q53TN8 Q9NVZ2,Ankyrin repeat and SOCS box protein 3,, PF12796;PF13606;PF07525;, GO:0005829;GO:0030315;GO:0035556;GO:0043687;GO:0036371;GO:0016567;GO:0055117;, C:cytosol; C:T-tubule;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein localization to T-tubule; P:protein ubiquitination; P:regulation of cardiac muscle contraction;|Q8WUX2 Q8WVI8,Glutathione-specific gamma-glutamylcyclotransferase 2 {ECO:0000303|PubMed:27913623},Cation transport regulator-like protein 2 {ECO:0000250|UniProtKB:Q9BUX1};, PF04752;, GO:0005737;GO:0005829;GO:0003839;GO:0061928;GO:0006750;GO:0006751;, C:cytoplasm; C:cytosol;, F:gamma-glutamylcyclotransferase activity; F:glutathione specific gamma-glutamylcyclotransferase activity;, P:glutathione biosynthetic process; P:glutathione catabolic process;|Q9Y575 B3KPA3 D6W5B4 D6W5B5 G8JLA9 Q2TAI4 Q53TN0 Q53TN8 Q9NVZ2,Ankyrin repeat and SOCS box protein 3,, PF12796;PF13606;PF07525;, GO:0005829;GO:0030315;GO:0035556;GO:0043687;GO:0036371;GO:0016567;GO:0055117;, C:cytosol; C:T-tubule;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein localization to T-tubule; P:protein ubiquitination; P:regulation of cardiac muscle contraction; scaffold6 indexed_genome mRNA 31370451 31698441 . + . ID=transcript_1657;Q9H3M2 Q9UDM6,Neurexin-1,Neurexin I-alpha;Neurexin-1-alpha;, PF00008;PF02210;PF01034;, GO:0042995;GO:0009986;GO:0005783;GO:0005887;GO:0043025;GO:0031965;GO:0005730;GO:0005886;GO:0042734;GO:0031982;GO:0033130;GO:0005246;GO:0005509;GO:0050839;GO:0097109;GO:0038023;GO:0030534;GO:0007411;GO:0007268;GO:0097116;GO:0007612;GO:0097118;GO:0050885;GO:0007158;GO:0007269;GO:2000463;GO:0051965;GO:0090129;GO:0051968;GO:0097119;GO:0097104;GO:0035176;GO:0007416;GO:0042297;GO:0071625;, C:cell projection; C:cell surface; C:endoplasmic reticulum; C:integral component of plasma membrane; C:neuronal cell body; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynaptic membrane; C:vesicle;, F:acetylcholine receptor binding; F:calcium channel regulator activity; F:calcium ion binding; F:cell adhesion molecule binding; F:neuroligin family protein binding; F:signaling receptor activity;, P:adult behavior; P:axon guidance; P:chemical synaptic transmission; P:gephyrin clustering involved in postsynaptic density assembly; P:learning; P:neuroligin clustering involved in postsynaptic membrane assembly; P:neuromuscular process controlling balance; P:neuron cell-cell adhesion; P:neurotransmitter secretion; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synapse assembly; P:positive regulation of synapse maturation; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:social behavior; P:synapse assembly; P:vocal learning; P:vocalization behavior;|Q9H3M2 Q9UDM6,Neurexin-1,Neurexin I-alpha;Neurexin-1-alpha;, PF00008;PF02210;PF01034;, GO:0042995;GO:0009986;GO:0005783;GO:0005887;GO:0043025;GO:0031965;GO:0005730;GO:0005886;GO:0042734;GO:0031982;GO:0033130;GO:0005246;GO:0005509;GO:0050839;GO:0097109;GO:0038023;GO:0030534;GO:0007411;GO:0007268;GO:0097116;GO:0007612;GO:0097118;GO:0050885;GO:0007158;GO:0007269;GO:2000463;GO:0051965;GO:0090129;GO:0051968;GO:0097119;GO:0097104;GO:0035176;GO:0007416;GO:0042297;GO:0071625;, C:cell projection; C:cell surface; C:endoplasmic reticulum; C:integral component of plasma membrane; C:neuronal cell body; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynaptic membrane; C:vesicle;, F:acetylcholine receptor binding; F:calcium channel regulator activity; F:calcium ion binding; F:cell adhesion molecule binding; F:neuroligin family protein binding; F:signaling receptor activity;, P:adult behavior; P:axon guidance; P:chemical synaptic transmission; P:gephyrin clustering involved in postsynaptic density assembly; P:learning; P:neuroligin clustering involved in postsynaptic membrane assembly; P:neuromuscular process controlling balance; P:neuron cell-cell adhesion; P:neurotransmitter secretion; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synapse assembly; P:positive regulation of synapse maturation; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:social behavior; P:synapse assembly; P:vocal learning; P:vocalization behavior; scaffold6 indexed_genome mRNA 31764961 31787439 . + . ID=transcript_1658;Q9H3M2 Q9UDM6,Neurexin-1,Neurexin I-alpha;Neurexin-1-alpha;, PF00008;PF02210;PF01034;, GO:0042995;GO:0009986;GO:0005783;GO:0005887;GO:0043025;GO:0031965;GO:0005730;GO:0005886;GO:0042734;GO:0031982;GO:0033130;GO:0005246;GO:0005509;GO:0050839;GO:0097109;GO:0038023;GO:0030534;GO:0007411;GO:0007268;GO:0097116;GO:0007612;GO:0097118;GO:0050885;GO:0007158;GO:0007269;GO:2000463;GO:0051965;GO:0090129;GO:0051968;GO:0097119;GO:0097104;GO:0035176;GO:0007416;GO:0042297;GO:0071625;, C:cell projection; C:cell surface; C:endoplasmic reticulum; C:integral component of plasma membrane; C:neuronal cell body; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynaptic membrane; C:vesicle;, F:acetylcholine receptor binding; F:calcium channel regulator activity; F:calcium ion binding; F:cell adhesion molecule binding; F:neuroligin family protein binding; F:signaling receptor activity;, P:adult behavior; P:axon guidance; P:chemical synaptic transmission; P:gephyrin clustering involved in postsynaptic density assembly; P:learning; P:neuroligin clustering involved in postsynaptic membrane assembly; P:neuromuscular process controlling balance; P:neuron cell-cell adhesion; P:neurotransmitter secretion; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synapse assembly; P:positive regulation of synapse maturation; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:social behavior; P:synapse assembly; P:vocal learning; P:vocalization behavior; scaffold6 indexed_genome mRNA 31804257 32273665 . + . ID=transcript_1659;Q9H3M2 Q9UDM6,Neurexin-1,Neurexin I-alpha;Neurexin-1-alpha;, PF00008;PF02210;PF01034;, GO:0042995;GO:0009986;GO:0005783;GO:0005887;GO:0043025;GO:0031965;GO:0005730;GO:0005886;GO:0042734;GO:0031982;GO:0033130;GO:0005246;GO:0005509;GO:0050839;GO:0097109;GO:0038023;GO:0030534;GO:0007411;GO:0007268;GO:0097116;GO:0007612;GO:0097118;GO:0050885;GO:0007158;GO:0007269;GO:2000463;GO:0051965;GO:0090129;GO:0051968;GO:0097119;GO:0097104;GO:0035176;GO:0007416;GO:0042297;GO:0071625;, C:cell projection; C:cell surface; C:endoplasmic reticulum; C:integral component of plasma membrane; C:neuronal cell body; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynaptic membrane; C:vesicle;, F:acetylcholine receptor binding; F:calcium channel regulator activity; F:calcium ion binding; F:cell adhesion molecule binding; F:neuroligin family protein binding; F:signaling receptor activity;, P:adult behavior; P:axon guidance; P:chemical synaptic transmission; P:gephyrin clustering involved in postsynaptic density assembly; P:learning; P:neuroligin clustering involved in postsynaptic membrane assembly; P:neuromuscular process controlling balance; P:neuron cell-cell adhesion; P:neurotransmitter secretion; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synapse assembly; P:positive regulation of synapse maturation; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:social behavior; P:synapse assembly; P:vocal learning; P:vocalization behavior; scaffold6 indexed_genome mRNA 32388314 32417381 . + . ID=transcript_1660;P58400 E7ETA5,Neurexin-1-beta,Neurexin I-beta;, PF02210;PF01034;, GO:0044295;GO:0009986;GO:0030139;GO:0005783;GO:0099056;GO:0043025;GO:0031965;GO:0005886;GO:0098793;GO:0042734;GO:0031982;GO:0048306;GO:0050839;GO:0046872;GO:0097109;GO:0005102;GO:0004888;GO:0005105;GO:0030534;GO:0001525;GO:0016339;GO:0071277;GO:0021707;GO:0045184;GO:0097112;GO:0097116;GO:0097117;GO:0007157;GO:0007612;GO:0051490;GO:0010629;GO:0097118;GO:0007158;GO:0031175;GO:0023041;GO:0097114;GO:0070374;GO:2000463;GO:0045743;GO:0010628;GO:0033138;GO:1905520;GO:0010739;GO:0051897;GO:1900020;GO:1903078;GO:0051965;GO:0051968;GO:0097119;GO:0097104;GO:0097105;GO:0035418;GO:0090126;GO:0097120;GO:2000311;GO:2000310;GO:0007165;GO:0035176;GO:0007416;GO:0097091;GO:0071625;, C:axonal growth cone; C:cell surface; C:endocytic vesicle; C:endoplasmic reticulum; C:integral component of presynaptic membrane; C:neuronal cell body; C:nuclear membrane; C:plasma membrane; C:presynapse; C:presynaptic membrane; C:vesicle;, F:calcium-dependent protein binding; F:cell adhesion molecule binding; F:metal ion binding; F:neuroligin family protein binding; F:signaling receptor binding; F:transmembrane signaling receptor activity; F:type 1 fibroblast growth factor receptor binding;, P:adult behavior; P:angiogenesis; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular response to calcium ion; P:cerebellar granule cell differentiation; P:establishment of protein localization; P:gamma-aminobutyric acid receptor clustering; P:gephyrin clustering involved in postsynaptic density assembly; P:guanylate kinase-associated protein clustering; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:learning; P:negative regulation of filopodium assembly; P:negative regulation of gene expression; P:neuroligin clustering involved in postsynaptic membrane assembly; P:neuron cell-cell adhesion; P:neuron projection development; P:neuronal signal transduction; P:NMDA glutamate receptor clustering; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of presynaptic active zone assembly; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein kinase C activity; P:positive regulation of protein localization to plasma membrane; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:presynaptic membrane assembly; P:protein localization to synapse; P:protein-containing complex assembly involved in synapse maturation; P:receptor localization to synapse; P:regulation of AMPA receptor activity; P:regulation of NMDA receptor activity; P:signal transduction; P:social behavior; P:synapse assembly; P:synaptic vesicle clustering; P:vocalization behavior;|P58400 E7ETA5,Neurexin-1-beta,Neurexin I-beta;, PF02210;PF01034;, GO:0044295;GO:0009986;GO:0030139;GO:0005783;GO:0099056;GO:0043025;GO:0031965;GO:0005886;GO:0098793;GO:0042734;GO:0031982;GO:0048306;GO:0050839;GO:0046872;GO:0097109;GO:0005102;GO:0004888;GO:0005105;GO:0030534;GO:0001525;GO:0016339;GO:0071277;GO:0021707;GO:0045184;GO:0097112;GO:0097116;GO:0097117;GO:0007157;GO:0007612;GO:0051490;GO:0010629;GO:0097118;GO:0007158;GO:0031175;GO:0023041;GO:0097114;GO:0070374;GO:2000463;GO:0045743;GO:0010628;GO:0033138;GO:1905520;GO:0010739;GO:0051897;GO:1900020;GO:1903078;GO:0051965;GO:0051968;GO:0097119;GO:0097104;GO:0097105;GO:0035418;GO:0090126;GO:0097120;GO:2000311;GO:2000310;GO:0007165;GO:0035176;GO:0007416;GO:0097091;GO:0071625;, C:axonal growth cone; C:cell surface; C:endocytic vesicle; C:endoplasmic reticulum; C:integral component of presynaptic membrane; C:neuronal cell body; C:nuclear membrane; C:plasma membrane; C:presynapse; C:presynaptic membrane; C:vesicle;, F:calcium-dependent protein binding; F:cell adhesion molecule binding; F:metal ion binding; F:neuroligin family protein binding; F:signaling receptor binding; F:transmembrane signaling receptor activity; F:type 1 fibroblast growth factor receptor binding;, P:adult behavior; P:angiogenesis; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular response to calcium ion; P:cerebellar granule cell differentiation; P:establishment of protein localization; P:gamma-aminobutyric acid receptor clustering; P:gephyrin clustering involved in postsynaptic density assembly; P:guanylate kinase-associated protein clustering; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:learning; P:negative regulation of filopodium assembly; P:negative regulation of gene expression; P:neuroligin clustering involved in postsynaptic membrane assembly; P:neuron cell-cell adhesion; P:neuron projection development; P:neuronal signal transduction; P:NMDA glutamate receptor clustering; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of presynaptic active zone assembly; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein kinase C activity; P:positive regulation of protein localization to plasma membrane; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:presynaptic membrane assembly; P:protein localization to synapse; P:protein-containing complex assembly involved in synapse maturation; P:receptor localization to synapse; P:regulation of AMPA receptor activity; P:regulation of NMDA receptor activity; P:signal transduction; P:social behavior; P:synapse assembly; P:synaptic vesicle clustering; P:vocalization behavior; scaffold6 indexed_genome mRNA 33735457 33790384 . - . ID=transcript_1661;Q9Y6Q2 A0A0A6YYH4 A8MXJ1 B5MCF5 B7ZL16 Q96JE3 Q9BYX3,Stonin-1,Stoned B-like factor;, PF00928;, GO:0030136;GO:0031410;GO:0043231;GO:0016020;GO:0008021;GO:0035615;GO:0030100;GO:0048488;GO:0016192;, C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:synaptic vesicle;, F:clathrin adaptor activity;, P:regulation of endocytosis; P:synaptic vesicle endocytosis; P:vesicle-mediated transport; scaffold6 indexed_genome mRNA 33801373 33853604 . - . ID=transcript_1662;Q6ZMI0 B7ZKY5 B7ZKY7 E1B6W7 Q2TA78 Q6ZMI6 Q8IW83 Q8J029 Q96ES8,Protein phosphatase 1 regulatory subunit 21,Coiled-coil domain-containing protein 128;KLRAQ motif-containing protein 1;, PF10205;PF10212;, GO:0005769;GO:0016020;, C:early endosome; C:membrane;|Q6ZMI0 B7ZKY5 B7ZKY7 E1B6W7 Q2TA78 Q6ZMI6 Q8IW83 Q8J029 Q96ES8,Protein phosphatase 1 regulatory subunit 21,Coiled-coil domain-containing protein 128;KLRAQ motif-containing protein 1;, PF10205;PF10212;, GO:0005769;GO:0016020;, C:early endosome; C:membrane;|Q6ZMI0 B7ZKY5 B7ZKY7 E1B6W7 Q2TA78 Q6ZMI6 Q8IW83 Q8J029 Q96ES8,Protein phosphatase 1 regulatory subunit 21,Coiled-coil domain-containing protein 128;KLRAQ motif-containing protein 1;, PF10205;PF10212;, GO:0005769;GO:0016020;, C:early endosome; C:membrane;|Q6ZMI0 B7ZKY5 B7ZKY7 E1B6W7 Q2TA78 Q6ZMI6 Q8IW83 Q8J029 Q96ES8,Protein phosphatase 1 regulatory subunit 21,Coiled-coil domain-containing protein 128;KLRAQ motif-containing protein 1;, PF10205;PF10212;, GO:0005769;GO:0016020;, C:early endosome; C:membrane;|Q6ZMI0 B7ZKY5 B7ZKY7 E1B6W7 Q2TA78 Q6ZMI6 Q8IW83 Q8J029 Q96ES8,Protein phosphatase 1 regulatory subunit 21,Coiled-coil domain-containing protein 128;KLRAQ motif-containing protein 1;, PF10205;PF10212;, GO:0005769;GO:0016020;, C:early endosome; C:membrane; scaffold6 indexed_genome mRNA 33900383 33956585 . - . ID=transcript_1663;P32314 Q15769 Q6P4Q2,Forkhead box protein N2,Human T-cell leukemia virus enhancer factor;, PF00250;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0000987;GO:0003700;GO:0000981;GO:1990837;GO:0006355;GO:0035914;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription, DNA-templated; P:skeletal muscle cell differentiation;|P32314 Q15769 Q6P4Q2,Forkhead box protein N2,Human T-cell leukemia virus enhancer factor;, PF00250;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0000987;GO:0003700;GO:0000981;GO:1990837;GO:0006355;GO:0035914;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription, DNA-templated; P:skeletal muscle cell differentiation; scaffold6 indexed_genome mRNA 34457341 34465764 . + . ID=transcript_1664;Q9NR14 Q9UFK1 Q9UHI1 Q9UKC2,F-box only protein 11,Protein arginine N-methyltransferase 9;Vitiligo-associated protein 1;, PF13229;PF12937;PF05048;PF02207;, GO:0005694;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0016274;GO:0004842;GO:0008270;GO:0006464;GO:0043687;GO:0000209;GO:0016567;GO:0042981;GO:0007605;GO:0006511;, C:chromosome; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:protein-arginine N-methyltransferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of apoptotic process; P:sensory perception of sound; P:ubiquitin-dependent protein catabolic process;|Q9NR14 Q9UFK1 Q9UHI1 Q9UKC2,F-box only protein 11,Protein arginine N-methyltransferase 9;Vitiligo-associated protein 1;, PF13229;PF12937;PF05048;PF02207;, GO:0005694;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0016274;GO:0004842;GO:0008270;GO:0006464;GO:0043687;GO:0000209;GO:0016567;GO:0042981;GO:0007605;GO:0006511;, C:chromosome; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:protein-arginine N-methyltransferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of apoptotic process; P:sensory perception of sound; P:ubiquitin-dependent protein catabolic process;|Q9NR14 Q9UFK1 Q9UHI1 Q9UKC2,F-box only protein 11,Protein arginine N-methyltransferase 9;Vitiligo-associated protein 1;, PF13229;PF12937;PF05048;PF02207;, GO:0005694;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0016274;GO:0004842;GO:0008270;GO:0006464;GO:0043687;GO:0000209;GO:0016567;GO:0042981;GO:0007605;GO:0006511;, C:chromosome; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:protein-arginine N-methyltransferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of apoptotic process; P:sensory perception of sound; P:ubiquitin-dependent protein catabolic process;|Q9NR14 Q9UFK1 Q9UHI1 Q9UKC2,F-box only protein 11,Protein arginine N-methyltransferase 9;Vitiligo-associated protein 1;, PF13229;PF12937;PF05048;PF02207;, GO:0005694;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0016274;GO:0004842;GO:0008270;GO:0006464;GO:0043687;GO:0000209;GO:0016567;GO:0042981;GO:0007605;GO:0006511;, C:chromosome; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:protein-arginine N-methyltransferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of apoptotic process; P:sensory perception of sound; P:ubiquitin-dependent protein catabolic process;|Q9NR14 Q9UFK1 Q9UHI1 Q9UKC2,F-box only protein 11,Protein arginine N-methyltransferase 9;Vitiligo-associated protein 1;, PF13229;PF12937;PF05048;PF02207;, GO:0005694;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0016274;GO:0004842;GO:0008270;GO:0006464;GO:0043687;GO:0000209;GO:0016567;GO:0042981;GO:0007605;GO:0006511;, C:chromosome; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:protein-arginine N-methyltransferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of apoptotic process; P:sensory perception of sound; P:ubiquitin-dependent protein catabolic process; scaffold6 indexed_genome mRNA 34465926 34487999 . - . ID=transcript_1665;P52701 B4DF41 B4E3I4 F5H2F9 O43706 O43917 Q8TCX4 Q9BTB5,DNA mismatch repair protein Msh6 {ECO:0000250|UniProtKB:P54276},G/T mismatch-binding protein {ECO:0000303|PubMed:7604265};MutS protein homolog 6 {ECO:0000312|HGNC:HGNC:7329};MutS-alpha 160 kDa subunit;, PF01624;PF05188;PF05192;PF05190;PF00488;PF00855;, GO:0000785;GO:0005829;GO:0005794;GO:0043231;GO:0032300;GO:0032301;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003684;GO:0008094;GO:0019899;GO:0032137;GO:0035064;GO:0030983;GO:0008340;GO:0006281;GO:0036297;GO:0097193;GO:0008630;GO:0045190;GO:0000710;GO:0006298;GO:0045910;GO:0051096;GO:0006290;GO:0009411;GO:0016446;GO:0016447;GO:0016032;, C:chromatin; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:mismatch repair complex; C:MutSalpha complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:damaged DNA binding; F:DNA-dependent ATPase activity; F:enzyme binding; F:guanine/thymine mispair binding; F:methylated histone binding; F:mismatched DNA binding;, P:determination of adult lifespan; P:DNA repair; P:interstrand cross-link repair; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:meiotic mismatch repair; P:mismatch repair; P:negative regulation of DNA recombination; P:positive regulation of helicase activity; P:pyrimidine dimer repair; P:response to UV; P:somatic hypermutation of immunoglobulin genes; P:somatic recombination of immunoglobulin gene segments; P:viral process;|P52701 B4DF41 B4E3I4 F5H2F9 O43706 O43917 Q8TCX4 Q9BTB5,DNA mismatch repair protein Msh6 {ECO:0000250|UniProtKB:P54276},G/T mismatch-binding protein {ECO:0000303|PubMed:7604265};MutS protein homolog 6 {ECO:0000312|HGNC:HGNC:7329};MutS-alpha 160 kDa subunit;, PF01624;PF05188;PF05192;PF05190;PF00488;PF00855;, GO:0000785;GO:0005829;GO:0005794;GO:0043231;GO:0032300;GO:0032301;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003684;GO:0008094;GO:0019899;GO:0032137;GO:0035064;GO:0030983;GO:0008340;GO:0006281;GO:0036297;GO:0097193;GO:0008630;GO:0045190;GO:0000710;GO:0006298;GO:0045910;GO:0051096;GO:0006290;GO:0009411;GO:0016446;GO:0016447;GO:0016032;, C:chromatin; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:mismatch repair complex; C:MutSalpha complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:damaged DNA binding; F:DNA-dependent ATPase activity; F:enzyme binding; F:guanine/thymine mispair binding; F:methylated histone binding; F:mismatched DNA binding;, P:determination of adult lifespan; P:DNA repair; P:interstrand cross-link repair; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:meiotic mismatch repair; P:mismatch repair; P:negative regulation of DNA recombination; P:positive regulation of helicase activity; P:pyrimidine dimer repair; P:response to UV; P:somatic hypermutation of immunoglobulin genes; P:somatic recombination of immunoglobulin gene segments; P:viral process; scaffold6 indexed_genome mRNA 34722655 34800908 . - . ID=transcript_1666;P43246 B4E2Z2 O75488,DNA mismatch repair protein Msh2,MutS protein homolog 2;, PF01624;PF05188;PF05192;PF05190;PF00488;, GO:0000781;GO:0016020;GO:0032300;GO:0032301;GO:0032302;GO:0005654;GO:0005634;GO:0005524;GO:0019237;GO:0003682;GO:0003684;GO:0003677;GO:0008094;GO:0000406;GO:0019899;GO:0032137;GO:0008022;GO:0042803;GO:0019901;GO:0030183;GO:0019724;GO:0007050;GO:0008340;GO:0006310;GO:0006281;GO:0006302;GO:0007281;GO:0001701;GO:0031573;GO:0042771;GO:0045190;GO:0043570;GO:0008584;GO:0006298;GO:0045910;GO:0043524;GO:0006119;GO:0051096;GO:0048298;GO:0048304;GO:0006301;GO:0071168;GO:0010224;GO:0010165;GO:0016446;GO:0016447;GO:0002204;, C:chromosome, telomeric region; C:membrane; C:mismatch repair complex; C:MutSalpha complex; C:MutSbeta complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:centromeric DNA binding; F:chromatin binding; F:damaged DNA binding; F:DNA binding; F:DNA-dependent ATPase activity; F:double-strand/single-strand DNA junction binding; F:enzyme binding; F:guanine/thymine mispair binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein kinase binding;, P:B cell differentiation; P:B cell mediated immunity; P:cell cycle arrest; P:determination of adult lifespan; P:DNA recombination; P:DNA repair; P:double-strand break repair; P:germ cell development; P:in utero embryonic development; P:intra-S DNA damage checkpoint; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:isotype switching; P:maintenance of DNA repeat elements; P:male gonad development; P:mismatch repair; P:negative regulation of DNA recombination; P:negative regulation of neuron apoptotic process; P:oxidative phosphorylation; P:positive regulation of helicase activity; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:postreplication repair; P:protein localization to chromatin; P:response to UV-B; P:response to X-ray; P:somatic hypermutation of immunoglobulin genes; P:somatic recombination of immunoglobulin gene segments; P:somatic recombination of immunoglobulin genes involved in immune response;|P43246 B4E2Z2 O75488,DNA mismatch repair protein Msh2,MutS protein homolog 2;, PF01624;PF05188;PF05192;PF05190;PF00488;, GO:0000781;GO:0016020;GO:0032300;GO:0032301;GO:0032302;GO:0005654;GO:0005634;GO:0005524;GO:0019237;GO:0003682;GO:0003684;GO:0003677;GO:0008094;GO:0000406;GO:0019899;GO:0032137;GO:0008022;GO:0042803;GO:0019901;GO:0030183;GO:0019724;GO:0007050;GO:0008340;GO:0006310;GO:0006281;GO:0006302;GO:0007281;GO:0001701;GO:0031573;GO:0042771;GO:0045190;GO:0043570;GO:0008584;GO:0006298;GO:0045910;GO:0043524;GO:0006119;GO:0051096;GO:0048298;GO:0048304;GO:0006301;GO:0071168;GO:0010224;GO:0010165;GO:0016446;GO:0016447;GO:0002204;, C:chromosome, telomeric region; C:membrane; C:mismatch repair complex; C:MutSalpha complex; C:MutSbeta complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:centromeric DNA binding; F:chromatin binding; F:damaged DNA binding; F:DNA binding; F:DNA-dependent ATPase activity; F:double-strand/single-strand DNA junction binding; F:enzyme binding; F:guanine/thymine mispair binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein kinase binding;, P:B cell differentiation; P:B cell mediated immunity; P:cell cycle arrest; P:determination of adult lifespan; P:DNA recombination; P:DNA repair; P:double-strand break repair; P:germ cell development; P:in utero embryonic development; P:intra-S DNA damage checkpoint; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:isotype switching; P:maintenance of DNA repeat elements; P:male gonad development; P:mismatch repair; P:negative regulation of DNA recombination; P:negative regulation of neuron apoptotic process; P:oxidative phosphorylation; P:positive regulation of helicase activity; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:postreplication repair; P:protein localization to chromatin; P:response to UV-B; P:response to X-ray; P:somatic hypermutation of immunoglobulin genes; P:somatic recombination of immunoglobulin gene segments; P:somatic recombination of immunoglobulin genes involved in immune response;|P43246 B4E2Z2 O75488,DNA mismatch repair protein Msh2,MutS protein homolog 2;, PF01624;PF05188;PF05192;PF05190;PF00488;, GO:0000781;GO:0016020;GO:0032300;GO:0032301;GO:0032302;GO:0005654;GO:0005634;GO:0005524;GO:0019237;GO:0003682;GO:0003684;GO:0003677;GO:0008094;GO:0000406;GO:0019899;GO:0032137;GO:0008022;GO:0042803;GO:0019901;GO:0030183;GO:0019724;GO:0007050;GO:0008340;GO:0006310;GO:0006281;GO:0006302;GO:0007281;GO:0001701;GO:0031573;GO:0042771;GO:0045190;GO:0043570;GO:0008584;GO:0006298;GO:0045910;GO:0043524;GO:0006119;GO:0051096;GO:0048298;GO:0048304;GO:0006301;GO:0071168;GO:0010224;GO:0010165;GO:0016446;GO:0016447;GO:0002204;, C:chromosome, telomeric region; C:membrane; C:mismatch repair complex; C:MutSalpha complex; C:MutSbeta complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:centromeric DNA binding; F:chromatin binding; F:damaged DNA binding; F:DNA binding; F:DNA-dependent ATPase activity; F:double-strand/single-strand DNA junction binding; F:enzyme binding; F:guanine/thymine mispair binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein kinase binding;, P:B cell differentiation; P:B cell mediated immunity; P:cell cycle arrest; P:determination of adult lifespan; P:DNA recombination; P:DNA repair; P:double-strand break repair; P:germ cell development; P:in utero embryonic development; P:intra-S DNA damage checkpoint; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:isotype switching; P:maintenance of DNA repeat elements; P:male gonad development; P:mismatch repair; P:negative regulation of DNA recombination; P:negative regulation of neuron apoptotic process; P:oxidative phosphorylation; P:positive regulation of helicase activity; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:postreplication repair; P:protein localization to chromatin; P:response to UV-B; P:response to X-ray; P:somatic hypermutation of immunoglobulin genes; P:somatic recombination of immunoglobulin gene segments; P:somatic recombination of immunoglobulin genes involved in immune response;|P43246 B4E2Z2 O75488,DNA mismatch repair protein Msh2,MutS protein homolog 2;, PF01624;PF05188;PF05192;PF05190;PF00488;, GO:0000781;GO:0016020;GO:0032300;GO:0032301;GO:0032302;GO:0005654;GO:0005634;GO:0005524;GO:0019237;GO:0003682;GO:0003684;GO:0003677;GO:0008094;GO:0000406;GO:0019899;GO:0032137;GO:0008022;GO:0042803;GO:0019901;GO:0030183;GO:0019724;GO:0007050;GO:0008340;GO:0006310;GO:0006281;GO:0006302;GO:0007281;GO:0001701;GO:0031573;GO:0042771;GO:0045190;GO:0043570;GO:0008584;GO:0006298;GO:0045910;GO:0043524;GO:0006119;GO:0051096;GO:0048298;GO:0048304;GO:0006301;GO:0071168;GO:0010224;GO:0010165;GO:0016446;GO:0016447;GO:0002204;, C:chromosome, telomeric region; C:membrane; C:mismatch repair complex; C:MutSalpha complex; C:MutSbeta complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:centromeric DNA binding; F:chromatin binding; F:damaged DNA binding; F:DNA binding; F:DNA-dependent ATPase activity; F:double-strand/single-strand DNA junction binding; F:enzyme binding; F:guanine/thymine mispair binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein kinase binding;, P:B cell differentiation; P:B cell mediated immunity; P:cell cycle arrest; P:determination of adult lifespan; P:DNA recombination; P:DNA repair; P:double-strand break repair; P:germ cell development; P:in utero embryonic development; P:intra-S DNA damage checkpoint; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:isotype switching; P:maintenance of DNA repeat elements; P:male gonad development; P:mismatch repair; P:negative regulation of DNA recombination; P:negative regulation of neuron apoptotic process; P:oxidative phosphorylation; P:positive regulation of helicase activity; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:postreplication repair; P:protein localization to chromatin; P:response to UV-B; P:response to X-ray; P:somatic hypermutation of immunoglobulin genes; P:somatic recombination of immunoglobulin gene segments; P:somatic recombination of immunoglobulin genes involved in immune response; scaffold6 indexed_genome mRNA 34809433 34821805 . - . ID=transcript_1667;P16422 P18180 Q6FG26 Q6FG49 Q96C47 Q9UCD0,Epithelial cell adhesion molecule,Adenocarcinoma-associated antigen;Cell surface glycoprotein Trop-1;Epithelial cell surface antigen;Epithelial glycoprotein;Epithelial glycoprotein 314;KS 1/4 antigen;KSA;Major gastrointestinal tumor-associated protein GA733-2;Tumor-associated calcium signal transducer 1;, PF18635;PF00086;, GO:0016324;GO:0016323;GO:0005923;GO:0070062;GO:0016021;GO:0016328;GO:0005886;GO:0098641;GO:0044877;GO:0050900;GO:2000048;GO:0008284;GO:2000648;GO:0045944;GO:0023019;GO:0048863;, C:apical plasma membrane; C:basolateral plasma membrane; C:bicellular tight junction; C:extracellular exosome; C:integral component of membrane; C:lateral plasma membrane; C:plasma membrane;, F:cadherin binding involved in cell-cell adhesion; F:protein-containing complex binding;, P:leukocyte migration; P:negative regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of cell population proliferation; P:positive regulation of stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:signal transduction involved in regulation of gene expression; P:stem cell differentiation; scaffold6 indexed_genome mRNA 35020793 35028623 . + . ID=transcript_1668;Q96HK3,Calmodulin-1 {ECO:0000312|HGNC:HGNC:1442},, PF13499;, GO:0034704;GO:1902494;GO:0005813;GO:0005737;GO:0005829;GO:0005576;GO:0030426;GO:0031966;GO:0043209;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0030017;GO:0005876;GO:0000922;GO:0030672;GO:0031982;GO:0008076;GO:0010856;GO:0008179;GO:0019855;GO:0005509;GO:0048306;GO:0097718;GO:0030234;GO:0044325;GO:0031997;GO:0050998;GO:0030235;GO:0043548;GO:0019904;GO:0019901;GO:0072542;GO:0043539;GO:0031432;GO:0031800;GO:0007190;GO:0016240;GO:0007268;GO:0005513;GO:0090151;GO:0038095;GO:0007186;GO:0000086;GO:0005980;GO:0043647;GO:0000165;GO:1990456;GO:0006936;GO:1901842;GO:0010801;GO:0060315;GO:0140056;GO:0002576;GO:0051343;GO:0043388;GO:0051000;GO:0010800;GO:0032516;GO:0031954;GO:0035307;GO:0071902;GO:0060316;GO:0098901;GO:0055117;GO:0010881;GO:1901844;GO:0032465;GO:0002027;GO:0050999;GO:0010880;GO:0022400;GO:0060314;GO:1900242;GO:2000300;GO:0001975;GO:0051592;GO:0051412;GO:0021762;GO:0046146;GO:0016032;GO:0007223;, C:calcium channel complex; C:catalytic complex; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular region; C:growth cone; C:mitochondrial membrane; C:myelin sheath; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:sarcomere; C:spindle microtubule; C:spindle pole; C:synaptic vesicle membrane; C:vesicle; C:voltage-gated potassium channel complex;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium-dependent protein binding; F:disordered domain specific binding; F:enzyme regulator activity; F:ion channel binding; F:N-terminal myristoylation domain binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase activator activity; F:protein serine/threonine kinase activator activity; F:titin binding; F:type 3 metabotropic glutamate receptor binding;, P:activation of adenylate cyclase activity; P:autophagosome membrane docking; P:chemical synaptic transmission; P:detection of calcium ion; P:establishment of protein localization to mitochondrial membrane; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:glycogen catabolic process; P:inositol phosphate metabolic process; P:MAPK cascade; P:mitochondrion-endoplasmic reticulum membrane tethering; P:muscle contraction; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:organelle localization by membrane tethering; P:platelet degranulation; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of DNA binding; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytokinesis; P:regulation of heart rate; P:regulation of nitric-oxide synthase activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of rhodopsin mediated signaling pathway; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic vesicle endocytosis; P:regulation of synaptic vesicle exocytosis; P:response to amphetamine; P:response to calcium ion; P:response to corticosterone; P:substantia nigra development; P:tetrahydrobiopterin metabolic process; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q96HK3,Calmodulin-1 {ECO:0000312|HGNC:HGNC:1442},, PF13499;, GO:0034704;GO:1902494;GO:0005813;GO:0005737;GO:0005829;GO:0005576;GO:0030426;GO:0031966;GO:0043209;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0030017;GO:0005876;GO:0000922;GO:0030672;GO:0031982;GO:0008076;GO:0010856;GO:0008179;GO:0019855;GO:0005509;GO:0048306;GO:0097718;GO:0030234;GO:0044325;GO:0031997;GO:0050998;GO:0030235;GO:0043548;GO:0019904;GO:0019901;GO:0072542;GO:0043539;GO:0031432;GO:0031800;GO:0007190;GO:0016240;GO:0007268;GO:0005513;GO:0090151;GO:0038095;GO:0007186;GO:0000086;GO:0005980;GO:0043647;GO:0000165;GO:1990456;GO:0006936;GO:1901842;GO:0010801;GO:0060315;GO:0140056;GO:0002576;GO:0051343;GO:0043388;GO:0051000;GO:0010800;GO:0032516;GO:0031954;GO:0035307;GO:0071902;GO:0060316;GO:0098901;GO:0055117;GO:0010881;GO:1901844;GO:0032465;GO:0002027;GO:0050999;GO:0010880;GO:0022400;GO:0060314;GO:1900242;GO:2000300;GO:0001975;GO:0051592;GO:0051412;GO:0021762;GO:0046146;GO:0016032;GO:0007223;, C:calcium channel complex; C:catalytic complex; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular region; C:growth cone; C:mitochondrial membrane; C:myelin sheath; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:sarcomere; C:spindle microtubule; C:spindle pole; C:synaptic vesicle membrane; C:vesicle; C:voltage-gated potassium channel complex;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium-dependent protein binding; F:disordered domain specific binding; F:enzyme regulator activity; F:ion channel binding; F:N-terminal myristoylation domain binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase activator activity; F:protein serine/threonine kinase activator activity; F:titin binding; F:type 3 metabotropic glutamate receptor binding;, P:activation of adenylate cyclase activity; P:autophagosome membrane docking; P:chemical synaptic transmission; P:detection of calcium ion; P:establishment of protein localization to mitochondrial membrane; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:glycogen catabolic process; P:inositol phosphate metabolic process; P:MAPK cascade; P:mitochondrion-endoplasmic reticulum membrane tethering; P:muscle contraction; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:organelle localization by membrane tethering; P:platelet degranulation; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of DNA binding; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytokinesis; P:regulation of heart rate; P:regulation of nitric-oxide synthase activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of rhodopsin mediated signaling pathway; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic vesicle endocytosis; P:regulation of synaptic vesicle exocytosis; P:response to amphetamine; P:response to calcium ion; P:response to corticosterone; P:substantia nigra development; P:tetrahydrobiopterin metabolic process; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q96HK3,Calmodulin-1 {ECO:0000312|HGNC:HGNC:1442},, PF13499;, GO:0034704;GO:1902494;GO:0005813;GO:0005737;GO:0005829;GO:0005576;GO:0030426;GO:0031966;GO:0043209;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0030017;GO:0005876;GO:0000922;GO:0030672;GO:0031982;GO:0008076;GO:0010856;GO:0008179;GO:0019855;GO:0005509;GO:0048306;GO:0097718;GO:0030234;GO:0044325;GO:0031997;GO:0050998;GO:0030235;GO:0043548;GO:0019904;GO:0019901;GO:0072542;GO:0043539;GO:0031432;GO:0031800;GO:0007190;GO:0016240;GO:0007268;GO:0005513;GO:0090151;GO:0038095;GO:0007186;GO:0000086;GO:0005980;GO:0043647;GO:0000165;GO:1990456;GO:0006936;GO:1901842;GO:0010801;GO:0060315;GO:0140056;GO:0002576;GO:0051343;GO:0043388;GO:0051000;GO:0010800;GO:0032516;GO:0031954;GO:0035307;GO:0071902;GO:0060316;GO:0098901;GO:0055117;GO:0010881;GO:1901844;GO:0032465;GO:0002027;GO:0050999;GO:0010880;GO:0022400;GO:0060314;GO:1900242;GO:2000300;GO:0001975;GO:0051592;GO:0051412;GO:0021762;GO:0046146;GO:0016032;GO:0007223;, C:calcium channel complex; C:catalytic complex; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular region; C:growth cone; C:mitochondrial membrane; C:myelin sheath; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:sarcomere; C:spindle microtubule; C:spindle pole; C:synaptic vesicle membrane; C:vesicle; C:voltage-gated potassium channel complex;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium-dependent protein binding; F:disordered domain specific binding; F:enzyme regulator activity; F:ion channel binding; F:N-terminal myristoylation domain binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase activator activity; F:protein serine/threonine kinase activator activity; F:titin binding; F:type 3 metabotropic glutamate receptor binding;, P:activation of adenylate cyclase activity; P:autophagosome membrane docking; P:chemical synaptic transmission; P:detection of calcium ion; P:establishment of protein localization to mitochondrial membrane; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:glycogen catabolic process; P:inositol phosphate metabolic process; P:MAPK cascade; P:mitochondrion-endoplasmic reticulum membrane tethering; P:muscle contraction; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:organelle localization by membrane tethering; P:platelet degranulation; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of DNA binding; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytokinesis; P:regulation of heart rate; P:regulation of nitric-oxide synthase activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of rhodopsin mediated signaling pathway; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic vesicle endocytosis; P:regulation of synaptic vesicle exocytosis; P:response to amphetamine; P:response to calcium ion; P:response to corticosterone; P:substantia nigra development; P:tetrahydrobiopterin metabolic process; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q96HK3,Calmodulin-1 {ECO:0000312|HGNC:HGNC:1442},, PF13499;, GO:0034704;GO:1902494;GO:0005813;GO:0005737;GO:0005829;GO:0005576;GO:0030426;GO:0031966;GO:0043209;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0030017;GO:0005876;GO:0000922;GO:0030672;GO:0031982;GO:0008076;GO:0010856;GO:0008179;GO:0019855;GO:0005509;GO:0048306;GO:0097718;GO:0030234;GO:0044325;GO:0031997;GO:0050998;GO:0030235;GO:0043548;GO:0019904;GO:0019901;GO:0072542;GO:0043539;GO:0031432;GO:0031800;GO:0007190;GO:0016240;GO:0007268;GO:0005513;GO:0090151;GO:0038095;GO:0007186;GO:0000086;GO:0005980;GO:0043647;GO:0000165;GO:1990456;GO:0006936;GO:1901842;GO:0010801;GO:0060315;GO:0140056;GO:0002576;GO:0051343;GO:0043388;GO:0051000;GO:0010800;GO:0032516;GO:0031954;GO:0035307;GO:0071902;GO:0060316;GO:0098901;GO:0055117;GO:0010881;GO:1901844;GO:0032465;GO:0002027;GO:0050999;GO:0010880;GO:0022400;GO:0060314;GO:1900242;GO:2000300;GO:0001975;GO:0051592;GO:0051412;GO:0021762;GO:0046146;GO:0016032;GO:0007223;, C:calcium channel complex; C:catalytic complex; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular region; C:growth cone; C:mitochondrial membrane; C:myelin sheath; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:sarcomere; C:spindle microtubule; C:spindle pole; C:synaptic vesicle membrane; C:vesicle; C:voltage-gated potassium channel complex;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium-dependent protein binding; F:disordered domain specific binding; F:enzyme regulator activity; F:ion channel binding; F:N-terminal myristoylation domain binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase activator activity; F:protein serine/threonine kinase activator activity; F:titin binding; F:type 3 metabotropic glutamate receptor binding;, P:activation of adenylate cyclase activity; P:autophagosome membrane docking; P:chemical synaptic transmission; P:detection of calcium ion; P:establishment of protein localization to mitochondrial membrane; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:glycogen catabolic process; P:inositol phosphate metabolic process; P:MAPK cascade; P:mitochondrion-endoplasmic reticulum membrane tethering; P:muscle contraction; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:organelle localization by membrane tethering; P:platelet degranulation; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of DNA binding; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytokinesis; P:regulation of heart rate; P:regulation of nitric-oxide synthase activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of rhodopsin mediated signaling pathway; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic vesicle endocytosis; P:regulation of synaptic vesicle exocytosis; P:response to amphetamine; P:response to calcium ion; P:response to corticosterone; P:substantia nigra development; P:tetrahydrobiopterin metabolic process; P:viral process; P:Wnt signaling pathway, calcium modulating pathway; scaffold6 indexed_genome mRNA 35063566 35064150 . - . ID=transcript_1669;Q8N801 H7C2Z2,Protein STPG4 {ECO:0000305},Gonad-specific expression gene protein {ECO:0000250|UniProtKB:Q9DAG5};Sperm-tail PG-rich repeat-containing protein 4 {ECO:0000312|HGNC:HGNC:26850};, PF07004;, GO:0005737;GO:0001939;GO:0042585;GO:0001940;GO:0005634;GO:0003682;GO:0042393;GO:0090116;GO:0006325;GO:0044727;GO:1901537;, C:cytoplasm; C:female pronucleus; C:germinal vesicle; C:male pronucleus; C:nucleus;, F:chromatin binding; F:histone binding;, P:C-5 methylation of cytosine; P:chromatin organization; P:DNA demethylation of male pronucleus; P:positive regulation of DNA demethylation; scaffold6 indexed_genome mRNA 35080972 35201034 . - . ID=transcript_1670;Q9ULT0 Q2T9J9 Q6PIX4 Q8ND67 Q9BUS3,Tetratricopeptide repeat protein 7A {ECO:0000305},, PF13181;, GO:0005737;GO:0005886;GO:0006879;GO:0030097;GO:0046854;GO:0072659;, C:cytoplasm; C:plasma membrane;, , P:cellular iron ion homeostasis; P:hemopoiesis; P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane; scaffold6 indexed_genome mRNA 35384669 35464151 . + . ID=transcript_1671;O75159 Q53SD4 Q8IYZ4,Suppressor of cytokine signaling 5,Cytokine-inducible SH2 protein 6;Cytokine-inducible SH2-containing protein 5;, PF00017;PF12610;PF07525;, GO:0005829;GO:0005942;GO:0046935;GO:0005154;GO:0030971;GO:0071404;GO:0019221;GO:0007173;GO:0035556;GO:0007175;GO:0050728;GO:0032715;GO:0071638;GO:0009968;GO:0045629;GO:0046854;GO:0032436;GO:0045627;GO:0043687;GO:0016567;GO:0007259;GO:0040008;GO:0097699;, C:cytosol; C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase regulator activity; F:epidermal growth factor receptor binding; F:receptor tyrosine kinase binding;, P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of inflammatory response; P:negative regulation of interleukin-6 production; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of signal transduction; P:negative regulation of T-helper 2 cell differentiation; P:phosphatidylinositol phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of T-helper 1 cell differentiation; P:post-translational protein modification; P:protein ubiquitination; P:receptor signaling pathway via JAK-STAT; P:regulation of growth; P:vascular endothelial cell response to fluid shear stress; scaffold6 indexed_genome mRNA 35525655 35539776 . - . ID=transcript_1672;Q9P021,Cysteine-rich PDZ-binding protein,Cysteine-rich interactor of PDZ three;, PF10235;, GO:0005737;GO:0030425;GO:0043198;GO:0043197;GO:0043025;GO:0014069;GO:0008017;GO:0030165;GO:0044877;GO:0097110;GO:0031122;GO:0045184;GO:0035372;GO:1902897;, C:cytoplasm; C:dendrite; C:dendritic shaft; C:dendritic spine; C:neuronal cell body; C:postsynaptic density;, F:microtubule binding; F:PDZ domain binding; F:protein-containing complex binding; F:scaffold protein binding;, P:cytoplasmic microtubule organization; P:establishment of protein localization; P:protein localization to microtubule; P:regulation of postsynaptic density protein 95 clustering;|Q9P021,Cysteine-rich PDZ-binding protein,Cysteine-rich interactor of PDZ three;, PF10235;, GO:0005737;GO:0030425;GO:0043198;GO:0043197;GO:0043025;GO:0014069;GO:0008017;GO:0030165;GO:0044877;GO:0097110;GO:0031122;GO:0045184;GO:0035372;GO:1902897;, C:cytoplasm; C:dendrite; C:dendritic shaft; C:dendritic spine; C:neuronal cell body; C:postsynaptic density;, F:microtubule binding; F:PDZ domain binding; F:protein-containing complex binding; F:scaffold protein binding;, P:cytoplasmic microtubule organization; P:establishment of protein localization; P:protein localization to microtubule; P:regulation of postsynaptic density protein 95 clustering;|Q9P021,Cysteine-rich PDZ-binding protein,Cysteine-rich interactor of PDZ three;, PF10235;, GO:0005737;GO:0030425;GO:0043198;GO:0043197;GO:0043025;GO:0014069;GO:0008017;GO:0030165;GO:0044877;GO:0097110;GO:0031122;GO:0045184;GO:0035372;GO:1902897;, C:cytoplasm; C:dendrite; C:dendritic shaft; C:dendritic spine; C:neuronal cell body; C:postsynaptic density;, F:microtubule binding; F:PDZ domain binding; F:protein-containing complex binding; F:scaffold protein binding;, P:cytoplasmic microtubule organization; P:establishment of protein localization; P:protein localization to microtubule; P:regulation of postsynaptic density protein 95 clustering; scaffold6 indexed_genome mRNA 35539947 35608656 . + . ID=transcript_1673;Q07326 Q8WW20,Phosphatidylinositol-glycan biosynthesis class F protein,GPI11 homolog;, PF06699;, GO:0005789;GO:0016021;GO:0004307;GO:0051377;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:ethanolaminephosphotransferase activity; F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q07326 Q8WW20,Phosphatidylinositol-glycan biosynthesis class F protein,GPI11 homolog;, PF06699;, GO:0005789;GO:0016021;GO:0004307;GO:0051377;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:ethanolaminephosphotransferase activity; F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|P17081 D6W5A6 Q0VGN1 Q52LS8 Q53SJ1 Q6NS39 Q6P146 Q7Z480,Rho-related GTP-binding protein RhoQ,Ras-like protein TC10;Ras-like protein family member 7A;, PF00071;, GO:0005884;GO:0005829;GO:0070062;GO:0030660;GO:0045121;GO:0005886;GO:0032427;GO:0005525;GO:0003924;GO:0005522;GO:0016477;GO:0030031;GO:0032869;GO:0030866;GO:0006897;GO:0046039;GO:0008286;GO:1903077;GO:0051491;GO:0046326;GO:0045944;GO:0032956;GO:0008360;GO:0051056;GO:0007264;, C:actin filament; C:cytosol; C:extracellular exosome; C:Golgi-associated vesicle membrane; C:membrane raft; C:plasma membrane;, F:GBD domain binding; F:GTP binding; F:GTPase activity; F:profilin binding;, P:cell migration; P:cell projection assembly; P:cellular response to insulin stimulus; P:cortical actin cytoskeleton organization; P:endocytosis; P:GTP metabolic process; P:insulin receptor signaling pathway; P:negative regulation of protein localization to plasma membrane; P:positive regulation of filopodium assembly; P:positive regulation of glucose import; P:positive regulation of transcription by RNA polymerase II; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction;|P17081 D6W5A6 Q0VGN1 Q52LS8 Q53SJ1 Q6NS39 Q6P146 Q7Z480,Rho-related GTP-binding protein RhoQ,Ras-like protein TC10;Ras-like protein family member 7A;, PF00071;, GO:0005884;GO:0005829;GO:0070062;GO:0030660;GO:0045121;GO:0005886;GO:0032427;GO:0005525;GO:0003924;GO:0005522;GO:0016477;GO:0030031;GO:0032869;GO:0030866;GO:0006897;GO:0046039;GO:0008286;GO:1903077;GO:0051491;GO:0046326;GO:0045944;GO:0032956;GO:0008360;GO:0051056;GO:0007264;, C:actin filament; C:cytosol; C:extracellular exosome; C:Golgi-associated vesicle membrane; C:membrane raft; C:plasma membrane;, F:GBD domain binding; F:GTP binding; F:GTPase activity; F:profilin binding;, P:cell migration; P:cell projection assembly; P:cellular response to insulin stimulus; P:cortical actin cytoskeleton organization; P:endocytosis; P:GTP metabolic process; P:insulin receptor signaling pathway; P:negative regulation of protein localization to plasma membrane; P:positive regulation of filopodium assembly; P:positive regulation of glucose import; P:positive regulation of transcription by RNA polymerase II; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; scaffold6 indexed_genome mRNA 35766260 35804731 . - . ID=transcript_1674;Q99814 Q86VA2 Q99630,Endothelial PAS domain-containing protein 1,Basic-helix-loop-helix-PAS protein MOP2;Class E basic helix-loop-helix protein 73;HIF-1-alpha-like factor;Hypoxia-inducible factor 2-alpha;Member of PAS protein 2;PAS domain-containing protein 2;, PF11413;PF08778;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0016607;GO:0005654;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0035035;GO:0046982;GO:0000978;GO:0000977;GO:0008134;GO:0001525;GO:0001974;GO:0048469;GO:0071456;GO:0001892;GO:0030218;GO:0055072;GO:0030324;GO:0007005;GO:0048625;GO:0042415;GO:0120162;GO:0045944;GO:0043687;GO:0016567;GO:0002027;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0001666;GO:0007165;GO:0035019;GO:0043129;GO:0007601;, C:chromatin; C:cytosol; C:nuclear speck; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:angiogenesis; P:blood vessel remodeling; P:cell maturation; P:cellular response to hypoxia; P:embryonic placenta development; P:erythrocyte differentiation; P:iron ion homeostasis; P:lung development; P:mitochondrion organization; P:myoblast fate commitment; P:norepinephrine metabolic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination; P:regulation of heart rate; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to hypoxia; P:signal transduction; P:somatic stem cell population maintenance; P:surfactant homeostasis; P:visual perception;|Q99814 Q86VA2 Q99630,Endothelial PAS domain-containing protein 1,Basic-helix-loop-helix-PAS protein MOP2;Class E basic helix-loop-helix protein 73;HIF-1-alpha-like factor;Hypoxia-inducible factor 2-alpha;Member of PAS protein 2;PAS domain-containing protein 2;, PF11413;PF08778;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0016607;GO:0005654;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0035035;GO:0046982;GO:0000978;GO:0000977;GO:0008134;GO:0001525;GO:0001974;GO:0048469;GO:0071456;GO:0001892;GO:0030218;GO:0055072;GO:0030324;GO:0007005;GO:0048625;GO:0042415;GO:0120162;GO:0045944;GO:0043687;GO:0016567;GO:0002027;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0001666;GO:0007165;GO:0035019;GO:0043129;GO:0007601;, C:chromatin; C:cytosol; C:nuclear speck; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:angiogenesis; P:blood vessel remodeling; P:cell maturation; P:cellular response to hypoxia; P:embryonic placenta development; P:erythrocyte differentiation; P:iron ion homeostasis; P:lung development; P:mitochondrion organization; P:myoblast fate commitment; P:norepinephrine metabolic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination; P:regulation of heart rate; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to hypoxia; P:signal transduction; P:somatic stem cell population maintenance; P:surfactant homeostasis; P:visual perception;|Q99814 Q86VA2 Q99630,Endothelial PAS domain-containing protein 1,Basic-helix-loop-helix-PAS protein MOP2;Class E basic helix-loop-helix protein 73;HIF-1-alpha-like factor;Hypoxia-inducible factor 2-alpha;Member of PAS protein 2;PAS domain-containing protein 2;, PF11413;PF08778;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0016607;GO:0005654;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0035035;GO:0046982;GO:0000978;GO:0000977;GO:0008134;GO:0001525;GO:0001974;GO:0048469;GO:0071456;GO:0001892;GO:0030218;GO:0055072;GO:0030324;GO:0007005;GO:0048625;GO:0042415;GO:0120162;GO:0045944;GO:0043687;GO:0016567;GO:0002027;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0001666;GO:0007165;GO:0035019;GO:0043129;GO:0007601;, C:chromatin; C:cytosol; C:nuclear speck; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:angiogenesis; P:blood vessel remodeling; P:cell maturation; P:cellular response to hypoxia; P:embryonic placenta development; P:erythrocyte differentiation; P:iron ion homeostasis; P:lung development; P:mitochondrion organization; P:myoblast fate commitment; P:norepinephrine metabolic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination; P:regulation of heart rate; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to hypoxia; P:signal transduction; P:somatic stem cell population maintenance; P:surfactant homeostasis; P:visual perception;|Q99814 Q86VA2 Q99630,Endothelial PAS domain-containing protein 1,Basic-helix-loop-helix-PAS protein MOP2;Class E basic helix-loop-helix protein 73;HIF-1-alpha-like factor;Hypoxia-inducible factor 2-alpha;Member of PAS protein 2;PAS domain-containing protein 2;, PF11413;PF08778;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0016607;GO:0005654;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0035035;GO:0046982;GO:0000978;GO:0000977;GO:0008134;GO:0001525;GO:0001974;GO:0048469;GO:0071456;GO:0001892;GO:0030218;GO:0055072;GO:0030324;GO:0007005;GO:0048625;GO:0042415;GO:0120162;GO:0045944;GO:0043687;GO:0016567;GO:0002027;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0001666;GO:0007165;GO:0035019;GO:0043129;GO:0007601;, C:chromatin; C:cytosol; C:nuclear speck; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:angiogenesis; P:blood vessel remodeling; P:cell maturation; P:cellular response to hypoxia; P:embryonic placenta development; P:erythrocyte differentiation; P:iron ion homeostasis; P:lung development; P:mitochondrion organization; P:myoblast fate commitment; P:norepinephrine metabolic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination; P:regulation of heart rate; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to hypoxia; P:signal transduction; P:somatic stem cell population maintenance; P:surfactant homeostasis; P:visual perception;|Q99814 Q86VA2 Q99630,Endothelial PAS domain-containing protein 1,Basic-helix-loop-helix-PAS protein MOP2;Class E basic helix-loop-helix protein 73;HIF-1-alpha-like factor;Hypoxia-inducible factor 2-alpha;Member of PAS protein 2;PAS domain-containing protein 2;, PF11413;PF08778;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0016607;GO:0005654;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0035035;GO:0046982;GO:0000978;GO:0000977;GO:0008134;GO:0001525;GO:0001974;GO:0048469;GO:0071456;GO:0001892;GO:0030218;GO:0055072;GO:0030324;GO:0007005;GO:0048625;GO:0042415;GO:0120162;GO:0045944;GO:0043687;GO:0016567;GO:0002027;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0001666;GO:0007165;GO:0035019;GO:0043129;GO:0007601;, C:chromatin; C:cytosol; C:nuclear speck; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:angiogenesis; P:blood vessel remodeling; P:cell maturation; P:cellular response to hypoxia; P:embryonic placenta development; P:erythrocyte differentiation; P:iron ion homeostasis; P:lung development; P:mitochondrion organization; P:myoblast fate commitment; P:norepinephrine metabolic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination; P:regulation of heart rate; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to hypoxia; P:signal transduction; P:somatic stem cell population maintenance; P:surfactant homeostasis; P:visual perception;|Q99814 Q86VA2 Q99630,Endothelial PAS domain-containing protein 1,Basic-helix-loop-helix-PAS protein MOP2;Class E basic helix-loop-helix protein 73;HIF-1-alpha-like factor;Hypoxia-inducible factor 2-alpha;Member of PAS protein 2;PAS domain-containing protein 2;, PF11413;PF08778;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0016607;GO:0005654;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0035035;GO:0046982;GO:0000978;GO:0000977;GO:0008134;GO:0001525;GO:0001974;GO:0048469;GO:0071456;GO:0001892;GO:0030218;GO:0055072;GO:0030324;GO:0007005;GO:0048625;GO:0042415;GO:0120162;GO:0045944;GO:0043687;GO:0016567;GO:0002027;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0001666;GO:0007165;GO:0035019;GO:0043129;GO:0007601;, C:chromatin; C:cytosol; C:nuclear speck; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:angiogenesis; P:blood vessel remodeling; P:cell maturation; P:cellular response to hypoxia; P:embryonic placenta development; P:erythrocyte differentiation; P:iron ion homeostasis; P:lung development; P:mitochondrion organization; P:myoblast fate commitment; P:norepinephrine metabolic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination; P:regulation of heart rate; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to hypoxia; P:signal transduction; P:somatic stem cell population maintenance; P:surfactant homeostasis; P:visual perception; scaffold6 indexed_genome mRNA 35956896 35989110 . - . ID=transcript_1675;Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81,Protein kinase C epsilon type,nPKC-epsilon;, PF00130;PF00168;PF00069;PF00433;, GO:0071944;GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0045111;GO:0043231;GO:0005739;GO:0005634;GO:0048471;GO:0005886;GO:0071889;GO:0003785;GO:0005524;GO:0004698;GO:0004699;GO:0008047;GO:0019899;GO:0035276;GO:0046872;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0030546;GO:0006915;GO:0007155;GO:0007049;GO:0051301;GO:0071361;GO:0071456;GO:0071380;GO:0038096;GO:0035556;GO:0031663;GO:0035641;GO:0002281;GO:0031397;GO:2000650;GO:0018105;GO:0030168;GO:0030838;GO:0010811;GO:2001031;GO:0032467;GO:0010634;GO:0010763;GO:0043123;GO:0032024;GO:0050996;GO:0043410;GO:0070257;GO:1903078;GO:0032230;GO:0090303;GO:0006468;GO:0061178;GO:0050730;GO:0051279;GO:0043278;GO:0007165;GO:0035669;, C:cell periphery; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:14-3-3 protein binding; F:actin monomer binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:calcium-independent protein kinase C activity; F:enzyme activator activity; F:enzyme binding; F:ethanol binding; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor activator activity;, P:apoptotic process; P:cell adhesion; P:cell cycle; P:cell division; P:cellular response to ethanol; P:cellular response to hypoxia; P:cellular response to prostaglandin E stimulus; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:locomotory exploration behavior; P:macrophage activation involved in immune response; P:negative regulation of protein ubiquitination; P:negative regulation of sodium ion transmembrane transporter activity; P:peptidyl-serine phosphorylation; P:platelet activation; P:positive regulation of actin filament polymerization; P:positive regulation of cell-substrate adhesion; P:positive regulation of cellular glucuronidation; P:positive regulation of cytokinesis; P:positive regulation of epithelial cell migration; P:positive regulation of fibroblast migration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of insulin secretion; P:positive regulation of lipid catabolic process; P:positive regulation of MAPK cascade; P:positive regulation of mucus secretion; P:positive regulation of protein localization to plasma membrane; P:positive regulation of synaptic transmission, GABAergic; P:positive regulation of wound healing; P:protein phosphorylation; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of release of sequestered calcium ion into cytosol; P:response to morphine; P:signal transduction; P:TRAM-dependent toll-like receptor 4 signaling pathway;|Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81,Protein kinase C epsilon type,nPKC-epsilon;, PF00130;PF00168;PF00069;PF00433;, GO:0071944;GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0045111;GO:0043231;GO:0005739;GO:0005634;GO:0048471;GO:0005886;GO:0071889;GO:0003785;GO:0005524;GO:0004698;GO:0004699;GO:0008047;GO:0019899;GO:0035276;GO:0046872;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0030546;GO:0006915;GO:0007155;GO:0007049;GO:0051301;GO:0071361;GO:0071456;GO:0071380;GO:0038096;GO:0035556;GO:0031663;GO:0035641;GO:0002281;GO:0031397;GO:2000650;GO:0018105;GO:0030168;GO:0030838;GO:0010811;GO:2001031;GO:0032467;GO:0010634;GO:0010763;GO:0043123;GO:0032024;GO:0050996;GO:0043410;GO:0070257;GO:1903078;GO:0032230;GO:0090303;GO:0006468;GO:0061178;GO:0050730;GO:0051279;GO:0043278;GO:0007165;GO:0035669;, C:cell periphery; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:14-3-3 protein binding; F:actin monomer binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:calcium-independent protein kinase C activity; F:enzyme activator activity; F:enzyme binding; F:ethanol binding; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor activator activity;, P:apoptotic process; P:cell adhesion; P:cell cycle; P:cell division; P:cellular response to ethanol; P:cellular response to hypoxia; P:cellular response to prostaglandin E stimulus; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:locomotory exploration behavior; P:macrophage activation involved in immune response; P:negative regulation of protein ubiquitination; P:negative regulation of sodium ion transmembrane transporter activity; P:peptidyl-serine phosphorylation; P:platelet activation; P:positive regulation of actin filament polymerization; P:positive regulation of cell-substrate adhesion; P:positive regulation of cellular glucuronidation; P:positive regulation of cytokinesis; P:positive regulation of epithelial cell migration; P:positive regulation of fibroblast migration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of insulin secretion; P:positive regulation of lipid catabolic process; P:positive regulation of MAPK cascade; P:positive regulation of mucus secretion; P:positive regulation of protein localization to plasma membrane; P:positive regulation of synaptic transmission, GABAergic; P:positive regulation of wound healing; P:protein phosphorylation; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of release of sequestered calcium ion into cytosol; P:response to morphine; P:signal transduction; P:TRAM-dependent toll-like receptor 4 signaling pathway; scaffold6 indexed_genome mRNA 36538081 36766280 . + . ID=transcript_1676;Q8N5C6 Q53T56 Q96TA4 Q9NW11,S1 RNA-binding domain-containing protein 1,, PF17674;PF00575;PF09371;PF16921;, GO:0003729;GO:0003735;GO:0006139;GO:0006412;, , F:mRNA binding; F:structural constituent of ribosome;, P:nucleobase-containing compound metabolic process; P:translation; scaffold6 indexed_genome mRNA 37348481 37407204 . - . ID=transcript_1677;Q7Z624 Q4ZG15 Q53SS6 Q8N6P5 Q9H5G8,Calmodulin-lysine N-methyltransferase,, PF10294;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0032991;GO:0018025;GO:0031072;GO:0007005;GO:0006479;GO:0022400;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:protein-containing complex;, F:calmodulin-lysine N-methyltransferase activity; F:heat shock protein binding;, P:mitochondrion organization; P:protein methylation; P:regulation of rhodopsin mediated signaling pathway; scaffold6 indexed_genome mRNA 37681664 37782745 . - . ID=transcript_1678;Q7Z624 Q4ZG15 Q53SS6 Q8N6P5 Q9H5G8,Calmodulin-lysine N-methyltransferase,, PF10294;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0032991;GO:0018025;GO:0031072;GO:0007005;GO:0006479;GO:0022400;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:protein-containing complex;, F:calmodulin-lysine N-methyltransferase activity; F:heat shock protein binding;, P:mitochondrion organization; P:protein methylation; P:regulation of rhodopsin mediated signaling pathway; scaffold6 indexed_genome mRNA 37783330 37822361 . + . ID=transcript_1679;Q4J6C6 A7E2X6 D6W5A3 O43163 Q4J6C3 Q4J6C4 Q4ZG39 Q6ZMW7 Q96DW7,Prolyl endopeptidase-like,Prolylendopeptidase-like;, PF00326;PF02897;, GO:0005856;GO:0005829;GO:0005794;GO:0005634;GO:0005802;GO:0008233;GO:0004252;GO:0043001;GO:2000300;GO:0042147;, C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:nucleus; C:trans-Golgi network;, F:peptidase activity; F:serine-type endopeptidase activity;, P:Golgi to plasma membrane protein transport; P:regulation of synaptic vesicle exocytosis; P:retrograde transport, endosome to Golgi;|Q4J6C6 A7E2X6 D6W5A3 O43163 Q4J6C3 Q4J6C4 Q4ZG39 Q6ZMW7 Q96DW7,Prolyl endopeptidase-like,Prolylendopeptidase-like;, PF00326;PF02897;, GO:0005856;GO:0005829;GO:0005794;GO:0005634;GO:0005802;GO:0008233;GO:0004252;GO:0043001;GO:2000300;GO:0042147;, C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:nucleus; C:trans-Golgi network;, F:peptidase activity; F:serine-type endopeptidase activity;, P:Golgi to plasma membrane protein transport; P:regulation of synaptic vesicle exocytosis; P:retrograde transport, endosome to Golgi;|Q4J6C6 A7E2X6 D6W5A3 O43163 Q4J6C3 Q4J6C4 Q4ZG39 Q6ZMW7 Q96DW7,Prolyl endopeptidase-like,Prolylendopeptidase-like;, PF00326;PF02897;, GO:0005856;GO:0005829;GO:0005794;GO:0005634;GO:0005802;GO:0008233;GO:0004252;GO:0043001;GO:2000300;GO:0042147;, C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:nucleus; C:trans-Golgi network;, F:peptidase activity; F:serine-type endopeptidase activity;, P:Golgi to plasma membrane protein transport; P:regulation of synaptic vesicle exocytosis; P:retrograde transport, endosome to Golgi;|Q4J6C6 A7E2X6 D6W5A3 O43163 Q4J6C3 Q4J6C4 Q4ZG39 Q6ZMW7 Q96DW7,Prolyl endopeptidase-like,Prolylendopeptidase-like;, PF00326;PF02897;, GO:0005856;GO:0005829;GO:0005794;GO:0005634;GO:0005802;GO:0008233;GO:0004252;GO:0043001;GO:2000300;GO:0042147;, C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:nucleus; C:trans-Golgi network;, F:peptidase activity; F:serine-type endopeptidase activity;, P:Golgi to plasma membrane protein transport; P:regulation of synaptic vesicle exocytosis; P:retrograde transport, endosome to Golgi;|Q4J6C6 A7E2X6 D6W5A3 O43163 Q4J6C3 Q4J6C4 Q4ZG39 Q6ZMW7 Q96DW7,Prolyl endopeptidase-like,Prolylendopeptidase-like;, PF00326;PF02897;, GO:0005856;GO:0005829;GO:0005794;GO:0005634;GO:0005802;GO:0008233;GO:0004252;GO:0043001;GO:2000300;GO:0042147;, C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:nucleus; C:trans-Golgi network;, F:peptidase activity; F:serine-type endopeptidase activity;, P:Golgi to plasma membrane protein transport; P:regulation of synaptic vesicle exocytosis; P:retrograde transport, endosome to Golgi; scaffold6 indexed_genome mRNA 37884741 37886535 . + . ID=transcript_1680;O75688 Q461Q2 Q4J6C1 Q4J6C2 Q658R4 Q96ER6 Q9HAY8,Protein phosphatase 1B,Protein phosphatase 2C isoform beta;, PF00481;PF07830;, GO:0005829;GO:0016020;GO:0005730;GO:0005634;GO:0000287;GO:0030145;GO:0106306;GO:0004722;GO:0106307;GO:0006499;GO:0050687;GO:0043124;GO:0032688;GO:1901223;GO:0035970;GO:0090263;GO:0006470;, C:cytosol; C:membrane; C:nucleolus; C:nucleus;, F:magnesium ion binding; F:manganese ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:N-terminal protein myristoylation; P:negative regulation of defense response to virus; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interferon-beta production; P:negative regulation of NIK/NF-kappaB signaling; P:peptidyl-threonine dephosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:protein dephosphorylation; scaffold6 indexed_genome mRNA 37890408 37964640 . - . ID=transcript_1681;O75688 Q461Q2 Q4J6C1 Q4J6C2 Q658R4 Q96ER6 Q9HAY8,Protein phosphatase 1B,Protein phosphatase 2C isoform beta;, PF00481;PF07830;, GO:0005829;GO:0016020;GO:0005730;GO:0005634;GO:0000287;GO:0030145;GO:0106306;GO:0004722;GO:0106307;GO:0006499;GO:0050687;GO:0043124;GO:0032688;GO:1901223;GO:0035970;GO:0090263;GO:0006470;, C:cytosol; C:membrane; C:nucleolus; C:nucleus;, F:magnesium ion binding; F:manganese ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:N-terminal protein myristoylation; P:negative regulation of defense response to virus; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interferon-beta production; P:negative regulation of NIK/NF-kappaB signaling; P:peptidyl-threonine dephosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:protein dephosphorylation; scaffold6 indexed_genome mRNA 38105311 38207147 . + . ID=transcript_1682;P42704 A0PJE3 A8K1V1 Q53PC0 Q53QN7 Q6ZUD8 Q7Z7A6 Q96D84,Leucine-rich PPR motif-containing protein, mitochondrial,130 kDa leucine-rich protein;GP130;, PF01535;PF13812;PF17177;, GO:0000794;GO:0005856;GO:0016020;GO:0005874;GO:0042645;GO:0005739;GO:0005637;GO:0005640;GO:0005654;GO:0005634;GO:0048471;GO:1990904;GO:0048487;GO:0008017;GO:0003723;GO:0003697;GO:0031625;GO:0047497;GO:0051028;GO:0000961;GO:0070129;, C:condensed nuclear chromosome; C:cytoskeleton; C:membrane; C:microtubule; C:mitochondrial nucleoid; C:mitochondrion; C:nuclear inner membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:ribonucleoprotein complex;, F:beta-tubulin binding; F:microtubule binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:mitochondrion transport along microtubule; P:mRNA transport; P:negative regulation of mitochondrial RNA catabolic process; P:regulation of mitochondrial translation;|P42704 A0PJE3 A8K1V1 Q53PC0 Q53QN7 Q6ZUD8 Q7Z7A6 Q96D84,Leucine-rich PPR motif-containing protein, mitochondrial,130 kDa leucine-rich protein;GP130;, PF01535;PF13812;PF17177;, GO:0000794;GO:0005856;GO:0016020;GO:0005874;GO:0042645;GO:0005739;GO:0005637;GO:0005640;GO:0005654;GO:0005634;GO:0048471;GO:1990904;GO:0048487;GO:0008017;GO:0003723;GO:0003697;GO:0031625;GO:0047497;GO:0051028;GO:0000961;GO:0070129;, C:condensed nuclear chromosome; C:cytoskeleton; C:membrane; C:microtubule; C:mitochondrial nucleoid; C:mitochondrion; C:nuclear inner membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:ribonucleoprotein complex;, F:beta-tubulin binding; F:microtubule binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:mitochondrion transport along microtubule; P:mRNA transport; P:negative regulation of mitochondrial RNA catabolic process; P:regulation of mitochondrial translation;|P42704 A0PJE3 A8K1V1 Q53PC0 Q53QN7 Q6ZUD8 Q7Z7A6 Q96D84,Leucine-rich PPR motif-containing protein, mitochondrial,130 kDa leucine-rich protein;GP130;, PF01535;PF13812;PF17177;, GO:0000794;GO:0005856;GO:0016020;GO:0005874;GO:0042645;GO:0005739;GO:0005637;GO:0005640;GO:0005654;GO:0005634;GO:0048471;GO:1990904;GO:0048487;GO:0008017;GO:0003723;GO:0003697;GO:0031625;GO:0047497;GO:0051028;GO:0000961;GO:0070129;, C:condensed nuclear chromosome; C:cytoskeleton; C:membrane; C:microtubule; C:mitochondrial nucleoid; C:mitochondrion; C:nuclear inner membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:ribonucleoprotein complex;, F:beta-tubulin binding; F:microtubule binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:mitochondrion transport along microtubule; P:mRNA transport; P:negative regulation of mitochondrial RNA catabolic process; P:regulation of mitochondrial translation;|P42704 A0PJE3 A8K1V1 Q53PC0 Q53QN7 Q6ZUD8 Q7Z7A6 Q96D84,Leucine-rich PPR motif-containing protein, mitochondrial,130 kDa leucine-rich protein;GP130;, PF01535;PF13812;PF17177;, GO:0000794;GO:0005856;GO:0016020;GO:0005874;GO:0042645;GO:0005739;GO:0005637;GO:0005640;GO:0005654;GO:0005634;GO:0048471;GO:1990904;GO:0048487;GO:0008017;GO:0003723;GO:0003697;GO:0031625;GO:0047497;GO:0051028;GO:0000961;GO:0070129;, C:condensed nuclear chromosome; C:cytoskeleton; C:membrane; C:microtubule; C:mitochondrial nucleoid; C:mitochondrion; C:nuclear inner membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:ribonucleoprotein complex;, F:beta-tubulin binding; F:microtubule binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:mitochondrion transport along microtubule; P:mRNA transport; P:negative regulation of mitochondrial RNA catabolic process; P:regulation of mitochondrial translation;|P42704 A0PJE3 A8K1V1 Q53PC0 Q53QN7 Q6ZUD8 Q7Z7A6 Q96D84,Leucine-rich PPR motif-containing protein, mitochondrial,130 kDa leucine-rich protein;GP130;, PF01535;PF13812;PF17177;, GO:0000794;GO:0005856;GO:0016020;GO:0005874;GO:0042645;GO:0005739;GO:0005637;GO:0005640;GO:0005654;GO:0005634;GO:0048471;GO:1990904;GO:0048487;GO:0008017;GO:0003723;GO:0003697;GO:0031625;GO:0047497;GO:0051028;GO:0000961;GO:0070129;, C:condensed nuclear chromosome; C:cytoskeleton; C:membrane; C:microtubule; C:mitochondrial nucleoid; C:mitochondrion; C:nuclear inner membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:ribonucleoprotein complex;, F:beta-tubulin binding; F:microtubule binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:mitochondrion transport along microtubule; P:mRNA transport; P:negative regulation of mitochondrial RNA catabolic process; P:regulation of mitochondrial translation; scaffold6 indexed_genome mRNA 38215005 38262538 . - . ID=transcript_1683;Q9H221 Q53QN8,ATP-binding cassette sub-family G member 8 {ECO:0000305},Sterolin-2 {ECO:0000303|PubMed:11452359};, PF01061;PF19055;PF00005;, GO:0016324;GO:0043190;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0016887;GO:0042626;GO:0120020;GO:0046872;GO:0046982;GO:0038183;GO:0033344;GO:0042632;GO:0007588;GO:0030299;GO:0030522;GO:0006869;GO:0045796;GO:0010949;GO:0015914;GO:0042493;GO:0014850;GO:0007584;GO:0015918;GO:0070328;, C:apical plasma membrane; C:ATP-binding cassette (ABC) transporter complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:cholesterol transfer activity; F:metal ion binding; F:protein heterodimerization activity;, P:bile acid signaling pathway; P:cholesterol efflux; P:cholesterol homeostasis; P:excretion; P:intestinal cholesterol absorption; P:intracellular receptor signaling pathway; P:lipid transport; P:negative regulation of intestinal cholesterol absorption; P:negative regulation of intestinal phytosterol absorption; P:phospholipid transport; P:response to drug; P:response to muscle activity; P:response to nutrient; P:sterol transport; P:triglyceride homeostasis;|Q9H221 Q53QN8,ATP-binding cassette sub-family G member 8 {ECO:0000305},Sterolin-2 {ECO:0000303|PubMed:11452359};, PF01061;PF19055;PF00005;, GO:0016324;GO:0043190;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0016887;GO:0042626;GO:0120020;GO:0046872;GO:0046982;GO:0038183;GO:0033344;GO:0042632;GO:0007588;GO:0030299;GO:0030522;GO:0006869;GO:0045796;GO:0010949;GO:0015914;GO:0042493;GO:0014850;GO:0007584;GO:0015918;GO:0070328;, C:apical plasma membrane; C:ATP-binding cassette (ABC) transporter complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:cholesterol transfer activity; F:metal ion binding; F:protein heterodimerization activity;, P:bile acid signaling pathway; P:cholesterol efflux; P:cholesterol homeostasis; P:excretion; P:intestinal cholesterol absorption; P:intracellular receptor signaling pathway; P:lipid transport; P:negative regulation of intestinal cholesterol absorption; P:negative regulation of intestinal phytosterol absorption; P:phospholipid transport; P:response to drug; P:response to muscle activity; P:response to nutrient; P:sterol transport; P:triglyceride homeostasis;|Q9H221 Q53QN8,ATP-binding cassette sub-family G member 8 {ECO:0000305},Sterolin-2 {ECO:0000303|PubMed:11452359};, PF01061;PF19055;PF00005;, GO:0016324;GO:0043190;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0016887;GO:0042626;GO:0120020;GO:0046872;GO:0046982;GO:0038183;GO:0033344;GO:0042632;GO:0007588;GO:0030299;GO:0030522;GO:0006869;GO:0045796;GO:0010949;GO:0015914;GO:0042493;GO:0014850;GO:0007584;GO:0015918;GO:0070328;, C:apical plasma membrane; C:ATP-binding cassette (ABC) transporter complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:cholesterol transfer activity; F:metal ion binding; F:protein heterodimerization activity;, P:bile acid signaling pathway; P:cholesterol efflux; P:cholesterol homeostasis; P:excretion; P:intestinal cholesterol absorption; P:intracellular receptor signaling pathway; P:lipid transport; P:negative regulation of intestinal cholesterol absorption; P:negative regulation of intestinal phytosterol absorption; P:phospholipid transport; P:response to drug; P:response to muscle activity; P:response to nutrient; P:sterol transport; P:triglyceride homeostasis;|Q9H222 Q2T9G2 Q96QZ2 Q96QZ3,ATP-binding cassette sub-family G member 5 {ECO:0000305},Sterolin-1 {ECO:0000303|PubMed:11452359};, PF01061;PF19055;PF00005;, GO:0016324;GO:0043190;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0042626;GO:0120020;GO:0046872;GO:0046982;GO:0038183;GO:0033344;GO:0042632;GO:0007588;GO:0030299;GO:0030522;GO:0006869;GO:0045796;GO:0010949;GO:0042493;GO:0010212;GO:0014850;GO:0007584;GO:0015918;GO:0070328;, C:apical plasma membrane; C:ATP-binding cassette (ABC) transporter complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol transfer activity; F:metal ion binding; F:protein heterodimerization activity;, P:bile acid signaling pathway; P:cholesterol efflux; P:cholesterol homeostasis; P:excretion; P:intestinal cholesterol absorption; P:intracellular receptor signaling pathway; P:lipid transport; P:negative regulation of intestinal cholesterol absorption; P:negative regulation of intestinal phytosterol absorption; P:response to drug; P:response to ionizing radiation; P:response to muscle activity; P:response to nutrient; P:sterol transport; P:triglyceride homeostasis; scaffold6 indexed_genome mRNA 38272367 38297420 . - . ID=transcript_1684;Q8TCX1 A8MVJ5 Q53F57 Q6PDB2 Q8IWA3 Q96B03 Q96J00 Q9Y370 Q9Y3S9,Cytoplasmic dynein 2 light intermediate chain 1,, PF05783;, GO:0045177;GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0035869;GO:0005929;GO:0005737;GO:0005868;GO:0005794;GO:0030990;GO:0005874;GO:0031514;GO:0045504;GO:0007368;GO:0035721;GO:0035735;GO:1902017;, C:apical part of cell; C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:ciliary transition zone; C:cilium; C:cytoplasm; C:cytoplasmic dynein complex; C:Golgi apparatus; C:intraciliary transport particle; C:microtubule; C:motile cilium;, F:dynein heavy chain binding;, P:determination of left/right symmetry; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:regulation of cilium assembly;|Q8TCX1 A8MVJ5 Q53F57 Q6PDB2 Q8IWA3 Q96B03 Q96J00 Q9Y370 Q9Y3S9,Cytoplasmic dynein 2 light intermediate chain 1,, PF05783;, GO:0045177;GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0035869;GO:0005929;GO:0005737;GO:0005868;GO:0005794;GO:0030990;GO:0005874;GO:0031514;GO:0045504;GO:0007368;GO:0035721;GO:0035735;GO:1902017;, C:apical part of cell; C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:ciliary transition zone; C:cilium; C:cytoplasm; C:cytoplasmic dynein complex; C:Golgi apparatus; C:intraciliary transport particle; C:microtubule; C:motile cilium;, F:dynein heavy chain binding;, P:determination of left/right symmetry; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:regulation of cilium assembly;|Q8TCX1 A8MVJ5 Q53F57 Q6PDB2 Q8IWA3 Q96B03 Q96J00 Q9Y370 Q9Y3S9,Cytoplasmic dynein 2 light intermediate chain 1,, PF05783;, GO:0045177;GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0035869;GO:0005929;GO:0005737;GO:0005868;GO:0005794;GO:0030990;GO:0005874;GO:0031514;GO:0045504;GO:0007368;GO:0035721;GO:0035735;GO:1902017;, C:apical part of cell; C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:ciliary transition zone; C:cilium; C:cytoplasm; C:cytoplasmic dynein complex; C:Golgi apparatus; C:intraciliary transport particle; C:microtubule; C:motile cilium;, F:dynein heavy chain binding;, P:determination of left/right symmetry; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:regulation of cilium assembly; scaffold6 indexed_genome mRNA 38315641 38374158 . - . ID=transcript_1685;Q8IVE3 Q5JPJ6 Q6P4Q1 Q8N3Q3,Pleckstrin homology domain-containing family H member 2,, PF00373;PF00784;PF00169;, GO:0030864;GO:0005737;GO:0005829;GO:0030027;GO:0016604;GO:0005654;GO:0005886;GO:0003779;GO:0030835;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:lamellipodium; C:nuclear body; C:nucleoplasm; C:plasma membrane;, F:actin binding;, P:negative regulation of actin filament depolymerization;|Q8IVE3 Q5JPJ6 Q6P4Q1 Q8N3Q3,Pleckstrin homology domain-containing family H member 2,, PF00373;PF00784;PF00169;, GO:0030864;GO:0005737;GO:0005829;GO:0030027;GO:0016604;GO:0005654;GO:0005886;GO:0003779;GO:0030835;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:lamellipodium; C:nuclear body; C:nucleoplasm; C:plasma membrane;, F:actin binding;, P:negative regulation of actin filament depolymerization;|Q8IVE3 Q5JPJ6 Q6P4Q1 Q8N3Q3,Pleckstrin homology domain-containing family H member 2,, PF00373;PF00784;PF00169;, GO:0030864;GO:0005737;GO:0005829;GO:0030027;GO:0016604;GO:0005654;GO:0005886;GO:0003779;GO:0030835;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:lamellipodium; C:nuclear body; C:nucleoplasm; C:plasma membrane;, F:actin binding;, P:negative regulation of actin filament depolymerization; scaffold6 indexed_genome mRNA 38374376 38412720 . - . ID=transcript_1686;Q8IVE3 Q5JPJ6 Q6P4Q1 Q8N3Q3,Pleckstrin homology domain-containing family H member 2,, PF00373;PF00784;PF00169;, GO:0030864;GO:0005737;GO:0005829;GO:0030027;GO:0016604;GO:0005654;GO:0005886;GO:0003779;GO:0030835;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:lamellipodium; C:nuclear body; C:nucleoplasm; C:plasma membrane;, F:actin binding;, P:negative regulation of actin filament depolymerization; scaffold6 indexed_genome mRNA 38450939 38726985 . + . ID=transcript_1687;Q8TAU8 Q96I88 Q9BZF7 Q9C096 Q9H6U0 Q9H6W7,Thyroid adenoma-associated protein,Gene inducing thyroid adenomas protein;, PF10350;, GO:0098554;GO:0005829;GO:1990845;GO:0055088;GO:1901895;GO:0032471;GO:0030488;, C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol;, , P:adaptive thermogenesis; P:lipid homeostasis; P:negative regulation of ATPase-coupled calcium transmembrane transporter activity; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:tRNA methylation;|Q8TAU8 Q96I88 Q9BZF7 Q9C096 Q9H6U0 Q9H6W7,Thyroid adenoma-associated protein,Gene inducing thyroid adenomas protein;, PF10350;, GO:0098554;GO:0005829;GO:1990845;GO:0055088;GO:1901895;GO:0032471;GO:0030488;, C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol;, , P:adaptive thermogenesis; P:lipid homeostasis; P:negative regulation of ATPase-coupled calcium transmembrane transporter activity; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:tRNA methylation; scaffold6 indexed_genome mRNA 38778717 38779572 . - . ID=transcript_1688;P47974 Q53TB4 Q9BSJ3,mRNA decay activator protein ZFP36L2 {ECO:0000305},Butyrate response factor 2 {ECO:0000303|PubMed:10367403};EGF-response factor 2 {ECO:0000303|PubMed:7835719};TPA-induced sequence 11d {ECO:0000303|PubMed:7835719};Zinc finger protein 36, C3H1 type-like 2 {ECO:0000312|HGNC:HGNC:1108};, PF04553;PF00642;, GO:0005737;GO:0005634;GO:0046872;GO:0035925;GO:0003723;GO:0061158;GO:0071364;GO:0044344;GO:0071385;GO:0097011;GO:0071560;GO:0071356;GO:0060216;GO:0070371;GO:0030097;GO:0006402;GO:0045599;GO:1901991;GO:2000737;GO:0000288;GO:1900153;GO:0045577;GO:0043488;GO:0009611;GO:0048103;GO:0035019;GO:0033077;, C:cytoplasm; C:nucleus;, F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to epidermal growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to glucocorticoid stimulus; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:definitive hemopoiesis; P:ERK1 and ERK2 cascade; P:hemopoiesis; P:mRNA catabolic process; P:negative regulation of fat cell differentiation; P:negative regulation of mitotic cell cycle phase transition; P:negative regulation of stem cell differentiation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:regulation of B cell differentiation; P:regulation of mRNA stability; P:response to wounding; P:somatic stem cell division; P:somatic stem cell population maintenance; P:T cell differentiation in thymus; scaffold6 indexed_genome mRNA 39157871 39173067 . + . ID=transcript_1689;P46952 A6NE56 B4DIN2 Q53QZ7 Q8N6N9,3-hydroxyanthranilate 3,4-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03019},3-hydroxyanthranilate oxygenase {ECO:0000255|HAMAP-Rule:MF_03019};3-hydroxyanthranilic acid dioxygenase {ECO:0000255|HAMAP-Rule:MF_03019};, PF06052;, GO:0005737;GO:0005829;GO:0000334;GO:0009055;GO:0008198;GO:0034354;GO:0043420;GO:0009435;GO:0070050;GO:0019805;GO:0046874;GO:0046686;GO:0010043;GO:0006569;, C:cytoplasm; C:cytosol;, F:3-hydroxyanthranilate 3,4-dioxygenase activity; F:electron transfer activity; F:ferrous iron binding;, P:'de novo' NAD biosynthetic process from tryptophan; P:anthranilate metabolic process; P:NAD biosynthetic process; P:neuron cellular homeostasis; P:quinolinate biosynthetic process; P:quinolinate metabolic process; P:response to cadmium ion; P:response to zinc ion; P:tryptophan catabolic process;|P46952 A6NE56 B4DIN2 Q53QZ7 Q8N6N9,3-hydroxyanthranilate 3,4-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03019},3-hydroxyanthranilate oxygenase {ECO:0000255|HAMAP-Rule:MF_03019};3-hydroxyanthranilic acid dioxygenase {ECO:0000255|HAMAP-Rule:MF_03019};, PF06052;, GO:0005737;GO:0005829;GO:0000334;GO:0009055;GO:0008198;GO:0034354;GO:0043420;GO:0009435;GO:0070050;GO:0019805;GO:0046874;GO:0046686;GO:0010043;GO:0006569;, C:cytoplasm; C:cytosol;, F:3-hydroxyanthranilate 3,4-dioxygenase activity; F:electron transfer activity; F:ferrous iron binding;, P:'de novo' NAD biosynthetic process from tryptophan; P:anthranilate metabolic process; P:NAD biosynthetic process; P:neuron cellular homeostasis; P:quinolinate biosynthetic process; P:quinolinate metabolic process; P:response to cadmium ion; P:response to zinc ion; P:tryptophan catabolic process;|P46952 A6NE56 B4DIN2 Q53QZ7 Q8N6N9,3-hydroxyanthranilate 3,4-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03019},3-hydroxyanthranilate oxygenase {ECO:0000255|HAMAP-Rule:MF_03019};3-hydroxyanthranilic acid dioxygenase {ECO:0000255|HAMAP-Rule:MF_03019};, PF06052;, GO:0005737;GO:0005829;GO:0000334;GO:0009055;GO:0008198;GO:0034354;GO:0043420;GO:0009435;GO:0070050;GO:0019805;GO:0046874;GO:0046686;GO:0010043;GO:0006569;, C:cytoplasm; C:cytosol;, F:3-hydroxyanthranilate 3,4-dioxygenase activity; F:electron transfer activity; F:ferrous iron binding;, P:'de novo' NAD biosynthetic process from tryptophan; P:anthranilate metabolic process; P:NAD biosynthetic process; P:neuron cellular homeostasis; P:quinolinate biosynthetic process; P:quinolinate metabolic process; P:response to cadmium ion; P:response to zinc ion; P:tryptophan catabolic process;|P46952 A6NE56 B4DIN2 Q53QZ7 Q8N6N9,3-hydroxyanthranilate 3,4-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03019},3-hydroxyanthranilate oxygenase {ECO:0000255|HAMAP-Rule:MF_03019};3-hydroxyanthranilic acid dioxygenase {ECO:0000255|HAMAP-Rule:MF_03019};, PF06052;, GO:0005737;GO:0005829;GO:0000334;GO:0009055;GO:0008198;GO:0034354;GO:0043420;GO:0009435;GO:0070050;GO:0019805;GO:0046874;GO:0046686;GO:0010043;GO:0006569;, C:cytoplasm; C:cytosol;, F:3-hydroxyanthranilate 3,4-dioxygenase activity; F:electron transfer activity; F:ferrous iron binding;, P:'de novo' NAD biosynthetic process from tryptophan; P:anthranilate metabolic process; P:NAD biosynthetic process; P:neuron cellular homeostasis; P:quinolinate biosynthetic process; P:quinolinate metabolic process; P:response to cadmium ion; P:response to zinc ion; P:tryptophan catabolic process;|P46952 A6NE56 B4DIN2 Q53QZ7 Q8N6N9,3-hydroxyanthranilate 3,4-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03019},3-hydroxyanthranilate oxygenase {ECO:0000255|HAMAP-Rule:MF_03019};3-hydroxyanthranilic acid dioxygenase {ECO:0000255|HAMAP-Rule:MF_03019};, PF06052;, GO:0005737;GO:0005829;GO:0000334;GO:0009055;GO:0008198;GO:0034354;GO:0043420;GO:0009435;GO:0070050;GO:0019805;GO:0046874;GO:0046686;GO:0010043;GO:0006569;, C:cytoplasm; C:cytosol;, F:3-hydroxyanthranilate 3,4-dioxygenase activity; F:electron transfer activity; F:ferrous iron binding;, P:'de novo' NAD biosynthetic process from tryptophan; P:anthranilate metabolic process; P:NAD biosynthetic process; P:neuron cellular homeostasis; P:quinolinate biosynthetic process; P:quinolinate metabolic process; P:response to cadmium ion; P:response to zinc ion; P:tryptophan catabolic process; scaffold6 indexed_genome mRNA 39173495 39176316 . + . ID=transcript_1690;Q8TDS5 Q86WP7 Q8NGW4,Oxoeicosanoid receptor 1,5-oxo-ETE G-protein coupled receptor;G-protein coupled receptor 170;G-protein coupled receptor R527;G-protein coupled receptor TG1019;, PF00001;, GO:0016021;GO:0005886;GO:0050648;GO:0050647;GO:0050646;GO:0004930;GO:0007193;GO:0007186;, C:integral component of membrane; C:plasma membrane;, F:5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding; F:5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding; F:5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding; F:G protein-coupled receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold6 indexed_genome mRNA 39204772 39353318 . - . ID=transcript_1691;Q9BTC8 Q9NSP2 Q9ULF4,Metastasis-associated protein MTA3,, PF01426;PF01448;PF00320;PF17226;PF00249;, GO:0005737;GO:0043231;GO:0005654;GO:0016581;GO:0003682;GO:0042826;GO:0044877;GO:0001103;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0016575;GO:0000122;GO:0045892;GO:0008284;GO:0010971;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:NuRD complex;, F:chromatin binding; F:histone deacetylase binding; F:protein-containing complex binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; scaffold6 indexed_genome mRNA 39518003 39529351 . + . ID=transcript_1692;O14548 Q9P118,Cytochrome c oxidase subunit 7A-related protein, mitochondrial,COX7a-related protein;Cytochrome c oxidase subunit VIIa-related protein;EB1;, PF02238;, GO:0005743;GO:0005746;GO:0005739;GO:0005730;GO:0004129;GO:0006123;GO:0097250;GO:0002082;, C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion; C:nucleolus;, F:cytochrome-c oxidase activity;, P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial respirasome assembly; P:regulation of oxidative phosphorylation; scaffold6 indexed_genome mRNA 39547698 39694438 . - . ID=transcript_1693;Q9NV40,Echinoderm microtubule-associated protein-like 4,Restrictedly overexpressed proliferation-associated protein;Ropp 120;, PF03451;PF00400;, GO:0005737;GO:0005829;GO:0016020;GO:0005874;GO:0005815;GO:0030496;GO:0072686;GO:0043014;GO:0048487;GO:0008017;GO:0008608;GO:0051301;GO:0000226;GO:0007017;GO:0000278;GO:0007080;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule; C:microtubule organizing center; C:midbody; C:mitotic spindle;, F:alpha-tubulin binding; F:beta-tubulin binding; F:microtubule binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:microtubule cytoskeleton organization; P:microtubule-based process; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:mitotic spindle organization;|Q9NV40,Echinoderm microtubule-associated protein-like 4,Restrictedly overexpressed proliferation-associated protein;Ropp 120;, PF03451;PF00400;, GO:0005737;GO:0005829;GO:0016020;GO:0005874;GO:0005815;GO:0030496;GO:0072686;GO:0043014;GO:0048487;GO:0008017;GO:0008608;GO:0051301;GO:0000226;GO:0007017;GO:0000278;GO:0007080;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule; C:microtubule organizing center; C:midbody; C:mitotic spindle;, F:alpha-tubulin binding; F:beta-tubulin binding; F:microtubule binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:microtubule cytoskeleton organization; P:microtubule-based process; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:mitotic spindle organization;|Q9NV40,Echinoderm microtubule-associated protein-like 4,Restrictedly overexpressed proliferation-associated protein;Ropp 120;, PF03451;PF00400;, GO:0005737;GO:0005829;GO:0016020;GO:0005874;GO:0005815;GO:0030496;GO:0072686;GO:0043014;GO:0048487;GO:0008017;GO:0008608;GO:0051301;GO:0000226;GO:0007017;GO:0000278;GO:0007080;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule; C:microtubule organizing center; C:midbody; C:mitotic spindle;, F:alpha-tubulin binding; F:beta-tubulin binding; F:microtubule binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:microtubule cytoskeleton organization; P:microtubule-based process; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:mitotic spindle organization;|Q9NV40,Echinoderm microtubule-associated protein-like 4,Restrictedly overexpressed proliferation-associated protein;Ropp 120;, PF03451;PF00400;, GO:0005737;GO:0005829;GO:0016020;GO:0005874;GO:0005815;GO:0030496;GO:0072686;GO:0043014;GO:0048487;GO:0008017;GO:0008608;GO:0051301;GO:0000226;GO:0007017;GO:0000278;GO:0007080;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule; C:microtubule organizing center; C:midbody; C:mitotic spindle;, F:alpha-tubulin binding; F:beta-tubulin binding; F:microtubule binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:microtubule cytoskeleton organization; P:microtubule-based process; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:mitotic spindle organization;|Q9NV40,Echinoderm microtubule-associated protein-like 4,Restrictedly overexpressed proliferation-associated protein;Ropp 120;, PF03451;PF00400;, GO:0005737;GO:0005829;GO:0016020;GO:0005874;GO:0005815;GO:0030496;GO:0072686;GO:0043014;GO:0048487;GO:0008017;GO:0008608;GO:0051301;GO:0000226;GO:0007017;GO:0000278;GO:0007080;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule; C:microtubule organizing center; C:midbody; C:mitotic spindle;, F:alpha-tubulin binding; F:beta-tubulin binding; F:microtubule binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:microtubule cytoskeleton organization; P:microtubule-based process; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:mitotic spindle organization; scaffold6 indexed_genome mRNA 39812275 39816610 . - . ID=transcript_1694;Q504Y2 D6W5A0 Q96I09,Extracellular tyrosine-protein kinase PKDCC {ECO:0000305},Protein kinase domain-containing protein, cytoplasmic {ECO:0000312|HGNC:HGNC:25123};Protein kinase-like protein SgK493;Sugen kinase 493;Vertebrate lonesome kinase {ECO:0000250|UniProtKB:Q5RJI4};, PF12260;, GO:0005576;GO:0005794;GO:0005524;GO:0004715;GO:0004672;GO:0004714;GO:0030282;GO:0030154;GO:0048566;GO:0035108;GO:0048286;GO:0035264;GO:0042997;GO:0018108;GO:0030501;GO:0032332;GO:0015031;GO:0060021;GO:0001501;, C:extracellular region; C:Golgi apparatus;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:bone mineralization; P:cell differentiation; P:embryonic digestive tract development; P:limb morphogenesis; P:lung alveolus development; P:multicellular organism growth; P:negative regulation of Golgi to plasma membrane protein transport; P:peptidyl-tyrosine phosphorylation; P:positive regulation of bone mineralization; P:positive regulation of chondrocyte differentiation; P:protein transport; P:roof of mouth development; P:skeletal system development;|Q504Y2 D6W5A0 Q96I09,Extracellular tyrosine-protein kinase PKDCC {ECO:0000305},Protein kinase domain-containing protein, cytoplasmic {ECO:0000312|HGNC:HGNC:25123};Protein kinase-like protein SgK493;Sugen kinase 493;Vertebrate lonesome kinase {ECO:0000250|UniProtKB:Q5RJI4};, PF12260;, GO:0005576;GO:0005794;GO:0005524;GO:0004715;GO:0004672;GO:0004714;GO:0030282;GO:0030154;GO:0048566;GO:0035108;GO:0048286;GO:0035264;GO:0042997;GO:0018108;GO:0030501;GO:0032332;GO:0015031;GO:0060021;GO:0001501;, C:extracellular region; C:Golgi apparatus;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:bone mineralization; P:cell differentiation; P:embryonic digestive tract development; P:limb morphogenesis; P:lung alveolus development; P:multicellular organism growth; P:negative regulation of Golgi to plasma membrane protein transport; P:peptidyl-tyrosine phosphorylation; P:positive regulation of bone mineralization; P:positive regulation of chondrocyte differentiation; P:protein transport; P:roof of mouth development; P:skeletal system development; scaffold6 indexed_genome mRNA 39817382 39817990 . - . ID=transcript_1695;Q504Y2 D6W5A0 Q96I09,Extracellular tyrosine-protein kinase PKDCC {ECO:0000305},Protein kinase domain-containing protein, cytoplasmic {ECO:0000312|HGNC:HGNC:25123};Protein kinase-like protein SgK493;Sugen kinase 493;Vertebrate lonesome kinase {ECO:0000250|UniProtKB:Q5RJI4};, PF12260;, GO:0005576;GO:0005794;GO:0005524;GO:0004715;GO:0004672;GO:0004714;GO:0030282;GO:0030154;GO:0048566;GO:0035108;GO:0048286;GO:0035264;GO:0042997;GO:0018108;GO:0030501;GO:0032332;GO:0015031;GO:0060021;GO:0001501;, C:extracellular region; C:Golgi apparatus;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:bone mineralization; P:cell differentiation; P:embryonic digestive tract development; P:limb morphogenesis; P:lung alveolus development; P:multicellular organism growth; P:negative regulation of Golgi to plasma membrane protein transport; P:peptidyl-tyrosine phosphorylation; P:positive regulation of bone mineralization; P:positive regulation of chondrocyte differentiation; P:protein transport; P:roof of mouth development; P:skeletal system development; scaffold6 indexed_genome mRNA 41481181 41832648 . + . ID=transcript_1696;Q9UDN1 Q9UDN2 Q9UKX6,Sodium/calcium exchanger 1,Na(+)/Ca(2+)-exchange protein 1;Solute carrier family 8 member 1;, PF03160;PF01699;PF16494;, GO:0030424;GO:0043679;GO:0071944;GO:0030425;GO:0043198;GO:0043197;GO:0005887;GO:0099055;GO:0014704;GO:0016020;GO:0005874;GO:0005739;GO:0043025;GO:0005654;GO:0005886;GO:0098794;GO:0014069;GO:0042383;GO:0045202;GO:0030315;GO:0030018;GO:0030506;GO:0005509;GO:1905060;GO:0005432;GO:0005516;GO:0015491;GO:0008092;GO:0099580;GO:0044325;GO:1901660;GO:0055074;GO:0070509;GO:0098703;GO:0070588;GO:0060402;GO:0055013;GO:0060048;GO:0086064;GO:0006874;GO:0071313;GO:0071320;GO:0071456;GO:0034614;GO:0006883;GO:0060401;GO:0006811;GO:0086012;GO:0030001;GO:0006936;GO:0051481;GO:0071901;GO:0030501;GO:0010763;GO:0098735;GO:1903779;GO:0010882;GO:0010881;GO:0010649;GO:0010468;GO:0002027;GO:0002028;GO:0002026;GO:0055119;GO:0044557;GO:0033198;GO:0042493;GO:0009749;GO:0042542;GO:0035902;GO:0035994;GO:0007584;GO:0036376;GO:0098719;GO:0035725;GO:0021537;GO:0014829;, C:axon; C:axon terminus; C:cell periphery; C:dendrite; C:dendritic shaft; C:dendritic spine; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:intercalated disc; C:membrane; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:sarcolemma; C:synapse; C:T-tubule; C:Z disc;, F:ankyrin binding; F:calcium ion binding; F:calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium:sodium antiporter activity; F:calmodulin binding; F:cation:cation antiporter activity; F:cytoskeletal protein binding; F:ion antiporter activity involved in regulation of postsynaptic membrane potential; F:ion channel binding;, P:calcium ion export; P:calcium ion homeostasis; P:calcium ion import; P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:calcium ion transport into cytosol; P:cardiac muscle cell development; P:cardiac muscle contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to cAMP; P:cellular response to hypoxia; P:cellular response to reactive oxygen species; P:cellular sodium ion homeostasis; P:cytosolic calcium ion transport; P:ion transport; P:membrane depolarization during cardiac muscle cell action potential; P:metal ion transport; P:muscle contraction; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of protein serine/threonine kinase activity; P:positive regulation of bone mineralization; P:positive regulation of fibroblast migration; P:positive regulation of the force of heart contraction; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of gene expression; P:regulation of heart rate; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:relaxation of smooth muscle; P:response to ATP; P:response to drug; P:response to glucose; P:response to hydrogen peroxide; P:response to immobilization stress; P:response to muscle stretch; P:response to nutrient; P:sodium ion export across plasma membrane; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport; P:telencephalon development; P:vascular associated smooth muscle contraction; scaffold6 indexed_genome mRNA 42138414 42158567 . + . ID=transcript_1697;Q9BTF0 A8K7I7 Q53TT8 Q53TV0,THUMP domain-containing protein 2,, PF02926;PF01170;, GO:0003723;GO:0016423;GO:0030488;, , F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q9BTF0 A8K7I7 Q53TT8 Q53TV0,THUMP domain-containing protein 2,, PF02926;PF01170;, GO:0003723;GO:0016423;GO:0030488;, , F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q9BTF0 A8K7I7 Q53TT8 Q53TV0,THUMP domain-containing protein 2,, PF02926;PF01170;, GO:0003723;GO:0016423;GO:0030488;, , F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q9BTF0 A8K7I7 Q53TT8 Q53TV0,THUMP domain-containing protein 2,, PF02926;PF01170;, GO:0003723;GO:0016423;GO:0030488;, , F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold6 indexed_genome mRNA 42158600 42176582 . - . ID=transcript_1698;Q9BTF0 A8K7I7 Q53TT8 Q53TV0,THUMP domain-containing protein 2,, PF02926;PF01170;, GO:0003723;GO:0016423;GO:0030488;, , F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q9BTF0 A8K7I7 Q53TT8 Q53TV0,THUMP domain-containing protein 2,, PF02926;PF01170;, GO:0003723;GO:0016423;GO:0030488;, , F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q9BTF0 A8K7I7 Q53TT8 Q53TV0,THUMP domain-containing protein 2,, PF02926;PF01170;, GO:0003723;GO:0016423;GO:0030488;, , F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation; scaffold6 indexed_genome mRNA 42197324 42212037 . + . ID=transcript_1699;Q8NBL3 Q6UWI6 Q8N6N4,Transmembrane protein 178A,, PF13903;, GO:0005789;GO:0016021;GO:0016020;GO:0045671;GO:0051480;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:negative regulation of osteoclast differentiation; P:regulation of cytosolic calcium ion concentration;|Q8NBL3 Q6UWI6 Q8N6N4,Transmembrane protein 178A,, PF13903;, GO:0005789;GO:0016021;GO:0016020;GO:0045671;GO:0051480;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:negative regulation of osteoclast differentiation; P:regulation of cytosolic calcium ion concentration;|Q8NBL3 Q6UWI6 Q8N6N4,Transmembrane protein 178A,, PF13903;, GO:0005789;GO:0016021;GO:0016020;GO:0045671;GO:0051480;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:negative regulation of osteoclast differentiation; P:regulation of cytosolic calcium ion concentration; scaffold6 indexed_genome mRNA 42253545 42254542 . + . ID=transcript_1700;Q8NBL3 Q6UWI6 Q8N6N4,Transmembrane protein 178A,, PF13903;, GO:0005789;GO:0016021;GO:0016020;GO:0045671;GO:0051480;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:negative regulation of osteoclast differentiation; P:regulation of cytosolic calcium ion concentration; scaffold6 indexed_genome mRNA 42254943 42256251 . - . ID=transcript_1701;Q8NBL3 Q6UWI6 Q8N6N4,Transmembrane protein 178A,, PF13903;, GO:0005789;GO:0016021;GO:0016020;GO:0045671;GO:0051480;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:negative regulation of osteoclast differentiation; P:regulation of cytosolic calcium ion concentration; scaffold6 indexed_genome mRNA 42567805 42644941 . + . ID=transcript_1702;Q8IVH8 Q6IQ39 Q8IVH7 Q9UDM5 Q9Y6R5,Mitogen-activated protein kinase kinase kinase kinase 3,Germinal center kinase-related protein kinase;MAPK/ERK kinase kinase kinase 3;, PF00780;PF00069;, GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0007254;GO:0006468;GO:0034612;GO:0009411;, , F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:response to tumor necrosis factor; P:response to UV;|Q8IVH8 Q6IQ39 Q8IVH7 Q9UDM5 Q9Y6R5,Mitogen-activated protein kinase kinase kinase kinase 3,Germinal center kinase-related protein kinase;MAPK/ERK kinase kinase kinase 3;, PF00780;PF00069;, GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0007254;GO:0006468;GO:0034612;GO:0009411;, , F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:response to tumor necrosis factor; P:response to UV;|Q8IVH8 Q6IQ39 Q8IVH7 Q9UDM5 Q9Y6R5,Mitogen-activated protein kinase kinase kinase kinase 3,Germinal center kinase-related protein kinase;MAPK/ERK kinase kinase kinase 3;, PF00780;PF00069;, GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0007254;GO:0006468;GO:0034612;GO:0009411;, , F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:response to tumor necrosis factor; P:response to UV;|Q8IVH8 Q6IQ39 Q8IVH7 Q9UDM5 Q9Y6R5,Mitogen-activated protein kinase kinase kinase kinase 3,Germinal center kinase-related protein kinase;MAPK/ERK kinase kinase kinase 3;, PF00780;PF00069;, GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0007254;GO:0006468;GO:0034612;GO:0009411;, , F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:response to tumor necrosis factor; P:response to UV;|Q8IVH8 Q6IQ39 Q8IVH7 Q9UDM5 Q9Y6R5,Mitogen-activated protein kinase kinase kinase kinase 3,Germinal center kinase-related protein kinase;MAPK/ERK kinase kinase kinase 3;, PF00780;PF00069;, GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0007254;GO:0006468;GO:0034612;GO:0009411;, , F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:response to tumor necrosis factor; P:response to UV;|Q8IVH8 Q6IQ39 Q8IVH7 Q9UDM5 Q9Y6R5,Mitogen-activated protein kinase kinase kinase kinase 3,Germinal center kinase-related protein kinase;MAPK/ERK kinase kinase kinase 3;, PF00780;PF00069;, GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0007254;GO:0006468;GO:0034612;GO:0009411;, , F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:response to tumor necrosis factor; P:response to UV;|Q8IVH8 Q6IQ39 Q8IVH7 Q9UDM5 Q9Y6R5,Mitogen-activated protein kinase kinase kinase kinase 3,Germinal center kinase-related protein kinase;MAPK/ERK kinase kinase kinase 3;, PF00780;PF00069;, GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0007254;GO:0006468;GO:0034612;GO:0009411;, , F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:response to tumor necrosis factor; P:response to UV; scaffold6 indexed_genome mRNA 42662306 42701856 . + . ID=transcript_1703;Q5MAI5 Q2NME9,Cyclin-dependent kinase-like 4,, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; scaffold6 indexed_genome mRNA 42861722 42990630 . - . ID=transcript_1704;Q07889 A8K2G3 B4DXG2,Son of sevenless homolog 1,, PF00125;PF00169;PF00617;PF00618;PF00621;, GO:0005737;GO:0005829;GO:0043025;GO:0005886;GO:0014069;GO:0003677;GO:0005096;GO:0005085;GO:0046982;GO:0017124;GO:0007411;GO:0001782;GO:0048514;GO:0003209;GO:0019221;GO:0007173;GO:0038128;GO:0061029;GO:0038095;GO:0007186;GO:0001942;GO:0061384;GO:0008286;GO:0050900;GO:0000165;GO:1904693;GO:0035264;GO:0048011;GO:0003344;GO:0043065;GO:0045742;GO:0051057;GO:0007265;GO:2000973;GO:0051056;GO:0033081;GO:0042129;GO:0060021;GO:0007165;GO:0007296;, C:cytoplasm; C:cytosol; C:neuronal cell body; C:plasma membrane; C:postsynaptic density;, F:DNA binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein heterodimerization activity; F:SH3 domain binding;, P:axon guidance; P:B cell homeostasis; P:blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:eyelid development in camera-type eye; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hair follicle development; P:heart trabecula morphogenesis; P:insulin receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:midbrain morphogenesis; P:multicellular organism growth; P:neurotrophin TRK receptor signaling pathway; P:pericardium morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of small GTPase mediated signal transduction; P:Ras protein signal transduction; P:regulation of pro-B cell differentiation; P:regulation of small GTPase mediated signal transduction; P:regulation of T cell differentiation in thymus; P:regulation of T cell proliferation; P:roof of mouth development; P:signal transduction; P:vitellogenesis;|Q07889 A8K2G3 B4DXG2,Son of sevenless homolog 1,, PF00125;PF00169;PF00617;PF00618;PF00621;, GO:0005737;GO:0005829;GO:0043025;GO:0005886;GO:0014069;GO:0003677;GO:0005096;GO:0005085;GO:0046982;GO:0017124;GO:0007411;GO:0001782;GO:0048514;GO:0003209;GO:0019221;GO:0007173;GO:0038128;GO:0061029;GO:0038095;GO:0007186;GO:0001942;GO:0061384;GO:0008286;GO:0050900;GO:0000165;GO:1904693;GO:0035264;GO:0048011;GO:0003344;GO:0043065;GO:0045742;GO:0051057;GO:0007265;GO:2000973;GO:0051056;GO:0033081;GO:0042129;GO:0060021;GO:0007165;GO:0007296;, C:cytoplasm; C:cytosol; C:neuronal cell body; C:plasma membrane; C:postsynaptic density;, F:DNA binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein heterodimerization activity; F:SH3 domain binding;, P:axon guidance; P:B cell homeostasis; P:blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:eyelid development in camera-type eye; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hair follicle development; P:heart trabecula morphogenesis; P:insulin receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:midbrain morphogenesis; P:multicellular organism growth; P:neurotrophin TRK receptor signaling pathway; P:pericardium morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of small GTPase mediated signal transduction; P:Ras protein signal transduction; P:regulation of pro-B cell differentiation; P:regulation of small GTPase mediated signal transduction; P:regulation of T cell differentiation in thymus; P:regulation of T cell proliferation; P:roof of mouth development; P:signal transduction; P:vitellogenesis;|A8MVX0 J3KPX2,Rho guanine nucleotide exchange factor 33,, PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity;|Q07889 A8K2G3 B4DXG2,Son of sevenless homolog 1,, PF00125;PF00169;PF00617;PF00618;PF00621;, GO:0005737;GO:0005829;GO:0043025;GO:0005886;GO:0014069;GO:0003677;GO:0005096;GO:0005085;GO:0046982;GO:0017124;GO:0007411;GO:0001782;GO:0048514;GO:0003209;GO:0019221;GO:0007173;GO:0038128;GO:0061029;GO:0038095;GO:0007186;GO:0001942;GO:0061384;GO:0008286;GO:0050900;GO:0000165;GO:1904693;GO:0035264;GO:0048011;GO:0003344;GO:0043065;GO:0045742;GO:0051057;GO:0007265;GO:2000973;GO:0051056;GO:0033081;GO:0042129;GO:0060021;GO:0007165;GO:0007296;, C:cytoplasm; C:cytosol; C:neuronal cell body; C:plasma membrane; C:postsynaptic density;, F:DNA binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein heterodimerization activity; F:SH3 domain binding;, P:axon guidance; P:B cell homeostasis; P:blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:eyelid development in camera-type eye; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hair follicle development; P:heart trabecula morphogenesis; P:insulin receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:midbrain morphogenesis; P:multicellular organism growth; P:neurotrophin TRK receptor signaling pathway; P:pericardium morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of small GTPase mediated signal transduction; P:Ras protein signal transduction; P:regulation of pro-B cell differentiation; P:regulation of small GTPase mediated signal transduction; P:regulation of T cell differentiation in thymus; P:regulation of T cell proliferation; P:roof of mouth development; P:signal transduction; P:vitellogenesis;|Q07889 A8K2G3 B4DXG2,Son of sevenless homolog 1,, PF00125;PF00169;PF00617;PF00618;PF00621;, GO:0005737;GO:0005829;GO:0043025;GO:0005886;GO:0014069;GO:0003677;GO:0005096;GO:0005085;GO:0046982;GO:0017124;GO:0007411;GO:0001782;GO:0048514;GO:0003209;GO:0019221;GO:0007173;GO:0038128;GO:0061029;GO:0038095;GO:0007186;GO:0001942;GO:0061384;GO:0008286;GO:0050900;GO:0000165;GO:1904693;GO:0035264;GO:0048011;GO:0003344;GO:0043065;GO:0045742;GO:0051057;GO:0007265;GO:2000973;GO:0051056;GO:0033081;GO:0042129;GO:0060021;GO:0007165;GO:0007296;, C:cytoplasm; C:cytosol; C:neuronal cell body; C:plasma membrane; C:postsynaptic density;, F:DNA binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein heterodimerization activity; F:SH3 domain binding;, P:axon guidance; P:B cell homeostasis; P:blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:eyelid development in camera-type eye; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hair follicle development; P:heart trabecula morphogenesis; P:insulin receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:midbrain morphogenesis; P:multicellular organism growth; P:neurotrophin TRK receptor signaling pathway; P:pericardium morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of small GTPase mediated signal transduction; P:Ras protein signal transduction; P:regulation of pro-B cell differentiation; P:regulation of small GTPase mediated signal transduction; P:regulation of T cell differentiation in thymus; P:regulation of T cell proliferation; P:roof of mouth development; P:signal transduction; P:vitellogenesis;|A8MVX0 J3KPX2,Rho guanine nucleotide exchange factor 33,, PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity;|A8MVX0 J3KPX2,Rho guanine nucleotide exchange factor 33,, PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity;|A8MVX0 J3KPX2,Rho guanine nucleotide exchange factor 33,, PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity;|A8MVX0 J3KPX2,Rho guanine nucleotide exchange factor 33,, PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity; scaffold6 indexed_genome mRNA 42993309 43001899 . - . ID=transcript_1705;Q502X0 Q6UL00,MORN repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30166},MORN motif protein in testis {ECO:0000303|PubMed:19913896};, PF02493;, GO:0001669;GO:0005634;GO:0030154;GO:0007283;, C:acrosomal vesicle; C:nucleus;, , P:cell differentiation; P:spermatogenesis; scaffold6 indexed_genome mRNA 43002018 43070324 . + . ID=transcript_1706;Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q6P158 A2RRC7 Q53SI4 Q6P9G1 Q7Z6H3 Q8NG17 Q96M33,Putative ATP-dependent RNA helicase DHX57,DEAH box protein 57;, PF00270;PF04408;PF00271;PF07717;PF05773;PF18044;, GO:0005524;GO:0046872;GO:0003723;GO:0003724;, , F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity; scaffold6 indexed_genome mRNA 43082326 43088314 . + . ID=transcript_1707;Q8WXD5 B2RDP8 Q53SI5 Q8WVB4 Q9H5G6,Gem-associated protein 6,SIP2;, PF06372;, GO:0005737;GO:0005829;GO:0097504;GO:0016604;GO:0005654;GO:0032797;GO:0034719;GO:0051170;GO:0000398;GO:0000245;GO:0000387;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:nuclear body; C:nucleoplasm; C:SMN complex; C:SMN-Sm protein complex;, , P:import into nucleus; P:mRNA splicing, via spliceosome; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly;|Q8WXD5 B2RDP8 Q53SI5 Q8WVB4 Q9H5G6,Gem-associated protein 6,SIP2;, PF06372;, GO:0005737;GO:0005829;GO:0097504;GO:0016604;GO:0005654;GO:0032797;GO:0034719;GO:0051170;GO:0000398;GO:0000245;GO:0000387;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:nuclear body; C:nucleoplasm; C:SMN complex; C:SMN-Sm protein complex;, , P:import into nucleus; P:mRNA splicing, via spliceosome; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly; scaffold6 indexed_genome mRNA 43106938 43107874 . - . ID=transcript_1708;Q5VTQ0 A5PLN1 B4DQ10 B4DQX4 B4DW93 Q8IVR7 Q8IXZ6 Q8N267,Tetratricopeptide repeat protein 39B,, PF10300;PF13174;, GO:0042632;GO:0006629;GO:0010887;GO:0010874;GO:0090181;, , , P:cholesterol homeostasis; P:lipid metabolic process; P:negative regulation of cholesterol storage; P:regulation of cholesterol efflux; P:regulation of cholesterol metabolic process; scaffold6 indexed_genome mRNA 43125104 43128253 . + . ID=transcript_1709;Q16629 B4DLU6 G5E9M3 Q564D3,Serine/arginine-rich splicing factor 7,Splicing factor 9G8;Splicing factor, arginine/serine-rich 7;, PF00076;, GO:0005737;GO:0070062;GO:0016607;GO:0005654;GO:0005634;GO:0019904;GO:0003723;GO:0008270;GO:1990830;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0006405;GO:0008380;, C:cytoplasm; C:extracellular exosome; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:protein domain specific binding; F:RNA binding; F:zinc ion binding;, P:cellular response to leukemia inhibitory factor; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; scaffold6 indexed_genome mRNA 43141108 43196179 . - . ID=transcript_1710;Q96C23 Q53RY1 Q8NIA2 V9HWA8,Galactose mutarotase {ECO:0000303|PubMed:12753898, ECO:0000303|PubMed:15026423},Aldose 1-epimerase {ECO:0000303|PubMed:12753898};, PF01263;, GO:0005737;GO:0070062;GO:0004034;GO:0030246;GO:0005975;GO:0033499;GO:0006012;GO:0006006;, C:cytoplasm; C:extracellular exosome;, F:aldose 1-epimerase activity; F:carbohydrate binding;, P:carbohydrate metabolic process; P:galactose catabolic process via UDP-galactose; P:galactose metabolic process; P:glucose metabolic process;|Q96C23 Q53RY1 Q8NIA2 V9HWA8,Galactose mutarotase {ECO:0000303|PubMed:12753898, ECO:0000303|PubMed:15026423},Aldose 1-epimerase {ECO:0000303|PubMed:12753898};, PF01263;, GO:0005737;GO:0070062;GO:0004034;GO:0030246;GO:0005975;GO:0033499;GO:0006012;GO:0006006;, C:cytoplasm; C:extracellular exosome;, F:aldose 1-epimerase activity; F:carbohydrate binding;, P:carbohydrate metabolic process; P:galactose catabolic process via UDP-galactose; P:galactose metabolic process; P:glucose metabolic process;|Q96C23 Q53RY1 Q8NIA2 V9HWA8,Galactose mutarotase {ECO:0000303|PubMed:12753898, ECO:0000303|PubMed:15026423},Aldose 1-epimerase {ECO:0000303|PubMed:12753898};, PF01263;, GO:0005737;GO:0070062;GO:0004034;GO:0030246;GO:0005975;GO:0033499;GO:0006012;GO:0006006;, C:cytoplasm; C:extracellular exosome;, F:aldose 1-epimerase activity; F:carbohydrate binding;, P:carbohydrate metabolic process; P:galactose catabolic process via UDP-galactose; P:galactose metabolic process; P:glucose metabolic process; scaffold6 indexed_genome mRNA 43255641 43290875 . + . ID=transcript_1711;Q8WVV9 Q53T80 Q5JB51 Q5JB52 Q659B9 Q8IVH5 Q8IVH6 Q96HR5,Heterogeneous nuclear ribonucleoprotein L-like,Stromal RNA-regulating factor;, PF00076;PF11835;, GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0006397;GO:0033120;GO:0043484;, C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA processing; P:positive regulation of RNA splicing; P:regulation of RNA splicing;|Q8WVV9 Q53T80 Q5JB51 Q5JB52 Q659B9 Q8IVH5 Q8IVH6 Q96HR5,Heterogeneous nuclear ribonucleoprotein L-like,Stromal RNA-regulating factor;, PF00076;PF11835;, GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0006397;GO:0033120;GO:0043484;, C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA processing; P:positive regulation of RNA splicing; P:regulation of RNA splicing;|Q8WVV9 Q53T80 Q5JB51 Q5JB52 Q659B9 Q8IVH5 Q8IVH6 Q96HR5,Heterogeneous nuclear ribonucleoprotein L-like,Stromal RNA-regulating factor;, PF00076;PF11835;, GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0006397;GO:0033120;GO:0043484;, C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA processing; P:positive regulation of RNA splicing; P:regulation of RNA splicing; scaffold6 indexed_genome mRNA 43525364 43526656 . - . ID=transcript_1712;Q8NHH9 B7Z1X2 B7Z7X8 Q4ZG30 Q7Z630 Q8NHH8 Q9H5M7,Atlastin-2,ADP-ribosylation factor-like protein 6-interacting protein 2;, PF02263;PF02841;, GO:0005783;GO:0005789;GO:0098826;GO:0016021;GO:0016020;GO:0005525;GO:0003924;GO:0042802;GO:0007029;GO:1990809;GO:0007030;GO:0051260;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network membrane; C:integral component of membrane; C:membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:Golgi organization; P:protein homooligomerization; scaffold6 indexed_genome mRNA 43526689 43528519 . + . ID=transcript_1713;Q8NHH9 B7Z1X2 B7Z7X8 Q4ZG30 Q7Z630 Q8NHH8 Q9H5M7,Atlastin-2,ADP-ribosylation factor-like protein 6-interacting protein 2;, PF02263;PF02841;, GO:0005783;GO:0005789;GO:0098826;GO:0016021;GO:0016020;GO:0005525;GO:0003924;GO:0042802;GO:0007029;GO:1990809;GO:0007030;GO:0051260;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network membrane; C:integral component of membrane; C:membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:Golgi organization; P:protein homooligomerization; scaffold6 indexed_genome mRNA 43528558 43532650 . - . ID=transcript_1714;Q8NHH9 B7Z1X2 B7Z7X8 Q4ZG30 Q7Z630 Q8NHH8 Q9H5M7,Atlastin-2,ADP-ribosylation factor-like protein 6-interacting protein 2;, PF02263;PF02841;, GO:0005783;GO:0005789;GO:0098826;GO:0016021;GO:0016020;GO:0005525;GO:0003924;GO:0042802;GO:0007029;GO:1990809;GO:0007030;GO:0051260;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network membrane; C:integral component of membrane; C:membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:Golgi organization; P:protein homooligomerization;|Q8NHH9 B7Z1X2 B7Z7X8 Q4ZG30 Q7Z630 Q8NHH8 Q9H5M7,Atlastin-2,ADP-ribosylation factor-like protein 6-interacting protein 2;, PF02263;PF02841;, GO:0005783;GO:0005789;GO:0098826;GO:0016021;GO:0016020;GO:0005525;GO:0003924;GO:0042802;GO:0007029;GO:1990809;GO:0007030;GO:0051260;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network membrane; C:integral component of membrane; C:membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:Golgi organization; P:protein homooligomerization; scaffold6 indexed_genome mRNA 43532691 43533752 . - . ID=transcript_1715;Q8NHH9 B7Z1X2 B7Z7X8 Q4ZG30 Q7Z630 Q8NHH8 Q9H5M7,Atlastin-2,ADP-ribosylation factor-like protein 6-interacting protein 2;, PF02263;PF02841;, GO:0005783;GO:0005789;GO:0098826;GO:0016021;GO:0016020;GO:0005525;GO:0003924;GO:0042802;GO:0007029;GO:1990809;GO:0007030;GO:0051260;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network membrane; C:integral component of membrane; C:membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:Golgi organization; P:protein homooligomerization; scaffold6 indexed_genome mRNA 43534412 43538056 . - . ID=transcript_1716;Q8NHH9 B7Z1X2 B7Z7X8 Q4ZG30 Q7Z630 Q8NHH8 Q9H5M7,Atlastin-2,ADP-ribosylation factor-like protein 6-interacting protein 2;, PF02263;PF02841;, GO:0005783;GO:0005789;GO:0098826;GO:0016021;GO:0016020;GO:0005525;GO:0003924;GO:0042802;GO:0007029;GO:1990809;GO:0007030;GO:0051260;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network membrane; C:integral component of membrane; C:membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:Golgi organization; P:protein homooligomerization; scaffold6 indexed_genome mRNA 43710135 43727625 . + . ID=transcript_1717;Q16678 Q5TZW8 Q93089 Q9H316,Cytochrome P450 1B1 {ECO:0000303|PubMed:10426814},CYPIB1;Hydroperoxy icosatetraenoate dehydratase {ECO:0000305|PubMed:21068195};, PF00067;, GO:0005789;GO:0043231;GO:0005739;GO:0070330;GO:0101020;GO:0020037;GO:0106256;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0001525;GO:0019369;GO:0048514;GO:0007155;GO:0006725;GO:0070301;GO:0071407;GO:0030199;GO:0043542;GO:0071603;GO:0019373;GO:0008210;GO:0008631;GO:0046466;GO:0033629;GO:0030336;GO:0008285;GO:0032088;GO:0006809;GO:0097267;GO:0045766;GO:0043065;GO:0046427;GO:0010575;GO:2000377;GO:0009636;GO:0061304;GO:0042574;GO:0042572;GO:0008202;GO:0016125;GO:0009404;GO:0002930;GO:0007601;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:hydroperoxy icosatetraenoate dehydratase activity; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding;, P:angiogenesis; P:arachidonic acid metabolic process; P:blood vessel morphogenesis; P:cell adhesion; P:cellular aromatic compound metabolic process; P:cellular response to hydrogen peroxide; P:cellular response to organic cyclic compound; P:collagen fibril organization; P:endothelial cell migration; P:endothelial cell-cell adhesion; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:membrane lipid catabolic process; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of NF-kappaB transcription factor activity; P:nitric oxide biosynthetic process; P:omega-hydroxylase P450 pathway; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of vascular endothelial growth factor production; P:regulation of reactive oxygen species metabolic process; P:response to toxic substance; P:retinal blood vessel morphogenesis; P:retinal metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:sterol metabolic process; P:toxin metabolic process; P:trabecular meshwork development; P:visual perception; P:xenobiotic metabolic process; scaffold6 indexed_genome mRNA 43776796 43779405 . + . ID=transcript_1718;O14978 B2R634 O43387 Q96H95,Zinc finger protein 263 {ECO:0000312|HGNC:HGNC:13056},Zinc finger protein FPM315 {ECO:0000312|HGNC:HGNC:13056};Zinc finger protein with KRAB and SCAN domains 12 {ECO:0000312|HGNC:HGNC:13056};, PF01352;PF02023;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:0045944;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold6 indexed_genome mRNA 43779418 43780195 . - . ID=transcript_1719;Q9P0L1 A0PJV3 A8K5H0 Q6WL09 Q96FQ2,Zinc finger protein with KRAB and SCAN domains 7,Zinc finger protein 167;Zinc finger protein 448;Zinc finger protein 64;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold6 indexed_genome mRNA 43787836 43788843 . - . ID=transcript_1720;Q96LZ7 A9UMZ7 A9UN00 Q4ZG33 Q6UXN4 Q8N657 Q8N9A2 Q8NCV6 Q8NHM0,Regulator of microtubule dynamics protein 2,Protein FAM82A1;, , GO:0005829;GO:0005794;GO:0016021;GO:0072686;GO:0097431;GO:0005876;GO:0008017;, C:cytosol; C:Golgi apparatus; C:integral component of membrane; C:mitotic spindle; C:mitotic spindle pole; C:spindle microtubule;, F:microtubule binding; scaffold6 indexed_genome mRNA 44093502 44118896 . + . ID=transcript_1721;Q9UKI2 B2R8S0 O95353 Q9UQJ0,Cdc42 effector protein 3,Binder of Rho GTPases 2;MSE55-related Cdc42-binding protein;, PF14957;PF00786;, GO:0015629;GO:0005737;GO:0005856;GO:0005829;GO:0012505;GO:0005886;GO:0005519;GO:0030838;GO:0031274;GO:0008360;GO:0007266;GO:0007165;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endomembrane system; C:plasma membrane;, F:cytoskeletal regulatory protein binding;, P:positive regulation of actin filament polymerization; P:positive regulation of pseudopodium assembly; P:regulation of cell shape; P:Rho protein signal transduction; P:signal transduction; scaffold6 indexed_genome mRNA 44361721 44391670 . - . ID=transcript_1722;Q16769 Q16770 Q3KRG6 Q53TR4,Glutaminyl-peptide cyclotransferase,Glutaminyl cyclase;Glutaminyl-tRNA cyclotransferase;Glutamyl cyclase;, PF04389;, GO:0070062;GO:0005576;GO:1904813;GO:0035580;GO:1904724;GO:0016603;GO:0008270;GO:0006464;GO:0043312;GO:0017186;, C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:specific granule lumen; C:tertiary granule lumen;, F:glutaminyl-peptide cyclotransferase activity; F:zinc ion binding;, P:cellular protein modification process; P:neutrophil degranulation; P:peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase; scaffold6 indexed_genome mRNA 44427486 44521719 . + . ID=transcript_1723;O94806 D6W587 Q53TR7 Q8NEL8,Serine/threonine-protein kinase D3,Protein kinase C nu type;Protein kinase EPK2;nPKC-nu;, PF00130;PF00169;PF00069;, GO:0005829;GO:0016020;GO:0005654;GO:0005524;GO:0004698;GO:0016301;GO:0046872;GO:0004697;GO:0106310;GO:0106311;GO:0007205;GO:0089700;GO:0006468;GO:0030148;, C:cytosol; C:membrane; C:nucleoplasm;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:kinase activity; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein kinase D signaling; P:protein phosphorylation; P:sphingolipid biosynthetic process;|O94806 D6W587 Q53TR7 Q8NEL8,Serine/threonine-protein kinase D3,Protein kinase C nu type;Protein kinase EPK2;nPKC-nu;, PF00130;PF00169;PF00069;, GO:0005829;GO:0016020;GO:0005654;GO:0005524;GO:0004698;GO:0016301;GO:0046872;GO:0004697;GO:0106310;GO:0106311;GO:0007205;GO:0089700;GO:0006468;GO:0030148;, C:cytosol; C:membrane; C:nucleoplasm;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:kinase activity; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein kinase D signaling; P:protein phosphorylation; P:sphingolipid biosynthetic process;|O94806 D6W587 Q53TR7 Q8NEL8,Serine/threonine-protein kinase D3,Protein kinase C nu type;Protein kinase EPK2;nPKC-nu;, PF00130;PF00169;PF00069;, GO:0005829;GO:0016020;GO:0005654;GO:0005524;GO:0004698;GO:0016301;GO:0046872;GO:0004697;GO:0106310;GO:0106311;GO:0007205;GO:0089700;GO:0006468;GO:0030148;, C:cytosol; C:membrane; C:nucleoplasm;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:kinase activity; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein kinase D signaling; P:protein phosphorylation; P:sphingolipid biosynthetic process;|O94806 D6W587 Q53TR7 Q8NEL8,Serine/threonine-protein kinase D3,Protein kinase C nu type;Protein kinase EPK2;nPKC-nu;, PF00130;PF00169;PF00069;, GO:0005829;GO:0016020;GO:0005654;GO:0005524;GO:0004698;GO:0016301;GO:0046872;GO:0004697;GO:0106310;GO:0106311;GO:0007205;GO:0089700;GO:0006468;GO:0030148;, C:cytosol; C:membrane; C:nucleoplasm;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:kinase activity; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein kinase D signaling; P:protein phosphorylation; P:sphingolipid biosynthetic process;|Q15139 A6NL64 B2RAF6,Serine/threonine-protein kinase D1,Protein kinase C mu type;Protein kinase D;nPKC-D1;nPKC-mu;, PF00130;PF00169;PF00069;, GO:0000421;GO:0005829;GO:0005794;GO:0005886;GO:0005802;GO:0005524;GO:0004698;GO:0042802;GO:0016301;GO:0046872;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0001525;GO:0006915;GO:0030154;GO:0034198;GO:0071447;GO:0034599;GO:0035924;GO:0007030;GO:0048193;GO:0006954;GO:0045087;GO:0007229;GO:0035556;GO:0060548;GO:0045806;GO:0007399;GO:0018105;GO:0018107;GO:0045766;GO:0010508;GO:0043536;GO:0032793;GO:2001028;GO:0038033;GO:0010595;GO:0001938;GO:1901727;GO:0043123;GO:0010976;GO:0051092;GO:0045669;GO:0033138;GO:0043552;GO:0045944;GO:0046777;GO:0089700;GO:0006468;GO:0007265;GO:2001044;GO:0010837;GO:0031647;GO:0007165;GO:0030148;GO:0048010;, C:autophagosome membrane; C:cytosol; C:Golgi apparatus; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:identical protein binding; F:kinase activity; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:angiogenesis; P:apoptotic process; P:cell differentiation; P:cellular response to amino acid starvation; P:cellular response to hydroperoxide; P:cellular response to oxidative stress; P:cellular response to vascular endothelial growth factor stimulus; P:Golgi organization; P:Golgi vesicle transport; P:inflammatory response; P:innate immune response; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell death; P:negative regulation of endocytosis; P:nervous system development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of CREB transcription factor activity; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of histone deacetylase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of osteoblast differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of transcription by RNA polymerase II; P:protein autophosphorylation; P:protein kinase D signaling; P:protein phosphorylation; P:Ras protein signal transduction; P:regulation of integrin-mediated signaling pathway; P:regulation of keratinocyte proliferation; P:regulation of protein stability; P:signal transduction; P:sphingolipid biosynthetic process; P:vascular endothelial growth factor receptor signaling pathway;|O94806 D6W587 Q53TR7 Q8NEL8,Serine/threonine-protein kinase D3,Protein kinase C nu type;Protein kinase EPK2;nPKC-nu;, PF00130;PF00169;PF00069;, GO:0005829;GO:0016020;GO:0005654;GO:0005524;GO:0004698;GO:0016301;GO:0046872;GO:0004697;GO:0106310;GO:0106311;GO:0007205;GO:0089700;GO:0006468;GO:0030148;, C:cytosol; C:membrane; C:nucleoplasm;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:kinase activity; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein kinase D signaling; P:protein phosphorylation; P:sphingolipid biosynthetic process;|Q7L592 Q7Z399 Q9P1G3,Protein arginine methyltransferase NDUFAF7, mitochondrial {ECO:0000305},NADH dehydrogenase [ubiquinone] complex I, assembly factor 7;Protein midA homolog {ECO:0000303|PubMed:20406883};, PF02636;, GO:0005615;GO:0005759;GO:0005739;GO:0019899;GO:0008168;GO:0035243;GO:0032981;GO:0019918;, C:extracellular space; C:mitochondrial matrix; C:mitochondrion;, F:enzyme binding; F:methyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity;, P:mitochondrial respiratory chain complex I assembly; P:peptidyl-arginine methylation, to symmetrical-dimethyl arginine;|Q7L592 Q7Z399 Q9P1G3,Protein arginine methyltransferase NDUFAF7, mitochondrial {ECO:0000305},NADH dehydrogenase [ubiquinone] complex I, assembly factor 7;Protein midA homolog {ECO:0000303|PubMed:20406883};, PF02636;, GO:0005615;GO:0005759;GO:0005739;GO:0019899;GO:0008168;GO:0035243;GO:0032981;GO:0019918;, C:extracellular space; C:mitochondrial matrix; C:mitochondrion;, F:enzyme binding; F:methyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity;, P:mitochondrial respiratory chain complex I assembly; P:peptidyl-arginine methylation, to symmetrical-dimethyl arginine;|Q7L592 Q7Z399 Q9P1G3,Protein arginine methyltransferase NDUFAF7, mitochondrial {ECO:0000305},NADH dehydrogenase [ubiquinone] complex I, assembly factor 7;Protein midA homolog {ECO:0000303|PubMed:20406883};, PF02636;, GO:0005615;GO:0005759;GO:0005739;GO:0019899;GO:0008168;GO:0035243;GO:0032981;GO:0019918;, C:extracellular space; C:mitochondrial matrix; C:mitochondrion;, F:enzyme binding; F:methyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity;, P:mitochondrial respiratory chain complex I assembly; P:peptidyl-arginine methylation, to symmetrical-dimethyl arginine; scaffold6 indexed_genome mRNA 44521802 44550569 . + . ID=transcript_1724;Q03701 Q8NE75,CCAAT/enhancer-binding protein zeta,CCAAT-box-binding transcription factor;, PF03914;, GO:0005634;GO:0003723;GO:0003713;GO:0045944;, C:nucleus;, F:RNA binding; F:transcription coactivator activity;, P:positive regulation of transcription by RNA polymerase II;|Q03701 Q8NE75,CCAAT/enhancer-binding protein zeta,CCAAT-box-binding transcription factor;, PF03914;, GO:0005634;GO:0003723;GO:0003713;GO:0045944;, C:nucleus;, F:RNA binding; F:transcription coactivator activity;, P:positive regulation of transcription by RNA polymerase II;|Q03701 Q8NE75,CCAAT/enhancer-binding protein zeta,CCAAT-box-binding transcription factor;, PF03914;, GO:0005634;GO:0003723;GO:0003713;GO:0045944;, C:nucleus;, F:RNA binding; F:transcription coactivator activity;, P:positive regulation of transcription by RNA polymerase II;|Q03701 Q8NE75,CCAAT/enhancer-binding protein zeta,CCAAT-box-binding transcription factor;, PF03914;, GO:0005634;GO:0003723;GO:0003713;GO:0045944;, C:nucleus;, F:RNA binding; F:transcription coactivator activity;, P:positive regulation of transcription by RNA polymerase II;|Q03701 Q8NE75,CCAAT/enhancer-binding protein zeta,CCAAT-box-binding transcription factor;, PF03914;, GO:0005634;GO:0003723;GO:0003713;GO:0045944;, C:nucleus;, F:RNA binding; F:transcription coactivator activity;, P:positive regulation of transcription by RNA polymerase II;|Q03701 Q8NE75,CCAAT/enhancer-binding protein zeta,CCAAT-box-binding transcription factor;, PF03914;, GO:0005634;GO:0003723;GO:0003713;GO:0045944;, C:nucleus;, F:RNA binding; F:transcription coactivator activity;, P:positive regulation of transcription by RNA polymerase II;|Q03701 Q8NE75,CCAAT/enhancer-binding protein zeta,CCAAT-box-binding transcription factor;, PF03914;, GO:0005634;GO:0003723;GO:0003713;GO:0045944;, C:nucleus;, F:RNA binding; F:transcription coactivator activity;, P:positive regulation of transcription by RNA polymerase II;|A8MTT3 A8MUR5,Protein CEBPZOS {ECO:0000305},CEBPZ antisense RNA 1 {ECO:0000312|HGNC:HGNC:49288};CEBPZ opposite strand {ECO:0000312|HGNC:HGNC:49288};, , GO:0016021;GO:0031966;, C:integral component of membrane; C:mitochondrial membrane; scaffold6 indexed_genome mRNA 44582974 44622226 . + . ID=transcript_1725;P19525 A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4,Interferon-induced, double-stranded RNA-activated protein kinase,Eukaryotic translation initiation factor 2-alpha kinase 2;Interferon-inducible RNA-dependent protein kinase;P1/eIF-2A protein kinase;Protein kinase RNA-activated;Tyrosine-protein kinase EIF2AK2;p68 kinase;, PF00035;PF00069;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0048471;GO:0005840;GO:0005524;GO:0003725;GO:0004694;GO:0042802;GO:0004715;GO:0004672;GO:0019888;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0004714;GO:0000186;GO:0034198;GO:0051607;GO:0045087;GO:0030683;GO:0008285;GO:0033689;GO:0017148;GO:0045071;GO:0032722;GO:0001819;GO:0051092;GO:1901224;GO:0032874;GO:0046777;GO:0006468;GO:1901532;GO:1902036;GO:1902033;GO:1900225;GO:0035455;GO:0009615;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:ribosome;, F:ATP binding; F:double-stranded RNA binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:identical protein binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity; F:protein phosphatase regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPKK activity; P:cellular response to amino acid starvation; P:defense response to virus; P:innate immune response; P:mitigation of host immune response by virus; P:negative regulation of cell population proliferation; P:negative regulation of osteoblast proliferation; P:negative regulation of translation; P:negative regulation of viral genome replication; P:positive regulation of chemokine production; P:positive regulation of cytokine production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of hematopoietic progenitor cell differentiation; P:regulation of hematopoietic stem cell differentiation; P:regulation of hematopoietic stem cell proliferation; P:regulation of NLRP3 inflammasome complex assembly; P:response to interferon-alpha; P:response to virus; scaffold6 indexed_genome mRNA 44622265 44634897 . - . ID=transcript_1726;Q8N954 A0A0A0MSF9 A8K0D9 B7Z2G4 B8ZZ44,G patch domain-containing protein 11,Coiled-coil domain-containing protein 75;, PF13821;PF01585;, GO:0000777;GO:0000776;GO:0003676;, C:condensed chromosome kinetochore; C:kinetochore;, F:nucleic acid binding;|Q8N954 A0A0A0MSF9 A8K0D9 B7Z2G4 B8ZZ44,G patch domain-containing protein 11,Coiled-coil domain-containing protein 75;, PF13821;PF01585;, GO:0000777;GO:0000776;GO:0003676;, C:condensed chromosome kinetochore; C:kinetochore;, F:nucleic acid binding;|Q8N954 A0A0A0MSF9 A8K0D9 B7Z2G4 B8ZZ44,G patch domain-containing protein 11,Coiled-coil domain-containing protein 75;, PF13821;PF01585;, GO:0000777;GO:0000776;GO:0003676;, C:condensed chromosome kinetochore; C:kinetochore;, F:nucleic acid binding; scaffold6 indexed_genome mRNA 44641317 44735235 . + . ID=transcript_1727;Q9P2D3 B5MDU8 Q7Z3B2 Q9NVL7,HEAT repeat-containing protein 5B,, , GO:0005829;GO:0030139;GO:0016020;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle; C:membrane;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q9P2D3 B5MDU8 Q7Z3B2 Q9NVL7,HEAT repeat-containing protein 5B,, , GO:0005829;GO:0030139;GO:0016020;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle; C:membrane;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q9P2D3 B5MDU8 Q7Z3B2 Q9NVL7,HEAT repeat-containing protein 5B,, , GO:0005829;GO:0030139;GO:0016020;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle; C:membrane;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q9P2D3 B5MDU8 Q7Z3B2 Q9NVL7,HEAT repeat-containing protein 5B,, , GO:0005829;GO:0030139;GO:0016020;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle; C:membrane;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q9P2D3 B5MDU8 Q7Z3B2 Q9NVL7,HEAT repeat-containing protein 5B,, , GO:0005829;GO:0030139;GO:0016020;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle; C:membrane;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q9P2D3 B5MDU8 Q7Z3B2 Q9NVL7,HEAT repeat-containing protein 5B,, , GO:0005829;GO:0030139;GO:0016020;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle; C:membrane;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi; scaffold6 indexed_genome mRNA 44757557 44862706 . + . ID=transcript_1728;O43815 Q3KP65 Q53TQ8 Q9NP38,Striatin,, PF08232;PF00400;, GO:0005923;GO:0005829;GO:0030425;GO:0043197;GO:0090443;GO:0016020;GO:0043025;GO:0014069;GO:0045211;GO:0070016;GO:0005516;GO:0030331;GO:0051721;GO:0044877;GO:0070830;GO:0016358;GO:0007626;GO:0008285;GO:0051897;GO:0016055;, C:bicellular tight junction; C:cytosol; C:dendrite; C:dendritic spine; C:FAR/SIN/STRIPAK complex; C:membrane; C:neuronal cell body; C:postsynaptic density; C:postsynaptic membrane;, F:armadillo repeat domain binding; F:calmodulin binding; F:estrogen receptor binding; F:protein phosphatase 2A binding; F:protein-containing complex binding;, P:bicellular tight junction assembly; P:dendrite development; P:locomotory behavior; P:negative regulation of cell population proliferation; P:positive regulation of protein kinase B signaling; P:Wnt signaling pathway;|O43815 Q3KP65 Q53TQ8 Q9NP38,Striatin,, PF08232;PF00400;, GO:0005923;GO:0005829;GO:0030425;GO:0043197;GO:0090443;GO:0016020;GO:0043025;GO:0014069;GO:0045211;GO:0070016;GO:0005516;GO:0030331;GO:0051721;GO:0044877;GO:0070830;GO:0016358;GO:0007626;GO:0008285;GO:0051897;GO:0016055;, C:bicellular tight junction; C:cytosol; C:dendrite; C:dendritic spine; C:FAR/SIN/STRIPAK complex; C:membrane; C:neuronal cell body; C:postsynaptic density; C:postsynaptic membrane;, F:armadillo repeat domain binding; F:calmodulin binding; F:estrogen receptor binding; F:protein phosphatase 2A binding; F:protein-containing complex binding;, P:bicellular tight junction assembly; P:dendrite development; P:locomotory behavior; P:negative regulation of cell population proliferation; P:positive regulation of protein kinase B signaling; P:Wnt signaling pathway; scaffold6 indexed_genome mRNA 44889674 45009724 . - . ID=transcript_1729;Q6UXI7 A1A526 A6NKI9 A8K7Y4 E9PF47 Q6P7T3 Q96DM8 Q96DT1 Q9UDN0,Vitrin,, PF03815;PF00092;, GO:0062023;GO:0005576;GO:0005614;GO:0005539;GO:0030198;GO:0010811;GO:0021510;, C:collagen-containing extracellular matrix; C:extracellular region; C:interstitial matrix;, F:glycosaminoglycan binding;, P:extracellular matrix organization; P:positive regulation of cell-substrate adhesion; P:spinal cord development;|Q6UXI7 A1A526 A6NKI9 A8K7Y4 E9PF47 Q6P7T3 Q96DM8 Q96DT1 Q9UDN0,Vitrin,, PF03815;PF00092;, GO:0062023;GO:0005576;GO:0005614;GO:0005539;GO:0030198;GO:0010811;GO:0021510;, C:collagen-containing extracellular matrix; C:extracellular region; C:interstitial matrix;, F:glycosaminoglycan binding;, P:extracellular matrix organization; P:positive regulation of cell-substrate adhesion; P:spinal cord development; scaffold6 indexed_genome mRNA 45095196 45139098 . + . ID=transcript_1730;Q9UHY8 Q5EBN3 Q76LN0 Q99690,Fasciculation and elongation protein zeta-2,Zygin II;Zygin-2;, PF07763;, GO:0030424;GO:0005737;GO:0007411;GO:1902902;GO:0007399;GO:0007165;, C:axon; C:cytoplasm;, , P:axon guidance; P:negative regulation of autophagosome assembly; P:nervous system development; P:signal transduction;|Q99689 O00679 O00728 Q6IBI7,Fasciculation and elongation protein zeta-1,Zygin I;Zygin-1;, PF07763;, GO:0030424;GO:0005813;GO:0005737;GO:0030425;GO:0005794;GO:0030426;GO:0005874;GO:0005739;GO:0043025;GO:0005886;GO:0043015;GO:0005080;GO:0047485;GO:0007411;GO:0007155;GO:0071363;GO:0030010;GO:0051654;GO:0021766;GO:0070584;GO:1902902;GO:0007399;GO:0061881;GO:0045666;GO:0010976;, C:axon; C:centrosome; C:cytoplasm; C:dendrite; C:Golgi apparatus; C:growth cone; C:microtubule; C:mitochondrion; C:neuronal cell body; C:plasma membrane;, F:gamma-tubulin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:axon guidance; P:cell adhesion; P:cellular response to growth factor stimulus; P:establishment of cell polarity; P:establishment of mitochondrion localization; P:hippocampus development; P:mitochondrion morphogenesis; P:negative regulation of autophagosome assembly; P:nervous system development; P:positive regulation of anterograde axonal transport of mitochondrion; P:positive regulation of neuron differentiation; P:positive regulation of neuron projection development; scaffold6 indexed_genome mRNA 45142173 45147428 . - . ID=transcript_1731;Q9NZV1 Q2M2G4 Q59GH0 Q7LCQ5 Q9H318,Cysteine-rich motor neuron 1 protein,Cysteine-rich repeat-containing protein S52;, PF02822;PF00219;PF00093;, GO:0005576;GO:0016021;GO:0005886;GO:0005520;GO:0005010;GO:0030165;GO:0004867;GO:0030514;GO:0045668;GO:0007399;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:insulin-like growth factor binding; F:insulin-like growth factor-activated receptor activity; F:PDZ domain binding; F:serine-type endopeptidase inhibitor activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of osteoblast differentiation; P:nervous system development; scaffold6 indexed_genome mRNA 47628172 47645028 . + . ID=transcript_1732;Q8NCA5 B2RNA2 Q9Y3Y6,Protein FAM98A {ECO:0000305},, PF10239;, GO:0072669;GO:0008276;GO:0003723;GO:0032418;GO:0008284;GO:0010628;GO:1900029;GO:0006479;, C:tRNA-splicing ligase complex;, F:protein methyltransferase activity; F:RNA binding;, P:lysosome localization; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of ruffle assembly; P:protein methylation;|Q8NCA5 B2RNA2 Q9Y3Y6,Protein FAM98A {ECO:0000305},, PF10239;, GO:0072669;GO:0008276;GO:0003723;GO:0032418;GO:0008284;GO:0010628;GO:1900029;GO:0006479;, C:tRNA-splicing ligase complex;, F:protein methyltransferase activity; F:RNA binding;, P:lysosome localization; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of ruffle assembly; P:protein methylation;|Q8NCA5 B2RNA2 Q9Y3Y6,Protein FAM98A {ECO:0000305},, PF10239;, GO:0072669;GO:0008276;GO:0003723;GO:0032418;GO:0008284;GO:0010628;GO:1900029;GO:0006479;, C:tRNA-splicing ligase complex;, F:protein methyltransferase activity; F:RNA binding;, P:lysosome localization; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of ruffle assembly; P:protein methylation;|Q8NCA5 B2RNA2 Q9Y3Y6,Protein FAM98A {ECO:0000305},, PF10239;, GO:0072669;GO:0008276;GO:0003723;GO:0032418;GO:0008284;GO:0010628;GO:1900029;GO:0006479;, C:tRNA-splicing ligase complex;, F:protein methyltransferase activity; F:RNA binding;, P:lysosome localization; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of ruffle assembly; P:protein methylation;|Q8NCA5 B2RNA2 Q9Y3Y6,Protein FAM98A {ECO:0000305},, PF10239;, GO:0072669;GO:0008276;GO:0003723;GO:0032418;GO:0008284;GO:0010628;GO:1900029;GO:0006479;, C:tRNA-splicing ligase complex;, F:protein methyltransferase activity; F:RNA binding;, P:lysosome localization; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of ruffle assembly; P:protein methylation;|Q8NCA5 B2RNA2 Q9Y3Y6,Protein FAM98A {ECO:0000305},, PF10239;, GO:0072669;GO:0008276;GO:0003723;GO:0032418;GO:0008284;GO:0010628;GO:1900029;GO:0006479;, C:tRNA-splicing ligase complex;, F:protein methyltransferase activity; F:RNA binding;, P:lysosome localization; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of ruffle assembly; P:protein methylation; scaffold6 indexed_genome mRNA 47662526 47709902 . - . ID=transcript_1733;Q8IV61 D6W583 O94931 Q53SD7,Ras guanyl-releasing protein 3,Calcium and DAG-regulated guanine nucleotide exchange factor III;Guanine nucleotide exchange factor for Rap1;, PF00130;PF13202;PF00617;, GO:0032045;GO:0005887;GO:0048471;GO:0005886;GO:0005509;GO:0019992;GO:0005096;GO:0005085;GO:0019900;GO:0031267;GO:0000165;GO:0007265;GO:0007264;, C:guanyl-nucleotide exchange factor complex; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding; F:diacylglycerol binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:small GTPase binding;, P:MAPK cascade; P:Ras protein signal transduction; P:small GTPase mediated signal transduction; scaffold6 indexed_genome mRNA 47830225 48272441 . - . ID=transcript_1734;Q14766 A1L3V1 P22064 Q53SD8 Q53SF3 Q53SG1 Q59HF7 Q8TD95,Latent-transforming growth factor beta-binding protein 1 {ECO:0000303|PubMed:8537398},Transforming growth factor beta-1-binding protein 1 {ECO:0000303|PubMed:2350783};, PF12662;PF07645;PF00683;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0001527;GO:0032991;GO:0005509;GO:0050436;GO:0050431;GO:0005024;GO:0044267;GO:0043687;GO:1901388;GO:0035583;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:microfibril; C:protein-containing complex;, F:calcium ion binding; F:microfibril binding; F:transforming growth factor beta binding; F:transforming growth factor beta-activated receptor activity;, P:cellular protein metabolic process; P:post-translational protein modification; P:regulation of transforming growth factor beta activation; P:sequestering of TGFbeta in extracellular matrix; scaffold6 indexed_genome mRNA 48368917 48374833 . - . ID=transcript_1735;Q6P3X3 A6NKJ0 Q96SS5 Q9BVF1 Q9NWR4 Q9NXG4,Tetratricopeptide repeat protein 27,, PF07719;|Q6P3X3 A6NKJ0 Q96SS5 Q9BVF1 Q9NWR4 Q9NXG4,Tetratricopeptide repeat protein 27,, PF07719; scaffold6 indexed_genome mRNA 48374834 48378252 . - . ID=transcript_1736;Q6P3X3 A6NKJ0 Q96SS5 Q9BVF1 Q9NWR4 Q9NXG4,Tetratricopeptide repeat protein 27,, PF07719;|Q6P3X3 A6NKJ0 Q96SS5 Q9BVF1 Q9NWR4 Q9NXG4,Tetratricopeptide repeat protein 27,, PF07719; scaffold6 indexed_genome mRNA 48393482 48530645 . - . ID=transcript_1737;Q6P3X3 A6NKJ0 Q96SS5 Q9BVF1 Q9NWR4 Q9NXG4,Tetratricopeptide repeat protein 27,, PF07719; scaffold6 indexed_genome mRNA 48552788 48554114 . - . ID=transcript_1738;Q9NR09 Q9ULD1,Baculoviral IAP repeat-containing protein 6,BIR repeat-containing ubiquitin-conjugating enzyme;RING-type E3 ubiquitin transferase BIRC6 {ECO:0000305};Ubiquitin-conjugating BIR domain enzyme apollon;, PF00653;PF12356;PF00179;, GO:0005768;GO:0090543;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005802;GO:0004869;GO:0061631;GO:0004842;GO:0006915;GO:0007049;GO:0051301;GO:0060711;GO:0043066;GO:2001237;GO:0008284;GO:0006468;GO:0016567;GO:0042127;GO:0032465;GO:0060712;GO:0006511;, C:endosome; C:Flemming body; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole; C:trans-Golgi network;, F:cysteine-type endopeptidase inhibitor activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cell cycle; P:cell division; P:labyrinthine layer development; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:protein ubiquitination; P:regulation of cell population proliferation; P:regulation of cytokinesis; P:spongiotrophoblast layer development; P:ubiquitin-dependent protein catabolic process; scaffold6 indexed_genome mRNA 48603867 48757808 . - . ID=transcript_1739;Q9NR09 Q9ULD1,Baculoviral IAP repeat-containing protein 6,BIR repeat-containing ubiquitin-conjugating enzyme;RING-type E3 ubiquitin transferase BIRC6 {ECO:0000305};Ubiquitin-conjugating BIR domain enzyme apollon;, PF00653;PF12356;PF00179;, GO:0005768;GO:0090543;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005802;GO:0004869;GO:0061631;GO:0004842;GO:0006915;GO:0007049;GO:0051301;GO:0060711;GO:0043066;GO:2001237;GO:0008284;GO:0006468;GO:0016567;GO:0042127;GO:0032465;GO:0060712;GO:0006511;, C:endosome; C:Flemming body; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole; C:trans-Golgi network;, F:cysteine-type endopeptidase inhibitor activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cell cycle; P:cell division; P:labyrinthine layer development; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:protein ubiquitination; P:regulation of cell population proliferation; P:regulation of cytokinesis; P:spongiotrophoblast layer development; P:ubiquitin-dependent protein catabolic process;|Q9NR09 Q9ULD1,Baculoviral IAP repeat-containing protein 6,BIR repeat-containing ubiquitin-conjugating enzyme;RING-type E3 ubiquitin transferase BIRC6 {ECO:0000305};Ubiquitin-conjugating BIR domain enzyme apollon;, PF00653;PF12356;PF00179;, GO:0005768;GO:0090543;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005802;GO:0004869;GO:0061631;GO:0004842;GO:0006915;GO:0007049;GO:0051301;GO:0060711;GO:0043066;GO:2001237;GO:0008284;GO:0006468;GO:0016567;GO:0042127;GO:0032465;GO:0060712;GO:0006511;, C:endosome; C:Flemming body; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole; C:trans-Golgi network;, F:cysteine-type endopeptidase inhibitor activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cell cycle; P:cell division; P:labyrinthine layer development; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:protein ubiquitination; P:regulation of cell population proliferation; P:regulation of cytokinesis; P:spongiotrophoblast layer development; P:ubiquitin-dependent protein catabolic process; scaffold6 indexed_genome mRNA 48793856 48832761 . - . ID=transcript_1740;Q9BSR8,Protein YIPF4,YIP1 family member 4;, PF04893;, GO:0005783;GO:0005794;GO:0016021;GO:0043231;GO:0005886;GO:0016032;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, , P:viral process;|Q9BSR8,Protein YIPF4,YIP1 family member 4;, PF04893;, GO:0005783;GO:0005794;GO:0016021;GO:0043231;GO:0005886;GO:0016032;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, , P:viral process;|Q9BSR8,Protein YIPF4,YIP1 family member 4;, PF04893;, GO:0005783;GO:0005794;GO:0016021;GO:0043231;GO:0005886;GO:0016032;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, , P:viral process;|Q9BSR8,Protein YIPF4,YIP1 family member 4;, PF04893;, GO:0005783;GO:0005794;GO:0016021;GO:0043231;GO:0005886;GO:0016032;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, , P:viral process; scaffold6 indexed_genome mRNA 48882020 48882684 . - . ID=transcript_1741;Q9NPP4 A8K9F8 B2RBQ3 B3KTF0 D6W580 Q96J81 Q96J82 Q96J83,NLR family CARD domain-containing protein 4,CARD, LRR, and NACHT-containing protein;Caspase recruitment domain-containing protein 12;Ice protease-activating factor;, PF00619;PF05729;PF17889;, GO:0005829;GO:0072557;GO:0005524;GO:0089720;GO:0061133;GO:0042802;GO:0000287;GO:0042803;GO:0097202;GO:0006919;GO:0002218;GO:0006915;GO:0042742;GO:0016045;GO:0006954;GO:0045087;GO:0043065;GO:0032731;GO:0051092;GO:0010954;GO:0051260;GO:0070269;GO:0042981;, C:cytosol; C:IPAF inflammasome complex;, F:ATP binding; F:caspase binding; F:endopeptidase activator activity; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of innate immune response; P:apoptotic process; P:defense response to bacterium; P:detection of bacterium; P:inflammatory response; P:innate immune response; P:positive regulation of apoptotic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein processing; P:protein homooligomerization; P:pyroptosis; P:regulation of apoptotic process; scaffold6 indexed_genome mRNA 48884910 48886094 . - . ID=transcript_1742;Q9NPP4 A8K9F8 B2RBQ3 B3KTF0 D6W580 Q96J81 Q96J82 Q96J83,NLR family CARD domain-containing protein 4,CARD, LRR, and NACHT-containing protein;Caspase recruitment domain-containing protein 12;Ice protease-activating factor;, PF00619;PF05729;PF17889;, GO:0005829;GO:0072557;GO:0005524;GO:0089720;GO:0061133;GO:0042802;GO:0000287;GO:0042803;GO:0097202;GO:0006919;GO:0002218;GO:0006915;GO:0042742;GO:0016045;GO:0006954;GO:0045087;GO:0043065;GO:0032731;GO:0051092;GO:0010954;GO:0051260;GO:0070269;GO:0042981;, C:cytosol; C:IPAF inflammasome complex;, F:ATP binding; F:caspase binding; F:endopeptidase activator activity; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of innate immune response; P:apoptotic process; P:defense response to bacterium; P:detection of bacterium; P:inflammatory response; P:innate immune response; P:positive regulation of apoptotic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein processing; P:protein homooligomerization; P:pyroptosis; P:regulation of apoptotic process; scaffold6 indexed_genome mRNA 48905824 48930726 . - . ID=transcript_1743;Q6NXT4 A5YM45 B7Z901 Q8N5C9 Q96NC3,Zinc transporter 6,Solute carrier family 30 member 6;, PF01545;, GO:0005794;GO:0000139;GO:0016021;GO:0008324;GO:0071577;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:cation transmembrane transporter activity;, P:zinc ion transmembrane transport;|Q6NXT4 A5YM45 B7Z901 Q8N5C9 Q96NC3,Zinc transporter 6,Solute carrier family 30 member 6;, PF01545;, GO:0005794;GO:0000139;GO:0016021;GO:0008324;GO:0071577;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:cation transmembrane transporter activity;, P:zinc ion transmembrane transport; scaffold6 indexed_genome mRNA 48933351 48955073 . - . ID=transcript_1744;Q6NXT4 A5YM45 B7Z901 Q8N5C9 Q96NC3,Zinc transporter 6,Solute carrier family 30 member 6;, PF01545;, GO:0005794;GO:0000139;GO:0016021;GO:0008324;GO:0071577;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:cation transmembrane transporter activity;, P:zinc ion transmembrane transport;|Q6NXT4 A5YM45 B7Z901 Q8N5C9 Q96NC3,Zinc transporter 6,Solute carrier family 30 member 6;, PF01545;, GO:0005794;GO:0000139;GO:0016021;GO:0008324;GO:0071577;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:cation transmembrane transporter activity;, P:zinc ion transmembrane transport; scaffold6 indexed_genome mRNA 48967081 49019343 . - . ID=transcript_1745;Q9UBP0 A7E2A7 Q9UPR9,Spastin {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000303|PubMed:10610178},Spastic paraplegia 4 protein;, PF00004;PF17862;PF09336;, GO:1904115;GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0071782;GO:0005768;GO:0070062;GO:0016021;GO:0005811;GO:0005874;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005819;GO:0043014;GO:0005524;GO:0016887;GO:0048487;GO:0016853;GO:0008017;GO:0008568;GO:0044877;GO:0008089;GO:0019896;GO:0007409;GO:0032506;GO:0031122;GO:0061640;GO:0006888;GO:0010458;GO:0090148;GO:0001578;GO:0051013;GO:0000281;GO:0007084;GO:0051228;GO:0031468;GO:0032467;GO:0031117;GO:0034214;GO:0051260;, C:axon cytoplasm; C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endosome; C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:microtubule; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle;, F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein-containing complex binding;, P:anterograde axonal transport; P:axonal transport of mitochondrion; P:axonogenesis; P:cytokinetic process; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exit from mitosis; P:membrane fission; P:microtubule bundle formation; P:microtubule severing; P:mitotic cytokinesis; P:mitotic nuclear envelope reassembly; P:mitotic spindle disassembly; P:nuclear envelope reassembly; P:positive regulation of cytokinesis; P:positive regulation of microtubule depolymerization; P:protein hexamerization; P:protein homooligomerization;|Q9UBP0 A7E2A7 Q9UPR9,Spastin {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000303|PubMed:10610178},Spastic paraplegia 4 protein;, PF00004;PF17862;PF09336;, GO:1904115;GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0071782;GO:0005768;GO:0070062;GO:0016021;GO:0005811;GO:0005874;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005819;GO:0043014;GO:0005524;GO:0016887;GO:0048487;GO:0016853;GO:0008017;GO:0008568;GO:0044877;GO:0008089;GO:0019896;GO:0007409;GO:0032506;GO:0031122;GO:0061640;GO:0006888;GO:0010458;GO:0090148;GO:0001578;GO:0051013;GO:0000281;GO:0007084;GO:0051228;GO:0031468;GO:0032467;GO:0031117;GO:0034214;GO:0051260;, C:axon cytoplasm; C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endosome; C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:microtubule; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle;, F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein-containing complex binding;, P:anterograde axonal transport; P:axonal transport of mitochondrion; P:axonogenesis; P:cytokinetic process; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exit from mitosis; P:membrane fission; P:microtubule bundle formation; P:microtubule severing; P:mitotic cytokinesis; P:mitotic nuclear envelope reassembly; P:mitotic spindle disassembly; P:nuclear envelope reassembly; P:positive regulation of cytokinesis; P:positive regulation of microtubule depolymerization; P:protein hexamerization; P:protein homooligomerization;|Q9UBP0 A7E2A7 Q9UPR9,Spastin {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000303|PubMed:10610178},Spastic paraplegia 4 protein;, PF00004;PF17862;PF09336;, GO:1904115;GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0071782;GO:0005768;GO:0070062;GO:0016021;GO:0005811;GO:0005874;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005819;GO:0043014;GO:0005524;GO:0016887;GO:0048487;GO:0016853;GO:0008017;GO:0008568;GO:0044877;GO:0008089;GO:0019896;GO:0007409;GO:0032506;GO:0031122;GO:0061640;GO:0006888;GO:0010458;GO:0090148;GO:0001578;GO:0051013;GO:0000281;GO:0007084;GO:0051228;GO:0031468;GO:0032467;GO:0031117;GO:0034214;GO:0051260;, C:axon cytoplasm; C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endosome; C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:microtubule; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle;, F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein-containing complex binding;, P:anterograde axonal transport; P:axonal transport of mitochondrion; P:axonogenesis; P:cytokinetic process; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exit from mitosis; P:membrane fission; P:microtubule bundle formation; P:microtubule severing; P:mitotic cytokinesis; P:mitotic nuclear envelope reassembly; P:mitotic spindle disassembly; P:nuclear envelope reassembly; P:positive regulation of cytokinesis; P:positive regulation of microtubule depolymerization; P:protein hexamerization; P:protein homooligomerization;|Q9UBP0 A7E2A7 Q9UPR9,Spastin {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000303|PubMed:10610178},Spastic paraplegia 4 protein;, PF00004;PF17862;PF09336;, GO:1904115;GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0071782;GO:0005768;GO:0070062;GO:0016021;GO:0005811;GO:0005874;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005819;GO:0043014;GO:0005524;GO:0016887;GO:0048487;GO:0016853;GO:0008017;GO:0008568;GO:0044877;GO:0008089;GO:0019896;GO:0007409;GO:0032506;GO:0031122;GO:0061640;GO:0006888;GO:0010458;GO:0090148;GO:0001578;GO:0051013;GO:0000281;GO:0007084;GO:0051228;GO:0031468;GO:0032467;GO:0031117;GO:0034214;GO:0051260;, C:axon cytoplasm; C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endosome; C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:microtubule; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle;, F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein-containing complex binding;, P:anterograde axonal transport; P:axonal transport of mitochondrion; P:axonogenesis; P:cytokinetic process; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exit from mitosis; P:membrane fission; P:microtubule bundle formation; P:microtubule severing; P:mitotic cytokinesis; P:mitotic nuclear envelope reassembly; P:mitotic spindle disassembly; P:nuclear envelope reassembly; P:positive regulation of cytokinesis; P:positive regulation of microtubule depolymerization; P:protein hexamerization; P:protein homooligomerization;|Q9UBP0 A7E2A7 Q9UPR9,Spastin {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000303|PubMed:10610178},Spastic paraplegia 4 protein;, PF00004;PF17862;PF09336;, GO:1904115;GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0071782;GO:0005768;GO:0070062;GO:0016021;GO:0005811;GO:0005874;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005819;GO:0043014;GO:0005524;GO:0016887;GO:0048487;GO:0016853;GO:0008017;GO:0008568;GO:0044877;GO:0008089;GO:0019896;GO:0007409;GO:0032506;GO:0031122;GO:0061640;GO:0006888;GO:0010458;GO:0090148;GO:0001578;GO:0051013;GO:0000281;GO:0007084;GO:0051228;GO:0031468;GO:0032467;GO:0031117;GO:0034214;GO:0051260;, C:axon cytoplasm; C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endosome; C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:microtubule; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle;, F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein-containing complex binding;, P:anterograde axonal transport; P:axonal transport of mitochondrion; P:axonogenesis; P:cytokinetic process; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exit from mitosis; P:membrane fission; P:microtubule bundle formation; P:microtubule severing; P:mitotic cytokinesis; P:mitotic nuclear envelope reassembly; P:mitotic spindle disassembly; P:nuclear envelope reassembly; P:positive regulation of cytokinesis; P:positive regulation of microtubule depolymerization; P:protein hexamerization; P:protein homooligomerization;|Q9UBP0 A7E2A7 Q9UPR9,Spastin {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000303|PubMed:10610178},Spastic paraplegia 4 protein;, PF00004;PF17862;PF09336;, GO:1904115;GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0071782;GO:0005768;GO:0070062;GO:0016021;GO:0005811;GO:0005874;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005819;GO:0043014;GO:0005524;GO:0016887;GO:0048487;GO:0016853;GO:0008017;GO:0008568;GO:0044877;GO:0008089;GO:0019896;GO:0007409;GO:0032506;GO:0031122;GO:0061640;GO:0006888;GO:0010458;GO:0090148;GO:0001578;GO:0051013;GO:0000281;GO:0007084;GO:0051228;GO:0031468;GO:0032467;GO:0031117;GO:0034214;GO:0051260;, C:axon cytoplasm; C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endosome; C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:microtubule; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle;, F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein-containing complex binding;, P:anterograde axonal transport; P:axonal transport of mitochondrion; P:axonogenesis; P:cytokinetic process; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exit from mitosis; P:membrane fission; P:microtubule bundle formation; P:microtubule severing; P:mitotic cytokinesis; P:mitotic nuclear envelope reassembly; P:mitotic spindle disassembly; P:nuclear envelope reassembly; P:positive regulation of cytokinesis; P:positive regulation of microtubule depolymerization; P:protein hexamerization; P:protein homooligomerization;|Q9UBP0 A7E2A7 Q9UPR9,Spastin {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000303|PubMed:10610178},Spastic paraplegia 4 protein;, PF00004;PF17862;PF09336;, GO:1904115;GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0071782;GO:0005768;GO:0070062;GO:0016021;GO:0005811;GO:0005874;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005819;GO:0043014;GO:0005524;GO:0016887;GO:0048487;GO:0016853;GO:0008017;GO:0008568;GO:0044877;GO:0008089;GO:0019896;GO:0007409;GO:0032506;GO:0031122;GO:0061640;GO:0006888;GO:0010458;GO:0090148;GO:0001578;GO:0051013;GO:0000281;GO:0007084;GO:0051228;GO:0031468;GO:0032467;GO:0031117;GO:0034214;GO:0051260;, C:axon cytoplasm; C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endosome; C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:microtubule; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle;, F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein-containing complex binding;, P:anterograde axonal transport; P:axonal transport of mitochondrion; P:axonogenesis; P:cytokinetic process; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exit from mitosis; P:membrane fission; P:microtubule bundle formation; P:microtubule severing; P:mitotic cytokinesis; P:mitotic nuclear envelope reassembly; P:mitotic spindle disassembly; P:nuclear envelope reassembly; P:positive regulation of cytokinesis; P:positive regulation of microtubule depolymerization; P:protein hexamerization; P:protein homooligomerization;|Q9UBP0 A7E2A7 Q9UPR9,Spastin {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000303|PubMed:10610178},Spastic paraplegia 4 protein;, PF00004;PF17862;PF09336;, GO:1904115;GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0071782;GO:0005768;GO:0070062;GO:0016021;GO:0005811;GO:0005874;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005819;GO:0043014;GO:0005524;GO:0016887;GO:0048487;GO:0016853;GO:0008017;GO:0008568;GO:0044877;GO:0008089;GO:0019896;GO:0007409;GO:0032506;GO:0031122;GO:0061640;GO:0006888;GO:0010458;GO:0090148;GO:0001578;GO:0051013;GO:0000281;GO:0007084;GO:0051228;GO:0031468;GO:0032467;GO:0031117;GO:0034214;GO:0051260;, C:axon cytoplasm; C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endosome; C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:microtubule; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle;, F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein-containing complex binding;, P:anterograde axonal transport; P:axonal transport of mitochondrion; P:axonogenesis; P:cytokinetic process; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exit from mitosis; P:membrane fission; P:microtubule bundle formation; P:microtubule severing; P:mitotic cytokinesis; P:mitotic nuclear envelope reassembly; P:mitotic spindle disassembly; P:nuclear envelope reassembly; P:positive regulation of cytokinesis; P:positive regulation of microtubule depolymerization; P:protein hexamerization; P:protein homooligomerization; scaffold6 indexed_genome mRNA 49038483 49048496 . + . ID=transcript_1746;Q9C005 D6W578,Protein dpy-30 homolog,Dpy-30-like protein;, PF05186;, GO:0000781;GO:0005794;GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0005802;GO:0042802;GO:0042803;GO:0006348;GO:0016197;GO:0051568;GO:0045652;, C:chromosome, telomeric region; C:Golgi apparatus; C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex; C:trans-Golgi network;, F:identical protein binding; F:protein homodimerization activity;, P:chromatin silencing at telomere; P:endosomal transport; P:histone H3-K4 methylation; P:regulation of megakaryocyte differentiation;|P57088 B3KSS8 Q9H953,Transmembrane protein 33,Protein DB83;SHINC-3 {ECO:0000303|PubMed:26268696};, PF03661;, GO:0005783;GO:0005789;GO:0030176;GO:0042470;GO:0005635;GO:0071786;GO:0061024;GO:1903896;GO:1903899;GO:1903371;GO:0034976;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:melanosome; C:nuclear envelope;, , P:endoplasmic reticulum tubular network organization; P:membrane organization; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of PERK-mediated unfolded protein response; P:regulation of endoplasmic reticulum tubular network organization; P:response to endoplasmic reticulum stress;|Q9C005 D6W578,Protein dpy-30 homolog,Dpy-30-like protein;, PF05186;, GO:0000781;GO:0005794;GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0005802;GO:0042802;GO:0042803;GO:0006348;GO:0016197;GO:0051568;GO:0045652;, C:chromosome, telomeric region; C:Golgi apparatus; C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex; C:trans-Golgi network;, F:identical protein binding; F:protein homodimerization activity;, P:chromatin silencing at telomere; P:endosomal transport; P:histone H3-K4 methylation; P:regulation of megakaryocyte differentiation; scaffold6 indexed_genome mRNA 49153957 49154988 . - . ID=transcript_1747;Q9Y316 B4DLS0 D6W575 Q5R2V8 Q5R2V9 Q6NSL5,Protein MEMO1,C21orf19-like protein;Hepatitis C virus NS5A-transactivated protein 7;Mediator of ErbB2-driven cell motility 1;, PF01875;, GO:0005829;GO:0005634;GO:2000145;GO:0032886;, C:cytosol; C:nucleus;, , P:regulation of cell motility; P:regulation of microtubule-based process; scaffold6 indexed_genome mRNA 49157807 49181238 . + . ID=transcript_1748;Q9Y316 B4DLS0 D6W575 Q5R2V8 Q5R2V9 Q6NSL5,Protein MEMO1,C21orf19-like protein;Hepatitis C virus NS5A-transactivated protein 7;Mediator of ErbB2-driven cell motility 1;, PF01875;, GO:0005829;GO:0005634;GO:2000145;GO:0032886;, C:cytosol; C:nucleus;, , P:regulation of cell motility; P:regulation of microtubule-based process;|Q9Y316 B4DLS0 D6W575 Q5R2V8 Q5R2V9 Q6NSL5,Protein MEMO1,C21orf19-like protein;Hepatitis C virus NS5A-transactivated protein 7;Mediator of ErbB2-driven cell motility 1;, PF01875;, GO:0005829;GO:0005634;GO:2000145;GO:0032886;, C:cytosol; C:nucleus;, , P:regulation of cell motility; P:regulation of microtubule-based process;|Q9Y316 B4DLS0 D6W575 Q5R2V8 Q5R2V9 Q6NSL5,Protein MEMO1,C21orf19-like protein;Hepatitis C virus NS5A-transactivated protein 7;Mediator of ErbB2-driven cell motility 1;, PF01875;, GO:0005829;GO:0005634;GO:2000145;GO:0032886;, C:cytosol; C:nucleus;, , P:regulation of cell motility; P:regulation of microtubule-based process; scaffold6 indexed_genome mRNA 49478013 49533545 . + . ID=transcript_1749;P47989 Q16681 Q16712 Q4PJ16,Xanthine dehydrogenase/oxidase,, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0005615;GO:0005777;GO:0016529;GO:0051537;GO:0009055;GO:0071949;GO:0050660;GO:0070674;GO:0070675;GO:0005506;GO:0043546;GO:0042803;GO:0004854;GO:0004855;GO:0006919;GO:0002250;GO:0006154;GO:0006196;GO:0046055;GO:0046038;GO:0006204;GO:0006148;GO:0016226;GO:0007595;GO:0045602;GO:0001937;GO:0010629;GO:0051898;GO:0001933;GO:1900747;GO:2001213;GO:1900745;GO:2000379;GO:0006195;GO:0009115;, C:cytosol; C:extracellular space; C:peroxisome; C:sarcoplasmic reticulum;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:hypoxanthine dehydrogenase activity; F:hypoxanthine oxidase activity; F:iron ion binding; F:molybdopterin cofactor binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity; F:xanthine oxidase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:adaptive immune response; P:adenosine catabolic process; P:AMP catabolic process; P:dGMP catabolic process; P:GMP catabolic process; P:IMP catabolic process; P:inosine catabolic process; P:iron-sulfur cluster assembly; P:lactation; P:negative regulation of endothelial cell differentiation; P:negative regulation of endothelial cell proliferation; P:negative regulation of gene expression; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of vascular endothelial growth factor signaling pathway; P:negative regulation of vasculogenesis; P:positive regulation of p38MAPK cascade; P:positive regulation of reactive oxygen species metabolic process; P:purine nucleotide catabolic process; P:xanthine catabolic process;|P47989 Q16681 Q16712 Q4PJ16,Xanthine dehydrogenase/oxidase,, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0005615;GO:0005777;GO:0016529;GO:0051537;GO:0009055;GO:0071949;GO:0050660;GO:0070674;GO:0070675;GO:0005506;GO:0043546;GO:0042803;GO:0004854;GO:0004855;GO:0006919;GO:0002250;GO:0006154;GO:0006196;GO:0046055;GO:0046038;GO:0006204;GO:0006148;GO:0016226;GO:0007595;GO:0045602;GO:0001937;GO:0010629;GO:0051898;GO:0001933;GO:1900747;GO:2001213;GO:1900745;GO:2000379;GO:0006195;GO:0009115;, C:cytosol; C:extracellular space; C:peroxisome; C:sarcoplasmic reticulum;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:hypoxanthine dehydrogenase activity; F:hypoxanthine oxidase activity; F:iron ion binding; F:molybdopterin cofactor binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity; F:xanthine oxidase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:adaptive immune response; P:adenosine catabolic process; P:AMP catabolic process; P:dGMP catabolic process; P:GMP catabolic process; P:IMP catabolic process; P:inosine catabolic process; P:iron-sulfur cluster assembly; P:lactation; P:negative regulation of endothelial cell differentiation; P:negative regulation of endothelial cell proliferation; P:negative regulation of gene expression; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of vascular endothelial growth factor signaling pathway; P:negative regulation of vasculogenesis; P:positive regulation of p38MAPK cascade; P:positive regulation of reactive oxygen species metabolic process; P:purine nucleotide catabolic process; P:xanthine catabolic process; scaffold6 indexed_genome mRNA 49544010 49548405 . + . ID=transcript_1750;Q96C01 Q96SS3,Protein FAM136A,, PF05811;, GO:0005737;, C:cytoplasm;|Q96C01 Q96SS3,Protein FAM136A,, PF05811;, GO:0005737;, C:cytoplasm;|Q96C01 Q96SS3,Protein FAM136A,, PF05811;, GO:0005737;, C:cytoplasm; scaffold6 indexed_genome mRNA 49704759 49813194 . - . ID=transcript_1751;P01135 A8K286 Q15577 Q53SK7 Q9BS56 Q9UEI3 Q9UKM1 Q9UKM2 Q9UKM3,Protransforming growth factor alpha,, , GO:0016323;GO:0009986;GO:0030669;GO:0031410;GO:0005789;GO:0033116;GO:0012507;GO:0005576;GO:0005615;GO:0016021;GO:0048471;GO:0005886;GO:0005154;GO:0008083;GO:0000187;GO:0048208;GO:0006888;GO:0007173;GO:0035556;GO:0000165;GO:0061024;GO:0042059;GO:0051781;GO:0008284;GO:0045741;GO:0050679;GO:0045840;GO:0051897;GO:0006357;GO:0007165;, C:basolateral plasma membrane; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:extracellular region; C:extracellular space; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:epidermal growth factor receptor binding; F:growth factor activity;, P:activation of MAPK activity; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of epithelial cell proliferation; P:positive regulation of mitotic nuclear division; P:positive regulation of protein kinase B signaling; P:regulation of transcription by RNA polymerase II; P:signal transduction; scaffold6 indexed_genome mRNA 49927072 50040970 . - . ID=transcript_1752;Q6P0P2 Q6PGQ4 Q7Z688 Q7Z689 Q7Z690 Q7Z691,Beta-adducin,Erythrocyte adducin subunit beta;, PF00596;, GO:0031410;GO:0005856;GO:0005829;GO:0008290;GO:0005886;GO:0044853;GO:0014069;GO:0003779;GO:0051015;GO:0005516;GO:0046982;GO:0042803;GO:0019901;GO:0030507;GO:0005200;GO:0030036;GO:0051017;GO:0051016;GO:0030097;GO:0050900;GO:0050901;GO:0032092;GO:0065003;GO:0007416;GO:0055085;, C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:hemopoiesis; P:leukocyte migration; P:leukocyte tethering or rolling; P:positive regulation of protein binding; P:protein-containing complex assembly; P:synapse assembly; P:transmembrane transport;|Q6P0P2 Q6PGQ4 Q7Z688 Q7Z689 Q7Z690 Q7Z691,Beta-adducin,Erythrocyte adducin subunit beta;, PF00596;, GO:0031410;GO:0005856;GO:0005829;GO:0008290;GO:0005886;GO:0044853;GO:0014069;GO:0003779;GO:0051015;GO:0005516;GO:0046982;GO:0042803;GO:0019901;GO:0030507;GO:0005200;GO:0030036;GO:0051017;GO:0051016;GO:0030097;GO:0050900;GO:0050901;GO:0032092;GO:0065003;GO:0007416;GO:0055085;, C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:hemopoiesis; P:leukocyte migration; P:leukocyte tethering or rolling; P:positive regulation of protein binding; P:protein-containing complex assembly; P:synapse assembly; P:transmembrane transport;|Q6P0P2 Q6PGQ4 Q7Z688 Q7Z689 Q7Z690 Q7Z691,Beta-adducin,Erythrocyte adducin subunit beta;, PF00596;, GO:0031410;GO:0005856;GO:0005829;GO:0008290;GO:0005886;GO:0044853;GO:0014069;GO:0003779;GO:0051015;GO:0005516;GO:0046982;GO:0042803;GO:0019901;GO:0030507;GO:0005200;GO:0030036;GO:0051017;GO:0051016;GO:0030097;GO:0050900;GO:0050901;GO:0032092;GO:0065003;GO:0007416;GO:0055085;, C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:hemopoiesis; P:leukocyte migration; P:leukocyte tethering or rolling; P:positive regulation of protein binding; P:protein-containing complex assembly; P:synapse assembly; P:transmembrane transport;|Q6P0P2 Q6PGQ4 Q7Z688 Q7Z689 Q7Z690 Q7Z691,Beta-adducin,Erythrocyte adducin subunit beta;, PF00596;, GO:0031410;GO:0005856;GO:0005829;GO:0008290;GO:0005886;GO:0044853;GO:0014069;GO:0003779;GO:0051015;GO:0005516;GO:0046982;GO:0042803;GO:0019901;GO:0030507;GO:0005200;GO:0030036;GO:0051017;GO:0051016;GO:0030097;GO:0050900;GO:0050901;GO:0032092;GO:0065003;GO:0007416;GO:0055085;, C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:hemopoiesis; P:leukocyte migration; P:leukocyte tethering or rolling; P:positive regulation of protein binding; P:protein-containing complex assembly; P:synapse assembly; P:transmembrane transport; scaffold6 indexed_genome mRNA 50074907 50083402 . - . ID=transcript_1753;Q8N1N0 A4QPA5,C-type lectin domain family 4 member F,C-type lectin superfamily member 13;, PF00059;, GO:0016021;GO:0030246;GO:0006897;, C:integral component of membrane;, F:carbohydrate binding;, P:endocytosis; scaffold6 indexed_genome mRNA 50223810 50231005 . - . ID=transcript_1754;Q6UWH6 A1A587 D6W5G9 Q8WUJ5,Protein TEX261,, PF04148;, GO:0030134;GO:0030176;GO:0030173;GO:0097020;GO:0006888;, C:COPII-coated ER to Golgi transport vesicle; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:COPII receptor activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q6UWH6 A1A587 D6W5G9 Q8WUJ5,Protein TEX261,, PF04148;, GO:0030134;GO:0030176;GO:0030173;GO:0097020;GO:0006888;, C:COPII-coated ER to Golgi transport vesicle; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:COPII receptor activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; scaffold6 indexed_genome mRNA 50261989 50270056 . + . ID=transcript_1755;Q9UJ70 B4DLZ5 Q53HD5 Q6IA84 Q9BS29 Q9BVP0 Q9NV37,N-acetyl-D-glucosamine kinase,GlcNAc kinase;, PF01869;, GO:0005829;GO:0070062;GO:0005524;GO:0045127;GO:0006044;GO:0006051;GO:0019262;GO:0006048;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:N-acetylglucosamine kinase activity;, P:N-acetylglucosamine metabolic process; P:N-acetylmannosamine metabolic process; P:N-acetylneuraminate catabolic process; P:UDP-N-acetylglucosamine biosynthetic process;|Q9UJ70 B4DLZ5 Q53HD5 Q6IA84 Q9BS29 Q9BVP0 Q9NV37,N-acetyl-D-glucosamine kinase,GlcNAc kinase;, PF01869;, GO:0005829;GO:0070062;GO:0005524;GO:0045127;GO:0006044;GO:0006051;GO:0019262;GO:0006048;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:N-acetylglucosamine kinase activity;, P:N-acetylglucosamine metabolic process; P:N-acetylmannosamine metabolic process; P:N-acetylneuraminate catabolic process; P:UDP-N-acetylglucosamine biosynthetic process;|Q9UJ70 B4DLZ5 Q53HD5 Q6IA84 Q9BS29 Q9BVP0 Q9NV37,N-acetyl-D-glucosamine kinase,GlcNAc kinase;, PF01869;, GO:0005829;GO:0070062;GO:0005524;GO:0045127;GO:0006044;GO:0006051;GO:0019262;GO:0006048;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:N-acetylglucosamine kinase activity;, P:N-acetylglucosamine metabolic process; P:N-acetylmannosamine metabolic process; P:N-acetylneuraminate catabolic process; P:UDP-N-acetylglucosamine biosynthetic process;|Q9UJ70 B4DLZ5 Q53HD5 Q6IA84 Q9BS29 Q9BVP0 Q9NV37,N-acetyl-D-glucosamine kinase,GlcNAc kinase;, PF01869;, GO:0005829;GO:0070062;GO:0005524;GO:0045127;GO:0006044;GO:0006051;GO:0019262;GO:0006048;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:N-acetylglucosamine kinase activity;, P:N-acetylglucosamine metabolic process; P:N-acetylmannosamine metabolic process; P:N-acetylneuraminate catabolic process; P:UDP-N-acetylglucosamine biosynthetic process;|Q9UJ70 B4DLZ5 Q53HD5 Q6IA84 Q9BS29 Q9BVP0 Q9NV37,N-acetyl-D-glucosamine kinase,GlcNAc kinase;, PF01869;, GO:0005829;GO:0070062;GO:0005524;GO:0045127;GO:0006044;GO:0006051;GO:0019262;GO:0006048;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:N-acetylglucosamine kinase activity;, P:N-acetylglucosamine metabolic process; P:N-acetylmannosamine metabolic process; P:N-acetylneuraminate catabolic process; P:UDP-N-acetylglucosamine biosynthetic process; scaffold6 indexed_genome mRNA 50272936 50312527 . - . ID=transcript_1756;Q9ULR5,Polyadenylate-binding protein-interacting protein 2B,, PF07145;, GO:0005737;GO:0030371;GO:0000900;GO:0017148;GO:0045947;, C:cytoplasm;, F:translation repressor activity; F:translation repressor activity, mRNA regulatory element binding;, P:negative regulation of translation; P:negative regulation of translational initiation;|Q9ULR5,Polyadenylate-binding protein-interacting protein 2B,, PF07145;, GO:0005737;GO:0030371;GO:0000900;GO:0017148;GO:0045947;, C:cytoplasm;, F:translation repressor activity; F:translation repressor activity, mRNA regulatory element binding;, P:negative regulation of translation; P:negative regulation of translational initiation; scaffold6 indexed_genome mRNA 50357516 50492537 . + . ID=transcript_1757;Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing;|Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing;|Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing;|Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing;|Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing;|Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing;|Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing;|Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing;|Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing;|Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing;|Q8NF92 Q8TCA1 Q9H2G1 Q9NP37,Zinc finger protein 638,Cutaneous T-cell lymphoma-associated antigen se33-1 {ECO:0000303|PubMed:11149944};Nuclear protein 220 {ECO:0000303|PubMed:8647861};Zinc finger matrin-like protein;, PF00076;PF12171;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0003723;GO:0008270;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:RNA splicing; scaffold6 indexed_genome mRNA 50527979 50753333 . + . ID=transcript_1758;Q53QY3 Q53TD2 Q8TEL8 Q9UEN7,Dysferlin,Dystrophy-associated fer-1-like protein;Fer-1-like protein 1;, PF00168;PF08165;PF08150;PF08151;PF16165;, GO:0034451;GO:0031410;GO:0030659;GO:0005769;GO:0030139;GO:0005768;GO:0070062;GO:0016021;GO:0005770;GO:0005886;GO:0042383;GO:0030315;GO:0005509;GO:0005544;GO:0005543;GO:0002281;GO:0061025;GO:0002280;GO:0006936;GO:0050765;GO:0007009;GO:0001778;GO:0033292;GO:0006906;, C:centriolar satellite; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:extracellular exosome; C:integral component of membrane; C:late endosome; C:plasma membrane; C:sarcolemma; C:T-tubule;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phospholipid binding;, P:macrophage activation involved in immune response; P:membrane fusion; P:monocyte activation involved in immune response; P:muscle contraction; P:negative regulation of phagocytosis; P:plasma membrane organization; P:plasma membrane repair; P:T-tubule organization; P:vesicle fusion;|Q53QY3 Q53TD2 Q8TEL8 Q9UEN7,Dysferlin,Dystrophy-associated fer-1-like protein;Fer-1-like protein 1;, PF00168;PF08165;PF08150;PF08151;PF16165;, GO:0034451;GO:0031410;GO:0030659;GO:0005769;GO:0030139;GO:0005768;GO:0070062;GO:0016021;GO:0005770;GO:0005886;GO:0042383;GO:0030315;GO:0005509;GO:0005544;GO:0005543;GO:0002281;GO:0061025;GO:0002280;GO:0006936;GO:0050765;GO:0007009;GO:0001778;GO:0033292;GO:0006906;, C:centriolar satellite; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:extracellular exosome; C:integral component of membrane; C:late endosome; C:plasma membrane; C:sarcolemma; C:T-tubule;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phospholipid binding;, P:macrophage activation involved in immune response; P:membrane fusion; P:monocyte activation involved in immune response; P:muscle contraction; P:negative regulation of phagocytosis; P:plasma membrane organization; P:plasma membrane repair; P:T-tubule organization; P:vesicle fusion;|Q53QY3 Q53TD2 Q8TEL8 Q9UEN7,Dysferlin,Dystrophy-associated fer-1-like protein;Fer-1-like protein 1;, PF00168;PF08165;PF08150;PF08151;PF16165;, GO:0034451;GO:0031410;GO:0030659;GO:0005769;GO:0030139;GO:0005768;GO:0070062;GO:0016021;GO:0005770;GO:0005886;GO:0042383;GO:0030315;GO:0005509;GO:0005544;GO:0005543;GO:0002281;GO:0061025;GO:0002280;GO:0006936;GO:0050765;GO:0007009;GO:0001778;GO:0033292;GO:0006906;, C:centriolar satellite; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:extracellular exosome; C:integral component of membrane; C:late endosome; C:plasma membrane; C:sarcolemma; C:T-tubule;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phospholipid binding;, P:macrophage activation involved in immune response; P:membrane fusion; P:monocyte activation involved in immune response; P:muscle contraction; P:negative regulation of phagocytosis; P:plasma membrane organization; P:plasma membrane repair; P:T-tubule organization; P:vesicle fusion; scaffold6 indexed_genome mRNA 51247491 51277062 . - . ID=transcript_1759;Q9NR63 B2R8M7 B7Z2K6 B7Z2P4 B7Z3B8 E4W5W7 Q32MC0 Q53TW1 Q9NP41,Cytochrome P450 26B1,Cytochrome P450 26A2;Cytochrome P450 retinoic acid-inactivating 2;Retinoic acid-metabolizing cytochrome;, PF00067;, GO:0005737;GO:0005789;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0008401;GO:0001972;GO:0060349;GO:0001709;GO:0071300;GO:0070268;GO:0030326;GO:0061436;GO:0001768;GO:0006954;GO:0001822;GO:0007140;GO:0048387;GO:0010628;GO:2001037;GO:0009954;GO:0045580;GO:0033189;GO:0034653;GO:0042573;GO:0048384;GO:0007283;GO:0016125;GO:0043587;GO:0006766;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:retinoic acid 4-hydroxylase activity; F:retinoic acid binding;, P:bone morphogenesis; P:cell fate determination; P:cellular response to retinoic acid; P:cornification; P:embryonic limb morphogenesis; P:establishment of skin barrier; P:establishment of T cell polarity; P:inflammatory response; P:kidney development; P:male meiotic nuclear division; P:negative regulation of retinoic acid receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of tongue muscle cell differentiation; P:proximal/distal pattern formation; P:regulation of T cell differentiation; P:response to vitamin A; P:retinoic acid catabolic process; P:retinoic acid metabolic process; P:retinoic acid receptor signaling pathway; P:spermatogenesis; P:sterol metabolic process; P:tongue morphogenesis; P:vitamin metabolic process; P:xenobiotic metabolic process;|Q9NR63 B2R8M7 B7Z2K6 B7Z2P4 B7Z3B8 E4W5W7 Q32MC0 Q53TW1 Q9NP41,Cytochrome P450 26B1,Cytochrome P450 26A2;Cytochrome P450 retinoic acid-inactivating 2;Retinoic acid-metabolizing cytochrome;, PF00067;, GO:0005737;GO:0005789;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0008401;GO:0001972;GO:0060349;GO:0001709;GO:0071300;GO:0070268;GO:0030326;GO:0061436;GO:0001768;GO:0006954;GO:0001822;GO:0007140;GO:0048387;GO:0010628;GO:2001037;GO:0009954;GO:0045580;GO:0033189;GO:0034653;GO:0042573;GO:0048384;GO:0007283;GO:0016125;GO:0043587;GO:0006766;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:retinoic acid 4-hydroxylase activity; F:retinoic acid binding;, P:bone morphogenesis; P:cell fate determination; P:cellular response to retinoic acid; P:cornification; P:embryonic limb morphogenesis; P:establishment of skin barrier; P:establishment of T cell polarity; P:inflammatory response; P:kidney development; P:male meiotic nuclear division; P:negative regulation of retinoic acid receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of tongue muscle cell differentiation; P:proximal/distal pattern formation; P:regulation of T cell differentiation; P:response to vitamin A; P:retinoic acid catabolic process; P:retinoic acid metabolic process; P:retinoic acid receptor signaling pathway; P:spermatogenesis; P:sterol metabolic process; P:tongue morphogenesis; P:vitamin metabolic process; P:xenobiotic metabolic process; scaffold6 indexed_genome mRNA 51298286 51863671 . - . ID=transcript_1760;Q9Y2D4 B8ZZY3,Exocyst complex component 6B,Exocyst complex component Sec15B;SEC15-like protein 2;, PF04091;, GO:0000145;GO:0016020;GO:0006887;GO:0006893;GO:0015031;GO:0006904;, C:exocyst; C:membrane;, , P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:vesicle docking involved in exocytosis;|Q9Y2D4 B8ZZY3,Exocyst complex component 6B,Exocyst complex component Sec15B;SEC15-like protein 2;, PF04091;, GO:0000145;GO:0016020;GO:0006887;GO:0006893;GO:0015031;GO:0006904;, C:exocyst; C:membrane;, , P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:vesicle docking involved in exocytosis; scaffold6 indexed_genome mRNA 52032460 52039168 . + . ID=transcript_1761;P35270 A8K741 D6W5H2 Q53GI9 Q9UBB1,Sepiapterin reductase,, PF00106;, GO:0005829;GO:0070062;GO:0005654;GO:0004033;GO:0050661;GO:0004757;GO:0006809;GO:0050999;GO:0006729;GO:0046146;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:aldo-keto reductase (NADP) activity; F:NADP binding; F:sepiapterin reductase activity;, P:nitric oxide biosynthetic process; P:regulation of nitric-oxide synthase activity; P:tetrahydrobiopterin biosynthetic process; P:tetrahydrobiopterin metabolic process; scaffold6 indexed_genome mRNA 52094319 52217132 . - . ID=transcript_1762;Q8TD22 A8K116 Q494Y3 Q53T29,Sideroflexin-5 {ECO:0000303|PubMed:12039050},, PF03820;, GO:0031305;GO:0005739;GO:0015137;GO:0022857;GO:0006865;GO:0015746;GO:1990542;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:citrate transmembrane transporter activity; F:transmembrane transporter activity;, P:amino acid transport; P:citrate transport; P:mitochondrial transmembrane transport; scaffold6 indexed_genome mRNA 52218718 52257969 . - . ID=transcript_1763;Q9BXF6 O94939 Q9P0M1,Rab11 family-interacting protein 5,Gamma-SNAP-associated factor 1;Phosphoprotein pp75;Rab11-interacting protein Rip11;, PF00168;PF09457;, GO:0034451;GO:0005769;GO:0031901;GO:0005794;GO:0000139;GO:0043231;GO:0005741;GO:0005739;GO:0045335;GO:0055037;GO:0055038;GO:0030141;GO:0030658;GO:0043015;GO:0031267;GO:0071468;GO:0035773;GO:0070164;GO:0045055;GO:2000008;, C:centriolar satellite; C:early endosome; C:early endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:mitochondrial outer membrane; C:mitochondrion; C:phagocytic vesicle; C:recycling endosome; C:recycling endosome membrane; C:secretory granule; C:transport vesicle membrane;, F:gamma-tubulin binding; F:small GTPase binding;, P:cellular response to acidic pH; P:insulin secretion involved in cellular response to glucose stimulus; P:negative regulation of adiponectin secretion; P:regulated exocytosis; P:regulation of protein localization to cell surface; scaffold6 indexed_genome mRNA 52351004 52366098 . - . ID=transcript_1764;Q9BSG0 Q2Z1P2,Protease-associated domain-containing protein 1,Protease-associated domain-containing protein of 21 kDa;, PF02225;, GO:0005576;, C:extracellular region;|Q6GMV2 D6W5H3 Q13558,SET and MYND domain-containing protein 5,Protein NN8-4AG;Retinoic acid-induced protein 15;, PF00856;, GO:0018024;GO:0046872;, , F:histone-lysine N-methyltransferase activity; F:metal ion binding;|Q6GMV2 D6W5H3 Q13558,SET and MYND domain-containing protein 5,Protein NN8-4AG;Retinoic acid-induced protein 15;, PF00856;, GO:0018024;GO:0046872;, , F:histone-lysine N-methyltransferase activity; F:metal ion binding;|Q6GMV2 D6W5H3 Q13558,SET and MYND domain-containing protein 5,Protein NN8-4AG;Retinoic acid-induced protein 15;, PF00856;, GO:0018024;GO:0046872;, , F:histone-lysine N-methyltransferase activity; F:metal ion binding;|Q9BSG0 Q2Z1P2,Protease-associated domain-containing protein 1,Protease-associated domain-containing protein of 21 kDa;, PF02225;, GO:0005576;, C:extracellular region;|Q9BSG0 Q2Z1P2,Protease-associated domain-containing protein 1,Protease-associated domain-containing protein of 21 kDa;, PF02225;, GO:0005576;, C:extracellular region; scaffold6 indexed_genome mRNA 52366858 52383507 . + . ID=transcript_1765;Q99832 A8K7E6 A8MWI8 B7WNW9 B7Z4T9 B7Z4Z7 O14871 Q6FI26,T-complex protein 1 subunit eta,CCT-eta;HIV-1 Nef-interacting protein;, PF00118;, GO:0044297;GO:0005832;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0042802;GO:0044183;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:cell body; C:chaperonin-containing T-complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|Q99832 A8K7E6 A8MWI8 B7WNW9 B7Z4T9 B7Z4Z7 O14871 Q6FI26,T-complex protein 1 subunit eta,CCT-eta;HIV-1 Nef-interacting protein;, PF00118;, GO:0044297;GO:0005832;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0042802;GO:0044183;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:cell body; C:chaperonin-containing T-complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|Q99832 A8K7E6 A8MWI8 B7WNW9 B7Z4T9 B7Z4Z7 O14871 Q6FI26,T-complex protein 1 subunit eta,CCT-eta;HIV-1 Nef-interacting protein;, PF00118;, GO:0044297;GO:0005832;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0042802;GO:0044183;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:cell body; C:chaperonin-containing T-complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport; scaffold6 indexed_genome mRNA 52390252 52392643 . + . ID=transcript_1766;Q8TF61 G3V0Z7 Q2M1V8,F-box only protein 41,, PF12937;, GO:0005829;GO:0043687;GO:0000209;, C:cytosol;, , P:post-translational protein modification; P:protein polyubiquitination;|Q8TF61 G3V0Z7 Q2M1V8,F-box only protein 41,, PF12937;, GO:0005829;GO:0043687;GO:0000209;, C:cytosol;, , P:post-translational protein modification; P:protein polyubiquitination; scaffold6 indexed_genome mRNA 52393582 52394133 . - . ID=transcript_1767;Q8TF61 G3V0Z7 Q2M1V8,F-box only protein 41,, PF12937;, GO:0005829;GO:0043687;GO:0000209;, C:cytosol;, , P:post-translational protein modification; P:protein polyubiquitination; scaffold6 indexed_genome mRNA 52394145 52415066 . - . ID=transcript_1768;Q8TF61 G3V0Z7 Q2M1V8,F-box only protein 41,, PF12937;, GO:0005829;GO:0043687;GO:0000209;, C:cytosol;, , P:post-translational protein modification; P:protein polyubiquitination; scaffold6 indexed_genome mRNA 52421840 52424960 . - . ID=transcript_1769;Q05215 B2RAE3 G3V1T5 Q2Z1P5,Early growth response protein 4,AT133;, PF00096;, GO:0000785;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0008284;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold6 indexed_genome mRNA 52577888 52700603 . + . ID=transcript_1770;Q8TCU4 A0A087WZY3 Q53S05 Q580Q8 Q86VP9 Q9Y4G4,Alstrom syndrome protein 1,, PF15309;PF18727;, GO:0005813;GO:0005929;GO:0005829;GO:0000922;GO:0008017;GO:0097711;GO:0016197;GO:0000086;GO:0120162;GO:0046599;GO:0010389;GO:0051492;, C:centrosome; C:cilium; C:cytosol; C:spindle pole;, F:microtubule binding;, P:ciliary basal body-plasma membrane docking; P:endosomal transport; P:G2/M transition of mitotic cell cycle; P:positive regulation of cold-induced thermogenesis; P:regulation of centriole replication; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of stress fiber assembly;|Q8TCU4 A0A087WZY3 Q53S05 Q580Q8 Q86VP9 Q9Y4G4,Alstrom syndrome protein 1,, PF15309;PF18727;, GO:0005813;GO:0005929;GO:0005829;GO:0000922;GO:0008017;GO:0097711;GO:0016197;GO:0000086;GO:0120162;GO:0046599;GO:0010389;GO:0051492;, C:centrosome; C:cilium; C:cytosol; C:spindle pole;, F:microtubule binding;, P:ciliary basal body-plasma membrane docking; P:endosomal transport; P:G2/M transition of mitotic cell cycle; P:positive regulation of cold-induced thermogenesis; P:regulation of centriole replication; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of stress fiber assembly;|Q8TCU4 A0A087WZY3 Q53S05 Q580Q8 Q86VP9 Q9Y4G4,Alstrom syndrome protein 1,, PF15309;PF18727;, GO:0005813;GO:0005929;GO:0005829;GO:0000922;GO:0008017;GO:0097711;GO:0016197;GO:0000086;GO:0120162;GO:0046599;GO:0010389;GO:0051492;, C:centrosome; C:cilium; C:cytosol; C:spindle pole;, F:microtubule binding;, P:ciliary basal body-plasma membrane docking; P:endosomal transport; P:G2/M transition of mitotic cell cycle; P:positive regulation of cold-induced thermogenesis; P:regulation of centriole replication; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of stress fiber assembly;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold6 indexed_genome mRNA 52700672 52701803 . - . ID=transcript_1771;Q9UHF3 Q0VAD9 Q6NT18,Putative N-acetyltransferase 8B,Acetyltransferase 1;Camello-like protein 2;, PF00583;, GO:0005789;GO:0005793;GO:0033116;GO:0016021;GO:0004468;GO:0008080;GO:1990000;GO:0050435;GO:0001702;GO:0043066;GO:0018003;GO:0010628;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane;, F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:N-acetyltransferase activity;, P:amyloid fibril formation; P:amyloid-beta metabolic process; P:gastrulation with mouth forming second; P:negative regulation of apoptotic process; P:peptidyl-lysine N6-acetylation; P:positive regulation of gene expression; scaffold6 indexed_genome mRNA 52708640 52717800 . - . ID=transcript_1772;Q9Y3C4 D6W5H6 Q8IWR6 Q8IWR7 Q9H3K4,EKC/KEOPS complex subunit TPRKB {ECO:0000305},PRPK-binding protein {ECO:0000303|PubMed:12659830};TP53RK-binding protein {ECO:0000303|PubMed:12659830};, PF08617;, GO:0005737;GO:0005829;GO:0000408;GO:0005634;GO:0019901;GO:0000722;GO:0002949;, C:cytoplasm; C:cytosol; C:EKC/KEOPS complex; C:nucleus;, F:protein kinase binding;, P:telomere maintenance via recombination; P:tRNA threonylcarbamoyladenosine modification;|Q9Y3C4 D6W5H6 Q8IWR6 Q8IWR7 Q9H3K4,EKC/KEOPS complex subunit TPRKB {ECO:0000305},PRPK-binding protein {ECO:0000303|PubMed:12659830};TP53RK-binding protein {ECO:0000303|PubMed:12659830};, PF08617;, GO:0005737;GO:0005829;GO:0000408;GO:0005634;GO:0019901;GO:0000722;GO:0002949;, C:cytoplasm; C:cytosol; C:EKC/KEOPS complex; C:nucleus;, F:protein kinase binding;, P:telomere maintenance via recombination; P:tRNA threonylcarbamoyladenosine modification;|Q9Y3C4 D6W5H6 Q8IWR6 Q8IWR7 Q9H3K4,EKC/KEOPS complex subunit TPRKB {ECO:0000305},PRPK-binding protein {ECO:0000303|PubMed:12659830};TP53RK-binding protein {ECO:0000303|PubMed:12659830};, PF08617;, GO:0005737;GO:0005829;GO:0000408;GO:0005634;GO:0019901;GO:0000722;GO:0002949;, C:cytoplasm; C:cytosol; C:EKC/KEOPS complex; C:nucleus;, F:protein kinase binding;, P:telomere maintenance via recombination; P:tRNA threonylcarbamoyladenosine modification;|Q9Y3C4 D6W5H6 Q8IWR6 Q8IWR7 Q9H3K4,EKC/KEOPS complex subunit TPRKB {ECO:0000305},PRPK-binding protein {ECO:0000303|PubMed:12659830};TP53RK-binding protein {ECO:0000303|PubMed:12659830};, PF08617;, GO:0005737;GO:0005829;GO:0000408;GO:0005634;GO:0019901;GO:0000722;GO:0002949;, C:cytoplasm; C:cytosol; C:EKC/KEOPS complex; C:nucleus;, F:protein kinase binding;, P:telomere maintenance via recombination; P:tRNA threonylcarbamoyladenosine modification; scaffold6 indexed_genome mRNA 52724888 52726912 . + . ID=transcript_1773;O75319 B2RCT8 C9JYA6 Q6AI47 Q9BWE3,RNA/RNP complex-1-interacting phosphatase,Dual specificity protein phosphatase 11;Phosphatase that interacts with RNA/RNP complex 1;, , GO:0001650;GO:0045171;GO:0016607;GO:0005654;GO:0005634;GO:0098519;GO:0016791;GO:0004651;GO:0004725;GO:0008138;GO:0003723;GO:0098507;GO:0006470;GO:0016070;GO:0006396;, C:fibrillar center; C:intercellular bridge; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:nucleotide phosphatase activity, acting on free nucleotides; F:phosphatase activity; F:polynucleotide 5'-phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:RNA binding;, P:polynucleotide 5' dephosphorylation; P:protein dephosphorylation; P:RNA metabolic process; P:RNA processing; scaffold6 indexed_genome mRNA 52727067 52731176 . + . ID=transcript_1774;O75319 B2RCT8 C9JYA6 Q6AI47 Q9BWE3,RNA/RNP complex-1-interacting phosphatase,Dual specificity protein phosphatase 11;Phosphatase that interacts with RNA/RNP complex 1;, , GO:0001650;GO:0045171;GO:0016607;GO:0005654;GO:0005634;GO:0098519;GO:0016791;GO:0004651;GO:0004725;GO:0008138;GO:0003723;GO:0098507;GO:0006470;GO:0016070;GO:0006396;, C:fibrillar center; C:intercellular bridge; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:nucleotide phosphatase activity, acting on free nucleotides; F:phosphatase activity; F:polynucleotide 5'-phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:RNA binding;, P:polynucleotide 5' dephosphorylation; P:protein dephosphorylation; P:RNA metabolic process; P:RNA processing;|O75319 B2RCT8 C9JYA6 Q6AI47 Q9BWE3,RNA/RNP complex-1-interacting phosphatase,Dual specificity protein phosphatase 11;Phosphatase that interacts with RNA/RNP complex 1;, , GO:0001650;GO:0045171;GO:0016607;GO:0005654;GO:0005634;GO:0098519;GO:0016791;GO:0004651;GO:0004725;GO:0008138;GO:0003723;GO:0098507;GO:0006470;GO:0016070;GO:0006396;, C:fibrillar center; C:intercellular bridge; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:nucleotide phosphatase activity, acting on free nucleotides; F:phosphatase activity; F:polynucleotide 5'-phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:RNA binding;, P:polynucleotide 5' dephosphorylation; P:protein dephosphorylation; P:RNA metabolic process; P:RNA processing;|O75319 B2RCT8 C9JYA6 Q6AI47 Q9BWE3,RNA/RNP complex-1-interacting phosphatase,Dual specificity protein phosphatase 11;Phosphatase that interacts with RNA/RNP complex 1;, , GO:0001650;GO:0045171;GO:0016607;GO:0005654;GO:0005634;GO:0098519;GO:0016791;GO:0004651;GO:0004725;GO:0008138;GO:0003723;GO:0098507;GO:0006470;GO:0016070;GO:0006396;, C:fibrillar center; C:intercellular bridge; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:nucleotide phosphatase activity, acting on free nucleotides; F:phosphatase activity; F:polynucleotide 5'-phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:RNA binding;, P:polynucleotide 5' dephosphorylation; P:protein dephosphorylation; P:RNA metabolic process; P:RNA processing; scaffold6 indexed_genome mRNA 52736607 52738277 . - . ID=transcript_1775;O75319 B2RCT8 C9JYA6 Q6AI47 Q9BWE3,RNA/RNP complex-1-interacting phosphatase,Dual specificity protein phosphatase 11;Phosphatase that interacts with RNA/RNP complex 1;, , GO:0001650;GO:0045171;GO:0016607;GO:0005654;GO:0005634;GO:0098519;GO:0016791;GO:0004651;GO:0004725;GO:0008138;GO:0003723;GO:0098507;GO:0006470;GO:0016070;GO:0006396;, C:fibrillar center; C:intercellular bridge; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:nucleotide phosphatase activity, acting on free nucleotides; F:phosphatase activity; F:polynucleotide 5'-phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:RNA binding;, P:polynucleotide 5' dephosphorylation; P:protein dephosphorylation; P:RNA metabolic process; P:RNA processing; scaffold6 indexed_genome mRNA 52767364 52791157 . + . ID=transcript_1776;O95630 B5M0B6 D6W5H7 Q3MJE7,STAM-binding protein,Associated molecule with the SH3 domain of STAM;Endosome-associated ubiquitin isopeptidase;, PF01398;PF08969;, GO:0032154;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0019904;GO:0004843;GO:0000281;GO:0014067;GO:0046580;GO:0008284;GO:0016579;GO:0070536;GO:0007259;, C:cleavage furrow; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:protein domain specific binding; F:thiol-dependent ubiquitin-specific protease activity;, P:mitotic cytokinesis; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of Ras protein signal transduction; P:positive regulation of cell population proliferation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:receptor signaling pathway via JAK-STAT;|O95630 B5M0B6 D6W5H7 Q3MJE7,STAM-binding protein,Associated molecule with the SH3 domain of STAM;Endosome-associated ubiquitin isopeptidase;, PF01398;PF08969;, GO:0032154;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0019904;GO:0004843;GO:0000281;GO:0014067;GO:0046580;GO:0008284;GO:0016579;GO:0070536;GO:0007259;, C:cleavage furrow; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:protein domain specific binding; F:thiol-dependent ubiquitin-specific protease activity;, P:mitotic cytokinesis; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of Ras protein signal transduction; P:positive regulation of cell population proliferation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:receptor signaling pathway via JAK-STAT;|O95630 B5M0B6 D6W5H7 Q3MJE7,STAM-binding protein,Associated molecule with the SH3 domain of STAM;Endosome-associated ubiquitin isopeptidase;, PF01398;PF08969;, GO:0032154;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0019904;GO:0004843;GO:0000281;GO:0014067;GO:0046580;GO:0008284;GO:0016579;GO:0070536;GO:0007259;, C:cleavage furrow; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:protein domain specific binding; F:thiol-dependent ubiquitin-specific protease activity;, P:mitotic cytokinesis; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of Ras protein signal transduction; P:positive regulation of cell population proliferation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:receptor signaling pathway via JAK-STAT; scaffold6 indexed_genome mRNA 52851277 52851809 . + . ID=transcript_1777;P68133 P02568 P99020 Q5T8M9,Actin, alpha skeletal muscle,Alpha-actin-1;, PF00022;, GO:0015629;GO:0005884;GO:0072562;GO:0044297;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0030027;GO:0030017;GO:0001725;GO:0005865;GO:0043531;GO:0005524;GO:0017022;GO:0005200;GO:0071417;GO:0090131;GO:0006936;GO:0030049;GO:0010628;GO:0009991;GO:0010226;GO:0009612;GO:0048545;GO:0043503;GO:0048741;GO:0030240;, C:actin cytoskeleton; C:actin filament; C:blood microparticle; C:cell body; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:lamellipodium; C:sarcomere; C:stress fiber; C:striated muscle thin filament;, F:ADP binding; F:ATP binding; F:myosin binding; F:structural constituent of cytoskeleton;, P:cellular response to organonitrogen compound; P:mesenchyme migration; P:muscle contraction; P:muscle filament sliding; P:positive regulation of gene expression; P:response to extracellular stimulus; P:response to lithium ion; P:response to mechanical stimulus; P:response to steroid hormone; P:skeletal muscle fiber adaptation; P:skeletal muscle fiber development; P:skeletal muscle thin filament assembly; scaffold6 indexed_genome mRNA 52860617 52899137 . + . ID=transcript_1778;Q16854 P78532 Q16759 Q4ZG09 Q7L1W9 Q96BC1,Deoxyguanosine kinase, mitochondrial,Deoxyadenosine kinase, mitochondrial;, PF01712;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005634;GO:0005524;GO:0004136;GO:0004138;GO:0019136;GO:0006754;GO:0046070;GO:0008617;GO:0042775;GO:0010977;GO:0006468;GO:0046122;GO:0043101;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:ATP binding; F:deoxyadenosine kinase activity; F:deoxyguanosine kinase activity; F:deoxynucleoside kinase activity;, P:ATP biosynthetic process; P:dGTP metabolic process; P:guanosine metabolic process; P:mitochondrial ATP synthesis coupled electron transport; P:negative regulation of neuron projection development; P:protein phosphorylation; P:purine deoxyribonucleoside metabolic process; P:purine-containing compound salvage;|Q16854 P78532 Q16759 Q4ZG09 Q7L1W9 Q96BC1,Deoxyguanosine kinase, mitochondrial,Deoxyadenosine kinase, mitochondrial;, PF01712;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005634;GO:0005524;GO:0004136;GO:0004138;GO:0019136;GO:0006754;GO:0046070;GO:0008617;GO:0042775;GO:0010977;GO:0006468;GO:0046122;GO:0043101;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:ATP binding; F:deoxyadenosine kinase activity; F:deoxyguanosine kinase activity; F:deoxynucleoside kinase activity;, P:ATP biosynthetic process; P:dGTP metabolic process; P:guanosine metabolic process; P:mitochondrial ATP synthesis coupled electron transport; P:negative regulation of neuron projection development; P:protein phosphorylation; P:purine deoxyribonucleoside metabolic process; P:purine-containing compound salvage;|Q16854 P78532 Q16759 Q4ZG09 Q7L1W9 Q96BC1,Deoxyguanosine kinase, mitochondrial,Deoxyadenosine kinase, mitochondrial;, PF01712;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005634;GO:0005524;GO:0004136;GO:0004138;GO:0019136;GO:0006754;GO:0046070;GO:0008617;GO:0042775;GO:0010977;GO:0006468;GO:0046122;GO:0043101;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:ATP binding; F:deoxyadenosine kinase activity; F:deoxyguanosine kinase activity; F:deoxynucleoside kinase activity;, P:ATP biosynthetic process; P:dGTP metabolic process; P:guanosine metabolic process; P:mitochondrial ATP synthesis coupled electron transport; P:negative regulation of neuron projection development; P:protein phosphorylation; P:purine deoxyribonucleoside metabolic process; P:purine-containing compound salvage; scaffold6 indexed_genome mRNA 52938487 52975922 . + . ID=transcript_1779;O43151 A6NEI3 J3KNF3 K9JJH7 Q86Z24 Q8TBM9,Methylcytosine dioxygenase TET3 {ECO:0000305},, PF12851;PF02008;, GO:0005694;GO:0005737;GO:0001939;GO:0001940;GO:0005634;GO:0008327;GO:0070579;GO:0008270;GO:0006211;GO:0080111;GO:0044727;GO:0080182;GO:0070989;GO:0045944;GO:0006493;, C:chromosome; C:cytoplasm; C:female pronucleus; C:male pronucleus; C:nucleus;, F:methyl-CpG binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:DNA demethylation; P:DNA demethylation of male pronucleus; P:histone H3-K4 trimethylation; P:oxidative demethylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation;|O43151 A6NEI3 J3KNF3 K9JJH7 Q86Z24 Q8TBM9,Methylcytosine dioxygenase TET3 {ECO:0000305},, PF12851;PF02008;, GO:0005694;GO:0005737;GO:0001939;GO:0001940;GO:0005634;GO:0008327;GO:0070579;GO:0008270;GO:0006211;GO:0080111;GO:0044727;GO:0080182;GO:0070989;GO:0045944;GO:0006493;, C:chromosome; C:cytoplasm; C:female pronucleus; C:male pronucleus; C:nucleus;, F:methyl-CpG binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:DNA demethylation; P:DNA demethylation of male pronucleus; P:histone H3-K4 trimethylation; P:oxidative demethylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation; scaffold6 indexed_genome mRNA 52975926 52977006 . + . ID=transcript_1780;O43151 A6NEI3 J3KNF3 K9JJH7 Q86Z24 Q8TBM9,Methylcytosine dioxygenase TET3 {ECO:0000305},, PF12851;PF02008;, GO:0005694;GO:0005737;GO:0001939;GO:0001940;GO:0005634;GO:0008327;GO:0070579;GO:0008270;GO:0006211;GO:0080111;GO:0044727;GO:0080182;GO:0070989;GO:0045944;GO:0006493;, C:chromosome; C:cytoplasm; C:female pronucleus; C:male pronucleus; C:nucleus;, F:methyl-CpG binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:DNA demethylation; P:DNA demethylation of male pronucleus; P:histone H3-K4 trimethylation; P:oxidative demethylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation; scaffold6 indexed_genome mRNA 53000809 53026875 . + . ID=transcript_1781;O43151 A6NEI3 J3KNF3 K9JJH7 Q86Z24 Q8TBM9,Methylcytosine dioxygenase TET3 {ECO:0000305},, PF12851;PF02008;, GO:0005694;GO:0005737;GO:0001939;GO:0001940;GO:0005634;GO:0008327;GO:0070579;GO:0008270;GO:0006211;GO:0080111;GO:0044727;GO:0080182;GO:0070989;GO:0045944;GO:0006493;, C:chromosome; C:cytoplasm; C:female pronucleus; C:male pronucleus; C:nucleus;, F:methyl-CpG binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:DNA demethylation; P:DNA demethylation of male pronucleus; P:histone H3-K4 trimethylation; P:oxidative demethylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation; scaffold6 indexed_genome mRNA 53073448 53077373 . - . ID=transcript_1782;Q53S33 G3XAB0,BolA-like protein 3 {ECO:0000305},, PF01722;, GO:0005829;GO:0005739;GO:0016604;, C:cytosol; C:mitochondrion; C:nuclear body; scaffold6 indexed_genome mRNA 53095164 53119942 . - . ID=transcript_1783;Q9H8S9 Q53S34 Q9H3T5 Q9HAI0 Q9NVE2,MOB kinase activator 1A,Mob1 alpha;Mob1 homolog 1B;Mps one binder kinase activator-like 1B;, PF03637;, GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0046872;GO:0035329;, C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm;, F:metal ion binding;, P:hippo signaling; scaffold6 indexed_genome mRNA 53143362 53173314 . + . ID=transcript_1784;P13995 Q53G90 Q53GV5 Q53S36 Q7Z650,Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial,, PF00763;PF02882;, GO:0005615;GO:0005759;GO:0005739;GO:0000287;GO:0004477;GO:0004487;GO:0004488;GO:0042301;GO:0046655;GO:0035999;GO:0046653;, C:extracellular space; C:mitochondrial matrix; C:mitochondrion;, F:magnesium ion binding; F:methenyltetrahydrofolate cyclohydrolase activity; F:methylenetetrahydrofolate dehydrogenase (NAD+) activity; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; F:phosphate ion binding;, P:folic acid metabolic process; P:tetrahydrofolate interconversion; P:tetrahydrofolate metabolic process; scaffold6 indexed_genome mRNA 53323455 53353376 . - . ID=transcript_1785;Q9UIU1 Q9UIU2,Dynactin subunit 1,150 kDa dynein-associated polypeptide;DAP-150;p135;p150-glued;, PF01302;PF12455;, GO:0030424;GO:0005938;GO:0099738;GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0030286;GO:0045171;GO:0000776;GO:0016020;GO:0005874;GO:0005875;GO:0015630;GO:0035371;GO:0072686;GO:0043005;GO:0043025;GO:0005635;GO:0005634;GO:0005819;GO:0000922;GO:0008017;GO:0051010;GO:0019901;GO:0048156;GO:0015631;GO:0019886;GO:0051301;GO:0010457;GO:0097711;GO:0031122;GO:0006888;GO:0000132;GO:0000086;GO:0036498;GO:0099558;GO:0034454;GO:0000278;GO:0061744;GO:0007399;GO:0007528;GO:0050905;GO:0070050;GO:1990535;GO:1905515;GO:0051081;GO:0007097;GO:0090063;GO:0031116;GO:1904398;GO:0010389;GO:0060236;GO:0042147;GO:0021517;, C:axon; C:cell cortex; C:cell cortex region; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:dynein complex; C:intercellular bridge; C:kinetochore; C:membrane; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:microtubule plus-end; C:mitotic spindle; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nucleus; C:spindle; C:spindle pole;, F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:tau protein binding; F:tubulin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:IRE1-mediated unfolded protein response; P:maintenance of synapse structure; P:microtubule anchoring at centrosome; P:mitotic cell cycle; P:motor behavior; P:nervous system development; P:neuromuscular junction development; P:neuromuscular process; P:neuron cellular homeostasis; P:neuron projection maintenance; P:non-motile cilium assembly; P:nuclear envelope disassembly; P:nuclear migration; P:positive regulation of microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of neuromuscular junction development; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:retrograde transport, endosome to Golgi; P:ventral spinal cord development;|Q9UIU1 Q9UIU2,Dynactin subunit 1,150 kDa dynein-associated polypeptide;DAP-150;p135;p150-glued;, PF01302;PF12455;, GO:0030424;GO:0005938;GO:0099738;GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0030286;GO:0045171;GO:0000776;GO:0016020;GO:0005874;GO:0005875;GO:0015630;GO:0035371;GO:0072686;GO:0043005;GO:0043025;GO:0005635;GO:0005634;GO:0005819;GO:0000922;GO:0008017;GO:0051010;GO:0019901;GO:0048156;GO:0015631;GO:0019886;GO:0051301;GO:0010457;GO:0097711;GO:0031122;GO:0006888;GO:0000132;GO:0000086;GO:0036498;GO:0099558;GO:0034454;GO:0000278;GO:0061744;GO:0007399;GO:0007528;GO:0050905;GO:0070050;GO:1990535;GO:1905515;GO:0051081;GO:0007097;GO:0090063;GO:0031116;GO:1904398;GO:0010389;GO:0060236;GO:0042147;GO:0021517;, C:axon; C:cell cortex; C:cell cortex region; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:dynein complex; C:intercellular bridge; C:kinetochore; C:membrane; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:microtubule plus-end; C:mitotic spindle; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nucleus; C:spindle; C:spindle pole;, F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:tau protein binding; F:tubulin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:IRE1-mediated unfolded protein response; P:maintenance of synapse structure; P:microtubule anchoring at centrosome; P:mitotic cell cycle; P:motor behavior; P:nervous system development; P:neuromuscular junction development; P:neuromuscular process; P:neuron cellular homeostasis; P:neuron projection maintenance; P:non-motile cilium assembly; P:nuclear envelope disassembly; P:nuclear migration; P:positive regulation of microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of neuromuscular junction development; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:retrograde transport, endosome to Golgi; P:ventral spinal cord development;|Q9UIU1 Q9UIU2,Dynactin subunit 1,150 kDa dynein-associated polypeptide;DAP-150;p135;p150-glued;, PF01302;PF12455;, GO:0030424;GO:0005938;GO:0099738;GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0030286;GO:0045171;GO:0000776;GO:0016020;GO:0005874;GO:0005875;GO:0015630;GO:0035371;GO:0072686;GO:0043005;GO:0043025;GO:0005635;GO:0005634;GO:0005819;GO:0000922;GO:0008017;GO:0051010;GO:0019901;GO:0048156;GO:0015631;GO:0019886;GO:0051301;GO:0010457;GO:0097711;GO:0031122;GO:0006888;GO:0000132;GO:0000086;GO:0036498;GO:0099558;GO:0034454;GO:0000278;GO:0061744;GO:0007399;GO:0007528;GO:0050905;GO:0070050;GO:1990535;GO:1905515;GO:0051081;GO:0007097;GO:0090063;GO:0031116;GO:1904398;GO:0010389;GO:0060236;GO:0042147;GO:0021517;, C:axon; C:cell cortex; C:cell cortex region; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:dynein complex; C:intercellular bridge; C:kinetochore; C:membrane; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:microtubule plus-end; C:mitotic spindle; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nucleus; C:spindle; C:spindle pole;, F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:tau protein binding; F:tubulin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:IRE1-mediated unfolded protein response; P:maintenance of synapse structure; P:microtubule anchoring at centrosome; P:mitotic cell cycle; P:motor behavior; P:nervous system development; P:neuromuscular junction development; P:neuromuscular process; P:neuron cellular homeostasis; P:neuron projection maintenance; P:non-motile cilium assembly; P:nuclear envelope disassembly; P:nuclear migration; P:positive regulation of microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of neuromuscular junction development; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:retrograde transport, endosome to Golgi; P:ventral spinal cord development;|Q9UIU1 Q9UIU2,Dynactin subunit 1,150 kDa dynein-associated polypeptide;DAP-150;p135;p150-glued;, PF01302;PF12455;, GO:0030424;GO:0005938;GO:0099738;GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0030286;GO:0045171;GO:0000776;GO:0016020;GO:0005874;GO:0005875;GO:0015630;GO:0035371;GO:0072686;GO:0043005;GO:0043025;GO:0005635;GO:0005634;GO:0005819;GO:0000922;GO:0008017;GO:0051010;GO:0019901;GO:0048156;GO:0015631;GO:0019886;GO:0051301;GO:0010457;GO:0097711;GO:0031122;GO:0006888;GO:0000132;GO:0000086;GO:0036498;GO:0099558;GO:0034454;GO:0000278;GO:0061744;GO:0007399;GO:0007528;GO:0050905;GO:0070050;GO:1990535;GO:1905515;GO:0051081;GO:0007097;GO:0090063;GO:0031116;GO:1904398;GO:0010389;GO:0060236;GO:0042147;GO:0021517;, C:axon; C:cell cortex; C:cell cortex region; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:dynein complex; C:intercellular bridge; C:kinetochore; C:membrane; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:microtubule plus-end; C:mitotic spindle; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nucleus; C:spindle; C:spindle pole;, F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:tau protein binding; F:tubulin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:IRE1-mediated unfolded protein response; P:maintenance of synapse structure; P:microtubule anchoring at centrosome; P:mitotic cell cycle; P:motor behavior; P:nervous system development; P:neuromuscular junction development; P:neuromuscular process; P:neuron cellular homeostasis; P:neuron projection maintenance; P:non-motile cilium assembly; P:nuclear envelope disassembly; P:nuclear migration; P:positive regulation of microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of neuromuscular junction development; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:retrograde transport, endosome to Golgi; P:ventral spinal cord development;|Q9UIU1 Q9UIU2,Dynactin subunit 1,150 kDa dynein-associated polypeptide;DAP-150;p135;p150-glued;, PF01302;PF12455;, GO:0030424;GO:0005938;GO:0099738;GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0030286;GO:0045171;GO:0000776;GO:0016020;GO:0005874;GO:0005875;GO:0015630;GO:0035371;GO:0072686;GO:0043005;GO:0043025;GO:0005635;GO:0005634;GO:0005819;GO:0000922;GO:0008017;GO:0051010;GO:0019901;GO:0048156;GO:0015631;GO:0019886;GO:0051301;GO:0010457;GO:0097711;GO:0031122;GO:0006888;GO:0000132;GO:0000086;GO:0036498;GO:0099558;GO:0034454;GO:0000278;GO:0061744;GO:0007399;GO:0007528;GO:0050905;GO:0070050;GO:1990535;GO:1905515;GO:0051081;GO:0007097;GO:0090063;GO:0031116;GO:1904398;GO:0010389;GO:0060236;GO:0042147;GO:0021517;, C:axon; C:cell cortex; C:cell cortex region; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:dynein complex; C:intercellular bridge; C:kinetochore; C:membrane; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:microtubule plus-end; C:mitotic spindle; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nucleus; C:spindle; C:spindle pole;, F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:tau protein binding; F:tubulin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:IRE1-mediated unfolded protein response; P:maintenance of synapse structure; P:microtubule anchoring at centrosome; P:mitotic cell cycle; P:motor behavior; P:nervous system development; P:neuromuscular junction development; P:neuromuscular process; P:neuron cellular homeostasis; P:neuron projection maintenance; P:non-motile cilium assembly; P:nuclear envelope disassembly; P:nuclear migration; P:positive regulation of microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of neuromuscular junction development; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:retrograde transport, endosome to Golgi; P:ventral spinal cord development; scaffold6 indexed_genome mRNA 53353490 53358210 . + . ID=transcript_1786;P05114 Q3KQR8,Non-histone chromosomal protein HMG-14,High mobility group nucleosome-binding domain-containing protein 1;, PF01101;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0031492;GO:0006325;GO:0032786;GO:0006283;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:nucleosomal DNA binding;, P:chromatin organization; P:positive regulation of DNA-templated transcription, elongation; P:transcription-coupled nucleotide-excision repair; scaffold6 indexed_genome mRNA 53367189 53375789 . - . ID=transcript_1787;A6NN90 A0A087WXZ4,Uncharacterized protein C2orf81 {ECO:0000305},, PF15479;|A6NN90 A0A087WXZ4,Uncharacterized protein C2orf81 {ECO:0000305},, PF15479; scaffold6 indexed_genome mRNA 53380658 53384534 . + . ID=transcript_1788;Q9H977 B9A049 D6W5I3 Q53H85 Q86V45,WD repeat-containing protein 54 {ECO:0000305},, , GO:0031982;GO:0042803;GO:0002091;GO:0042058;GO:0043408;, C:vesicle;, F:protein homodimerization activity;, P:negative regulation of receptor internalization; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of MAPK cascade;|Q9H977 B9A049 D6W5I3 Q53H85 Q86V45,WD repeat-containing protein 54 {ECO:0000305},, , GO:0031982;GO:0042803;GO:0002091;GO:0042058;GO:0043408;, C:vesicle;, F:protein homodimerization activity;, P:negative regulation of receptor internalization; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of MAPK cascade;|Q9H977 B9A049 D6W5I3 Q53H85 Q86V45,WD repeat-containing protein 54 {ECO:0000305},, , GO:0031982;GO:0042803;GO:0002091;GO:0042058;GO:0043408;, C:vesicle;, F:protein homodimerization activity;, P:negative regulation of receptor internalization; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of MAPK cascade;|Q9H977 B9A049 D6W5I3 Q53H85 Q86V45,WD repeat-containing protein 54 {ECO:0000305},, , GO:0031982;GO:0042803;GO:0002091;GO:0042058;GO:0043408;, C:vesicle;, F:protein homodimerization activity;, P:negative regulation of receptor internalization; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of MAPK cascade; scaffold6 indexed_genome mRNA 53384609 53389292 . - . ID=transcript_1789;Q9BST9 H7BXD4 Q8WVN1 Q96PT6 Q9HB05,Rhotekin,, PF08174;PF00169;, GO:0005826;GO:0005829;GO:0005525;GO:0005095;GO:0031267;GO:0000915;GO:0006915;GO:0000281;GO:0042981;GO:0007266;GO:0031106;GO:0007165;, C:actomyosin contractile ring; C:cytosol;, F:GTP binding; F:GTPase inhibitor activity; F:small GTPase binding;, P:actomyosin contractile ring assembly; P:apoptotic process; P:mitotic cytokinesis; P:regulation of apoptotic process; P:Rho protein signal transduction; P:septin ring organization; P:signal transduction; scaffold6 indexed_genome mRNA 53391094 53391852 . - . ID=transcript_1790;Q9BST9 H7BXD4 Q8WVN1 Q96PT6 Q9HB05,Rhotekin,, PF08174;PF00169;, GO:0005826;GO:0005829;GO:0005525;GO:0005095;GO:0031267;GO:0000915;GO:0006915;GO:0000281;GO:0042981;GO:0007266;GO:0031106;GO:0007165;, C:actomyosin contractile ring; C:cytosol;, F:GTP binding; F:GTPase inhibitor activity; F:small GTPase binding;, P:actomyosin contractile ring assembly; P:apoptotic process; P:mitotic cytokinesis; P:regulation of apoptotic process; P:Rho protein signal transduction; P:septin ring organization; P:signal transduction; scaffold6 indexed_genome mRNA 53401772 53402332 . - . ID=transcript_1791;P13693 B2R7E5 Q6YLS2 Q7Z4J4 Q8TBK7 Q96EE2 Q9UC70,Translationally-controlled tumor protein,Fortilin;Histamine-releasing factor;p23;, PF00838;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0005615;GO:0005771;GO:0005634;GO:0000922;GO:0005509;GO:0003723;GO:0006816;GO:0006874;GO:0043066;GO:1902230;GO:0042981;GO:0009615;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extracellular space; C:multivesicular body; C:nucleus; C:spindle pole;, F:calcium ion binding; F:RNA binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:regulation of apoptotic process; P:response to virus; scaffold6 indexed_genome mRNA 53415370 53418171 . + . ID=transcript_1792;Q9C086,INO80 complex subunit B,High mobility group AT-hook 1-like 4;IES2 homolog;PAP-1-associated protein 1;Zinc finger HIT domain-containing protein 4;, PF04795;PF04438;, GO:0031011;GO:0005730;GO:0005654;GO:0046872;GO:0043044;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleolus; C:nucleoplasm;, F:metal ion binding;, P:ATP-dependent chromatin remodeling; P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q9C086,INO80 complex subunit B,High mobility group AT-hook 1-like 4;IES2 homolog;PAP-1-associated protein 1;Zinc finger HIT domain-containing protein 4;, PF04795;PF04438;, GO:0031011;GO:0005730;GO:0005654;GO:0046872;GO:0043044;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleolus; C:nucleoplasm;, F:metal ion binding;, P:ATP-dependent chromatin remodeling; P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q9C086,INO80 complex subunit B,High mobility group AT-hook 1-like 4;IES2 homolog;PAP-1-associated protein 1;Zinc finger HIT domain-containing protein 4;, PF04795;PF04438;, GO:0031011;GO:0005730;GO:0005654;GO:0046872;GO:0043044;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleolus; C:nucleoplasm;, F:metal ion binding;, P:ATP-dependent chromatin remodeling; P:DNA recombination; P:DNA repair; P:protein deubiquitination; scaffold6 indexed_genome mRNA 53418688 53421014 . + . ID=transcript_1793;Q96G27 B2RE02 O95637,WW domain-binding protein 1,, PF11669;, GO:0050699;, , F:WW domain binding;|Q96G27 B2RE02 O95637,WW domain-binding protein 1,, PF11669;, GO:0050699;, , F:WW domain binding; scaffold6 indexed_genome mRNA 53421179 53424966 . - . ID=transcript_1794;Q13724 A8K938 F5H6D0 Q17RN9 Q8TCT5,Mannosyl-oligosaccharide glucosidase,Processing A-glucosidase I;, PF03200;PF16923;, GO:0005783;GO:0005789;GO:0070062;GO:0016021;GO:0016020;GO:0015926;GO:0004573;GO:0009311;GO:0006457;GO:0006487;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:membrane;, F:glucosidase activity; F:mannosyl-oligosaccharide glucosidase activity;, P:oligosaccharide metabolic process; P:protein folding; P:protein N-linked glycosylation; P:viral protein processing;|Q13724 A8K938 F5H6D0 Q17RN9 Q8TCT5,Mannosyl-oligosaccharide glucosidase,Processing A-glucosidase I;, PF03200;PF16923;, GO:0005783;GO:0005789;GO:0070062;GO:0016021;GO:0016020;GO:0015926;GO:0004573;GO:0009311;GO:0006457;GO:0006487;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:membrane;, F:glucosidase activity; F:mannosyl-oligosaccharide glucosidase activity;, P:oligosaccharide metabolic process; P:protein folding; P:protein N-linked glycosylation; P:viral protein processing; scaffold6 indexed_genome mRNA 53426915 53433138 . + . ID=transcript_1795;Q96EL3,39S ribosomal protein L53, mitochondrial,Mitochondrial large ribosomal subunit protein mL53 {ECO:0000303|PubMed:25278503};, PF10780;, GO:0005743;GO:0005762;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q96EL3,39S ribosomal protein L53, mitochondrial,Mitochondrial large ribosomal subunit protein mL53 {ECO:0000303|PubMed:25278503};, PF10780;, GO:0005743;GO:0005762;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q17RM4 B7ZKV5 Q8NBJ3 Q8NBV2 Q96KA7,Coiled-coil domain-containing protein 142,, PF14923;|Q17RM4 B7ZKV5 Q8NBJ3 Q8NBV2 Q96KA7,Coiled-coil domain-containing protein 142,, PF14923; scaffold6 indexed_genome mRNA 53433826 53437166 . - . ID=transcript_1796;Q17RM4 B7ZKV5 Q8NBJ3 Q8NBV2 Q96KA7,Coiled-coil domain-containing protein 142,, PF14923; scaffold6 indexed_genome mRNA 53441281 53443332 . - . ID=transcript_1797;Q49AM3 Q4KN40 Q53FD4 Q9H9F7,Tetratricopeptide repeat protein 31 scaffold6 indexed_genome mRNA 53453917 53455912 . - . ID=transcript_1798;Q9BSM1 Q7Z506,Polycomb group RING finger protein 1,Nervous system Polycomb-1;RING finger protein 68;, PF16207;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0046872;GO:1990841;GO:0008022;GO:0006342;GO:0035518;GO:0036353;GO:0000122;GO:0006355;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:metal ion binding; F:promoter-specific chromatin binding; F:protein C-terminus binding;, P:chromatin silencing; P:histone H2A monoubiquitination; P:histone H2A-K119 monoubiquitination; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9BSM1 Q7Z506,Polycomb group RING finger protein 1,Nervous system Polycomb-1;RING finger protein 68;, PF16207;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0046872;GO:1990841;GO:0008022;GO:0006342;GO:0035518;GO:0036353;GO:0000122;GO:0006355;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:metal ion binding; F:promoter-specific chromatin binding; F:protein C-terminus binding;, P:chromatin silencing; P:histone H2A monoubiquitination; P:histone H2A-K119 monoubiquitination; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9BSM1 Q7Z506,Polycomb group RING finger protein 1,Nervous system Polycomb-1;RING finger protein 68;, PF16207;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0046872;GO:1990841;GO:0008022;GO:0006342;GO:0035518;GO:0036353;GO:0000122;GO:0006355;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:metal ion binding; F:promoter-specific chromatin binding; F:protein C-terminus binding;, P:chromatin silencing; P:histone H2A monoubiquitination; P:histone H2A-K119 monoubiquitination; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold6 indexed_genome mRNA 53470389 53471823 . - . ID=transcript_1799;Q8TE96 Q6B017 Q8NAM8,ATP-dependent RNA helicase DQX1,DEAQ box polypeptide 1;, PF04408;PF07717;, GO:0005681;GO:0005524;GO:0003678;GO:0003723;, C:spliceosomal complex;, F:ATP binding; F:DNA helicase activity; F:RNA binding; scaffold6 indexed_genome mRNA 53477346 53480625 . - . ID=transcript_1800;Q9Y679 C0H5W8 Q9H866 Q9UNQ6 Q9Y685,Lipid droplet-regulating VLDL assembly factor AUP1 {ECO:0000312|HGNC:HGNC:891},Ancient ubiquitous protein 1 {ECO:0000303|PubMed:12042322};, PF02845;, GO:0005776;GO:0031410;GO:0005783;GO:0070062;GO:0000839;GO:0030176;GO:0005811;GO:0016020;GO:0043130;GO:0031624;GO:0031625;GO:0097027;GO:0071712;GO:0140042;GO:0034389;GO:0061724;GO:1990044;GO:0009615;GO:0030970;GO:0030433;GO:0016032;, C:autophagosome; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:lipid droplet; C:membrane;, F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:ER-associated misfolded protein catabolic process; P:lipid droplet formation; P:lipid droplet organization; P:lipophagy; P:protein localization to lipid droplet; P:response to virus; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9Y679 C0H5W8 Q9H866 Q9UNQ6 Q9Y685,Lipid droplet-regulating VLDL assembly factor AUP1 {ECO:0000312|HGNC:HGNC:891},Ancient ubiquitous protein 1 {ECO:0000303|PubMed:12042322};, PF02845;, GO:0005776;GO:0031410;GO:0005783;GO:0070062;GO:0000839;GO:0030176;GO:0005811;GO:0016020;GO:0043130;GO:0031624;GO:0031625;GO:0097027;GO:0071712;GO:0140042;GO:0034389;GO:0061724;GO:1990044;GO:0009615;GO:0030970;GO:0030433;GO:0016032;, C:autophagosome; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:lipid droplet; C:membrane;, F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:ER-associated misfolded protein catabolic process; P:lipid droplet formation; P:lipid droplet organization; P:lipophagy; P:protein localization to lipid droplet; P:response to virus; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9Y679 C0H5W8 Q9H866 Q9UNQ6 Q9Y685,Lipid droplet-regulating VLDL assembly factor AUP1 {ECO:0000312|HGNC:HGNC:891},Ancient ubiquitous protein 1 {ECO:0000303|PubMed:12042322};, PF02845;, GO:0005776;GO:0031410;GO:0005783;GO:0070062;GO:0000839;GO:0030176;GO:0005811;GO:0016020;GO:0043130;GO:0031624;GO:0031625;GO:0097027;GO:0071712;GO:0140042;GO:0034389;GO:0061724;GO:1990044;GO:0009615;GO:0030970;GO:0030433;GO:0016032;, C:autophagosome; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:lipid droplet; C:membrane;, F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:ER-associated misfolded protein catabolic process; P:lipid droplet formation; P:lipid droplet organization; P:lipophagy; P:protein localization to lipid droplet; P:response to virus; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:viral process; scaffold6 indexed_genome mRNA 53480638 53489073 . + . ID=transcript_1801;O43464 Q9HBZ4 Q9P0Y3 Q9P0Y4,Serine protease HTRA2, mitochondrial,High temperature requirement protein A2;Omi stress-regulated endoprotease;Serine protease 25;Serine proteinase OMI;, PF17820;, GO:0035631;GO:0000785;GO:0009898;GO:0005856;GO:0005829;GO:0005783;GO:0005789;GO:0016020;GO:0005758;GO:0031966;GO:0005739;GO:0005634;GO:1905370;GO:0042802;GO:0008233;GO:0004252;GO:0008236;GO:0051082;GO:0007628;GO:0007568;GO:0044257;GO:0071363;GO:0034605;GO:0035458;GO:0034599;GO:0071300;GO:0006672;GO:0097194;GO:0030900;GO:0008630;GO:0007005;GO:0045786;GO:1904924;GO:1901215;GO:1902176;GO:0048666;GO:0019742;GO:0043065;GO:0043280;GO:2001269;GO:2001241;GO:0010822;GO:1903955;GO:0012501;GO:0016540;GO:0006508;GO:1903146;GO:0040014;GO:0009635;, C:CD40 receptor complex; C:chromatin; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:serine-type endopeptidase complex;, F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:unfolded protein binding;, P:adult walking behavior; P:aging; P:cellular protein catabolic process; P:cellular response to growth factor stimulus; P:cellular response to heat; P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:cellular response to retinoic acid; P:ceramide metabolic process; P:execution phase of apoptosis; P:forebrain development; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:mitochondrion organization; P:negative regulation of cell cycle; P:negative regulation of mitophagy in response to mitochondrial depolarization; P:negative regulation of neuron death; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:neuron development; P:pentacyclic triterpenoid metabolic process; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of mitochondrion organization; P:positive regulation of protein targeting to mitochondrion; P:programmed cell death; P:protein autoprocessing; P:proteolysis; P:regulation of autophagy of mitochondrion; P:regulation of multicellular organism growth; P:response to herbicide;|P58215 D6W5J1 Q2EHP2 Q6IPL7 Q96RS1,Lysyl oxidase homolog 3 {ECO:0000305},Lysyl oxidase-like protein 3 {ECO:0000303|PubMed:11386757};, PF01186;PF00530;, GO:0005737;GO:0005576;GO:0005615;GO:0016020;GO:0005634;GO:0005507;GO:0001968;GO:0004720;GO:0005044;GO:0030199;GO:0001837;GO:1905590;GO:0006954;GO:0030324;GO:2000329;GO:0045892;GO:0018057;GO:2001046;GO:0060021;GO:0061053;GO:0021510;, C:cytoplasm; C:extracellular region; C:extracellular space; C:membrane; C:nucleus;, F:copper ion binding; F:fibronectin binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:collagen fibril organization; P:epithelial to mesenchymal transition; P:fibronectin fibril organization; P:inflammatory response; P:lung development; P:negative regulation of T-helper 17 cell lineage commitment; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine oxidation; P:positive regulation of integrin-mediated signaling pathway; P:roof of mouth development; P:somite development; P:spinal cord development;|O43464 Q9HBZ4 Q9P0Y3 Q9P0Y4,Serine protease HTRA2, mitochondrial,High temperature requirement protein A2;Omi stress-regulated endoprotease;Serine protease 25;Serine proteinase OMI;, PF17820;, GO:0035631;GO:0000785;GO:0009898;GO:0005856;GO:0005829;GO:0005783;GO:0005789;GO:0016020;GO:0005758;GO:0031966;GO:0005739;GO:0005634;GO:1905370;GO:0042802;GO:0008233;GO:0004252;GO:0008236;GO:0051082;GO:0007628;GO:0007568;GO:0044257;GO:0071363;GO:0034605;GO:0035458;GO:0034599;GO:0071300;GO:0006672;GO:0097194;GO:0030900;GO:0008630;GO:0007005;GO:0045786;GO:1904924;GO:1901215;GO:1902176;GO:0048666;GO:0019742;GO:0043065;GO:0043280;GO:2001269;GO:2001241;GO:0010822;GO:1903955;GO:0012501;GO:0016540;GO:0006508;GO:1903146;GO:0040014;GO:0009635;, C:CD40 receptor complex; C:chromatin; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:serine-type endopeptidase complex;, F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:unfolded protein binding;, P:adult walking behavior; P:aging; P:cellular protein catabolic process; P:cellular response to growth factor stimulus; P:cellular response to heat; P:cellular response to interferon-beta; P:cellular response to oxidative stress; P:cellular response to retinoic acid; P:ceramide metabolic process; P:execution phase of apoptosis; P:forebrain development; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:mitochondrion organization; P:negative regulation of cell cycle; P:negative regulation of mitophagy in response to mitochondrial depolarization; P:negative regulation of neuron death; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:neuron development; P:pentacyclic triterpenoid metabolic process; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of mitochondrion organization; P:positive regulation of protein targeting to mitochondrion; P:programmed cell death; P:protein autoprocessing; P:proteolysis; P:regulation of autophagy of mitochondrion; P:regulation of multicellular organism growth; P:response to herbicide; scaffold6 indexed_genome mRNA 53496384 53500078 . - . ID=transcript_1802;P58215 D6W5J1 Q2EHP2 Q6IPL7 Q96RS1,Lysyl oxidase homolog 3 {ECO:0000305},Lysyl oxidase-like protein 3 {ECO:0000303|PubMed:11386757};, PF01186;PF00530;, GO:0005737;GO:0005576;GO:0005615;GO:0016020;GO:0005634;GO:0005507;GO:0001968;GO:0004720;GO:0005044;GO:0030199;GO:0001837;GO:1905590;GO:0006954;GO:0030324;GO:2000329;GO:0045892;GO:0018057;GO:2001046;GO:0060021;GO:0061053;GO:0021510;, C:cytoplasm; C:extracellular region; C:extracellular space; C:membrane; C:nucleus;, F:copper ion binding; F:fibronectin binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:collagen fibril organization; P:epithelial to mesenchymal transition; P:fibronectin fibril organization; P:inflammatory response; P:lung development; P:negative regulation of T-helper 17 cell lineage commitment; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine oxidation; P:positive regulation of integrin-mediated signaling pathway; P:roof of mouth development; P:somite development; P:spinal cord development; scaffold6 indexed_genome mRNA 53502366 53505214 . + . ID=transcript_1803;Q99704 O43204 Q53TY2 Q9UHG6,Docking protein 1,Downstream of tyrosine kinase 1;p62(dok);pp62;, PF02174;PF00169;, GO:0005829;GO:0005634;GO:0048471;GO:0007411;GO:0007166;GO:0038145;GO:0045742;GO:0007265;GO:0007165;GO:0007169;, C:cytosol; C:nucleus; C:perinuclear region of cytoplasm;, , P:axon guidance; P:cell surface receptor signaling pathway; P:macrophage colony-stimulating factor signaling pathway; P:positive regulation of epidermal growth factor receptor signaling pathway; P:Ras protein signal transduction; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold6 indexed_genome mRNA 53507308 53508163 . - . ID=transcript_1804;Q8TC57 B7Z6E7 E9PGG8 Q6ZP30 Q96L07,Meiosis 1 arrest protein,Meiosis 1-arresting protein;Meiosis 1-associated protein;Spermatogenesis-associated protein 37;, , GO:0005737;GO:0016021;GO:0042802;GO:0030154;GO:0031497;GO:0007292;GO:0051308;GO:0007127;GO:0006396;GO:0007283;, C:cytoplasm; C:integral component of membrane;, F:identical protein binding;, P:cell differentiation; P:chromatin assembly; P:female gamete generation; P:male meiosis chromosome separation; P:meiosis I; P:RNA processing; P:spermatogenesis; scaffold6 indexed_genome mRNA 53599152 53623110 . + . ID=transcript_1805;O95754 Q542Y7 Q9NS35,Semaphorin-4F,Semaphorin-M;Semaphorin-W;, PF01437;PF01403;, GO:0030425;GO:0005783;GO:0005615;GO:0005887;GO:0016020;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0045499;GO:0030215;GO:0007411;GO:0007267;GO:0050919;GO:0048843;GO:0007399;GO:0001755;GO:0030335;GO:0031290;GO:0071526;, C:dendrite; C:endoplasmic reticulum; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell-cell signaling; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:nervous system development; P:neural crest cell migration; P:positive regulation of cell migration; P:retinal ganglion cell axon guidance; P:semaphorin-plexin signaling pathway;|O95754 Q542Y7 Q9NS35,Semaphorin-4F,Semaphorin-M;Semaphorin-W;, PF01437;PF01403;, GO:0030425;GO:0005783;GO:0005615;GO:0005887;GO:0016020;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0045499;GO:0030215;GO:0007411;GO:0007267;GO:0050919;GO:0048843;GO:0007399;GO:0001755;GO:0030335;GO:0031290;GO:0071526;, C:dendrite; C:endoplasmic reticulum; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell-cell signaling; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:nervous system development; P:neural crest cell migration; P:positive regulation of cell migration; P:retinal ganglion cell axon guidance; P:semaphorin-plexin signaling pathway; scaffold6 indexed_genome mRNA 53761766 53828914 . + . ID=transcript_1806;P52789 D6W5J2 Q8WU87 Q9UN82,Hexokinase-2 {ECO:0000305},Hexokinase type II {ECO:0000303|PubMed:8250948, ECO:0000303|PubMed:8786021};Hexokinase-B {ECO:0000250|UniProtKB:P27881};Muscle form hexokinase {ECO:0000303|PubMed:8250948};, PF00349;PF03727;, GO:0005813;GO:0005829;GO:0043231;GO:0016020;GO:0005741;GO:0005739;GO:0005886;GO:0016529;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0004396;GO:0019158;GO:0008637;GO:0061621;GO:0001678;GO:1990830;GO:0072655;GO:0006002;GO:0051156;GO:0006096;GO:0007595;GO:0072656;GO:0035795;GO:2000378;GO:0045766;GO:1904925;GO:0046324;GO:0001666;GO:0002931;, C:centrosome; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:plasma membrane; C:sarcoplasmic reticulum;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:hexokinase activity; F:mannokinase activity;, P:apoptotic mitochondrial changes; P:canonical glycolysis; P:cellular glucose homeostasis; P:cellular response to leukemia inhibitory factor; P:establishment of protein localization to mitochondrion; P:fructose 6-phosphate metabolic process; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:lactation; P:maintenance of protein location in mitochondrion; P:negative regulation of mitochondrial membrane permeability; P:negative regulation of reactive oxygen species metabolic process; P:positive regulation of angiogenesis; P:positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization; P:regulation of glucose import; P:response to hypoxia; P:response to ischemia;|P52789 D6W5J2 Q8WU87 Q9UN82,Hexokinase-2 {ECO:0000305},Hexokinase type II {ECO:0000303|PubMed:8250948, ECO:0000303|PubMed:8786021};Hexokinase-B {ECO:0000250|UniProtKB:P27881};Muscle form hexokinase {ECO:0000303|PubMed:8250948};, PF00349;PF03727;, GO:0005813;GO:0005829;GO:0043231;GO:0016020;GO:0005741;GO:0005739;GO:0005886;GO:0016529;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0004396;GO:0019158;GO:0008637;GO:0061621;GO:0001678;GO:1990830;GO:0072655;GO:0006002;GO:0051156;GO:0006096;GO:0007595;GO:0072656;GO:0035795;GO:2000378;GO:0045766;GO:1904925;GO:0046324;GO:0001666;GO:0002931;, C:centrosome; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:plasma membrane; C:sarcoplasmic reticulum;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:hexokinase activity; F:mannokinase activity;, P:apoptotic mitochondrial changes; P:canonical glycolysis; P:cellular glucose homeostasis; P:cellular response to leukemia inhibitory factor; P:establishment of protein localization to mitochondrion; P:fructose 6-phosphate metabolic process; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:lactation; P:maintenance of protein location in mitochondrion; P:negative regulation of mitochondrial membrane permeability; P:negative regulation of reactive oxygen species metabolic process; P:positive regulation of angiogenesis; P:positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization; P:regulation of glucose import; P:response to hypoxia; P:response to ischemia; scaffold6 indexed_genome mRNA 53851578 53862674 . + . ID=transcript_1807;Q9NR33 Q53TR2,DNA polymerase epsilon subunit 4,DNA polymerase II subunit 4;DNA polymerase epsilon subunit p12;, PF00808;, GO:0005671;GO:0008622;GO:0005654;GO:0005634;GO:0003677;GO:0003887;GO:0046982;GO:0006270;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:epsilon DNA polymerase complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-directed DNA polymerase activity; F:protein heterodimerization activity;, P:DNA replication initiation; scaffold6 indexed_genome mRNA 54255874 54264676 . + . ID=transcript_1808;Q14192 Q13229 Q13644 Q2I5I4 Q5TM15 Q9P294,Four and a half LIM domains protein 2,LIM domain protein DRAL;Skeletal muscle LIM-protein 3;, PF00412;, GO:0005925;GO:0031430;GO:0005654;GO:0005634;GO:0030018;GO:0043425;GO:0042802;GO:0046872;GO:0003712;GO:0003714;GO:0008134;GO:0055014;GO:0060347;GO:0043066;GO:0070885;GO:0000122;GO:0001649;GO:0019222;GO:0009725;GO:0055015;, C:focal adhesion; C:M band; C:nucleoplasm; C:nucleus; C:Z disc;, F:bHLH transcription factor binding; F:identical protein binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:atrial cardiac muscle cell development; P:heart trabecula formation; P:negative regulation of apoptotic process; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of transcription by RNA polymerase II; P:osteoblast differentiation; P:regulation of metabolic process; P:response to hormone; P:ventricular cardiac muscle cell development;|Q14192 Q13229 Q13644 Q2I5I4 Q5TM15 Q9P294,Four and a half LIM domains protein 2,LIM domain protein DRAL;Skeletal muscle LIM-protein 3;, PF00412;, GO:0005925;GO:0031430;GO:0005654;GO:0005634;GO:0030018;GO:0043425;GO:0042802;GO:0046872;GO:0003712;GO:0003714;GO:0008134;GO:0055014;GO:0060347;GO:0043066;GO:0070885;GO:0000122;GO:0001649;GO:0019222;GO:0009725;GO:0055015;, C:focal adhesion; C:M band; C:nucleoplasm; C:nucleus; C:Z disc;, F:bHLH transcription factor binding; F:identical protein binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:atrial cardiac muscle cell development; P:heart trabecula formation; P:negative regulation of apoptotic process; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of transcription by RNA polymerase II; P:osteoblast differentiation; P:regulation of metabolic process; P:response to hormone; P:ventricular cardiac muscle cell development;|Q14192 Q13229 Q13644 Q2I5I4 Q5TM15 Q9P294,Four and a half LIM domains protein 2,LIM domain protein DRAL;Skeletal muscle LIM-protein 3;, PF00412;, GO:0005925;GO:0031430;GO:0005654;GO:0005634;GO:0030018;GO:0043425;GO:0042802;GO:0046872;GO:0003712;GO:0003714;GO:0008134;GO:0055014;GO:0060347;GO:0043066;GO:0070885;GO:0000122;GO:0001649;GO:0019222;GO:0009725;GO:0055015;, C:focal adhesion; C:M band; C:nucleoplasm; C:nucleus; C:Z disc;, F:bHLH transcription factor binding; F:identical protein binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:atrial cardiac muscle cell development; P:heart trabecula formation; P:negative regulation of apoptotic process; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of transcription by RNA polymerase II; P:osteoblast differentiation; P:regulation of metabolic process; P:response to hormone; P:ventricular cardiac muscle cell development; scaffold6 indexed_genome mRNA 54264693 54270032 . + . ID=transcript_1809;Q14192 Q13229 Q13644 Q2I5I4 Q5TM15 Q9P294,Four and a half LIM domains protein 2,LIM domain protein DRAL;Skeletal muscle LIM-protein 3;, PF00412;, GO:0005925;GO:0031430;GO:0005654;GO:0005634;GO:0030018;GO:0043425;GO:0042802;GO:0046872;GO:0003712;GO:0003714;GO:0008134;GO:0055014;GO:0060347;GO:0043066;GO:0070885;GO:0000122;GO:0001649;GO:0019222;GO:0009725;GO:0055015;, C:focal adhesion; C:M band; C:nucleoplasm; C:nucleus; C:Z disc;, F:bHLH transcription factor binding; F:identical protein binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:atrial cardiac muscle cell development; P:heart trabecula formation; P:negative regulation of apoptotic process; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of transcription by RNA polymerase II; P:osteoblast differentiation; P:regulation of metabolic process; P:response to hormone; P:ventricular cardiac muscle cell development; scaffold6 indexed_genome mRNA 54274488 54275909 . + . ID=transcript_1810;Q9BVC5 B3KXN3 B4E2G9,Ashwin,, PF15323;, GO:0005654;GO:0005634;GO:0072669;GO:0048598;GO:0006388;, C:nucleoplasm; C:nucleus; C:tRNA-splicing ligase complex;, , P:embryonic morphogenesis; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold6 indexed_genome mRNA 54276052 54276575 . + . ID=transcript_1811;Q9BVC5 B3KXN3 B4E2G9,Ashwin,, PF15323;, GO:0005654;GO:0005634;GO:0072669;GO:0048598;GO:0006388;, C:nucleoplasm; C:nucleus; C:tRNA-splicing ligase complex;, , P:embryonic morphogenesis; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold6 indexed_genome mRNA 54279211 54279750 . + . ID=transcript_1812;Q9BVC5 B3KXN3 B4E2G9,Ashwin,, PF15323;, GO:0005654;GO:0005634;GO:0072669;GO:0048598;GO:0006388;, C:nucleoplasm; C:nucleus; C:tRNA-splicing ligase complex;, , P:embryonic morphogenesis; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold6 indexed_genome mRNA 54293250 54317684 . + . ID=transcript_1813;Q8WUH2 A8K5R7 D3DVJ8 O60466,Transforming growth factor-beta receptor-associated protein 1,, PF00637;PF00780;PF10366;PF10367;, GO:0033263;GO:0005737;GO:0005769;GO:0043231;GO:0016020;GO:0046332;GO:0005160;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:0006355;GO:0007165;GO:0007179;, C:CORVET complex; C:cytoplasm; C:early endosome; C:intracellular membrane-bounded organelle; C:membrane;, F:SMAD binding; F:transforming growth factor beta receptor binding;, P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of transcription, DNA-templated; P:signal transduction; P:transforming growth factor beta receptor signaling pathway;|Q8WUH2 A8K5R7 D3DVJ8 O60466,Transforming growth factor-beta receptor-associated protein 1,, PF00637;PF00780;PF10366;PF10367;, GO:0033263;GO:0005737;GO:0005769;GO:0043231;GO:0016020;GO:0046332;GO:0005160;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:0006355;GO:0007165;GO:0007179;, C:CORVET complex; C:cytoplasm; C:early endosome; C:intracellular membrane-bounded organelle; C:membrane;, F:SMAD binding; F:transforming growth factor beta receptor binding;, P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of transcription, DNA-templated; P:signal transduction; P:transforming growth factor beta receptor signaling pathway;|Q8WUH2 A8K5R7 D3DVJ8 O60466,Transforming growth factor-beta receptor-associated protein 1,, PF00637;PF00780;PF10366;PF10367;, GO:0033263;GO:0005737;GO:0005769;GO:0043231;GO:0016020;GO:0046332;GO:0005160;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:0006355;GO:0007165;GO:0007179;, C:CORVET complex; C:cytoplasm; C:early endosome; C:intracellular membrane-bounded organelle; C:membrane;, F:SMAD binding; F:transforming growth factor beta receptor binding;, P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of transcription, DNA-templated; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; scaffold6 indexed_genome mRNA 54323423 54324135 . - . ID=transcript_1814;Q9Y5Y3 Q6NWS4 Q6NXU6,Probable G-protein coupled receptor 45,PSP24-1;PSP24-alpha;, PF00001;, GO:0016021;GO:0005886;GO:0004930;GO:0007186;GO:0002862;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; scaffold6 indexed_genome mRNA 54383315 54424758 . - . ID=transcript_1815;P82933 Q6PG40,28S ribosomal protein S9, mitochondrial,Mitochondrial small ribosomal subunit protein uS9m {ECO:0000303|PubMed:25838379};, PF00380;, GO:0005743;GO:0005763;GO:0005739;GO:0005730;GO:0015935;GO:0003723;GO:0003735;GO:0042769;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleolus; C:small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:DNA damage response, detection of DNA damage; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold6 indexed_genome mRNA 55978643 56025656 . - . ID=transcript_1816;Q6ZP80 C9JML7 Q3B7B8 Q53TT9 Q6GMU0 Q8WW45 Q96NR4,Transmembrane protein 182,, PF13903;, GO:0016021;, C:integral component of membrane;|Q6ZP80 C9JML7 Q3B7B8 Q53TT9 Q6GMU0 Q8WW45 Q96NR4,Transmembrane protein 182,, PF13903;, GO:0016021;, C:integral component of membrane; scaffold6 indexed_genome mRNA 56047134 56059856 . + . ID=transcript_1817;Q8NBP5 Q4ZG89 Q53TU0 Q96GQ4 Q9BRI8,Major facilitator superfamily domain-containing protein 9,, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q8NBP5 Q4ZG89 Q53TU0 Q96GQ4 Q9BRI8,Major facilitator superfamily domain-containing protein 9,, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold6 indexed_genome mRNA 56062342 56116398 . - . ID=transcript_1818;Q9UBY0 B2RMS2,Sodium/hydrogen exchanger 2,Na(+)/H(+) exchanger 2;Solute carrier family 9 member 2;, PF00999;PF16644;, GO:0016021;GO:0005886;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0008104;GO:0051453;GO:0098719;, C:integral component of membrane; C:plasma membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:protein localization; P:regulation of intracellular pH; P:sodium ion import across plasma membrane; scaffold6 indexed_genome mRNA 56351208 56357452 . - . ID=transcript_1819;Q01638 A8K6B3 B4E0I3 Q53TU7 Q8NEJ3 Q9ULV7 Q9UQ44,Interleukin-1 receptor-like 1,Protein ST2;, PF07679;PF01582;, GO:0005829;GO:0009897;GO:0005576;GO:0005925;GO:0016021;GO:0005886;GO:0004896;GO:0004908;GO:0002113;GO:0002114;GO:0050135;GO:0061809;GO:0006955;GO:0038172;GO:0032689;GO:0002826;GO:0032722;GO:0050729;GO:0032754;GO:0043032;GO:0007165;, C:cytosol; C:external side of plasma membrane; C:extracellular region; C:focal adhesion; C:integral component of membrane; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-1 receptor activity; F:interleukin-33 binding; F:interleukin-33 receptor activity; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating;, P:immune response; P:interleukin-33-mediated signaling pathway; P:negative regulation of interferon-gamma production; P:negative regulation of T-helper 1 type immune response; P:positive regulation of chemokine production; P:positive regulation of inflammatory response; P:positive regulation of interleukin-5 production; P:positive regulation of macrophage activation; P:signal transduction; scaffold6 indexed_genome mRNA 56436781 56463100 . - . ID=transcript_1820;Q9HB29 A4FU63 Q13525 Q45H74 Q53TU8 Q587I8,Interleukin-1 receptor-like 2,IL-36 receptor;Interleukin-1 receptor-related protein 2;, PF13895;PF18452;PF01582;, GO:0005887;GO:0005886;GO:0004908;GO:0004909;GO:0050135;GO:0061809;GO:0006968;GO:0071345;GO:0019221;GO:0006954;GO:0045087;GO:0032755;GO:0045582;GO:0050727;GO:0007165;, C:integral component of plasma membrane; C:plasma membrane;, F:interleukin-1 receptor activity; F:interleukin-1, type I, activating receptor activity; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating;, P:cellular defense response; P:cellular response to cytokine stimulus; P:cytokine-mediated signaling pathway; P:inflammatory response; P:innate immune response; P:positive regulation of interleukin-6 production; P:positive regulation of T cell differentiation; P:regulation of inflammatory response; P:signal transduction; scaffold6 indexed_genome mRNA 56529613 56617372 . - . ID=transcript_1821;P14778 Q587I7,Interleukin-1 receptor type 1,CD121 antigen-like family member A;Interleukin-1 receptor alpha;Interleukin-1 receptor type I;p80;, PF13895;PF18452;PF01582;, GO:0009897;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0019966;GO:0004908;GO:0004909;GO:0050135;GO:0061809;GO:0005161;GO:0002020;GO:0004888;GO:0007166;GO:0019221;GO:0006955;GO:0006954;GO:0070498;GO:0032729;GO:2000661;GO:2000391;GO:2000556;GO:0050727;GO:0070555;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:interleukin-1 binding; F:interleukin-1 receptor activity; F:interleukin-1, type I, activating receptor activity; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:platelet-derived growth factor receptor binding; F:protease binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1-mediated signaling pathway; P:positive regulation of neutrophil extravasation; P:positive regulation of T-helper 1 cell cytokine production; P:regulation of inflammatory response; P:response to interleukin-1;|P14778 Q587I7,Interleukin-1 receptor type 1,CD121 antigen-like family member A;Interleukin-1 receptor alpha;Interleukin-1 receptor type I;p80;, PF13895;PF18452;PF01582;, GO:0009897;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0019966;GO:0004908;GO:0004909;GO:0050135;GO:0061809;GO:0005161;GO:0002020;GO:0004888;GO:0007166;GO:0019221;GO:0006955;GO:0006954;GO:0070498;GO:0032729;GO:2000661;GO:2000391;GO:2000556;GO:0050727;GO:0070555;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:interleukin-1 binding; F:interleukin-1 receptor activity; F:interleukin-1, type I, activating receptor activity; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:platelet-derived growth factor receptor binding; F:protease binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1-mediated signaling pathway; P:positive regulation of neutrophil extravasation; P:positive regulation of T-helper 1 cell cytokine production; P:regulation of inflammatory response; P:response to interleukin-1;|P14778 Q587I7,Interleukin-1 receptor type 1,CD121 antigen-like family member A;Interleukin-1 receptor alpha;Interleukin-1 receptor type I;p80;, PF13895;PF18452;PF01582;, GO:0009897;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0019966;GO:0004908;GO:0004909;GO:0050135;GO:0061809;GO:0005161;GO:0002020;GO:0004888;GO:0007166;GO:0019221;GO:0006955;GO:0006954;GO:0070498;GO:0032729;GO:2000661;GO:2000391;GO:2000556;GO:0050727;GO:0070555;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:interleukin-1 binding; F:interleukin-1 receptor activity; F:interleukin-1, type I, activating receptor activity; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:platelet-derived growth factor receptor binding; F:protease binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1-mediated signaling pathway; P:positive regulation of neutrophil extravasation; P:positive regulation of T-helper 1 cell cytokine production; P:regulation of inflammatory response; P:response to interleukin-1; scaffold6 indexed_genome mRNA 56715591 56735472 . - . ID=transcript_1822;P27930 D3DVJ5 Q6LCE6 Q9UE68,Interleukin-1 receptor type 2,CD121 antigen-like family member B;CDw121b;IL-1 type II receptor;Interleukin-1 receptor beta;Interleukin-1 receptor type II;, PF00047;PF18452;, GO:0005737;GO:0005576;GO:0016021;GO:0005886;GO:0019966;GO:0004908;GO:0004910;GO:0019221;GO:0006955;GO:0070498;GO:1900016;GO:0032690;GO:2000660;GO:0010955;, C:cytoplasm; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:interleukin-1 binding; F:interleukin-1 receptor activity; F:interleukin-1, type II, blocking receptor activity;, P:cytokine-mediated signaling pathway; P:immune response; P:interleukin-1-mediated signaling pathway; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of interleukin-1 alpha production; P:negative regulation of interleukin-1-mediated signaling pathway; P:negative regulation of protein processing; scaffold6 indexed_genome mRNA 56816364 56841646 . - . ID=transcript_1823;O95819 E7ESS2 O75172 Q9NST7,Mitogen-activated protein kinase kinase kinase kinase 4,HPK/GCK-like kinase HGK;MAPK/ERK kinase kinase kinase 4;Nck-interacting kinase;, PF00780;PF00069;, GO:0005737;GO:0005925;GO:0005524;GO:0004111;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0035556;GO:0000165;GO:0043066;GO:0001953;GO:0048812;GO:0032014;GO:0030335;GO:0051894;GO:0120183;GO:0043547;GO:0051549;GO:0006468;GO:0046328;GO:0031098;, C:cytoplasm; C:focal adhesion;, F:ATP binding; F:creatine kinase activity; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell-matrix adhesion; P:neuron projection morphogenesis; P:positive regulation of ARF protein signal transduction; P:positive regulation of cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:protein phosphorylation; P:regulation of JNK cascade; P:stress-activated protein kinase signaling cascade;|O95819 E7ESS2 O75172 Q9NST7,Mitogen-activated protein kinase kinase kinase kinase 4,HPK/GCK-like kinase HGK;MAPK/ERK kinase kinase kinase 4;Nck-interacting kinase;, PF00780;PF00069;, GO:0005737;GO:0005925;GO:0005524;GO:0004111;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0035556;GO:0000165;GO:0043066;GO:0001953;GO:0048812;GO:0032014;GO:0030335;GO:0051894;GO:0120183;GO:0043547;GO:0051549;GO:0006468;GO:0046328;GO:0031098;, C:cytoplasm; C:focal adhesion;, F:ATP binding; F:creatine kinase activity; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell-matrix adhesion; P:neuron projection morphogenesis; P:positive regulation of ARF protein signal transduction; P:positive regulation of cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:protein phosphorylation; P:regulation of JNK cascade; P:stress-activated protein kinase signaling cascade;|O95819 E7ESS2 O75172 Q9NST7,Mitogen-activated protein kinase kinase kinase kinase 4,HPK/GCK-like kinase HGK;MAPK/ERK kinase kinase kinase 4;Nck-interacting kinase;, PF00780;PF00069;, GO:0005737;GO:0005925;GO:0005524;GO:0004111;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0035556;GO:0000165;GO:0043066;GO:0001953;GO:0048812;GO:0032014;GO:0030335;GO:0051894;GO:0120183;GO:0043547;GO:0051549;GO:0006468;GO:0046328;GO:0031098;, C:cytoplasm; C:focal adhesion;, F:ATP binding; F:creatine kinase activity; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell-matrix adhesion; P:neuron projection morphogenesis; P:positive regulation of ARF protein signal transduction; P:positive regulation of cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:protein phosphorylation; P:regulation of JNK cascade; P:stress-activated protein kinase signaling cascade;|O95819 E7ESS2 O75172 Q9NST7,Mitogen-activated protein kinase kinase kinase kinase 4,HPK/GCK-like kinase HGK;MAPK/ERK kinase kinase kinase 4;Nck-interacting kinase;, PF00780;PF00069;, GO:0005737;GO:0005925;GO:0005524;GO:0004111;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0035556;GO:0000165;GO:0043066;GO:0001953;GO:0048812;GO:0032014;GO:0030335;GO:0051894;GO:0120183;GO:0043547;GO:0051549;GO:0006468;GO:0046328;GO:0031098;, C:cytoplasm; C:focal adhesion;, F:ATP binding; F:creatine kinase activity; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell-matrix adhesion; P:neuron projection morphogenesis; P:positive regulation of ARF protein signal transduction; P:positive regulation of cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:protein phosphorylation; P:regulation of JNK cascade; P:stress-activated protein kinase signaling cascade;|O95819 E7ESS2 O75172 Q9NST7,Mitogen-activated protein kinase kinase kinase kinase 4,HPK/GCK-like kinase HGK;MAPK/ERK kinase kinase kinase 4;Nck-interacting kinase;, PF00780;PF00069;, GO:0005737;GO:0005925;GO:0005524;GO:0004111;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0035556;GO:0000165;GO:0043066;GO:0001953;GO:0048812;GO:0032014;GO:0030335;GO:0051894;GO:0120183;GO:0043547;GO:0051549;GO:0006468;GO:0046328;GO:0031098;, C:cytoplasm; C:focal adhesion;, F:ATP binding; F:creatine kinase activity; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell-matrix adhesion; P:neuron projection morphogenesis; P:positive regulation of ARF protein signal transduction; P:positive regulation of cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:protein phosphorylation; P:regulation of JNK cascade; P:stress-activated protein kinase signaling cascade;|O95819 E7ESS2 O75172 Q9NST7,Mitogen-activated protein kinase kinase kinase kinase 4,HPK/GCK-like kinase HGK;MAPK/ERK kinase kinase kinase 4;Nck-interacting kinase;, PF00780;PF00069;, GO:0005737;GO:0005925;GO:0005524;GO:0004111;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0035556;GO:0000165;GO:0043066;GO:0001953;GO:0048812;GO:0032014;GO:0030335;GO:0051894;GO:0120183;GO:0043547;GO:0051549;GO:0006468;GO:0046328;GO:0031098;, C:cytoplasm; C:focal adhesion;, F:ATP binding; F:creatine kinase activity; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell-matrix adhesion; P:neuron projection morphogenesis; P:positive regulation of ARF protein signal transduction; P:positive regulation of cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:protein phosphorylation; P:regulation of JNK cascade; P:stress-activated protein kinase signaling cascade;|O95819 E7ESS2 O75172 Q9NST7,Mitogen-activated protein kinase kinase kinase kinase 4,HPK/GCK-like kinase HGK;MAPK/ERK kinase kinase kinase 4;Nck-interacting kinase;, PF00780;PF00069;, GO:0005737;GO:0005925;GO:0005524;GO:0004111;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0035556;GO:0000165;GO:0043066;GO:0001953;GO:0048812;GO:0032014;GO:0030335;GO:0051894;GO:0120183;GO:0043547;GO:0051549;GO:0006468;GO:0046328;GO:0031098;, C:cytoplasm; C:focal adhesion;, F:ATP binding; F:creatine kinase activity; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell-matrix adhesion; P:neuron projection morphogenesis; P:positive regulation of ARF protein signal transduction; P:positive regulation of cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:protein phosphorylation; P:regulation of JNK cascade; P:stress-activated protein kinase signaling cascade;|O95819 E7ESS2 O75172 Q9NST7,Mitogen-activated protein kinase kinase kinase kinase 4,HPK/GCK-like kinase HGK;MAPK/ERK kinase kinase kinase 4;Nck-interacting kinase;, PF00780;PF00069;, GO:0005737;GO:0005925;GO:0005524;GO:0004111;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0035556;GO:0000165;GO:0043066;GO:0001953;GO:0048812;GO:0032014;GO:0030335;GO:0051894;GO:0120183;GO:0043547;GO:0051549;GO:0006468;GO:0046328;GO:0031098;, C:cytoplasm; C:focal adhesion;, F:ATP binding; F:creatine kinase activity; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell-matrix adhesion; P:neuron projection morphogenesis; P:positive regulation of ARF protein signal transduction; P:positive regulation of cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:protein phosphorylation; P:regulation of JNK cascade; P:stress-activated protein kinase signaling cascade; scaffold6 indexed_genome mRNA 57258445 57270059 . + . ID=transcript_1824;Q8NC42 Q53S14 Q8N5I8 Q8NBY5 Q8WUU3,E3 ubiquitin-protein ligase RNF149,DNA polymerase-transactivated protein 2;RING finger protein 149;RING-type E3 ubiquitin transferase RNF149 {ECO:0000305};, PF02225;PF13639;, GO:0005737;GO:0016021;GO:0016020;GO:0046872;GO:0061630;GO:0035690;GO:0043409;GO:0031647;GO:0006511;, C:cytoplasm; C:integral component of membrane; C:membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:cellular response to drug; P:negative regulation of MAPK cascade; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process; scaffold6 indexed_genome mRNA 57275932 57282104 . - . ID=transcript_1825;Q9UKZ1 Q6P2M9 Q8N681,CCR4-NOT transcription complex subunit 11,, PF10155;, GO:0030014;GO:0005829;GO:0005634;GO:0006977;GO:0031047;GO:0000289;GO:0006417;, C:CCR4-NOT complex; C:cytosol; C:nucleus;, , P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of translation; scaffold6 indexed_genome mRNA 57471849 57509329 . + . ID=transcript_1826;Q99743 Q4ZFV9 Q53SQ3 Q86V96 Q99629,Neuronal PAS domain-containing protein 2,Basic-helix-loop-helix-PAS protein MOP4;Class E basic helix-loop-helix protein 9;Member of PAS protein 4;PAS domain-containing protein 4;, PF00010;PF00989;, GO:0000785;GO:1990513;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0003700;GO:0000981;GO:0051879;GO:0046872;GO:0046983;GO:0000978;GO:1990837;GO:0006974;GO:0007417;GO:0032922;GO:0007623;GO:0060548;GO:2000987;GO:0045739;GO:0045944;GO:0045893;GO:2001020;GO:0006357;GO:0042493;GO:0051775;, C:chromatin; C:CLOCK-BMAL transcription complex; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:Hsp90 protein binding; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:central nervous system development; P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cell death; P:positive regulation of behavioral fear response; P:positive regulation of DNA repair; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of response to DNA damage stimulus; P:regulation of transcription by RNA polymerase II; P:response to drug; P:response to redox state;|Q99743 Q4ZFV9 Q53SQ3 Q86V96 Q99629,Neuronal PAS domain-containing protein 2,Basic-helix-loop-helix-PAS protein MOP4;Class E basic helix-loop-helix protein 9;Member of PAS protein 4;PAS domain-containing protein 4;, PF00010;PF00989;, GO:0000785;GO:1990513;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0003700;GO:0000981;GO:0051879;GO:0046872;GO:0046983;GO:0000978;GO:1990837;GO:0006974;GO:0007417;GO:0032922;GO:0007623;GO:0060548;GO:2000987;GO:0045739;GO:0045944;GO:0045893;GO:2001020;GO:0006357;GO:0042493;GO:0051775;, C:chromatin; C:CLOCK-BMAL transcription complex; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:Hsp90 protein binding; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:central nervous system development; P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cell death; P:positive regulation of behavioral fear response; P:positive regulation of DNA repair; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of response to DNA damage stimulus; P:regulation of transcription by RNA polymerase II; P:response to drug; P:response to redox state;|Q99743 Q4ZFV9 Q53SQ3 Q86V96 Q99629,Neuronal PAS domain-containing protein 2,Basic-helix-loop-helix-PAS protein MOP4;Class E basic helix-loop-helix protein 9;Member of PAS protein 4;PAS domain-containing protein 4;, PF00010;PF00989;, GO:0000785;GO:1990513;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0003700;GO:0000981;GO:0051879;GO:0046872;GO:0046983;GO:0000978;GO:1990837;GO:0006974;GO:0007417;GO:0032922;GO:0007623;GO:0060548;GO:2000987;GO:0045739;GO:0045944;GO:0045893;GO:2001020;GO:0006357;GO:0042493;GO:0051775;, C:chromatin; C:CLOCK-BMAL transcription complex; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:Hsp90 protein binding; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:central nervous system development; P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cell death; P:positive regulation of behavioral fear response; P:positive regulation of DNA repair; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of response to DNA damage stimulus; P:regulation of transcription by RNA polymerase II; P:response to drug; P:response to redox state; scaffold6 indexed_genome mRNA 57870206 57889755 . - . ID=transcript_1827;Q9H2J4 B2RA00 Q53S68,Phosducin-like protein 3,HTPHLP;PhPL3;Viral IAP-associated factor 1 {ECO:0000303|PubMed:15371430};, PF02114;, GO:0005737;GO:0005829;GO:0005783;GO:0005654;GO:0048471;GO:0097356;GO:0032991;GO:0044183;GO:0043184;GO:0030036;GO:0001525;GO:0006915;GO:0034605;GO:0061077;GO:1903645;GO:2000059;GO:0045766;GO:0001938;GO:0010628;GO:0050821;GO:0050730;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleoplasm; C:perinuclear region of cytoplasm; C:perinucleolar compartment; C:protein-containing complex;, F:protein folding chaperone; F:vascular endothelial growth factor receptor 2 binding;, P:actin cytoskeleton organization; P:angiogenesis; P:apoptotic process; P:cellular response to heat; P:chaperone-mediated protein folding; P:negative regulation of chaperone-mediated protein folding; P:negative regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of gene expression; P:protein stabilization; P:regulation of peptidyl-tyrosine phosphorylation;|Q9H2J4 B2RA00 Q53S68,Phosducin-like protein 3,HTPHLP;PhPL3;Viral IAP-associated factor 1 {ECO:0000303|PubMed:15371430};, PF02114;, GO:0005737;GO:0005829;GO:0005783;GO:0005654;GO:0048471;GO:0097356;GO:0032991;GO:0044183;GO:0043184;GO:0030036;GO:0001525;GO:0006915;GO:0034605;GO:0061077;GO:1903645;GO:2000059;GO:0045766;GO:0001938;GO:0010628;GO:0050821;GO:0050730;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleoplasm; C:perinuclear region of cytoplasm; C:perinucleolar compartment; C:protein-containing complex;, F:protein folding chaperone; F:vascular endothelial growth factor receptor 2 binding;, P:actin cytoskeleton organization; P:angiogenesis; P:apoptotic process; P:cellular response to heat; P:chaperone-mediated protein folding; P:negative regulation of chaperone-mediated protein folding; P:negative regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of gene expression; P:protein stabilization; P:regulation of peptidyl-tyrosine phosphorylation; scaffold6 indexed_genome mRNA 57965948 57975864 . + . ID=transcript_1828;O43529 Q53T18,Carbohydrate sulfotransferase 10,HNK-1 sulfotransferase;, PF03567;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0008146;GO:0016051;GO:0007155;GO:0030166;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:sulfotransferase activity;, P:carbohydrate biosynthetic process; P:cell adhesion; P:proteoglycan biosynthetic process;|O43529 Q53T18,Carbohydrate sulfotransferase 10,HNK-1 sulfotransferase;, PF03567;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0008146;GO:0016051;GO:0007155;GO:0030166;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:sulfotransferase activity;, P:carbohydrate biosynthetic process; P:cell adhesion; P:proteoglycan biosynthetic process; scaffold6 indexed_genome mRNA 57988839 57991748 . + . ID=transcript_1829;Q1L5Z9 B9A006 Q6ZSR4,LON peptidase N-terminal domain and RING finger protein 2,Neuroblastoma apoptosis-related protease;RING finger protein 192;, PF02190;PF13445;, GO:0046872;, , F:metal ion binding; scaffold6 indexed_genome mRNA 57993488 57995309 . + . ID=transcript_1830;Q1L5Z9 B9A006 Q6ZSR4,LON peptidase N-terminal domain and RING finger protein 2,Neuroblastoma apoptosis-related protease;RING finger protein 192;, PF02190;PF13445;, GO:0046872;, , F:metal ion binding; scaffold6 indexed_genome mRNA 57995978 58004923 . + . ID=transcript_1831;Q1L5Z9 B9A006 Q6ZSR4,LON peptidase N-terminal domain and RING finger protein 2,Neuroblastoma apoptosis-related protease;RING finger protein 192;, PF02190;PF13445;, GO:0046872;, , F:metal ion binding; scaffold6 indexed_genome mRNA 58215602 58729947 . + . ID=transcript_1832;Q8IWJ5,AF4/FMR2 family member 3,Lymphoid nuclear protein related to AF4;, PF18876;PF18875;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032783;GO:0003700;GO:0003690;GO:0035116;GO:0010468;GO:0034612;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:super elongation complex;, F:DNA-binding transcription factor activity; F:double-stranded DNA binding;, P:embryonic hindlimb morphogenesis; P:regulation of gene expression; P:response to tumor necrosis factor; scaffold6 indexed_genome mRNA 58730398 58781216 . + . ID=transcript_1833;Q8IWJ5,AF4/FMR2 family member 3,Lymphoid nuclear protein related to AF4;, PF18876;PF18875;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032783;GO:0003700;GO:0003690;GO:0035116;GO:0010468;GO:0034612;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:super elongation complex;, F:DNA-binding transcription factor activity; F:double-stranded DNA binding;, P:embryonic hindlimb morphogenesis; P:regulation of gene expression; P:response to tumor necrosis factor; scaffold6 indexed_genome mRNA 58848402 58934524 . + . ID=transcript_1834;Q9UBZ9 O95941 Q53SI7 Q9C0J4 Q9NUP2,DNA repair protein REV1,Alpha integrin-binding protein 80;Rev1-like terminal deoxycytidyl transferase;, PF16589;PF00817;PF11799;PF16727;PF14377;, GO:0005654;GO:0003684;GO:0017125;GO:0003887;GO:0046872;GO:0006260;GO:0070987;GO:0042276;GO:0009411;GO:0019985;, C:nucleoplasm;, F:damaged DNA binding; F:deoxycytidyl transferase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:response to UV; P:translesion synthesis;|Q9UBZ9 O95941 Q53SI7 Q9C0J4 Q9NUP2,DNA repair protein REV1,Alpha integrin-binding protein 80;Rev1-like terminal deoxycytidyl transferase;, PF16589;PF00817;PF11799;PF16727;PF14377;, GO:0005654;GO:0003684;GO:0017125;GO:0003887;GO:0046872;GO:0006260;GO:0070987;GO:0042276;GO:0009411;GO:0019985;, C:nucleoplasm;, F:damaged DNA binding; F:deoxycytidyl transferase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:response to UV; P:translesion synthesis;|Q9UBZ9 O95941 Q53SI7 Q9C0J4 Q9NUP2,DNA repair protein REV1,Alpha integrin-binding protein 80;Rev1-like terminal deoxycytidyl transferase;, PF16589;PF00817;PF11799;PF16727;PF14377;, GO:0005654;GO:0003684;GO:0017125;GO:0003887;GO:0046872;GO:0006260;GO:0070987;GO:0042276;GO:0009411;GO:0019985;, C:nucleoplasm;, F:damaged DNA binding; F:deoxycytidyl transferase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:response to UV; P:translesion synthesis;|Q9UBZ9 O95941 Q53SI7 Q9C0J4 Q9NUP2,DNA repair protein REV1,Alpha integrin-binding protein 80;Rev1-like terminal deoxycytidyl transferase;, PF16589;PF00817;PF11799;PF16727;PF14377;, GO:0005654;GO:0003684;GO:0017125;GO:0003887;GO:0046872;GO:0006260;GO:0070987;GO:0042276;GO:0009411;GO:0019985;, C:nucleoplasm;, F:damaged DNA binding; F:deoxycytidyl transferase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:response to UV; P:translesion synthesis;|Q9UBZ9 O95941 Q53SI7 Q9C0J4 Q9NUP2,DNA repair protein REV1,Alpha integrin-binding protein 80;Rev1-like terminal deoxycytidyl transferase;, PF16589;PF00817;PF11799;PF16727;PF14377;, GO:0005654;GO:0003684;GO:0017125;GO:0003887;GO:0046872;GO:0006260;GO:0070987;GO:0042276;GO:0009411;GO:0019985;, C:nucleoplasm;, F:damaged DNA binding; F:deoxycytidyl transferase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:response to UV; P:translesion synthesis;|Q9UBZ9 O95941 Q53SI7 Q9C0J4 Q9NUP2,DNA repair protein REV1,Alpha integrin-binding protein 80;Rev1-like terminal deoxycytidyl transferase;, PF16589;PF00817;PF11799;PF16727;PF14377;, GO:0005654;GO:0003684;GO:0017125;GO:0003887;GO:0046872;GO:0006260;GO:0070987;GO:0042276;GO:0009411;GO:0019985;, C:nucleoplasm;, F:damaged DNA binding; F:deoxycytidyl transferase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:response to UV; P:translesion synthesis;|Q9UBZ9 O95941 Q53SI7 Q9C0J4 Q9NUP2,DNA repair protein REV1,Alpha integrin-binding protein 80;Rev1-like terminal deoxycytidyl transferase;, PF16589;PF00817;PF11799;PF16727;PF14377;, GO:0005654;GO:0003684;GO:0017125;GO:0003887;GO:0046872;GO:0006260;GO:0070987;GO:0042276;GO:0009411;GO:0019985;, C:nucleoplasm;, F:damaged DNA binding; F:deoxycytidyl transferase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:response to UV; P:translesion synthesis;|Q9UBZ9 O95941 Q53SI7 Q9C0J4 Q9NUP2,DNA repair protein REV1,Alpha integrin-binding protein 80;Rev1-like terminal deoxycytidyl transferase;, PF16589;PF00817;PF11799;PF16727;PF14377;, GO:0005654;GO:0003684;GO:0017125;GO:0003887;GO:0046872;GO:0006260;GO:0070987;GO:0042276;GO:0009411;GO:0019985;, C:nucleoplasm;, F:damaged DNA binding; F:deoxycytidyl transferase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:response to UV; P:translesion synthesis;|Q9UBZ9 O95941 Q53SI7 Q9C0J4 Q9NUP2,DNA repair protein REV1,Alpha integrin-binding protein 80;Rev1-like terminal deoxycytidyl transferase;, PF16589;PF00817;PF11799;PF16727;PF14377;, GO:0005654;GO:0003684;GO:0017125;GO:0003887;GO:0046872;GO:0006260;GO:0070987;GO:0042276;GO:0009411;GO:0019985;, C:nucleoplasm;, F:damaged DNA binding; F:deoxycytidyl transferase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:response to UV; P:translesion synthesis;|O60841 O95805 Q53RV7 Q53SI8 Q9UF81 Q9UMN7,Eukaryotic translation initiation factor 5B,Translation initiation factor IF-2;, PF00009;PF03144;PF11987;, GO:0005737;GO:0005829;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0003743;GO:0006446;, C:cytoplasm; C:cytosol;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation;|Q9UBZ9 O95941 Q53SI7 Q9C0J4 Q9NUP2,DNA repair protein REV1,Alpha integrin-binding protein 80;Rev1-like terminal deoxycytidyl transferase;, PF16589;PF00817;PF11799;PF16727;PF14377;, GO:0005654;GO:0003684;GO:0017125;GO:0003887;GO:0046872;GO:0006260;GO:0070987;GO:0042276;GO:0009411;GO:0019985;, C:nucleoplasm;, F:damaged DNA binding; F:deoxycytidyl transferase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:response to UV; P:translesion synthesis;|O60841 O95805 Q53RV7 Q53SI8 Q9UF81 Q9UMN7,Eukaryotic translation initiation factor 5B,Translation initiation factor IF-2;, PF00009;PF03144;PF11987;, GO:0005737;GO:0005829;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0003743;GO:0006446;, C:cytoplasm; C:cytosol;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation;|O60841 O95805 Q53RV7 Q53SI8 Q9UF81 Q9UMN7,Eukaryotic translation initiation factor 5B,Translation initiation factor IF-2;, PF00009;PF03144;PF11987;, GO:0005737;GO:0005829;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0003743;GO:0006446;, C:cytoplasm; C:cytosol;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation;|O60841 O95805 Q53RV7 Q53SI8 Q9UF81 Q9UMN7,Eukaryotic translation initiation factor 5B,Translation initiation factor IF-2;, PF00009;PF03144;PF11987;, GO:0005737;GO:0005829;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0003743;GO:0006446;, C:cytoplasm; C:cytosol;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation; scaffold6 indexed_genome mRNA 58939017 58988238 . - . ID=transcript_1835;O60841 O95805 Q53RV7 Q53SI8 Q9UF81 Q9UMN7,Eukaryotic translation initiation factor 5B,Translation initiation factor IF-2;, PF00009;PF03144;PF11987;, GO:0005737;GO:0005829;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0003743;GO:0006446;, C:cytoplasm; C:cytosol;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation; scaffold6 indexed_genome mRNA 58989226 59000765 . + . ID=transcript_1836;O14530 B2R9G8 D3DVI4 Q53HG4 Q53RV8 Q6NSF5 Q8TB70 Q9BRU6,Thioredoxin domain-containing protein 9,ATP-binding protein associated with cell differentiation;Protein 1-4;, PF00085;, GO:0005813;GO:0005829;GO:0030496;GO:0005634;GO:0045296;, C:centrosome; C:cytosol; C:midbody; C:nucleus;, F:cadherin binding;|O14530 B2R9G8 D3DVI4 Q53HG4 Q53RV8 Q6NSF5 Q8TB70 Q9BRU6,Thioredoxin domain-containing protein 9,ATP-binding protein associated with cell differentiation;Protein 1-4;, PF00085;, GO:0005813;GO:0005829;GO:0030496;GO:0005634;GO:0045296;, C:centrosome; C:cytosol; C:midbody; C:nucleus;, F:cadherin binding;|O14530 B2R9G8 D3DVI4 Q53HG4 Q53RV8 Q6NSF5 Q8TB70 Q9BRU6,Thioredoxin domain-containing protein 9,ATP-binding protein associated with cell differentiation;Protein 1-4;, PF00085;, GO:0005813;GO:0005829;GO:0030496;GO:0005634;GO:0045296;, C:centrosome; C:cytosol; C:midbody; C:nucleus;, F:cadherin binding; scaffold6 indexed_genome mRNA 59117540 59128426 . - . ID=transcript_1837;Q8TCC3 A6NIC6 D3DVI0 D3DVI3 Q0D2Q7 Q6ZTP4 Q96Q69 Q9P0N0,39S ribosomal protein L30, mitochondrial,39S ribosomal protein L28, mitochondrial;Mitochondrial large ribosomal subunit protein uL30m {ECO:0000303|PubMed:25278503};, PF00327;, GO:0005743;GO:0005762;GO:0005739;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold6 indexed_genome mRNA 59137197 59142713 . + . ID=transcript_1838;Q8WV92 Q69YV0,MIT domain-containing protein 1,, PF04212;PF16565;, GO:0070062;GO:0019898;GO:0043231;GO:0031902;GO:0030496;GO:0042802;GO:0035091;GO:0019904;GO:0061952;GO:0000281;GO:0032091;, C:extracellular exosome; C:extrinsic component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:midbody;, F:identical protein binding; F:phosphatidylinositol binding; F:protein domain specific binding;, P:midbody abscission; P:mitotic cytokinesis; P:negative regulation of protein binding;|Q8WV92 Q69YV0,MIT domain-containing protein 1,, PF04212;PF16565;, GO:0070062;GO:0019898;GO:0043231;GO:0031902;GO:0030496;GO:0042802;GO:0035091;GO:0019904;GO:0061952;GO:0000281;GO:0032091;, C:extracellular exosome; C:extrinsic component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:midbody;, F:identical protein binding; F:phosphatidylinositol binding; F:protein domain specific binding;, P:midbody abscission; P:mitotic cytokinesis; P:negative regulation of protein binding;|Q8WV92 Q69YV0,MIT domain-containing protein 1,, PF04212;PF16565;, GO:0070062;GO:0019898;GO:0043231;GO:0031902;GO:0030496;GO:0042802;GO:0035091;GO:0019904;GO:0061952;GO:0000281;GO:0032091;, C:extracellular exosome; C:extrinsic component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:midbody;, F:identical protein binding; F:phosphatidylinositol binding; F:protein domain specific binding;, P:midbody abscission; P:mitotic cytokinesis; P:negative regulation of protein binding;|Q8WV92 Q69YV0,MIT domain-containing protein 1,, PF04212;PF16565;, GO:0070062;GO:0019898;GO:0043231;GO:0031902;GO:0030496;GO:0042802;GO:0035091;GO:0019904;GO:0061952;GO:0000281;GO:0032091;, C:extracellular exosome; C:extrinsic component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:midbody;, F:identical protein binding; F:phosphatidylinositol binding; F:protein domain specific binding;, P:midbody abscission; P:mitotic cytokinesis; P:negative regulation of protein binding; scaffold6 indexed_genome mRNA 59146057 59147553 . - . ID=transcript_1839;Q9Y234 Q4ZFZ1,Lipoyltransferase 1, mitochondrial,Lipoate biosynthesis protein;Lipoate-protein ligase;Lipoyl ligase;, , GO:0005737;GO:0005759;GO:0005739;GO:0016979;GO:0017118;GO:0019752;GO:0006464;GO:0006629;GO:0009249;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:lipoate-protein ligase activity; F:lipoyltransferase activity;, P:carboxylic acid metabolic process; P:cellular protein modification process; P:lipid metabolic process; P:protein lipoylation; scaffold6 indexed_genome mRNA 59162464 59200859 . + . ID=transcript_1840;Q9BZW7 B7Z925 D3DVH7 Q8NEP0 Q9BWX0,Testis-specific gene 10 protein,Testis development protein NYD-SP7;, , GO:0005814;GO:0005737;GO:0007283;, C:centriole; C:cytoplasm;, , P:spermatogenesis;|Q9BZW7 B7Z925 D3DVH7 Q8NEP0 Q9BWX0,Testis-specific gene 10 protein,Testis development protein NYD-SP7;, , GO:0005814;GO:0005737;GO:0007283;, C:centriole; C:cytoplasm;, , P:spermatogenesis;|Q9BZW7 B7Z925 D3DVH7 Q8NEP0 Q9BWX0,Testis-specific gene 10 protein,Testis development protein NYD-SP7;, , GO:0005814;GO:0005737;GO:0007283;, C:centriole; C:cytoplasm;, , P:spermatogenesis; scaffold6 indexed_genome mRNA 59212486 59243106 . + . ID=transcript_1841;Q9BZW7 B7Z925 D3DVH7 Q8NEP0 Q9BWX0,Testis-specific gene 10 protein,Testis development protein NYD-SP7;, , GO:0005814;GO:0005737;GO:0007283;, C:centriole; C:cytoplasm;, , P:spermatogenesis;|Q9BZW7 B7Z925 D3DVH7 Q8NEP0 Q9BWX0,Testis-specific gene 10 protein,Testis development protein NYD-SP7;, , GO:0005814;GO:0005737;GO:0007283;, C:centriole; C:cytoplasm;, , P:spermatogenesis;|Q9BZW7 B7Z925 D3DVH7 Q8NEP0 Q9BWX0,Testis-specific gene 10 protein,Testis development protein NYD-SP7;, , GO:0005814;GO:0005737;GO:0007283;, C:centriole; C:cytoplasm;, , P:spermatogenesis;|Q9BZW7 B7Z925 D3DVH7 Q8NEP0 Q9BWX0,Testis-specific gene 10 protein,Testis development protein NYD-SP7;, , GO:0005814;GO:0005737;GO:0007283;, C:centriole; C:cytoplasm;, , P:spermatogenesis; scaffold6 indexed_genome mRNA 59368302 59406535 . + . ID=transcript_1842;Q6NV74,CRACD-like protein {ECO:0000305},, PF15262; scaffold6 indexed_genome mRNA 59547405 59621399 . + . ID=transcript_1843;Q9UM21 B4E2R6 D3DVH6 E9PEN2 Q53S97 Q86Z15,Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A,N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa;UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVa;, , GO:0005783;GO:0005788;GO:0005793;GO:0070062;GO:0000139;GO:0005795;GO:0016021;GO:0008375;GO:0008454;GO:0046872;GO:0044267;GO:0006491;GO:0043687;GO:0006487;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; F:metal ion binding;, P:cellular protein metabolic process; P:N-glycan processing; P:post-translational protein modification; P:protein N-linked glycosylation; P:viral protein processing; scaffold6 indexed_genome mRNA 59621657 59629651 . - . ID=transcript_1844;Q53HI1 D3DVH4 Q53S98 Q53TD6 Q5U5U2 Q6X7B9 Q9UQF4 Q9Y4S6,Protein unc-50 homolog,Periodontal ligament-specific protein 22;Protein GMH1 homolog;Uncoordinated-like protein;, PF05216;, GO:0030173;GO:0005637;GO:0003723;GO:0015031;, C:integral component of Golgi membrane; C:nuclear inner membrane;, F:RNA binding;, P:protein transport;|Q53HI1 D3DVH4 Q53S98 Q53TD6 Q5U5U2 Q6X7B9 Q9UQF4 Q9Y4S6,Protein unc-50 homolog,Periodontal ligament-specific protein 22;Protein GMH1 homolog;Uncoordinated-like protein;, PF05216;, GO:0030173;GO:0005637;GO:0003723;GO:0015031;, C:integral component of Golgi membrane; C:nuclear inner membrane;, F:RNA binding;, P:protein transport;|Q53HI1 D3DVH4 Q53S98 Q53TD6 Q5U5U2 Q6X7B9 Q9UQF4 Q9Y4S6,Protein unc-50 homolog,Periodontal ligament-specific protein 22;Protein GMH1 homolog;Uncoordinated-like protein;, PF05216;, GO:0030173;GO:0005637;GO:0003723;GO:0015031;, C:integral component of Golgi membrane; C:nuclear inner membrane;, F:RNA binding;, P:protein transport;|Q53HI1 D3DVH4 Q53S98 Q53TD6 Q5U5U2 Q6X7B9 Q9UQF4 Q9Y4S6,Protein unc-50 homolog,Periodontal ligament-specific protein 22;Protein GMH1 homolog;Uncoordinated-like protein;, PF05216;, GO:0030173;GO:0005637;GO:0003723;GO:0015031;, C:integral component of Golgi membrane; C:nuclear inner membrane;, F:RNA binding;, P:protein transport; scaffold6 indexed_genome mRNA 59680980 59734574 . - . ID=transcript_1845;Q96PE3 O15326 Q13187 Q53TD8 Q8TC02,Inositol polyphosphate-4-phosphatase type I A {ECO:0000312|HGNC:HGNC:6074},Inositol polyphosphate 4-phosphatase type I {ECO:0000303|PubMed:30071275};Type I inositol 3,4-bisphosphate 4-phosphatase;, , GO:0005737;GO:0005829;GO:0031901;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0055038;GO:0017161;GO:0052828;GO:0016316;GO:0034597;GO:0043647;GO:0006661;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane;, F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:inositol phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:signal transduction;|Q96PE3 O15326 Q13187 Q53TD8 Q8TC02,Inositol polyphosphate-4-phosphatase type I A {ECO:0000312|HGNC:HGNC:6074},Inositol polyphosphate 4-phosphatase type I {ECO:0000303|PubMed:30071275};Type I inositol 3,4-bisphosphate 4-phosphatase;, , GO:0005737;GO:0005829;GO:0031901;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0055038;GO:0017161;GO:0052828;GO:0016316;GO:0034597;GO:0043647;GO:0006661;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane;, F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:inositol phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:signal transduction;|Q96PE3 O15326 Q13187 Q53TD8 Q8TC02,Inositol polyphosphate-4-phosphatase type I A {ECO:0000312|HGNC:HGNC:6074},Inositol polyphosphate 4-phosphatase type I {ECO:0000303|PubMed:30071275};Type I inositol 3,4-bisphosphate 4-phosphatase;, , GO:0005737;GO:0005829;GO:0031901;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0055038;GO:0017161;GO:0052828;GO:0016316;GO:0034597;GO:0043647;GO:0006661;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane;, F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:inositol phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:signal transduction;|Q96PE3 O15326 Q13187 Q53TD8 Q8TC02,Inositol polyphosphate-4-phosphatase type I A {ECO:0000312|HGNC:HGNC:6074},Inositol polyphosphate 4-phosphatase type I {ECO:0000303|PubMed:30071275};Type I inositol 3,4-bisphosphate 4-phosphatase;, , GO:0005737;GO:0005829;GO:0031901;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0055038;GO:0017161;GO:0052828;GO:0016316;GO:0034597;GO:0043647;GO:0006661;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane;, F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:inositol phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:signal transduction;|Q96PE3 O15326 Q13187 Q53TD8 Q8TC02,Inositol polyphosphate-4-phosphatase type I A {ECO:0000312|HGNC:HGNC:6074},Inositol polyphosphate 4-phosphatase type I {ECO:0000303|PubMed:30071275};Type I inositol 3,4-bisphosphate 4-phosphatase;, , GO:0005737;GO:0005829;GO:0031901;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0055038;GO:0017161;GO:0052828;GO:0016316;GO:0034597;GO:0043647;GO:0006661;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane;, F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:inositol phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:signal transduction;|Q96PE3 O15326 Q13187 Q53TD8 Q8TC02,Inositol polyphosphate-4-phosphatase type I A {ECO:0000312|HGNC:HGNC:6074},Inositol polyphosphate 4-phosphatase type I {ECO:0000303|PubMed:30071275};Type I inositol 3,4-bisphosphate 4-phosphatase;, , GO:0005737;GO:0005829;GO:0031901;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0055038;GO:0017161;GO:0052828;GO:0016316;GO:0034597;GO:0043647;GO:0006661;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane;, F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:inositol phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:signal transduction;|Q96PE3 O15326 Q13187 Q53TD8 Q8TC02,Inositol polyphosphate-4-phosphatase type I A {ECO:0000312|HGNC:HGNC:6074},Inositol polyphosphate 4-phosphatase type I {ECO:0000303|PubMed:30071275};Type I inositol 3,4-bisphosphate 4-phosphatase;, , GO:0005737;GO:0005829;GO:0031901;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0055038;GO:0017161;GO:0052828;GO:0016316;GO:0034597;GO:0043647;GO:0006661;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane;, F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:inositol phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:signal transduction;|Q96PE3 O15326 Q13187 Q53TD8 Q8TC02,Inositol polyphosphate-4-phosphatase type I A {ECO:0000312|HGNC:HGNC:6074},Inositol polyphosphate 4-phosphatase type I {ECO:0000303|PubMed:30071275};Type I inositol 3,4-bisphosphate 4-phosphatase;, , GO:0005737;GO:0005829;GO:0031901;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0055038;GO:0017161;GO:0052828;GO:0016316;GO:0034597;GO:0043647;GO:0006661;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane;, F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:inositol phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:signal transduction;|Q96PE3 O15326 Q13187 Q53TD8 Q8TC02,Inositol polyphosphate-4-phosphatase type I A {ECO:0000312|HGNC:HGNC:6074},Inositol polyphosphate 4-phosphatase type I {ECO:0000303|PubMed:30071275};Type I inositol 3,4-bisphosphate 4-phosphatase;, , GO:0005737;GO:0005829;GO:0031901;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0055038;GO:0017161;GO:0052828;GO:0016316;GO:0034597;GO:0043647;GO:0006661;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane;, F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:inositol phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:signal transduction; scaffold6 indexed_genome mRNA 59899022 59912352 . - . ID=transcript_1846;Q502W6 B9EK71 Q86T73 Q8N2D0 Q8N770 Q8NA79 Q8ND63 Q8ND65 Q8WW02,von Willebrand factor A domain-containing protein 3B,, PF15057;PF13768;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold6 indexed_genome mRNA 59956062 60010211 . - . ID=transcript_1847;Q502W6 B9EK71 Q86T73 Q8N2D0 Q8N770 Q8NA79 Q8ND63 Q8ND65 Q8WW02,von Willebrand factor A domain-containing protein 3B,, PF15057;PF13768;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold6 indexed_genome mRNA 60256542 60361007 . + . ID=transcript_1848;Q92545,Transmembrane protein 131,Protein RW1;, PF12371;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q92545,Transmembrane protein 131,Protein RW1;, PF12371;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q92545,Transmembrane protein 131,Protein RW1;, PF12371;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q92545,Transmembrane protein 131,Protein RW1;, PF12371;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q92545,Transmembrane protein 131,Protein RW1;, PF12371;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q92545,Transmembrane protein 131,Protein RW1;, PF12371;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q92545,Transmembrane protein 131,Protein RW1;, PF12371;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q92545,Transmembrane protein 131,Protein RW1;, PF12371;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q92545,Transmembrane protein 131,Protein RW1;, PF12371;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane; scaffold6 indexed_genome mRNA 60391869 60418294 . - . ID=transcript_1849;P43403 A6NFP4 Q6PIA4 Q8IXD6 Q9UBS6,Tyrosine-protein kinase ZAP-70,70 kDa zeta-chain associated protein;Syk-related tyrosine kinase;, PF07714;PF00017;, GO:0005911;GO:0005737;GO:0005829;GO:0031234;GO:0001772;GO:0005886;GO:0042101;GO:0005524;GO:0004715;GO:0001784;GO:0004713;GO:0005102;GO:0004714;GO:0002250;GO:0042113;GO:0043366;GO:0030154;GO:0006955;GO:0045087;GO:0035556;GO:0045060;GO:0018108;GO:0046638;GO:0046641;GO:0050850;GO:0045582;GO:0045059;GO:0046777;GO:0006468;GO:0042110;GO:0070489;GO:0030217;GO:0072678;GO:0050852;GO:0007169;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:immunological synapse; C:plasma membrane; C:T cell receptor complex;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell activation; P:beta selection; P:cell differentiation; P:immune response; P:innate immune response; P:intracellular signal transduction; P:negative thymic T cell selection; P:peptidyl-tyrosine phosphorylation; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of calcium-mediated signaling; P:positive regulation of T cell differentiation; P:positive thymic T cell selection; P:protein autophosphorylation; P:protein phosphorylation; P:T cell activation; P:T cell aggregation; P:T cell differentiation; P:T cell migration; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P43403 A6NFP4 Q6PIA4 Q8IXD6 Q9UBS6,Tyrosine-protein kinase ZAP-70,70 kDa zeta-chain associated protein;Syk-related tyrosine kinase;, PF07714;PF00017;, GO:0005911;GO:0005737;GO:0005829;GO:0031234;GO:0001772;GO:0005886;GO:0042101;GO:0005524;GO:0004715;GO:0001784;GO:0004713;GO:0005102;GO:0004714;GO:0002250;GO:0042113;GO:0043366;GO:0030154;GO:0006955;GO:0045087;GO:0035556;GO:0045060;GO:0018108;GO:0046638;GO:0046641;GO:0050850;GO:0045582;GO:0045059;GO:0046777;GO:0006468;GO:0042110;GO:0070489;GO:0030217;GO:0072678;GO:0050852;GO:0007169;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:immunological synapse; C:plasma membrane; C:T cell receptor complex;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell activation; P:beta selection; P:cell differentiation; P:immune response; P:innate immune response; P:intracellular signal transduction; P:negative thymic T cell selection; P:peptidyl-tyrosine phosphorylation; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of calcium-mediated signaling; P:positive regulation of T cell differentiation; P:positive thymic T cell selection; P:protein autophosphorylation; P:protein phosphorylation; P:T cell activation; P:T cell aggregation; P:T cell differentiation; P:T cell migration; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P43403 A6NFP4 Q6PIA4 Q8IXD6 Q9UBS6,Tyrosine-protein kinase ZAP-70,70 kDa zeta-chain associated protein;Syk-related tyrosine kinase;, PF07714;PF00017;, GO:0005911;GO:0005737;GO:0005829;GO:0031234;GO:0001772;GO:0005886;GO:0042101;GO:0005524;GO:0004715;GO:0001784;GO:0004713;GO:0005102;GO:0004714;GO:0002250;GO:0042113;GO:0043366;GO:0030154;GO:0006955;GO:0045087;GO:0035556;GO:0045060;GO:0018108;GO:0046638;GO:0046641;GO:0050850;GO:0045582;GO:0045059;GO:0046777;GO:0006468;GO:0042110;GO:0070489;GO:0030217;GO:0072678;GO:0050852;GO:0007169;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:immunological synapse; C:plasma membrane; C:T cell receptor complex;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell activation; P:beta selection; P:cell differentiation; P:immune response; P:innate immune response; P:intracellular signal transduction; P:negative thymic T cell selection; P:peptidyl-tyrosine phosphorylation; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of calcium-mediated signaling; P:positive regulation of T cell differentiation; P:positive thymic T cell selection; P:protein autophosphorylation; P:protein phosphorylation; P:T cell activation; P:T cell aggregation; P:T cell differentiation; P:T cell migration; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P43403 A6NFP4 Q6PIA4 Q8IXD6 Q9UBS6,Tyrosine-protein kinase ZAP-70,70 kDa zeta-chain associated protein;Syk-related tyrosine kinase;, PF07714;PF00017;, GO:0005911;GO:0005737;GO:0005829;GO:0031234;GO:0001772;GO:0005886;GO:0042101;GO:0005524;GO:0004715;GO:0001784;GO:0004713;GO:0005102;GO:0004714;GO:0002250;GO:0042113;GO:0043366;GO:0030154;GO:0006955;GO:0045087;GO:0035556;GO:0045060;GO:0018108;GO:0046638;GO:0046641;GO:0050850;GO:0045582;GO:0045059;GO:0046777;GO:0006468;GO:0042110;GO:0070489;GO:0030217;GO:0072678;GO:0050852;GO:0007169;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:immunological synapse; C:plasma membrane; C:T cell receptor complex;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell activation; P:beta selection; P:cell differentiation; P:immune response; P:innate immune response; P:intracellular signal transduction; P:negative thymic T cell selection; P:peptidyl-tyrosine phosphorylation; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of calcium-mediated signaling; P:positive regulation of T cell differentiation; P:positive thymic T cell selection; P:protein autophosphorylation; P:protein phosphorylation; P:T cell activation; P:T cell aggregation; P:T cell differentiation; P:T cell migration; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold6 indexed_genome mRNA 60484943 60493752 . + . ID=transcript_1850;P61163 B2R6B0 P42024,Alpha-centractin,ARP1;Actin-RPV;Centrosome-associated actin homolog;, PF00022;, GO:0099738;GO:0005814;GO:0005813;GO:0030137;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0002177;GO:0005875;GO:0015630;GO:0005524;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0010389;GO:0007283;GO:0016192;, C:cell cortex region; C:centriole; C:centrosome; C:COPI-coated vesicle; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:manchette; C:microtubule associated complex; C:microtubule cytoskeleton;, F:ATP binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spermatogenesis; P:vesicle-mediated transport;|P42025 D3DVH2 Q53SK5 Q9BRB7,Beta-centractin,Actin-related protein 1B;, PF00022;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0015630;GO:0034774;GO:0005524;GO:0019886;GO:0043312;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:microtubule cytoskeleton; C:secretory granule lumen;, F:ATP binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:neutrophil degranulation;|P42025 D3DVH2 Q53SK5 Q9BRB7,Beta-centractin,Actin-related protein 1B;, PF00022;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0015630;GO:0034774;GO:0005524;GO:0019886;GO:0043312;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:microtubule cytoskeleton; C:secretory granule lumen;, F:ATP binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:neutrophil degranulation;|P42025 D3DVH2 Q53SK5 Q9BRB7,Beta-centractin,Actin-related protein 1B;, PF00022;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0015630;GO:0034774;GO:0005524;GO:0019886;GO:0043312;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:microtubule cytoskeleton; C:secretory granule lumen;, F:ATP binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:neutrophil degranulation; scaffold6 indexed_genome mRNA 60509100 60514758 . + . ID=transcript_1851;P10606 Q53YB7 Q96J18 Q99610,Cytochrome c oxidase subunit 5B, mitochondrial,Cytochrome c oxidase polypeptide Vb;, PF01215;, GO:0005743;GO:0005739;GO:0004129;GO:0046872;GO:0006123;GO:0007585;, C:mitochondrial inner membrane; C:mitochondrion;, F:cytochrome-c oxidase activity; F:metal ion binding;, P:mitochondrial electron transport, cytochrome c to oxygen; P:respiratory gaseous exchange by respiratory system;|P10606 Q53YB7 Q96J18 Q99610,Cytochrome c oxidase subunit 5B, mitochondrial,Cytochrome c oxidase polypeptide Vb;, PF01215;, GO:0005743;GO:0005739;GO:0004129;GO:0046872;GO:0006123;GO:0007585;, C:mitochondrial inner membrane; C:mitochondrion;, F:cytochrome-c oxidase activity; F:metal ion binding;, P:mitochondrial electron transport, cytochrome c to oxygen; P:respiratory gaseous exchange by respiratory system; scaffold6 indexed_genome mRNA 60620668 60623925 . + . ID=transcript_1852;Q8IXR5 A8MXN2 E9PD86 Q8IUY0 Q9P0P4,Protein FAM178B {ECO:0000305},, PF14816; scaffold6 indexed_genome mRNA 60627851 60641506 . + . ID=transcript_1853;Q9C0C4 Q32MJ3 Q7Z5X0,Semaphorin-4C,, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0014069;GO:0098839;GO:0030672;GO:0045499;GO:0030215;GO:0007411;GO:0021535;GO:0021549;GO:0042692;GO:0050919;GO:0048843;GO:0001755;GO:0001843;GO:0030335;GO:0032874;GO:0071526;, C:extracellular space; C:integral component of plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:synaptic vesicle membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell migration in hindbrain; P:cerebellum development; P:muscle cell differentiation; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:neural tube closure; P:positive regulation of cell migration; P:positive regulation of stress-activated MAPK cascade; P:semaphorin-plexin signaling pathway;|Q9C0C4 Q32MJ3 Q7Z5X0,Semaphorin-4C,, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0014069;GO:0098839;GO:0030672;GO:0045499;GO:0030215;GO:0007411;GO:0021535;GO:0021549;GO:0042692;GO:0050919;GO:0048843;GO:0001755;GO:0001843;GO:0030335;GO:0032874;GO:0071526;, C:extracellular space; C:integral component of plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:synaptic vesicle membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell migration in hindbrain; P:cerebellum development; P:muscle cell differentiation; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:neural tube closure; P:positive regulation of cell migration; P:positive regulation of stress-activated MAPK cascade; P:semaphorin-plexin signaling pathway;|Q9C0C4 Q32MJ3 Q7Z5X0,Semaphorin-4C,, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0014069;GO:0098839;GO:0030672;GO:0045499;GO:0030215;GO:0007411;GO:0021535;GO:0021549;GO:0042692;GO:0050919;GO:0048843;GO:0001755;GO:0001843;GO:0030335;GO:0032874;GO:0071526;, C:extracellular space; C:integral component of plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:synaptic vesicle membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell migration in hindbrain; P:cerebellum development; P:muscle cell differentiation; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:neural tube closure; P:positive regulation of cell migration; P:positive regulation of stress-activated MAPK cascade; P:semaphorin-plexin signaling pathway; scaffold6 indexed_genome mRNA 60653281 60655198 . - . ID=transcript_1854;Q53RE8 Q59FU2 Q8N5X5 Q9P0S5,Ankyrin repeat domain-containing protein 39,, PF12796;, GO:0070531;GO:0031436;GO:0085020;, C:BRCA1-A complex; C:BRCA1-BARD1 complex;, , P:protein K6-linked ubiquitination; scaffold6 indexed_genome mRNA 60658265 60668150 . + . ID=transcript_1855;Q86SG2 Q711K7 Q8NAJ7,Ankyrin repeat domain-containing protein 23,Diabetes-related ankyrin repeat protein;Muscle ankyrin repeat protein 3;, PF12796;PF13606;, GO:0015629;GO:0005829;GO:0014704;GO:0030016;GO:0005654;GO:0031432;GO:0009612;, C:actin cytoskeleton; C:cytosol; C:intercalated disc; C:myofibril; C:nucleoplasm;, F:titin binding;, P:response to mechanical stimulus;|Q86SG2 Q711K7 Q8NAJ7,Ankyrin repeat domain-containing protein 23,Diabetes-related ankyrin repeat protein;Muscle ankyrin repeat protein 3;, PF12796;PF13606;, GO:0015629;GO:0005829;GO:0014704;GO:0030016;GO:0005654;GO:0031432;GO:0009612;, C:actin cytoskeleton; C:cytosol; C:intercalated disc; C:myofibril; C:nucleoplasm;, F:titin binding;, P:response to mechanical stimulus; scaffold6 indexed_genome mRNA 60672524 60679136 . - . ID=transcript_1856;Q8NE01 B3KX67 Q8TBV4 Q96IW4 Q9NRK4 Q9NXW6,Metal transporter CNNM3,Ancient conserved domain-containing protein 3;Cyclin-M3;, PF00571;, GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0022857;GO:0006811;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, F:transmembrane transporter activity;, P:ion transport;|Q8NE01 B3KX67 Q8TBV4 Q96IW4 Q9NRK4 Q9NXW6,Metal transporter CNNM3,Ancient conserved domain-containing protein 3;Cyclin-M3;, PF00571;, GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0022857;GO:0006811;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, F:transmembrane transporter activity;, P:ion transport; scaffold6 indexed_genome mRNA 60680238 60681501 . + . ID=transcript_1857;P23434 Q9H1E9,Glycine cleavage system H protein, mitochondrial {ECO:0000303|PubMed:1671321},Lipoic acid-containing protein;, PF01597;, GO:0005737;GO:0005960;GO:0005759;GO:0005739;GO:0004047;GO:0006546;GO:0019464;GO:0009249;, C:cytoplasm; C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion;, F:aminomethyltransferase activity;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein lipoylation; scaffold6 indexed_genome mRNA 60715953 60718393 . - . ID=transcript_1858;Q6P4Q7 B7Z1U0 C7SQM3 C7SQM4 C7SQM5 Q53RE5 Q9H9G3 Q9HCI0 Q9NRN1,Metal transporter CNNM4,Ancient conserved domain-containing protein 4;Cyclin-M4;, PF00571;PF01595;, GO:0016323;GO:0030425;GO:0016021;GO:0043231;GO:0043025;GO:0005886;GO:0032991;GO:0015095;GO:0015081;GO:0022857;GO:0070166;GO:0010960;GO:0015693;GO:0055065;GO:0050896;GO:0007601;, C:basolateral plasma membrane; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:plasma membrane; C:protein-containing complex;, F:magnesium ion transmembrane transporter activity; F:sodium ion transmembrane transporter activity; F:transmembrane transporter activity;, P:enamel mineralization; P:magnesium ion homeostasis; P:magnesium ion transport; P:metal ion homeostasis; P:response to stimulus; P:visual perception; scaffold6 indexed_genome mRNA 60719089 60722399 . + . ID=transcript_1859;Q6P4Q7 B7Z1U0 C7SQM3 C7SQM4 C7SQM5 Q53RE5 Q9H9G3 Q9HCI0 Q9NRN1,Metal transporter CNNM4,Ancient conserved domain-containing protein 4;Cyclin-M4;, PF00571;PF01595;, GO:0016323;GO:0030425;GO:0016021;GO:0043231;GO:0043025;GO:0005886;GO:0032991;GO:0015095;GO:0015081;GO:0022857;GO:0070166;GO:0010960;GO:0015693;GO:0055065;GO:0050896;GO:0007601;, C:basolateral plasma membrane; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:plasma membrane; C:protein-containing complex;, F:magnesium ion transmembrane transporter activity; F:sodium ion transmembrane transporter activity; F:transmembrane transporter activity;, P:enamel mineralization; P:magnesium ion homeostasis; P:magnesium ion transport; P:metal ion homeostasis; P:response to stimulus; P:visual perception; scaffold6 indexed_genome mRNA 60728883 60756740 . - . ID=transcript_1860;Q6P4Q7 B7Z1U0 C7SQM3 C7SQM4 C7SQM5 Q53RE5 Q9H9G3 Q9HCI0 Q9NRN1,Metal transporter CNNM4,Ancient conserved domain-containing protein 4;Cyclin-M4;, PF00571;PF01595;, GO:0016323;GO:0030425;GO:0016021;GO:0043231;GO:0043025;GO:0005886;GO:0032991;GO:0015095;GO:0015081;GO:0022857;GO:0070166;GO:0010960;GO:0015693;GO:0055065;GO:0050896;GO:0007601;, C:basolateral plasma membrane; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:plasma membrane; C:protein-containing complex;, F:magnesium ion transmembrane transporter activity; F:sodium ion transmembrane transporter activity; F:transmembrane transporter activity;, P:enamel mineralization; P:magnesium ion homeostasis; P:magnesium ion transport; P:metal ion homeostasis; P:response to stimulus; P:visual perception;|Q6P4Q7 B7Z1U0 C7SQM3 C7SQM4 C7SQM5 Q53RE5 Q9H9G3 Q9HCI0 Q9NRN1,Metal transporter CNNM4,Ancient conserved domain-containing protein 4;Cyclin-M4;, PF00571;PF01595;, GO:0016323;GO:0030425;GO:0016021;GO:0043231;GO:0043025;GO:0005886;GO:0032991;GO:0015095;GO:0015081;GO:0022857;GO:0070166;GO:0010960;GO:0015693;GO:0055065;GO:0050896;GO:0007601;, C:basolateral plasma membrane; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:plasma membrane; C:protein-containing complex;, F:magnesium ion transmembrane transporter activity; F:sodium ion transmembrane transporter activity; F:transmembrane transporter activity;, P:enamel mineralization; P:magnesium ion homeostasis; P:magnesium ion transport; P:metal ion homeostasis; P:response to stimulus; P:visual perception; scaffold6 indexed_genome mRNA 60775285 60794571 . + . ID=transcript_1861;Q9H0V9 B4DSH3 D3DXH6 Q53GV3 Q53S67 Q63HN6 Q8NBQ6 Q9BQ14,VIP36-like protein,Lectin mannose-binding 2-like;, PF03388;, GO:0030134;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0016021;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0006457;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein folding; P:protein transport;|Q9H0V9 B4DSH3 D3DXH6 Q53GV3 Q53S67 Q63HN6 Q8NBQ6 Q9BQ14,VIP36-like protein,Lectin mannose-binding 2-like;, PF03388;, GO:0030134;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0016021;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0006457;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein folding; P:protein transport;|Q9H0V9 B4DSH3 D3DXH6 Q53GV3 Q53S67 Q63HN6 Q8NBQ6 Q9BQ14,VIP36-like protein,Lectin mannose-binding 2-like;, PF03388;, GO:0030134;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0016021;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0006457;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein folding; P:protein transport;|Q9H0V9 B4DSH3 D3DXH6 Q53GV3 Q53S67 Q63HN6 Q8NBQ6 Q9BQ14,VIP36-like protein,Lectin mannose-binding 2-like;, PF03388;, GO:0030134;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0016021;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0006457;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein folding; P:protein transport;|Q9H0V9 B4DSH3 D3DXH6 Q53GV3 Q53S67 Q63HN6 Q8NBQ6 Q9BQ14,VIP36-like protein,Lectin mannose-binding 2-like;, PF03388;, GO:0030134;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0016021;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0006457;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein folding; P:protein transport;|Q9H0V9 B4DSH3 D3DXH6 Q53GV3 Q53S67 Q63HN6 Q8NBQ6 Q9BQ14,VIP36-like protein,Lectin mannose-binding 2-like;, PF03388;, GO:0030134;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0016021;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0006457;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein folding; P:protein transport;|Q9H0V9 B4DSH3 D3DXH6 Q53GV3 Q53S67 Q63HN6 Q8NBQ6 Q9BQ14,VIP36-like protein,Lectin mannose-binding 2-like;, PF03388;, GO:0030134;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0016021;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0006457;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein folding; P:protein transport;|Q9H0V9 B4DSH3 D3DXH6 Q53GV3 Q53S67 Q63HN6 Q8NBQ6 Q9BQ14,VIP36-like protein,Lectin mannose-binding 2-like;, PF03388;, GO:0030134;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0016021;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0006457;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein folding; P:protein transport; scaffold6 indexed_genome mRNA 60854623 60899049 . + . ID=transcript_1862;Q9H0C9 Q9H8C9 Q9HAP8 Q9NWE5,KAT8 regulatory NSL complex subunit 3,NSL complex protein NSL3;Non-specific lethal 3 homolog;Serum inhibited-related protein;Testis development protein PRTD;, , GO:0000123;GO:0043231;GO:0044545;GO:0005654;GO:0043984;GO:0043981;GO:0043982;GO:0045944;, C:histone acetyltransferase complex; C:intracellular membrane-bounded organelle; C:NSL complex; C:nucleoplasm;, , P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:positive regulation of transcription by RNA polymerase II;|Q9H0C9 Q9H8C9 Q9HAP8 Q9NWE5,KAT8 regulatory NSL complex subunit 3,NSL complex protein NSL3;Non-specific lethal 3 homolog;Serum inhibited-related protein;Testis development protein PRTD;, , GO:0000123;GO:0043231;GO:0044545;GO:0005654;GO:0043984;GO:0043981;GO:0043982;GO:0045944;, C:histone acetyltransferase complex; C:intracellular membrane-bounded organelle; C:NSL complex; C:nucleoplasm;, , P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:positive regulation of transcription by RNA polymerase II;|Q9H0C9 Q9H8C9 Q9HAP8 Q9NWE5,KAT8 regulatory NSL complex subunit 3,NSL complex protein NSL3;Non-specific lethal 3 homolog;Serum inhibited-related protein;Testis development protein PRTD;, , GO:0000123;GO:0043231;GO:0044545;GO:0005654;GO:0043984;GO:0043981;GO:0043982;GO:0045944;, C:histone acetyltransferase complex; C:intracellular membrane-bounded organelle; C:NSL complex; C:nucleoplasm;, , P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:positive regulation of transcription by RNA polymerase II;|Q9H0C9 Q9H8C9 Q9HAP8 Q9NWE5,KAT8 regulatory NSL complex subunit 3,NSL complex protein NSL3;Non-specific lethal 3 homolog;Serum inhibited-related protein;Testis development protein PRTD;, , GO:0000123;GO:0043231;GO:0044545;GO:0005654;GO:0043984;GO:0043981;GO:0043982;GO:0045944;, C:histone acetyltransferase complex; C:intracellular membrane-bounded organelle; C:NSL complex; C:nucleoplasm;, , P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:positive regulation of transcription by RNA polymerase II; scaffold6 indexed_genome mRNA 60908878 60916548 . - . ID=transcript_1863;Q03989 C9J1Q0 Q6NX37,AT-rich interactive domain-containing protein 5A,Modulator recognition factor 1;, PF01388;, GO:0005730;GO:0005654;GO:0005634;GO:0050681;GO:0003677;GO:0030331;GO:0042802;GO:0046965;GO:0003723;GO:0043565;GO:0046966;GO:0003714;GO:0008134;GO:0000976;GO:0071391;GO:0045087;GO:0000122;GO:0045892;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:DNA binding; F:estrogen receptor binding; F:identical protein binding; F:retinoid X receptor binding; F:RNA binding; F:sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to estrogen stimulus; P:innate immune response; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q03989 C9J1Q0 Q6NX37,AT-rich interactive domain-containing protein 5A,Modulator recognition factor 1;, PF01388;, GO:0005730;GO:0005654;GO:0005634;GO:0050681;GO:0003677;GO:0030331;GO:0042802;GO:0046965;GO:0003723;GO:0043565;GO:0046966;GO:0003714;GO:0008134;GO:0000976;GO:0071391;GO:0045087;GO:0000122;GO:0045892;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:DNA binding; F:estrogen receptor binding; F:identical protein binding; F:retinoid X receptor binding; F:RNA binding; F:sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to estrogen stimulus; P:innate immune response; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q03989 C9J1Q0 Q6NX37,AT-rich interactive domain-containing protein 5A,Modulator recognition factor 1;, PF01388;, GO:0005730;GO:0005654;GO:0005634;GO:0050681;GO:0003677;GO:0030331;GO:0042802;GO:0046965;GO:0003723;GO:0043565;GO:0046966;GO:0003714;GO:0008134;GO:0000976;GO:0071391;GO:0045087;GO:0000122;GO:0045892;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:DNA binding; F:estrogen receptor binding; F:identical protein binding; F:retinoid X receptor binding; F:RNA binding; F:sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to estrogen stimulus; P:innate immune response; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold6 indexed_genome mRNA 61002177 61026635 . - . ID=transcript_1864;Q15003 B4E189 Q8TB87,Condensin complex subunit 2,Barren homolog protein 1;Chromosome-associated protein H;Non-SMC condensin I complex subunit H;XCAP-H homolog;, PF05786;, GO:0000796;GO:0005829;GO:0016020;GO:0005654;GO:0003682;GO:0044547;GO:0072587;GO:0051301;GO:0007076;, C:condensin complex; C:cytosol; C:membrane; C:nucleoplasm;, F:chromatin binding; F:DNA topoisomerase binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity;, P:cell division; P:mitotic chromosome condensation;|Q15003 B4E189 Q8TB87,Condensin complex subunit 2,Barren homolog protein 1;Chromosome-associated protein H;Non-SMC condensin I complex subunit H;XCAP-H homolog;, PF05786;, GO:0000796;GO:0005829;GO:0016020;GO:0005654;GO:0003682;GO:0044547;GO:0072587;GO:0051301;GO:0007076;, C:condensin complex; C:cytosol; C:membrane; C:nucleoplasm;, F:chromatin binding; F:DNA topoisomerase binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity;, P:cell division; P:mitotic chromosome condensation;|Q15003 B4E189 Q8TB87,Condensin complex subunit 2,Barren homolog protein 1;Chromosome-associated protein H;Non-SMC condensin I complex subunit H;XCAP-H homolog;, PF05786;, GO:0000796;GO:0005829;GO:0016020;GO:0005654;GO:0003682;GO:0044547;GO:0072587;GO:0051301;GO:0007076;, C:condensin complex; C:cytosol; C:membrane; C:nucleoplasm;, F:chromatin binding; F:DNA topoisomerase binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity;, P:cell division; P:mitotic chromosome condensation; scaffold6 indexed_genome mRNA 61037879 61041993 . - . ID=transcript_1865;Q6GPH6 F5H1L8 Q8NE61,Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1,, PF03281;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane; scaffold6 indexed_genome mRNA 61067527 61092191 . + . ID=transcript_1866;O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);|O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);|O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);|O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);|O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);|O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);|O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);|O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);|O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);|O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);|O75643 O94884 Q6NZY0 Q6PX59 Q8NBE6 Q96IF2 Q9H7S0,U5 small nuclear ribonucleoprotein 200 kDa helicase,Activating signal cointegrator 1 complex subunit 3-like 1;BRR2 homolog;U5 snRNP-specific 200 kDa protein;, PF00270;PF00271;PF18149;PF02889;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071005;GO:0046540;GO:0005682;GO:0005524;GO:0004386;GO:0042802;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0001649;GO:0000388;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:helicase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:spliceosome conformational change to release U4 (or U4atac) and U1 (or U11); scaffold6 indexed_genome mRNA 61092851 61097866 . - . ID=transcript_1867;O76071 A0MNN9 Q53FM5,Probable cytosolic iron-sulfur protein assembly protein CIAO1 {ECO:0000255|HAMAP-Rule:MF_03037},WD repeat-containing protein 39 {ECO:0000255|HAMAP-Rule:MF_03037};, PF00400;, GO:0097361;GO:0005737;GO:0071817;GO:0007059;GO:0016226;GO:0008284;GO:0097428;GO:0006357;, C:CIA complex; C:cytoplasm; C:MMXD complex;, , P:chromosome segregation; P:iron-sulfur cluster assembly; P:positive regulation of cell population proliferation; P:protein maturation by iron-sulfur cluster transfer; P:regulation of transcription by RNA polymerase II;|O76071 A0MNN9 Q53FM5,Probable cytosolic iron-sulfur protein assembly protein CIAO1 {ECO:0000255|HAMAP-Rule:MF_03037},WD repeat-containing protein 39 {ECO:0000255|HAMAP-Rule:MF_03037};, PF00400;, GO:0097361;GO:0005737;GO:0071817;GO:0007059;GO:0016226;GO:0008284;GO:0097428;GO:0006357;, C:CIA complex; C:cytoplasm; C:MMXD complex;, , P:chromosome segregation; P:iron-sulfur cluster assembly; P:positive regulation of cell population proliferation; P:protein maturation by iron-sulfur cluster transfer; P:regulation of transcription by RNA polymerase II; scaffold6 indexed_genome mRNA 61098835 61099419 . - . ID=transcript_1868;O76071 A0MNN9 Q53FM5,Probable cytosolic iron-sulfur protein assembly protein CIAO1 {ECO:0000255|HAMAP-Rule:MF_03037},WD repeat-containing protein 39 {ECO:0000255|HAMAP-Rule:MF_03037};, PF00400;, GO:0097361;GO:0005737;GO:0071817;GO:0007059;GO:0016226;GO:0008284;GO:0097428;GO:0006357;, C:CIA complex; C:cytoplasm; C:MMXD complex;, , P:chromosome segregation; P:iron-sulfur cluster assembly; P:positive regulation of cell population proliferation; P:protein maturation by iron-sulfur cluster transfer; P:regulation of transcription by RNA polymerase II; scaffold6 indexed_genome mRNA 61099724 61112646 . + . ID=transcript_1869;O75204 D3DXH0,Transmembrane protein 127,, , GO:0005737;GO:0005769;GO:0016021;GO:0016020;GO:0005886;GO:0031267;GO:0007032;GO:0008285;GO:0032007;GO:0032006;, C:cytoplasm; C:early endosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:small GTPase binding;, P:endosome organization; P:negative regulation of cell population proliferation; P:negative regulation of TOR signaling; P:regulation of TOR signaling;|O75204 D3DXH0,Transmembrane protein 127,, , GO:0005737;GO:0005769;GO:0016021;GO:0016020;GO:0005886;GO:0031267;GO:0007032;GO:0008285;GO:0032007;GO:0032006;, C:cytoplasm; C:early endosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:small GTPase binding;, P:endosome organization; P:negative regulation of cell population proliferation; P:negative regulation of TOR signaling; P:regulation of TOR signaling;|O75204 D3DXH0,Transmembrane protein 127,, , GO:0005737;GO:0005769;GO:0016021;GO:0016020;GO:0005886;GO:0031267;GO:0007032;GO:0008285;GO:0032007;GO:0032006;, C:cytoplasm; C:early endosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:small GTPase binding;, P:endosome organization; P:negative regulation of cell population proliferation; P:negative regulation of TOR signaling; P:regulation of TOR signaling; scaffold6 indexed_genome mRNA 61128282 61149324 . + . ID=transcript_1870;Q9NQZ5 D3DXG9 Q53T44 Q6GU43 Q969M6,StAR-related lipid transfer protein 7, mitochondrial,Gestational trophoblastic tumor protein 1;START domain-containing protein 7;, PF01852;, GO:0005741;GO:0008289;GO:0006656;, C:mitochondrial outer membrane;, F:lipid binding;, P:phosphatidylcholine biosynthetic process;|Q9NQZ5 D3DXG9 Q53T44 Q6GU43 Q969M6,StAR-related lipid transfer protein 7, mitochondrial,Gestational trophoblastic tumor protein 1;START domain-containing protein 7;, PF01852;, GO:0005741;GO:0008289;GO:0006656;, C:mitochondrial outer membrane;, F:lipid binding;, P:phosphatidylcholine biosynthetic process; scaffold6 indexed_genome mRNA 61184177 61185403 . + . ID=transcript_1871;Q05923 Q53T45,Dual specificity protein phosphatase 2,Dual specificity protein phosphatase PAC-1;, PF00581;, GO:0005737;GO:0031965;GO:0005654;GO:0005634;GO:0017017;GO:0051019;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0001706;GO:0000188;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:endoderm formation; P:inactivation of MAPK activity; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; scaffold6 indexed_genome mRNA 61211715 61214833 . - . ID=transcript_1872;P18089 A2RUS0 Q4TUH9 Q53RF2 Q9BZK0,Alpha-2B adrenergic receptor,Alpha-2 adrenergic receptor subtype C2;Alpha-2B adrenoreceptor;, PF00001;, GO:0009986;GO:0005829;GO:0005887;GO:0043231;GO:0005886;GO:0004938;GO:0051379;GO:0004930;GO:0000187;GO:0032148;GO:0071880;GO:0071875;GO:0007267;GO:0007565;GO:0007186;GO:0032811;GO:0010700;GO:0030168;GO:0045777;GO:0043410;GO:0045666;GO:0070474;GO:0035624;GO:0003056;, C:cell surface; C:cytosol; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:alpha2-adrenergic receptor activity; F:epinephrine binding; F:G protein-coupled receptor activity;, P:activation of MAPK activity; P:activation of protein kinase B activity; P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:adrenergic receptor signaling pathway; P:cell-cell signaling; P:female pregnancy; P:G protein-coupled receptor signaling pathway; P:negative regulation of epinephrine secretion; P:negative regulation of norepinephrine secretion; P:platelet activation; P:positive regulation of blood pressure; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of uterine smooth muscle contraction; P:receptor transactivation; P:regulation of vascular associated smooth muscle contraction; scaffold7 indexed_genome mRNA 8718 12953 . - . ID=transcript_1873;Q04828 P52896 Q5SR15 Q7M4N2 Q9UCX2,Aldo-keto reductase family 1 member C1 {ECO:0000305},20-alpha-hydroxysteroid dehydrogenase {ECO:0000303|PubMed:11013348};Chlordecone reductase homolog HAKRC;Dihydrodiol dehydrogenase 1 {ECO:0000303|PubMed:8573067};High-affinity hepatic bile acid-binding protein;, PF00248;, GO:0005829;GO:0070062;GO:0047006;GO:0044594;GO:0072582;GO:0033703;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047042;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0035410;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047045;GO:0030283;GO:0047115;GO:0015721;GO:0008206;GO:0071395;GO:0042632;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0030299;GO:0042448;GO:0006693;GO:0046683;GO:0042574;GO:0001523;GO:0008202;GO:0006805;, C:cytosol; C:extracellular exosome;, F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3beta-hydroxy-5beta-steroid dehydrogenase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase (B-specific) activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:cellular response to jasmonic acid stimulus; P:cholesterol homeostasis; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:intestinal cholesterol absorption; P:progesterone metabolic process; P:prostaglandin metabolic process; P:response to organophosphorus; P:retinal metabolic process; P:retinoid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process; scaffold7 indexed_genome mRNA 131009 148343 . - . ID=transcript_1874;Q04828 P52896 Q5SR15 Q7M4N2 Q9UCX2,Aldo-keto reductase family 1 member C1 {ECO:0000305},20-alpha-hydroxysteroid dehydrogenase {ECO:0000303|PubMed:11013348};Chlordecone reductase homolog HAKRC;Dihydrodiol dehydrogenase 1 {ECO:0000303|PubMed:8573067};High-affinity hepatic bile acid-binding protein;, PF00248;, GO:0005829;GO:0070062;GO:0047006;GO:0044594;GO:0072582;GO:0033703;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047042;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0035410;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047045;GO:0030283;GO:0047115;GO:0015721;GO:0008206;GO:0071395;GO:0042632;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0030299;GO:0042448;GO:0006693;GO:0046683;GO:0042574;GO:0001523;GO:0008202;GO:0006805;, C:cytosol; C:extracellular exosome;, F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3beta-hydroxy-5beta-steroid dehydrogenase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase (B-specific) activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:cellular response to jasmonic acid stimulus; P:cholesterol homeostasis; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:intestinal cholesterol absorption; P:progesterone metabolic process; P:prostaglandin metabolic process; P:response to organophosphorus; P:retinal metabolic process; P:retinoid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process; scaffold7 indexed_genome mRNA 194215 213977 . + . ID=transcript_1875;Q9UKL9,Aldo-keto reductase family 1 member C3,17-beta-hydroxysteroid dehydrogenase type 5 {ECO:0000303|PubMed:11165022};3-alpha-HSD type II, brain;3-alpha-hydroxysteroid dehydrogenase type 2;Chlordecone reductase homolog HAKRb;Dihydrodiol dehydrogenase 3;Dihydrodiol dehydrogenase type I;HA1753;Prostaglandin F synthase {ECO:0000303|PubMed:10622721};Testosterone 17-beta-dehydrogenase 5;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0047020;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0047834;GO:0047787;GO:0035410;GO:0045550;GO:0045703;GO:0047086;GO:0016655;GO:0018636;GO:0036131;GO:0036130;GO:0047017;GO:0001758;GO:0004745;GO:0016229;GO:0047045;GO:0047035;GO:0071276;GO:0071277;GO:0071384;GO:0071395;GO:0071799;GO:0071379;GO:0034614;GO:0009267;GO:0019371;GO:0044597;GO:0044598;GO:0016488;GO:0007186;GO:0030216;GO:0043170;GO:0008584;GO:1900053;GO:0010942;GO:0008284;GO:2000353;GO:0051897;GO:2000379;GO:0042448;GO:0006693;GO:0048385;GO:2000224;GO:0070293;GO:0007584;GO:0042574;GO:0001523;GO:0042572;GO:0008202;GO:0061370;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:geranylgeranyl reductase activity; F:ketoreductase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:prostaglandin D2 11-ketoreductase activity; F:prostaglandin H2 endoperoxidase reductase activity; F:prostaglandin-F synthase activity; F:retinal dehydrogenase activity; F:retinol dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:cellular response to cadmium ion; P:cellular response to calcium ion; P:cellular response to corticosteroid stimulus; P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:cellular response to prostaglandin stimulus; P:cellular response to reactive oxygen species; P:cellular response to starvation; P:cyclooxygenase pathway; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:farnesol catabolic process; P:G protein-coupled receptor signaling pathway; P:keratinocyte differentiation; P:macromolecule metabolic process; P:male gonad development; P:negative regulation of retinoic acid biosynthetic process; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:regulation of retinoic acid receptor signaling pathway; P:regulation of testosterone biosynthetic process; P:renal absorption; P:response to nutrient; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:testosterone biosynthetic process;|Q9UKL9,Aldo-keto reductase family 1 member C3,17-beta-hydroxysteroid dehydrogenase type 5 {ECO:0000303|PubMed:11165022};3-alpha-HSD type II, brain;3-alpha-hydroxysteroid dehydrogenase type 2;Chlordecone reductase homolog HAKRb;Dihydrodiol dehydrogenase 3;Dihydrodiol dehydrogenase type I;HA1753;Prostaglandin F synthase {ECO:0000303|PubMed:10622721};Testosterone 17-beta-dehydrogenase 5;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0047020;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0047834;GO:0047787;GO:0035410;GO:0045550;GO:0045703;GO:0047086;GO:0016655;GO:0018636;GO:0036131;GO:0036130;GO:0047017;GO:0001758;GO:0004745;GO:0016229;GO:0047045;GO:0047035;GO:0071276;GO:0071277;GO:0071384;GO:0071395;GO:0071799;GO:0071379;GO:0034614;GO:0009267;GO:0019371;GO:0044597;GO:0044598;GO:0016488;GO:0007186;GO:0030216;GO:0043170;GO:0008584;GO:1900053;GO:0010942;GO:0008284;GO:2000353;GO:0051897;GO:2000379;GO:0042448;GO:0006693;GO:0048385;GO:2000224;GO:0070293;GO:0007584;GO:0042574;GO:0001523;GO:0042572;GO:0008202;GO:0061370;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:geranylgeranyl reductase activity; F:ketoreductase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:prostaglandin D2 11-ketoreductase activity; F:prostaglandin H2 endoperoxidase reductase activity; F:prostaglandin-F synthase activity; F:retinal dehydrogenase activity; F:retinol dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:cellular response to cadmium ion; P:cellular response to calcium ion; P:cellular response to corticosteroid stimulus; P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:cellular response to prostaglandin stimulus; P:cellular response to reactive oxygen species; P:cellular response to starvation; P:cyclooxygenase pathway; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:farnesol catabolic process; P:G protein-coupled receptor signaling pathway; P:keratinocyte differentiation; P:macromolecule metabolic process; P:male gonad development; P:negative regulation of retinoic acid biosynthetic process; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:regulation of retinoic acid receptor signaling pathway; P:regulation of testosterone biosynthetic process; P:renal absorption; P:response to nutrient; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:testosterone biosynthetic process; scaffold7 indexed_genome mRNA 235461 249724 . - . ID=transcript_1876;Q04828 P52896 Q5SR15 Q7M4N2 Q9UCX2,Aldo-keto reductase family 1 member C1 {ECO:0000305},20-alpha-hydroxysteroid dehydrogenase {ECO:0000303|PubMed:11013348};Chlordecone reductase homolog HAKRC;Dihydrodiol dehydrogenase 1 {ECO:0000303|PubMed:8573067};High-affinity hepatic bile acid-binding protein;, PF00248;, GO:0005829;GO:0070062;GO:0047006;GO:0044594;GO:0072582;GO:0033703;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047042;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0035410;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047045;GO:0030283;GO:0047115;GO:0015721;GO:0008206;GO:0071395;GO:0042632;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0030299;GO:0042448;GO:0006693;GO:0046683;GO:0042574;GO:0001523;GO:0008202;GO:0006805;, C:cytosol; C:extracellular exosome;, F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3beta-hydroxy-5beta-steroid dehydrogenase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase (B-specific) activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:cellular response to jasmonic acid stimulus; P:cholesterol homeostasis; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:intestinal cholesterol absorption; P:progesterone metabolic process; P:prostaglandin metabolic process; P:response to organophosphorus; P:retinal metabolic process; P:retinoid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process; scaffold7 indexed_genome mRNA 355912 359558 . - . ID=transcript_1877;Q96JD6 Q86Z16 Q86Z17 Q86Z18 Q9BU71,1,5-anhydro-D-fructose reductase,Aldo-keto reductase family 1 member C-like protein 2;Aldo-keto reductase family 1 member E2;LoopADR;Testis aldo-keto reductase {ECO:0000303|PubMed:15118078};Testis-specific protein;, PF00248;, GO:0005829;GO:0050571;GO:0004032;GO:0047834;GO:0016491;, C:cytosol;, F:1,5-anhydro-D-fructose reductase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:oxidoreductase activity;|Q96JD6 Q86Z16 Q86Z17 Q86Z18 Q9BU71,1,5-anhydro-D-fructose reductase,Aldo-keto reductase family 1 member C-like protein 2;Aldo-keto reductase family 1 member E2;LoopADR;Testis aldo-keto reductase {ECO:0000303|PubMed:15118078};Testis-specific protein;, PF00248;, GO:0005829;GO:0050571;GO:0004032;GO:0047834;GO:0016491;, C:cytosol;, F:1,5-anhydro-D-fructose reductase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:oxidoreductase activity; scaffold7 indexed_genome mRNA 361085 366208 . + . ID=transcript_1878;Q96JD6 Q86Z16 Q86Z17 Q86Z18 Q9BU71,1,5-anhydro-D-fructose reductase,Aldo-keto reductase family 1 member C-like protein 2;Aldo-keto reductase family 1 member E2;LoopADR;Testis aldo-keto reductase {ECO:0000303|PubMed:15118078};Testis-specific protein;, PF00248;, GO:0005829;GO:0050571;GO:0004032;GO:0047834;GO:0016491;, C:cytosol;, F:1,5-anhydro-D-fructose reductase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:oxidoreductase activity;|Q96JD6 Q86Z16 Q86Z17 Q86Z18 Q9BU71,1,5-anhydro-D-fructose reductase,Aldo-keto reductase family 1 member C-like protein 2;Aldo-keto reductase family 1 member E2;LoopADR;Testis aldo-keto reductase {ECO:0000303|PubMed:15118078};Testis-specific protein;, PF00248;, GO:0005829;GO:0050571;GO:0004032;GO:0047834;GO:0016491;, C:cytosol;, F:1,5-anhydro-D-fructose reductase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:oxidoreductase activity; scaffold7 indexed_genome mRNA 367636 371016 . + . ID=transcript_1879;Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response; scaffold7 indexed_genome mRNA 381461 382986 . - . ID=transcript_1880;Q9ULC4 B4DGY2 Q502X6,Malignant T-cell-amplified sequence 1,Multiple copies T-cell malignancies;, PF17832;PF01472;, GO:0005829;GO:0005886;GO:0003743;GO:0007049;GO:0006974;GO:0001731;GO:0075522;GO:0008284;GO:0040008;GO:0032790;GO:0002188;, C:cytosol; C:plasma membrane;, F:translation initiation factor activity;, P:cell cycle; P:cellular response to DNA damage stimulus; P:formation of translation preinitiation complex; P:IRES-dependent viral translational initiation; P:positive regulation of cell population proliferation; P:regulation of growth; P:ribosome disassembly; P:translation reinitiation; scaffold7 indexed_genome mRNA 1066153 1069114 . + . ID=transcript_1881;Q99612 B2RE86 B4DDN0 D3DRR1 F5H3M5 Q5VUT7 Q5VUT8 Q9BT79,Krueppel-like factor 6,B-cell-derived protein 1;Core promoter element-binding protein;GC-rich sites-binding factor GBF;Proto-oncogene BCD1;Suppressor of tumorigenicity 12 protein;Transcription factor Zf9;, PF00096;, GO:0000785;GO:0005829;GO:0001650;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0030183;GO:0045944;GO:0045893;GO:0006357;, C:chromatin; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:B cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q99612 B2RE86 B4DDN0 D3DRR1 F5H3M5 Q5VUT7 Q5VUT8 Q9BT79,Krueppel-like factor 6,B-cell-derived protein 1;Core promoter element-binding protein;GC-rich sites-binding factor GBF;Proto-oncogene BCD1;Suppressor of tumorigenicity 12 protein;Transcription factor Zf9;, PF00096;, GO:0000785;GO:0005829;GO:0001650;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0030183;GO:0045944;GO:0045893;GO:0006357;, C:chromatin; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:B cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q99612 B2RE86 B4DDN0 D3DRR1 F5H3M5 Q5VUT7 Q5VUT8 Q9BT79,Krueppel-like factor 6,B-cell-derived protein 1;Core promoter element-binding protein;GC-rich sites-binding factor GBF;Proto-oncogene BCD1;Suppressor of tumorigenicity 12 protein;Transcription factor Zf9;, PF00096;, GO:0000785;GO:0005829;GO:0001650;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0030183;GO:0045944;GO:0045893;GO:0006357;, C:chromatin; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:B cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold7 indexed_genome mRNA 1508542 1533950 . + . ID=transcript_1882;Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis;|Q7L5Z7 Q9BSI6 Q9BVJ5 Q9UPP8,Presequence protease, mitochondrial {ECO:0000305|PubMed:16849325},Pitrilysin metalloproteinase 1 {ECO:0000303|PubMed:10360838};, PF08367;PF00675;PF05193;, GO:0005759;GO:0005739;GO:0008047;GO:0004222;GO:0008237;GO:0008270;GO:0016485;GO:0006626;GO:0006508;, C:mitochondrial matrix; C:mitochondrion;, F:enzyme activator activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:protein processing; P:protein targeting to mitochondrion; P:proteolysis; scaffold7 indexed_genome mRNA 1533967 1591845 . - . ID=transcript_1883;Q01813 B3KS15 Q5VSR7 Q5VSR8,ATP-dependent 6-phosphofructokinase, platelet type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type C;Phosphofructo-1-kinase isozyme C;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0003872;GO:0016208;GO:0005524;GO:0045296;GO:0070095;GO:0042802;GO:0046872;GO:0048029;GO:0044877;GO:0061621;GO:1990830;GO:0030388;GO:0006002;, C:6-phosphofructokinase complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:cadherin binding; F:fructose-6-phosphate binding; F:identical protein binding; F:metal ion binding; F:monosaccharide binding; F:protein-containing complex binding;, P:canonical glycolysis; P:cellular response to leukemia inhibitory factor; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process;|Q01813 B3KS15 Q5VSR7 Q5VSR8,ATP-dependent 6-phosphofructokinase, platelet type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type C;Phosphofructo-1-kinase isozyme C;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0003872;GO:0016208;GO:0005524;GO:0045296;GO:0070095;GO:0042802;GO:0046872;GO:0048029;GO:0044877;GO:0061621;GO:1990830;GO:0030388;GO:0006002;, C:6-phosphofructokinase complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:cadherin binding; F:fructose-6-phosphate binding; F:identical protein binding; F:metal ion binding; F:monosaccharide binding; F:protein-containing complex binding;, P:canonical glycolysis; P:cellular response to leukemia inhibitory factor; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process;|Q01813 B3KS15 Q5VSR7 Q5VSR8,ATP-dependent 6-phosphofructokinase, platelet type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type C;Phosphofructo-1-kinase isozyme C;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0003872;GO:0016208;GO:0005524;GO:0045296;GO:0070095;GO:0042802;GO:0046872;GO:0048029;GO:0044877;GO:0061621;GO:1990830;GO:0030388;GO:0006002;, C:6-phosphofructokinase complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:cadherin binding; F:fructose-6-phosphate binding; F:identical protein binding; F:metal ion binding; F:monosaccharide binding; F:protein-containing complex binding;, P:canonical glycolysis; P:cellular response to leukemia inhibitory factor; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; scaffold7 indexed_genome mRNA 2622534 2629067 . + . ID=transcript_1884;Q9NS39 B2RPJ5 Q5VUT6 Q5VW42,Double-stranded RNA-specific editase B2,RNA-dependent adenosine deaminase 3;RNA-editing deaminase 2;RNA-editing enzyme 2;dsRNA adenosine deaminase B2;, PF02137;PF00035;, GO:0005737;GO:0005730;GO:0004000;GO:0003726;GO:0003725;GO:0046872;GO:0003723;GO:0003727;GO:0008251;GO:0006382;GO:0006397;GO:0006396;, C:cytoplasm; C:nucleolus;, F:adenosine deaminase activity; F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:metal ion binding; F:RNA binding; F:single-stranded RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:mRNA processing; P:RNA processing; scaffold7 indexed_genome mRNA 2649925 2675793 . + . ID=transcript_1885;Q9Y2I8 A8K976 D3DRQ7 Q5SW03 Q8WVG2 Q9NTJ6,WD repeat-containing protein 37,, PF00400;, GO:0005737;GO:0005634;GO:0030687;, C:cytoplasm; C:nucleus; C:preribosome, large subunit precursor;|Q9Y2I8 A8K976 D3DRQ7 Q5SW03 Q8WVG2 Q9NTJ6,WD repeat-containing protein 37,, PF00400;, GO:0005737;GO:0005634;GO:0030687;, C:cytoplasm; C:nucleus; C:preribosome, large subunit precursor;|Q9Y2I8 A8K976 D3DRQ7 Q5SW03 Q8WVG2 Q9NTJ6,WD repeat-containing protein 37,, PF00400;, GO:0005737;GO:0005634;GO:0030687;, C:cytoplasm; C:nucleus; C:preribosome, large subunit precursor;|Q9Y2I8 A8K976 D3DRQ7 Q5SW03 Q8WVG2 Q9NTJ6,WD repeat-containing protein 37,, PF00400;, GO:0005737;GO:0005634;GO:0030687;, C:cytoplasm; C:nucleus; C:preribosome, large subunit precursor;|Q9Y2I8 A8K976 D3DRQ7 Q5SW03 Q8WVG2 Q9NTJ6,WD repeat-containing protein 37,, PF00400;, GO:0005737;GO:0005634;GO:0030687;, C:cytoplasm; C:nucleus; C:preribosome, large subunit precursor;|Q9Y2I8 A8K976 D3DRQ7 Q5SW03 Q8WVG2 Q9NTJ6,WD repeat-containing protein 37,, PF00400;, GO:0005737;GO:0005634;GO:0030687;, C:cytoplasm; C:nucleus; C:preribosome, large subunit precursor; scaffold7 indexed_genome mRNA 2683830 2691903 . + . ID=transcript_1886;Q13907 B4E155 Q32Q13 Q53GQ6 Q86U81 Q8WUX8 Q96IZ4 Q9BQ74,Isopentenyl-diphosphate Delta-isomerase 1,Isopentenyl pyrophosphate isomerase 1;, PF00293;, GO:0005737;GO:0005829;GO:0005777;GO:0016787;GO:0004452;GO:0000287;GO:0030145;GO:0046872;GO:0006695;GO:0050992;GO:0009240;GO:0008299;GO:0019216;, C:cytoplasm; C:cytosol; C:peroxisome;, F:hydrolase activity; F:isopentenyl-diphosphate delta-isomerase activity; F:magnesium ion binding; F:manganese ion binding; F:metal ion binding;, P:cholesterol biosynthetic process; P:dimethylallyl diphosphate biosynthetic process; P:isopentenyl diphosphate biosynthetic process; P:isoprenoid biosynthetic process; P:regulation of lipid metabolic process;|Q13907 B4E155 Q32Q13 Q53GQ6 Q86U81 Q8WUX8 Q96IZ4 Q9BQ74,Isopentenyl-diphosphate Delta-isomerase 1,Isopentenyl pyrophosphate isomerase 1;, PF00293;, GO:0005737;GO:0005829;GO:0005777;GO:0016787;GO:0004452;GO:0000287;GO:0030145;GO:0046872;GO:0006695;GO:0050992;GO:0009240;GO:0008299;GO:0019216;, C:cytoplasm; C:cytosol; C:peroxisome;, F:hydrolase activity; F:isopentenyl-diphosphate delta-isomerase activity; F:magnesium ion binding; F:manganese ion binding; F:metal ion binding;, P:cholesterol biosynthetic process; P:dimethylallyl diphosphate biosynthetic process; P:isopentenyl diphosphate biosynthetic process; P:isoprenoid biosynthetic process; P:regulation of lipid metabolic process; scaffold7 indexed_genome mRNA 2693386 2707831 . - . ID=transcript_1887;Q9BZE4 B3KMC5 B4DY13 B7Z7A3 O95446 Q5T3R8 Q9NVJ8,Nucleolar GTP-binding protein 1,Chronic renal failure gene protein;GTP-binding protein NGB;, PF06858;PF17835;PF08155;, GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005525;GO:0003924;GO:0003723;GO:0000463;GO:0030336;GO:0008285;GO:0022408;GO:0033342;GO:0008156;GO:0031397;GO:0001649;GO:0050821;GO:0000079;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of collagen binding; P:negative regulation of DNA replication; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BZE4 B3KMC5 B4DY13 B7Z7A3 O95446 Q5T3R8 Q9NVJ8,Nucleolar GTP-binding protein 1,Chronic renal failure gene protein;GTP-binding protein NGB;, PF06858;PF17835;PF08155;, GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005525;GO:0003924;GO:0003723;GO:0000463;GO:0030336;GO:0008285;GO:0022408;GO:0033342;GO:0008156;GO:0031397;GO:0001649;GO:0050821;GO:0000079;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of collagen binding; P:negative regulation of DNA replication; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BZE4 B3KMC5 B4DY13 B7Z7A3 O95446 Q5T3R8 Q9NVJ8,Nucleolar GTP-binding protein 1,Chronic renal failure gene protein;GTP-binding protein NGB;, PF06858;PF17835;PF08155;, GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005525;GO:0003924;GO:0003723;GO:0000463;GO:0030336;GO:0008285;GO:0022408;GO:0033342;GO:0008156;GO:0031397;GO:0001649;GO:0050821;GO:0000079;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of collagen binding; P:negative regulation of DNA replication; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BZE4 B3KMC5 B4DY13 B7Z7A3 O95446 Q5T3R8 Q9NVJ8,Nucleolar GTP-binding protein 1,Chronic renal failure gene protein;GTP-binding protein NGB;, PF06858;PF17835;PF08155;, GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005525;GO:0003924;GO:0003723;GO:0000463;GO:0030336;GO:0008285;GO:0022408;GO:0033342;GO:0008156;GO:0031397;GO:0001649;GO:0050821;GO:0000079;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of collagen binding; P:negative regulation of DNA replication; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BZE4 B3KMC5 B4DY13 B7Z7A3 O95446 Q5T3R8 Q9NVJ8,Nucleolar GTP-binding protein 1,Chronic renal failure gene protein;GTP-binding protein NGB;, PF06858;PF17835;PF08155;, GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005525;GO:0003924;GO:0003723;GO:0000463;GO:0030336;GO:0008285;GO:0022408;GO:0033342;GO:0008156;GO:0031397;GO:0001649;GO:0050821;GO:0000079;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of collagen binding; P:negative regulation of DNA replication; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BZE4 B3KMC5 B4DY13 B7Z7A3 O95446 Q5T3R8 Q9NVJ8,Nucleolar GTP-binding protein 1,Chronic renal failure gene protein;GTP-binding protein NGB;, PF06858;PF17835;PF08155;, GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005525;GO:0003924;GO:0003723;GO:0000463;GO:0030336;GO:0008285;GO:0022408;GO:0033342;GO:0008156;GO:0031397;GO:0001649;GO:0050821;GO:0000079;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of collagen binding; P:negative regulation of DNA replication; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BZE4 B3KMC5 B4DY13 B7Z7A3 O95446 Q5T3R8 Q9NVJ8,Nucleolar GTP-binding protein 1,Chronic renal failure gene protein;GTP-binding protein NGB;, PF06858;PF17835;PF08155;, GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005525;GO:0003924;GO:0003723;GO:0000463;GO:0030336;GO:0008285;GO:0022408;GO:0033342;GO:0008156;GO:0031397;GO:0001649;GO:0050821;GO:0000079;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of collagen binding; P:negative regulation of DNA replication; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BZE4 B3KMC5 B4DY13 B7Z7A3 O95446 Q5T3R8 Q9NVJ8,Nucleolar GTP-binding protein 1,Chronic renal failure gene protein;GTP-binding protein NGB;, PF06858;PF17835;PF08155;, GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005525;GO:0003924;GO:0003723;GO:0000463;GO:0030336;GO:0008285;GO:0022408;GO:0033342;GO:0008156;GO:0031397;GO:0001649;GO:0050821;GO:0000079;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of collagen binding; P:negative regulation of DNA replication; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold7 indexed_genome mRNA 2786954 2841978 . + . ID=transcript_1888;Q92615 A7MD20 Q5T3R3 Q5T3R4 Q5T3R5 Q68CY4,La-related protein 4B,La ribonucleoprotein domain family member 4B;La ribonucleoprotein domain family member 5;La-related protein 5;, PF05383;, GO:0010494;GO:0005829;GO:0016020;GO:0005730;GO:0042788;GO:0003730;GO:0003723;GO:1905870;GO:0045727;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nucleolus; C:polysomal ribosome;, F:mRNA 3'-UTR binding; F:RNA binding;, P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:positive regulation of translation;|Q92615 A7MD20 Q5T3R3 Q5T3R4 Q5T3R5 Q68CY4,La-related protein 4B,La ribonucleoprotein domain family member 4B;La ribonucleoprotein domain family member 5;La-related protein 5;, PF05383;, GO:0010494;GO:0005829;GO:0016020;GO:0005730;GO:0042788;GO:0003730;GO:0003723;GO:1905870;GO:0045727;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nucleolus; C:polysomal ribosome;, F:mRNA 3'-UTR binding; F:RNA binding;, P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:positive regulation of translation;|Q92615 A7MD20 Q5T3R3 Q5T3R4 Q5T3R5 Q68CY4,La-related protein 4B,La ribonucleoprotein domain family member 4B;La ribonucleoprotein domain family member 5;La-related protein 5;, PF05383;, GO:0010494;GO:0005829;GO:0016020;GO:0005730;GO:0042788;GO:0003730;GO:0003723;GO:1905870;GO:0045727;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nucleolus; C:polysomal ribosome;, F:mRNA 3'-UTR binding; F:RNA binding;, P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:positive regulation of translation;|Q92615 A7MD20 Q5T3R3 Q5T3R4 Q5T3R5 Q68CY4,La-related protein 4B,La ribonucleoprotein domain family member 4B;La ribonucleoprotein domain family member 5;La-related protein 5;, PF05383;, GO:0010494;GO:0005829;GO:0016020;GO:0005730;GO:0042788;GO:0003730;GO:0003723;GO:1905870;GO:0045727;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nucleolus; C:polysomal ribosome;, F:mRNA 3'-UTR binding; F:RNA binding;, P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:positive regulation of translation;|Q92615 A7MD20 Q5T3R3 Q5T3R4 Q5T3R5 Q68CY4,La-related protein 4B,La ribonucleoprotein domain family member 4B;La ribonucleoprotein domain family member 5;La-related protein 5;, PF05383;, GO:0010494;GO:0005829;GO:0016020;GO:0005730;GO:0042788;GO:0003730;GO:0003723;GO:1905870;GO:0045727;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nucleolus; C:polysomal ribosome;, F:mRNA 3'-UTR binding; F:RNA binding;, P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:positive regulation of translation; scaffold7 indexed_genome mRNA 3034360 3174078 . + . ID=transcript_1889;Q9Y2E4 B4DPI5 Q5SS78,Disco-interacting protein 2 homolog C,, PF00501;PF06464;|Q9Y2E4 B4DPI5 Q5SS78,Disco-interacting protein 2 homolog C,, PF00501;PF06464; scaffold7 indexed_genome mRNA 3185783 3226286 . - . ID=transcript_1890;Q8N4B3,Zinc finger MYND domain-containing protein 11 {ECO:0000305},Adenovirus 5 E1A-binding protein;Bone morphogenetic protein receptor-associated molecule 1;Protein BS69;, PF00439;PF00855;, GO:0005694;GO:0005654;GO:0005634;GO:0003690;GO:0035064;GO:0003714;GO:0008270;GO:0007049;GO:0006325;GO:0051607;GO:2001237;GO:0043124;GO:0046329;GO:0045892;GO:0034243;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:methylated histone binding; F:transcription corepressor activity; F:zinc ion binding;, P:cell cycle; P:chromatin organization; P:defense response to virus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription, DNA-templated; P:regulation of transcription elongation from RNA polymerase II promoter; P:viral process;|Q8N4B3,Zinc finger MYND domain-containing protein 11 {ECO:0000305},Adenovirus 5 E1A-binding protein;Bone morphogenetic protein receptor-associated molecule 1;Protein BS69;, PF00439;PF00855;, GO:0005694;GO:0005654;GO:0005634;GO:0003690;GO:0035064;GO:0003714;GO:0008270;GO:0007049;GO:0006325;GO:0051607;GO:2001237;GO:0043124;GO:0046329;GO:0045892;GO:0034243;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:methylated histone binding; F:transcription corepressor activity; F:zinc ion binding;, P:cell cycle; P:chromatin organization; P:defense response to virus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription, DNA-templated; P:regulation of transcription elongation from RNA polymerase II promoter; P:viral process;|Q8N4B3,Zinc finger MYND domain-containing protein 11 {ECO:0000305},Adenovirus 5 E1A-binding protein;Bone morphogenetic protein receptor-associated molecule 1;Protein BS69;, PF00439;PF00855;, GO:0005694;GO:0005654;GO:0005634;GO:0003690;GO:0035064;GO:0003714;GO:0008270;GO:0007049;GO:0006325;GO:0051607;GO:2001237;GO:0043124;GO:0046329;GO:0045892;GO:0034243;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:methylated histone binding; F:transcription corepressor activity; F:zinc ion binding;, P:cell cycle; P:chromatin organization; P:defense response to virus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription, DNA-templated; P:regulation of transcription elongation from RNA polymerase II promoter; P:viral process;|Q8N4B3,Zinc finger MYND domain-containing protein 11 {ECO:0000305},Adenovirus 5 E1A-binding protein;Bone morphogenetic protein receptor-associated molecule 1;Protein BS69;, PF00439;PF00855;, GO:0005694;GO:0005654;GO:0005634;GO:0003690;GO:0035064;GO:0003714;GO:0008270;GO:0007049;GO:0006325;GO:0051607;GO:2001237;GO:0043124;GO:0046329;GO:0045892;GO:0034243;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:methylated histone binding; F:transcription corepressor activity; F:zinc ion binding;, P:cell cycle; P:chromatin organization; P:defense response to virus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription, DNA-templated; P:regulation of transcription elongation from RNA polymerase II promoter; P:viral process;|Q8N4B3,Zinc finger MYND domain-containing protein 11 {ECO:0000305},Adenovirus 5 E1A-binding protein;Bone morphogenetic protein receptor-associated molecule 1;Protein BS69;, PF00439;PF00855;, GO:0005694;GO:0005654;GO:0005634;GO:0003690;GO:0035064;GO:0003714;GO:0008270;GO:0007049;GO:0006325;GO:0051607;GO:2001237;GO:0043124;GO:0046329;GO:0045892;GO:0034243;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:methylated histone binding; F:transcription corepressor activity; F:zinc ion binding;, P:cell cycle; P:chromatin organization; P:defense response to virus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription, DNA-templated; P:regulation of transcription elongation from RNA polymerase II promoter; P:viral process;|Q8N4B3,Zinc finger MYND domain-containing protein 11 {ECO:0000305},Adenovirus 5 E1A-binding protein;Bone morphogenetic protein receptor-associated molecule 1;Protein BS69;, PF00439;PF00855;, GO:0005694;GO:0005654;GO:0005634;GO:0003690;GO:0035064;GO:0003714;GO:0008270;GO:0007049;GO:0006325;GO:0051607;GO:2001237;GO:0043124;GO:0046329;GO:0045892;GO:0034243;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:methylated histone binding; F:transcription corepressor activity; F:zinc ion binding;, P:cell cycle; P:chromatin organization; P:defense response to virus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription, DNA-templated; P:regulation of transcription elongation from RNA polymerase II promoter; P:viral process;|Q8N4B3,Zinc finger MYND domain-containing protein 11 {ECO:0000305},Adenovirus 5 E1A-binding protein;Bone morphogenetic protein receptor-associated molecule 1;Protein BS69;, PF00439;PF00855;, GO:0005694;GO:0005654;GO:0005634;GO:0003690;GO:0035064;GO:0003714;GO:0008270;GO:0007049;GO:0006325;GO:0051607;GO:2001237;GO:0043124;GO:0046329;GO:0045892;GO:0034243;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:methylated histone binding; F:transcription corepressor activity; F:zinc ion binding;, P:cell cycle; P:chromatin organization; P:defense response to virus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription, DNA-templated; P:regulation of transcription elongation from RNA polymerase II promoter; P:viral process;|Q8N4B3,Zinc finger MYND domain-containing protein 11 {ECO:0000305},Adenovirus 5 E1A-binding protein;Bone morphogenetic protein receptor-associated molecule 1;Protein BS69;, PF00439;PF00855;, GO:0005694;GO:0005654;GO:0005634;GO:0003690;GO:0035064;GO:0003714;GO:0008270;GO:0007049;GO:0006325;GO:0051607;GO:2001237;GO:0043124;GO:0046329;GO:0045892;GO:0034243;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:methylated histone binding; F:transcription corepressor activity; F:zinc ion binding;, P:cell cycle; P:chromatin organization; P:defense response to virus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription, DNA-templated; P:regulation of transcription elongation from RNA polymerase II promoter; P:viral process; scaffold7 indexed_genome mRNA 3411737 3433002 . + . ID=transcript_1891;Q9UP19,Major prion protein,ASCR;PrP27-30;PrP33-35C;, PF00377;PF11587;, GO:0031362;GO:0009986;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0019898;GO:0005794;GO:0016234;GO:0043231;GO:0045121;GO:0031965;GO:0005634;GO:0005886;GO:0098794;GO:0014069;GO:0001540;GO:0019828;GO:0005509;GO:0005507;GO:1903136;GO:0005539;GO:0042802;GO:0008017;GO:0002020;GO:0044877;GO:0038023;GO:0015631;GO:0031802;GO:0035584;GO:0007050;GO:0006878;GO:1904646;GO:0071280;GO:0097062;GO:0007611;GO:0007616;GO:0090647;GO:0046007;GO:1902992;GO:1902430;GO:0070885;GO:1902951;GO:0043433;GO:0032689;GO:0032700;GO:0032703;GO:0001933;GO:0010955;GO:0050860;GO:1990535;GO:0043525;GO:1901216;GO:0050731;GO:0090314;GO:0061098;GO:0031648;GO:0051260;GO:0045048;GO:1905664;GO:1900449;GO:1902938;GO:0050730;GO:1904645;GO:0006979;, C:anchored component of external side of plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:extrinsic component of membrane; C:Golgi apparatus; C:inclusion body; C:intracellular membrane-bounded organelle; C:membrane raft; C:nuclear membrane; C:nucleus; C:plasma membrane; C:postsynapse; C:postsynaptic density;, F:amyloid-beta binding; F:aspartic-type endopeptidase inhibitor activity; F:calcium ion binding; F:copper ion binding; F:cuprous ion binding; F:glycosaminoglycan binding; F:identical protein binding; F:microtubule binding; F:protease binding; F:protein-containing complex binding; F:signaling receptor activity; F:tubulin binding; F:type 5 metabotropic glutamate receptor binding;, P:calcium-mediated signaling using intracellular calcium source; P:cell cycle arrest; P:cellular copper ion homeostasis; P:cellular response to amyloid-beta; P:cellular response to copper ion; P:dendritic spine maintenance; P:learning or memory; P:long-term memory; P:modulation of age-related behavioral decline; P:negative regulation of activated T cell proliferation; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of amyloid-beta formation; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of dendritic spine maintenance; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-2 production; P:negative regulation of protein phosphorylation; P:negative regulation of protein processing; P:negative regulation of T cell receptor signaling pathway; P:neuron projection maintenance; P:positive regulation of neuron apoptotic process; P:positive regulation of neuron death; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of protein tyrosine kinase activity; P:protein destabilization; P:protein homooligomerization; P:protein insertion into ER membrane; P:regulation of calcium ion import across plasma membrane; P:regulation of glutamate receptor signaling pathway; P:regulation of intracellular calcium activated chloride channel activity; P:regulation of peptidyl-tyrosine phosphorylation; P:response to amyloid-beta; P:response to oxidative stress;|Q9UP19,Major prion protein,ASCR;PrP27-30;PrP33-35C;, PF00377;PF11587;, GO:0031362;GO:0009986;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0019898;GO:0005794;GO:0016234;GO:0043231;GO:0045121;GO:0031965;GO:0005634;GO:0005886;GO:0098794;GO:0014069;GO:0001540;GO:0019828;GO:0005509;GO:0005507;GO:1903136;GO:0005539;GO:0042802;GO:0008017;GO:0002020;GO:0044877;GO:0038023;GO:0015631;GO:0031802;GO:0035584;GO:0007050;GO:0006878;GO:1904646;GO:0071280;GO:0097062;GO:0007611;GO:0007616;GO:0090647;GO:0046007;GO:1902992;GO:1902430;GO:0070885;GO:1902951;GO:0043433;GO:0032689;GO:0032700;GO:0032703;GO:0001933;GO:0010955;GO:0050860;GO:1990535;GO:0043525;GO:1901216;GO:0050731;GO:0090314;GO:0061098;GO:0031648;GO:0051260;GO:0045048;GO:1905664;GO:1900449;GO:1902938;GO:0050730;GO:1904645;GO:0006979;, C:anchored component of external side of plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:extrinsic component of membrane; C:Golgi apparatus; C:inclusion body; C:intracellular membrane-bounded organelle; C:membrane raft; C:nuclear membrane; C:nucleus; C:plasma membrane; C:postsynapse; C:postsynaptic density;, F:amyloid-beta binding; F:aspartic-type endopeptidase inhibitor activity; F:calcium ion binding; F:copper ion binding; F:cuprous ion binding; F:glycosaminoglycan binding; F:identical protein binding; F:microtubule binding; F:protease binding; F:protein-containing complex binding; F:signaling receptor activity; F:tubulin binding; F:type 5 metabotropic glutamate receptor binding;, P:calcium-mediated signaling using intracellular calcium source; P:cell cycle arrest; P:cellular copper ion homeostasis; P:cellular response to amyloid-beta; P:cellular response to copper ion; P:dendritic spine maintenance; P:learning or memory; P:long-term memory; P:modulation of age-related behavioral decline; P:negative regulation of activated T cell proliferation; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of amyloid-beta formation; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of dendritic spine maintenance; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-2 production; P:negative regulation of protein phosphorylation; P:negative regulation of protein processing; P:negative regulation of T cell receptor signaling pathway; P:neuron projection maintenance; P:positive regulation of neuron apoptotic process; P:positive regulation of neuron death; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of protein tyrosine kinase activity; P:protein destabilization; P:protein homooligomerization; P:protein insertion into ER membrane; P:regulation of calcium ion import across plasma membrane; P:regulation of glutamate receptor signaling pathway; P:regulation of intracellular calcium activated chloride channel activity; P:regulation of peptidyl-tyrosine phosphorylation; P:response to amyloid-beta; P:response to oxidative stress; scaffold7 indexed_genome mRNA 3499332 3553000 . - . ID=transcript_1892;P50749 A6NIX9 A8K5Z3 Q17S06 Q53HD0 Q6AHZ2 Q8IZA5,Ras association domain-containing protein 2,, PF16517;PF00788;, GO:0000777;GO:0005737;GO:0005829;GO:0005794;GO:0000776;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0004672;GO:0046849;GO:0007049;GO:0038168;GO:0048872;GO:1901223;GO:0033137;GO:0001503;GO:0043065;GO:0046330;GO:0031954;GO:0045860;GO:0050821;GO:1901222;GO:0045667;GO:0045670;GO:0007165;GO:0001501;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:kinetochore; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:protein kinase activity;, P:bone remodeling; P:cell cycle; P:epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade; P:homeostasis of number of cells; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of peptidyl-serine phosphorylation; P:ossification; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase activity; P:protein stabilization; P:regulation of NIK/NF-kappaB signaling; P:regulation of osteoblast differentiation; P:regulation of osteoclast differentiation; P:signal transduction; P:skeletal system development; scaffold7 indexed_genome mRNA 3583577 3725706 . - . ID=transcript_1893;Q9UGH3 B4DJZ1 Q8WWR4 Q92512 Q96D54 Q9UNU1 Q9UP85,Solute carrier family 23 member 2,Na(+)/L-ascorbic acid transporter 2;Nucleobase transporter-like 1 protein;Sodium-dependent vitamin C transporter 2;Yolk sac permease-like molecule 2;, PF00860;, GO:0016324;GO:0009925;GO:0016323;GO:0005737;GO:0016021;GO:0005887;GO:0005886;GO:0008520;GO:0015229;GO:0071361;GO:0019852;GO:0015882;GO:1901215;GO:1903861;GO:0006979;GO:0070904;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:L-ascorbate:sodium symporter activity; F:L-ascorbic acid transmembrane transporter activity;, P:cellular response to ethanol; P:L-ascorbic acid metabolic process; P:L-ascorbic acid transmembrane transport; P:negative regulation of neuron death; P:positive regulation of dendrite extension; P:response to oxidative stress; P:transepithelial L-ascorbic acid transport;|Q9UGH3 B4DJZ1 Q8WWR4 Q92512 Q96D54 Q9UNU1 Q9UP85,Solute carrier family 23 member 2,Na(+)/L-ascorbic acid transporter 2;Nucleobase transporter-like 1 protein;Sodium-dependent vitamin C transporter 2;Yolk sac permease-like molecule 2;, PF00860;, GO:0016324;GO:0009925;GO:0016323;GO:0005737;GO:0016021;GO:0005887;GO:0005886;GO:0008520;GO:0015229;GO:0071361;GO:0019852;GO:0015882;GO:1901215;GO:1903861;GO:0006979;GO:0070904;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:L-ascorbate:sodium symporter activity; F:L-ascorbic acid transmembrane transporter activity;, P:cellular response to ethanol; P:L-ascorbic acid metabolic process; P:L-ascorbic acid transmembrane transport; P:negative regulation of neuron death; P:positive regulation of dendrite extension; P:response to oxidative stress; P:transepithelial L-ascorbic acid transport; scaffold7 indexed_genome mRNA 3818838 3827845 . - . ID=transcript_1894;Q96A57 B2RDM8 D3DVZ9 Q0VGC8 Q5TDS5 Q96ES2 Q9P0A7,Transmembrane protein 230,, PF05915;, GO:0005776;GO:0005769;GO:0005783;GO:0016021;GO:0005770;GO:0055037;GO:0008021;GO:0005802;GO:0048489;, C:autophagosome; C:early endosome; C:endoplasmic reticulum; C:integral component of membrane; C:late endosome; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, , P:synaptic vesicle transport;|Q96A57 B2RDM8 D3DVZ9 Q0VGC8 Q5TDS5 Q96ES2 Q9P0A7,Transmembrane protein 230,, PF05915;, GO:0005776;GO:0005769;GO:0005783;GO:0016021;GO:0005770;GO:0055037;GO:0008021;GO:0005802;GO:0048489;, C:autophagosome; C:early endosome; C:endoplasmic reticulum; C:integral component of membrane; C:late endosome; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, , P:synaptic vesicle transport;|Q96A57 B2RDM8 D3DVZ9 Q0VGC8 Q5TDS5 Q96ES2 Q9P0A7,Transmembrane protein 230,, PF05915;, GO:0005776;GO:0005769;GO:0005783;GO:0016021;GO:0005770;GO:0055037;GO:0008021;GO:0005802;GO:0048489;, C:autophagosome; C:early endosome; C:endoplasmic reticulum; C:integral component of membrane; C:late endosome; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, , P:synaptic vesicle transport;|Q96A57 B2RDM8 D3DVZ9 Q0VGC8 Q5TDS5 Q96ES2 Q9P0A7,Transmembrane protein 230,, PF05915;, GO:0005776;GO:0005769;GO:0005783;GO:0016021;GO:0005770;GO:0055037;GO:0008021;GO:0005802;GO:0048489;, C:autophagosome; C:early endosome; C:endoplasmic reticulum; C:integral component of membrane; C:late endosome; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, , P:synaptic vesicle transport;|Q96A57 B2RDM8 D3DVZ9 Q0VGC8 Q5TDS5 Q96ES2 Q9P0A7,Transmembrane protein 230,, PF05915;, GO:0005776;GO:0005769;GO:0005783;GO:0016021;GO:0005770;GO:0055037;GO:0008021;GO:0005802;GO:0048489;, C:autophagosome; C:early endosome; C:endoplasmic reticulum; C:integral component of membrane; C:late endosome; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, , P:synaptic vesicle transport; scaffold7 indexed_genome mRNA 3828966 3834098 . - . ID=transcript_1895;P12004 B2R897 D3DW02,Proliferating cell nuclear antigen,Cyclin;, PF02747;PF00705;, GO:0005813;GO:0000785;GO:0000781;GO:0000307;GO:0070062;GO:0016604;GO:0005652;GO:0043596;GO:0005654;GO:0005634;GO:0043626;GO:0070557;GO:0005657;GO:0030894;GO:0003682;GO:0003684;GO:0032139;GO:0070182;GO:0030337;GO:0019899;GO:0030331;GO:0035035;GO:0042802;GO:0032405;GO:0008022;GO:0044877;GO:0000701;GO:0030971;GO:0006287;GO:0070301;GO:0034644;GO:0071466;GO:0042769;GO:0006977;GO:0030855;GO:0070987;GO:0042276;GO:0044849;GO:0007507;GO:0006272;GO:0097421;GO:0006298;GO:1902990;GO:0000122;GO:0006297;GO:0033683;GO:0006296;GO:0032077;GO:0045739;GO:0045740;GO:1900264;GO:0016567;GO:0000083;GO:0031297;GO:0046686;GO:0071548;GO:0032355;GO:1902065;GO:0000723;GO:0032201;GO:0006283;GO:0019985;GO:0016032;, C:centrosome; C:chromatin; C:chromosome, telomeric region; C:cyclin-dependent protein kinase holoenzyme complex; C:extracellular exosome; C:nuclear body; C:nuclear lamina; C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:PCNA complex; C:PCNA-p21 complex; C:replication fork; C:replisome;, F:chromatin binding; F:damaged DNA binding; F:dinucleotide insertion or deletion binding; F:DNA polymerase binding; F:DNA polymerase processivity factor activity; F:enzyme binding; F:estrogen receptor binding; F:histone acetyltransferase binding; F:identical protein binding; F:MutLalpha complex binding; F:protein C-terminus binding; F:protein-containing complex binding; F:purine-specific mismatch base pair DNA N-glycosylase activity; F:receptor tyrosine kinase binding;, P:base-excision repair, gap-filling; P:cellular response to hydrogen peroxide; P:cellular response to UV; P:cellular response to xenobiotic stimulus; P:DNA damage response, detection of DNA damage; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epithelial cell differentiation; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:estrous cycle; P:heart development; P:leading strand elongation; P:liver regeneration; P:mismatch repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of deoxyribonuclease activity; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA-directed DNA polymerase activity; P:protein ubiquitination; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:replication fork processing; P:response to cadmium ion; P:response to dexamethasone; P:response to estradiol; P:response to L-glutamate; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; P:viral process;|P12004 B2R897 D3DW02,Proliferating cell nuclear antigen,Cyclin;, PF02747;PF00705;, GO:0005813;GO:0000785;GO:0000781;GO:0000307;GO:0070062;GO:0016604;GO:0005652;GO:0043596;GO:0005654;GO:0005634;GO:0043626;GO:0070557;GO:0005657;GO:0030894;GO:0003682;GO:0003684;GO:0032139;GO:0070182;GO:0030337;GO:0019899;GO:0030331;GO:0035035;GO:0042802;GO:0032405;GO:0008022;GO:0044877;GO:0000701;GO:0030971;GO:0006287;GO:0070301;GO:0034644;GO:0071466;GO:0042769;GO:0006977;GO:0030855;GO:0070987;GO:0042276;GO:0044849;GO:0007507;GO:0006272;GO:0097421;GO:0006298;GO:1902990;GO:0000122;GO:0006297;GO:0033683;GO:0006296;GO:0032077;GO:0045739;GO:0045740;GO:1900264;GO:0016567;GO:0000083;GO:0031297;GO:0046686;GO:0071548;GO:0032355;GO:1902065;GO:0000723;GO:0032201;GO:0006283;GO:0019985;GO:0016032;, C:centrosome; C:chromatin; C:chromosome, telomeric region; C:cyclin-dependent protein kinase holoenzyme complex; C:extracellular exosome; C:nuclear body; C:nuclear lamina; C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:PCNA complex; C:PCNA-p21 complex; C:replication fork; C:replisome;, F:chromatin binding; F:damaged DNA binding; F:dinucleotide insertion or deletion binding; F:DNA polymerase binding; F:DNA polymerase processivity factor activity; F:enzyme binding; F:estrogen receptor binding; F:histone acetyltransferase binding; F:identical protein binding; F:MutLalpha complex binding; F:protein C-terminus binding; F:protein-containing complex binding; F:purine-specific mismatch base pair DNA N-glycosylase activity; F:receptor tyrosine kinase binding;, P:base-excision repair, gap-filling; P:cellular response to hydrogen peroxide; P:cellular response to UV; P:cellular response to xenobiotic stimulus; P:DNA damage response, detection of DNA damage; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epithelial cell differentiation; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:estrous cycle; P:heart development; P:leading strand elongation; P:liver regeneration; P:mismatch repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of deoxyribonuclease activity; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA-directed DNA polymerase activity; P:protein ubiquitination; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:replication fork processing; P:response to cadmium ion; P:response to dexamethasone; P:response to estradiol; P:response to L-glutamate; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; P:viral process;|P12004 B2R897 D3DW02,Proliferating cell nuclear antigen,Cyclin;, PF02747;PF00705;, GO:0005813;GO:0000785;GO:0000781;GO:0000307;GO:0070062;GO:0016604;GO:0005652;GO:0043596;GO:0005654;GO:0005634;GO:0043626;GO:0070557;GO:0005657;GO:0030894;GO:0003682;GO:0003684;GO:0032139;GO:0070182;GO:0030337;GO:0019899;GO:0030331;GO:0035035;GO:0042802;GO:0032405;GO:0008022;GO:0044877;GO:0000701;GO:0030971;GO:0006287;GO:0070301;GO:0034644;GO:0071466;GO:0042769;GO:0006977;GO:0030855;GO:0070987;GO:0042276;GO:0044849;GO:0007507;GO:0006272;GO:0097421;GO:0006298;GO:1902990;GO:0000122;GO:0006297;GO:0033683;GO:0006296;GO:0032077;GO:0045739;GO:0045740;GO:1900264;GO:0016567;GO:0000083;GO:0031297;GO:0046686;GO:0071548;GO:0032355;GO:1902065;GO:0000723;GO:0032201;GO:0006283;GO:0019985;GO:0016032;, C:centrosome; C:chromatin; C:chromosome, telomeric region; C:cyclin-dependent protein kinase holoenzyme complex; C:extracellular exosome; C:nuclear body; C:nuclear lamina; C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:PCNA complex; C:PCNA-p21 complex; C:replication fork; C:replisome;, F:chromatin binding; F:damaged DNA binding; F:dinucleotide insertion or deletion binding; F:DNA polymerase binding; F:DNA polymerase processivity factor activity; F:enzyme binding; F:estrogen receptor binding; F:histone acetyltransferase binding; F:identical protein binding; F:MutLalpha complex binding; F:protein C-terminus binding; F:protein-containing complex binding; F:purine-specific mismatch base pair DNA N-glycosylase activity; F:receptor tyrosine kinase binding;, P:base-excision repair, gap-filling; P:cellular response to hydrogen peroxide; P:cellular response to UV; P:cellular response to xenobiotic stimulus; P:DNA damage response, detection of DNA damage; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epithelial cell differentiation; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:estrous cycle; P:heart development; P:leading strand elongation; P:liver regeneration; P:mismatch repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of deoxyribonuclease activity; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA-directed DNA polymerase activity; P:protein ubiquitination; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:replication fork processing; P:response to cadmium ion; P:response to dexamethasone; P:response to estradiol; P:response to L-glutamate; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; P:viral process; scaffold7 indexed_genome mRNA 3839725 3907915 . + . ID=transcript_1896;O95674 B2RDC6 D3DW04 Q5TDY2 Q5TDY3 Q5TDY4 Q5TDY5 Q9BYK5 Q9NTT2,Phosphatidate cytidylyltransferase 2 {ECO:0000305},CDP-DAG synthase 2;CDP-DG synthase 2;CDP-diacylglycerol synthase 2;CDP-diglyceride pyrophosphorylase 2;CDP-diglyceride synthase 2;CTP:phosphatidate cytidylyltransferase 2;, , GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005743;GO:0004605;GO:0016024;GO:0140042;GO:0006655;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial inner membrane;, F:phosphatidate cytidylyltransferase activity;, P:CDP-diacylglycerol biosynthetic process; P:lipid droplet formation; P:phosphatidylglycerol biosynthetic process;|O95674 B2RDC6 D3DW04 Q5TDY2 Q5TDY3 Q5TDY4 Q5TDY5 Q9BYK5 Q9NTT2,Phosphatidate cytidylyltransferase 2 {ECO:0000305},CDP-DAG synthase 2;CDP-DG synthase 2;CDP-diacylglycerol synthase 2;CDP-diglyceride pyrophosphorylase 2;CDP-diglyceride synthase 2;CTP:phosphatidate cytidylyltransferase 2;, , GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005743;GO:0004605;GO:0016024;GO:0140042;GO:0006655;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial inner membrane;, F:phosphatidate cytidylyltransferase activity;, P:CDP-diacylglycerol biosynthetic process; P:lipid droplet formation; P:phosphatidylglycerol biosynthetic process;|O95674 B2RDC6 D3DW04 Q5TDY2 Q5TDY3 Q5TDY4 Q5TDY5 Q9BYK5 Q9NTT2,Phosphatidate cytidylyltransferase 2 {ECO:0000305},CDP-DAG synthase 2;CDP-DG synthase 2;CDP-diacylglycerol synthase 2;CDP-diglyceride pyrophosphorylase 2;CDP-diglyceride synthase 2;CTP:phosphatidate cytidylyltransferase 2;, , GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005743;GO:0004605;GO:0016024;GO:0140042;GO:0006655;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial inner membrane;, F:phosphatidate cytidylyltransferase activity;, P:CDP-diacylglycerol biosynthetic process; P:lipid droplet formation; P:phosphatidylglycerol biosynthetic process;|Q6R2W3 Q2NKL9 Q5SRJ3 Q8TCN2 Q96MV9 Q96PW3,SCAN domain-containing protein 3,Transposon-derived Buster4 transposase-like protein;Zinc finger BED domain-containing protein 9;, PF02023;, GO:0005737;GO:0005634;GO:0003676;GO:0015074;GO:0045787;GO:0050679;, C:cytoplasm; C:nucleus;, F:nucleic acid binding;, P:DNA integration; P:positive regulation of cell cycle; P:positive regulation of epithelial cell proliferation;|O95674 B2RDC6 D3DW04 Q5TDY2 Q5TDY3 Q5TDY4 Q5TDY5 Q9BYK5 Q9NTT2,Phosphatidate cytidylyltransferase 2 {ECO:0000305},CDP-DAG synthase 2;CDP-DG synthase 2;CDP-diacylglycerol synthase 2;CDP-diglyceride pyrophosphorylase 2;CDP-diglyceride synthase 2;CTP:phosphatidate cytidylyltransferase 2;, , GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005743;GO:0004605;GO:0016024;GO:0140042;GO:0006655;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial inner membrane;, F:phosphatidate cytidylyltransferase activity;, P:CDP-diacylglycerol biosynthetic process; P:lipid droplet formation; P:phosphatidylglycerol biosynthetic process; scaffold7 indexed_genome mRNA 3971916 3984617 . - . ID=transcript_1897;Q8NFJ6 A5JUU1 Q2M3C0 Q5TDY1 Q9NTT0,Prokineticin receptor 2,G-protein coupled receptor 73-like 1;G-protein coupled receptor I5E;GPR73b;GPRg2;, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0004983;GO:0007623;GO:0007186;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:neuropeptide Y receptor activity;, P:circadian rhythm; P:G protein-coupled receptor signaling pathway;|Q8NFJ6 A5JUU1 Q2M3C0 Q5TDY1 Q9NTT0,Prokineticin receptor 2,G-protein coupled receptor 73-like 1;G-protein coupled receptor I5E;GPR73b;GPRg2;, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0004983;GO:0007623;GO:0007186;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:neuropeptide Y receptor activity;, P:circadian rhythm; P:G protein-coupled receptor signaling pathway;|Q8NFJ6 A5JUU1 Q2M3C0 Q5TDY1 Q9NTT0,Prokineticin receptor 2,G-protein coupled receptor 73-like 1;G-protein coupled receptor I5E;GPR73b;GPRg2;, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0004983;GO:0007623;GO:0007186;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:neuropeptide Y receptor activity;, P:circadian rhythm; P:G protein-coupled receptor signaling pathway;|Q8NFJ6 A5JUU1 Q2M3C0 Q5TDY1 Q9NTT0,Prokineticin receptor 2,G-protein coupled receptor 73-like 1;G-protein coupled receptor I5E;GPR73b;GPRg2;, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0004983;GO:0007623;GO:0007186;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:neuropeptide Y receptor activity;, P:circadian rhythm; P:G protein-coupled receptor signaling pathway; scaffold7 indexed_genome mRNA 4197985 4261839 . - . ID=transcript_1898;Q9NPB8 D3DW06 Q9BQL8 Q9NUX0,Glycerophosphocholine phosphodiesterase GPCPD1,Glycerophosphodiester phosphodiesterase 5;, PF00686;PF03009;, GO:0005829;GO:0047389;GO:2001070;GO:0046475;GO:0007519;, C:cytosol;, F:glycerophosphocholine phosphodiesterase activity; F:starch binding;, P:glycerophospholipid catabolic process; P:skeletal muscle tissue development;|Q9NPB8 D3DW06 Q9BQL8 Q9NUX0,Glycerophosphocholine phosphodiesterase GPCPD1,Glycerophosphodiester phosphodiesterase 5;, PF00686;PF03009;, GO:0005829;GO:0047389;GO:2001070;GO:0046475;GO:0007519;, C:cytosol;, F:glycerophosphocholine phosphodiesterase activity; F:starch binding;, P:glycerophospholipid catabolic process; P:skeletal muscle tissue development;|Q9NPB8 D3DW06 Q9BQL8 Q9NUX0,Glycerophosphocholine phosphodiesterase GPCPD1,Glycerophosphodiester phosphodiesterase 5;, PF00686;PF03009;, GO:0005829;GO:0047389;GO:2001070;GO:0046475;GO:0007519;, C:cytosol;, F:glycerophosphocholine phosphodiesterase activity; F:starch binding;, P:glycerophospholipid catabolic process; P:skeletal muscle tissue development;|Q9NPB8 D3DW06 Q9BQL8 Q9NUX0,Glycerophosphocholine phosphodiesterase GPCPD1,Glycerophosphodiester phosphodiesterase 5;, PF00686;PF03009;, GO:0005829;GO:0047389;GO:2001070;GO:0046475;GO:0007519;, C:cytosol;, F:glycerophosphocholine phosphodiesterase activity; F:starch binding;, P:glycerophospholipid catabolic process; P:skeletal muscle tissue development;|Q9NPB8 D3DW06 Q9BQL8 Q9NUX0,Glycerophosphocholine phosphodiesterase GPCPD1,Glycerophosphodiester phosphodiesterase 5;, PF00686;PF03009;, GO:0005829;GO:0047389;GO:2001070;GO:0046475;GO:0007519;, C:cytosol;, F:glycerophosphocholine phosphodiesterase activity; F:starch binding;, P:glycerophospholipid catabolic process; P:skeletal muscle tissue development;|Q9NPB8 D3DW06 Q9BQL8 Q9NUX0,Glycerophosphocholine phosphodiesterase GPCPD1,Glycerophosphodiester phosphodiesterase 5;, PF00686;PF03009;, GO:0005829;GO:0047389;GO:2001070;GO:0046475;GO:0007519;, C:cytosol;, F:glycerophosphocholine phosphodiesterase activity; F:starch binding;, P:glycerophospholipid catabolic process; P:skeletal muscle tissue development;|Q9NPB8 D3DW06 Q9BQL8 Q9NUX0,Glycerophosphocholine phosphodiesterase GPCPD1,Glycerophosphodiester phosphodiesterase 5;, PF00686;PF03009;, GO:0005829;GO:0047389;GO:2001070;GO:0046475;GO:0007519;, C:cytosol;, F:glycerophosphocholine phosphodiesterase activity; F:starch binding;, P:glycerophospholipid catabolic process; P:skeletal muscle tissue development; scaffold7 indexed_genome mRNA 4398454 4494421 . + . ID=transcript_1899;Q8IYI0 A8K9J3 Q5TGA9 Q96LU1,Shieldin complex subunit 1 {ECO:0000312|HGNC:HGNC:26318},RINN1-REV7-interacting novel NHEJ regulator 3 {ECO:0000303|PubMed:29656893};Shield complex subunit 1;, PF15021;, GO:0005694;GO:0035861;GO:0006281;GO:2000042;GO:2001034;GO:0045830;, C:chromosome; C:site of double-strand break;, , P:DNA repair; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching; scaffold7 indexed_genome mRNA 4531759 4546943 . + . ID=transcript_1900;P05060 A8K021 Q59EU9 Q6IBS6 Q9BQV6 Q9UC25 Q9UJA6,Secretogranin-1,Chromogranin-B;Secretogranin I;, PF01271;, GO:0005788;GO:0005615;GO:0030141;GO:0005179;GO:0044267;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular space; C:secretory granule;, F:hormone activity;, P:cellular protein metabolic process; P:post-translational protein modification;|P05060 A8K021 Q59EU9 Q6IBS6 Q9BQV6 Q9UC25 Q9UJA6,Secretogranin-1,Chromogranin-B;Secretogranin I;, PF01271;, GO:0005788;GO:0005615;GO:0030141;GO:0005179;GO:0044267;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular space; C:secretory granule;, F:hormone activity;, P:cellular protein metabolic process; P:post-translational protein modification; scaffold7 indexed_genome mRNA 4567252 4578855 . - . ID=transcript_1901;Q9UJA5 B4DUV6 Q76P92 Q9BQV5 Q9ULR7 Q9Y2Z8,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6,mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6 {ECO:0000303|PubMed:29072297};tRNA(m1A58)-methyltransferase subunit TRM6;, PF04189;, GO:0005654;GO:0005634;GO:0031515;GO:0003723;GO:0080009;GO:0030488;GO:0006400;, C:nucleoplasm; C:nucleus; C:tRNA (m1A) methyltransferase complex;, F:RNA binding;, P:mRNA methylation; P:tRNA methylation; P:tRNA modification;|Q9UJA5 B4DUV6 Q76P92 Q9BQV5 Q9ULR7 Q9Y2Z8,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6,mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6 {ECO:0000303|PubMed:29072297};tRNA(m1A58)-methyltransferase subunit TRM6;, PF04189;, GO:0005654;GO:0005634;GO:0031515;GO:0003723;GO:0080009;GO:0030488;GO:0006400;, C:nucleoplasm; C:nucleus; C:tRNA (m1A) methyltransferase complex;, F:RNA binding;, P:mRNA methylation; P:tRNA methylation; P:tRNA modification;|Q9UJA5 B4DUV6 Q76P92 Q9BQV5 Q9ULR7 Q9Y2Z8,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6,mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6 {ECO:0000303|PubMed:29072297};tRNA(m1A58)-methyltransferase subunit TRM6;, PF04189;, GO:0005654;GO:0005634;GO:0031515;GO:0003723;GO:0080009;GO:0030488;GO:0006400;, C:nucleoplasm; C:nucleus; C:tRNA (m1A) methyltransferase complex;, F:RNA binding;, P:mRNA methylation; P:tRNA methylation; P:tRNA modification;|Q9UJA5 B4DUV6 Q76P92 Q9BQV5 Q9ULR7 Q9Y2Z8,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6,mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6 {ECO:0000303|PubMed:29072297};tRNA(m1A58)-methyltransferase subunit TRM6;, PF04189;, GO:0005654;GO:0005634;GO:0031515;GO:0003723;GO:0080009;GO:0030488;GO:0006400;, C:nucleoplasm; C:nucleus; C:tRNA (m1A) methyltransferase complex;, F:RNA binding;, P:mRNA methylation; P:tRNA methylation; P:tRNA modification;|Q9UJA5 B4DUV6 Q76P92 Q9BQV5 Q9ULR7 Q9Y2Z8,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6,mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6 {ECO:0000303|PubMed:29072297};tRNA(m1A58)-methyltransferase subunit TRM6;, PF04189;, GO:0005654;GO:0005634;GO:0031515;GO:0003723;GO:0080009;GO:0030488;GO:0006400;, C:nucleoplasm; C:nucleus; C:tRNA (m1A) methyltransferase complex;, F:RNA binding;, P:mRNA methylation; P:tRNA methylation; P:tRNA modification;|Q9UJA5 B4DUV6 Q76P92 Q9BQV5 Q9ULR7 Q9Y2Z8,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6,mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6 {ECO:0000303|PubMed:29072297};tRNA(m1A58)-methyltransferase subunit TRM6;, PF04189;, GO:0005654;GO:0005634;GO:0031515;GO:0003723;GO:0080009;GO:0030488;GO:0006400;, C:nucleoplasm; C:nucleus; C:tRNA (m1A) methyltransferase complex;, F:RNA binding;, P:mRNA methylation; P:tRNA methylation; P:tRNA modification;|Q9UJA5 B4DUV6 Q76P92 Q9BQV5 Q9ULR7 Q9Y2Z8,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6,mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6 {ECO:0000303|PubMed:29072297};tRNA(m1A58)-methyltransferase subunit TRM6;, PF04189;, GO:0005654;GO:0005634;GO:0031515;GO:0003723;GO:0080009;GO:0030488;GO:0006400;, C:nucleoplasm; C:nucleus; C:tRNA (m1A) methyltransferase complex;, F:RNA binding;, P:mRNA methylation; P:tRNA methylation; P:tRNA modification; scaffold7 indexed_genome mRNA 4601165 4630660 . + . ID=transcript_1902;Q9UJA3 B2RBG7 D3DW08 E7EQU7 Q495R4 Q495R6 Q495R7 Q86US4 Q969I5,DNA helicase MCM8,Minichromosome maintenance 8;, PF00493;PF17855;PF17207;, GO:0005694;GO:0005829;GO:0042555;GO:0097362;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0003688;GO:0019899;GO:0032406;GO:0032407;GO:0032408;GO:0003697;GO:0007049;GO:0006974;GO:0006260;GO:0006270;GO:0000724;GO:0007292;GO:0048232;GO:0036388;GO:0071168;GO:0050821;GO:0036298;, C:chromosome; C:cytosol; C:MCM complex; C:MCM8-MCM9 complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:DNA replication origin binding; F:enzyme binding; F:MutLbeta complex binding; F:MutSalpha complex binding; F:MutSbeta complex binding; F:single-stranded DNA binding;, P:cell cycle; P:cellular response to DNA damage stimulus; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via homologous recombination; P:female gamete generation; P:male gamete generation; P:pre-replicative complex assembly; P:protein localization to chromatin; P:protein stabilization; P:recombinational interstrand cross-link repair; scaffold7 indexed_genome mRNA 4659790 4686051 . + . ID=transcript_1903;Q9UJA2 D3DW09 E9PAT4 Q27RP0 Q69YQ5,Cardiolipin synthase (CMP-forming),Protein GCD10 homolog;, PF01066;, GO:0016021;GO:0005743;GO:0005739;GO:0008808;GO:0043337;GO:0032049;GO:0046474;GO:0036148;GO:1905711;GO:0097068;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:cardiolipin synthase activity; F:CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity;, P:cardiolipin biosynthetic process; P:glycerophospholipid biosynthetic process; P:phosphatidylglycerol acyl-chain remodeling; P:response to phosphatidylethanolamine; P:response to thyroxine;|Q9UJA2 D3DW09 E9PAT4 Q27RP0 Q69YQ5,Cardiolipin synthase (CMP-forming),Protein GCD10 homolog;, PF01066;, GO:0016021;GO:0005743;GO:0005739;GO:0008808;GO:0043337;GO:0032049;GO:0046474;GO:0036148;GO:1905711;GO:0097068;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:cardiolipin synthase activity; F:CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity;, P:cardiolipin biosynthetic process; P:glycerophospholipid biosynthetic process; P:phosphatidylglycerol acyl-chain remodeling; P:response to phosphatidylethanolamine; P:response to thyroxine; scaffold7 indexed_genome mRNA 4692469 4706318 . - . ID=transcript_1904;Q8WUT4 A8K258 Q5JWV6 Q9H419,Leucine-rich repeat neuronal protein 4,Neuronal leucine-rich repeat protein 4;, PF00041;PF13855;, GO:0070062;GO:0005887;GO:0007616;GO:0008542;, C:extracellular exosome; C:integral component of plasma membrane;, , P:long-term memory; P:visual learning; scaffold7 indexed_genome mRNA 4733615 4787833 . - . ID=transcript_1905;Q9BQL6 D3DW10 Q8IX34 Q8IYH2 Q9NWM2 Q9NXQ3,Fermitin family homolog 1,Kindlerin;Kindlin syndrome protein;Kindlin-1;Unc-112-related protein 1;, PF00373;PF18124;PF00169;, GO:0030054;GO:0071944;GO:0030055;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0032587;GO:0051015;GO:0005178;GO:0071711;GO:0007155;GO:0007160;GO:0090162;GO:0007229;GO:0051546;GO:0043616;GO:0090090;GO:0010629;GO:0042308;GO:2000647;GO:0051886;GO:0033630;GO:0001954;GO:0033625;GO:0071636;GO:0030511;GO:1903691;, C:cell junction; C:cell periphery; C:cell-substrate junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:ruffle membrane;, F:actin filament binding; F:integrin binding;, P:basement membrane organization; P:cell adhesion; P:cell-matrix adhesion; P:establishment of epithelial cell polarity; P:integrin-mediated signaling pathway; P:keratinocyte migration; P:keratinocyte proliferation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:negative regulation of protein import into nucleus; P:negative regulation of stem cell proliferation; P:negative regulation of timing of anagen; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell-matrix adhesion; P:positive regulation of integrin activation; P:positive regulation of transforming growth factor beta production; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of wound healing, spreading of epidermal cells; scaffold7 indexed_genome mRNA 5558255 5569121 . + . ID=transcript_1906;P12643,Bone morphogenetic protein 2,Bone morphogenetic protein 2A;, PF00019;PF00688;, GO:0070724;GO:0009986;GO:0005576;GO:0005615;GO:0043231;GO:0070700;GO:0039706;GO:0005125;GO:0008083;GO:0019211;GO:0005102;GO:0046332;GO:0000187;GO:0009887;GO:0003176;GO:1905222;GO:0003181;GO:0030509;GO:0061312;GO:0003130;GO:0030282;GO:0035630;GO:0001658;GO:0003210;GO:0060317;GO:1905072;GO:0055007;GO:0055008;GO:0035051;GO:0045165;GO:0007267;GO:0071773;GO:0071407;GO:0002062;GO:0060128;GO:0035054;GO:0003272;GO:0003203;GO:0001837;GO:0007507;GO:0001701;GO:0006954;GO:0048839;GO:0048762;GO:0072138;GO:0060485;GO:0032348;GO:0030514;GO:0051042;GO:0090090;GO:2000726;GO:0045786;GO:0008285;GO:2000065;GO:0010629;GO:0043569;GO:0010894;GO:0000122;GO:0045892;GO:0003308;GO:0007219;GO:0042475;GO:0001649;GO:0060389;GO:0060039;GO:0043065;GO:0048711;GO:0030501;GO:0061036;GO:0030335;GO:0001938;GO:0010718;GO:0070374;GO:0003331;GO:0045600;GO:0010628;GO:0043410;GO:0045666;GO:0042482;GO:0045778;GO:0045669;GO:0033690;GO:1900745;GO:0010862;GO:0010922;GO:1902895;GO:0032092;GO:0001934;GO:0045944;GO:1901522;GO:0045893;GO:0030177;GO:0060804;GO:0031648;GO:0006468;GO:0006029;GO:0042487;GO:0006355;GO:0009617;GO:0001666;GO:0038098;GO:0001501;GO:0060395;GO:0021537;GO:0021978;GO:0060129;, C:BMP receptor complex; C:cell surface; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:BMP receptor binding; F:co-receptor binding; F:cytokine activity; F:growth factor activity; F:phosphatase activator activity; F:signaling receptor binding; F:SMAD binding;, P:activation of MAPK activity; P:animal organ morphogenesis; P:aortic valve development; P:atrioventricular canal morphogenesis; P:atrioventricular valve morphogenesis; P:BMP signaling pathway; P:BMP signaling pathway involved in heart development; P:BMP signaling pathway involved in heart induction; P:bone mineralization; P:bone mineralization involved in bone maturation; P:branching involved in ureteric bud morphogenesis; P:cardiac atrium formation; P:cardiac epithelial to mesenchymal transition; P:cardiac jelly development; P:cardiac muscle cell differentiation; P:cardiac muscle tissue morphogenesis; P:cardiocyte differentiation; P:cell fate commitment; P:cell-cell signaling; P:cellular response to BMP stimulus; P:cellular response to organic cyclic compound; P:chondrocyte differentiation; P:corticotropin hormone secreting cell differentiation; P:embryonic heart tube anterior/posterior pattern specification; P:endocardial cushion formation; P:endocardial cushion morphogenesis; P:epithelial to mesenchymal transition; P:heart development; P:in utero embryonic development; P:inflammatory response; P:inner ear development; P:mesenchymal cell differentiation; P:mesenchymal cell proliferation involved in ureteric bud development; P:mesenchyme development; P:negative regulation of aldosterone biosynthetic process; P:negative regulation of BMP signaling pathway; P:negative regulation of calcium-independent cell-cell adhesion; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cardiac muscle cell differentiation; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of cortisol biosynthetic process; P:negative regulation of gene expression; P:negative regulation of insulin-like growth factor receptor signaling pathway; P:negative regulation of steroid biosynthetic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway involved in heart development; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:pathway-restricted SMAD protein phosphorylation; P:pericardium development; P:positive regulation of apoptotic process; P:positive regulation of astrocyte differentiation; P:positive regulation of bone mineralization; P:positive regulation of cartilage development; P:positive regulation of cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extracellular matrix constituent secretion; P:positive regulation of fat cell differentiation; P:positive regulation of gene expression; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of odontogenesis; P:positive regulation of ossification; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of p38MAPK cascade; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of phosphatase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:positive regulation of Wnt signaling pathway by BMP signaling pathway; P:protein destabilization; P:protein phosphorylation; P:proteoglycan metabolic process; P:regulation of odontogenesis of dentin-containing tooth; P:regulation of transcription, DNA-templated; P:response to bacterium; P:response to hypoxia; P:sequestering of BMP from receptor via BMP binding; P:skeletal system development; P:SMAD protein signal transduction; P:telencephalon development; P:telencephalon regionalization; P:thyroid-stimulating hormone-secreting cell differentiation; scaffold7 indexed_genome mRNA 6897509 6954774 . - . ID=transcript_1907;Q9UJM8 Q14CQ0 Q9UPZ0 Q9Y3I7,Hydroxyacid oxidase 1,Glycolate oxidase;, PF01070;, GO:0005829;GO:0005782;GO:0005777;GO:0003973;GO:0010181;GO:0008891;GO:0052853;GO:0052854;GO:0052852;GO:0019752;GO:0001561;GO:0046296;GO:0008104;GO:0006979;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:(S)-2-hydroxy-acid oxidase activity; F:FMN binding; F:glycolate oxidase activity; F:long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity; F:medium-chain-(S)-2-hydroxy-acid oxidase activity; F:very-long-chain-(S)-2-hydroxy-acid oxidase activity;, P:carboxylic acid metabolic process; P:fatty acid alpha-oxidation; P:glycolate catabolic process; P:protein localization; P:response to oxidative stress; scaffold7 indexed_genome mRNA 7080638 7084669 . - . ID=transcript_1908;Q8N4L8 Q6RWT2,Coiled-coil domain-containing protein 24,, PF15669;, GO:0001835;, , , P:blastocyst hatching;|Q8N4L8 Q6RWT2,Coiled-coil domain-containing protein 24,, PF15669;, GO:0001835;, , , P:blastocyst hatching; scaffold7 indexed_genome mRNA 7373206 7377942 . - . ID=transcript_1909;Q9UF15 Q9UME4,Calcipressin-1,Adapt78;Down syndrome critical region protein 1;Myocyte-enriched calcineurin-interacting protein 1;Regulator of calcineurin 1;, PF04847;, GO:0005737;GO:0005634;GO:0008597;GO:0042802;GO:0003676;GO:0033173;GO:0019722;GO:0070885;, C:cytoplasm; C:nucleus;, F:calcium-dependent protein serine/threonine phosphatase regulator activity; F:identical protein binding; F:nucleic acid binding;, P:calcineurin-NFAT signaling cascade; P:calcium-mediated signaling; P:negative regulation of calcineurin-NFAT signaling cascade; scaffold7 indexed_genome mRNA 7413793 7421687 . + . ID=transcript_1910;P15382 A5H1P2 Q8N709 Q91Z94,Potassium voltage-gated channel subfamily E member 1,Delayed rectifier potassium channel subunit IsK;IKs producing slow voltage-gated potassium channel subunit beta Mink;Minimal potassium channel;, PF02060;, GO:0016324;GO:0009986;GO:0005764;GO:0045121;GO:0005886;GO:0008076;GO:0030018;GO:0005251;GO:0044325;GO:0015459;GO:0031433;GO:0061337;GO:0086002;GO:0071320;GO:0086009;GO:0086011;GO:0086013;GO:0098915;GO:1902260;GO:0090315;GO:1901381;GO:0097623;GO:0071805;GO:1902259;GO:0086091;GO:1901379;GO:0060307;GO:0007605;GO:0086005;, C:apical plasma membrane; C:cell surface; C:lysosome; C:membrane raft; C:plasma membrane; C:voltage-gated potassium channel complex; C:Z disc;, F:delayed rectifier potassium channel activity; F:ion channel binding; F:potassium channel regulator activity; F:telethonin binding;, P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cellular response to cAMP; P:membrane repolarization; P:membrane repolarization during action potential; P:membrane repolarization during cardiac muscle cell action potential; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:negative regulation of delayed rectifier potassium channel activity; P:negative regulation of protein targeting to membrane; P:positive regulation of potassium ion transmembrane transport; P:potassium ion export across plasma membrane; P:potassium ion transmembrane transport; P:regulation of delayed rectifier potassium channel activity; P:regulation of heart rate by cardiac conduction; P:regulation of potassium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:sensory perception of sound; P:ventricular cardiac muscle cell action potential; scaffold7 indexed_genome mRNA 7450610 7451245 . - . ID=transcript_1911;P0DPE8,Small integral membrane protein 34B {ECO:0000305},, , GO:0016021;, C:integral component of membrane; scaffold7 indexed_genome mRNA 7478202 7479430 . + . ID=transcript_1912;P0DPQ4,Protein FAM243B {ECO:0000305} scaffold7 indexed_genome mRNA 7482053 7494408 . - . ID=transcript_1913;P58511,Small integral membrane protein 11A {ECO:0000312|HGNC:HGNC:1293},, PF14981;, GO:0016021;, C:integral component of membrane;|P58511,Small integral membrane protein 11A {ECO:0000312|HGNC:HGNC:1293},, PF14981;, GO:0016021;, C:integral component of membrane; scaffold7 indexed_genome mRNA 7498772 7501555 . + . ID=transcript_1914;Q9Y6J6 A5H1P3 D3DSF8 Q52LJ5,Potassium voltage-gated channel subfamily E member 2,MinK-related peptide 1;Minimum potassium ion channel-related peptide 1;Potassium channel subunit beta MiRP1;, PF02060;, GO:0009986;GO:0005783;GO:0005794;GO:0005764;GO:0005886;GO:0008076;GO:0005251;GO:0042802;GO:0005242;GO:0044325;GO:0015459;GO:1902282;GO:0007568;GO:0061337;GO:0086002;GO:0035690;GO:0086009;GO:0086011;GO:0098915;GO:1902260;GO:1901800;GO:1901387;GO:0097623;GO:1990573;GO:0071805;GO:1902159;GO:1902259;GO:0086091;GO:1901979;GO:0060306;GO:1901379;GO:0060307;GO:0043586;GO:0086005;, C:cell surface; C:endoplasmic reticulum; C:Golgi apparatus; C:lysosome; C:plasma membrane; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:identical protein binding; F:inward rectifier potassium channel activity; F:ion channel binding; F:potassium channel regulator activity; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:aging; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cellular response to drug; P:membrane repolarization; P:membrane repolarization during action potential; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:negative regulation of delayed rectifier potassium channel activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of voltage-gated calcium channel activity; P:potassium ion export across plasma membrane; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of cyclic nucleotide-gated ion channel activity; P:regulation of delayed rectifier potassium channel activity; P:regulation of heart rate by cardiac conduction; P:regulation of inward rectifier potassium channel activity; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:tongue development; P:ventricular cardiac muscle cell action potential; scaffold7 indexed_genome mRNA 7763534 7764249 . - . ID=transcript_1915;P82932 B2R573 Q96Q64 Q9BSK8 Q9BW89,28S ribosomal protein S6, mitochondrial,Mitochondrial small ribosomal subunit protein bS6m {ECO:0000303|PubMed:25838379};, PF01250;, GO:0005743;GO:0005763;GO:0005739;GO:0015935;GO:0070181;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:small ribosomal subunit;, F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold7 indexed_genome mRNA 7778765 7781035 . + . ID=transcript_1916;P82932 B2R573 Q96Q64 Q9BSK8 Q9BW89,28S ribosomal protein S6, mitochondrial,Mitochondrial small ribosomal subunit protein bS6m {ECO:0000303|PubMed:25838379};, PF01250;, GO:0005743;GO:0005763;GO:0005739;GO:0015935;GO:0070181;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:small ribosomal subunit;, F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold7 indexed_genome mRNA 7801647 7804810 . + . ID=transcript_1917;P53794 O43489,Sodium/myo-inositol cotransporter,Sodium/myo-inositol transporter 1;Solute carrier family 5 member 3;, PF00474;, GO:0016021;GO:0005887;GO:0048471;GO:0005886;GO:0015150;GO:0005412;GO:0044325;GO:0005365;GO:0005367;GO:0015146;GO:0015166;GO:0015459;GO:0015756;GO:1904659;GO:0006020;GO:1904679;GO:0015798;GO:0015750;GO:0007422;GO:0015791;GO:0043085;GO:1905477;GO:1903428;GO:0043576;GO:0150104;, C:integral component of membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:fucose transmembrane transporter activity; F:glucose:sodium symporter activity; F:ion channel binding; F:myo-inositol transmembrane transporter activity; F:myo-inositol:sodium symporter activity; F:pentose transmembrane transporter activity; F:polyol transmembrane transporter activity; F:potassium channel regulator activity;, P:fucose transmembrane transport; P:glucose transmembrane transport; P:inositol metabolic process; P:myo-inositol import across plasma membrane; P:myo-inositol transport; P:pentose transmembrane transport; P:peripheral nervous system development; P:polyol transport; P:positive regulation of catalytic activity; P:positive regulation of protein localization to membrane; P:positive regulation of reactive oxygen species biosynthetic process; P:regulation of respiratory gaseous exchange; P:transport across blood-brain barrier; scaffold7 indexed_genome mRNA 8019894 8027635 . + . ID=transcript_1918;P48047 B2R4E2 Q5U042 Q6IBI2,ATP synthase subunit O, mitochondrial {ECO:0000305},ATP synthase peripheral stalk subunit OSCP {ECO:0000305};Oligomycin sensitivity conferral protein;, PF00213;, GO:0005743;GO:0005753;GO:0000274;GO:0005739;GO:0005634;GO:0005886;GO:0045261;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;GO:1902600;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase, stator stalk; C:mitochondrion; C:nucleus; C:plasma membrane; C:proton-transporting ATP synthase complex, catalytic core F(1);, F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:proton transmembrane transport;|P48047 B2R4E2 Q5U042 Q6IBI2,ATP synthase subunit O, mitochondrial {ECO:0000305},ATP synthase peripheral stalk subunit OSCP {ECO:0000305};Oligomycin sensitivity conferral protein;, PF00213;, GO:0005743;GO:0005753;GO:0000274;GO:0005739;GO:0005634;GO:0005886;GO:0045261;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;GO:1902600;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase, stator stalk; C:mitochondrion; C:nucleus; C:plasma membrane; C:proton-transporting ATP synthase complex, catalytic core F(1);, F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:proton transmembrane transport; scaffold7 indexed_genome mRNA 8031075 8055171 . - . ID=transcript_1919;Q20BK3 Q9UET5 Q9UK60 Q9UNK1 Q9UNK2 Q9UQ92,Intersectin-1,SH3 domain-containing protein 1A {ECO:0000303|PubMed:9465890};SH3P17;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0097440;GO:0005905;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0030027;GO:0043025;GO:0005635;GO:0005886;GO:0098871;GO:0098793;GO:0055037;GO:0005509;GO:0005085;GO:0060090;GO:0070064;GO:0007420;GO:0034613;GO:0150007;GO:0006897;GO:0016197;GO:0048013;GO:0006887;GO:0007186;GO:0035556;GO:0061024;GO:0043065;GO:2001288;GO:0060999;GO:0060124;GO:0015031;GO:1905274;GO:0051056;GO:0016032;, C:apical dendrite; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:lamellipodium; C:neuronal cell body; C:nuclear envelope; C:plasma membrane; C:postsynaptic actin cytoskeleton; C:presynapse; C:recycling endosome;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity; F:proline-rich region binding;, P:brain development; P:cellular protein localization; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:ephrin receptor signaling pathway; P:exocytosis; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:membrane organization; P:positive regulation of apoptotic process; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendritic spine development; P:positive regulation of growth hormone secretion; P:protein transport; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of small GTPase mediated signal transduction; P:viral process; scaffold7 indexed_genome mRNA 8061660 8119863 . - . ID=transcript_1920;Q20BK3 Q9UET5 Q9UK60 Q9UNK1 Q9UNK2 Q9UQ92,Intersectin-1,SH3 domain-containing protein 1A {ECO:0000303|PubMed:9465890};SH3P17;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0097440;GO:0005905;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0030027;GO:0043025;GO:0005635;GO:0005886;GO:0098871;GO:0098793;GO:0055037;GO:0005509;GO:0005085;GO:0060090;GO:0070064;GO:0007420;GO:0034613;GO:0150007;GO:0006897;GO:0016197;GO:0048013;GO:0006887;GO:0007186;GO:0035556;GO:0061024;GO:0043065;GO:2001288;GO:0060999;GO:0060124;GO:0015031;GO:1905274;GO:0051056;GO:0016032;, C:apical dendrite; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:lamellipodium; C:neuronal cell body; C:nuclear envelope; C:plasma membrane; C:postsynaptic actin cytoskeleton; C:presynapse; C:recycling endosome;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity; F:proline-rich region binding;, P:brain development; P:cellular protein localization; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:ephrin receptor signaling pathway; P:exocytosis; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:membrane organization; P:positive regulation of apoptotic process; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendritic spine development; P:positive regulation of growth hormone secretion; P:protein transport; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of small GTPase mediated signal transduction; P:viral process;|Q20BK3 Q9UET5 Q9UK60 Q9UNK1 Q9UNK2 Q9UQ92,Intersectin-1,SH3 domain-containing protein 1A {ECO:0000303|PubMed:9465890};SH3P17;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0097440;GO:0005905;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0030027;GO:0043025;GO:0005635;GO:0005886;GO:0098871;GO:0098793;GO:0055037;GO:0005509;GO:0005085;GO:0060090;GO:0070064;GO:0007420;GO:0034613;GO:0150007;GO:0006897;GO:0016197;GO:0048013;GO:0006887;GO:0007186;GO:0035556;GO:0061024;GO:0043065;GO:2001288;GO:0060999;GO:0060124;GO:0015031;GO:1905274;GO:0051056;GO:0016032;, C:apical dendrite; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:lamellipodium; C:neuronal cell body; C:nuclear envelope; C:plasma membrane; C:postsynaptic actin cytoskeleton; C:presynapse; C:recycling endosome;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity; F:proline-rich region binding;, P:brain development; P:cellular protein localization; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:ephrin receptor signaling pathway; P:exocytosis; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:membrane organization; P:positive regulation of apoptotic process; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendritic spine development; P:positive regulation of growth hormone secretion; P:protein transport; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of small GTPase mediated signal transduction; P:viral process;|Q20BK3 Q9UET5 Q9UK60 Q9UNK1 Q9UNK2 Q9UQ92,Intersectin-1,SH3 domain-containing protein 1A {ECO:0000303|PubMed:9465890};SH3P17;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0097440;GO:0005905;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0030027;GO:0043025;GO:0005635;GO:0005886;GO:0098871;GO:0098793;GO:0055037;GO:0005509;GO:0005085;GO:0060090;GO:0070064;GO:0007420;GO:0034613;GO:0150007;GO:0006897;GO:0016197;GO:0048013;GO:0006887;GO:0007186;GO:0035556;GO:0061024;GO:0043065;GO:2001288;GO:0060999;GO:0060124;GO:0015031;GO:1905274;GO:0051056;GO:0016032;, C:apical dendrite; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:lamellipodium; C:neuronal cell body; C:nuclear envelope; C:plasma membrane; C:postsynaptic actin cytoskeleton; C:presynapse; C:recycling endosome;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity; F:proline-rich region binding;, P:brain development; P:cellular protein localization; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:ephrin receptor signaling pathway; P:exocytosis; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:membrane organization; P:positive regulation of apoptotic process; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendritic spine development; P:positive regulation of growth hormone secretion; P:protein transport; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of small GTPase mediated signal transduction; P:viral process;|Q20BK3 Q9UET5 Q9UK60 Q9UNK1 Q9UNK2 Q9UQ92,Intersectin-1,SH3 domain-containing protein 1A {ECO:0000303|PubMed:9465890};SH3P17;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0097440;GO:0005905;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0030027;GO:0043025;GO:0005635;GO:0005886;GO:0098871;GO:0098793;GO:0055037;GO:0005509;GO:0005085;GO:0060090;GO:0070064;GO:0007420;GO:0034613;GO:0150007;GO:0006897;GO:0016197;GO:0048013;GO:0006887;GO:0007186;GO:0035556;GO:0061024;GO:0043065;GO:2001288;GO:0060999;GO:0060124;GO:0015031;GO:1905274;GO:0051056;GO:0016032;, C:apical dendrite; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:lamellipodium; C:neuronal cell body; C:nuclear envelope; C:plasma membrane; C:postsynaptic actin cytoskeleton; C:presynapse; C:recycling endosome;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity; F:proline-rich region binding;, P:brain development; P:cellular protein localization; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:ephrin receptor signaling pathway; P:exocytosis; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:membrane organization; P:positive regulation of apoptotic process; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendritic spine development; P:positive regulation of growth hormone secretion; P:protein transport; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of small GTPase mediated signal transduction; P:viral process; scaffold7 indexed_genome mRNA 8130372 8209078 . - . ID=transcript_1921;Q20BK3 Q9UET5 Q9UK60 Q9UNK1 Q9UNK2 Q9UQ92,Intersectin-1,SH3 domain-containing protein 1A {ECO:0000303|PubMed:9465890};SH3P17;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0097440;GO:0005905;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0030027;GO:0043025;GO:0005635;GO:0005886;GO:0098871;GO:0098793;GO:0055037;GO:0005509;GO:0005085;GO:0060090;GO:0070064;GO:0007420;GO:0034613;GO:0150007;GO:0006897;GO:0016197;GO:0048013;GO:0006887;GO:0007186;GO:0035556;GO:0061024;GO:0043065;GO:2001288;GO:0060999;GO:0060124;GO:0015031;GO:1905274;GO:0051056;GO:0016032;, C:apical dendrite; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:lamellipodium; C:neuronal cell body; C:nuclear envelope; C:plasma membrane; C:postsynaptic actin cytoskeleton; C:presynapse; C:recycling endosome;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity; F:proline-rich region binding;, P:brain development; P:cellular protein localization; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:ephrin receptor signaling pathway; P:exocytosis; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:membrane organization; P:positive regulation of apoptotic process; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendritic spine development; P:positive regulation of growth hormone secretion; P:protein transport; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of small GTPase mediated signal transduction; P:viral process; scaffold7 indexed_genome mRNA 8303319 8333668 . + . ID=transcript_1922;O95825 B2RDX1 B3KQ77 Q96DY0 Q9NVY7,Quinone oxidoreductase-like protein 1,Protein 4P11;Quinone oxidoreductase homolog 1;Zeta-crystallin homolog;, , GO:0005829;GO:0050661;GO:0003960;GO:1901661;, C:cytosol;, F:NADP binding; F:NADPH:quinone reductase activity;, P:quinone metabolic process;|O95825 B2RDX1 B3KQ77 Q96DY0 Q9NVY7,Quinone oxidoreductase-like protein 1,Protein 4P11;Quinone oxidoreductase homolog 1;Zeta-crystallin homolog;, , GO:0005829;GO:0050661;GO:0003960;GO:1901661;, C:cytosol;, F:NADP binding; F:NADPH:quinone reductase activity;, P:quinone metabolic process;|O95825 B2RDX1 B3KQ77 Q96DY0 Q9NVY7,Quinone oxidoreductase-like protein 1,Protein 4P11;Quinone oxidoreductase homolog 1;Zeta-crystallin homolog;, , GO:0005829;GO:0050661;GO:0003960;GO:1901661;, C:cytosol;, F:NADP binding; F:NADPH:quinone reductase activity;, P:quinone metabolic process;|O95825 B2RDX1 B3KQ77 Q96DY0 Q9NVY7,Quinone oxidoreductase-like protein 1,Protein 4P11;Quinone oxidoreductase homolog 1;Zeta-crystallin homolog;, , GO:0005829;GO:0050661;GO:0003960;GO:1901661;, C:cytosol;, F:NADP binding; F:NADPH:quinone reductase activity;, P:quinone metabolic process;|O95825 B2RDX1 B3KQ77 Q96DY0 Q9NVY7,Quinone oxidoreductase-like protein 1,Protein 4P11;Quinone oxidoreductase homolog 1;Zeta-crystallin homolog;, , GO:0005829;GO:0050661;GO:0003960;GO:1901661;, C:cytosol;, F:NADP binding; F:NADPH:quinone reductase activity;, P:quinone metabolic process;|O95825 B2RDX1 B3KQ77 Q96DY0 Q9NVY7,Quinone oxidoreductase-like protein 1,Protein 4P11;Quinone oxidoreductase homolog 1;Zeta-crystallin homolog;, , GO:0005829;GO:0050661;GO:0003960;GO:1901661;, C:cytosol;, F:NADP binding; F:NADPH:quinone reductase activity;, P:quinone metabolic process;|O95825 B2RDX1 B3KQ77 Q96DY0 Q9NVY7,Quinone oxidoreductase-like protein 1,Protein 4P11;Quinone oxidoreductase homolog 1;Zeta-crystallin homolog;, , GO:0005829;GO:0050661;GO:0003960;GO:1901661;, C:cytosol;, F:NADP binding; F:NADPH:quinone reductase activity;, P:quinone metabolic process;|O95825 B2RDX1 B3KQ77 Q96DY0 Q9NVY7,Quinone oxidoreductase-like protein 1,Protein 4P11;Quinone oxidoreductase homolog 1;Zeta-crystallin homolog;, , GO:0005829;GO:0050661;GO:0003960;GO:1901661;, C:cytosol;, F:NADP binding; F:NADPH:quinone reductase activity;, P:quinone metabolic process;|O95825 B2RDX1 B3KQ77 Q96DY0 Q9NVY7,Quinone oxidoreductase-like protein 1,Protein 4P11;Quinone oxidoreductase homolog 1;Zeta-crystallin homolog;, , GO:0005829;GO:0050661;GO:0003960;GO:1901661;, C:cytosol;, F:NADP binding; F:NADPH:quinone reductase activity;, P:quinone metabolic process;|Q9NYP3 Q8NC53 Q9NSR9 Q9NVZ5 Q9NYP1 Q9NYP2,Protein downstream neighbor of Son,B17;, , GO:0005634;GO:0005657;GO:0030894;GO:0000077;GO:0006260;GO:0007095;GO:0007275;GO:0033260;GO:0048478;, C:nucleus; C:replication fork; C:replisome;, , P:DNA damage checkpoint; P:DNA replication; P:mitotic G2 DNA damage checkpoint; P:multicellular organism development; P:nuclear DNA replication; P:replication fork protection;|Q9NYP3 Q8NC53 Q9NSR9 Q9NVZ5 Q9NYP1 Q9NYP2,Protein downstream neighbor of Son,B17;, , GO:0005634;GO:0005657;GO:0030894;GO:0000077;GO:0006260;GO:0007095;GO:0007275;GO:0033260;GO:0048478;, C:nucleus; C:replication fork; C:replisome;, , P:DNA damage checkpoint; P:DNA replication; P:mitotic G2 DNA damage checkpoint; P:multicellular organism development; P:nuclear DNA replication; P:replication fork protection;|Q9NYP3 Q8NC53 Q9NSR9 Q9NVZ5 Q9NYP1 Q9NYP2,Protein downstream neighbor of Son,B17;, , GO:0005634;GO:0005657;GO:0030894;GO:0000077;GO:0006260;GO:0007095;GO:0007275;GO:0033260;GO:0048478;, C:nucleus; C:replication fork; C:replisome;, , P:DNA damage checkpoint; P:DNA replication; P:mitotic G2 DNA damage checkpoint; P:multicellular organism development; P:nuclear DNA replication; P:replication fork protection; scaffold7 indexed_genome mRNA 8333701 8358551 . + . ID=transcript_1923;Q9NYP3 Q8NC53 Q9NSR9 Q9NVZ5 Q9NYP1 Q9NYP2,Protein downstream neighbor of Son,B17;, , GO:0005634;GO:0005657;GO:0030894;GO:0000077;GO:0006260;GO:0007095;GO:0007275;GO:0033260;GO:0048478;, C:nucleus; C:replication fork; C:replisome;, , P:DNA damage checkpoint; P:DNA replication; P:mitotic G2 DNA damage checkpoint; P:multicellular organism development; P:nuclear DNA replication; P:replication fork protection;|Q9NYP3 Q8NC53 Q9NSR9 Q9NVZ5 Q9NYP1 Q9NYP2,Protein downstream neighbor of Son,B17;, , GO:0005634;GO:0005657;GO:0030894;GO:0000077;GO:0006260;GO:0007095;GO:0007275;GO:0033260;GO:0048478;, C:nucleus; C:replication fork; C:replisome;, , P:DNA damage checkpoint; P:DNA replication; P:mitotic G2 DNA damage checkpoint; P:multicellular organism development; P:nuclear DNA replication; P:replication fork protection;|Q14120 Q6PKE0 Q9H7B1 Q9P070 Q9P072 Q9UKP9 Q9UPY0,Protein SON,Bax antagonist selected in saccharomyces 1;Negative regulatory element-binding protein;Protein DBP-5;SON3;, PF01585;, GO:0016607;GO:0003677;GO:0003723;GO:0000226;GO:0000281;GO:0006397;GO:0043066;GO:0051726;GO:0048024;GO:0043484;GO:0008380;, C:nuclear speck;, F:DNA binding; F:RNA binding;, P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:mRNA processing; P:negative regulation of apoptotic process; P:regulation of cell cycle; P:regulation of mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing;|Q9NYP3 Q8NC53 Q9NSR9 Q9NVZ5 Q9NYP1 Q9NYP2,Protein downstream neighbor of Son,B17;, , GO:0005634;GO:0005657;GO:0030894;GO:0000077;GO:0006260;GO:0007095;GO:0007275;GO:0033260;GO:0048478;, C:nucleus; C:replication fork; C:replisome;, , P:DNA damage checkpoint; P:DNA replication; P:mitotic G2 DNA damage checkpoint; P:multicellular organism development; P:nuclear DNA replication; P:replication fork protection;|Q9NYP3 Q8NC53 Q9NSR9 Q9NVZ5 Q9NYP1 Q9NYP2,Protein downstream neighbor of Son,B17;, , GO:0005634;GO:0005657;GO:0030894;GO:0000077;GO:0006260;GO:0007095;GO:0007275;GO:0033260;GO:0048478;, C:nucleus; C:replication fork; C:replisome;, , P:DNA damage checkpoint; P:DNA replication; P:mitotic G2 DNA damage checkpoint; P:multicellular organism development; P:nuclear DNA replication; P:replication fork protection;|Q14120 Q6PKE0 Q9H7B1 Q9P070 Q9P072 Q9UKP9 Q9UPY0,Protein SON,Bax antagonist selected in saccharomyces 1;Negative regulatory element-binding protein;Protein DBP-5;SON3;, PF01585;, GO:0016607;GO:0003677;GO:0003723;GO:0000226;GO:0000281;GO:0006397;GO:0043066;GO:0051726;GO:0048024;GO:0043484;GO:0008380;, C:nuclear speck;, F:DNA binding; F:RNA binding;, P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:mRNA processing; P:negative regulation of apoptotic process; P:regulation of cell cycle; P:regulation of mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing;|Q14120 Q6PKE0 Q9H7B1 Q9P070 Q9P072 Q9UKP9 Q9UPY0,Protein SON,Bax antagonist selected in saccharomyces 1;Negative regulatory element-binding protein;Protein DBP-5;SON3;, PF01585;, GO:0016607;GO:0003677;GO:0003723;GO:0000226;GO:0000281;GO:0006397;GO:0043066;GO:0051726;GO:0048024;GO:0043484;GO:0008380;, C:nuclear speck;, F:DNA binding; F:RNA binding;, P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:mRNA processing; P:negative regulation of apoptotic process; P:regulation of cell cycle; P:regulation of mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing;|Q14120 Q6PKE0 Q9H7B1 Q9P070 Q9P072 Q9UKP9 Q9UPY0,Protein SON,Bax antagonist selected in saccharomyces 1;Negative regulatory element-binding protein;Protein DBP-5;SON3;, PF01585;, GO:0016607;GO:0003677;GO:0003723;GO:0000226;GO:0000281;GO:0006397;GO:0043066;GO:0051726;GO:0048024;GO:0043484;GO:0008380;, C:nuclear speck;, F:DNA binding; F:RNA binding;, P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:mRNA processing; P:negative regulation of apoptotic process; P:regulation of cell cycle; P:regulation of mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing; scaffold7 indexed_genome mRNA 8358627 8371346 . - . ID=transcript_1924;Q14120 Q6PKE0 Q9H7B1 Q9P070 Q9P072 Q9UKP9 Q9UPY0,Protein SON,Bax antagonist selected in saccharomyces 1;Negative regulatory element-binding protein;Protein DBP-5;SON3;, PF01585;, GO:0016607;GO:0003677;GO:0003723;GO:0000226;GO:0000281;GO:0006397;GO:0043066;GO:0051726;GO:0048024;GO:0043484;GO:0008380;, C:nuclear speck;, F:DNA binding; F:RNA binding;, P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:mRNA processing; P:negative regulation of apoptotic process; P:regulation of cell cycle; P:regulation of mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing; scaffold7 indexed_genome mRNA 8371544 8385999 . + . ID=transcript_1925;P22102 A8K945 A8KA32 D3DSF3 D3DSF4 O14659 Q52M77,Trifunctional purine biosynthetic protein adenosine-3,, PF00586;PF02769;PF00551;PF01071;PF02843;PF02844;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004637;GO:0004641;GO:0004644;GO:0006189;GO:0046084;GO:0003360;GO:0021549;GO:0021987;GO:0006544;GO:0006164;GO:0009168;GO:0010035;GO:0010033;GO:0046654;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylamine-glycine ligase activity; F:phosphoribosylformylglycinamidine cyclo-ligase activity; F:phosphoribosylglycinamide formyltransferase activity;, P:'de novo' IMP biosynthetic process; P:adenine biosynthetic process; P:brainstem development; P:cerebellum development; P:cerebral cortex development; P:glycine metabolic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:response to organic substance; P:tetrahydrofolate biosynthetic process; scaffold7 indexed_genome mRNA 8386138 8387999 . - . ID=transcript_1926;P22102 A8K945 A8KA32 D3DSF3 D3DSF4 O14659 Q52M77,Trifunctional purine biosynthetic protein adenosine-3,, PF00586;PF02769;PF00551;PF01071;PF02843;PF02844;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004637;GO:0004641;GO:0004644;GO:0006189;GO:0046084;GO:0003360;GO:0021549;GO:0021987;GO:0006544;GO:0006164;GO:0009168;GO:0010035;GO:0010033;GO:0046654;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylamine-glycine ligase activity; F:phosphoribosylformylglycinamidine cyclo-ligase activity; F:phosphoribosylglycinamide formyltransferase activity;, P:'de novo' IMP biosynthetic process; P:adenine biosynthetic process; P:brainstem development; P:cerebellum development; P:cerebral cortex development; P:glycine metabolic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:response to organic substance; P:tetrahydrofolate biosynthetic process; scaffold7 indexed_genome mRNA 8388016 8398716 . + . ID=transcript_1927;P22102 A8K945 A8KA32 D3DSF3 D3DSF4 O14659 Q52M77,Trifunctional purine biosynthetic protein adenosine-3,, PF00586;PF02769;PF00551;PF01071;PF02843;PF02844;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004637;GO:0004641;GO:0004644;GO:0006189;GO:0046084;GO:0003360;GO:0021549;GO:0021987;GO:0006544;GO:0006164;GO:0009168;GO:0010035;GO:0010033;GO:0046654;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylamine-glycine ligase activity; F:phosphoribosylformylglycinamidine cyclo-ligase activity; F:phosphoribosylglycinamide formyltransferase activity;, P:'de novo' IMP biosynthetic process; P:adenine biosynthetic process; P:brainstem development; P:cerebellum development; P:cerebral cortex development; P:glycine metabolic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:response to organic substance; P:tetrahydrofolate biosynthetic process;|P22102 A8K945 A8KA32 D3DSF3 D3DSF4 O14659 Q52M77,Trifunctional purine biosynthetic protein adenosine-3,, PF00586;PF02769;PF00551;PF01071;PF02843;PF02844;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004637;GO:0004641;GO:0004644;GO:0006189;GO:0046084;GO:0003360;GO:0021549;GO:0021987;GO:0006544;GO:0006164;GO:0009168;GO:0010035;GO:0010033;GO:0046654;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylamine-glycine ligase activity; F:phosphoribosylformylglycinamidine cyclo-ligase activity; F:phosphoribosylglycinamide formyltransferase activity;, P:'de novo' IMP biosynthetic process; P:adenine biosynthetic process; P:brainstem development; P:cerebellum development; P:cerebral cortex development; P:glycine metabolic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:response to organic substance; P:tetrahydrofolate biosynthetic process;|P22102 A8K945 A8KA32 D3DSF3 D3DSF4 O14659 Q52M77,Trifunctional purine biosynthetic protein adenosine-3,, PF00586;PF02769;PF00551;PF01071;PF02843;PF02844;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004637;GO:0004641;GO:0004644;GO:0006189;GO:0046084;GO:0003360;GO:0021549;GO:0021987;GO:0006544;GO:0006164;GO:0009168;GO:0010035;GO:0010033;GO:0046654;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylamine-glycine ligase activity; F:phosphoribosylformylglycinamidine cyclo-ligase activity; F:phosphoribosylglycinamide formyltransferase activity;, P:'de novo' IMP biosynthetic process; P:adenine biosynthetic process; P:brainstem development; P:cerebellum development; P:cerebral cortex development; P:glycine metabolic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:response to organic substance; P:tetrahydrofolate biosynthetic process;|P22102 A8K945 A8KA32 D3DSF3 D3DSF4 O14659 Q52M77,Trifunctional purine biosynthetic protein adenosine-3,, PF00586;PF02769;PF00551;PF01071;PF02843;PF02844;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004637;GO:0004641;GO:0004644;GO:0006189;GO:0046084;GO:0003360;GO:0021549;GO:0021987;GO:0006544;GO:0006164;GO:0009168;GO:0010035;GO:0010033;GO:0046654;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylamine-glycine ligase activity; F:phosphoribosylformylglycinamidine cyclo-ligase activity; F:phosphoribosylglycinamide formyltransferase activity;, P:'de novo' IMP biosynthetic process; P:adenine biosynthetic process; P:brainstem development; P:cerebellum development; P:cerebral cortex development; P:glycine metabolic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:response to organic substance; P:tetrahydrofolate biosynthetic process;|P22102 A8K945 A8KA32 D3DSF3 D3DSF4 O14659 Q52M77,Trifunctional purine biosynthetic protein adenosine-3,, PF00586;PF02769;PF00551;PF01071;PF02843;PF02844;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004637;GO:0004641;GO:0004644;GO:0006189;GO:0046084;GO:0003360;GO:0021549;GO:0021987;GO:0006544;GO:0006164;GO:0009168;GO:0010035;GO:0010033;GO:0046654;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylamine-glycine ligase activity; F:phosphoribosylformylglycinamidine cyclo-ligase activity; F:phosphoribosylglycinamide formyltransferase activity;, P:'de novo' IMP biosynthetic process; P:adenine biosynthetic process; P:brainstem development; P:cerebellum development; P:cerebral cortex development; P:glycine metabolic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:response to organic substance; P:tetrahydrofolate biosynthetic process;|P22102 A8K945 A8KA32 D3DSF3 D3DSF4 O14659 Q52M77,Trifunctional purine biosynthetic protein adenosine-3,, PF00586;PF02769;PF00551;PF01071;PF02843;PF02844;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004637;GO:0004641;GO:0004644;GO:0006189;GO:0046084;GO:0003360;GO:0021549;GO:0021987;GO:0006544;GO:0006164;GO:0009168;GO:0010035;GO:0010033;GO:0046654;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylamine-glycine ligase activity; F:phosphoribosylformylglycinamidine cyclo-ligase activity; F:phosphoribosylglycinamide formyltransferase activity;, P:'de novo' IMP biosynthetic process; P:adenine biosynthetic process; P:brainstem development; P:cerebellum development; P:cerebral cortex development; P:glycine metabolic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:response to organic substance; P:tetrahydrofolate biosynthetic process;|P22102 A8K945 A8KA32 D3DSF3 D3DSF4 O14659 Q52M77,Trifunctional purine biosynthetic protein adenosine-3,, PF00586;PF02769;PF00551;PF01071;PF02843;PF02844;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004637;GO:0004641;GO:0004644;GO:0006189;GO:0046084;GO:0003360;GO:0021549;GO:0021987;GO:0006544;GO:0006164;GO:0009168;GO:0010035;GO:0010033;GO:0046654;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylamine-glycine ligase activity; F:phosphoribosylformylglycinamidine cyclo-ligase activity; F:phosphoribosylglycinamide formyltransferase activity;, P:'de novo' IMP biosynthetic process; P:adenine biosynthetic process; P:brainstem development; P:cerebellum development; P:cerebral cortex development; P:glycine metabolic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:response to organic substance; P:tetrahydrofolate biosynthetic process; scaffold7 indexed_genome mRNA 8411695 8416202 . + . ID=transcript_1928;Q9NX36 D3DSF2,DnaJ homolog subfamily C member 28,, PF00226;PF09350;, GO:0017119;GO:0007030;GO:0048213;GO:0006890;, C:Golgi transport complex;, , P:Golgi organization; P:Golgi vesicle prefusion complex stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold7 indexed_genome mRNA 8457302 8475463 . + . ID=transcript_1929;P56557 B2R4L4 D3DSF1 O60537 Q5PY47,Transmembrane protein 50B,HCV p7-trans-regulated protein 3;, PF05255;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005886;GO:0032511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, , P:late endosome to vacuole transport via multivesicular body sorting pathway;|P56557 B2R4L4 D3DSF1 O60537 Q5PY47,Transmembrane protein 50B,HCV p7-trans-regulated protein 3;, PF05255;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005886;GO:0032511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, , P:late endosome to vacuole transport via multivesicular body sorting pathway;|P56557 B2R4L4 D3DSF1 O60537 Q5PY47,Transmembrane protein 50B,HCV p7-trans-regulated protein 3;, PF05255;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005886;GO:0032511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, , P:late endosome to vacuole transport via multivesicular body sorting pathway; scaffold7 indexed_genome mRNA 8487266 8512771 . - . ID=transcript_1930;P38484 Q9BTL5,Interferon gamma receptor 2 {ECO:0000312|HGNC:HGNC:5440},Interferon gamma receptor accessory factor 1 {ECO:0000303|PubMed:8124716};Interferon gamma receptor beta-chain {ECO:0000303|PubMed:7615558};Interferon gamma transducer 1 {ECO:0000312|HGNC:HGNC:5440};, PF09294;PF01108;, GO:0030659;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005887;GO:0005886;GO:0004896;GO:0004906;GO:0007166;GO:0019221;GO:0060333;GO:0060334;GO:0009615;, C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine receptor activity; F:interferon-gamma receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:regulation of interferon-gamma-mediated signaling pathway; P:response to virus;|P38484 Q9BTL5,Interferon gamma receptor 2 {ECO:0000312|HGNC:HGNC:5440},Interferon gamma receptor accessory factor 1 {ECO:0000303|PubMed:8124716};Interferon gamma receptor beta-chain {ECO:0000303|PubMed:7615558};Interferon gamma transducer 1 {ECO:0000312|HGNC:HGNC:5440};, PF09294;PF01108;, GO:0030659;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005887;GO:0005886;GO:0004896;GO:0004906;GO:0007166;GO:0019221;GO:0060333;GO:0060334;GO:0009615;, C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine receptor activity; F:interferon-gamma receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:regulation of interferon-gamma-mediated signaling pathway; P:response to virus;|P38484 Q9BTL5,Interferon gamma receptor 2 {ECO:0000312|HGNC:HGNC:5440},Interferon gamma receptor accessory factor 1 {ECO:0000303|PubMed:8124716};Interferon gamma receptor beta-chain {ECO:0000303|PubMed:7615558};Interferon gamma transducer 1 {ECO:0000312|HGNC:HGNC:5440};, PF09294;PF01108;, GO:0030659;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005887;GO:0005886;GO:0004896;GO:0004906;GO:0007166;GO:0019221;GO:0060333;GO:0060334;GO:0009615;, C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine receptor activity; F:interferon-gamma receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:regulation of interferon-gamma-mediated signaling pathway; P:response to virus;|P38484 Q9BTL5,Interferon gamma receptor 2 {ECO:0000312|HGNC:HGNC:5440},Interferon gamma receptor accessory factor 1 {ECO:0000303|PubMed:8124716};Interferon gamma receptor beta-chain {ECO:0000303|PubMed:7615558};Interferon gamma transducer 1 {ECO:0000312|HGNC:HGNC:5440};, PF09294;PF01108;, GO:0030659;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005887;GO:0005886;GO:0004896;GO:0004906;GO:0007166;GO:0019221;GO:0060333;GO:0060334;GO:0009615;, C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine receptor activity; F:interferon-gamma receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:regulation of interferon-gamma-mediated signaling pathway; P:response to virus; scaffold7 indexed_genome mRNA 8591141 8618588 . - . ID=transcript_1931;P17181 B2R6L9 B4DNT3 D3DSF0 Q53GW9 Q53H11 Q6PKD7 Q7M4L2 Q8WTZ2,Interferon alpha/beta receptor 1,Cytokine receptor class-II member 1;Cytokine receptor family 2 member 1;Type I interferon receptor 1;, PF09294;PF01108;, GO:0016021;GO:0005887;GO:0005770;GO:0005764;GO:0005886;GO:0004896;GO:0019962;GO:0004905;GO:0035457;GO:0019221;GO:0007259;GO:0032496;GO:0009615;GO:0060337;, C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:plasma membrane;, F:cytokine receptor activity; F:type I interferon binding; F:type I interferon receptor activity;, P:cellular response to interferon-alpha; P:cytokine-mediated signaling pathway; P:receptor signaling pathway via JAK-STAT; P:response to lipopolysaccharide; P:response to virus; P:type I interferon signaling pathway;|P17181 B2R6L9 B4DNT3 D3DSF0 Q53GW9 Q53H11 Q6PKD7 Q7M4L2 Q8WTZ2,Interferon alpha/beta receptor 1,Cytokine receptor class-II member 1;Cytokine receptor family 2 member 1;Type I interferon receptor 1;, PF09294;PF01108;, GO:0016021;GO:0005887;GO:0005770;GO:0005764;GO:0005886;GO:0004896;GO:0019962;GO:0004905;GO:0035457;GO:0019221;GO:0007259;GO:0032496;GO:0009615;GO:0060337;, C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:plasma membrane;, F:cytokine receptor activity; F:type I interferon binding; F:type I interferon receptor activity;, P:cellular response to interferon-alpha; P:cytokine-mediated signaling pathway; P:receptor signaling pathway via JAK-STAT; P:response to lipopolysaccharide; P:response to virus; P:type I interferon signaling pathway;|P17181 B2R6L9 B4DNT3 D3DSF0 Q53GW9 Q53H11 Q6PKD7 Q7M4L2 Q8WTZ2,Interferon alpha/beta receptor 1,Cytokine receptor class-II member 1;Cytokine receptor family 2 member 1;Type I interferon receptor 1;, PF09294;PF01108;, GO:0016021;GO:0005887;GO:0005770;GO:0005764;GO:0005886;GO:0004896;GO:0019962;GO:0004905;GO:0035457;GO:0019221;GO:0007259;GO:0032496;GO:0009615;GO:0060337;, C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:plasma membrane;, F:cytokine receptor activity; F:type I interferon binding; F:type I interferon receptor activity;, P:cellular response to interferon-alpha; P:cytokine-mediated signaling pathway; P:receptor signaling pathway via JAK-STAT; P:response to lipopolysaccharide; P:response to virus; P:type I interferon signaling pathway; scaffold7 indexed_genome mRNA 8683701 8711275 . - . ID=transcript_1932;Q08334 Q9BUU4,Interleukin-10 receptor subunit beta,Cytokine receptor class-II member 4;Cytokine receptor family 2 member 4;Interleukin-10 receptor subunit 2;, PF09294;PF01108;, GO:0016021;GO:0032002;GO:0005886;GO:0004896;GO:0004920;GO:0038023;GO:0019221;GO:0051607;GO:0006955;GO:0006954;GO:0046427;GO:0007165;, C:integral component of membrane; C:interleukin-28 receptor complex; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-10 receptor activity; F:signaling receptor activity;, P:cytokine-mediated signaling pathway; P:defense response to virus; P:immune response; P:inflammatory response; P:positive regulation of receptor signaling pathway via JAK-STAT; P:signal transduction;|Q08334 Q9BUU4,Interleukin-10 receptor subunit beta,Cytokine receptor class-II member 4;Cytokine receptor family 2 member 4;Interleukin-10 receptor subunit 2;, PF09294;PF01108;, GO:0016021;GO:0032002;GO:0005886;GO:0004896;GO:0004920;GO:0038023;GO:0019221;GO:0051607;GO:0006955;GO:0006954;GO:0046427;GO:0007165;, C:integral component of membrane; C:interleukin-28 receptor complex; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-10 receptor activity; F:signaling receptor activity;, P:cytokine-mediated signaling pathway; P:defense response to virus; P:immune response; P:inflammatory response; P:positive regulation of receptor signaling pathway via JAK-STAT; P:signal transduction; scaffold7 indexed_genome mRNA 8718386 8752417 . - . ID=transcript_1933;P48551 A8KAJ4 D3DSE8 D3DSE9 Q15467 Q6FHD7,Interferon alpha/beta receptor 2,Interferon alpha binding protein;Type I interferon receptor 2;, PF09294;PF01108;, GO:0005576;GO:0005615;GO:0016021;GO:0005887;GO:0005886;GO:0004896;GO:0019901;GO:0019962;GO:0004905;GO:0007166;GO:0019221;GO:0051607;GO:0007259;GO:0060338;GO:0035455;GO:0035456;GO:0009615;GO:0060337;, C:extracellular region; C:extracellular space; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine receptor activity; F:protein kinase binding; F:type I interferon binding; F:type I interferon receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of type I interferon-mediated signaling pathway; P:response to interferon-alpha; P:response to interferon-beta; P:response to virus; P:type I interferon signaling pathway;|P48551 A8KAJ4 D3DSE8 D3DSE9 Q15467 Q6FHD7,Interferon alpha/beta receptor 2,Interferon alpha binding protein;Type I interferon receptor 2;, PF09294;PF01108;, GO:0005576;GO:0005615;GO:0016021;GO:0005887;GO:0005886;GO:0004896;GO:0019901;GO:0019962;GO:0004905;GO:0007166;GO:0019221;GO:0051607;GO:0007259;GO:0060338;GO:0035455;GO:0035456;GO:0009615;GO:0060337;, C:extracellular region; C:extracellular space; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine receptor activity; F:protein kinase binding; F:type I interferon binding; F:type I interferon receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of type I interferon-mediated signaling pathway; P:response to interferon-alpha; P:response to interferon-beta; P:response to virus; P:type I interferon signaling pathway;|P48551 A8KAJ4 D3DSE8 D3DSE9 Q15467 Q6FHD7,Interferon alpha/beta receptor 2,Interferon alpha binding protein;Type I interferon receptor 2;, PF09294;PF01108;, GO:0005576;GO:0005615;GO:0016021;GO:0005887;GO:0005886;GO:0004896;GO:0019901;GO:0019962;GO:0004905;GO:0007166;GO:0019221;GO:0051607;GO:0007259;GO:0060338;GO:0035455;GO:0035456;GO:0009615;GO:0060337;, C:extracellular region; C:extracellular space; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine receptor activity; F:protein kinase binding; F:type I interferon binding; F:type I interferon receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of type I interferon-mediated signaling pathway; P:response to interferon-alpha; P:response to interferon-beta; P:response to virus; P:type I interferon signaling pathway; scaffold7 indexed_genome mRNA 9170130 9171706 . + . ID=transcript_1934;Q9NYP8 A8K4L8,Uncharacterized protein C21orf62,B37;, PF15137; scaffold7 indexed_genome mRNA 9201298 9233824 . - . ID=transcript_1935;Q9Y5B6 D3DSE7 Q96DU8 Q9NYQ0,PAX3- and PAX7-binding protein 1,GC-rich sequence DNA-binding factor 1;, PF07842;, GO:0005829;GO:0005634;GO:0003677;GO:0008134;GO:0000398;GO:0007517;GO:0031062;GO:2000288;GO:0045944;GO:0014842;, C:cytosol; C:nucleus;, F:DNA binding; F:transcription factor binding;, P:mRNA splicing, via spliceosome; P:muscle organ development; P:positive regulation of histone methylation; P:positive regulation of myoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of skeletal muscle satellite cell proliferation;|Q9Y5B6 D3DSE7 Q96DU8 Q9NYQ0,PAX3- and PAX7-binding protein 1,GC-rich sequence DNA-binding factor 1;, PF07842;, GO:0005829;GO:0005634;GO:0003677;GO:0008134;GO:0000398;GO:0007517;GO:0031062;GO:2000288;GO:0045944;GO:0014842;, C:cytosol; C:nucleus;, F:DNA binding; F:transcription factor binding;, P:mRNA splicing, via spliceosome; P:muscle organ development; P:positive regulation of histone methylation; P:positive regulation of myoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of skeletal muscle satellite cell proliferation;|Q9Y5B6 D3DSE7 Q96DU8 Q9NYQ0,PAX3- and PAX7-binding protein 1,GC-rich sequence DNA-binding factor 1;, PF07842;, GO:0005829;GO:0005634;GO:0003677;GO:0008134;GO:0000398;GO:0007517;GO:0031062;GO:2000288;GO:0045944;GO:0014842;, C:cytosol; C:nucleus;, F:DNA binding; F:transcription factor binding;, P:mRNA splicing, via spliceosome; P:muscle organ development; P:positive regulation of histone methylation; P:positive regulation of myoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of skeletal muscle satellite cell proliferation;|Q9Y5B6 D3DSE7 Q96DU8 Q9NYQ0,PAX3- and PAX7-binding protein 1,GC-rich sequence DNA-binding factor 1;, PF07842;, GO:0005829;GO:0005634;GO:0003677;GO:0008134;GO:0000398;GO:0007517;GO:0031062;GO:2000288;GO:0045944;GO:0014842;, C:cytosol; C:nucleus;, F:DNA binding; F:transcription factor binding;, P:mRNA splicing, via spliceosome; P:muscle organ development; P:positive regulation of histone methylation; P:positive regulation of myoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of skeletal muscle satellite cell proliferation;|Q9Y5B6 D3DSE7 Q96DU8 Q9NYQ0,PAX3- and PAX7-binding protein 1,GC-rich sequence DNA-binding factor 1;, PF07842;, GO:0005829;GO:0005634;GO:0003677;GO:0008134;GO:0000398;GO:0007517;GO:0031062;GO:2000288;GO:0045944;GO:0014842;, C:cytosol; C:nucleus;, F:DNA binding; F:transcription factor binding;, P:mRNA splicing, via spliceosome; P:muscle organ development; P:positive regulation of histone methylation; P:positive regulation of myoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of skeletal muscle satellite cell proliferation;|Q9Y5B6 D3DSE7 Q96DU8 Q9NYQ0,PAX3- and PAX7-binding protein 1,GC-rich sequence DNA-binding factor 1;, PF07842;, GO:0005829;GO:0005634;GO:0003677;GO:0008134;GO:0000398;GO:0007517;GO:0031062;GO:2000288;GO:0045944;GO:0014842;, C:cytosol; C:nucleus;, F:DNA binding; F:transcription factor binding;, P:mRNA splicing, via spliceosome; P:muscle organ development; P:positive regulation of histone methylation; P:positive regulation of myoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of skeletal muscle satellite cell proliferation;|Q9Y5B6 D3DSE7 Q96DU8 Q9NYQ0,PAX3- and PAX7-binding protein 1,GC-rich sequence DNA-binding factor 1;, PF07842;, GO:0005829;GO:0005634;GO:0003677;GO:0008134;GO:0000398;GO:0007517;GO:0031062;GO:2000288;GO:0045944;GO:0014842;, C:cytosol; C:nucleus;, F:DNA binding; F:transcription factor binding;, P:mRNA splicing, via spliceosome; P:muscle organ development; P:positive regulation of histone methylation; P:positive regulation of myoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of skeletal muscle satellite cell proliferation; scaffold7 indexed_genome mRNA 9234036 9280671 . + . ID=transcript_1936;O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating; scaffold7 indexed_genome mRNA 9283183 9285737 . + . ID=transcript_1937;O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating;|O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating; scaffold7 indexed_genome mRNA 9288191 9291217 . - . ID=transcript_1938;O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating;|O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating; scaffold7 indexed_genome mRNA 9297736 9308817 . + . ID=transcript_1939;O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating;|O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating;|O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating; scaffold7 indexed_genome mRNA 9308831 9328247 . + . ID=transcript_1940;O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating;|O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating;|O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating;|O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating; scaffold7 indexed_genome mRNA 9329878 9332608 . + . ID=transcript_1941;P62847 E7EPK6 P16632 Q5T0P7 Q5T0P8 Q7Z3D1,40S ribosomal protein S24,Small ribosomal subunit protein eS24 {ECO:0000303|PubMed:24524803};, PF01282;, GO:0005829;GO:0022627;GO:0005783;GO:0016020;GO:0005654;GO:0005634;GO:0015935;GO:0003723;GO:0003735;GO:0031369;GO:0034101;GO:0000184;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:membrane; C:nucleoplasm; C:nucleus; C:small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome; F:translation initiation factor binding;, P:erythrocyte homeostasis; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold7 indexed_genome mRNA 9333554 9361297 . + . ID=transcript_1942;P57076 Q53FH0,Cilia- and flagella-associated protein 298 {ECO:0000305},Protein kurly homolog {ECO:0000305};, PF11069;, GO:0005929;GO:0005856;GO:0005829;GO:0005634;GO:0060271;GO:0003352;, C:cilium; C:cytoskeleton; C:cytosol; C:nucleus;, , P:cilium assembly; P:regulation of cilium movement;|P57076 Q53FH0,Cilia- and flagella-associated protein 298 {ECO:0000305},Protein kurly homolog {ECO:0000305};, PF11069;, GO:0005929;GO:0005856;GO:0005829;GO:0005634;GO:0060271;GO:0003352;, C:cilium; C:cytoskeleton; C:cytosol; C:nucleus;, , P:cilium assembly; P:regulation of cilium movement;|P57076 Q53FH0,Cilia- and flagella-associated protein 298 {ECO:0000305},Protein kurly homolog {ECO:0000305};, PF11069;, GO:0005929;GO:0005856;GO:0005829;GO:0005634;GO:0060271;GO:0003352;, C:cilium; C:cytoskeleton; C:cytosol; C:nucleus;, , P:cilium assembly; P:regulation of cilium movement;|P57076 Q53FH0,Cilia- and flagella-associated protein 298 {ECO:0000305},Protein kurly homolog {ECO:0000305};, PF11069;, GO:0005929;GO:0005856;GO:0005829;GO:0005634;GO:0060271;GO:0003352;, C:cilium; C:cytoskeleton; C:cytosol; C:nucleus;, , P:cilium assembly; P:regulation of cilium movement;|P57076 Q53FH0,Cilia- and flagella-associated protein 298 {ECO:0000305},Protein kurly homolog {ECO:0000305};, PF11069;, GO:0005929;GO:0005856;GO:0005829;GO:0005634;GO:0060271;GO:0003352;, C:cilium; C:cytoskeleton; C:cytosol; C:nucleus;, , P:cilium assembly; P:regulation of cilium movement;|P57076 Q53FH0,Cilia- and flagella-associated protein 298 {ECO:0000305},Protein kurly homolog {ECO:0000305};, PF11069;, GO:0005929;GO:0005856;GO:0005829;GO:0005634;GO:0060271;GO:0003352;, C:cilium; C:cytoskeleton; C:cytosol; C:nucleus;, , P:cilium assembly; P:regulation of cilium movement; scaffold7 indexed_genome mRNA 9396992 9431326 . - . ID=transcript_1943;P58658 A6ND58 Q8IXZ0,Protein eva-1 homolog C,Protein FAM176C;SUE21;, PF14851;PF02140;, GO:0016021;GO:0030246;GO:0008201;, C:integral component of membrane;, F:carbohydrate binding; F:heparin binding;|P58658 A6ND58 Q8IXZ0,Protein eva-1 homolog C,Protein FAM176C;SUE21;, PF14851;PF02140;, GO:0016021;GO:0030246;GO:0008201;, C:integral component of membrane;, F:carbohydrate binding; F:heparin binding; scaffold7 indexed_genome mRNA 9444238 9491095 . - . ID=transcript_1944;P58658 A6ND58 Q8IXZ0,Protein eva-1 homolog C,Protein FAM176C;SUE21;, PF14851;PF02140;, GO:0016021;GO:0030246;GO:0008201;, C:integral component of membrane;, F:carbohydrate binding; F:heparin binding; scaffold7 indexed_genome mRNA 9509503 9582900 . + . ID=transcript_1945;O60287 D3DSE5 Q96NX1 Q9NYQ1,Nucleolar pre-ribosomal-associated protein 1,Nucleolar protein 254 kDa;URB1 ribosome biogenesis 1 homolog;, PF16201;PF11707;, GO:0001650;GO:0005730;GO:0003723;GO:0000466;GO:0000463;, C:fibrillar center; C:nucleolus;, F:RNA binding;, P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|O60287 D3DSE5 Q96NX1 Q9NYQ1,Nucleolar pre-ribosomal-associated protein 1,Nucleolar protein 254 kDa;URB1 ribosome biogenesis 1 homolog;, PF16201;PF11707;, GO:0001650;GO:0005730;GO:0003723;GO:0000466;GO:0000463;, C:fibrillar center; C:nucleolus;, F:RNA binding;, P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|O60287 D3DSE5 Q96NX1 Q9NYQ1,Nucleolar pre-ribosomal-associated protein 1,Nucleolar protein 254 kDa;URB1 ribosome biogenesis 1 homolog;, PF16201;PF11707;, GO:0001650;GO:0005730;GO:0003723;GO:0000466;GO:0000463;, C:fibrillar center; C:nucleolus;, F:RNA binding;, P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|O60287 D3DSE5 Q96NX1 Q9NYQ1,Nucleolar pre-ribosomal-associated protein 1,Nucleolar protein 254 kDa;URB1 ribosome biogenesis 1 homolog;, PF16201;PF11707;, GO:0001650;GO:0005730;GO:0003723;GO:0000466;GO:0000463;, C:fibrillar center; C:nucleolus;, F:RNA binding;, P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); scaffold7 indexed_genome mRNA 9624892 9634748 . + . ID=transcript_1946;Q9NYP9 B2R562 Q542Z0,Protein Mis18-alpha,FAPP1-associated protein 1;, PF03226;, GO:0000785;GO:0000775;GO:0005829;GO:0005654;GO:0005634;GO:0042802;GO:0046872;GO:0007049;GO:0051301;GO:0034080;GO:0007059;GO:0044030;, C:chromatin; C:chromosome, centromeric region; C:cytosol; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:metal ion binding;, P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; P:chromosome segregation; P:regulation of DNA methylation; scaffold7 indexed_genome mRNA 9889235 10014571 . - . ID=transcript_1947;P57058,Hormonally up-regulated neu tumor-associated kinase,B19;Serine/threonine-protein kinase MAK-V;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0007275;GO:0006468;GO:0007165;, C:cytoplasm; C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:multicellular organism development; P:protein phosphorylation; P:signal transduction; scaffold7 indexed_genome mRNA 10191749 10230947 . + . ID=transcript_1948;O95104 C9JLZ0 Q0P5W8 Q6P1M5 Q8N3I8 Q9UFM1 Q9ULP8,SR-related and CTD-associated factor 4 {ECO:0000303|PubMed:31104839},CTD-binding SR-like protein RA4 {ECO:0000305};Splicing factor, arginine/serine-rich 15 {ECO:0000305};, PF04818;PF00076;, GO:0005654;GO:0005634;GO:0008022;GO:0003723;GO:1990269;GO:0006397;GO:2000805;, C:nucleoplasm; C:nucleus;, F:protein C-terminus binding; F:RNA binding; F:RNA polymerase II C-terminal domain phosphoserine binding;, P:mRNA processing; P:negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled;|O95104 C9JLZ0 Q0P5W8 Q6P1M5 Q8N3I8 Q9UFM1 Q9ULP8,SR-related and CTD-associated factor 4 {ECO:0000303|PubMed:31104839},CTD-binding SR-like protein RA4 {ECO:0000305};Splicing factor, arginine/serine-rich 15 {ECO:0000305};, PF04818;PF00076;, GO:0005654;GO:0005634;GO:0008022;GO:0003723;GO:1990269;GO:0006397;GO:2000805;, C:nucleoplasm; C:nucleus;, F:protein C-terminus binding; F:RNA binding; F:RNA polymerase II C-terminal domain phosphoserine binding;, P:mRNA processing; P:negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled;|O95104 C9JLZ0 Q0P5W8 Q6P1M5 Q8N3I8 Q9UFM1 Q9ULP8,SR-related and CTD-associated factor 4 {ECO:0000303|PubMed:31104839},CTD-binding SR-like protein RA4 {ECO:0000305};Splicing factor, arginine/serine-rich 15 {ECO:0000305};, PF04818;PF00076;, GO:0005654;GO:0005634;GO:0008022;GO:0003723;GO:1990269;GO:0006397;GO:2000805;, C:nucleoplasm; C:nucleus;, F:protein C-terminus binding; F:RNA binding; F:RNA polymerase II C-terminal domain phosphoserine binding;, P:mRNA processing; P:negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled;|O95104 C9JLZ0 Q0P5W8 Q6P1M5 Q8N3I8 Q9UFM1 Q9ULP8,SR-related and CTD-associated factor 4 {ECO:0000303|PubMed:31104839},CTD-binding SR-like protein RA4 {ECO:0000305};Splicing factor, arginine/serine-rich 15 {ECO:0000305};, PF04818;PF00076;, GO:0005654;GO:0005634;GO:0008022;GO:0003723;GO:1990269;GO:0006397;GO:2000805;, C:nucleoplasm; C:nucleus;, F:protein C-terminus binding; F:RNA binding; F:RNA polymerase II C-terminal domain phosphoserine binding;, P:mRNA processing; P:negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled; scaffold7 indexed_genome mRNA 10232855 10256122 . + . ID=transcript_1949;P00441 A6NHJ0 D3DSE4 Q16669 Q16711 Q16838 Q16839 Q16840 Q6NR85,Superoxide dismutase [Cu-Zn],Superoxide dismutase 1;, PF00080;, GO:1904115;GO:0005737;GO:0031410;GO:0005829;GO:0032839;GO:0031045;GO:0070062;GO:0005576;GO:0005615;GO:0005764;GO:0005758;GO:0005759;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0005777;GO:0032991;GO:0051087;GO:0005507;GO:0042802;GO:0030346;GO:0031267;GO:0004784;GO:0008270;GO:0000187;GO:0008089;GO:0060088;GO:0007569;GO:0006879;GO:0071318;GO:0071276;GO:0034599;GO:0035865;GO:0007566;GO:0006749;GO:0060047;GO:0050665;GO:0035722;GO:0007626;GO:0046716;GO:0002262;GO:0045541;GO:0050728;GO:0043524;GO:0060052;GO:0001541;GO:0032287;GO:0001890;GO:0002576;GO:0043065;GO:0043085;GO:0001819;GO:1902177;GO:0050766;GO:0032930;GO:0072593;GO:0008217;GO:0043087;GO:0051881;GO:0040014;GO:0046620;GO:0045859;GO:0033081;GO:0060087;GO:0019430;GO:0001975;GO:0046677;GO:0097332;GO:0048678;GO:0034465;GO:0046688;GO:0042493;GO:0045471;GO:0009408;GO:0042542;GO:0031667;GO:0010033;GO:0000303;GO:0001895;GO:0008090;GO:0007605;GO:0007283;GO:0042554;GO:0006801;GO:0048538;GO:0019226;, C:axon cytoplasm; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite cytoplasm; C:dense core granule; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:peroxisome; C:protein-containing complex;, F:chaperone binding; F:copper ion binding; F:identical protein binding; F:protein phosphatase 2B binding; F:small GTPase binding; F:superoxide dismutase activity; F:zinc ion binding;, P:activation of MAPK activity; P:anterograde axonal transport; P:auditory receptor cell stereocilium organization; P:cell aging; P:cellular iron ion homeostasis; P:cellular response to ATP; P:cellular response to cadmium ion; P:cellular response to oxidative stress; P:cellular response to potassium ion; P:embryo implantation; P:glutathione metabolic process; P:heart contraction; P:hydrogen peroxide biosynthetic process; P:interleukin-12-mediated signaling pathway; P:locomotory behavior; P:muscle cell cellular homeostasis; P:myeloid cell homeostasis; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of inflammatory response; P:negative regulation of neuron apoptotic process; P:neurofilament cytoskeleton organization; P:ovarian follicle development; P:peripheral nervous system myelin maintenance; P:placenta development; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of cytokine production; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of phagocytosis; P:positive regulation of superoxide anion generation; P:reactive oxygen species metabolic process; P:regulation of blood pressure; P:regulation of GTPase activity; P:regulation of mitochondrial membrane potential; P:regulation of multicellular organism growth; P:regulation of organ growth; P:regulation of protein kinase activity; P:regulation of T cell differentiation in thymus; P:relaxation of vascular associated smooth muscle; P:removal of superoxide radicals; P:response to amphetamine; P:response to antibiotic; P:response to antipsychotic drug; P:response to axon injury; P:response to carbon monoxide; P:response to copper ion; P:response to drug; P:response to ethanol; P:response to heat; P:response to hydrogen peroxide; P:response to nutrient levels; P:response to organic substance; P:response to superoxide; P:retina homeostasis; P:retrograde axonal transport; P:sensory perception of sound; P:spermatogenesis; P:superoxide anion generation; P:superoxide metabolic process; P:thymus development; P:transmission of nerve impulse;|P00441 A6NHJ0 D3DSE4 Q16669 Q16711 Q16838 Q16839 Q16840 Q6NR85,Superoxide dismutase [Cu-Zn],Superoxide dismutase 1;, PF00080;, GO:1904115;GO:0005737;GO:0031410;GO:0005829;GO:0032839;GO:0031045;GO:0070062;GO:0005576;GO:0005615;GO:0005764;GO:0005758;GO:0005759;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0005777;GO:0032991;GO:0051087;GO:0005507;GO:0042802;GO:0030346;GO:0031267;GO:0004784;GO:0008270;GO:0000187;GO:0008089;GO:0060088;GO:0007569;GO:0006879;GO:0071318;GO:0071276;GO:0034599;GO:0035865;GO:0007566;GO:0006749;GO:0060047;GO:0050665;GO:0035722;GO:0007626;GO:0046716;GO:0002262;GO:0045541;GO:0050728;GO:0043524;GO:0060052;GO:0001541;GO:0032287;GO:0001890;GO:0002576;GO:0043065;GO:0043085;GO:0001819;GO:1902177;GO:0050766;GO:0032930;GO:0072593;GO:0008217;GO:0043087;GO:0051881;GO:0040014;GO:0046620;GO:0045859;GO:0033081;GO:0060087;GO:0019430;GO:0001975;GO:0046677;GO:0097332;GO:0048678;GO:0034465;GO:0046688;GO:0042493;GO:0045471;GO:0009408;GO:0042542;GO:0031667;GO:0010033;GO:0000303;GO:0001895;GO:0008090;GO:0007605;GO:0007283;GO:0042554;GO:0006801;GO:0048538;GO:0019226;, C:axon cytoplasm; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite cytoplasm; C:dense core granule; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:peroxisome; C:protein-containing complex;, F:chaperone binding; F:copper ion binding; F:identical protein binding; F:protein phosphatase 2B binding; F:small GTPase binding; F:superoxide dismutase activity; F:zinc ion binding;, P:activation of MAPK activity; P:anterograde axonal transport; P:auditory receptor cell stereocilium organization; P:cell aging; P:cellular iron ion homeostasis; P:cellular response to ATP; P:cellular response to cadmium ion; P:cellular response to oxidative stress; P:cellular response to potassium ion; P:embryo implantation; P:glutathione metabolic process; P:heart contraction; P:hydrogen peroxide biosynthetic process; P:interleukin-12-mediated signaling pathway; P:locomotory behavior; P:muscle cell cellular homeostasis; P:myeloid cell homeostasis; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of inflammatory response; P:negative regulation of neuron apoptotic process; P:neurofilament cytoskeleton organization; P:ovarian follicle development; P:peripheral nervous system myelin maintenance; P:placenta development; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of cytokine production; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of phagocytosis; P:positive regulation of superoxide anion generation; P:reactive oxygen species metabolic process; P:regulation of blood pressure; P:regulation of GTPase activity; P:regulation of mitochondrial membrane potential; P:regulation of multicellular organism growth; P:regulation of organ growth; P:regulation of protein kinase activity; P:regulation of T cell differentiation in thymus; P:relaxation of vascular associated smooth muscle; P:removal of superoxide radicals; P:response to amphetamine; P:response to antibiotic; P:response to antipsychotic drug; P:response to axon injury; P:response to carbon monoxide; P:response to copper ion; P:response to drug; P:response to ethanol; P:response to heat; P:response to hydrogen peroxide; P:response to nutrient levels; P:response to organic substance; P:response to superoxide; P:retina homeostasis; P:retrograde axonal transport; P:sensory perception of sound; P:spermatogenesis; P:superoxide anion generation; P:superoxide metabolic process; P:thymus development; P:transmission of nerve impulse;|P00441 A6NHJ0 D3DSE4 Q16669 Q16711 Q16838 Q16839 Q16840 Q6NR85,Superoxide dismutase [Cu-Zn],Superoxide dismutase 1;, PF00080;, GO:1904115;GO:0005737;GO:0031410;GO:0005829;GO:0032839;GO:0031045;GO:0070062;GO:0005576;GO:0005615;GO:0005764;GO:0005758;GO:0005759;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0005777;GO:0032991;GO:0051087;GO:0005507;GO:0042802;GO:0030346;GO:0031267;GO:0004784;GO:0008270;GO:0000187;GO:0008089;GO:0060088;GO:0007569;GO:0006879;GO:0071318;GO:0071276;GO:0034599;GO:0035865;GO:0007566;GO:0006749;GO:0060047;GO:0050665;GO:0035722;GO:0007626;GO:0046716;GO:0002262;GO:0045541;GO:0050728;GO:0043524;GO:0060052;GO:0001541;GO:0032287;GO:0001890;GO:0002576;GO:0043065;GO:0043085;GO:0001819;GO:1902177;GO:0050766;GO:0032930;GO:0072593;GO:0008217;GO:0043087;GO:0051881;GO:0040014;GO:0046620;GO:0045859;GO:0033081;GO:0060087;GO:0019430;GO:0001975;GO:0046677;GO:0097332;GO:0048678;GO:0034465;GO:0046688;GO:0042493;GO:0045471;GO:0009408;GO:0042542;GO:0031667;GO:0010033;GO:0000303;GO:0001895;GO:0008090;GO:0007605;GO:0007283;GO:0042554;GO:0006801;GO:0048538;GO:0019226;, C:axon cytoplasm; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite cytoplasm; C:dense core granule; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:peroxisome; C:protein-containing complex;, F:chaperone binding; F:copper ion binding; F:identical protein binding; F:protein phosphatase 2B binding; F:small GTPase binding; F:superoxide dismutase activity; F:zinc ion binding;, P:activation of MAPK activity; P:anterograde axonal transport; P:auditory receptor cell stereocilium organization; P:cell aging; P:cellular iron ion homeostasis; P:cellular response to ATP; P:cellular response to cadmium ion; P:cellular response to oxidative stress; P:cellular response to potassium ion; P:embryo implantation; P:glutathione metabolic process; P:heart contraction; P:hydrogen peroxide biosynthetic process; P:interleukin-12-mediated signaling pathway; P:locomotory behavior; P:muscle cell cellular homeostasis; P:myeloid cell homeostasis; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of inflammatory response; P:negative regulation of neuron apoptotic process; P:neurofilament cytoskeleton organization; P:ovarian follicle development; P:peripheral nervous system myelin maintenance; P:placenta development; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of cytokine production; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of phagocytosis; P:positive regulation of superoxide anion generation; P:reactive oxygen species metabolic process; P:regulation of blood pressure; P:regulation of GTPase activity; P:regulation of mitochondrial membrane potential; P:regulation of multicellular organism growth; P:regulation of organ growth; P:regulation of protein kinase activity; P:regulation of T cell differentiation in thymus; P:relaxation of vascular associated smooth muscle; P:removal of superoxide radicals; P:response to amphetamine; P:response to antibiotic; P:response to antipsychotic drug; P:response to axon injury; P:response to carbon monoxide; P:response to copper ion; P:response to drug; P:response to ethanol; P:response to heat; P:response to hydrogen peroxide; P:response to nutrient levels; P:response to organic substance; P:response to superoxide; P:retina homeostasis; P:retrograde axonal transport; P:sensory perception of sound; P:spermatogenesis; P:superoxide anion generation; P:superoxide metabolic process; P:thymus development; P:transmission of nerve impulse;|P00441 A6NHJ0 D3DSE4 Q16669 Q16711 Q16838 Q16839 Q16840 Q6NR85,Superoxide dismutase [Cu-Zn],Superoxide dismutase 1;, PF00080;, GO:1904115;GO:0005737;GO:0031410;GO:0005829;GO:0032839;GO:0031045;GO:0070062;GO:0005576;GO:0005615;GO:0005764;GO:0005758;GO:0005759;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0005777;GO:0032991;GO:0051087;GO:0005507;GO:0042802;GO:0030346;GO:0031267;GO:0004784;GO:0008270;GO:0000187;GO:0008089;GO:0060088;GO:0007569;GO:0006879;GO:0071318;GO:0071276;GO:0034599;GO:0035865;GO:0007566;GO:0006749;GO:0060047;GO:0050665;GO:0035722;GO:0007626;GO:0046716;GO:0002262;GO:0045541;GO:0050728;GO:0043524;GO:0060052;GO:0001541;GO:0032287;GO:0001890;GO:0002576;GO:0043065;GO:0043085;GO:0001819;GO:1902177;GO:0050766;GO:0032930;GO:0072593;GO:0008217;GO:0043087;GO:0051881;GO:0040014;GO:0046620;GO:0045859;GO:0033081;GO:0060087;GO:0019430;GO:0001975;GO:0046677;GO:0097332;GO:0048678;GO:0034465;GO:0046688;GO:0042493;GO:0045471;GO:0009408;GO:0042542;GO:0031667;GO:0010033;GO:0000303;GO:0001895;GO:0008090;GO:0007605;GO:0007283;GO:0042554;GO:0006801;GO:0048538;GO:0019226;, C:axon cytoplasm; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite cytoplasm; C:dense core granule; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosome; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:peroxisome; C:protein-containing complex;, F:chaperone binding; F:copper ion binding; F:identical protein binding; F:protein phosphatase 2B binding; F:small GTPase binding; F:superoxide dismutase activity; F:zinc ion binding;, P:activation of MAPK activity; P:anterograde axonal transport; P:auditory receptor cell stereocilium organization; P:cell aging; P:cellular iron ion homeostasis; P:cellular response to ATP; P:cellular response to cadmium ion; P:cellular response to oxidative stress; P:cellular response to potassium ion; P:embryo implantation; P:glutathione metabolic process; P:heart contraction; P:hydrogen peroxide biosynthetic process; P:interleukin-12-mediated signaling pathway; P:locomotory behavior; P:muscle cell cellular homeostasis; P:myeloid cell homeostasis; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of inflammatory response; P:negative regulation of neuron apoptotic process; P:neurofilament cytoskeleton organization; P:ovarian follicle development; P:peripheral nervous system myelin maintenance; P:placenta development; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of cytokine production; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of phagocytosis; P:positive regulation of superoxide anion generation; P:reactive oxygen species metabolic process; P:regulation of blood pressure; P:regulation of GTPase activity; P:regulation of mitochondrial membrane potential; P:regulation of multicellular organism growth; P:regulation of organ growth; P:regulation of protein kinase activity; P:regulation of T cell differentiation in thymus; P:relaxation of vascular associated smooth muscle; P:removal of superoxide radicals; P:response to amphetamine; P:response to antibiotic; P:response to antipsychotic drug; P:response to axon injury; P:response to carbon monoxide; P:response to copper ion; P:response to drug; P:response to ethanol; P:response to heat; P:response to hydrogen peroxide; P:response to nutrient levels; P:response to organic substance; P:response to superoxide; P:retina homeostasis; P:retrograde axonal transport; P:sensory perception of sound; P:spermatogenesis; P:superoxide anion generation; P:superoxide metabolic process; P:thymus development; P:transmission of nerve impulse; scaffold7 indexed_genome mRNA 10695880 10803920 . + . ID=transcript_1950;Q13009 B7ZLR6 F5GZ53 Q17RT7,T-lymphoma invasion and metastasis-inducing protein 1,, PF00595;PF00169;PF02196;PF00621;PF18385;, GO:0044295;GO:0044291;GO:0005911;GO:0005829;GO:0043197;GO:0031234;GO:0099147;GO:0098978;GO:0044304;GO:0016020;GO:0005874;GO:0043025;GO:0005634;GO:0005886;GO:0032587;GO:0045202;GO:0005085;GO:0019900;GO:0008289;GO:0008017;GO:0030971;GO:0090630;GO:0006915;GO:0003300;GO:0016477;GO:0007160;GO:0034622;GO:0048013;GO:0007186;GO:1990138;GO:0098989;GO:0043065;GO:0050772;GO:0030335;GO:0008284;GO:0061003;GO:0010718;GO:0043507;GO:0032092;GO:1904268;GO:0072657;GO:0016601;GO:1904338;GO:0010717;GO:0070372;GO:0061178;GO:1905274;GO:2000050;GO:0051056;GO:0042220;GO:0007264;GO:0060071;, C:axonal growth cone; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:main axon; C:membrane; C:microtubule; C:neuronal cell body; C:nucleus; C:plasma membrane; C:ruffle membrane; C:synapse;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:lipid binding; F:microtubule binding; F:receptor tyrosine kinase binding;, P:activation of GTPase activity; P:apoptotic process; P:cardiac muscle hypertrophy; P:cell migration; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neuron projection extension; P:NMDA selective glutamate receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of JUN kinase activity; P:positive regulation of protein binding; P:positive regulation of Schwann cell chemotaxis; P:protein localization to membrane; P:Rac protein signal transduction; P:regulation of dopaminergic neuron differentiation; P:regulation of epithelial to mesenchymal transition; P:regulation of ERK1 and ERK2 cascade; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of non-canonical Wnt signaling pathway; P:regulation of small GTPase mediated signal transduction; P:response to cocaine; P:small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; scaffold7 indexed_genome mRNA 10810579 10854027 . + . ID=transcript_1951;Q13009 B7ZLR6 F5GZ53 Q17RT7,T-lymphoma invasion and metastasis-inducing protein 1,, PF00595;PF00169;PF02196;PF00621;PF18385;, GO:0044295;GO:0044291;GO:0005911;GO:0005829;GO:0043197;GO:0031234;GO:0099147;GO:0098978;GO:0044304;GO:0016020;GO:0005874;GO:0043025;GO:0005634;GO:0005886;GO:0032587;GO:0045202;GO:0005085;GO:0019900;GO:0008289;GO:0008017;GO:0030971;GO:0090630;GO:0006915;GO:0003300;GO:0016477;GO:0007160;GO:0034622;GO:0048013;GO:0007186;GO:1990138;GO:0098989;GO:0043065;GO:0050772;GO:0030335;GO:0008284;GO:0061003;GO:0010718;GO:0043507;GO:0032092;GO:1904268;GO:0072657;GO:0016601;GO:1904338;GO:0010717;GO:0070372;GO:0061178;GO:1905274;GO:2000050;GO:0051056;GO:0042220;GO:0007264;GO:0060071;, C:axonal growth cone; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:main axon; C:membrane; C:microtubule; C:neuronal cell body; C:nucleus; C:plasma membrane; C:ruffle membrane; C:synapse;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:lipid binding; F:microtubule binding; F:receptor tyrosine kinase binding;, P:activation of GTPase activity; P:apoptotic process; P:cardiac muscle hypertrophy; P:cell migration; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neuron projection extension; P:NMDA selective glutamate receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of JUN kinase activity; P:positive regulation of protein binding; P:positive regulation of Schwann cell chemotaxis; P:protein localization to membrane; P:Rac protein signal transduction; P:regulation of dopaminergic neuron differentiation; P:regulation of epithelial to mesenchymal transition; P:regulation of ERK1 and ERK2 cascade; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of non-canonical Wnt signaling pathway; P:regulation of small GTPase mediated signal transduction; P:response to cocaine; P:small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway;|Q13009 B7ZLR6 F5GZ53 Q17RT7,T-lymphoma invasion and metastasis-inducing protein 1,, PF00595;PF00169;PF02196;PF00621;PF18385;, GO:0044295;GO:0044291;GO:0005911;GO:0005829;GO:0043197;GO:0031234;GO:0099147;GO:0098978;GO:0044304;GO:0016020;GO:0005874;GO:0043025;GO:0005634;GO:0005886;GO:0032587;GO:0045202;GO:0005085;GO:0019900;GO:0008289;GO:0008017;GO:0030971;GO:0090630;GO:0006915;GO:0003300;GO:0016477;GO:0007160;GO:0034622;GO:0048013;GO:0007186;GO:1990138;GO:0098989;GO:0043065;GO:0050772;GO:0030335;GO:0008284;GO:0061003;GO:0010718;GO:0043507;GO:0032092;GO:1904268;GO:0072657;GO:0016601;GO:1904338;GO:0010717;GO:0070372;GO:0061178;GO:1905274;GO:2000050;GO:0051056;GO:0042220;GO:0007264;GO:0060071;, C:axonal growth cone; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:main axon; C:membrane; C:microtubule; C:neuronal cell body; C:nucleus; C:plasma membrane; C:ruffle membrane; C:synapse;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:lipid binding; F:microtubule binding; F:receptor tyrosine kinase binding;, P:activation of GTPase activity; P:apoptotic process; P:cardiac muscle hypertrophy; P:cell migration; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neuron projection extension; P:NMDA selective glutamate receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of JUN kinase activity; P:positive regulation of protein binding; P:positive regulation of Schwann cell chemotaxis; P:protein localization to membrane; P:Rac protein signal transduction; P:regulation of dopaminergic neuron differentiation; P:regulation of epithelial to mesenchymal transition; P:regulation of ERK1 and ERK2 cascade; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of non-canonical Wnt signaling pathway; P:regulation of small GTPase mediated signal transduction; P:response to cocaine; P:small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway;|Q13009 B7ZLR6 F5GZ53 Q17RT7,T-lymphoma invasion and metastasis-inducing protein 1,, PF00595;PF00169;PF02196;PF00621;PF18385;, GO:0044295;GO:0044291;GO:0005911;GO:0005829;GO:0043197;GO:0031234;GO:0099147;GO:0098978;GO:0044304;GO:0016020;GO:0005874;GO:0043025;GO:0005634;GO:0005886;GO:0032587;GO:0045202;GO:0005085;GO:0019900;GO:0008289;GO:0008017;GO:0030971;GO:0090630;GO:0006915;GO:0003300;GO:0016477;GO:0007160;GO:0034622;GO:0048013;GO:0007186;GO:1990138;GO:0098989;GO:0043065;GO:0050772;GO:0030335;GO:0008284;GO:0061003;GO:0010718;GO:0043507;GO:0032092;GO:1904268;GO:0072657;GO:0016601;GO:1904338;GO:0010717;GO:0070372;GO:0061178;GO:1905274;GO:2000050;GO:0051056;GO:0042220;GO:0007264;GO:0060071;, C:axonal growth cone; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:main axon; C:membrane; C:microtubule; C:neuronal cell body; C:nucleus; C:plasma membrane; C:ruffle membrane; C:synapse;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:lipid binding; F:microtubule binding; F:receptor tyrosine kinase binding;, P:activation of GTPase activity; P:apoptotic process; P:cardiac muscle hypertrophy; P:cell migration; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neuron projection extension; P:NMDA selective glutamate receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of JUN kinase activity; P:positive regulation of protein binding; P:positive regulation of Schwann cell chemotaxis; P:protein localization to membrane; P:Rac protein signal transduction; P:regulation of dopaminergic neuron differentiation; P:regulation of epithelial to mesenchymal transition; P:regulation of ERK1 and ERK2 cascade; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of non-canonical Wnt signaling pathway; P:regulation of small GTPase mediated signal transduction; P:response to cocaine; P:small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway;|Q13009 B7ZLR6 F5GZ53 Q17RT7,T-lymphoma invasion and metastasis-inducing protein 1,, PF00595;PF00169;PF02196;PF00621;PF18385;, GO:0044295;GO:0044291;GO:0005911;GO:0005829;GO:0043197;GO:0031234;GO:0099147;GO:0098978;GO:0044304;GO:0016020;GO:0005874;GO:0043025;GO:0005634;GO:0005886;GO:0032587;GO:0045202;GO:0005085;GO:0019900;GO:0008289;GO:0008017;GO:0030971;GO:0090630;GO:0006915;GO:0003300;GO:0016477;GO:0007160;GO:0034622;GO:0048013;GO:0007186;GO:1990138;GO:0098989;GO:0043065;GO:0050772;GO:0030335;GO:0008284;GO:0061003;GO:0010718;GO:0043507;GO:0032092;GO:1904268;GO:0072657;GO:0016601;GO:1904338;GO:0010717;GO:0070372;GO:0061178;GO:1905274;GO:2000050;GO:0051056;GO:0042220;GO:0007264;GO:0060071;, C:axonal growth cone; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:main axon; C:membrane; C:microtubule; C:neuronal cell body; C:nucleus; C:plasma membrane; C:ruffle membrane; C:synapse;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:lipid binding; F:microtubule binding; F:receptor tyrosine kinase binding;, P:activation of GTPase activity; P:apoptotic process; P:cardiac muscle hypertrophy; P:cell migration; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neuron projection extension; P:NMDA selective glutamate receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of JUN kinase activity; P:positive regulation of protein binding; P:positive regulation of Schwann cell chemotaxis; P:protein localization to membrane; P:Rac protein signal transduction; P:regulation of dopaminergic neuron differentiation; P:regulation of epithelial to mesenchymal transition; P:regulation of ERK1 and ERK2 cascade; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of non-canonical Wnt signaling pathway; P:regulation of small GTPase mediated signal transduction; P:response to cocaine; P:small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway;|Q13009 B7ZLR6 F5GZ53 Q17RT7,T-lymphoma invasion and metastasis-inducing protein 1,, PF00595;PF00169;PF02196;PF00621;PF18385;, GO:0044295;GO:0044291;GO:0005911;GO:0005829;GO:0043197;GO:0031234;GO:0099147;GO:0098978;GO:0044304;GO:0016020;GO:0005874;GO:0043025;GO:0005634;GO:0005886;GO:0032587;GO:0045202;GO:0005085;GO:0019900;GO:0008289;GO:0008017;GO:0030971;GO:0090630;GO:0006915;GO:0003300;GO:0016477;GO:0007160;GO:0034622;GO:0048013;GO:0007186;GO:1990138;GO:0098989;GO:0043065;GO:0050772;GO:0030335;GO:0008284;GO:0061003;GO:0010718;GO:0043507;GO:0032092;GO:1904268;GO:0072657;GO:0016601;GO:1904338;GO:0010717;GO:0070372;GO:0061178;GO:1905274;GO:2000050;GO:0051056;GO:0042220;GO:0007264;GO:0060071;, C:axonal growth cone; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:main axon; C:membrane; C:microtubule; C:neuronal cell body; C:nucleus; C:plasma membrane; C:ruffle membrane; C:synapse;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:lipid binding; F:microtubule binding; F:receptor tyrosine kinase binding;, P:activation of GTPase activity; P:apoptotic process; P:cardiac muscle hypertrophy; P:cell migration; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neuron projection extension; P:NMDA selective glutamate receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of JUN kinase activity; P:positive regulation of protein binding; P:positive regulation of Schwann cell chemotaxis; P:protein localization to membrane; P:Rac protein signal transduction; P:regulation of dopaminergic neuron differentiation; P:regulation of epithelial to mesenchymal transition; P:regulation of ERK1 and ERK2 cascade; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of non-canonical Wnt signaling pathway; P:regulation of small GTPase mediated signal transduction; P:response to cocaine; P:small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway;|Q13009 B7ZLR6 F5GZ53 Q17RT7,T-lymphoma invasion and metastasis-inducing protein 1,, PF00595;PF00169;PF02196;PF00621;PF18385;, GO:0044295;GO:0044291;GO:0005911;GO:0005829;GO:0043197;GO:0031234;GO:0099147;GO:0098978;GO:0044304;GO:0016020;GO:0005874;GO:0043025;GO:0005634;GO:0005886;GO:0032587;GO:0045202;GO:0005085;GO:0019900;GO:0008289;GO:0008017;GO:0030971;GO:0090630;GO:0006915;GO:0003300;GO:0016477;GO:0007160;GO:0034622;GO:0048013;GO:0007186;GO:1990138;GO:0098989;GO:0043065;GO:0050772;GO:0030335;GO:0008284;GO:0061003;GO:0010718;GO:0043507;GO:0032092;GO:1904268;GO:0072657;GO:0016601;GO:1904338;GO:0010717;GO:0070372;GO:0061178;GO:1905274;GO:2000050;GO:0051056;GO:0042220;GO:0007264;GO:0060071;, C:axonal growth cone; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:main axon; C:membrane; C:microtubule; C:neuronal cell body; C:nucleus; C:plasma membrane; C:ruffle membrane; C:synapse;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:lipid binding; F:microtubule binding; F:receptor tyrosine kinase binding;, P:activation of GTPase activity; P:apoptotic process; P:cardiac muscle hypertrophy; P:cell migration; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neuron projection extension; P:NMDA selective glutamate receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of JUN kinase activity; P:positive regulation of protein binding; P:positive regulation of Schwann cell chemotaxis; P:protein localization to membrane; P:Rac protein signal transduction; P:regulation of dopaminergic neuron differentiation; P:regulation of epithelial to mesenchymal transition; P:regulation of ERK1 and ERK2 cascade; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of non-canonical Wnt signaling pathway; P:regulation of small GTPase mediated signal transduction; P:response to cocaine; P:small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway;|Q13009 B7ZLR6 F5GZ53 Q17RT7,T-lymphoma invasion and metastasis-inducing protein 1,, PF00595;PF00169;PF02196;PF00621;PF18385;, GO:0044295;GO:0044291;GO:0005911;GO:0005829;GO:0043197;GO:0031234;GO:0099147;GO:0098978;GO:0044304;GO:0016020;GO:0005874;GO:0043025;GO:0005634;GO:0005886;GO:0032587;GO:0045202;GO:0005085;GO:0019900;GO:0008289;GO:0008017;GO:0030971;GO:0090630;GO:0006915;GO:0003300;GO:0016477;GO:0007160;GO:0034622;GO:0048013;GO:0007186;GO:1990138;GO:0098989;GO:0043065;GO:0050772;GO:0030335;GO:0008284;GO:0061003;GO:0010718;GO:0043507;GO:0032092;GO:1904268;GO:0072657;GO:0016601;GO:1904338;GO:0010717;GO:0070372;GO:0061178;GO:1905274;GO:2000050;GO:0051056;GO:0042220;GO:0007264;GO:0060071;, C:axonal growth cone; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:main axon; C:membrane; C:microtubule; C:neuronal cell body; C:nucleus; C:plasma membrane; C:ruffle membrane; C:synapse;, F:guanyl-nucleotide exchange factor activity; F:kinase binding; F:lipid binding; F:microtubule binding; F:receptor tyrosine kinase binding;, P:activation of GTPase activity; P:apoptotic process; P:cardiac muscle hypertrophy; P:cell migration; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neuron projection extension; P:NMDA selective glutamate receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of JUN kinase activity; P:positive regulation of protein binding; P:positive regulation of Schwann cell chemotaxis; P:protein localization to membrane; P:Rac protein signal transduction; P:regulation of dopaminergic neuron differentiation; P:regulation of epithelial to mesenchymal transition; P:regulation of ERK1 and ERK2 cascade; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of non-canonical Wnt signaling pathway; P:regulation of small GTPase mediated signal transduction; P:response to cocaine; P:small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; scaffold7 indexed_genome mRNA 12563034 12693800 . + . ID=transcript_1952;P39086 Q13001 Q86SU9,Glutamate receptor ionotropic, kainate 1,Excitatory amino acid receptor 3;Glutamate receptor 5;, PF01094;PF00060;PF10613;, GO:0005887;GO:0005886;GO:0045211;GO:0008066;GO:0015277;GO:0015276;GO:0038023;GO:1904315;GO:0007417;GO:0007268;GO:0007215;GO:0050804;GO:0007399;GO:0051966;GO:0035249;, C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane;, F:glutamate receptor activity; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:central nervous system development; P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:modulation of chemical synaptic transmission; P:nervous system development; P:regulation of synaptic transmission, glutamatergic; P:synaptic transmission, glutamatergic; scaffold7 indexed_genome mRNA 12906009 12924937 . - . ID=transcript_1953;O14867 O43285 Q6ICU0,Transcription regulator protein BACH1 {ECO:0000305},BTB and CNC homolog 1 {ECO:0000303|PubMed:9544839};HA2303;, PF00651;PF03131;, GO:0000785;GO:0005737;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0020037;GO:0000978;GO:0006281;GO:0000122;GO:0006357;GO:0061418;GO:0000083;GO:0000117;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:heme binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:DNA repair; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:regulation of transcription involved in G2/M transition of mitotic cell cycle; P:regulation of transcription, DNA-templated; scaffold7 indexed_genome mRNA 13104575 13152476 . - . ID=transcript_1954;P57077 D3DSE0 Q8TCL9,MAP3K7 C-terminal-like protein,TAK1-like protein;, , GO:0005829;GO:0005634;, C:cytosol; C:nucleus; scaffold7 indexed_genome mRNA 13212978 13251634 . + . ID=transcript_1955;P50990 A6NN54 B4DEM7 B4DQH4 Q4VBP8,T-complex protein 1 subunit theta,CCT-theta;Chaperonin containing T-complex polypeptide 1 subunit 8;Renal carcinoma antigen NY-REN-15;, PF00118;, GO:0035578;GO:0044297;GO:0005813;GO:0005832;GO:0005929;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0045111;GO:0005874;GO:0005654;GO:0034774;GO:0002199;GO:0005524;GO:0016887;GO:0045296;GO:0044183;GO:0051082;GO:0007339;GO:0043312;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:azurophil granule lumen; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cilium; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:intermediate filament cytoskeleton; C:microtubule; C:nucleoplasm; C:secretory granule lumen; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:neutrophil degranulation; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|P50990 A6NN54 B4DEM7 B4DQH4 Q4VBP8,T-complex protein 1 subunit theta,CCT-theta;Chaperonin containing T-complex polypeptide 1 subunit 8;Renal carcinoma antigen NY-REN-15;, PF00118;, GO:0035578;GO:0044297;GO:0005813;GO:0005832;GO:0005929;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0045111;GO:0005874;GO:0005654;GO:0034774;GO:0002199;GO:0005524;GO:0016887;GO:0045296;GO:0044183;GO:0051082;GO:0007339;GO:0043312;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:azurophil granule lumen; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cilium; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:intermediate filament cytoskeleton; C:microtubule; C:nucleoplasm; C:secretory granule lumen; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:neutrophil degranulation; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|P50990 A6NN54 B4DEM7 B4DQH4 Q4VBP8,T-complex protein 1 subunit theta,CCT-theta;Chaperonin containing T-complex polypeptide 1 subunit 8;Renal carcinoma antigen NY-REN-15;, PF00118;, GO:0035578;GO:0044297;GO:0005813;GO:0005832;GO:0005929;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0045111;GO:0005874;GO:0005654;GO:0034774;GO:0002199;GO:0005524;GO:0016887;GO:0045296;GO:0044183;GO:0051082;GO:0007339;GO:0043312;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:azurophil granule lumen; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cilium; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:intermediate filament cytoskeleton; C:microtubule; C:nucleoplasm; C:secretory granule lumen; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:neutrophil degranulation; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|P50990 A6NN54 B4DEM7 B4DQH4 Q4VBP8,T-complex protein 1 subunit theta,CCT-theta;Chaperonin containing T-complex polypeptide 1 subunit 8;Renal carcinoma antigen NY-REN-15;, PF00118;, GO:0035578;GO:0044297;GO:0005813;GO:0005832;GO:0005929;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0045111;GO:0005874;GO:0005654;GO:0034774;GO:0002199;GO:0005524;GO:0016887;GO:0045296;GO:0044183;GO:0051082;GO:0007339;GO:0043312;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:azurophil granule lumen; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cilium; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:intermediate filament cytoskeleton; C:microtubule; C:nucleoplasm; C:secretory granule lumen; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:neutrophil degranulation; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|P50990 A6NN54 B4DEM7 B4DQH4 Q4VBP8,T-complex protein 1 subunit theta,CCT-theta;Chaperonin containing T-complex polypeptide 1 subunit 8;Renal carcinoma antigen NY-REN-15;, PF00118;, GO:0035578;GO:0044297;GO:0005813;GO:0005832;GO:0005929;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0045111;GO:0005874;GO:0005654;GO:0034774;GO:0002199;GO:0005524;GO:0016887;GO:0045296;GO:0044183;GO:0051082;GO:0007339;GO:0043312;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:azurophil granule lumen; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cilium; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:intermediate filament cytoskeleton; C:microtubule; C:nucleoplasm; C:secretory granule lumen; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:neutrophil degranulation; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|P50990 A6NN54 B4DEM7 B4DQH4 Q4VBP8,T-complex protein 1 subunit theta,CCT-theta;Chaperonin containing T-complex polypeptide 1 subunit 8;Renal carcinoma antigen NY-REN-15;, PF00118;, GO:0035578;GO:0044297;GO:0005813;GO:0005832;GO:0005929;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0045111;GO:0005874;GO:0005654;GO:0034774;GO:0002199;GO:0005524;GO:0016887;GO:0045296;GO:0044183;GO:0051082;GO:0007339;GO:0043312;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:azurophil granule lumen; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cilium; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:intermediate filament cytoskeleton; C:microtubule; C:nucleoplasm; C:secretory granule lumen; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:neutrophil degranulation; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|P50990 A6NN54 B4DEM7 B4DQH4 Q4VBP8,T-complex protein 1 subunit theta,CCT-theta;Chaperonin containing T-complex polypeptide 1 subunit 8;Renal carcinoma antigen NY-REN-15;, PF00118;, GO:0035578;GO:0044297;GO:0005813;GO:0005832;GO:0005929;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0045111;GO:0005874;GO:0005654;GO:0034774;GO:0002199;GO:0005524;GO:0016887;GO:0045296;GO:0044183;GO:0051082;GO:0007339;GO:0043312;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:azurophil granule lumen; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cilium; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:intermediate filament cytoskeleton; C:microtubule; C:nucleoplasm; C:secretory granule lumen; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:neutrophil degranulation; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|Q8NEL3 Q9H3E6,Ubiquitin carboxyl-terminal hydrolase 16 {ECO:0000255|HAMAP-Rule:MF_03062},Deubiquitinating enzyme 16 {ECO:0000255|HAMAP-Rule:MF_03062};Ubiquitin thioesterase 16 {ECO:0000255|HAMAP-Rule:MF_03062};Ubiquitin-processing protease UBP-M;Ubiquitin-specific-processing protease 16 {ECO:0000255|HAMAP-Rule:MF_03062};, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0004197;GO:0042393;GO:0004843;GO:0003713;GO:0043130;GO:0008270;GO:0051301;GO:0006974;GO:0016578;GO:0070537;GO:0000278;GO:0140014;GO:0035522;GO:0045944;GO:0045893;GO:0045901;GO:0016579;GO:0051289;GO:0051726;GO:0006357;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:histone binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:ubiquitin binding; F:zinc ion binding;, P:cell division; P:cellular response to DNA damage stimulus; P:histone deubiquitination; P:histone H2A K63-linked deubiquitination; P:mitotic cell cycle; P:mitotic nuclear division; P:monoubiquitinated histone H2A deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translational elongation; P:protein deubiquitination; P:protein homotetramerization; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:ubiquitin-dependent protein catabolic process;|Q8NEL3 Q9H3E6,Ubiquitin carboxyl-terminal hydrolase 16 {ECO:0000255|HAMAP-Rule:MF_03062},Deubiquitinating enzyme 16 {ECO:0000255|HAMAP-Rule:MF_03062};Ubiquitin thioesterase 16 {ECO:0000255|HAMAP-Rule:MF_03062};Ubiquitin-processing protease UBP-M;Ubiquitin-specific-processing protease 16 {ECO:0000255|HAMAP-Rule:MF_03062};, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0004197;GO:0042393;GO:0004843;GO:0003713;GO:0043130;GO:0008270;GO:0051301;GO:0006974;GO:0016578;GO:0070537;GO:0000278;GO:0140014;GO:0035522;GO:0045944;GO:0045893;GO:0045901;GO:0016579;GO:0051289;GO:0051726;GO:0006357;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:histone binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:ubiquitin binding; F:zinc ion binding;, P:cell division; P:cellular response to DNA damage stimulus; P:histone deubiquitination; P:histone H2A K63-linked deubiquitination; P:mitotic cell cycle; P:mitotic nuclear division; P:monoubiquitinated histone H2A deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translational elongation; P:protein deubiquitination; P:protein homotetramerization; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:ubiquitin-dependent protein catabolic process;|Q8NEL3 Q9H3E6,Ubiquitin carboxyl-terminal hydrolase 16 {ECO:0000255|HAMAP-Rule:MF_03062},Deubiquitinating enzyme 16 {ECO:0000255|HAMAP-Rule:MF_03062};Ubiquitin thioesterase 16 {ECO:0000255|HAMAP-Rule:MF_03062};Ubiquitin-processing protease UBP-M;Ubiquitin-specific-processing protease 16 {ECO:0000255|HAMAP-Rule:MF_03062};, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0004197;GO:0042393;GO:0004843;GO:0003713;GO:0043130;GO:0008270;GO:0051301;GO:0006974;GO:0016578;GO:0070537;GO:0000278;GO:0140014;GO:0035522;GO:0045944;GO:0045893;GO:0045901;GO:0016579;GO:0051289;GO:0051726;GO:0006357;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:histone binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:ubiquitin binding; F:zinc ion binding;, P:cell division; P:cellular response to DNA damage stimulus; P:histone deubiquitination; P:histone H2A K63-linked deubiquitination; P:mitotic cell cycle; P:mitotic nuclear division; P:monoubiquitinated histone H2A deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translational elongation; P:protein deubiquitination; P:protein homotetramerization; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:ubiquitin-dependent protein catabolic process;|Q8NEL3 Q9H3E6,Ubiquitin carboxyl-terminal hydrolase 16 {ECO:0000255|HAMAP-Rule:MF_03062},Deubiquitinating enzyme 16 {ECO:0000255|HAMAP-Rule:MF_03062};Ubiquitin thioesterase 16 {ECO:0000255|HAMAP-Rule:MF_03062};Ubiquitin-processing protease UBP-M;Ubiquitin-specific-processing protease 16 {ECO:0000255|HAMAP-Rule:MF_03062};, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0004197;GO:0042393;GO:0004843;GO:0003713;GO:0043130;GO:0008270;GO:0051301;GO:0006974;GO:0016578;GO:0070537;GO:0000278;GO:0140014;GO:0035522;GO:0045944;GO:0045893;GO:0045901;GO:0016579;GO:0051289;GO:0051726;GO:0006357;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:histone binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:ubiquitin binding; F:zinc ion binding;, P:cell division; P:cellular response to DNA damage stimulus; P:histone deubiquitination; P:histone H2A K63-linked deubiquitination; P:mitotic cell cycle; P:mitotic nuclear division; P:monoubiquitinated histone H2A deubiquitination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translational elongation; P:protein deubiquitination; P:protein homotetramerization; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:ubiquitin-dependent protein catabolic process; scaffold7 indexed_genome mRNA 13263293 13267673 . + . ID=transcript_1956;P57060,RWD domain-containing protein 2B,, PF06544;PF05773; scaffold7 indexed_genome mRNA 13275201 13336358 . + . ID=transcript_1957;Q9P0E9,E3 ubiquitin-protein ligase listerin,RING finger protein 160;RING-type E3 ubiquitin transferase listerin {ECO:0000305};Zinc finger protein 294;, , GO:0005829;GO:1990112;GO:0043023;GO:0061630;GO:0008270;GO:0051865;GO:0072344;GO:1990116;, C:cytosol; C:RQC complex;, F:ribosomal large subunit binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:protein autoubiquitination; P:rescue of stalled ribosome; P:ribosome-associated ubiquitin-dependent protein catabolic process;|Q9P0E9,E3 ubiquitin-protein ligase listerin,RING finger protein 160;RING-type E3 ubiquitin transferase listerin {ECO:0000305};Zinc finger protein 294;, , GO:0005829;GO:1990112;GO:0043023;GO:0061630;GO:0008270;GO:0051865;GO:0072344;GO:1990116;, C:cytosol; C:RQC complex;, F:ribosomal large subunit binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:protein autoubiquitination; P:rescue of stalled ribosome; P:ribosome-associated ubiquitin-dependent protein catabolic process;|Q9P0E9,E3 ubiquitin-protein ligase listerin,RING finger protein 160;RING-type E3 ubiquitin transferase listerin {ECO:0000305};Zinc finger protein 294;, , GO:0005829;GO:1990112;GO:0043023;GO:0061630;GO:0008270;GO:0051865;GO:0072344;GO:1990116;, C:cytosol; C:RQC complex;, F:ribosomal large subunit binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:protein autoubiquitination; P:rescue of stalled ribosome; P:ribosome-associated ubiquitin-dependent protein catabolic process; scaffold7 indexed_genome mRNA 13364378 13376168 . - . ID=transcript_1958;Q9Y5N5 B2RA97 Q96F73,Methyltransferase N6AMT1 {ECO:0000305},HemK methyltransferase family member 2 {ECO:0000303|PubMed:18539146};Lysine N-methyltransferase 9 {ECO:0000303|PubMed:31061526};Methylarsonite methyltransferase N6AMT1;Protein N(5)-glutamine methyltransferase {ECO:0000305};, PF05175;, GO:0005829;GO:0035657;GO:0005634;GO:0032991;GO:0018024;GO:0030792;GO:0003676;GO:0008276;GO:0036009;GO:1904047;GO:0008757;GO:0009007;GO:0018872;GO:0032775;GO:0034968;GO:0032259;GO:0018364;GO:0030307;GO:0009404;GO:0006415;, C:cytosol; C:eRF1 methyltransferase complex; C:nucleus; C:protein-containing complex;, F:histone-lysine N-methyltransferase activity; F:methylarsonite methyltransferase activity; F:nucleic acid binding; F:protein methyltransferase activity; F:protein-glutamine N-methyltransferase activity; F:S-adenosyl-L-methionine binding; F:S-adenosylmethionine-dependent methyltransferase activity; F:site-specific DNA-methyltransferase (adenine-specific) activity;, P:arsonoacetate metabolic process; P:DNA methylation on adenine; P:histone lysine methylation; P:methylation; P:peptidyl-glutamine methylation; P:positive regulation of cell growth; P:toxin metabolic process; P:translational termination; scaffold7 indexed_genome mRNA 15137054 15189421 . + . ID=transcript_1959;Q9UNA0 Q52LV4 Q9UKP2,A disintegrin and metalloproteinase with thrombospondin motifs 5,A disintegrin and metalloproteinase with thrombospondin motifs 11;ADMP-2;Aggrecanase-2;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0004175;GO:0050840;GO:0008201;GO:0005178;GO:0004222;GO:0008237;GO:0008233;GO:0008270;GO:0042742;GO:0022617;GO:0030198;GO:0007520;GO:0120163;GO:0006508;GO:0044691;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:endopeptidase activity; F:extracellular matrix binding; F:heparin binding; F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:zinc ion binding;, P:defense response to bacterium; P:extracellular matrix disassembly; P:extracellular matrix organization; P:myoblast fusion; P:negative regulation of cold-induced thermogenesis; P:proteolysis; P:tooth eruption; scaffold7 indexed_genome mRNA 15189450 15202146 . + . ID=transcript_1960;Q9UNA0 Q52LV4 Q9UKP2,A disintegrin and metalloproteinase with thrombospondin motifs 5,A disintegrin and metalloproteinase with thrombospondin motifs 11;ADMP-2;Aggrecanase-2;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0004175;GO:0050840;GO:0008201;GO:0005178;GO:0004222;GO:0008237;GO:0008233;GO:0008270;GO:0042742;GO:0022617;GO:0030198;GO:0007520;GO:0120163;GO:0006508;GO:0044691;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:endopeptidase activity; F:extracellular matrix binding; F:heparin binding; F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:zinc ion binding;, P:defense response to bacterium; P:extracellular matrix disassembly; P:extracellular matrix organization; P:myoblast fusion; P:negative regulation of cold-induced thermogenesis; P:proteolysis; P:tooth eruption; scaffold7 indexed_genome mRNA 15584069 15703110 . + . ID=transcript_1961;Q96J86 A0A059TD09 A8MTU9 B2R845 Q53ER3 Q5JPD0 Q96NV7 R9QAJ4 W8CQB3,Cysteine and tyrosine-rich protein 1,Proline-rich domain-containing protein;, PF10873;, GO:0016021;, C:integral component of membrane; scaffold7 indexed_genome mRNA 15929578 16222743 . + . ID=transcript_1962;Q9UC33 Q9UCA9 Q9UCB6 Q9UCC8 Q9UCD1 Q9UQ58,Amyloid-beta precursor protein {ECO:0000305},ABPP;APPI;Alzheimer disease amyloid protein;Amyloid precursor protein {ECO:0000305};Amyloid-beta A4 protein;Cerebral vascular amyloid peptide;PreA4;Protease nexin-II;, PF10515;PF12924;PF12925;PF02177;PF03494;PF00014;, GO:0106003;GO:0045177;GO:0097449;GO:0030424;GO:0009986;GO:0005911;GO:0035253;GO:0005905;GO:0030134;GO:0005737;GO:0005829;GO:0043198;GO:0043197;GO:0005769;GO:0005788;GO:0005768;GO:0031904;GO:0070381;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0005796;GO:0005798;GO:1990812;GO:1990761;GO:0034364;GO:0016021;GO:0005887;GO:0034363;GO:1990777;GO:0044304;GO:0016020;GO:0045121;GO:0005739;GO:0031594;GO:0005641;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0031093;GO:0048786;GO:0032991;GO:0043235;GO:0055037;GO:0005791;GO:0005790;GO:0051233;GO:0045202;GO:0008021;GO:0032588;GO:0030549;GO:0033130;GO:0097645;GO:0034185;GO:0051087;GO:0042056;GO:0003682;GO:0003677;GO:0019899;GO:0046875;GO:0005109;GO:0001664;GO:0070851;GO:1904399;GO:0043395;GO:0008201;GO:0042802;GO:0005158;GO:0005178;GO:0050750;GO:0016504;GO:0046983;GO:0046982;GO:0042803;GO:0051425;GO:0050786;GO:0000978;GO:0004867;GO:0030546;GO:0005102;GO:0046914;GO:0000187;GO:0000185;GO:0007189;GO:0007193;GO:0008344;GO:1990000;GO:0019731;GO:0019732;GO:0061844;GO:0008306;GO:0048143;GO:0002265;GO:0008088;GO:0016199;GO:0007409;GO:0019722;GO:0007155;GO:0006878;GO:0009987;GO:0044267;GO:1904646;GO:0071320;GO:0071280;GO:0071287;GO:1990090;GO:0071874;GO:0008203;GO:0050890;GO:0048669;GO:0050829;GO:0050830;GO:0016358;GO:0006897;GO:0030198;GO:0030900;GO:0007186;GO:0045087;GO:0035235;GO:0007612;GO:0007611;GO:0042157;GO:0007626;GO:0007617;GO:0007613;GO:0014005;GO:0001774;GO:0090647;GO:0098815;GO:0006378;GO:1903523;GO:0090090;GO:0008285;GO:0010629;GO:1900272;GO:0010823;GO:1901215;GO:0045665;GO:1902894;GO:1900181;GO:0000122;GO:0050885;GO:0051402;GO:0031175;GO:1990535;GO:0016322;GO:0007219;GO:0002576;GO:0061903;GO:1905908;GO:0043065;GO:1902961;GO:0050867;GO:1905893;GO:1905896;GO:0032722;GO:0043280;GO:0007204;GO:0051091;GO:1904472;GO:0070374;GO:2000463;GO:1904022;GO:0045745;GO:0010971;GO:0010628;GO:0045821;GO:0035066;GO:0050729;GO:0032729;GO:0032731;GO:0032755;GO:0046330;GO:1900273;GO:0043410;GO:0051044;GO:0045931;GO:0090026;GO:0043525;GO:1901216;GO:0045666;GO:0051092;GO:1901224;GO:0045429;GO:1903223;GO:0033138;GO:0010800;GO:0042327;GO:0032092;GO:1904591;GO:0010739;GO:0051897;GO:0051247;GO:0001934;GO:0061098;GO:1900122;GO:1905898;GO:0032930;GO:2000406;GO:1902949;GO:0045944;GO:0032760;GO:0006892;GO:0043687;GO:0051260;GO:0045048;GO:0006468;GO:0051262;GO:0070206;GO:0035590;GO:1903048;GO:1905906;GO:1900221;GO:1902950;GO:0007176;GO:0010468;GO:0048169;GO:0040014;GO:2000310;GO:0050730;GO:1905606;GO:1905945;GO:0150003;GO:0050803;GO:0034121;GO:0006357;GO:0006417;GO:0030111;GO:0070555;GO:0010288;GO:0006979;GO:0001878;GO:0051563;GO:0001967;GO:0050808;GO:0051124;GO:0008542;, C:amyloid-beta complex; C:apical part of cell; C:astrocyte projection; C:axon; C:cell surface; C:cell-cell junction; C:ciliary rootlet; C:clathrin-coated pit; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:dendritic shaft; C:dendritic spine; C:early endosome; C:endoplasmic reticulum lumen; C:endosome; C:endosome lumen; C:endosome to plasma membrane transport vesicle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi lumen; C:Golgi-associated vesicle; C:growth cone filopodium; C:growth cone lamellipodium; C:high-density lipoprotein particle; C:integral component of membrane; C:integral component of plasma membrane; C:intermediate-density lipoprotein particle; C:lipoprotein particle; C:main axon; C:membrane; C:membrane raft; C:mitochondrion; C:neuromuscular junction; C:nuclear envelope lumen; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet alpha granule lumen; C:presynaptic active zone; C:protein-containing complex; C:receptor complex; C:recycling endosome; C:rough endoplasmic reticulum; C:smooth endoplasmic reticulum; C:spindle midzone; C:synapse; C:synaptic vesicle; C:trans-Golgi network membrane;, F:acetylcholine receptor activator activity; F:acetylcholine receptor binding; F:amylin binding; F:apolipoprotein binding; F:chaperone binding; F:chemoattractant activity; F:chromatin binding; F:DNA binding; F:enzyme binding; F:ephrin receptor binding; F:frizzled binding; F:G protein-coupled receptor binding; F:growth factor receptor binding; F:heparan sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:identical protein binding; F:insulin receptor binding; F:integrin binding; F:low-density lipoprotein particle receptor binding; F:peptidase activator activity; F:protein dimerization activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:PTB domain binding; F:RAGE receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor activator activity; F:signaling receptor binding; F:transition metal ion binding;, P:activation of MAPK activity; P:activation of MAPKKK activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adult locomotory behavior; P:amyloid fibril formation; P:antibacterial humoral response; P:antifungal humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:associative learning; P:astrocyte activation; P:astrocyte activation involved in immune response; P:axo-dendritic transport; P:axon midline choice point recognition; P:axonogenesis; P:calcium-mediated signaling; P:cell adhesion; P:cellular copper ion homeostasis; P:cellular process; P:cellular protein metabolic process; P:cellular response to amyloid-beta; P:cellular response to cAMP; P:cellular response to copper ion; P:cellular response to manganese ion; P:cellular response to nerve growth factor stimulus; P:cellular response to norepinephrine stimulus; P:cholesterol metabolic process; P:cognition; P:collateral sprouting in absence of injury; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:dendrite development; P:endocytosis; P:extracellular matrix organization; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:ionotropic glutamate receptor signaling pathway; P:learning; P:learning or memory; P:lipoprotein metabolic process; P:locomotory behavior; P:mating behavior; P:memory; P:microglia development; P:microglial cell activation; P:modulation of age-related behavioral decline; P:modulation of excitatory postsynaptic potential; P:mRNA polyadenylation; P:negative regulation of blood circulation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mitochondrion organization; P:negative regulation of neuron death; P:negative regulation of neuron differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein localization to nucleus; P:negative regulation of transcription by RNA polymerase II; P:neuromuscular process controlling balance; P:neuron apoptotic process; P:neuron projection development; P:neuron projection maintenance; P:neuron remodeling; P:Notch signaling pathway; P:platelet degranulation; P:positive regulation of 1-phosphatidylinositol-3-kinase activity; P:positive regulation of amyloid fibril formation; P:positive regulation of apoptotic process; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of cell activation; P:positive regulation of cellular response to thapsigargin; P:positive regulation of cellular response to tunicamycin; P:positive regulation of chemokine production; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelin production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of G protein-coupled receptor internalization; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of histone acetylation; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of long-term synaptic potentiation; P:positive regulation of MAPK cascade; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of mitotic cell cycle; P:positive regulation of monocyte chemotaxis; P:positive regulation of neuron apoptotic process; P:positive regulation of neuron death; P:positive regulation of neuron differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of oxidative stress-induced neuron death; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein import; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein metabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of receptor binding; P:positive regulation of response to endoplasmic reticulum stress; P:positive regulation of superoxide anion generation; P:positive regulation of T cell migration; P:positive regulation of tau-protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:post-Golgi vesicle-mediated transport; P:post-translational protein modification; P:protein homooligomerization; P:protein insertion into ER membrane; P:protein phosphorylation; P:protein tetramerization; P:protein trimerization; P:purinergic nucleotide receptor signaling pathway; P:regulation of acetylcholine-gated cation channel activity; P:regulation of amyloid fibril formation; P:regulation of amyloid-beta clearance; P:regulation of dendritic spine maintenance; P:regulation of epidermal growth factor-activated receptor activity; P:regulation of gene expression; P:regulation of long-term neuronal synaptic plasticity; P:regulation of multicellular organism growth; P:regulation of NMDA receptor activity; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of presynapse assembly; P:regulation of response to calcium ion; P:regulation of spontaneous synaptic transmission; P:regulation of synapse structure or activity; P:regulation of toll-like receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:regulation of Wnt signaling pathway; P:response to interleukin-1; P:response to lead ion; P:response to oxidative stress; P:response to yeast; P:smooth endoplasmic reticulum calcium ion homeostasis; P:suckling behavior; P:synapse organization; P:synaptic growth at neuromuscular junction; P:visual learning;|Q9UC33 Q9UCA9 Q9UCB6 Q9UCC8 Q9UCD1 Q9UQ58,Amyloid-beta precursor protein {ECO:0000305},ABPP;APPI;Alzheimer disease amyloid protein;Amyloid precursor protein {ECO:0000305};Amyloid-beta A4 protein;Cerebral vascular amyloid peptide;PreA4;Protease nexin-II;, PF10515;PF12924;PF12925;PF02177;PF03494;PF00014;, GO:0106003;GO:0045177;GO:0097449;GO:0030424;GO:0009986;GO:0005911;GO:0035253;GO:0005905;GO:0030134;GO:0005737;GO:0005829;GO:0043198;GO:0043197;GO:0005769;GO:0005788;GO:0005768;GO:0031904;GO:0070381;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0005796;GO:0005798;GO:1990812;GO:1990761;GO:0034364;GO:0016021;GO:0005887;GO:0034363;GO:1990777;GO:0044304;GO:0016020;GO:0045121;GO:0005739;GO:0031594;GO:0005641;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0031093;GO:0048786;GO:0032991;GO:0043235;GO:0055037;GO:0005791;GO:0005790;GO:0051233;GO:0045202;GO:0008021;GO:0032588;GO:0030549;GO:0033130;GO:0097645;GO:0034185;GO:0051087;GO:0042056;GO:0003682;GO:0003677;GO:0019899;GO:0046875;GO:0005109;GO:0001664;GO:0070851;GO:1904399;GO:0043395;GO:0008201;GO:0042802;GO:0005158;GO:0005178;GO:0050750;GO:0016504;GO:0046983;GO:0046982;GO:0042803;GO:0051425;GO:0050786;GO:0000978;GO:0004867;GO:0030546;GO:0005102;GO:0046914;GO:0000187;GO:0000185;GO:0007189;GO:0007193;GO:0008344;GO:1990000;GO:0019731;GO:0019732;GO:0061844;GO:0008306;GO:0048143;GO:0002265;GO:0008088;GO:0016199;GO:0007409;GO:0019722;GO:0007155;GO:0006878;GO:0009987;GO:0044267;GO:1904646;GO:0071320;GO:0071280;GO:0071287;GO:1990090;GO:0071874;GO:0008203;GO:0050890;GO:0048669;GO:0050829;GO:0050830;GO:0016358;GO:0006897;GO:0030198;GO:0030900;GO:0007186;GO:0045087;GO:0035235;GO:0007612;GO:0007611;GO:0042157;GO:0007626;GO:0007617;GO:0007613;GO:0014005;GO:0001774;GO:0090647;GO:0098815;GO:0006378;GO:1903523;GO:0090090;GO:0008285;GO:0010629;GO:1900272;GO:0010823;GO:1901215;GO:0045665;GO:1902894;GO:1900181;GO:0000122;GO:0050885;GO:0051402;GO:0031175;GO:1990535;GO:0016322;GO:0007219;GO:0002576;GO:0061903;GO:1905908;GO:0043065;GO:1902961;GO:0050867;GO:1905893;GO:1905896;GO:0032722;GO:0043280;GO:0007204;GO:0051091;GO:1904472;GO:0070374;GO:2000463;GO:1904022;GO:0045745;GO:0010971;GO:0010628;GO:0045821;GO:0035066;GO:0050729;GO:0032729;GO:0032731;GO:0032755;GO:0046330;GO:1900273;GO:0043410;GO:0051044;GO:0045931;GO:0090026;GO:0043525;GO:1901216;GO:0045666;GO:0051092;GO:1901224;GO:0045429;GO:1903223;GO:0033138;GO:0010800;GO:0042327;GO:0032092;GO:1904591;GO:0010739;GO:0051897;GO:0051247;GO:0001934;GO:0061098;GO:1900122;GO:1905898;GO:0032930;GO:2000406;GO:1902949;GO:0045944;GO:0032760;GO:0006892;GO:0043687;GO:0051260;GO:0045048;GO:0006468;GO:0051262;GO:0070206;GO:0035590;GO:1903048;GO:1905906;GO:1900221;GO:1902950;GO:0007176;GO:0010468;GO:0048169;GO:0040014;GO:2000310;GO:0050730;GO:1905606;GO:1905945;GO:0150003;GO:0050803;GO:0034121;GO:0006357;GO:0006417;GO:0030111;GO:0070555;GO:0010288;GO:0006979;GO:0001878;GO:0051563;GO:0001967;GO:0050808;GO:0051124;GO:0008542;, C:amyloid-beta complex; C:apical part of cell; C:astrocyte projection; C:axon; C:cell surface; C:cell-cell junction; C:ciliary rootlet; C:clathrin-coated pit; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:dendritic shaft; C:dendritic spine; C:early endosome; C:endoplasmic reticulum lumen; C:endosome; C:endosome lumen; C:endosome to plasma membrane transport vesicle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi lumen; C:Golgi-associated vesicle; C:growth cone filopodium; C:growth cone lamellipodium; C:high-density lipoprotein particle; C:integral component of membrane; C:integral component of plasma membrane; C:intermediate-density lipoprotein particle; C:lipoprotein particle; C:main axon; C:membrane; C:membrane raft; C:mitochondrion; C:neuromuscular junction; C:nuclear envelope lumen; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet alpha granule lumen; C:presynaptic active zone; C:protein-containing complex; C:receptor complex; C:recycling endosome; C:rough endoplasmic reticulum; C:smooth endoplasmic reticulum; C:spindle midzone; C:synapse; C:synaptic vesicle; C:trans-Golgi network membrane;, F:acetylcholine receptor activator activity; F:acetylcholine receptor binding; F:amylin binding; F:apolipoprotein binding; F:chaperone binding; F:chemoattractant activity; F:chromatin binding; F:DNA binding; F:enzyme binding; F:ephrin receptor binding; F:frizzled binding; F:G protein-coupled receptor binding; F:growth factor receptor binding; F:heparan sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:identical protein binding; F:insulin receptor binding; F:integrin binding; F:low-density lipoprotein particle receptor binding; F:peptidase activator activity; F:protein dimerization activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:PTB domain binding; F:RAGE receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor activator activity; F:signaling receptor binding; F:transition metal ion binding;, P:activation of MAPK activity; P:activation of MAPKKK activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adult locomotory behavior; P:amyloid fibril formation; P:antibacterial humoral response; P:antifungal humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:associative learning; P:astrocyte activation; P:astrocyte activation involved in immune response; P:axo-dendritic transport; P:axon midline choice point recognition; P:axonogenesis; P:calcium-mediated signaling; P:cell adhesion; P:cellular copper ion homeostasis; P:cellular process; P:cellular protein metabolic process; P:cellular response to amyloid-beta; P:cellular response to cAMP; P:cellular response to copper ion; P:cellular response to manganese ion; P:cellular response to nerve growth factor stimulus; P:cellular response to norepinephrine stimulus; P:cholesterol metabolic process; P:cognition; P:collateral sprouting in absence of injury; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:dendrite development; P:endocytosis; P:extracellular matrix organization; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:ionotropic glutamate receptor signaling pathway; P:learning; P:learning or memory; P:lipoprotein metabolic process; P:locomotory behavior; P:mating behavior; P:memory; P:microglia development; P:microglial cell activation; P:modulation of age-related behavioral decline; P:modulation of excitatory postsynaptic potential; P:mRNA polyadenylation; P:negative regulation of blood circulation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mitochondrion organization; P:negative regulation of neuron death; P:negative regulation of neuron differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein localization to nucleus; P:negative regulation of transcription by RNA polymerase II; P:neuromuscular process controlling balance; P:neuron apoptotic process; P:neuron projection development; P:neuron projection maintenance; P:neuron remodeling; P:Notch signaling pathway; P:platelet degranulation; P:positive regulation of 1-phosphatidylinositol-3-kinase activity; P:positive regulation of amyloid fibril formation; P:positive regulation of apoptotic process; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of cell activation; P:positive regulation of cellular response to thapsigargin; P:positive regulation of cellular response to tunicamycin; P:positive regulation of chemokine production; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelin production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of G protein-coupled receptor internalization; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of histone acetylation; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of long-term synaptic potentiation; P:positive regulation of MAPK cascade; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of mitotic cell cycle; P:positive regulation of monocyte chemotaxis; P:positive regulation of neuron apoptotic process; P:positive regulation of neuron death; P:positive regulation of neuron differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of oxidative stress-induced neuron death; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein import; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein metabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of receptor binding; P:positive regulation of response to endoplasmic reticulum stress; P:positive regulation of superoxide anion generation; P:positive regulation of T cell migration; P:positive regulation of tau-protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:post-Golgi vesicle-mediated transport; P:post-translational protein modification; P:protein homooligomerization; P:protein insertion into ER membrane; P:protein phosphorylation; P:protein tetramerization; P:protein trimerization; P:purinergic nucleotide receptor signaling pathway; P:regulation of acetylcholine-gated cation channel activity; P:regulation of amyloid fibril formation; P:regulation of amyloid-beta clearance; P:regulation of dendritic spine maintenance; P:regulation of epidermal growth factor-activated receptor activity; P:regulation of gene expression; P:regulation of long-term neuronal synaptic plasticity; P:regulation of multicellular organism growth; P:regulation of NMDA receptor activity; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of presynapse assembly; P:regulation of response to calcium ion; P:regulation of spontaneous synaptic transmission; P:regulation of synapse structure or activity; P:regulation of toll-like receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:regulation of Wnt signaling pathway; P:response to interleukin-1; P:response to lead ion; P:response to oxidative stress; P:response to yeast; P:smooth endoplasmic reticulum calcium ion homeostasis; P:suckling behavior; P:synapse organization; P:synaptic growth at neuromuscular junction; P:visual learning;|Q9UC33 Q9UCA9 Q9UCB6 Q9UCC8 Q9UCD1 Q9UQ58,Amyloid-beta precursor protein {ECO:0000305},ABPP;APPI;Alzheimer disease amyloid protein;Amyloid precursor protein {ECO:0000305};Amyloid-beta A4 protein;Cerebral vascular amyloid peptide;PreA4;Protease nexin-II;, PF10515;PF12924;PF12925;PF02177;PF03494;PF00014;, GO:0106003;GO:0045177;GO:0097449;GO:0030424;GO:0009986;GO:0005911;GO:0035253;GO:0005905;GO:0030134;GO:0005737;GO:0005829;GO:0043198;GO:0043197;GO:0005769;GO:0005788;GO:0005768;GO:0031904;GO:0070381;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0005796;GO:0005798;GO:1990812;GO:1990761;GO:0034364;GO:0016021;GO:0005887;GO:0034363;GO:1990777;GO:0044304;GO:0016020;GO:0045121;GO:0005739;GO:0031594;GO:0005641;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0031093;GO:0048786;GO:0032991;GO:0043235;GO:0055037;GO:0005791;GO:0005790;GO:0051233;GO:0045202;GO:0008021;GO:0032588;GO:0030549;GO:0033130;GO:0097645;GO:0034185;GO:0051087;GO:0042056;GO:0003682;GO:0003677;GO:0019899;GO:0046875;GO:0005109;GO:0001664;GO:0070851;GO:1904399;GO:0043395;GO:0008201;GO:0042802;GO:0005158;GO:0005178;GO:0050750;GO:0016504;GO:0046983;GO:0046982;GO:0042803;GO:0051425;GO:0050786;GO:0000978;GO:0004867;GO:0030546;GO:0005102;GO:0046914;GO:0000187;GO:0000185;GO:0007189;GO:0007193;GO:0008344;GO:1990000;GO:0019731;GO:0019732;GO:0061844;GO:0008306;GO:0048143;GO:0002265;GO:0008088;GO:0016199;GO:0007409;GO:0019722;GO:0007155;GO:0006878;GO:0009987;GO:0044267;GO:1904646;GO:0071320;GO:0071280;GO:0071287;GO:1990090;GO:0071874;GO:0008203;GO:0050890;GO:0048669;GO:0050829;GO:0050830;GO:0016358;GO:0006897;GO:0030198;GO:0030900;GO:0007186;GO:0045087;GO:0035235;GO:0007612;GO:0007611;GO:0042157;GO:0007626;GO:0007617;GO:0007613;GO:0014005;GO:0001774;GO:0090647;GO:0098815;GO:0006378;GO:1903523;GO:0090090;GO:0008285;GO:0010629;GO:1900272;GO:0010823;GO:1901215;GO:0045665;GO:1902894;GO:1900181;GO:0000122;GO:0050885;GO:0051402;GO:0031175;GO:1990535;GO:0016322;GO:0007219;GO:0002576;GO:0061903;GO:1905908;GO:0043065;GO:1902961;GO:0050867;GO:1905893;GO:1905896;GO:0032722;GO:0043280;GO:0007204;GO:0051091;GO:1904472;GO:0070374;GO:2000463;GO:1904022;GO:0045745;GO:0010971;GO:0010628;GO:0045821;GO:0035066;GO:0050729;GO:0032729;GO:0032731;GO:0032755;GO:0046330;GO:1900273;GO:0043410;GO:0051044;GO:0045931;GO:0090026;GO:0043525;GO:1901216;GO:0045666;GO:0051092;GO:1901224;GO:0045429;GO:1903223;GO:0033138;GO:0010800;GO:0042327;GO:0032092;GO:1904591;GO:0010739;GO:0051897;GO:0051247;GO:0001934;GO:0061098;GO:1900122;GO:1905898;GO:0032930;GO:2000406;GO:1902949;GO:0045944;GO:0032760;GO:0006892;GO:0043687;GO:0051260;GO:0045048;GO:0006468;GO:0051262;GO:0070206;GO:0035590;GO:1903048;GO:1905906;GO:1900221;GO:1902950;GO:0007176;GO:0010468;GO:0048169;GO:0040014;GO:2000310;GO:0050730;GO:1905606;GO:1905945;GO:0150003;GO:0050803;GO:0034121;GO:0006357;GO:0006417;GO:0030111;GO:0070555;GO:0010288;GO:0006979;GO:0001878;GO:0051563;GO:0001967;GO:0050808;GO:0051124;GO:0008542;, C:amyloid-beta complex; C:apical part of cell; C:astrocyte projection; C:axon; C:cell surface; C:cell-cell junction; C:ciliary rootlet; C:clathrin-coated pit; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:dendritic shaft; C:dendritic spine; C:early endosome; C:endoplasmic reticulum lumen; C:endosome; C:endosome lumen; C:endosome to plasma membrane transport vesicle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi lumen; C:Golgi-associated vesicle; C:growth cone filopodium; C:growth cone lamellipodium; C:high-density lipoprotein particle; C:integral component of membrane; C:integral component of plasma membrane; C:intermediate-density lipoprotein particle; C:lipoprotein particle; C:main axon; C:membrane; C:membrane raft; C:mitochondrion; C:neuromuscular junction; C:nuclear envelope lumen; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet alpha granule lumen; C:presynaptic active zone; C:protein-containing complex; C:receptor complex; C:recycling endosome; C:rough endoplasmic reticulum; C:smooth endoplasmic reticulum; C:spindle midzone; C:synapse; C:synaptic vesicle; C:trans-Golgi network membrane;, F:acetylcholine receptor activator activity; F:acetylcholine receptor binding; F:amylin binding; F:apolipoprotein binding; F:chaperone binding; F:chemoattractant activity; F:chromatin binding; F:DNA binding; F:enzyme binding; F:ephrin receptor binding; F:frizzled binding; F:G protein-coupled receptor binding; F:growth factor receptor binding; F:heparan sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:identical protein binding; F:insulin receptor binding; F:integrin binding; F:low-density lipoprotein particle receptor binding; F:peptidase activator activity; F:protein dimerization activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:PTB domain binding; F:RAGE receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor activator activity; F:signaling receptor binding; F:transition metal ion binding;, P:activation of MAPK activity; P:activation of MAPKKK activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adult locomotory behavior; P:amyloid fibril formation; P:antibacterial humoral response; P:antifungal humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:associative learning; P:astrocyte activation; P:astrocyte activation involved in immune response; P:axo-dendritic transport; P:axon midline choice point recognition; P:axonogenesis; P:calcium-mediated signaling; P:cell adhesion; P:cellular copper ion homeostasis; P:cellular process; P:cellular protein metabolic process; P:cellular response to amyloid-beta; P:cellular response to cAMP; P:cellular response to copper ion; P:cellular response to manganese ion; P:cellular response to nerve growth factor stimulus; P:cellular response to norepinephrine stimulus; P:cholesterol metabolic process; P:cognition; P:collateral sprouting in absence of injury; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:dendrite development; P:endocytosis; P:extracellular matrix organization; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:ionotropic glutamate receptor signaling pathway; P:learning; P:learning or memory; P:lipoprotein metabolic process; P:locomotory behavior; P:mating behavior; P:memory; P:microglia development; P:microglial cell activation; P:modulation of age-related behavioral decline; P:modulation of excitatory postsynaptic potential; P:mRNA polyadenylation; P:negative regulation of blood circulation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mitochondrion organization; P:negative regulation of neuron death; P:negative regulation of neuron differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein localization to nucleus; P:negative regulation of transcription by RNA polymerase II; P:neuromuscular process controlling balance; P:neuron apoptotic process; P:neuron projection development; P:neuron projection maintenance; P:neuron remodeling; P:Notch signaling pathway; P:platelet degranulation; P:positive regulation of 1-phosphatidylinositol-3-kinase activity; P:positive regulation of amyloid fibril formation; P:positive regulation of apoptotic process; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of cell activation; P:positive regulation of cellular response to thapsigargin; P:positive regulation of cellular response to tunicamycin; P:positive regulation of chemokine production; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelin production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of G protein-coupled receptor internalization; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of histone acetylation; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of long-term synaptic potentiation; P:positive regulation of MAPK cascade; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of mitotic cell cycle; P:positive regulation of monocyte chemotaxis; P:positive regulation of neuron apoptotic process; P:positive regulation of neuron death; P:positive regulation of neuron differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of oxidative stress-induced neuron death; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein import; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein metabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of receptor binding; P:positive regulation of response to endoplasmic reticulum stress; P:positive regulation of superoxide anion generation; P:positive regulation of T cell migration; P:positive regulation of tau-protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:post-Golgi vesicle-mediated transport; P:post-translational protein modification; P:protein homooligomerization; P:protein insertion into ER membrane; P:protein phosphorylation; P:protein tetramerization; P:protein trimerization; P:purinergic nucleotide receptor signaling pathway; P:regulation of acetylcholine-gated cation channel activity; P:regulation of amyloid fibril formation; P:regulation of amyloid-beta clearance; P:regulation of dendritic spine maintenance; P:regulation of epidermal growth factor-activated receptor activity; P:regulation of gene expression; P:regulation of long-term neuronal synaptic plasticity; P:regulation of multicellular organism growth; P:regulation of NMDA receptor activity; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of presynapse assembly; P:regulation of response to calcium ion; P:regulation of spontaneous synaptic transmission; P:regulation of synapse structure or activity; P:regulation of toll-like receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:regulation of Wnt signaling pathway; P:response to interleukin-1; P:response to lead ion; P:response to oxidative stress; P:response to yeast; P:smooth endoplasmic reticulum calcium ion homeostasis; P:suckling behavior; P:synapse organization; P:synaptic growth at neuromuscular junction; P:visual learning; scaffold7 indexed_genome mRNA 16327174 16379924 . + . ID=transcript_1963;Q06546 Q12939,GA-binding protein alpha chain,Nuclear respiratory factor 2 subunit alpha;Transcription factor E4TF1-60;, PF00178;PF11620;PF02198;, GO:0000785;GO:0005654;GO:0005634;GO:0033613;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0001825;GO:0030154;GO:1903351;GO:0007005;GO:0045653;GO:0000122;GO:0010628;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:blastocyst formation; P:cell differentiation; P:cellular response to dopamine; P:mitochondrion organization; P:negative regulation of megakaryocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q06546 Q12939,GA-binding protein alpha chain,Nuclear respiratory factor 2 subunit alpha;Transcription factor E4TF1-60;, PF00178;PF11620;PF02198;, GO:0000785;GO:0005654;GO:0005634;GO:0033613;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0001825;GO:0030154;GO:1903351;GO:0007005;GO:0045653;GO:0000122;GO:0010628;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:blastocyst formation; P:cell differentiation; P:cellular response to dopamine; P:mitochondrion organization; P:negative regulation of megakaryocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q06546 Q12939,GA-binding protein alpha chain,Nuclear respiratory factor 2 subunit alpha;Transcription factor E4TF1-60;, PF00178;PF11620;PF02198;, GO:0000785;GO:0005654;GO:0005634;GO:0033613;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0001825;GO:0030154;GO:1903351;GO:0007005;GO:0045653;GO:0000122;GO:0010628;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:blastocyst formation; P:cell differentiation; P:cellular response to dopamine; P:mitochondrion organization; P:negative regulation of megakaryocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P18859 J3KQ83,ATP synthase-coupling factor 6, mitochondrial {ECO:0000305},ATP synthase peripheral stalk subunit F6 {ECO:0000305};, PF05511;, GO:0005743;GO:0005753;GO:0000276;GO:0005739;GO:0015078;GO:0006754;GO:0042407;GO:0042776;GO:0021762;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion;, F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:substantia nigra development; scaffold7 indexed_genome mRNA 16379952 16382185 . + . ID=transcript_1964;P18859 J3KQ83,ATP synthase-coupling factor 6, mitochondrial {ECO:0000305},ATP synthase peripheral stalk subunit F6 {ECO:0000305};, PF05511;, GO:0005743;GO:0005753;GO:0000276;GO:0005739;GO:0015078;GO:0006754;GO:0042407;GO:0042776;GO:0021762;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion;, F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:substantia nigra development; scaffold7 indexed_genome mRNA 16390805 16476970 . - . ID=transcript_1965;P57087 B2R6T9 B4DGT9 Q6UXG6 Q6YNC1,Junctional adhesion molecule B,Junctional adhesion molecule 2 {ECO:0000303|PubMed:10945976};Vascular endothelial junction-associated molecule {ECO:0000303|PubMed:10779521};, PF07686;, GO:0005923;GO:0009986;GO:0044291;GO:0005887;GO:0005886;GO:0098636;GO:0036477;GO:0070160;GO:0005178;GO:0098609;GO:0045123;GO:0030198;GO:0097241;GO:0050900;GO:0050901;GO:0071593;GO:0035633;GO:0007520;GO:0031642;GO:2000403;GO:0007286;, C:bicellular tight junction; C:cell surface; C:cell-cell contact zone; C:integral component of plasma membrane; C:plasma membrane; C:protein complex involved in cell adhesion; C:somatodendritic compartment; C:tight junction;, F:integrin binding;, P:cell-cell adhesion; P:cellular extravasation; P:extracellular matrix organization; P:hematopoietic stem cell migration to bone marrow; P:leukocyte migration; P:leukocyte tethering or rolling; P:lymphocyte aggregation; P:maintenance of blood-brain barrier; P:myoblast fusion; P:negative regulation of myelination; P:positive regulation of lymphocyte migration; P:spermatid development; scaffold7 indexed_genome mRNA 16508737 16538493 . + . ID=transcript_1966;Q9NYK5 C9JYA5 Q32Q74 Q5QTR3 Q96Q65 Q9BSQ7 Q9BZV6 Q9NX44,39S ribosomal protein L39, mitochondrial,39S ribosomal protein L5, mitochondrial;Mitochondrial large ribosomal subunit protein mL39 {ECO:0000303|PubMed:25278503};, , GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0000166;GO:0003723;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:nucleotide binding; F:RNA binding;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q9NYK5 C9JYA5 Q32Q74 Q5QTR3 Q96Q65 Q9BSQ7 Q9BZV6 Q9NX44,39S ribosomal protein L39, mitochondrial,39S ribosomal protein L5, mitochondrial;Mitochondrial large ribosomal subunit protein mL39 {ECO:0000303|PubMed:25278503};, , GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0000166;GO:0003723;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:nucleotide binding; F:RNA binding;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold7 indexed_genome mRNA 20218361 20229388 . - . ID=transcript_1967;O15394 A8MQ06 B7Z841 Q7Z7F2,Neural cell adhesion molecule 2,, PF00041;PF07679;, GO:0030424;GO:0016021;GO:0043005;GO:0016604;GO:0005886;GO:0042802;GO:0007413;GO:0007158;GO:0007608;, C:axon; C:integral component of membrane; C:neuron projection; C:nuclear body; C:plasma membrane;, F:identical protein binding;, P:axonal fasciculation; P:neuron cell-cell adhesion; P:sensory perception of smell; scaffold7 indexed_genome mRNA 20255172 20754203 . - . ID=transcript_1968;O15394 A8MQ06 B7Z841 Q7Z7F2,Neural cell adhesion molecule 2,, PF00041;PF07679;, GO:0030424;GO:0016021;GO:0043005;GO:0016604;GO:0005886;GO:0042802;GO:0007413;GO:0007158;GO:0007608;, C:axon; C:integral component of membrane; C:neuron projection; C:nuclear body; C:plasma membrane;, F:identical protein binding;, P:axonal fasciculation; P:neuron cell-cell adhesion; P:sensory perception of smell; scaffold7 indexed_genome mRNA 23846023 23853874 . + . ID=transcript_1969;Q9NYK6 B2RB30 Q96BK9 Q9H8C6,Protein EURL homolog {ECO:0000305},, PF06937;, GO:0021895;GO:0060999;, , , P:cerebral cortex neuron differentiation; P:positive regulation of dendritic spine development; scaffold7 indexed_genome mRNA 24003238 24022975 . + . ID=transcript_1970;Q14201 D3DSC4 Q53XV1 Q96ET7,Protein BTG3,Abundant in neuroepithelium area protein;BTG family member 3;Protein Tob5;, PF07742;, GO:0005737;GO:0005634;GO:0008285;GO:0045930;, C:cytoplasm; C:nucleus;, , P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle;|Q14201 D3DSC4 Q53XV1 Q96ET7,Protein BTG3,Abundant in neuroepithelium area protein;BTG family member 3;Protein Tob5;, PF07742;, GO:0005737;GO:0005634;GO:0008285;GO:0045930;, C:cytoplasm; C:nucleus;, , P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle; scaffold7 indexed_genome mRNA 24049852 24091223 . - . ID=transcript_1971;P78310 B2R8V8 B7WPI3 D3YHP0 O00694 Q8WWT6 Q8WWT7 Q8WWT8 Q9UKV4,Coxsackievirus and adenovirus receptor,CVB3-binding protein;Coxsackievirus B-adenovirus receptor;HCVADR;, PF00047;PF07686;, GO:0001669;GO:0005912;GO:0016327;GO:0016323;GO:0005923;GO:0044297;GO:0030054;GO:0005911;GO:0005737;GO:0005576;GO:0005615;GO:0030175;GO:0030426;GO:0005887;GO:0014704;GO:0045121;GO:0031594;GO:0043005;GO:0005654;GO:0005886;GO:0032991;GO:0008013;GO:0050839;GO:0086082;GO:0071253;GO:0042802;GO:0005178;GO:0030165;GO:0005102;GO:0001618;GO:0031532;GO:0086067;GO:0086072;GO:0048739;GO:0045216;GO:0051607;GO:0010669;GO:0046629;GO:0008354;GO:0007507;GO:0007157;GO:0034109;GO:0050900;GO:0007005;GO:0030593;GO:0098904;GO:0050776;GO:0070633;, C:acrosomal vesicle; C:adherens junction; C:apicolateral plasma membrane; C:basolateral plasma membrane; C:bicellular tight junction; C:cell body; C:cell junction; C:cell-cell junction; C:cytoplasm; C:extracellular region; C:extracellular space; C:filopodium; C:growth cone; C:integral component of plasma membrane; C:intercalated disc; C:membrane raft; C:neuromuscular junction; C:neuron projection; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:beta-catenin binding; F:cell adhesion molecule binding; F:cell adhesive protein binding involved in AV node cell-bundle of His cell communication; F:connexin binding; F:identical protein binding; F:integrin binding; F:PDZ domain binding; F:signaling receptor binding; F:virus receptor activity;, P:actin cytoskeleton reorganization; P:AV node cell to bundle of His cell communication; P:AV node cell-bundle of His cell adhesion involved in cell communication; P:cardiac muscle fiber development; P:cell-cell junction organization; P:defense response to virus; P:epithelial structure maintenance; P:gamma-delta T cell activation; P:germ cell migration; P:heart development; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homotypic cell-cell adhesion; P:leukocyte migration; P:mitochondrion organization; P:neutrophil chemotaxis; P:regulation of AV node cell action potential; P:regulation of immune response; P:transepithelial transport; scaffold7 indexed_genome mRNA 25628049 25769582 . - . ID=transcript_1972;Q9UHP3 C0LSZ0 Q6DHZ9 Q9H9W1,Ubiquitin carboxyl-terminal hydrolase 25,Deubiquitinating enzyme 25;USP on chromosome 21;Ubiquitin thioesterase 25;Ubiquitin-specific-processing protease 25;, PF00443;PF02809;, GO:0005829;GO:0005783;GO:0005634;GO:0051117;GO:0004197;GO:0008233;GO:0032183;GO:0004843;GO:0043130;GO:0031625;GO:0019783;GO:0006464;GO:1904293;GO:0016579;GO:0071108;GO:0070536;GO:0006508;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:nucleus;, F:ATPase binding; F:cysteine-type endopeptidase activity; F:peptidase activity; F:SUMO binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein-specific protease activity;, P:cellular protein modification process; P:negative regulation of ERAD pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:proteolysis; P:ubiquitin-dependent protein catabolic process;|Q9UHP3 C0LSZ0 Q6DHZ9 Q9H9W1,Ubiquitin carboxyl-terminal hydrolase 25,Deubiquitinating enzyme 25;USP on chromosome 21;Ubiquitin thioesterase 25;Ubiquitin-specific-processing protease 25;, PF00443;PF02809;, GO:0005829;GO:0005783;GO:0005634;GO:0051117;GO:0004197;GO:0008233;GO:0032183;GO:0004843;GO:0043130;GO:0031625;GO:0019783;GO:0006464;GO:1904293;GO:0016579;GO:0071108;GO:0070536;GO:0006508;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:nucleus;, F:ATPase binding; F:cysteine-type endopeptidase activity; F:peptidase activity; F:SUMO binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein-specific protease activity;, P:cellular protein modification process; P:negative regulation of ERAD pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:proteolysis; P:ubiquitin-dependent protein catabolic process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9UHP3 C0LSZ0 Q6DHZ9 Q9H9W1,Ubiquitin carboxyl-terminal hydrolase 25,Deubiquitinating enzyme 25;USP on chromosome 21;Ubiquitin thioesterase 25;Ubiquitin-specific-processing protease 25;, PF00443;PF02809;, GO:0005829;GO:0005783;GO:0005634;GO:0051117;GO:0004197;GO:0008233;GO:0032183;GO:0004843;GO:0043130;GO:0031625;GO:0019783;GO:0006464;GO:1904293;GO:0016579;GO:0071108;GO:0070536;GO:0006508;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:nucleus;, F:ATPase binding; F:cysteine-type endopeptidase activity; F:peptidase activity; F:SUMO binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein-specific protease activity;, P:cellular protein modification process; P:negative regulation of ERAD pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:proteolysis; P:ubiquitin-dependent protein catabolic process;|Q9UHP3 C0LSZ0 Q6DHZ9 Q9H9W1,Ubiquitin carboxyl-terminal hydrolase 25,Deubiquitinating enzyme 25;USP on chromosome 21;Ubiquitin thioesterase 25;Ubiquitin-specific-processing protease 25;, PF00443;PF02809;, GO:0005829;GO:0005783;GO:0005634;GO:0051117;GO:0004197;GO:0008233;GO:0032183;GO:0004843;GO:0043130;GO:0031625;GO:0019783;GO:0006464;GO:1904293;GO:0016579;GO:0071108;GO:0070536;GO:0006508;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:nucleus;, F:ATPase binding; F:cysteine-type endopeptidase activity; F:peptidase activity; F:SUMO binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein-specific protease activity;, P:cellular protein modification process; P:negative regulation of ERAD pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:proteolysis; P:ubiquitin-dependent protein catabolic process; scaffold7 indexed_genome mRNA 26633984 26641370 . - . ID=transcript_1973;P48552 Q8IWE8,Nuclear receptor-interacting protein 1,Nuclear factor RIP140;Receptor-interacting protein 140;, PF15687;PF15688;PF15689;PF15690;, GO:0000785;GO:0005829;GO:0001650;GO:0000118;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0030331;GO:0035259;GO:0042826;GO:0035257;GO:0046965;GO:0000978;GO:0003713;GO:0003714;GO:0071392;GO:0032922;GO:0007623;GO:0030522;GO:0019915;GO:0000122;GO:0001543;GO:0045944;, C:chromatin; C:cytosol; C:fibrillar center; C:histone deacetylase complex; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:estrogen receptor binding; F:glucocorticoid receptor binding; F:histone deacetylase binding; F:nuclear hormone receptor binding; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:cellular response to estradiol stimulus; P:circadian regulation of gene expression; P:circadian rhythm; P:intracellular receptor signaling pathway; P:lipid storage; P:negative regulation of transcription by RNA polymerase II; P:ovarian follicle rupture; P:positive regulation of transcription by RNA polymerase II; scaffold7 indexed_genome mRNA 27062494 27092467 . + . ID=transcript_1974;Q9NSI8 B3KWJ3 F8WAA1 Q8NFF7 Q9C041,SAM domain-containing protein SAMSN-1,Hematopoietic adaptor containing SH3 and SAM domains 1;Nash1;SAM domain, SH3 domain and nuclear localization signals protein 1;SH3-SAM adaptor protein;, PF07647;PF07653;PF12485;, GO:0005737;GO:0005634;GO:0001726;GO:0001784;GO:0003723;GO:0002820;GO:0050869;GO:0050732;, C:cytoplasm; C:nucleus; C:ruffle;, F:phosphotyrosine residue binding; F:RNA binding;, P:negative regulation of adaptive immune response; P:negative regulation of B cell activation; P:negative regulation of peptidyl-tyrosine phosphorylation; scaffold7 indexed_genome mRNA 27191055 27203236 . + . ID=transcript_1975;P48723 B2R616 Q8NE40,Heat shock 70 kDa protein 13,Microsomal stress-70 protein ATPase core;Stress-70 protein chaperone microsome-associated 60 kDa protein;, PF00012;, GO:0005737;GO:0005783;GO:0070062;GO:0043231;GO:0005739;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0034620;GO:0051085;GO:0042026;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding;|P48723 B2R616 Q8NE40,Heat shock 70 kDa protein 13,Microsomal stress-70 protein ATPase core;Stress-70 protein chaperone microsome-associated 60 kDa protein;, PF00012;, GO:0005737;GO:0005783;GO:0070062;GO:0043231;GO:0005739;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0034620;GO:0051085;GO:0042026;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding;|P48723 B2R616 Q8NE40,Heat shock 70 kDa protein 13,Microsomal stress-70 protein ATPase core;Stress-70 protein chaperone microsome-associated 60 kDa protein;, PF00012;, GO:0005737;GO:0005783;GO:0070062;GO:0043231;GO:0005739;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0034620;GO:0051085;GO:0042026;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding;|P48723 B2R616 Q8NE40,Heat shock 70 kDa protein 13,Microsomal stress-70 protein ATPase core;Stress-70 protein chaperone microsome-associated 60 kDa protein;, PF00012;, GO:0005737;GO:0005783;GO:0070062;GO:0043231;GO:0005739;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0034620;GO:0051085;GO:0042026;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding;|P48723 B2R616 Q8NE40,Heat shock 70 kDa protein 13,Microsomal stress-70 protein ATPase core;Stress-70 protein chaperone microsome-associated 60 kDa protein;, PF00012;, GO:0005737;GO:0005783;GO:0070062;GO:0043231;GO:0005739;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0034620;GO:0051085;GO:0042026;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; scaffold7 indexed_genome mRNA 27211072 27255643 . - . ID=transcript_1976;Q92887 B2RMT8 Q14022 Q5T2B1 Q92500 Q92798 Q99663 Q9UMS2,ATP-binding cassette sub-family C member 2,Canalicular multidrug resistance protein;Canalicular multispecific organic anion transporter 1 {ECO:0000305};Multidrug resistance-associated protein 2;, PF00664;PF00005;, GO:0016324;GO:0031526;GO:0009986;GO:0005887;GO:0046581;GO:0046691;GO:0016020;GO:0005886;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015127;GO:0008514;GO:0019904;GO:0042910;GO:1901086;GO:0015721;GO:0038183;GO:0015723;GO:0015722;GO:0030644;GO:0071549;GO:0035690;GO:0071347;GO:0071354;GO:0071222;GO:0071356;GO:0046618;GO:0006855;GO:0007565;GO:0042167;GO:0006954;GO:0071716;GO:0015694;GO:0010629;GO:0015732;GO:0120188;GO:1904486;GO:0097327;GO:0046685;GO:0032355;GO:0043627;GO:0033762;GO:0009408;GO:0031427;GO:0006979;GO:0070327;GO:0070633;GO:0055085;GO:0150104;GO:0042178;GO:1990961;GO:1990962;, C:apical plasma membrane; C:brush border membrane; C:cell surface; C:integral component of plasma membrane; C:intercellular canaliculus; C:intracellular canaliculus; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bilirubin transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:protein domain specific binding; F:xenobiotic transmembrane transporter activity;, P:benzylpenicillin metabolic process; P:bile acid and bile salt transport; P:bile acid signaling pathway; P:bilirubin transport; P:canalicular bile acid transport; P:cellular chloride ion homeostasis; P:cellular response to dexamethasone stimulus; P:cellular response to drug; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:drug export; P:drug transmembrane transport; P:female pregnancy; P:heme catabolic process; P:inflammatory response; P:leukotriene transport; P:mercury ion transport; P:negative regulation of gene expression; P:prostaglandin transport; P:regulation of bile acid secretion; P:response to 17alpha-ethynylestradiol; P:response to antineoplastic agent; P:response to arsenic-containing substance; P:response to estradiol; P:response to estrogen; P:response to glucagon; P:response to heat; P:response to methotrexate; P:response to oxidative stress; P:thyroid hormone transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic catabolic process; P:xenobiotic detoxification by transmembrane export across the plasma membrane; P:xenobiotic transport across blood-brain barrier;|Q9UQA0,Multidrug resistance-associated protein 1 {ECO:0000305},ATP-binding cassette sub-family C member 1;Glutathione-S-conjugate-translocating ATPase ABCC1 {ECO:0000250|UniProtKB:O35379};Leukotriene C(4) transporter;, PF00664;PF00005;, GO:0016324;GO:0009925;GO:0016323;GO:0070062;GO:0005887;GO:0016328;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0034040;GO:0042626;GO:0046943;GO:0015562;GO:0034634;GO:0042910;GO:1905039;GO:0060326;GO:1904646;GO:0009235;GO:0015889;GO:0140115;GO:0034775;GO:0042167;GO:0006691;GO:0071716;GO:0045332;GO:0050729;GO:0042493;GO:0099039;GO:0070633;GO:0055085;GO:0150104;GO:0042908;GO:1990962;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:lateral plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled lipid transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:carboxylic acid transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:carboxylic acid transmembrane transport; P:cell chemotaxis; P:cellular response to amyloid-beta; P:cobalamin metabolic process; P:cobalamin transport; P:export across plasma membrane; P:glutathione transmembrane transport; P:heme catabolic process; P:leukotriene metabolic process; P:leukotriene transport; P:phospholipid translocation; P:positive regulation of inflammatory response; P:response to drug; P:sphingolipid translocation; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport; P:xenobiotic transport across blood-brain barrier; scaffold7 indexed_genome mRNA 27255645 27272391 . - . ID=transcript_1977;Q86X85 Q9UN52,ATP-binding cassette sub-family C member 3,Canalicular multispecific organic anion transporter 2 {ECO:0000303|PubMed:9813153};Multi-specific organic anion transporter D {ECO:0000303|PubMed:9827529};Multidrug resistance-associated protein 3;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0016020;GO:0005886;GO:0015432;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015164;GO:0071714;GO:0042910;GO:0015721;GO:0015722;GO:0006855;GO:0071716;GO:0055085;GO:0150104;GO:0042908;, C:basolateral plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:glucuronoside transmembrane transporter activity; F:icosanoid transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:canalicular bile acid transport; P:drug transmembrane transport; P:leukotriene transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport; scaffold7 indexed_genome mRNA 27340508 27357290 . - . ID=transcript_1978;P57052 Q6YNC2 Q8NBA1 Q8NFF6,Splicing regulator RBM11,RNA-binding motif protein 11;, PF00076;, GO:0016607;GO:0005654;GO:0005634;GO:0008266;GO:0042803;GO:0003727;GO:0030154;GO:0034599;GO:0006397;GO:0007275;GO:0000381;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:poly(U) RNA binding; F:protein homodimerization activity; F:single-stranded RNA binding;, P:cell differentiation; P:cellular response to oxidative stress; P:mRNA processing; P:multicellular organism development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; scaffold7 indexed_genome mRNA 27379059 27394475 . + . ID=transcript_1979;Q6XZB0 G1JSG3 G1JSG4 G1JSG5 G1JSG6 G1JSG7 G1JSG8 G1JSG9,Lipase member I,Cancer/testis antigen 17;LPD lipase;Membrane-associated phosphatidic acid-selective phospholipase A1-beta;, PF00151;, GO:0005615;GO:0005886;GO:0008201;GO:0016298;GO:0004465;GO:0004620;GO:0006633;GO:0016042;GO:0006654;GO:0019433;, C:extracellular space; C:plasma membrane;, F:heparin binding; F:lipase activity; F:lipoprotein lipase activity; F:phospholipase activity;, P:fatty acid biosynthetic process; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:triglyceride catabolic process; scaffold7 indexed_genome mRNA 27425174 27426037 . - . ID=transcript_1980;Q6XZB0 G1JSG3 G1JSG4 G1JSG5 G1JSG6 G1JSG7 G1JSG8 G1JSG9,Lipase member I,Cancer/testis antigen 17;LPD lipase;Membrane-associated phosphatidic acid-selective phospholipase A1-beta;, PF00151;, GO:0005615;GO:0005886;GO:0008201;GO:0016298;GO:0004465;GO:0004620;GO:0006633;GO:0016042;GO:0006654;GO:0019433;, C:extracellular space; C:plasma membrane;, F:heparin binding; F:lipase activity; F:lipoprotein lipase activity; F:phospholipase activity;, P:fatty acid biosynthetic process; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:triglyceride catabolic process; scaffold7 indexed_genome mRNA 29309855 29387201 . + . ID=transcript_1981;Q9HCK4 O43608 Q19AB4 Q19AB5,Roundabout homolog 2,, PF00041;PF07679;, GO:0030673;GO:0009986;GO:0070062;GO:0016021;GO:0005886;GO:0008046;GO:0042802;GO:0035904;GO:0003180;GO:0061364;GO:0007411;GO:0016199;GO:0007420;GO:0032870;GO:0007417;GO:0003272;GO:0007156;GO:0001656;GO:0050925;GO:0051964;GO:0021891;GO:0003148;GO:0050772;GO:0035481;GO:0003184;GO:0031290;GO:0001657;GO:0060412;, C:axolemma; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:axon guidance receptor activity; F:identical protein binding;, P:aorta development; P:aortic valve morphogenesis; P:apoptotic process involved in luteolysis; P:axon guidance; P:axon midline choice point recognition; P:brain development; P:cellular response to hormone stimulus; P:central nervous system development; P:endocardial cushion formation; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:metanephros development; P:negative regulation of negative chemotaxis; P:negative regulation of synapse assembly; P:olfactory bulb interneuron development; P:outflow tract septum morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of Notch signaling pathway involved in heart induction; P:pulmonary valve morphogenesis; P:retinal ganglion cell axon guidance; P:ureteric bud development; P:ventricular septum morphogenesis;|Q9HCK4 O43608 Q19AB4 Q19AB5,Roundabout homolog 2,, PF00041;PF07679;, GO:0030673;GO:0009986;GO:0070062;GO:0016021;GO:0005886;GO:0008046;GO:0042802;GO:0035904;GO:0003180;GO:0061364;GO:0007411;GO:0016199;GO:0007420;GO:0032870;GO:0007417;GO:0003272;GO:0007156;GO:0001656;GO:0050925;GO:0051964;GO:0021891;GO:0003148;GO:0050772;GO:0035481;GO:0003184;GO:0031290;GO:0001657;GO:0060412;, C:axolemma; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:axon guidance receptor activity; F:identical protein binding;, P:aorta development; P:aortic valve morphogenesis; P:apoptotic process involved in luteolysis; P:axon guidance; P:axon midline choice point recognition; P:brain development; P:cellular response to hormone stimulus; P:central nervous system development; P:endocardial cushion formation; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:metanephros development; P:negative regulation of negative chemotaxis; P:negative regulation of synapse assembly; P:olfactory bulb interneuron development; P:outflow tract septum morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of Notch signaling pathway involved in heart induction; P:pulmonary valve morphogenesis; P:retinal ganglion cell axon guidance; P:ureteric bud development; P:ventricular septum morphogenesis;|Q9HCK4 O43608 Q19AB4 Q19AB5,Roundabout homolog 2,, PF00041;PF07679;, GO:0030673;GO:0009986;GO:0070062;GO:0016021;GO:0005886;GO:0008046;GO:0042802;GO:0035904;GO:0003180;GO:0061364;GO:0007411;GO:0016199;GO:0007420;GO:0032870;GO:0007417;GO:0003272;GO:0007156;GO:0001656;GO:0050925;GO:0051964;GO:0021891;GO:0003148;GO:0050772;GO:0035481;GO:0003184;GO:0031290;GO:0001657;GO:0060412;, C:axolemma; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:axon guidance receptor activity; F:identical protein binding;, P:aorta development; P:aortic valve morphogenesis; P:apoptotic process involved in luteolysis; P:axon guidance; P:axon midline choice point recognition; P:brain development; P:cellular response to hormone stimulus; P:central nervous system development; P:endocardial cushion formation; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:metanephros development; P:negative regulation of negative chemotaxis; P:negative regulation of synapse assembly; P:olfactory bulb interneuron development; P:outflow tract septum morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of Notch signaling pathway involved in heart induction; P:pulmonary valve morphogenesis; P:retinal ganglion cell axon guidance; P:ureteric bud development; P:ventricular septum morphogenesis; scaffold7 indexed_genome mRNA 30354728 30797231 . - . ID=transcript_1982;Q9Y6N7 B2RXI1 D3DU36 E9PD49 Q1RMC7 Q7Z300 Q9BUS7,Roundabout homolog 1,Deleted in U twenty twenty;H-Robo-1;, PF00041;PF07679;, GO:0030424;GO:0009986;GO:0005737;GO:0033116;GO:0005887;GO:0005886;GO:0008046;GO:0042802;GO:0030275;GO:0006919;GO:0035904;GO:0003180;GO:0007411;GO:0016199;GO:0007155;GO:0002042;GO:0021836;GO:0003272;GO:0007156;GO:0030336;GO:0070100;GO:0010629;GO:0033600;GO:0050925;GO:0007399;GO:0003148;GO:0050772;GO:0010628;GO:0043406;GO:0035481;GO:0035025;GO:1900748;GO:0003184;GO:0035385;GO:0060412;, C:axon; C:cell surface; C:cytoplasm; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of plasma membrane; C:plasma membrane;, F:axon guidance receptor activity; F:identical protein binding; F:LRR domain binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:aorta development; P:aortic valve morphogenesis; P:axon guidance; P:axon midline choice point recognition; P:cell adhesion; P:cell migration involved in sprouting angiogenesis; P:chemorepulsion involved in postnatal olfactory bulb interneuron migration; P:endocardial cushion formation; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell migration; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of gene expression; P:negative regulation of mammary gland epithelial cell proliferation; P:negative regulation of negative chemotaxis; P:nervous system development; P:outflow tract septum morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of gene expression; P:positive regulation of MAP kinase activity; P:positive regulation of Notch signaling pathway involved in heart induction; P:positive regulation of Rho protein signal transduction; P:positive regulation of vascular endothelial growth factor signaling pathway; P:pulmonary valve morphogenesis; P:Roundabout signaling pathway; P:ventricular septum morphogenesis; scaffold7 indexed_genome mRNA 33139658 33283091 . - . ID=transcript_1983;Q04446 B3KWV3 Q96EN0,1,4-alpha-glucan-branching enzyme,Brancher enzyme;Glycogen-branching enzyme;, PF00128;PF02806;PF02922;, GO:0005737;GO:0005829;GO:0070062;GO:0003844;GO:0102752;GO:0030246;GO:0043169;GO:0004553;GO:0005975;GO:0006091;GO:0005978;GO:0005977;GO:0043524;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:1,4-alpha-glucan branching enzyme activity; F:1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis); F:carbohydrate binding; F:cation binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds;, P:carbohydrate metabolic process; P:generation of precursor metabolites and energy; P:glycogen biosynthetic process; P:glycogen metabolic process; P:negative regulation of neuron apoptotic process;|Q04446 B3KWV3 Q96EN0,1,4-alpha-glucan-branching enzyme,Brancher enzyme;Glycogen-branching enzyme;, PF00128;PF02806;PF02922;, GO:0005737;GO:0005829;GO:0070062;GO:0003844;GO:0102752;GO:0030246;GO:0043169;GO:0004553;GO:0005975;GO:0006091;GO:0005978;GO:0005977;GO:0043524;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:1,4-alpha-glucan branching enzyme activity; F:1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis); F:carbohydrate binding; F:cation binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds;, P:carbohydrate metabolic process; P:generation of precursor metabolites and energy; P:glycogen biosynthetic process; P:glycogen metabolic process; P:negative regulation of neuron apoptotic process;|Q04446 B3KWV3 Q96EN0,1,4-alpha-glucan-branching enzyme,Brancher enzyme;Glycogen-branching enzyme;, PF00128;PF02806;PF02922;, GO:0005737;GO:0005829;GO:0070062;GO:0003844;GO:0102752;GO:0030246;GO:0043169;GO:0004553;GO:0005975;GO:0006091;GO:0005978;GO:0005977;GO:0043524;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:1,4-alpha-glucan branching enzyme activity; F:1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis); F:carbohydrate binding; F:cation binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds;, P:carbohydrate metabolic process; P:generation of precursor metabolites and energy; P:glycogen biosynthetic process; P:glycogen metabolic process; P:negative regulation of neuron apoptotic process; scaffold7 indexed_genome mRNA 36426847 37553364 . + . ID=transcript_1984;Q8N3J6 G3XHN7 G3XHN8 Q3KQY9 Q658Q7 Q8IZP8,Cell adhesion molecule 2,Immunoglobulin superfamily member 4D;Nectin-like protein 3;Synaptic cell adhesion molecule 2;, PF08205;PF07686;, GO:0030424;GO:0016021;GO:0005886;GO:0045202;GO:0034332;GO:0007155;, C:axon; C:integral component of membrane; C:plasma membrane; C:synapse;, , P:adherens junction organization; P:cell adhesion;|Q8N3J6 G3XHN7 G3XHN8 Q3KQY9 Q658Q7 Q8IZP8,Cell adhesion molecule 2,Immunoglobulin superfamily member 4D;Nectin-like protein 3;Synaptic cell adhesion molecule 2;, PF08205;PF07686;, GO:0030424;GO:0016021;GO:0005886;GO:0045202;GO:0034332;GO:0007155;, C:axon; C:integral component of membrane; C:plasma membrane; C:synapse;, , P:adherens junction organization; P:cell adhesion; scaffold7 indexed_genome mRNA 37624480 37635350 . + . ID=transcript_1985;Q8N3J6 G3XHN7 G3XHN8 Q3KQY9 Q658Q7 Q8IZP8,Cell adhesion molecule 2,Immunoglobulin superfamily member 4D;Nectin-like protein 3;Synaptic cell adhesion molecule 2;, PF08205;PF07686;, GO:0030424;GO:0016021;GO:0005886;GO:0045202;GO:0034332;GO:0007155;, C:axon; C:integral component of membrane; C:plasma membrane; C:synapse;, , P:adherens junction organization; P:cell adhesion;|Q8N3J6 G3XHN7 G3XHN8 Q3KQY9 Q658Q7 Q8IZP8,Cell adhesion molecule 2,Immunoglobulin superfamily member 4D;Nectin-like protein 3;Synaptic cell adhesion molecule 2;, PF08205;PF07686;, GO:0030424;GO:0016021;GO:0005886;GO:0045202;GO:0034332;GO:0007155;, C:axon; C:integral component of membrane; C:plasma membrane; C:synapse;, , P:adherens junction organization; P:cell adhesion; scaffold7 indexed_genome mRNA 38483807 38507159 . - . ID=transcript_1986;A8MV65 D3DU37 Q504T7,Transcription cofactor vestigial-like protein 3,, PF07545;, GO:0005634;GO:0006357;, C:nucleus;, , P:regulation of transcription by RNA polymerase II; scaffold7 indexed_genome mRNA 38775440 38805188 . + . ID=transcript_1987;Q9UQN3 B4DJG8 Q53HC7 Q9Y4U6,Charged multivesicular body protein 2b,CHMP2.5;Chromatin-modifying protein 2b;Vacuolar protein sorting-associated protein 2-2;, PF03357;, GO:0005737;GO:0005829;GO:0000815;GO:0070062;GO:0031902;GO:0005771;GO:0045296;GO:0019904;GO:0006914;GO:0050890;GO:0016197;GO:0007032;GO:0032509;GO:1904903;GO:0045324;GO:0016236;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0061763;GO:0070050;GO:0006997;GO:1902188;GO:0015031;GO:0010824;GO:1901673;GO:0039702;GO:0019058;, C:cytoplasm; C:cytosol; C:ESCRT III complex; C:extracellular exosome; C:late endosome membrane; C:multivesicular body;, F:cadherin binding; F:protein domain specific binding;, P:autophagy; P:cognition; P:endosomal transport; P:endosome organization; P:endosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:late endosome to vacuole transport; P:macroautophagy; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:multivesicular body-lysosome fusion; P:neuron cellular homeostasis; P:nucleus organization; P:positive regulation of viral release from host cell; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold7 indexed_genome mRNA 39349530 39350224 . + . ID=transcript_1988;P30939,5-hydroxytryptamine receptor 1F,Serotonin receptor 1F;, PF00001;, GO:0030425;GO:0005887;GO:0005886;GO:0045202;GO:0004993;GO:0030594;GO:0051378;GO:0007193;GO:0007198;GO:0007268;GO:0007186;GO:0007187;, C:dendrite; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity; F:serotonin binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; scaffold7 indexed_genome mRNA 39350250 39350940 . + . ID=transcript_1989;P30939,5-hydroxytryptamine receptor 1F,Serotonin receptor 1F;, PF00001;, GO:0030425;GO:0005887;GO:0005886;GO:0045202;GO:0004993;GO:0030594;GO:0051378;GO:0007193;GO:0007198;GO:0007268;GO:0007186;GO:0007187;, C:dendrite; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity; F:serotonin binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; scaffold7 indexed_genome mRNA 39394156 39397360 . + . ID=transcript_1990;Q9UFW8 D3DU38 O15183,CGG triplet repeat-binding protein 1,20 kDa CGG-binding protein;p20-CGGBP DNA-binding protein;, , GO:0005654;GO:0005634;GO:0003690;GO:0042802;GO:0090579;GO:0000122;GO:0010468;, C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:identical protein binding;, P:dsDNA loop formation; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression;|Q9UFW8 D3DU38 O15183,CGG triplet repeat-binding protein 1,20 kDa CGG-binding protein;p20-CGGBP DNA-binding protein;, , GO:0005654;GO:0005634;GO:0003690;GO:0042802;GO:0090579;GO:0000122;GO:0010468;, C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:identical protein binding;, P:dsDNA loop formation; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold7 indexed_genome mRNA 39398461 39466703 . + . ID=transcript_1991;Q13129 Q14CQ1 Q9NU60,Zinc finger protein Rlf,Rearranged L-myc fusion gene protein;Zn-15-related protein;, PF00096;, GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0046872;GO:0097692;GO:0045944;GO:0045893;GO:0044030;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA methylation; P:regulation of transcription by RNA polymerase II; scaffold7 indexed_genome mRNA 39477362 39505491 . + . ID=transcript_1992;Q8IZM8 Q9H791 Q9NV14,Zinc finger protein 654,Melanoma-associated antigen;, PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of transcription by RNA polymerase II;|Q5JPI3 B2R8X6 Q8TC85,Uncharacterized protein C3orf38,, PF15008;, GO:0005634;GO:0006915;GO:0043065;, C:nucleus;, , P:apoptotic process; P:positive regulation of apoptotic process; scaffold7 indexed_genome mRNA 40724569 40745827 . + . ID=transcript_1993;P29320 Q9H2V3 Q9H2V4,Ephrin type-A receptor 3,EPH-like kinase 4;HEK;Tyrosine-protein kinase TYRO4;Tyrosine-protein kinase receptor ETK1;, PF14575;PF01404;PF07699;PF00041;PF07714;PF07647;, GO:0015629;GO:0005829;GO:0005769;GO:0005576;GO:0005887;GO:0043005;GO:0031965;GO:0005654;GO:0005886;GO:0043235;GO:0005524;GO:0005003;GO:0005004;GO:0004714;GO:0005005;GO:0007411;GO:0007155;GO:0016477;GO:0071300;GO:0048013;GO:0097156;GO:0097155;GO:0007275;GO:0045806;GO:0018108;GO:0033674;GO:0010976;GO:1903078;GO:0032956;GO:0010717;GO:0051893;GO:0043087;GO:0070507;GO:0007169;, C:actin cytoskeleton; C:cytosol; C:early endosome; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:nuclear membrane; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ephrin receptor activity; F:GPI-linked ephrin receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:cell adhesion; P:cell migration; P:cellular response to retinoic acid; P:ephrin receptor signaling pathway; P:fasciculation of motor neuron axon; P:fasciculation of sensory neuron axon; P:multicellular organism development; P:negative regulation of endocytosis; P:peptidyl-tyrosine phosphorylation; P:positive regulation of kinase activity; P:positive regulation of neuron projection development; P:positive regulation of protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of GTPase activity; P:regulation of microtubule cytoskeleton organization; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold7 indexed_genome mRNA 41400307 41443074 . - . ID=transcript_1994;P07225 A8KAC9 D3DN28 Q15518 Q7Z715 Q9UCZ8,Vitamin K-dependent protein S,, PF00008;PF07645;PF00594;PF00054;PF02210;, GO:0072562;GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0000139;GO:0005886;GO:0031093;GO:0005509;GO:0004866;GO:0007596;GO:0006888;GO:0042730;GO:0050900;GO:0002576;GO:0030449;, C:blood microparticle; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:Golgi membrane; C:plasma membrane; C:platelet alpha granule lumen;, F:calcium ion binding; F:endopeptidase inhibitor activity;, P:blood coagulation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fibrinolysis; P:leukocyte migration; P:platelet degranulation; P:regulation of complement activation;|P07225 A8KAC9 D3DN28 Q15518 Q7Z715 Q9UCZ8,Vitamin K-dependent protein S,, PF00008;PF07645;PF00594;PF00054;PF02210;, GO:0072562;GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0000139;GO:0005886;GO:0031093;GO:0005509;GO:0004866;GO:0007596;GO:0006888;GO:0042730;GO:0050900;GO:0002576;GO:0030449;, C:blood microparticle; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:Golgi membrane; C:plasma membrane; C:platelet alpha granule lumen;, F:calcium ion binding; F:endopeptidase inhibitor activity;, P:blood coagulation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fibrinolysis; P:leukocyte migration; P:platelet degranulation; P:regulation of complement activation; scaffold7 indexed_genome mRNA 41475797 41541043 . + . ID=transcript_1995;Q3SXY8 D3DN29 G3V1S8 Q504W8 Q8TCL5,ADP-ribosylation factor-like protein 13B,ADP-ribosylation factor-like protein 2-like 1;, PF00025;, GO:0060170;GO:0005929;GO:0005829;GO:0031514;GO:0097730;GO:0005525;GO:0035973;GO:0060271;GO:0021943;GO:0021830;GO:0021532;GO:1905515;GO:0097500;GO:0007224;, C:ciliary membrane; C:cilium; C:cytosol; C:motile cilium; C:non-motile cilium;, F:GTP binding;, P:aggrephagy; P:cilium assembly; P:formation of radial glial scaffolds; P:interneuron migration from the subpallium to the cortex; P:neural tube patterning; P:non-motile cilium assembly; P:receptor localization to non-motile cilium; P:smoothened signaling pathway;|Q3SXY8 D3DN29 G3V1S8 Q504W8 Q8TCL5,ADP-ribosylation factor-like protein 13B,ADP-ribosylation factor-like protein 2-like 1;, PF00025;, GO:0060170;GO:0005929;GO:0005829;GO:0031514;GO:0097730;GO:0005525;GO:0035973;GO:0060271;GO:0021943;GO:0021830;GO:0021532;GO:1905515;GO:0097500;GO:0007224;, C:ciliary membrane; C:cilium; C:cytosol; C:motile cilium; C:non-motile cilium;, F:GTP binding;, P:aggrephagy; P:cilium assembly; P:formation of radial glial scaffolds; P:interneuron migration from the subpallium to the cortex; P:neural tube patterning; P:non-motile cilium assembly; P:receptor localization to non-motile cilium; P:smoothened signaling pathway;|Q8N4C7,Syntaxin-19,, PF00804;, GO:0012505;GO:0016021;GO:0005886;GO:0048787;GO:0031201;GO:0008021;GO:0005484;GO:0000149;GO:0006887;GO:0006886;GO:0031629;GO:0048278;GO:0006906;, C:endomembrane system; C:integral component of membrane; C:plasma membrane; C:presynaptic active zone membrane; C:SNARE complex; C:synaptic vesicle;, F:SNAP receptor activity; F:SNARE binding;, P:exocytosis; P:intracellular protein transport; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle fusion;|Q3SXY8 D3DN29 G3V1S8 Q504W8 Q8TCL5,ADP-ribosylation factor-like protein 13B,ADP-ribosylation factor-like protein 2-like 1;, PF00025;, GO:0060170;GO:0005929;GO:0005829;GO:0031514;GO:0097730;GO:0005525;GO:0035973;GO:0060271;GO:0021943;GO:0021830;GO:0021532;GO:1905515;GO:0097500;GO:0007224;, C:ciliary membrane; C:cilium; C:cytosol; C:motile cilium; C:non-motile cilium;, F:GTP binding;, P:aggrephagy; P:cilium assembly; P:formation of radial glial scaffolds; P:interneuron migration from the subpallium to the cortex; P:neural tube patterning; P:non-motile cilium assembly; P:receptor localization to non-motile cilium; P:smoothened signaling pathway; scaffold7 indexed_genome mRNA 41551903 41553874 . + . ID=transcript_1996;Q3SXY8 D3DN29 G3V1S8 Q504W8 Q8TCL5,ADP-ribosylation factor-like protein 13B,ADP-ribosylation factor-like protein 2-like 1;, PF00025;, GO:0060170;GO:0005929;GO:0005829;GO:0031514;GO:0097730;GO:0005525;GO:0035973;GO:0060271;GO:0021943;GO:0021830;GO:0021532;GO:1905515;GO:0097500;GO:0007224;, C:ciliary membrane; C:cilium; C:cytosol; C:motile cilium; C:non-motile cilium;, F:GTP binding;, P:aggrephagy; P:cilium assembly; P:formation of radial glial scaffolds; P:interneuron migration from the subpallium to the cortex; P:neural tube patterning; P:non-motile cilium assembly; P:receptor localization to non-motile cilium; P:smoothened signaling pathway; scaffold7 indexed_genome mRNA 41559256 41621640 . + . ID=transcript_1997;Q9H649 Q6PG41 Q8IXG9 Q9H6M2,tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial,NOL1/NOP2/Sun domain family member 3 {ECO:0000312|HGNC:HGNC:26208};, PF01189;, GO:0005762;GO:0005759;GO:0005739;GO:0008168;GO:0016428;GO:0000049;GO:0070129;GO:0001510;GO:0031167;GO:0002127;, C:mitochondrial large ribosomal subunit; C:mitochondrial matrix; C:mitochondrion;, F:methyltransferase activity; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA binding;, P:regulation of mitochondrial translation; P:RNA methylation; P:rRNA methylation; P:tRNA wobble base cytosine methylation;|Q9H649 Q6PG41 Q8IXG9 Q9H6M2,tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial,NOL1/NOP2/Sun domain family member 3 {ECO:0000312|HGNC:HGNC:26208};, PF01189;, GO:0005762;GO:0005759;GO:0005739;GO:0008168;GO:0016428;GO:0000049;GO:0070129;GO:0001510;GO:0031167;GO:0002127;, C:mitochondrial large ribosomal subunit; C:mitochondrial matrix; C:mitochondrion;, F:methyltransferase activity; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA binding;, P:regulation of mitochondrial translation; P:RNA methylation; P:rRNA methylation; P:tRNA wobble base cytosine methylation;|Q9H649 Q6PG41 Q8IXG9 Q9H6M2,tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial,NOL1/NOP2/Sun domain family member 3 {ECO:0000312|HGNC:HGNC:26208};, PF01189;, GO:0005762;GO:0005759;GO:0005739;GO:0008168;GO:0016428;GO:0000049;GO:0070129;GO:0001510;GO:0031167;GO:0002127;, C:mitochondrial large ribosomal subunit; C:mitochondrial matrix; C:mitochondrion;, F:methyltransferase activity; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA binding;, P:regulation of mitochondrial translation; P:RNA methylation; P:rRNA methylation; P:tRNA wobble base cytosine methylation;|Q9H649 Q6PG41 Q8IXG9 Q9H6M2,tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial,NOL1/NOP2/Sun domain family member 3 {ECO:0000312|HGNC:HGNC:26208};, PF01189;, GO:0005762;GO:0005759;GO:0005739;GO:0008168;GO:0016428;GO:0000049;GO:0070129;GO:0001510;GO:0031167;GO:0002127;, C:mitochondrial large ribosomal subunit; C:mitochondrial matrix; C:mitochondrion;, F:methyltransferase activity; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA binding;, P:regulation of mitochondrial translation; P:RNA methylation; P:rRNA methylation; P:tRNA wobble base cytosine methylation; scaffold7 indexed_genome mRNA 44702256 44735619 . + . ID=transcript_1998;Q9H0F7 A8KA93 D3DN31,ADP-ribosylation factor-like protein 6,Bardet-Biedl syndrome 3 protein;, PF00025;, GO:0005879;GO:0005930;GO:0005929;GO:0005737;GO:0070062;GO:0016020;GO:0030117;GO:0005886;GO:0005525;GO:0003924;GO:0046872;GO:0005543;GO:0060271;GO:0007368;GO:0006886;GO:0032402;GO:0061512;GO:0051258;GO:0006612;GO:0016192;GO:0007601;GO:0016055;, C:axonemal microtubule; C:axoneme; C:cilium; C:cytoplasm; C:extracellular exosome; C:membrane; C:membrane coat; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:phospholipid binding;, P:cilium assembly; P:determination of left/right symmetry; P:intracellular protein transport; P:melanosome transport; P:protein localization to cilium; P:protein polymerization; P:protein targeting to membrane; P:vesicle-mediated transport; P:visual perception; P:Wnt signaling pathway;|Q9H0F7 A8KA93 D3DN31,ADP-ribosylation factor-like protein 6,Bardet-Biedl syndrome 3 protein;, PF00025;, GO:0005879;GO:0005930;GO:0005929;GO:0005737;GO:0070062;GO:0016020;GO:0030117;GO:0005886;GO:0005525;GO:0003924;GO:0046872;GO:0005543;GO:0060271;GO:0007368;GO:0006886;GO:0032402;GO:0061512;GO:0051258;GO:0006612;GO:0016192;GO:0007601;GO:0016055;, C:axonemal microtubule; C:axoneme; C:cilium; C:cytoplasm; C:extracellular exosome; C:membrane; C:membrane coat; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:phospholipid binding;, P:cilium assembly; P:determination of left/right symmetry; P:intracellular protein transport; P:melanosome transport; P:protein localization to cilium; P:protein polymerization; P:protein targeting to membrane; P:vesicle-mediated transport; P:visual perception; P:Wnt signaling pathway;|Q9H0F7 A8KA93 D3DN31,ADP-ribosylation factor-like protein 6,Bardet-Biedl syndrome 3 protein;, PF00025;, GO:0005879;GO:0005930;GO:0005929;GO:0005737;GO:0070062;GO:0016020;GO:0030117;GO:0005886;GO:0005525;GO:0003924;GO:0046872;GO:0005543;GO:0060271;GO:0007368;GO:0006886;GO:0032402;GO:0061512;GO:0051258;GO:0006612;GO:0016192;GO:0007601;GO:0016055;, C:axonemal microtubule; C:axoneme; C:cilium; C:cytoplasm; C:extracellular exosome; C:membrane; C:membrane coat; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:phospholipid binding;, P:cilium assembly; P:determination of left/right symmetry; P:intracellular protein transport; P:melanosome transport; P:protein localization to cilium; P:protein polymerization; P:protein targeting to membrane; P:vesicle-mediated transport; P:visual perception; P:Wnt signaling pathway; scaffold7 indexed_genome mRNA 44775100 44889392 . + . ID=transcript_1999;Q68DQ2 B4DLE8 F6VHI2 Q4G0V8 Q7Z4R9 Q86VD0 Q8N262 Q8N7F1 Q8NDQ8,Very large A-kinase anchor protein,Beta/gamma crystallin domain-containing protein 3;, PF00030;PF00652;, GO:0032991;GO:0030246;GO:0051018;GO:0005212;GO:0002088;GO:0007601;, C:protein-containing complex;, F:carbohydrate binding; F:protein kinase A binding; F:structural constituent of eye lens;, P:lens development in camera-type eye; P:visual perception;|Q68DQ2 B4DLE8 F6VHI2 Q4G0V8 Q7Z4R9 Q86VD0 Q8N262 Q8N7F1 Q8NDQ8,Very large A-kinase anchor protein,Beta/gamma crystallin domain-containing protein 3;, PF00030;PF00652;, GO:0032991;GO:0030246;GO:0051018;GO:0005212;GO:0002088;GO:0007601;, C:protein-containing complex;, F:carbohydrate binding; F:protein kinase A binding; F:structural constituent of eye lens;, P:lens development in camera-type eye; P:visual perception;|Q68DQ2 B4DLE8 F6VHI2 Q4G0V8 Q7Z4R9 Q86VD0 Q8N262 Q8N7F1 Q8NDQ8,Very large A-kinase anchor protein,Beta/gamma crystallin domain-containing protein 3;, PF00030;PF00652;, GO:0032991;GO:0030246;GO:0051018;GO:0005212;GO:0002088;GO:0007601;, C:protein-containing complex;, F:carbohydrate binding; F:protein kinase A binding; F:structural constituent of eye lens;, P:lens development in camera-type eye; P:visual perception;|Q8IUF8 D3DN35 Q6AHW4 Q6SKS0 Q8IU69 Q8IUF6 Q8IUF7 Q96C17 Q96KB0,Ribosomal oxygenase 2 {ECO:0000312|HGNC:HGNC:19441},60S ribosomal protein L27a histidine hydroxylase;Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA;Histone lysine demethylase MINA;MYC-induced nuclear antigen;Mineral dust-induced gene protein;Nucleolar protein 52;Ribosomal oxygenase MINA;, PF08007;, GO:0005829;GO:0005730;GO:0005654;GO:0005667;GO:0016706;GO:0051864;GO:0032453;GO:0042802;GO:0046872;GO:0003714;GO:0070544;GO:0034720;GO:0042254;, C:cytosol; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:2-oxoglutarate-dependent dioxygenase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K4 specific); F:identical protein binding; F:metal ion binding; F:transcription corepressor activity;, P:histone H3-K36 demethylation; P:histone H3-K4 demethylation; P:ribosome biogenesis;|Q8IUF8 D3DN35 Q6AHW4 Q6SKS0 Q8IU69 Q8IUF6 Q8IUF7 Q96C17 Q96KB0,Ribosomal oxygenase 2 {ECO:0000312|HGNC:HGNC:19441},60S ribosomal protein L27a histidine hydroxylase;Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA;Histone lysine demethylase MINA;MYC-induced nuclear antigen;Mineral dust-induced gene protein;Nucleolar protein 52;Ribosomal oxygenase MINA;, PF08007;, GO:0005829;GO:0005730;GO:0005654;GO:0005667;GO:0016706;GO:0051864;GO:0032453;GO:0042802;GO:0046872;GO:0003714;GO:0070544;GO:0034720;GO:0042254;, C:cytosol; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:2-oxoglutarate-dependent dioxygenase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K4 specific); F:identical protein binding; F:metal ion binding; F:transcription corepressor activity;, P:histone H3-K36 demethylation; P:histone H3-K4 demethylation; P:ribosome biogenesis; scaffold7 indexed_genome mRNA 44889414 44918633 . + . ID=transcript_2000;Q8IUF8 D3DN35 Q6AHW4 Q6SKS0 Q8IU69 Q8IUF6 Q8IUF7 Q96C17 Q96KB0,Ribosomal oxygenase 2 {ECO:0000312|HGNC:HGNC:19441},60S ribosomal protein L27a histidine hydroxylase;Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA;Histone lysine demethylase MINA;MYC-induced nuclear antigen;Mineral dust-induced gene protein;Nucleolar protein 52;Ribosomal oxygenase MINA;, PF08007;, GO:0005829;GO:0005730;GO:0005654;GO:0005667;GO:0016706;GO:0051864;GO:0032453;GO:0042802;GO:0046872;GO:0003714;GO:0070544;GO:0034720;GO:0042254;, C:cytosol; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:2-oxoglutarate-dependent dioxygenase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K4 specific); F:identical protein binding; F:metal ion binding; F:transcription corepressor activity;, P:histone H3-K36 demethylation; P:histone H3-K4 demethylation; P:ribosome biogenesis;|Q8IUF8 D3DN35 Q6AHW4 Q6SKS0 Q8IU69 Q8IUF6 Q8IUF7 Q96C17 Q96KB0,Ribosomal oxygenase 2 {ECO:0000312|HGNC:HGNC:19441},60S ribosomal protein L27a histidine hydroxylase;Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA;Histone lysine demethylase MINA;MYC-induced nuclear antigen;Mineral dust-induced gene protein;Nucleolar protein 52;Ribosomal oxygenase MINA;, PF08007;, GO:0005829;GO:0005730;GO:0005654;GO:0005667;GO:0016706;GO:0051864;GO:0032453;GO:0042802;GO:0046872;GO:0003714;GO:0070544;GO:0034720;GO:0042254;, C:cytosol; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:2-oxoglutarate-dependent dioxygenase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K4 specific); F:identical protein binding; F:metal ion binding; F:transcription corepressor activity;, P:histone H3-K36 demethylation; P:histone H3-K4 demethylation; P:ribosome biogenesis; scaffold7 indexed_genome mRNA 45471335 45475210 . - . ID=transcript_2001;Q9NY35 B3KQR1 D3DN36 F2Z2D9 Q502Y8 Q6UVX2 Q9BUZ9 Q9NZZ5 Q9Y4S9,Claudin domain-containing protein 1,Membrane protein GENX-3745;, PF13903;, GO:0009986;GO:0016021;, C:cell surface; C:integral component of membrane; scaffold7 indexed_genome mRNA 45475223 45479107 . - . ID=transcript_2002;Q9NY35 B3KQR1 D3DN36 F2Z2D9 Q502Y8 Q6UVX2 Q9BUZ9 Q9NZZ5 Q9Y4S9,Claudin domain-containing protein 1,Membrane protein GENX-3745;, PF13903;, GO:0009986;GO:0016021;, C:cell surface; C:integral component of membrane; scaffold7 indexed_genome mRNA 45533589 45536637 . - . ID=transcript_2003;P36551 A8K275 B4DSD5 Q14060 Q53F08 Q8IZ45 Q96AF3,Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial,, PF01218;, GO:0005737;GO:0005829;GO:0005758;GO:0005739;GO:0004109;GO:0042803;GO:0006783;GO:0006782;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:mitochondrion;, F:coproporphyrinogen oxidase activity; F:protein homodimerization activity;, P:heme biosynthetic process; P:protoporphyrinogen IX biosynthetic process; scaffold7 indexed_genome mRNA 45576817 45591859 . + . ID=transcript_2004;P02794 B3KNR5 Q3KRA8 Q3SWW1,Ferritin heavy chain,Cell proliferation-inducing gene 15 protein;, PF00210;, GO:0044754;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0008043;GO:0005634;GO:1904724;GO:0008199;GO:0008198;GO:0004322;GO:0005506;GO:0006879;GO:0006955;GO:0006880;GO:0006826;GO:0008285;GO:0048147;GO:0043312;GO:0006892;, C:autolysosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:intracellular ferritin complex; C:nucleus; C:tertiary granule lumen;, F:ferric iron binding; F:ferrous iron binding; F:ferroxidase activity; F:iron ion binding;, P:cellular iron ion homeostasis; P:immune response; P:intracellular sequestering of iron ion; P:iron ion transport; P:negative regulation of cell population proliferation; P:negative regulation of fibroblast proliferation; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; scaffold7 indexed_genome mRNA 45700879 45755088 . + . ID=transcript_2005;Q9Y274 B2RCH2 B3KMI1 D3DN39 F8W6U0,Type 2 lactosamine alpha-2,3-sialyltransferase,CMP-NeuAc:beta-galactoside alpha-2,3-sialyltransferase VI;ST3Gal VI;Sialyltransferase 10;, PF00777;, GO:0070062;GO:0000139;GO:0016021;GO:0052798;GO:0008373;GO:0006464;GO:0071354;GO:0006664;GO:0018146;GO:0009312;GO:0009311;GO:0006486;, C:extracellular exosome; C:Golgi membrane; C:integral component of membrane;, F:beta-galactoside alpha-2,3-sialyltransferase activity; F:sialyltransferase activity;, P:cellular protein modification process; P:cellular response to interleukin-6; P:glycolipid metabolic process; P:keratan sulfate biosynthetic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation;|Q9Y274 B2RCH2 B3KMI1 D3DN39 F8W6U0,Type 2 lactosamine alpha-2,3-sialyltransferase,CMP-NeuAc:beta-galactoside alpha-2,3-sialyltransferase VI;ST3Gal VI;Sialyltransferase 10;, PF00777;, GO:0070062;GO:0000139;GO:0016021;GO:0052798;GO:0008373;GO:0006464;GO:0071354;GO:0006664;GO:0018146;GO:0009312;GO:0009311;GO:0006486;, C:extracellular exosome; C:Golgi membrane; C:integral component of membrane;, F:beta-galactoside alpha-2,3-sialyltransferase activity; F:sialyltransferase activity;, P:cellular protein modification process; P:cellular response to interleukin-6; P:glycolipid metabolic process; P:keratan sulfate biosynthetic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation;|Q96PD2 B7WNL1 D3DN41 Q8N6M4 Q8TDX2,Discoidin, CUB and LCCL domain-containing protein 2,CUB, LCCL and coagulation factor V/VIII-homology domains protein 1;Endothelial and smooth muscle cell-derived neuropilin-like protein;, PF00431;PF00754;PF03815;, GO:0009986;GO:0005887;GO:0030522;GO:0030308;GO:0042060;, C:cell surface; C:integral component of plasma membrane;, , P:intracellular receptor signaling pathway; P:negative regulation of cell growth; P:wound healing; scaffold7 indexed_genome mRNA 45772009 45825965 . - . ID=transcript_2006;Q96PD2 B7WNL1 D3DN41 Q8N6M4 Q8TDX2,Discoidin, CUB and LCCL domain-containing protein 2,CUB, LCCL and coagulation factor V/VIII-homology domains protein 1;Endothelial and smooth muscle cell-derived neuropilin-like protein;, PF00431;PF00754;PF03815;, GO:0009986;GO:0005887;GO:0030522;GO:0030308;GO:0042060;, C:cell surface; C:integral component of plasma membrane;, , P:intracellular receptor signaling pathway; P:negative regulation of cell growth; P:wound healing; scaffold7 indexed_genome mRNA 46483661 46633635 . + . ID=transcript_2007;P27658 D3DN42 Q53XI6 Q96D07,Collagen alpha-1(VIII) chain,Endothelial collagen;, PF00386;PF01391;, GO:0005591;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0001525;GO:0048593;GO:0007155;GO:0030199;GO:0035987;GO:0050673;GO:0030198;GO:0010811;, C:collagen type VIII trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:angiogenesis; P:camera-type eye morphogenesis; P:cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; P:epithelial cell proliferation; P:extracellular matrix organization; P:positive regulation of cell-substrate adhesion; scaffold7 indexed_genome mRNA 46635957 46640947 . - . ID=transcript_2008;P27658 D3DN42 Q53XI6 Q96D07,Collagen alpha-1(VIII) chain,Endothelial collagen;, PF00386;PF01391;, GO:0005591;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0001525;GO:0048593;GO:0007155;GO:0030199;GO:0035987;GO:0050673;GO:0030198;GO:0010811;, C:collagen type VIII trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:angiogenesis; P:camera-type eye morphogenesis; P:cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; P:epithelial cell proliferation; P:extracellular matrix organization; P:positive regulation of cell-substrate adhesion; scaffold7 indexed_genome mRNA 46680682 46963285 . - . ID=transcript_2009;Q8N6Z0,Filamin A-interacting protein 1-like,130 kDa GPBP-interacting protein;90 kDa GPBP-interacting protein;Protein down-regulated in ovarian cancer 1;, PF09727;, GO:0005737;GO:0016020;GO:0005634;, C:cytoplasm; C:membrane; C:nucleus; scaffold7 indexed_genome mRNA 47009299 47029920 . + . ID=transcript_2010;Q9BQ75 A8K5S7 B4DUM1 E9PHS3,Protein CMSS1,Cms1 ribosomal small subunit homolog;, PF14617;, GO:0003723;, , F:RNA binding; scaffold7 indexed_genome mRNA 47100842 47154842 . + . ID=transcript_2011;Q9NUY8 B9A6M5 Q8TCN8 Q8WUB7 Q96D90 Q9NV75,TBC1 domain family member 23,HCV non-structural protein 4A-transactivated protein 1;, PF00566;PF00581;, GO:0031410;GO:0005829;GO:0005794;GO:0005802;GO:0007420;GO:1990403;GO:0031175;GO:0042147;GO:0099041;GO:0016192;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:trans-Golgi network;, , P:brain development; P:embryonic brain development; P:neuron projection development; P:retrograde transport, endosome to Golgi; P:vesicle tethering to Golgi; P:vesicle-mediated transport;|Q9NUY8 B9A6M5 Q8TCN8 Q8WUB7 Q96D90 Q9NV75,TBC1 domain family member 23,HCV non-structural protein 4A-transactivated protein 1;, PF00566;PF00581;, GO:0031410;GO:0005829;GO:0005794;GO:0005802;GO:0007420;GO:1990403;GO:0031175;GO:0042147;GO:0099041;GO:0016192;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:trans-Golgi network;, , P:brain development; P:embryonic brain development; P:neuron projection development; P:retrograde transport, endosome to Golgi; P:vesicle tethering to Golgi; P:vesicle-mediated transport;|Q9NUY8 B9A6M5 Q8TCN8 Q8WUB7 Q96D90 Q9NV75,TBC1 domain family member 23,HCV non-structural protein 4A-transactivated protein 1;, PF00566;PF00581;, GO:0031410;GO:0005829;GO:0005794;GO:0005802;GO:0007420;GO:1990403;GO:0031175;GO:0042147;GO:0099041;GO:0016192;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:trans-Golgi network;, , P:brain development; P:embryonic brain development; P:neuron projection development; P:retrograde transport, endosome to Golgi; P:vesicle tethering to Golgi; P:vesicle-mediated transport; scaffold7 indexed_genome mRNA 47169668 47184369 . + . ID=transcript_2012;Q9NQR4 B2R9A3 D3DN47 Q8WUF0,Omega-amidase NIT2,Nitrilase homolog 2;, PF00795;, GO:0005813;GO:0005829;GO:0070062;GO:0005576;GO:0035580;GO:1904724;GO:0106008;GO:0050152;GO:0006528;GO:0006541;GO:0043312;GO:0006107;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:specific granule lumen; C:tertiary granule lumen;, F:2-oxoglutaramate amidase activity; F:omega-amidase activity;, P:asparagine metabolic process; P:glutamine metabolic process; P:neutrophil degranulation; P:oxaloacetate metabolic process;|Q9NQR4 B2R9A3 D3DN47 Q8WUF0,Omega-amidase NIT2,Nitrilase homolog 2;, PF00795;, GO:0005813;GO:0005829;GO:0070062;GO:0005576;GO:0035580;GO:1904724;GO:0106008;GO:0050152;GO:0006528;GO:0006541;GO:0043312;GO:0006107;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:specific granule lumen; C:tertiary granule lumen;, F:2-oxoglutaramate amidase activity; F:omega-amidase activity;, P:asparagine metabolic process; P:glutamine metabolic process; P:neutrophil degranulation; P:oxaloacetate metabolic process;|Q9NQR4 B2R9A3 D3DN47 Q8WUF0,Omega-amidase NIT2,Nitrilase homolog 2;, PF00795;, GO:0005813;GO:0005829;GO:0070062;GO:0005576;GO:0035580;GO:1904724;GO:0106008;GO:0050152;GO:0006528;GO:0006541;GO:0043312;GO:0006107;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:specific granule lumen; C:tertiary granule lumen;, F:2-oxoglutaramate amidase activity; F:omega-amidase activity;, P:asparagine metabolic process; P:glutamine metabolic process; P:neutrophil degranulation; P:oxaloacetate metabolic process;|Q9NQR4 B2R9A3 D3DN47 Q8WUF0,Omega-amidase NIT2,Nitrilase homolog 2;, PF00795;, GO:0005813;GO:0005829;GO:0070062;GO:0005576;GO:0035580;GO:1904724;GO:0106008;GO:0050152;GO:0006528;GO:0006541;GO:0043312;GO:0006107;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:specific granule lumen; C:tertiary granule lumen;, F:2-oxoglutaramate amidase activity; F:omega-amidase activity;, P:asparagine metabolic process; P:glutamine metabolic process; P:neutrophil degranulation; P:oxaloacetate metabolic process;|Q9NQR4 B2R9A3 D3DN47 Q8WUF0,Omega-amidase NIT2,Nitrilase homolog 2;, PF00795;, GO:0005813;GO:0005829;GO:0070062;GO:0005576;GO:0035580;GO:1904724;GO:0106008;GO:0050152;GO:0006528;GO:0006541;GO:0043312;GO:0006107;, C:centrosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:specific granule lumen; C:tertiary granule lumen;, F:2-oxoglutaramate amidase activity; F:omega-amidase activity;, P:asparagine metabolic process; P:glutamine metabolic process; P:neutrophil degranulation; P:oxaloacetate metabolic process; scaffold7 indexed_genome mRNA 47194350 47229777 . + . ID=transcript_2013;O94826 D3DN48,Mitochondrial import receptor subunit TOM70 {ECO:0000305},Mitochondrial precursor proteins import receptor;Translocase of outer membrane 70 kDa subunit;Translocase of outer mitochondrial membrane protein 70 {ECO:0000312|HGNC:HGNC:11985};, PF00515;PF13181;, GO:0070062;GO:0016021;GO:0016020;GO:0005741;GO:0005742;GO:0005739;GO:0030943;GO:0008320;GO:0002218;GO:0098586;GO:0016236;GO:0002230;GO:0032728;GO:0030150;GO:0045039;GO:0006626;GO:0042981;, C:extracellular exosome; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:mitochondrion targeting sequence binding; F:protein transmembrane transporter activity;, P:activation of innate immune response; P:cellular response to virus; P:macroautophagy; P:positive regulation of defense response to virus by host; P:positive regulation of interferon-beta production; P:protein import into mitochondrial matrix; P:protein insertion into mitochondrial inner membrane; P:protein targeting to mitochondrion; P:regulation of apoptotic process;|O94826 D3DN48,Mitochondrial import receptor subunit TOM70 {ECO:0000305},Mitochondrial precursor proteins import receptor;Translocase of outer membrane 70 kDa subunit;Translocase of outer mitochondrial membrane protein 70 {ECO:0000312|HGNC:HGNC:11985};, PF00515;PF13181;, GO:0070062;GO:0016021;GO:0016020;GO:0005741;GO:0005742;GO:0005739;GO:0030943;GO:0008320;GO:0002218;GO:0098586;GO:0016236;GO:0002230;GO:0032728;GO:0030150;GO:0045039;GO:0006626;GO:0042981;, C:extracellular exosome; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:mitochondrion targeting sequence binding; F:protein transmembrane transporter activity;, P:activation of innate immune response; P:cellular response to virus; P:macroautophagy; P:positive regulation of defense response to virus by host; P:positive regulation of interferon-beta production; P:protein import into mitochondrial matrix; P:protein insertion into mitochondrial inner membrane; P:protein targeting to mitochondrion; P:regulation of apoptotic process;|O94826 D3DN48,Mitochondrial import receptor subunit TOM70 {ECO:0000305},Mitochondrial precursor proteins import receptor;Translocase of outer membrane 70 kDa subunit;Translocase of outer mitochondrial membrane protein 70 {ECO:0000312|HGNC:HGNC:11985};, PF00515;PF13181;, GO:0070062;GO:0016021;GO:0016020;GO:0005741;GO:0005742;GO:0005739;GO:0030943;GO:0008320;GO:0002218;GO:0098586;GO:0016236;GO:0002230;GO:0032728;GO:0030150;GO:0045039;GO:0006626;GO:0042981;, C:extracellular exosome; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:mitochondrion targeting sequence binding; F:protein transmembrane transporter activity;, P:activation of innate immune response; P:cellular response to virus; P:macroautophagy; P:positive regulation of defense response to virus by host; P:positive regulation of interferon-beta production; P:protein import into mitochondrial matrix; P:protein insertion into mitochondrial inner membrane; P:protein targeting to mitochondrion; P:regulation of apoptotic process; scaffold7 indexed_genome mRNA 47230433 47268562 . + . ID=transcript_2014;A1A4G5 B7ZLT3,Leukemia NUP98 fusion partner 1,, PF15419; scaffold7 indexed_genome mRNA 47418477 47519026 . + . ID=transcript_2015;Q9NWC5 Q53YW5,Transmembrane protein 45A,DNA polymerase-transactivated protein 4;Dermal papilla-derived protein 7;, PF04819;, GO:0016021;, C:integral component of membrane;|Q9NWC5 Q53YW5,Transmembrane protein 45A,DNA polymerase-transactivated protein 4;Dermal papilla-derived protein 7;, PF04819;, GO:0016021;, C:integral component of membrane; scaffold7 indexed_genome mRNA 47605963 47826178 . + . ID=transcript_2016;Q92734 D3DN49 G5E9V1 K0J5S8 K0J6K2 Q15656 Q969I2,Protein TFG,TRK-fused gene protein;, PF00564;, GO:0005737;GO:0005829;GO:0070971;GO:0043231;GO:0042802;GO:0048208;GO:0006888;GO:0043123;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum exit site; C:intracellular membrane-bounded organelle;, F:identical protein binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q92734 D3DN49 G5E9V1 K0J5S8 K0J6K2 Q15656 Q969I2,Protein TFG,TRK-fused gene protein;, PF00564;, GO:0005737;GO:0005829;GO:0070971;GO:0043231;GO:0042802;GO:0048208;GO:0006888;GO:0043123;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum exit site; C:intracellular membrane-bounded organelle;, F:identical protein binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q7Z7G0 B3KSL4 Q6ZW20 Q6ZW22 Q9C082 Q9UFI6,Target of Nesh-SH3,ABI gene family member 3-binding protein;Nesh-binding protein;, PF00041;, GO:0062023;GO:0005576;GO:0005615;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;|Q7Z7G0 B3KSL4 Q6ZW20 Q6ZW22 Q9C082 Q9UFI6,Target of Nesh-SH3,ABI gene family member 3-binding protein;Nesh-binding protein;, PF00041;, GO:0062023;GO:0005576;GO:0005615;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; scaffold7 indexed_genome mRNA 48171739 48187987 . - . ID=transcript_2017;Q9BZV3 A8MWT5 Q9UKD4 Q9UKK5,Interphotoreceptor matrix proteoglycan 2,Interphotoreceptor matrix proteoglycan of 200 kDa;Sialoprotein associated with cones and rods proteoglycan;, PF01390;, GO:0042995;GO:0031012;GO:0005576;GO:0016021;GO:0033165;GO:0043235;GO:0005201;GO:0008201;GO:0005540;GO:0007601;, C:cell projection; C:extracellular matrix; C:extracellular region; C:integral component of membrane; C:interphotoreceptor matrix; C:receptor complex;, F:extracellular matrix structural constituent; F:heparin binding; F:hyaluronic acid binding;, P:visual perception;|Q9BZV3 A8MWT5 Q9UKD4 Q9UKK5,Interphotoreceptor matrix proteoglycan 2,Interphotoreceptor matrix proteoglycan of 200 kDa;Sialoprotein associated with cones and rods proteoglycan;, PF01390;, GO:0042995;GO:0031012;GO:0005576;GO:0016021;GO:0033165;GO:0043235;GO:0005201;GO:0008201;GO:0005540;GO:0007601;, C:cell projection; C:extracellular matrix; C:extracellular region; C:integral component of membrane; C:interphotoreceptor matrix; C:receptor complex;, F:extracellular matrix structural constituent; F:heparin binding; F:hyaluronic acid binding;, P:visual perception; scaffold7 indexed_genome mRNA 48188466 48189047 . - . ID=transcript_2018;Q9BZV3 A8MWT5 Q9UKD4 Q9UKK5,Interphotoreceptor matrix proteoglycan 2,Interphotoreceptor matrix proteoglycan of 200 kDa;Sialoprotein associated with cones and rods proteoglycan;, PF01390;, GO:0042995;GO:0031012;GO:0005576;GO:0016021;GO:0033165;GO:0043235;GO:0005201;GO:0008201;GO:0005540;GO:0007601;, C:cell projection; C:extracellular matrix; C:extracellular region; C:integral component of membrane; C:interphotoreceptor matrix; C:receptor complex;, F:extracellular matrix structural constituent; F:heparin binding; F:hyaluronic acid binding;, P:visual perception; scaffold7 indexed_genome mRNA 48189049 48203572 . - . ID=transcript_2019;Q9BZV3 A8MWT5 Q9UKD4 Q9UKK5,Interphotoreceptor matrix proteoglycan 2,Interphotoreceptor matrix proteoglycan of 200 kDa;Sialoprotein associated with cones and rods proteoglycan;, PF01390;, GO:0042995;GO:0031012;GO:0005576;GO:0016021;GO:0033165;GO:0043235;GO:0005201;GO:0008201;GO:0005540;GO:0007601;, C:cell projection; C:extracellular matrix; C:extracellular region; C:integral component of membrane; C:interphotoreceptor matrix; C:receptor complex;, F:extracellular matrix structural constituent; F:heparin binding; F:hyaluronic acid binding;, P:visual perception; scaffold7 indexed_genome mRNA 48212051 48236671 . - . ID=transcript_2020;Q9BZV3 A8MWT5 Q9UKD4 Q9UKK5,Interphotoreceptor matrix proteoglycan 2,Interphotoreceptor matrix proteoglycan of 200 kDa;Sialoprotein associated with cones and rods proteoglycan;, PF01390;, GO:0042995;GO:0031012;GO:0005576;GO:0016021;GO:0033165;GO:0043235;GO:0005201;GO:0008201;GO:0005540;GO:0007601;, C:cell projection; C:extracellular matrix; C:extracellular region; C:integral component of membrane; C:interphotoreceptor matrix; C:receptor complex;, F:extracellular matrix structural constituent; F:heparin binding; F:hyaluronic acid binding;, P:visual perception; scaffold7 indexed_genome mRNA 48244881 48382158 . - . ID=transcript_2021;Q9BQF6 A1L3A5 A8MW39 B7WNW8 Q7Z3F4 Q96PS5 Q9C0F6 Q9HBT5,Sentrin-specific protease 7,SUMO-1-specific protease 2;Sentrin/SUMO-specific protease SENP7;, PF02902;, GO:0005737;GO:0005634;GO:0070139;GO:0016926;, C:cytoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation;|Q9BQF6 A1L3A5 A8MW39 B7WNW8 Q7Z3F4 Q96PS5 Q9C0F6 Q9HBT5,Sentrin-specific protease 7,SUMO-1-specific protease 2;Sentrin/SUMO-specific protease SENP7;, PF02902;, GO:0005737;GO:0005634;GO:0070139;GO:0016926;, C:cytoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation;|Q9BQF6 A1L3A5 A8MW39 B7WNW8 Q7Z3F4 Q96PS5 Q9C0F6 Q9HBT5,Sentrin-specific protease 7,SUMO-1-specific protease 2;Sentrin/SUMO-specific protease SENP7;, PF02902;, GO:0005737;GO:0005634;GO:0070139;GO:0016926;, C:cytoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation;|Q9BQF6 A1L3A5 A8MW39 B7WNW8 Q7Z3F4 Q96PS5 Q9C0F6 Q9HBT5,Sentrin-specific protease 7,SUMO-1-specific protease 2;Sentrin/SUMO-specific protease SENP7;, PF02902;, GO:0005737;GO:0005634;GO:0070139;GO:0016926;, C:cytoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation;|Q9BQF6 A1L3A5 A8MW39 B7WNW8 Q7Z3F4 Q96PS5 Q9C0F6 Q9HBT5,Sentrin-specific protease 7,SUMO-1-specific protease 2;Sentrin/SUMO-specific protease SENP7;, PF02902;, GO:0005737;GO:0005634;GO:0070139;GO:0016926;, C:cytoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation;|Q9BQF6 A1L3A5 A8MW39 B7WNW8 Q7Z3F4 Q96PS5 Q9C0F6 Q9HBT5,Sentrin-specific protease 7,SUMO-1-specific protease 2;Sentrin/SUMO-specific protease SENP7;, PF02902;, GO:0005737;GO:0005634;GO:0070139;GO:0016926;, C:cytoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation;|Q9BQF6 A1L3A5 A8MW39 B7WNW8 Q7Z3F4 Q96PS5 Q9C0F6 Q9HBT5,Sentrin-specific protease 7,SUMO-1-specific protease 2;Sentrin/SUMO-specific protease SENP7;, PF02902;, GO:0005737;GO:0005634;GO:0070139;GO:0016926;, C:cytoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation;|A6NC97,Putative protein FAM172B,FAM172B pseudogene;, , GO:0016021;GO:0005634;GO:0031048;, C:integral component of membrane; C:nucleus;, , P:heterochromatin assembly by small RNA; scaffold7 indexed_genome mRNA 48397179 48435320 . + . ID=transcript_2022;Q86VE0,Myb-related transcription factor, partner of profilin,Myb-related protein p42POP;Partner of profilin;, PF13873;, GO:0005634;GO:0000981;GO:0001227;GO:0042802;GO:0000978;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q7L0Y3 Q9NRG5 Q9NX54 Q9Y596,tRNA methyltransferase 10 homolog C {ECO:0000305},HBV pre-S2 trans-regulated protein 2 {ECO:0000303|PubMed:12546731};Mitochondrial ribonuclease P protein 1 {ECO:0000303|PubMed:18984158};RNA (guanine-9-)-methyltransferase domain-containing protein 1;Renal carcinoma antigen NY-REN-49 {ECO:0000303|PubMed:10508479};mRNA methyladenosine-N(1)-methyltransferase {ECO:0000303|PubMed:29072297};tRNA (adenine(9)-N(1))-methyltransferase;tRNA (guanine(9)-N(1))-methyltransferase;, PF01746;, GO:0005759;GO:0042645;GO:0030678;GO:0005739;GO:0005654;GO:0005634;GO:0042802;GO:0061953;GO:0003723;GO:0016429;GO:0052905;GO:0009019;GO:0000049;GO:0000964;GO:1990180;GO:0097745;GO:0070901;GO:0090646;GO:0080009;GO:0070131;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrial ribonuclease P complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:mRNA (adenine-N1-)-methyltransferase activity; F:RNA binding; F:tRNA (adenine-N1-)-methyltransferase activity; F:tRNA (guanine(9)-N(1))-methyltransferase activity; F:tRNA (guanine-N1-)-methyltransferase activity; F:tRNA binding;, P:mitochondrial RNA 5'-end processing; P:mitochondrial tRNA 3'-end processing; P:mitochondrial tRNA 5'-end processing; P:mitochondrial tRNA methylation; P:mitochondrial tRNA processing; P:mRNA methylation; P:positive regulation of mitochondrial translation;|Q8WW12 B2RBE7 D3DN52 Q53GF3 Q6AI44 Q96CU3 Q9NS81,PEST proteolytic signal-containing nuclear protein,, PF15473;, GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0043161;GO:0016567;, C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q8WW12 B2RBE7 D3DN52 Q53GF3 Q6AI44 Q96CU3 Q9NS81,PEST proteolytic signal-containing nuclear protein,, PF15473;, GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0043161;GO:0016567;, C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q8WW12 B2RBE7 D3DN52 Q53GF3 Q6AI44 Q96CU3 Q9NS81,PEST proteolytic signal-containing nuclear protein,, PF15473;, GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0043161;GO:0016567;, C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; scaffold7 indexed_genome mRNA 48441383 48447444 . - . ID=transcript_2023;O95625 Q2NKP9,Zinc finger and BTB domain-containing protein 11 {ECO:0000305},, PF00651;PF17921;PF00096;, GO:0005730;GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|O95625 Q2NKP9,Zinc finger and BTB domain-containing protein 11 {ECO:0000305},, PF00651;PF17921;PF00096;, GO:0005730;GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold7 indexed_genome mRNA 48447564 48462578 . - . ID=transcript_2024;O95625 Q2NKP9,Zinc finger and BTB domain-containing protein 11 {ECO:0000305},, PF00651;PF17921;PF00096;, GO:0005730;GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|O95625 Q2NKP9,Zinc finger and BTB domain-containing protein 11 {ECO:0000305},, PF00651;PF17921;PF00096;, GO:0005730;GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|O95625 Q2NKP9,Zinc finger and BTB domain-containing protein 11 {ECO:0000305},, PF00651;PF17921;PF00096;, GO:0005730;GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|O95625 Q2NKP9,Zinc finger and BTB domain-containing protein 11 {ECO:0000305},, PF00651;PF17921;PF00096;, GO:0005730;GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold7 indexed_genome mRNA 48470243 48478808 . - . ID=transcript_2025;O95625 Q2NKP9,Zinc finger and BTB domain-containing protein 11 {ECO:0000305},, PF00651;PF17921;PF00096;, GO:0005730;GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|P83731 B2R4Y3 P38663 Q6IBS3,60S ribosomal protein L24,60S ribosomal protein L30;Large ribosomal subunit protein eL24 {ECO:0000303|PubMed:24524803};, PF01246;, GO:0005737;GO:0005829;GO:0022625;GO:0005783;GO:0070062;GO:0016020;GO:0042788;GO:0045202;GO:0045296;GO:0003723;GO:0003735;GO:1902626;GO:0002181;GO:0010458;GO:0000184;GO:0021554;GO:0060041;GO:0031290;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:membrane; C:polysomal ribosome; C:synapse;, F:cadherin binding; F:RNA binding; F:structural constituent of ribosome;, P:assembly of large subunit precursor of preribosome; P:cytoplasmic translation; P:exit from mitosis; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:optic nerve development; P:retina development in camera-type eye; P:retinal ganglion cell axon guidance; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold7 indexed_genome mRNA 48488737 48507791 . + . ID=transcript_2026;Q8IW35 B5MDY8 Q8NA71 Q9H5T9,Centrosomal protein of 97 kDa,Leucine-rich repeat and IQ domain-containing protein 2;, , GO:0034451;GO:0005813;GO:0005829;GO:0032991;GO:0005516;GO:0097711;GO:1902018;GO:1901673;, C:centriolar satellite; C:centrosome; C:cytosol; C:protein-containing complex;, F:calmodulin binding;, P:ciliary basal body-plasma membrane docking; P:negative regulation of cilium assembly; P:regulation of mitotic spindle assembly;|Q8IW35 B5MDY8 Q8NA71 Q9H5T9,Centrosomal protein of 97 kDa,Leucine-rich repeat and IQ domain-containing protein 2;, , GO:0034451;GO:0005813;GO:0005829;GO:0032991;GO:0005516;GO:0097711;GO:1902018;GO:1901673;, C:centriolar satellite; C:centrosome; C:cytosol; C:protein-containing complex;, F:calmodulin binding;, P:ciliary basal body-plasma membrane docking; P:negative regulation of cilium assembly; P:regulation of mitotic spindle assembly;|Q8IW35 B5MDY8 Q8NA71 Q9H5T9,Centrosomal protein of 97 kDa,Leucine-rich repeat and IQ domain-containing protein 2;, , GO:0034451;GO:0005813;GO:0005829;GO:0032991;GO:0005516;GO:0097711;GO:1902018;GO:1901673;, C:centriolar satellite; C:centrosome; C:cytosol; C:protein-containing complex;, F:calmodulin binding;, P:ciliary basal body-plasma membrane docking; P:negative regulation of cilium assembly; P:regulation of mitotic spindle assembly;|Q8IW35 B5MDY8 Q8NA71 Q9H5T9,Centrosomal protein of 97 kDa,Leucine-rich repeat and IQ domain-containing protein 2;, , GO:0034451;GO:0005813;GO:0005829;GO:0032991;GO:0005516;GO:0097711;GO:1902018;GO:1901673;, C:centriolar satellite; C:centrosome; C:cytosol; C:protein-containing complex;, F:calmodulin binding;, P:ciliary basal body-plasma membrane docking; P:negative regulation of cilium assembly; P:regulation of mitotic spindle assembly; scaffold7 indexed_genome mRNA 48521188 48578076 . + . ID=transcript_2027;Q969Y0 A8K0X4 D3DN53 Q7Z2S8,NXPE family member 3,Protein FAM55C;, PF06312;, GO:0005576;, C:extracellular region; scaffold7 indexed_genome mRNA 48612675 48621690 . - . ID=transcript_2028;Q9BYH8 B3KNR2 D3DN54 Q8IUL4 Q8NAZ8,NF-kappa-B inhibitor zeta,I-kappa-B-zeta;IL-1 inducible nuclear ankyrin-repeat protein;Molecule possessing ankyrin repeats induced by lipopolysaccharide;, PF12796;, GO:0036464;GO:0016607;GO:0005634;GO:0006954;GO:0050729;GO:2000321;GO:0010468;GO:0050852;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleus;, , P:inflammatory response; P:positive regulation of inflammatory response; P:positive regulation of T-helper 17 cell differentiation; P:regulation of gene expression; P:T cell receptor signaling pathway;|Q9BYH8 B3KNR2 D3DN54 Q8IUL4 Q8NAZ8,NF-kappa-B inhibitor zeta,I-kappa-B-zeta;IL-1 inducible nuclear ankyrin-repeat protein;Molecule possessing ankyrin repeats induced by lipopolysaccharide;, PF12796;, GO:0036464;GO:0016607;GO:0005634;GO:0006954;GO:0050729;GO:2000321;GO:0010468;GO:0050852;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleus;, , P:inflammatory response; P:positive regulation of inflammatory response; P:positive regulation of T-helper 17 cell differentiation; P:regulation of gene expression; P:T cell receptor signaling pathway;|Q9BYH8 B3KNR2 D3DN54 Q8IUL4 Q8NAZ8,NF-kappa-B inhibitor zeta,I-kappa-B-zeta;IL-1 inducible nuclear ankyrin-repeat protein;Molecule possessing ankyrin repeats induced by lipopolysaccharide;, PF12796;, GO:0036464;GO:0016607;GO:0005634;GO:0006954;GO:0050729;GO:2000321;GO:0010468;GO:0050852;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleus;, , P:inflammatory response; P:positive regulation of inflammatory response; P:positive regulation of T-helper 17 cell differentiation; P:regulation of gene expression; P:T cell receptor signaling pathway; scaffold7 indexed_genome mRNA 51938914 52152721 . + . ID=transcript_2029;Q13740 B2RNS3 B4DTU0 O60892 Q1HGM8 Q1HGM9 Q6PEY4 Q6ZS95,CD166 antigen,Activated leukocyte cell adhesion molecule;, PF08205;, GO:0030424;GO:0030425;GO:0009897;GO:0070062;GO:0005925;GO:0001772;GO:0005887;GO:0031226;GO:0043025;GO:0042802;GO:0005102;GO:0002250;GO:0048846;GO:0007155;GO:0007157;GO:0008045;GO:1990138;GO:0031290;GO:0007165;, C:axon; C:dendrite; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:neuronal cell body;, F:identical protein binding; F:signaling receptor binding;, P:adaptive immune response; P:axon extension involved in axon guidance; P:cell adhesion; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:motor neuron axon guidance; P:neuron projection extension; P:retinal ganglion cell axon guidance; P:signal transduction;|Q13740 B2RNS3 B4DTU0 O60892 Q1HGM8 Q1HGM9 Q6PEY4 Q6ZS95,CD166 antigen,Activated leukocyte cell adhesion molecule;, PF08205;, GO:0030424;GO:0030425;GO:0009897;GO:0070062;GO:0005925;GO:0001772;GO:0005887;GO:0031226;GO:0043025;GO:0042802;GO:0005102;GO:0002250;GO:0048846;GO:0007155;GO:0007157;GO:0008045;GO:1990138;GO:0031290;GO:0007165;, C:axon; C:dendrite; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:neuronal cell body;, F:identical protein binding; F:signaling receptor binding;, P:adaptive immune response; P:axon extension involved in axon guidance; P:cell adhesion; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:motor neuron axon guidance; P:neuron projection extension; P:retinal ganglion cell axon guidance; P:signal transduction;|Q13740 B2RNS3 B4DTU0 O60892 Q1HGM8 Q1HGM9 Q6PEY4 Q6ZS95,CD166 antigen,Activated leukocyte cell adhesion molecule;, PF08205;, GO:0030424;GO:0030425;GO:0009897;GO:0070062;GO:0005925;GO:0001772;GO:0005887;GO:0031226;GO:0043025;GO:0042802;GO:0005102;GO:0002250;GO:0048846;GO:0007155;GO:0007157;GO:0008045;GO:1990138;GO:0031290;GO:0007165;, C:axon; C:dendrite; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:neuronal cell body;, F:identical protein binding; F:signaling receptor binding;, P:adaptive immune response; P:axon extension involved in axon guidance; P:cell adhesion; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:motor neuron axon guidance; P:neuron projection extension; P:retinal ganglion cell axon guidance; P:signal transduction; scaffold7 indexed_genome mRNA 53962462 54244167 . + . ID=transcript_2030;Q8WY36 A2RRM7 Q2TAJ1 Q7L3J8 Q7LBY8 Q8NDB0 Q8WY35 Q9H0J6,HMG box transcription factor BBX,Bobby sox homolog;HMG box-containing protein 2;, PF09667;PF00505;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0000977;GO:1990837;GO:0060348;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:bone development; P:regulation of transcription by RNA polymerase II; scaffold7 indexed_genome mRNA 54657981 54719398 . - . ID=transcript_2031;Q9NWB7 Q96DA9,Intraflagellar transport protein 57 homolog,Dermal papilla-derived protein 8;Estrogen-related receptor beta-like protein 1;HIP1-interacting protein;MHS4R2;, PF10498;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0044292;GO:0005794;GO:0030992;GO:0032391;GO:0003677;GO:0006919;GO:0006915;GO:0001947;GO:0042073;GO:0035735;GO:0060972;GO:0044458;GO:0050680;GO:0001843;GO:1905515;GO:0042981;GO:0007224;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:dendrite terminus; C:Golgi apparatus; C:intraciliary transport particle B; C:photoreceptor connecting cilium;, F:DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:heart looping; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right pattern formation; P:motile cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube closure; P:non-motile cilium assembly; P:regulation of apoptotic process; P:smoothened signaling pathway;|Q9NWB7 Q96DA9,Intraflagellar transport protein 57 homolog,Dermal papilla-derived protein 8;Estrogen-related receptor beta-like protein 1;HIP1-interacting protein;MHS4R2;, PF10498;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0044292;GO:0005794;GO:0030992;GO:0032391;GO:0003677;GO:0006919;GO:0006915;GO:0001947;GO:0042073;GO:0035735;GO:0060972;GO:0044458;GO:0050680;GO:0001843;GO:1905515;GO:0042981;GO:0007224;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:dendrite terminus; C:Golgi apparatus; C:intraciliary transport particle B; C:photoreceptor connecting cilium;, F:DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:heart looping; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right pattern formation; P:motile cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube closure; P:non-motile cilium assembly; P:regulation of apoptotic process; P:smoothened signaling pathway;|Q9NWB7 Q96DA9,Intraflagellar transport protein 57 homolog,Dermal papilla-derived protein 8;Estrogen-related receptor beta-like protein 1;HIP1-interacting protein;MHS4R2;, PF10498;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0044292;GO:0005794;GO:0030992;GO:0032391;GO:0003677;GO:0006919;GO:0006915;GO:0001947;GO:0042073;GO:0035735;GO:0060972;GO:0044458;GO:0050680;GO:0001843;GO:1905515;GO:0042981;GO:0007224;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:dendrite terminus; C:Golgi apparatus; C:intraciliary transport particle B; C:photoreceptor connecting cilium;, F:DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:heart looping; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right pattern formation; P:motile cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube closure; P:non-motile cilium assembly; P:regulation of apoptotic process; P:smoothened signaling pathway;|Q9NWB7 Q96DA9,Intraflagellar transport protein 57 homolog,Dermal papilla-derived protein 8;Estrogen-related receptor beta-like protein 1;HIP1-interacting protein;MHS4R2;, PF10498;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0044292;GO:0005794;GO:0030992;GO:0032391;GO:0003677;GO:0006919;GO:0006915;GO:0001947;GO:0042073;GO:0035735;GO:0060972;GO:0044458;GO:0050680;GO:0001843;GO:1905515;GO:0042981;GO:0007224;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:dendrite terminus; C:Golgi apparatus; C:intraciliary transport particle B; C:photoreceptor connecting cilium;, F:DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:heart looping; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right pattern formation; P:motile cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube closure; P:non-motile cilium assembly; P:regulation of apoptotic process; P:smoothened signaling pathway; scaffold7 indexed_genome mRNA 55070925 55098470 . - . ID=transcript_2032;Q8TCG1 A1L4J7 B9EGC3 Q6P4G6 Q8WVP8 Q96PI2 Q9H9C6 Q9P204,Protein CIP2A {ECO:0000305},Cancerous inhibitor of PP2A {ECO:0000303|PubMed:17632056};p90 autoantigen {ECO:0000303|PubMed:12118381};, , GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045296;GO:0042803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:protein homodimerization activity;|Q8TCG1 A1L4J7 B9EGC3 Q6P4G6 Q8WVP8 Q96PI2 Q9H9C6 Q9P204,Protein CIP2A {ECO:0000305},Cancerous inhibitor of PP2A {ECO:0000303|PubMed:17632056};p90 autoantigen {ECO:0000303|PubMed:12118381};, , GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045296;GO:0042803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:protein homodimerization activity;|Q8TCG1 A1L4J7 B9EGC3 Q6P4G6 Q8WVP8 Q96PI2 Q9H9C6 Q9P204,Protein CIP2A {ECO:0000305},Cancerous inhibitor of PP2A {ECO:0000303|PubMed:17632056};p90 autoantigen {ECO:0000303|PubMed:12118381};, , GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045296;GO:0042803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:protein homodimerization activity; scaffold7 indexed_genome mRNA 55113011 55216489 . + . ID=transcript_2033;Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q96RS9,E3 ubiquitin-protein ligase DZIP3,DAZ-interacting protein 3;RING-type E3 ubiquitin transferase DZIP3 {ECO:0000305};RNA-binding ubiquitin ligase of 138 kDa;, PF19179;PF18738;PF13639;, GO:0005737;GO:0046872;GO:0019902;GO:0031593;GO:0003723;GO:0061630;GO:0004842;GO:0000209;, C:cytoplasm;, F:metal ion binding; F:phosphatase binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:protein polyubiquitination; scaffold7 indexed_genome mRNA 55438674 55488164 . - . ID=transcript_2034;Q86VD1 B4DYX1 E7ERX1 Q7L8E2 Q9NSG7 Q9Y6D4,MORC family CW-type zinc finger protein 1,Cancer/testis antigen 33;, PF17942;PF07496;, GO:0001673;GO:0005634;GO:0008270;GO:0001662;GO:0030154;GO:0044026;GO:0043046;GO:0031047;GO:0007275;GO:2000143;GO:0010529;GO:0040029;GO:0007283;, C:male germ cell nucleus; C:nucleus;, F:zinc ion binding;, P:behavioral fear response; P:cell differentiation; P:DNA hypermethylation; P:DNA methylation involved in gamete generation; P:gene silencing by RNA; P:multicellular organism development; P:negative regulation of DNA-templated transcription, initiation; P:negative regulation of transposition; P:regulation of gene expression, epigenetic; P:spermatogenesis;|Q86VD1 B4DYX1 E7ERX1 Q7L8E2 Q9NSG7 Q9Y6D4,MORC family CW-type zinc finger protein 1,Cancer/testis antigen 33;, PF17942;PF07496;, GO:0001673;GO:0005634;GO:0008270;GO:0001662;GO:0030154;GO:0044026;GO:0043046;GO:0031047;GO:0007275;GO:2000143;GO:0010529;GO:0040029;GO:0007283;, C:male germ cell nucleus; C:nucleus;, F:zinc ion binding;, P:behavioral fear response; P:cell differentiation; P:DNA hypermethylation; P:DNA methylation involved in gamete generation; P:gene silencing by RNA; P:multicellular organism development; P:negative regulation of DNA-templated transcription, initiation; P:negative regulation of transposition; P:regulation of gene expression, epigenetic; P:spermatogenesis; scaffold7 indexed_genome mRNA 55527296 55585701 . - . ID=transcript_2035;Q86VD1 B4DYX1 E7ERX1 Q7L8E2 Q9NSG7 Q9Y6D4,MORC family CW-type zinc finger protein 1,Cancer/testis antigen 33;, PF17942;PF07496;, GO:0001673;GO:0005634;GO:0008270;GO:0001662;GO:0030154;GO:0044026;GO:0043046;GO:0031047;GO:0007275;GO:2000143;GO:0010529;GO:0040029;GO:0007283;, C:male germ cell nucleus; C:nucleus;, F:zinc ion binding;, P:behavioral fear response; P:cell differentiation; P:DNA hypermethylation; P:DNA methylation involved in gamete generation; P:gene silencing by RNA; P:multicellular organism development; P:negative regulation of DNA-templated transcription, initiation; P:negative regulation of transposition; P:regulation of gene expression, epigenetic; P:spermatogenesis; scaffold7 indexed_genome mRNA 57341319 57341860 . - . ID=transcript_2036;Q9NQS3 E9PFR0 Q6NVZ3 Q8NC05 Q8WVU4 Q9BVA9 Q9Y412,Nectin-3,CDw113;Nectin cell adhesion molecule 3 {ECO:0000312|HGNC:HGNC:17664};Poliovirus receptor-related protein 3;, PF08205;PF07686;, GO:0005912;GO:0043296;GO:0030424;GO:0044291;GO:0005911;GO:0030425;GO:0098686;GO:0099061;GO:0005886;GO:0050839;GO:0042802;GO:0042803;GO:0034332;GO:0061951;GO:0009566;GO:0007157;GO:0007156;GO:0002089;GO:1902414;GO:0060042;GO:0007286;, C:adherens junction; C:apical junction complex; C:axon; C:cell-cell contact zone; C:cell-cell junction; C:dendrite; C:hippocampal mossy fiber to CA3 synapse; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:cell adhesion molecule binding; F:identical protein binding; F:protein homodimerization activity;, P:adherens junction organization; P:establishment of protein localization to plasma membrane; P:fertilization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:lens morphogenesis in camera-type eye; P:protein localization to cell junction; P:retina morphogenesis in camera-type eye; P:spermatid development; scaffold7 indexed_genome mRNA 57658877 57752042 . + . ID=transcript_2037;P40200 Q5JPB3,T-cell surface protein tactile,Cell surface antigen CD96;T cell-activated increased late expression protein;, , GO:0005737;GO:0005887;GO:0005886;GO:0007155;GO:0007160;GO:0006955;GO:0006954;GO:0032689;GO:0002728;GO:0050776;GO:0032496;, C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, , P:cell adhesion; P:cell-matrix adhesion; P:immune response; P:inflammatory response; P:negative regulation of interferon-gamma production; P:negative regulation of natural killer cell cytokine production; P:regulation of immune response; P:response to lipopolysaccharide; scaffold7 indexed_genome mRNA 57771047 57819121 . + . ID=transcript_2038;Q0VAA5 Q96N12,PI-PLC X domain-containing protein 2,, , GO:0005634;GO:0008081;GO:0016042;GO:0007165;, C:nucleus;, F:phosphoric diester hydrolase activity;, P:lipid catabolic process; P:signal transduction;|Q0VAA5 Q96N12,PI-PLC X domain-containing protein 2,, , GO:0005634;GO:0008081;GO:0016042;GO:0007165;, C:nucleus;, F:phosphoric diester hydrolase activity;, P:lipid catabolic process; P:signal transduction; scaffold7 indexed_genome mRNA 57983005 58074744 . + . ID=transcript_2039;Q86SQ0 A5PKZ3 Q59EA8 Q68CY3 Q6NT98 Q8N8U8 Q8NAB1 Q8NCU5,Pleckstrin homology-like domain family B member 2,Protein LL5-beta;, PF00169;, GO:0045180;GO:0031252;GO:0005829;GO:0045111;GO:0005886;GO:0045296;GO:0045184;GO:0000226;GO:0051895;GO:0051497;GO:1903690;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex; C:cell leading edge; C:cytosol; C:intermediate filament cytoskeleton; C:plasma membrane;, F:cadherin binding;, P:establishment of protein localization; P:microtubule cytoskeleton organization; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86SQ0 A5PKZ3 Q59EA8 Q68CY3 Q6NT98 Q8N8U8 Q8NAB1 Q8NCU5,Pleckstrin homology-like domain family B member 2,Protein LL5-beta;, PF00169;, GO:0045180;GO:0031252;GO:0005829;GO:0045111;GO:0005886;GO:0045296;GO:0045184;GO:0000226;GO:0051895;GO:0051497;GO:1903690;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex; C:cell leading edge; C:cytosol; C:intermediate filament cytoskeleton; C:plasma membrane;, F:cadherin binding;, P:establishment of protein localization; P:microtubule cytoskeleton organization; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86SQ0 A5PKZ3 Q59EA8 Q68CY3 Q6NT98 Q8N8U8 Q8NAB1 Q8NCU5,Pleckstrin homology-like domain family B member 2,Protein LL5-beta;, PF00169;, GO:0045180;GO:0031252;GO:0005829;GO:0045111;GO:0005886;GO:0045296;GO:0045184;GO:0000226;GO:0051895;GO:0051497;GO:1903690;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex; C:cell leading edge; C:cytosol; C:intermediate filament cytoskeleton; C:plasma membrane;, F:cadherin binding;, P:establishment of protein localization; P:microtubule cytoskeleton organization; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86SQ0 A5PKZ3 Q59EA8 Q68CY3 Q6NT98 Q8N8U8 Q8NAB1 Q8NCU5,Pleckstrin homology-like domain family B member 2,Protein LL5-beta;, PF00169;, GO:0045180;GO:0031252;GO:0005829;GO:0045111;GO:0005886;GO:0045296;GO:0045184;GO:0000226;GO:0051895;GO:0051497;GO:1903690;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex; C:cell leading edge; C:cytosol; C:intermediate filament cytoskeleton; C:plasma membrane;, F:cadherin binding;, P:establishment of protein localization; P:microtubule cytoskeleton organization; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86SQ0 A5PKZ3 Q59EA8 Q68CY3 Q6NT98 Q8N8U8 Q8NAB1 Q8NCU5,Pleckstrin homology-like domain family B member 2,Protein LL5-beta;, PF00169;, GO:0045180;GO:0031252;GO:0005829;GO:0045111;GO:0005886;GO:0045296;GO:0045184;GO:0000226;GO:0051895;GO:0051497;GO:1903690;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex; C:cell leading edge; C:cytosol; C:intermediate filament cytoskeleton; C:plasma membrane;, F:cadherin binding;, P:establishment of protein localization; P:microtubule cytoskeleton organization; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86SQ0 A5PKZ3 Q59EA8 Q68CY3 Q6NT98 Q8N8U8 Q8NAB1 Q8NCU5,Pleckstrin homology-like domain family B member 2,Protein LL5-beta;, PF00169;, GO:0045180;GO:0031252;GO:0005829;GO:0045111;GO:0005886;GO:0045296;GO:0045184;GO:0000226;GO:0051895;GO:0051497;GO:1903690;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex; C:cell leading edge; C:cytosol; C:intermediate filament cytoskeleton; C:plasma membrane;, F:cadherin binding;, P:establishment of protein localization; P:microtubule cytoskeleton organization; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86SQ0 A5PKZ3 Q59EA8 Q68CY3 Q6NT98 Q8N8U8 Q8NAB1 Q8NCU5,Pleckstrin homology-like domain family B member 2,Protein LL5-beta;, PF00169;, GO:0045180;GO:0031252;GO:0005829;GO:0045111;GO:0005886;GO:0045296;GO:0045184;GO:0000226;GO:0051895;GO:0051497;GO:1903690;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex; C:cell leading edge; C:cytosol; C:intermediate filament cytoskeleton; C:plasma membrane;, F:cadherin binding;, P:establishment of protein localization; P:microtubule cytoskeleton organization; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86SQ0 A5PKZ3 Q59EA8 Q68CY3 Q6NT98 Q8N8U8 Q8NAB1 Q8NCU5,Pleckstrin homology-like domain family B member 2,Protein LL5-beta;, PF00169;, GO:0045180;GO:0031252;GO:0005829;GO:0045111;GO:0005886;GO:0045296;GO:0045184;GO:0000226;GO:0051895;GO:0051497;GO:1903690;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex; C:cell leading edge; C:cytosol; C:intermediate filament cytoskeleton; C:plasma membrane;, F:cadherin binding;, P:establishment of protein localization; P:microtubule cytoskeleton organization; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86SQ0 A5PKZ3 Q59EA8 Q68CY3 Q6NT98 Q8N8U8 Q8NAB1 Q8NCU5,Pleckstrin homology-like domain family B member 2,Protein LL5-beta;, PF00169;, GO:0045180;GO:0031252;GO:0005829;GO:0045111;GO:0005886;GO:0045296;GO:0045184;GO:0000226;GO:0051895;GO:0051497;GO:1903690;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex; C:cell leading edge; C:cytosol; C:intermediate filament cytoskeleton; C:plasma membrane;, F:cadherin binding;, P:establishment of protein localization; P:microtubule cytoskeleton organization; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86SQ0 A5PKZ3 Q59EA8 Q68CY3 Q6NT98 Q8N8U8 Q8NAB1 Q8NCU5,Pleckstrin homology-like domain family B member 2,Protein LL5-beta;, PF00169;, GO:0045180;GO:0031252;GO:0005829;GO:0045111;GO:0005886;GO:0045296;GO:0045184;GO:0000226;GO:0051895;GO:0051497;GO:1903690;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex; C:cell leading edge; C:cytosol; C:intermediate filament cytoskeleton; C:plasma membrane;, F:cadherin binding;, P:establishment of protein localization; P:microtubule cytoskeleton organization; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; scaffold7 indexed_genome mRNA 58084587 58097882 . + . ID=transcript_2040;Q9NUJ1 B7Z6A8 C9IZX5 D3DN63 Q8TCF9,Palmitoyl-protein thioesterase ABHD10, mitochondrial {ECO:0000303|PubMed:31740833},Acyl-protein thioesterase ABHD10 {ECO:0000303|PubMed:31740833};Alpha/beta hydrolase domain-containing protein 10 {ECO:0000303|PubMed:22294686};Mycophenolic acid acyl-glucuronide esterase, mitochondrial {ECO:0000303|PubMed:22294686};, PF00561;, GO:0005829;GO:0005759;GO:0005739;GO:0004553;GO:0102390;GO:0008474;GO:0052695;GO:0019391;GO:0002084;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:mycophenolic acid acyl-glucuronide esterase activity; F:palmitoyl-(protein) hydrolase activity;, P:cellular glucuronidation; P:glucuronoside catabolic process; P:protein depalmitoylation;|Q9NUJ1 B7Z6A8 C9IZX5 D3DN63 Q8TCF9,Palmitoyl-protein thioesterase ABHD10, mitochondrial {ECO:0000303|PubMed:31740833},Acyl-protein thioesterase ABHD10 {ECO:0000303|PubMed:31740833};Alpha/beta hydrolase domain-containing protein 10 {ECO:0000303|PubMed:22294686};Mycophenolic acid acyl-glucuronide esterase, mitochondrial {ECO:0000303|PubMed:22294686};, PF00561;, GO:0005829;GO:0005759;GO:0005739;GO:0004553;GO:0102390;GO:0008474;GO:0052695;GO:0019391;GO:0002084;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:mycophenolic acid acyl-glucuronide esterase activity; F:palmitoyl-(protein) hydrolase activity;, P:cellular glucuronidation; P:glucuronoside catabolic process; P:protein depalmitoylation;|Q9NUJ1 B7Z6A8 C9IZX5 D3DN63 Q8TCF9,Palmitoyl-protein thioesterase ABHD10, mitochondrial {ECO:0000303|PubMed:31740833},Acyl-protein thioesterase ABHD10 {ECO:0000303|PubMed:31740833};Alpha/beta hydrolase domain-containing protein 10 {ECO:0000303|PubMed:22294686};Mycophenolic acid acyl-glucuronide esterase, mitochondrial {ECO:0000303|PubMed:22294686};, PF00561;, GO:0005829;GO:0005759;GO:0005739;GO:0004553;GO:0102390;GO:0008474;GO:0052695;GO:0019391;GO:0002084;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:mycophenolic acid acyl-glucuronide esterase activity; F:palmitoyl-(protein) hydrolase activity;, P:cellular glucuronidation; P:glucuronoside catabolic process; P:protein depalmitoylation;|Q9NUJ1 B7Z6A8 C9IZX5 D3DN63 Q8TCF9,Palmitoyl-protein thioesterase ABHD10, mitochondrial {ECO:0000303|PubMed:31740833},Acyl-protein thioesterase ABHD10 {ECO:0000303|PubMed:31740833};Alpha/beta hydrolase domain-containing protein 10 {ECO:0000303|PubMed:22294686};Mycophenolic acid acyl-glucuronide esterase, mitochondrial {ECO:0000303|PubMed:22294686};, PF00561;, GO:0005829;GO:0005759;GO:0005739;GO:0004553;GO:0102390;GO:0008474;GO:0052695;GO:0019391;GO:0002084;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:mycophenolic acid acyl-glucuronide esterase activity; F:palmitoyl-(protein) hydrolase activity;, P:cellular glucuronidation; P:glucuronoside catabolic process; P:protein depalmitoylation; scaffold7 indexed_genome mRNA 58106142 58110186 . + . ID=transcript_2041;Q9UI15 D3DN64 Q96A74,Transgelin-3,Neuronal protein 22;Neuronal protein NP25;, PF00402;PF00307;, GO:0005634;GO:0007417;GO:0000122;, C:nucleus;, , P:central nervous system development; P:negative regulation of transcription by RNA polymerase II; scaffold7 indexed_genome mRNA 58115932 58120814 . + . ID=transcript_2042;Q9UI15 D3DN64 Q96A74,Transgelin-3,Neuronal protein 22;Neuronal protein NP25;, PF00402;PF00307;, GO:0005634;GO:0007417;GO:0000122;, C:nucleus;, , P:central nervous system development; P:negative regulation of transcription by RNA polymerase II;|Q9UI15 D3DN64 Q96A74,Transgelin-3,Neuronal protein 22;Neuronal protein NP25;, PF00402;PF00307;, GO:0005634;GO:0007417;GO:0000122;, C:nucleus;, , P:central nervous system development; P:negative regulation of transcription by RNA polymerase II; scaffold7 indexed_genome mRNA 58203012 58238879 . + . ID=transcript_2043;Q5BVD1 B4DNV2 B4E0Z2 Q96AJ4 Q9H5Q1,TPA-induced transmembrane protein,, , GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane; scaffold7 indexed_genome mRNA 58416112 58434949 . + . ID=transcript_2044;P41217 B3KQI1 B4DLW9 D3DN65 Q6J2Q6 Q6PIQ4 Q8TB85 Q9H3J3,OX-2 membrane glycoprotein,, PF00047;, GO:0030424;GO:0044297;GO:0009986;GO:0005887;GO:0016020;GO:0043005;GO:0043025;GO:0005886;GO:0140081;GO:0086080;GO:0098609;GO:0034113;GO:0008285;GO:0032715;GO:0002695;GO:0043031;GO:1905522;GO:1904465;GO:0150079;GO:1901215;GO:0032088;GO:2000405;GO:0150072;GO:0032793;GO:0150074;GO:0071636;GO:0050776;GO:0150077;, C:axon; C:cell body; C:cell surface; C:integral component of plasma membrane; C:membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:glycosylated region protein binding; F:protein binding involved in heterotypic cell-cell adhesion;, P:cell-cell adhesion; P:heterotypic cell-cell adhesion; P:negative regulation of cell population proliferation; P:negative regulation of interleukin-6 production; P:negative regulation of leukocyte activation; P:negative regulation of macrophage activation; P:negative regulation of macrophage migration; P:negative regulation of matrix metallopeptidase secretion; P:negative regulation of neuroinflammatory response; P:negative regulation of neuron death; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell migration; P:positive regulation of arginase activity; P:positive regulation of CREB transcription factor activity; P:positive regulation of protein-glutamine gamma-glutamyltransferase activity; P:positive regulation of transforming growth factor beta production; P:regulation of immune response; P:regulation of neuroinflammatory response;|P41217 B3KQI1 B4DLW9 D3DN65 Q6J2Q6 Q6PIQ4 Q8TB85 Q9H3J3,OX-2 membrane glycoprotein,, PF00047;, GO:0030424;GO:0044297;GO:0009986;GO:0005887;GO:0016020;GO:0043005;GO:0043025;GO:0005886;GO:0140081;GO:0086080;GO:0098609;GO:0034113;GO:0008285;GO:0032715;GO:0002695;GO:0043031;GO:1905522;GO:1904465;GO:0150079;GO:1901215;GO:0032088;GO:2000405;GO:0150072;GO:0032793;GO:0150074;GO:0071636;GO:0050776;GO:0150077;, C:axon; C:cell body; C:cell surface; C:integral component of plasma membrane; C:membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:glycosylated region protein binding; F:protein binding involved in heterotypic cell-cell adhesion;, P:cell-cell adhesion; P:heterotypic cell-cell adhesion; P:negative regulation of cell population proliferation; P:negative regulation of interleukin-6 production; P:negative regulation of leukocyte activation; P:negative regulation of macrophage activation; P:negative regulation of macrophage migration; P:negative regulation of matrix metallopeptidase secretion; P:negative regulation of neuroinflammatory response; P:negative regulation of neuron death; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell migration; P:positive regulation of arginase activity; P:positive regulation of CREB transcription factor activity; P:positive regulation of protein-glutamine gamma-glutamyltransferase activity; P:positive regulation of transforming growth factor beta production; P:regulation of immune response; P:regulation of neuroinflammatory response; scaffold7 indexed_genome mRNA 58533711 58562866 . + . ID=transcript_2045;Q9NXG5,GPI ethanolamine phosphate transferase 2,GPI7 homolog;Phosphatidylinositol-glycan biosynthesis class G protein;, PF01663;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0051267;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:CP2 mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NXG5,GPI ethanolamine phosphate transferase 2,GPI7 homolog;Phosphatidylinositol-glycan biosynthesis class G protein;, PF01663;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0051267;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:CP2 mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NXG5,GPI ethanolamine phosphate transferase 2,GPI7 homolog;Phosphatidylinositol-glycan biosynthesis class G protein;, PF01663;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0051267;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:CP2 mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NXG5,GPI ethanolamine phosphate transferase 2,GPI7 homolog;Phosphatidylinositol-glycan biosynthesis class G protein;, PF01663;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0051267;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:CP2 mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NXG5,GPI ethanolamine phosphate transferase 2,GPI7 homolog;Phosphatidylinositol-glycan biosynthesis class G protein;, PF01663;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0051267;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:CP2 mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NXG5,GPI ethanolamine phosphate transferase 2,GPI7 homolog;Phosphatidylinositol-glycan biosynthesis class G protein;, PF01663;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0051267;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:CP2 mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold7 indexed_genome mRNA 58633976 58640630 . + . ID=transcript_2046;P35913 B7Z9T9 E7ETT3 Q53XN5 Q9BWH5 Q9UD49,Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta,, PF01590;PF00233;, GO:0097381;GO:0042622;GO:0005886;GO:0047555;GO:0004114;GO:0046872;GO:0043153;GO:0007603;GO:0022400;GO:0060041;GO:0016056;GO:0007165;GO:0007601;GO:0007223;, C:photoreceptor disc membrane; C:photoreceptor outer segment membrane; C:plasma membrane;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:entrainment of circadian clock by photoperiod; P:phototransduction, visible light; P:regulation of rhodopsin mediated signaling pathway; P:retina development in camera-type eye; P:rhodopsin mediated signaling pathway; P:signal transduction; P:visual perception; P:Wnt signaling pathway, calcium modulating pathway; scaffold7 indexed_genome mRNA 58642006 58643600 . - . ID=transcript_2047;P56385 Q0D2L9,ATP synthase subunit e, mitochondrial {ECO:0000305},ATP synthase membrane subunit e {ECO:0000305};, PF05680;, GO:0005743;GO:0005753;GO:0000276;GO:0005739;GO:0044877;GO:0015078;GO:0006754;GO:0042407;GO:0042776;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion;, F:protein-containing complex binding; F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; scaffold7 indexed_genome mRNA 58644583 58654130 . - . ID=transcript_2048;Q02045 Q8IXL8,Myosin light chain 5,Myosin regulatory light chain 5;Superfast myosin regulatory light chain 2;, PF00036;PF13202;, GO:0005829;GO:0005859;GO:0005509;GO:0008307;GO:0006936;GO:0006937;, C:cytosol; C:muscle myosin complex;, F:calcium ion binding; F:structural constituent of muscle;, P:muscle contraction; P:regulation of muscle contraction;|Q6UXD7 A8K7J5 Q6XYD4 Q8N6H1 Q9H6H6,Solute carrier family 49 member A3 {ECO:0000312|HGNC:HGNC:26177},Major facilitator superfamily domain-containing protein 7;Myosin light polypeptide 5 regulatory protein;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q6UXD7 A8K7J5 Q6XYD4 Q8N6H1 Q9H6H6,Solute carrier family 49 member A3 {ECO:0000312|HGNC:HGNC:26177},Major facilitator superfamily domain-containing protein 7;Myosin light polypeptide 5 regulatory protein;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q6UXD7 A8K7J5 Q6XYD4 Q8N6H1 Q9H6H6,Solute carrier family 49 member A3 {ECO:0000312|HGNC:HGNC:26177},Major facilitator superfamily domain-containing protein 7;Myosin light polypeptide 5 regulatory protein;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q6UXD7 A8K7J5 Q6XYD4 Q8N6H1 Q9H6H6,Solute carrier family 49 member A3 {ECO:0000312|HGNC:HGNC:26177},Major facilitator superfamily domain-containing protein 7;Myosin light polypeptide 5 regulatory protein;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q6UXD7 A8K7J5 Q6XYD4 Q8N6H1 Q9H6H6,Solute carrier family 49 member A3 {ECO:0000312|HGNC:HGNC:26177},Major facilitator superfamily domain-containing protein 7;Myosin light polypeptide 5 regulatory protein;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold7 indexed_genome mRNA 58703189 58734492 . + . ID=transcript_2049;Q3KNV8 D3DVN1 O15262,Polycomb group RING finger protein 3,RING finger protein 3A;, PF16207;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0000805;GO:0046872;GO:0036353;GO:0060819;GO:0006357;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:X chromosome;, F:metal ion binding;, P:histone H2A-K119 monoubiquitination; P:inactivation of X chromosome by genetic imprinting; P:regulation of transcription by RNA polymerase II;|Q3KNV8 D3DVN1 O15262,Polycomb group RING finger protein 3,RING finger protein 3A;, PF16207;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0000805;GO:0046872;GO:0036353;GO:0060819;GO:0006357;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:X chromosome;, F:metal ion binding;, P:histone H2A-K119 monoubiquitination; P:inactivation of X chromosome by genetic imprinting; P:regulation of transcription by RNA polymerase II;|Q3KNV8 D3DVN1 O15262,Polycomb group RING finger protein 3,RING finger protein 3A;, PF16207;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0000805;GO:0046872;GO:0036353;GO:0060819;GO:0006357;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:X chromosome;, F:metal ion binding;, P:histone H2A-K119 monoubiquitination; P:inactivation of X chromosome by genetic imprinting; P:regulation of transcription by RNA polymerase II;|Q3KNV8 D3DVN1 O15262,Polycomb group RING finger protein 3,RING finger protein 3A;, PF16207;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0000805;GO:0046872;GO:0036353;GO:0060819;GO:0006357;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:X chromosome;, F:metal ion binding;, P:histone H2A-K119 monoubiquitination; P:inactivation of X chromosome by genetic imprinting; P:regulation of transcription by RNA polymerase II; scaffold7 indexed_genome mRNA 58753044 58755311 . + . ID=transcript_2050;O14810 A6NI80 B2R4R5 D3DVN3 F1T0G1,Complexin-1,Complexin I;Synaphin-2;, PF05835;, GO:0044305;GO:0005829;GO:0030425;GO:0098978;GO:0043204;GO:0098794;GO:0098685;GO:0031201;GO:0070032;GO:0070554;GO:0043195;GO:0005326;GO:0000149;GO:0017075;GO:0007268;GO:0098967;GO:0006887;GO:0030073;GO:0007269;GO:0006836;GO:0017157;GO:0046928;GO:0031630;GO:0016079;, C:calyx of Held; C:cytosol; C:dendrite; C:glutamatergic synapse; C:perikaryon; C:postsynapse; C:Schaffer collateral - CA1 synapse; C:SNARE complex; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex; C:synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex; C:terminal bouton;, F:neurotransmitter transmembrane transporter activity; F:SNARE binding; F:syntaxin-1 binding;, P:chemical synaptic transmission; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:insulin secretion; P:neurotransmitter secretion; P:neurotransmitter transport; P:regulation of exocytosis; P:regulation of neurotransmitter secretion; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle exocytosis; scaffold7 indexed_genome mRNA 58758626 58759268 . + . ID=transcript_2051;O14810 A6NI80 B2R4R5 D3DVN3 F1T0G1,Complexin-1,Complexin I;Synaphin-2;, PF05835;, GO:0044305;GO:0005829;GO:0030425;GO:0098978;GO:0043204;GO:0098794;GO:0098685;GO:0031201;GO:0070032;GO:0070554;GO:0043195;GO:0005326;GO:0000149;GO:0017075;GO:0007268;GO:0098967;GO:0006887;GO:0030073;GO:0007269;GO:0006836;GO:0017157;GO:0046928;GO:0031630;GO:0016079;, C:calyx of Held; C:cytosol; C:dendrite; C:glutamatergic synapse; C:perikaryon; C:postsynapse; C:Schaffer collateral - CA1 synapse; C:SNARE complex; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex; C:synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex; C:terminal bouton;, F:neurotransmitter transmembrane transporter activity; F:SNARE binding; F:syntaxin-1 binding;, P:chemical synaptic transmission; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:insulin secretion; P:neurotransmitter secretion; P:neurotransmitter transport; P:regulation of exocytosis; P:regulation of neurotransmitter secretion; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle exocytosis; scaffold7 indexed_genome mRNA 58805081 58815259 . + . ID=transcript_2052;O14976 Q5U4P5 Q9BVY6,Cyclin-G-associated kinase,, PF00069;PF10409;, GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;, C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;, F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating;|O14976 Q5U4P5 Q9BVY6,Cyclin-G-associated kinase,, PF00069;PF10409;, GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;, C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;, F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating;|O14976 Q5U4P5 Q9BVY6,Cyclin-G-associated kinase,, PF00069;PF10409;, GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;, C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;, F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating; scaffold7 indexed_genome mRNA 58815262 58841911 . - . ID=transcript_2053;O14976 Q5U4P5 Q9BVY6,Cyclin-G-associated kinase,, PF00069;PF10409;, GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;, C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;, F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating;|O14976 Q5U4P5 Q9BVY6,Cyclin-G-associated kinase,, PF00069;PF10409;, GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;, C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;, F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating;|O14976 Q5U4P5 Q9BVY6,Cyclin-G-associated kinase,, PF00069;PF10409;, GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;, C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;, F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating;|O14976 Q5U4P5 Q9BVY6,Cyclin-G-associated kinase,, PF00069;PF10409;, GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;, C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;, F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating;|O14976 Q5U4P5 Q9BVY6,Cyclin-G-associated kinase,, PF00069;PF10409;, GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;, C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;, F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating;|O14976 Q5U4P5 Q9BVY6,Cyclin-G-associated kinase,, PF00069;PF10409;, GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;, C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;, F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating; scaffold7 indexed_genome mRNA 58857700 58873797 . + . ID=transcript_2054;Q9BSA9 D3DVN4 Q8ND13,Endosomal/lysosomal potassium channel TMEM175 {ECO:0000305},Transmembrane protein 175 {ECO:0000312|HGNC:HGNC:28709};, PF06736;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0005267;GO:0022841;GO:0090385;GO:0071805;GO:0035751;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:potassium channel activity; F:potassium ion leak channel activity;, P:phagosome-lysosome fusion; P:potassium ion transmembrane transport; P:regulation of lysosomal lumen pH;|Q9BSA9 D3DVN4 Q8ND13,Endosomal/lysosomal potassium channel TMEM175 {ECO:0000305},Transmembrane protein 175 {ECO:0000312|HGNC:HGNC:28709};, PF06736;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0005267;GO:0022841;GO:0090385;GO:0071805;GO:0035751;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:potassium channel activity; F:potassium ion leak channel activity;, P:phagosome-lysosome fusion; P:potassium ion transmembrane transport; P:regulation of lysosomal lumen pH;|Q9BSA9 D3DVN4 Q8ND13,Endosomal/lysosomal potassium channel TMEM175 {ECO:0000305},Transmembrane protein 175 {ECO:0000312|HGNC:HGNC:28709};, PF06736;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0005267;GO:0022841;GO:0090385;GO:0071805;GO:0035751;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:potassium channel activity; F:potassium ion leak channel activity;, P:phagosome-lysosome fusion; P:potassium ion transmembrane transport; P:regulation of lysosomal lumen pH; scaffold7 indexed_genome mRNA 58874749 58886921 . + . ID=transcript_2055;P52824 Q6P3W4,Diacylglycerol kinase theta {ECO:0000305},Diglyceride kinase theta;, PF00130;PF00609;PF00781;PF00788;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0098978;GO:0016363;GO:0016607;GO:0005634;GO:0005886;GO:0098794;GO:0098793;GO:0012506;GO:0033613;GO:0005524;GO:0004143;GO:0019900;GO:0046872;GO:0003951;GO:0043274;GO:0030297;GO:0019933;GO:0046339;GO:0007186;GO:0046486;GO:0035556;GO:0046834;GO:0010629;GO:0010801;GO:0018105;GO:0006654;GO:0030168;GO:0010628;GO:0050731;GO:0070528;GO:0007205;GO:0090181;GO:2000064;GO:0008277;GO:0006111;GO:2000182;GO:1900242;GO:1903432;GO:0006357;GO:0033198;GO:0051591;GO:0070493;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:glutamatergic synapse; C:nuclear matrix; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynapse; C:presynapse; C:vesicle membrane;, F:activating transcription factor binding; F:ATP binding; F:diacylglycerol kinase activity; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:phospholipase binding; F:transmembrane receptor protein tyrosine kinase activator activity;, P:cAMP-mediated signaling; P:diacylglycerol metabolic process; P:G protein-coupled receptor signaling pathway; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of gene expression; P:negative regulation of peptidyl-threonine phosphorylation; P:peptidyl-serine phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of gene expression; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein kinase C signaling; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of cholesterol metabolic process; P:regulation of cortisol biosynthetic process; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of gluconeogenesis; P:regulation of progesterone biosynthetic process; P:regulation of synaptic vesicle endocytosis; P:regulation of TORC1 signaling; P:regulation of transcription by RNA polymerase II; P:response to ATP; P:response to cAMP; P:thrombin-activated receptor signaling pathway;|P52824 Q6P3W4,Diacylglycerol kinase theta {ECO:0000305},Diglyceride kinase theta;, PF00130;PF00609;PF00781;PF00788;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0098978;GO:0016363;GO:0016607;GO:0005634;GO:0005886;GO:0098794;GO:0098793;GO:0012506;GO:0033613;GO:0005524;GO:0004143;GO:0019900;GO:0046872;GO:0003951;GO:0043274;GO:0030297;GO:0019933;GO:0046339;GO:0007186;GO:0046486;GO:0035556;GO:0046834;GO:0010629;GO:0010801;GO:0018105;GO:0006654;GO:0030168;GO:0010628;GO:0050731;GO:0070528;GO:0007205;GO:0090181;GO:2000064;GO:0008277;GO:0006111;GO:2000182;GO:1900242;GO:1903432;GO:0006357;GO:0033198;GO:0051591;GO:0070493;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:glutamatergic synapse; C:nuclear matrix; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynapse; C:presynapse; C:vesicle membrane;, F:activating transcription factor binding; F:ATP binding; F:diacylglycerol kinase activity; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:phospholipase binding; F:transmembrane receptor protein tyrosine kinase activator activity;, P:cAMP-mediated signaling; P:diacylglycerol metabolic process; P:G protein-coupled receptor signaling pathway; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of gene expression; P:negative regulation of peptidyl-threonine phosphorylation; P:peptidyl-serine phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of gene expression; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein kinase C signaling; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of cholesterol metabolic process; P:regulation of cortisol biosynthetic process; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of gluconeogenesis; P:regulation of progesterone biosynthetic process; P:regulation of synaptic vesicle endocytosis; P:regulation of TORC1 signaling; P:regulation of transcription by RNA polymerase II; P:response to ATP; P:response to cAMP; P:thrombin-activated receptor signaling pathway;|P52824 Q6P3W4,Diacylglycerol kinase theta {ECO:0000305},Diglyceride kinase theta;, PF00130;PF00609;PF00781;PF00788;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0098978;GO:0016363;GO:0016607;GO:0005634;GO:0005886;GO:0098794;GO:0098793;GO:0012506;GO:0033613;GO:0005524;GO:0004143;GO:0019900;GO:0046872;GO:0003951;GO:0043274;GO:0030297;GO:0019933;GO:0046339;GO:0007186;GO:0046486;GO:0035556;GO:0046834;GO:0010629;GO:0010801;GO:0018105;GO:0006654;GO:0030168;GO:0010628;GO:0050731;GO:0070528;GO:0007205;GO:0090181;GO:2000064;GO:0008277;GO:0006111;GO:2000182;GO:1900242;GO:1903432;GO:0006357;GO:0033198;GO:0051591;GO:0070493;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:glutamatergic synapse; C:nuclear matrix; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynapse; C:presynapse; C:vesicle membrane;, F:activating transcription factor binding; F:ATP binding; F:diacylglycerol kinase activity; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:phospholipase binding; F:transmembrane receptor protein tyrosine kinase activator activity;, P:cAMP-mediated signaling; P:diacylglycerol metabolic process; P:G protein-coupled receptor signaling pathway; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of gene expression; P:negative regulation of peptidyl-threonine phosphorylation; P:peptidyl-serine phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of gene expression; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein kinase C signaling; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of cholesterol metabolic process; P:regulation of cortisol biosynthetic process; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of gluconeogenesis; P:regulation of progesterone biosynthetic process; P:regulation of synaptic vesicle endocytosis; P:regulation of TORC1 signaling; P:regulation of transcription by RNA polymerase II; P:response to ATP; P:response to cAMP; P:thrombin-activated receptor signaling pathway;|P52824 Q6P3W4,Diacylglycerol kinase theta {ECO:0000305},Diglyceride kinase theta;, PF00130;PF00609;PF00781;PF00788;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0098978;GO:0016363;GO:0016607;GO:0005634;GO:0005886;GO:0098794;GO:0098793;GO:0012506;GO:0033613;GO:0005524;GO:0004143;GO:0019900;GO:0046872;GO:0003951;GO:0043274;GO:0030297;GO:0019933;GO:0046339;GO:0007186;GO:0046486;GO:0035556;GO:0046834;GO:0010629;GO:0010801;GO:0018105;GO:0006654;GO:0030168;GO:0010628;GO:0050731;GO:0070528;GO:0007205;GO:0090181;GO:2000064;GO:0008277;GO:0006111;GO:2000182;GO:1900242;GO:1903432;GO:0006357;GO:0033198;GO:0051591;GO:0070493;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:glutamatergic synapse; C:nuclear matrix; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynapse; C:presynapse; C:vesicle membrane;, F:activating transcription factor binding; F:ATP binding; F:diacylglycerol kinase activity; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:phospholipase binding; F:transmembrane receptor protein tyrosine kinase activator activity;, P:cAMP-mediated signaling; P:diacylglycerol metabolic process; P:G protein-coupled receptor signaling pathway; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of gene expression; P:negative regulation of peptidyl-threonine phosphorylation; P:peptidyl-serine phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of gene expression; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein kinase C signaling; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of cholesterol metabolic process; P:regulation of cortisol biosynthetic process; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of gluconeogenesis; P:regulation of progesterone biosynthetic process; P:regulation of synaptic vesicle endocytosis; P:regulation of TORC1 signaling; P:regulation of transcription by RNA polymerase II; P:response to ATP; P:response to cAMP; P:thrombin-activated receptor signaling pathway;|P52824 Q6P3W4,Diacylglycerol kinase theta {ECO:0000305},Diglyceride kinase theta;, PF00130;PF00609;PF00781;PF00788;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0098978;GO:0016363;GO:0016607;GO:0005634;GO:0005886;GO:0098794;GO:0098793;GO:0012506;GO:0033613;GO:0005524;GO:0004143;GO:0019900;GO:0046872;GO:0003951;GO:0043274;GO:0030297;GO:0019933;GO:0046339;GO:0007186;GO:0046486;GO:0035556;GO:0046834;GO:0010629;GO:0010801;GO:0018105;GO:0006654;GO:0030168;GO:0010628;GO:0050731;GO:0070528;GO:0007205;GO:0090181;GO:2000064;GO:0008277;GO:0006111;GO:2000182;GO:1900242;GO:1903432;GO:0006357;GO:0033198;GO:0051591;GO:0070493;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:glutamatergic synapse; C:nuclear matrix; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynapse; C:presynapse; C:vesicle membrane;, F:activating transcription factor binding; F:ATP binding; F:diacylglycerol kinase activity; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:phospholipase binding; F:transmembrane receptor protein tyrosine kinase activator activity;, P:cAMP-mediated signaling; P:diacylglycerol metabolic process; P:G protein-coupled receptor signaling pathway; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of gene expression; P:negative regulation of peptidyl-threonine phosphorylation; P:peptidyl-serine phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of gene expression; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein kinase C signaling; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of cholesterol metabolic process; P:regulation of cortisol biosynthetic process; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of gluconeogenesis; P:regulation of progesterone biosynthetic process; P:regulation of synaptic vesicle endocytosis; P:regulation of TORC1 signaling; P:regulation of transcription by RNA polymerase II; P:response to ATP; P:response to cAMP; P:thrombin-activated receptor signaling pathway; scaffold7 indexed_genome mRNA 58899172 58903799 . - . ID=transcript_2056;Q9H2B4 A8K9N2 Q7Z5R3 Q96BK0,Sulfate anion transporter 1,Solute carrier family 26 member 1;, PF01740;PF00916;, GO:0016323;GO:0016021;GO:0005887;GO:0005886;GO:0015301;GO:0015106;GO:0015108;GO:0019531;GO:0008271;GO:0015116;GO:0050428;GO:0006821;GO:0006811;GO:0019532;GO:0008272;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; P:chloride transport; P:ion transport; P:oxalate transport; P:sulfate transport; scaffold7 indexed_genome mRNA 58909087 58913837 . + . ID=transcript_2057;P35475 B3KWK6,Alpha-L-iduronidase,, PF01229;, GO:0030135;GO:0070062;GO:0043202;GO:0004553;GO:0003940;GO:0005102;GO:0030207;GO:0030209;GO:0005984;GO:0006027;GO:0030211;, C:coated vesicle; C:extracellular exosome; C:lysosomal lumen;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:L-iduronidase activity; F:signaling receptor binding;, P:chondroitin sulfate catabolic process; P:dermatan sulfate catabolic process; P:disaccharide metabolic process; P:glycosaminoglycan catabolic process; P:heparin catabolic process;|P35475 B3KWK6,Alpha-L-iduronidase,, PF01229;, GO:0030135;GO:0070062;GO:0043202;GO:0004553;GO:0003940;GO:0005102;GO:0030207;GO:0030209;GO:0005984;GO:0006027;GO:0030211;, C:coated vesicle; C:extracellular exosome; C:lysosomal lumen;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:L-iduronidase activity; F:signaling receptor binding;, P:chondroitin sulfate catabolic process; P:dermatan sulfate catabolic process; P:disaccharide metabolic process; P:glycosaminoglycan catabolic process; P:heparin catabolic process;|P35475 B3KWK6,Alpha-L-iduronidase,, PF01229;, GO:0030135;GO:0070062;GO:0043202;GO:0004553;GO:0003940;GO:0005102;GO:0030207;GO:0030209;GO:0005984;GO:0006027;GO:0030211;, C:coated vesicle; C:extracellular exosome; C:lysosomal lumen;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:L-iduronidase activity; F:signaling receptor binding;, P:chondroitin sulfate catabolic process; P:dermatan sulfate catabolic process; P:disaccharide metabolic process; P:glycosaminoglycan catabolic process; P:heparin catabolic process;|P35475 B3KWK6,Alpha-L-iduronidase,, PF01229;, GO:0030135;GO:0070062;GO:0043202;GO:0004553;GO:0003940;GO:0005102;GO:0030207;GO:0030209;GO:0005984;GO:0006027;GO:0030211;, C:coated vesicle; C:extracellular exosome; C:lysosomal lumen;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:L-iduronidase activity; F:signaling receptor binding;, P:chondroitin sulfate catabolic process; P:dermatan sulfate catabolic process; P:disaccharide metabolic process; P:glycosaminoglycan catabolic process; P:heparin catabolic process; scaffold8 indexed_genome mRNA 2535 3077 . - . ID=transcript_2058;P21439 A0A2V7 A4D1D3 A4D1D4 A4D1D5 D6W5P3 D6W5P4 Q14813,Phosphatidylcholine translocator ABCB4 {ECO:0000305},ATP-binding cassette sub-family B member 4 {ECO:0000312|HGNC:HGNC:45};Multidrug resistance protein 3 {ECO:0000303|PubMed:2892668};P-glycoprotein 3 {ECO:0000250|UniProtKB:Q08201};, PF00664;PF00005;, GO:0015629;GO:0016324;GO:0030136;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0046581;GO:0016020;GO:0045121;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0090554;GO:0090555;GO:0042910;GO:0032782;GO:1903413;GO:0099040;GO:0055088;GO:0006629;GO:0045332;GO:0032376;GO:0061092;GO:2001140;GO:0019222;GO:1901557;GO:0055085;, C:actin cytoskeleton; C:apical plasma membrane; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:intercellular canaliculus; C:membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylethanolamine flippase activity; F:xenobiotic transmembrane transporter activity;, P:bile acid secretion; P:cellular response to bile acid; P:ceramide translocation; P:lipid homeostasis; P:lipid metabolic process; P:phospholipid translocation; P:positive regulation of cholesterol transport; P:positive regulation of phospholipid translocation; P:positive regulation of phospholipid transport; P:regulation of metabolic process; P:response to fenofibrate; P:transmembrane transport; scaffold8 indexed_genome mRNA 9381 10569 . - . ID=transcript_2059;P08183 A8K294 B5AK60 Q12755 Q14812,ATP-dependent translocase ABCB1 {ECO:0000305},ATP-binding cassette sub-family B member 1 {ECO:0000305};Multidrug resistance protein 1;P-glycoprotein 1;Phospholipid transporter ABCB1 {ECO:0000305};, PF00664;PF00005;, GO:0016324;GO:0009986;GO:0098591;GO:0070062;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0046943;GO:0099038;GO:0015562;GO:0140328;GO:0090554;GO:0090555;GO:0022857;GO:0031625;GO:0042910;GO:1905039;GO:0099040;GO:0140115;GO:0000086;GO:0045332;GO:1901529;GO:2001225;GO:0047484;GO:0042493;GO:0072089;GO:0046865;GO:0070633;GO:0055085;GO:0150104;GO:1990962;, C:apical plasma membrane; C:cell surface; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:carboxylic acid transmembrane transporter activity; F:ceramide floppase activity; F:efflux transmembrane transporter activity; F:floppase activity; F:phosphatidylcholine floppase activity; F:phosphatidylethanolamine flippase activity; F:transmembrane transporter activity; F:ubiquitin protein ligase binding; F:xenobiotic transmembrane transporter activity;, P:carboxylic acid transmembrane transport; P:ceramide translocation; P:export across plasma membrane; P:G2/M transition of mitotic cell cycle; P:phospholipid translocation; P:positive regulation of anion channel activity; P:regulation of chloride transport; P:regulation of response to osmotic stress; P:response to drug; P:stem cell proliferation; P:terpenoid transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport across blood-brain barrier; scaffold8 indexed_genome mRNA 16592 32361 . - . ID=transcript_2060;P21439 A0A2V7 A4D1D3 A4D1D4 A4D1D5 D6W5P3 D6W5P4 Q14813,Phosphatidylcholine translocator ABCB4 {ECO:0000305},ATP-binding cassette sub-family B member 4 {ECO:0000312|HGNC:HGNC:45};Multidrug resistance protein 3 {ECO:0000303|PubMed:2892668};P-glycoprotein 3 {ECO:0000250|UniProtKB:Q08201};, PF00664;PF00005;, GO:0015629;GO:0016324;GO:0030136;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0046581;GO:0016020;GO:0045121;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0090554;GO:0090555;GO:0042910;GO:0032782;GO:1903413;GO:0099040;GO:0055088;GO:0006629;GO:0045332;GO:0032376;GO:0061092;GO:2001140;GO:0019222;GO:1901557;GO:0055085;, C:actin cytoskeleton; C:apical plasma membrane; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:intercellular canaliculus; C:membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylethanolamine flippase activity; F:xenobiotic transmembrane transporter activity;, P:bile acid secretion; P:cellular response to bile acid; P:ceramide translocation; P:lipid homeostasis; P:lipid metabolic process; P:phospholipid translocation; P:positive regulation of cholesterol transport; P:positive regulation of phospholipid translocation; P:positive regulation of phospholipid transport; P:regulation of metabolic process; P:response to fenofibrate; P:transmembrane transport;|P21439 A0A2V7 A4D1D3 A4D1D4 A4D1D5 D6W5P3 D6W5P4 Q14813,Phosphatidylcholine translocator ABCB4 {ECO:0000305},ATP-binding cassette sub-family B member 4 {ECO:0000312|HGNC:HGNC:45};Multidrug resistance protein 3 {ECO:0000303|PubMed:2892668};P-glycoprotein 3 {ECO:0000250|UniProtKB:Q08201};, PF00664;PF00005;, GO:0015629;GO:0016324;GO:0030136;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0046581;GO:0016020;GO:0045121;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0090554;GO:0090555;GO:0042910;GO:0032782;GO:1903413;GO:0099040;GO:0055088;GO:0006629;GO:0045332;GO:0032376;GO:0061092;GO:2001140;GO:0019222;GO:1901557;GO:0055085;, C:actin cytoskeleton; C:apical plasma membrane; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:intercellular canaliculus; C:membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylethanolamine flippase activity; F:xenobiotic transmembrane transporter activity;, P:bile acid secretion; P:cellular response to bile acid; P:ceramide translocation; P:lipid homeostasis; P:lipid metabolic process; P:phospholipid translocation; P:positive regulation of cholesterol transport; P:positive regulation of phospholipid translocation; P:positive regulation of phospholipid transport; P:regulation of metabolic process; P:response to fenofibrate; P:transmembrane transport; scaffold8 indexed_genome mRNA 39578 41658 . + . ID=transcript_2061;Q96NL0 B4DFD0 E9PBR4 Q8IWW5 Q8NB55 Q8TBG7,RUN domain-containing protein 3B,Rap2-binding protein 9;Rap2-interacting protein 9;, PF02759; scaffold8 indexed_genome mRNA 68562 69150 . + . ID=transcript_2062;Q96NL0 B4DFD0 E9PBR4 Q8IWW5 Q8NB55 Q8TBG7,RUN domain-containing protein 3B,Rap2-binding protein 9;Rap2-interacting protein 9;, PF02759; scaffold8 indexed_genome mRNA 201614 238136 . + . ID=transcript_2063;P08183 A8K294 B5AK60 Q12755 Q14812,ATP-dependent translocase ABCB1 {ECO:0000305},ATP-binding cassette sub-family B member 1 {ECO:0000305};Multidrug resistance protein 1;P-glycoprotein 1;Phospholipid transporter ABCB1 {ECO:0000305};, PF00664;PF00005;, GO:0016324;GO:0009986;GO:0098591;GO:0070062;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0046943;GO:0099038;GO:0015562;GO:0140328;GO:0090554;GO:0090555;GO:0022857;GO:0031625;GO:0042910;GO:1905039;GO:0099040;GO:0140115;GO:0000086;GO:0045332;GO:1901529;GO:2001225;GO:0047484;GO:0042493;GO:0072089;GO:0046865;GO:0070633;GO:0055085;GO:0150104;GO:1990962;, C:apical plasma membrane; C:cell surface; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:carboxylic acid transmembrane transporter activity; F:ceramide floppase activity; F:efflux transmembrane transporter activity; F:floppase activity; F:phosphatidylcholine floppase activity; F:phosphatidylethanolamine flippase activity; F:transmembrane transporter activity; F:ubiquitin protein ligase binding; F:xenobiotic transmembrane transporter activity;, P:carboxylic acid transmembrane transport; P:ceramide translocation; P:export across plasma membrane; P:G2/M transition of mitotic cell cycle; P:phospholipid translocation; P:positive regulation of anion channel activity; P:regulation of chloride transport; P:regulation of response to osmotic stress; P:response to drug; P:stem cell proliferation; P:terpenoid transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport across blood-brain barrier;|P08183 A8K294 B5AK60 Q12755 Q14812,ATP-dependent translocase ABCB1 {ECO:0000305},ATP-binding cassette sub-family B member 1 {ECO:0000305};Multidrug resistance protein 1;P-glycoprotein 1;Phospholipid transporter ABCB1 {ECO:0000305};, PF00664;PF00005;, GO:0016324;GO:0009986;GO:0098591;GO:0070062;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0046943;GO:0099038;GO:0015562;GO:0140328;GO:0090554;GO:0090555;GO:0022857;GO:0031625;GO:0042910;GO:1905039;GO:0099040;GO:0140115;GO:0000086;GO:0045332;GO:1901529;GO:2001225;GO:0047484;GO:0042493;GO:0072089;GO:0046865;GO:0070633;GO:0055085;GO:0150104;GO:1990962;, C:apical plasma membrane; C:cell surface; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:carboxylic acid transmembrane transporter activity; F:ceramide floppase activity; F:efflux transmembrane transporter activity; F:floppase activity; F:phosphatidylcholine floppase activity; F:phosphatidylethanolamine flippase activity; F:transmembrane transporter activity; F:ubiquitin protein ligase binding; F:xenobiotic transmembrane transporter activity;, P:carboxylic acid transmembrane transport; P:ceramide translocation; P:export across plasma membrane; P:G2/M transition of mitotic cell cycle; P:phospholipid translocation; P:positive regulation of anion channel activity; P:regulation of chloride transport; P:regulation of response to osmotic stress; P:response to drug; P:stem cell proliferation; P:terpenoid transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport across blood-brain barrier; scaffold8 indexed_genome mRNA 265869 289977 . + . ID=transcript_2064;P21439 A0A2V7 A4D1D3 A4D1D4 A4D1D5 D6W5P3 D6W5P4 Q14813,Phosphatidylcholine translocator ABCB4 {ECO:0000305},ATP-binding cassette sub-family B member 4 {ECO:0000312|HGNC:HGNC:45};Multidrug resistance protein 3 {ECO:0000303|PubMed:2892668};P-glycoprotein 3 {ECO:0000250|UniProtKB:Q08201};, PF00664;PF00005;, GO:0015629;GO:0016324;GO:0030136;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0046581;GO:0016020;GO:0045121;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0090554;GO:0090555;GO:0042910;GO:0032782;GO:1903413;GO:0099040;GO:0055088;GO:0006629;GO:0045332;GO:0032376;GO:0061092;GO:2001140;GO:0019222;GO:1901557;GO:0055085;, C:actin cytoskeleton; C:apical plasma membrane; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:intercellular canaliculus; C:membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylethanolamine flippase activity; F:xenobiotic transmembrane transporter activity;, P:bile acid secretion; P:cellular response to bile acid; P:ceramide translocation; P:lipid homeostasis; P:lipid metabolic process; P:phospholipid translocation; P:positive regulation of cholesterol transport; P:positive regulation of phospholipid translocation; P:positive regulation of phospholipid transport; P:regulation of metabolic process; P:response to fenofibrate; P:transmembrane transport; scaffold8 indexed_genome mRNA 296007 297196 . - . ID=transcript_2065;P08183 A8K294 B5AK60 Q12755 Q14812,ATP-dependent translocase ABCB1 {ECO:0000305},ATP-binding cassette sub-family B member 1 {ECO:0000305};Multidrug resistance protein 1;P-glycoprotein 1;Phospholipid transporter ABCB1 {ECO:0000305};, PF00664;PF00005;, GO:0016324;GO:0009986;GO:0098591;GO:0070062;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0046943;GO:0099038;GO:0015562;GO:0140328;GO:0090554;GO:0090555;GO:0022857;GO:0031625;GO:0042910;GO:1905039;GO:0099040;GO:0140115;GO:0000086;GO:0045332;GO:1901529;GO:2001225;GO:0047484;GO:0042493;GO:0072089;GO:0046865;GO:0070633;GO:0055085;GO:0150104;GO:1990962;, C:apical plasma membrane; C:cell surface; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:carboxylic acid transmembrane transporter activity; F:ceramide floppase activity; F:efflux transmembrane transporter activity; F:floppase activity; F:phosphatidylcholine floppase activity; F:phosphatidylethanolamine flippase activity; F:transmembrane transporter activity; F:ubiquitin protein ligase binding; F:xenobiotic transmembrane transporter activity;, P:carboxylic acid transmembrane transport; P:ceramide translocation; P:export across plasma membrane; P:G2/M transition of mitotic cell cycle; P:phospholipid translocation; P:positive regulation of anion channel activity; P:regulation of chloride transport; P:regulation of response to osmotic stress; P:response to drug; P:stem cell proliferation; P:terpenoid transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport across blood-brain barrier; scaffold8 indexed_genome mRNA 297703 335431 . + . ID=transcript_2066;P21439 A0A2V7 A4D1D3 A4D1D4 A4D1D5 D6W5P3 D6W5P4 Q14813,Phosphatidylcholine translocator ABCB4 {ECO:0000305},ATP-binding cassette sub-family B member 4 {ECO:0000312|HGNC:HGNC:45};Multidrug resistance protein 3 {ECO:0000303|PubMed:2892668};P-glycoprotein 3 {ECO:0000250|UniProtKB:Q08201};, PF00664;PF00005;, GO:0015629;GO:0016324;GO:0030136;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0046581;GO:0016020;GO:0045121;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0090554;GO:0090555;GO:0042910;GO:0032782;GO:1903413;GO:0099040;GO:0055088;GO:0006629;GO:0045332;GO:0032376;GO:0061092;GO:2001140;GO:0019222;GO:1901557;GO:0055085;, C:actin cytoskeleton; C:apical plasma membrane; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:intercellular canaliculus; C:membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylethanolamine flippase activity; F:xenobiotic transmembrane transporter activity;, P:bile acid secretion; P:cellular response to bile acid; P:ceramide translocation; P:lipid homeostasis; P:lipid metabolic process; P:phospholipid translocation; P:positive regulation of cholesterol transport; P:positive regulation of phospholipid translocation; P:positive regulation of phospholipid transport; P:regulation of metabolic process; P:response to fenofibrate; P:transmembrane transport; scaffold8 indexed_genome mRNA 336901 338211 . - . ID=transcript_2067;P21439 A0A2V7 A4D1D3 A4D1D4 A4D1D5 D6W5P3 D6W5P4 Q14813,Phosphatidylcholine translocator ABCB4 {ECO:0000305},ATP-binding cassette sub-family B member 4 {ECO:0000312|HGNC:HGNC:45};Multidrug resistance protein 3 {ECO:0000303|PubMed:2892668};P-glycoprotein 3 {ECO:0000250|UniProtKB:Q08201};, PF00664;PF00005;, GO:0015629;GO:0016324;GO:0030136;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0046581;GO:0016020;GO:0045121;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0090554;GO:0090555;GO:0042910;GO:0032782;GO:1903413;GO:0099040;GO:0055088;GO:0006629;GO:0045332;GO:0032376;GO:0061092;GO:2001140;GO:0019222;GO:1901557;GO:0055085;, C:actin cytoskeleton; C:apical plasma membrane; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:intercellular canaliculus; C:membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylethanolamine flippase activity; F:xenobiotic transmembrane transporter activity;, P:bile acid secretion; P:cellular response to bile acid; P:ceramide translocation; P:lipid homeostasis; P:lipid metabolic process; P:phospholipid translocation; P:positive regulation of cholesterol transport; P:positive regulation of phospholipid translocation; P:positive regulation of phospholipid transport; P:regulation of metabolic process; P:response to fenofibrate; P:transmembrane transport; scaffold8 indexed_genome mRNA 338267 396196 . - . ID=transcript_2068;Q9UKG9 A4D1D6 E7EQF2 Q86V17 Q8IUW9 Q9Y6I2,Peroxisomal carnitine O-octanoyltransferase,, PF00755;, GO:0005829;GO:0043231;GO:0005782;GO:0005777;GO:0008458;GO:0009437;GO:0015936;GO:0006635;GO:0033540;GO:0006631;GO:0015908;GO:0006091;GO:0051791;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisomal matrix; C:peroxisome;, F:carnitine O-octanoyltransferase activity;, P:carnitine metabolic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:medium-chain fatty acid metabolic process; P:protein localization;|Q9UKG9 A4D1D6 E7EQF2 Q86V17 Q8IUW9 Q9Y6I2,Peroxisomal carnitine O-octanoyltransferase,, PF00755;, GO:0005829;GO:0043231;GO:0005782;GO:0005777;GO:0008458;GO:0009437;GO:0015936;GO:0006635;GO:0033540;GO:0006631;GO:0015908;GO:0006091;GO:0051791;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisomal matrix; C:peroxisome;, F:carnitine O-octanoyltransferase activity;, P:carnitine metabolic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:medium-chain fatty acid metabolic process; P:protein localization;|Q9UKG9 A4D1D6 E7EQF2 Q86V17 Q8IUW9 Q9Y6I2,Peroxisomal carnitine O-octanoyltransferase,, PF00755;, GO:0005829;GO:0043231;GO:0005782;GO:0005777;GO:0008458;GO:0009437;GO:0015936;GO:0006635;GO:0033540;GO:0006631;GO:0015908;GO:0006091;GO:0051791;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisomal matrix; C:peroxisome;, F:carnitine O-octanoyltransferase activity;, P:carnitine metabolic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:medium-chain fatty acid metabolic process; P:protein localization;|Q9UKG9 A4D1D6 E7EQF2 Q86V17 Q8IUW9 Q9Y6I2,Peroxisomal carnitine O-octanoyltransferase,, PF00755;, GO:0005829;GO:0043231;GO:0005782;GO:0005777;GO:0008458;GO:0009437;GO:0015936;GO:0006635;GO:0033540;GO:0006631;GO:0015908;GO:0006091;GO:0051791;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisomal matrix; C:peroxisome;, F:carnitine O-octanoyltransferase activity;, P:carnitine metabolic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:medium-chain fatty acid metabolic process; P:protein localization;|Q9UKG9 A4D1D6 E7EQF2 Q86V17 Q8IUW9 Q9Y6I2,Peroxisomal carnitine O-octanoyltransferase,, PF00755;, GO:0005829;GO:0043231;GO:0005782;GO:0005777;GO:0008458;GO:0009437;GO:0015936;GO:0006635;GO:0033540;GO:0006631;GO:0015908;GO:0006091;GO:0051791;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisomal matrix; C:peroxisome;, F:carnitine O-octanoyltransferase activity;, P:carnitine metabolic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:medium-chain fatty acid metabolic process; P:protein localization;|Q9UKG9 A4D1D6 E7EQF2 Q86V17 Q8IUW9 Q9Y6I2,Peroxisomal carnitine O-octanoyltransferase,, PF00755;, GO:0005829;GO:0043231;GO:0005782;GO:0005777;GO:0008458;GO:0009437;GO:0015936;GO:0006635;GO:0033540;GO:0006631;GO:0015908;GO:0006091;GO:0051791;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisomal matrix; C:peroxisome;, F:carnitine O-octanoyltransferase activity;, P:carnitine metabolic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:medium-chain fatty acid metabolic process; P:protein localization; scaffold8 indexed_genome mRNA 497889 499793 . - . ID=transcript_2069;Q9BU79 A4D1C6 B2R9I4 D6W5P1,Transmembrane protein 243,MDR1- and mitochondrial taxol resistance-associated protein {ECO:0000303|PubMed:15556294};, PF10856;, GO:0016021;, C:integral component of membrane; scaffold8 indexed_genome mRNA 499810 516077 . + . ID=transcript_2070;Q9BU79 A4D1C6 B2R9I4 D6W5P1,Transmembrane protein 243,MDR1- and mitochondrial taxol resistance-associated protein {ECO:0000303|PubMed:15556294};, PF10856;, GO:0016021;, C:integral component of membrane;|Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold8 indexed_genome mRNA 516901 517773 . + . ID=transcript_2071;Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold8 indexed_genome mRNA 523096 547711 . - . ID=transcript_2072;Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9Y222 B2RBE1 B4DJS5 Q05C48 Q59G79 Q6IS13 Q969T2 Q9H2Z2 Q9H2Z3,Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1;, PF00249;, GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0007049;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold8 indexed_genome mRNA 783986 790495 . + . ID=transcript_2073;A8MWY0 A4D1C9 B4DJV3 Q17RI6 Q96DP2,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 {ECO:0000305},Estrogen-induced gene 121-like protein {ECO:0000303|PubMed:17475571};, , GO:0016021;GO:0005886;GO:0070700;GO:0051961;GO:0030513;GO:0045684;, C:integral component of membrane; C:plasma membrane;, F:BMP receptor binding;, P:negative regulation of nervous system development; P:positive regulation of BMP signaling pathway; P:positive regulation of epidermis development; scaffold8 indexed_genome mRNA 792471 856252 . - . ID=transcript_2074;A8MWY0 A4D1C9 B4DJV3 Q17RI6 Q96DP2,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 {ECO:0000305},Estrogen-induced gene 121-like protein {ECO:0000303|PubMed:17475571};, , GO:0016021;GO:0005886;GO:0070700;GO:0051961;GO:0030513;GO:0045684;, C:integral component of membrane; C:plasma membrane;, F:BMP receptor binding;, P:negative regulation of nervous system development; P:positive regulation of BMP signaling pathway; P:positive regulation of epidermis development;|A8MWY0 A4D1C9 B4DJV3 Q17RI6 Q96DP2,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 {ECO:0000305},Estrogen-induced gene 121-like protein {ECO:0000303|PubMed:17475571};, , GO:0016021;GO:0005886;GO:0070700;GO:0051961;GO:0030513;GO:0045684;, C:integral component of membrane; C:plasma membrane;, F:BMP receptor binding;, P:negative regulation of nervous system development; P:positive regulation of BMP signaling pathway; P:positive regulation of epidermis development;|A8MWY0 A4D1C9 B4DJV3 Q17RI6 Q96DP2,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 {ECO:0000305},Estrogen-induced gene 121-like protein {ECO:0000303|PubMed:17475571};, , GO:0016021;GO:0005886;GO:0070700;GO:0051961;GO:0030513;GO:0045684;, C:integral component of membrane; C:plasma membrane;, F:BMP receptor binding;, P:negative regulation of nervous system development; P:positive regulation of BMP signaling pathway; P:positive regulation of epidermis development;|A8MWY0 A4D1C9 B4DJV3 Q17RI6 Q96DP2,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 {ECO:0000305},Estrogen-induced gene 121-like protein {ECO:0000303|PubMed:17475571};, , GO:0016021;GO:0005886;GO:0070700;GO:0051961;GO:0030513;GO:0045684;, C:integral component of membrane; C:plasma membrane;, F:BMP receptor binding;, P:negative regulation of nervous system development; P:positive regulation of BMP signaling pathway; P:positive regulation of epidermis development;|A8MWY0 A4D1C9 B4DJV3 Q17RI6 Q96DP2,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 {ECO:0000305},Estrogen-induced gene 121-like protein {ECO:0000303|PubMed:17475571};, , GO:0016021;GO:0005886;GO:0070700;GO:0051961;GO:0030513;GO:0045684;, C:integral component of membrane; C:plasma membrane;, F:BMP receptor binding;, P:negative regulation of nervous system development; P:positive regulation of BMP signaling pathway; P:positive regulation of epidermis development;|A8MWY0 A4D1C9 B4DJV3 Q17RI6 Q96DP2,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 {ECO:0000305},Estrogen-induced gene 121-like protein {ECO:0000303|PubMed:17475571};, , GO:0016021;GO:0005886;GO:0070700;GO:0051961;GO:0030513;GO:0045684;, C:integral component of membrane; C:plasma membrane;, F:BMP receptor binding;, P:negative regulation of nervous system development; P:positive regulation of BMP signaling pathway; P:positive regulation of epidermis development;|A8MWY0 A4D1C9 B4DJV3 Q17RI6 Q96DP2,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 {ECO:0000305},Estrogen-induced gene 121-like protein {ECO:0000303|PubMed:17475571};, , GO:0016021;GO:0005886;GO:0070700;GO:0051961;GO:0030513;GO:0045684;, C:integral component of membrane; C:plasma membrane;, F:BMP receptor binding;, P:negative regulation of nervous system development; P:positive regulation of BMP signaling pathway; P:positive regulation of epidermis development; scaffold8 indexed_genome mRNA 885217 955444 . - . ID=transcript_2075;Q14832 Q2PNZ6 Q75MV4 Q75N17 Q86YG6 Q8TBH9,Metabotropic glutamate receptor 3,, PF00003;PF01094;PF07562;, GO:0097449;GO:0030424;GO:0043197;GO:0098978;GO:0005887;GO:0099055;GO:0099056;GO:0005886;GO:0014069;GO:0001640;GO:0005246;GO:0004930;GO:0008066;GO:0001641;GO:0097110;GO:0007268;GO:0007216;GO:0007186;GO:0010467;GO:0007194;GO:0051966;, C:astrocyte projection; C:axon; C:dendritic spine; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:postsynaptic density;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:calcium channel regulator activity; F:G protein-coupled receptor activity; F:glutamate receptor activity; F:group II metabotropic glutamate receptor activity; F:scaffold protein binding;, P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gene expression; P:negative regulation of adenylate cyclase activity; P:regulation of synaptic transmission, glutamatergic; scaffold8 indexed_genome mRNA 2600408 2711718 . + . ID=transcript_2076;O95025 A6NK46 Q6UW77 Q8NCQ1,Semaphorin-3D,, PF01403;, GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold8 indexed_genome mRNA 3626310 3664879 . + . ID=transcript_2077;Q14563,Semaphorin-3A,Semaphorin III;, PF01403;, GO:0030424;GO:0030425;GO:0005576;GO:0005615;GO:0005887;GO:0045499;GO:0038191;GO:0030215;GO:0006915;GO:0048846;GO:0007411;GO:0007413;GO:0060385;GO:0150020;GO:0021785;GO:0060666;GO:0021612;GO:1903375;GO:0021828;GO:0008045;GO:0050919;GO:0048843;GO:0010633;GO:0010977;GO:0021675;GO:0001755;GO:1901166;GO:1903045;GO:0001764;GO:0021772;GO:0030335;GO:0046330;GO:2000020;GO:2001224;GO:0048841;GO:0002027;GO:0071526;GO:1902287;GO:1902285;GO:0048880;GO:0061549;GO:0048485;GO:0097490;GO:0097491;GO:0061551;GO:0021637;GO:0036486;, C:axon; C:dendrite; C:extracellular region; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:neuropilin binding; F:semaphorin receptor binding;, P:apoptotic process; P:axon extension involved in axon guidance; P:axon guidance; P:axonal fasciculation; P:axonogenesis involved in innervation; P:basal dendrite arborization; P:branchiomotor neuron axon guidance; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:facial nerve structural organization; P:facioacoustic ganglion development; P:gonadotrophin-releasing hormone neuronal migration to the hypothalamus; P:motor neuron axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of epithelial cell migration; P:negative regulation of neuron projection development; P:nerve development; P:neural crest cell migration; P:neural crest cell migration involved in autonomic nervous system development; P:neural crest cell migration involved in sympathetic nervous system development; P:neuron migration; P:olfactory bulb development; P:positive regulation of cell migration; P:positive regulation of JNK cascade; P:positive regulation of male gonad development; P:positive regulation of neuron migration; P:regulation of axon extension involved in axon guidance; P:regulation of heart rate; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; P:sensory system development; P:sympathetic ganglion development; P:sympathetic nervous system development; P:sympathetic neuron projection extension; P:sympathetic neuron projection guidance; P:trigeminal ganglion development; P:trigeminal nerve structural organization; P:ventral trunk neural crest cell migration; scaffold8 indexed_genome mRNA 3664887 3665708 . + . ID=transcript_2078;Q14563,Semaphorin-3A,Semaphorin III;, PF01403;, GO:0030424;GO:0030425;GO:0005576;GO:0005615;GO:0005887;GO:0045499;GO:0038191;GO:0030215;GO:0006915;GO:0048846;GO:0007411;GO:0007413;GO:0060385;GO:0150020;GO:0021785;GO:0060666;GO:0021612;GO:1903375;GO:0021828;GO:0008045;GO:0050919;GO:0048843;GO:0010633;GO:0010977;GO:0021675;GO:0001755;GO:1901166;GO:1903045;GO:0001764;GO:0021772;GO:0030335;GO:0046330;GO:2000020;GO:2001224;GO:0048841;GO:0002027;GO:0071526;GO:1902287;GO:1902285;GO:0048880;GO:0061549;GO:0048485;GO:0097490;GO:0097491;GO:0061551;GO:0021637;GO:0036486;, C:axon; C:dendrite; C:extracellular region; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:neuropilin binding; F:semaphorin receptor binding;, P:apoptotic process; P:axon extension involved in axon guidance; P:axon guidance; P:axonal fasciculation; P:axonogenesis involved in innervation; P:basal dendrite arborization; P:branchiomotor neuron axon guidance; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:facial nerve structural organization; P:facioacoustic ganglion development; P:gonadotrophin-releasing hormone neuronal migration to the hypothalamus; P:motor neuron axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of epithelial cell migration; P:negative regulation of neuron projection development; P:nerve development; P:neural crest cell migration; P:neural crest cell migration involved in autonomic nervous system development; P:neural crest cell migration involved in sympathetic nervous system development; P:neuron migration; P:olfactory bulb development; P:positive regulation of cell migration; P:positive regulation of JNK cascade; P:positive regulation of male gonad development; P:positive regulation of neuron migration; P:regulation of axon extension involved in axon guidance; P:regulation of heart rate; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; P:sensory system development; P:sympathetic ganglion development; P:sympathetic nervous system development; P:sympathetic neuron projection extension; P:sympathetic neuron projection guidance; P:trigeminal ganglion development; P:trigeminal nerve structural organization; P:ventral trunk neural crest cell migration; scaffold8 indexed_genome mRNA 3994687 4265370 . + . ID=transcript_2079;O15041 B4E1P1 Q75M94 Q75M97,Semaphorin-3E,, PF00047;PF01403;, GO:0005576;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0001569;GO:0050919;GO:0016525;GO:0048843;GO:0001953;GO:0001755;GO:0030335;GO:2000249;GO:0008360;GO:0071526;GO:0002040;GO:0050808;, C:extracellular region; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:branching involved in blood vessel morphogenesis; P:negative chemotaxis; P:negative regulation of angiogenesis; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of cell-matrix adhesion; P:neural crest cell migration; P:positive regulation of cell migration; P:regulation of actin cytoskeleton reorganization; P:regulation of cell shape; P:semaphorin-plexin signaling pathway; P:sprouting angiogenesis; P:synapse organization; scaffold8 indexed_genome mRNA 4443089 4652216 . + . ID=transcript_2080;Q9Y6V0 A4D1A7 A6NNX9 O43373 O60305 Q08E72 Q9BVC8 Q9UIV2 Q9Y6U9,Protein piccolo,Aczonin;, PF00168;PF00595;PF05715;, GO:0030424;GO:0005856;GO:0048788;GO:0070062;GO:0098982;GO:0098978;GO:0014069;GO:0045202;GO:0005509;GO:0005544;GO:0005522;GO:0098882;GO:0019933;GO:0007010;GO:0030073;GO:0099526;GO:1904071;GO:0035418;GO:0017157;GO:0097091;GO:0016079;, C:axon; C:cytoskeleton; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:postsynaptic density; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:profilin binding; F:structural constituent of presynaptic active zone;, P:cAMP-mediated signaling; P:cytoskeleton organization; P:insulin secretion; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of exocytosis; P:synaptic vesicle clustering; P:synaptic vesicle exocytosis;|Q9Y6V0 A4D1A7 A6NNX9 O43373 O60305 Q08E72 Q9BVC8 Q9UIV2 Q9Y6U9,Protein piccolo,Aczonin;, PF00168;PF00595;PF05715;, GO:0030424;GO:0005856;GO:0048788;GO:0070062;GO:0098982;GO:0098978;GO:0014069;GO:0045202;GO:0005509;GO:0005544;GO:0005522;GO:0098882;GO:0019933;GO:0007010;GO:0030073;GO:0099526;GO:1904071;GO:0035418;GO:0017157;GO:0097091;GO:0016079;, C:axon; C:cytoskeleton; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:postsynaptic density; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:profilin binding; F:structural constituent of presynaptic active zone;, P:cAMP-mediated signaling; P:cytoskeleton organization; P:insulin secretion; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of exocytosis; P:synaptic vesicle clustering; P:synaptic vesicle exocytosis; scaffold8 indexed_genome mRNA 4724481 4805382 . + . ID=transcript_2081;Q9Y6V0 A4D1A7 A6NNX9 O43373 O60305 Q08E72 Q9BVC8 Q9UIV2 Q9Y6U9,Protein piccolo,Aczonin;, PF00168;PF00595;PF05715;, GO:0030424;GO:0005856;GO:0048788;GO:0070062;GO:0098982;GO:0098978;GO:0014069;GO:0045202;GO:0005509;GO:0005544;GO:0005522;GO:0098882;GO:0019933;GO:0007010;GO:0030073;GO:0099526;GO:1904071;GO:0035418;GO:0017157;GO:0097091;GO:0016079;, C:axon; C:cytoskeleton; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:postsynaptic density; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:profilin binding; F:structural constituent of presynaptic active zone;, P:cAMP-mediated signaling; P:cytoskeleton organization; P:insulin secretion; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of exocytosis; P:synaptic vesicle clustering; P:synaptic vesicle exocytosis;|Q9Y6V0 A4D1A7 A6NNX9 O43373 O60305 Q08E72 Q9BVC8 Q9UIV2 Q9Y6U9,Protein piccolo,Aczonin;, PF00168;PF00595;PF05715;, GO:0030424;GO:0005856;GO:0048788;GO:0070062;GO:0098982;GO:0098978;GO:0014069;GO:0045202;GO:0005509;GO:0005544;GO:0005522;GO:0098882;GO:0019933;GO:0007010;GO:0030073;GO:0099526;GO:1904071;GO:0035418;GO:0017157;GO:0097091;GO:0016079;, C:axon; C:cytoskeleton; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:postsynaptic density; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:profilin binding; F:structural constituent of presynaptic active zone;, P:cAMP-mediated signaling; P:cytoskeleton organization; P:insulin secretion; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of exocytosis; P:synaptic vesicle clustering; P:synaptic vesicle exocytosis;|Q9Y6V0 A4D1A7 A6NNX9 O43373 O60305 Q08E72 Q9BVC8 Q9UIV2 Q9Y6U9,Protein piccolo,Aczonin;, PF00168;PF00595;PF05715;, GO:0030424;GO:0005856;GO:0048788;GO:0070062;GO:0098982;GO:0098978;GO:0014069;GO:0045202;GO:0005509;GO:0005544;GO:0005522;GO:0098882;GO:0019933;GO:0007010;GO:0030073;GO:0099526;GO:1904071;GO:0035418;GO:0017157;GO:0097091;GO:0016079;, C:axon; C:cytoskeleton; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:postsynaptic density; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:profilin binding; F:structural constituent of presynaptic active zone;, P:cAMP-mediated signaling; P:cytoskeleton organization; P:insulin secretion; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of exocytosis; P:synaptic vesicle clustering; P:synaptic vesicle exocytosis;|Q9Y6V0 A4D1A7 A6NNX9 O43373 O60305 Q08E72 Q9BVC8 Q9UIV2 Q9Y6U9,Protein piccolo,Aczonin;, PF00168;PF00595;PF05715;, GO:0030424;GO:0005856;GO:0048788;GO:0070062;GO:0098982;GO:0098978;GO:0014069;GO:0045202;GO:0005509;GO:0005544;GO:0005522;GO:0098882;GO:0019933;GO:0007010;GO:0030073;GO:0099526;GO:1904071;GO:0035418;GO:0017157;GO:0097091;GO:0016079;, C:axon; C:cytoskeleton; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:postsynaptic density; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:profilin binding; F:structural constituent of presynaptic active zone;, P:cAMP-mediated signaling; P:cytoskeleton organization; P:insulin secretion; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of exocytosis; P:synaptic vesicle clustering; P:synaptic vesicle exocytosis; scaffold8 indexed_genome mRNA 5240471 5612992 . + . ID=transcript_2082;P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82,Voltage-dependent calcium channel subunit alpha-2/delta-1,Voltage-gated calcium channel subunit alpha-2/delta-1;, PF08473;PF00092;PF08399;, GO:0070062;GO:1990454;GO:0016529;GO:0005891;GO:0046872;GO:0005245;GO:0098703;GO:0061577;GO:0006816;GO:0060402;GO:0086002;GO:1904646;GO:0086048;GO:1901843;GO:1902514;GO:0051924;GO:0086091;GO:0098903;GO:0060307;, C:extracellular exosome; C:L-type voltage-gated calcium channel complex; C:sarcoplasmic reticulum; C:voltage-gated calcium channel complex;, F:metal ion binding; F:voltage-gated calcium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:cardiac muscle cell action potential involved in contraction; P:cellular response to amyloid-beta; P:membrane depolarization during bundle of His cell action potential; P:positive regulation of high voltage-gated calcium channel activity; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of calcium ion transport; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization during action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; scaffold8 indexed_genome mRNA 5848647 5926455 . + . ID=transcript_2083;Q9UDU6,Hepatocyte growth factor,Hepatopoietin-A;Scatter factor;, PF00051;PF00024;PF00089;, GO:0005576;GO:0005615;GO:0016020;GO:0031093;GO:0042056;GO:0008083;GO:0042802;GO:0044877;GO:0004252;GO:0000187;GO:0031100;GO:0060326;GO:0000902;GO:0035729;GO:0019221;GO:0050673;GO:0001837;GO:0048012;GO:0030212;GO:0001889;GO:0000165;GO:0000278;GO:0051450;GO:0043066;GO:0010507;GO:0043154;GO:1902042;GO:1901299;GO:0050728;GO:0032715;GO:0033137;GO:0090201;GO:0002576;GO:0045766;GO:0030335;GO:2000573;GO:0032733;GO:0031643;GO:0070572;GO:0045669;GO:0050731;GO:0014068;GO:0051897;GO:0001934;GO:0045944;GO:0060665;GO:1900744;GO:1902947;, C:extracellular region; C:extracellular space; C:membrane; C:platelet alpha granule lumen;, F:chemoattractant activity; F:growth factor activity; F:identical protein binding; F:protein-containing complex binding; F:serine-type endopeptidase activity;, P:activation of MAPK activity; P:animal organ regeneration; P:cell chemotaxis; P:cell morphogenesis; P:cellular response to hepatocyte growth factor stimulus; P:cytokine-mediated signaling pathway; P:epithelial cell proliferation; P:epithelial to mesenchymal transition; P:hepatocyte growth factor receptor signaling pathway; P:hyaluronan metabolic process; P:liver development; P:MAPK cascade; P:mitotic cell cycle; P:myoblast proliferation; P:negative regulation of apoptotic process; P:negative regulation of autophagy; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of hydrogen peroxide-mediated programmed cell death; P:negative regulation of inflammatory response; P:negative regulation of interleukin-6 production; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of release of cytochrome c from mitochondria; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of DNA biosynthetic process; P:positive regulation of interleukin-10 production; P:positive regulation of myelination; P:positive regulation of neuron projection regeneration; P:positive regulation of osteoblast differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling; P:regulation of p38MAPK cascade; P:regulation of tau-protein kinase activity; scaffold8 indexed_genome mRNA 6818294 7015740 . + . ID=transcript_2084;Q99985 B4DRL8,Semaphorin-3C,Semaphorin-E;, PF07679;PF01403;, GO:0070062;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0001974;GO:0140074;GO:0003215;GO:0060666;GO:0006955;GO:0060174;GO:0050919;GO:0048843;GO:0001755;GO:0021915;GO:0003148;GO:1905312;GO:0030335;GO:0009791;GO:0003350;GO:0042493;GO:0071526;GO:0001756;, C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:blood vessel remodeling; P:cardiac endothelial to mesenchymal transition; P:cardiac right ventricle morphogenesis; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:immune response; P:limb bud formation; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:neural tube development; P:outflow tract septum morphogenesis; P:positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis; P:positive regulation of cell migration; P:post-embryonic development; P:pulmonary myocardium development; P:response to drug; P:semaphorin-plexin signaling pathway; P:somitogenesis; scaffold8 indexed_genome mRNA 7176101 7211887 . - . ID=transcript_2085;Q9BQC2 Q9BZM8 Q9BZN3 Q9BZN4 Q9BZN5,Platelet glycoprotein 4,Fatty acid translocase;Glycoprotein IIIb;Leukocyte differentiation antigen CD36;PAS IV;PAS-4;Platelet collagen receptor;Platelet glycoprotein IV;Thrombospondin receptor;, PF01130;, GO:0016324;GO:0031526;GO:0005901;GO:0071944;GO:0009986;GO:0005737;GO:0030666;GO:0009897;GO:0005615;GO:0005794;GO:0005887;GO:0016020;GO:0045121;GO:0045335;GO:0005886;GO:0031092;GO:0043235;GO:0035579;GO:0001540;GO:0008035;GO:0008289;GO:0071813;GO:0070892;GO:0005324;GO:0030169;GO:0005041;GO:1901480;GO:0150025;GO:0044877;GO:0005044;GO:0015636;GO:0070053;GO:0035325;GO:0050431;GO:1990000;GO:0150094;GO:0002479;GO:0043277;GO:0007596;GO:0007155;GO:1904646;GO:0071726;GO:0071447;GO:0071222;GO:0071223;GO:0071404;GO:0140052;GO:0019934;GO:0070508;GO:0030301;GO:0019221;GO:0050830;GO:0097009;GO:0006631;GO:0050892;GO:0030299;GO:0006629;GO:0019915;GO:1990379;GO:0042953;GO:0015911;GO:0044539;GO:0015909;GO:0034383;GO:0055096;GO:0002755;GO:0042308;GO:0000122;GO:0043312;GO:0007263;GO:0150024;GO:0006911;GO:0006910;GO:0034381;GO:0002576;GO:0030194;GO:2000334;GO:0010942;GO:0001954;GO:0010886;GO:0120162;GO:0007204;GO:0070374;GO:0010628;GO:0043123;GO:0032731;GO:0032735;GO:0032755;GO:0060907;GO:0010744;GO:0051092;GO:0045429;GO:1900227;GO:0050731;GO:0060100;GO:1903428;GO:0032760;GO:0002532;GO:0031623;GO:0006898;GO:0098900;GO:0031664;GO:0019222;GO:0043254;GO:2000121;GO:0034121;GO:0070542;GO:0070543;GO:0033993;GO:0035634;GO:0050909;GO:0015912;GO:0002224;GO:0038124;GO:0034197;, C:apical plasma membrane; C:brush border membrane; C:caveola; C:cell periphery; C:cell surface; C:cytoplasm; C:endocytic vesicle membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule membrane; C:receptor complex; C:specific granule membrane;, F:amyloid-beta binding; F:high-density lipoprotein particle binding; F:lipid binding; F:lipoprotein particle binding; F:lipoteichoic acid immune receptor activity; F:long-chain fatty acid transporter activity; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:oleate transmembrane transporter activity; F:oxidised low-density lipoprotein particle receptor activity; F:protein-containing complex binding; F:scavenger receptor activity; F:short-chain fatty acid transmembrane transporter activity; F:thrombospondin receptor activity; F:Toll-like receptor binding; F:transforming growth factor beta binding;, P:amyloid fibril formation; P:amyloid-beta clearance by cellular catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic cell clearance; P:blood coagulation; P:cell adhesion; P:cellular response to amyloid-beta; P:cellular response to diacyl bacterial lipopeptide; P:cellular response to hydroperoxide; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cGMP-mediated signaling; P:cholesterol import; P:cholesterol transport; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:energy homeostasis; P:fatty acid metabolic process; P:intestinal absorption; P:intestinal cholesterol absorption; P:lipid metabolic process; P:lipid storage; P:lipid transport across blood-brain barrier; P:lipoprotein transport; P:long-chain fatty acid import across plasma membrane; P:long-chain fatty acid import into cell; P:long-chain fatty acid transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle mediated signaling; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of protein import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:neutrophil degranulation; P:nitric oxide mediated signal transduction; P:oxidised low-density lipoprotein particle clearance; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:plasma lipoprotein particle clearance; P:platelet degranulation; P:positive regulation of blood coagulation; P:positive regulation of blood microparticle formation; P:positive regulation of cell death; P:positive regulation of cell-matrix adhesion; P:positive regulation of cholesterol storage; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis, engulfment; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of tumor necrosis factor production; P:production of molecular mediator involved in inflammatory response; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of action potential; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of metabolic process; P:regulation of protein-containing complex assembly; P:regulation of removal of superoxide radicals; P:regulation of toll-like receptor signaling pathway; P:response to fatty acid; P:response to linoleic acid; P:response to lipid; P:response to stilbenoid; P:sensory perception of taste; P:short-chain fatty acid transport; P:toll-like receptor signaling pathway; P:toll-like receptor TLR6:TLR2 signaling pathway; P:triglyceride transport;|Q9BQC2 Q9BZM8 Q9BZN3 Q9BZN4 Q9BZN5,Platelet glycoprotein 4,Fatty acid translocase;Glycoprotein IIIb;Leukocyte differentiation antigen CD36;PAS IV;PAS-4;Platelet collagen receptor;Platelet glycoprotein IV;Thrombospondin receptor;, PF01130;, GO:0016324;GO:0031526;GO:0005901;GO:0071944;GO:0009986;GO:0005737;GO:0030666;GO:0009897;GO:0005615;GO:0005794;GO:0005887;GO:0016020;GO:0045121;GO:0045335;GO:0005886;GO:0031092;GO:0043235;GO:0035579;GO:0001540;GO:0008035;GO:0008289;GO:0071813;GO:0070892;GO:0005324;GO:0030169;GO:0005041;GO:1901480;GO:0150025;GO:0044877;GO:0005044;GO:0015636;GO:0070053;GO:0035325;GO:0050431;GO:1990000;GO:0150094;GO:0002479;GO:0043277;GO:0007596;GO:0007155;GO:1904646;GO:0071726;GO:0071447;GO:0071222;GO:0071223;GO:0071404;GO:0140052;GO:0019934;GO:0070508;GO:0030301;GO:0019221;GO:0050830;GO:0097009;GO:0006631;GO:0050892;GO:0030299;GO:0006629;GO:0019915;GO:1990379;GO:0042953;GO:0015911;GO:0044539;GO:0015909;GO:0034383;GO:0055096;GO:0002755;GO:0042308;GO:0000122;GO:0043312;GO:0007263;GO:0150024;GO:0006911;GO:0006910;GO:0034381;GO:0002576;GO:0030194;GO:2000334;GO:0010942;GO:0001954;GO:0010886;GO:0120162;GO:0007204;GO:0070374;GO:0010628;GO:0043123;GO:0032731;GO:0032735;GO:0032755;GO:0060907;GO:0010744;GO:0051092;GO:0045429;GO:1900227;GO:0050731;GO:0060100;GO:1903428;GO:0032760;GO:0002532;GO:0031623;GO:0006898;GO:0098900;GO:0031664;GO:0019222;GO:0043254;GO:2000121;GO:0034121;GO:0070542;GO:0070543;GO:0033993;GO:0035634;GO:0050909;GO:0015912;GO:0002224;GO:0038124;GO:0034197;, C:apical plasma membrane; C:brush border membrane; C:caveola; C:cell periphery; C:cell surface; C:cytoplasm; C:endocytic vesicle membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule membrane; C:receptor complex; C:specific granule membrane;, F:amyloid-beta binding; F:high-density lipoprotein particle binding; F:lipid binding; F:lipoprotein particle binding; F:lipoteichoic acid immune receptor activity; F:long-chain fatty acid transporter activity; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:oleate transmembrane transporter activity; F:oxidised low-density lipoprotein particle receptor activity; F:protein-containing complex binding; F:scavenger receptor activity; F:short-chain fatty acid transmembrane transporter activity; F:thrombospondin receptor activity; F:Toll-like receptor binding; F:transforming growth factor beta binding;, P:amyloid fibril formation; P:amyloid-beta clearance by cellular catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic cell clearance; P:blood coagulation; P:cell adhesion; P:cellular response to amyloid-beta; P:cellular response to diacyl bacterial lipopeptide; P:cellular response to hydroperoxide; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cGMP-mediated signaling; P:cholesterol import; P:cholesterol transport; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:energy homeostasis; P:fatty acid metabolic process; P:intestinal absorption; P:intestinal cholesterol absorption; P:lipid metabolic process; P:lipid storage; P:lipid transport across blood-brain barrier; P:lipoprotein transport; P:long-chain fatty acid import across plasma membrane; P:long-chain fatty acid import into cell; P:long-chain fatty acid transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle mediated signaling; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of protein import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:neutrophil degranulation; P:nitric oxide mediated signal transduction; P:oxidised low-density lipoprotein particle clearance; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:plasma lipoprotein particle clearance; P:platelet degranulation; P:positive regulation of blood coagulation; P:positive regulation of blood microparticle formation; P:positive regulation of cell death; P:positive regulation of cell-matrix adhesion; P:positive regulation of cholesterol storage; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis, engulfment; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of tumor necrosis factor production; P:production of molecular mediator involved in inflammatory response; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of action potential; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of metabolic process; P:regulation of protein-containing complex assembly; P:regulation of removal of superoxide radicals; P:regulation of toll-like receptor signaling pathway; P:response to fatty acid; P:response to linoleic acid; P:response to lipid; P:response to stilbenoid; P:sensory perception of taste; P:short-chain fatty acid transport; P:toll-like receptor signaling pathway; P:toll-like receptor TLR6:TLR2 signaling pathway; P:triglyceride transport;|Q9BQC2 Q9BZM8 Q9BZN3 Q9BZN4 Q9BZN5,Platelet glycoprotein 4,Fatty acid translocase;Glycoprotein IIIb;Leukocyte differentiation antigen CD36;PAS IV;PAS-4;Platelet collagen receptor;Platelet glycoprotein IV;Thrombospondin receptor;, PF01130;, GO:0016324;GO:0031526;GO:0005901;GO:0071944;GO:0009986;GO:0005737;GO:0030666;GO:0009897;GO:0005615;GO:0005794;GO:0005887;GO:0016020;GO:0045121;GO:0045335;GO:0005886;GO:0031092;GO:0043235;GO:0035579;GO:0001540;GO:0008035;GO:0008289;GO:0071813;GO:0070892;GO:0005324;GO:0030169;GO:0005041;GO:1901480;GO:0150025;GO:0044877;GO:0005044;GO:0015636;GO:0070053;GO:0035325;GO:0050431;GO:1990000;GO:0150094;GO:0002479;GO:0043277;GO:0007596;GO:0007155;GO:1904646;GO:0071726;GO:0071447;GO:0071222;GO:0071223;GO:0071404;GO:0140052;GO:0019934;GO:0070508;GO:0030301;GO:0019221;GO:0050830;GO:0097009;GO:0006631;GO:0050892;GO:0030299;GO:0006629;GO:0019915;GO:1990379;GO:0042953;GO:0015911;GO:0044539;GO:0015909;GO:0034383;GO:0055096;GO:0002755;GO:0042308;GO:0000122;GO:0043312;GO:0007263;GO:0150024;GO:0006911;GO:0006910;GO:0034381;GO:0002576;GO:0030194;GO:2000334;GO:0010942;GO:0001954;GO:0010886;GO:0120162;GO:0007204;GO:0070374;GO:0010628;GO:0043123;GO:0032731;GO:0032735;GO:0032755;GO:0060907;GO:0010744;GO:0051092;GO:0045429;GO:1900227;GO:0050731;GO:0060100;GO:1903428;GO:0032760;GO:0002532;GO:0031623;GO:0006898;GO:0098900;GO:0031664;GO:0019222;GO:0043254;GO:2000121;GO:0034121;GO:0070542;GO:0070543;GO:0033993;GO:0035634;GO:0050909;GO:0015912;GO:0002224;GO:0038124;GO:0034197;, C:apical plasma membrane; C:brush border membrane; C:caveola; C:cell periphery; C:cell surface; C:cytoplasm; C:endocytic vesicle membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule membrane; C:receptor complex; C:specific granule membrane;, F:amyloid-beta binding; F:high-density lipoprotein particle binding; F:lipid binding; F:lipoprotein particle binding; F:lipoteichoic acid immune receptor activity; F:long-chain fatty acid transporter activity; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:oleate transmembrane transporter activity; F:oxidised low-density lipoprotein particle receptor activity; F:protein-containing complex binding; F:scavenger receptor activity; F:short-chain fatty acid transmembrane transporter activity; F:thrombospondin receptor activity; F:Toll-like receptor binding; F:transforming growth factor beta binding;, P:amyloid fibril formation; P:amyloid-beta clearance by cellular catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic cell clearance; P:blood coagulation; P:cell adhesion; P:cellular response to amyloid-beta; P:cellular response to diacyl bacterial lipopeptide; P:cellular response to hydroperoxide; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cGMP-mediated signaling; P:cholesterol import; P:cholesterol transport; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:energy homeostasis; P:fatty acid metabolic process; P:intestinal absorption; P:intestinal cholesterol absorption; P:lipid metabolic process; P:lipid storage; P:lipid transport across blood-brain barrier; P:lipoprotein transport; P:long-chain fatty acid import across plasma membrane; P:long-chain fatty acid import into cell; P:long-chain fatty acid transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle mediated signaling; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of protein import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:neutrophil degranulation; P:nitric oxide mediated signal transduction; P:oxidised low-density lipoprotein particle clearance; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:plasma lipoprotein particle clearance; P:platelet degranulation; P:positive regulation of blood coagulation; P:positive regulation of blood microparticle formation; P:positive regulation of cell death; P:positive regulation of cell-matrix adhesion; P:positive regulation of cholesterol storage; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis, engulfment; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of tumor necrosis factor production; P:production of molecular mediator involved in inflammatory response; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of action potential; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of metabolic process; P:regulation of protein-containing complex assembly; P:regulation of removal of superoxide radicals; P:regulation of toll-like receptor signaling pathway; P:response to fatty acid; P:response to linoleic acid; P:response to lipid; P:response to stilbenoid; P:sensory perception of taste; P:short-chain fatty acid transport; P:toll-like receptor signaling pathway; P:toll-like receptor TLR6:TLR2 signaling pathway; P:triglyceride transport; scaffold8 indexed_genome mRNA 7235470 7274530 . - . ID=transcript_2086;Q9BQC2 Q9BZM8 Q9BZN3 Q9BZN4 Q9BZN5,Platelet glycoprotein 4,Fatty acid translocase;Glycoprotein IIIb;Leukocyte differentiation antigen CD36;PAS IV;PAS-4;Platelet collagen receptor;Platelet glycoprotein IV;Thrombospondin receptor;, PF01130;, GO:0016324;GO:0031526;GO:0005901;GO:0071944;GO:0009986;GO:0005737;GO:0030666;GO:0009897;GO:0005615;GO:0005794;GO:0005887;GO:0016020;GO:0045121;GO:0045335;GO:0005886;GO:0031092;GO:0043235;GO:0035579;GO:0001540;GO:0008035;GO:0008289;GO:0071813;GO:0070892;GO:0005324;GO:0030169;GO:0005041;GO:1901480;GO:0150025;GO:0044877;GO:0005044;GO:0015636;GO:0070053;GO:0035325;GO:0050431;GO:1990000;GO:0150094;GO:0002479;GO:0043277;GO:0007596;GO:0007155;GO:1904646;GO:0071726;GO:0071447;GO:0071222;GO:0071223;GO:0071404;GO:0140052;GO:0019934;GO:0070508;GO:0030301;GO:0019221;GO:0050830;GO:0097009;GO:0006631;GO:0050892;GO:0030299;GO:0006629;GO:0019915;GO:1990379;GO:0042953;GO:0015911;GO:0044539;GO:0015909;GO:0034383;GO:0055096;GO:0002755;GO:0042308;GO:0000122;GO:0043312;GO:0007263;GO:0150024;GO:0006911;GO:0006910;GO:0034381;GO:0002576;GO:0030194;GO:2000334;GO:0010942;GO:0001954;GO:0010886;GO:0120162;GO:0007204;GO:0070374;GO:0010628;GO:0043123;GO:0032731;GO:0032735;GO:0032755;GO:0060907;GO:0010744;GO:0051092;GO:0045429;GO:1900227;GO:0050731;GO:0060100;GO:1903428;GO:0032760;GO:0002532;GO:0031623;GO:0006898;GO:0098900;GO:0031664;GO:0019222;GO:0043254;GO:2000121;GO:0034121;GO:0070542;GO:0070543;GO:0033993;GO:0035634;GO:0050909;GO:0015912;GO:0002224;GO:0038124;GO:0034197;, C:apical plasma membrane; C:brush border membrane; C:caveola; C:cell periphery; C:cell surface; C:cytoplasm; C:endocytic vesicle membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule membrane; C:receptor complex; C:specific granule membrane;, F:amyloid-beta binding; F:high-density lipoprotein particle binding; F:lipid binding; F:lipoprotein particle binding; F:lipoteichoic acid immune receptor activity; F:long-chain fatty acid transporter activity; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:oleate transmembrane transporter activity; F:oxidised low-density lipoprotein particle receptor activity; F:protein-containing complex binding; F:scavenger receptor activity; F:short-chain fatty acid transmembrane transporter activity; F:thrombospondin receptor activity; F:Toll-like receptor binding; F:transforming growth factor beta binding;, P:amyloid fibril formation; P:amyloid-beta clearance by cellular catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic cell clearance; P:blood coagulation; P:cell adhesion; P:cellular response to amyloid-beta; P:cellular response to diacyl bacterial lipopeptide; P:cellular response to hydroperoxide; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cGMP-mediated signaling; P:cholesterol import; P:cholesterol transport; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:energy homeostasis; P:fatty acid metabolic process; P:intestinal absorption; P:intestinal cholesterol absorption; P:lipid metabolic process; P:lipid storage; P:lipid transport across blood-brain barrier; P:lipoprotein transport; P:long-chain fatty acid import across plasma membrane; P:long-chain fatty acid import into cell; P:long-chain fatty acid transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle mediated signaling; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of protein import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:neutrophil degranulation; P:nitric oxide mediated signal transduction; P:oxidised low-density lipoprotein particle clearance; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:plasma lipoprotein particle clearance; P:platelet degranulation; P:positive regulation of blood coagulation; P:positive regulation of blood microparticle formation; P:positive regulation of cell death; P:positive regulation of cell-matrix adhesion; P:positive regulation of cholesterol storage; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis, engulfment; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of tumor necrosis factor production; P:production of molecular mediator involved in inflammatory response; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of action potential; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of metabolic process; P:regulation of protein-containing complex assembly; P:regulation of removal of superoxide radicals; P:regulation of toll-like receptor signaling pathway; P:response to fatty acid; P:response to linoleic acid; P:response to lipid; P:response to stilbenoid; P:sensory perception of taste; P:short-chain fatty acid transport; P:toll-like receptor signaling pathway; P:toll-like receptor TLR6:TLR2 signaling pathway; P:triglyceride transport;|Q9BQC2 Q9BZM8 Q9BZN3 Q9BZN4 Q9BZN5,Platelet glycoprotein 4,Fatty acid translocase;Glycoprotein IIIb;Leukocyte differentiation antigen CD36;PAS IV;PAS-4;Platelet collagen receptor;Platelet glycoprotein IV;Thrombospondin receptor;, PF01130;, GO:0016324;GO:0031526;GO:0005901;GO:0071944;GO:0009986;GO:0005737;GO:0030666;GO:0009897;GO:0005615;GO:0005794;GO:0005887;GO:0016020;GO:0045121;GO:0045335;GO:0005886;GO:0031092;GO:0043235;GO:0035579;GO:0001540;GO:0008035;GO:0008289;GO:0071813;GO:0070892;GO:0005324;GO:0030169;GO:0005041;GO:1901480;GO:0150025;GO:0044877;GO:0005044;GO:0015636;GO:0070053;GO:0035325;GO:0050431;GO:1990000;GO:0150094;GO:0002479;GO:0043277;GO:0007596;GO:0007155;GO:1904646;GO:0071726;GO:0071447;GO:0071222;GO:0071223;GO:0071404;GO:0140052;GO:0019934;GO:0070508;GO:0030301;GO:0019221;GO:0050830;GO:0097009;GO:0006631;GO:0050892;GO:0030299;GO:0006629;GO:0019915;GO:1990379;GO:0042953;GO:0015911;GO:0044539;GO:0015909;GO:0034383;GO:0055096;GO:0002755;GO:0042308;GO:0000122;GO:0043312;GO:0007263;GO:0150024;GO:0006911;GO:0006910;GO:0034381;GO:0002576;GO:0030194;GO:2000334;GO:0010942;GO:0001954;GO:0010886;GO:0120162;GO:0007204;GO:0070374;GO:0010628;GO:0043123;GO:0032731;GO:0032735;GO:0032755;GO:0060907;GO:0010744;GO:0051092;GO:0045429;GO:1900227;GO:0050731;GO:0060100;GO:1903428;GO:0032760;GO:0002532;GO:0031623;GO:0006898;GO:0098900;GO:0031664;GO:0019222;GO:0043254;GO:2000121;GO:0034121;GO:0070542;GO:0070543;GO:0033993;GO:0035634;GO:0050909;GO:0015912;GO:0002224;GO:0038124;GO:0034197;, C:apical plasma membrane; C:brush border membrane; C:caveola; C:cell periphery; C:cell surface; C:cytoplasm; C:endocytic vesicle membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule membrane; C:receptor complex; C:specific granule membrane;, F:amyloid-beta binding; F:high-density lipoprotein particle binding; F:lipid binding; F:lipoprotein particle binding; F:lipoteichoic acid immune receptor activity; F:long-chain fatty acid transporter activity; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:oleate transmembrane transporter activity; F:oxidised low-density lipoprotein particle receptor activity; F:protein-containing complex binding; F:scavenger receptor activity; F:short-chain fatty acid transmembrane transporter activity; F:thrombospondin receptor activity; F:Toll-like receptor binding; F:transforming growth factor beta binding;, P:amyloid fibril formation; P:amyloid-beta clearance by cellular catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic cell clearance; P:blood coagulation; P:cell adhesion; P:cellular response to amyloid-beta; P:cellular response to diacyl bacterial lipopeptide; P:cellular response to hydroperoxide; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cGMP-mediated signaling; P:cholesterol import; P:cholesterol transport; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:energy homeostasis; P:fatty acid metabolic process; P:intestinal absorption; P:intestinal cholesterol absorption; P:lipid metabolic process; P:lipid storage; P:lipid transport across blood-brain barrier; P:lipoprotein transport; P:long-chain fatty acid import across plasma membrane; P:long-chain fatty acid import into cell; P:long-chain fatty acid transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle mediated signaling; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of protein import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:neutrophil degranulation; P:nitric oxide mediated signal transduction; P:oxidised low-density lipoprotein particle clearance; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:plasma lipoprotein particle clearance; P:platelet degranulation; P:positive regulation of blood coagulation; P:positive regulation of blood microparticle formation; P:positive regulation of cell death; P:positive regulation of cell-matrix adhesion; P:positive regulation of cholesterol storage; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage cytokine production; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis, engulfment; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of tumor necrosis factor production; P:production of molecular mediator involved in inflammatory response; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of action potential; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of metabolic process; P:regulation of protein-containing complex assembly; P:regulation of removal of superoxide radicals; P:regulation of toll-like receptor signaling pathway; P:response to fatty acid; P:response to linoleic acid; P:response to lipid; P:response to stilbenoid; P:sensory perception of taste; P:short-chain fatty acid transport; P:toll-like receptor signaling pathway; P:toll-like receptor TLR6:TLR2 signaling pathway; P:triglyceride transport; scaffold8 indexed_genome mRNA 7370301 7371588 . - . ID=transcript_2087;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold8 indexed_genome mRNA 7780021 7887870 . - . ID=transcript_2088;Q9UGA4,Guanine nucleotide-binding protein G(i) subunit alpha-1,Adenylate cyclase-inhibiting G alpha protein;, PF00503;, GO:0099738;GO:0005813;GO:0005737;GO:0070062;GO:0005834;GO:0005765;GO:0045121;GO:0030496;GO:0005634;GO:0005886;GO:0001664;GO:0031821;GO:0031683;GO:0019003;GO:0005525;GO:0032794;GO:0003924;GO:0000287;GO:0007193;GO:0007188;GO:0007049;GO:0051301;GO:1904322;GO:0007186;GO:0050805;GO:0030168;GO:1904778;GO:0006457;GO:0043949;GO:0060236;GO:0043434;, C:cell cortex region; C:centrosome; C:cytoplasm; C:extracellular exosome; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane raft; C:midbody; C:nucleus; C:plasma membrane;, F:G protein-coupled receptor binding; F:G protein-coupled serotonin receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GDP binding; F:GTP binding; F:GTPase activating protein binding; F:GTPase activity; F:magnesium ion binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell cycle; P:cell division; P:cellular response to forskolin; P:G protein-coupled receptor signaling pathway; P:negative regulation of synaptic transmission; P:platelet activation; P:positive regulation of protein localization to cell cortex; P:protein folding; P:regulation of cAMP-mediated signaling; P:regulation of mitotic spindle organization; P:response to peptide hormone; scaffold8 indexed_genome mRNA 9971440 9973968 . - . ID=transcript_2089;Q86UL8 A4D1C1 A7E2C3 O60434 O60510 Q86UI7 Q9NP44 Q9UDQ5 Q9UDU1,Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2,Atrophin-1-interacting protein 1;Atrophin-1-interacting protein A;Membrane-associated guanylate kinase inverted 2;, PF00625;PF00595;PF00397;, GO:0005923;GO:0005911;GO:0005737;GO:0030425;GO:0005770;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0032991;GO:0036057;GO:0045202;GO:0031697;GO:0019902;GO:0030159;GO:0046332;GO:0070699;GO:1990090;GO:0072015;GO:0071850;GO:0032926;GO:0030336;GO:0008285;GO:0051898;GO:0038180;GO:0007399;GO:0003402;GO:0010976;GO:0032516;GO:0002092;GO:0043113;GO:0007165;GO:0060395;, C:bicellular tight junction; C:cell-cell junction; C:cytoplasm; C:dendrite; C:late endosome; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:slit diaphragm; C:synapse;, F:beta-1 adrenergic receptor binding; F:phosphatase binding; F:signaling receptor complex adaptor activity; F:SMAD binding; F:type II activin receptor binding;, P:cellular response to nerve growth factor stimulus; P:glomerular visceral epithelial cell development; P:mitotic cell cycle arrest; P:negative regulation of activin receptor signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase B signaling; P:nerve growth factor signaling pathway; P:nervous system development; P:planar cell polarity pathway involved in axis elongation; P:positive regulation of neuron projection development; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of receptor internalization; P:receptor clustering; P:signal transduction; P:SMAD protein signal transduction; scaffold8 indexed_genome mRNA 9974951 9975975 . - . ID=transcript_2090;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold8 indexed_genome mRNA 10020151 10148922 . - . ID=transcript_2091;Q9H099,Protein PHTF2 {ECO:0000305},, PF12129;, GO:0005783;GO:0016021;, C:endoplasmic reticulum; C:integral component of membrane;|Q9H099,Protein PHTF2 {ECO:0000305},, PF12129;, GO:0005783;GO:0016021;, C:endoplasmic reticulum; C:integral component of membrane;|Q9H099,Protein PHTF2 {ECO:0000305},, PF12129;, GO:0005783;GO:0016021;, C:endoplasmic reticulum; C:integral component of membrane; scaffold8 indexed_genome mRNA 10149249 10153214 . + . ID=transcript_2092;Q9H2L4 A4D1C3 Q86UM0,Transmembrane protein 60,, PF10269;, GO:0016021;, C:integral component of membrane; scaffold8 indexed_genome mRNA 10159999 10247987 . - . ID=transcript_2093;Q6PCB5 C9K0P1 Q6ZS58 Q6ZVI9 Q86X48,Lysine-specific demethylase RSBN1L {ECO:0000305},Round spermatid basic protein 1-like protein;, , GO:0005634;GO:0051213;GO:0046872;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;|Q6PCB5 C9K0P1 Q6ZS58 Q6ZVI9 Q86X48,Lysine-specific demethylase RSBN1L {ECO:0000305},Round spermatid basic protein 1-like protein;, , GO:0005634;GO:0051213;GO:0046872;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;|Q6PCB5 C9K0P1 Q6ZS58 Q6ZVI9 Q86X48,Lysine-specific demethylase RSBN1L {ECO:0000305},Round spermatid basic protein 1-like protein;, , GO:0005634;GO:0051213;GO:0046872;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;|Q6PCB5 C9K0P1 Q6ZS58 Q6ZVI9 Q86X48,Lysine-specific demethylase RSBN1L {ECO:0000305},Round spermatid basic protein 1-like protein;, , GO:0005634;GO:0051213;GO:0046872;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;|Q6PCB5 C9K0P1 Q6ZS58 Q6ZVI9 Q86X48,Lysine-specific demethylase RSBN1L {ECO:0000305},Round spermatid basic protein 1-like protein;, , GO:0005634;GO:0051213;GO:0046872;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;|Q6PCB5 C9K0P1 Q6ZS58 Q6ZVI9 Q86X48,Lysine-specific demethylase RSBN1L {ECO:0000305},Round spermatid basic protein 1-like protein;, , GO:0005634;GO:0051213;GO:0046872;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;|Q6PCB5 C9K0P1 Q6ZS58 Q6ZVI9 Q86X48,Lysine-specific demethylase RSBN1L {ECO:0000305},Round spermatid basic protein 1-like protein;, , GO:0005634;GO:0051213;GO:0046872;, C:nucleus;, F:dioxygenase activity; F:metal ion binding; scaffold8 indexed_genome mRNA 10297017 10299351 . - . ID=transcript_2094;Q05209 A4D1C5 B4DKY2 E9PBR5 E9PEH9 Q16130 Q59FD6 Q75MN8 Q86XU4,Tyrosine-protein phosphatase non-receptor type 12,PTP-PEST {ECO:0000303|PubMed:8454633};Protein-tyrosine phosphatase G1;, PF00102;, GO:0042995;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0002102;GO:0004726;GO:0004721;GO:0004725;GO:0017124;GO:0071345;GO:0071364;GO:0038128;GO:1901185;GO:2000587;GO:0035335;GO:0006470;GO:0042058;GO:0042246;, C:cell projection; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:podosome;, F:non-membrane spanning protein tyrosine phosphatase activity; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity; F:SH3 domain binding;, P:cellular response to cytokine stimulus; P:cellular response to epidermal growth factor stimulus; P:ERBB2 signaling pathway; P:negative regulation of ERBB signaling pathway; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of epidermal growth factor receptor signaling pathway; P:tissue regeneration;|Q05209 A4D1C5 B4DKY2 E9PBR5 E9PEH9 Q16130 Q59FD6 Q75MN8 Q86XU4,Tyrosine-protein phosphatase non-receptor type 12,PTP-PEST {ECO:0000303|PubMed:8454633};Protein-tyrosine phosphatase G1;, PF00102;, GO:0042995;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0002102;GO:0004726;GO:0004721;GO:0004725;GO:0017124;GO:0071345;GO:0071364;GO:0038128;GO:1901185;GO:2000587;GO:0035335;GO:0006470;GO:0042058;GO:0042246;, C:cell projection; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:podosome;, F:non-membrane spanning protein tyrosine phosphatase activity; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity; F:SH3 domain binding;, P:cellular response to cytokine stimulus; P:cellular response to epidermal growth factor stimulus; P:ERBB2 signaling pathway; P:negative regulation of ERBB signaling pathway; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of epidermal growth factor receptor signaling pathway; P:tissue regeneration; scaffold8 indexed_genome mRNA 10301782 10333473 . - . ID=transcript_2095;Q05209 A4D1C5 B4DKY2 E9PBR5 E9PEH9 Q16130 Q59FD6 Q75MN8 Q86XU4,Tyrosine-protein phosphatase non-receptor type 12,PTP-PEST {ECO:0000303|PubMed:8454633};Protein-tyrosine phosphatase G1;, PF00102;, GO:0042995;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0002102;GO:0004726;GO:0004721;GO:0004725;GO:0017124;GO:0071345;GO:0071364;GO:0038128;GO:1901185;GO:2000587;GO:0035335;GO:0006470;GO:0042058;GO:0042246;, C:cell projection; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:podosome;, F:non-membrane spanning protein tyrosine phosphatase activity; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity; F:SH3 domain binding;, P:cellular response to cytokine stimulus; P:cellular response to epidermal growth factor stimulus; P:ERBB2 signaling pathway; P:negative regulation of ERBB signaling pathway; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of epidermal growth factor receptor signaling pathway; P:tissue regeneration;|Q05209 A4D1C5 B4DKY2 E9PBR5 E9PEH9 Q16130 Q59FD6 Q75MN8 Q86XU4,Tyrosine-protein phosphatase non-receptor type 12,PTP-PEST {ECO:0000303|PubMed:8454633};Protein-tyrosine phosphatase G1;, PF00102;, GO:0042995;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0002102;GO:0004726;GO:0004721;GO:0004725;GO:0017124;GO:0071345;GO:0071364;GO:0038128;GO:1901185;GO:2000587;GO:0035335;GO:0006470;GO:0042058;GO:0042246;, C:cell projection; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:podosome;, F:non-membrane spanning protein tyrosine phosphatase activity; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity; F:SH3 domain binding;, P:cellular response to cytokine stimulus; P:cellular response to epidermal growth factor stimulus; P:ERBB2 signaling pathway; P:negative regulation of ERBB signaling pathway; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of epidermal growth factor receptor signaling pathway; P:tissue regeneration;|Q05209 A4D1C5 B4DKY2 E9PBR5 E9PEH9 Q16130 Q59FD6 Q75MN8 Q86XU4,Tyrosine-protein phosphatase non-receptor type 12,PTP-PEST {ECO:0000303|PubMed:8454633};Protein-tyrosine phosphatase G1;, PF00102;, GO:0042995;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0002102;GO:0004726;GO:0004721;GO:0004725;GO:0017124;GO:0071345;GO:0071364;GO:0038128;GO:1901185;GO:2000587;GO:0035335;GO:0006470;GO:0042058;GO:0042246;, C:cell projection; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:podosome;, F:non-membrane spanning protein tyrosine phosphatase activity; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity; F:SH3 domain binding;, P:cellular response to cytokine stimulus; P:cellular response to epidermal growth factor stimulus; P:ERBB2 signaling pathway; P:negative regulation of ERBB signaling pathway; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of epidermal growth factor receptor signaling pathway; P:tissue regeneration; scaffold8 indexed_genome mRNA 10495066 10603757 . + . ID=transcript_2096;A4D1B5 A4D1B6 Q3MJC0 Q8ND73 Q9UMH3 Q9Y4L9,Gamma-secretase-activating protein,Protein pigeon homolog;, PF14959;, GO:0005802;GO:0001540;GO:1902004;GO:0030162;, C:trans-Golgi network;, F:amyloid-beta binding;, P:positive regulation of amyloid-beta formation; P:regulation of proteolysis;|A4D1B5 A4D1B6 Q3MJC0 Q8ND73 Q9UMH3 Q9Y4L9,Gamma-secretase-activating protein,Protein pigeon homolog;, PF14959;, GO:0005802;GO:0001540;GO:1902004;GO:0030162;, C:trans-Golgi network;, F:amyloid-beta binding;, P:positive regulation of amyloid-beta formation; P:regulation of proteolysis;|A4D1B5 A4D1B6 Q3MJC0 Q8ND73 Q9UMH3 Q9Y4L9,Gamma-secretase-activating protein,Protein pigeon homolog;, PF14959;, GO:0005802;GO:0001540;GO:1902004;GO:0030162;, C:trans-Golgi network;, F:amyloid-beta binding;, P:positive regulation of amyloid-beta formation; P:regulation of proteolysis;|A4D1B5 A4D1B6 Q3MJC0 Q8ND73 Q9UMH3 Q9Y4L9,Gamma-secretase-activating protein,Protein pigeon homolog;, PF14959;, GO:0005802;GO:0001540;GO:1902004;GO:0030162;, C:trans-Golgi network;, F:amyloid-beta binding;, P:positive regulation of amyloid-beta formation; P:regulation of proteolysis;|A4D1B5 A4D1B6 Q3MJC0 Q8ND73 Q9UMH3 Q9Y4L9,Gamma-secretase-activating protein,Protein pigeon homolog;, PF14959;, GO:0005802;GO:0001540;GO:1902004;GO:0030162;, C:trans-Golgi network;, F:amyloid-beta binding;, P:positive regulation of amyloid-beta formation; P:regulation of proteolysis;|A4D1B5 A4D1B6 Q3MJC0 Q8ND73 Q9UMH3 Q9Y4L9,Gamma-secretase-activating protein,Protein pigeon homolog;, PF14959;, GO:0005802;GO:0001540;GO:1902004;GO:0030162;, C:trans-Golgi network;, F:amyloid-beta binding;, P:positive regulation of amyloid-beta formation; P:regulation of proteolysis;|A4D1B5 A4D1B6 Q3MJC0 Q8ND73 Q9UMH3 Q9Y4L9,Gamma-secretase-activating protein,Protein pigeon homolog;, PF14959;, GO:0005802;GO:0001540;GO:1902004;GO:0030162;, C:trans-Golgi network;, F:amyloid-beta binding;, P:positive regulation of amyloid-beta formation; P:regulation of proteolysis;|A4D1B5 A4D1B6 Q3MJC0 Q8ND73 Q9UMH3 Q9Y4L9,Gamma-secretase-activating protein,Protein pigeon homolog;, PF14959;, GO:0005802;GO:0001540;GO:1902004;GO:0030162;, C:trans-Golgi network;, F:amyloid-beta binding;, P:positive regulation of amyloid-beta formation; P:regulation of proteolysis;|Q8IYE0 A8K8X6 Q9P223,Coiled-coil domain-containing protein 146,, , GO:0005814;GO:0005737;GO:0005856;, C:centriole; C:cytoplasm; C:cytoskeleton;|Q8IYE0 A8K8X6 Q9P223,Coiled-coil domain-containing protein 146,, , GO:0005814;GO:0005737;GO:0005856;, C:centriole; C:cytoplasm; C:cytoskeleton; scaffold8 indexed_genome mRNA 10622476 10727444 . - . ID=transcript_2097;Q8IYE0 A8K8X6 Q9P223,Coiled-coil domain-containing protein 146,, , GO:0005814;GO:0005737;GO:0005856;, C:centriole; C:cytoplasm; C:cytoskeleton;|Q8IYE0 A8K8X6 Q9P223,Coiled-coil domain-containing protein 146,, , GO:0005814;GO:0005737;GO:0005856;, C:centriole; C:cytoplasm; C:cytoskeleton;|Q14314,Fibroleukin,Fibrinogen-like protein 2;pT49;, PF00147;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005577;GO:1904813;GO:0008233;GO:0005102;GO:0050687;GO:0002605;GO:0002617;GO:0043381;GO:0043312;GO:0002291;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:ficolin-1-rich granule lumen;, F:peptidase activity; F:signaling receptor binding;, P:negative regulation of defense response to virus; P:negative regulation of dendritic cell antigen processing and presentation; P:negative regulation of macrophage antigen processing and presentation; P:negative regulation of memory T cell differentiation; P:neutrophil degranulation; P:T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; scaffold8 indexed_genome mRNA 10727642 10801058 . + . ID=transcript_2098;Q8N0U4 A8MUR7 B4DQD3 C9IZ91,Protein FAM185A,, PF13349; scaffold8 indexed_genome mRNA 10895460 10929937 . + . ID=transcript_2099;Q8N6Y2 Q13288 Q6UWA7 Q75MG5,Leucine-rich repeat-containing protein 17,p37NB;, PF13855;, GO:0031012;GO:0005615;GO:0048539;GO:0045671;GO:0001503;, C:extracellular matrix; C:extracellular space;, , P:bone marrow development; P:negative regulation of osteoclast differentiation; P:ossification; scaffold8 indexed_genome mRNA 11049294 11130056 . + . ID=transcript_2100;Q6IQ20 Q5CZ87 Q769K1,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D {ECO:0000303|PubMed:25684574},, PF12706;, GO:0005737;GO:0005769;GO:0031901;GO:0070062;GO:0005794;GO:0000139;GO:0043227;GO:0005635;GO:0005654;GO:0042622;GO:0032052;GO:0042802;GO:0102200;GO:0070290;GO:0008270;GO:0007568;GO:0048874;GO:0070291;GO:0070292;GO:1903999;GO:0009395;GO:0090336;GO:0050729;GO:0035900;GO:0001523;GO:0001659;, C:cytoplasm; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:membrane-bounded organelle; C:nuclear envelope; C:nucleoplasm; C:photoreceptor outer segment membrane;, F:bile acid binding; F:identical protein binding; F:N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity; F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:zinc ion binding;, P:aging; P:host-mediated regulation of intestinal microbiota composition; P:N-acylethanolamine metabolic process; P:N-acylphosphatidylethanolamine metabolic process; P:negative regulation of eating behavior; P:phospholipid catabolic process; P:positive regulation of brown fat cell differentiation; P:positive regulation of inflammatory response; P:response to isolation stress; P:retinoid metabolic process; P:temperature homeostasis;|Q6IQ20 Q5CZ87 Q769K1,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D {ECO:0000303|PubMed:25684574},, PF12706;, GO:0005737;GO:0005769;GO:0031901;GO:0070062;GO:0005794;GO:0000139;GO:0043227;GO:0005635;GO:0005654;GO:0042622;GO:0032052;GO:0042802;GO:0102200;GO:0070290;GO:0008270;GO:0007568;GO:0048874;GO:0070291;GO:0070292;GO:1903999;GO:0009395;GO:0090336;GO:0050729;GO:0035900;GO:0001523;GO:0001659;, C:cytoplasm; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:membrane-bounded organelle; C:nuclear envelope; C:nucleoplasm; C:photoreceptor outer segment membrane;, F:bile acid binding; F:identical protein binding; F:N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity; F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:zinc ion binding;, P:aging; P:host-mediated regulation of intestinal microbiota composition; P:N-acylethanolamine metabolic process; P:N-acylphosphatidylethanolamine metabolic process; P:negative regulation of eating behavior; P:phospholipid catabolic process; P:positive regulation of brown fat cell differentiation; P:positive regulation of inflammatory response; P:response to isolation stress; P:retinoid metabolic process; P:temperature homeostasis;|Q6IQ20 Q5CZ87 Q769K1,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D {ECO:0000303|PubMed:25684574},, PF12706;, GO:0005737;GO:0005769;GO:0031901;GO:0070062;GO:0005794;GO:0000139;GO:0043227;GO:0005635;GO:0005654;GO:0042622;GO:0032052;GO:0042802;GO:0102200;GO:0070290;GO:0008270;GO:0007568;GO:0048874;GO:0070291;GO:0070292;GO:1903999;GO:0009395;GO:0090336;GO:0050729;GO:0035900;GO:0001523;GO:0001659;, C:cytoplasm; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:membrane-bounded organelle; C:nuclear envelope; C:nucleoplasm; C:photoreceptor outer segment membrane;, F:bile acid binding; F:identical protein binding; F:N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity; F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:zinc ion binding;, P:aging; P:host-mediated regulation of intestinal microbiota composition; P:N-acylethanolamine metabolic process; P:N-acylphosphatidylethanolamine metabolic process; P:negative regulation of eating behavior; P:phospholipid catabolic process; P:positive regulation of brown fat cell differentiation; P:positive regulation of inflammatory response; P:response to isolation stress; P:retinoid metabolic process; P:temperature homeostasis;|Q6IQ20 Q5CZ87 Q769K1,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D {ECO:0000303|PubMed:25684574},, PF12706;, GO:0005737;GO:0005769;GO:0031901;GO:0070062;GO:0005794;GO:0000139;GO:0043227;GO:0005635;GO:0005654;GO:0042622;GO:0032052;GO:0042802;GO:0102200;GO:0070290;GO:0008270;GO:0007568;GO:0048874;GO:0070291;GO:0070292;GO:1903999;GO:0009395;GO:0090336;GO:0050729;GO:0035900;GO:0001523;GO:0001659;, C:cytoplasm; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:membrane-bounded organelle; C:nuclear envelope; C:nucleoplasm; C:photoreceptor outer segment membrane;, F:bile acid binding; F:identical protein binding; F:N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity; F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:zinc ion binding;, P:aging; P:host-mediated regulation of intestinal microbiota composition; P:N-acylethanolamine metabolic process; P:N-acylphosphatidylethanolamine metabolic process; P:negative regulation of eating behavior; P:phospholipid catabolic process; P:positive regulation of brown fat cell differentiation; P:positive regulation of inflammatory response; P:response to isolation stress; P:retinoid metabolic process; P:temperature homeostasis; scaffold8 indexed_genome mRNA 11192274 11194781 . - . ID=transcript_2101;Q9BVJ6 A8K7A3 A8MVQ1 B4DQ08 E9PEL7 Q5JYF1,U3 small nucleolar RNA-associated protein 14 homolog A,Antigen NY-CO-16;Serologically defined colon cancer antigen 16;, , GO:0005829;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:cytosol; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing; scaffold8 indexed_genome mRNA 11209348 11257319 . + . ID=transcript_2102;O75439 O60416 Q96FV4,Mitochondrial-processing peptidase subunit beta,Beta-MPP;P-52;, PF00675;PF05193;, GO:0005743;GO:0017087;GO:0005739;GO:0046872;GO:0004222;GO:0006851;GO:0006627;, C:mitochondrial inner membrane; C:mitochondrial processing peptidase complex; C:mitochondrion;, F:metal ion binding; F:metalloendopeptidase activity;, P:mitochondrial calcium ion transmembrane transport; P:protein processing involved in protein targeting to mitochondrion;|O75439 O60416 Q96FV4,Mitochondrial-processing peptidase subunit beta,Beta-MPP;P-52;, PF00675;PF05193;, GO:0005743;GO:0017087;GO:0005739;GO:0046872;GO:0004222;GO:0006851;GO:0006627;, C:mitochondrial inner membrane; C:mitochondrial processing peptidase complex; C:mitochondrion;, F:metal ion binding; F:metalloendopeptidase activity;, P:mitochondrial calcium ion transmembrane transport; P:protein processing involved in protein targeting to mitochondrion;|O75439 O60416 Q96FV4,Mitochondrial-processing peptidase subunit beta,Beta-MPP;P-52;, PF00675;PF05193;, GO:0005743;GO:0017087;GO:0005739;GO:0046872;GO:0004222;GO:0006851;GO:0006627;, C:mitochondrial inner membrane; C:mitochondrial processing peptidase complex; C:mitochondrion;, F:metal ion binding; F:metalloendopeptidase activity;, P:mitochondrial calcium ion transmembrane transport; P:protein processing involved in protein targeting to mitochondrion;|Q99543 A4VCI0 Q9BVX1,DnaJ homolog subfamily C member 2,M-phase phosphoprotein 11;Zuotin-related factor 1;, PF00226;PF00249;PF16717;, GO:0005737;GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0030544;GO:0003723;GO:0061649;GO:0051083;GO:0006325;GO:0006260;GO:2000279;GO:0045893;GO:1900034;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:Hsp70 protein binding; F:RNA binding; F:ubiquitin modification-dependent histone binding;, P:'de novo' cotranslational protein folding; P:chromatin organization; P:DNA replication; P:negative regulation of DNA biosynthetic process; P:positive regulation of transcription, DNA-templated; P:regulation of cellular response to heat;|Q99543 A4VCI0 Q9BVX1,DnaJ homolog subfamily C member 2,M-phase phosphoprotein 11;Zuotin-related factor 1;, PF00226;PF00249;PF16717;, GO:0005737;GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0030544;GO:0003723;GO:0061649;GO:0051083;GO:0006325;GO:0006260;GO:2000279;GO:0045893;GO:1900034;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:Hsp70 protein binding; F:RNA binding; F:ubiquitin modification-dependent histone binding;, P:'de novo' cotranslational protein folding; P:chromatin organization; P:DNA replication; P:negative regulation of DNA biosynthetic process; P:positive regulation of transcription, DNA-templated; P:regulation of cellular response to heat;|Q99543 A4VCI0 Q9BVX1,DnaJ homolog subfamily C member 2,M-phase phosphoprotein 11;Zuotin-related factor 1;, PF00226;PF00249;PF16717;, GO:0005737;GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0030544;GO:0003723;GO:0061649;GO:0051083;GO:0006325;GO:0006260;GO:2000279;GO:0045893;GO:1900034;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:Hsp70 protein binding; F:RNA binding; F:ubiquitin modification-dependent histone binding;, P:'de novo' cotranslational protein folding; P:chromatin organization; P:DNA replication; P:negative regulation of DNA biosynthetic process; P:positive regulation of transcription, DNA-templated; P:regulation of cellular response to heat;|Q99543 A4VCI0 Q9BVX1,DnaJ homolog subfamily C member 2,M-phase phosphoprotein 11;Zuotin-related factor 1;, PF00226;PF00249;PF16717;, GO:0005737;GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0030544;GO:0003723;GO:0061649;GO:0051083;GO:0006325;GO:0006260;GO:2000279;GO:0045893;GO:1900034;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:Hsp70 protein binding; F:RNA binding; F:ubiquitin modification-dependent histone binding;, P:'de novo' cotranslational protein folding; P:chromatin organization; P:DNA replication; P:negative regulation of DNA biosynthetic process; P:positive regulation of transcription, DNA-templated; P:regulation of cellular response to heat;|Q99543 A4VCI0 Q9BVX1,DnaJ homolog subfamily C member 2,M-phase phosphoprotein 11;Zuotin-related factor 1;, PF00226;PF00249;PF16717;, GO:0005737;GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0030544;GO:0003723;GO:0061649;GO:0051083;GO:0006325;GO:0006260;GO:2000279;GO:0045893;GO:1900034;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:Hsp70 protein binding; F:RNA binding; F:ubiquitin modification-dependent histone binding;, P:'de novo' cotranslational protein folding; P:chromatin organization; P:DNA replication; P:negative regulation of DNA biosynthetic process; P:positive regulation of transcription, DNA-templated; P:regulation of cellular response to heat;|Q99543 A4VCI0 Q9BVX1,DnaJ homolog subfamily C member 2,M-phase phosphoprotein 11;Zuotin-related factor 1;, PF00226;PF00249;PF16717;, GO:0005737;GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0030544;GO:0003723;GO:0061649;GO:0051083;GO:0006325;GO:0006260;GO:2000279;GO:0045893;GO:1900034;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:Hsp70 protein binding; F:RNA binding; F:ubiquitin modification-dependent histone binding;, P:'de novo' cotranslational protein folding; P:chromatin organization; P:DNA replication; P:negative regulation of DNA biosynthetic process; P:positive regulation of transcription, DNA-templated; P:regulation of cellular response to heat;|Q99543 A4VCI0 Q9BVX1,DnaJ homolog subfamily C member 2,M-phase phosphoprotein 11;Zuotin-related factor 1;, PF00226;PF00249;PF16717;, GO:0005737;GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0030544;GO:0003723;GO:0061649;GO:0051083;GO:0006325;GO:0006260;GO:2000279;GO:0045893;GO:1900034;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:Hsp70 protein binding; F:RNA binding; F:ubiquitin modification-dependent histone binding;, P:'de novo' cotranslational protein folding; P:chromatin organization; P:DNA replication; P:negative regulation of DNA biosynthetic process; P:positive regulation of transcription, DNA-templated; P:regulation of cellular response to heat;|Q9GZP9 Q9Y3A7,Derlin-2 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 2;Der1-like protein 2 {ECO:0000303|PubMed:15215855};F-LAN-1 {ECO:0000312|EMBL:AAG43049.1};F-LANa {ECO:0000303|PubMed:11500051};, PF04511;, GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0005770;GO:0016020;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:1904380;GO:0030968;GO:1904153;GO:0030307;GO:0008284;GO:0030970;GO:0001967;GO:0030433;GO:0016032;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:late endosome; C:membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:retrograde protein transport, ER to cytosol; P:suckling behavior; P:ubiquitin-dependent ERAD pathway; P:viral process; scaffold8 indexed_genome mRNA 11258124 11271034 . + . ID=transcript_2103;P35998 A4D0Q1 B7Z5E2 Q3LIA5 Q9UDI3,26S proteasome regulatory subunit 7,26S proteasome AAA-ATPase subunit RPT1;Proteasome 26S subunit ATPase 2;Protein MSS1;, PF00004;PF17862;, GO:0005737;GO:0036464;GO:0005829;GO:0043197;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0022624;GO:0000502;GO:0008540;GO:0034774;GO:0005524;GO:0016887;GO:0036402;GO:0017025;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0001649;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic spine; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:TBP-class protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:osteoblast differentiation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P35998 A4D0Q1 B7Z5E2 Q3LIA5 Q9UDI3,26S proteasome regulatory subunit 7,26S proteasome AAA-ATPase subunit RPT1;Proteasome 26S subunit ATPase 2;Protein MSS1;, PF00004;PF17862;, GO:0005737;GO:0036464;GO:0005829;GO:0043197;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0022624;GO:0000502;GO:0008540;GO:0034774;GO:0005524;GO:0016887;GO:0036402;GO:0017025;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0001649;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic spine; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:TBP-class protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:osteoblast differentiation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P35998 A4D0Q1 B7Z5E2 Q3LIA5 Q9UDI3,26S proteasome regulatory subunit 7,26S proteasome AAA-ATPase subunit RPT1;Proteasome 26S subunit ATPase 2;Protein MSS1;, PF00004;PF17862;, GO:0005737;GO:0036464;GO:0005829;GO:0043197;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0022624;GO:0000502;GO:0008540;GO:0034774;GO:0005524;GO:0016887;GO:0036402;GO:0017025;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0001649;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic spine; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:TBP-class protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:osteoblast differentiation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P35998 A4D0Q1 B7Z5E2 Q3LIA5 Q9UDI3,26S proteasome regulatory subunit 7,26S proteasome AAA-ATPase subunit RPT1;Proteasome 26S subunit ATPase 2;Protein MSS1;, PF00004;PF17862;, GO:0005737;GO:0036464;GO:0005829;GO:0043197;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0022624;GO:0000502;GO:0008540;GO:0034774;GO:0005524;GO:0016887;GO:0036402;GO:0017025;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0001649;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic spine; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:TBP-class protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:osteoblast differentiation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P35998 A4D0Q1 B7Z5E2 Q3LIA5 Q9UDI3,26S proteasome regulatory subunit 7,26S proteasome AAA-ATPase subunit RPT1;Proteasome 26S subunit ATPase 2;Protein MSS1;, PF00004;PF17862;, GO:0005737;GO:0036464;GO:0005829;GO:0043197;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0022624;GO:0000502;GO:0008540;GO:0034774;GO:0005524;GO:0016887;GO:0036402;GO:0017025;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0001649;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic spine; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:TBP-class protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:osteoblast differentiation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P35998 A4D0Q1 B7Z5E2 Q3LIA5 Q9UDI3,26S proteasome regulatory subunit 7,26S proteasome AAA-ATPase subunit RPT1;Proteasome 26S subunit ATPase 2;Protein MSS1;, PF00004;PF17862;, GO:0005737;GO:0036464;GO:0005829;GO:0043197;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0022624;GO:0000502;GO:0008540;GO:0034774;GO:0005524;GO:0016887;GO:0036402;GO:0017025;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0001649;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic spine; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:TBP-class protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:osteoblast differentiation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold8 indexed_genome mRNA 11344367 11351413 . + . ID=transcript_2104;P78509 A4D0P9 A4D0Q0 Q86UJ0 Q86UJ8 Q8NDV0 Q9UDQ2,Reelin,, PF18720;PF02014;, GO:0005737;GO:0030425;GO:0005576;GO:0005615;GO:0043005;GO:0070325;GO:0046872;GO:0008236;GO:0070326;GO:0007411;GO:0007420;GO:0007155;GO:0000904;GO:0007417;GO:0021800;GO:0010001;GO:0021766;GO:0050804;GO:0001764;GO:0018108;GO:2000969;GO:0032793;GO:0061003;GO:2000463;GO:1900273;GO:0010976;GO:0050731;GO:0045860;GO:0061098;GO:0051057;GO:0090129;GO:0051968;GO:0038026;GO:0050795;GO:2000310;GO:0048265;GO:0021511;, C:cytoplasm; C:dendrite; C:extracellular region; C:extracellular space; C:neuron projection;, F:lipoprotein particle receptor binding; F:metal ion binding; F:serine-type peptidase activity; F:very-low-density lipoprotein particle receptor binding;, P:axon guidance; P:brain development; P:cell adhesion; P:cell morphogenesis involved in differentiation; P:central nervous system development; P:cerebral cortex tangential migration; P:glial cell differentiation; P:hippocampus development; P:modulation of chemical synaptic transmission; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:positive regulation of AMPA receptor activity; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of long-term synaptic potentiation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of synapse maturation; P:positive regulation of synaptic transmission, glutamatergic; P:reelin-mediated signaling pathway; P:regulation of behavior; P:regulation of NMDA receptor activity; P:response to pain; P:spinal cord patterning; scaffold8 indexed_genome mRNA 11355386 11365024 . - . ID=transcript_2105;P78509 A4D0P9 A4D0Q0 Q86UJ0 Q86UJ8 Q8NDV0 Q9UDQ2,Reelin,, PF18720;PF02014;, GO:0005737;GO:0030425;GO:0005576;GO:0005615;GO:0043005;GO:0070325;GO:0046872;GO:0008236;GO:0070326;GO:0007411;GO:0007420;GO:0007155;GO:0000904;GO:0007417;GO:0021800;GO:0010001;GO:0021766;GO:0050804;GO:0001764;GO:0018108;GO:2000969;GO:0032793;GO:0061003;GO:2000463;GO:1900273;GO:0010976;GO:0050731;GO:0045860;GO:0061098;GO:0051057;GO:0090129;GO:0051968;GO:0038026;GO:0050795;GO:2000310;GO:0048265;GO:0021511;, C:cytoplasm; C:dendrite; C:extracellular region; C:extracellular space; C:neuron projection;, F:lipoprotein particle receptor binding; F:metal ion binding; F:serine-type peptidase activity; F:very-low-density lipoprotein particle receptor binding;, P:axon guidance; P:brain development; P:cell adhesion; P:cell morphogenesis involved in differentiation; P:central nervous system development; P:cerebral cortex tangential migration; P:glial cell differentiation; P:hippocampus development; P:modulation of chemical synaptic transmission; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:positive regulation of AMPA receptor activity; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of long-term synaptic potentiation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of synapse maturation; P:positive regulation of synaptic transmission, glutamatergic; P:reelin-mediated signaling pathway; P:regulation of behavior; P:regulation of NMDA receptor activity; P:response to pain; P:spinal cord patterning; scaffold8 indexed_genome mRNA 11367160 11632048 . - . ID=transcript_2106;P78509 A4D0P9 A4D0Q0 Q86UJ0 Q86UJ8 Q8NDV0 Q9UDQ2,Reelin,, PF18720;PF02014;, GO:0005737;GO:0030425;GO:0005576;GO:0005615;GO:0043005;GO:0070325;GO:0046872;GO:0008236;GO:0070326;GO:0007411;GO:0007420;GO:0007155;GO:0000904;GO:0007417;GO:0021800;GO:0010001;GO:0021766;GO:0050804;GO:0001764;GO:0018108;GO:2000969;GO:0032793;GO:0061003;GO:2000463;GO:1900273;GO:0010976;GO:0050731;GO:0045860;GO:0061098;GO:0051057;GO:0090129;GO:0051968;GO:0038026;GO:0050795;GO:2000310;GO:0048265;GO:0021511;, C:cytoplasm; C:dendrite; C:extracellular region; C:extracellular space; C:neuron projection;, F:lipoprotein particle receptor binding; F:metal ion binding; F:serine-type peptidase activity; F:very-low-density lipoprotein particle receptor binding;, P:axon guidance; P:brain development; P:cell adhesion; P:cell morphogenesis involved in differentiation; P:central nervous system development; P:cerebral cortex tangential migration; P:glial cell differentiation; P:hippocampus development; P:modulation of chemical synaptic transmission; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:positive regulation of AMPA receptor activity; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of long-term synaptic potentiation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of synapse maturation; P:positive regulation of synaptic transmission, glutamatergic; P:reelin-mediated signaling pathway; P:regulation of behavior; P:regulation of NMDA receptor activity; P:response to pain; P:spinal cord patterning; scaffold8 indexed_genome mRNA 11889007 11890770 . + . ID=transcript_2107;P18124 A8K504 Q15289 Q3KQU0 Q5I0X1 Q6IBM9,60S ribosomal protein L7,Large ribosomal subunit protein uL30 {ECO:0000303|PubMed:24524803};, PF00327;PF08079;, GO:0005737;GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:0014069;GO:1990904;GO:0003677;GO:0042802;GO:0003729;GO:0003723;GO:0003735;GO:0000463;GO:0000184;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:postsynaptic density; C:ribonucleoprotein complex;, F:DNA binding; F:identical protein binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold8 indexed_genome mRNA 12017898 12087850 . + . ID=transcript_2108;O43913 A4D0P8 O60590 O95268,Origin recognition complex subunit 5,, PF13191;PF14630;, GO:0000785;GO:0000781;GO:0005829;GO:0005664;GO:0005654;GO:0005634;GO:0000808;GO:0005524;GO:0003688;GO:0000166;GO:0006260;GO:0006270;GO:0036388;GO:0006275;, C:chromatin; C:chromosome, telomeric region; C:cytosol; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:ATP binding; F:DNA replication origin binding; F:nucleotide binding;, P:DNA replication; P:DNA replication initiation; P:pre-replicative complex assembly; P:regulation of DNA replication;|O43913 A4D0P8 O60590 O95268,Origin recognition complex subunit 5,, PF13191;PF14630;, GO:0000785;GO:0000781;GO:0005829;GO:0005664;GO:0005654;GO:0005634;GO:0000808;GO:0005524;GO:0003688;GO:0000166;GO:0006260;GO:0006270;GO:0036388;GO:0006275;, C:chromatin; C:chromosome, telomeric region; C:cytosol; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:ATP binding; F:DNA replication origin binding; F:nucleotide binding;, P:DNA replication; P:DNA replication initiation; P:pre-replicative complex assembly; P:regulation of DNA replication; scaffold8 indexed_genome mRNA 12743953 12746277 . + . ID=transcript_2109;Q86UP9 A1L383 A4D0Q5,LHFPL tetraspan subfamily member 3 protein {ECO:0000312|HGNC:HGNC:6589},Lipoma HMGIC fusion partner-like 3 protein {ECO:0000312|HGNC:HGNC:6589};, PF10242;, GO:0016021;GO:0016020;GO:0005886;GO:0007605;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:sensory perception of sound; scaffold8 indexed_genome mRNA 12869935 12870667 . + . ID=transcript_2110;Q86WG0 Q86WL2 Q8IV78 Q8IWR5 Q8NFF8 Q9NWE7,Inactive histone-lysine N-methyltransferase 2E {ECO:0000305},Myeloid/lymphoid or mixed-lineage leukemia protein 5;, PF00628;PF00856;, GO:0000785;GO:0005737;GO:0005815;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0035327;GO:0019899;GO:0046872;GO:0035064;GO:0007050;GO:0006306;GO:0030218;GO:0034968;GO:0042119;GO:0002446;GO:1900087;GO:1905437;GO:0045893;GO:0045652;, C:chromatin; C:cytoplasm; C:microtubule organizing center; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:transcriptionally active chromatin;, F:enzyme binding; F:metal ion binding; F:methylated histone binding;, P:cell cycle arrest; P:DNA methylation; P:erythrocyte differentiation; P:histone lysine methylation; P:neutrophil activation; P:neutrophil mediated immunity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of histone H3-K4 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation; scaffold8 indexed_genome mRNA 12897453 12900425 . + . ID=transcript_2111;Q86WG0 Q86WL2 Q8IV78 Q8IWR5 Q8NFF8 Q9NWE7,Inactive histone-lysine N-methyltransferase 2E {ECO:0000305},Myeloid/lymphoid or mixed-lineage leukemia protein 5;, PF00628;PF00856;, GO:0000785;GO:0005737;GO:0005815;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0035327;GO:0019899;GO:0046872;GO:0035064;GO:0007050;GO:0006306;GO:0030218;GO:0034968;GO:0042119;GO:0002446;GO:1900087;GO:1905437;GO:0045893;GO:0045652;, C:chromatin; C:cytoplasm; C:microtubule organizing center; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:transcriptionally active chromatin;, F:enzyme binding; F:metal ion binding; F:methylated histone binding;, P:cell cycle arrest; P:DNA methylation; P:erythrocyte differentiation; P:histone lysine methylation; P:neutrophil activation; P:neutrophil mediated immunity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of histone H3-K4 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation; scaffold8 indexed_genome mRNA 12911943 13069172 . + . ID=transcript_2112;Q86WG0 Q86WL2 Q8IV78 Q8IWR5 Q8NFF8 Q9NWE7,Inactive histone-lysine N-methyltransferase 2E {ECO:0000305},Myeloid/lymphoid or mixed-lineage leukemia protein 5;, PF00628;PF00856;, GO:0000785;GO:0005737;GO:0005815;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0035327;GO:0019899;GO:0046872;GO:0035064;GO:0007050;GO:0006306;GO:0030218;GO:0034968;GO:0042119;GO:0002446;GO:1900087;GO:1905437;GO:0045893;GO:0045652;, C:chromatin; C:cytoplasm; C:microtubule organizing center; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:transcriptionally active chromatin;, F:enzyme binding; F:metal ion binding; F:methylated histone binding;, P:cell cycle arrest; P:DNA methylation; P:erythrocyte differentiation; P:histone lysine methylation; P:neutrophil activation; P:neutrophil mediated immunity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of histone H3-K4 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q86WG0 Q86WL2 Q8IV78 Q8IWR5 Q8NFF8 Q9NWE7,Inactive histone-lysine N-methyltransferase 2E {ECO:0000305},Myeloid/lymphoid or mixed-lineage leukemia protein 5;, PF00628;PF00856;, GO:0000785;GO:0005737;GO:0005815;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0035327;GO:0019899;GO:0046872;GO:0035064;GO:0007050;GO:0006306;GO:0030218;GO:0034968;GO:0042119;GO:0002446;GO:1900087;GO:1905437;GO:0045893;GO:0045652;, C:chromatin; C:cytoplasm; C:microtubule organizing center; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:transcriptionally active chromatin;, F:enzyme binding; F:metal ion binding; F:methylated histone binding;, P:cell cycle arrest; P:DNA methylation; P:erythrocyte differentiation; P:histone lysine methylation; P:neutrophil activation; P:neutrophil mediated immunity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of histone H3-K4 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q86WG0 Q86WL2 Q8IV78 Q8IWR5 Q8NFF8 Q9NWE7,Inactive histone-lysine N-methyltransferase 2E {ECO:0000305},Myeloid/lymphoid or mixed-lineage leukemia protein 5;, PF00628;PF00856;, GO:0000785;GO:0005737;GO:0005815;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0035327;GO:0019899;GO:0046872;GO:0035064;GO:0007050;GO:0006306;GO:0030218;GO:0034968;GO:0042119;GO:0002446;GO:1900087;GO:1905437;GO:0045893;GO:0045652;, C:chromatin; C:cytoplasm; C:microtubule organizing center; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:transcriptionally active chromatin;, F:enzyme binding; F:metal ion binding; F:methylated histone binding;, P:cell cycle arrest; P:DNA methylation; P:erythrocyte differentiation; P:histone lysine methylation; P:neutrophil activation; P:neutrophil mediated immunity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of histone H3-K4 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q86WG0 Q86WL2 Q8IV78 Q8IWR5 Q8NFF8 Q9NWE7,Inactive histone-lysine N-methyltransferase 2E {ECO:0000305},Myeloid/lymphoid or mixed-lineage leukemia protein 5;, PF00628;PF00856;, GO:0000785;GO:0005737;GO:0005815;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0035327;GO:0019899;GO:0046872;GO:0035064;GO:0007050;GO:0006306;GO:0030218;GO:0034968;GO:0042119;GO:0002446;GO:1900087;GO:1905437;GO:0045893;GO:0045652;, C:chromatin; C:cytoplasm; C:microtubule organizing center; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:transcriptionally active chromatin;, F:enzyme binding; F:metal ion binding; F:methylated histone binding;, P:cell cycle arrest; P:DNA methylation; P:erythrocyte differentiation; P:histone lysine methylation; P:neutrophil activation; P:neutrophil mediated immunity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of histone H3-K4 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q86WG0 Q86WL2 Q8IV78 Q8IWR5 Q8NFF8 Q9NWE7,Inactive histone-lysine N-methyltransferase 2E {ECO:0000305},Myeloid/lymphoid or mixed-lineage leukemia protein 5;, PF00628;PF00856;, GO:0000785;GO:0005737;GO:0005815;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0035327;GO:0019899;GO:0046872;GO:0035064;GO:0007050;GO:0006306;GO:0030218;GO:0034968;GO:0042119;GO:0002446;GO:1900087;GO:1905437;GO:0045893;GO:0045652;, C:chromatin; C:cytoplasm; C:microtubule organizing center; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:transcriptionally active chromatin;, F:enzyme binding; F:metal ion binding; F:methylated histone binding;, P:cell cycle arrest; P:DNA methylation; P:erythrocyte differentiation; P:histone lysine methylation; P:neutrophil activation; P:neutrophil mediated immunity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of histone H3-K4 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q86WG0 Q86WL2 Q8IV78 Q8IWR5 Q8NFF8 Q9NWE7,Inactive histone-lysine N-methyltransferase 2E {ECO:0000305},Myeloid/lymphoid or mixed-lineage leukemia protein 5;, PF00628;PF00856;, GO:0000785;GO:0005737;GO:0005815;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0035327;GO:0019899;GO:0046872;GO:0035064;GO:0007050;GO:0006306;GO:0030218;GO:0034968;GO:0042119;GO:0002446;GO:1900087;GO:1905437;GO:0045893;GO:0045652;, C:chromatin; C:cytoplasm; C:microtubule organizing center; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:transcriptionally active chromatin;, F:enzyme binding; F:metal ion binding; F:methylated histone binding;, P:cell cycle arrest; P:DNA methylation; P:erythrocyte differentiation; P:histone lysine methylation; P:neutrophil activation; P:neutrophil mediated immunity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of histone H3-K4 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q86WG0 Q86WL2 Q8IV78 Q8IWR5 Q8NFF8 Q9NWE7,Inactive histone-lysine N-methyltransferase 2E {ECO:0000305},Myeloid/lymphoid or mixed-lineage leukemia protein 5;, PF00628;PF00856;, GO:0000785;GO:0005737;GO:0005815;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0035327;GO:0019899;GO:0046872;GO:0035064;GO:0007050;GO:0006306;GO:0030218;GO:0034968;GO:0042119;GO:0002446;GO:1900087;GO:1905437;GO:0045893;GO:0045652;, C:chromatin; C:cytoplasm; C:microtubule organizing center; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:transcriptionally active chromatin;, F:enzyme binding; F:metal ion binding; F:methylated histone binding;, P:cell cycle arrest; P:DNA methylation; P:erythrocyte differentiation; P:histone lysine methylation; P:neutrophil activation; P:neutrophil mediated immunity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of histone H3-K4 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|P78362 A8MVX2 O75220 O75221 Q6NUL0 Q6V1X2 Q8IYQ3,SRSF protein kinase 2,SFRS protein kinase 2;Serine/arginine-rich protein-specific kinase 2;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0071889;GO:0005524;GO:0000287;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0001525;GO:0030154;GO:0045087;GO:0035556;GO:0045071;GO:0035063;GO:0018105;GO:0045787;GO:0008284;GO:0010628;GO:0043525;GO:0045070;GO:0006468;GO:0062176;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0000245;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:nuclear speck organization; P:peptidyl-serine phosphorylation; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of neuron apoptotic process; P:positive regulation of viral genome replication; P:protein phosphorylation; P:R-loop disassembly; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly;|Q96SB4 B4DS61 Q12890 Q5R364 Q5R365 Q8IY12,SRSF protein kinase 1,SFRS protein kinase 1;Serine/arginine-rich protein-specific kinase 1;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0007059;GO:0045087;GO:0035556;GO:0045071;GO:0045070;GO:0006468;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0035092;GO:0000245;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:chromosome segregation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:sperm chromatin condensation; P:spliceosomal complex assembly; P:viral process;|P78362 A8MVX2 O75220 O75221 Q6NUL0 Q6V1X2 Q8IYQ3,SRSF protein kinase 2,SFRS protein kinase 2;Serine/arginine-rich protein-specific kinase 2;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0071889;GO:0005524;GO:0000287;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0001525;GO:0030154;GO:0045087;GO:0035556;GO:0045071;GO:0035063;GO:0018105;GO:0045787;GO:0008284;GO:0010628;GO:0043525;GO:0045070;GO:0006468;GO:0062176;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0000245;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:nuclear speck organization; P:peptidyl-serine phosphorylation; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of neuron apoptotic process; P:positive regulation of viral genome replication; P:protein phosphorylation; P:R-loop disassembly; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly;|Q9UPE1 Q13583 Q4F970 Q562F5 Q9UM62,SRSF protein kinase 3,Muscle-specific serine kinase 1;Serine/arginine-rich protein-specific kinase 3;Serine/threonine-protein kinase 23;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0030154;GO:0035556;GO:0007517;GO:0060537;GO:0010468;GO:0050684;GO:0000245;, C:cytoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:intracellular signal transduction; P:muscle organ development; P:muscle tissue development; P:regulation of gene expression; P:regulation of mRNA processing; P:spliceosomal complex assembly;|P78362 A8MVX2 O75220 O75221 Q6NUL0 Q6V1X2 Q8IYQ3,SRSF protein kinase 2,SFRS protein kinase 2;Serine/arginine-rich protein-specific kinase 2;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0071889;GO:0005524;GO:0000287;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0001525;GO:0030154;GO:0045087;GO:0035556;GO:0045071;GO:0035063;GO:0018105;GO:0045787;GO:0008284;GO:0010628;GO:0043525;GO:0045070;GO:0006468;GO:0062176;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0000245;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:nuclear speck organization; P:peptidyl-serine phosphorylation; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of neuron apoptotic process; P:positive regulation of viral genome replication; P:protein phosphorylation; P:R-loop disassembly; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly;|P78362 A8MVX2 O75220 O75221 Q6NUL0 Q6V1X2 Q8IYQ3,SRSF protein kinase 2,SFRS protein kinase 2;Serine/arginine-rich protein-specific kinase 2;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0071889;GO:0005524;GO:0000287;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0001525;GO:0030154;GO:0045087;GO:0035556;GO:0045071;GO:0035063;GO:0018105;GO:0045787;GO:0008284;GO:0010628;GO:0043525;GO:0045070;GO:0006468;GO:0062176;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0000245;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:nuclear speck organization; P:peptidyl-serine phosphorylation; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of neuron apoptotic process; P:positive regulation of viral genome replication; P:protein phosphorylation; P:R-loop disassembly; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly;|P78362 A8MVX2 O75220 O75221 Q6NUL0 Q6V1X2 Q8IYQ3,SRSF protein kinase 2,SFRS protein kinase 2;Serine/arginine-rich protein-specific kinase 2;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0071889;GO:0005524;GO:0000287;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0001525;GO:0030154;GO:0045087;GO:0035556;GO:0045071;GO:0035063;GO:0018105;GO:0045787;GO:0008284;GO:0010628;GO:0043525;GO:0045070;GO:0006468;GO:0062176;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0000245;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:nuclear speck organization; P:peptidyl-serine phosphorylation; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of neuron apoptotic process; P:positive regulation of viral genome replication; P:protein phosphorylation; P:R-loop disassembly; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly;|P78362 A8MVX2 O75220 O75221 Q6NUL0 Q6V1X2 Q8IYQ3,SRSF protein kinase 2,SFRS protein kinase 2;Serine/arginine-rich protein-specific kinase 2;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0071889;GO:0005524;GO:0000287;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0001525;GO:0030154;GO:0045087;GO:0035556;GO:0045071;GO:0035063;GO:0018105;GO:0045787;GO:0008284;GO:0010628;GO:0043525;GO:0045070;GO:0006468;GO:0062176;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0000245;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:nuclear speck organization; P:peptidyl-serine phosphorylation; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of neuron apoptotic process; P:positive regulation of viral genome replication; P:protein phosphorylation; P:R-loop disassembly; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly; scaffold8 indexed_genome mRNA 13211604 13215443 . - . ID=transcript_2113;Q96PZ0 Q75MG4 Q9NX19,Pseudouridylate synthase 7 homolog {ECO:0000305},, PF01142;, GO:0005634;GO:0019899;GO:0009982;GO:0003723;GO:1990481;GO:0017148;GO:0001522;GO:1902036;GO:2000380;GO:0031119;, C:nucleus;, F:enzyme binding; F:pseudouridine synthase activity; F:RNA binding;, P:mRNA pseudouridine synthesis; P:negative regulation of translation; P:pseudouridine synthesis; P:regulation of hematopoietic stem cell differentiation; P:regulation of mesoderm development; P:tRNA pseudouridine synthesis; scaffold8 indexed_genome mRNA 13216529 13263413 . - . ID=transcript_2114;Q96PZ0 Q75MG4 Q9NX19,Pseudouridylate synthase 7 homolog {ECO:0000305},, PF01142;, GO:0005634;GO:0019899;GO:0009982;GO:0003723;GO:1990481;GO:0017148;GO:0001522;GO:1902036;GO:2000380;GO:0031119;, C:nucleus;, F:enzyme binding; F:pseudouridine synthase activity; F:RNA binding;, P:mRNA pseudouridine synthesis; P:negative regulation of translation; P:pseudouridine synthesis; P:regulation of hematopoietic stem cell differentiation; P:regulation of mesoderm development; P:tRNA pseudouridine synthesis;|Q96PZ0 Q75MG4 Q9NX19,Pseudouridylate synthase 7 homolog {ECO:0000305},, PF01142;, GO:0005634;GO:0019899;GO:0009982;GO:0003723;GO:1990481;GO:0017148;GO:0001522;GO:1902036;GO:2000380;GO:0031119;, C:nucleus;, F:enzyme binding; F:pseudouridine synthase activity; F:RNA binding;, P:mRNA pseudouridine synthesis; P:negative regulation of translation; P:pseudouridine synthesis; P:regulation of hematopoietic stem cell differentiation; P:regulation of mesoderm development; P:tRNA pseudouridine synthesis;|Q96PZ0 Q75MG4 Q9NX19,Pseudouridylate synthase 7 homolog {ECO:0000305},, PF01142;, GO:0005634;GO:0019899;GO:0009982;GO:0003723;GO:1990481;GO:0017148;GO:0001522;GO:1902036;GO:2000380;GO:0031119;, C:nucleus;, F:enzyme binding; F:pseudouridine synthase activity; F:RNA binding;, P:mRNA pseudouridine synthesis; P:negative regulation of translation; P:pseudouridine synthesis; P:regulation of hematopoietic stem cell differentiation; P:regulation of mesoderm development; P:tRNA pseudouridine synthesis;|Q96PZ0 Q75MG4 Q9NX19,Pseudouridylate synthase 7 homolog {ECO:0000305},, PF01142;, GO:0005634;GO:0019899;GO:0009982;GO:0003723;GO:1990481;GO:0017148;GO:0001522;GO:1902036;GO:2000380;GO:0031119;, C:nucleus;, F:enzyme binding; F:pseudouridine synthase activity; F:RNA binding;, P:mRNA pseudouridine synthesis; P:negative regulation of translation; P:pseudouridine synthesis; P:regulation of hematopoietic stem cell differentiation; P:regulation of mesoderm development; P:tRNA pseudouridine synthesis;|Q96PZ0 Q75MG4 Q9NX19,Pseudouridylate synthase 7 homolog {ECO:0000305},, PF01142;, GO:0005634;GO:0019899;GO:0009982;GO:0003723;GO:1990481;GO:0017148;GO:0001522;GO:1902036;GO:2000380;GO:0031119;, C:nucleus;, F:enzyme binding; F:pseudouridine synthase activity; F:RNA binding;, P:mRNA pseudouridine synthesis; P:negative regulation of translation; P:pseudouridine synthesis; P:regulation of hematopoietic stem cell differentiation; P:regulation of mesoderm development; P:tRNA pseudouridine synthesis;|Q96PZ0 Q75MG4 Q9NX19,Pseudouridylate synthase 7 homolog {ECO:0000305},, PF01142;, GO:0005634;GO:0019899;GO:0009982;GO:0003723;GO:1990481;GO:0017148;GO:0001522;GO:1902036;GO:2000380;GO:0031119;, C:nucleus;, F:enzyme binding; F:pseudouridine synthase activity; F:RNA binding;, P:mRNA pseudouridine synthesis; P:negative regulation of translation; P:pseudouridine synthesis; P:regulation of hematopoietic stem cell differentiation; P:regulation of mesoderm development; P:tRNA pseudouridine synthesis;|Q96PZ0 Q75MG4 Q9NX19,Pseudouridylate synthase 7 homolog {ECO:0000305},, PF01142;, GO:0005634;GO:0019899;GO:0009982;GO:0003723;GO:1990481;GO:0017148;GO:0001522;GO:1902036;GO:2000380;GO:0031119;, C:nucleus;, F:enzyme binding; F:pseudouridine synthase activity; F:RNA binding;, P:mRNA pseudouridine synthesis; P:negative regulation of translation; P:pseudouridine synthesis; P:regulation of hematopoietic stem cell differentiation; P:regulation of mesoderm development; P:tRNA pseudouridine synthesis; scaffold8 indexed_genome mRNA 13268396 13294840 . + . ID=transcript_2115;Q6NUQ1 Q75MG9 Q75MH0 Q96IW8 Q9H229 Q9HAD9,RAD50-interacting protein 1,RAD50 interactor 1;, PF04437;, GO:0005829;GO:0070939;GO:0005783;GO:0005789;GO:0007049;GO:0015031;GO:0060628;GO:1902504;GO:0006890;, C:cytosol; C:Dsl1/NZR complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, , P:cell cycle; P:protein transport; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of signal transduction involved in mitotic G2 DNA damage checkpoint; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q6NUQ1 Q75MG9 Q75MH0 Q96IW8 Q9H229 Q9HAD9,RAD50-interacting protein 1,RAD50 interactor 1;, PF04437;, GO:0005829;GO:0070939;GO:0005783;GO:0005789;GO:0007049;GO:0015031;GO:0060628;GO:1902504;GO:0006890;, C:cytosol; C:Dsl1/NZR complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, , P:cell cycle; P:protein transport; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of signal transduction involved in mitotic G2 DNA damage checkpoint; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold8 indexed_genome mRNA 13320733 13350635 . - . ID=transcript_2116;Q9ULK2 A4D0Q2 B4DTS1 Q8N2T0,Ataxin-7-like protein 1,Ataxin-7-like protein 4;, PF08313; scaffold8 indexed_genome mRNA 13453578 13573603 . - . ID=transcript_2117;Q9ULK2 A4D0Q2 B4DTS1 Q8N2T0,Ataxin-7-like protein 1,Ataxin-7-like protein 4;, PF08313; scaffold8 indexed_genome mRNA 13663042 13690059 . + . ID=transcript_2118;Q6ZTQ4 Q8TCI7,Cadherin-related family member 3,Cadherin-like protein 28;, PF00028;, GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0001618;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding; F:virus receptor activity;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold8 indexed_genome mRNA 13700308 13714349 . + . ID=transcript_2119;Q6ZTQ4 Q8TCI7,Cadherin-related family member 3,Cadherin-like protein 28;, PF00028;, GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0001618;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding; F:virus receptor activity;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold8 indexed_genome mRNA 13759709 13771213 . - . ID=transcript_2120;Q16563 A4D0R2 Q96AR8,Synaptophysin-like protein 1,Pantophysin;, PF01284;, GO:0070062;GO:0016021;GO:0005887;GO:0030285;GO:0042470;GO:0030141;GO:0030672;GO:0017075;GO:0007268;, C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:melanosome; C:secretory granule; C:synaptic vesicle membrane;, F:syntaxin-1 binding;, P:chemical synaptic transmission;|Q16563 A4D0R2 Q96AR8,Synaptophysin-like protein 1,Pantophysin;, PF01284;, GO:0070062;GO:0016021;GO:0005887;GO:0030285;GO:0042470;GO:0030141;GO:0030672;GO:0017075;GO:0007268;, C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:melanosome; C:secretory granule; C:synaptic vesicle membrane;, F:syntaxin-1 binding;, P:chemical synaptic transmission;|Q16563 A4D0R2 Q96AR8,Synaptophysin-like protein 1,Pantophysin;, PF01284;, GO:0070062;GO:0016021;GO:0005887;GO:0030285;GO:0042470;GO:0030141;GO:0030672;GO:0017075;GO:0007268;, C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:melanosome; C:secretory granule; C:synaptic vesicle membrane;, F:syntaxin-1 binding;, P:chemical synaptic transmission; scaffold8 indexed_genome mRNA 13931542 13960056 . - . ID=transcript_2121;P43490 A4D0Q9 A4D0R0 Q3KQV0 Q8WW95,Nicotinamide phosphoribosyltransferase,Pre-B-cell colony-enhancing factor 1;Visfatin;, PF18127;PF04095;, GO:0030054;GO:0005829;GO:0070062;GO:0016607;GO:0005125;GO:0042802;GO:0047280;GO:0004514;GO:0007267;GO:0032922;GO:0034356;GO:0008284;GO:0051770;GO:0045944;GO:0007165;, C:cell junction; C:cytosol; C:extracellular exosome; C:nuclear speck;, F:cytokine activity; F:identical protein binding; F:nicotinamide phosphoribosyltransferase activity; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity;, P:cell-cell signaling; P:circadian regulation of gene expression; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:positive regulation of cell population proliferation; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:signal transduction;|P43490 A4D0Q9 A4D0R0 Q3KQV0 Q8WW95,Nicotinamide phosphoribosyltransferase,Pre-B-cell colony-enhancing factor 1;Visfatin;, PF18127;PF04095;, GO:0030054;GO:0005829;GO:0070062;GO:0016607;GO:0005125;GO:0042802;GO:0047280;GO:0004514;GO:0007267;GO:0032922;GO:0034356;GO:0008284;GO:0051770;GO:0045944;GO:0007165;, C:cell junction; C:cytosol; C:extracellular exosome; C:nuclear speck;, F:cytokine activity; F:identical protein binding; F:nicotinamide phosphoribosyltransferase activity; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity;, P:cell-cell signaling; P:circadian regulation of gene expression; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:positive regulation of cell population proliferation; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:signal transduction; scaffold8 indexed_genome mRNA 14579933 14609361 . + . ID=transcript_2122;P48736 A4D0Q6 Q8IV23 Q9BZC8,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma;Phosphoinositide-3-kinase catalytic gamma polypeptide;Serine/threonine protein kinase PIK3CG;p120-PI3K;, PF00454;PF00792;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0016020;GO:0005942;GO:0005943;GO:0005944;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0046875;GO:0042802;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0004672;GO:0106310;GO:0106311;GO:0002250;GO:0001525;GO:0016477;GO:0071320;GO:0002407;GO:0006897;GO:0007186;GO:0097284;GO:0006954;GO:0045087;GO:0043303;GO:0035747;GO:0055118;GO:2000270;GO:0010897;GO:0030593;GO:0072672;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0030168;GO:0070527;GO:0002675;GO:0001819;GO:0007204;GO:0010595;GO:0043406;GO:0014068;GO:0051897;GO:0035022;GO:1903169;GO:0033628;GO:0002679;GO:0032252;GO:0003376;GO:0042110;GO:0010818;GO:0042098;, C:cytoplasm; C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IA; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:ephrin receptor binding; F:identical protein binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:adaptive immune response; P:angiogenesis; P:cell migration; P:cellular response to cAMP; P:dendritic cell chemotaxis; P:endocytosis; P:G protein-coupled receptor signaling pathway; P:hepatocyte apoptotic process; P:inflammatory response; P:innate immune response; P:mast cell degranulation; P:natural killer cell chemotaxis; P:negative regulation of cardiac muscle contraction; P:negative regulation of fibroblast apoptotic process; P:negative regulation of triglyceride catabolic process; P:neutrophil chemotaxis; P:neutrophil extravasation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:platelet activation; P:platelet aggregation; P:positive regulation of acute inflammatory response; P:positive regulation of cytokine production; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell migration; P:positive regulation of MAP kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of Rac protein signal transduction; P:regulation of calcium ion transmembrane transport; P:regulation of cell adhesion mediated by integrin; P:respiratory burst involved in defense response; P:secretory granule localization; P:sphingosine-1-phosphate receptor signaling pathway; P:T cell activation; P:T cell chemotaxis; P:T cell proliferation;|P48736 A4D0Q6 Q8IV23 Q9BZC8,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma;Phosphoinositide-3-kinase catalytic gamma polypeptide;Serine/threonine protein kinase PIK3CG;p120-PI3K;, PF00454;PF00792;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0016020;GO:0005942;GO:0005943;GO:0005944;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0046875;GO:0042802;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0004672;GO:0106310;GO:0106311;GO:0002250;GO:0001525;GO:0016477;GO:0071320;GO:0002407;GO:0006897;GO:0007186;GO:0097284;GO:0006954;GO:0045087;GO:0043303;GO:0035747;GO:0055118;GO:2000270;GO:0010897;GO:0030593;GO:0072672;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0030168;GO:0070527;GO:0002675;GO:0001819;GO:0007204;GO:0010595;GO:0043406;GO:0014068;GO:0051897;GO:0035022;GO:1903169;GO:0033628;GO:0002679;GO:0032252;GO:0003376;GO:0042110;GO:0010818;GO:0042098;, C:cytoplasm; C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IA; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:ephrin receptor binding; F:identical protein binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:adaptive immune response; P:angiogenesis; P:cell migration; P:cellular response to cAMP; P:dendritic cell chemotaxis; P:endocytosis; P:G protein-coupled receptor signaling pathway; P:hepatocyte apoptotic process; P:inflammatory response; P:innate immune response; P:mast cell degranulation; P:natural killer cell chemotaxis; P:negative regulation of cardiac muscle contraction; P:negative regulation of fibroblast apoptotic process; P:negative regulation of triglyceride catabolic process; P:neutrophil chemotaxis; P:neutrophil extravasation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:platelet activation; P:platelet aggregation; P:positive regulation of acute inflammatory response; P:positive regulation of cytokine production; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell migration; P:positive regulation of MAP kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of Rac protein signal transduction; P:regulation of calcium ion transmembrane transport; P:regulation of cell adhesion mediated by integrin; P:respiratory burst involved in defense response; P:secretory granule localization; P:sphingosine-1-phosphate receptor signaling pathway; P:T cell activation; P:T cell chemotaxis; P:T cell proliferation;|P48736 A4D0Q6 Q8IV23 Q9BZC8,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma;Phosphoinositide-3-kinase catalytic gamma polypeptide;Serine/threonine protein kinase PIK3CG;p120-PI3K;, PF00454;PF00792;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0016020;GO:0005942;GO:0005943;GO:0005944;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0046875;GO:0042802;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0004672;GO:0106310;GO:0106311;GO:0002250;GO:0001525;GO:0016477;GO:0071320;GO:0002407;GO:0006897;GO:0007186;GO:0097284;GO:0006954;GO:0045087;GO:0043303;GO:0035747;GO:0055118;GO:2000270;GO:0010897;GO:0030593;GO:0072672;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0030168;GO:0070527;GO:0002675;GO:0001819;GO:0007204;GO:0010595;GO:0043406;GO:0014068;GO:0051897;GO:0035022;GO:1903169;GO:0033628;GO:0002679;GO:0032252;GO:0003376;GO:0042110;GO:0010818;GO:0042098;, C:cytoplasm; C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IA; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:ephrin receptor binding; F:identical protein binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:adaptive immune response; P:angiogenesis; P:cell migration; P:cellular response to cAMP; P:dendritic cell chemotaxis; P:endocytosis; P:G protein-coupled receptor signaling pathway; P:hepatocyte apoptotic process; P:inflammatory response; P:innate immune response; P:mast cell degranulation; P:natural killer cell chemotaxis; P:negative regulation of cardiac muscle contraction; P:negative regulation of fibroblast apoptotic process; P:negative regulation of triglyceride catabolic process; P:neutrophil chemotaxis; P:neutrophil extravasation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:platelet activation; P:platelet aggregation; P:positive regulation of acute inflammatory response; P:positive regulation of cytokine production; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell migration; P:positive regulation of MAP kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of Rac protein signal transduction; P:regulation of calcium ion transmembrane transport; P:regulation of cell adhesion mediated by integrin; P:respiratory burst involved in defense response; P:secretory granule localization; P:sphingosine-1-phosphate receptor signaling pathway; P:T cell activation; P:T cell chemotaxis; P:T cell proliferation; scaffold8 indexed_genome mRNA 14740382 14843663 . + . ID=transcript_2123;P31323 A4D0R9,cAMP-dependent protein kinase type II-beta regulatory subunit,, PF00027;PF02197;, GO:0005952;GO:0005813;GO:0097546;GO:0005737;GO:0005829;GO:0043198;GO:0043197;GO:0070062;GO:0098978;GO:0045121;GO:0043025;GO:0048471;GO:0005886;GO:0030552;GO:0004862;GO:0008603;GO:0019904;GO:0034236;GO:0031625;GO:0034199;GO:0007596;GO:0071377;GO:0007268;GO:0097711;GO:0006631;GO:0000086;GO:0035556;GO:0007612;GO:0050804;GO:2000480;GO:0002862;GO:0043949;GO:0010389;GO:0010738;GO:0003091;GO:0097332;GO:0097338;, C:cAMP-dependent protein kinase complex; C:centrosome; C:ciliary base; C:cytoplasm; C:cytosol; C:dendritic shaft; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane raft; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cAMP binding; F:cAMP-dependent protein kinase inhibitor activity; F:cAMP-dependent protein kinase regulator activity; F:protein domain specific binding; F:protein kinase A catalytic subunit binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase A activity; P:blood coagulation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:fatty acid metabolic process; P:G2/M transition of mitotic cell cycle; P:intracellular signal transduction; P:learning; P:modulation of chemical synaptic transmission; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of inflammatory response to antigenic stimulus; P:regulation of cAMP-mediated signaling; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of protein kinase A signaling; P:renal water homeostasis; P:response to antipsychotic drug; P:response to clozapine; scaffold8 indexed_genome mRNA 14859673 15143424 . - . ID=transcript_2124;O60381 B3KVB7 Q8TBM1 Q8TE93 Q96AJ2,HMG box-containing protein 1,HMG box transcription factor 1;High mobility group box transcription factor 1;, PF08517;PF00505;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0000981;GO:0003723;GO:0000978;GO:0007050;GO:0006357;GO:0016055;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle arrest; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|O60381 B3KVB7 Q8TBM1 Q8TE93 Q96AJ2,HMG box-containing protein 1,HMG box transcription factor 1;High mobility group box transcription factor 1;, PF08517;PF00505;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0000981;GO:0003723;GO:0000978;GO:0007050;GO:0006357;GO:0016055;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle arrest; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|O60381 B3KVB7 Q8TBM1 Q8TE93 Q96AJ2,HMG box-containing protein 1,HMG box transcription factor 1;High mobility group box transcription factor 1;, PF08517;PF00505;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0000981;GO:0003723;GO:0000978;GO:0007050;GO:0006357;GO:0016055;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle arrest; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|O60381 B3KVB7 Q8TBM1 Q8TE93 Q96AJ2,HMG box-containing protein 1,HMG box transcription factor 1;High mobility group box transcription factor 1;, PF08517;PF00505;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0000981;GO:0003723;GO:0000978;GO:0007050;GO:0006357;GO:0016055;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle arrest; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|O60381 B3KVB7 Q8TBM1 Q8TE93 Q96AJ2,HMG box-containing protein 1,HMG box transcription factor 1;High mobility group box transcription factor 1;, PF08517;PF00505;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0000981;GO:0003723;GO:0000978;GO:0007050;GO:0006357;GO:0016055;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle arrest; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|O60381 B3KVB7 Q8TBM1 Q8TE93 Q96AJ2,HMG box-containing protein 1,HMG box transcription factor 1;High mobility group box transcription factor 1;, PF08517;PF00505;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0000981;GO:0003723;GO:0000978;GO:0007050;GO:0006357;GO:0016055;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle arrest; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|O60381 B3KVB7 Q8TBM1 Q8TE93 Q96AJ2,HMG box-containing protein 1,HMG box transcription factor 1;High mobility group box transcription factor 1;, PF08517;PF00505;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0000981;GO:0003723;GO:0000978;GO:0007050;GO:0006357;GO:0016055;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle arrest; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|Q9UP83 A4D0R6 A4D0R7 O14555 O95008 Q6NUL5,Conserved oligomeric Golgi complex subunit 5,13S Golgi transport complex 90 kDa subunit;Component of oligomeric Golgi complex 5;Golgi transport complex 1;, PF10392;, GO:0005829;GO:0005794;GO:0000139;GO:0017119;GO:0016020;GO:0005654;GO:0032588;GO:0006888;GO:0048219;GO:0006891;GO:0015031;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:membrane; C:nucleoplasm; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:inter-Golgi cisterna vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q9UP83 A4D0R6 A4D0R7 O14555 O95008 Q6NUL5,Conserved oligomeric Golgi complex subunit 5,13S Golgi transport complex 90 kDa subunit;Component of oligomeric Golgi complex 5;Golgi transport complex 1;, PF10392;, GO:0005829;GO:0005794;GO:0000139;GO:0017119;GO:0016020;GO:0005654;GO:0032588;GO:0006888;GO:0048219;GO:0006891;GO:0015031;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:membrane; C:nucleoplasm; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:inter-Golgi cisterna vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q9UP83 A4D0R6 A4D0R7 O14555 O95008 Q6NUL5,Conserved oligomeric Golgi complex subunit 5,13S Golgi transport complex 90 kDa subunit;Component of oligomeric Golgi complex 5;Golgi transport complex 1;, PF10392;, GO:0005829;GO:0005794;GO:0000139;GO:0017119;GO:0016020;GO:0005654;GO:0032588;GO:0006888;GO:0048219;GO:0006891;GO:0015031;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:membrane; C:nucleoplasm; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:inter-Golgi cisterna vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q99680 A4D0R8 O14554,G-protein coupled receptor 22,, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0042277;GO:0030030;GO:0007186;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:peptide binding;, P:cell projection organization; P:G protein-coupled receptor signaling pathway; scaffold8 indexed_genome mRNA 15143901 15160544 . + . ID=transcript_2125;O95620 B4DLX0 Q2NKK1,tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like,pp35;tRNA-dihydrouridine synthase 4-like;, PF01207;, GO:0050660;GO:0017150;, , F:flavin adenine dinucleotide binding; F:tRNA dihydrouridine synthase activity;|O95620 B4DLX0 Q2NKK1,tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like,pp35;tRNA-dihydrouridine synthase 4-like;, PF01207;, GO:0050660;GO:0017150;, , F:flavin adenine dinucleotide binding; F:tRNA dihydrouridine synthase activity;|O95620 B4DLX0 Q2NKK1,tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like,pp35;tRNA-dihydrouridine synthase 4-like;, PF01207;, GO:0050660;GO:0017150;, , F:flavin adenine dinucleotide binding; F:tRNA dihydrouridine synthase activity;|O95620 B4DLX0 Q2NKK1,tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like,pp35;tRNA-dihydrouridine synthase 4-like;, PF01207;, GO:0050660;GO:0017150;, , F:flavin adenine dinucleotide binding; F:tRNA dihydrouridine synthase activity; scaffold8 indexed_genome mRNA 15182430 15188315 . + . ID=transcript_2126;Q9UHQ4 G5E9L4 O95003,B-cell receptor-associated protein 29,, PF05529;PF18035;, GO:0005789;GO:0016021;GO:0016020;GO:0006915;GO:0006888;GO:0006886;GO:0001649;GO:0070973;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:apoptotic process; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:osteoblast differentiation; P:protein localization to endoplasmic reticulum exit site; scaffold8 indexed_genome mRNA 15190813 15216252 . + . ID=transcript_2127;Q9UHQ4 G5E9L4 O95003,B-cell receptor-associated protein 29,, PF05529;PF18035;, GO:0005789;GO:0016021;GO:0016020;GO:0006915;GO:0006888;GO:0006886;GO:0001649;GO:0070973;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:apoptotic process; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:osteoblast differentiation; P:protein localization to endoplasmic reticulum exit site;|Q9UHQ4 G5E9L4 O95003,B-cell receptor-associated protein 29,, PF05529;PF18035;, GO:0005789;GO:0016021;GO:0016020;GO:0006915;GO:0006888;GO:0006886;GO:0001649;GO:0070973;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:apoptotic process; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:osteoblast differentiation; P:protein localization to endoplasmic reticulum exit site; scaffold8 indexed_genome mRNA 15327817 15330608 . + . ID=transcript_2128;Q75N03 B7ZM03 Q8TAJ4 Q9H5S6,E3 ubiquitin-protein ligase Hakai {ECO:0000305},Casitas B-lineage lymphoma-transforming sequence-like protein 1 {ECO:0000250|UniProtKB:Q9JIY2};RING finger protein 188;RING-type E3 ubiquitin transferase Hakai {ECO:0000305};, PF18408;, GO:0005737;GO:0005829;GO:0016607;GO:0036396;GO:0000151;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0098609;GO:0035635;GO:0080009;GO:0007275;GO:0007162;GO:0030335;GO:0045807;GO:0016567;GO:0030155;, C:cytoplasm; C:cytosol; C:nuclear speck; C:RNA N6-methyladenosine methyltransferase complex; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell-cell adhesion; P:entry of bacterium into host cell; P:mRNA methylation; P:multicellular organism development; P:negative regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of endocytosis; P:protein ubiquitination; P:regulation of cell adhesion; scaffold8 indexed_genome mRNA 15330843 15339031 . + . ID=transcript_2129;Q75N03 B7ZM03 Q8TAJ4 Q9H5S6,E3 ubiquitin-protein ligase Hakai {ECO:0000305},Casitas B-lineage lymphoma-transforming sequence-like protein 1 {ECO:0000250|UniProtKB:Q9JIY2};RING finger protein 188;RING-type E3 ubiquitin transferase Hakai {ECO:0000305};, PF18408;, GO:0005737;GO:0005829;GO:0016607;GO:0036396;GO:0000151;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0098609;GO:0035635;GO:0080009;GO:0007275;GO:0007162;GO:0030335;GO:0045807;GO:0016567;GO:0030155;, C:cytoplasm; C:cytosol; C:nuclear speck; C:RNA N6-methyladenosine methyltransferase complex; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell-cell adhesion; P:entry of bacterium into host cell; P:mRNA methylation; P:multicellular organism development; P:negative regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of endocytosis; P:protein ubiquitination; P:regulation of cell adhesion;|Q75N03 B7ZM03 Q8TAJ4 Q9H5S6,E3 ubiquitin-protein ligase Hakai {ECO:0000305},Casitas B-lineage lymphoma-transforming sequence-like protein 1 {ECO:0000250|UniProtKB:Q9JIY2};RING finger protein 188;RING-type E3 ubiquitin transferase Hakai {ECO:0000305};, PF18408;, GO:0005737;GO:0005829;GO:0016607;GO:0036396;GO:0000151;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0098609;GO:0035635;GO:0080009;GO:0007275;GO:0007162;GO:0030335;GO:0045807;GO:0016567;GO:0030155;, C:cytoplasm; C:cytosol; C:nuclear speck; C:RNA N6-methyladenosine methyltransferase complex; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell-cell adhesion; P:entry of bacterium into host cell; P:mRNA methylation; P:multicellular organism development; P:negative regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of endocytosis; P:protein ubiquitination; P:regulation of cell adhesion;|Q75N03 B7ZM03 Q8TAJ4 Q9H5S6,E3 ubiquitin-protein ligase Hakai {ECO:0000305},Casitas B-lineage lymphoma-transforming sequence-like protein 1 {ECO:0000250|UniProtKB:Q9JIY2};RING finger protein 188;RING-type E3 ubiquitin transferase Hakai {ECO:0000305};, PF18408;, GO:0005737;GO:0005829;GO:0016607;GO:0036396;GO:0000151;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0098609;GO:0035635;GO:0080009;GO:0007275;GO:0007162;GO:0030335;GO:0045807;GO:0016567;GO:0030155;, C:cytoplasm; C:cytosol; C:nuclear speck; C:RNA N6-methyladenosine methyltransferase complex; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell-cell adhesion; P:entry of bacterium into host cell; P:mRNA methylation; P:multicellular organism development; P:negative regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of endocytosis; P:protein ubiquitination; P:regulation of cell adhesion; scaffold8 indexed_genome mRNA 15362353 15362971 . - . ID=transcript_2130;P40879,Chloride anion exchanger,Down-regulated in adenoma;Solute carrier family 26 member 3;, PF01740;PF00916;, GO:0016324;GO:0031526;GO:0005887;GO:0016020;GO:0005886;GO:0097225;GO:0015301;GO:0015106;GO:0015108;GO:0019531;GO:0008271;GO:0015116;GO:0005215;GO:0006820;GO:0071320;GO:0007588;GO:0051454;GO:0006811;GO:0060081;GO:0048240;, C:apical plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:sperm midpiece;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:transporter activity;, P:anion transport; P:cellular response to cAMP; P:excretion; P:intracellular pH elevation; P:ion transport; P:membrane hyperpolarization; P:sperm capacitation; scaffold8 indexed_genome mRNA 15493473 15515121 . + . ID=transcript_2131;P09622 B2R5X0 B4DHG0 B4DT69 Q14131 Q14167 Q59EV8 Q8WTS4,Dihydrolipoyl dehydrogenase, mitochondrial,Dihydrolipoamide dehydrogenase;Glycine cleavage system L protein;, PF07992;PF02852;, GO:0043159;GO:0005759;GO:0005739;GO:0031514;GO:0005634;GO:0045252;GO:0045254;GO:0004148;GO:0050660;GO:0043544;GO:0051287;GO:0006103;GO:0007568;GO:0009083;GO:0045454;GO:0051068;GO:0007369;GO:0006546;GO:0106077;GO:0009106;GO:0006554;GO:0061732;GO:0006120;GO:0006508;GO:0006090;GO:0042391;GO:0048240;GO:0006099;, C:acrosomal matrix; C:mitochondrial matrix; C:mitochondrion; C:motile cilium; C:nucleus; C:oxoglutarate dehydrogenase complex; C:pyruvate dehydrogenase complex;, F:dihydrolipoyl dehydrogenase activity; F:flavin adenine dinucleotide binding; F:lipoamide binding; F:NAD binding;, P:2-oxoglutarate metabolic process; P:aging; P:branched-chain amino acid catabolic process; P:cell redox homeostasis; P:dihydrolipoamide metabolic process; P:gastrulation; P:glycine catabolic process; P:histone succinylation; P:lipoate metabolic process; P:lysine catabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:mitochondrial electron transport, NADH to ubiquinone; P:proteolysis; P:pyruvate metabolic process; P:regulation of membrane potential; P:sperm capacitation; P:tricarboxylic acid cycle;|P09622 B2R5X0 B4DHG0 B4DT69 Q14131 Q14167 Q59EV8 Q8WTS4,Dihydrolipoyl dehydrogenase, mitochondrial,Dihydrolipoamide dehydrogenase;Glycine cleavage system L protein;, PF07992;PF02852;, GO:0043159;GO:0005759;GO:0005739;GO:0031514;GO:0005634;GO:0045252;GO:0045254;GO:0004148;GO:0050660;GO:0043544;GO:0051287;GO:0006103;GO:0007568;GO:0009083;GO:0045454;GO:0051068;GO:0007369;GO:0006546;GO:0106077;GO:0009106;GO:0006554;GO:0061732;GO:0006120;GO:0006508;GO:0006090;GO:0042391;GO:0048240;GO:0006099;, C:acrosomal matrix; C:mitochondrial matrix; C:mitochondrion; C:motile cilium; C:nucleus; C:oxoglutarate dehydrogenase complex; C:pyruvate dehydrogenase complex;, F:dihydrolipoyl dehydrogenase activity; F:flavin adenine dinucleotide binding; F:lipoamide binding; F:NAD binding;, P:2-oxoglutarate metabolic process; P:aging; P:branched-chain amino acid catabolic process; P:cell redox homeostasis; P:dihydrolipoamide metabolic process; P:gastrulation; P:glycine catabolic process; P:histone succinylation; P:lipoate metabolic process; P:lysine catabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:mitochondrial electron transport, NADH to ubiquinone; P:proteolysis; P:pyruvate metabolic process; P:regulation of membrane potential; P:sperm capacitation; P:tricarboxylic acid cycle;|P09622 B2R5X0 B4DHG0 B4DT69 Q14131 Q14167 Q59EV8 Q8WTS4,Dihydrolipoyl dehydrogenase, mitochondrial,Dihydrolipoamide dehydrogenase;Glycine cleavage system L protein;, PF07992;PF02852;, GO:0043159;GO:0005759;GO:0005739;GO:0031514;GO:0005634;GO:0045252;GO:0045254;GO:0004148;GO:0050660;GO:0043544;GO:0051287;GO:0006103;GO:0007568;GO:0009083;GO:0045454;GO:0051068;GO:0007369;GO:0006546;GO:0106077;GO:0009106;GO:0006554;GO:0061732;GO:0006120;GO:0006508;GO:0006090;GO:0042391;GO:0048240;GO:0006099;, C:acrosomal matrix; C:mitochondrial matrix; C:mitochondrion; C:motile cilium; C:nucleus; C:oxoglutarate dehydrogenase complex; C:pyruvate dehydrogenase complex;, F:dihydrolipoyl dehydrogenase activity; F:flavin adenine dinucleotide binding; F:lipoamide binding; F:NAD binding;, P:2-oxoglutarate metabolic process; P:aging; P:branched-chain amino acid catabolic process; P:cell redox homeostasis; P:dihydrolipoamide metabolic process; P:gastrulation; P:glycine catabolic process; P:histone succinylation; P:lipoate metabolic process; P:lysine catabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:mitochondrial electron transport, NADH to ubiquinone; P:proteolysis; P:pyruvate metabolic process; P:regulation of membrane potential; P:sperm capacitation; P:tricarboxylic acid cycle;|P09622 B2R5X0 B4DHG0 B4DT69 Q14131 Q14167 Q59EV8 Q8WTS4,Dihydrolipoyl dehydrogenase, mitochondrial,Dihydrolipoamide dehydrogenase;Glycine cleavage system L protein;, PF07992;PF02852;, GO:0043159;GO:0005759;GO:0005739;GO:0031514;GO:0005634;GO:0045252;GO:0045254;GO:0004148;GO:0050660;GO:0043544;GO:0051287;GO:0006103;GO:0007568;GO:0009083;GO:0045454;GO:0051068;GO:0007369;GO:0006546;GO:0106077;GO:0009106;GO:0006554;GO:0061732;GO:0006120;GO:0006508;GO:0006090;GO:0042391;GO:0048240;GO:0006099;, C:acrosomal matrix; C:mitochondrial matrix; C:mitochondrion; C:motile cilium; C:nucleus; C:oxoglutarate dehydrogenase complex; C:pyruvate dehydrogenase complex;, F:dihydrolipoyl dehydrogenase activity; F:flavin adenine dinucleotide binding; F:lipoamide binding; F:NAD binding;, P:2-oxoglutarate metabolic process; P:aging; P:branched-chain amino acid catabolic process; P:cell redox homeostasis; P:dihydrolipoamide metabolic process; P:gastrulation; P:glycine catabolic process; P:histone succinylation; P:lipoate metabolic process; P:lysine catabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:mitochondrial electron transport, NADH to ubiquinone; P:proteolysis; P:pyruvate metabolic process; P:regulation of membrane potential; P:sperm capacitation; P:tricarboxylic acid cycle;|P09622 B2R5X0 B4DHG0 B4DT69 Q14131 Q14167 Q59EV8 Q8WTS4,Dihydrolipoyl dehydrogenase, mitochondrial,Dihydrolipoamide dehydrogenase;Glycine cleavage system L protein;, PF07992;PF02852;, GO:0043159;GO:0005759;GO:0005739;GO:0031514;GO:0005634;GO:0045252;GO:0045254;GO:0004148;GO:0050660;GO:0043544;GO:0051287;GO:0006103;GO:0007568;GO:0009083;GO:0045454;GO:0051068;GO:0007369;GO:0006546;GO:0106077;GO:0009106;GO:0006554;GO:0061732;GO:0006120;GO:0006508;GO:0006090;GO:0042391;GO:0048240;GO:0006099;, C:acrosomal matrix; C:mitochondrial matrix; C:mitochondrion; C:motile cilium; C:nucleus; C:oxoglutarate dehydrogenase complex; C:pyruvate dehydrogenase complex;, F:dihydrolipoyl dehydrogenase activity; F:flavin adenine dinucleotide binding; F:lipoamide binding; F:NAD binding;, P:2-oxoglutarate metabolic process; P:aging; P:branched-chain amino acid catabolic process; P:cell redox homeostasis; P:dihydrolipoamide metabolic process; P:gastrulation; P:glycine catabolic process; P:histone succinylation; P:lipoate metabolic process; P:lysine catabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:mitochondrial electron transport, NADH to ubiquinone; P:proteolysis; P:pyruvate metabolic process; P:regulation of membrane potential; P:sperm capacitation; P:tricarboxylic acid cycle;|P09622 B2R5X0 B4DHG0 B4DT69 Q14131 Q14167 Q59EV8 Q8WTS4,Dihydrolipoyl dehydrogenase, mitochondrial,Dihydrolipoamide dehydrogenase;Glycine cleavage system L protein;, PF07992;PF02852;, GO:0043159;GO:0005759;GO:0005739;GO:0031514;GO:0005634;GO:0045252;GO:0045254;GO:0004148;GO:0050660;GO:0043544;GO:0051287;GO:0006103;GO:0007568;GO:0009083;GO:0045454;GO:0051068;GO:0007369;GO:0006546;GO:0106077;GO:0009106;GO:0006554;GO:0061732;GO:0006120;GO:0006508;GO:0006090;GO:0042391;GO:0048240;GO:0006099;, C:acrosomal matrix; C:mitochondrial matrix; C:mitochondrion; C:motile cilium; C:nucleus; C:oxoglutarate dehydrogenase complex; C:pyruvate dehydrogenase complex;, F:dihydrolipoyl dehydrogenase activity; F:flavin adenine dinucleotide binding; F:lipoamide binding; F:NAD binding;, P:2-oxoglutarate metabolic process; P:aging; P:branched-chain amino acid catabolic process; P:cell redox homeostasis; P:dihydrolipoamide metabolic process; P:gastrulation; P:glycine catabolic process; P:histone succinylation; P:lipoate metabolic process; P:lysine catabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:mitochondrial electron transport, NADH to ubiquinone; P:proteolysis; P:pyruvate metabolic process; P:regulation of membrane potential; P:sperm capacitation; P:tricarboxylic acid cycle; scaffold8 indexed_genome mRNA 15522716 15599903 . - . ID=transcript_2132;P07942 Q14D91,Laminin subunit beta-1,Laminin B1 chain;Laminin-1 subunit beta;Laminin-10 subunit beta;Laminin-12 subunit beta;Laminin-2 subunit beta;Laminin-6 subunit beta;Laminin-8 subunit beta;, PF00053;PF00055;, GO:0005604;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0043256;GO:0005606;GO:0043259;GO:0005607;GO:0043257;GO:0048471;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0070831;GO:0007155;GO:0016477;GO:0044267;GO:0035987;GO:0030198;GO:0031175;GO:0021812;GO:0042476;GO:0030335;GO:0050679;GO:0043687;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin complex; C:laminin-1 complex; C:laminin-10 complex; C:laminin-2 complex; C:laminin-8 complex; C:perinuclear region of cytoplasm;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:basement membrane assembly; P:cell adhesion; P:cell migration; P:cellular protein metabolic process; P:endodermal cell differentiation; P:extracellular matrix organization; P:neuron projection development; P:neuronal-glial interaction involved in cerebral cortex radial glia guided migration; P:odontogenesis; P:positive regulation of cell migration; P:positive regulation of epithelial cell proliferation; P:post-translational protein modification; P:substrate adhesion-dependent cell spreading; P:tissue development; scaffold8 indexed_genome mRNA 15778366 15872270 . - . ID=transcript_2133;Q92823 A4D0S3 E9PDA4 O15051 O15179 Q14BM2 Q9UHI3 Q9UHI4,Neuronal cell adhesion molecule,Neuronal surface protein Bravo {ECO:0000303|PubMed:8812479};NgCAM-related cell adhesion molecule;, PF13882;PF00041;PF07679;, GO:0043194;GO:0009897;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0030506;GO:0001525;GO:0007411;GO:0007413;GO:0007409;GO:0098609;GO:0007417;GO:0045162;GO:0001764;GO:0045666;GO:0030516;GO:0007416;, C:axon initial segment; C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:ankyrin binding;, P:angiogenesis; P:axon guidance; P:axonal fasciculation; P:axonogenesis; P:cell-cell adhesion; P:central nervous system development; P:clustering of voltage-gated sodium channels; P:neuron migration; P:positive regulation of neuron differentiation; P:regulation of axon extension; P:synapse assembly;|Q92823 A4D0S3 E9PDA4 O15051 O15179 Q14BM2 Q9UHI3 Q9UHI4,Neuronal cell adhesion molecule,Neuronal surface protein Bravo {ECO:0000303|PubMed:8812479};NgCAM-related cell adhesion molecule;, PF13882;PF00041;PF07679;, GO:0043194;GO:0009897;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0030506;GO:0001525;GO:0007411;GO:0007413;GO:0007409;GO:0098609;GO:0007417;GO:0045162;GO:0001764;GO:0045666;GO:0030516;GO:0007416;, C:axon initial segment; C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:ankyrin binding;, P:angiogenesis; P:axon guidance; P:axonal fasciculation; P:axonogenesis; P:cell-cell adhesion; P:central nervous system development; P:clustering of voltage-gated sodium channels; P:neuron migration; P:positive regulation of neuron differentiation; P:regulation of axon extension; P:synapse assembly;|Q92823 A4D0S3 E9PDA4 O15051 O15179 Q14BM2 Q9UHI3 Q9UHI4,Neuronal cell adhesion molecule,Neuronal surface protein Bravo {ECO:0000303|PubMed:8812479};NgCAM-related cell adhesion molecule;, PF13882;PF00041;PF07679;, GO:0043194;GO:0009897;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0030506;GO:0001525;GO:0007411;GO:0007413;GO:0007409;GO:0098609;GO:0007417;GO:0045162;GO:0001764;GO:0045666;GO:0030516;GO:0007416;, C:axon initial segment; C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:ankyrin binding;, P:angiogenesis; P:axon guidance; P:axonal fasciculation; P:axonogenesis; P:cell-cell adhesion; P:central nervous system development; P:clustering of voltage-gated sodium channels; P:neuron migration; P:positive regulation of neuron differentiation; P:regulation of axon extension; P:synapse assembly;|Q92823 A4D0S3 E9PDA4 O15051 O15179 Q14BM2 Q9UHI3 Q9UHI4,Neuronal cell adhesion molecule,Neuronal surface protein Bravo {ECO:0000303|PubMed:8812479};NgCAM-related cell adhesion molecule;, PF13882;PF00041;PF07679;, GO:0043194;GO:0009897;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0030506;GO:0001525;GO:0007411;GO:0007413;GO:0007409;GO:0098609;GO:0007417;GO:0045162;GO:0001764;GO:0045666;GO:0030516;GO:0007416;, C:axon initial segment; C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:ankyrin binding;, P:angiogenesis; P:axon guidance; P:axonal fasciculation; P:axonogenesis; P:cell-cell adhesion; P:central nervous system development; P:clustering of voltage-gated sodium channels; P:neuron migration; P:positive regulation of neuron differentiation; P:regulation of axon extension; P:synapse assembly; scaffold8 indexed_genome mRNA 16132235 16175320 . - . ID=transcript_2134;Q9NP80 A4D0S1 C9JZI4 O95035 Q8N3I3 Q9H7T5 Q9NR17 Q9NUN2 Q9NZ79,Calcium-independent phospholipase A2-gamma {ECO:0000305},Intracellular membrane-associated calcium-independent phospholipase A2 gamma;PNPLA-gamma;Patatin-like phospholipase domain-containing protein 8;iPLA2-2;, PF01734;, GO:0005789;GO:0016021;GO:0016020;GO:0031966;GO:0005739;GO:0005778;GO:0005777;GO:0005524;GO:0047499;GO:0004622;GO:0102545;GO:0004620;GO:0019369;GO:0050482;GO:0008219;GO:0006631;GO:0043651;GO:0055088;GO:0036151;GO:0034638;GO:0036152;GO:0046338;GO:0001516;GO:0070328;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:calcium-independent phospholipase A2 activity; F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:phospholipase activity;, P:arachidonic acid metabolic process; P:arachidonic acid secretion; P:cell death; P:fatty acid metabolic process; P:linoleic acid metabolic process; P:lipid homeostasis; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylethanolamine catabolic process; P:prostaglandin biosynthetic process; P:triglyceride homeostasis;|Q9NP80 A4D0S1 C9JZI4 O95035 Q8N3I3 Q9H7T5 Q9NR17 Q9NUN2 Q9NZ79,Calcium-independent phospholipase A2-gamma {ECO:0000305},Intracellular membrane-associated calcium-independent phospholipase A2 gamma;PNPLA-gamma;Patatin-like phospholipase domain-containing protein 8;iPLA2-2;, PF01734;, GO:0005789;GO:0016021;GO:0016020;GO:0031966;GO:0005739;GO:0005778;GO:0005777;GO:0005524;GO:0047499;GO:0004622;GO:0102545;GO:0004620;GO:0019369;GO:0050482;GO:0008219;GO:0006631;GO:0043651;GO:0055088;GO:0036151;GO:0034638;GO:0036152;GO:0046338;GO:0001516;GO:0070328;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:calcium-independent phospholipase A2 activity; F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:phospholipase activity;, P:arachidonic acid metabolic process; P:arachidonic acid secretion; P:cell death; P:fatty acid metabolic process; P:linoleic acid metabolic process; P:lipid homeostasis; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylethanolamine catabolic process; P:prostaglandin biosynthetic process; P:triglyceride homeostasis;|Q9NP80 A4D0S1 C9JZI4 O95035 Q8N3I3 Q9H7T5 Q9NR17 Q9NUN2 Q9NZ79,Calcium-independent phospholipase A2-gamma {ECO:0000305},Intracellular membrane-associated calcium-independent phospholipase A2 gamma;PNPLA-gamma;Patatin-like phospholipase domain-containing protein 8;iPLA2-2;, PF01734;, GO:0005789;GO:0016021;GO:0016020;GO:0031966;GO:0005739;GO:0005778;GO:0005777;GO:0005524;GO:0047499;GO:0004622;GO:0102545;GO:0004620;GO:0019369;GO:0050482;GO:0008219;GO:0006631;GO:0043651;GO:0055088;GO:0036151;GO:0034638;GO:0036152;GO:0046338;GO:0001516;GO:0070328;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:calcium-independent phospholipase A2 activity; F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:phospholipase activity;, P:arachidonic acid metabolic process; P:arachidonic acid secretion; P:cell death; P:fatty acid metabolic process; P:linoleic acid metabolic process; P:lipid homeostasis; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylethanolamine catabolic process; P:prostaglandin biosynthetic process; P:triglyceride homeostasis; scaffold8 indexed_genome mRNA 16270266 16280121 . - . ID=transcript_2135;Q6FHJ7 B4DYC1 O14877 Q05BG7 Q1ZYW2 Q4G124 Q6FHM0 Q6PD64,Secreted frizzled-related protein 4,Frizzled protein, human endometrium;, PF01392;PF01759;, GO:0009986;GO:0005737;GO:0005615;GO:0005634;GO:0017147;GO:0060349;GO:0060070;GO:0030154;GO:0090090;GO:0008285;GO:0043433;GO:2000051;GO:2000119;GO:0030178;GO:0055062;GO:0043065;GO:0090263;GO:0045606;GO:0010628;GO:1902174;GO:0002092;GO:0030510;GO:0009725;, C:cell surface; C:cytoplasm; C:extracellular space; C:nucleus;, F:Wnt-protein binding;, P:bone morphogenesis; P:canonical Wnt signaling pathway; P:cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of non-canonical Wnt signaling pathway; P:negative regulation of sodium-dependent phosphate transport; P:negative regulation of Wnt signaling pathway; P:phosphate ion homeostasis; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of epidermal cell differentiation; P:positive regulation of gene expression; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of receptor internalization; P:regulation of BMP signaling pathway; P:response to hormone;|Q6FHJ7 B4DYC1 O14877 Q05BG7 Q1ZYW2 Q4G124 Q6FHM0 Q6PD64,Secreted frizzled-related protein 4,Frizzled protein, human endometrium;, PF01392;PF01759;, GO:0009986;GO:0005737;GO:0005615;GO:0005634;GO:0017147;GO:0060349;GO:0060070;GO:0030154;GO:0090090;GO:0008285;GO:0043433;GO:2000051;GO:2000119;GO:0030178;GO:0055062;GO:0043065;GO:0090263;GO:0045606;GO:0010628;GO:1902174;GO:0002092;GO:0030510;GO:0009725;, C:cell surface; C:cytoplasm; C:extracellular space; C:nucleus;, F:Wnt-protein binding;, P:bone morphogenesis; P:canonical Wnt signaling pathway; P:cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of non-canonical Wnt signaling pathway; P:negative regulation of sodium-dependent phosphate transport; P:negative regulation of Wnt signaling pathway; P:phosphate ion homeostasis; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of epidermal cell differentiation; P:positive regulation of gene expression; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of receptor internalization; P:regulation of BMP signaling pathway; P:response to hormone;|Q6FHJ7 B4DYC1 O14877 Q05BG7 Q1ZYW2 Q4G124 Q6FHM0 Q6PD64,Secreted frizzled-related protein 4,Frizzled protein, human endometrium;, PF01392;PF01759;, GO:0009986;GO:0005737;GO:0005615;GO:0005634;GO:0017147;GO:0060349;GO:0060070;GO:0030154;GO:0090090;GO:0008285;GO:0043433;GO:2000051;GO:2000119;GO:0030178;GO:0055062;GO:0043065;GO:0090263;GO:0045606;GO:0010628;GO:1902174;GO:0002092;GO:0030510;GO:0009725;, C:cell surface; C:cytoplasm; C:extracellular space; C:nucleus;, F:Wnt-protein binding;, P:bone morphogenesis; P:canonical Wnt signaling pathway; P:cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of non-canonical Wnt signaling pathway; P:negative regulation of sodium-dependent phosphate transport; P:negative regulation of Wnt signaling pathway; P:phosphate ion homeostasis; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of epidermal cell differentiation; P:positive regulation of gene expression; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of receptor internalization; P:regulation of BMP signaling pathway; P:response to hormone; scaffold8 indexed_genome mRNA 16285903 16317771 . + . ID=transcript_2136;Q9UM22 A8K4C0 C9JYS3 Q06BL0 Q99M77,Mammalian ependymin-related protein 1,Upregulated in colorectal cancer gene 1 protein;, PF00811;, GO:0005576;GO:0043202;GO:0005764;GO:0005509;GO:1905573;GO:0042802;GO:0005543;GO:0007160;GO:1990764;, C:extracellular region; C:lysosomal lumen; C:lysosome;, F:calcium ion binding; F:ganglioside GM1 binding; F:identical protein binding; F:phospholipid binding;, P:cell-matrix adhesion; P:myofibroblast contraction;|Q9UM22 A8K4C0 C9JYS3 Q06BL0 Q99M77,Mammalian ependymin-related protein 1,Upregulated in colorectal cancer gene 1 protein;, PF00811;, GO:0005576;GO:0043202;GO:0005764;GO:0005509;GO:1905573;GO:0042802;GO:0005543;GO:0007160;GO:1990764;, C:extracellular region; C:lysosomal lumen; C:lysosome;, F:calcium ion binding; F:ganglioside GM1 binding; F:identical protein binding; F:phospholipid binding;, P:cell-matrix adhesion; P:myofibroblast contraction; scaffold8 indexed_genome mRNA 16500897 16559570 . + . ID=transcript_2137;O95772 A4D1X0,STARD3 N-terminal-like protein {ECO:0000303|PubMed:24105263},MLN64 N-terminal domain homolog;, PF10457;, GO:0005829;GO:0140284;GO:0005768;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0016020;GO:0044232;GO:0015485;GO:0042803;GO:0006700;GO:0099044;, C:cytosol; C:endoplasmic reticulum-endosome membrane contact site; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:organelle membrane contact site;, F:cholesterol binding; F:protein homodimerization activity;, P:C21-steroid hormone biosynthetic process; P:vesicle tethering to endoplasmic reticulum;|O95772 A4D1X0,STARD3 N-terminal-like protein {ECO:0000303|PubMed:24105263},MLN64 N-terminal domain homolog;, PF10457;, GO:0005829;GO:0140284;GO:0005768;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0016020;GO:0044232;GO:0015485;GO:0042803;GO:0006700;GO:0099044;, C:cytosol; C:endoplasmic reticulum-endosome membrane contact site; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:organelle membrane contact site;, F:cholesterol binding; F:protein homodimerization activity;, P:C21-steroid hormone biosynthetic process; P:vesicle tethering to endoplasmic reticulum;|O95772 A4D1X0,STARD3 N-terminal-like protein {ECO:0000303|PubMed:24105263},MLN64 N-terminal domain homolog;, PF10457;, GO:0005829;GO:0140284;GO:0005768;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0016020;GO:0044232;GO:0015485;GO:0042803;GO:0006700;GO:0099044;, C:cytosol; C:endoplasmic reticulum-endosome membrane contact site; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:organelle membrane contact site;, F:cholesterol binding; F:protein homodimerization activity;, P:C21-steroid hormone biosynthetic process; P:vesicle tethering to endoplasmic reticulum;|O95772 A4D1X0,STARD3 N-terminal-like protein {ECO:0000303|PubMed:24105263},MLN64 N-terminal domain homolog;, PF10457;, GO:0005829;GO:0140284;GO:0005768;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0016020;GO:0044232;GO:0015485;GO:0042803;GO:0006700;GO:0099044;, C:cytosol; C:endoplasmic reticulum-endosome membrane contact site; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:organelle membrane contact site;, F:cholesterol binding; F:protein homodimerization activity;, P:C21-steroid hormone biosynthetic process; P:vesicle tethering to endoplasmic reticulum; scaffold8 indexed_genome mRNA 16563838 16574302 . - . ID=transcript_2138;P03986 A0A075B6R6,T cell receptor gamma constant 2 {ECO:0000303|Ref.4},, PF07654;, GO:0009897;GO:0005887;GO:0042101;GO:0004888;GO:0002250;GO:0006955;, C:external side of plasma membrane; C:integral component of plasma membrane; C:T cell receptor complex;, F:transmembrane signaling receptor activity;, P:adaptive immune response; P:immune response; scaffold8 indexed_genome mRNA 16931321 17082778 . + . ID=transcript_2139;Q8WZ74 O43389 Q7LG11 Q9C0A5,Cortactin-binding protein 2,, PF12796;PF09727;, GO:0005938;GO:0043197;GO:0098978;GO:0098871;GO:0008021;GO:0017124;GO:0007420;GO:1905274;, C:cell cortex; C:dendritic spine; C:glutamatergic synapse; C:postsynaptic actin cytoskeleton; C:synaptic vesicle;, F:SH3 domain binding;, P:brain development; P:regulation of modification of postsynaptic actin cytoskeleton;|Q8WZ74 O43389 Q7LG11 Q9C0A5,Cortactin-binding protein 2,, PF12796;PF09727;, GO:0005938;GO:0043197;GO:0098978;GO:0098871;GO:0008021;GO:0017124;GO:0007420;GO:1905274;, C:cell cortex; C:dendritic spine; C:glutamatergic synapse; C:postsynaptic actin cytoskeleton; C:synaptic vesicle;, F:SH3 domain binding;, P:brain development; P:regulation of modification of postsynaptic actin cytoskeleton;|Q8WZ74 O43389 Q7LG11 Q9C0A5,Cortactin-binding protein 2,, PF12796;PF09727;, GO:0005938;GO:0043197;GO:0098978;GO:0098871;GO:0008021;GO:0017124;GO:0007420;GO:1905274;, C:cell cortex; C:dendritic spine; C:glutamatergic synapse; C:postsynaptic actin cytoskeleton; C:synaptic vesicle;, F:SH3 domain binding;, P:brain development; P:regulation of modification of postsynaptic actin cytoskeleton;|Q8WZ74 O43389 Q7LG11 Q9C0A5,Cortactin-binding protein 2,, PF12796;PF09727;, GO:0005938;GO:0043197;GO:0098978;GO:0098871;GO:0008021;GO:0017124;GO:0007420;GO:1905274;, C:cell cortex; C:dendritic spine; C:glutamatergic synapse; C:postsynaptic actin cytoskeleton; C:synaptic vesicle;, F:SH3 domain binding;, P:brain development; P:regulation of modification of postsynaptic actin cytoskeleton;|Q8WZ74 O43389 Q7LG11 Q9C0A5,Cortactin-binding protein 2,, PF12796;PF09727;, GO:0005938;GO:0043197;GO:0098978;GO:0098871;GO:0008021;GO:0017124;GO:0007420;GO:1905274;, C:cell cortex; C:dendritic spine; C:glutamatergic synapse; C:postsynaptic actin cytoskeleton; C:synaptic vesicle;, F:SH3 domain binding;, P:brain development; P:regulation of modification of postsynaptic actin cytoskeleton;|Q8WZ74 O43389 Q7LG11 Q9C0A5,Cortactin-binding protein 2,, PF12796;PF09727;, GO:0005938;GO:0043197;GO:0098978;GO:0098871;GO:0008021;GO:0017124;GO:0007420;GO:1905274;, C:cell cortex; C:dendritic spine; C:glutamatergic synapse; C:postsynaptic actin cytoskeleton; C:synaptic vesicle;, F:SH3 domain binding;, P:brain development; P:regulation of modification of postsynaptic actin cytoskeleton;|Q8WZ74 O43389 Q7LG11 Q9C0A5,Cortactin-binding protein 2,, PF12796;PF09727;, GO:0005938;GO:0043197;GO:0098978;GO:0098871;GO:0008021;GO:0017124;GO:0007420;GO:1905274;, C:cell cortex; C:dendritic spine; C:glutamatergic synapse; C:postsynaptic actin cytoskeleton; C:synaptic vesicle;, F:SH3 domain binding;, P:brain development; P:regulation of modification of postsynaptic actin cytoskeleton;|Q8WZ74 O43389 Q7LG11 Q9C0A5,Cortactin-binding protein 2,, PF12796;PF09727;, GO:0005938;GO:0043197;GO:0098978;GO:0098871;GO:0008021;GO:0017124;GO:0007420;GO:1905274;, C:cell cortex; C:dendritic spine; C:glutamatergic synapse; C:postsynaptic actin cytoskeleton; C:synaptic vesicle;, F:SH3 domain binding;, P:brain development; P:regulation of modification of postsynaptic actin cytoskeleton; scaffold8 indexed_genome mRNA 17180320 17343814 . - . ID=transcript_2140;P13569 Q20BG8 Q20BH2 Q2I0A1 Q2I102,Cystic fibrosis transmembrane conductance regulator,ATP-binding cassette sub-family C member 7;Channel conductance-controlling ATPase;cAMP-dependent chloride channel;, PF00664;PF00005;PF14396;, GO:0016324;GO:0009986;GO:0034707;GO:0030669;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005789;GO:0010008;GO:0030660;GO:0016021;GO:0005887;GO:0005765;GO:0016020;GO:0005634;GO:0005886;GO:0032991;GO:0055037;GO:0055038;GO:0005524;GO:0016887;GO:0042626;GO:0015106;GO:0051087;GO:0005254;GO:0019869;GO:0015108;GO:0019899;GO:0005260;GO:0016853;GO:0030165;GO:0106138;GO:0035973;GO:0015701;GO:0071320;GO:1904322;GO:1902476;GO:0006695;GO:0030301;GO:0051454;GO:0060081;GO:0061024;GO:0050891;GO:1902161;GO:0045921;GO:0035774;GO:1902943;GO:0016579;GO:0034976;GO:0048240;GO:0035377;GO:0055085;GO:0006904;, C:apical plasma membrane; C:cell surface; C:chloride channel complex; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:nucleus; C:plasma membrane; C:protein-containing complex; C:recycling endosome; C:recycling endosome membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bicarbonate transmembrane transporter activity; F:chaperone binding; F:chloride channel activity; F:chloride channel inhibitor activity; F:chloride transmembrane transporter activity; F:enzyme binding; F:intracellularly ATP-gated chloride channel activity; F:isomerase activity; F:PDZ domain binding; F:Sec61 translocon complex binding;, P:aggrephagy; P:bicarbonate transport; P:cellular response to cAMP; P:cellular response to forskolin; P:chloride transmembrane transport; P:cholesterol biosynthetic process; P:cholesterol transport; P:intracellular pH elevation; P:membrane hyperpolarization; P:membrane organization; P:multicellular organismal water homeostasis; P:positive regulation of cyclic nucleotide-gated ion channel activity; P:positive regulation of exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of voltage-gated chloride channel activity; P:protein deubiquitination; P:response to endoplasmic reticulum stress; P:sperm capacitation; P:transepithelial water transport; P:transmembrane transport; P:vesicle docking involved in exocytosis;|P13569 Q20BG8 Q20BH2 Q2I0A1 Q2I102,Cystic fibrosis transmembrane conductance regulator,ATP-binding cassette sub-family C member 7;Channel conductance-controlling ATPase;cAMP-dependent chloride channel;, PF00664;PF00005;PF14396;, GO:0016324;GO:0009986;GO:0034707;GO:0030669;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005789;GO:0010008;GO:0030660;GO:0016021;GO:0005887;GO:0005765;GO:0016020;GO:0005634;GO:0005886;GO:0032991;GO:0055037;GO:0055038;GO:0005524;GO:0016887;GO:0042626;GO:0015106;GO:0051087;GO:0005254;GO:0019869;GO:0015108;GO:0019899;GO:0005260;GO:0016853;GO:0030165;GO:0106138;GO:0035973;GO:0015701;GO:0071320;GO:1904322;GO:1902476;GO:0006695;GO:0030301;GO:0051454;GO:0060081;GO:0061024;GO:0050891;GO:1902161;GO:0045921;GO:0035774;GO:1902943;GO:0016579;GO:0034976;GO:0048240;GO:0035377;GO:0055085;GO:0006904;, C:apical plasma membrane; C:cell surface; C:chloride channel complex; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:nucleus; C:plasma membrane; C:protein-containing complex; C:recycling endosome; C:recycling endosome membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bicarbonate transmembrane transporter activity; F:chaperone binding; F:chloride channel activity; F:chloride channel inhibitor activity; F:chloride transmembrane transporter activity; F:enzyme binding; F:intracellularly ATP-gated chloride channel activity; F:isomerase activity; F:PDZ domain binding; F:Sec61 translocon complex binding;, P:aggrephagy; P:bicarbonate transport; P:cellular response to cAMP; P:cellular response to forskolin; P:chloride transmembrane transport; P:cholesterol biosynthetic process; P:cholesterol transport; P:intracellular pH elevation; P:membrane hyperpolarization; P:membrane organization; P:multicellular organismal water homeostasis; P:positive regulation of cyclic nucleotide-gated ion channel activity; P:positive regulation of exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of voltage-gated chloride channel activity; P:protein deubiquitination; P:response to endoplasmic reticulum stress; P:sperm capacitation; P:transepithelial water transport; P:transmembrane transport; P:vesicle docking involved in exocytosis;|P13569 Q20BG8 Q20BH2 Q2I0A1 Q2I102,Cystic fibrosis transmembrane conductance regulator,ATP-binding cassette sub-family C member 7;Channel conductance-controlling ATPase;cAMP-dependent chloride channel;, PF00664;PF00005;PF14396;, GO:0016324;GO:0009986;GO:0034707;GO:0030669;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005789;GO:0010008;GO:0030660;GO:0016021;GO:0005887;GO:0005765;GO:0016020;GO:0005634;GO:0005886;GO:0032991;GO:0055037;GO:0055038;GO:0005524;GO:0016887;GO:0042626;GO:0015106;GO:0051087;GO:0005254;GO:0019869;GO:0015108;GO:0019899;GO:0005260;GO:0016853;GO:0030165;GO:0106138;GO:0035973;GO:0015701;GO:0071320;GO:1904322;GO:1902476;GO:0006695;GO:0030301;GO:0051454;GO:0060081;GO:0061024;GO:0050891;GO:1902161;GO:0045921;GO:0035774;GO:1902943;GO:0016579;GO:0034976;GO:0048240;GO:0035377;GO:0055085;GO:0006904;, C:apical plasma membrane; C:cell surface; C:chloride channel complex; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:nucleus; C:plasma membrane; C:protein-containing complex; C:recycling endosome; C:recycling endosome membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bicarbonate transmembrane transporter activity; F:chaperone binding; F:chloride channel activity; F:chloride channel inhibitor activity; F:chloride transmembrane transporter activity; F:enzyme binding; F:intracellularly ATP-gated chloride channel activity; F:isomerase activity; F:PDZ domain binding; F:Sec61 translocon complex binding;, P:aggrephagy; P:bicarbonate transport; P:cellular response to cAMP; P:cellular response to forskolin; P:chloride transmembrane transport; P:cholesterol biosynthetic process; P:cholesterol transport; P:intracellular pH elevation; P:membrane hyperpolarization; P:membrane organization; P:multicellular organismal water homeostasis; P:positive regulation of cyclic nucleotide-gated ion channel activity; P:positive regulation of exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of voltage-gated chloride channel activity; P:protein deubiquitination; P:response to endoplasmic reticulum stress; P:sperm capacitation; P:transepithelial water transport; P:transmembrane transport; P:vesicle docking involved in exocytosis;|P13569 Q20BG8 Q20BH2 Q2I0A1 Q2I102,Cystic fibrosis transmembrane conductance regulator,ATP-binding cassette sub-family C member 7;Channel conductance-controlling ATPase;cAMP-dependent chloride channel;, PF00664;PF00005;PF14396;, GO:0016324;GO:0009986;GO:0034707;GO:0030669;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005789;GO:0010008;GO:0030660;GO:0016021;GO:0005887;GO:0005765;GO:0016020;GO:0005634;GO:0005886;GO:0032991;GO:0055037;GO:0055038;GO:0005524;GO:0016887;GO:0042626;GO:0015106;GO:0051087;GO:0005254;GO:0019869;GO:0015108;GO:0019899;GO:0005260;GO:0016853;GO:0030165;GO:0106138;GO:0035973;GO:0015701;GO:0071320;GO:1904322;GO:1902476;GO:0006695;GO:0030301;GO:0051454;GO:0060081;GO:0061024;GO:0050891;GO:1902161;GO:0045921;GO:0035774;GO:1902943;GO:0016579;GO:0034976;GO:0048240;GO:0035377;GO:0055085;GO:0006904;, C:apical plasma membrane; C:cell surface; C:chloride channel complex; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:nucleus; C:plasma membrane; C:protein-containing complex; C:recycling endosome; C:recycling endosome membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bicarbonate transmembrane transporter activity; F:chaperone binding; F:chloride channel activity; F:chloride channel inhibitor activity; F:chloride transmembrane transporter activity; F:enzyme binding; F:intracellularly ATP-gated chloride channel activity; F:isomerase activity; F:PDZ domain binding; F:Sec61 translocon complex binding;, P:aggrephagy; P:bicarbonate transport; P:cellular response to cAMP; P:cellular response to forskolin; P:chloride transmembrane transport; P:cholesterol biosynthetic process; P:cholesterol transport; P:intracellular pH elevation; P:membrane hyperpolarization; P:membrane organization; P:multicellular organismal water homeostasis; P:positive regulation of cyclic nucleotide-gated ion channel activity; P:positive regulation of exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of voltage-gated chloride channel activity; P:protein deubiquitination; P:response to endoplasmic reticulum stress; P:sperm capacitation; P:transepithelial water transport; P:transmembrane transport; P:vesicle docking involved in exocytosis; scaffold8 indexed_genome mRNA 17604651 17797364 . - . ID=transcript_2141;Q8TDW1 Q8TDW2 Q8TDW3 Q9NXF3,Suppressor of tumorigenicity 7 protein-like,ST7-related protein;, PF04184;, GO:0016021;GO:0030308;, C:integral component of membrane;, , P:negative regulation of cell growth;|Q9BWX4 Q9NRC2 Q9NXZ7,Suppressor of tumorigenicity 7 protein,Protein FAM4A1;Protein HELG;, PF04184;, GO:0016021;GO:0030198;GO:0045595;, C:integral component of membrane;, , P:extracellular matrix organization; P:regulation of cell differentiation;|Q9BWX4 Q9NRC2 Q9NXZ7,Suppressor of tumorigenicity 7 protein,Protein FAM4A1;Protein HELG;, PF04184;, GO:0016021;GO:0030198;GO:0045595;, C:integral component of membrane;, , P:extracellular matrix organization; P:regulation of cell differentiation; scaffold8 indexed_genome mRNA 17880031 17909566 . - . ID=transcript_2142;P47755 B4DG50,F-actin-capping protein subunit alpha-2,CapZ alpha-2;, PF01267;, GO:0015629;GO:0005903;GO:0030863;GO:0005829;GO:0070062;GO:0005576;GO:0008290;GO:0016020;GO:0051015;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0006888;GO:0045087;GO:0065003;, C:actin cytoskeleton; C:brush border; C:cortical cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:F-actin capping protein complex; C:membrane;, F:actin filament binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:protein-containing complex assembly;|P52907 Q53FQ6 Q6FHD5,F-actin-capping protein subunit alpha-1,CapZ alpha-1;, PF01267;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0008290;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0034329;GO:0006888;GO:0045087;GO:0035722;GO:0065003;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:F-actin capping protein complex; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell junction assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:interleukin-12-mediated signaling pathway; P:protein-containing complex assembly; scaffold8 indexed_genome mRNA 18013784 18123500 . - . ID=transcript_2143;P08581 A1L467 B5A932 E7EQ94 O60366 Q12875 Q9UDX7 Q9UPL8,Hepatocyte growth factor receptor,HGF/SF receptor;Proto-oncogene c-Met;Scatter factor receptor;Tyrosine-protein kinase Met;, PF07714;PF01437;PF01403;PF01833;, GO:0009925;GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0005008;GO:0042802;GO:0019903;GO:0004713;GO:0017154;GO:0004714;GO:0048754;GO:0016477;GO:0007166;GO:0001886;GO:0035635;GO:0061436;GO:0001889;GO:0000165;GO:0007275;GO:0010507;GO:1905098;GO:1901299;GO:0035024;GO:0051497;GO:0070495;GO:0007399;GO:0030182;GO:0031016;GO:0006909;GO:0050918;GO:2001028;GO:0033674;GO:0031116;GO:0051897;GO:0045944;GO:0071526;GO:0007165;GO:0007169;, C:basal plasma membrane; C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:hepatocyte growth factor-activated receptor activity; F:identical protein binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:semaphorin receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:branching morphogenesis of an epithelial tube; P:cell migration; P:cell surface receptor signaling pathway; P:endothelial cell morphogenesis; P:entry of bacterium into host cell; P:establishment of skin barrier; P:liver development; P:MAPK cascade; P:multicellular organism development; P:negative regulation of autophagy; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of hydrogen peroxide-mediated programmed cell death; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:negative regulation of thrombin-activated receptor signaling pathway; P:nervous system development; P:neuron differentiation; P:pancreas development; P:phagocytosis; P:positive chemotaxis; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:semaphorin-plexin signaling pathway; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P08581 A1L467 B5A932 E7EQ94 O60366 Q12875 Q9UDX7 Q9UPL8,Hepatocyte growth factor receptor,HGF/SF receptor;Proto-oncogene c-Met;Scatter factor receptor;Tyrosine-protein kinase Met;, PF07714;PF01437;PF01403;PF01833;, GO:0009925;GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0005008;GO:0042802;GO:0019903;GO:0004713;GO:0017154;GO:0004714;GO:0048754;GO:0016477;GO:0007166;GO:0001886;GO:0035635;GO:0061436;GO:0001889;GO:0000165;GO:0007275;GO:0010507;GO:1905098;GO:1901299;GO:0035024;GO:0051497;GO:0070495;GO:0007399;GO:0030182;GO:0031016;GO:0006909;GO:0050918;GO:2001028;GO:0033674;GO:0031116;GO:0051897;GO:0045944;GO:0071526;GO:0007165;GO:0007169;, C:basal plasma membrane; C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:hepatocyte growth factor-activated receptor activity; F:identical protein binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:semaphorin receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:branching morphogenesis of an epithelial tube; P:cell migration; P:cell surface receptor signaling pathway; P:endothelial cell morphogenesis; P:entry of bacterium into host cell; P:establishment of skin barrier; P:liver development; P:MAPK cascade; P:multicellular organism development; P:negative regulation of autophagy; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of hydrogen peroxide-mediated programmed cell death; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:negative regulation of thrombin-activated receptor signaling pathway; P:nervous system development; P:neuron differentiation; P:pancreas development; P:phagocytosis; P:positive chemotaxis; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:semaphorin-plexin signaling pathway; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P08581 A1L467 B5A932 E7EQ94 O60366 Q12875 Q9UDX7 Q9UPL8,Hepatocyte growth factor receptor,HGF/SF receptor;Proto-oncogene c-Met;Scatter factor receptor;Tyrosine-protein kinase Met;, PF07714;PF01437;PF01403;PF01833;, GO:0009925;GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0005008;GO:0042802;GO:0019903;GO:0004713;GO:0017154;GO:0004714;GO:0048754;GO:0016477;GO:0007166;GO:0001886;GO:0035635;GO:0061436;GO:0001889;GO:0000165;GO:0007275;GO:0010507;GO:1905098;GO:1901299;GO:0035024;GO:0051497;GO:0070495;GO:0007399;GO:0030182;GO:0031016;GO:0006909;GO:0050918;GO:2001028;GO:0033674;GO:0031116;GO:0051897;GO:0045944;GO:0071526;GO:0007165;GO:0007169;, C:basal plasma membrane; C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:hepatocyte growth factor-activated receptor activity; F:identical protein binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:semaphorin receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:branching morphogenesis of an epithelial tube; P:cell migration; P:cell surface receptor signaling pathway; P:endothelial cell morphogenesis; P:entry of bacterium into host cell; P:establishment of skin barrier; P:liver development; P:MAPK cascade; P:multicellular organism development; P:negative regulation of autophagy; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of hydrogen peroxide-mediated programmed cell death; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:negative regulation of thrombin-activated receptor signaling pathway; P:nervous system development; P:neuron differentiation; P:pancreas development; P:phagocytosis; P:positive chemotaxis; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:semaphorin-plexin signaling pathway; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P08581 A1L467 B5A932 E7EQ94 O60366 Q12875 Q9UDX7 Q9UPL8,Hepatocyte growth factor receptor,HGF/SF receptor;Proto-oncogene c-Met;Scatter factor receptor;Tyrosine-protein kinase Met;, PF07714;PF01437;PF01403;PF01833;, GO:0009925;GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0005008;GO:0042802;GO:0019903;GO:0004713;GO:0017154;GO:0004714;GO:0048754;GO:0016477;GO:0007166;GO:0001886;GO:0035635;GO:0061436;GO:0001889;GO:0000165;GO:0007275;GO:0010507;GO:1905098;GO:1901299;GO:0035024;GO:0051497;GO:0070495;GO:0007399;GO:0030182;GO:0031016;GO:0006909;GO:0050918;GO:2001028;GO:0033674;GO:0031116;GO:0051897;GO:0045944;GO:0071526;GO:0007165;GO:0007169;, C:basal plasma membrane; C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:hepatocyte growth factor-activated receptor activity; F:identical protein binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:semaphorin receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:branching morphogenesis of an epithelial tube; P:cell migration; P:cell surface receptor signaling pathway; P:endothelial cell morphogenesis; P:entry of bacterium into host cell; P:establishment of skin barrier; P:liver development; P:MAPK cascade; P:multicellular organism development; P:negative regulation of autophagy; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of hydrogen peroxide-mediated programmed cell death; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:negative regulation of thrombin-activated receptor signaling pathway; P:nervous system development; P:neuron differentiation; P:pancreas development; P:phagocytosis; P:positive chemotaxis; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:semaphorin-plexin signaling pathway; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold8 indexed_genome mRNA 18246999 18251010 . + . ID=transcript_2144;Q03135 Q9UGP1 Q9UNG1 Q9UQH6,Caveolin-1,, PF01146;, GO:0002080;GO:0016324;GO:0016323;GO:0005901;GO:0002095;GO:0005938;GO:0005929;GO:0031410;GO:0031901;GO:0030666;GO:0005783;GO:0005789;GO:0005768;GO:0005925;GO:0005794;GO:0000139;GO:0005887;GO:0005811;GO:0016020;GO:0045121;GO:0048471;GO:0005886;GO:0032991;GO:0051117;GO:0015485;GO:0019899;GO:0042802;GO:0070320;GO:0044325;GO:0060090;GO:0050998;GO:0005113;GO:0016504;GO:0046982;GO:0019901;GO:0044877;GO:0030674;GO:0005102;GO:0031267;GO:0001525;GO:0086098;GO:0097190;GO:0071711;GO:1904886;GO:0055074;GO:0006816;GO:0070836;GO:0072584;GO:0030154;GO:0006874;GO:0071360;GO:0071455;GO:0071375;GO:0009267;GO:0071560;GO:0042632;GO:0030301;GO:0000188;GO:0038016;GO:0007595;GO:0050900;GO:0019915;GO:0032507;GO:0030879;GO:0060056;GO:0051899;GO:2000811;GO:0030514;GO:0090090;GO:0001960;GO:0001937;GO:0030857;GO:1903609;GO:0043409;GO:0060546;GO:0045019;GO:0051001;GO:0033137;GO:1900085;GO:0048550;GO:1901380;GO:0032091;GO:0061099;GO:0031397;GO:0046426;GO:0000122;GO:0030512;GO:0042532;GO:0033484;GO:0010524;GO:0090263;GO:0043085;GO:0060355;GO:0030335;GO:0010875;GO:0120162;GO:1903071;GO:2001238;GO:1903598;GO:0010628;GO:2001244;GO:0051092;GO:0033138;GO:0032092;GO:0031398;GO:0034141;GO:0045907;GO:0010608;GO:0008104;GO:1903361;GO:0044860;GO:0015031;GO:0031623;GO:2000286;GO:0019065;GO:0030193;GO:0098909;GO:1901844;GO:0051480;GO:2000535;GO:0019217;GO:0086091;GO:0098903;GO:0050999;GO:0052547;GO:1900027;GO:0006940;GO:0003057;GO:0098911;GO:0009617;GO:0051592;GO:0043627;GO:0001666;GO:0002931;GO:0032570;GO:0007519;GO:0031295;GO:0006641;GO:0001570;GO:0042310;GO:0016050;, C:acrosomal membrane; C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:caveolar macromolecular signaling complex; C:cell cortex; C:cilium; C:cytoplasmic vesicle; C:early endosome membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:focal adhesion; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:lipid droplet; C:membrane; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:ATPase binding; F:cholesterol binding; F:enzyme binding; F:identical protein binding; F:inward rectifier potassium channel inhibitor activity; F:ion channel binding; F:molecular adaptor activity; F:nitric-oxide synthase binding; F:patched binding; F:peptidase activator activity; F:protein heterodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:signaling receptor binding; F:small GTPase binding;, P:angiogenesis; P:angiotensin-activated signaling pathway involved in heart process; P:apoptotic signaling pathway; P:basement membrane organization; P:beta-catenin destruction complex disassembly; P:calcium ion homeostasis; P:calcium ion transport; P:caveola assembly; P:caveolin-mediated endocytosis; P:cell differentiation; P:cellular calcium ion homeostasis; P:cellular response to exogenous dsRNA; P:cellular response to hyperoxia; P:cellular response to peptide hormone stimulus; P:cellular response to starvation; P:cellular response to transforming growth factor beta stimulus; P:cholesterol homeostasis; P:cholesterol transport; P:inactivation of MAPK activity; P:insulin receptor internalization; P:lactation; P:leukocyte migration; P:lipid storage; P:maintenance of protein location in cell; P:mammary gland development; P:mammary gland involution; P:membrane depolarization; P:negative regulation of anoikis; P:negative regulation of BMP signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of endothelial cell proliferation; P:negative regulation of epithelial cell differentiation; P:negative regulation of inward rectifier potassium channel activity; P:negative regulation of MAPK cascade; P:negative regulation of necroptotic process; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-tyrosine autophosphorylation; P:negative regulation of pinocytosis; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of protein binding; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of protein ubiquitination; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nitric oxide homeostasis; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of catalytic activity; P:positive regulation of cell adhesion molecule production; P:positive regulation of cell migration; P:positive regulation of cholesterol efflux; P:positive regulation of cold-induced thermogenesis; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of gap junction assembly; P:positive regulation of gene expression; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of vasoconstriction; P:posttranscriptional regulation of gene expression; P:protein localization; P:protein localization to basolateral plasma membrane; P:protein localization to plasma membrane raft; P:protein transport; P:receptor internalization; P:receptor internalization involved in canonical Wnt signaling pathway; P:receptor-mediated endocytosis of virus by host cell; P:regulation of blood coagulation; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:regulation of entry of bacterium into host cell; P:regulation of fatty acid metabolic process; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization during action potential; P:regulation of nitric-oxide synthase activity; P:regulation of peptidase activity; P:regulation of ruffle assembly; P:regulation of smooth muscle contraction; P:regulation of the force of heart contraction by chemical signal; P:regulation of ventricular cardiac muscle cell action potential; P:response to bacterium; P:response to calcium ion; P:response to estrogen; P:response to hypoxia; P:response to ischemia; P:response to progesterone; P:skeletal muscle tissue development; P:T cell costimulation; P:triglyceride metabolic process; P:vasculogenesis; P:vasoconstriction; P:vesicle organization; scaffold8 indexed_genome mRNA 18259843 18280812 . - . ID=transcript_2145;Q03135 Q9UGP1 Q9UNG1 Q9UQH6,Caveolin-1,, PF01146;, GO:0002080;GO:0016324;GO:0016323;GO:0005901;GO:0002095;GO:0005938;GO:0005929;GO:0031410;GO:0031901;GO:0030666;GO:0005783;GO:0005789;GO:0005768;GO:0005925;GO:0005794;GO:0000139;GO:0005887;GO:0005811;GO:0016020;GO:0045121;GO:0048471;GO:0005886;GO:0032991;GO:0051117;GO:0015485;GO:0019899;GO:0042802;GO:0070320;GO:0044325;GO:0060090;GO:0050998;GO:0005113;GO:0016504;GO:0046982;GO:0019901;GO:0044877;GO:0030674;GO:0005102;GO:0031267;GO:0001525;GO:0086098;GO:0097190;GO:0071711;GO:1904886;GO:0055074;GO:0006816;GO:0070836;GO:0072584;GO:0030154;GO:0006874;GO:0071360;GO:0071455;GO:0071375;GO:0009267;GO:0071560;GO:0042632;GO:0030301;GO:0000188;GO:0038016;GO:0007595;GO:0050900;GO:0019915;GO:0032507;GO:0030879;GO:0060056;GO:0051899;GO:2000811;GO:0030514;GO:0090090;GO:0001960;GO:0001937;GO:0030857;GO:1903609;GO:0043409;GO:0060546;GO:0045019;GO:0051001;GO:0033137;GO:1900085;GO:0048550;GO:1901380;GO:0032091;GO:0061099;GO:0031397;GO:0046426;GO:0000122;GO:0030512;GO:0042532;GO:0033484;GO:0010524;GO:0090263;GO:0043085;GO:0060355;GO:0030335;GO:0010875;GO:0120162;GO:1903071;GO:2001238;GO:1903598;GO:0010628;GO:2001244;GO:0051092;GO:0033138;GO:0032092;GO:0031398;GO:0034141;GO:0045907;GO:0010608;GO:0008104;GO:1903361;GO:0044860;GO:0015031;GO:0031623;GO:2000286;GO:0019065;GO:0030193;GO:0098909;GO:1901844;GO:0051480;GO:2000535;GO:0019217;GO:0086091;GO:0098903;GO:0050999;GO:0052547;GO:1900027;GO:0006940;GO:0003057;GO:0098911;GO:0009617;GO:0051592;GO:0043627;GO:0001666;GO:0002931;GO:0032570;GO:0007519;GO:0031295;GO:0006641;GO:0001570;GO:0042310;GO:0016050;, C:acrosomal membrane; C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:caveolar macromolecular signaling complex; C:cell cortex; C:cilium; C:cytoplasmic vesicle; C:early endosome membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:focal adhesion; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:lipid droplet; C:membrane; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:ATPase binding; F:cholesterol binding; F:enzyme binding; F:identical protein binding; F:inward rectifier potassium channel inhibitor activity; F:ion channel binding; F:molecular adaptor activity; F:nitric-oxide synthase binding; F:patched binding; F:peptidase activator activity; F:protein heterodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:signaling receptor binding; F:small GTPase binding;, P:angiogenesis; P:angiotensin-activated signaling pathway involved in heart process; P:apoptotic signaling pathway; P:basement membrane organization; P:beta-catenin destruction complex disassembly; P:calcium ion homeostasis; P:calcium ion transport; P:caveola assembly; P:caveolin-mediated endocytosis; P:cell differentiation; P:cellular calcium ion homeostasis; P:cellular response to exogenous dsRNA; P:cellular response to hyperoxia; P:cellular response to peptide hormone stimulus; P:cellular response to starvation; P:cellular response to transforming growth factor beta stimulus; P:cholesterol homeostasis; P:cholesterol transport; P:inactivation of MAPK activity; P:insulin receptor internalization; P:lactation; P:leukocyte migration; P:lipid storage; P:maintenance of protein location in cell; P:mammary gland development; P:mammary gland involution; P:membrane depolarization; P:negative regulation of anoikis; P:negative regulation of BMP signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of endothelial cell proliferation; P:negative regulation of epithelial cell differentiation; P:negative regulation of inward rectifier potassium channel activity; P:negative regulation of MAPK cascade; P:negative regulation of necroptotic process; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-tyrosine autophosphorylation; P:negative regulation of pinocytosis; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of protein binding; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of protein ubiquitination; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nitric oxide homeostasis; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of catalytic activity; P:positive regulation of cell adhesion molecule production; P:positive regulation of cell migration; P:positive regulation of cholesterol efflux; P:positive regulation of cold-induced thermogenesis; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of gap junction assembly; P:positive regulation of gene expression; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of vasoconstriction; P:posttranscriptional regulation of gene expression; P:protein localization; P:protein localization to basolateral plasma membrane; P:protein localization to plasma membrane raft; P:protein transport; P:receptor internalization; P:receptor internalization involved in canonical Wnt signaling pathway; P:receptor-mediated endocytosis of virus by host cell; P:regulation of blood coagulation; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:regulation of entry of bacterium into host cell; P:regulation of fatty acid metabolic process; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization during action potential; P:regulation of nitric-oxide synthase activity; P:regulation of peptidase activity; P:regulation of ruffle assembly; P:regulation of smooth muscle contraction; P:regulation of the force of heart contraction by chemical signal; P:regulation of ventricular cardiac muscle cell action potential; P:response to bacterium; P:response to calcium ion; P:response to estrogen; P:response to hypoxia; P:response to ischemia; P:response to progesterone; P:skeletal muscle tissue development; P:T cell costimulation; P:triglyceride metabolic process; P:vasculogenesis; P:vasoconstriction; P:vesicle organization; scaffold8 indexed_genome mRNA 18299559 18306932 . - . ID=transcript_2146;P51636 A4D0U2 Q9UGM7,Caveolin-2,, PF01146;, GO:0002080;GO:0005901;GO:0002095;GO:0031410;GO:0031234;GO:0005925;GO:0005794;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030133;GO:0031748;GO:0060090;GO:0046982;GO:0042803;GO:0019901;GO:0030674;GO:0097110;GO:0071711;GO:0070836;GO:0030154;GO:0007029;GO:0008286;GO:0007005;GO:0001937;GO:0030512;GO:0044794;GO:0044791;GO:0060161;GO:0001938;GO:0043547;GO:0043410;GO:0019065;GO:0051480;GO:0007088;GO:0048741;GO:0048278;GO:0006906;GO:0016050;, C:acrosomal membrane; C:caveola; C:caveolar macromolecular signaling complex; C:cytoplasmic vesicle; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:transport vesicle;, F:D1 dopamine receptor binding; F:molecular adaptor activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:scaffold protein binding;, P:basement membrane organization; P:caveola assembly; P:cell differentiation; P:endoplasmic reticulum organization; P:insulin receptor signaling pathway; P:mitochondrion organization; P:negative regulation of endothelial cell proliferation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation by host of viral process; P:positive regulation by host of viral release from host cell; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of endothelial cell proliferation; P:positive regulation of GTPase activity; P:positive regulation of MAPK cascade; P:receptor-mediated endocytosis of virus by host cell; P:regulation of cytosolic calcium ion concentration; P:regulation of mitotic nuclear division; P:skeletal muscle fiber development; P:vesicle docking; P:vesicle fusion; P:vesicle organization;|P51636 A4D0U2 Q9UGM7,Caveolin-2,, PF01146;, GO:0002080;GO:0005901;GO:0002095;GO:0031410;GO:0031234;GO:0005925;GO:0005794;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030133;GO:0031748;GO:0060090;GO:0046982;GO:0042803;GO:0019901;GO:0030674;GO:0097110;GO:0071711;GO:0070836;GO:0030154;GO:0007029;GO:0008286;GO:0007005;GO:0001937;GO:0030512;GO:0044794;GO:0044791;GO:0060161;GO:0001938;GO:0043547;GO:0043410;GO:0019065;GO:0051480;GO:0007088;GO:0048741;GO:0048278;GO:0006906;GO:0016050;, C:acrosomal membrane; C:caveola; C:caveolar macromolecular signaling complex; C:cytoplasmic vesicle; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:transport vesicle;, F:D1 dopamine receptor binding; F:molecular adaptor activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:scaffold protein binding;, P:basement membrane organization; P:caveola assembly; P:cell differentiation; P:endoplasmic reticulum organization; P:insulin receptor signaling pathway; P:mitochondrion organization; P:negative regulation of endothelial cell proliferation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation by host of viral process; P:positive regulation by host of viral release from host cell; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of endothelial cell proliferation; P:positive regulation of GTPase activity; P:positive regulation of MAPK cascade; P:receptor-mediated endocytosis of virus by host cell; P:regulation of cytosolic calcium ion concentration; P:regulation of mitotic nuclear division; P:skeletal muscle fiber development; P:vesicle docking; P:vesicle fusion; P:vesicle organization; scaffold8 indexed_genome mRNA 18528302 18581161 . - . ID=transcript_2147;Q9UGI8 A4D0U6 Q9GZQ1 Q9HAJ9,Testin,TESS;, PF00412;PF06297;, GO:0030054;GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0032991;GO:0045296;GO:0003723;GO:0008270;GO:0008285;, C:cell junction; C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:cadherin binding; F:RNA binding; F:zinc ion binding;, P:negative regulation of cell population proliferation; scaffold8 indexed_genome mRNA 18786530 18836262 . + . ID=transcript_2148;O14948 B2R8X5 Q5H9U8 Q709A4 Q8N6J9,Transcription factor EC,Class E basic helix-loop-helix protein 34;Transcription factor EC-like;, PF11851;PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:1990837;GO:0034605;GO:0000122;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to heat; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 18852483 18853395 . - . ID=transcript_2149;O14948 B2R8X5 Q5H9U8 Q709A4 Q8N6J9,Transcription factor EC,Class E basic helix-loop-helix protein 34;Transcription factor EC-like;, PF11851;PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:1990837;GO:0034605;GO:0000122;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to heat; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 19777321 19871464 . - . ID=transcript_2150;Q9P1T7 Q9P1T6,MyoD family inhibitor domain-containing protein,I-mfa domain-containing protein;, PF15316;, GO:0005737;GO:0005730;GO:0005634;GO:0030332;GO:0030957;GO:0008134;GO:0007257;GO:0042308;GO:0045892;GO:0045893;GO:0050434;GO:0030111;GO:0016032;, C:cytoplasm; C:nucleolus; C:nucleus;, F:cyclin binding; F:Tat protein binding; F:transcription factor binding;, P:activation of JUN kinase activity; P:negative regulation of protein import into nucleus; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral transcription; P:regulation of Wnt signaling pathway; P:viral process;|Q9P1T7 Q9P1T6,MyoD family inhibitor domain-containing protein,I-mfa domain-containing protein;, PF15316;, GO:0005737;GO:0005730;GO:0005634;GO:0030332;GO:0030957;GO:0008134;GO:0007257;GO:0042308;GO:0045892;GO:0045893;GO:0050434;GO:0030111;GO:0016032;, C:cytoplasm; C:nucleolus; C:nucleus;, F:cyclin binding; F:Tat protein binding; F:transcription factor binding;, P:activation of JUN kinase activity; P:negative regulation of protein import into nucleus; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral transcription; P:regulation of Wnt signaling pathway; P:viral process; scaffold8 indexed_genome mRNA 20077345 20115748 . - . ID=transcript_2151;Q8N6B7 Q8N6B8 Q8NFQ1 Q8NFQ2 Q8NFQ3 Q8NFQ4 Q8TD74,Forkhead box protein P2,CAG repeat protein 44;Trinucleotide repeat-containing gene 10 protein;, PF00250;PF16159;, GO:0000785;GO:0005634;GO:0050681;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0042802;GO:0046872;GO:0042803;GO:0000978;GO:0043565;GO:0021757;GO:0021987;GO:0098582;GO:0000122;GO:0045892;GO:0021758;GO:0006357;GO:0033574;, C:chromatin; C:nucleus;, F:androgen receptor binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:caudate nucleus development; P:cerebral cortex development; P:innate vocalization behavior; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:putamen development; P:regulation of transcription by RNA polymerase II; P:response to testosterone; scaffold8 indexed_genome mRNA 20800732 20839410 . + . ID=transcript_2152;Q16821 A0AVQ2 A4D0T6 O43476 Q75LN8 Q7KYM8 Q86UI6,Protein phosphatase 1 regulatory subunit 3A,Protein phosphatase 1 glycogen-associated regulatory subunit;Protein phosphatase type-1 glycogen targeting subunit;, PF03370;, GO:0016021;GO:0000164;GO:2001069;GO:0008157;GO:0005977;GO:0005979;, C:integral component of membrane; C:protein phosphatase type 1 complex;, F:glycogen binding; F:protein phosphatase 1 binding;, P:glycogen metabolic process; P:regulation of glycogen biosynthetic process;|Q16821 A0AVQ2 A4D0T6 O43476 Q75LN8 Q7KYM8 Q86UI6,Protein phosphatase 1 regulatory subunit 3A,Protein phosphatase 1 glycogen-associated regulatory subunit;Protein phosphatase type-1 glycogen targeting subunit;, PF03370;, GO:0016021;GO:0000164;GO:2001069;GO:0008157;GO:0005977;GO:0005979;, C:integral component of membrane; C:protein phosphatase type 1 complex;, F:glycogen binding; F:protein phosphatase 1 binding;, P:glycogen metabolic process; P:regulation of glycogen biosynthetic process; scaffold8 indexed_genome mRNA 21530307 21532696 . + . ID=transcript_2153;A4D0T7 Q32Q38,Small integral membrane protein 30,, PF15873;, GO:0016021;, C:integral component of membrane; scaffold8 indexed_genome mRNA 21558875 21563049 . + . ID=transcript_2154;P60893 Q9JHI6 Q9NPD1,Probable G-protein coupled receptor 85,Super conserved receptor expressed in brain 2;, PF00001;, GO:0005783;GO:0016021;GO:0005886;GO:0004930;GO:0007165;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:signal transduction; scaffold8 indexed_genome mRNA 21686164 21765575 . + . ID=transcript_2155;Q1RMZ1 Q8N3D0 Q96MV7,S-adenosylmethionine sensor upstream of mTORC1 {ECO:0000255|HAMAP-Rule:MF_03044, ECO:0000303|PubMed:29123071},Probable methyltransferase BMT2 homolog {ECO:0000255|HAMAP-Rule:MF_03044};, PF11968;, GO:0005829;GO:0005730;GO:0016433;GO:1904047;GO:0034198;GO:1904262;, C:cytosol; C:nucleolus;, F:rRNA (adenine) methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:cellular response to amino acid starvation; P:negative regulation of TORC1 signaling;|Q1RMZ1 Q8N3D0 Q96MV7,S-adenosylmethionine sensor upstream of mTORC1 {ECO:0000255|HAMAP-Rule:MF_03044, ECO:0000303|PubMed:29123071},Probable methyltransferase BMT2 homolog {ECO:0000255|HAMAP-Rule:MF_03044};, PF11968;, GO:0005829;GO:0005730;GO:0016433;GO:1904047;GO:0034198;GO:1904262;, C:cytosol; C:nucleolus;, F:rRNA (adenine) methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:cellular response to amino acid starvation; P:negative regulation of TORC1 signaling; scaffold8 indexed_genome mRNA 21780997 21831450 . + . ID=transcript_2156;Q9H0V1 A4D0T9 B4DDS0 Q8NEK4 Q9H8J2,Transmembrane protein 168,, , GO:0016021;GO:0030133;, C:integral component of membrane; C:transport vesicle; scaffold8 indexed_genome mRNA 22045541 22055824 . + . ID=transcript_2157;Q8N8F7 Q49AR6,Leucine-rich single-pass membrane protein 1,, PF15145;, GO:0016021;, C:integral component of membrane;|Q8N8F7 Q49AR6,Leucine-rich single-pass membrane protein 1,, PF15145;, GO:0016021;, C:integral component of membrane;|Q8N8F7 Q49AR6,Leucine-rich single-pass membrane protein 1,, PF15145;, GO:0016021;, C:integral component of membrane; scaffold8 indexed_genome mRNA 22060911 22069268 . - . ID=transcript_2158;O00458 B7Z5G1 O75234 Q5U013 Q9BVE4,Interferon-related developmental regulator 1,Nerve growth factor-inducible protein PC4;, PF05004;PF04836;, GO:0005634;GO:0007275;GO:0007518;GO:0006357;, C:nucleus;, , P:multicellular organism development; P:myoblast fate determination; P:regulation of transcription by RNA polymerase II;|O00458 B7Z5G1 O75234 Q5U013 Q9BVE4,Interferon-related developmental regulator 1,Nerve growth factor-inducible protein PC4;, PF05004;PF04836;, GO:0005634;GO:0007275;GO:0007518;GO:0006357;, C:nucleus;, , P:multicellular organism development; P:myoblast fate determination; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 22069292 22075181 . - . ID=transcript_2159;O00458 B7Z5G1 O75234 Q5U013 Q9BVE4,Interferon-related developmental regulator 1,Nerve growth factor-inducible protein PC4;, PF05004;PF04836;, GO:0005634;GO:0007275;GO:0007518;GO:0006357;, C:nucleus;, , P:multicellular organism development; P:myoblast fate determination; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 22075213 22154451 . + . ID=transcript_2160;O00458 B7Z5G1 O75234 Q5U013 Q9BVE4,Interferon-related developmental regulator 1,Nerve growth factor-inducible protein PC4;, PF05004;PF04836;, GO:0005634;GO:0007275;GO:0007518;GO:0006357;, C:nucleus;, , P:multicellular organism development; P:myoblast fate determination; P:regulation of transcription by RNA polymerase II;|O00458 B7Z5G1 O75234 Q5U013 Q9BVE4,Interferon-related developmental regulator 1,Nerve growth factor-inducible protein PC4;, PF05004;PF04836;, GO:0005634;GO:0007275;GO:0007518;GO:0006357;, C:nucleus;, , P:multicellular organism development; P:myoblast fate determination; P:regulation of transcription by RNA polymerase II;|O00458 B7Z5G1 O75234 Q5U013 Q9BVE4,Interferon-related developmental regulator 1,Nerve growth factor-inducible protein PC4;, PF05004;PF04836;, GO:0005634;GO:0007275;GO:0007518;GO:0006357;, C:nucleus;, , P:multicellular organism development; P:myoblast fate determination; P:regulation of transcription by RNA polymerase II;|O00458 B7Z5G1 O75234 Q5U013 Q9BVE4,Interferon-related developmental regulator 1,Nerve growth factor-inducible protein PC4;, PF05004;PF04836;, GO:0005634;GO:0007275;GO:0007518;GO:0006357;, C:nucleus;, , P:multicellular organism development; P:myoblast fate determination; P:regulation of transcription by RNA polymerase II;|O00458 B7Z5G1 O75234 Q5U013 Q9BVE4,Interferon-related developmental regulator 1,Nerve growth factor-inducible protein PC4;, PF05004;PF04836;, GO:0005634;GO:0007275;GO:0007518;GO:0006357;, C:nucleus;, , P:multicellular organism development; P:myoblast fate determination; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 22173785 22307513 . - . ID=transcript_2161;Q9NRM2 Q75MZ2 Q75MZ3 Q8WY14,Zinc finger protein 277,Nuclear receptor-interacting factor 4;, PF12756;, GO:0005634;GO:0046872;GO:0000978;GO:0070301;GO:2000772;, C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to hydrogen peroxide; P:regulation of cellular senescence;|Q9NRM2 Q75MZ2 Q75MZ3 Q8WY14,Zinc finger protein 277,Nuclear receptor-interacting factor 4;, PF12756;, GO:0005634;GO:0046872;GO:0000978;GO:0070301;GO:2000772;, C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to hydrogen peroxide; P:regulation of cellular senescence; scaffold8 indexed_genome mRNA 22307831 22778447 . + . ID=transcript_2162;Q8N1I0 O14584 O94824 Q8NB45,Dedicator of cytokinesis protein 4,, PF06920;PF14429;PF16172;PF07653;, GO:0005829;GO:0005794;GO:0016020;GO:0005730;GO:0005886;GO:0032420;GO:0032421;GO:0005096;GO:0005085;GO:0030165;GO:0030971;GO:0017124;GO:0031267;GO:0060326;GO:1904694;GO:1904754;GO:0007264;, C:cytosol; C:Golgi apparatus; C:membrane; C:nucleolus; C:plasma membrane; C:stereocilium; C:stereocilium bundle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:receptor tyrosine kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:cell chemotaxis; P:negative regulation of vascular associated smooth muscle contraction; P:positive regulation of vascular associated smooth muscle cell migration; P:small GTPase mediated signal transduction;|Q8N1I0 O14584 O94824 Q8NB45,Dedicator of cytokinesis protein 4,, PF06920;PF14429;PF16172;PF07653;, GO:0005829;GO:0005794;GO:0016020;GO:0005730;GO:0005886;GO:0032420;GO:0032421;GO:0005096;GO:0005085;GO:0030165;GO:0030971;GO:0017124;GO:0031267;GO:0060326;GO:1904694;GO:1904754;GO:0007264;, C:cytosol; C:Golgi apparatus; C:membrane; C:nucleolus; C:plasma membrane; C:stereocilium; C:stereocilium bundle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:receptor tyrosine kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:cell chemotaxis; P:negative regulation of vascular associated smooth muscle contraction; P:positive regulation of vascular associated smooth muscle cell migration; P:small GTPase mediated signal transduction;|Q8N1I0 O14584 O94824 Q8NB45,Dedicator of cytokinesis protein 4,, PF06920;PF14429;PF16172;PF07653;, GO:0005829;GO:0005794;GO:0016020;GO:0005730;GO:0005886;GO:0032420;GO:0032421;GO:0005096;GO:0005085;GO:0030165;GO:0030971;GO:0017124;GO:0031267;GO:0060326;GO:1904694;GO:1904754;GO:0007264;, C:cytosol; C:Golgi apparatus; C:membrane; C:nucleolus; C:plasma membrane; C:stereocilium; C:stereocilium bundle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:receptor tyrosine kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:cell chemotaxis; P:negative regulation of vascular associated smooth muscle contraction; P:positive regulation of vascular associated smooth muscle cell migration; P:small GTPase mediated signal transduction;|Q8N1I0 O14584 O94824 Q8NB45,Dedicator of cytokinesis protein 4,, PF06920;PF14429;PF16172;PF07653;, GO:0005829;GO:0005794;GO:0016020;GO:0005730;GO:0005886;GO:0032420;GO:0032421;GO:0005096;GO:0005085;GO:0030165;GO:0030971;GO:0017124;GO:0031267;GO:0060326;GO:1904694;GO:1904754;GO:0007264;, C:cytosol; C:Golgi apparatus; C:membrane; C:nucleolus; C:plasma membrane; C:stereocilium; C:stereocilium bundle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:receptor tyrosine kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:cell chemotaxis; P:negative regulation of vascular associated smooth muscle contraction; P:positive regulation of vascular associated smooth muscle cell migration; P:small GTPase mediated signal transduction; scaffold8 indexed_genome mRNA 23006592 23478451 . - . ID=transcript_2163;Q96T52 Q75MF1 Q75MN9 Q75MP0 Q75MS5 Q75MS8 Q96HJ2,Mitochondrial inner membrane protease subunit 2,IMP2-like protein;, PF10502;, GO:0016021;GO:0042720;GO:0008233;GO:0004252;GO:0008015;GO:0007420;GO:0006974;GO:0061300;GO:0033108;GO:0001541;GO:0030728;GO:0006627;GO:0022904;GO:0006465;GO:0007283;GO:0006801;, C:integral component of membrane; C:mitochondrial inner membrane peptidase complex;, F:peptidase activity; F:serine-type endopeptidase activity;, P:blood circulation; P:brain development; P:cellular response to DNA damage stimulus; P:cerebellum vasculature development; P:mitochondrial respiratory chain complex assembly; P:ovarian follicle development; P:ovulation; P:protein processing involved in protein targeting to mitochondrion; P:respiratory electron transport chain; P:signal peptide processing; P:spermatogenesis; P:superoxide metabolic process;|Q9H3W5 O43377 Q6I9V8 Q8IYQ6,Leucine-rich repeat neuronal protein 3,Neuronal leucine-rich repeat protein 3;, PF00041;PF07679;PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0051965;, C:extracellular matrix; C:extracellular space; C:integral component of membrane;, , P:positive regulation of synapse assembly; scaffold8 indexed_genome mRNA 25547773 25552828 . - . ID=transcript_2164;Q9UBS3,DnaJ homolog subfamily B member 9 {ECO:0000305},Endoplasmic reticulum DNA J domain-containing protein 4 {ECO:0000303|PubMed:18400946};Microvascular endothelial differentiation gene 1 protein {ECO:0000303|Ref.1};, PF00226;, GO:0005737;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005730;GO:0051087;GO:0030544;GO:0051787;GO:0030183;GO:0036498;GO:1903895;GO:0002639;GO:0034976;GO:0030433;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:nucleolus;, F:chaperone binding; F:Hsp70 protein binding; F:misfolded protein binding;, P:B cell differentiation; P:IRE1-mediated unfolded protein response; P:negative regulation of IRE1-mediated unfolded protein response; P:positive regulation of immunoglobulin production; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent ERAD pathway;|Q9UBS3,DnaJ homolog subfamily B member 9 {ECO:0000305},Endoplasmic reticulum DNA J domain-containing protein 4 {ECO:0000303|PubMed:18400946};Microvascular endothelial differentiation gene 1 protein {ECO:0000303|Ref.1};, PF00226;, GO:0005737;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005730;GO:0051087;GO:0030544;GO:0051787;GO:0030183;GO:0036498;GO:1903895;GO:0002639;GO:0034976;GO:0030433;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:nucleolus;, F:chaperone binding; F:Hsp70 protein binding; F:misfolded protein binding;, P:B cell differentiation; P:IRE1-mediated unfolded protein response; P:negative regulation of IRE1-mediated unfolded protein response; P:positive regulation of immunoglobulin production; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent ERAD pathway; scaffold8 indexed_genome mRNA 25556472 25566196 . + . ID=transcript_2165;Q7Z6K1,THAP domain-containing protein 5,, PF05485;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0002020;GO:0007049;GO:0045786;GO:0000122;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:protease binding;, P:cell cycle; P:negative regulation of cell cycle; P:negative regulation of transcription by RNA polymerase II;|Q7Z6K1,THAP domain-containing protein 5,, PF05485;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0002020;GO:0007049;GO:0045786;GO:0000122;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:protease binding;, P:cell cycle; P:negative regulation of cell cycle; P:negative regulation of transcription by RNA polymerase II;|Q7Z6K1,THAP domain-containing protein 5,, PF05485;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0002020;GO:0007049;GO:0045786;GO:0000122;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:protease binding;, P:cell cycle; P:negative regulation of cell cycle; P:negative regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 25595621 25597913 . - . ID=transcript_2166;Q7Z602 A4D1X7 Q0VAR5 Q86SP3,Probable G-protein coupled receptor 141,G-protein coupled receptor PGR13;, PF00001;, GO:0016021;GO:0005886;GO:0004930;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity; scaffold8 indexed_genome mRNA 25802841 26081285 . + . ID=transcript_2167;Q92556 A4D1X6 Q29R79 Q6ZTJ0 Q96PB0 Q9H0I1,Engulfment and cell motility protein 1,Protein ced-12 homolog;, PF11841;PF04727;PF16457;, GO:0005737;GO:0005829;GO:0032045;GO:0016020;GO:0005886;GO:0017124;GO:0030036;GO:0007015;GO:0006915;GO:0016477;GO:0048870;GO:0038096;GO:0006911;GO:0016601;GO:0050790;GO:0050690;GO:0048010;, C:cytoplasm; C:cytosol; C:guanyl-nucleotide exchange factor complex; C:membrane; C:plasma membrane;, F:SH3 domain binding;, P:actin cytoskeleton organization; P:actin filament organization; P:apoptotic process; P:cell migration; P:cell motility; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:phagocytosis, engulfment; P:Rac protein signal transduction; P:regulation of catalytic activity; P:regulation of defense response to virus by virus; P:vascular endothelial growth factor receptor signaling pathway; scaffold8 indexed_genome mRNA 26340241 26381625 . + . ID=transcript_2168;Q92556 A4D1X6 Q29R79 Q6ZTJ0 Q96PB0 Q9H0I1,Engulfment and cell motility protein 1,Protein ced-12 homolog;, PF11841;PF04727;PF16457;, GO:0005737;GO:0005829;GO:0032045;GO:0016020;GO:0005886;GO:0017124;GO:0030036;GO:0007015;GO:0006915;GO:0016477;GO:0048870;GO:0038096;GO:0006911;GO:0016601;GO:0050790;GO:0050690;GO:0048010;, C:cytoplasm; C:cytosol; C:guanyl-nucleotide exchange factor complex; C:membrane; C:plasma membrane;, F:SH3 domain binding;, P:actin cytoskeleton organization; P:actin filament organization; P:apoptotic process; P:cell migration; P:cell motility; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:phagocytosis, engulfment; P:Rac protein signal transduction; P:regulation of catalytic activity; P:regulation of defense response to virus by virus; P:vascular endothelial growth factor receptor signaling pathway;|Q92556 A4D1X6 Q29R79 Q6ZTJ0 Q96PB0 Q9H0I1,Engulfment and cell motility protein 1,Protein ced-12 homolog;, PF11841;PF04727;PF16457;, GO:0005737;GO:0005829;GO:0032045;GO:0016020;GO:0005886;GO:0017124;GO:0030036;GO:0007015;GO:0006915;GO:0016477;GO:0048870;GO:0038096;GO:0006911;GO:0016601;GO:0050790;GO:0050690;GO:0048010;, C:cytoplasm; C:cytosol; C:guanyl-nucleotide exchange factor complex; C:membrane; C:plasma membrane;, F:SH3 domain binding;, P:actin cytoskeleton organization; P:actin filament organization; P:apoptotic process; P:cell migration; P:cell motility; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:phagocytosis, engulfment; P:Rac protein signal transduction; P:regulation of catalytic activity; P:regulation of defense response to virus by virus; P:vascular endothelial growth factor receptor signaling pathway; scaffold8 indexed_genome mRNA 26475586 26655067 . + . ID=transcript_2169;P28039 A4D1Y5 B7Z490 Q53F13,Acyloxyacyl hydrolase {ECO:0000303|PubMed:1883828},, PF00657;PF03489;, GO:0031410;GO:0005576;GO:0043231;GO:0050528;GO:0005509;GO:0006631;GO:0009104;GO:0050728;, C:cytoplasmic vesicle; C:extracellular region; C:intracellular membrane-bounded organelle;, F:acyloxyacyl hydrolase activity; F:calcium ion binding;, P:fatty acid metabolic process; P:lipopolysaccharide catabolic process; P:negative regulation of inflammatory response; scaffold8 indexed_genome mRNA 26695767 26742016 . - . ID=transcript_2170;Q9NQW6 Q5CZ78 Q6NSK5 Q9H8Y4 Q9NVN9 Q9NVP0,Anillin,, PF08174;PF16018;PF00169;, GO:0015629;GO:0005826;GO:0032059;GO:0099738;GO:0030496;GO:0005654;GO:0003779;GO:0045296;GO:0000915;GO:0090521;GO:0000281;GO:1904172;GO:0007096;GO:0000921;GO:0031106;, C:actin cytoskeleton; C:actomyosin contractile ring; C:bleb; C:cell cortex region; C:midbody; C:nucleoplasm;, F:actin binding; F:cadherin binding;, P:actomyosin contractile ring assembly; P:glomerular visceral epithelial cell migration; P:mitotic cytokinesis; P:positive regulation of bleb assembly; P:regulation of exit from mitosis; P:septin ring assembly; P:septin ring organization;|Q9NQW6 Q5CZ78 Q6NSK5 Q9H8Y4 Q9NVN9 Q9NVP0,Anillin,, PF08174;PF16018;PF00169;, GO:0015629;GO:0005826;GO:0032059;GO:0099738;GO:0030496;GO:0005654;GO:0003779;GO:0045296;GO:0000915;GO:0090521;GO:0000281;GO:1904172;GO:0007096;GO:0000921;GO:0031106;, C:actin cytoskeleton; C:actomyosin contractile ring; C:bleb; C:cell cortex region; C:midbody; C:nucleoplasm;, F:actin binding; F:cadherin binding;, P:actomyosin contractile ring assembly; P:glomerular visceral epithelial cell migration; P:mitotic cytokinesis; P:positive regulation of bleb assembly; P:regulation of exit from mitosis; P:septin ring assembly; P:septin ring organization;|Q9NQW6 Q5CZ78 Q6NSK5 Q9H8Y4 Q9NVN9 Q9NVP0,Anillin,, PF08174;PF16018;PF00169;, GO:0015629;GO:0005826;GO:0032059;GO:0099738;GO:0030496;GO:0005654;GO:0003779;GO:0045296;GO:0000915;GO:0090521;GO:0000281;GO:1904172;GO:0007096;GO:0000921;GO:0031106;, C:actin cytoskeleton; C:actomyosin contractile ring; C:bleb; C:cell cortex region; C:midbody; C:nucleoplasm;, F:actin binding; F:cadherin binding;, P:actomyosin contractile ring assembly; P:glomerular visceral epithelial cell migration; P:mitotic cytokinesis; P:positive regulation of bleb assembly; P:regulation of exit from mitosis; P:septin ring assembly; P:septin ring organization; scaffold8 indexed_genome mRNA 26859987 26982248 . - . ID=transcript_2171;Q7L9B9 Q96K64 Q9C0F7,Endonuclease/exonuclease/phosphatase family domain-containing protein 1,, , GO:0046658;GO:0005886;GO:0003677;GO:0006281;GO:0030522;GO:0010875;, C:anchored component of plasma membrane; C:plasma membrane;, F:DNA binding;, P:DNA repair; P:intracellular receptor signaling pathway; P:positive regulation of cholesterol efflux; scaffold8 indexed_genome mRNA 27111130 27206462 . - . ID=transcript_2172;Q16181 Q52M76 Q6NX50,Septin-7,CDC10 protein homolog;, PF00735;, GO:0005930;GO:0032153;GO:0032154;GO:0000777;GO:0005829;GO:0070062;GO:0015630;GO:0030496;GO:0097730;GO:0005634;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0001725;GO:0045296;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0005198;GO:0030154;GO:0034613;GO:0060271;GO:0061640;GO:1902857;GO:0016476;GO:0007283;, C:axoneme; C:cell division site; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:midbody; C:non-motile cilium; C:nucleus; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:stress fiber;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity; F:structural molecule activity;, P:cell differentiation; P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:positive regulation of non-motile cilium assembly; P:regulation of embryonic cell shape; P:spermatogenesis;|Q16181 Q52M76 Q6NX50,Septin-7,CDC10 protein homolog;, PF00735;, GO:0005930;GO:0032153;GO:0032154;GO:0000777;GO:0005829;GO:0070062;GO:0015630;GO:0030496;GO:0097730;GO:0005634;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0001725;GO:0045296;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0005198;GO:0030154;GO:0034613;GO:0060271;GO:0061640;GO:1902857;GO:0016476;GO:0007283;, C:axoneme; C:cell division site; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:midbody; C:non-motile cilium; C:nucleus; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:stress fiber;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity; F:structural molecule activity;, P:cell differentiation; P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:positive regulation of non-motile cilium assembly; P:regulation of embryonic cell shape; P:spermatogenesis;|Q16181 Q52M76 Q6NX50,Septin-7,CDC10 protein homolog;, PF00735;, GO:0005930;GO:0032153;GO:0032154;GO:0000777;GO:0005829;GO:0070062;GO:0015630;GO:0030496;GO:0097730;GO:0005634;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0001725;GO:0045296;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0005198;GO:0030154;GO:0034613;GO:0060271;GO:0061640;GO:1902857;GO:0016476;GO:0007283;, C:axoneme; C:cell division site; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:midbody; C:non-motile cilium; C:nucleus; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:stress fiber;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity; F:structural molecule activity;, P:cell differentiation; P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:positive regulation of non-motile cilium assembly; P:regulation of embryonic cell shape; P:spermatogenesis;|Q16181 Q52M76 Q6NX50,Septin-7,CDC10 protein homolog;, PF00735;, GO:0005930;GO:0032153;GO:0032154;GO:0000777;GO:0005829;GO:0070062;GO:0015630;GO:0030496;GO:0097730;GO:0005634;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0001725;GO:0045296;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0005198;GO:0030154;GO:0034613;GO:0060271;GO:0061640;GO:1902857;GO:0016476;GO:0007283;, C:axoneme; C:cell division site; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:midbody; C:non-motile cilium; C:nucleus; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:stress fiber;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity; F:structural molecule activity;, P:cell differentiation; P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:positive regulation of non-motile cilium assembly; P:regulation of embryonic cell shape; P:spermatogenesis; scaffold8 indexed_genome mRNA 27297922 27345366 . + . ID=transcript_2173;Q9BSE4 A4D1Y8 Q9H6F9,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein,, PF00240;, GO:0016021;GO:0030968;GO:0007283;, C:integral component of membrane;, , P:endoplasmic reticulum unfolded protein response; P:spermatogenesis;|Q9BSE4 A4D1Y8 Q9H6F9,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein,, PF00240;, GO:0016021;GO:0030968;GO:0007283;, C:integral component of membrane;, , P:endoplasmic reticulum unfolded protein response; P:spermatogenesis; scaffold8 indexed_genome mRNA 27683486 27729836 . + . ID=transcript_2174;Q9UMR3 A4D1Y6 Q000T4 Q0IJ70 Q0VAS1 Q9Y2N5,T-box transcription factor TBX20,, PF00907;, GO:0000785;GO:0005737;GO:0005634;GO:0001228;GO:0000981;GO:0001102;GO:0000978;GO:0001085;GO:0000977;GO:1990837;GO:0003180;GO:0060413;GO:0036302;GO:0003171;GO:0008015;GO:0001569;GO:0003207;GO:0055008;GO:0003215;GO:0003279;GO:0001708;GO:0008283;GO:0009953;GO:0036306;GO:0003143;GO:0003272;GO:0003203;GO:0001706;GO:0035922;GO:0001947;GO:0048370;GO:0014031;GO:0006936;GO:0010991;GO:0000122;GO:0045892;GO:0001764;GO:0003148;GO:0003344;GO:0030513;GO:0060045;GO:0010718;GO:0003193;GO:0060577;GO:0006357;GO:0003175;GO:0001570;GO:0021524;, C:chromatin; C:cytoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:aortic valve morphogenesis; P:atrial septum morphogenesis; P:atrioventricular canal development; P:atrioventricular valve development; P:blood circulation; P:branching involved in blood vessel morphogenesis; P:cardiac chamber formation; P:cardiac muscle tissue morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum development; P:cell fate specification; P:cell population proliferation; P:dorsal/ventral pattern formation; P:embryonic heart tube elongation; P:embryonic heart tube morphogenesis; P:endocardial cushion formation; P:endocardial cushion morphogenesis; P:endoderm formation; P:foramen ovale closure; P:heart looping; P:lateral mesoderm formation; P:mesenchymal cell development; P:muscle contraction; P:negative regulation of SMAD protein complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron migration; P:outflow tract septum morphogenesis; P:pericardium morphogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:pulmonary valve formation; P:pulmonary vein morphogenesis; P:regulation of transcription by RNA polymerase II; P:tricuspid valve development; P:vasculogenesis; P:visceral motor neuron differentiation; scaffold8 indexed_genome mRNA 27873516 27965794 . + . ID=transcript_2175;Q2PZI1 O94954 Q4G151,Probable C-mannosyltransferase DPY19L1,Dpy-19-like protein 1;Protein dpy-19 homolog 1;, PF10034;, GO:0016021;GO:0016020;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;|Q2PZI1 O94954 Q4G151,Probable C-mannosyltransferase DPY19L1,Dpy-19-like protein 1;Protein dpy-19 homolog 1;, PF10034;, GO:0016021;GO:0016020;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;|Q2PZI1 O94954 Q4G151,Probable C-mannosyltransferase DPY19L1,Dpy-19-like protein 1;Protein dpy-19 homolog 1;, PF10034;, GO:0016021;GO:0016020;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;|Q2PZI1 O94954 Q4G151,Probable C-mannosyltransferase DPY19L1,Dpy-19-like protein 1;Protein dpy-19 homolog 1;, PF10034;, GO:0016021;GO:0016020;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;|Q2PZI1 O94954 Q4G151,Probable C-mannosyltransferase DPY19L1,Dpy-19-like protein 1;Protein dpy-19 homolog 1;, PF10034;, GO:0016021;GO:0016020;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;|Q2PZI1 O94954 Q4G151,Probable C-mannosyltransferase DPY19L1,Dpy-19-like protein 1;Protein dpy-19 homolog 1;, PF10034;, GO:0016021;GO:0016020;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan; scaffold8 indexed_genome mRNA 28499612 28751586 . - . ID=transcript_2176;Q8N8U9 A8K1P8 Q8TF36,BMP-binding endothelial regulator protein,Bone morphogenetic protein-binding endothelial cell precursor-derived regulator;Protein crossveinless-2;, PF08742;PF01826;PF00093;PF00094;, GO:0031012;GO:0005615;GO:0001568;GO:0002043;GO:0042118;GO:0048839;GO:0030514;GO:0070374;GO:1903672;GO:0045765;GO:0010594;GO:0060393;GO:0001657;, C:extracellular matrix; C:extracellular space;, , P:blood vessel development; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:endothelial cell activation; P:inner ear development; P:negative regulation of BMP signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of sprouting angiogenesis; P:regulation of angiogenesis; P:regulation of endothelial cell migration; P:regulation of pathway-restricted SMAD protein phosphorylation; P:ureteric bud development; scaffold8 indexed_genome mRNA 29063630 29521324 . - . ID=transcript_2177;Q9Y6A0,Protein PTHB1,Bardet-Biedl syndrome 9 protein;Parathyroid hormone-responsive B1 gene protein;, PF14728;PF14727;, GO:0034464;GO:0034451;GO:0060170;GO:0035869;GO:0005929;GO:0005829;GO:0016020;GO:0000242;GO:0060271;GO:0045444;GO:0061512;GO:0015031;GO:0050896;GO:0007601;, C:BBSome; C:centriolar satellite; C:ciliary membrane; C:ciliary transition zone; C:cilium; C:cytosol; C:membrane; C:pericentriolar material;, , P:cilium assembly; P:fat cell differentiation; P:protein localization to cilium; P:protein transport; P:response to stimulus; P:visual perception; scaffold8 indexed_genome mRNA 29533073 29666932 . + . ID=transcript_2178;Q8TA86,Retinitis pigmentosa 9 protein,Pim-1-associated protein;, , GO:0005634;GO:0046872;GO:0003723;GO:0050890;GO:0008380;, C:nucleus;, F:metal ion binding; F:RNA binding;, P:cognition; P:RNA splicing;|Q8TA86,Retinitis pigmentosa 9 protein,Pim-1-associated protein;, , GO:0005634;GO:0046872;GO:0003723;GO:0050890;GO:0008380;, C:nucleus;, F:metal ion binding; F:RNA binding;, P:cognition; P:RNA splicing;|Q8TA86,Retinitis pigmentosa 9 protein,Pim-1-associated protein;, , GO:0005634;GO:0046872;GO:0003723;GO:0050890;GO:0008380;, C:nucleus;, F:metal ion binding; F:RNA binding;, P:cognition; P:RNA splicing;|Q9UC43 Q9UC44 Q9UC45,Cytosolic 5'-nucleotidase 3A {ECO:0000305|PubMed:15968458, ECO:0000305|PubMed:24603684},7-methylguanosine phosphate-specific 5'-nucleotidase {ECO:0000305|PubMed:24603684};Cytosolic 5'-nucleotidase 3;Cytosolic 5'-nucleotidase III;Pyrimidine 5'-nucleotidase 1;Uridine 5'-monophosphate hydrolase 1;p36;, PF05822;, GO:0005737;GO:0005829;GO:0005783;GO:0008253;GO:0000287;GO:0000166;GO:0000215;GO:0051607;GO:0009117;GO:0046135;GO:0006213;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum;, F:5'-nucleotidase activity; F:magnesium ion binding; F:nucleotide binding; F:tRNA 2'-phosphotransferase activity;, P:defense response to virus; P:nucleotide metabolic process; P:pyrimidine nucleoside catabolic process; P:pyrimidine nucleoside metabolic process;|Q9UC43 Q9UC44 Q9UC45,Cytosolic 5'-nucleotidase 3A {ECO:0000305|PubMed:15968458, ECO:0000305|PubMed:24603684},7-methylguanosine phosphate-specific 5'-nucleotidase {ECO:0000305|PubMed:24603684};Cytosolic 5'-nucleotidase 3;Cytosolic 5'-nucleotidase III;Pyrimidine 5'-nucleotidase 1;Uridine 5'-monophosphate hydrolase 1;p36;, PF05822;, GO:0005737;GO:0005829;GO:0005783;GO:0008253;GO:0000287;GO:0000166;GO:0000215;GO:0051607;GO:0009117;GO:0046135;GO:0006213;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum;, F:5'-nucleotidase activity; F:magnesium ion binding; F:nucleotide binding; F:tRNA 2'-phosphotransferase activity;, P:defense response to virus; P:nucleotide metabolic process; P:pyrimidine nucleoside catabolic process; P:pyrimidine nucleoside metabolic process;|Q9UC43 Q9UC44 Q9UC45,Cytosolic 5'-nucleotidase 3A {ECO:0000305|PubMed:15968458, ECO:0000305|PubMed:24603684},7-methylguanosine phosphate-specific 5'-nucleotidase {ECO:0000305|PubMed:24603684};Cytosolic 5'-nucleotidase 3;Cytosolic 5'-nucleotidase III;Pyrimidine 5'-nucleotidase 1;Uridine 5'-monophosphate hydrolase 1;p36;, PF05822;, GO:0005737;GO:0005829;GO:0005783;GO:0008253;GO:0000287;GO:0000166;GO:0000215;GO:0051607;GO:0009117;GO:0046135;GO:0006213;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum;, F:5'-nucleotidase activity; F:magnesium ion binding; F:nucleotide binding; F:tRNA 2'-phosphotransferase activity;, P:defense response to virus; P:nucleotide metabolic process; P:pyrimidine nucleoside catabolic process; P:pyrimidine nucleoside metabolic process;|Q9UC43 Q9UC44 Q9UC45,Cytosolic 5'-nucleotidase 3A {ECO:0000305|PubMed:15968458, ECO:0000305|PubMed:24603684},7-methylguanosine phosphate-specific 5'-nucleotidase {ECO:0000305|PubMed:24603684};Cytosolic 5'-nucleotidase 3;Cytosolic 5'-nucleotidase III;Pyrimidine 5'-nucleotidase 1;Uridine 5'-monophosphate hydrolase 1;p36;, PF05822;, GO:0005737;GO:0005829;GO:0005783;GO:0008253;GO:0000287;GO:0000166;GO:0000215;GO:0051607;GO:0009117;GO:0046135;GO:0006213;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum;, F:5'-nucleotidase activity; F:magnesium ion binding; F:nucleotide binding; F:tRNA 2'-phosphotransferase activity;, P:defense response to virus; P:nucleotide metabolic process; P:pyrimidine nucleoside catabolic process; P:pyrimidine nucleoside metabolic process;|Q96IJ9,Peptidyl-prolyl cis-trans isomerase FKBP9,63 kDa FK506-binding protein;FK506-binding protein 9;Rotamase;, PF00254;, GO:0005783;GO:0005509;GO:0003755;GO:0006457;, C:endoplasmic reticulum;, F:calcium ion binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding;|Q8TA86,Retinitis pigmentosa 9 protein,Pim-1-associated protein;, , GO:0005634;GO:0046872;GO:0003723;GO:0050890;GO:0008380;, C:nucleus;, F:metal ion binding; F:RNA binding;, P:cognition; P:RNA splicing; scaffold8 indexed_genome mRNA 29714769 29726647 . + . ID=transcript_2179;Q8IY47 A8K9T7 Q86Y62 Q9P239 Q9UFM7 Q9Y382,Kelch repeat and BTB domain-containing protein 2,BTB and kelch domain-containing protein 1;, PF07707;PF00651;PF01344;, GO:0010467;GO:0006006;GO:0006629;GO:0014065;GO:0032868;, , , P:gene expression; P:glucose metabolic process; P:lipid metabolic process; P:phosphatidylinositol 3-kinase signaling; P:response to insulin;|Q8IY47 A8K9T7 Q86Y62 Q9P239 Q9UFM7 Q9Y382,Kelch repeat and BTB domain-containing protein 2,BTB and kelch domain-containing protein 1;, PF07707;PF00651;PF01344;, GO:0010467;GO:0006006;GO:0006629;GO:0014065;GO:0032868;, , , P:gene expression; P:glucose metabolic process; P:lipid metabolic process; P:phosphatidylinositol 3-kinase signaling; P:response to insulin; scaffold8 indexed_genome mRNA 29750245 29805820 . - . ID=transcript_2180;Q8NBF6 Q92573,Late secretory pathway protein AVL9 homolog,, PF09794;, GO:0005737;GO:0016021;GO:0055037;GO:0016477;, C:cytoplasm; C:integral component of membrane; C:recycling endosome;, , P:cell migration;|Q8NBF6 Q92573,Late secretory pathway protein AVL9 homolog,, PF09794;, GO:0005737;GO:0016021;GO:0055037;GO:0016477;, C:cytoplasm; C:integral component of membrane; C:recycling endosome;, , P:cell migration;|Q8NBF6 Q92573,Late secretory pathway protein AVL9 homolog,, PF09794;, GO:0005737;GO:0016021;GO:0055037;GO:0016477;, C:cytoplasm; C:integral component of membrane; C:recycling endosome;, , P:cell migration;|Q8NBF6 Q92573,Late secretory pathway protein AVL9 homolog,, PF09794;, GO:0005737;GO:0016021;GO:0055037;GO:0016477;, C:cytoplasm; C:integral component of membrane; C:recycling endosome;, , P:cell migration;|Q8NBF6 Q92573,Late secretory pathway protein AVL9 homolog,, PF09794;, GO:0005737;GO:0016021;GO:0055037;GO:0016477;, C:cytoplasm; C:integral component of membrane; C:recycling endosome;, , P:cell migration; scaffold8 indexed_genome mRNA 29810016 29814059 . + . ID=transcript_2181;Q9Y4Y9,U6 snRNA-associated Sm-like protein LSm5,, PF01423;, GO:0005737;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0071005;GO:0046540;GO:0005688;GO:0046982;GO:0003723;GO:0043928;GO:0006402;GO:0006397;GO:0000398;GO:0009617;, C:cytoplasm; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:protein heterodimerization activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA catabolic process; P:mRNA processing; P:mRNA splicing, via spliceosome; P:response to bacterium;|Q9Y4Y9,U6 snRNA-associated Sm-like protein LSm5,, PF01423;, GO:0005737;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0071005;GO:0046540;GO:0005688;GO:0046982;GO:0003723;GO:0043928;GO:0006402;GO:0006397;GO:0000398;GO:0009617;, C:cytoplasm; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:protein heterodimerization activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA catabolic process; P:mRNA processing; P:mRNA splicing, via spliceosome; P:response to bacterium;|Q9Y4Y9,U6 snRNA-associated Sm-like protein LSm5,, PF01423;, GO:0005737;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0071005;GO:0046540;GO:0005688;GO:0046982;GO:0003723;GO:0043928;GO:0006402;GO:0006397;GO:0000398;GO:0009617;, C:cytoplasm; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:protein heterodimerization activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA catabolic process; P:mRNA processing; P:mRNA splicing, via spliceosome; P:response to bacterium; scaffold8 indexed_genome mRNA 30159088 30438002 . + . ID=transcript_2182;Q14123 B3KPC6 E9PE92 Q14124 Q8NB10,Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C,3',5'-cyclic-AMP phosphodiesterase;3',5'-cyclic-GMP phosphodiesterase;Hcam3 {ECO:0000303|PubMed:8557689};, PF00233;PF08499;, GO:0005829;GO:0043025;GO:0004115;GO:0004114;GO:0048101;GO:0005516;GO:0004117;GO:0046872;GO:0007165;, C:cytosol; C:neuronal cell body;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; F:calmodulin binding; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:signal transduction;|Q14123 B3KPC6 E9PE92 Q14124 Q8NB10,Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C,3',5'-cyclic-AMP phosphodiesterase;3',5'-cyclic-GMP phosphodiesterase;Hcam3 {ECO:0000303|PubMed:8557689};, PF00233;PF08499;, GO:0005829;GO:0043025;GO:0004115;GO:0004114;GO:0048101;GO:0005516;GO:0004117;GO:0046872;GO:0007165;, C:cytosol; C:neuronal cell body;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; F:calmodulin binding; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:signal transduction;|Q14123 B3KPC6 E9PE92 Q14124 Q8NB10,Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C,3',5'-cyclic-AMP phosphodiesterase;3',5'-cyclic-GMP phosphodiesterase;Hcam3 {ECO:0000303|PubMed:8557689};, PF00233;PF08499;, GO:0005829;GO:0043025;GO:0004115;GO:0004114;GO:0048101;GO:0005516;GO:0004117;GO:0046872;GO:0007165;, C:cytosol; C:neuronal cell body;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; F:calmodulin binding; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:signal transduction;|Q14123 B3KPC6 E9PE92 Q14124 Q8NB10,Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C,3',5'-cyclic-AMP phosphodiesterase;3',5'-cyclic-GMP phosphodiesterase;Hcam3 {ECO:0000303|PubMed:8557689};, PF00233;PF08499;, GO:0005829;GO:0043025;GO:0004115;GO:0004114;GO:0048101;GO:0005516;GO:0004117;GO:0046872;GO:0007165;, C:cytosol; C:neuronal cell body;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; F:calmodulin binding; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:signal transduction; scaffold8 indexed_genome mRNA 30444930 30453885 . + . ID=transcript_2183;Q14123 B3KPC6 E9PE92 Q14124 Q8NB10,Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C,3',5'-cyclic-AMP phosphodiesterase;3',5'-cyclic-GMP phosphodiesterase;Hcam3 {ECO:0000303|PubMed:8557689};, PF00233;PF08499;, GO:0005829;GO:0043025;GO:0004115;GO:0004114;GO:0048101;GO:0005516;GO:0004117;GO:0046872;GO:0007165;, C:cytosol; C:neuronal cell body;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; F:calmodulin binding; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:signal transduction; scaffold8 indexed_genome mRNA 30499849 30518898 . - . ID=transcript_2184;O96001 B4DE58 Q9UDQ0,Protein phosphatase 1 regulatory subunit 17,G-substrate;, , GO:0004865;GO:0007417;GO:0035556;GO:0010921;, , F:protein serine/threonine phosphatase inhibitor activity;, P:central nervous system development; P:intracellular signal transduction; P:regulation of phosphatase activity; scaffold8 indexed_genome mRNA 30805224 30808567 . + . ID=transcript_2185;Q96NK8 Q548T9 Q9H3H6,Neurogenic differentiation factor 6,Class A basic helix-loop-helix protein 2;Protein atonal homolog 2;, PF00010;PF12533;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0046983;GO:0000978;GO:0021542;GO:0030182;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:dentate gyrus development; P:neuron differentiation; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 30964019 31013798 . - . ID=transcript_2186;P41586 A8K1Y1 B7ZLA7 B8ZZK3 Q17S10,Pituitary adenylate cyclase-activating polypeptide type I receptor,, PF00002;PF02793;, GO:0005887;GO:0043231;GO:0043005;GO:0005886;GO:0043235;GO:0008528;GO:0017046;GO:0038023;GO:0004999;GO:0007188;GO:0030154;GO:0007166;GO:0007186;GO:0007275;GO:0002862;GO:0007283;, C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:neuron projection; C:plasma membrane; C:receptor complex;, F:G protein-coupled peptide receptor activity; F:peptide hormone binding; F:signaling receptor activity; F:vasoactive intestinal polypeptide receptor activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell differentiation; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:negative regulation of inflammatory response to antigenic stimulus; P:spermatogenesis;|P41586 A8K1Y1 B7ZLA7 B8ZZK3 Q17S10,Pituitary adenylate cyclase-activating polypeptide type I receptor,, PF00002;PF02793;, GO:0005887;GO:0043231;GO:0043005;GO:0005886;GO:0043235;GO:0008528;GO:0017046;GO:0038023;GO:0004999;GO:0007188;GO:0030154;GO:0007166;GO:0007186;GO:0007275;GO:0002862;GO:0007283;, C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:neuron projection; C:plasma membrane; C:receptor complex;, F:G protein-coupled peptide receptor activity; F:peptide hormone binding; F:signaling receptor activity; F:vasoactive intestinal polypeptide receptor activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell differentiation; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:negative regulation of inflammatory response to antigenic stimulus; P:spermatogenesis; scaffold8 indexed_genome mRNA 31097214 31104046 . - . ID=transcript_2187;Q02643 Q99863,Growth hormone-releasing hormone receptor,Growth hormone-releasing factor receptor;, PF00002;PF02793;, GO:0009986;GO:0005737;GO:0016021;GO:0005637;GO:0016363;GO:0005640;GO:0005886;GO:0042383;GO:0030141;GO:0008528;GO:0004930;GO:0019838;GO:0016520;GO:0017046;GO:0007190;GO:0007189;GO:0007188;GO:0019933;GO:0048469;GO:0007166;GO:0071333;GO:0032869;GO:0008340;GO:0007186;GO:0042445;GO:0007595;GO:0048609;GO:0002862;GO:0008284;GO:0046010;GO:0060124;GO:0043568;GO:0040018;GO:0033143;GO:0051246;GO:0043627;GO:0051384;GO:0032868;GO:0060133;GO:0030104;, C:cell surface; C:cytoplasm; C:integral component of membrane; C:nuclear inner membrane; C:nuclear matrix; C:nuclear outer membrane; C:plasma membrane; C:sarcolemma; C:secretory granule;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:growth factor binding; F:growth hormone-releasing hormone receptor activity; F:peptide hormone binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP-mediated signaling; P:cell maturation; P:cell surface receptor signaling pathway; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:determination of adult lifespan; P:G protein-coupled receptor signaling pathway; P:hormone metabolic process; P:lactation; P:multicellular organismal reproductive process; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of cell population proliferation; P:positive regulation of circadian sleep/wake cycle, non-REM sleep; P:positive regulation of growth hormone secretion; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of multicellular organism growth; P:regulation of intracellular steroid hormone receptor signaling pathway; P:regulation of protein metabolic process; P:response to estrogen; P:response to glucocorticoid; P:response to insulin; P:somatotropin secreting cell development; P:water homeostasis;|Q02643 Q99863,Growth hormone-releasing hormone receptor,Growth hormone-releasing factor receptor;, PF00002;PF02793;, GO:0009986;GO:0005737;GO:0016021;GO:0005637;GO:0016363;GO:0005640;GO:0005886;GO:0042383;GO:0030141;GO:0008528;GO:0004930;GO:0019838;GO:0016520;GO:0017046;GO:0007190;GO:0007189;GO:0007188;GO:0019933;GO:0048469;GO:0007166;GO:0071333;GO:0032869;GO:0008340;GO:0007186;GO:0042445;GO:0007595;GO:0048609;GO:0002862;GO:0008284;GO:0046010;GO:0060124;GO:0043568;GO:0040018;GO:0033143;GO:0051246;GO:0043627;GO:0051384;GO:0032868;GO:0060133;GO:0030104;, C:cell surface; C:cytoplasm; C:integral component of membrane; C:nuclear inner membrane; C:nuclear matrix; C:nuclear outer membrane; C:plasma membrane; C:sarcolemma; C:secretory granule;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:growth factor binding; F:growth hormone-releasing hormone receptor activity; F:peptide hormone binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP-mediated signaling; P:cell maturation; P:cell surface receptor signaling pathway; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:determination of adult lifespan; P:G protein-coupled receptor signaling pathway; P:hormone metabolic process; P:lactation; P:multicellular organismal reproductive process; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of cell population proliferation; P:positive regulation of circadian sleep/wake cycle, non-REM sleep; P:positive regulation of growth hormone secretion; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of multicellular organism growth; P:regulation of intracellular steroid hormone receptor signaling pathway; P:regulation of protein metabolic process; P:response to estrogen; P:response to glucocorticoid; P:response to insulin; P:somatotropin secreting cell development; P:water homeostasis; scaffold8 indexed_genome mRNA 31104543 31113017 . - . ID=transcript_2188;Q02643 Q99863,Growth hormone-releasing hormone receptor,Growth hormone-releasing factor receptor;, PF00002;PF02793;, GO:0009986;GO:0005737;GO:0016021;GO:0005637;GO:0016363;GO:0005640;GO:0005886;GO:0042383;GO:0030141;GO:0008528;GO:0004930;GO:0019838;GO:0016520;GO:0017046;GO:0007190;GO:0007189;GO:0007188;GO:0019933;GO:0048469;GO:0007166;GO:0071333;GO:0032869;GO:0008340;GO:0007186;GO:0042445;GO:0007595;GO:0048609;GO:0002862;GO:0008284;GO:0046010;GO:0060124;GO:0043568;GO:0040018;GO:0033143;GO:0051246;GO:0043627;GO:0051384;GO:0032868;GO:0060133;GO:0030104;, C:cell surface; C:cytoplasm; C:integral component of membrane; C:nuclear inner membrane; C:nuclear matrix; C:nuclear outer membrane; C:plasma membrane; C:sarcolemma; C:secretory granule;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:growth factor binding; F:growth hormone-releasing hormone receptor activity; F:peptide hormone binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP-mediated signaling; P:cell maturation; P:cell surface receptor signaling pathway; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:determination of adult lifespan; P:G protein-coupled receptor signaling pathway; P:hormone metabolic process; P:lactation; P:multicellular organismal reproductive process; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of cell population proliferation; P:positive regulation of circadian sleep/wake cycle, non-REM sleep; P:positive regulation of growth hormone secretion; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of multicellular organism growth; P:regulation of intracellular steroid hormone receptor signaling pathway; P:regulation of protein metabolic process; P:response to estrogen; P:response to glucocorticoid; P:response to insulin; P:somatotropin secreting cell development; P:water homeostasis;|Q02643 Q99863,Growth hormone-releasing hormone receptor,Growth hormone-releasing factor receptor;, PF00002;PF02793;, GO:0009986;GO:0005737;GO:0016021;GO:0005637;GO:0016363;GO:0005640;GO:0005886;GO:0042383;GO:0030141;GO:0008528;GO:0004930;GO:0019838;GO:0016520;GO:0017046;GO:0007190;GO:0007189;GO:0007188;GO:0019933;GO:0048469;GO:0007166;GO:0071333;GO:0032869;GO:0008340;GO:0007186;GO:0042445;GO:0007595;GO:0048609;GO:0002862;GO:0008284;GO:0046010;GO:0060124;GO:0043568;GO:0040018;GO:0033143;GO:0051246;GO:0043627;GO:0051384;GO:0032868;GO:0060133;GO:0030104;, C:cell surface; C:cytoplasm; C:integral component of membrane; C:nuclear inner membrane; C:nuclear matrix; C:nuclear outer membrane; C:plasma membrane; C:sarcolemma; C:secretory granule;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:growth factor binding; F:growth hormone-releasing hormone receptor activity; F:peptide hormone binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP-mediated signaling; P:cell maturation; P:cell surface receptor signaling pathway; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:determination of adult lifespan; P:G protein-coupled receptor signaling pathway; P:hormone metabolic process; P:lactation; P:multicellular organismal reproductive process; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of cell population proliferation; P:positive regulation of circadian sleep/wake cycle, non-REM sleep; P:positive regulation of growth hormone secretion; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of multicellular organism growth; P:regulation of intracellular steroid hormone receptor signaling pathway; P:regulation of protein metabolic process; P:response to estrogen; P:response to glucocorticoid; P:response to insulin; P:somatotropin secreting cell development; P:water homeostasis;|Q02643 Q99863,Growth hormone-releasing hormone receptor,Growth hormone-releasing factor receptor;, PF00002;PF02793;, GO:0009986;GO:0005737;GO:0016021;GO:0005637;GO:0016363;GO:0005640;GO:0005886;GO:0042383;GO:0030141;GO:0008528;GO:0004930;GO:0019838;GO:0016520;GO:0017046;GO:0007190;GO:0007189;GO:0007188;GO:0019933;GO:0048469;GO:0007166;GO:0071333;GO:0032869;GO:0008340;GO:0007186;GO:0042445;GO:0007595;GO:0048609;GO:0002862;GO:0008284;GO:0046010;GO:0060124;GO:0043568;GO:0040018;GO:0033143;GO:0051246;GO:0043627;GO:0051384;GO:0032868;GO:0060133;GO:0030104;, C:cell surface; C:cytoplasm; C:integral component of membrane; C:nuclear inner membrane; C:nuclear matrix; C:nuclear outer membrane; C:plasma membrane; C:sarcolemma; C:secretory granule;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:growth factor binding; F:growth hormone-releasing hormone receptor activity; F:peptide hormone binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP-mediated signaling; P:cell maturation; P:cell surface receptor signaling pathway; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:determination of adult lifespan; P:G protein-coupled receptor signaling pathway; P:hormone metabolic process; P:lactation; P:multicellular organismal reproductive process; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of cell population proliferation; P:positive regulation of circadian sleep/wake cycle, non-REM sleep; P:positive regulation of growth hormone secretion; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of multicellular organism growth; P:regulation of intracellular steroid hormone receptor signaling pathway; P:regulation of protein metabolic process; P:response to estrogen; P:response to glucocorticoid; P:response to insulin; P:somatotropin secreting cell development; P:water homeostasis; scaffold8 indexed_genome mRNA 31131493 31142888 . - . ID=transcript_2189;P29972 B5BU39 E7EM69 E9PC21 F5GY19 Q8TBI5 Q8TDC1,Aquaporin-1,Aquaporin-CHIP;Urine water channel;Water channel protein for red blood cells and kidney proximal tubule;, PF00230;, GO:0045177;GO:0016324;GO:0009925;GO:0016323;GO:0005903;GO:0031526;GO:0005737;GO:0070062;GO:0016021;GO:0005887;GO:0031965;GO:0005634;GO:0005886;GO:0042383;GO:0020003;GO:0008519;GO:0035379;GO:0015168;GO:0042802;GO:0005223;GO:0030184;GO:0005267;GO:0015079;GO:0022857;GO:0015250;GO:0005372;GO:0015696;GO:0015701;GO:0035378;GO:0015670;GO:0006884;GO:0019725;GO:0071474;GO:0071320;GO:0071280;GO:0071549;GO:0070301;GO:0071456;GO:0071241;GO:0071260;GO:0071288;GO:0071732;GO:0071300;GO:0071472;GO:0034644;GO:0009992;GO:0033326;GO:0019934;GO:0050829;GO:0030950;GO:0015793;GO:0006972;GO:0021670;GO:0085018;GO:0050891;GO:0043066;GO:0043154;GO:0030185;GO:0042476;GO:0030157;GO:0045766;GO:0048146;GO:0046878;GO:0006813;GO:0003091;GO:0003097;GO:0035377;GO:0006833;, C:apical part of cell; C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:brush border; C:brush border membrane; C:cytoplasm; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear membrane; C:nucleus; C:plasma membrane; C:sarcolemma; C:symbiont-containing vacuole;, F:ammonium transmembrane transporter activity; F:carbon dioxide transmembrane transporter activity; F:glycerol transmembrane transporter activity; F:identical protein binding; F:intracellular cGMP-activated cation channel activity; F:nitric oxide transmembrane transporter activity; F:potassium channel activity; F:potassium ion transmembrane transporter activity; F:transmembrane transporter activity; F:water channel activity; F:water transmembrane transporter activity;, P:ammonium transport; P:bicarbonate transport; P:carbon dioxide transmembrane transport; P:carbon dioxide transport; P:cell volume homeostasis; P:cellular homeostasis; P:cellular hyperosmotic response; P:cellular response to cAMP; P:cellular response to copper ion; P:cellular response to dexamethasone stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to inorganic substance; P:cellular response to mechanical stimulus; P:cellular response to mercury ion; P:cellular response to nitric oxide; P:cellular response to retinoic acid; P:cellular response to salt stress; P:cellular response to UV; P:cellular water homeostasis; P:cerebrospinal fluid secretion; P:cGMP-mediated signaling; P:defense response to Gram-negative bacterium; P:establishment or maintenance of actin cytoskeleton polarity; P:glycerol transport; P:hyperosmotic response; P:lateral ventricle development; P:maintenance of symbiont-containing vacuole by host; P:multicellular organismal water homeostasis; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:nitric oxide transport; P:odontogenesis; P:pancreatic juice secretion; P:positive regulation of angiogenesis; P:positive regulation of fibroblast proliferation; P:positive regulation of saliva secretion; P:potassium ion transport; P:renal water homeostasis; P:renal water transport; P:transepithelial water transport; P:water transport; scaffold8 indexed_genome mRNA 31173157 31274024 . - . ID=transcript_2190;Q4G0A6 Q71AZ7 Q9H6D2,Probable ubiquitin carboxyl-terminal hydrolase MINDY-4,Probable deubiquitinating enzyme MINDY-4;, PF13898;, GO:0008234;GO:1990380;GO:0004843;, , F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; scaffold8 indexed_genome mRNA 31297672 31298347 . - . ID=transcript_2191;O95050 B8ZZ69 Q3KP49 Q9P1Y2 Q9UBY4 Q9UHQ0,Indolethylamine N-methyltransferase,Aromatic alkylamine N-methyltransferase;Thioether S-methyltransferase;, PF01234;, GO:0005829;GO:0030748;GO:0008170;GO:0102707;GO:0004790;GO:0009308;GO:0032259;GO:0009636;, C:cytosol;, F:amine N-methyltransferase activity; F:N-methyltransferase activity; F:S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity; F:thioether S-methyltransferase activity;, P:amine metabolic process; P:methylation; P:response to toxic substance; scaffold8 indexed_genome mRNA 31298878 31308425 . + . ID=transcript_2192;O95050 B8ZZ69 Q3KP49 Q9P1Y2 Q9UBY4 Q9UHQ0,Indolethylamine N-methyltransferase,Aromatic alkylamine N-methyltransferase;Thioether S-methyltransferase;, PF01234;, GO:0005829;GO:0030748;GO:0008170;GO:0102707;GO:0004790;GO:0009308;GO:0032259;GO:0009636;, C:cytosol;, F:amine N-methyltransferase activity; F:N-methyltransferase activity; F:S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity; F:thioether S-methyltransferase activity;, P:amine metabolic process; P:methylation; P:response to toxic substance;|P40261,Nicotinamide N-methyltransferase,, PF01234;, GO:0005829;GO:0008170;GO:0008112;GO:0031100;GO:0032259;GO:0034356;GO:0042493;GO:0010243;, C:cytosol;, F:N-methyltransferase activity; F:nicotinamide N-methyltransferase activity;, P:animal organ regeneration; P:methylation; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:response to drug; P:response to organonitrogen compound; scaffold8 indexed_genome mRNA 31358455 31373039 . + . ID=transcript_2193;Q99431,Corticotropin-releasing factor receptor 2,Corticotropin-releasing hormone receptor 2;, PF00002;PF02793;, GO:0043679;GO:0030425;GO:0005887;GO:0005886;GO:0015056;GO:0043404;GO:0008528;GO:0017046;GO:0007188;GO:0007166;GO:0007186;GO:0060291;GO:0002862;, C:axon terminus; C:dendrite; C:integral component of plasma membrane; C:plasma membrane;, F:corticotrophin-releasing factor receptor activity; F:corticotropin-releasing hormone receptor activity; F:G protein-coupled peptide receptor activity; F:peptide hormone binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:long-term synaptic potentiation; P:negative regulation of inflammatory response to antigenic stimulus; scaffold8 indexed_genome mRNA 31384223 31427620 . - . ID=transcript_2194;P41250 A0A090N8G0 B3KQA2 B4DIA0 Q969Y1,Glycine--tRNA ligase,Diadenosine tetraphosphate synthetase {ECO:0000305|PubMed:19710017};Glycyl-tRNA synthetase {ECO:0000303|PubMed:19710017};Glycyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:4162};, PF03129;PF00587;PF00458;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005524;GO:0004081;GO:0004820;GO:0042802;GO:0046983;GO:0016740;GO:0015966;GO:0006426;GO:0070150;GO:0006418;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity; F:glycine-tRNA ligase activity; F:identical protein binding; F:protein dimerization activity; F:transferase activity;, P:diadenosine tetraphosphate biosynthetic process; P:glycyl-tRNA aminoacylation; P:mitochondrial glycyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P41250 A0A090N8G0 B3KQA2 B4DIA0 Q969Y1,Glycine--tRNA ligase,Diadenosine tetraphosphate synthetase {ECO:0000305|PubMed:19710017};Glycyl-tRNA synthetase {ECO:0000303|PubMed:19710017};Glycyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:4162};, PF03129;PF00587;PF00458;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005524;GO:0004081;GO:0004820;GO:0042802;GO:0046983;GO:0016740;GO:0015966;GO:0006426;GO:0070150;GO:0006418;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity; F:glycine-tRNA ligase activity; F:identical protein binding; F:protein dimerization activity; F:transferase activity;, P:diadenosine tetraphosphate biosynthetic process; P:glycyl-tRNA aminoacylation; P:mitochondrial glycyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P41250 A0A090N8G0 B3KQA2 B4DIA0 Q969Y1,Glycine--tRNA ligase,Diadenosine tetraphosphate synthetase {ECO:0000305|PubMed:19710017};Glycyl-tRNA synthetase {ECO:0000303|PubMed:19710017};Glycyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:4162};, PF03129;PF00587;PF00458;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005524;GO:0004081;GO:0004820;GO:0042802;GO:0046983;GO:0016740;GO:0015966;GO:0006426;GO:0070150;GO:0006418;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity; F:glycine-tRNA ligase activity; F:identical protein binding; F:protein dimerization activity; F:transferase activity;, P:diadenosine tetraphosphate biosynthetic process; P:glycyl-tRNA aminoacylation; P:mitochondrial glycyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P41250 A0A090N8G0 B3KQA2 B4DIA0 Q969Y1,Glycine--tRNA ligase,Diadenosine tetraphosphate synthetase {ECO:0000305|PubMed:19710017};Glycyl-tRNA synthetase {ECO:0000303|PubMed:19710017};Glycyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:4162};, PF03129;PF00587;PF00458;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005524;GO:0004081;GO:0004820;GO:0042802;GO:0046983;GO:0016740;GO:0015966;GO:0006426;GO:0070150;GO:0006418;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity; F:glycine-tRNA ligase activity; F:identical protein binding; F:protein dimerization activity; F:transferase activity;, P:diadenosine tetraphosphate biosynthetic process; P:glycyl-tRNA aminoacylation; P:mitochondrial glycyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; scaffold8 indexed_genome mRNA 31481005 31490764 . + . ID=transcript_2195;O75223 B2RDN0 B8ZZN4 B8ZZR8 Q9BS37,Gamma-glutamylcyclotransferase,Cytochrome c-releasing factor 21;, , GO:0005829;GO:0070062;GO:0003839;GO:0042803;GO:0006750;GO:0001836;, C:cytosol; C:extracellular exosome;, F:gamma-glutamylcyclotransferase activity; F:protein homodimerization activity;, P:glutathione biosynthetic process; P:release of cytochrome c from mitochondria; scaffold8 indexed_genome mRNA 31541769 31582920 . + . ID=transcript_2196;Q9Y239 B4DTU3 Q549U4 Q8IWF5,Nucleotide-binding oligomerization domain-containing protein 1,Caspase recruitment domain-containing protein 4;, PF00619;PF13516;PF05729;PF17776;PF17779;, GO:0046658;GO:0016324;GO:0016323;GO:0005737;GO:0005829;GO:0045335;GO:0005524;GO:0050700;GO:0008656;GO:0042802;GO:0038187;GO:0042834;GO:0042803;GO:0044877;GO:0006919;GO:0000187;GO:0006915;GO:0071225;GO:0006952;GO:0042742;GO:0050830;GO:0016045;GO:0009595;GO:0006954;GO:0045087;GO:0070498;GO:0035556;GO:0007254;GO:0070423;GO:0002221;GO:0010942;GO:0043280;GO:0002606;GO:0070374;GO:0043123;GO:0032731;GO:0032755;GO:0032757;GO:0046330;GO:0051092;GO:1901224;GO:0051000;GO:0032760;GO:1904417;GO:0042981;GO:0007165;, C:anchored component of plasma membrane; C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:cytosol; C:phagocytic vesicle;, F:ATP binding; F:CARD domain binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:identical protein binding; F:pattern recognition receptor activity; F:peptidoglycan binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of MAPK activity; P:apoptotic process; P:cellular response to muramyl dipeptide; P:defense response; P:defense response to bacterium; P:defense response to Gram-positive bacterium; P:detection of bacterium; P:detection of biotic stimulus; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:nucleotide-binding oligomerization domain containing signaling pathway; P:pattern recognition receptor signaling pathway; P:positive regulation of cell death; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of tumor necrosis factor production; P:positive regulation of xenophagy; P:regulation of apoptotic process; P:signal transduction; scaffold8 indexed_genome mRNA 31610177 31611684 . - . ID=transcript_2197;Q99570 Q2TBF4,Phosphoinositide 3-kinase regulatory subunit 4,PI3-kinase p150 subunit;Phosphoinositide 3-kinase adaptor protein;, PF00069;PF00400;, GO:0005776;GO:0005930;GO:0005829;GO:0043231;GO:0005770;GO:0016020;GO:0015630;GO:0071561;GO:0030670;GO:0035032;GO:0034271;GO:0034272;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0030242;GO:0042149;GO:0045324;GO:0016236;GO:0006661;GO:0043552;GO:0006468;GO:0006623;GO:0032801;GO:0032465;GO:0034162;, C:autophagosome; C:axoneme; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:membrane; C:microtubule cytoskeleton; C:nucleus-vacuole junction; C:phagocytic vesicle membrane; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy of peroxisome; P:cellular response to glucose starvation; P:late endosome to vacuole transport; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:protein phosphorylation; P:protein targeting to vacuole; P:receptor catabolic process; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway; scaffold8 indexed_genome mRNA 31626428 31636225 . - . ID=transcript_2198;Q8NHG8,E3 ubiquitin-protein ligase ZNRF2,Protein Ells2;RING finger protein 202;RING-type E3 ubiquitin transferase ZNRF2;Zinc/RING finger protein 2;, PF13639;, GO:0042995;GO:0005737;GO:0030659;GO:0005829;GO:0010008;GO:0001650;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0042734;GO:0032991;GO:0046872;GO:0061630;GO:0000209;, C:cell projection; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome membrane; C:fibrillar center; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:presynaptic membrane; C:protein-containing complex;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:protein polyubiquitination; scaffold8 indexed_genome mRNA 31717754 31720131 . + . ID=transcript_2199;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold8 indexed_genome mRNA 31845463 31887434 . - . ID=transcript_2200;Q8N3F0 B8ZZW9 Q8N791 Q8N8M4 Q8NEX2,Maturin,Maturin neural progenitor differentiation regulator protein homolog;Protein Ells1;, PF15167;, GO:0005737;GO:0007275;GO:0032088;GO:0070374;GO:0046330;GO:0045654;, C:cytoplasm;, , P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of JNK cascade; P:positive regulation of megakaryocyte differentiation;|Q8N3F0 B8ZZW9 Q8N791 Q8N8M4 Q8NEX2,Maturin,Maturin neural progenitor differentiation regulator protein homolog;Protein Ells1;, PF15167;, GO:0005737;GO:0007275;GO:0032088;GO:0070374;GO:0046330;GO:0045654;, C:cytoplasm;, , P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of JNK cascade; P:positive regulation of megakaryocyte differentiation; scaffold8 indexed_genome mRNA 31932807 31999005 . - . ID=transcript_2201;Q96JA3 B4DH00 Q7Z5V8 Q9BU78 Q9H274 Q9H8Z7,Pleckstrin homology domain-containing family A member 8,Phosphatidylinositol-four-phosphate adapter protein 2;Serologically defined breast cancer antigen NY-BR-86;, PF08718;PF00169;, GO:0005829;GO:0005794;GO:0000139;GO:0016020;GO:0005654;GO:0005802;GO:1902387;GO:1902388;GO:0097001;GO:0051861;GO:0017089;GO:0070273;GO:0035627;GO:0035621;GO:0120009;GO:0006869;GO:0006661;GO:0015031;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:nucleoplasm; C:trans-Golgi network;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:ceramide binding; F:glycolipid binding; F:glycolipid transfer activity; F:phosphatidylinositol-4-phosphate binding;, P:ceramide transport; P:ER to Golgi ceramide transport; P:intermembrane lipid transfer; P:lipid transport; P:phosphatidylinositol biosynthetic process; P:protein transport;|Q96JA3 B4DH00 Q7Z5V8 Q9BU78 Q9H274 Q9H8Z7,Pleckstrin homology domain-containing family A member 8,Phosphatidylinositol-four-phosphate adapter protein 2;Serologically defined breast cancer antigen NY-BR-86;, PF08718;PF00169;, GO:0005829;GO:0005794;GO:0000139;GO:0016020;GO:0005654;GO:0005802;GO:1902387;GO:1902388;GO:0097001;GO:0051861;GO:0017089;GO:0070273;GO:0035627;GO:0035621;GO:0120009;GO:0006869;GO:0006661;GO:0015031;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:nucleoplasm; C:trans-Golgi network;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:ceramide binding; F:glycolipid binding; F:glycolipid transfer activity; F:phosphatidylinositol-4-phosphate binding;, P:ceramide transport; P:ER to Golgi ceramide transport; P:intermembrane lipid transfer; P:lipid transport; P:phosphatidylinositol biosynthetic process; P:protein transport;|Q96JA3 B4DH00 Q7Z5V8 Q9BU78 Q9H274 Q9H8Z7,Pleckstrin homology domain-containing family A member 8,Phosphatidylinositol-four-phosphate adapter protein 2;Serologically defined breast cancer antigen NY-BR-86;, PF08718;PF00169;, GO:0005829;GO:0005794;GO:0000139;GO:0016020;GO:0005654;GO:0005802;GO:1902387;GO:1902388;GO:0097001;GO:0051861;GO:0017089;GO:0070273;GO:0035627;GO:0035621;GO:0120009;GO:0006869;GO:0006661;GO:0015031;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:nucleoplasm; C:trans-Golgi network;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:ceramide binding; F:glycolipid binding; F:glycolipid transfer activity; F:phosphatidylinositol-4-phosphate binding;, P:ceramide transport; P:ER to Golgi ceramide transport; P:intermembrane lipid transfer; P:lipid transport; P:phosphatidylinositol biosynthetic process; P:protein transport; scaffold8 indexed_genome mRNA 32001662 32011744 . + . ID=transcript_2202;Q9NWM8,Peptidyl-prolyl cis-trans isomerase FKBP14,22 kDa FK506-binding protein;FK506-binding protein 14;Rotamase;, PF13499;PF00254;, GO:0005788;GO:0005509;GO:0003755;GO:0036498;, C:endoplasmic reticulum lumen;, F:calcium ion binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:IRE1-mediated unfolded protein response;|Q9NWM8,Peptidyl-prolyl cis-trans isomerase FKBP14,22 kDa FK506-binding protein;FK506-binding protein 14;Rotamase;, PF13499;PF00254;, GO:0005788;GO:0005509;GO:0003755;GO:0036498;, C:endoplasmic reticulum lumen;, F:calcium ion binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:IRE1-mediated unfolded protein response; scaffold8 indexed_genome mRNA 32026286 32084881 . + . ID=transcript_2203;Q12765 A8K0E9 B4DHM0 B4DIP5 C9JPG0 Q25QX7 Q8IWD1,Secernin-1,, PF03577;, GO:0005737;GO:0031965;GO:0005634;GO:0070004;GO:0016805;GO:0006887;, C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cysteine-type exopeptidase activity; F:dipeptidase activity;, P:exocytosis;|Q12765 A8K0E9 B4DHM0 B4DIP5 C9JPG0 Q25QX7 Q8IWD1,Secernin-1,, PF03577;, GO:0005737;GO:0031965;GO:0005634;GO:0070004;GO:0016805;GO:0006887;, C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cysteine-type exopeptidase activity; F:dipeptidase activity;, P:exocytosis;|Q12765 A8K0E9 B4DHM0 B4DIP5 C9JPG0 Q25QX7 Q8IWD1,Secernin-1,, PF03577;, GO:0005737;GO:0031965;GO:0005634;GO:0070004;GO:0016805;GO:0006887;, C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cysteine-type exopeptidase activity; F:dipeptidase activity;, P:exocytosis;|Q12765 A8K0E9 B4DHM0 B4DIP5 C9JPG0 Q25QX7 Q8IWD1,Secernin-1,, PF03577;, GO:0005737;GO:0031965;GO:0005634;GO:0070004;GO:0016805;GO:0006887;, C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cysteine-type exopeptidase activity; F:dipeptidase activity;, P:exocytosis;|Q12765 A8K0E9 B4DHM0 B4DIP5 C9JPG0 Q25QX7 Q8IWD1,Secernin-1,, PF03577;, GO:0005737;GO:0031965;GO:0005634;GO:0070004;GO:0016805;GO:0006887;, C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cysteine-type exopeptidase activity; F:dipeptidase activity;, P:exocytosis; scaffold8 indexed_genome mRNA 32085337 32088796 . + . ID=transcript_2204;Q12765 A8K0E9 B4DHM0 B4DIP5 C9JPG0 Q25QX7 Q8IWD1,Secernin-1,, PF03577;, GO:0005737;GO:0031965;GO:0005634;GO:0070004;GO:0016805;GO:0006887;, C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cysteine-type exopeptidase activity; F:dipeptidase activity;, P:exocytosis; scaffold8 indexed_genome mRNA 32091507 32150676 . - . ID=transcript_2205;A6NGB9 B8ZZV2,WAS/WASL-interacting protein family member 3,Corticosteroids and regional expression protein 16 homolog;, PF02205;, GO:0005884;GO:0005829;GO:0003779;GO:0017124;GO:0030048;GO:0030154;GO:0038096;GO:0007275;GO:0007283;, C:actin filament; C:cytosol;, F:actin binding; F:SH3 domain binding;, P:actin filament-based movement; P:cell differentiation; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:multicellular organism development; P:spermatogenesis;|A6NGB9 B8ZZV2,WAS/WASL-interacting protein family member 3,Corticosteroids and regional expression protein 16 homolog;, PF02205;, GO:0005884;GO:0005829;GO:0003779;GO:0017124;GO:0030048;GO:0030154;GO:0038096;GO:0007275;GO:0007283;, C:actin filament; C:cytosol;, F:actin binding; F:SH3 domain binding;, P:actin filament-based movement; P:cell differentiation; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:multicellular organism development; P:spermatogenesis;|A6NGB9 B8ZZV2,WAS/WASL-interacting protein family member 3,Corticosteroids and regional expression protein 16 homolog;, PF02205;, GO:0005884;GO:0005829;GO:0003779;GO:0017124;GO:0030048;GO:0030154;GO:0038096;GO:0007275;GO:0007283;, C:actin filament; C:cytosol;, F:actin binding; F:SH3 domain binding;, P:actin filament-based movement; P:cell differentiation; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:multicellular organism development; P:spermatogenesis;|A6NGB9 B8ZZV2,WAS/WASL-interacting protein family member 3,Corticosteroids and regional expression protein 16 homolog;, PF02205;, GO:0005884;GO:0005829;GO:0003779;GO:0017124;GO:0030048;GO:0030154;GO:0038096;GO:0007275;GO:0007283;, C:actin filament; C:cytosol;, F:actin binding; F:SH3 domain binding;, P:actin filament-based movement; P:cell differentiation; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:multicellular organism development; P:spermatogenesis; scaffold8 indexed_genome mRNA 32276239 32277292 . - . ID=transcript_2206;Q8IV56,Proline-rich protein 15,, PF15321;, GO:0007275;, , , P:multicellular organism development; scaffold8 indexed_genome mRNA 32300910 32626626 . - . ID=transcript_2207;F8QPL9 Q2M203 Q75MM2,Beta-chimaerin,Beta-chimerin;Rho GTPase-activating protein 3;, PF00130;PF00620;PF00017;, GO:0005829;GO:0016020;GO:0045202;GO:0005096;GO:0046872;GO:0035556;GO:0043087;GO:0051056;, C:cytosol; C:membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:intracellular signal transduction; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|F8QPL9 Q2M203 Q75MM2,Beta-chimaerin,Beta-chimerin;Rho GTPase-activating protein 3;, PF00130;PF00620;PF00017;, GO:0005829;GO:0016020;GO:0045202;GO:0005096;GO:0046872;GO:0035556;GO:0043087;GO:0051056;, C:cytosol; C:membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:intracellular signal transduction; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|F8QPL9 Q2M203 Q75MM2,Beta-chimaerin,Beta-chimerin;Rho GTPase-activating protein 3;, PF00130;PF00620;PF00017;, GO:0005829;GO:0016020;GO:0045202;GO:0005096;GO:0046872;GO:0035556;GO:0043087;GO:0051056;, C:cytosol; C:membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:intracellular signal transduction; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|F8QPL9 Q2M203 Q75MM2,Beta-chimaerin,Beta-chimerin;Rho GTPase-activating protein 3;, PF00130;PF00620;PF00017;, GO:0005829;GO:0016020;GO:0045202;GO:0005096;GO:0046872;GO:0035556;GO:0043087;GO:0051056;, C:cytosol; C:membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:intracellular signal transduction; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|F8QPL9 Q2M203 Q75MM2,Beta-chimaerin,Beta-chimerin;Rho GTPase-activating protein 3;, PF00130;PF00620;PF00017;, GO:0005829;GO:0016020;GO:0045202;GO:0005096;GO:0046872;GO:0035556;GO:0043087;GO:0051056;, C:cytosol; C:membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:intracellular signal transduction; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|F8QPL9 Q2M203 Q75MM2,Beta-chimaerin,Beta-chimerin;Rho GTPase-activating protein 3;, PF00130;PF00620;PF00017;, GO:0005829;GO:0016020;GO:0045202;GO:0005096;GO:0046872;GO:0035556;GO:0043087;GO:0051056;, C:cytosol; C:membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:intracellular signal transduction; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold8 indexed_genome mRNA 32720714 32774606 . + . ID=transcript_2208;Q9H3G5 A4D1A4 Q6UX20 Q8NBL7 Q96AR7 Q9HB41,Probable serine carboxypeptidase CPVL,Carboxypeptidase, vitellogenic-like;Vitellogenic carboxypeptidase-like protein;, PF00450;, GO:0070062;GO:0004185;, C:extracellular exosome;, F:serine-type carboxypeptidase activity; scaffold8 indexed_genome mRNA 32781295 32797143 . + . ID=transcript_2209;Q9H3G5 A4D1A4 Q6UX20 Q8NBL7 Q96AR7 Q9HB41,Probable serine carboxypeptidase CPVL,Carboxypeptidase, vitellogenic-like;Vitellogenic carboxypeptidase-like protein;, PF00450;, GO:0070062;GO:0004185;, C:extracellular exosome;, F:serine-type carboxypeptidase activity; scaffold8 indexed_genome mRNA 32837041 32842037 . - . ID=transcript_2210;Q7L0X0 A4D1A6 O75139,TLR4 interactor with leucine rich repeats,Leucine-rich repeat-containing protein KIAA0644;, PF13855;PF01463;, GO:0031012;GO:0005615;GO:0046696;GO:0001530;GO:0006954;GO:0045087;GO:0002718;GO:0034142;, C:extracellular matrix; C:extracellular space; C:lipopolysaccharide receptor complex;, F:lipopolysaccharide binding;, P:inflammatory response; P:innate immune response; P:regulation of cytokine production involved in immune response; P:toll-like receptor 4 signaling pathway; scaffold8 indexed_genome mRNA 32948571 32950959 . - . ID=transcript_2211;Q02930 A8KA51 B4DU13 B5BUH3 C9JK47 Q05886 Q06246 Q75N02 Q86UJ9,Cyclic AMP-responsive element-binding protein 5,cAMP-response element-binding protein A;, PF00170;, GO:0000785;GO:0070062;GO:0005634;GO:0035497;GO:0003700;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0045893;GO:0006357;, C:chromatin; C:extracellular exosome; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 32958341 33074178 . - . ID=transcript_2212;Q02930 A8KA51 B4DU13 B5BUH3 C9JK47 Q05886 Q06246 Q75N02 Q86UJ9,Cyclic AMP-responsive element-binding protein 5,cAMP-response element-binding protein A;, PF00170;, GO:0000785;GO:0070062;GO:0005634;GO:0035497;GO:0003700;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0045893;GO:0006357;, C:chromatin; C:extracellular exosome; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 33785947 33922424 . + . ID=transcript_2213;Q86VZ6 A4D195 Q8N3L7,Juxtaposed with another zinc finger protein 1,TAK1-interacting protein 27;Zinc finger protein 802;, , GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0017053;GO:0046872;GO:0003714;GO:0006629;GO:0000122;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:metal ion binding; F:transcription corepressor activity;, P:lipid metabolic process; P:negative regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 33922427 34016105 . - . ID=transcript_2214;Q86VP1 A4D196 B4DKU7 E7ENV2 O60398 O95770 Q13311 Q9BQG5 Q9UI88,Tax1-binding protein 1,TRAF6-binding protein;, PF07888;PF17751;PF18112;, GO:0005829;GO:0070062;GO:0019900;GO:0046872;GO:0006915;GO:0043066;GO:0032088;GO:0032480;GO:0010803;, C:cytosol; C:extracellular exosome;, F:kinase binding; F:metal ion binding;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q86VP1 A4D196 B4DKU7 E7ENV2 O60398 O95770 Q13311 Q9BQG5 Q9UI88,Tax1-binding protein 1,TRAF6-binding protein;, PF07888;PF17751;PF18112;, GO:0005829;GO:0070062;GO:0019900;GO:0046872;GO:0006915;GO:0043066;GO:0032088;GO:0032480;GO:0010803;, C:cytosol; C:extracellular exosome;, F:kinase binding; F:metal ion binding;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q86VP1 A4D196 B4DKU7 E7ENV2 O60398 O95770 Q13311 Q9BQG5 Q9UI88,Tax1-binding protein 1,TRAF6-binding protein;, PF07888;PF17751;PF18112;, GO:0005829;GO:0070062;GO:0019900;GO:0046872;GO:0006915;GO:0043066;GO:0032088;GO:0032480;GO:0010803;, C:cytosol; C:extracellular exosome;, F:kinase binding; F:metal ion binding;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q86VP1 A4D196 B4DKU7 E7ENV2 O60398 O95770 Q13311 Q9BQG5 Q9UI88,Tax1-binding protein 1,TRAF6-binding protein;, PF07888;PF17751;PF18112;, GO:0005829;GO:0070062;GO:0019900;GO:0046872;GO:0006915;GO:0043066;GO:0032088;GO:0032480;GO:0010803;, C:cytosol; C:extracellular exosome;, F:kinase binding; F:metal ion binding;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:regulation of tumor necrosis factor-mediated signaling pathway; scaffold8 indexed_genome mRNA 34083140 34194491 . + . ID=transcript_2215;P31937 Q546Z2 Q9UDN3,3-hydroxyisobutyrate dehydrogenase, mitochondrial,, PF14833;PF03446;, GO:0005759;GO:0005739;GO:0008442;GO:0051287;GO:0050661;GO:0016616;GO:0009083;GO:0006574;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxyisobutyrate dehydrogenase activity; F:NAD binding; F:NADP binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:branched-chain amino acid catabolic process; P:valine catabolic process;|P31937 Q546Z2 Q9UDN3,3-hydroxyisobutyrate dehydrogenase, mitochondrial,, PF14833;PF03446;, GO:0005759;GO:0005739;GO:0008442;GO:0051287;GO:0050661;GO:0016616;GO:0009083;GO:0006574;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxyisobutyrate dehydrogenase activity; F:NAD binding; F:NADP binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:branched-chain amino acid catabolic process; P:valine catabolic process;|P31937 Q546Z2 Q9UDN3,3-hydroxyisobutyrate dehydrogenase, mitochondrial,, PF14833;PF03446;, GO:0005759;GO:0005739;GO:0008442;GO:0051287;GO:0050661;GO:0016616;GO:0009083;GO:0006574;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxyisobutyrate dehydrogenase activity; F:NAD binding; F:NADP binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:branched-chain amino acid catabolic process; P:valine catabolic process;|P31937 Q546Z2 Q9UDN3,3-hydroxyisobutyrate dehydrogenase, mitochondrial,, PF14833;PF03446;, GO:0005759;GO:0005739;GO:0008442;GO:0051287;GO:0050661;GO:0016616;GO:0009083;GO:0006574;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxyisobutyrate dehydrogenase activity; F:NAD binding; F:NADP binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:branched-chain amino acid catabolic process; P:valine catabolic process;|P31937 Q546Z2 Q9UDN3,3-hydroxyisobutyrate dehydrogenase, mitochondrial,, PF14833;PF03446;, GO:0005759;GO:0005739;GO:0008442;GO:0051287;GO:0050661;GO:0016616;GO:0009083;GO:0006574;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxyisobutyrate dehydrogenase activity; F:NAD binding; F:NADP binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:branched-chain amino acid catabolic process; P:valine catabolic process; scaffold8 indexed_genome mRNA 34495042 34496885 . + . ID=transcript_2216;P31260 O43370 O43605 Q15949 Q504T1,Homeobox protein Hox-A10,Homeobox protein Hox-1.8;Homeobox protein Hox-1H;PL;, PF00046;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0000981;GO:0042826;GO:0000978;GO:1990837;GO:0009952;GO:0030326;GO:0008584;GO:0007275;GO:0045944;GO:0009954;GO:0006357;GO:0007338;GO:0001501;GO:0007283;GO:0060065;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:embryonic limb morphogenesis; P:male gonad development; P:multicellular organism development; P:positive regulation of transcription by RNA polymerase II; P:proximal/distal pattern formation; P:regulation of transcription by RNA polymerase II; P:single fertilization; P:skeletal system development; P:spermatogenesis; P:uterus development; scaffold8 indexed_genome mRNA 34501971 34504141 . + . ID=transcript_2217;P31269 O43369 O43429 Q99820,Homeobox protein Hox-A9,Homeobox protein Hox-1G;, PF00046;PF04617;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0000978;GO:1990837;GO:0009952;GO:0060216;GO:0035115;GO:0048704;GO:0042118;GO:0008584;GO:0030879;GO:0007275;GO:0045638;GO:0009954;GO:0006357;GO:0007338;GO:0007283;GO:0006351;GO:0060065;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:definitive hemopoiesis; P:embryonic forelimb morphogenesis; P:embryonic skeletal system morphogenesis; P:endothelial cell activation; P:male gonad development; P:mammary gland development; P:multicellular organism development; P:negative regulation of myeloid cell differentiation; P:proximal/distal pattern formation; P:regulation of transcription by RNA polymerase II; P:single fertilization; P:spermatogenesis; P:transcription, DNA-templated; P:uterus development;|P31269 O43369 O43429 Q99820,Homeobox protein Hox-A9,Homeobox protein Hox-1G;, PF00046;PF04617;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0000978;GO:1990837;GO:0009952;GO:0060216;GO:0035115;GO:0048704;GO:0042118;GO:0008584;GO:0030879;GO:0007275;GO:0045638;GO:0009954;GO:0006357;GO:0007338;GO:0007283;GO:0006351;GO:0060065;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:definitive hemopoiesis; P:embryonic forelimb morphogenesis; P:embryonic skeletal system morphogenesis; P:endothelial cell activation; P:male gonad development; P:mammary gland development; P:multicellular organism development; P:negative regulation of myeloid cell differentiation; P:proximal/distal pattern formation; P:regulation of transcription by RNA polymerase II; P:single fertilization; P:spermatogenesis; P:transcription, DNA-templated; P:uterus development; scaffold8 indexed_genome mRNA 34510363 34513434 . + . ID=transcript_2218;P31268 A4D191 O43368 O43486 O95655 Q9NSC8 Q9UDM1,Homeobox protein Hox-A7,Homeobox protein Hox 1.1;Homeobox protein Hox-1A;, PF00046;, GO:0000785;GO:0031965;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0001525;GO:0009952;GO:0048704;GO:0001953;GO:0045617;GO:0002686;GO:0045656;GO:0000122;GO:0045892;GO:0045944;GO:0006357;GO:0048863;, C:chromatin; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:angiogenesis; P:anterior/posterior pattern specification; P:embryonic skeletal system morphogenesis; P:negative regulation of cell-matrix adhesion; P:negative regulation of keratinocyte differentiation; P:negative regulation of leukocyte migration; P:negative regulation of monocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:stem cell differentiation; scaffold8 indexed_genome mRNA 34522778 34526246 . + . ID=transcript_2219;P20719 A4D179 O43367 Q96CY6,Homeobox protein Hox-A5,Homeobox protein Hox-1C;, PF00046;, GO:0000785;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0009952;GO:0060435;GO:0016477;GO:0060764;GO:0048704;GO:0060441;GO:0060574;GO:0048286;GO:0060480;GO:0060484;GO:0060749;GO:0060644;GO:0060638;GO:0035264;GO:0016525;GO:0045647;GO:0043065;GO:0010628;GO:0045639;GO:0045944;GO:0033599;GO:0006357;GO:0003016;GO:0030878;GO:0060535;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:bronchiole development; P:cell migration; P:cell-cell signaling involved in mammary gland development; P:embryonic skeletal system morphogenesis; P:epithelial tube branching involved in lung morphogenesis; P:intestinal epithelial cell maturation; P:lung alveolus development; P:lung goblet cell differentiation; P:lung-associated mesenchyme development; P:mammary gland alveolus development; P:mammary gland epithelial cell differentiation; P:mesenchymal-epithelial cell signaling; P:multicellular organism growth; P:negative regulation of angiogenesis; P:negative regulation of erythrocyte differentiation; P:positive regulation of apoptotic process; P:positive regulation of gene expression; P:positive regulation of myeloid cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:respiratory system process; P:thyroid gland development; P:trachea cartilage morphogenesis; scaffold8 indexed_genome mRNA 34549635 34561263 . + . ID=transcript_2220;O43365 A4D181,Homeobox protein Hox-A3,Homeobox protein Hox-1E;, PF13293;PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000981;GO:0071837;GO:0000978;GO:0001525;GO:0048645;GO:0009952;GO:0001974;GO:0051216;GO:0048704;GO:0010467;GO:0021615;GO:0060017;GO:0008284;GO:0006357;GO:0010159;GO:0048538;GO:0030878;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:HMG box domain binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:animal organ formation; P:anterior/posterior pattern specification; P:blood vessel remodeling; P:cartilage development; P:embryonic skeletal system morphogenesis; P:gene expression; P:glossopharyngeal nerve morphogenesis; P:parathyroid gland development; P:positive regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:specification of animal organ position; P:thymus development; P:thyroid gland development; scaffold8 indexed_genome mRNA 34561283 34564069 . + . ID=transcript_2221;O43365 A4D181,Homeobox protein Hox-A3,Homeobox protein Hox-1E;, PF13293;PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000981;GO:0071837;GO:0000978;GO:0001525;GO:0048645;GO:0009952;GO:0001974;GO:0051216;GO:0048704;GO:0010467;GO:0021615;GO:0060017;GO:0008284;GO:0006357;GO:0010159;GO:0048538;GO:0030878;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:HMG box domain binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:animal organ formation; P:anterior/posterior pattern specification; P:blood vessel remodeling; P:cartilage development; P:embryonic skeletal system morphogenesis; P:gene expression; P:glossopharyngeal nerve morphogenesis; P:parathyroid gland development; P:positive regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:specification of animal organ position; P:thymus development; P:thyroid gland development; scaffold8 indexed_genome mRNA 34568967 34575857 . + . ID=transcript_2222;O43364 A1L4K3 B2RMW3,Homeobox protein Hox-A2,Homeobox protein Hox-1K;, PF00046;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0009952;GO:0035284;GO:0001709;GO:0071300;GO:0009953;GO:0048703;GO:0042474;GO:0008045;GO:0045665;GO:0045668;GO:0002076;GO:0045944;GO:0006357;GO:0021568;GO:0021658;GO:0007379;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:brain segmentation; P:cell fate determination; P:cellular response to retinoic acid; P:dorsal/ventral pattern formation; P:embryonic viscerocranium morphogenesis; P:middle ear morphogenesis; P:motor neuron axon guidance; P:negative regulation of neuron differentiation; P:negative regulation of osteoblast differentiation; P:osteoblast development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:rhombomere 2 development; P:rhombomere 3 morphogenesis; P:segment specification; scaffold8 indexed_genome mRNA 34581173 34582278 . + . ID=transcript_2223;P49639 A4D184 B2R8U7 O43363,Homeobox protein Hox-A1,Homeobox protein Hox-1F;, PF00046;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0000978;GO:0043565;GO:1990837;GO:0021599;GO:0009653;GO:0060840;GO:0048844;GO:0090102;GO:0090103;GO:0050890;GO:0048702;GO:0048839;GO:0007275;GO:0050905;GO:0007634;GO:0042473;GO:0045944;GO:0050795;GO:0006357;GO:0060876;GO:0007605;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:abducens nerve formation; P:anatomical structure morphogenesis; P:artery development; P:artery morphogenesis; P:cochlea development; P:cochlea morphogenesis; P:cognition; P:embryonic neurocranium morphogenesis; P:inner ear development; P:multicellular organism development; P:neuromuscular process; P:optokinetic behavior; P:outer ear morphogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of behavior; P:regulation of transcription by RNA polymerase II; P:semicircular canal formation; P:sensory perception of sound; scaffold8 indexed_genome mRNA 34748785 34916789 . + . ID=transcript_2224;O75563 A4D173 Q53GP6 Q75MK6 Q75MZ4 Q9UBZ3 Q9UED8,Src kinase-associated phosphoprotein 2,Pyk2/RAFTK-associated protein;Retinoic acid-induced protein 70;SKAP55 homolog;Src family-associated phosphoprotein 2;Src kinase-associated phosphoprotein 55-related protein;Src-associated adapter protein with PH and SH3 domains;, PF00169;PF00018;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0042113;GO:0008285;GO:0065003;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, , P:B cell activation; P:negative regulation of cell population proliferation; P:protein-containing complex assembly; P:signal transduction;|O75563 A4D173 Q53GP6 Q75MK6 Q75MZ4 Q9UBZ3 Q9UED8,Src kinase-associated phosphoprotein 2,Pyk2/RAFTK-associated protein;Retinoic acid-induced protein 70;SKAP55 homolog;Src family-associated phosphoprotein 2;Src kinase-associated phosphoprotein 55-related protein;Src-associated adapter protein with PH and SH3 domains;, PF00169;PF00018;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0042113;GO:0008285;GO:0065003;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, , P:B cell activation; P:negative regulation of cell population proliferation; P:protein-containing complex assembly; P:signal transduction; scaffold8 indexed_genome mRNA 35187854 35204390 . - . ID=transcript_2225;Q9Y5X0 E9PFH5 Q8IYT5,Sorting nexin-10,, PF00787;, GO:0090651;GO:0005783;GO:0031313;GO:0005815;GO:0005634;GO:0030141;GO:0005545;GO:0051117;GO:0035630;GO:0045453;GO:0055074;GO:1990830;GO:0060271;GO:0006897;GO:0007032;GO:0001696;GO:0006886;GO:0030316;GO:0071539;GO:0061512;GO:0097178;GO:0044691;, C:apical cytoplasm; C:endoplasmic reticulum; C:extrinsic component of endosome membrane; C:microtubule organizing center; C:nucleus; C:secretory granule;, F:1-phosphatidylinositol binding; F:ATPase binding;, P:bone mineralization involved in bone maturation; P:bone resorption; P:calcium ion homeostasis; P:cellular response to leukemia inhibitory factor; P:cilium assembly; P:endocytosis; P:endosome organization; P:gastric acid secretion; P:intracellular protein transport; P:osteoclast differentiation; P:protein localization to centrosome; P:protein localization to cilium; P:ruffle assembly; P:tooth eruption;|Q9Y5X0 E9PFH5 Q8IYT5,Sorting nexin-10,, PF00787;, GO:0090651;GO:0005783;GO:0031313;GO:0005815;GO:0005634;GO:0030141;GO:0005545;GO:0051117;GO:0035630;GO:0045453;GO:0055074;GO:1990830;GO:0060271;GO:0006897;GO:0007032;GO:0001696;GO:0006886;GO:0030316;GO:0071539;GO:0061512;GO:0097178;GO:0044691;, C:apical cytoplasm; C:endoplasmic reticulum; C:extrinsic component of endosome membrane; C:microtubule organizing center; C:nucleus; C:secretory granule;, F:1-phosphatidylinositol binding; F:ATPase binding;, P:bone mineralization involved in bone maturation; P:bone resorption; P:calcium ion homeostasis; P:cellular response to leukemia inhibitory factor; P:cilium assembly; P:endocytosis; P:endosome organization; P:gastric acid secretion; P:intracellular protein transport; P:osteoclast differentiation; P:protein localization to centrosome; P:protein localization to cilium; P:ruffle assembly; P:tooth eruption; scaffold8 indexed_genome mRNA 35314149 35335981 . - . ID=transcript_2226;Q13185 Q96CD7 Q99409 Q9BVS3 Q9P0Z6,Chromobox protein homolog 3,HECH;Heterochromatin protein 1 homolog gamma;Modifier 2 protein;, PF00385;PF01393;, GO:0000785;GO:0000775;GO:0000781;GO:0000779;GO:0000791;GO:0000792;GO:0005635;GO:0005637;GO:0005654;GO:0005634;GO:0005721;GO:0090575;GO:0035985;GO:0090734;GO:0005819;GO:0019899;GO:1990226;GO:0042802;GO:0019904;GO:0008134;GO:0071549;GO:0006974;GO:0006338;GO:0070317;GO:0045892;GO:0048511;, C:chromatin; C:chromosome, centromeric region; C:chromosome, telomeric region; C:condensed chromosome, centromeric region; C:euchromatin; C:heterochromatin; C:nuclear envelope; C:nuclear inner membrane; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:RNA polymerase II transcription regulator complex; C:senescence-associated heterochromatin focus; C:site of DNA damage; C:spindle;, F:enzyme binding; F:histone methyltransferase binding; F:identical protein binding; F:protein domain specific binding; F:transcription factor binding;, P:cellular response to dexamethasone stimulus; P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated; P:rhythmic process;|Q13185 Q96CD7 Q99409 Q9BVS3 Q9P0Z6,Chromobox protein homolog 3,HECH;Heterochromatin protein 1 homolog gamma;Modifier 2 protein;, PF00385;PF01393;, GO:0000785;GO:0000775;GO:0000781;GO:0000779;GO:0000791;GO:0000792;GO:0005635;GO:0005637;GO:0005654;GO:0005634;GO:0005721;GO:0090575;GO:0035985;GO:0090734;GO:0005819;GO:0019899;GO:1990226;GO:0042802;GO:0019904;GO:0008134;GO:0071549;GO:0006974;GO:0006338;GO:0070317;GO:0045892;GO:0048511;, C:chromatin; C:chromosome, centromeric region; C:chromosome, telomeric region; C:condensed chromosome, centromeric region; C:euchromatin; C:heterochromatin; C:nuclear envelope; C:nuclear inner membrane; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:RNA polymerase II transcription regulator complex; C:senescence-associated heterochromatin focus; C:site of DNA damage; C:spindle;, F:enzyme binding; F:histone methyltransferase binding; F:identical protein binding; F:protein domain specific binding; F:transcription factor binding;, P:cellular response to dexamethasone stimulus; P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated; P:rhythmic process; scaffold8 indexed_genome mRNA 35341511 35354437 . - . ID=transcript_2227;Q9Y4A8 Q6NUS0 Q7Z498 Q86UJ4 Q86VR5 Q9UQA4,Nuclear factor erythroid 2-related factor 3,Nuclear factor, erythroid derived 2, like 3;, PF03131;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q9Y4A8 Q6NUS0 Q7Z498 Q86UJ4 Q86VR5 Q9UQA4,Nuclear factor erythroid 2-related factor 3,Nuclear factor, erythroid derived 2, like 3;, PF03131;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q9Y4A8 Q6NUS0 Q7Z498 Q86UJ4 Q86VR5 Q9UQA4,Nuclear factor erythroid 2-related factor 3,Nuclear factor, erythroid derived 2, like 3;, PF03131;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q9Y4A8 Q6NUS0 Q7Z498 Q86UJ4 Q86VR5 Q9UQA4,Nuclear factor erythroid 2-related factor 3,Nuclear factor, erythroid derived 2, like 3;, PF03131;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 36280583 36281224 . - . ID=transcript_2228;Q8N865 A4D165 Q6MZV8 Q6P989 Q7LE28 Q86XK1 Q8N1H5 Q96BN4,Uncharacterized protein C7orf31,, PF15093;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm; scaffold8 indexed_genome mRNA 36288347 36294718 . + . ID=transcript_2229;P99999 A4D166 B2R4I1 P00001 Q6NUR2 Q6NX69 Q96BV4,Cytochrome c,, PF00034;, GO:0005829;GO:0005743;GO:0005758;GO:0005739;GO:0005634;GO:0070469;GO:0009055;GO:0020037;GO:0046872;GO:0008635;GO:0006915;GO:0045333;GO:0034599;GO:0006123;GO:0006122;GO:0007005;GO:0043280;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus; C:respirasome;, F:electron transfer activity; F:heme binding; F:metal ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:apoptotic process; P:cellular respiration; P:cellular response to oxidative stress; P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:mitochondrion organization; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; scaffold8 indexed_genome mRNA 36385147 36517221 . + . ID=transcript_2230;Q8NI13 Q9BZF4 Q9UED6,Oxysterol-binding protein-related protein 3,, PF01237;PF15409;, GO:0005829;GO:0005789;GO:0032433;GO:0043231;GO:0016020;GO:0031965;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;, C:cytosol; C:endoplasmic reticulum membrane; C:filopodium tip; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; scaffold8 indexed_genome mRNA 36527757 36584935 . + . ID=transcript_2231;Q8NI13 Q9BZF4 Q9UED6,Oxysterol-binding protein-related protein 3,, PF01237;PF15409;, GO:0005829;GO:0005789;GO:0032433;GO:0043231;GO:0016020;GO:0031965;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;, C:cytosol; C:endoplasmic reticulum membrane; C:filopodium tip; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; scaffold8 indexed_genome mRNA 36625495 36681139 . + . ID=transcript_2232;O60443 A4D156 B2RAX9 B3KT05 O14590 Q08AQ8 Q9UBV3,Gasdermin-E {ECO:0000303|PubMed:28459430},Inversely correlated with estrogen receptor expression 1 {ECO:0000303|PubMed:9523727};Non-syndromic hearing impairment protein 5 {ECO:0000303|PubMed:9771715};, PF04598;PF17708;, GO:0005829;GO:0016021;GO:0016020;GO:0005886;GO:1901612;GO:0005546;GO:0022829;GO:0008219;GO:0071356;GO:0098586;GO:0140507;GO:0060113;GO:0070265;GO:0008285;GO:0002839;GO:2001244;GO:0043410;GO:0070269;GO:0007605;, C:cytosol; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cardiolipin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:wide pore channel activity;, P:cell death; P:cellular response to tumor necrosis factor; P:cellular response to virus; P:granzyme-mediated programmed cell death signaling pathway; P:inner ear receptor cell differentiation; P:necrotic cell death; P:negative regulation of cell population proliferation; P:positive regulation of immune response to tumor cell; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of MAPK cascade; P:pyroptosis; P:sensory perception of sound; scaffold8 indexed_genome mRNA 36695959 36759127 . - . ID=transcript_2233;Q9NZW5 A4D157 Q9H0E1,MAGUK p55 subfamily member 6,Veli-associated MAGUK 1;, PF00625;PF02828;PF00595;PF07653;, GO:0070062;GO:0016020;GO:0005886;GO:0065003;, C:extracellular exosome; C:membrane; C:plasma membrane;, , P:protein-containing complex assembly;|Q9NZW5 A4D157 Q9H0E1,MAGUK p55 subfamily member 6,Veli-associated MAGUK 1;, PF00625;PF02828;PF00595;PF07653;, GO:0070062;GO:0016020;GO:0005886;GO:0065003;, C:extracellular exosome; C:membrane; C:plasma membrane;, , P:protein-containing complex assembly;|Q9NZW5 A4D157 Q9H0E1,MAGUK p55 subfamily member 6,Veli-associated MAGUK 1;, PF00625;PF02828;PF00595;PF07653;, GO:0070062;GO:0016020;GO:0005886;GO:0065003;, C:extracellular exosome; C:membrane; C:plasma membrane;, , P:protein-containing complex assembly; scaffold8 indexed_genome mRNA 37436804 37500694 . - . ID=transcript_2234;Q9BXU1 B4DZ06 B7WPP5 C9J4F9 Q6PCD3 Q9BXH8,Serine/threonine-protein kinase 31,Serine/threonine-protein kinase NYD-SPK;Sugen kinase 396;, PF00069;PF00567;, GO:0001669;GO:0005737;GO:0005634;GO:0005524;GO:0004518;GO:0106310;GO:0106311;, C:acrosomal vesicle; C:cytoplasm; C:nucleus;, F:ATP binding; F:nuclease activity; F:protein serine kinase activity; F:protein threonine kinase activity;|Q9BXU1 B4DZ06 B7WPP5 C9J4F9 Q6PCD3 Q9BXH8,Serine/threonine-protein kinase 31,Serine/threonine-protein kinase NYD-SPK;Sugen kinase 396;, PF00069;PF00567;, GO:0001669;GO:0005737;GO:0005634;GO:0005524;GO:0004518;GO:0106310;GO:0106311;, C:acrosomal vesicle; C:cytoplasm; C:nucleus;, F:ATP binding; F:nuclease activity; F:protein serine kinase activity; F:protein threonine kinase activity;|Q9BXU1 B4DZ06 B7WPP5 C9J4F9 Q6PCD3 Q9BXH8,Serine/threonine-protein kinase 31,Serine/threonine-protein kinase NYD-SPK;Sugen kinase 396;, PF00069;PF00567;, GO:0001669;GO:0005737;GO:0005634;GO:0005524;GO:0004518;GO:0106310;GO:0106311;, C:acrosomal vesicle; C:cytoplasm; C:nucleus;, F:ATP binding; F:nuclease activity; F:protein serine kinase activity; F:protein threonine kinase activity; scaffold8 indexed_genome mRNA 37505354 37528201 . - . ID=transcript_2235;A4D161 Q05CG4 Q4G0Q7 Q6P519,Protein FAM221A,, PF14753;|A4D161 Q05CG4 Q4G0Q7 Q6P519,Protein FAM221A,, PF14753;|A4D161 Q05CG4 Q4G0Q7 Q6P519,Protein FAM221A,, PF14753;|A4D161 Q05CG4 Q4G0Q7 Q6P519,Protein FAM221A,, PF14753; scaffold8 indexed_genome mRNA 37545288 37781974 . + . ID=transcript_2236;Q9P0K1 O75075 O75076 Q9P0K2 Q9UIA1 Q9UKK2,Disintegrin and metalloproteinase domain-containing protein 22,Metalloproteinase-disintegrin ADAM22-3;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0030424;GO:0098978;GO:0016021;GO:0099061;GO:0005886;GO:0005178;GO:0004222;GO:0008344;GO:0007155;GO:0007417;GO:0022011;GO:0007162;GO:0099645;, C:axon; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity;, P:adult locomotory behavior; P:cell adhesion; P:central nervous system development; P:myelination in peripheral nervous system; P:negative regulation of cell adhesion; P:neurotransmitter receptor localization to postsynaptic specialization membrane;|Q9P0K1 O75075 O75076 Q9P0K2 Q9UIA1 Q9UKK2,Disintegrin and metalloproteinase domain-containing protein 22,Metalloproteinase-disintegrin ADAM22-3;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0030424;GO:0098978;GO:0016021;GO:0099061;GO:0005886;GO:0005178;GO:0004222;GO:0008344;GO:0007155;GO:0007417;GO:0022011;GO:0007162;GO:0099645;, C:axon; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity;, P:adult locomotory behavior; P:cell adhesion; P:central nervous system development; P:myelination in peripheral nervous system; P:negative regulation of cell adhesion; P:neurotransmitter receptor localization to postsynaptic specialization membrane;|Q9P0K1 O75075 O75076 Q9P0K2 Q9UIA1 Q9UKK2,Disintegrin and metalloproteinase domain-containing protein 22,Metalloproteinase-disintegrin ADAM22-3;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0030424;GO:0098978;GO:0016021;GO:0099061;GO:0005886;GO:0005178;GO:0004222;GO:0008344;GO:0007155;GO:0007417;GO:0022011;GO:0007162;GO:0099645;, C:axon; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity;, P:adult locomotory behavior; P:cell adhesion; P:central nervous system development; P:myelination in peripheral nervous system; P:negative regulation of cell adhesion; P:neurotransmitter receptor localization to postsynaptic specialization membrane;|Q9P0K1 O75075 O75076 Q9P0K2 Q9UIA1 Q9UKK2,Disintegrin and metalloproteinase domain-containing protein 22,Metalloproteinase-disintegrin ADAM22-3;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0030424;GO:0098978;GO:0016021;GO:0099061;GO:0005886;GO:0005178;GO:0004222;GO:0008344;GO:0007155;GO:0007417;GO:0022011;GO:0007162;GO:0099645;, C:axon; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity;, P:adult locomotory behavior; P:cell adhesion; P:central nervous system development; P:myelination in peripheral nervous system; P:negative regulation of cell adhesion; P:neurotransmitter receptor localization to postsynaptic specialization membrane;|Q9P0K1 O75075 O75076 Q9P0K2 Q9UIA1 Q9UKK2,Disintegrin and metalloproteinase domain-containing protein 22,Metalloproteinase-disintegrin ADAM22-3;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0030424;GO:0098978;GO:0016021;GO:0099061;GO:0005886;GO:0005178;GO:0004222;GO:0008344;GO:0007155;GO:0007417;GO:0022011;GO:0007162;GO:0099645;, C:axon; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity;, P:adult locomotory behavior; P:cell adhesion; P:central nervous system development; P:myelination in peripheral nervous system; P:negative regulation of cell adhesion; P:neurotransmitter receptor localization to postsynaptic specialization membrane;|Q9P0K1 O75075 O75076 Q9P0K2 Q9UIA1 Q9UKK2,Disintegrin and metalloproteinase domain-containing protein 22,Metalloproteinase-disintegrin ADAM22-3;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0030424;GO:0098978;GO:0016021;GO:0099061;GO:0005886;GO:0005178;GO:0004222;GO:0008344;GO:0007155;GO:0007417;GO:0022011;GO:0007162;GO:0099645;, C:axon; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity;, P:adult locomotory behavior; P:cell adhesion; P:central nervous system development; P:myelination in peripheral nervous system; P:negative regulation of cell adhesion; P:neurotransmitter receptor localization to postsynaptic specialization membrane;|Q9P0K1 O75075 O75076 Q9P0K2 Q9UIA1 Q9UKK2,Disintegrin and metalloproteinase domain-containing protein 22,Metalloproteinase-disintegrin ADAM22-3;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0030424;GO:0098978;GO:0016021;GO:0099061;GO:0005886;GO:0005178;GO:0004222;GO:0008344;GO:0007155;GO:0007417;GO:0022011;GO:0007162;GO:0099645;, C:axon; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity;, P:adult locomotory behavior; P:cell adhesion; P:central nervous system development; P:myelination in peripheral nervous system; P:negative regulation of cell adhesion; P:neurotransmitter receptor localization to postsynaptic specialization membrane;|P30626 A8MTH6 B4DKK2 D6W5Q0,Sorcin,22 kDa protein;CP-22;V19;, PF13499;PF13833;, GO:0043679;GO:0005737;GO:0005829;GO:0044326;GO:0005789;GO:0070062;GO:0016020;GO:0005739;GO:0005654;GO:0016529;GO:0033017;GO:0005790;GO:0030315;GO:0030018;GO:0005246;GO:0005509;GO:0042802;GO:0044325;GO:0002020;GO:0046982;GO:0070491;GO:0005102;GO:0001508;GO:0006816;GO:0042994;GO:0007507;GO:0006880;GO:0007517;GO:0055118;GO:0010459;GO:0060315;GO:2000678;GO:0035774;GO:0051281;GO:0051924;GO:0086004;GO:0010649;GO:1901844;GO:0008016;GO:1901841;GO:1901077;GO:0010880;GO:0006942;GO:0007165;, C:axon terminus; C:cytoplasm; C:cytosol; C:dendritic spine neck; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:mitochondrion; C:nucleoplasm; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:T-tubule; C:Z disc;, F:calcium channel regulator activity; F:calcium ion binding; F:identical protein binding; F:ion channel binding; F:protease binding; F:protein heterodimerization activity; F:repressing transcription factor binding; F:signaling receptor binding;, P:action potential; P:calcium ion transport; P:cytoplasmic sequestering of transcription factor; P:heart development; P:intracellular sequestering of iron ion; P:muscle organ development; P:negative regulation of cardiac muscle contraction; P:negative regulation of heart rate; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:negative regulation of transcription regulatory region DNA binding; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cell communication by electrical coupling; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of heart contraction; P:regulation of high voltage-gated calcium channel activity; P:regulation of relaxation of muscle; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of striated muscle contraction; P:signal transduction;|P30626 A8MTH6 B4DKK2 D6W5Q0,Sorcin,22 kDa protein;CP-22;V19;, PF13499;PF13833;, GO:0043679;GO:0005737;GO:0005829;GO:0044326;GO:0005789;GO:0070062;GO:0016020;GO:0005739;GO:0005654;GO:0016529;GO:0033017;GO:0005790;GO:0030315;GO:0030018;GO:0005246;GO:0005509;GO:0042802;GO:0044325;GO:0002020;GO:0046982;GO:0070491;GO:0005102;GO:0001508;GO:0006816;GO:0042994;GO:0007507;GO:0006880;GO:0007517;GO:0055118;GO:0010459;GO:0060315;GO:2000678;GO:0035774;GO:0051281;GO:0051924;GO:0086004;GO:0010649;GO:1901844;GO:0008016;GO:1901841;GO:1901077;GO:0010880;GO:0006942;GO:0007165;, C:axon terminus; C:cytoplasm; C:cytosol; C:dendritic spine neck; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:mitochondrion; C:nucleoplasm; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:T-tubule; C:Z disc;, F:calcium channel regulator activity; F:calcium ion binding; F:identical protein binding; F:ion channel binding; F:protease binding; F:protein heterodimerization activity; F:repressing transcription factor binding; F:signaling receptor binding;, P:action potential; P:calcium ion transport; P:cytoplasmic sequestering of transcription factor; P:heart development; P:intracellular sequestering of iron ion; P:muscle organ development; P:negative regulation of cardiac muscle contraction; P:negative regulation of heart rate; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:negative regulation of transcription regulatory region DNA binding; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cell communication by electrical coupling; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of heart contraction; P:regulation of high voltage-gated calcium channel activity; P:regulation of relaxation of muscle; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of striated muscle contraction; P:signal transduction;|P30626 A8MTH6 B4DKK2 D6W5Q0,Sorcin,22 kDa protein;CP-22;V19;, PF13499;PF13833;, GO:0043679;GO:0005737;GO:0005829;GO:0044326;GO:0005789;GO:0070062;GO:0016020;GO:0005739;GO:0005654;GO:0016529;GO:0033017;GO:0005790;GO:0030315;GO:0030018;GO:0005246;GO:0005509;GO:0042802;GO:0044325;GO:0002020;GO:0046982;GO:0070491;GO:0005102;GO:0001508;GO:0006816;GO:0042994;GO:0007507;GO:0006880;GO:0007517;GO:0055118;GO:0010459;GO:0060315;GO:2000678;GO:0035774;GO:0051281;GO:0051924;GO:0086004;GO:0010649;GO:1901844;GO:0008016;GO:1901841;GO:1901077;GO:0010880;GO:0006942;GO:0007165;, C:axon terminus; C:cytoplasm; C:cytosol; C:dendritic spine neck; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:mitochondrion; C:nucleoplasm; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:T-tubule; C:Z disc;, F:calcium channel regulator activity; F:calcium ion binding; F:identical protein binding; F:ion channel binding; F:protease binding; F:protein heterodimerization activity; F:repressing transcription factor binding; F:signaling receptor binding;, P:action potential; P:calcium ion transport; P:cytoplasmic sequestering of transcription factor; P:heart development; P:intracellular sequestering of iron ion; P:muscle organ development; P:negative regulation of cardiac muscle contraction; P:negative regulation of heart rate; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:negative regulation of transcription regulatory region DNA binding; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cell communication by electrical coupling; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of heart contraction; P:regulation of high voltage-gated calcium channel activity; P:regulation of relaxation of muscle; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of striated muscle contraction; P:signal transduction;|P30626 A8MTH6 B4DKK2 D6W5Q0,Sorcin,22 kDa protein;CP-22;V19;, PF13499;PF13833;, GO:0043679;GO:0005737;GO:0005829;GO:0044326;GO:0005789;GO:0070062;GO:0016020;GO:0005739;GO:0005654;GO:0016529;GO:0033017;GO:0005790;GO:0030315;GO:0030018;GO:0005246;GO:0005509;GO:0042802;GO:0044325;GO:0002020;GO:0046982;GO:0070491;GO:0005102;GO:0001508;GO:0006816;GO:0042994;GO:0007507;GO:0006880;GO:0007517;GO:0055118;GO:0010459;GO:0060315;GO:2000678;GO:0035774;GO:0051281;GO:0051924;GO:0086004;GO:0010649;GO:1901844;GO:0008016;GO:1901841;GO:1901077;GO:0010880;GO:0006942;GO:0007165;, C:axon terminus; C:cytoplasm; C:cytosol; C:dendritic spine neck; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:mitochondrion; C:nucleoplasm; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:T-tubule; C:Z disc;, F:calcium channel regulator activity; F:calcium ion binding; F:identical protein binding; F:ion channel binding; F:protease binding; F:protein heterodimerization activity; F:repressing transcription factor binding; F:signaling receptor binding;, P:action potential; P:calcium ion transport; P:cytoplasmic sequestering of transcription factor; P:heart development; P:intracellular sequestering of iron ion; P:muscle organ development; P:negative regulation of cardiac muscle contraction; P:negative regulation of heart rate; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:negative regulation of transcription regulatory region DNA binding; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cell communication by electrical coupling; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of heart contraction; P:regulation of high voltage-gated calcium channel activity; P:regulation of relaxation of muscle; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of striated muscle contraction; P:signal transduction; scaffold8 indexed_genome mRNA 37840885 37881008 . - . ID=transcript_2237;Q687X5 Q658Q9 Q687X4 Q8WWB0 Q9H5R1,Metalloreductase STEAP4,Six-transmembrane epithelial antigen of prostate 4;SixTransMembrane protein of prostate 2;Tumor necrosis factor, alpha-induced protein 9;, PF03807;PF01794;, GO:0031901;GO:0005768;GO:0070062;GO:0000139;GO:0016021;GO:0005654;GO:0005886;GO:0008823;GO:0009055;GO:0071949;GO:0052851;GO:0020037;GO:0046872;GO:0015677;GO:0045444;GO:0033212;GO:0070207;, C:early endosome membrane; C:endosome; C:extracellular exosome; C:Golgi membrane; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:cupric reductase activity; F:electron transfer activity; F:FAD binding; F:ferric-chelate reductase (NADPH) activity; F:heme binding; F:metal ion binding;, P:copper ion import; P:fat cell differentiation; P:iron import into cell; P:protein homotrimerization; scaffold8 indexed_genome mRNA 38838286 38838831 . - . ID=transcript_2238;A4D1E1 B2RTV2 Q7Z714 Q96MN7,Zinc finger protein 804B,, PF12171;, GO:0005634;GO:0046872;, C:nucleus;, F:metal ion binding; scaffold8 indexed_genome mRNA 39690993 39698343 . + . ID=transcript_2239;Q9UHE8 A4D1E0 O95034,Metalloreductase STEAP1,Six-transmembrane epithelial antigen of prostate 1;, PF01794;, GO:0005911;GO:0005768;GO:0010008;GO:0005887;GO:0016020;GO:0005886;GO:0015267;GO:0046872;GO:0016491;GO:0005215;GO:0006811;GO:0055072;, C:cell-cell junction; C:endosome; C:endosome membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:channel activity; F:metal ion binding; F:oxidoreductase activity; F:transporter activity;, P:ion transport; P:iron ion homeostasis; scaffold8 indexed_genome mRNA 39731640 39754346 . + . ID=transcript_2240;Q8NFT2 A4D1F1 G5E9C6 Q6UXN6 Q6YPB1 Q8IUE7,Metalloreductase STEAP2,Prostate cancer-associated protein 1;Protein up-regulated in metastatic prostate cancer;Six-transmembrane epithelial antigen of prostate 2;SixTransMembrane protein of prostate 1;, PF03807;PF01794;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0030173;GO:0005886;GO:0030140;GO:0008823;GO:0052851;GO:0046872;GO:0015677;GO:0098705;GO:0006897;GO:0006893;GO:0098711;GO:0045055;GO:0009725;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:integral component of Golgi membrane; C:plasma membrane; C:trans-Golgi network transport vesicle;, F:cupric reductase activity; F:ferric-chelate reductase (NADPH) activity; F:metal ion binding;, P:copper ion import; P:copper ion import across plasma membrane; P:endocytosis; P:Golgi to plasma membrane transport; P:iron ion import across plasma membrane; P:regulated exocytosis; P:response to hormone;|Q8NFT2 A4D1F1 G5E9C6 Q6UXN6 Q6YPB1 Q8IUE7,Metalloreductase STEAP2,Prostate cancer-associated protein 1;Protein up-regulated in metastatic prostate cancer;Six-transmembrane epithelial antigen of prostate 2;SixTransMembrane protein of prostate 1;, PF03807;PF01794;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0030173;GO:0005886;GO:0030140;GO:0008823;GO:0052851;GO:0046872;GO:0015677;GO:0098705;GO:0006897;GO:0006893;GO:0098711;GO:0045055;GO:0009725;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:integral component of Golgi membrane; C:plasma membrane; C:trans-Golgi network transport vesicle;, F:cupric reductase activity; F:ferric-chelate reductase (NADPH) activity; F:metal ion binding;, P:copper ion import; P:copper ion import across plasma membrane; P:endocytosis; P:Golgi to plasma membrane transport; P:iron ion import across plasma membrane; P:regulated exocytosis; P:response to hormone; scaffold8 indexed_genome mRNA 39799742 39820547 . + . ID=transcript_2241;A5D8W1 A3KMP9 B4DYW6 B4DZP7 B9EIM7 Q6V705 Q8IY89 Q9H7C2,Cilia- and flagella-associated protein 69 {ECO:0000312|HGNC:HGNC:26107},, , GO:0005737;GO:0097730;GO:0097225;GO:0030317;GO:0042048;GO:1905516;GO:1902093;GO:1990834;GO:0007608;GO:0007288;, C:cytoplasm; C:non-motile cilium; C:sperm midpiece;, , P:flagellated sperm motility; P:olfactory behavior; P:positive regulation of fertilization; P:positive regulation of flagellated sperm motility; P:response to odorant; P:sensory perception of smell; P:sperm axoneme assembly; scaffold8 indexed_genome mRNA 39824986 39826815 . + . ID=transcript_2242;A5D8W1 A3KMP9 B4DYW6 B4DZP7 B9EIM7 Q6V705 Q8IY89 Q9H7C2,Cilia- and flagella-associated protein 69 {ECO:0000312|HGNC:HGNC:26107},, , GO:0005737;GO:0097730;GO:0097225;GO:0030317;GO:0042048;GO:1905516;GO:1902093;GO:1990834;GO:0007608;GO:0007288;, C:cytoplasm; C:non-motile cilium; C:sperm midpiece;, , P:flagellated sperm motility; P:olfactory behavior; P:positive regulation of fertilization; P:positive regulation of flagellated sperm motility; P:response to odorant; P:sensory perception of smell; P:sperm axoneme assembly;|A5D8W1 A3KMP9 B4DYW6 B4DZP7 B9EIM7 Q6V705 Q8IY89 Q9H7C2,Cilia- and flagella-associated protein 69 {ECO:0000312|HGNC:HGNC:26107},, , GO:0005737;GO:0097730;GO:0097225;GO:0030317;GO:0042048;GO:1905516;GO:1902093;GO:1990834;GO:0007608;GO:0007288;, C:cytoplasm; C:non-motile cilium; C:sperm midpiece;, , P:flagellated sperm motility; P:olfactory behavior; P:positive regulation of fertilization; P:positive regulation of flagellated sperm motility; P:response to odorant; P:sensory perception of smell; P:sperm axoneme assembly; scaffold8 indexed_genome mRNA 39854705 39881547 . + . ID=transcript_2243;A4D1E9 B4DFY6 Q3B7A6 Q5H9V2 Q8IXG8 Q8N982 Q8WU16 Q9BSP1 Q9Y6T6,GTP-binding protein 10,Protein obg homolog 2;, PF01018;PF01926;, GO:0005694;GO:0005739;GO:0005730;GO:0005525;GO:0003924;GO:0003723;GO:0042254;, C:chromosome; C:mitochondrion; C:nucleolus;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:ribosome biogenesis;|A4D1E9 B4DFY6 Q3B7A6 Q5H9V2 Q8IXG8 Q8N982 Q8WU16 Q9BSP1 Q9Y6T6,GTP-binding protein 10,Protein obg homolog 2;, PF01018;PF01926;, GO:0005694;GO:0005739;GO:0005730;GO:0005525;GO:0003924;GO:0003723;GO:0042254;, C:chromosome; C:mitochondrion; C:nucleolus;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:ribosome biogenesis;|A4D1E9 B4DFY6 Q3B7A6 Q5H9V2 Q8IXG8 Q8N982 Q8WU16 Q9BSP1 Q9Y6T6,GTP-binding protein 10,Protein obg homolog 2;, PF01018;PF01926;, GO:0005694;GO:0005739;GO:0005730;GO:0005525;GO:0003924;GO:0003723;GO:0042254;, C:chromosome; C:mitochondrion; C:nucleolus;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:ribosome biogenesis; scaffold8 indexed_genome mRNA 39893667 39894520 . + . ID=transcript_2244;O60921 B4DFI9,Checkpoint protein HUS1,, PF04005;, GO:0030896;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0000724;GO:0009792;GO:0031573;GO:0044778;GO:0033314;GO:0006289;GO:0006468;GO:0001932;GO:1901796;GO:0009411;GO:0000723;, C:checkpoint clamp complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, , P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:embryo development ending in birth or egg hatching; P:intra-S DNA damage checkpoint; P:meiotic DNA integrity checkpoint; P:mitotic DNA replication checkpoint; P:nucleotide-excision repair; P:protein phosphorylation; P:regulation of protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:response to UV; P:telomere maintenance; scaffold8 indexed_genome mRNA 39894655 39910010 . + . ID=transcript_2245;O60921 B4DFI9,Checkpoint protein HUS1,, PF04005;, GO:0030896;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0000724;GO:0009792;GO:0031573;GO:0044778;GO:0033314;GO:0006289;GO:0006468;GO:0001932;GO:1901796;GO:0009411;GO:0000723;, C:checkpoint clamp complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, , P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:embryo development ending in birth or egg hatching; P:intra-S DNA damage checkpoint; P:meiotic DNA integrity checkpoint; P:mitotic DNA replication checkpoint; P:nucleotide-excision repair; P:protein phosphorylation; P:regulation of protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:response to UV; P:telomere maintenance;|O60921 B4DFI9,Checkpoint protein HUS1,, PF04005;, GO:0030896;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0000724;GO:0009792;GO:0031573;GO:0044778;GO:0033314;GO:0006289;GO:0006468;GO:0001932;GO:1901796;GO:0009411;GO:0000723;, C:checkpoint clamp complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, , P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:embryo development ending in birth or egg hatching; P:intra-S DNA damage checkpoint; P:meiotic DNA integrity checkpoint; P:mitotic DNA replication checkpoint; P:nucleotide-excision repair; P:protein phosphorylation; P:regulation of protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:response to UV; P:telomere maintenance;|O60921 B4DFI9,Checkpoint protein HUS1,, PF04005;, GO:0030896;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0000724;GO:0009792;GO:0031573;GO:0044778;GO:0033314;GO:0006289;GO:0006468;GO:0001932;GO:1901796;GO:0009411;GO:0000723;, C:checkpoint clamp complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, , P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:embryo development ending in birth or egg hatching; P:intra-S DNA damage checkpoint; P:meiotic DNA integrity checkpoint; P:mitotic DNA replication checkpoint; P:nucleotide-excision repair; P:protein phosphorylation; P:regulation of protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:response to UV; P:telomere maintenance;|O60921 B4DFI9,Checkpoint protein HUS1,, PF04005;, GO:0030896;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0000724;GO:0009792;GO:0031573;GO:0044778;GO:0033314;GO:0006289;GO:0006468;GO:0001932;GO:1901796;GO:0009411;GO:0000723;, C:checkpoint clamp complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, , P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:embryo development ending in birth or egg hatching; P:intra-S DNA damage checkpoint; P:meiotic DNA integrity checkpoint; P:mitotic DNA replication checkpoint; P:nucleotide-excision repair; P:protein phosphorylation; P:regulation of protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:response to UV; P:telomere maintenance;|O60921 B4DFI9,Checkpoint protein HUS1,, PF04005;, GO:0030896;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0000724;GO:0009792;GO:0031573;GO:0044778;GO:0033314;GO:0006289;GO:0006468;GO:0001932;GO:1901796;GO:0009411;GO:0000723;, C:checkpoint clamp complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, , P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:embryo development ending in birth or egg hatching; P:intra-S DNA damage checkpoint; P:meiotic DNA integrity checkpoint; P:mitotic DNA replication checkpoint; P:nucleotide-excision repair; P:protein phosphorylation; P:regulation of protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:response to UV; P:telomere maintenance;|O60921 B4DFI9,Checkpoint protein HUS1,, PF04005;, GO:0030896;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0000724;GO:0009792;GO:0031573;GO:0044778;GO:0033314;GO:0006289;GO:0006468;GO:0001932;GO:1901796;GO:0009411;GO:0000723;, C:checkpoint clamp complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, , P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:embryo development ending in birth or egg hatching; P:intra-S DNA damage checkpoint; P:meiotic DNA integrity checkpoint; P:mitotic DNA replication checkpoint; P:nucleotide-excision repair; P:protein phosphorylation; P:regulation of protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:response to UV; P:telomere maintenance;|O60921 B4DFI9,Checkpoint protein HUS1,, PF04005;, GO:0030896;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0000724;GO:0009792;GO:0031573;GO:0044778;GO:0033314;GO:0006289;GO:0006468;GO:0001932;GO:1901796;GO:0009411;GO:0000723;, C:checkpoint clamp complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, , P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:embryo development ending in birth or egg hatching; P:intra-S DNA damage checkpoint; P:meiotic DNA integrity checkpoint; P:mitotic DNA replication checkpoint; P:nucleotide-excision repair; P:protein phosphorylation; P:regulation of protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:response to UV; P:telomere maintenance; scaffold8 indexed_genome mRNA 40091754 40273823 . + . ID=transcript_2246;Q68CZ2 B2RNV1 Q6IPQ2 Q8IZW7 Q8NAD0 Q96PE0 Q96S48,Tensin-3,Tensin-like SH2 domain-containing protein 1;Tumor endothelial marker 6;, PF08416;PF10409;PF00017;, GO:0005829;GO:0005925;, C:cytosol; C:focal adhesion; scaffold8 indexed_genome mRNA 40284281 40320544 . + . ID=transcript_2247;Q68CZ2 B2RNV1 Q6IPQ2 Q8IZW7 Q8NAD0 Q96PE0 Q96S48,Tensin-3,Tensin-like SH2 domain-containing protein 1;Tumor endothelial marker 6;, PF08416;PF10409;PF00017;, GO:0005829;GO:0005925;, C:cytosol; C:focal adhesion;|Q68CZ2 B2RNV1 Q6IPQ2 Q8IZW7 Q8NAD0 Q96PE0 Q96S48,Tensin-3,Tensin-like SH2 domain-containing protein 1;Tumor endothelial marker 6;, PF08416;PF10409;PF00017;, GO:0005829;GO:0005925;, C:cytosol; C:focal adhesion;|Q68CZ2 B2RNV1 Q6IPQ2 Q8IZW7 Q8NAD0 Q96PE0 Q96S48,Tensin-3,Tensin-like SH2 domain-containing protein 1;Tumor endothelial marker 6;, PF08416;PF10409;PF00017;, GO:0005829;GO:0005925;, C:cytosol; C:focal adhesion;|Q68CZ2 B2RNV1 Q6IPQ2 Q8IZW7 Q8NAD0 Q96PE0 Q96S48,Tensin-3,Tensin-like SH2 domain-containing protein 1;Tumor endothelial marker 6;, PF08416;PF10409;PF00017;, GO:0005829;GO:0005925;, C:cytosol; C:focal adhesion; scaffold8 indexed_genome mRNA 41429926 41434375 . - . ID=transcript_2248;P08833 A4D2F4 D3DVL9 Q8IYP5,Insulin-like growth factor-binding protein 1,Placental protein 12;, PF00219;PF00086;, GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0005520;GO:0031994;GO:0031995;GO:0005102;GO:0007568;GO:0044267;GO:0008286;GO:0090090;GO:0036499;GO:0030307;GO:0043687;GO:0043567;GO:0007165;GO:0042246;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus;, F:insulin-like growth factor binding; F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:signaling receptor binding;, P:aging; P:cellular protein metabolic process; P:insulin receptor signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:PERK-mediated unfolded protein response; P:positive regulation of cell growth; P:post-translational protein modification; P:regulation of insulin-like growth factor receptor signaling pathway; P:signal transduction; P:tissue regeneration;|P08833 A4D2F4 D3DVL9 Q8IYP5,Insulin-like growth factor-binding protein 1,Placental protein 12;, PF00219;PF00086;, GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0005520;GO:0031994;GO:0031995;GO:0005102;GO:0007568;GO:0044267;GO:0008286;GO:0090090;GO:0036499;GO:0030307;GO:0043687;GO:0043567;GO:0007165;GO:0042246;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus;, F:insulin-like growth factor binding; F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:signaling receptor binding;, P:aging; P:cellular protein metabolic process; P:insulin receptor signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:PERK-mediated unfolded protein response; P:positive regulation of cell growth; P:post-translational protein modification; P:regulation of insulin-like growth factor receptor signaling pathway; P:signal transduction; P:tissue regeneration; scaffold8 indexed_genome mRNA 41464449 41567140 . - . ID=transcript_2249;Q08828 A4D2L8 Q75MI1,Adenylate cyclase type 1,ATP pyrophosphate-lyase 1;Adenylate cyclase type I;Adenylyl cyclase 1;Ca(2+)/calmodulin-activated adenylyl cyclase;, PF16214;PF00211;, GO:0005737;GO:0070062;GO:0098978;GO:0098686;GO:0005887;GO:0099061;GO:0045121;GO:0005634;GO:0005886;GO:0098685;GO:0004016;GO:0005524;GO:0008294;GO:0005516;GO:0046872;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007409;GO:0007420;GO:0006171;GO:0019933;GO:0071277;GO:1904322;GO:0071377;GO:0007623;GO:0007186;GO:0007616;GO:0002862;GO:0150076;GO:0032793;GO:1900273;GO:0042752;GO:2000300;GO:0003091;GO:0042493;GO:0010226;, C:cytoplasm; C:extracellular exosome; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:adenylate cyclase activity; F:ATP binding; F:calcium- and calmodulin-responsive adenylate cyclase activity; F:calmodulin binding; F:metal ion binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:axonogenesis; P:brain development; P:cAMP biosynthetic process; P:cAMP-mediated signaling; P:cellular response to calcium ion; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:circadian rhythm; P:G protein-coupled receptor signaling pathway; P:long-term memory; P:negative regulation of inflammatory response to antigenic stimulus; P:neuroinflammatory response; P:positive regulation of CREB transcription factor activity; P:positive regulation of long-term synaptic potentiation; P:regulation of circadian rhythm; P:regulation of synaptic vesicle exocytosis; P:renal water homeostasis; P:response to drug; P:response to lithium ion; scaffold8 indexed_genome mRNA 41775971 41797980 . - . ID=transcript_2250;O60896 Q7Z2Y1,Receptor activity-modifying protein 3,Calcitonin-receptor-like receptor activity-modifying protein 3;, PF04901;, GO:1903143;GO:0150058;GO:0009986;GO:0005887;GO:0005764;GO:0005886;GO:0043235;GO:0001605;GO:0001540;GO:0015026;GO:0007189;GO:1990410;GO:0097647;GO:0001525;GO:0006816;GO:0071392;GO:0032870;GO:0038041;GO:0007186;GO:0086103;GO:0006886;GO:0002862;GO:1905665;GO:0010942;GO:0070374;GO:0010628;GO:0033138;GO:0010739;GO:0051897;GO:1903078;GO:0001921;GO:0072659;GO:0015031;GO:0031623;GO:1904645;, C:adrenomedullin receptor complex; C:amylin receptor complex 3; C:cell surface; C:integral component of plasma membrane; C:lysosome; C:plasma membrane; C:receptor complex;, F:adrenomedullin receptor activity; F:amyloid-beta binding; F:coreceptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adrenomedullin receptor signaling pathway; P:amylin receptor signaling pathway; P:angiogenesis; P:calcium ion transport; P:cellular response to estradiol stimulus; P:cellular response to hormone stimulus; P:cross-receptor inhibition within G protein-coupled receptor heterodimer; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway involved in heart process; P:intracellular protein transport; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of calcium ion import across plasma membrane; P:positive regulation of cell death; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of receptor recycling; P:protein localization to plasma membrane; P:protein transport; P:receptor internalization; P:response to amyloid-beta; scaffold8 indexed_genome mRNA 41826416 41835684 . + . ID=transcript_2251;Q9Y2F6,FAST kinase domain-containing protein 4 {ECO:0000303|PubMed:20869947},Cell cycle progression restoration protein 2;Protein TBRG4;Transforming growth factor beta regulator 4 {ECO:0000312|HGNC:HGNC:17443};, PF06743;PF08368;PF08373;, GO:0005759;GO:0005739;GO:0003723;GO:0007050;GO:0090615;GO:0016071;GO:0008284;GO:0044528;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding;, P:cell cycle arrest; P:mitochondrial mRNA processing; P:mRNA metabolic process; P:positive regulation of cell population proliferation; P:regulation of mitochondrial mRNA stability;|Q9Y2F6,FAST kinase domain-containing protein 4 {ECO:0000303|PubMed:20869947},Cell cycle progression restoration protein 2;Protein TBRG4;Transforming growth factor beta regulator 4 {ECO:0000312|HGNC:HGNC:17443};, PF06743;PF08368;PF08373;, GO:0005759;GO:0005739;GO:0003723;GO:0007050;GO:0090615;GO:0016071;GO:0008284;GO:0044528;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding;, P:cell cycle arrest; P:mitochondrial mRNA processing; P:mRNA metabolic process; P:positive regulation of cell population proliferation; P:regulation of mitochondrial mRNA stability;|Q9Y2F6,FAST kinase domain-containing protein 4 {ECO:0000303|PubMed:20869947},Cell cycle progression restoration protein 2;Protein TBRG4;Transforming growth factor beta regulator 4 {ECO:0000312|HGNC:HGNC:17443};, PF06743;PF08368;PF08373;, GO:0005759;GO:0005739;GO:0003723;GO:0007050;GO:0090615;GO:0016071;GO:0008284;GO:0044528;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding;, P:cell cycle arrest; P:mitochondrial mRNA processing; P:mRNA metabolic process; P:positive regulation of cell population proliferation; P:regulation of mitochondrial mRNA stability;|Q9Y2F6,FAST kinase domain-containing protein 4 {ECO:0000303|PubMed:20869947},Cell cycle progression restoration protein 2;Protein TBRG4;Transforming growth factor beta regulator 4 {ECO:0000312|HGNC:HGNC:17443};, PF06743;PF08368;PF08373;, GO:0005759;GO:0005739;GO:0003723;GO:0007050;GO:0090615;GO:0016071;GO:0008284;GO:0044528;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding;, P:cell cycle arrest; P:mitochondrial mRNA processing; P:mRNA metabolic process; P:positive regulation of cell population proliferation; P:regulation of mitochondrial mRNA stability;|Q9Y2F6,FAST kinase domain-containing protein 4 {ECO:0000303|PubMed:20869947},Cell cycle progression restoration protein 2;Protein TBRG4;Transforming growth factor beta regulator 4 {ECO:0000312|HGNC:HGNC:17443};, PF06743;PF08368;PF08373;, GO:0005759;GO:0005739;GO:0003723;GO:0007050;GO:0090615;GO:0016071;GO:0008284;GO:0044528;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding;, P:cell cycle arrest; P:mitochondrial mRNA processing; P:mRNA metabolic process; P:positive regulation of cell population proliferation; P:regulation of mitochondrial mRNA stability;|Q9Y2F6,FAST kinase domain-containing protein 4 {ECO:0000303|PubMed:20869947},Cell cycle progression restoration protein 2;Protein TBRG4;Transforming growth factor beta regulator 4 {ECO:0000312|HGNC:HGNC:17443};, PF06743;PF08368;PF08373;, GO:0005759;GO:0005739;GO:0003723;GO:0007050;GO:0090615;GO:0016071;GO:0008284;GO:0044528;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding;, P:cell cycle arrest; P:mitochondrial mRNA processing; P:mRNA metabolic process; P:positive regulation of cell population proliferation; P:regulation of mitochondrial mRNA stability;|Q9Y2F6,FAST kinase domain-containing protein 4 {ECO:0000303|PubMed:20869947},Cell cycle progression restoration protein 2;Protein TBRG4;Transforming growth factor beta regulator 4 {ECO:0000312|HGNC:HGNC:17443};, PF06743;PF08368;PF08373;, GO:0005759;GO:0005739;GO:0003723;GO:0007050;GO:0090615;GO:0016071;GO:0008284;GO:0044528;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding;, P:cell cycle arrest; P:mitochondrial mRNA processing; P:mRNA metabolic process; P:positive regulation of cell population proliferation; P:regulation of mitochondrial mRNA stability; scaffold8 indexed_genome mRNA 41852120 41853737 . - . ID=transcript_2252;Q9BSQ5 A4D2L4 B3KUV0 D3DVL4 E9PDJ3 F5H0E1 F5H551 Q71RE5 Q8TAT4,Cerebral cavernous malformations 2 protein,Malcavernin {ECO:0000303|PubMed:12853948};, PF16545;, GO:0005737;GO:0005739;GO:0032991;GO:0060837;GO:0045216;GO:0001885;GO:0061154;GO:0001701;GO:0048839;GO:0007229;GO:0035264;GO:0060039;GO:0051403;GO:0001570;GO:0048845;, C:cytoplasm; C:mitochondrion; C:protein-containing complex;, , P:blood vessel endothelial cell differentiation; P:cell-cell junction organization; P:endothelial cell development; P:endothelial tube morphogenesis; P:in utero embryonic development; P:inner ear development; P:integrin-mediated signaling pathway; P:multicellular organism growth; P:pericardium development; P:stress-activated MAPK cascade; P:vasculogenesis; P:venous blood vessel morphogenesis; scaffold8 indexed_genome mRNA 41860017 41903282 . - . ID=transcript_2253;Q9BSQ5 A4D2L4 B3KUV0 D3DVL4 E9PDJ3 F5H0E1 F5H551 Q71RE5 Q8TAT4,Cerebral cavernous malformations 2 protein,Malcavernin {ECO:0000303|PubMed:12853948};, PF16545;, GO:0005737;GO:0005739;GO:0032991;GO:0060837;GO:0045216;GO:0001885;GO:0061154;GO:0001701;GO:0048839;GO:0007229;GO:0035264;GO:0060039;GO:0051403;GO:0001570;GO:0048845;, C:cytoplasm; C:mitochondrion; C:protein-containing complex;, , P:blood vessel endothelial cell differentiation; P:cell-cell junction organization; P:endothelial cell development; P:endothelial tube morphogenesis; P:in utero embryonic development; P:inner ear development; P:integrin-mediated signaling pathway; P:multicellular organism growth; P:pericardium development; P:stress-activated MAPK cascade; P:vasculogenesis; P:venous blood vessel morphogenesis;|Q9BSQ5 A4D2L4 B3KUV0 D3DVL4 E9PDJ3 F5H0E1 F5H551 Q71RE5 Q8TAT4,Cerebral cavernous malformations 2 protein,Malcavernin {ECO:0000303|PubMed:12853948};, PF16545;, GO:0005737;GO:0005739;GO:0032991;GO:0060837;GO:0045216;GO:0001885;GO:0061154;GO:0001701;GO:0048839;GO:0007229;GO:0035264;GO:0060039;GO:0051403;GO:0001570;GO:0048845;, C:cytoplasm; C:mitochondrion; C:protein-containing complex;, , P:blood vessel endothelial cell differentiation; P:cell-cell junction organization; P:endothelial cell development; P:endothelial tube morphogenesis; P:in utero embryonic development; P:inner ear development; P:integrin-mediated signaling pathway; P:multicellular organism growth; P:pericardium development; P:stress-activated MAPK cascade; P:vasculogenesis; P:venous blood vessel morphogenesis; scaffold8 indexed_genome mRNA 41926749 41942652 . + . ID=transcript_2254;B0I1T2 Q8TEI9 Q8TES2 Q96BE2 Q96RI5 Q96RI6,Unconventional myosin-Ig,, PF00063;PF06017;, GO:0015629;GO:0005737;GO:0070062;GO:0030175;GO:0030027;GO:0031256;GO:0016020;GO:0005902;GO:0016459;GO:0005654;GO:0001891;GO:0005886;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0005547;GO:0043325;GO:0005546;GO:0007015;GO:0071976;GO:0031589;GO:0006887;GO:0038096;GO:0120117;GO:0002456;GO:0072678;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:filopodium; C:lamellipodium; C:leading edge membrane; C:membrane; C:microvillus; C:myosin complex; C:nucleoplasm; C:phagocytic cup; C:plasma membrane; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament organization; P:cell gliding; P:cell-substrate adhesion; P:exocytosis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:T cell meandering migration; P:T cell mediated immunity; P:T cell migration; P:vesicle transport along actin filament; scaffold8 indexed_genome mRNA 41969528 41977411 . - . ID=transcript_2255;Q96QR8 A4D2L7,Transcriptional activator protein Pur-beta,Purine-rich element-binding protein B;, PF04845;, GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0003729;GO:0032422;GO:0003723;GO:0000977;GO:0003697;GO:0046332;GO:0008134;GO:0030154;GO:0008283;GO:0045637;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:mRNA binding; F:purine-rich negative regulatory element binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:SMAD binding; F:transcription factor binding;, P:cell differentiation; P:cell population proliferation; P:regulation of myeloid cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 42001968 42013055 . + . ID=transcript_2256;Q71UI9 A6NFA8 A6NKY0 A6NN01 A8MQC5 Q59GV8 Q6PK98,Histone H2A.V,H2A.F/Z;H2A.Z variant histone 2 {ECO:0000312|HGNC:HGNC:20664};, PF00125;PF16211;, GO:0070062;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006342;, C:extracellular exosome; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:chromatin silencing;|Q71UI9 A6NFA8 A6NKY0 A6NN01 A8MQC5 Q59GV8 Q6PK98,Histone H2A.V,H2A.F/Z;H2A.Z variant histone 2 {ECO:0000312|HGNC:HGNC:20664};, PF00125;PF16211;, GO:0070062;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006342;, C:extracellular exosome; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:chromatin silencing;|Q71UI9 A6NFA8 A6NKY0 A6NN01 A8MQC5 Q59GV8 Q6PK98,Histone H2A.V,H2A.F/Z;H2A.Z variant histone 2 {ECO:0000312|HGNC:HGNC:20664};, PF00125;PF16211;, GO:0070062;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006342;, C:extracellular exosome; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:chromatin silencing; scaffold8 indexed_genome mRNA 42019696 42023755 . - . ID=transcript_2257;Q9UC61,Peptidyl-prolyl cis-trans isomerase A,Cyclophilin A;Cyclosporin A-binding protein;Rotamase A;, PF00160;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0043231;GO:0016020;GO:0005634;GO:0032991;GO:0034774;GO:0031982;GO:0016018;GO:1904399;GO:0005178;GO:0003755;GO:0003723;GO:0051082;GO:0046790;GO:0000187;GO:0032148;GO:0006915;GO:0060352;GO:0034599;GO:0042118;GO:0044409;GO:0075713;GO:0019064;GO:0035722;GO:0030595;GO:0050900;GO:0034389;GO:1902176;GO:0061944;GO:0006469;GO:0001933;GO:0032873;GO:1903901;GO:0030593;GO:0043312;GO:0030168;GO:0070527;GO:0051092;GO:0035307;GO:0001934;GO:0050714;GO:0045070;GO:0006457;GO:0000413;GO:2001233;GO:0045069;GO:0006278;GO:0019061;GO:0019058;GO:0019076;GO:0019068;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:protein-containing complex; C:secretory granule lumen; C:vesicle;, F:cyclosporin A binding; F:heparan sulfate binding; F:integrin binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding; F:unfolded protein binding; F:virion binding;, P:activation of MAPK activity; P:activation of protein kinase B activity; P:apoptotic process; P:cell adhesion molecule production; P:cellular response to oxidative stress; P:endothelial cell activation; P:entry into host; P:establishment of integrated proviral latency; P:fusion of virus membrane with host plasma membrane; P:interleukin-12-mediated signaling pathway; P:leukocyte chemotaxis; P:leukocyte migration; P:lipid droplet organization; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein K48-linked ubiquitination; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of viral life cycle; P:neutrophil chemotaxis; P:neutrophil degranulation; P:platelet activation; P:platelet aggregation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein dephosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein secretion; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of apoptotic signaling pathway; P:regulation of viral genome replication; P:RNA-dependent DNA biosynthetic process; P:uncoating of virus; P:viral life cycle; P:viral release from host cell; P:virion assembly;|Q9UC61,Peptidyl-prolyl cis-trans isomerase A,Cyclophilin A;Cyclosporin A-binding protein;Rotamase A;, PF00160;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0043231;GO:0016020;GO:0005634;GO:0032991;GO:0034774;GO:0031982;GO:0016018;GO:1904399;GO:0005178;GO:0003755;GO:0003723;GO:0051082;GO:0046790;GO:0000187;GO:0032148;GO:0006915;GO:0060352;GO:0034599;GO:0042118;GO:0044409;GO:0075713;GO:0019064;GO:0035722;GO:0030595;GO:0050900;GO:0034389;GO:1902176;GO:0061944;GO:0006469;GO:0001933;GO:0032873;GO:1903901;GO:0030593;GO:0043312;GO:0030168;GO:0070527;GO:0051092;GO:0035307;GO:0001934;GO:0050714;GO:0045070;GO:0006457;GO:0000413;GO:2001233;GO:0045069;GO:0006278;GO:0019061;GO:0019058;GO:0019076;GO:0019068;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:protein-containing complex; C:secretory granule lumen; C:vesicle;, F:cyclosporin A binding; F:heparan sulfate binding; F:integrin binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding; F:unfolded protein binding; F:virion binding;, P:activation of MAPK activity; P:activation of protein kinase B activity; P:apoptotic process; P:cell adhesion molecule production; P:cellular response to oxidative stress; P:endothelial cell activation; P:entry into host; P:establishment of integrated proviral latency; P:fusion of virus membrane with host plasma membrane; P:interleukin-12-mediated signaling pathway; P:leukocyte chemotaxis; P:leukocyte migration; P:lipid droplet organization; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein K48-linked ubiquitination; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of viral life cycle; P:neutrophil chemotaxis; P:neutrophil degranulation; P:platelet activation; P:platelet aggregation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein dephosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein secretion; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of apoptotic signaling pathway; P:regulation of viral genome replication; P:RNA-dependent DNA biosynthetic process; P:uncoating of virus; P:viral life cycle; P:viral release from host cell; P:virion assembly; scaffold8 indexed_genome mRNA 42040607 42050354 . - . ID=transcript_2258;Q9BQH7,Zinc finger MIZ domain-containing protein 2,PIAS-like protein Zimp7;, PF02891;, GO:0005739;GO:0043596;GO:0005654;GO:0005634;GO:0030374;GO:0008270;GO:0048096;GO:0045944;GO:0006357;, C:mitochondrion; C:nuclear replication fork; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:zinc ion binding;, P:chromatin-mediated maintenance of transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BQH7,Zinc finger MIZ domain-containing protein 2,PIAS-like protein Zimp7;, PF02891;, GO:0005739;GO:0043596;GO:0005654;GO:0005634;GO:0030374;GO:0008270;GO:0048096;GO:0045944;GO:0006357;, C:mitochondrion; C:nuclear replication fork; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:zinc ion binding;, P:chromatin-mediated maintenance of transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BQH7,Zinc finger MIZ domain-containing protein 2,PIAS-like protein Zimp7;, PF02891;, GO:0005739;GO:0043596;GO:0005654;GO:0005634;GO:0030374;GO:0008270;GO:0048096;GO:0045944;GO:0006357;, C:mitochondrion; C:nuclear replication fork; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:zinc ion binding;, P:chromatin-mediated maintenance of transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BQH7,Zinc finger MIZ domain-containing protein 2,PIAS-like protein Zimp7;, PF02891;, GO:0005739;GO:0043596;GO:0005654;GO:0005634;GO:0030374;GO:0008270;GO:0048096;GO:0045944;GO:0006357;, C:mitochondrion; C:nuclear replication fork; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:zinc ion binding;, P:chromatin-mediated maintenance of transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BQH7,Zinc finger MIZ domain-containing protein 2,PIAS-like protein Zimp7;, PF02891;, GO:0005739;GO:0043596;GO:0005654;GO:0005634;GO:0030374;GO:0008270;GO:0048096;GO:0045944;GO:0006357;, C:mitochondrion; C:nuclear replication fork; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:zinc ion binding;, P:chromatin-mediated maintenance of transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BQH7,Zinc finger MIZ domain-containing protein 2,PIAS-like protein Zimp7;, PF02891;, GO:0005739;GO:0043596;GO:0005654;GO:0005634;GO:0030374;GO:0008270;GO:0048096;GO:0045944;GO:0006357;, C:mitochondrion; C:nuclear replication fork; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:zinc ion binding;, P:chromatin-mediated maintenance of transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 42074000 42140874 . - . ID=transcript_2259;Q02218 B4E2U9 D3DVL0 E9PBM1 Q96DD3 Q9UDX0,2-oxoglutarate dehydrogenase, mitochondrial,2-oxoglutarate dehydrogenase complex component E1;Alpha-ketoglutarate dehydrogenase;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0031966;GO:0005739;GO:0005634;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006091;GO:0006096;GO:0106077;GO:0006554;GO:0006104;GO:0006099;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:generation of precursor metabolites and energy; P:glycolytic process; P:histone succinylation; P:lysine catabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle;|Q02218 B4E2U9 D3DVL0 E9PBM1 Q96DD3 Q9UDX0,2-oxoglutarate dehydrogenase, mitochondrial,2-oxoglutarate dehydrogenase complex component E1;Alpha-ketoglutarate dehydrogenase;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0031966;GO:0005739;GO:0005634;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006091;GO:0006096;GO:0106077;GO:0006554;GO:0006104;GO:0006099;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:generation of precursor metabolites and energy; P:glycolytic process; P:histone succinylation; P:lysine catabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle;|Q02218 B4E2U9 D3DVL0 E9PBM1 Q96DD3 Q9UDX0,2-oxoglutarate dehydrogenase, mitochondrial,2-oxoglutarate dehydrogenase complex component E1;Alpha-ketoglutarate dehydrogenase;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0031966;GO:0005739;GO:0005634;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006091;GO:0006096;GO:0106077;GO:0006554;GO:0006104;GO:0006099;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:generation of precursor metabolites and energy; P:glycolytic process; P:histone succinylation; P:lysine catabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle;|Q02218 B4E2U9 D3DVL0 E9PBM1 Q96DD3 Q9UDX0,2-oxoglutarate dehydrogenase, mitochondrial,2-oxoglutarate dehydrogenase complex component E1;Alpha-ketoglutarate dehydrogenase;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0031966;GO:0005739;GO:0005634;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006091;GO:0006096;GO:0106077;GO:0006554;GO:0006104;GO:0006099;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:generation of precursor metabolites and energy; P:glycolytic process; P:histone succinylation; P:lysine catabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle;|Q02218 B4E2U9 D3DVL0 E9PBM1 Q96DD3 Q9UDX0,2-oxoglutarate dehydrogenase, mitochondrial,2-oxoglutarate dehydrogenase complex component E1;Alpha-ketoglutarate dehydrogenase;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0031966;GO:0005739;GO:0005634;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006091;GO:0006096;GO:0106077;GO:0006554;GO:0006104;GO:0006099;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:generation of precursor metabolites and energy; P:glycolytic process; P:histone succinylation; P:lysine catabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle; scaffold8 indexed_genome mRNA 42151678 42154945 . + . ID=transcript_2260;Q7Z7H5 A4D2K8 B4DFJ4 Q56VW3 Q7Z432 Q8N2P6,Transmembrane emp24 domain-containing protein 4,Endoplasmic reticulum stress-response protein 25;GMP25iso;Putative NF-kappa-B-activating protein 156;p24 family protein alpha-3;, PF01105;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0016021;GO:0006888;GO:0007030;GO:0006886;GO:0043123;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q7Z7H5 A4D2K8 B4DFJ4 Q56VW3 Q7Z432 Q8N2P6,Transmembrane emp24 domain-containing protein 4,Endoplasmic reticulum stress-response protein 25;GMP25iso;Putative NF-kappa-B-activating protein 156;p24 family protein alpha-3;, PF01105;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0016021;GO:0006888;GO:0007030;GO:0006886;GO:0043123;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold8 indexed_genome mRNA 42157499 42166934 . + . ID=transcript_2261;Q9NY93 A4D2K9 C9JV95 Q6IAE2 Q9H9I8,Probable ATP-dependent RNA helicase DDX56,ATP-dependent 61 kDa nucleolar RNA helicase;DEAD box protein 21;DEAD box protein 56;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0010976;GO:0006364;, C:membrane; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:positive regulation of neuron projection development; P:rRNA processing;|Q9NY93 A4D2K9 C9JV95 Q6IAE2 Q9H9I8,Probable ATP-dependent RNA helicase DDX56,ATP-dependent 61 kDa nucleolar RNA helicase;DEAD box protein 21;DEAD box protein 56;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0010976;GO:0006364;, C:membrane; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:positive regulation of neuron projection development; P:rRNA processing;|Q9NY93 A4D2K9 C9JV95 Q6IAE2 Q9H9I8,Probable ATP-dependent RNA helicase DDX56,ATP-dependent 61 kDa nucleolar RNA helicase;DEAD box protein 21;DEAD box protein 56;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0010976;GO:0006364;, C:membrane; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:positive regulation of neuron projection development; P:rRNA processing; scaffold8 indexed_genome mRNA 42210061 42216404 . + . ID=transcript_2262;Q8IVD9 Q9BTI3 Q9H7W9 Q9UPT4,NudC domain-containing protein 3,, PF04969;PF14050;, GO:0005737;GO:0005868;GO:0051082;GO:0060271;GO:0006457;GO:1905793;, C:cytoplasm; C:cytoplasmic dynein complex;, F:unfolded protein binding;, P:cilium assembly; P:protein folding; P:protein localization to pericentriolar material; scaffold8 indexed_genome mRNA 42254811 42280110 . + . ID=transcript_2263;Q8IVD9 Q9BTI3 Q9H7W9 Q9UPT4,NudC domain-containing protein 3,, PF04969;PF14050;, GO:0005737;GO:0005868;GO:0051082;GO:0060271;GO:0006457;GO:1905793;, C:cytoplasm; C:cytoplasmic dynein complex;, F:unfolded protein binding;, P:cilium assembly; P:protein folding; P:protein localization to pericentriolar material;|P20290 A8K510 Q13893 Q76M56,Transcription factor BTF3,Nascent polypeptide-associated complex subunit beta;RNA polymerase B transcription factor 3;, PF01849;, GO:0005829;GO:0005854;GO:0005634;GO:0042788;GO:0003723;GO:0001701;GO:0015031;GO:0006366;, C:cytosol; C:nascent polypeptide-associated complex; C:nucleus; C:polysomal ribosome;, F:RNA binding;, P:in utero embryonic development; P:protein transport; P:transcription by RNA polymerase II;|Q8IVD9 Q9BTI3 Q9H7W9 Q9UPT4,NudC domain-containing protein 3,, PF04969;PF14050;, GO:0005737;GO:0005868;GO:0051082;GO:0060271;GO:0006457;GO:1905793;, C:cytoplasm; C:cytoplasmic dynein complex;, F:unfolded protein binding;, P:cilium assembly; P:protein folding; P:protein localization to pericentriolar material; scaffold8 indexed_genome mRNA 42376380 42378411 . - . ID=transcript_2264;Q9Y6F4,Calcium/calmodulin-dependent protein kinase type II subunit beta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0005815;GO:0043005;GO:0005654;GO:0033017;GO:0045202;GO:0003779;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0060333;GO:0000165;GO:0061003;GO:0010976;GO:0090129;GO:0046777;GO:0006468;GO:0051924;GO:1900034;GO:0060998;GO:0048169;GO:2001222;GO:2000310;GO:0014733;GO:0051823;GO:0007165;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:microtubule organizing center; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane; C:synapse;, F:actin binding; F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neuron projection development; P:positive regulation of synapse maturation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of dendritic spine development; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuron migration; P:regulation of NMDA receptor activity; P:regulation of skeletal muscle adaptation; P:regulation of synapse structural plasticity; P:signal transduction; scaffold8 indexed_genome mRNA 42382354 42413716 . + . ID=transcript_2265;Q9UQM7 Q9UL21 Q9Y2H4 Q9Y352,Calcium/calmodulin-dependent protein kinase type II subunit alpha,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0043197;GO:0030666;GO:0005739;GO:0043005;GO:0005654;GO:0005634;GO:0014069;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0035254;GO:0042802;GO:0016301;GO:0046872;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0038166;GO:0006816;GO:0060996;GO:0000082;GO:0060333;GO:0000165;GO:0051346;GO:0018105;GO:1990443;GO:0051928;GO:0010666;GO:0051092;GO:0046777;GO:0006468;GO:1900034;GO:2000124;GO:1902108;GO:2001222;GO:0048168;GO:0046928;GO:2000310;GO:0002931;GO:0007223;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:dendritic spine; C:endocytic vesicle membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:glutamate receptor binding; F:identical protein binding; F:kinase activity; F:metal ion binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:angiotensin-activated signaling pathway; P:calcium ion transport; P:dendritic spine development; P:G1/S transition of mitotic cell cycle; P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:negative regulation of hydrolase activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine autophosphorylation; P:positive regulation of calcium ion transport; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cellular response to heat; P:regulation of endocannabinoid signaling pathway; P:regulation of mitochondrial membrane permeability involved in apoptotic process; P:regulation of neuron migration; P:regulation of neuronal synaptic plasticity; P:regulation of neurotransmitter secretion; P:regulation of NMDA receptor activity; P:response to ischemia; P:Wnt signaling pathway, calcium modulating pathway;|Q9Y6F4,Calcium/calmodulin-dependent protein kinase type II subunit beta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0005815;GO:0043005;GO:0005654;GO:0033017;GO:0045202;GO:0003779;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0060333;GO:0000165;GO:0061003;GO:0010976;GO:0090129;GO:0046777;GO:0006468;GO:0051924;GO:1900034;GO:0060998;GO:0048169;GO:2001222;GO:2000310;GO:0014733;GO:0051823;GO:0007165;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:microtubule organizing center; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane; C:synapse;, F:actin binding; F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neuron projection development; P:positive regulation of synapse maturation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of dendritic spine development; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuron migration; P:regulation of NMDA receptor activity; P:regulation of skeletal muscle adaptation; P:regulation of synapse structural plasticity; P:signal transduction;|Q9Y6F4,Calcium/calmodulin-dependent protein kinase type II subunit beta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0005815;GO:0043005;GO:0005654;GO:0033017;GO:0045202;GO:0003779;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0060333;GO:0000165;GO:0061003;GO:0010976;GO:0090129;GO:0046777;GO:0006468;GO:0051924;GO:1900034;GO:0060998;GO:0048169;GO:2001222;GO:2000310;GO:0014733;GO:0051823;GO:0007165;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:microtubule organizing center; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane; C:synapse;, F:actin binding; F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neuron projection development; P:positive regulation of synapse maturation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of dendritic spine development; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuron migration; P:regulation of NMDA receptor activity; P:regulation of skeletal muscle adaptation; P:regulation of synapse structural plasticity; P:signal transduction;|Q9Y6F4,Calcium/calmodulin-dependent protein kinase type II subunit beta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0005815;GO:0043005;GO:0005654;GO:0033017;GO:0045202;GO:0003779;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0060333;GO:0000165;GO:0061003;GO:0010976;GO:0090129;GO:0046777;GO:0006468;GO:0051924;GO:1900034;GO:0060998;GO:0048169;GO:2001222;GO:2000310;GO:0014733;GO:0051823;GO:0007165;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:microtubule organizing center; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane; C:synapse;, F:actin binding; F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neuron projection development; P:positive regulation of synapse maturation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of dendritic spine development; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuron migration; P:regulation of NMDA receptor activity; P:regulation of skeletal muscle adaptation; P:regulation of synapse structural plasticity; P:signal transduction;|Q9Y6F4,Calcium/calmodulin-dependent protein kinase type II subunit beta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0005815;GO:0043005;GO:0005654;GO:0033017;GO:0045202;GO:0003779;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0060333;GO:0000165;GO:0061003;GO:0010976;GO:0090129;GO:0046777;GO:0006468;GO:0051924;GO:1900034;GO:0060998;GO:0048169;GO:2001222;GO:2000310;GO:0014733;GO:0051823;GO:0007165;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:microtubule organizing center; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane; C:synapse;, F:actin binding; F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neuron projection development; P:positive regulation of synapse maturation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of dendritic spine development; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuron migration; P:regulation of NMDA receptor activity; P:regulation of skeletal muscle adaptation; P:regulation of synapse structural plasticity; P:signal transduction;|Q9Y6F4,Calcium/calmodulin-dependent protein kinase type II subunit beta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0005815;GO:0043005;GO:0005654;GO:0033017;GO:0045202;GO:0003779;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0060333;GO:0000165;GO:0061003;GO:0010976;GO:0090129;GO:0046777;GO:0006468;GO:0051924;GO:1900034;GO:0060998;GO:0048169;GO:2001222;GO:2000310;GO:0014733;GO:0051823;GO:0007165;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:microtubule organizing center; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane; C:synapse;, F:actin binding; F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neuron projection development; P:positive regulation of synapse maturation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of dendritic spine development; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuron migration; P:regulation of NMDA receptor activity; P:regulation of skeletal muscle adaptation; P:regulation of synapse structural plasticity; P:signal transduction;|Q9Y6F4,Calcium/calmodulin-dependent protein kinase type II subunit beta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0005815;GO:0043005;GO:0005654;GO:0033017;GO:0045202;GO:0003779;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0060333;GO:0000165;GO:0061003;GO:0010976;GO:0090129;GO:0046777;GO:0006468;GO:0051924;GO:1900034;GO:0060998;GO:0048169;GO:2001222;GO:2000310;GO:0014733;GO:0051823;GO:0007165;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:microtubule organizing center; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane; C:synapse;, F:actin binding; F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neuron projection development; P:positive regulation of synapse maturation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of dendritic spine development; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuron migration; P:regulation of NMDA receptor activity; P:regulation of skeletal muscle adaptation; P:regulation of synapse structural plasticity; P:signal transduction;|Q9Y6F4,Calcium/calmodulin-dependent protein kinase type II subunit beta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0005815;GO:0043005;GO:0005654;GO:0033017;GO:0045202;GO:0003779;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0060333;GO:0000165;GO:0061003;GO:0010976;GO:0090129;GO:0046777;GO:0006468;GO:0051924;GO:1900034;GO:0060998;GO:0048169;GO:2001222;GO:2000310;GO:0014733;GO:0051823;GO:0007165;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:microtubule organizing center; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane; C:synapse;, F:actin binding; F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neuron projection development; P:positive regulation of synapse maturation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of dendritic spine development; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuron migration; P:regulation of NMDA receptor activity; P:regulation of skeletal muscle adaptation; P:regulation of synapse structural plasticity; P:signal transduction;|Q9Y6F4,Calcium/calmodulin-dependent protein kinase type II subunit beta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0005815;GO:0043005;GO:0005654;GO:0033017;GO:0045202;GO:0003779;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0060333;GO:0000165;GO:0061003;GO:0010976;GO:0090129;GO:0046777;GO:0006468;GO:0051924;GO:1900034;GO:0060998;GO:0048169;GO:2001222;GO:2000310;GO:0014733;GO:0051823;GO:0007165;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:microtubule organizing center; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane; C:synapse;, F:actin binding; F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neuron projection development; P:positive regulation of synapse maturation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of dendritic spine development; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuron migration; P:regulation of NMDA receptor activity; P:regulation of skeletal muscle adaptation; P:regulation of synapse structural plasticity; P:signal transduction;|Q9Y6F4,Calcium/calmodulin-dependent protein kinase type II subunit beta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0005815;GO:0043005;GO:0005654;GO:0033017;GO:0045202;GO:0003779;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0060333;GO:0000165;GO:0061003;GO:0010976;GO:0090129;GO:0046777;GO:0006468;GO:0051924;GO:1900034;GO:0060998;GO:0048169;GO:2001222;GO:2000310;GO:0014733;GO:0051823;GO:0007165;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:microtubule organizing center; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane; C:synapse;, F:actin binding; F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neuron projection development; P:positive regulation of synapse maturation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of dendritic spine development; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuron migration; P:regulation of NMDA receptor activity; P:regulation of skeletal muscle adaptation; P:regulation of synapse structural plasticity; P:signal transduction; scaffold8 indexed_genome mRNA 42417865 42421215 . - . ID=transcript_2266;O15498 B4DR94 Q53F01 Q6FGU9 Q6IB15,Synaptobrevin homolog YKT6,, PF13774;PF00957;, GO:0097440;GO:0097441;GO:0005737;GO:0030659;GO:0005829;GO:0005783;GO:0033116;GO:0005768;GO:0005794;GO:0000139;GO:0005887;GO:0005739;GO:0043025;GO:0031201;GO:0030133;GO:0045296;GO:0019706;GO:0005484;GO:0006888;GO:0015031;GO:0042147;GO:0006904;GO:0006903;, C:apical dendrite; C:basal dendrite; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:mitochondrion; C:neuronal cell body; C:SNARE complex; C:transport vesicle;, F:cadherin binding; F:protein-cysteine S-palmitoyltransferase activity; F:SNAP receptor activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking involved in exocytosis; P:vesicle targeting;|O15498 B4DR94 Q53F01 Q6FGU9 Q6IB15,Synaptobrevin homolog YKT6,, PF13774;PF00957;, GO:0097440;GO:0097441;GO:0005737;GO:0030659;GO:0005829;GO:0005783;GO:0033116;GO:0005768;GO:0005794;GO:0000139;GO:0005887;GO:0005739;GO:0043025;GO:0031201;GO:0030133;GO:0045296;GO:0019706;GO:0005484;GO:0006888;GO:0015031;GO:0042147;GO:0006904;GO:0006903;, C:apical dendrite; C:basal dendrite; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:mitochondrion; C:neuronal cell body; C:SNARE complex; C:transport vesicle;, F:cadherin binding; F:protein-cysteine S-palmitoyltransferase activity; F:SNAP receptor activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking involved in exocytosis; P:vesicle targeting; scaffold8 indexed_genome mRNA 42421253 42423341 . - . ID=transcript_2267;O15498 B4DR94 Q53F01 Q6FGU9 Q6IB15,Synaptobrevin homolog YKT6,, PF13774;PF00957;, GO:0097440;GO:0097441;GO:0005737;GO:0030659;GO:0005829;GO:0005783;GO:0033116;GO:0005768;GO:0005794;GO:0000139;GO:0005887;GO:0005739;GO:0043025;GO:0031201;GO:0030133;GO:0045296;GO:0019706;GO:0005484;GO:0006888;GO:0015031;GO:0042147;GO:0006904;GO:0006903;, C:apical dendrite; C:basal dendrite; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:mitochondrion; C:neuronal cell body; C:SNARE complex; C:transport vesicle;, F:cadherin binding; F:protein-cysteine S-palmitoyltransferase activity; F:SNAP receptor activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking involved in exocytosis; P:vesicle targeting; scaffold8 indexed_genome mRNA 42433641 42464288 . + . ID=transcript_2268;P35557 A4D2J2 A4D2J3 Q05810,Hexokinase-4 {ECO:0000305},Glucokinase {ECO:0000303|PubMed:1354840};Hexokinase type IV {ECO:0000250|UniProtKB:P17712};Hexokinase-D {ECO:0000250|UniProtKB:P17712};, PF00349;PF03727;, GO:0005829;GO:0005739;GO:0005654;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0019158;GO:0061621;GO:0001678;GO:0032869;GO:0044320;GO:0051594;GO:0051156;GO:0042593;GO:0006096;GO:0045721;GO:0045725;GO:0032024;GO:0006110;GO:0050796;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:mannokinase activity;, P:canonical glycolysis; P:cellular glucose homeostasis; P:cellular response to insulin stimulus; P:cellular response to leptin stimulus; P:detection of glucose; P:glucose 6-phosphate metabolic process; P:glucose homeostasis; P:glycolytic process; P:negative regulation of gluconeogenesis; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin secretion; P:regulation of glycolytic process; P:regulation of insulin secretion; scaffold8 indexed_genome mRNA 42464292 42469300 . + . ID=transcript_2269;P35557 A4D2J2 A4D2J3 Q05810,Hexokinase-4 {ECO:0000305},Glucokinase {ECO:0000303|PubMed:1354840};Hexokinase type IV {ECO:0000250|UniProtKB:P17712};Hexokinase-D {ECO:0000250|UniProtKB:P17712};, PF00349;PF03727;, GO:0005829;GO:0005739;GO:0005654;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0019158;GO:0061621;GO:0001678;GO:0032869;GO:0044320;GO:0051594;GO:0051156;GO:0042593;GO:0006096;GO:0045721;GO:0045725;GO:0032024;GO:0006110;GO:0050796;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:mannokinase activity;, P:canonical glycolysis; P:cellular glucose homeostasis; P:cellular response to insulin stimulus; P:cellular response to leptin stimulus; P:detection of glucose; P:glucose 6-phosphate metabolic process; P:glucose homeostasis; P:glycolytic process; P:negative regulation of gluconeogenesis; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin secretion; P:regulation of glycolytic process; P:regulation of insulin secretion; scaffold8 indexed_genome mRNA 42472701 42475009 . + . ID=transcript_2270;Q01449 B2R4L3,Myosin regulatory light chain 2, atrial isoform,Myosin regulatory light chain 7;, PF13202;PF13833;, GO:0031672;GO:0005829;GO:0016459;GO:0005509;GO:0006936;, C:A band; C:cytosol; C:myosin complex;, F:calcium ion binding;, P:muscle contraction; scaffold8 indexed_genome mRNA 42488072 42496631 . + . ID=transcript_2271;P49005 A4D2J4 B2R5S4,DNA polymerase delta subunit 2,DNA polymerase delta subunit p50;, PF18018;PF04042;, GO:0043625;GO:0042575;GO:0005654;GO:0005634;GO:0016035;GO:0003677;GO:0006287;GO:0071897;GO:0042769;GO:0006260;GO:0006271;GO:0006298;GO:0006297;GO:0033683;GO:0006296;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:delta DNA polymerase complex; C:DNA polymerase complex; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:DNA binding;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA damage response, detection of DNA damage; P:DNA replication; P:DNA strand elongation involved in DNA replication; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P49005 A4D2J4 B2R5S4,DNA polymerase delta subunit 2,DNA polymerase delta subunit p50;, PF18018;PF04042;, GO:0043625;GO:0042575;GO:0005654;GO:0005634;GO:0016035;GO:0003677;GO:0006287;GO:0071897;GO:0042769;GO:0006260;GO:0006271;GO:0006298;GO:0006297;GO:0033683;GO:0006296;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:delta DNA polymerase complex; C:DNA polymerase complex; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:DNA binding;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA damage response, detection of DNA damage; P:DNA replication; P:DNA strand elongation involved in DNA replication; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P49005 A4D2J4 B2R5S4,DNA polymerase delta subunit 2,DNA polymerase delta subunit p50;, PF18018;PF04042;, GO:0043625;GO:0042575;GO:0005654;GO:0005634;GO:0016035;GO:0003677;GO:0006287;GO:0071897;GO:0042769;GO:0006260;GO:0006271;GO:0006298;GO:0006297;GO:0033683;GO:0006296;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:delta DNA polymerase complex; C:DNA polymerase complex; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:DNA binding;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA damage response, detection of DNA damage; P:DNA replication; P:DNA strand elongation involved in DNA replication; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold8 indexed_genome mRNA 42496742 42503571 . - . ID=transcript_2272;Q8IUX7 Q14113 Q59ER7 Q6ZSC7 Q7KZ79,Adipocyte enhancer-binding protein 1,Aortic carboxypeptidase-like protein;, PF00754;PF00246;, GO:0062023;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0005516;GO:0004180;GO:0005518;GO:0001227;GO:0000977;GO:0008270;GO:0000122;GO:1904026;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus;, F:calmodulin binding; F:carboxypeptidase activity; F:collagen binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of collagen fibril organization; scaffold8 indexed_genome mRNA 42534200 42535629 . + . ID=transcript_2273;Q9NP87 D3DVK4 Q6P5X8 Q86WQ9,DNA-directed DNA/RNA polymerase mu,Terminal transferase;, PF14792;PF14791;PF10391;PF14716;, GO:0005654;GO:0005634;GO:0003677;GO:0003887;GO:0046872;GO:0006310;GO:0006303;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA recombination; P:double-strand break repair via nonhomologous end joining; scaffold8 indexed_genome mRNA 42585227 42634546 . - . ID=transcript_2274;P53004 A8K747 O95019 Q86UX0 Q96QL4 Q9BRW8,Biliverdin reductase A,Biliverdin-IX alpha-reductase;, PF09166;PF01408;, GO:0005829;GO:0070062;GO:0106276;GO:0004074;GO:0106277;GO:0008270;GO:0042167;, C:cytosol; C:extracellular exosome;, F:biliberdin reductase NAD+ activity; F:biliverdin reductase (NAD(P)+) activity; F:biliverdin reductase (NADP+) activity; F:zinc ion binding;, P:heme catabolic process; scaffold8 indexed_genome mRNA 42666287 42756608 . + . ID=transcript_2275;Q9GZY4 A6NJU8 A8KAH8 Q9HAB7 Q9NVD2,Cytochrome c oxidase assembly factor 1 homolog,Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 15 kDa;, PF08695;, GO:0005829;GO:0031305;GO:0005739;GO:0033617;GO:0032981;, C:cytosol; C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial cytochrome c oxidase assembly; P:mitochondrial respiratory chain complex I assembly;|Q9GZY4 A6NJU8 A8KAH8 Q9HAB7 Q9NVD2,Cytochrome c oxidase assembly factor 1 homolog,Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 15 kDa;, PF08695;, GO:0005829;GO:0031305;GO:0005739;GO:0033617;GO:0032981;, C:cytosol; C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial cytochrome c oxidase assembly; P:mitochondrial respiratory chain complex I assembly;|Q9GZY4 A6NJU8 A8KAH8 Q9HAB7 Q9NVD2,Cytochrome c oxidase assembly factor 1 homolog,Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 15 kDa;, PF08695;, GO:0005829;GO:0031305;GO:0005739;GO:0033617;GO:0032981;, C:cytosol; C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial cytochrome c oxidase assembly; P:mitochondrial respiratory chain complex I assembly;|Q9GZY4 A6NJU8 A8KAH8 Q9HAB7 Q9NVD2,Cytochrome c oxidase assembly factor 1 homolog,Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 15 kDa;, PF08695;, GO:0005829;GO:0031305;GO:0005739;GO:0033617;GO:0032981;, C:cytosol; C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial cytochrome c oxidase assembly; P:mitochondrial respiratory chain complex I assembly; scaffold8 indexed_genome mRNA 42767362 42807768 . - . ID=transcript_2276;Q9UEE5 A4D1V6 Q8IVC8,Serine/threonine-protein kinase 17A,DAP kinase-related apoptosis-inducing protein kinase 1;, PF00069;, GO:0016607;GO:0005634;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0035556;GO:0043065;GO:2000271;GO:0006468;GO:2000377;, C:nuclear speck; C:nucleus; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of fibroblast apoptotic process; P:protein phosphorylation; P:regulation of reactive oxygen species metabolic process;|Q9UEE5 A4D1V6 Q8IVC8,Serine/threonine-protein kinase 17A,DAP kinase-related apoptosis-inducing protein kinase 1;, PF00069;, GO:0016607;GO:0005634;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0035556;GO:0043065;GO:2000271;GO:0006468;GO:2000377;, C:nuclear speck; C:nucleus; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of fibroblast apoptotic process; P:protein phosphorylation; P:regulation of reactive oxygen species metabolic process; scaffold8 indexed_genome mRNA 42827808 42843493 . - . ID=transcript_2277;Q76N89 A7E2X0 A8MYS3 B4DH42 O15036 Q9HCC7,E3 ubiquitin-protein ligase HECW1,HECT, C2 and WW domain-containing protein 1;HECT-type E3 ubiquitin transferase HECW1;NEDD4-like E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF18436;PF16562;PF00397;, GO:0005737;GO:0005829;GO:0061630;GO:0090090;GO:2000650;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0048814;, C:cytoplasm; C:cytosol;, F:ubiquitin protein ligase activity;, P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of sodium ion transmembrane transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; scaffold8 indexed_genome mRNA 42844865 42910483 . - . ID=transcript_2278;Q76N89 A7E2X0 A8MYS3 B4DH42 O15036 Q9HCC7,E3 ubiquitin-protein ligase HECW1,HECT, C2 and WW domain-containing protein 1;HECT-type E3 ubiquitin transferase HECW1;NEDD4-like E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF18436;PF16562;PF00397;, GO:0005737;GO:0005829;GO:0061630;GO:0090090;GO:2000650;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0048814;, C:cytoplasm; C:cytosol;, F:ubiquitin protein ligase activity;, P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of sodium ion transmembrane transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; scaffold8 indexed_genome mRNA 42922615 42939962 . - . ID=transcript_2279;Q76N89 A7E2X0 A8MYS3 B4DH42 O15036 Q9HCC7,E3 ubiquitin-protein ligase HECW1,HECT, C2 and WW domain-containing protein 1;HECT-type E3 ubiquitin transferase HECW1;NEDD4-like E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF18436;PF16562;PF00397;, GO:0005737;GO:0005829;GO:0061630;GO:0090090;GO:2000650;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0048814;, C:cytoplasm; C:cytosol;, F:ubiquitin protein ligase activity;, P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of sodium ion transmembrane transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; scaffold8 indexed_genome mRNA 42945027 42945614 . + . ID=transcript_2280;Q76N89 A7E2X0 A8MYS3 B4DH42 O15036 Q9HCC7,E3 ubiquitin-protein ligase HECW1,HECT, C2 and WW domain-containing protein 1;HECT-type E3 ubiquitin transferase HECW1;NEDD4-like E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF18436;PF16562;PF00397;, GO:0005737;GO:0005829;GO:0061630;GO:0090090;GO:2000650;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0048814;, C:cytoplasm; C:cytosol;, F:ubiquitin protein ligase activity;, P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of sodium ion transmembrane transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; scaffold8 indexed_genome mRNA 42945886 42994480 . - . ID=transcript_2281;Q76N89 A7E2X0 A8MYS3 B4DH42 O15036 Q9HCC7,E3 ubiquitin-protein ligase HECW1,HECT, C2 and WW domain-containing protein 1;HECT-type E3 ubiquitin transferase HECW1;NEDD4-like E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF18436;PF16562;PF00397;, GO:0005737;GO:0005829;GO:0061630;GO:0090090;GO:2000650;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0048814;, C:cytoplasm; C:cytosol;, F:ubiquitin protein ligase activity;, P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of sodium ion transmembrane transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; scaffold8 indexed_genome mRNA 43394906 43398348 . + . ID=transcript_2282;P25787 Q6ICS6 Q9BU45,Proteasome subunit alpha type-2,Macropain subunit C3;Multicatalytic endopeptidase complex subunit C3;Proteasome component C3;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000932;GO:0000502;GO:0005839;GO:0019773;GO:0034774;GO:0004175;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0009615;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:secretory granule lumen;, F:endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to virus; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P25787 Q6ICS6 Q9BU45,Proteasome subunit alpha type-2,Macropain subunit C3;Multicatalytic endopeptidase complex subunit C3;Proteasome component C3;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000932;GO:0000502;GO:0005839;GO:0019773;GO:0034774;GO:0004175;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0009615;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:secretory granule lumen;, F:endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to virus; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P25787 Q6ICS6 Q9BU45,Proteasome subunit alpha type-2,Macropain subunit C3;Multicatalytic endopeptidase complex subunit C3;Proteasome component C3;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000932;GO:0000502;GO:0005839;GO:0019773;GO:0034774;GO:0004175;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0009615;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:secretory granule lumen;, F:endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to virus; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold8 indexed_genome mRNA 43405166 43407947 . + . ID=transcript_2283;Q9BPX7 A4D1V2 J3KR36 Q9H779,UPF0415 protein C7orf25,, PF07000;PF18474; scaffold8 indexed_genome mRNA 44066475 44273965 . + . ID=transcript_2284;P10071 A4D1W1 O75219 Q17RW4 Q75MT0 Q75MU9 Q9UDT5 Q9UJ39,Transcriptional activator GLI3,GLI3 form of 190 kDa;GLI3 full-length protein;, PF00096;, GO:0005930;GO:0097546;GO:0097542;GO:0005929;GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0017053;GO:0008013;GO:0003682;GO:0003700;GO:0000981;GO:0035035;GO:0042826;GO:0036033;GO:0046872;GO:0000978;GO:0000977;GO:1990837;GO:0060873;GO:0009952;GO:0060840;GO:0007411;GO:0001658;GO:0048593;GO:0061005;GO:0048589;GO:0048566;GO:0048557;GO:0042733;GO:0048702;GO:0021798;GO:0021861;GO:0060364;GO:0007507;GO:0007442;GO:0021766;GO:0001701;GO:0060366;GO:0120223;GO:0022018;GO:0060875;GO:0021819;GO:0035108;GO:0097421;GO:0030324;GO:0060594;GO:0030318;GO:0001656;GO:0046639;GO:0043066;GO:0090090;GO:0008285;GO:0045665;GO:0045879;GO:0000122;GO:0045892;GO:0045060;GO:0043585;GO:0042475;GO:0048709;GO:0021631;GO:0046638;GO:0032332;GO:0002052;GO:0045669;GO:0042307;GO:0045944;GO:0045893;GO:0030850;GO:0016485;GO:0009954;GO:1903010;GO:1901620;GO:0006357;GO:0043627;GO:0060021;GO:0060367;GO:0007224;GO:0060831;GO:0021776;GO:0021775;GO:0033077;GO:0070242;GO:0043586;GO:0071625;GO:0042060;, C:axoneme; C:ciliary base; C:ciliary tip; C:cilium; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:beta-catenin binding; F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:histone deacetylase binding; F:mediator complex binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior semicircular canal development; P:anterior/posterior pattern specification; P:artery development; P:axon guidance; P:branching involved in ureteric bud morphogenesis; P:camera-type eye morphogenesis; P:cell differentiation involved in kidney development; P:developmental growth; P:embryonic digestive tract development; P:embryonic digestive tract morphogenesis; P:embryonic digit morphogenesis; P:embryonic neurocranium morphogenesis; P:forebrain dorsal/ventral pattern formation; P:forebrain radial glial cell differentiation; P:frontal suture morphogenesis; P:heart development; P:hindgut morphogenesis; P:hippocampus development; P:in utero embryonic development; P:lambdoid suture morphogenesis; P:larynx morphogenesis; P:lateral ganglionic eminence cell proliferation; P:lateral semicircular canal development; P:layer formation in cerebral cortex; P:limb morphogenesis; P:liver regeneration; P:lung development; P:mammary gland specification; P:melanocyte differentiation; P:metanephros development; P:negative regulation of alpha-beta T cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of neuron differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative thymic T cell selection; P:nose morphogenesis; P:odontogenesis of dentin-containing tooth; P:oligodendrocyte differentiation; P:optic nerve morphogenesis; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of chondrocyte differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of osteoblast differentiation; P:positive regulation of protein import into nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:protein processing; P:proximal/distal pattern formation; P:regulation of bone development; P:regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:regulation of transcription by RNA polymerase II; P:response to estrogen; P:roof of mouth development; P:sagittal suture morphogenesis; P:smoothened signaling pathway; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; P:T cell differentiation in thymus; P:thymocyte apoptotic process; P:tongue development; P:vocalization behavior; P:wound healing;|P10071 A4D1W1 O75219 Q17RW4 Q75MT0 Q75MU9 Q9UDT5 Q9UJ39,Transcriptional activator GLI3,GLI3 form of 190 kDa;GLI3 full-length protein;, PF00096;, GO:0005930;GO:0097546;GO:0097542;GO:0005929;GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0017053;GO:0008013;GO:0003682;GO:0003700;GO:0000981;GO:0035035;GO:0042826;GO:0036033;GO:0046872;GO:0000978;GO:0000977;GO:1990837;GO:0060873;GO:0009952;GO:0060840;GO:0007411;GO:0001658;GO:0048593;GO:0061005;GO:0048589;GO:0048566;GO:0048557;GO:0042733;GO:0048702;GO:0021798;GO:0021861;GO:0060364;GO:0007507;GO:0007442;GO:0021766;GO:0001701;GO:0060366;GO:0120223;GO:0022018;GO:0060875;GO:0021819;GO:0035108;GO:0097421;GO:0030324;GO:0060594;GO:0030318;GO:0001656;GO:0046639;GO:0043066;GO:0090090;GO:0008285;GO:0045665;GO:0045879;GO:0000122;GO:0045892;GO:0045060;GO:0043585;GO:0042475;GO:0048709;GO:0021631;GO:0046638;GO:0032332;GO:0002052;GO:0045669;GO:0042307;GO:0045944;GO:0045893;GO:0030850;GO:0016485;GO:0009954;GO:1903010;GO:1901620;GO:0006357;GO:0043627;GO:0060021;GO:0060367;GO:0007224;GO:0060831;GO:0021776;GO:0021775;GO:0033077;GO:0070242;GO:0043586;GO:0071625;GO:0042060;, C:axoneme; C:ciliary base; C:ciliary tip; C:cilium; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:beta-catenin binding; F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:histone deacetylase binding; F:mediator complex binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior semicircular canal development; P:anterior/posterior pattern specification; P:artery development; P:axon guidance; P:branching involved in ureteric bud morphogenesis; P:camera-type eye morphogenesis; P:cell differentiation involved in kidney development; P:developmental growth; P:embryonic digestive tract development; P:embryonic digestive tract morphogenesis; P:embryonic digit morphogenesis; P:embryonic neurocranium morphogenesis; P:forebrain dorsal/ventral pattern formation; P:forebrain radial glial cell differentiation; P:frontal suture morphogenesis; P:heart development; P:hindgut morphogenesis; P:hippocampus development; P:in utero embryonic development; P:lambdoid suture morphogenesis; P:larynx morphogenesis; P:lateral ganglionic eminence cell proliferation; P:lateral semicircular canal development; P:layer formation in cerebral cortex; P:limb morphogenesis; P:liver regeneration; P:lung development; P:mammary gland specification; P:melanocyte differentiation; P:metanephros development; P:negative regulation of alpha-beta T cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of neuron differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative thymic T cell selection; P:nose morphogenesis; P:odontogenesis of dentin-containing tooth; P:oligodendrocyte differentiation; P:optic nerve morphogenesis; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of chondrocyte differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of osteoblast differentiation; P:positive regulation of protein import into nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:protein processing; P:proximal/distal pattern formation; P:regulation of bone development; P:regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:regulation of transcription by RNA polymerase II; P:response to estrogen; P:roof of mouth development; P:sagittal suture morphogenesis; P:smoothened signaling pathway; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; P:T cell differentiation in thymus; P:thymocyte apoptotic process; P:tongue development; P:vocalization behavior; P:wound healing; scaffold8 indexed_genome mRNA 44484183 44494967 . + . ID=transcript_2285;P08476 Q14599,Inhibin beta A chain,Activin beta-A chain;Erythroid differentiation protein;, PF00019;PF00688;, GO:0043509;GO:0005576;GO:0005615;GO:0043512;GO:0048471;GO:0005125;GO:0008083;GO:0005179;GO:0042802;GO:0034711;GO:0017046;GO:0044877;GO:0070699;GO:0032924;GO:0007050;GO:0030154;GO:0007166;GO:0007267;GO:0071397;GO:0071372;GO:0006952;GO:0035987;GO:0030218;GO:0097191;GO:0061029;GO:0000082;GO:0097154;GO:0001942;GO:0002244;GO:0042541;GO:0008584;GO:0048333;GO:0045578;GO:0045786;GO:0030308;GO:0008285;GO:0046882;GO:0032689;GO:0045650;GO:0042326;GO:0007399;GO:0042476;GO:0001541;GO:0032270;GO:0045648;GO:2001241;GO:0046881;GO:0010628;GO:0060279;GO:0010862;GO:0045944;GO:0045893;GO:0042701;GO:0046880;GO:0006357;GO:0042493;GO:0060021;GO:0060395;GO:0021773;, C:activin A complex; C:extracellular region; C:extracellular space; C:inhibin A complex; C:perinuclear region of cytoplasm;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:identical protein binding; F:inhibin binding; F:peptide hormone binding; F:protein-containing complex binding; F:type II activin receptor binding;, P:activin receptor signaling pathway; P:cell cycle arrest; P:cell differentiation; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cellular response to cholesterol; P:cellular response to follicle-stimulating hormone stimulus; P:defense response; P:endodermal cell differentiation; P:erythrocyte differentiation; P:extrinsic apoptotic signaling pathway; P:eyelid development in camera-type eye; P:G1/S transition of mitotic cell cycle; P:GABAergic neuron differentiation; P:hair follicle development; P:hematopoietic progenitor cell differentiation; P:hemoglobin biosynthetic process; P:male gonad development; P:mesodermal cell differentiation; P:negative regulation of B cell differentiation; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of follicle-stimulating hormone secretion; P:negative regulation of interferon-gamma production; P:negative regulation of macrophage differentiation; P:negative regulation of phosphorylation; P:nervous system development; P:odontogenesis; P:ovarian follicle development; P:positive regulation of cellular protein metabolic process; P:positive regulation of erythrocyte differentiation; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of follicle-stimulating hormone secretion; P:positive regulation of gene expression; P:positive regulation of ovulation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:progesterone secretion; P:regulation of follicle-stimulating hormone secretion; P:regulation of transcription by RNA polymerase II; P:response to drug; P:roof of mouth development; P:SMAD protein signal transduction; P:striatal medium spiny neuron differentiation; scaffold8 indexed_genome mRNA 44494981 44495509 . - . ID=transcript_2286;P08476 Q14599,Inhibin beta A chain,Activin beta-A chain;Erythroid differentiation protein;, PF00019;PF00688;, GO:0043509;GO:0005576;GO:0005615;GO:0043512;GO:0048471;GO:0005125;GO:0008083;GO:0005179;GO:0042802;GO:0034711;GO:0017046;GO:0044877;GO:0070699;GO:0032924;GO:0007050;GO:0030154;GO:0007166;GO:0007267;GO:0071397;GO:0071372;GO:0006952;GO:0035987;GO:0030218;GO:0097191;GO:0061029;GO:0000082;GO:0097154;GO:0001942;GO:0002244;GO:0042541;GO:0008584;GO:0048333;GO:0045578;GO:0045786;GO:0030308;GO:0008285;GO:0046882;GO:0032689;GO:0045650;GO:0042326;GO:0007399;GO:0042476;GO:0001541;GO:0032270;GO:0045648;GO:2001241;GO:0046881;GO:0010628;GO:0060279;GO:0010862;GO:0045944;GO:0045893;GO:0042701;GO:0046880;GO:0006357;GO:0042493;GO:0060021;GO:0060395;GO:0021773;, C:activin A complex; C:extracellular region; C:extracellular space; C:inhibin A complex; C:perinuclear region of cytoplasm;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:identical protein binding; F:inhibin binding; F:peptide hormone binding; F:protein-containing complex binding; F:type II activin receptor binding;, P:activin receptor signaling pathway; P:cell cycle arrest; P:cell differentiation; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cellular response to cholesterol; P:cellular response to follicle-stimulating hormone stimulus; P:defense response; P:endodermal cell differentiation; P:erythrocyte differentiation; P:extrinsic apoptotic signaling pathway; P:eyelid development in camera-type eye; P:G1/S transition of mitotic cell cycle; P:GABAergic neuron differentiation; P:hair follicle development; P:hematopoietic progenitor cell differentiation; P:hemoglobin biosynthetic process; P:male gonad development; P:mesodermal cell differentiation; P:negative regulation of B cell differentiation; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of follicle-stimulating hormone secretion; P:negative regulation of interferon-gamma production; P:negative regulation of macrophage differentiation; P:negative regulation of phosphorylation; P:nervous system development; P:odontogenesis; P:ovarian follicle development; P:positive regulation of cellular protein metabolic process; P:positive regulation of erythrocyte differentiation; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of follicle-stimulating hormone secretion; P:positive regulation of gene expression; P:positive regulation of ovulation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:progesterone secretion; P:regulation of follicle-stimulating hormone secretion; P:regulation of transcription by RNA polymerase II; P:response to drug; P:roof of mouth development; P:SMAD protein signal transduction; P:striatal medium spiny neuron differentiation; scaffold8 indexed_genome mRNA 45300628 46042503 . - . ID=transcript_2287;Q9HAC7 A4D1W5 B4DR73 Q4KMW4 Q4KMW8 Q4KMZ0 Q8TE00 Q8TEY1,Succinate--hydroxymethylglutarate CoA-transferase,Dermal papilla-derived protein 13;SuccinylCoA:glutarate-CoA transferase;, PF02515;, GO:0005739;GO:0047369;, C:mitochondrion;, F:succinate-hydroxymethylglutarate CoA-transferase activity;|Q9HAC7 A4D1W5 B4DR73 Q4KMW4 Q4KMW8 Q4KMZ0 Q8TE00 Q8TEY1,Succinate--hydroxymethylglutarate CoA-transferase,Dermal papilla-derived protein 13;SuccinylCoA:glutarate-CoA transferase;, PF02515;, GO:0005739;GO:0047369;, C:mitochondrion;, F:succinate-hydroxymethylglutarate CoA-transferase activity;|Q9HAC7 A4D1W5 B4DR73 Q4KMW4 Q4KMW8 Q4KMZ0 Q8TE00 Q8TEY1,Succinate--hydroxymethylglutarate CoA-transferase,Dermal papilla-derived protein 13;SuccinylCoA:glutarate-CoA transferase;, PF02515;, GO:0005739;GO:0047369;, C:mitochondrion;, F:succinate-hydroxymethylglutarate CoA-transferase activity; scaffold8 indexed_genome mRNA 46042827 46048663 . + . ID=transcript_2288;Q8TAP9,M-phase-specific PLK1-interacting protein,TTD non-photosensitive 1 protein;, PF15502;, GO:0005813;GO:0005737;GO:0005794;GO:0043231;GO:0030496;GO:0005654;GO:0005634;GO:0007049;GO:0051301;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:midbody; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; scaffold8 indexed_genome mRNA 46062062 46070369 . - . ID=transcript_2289;Q14004 Q53G78 Q6DKQ9 Q75MH4 Q75MH5 Q96JN4 Q9H4A0 Q9H4A1 Q9UDR4,Cyclin-dependent kinase 13,CDC2-related protein kinase 5;Cell division cycle 2-like protein kinase 5;Cell division protein kinase 13;Cholinesterase-related cell division controller;, PF00069;, GO:0002945;GO:0000307;GO:0008024;GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0003723;GO:0008353;GO:0000380;GO:0030097;GO:0007275;GO:2000737;GO:0043312;GO:0070816;GO:0008284;GO:0032968;GO:0006468;GO:0007088;GO:0006368;GO:0016032;, C:cyclin K-CDK13 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:alternative mRNA splicing, via spliceosome; P:hemopoiesis; P:multicellular organism development; P:negative regulation of stem cell differentiation; P:neutrophil degranulation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cell population proliferation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein phosphorylation; P:regulation of mitotic nuclear division; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q14004 Q53G78 Q6DKQ9 Q75MH4 Q75MH5 Q96JN4 Q9H4A0 Q9H4A1 Q9UDR4,Cyclin-dependent kinase 13,CDC2-related protein kinase 5;Cell division cycle 2-like protein kinase 5;Cell division protein kinase 13;Cholinesterase-related cell division controller;, PF00069;, GO:0002945;GO:0000307;GO:0008024;GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0003723;GO:0008353;GO:0000380;GO:0030097;GO:0007275;GO:2000737;GO:0043312;GO:0070816;GO:0008284;GO:0032968;GO:0006468;GO:0007088;GO:0006368;GO:0016032;, C:cyclin K-CDK13 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:alternative mRNA splicing, via spliceosome; P:hemopoiesis; P:multicellular organism development; P:negative regulation of stem cell differentiation; P:neutrophil degranulation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cell population proliferation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein phosphorylation; P:regulation of mitotic nuclear division; P:transcription elongation from RNA polymerase II promoter; P:viral process; scaffold8 indexed_genome mRNA 46070987 46093196 . - . ID=transcript_2290;Q14004 Q53G78 Q6DKQ9 Q75MH4 Q75MH5 Q96JN4 Q9H4A0 Q9H4A1 Q9UDR4,Cyclin-dependent kinase 13,CDC2-related protein kinase 5;Cell division cycle 2-like protein kinase 5;Cell division protein kinase 13;Cholinesterase-related cell division controller;, PF00069;, GO:0002945;GO:0000307;GO:0008024;GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0003723;GO:0008353;GO:0000380;GO:0030097;GO:0007275;GO:2000737;GO:0043312;GO:0070816;GO:0008284;GO:0032968;GO:0006468;GO:0007088;GO:0006368;GO:0016032;, C:cyclin K-CDK13 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:alternative mRNA splicing, via spliceosome; P:hemopoiesis; P:multicellular organism development; P:negative regulation of stem cell differentiation; P:neutrophil degranulation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cell population proliferation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein phosphorylation; P:regulation of mitotic nuclear division; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q14004 Q53G78 Q6DKQ9 Q75MH4 Q75MH5 Q96JN4 Q9H4A0 Q9H4A1 Q9UDR4,Cyclin-dependent kinase 13,CDC2-related protein kinase 5;Cell division cycle 2-like protein kinase 5;Cell division protein kinase 13;Cholinesterase-related cell division controller;, PF00069;, GO:0002945;GO:0000307;GO:0008024;GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0003723;GO:0008353;GO:0000380;GO:0030097;GO:0007275;GO:2000737;GO:0043312;GO:0070816;GO:0008284;GO:0032968;GO:0006468;GO:0007088;GO:0006368;GO:0016032;, C:cyclin K-CDK13 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:alternative mRNA splicing, via spliceosome; P:hemopoiesis; P:multicellular organism development; P:negative regulation of stem cell differentiation; P:neutrophil degranulation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cell population proliferation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein phosphorylation; P:regulation of mitotic nuclear division; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q14004 Q53G78 Q6DKQ9 Q75MH4 Q75MH5 Q96JN4 Q9H4A0 Q9H4A1 Q9UDR4,Cyclin-dependent kinase 13,CDC2-related protein kinase 5;Cell division cycle 2-like protein kinase 5;Cell division protein kinase 13;Cholinesterase-related cell division controller;, PF00069;, GO:0002945;GO:0000307;GO:0008024;GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0003723;GO:0008353;GO:0000380;GO:0030097;GO:0007275;GO:2000737;GO:0043312;GO:0070816;GO:0008284;GO:0032968;GO:0006468;GO:0007088;GO:0006368;GO:0016032;, C:cyclin K-CDK13 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:alternative mRNA splicing, via spliceosome; P:hemopoiesis; P:multicellular organism development; P:negative regulation of stem cell differentiation; P:neutrophil degranulation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cell population proliferation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein phosphorylation; P:regulation of mitotic nuclear division; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q14004 Q53G78 Q6DKQ9 Q75MH4 Q75MH5 Q96JN4 Q9H4A0 Q9H4A1 Q9UDR4,Cyclin-dependent kinase 13,CDC2-related protein kinase 5;Cell division cycle 2-like protein kinase 5;Cell division protein kinase 13;Cholinesterase-related cell division controller;, PF00069;, GO:0002945;GO:0000307;GO:0008024;GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0003723;GO:0008353;GO:0000380;GO:0030097;GO:0007275;GO:2000737;GO:0043312;GO:0070816;GO:0008284;GO:0032968;GO:0006468;GO:0007088;GO:0006368;GO:0016032;, C:cyclin K-CDK13 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:alternative mRNA splicing, via spliceosome; P:hemopoiesis; P:multicellular organism development; P:negative regulation of stem cell differentiation; P:neutrophil degranulation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cell population proliferation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein phosphorylation; P:regulation of mitotic nuclear division; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q14004 Q53G78 Q6DKQ9 Q75MH4 Q75MH5 Q96JN4 Q9H4A0 Q9H4A1 Q9UDR4,Cyclin-dependent kinase 13,CDC2-related protein kinase 5;Cell division cycle 2-like protein kinase 5;Cell division protein kinase 13;Cholinesterase-related cell division controller;, PF00069;, GO:0002945;GO:0000307;GO:0008024;GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0003723;GO:0008353;GO:0000380;GO:0030097;GO:0007275;GO:2000737;GO:0043312;GO:0070816;GO:0008284;GO:0032968;GO:0006468;GO:0007088;GO:0006368;GO:0016032;, C:cyclin K-CDK13 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:alternative mRNA splicing, via spliceosome; P:hemopoiesis; P:multicellular organism development; P:negative regulation of stem cell differentiation; P:neutrophil degranulation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cell population proliferation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein phosphorylation; P:regulation of mitotic nuclear division; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q14004 Q53G78 Q6DKQ9 Q75MH4 Q75MH5 Q96JN4 Q9H4A0 Q9H4A1 Q9UDR4,Cyclin-dependent kinase 13,CDC2-related protein kinase 5;Cell division cycle 2-like protein kinase 5;Cell division protein kinase 13;Cholinesterase-related cell division controller;, PF00069;, GO:0002945;GO:0000307;GO:0008024;GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0003723;GO:0008353;GO:0000380;GO:0030097;GO:0007275;GO:2000737;GO:0043312;GO:0070816;GO:0008284;GO:0032968;GO:0006468;GO:0007088;GO:0006368;GO:0016032;, C:cyclin K-CDK13 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:alternative mRNA splicing, via spliceosome; P:hemopoiesis; P:multicellular organism development; P:negative regulation of stem cell differentiation; P:neutrophil degranulation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cell population proliferation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein phosphorylation; P:regulation of mitotic nuclear division; P:transcription elongation from RNA polymerase II promoter; P:viral process; scaffold8 indexed_genome mRNA 46146837 46147478 . - . ID=transcript_2291;Q14004 Q53G78 Q6DKQ9 Q75MH4 Q75MH5 Q96JN4 Q9H4A0 Q9H4A1 Q9UDR4,Cyclin-dependent kinase 13,CDC2-related protein kinase 5;Cell division cycle 2-like protein kinase 5;Cell division protein kinase 13;Cholinesterase-related cell division controller;, PF00069;, GO:0002945;GO:0000307;GO:0008024;GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0003723;GO:0008353;GO:0000380;GO:0030097;GO:0007275;GO:2000737;GO:0043312;GO:0070816;GO:0008284;GO:0032968;GO:0006468;GO:0007088;GO:0006368;GO:0016032;, C:cyclin K-CDK13 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:alternative mRNA splicing, via spliceosome; P:hemopoiesis; P:multicellular organism development; P:negative regulation of stem cell differentiation; P:neutrophil degranulation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cell population proliferation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein phosphorylation; P:regulation of mitotic nuclear division; P:transcription elongation from RNA polymerase II promoter; P:viral process; scaffold8 indexed_genome mRNA 46295136 46365052 . - . ID=transcript_2292;P11233 A4D1W3,Ras-related protein Ral-A,, PF00071;, GO:0009986;GO:0032154;GO:0030659;GO:0070062;GO:0090543;GO:0005925;GO:0005886;GO:0051117;GO:0031755;GO:0019003;GO:0005525;GO:0003924;GO:0017022;GO:0031625;GO:0031532;GO:0007049;GO:0051301;GO:0006935;GO:0006887;GO:0035722;GO:0051665;GO:0001843;GO:0051491;GO:0007265;GO:0017157;GO:0007165;, C:cell surface; C:cleavage furrow; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:Flemming body; C:focal adhesion; C:plasma membrane;, F:ATPase binding; F:Edg-2 lysophosphatidic acid receptor binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin binding; F:ubiquitin protein ligase binding;, P:actin cytoskeleton reorganization; P:cell cycle; P:cell division; P:chemotaxis; P:exocytosis; P:interleukin-12-mediated signaling pathway; P:membrane raft localization; P:neural tube closure; P:positive regulation of filopodium assembly; P:Ras protein signal transduction; P:regulation of exocytosis; P:signal transduction;|P11233 A4D1W3,Ras-related protein Ral-A,, PF00071;, GO:0009986;GO:0032154;GO:0030659;GO:0070062;GO:0090543;GO:0005925;GO:0005886;GO:0051117;GO:0031755;GO:0019003;GO:0005525;GO:0003924;GO:0017022;GO:0031625;GO:0031532;GO:0007049;GO:0051301;GO:0006935;GO:0006887;GO:0035722;GO:0051665;GO:0001843;GO:0051491;GO:0007265;GO:0017157;GO:0007165;, C:cell surface; C:cleavage furrow; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:Flemming body; C:focal adhesion; C:plasma membrane;, F:ATPase binding; F:Edg-2 lysophosphatidic acid receptor binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin binding; F:ubiquitin protein ligase binding;, P:actin cytoskeleton reorganization; P:cell cycle; P:cell division; P:chemotaxis; P:exocytosis; P:interleukin-12-mediated signaling pathway; P:membrane raft localization; P:neural tube closure; P:positive regulation of filopodium assembly; P:Ras protein signal transduction; P:regulation of exocytosis; P:signal transduction; scaffold8 indexed_genome mRNA 46388585 46396218 . - . ID=transcript_2293;Q9NRH1 A4D1W4 B4DE83 Q6IAF7 Q8WVZ5,Protein YAE1 homolog {ECO:0000305},Yae1 domain-containing protein 1;, PF09811;, GO:0005737;GO:0005634;GO:0106035;, C:cytoplasm; C:nucleus;, , P:protein maturation by [4Fe-4S] cluster transfer; scaffold8 indexed_genome mRNA 47097319 47250541 . + . ID=transcript_2294;P49754 E9PF36 Q86TP8 Q99851 Q99852,Vacuolar protein sorting-associated protein 41 homolog,S53;, PF00637;, GO:0030123;GO:0030136;GO:0005829;GO:0005769;GO:0010008;GO:0005794;GO:0005798;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0005764;GO:0016020;GO:0015630;GO:0042802;GO:0046872;GO:0008017;GO:0043621;GO:0009267;GO:0034058;GO:0008333;GO:0048193;GO:1902774;GO:0016236;GO:0006623;GO:0045055;, C:AP-3 adaptor complex; C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi-associated vesicle; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:lysosome; C:membrane; C:microtubule cytoskeleton;, F:identical protein binding; F:metal ion binding; F:microtubule binding; F:protein self-association;, P:cellular response to starvation; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:Golgi vesicle transport; P:late endosome to lysosome transport; P:macroautophagy; P:protein targeting to vacuole; P:regulated exocytosis;|P49754 E9PF36 Q86TP8 Q99851 Q99852,Vacuolar protein sorting-associated protein 41 homolog,S53;, PF00637;, GO:0030123;GO:0030136;GO:0005829;GO:0005769;GO:0010008;GO:0005794;GO:0005798;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0005764;GO:0016020;GO:0015630;GO:0042802;GO:0046872;GO:0008017;GO:0043621;GO:0009267;GO:0034058;GO:0008333;GO:0048193;GO:1902774;GO:0016236;GO:0006623;GO:0045055;, C:AP-3 adaptor complex; C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi-associated vesicle; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:lysosome; C:membrane; C:microtubule cytoskeleton;, F:identical protein binding; F:metal ion binding; F:microtubule binding; F:protein self-association;, P:cellular response to starvation; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:Golgi vesicle transport; P:late endosome to lysosome transport; P:macroautophagy; P:protein targeting to vacuole; P:regulated exocytosis; scaffold8 indexed_genome mRNA 47369808 47581171 . + . ID=transcript_2295;P49418 A4D1X8 A4D1X9 O43538 Q75MJ8 Q75MK5 Q75MM3 Q8N4G0,Amphiphysin,, PF03114;PF14604;, GO:0015629;GO:0005829;GO:0031256;GO:0005886;GO:0008021;GO:0030672;GO:0005543;GO:0007268;GO:0006897;GO:0061024;GO:0048488;, C:actin cytoskeleton; C:cytosol; C:leading edge membrane; C:plasma membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:phospholipid binding;, P:chemical synaptic transmission; P:endocytosis; P:membrane organization; P:synaptic vesicle endocytosis;|P49418 A4D1X8 A4D1X9 O43538 Q75MJ8 Q75MK5 Q75MM3 Q8N4G0,Amphiphysin,, PF03114;PF14604;, GO:0015629;GO:0005829;GO:0031256;GO:0005886;GO:0008021;GO:0030672;GO:0005543;GO:0007268;GO:0006897;GO:0061024;GO:0048488;, C:actin cytoskeleton; C:cytosol; C:leading edge membrane; C:plasma membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:phospholipid binding;, P:chemical synaptic transmission; P:endocytosis; P:membrane organization; P:synaptic vesicle endocytosis;|P49418 A4D1X8 A4D1X9 O43538 Q75MJ8 Q75MK5 Q75MM3 Q8N4G0,Amphiphysin,, PF03114;PF14604;, GO:0015629;GO:0005829;GO:0031256;GO:0005886;GO:0008021;GO:0030672;GO:0005543;GO:0007268;GO:0006897;GO:0061024;GO:0048488;, C:actin cytoskeleton; C:cytosol; C:leading edge membrane; C:plasma membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:phospholipid binding;, P:chemical synaptic transmission; P:endocytosis; P:membrane organization; P:synaptic vesicle endocytosis; scaffold8 indexed_genome mRNA 47632222 47639216 . + . ID=transcript_2296;P0CF51 A0A075B6Q9,T cell receptor gamma constant 1 {ECO:0000303|Ref.3},, PF07654;, GO:0009897;GO:0016021;GO:0042101;GO:0002250;, C:external side of plasma membrane; C:integral component of membrane; C:T cell receptor complex;, , P:adaptive immune response; scaffold8 indexed_genome mRNA 47785364 47797042 . + . ID=transcript_2297;O95777,U6 snRNA-associated Sm-like protein LSm8,, PF01423;, GO:0120115;GO:0005654;GO:0005634;GO:0071011;GO:0071005;GO:0046540;GO:0005688;GO:0003723;GO:0017070;GO:0000398;GO:0016070;, C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:RNA binding; F:U6 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA metabolic process;|O95777,U6 snRNA-associated Sm-like protein LSm8,, PF01423;, GO:0120115;GO:0005654;GO:0005634;GO:0071011;GO:0071005;GO:0046540;GO:0005688;GO:0003723;GO:0017070;GO:0000398;GO:0016070;, C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:RNA binding; F:U6 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA metabolic process; scaffold8 indexed_genome mRNA 49505784 50054825 . + . ID=transcript_2298;Q9NZV8 O95012 O95021 Q2TBD3 Q9UBY7 Q9UN98 Q9UNH9,Potassium voltage-gated channel subfamily D member 2,Voltage-gated potassium channel subunit Kv4.2;, PF02214;PF11879;PF00520;PF11601;, GO:0043197;GO:0098982;GO:0098978;GO:0016021;GO:0005887;GO:0099060;GO:0031226;GO:0032809;GO:0043204;GO:0005886;GO:0044853;GO:0014069;GO:0045211;GO:0008076;GO:0005250;GO:0046872;GO:1905030;GO:0005249;GO:0001508;GO:0061337;GO:0071456;GO:0007268;GO:0045475;GO:0019228;GO:0071805;GO:0051260;GO:0034765;GO:0019233;, C:dendritic spine; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:intrinsic component of plasma membrane; C:neuronal cell body membrane; C:perikaryon; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:postsynaptic membrane; C:voltage-gated potassium channel complex;, F:A-type (transient outward) potassium channel activity; F:metal ion binding; F:voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:voltage-gated potassium channel activity;, P:action potential; P:cardiac conduction; P:cellular response to hypoxia; P:chemical synaptic transmission; P:locomotor rhythm; P:neuronal action potential; P:potassium ion transmembrane transport; P:protein homooligomerization; P:regulation of ion transmembrane transport; P:sensory perception of pain;|Q9UI09 F8VQS7 Q53XX0 Q9BRV6,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12,13 kDa differentiation-associated protein;Complex I-B17.2;NADH-ubiquinone oxidoreductase subunit B17.2;, PF05071;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0008137;GO:0042775;GO:0006120;GO:0032981;GO:0007585;GO:0006979;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:respiratory gaseous exchange by respiratory system; P:response to oxidative stress;|Q9NZV8 O95012 O95021 Q2TBD3 Q9UBY7 Q9UN98 Q9UNH9,Potassium voltage-gated channel subfamily D member 2,Voltage-gated potassium channel subunit Kv4.2;, PF02214;PF11879;PF00520;PF11601;, GO:0043197;GO:0098982;GO:0098978;GO:0016021;GO:0005887;GO:0099060;GO:0031226;GO:0032809;GO:0043204;GO:0005886;GO:0044853;GO:0014069;GO:0045211;GO:0008076;GO:0005250;GO:0046872;GO:1905030;GO:0005249;GO:0001508;GO:0061337;GO:0071456;GO:0007268;GO:0045475;GO:0019228;GO:0071805;GO:0051260;GO:0034765;GO:0019233;, C:dendritic spine; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:intrinsic component of plasma membrane; C:neuronal cell body membrane; C:perikaryon; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:postsynaptic membrane; C:voltage-gated potassium channel complex;, F:A-type (transient outward) potassium channel activity; F:metal ion binding; F:voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:voltage-gated potassium channel activity;, P:action potential; P:cardiac conduction; P:cellular response to hypoxia; P:chemical synaptic transmission; P:locomotor rhythm; P:neuronal action potential; P:potassium ion transmembrane transport; P:protein homooligomerization; P:regulation of ion transmembrane transport; P:sensory perception of pain; scaffold8 indexed_genome mRNA 50086135 50150966 . - . ID=transcript_2299;O95859 A4D0V8 B4DRG6 Q549U9 Q8N5Y0,Tetraspanin-12,Tetraspan NET-2;Transmembrane 4 superfamily member 12;, PF00335;, GO:0016021;GO:0005887;GO:0016020;GO:0001525;GO:0007166;GO:0045765;GO:1900746;GO:0010842;GO:0016055;, C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, , P:angiogenesis; P:cell surface receptor signaling pathway; P:regulation of angiogenesis; P:regulation of vascular endothelial growth factor signaling pathway; P:retina layer formation; P:Wnt signaling pathway; scaffold8 indexed_genome mRNA 50233458 50253923 . + . ID=transcript_2300;Q9P081,Inhibitor of growth protein 3,p47ING3;, PF12998;, GO:0035267;GO:0005654;GO:0032777;GO:0000812;GO:0046872;GO:0035064;GO:0043968;GO:0043967;GO:0043065;GO:0040008;, C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:Piccolo NuA4 histone acetyltransferase complex; C:Swr1 complex;, F:metal ion binding; F:methylated histone binding;, P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of apoptotic process; P:regulation of growth;|Q9P081,Inhibitor of growth protein 3,p47ING3;, PF12998;, GO:0035267;GO:0005654;GO:0032777;GO:0000812;GO:0046872;GO:0035064;GO:0043968;GO:0043967;GO:0043065;GO:0040008;, C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:Piccolo NuA4 histone acetyltransferase complex; C:Swr1 complex;, F:metal ion binding; F:methylated histone binding;, P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of apoptotic process; P:regulation of growth;|Q9P081,Inhibitor of growth protein 3,p47ING3;, PF12998;, GO:0035267;GO:0005654;GO:0032777;GO:0000812;GO:0046872;GO:0035064;GO:0043968;GO:0043967;GO:0043065;GO:0040008;, C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:Piccolo NuA4 histone acetyltransferase complex; C:Swr1 complex;, F:metal ion binding; F:methylated histone binding;, P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of apoptotic process; P:regulation of growth;|Q9P081,Inhibitor of growth protein 3,p47ING3;, PF12998;, GO:0035267;GO:0005654;GO:0032777;GO:0000812;GO:0046872;GO:0035064;GO:0043968;GO:0043967;GO:0043065;GO:0040008;, C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:Piccolo NuA4 histone acetyltransferase complex; C:Swr1 complex;, F:metal ion binding; F:methylated histone binding;, P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of apoptotic process; P:regulation of growth; scaffold8 indexed_genome mRNA 50264146 50554429 . + . ID=transcript_2301;A4D0V7 A8K1R3 Q6UXT1 Q86T76 Q86T84 Q8N2T5 Q96NC9,Cadherin-like and PC-esterase domain-containing protein 1,, , GO:0005783;, C:endoplasmic reticulum;|A4D0V7 A8K1R3 Q6UXT1 Q86T76 Q86T84 Q8N2T5 Q96NC9,Cadherin-like and PC-esterase domain-containing protein 1,, , GO:0005783;, C:endoplasmic reticulum; scaffold8 indexed_genome mRNA 50572740 50574813 . + . ID=transcript_2302;A4D0V7 A8K1R3 Q6UXT1 Q86T76 Q86T84 Q8N2T5 Q96NC9,Cadherin-like and PC-esterase domain-containing protein 1,, , GO:0005783;, C:endoplasmic reticulum; scaffold8 indexed_genome mRNA 50621195 50678593 . - . ID=transcript_2303;Q92520 A6NDN2 A8K3R7,Protein FAM3C,Interleukin-like EMT inducer;, PF15711;, GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0031089;GO:0005125;GO:0007275;GO:0045721;GO:0002576;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:platelet dense granule lumen;, F:cytokine activity;, P:multicellular organism development; P:negative regulation of gluconeogenesis; P:platelet degranulation; scaffold8 indexed_genome mRNA 51045835 51237972 . + . ID=transcript_2304;P23471 A4D0W5 C9JFM0 O76043 Q9UDR6,Receptor-type tyrosine-protein phosphatase zeta,Protein-tyrosine phosphatase receptor type Z polypeptide 1;Protein-tyrosine phosphatase receptor type Z polypeptide 2;R-PTP-zeta-2;, PF00194;PF00041;PF00102;, GO:0005576;GO:0005887;GO:0031226;GO:0005886;GO:0005178;GO:0004725;GO:0005001;GO:0007417;GO:0019221;GO:0007611;GO:0043524;GO:0048709;GO:0035335;GO:0048714;GO:0006470;GO:0031641;GO:0070445;, C:extracellular region; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:integrin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:central nervous system development; P:cytokine-mediated signaling pathway; P:learning or memory; P:negative regulation of neuron apoptotic process; P:oligodendrocyte differentiation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of oligodendrocyte differentiation; P:protein dephosphorylation; P:regulation of myelination; P:regulation of oligodendrocyte progenitor proliferation;|P23471 A4D0W5 C9JFM0 O76043 Q9UDR6,Receptor-type tyrosine-protein phosphatase zeta,Protein-tyrosine phosphatase receptor type Z polypeptide 1;Protein-tyrosine phosphatase receptor type Z polypeptide 2;R-PTP-zeta-2;, PF00194;PF00041;PF00102;, GO:0005576;GO:0005887;GO:0031226;GO:0005886;GO:0005178;GO:0004725;GO:0005001;GO:0007417;GO:0019221;GO:0007611;GO:0043524;GO:0048709;GO:0035335;GO:0048714;GO:0006470;GO:0031641;GO:0070445;, C:extracellular region; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:integrin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:central nervous system development; P:cytokine-mediated signaling pathway; P:learning or memory; P:negative regulation of neuron apoptotic process; P:oligodendrocyte differentiation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of oligodendrocyte differentiation; P:protein dephosphorylation; P:regulation of myelination; P:regulation of oligodendrocyte progenitor proliferation;|P23471 A4D0W5 C9JFM0 O76043 Q9UDR6,Receptor-type tyrosine-protein phosphatase zeta,Protein-tyrosine phosphatase receptor type Z polypeptide 1;Protein-tyrosine phosphatase receptor type Z polypeptide 2;R-PTP-zeta-2;, PF00194;PF00041;PF00102;, GO:0005576;GO:0005887;GO:0031226;GO:0005886;GO:0005178;GO:0004725;GO:0005001;GO:0007417;GO:0019221;GO:0007611;GO:0043524;GO:0048709;GO:0035335;GO:0048714;GO:0006470;GO:0031641;GO:0070445;, C:extracellular region; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:integrin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:central nervous system development; P:cytokine-mediated signaling pathway; P:learning or memory; P:negative regulation of neuron apoptotic process; P:oligodendrocyte differentiation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of oligodendrocyte differentiation; P:protein dephosphorylation; P:regulation of myelination; P:regulation of oligodendrocyte progenitor proliferation;|P23471 A4D0W5 C9JFM0 O76043 Q9UDR6,Receptor-type tyrosine-protein phosphatase zeta,Protein-tyrosine phosphatase receptor type Z polypeptide 1;Protein-tyrosine phosphatase receptor type Z polypeptide 2;R-PTP-zeta-2;, PF00194;PF00041;PF00102;, GO:0005576;GO:0005887;GO:0031226;GO:0005886;GO:0005178;GO:0004725;GO:0005001;GO:0007417;GO:0019221;GO:0007611;GO:0043524;GO:0048709;GO:0035335;GO:0048714;GO:0006470;GO:0031641;GO:0070445;, C:extracellular region; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:integrin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:central nervous system development; P:cytokine-mediated signaling pathway; P:learning or memory; P:negative regulation of neuron apoptotic process; P:oligodendrocyte differentiation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of oligodendrocyte differentiation; P:protein dephosphorylation; P:regulation of myelination; P:regulation of oligodendrocyte progenitor proliferation;|P23471 A4D0W5 C9JFM0 O76043 Q9UDR6,Receptor-type tyrosine-protein phosphatase zeta,Protein-tyrosine phosphatase receptor type Z polypeptide 1;Protein-tyrosine phosphatase receptor type Z polypeptide 2;R-PTP-zeta-2;, PF00194;PF00041;PF00102;, GO:0005576;GO:0005887;GO:0031226;GO:0005886;GO:0005178;GO:0004725;GO:0005001;GO:0007417;GO:0019221;GO:0007611;GO:0043524;GO:0048709;GO:0035335;GO:0048714;GO:0006470;GO:0031641;GO:0070445;, C:extracellular region; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:integrin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:central nervous system development; P:cytokine-mediated signaling pathway; P:learning or memory; P:negative regulation of neuron apoptotic process; P:oligodendrocyte differentiation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of oligodendrocyte differentiation; P:protein dephosphorylation; P:regulation of myelination; P:regulation of oligodendrocyte progenitor proliferation;|P23471 A4D0W5 C9JFM0 O76043 Q9UDR6,Receptor-type tyrosine-protein phosphatase zeta,Protein-tyrosine phosphatase receptor type Z polypeptide 1;Protein-tyrosine phosphatase receptor type Z polypeptide 2;R-PTP-zeta-2;, PF00194;PF00041;PF00102;, GO:0005576;GO:0005887;GO:0031226;GO:0005886;GO:0005178;GO:0004725;GO:0005001;GO:0007417;GO:0019221;GO:0007611;GO:0043524;GO:0048709;GO:0035335;GO:0048714;GO:0006470;GO:0031641;GO:0070445;, C:extracellular region; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:integrin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:central nervous system development; P:cytokine-mediated signaling pathway; P:learning or memory; P:negative regulation of neuron apoptotic process; P:oligodendrocyte differentiation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of oligodendrocyte differentiation; P:protein dephosphorylation; P:regulation of myelination; P:regulation of oligodendrocyte progenitor proliferation; scaffold8 indexed_genome mRNA 51240652 51305159 . - . ID=transcript_2305;Q9UDR5 O95462,Alpha-aminoadipic semialdehyde synthase, mitochondrial,LKR/SDH;, PF05222;PF16653;PF03435;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0005634;GO:0042393;GO:0047131;GO:0004754;GO:0047130;GO:0004753;GO:0003714;GO:0033512;GO:0019878;GO:0006554;GO:0031061;GO:0000122;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:histone binding; F:saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity; F:saccharopine dehydrogenase (NAD+, L-lysine-forming) activity; F:saccharopine dehydrogenase (NADP+, L-lysine-forming) activity; F:saccharopine dehydrogenase activity; F:transcription corepressor activity;, P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine biosynthetic process via aminoadipic acid; P:lysine catabolic process; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II;|Q9UDR5 O95462,Alpha-aminoadipic semialdehyde synthase, mitochondrial,LKR/SDH;, PF05222;PF16653;PF03435;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0005634;GO:0042393;GO:0047131;GO:0004754;GO:0047130;GO:0004753;GO:0003714;GO:0033512;GO:0019878;GO:0006554;GO:0031061;GO:0000122;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:histone binding; F:saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity; F:saccharopine dehydrogenase (NAD+, L-lysine-forming) activity; F:saccharopine dehydrogenase (NADP+, L-lysine-forming) activity; F:saccharopine dehydrogenase activity; F:transcription corepressor activity;, P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine biosynthetic process via aminoadipic acid; P:lysine catabolic process; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II;|Q9UDR5 O95462,Alpha-aminoadipic semialdehyde synthase, mitochondrial,LKR/SDH;, PF05222;PF16653;PF03435;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0005634;GO:0042393;GO:0047131;GO:0004754;GO:0047130;GO:0004753;GO:0003714;GO:0033512;GO:0019878;GO:0006554;GO:0031061;GO:0000122;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:histone binding; F:saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity; F:saccharopine dehydrogenase (NAD+, L-lysine-forming) activity; F:saccharopine dehydrogenase (NADP+, L-lysine-forming) activity; F:saccharopine dehydrogenase activity; F:transcription corepressor activity;, P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine biosynthetic process via aminoadipic acid; P:lysine catabolic process; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II;|Q9UDR5 O95462,Alpha-aminoadipic semialdehyde synthase, mitochondrial,LKR/SDH;, PF05222;PF16653;PF03435;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0005634;GO:0042393;GO:0047131;GO:0004754;GO:0047130;GO:0004753;GO:0003714;GO:0033512;GO:0019878;GO:0006554;GO:0031061;GO:0000122;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:histone binding; F:saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity; F:saccharopine dehydrogenase (NAD+, L-lysine-forming) activity; F:saccharopine dehydrogenase (NADP+, L-lysine-forming) activity; F:saccharopine dehydrogenase activity; F:transcription corepressor activity;, P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine biosynthetic process via aminoadipic acid; P:lysine catabolic process; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 51446005 51454140 . + . ID=transcript_2306;Q9NWK8,Calcium-dependent secretion activator 2,Calcium-dependent activator protein for secretion 2;, PF06292;PF00169;, GO:0030659;GO:0098978;GO:0043231;GO:0005654;GO:0098793;GO:0008289;GO:0046872;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytoplasmic vesicle membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:presynapse;, F:lipid binding; F:metal ion binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis; scaffold8 indexed_genome mRNA 51471230 51472551 . + . ID=transcript_2307;Q9NWK8,Calcium-dependent secretion activator 2,Calcium-dependent activator protein for secretion 2;, PF06292;PF00169;, GO:0030659;GO:0098978;GO:0043231;GO:0005654;GO:0098793;GO:0008289;GO:0046872;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytoplasmic vesicle membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:presynapse;, F:lipid binding; F:metal ion binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis; scaffold8 indexed_genome mRNA 51487309 51488012 . - . ID=transcript_2308;Q9NWK8,Calcium-dependent secretion activator 2,Calcium-dependent activator protein for secretion 2;, PF06292;PF00169;, GO:0030659;GO:0098978;GO:0043231;GO:0005654;GO:0098793;GO:0008289;GO:0046872;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytoplasmic vesicle membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:presynapse;, F:lipid binding; F:metal ion binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis; scaffold8 indexed_genome mRNA 51512749 51545461 . + . ID=transcript_2309;Q9NWK8,Calcium-dependent secretion activator 2,Calcium-dependent activator protein for secretion 2;, PF06292;PF00169;, GO:0030659;GO:0098978;GO:0043231;GO:0005654;GO:0098793;GO:0008289;GO:0046872;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytoplasmic vesicle membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:presynapse;, F:lipid binding; F:metal ion binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis;|Q9NWK8,Calcium-dependent secretion activator 2,Calcium-dependent activator protein for secretion 2;, PF06292;PF00169;, GO:0030659;GO:0098978;GO:0043231;GO:0005654;GO:0098793;GO:0008289;GO:0046872;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytoplasmic vesicle membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:presynapse;, F:lipid binding; F:metal ion binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis;|Q9NWK8,Calcium-dependent secretion activator 2,Calcium-dependent activator protein for secretion 2;, PF06292;PF00169;, GO:0030659;GO:0098978;GO:0043231;GO:0005654;GO:0098793;GO:0008289;GO:0046872;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytoplasmic vesicle membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:presynapse;, F:lipid binding; F:metal ion binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis; scaffold8 indexed_genome mRNA 51568310 51985634 . - . ID=transcript_2310;Q9NWK8,Calcium-dependent secretion activator 2,Calcium-dependent activator protein for secretion 2;, PF06292;PF00169;, GO:0030659;GO:0098978;GO:0043231;GO:0005654;GO:0098793;GO:0008289;GO:0046872;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytoplasmic vesicle membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:presynapse;, F:lipid binding; F:metal ion binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis;|Q9NWK8,Calcium-dependent secretion activator 2,Calcium-dependent activator protein for secretion 2;, PF06292;PF00169;, GO:0030659;GO:0098978;GO:0043231;GO:0005654;GO:0098793;GO:0008289;GO:0046872;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytoplasmic vesicle membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:presynapse;, F:lipid binding; F:metal ion binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis; scaffold8 indexed_genome mRNA 52411627 52469818 . + . ID=transcript_2311;Q8NA54 A4D0X0 Q49AL6 Q4G189 Q5BJD9 Q6NUH6 Q8N9Y2,IQ and ubiquitin-like domain-containing protein,, PF00240;, GO:0001669;GO:0031514;GO:0060271;GO:0007224;, C:acrosomal vesicle; C:motile cilium;, , P:cilium assembly; P:smoothened signaling pathway;|Q8NA54 A4D0X0 Q49AL6 Q4G189 Q5BJD9 Q6NUH6 Q8N9Y2,IQ and ubiquitin-like domain-containing protein,, PF00240;, GO:0001669;GO:0031514;GO:0060271;GO:0007224;, C:acrosomal vesicle; C:motile cilium;, , P:cilium assembly; P:smoothened signaling pathway; scaffold8 indexed_genome mRNA 52474149 52484742 . - . ID=transcript_2312;Q8NA54 A4D0X0 Q49AL6 Q4G189 Q5BJD9 Q6NUH6 Q8N9Y2,IQ and ubiquitin-like domain-containing protein,, PF00240;, GO:0001669;GO:0031514;GO:0060271;GO:0007224;, C:acrosomal vesicle; C:motile cilium;, , P:cilium assembly; P:smoothened signaling pathway; scaffold8 indexed_genome mRNA 52496306 52506673 . - . ID=transcript_2313;Q16718 B2RD98 Q5H9R2 Q6IRX7,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,Complex I subunit B13;Complex I-13kD-B;NADH-ubiquinone oxidoreductase 13 kDa-B subunit;, PF04716;, GO:0005743;GO:0005747;GO:0008137;GO:0006120;GO:0032981;GO:0022904;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:respiratory electron transport chain; scaffold8 indexed_genome mRNA 52528098 52562152 . + . ID=transcript_2314;Q8WXK1 Q3ZCP3 Q3ZCP5 Q68D37,Ankyrin repeat and SOCS box protein 15,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; scaffold8 indexed_genome mRNA 52579409 52590028 . + . ID=transcript_2315;Q6P5Q4 A4D0W9 A4D0Y2 Q8WVJ8,Leiomodin-2,Cardiac leiomodin;Leiomodin {ECO:0000303|PubMed:18403713};, PF03250;, GO:0005884;GO:0005856;GO:0031430;GO:0030016;GO:0030017;GO:0005865;GO:0003779;GO:0003785;GO:0005523;GO:0007015;GO:0030041;GO:0045010;GO:0006936;GO:0030239;GO:0051694;GO:0030838;GO:0045214;, C:actin filament; C:cytoskeleton; C:M band; C:myofibril; C:sarcomere; C:striated muscle thin filament;, F:actin binding; F:actin monomer binding; F:tropomyosin binding;, P:actin filament organization; P:actin filament polymerization; P:actin nucleation; P:muscle contraction; P:myofibril assembly; P:pointed-end actin filament capping; P:positive regulation of actin filament polymerization; P:sarcomere organization;|Q6P5Q4 A4D0W9 A4D0Y2 Q8WVJ8,Leiomodin-2,Cardiac leiomodin;Leiomodin {ECO:0000303|PubMed:18403713};, PF03250;, GO:0005884;GO:0005856;GO:0031430;GO:0030016;GO:0030017;GO:0005865;GO:0003779;GO:0003785;GO:0005523;GO:0007015;GO:0030041;GO:0045010;GO:0006936;GO:0030239;GO:0051694;GO:0030838;GO:0045214;, C:actin filament; C:cytoskeleton; C:M band; C:myofibril; C:sarcomere; C:striated muscle thin filament;, F:actin binding; F:actin monomer binding; F:tropomyosin binding;, P:actin filament organization; P:actin filament polymerization; P:actin nucleation; P:muscle contraction; P:myofibril assembly; P:pointed-end actin filament capping; P:positive regulation of actin filament polymerization; P:sarcomere organization; scaffold8 indexed_genome mRNA 52612378 52624808 . - . ID=transcript_2316;O00401 A1JUI9 Q7Z746,Neural Wiskott-Aldrich syndrome protein {ECO:0000303|PubMed:16767080},, PF00786;PF00568;PF02205;, GO:0030478;GO:0015629;GO:0005884;GO:0031410;GO:0005829;GO:0030666;GO:0070062;GO:0030027;GO:0005634;GO:0005886;GO:0003779;GO:0030695;GO:0030041;GO:0030048;GO:0008154;GO:0051301;GO:0034629;GO:0060997;GO:0048013;GO:0038096;GO:0061024;GO:2000402;GO:1903526;GO:2000601;GO:2000370;GO:0051491;GO:0045944;GO:0065003;GO:0050999;GO:0032880;GO:0009617;GO:0051653;GO:0006900;GO:0016050;GO:0030050;, C:actin cap; C:actin cytoskeleton; C:actin filament; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:extracellular exosome; C:lamellipodium; C:nucleus; C:plasma membrane;, F:actin binding; F:GTPase regulator activity;, P:actin filament polymerization; P:actin filament-based movement; P:actin polymerization or depolymerization; P:cell division; P:cellular protein-containing complex localization; P:dendritic spine morphogenesis; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:negative regulation of lymphocyte migration; P:negative regulation of membrane tubulation; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of filopodium assembly; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of nitric-oxide synthase activity; P:regulation of protein localization; P:response to bacterium; P:spindle localization; P:vesicle budding from membrane; P:vesicle organization; P:vesicle transport along actin filament; scaffold8 indexed_genome mRNA 52628371 52685567 . - . ID=transcript_2317;O00401 A1JUI9 Q7Z746,Neural Wiskott-Aldrich syndrome protein {ECO:0000303|PubMed:16767080},, PF00786;PF00568;PF02205;, GO:0030478;GO:0015629;GO:0005884;GO:0031410;GO:0005829;GO:0030666;GO:0070062;GO:0030027;GO:0005634;GO:0005886;GO:0003779;GO:0030695;GO:0030041;GO:0030048;GO:0008154;GO:0051301;GO:0034629;GO:0060997;GO:0048013;GO:0038096;GO:0061024;GO:2000402;GO:1903526;GO:2000601;GO:2000370;GO:0051491;GO:0045944;GO:0065003;GO:0050999;GO:0032880;GO:0009617;GO:0051653;GO:0006900;GO:0016050;GO:0030050;, C:actin cap; C:actin cytoskeleton; C:actin filament; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:extracellular exosome; C:lamellipodium; C:nucleus; C:plasma membrane;, F:actin binding; F:GTPase regulator activity;, P:actin filament polymerization; P:actin filament-based movement; P:actin polymerization or depolymerization; P:cell division; P:cellular protein-containing complex localization; P:dendritic spine morphogenesis; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:negative regulation of lymphocyte migration; P:negative regulation of membrane tubulation; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of filopodium assembly; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of nitric-oxide synthase activity; P:regulation of protein localization; P:response to bacterium; P:spindle localization; P:vesicle budding from membrane; P:vesicle organization; P:vesicle transport along actin filament; scaffold8 indexed_genome mRNA 52809013 52838950 . - . ID=transcript_2318;O00401 A1JUI9 Q7Z746,Neural Wiskott-Aldrich syndrome protein {ECO:0000303|PubMed:16767080},, PF00786;PF00568;PF02205;, GO:0030478;GO:0015629;GO:0005884;GO:0031410;GO:0005829;GO:0030666;GO:0070062;GO:0030027;GO:0005634;GO:0005886;GO:0003779;GO:0030695;GO:0030041;GO:0030048;GO:0008154;GO:0051301;GO:0034629;GO:0060997;GO:0048013;GO:0038096;GO:0061024;GO:2000402;GO:1903526;GO:2000601;GO:2000370;GO:0051491;GO:0045944;GO:0065003;GO:0050999;GO:0032880;GO:0009617;GO:0051653;GO:0006900;GO:0016050;GO:0030050;, C:actin cap; C:actin cytoskeleton; C:actin filament; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:extracellular exosome; C:lamellipodium; C:nucleus; C:plasma membrane;, F:actin binding; F:GTPase regulator activity;, P:actin filament polymerization; P:actin filament-based movement; P:actin polymerization or depolymerization; P:cell division; P:cellular protein-containing complex localization; P:dendritic spine morphogenesis; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:negative regulation of lymphocyte migration; P:negative regulation of membrane tubulation; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of filopodium assembly; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of nitric-oxide synthase activity; P:regulation of protein localization; P:response to bacterium; P:spindle localization; P:vesicle budding from membrane; P:vesicle organization; P:vesicle transport along actin filament; scaffold8 indexed_genome mRNA 53570859 53588582 . - . ID=transcript_2319;O15354 A4D0Y6 O00348 O14768 Q8TD39,Prosaposin receptor GPR37,Endothelin B receptor-like protein 1;G-protein coupled receptor 37;Parkin-associated endothelin receptor-like receptor;, PF00001;, GO:0009986;GO:0005737;GO:0005783;GO:0005789;GO:0005887;GO:0005886;GO:0043235;GO:0000151;GO:0008528;GO:0004930;GO:0031072;GO:0030544;GO:0042923;GO:0008188;GO:0042277;GO:0036505;GO:0031625;GO:0007193;GO:0042416;GO:0007186;GO:0031987;GO:1903206;GO:0007218;GO:0045964;GO:0043410;, C:cell surface; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:ubiquitin ligase complex;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:heat shock protein binding; F:Hsp70 protein binding; F:neuropeptide binding; F:neuropeptide receptor activity; F:peptide binding; F:prosaposin receptor activity; F:ubiquitin protein ligase binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:dopamine biosynthetic process; P:G protein-coupled receptor signaling pathway; P:locomotion involved in locomotory behavior; P:negative regulation of hydrogen peroxide-induced cell death; P:neuropeptide signaling pathway; P:positive regulation of dopamine metabolic process; P:positive regulation of MAPK cascade;|O15354 A4D0Y6 O00348 O14768 Q8TD39,Prosaposin receptor GPR37,Endothelin B receptor-like protein 1;G-protein coupled receptor 37;Parkin-associated endothelin receptor-like receptor;, PF00001;, GO:0009986;GO:0005737;GO:0005783;GO:0005789;GO:0005887;GO:0005886;GO:0043235;GO:0000151;GO:0008528;GO:0004930;GO:0031072;GO:0030544;GO:0042923;GO:0008188;GO:0042277;GO:0036505;GO:0031625;GO:0007193;GO:0042416;GO:0007186;GO:0031987;GO:1903206;GO:0007218;GO:0045964;GO:0043410;, C:cell surface; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:ubiquitin ligase complex;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:heat shock protein binding; F:Hsp70 protein binding; F:neuropeptide binding; F:neuropeptide receptor activity; F:peptide binding; F:prosaposin receptor activity; F:ubiquitin protein ligase binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:dopamine biosynthetic process; P:G protein-coupled receptor signaling pathway; P:locomotion involved in locomotory behavior; P:negative regulation of hydrogen peroxide-induced cell death; P:neuropeptide signaling pathway; P:positive regulation of dopamine metabolic process; P:positive regulation of MAPK cascade; scaffold8 indexed_genome mRNA 53637694 53727323 . - . ID=transcript_2320;Q9NUX5 O95018 Q5MJ36 Q9H662 Q9NW19 Q9UG95,Protection of telomeres protein 1,POT1-like telomere end-binding protein;, PF02765;PF16686;, GO:0000781;GO:0000783;GO:0005654;GO:0070187;GO:1905773;GO:0017151;GO:1990955;GO:0098505;GO:0043047;GO:0010521;GO:0061821;GO:0042162;GO:0045007;GO:0032508;GO:0070200;GO:0048239;GO:0051974;GO:0032211;GO:1905776;GO:0060383;GO:0051096;GO:1900051;GO:0051973;GO:0032212;GO:1905774;GO:2001032;GO:0032210;GO:0032202;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0061820;, C:chromosome, telomeric region; C:nuclear telomere cap complex; C:nucleoplasm; C:shelterin complex;, F:8-hydroxy-2'-deoxyguanosine DNA binding; F:DEAD/H-box RNA helicase binding; F:G-rich single-stranded DNA binding; F:G-rich strand telomeric DNA binding; F:single-stranded telomeric DNA binding; F:telomerase inhibitor activity; F:telomeric D-loop binding; F:telomeric DNA binding;, P:depurination; P:DNA duplex unwinding; P:establishment of protein localization to telomere; P:negative regulation of DNA recombination at telomere; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA helicase activity; P:positive regulation of DNA strand elongation; P:positive regulation of helicase activity; P:positive regulation of histone exchange; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:regulation of DNA helicase activity; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of telomere maintenance via telomerase; P:telomere assembly; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomeric D-loop disassembly;|Q9NUX5 O95018 Q5MJ36 Q9H662 Q9NW19 Q9UG95,Protection of telomeres protein 1,POT1-like telomere end-binding protein;, PF02765;PF16686;, GO:0000781;GO:0000783;GO:0005654;GO:0070187;GO:1905773;GO:0017151;GO:1990955;GO:0098505;GO:0043047;GO:0010521;GO:0061821;GO:0042162;GO:0045007;GO:0032508;GO:0070200;GO:0048239;GO:0051974;GO:0032211;GO:1905776;GO:0060383;GO:0051096;GO:1900051;GO:0051973;GO:0032212;GO:1905774;GO:2001032;GO:0032210;GO:0032202;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0061820;, C:chromosome, telomeric region; C:nuclear telomere cap complex; C:nucleoplasm; C:shelterin complex;, F:8-hydroxy-2'-deoxyguanosine DNA binding; F:DEAD/H-box RNA helicase binding; F:G-rich single-stranded DNA binding; F:G-rich strand telomeric DNA binding; F:single-stranded telomeric DNA binding; F:telomerase inhibitor activity; F:telomeric D-loop binding; F:telomeric DNA binding;, P:depurination; P:DNA duplex unwinding; P:establishment of protein localization to telomere; P:negative regulation of DNA recombination at telomere; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA helicase activity; P:positive regulation of DNA strand elongation; P:positive regulation of helicase activity; P:positive regulation of histone exchange; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:regulation of DNA helicase activity; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of telomere maintenance via telomerase; P:telomere assembly; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomeric D-loop disassembly; scaffold8 indexed_genome mRNA 55075879 55083364 . - . ID=transcript_2321;Q6J165,Metabotropic glutamate receptor 8,, PF00003;PF01094;PF07562;, GO:0005887;GO:0005886;GO:0001640;GO:0004930;GO:0008066;GO:0001642;GO:0007196;GO:0007193;GO:0007216;GO:0007186;GO:0051966;GO:0007601;, C:integral component of plasma membrane; C:plasma membrane;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled receptor activity; F:glutamate receptor activity; F:group III metabotropic glutamate receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, glutamatergic; P:visual perception; scaffold8 indexed_genome mRNA 55967510 55971263 . - . ID=transcript_2322;Q2TB10 Q9HBN0,Zinc finger protein 800,, PF00096;PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding; scaffold8 indexed_genome mRNA 55996623 55999744 . - . ID=transcript_2323;Q2TB10 Q9HBN0,Zinc finger protein 800,, PF00096;PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding; scaffold8 indexed_genome mRNA 56197111 56201029 . - . ID=transcript_2324;Q96CN9 Q9H6N7,GRIP and coiled-coil domain-containing protein 1,Golgi coiled-coil protein 1;, PF01465;, GO:0005829;GO:0005794;GO:0000139;GO:0000138;GO:0031267;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:Golgi trans cisterna;, F:small GTPase binding; scaffold8 indexed_genome mRNA 56204404 56207619 . + . ID=transcript_2325;P84085 P26437,ADP-ribosylation factor 5,, PF00025;, GO:0070062;GO:0005794;GO:0048471;GO:0005886;GO:0005525;GO:0003924;GO:0006886;GO:0006890;GO:0016192;, C:extracellular exosome; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport;|P84085 P26437,ADP-ribosylation factor 5,, PF00025;, GO:0070062;GO:0005794;GO:0048471;GO:0005886;GO:0005525;GO:0003924;GO:0006886;GO:0006890;GO:0016192;, C:extracellular exosome; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport; scaffold8 indexed_genome mRNA 56256159 56439946 . + . ID=transcript_2326;Q7KZF4 Q13122 Q96AG0,Staphylococcal nuclease domain-containing protein 1,100 kDa coactivator;EBNA2 coactivator p100;Tudor domain-containing protein 11;p100 co-activator;, PF00565;PF00567;, GO:0005737;GO:0005829;GO:0097433;GO:0070062;GO:0042470;GO:0016020;GO:0005634;GO:0016442;GO:0045296;GO:0004519;GO:0004521;GO:0004518;GO:1905172;GO:0003723;GO:0003712;GO:0031047;GO:0010587;GO:0001649;GO:0010564;GO:0006401;GO:0016032;, C:cytoplasm; C:cytosol; C:dense body; C:extracellular exosome; C:melanosome; C:membrane; C:nucleus; C:RISC complex;, F:cadherin binding; F:endonuclease activity; F:endoribonuclease activity; F:nuclease activity; F:RISC complex binding; F:RNA binding; F:transcription coregulator activity;, P:gene silencing by RNA; P:miRNA catabolic process; P:osteoblast differentiation; P:regulation of cell cycle process; P:RNA catabolic process; P:viral process; scaffold8 indexed_genome mRNA 56570190 56570896 . + . ID=transcript_2327;Q7KZF4 Q13122 Q96AG0,Staphylococcal nuclease domain-containing protein 1,100 kDa coactivator;EBNA2 coactivator p100;Tudor domain-containing protein 11;p100 co-activator;, PF00565;PF00567;, GO:0005737;GO:0005829;GO:0097433;GO:0070062;GO:0042470;GO:0016020;GO:0005634;GO:0016442;GO:0045296;GO:0004519;GO:0004521;GO:0004518;GO:1905172;GO:0003723;GO:0003712;GO:0031047;GO:0010587;GO:0001649;GO:0010564;GO:0006401;GO:0016032;, C:cytoplasm; C:cytosol; C:dense body; C:extracellular exosome; C:melanosome; C:membrane; C:nucleus; C:RISC complex;, F:cadherin binding; F:endonuclease activity; F:endoribonuclease activity; F:nuclease activity; F:RISC complex binding; F:RNA binding; F:transcription coregulator activity;, P:gene silencing by RNA; P:miRNA catabolic process; P:osteoblast differentiation; P:regulation of cell cycle process; P:RNA catabolic process; P:viral process; scaffold8 indexed_genome mRNA 56603963 56607703 . - . ID=transcript_2328;Q9HBW1 A4D0Y9 Q14DU9 Q6ZMI8 Q96A85,Leucine-rich repeat-containing protein 4,Brain tumor-associated protein BAG;Nasopharyngeal carcinoma-associated gene 14 protein;Netrin-G2 ligand;, PF07679;PF13855;, GO:0043197;GO:0060076;GO:0098978;GO:0099061;GO:0098685;GO:1904861;GO:0050804;GO:0097119;GO:0099560;, C:dendritic spine; C:excitatory synapse; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:Schaffer collateral - CA1 synapse;, , P:excitatory synapse assembly; P:modulation of chemical synaptic transmission; P:postsynaptic density protein 95 clustering; P:synaptic membrane adhesion; scaffold8 indexed_genome mRNA 56658407 56672609 . + . ID=transcript_2329;Q7KZF4 Q13122 Q96AG0,Staphylococcal nuclease domain-containing protein 1,100 kDa coactivator;EBNA2 coactivator p100;Tudor domain-containing protein 11;p100 co-activator;, PF00565;PF00567;, GO:0005737;GO:0005829;GO:0097433;GO:0070062;GO:0042470;GO:0016020;GO:0005634;GO:0016442;GO:0045296;GO:0004519;GO:0004521;GO:0004518;GO:1905172;GO:0003723;GO:0003712;GO:0031047;GO:0010587;GO:0001649;GO:0010564;GO:0006401;GO:0016032;, C:cytoplasm; C:cytosol; C:dense body; C:extracellular exosome; C:melanosome; C:membrane; C:nucleus; C:RISC complex;, F:cadherin binding; F:endonuclease activity; F:endoribonuclease activity; F:nuclease activity; F:RISC complex binding; F:RNA binding; F:transcription coregulator activity;, P:gene silencing by RNA; P:miRNA catabolic process; P:osteoblast differentiation; P:regulation of cell cycle process; P:RNA catabolic process; P:viral process;|Q7KZF4 Q13122 Q96AG0,Staphylococcal nuclease domain-containing protein 1,100 kDa coactivator;EBNA2 coactivator p100;Tudor domain-containing protein 11;p100 co-activator;, PF00565;PF00567;, GO:0005737;GO:0005829;GO:0097433;GO:0070062;GO:0042470;GO:0016020;GO:0005634;GO:0016442;GO:0045296;GO:0004519;GO:0004521;GO:0004518;GO:1905172;GO:0003723;GO:0003712;GO:0031047;GO:0010587;GO:0001649;GO:0010564;GO:0006401;GO:0016032;, C:cytoplasm; C:cytosol; C:dense body; C:extracellular exosome; C:melanosome; C:membrane; C:nucleus; C:RISC complex;, F:cadherin binding; F:endonuclease activity; F:endoribonuclease activity; F:nuclease activity; F:RISC complex binding; F:RNA binding; F:transcription coregulator activity;, P:gene silencing by RNA; P:miRNA catabolic process; P:osteoblast differentiation; P:regulation of cell cycle process; P:RNA catabolic process; P:viral process;|Q7KZF4 Q13122 Q96AG0,Staphylococcal nuclease domain-containing protein 1,100 kDa coactivator;EBNA2 coactivator p100;Tudor domain-containing protein 11;p100 co-activator;, PF00565;PF00567;, GO:0005737;GO:0005829;GO:0097433;GO:0070062;GO:0042470;GO:0016020;GO:0005634;GO:0016442;GO:0045296;GO:0004519;GO:0004521;GO:0004518;GO:1905172;GO:0003723;GO:0003712;GO:0031047;GO:0010587;GO:0001649;GO:0010564;GO:0006401;GO:0016032;, C:cytoplasm; C:cytosol; C:dense body; C:extracellular exosome; C:melanosome; C:membrane; C:nucleus; C:RISC complex;, F:cadherin binding; F:endonuclease activity; F:endoribonuclease activity; F:nuclease activity; F:RISC complex binding; F:RNA binding; F:transcription coregulator activity;, P:gene silencing by RNA; P:miRNA catabolic process; P:osteoblast differentiation; P:regulation of cell cycle process; P:RNA catabolic process; P:viral process; scaffold8 indexed_genome mRNA 56870932 56904064 . - . ID=transcript_2330;Q9NW13 A4D100 B4DU52 E9PDD9 Q53H65 Q96CV3,RNA-binding protein 28,RNA-binding motif protein 28;, PF00076;, GO:0005730;GO:0005681;GO:0003723;GO:0006397;GO:0008380;, C:nucleolus; C:spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:RNA splicing; scaffold8 indexed_genome mRNA 56943679 56947045 . - . ID=transcript_2331;J3KNX8 Q8N194 Q96NU2,Inosine-5'-monophosphate dehydrogenase 1 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-I;, PF00571;PF00478;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0003677;GO:0042802;GO:0003938;GO:0046872;GO:0003676;GO:0000166;GO:0003723;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:identical protein binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleic acid binding; F:nucleotide binding; F:RNA binding;, P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process;|J3KNX8 Q8N194 Q96NU2,Inosine-5'-monophosphate dehydrogenase 1 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-I;, PF00571;PF00478;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0003677;GO:0042802;GO:0003938;GO:0046872;GO:0003676;GO:0000166;GO:0003723;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:identical protein binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleic acid binding; F:nucleotide binding; F:RNA binding;, P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process;|J3KNX8 Q8N194 Q96NU2,Inosine-5'-monophosphate dehydrogenase 1 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-I;, PF00571;PF00478;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0003677;GO:0042802;GO:0003938;GO:0046872;GO:0003676;GO:0000166;GO:0003723;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:identical protein binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleic acid binding; F:nucleotide binding; F:RNA binding;, P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process;|J3KNX8 Q8N194 Q96NU2,Inosine-5'-monophosphate dehydrogenase 1 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-I;, PF00571;PF00478;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0003677;GO:0042802;GO:0003938;GO:0046872;GO:0003676;GO:0000166;GO:0003723;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:identical protein binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleic acid binding; F:nucleotide binding; F:RNA binding;, P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process; scaffold8 indexed_genome mRNA 56947115 56948787 . + . ID=transcript_2332;J3KNX8 Q8N194 Q96NU2,Inosine-5'-monophosphate dehydrogenase 1 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-I;, PF00571;PF00478;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0003677;GO:0042802;GO:0003938;GO:0046872;GO:0003676;GO:0000166;GO:0003723;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:identical protein binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleic acid binding; F:nucleotide binding; F:RNA binding;, P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process;|J3KNX8 Q8N194 Q96NU2,Inosine-5'-monophosphate dehydrogenase 1 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-I;, PF00571;PF00478;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0003677;GO:0042802;GO:0003938;GO:0046872;GO:0003676;GO:0000166;GO:0003723;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:identical protein binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleic acid binding; F:nucleotide binding; F:RNA binding;, P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process; scaffold8 indexed_genome mRNA 56949669 56952031 . + . ID=transcript_2333;J3KNX8 Q8N194 Q96NU2,Inosine-5'-monophosphate dehydrogenase 1 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-I;, PF00571;PF00478;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0003677;GO:0042802;GO:0003938;GO:0046872;GO:0003676;GO:0000166;GO:0003723;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:identical protein binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleic acid binding; F:nucleotide binding; F:RNA binding;, P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process; scaffold8 indexed_genome mRNA 57003019 57005062 . + . ID=transcript_2334;Q9Y5L2 A4D0Z5 Q52LY5 Q53HJ7,Hypoxia-inducible lipid droplet-associated protein,Hypoxia-inducible gene 2 protein;, PF15220;, GO:0009986;GO:0005829;GO:0005615;GO:0016021;GO:0005811;GO:0005654;GO:0030141;GO:0005102;GO:0035425;GO:0071456;GO:0034389;GO:0008284;GO:0001819;GO:0010884;, C:cell surface; C:cytosol; C:extracellular space; C:integral component of membrane; C:lipid droplet; C:nucleoplasm; C:secretory granule;, F:signaling receptor binding;, P:autocrine signaling; P:cellular response to hypoxia; P:lipid droplet organization; P:positive regulation of cell population proliferation; P:positive regulation of cytokine production; P:positive regulation of lipid storage; scaffold8 indexed_genome mRNA 57058243 57059167 . - . ID=transcript_2335;Q96KD3 Q8IY75 Q8NA48,Protein FAM71F1,Protein FAM137A;Testis development protein NYD-SP18;, PF12480; scaffold8 indexed_genome mRNA 57081858 57082465 . + . ID=transcript_2336;Q96RL3 Q9NR43,Calumenin,Crocalbin;IEF SSP 9302;, PF13202;PF13833;, GO:0005783;GO:0005788;GO:0005789;GO:0005576;GO:0005794;GO:0042470;GO:0016020;GO:0033018;GO:0005509;GO:0044267;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:melanosome; C:membrane; C:sarcoplasmic reticulum lumen;, F:calcium ion binding;, P:cellular protein metabolic process; P:post-translational protein modification; scaffold8 indexed_genome mRNA 57086306 57086915 . - . ID=transcript_2337;Q96RL3 Q9NR43,Calumenin,Crocalbin;IEF SSP 9302;, PF13202;PF13833;, GO:0005783;GO:0005788;GO:0005789;GO:0005576;GO:0005794;GO:0042470;GO:0016020;GO:0033018;GO:0005509;GO:0044267;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:melanosome; C:membrane; C:sarcoplasmic reticulum lumen;, F:calcium ion binding;, P:cellular protein metabolic process; P:post-translational protein modification; scaffold8 indexed_genome mRNA 57087170 57087701 . + . ID=transcript_2338;Q96RL3 Q9NR43,Calumenin,Crocalbin;IEF SSP 9302;, PF13202;PF13833;, GO:0005783;GO:0005788;GO:0005789;GO:0005576;GO:0005794;GO:0042470;GO:0016020;GO:0033018;GO:0005509;GO:0044267;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:melanosome; C:membrane; C:sarcoplasmic reticulum lumen;, F:calcium ion binding;, P:cellular protein metabolic process; P:post-translational protein modification; scaffold8 indexed_genome mRNA 57090000 57097301 . - . ID=transcript_2339;Q96RL3 Q9NR43,Calumenin,Crocalbin;IEF SSP 9302;, PF13202;PF13833;, GO:0005783;GO:0005788;GO:0005789;GO:0005576;GO:0005794;GO:0042470;GO:0016020;GO:0033018;GO:0005509;GO:0044267;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:melanosome; C:membrane; C:sarcoplasmic reticulum lumen;, F:calcium ion binding;, P:cellular protein metabolic process; P:post-translational protein modification;|Q96RL3 Q9NR43,Calumenin,Crocalbin;IEF SSP 9302;, PF13202;PF13833;, GO:0005783;GO:0005788;GO:0005789;GO:0005576;GO:0005794;GO:0042470;GO:0016020;GO:0033018;GO:0005509;GO:0044267;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:melanosome; C:membrane; C:sarcoplasmic reticulum lumen;, F:calcium ion binding;, P:cellular protein metabolic process; P:post-translational protein modification;|Q96RL3 Q9NR43,Calumenin,Crocalbin;IEF SSP 9302;, PF13202;PF13833;, GO:0005783;GO:0005788;GO:0005789;GO:0005576;GO:0005794;GO:0042470;GO:0016020;GO:0033018;GO:0005509;GO:0044267;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:melanosome; C:membrane; C:sarcoplasmic reticulum lumen;, F:calcium ion binding;, P:cellular protein metabolic process; P:post-translational protein modification; scaffold8 indexed_genome mRNA 57119096 57145929 . + . ID=transcript_2340;Q96JN2 A4D1K1 A7MCY7 A8MYA7 Q6ZVK7 Q9H8M3 Q9UFE1,Coiled-coil domain-containing protein 136,Nasopharyngeal carcinoma-associated gene 6 protein;, , GO:0002080;GO:0016021;GO:0001675;GO:0007338;GO:0007283;, C:acrosomal membrane; C:integral component of membrane;, , P:acrosome assembly; P:single fertilization; P:spermatogenesis;|Q96JN2 A4D1K1 A7MCY7 A8MYA7 Q6ZVK7 Q9H8M3 Q9UFE1,Coiled-coil domain-containing protein 136,Nasopharyngeal carcinoma-associated gene 6 protein;, , GO:0002080;GO:0016021;GO:0001675;GO:0007338;GO:0007283;, C:acrosomal membrane; C:integral component of membrane;, , P:acrosome assembly; P:single fertilization; P:spermatogenesis;|Q96JN2 A4D1K1 A7MCY7 A8MYA7 Q6ZVK7 Q9H8M3 Q9UFE1,Coiled-coil domain-containing protein 136,Nasopharyngeal carcinoma-associated gene 6 protein;, , GO:0002080;GO:0016021;GO:0001675;GO:0007338;GO:0007283;, C:acrosomal membrane; C:integral component of membrane;, , P:acrosome assembly; P:single fertilization; P:spermatogenesis; scaffold8 indexed_genome mRNA 57157197 57185186 . + . ID=transcript_2341;Q14315 B2ZZ88 O95303 Q07985 Q9NS12 Q9NYE5 Q9UMR8 Q9Y503,Filamin-C,ABP-280-like protein;ABP-L;Actin-binding-like protein;Filamin-2;Gamma-filamin;, PF00307;PF00630;, GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0005886;GO:0042383;GO:0016528;GO:0030018;GO:0003779;GO:0030506;GO:0008092;GO:0042802;GO:0034329;GO:0048747;, C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:plasma membrane; C:sarcolemma; C:sarcoplasm; C:Z disc;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein binding; F:identical protein binding;, P:cell junction assembly; P:muscle fiber development;|Q14315 B2ZZ88 O95303 Q07985 Q9NS12 Q9NYE5 Q9UMR8 Q9Y503,Filamin-C,ABP-280-like protein;ABP-L;Actin-binding-like protein;Filamin-2;Gamma-filamin;, PF00307;PF00630;, GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0005886;GO:0042383;GO:0016528;GO:0030018;GO:0003779;GO:0030506;GO:0008092;GO:0042802;GO:0034329;GO:0048747;, C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:plasma membrane; C:sarcolemma; C:sarcoplasm; C:Z disc;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein binding; F:identical protein binding;, P:cell junction assembly; P:muscle fiber development;|Q14315 B2ZZ88 O95303 Q07985 Q9NS12 Q9NYE5 Q9UMR8 Q9Y503,Filamin-C,ABP-280-like protein;ABP-L;Actin-binding-like protein;Filamin-2;Gamma-filamin;, PF00307;PF00630;, GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0005886;GO:0042383;GO:0016528;GO:0030018;GO:0003779;GO:0030506;GO:0008092;GO:0042802;GO:0034329;GO:0048747;, C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:plasma membrane; C:sarcolemma; C:sarcoplasm; C:Z disc;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein binding; F:identical protein binding;, P:cell junction assembly; P:muscle fiber development;|Q14315 B2ZZ88 O95303 Q07985 Q9NS12 Q9NYE5 Q9UMR8 Q9Y503,Filamin-C,ABP-280-like protein;ABP-L;Actin-binding-like protein;Filamin-2;Gamma-filamin;, PF00307;PF00630;, GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0005886;GO:0042383;GO:0016528;GO:0030018;GO:0003779;GO:0030506;GO:0008092;GO:0042802;GO:0034329;GO:0048747;, C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:plasma membrane; C:sarcolemma; C:sarcoplasm; C:Z disc;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein binding; F:identical protein binding;, P:cell junction assembly; P:muscle fiber development;|Q14315 B2ZZ88 O95303 Q07985 Q9NS12 Q9NYE5 Q9UMR8 Q9Y503,Filamin-C,ABP-280-like protein;ABP-L;Actin-binding-like protein;Filamin-2;Gamma-filamin;, PF00307;PF00630;, GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0005886;GO:0042383;GO:0016528;GO:0030018;GO:0003779;GO:0030506;GO:0008092;GO:0042802;GO:0034329;GO:0048747;, C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:plasma membrane; C:sarcolemma; C:sarcoplasm; C:Z disc;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein binding; F:identical protein binding;, P:cell junction assembly; P:muscle fiber development;|Q14315 B2ZZ88 O95303 Q07985 Q9NS12 Q9NYE5 Q9UMR8 Q9Y503,Filamin-C,ABP-280-like protein;ABP-L;Actin-binding-like protein;Filamin-2;Gamma-filamin;, PF00307;PF00630;, GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0005886;GO:0042383;GO:0016528;GO:0030018;GO:0003779;GO:0030506;GO:0008092;GO:0042802;GO:0034329;GO:0048747;, C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:plasma membrane; C:sarcolemma; C:sarcoplasm; C:Z disc;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein binding; F:identical protein binding;, P:cell junction assembly; P:muscle fiber development;|Q14315 B2ZZ88 O95303 Q07985 Q9NS12 Q9NYE5 Q9UMR8 Q9Y503,Filamin-C,ABP-280-like protein;ABP-L;Actin-binding-like protein;Filamin-2;Gamma-filamin;, PF00307;PF00630;, GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0005886;GO:0042383;GO:0016528;GO:0030018;GO:0003779;GO:0030506;GO:0008092;GO:0042802;GO:0034329;GO:0048747;, C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:plasma membrane; C:sarcolemma; C:sarcoplasm; C:Z disc;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein binding; F:identical protein binding;, P:cell junction assembly; P:muscle fiber development;|Q14315 B2ZZ88 O95303 Q07985 Q9NS12 Q9NYE5 Q9UMR8 Q9Y503,Filamin-C,ABP-280-like protein;ABP-L;Actin-binding-like protein;Filamin-2;Gamma-filamin;, PF00307;PF00630;, GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0005886;GO:0042383;GO:0016528;GO:0030018;GO:0003779;GO:0030506;GO:0008092;GO:0042802;GO:0034329;GO:0048747;, C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:plasma membrane; C:sarcolemma; C:sarcoplasm; C:Z disc;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein binding; F:identical protein binding;, P:cell junction assembly; P:muscle fiber development; scaffold8 indexed_genome mRNA 57188134 57201343 . + . ID=transcript_2342;Q16864 C9J2K4 Q6IBA8,V-type proton ATPase subunit F,V-ATPase 14 kDa subunit;Vacuolar proton pump subunit F;, PF01990;, GO:0005829;GO:0070062;GO:0016020;GO:0016469;GO:0033180;GO:0016471;GO:0016887;GO:0042625;GO:0015078;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0033572;, C:cytosol; C:extracellular exosome; C:membrane; C:proton-transporting two-sector ATPase complex; C:proton-transporting V-type ATPase, V1 domain; C:vacuolar proton-transporting V-type ATPase complex;, F:ATPase activity; F:ATPase-coupled ion transmembrane transporter activity; F:proton transmembrane transporter activity; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:transferrin transport; scaffold8 indexed_genome mRNA 57263277 57269147 . + . ID=transcript_2343;Q64GB2 Q6RCM8 Q9BQF0,Interferon regulatory factor 5 {ECO:0000303|PubMed:11303025},, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0019901;GO:0000978;GO:0043565;GO:1990837;GO:0019221;GO:0051607;GO:0002376;GO:0006954;GO:0045087;GO:0060333;GO:0043065;GO:0032727;GO:0032728;GO:0032735;GO:0045944;GO:0032481;GO:0006357;GO:0032495;GO:0032494;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cytokine-mediated signaling pathway; P:defense response to virus; P:immune system process; P:inflammatory response; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-12 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:response to muramyl dipeptide; P:response to peptidoglycan; P:type I interferon signaling pathway;|Q64GB2 Q6RCM8 Q9BQF0,Interferon regulatory factor 5 {ECO:0000303|PubMed:11303025},, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0019901;GO:0000978;GO:0043565;GO:1990837;GO:0019221;GO:0051607;GO:0002376;GO:0006954;GO:0045087;GO:0060333;GO:0043065;GO:0032727;GO:0032728;GO:0032735;GO:0045944;GO:0032481;GO:0006357;GO:0032495;GO:0032494;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cytokine-mediated signaling pathway; P:defense response to virus; P:immune system process; P:inflammatory response; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-12 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:response to muramyl dipeptide; P:response to peptidoglycan; P:type I interferon signaling pathway; scaffold8 indexed_genome mRNA 57275218 57350632 . - . ID=transcript_2344;Q9Y5L0 A4D1K9 C9IZM0 Q6NUM1 Q96G71 Q96GU9 Q9Y3R2,Transportin-3 {ECO:0000303|PubMed:23667635},Importin-12;Transportin-SR {ECO:0000303|PubMed:10366588, ECO:0000303|PubMed:18722123};, PF08389;, GO:0005642;GO:0005737;GO:0043231;GO:0005635;GO:0042802;GO:0061608;GO:0031267;GO:0006606;, C:annulate lamellae; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear envelope;, F:identical protein binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus;|Q9Y5L0 A4D1K9 C9IZM0 Q6NUM1 Q96G71 Q96GU9 Q9Y3R2,Transportin-3 {ECO:0000303|PubMed:23667635},Importin-12;Transportin-SR {ECO:0000303|PubMed:10366588, ECO:0000303|PubMed:18722123};, PF08389;, GO:0005642;GO:0005737;GO:0043231;GO:0005635;GO:0042802;GO:0061608;GO:0031267;GO:0006606;, C:annulate lamellae; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear envelope;, F:identical protein binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus;|Q9Y5L0 A4D1K9 C9IZM0 Q6NUM1 Q96G71 Q96GU9 Q9Y3R2,Transportin-3 {ECO:0000303|PubMed:23667635},Importin-12;Transportin-SR {ECO:0000303|PubMed:10366588, ECO:0000303|PubMed:18722123};, PF08389;, GO:0005642;GO:0005737;GO:0043231;GO:0005635;GO:0042802;GO:0061608;GO:0031267;GO:0006606;, C:annulate lamellae; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear envelope;, F:identical protein binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus; scaffold8 indexed_genome mRNA 57426094 57445899 . + . ID=transcript_2345;Q86UF1,Tetraspanin-33,Penumbra;Proerythroblast new membrane;, PF00335;, GO:0005912;GO:0009986;GO:0005788;GO:0005887;GO:0005886;GO:0046930;GO:0097197;GO:0019899;GO:1990000;GO:0046931;GO:0072659;GO:0051604;, C:adherens junction; C:cell surface; C:endoplasmic reticulum lumen; C:integral component of plasma membrane; C:plasma membrane; C:pore complex; C:tetraspanin-enriched microdomain;, F:enzyme binding;, P:amyloid fibril formation; P:pore complex assembly; P:protein localization to plasma membrane; P:protein maturation; scaffold8 indexed_genome mRNA 57466507 57485017 . + . ID=transcript_2346;Q99835 A4D1K5,Smoothened homolog,Protein Gx;, PF01534;PF01392;, GO:0097731;GO:0060170;GO:0097542;GO:0005929;GO:0030425;GO:0030666;GO:0070062;GO:0016021;GO:0043231;GO:0005886;GO:0004930;GO:0005113;GO:0009952;GO:0048143;GO:0060413;GO:0001708;GO:0071397;GO:0007417;GO:0021953;GO:0021696;GO:0021987;GO:0071679;GO:0060242;GO:0021542;GO:0003140;GO:0021904;GO:0060684;GO:0048853;GO:0031069;GO:0001947;GO:0048873;GO:0001701;GO:0070986;GO:0060644;GO:0072285;GO:0007494;GO:0035264;GO:0051451;GO:0043066;GO:0043392;GO:0030857;GO:0010629;GO:0051799;GO:0000122;GO:0001755;GO:0042475;GO:0001649;GO:0061113;GO:0090190;GO:0030335;GO:0050679;GO:0010628;GO:0007228;GO:0002053;GO:0040018;GO:0002052;GO:0046622;GO:0042307;GO:0045880;GO:0045944;GO:0034504;GO:0050821;GO:2000826;GO:2000036;GO:0048741;GO:0048745;GO:0007224;GO:0021938;GO:0021910;GO:0061053;GO:0021794;GO:0003323;GO:0001570;GO:0007371;, C:9+0 non-motile cilium; C:ciliary membrane; C:ciliary tip; C:cilium; C:dendrite; C:endocytic vesicle membrane; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:G protein-coupled receptor activity; F:patched binding;, P:anterior/posterior pattern specification; P:astrocyte activation; P:atrial septum morphogenesis; P:cell fate specification; P:cellular response to cholesterol; P:central nervous system development; P:central nervous system neuron differentiation; P:cerebellar cortex morphogenesis; P:cerebral cortex development; P:commissural neuron axon guidance; P:contact inhibition; P:dentate gyrus development; P:determination of left/right asymmetry in lateral mesoderm; P:dorsal/ventral neural tube patterning; P:epithelial-mesenchymal cell signaling; P:forebrain morphogenesis; P:hair follicle morphogenesis; P:heart looping; P:homeostasis of number of cells within a tissue; P:in utero embryonic development; P:left/right axis specification; P:mammary gland epithelial cell differentiation; P:mesenchymal to epithelial transition involved in metanephric renal vesicle formation; P:midgut development; P:multicellular organism growth; P:myoblast migration; P:negative regulation of apoptotic process; P:negative regulation of DNA binding; P:negative regulation of epithelial cell differentiation; P:negative regulation of gene expression; P:negative regulation of hair follicle development; P:negative regulation of transcription by RNA polymerase II; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:pancreas morphogenesis; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cell migration; P:positive regulation of epithelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of hh target transcription factor activity; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of multicellular organism growth; P:positive regulation of neuroblast proliferation; P:positive regulation of organ growth; P:positive regulation of protein import into nucleus; P:positive regulation of smoothened signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:protein localization to nucleus; P:protein stabilization; P:regulation of heart morphogenesis; P:regulation of stem cell population maintenance; P:skeletal muscle fiber development; P:smooth muscle tissue development; P:smoothened signaling pathway; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; P:smoothened signaling pathway involved in ventral spinal cord patterning; P:somite development; P:thalamus development; P:type B pancreatic cell development; P:vasculogenesis; P:ventral midline determination; scaffold8 indexed_genome mRNA 57485913 57490219 . + . ID=transcript_2347;Q99835 A4D1K5,Smoothened homolog,Protein Gx;, PF01534;PF01392;, GO:0097731;GO:0060170;GO:0097542;GO:0005929;GO:0030425;GO:0030666;GO:0070062;GO:0016021;GO:0043231;GO:0005886;GO:0004930;GO:0005113;GO:0009952;GO:0048143;GO:0060413;GO:0001708;GO:0071397;GO:0007417;GO:0021953;GO:0021696;GO:0021987;GO:0071679;GO:0060242;GO:0021542;GO:0003140;GO:0021904;GO:0060684;GO:0048853;GO:0031069;GO:0001947;GO:0048873;GO:0001701;GO:0070986;GO:0060644;GO:0072285;GO:0007494;GO:0035264;GO:0051451;GO:0043066;GO:0043392;GO:0030857;GO:0010629;GO:0051799;GO:0000122;GO:0001755;GO:0042475;GO:0001649;GO:0061113;GO:0090190;GO:0030335;GO:0050679;GO:0010628;GO:0007228;GO:0002053;GO:0040018;GO:0002052;GO:0046622;GO:0042307;GO:0045880;GO:0045944;GO:0034504;GO:0050821;GO:2000826;GO:2000036;GO:0048741;GO:0048745;GO:0007224;GO:0021938;GO:0021910;GO:0061053;GO:0021794;GO:0003323;GO:0001570;GO:0007371;, C:9+0 non-motile cilium; C:ciliary membrane; C:ciliary tip; C:cilium; C:dendrite; C:endocytic vesicle membrane; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:G protein-coupled receptor activity; F:patched binding;, P:anterior/posterior pattern specification; P:astrocyte activation; P:atrial septum morphogenesis; P:cell fate specification; P:cellular response to cholesterol; P:central nervous system development; P:central nervous system neuron differentiation; P:cerebellar cortex morphogenesis; P:cerebral cortex development; P:commissural neuron axon guidance; P:contact inhibition; P:dentate gyrus development; P:determination of left/right asymmetry in lateral mesoderm; P:dorsal/ventral neural tube patterning; P:epithelial-mesenchymal cell signaling; P:forebrain morphogenesis; P:hair follicle morphogenesis; P:heart looping; P:homeostasis of number of cells within a tissue; P:in utero embryonic development; P:left/right axis specification; P:mammary gland epithelial cell differentiation; P:mesenchymal to epithelial transition involved in metanephric renal vesicle formation; P:midgut development; P:multicellular organism growth; P:myoblast migration; P:negative regulation of apoptotic process; P:negative regulation of DNA binding; P:negative regulation of epithelial cell differentiation; P:negative regulation of gene expression; P:negative regulation of hair follicle development; P:negative regulation of transcription by RNA polymerase II; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:pancreas morphogenesis; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cell migration; P:positive regulation of epithelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of hh target transcription factor activity; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of multicellular organism growth; P:positive regulation of neuroblast proliferation; P:positive regulation of organ growth; P:positive regulation of protein import into nucleus; P:positive regulation of smoothened signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:protein localization to nucleus; P:protein stabilization; P:regulation of heart morphogenesis; P:regulation of stem cell population maintenance; P:skeletal muscle fiber development; P:smooth muscle tissue development; P:smoothened signaling pathway; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; P:smoothened signaling pathway involved in ventral spinal cord patterning; P:somite development; P:thalamus development; P:type B pancreatic cell development; P:vasculogenesis; P:ventral midline determination; scaffold8 indexed_genome mRNA 57498595 57687241 . + . ID=transcript_2348;Q96HN2 B4DIZ5 D9N155 O94917,Adenosylhomocysteinase 3,IP(3)Rs binding protein released with IP(3) 2;Long-IRBIT {ECO:0000303|PubMed:19220705};S-adenosyl-L-homocysteine hydrolase 3;S-adenosylhomocysteine hydrolase-like protein 2;, PF05221;PF00670;, GO:0005829;GO:0005783;GO:0043005;GO:0016787;GO:0006730;GO:0033353;, C:cytosol; C:endoplasmic reticulum; C:neuron projection;, F:hydrolase activity;, P:one-carbon metabolic process; P:S-adenosylmethionine cycle;|Q96HN2 B4DIZ5 D9N155 O94917,Adenosylhomocysteinase 3,IP(3)Rs binding protein released with IP(3) 2;Long-IRBIT {ECO:0000303|PubMed:19220705};S-adenosyl-L-homocysteine hydrolase 3;S-adenosylhomocysteine hydrolase-like protein 2;, PF05221;PF00670;, GO:0005829;GO:0005783;GO:0043005;GO:0016787;GO:0006730;GO:0033353;, C:cytosol; C:endoplasmic reticulum; C:neuron projection;, F:hydrolase activity;, P:one-carbon metabolic process; P:S-adenosylmethionine cycle;|Q96HN2 B4DIZ5 D9N155 O94917,Adenosylhomocysteinase 3,IP(3)Rs binding protein released with IP(3) 2;Long-IRBIT {ECO:0000303|PubMed:19220705};S-adenosyl-L-homocysteine hydrolase 3;S-adenosylhomocysteine hydrolase-like protein 2;, PF05221;PF00670;, GO:0005829;GO:0005783;GO:0043005;GO:0016787;GO:0006730;GO:0033353;, C:cytosol; C:endoplasmic reticulum; C:neuron projection;, F:hydrolase activity;, P:one-carbon metabolic process; P:S-adenosylmethionine cycle; scaffold8 indexed_genome mRNA 57691956 57740854 . + . ID=transcript_2349;Q9ULQ0 Q8WUZ4,Striatin-interacting protein 2,Protein FAM40B;, PF11882;PF07923;, GO:0005737;GO:0005829;GO:0016477;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol;, , P:cell migration; P:cytoskeleton organization; P:regulation of cell shape;|Q9ULQ0 Q8WUZ4,Striatin-interacting protein 2,Protein FAM40B;, PF11882;PF07923;, GO:0005737;GO:0005829;GO:0016477;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol;, , P:cell migration; P:cytoskeleton organization; P:regulation of cell shape;|Q9ULQ0 Q8WUZ4,Striatin-interacting protein 2,Protein FAM40B;, PF11882;PF07923;, GO:0005737;GO:0005829;GO:0016477;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol;, , P:cell migration; P:cytoskeleton organization; P:regulation of cell shape;|Q9ULQ0 Q8WUZ4,Striatin-interacting protein 2,Protein FAM40B;, PF11882;PF07923;, GO:0005737;GO:0005829;GO:0016477;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol;, , P:cell migration; P:cytoskeleton organization; P:regulation of cell shape;|Q9ULQ0 Q8WUZ4,Striatin-interacting protein 2,Protein FAM40B;, PF11882;PF07923;, GO:0005737;GO:0005829;GO:0016477;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol;, , P:cell migration; P:cytoskeleton organization; P:regulation of cell shape; scaffold8 indexed_genome mRNA 57746770 57753480 . + . ID=transcript_2350;H3BMG3,Small lysine-rich protein 1 scaffold8 indexed_genome mRNA 57845785 57929426 . + . ID=transcript_2351;Q16656 A8K4C6 B4DDV6 Q15305 Q96AN2,Nuclear respiratory factor 1,Alpha palindromic-binding protein;, PF10492;PF10491;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042803;GO:0000978;GO:0007005;GO:0045944;GO:0006357;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:mitochondrion organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q16656 A8K4C6 B4DDV6 Q15305 Q96AN2,Nuclear respiratory factor 1,Alpha palindromic-binding protein;, PF10492;PF10491;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042803;GO:0000978;GO:0007005;GO:0045944;GO:0006357;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:mitochondrion organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q16656 A8K4C6 B4DDV6 Q15305 Q96AN2,Nuclear respiratory factor 1,Alpha palindromic-binding protein;, PF10492;PF10491;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042803;GO:0000978;GO:0007005;GO:0045944;GO:0006357;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:mitochondrion organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold8 indexed_genome mRNA 57999629 58000830 . - . ID=transcript_2352;P62256 A4D1L6 C9JY93 P37286 Q7Z6F4,Ubiquitin-conjugating enzyme E2 H,(E3-independent) E2 ubiquitin-conjugating enzyme H;E2 ubiquitin-conjugating enzyme H;UbcH2;Ubiquitin carrier protein H;Ubiquitin-conjugating enzyme E2-20K;Ubiquitin-protein ligase H;, PF00179;, GO:0005829;GO:0005634;GO:0005524;GO:0061631;GO:0004842;GO:0043161;GO:0070979;GO:0070936;GO:0000209;GO:0016567;GO:0006511;, C:cytosol; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold9 indexed_genome mRNA 353 1821 . - . ID=transcript_2353;Q96KA5 D3DTC1 Q658W6 Q7LG29 Q96AZ0 Q9H3N4,Cleft lip and palate transmembrane protein 1-like protein,Cisplatin resistance-related protein 9;, PF05602;, GO:0012505;GO:0016021;GO:0016020;GO:0006915;, C:endomembrane system; C:integral component of membrane; C:membrane;, , P:apoptotic process; scaffold9 indexed_genome mRNA 6526 10556 . - . ID=transcript_2354;Q96KA5 D3DTC1 Q658W6 Q7LG29 Q96AZ0 Q9H3N4,Cleft lip and palate transmembrane protein 1-like protein,Cisplatin resistance-related protein 9;, PF05602;, GO:0012505;GO:0016021;GO:0016020;GO:0006915;, C:endomembrane system; C:integral component of membrane; C:membrane;, , P:apoptotic process; scaffold9 indexed_genome mRNA 37113 41582 . + . ID=transcript_2355;O14746 O14783 Q2XS35 Q8N6C3 Q8NG38 Q8NG46,Telomerase reverse transcriptase,HEST2;Telomerase catalytic subunit;Telomerase-associated protein 2;, PF00078;PF12009;, GO:0000781;GO:0005829;GO:0042645;GO:0016607;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0031379;GO:0000333;GO:0005697;GO:1990572;GO:0051087;GO:0003677;GO:0042802;GO:0046872;GO:0008022;GO:0042803;GO:0047485;GO:0003723;GO:0003968;GO:0003964;GO:0003720;GO:0070034;GO:0003721;GO:0042162;GO:0098680;GO:0001223;GO:0000049;GO:1904837;GO:0071456;GO:0071897;GO:0022616;GO:0062103;GO:0070200;GO:0007005;GO:2000773;GO:2000352;GO:2001240;GO:0010629;GO:0043524;GO:1903799;GO:1903704;GO:0045766;GO:1900087;GO:0046326;GO:0042635;GO:0051000;GO:1902895;GO:0032092;GO:1904751;GO:2000648;GO:1903620;GO:1904754;GO:1904707;GO:0030177;GO:0030422;GO:0031647;GO:0090399;GO:0046686;GO:0006278;GO:0000723;GO:0007004;GO:0001172;, C:chromosome, telomeric region; C:cytosol; C:mitochondrial nucleoid; C:nuclear speck; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:RNA-directed RNA polymerase complex; C:telomerase catalytic core complex; C:telomerase holoenzyme complex; C:TERT-RMRP complex;, F:chaperone binding; F:DNA binding; F:identical protein binding; F:metal ion binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein N-terminus binding; F:RNA binding; F:RNA-directed 5'-3' RNA polymerase activity; F:RNA-directed DNA polymerase activity; F:telomerase activity; F:telomerase RNA binding; F:telomerase RNA reverse transcriptase activity; F:telomeric DNA binding; F:template-free RNA nucleotidyltransferase; F:transcription coactivator binding; F:tRNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to hypoxia; P:DNA biosynthetic process; P:DNA strand elongation; P:double-stranded RNA biosynthetic process; P:establishment of protein localization to telomere; P:mitochondrion organization; P:negative regulation of cellular senescence; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of production of siRNA involved in RNA interference; P:positive regulation of angiogenesis; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of glucose import; P:positive regulation of hair cycle; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein binding; P:positive regulation of protein localization to nucleolus; P:positive regulation of stem cell proliferation; P:positive regulation of transdifferentiation; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of Wnt signaling pathway; P:production of siRNA involved in RNA interference; P:regulation of protein stability; P:replicative senescence; P:response to cadmium ion; P:RNA-dependent DNA biosynthetic process; P:telomere maintenance; P:telomere maintenance via telomerase; P:transcription, RNA-templated; scaffold9 indexed_genome mRNA 41595 45403 . + . ID=transcript_2356;O14746 O14783 Q2XS35 Q8N6C3 Q8NG38 Q8NG46,Telomerase reverse transcriptase,HEST2;Telomerase catalytic subunit;Telomerase-associated protein 2;, PF00078;PF12009;, GO:0000781;GO:0005829;GO:0042645;GO:0016607;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0031379;GO:0000333;GO:0005697;GO:1990572;GO:0051087;GO:0003677;GO:0042802;GO:0046872;GO:0008022;GO:0042803;GO:0047485;GO:0003723;GO:0003968;GO:0003964;GO:0003720;GO:0070034;GO:0003721;GO:0042162;GO:0098680;GO:0001223;GO:0000049;GO:1904837;GO:0071456;GO:0071897;GO:0022616;GO:0062103;GO:0070200;GO:0007005;GO:2000773;GO:2000352;GO:2001240;GO:0010629;GO:0043524;GO:1903799;GO:1903704;GO:0045766;GO:1900087;GO:0046326;GO:0042635;GO:0051000;GO:1902895;GO:0032092;GO:1904751;GO:2000648;GO:1903620;GO:1904754;GO:1904707;GO:0030177;GO:0030422;GO:0031647;GO:0090399;GO:0046686;GO:0006278;GO:0000723;GO:0007004;GO:0001172;, C:chromosome, telomeric region; C:cytosol; C:mitochondrial nucleoid; C:nuclear speck; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:RNA-directed RNA polymerase complex; C:telomerase catalytic core complex; C:telomerase holoenzyme complex; C:TERT-RMRP complex;, F:chaperone binding; F:DNA binding; F:identical protein binding; F:metal ion binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein N-terminus binding; F:RNA binding; F:RNA-directed 5'-3' RNA polymerase activity; F:RNA-directed DNA polymerase activity; F:telomerase activity; F:telomerase RNA binding; F:telomerase RNA reverse transcriptase activity; F:telomeric DNA binding; F:template-free RNA nucleotidyltransferase; F:transcription coactivator binding; F:tRNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to hypoxia; P:DNA biosynthetic process; P:DNA strand elongation; P:double-stranded RNA biosynthetic process; P:establishment of protein localization to telomere; P:mitochondrion organization; P:negative regulation of cellular senescence; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of production of siRNA involved in RNA interference; P:positive regulation of angiogenesis; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of glucose import; P:positive regulation of hair cycle; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein binding; P:positive regulation of protein localization to nucleolus; P:positive regulation of stem cell proliferation; P:positive regulation of transdifferentiation; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of Wnt signaling pathway; P:production of siRNA involved in RNA interference; P:regulation of protein stability; P:replicative senescence; P:response to cadmium ion; P:RNA-dependent DNA biosynthetic process; P:telomere maintenance; P:telomere maintenance via telomerase; P:transcription, RNA-templated; scaffold9 indexed_genome mRNA 161672 162355 . - . ID=transcript_2357;Q9Y666 A6NDS8 Q4G0F3 Q96I81 Q9H7I3 Q9H7I7 Q9UFW2,Solute carrier family 12 member 7,Electroneutral potassium-chloride cotransporter 4;K-Cl cotransporter 4;, PF00324;PF03522;, GO:0005887;GO:0005886;GO:0032991;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; scaffold9 indexed_genome mRNA 179002 183063 . - . ID=transcript_2358;Q9Y666 A6NDS8 Q4G0F3 Q96I81 Q9H7I3 Q9H7I7 Q9UFW2,Solute carrier family 12 member 7,Electroneutral potassium-chloride cotransporter 4;K-Cl cotransporter 4;, PF00324;PF03522;, GO:0005887;GO:0005886;GO:0032991;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|Q9Y666 A6NDS8 Q4G0F3 Q96I81 Q9H7I3 Q9H7I7 Q9UFW2,Solute carrier family 12 member 7,Electroneutral potassium-chloride cotransporter 4;K-Cl cotransporter 4;, PF00324;PF03522;, GO:0005887;GO:0005886;GO:0032991;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; scaffold9 indexed_genome mRNA 191535 194705 . + . ID=transcript_2359;Q9Y666 A6NDS8 Q4G0F3 Q96I81 Q9H7I3 Q9H7I7 Q9UFW2,Solute carrier family 12 member 7,Electroneutral potassium-chloride cotransporter 4;K-Cl cotransporter 4;, PF00324;PF03522;, GO:0005887;GO:0005886;GO:0032991;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; scaffold9 indexed_genome mRNA 194719 195450 . - . ID=transcript_2360;Q9Y666 A6NDS8 Q4G0F3 Q96I81 Q9H7I3 Q9H7I7 Q9UFW2,Solute carrier family 12 member 7,Electroneutral potassium-chloride cotransporter 4;K-Cl cotransporter 4;, PF00324;PF03522;, GO:0005887;GO:0005886;GO:0032991;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; scaffold9 indexed_genome mRNA 195794 196370 . + . ID=transcript_2361;Q9Y666 A6NDS8 Q4G0F3 Q96I81 Q9H7I3 Q9H7I7 Q9UFW2,Solute carrier family 12 member 7,Electroneutral potassium-chloride cotransporter 4;K-Cl cotransporter 4;, PF00324;PF03522;, GO:0005887;GO:0005886;GO:0032991;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; scaffold9 indexed_genome mRNA 201457 237599 . - . ID=transcript_2362;Q969F2 Q96EK8 Q9BSN0,Protein naked cuticle homolog 2,, , GO:0016323;GO:0071944;GO:0005737;GO:0031410;GO:0070382;GO:0016328;GO:0005886;GO:0051117;GO:0005509;GO:0019838;GO:0032036;GO:0031625;GO:0006887;GO:0048210;GO:0090090;GO:0030178;GO:0032436;GO:1903078;GO:0010954;GO:0072659;GO:0016055;, C:basolateral plasma membrane; C:cell periphery; C:cytoplasm; C:cytoplasmic vesicle; C:exocytic vesicle; C:lateral plasma membrane; C:plasma membrane;, F:ATPase binding; F:calcium ion binding; F:growth factor binding; F:myosin heavy chain binding; F:ubiquitin protein ligase binding;, P:exocytosis; P:Golgi vesicle fusion to target membrane; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein processing; P:protein localization to plasma membrane; P:Wnt signaling pathway;|Q969F2 Q96EK8 Q9BSN0,Protein naked cuticle homolog 2,, , GO:0016323;GO:0071944;GO:0005737;GO:0031410;GO:0070382;GO:0016328;GO:0005886;GO:0051117;GO:0005509;GO:0019838;GO:0032036;GO:0031625;GO:0006887;GO:0048210;GO:0090090;GO:0030178;GO:0032436;GO:1903078;GO:0010954;GO:0072659;GO:0016055;, C:basolateral plasma membrane; C:cell periphery; C:cytoplasm; C:cytoplasmic vesicle; C:exocytic vesicle; C:lateral plasma membrane; C:plasma membrane;, F:ATPase binding; F:calcium ion binding; F:growth factor binding; F:myosin heavy chain binding; F:ubiquitin protein ligase binding;, P:exocytosis; P:Golgi vesicle fusion to target membrane; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein processing; P:protein localization to plasma membrane; P:Wnt signaling pathway; scaffold9 indexed_genome mRNA 263971 278480 . - . ID=transcript_2363;Q15645 C9K0T3 D3DTC0 O15324,Pachytene checkpoint protein 2 homolog,Human papillomavirus type 16 E1 protein-binding protein;Thyroid hormone receptor interactor 13;Thyroid receptor-interacting protein 13;, PF00004;, GO:0005694;GO:0001673;GO:0005634;GO:0005524;GO:0016887;GO:0042802;GO:0003712;GO:0006302;GO:0007144;GO:0007141;GO:0051598;GO:0007094;GO:0001556;GO:0048477;GO:0007131;GO:0007286;GO:0007283;GO:0007130;GO:0006366;, C:chromosome; C:male germ cell nucleus; C:nucleus;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:transcription coregulator activity;, P:double-strand break repair; P:female meiosis I; P:male meiosis I; P:meiotic recombination checkpoint; P:mitotic spindle assembly checkpoint; P:oocyte maturation; P:oogenesis; P:reciprocal meiotic recombination; P:spermatid development; P:spermatogenesis; P:synaptonemal complex assembly; P:transcription by RNA polymerase II;|Q15645 C9K0T3 D3DTC0 O15324,Pachytene checkpoint protein 2 homolog,Human papillomavirus type 16 E1 protein-binding protein;Thyroid hormone receptor interactor 13;Thyroid receptor-interacting protein 13;, PF00004;, GO:0005694;GO:0001673;GO:0005634;GO:0005524;GO:0016887;GO:0042802;GO:0003712;GO:0006302;GO:0007144;GO:0007141;GO:0051598;GO:0007094;GO:0001556;GO:0048477;GO:0007131;GO:0007286;GO:0007283;GO:0007130;GO:0006366;, C:chromosome; C:male germ cell nucleus; C:nucleus;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:transcription coregulator activity;, P:double-strand break repair; P:female meiosis I; P:male meiosis I; P:meiotic recombination checkpoint; P:mitotic spindle assembly checkpoint; P:oocyte maturation; P:oogenesis; P:reciprocal meiotic recombination; P:spermatid development; P:spermatogenesis; P:synaptonemal complex assembly; P:transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 278860 285523 . + . ID=transcript_2364;Q9H8M2 A6NFY8 B4DMQ2 B4DR93 Q2XUS1 Q6UWU9 Q8IUS4 Q9H5Q5 Q9H7R9,Bromodomain-containing protein 9,Rhabdomyosarcoma antigen MU-RMS-40.8;, PF00439;PF12024;, GO:0005654;GO:0005634;GO:0016514;GO:0070577;GO:0003676;GO:0006325;GO:0006357;, C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:lysine-acetylated histone binding; F:nucleic acid binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II;|Q9H8M2 A6NFY8 B4DMQ2 B4DR93 Q2XUS1 Q6UWU9 Q8IUS4 Q9H5Q5 Q9H7R9,Bromodomain-containing protein 9,Rhabdomyosarcoma antigen MU-RMS-40.8;, PF00439;PF12024;, GO:0005654;GO:0005634;GO:0016514;GO:0070577;GO:0003676;GO:0006325;GO:0006357;, C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:lysine-acetylated histone binding; F:nucleic acid binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 286210 295828 . - . ID=transcript_2365;Q9H8M2 A6NFY8 B4DMQ2 B4DR93 Q2XUS1 Q6UWU9 Q8IUS4 Q9H5Q5 Q9H7R9,Bromodomain-containing protein 9,Rhabdomyosarcoma antigen MU-RMS-40.8;, PF00439;PF12024;, GO:0005654;GO:0005634;GO:0016514;GO:0070577;GO:0003676;GO:0006325;GO:0006357;, C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:lysine-acetylated histone binding; F:nucleic acid binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II;|Q9H8M2 A6NFY8 B4DMQ2 B4DR93 Q2XUS1 Q6UWU9 Q8IUS4 Q9H5Q5 Q9H7R9,Bromodomain-containing protein 9,Rhabdomyosarcoma antigen MU-RMS-40.8;, PF00439;PF12024;, GO:0005654;GO:0005634;GO:0016514;GO:0070577;GO:0003676;GO:0006325;GO:0006357;, C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:lysine-acetylated histone binding; F:nucleic acid binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II;|Q9H8M2 A6NFY8 B4DMQ2 B4DR93 Q2XUS1 Q6UWU9 Q8IUS4 Q9H5Q5 Q9H7R9,Bromodomain-containing protein 9,Rhabdomyosarcoma antigen MU-RMS-40.8;, PF00439;PF12024;, GO:0005654;GO:0005634;GO:0016514;GO:0070577;GO:0003676;GO:0006325;GO:0006357;, C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:lysine-acetylated histone binding; F:nucleic acid binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 295966 297492 . - . ID=transcript_2366;Q9H8M2 A6NFY8 B4DMQ2 B4DR93 Q2XUS1 Q6UWU9 Q8IUS4 Q9H5Q5 Q9H7R9,Bromodomain-containing protein 9,Rhabdomyosarcoma antigen MU-RMS-40.8;, PF00439;PF12024;, GO:0005654;GO:0005634;GO:0016514;GO:0070577;GO:0003676;GO:0006325;GO:0006357;, C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:lysine-acetylated histone binding; F:nucleic acid binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 369170 379315 . + . ID=transcript_2367;O94811,Tubulin polymerization-promoting protein {ECO:0000303|PubMed:17105200},25 kDa brain-specific protein {ECO:0000303|PubMed:15590652};TPPP/p25 {ECO:0000303|PubMed:15590652};p24;p25-alpha {ECO:0000303|PubMed:15590652};, PF05517;, GO:0005737;GO:0005829;GO:0005874;GO:0005739;GO:0072686;GO:0005634;GO:0048471;GO:0150051;GO:0003924;GO:0000287;GO:0008017;GO:0042803;GO:0015631;GO:0030953;GO:0051301;GO:0001578;GO:0051418;GO:0046785;GO:0032288;GO:1904428;GO:0014003;GO:0048709;GO:0031643;GO:0032273;GO:0031334;GO:0070507;, C:cytoplasm; C:cytosol; C:microtubule; C:mitochondrion; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic Golgi apparatus;, F:GTPase activity; F:magnesium ion binding; F:microtubule binding; F:protein homodimerization activity; F:tubulin binding;, P:astral microtubule organization; P:cell division; P:microtubule bundle formation; P:microtubule nucleation by microtubule organizing center; P:microtubule polymerization; P:myelin assembly; P:negative regulation of tubulin deacetylation; P:oligodendrocyte development; P:oligodendrocyte differentiation; P:positive regulation of myelination; P:positive regulation of protein polymerization; P:positive regulation of protein-containing complex assembly; P:regulation of microtubule cytoskeleton organization; scaffold9 indexed_genome mRNA 382479 393009 . - . ID=transcript_2368;Q9P209 B4DR26 Q9BV03 Q9BWM3 Q9NVR4,Centrosomal protein of 72 kDa,, , GO:0034451;GO:0005813;GO:0005829;GO:0042802;GO:0007099;GO:0097711;GO:0000086;GO:0033566;GO:0010389;GO:1904779;GO:0007051;, C:centriolar satellite; C:centrosome; C:cytosol;, F:identical protein binding;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:gamma-tubulin complex localization; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of protein localization to centrosome; P:spindle organization; scaffold9 indexed_genome mRNA 393233 411304 . - . ID=transcript_2369;Q9P209 B4DR26 Q9BV03 Q9BWM3 Q9NVR4,Centrosomal protein of 72 kDa,, , GO:0034451;GO:0005813;GO:0005829;GO:0042802;GO:0007099;GO:0097711;GO:0000086;GO:0033566;GO:0010389;GO:1904779;GO:0007051;, C:centriolar satellite; C:centrosome; C:cytosol;, F:identical protein binding;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:gamma-tubulin complex localization; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of protein localization to centrosome; P:spindle organization;|Q9P209 B4DR26 Q9BV03 Q9BWM3 Q9NVR4,Centrosomal protein of 72 kDa,, , GO:0034451;GO:0005813;GO:0005829;GO:0042802;GO:0007099;GO:0097711;GO:0000086;GO:0033566;GO:0010389;GO:1904779;GO:0007051;, C:centriolar satellite; C:centrosome; C:cytosol;, F:identical protein binding;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:gamma-tubulin complex localization; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of protein localization to centrosome; P:spindle organization; scaffold9 indexed_genome mRNA 497821 522946 . + . ID=transcript_2370;P48764 B7ZKR2 E9PF67 Q3MIW3,Sodium/hydrogen exchanger 3 {ECO:0000305},Na(+)/H(+) exchanger 3 {ECO:0000303|PubMed:7631746};Solute carrier family 9 member 3;, PF00999;, GO:0016324;GO:0005903;GO:0031526;GO:0009986;GO:0070062;GO:0016021;GO:0005886;GO:0030165;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:PDZ domain binding; F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|P48764 B7ZKR2 E9PF67 Q3MIW3,Sodium/hydrogen exchanger 3 {ECO:0000305},Na(+)/H(+) exchanger 3 {ECO:0000303|PubMed:7631746};Solute carrier family 9 member 3;, PF00999;, GO:0016324;GO:0005903;GO:0031526;GO:0009986;GO:0070062;GO:0016021;GO:0005886;GO:0030165;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:PDZ domain binding; F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane; scaffold9 indexed_genome mRNA 530100 530741 . - . ID=transcript_2371;P48764 B7ZKR2 E9PF67 Q3MIW3,Sodium/hydrogen exchanger 3 {ECO:0000305},Na(+)/H(+) exchanger 3 {ECO:0000303|PubMed:7631746};Solute carrier family 9 member 3;, PF00999;, GO:0016324;GO:0005903;GO:0031526;GO:0009986;GO:0070062;GO:0016021;GO:0005886;GO:0030165;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:PDZ domain binding; F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane; scaffold9 indexed_genome mRNA 530773 531384 . - . ID=transcript_2372;P48764 B7ZKR2 E9PF67 Q3MIW3,Sodium/hydrogen exchanger 3 {ECO:0000305},Na(+)/H(+) exchanger 3 {ECO:0000303|PubMed:7631746};Solute carrier family 9 member 3;, PF00999;, GO:0016324;GO:0005903;GO:0031526;GO:0009986;GO:0070062;GO:0016021;GO:0005886;GO:0030165;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:PDZ domain binding; F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane; scaffold9 indexed_genome mRNA 543436 573949 . - . ID=transcript_2373;O60645 Q6P2E8 Q8TEN6 Q8WUW0 Q96DI4,Exocyst complex component 3,Exocyst complex component Sec6;, PF06046;, GO:0005829;GO:0000145;GO:0005794;GO:0030426;GO:0030496;GO:0048471;GO:0042734;GO:0030667;GO:0045296;GO:0000149;GO:0060271;GO:0051601;GO:0006887;GO:0015031;, C:cytosol; C:exocyst; C:Golgi apparatus; C:growth cone; C:midbody; C:perinuclear region of cytoplasm; C:presynaptic membrane; C:secretory granule membrane;, F:cadherin binding; F:SNARE binding;, P:cilium assembly; P:exocyst localization; P:exocytosis; P:protein transport;|O60645 Q6P2E8 Q8TEN6 Q8WUW0 Q96DI4,Exocyst complex component 3,Exocyst complex component Sec6;, PF06046;, GO:0005829;GO:0000145;GO:0005794;GO:0030426;GO:0030496;GO:0048471;GO:0042734;GO:0030667;GO:0045296;GO:0000149;GO:0060271;GO:0051601;GO:0006887;GO:0015031;, C:cytosol; C:exocyst; C:Golgi apparatus; C:growth cone; C:midbody; C:perinuclear region of cytoplasm; C:presynaptic membrane; C:secretory granule membrane;, F:cadherin binding; F:SNARE binding;, P:cilium assembly; P:exocyst localization; P:exocytosis; P:protein transport;|O60645 Q6P2E8 Q8TEN6 Q8WUW0 Q96DI4,Exocyst complex component 3,Exocyst complex component Sec6;, PF06046;, GO:0005829;GO:0000145;GO:0005794;GO:0030426;GO:0030496;GO:0048471;GO:0042734;GO:0030667;GO:0045296;GO:0000149;GO:0060271;GO:0051601;GO:0006887;GO:0015031;, C:cytosol; C:exocyst; C:Golgi apparatus; C:growth cone; C:midbody; C:perinuclear region of cytoplasm; C:presynaptic membrane; C:secretory granule membrane;, F:cadherin binding; F:SNARE binding;, P:cilium assembly; P:exocyst localization; P:exocytosis; P:protein transport;|O60645 Q6P2E8 Q8TEN6 Q8WUW0 Q96DI4,Exocyst complex component 3,Exocyst complex component Sec6;, PF06046;, GO:0005829;GO:0000145;GO:0005794;GO:0030426;GO:0030496;GO:0048471;GO:0042734;GO:0030667;GO:0045296;GO:0000149;GO:0060271;GO:0051601;GO:0006887;GO:0015031;, C:cytosol; C:exocyst; C:Golgi apparatus; C:growth cone; C:midbody; C:perinuclear region of cytoplasm; C:presynaptic membrane; C:secretory granule membrane;, F:cadherin binding; F:SNARE binding;, P:cilium assembly; P:exocyst localization; P:exocytosis; P:protein transport; scaffold9 indexed_genome mRNA 577322 586616 . - . ID=transcript_2374;A9YTQ3 A7MBN5 D6RAZ1 Q9HAZ3 Q9ULI6,Aryl hydrocarbon receptor repressor,Class E basic helix-loop-helix protein 77;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0004879;GO:0046983;GO:0000976;GO:0006357;GO:0006805;, C:aryl hydrocarbon receptor complex; C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein dimerization activity; F:transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:xenobiotic metabolic process; scaffold9 indexed_genome mRNA 687923 702620 . - . ID=transcript_2375;O75340 B2RD16 E7ESR3 Q2YDC2 Q5TZS0,Programmed cell death protein 6,Apoptosis-linked gene 2 protein homolog {ECO:0000250|UniProtKB:P12815};, PF13202;PF13499;, GO:0030127;GO:0031463;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0005768;GO:0070062;GO:0005654;GO:0005634;GO:0005509;GO:0048306;GO:0042802;GO:0000287;GO:0046983;GO:0042803;GO:0030674;GO:0043495;GO:1990756;GO:0006919;GO:0001525;GO:0097190;GO:0034605;GO:0048208;GO:0006888;GO:0006886;GO:0051898;GO:0032007;GO:0030948;GO:0014032;GO:0014029;GO:0045766;GO:0043280;GO:0010595;GO:0001938;GO:1902527;GO:0051592;GO:0036324;, C:COPII vesicle coat; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:calcium-dependent protein binding; F:identical protein binding; F:magnesium ion binding; F:protein dimerization activity; F:protein homodimerization activity; F:protein-macromolecule adaptor activity; F:protein-membrane adaptor activity; F:ubiquitin ligase-substrate adaptor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:angiogenesis; P:apoptotic signaling pathway; P:cellular response to heat; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:neural crest cell development; P:neural crest formation; P:positive regulation of angiogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of protein monoubiquitination; P:response to calcium ion; P:vascular endothelial growth factor receptor-2 signaling pathway;|O75340 B2RD16 E7ESR3 Q2YDC2 Q5TZS0,Programmed cell death protein 6,Apoptosis-linked gene 2 protein homolog {ECO:0000250|UniProtKB:P12815};, PF13202;PF13499;, GO:0030127;GO:0031463;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0005768;GO:0070062;GO:0005654;GO:0005634;GO:0005509;GO:0048306;GO:0042802;GO:0000287;GO:0046983;GO:0042803;GO:0030674;GO:0043495;GO:1990756;GO:0006919;GO:0001525;GO:0097190;GO:0034605;GO:0048208;GO:0006888;GO:0006886;GO:0051898;GO:0032007;GO:0030948;GO:0014032;GO:0014029;GO:0045766;GO:0043280;GO:0010595;GO:0001938;GO:1902527;GO:0051592;GO:0036324;, C:COPII vesicle coat; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:calcium-dependent protein binding; F:identical protein binding; F:magnesium ion binding; F:protein dimerization activity; F:protein homodimerization activity; F:protein-macromolecule adaptor activity; F:protein-membrane adaptor activity; F:ubiquitin ligase-substrate adaptor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:angiogenesis; P:apoptotic signaling pathway; P:cellular response to heat; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:neural crest cell development; P:neural crest formation; P:positive regulation of angiogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of protein monoubiquitination; P:response to calcium ion; P:vascular endothelial growth factor receptor-2 signaling pathway;|O75340 B2RD16 E7ESR3 Q2YDC2 Q5TZS0,Programmed cell death protein 6,Apoptosis-linked gene 2 protein homolog {ECO:0000250|UniProtKB:P12815};, PF13202;PF13499;, GO:0030127;GO:0031463;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0005768;GO:0070062;GO:0005654;GO:0005634;GO:0005509;GO:0048306;GO:0042802;GO:0000287;GO:0046983;GO:0042803;GO:0030674;GO:0043495;GO:1990756;GO:0006919;GO:0001525;GO:0097190;GO:0034605;GO:0048208;GO:0006888;GO:0006886;GO:0051898;GO:0032007;GO:0030948;GO:0014032;GO:0014029;GO:0045766;GO:0043280;GO:0010595;GO:0001938;GO:1902527;GO:0051592;GO:0036324;, C:COPII vesicle coat; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:calcium-dependent protein binding; F:identical protein binding; F:magnesium ion binding; F:protein dimerization activity; F:protein homodimerization activity; F:protein-macromolecule adaptor activity; F:protein-membrane adaptor activity; F:ubiquitin ligase-substrate adaptor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:angiogenesis; P:apoptotic signaling pathway; P:cellular response to heat; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:neural crest cell development; P:neural crest formation; P:positive regulation of angiogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of protein monoubiquitination; P:response to calcium ion; P:vascular endothelial growth factor receptor-2 signaling pathway;|O75340 B2RD16 E7ESR3 Q2YDC2 Q5TZS0,Programmed cell death protein 6,Apoptosis-linked gene 2 protein homolog {ECO:0000250|UniProtKB:P12815};, PF13202;PF13499;, GO:0030127;GO:0031463;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0005768;GO:0070062;GO:0005654;GO:0005634;GO:0005509;GO:0048306;GO:0042802;GO:0000287;GO:0046983;GO:0042803;GO:0030674;GO:0043495;GO:1990756;GO:0006919;GO:0001525;GO:0097190;GO:0034605;GO:0048208;GO:0006888;GO:0006886;GO:0051898;GO:0032007;GO:0030948;GO:0014032;GO:0014029;GO:0045766;GO:0043280;GO:0010595;GO:0001938;GO:1902527;GO:0051592;GO:0036324;, C:COPII vesicle coat; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:calcium-dependent protein binding; F:identical protein binding; F:magnesium ion binding; F:protein dimerization activity; F:protein homodimerization activity; F:protein-macromolecule adaptor activity; F:protein-membrane adaptor activity; F:ubiquitin ligase-substrate adaptor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:angiogenesis; P:apoptotic signaling pathway; P:cellular response to heat; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:neural crest cell development; P:neural crest formation; P:positive regulation of angiogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of protein monoubiquitination; P:response to calcium ion; P:vascular endothelial growth factor receptor-2 signaling pathway; scaffold9 indexed_genome mRNA 710565 732601 . + . ID=transcript_2376;P31040 A8K5J6 B4DJ60 E9PBJ5 Q16395 Q59GW8 Q8IW48 Q9UMY5,Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial,Flavoprotein subunit of complex II;, PF00890;PF02910;, GO:0005743;GO:0005749;GO:0005739;GO:0005730;GO:0009055;GO:0050660;GO:0008177;GO:0006121;GO:0007399;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleolus;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:succinate dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, succinate to ubiquinone; P:nervous system development; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle;|P31040 A8K5J6 B4DJ60 E9PBJ5 Q16395 Q59GW8 Q8IW48 Q9UMY5,Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial,Flavoprotein subunit of complex II;, PF00890;PF02910;, GO:0005743;GO:0005749;GO:0005739;GO:0005730;GO:0009055;GO:0050660;GO:0008177;GO:0006121;GO:0007399;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleolus;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:succinate dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, succinate to ubiquinone; P:nervous system development; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle;|P31040 A8K5J6 B4DJ60 E9PBJ5 Q16395 Q59GW8 Q8IW48 Q9UMY5,Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial,Flavoprotein subunit of complex II;, PF00890;PF02910;, GO:0005743;GO:0005749;GO:0005739;GO:0005730;GO:0009055;GO:0050660;GO:0008177;GO:0006121;GO:0007399;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleolus;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:succinate dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, succinate to ubiquinone; P:nervous system development; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle;|P31040 A8K5J6 B4DJ60 E9PBJ5 Q16395 Q59GW8 Q8IW48 Q9UMY5,Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial,Flavoprotein subunit of complex II;, PF00890;PF02910;, GO:0005743;GO:0005749;GO:0005739;GO:0005730;GO:0009055;GO:0050660;GO:0008177;GO:0006121;GO:0007399;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleolus;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:succinate dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, succinate to ubiquinone; P:nervous system development; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle;|P31040 A8K5J6 B4DJ60 E9PBJ5 Q16395 Q59GW8 Q8IW48 Q9UMY5,Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial,Flavoprotein subunit of complex II;, PF00890;PF02910;, GO:0005743;GO:0005749;GO:0005739;GO:0005730;GO:0009055;GO:0050660;GO:0008177;GO:0006121;GO:0007399;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleolus;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:succinate dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, succinate to ubiquinone; P:nervous system development; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle;|P31040 A8K5J6 B4DJ60 E9PBJ5 Q16395 Q59GW8 Q8IW48 Q9UMY5,Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial,Flavoprotein subunit of complex II;, PF00890;PF02910;, GO:0005743;GO:0005749;GO:0005739;GO:0005730;GO:0009055;GO:0050660;GO:0008177;GO:0006121;GO:0007399;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleolus;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:succinate dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, succinate to ubiquinone; P:nervous system development; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle;|P31040 A8K5J6 B4DJ60 E9PBJ5 Q16395 Q59GW8 Q8IW48 Q9UMY5,Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial,Flavoprotein subunit of complex II;, PF00890;PF02910;, GO:0005743;GO:0005749;GO:0005739;GO:0005730;GO:0009055;GO:0050660;GO:0008177;GO:0006121;GO:0007399;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleolus;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:succinate dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, succinate to ubiquinone; P:nervous system development; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle; scaffold9 indexed_genome mRNA 743724 752631 . + . ID=transcript_2377;Q96BQ5,Coiled-coil domain-containing protein 127 scaffold9 indexed_genome mRNA 753328 758754 . + . ID=transcript_2378;Q96BQ5,Coiled-coil domain-containing protein 127|Q96BQ5,Coiled-coil domain-containing protein 127|Q96BQ5,Coiled-coil domain-containing protein 127 scaffold9 indexed_genome mRNA 762454 768435 . - . ID=transcript_2379;A6NHZ5,Leucine-rich repeat-containing protein 14B {ECO:0000305},, , GO:0005737;, C:cytoplasm; scaffold9 indexed_genome mRNA 1306162 1310004 . - . ID=transcript_2380;P04921 B2R522 Q53SV9 Q92642,Glycophorin-C,Glycoconnectin;Glycophorin-D;Glycoprotein beta;PAS-2';Sialoglycoprotein D;, , GO:0030863;GO:0005887;GO:0016020;GO:0005886;GO:0050900;, C:cortical cytoskeleton; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, , P:leukocyte migration; scaffold9 indexed_genome mRNA 3152645 3154790 . + . ID=transcript_2381;Q8WYK1 Q4ZFW2 Q4ZG21 Q53R09 Q53RX1 Q53SG3 Q584P3 Q96MS7,Contactin-associated protein-like 5,Cell recognition molecule Caspr5;, PF00754;PF02210;, GO:0016021;GO:0007155;, C:integral component of membrane;, , P:cell adhesion; scaffold9 indexed_genome mRNA 3157465 3210587 . - . ID=transcript_2382;Q8WYK1 Q4ZFW2 Q4ZG21 Q53R09 Q53RX1 Q53SG3 Q584P3 Q96MS7,Contactin-associated protein-like 5,Cell recognition molecule Caspr5;, PF00754;PF02210;, GO:0016021;GO:0007155;, C:integral component of membrane;, , P:cell adhesion; scaffold9 indexed_genome mRNA 3291809 3341623 . - . ID=transcript_2383;Q8WYK1 Q4ZFW2 Q4ZG21 Q53R09 Q53RX1 Q53SG3 Q584P3 Q96MS7,Contactin-associated protein-like 5,Cell recognition molecule Caspr5;, PF00754;PF02210;, GO:0016021;GO:0007155;, C:integral component of membrane;, , P:cell adhesion; scaffold9 indexed_genome mRNA 3568354 3636436 . - . ID=transcript_2384;Q8WYK1 Q4ZFW2 Q4ZG21 Q53R09 Q53RX1 Q53SG3 Q584P3 Q96MS7,Contactin-associated protein-like 5,Cell recognition molecule Caspr5;, PF00754;PF02210;, GO:0016021;GO:0007155;, C:integral component of membrane;, , P:cell adhesion; scaffold9 indexed_genome mRNA 3661526 3915059 . - . ID=transcript_2385;Q8WYK1 Q4ZFW2 Q4ZG21 Q53R09 Q53RX1 Q53SG3 Q584P3 Q96MS7,Contactin-associated protein-like 5,Cell recognition molecule Caspr5;, PF00754;PF02210;, GO:0016021;GO:0007155;, C:integral component of membrane;, , P:cell adhesion; scaffold9 indexed_genome mRNA 6356514 6359055 . + . ID=transcript_2386;Q9Y241 Q9UFZ2,HIG1 domain family member 1A, mitochondrial,Hypoxia-inducible gene 1 protein;RCF1 homolog A;, PF04588;, GO:0016021;GO:0005743;GO:0005739;GO:0005654;GO:0032991;GO:0070469;GO:0097250;GO:0043066;GO:0061418;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:protein-containing complex; C:respirasome;, , P:mitochondrial respirasome assembly; P:negative regulation of apoptotic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; scaffold9 indexed_genome mRNA 6376573 6385080 . - . ID=transcript_2387;Q15631 B7Z3X8 Q5U0K7,Translin,Component 3 of promoter of RISC;, PF01997;, GO:0005737;GO:0005829;GO:0005783;GO:0005654;GO:0005634;GO:0003677;GO:0004521;GO:0042802;GO:0044877;GO:0003723;GO:0043565;GO:0003697;GO:0006310;GO:0030422;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleoplasm; C:nucleus;, F:DNA binding; F:endoribonuclease activity; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:sequence-specific DNA binding; F:single-stranded DNA binding;, P:DNA recombination; P:production of siRNA involved in RNA interference;|Q15631 B7Z3X8 Q5U0K7,Translin,Component 3 of promoter of RISC;, PF01997;, GO:0005737;GO:0005829;GO:0005783;GO:0005654;GO:0005634;GO:0003677;GO:0004521;GO:0042802;GO:0044877;GO:0003723;GO:0043565;GO:0003697;GO:0006310;GO:0030422;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleoplasm; C:nucleus;, F:DNA binding; F:endoribonuclease activity; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:sequence-specific DNA binding; F:single-stranded DNA binding;, P:DNA recombination; P:production of siRNA involved in RNA interference;|Q15631 B7Z3X8 Q5U0K7,Translin,Component 3 of promoter of RISC;, PF01997;, GO:0005737;GO:0005829;GO:0005783;GO:0005654;GO:0005634;GO:0003677;GO:0004521;GO:0042802;GO:0044877;GO:0003723;GO:0043565;GO:0003697;GO:0006310;GO:0030422;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleoplasm; C:nucleus;, F:DNA binding; F:endoribonuclease activity; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:sequence-specific DNA binding; F:single-stranded DNA binding;, P:DNA recombination; P:production of siRNA involved in RNA interference; scaffold9 indexed_genome mRNA 6403350 6404188 . - . ID=transcript_2388;Q9BYG3 A8K788 Q8TB66 Q96ED4,MKI67 FHA domain-interacting nucleolar phosphoprotein,Nucleolar phosphoprotein Nopp34;Nucleolar protein interacting with the FHA domain of pKI-67;, PF12196;PF00076;, GO:0005694;GO:0000794;GO:0005737;GO:0005730;GO:0005654;GO:0003723;GO:0000463;GO:0065003;GO:0016072;GO:0009303;, C:chromosome; C:condensed nuclear chromosome; C:cytoplasm; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:protein-containing complex assembly; P:rRNA metabolic process; P:rRNA transcription; scaffold9 indexed_genome mRNA 6447301 6712473 . + . ID=transcript_2389;Q7Z460 A2RU21 B7ZLX3 F5GWS0 O75118 Q2KHQ9 Q5H9P0 Q8N5B8 Q9BQT5,CLIP-associating protein 1,Cytoplasmic linker-associated protein 1;Multiple asters homolog 1;Protein Orbit homolog 1;, PF12348;, GO:0045180;GO:0005938;GO:0031592;GO:0005813;GO:0000777;GO:0030981;GO:0005881;GO:0005829;GO:0005794;GO:0000776;GO:0005828;GO:0016020;GO:0005815;GO:0035371;GO:0072686;GO:0005876;GO:0002162;GO:0043515;GO:0008017;GO:0051010;GO:0030953;GO:0051301;GO:0097711;GO:0090162;GO:0040001;GO:0051294;GO:0007163;GO:0010458;GO:0000086;GO:0007030;GO:0034453;GO:0001578;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0007026;GO:0031111;GO:0051497;GO:1903690;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0031116;GO:0010717;GO:0051893;GO:0010389;GO:0010470;GO:0070507;GO:0006903;, C:basal cortex; C:cell cortex; C:centrosomal corona; C:centrosome; C:condensed chromosome kinetochore; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle; C:spindle microtubule;, F:dystroglycan binding; F:kinetochore binding; F:microtubule binding; F:microtubule plus-end binding;, P:astral microtubule organization; P:cell division; P:ciliary basal body-plasma membrane docking; P:establishment of epithelial cell polarity; P:establishment of mitotic spindle localization; P:establishment of spindle orientation; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule anchoring; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:positive regulation of microtubule polymerization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; P:vesicle targeting;|Q7Z460 A2RU21 B7ZLX3 F5GWS0 O75118 Q2KHQ9 Q5H9P0 Q8N5B8 Q9BQT5,CLIP-associating protein 1,Cytoplasmic linker-associated protein 1;Multiple asters homolog 1;Protein Orbit homolog 1;, PF12348;, GO:0045180;GO:0005938;GO:0031592;GO:0005813;GO:0000777;GO:0030981;GO:0005881;GO:0005829;GO:0005794;GO:0000776;GO:0005828;GO:0016020;GO:0005815;GO:0035371;GO:0072686;GO:0005876;GO:0002162;GO:0043515;GO:0008017;GO:0051010;GO:0030953;GO:0051301;GO:0097711;GO:0090162;GO:0040001;GO:0051294;GO:0007163;GO:0010458;GO:0000086;GO:0007030;GO:0034453;GO:0001578;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0007026;GO:0031111;GO:0051497;GO:1903690;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0031116;GO:0010717;GO:0051893;GO:0010389;GO:0010470;GO:0070507;GO:0006903;, C:basal cortex; C:cell cortex; C:centrosomal corona; C:centrosome; C:condensed chromosome kinetochore; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle; C:spindle microtubule;, F:dystroglycan binding; F:kinetochore binding; F:microtubule binding; F:microtubule plus-end binding;, P:astral microtubule organization; P:cell division; P:ciliary basal body-plasma membrane docking; P:establishment of epithelial cell polarity; P:establishment of mitotic spindle localization; P:establishment of spindle orientation; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule anchoring; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:positive regulation of microtubule polymerization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; P:vesicle targeting;|Q7Z460 A2RU21 B7ZLX3 F5GWS0 O75118 Q2KHQ9 Q5H9P0 Q8N5B8 Q9BQT5,CLIP-associating protein 1,Cytoplasmic linker-associated protein 1;Multiple asters homolog 1;Protein Orbit homolog 1;, PF12348;, GO:0045180;GO:0005938;GO:0031592;GO:0005813;GO:0000777;GO:0030981;GO:0005881;GO:0005829;GO:0005794;GO:0000776;GO:0005828;GO:0016020;GO:0005815;GO:0035371;GO:0072686;GO:0005876;GO:0002162;GO:0043515;GO:0008017;GO:0051010;GO:0030953;GO:0051301;GO:0097711;GO:0090162;GO:0040001;GO:0051294;GO:0007163;GO:0010458;GO:0000086;GO:0007030;GO:0034453;GO:0001578;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0007026;GO:0031111;GO:0051497;GO:1903690;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0031116;GO:0010717;GO:0051893;GO:0010389;GO:0010470;GO:0070507;GO:0006903;, C:basal cortex; C:cell cortex; C:centrosomal corona; C:centrosome; C:condensed chromosome kinetochore; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle; C:spindle microtubule;, F:dystroglycan binding; F:kinetochore binding; F:microtubule binding; F:microtubule plus-end binding;, P:astral microtubule organization; P:cell division; P:ciliary basal body-plasma membrane docking; P:establishment of epithelial cell polarity; P:establishment of mitotic spindle localization; P:establishment of spindle orientation; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule anchoring; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:positive regulation of microtubule polymerization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; P:vesicle targeting;|Q7Z460 A2RU21 B7ZLX3 F5GWS0 O75118 Q2KHQ9 Q5H9P0 Q8N5B8 Q9BQT5,CLIP-associating protein 1,Cytoplasmic linker-associated protein 1;Multiple asters homolog 1;Protein Orbit homolog 1;, PF12348;, GO:0045180;GO:0005938;GO:0031592;GO:0005813;GO:0000777;GO:0030981;GO:0005881;GO:0005829;GO:0005794;GO:0000776;GO:0005828;GO:0016020;GO:0005815;GO:0035371;GO:0072686;GO:0005876;GO:0002162;GO:0043515;GO:0008017;GO:0051010;GO:0030953;GO:0051301;GO:0097711;GO:0090162;GO:0040001;GO:0051294;GO:0007163;GO:0010458;GO:0000086;GO:0007030;GO:0034453;GO:0001578;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0007026;GO:0031111;GO:0051497;GO:1903690;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0031116;GO:0010717;GO:0051893;GO:0010389;GO:0010470;GO:0070507;GO:0006903;, C:basal cortex; C:cell cortex; C:centrosomal corona; C:centrosome; C:condensed chromosome kinetochore; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle; C:spindle microtubule;, F:dystroglycan binding; F:kinetochore binding; F:microtubule binding; F:microtubule plus-end binding;, P:astral microtubule organization; P:cell division; P:ciliary basal body-plasma membrane docking; P:establishment of epithelial cell polarity; P:establishment of mitotic spindle localization; P:establishment of spindle orientation; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule anchoring; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:positive regulation of microtubule polymerization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; P:vesicle targeting;|Q7Z460 A2RU21 B7ZLX3 F5GWS0 O75118 Q2KHQ9 Q5H9P0 Q8N5B8 Q9BQT5,CLIP-associating protein 1,Cytoplasmic linker-associated protein 1;Multiple asters homolog 1;Protein Orbit homolog 1;, PF12348;, GO:0045180;GO:0005938;GO:0031592;GO:0005813;GO:0000777;GO:0030981;GO:0005881;GO:0005829;GO:0005794;GO:0000776;GO:0005828;GO:0016020;GO:0005815;GO:0035371;GO:0072686;GO:0005876;GO:0002162;GO:0043515;GO:0008017;GO:0051010;GO:0030953;GO:0051301;GO:0097711;GO:0090162;GO:0040001;GO:0051294;GO:0007163;GO:0010458;GO:0000086;GO:0007030;GO:0034453;GO:0001578;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0007026;GO:0031111;GO:0051497;GO:1903690;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0031116;GO:0010717;GO:0051893;GO:0010389;GO:0010470;GO:0070507;GO:0006903;, C:basal cortex; C:cell cortex; C:centrosomal corona; C:centrosome; C:condensed chromosome kinetochore; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle; C:spindle microtubule;, F:dystroglycan binding; F:kinetochore binding; F:microtubule binding; F:microtubule plus-end binding;, P:astral microtubule organization; P:cell division; P:ciliary basal body-plasma membrane docking; P:establishment of epithelial cell polarity; P:establishment of mitotic spindle localization; P:establishment of spindle orientation; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule anchoring; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:positive regulation of microtubule polymerization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; P:vesicle targeting;|Q7Z460 A2RU21 B7ZLX3 F5GWS0 O75118 Q2KHQ9 Q5H9P0 Q8N5B8 Q9BQT5,CLIP-associating protein 1,Cytoplasmic linker-associated protein 1;Multiple asters homolog 1;Protein Orbit homolog 1;, PF12348;, GO:0045180;GO:0005938;GO:0031592;GO:0005813;GO:0000777;GO:0030981;GO:0005881;GO:0005829;GO:0005794;GO:0000776;GO:0005828;GO:0016020;GO:0005815;GO:0035371;GO:0072686;GO:0005876;GO:0002162;GO:0043515;GO:0008017;GO:0051010;GO:0030953;GO:0051301;GO:0097711;GO:0090162;GO:0040001;GO:0051294;GO:0007163;GO:0010458;GO:0000086;GO:0007030;GO:0034453;GO:0001578;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0007026;GO:0031111;GO:0051497;GO:1903690;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0031116;GO:0010717;GO:0051893;GO:0010389;GO:0010470;GO:0070507;GO:0006903;, C:basal cortex; C:cell cortex; C:centrosomal corona; C:centrosome; C:condensed chromosome kinetochore; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle; C:spindle microtubule;, F:dystroglycan binding; F:kinetochore binding; F:microtubule binding; F:microtubule plus-end binding;, P:astral microtubule organization; P:cell division; P:ciliary basal body-plasma membrane docking; P:establishment of epithelial cell polarity; P:establishment of mitotic spindle localization; P:establishment of spindle orientation; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule anchoring; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:positive regulation of microtubule polymerization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; P:vesicle targeting;|Q7Z460 A2RU21 B7ZLX3 F5GWS0 O75118 Q2KHQ9 Q5H9P0 Q8N5B8 Q9BQT5,CLIP-associating protein 1,Cytoplasmic linker-associated protein 1;Multiple asters homolog 1;Protein Orbit homolog 1;, PF12348;, GO:0045180;GO:0005938;GO:0031592;GO:0005813;GO:0000777;GO:0030981;GO:0005881;GO:0005829;GO:0005794;GO:0000776;GO:0005828;GO:0016020;GO:0005815;GO:0035371;GO:0072686;GO:0005876;GO:0002162;GO:0043515;GO:0008017;GO:0051010;GO:0030953;GO:0051301;GO:0097711;GO:0090162;GO:0040001;GO:0051294;GO:0007163;GO:0010458;GO:0000086;GO:0007030;GO:0034453;GO:0001578;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0007026;GO:0031111;GO:0051497;GO:1903690;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0031116;GO:0010717;GO:0051893;GO:0010389;GO:0010470;GO:0070507;GO:0006903;, C:basal cortex; C:cell cortex; C:centrosomal corona; C:centrosome; C:condensed chromosome kinetochore; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle; C:spindle microtubule;, F:dystroglycan binding; F:kinetochore binding; F:microtubule binding; F:microtubule plus-end binding;, P:astral microtubule organization; P:cell division; P:ciliary basal body-plasma membrane docking; P:establishment of epithelial cell polarity; P:establishment of mitotic spindle localization; P:establishment of spindle orientation; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule anchoring; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:positive regulation of microtubule polymerization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; P:vesicle targeting;|Q7Z460 A2RU21 B7ZLX3 F5GWS0 O75118 Q2KHQ9 Q5H9P0 Q8N5B8 Q9BQT5,CLIP-associating protein 1,Cytoplasmic linker-associated protein 1;Multiple asters homolog 1;Protein Orbit homolog 1;, PF12348;, GO:0045180;GO:0005938;GO:0031592;GO:0005813;GO:0000777;GO:0030981;GO:0005881;GO:0005829;GO:0005794;GO:0000776;GO:0005828;GO:0016020;GO:0005815;GO:0035371;GO:0072686;GO:0005876;GO:0002162;GO:0043515;GO:0008017;GO:0051010;GO:0030953;GO:0051301;GO:0097711;GO:0090162;GO:0040001;GO:0051294;GO:0007163;GO:0010458;GO:0000086;GO:0007030;GO:0034453;GO:0001578;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0007026;GO:0031111;GO:0051497;GO:1903690;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0031116;GO:0010717;GO:0051893;GO:0010389;GO:0010470;GO:0070507;GO:0006903;, C:basal cortex; C:cell cortex; C:centrosomal corona; C:centrosome; C:condensed chromosome kinetochore; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle; C:spindle microtubule;, F:dystroglycan binding; F:kinetochore binding; F:microtubule binding; F:microtubule plus-end binding;, P:astral microtubule organization; P:cell division; P:ciliary basal body-plasma membrane docking; P:establishment of epithelial cell polarity; P:establishment of mitotic spindle localization; P:establishment of spindle orientation; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule anchoring; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:positive regulation of microtubule polymerization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; P:vesicle targeting;|Q7Z460 A2RU21 B7ZLX3 F5GWS0 O75118 Q2KHQ9 Q5H9P0 Q8N5B8 Q9BQT5,CLIP-associating protein 1,Cytoplasmic linker-associated protein 1;Multiple asters homolog 1;Protein Orbit homolog 1;, PF12348;, GO:0045180;GO:0005938;GO:0031592;GO:0005813;GO:0000777;GO:0030981;GO:0005881;GO:0005829;GO:0005794;GO:0000776;GO:0005828;GO:0016020;GO:0005815;GO:0035371;GO:0072686;GO:0005876;GO:0002162;GO:0043515;GO:0008017;GO:0051010;GO:0030953;GO:0051301;GO:0097711;GO:0090162;GO:0040001;GO:0051294;GO:0007163;GO:0010458;GO:0000086;GO:0007030;GO:0034453;GO:0001578;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0007026;GO:0031111;GO:0051497;GO:1903690;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0031116;GO:0010717;GO:0051893;GO:0010389;GO:0010470;GO:0070507;GO:0006903;, C:basal cortex; C:cell cortex; C:centrosomal corona; C:centrosome; C:condensed chromosome kinetochore; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle; C:spindle microtubule;, F:dystroglycan binding; F:kinetochore binding; F:microtubule binding; F:microtubule plus-end binding;, P:astral microtubule organization; P:cell division; P:ciliary basal body-plasma membrane docking; P:establishment of epithelial cell polarity; P:establishment of mitotic spindle localization; P:establishment of spindle orientation; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule anchoring; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:positive regulation of microtubule polymerization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; P:vesicle targeting;|Q7Z460 A2RU21 B7ZLX3 F5GWS0 O75118 Q2KHQ9 Q5H9P0 Q8N5B8 Q9BQT5,CLIP-associating protein 1,Cytoplasmic linker-associated protein 1;Multiple asters homolog 1;Protein Orbit homolog 1;, PF12348;, GO:0045180;GO:0005938;GO:0031592;GO:0005813;GO:0000777;GO:0030981;GO:0005881;GO:0005829;GO:0005794;GO:0000776;GO:0005828;GO:0016020;GO:0005815;GO:0035371;GO:0072686;GO:0005876;GO:0002162;GO:0043515;GO:0008017;GO:0051010;GO:0030953;GO:0051301;GO:0097711;GO:0090162;GO:0040001;GO:0051294;GO:0007163;GO:0010458;GO:0000086;GO:0007030;GO:0034453;GO:0001578;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0007026;GO:0031111;GO:0051497;GO:1903690;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0031116;GO:0010717;GO:0051893;GO:0010389;GO:0010470;GO:0070507;GO:0006903;, C:basal cortex; C:cell cortex; C:centrosomal corona; C:centrosome; C:condensed chromosome kinetochore; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle; C:spindle microtubule;, F:dystroglycan binding; F:kinetochore binding; F:microtubule binding; F:microtubule plus-end binding;, P:astral microtubule organization; P:cell division; P:ciliary basal body-plasma membrane docking; P:establishment of epithelial cell polarity; P:establishment of mitotic spindle localization; P:establishment of spindle orientation; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule anchoring; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:positive regulation of microtubule polymerization; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; P:vesicle targeting; scaffold9 indexed_genome mRNA 7026060 7026741 . + . ID=transcript_2390;P10070 O60252 O60253 O60254 O60255 Q15590 Q15591 Q4JHT4,Zinc finger protein GLI2 {ECO:0000305},GLI family zinc finger protein 2 {ECO:0000312|HGNC:HGNC:4318};Tax helper protein {ECO:0000303|PubMed:9557682};, PF00096;, GO:0005930;GO:0097546;GO:0097542;GO:0005929;GO:0005829;GO:0016020;GO:0031514;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:1990841;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0008270;GO:0009952;GO:0007411;GO:0048754;GO:0071407;GO:0098586;GO:0021696;GO:0002062;GO:0090103;GO:0048589;GO:0048566;GO:0042733;GO:0009913;GO:0021508;GO:0031069;GO:0007507;GO:0030902;GO:0007442;GO:0001701;GO:0001822;GO:0030324;GO:0030879;GO:0060603;GO:0043066;GO:0032331;GO:0045879;GO:0000122;GO:0048666;GO:0060032;GO:0042475;GO:0002076;GO:0001649;GO:0007389;GO:0021983;GO:0045740;GO:0045666;GO:0033089;GO:0045944;GO:0045893;GO:0060513;GO:0009954;GO:1901620;GO:0006357;GO:0001501;GO:0007224;GO:0060831;GO:0021938;GO:0021776;GO:0021775;GO:0021513;GO:0021965;GO:0035295;GO:0007418;GO:0021517;, C:axoneme; C:ciliary base; C:ciliary tip; C:cilium; C:cytosol; C:membrane; C:motile cilium; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:zinc ion binding;, P:anterior/posterior pattern specification; P:axon guidance; P:branching morphogenesis of an epithelial tube; P:cellular response to organic cyclic compound; P:cellular response to virus; P:cerebellar cortex morphogenesis; P:chondrocyte differentiation; P:cochlea morphogenesis; P:developmental growth; P:embryonic digestive tract development; P:embryonic digit morphogenesis; P:epidermal cell differentiation; P:floor plate formation; P:hair follicle morphogenesis; P:heart development; P:hindbrain development; P:hindgut morphogenesis; P:in utero embryonic development; P:kidney development; P:lung development; P:mammary gland development; P:mammary gland duct morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of chondrocyte differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neuron development; P:notochord regression; P:odontogenesis of dentin-containing tooth; P:osteoblast development; P:osteoblast differentiation; P:pattern specification process; P:pituitary gland development; P:positive regulation of DNA replication; P:positive regulation of neuron differentiation; P:positive regulation of T cell differentiation in thymus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostatic bud formation; P:proximal/distal pattern formation; P:regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:regulation of transcription by RNA polymerase II; P:skeletal system development; P:smoothened signaling pathway; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; P:spinal cord dorsal/ventral patterning; P:spinal cord ventral commissure morphogenesis; P:tube development; P:ventral midline development; P:ventral spinal cord development; scaffold9 indexed_genome mRNA 7027006 7027533 . + . ID=transcript_2391;P10070 O60252 O60253 O60254 O60255 Q15590 Q15591 Q4JHT4,Zinc finger protein GLI2 {ECO:0000305},GLI family zinc finger protein 2 {ECO:0000312|HGNC:HGNC:4318};Tax helper protein {ECO:0000303|PubMed:9557682};, PF00096;, GO:0005930;GO:0097546;GO:0097542;GO:0005929;GO:0005829;GO:0016020;GO:0031514;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:1990841;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0008270;GO:0009952;GO:0007411;GO:0048754;GO:0071407;GO:0098586;GO:0021696;GO:0002062;GO:0090103;GO:0048589;GO:0048566;GO:0042733;GO:0009913;GO:0021508;GO:0031069;GO:0007507;GO:0030902;GO:0007442;GO:0001701;GO:0001822;GO:0030324;GO:0030879;GO:0060603;GO:0043066;GO:0032331;GO:0045879;GO:0000122;GO:0048666;GO:0060032;GO:0042475;GO:0002076;GO:0001649;GO:0007389;GO:0021983;GO:0045740;GO:0045666;GO:0033089;GO:0045944;GO:0045893;GO:0060513;GO:0009954;GO:1901620;GO:0006357;GO:0001501;GO:0007224;GO:0060831;GO:0021938;GO:0021776;GO:0021775;GO:0021513;GO:0021965;GO:0035295;GO:0007418;GO:0021517;, C:axoneme; C:ciliary base; C:ciliary tip; C:cilium; C:cytosol; C:membrane; C:motile cilium; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:zinc ion binding;, P:anterior/posterior pattern specification; P:axon guidance; P:branching morphogenesis of an epithelial tube; P:cellular response to organic cyclic compound; P:cellular response to virus; P:cerebellar cortex morphogenesis; P:chondrocyte differentiation; P:cochlea morphogenesis; P:developmental growth; P:embryonic digestive tract development; P:embryonic digit morphogenesis; P:epidermal cell differentiation; P:floor plate formation; P:hair follicle morphogenesis; P:heart development; P:hindbrain development; P:hindgut morphogenesis; P:in utero embryonic development; P:kidney development; P:lung development; P:mammary gland development; P:mammary gland duct morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of chondrocyte differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neuron development; P:notochord regression; P:odontogenesis of dentin-containing tooth; P:osteoblast development; P:osteoblast differentiation; P:pattern specification process; P:pituitary gland development; P:positive regulation of DNA replication; P:positive regulation of neuron differentiation; P:positive regulation of T cell differentiation in thymus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostatic bud formation; P:proximal/distal pattern formation; P:regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:regulation of transcription by RNA polymerase II; P:skeletal system development; P:smoothened signaling pathway; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; P:spinal cord dorsal/ventral patterning; P:spinal cord ventral commissure morphogenesis; P:tube development; P:ventral midline development; P:ventral spinal cord development; scaffold9 indexed_genome mRNA 7819524 7900454 . - . ID=transcript_2392;Q9HCM4 Q7Z5S1 Q8IZ12 Q9H975,Band 4.1-like protein 5,Erythrocyte membrane protein band 4.1-like 5 {ECO:0000312|HGNC:HGNC:19819};, PF08736;PF09380;PF00373;PF09379;, GO:0005912;GO:0005856;GO:0005829;GO:0005925;GO:0005654;GO:0001917;GO:0005886;GO:0032587;GO:0008092;GO:0019904;GO:0031032;GO:0003383;GO:0048319;GO:0071560;GO:0007398;GO:0048617;GO:0007492;GO:0001837;GO:0001701;GO:0070986;GO:0007509;GO:0022408;GO:0032091;GO:0001839;GO:0048339;GO:0010634;GO:0051894;GO:0032092;GO:0010608;GO:0070201;GO:0032525;GO:0006931;GO:0009826;, C:adherens junction; C:cytoskeleton; C:cytosol; C:focal adhesion; C:nucleoplasm; C:photoreceptor inner segment; C:plasma membrane; C:ruffle membrane;, F:cytoskeletal protein binding; F:protein domain specific binding;, P:actomyosin structure organization; P:apical constriction; P:axial mesoderm morphogenesis; P:cellular response to transforming growth factor beta stimulus; P:ectoderm development; P:embryonic foregut morphogenesis; P:endoderm development; P:epithelial to mesenchymal transition; P:in utero embryonic development; P:left/right axis specification; P:mesoderm migration involved in gastrulation; P:negative regulation of cell-cell adhesion; P:negative regulation of protein binding; P:neural plate morphogenesis; P:paraxial mesoderm development; P:positive regulation of epithelial cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of protein binding; P:posttranscriptional regulation of gene expression; P:regulation of establishment of protein localization; P:somite rostral/caudal axis specification; P:substrate-dependent cell migration, cell attachment to substrate; P:unidimensional cell growth;|Q9HCM4 Q7Z5S1 Q8IZ12 Q9H975,Band 4.1-like protein 5,Erythrocyte membrane protein band 4.1-like 5 {ECO:0000312|HGNC:HGNC:19819};, PF08736;PF09380;PF00373;PF09379;, GO:0005912;GO:0005856;GO:0005829;GO:0005925;GO:0005654;GO:0001917;GO:0005886;GO:0032587;GO:0008092;GO:0019904;GO:0031032;GO:0003383;GO:0048319;GO:0071560;GO:0007398;GO:0048617;GO:0007492;GO:0001837;GO:0001701;GO:0070986;GO:0007509;GO:0022408;GO:0032091;GO:0001839;GO:0048339;GO:0010634;GO:0051894;GO:0032092;GO:0010608;GO:0070201;GO:0032525;GO:0006931;GO:0009826;, C:adherens junction; C:cytoskeleton; C:cytosol; C:focal adhesion; C:nucleoplasm; C:photoreceptor inner segment; C:plasma membrane; C:ruffle membrane;, F:cytoskeletal protein binding; F:protein domain specific binding;, P:actomyosin structure organization; P:apical constriction; P:axial mesoderm morphogenesis; P:cellular response to transforming growth factor beta stimulus; P:ectoderm development; P:embryonic foregut morphogenesis; P:endoderm development; P:epithelial to mesenchymal transition; P:in utero embryonic development; P:left/right axis specification; P:mesoderm migration involved in gastrulation; P:negative regulation of cell-cell adhesion; P:negative regulation of protein binding; P:neural plate morphogenesis; P:paraxial mesoderm development; P:positive regulation of epithelial cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of protein binding; P:posttranscriptional regulation of gene expression; P:regulation of establishment of protein localization; P:somite rostral/caudal axis specification; P:substrate-dependent cell migration, cell attachment to substrate; P:unidimensional cell growth; scaffold9 indexed_genome mRNA 7919451 8099251 . - . ID=transcript_2393;P29074 B2RBV8 Q9UDA7,Tyrosine-protein phosphatase non-receptor type 4,Protein-tyrosine phosphatase MEG1;, PF08736;PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0005737;GO:0009898;GO:0005856;GO:0005829;GO:0005654;GO:0008092;GO:0004726;GO:0004725;GO:0071345;GO:0006470;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:nucleoplasm;, F:cytoskeletal protein binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:protein dephosphorylation;|P29074 B2RBV8 Q9UDA7,Tyrosine-protein phosphatase non-receptor type 4,Protein-tyrosine phosphatase MEG1;, PF08736;PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0005737;GO:0009898;GO:0005856;GO:0005829;GO:0005654;GO:0008092;GO:0004726;GO:0004725;GO:0071345;GO:0006470;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:nucleoplasm;, F:cytoskeletal protein binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:protein dephosphorylation;|P29074 B2RBV8 Q9UDA7,Tyrosine-protein phosphatase non-receptor type 4,Protein-tyrosine phosphatase MEG1;, PF08736;PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0005737;GO:0009898;GO:0005856;GO:0005829;GO:0005654;GO:0008092;GO:0004726;GO:0004725;GO:0071345;GO:0006470;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:nucleoplasm;, F:cytoskeletal protein binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:protein dephosphorylation;|P29074 B2RBV8 Q9UDA7,Tyrosine-protein phosphatase non-receptor type 4,Protein-tyrosine phosphatase MEG1;, PF08736;PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0005737;GO:0009898;GO:0005856;GO:0005829;GO:0005654;GO:0008092;GO:0004726;GO:0004725;GO:0071345;GO:0006470;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:nucleoplasm;, F:cytoskeletal protein binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:protein dephosphorylation;|P29074 B2RBV8 Q9UDA7,Tyrosine-protein phosphatase non-receptor type 4,Protein-tyrosine phosphatase MEG1;, PF08736;PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0005737;GO:0009898;GO:0005856;GO:0005829;GO:0005654;GO:0008092;GO:0004726;GO:0004725;GO:0071345;GO:0006470;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:nucleoplasm;, F:cytoskeletal protein binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:protein dephosphorylation; scaffold9 indexed_genome mRNA 8099256 9010309 . + . ID=transcript_2394;Q05925 Q4ZG44,Homeobox protein engrailed-1,, PF10525;PF00046;, GO:0000785;GO:0016020;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0008344;GO:0009653;GO:0021549;GO:0071542;GO:0009953;GO:0042756;GO:1990403;GO:0035115;GO:0030901;GO:0030917;GO:0061743;GO:0035264;GO:0043524;GO:0000122;GO:0048666;GO:0030182;GO:0043473;GO:0045944;GO:0009954;GO:0006357;GO:0042220;GO:0001501;GO:0035176;, C:chromatin; C:membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adult locomotory behavior; P:anatomical structure morphogenesis; P:cerebellum development; P:dopaminergic neuron differentiation; P:dorsal/ventral pattern formation; P:drinking behavior; P:embryonic brain development; P:embryonic forelimb morphogenesis; P:midbrain development; P:midbrain-hindbrain boundary development; P:motor learning; P:multicellular organism growth; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:neuron development; P:neuron differentiation; P:pigmentation; P:positive regulation of transcription by RNA polymerase II; P:proximal/distal pattern formation; P:regulation of transcription by RNA polymerase II; P:response to cocaine; P:skeletal system development; P:social behavior;|Q53S58 Q9BT20,Transmembrane protein 177,, , GO:0031305;, C:integral component of mitochondrial inner membrane;|Q4G0U5 B4DEK0 B4E2T5,Cilia- and flagella-associated protein 221 {ECO:0000312|HGNC:HGNC:33720},Primary ciliary dyskinesia protein 1 {ECO:0000303|PubMed:18039845};, , GO:0005930;GO:0005929;GO:0005516;GO:0060271;GO:0003341;GO:0044458;, C:axoneme; C:cilium;, F:calmodulin binding;, P:cilium assembly; P:cilium movement; P:motile cilium assembly;|Q4G0U5 B4DEK0 B4E2T5,Cilia- and flagella-associated protein 221 {ECO:0000312|HGNC:HGNC:33720},Primary ciliary dyskinesia protein 1 {ECO:0000303|PubMed:18039845};, , GO:0005930;GO:0005929;GO:0005516;GO:0060271;GO:0003341;GO:0044458;, C:axoneme; C:cilium;, F:calmodulin binding;, P:cilium assembly; P:cilium movement; P:motile cilium assembly;|Q4G0U5 B4DEK0 B4E2T5,Cilia- and flagella-associated protein 221 {ECO:0000312|HGNC:HGNC:33720},Primary ciliary dyskinesia protein 1 {ECO:0000303|PubMed:18039845};, , GO:0005930;GO:0005929;GO:0005516;GO:0060271;GO:0003341;GO:0044458;, C:axoneme; C:cilium;, F:calmodulin binding;, P:cilium assembly; P:cilium movement; P:motile cilium assembly;|P47872 Q12961 Q13213 Q53T00,Secretin receptor,, PF00002;PF02793;, GO:0005881;GO:0016021;GO:0005886;GO:0008528;GO:0017046;GO:0015055;GO:0007188;GO:0007420;GO:0007166;GO:0009992;GO:0002024;GO:0007186;GO:0002862;GO:0043950;GO:0032098;GO:0048167;GO:0031667;, C:cytoplasmic microtubule; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:peptide hormone binding; F:secretin receptor activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:brain development; P:cell surface receptor signaling pathway; P:cellular water homeostasis; P:diet induced thermogenesis; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of cAMP-mediated signaling; P:regulation of appetite; P:regulation of synaptic plasticity; P:response to nutrient levels;|P07108 B8ZWD2 B8ZWD6 B8ZWD7 P08869 Q4VWZ6 Q53SQ7 Q6IB48 Q9UCI8,Acyl-CoA-binding protein,Diazepam-binding inhibitor;Endozepine;, PF00887;, GO:0005788;GO:0070062;GO:0005794;GO:0097038;GO:0032994;GO:0030156;GO:0042802;GO:0008289;GO:0036042;GO:0006637;GO:1903060;GO:0036151;GO:1905920;GO:2001140;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:Golgi apparatus; C:perinuclear endoplasmic reticulum; C:protein-lipid complex;, F:benzodiazepine receptor binding; F:identical protein binding; F:lipid binding; F:long-chain fatty acyl-CoA binding;, P:acyl-CoA metabolic process; P:negative regulation of protein lipidation; P:phosphatidylcholine acyl-chain remodeling; P:positive regulation of CoA-transferase activity; P:positive regulation of phospholipid transport;|P07108 B8ZWD2 B8ZWD6 B8ZWD7 P08869 Q4VWZ6 Q53SQ7 Q6IB48 Q9UCI8,Acyl-CoA-binding protein,Diazepam-binding inhibitor;Endozepine;, PF00887;, GO:0005788;GO:0070062;GO:0005794;GO:0097038;GO:0032994;GO:0030156;GO:0042802;GO:0008289;GO:0036042;GO:0006637;GO:1903060;GO:0036151;GO:1905920;GO:2001140;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:Golgi apparatus; C:perinuclear endoplasmic reticulum; C:protein-lipid complex;, F:benzodiazepine receptor binding; F:identical protein binding; F:lipid binding; F:long-chain fatty acyl-CoA binding;, P:acyl-CoA metabolic process; P:negative regulation of protein lipidation; P:phosphatidylcholine acyl-chain remodeling; P:positive regulation of CoA-transferase activity; P:positive regulation of phospholipid transport;|Q3KRA6 B7ZLS8 Q4VC35,UPF0538 protein C2orf76,, PF10209;|Q3KRA6 B7ZLS8 Q4VC35,UPF0538 protein C2orf76,, PF10209;|Q3KRA6 B7ZLS8 Q4VC35,UPF0538 protein C2orf76,, PF10209;|Q8TF03 Q9NVB5,Metalloreductase STEAP3,Dudulin-2;Six-transmembrane epithelial antigen of prostate 3;Tumor suppressor-activated pathway protein 6;pHyde;, PF03807;PF01794;, GO:0005737;GO:0005768;GO:0010008;GO:0016021;GO:0005771;GO:0005886;GO:0008823;GO:0052851;GO:0042802;GO:0046872;GO:0006915;GO:0007049;GO:0015677;GO:0055072;GO:0009306;GO:0042981;GO:0033572;, C:cytoplasm; C:endosome; C:endosome membrane; C:integral component of membrane; C:multivesicular body; C:plasma membrane;, F:cupric reductase activity; F:ferric-chelate reductase (NADPH) activity; F:identical protein binding; F:metal ion binding;, P:apoptotic process; P:cell cycle; P:copper ion import; P:iron ion homeostasis; P:protein secretion; P:regulation of apoptotic process; P:transferrin transport;|Q8TF03 Q9NVB5,Metalloreductase STEAP3,Dudulin-2;Six-transmembrane epithelial antigen of prostate 3;Tumor suppressor-activated pathway protein 6;pHyde;, PF03807;PF01794;, GO:0005737;GO:0005768;GO:0010008;GO:0016021;GO:0005771;GO:0005886;GO:0008823;GO:0052851;GO:0042802;GO:0046872;GO:0006915;GO:0007049;GO:0015677;GO:0055072;GO:0009306;GO:0042981;GO:0033572;, C:cytoplasm; C:endosome; C:endosome membrane; C:integral component of membrane; C:multivesicular body; C:plasma membrane;, F:cupric reductase activity; F:ferric-chelate reductase (NADPH) activity; F:identical protein binding; F:metal ion binding;, P:apoptotic process; P:cell cycle; P:copper ion import; P:iron ion homeostasis; P:protein secretion; P:regulation of apoptotic process; P:transferrin transport;|Q8TF03 Q9NVB5,Metalloreductase STEAP3,Dudulin-2;Six-transmembrane epithelial antigen of prostate 3;Tumor suppressor-activated pathway protein 6;pHyde;, PF03807;PF01794;, GO:0005737;GO:0005768;GO:0010008;GO:0016021;GO:0005771;GO:0005886;GO:0008823;GO:0052851;GO:0042802;GO:0046872;GO:0006915;GO:0007049;GO:0015677;GO:0055072;GO:0009306;GO:0042981;GO:0033572;, C:cytoplasm; C:endosome; C:endosome membrane; C:integral component of membrane; C:multivesicular body; C:plasma membrane;, F:cupric reductase activity; F:ferric-chelate reductase (NADPH) activity; F:identical protein binding; F:metal ion binding;, P:apoptotic process; P:cell cycle; P:copper ion import; P:iron ion homeostasis; P:protein secretion; P:regulation of apoptotic process; P:transferrin transport;|Q9UEW3 B4DW79 Q9Y5S3,Macrophage receptor MARCO,Macrophage receptor with collagenous structure;Scavenger receptor class A member 2;, PF01391;PF00530;, GO:0005581;GO:0005737;GO:0030666;GO:0005887;GO:0005886;GO:0001540;GO:0038024;GO:0001664;GO:0038187;GO:0005044;GO:0004888;GO:0007193;GO:0097242;GO:0043277;GO:0007166;GO:0006897;GO:0045087;GO:0006911;GO:0070374;GO:0001934;GO:0006898;, C:collagen trimer; C:cytoplasm; C:endocytic vesicle membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amyloid-beta binding; F:cargo receptor activity; F:G protein-coupled receptor binding; F:pattern recognition receptor activity; F:scavenger receptor activity; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:amyloid-beta clearance; P:apoptotic cell clearance; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phagocytosis, engulfment; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; P:receptor-mediated endocytosis; scaffold9 indexed_genome mRNA 9765475 9786186 . - . ID=transcript_2395;Q9Y5U4 A8K5W8 Q8TBI8,Insulin-induced gene 2 protein {ECO:0000303|PubMed:12242332},, PF07281;, GO:0005783;GO:0005789;GO:0032937;GO:0008142;GO:0032869;GO:0006695;GO:0032933;GO:0036316;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:SREBP-SCAP-Insig complex;, F:oxysterol binding;, P:cellular response to insulin stimulus; P:cholesterol biosynthetic process; P:SREBP signaling pathway; P:SREBP-SCAP complex retention in endoplasmic reticulum; P:sterol biosynthetic process;|Q9Y5U4 A8K5W8 Q8TBI8,Insulin-induced gene 2 protein {ECO:0000303|PubMed:12242332},, PF07281;, GO:0005783;GO:0005789;GO:0032937;GO:0008142;GO:0032869;GO:0006695;GO:0032933;GO:0036316;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:SREBP-SCAP-Insig complex;, F:oxysterol binding;, P:cellular response to insulin stimulus; P:cholesterol biosynthetic process; P:SREBP signaling pathway; P:SREBP-SCAP complex retention in endoplasmic reticulum; P:sterol biosynthetic process; scaffold9 indexed_genome mRNA 9876584 9963308 . + . ID=transcript_2396;Q567U6 A8K3V7 Q4LE78 Q53TJ2 Q8TBX5 Q9H6R5 Q9NV15,Coiled-coil domain-containing protein 93,, PF09762;, GO:0005769;GO:0043231;GO:0032456;GO:0006893;GO:0015031;GO:1990126;, C:early endosome; C:intracellular membrane-bounded organelle;, , P:endocytic recycling; P:Golgi to plasma membrane transport; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q567U6 A8K3V7 Q4LE78 Q53TJ2 Q8TBX5 Q9H6R5 Q9NV15,Coiled-coil domain-containing protein 93,, PF09762;, GO:0005769;GO:0043231;GO:0032456;GO:0006893;GO:0015031;GO:1990126;, C:early endosome; C:intracellular membrane-bounded organelle;, , P:endocytic recycling; P:Golgi to plasma membrane transport; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q567U6 A8K3V7 Q4LE78 Q53TJ2 Q8TBX5 Q9H6R5 Q9NV15,Coiled-coil domain-containing protein 93,, PF09762;, GO:0005769;GO:0043231;GO:0032456;GO:0006893;GO:0015031;GO:1990126;, C:early endosome; C:intracellular membrane-bounded organelle;, , P:endocytic recycling; P:Golgi to plasma membrane transport; P:protein transport; P:retrograde transport, endosome to plasma membrane; scaffold9 indexed_genome mRNA 10022016 10028192 . - . ID=transcript_2397;Q9NVP1 Q6GTZ9 Q6IAU4 Q92732 Q9BQB7,ATP-dependent RNA helicase DDX18,DEAD box protein 18;Myc-regulated DEAD box protein;, PF00270;PF13959;PF00271;, GO:0005694;GO:0016020;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0071392;GO:0000463;, C:chromosome; C:membrane; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cellular response to estradiol stimulus; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q9NVP1 Q6GTZ9 Q6IAU4 Q92732 Q9BQB7,ATP-dependent RNA helicase DDX18,DEAD box protein 18;Myc-regulated DEAD box protein;, PF00270;PF13959;PF00271;, GO:0005694;GO:0016020;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0071392;GO:0000463;, C:chromosome; C:membrane; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cellular response to estradiol stimulus; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); scaffold9 indexed_genome mRNA 11605803 11770636 . - . ID=transcript_2398;Q6TTV4 Q86YR9 Q9P236,Inactive dipeptidyl peptidase 10,Dipeptidyl peptidase IV-related protein 3;Dipeptidyl peptidase X;Dipeptidyl peptidase-like protein 2;, PF00930;PF00326;, GO:0016020;GO:0005886;GO:0008076;GO:0044325;GO:0015459;GO:0008236;GO:1903078;GO:0072659;GO:1901379;, C:membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:ion channel binding; F:potassium channel regulator activity; F:serine-type peptidase activity;, P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport;|Q6TTV4 Q86YR9 Q9P236,Inactive dipeptidyl peptidase 10,Dipeptidyl peptidase IV-related protein 3;Dipeptidyl peptidase X;Dipeptidyl peptidase-like protein 2;, PF00930;PF00326;, GO:0016020;GO:0005886;GO:0008076;GO:0044325;GO:0015459;GO:0008236;GO:1903078;GO:0072659;GO:1901379;, C:membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:ion channel binding; F:potassium channel regulator activity; F:serine-type peptidase activity;, P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport;|Q6TTV4 Q86YR9 Q9P236,Inactive dipeptidyl peptidase 10,Dipeptidyl peptidase IV-related protein 3;Dipeptidyl peptidase X;Dipeptidyl peptidase-like protein 2;, PF00930;PF00326;, GO:0016020;GO:0005886;GO:0008076;GO:0044325;GO:0015459;GO:0008236;GO:1903078;GO:0072659;GO:1901379;, C:membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:ion channel binding; F:potassium channel regulator activity; F:serine-type peptidase activity;, P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport;|Q6TTV4 Q86YR9 Q9P236,Inactive dipeptidyl peptidase 10,Dipeptidyl peptidase IV-related protein 3;Dipeptidyl peptidase X;Dipeptidyl peptidase-like protein 2;, PF00930;PF00326;, GO:0016020;GO:0005886;GO:0008076;GO:0044325;GO:0015459;GO:0008236;GO:1903078;GO:0072659;GO:1901379;, C:membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:ion channel binding; F:potassium channel regulator activity; F:serine-type peptidase activity;, P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport;|Q6TTV4 Q86YR9 Q9P236,Inactive dipeptidyl peptidase 10,Dipeptidyl peptidase IV-related protein 3;Dipeptidyl peptidase X;Dipeptidyl peptidase-like protein 2;, PF00930;PF00326;, GO:0016020;GO:0005886;GO:0008076;GO:0044325;GO:0015459;GO:0008236;GO:1903078;GO:0072659;GO:1901379;, C:membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:ion channel binding; F:potassium channel regulator activity; F:serine-type peptidase activity;, P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport; scaffold9 indexed_genome mRNA 13642663 13643780 . + . ID=transcript_2399;P61158 P32391 Q53QM2,Actin-related protein 3,Actin-like protein 3;, PF00022;, GO:0015629;GO:0005885;GO:0005903;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030027;GO:0016020;GO:0005634;GO:0035861;GO:0003779;GO:0005524;GO:0005200;GO:0070358;GO:0034314;GO:0008356;GO:0071346;GO:0060271;GO:0048013;GO:0007163;GO:0038096;GO:0016344;GO:0033206;GO:0061024;GO:0010592;GO:0045944;GO:0051653;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:brush border; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleus; C:site of double-strand break;, F:actin binding; F:ATP binding; F:structural constituent of cytoskeleton;, P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:asymmetric cell division; P:cellular response to interferon-gamma; P:cilium assembly; P:ephrin receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:meiotic chromosome movement towards spindle pole; P:meiotic cytokinesis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of transcription by RNA polymerase II; P:spindle localization; scaffold9 indexed_genome mRNA 13644371 13644979 . - . ID=transcript_2400;P61158 P32391 Q53QM2,Actin-related protein 3,Actin-like protein 3;, PF00022;, GO:0015629;GO:0005885;GO:0005903;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030027;GO:0016020;GO:0005634;GO:0035861;GO:0003779;GO:0005524;GO:0005200;GO:0070358;GO:0034314;GO:0008356;GO:0071346;GO:0060271;GO:0048013;GO:0007163;GO:0038096;GO:0016344;GO:0033206;GO:0061024;GO:0010592;GO:0045944;GO:0051653;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:brush border; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleus; C:site of double-strand break;, F:actin binding; F:ATP binding; F:structural constituent of cytoskeleton;, P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:asymmetric cell division; P:cellular response to interferon-gamma; P:cilium assembly; P:ephrin receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:meiotic chromosome movement towards spindle pole; P:meiotic cytokinesis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of transcription by RNA polymerase II; P:spindle localization; scaffold9 indexed_genome mRNA 13653278 13654713 . + . ID=transcript_2401;P61158 P32391 Q53QM2,Actin-related protein 3,Actin-like protein 3;, PF00022;, GO:0015629;GO:0005885;GO:0005903;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030027;GO:0016020;GO:0005634;GO:0035861;GO:0003779;GO:0005524;GO:0005200;GO:0070358;GO:0034314;GO:0008356;GO:0071346;GO:0060271;GO:0048013;GO:0007163;GO:0038096;GO:0016344;GO:0033206;GO:0061024;GO:0010592;GO:0045944;GO:0051653;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:brush border; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleus; C:site of double-strand break;, F:actin binding; F:ATP binding; F:structural constituent of cytoskeleton;, P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:asymmetric cell division; P:cellular response to interferon-gamma; P:cilium assembly; P:ephrin receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:meiotic chromosome movement towards spindle pole; P:meiotic cytokinesis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of transcription by RNA polymerase II; P:spindle localization; scaffold9 indexed_genome mRNA 13835407 13847210 . + . ID=transcript_2402;Q8WV83 Q9H6P8 Q9H7D8,Solute carrier family 35 member F5,Hepatitis C virus NS5A-transactivated protein 3;, PF00892;, GO:0016021;, C:integral component of membrane;|Q8WV83 Q9H6P8 Q9H7D8,Solute carrier family 35 member F5,Hepatitis C virus NS5A-transactivated protein 3;, PF00892;, GO:0016021;, C:integral component of membrane;|Q8WV83 Q9H6P8 Q9H7D8,Solute carrier family 35 member F5,Hepatitis C virus NS5A-transactivated protein 3;, PF00892;, GO:0016021;, C:integral component of membrane;|Q8WV83 Q9H6P8 Q9H7D8,Solute carrier family 35 member F5,Hepatitis C virus NS5A-transactivated protein 3;, PF00892;, GO:0016021;, C:integral component of membrane;|Q8WV83 Q9H6P8 Q9H7D8,Solute carrier family 35 member F5,Hepatitis C virus NS5A-transactivated protein 3;, PF00892;, GO:0016021;, C:integral component of membrane; scaffold9 indexed_genome mRNA 13851618 13873527 . + . ID=transcript_2403;Q8WV83 Q9H6P8 Q9H7D8,Solute carrier family 35 member F5,Hepatitis C virus NS5A-transactivated protein 3;, PF00892;, GO:0016021;, C:integral component of membrane; scaffold9 indexed_genome mRNA 14002235 14253059 . + . ID=transcript_2404;O43194 B2RC12 B6V9G4 Q08AS2 Q53R01,G-protein coupled receptor 39,, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0046872;GO:0007186;GO:0002862;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:metal ion binding;, P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; scaffold9 indexed_genome mRNA 14253114 14253894 . - . ID=transcript_2405;Q8N2G4 H7BXW6 Q6ZP52 Q6ZWI4 Q96AC2,Ly6/PLAUR domain-containing protein 1,Putative HeLa tumor suppressor;, , GO:0031225;GO:0005576;GO:0005886;GO:0045202;GO:0030550;GO:0095500;, C:anchored component of membrane; C:extracellular region; C:plasma membrane; C:synapse;, F:acetylcholine receptor inhibitor activity;, P:acetylcholine receptor signaling pathway; scaffold9 indexed_genome mRNA 14442815 15406047 . - . ID=transcript_2406;O14513 B8ZZL0 Q29SS9 Q29ST0 Q2NL90 Q6ZVE2 Q8NAS3,Nck-associated protein 5,Peripheral clock protein;, PF15246;, GO:0035371;GO:0001578;GO:0007019;, C:microtubule plus-end;, , P:microtubule bundle formation; P:microtubule depolymerization; scaffold9 indexed_genome mRNA 15879068 16267685 . + . ID=transcript_2407;Q09328 D3DP70,Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A,Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V {ECO:0000303|PubMed:10395745};GlcNAc-T V {ECO:0000303|PubMed:10395745};Mannoside acetylglucosaminyltransferase 5;N-acetylglucosaminyl-transferase V;, PF15027;PF15024;, GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0030144;GO:0030145;GO:0004864;GO:1903614;GO:0030335;GO:1904894;GO:0006487;GO:0018279;GO:0019082;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity; F:manganese ion binding; F:protein phosphatase inhibitor activity;, P:negative regulation of protein tyrosine phosphatase activity; P:positive regulation of cell migration; P:positive regulation of receptor signaling pathway via STAT; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing;|Q09328 D3DP70,Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A,Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V {ECO:0000303|PubMed:10395745};GlcNAc-T V {ECO:0000303|PubMed:10395745};Mannoside acetylglucosaminyltransferase 5;N-acetylglucosaminyl-transferase V;, PF15027;PF15024;, GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0030144;GO:0030145;GO:0004864;GO:1903614;GO:0030335;GO:1904894;GO:0006487;GO:0018279;GO:0019082;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity; F:manganese ion binding; F:protein phosphatase inhibitor activity;, P:negative regulation of protein tyrosine phosphatase activity; P:positive regulation of cell migration; P:positive regulation of receptor signaling pathway via STAT; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing; scaffold9 indexed_genome mRNA 16267704 16535431 . - . ID=transcript_2408;Q8TC26 Q53QM3 Q53SV7 Q69YH3 Q9UFG3,Transmembrane protein 163,, , GO:0031901;GO:0030285;GO:0016020;GO:0008270;GO:0099180;, C:early endosome membrane; C:integral component of synaptic vesicle membrane; C:membrane;, F:zinc ion binding;, P:zinc ion import into synaptic vesicle;|Q8TC26 Q53QM3 Q53SV7 Q69YH3 Q9UFG3,Transmembrane protein 163,, , GO:0031901;GO:0030285;GO:0016020;GO:0008270;GO:0099180;, C:early endosome membrane; C:integral component of synaptic vesicle membrane; C:membrane;, F:zinc ion binding;, P:zinc ion import into synaptic vesicle; scaffold9 indexed_genome mRNA 16625840 16687398 . + . ID=transcript_2409;Q8TDX5 Q3B7X3 Q53SR5 Q96KY2,2-amino-3-carboxymuconate-6-semialdehyde decarboxylase {ECO:0000303|PubMed:12140278},Picolinate carboxylase {ECO:0000303|PubMed:12140278};, PF04909;, GO:0005737;GO:0005829;GO:0001760;GO:0016831;GO:0016787;GO:0008270;GO:1904985;GO:1905004;GO:1905012;GO:0019748;GO:0006569;, C:cytoplasm; C:cytosol;, F:aminocarboxymuconate-semialdehyde decarboxylase activity; F:carboxy-lyase activity; F:hydrolase activity; F:zinc ion binding;, P:negative regulation of quinolinate biosynthetic process; P:picolinic acid biosynthetic process; P:regulation of 'de novo' NAD biosynthetic process from tryptophan; P:secondary metabolic process; P:tryptophan catabolic process;|Q8TDX5 Q3B7X3 Q53SR5 Q96KY2,2-amino-3-carboxymuconate-6-semialdehyde decarboxylase {ECO:0000303|PubMed:12140278},Picolinate carboxylase {ECO:0000303|PubMed:12140278};, PF04909;, GO:0005737;GO:0005829;GO:0001760;GO:0016831;GO:0016787;GO:0008270;GO:1904985;GO:1905004;GO:1905012;GO:0019748;GO:0006569;, C:cytoplasm; C:cytosol;, F:aminocarboxymuconate-semialdehyde decarboxylase activity; F:carboxy-lyase activity; F:hydrolase activity; F:zinc ion binding;, P:negative regulation of quinolinate biosynthetic process; P:picolinic acid biosynthetic process; P:regulation of 'de novo' NAD biosynthetic process from tryptophan; P:secondary metabolic process; P:tryptophan catabolic process; scaffold9 indexed_genome mRNA 16711001 16716757 . + . ID=transcript_2410;O60583 A8KA48 D3DP73 D3DP74 O60582 Q29R66 Q53SR4 Q5I1Y0,Cyclin-T2 {ECO:0000250|UniProtKB:Q7TQK0},, PF00134;, GO:0008024;GO:0005829;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0097322;GO:0003682;GO:0061575;GO:0016538;GO:0019901;GO:0070063;GO:0001223;GO:0007049;GO:0051301;GO:0019085;GO:0019086;GO:0032786;GO:0045944;GO:0000079;GO:0051147;GO:0006357;GO:0007519;GO:0042795;GO:0006366;GO:0006368;, C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:7SK snRNA binding; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding; F:RNA polymerase binding; F:transcription coactivator binding;, P:cell cycle; P:cell division; P:early viral transcription; P:late viral transcription; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle tissue development; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O60583 A8KA48 D3DP73 D3DP74 O60582 Q29R66 Q53SR4 Q5I1Y0,Cyclin-T2 {ECO:0000250|UniProtKB:Q7TQK0},, PF00134;, GO:0008024;GO:0005829;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0097322;GO:0003682;GO:0061575;GO:0016538;GO:0019901;GO:0070063;GO:0001223;GO:0007049;GO:0051301;GO:0019085;GO:0019086;GO:0032786;GO:0045944;GO:0000079;GO:0051147;GO:0006357;GO:0007519;GO:0042795;GO:0006366;GO:0006368;, C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:7SK snRNA binding; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding; F:RNA polymerase binding; F:transcription coactivator binding;, P:cell cycle; P:cell division; P:early viral transcription; P:late viral transcription; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle tissue development; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold9 indexed_genome mRNA 16717893 16728418 . + . ID=transcript_2411;O60583 A8KA48 D3DP73 D3DP74 O60582 Q29R66 Q53SR4 Q5I1Y0,Cyclin-T2 {ECO:0000250|UniProtKB:Q7TQK0},, PF00134;, GO:0008024;GO:0005829;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0097322;GO:0003682;GO:0061575;GO:0016538;GO:0019901;GO:0070063;GO:0001223;GO:0007049;GO:0051301;GO:0019085;GO:0019086;GO:0032786;GO:0045944;GO:0000079;GO:0051147;GO:0006357;GO:0007519;GO:0042795;GO:0006366;GO:0006368;, C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:7SK snRNA binding; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding; F:RNA polymerase binding; F:transcription coactivator binding;, P:cell cycle; P:cell division; P:early viral transcription; P:late viral transcription; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle tissue development; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O60583 A8KA48 D3DP73 D3DP74 O60582 Q29R66 Q53SR4 Q5I1Y0,Cyclin-T2 {ECO:0000250|UniProtKB:Q7TQK0},, PF00134;, GO:0008024;GO:0005829;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0097322;GO:0003682;GO:0061575;GO:0016538;GO:0019901;GO:0070063;GO:0001223;GO:0007049;GO:0051301;GO:0019085;GO:0019086;GO:0032786;GO:0045944;GO:0000079;GO:0051147;GO:0006357;GO:0007519;GO:0042795;GO:0006366;GO:0006368;, C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:7SK snRNA binding; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding; F:RNA polymerase binding; F:transcription coactivator binding;, P:cell cycle; P:cell division; P:early viral transcription; P:late viral transcription; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle tissue development; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O60583 A8KA48 D3DP73 D3DP74 O60582 Q29R66 Q53SR4 Q5I1Y0,Cyclin-T2 {ECO:0000250|UniProtKB:Q7TQK0},, PF00134;, GO:0008024;GO:0005829;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0097322;GO:0003682;GO:0061575;GO:0016538;GO:0019901;GO:0070063;GO:0001223;GO:0007049;GO:0051301;GO:0019085;GO:0019086;GO:0032786;GO:0045944;GO:0000079;GO:0051147;GO:0006357;GO:0007519;GO:0042795;GO:0006366;GO:0006368;, C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:7SK snRNA binding; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding; F:RNA polymerase binding; F:transcription coactivator binding;, P:cell cycle; P:cell division; P:early viral transcription; P:late viral transcription; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle tissue development; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold9 indexed_genome mRNA 16803392 16898095 . + . ID=transcript_2412;Q15042 A6H8Z3 C9J837 Q659F5 Q8TBB4,Rab3 GTPase-activating protein catalytic subunit,RAB3 GTPase-activating protein 130 kDa subunit;Rab3-GAP p130;, PF13890;, GO:0005829;GO:0005789;GO:0071782;GO:0070062;GO:0005794;GO:0005811;GO:0098794;GO:0032991;GO:0005096;GO:0031267;GO:0007420;GO:0043010;GO:0097051;GO:0060079;GO:0060325;GO:0021854;GO:0034389;GO:2000786;GO:1903373;GO:0061646;GO:0043547;GO:1903061;GO:1903233;GO:0043087;GO:0048172;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:extracellular exosome; C:Golgi apparatus; C:lipid droplet; C:postsynapse; C:protein-containing complex;, F:GTPase activator activity; F:small GTPase binding;, P:brain development; P:camera-type eye development; P:establishment of protein localization to endoplasmic reticulum membrane; P:excitatory postsynaptic potential; P:face morphogenesis; P:hypothalamus development; P:lipid droplet organization; P:positive regulation of autophagosome assembly; P:positive regulation of endoplasmic reticulum tubular network organization; P:positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization; P:positive regulation of GTPase activity; P:positive regulation of protein lipidation; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; P:regulation of GTPase activity; P:regulation of short-term neuronal synaptic plasticity;|Q15042 A6H8Z3 C9J837 Q659F5 Q8TBB4,Rab3 GTPase-activating protein catalytic subunit,RAB3 GTPase-activating protein 130 kDa subunit;Rab3-GAP p130;, PF13890;, GO:0005829;GO:0005789;GO:0071782;GO:0070062;GO:0005794;GO:0005811;GO:0098794;GO:0032991;GO:0005096;GO:0031267;GO:0007420;GO:0043010;GO:0097051;GO:0060079;GO:0060325;GO:0021854;GO:0034389;GO:2000786;GO:1903373;GO:0061646;GO:0043547;GO:1903061;GO:1903233;GO:0043087;GO:0048172;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:extracellular exosome; C:Golgi apparatus; C:lipid droplet; C:postsynapse; C:protein-containing complex;, F:GTPase activator activity; F:small GTPase binding;, P:brain development; P:camera-type eye development; P:establishment of protein localization to endoplasmic reticulum membrane; P:excitatory postsynaptic potential; P:face morphogenesis; P:hypothalamus development; P:lipid droplet organization; P:positive regulation of autophagosome assembly; P:positive regulation of endoplasmic reticulum tubular network organization; P:positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization; P:positive regulation of GTPase activity; P:positive regulation of protein lipidation; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; P:regulation of GTPase activity; P:regulation of short-term neuronal synaptic plasticity; scaffold9 indexed_genome mRNA 16919523 16977595 . - . ID=transcript_2413;Q9H0E8,DNA annealing helicase and endonuclease ZRANB3 {ECO:0000305},Annealing helicase 2 {ECO:0000303|PubMed:21078962};Zinc finger Ran-binding domain-containing protein 3 {ECO:0000305};, PF00271;PF01844;PF00176;PF00641;, GO:0043596;GO:0005654;GO:0036310;GO:0005524;GO:0004520;GO:0004386;GO:0070530;GO:0046872;GO:0070615;GO:0006974;GO:0032508;GO:0006281;GO:0036292;GO:0045910;GO:0031297;GO:0048478;GO:0009411;, C:nuclear replication fork; C:nucleoplasm;, F:annealing helicase activity; F:ATP binding; F:endodeoxyribonuclease activity; F:helicase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA duplex unwinding; P:DNA repair; P:DNA rewinding; P:negative regulation of DNA recombination; P:replication fork processing; P:replication fork protection; P:response to UV;|Q9H0E8,DNA annealing helicase and endonuclease ZRANB3 {ECO:0000305},Annealing helicase 2 {ECO:0000303|PubMed:21078962};Zinc finger Ran-binding domain-containing protein 3 {ECO:0000305};, PF00271;PF01844;PF00176;PF00641;, GO:0043596;GO:0005654;GO:0036310;GO:0005524;GO:0004520;GO:0004386;GO:0070530;GO:0046872;GO:0070615;GO:0006974;GO:0032508;GO:0006281;GO:0036292;GO:0045910;GO:0031297;GO:0048478;GO:0009411;, C:nuclear replication fork; C:nucleoplasm;, F:annealing helicase activity; F:ATP binding; F:endodeoxyribonuclease activity; F:helicase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA duplex unwinding; P:DNA repair; P:DNA rewinding; P:negative regulation of DNA recombination; P:replication fork processing; P:replication fork protection; P:response to UV; scaffold9 indexed_genome mRNA 17007234 17047199 . - . ID=transcript_2414;Q9H0E8,DNA annealing helicase and endonuclease ZRANB3 {ECO:0000305},Annealing helicase 2 {ECO:0000303|PubMed:21078962};Zinc finger Ran-binding domain-containing protein 3 {ECO:0000305};, PF00271;PF01844;PF00176;PF00641;, GO:0043596;GO:0005654;GO:0036310;GO:0005524;GO:0004520;GO:0004386;GO:0070530;GO:0046872;GO:0070615;GO:0006974;GO:0032508;GO:0006281;GO:0036292;GO:0045910;GO:0031297;GO:0048478;GO:0009411;, C:nuclear replication fork; C:nucleoplasm;, F:annealing helicase activity; F:ATP binding; F:endodeoxyribonuclease activity; F:helicase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA duplex unwinding; P:DNA repair; P:DNA rewinding; P:negative regulation of DNA recombination; P:replication fork processing; P:replication fork protection; P:response to UV; scaffold9 indexed_genome mRNA 17194943 17263241 . + . ID=transcript_2415;Q15032 A8K1V0 B3KXQ9 E9PBB4 E9PG42 G5E9G8 Q8IW32,R3H domain-containing protein 1,, PF01424;PF12752;, GO:0003723;, , F:RNA binding; scaffold9 indexed_genome mRNA 17281796 17351176 . + . ID=transcript_2416;Q15032 A8K1V0 B3KXQ9 E9PBB4 E9PG42 G5E9G8 Q8IW32,R3H domain-containing protein 1,, PF01424;PF12752;, GO:0003723;, , F:RNA binding;|Q15032 A8K1V0 B3KXQ9 E9PBB4 E9PG42 G5E9G8 Q8IW32,R3H domain-containing protein 1,, PF01424;PF12752;, GO:0003723;, , F:RNA binding;|Q15032 A8K1V0 B3KXQ9 E9PBB4 E9PG42 G5E9G8 Q8IW32,R3H domain-containing protein 1,, PF01424;PF12752;, GO:0003723;, , F:RNA binding;|Q15032 A8K1V0 B3KXQ9 E9PBB4 E9PG42 G5E9G8 Q8IW32,R3H domain-containing protein 1,, PF01424;PF12752;, GO:0003723;, , F:RNA binding; scaffold9 indexed_genome mRNA 17369904 17402988 . + . ID=transcript_2417;Q92575 A8K9W4 Q4ZG56 Q8IYM5,UBX domain-containing protein 4,Erasin;UBX domain-containing protein 2;, PF00789;, GO:0005829;GO:0005783;GO:0005789;GO:0005635;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nuclear envelope;, , P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q92575 A8K9W4 Q4ZG56 Q8IYM5,UBX domain-containing protein 4,Erasin;UBX domain-containing protein 2;, PF00789;, GO:0005829;GO:0005783;GO:0005789;GO:0005635;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nuclear envelope;, , P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q92575 A8K9W4 Q4ZG56 Q8IYM5,UBX domain-containing protein 4,Erasin;UBX domain-containing protein 2;, PF00789;, GO:0005829;GO:0005783;GO:0005789;GO:0005635;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nuclear envelope;, , P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q92575 A8K9W4 Q4ZG56 Q8IYM5,UBX domain-containing protein 4,Erasin;UBX domain-containing protein 2;, PF00789;, GO:0005829;GO:0005783;GO:0005789;GO:0005635;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nuclear envelope;, , P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q92575 A8K9W4 Q4ZG56 Q8IYM5,UBX domain-containing protein 4,Erasin;UBX domain-containing protein 2;, PF00789;, GO:0005829;GO:0005783;GO:0005789;GO:0005635;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nuclear envelope;, , P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q92575 A8K9W4 Q4ZG56 Q8IYM5,UBX domain-containing protein 4,Erasin;UBX domain-containing protein 2;, PF00789;, GO:0005829;GO:0005783;GO:0005789;GO:0005635;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nuclear envelope;, , P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q92575 A8K9W4 Q4ZG56 Q8IYM5,UBX domain-containing protein 4,Erasin;UBX domain-containing protein 2;, PF00789;, GO:0005829;GO:0005783;GO:0005789;GO:0005635;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nuclear envelope;, , P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q92575 A8K9W4 Q4ZG56 Q8IYM5,UBX domain-containing protein 4,Erasin;UBX domain-containing protein 2;, PF00789;, GO:0005829;GO:0005783;GO:0005789;GO:0005635;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nuclear envelope;, , P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway; scaffold9 indexed_genome mRNA 17403541 17406475 . - . ID=transcript_2418;P09848 Q4ZG58,Lactase-phlorizin hydrolase,Lactase-glycosylceramidase;, PF00232;, GO:0016324;GO:0005783;GO:0005887;GO:0016020;GO:0005886;GO:0008422;GO:0017042;GO:0000016;GO:0005975;GO:0044245;, C:apical plasma membrane; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:beta-glucosidase activity; F:glycosylceramidase activity; F:lactase activity;, P:carbohydrate metabolic process; P:polysaccharide digestion;|P09848 Q4ZG58,Lactase-phlorizin hydrolase,Lactase-glycosylceramidase;, PF00232;, GO:0016324;GO:0005783;GO:0005887;GO:0016020;GO:0005886;GO:0008422;GO:0017042;GO:0000016;GO:0005975;GO:0044245;, C:apical plasma membrane; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:beta-glucosidase activity; F:glycosylceramidase activity; F:lactase activity;, P:carbohydrate metabolic process; P:polysaccharide digestion; scaffold9 indexed_genome mRNA 17460368 17496046 . - . ID=transcript_2419;Q14566 B2R6H2 Q13504 Q99859,DNA replication licensing factor MCM6,p105MCM;, PF00493;PF18263;PF17855;PF14551;PF17207;, GO:0000781;GO:0071162;GO:0042555;GO:0005654;GO:0005634;GO:0005524;GO:0003678;GO:0003688;GO:0042802;GO:0003697;GO:0006260;GO:0006270;GO:0006268;GO:0000727;GO:1902969;GO:0036388;GO:0006267;, C:chromosome, telomeric region; C:CMG complex; C:MCM complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA helicase activity; F:DNA replication origin binding; F:identical protein binding; F:single-stranded DNA binding;, P:DNA replication; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:double-strand break repair via break-induced replication; P:mitotic DNA replication; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication;|Q14566 B2R6H2 Q13504 Q99859,DNA replication licensing factor MCM6,p105MCM;, PF00493;PF18263;PF17855;PF14551;PF17207;, GO:0000781;GO:0071162;GO:0042555;GO:0005654;GO:0005634;GO:0005524;GO:0003678;GO:0003688;GO:0042802;GO:0003697;GO:0006260;GO:0006270;GO:0006268;GO:0000727;GO:1902969;GO:0036388;GO:0006267;, C:chromosome, telomeric region; C:CMG complex; C:MCM complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA helicase activity; F:DNA replication origin binding; F:identical protein binding; F:single-stranded DNA binding;, P:DNA replication; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:double-strand break repair via break-induced replication; P:mitotic DNA replication; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; scaffold9 indexed_genome mRNA 17528497 17591309 . + . ID=transcript_2420;P14868 A8K3J2 D3DP77 Q2TNI3 Q32Q69 Q53HV4 Q53YC5 Q68CR9 Q9BW52,Aspartate--tRNA ligase, cytoplasmic {ECO:0000305},Aspartyl-tRNA synthetase;Cell proliferation-inducing gene 40 protein;, PF00152;PF01336;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045202;GO:0004046;GO:0004815;GO:0005524;GO:0003723;GO:0006422;GO:0065003;GO:0006412;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:synapse;, F:aminoacylase activity; F:aspartate-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:aspartyl-tRNA aminoacylation; P:protein-containing complex assembly; P:translation; P:tRNA aminoacylation for protein translation;|P14868 A8K3J2 D3DP77 Q2TNI3 Q32Q69 Q53HV4 Q53YC5 Q68CR9 Q9BW52,Aspartate--tRNA ligase, cytoplasmic {ECO:0000305},Aspartyl-tRNA synthetase;Cell proliferation-inducing gene 40 protein;, PF00152;PF01336;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045202;GO:0004046;GO:0004815;GO:0005524;GO:0003723;GO:0006422;GO:0065003;GO:0006412;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:synapse;, F:aminoacylase activity; F:aspartate-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:aspartyl-tRNA aminoacylation; P:protein-containing complex assembly; P:translation; P:tRNA aminoacylation for protein translation;|P14868 A8K3J2 D3DP77 Q2TNI3 Q32Q69 Q53HV4 Q53YC5 Q68CR9 Q9BW52,Aspartate--tRNA ligase, cytoplasmic {ECO:0000305},Aspartyl-tRNA synthetase;Cell proliferation-inducing gene 40 protein;, PF00152;PF01336;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045202;GO:0004046;GO:0004815;GO:0005524;GO:0003723;GO:0006422;GO:0065003;GO:0006412;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:synapse;, F:aminoacylase activity; F:aspartate-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:aspartyl-tRNA aminoacylation; P:protein-containing complex assembly; P:translation; P:tRNA aminoacylation for protein translation;|P14868 A8K3J2 D3DP77 Q2TNI3 Q32Q69 Q53HV4 Q53YC5 Q68CR9 Q9BW52,Aspartate--tRNA ligase, cytoplasmic {ECO:0000305},Aspartyl-tRNA synthetase;Cell proliferation-inducing gene 40 protein;, PF00152;PF01336;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045202;GO:0004046;GO:0004815;GO:0005524;GO:0003723;GO:0006422;GO:0065003;GO:0006412;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:synapse;, F:aminoacylase activity; F:aspartate-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:aspartyl-tRNA aminoacylation; P:protein-containing complex assembly; P:translation; P:tRNA aminoacylation for protein translation; scaffold9 indexed_genome mRNA 17724100 17726247 . + . ID=transcript_2421;P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2,C-X-C chemokine receptor type 4,FB22;Fusin;HM89;LCR1;Leukocyte-derived seven transmembrane domain receptor;Lipopolysaccharide-associated protein 3;NPYRL;Stromal cell-derived factor 1 receptor;, PF00001;PF12109;, GO:0030054;GO:0031252;GO:0009986;GO:0005737;GO:0031410;GO:0005769;GO:0009897;GO:0070062;GO:0016021;GO:0005770;GO:0005764;GO:0005634;GO:0005886;GO:0032991;GO:0003779;GO:0019957;GO:0016493;GO:0016494;GO:0038147;GO:0015026;GO:0004930;GO:0032027;GO:0043130;GO:0031625;GO:0001618;GO:0000187;GO:0006915;GO:0007411;GO:0007420;GO:0019722;GO:0060048;GO:0060326;GO:0071345;GO:0035690;GO:0038160;GO:0002407;GO:0050966;GO:0050965;GO:0045446;GO:0061154;GO:0044409;GO:0002064;GO:0019064;GO:0007186;GO:0006955;GO:0006954;GO:0043217;GO:0022008;GO:0001764;GO:0008038;GO:0050921;GO:0120162;GO:0007204;GO:1903861;GO:2000448;GO:1905322;GO:0048714;GO:0035470;GO:0051924;GO:0030155;GO:0050920;GO:0043067;GO:0050792;GO:0014823;GO:0001666;GO:0043278;GO:1990478;GO:0009615;GO:0022029;, C:cell junction; C:cell leading edge; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:early endosome; C:external side of plasma membrane; C:extracellular exosome; C:integral component of membrane; C:late endosome; C:lysosome; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:actin binding; F:C-C chemokine binding; F:C-C chemokine receptor activity; F:C-X-C chemokine receptor activity; F:C-X-C motif chemokine 12 receptor activity; F:coreceptor activity; F:G protein-coupled receptor activity; F:myosin light chain binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:virus receptor activity;, P:activation of MAPK activity; P:apoptotic process; P:axon guidance; P:brain development; P:calcium-mediated signaling; P:cardiac muscle contraction; P:cell chemotaxis; P:cellular response to cytokine stimulus; P:cellular response to drug; P:CXCL12-activated CXCR4 signaling pathway; P:dendritic cell chemotaxis; P:detection of mechanical stimulus involved in sensory perception of pain; P:detection of temperature stimulus involved in sensory perception of pain; P:endothelial cell differentiation; P:endothelial tube morphogenesis; P:entry into host; P:epithelial cell development; P:fusion of virus membrane with host plasma membrane; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:myelin maintenance; P:neurogenesis; P:neuron migration; P:neuron recognition; P:positive regulation of chemotaxis; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of dendrite extension; P:positive regulation of macrophage migration inhibitory factor signaling pathway; P:positive regulation of mesenchymal stem cell migration; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of vascular wound healing; P:regulation of calcium ion transport; P:regulation of cell adhesion; P:regulation of chemotaxis; P:regulation of programmed cell death; P:regulation of viral process; P:response to activity; P:response to hypoxia; P:response to morphine; P:response to ultrasound; P:response to virus; P:telencephalon cell migration; scaffold9 indexed_genome mRNA 19313578 19334894 . + . ID=transcript_2422;Q9C0I4 E7EM75,Thrombospondin type-1 domain-containing protein 7B {ECO:0000305},, PF19028;PF00090;, GO:0016021;GO:0005886;GO:0031532;, C:integral component of membrane; C:plasma membrane;, , P:actin cytoskeleton reorganization; scaffold9 indexed_genome mRNA 19637737 19677600 . + . ID=transcript_2423;P50135 B2R9J3 Q546Z6 Q7Z7I2 Q8IU56 Q8WW98 Q9BRW6,Histamine N-methyltransferase,, , GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0043005;GO:0005654;GO:0046539;GO:0007420;GO:0001695;GO:0001692;GO:0006548;GO:0006972;GO:0032259;GO:0007585;GO:0014075;GO:0042220;GO:0051384;GO:0035902;GO:0070555;GO:0002347;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuron projection; C:nucleoplasm;, F:histamine N-methyltransferase activity;, P:brain development; P:histamine catabolic process; P:histamine metabolic process; P:histidine catabolic process; P:hyperosmotic response; P:methylation; P:respiratory gaseous exchange by respiratory system; P:response to amine; P:response to cocaine; P:response to glucocorticoid; P:response to immobilization stress; P:response to interleukin-1; P:response to tumor cell; scaffold9 indexed_genome mRNA 20177303 20225155 . + . ID=transcript_2424;Q6IQ16,Speckle-type POZ protein-like,HIB homolog 2;Roadkill homolog 2;, PF00651;PF00917;, GO:0031463;GO:0005737;GO:0005634;GO:0031625;GO:0031397;GO:0043161;GO:0016567;GO:0030162;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:nucleus;, F:ubiquitin protein ligase binding;, P:negative regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of proteolysis;|Q6IQ16,Speckle-type POZ protein-like,HIB homolog 2;Roadkill homolog 2;, PF00651;PF00917;, GO:0031463;GO:0005737;GO:0005634;GO:0031625;GO:0031397;GO:0043161;GO:0016567;GO:0030162;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:nucleus;, F:ubiquitin protein ligase binding;, P:negative regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of proteolysis; scaffold9 indexed_genome mRNA 20320164 20447721 . - . ID=transcript_2425;O95156 B7WP24 Q494R1 Q75QC3,Neurexophilin-2,, PF06312;, GO:0005576;GO:0005102;GO:0007218;, C:extracellular region;, F:signaling receptor binding;, P:neuropeptide signaling pathway; scaffold9 indexed_genome mRNA 21843981 22148750 . - . ID=transcript_2426;Q9NZR2 Q8WY29 Q8WY30 Q8WY31,Low-density lipoprotein receptor-related protein 1B,Low-density lipoprotein receptor-related protein-deleted in tumor;, PF12662;PF16472;PF00008;PF07645;PF00057;PF00058;, GO:0016021;GO:0005886;GO:0043235;GO:0005509;GO:0005041;GO:0015031;GO:0006898;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:low-density lipoprotein particle receptor activity;, P:protein transport; P:receptor-mediated endocytosis;|Q9NZR2 Q8WY29 Q8WY30 Q8WY31,Low-density lipoprotein receptor-related protein 1B,Low-density lipoprotein receptor-related protein-deleted in tumor;, PF12662;PF16472;PF00008;PF07645;PF00057;PF00058;, GO:0016021;GO:0005886;GO:0043235;GO:0005509;GO:0005041;GO:0015031;GO:0006898;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:low-density lipoprotein particle receptor activity;, P:protein transport; P:receptor-mediated endocytosis;|Q9NZR2 Q8WY29 Q8WY30 Q8WY31,Low-density lipoprotein receptor-related protein 1B,Low-density lipoprotein receptor-related protein-deleted in tumor;, PF12662;PF16472;PF00008;PF07645;PF00057;PF00058;, GO:0016021;GO:0005886;GO:0043235;GO:0005509;GO:0005041;GO:0015031;GO:0006898;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:low-density lipoprotein particle receptor activity;, P:protein transport; P:receptor-mediated endocytosis; scaffold9 indexed_genome mRNA 22148815 22447687 . - . ID=transcript_2427;Q9NZR2 Q8WY29 Q8WY30 Q8WY31,Low-density lipoprotein receptor-related protein 1B,Low-density lipoprotein receptor-related protein-deleted in tumor;, PF12662;PF16472;PF00008;PF07645;PF00057;PF00058;, GO:0016021;GO:0005886;GO:0043235;GO:0005509;GO:0005041;GO:0015031;GO:0006898;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:low-density lipoprotein particle receptor activity;, P:protein transport; P:receptor-mediated endocytosis; scaffold9 indexed_genome mRNA 22538268 22571326 . - . ID=transcript_2428;Q9NZR2 Q8WY29 Q8WY30 Q8WY31,Low-density lipoprotein receptor-related protein 1B,Low-density lipoprotein receptor-related protein-deleted in tumor;, PF12662;PF16472;PF00008;PF07645;PF00057;PF00058;, GO:0016021;GO:0005886;GO:0043235;GO:0005509;GO:0005041;GO:0015031;GO:0006898;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:low-density lipoprotein particle receptor activity;, P:protein transport; P:receptor-mediated endocytosis; scaffold9 indexed_genome mRNA 22739245 22948441 . - . ID=transcript_2429;Q9NZR2 Q8WY29 Q8WY30 Q8WY31,Low-density lipoprotein receptor-related protein 1B,Low-density lipoprotein receptor-related protein-deleted in tumor;, PF12662;PF16472;PF00008;PF07645;PF00057;PF00058;, GO:0016021;GO:0005886;GO:0043235;GO:0005509;GO:0005041;GO:0015031;GO:0006898;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:low-density lipoprotein particle receptor activity;, P:protein transport; P:receptor-mediated endocytosis; scaffold9 indexed_genome mRNA 22967223 23535148 . - . ID=transcript_2430;Q9NZR2 Q8WY29 Q8WY30 Q8WY31,Low-density lipoprotein receptor-related protein 1B,Low-density lipoprotein receptor-related protein-deleted in tumor;, PF12662;PF16472;PF00008;PF07645;PF00057;PF00058;, GO:0016021;GO:0005886;GO:0043235;GO:0005509;GO:0005041;GO:0015031;GO:0006898;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:low-density lipoprotein particle receptor activity;, P:protein transport; P:receptor-mediated endocytosis; scaffold9 indexed_genome mRNA 24579079 24693671 . + . ID=transcript_2431;Q16719 B2RCZ5 D3DP79 Q6I9T2 Q9BVW3,Kynureninase {ECO:0000255|HAMAP-Rule:MF_03017},L-kynurenine hydrolase {ECO:0000255|HAMAP-Rule:MF_03017};, PF00266;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0061981;GO:0030429;GO:0042803;GO:0030170;GO:0034354;GO:0007568;GO:0043420;GO:0097053;GO:0009435;GO:0019805;GO:0034341;GO:0034516;GO:0006569;GO:0019442;GO:0019441;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm;, F:3-hydroxykynureninase activity; F:kynureninase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:'de novo' NAD biosynthetic process from tryptophan; P:aging; P:anthranilate metabolic process; P:L-kynurenine catabolic process; P:NAD biosynthetic process; P:quinolinate biosynthetic process; P:response to interferon-gamma; P:response to vitamin B6; P:tryptophan catabolic process; P:tryptophan catabolic process to acetyl-CoA; P:tryptophan catabolic process to kynurenine;|Q16719 B2RCZ5 D3DP79 Q6I9T2 Q9BVW3,Kynureninase {ECO:0000255|HAMAP-Rule:MF_03017},L-kynurenine hydrolase {ECO:0000255|HAMAP-Rule:MF_03017};, PF00266;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0061981;GO:0030429;GO:0042803;GO:0030170;GO:0034354;GO:0007568;GO:0043420;GO:0097053;GO:0009435;GO:0019805;GO:0034341;GO:0034516;GO:0006569;GO:0019442;GO:0019441;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm;, F:3-hydroxykynureninase activity; F:kynureninase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:'de novo' NAD biosynthetic process from tryptophan; P:aging; P:anthranilate metabolic process; P:L-kynurenine catabolic process; P:NAD biosynthetic process; P:quinolinate biosynthetic process; P:response to interferon-gamma; P:response to vitamin B6; P:tryptophan catabolic process; P:tryptophan catabolic process to acetyl-CoA; P:tryptophan catabolic process to kynurenine;|Q16719 B2RCZ5 D3DP79 Q6I9T2 Q9BVW3,Kynureninase {ECO:0000255|HAMAP-Rule:MF_03017},L-kynurenine hydrolase {ECO:0000255|HAMAP-Rule:MF_03017};, PF00266;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0061981;GO:0030429;GO:0042803;GO:0030170;GO:0034354;GO:0007568;GO:0043420;GO:0097053;GO:0009435;GO:0019805;GO:0034341;GO:0034516;GO:0006569;GO:0019442;GO:0019441;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm;, F:3-hydroxykynureninase activity; F:kynureninase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:'de novo' NAD biosynthetic process from tryptophan; P:aging; P:anthranilate metabolic process; P:L-kynurenine catabolic process; P:NAD biosynthetic process; P:quinolinate biosynthetic process; P:response to interferon-gamma; P:response to vitamin B6; P:tryptophan catabolic process; P:tryptophan catabolic process to acetyl-CoA; P:tryptophan catabolic process to kynurenine; scaffold9 indexed_genome mRNA 24863802 25437535 . + . ID=transcript_2432;Q9NRL8 Q9NZ77 Q9NZ91,Rho GTPase-activating protein 15,ArhGAP15;Rho-type GTPase-activating protein 15;, PF00169;PF00620;, GO:0005737;GO:0005829;GO:0016020;GO:0005096;GO:0008360;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:membrane;, F:GTPase activator activity;, P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold9 indexed_genome mRNA 25595106 25820688 . - . ID=transcript_2433;Q6P7E7 Q6PJB6 Q6WKW6 Q9HAE5,Glycosyltransferase-like domain-containing protein 1,Mannosyltransferase-like protein Xa {ECO:0000303|PubMed:21821951};Mat-Xa {ECO:0000303|PubMed:21821951};, PF12038;PF00534;, GO:0016757;, , F:transferase activity, transferring glycosyl groups; scaffold9 indexed_genome mRNA 26077109 26213228 . - . ID=transcript_2434;O60315 A0JP09 B7Z2P2 F5H814 Q9UED1,Zinc finger E-box-binding homeobox 2,Smad-interacting protein 1 {ECO:0000303|PubMed:11448942};Zinc finger homeobox protein 1b;, PF00096;PF05605;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0019208;GO:0000978;GO:0043565;GO:0048856;GO:0048066;GO:0097324;GO:0000122;GO:0007399;GO:0090263;GO:0048023;GO:0045636;GO:0045944;GO:0030511;GO:1903056;GO:0006357;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:phosphatase regulator activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:anatomical structure development; P:developmental pigmentation; P:melanocyte migration; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of melanin biosynthetic process; P:positive regulation of melanocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of melanosome organization; P:regulation of transcription by RNA polymerase II;|O60315 A0JP09 B7Z2P2 F5H814 Q9UED1,Zinc finger E-box-binding homeobox 2,Smad-interacting protein 1 {ECO:0000303|PubMed:11448942};Zinc finger homeobox protein 1b;, PF00096;PF05605;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0019208;GO:0000978;GO:0043565;GO:0048856;GO:0048066;GO:0097324;GO:0000122;GO:0007399;GO:0090263;GO:0048023;GO:0045636;GO:0045944;GO:0030511;GO:1903056;GO:0006357;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:phosphatase regulator activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:anatomical structure development; P:developmental pigmentation; P:melanocyte migration; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of melanin biosynthetic process; P:positive regulation of melanocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of melanosome organization; P:regulation of transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 29763923 29931549 . + . ID=transcript_2435;P27037 B2RAB8 B4DWQ2 D3DP85 Q53TH4 Q6NWV2 Q92474,Activin receptor type-2A,Activin receptor type IIA;, PF01064;PF00069;, GO:0048179;GO:0009986;GO:0005737;GO:0034673;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0005524;GO:0098821;GO:0015026;GO:0019838;GO:0034711;GO:0046872;GO:0030165;GO:0043621;GO:0004674;GO:0004675;GO:0032924;GO:0009952;GO:0030509;GO:0071773;GO:0071363;GO:0007368;GO:0048706;GO:0001702;GO:0007498;GO:0030514;GO:0043084;GO:0032927;GO:0030513;GO:0030501;GO:0045648;GO:0045669;GO:0010862;GO:0001934;GO:0045944;GO:0006468;GO:0050999;GO:0060011;GO:0042713;GO:0007283;GO:0007178;, C:activin receptor complex; C:cell surface; C:cytoplasm; C:inhibin-betaglycan-ActRII complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:ATP binding; F:BMP receptor activity; F:coreceptor activity; F:growth factor binding; F:inhibin binding; F:metal ion binding; F:PDZ domain binding; F:protein self-association; F:protein serine/threonine kinase activity; F:transmembrane receptor protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:anterior/posterior pattern specification; P:BMP signaling pathway; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:determination of left/right symmetry; P:embryonic skeletal system development; P:gastrulation with mouth forming second; P:mesoderm development; P:negative regulation of BMP signaling pathway; P:penile erection; P:positive regulation of activin receptor signaling pathway; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of nitric-oxide synthase activity; P:Sertoli cell proliferation; P:sperm ejaculation; P:spermatogenesis; P:transmembrane receptor protein serine/threonine kinase signaling pathway;|P27037 B2RAB8 B4DWQ2 D3DP85 Q53TH4 Q6NWV2 Q92474,Activin receptor type-2A,Activin receptor type IIA;, PF01064;PF00069;, GO:0048179;GO:0009986;GO:0005737;GO:0034673;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0005524;GO:0098821;GO:0015026;GO:0019838;GO:0034711;GO:0046872;GO:0030165;GO:0043621;GO:0004674;GO:0004675;GO:0032924;GO:0009952;GO:0030509;GO:0071773;GO:0071363;GO:0007368;GO:0048706;GO:0001702;GO:0007498;GO:0030514;GO:0043084;GO:0032927;GO:0030513;GO:0030501;GO:0045648;GO:0045669;GO:0010862;GO:0001934;GO:0045944;GO:0006468;GO:0050999;GO:0060011;GO:0042713;GO:0007283;GO:0007178;, C:activin receptor complex; C:cell surface; C:cytoplasm; C:inhibin-betaglycan-ActRII complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:ATP binding; F:BMP receptor activity; F:coreceptor activity; F:growth factor binding; F:inhibin binding; F:metal ion binding; F:PDZ domain binding; F:protein self-association; F:protein serine/threonine kinase activity; F:transmembrane receptor protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:anterior/posterior pattern specification; P:BMP signaling pathway; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:determination of left/right symmetry; P:embryonic skeletal system development; P:gastrulation with mouth forming second; P:mesoderm development; P:negative regulation of BMP signaling pathway; P:penile erection; P:positive regulation of activin receptor signaling pathway; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of nitric-oxide synthase activity; P:Sertoli cell proliferation; P:sperm ejaculation; P:spermatogenesis; P:transmembrane receptor protein serine/threonine kinase signaling pathway;|P27037 B2RAB8 B4DWQ2 D3DP85 Q53TH4 Q6NWV2 Q92474,Activin receptor type-2A,Activin receptor type IIA;, PF01064;PF00069;, GO:0048179;GO:0009986;GO:0005737;GO:0034673;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0005524;GO:0098821;GO:0015026;GO:0019838;GO:0034711;GO:0046872;GO:0030165;GO:0043621;GO:0004674;GO:0004675;GO:0032924;GO:0009952;GO:0030509;GO:0071773;GO:0071363;GO:0007368;GO:0048706;GO:0001702;GO:0007498;GO:0030514;GO:0043084;GO:0032927;GO:0030513;GO:0030501;GO:0045648;GO:0045669;GO:0010862;GO:0001934;GO:0045944;GO:0006468;GO:0050999;GO:0060011;GO:0042713;GO:0007283;GO:0007178;, C:activin receptor complex; C:cell surface; C:cytoplasm; C:inhibin-betaglycan-ActRII complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:ATP binding; F:BMP receptor activity; F:coreceptor activity; F:growth factor binding; F:inhibin binding; F:metal ion binding; F:PDZ domain binding; F:protein self-association; F:protein serine/threonine kinase activity; F:transmembrane receptor protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:anterior/posterior pattern specification; P:BMP signaling pathway; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:determination of left/right symmetry; P:embryonic skeletal system development; P:gastrulation with mouth forming second; P:mesoderm development; P:negative regulation of BMP signaling pathway; P:penile erection; P:positive regulation of activin receptor signaling pathway; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of nitric-oxide synthase activity; P:Sertoli cell proliferation; P:sperm ejaculation; P:spermatogenesis; P:transmembrane receptor protein serine/threonine kinase signaling pathway;|P27037 B2RAB8 B4DWQ2 D3DP85 Q53TH4 Q6NWV2 Q92474,Activin receptor type-2A,Activin receptor type IIA;, PF01064;PF00069;, GO:0048179;GO:0009986;GO:0005737;GO:0034673;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0005524;GO:0098821;GO:0015026;GO:0019838;GO:0034711;GO:0046872;GO:0030165;GO:0043621;GO:0004674;GO:0004675;GO:0032924;GO:0009952;GO:0030509;GO:0071773;GO:0071363;GO:0007368;GO:0048706;GO:0001702;GO:0007498;GO:0030514;GO:0043084;GO:0032927;GO:0030513;GO:0030501;GO:0045648;GO:0045669;GO:0010862;GO:0001934;GO:0045944;GO:0006468;GO:0050999;GO:0060011;GO:0042713;GO:0007283;GO:0007178;, C:activin receptor complex; C:cell surface; C:cytoplasm; C:inhibin-betaglycan-ActRII complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:ATP binding; F:BMP receptor activity; F:coreceptor activity; F:growth factor binding; F:inhibin binding; F:metal ion binding; F:PDZ domain binding; F:protein self-association; F:protein serine/threonine kinase activity; F:transmembrane receptor protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:anterior/posterior pattern specification; P:BMP signaling pathway; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:determination of left/right symmetry; P:embryonic skeletal system development; P:gastrulation with mouth forming second; P:mesoderm development; P:negative regulation of BMP signaling pathway; P:penile erection; P:positive regulation of activin receptor signaling pathway; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of nitric-oxide synthase activity; P:Sertoli cell proliferation; P:sperm ejaculation; P:spermatogenesis; P:transmembrane receptor protein serine/threonine kinase signaling pathway;|P27037 B2RAB8 B4DWQ2 D3DP85 Q53TH4 Q6NWV2 Q92474,Activin receptor type-2A,Activin receptor type IIA;, PF01064;PF00069;, GO:0048179;GO:0009986;GO:0005737;GO:0034673;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0005524;GO:0098821;GO:0015026;GO:0019838;GO:0034711;GO:0046872;GO:0030165;GO:0043621;GO:0004674;GO:0004675;GO:0032924;GO:0009952;GO:0030509;GO:0071773;GO:0071363;GO:0007368;GO:0048706;GO:0001702;GO:0007498;GO:0030514;GO:0043084;GO:0032927;GO:0030513;GO:0030501;GO:0045648;GO:0045669;GO:0010862;GO:0001934;GO:0045944;GO:0006468;GO:0050999;GO:0060011;GO:0042713;GO:0007283;GO:0007178;, C:activin receptor complex; C:cell surface; C:cytoplasm; C:inhibin-betaglycan-ActRII complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:ATP binding; F:BMP receptor activity; F:coreceptor activity; F:growth factor binding; F:inhibin binding; F:metal ion binding; F:PDZ domain binding; F:protein self-association; F:protein serine/threonine kinase activity; F:transmembrane receptor protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:anterior/posterior pattern specification; P:BMP signaling pathway; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:determination of left/right symmetry; P:embryonic skeletal system development; P:gastrulation with mouth forming second; P:mesoderm development; P:negative regulation of BMP signaling pathway; P:penile erection; P:positive regulation of activin receptor signaling pathway; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of nitric-oxide synthase activity; P:Sertoli cell proliferation; P:sperm ejaculation; P:spermatogenesis; P:transmembrane receptor protein serine/threonine kinase signaling pathway;|P27037 B2RAB8 B4DWQ2 D3DP85 Q53TH4 Q6NWV2 Q92474,Activin receptor type-2A,Activin receptor type IIA;, PF01064;PF00069;, GO:0048179;GO:0009986;GO:0005737;GO:0034673;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0005524;GO:0098821;GO:0015026;GO:0019838;GO:0034711;GO:0046872;GO:0030165;GO:0043621;GO:0004674;GO:0004675;GO:0032924;GO:0009952;GO:0030509;GO:0071773;GO:0071363;GO:0007368;GO:0048706;GO:0001702;GO:0007498;GO:0030514;GO:0043084;GO:0032927;GO:0030513;GO:0030501;GO:0045648;GO:0045669;GO:0010862;GO:0001934;GO:0045944;GO:0006468;GO:0050999;GO:0060011;GO:0042713;GO:0007283;GO:0007178;, C:activin receptor complex; C:cell surface; C:cytoplasm; C:inhibin-betaglycan-ActRII complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:ATP binding; F:BMP receptor activity; F:coreceptor activity; F:growth factor binding; F:inhibin binding; F:metal ion binding; F:PDZ domain binding; F:protein self-association; F:protein serine/threonine kinase activity; F:transmembrane receptor protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:anterior/posterior pattern specification; P:BMP signaling pathway; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:determination of left/right symmetry; P:embryonic skeletal system development; P:gastrulation with mouth forming second; P:mesoderm development; P:negative regulation of BMP signaling pathway; P:penile erection; P:positive regulation of activin receptor signaling pathway; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of nitric-oxide synthase activity; P:Sertoli cell proliferation; P:sperm ejaculation; P:spermatogenesis; P:transmembrane receptor protein serine/threonine kinase signaling pathway;|P27037 B2RAB8 B4DWQ2 D3DP85 Q53TH4 Q6NWV2 Q92474,Activin receptor type-2A,Activin receptor type IIA;, PF01064;PF00069;, GO:0048179;GO:0009986;GO:0005737;GO:0034673;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0005524;GO:0098821;GO:0015026;GO:0019838;GO:0034711;GO:0046872;GO:0030165;GO:0043621;GO:0004674;GO:0004675;GO:0032924;GO:0009952;GO:0030509;GO:0071773;GO:0071363;GO:0007368;GO:0048706;GO:0001702;GO:0007498;GO:0030514;GO:0043084;GO:0032927;GO:0030513;GO:0030501;GO:0045648;GO:0045669;GO:0010862;GO:0001934;GO:0045944;GO:0006468;GO:0050999;GO:0060011;GO:0042713;GO:0007283;GO:0007178;, C:activin receptor complex; C:cell surface; C:cytoplasm; C:inhibin-betaglycan-ActRII complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:ATP binding; F:BMP receptor activity; F:coreceptor activity; F:growth factor binding; F:inhibin binding; F:metal ion binding; F:PDZ domain binding; F:protein self-association; F:protein serine/threonine kinase activity; F:transmembrane receptor protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:anterior/posterior pattern specification; P:BMP signaling pathway; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:determination of left/right symmetry; P:embryonic skeletal system development; P:gastrulation with mouth forming second; P:mesoderm development; P:negative regulation of BMP signaling pathway; P:penile erection; P:positive regulation of activin receptor signaling pathway; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of nitric-oxide synthase activity; P:Sertoli cell proliferation; P:sperm ejaculation; P:spermatogenesis; P:transmembrane receptor protein serine/threonine kinase signaling pathway;|P27037 B2RAB8 B4DWQ2 D3DP85 Q53TH4 Q6NWV2 Q92474,Activin receptor type-2A,Activin receptor type IIA;, PF01064;PF00069;, GO:0048179;GO:0009986;GO:0005737;GO:0034673;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0005524;GO:0098821;GO:0015026;GO:0019838;GO:0034711;GO:0046872;GO:0030165;GO:0043621;GO:0004674;GO:0004675;GO:0032924;GO:0009952;GO:0030509;GO:0071773;GO:0071363;GO:0007368;GO:0048706;GO:0001702;GO:0007498;GO:0030514;GO:0043084;GO:0032927;GO:0030513;GO:0030501;GO:0045648;GO:0045669;GO:0010862;GO:0001934;GO:0045944;GO:0006468;GO:0050999;GO:0060011;GO:0042713;GO:0007283;GO:0007178;, C:activin receptor complex; C:cell surface; C:cytoplasm; C:inhibin-betaglycan-ActRII complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:ATP binding; F:BMP receptor activity; F:coreceptor activity; F:growth factor binding; F:inhibin binding; F:metal ion binding; F:PDZ domain binding; F:protein self-association; F:protein serine/threonine kinase activity; F:transmembrane receptor protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:anterior/posterior pattern specification; P:BMP signaling pathway; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:determination of left/right symmetry; P:embryonic skeletal system development; P:gastrulation with mouth forming second; P:mesoderm development; P:negative regulation of BMP signaling pathway; P:penile erection; P:positive regulation of activin receptor signaling pathway; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of nitric-oxide synthase activity; P:Sertoli cell proliferation; P:sperm ejaculation; P:spermatogenesis; P:transmembrane receptor protein serine/threonine kinase signaling pathway;|O43929 B7Z3D0 B7Z5F1 D3DP86 F5H069 Q96C42,Origin recognition complex subunit 4,, PF13191;PF14629;, GO:0000781;GO:0005829;GO:0005664;GO:0005730;GO:0005654;GO:0005634;GO:0000808;GO:0005524;GO:0003688;GO:0000166;GO:0006260;GO:0006270;GO:0036388;, C:chromosome, telomeric region; C:cytosol; C:nuclear origin of replication recognition complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:ATP binding; F:DNA replication origin binding; F:nucleotide binding;, P:DNA replication; P:DNA replication initiation; P:pre-replicative complex assembly;|O43929 B7Z3D0 B7Z5F1 D3DP86 F5H069 Q96C42,Origin recognition complex subunit 4,, PF13191;PF14629;, GO:0000781;GO:0005829;GO:0005664;GO:0005730;GO:0005654;GO:0005634;GO:0000808;GO:0005524;GO:0003688;GO:0000166;GO:0006260;GO:0006270;GO:0036388;, C:chromosome, telomeric region; C:cytosol; C:nuclear origin of replication recognition complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:ATP binding; F:DNA replication origin binding; F:nucleotide binding;, P:DNA replication; P:DNA replication initiation; P:pre-replicative complex assembly;|O43929 B7Z3D0 B7Z5F1 D3DP86 F5H069 Q96C42,Origin recognition complex subunit 4,, PF13191;PF14629;, GO:0000781;GO:0005829;GO:0005664;GO:0005730;GO:0005654;GO:0005634;GO:0000808;GO:0005524;GO:0003688;GO:0000166;GO:0006260;GO:0006270;GO:0036388;, C:chromosome, telomeric region; C:cytosol; C:nuclear origin of replication recognition complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:ATP binding; F:DNA replication origin binding; F:nucleotide binding;, P:DNA replication; P:DNA replication initiation; P:pre-replicative complex assembly;|O43929 B7Z3D0 B7Z5F1 D3DP86 F5H069 Q96C42,Origin recognition complex subunit 4,, PF13191;PF14629;, GO:0000781;GO:0005829;GO:0005664;GO:0005730;GO:0005654;GO:0005634;GO:0000808;GO:0005524;GO:0003688;GO:0000166;GO:0006260;GO:0006270;GO:0036388;, C:chromosome, telomeric region; C:cytosol; C:nuclear origin of replication recognition complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:ATP binding; F:DNA replication origin binding; F:nucleotide binding;, P:DNA replication; P:DNA replication initiation; P:pre-replicative complex assembly;|O43929 B7Z3D0 B7Z5F1 D3DP86 F5H069 Q96C42,Origin recognition complex subunit 4,, PF13191;PF14629;, GO:0000781;GO:0005829;GO:0005664;GO:0005730;GO:0005654;GO:0005634;GO:0000808;GO:0005524;GO:0003688;GO:0000166;GO:0006260;GO:0006270;GO:0036388;, C:chromosome, telomeric region; C:cytosol; C:nuclear origin of replication recognition complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:ATP binding; F:DNA replication origin binding; F:nucleotide binding;, P:DNA replication; P:DNA replication initiation; P:pre-replicative complex assembly;|O43929 B7Z3D0 B7Z5F1 D3DP86 F5H069 Q96C42,Origin recognition complex subunit 4,, PF13191;PF14629;, GO:0000781;GO:0005829;GO:0005664;GO:0005730;GO:0005654;GO:0005634;GO:0000808;GO:0005524;GO:0003688;GO:0000166;GO:0006260;GO:0006270;GO:0036388;, C:chromosome, telomeric region; C:cytosol; C:nuclear origin of replication recognition complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:ATP binding; F:DNA replication origin binding; F:nucleotide binding;, P:DNA replication; P:DNA replication initiation; P:pre-replicative complex assembly;|O43929 B7Z3D0 B7Z5F1 D3DP86 F5H069 Q96C42,Origin recognition complex subunit 4,, PF13191;PF14629;, GO:0000781;GO:0005829;GO:0005664;GO:0005730;GO:0005654;GO:0005634;GO:0000808;GO:0005524;GO:0003688;GO:0000166;GO:0006260;GO:0006270;GO:0036388;, C:chromosome, telomeric region; C:cytosol; C:nuclear origin of replication recognition complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:ATP binding; F:DNA replication origin binding; F:nucleotide binding;, P:DNA replication; P:DNA replication initiation; P:pre-replicative complex assembly;|O43929 B7Z3D0 B7Z5F1 D3DP86 F5H069 Q96C42,Origin recognition complex subunit 4,, PF13191;PF14629;, GO:0000781;GO:0005829;GO:0005664;GO:0005730;GO:0005654;GO:0005634;GO:0000808;GO:0005524;GO:0003688;GO:0000166;GO:0006260;GO:0006270;GO:0036388;, C:chromosome, telomeric region; C:cytosol; C:nuclear origin of replication recognition complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:ATP binding; F:DNA replication origin binding; F:nucleotide binding;, P:DNA replication; P:DNA replication initiation; P:pre-replicative complex assembly; scaffold9 indexed_genome mRNA 29937456 30387550 . + . ID=transcript_2436;Q9P267 A5HMQ4 A7E2B1 Q53SR1 Q9NUV6,Methyl-CpG-binding domain protein 5,Methyl-CpG-binding protein MBD5;, , GO:0010369;GO:0005694;GO:0070062;GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0042593;GO:0007399;GO:0060399;GO:0016579;GO:0050795;GO:0040014;, C:chromocenter; C:chromosome; C:extracellular exosome; C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:glucose homeostasis; P:nervous system development; P:positive regulation of growth hormone receptor signaling pathway; P:protein deubiquitination; P:regulation of behavior; P:regulation of multicellular organism growth;|Q9P267 A5HMQ4 A7E2B1 Q53SR1 Q9NUV6,Methyl-CpG-binding domain protein 5,Methyl-CpG-binding protein MBD5;, , GO:0010369;GO:0005694;GO:0070062;GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0042593;GO:0007399;GO:0060399;GO:0016579;GO:0050795;GO:0040014;, C:chromocenter; C:chromosome; C:extracellular exosome; C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:glucose homeostasis; P:nervous system development; P:positive regulation of growth hormone receptor signaling pathway; P:protein deubiquitination; P:regulation of behavior; P:regulation of multicellular organism growth; scaffold9 indexed_genome mRNA 30530887 30654539 . + . ID=transcript_2437;Q52LR7 B3KWT7 D3DP89 Q7L9J1 Q96RR7 Q9NUT8 Q9NVR1 Q9UFM9,Enhancer of polycomb homolog 2,EPC-like;, PF06752;PF10513;, GO:0032777;GO:0006281;GO:0016573;GO:0006357;, C:Piccolo NuA4 histone acetyltransferase complex;, , P:DNA repair; P:histone acetylation; P:regulation of transcription by RNA polymerase II;|Q52LR7 B3KWT7 D3DP89 Q7L9J1 Q96RR7 Q9NUT8 Q9NVR1 Q9UFM9,Enhancer of polycomb homolog 2,EPC-like;, PF06752;PF10513;, GO:0032777;GO:0006281;GO:0016573;GO:0006357;, C:Piccolo NuA4 histone acetyltransferase complex;, , P:DNA repair; P:histone acetylation; P:regulation of transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 30706451 30782716 . + . ID=transcript_2438;O60282 O95079 Q2YDC5,Kinesin heavy chain isoform 5C,Kinesin heavy chain neuron-specific 2;, PF00225;, GO:1904115;GO:0044295;GO:0035253;GO:0032839;GO:0150034;GO:0005871;GO:0005874;GO:0043025;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0099641;GO:0098971;GO:0007411;GO:0030705;GO:0007018;GO:0008045;GO:0051028;GO:0006996;GO:0048489;, C:axon cytoplasm; C:axonal growth cone; C:ciliary rootlet; C:dendrite cytoplasm; C:distal axon; C:kinesin complex; C:microtubule; C:neuronal cell body;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:axon guidance; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:motor neuron axon guidance; P:mRNA transport; P:organelle organization; P:synaptic vesicle transport;|O60282 O95079 Q2YDC5,Kinesin heavy chain isoform 5C,Kinesin heavy chain neuron-specific 2;, PF00225;, GO:1904115;GO:0044295;GO:0035253;GO:0032839;GO:0150034;GO:0005871;GO:0005874;GO:0043025;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0099641;GO:0098971;GO:0007411;GO:0030705;GO:0007018;GO:0008045;GO:0051028;GO:0006996;GO:0048489;, C:axon cytoplasm; C:axonal growth cone; C:ciliary rootlet; C:dendrite cytoplasm; C:distal axon; C:kinesin complex; C:microtubule; C:neuronal cell body;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:axon guidance; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:motor neuron axon guidance; P:mRNA transport; P:organelle organization; P:synaptic vesicle transport; scaffold9 indexed_genome mRNA 30784221 30860597 . + . ID=transcript_2439;O60282 O95079 Q2YDC5,Kinesin heavy chain isoform 5C,Kinesin heavy chain neuron-specific 2;, PF00225;, GO:1904115;GO:0044295;GO:0035253;GO:0032839;GO:0150034;GO:0005871;GO:0005874;GO:0043025;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0099641;GO:0098971;GO:0007411;GO:0030705;GO:0007018;GO:0008045;GO:0051028;GO:0006996;GO:0048489;, C:axon cytoplasm; C:axonal growth cone; C:ciliary rootlet; C:dendrite cytoplasm; C:distal axon; C:kinesin complex; C:microtubule; C:neuronal cell body;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:axon guidance; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:motor neuron axon guidance; P:mRNA transport; P:organelle organization; P:synaptic vesicle transport;|O60282 O95079 Q2YDC5,Kinesin heavy chain isoform 5C,Kinesin heavy chain neuron-specific 2;, PF00225;, GO:1904115;GO:0044295;GO:0035253;GO:0032839;GO:0150034;GO:0005871;GO:0005874;GO:0043025;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0099641;GO:0098971;GO:0007411;GO:0030705;GO:0007018;GO:0008045;GO:0051028;GO:0006996;GO:0048489;, C:axon cytoplasm; C:axonal growth cone; C:ciliary rootlet; C:dendrite cytoplasm; C:distal axon; C:kinesin complex; C:microtubule; C:neuronal cell body;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:axon guidance; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:motor neuron axon guidance; P:mRNA transport; P:organelle organization; P:synaptic vesicle transport;|O60282 O95079 Q2YDC5,Kinesin heavy chain isoform 5C,Kinesin heavy chain neuron-specific 2;, PF00225;, GO:1904115;GO:0044295;GO:0035253;GO:0032839;GO:0150034;GO:0005871;GO:0005874;GO:0043025;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0099641;GO:0098971;GO:0007411;GO:0030705;GO:0007018;GO:0008045;GO:0051028;GO:0006996;GO:0048489;, C:axon cytoplasm; C:axonal growth cone; C:ciliary rootlet; C:dendrite cytoplasm; C:distal axon; C:kinesin complex; C:microtubule; C:neuronal cell body;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:axon guidance; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:motor neuron axon guidance; P:mRNA transport; P:organelle organization; P:synaptic vesicle transport; scaffold9 indexed_genome mRNA 31079856 31092786 . + . ID=transcript_2440;Q8NI32 D3DP90 Q53TK0 Q7Z747 Q8IXK7,Ly6/PLAUR domain-containing protein 6B,, , GO:0031225;GO:0005576;GO:0005886;GO:0030548;, C:anchored component of membrane; C:extracellular region; C:plasma membrane;, F:acetylcholine receptor regulator activity; scaffold9 indexed_genome mRNA 31465472 31483315 . - . ID=transcript_2441;Q9H3L0 B2R895 D3DP91 O95891,Cobalamin trafficking protein CblD {ECO:0000303|PubMed:26364851},CblD {ECO:0000303|PubMed:23415655, ECO:0000303|PubMed:24722857, ECO:0000303|PubMed:26364851};Methylmalonic aciduria and homocystinuria type D protein, mitochondrial;, PF10229;, GO:0005737;GO:0005829;GO:0005739;GO:0009235;, C:cytoplasm; C:cytosol; C:mitochondrion;, , P:cobalamin metabolic process;|Q9H3L0 B2R895 D3DP91 O95891,Cobalamin trafficking protein CblD {ECO:0000303|PubMed:26364851},CblD {ECO:0000303|PubMed:23415655, ECO:0000303|PubMed:24722857, ECO:0000303|PubMed:26364851};Methylmalonic aciduria and homocystinuria type D protein, mitochondrial;, PF10229;, GO:0005737;GO:0005829;GO:0005739;GO:0009235;, C:cytoplasm; C:cytosol; C:mitochondrion;, , P:cobalamin metabolic process;|Q9H3L0 B2R895 D3DP91 O95891,Cobalamin trafficking protein CblD {ECO:0000303|PubMed:26364851},CblD {ECO:0000303|PubMed:23415655, ECO:0000303|PubMed:24722857, ECO:0000303|PubMed:26364851};Methylmalonic aciduria and homocystinuria type D protein, mitochondrial;, PF10229;, GO:0005737;GO:0005829;GO:0005739;GO:0009235;, C:cytoplasm; C:cytosol; C:mitochondrion;, , P:cobalamin metabolic process; scaffold9 indexed_genome mRNA 31786512 31787601 . - . ID=transcript_2442;Q6EKJ0 B2RNE9 Q69GU6 Q8N979 Q9H739,General transcription factor II-I repeat domain-containing protein 2B,Transcription factor GTF2IRD2-beta;, PF02946;PF18658;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; scaffold9 indexed_genome mRNA 32266811 32287936 . - . ID=transcript_2443;P61587 D3DP95 P52199,Rho-related GTP-binding protein RhoE,Protein MemB;Rho family GTPase 3;Rho-related GTP-binding protein Rho8;Rnd3;, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005925;GO:0000139;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0030036;GO:0007015;GO:0007155;GO:0016477;GO:0030865;GO:0007163;GO:0032956;GO:0008360;GO:0007264;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:focal adhesion; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:cell adhesion; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:small GTPase mediated signal transduction;|P61587 D3DP95 P52199,Rho-related GTP-binding protein RhoE,Protein MemB;Rho family GTPase 3;Rho-related GTP-binding protein Rho8;Rnd3;, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005925;GO:0000139;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0030036;GO:0007015;GO:0007155;GO:0016477;GO:0030865;GO:0007163;GO:0032956;GO:0008360;GO:0007264;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:focal adhesion; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:cell adhesion; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:small GTPase mediated signal transduction;|P61587 D3DP95 P52199,Rho-related GTP-binding protein RhoE,Protein MemB;Rho family GTPase 3;Rho-related GTP-binding protein Rho8;Rnd3;, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005925;GO:0000139;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0030036;GO:0007015;GO:0007155;GO:0016477;GO:0030865;GO:0007163;GO:0032956;GO:0008360;GO:0007264;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:focal adhesion; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:cell adhesion; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:small GTPase mediated signal transduction;|P61587 D3DP95 P52199,Rho-related GTP-binding protein RhoE,Protein MemB;Rho family GTPase 3;Rho-related GTP-binding protein Rho8;Rnd3;, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005925;GO:0000139;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0030036;GO:0007015;GO:0007155;GO:0016477;GO:0030865;GO:0007163;GO:0032956;GO:0008360;GO:0007264;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:focal adhesion; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:cell adhesion; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:small GTPase mediated signal transduction; scaffold9 indexed_genome mRNA 33022432 33031889 . - . ID=transcript_2444;Q6ZSC3 B2RMT5,RNA-binding protein 43,RNA-binding motif protein 43;, , GO:0003723;, , F:RNA binding; scaffold9 indexed_genome mRNA 33041384 33060476 . - . ID=transcript_2445;Q13287 B5BU69 Q53TI8 Q8WTW2 Q9BVE5,N-myc-interactor {ECO:0000303|PubMed:8668343},N-myc and STAT interactor {ECO:0000303|PubMed:26342464};, PF07334;PF07292;, GO:0005737;GO:0005829;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0003712;GO:0060333;GO:0002281;GO:0008285;GO:0045824;GO:0032687;GO:0032688;GO:1901223;GO:0050729;GO:0045089;GO:1901224;GO:1902524;GO:0007259;GO:0009615;GO:0034142;GO:0006366;, C:cytoplasm; C:cytosol; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:transcription coregulator activity;, P:interferon-gamma-mediated signaling pathway; P:macrophage activation involved in immune response; P:negative regulation of cell population proliferation; P:negative regulation of innate immune response; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K48-linked ubiquitination; P:receptor signaling pathway via JAK-STAT; P:response to virus; P:toll-like receptor 4 signaling pathway; P:transcription by RNA polymerase II;|Q13287 B5BU69 Q53TI8 Q8WTW2 Q9BVE5,N-myc-interactor {ECO:0000303|PubMed:8668343},N-myc and STAT interactor {ECO:0000303|PubMed:26342464};, PF07334;PF07292;, GO:0005737;GO:0005829;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0003712;GO:0060333;GO:0002281;GO:0008285;GO:0045824;GO:0032687;GO:0032688;GO:1901223;GO:0050729;GO:0045089;GO:1901224;GO:1902524;GO:0007259;GO:0009615;GO:0034142;GO:0006366;, C:cytoplasm; C:cytosol; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:transcription coregulator activity;, P:interferon-gamma-mediated signaling pathway; P:macrophage activation involved in immune response; P:negative regulation of cell population proliferation; P:negative regulation of innate immune response; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K48-linked ubiquitination; P:receptor signaling pathway via JAK-STAT; P:response to virus; P:toll-like receptor 4 signaling pathway; P:transcription by RNA polymerase II;|Q13287 B5BU69 Q53TI8 Q8WTW2 Q9BVE5,N-myc-interactor {ECO:0000303|PubMed:8668343},N-myc and STAT interactor {ECO:0000303|PubMed:26342464};, PF07334;PF07292;, GO:0005737;GO:0005829;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0003712;GO:0060333;GO:0002281;GO:0008285;GO:0045824;GO:0032687;GO:0032688;GO:1901223;GO:0050729;GO:0045089;GO:1901224;GO:1902524;GO:0007259;GO:0009615;GO:0034142;GO:0006366;, C:cytoplasm; C:cytosol; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:transcription coregulator activity;, P:interferon-gamma-mediated signaling pathway; P:macrophage activation involved in immune response; P:negative regulation of cell population proliferation; P:negative regulation of innate immune response; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K48-linked ubiquitination; P:receptor signaling pathway via JAK-STAT; P:response to virus; P:toll-like receptor 4 signaling pathway; P:transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 33114023 33131148 . + . ID=transcript_2446;P98066 Q53TI7 Q8WWI9,Tumor necrosis factor-inducible gene 6 protein,Hyaluronate-binding protein;TNF-stimulated gene 6 protein;Tumor necrosis factor alpha-induced protein 6;, PF00431;PF00193;, GO:0005576;GO:0005615;GO:1904813;GO:1904724;GO:0005540;GO:0007155;GO:0007267;GO:0006954;GO:0050728;GO:0043312;GO:0030728;GO:0030335;GO:0007165;, C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:tertiary granule lumen;, F:hyaluronic acid binding;, P:cell adhesion; P:cell-cell signaling; P:inflammatory response; P:negative regulation of inflammatory response; P:neutrophil degranulation; P:ovulation; P:positive regulation of cell migration; P:signal transduction; scaffold9 indexed_genome mRNA 33171054 33227355 . + . ID=transcript_2447;Q9H830 Q9H9B9 Q9NVP5 Q9Y4R4,Telomere-associated protein RIF1 {ECO:0000305},Rap1-interacting factor 1 homolog {ECO:0000305|PubMed:15342490};, PF12231;, GO:0000785;GO:0000781;GO:0000793;GO:0005737;GO:0001939;GO:0001940;GO:0016604;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0035861;GO:0051233;GO:0007049;GO:0006974;GO:1990830;GO:0006348;GO:0006303;GO:2000042;GO:0000122;GO:2001034;GO:0051574;GO:0045830;GO:0019827;GO:0000723;GO:0043247;, C:chromatin; C:chromosome, telomeric region; C:condensed chromosome; C:cytoplasm; C:female pronucleus; C:male pronucleus; C:nuclear body; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:site of double-strand break; C:spindle midzone;, , P:cell cycle; P:cellular response to DNA damage stimulus; P:cellular response to leukemia inhibitory factor; P:chromatin silencing at telomere; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of histone H3-K9 methylation; P:positive regulation of isotype switching; P:stem cell population maintenance; P:telomere maintenance; P:telomere maintenance in response to DNA damage;|Q9H830 Q9H9B9 Q9NVP5 Q9Y4R4,Telomere-associated protein RIF1 {ECO:0000305},Rap1-interacting factor 1 homolog {ECO:0000305|PubMed:15342490};, PF12231;, GO:0000785;GO:0000781;GO:0000793;GO:0005737;GO:0001939;GO:0001940;GO:0016604;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0035861;GO:0051233;GO:0007049;GO:0006974;GO:1990830;GO:0006348;GO:0006303;GO:2000042;GO:0000122;GO:2001034;GO:0051574;GO:0045830;GO:0019827;GO:0000723;GO:0043247;, C:chromatin; C:chromosome, telomeric region; C:condensed chromosome; C:cytoplasm; C:female pronucleus; C:male pronucleus; C:nuclear body; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:site of double-strand break; C:spindle midzone;, , P:cell cycle; P:cellular response to DNA damage stimulus; P:cellular response to leukemia inhibitory factor; P:chromatin silencing at telomere; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of histone H3-K9 methylation; P:positive regulation of isotype switching; P:stem cell population maintenance; P:telomere maintenance; P:telomere maintenance in response to DNA damage;|Q9H830 Q9H9B9 Q9NVP5 Q9Y4R4,Telomere-associated protein RIF1 {ECO:0000305},Rap1-interacting factor 1 homolog {ECO:0000305|PubMed:15342490};, PF12231;, GO:0000785;GO:0000781;GO:0000793;GO:0005737;GO:0001939;GO:0001940;GO:0016604;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0035861;GO:0051233;GO:0007049;GO:0006974;GO:1990830;GO:0006348;GO:0006303;GO:2000042;GO:0000122;GO:2001034;GO:0051574;GO:0045830;GO:0019827;GO:0000723;GO:0043247;, C:chromatin; C:chromosome, telomeric region; C:condensed chromosome; C:cytoplasm; C:female pronucleus; C:male pronucleus; C:nuclear body; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:site of double-strand break; C:spindle midzone;, , P:cell cycle; P:cellular response to DNA damage stimulus; P:cellular response to leukemia inhibitory factor; P:chromatin silencing at telomere; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of histone H3-K9 methylation; P:positive regulation of isotype switching; P:stem cell population maintenance; P:telomere maintenance; P:telomere maintenance in response to DNA damage;|Q9H830 Q9H9B9 Q9NVP5 Q9Y4R4,Telomere-associated protein RIF1 {ECO:0000305},Rap1-interacting factor 1 homolog {ECO:0000305|PubMed:15342490};, PF12231;, GO:0000785;GO:0000781;GO:0000793;GO:0005737;GO:0001939;GO:0001940;GO:0016604;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0035861;GO:0051233;GO:0007049;GO:0006974;GO:1990830;GO:0006348;GO:0006303;GO:2000042;GO:0000122;GO:2001034;GO:0051574;GO:0045830;GO:0019827;GO:0000723;GO:0043247;, C:chromatin; C:chromosome, telomeric region; C:condensed chromosome; C:cytoplasm; C:female pronucleus; C:male pronucleus; C:nuclear body; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:site of double-strand break; C:spindle midzone;, , P:cell cycle; P:cellular response to DNA damage stimulus; P:cellular response to leukemia inhibitory factor; P:chromatin silencing at telomere; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of histone H3-K9 methylation; P:positive regulation of isotype switching; P:stem cell population maintenance; P:telomere maintenance; P:telomere maintenance in response to DNA damage;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold9 indexed_genome mRNA 33233875 33331342 . - . ID=transcript_2448;P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development;|P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development;|P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development;|P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development;|P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development;|P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development;|P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development;|P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development;|P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development; scaffold9 indexed_genome mRNA 33331364 33337556 . - . ID=transcript_2449;P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development; scaffold9 indexed_genome mRNA 33337571 33343258 . - . ID=transcript_2450;P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development; scaffold9 indexed_genome mRNA 33350106 33355888 . - . ID=transcript_2451;P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development; scaffold9 indexed_genome mRNA 33359647 33370651 . - . ID=transcript_2452;P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development;|P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development; scaffold9 indexed_genome mRNA 33370678 33380612 . - . ID=transcript_2453;P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development; scaffold9 indexed_genome mRNA 33380692 33404711 . - . ID=transcript_2454;P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development;|P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development; scaffold9 indexed_genome mRNA 33404964 33439594 . - . ID=transcript_2455;P20929 F8WCL5 F8WCP0 Q15346 Q53QQ2 Q53TG8,Nebulin,, PF00880;PF14604;, GO:0015629;GO:0005829;GO:0070062;GO:0030018;GO:0051015;GO:0008307;GO:0071691;GO:0048747;GO:0030049;GO:0007517;GO:0030832;GO:0007525;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:Z disc;, F:actin filament binding; F:structural constituent of muscle;, P:cardiac muscle thin filament assembly; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:regulation of actin filament length; P:somatic muscle development; scaffold9 indexed_genome mRNA 33479284 33507865 . - . ID=transcript_2456;Q9Y689 Q580I5,ADP-ribosylation factor-like protein 5A,, PF00025;, GO:0005802;GO:0005525;GO:0006886;GO:1903292;GO:0016192;, C:trans-Golgi network;, F:GTP binding;, P:intracellular protein transport; P:protein localization to Golgi membrane; P:vesicle-mediated transport; scaffold9 indexed_genome mRNA 33516963 33661019 . - . ID=transcript_2457;O00305 A7BJ74 A8K1Y4 B4DG40 O60515 Q6B000 Q96L40,Voltage-dependent L-type calcium channel subunit beta-4 {ECO:0000305},Calcium channel voltage-dependent subunit beta 4 {ECO:0000305};, PF00625;PF12052;, GO:0009898;GO:0005829;GO:0005886;GO:0045202;GO:0005891;GO:0005245;GO:0007268;GO:0051899;GO:0007528;GO:1901385;, C:cytoplasmic side of plasma membrane; C:cytosol; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:voltage-gated calcium channel activity;, P:chemical synaptic transmission; P:membrane depolarization; P:neuromuscular junction development; P:regulation of voltage-gated calcium channel activity;|O00305 A7BJ74 A8K1Y4 B4DG40 O60515 Q6B000 Q96L40,Voltage-dependent L-type calcium channel subunit beta-4 {ECO:0000305},Calcium channel voltage-dependent subunit beta 4 {ECO:0000305};, PF00625;PF12052;, GO:0009898;GO:0005829;GO:0005886;GO:0045202;GO:0005891;GO:0005245;GO:0007268;GO:0051899;GO:0007528;GO:1901385;, C:cytoplasmic side of plasma membrane; C:cytosol; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:voltage-gated calcium channel activity;, P:chemical synaptic transmission; P:membrane depolarization; P:neuromuscular junction development; P:regulation of voltage-gated calcium channel activity;|Q02641 A8K114 O15331 Q02639 Q02640 Q8N3X9 Q9C085 Q9UD79,Voltage-dependent L-type calcium channel subunit beta-1,Calcium channel voltage-dependent subunit beta 1;, PF00625;PF12052;, GO:0005886;GO:0042383;GO:0045202;GO:0005891;GO:0008331;GO:0005245;GO:0061337;GO:1904646;GO:0007268;GO:0007528;GO:1902514;GO:1901385;, C:plasma membrane; C:sarcolemma; C:synapse; C:voltage-gated calcium channel complex;, F:high voltage-gated calcium channel activity; F:voltage-gated calcium channel activity;, P:cardiac conduction; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:neuromuscular junction development; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of voltage-gated calcium channel activity;|Q02641 A8K114 O15331 Q02639 Q02640 Q8N3X9 Q9C085 Q9UD79,Voltage-dependent L-type calcium channel subunit beta-1,Calcium channel voltage-dependent subunit beta 1;, PF00625;PF12052;, GO:0005886;GO:0042383;GO:0045202;GO:0005891;GO:0008331;GO:0005245;GO:0061337;GO:1904646;GO:0007268;GO:0007528;GO:1902514;GO:1901385;, C:plasma membrane; C:sarcolemma; C:synapse; C:voltage-gated calcium channel complex;, F:high voltage-gated calcium channel activity; F:voltage-gated calcium channel activity;, P:cardiac conduction; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:neuromuscular junction development; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of voltage-gated calcium channel activity; scaffold9 indexed_genome mRNA 33789861 33837150 . - . ID=transcript_2458;O75886 A8K8A0 D3DPA1 Q7LDQ0 Q9UF58,Signal transducing adapter molecule 2,Hrs-binding protein;, PF00018;PF02809;PF00790;, GO:0005737;GO:0005829;GO:0031901;GO:0030139;GO:0033565;GO:0043231;GO:0005654;GO:0016197;GO:0006886;GO:0016236;GO:0061024;GO:0036258;GO:0042059;GO:0016579;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endocytic vesicle; C:ESCRT-0 complex; C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:endosomal transport; P:intracellular protein transport; P:macroautophagy; P:membrane organization; P:multivesicular body assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein deubiquitination; P:signal transduction;|O75886 A8K8A0 D3DPA1 Q7LDQ0 Q9UF58,Signal transducing adapter molecule 2,Hrs-binding protein;, PF00018;PF02809;PF00790;, GO:0005737;GO:0005829;GO:0031901;GO:0030139;GO:0033565;GO:0043231;GO:0005654;GO:0016197;GO:0006886;GO:0016236;GO:0061024;GO:0036258;GO:0042059;GO:0016579;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endocytic vesicle; C:ESCRT-0 complex; C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:endosomal transport; P:intracellular protein transport; P:macroautophagy; P:membrane organization; P:multivesicular body assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein deubiquitination; P:signal transduction;|O75886 A8K8A0 D3DPA1 Q7LDQ0 Q9UF58,Signal transducing adapter molecule 2,Hrs-binding protein;, PF00018;PF02809;PF00790;, GO:0005737;GO:0005829;GO:0031901;GO:0030139;GO:0033565;GO:0043231;GO:0005654;GO:0016197;GO:0006886;GO:0016236;GO:0061024;GO:0036258;GO:0042059;GO:0016579;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endocytic vesicle; C:ESCRT-0 complex; C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:endosomal transport; P:intracellular protein transport; P:macroautophagy; P:membrane organization; P:multivesicular body assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein deubiquitination; P:signal transduction;|O75886 A8K8A0 D3DPA1 Q7LDQ0 Q9UF58,Signal transducing adapter molecule 2,Hrs-binding protein;, PF00018;PF02809;PF00790;, GO:0005737;GO:0005829;GO:0031901;GO:0030139;GO:0033565;GO:0043231;GO:0005654;GO:0016197;GO:0006886;GO:0016236;GO:0061024;GO:0036258;GO:0042059;GO:0016579;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endocytic vesicle; C:ESCRT-0 complex; C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:endosomal transport; P:intracellular protein transport; P:macroautophagy; P:membrane organization; P:multivesicular body assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein deubiquitination; P:signal transduction;|O75886 A8K8A0 D3DPA1 Q7LDQ0 Q9UF58,Signal transducing adapter molecule 2,Hrs-binding protein;, PF00018;PF02809;PF00790;, GO:0005737;GO:0005829;GO:0031901;GO:0030139;GO:0033565;GO:0043231;GO:0005654;GO:0016197;GO:0006886;GO:0016236;GO:0061024;GO:0036258;GO:0042059;GO:0016579;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endocytic vesicle; C:ESCRT-0 complex; C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:endosomal transport; P:intracellular protein transport; P:macroautophagy; P:membrane organization; P:multivesicular body assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein deubiquitination; P:signal transduction;|O75886 A8K8A0 D3DPA1 Q7LDQ0 Q9UF58,Signal transducing adapter molecule 2,Hrs-binding protein;, PF00018;PF02809;PF00790;, GO:0005737;GO:0005829;GO:0031901;GO:0030139;GO:0033565;GO:0043231;GO:0005654;GO:0016197;GO:0006886;GO:0016236;GO:0061024;GO:0036258;GO:0042059;GO:0016579;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endocytic vesicle; C:ESCRT-0 complex; C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:endosomal transport; P:intracellular protein transport; P:macroautophagy; P:membrane organization; P:multivesicular body assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein deubiquitination; P:signal transduction;|O75886 A8K8A0 D3DPA1 Q7LDQ0 Q9UF58,Signal transducing adapter molecule 2,Hrs-binding protein;, PF00018;PF02809;PF00790;, GO:0005737;GO:0005829;GO:0031901;GO:0030139;GO:0033565;GO:0043231;GO:0005654;GO:0016197;GO:0006886;GO:0016236;GO:0061024;GO:0036258;GO:0042059;GO:0016579;GO:0007165;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endocytic vesicle; C:ESCRT-0 complex; C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:endosomal transport; P:intracellular protein transport; P:macroautophagy; P:membrane organization; P:multivesicular body assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein deubiquitination; P:signal transduction;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold9 indexed_genome mRNA 33963036 34266503 . + . ID=transcript_2459;Q96PY5 B2RZH5 Q14CC9 Q4ZG52 Q8N3E0,Formin-like protein 2,Formin homology 2 domain-containing protein 2;, PF06367;PF06371;PF02181;, GO:0005829;GO:0051015;GO:0045296;GO:0031267;GO:0016477;GO:0030866;GO:0007010;GO:0022604;GO:0008360;, C:cytosol;, F:actin filament binding; F:cadherin binding; F:small GTPase binding;, P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell morphogenesis; P:regulation of cell shape; scaffold9 indexed_genome mRNA 34271144 34292017 . + . ID=transcript_2460;Q96PY5 B2RZH5 Q14CC9 Q4ZG52 Q8N3E0,Formin-like protein 2,Formin homology 2 domain-containing protein 2;, PF06367;PF06371;PF02181;, GO:0005829;GO:0051015;GO:0045296;GO:0031267;GO:0016477;GO:0030866;GO:0007010;GO:0022604;GO:0008360;, C:cytosol;, F:actin filament binding; F:cadherin binding; F:small GTPase binding;, P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell morphogenesis; P:regulation of cell shape;|Q96PY5 B2RZH5 Q14CC9 Q4ZG52 Q8N3E0,Formin-like protein 2,Formin homology 2 domain-containing protein 2;, PF06367;PF06371;PF02181;, GO:0005829;GO:0051015;GO:0045296;GO:0031267;GO:0016477;GO:0030866;GO:0007010;GO:0022604;GO:0008360;, C:cytosol;, F:actin filament binding; F:cadherin binding; F:small GTPase binding;, P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell morphogenesis; P:regulation of cell shape;|Q96PY5 B2RZH5 Q14CC9 Q4ZG52 Q8N3E0,Formin-like protein 2,Formin homology 2 domain-containing protein 2;, PF06367;PF06371;PF02181;, GO:0005829;GO:0051015;GO:0045296;GO:0031267;GO:0016477;GO:0030866;GO:0007010;GO:0022604;GO:0008360;, C:cytosol;, F:actin filament binding; F:cadherin binding; F:small GTPase binding;, P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell morphogenesis; P:regulation of cell shape;|Q96PY5 B2RZH5 Q14CC9 Q4ZG52 Q8N3E0,Formin-like protein 2,Formin homology 2 domain-containing protein 2;, PF06367;PF06371;PF02181;, GO:0005829;GO:0051015;GO:0045296;GO:0031267;GO:0016477;GO:0030866;GO:0007010;GO:0022604;GO:0008360;, C:cytosol;, F:actin filament binding; F:cadherin binding; F:small GTPase binding;, P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell morphogenesis; P:regulation of cell shape;|Q96PY5 B2RZH5 Q14CC9 Q4ZG52 Q8N3E0,Formin-like protein 2,Formin homology 2 domain-containing protein 2;, PF06367;PF06371;PF02181;, GO:0005829;GO:0051015;GO:0045296;GO:0031267;GO:0016477;GO:0030866;GO:0007010;GO:0022604;GO:0008360;, C:cytosol;, F:actin filament binding; F:cadherin binding; F:small GTPase binding;, P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell morphogenesis; P:regulation of cell shape; scaffold9 indexed_genome mRNA 34297605 34356050 . - . ID=transcript_2461;O75400 O43856 O75404 Q8TBQ1 Q9H782 Q9NWU9 Q9P0Q2 Q9Y5A8,Pre-mRNA-processing factor 40 homolog A,Fas ligand-associated factor 1;Formin-binding protein 11;Formin-binding protein 3;Huntingtin yeast partner A;Huntingtin-interacting protein 10;Huntingtin-interacting protein A;Renal carcinoma antigen NY-REN-6;, PF01846;PF00397;, GO:0016020;GO:0016363;GO:0016607;GO:0005654;GO:0005685;GO:0071004;GO:0003723;GO:0007049;GO:0051301;GO:0016477;GO:0007010;GO:0045292;GO:0000398;GO:0008360;GO:0032465;, C:membrane; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:U1 snRNP; C:U2-type prespliceosome;, F:RNA binding;, P:cell cycle; P:cell division; P:cell migration; P:cytoskeleton organization; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:regulation of cell shape; P:regulation of cytokinesis;|O75400 O43856 O75404 Q8TBQ1 Q9H782 Q9NWU9 Q9P0Q2 Q9Y5A8,Pre-mRNA-processing factor 40 homolog A,Fas ligand-associated factor 1;Formin-binding protein 11;Formin-binding protein 3;Huntingtin yeast partner A;Huntingtin-interacting protein 10;Huntingtin-interacting protein A;Renal carcinoma antigen NY-REN-6;, PF01846;PF00397;, GO:0016020;GO:0016363;GO:0016607;GO:0005654;GO:0005685;GO:0071004;GO:0003723;GO:0007049;GO:0051301;GO:0016477;GO:0007010;GO:0045292;GO:0000398;GO:0008360;GO:0032465;, C:membrane; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:U1 snRNP; C:U2-type prespliceosome;, F:RNA binding;, P:cell cycle; P:cell division; P:cell migration; P:cytoskeleton organization; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:regulation of cell shape; P:regulation of cytokinesis;|O75400 O43856 O75404 Q8TBQ1 Q9H782 Q9NWU9 Q9P0Q2 Q9Y5A8,Pre-mRNA-processing factor 40 homolog A,Fas ligand-associated factor 1;Formin-binding protein 11;Formin-binding protein 3;Huntingtin yeast partner A;Huntingtin-interacting protein 10;Huntingtin-interacting protein A;Renal carcinoma antigen NY-REN-6;, PF01846;PF00397;, GO:0016020;GO:0016363;GO:0016607;GO:0005654;GO:0005685;GO:0071004;GO:0003723;GO:0007049;GO:0051301;GO:0016477;GO:0007010;GO:0045292;GO:0000398;GO:0008360;GO:0032465;, C:membrane; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:U1 snRNP; C:U2-type prespliceosome;, F:RNA binding;, P:cell cycle; P:cell division; P:cell migration; P:cytoskeleton organization; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:regulation of cell shape; P:regulation of cytokinesis;|O75400 O43856 O75404 Q8TBQ1 Q9H782 Q9NWU9 Q9P0Q2 Q9Y5A8,Pre-mRNA-processing factor 40 homolog A,Fas ligand-associated factor 1;Formin-binding protein 11;Formin-binding protein 3;Huntingtin yeast partner A;Huntingtin-interacting protein 10;Huntingtin-interacting protein A;Renal carcinoma antigen NY-REN-6;, PF01846;PF00397;, GO:0016020;GO:0016363;GO:0016607;GO:0005654;GO:0005685;GO:0071004;GO:0003723;GO:0007049;GO:0051301;GO:0016477;GO:0007010;GO:0045292;GO:0000398;GO:0008360;GO:0032465;, C:membrane; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:U1 snRNP; C:U2-type prespliceosome;, F:RNA binding;, P:cell cycle; P:cell division; P:cell migration; P:cytoskeleton organization; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:regulation of cell shape; P:regulation of cytokinesis; scaffold9 indexed_genome mRNA 34356248 34389514 . + . ID=transcript_2462;Q8N6S5 B2RDS6 Q7Z4G7,ADP-ribosylation factor-like protein 6-interacting protein 6,Phosphonoformate immuno-associated protein 1;, PF15062;, GO:0016021;GO:0005637;, C:integral component of membrane; C:nuclear inner membrane;|Q8N6S5 B2RDS6 Q7Z4G7,ADP-ribosylation factor-like protein 6-interacting protein 6,Phosphonoformate immuno-associated protein 1;, PF15062;, GO:0016021;GO:0005637;, C:integral component of membrane; C:nuclear inner membrane;|Q8N6S5 B2RDS6 Q7Z4G7,ADP-ribosylation factor-like protein 6-interacting protein 6,Phosphonoformate immuno-associated protein 1;, PF15062;, GO:0016021;GO:0005637;, C:integral component of membrane; C:nuclear inner membrane; scaffold9 indexed_genome mRNA 35650032 35996982 . + . ID=transcript_2463;Q8IUC8 Q08ER7 Q68VI8 Q6ZWG1 Q96PX0 Q9UIE5,Polypeptide N-acetylgalactosaminyltransferase 13,Polypeptide GalNAc transferase 13;Protein-UDP acetylgalactosaminyltransferase 13;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;GO:0018242;GO:0018243;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q8IUC8 Q08ER7 Q68VI8 Q6ZWG1 Q96PX0 Q9UIE5,Polypeptide N-acetylgalactosaminyltransferase 13,Polypeptide GalNAc transferase 13;Protein-UDP acetylgalactosaminyltransferase 13;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;GO:0018242;GO:0018243;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q8IUC8 Q08ER7 Q68VI8 Q6ZWG1 Q96PX0 Q9UIE5,Polypeptide N-acetylgalactosaminyltransferase 13,Polypeptide GalNAc transferase 13;Protein-UDP acetylgalactosaminyltransferase 13;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;GO:0018242;GO:0018243;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine; scaffold9 indexed_genome mRNA 36274579 36449899 . + . ID=transcript_2464;P48549 B4DEW7 Q8TBI0,G protein-activated inward rectifier potassium channel 1,Inward rectifier K(+) channel Kir3.1;Potassium channel, inwardly rectifying subfamily J member 3;, PF01007;PF17655;, GO:0009897;GO:0099056;GO:0098688;GO:0005886;GO:0030315;GO:0008076;GO:0015467;GO:0086089;GO:1902282;GO:0098914;GO:1901381;GO:1990573;GO:0006813;GO:0086091;GO:0034765;GO:0051602;GO:0099625;, C:external side of plasma membrane; C:integral component of presynaptic membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:T-tubule; C:voltage-gated potassium channel complex;, F:G-protein activated inward rectifier potassium channel activity; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:membrane repolarization during atrial cardiac muscle cell action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transport; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:response to electrical stimulus; P:ventricular cardiac muscle cell membrane repolarization;|P48549 B4DEW7 Q8TBI0,G protein-activated inward rectifier potassium channel 1,Inward rectifier K(+) channel Kir3.1;Potassium channel, inwardly rectifying subfamily J member 3;, PF01007;PF17655;, GO:0009897;GO:0099056;GO:0098688;GO:0005886;GO:0030315;GO:0008076;GO:0015467;GO:0086089;GO:1902282;GO:0098914;GO:1901381;GO:1990573;GO:0006813;GO:0086091;GO:0034765;GO:0051602;GO:0099625;, C:external side of plasma membrane; C:integral component of presynaptic membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:T-tubule; C:voltage-gated potassium channel complex;, F:G-protein activated inward rectifier potassium channel activity; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:membrane repolarization during atrial cardiac muscle cell action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transport; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:response to electrical stimulus; P:ventricular cardiac muscle cell membrane repolarization;|P48549 B4DEW7 Q8TBI0,G protein-activated inward rectifier potassium channel 1,Inward rectifier K(+) channel Kir3.1;Potassium channel, inwardly rectifying subfamily J member 3;, PF01007;PF17655;, GO:0009897;GO:0099056;GO:0098688;GO:0005886;GO:0030315;GO:0008076;GO:0015467;GO:0086089;GO:1902282;GO:0098914;GO:1901381;GO:1990573;GO:0006813;GO:0086091;GO:0034765;GO:0051602;GO:0099625;, C:external side of plasma membrane; C:integral component of presynaptic membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:T-tubule; C:voltage-gated potassium channel complex;, F:G-protein activated inward rectifier potassium channel activity; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:membrane repolarization during atrial cardiac muscle cell action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transport; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:response to electrical stimulus; P:ventricular cardiac muscle cell membrane repolarization; scaffold9 indexed_genome mRNA 37591498 37597920 . - . ID=transcript_2465;P43354 Q16311 Q53RZ2 Q6NXU0,Nuclear receptor subfamily 4 group A member 2,Immediate-early response protein NOT;Orphan nuclear receptor NURR1;Transcriptionally-inducible nuclear receptor;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0008013;GO:0003677;GO:0001228;GO:0000981;GO:0035259;GO:0004879;GO:0046982;GO:0046965;GO:0000978;GO:1990837;GO:0008270;GO:0008344;GO:0060070;GO:0071376;GO:0031668;GO:0034599;GO:0021953;GO:0021952;GO:0042416;GO:0071542;GO:0045444;GO:0051866;GO:0021986;GO:1904948;GO:2001234;GO:0043524;GO:0000122;GO:0042551;GO:0001764;GO:0043085;GO:0045944;GO:0009791;GO:0042053;GO:0043576;GO:0006357;GO:0001975;GO:0001666;GO:0007165;GO:0006367;GO:0006351;, C:chromatin; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:nuclear receptor activity; F:protein heterodimerization activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:adult locomotory behavior; P:canonical Wnt signaling pathway; P:cellular response to corticotropin-releasing hormone stimulus; P:cellular response to extracellular stimulus; P:cellular response to oxidative stress; P:central nervous system neuron differentiation; P:central nervous system projection neuron axonogenesis; P:dopamine biosynthetic process; P:dopaminergic neuron differentiation; P:fat cell differentiation; P:general adaptation syndrome; P:habenula development; P:midbrain dopaminergic neuron differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:neuron maturation; P:neuron migration; P:positive regulation of catalytic activity; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:regulation of dopamine metabolic process; P:regulation of respiratory gaseous exchange; P:regulation of transcription by RNA polymerase II; P:response to amphetamine; P:response to hypoxia; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated;|P43354 Q16311 Q53RZ2 Q6NXU0,Nuclear receptor subfamily 4 group A member 2,Immediate-early response protein NOT;Orphan nuclear receptor NURR1;Transcriptionally-inducible nuclear receptor;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0008013;GO:0003677;GO:0001228;GO:0000981;GO:0035259;GO:0004879;GO:0046982;GO:0046965;GO:0000978;GO:1990837;GO:0008270;GO:0008344;GO:0060070;GO:0071376;GO:0031668;GO:0034599;GO:0021953;GO:0021952;GO:0042416;GO:0071542;GO:0045444;GO:0051866;GO:0021986;GO:1904948;GO:2001234;GO:0043524;GO:0000122;GO:0042551;GO:0001764;GO:0043085;GO:0045944;GO:0009791;GO:0042053;GO:0043576;GO:0006357;GO:0001975;GO:0001666;GO:0007165;GO:0006367;GO:0006351;, C:chromatin; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:nuclear receptor activity; F:protein heterodimerization activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:adult locomotory behavior; P:canonical Wnt signaling pathway; P:cellular response to corticotropin-releasing hormone stimulus; P:cellular response to extracellular stimulus; P:cellular response to oxidative stress; P:central nervous system neuron differentiation; P:central nervous system projection neuron axonogenesis; P:dopamine biosynthetic process; P:dopaminergic neuron differentiation; P:fat cell differentiation; P:general adaptation syndrome; P:habenula development; P:midbrain dopaminergic neuron differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:neuron maturation; P:neuron migration; P:positive regulation of catalytic activity; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:regulation of dopamine metabolic process; P:regulation of respiratory gaseous exchange; P:regulation of transcription by RNA polymerase II; P:response to amphetamine; P:response to hypoxia; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated;|P43354 Q16311 Q53RZ2 Q6NXU0,Nuclear receptor subfamily 4 group A member 2,Immediate-early response protein NOT;Orphan nuclear receptor NURR1;Transcriptionally-inducible nuclear receptor;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0008013;GO:0003677;GO:0001228;GO:0000981;GO:0035259;GO:0004879;GO:0046982;GO:0046965;GO:0000978;GO:1990837;GO:0008270;GO:0008344;GO:0060070;GO:0071376;GO:0031668;GO:0034599;GO:0021953;GO:0021952;GO:0042416;GO:0071542;GO:0045444;GO:0051866;GO:0021986;GO:1904948;GO:2001234;GO:0043524;GO:0000122;GO:0042551;GO:0001764;GO:0043085;GO:0045944;GO:0009791;GO:0042053;GO:0043576;GO:0006357;GO:0001975;GO:0001666;GO:0007165;GO:0006367;GO:0006351;, C:chromatin; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:nuclear receptor activity; F:protein heterodimerization activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:adult locomotory behavior; P:canonical Wnt signaling pathway; P:cellular response to corticotropin-releasing hormone stimulus; P:cellular response to extracellular stimulus; P:cellular response to oxidative stress; P:central nervous system neuron differentiation; P:central nervous system projection neuron axonogenesis; P:dopamine biosynthetic process; P:dopaminergic neuron differentiation; P:fat cell differentiation; P:general adaptation syndrome; P:habenula development; P:midbrain dopaminergic neuron differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:neuron maturation; P:neuron migration; P:positive regulation of catalytic activity; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:regulation of dopamine metabolic process; P:regulation of respiratory gaseous exchange; P:regulation of transcription by RNA polymerase II; P:response to amphetamine; P:response to hypoxia; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated;|P43354 Q16311 Q53RZ2 Q6NXU0,Nuclear receptor subfamily 4 group A member 2,Immediate-early response protein NOT;Orphan nuclear receptor NURR1;Transcriptionally-inducible nuclear receptor;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0008013;GO:0003677;GO:0001228;GO:0000981;GO:0035259;GO:0004879;GO:0046982;GO:0046965;GO:0000978;GO:1990837;GO:0008270;GO:0008344;GO:0060070;GO:0071376;GO:0031668;GO:0034599;GO:0021953;GO:0021952;GO:0042416;GO:0071542;GO:0045444;GO:0051866;GO:0021986;GO:1904948;GO:2001234;GO:0043524;GO:0000122;GO:0042551;GO:0001764;GO:0043085;GO:0045944;GO:0009791;GO:0042053;GO:0043576;GO:0006357;GO:0001975;GO:0001666;GO:0007165;GO:0006367;GO:0006351;, C:chromatin; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:nuclear receptor activity; F:protein heterodimerization activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:adult locomotory behavior; P:canonical Wnt signaling pathway; P:cellular response to corticotropin-releasing hormone stimulus; P:cellular response to extracellular stimulus; P:cellular response to oxidative stress; P:central nervous system neuron differentiation; P:central nervous system projection neuron axonogenesis; P:dopamine biosynthetic process; P:dopaminergic neuron differentiation; P:fat cell differentiation; P:general adaptation syndrome; P:habenula development; P:midbrain dopaminergic neuron differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:neuron maturation; P:neuron migration; P:positive regulation of catalytic activity; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:regulation of dopamine metabolic process; P:regulation of respiratory gaseous exchange; P:regulation of transcription by RNA polymerase II; P:response to amphetamine; P:response to hypoxia; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; scaffold9 indexed_genome mRNA 37779378 37849980 . + . ID=transcript_2466;P43304 A8K4V0 B3KSA9 Q59FR1 Q9HAP9,Glycerol-3-phosphate dehydrogenase, mitochondrial {ECO:0000305},mitohondrial glycerophosphate dehydrogenase gene {ECO:0000303|PubMed:9070847};mtGPD;, PF01266;PF16901;PF13499;, GO:0009331;GO:0005743;GO:0005739;GO:0005509;GO:0004368;GO:0052591;GO:0019563;GO:0006072;GO:0006127;, C:glycerol-3-phosphate dehydrogenase complex; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:glycerol-3-phosphate dehydrogenase (quinone) activity; F:sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity;, P:glycerol catabolic process; P:glycerol-3-phosphate metabolic process; P:glycerophosphate shuttle; scaffold9 indexed_genome mRNA 38400604 38401177 . - . ID=transcript_2467;Q7Z7M9 A5PKZ1 Q9UGK7 Q9UHL6,Polypeptide N-acetylgalactosaminyltransferase 5,Polypeptide GalNAc transferase 5;Protein-UDP acetylgalactosaminyltransferase 5;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0006024;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:glycosaminoglycan biosynthetic process; P:O-glycan processing; scaffold9 indexed_genome mRNA 38414290 38440457 . + . ID=transcript_2468;Q7Z7M9 A5PKZ1 Q9UGK7 Q9UHL6,Polypeptide N-acetylgalactosaminyltransferase 5,Polypeptide GalNAc transferase 5;Protein-UDP acetylgalactosaminyltransferase 5;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0006024;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:glycosaminoglycan biosynthetic process; P:O-glycan processing; scaffold9 indexed_genome mRNA 38445251 38453063 . - . ID=transcript_2469;Q8TAM6 B4DKA6 Q9ULN1,Ermin,Juxtanodin;, , GO:0005938;GO:0005737;GO:0005856;GO:0070062;GO:0030175;GO:0033269;GO:0043209;GO:0043025;GO:0033270;GO:0051015;GO:0007015;GO:0001763;GO:0031344;GO:0008360;, C:cell cortex; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:filopodium; C:internode region of axon; C:myelin sheath; C:neuronal cell body; C:paranode region of axon;, F:actin filament binding;, P:actin filament organization; P:morphogenesis of a branching structure; P:regulation of cell projection organization; P:regulation of cell shape; scaffold9 indexed_genome mRNA 38516817 38546343 . - . ID=transcript_2470;O60759 B4DWH9 Q15630 Q8NE32,Cytohesin-interacting protein,Cytohesin binder and regulator;Cytohesin-associated scaffolding protein;Cytohesin-binding protein HE;Pleckstrin homology Sec7 and coiled-coil domains-binding protein;, PF00595;, GO:0005938;GO:0005737;GO:0005829;GO:0005769;GO:0005654;GO:0030155;, C:cell cortex; C:cytoplasm; C:cytosol; C:early endosome; C:nucleoplasm;, , P:regulation of cell adhesion; scaffold9 indexed_genome mRNA 38623470 38623973 . + . ID=transcript_2471;Q8NER5 Q4ZFZ8 Q86UL1 Q86UL2 Q8TBG2,Activin receptor type-1C,Activin receptor type IC;Activin receptor-like kinase 7;, PF01064;PF07714;PF08515;, GO:0048179;GO:0005886;GO:0043235;GO:0016361;GO:0005524;GO:0019838;GO:0046872;GO:0038100;GO:0004674;GO:0032924;GO:0030262;GO:0030154;GO:0071363;GO:0019915;GO:1901383;GO:0046676;GO:1901164;GO:0007399;GO:0038092;GO:0043065;GO:0043280;GO:0006468;GO:0002021;GO:0009749;GO:0032868;GO:0001834;, C:activin receptor complex; C:plasma membrane; C:receptor complex;, F:activin receptor activity, type I; F:ATP binding; F:growth factor binding; F:metal ion binding; F:nodal binding; F:protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:apoptotic nuclear changes; P:cell differentiation; P:cellular response to growth factor stimulus; P:lipid storage; P:negative regulation of chorionic trophoblast cell proliferation; P:negative regulation of insulin secretion; P:negative regulation of trophoblast cell migration; P:nervous system development; P:nodal signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:protein phosphorylation; P:response to dietary excess; P:response to glucose; P:response to insulin; P:trophectodermal cell proliferation; scaffold9 indexed_genome mRNA 38851904 38978410 . - . ID=transcript_2472;Q04771,Activin receptor type-1,Activin receptor type I;Activin receptor-like kinase 2;Serine/threonine-protein kinase receptor R1;TGF-B superfamily receptor type I;, PF01064;PF07714;PF08515;, GO:0048179;GO:0045177;GO:0070724;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0016361;GO:0005524;GO:0045296;GO:0046872;GO:0017046;GO:0042803;GO:0004672;GO:0004674;GO:1990782;GO:0046332;GO:0050431;GO:0005025;GO:0004675;GO:0032924;GO:0002526;GO:0001525;GO:0003289;GO:0003181;GO:0030509;GO:0061312;GO:0001569;GO:0060923;GO:0071773;GO:0071363;GO:0007368;GO:0009953;GO:0003143;GO:0061445;GO:0003274;GO:0003203;GO:0000082;GO:0001702;GO:0007281;GO:0007507;GO:0001701;GO:0001707;GO:0003183;GO:0032926;GO:2001237;GO:0009968;GO:0001755;GO:0060389;GO:0018107;GO:0060037;GO:0030501;GO:0030335;GO:2000017;GO:1905007;GO:0045669;GO:0010862;GO:0050731;GO:0045944;GO:0045893;GO:0006468;GO:0030278;GO:0051145;GO:0007179;GO:0060412;, C:activin receptor complex; C:apical part of cell; C:BMP receptor complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:activin receptor activity, type I; F:ATP binding; F:cadherin binding; F:metal ion binding; F:peptide hormone binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine/threonine kinase activity; F:protein tyrosine kinase binding; F:SMAD binding; F:transforming growth factor beta binding; F:transforming growth factor beta receptor activity, type I; F:transmembrane receptor protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:acute inflammatory response; P:angiogenesis; P:atrial septum primum morphogenesis; P:atrioventricular valve morphogenesis; P:BMP signaling pathway; P:BMP signaling pathway involved in heart development; P:branching involved in blood vessel morphogenesis; P:cardiac muscle cell fate commitment; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:determination of left/right symmetry; P:dorsal/ventral pattern formation; P:embryonic heart tube morphogenesis; P:endocardial cushion cell fate commitment; P:endocardial cushion fusion; P:endocardial cushion morphogenesis; P:G1/S transition of mitotic cell cycle; P:gastrulation with mouth forming second; P:germ cell development; P:heart development; P:in utero embryonic development; P:mesoderm formation; P:mitral valve morphogenesis; P:negative regulation of activin receptor signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of signal transduction; P:neural crest cell migration; P:pathway-restricted SMAD protein phosphorylation; P:peptidyl-threonine phosphorylation; P:pharyngeal system development; P:positive regulation of bone mineralization; P:positive regulation of cell migration; P:positive regulation of determination of dorsal identity; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of ossification; P:smooth muscle cell differentiation; P:transforming growth factor beta receptor signaling pathway; P:ventricular septum morphogenesis; scaffold9 indexed_genome mRNA 39175780 39217520 . + . ID=transcript_2473;O95045 B3KV87,Uridine phosphorylase 2 {ECO:0000303|PubMed:12849978},, PF01048;, GO:0005829;GO:0045098;GO:0047847;GO:0042802;GO:0004850;GO:0006249;GO:0009116;GO:0046135;GO:0043097;GO:0044206;GO:0006218;GO:0046108;, C:cytosol; C:type III intermediate filament;, F:deoxyuridine phosphorylase activity; F:identical protein binding; F:uridine phosphorylase activity;, P:dCMP catabolic process; P:nucleoside metabolic process; P:pyrimidine nucleoside catabolic process; P:pyrimidine nucleoside salvage; P:UMP salvage; P:uridine catabolic process; P:uridine metabolic process; scaffold9 indexed_genome mRNA 39243981 39524821 . - . ID=transcript_2474;Q96LM2,Coiled-coil domain-containing protein 148 scaffold9 indexed_genome mRNA 39692371 39826364 . + . ID=transcript_2475;Q9C0D5 C9JD88 Q49AI8,Protein TANC1,Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1;, PF00023;PF12796;, GO:0043679;GO:0030425;GO:0043025;GO:0014069;GO:0097062;GO:0007520;GO:0008542;, C:axon terminus; C:dendrite; C:neuronal cell body; C:postsynaptic density;, , P:dendritic spine maintenance; P:myoblast fusion; P:visual learning;|Q9C0D5 C9JD88 Q49AI8,Protein TANC1,Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1;, PF00023;PF12796;, GO:0043679;GO:0030425;GO:0043025;GO:0014069;GO:0097062;GO:0007520;GO:0008542;, C:axon terminus; C:dendrite; C:neuronal cell body; C:postsynaptic density;, , P:dendritic spine maintenance; P:myoblast fusion; P:visual learning;|Q9C0D5 C9JD88 Q49AI8,Protein TANC1,Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1;, PF00023;PF12796;, GO:0043679;GO:0030425;GO:0043025;GO:0014069;GO:0097062;GO:0007520;GO:0008542;, C:axon terminus; C:dendrite; C:neuronal cell body; C:postsynaptic density;, , P:dendritic spine maintenance; P:myoblast fusion; P:visual learning; scaffold9 indexed_genome mRNA 39826389 39889623 . - . ID=transcript_2476;Q8N9V3 Q53TI9 Q8N6N8,WD repeat, SAM and U-box domain-containing protein 1,, PF07647;PF04564;PF00400;, GO:0004842;, , F:ubiquitin-protein transferase activity;|Q8N9V3 Q53TI9 Q8N6N8,WD repeat, SAM and U-box domain-containing protein 1,, PF07647;PF04564;PF00400;, GO:0004842;, , F:ubiquitin-protein transferase activity; scaffold9 indexed_genome mRNA 39901090 39925308 . - . ID=transcript_2477;Q9UIF8 D3DPA8 Q96EA1 Q96SQ8 Q9P252 Q9Y4N8,Bromodomain adjacent to zinc finger domain protein 2B,hWALp4;, PF00439;PF02791;PF01429;PF00628;PF15613;, GO:0005634;GO:0003677;GO:0046872;GO:0006338;GO:0006357;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin remodeling; P:regulation of transcription by RNA polymerase II;|Q9UIF8 D3DPA8 Q96EA1 Q96SQ8 Q9P252 Q9Y4N8,Bromodomain adjacent to zinc finger domain protein 2B,hWALp4;, PF00439;PF02791;PF01429;PF00628;PF15613;, GO:0005634;GO:0003677;GO:0046872;GO:0006338;GO:0006357;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin remodeling; P:regulation of transcription by RNA polymerase II;|Q9UIF8 D3DPA8 Q96EA1 Q96SQ8 Q9P252 Q9Y4N8,Bromodomain adjacent to zinc finger domain protein 2B,hWALp4;, PF00439;PF02791;PF01429;PF00628;PF15613;, GO:0005634;GO:0003677;GO:0046872;GO:0006338;GO:0006357;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin remodeling; P:regulation of transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 39937441 40046981 . - . ID=transcript_2478;Q9UIF8 D3DPA8 Q96EA1 Q96SQ8 Q9P252 Q9Y4N8,Bromodomain adjacent to zinc finger domain protein 2B,hWALp4;, PF00439;PF02791;PF01429;PF00628;PF15613;, GO:0005634;GO:0003677;GO:0046872;GO:0006338;GO:0006357;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin remodeling; P:regulation of transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 40323988 40399243 . + . ID=transcript_2479;Q9H992 A8K9X1 B7Z7P5 D3DPB0 Q53GQ1 Q9BTR9,E3 ubiquitin-protein ligase MARCHF7,Axotrophin;Membrane-associated RING finger protein 7;Membrane-associated RING-CH protein VII;RING finger protein 177;RING-type E3 ubiquitin transferase MARCHF7 {ECO:0000305};, PF12906;, GO:0005829;GO:0005634;GO:0005886;GO:0097371;GO:0016740;GO:0043130;GO:0031624;GO:0008270;GO:0043518;GO:1902166;GO:1901799;GO:1905524;GO:0042130;GO:0008284;GO:1902916;GO:0051865;GO:0006513;GO:0050821;GO:0002643;, C:cytosol; C:nucleus; C:plasma membrane;, F:MDM2/MDM4 family protein binding; F:transferase activity; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:zinc ion binding;, P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of protein autoubiquitination; P:negative regulation of T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of protein polyubiquitination; P:protein autoubiquitination; P:protein monoubiquitination; P:protein stabilization; P:regulation of tolerance induction;|Q9H992 A8K9X1 B7Z7P5 D3DPB0 Q53GQ1 Q9BTR9,E3 ubiquitin-protein ligase MARCHF7,Axotrophin;Membrane-associated RING finger protein 7;Membrane-associated RING-CH protein VII;RING finger protein 177;RING-type E3 ubiquitin transferase MARCHF7 {ECO:0000305};, PF12906;, GO:0005829;GO:0005634;GO:0005886;GO:0097371;GO:0016740;GO:0043130;GO:0031624;GO:0008270;GO:0043518;GO:1902166;GO:1901799;GO:1905524;GO:0042130;GO:0008284;GO:1902916;GO:0051865;GO:0006513;GO:0050821;GO:0002643;, C:cytosol; C:nucleus; C:plasma membrane;, F:MDM2/MDM4 family protein binding; F:transferase activity; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:zinc ion binding;, P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of protein autoubiquitination; P:negative regulation of T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of protein polyubiquitination; P:protein autoubiquitination; P:protein monoubiquitination; P:protein stabilization; P:regulation of tolerance induction;|Q9H992 A8K9X1 B7Z7P5 D3DPB0 Q53GQ1 Q9BTR9,E3 ubiquitin-protein ligase MARCHF7,Axotrophin;Membrane-associated RING finger protein 7;Membrane-associated RING-CH protein VII;RING finger protein 177;RING-type E3 ubiquitin transferase MARCHF7 {ECO:0000305};, PF12906;, GO:0005829;GO:0005634;GO:0005886;GO:0097371;GO:0016740;GO:0043130;GO:0031624;GO:0008270;GO:0043518;GO:1902166;GO:1901799;GO:1905524;GO:0042130;GO:0008284;GO:1902916;GO:0051865;GO:0006513;GO:0050821;GO:0002643;, C:cytosol; C:nucleus; C:plasma membrane;, F:MDM2/MDM4 family protein binding; F:transferase activity; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:zinc ion binding;, P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of protein autoubiquitination; P:negative regulation of T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of protein polyubiquitination; P:protein autoubiquitination; P:protein monoubiquitination; P:protein stabilization; P:regulation of tolerance induction;|Q9H992 A8K9X1 B7Z7P5 D3DPB0 Q53GQ1 Q9BTR9,E3 ubiquitin-protein ligase MARCHF7,Axotrophin;Membrane-associated RING finger protein 7;Membrane-associated RING-CH protein VII;RING finger protein 177;RING-type E3 ubiquitin transferase MARCHF7 {ECO:0000305};, PF12906;, GO:0005829;GO:0005634;GO:0005886;GO:0097371;GO:0016740;GO:0043130;GO:0031624;GO:0008270;GO:0043518;GO:1902166;GO:1901799;GO:1905524;GO:0042130;GO:0008284;GO:1902916;GO:0051865;GO:0006513;GO:0050821;GO:0002643;, C:cytosol; C:nucleus; C:plasma membrane;, F:MDM2/MDM4 family protein binding; F:transferase activity; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:zinc ion binding;, P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of protein autoubiquitination; P:negative regulation of T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of protein polyubiquitination; P:protein autoubiquitination; P:protein monoubiquitination; P:protein stabilization; P:regulation of tolerance induction;|Q9H992 A8K9X1 B7Z7P5 D3DPB0 Q53GQ1 Q9BTR9,E3 ubiquitin-protein ligase MARCHF7,Axotrophin;Membrane-associated RING finger protein 7;Membrane-associated RING-CH protein VII;RING finger protein 177;RING-type E3 ubiquitin transferase MARCHF7 {ECO:0000305};, PF12906;, GO:0005829;GO:0005634;GO:0005886;GO:0097371;GO:0016740;GO:0043130;GO:0031624;GO:0008270;GO:0043518;GO:1902166;GO:1901799;GO:1905524;GO:0042130;GO:0008284;GO:1902916;GO:0051865;GO:0006513;GO:0050821;GO:0002643;, C:cytosol; C:nucleus; C:plasma membrane;, F:MDM2/MDM4 family protein binding; F:transferase activity; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:zinc ion binding;, P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of protein autoubiquitination; P:negative regulation of T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of protein polyubiquitination; P:protein autoubiquitination; P:protein monoubiquitination; P:protein stabilization; P:regulation of tolerance induction;|Q9H992 A8K9X1 B7Z7P5 D3DPB0 Q53GQ1 Q9BTR9,E3 ubiquitin-protein ligase MARCHF7,Axotrophin;Membrane-associated RING finger protein 7;Membrane-associated RING-CH protein VII;RING finger protein 177;RING-type E3 ubiquitin transferase MARCHF7 {ECO:0000305};, PF12906;, GO:0005829;GO:0005634;GO:0005886;GO:0097371;GO:0016740;GO:0043130;GO:0031624;GO:0008270;GO:0043518;GO:1902166;GO:1901799;GO:1905524;GO:0042130;GO:0008284;GO:1902916;GO:0051865;GO:0006513;GO:0050821;GO:0002643;, C:cytosol; C:nucleus; C:plasma membrane;, F:MDM2/MDM4 family protein binding; F:transferase activity; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:zinc ion binding;, P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of protein autoubiquitination; P:negative regulation of T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of protein polyubiquitination; P:protein autoubiquitination; P:protein monoubiquitination; P:protein stabilization; P:regulation of tolerance induction;|Q8IX05 A8K5G4 B4E2T9 Q15009,CD302 antigen,C-type lectin BIMLEC;C-type lectin domain family 13 member A;DEC205-associated C-type lectin 1;Type I transmembrane C-type lectin receptor DCL-1;, PF00059;, GO:0005938;GO:0009897;GO:0030175;GO:0016021;GO:0016020;GO:0005902;GO:0030246;GO:0038023;GO:0006909;, C:cell cortex; C:external side of plasma membrane; C:filopodium; C:integral component of membrane; C:membrane; C:microvillus;, F:carbohydrate binding; F:signaling receptor activity;, P:phagocytosis;|Q9H992 A8K9X1 B7Z7P5 D3DPB0 Q53GQ1 Q9BTR9,E3 ubiquitin-protein ligase MARCHF7,Axotrophin;Membrane-associated RING finger protein 7;Membrane-associated RING-CH protein VII;RING finger protein 177;RING-type E3 ubiquitin transferase MARCHF7 {ECO:0000305};, PF12906;, GO:0005829;GO:0005634;GO:0005886;GO:0097371;GO:0016740;GO:0043130;GO:0031624;GO:0008270;GO:0043518;GO:1902166;GO:1901799;GO:1905524;GO:0042130;GO:0008284;GO:1902916;GO:0051865;GO:0006513;GO:0050821;GO:0002643;, C:cytosol; C:nucleus; C:plasma membrane;, F:MDM2/MDM4 family protein binding; F:transferase activity; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:zinc ion binding;, P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of protein autoubiquitination; P:negative regulation of T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of protein polyubiquitination; P:protein autoubiquitination; P:protein monoubiquitination; P:protein stabilization; P:regulation of tolerance induction;|Q8IX05 A8K5G4 B4E2T9 Q15009,CD302 antigen,C-type lectin BIMLEC;C-type lectin domain family 13 member A;DEC205-associated C-type lectin 1;Type I transmembrane C-type lectin receptor DCL-1;, PF00059;, GO:0005938;GO:0009897;GO:0030175;GO:0016021;GO:0016020;GO:0005902;GO:0030246;GO:0038023;GO:0006909;, C:cell cortex; C:external side of plasma membrane; C:filopodium; C:integral component of membrane; C:membrane; C:microvillus;, F:carbohydrate binding; F:signaling receptor activity;, P:phagocytosis;|Q8IX05 A8K5G4 B4E2T9 Q15009,CD302 antigen,C-type lectin BIMLEC;C-type lectin domain family 13 member A;DEC205-associated C-type lectin 1;Type I transmembrane C-type lectin receptor DCL-1;, PF00059;, GO:0005938;GO:0009897;GO:0030175;GO:0016021;GO:0016020;GO:0005902;GO:0030246;GO:0038023;GO:0006909;, C:cell cortex; C:external side of plasma membrane; C:filopodium; C:integral component of membrane; C:membrane; C:microvillus;, F:carbohydrate binding; F:signaling receptor activity;, P:phagocytosis;|Q8IX05 A8K5G4 B4E2T9 Q15009,CD302 antigen,C-type lectin BIMLEC;C-type lectin domain family 13 member A;DEC205-associated C-type lectin 1;Type I transmembrane C-type lectin receptor DCL-1;, PF00059;, GO:0005938;GO:0009897;GO:0030175;GO:0016021;GO:0016020;GO:0005902;GO:0030246;GO:0038023;GO:0006909;, C:cell cortex; C:external side of plasma membrane; C:filopodium; C:integral component of membrane; C:membrane; C:microvillus;, F:carbohydrate binding; F:signaling receptor activity;, P:phagocytosis;|Q8IX05 A8K5G4 B4E2T9 Q15009,CD302 antigen,C-type lectin BIMLEC;C-type lectin domain family 13 member A;DEC205-associated C-type lectin 1;Type I transmembrane C-type lectin receptor DCL-1;, PF00059;, GO:0005938;GO:0009897;GO:0030175;GO:0016021;GO:0016020;GO:0005902;GO:0030246;GO:0038023;GO:0006909;, C:cell cortex; C:external side of plasma membrane; C:filopodium; C:integral component of membrane; C:membrane; C:microvillus;, F:carbohydrate binding; F:signaling receptor activity;, P:phagocytosis;|Q8IX05 A8K5G4 B4E2T9 Q15009,CD302 antigen,C-type lectin BIMLEC;C-type lectin domain family 13 member A;DEC205-associated C-type lectin 1;Type I transmembrane C-type lectin receptor DCL-1;, PF00059;, GO:0005938;GO:0009897;GO:0030175;GO:0016021;GO:0016020;GO:0005902;GO:0030246;GO:0038023;GO:0006909;, C:cell cortex; C:external side of plasma membrane; C:filopodium; C:integral component of membrane; C:membrane; C:microvillus;, F:carbohydrate binding; F:signaling receptor activity;, P:phagocytosis; scaffold9 indexed_genome mRNA 40404438 40414204 . - . ID=transcript_2480;O60449 O75913 Q53R46 Q53TF5 Q7Z575 Q7Z577,Lymphocyte antigen 75,C-type lectin domain family 13 member B;DEC-205;gp200-MR6;, PF00040;PF00059;, GO:0009897;GO:0070062;GO:0005887;GO:0030246;GO:0038023;GO:0006897;GO:0006955;GO:0006954;, C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane;, F:carbohydrate binding; F:signaling receptor activity;, P:endocytosis; P:immune response; P:inflammatory response; scaffold9 indexed_genome mRNA 40414802 40488895 . - . ID=transcript_2481;O60449 O75913 Q53R46 Q53TF5 Q7Z575 Q7Z577,Lymphocyte antigen 75,C-type lectin domain family 13 member B;DEC-205;gp200-MR6;, PF00040;PF00059;, GO:0009897;GO:0070062;GO:0005887;GO:0030246;GO:0038023;GO:0006897;GO:0006955;GO:0006954;, C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane;, F:carbohydrate binding; F:signaling receptor activity;, P:endocytosis; P:immune response; P:inflammatory response;|O60449 O75913 Q53R46 Q53TF5 Q7Z575 Q7Z577,Lymphocyte antigen 75,C-type lectin domain family 13 member B;DEC-205;gp200-MR6;, PF00040;PF00059;, GO:0009897;GO:0070062;GO:0005887;GO:0030246;GO:0038023;GO:0006897;GO:0006955;GO:0006954;, C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane;, F:carbohydrate binding; F:signaling receptor activity;, P:endocytosis; P:immune response; P:inflammatory response;|O60449 O75913 Q53R46 Q53TF5 Q7Z575 Q7Z577,Lymphocyte antigen 75,C-type lectin domain family 13 member B;DEC-205;gp200-MR6;, PF00040;PF00059;, GO:0009897;GO:0070062;GO:0005887;GO:0030246;GO:0038023;GO:0006897;GO:0006955;GO:0006954;, C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane;, F:carbohydrate binding; F:signaling receptor activity;, P:endocytosis; P:immune response; P:inflammatory response; scaffold9 indexed_genome mRNA 40527954 40652892 . - . ID=transcript_2482;Q13018 B2RTU9 D3DPB1 Q13019 Q15095 Q53R45 Q53RR7,Secretory phospholipase A2 receptor,180 kDa secretory phospholipase A2 receptor;C-type lectin domain family 13 member C;M-type receptor;, PF00040;PF00059;, GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0043235;GO:0030246;GO:0043274;GO:0038023;GO:1900139;GO:1900138;GO:0090403;GO:0090238;GO:0001819;GO:0043517;GO:1904635;GO:0072593;GO:0006898;GO:0090399;, C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:carbohydrate binding; F:phospholipase binding; F:signaling receptor activity;, P:negative regulation of arachidonic acid secretion; P:negative regulation of phospholipase A2 activity; P:oxidative stress-induced premature senescence; P:positive regulation of arachidonic acid secretion; P:positive regulation of cytokine production; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of glomerular visceral epithelial cell apoptotic process; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:replicative senescence;|Q13018 B2RTU9 D3DPB1 Q13019 Q15095 Q53R45 Q53RR7,Secretory phospholipase A2 receptor,180 kDa secretory phospholipase A2 receptor;C-type lectin domain family 13 member C;M-type receptor;, PF00040;PF00059;, GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0043235;GO:0030246;GO:0043274;GO:0038023;GO:1900139;GO:1900138;GO:0090403;GO:0090238;GO:0001819;GO:0043517;GO:1904635;GO:0072593;GO:0006898;GO:0090399;, C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:carbohydrate binding; F:phospholipase binding; F:signaling receptor activity;, P:negative regulation of arachidonic acid secretion; P:negative regulation of phospholipase A2 activity; P:oxidative stress-induced premature senescence; P:positive regulation of arachidonic acid secretion; P:positive regulation of cytokine production; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of glomerular visceral epithelial cell apoptotic process; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:replicative senescence;|Q13018 B2RTU9 D3DPB1 Q13019 Q15095 Q53R45 Q53RR7,Secretory phospholipase A2 receptor,180 kDa secretory phospholipase A2 receptor;C-type lectin domain family 13 member C;M-type receptor;, PF00040;PF00059;, GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0043235;GO:0030246;GO:0043274;GO:0038023;GO:1900139;GO:1900138;GO:0090403;GO:0090238;GO:0001819;GO:0043517;GO:1904635;GO:0072593;GO:0006898;GO:0090399;, C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:carbohydrate binding; F:phospholipase binding; F:signaling receptor activity;, P:negative regulation of arachidonic acid secretion; P:negative regulation of phospholipase A2 activity; P:oxidative stress-induced premature senescence; P:positive regulation of arachidonic acid secretion; P:positive regulation of cytokine production; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of glomerular visceral epithelial cell apoptotic process; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:replicative senescence;|Q13018 B2RTU9 D3DPB1 Q13019 Q15095 Q53R45 Q53RR7,Secretory phospholipase A2 receptor,180 kDa secretory phospholipase A2 receptor;C-type lectin domain family 13 member C;M-type receptor;, PF00040;PF00059;, GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0043235;GO:0030246;GO:0043274;GO:0038023;GO:1900139;GO:1900138;GO:0090403;GO:0090238;GO:0001819;GO:0043517;GO:1904635;GO:0072593;GO:0006898;GO:0090399;, C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:carbohydrate binding; F:phospholipase binding; F:signaling receptor activity;, P:negative regulation of arachidonic acid secretion; P:negative regulation of phospholipase A2 activity; P:oxidative stress-induced premature senescence; P:positive regulation of arachidonic acid secretion; P:positive regulation of cytokine production; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of glomerular visceral epithelial cell apoptotic process; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:replicative senescence; scaffold9 indexed_genome mRNA 40676925 40758124 . - . ID=transcript_2483;P18564 B2R9W5 C9JA97 Q0VA95 Q16500 Q53RG5 Q53RR6,Integrin beta-6,, PF07974;PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0030054;GO:0005813;GO:0009897;GO:0005925;GO:0034685;GO:0008305;GO:0005654;GO:0005886;GO:0043235;GO:0005178;GO:0038023;GO:0001618;GO:0060348;GO:0060435;GO:0007155;GO:0033627;GO:0016477;GO:0000902;GO:0007160;GO:0071479;GO:0070166;GO:0030198;GO:0060022;GO:0006955;GO:0006954;GO:0007229;GO:0061520;GO:0048286;GO:0055091;GO:1901388;GO:0009615;GO:0043588;GO:0060395;GO:0043129;GO:0071604;GO:0007179;GO:0042060;, C:cell junction; C:centrosome; C:external side of plasma membrane; C:focal adhesion; C:integrin alphav-beta6 complex; C:integrin complex; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:integrin binding; F:signaling receptor activity; F:virus receptor activity;, P:bone development; P:bronchiole development; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell morphogenesis; P:cell-matrix adhesion; P:cellular response to ionizing radiation; P:enamel mineralization; P:extracellular matrix organization; P:hard palate development; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:Langerhans cell differentiation; P:lung alveolus development; P:phospholipid homeostasis; P:regulation of transforming growth factor beta activation; P:response to virus; P:skin development; P:SMAD protein signal transduction; P:surfactant homeostasis; P:transforming growth factor beta production; P:transforming growth factor beta receptor signaling pathway; P:wound healing; scaffold9 indexed_genome mRNA 40836839 41058169 . - . ID=transcript_2484;P29558 Q14869 Q15433 Q53P46 Q53QX8 Q53RG6 Q8WV20,RNA-binding motif, single-stranded-interacting protein 1,Single-stranded DNA-binding protein MSSP-1;Suppressor of CDC2 with RNA-binding motif 2;, PF00076;, GO:0005829;GO:0005634;GO:1990904;GO:0003690;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0003697;GO:0006260;GO:0006396;, C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:double-stranded DNA binding; F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding; F:single-stranded DNA binding;, P:DNA replication; P:RNA processing;|P29558 Q14869 Q15433 Q53P46 Q53QX8 Q53RG6 Q8WV20,RNA-binding motif, single-stranded-interacting protein 1,Single-stranded DNA-binding protein MSSP-1;Suppressor of CDC2 with RNA-binding motif 2;, PF00076;, GO:0005829;GO:0005634;GO:1990904;GO:0003690;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0003697;GO:0006260;GO:0006396;, C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:double-stranded DNA binding; F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding; F:single-stranded DNA binding;, P:DNA replication; P:RNA processing;|P29558 Q14869 Q15433 Q53P46 Q53QX8 Q53RG6 Q8WV20,RNA-binding motif, single-stranded-interacting protein 1,Single-stranded DNA-binding protein MSSP-1;Suppressor of CDC2 with RNA-binding motif 2;, PF00076;, GO:0005829;GO:0005634;GO:1990904;GO:0003690;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0003697;GO:0006260;GO:0006396;, C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:double-stranded DNA binding; F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding; F:single-stranded DNA binding;, P:DNA replication; P:RNA processing;|P29558 Q14869 Q15433 Q53P46 Q53QX8 Q53RG6 Q8WV20,RNA-binding motif, single-stranded-interacting protein 1,Single-stranded DNA-binding protein MSSP-1;Suppressor of CDC2 with RNA-binding motif 2;, PF00076;, GO:0005829;GO:0005634;GO:1990904;GO:0003690;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0003697;GO:0006260;GO:0006396;, C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:double-stranded DNA binding; F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding; F:single-stranded DNA binding;, P:DNA replication; P:RNA processing;|P29558 Q14869 Q15433 Q53P46 Q53QX8 Q53RG6 Q8WV20,RNA-binding motif, single-stranded-interacting protein 1,Single-stranded DNA-binding protein MSSP-1;Suppressor of CDC2 with RNA-binding motif 2;, PF00076;, GO:0005829;GO:0005634;GO:1990904;GO:0003690;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0003697;GO:0006260;GO:0006396;, C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:double-stranded DNA binding; F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding; F:single-stranded DNA binding;, P:DNA replication; P:RNA processing; scaffold9 indexed_genome mRNA 41707121 41738191 . + . ID=transcript_2485;Q92844 D3DPB5 Q7Z4J6 Q92885,TRAF family member-associated NF-kappa-B activator,TRAF-interacting protein;, PF12845;, GO:0005829;GO:0032991;GO:0035800;GO:0046872;GO:0031625;GO:0006974;GO:0071347;GO:0071479;GO:0071356;GO:0007249;GO:0043124;GO:1903003;GO:2000158;GO:0018215;GO:0006508;GO:0007165;GO:0035666;GO:0016032;, C:cytosol; C:protein-containing complex;, F:deubiquitinase activator activity; F:metal ion binding; F:ubiquitin protein ligase binding;, P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:cellular response to ionizing radiation; P:cellular response to tumor necrosis factor; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein deubiquitination; P:positive regulation of ubiquitin-specific protease activity; P:protein phosphopantetheinylation; P:proteolysis; P:signal transduction; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|Q92844 D3DPB5 Q7Z4J6 Q92885,TRAF family member-associated NF-kappa-B activator,TRAF-interacting protein;, PF12845;, GO:0005829;GO:0032991;GO:0035800;GO:0046872;GO:0031625;GO:0006974;GO:0071347;GO:0071479;GO:0071356;GO:0007249;GO:0043124;GO:1903003;GO:2000158;GO:0018215;GO:0006508;GO:0007165;GO:0035666;GO:0016032;, C:cytosol; C:protein-containing complex;, F:deubiquitinase activator activity; F:metal ion binding; F:ubiquitin protein ligase binding;, P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:cellular response to ionizing radiation; P:cellular response to tumor necrosis factor; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein deubiquitination; P:positive regulation of ubiquitin-specific protease activity; P:protein phosphopantetheinylation; P:proteolysis; P:signal transduction; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process; scaffold9 indexed_genome mRNA 41795333 41896020 . + . ID=transcript_2486;O00487 B3KNW2 O00176,26S proteasome non-ATPase regulatory subunit 14,26S proteasome regulatory subunit RPN11;26S proteasome-associated PAD1 homolog 1;, PF01398;PF13012;, GO:0005829;GO:0031597;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0061133;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0070628;GO:0004843;GO:0031145;GO:0002479;GO:0000724;GO:0006303;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0070536;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0045471;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:endopeptidase activator activity; F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to ethanol; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00487 B3KNW2 O00176,26S proteasome non-ATPase regulatory subunit 14,26S proteasome regulatory subunit RPN11;26S proteasome-associated PAD1 homolog 1;, PF01398;PF13012;, GO:0005829;GO:0031597;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0061133;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0070628;GO:0004843;GO:0031145;GO:0002479;GO:0000724;GO:0006303;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0070536;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0045471;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:endopeptidase activator activity; F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to ethanol; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00487 B3KNW2 O00176,26S proteasome non-ATPase regulatory subunit 14,26S proteasome regulatory subunit RPN11;26S proteasome-associated PAD1 homolog 1;, PF01398;PF13012;, GO:0005829;GO:0031597;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0061133;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0070628;GO:0004843;GO:0031145;GO:0002479;GO:0000724;GO:0006303;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0070536;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0045471;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:endopeptidase activator activity; F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to ethanol; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold9 indexed_genome mRNA 42131146 42265174 . + . ID=transcript_2487;Q6U841 B7Z1R0 B7Z2J0 B7ZLC5 B9EG69 F8W675 Q4ZFX6 Q8TCP2 Q9HCQ6,Sodium-driven chloride bicarbonate exchanger {ECO:0000303|PubMed:10993873},Solute carrier family 4 member 10 {ECO:0000312|HGNC:HGNC:13811};, PF07565;PF00955;, GO:0097440;GO:0016324;GO:0043679;GO:0097441;GO:0016323;GO:0097442;GO:0030425;GO:0016021;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0036477;GO:0045202;GO:0015301;GO:0005452;GO:0008510;GO:0022857;GO:0015701;GO:0048854;GO:0006821;GO:0050801;GO:0035641;GO:0035264;GO:0009791;GO:1902600;GO:0021860;GO:0051453;GO:0048172;GO:0009416;GO:0055085;GO:0007601;, C:apical dendrite; C:apical plasma membrane; C:axon terminus; C:basal dendrite; C:basolateral plasma membrane; C:CA3 pyramidal cell dendrite; C:dendrite; C:integral component of membrane; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:somatodendritic compartment; C:synapse;, F:anion:anion antiporter activity; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:brain morphogenesis; P:chloride transport; P:ion homeostasis; P:locomotory exploration behavior; P:multicellular organism growth; P:post-embryonic development; P:proton transmembrane transport; P:pyramidal neuron development; P:regulation of intracellular pH; P:regulation of short-term neuronal synaptic plasticity; P:response to light stimulus; P:transmembrane transport; P:visual perception;|Q6U841 B7Z1R0 B7Z2J0 B7ZLC5 B9EG69 F8W675 Q4ZFX6 Q8TCP2 Q9HCQ6,Sodium-driven chloride bicarbonate exchanger {ECO:0000303|PubMed:10993873},Solute carrier family 4 member 10 {ECO:0000312|HGNC:HGNC:13811};, PF07565;PF00955;, GO:0097440;GO:0016324;GO:0043679;GO:0097441;GO:0016323;GO:0097442;GO:0030425;GO:0016021;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0036477;GO:0045202;GO:0015301;GO:0005452;GO:0008510;GO:0022857;GO:0015701;GO:0048854;GO:0006821;GO:0050801;GO:0035641;GO:0035264;GO:0009791;GO:1902600;GO:0021860;GO:0051453;GO:0048172;GO:0009416;GO:0055085;GO:0007601;, C:apical dendrite; C:apical plasma membrane; C:axon terminus; C:basal dendrite; C:basolateral plasma membrane; C:CA3 pyramidal cell dendrite; C:dendrite; C:integral component of membrane; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:somatodendritic compartment; C:synapse;, F:anion:anion antiporter activity; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:brain morphogenesis; P:chloride transport; P:ion homeostasis; P:locomotory exploration behavior; P:multicellular organism growth; P:post-embryonic development; P:proton transmembrane transport; P:pyramidal neuron development; P:regulation of intracellular pH; P:regulation of short-term neuronal synaptic plasticity; P:response to light stimulus; P:transmembrane transport; P:visual perception;|Q6U841 B7Z1R0 B7Z2J0 B7ZLC5 B9EG69 F8W675 Q4ZFX6 Q8TCP2 Q9HCQ6,Sodium-driven chloride bicarbonate exchanger {ECO:0000303|PubMed:10993873},Solute carrier family 4 member 10 {ECO:0000312|HGNC:HGNC:13811};, PF07565;PF00955;, GO:0097440;GO:0016324;GO:0043679;GO:0097441;GO:0016323;GO:0097442;GO:0030425;GO:0016021;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0036477;GO:0045202;GO:0015301;GO:0005452;GO:0008510;GO:0022857;GO:0015701;GO:0048854;GO:0006821;GO:0050801;GO:0035641;GO:0035264;GO:0009791;GO:1902600;GO:0021860;GO:0051453;GO:0048172;GO:0009416;GO:0055085;GO:0007601;, C:apical dendrite; C:apical plasma membrane; C:axon terminus; C:basal dendrite; C:basolateral plasma membrane; C:CA3 pyramidal cell dendrite; C:dendrite; C:integral component of membrane; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:somatodendritic compartment; C:synapse;, F:anion:anion antiporter activity; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:brain morphogenesis; P:chloride transport; P:ion homeostasis; P:locomotory exploration behavior; P:multicellular organism growth; P:post-embryonic development; P:proton transmembrane transport; P:pyramidal neuron development; P:regulation of intracellular pH; P:regulation of short-term neuronal synaptic plasticity; P:response to light stimulus; P:transmembrane transport; P:visual perception; scaffold9 indexed_genome mRNA 42265184 42367272 . + . ID=transcript_2488;Q6U841 B7Z1R0 B7Z2J0 B7ZLC5 B9EG69 F8W675 Q4ZFX6 Q8TCP2 Q9HCQ6,Sodium-driven chloride bicarbonate exchanger {ECO:0000303|PubMed:10993873},Solute carrier family 4 member 10 {ECO:0000312|HGNC:HGNC:13811};, PF07565;PF00955;, GO:0097440;GO:0016324;GO:0043679;GO:0097441;GO:0016323;GO:0097442;GO:0030425;GO:0016021;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0036477;GO:0045202;GO:0015301;GO:0005452;GO:0008510;GO:0022857;GO:0015701;GO:0048854;GO:0006821;GO:0050801;GO:0035641;GO:0035264;GO:0009791;GO:1902600;GO:0021860;GO:0051453;GO:0048172;GO:0009416;GO:0055085;GO:0007601;, C:apical dendrite; C:apical plasma membrane; C:axon terminus; C:basal dendrite; C:basolateral plasma membrane; C:CA3 pyramidal cell dendrite; C:dendrite; C:integral component of membrane; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:somatodendritic compartment; C:synapse;, F:anion:anion antiporter activity; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:brain morphogenesis; P:chloride transport; P:ion homeostasis; P:locomotory exploration behavior; P:multicellular organism growth; P:post-embryonic development; P:proton transmembrane transport; P:pyramidal neuron development; P:regulation of intracellular pH; P:regulation of short-term neuronal synaptic plasticity; P:response to light stimulus; P:transmembrane transport; P:visual perception;|Q6U841 B7Z1R0 B7Z2J0 B7ZLC5 B9EG69 F8W675 Q4ZFX6 Q8TCP2 Q9HCQ6,Sodium-driven chloride bicarbonate exchanger {ECO:0000303|PubMed:10993873},Solute carrier family 4 member 10 {ECO:0000312|HGNC:HGNC:13811};, PF07565;PF00955;, GO:0097440;GO:0016324;GO:0043679;GO:0097441;GO:0016323;GO:0097442;GO:0030425;GO:0016021;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0036477;GO:0045202;GO:0015301;GO:0005452;GO:0008510;GO:0022857;GO:0015701;GO:0048854;GO:0006821;GO:0050801;GO:0035641;GO:0035264;GO:0009791;GO:1902600;GO:0021860;GO:0051453;GO:0048172;GO:0009416;GO:0055085;GO:0007601;, C:apical dendrite; C:apical plasma membrane; C:axon terminus; C:basal dendrite; C:basolateral plasma membrane; C:CA3 pyramidal cell dendrite; C:dendrite; C:integral component of membrane; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:somatodendritic compartment; C:synapse;, F:anion:anion antiporter activity; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:brain morphogenesis; P:chloride transport; P:ion homeostasis; P:locomotory exploration behavior; P:multicellular organism growth; P:post-embryonic development; P:proton transmembrane transport; P:pyramidal neuron development; P:regulation of intracellular pH; P:regulation of short-term neuronal synaptic plasticity; P:response to light stimulus; P:transmembrane transport; P:visual perception; scaffold9 indexed_genome mRNA 42373521 42454181 . - . ID=transcript_2489;P27487 Q53TN1,Dipeptidyl peptidase 4 {ECO:0000305},ADABP;Adenosine deaminase complexing protein 2;Dipeptidyl peptidase IV;T-cell activation antigen CD26;TP103;, PF00930;PF00326;, GO:0016324;GO:0009986;GO:0030139;GO:0070062;GO:0005576;GO:0005925;GO:0016021;GO:0046581;GO:0030027;GO:0031258;GO:0005765;GO:0016020;GO:0045121;GO:0005886;GO:0004177;GO:0045499;GO:0008239;GO:0042802;GO:0002020;GO:0042803;GO:0004252;GO:0008236;GO:0005102;GO:0001618;GO:0001662;GO:0007155;GO:0043542;GO:0035641;GO:0010716;GO:0090024;GO:0008284;GO:0006508;GO:0036343;GO:0033632;GO:0050796;GO:0001666;GO:0042110;GO:0031295;, C:apical plasma membrane; C:cell surface; C:endocytic vesicle; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:integral component of membrane; C:intercellular canaliculus; C:lamellipodium; C:lamellipodium membrane; C:lysosomal membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:aminopeptidase activity; F:chemorepellent activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:protease binding; F:protein homodimerization activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding; F:virus receptor activity;, P:behavioral fear response; P:cell adhesion; P:endothelial cell migration; P:locomotory exploration behavior; P:negative regulation of extracellular matrix disassembly; P:negative regulation of neutrophil chemotaxis; P:positive regulation of cell population proliferation; P:proteolysis; P:psychomotor behavior; P:regulation of cell-cell adhesion mediated by integrin; P:regulation of insulin secretion; P:response to hypoxia; P:T cell activation; P:T cell costimulation;|P27487 Q53TN1,Dipeptidyl peptidase 4 {ECO:0000305},ADABP;Adenosine deaminase complexing protein 2;Dipeptidyl peptidase IV;T-cell activation antigen CD26;TP103;, PF00930;PF00326;, GO:0016324;GO:0009986;GO:0030139;GO:0070062;GO:0005576;GO:0005925;GO:0016021;GO:0046581;GO:0030027;GO:0031258;GO:0005765;GO:0016020;GO:0045121;GO:0005886;GO:0004177;GO:0045499;GO:0008239;GO:0042802;GO:0002020;GO:0042803;GO:0004252;GO:0008236;GO:0005102;GO:0001618;GO:0001662;GO:0007155;GO:0043542;GO:0035641;GO:0010716;GO:0090024;GO:0008284;GO:0006508;GO:0036343;GO:0033632;GO:0050796;GO:0001666;GO:0042110;GO:0031295;, C:apical plasma membrane; C:cell surface; C:endocytic vesicle; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:integral component of membrane; C:intercellular canaliculus; C:lamellipodium; C:lamellipodium membrane; C:lysosomal membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:aminopeptidase activity; F:chemorepellent activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:protease binding; F:protein homodimerization activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding; F:virus receptor activity;, P:behavioral fear response; P:cell adhesion; P:endothelial cell migration; P:locomotory exploration behavior; P:negative regulation of extracellular matrix disassembly; P:negative regulation of neutrophil chemotaxis; P:positive regulation of cell population proliferation; P:proteolysis; P:psychomotor behavior; P:regulation of cell-cell adhesion mediated by integrin; P:regulation of insulin secretion; P:response to hypoxia; P:T cell activation; P:T cell costimulation;|P27487 Q53TN1,Dipeptidyl peptidase 4 {ECO:0000305},ADABP;Adenosine deaminase complexing protein 2;Dipeptidyl peptidase IV;T-cell activation antigen CD26;TP103;, PF00930;PF00326;, GO:0016324;GO:0009986;GO:0030139;GO:0070062;GO:0005576;GO:0005925;GO:0016021;GO:0046581;GO:0030027;GO:0031258;GO:0005765;GO:0016020;GO:0045121;GO:0005886;GO:0004177;GO:0045499;GO:0008239;GO:0042802;GO:0002020;GO:0042803;GO:0004252;GO:0008236;GO:0005102;GO:0001618;GO:0001662;GO:0007155;GO:0043542;GO:0035641;GO:0010716;GO:0090024;GO:0008284;GO:0006508;GO:0036343;GO:0033632;GO:0050796;GO:0001666;GO:0042110;GO:0031295;, C:apical plasma membrane; C:cell surface; C:endocytic vesicle; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:integral component of membrane; C:intercellular canaliculus; C:lamellipodium; C:lamellipodium membrane; C:lysosomal membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:aminopeptidase activity; F:chemorepellent activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:protease binding; F:protein homodimerization activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding; F:virus receptor activity;, P:behavioral fear response; P:cell adhesion; P:endothelial cell migration; P:locomotory exploration behavior; P:negative regulation of extracellular matrix disassembly; P:negative regulation of neutrophil chemotaxis; P:positive regulation of cell population proliferation; P:proteolysis; P:psychomotor behavior; P:regulation of cell-cell adhesion mediated by integrin; P:regulation of insulin secretion; P:response to hypoxia; P:T cell activation; P:T cell costimulation; scaffold9 indexed_genome mRNA 42561498 42565508 . - . ID=transcript_2490;Q12884 O00199 Q53TP5 Q86Z29 Q99998 Q9UID4,Prolyl endopeptidase FAP {ECO:0000305},170 kDa melanoma membrane-bound gelatinase {ECO:0000303|PubMed:2172980, ECO:0000303|PubMed:9065413};Dipeptidyl peptidase FAP {ECO:0000305};Fibroblast activation protein alpha {ECO:0000303|PubMed:7911242};Gelatine degradation protease FAP {ECO:0000305};Integral membrane serine protease {ECO:0000303|PubMed:9247085};Post-proline cleaving enzyme {ECO:0000305};Serine integral membrane protease {ECO:0000303|PubMed:9247085};Surface-expressed protease {ECO:0000303|PubMed:2172980};, PF00930;PF00326;, GO:0045177;GO:0045178;GO:0009986;GO:0005737;GO:0005615;GO:0005925;GO:0016021;GO:0030027;GO:0031258;GO:1905368;GO:0005886;GO:0032587;GO:0008239;GO:0004175;GO:0042802;GO:0005178;GO:0008233;GO:0002020;GO:0042803;GO:0004252;GO:0008236;GO:0001525;GO:0007155;GO:0043542;GO:1902362;GO:0097325;GO:0071850;GO:0060244;GO:0010716;GO:1903054;GO:0071158;GO:1900119;GO:0006508;GO:0051603;GO:0010710;GO:0051917;, C:apical part of cell; C:basal part of cell; C:cell surface; C:cytoplasm; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:lamellipodium; C:lamellipodium membrane; C:peptidase complex; C:plasma membrane; C:ruffle membrane;, F:dipeptidyl-peptidase activity; F:endopeptidase activity; F:identical protein binding; F:integrin binding; F:peptidase activity; F:protease binding; F:protein homodimerization activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:angiogenesis; P:cell adhesion; P:endothelial cell migration; P:melanocyte apoptotic process; P:melanocyte proliferation; P:mitotic cell cycle arrest; P:negative regulation of cell proliferation involved in contact inhibition; P:negative regulation of extracellular matrix disassembly; P:negative regulation of extracellular matrix organization; P:positive regulation of cell cycle arrest; P:positive regulation of execution phase of apoptosis; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of collagen catabolic process; P:regulation of fibrinolysis; scaffold9 indexed_genome mRNA 42565525 42635621 . - . ID=transcript_2491;Q12884 O00199 Q53TP5 Q86Z29 Q99998 Q9UID4,Prolyl endopeptidase FAP {ECO:0000305},170 kDa melanoma membrane-bound gelatinase {ECO:0000303|PubMed:2172980, ECO:0000303|PubMed:9065413};Dipeptidyl peptidase FAP {ECO:0000305};Fibroblast activation protein alpha {ECO:0000303|PubMed:7911242};Gelatine degradation protease FAP {ECO:0000305};Integral membrane serine protease {ECO:0000303|PubMed:9247085};Post-proline cleaving enzyme {ECO:0000305};Serine integral membrane protease {ECO:0000303|PubMed:9247085};Surface-expressed protease {ECO:0000303|PubMed:2172980};, PF00930;PF00326;, GO:0045177;GO:0045178;GO:0009986;GO:0005737;GO:0005615;GO:0005925;GO:0016021;GO:0030027;GO:0031258;GO:1905368;GO:0005886;GO:0032587;GO:0008239;GO:0004175;GO:0042802;GO:0005178;GO:0008233;GO:0002020;GO:0042803;GO:0004252;GO:0008236;GO:0001525;GO:0007155;GO:0043542;GO:1902362;GO:0097325;GO:0071850;GO:0060244;GO:0010716;GO:1903054;GO:0071158;GO:1900119;GO:0006508;GO:0051603;GO:0010710;GO:0051917;, C:apical part of cell; C:basal part of cell; C:cell surface; C:cytoplasm; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:lamellipodium; C:lamellipodium membrane; C:peptidase complex; C:plasma membrane; C:ruffle membrane;, F:dipeptidyl-peptidase activity; F:endopeptidase activity; F:identical protein binding; F:integrin binding; F:peptidase activity; F:protease binding; F:protein homodimerization activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:angiogenesis; P:cell adhesion; P:endothelial cell migration; P:melanocyte apoptotic process; P:melanocyte proliferation; P:mitotic cell cycle arrest; P:negative regulation of cell proliferation involved in contact inhibition; P:negative regulation of extracellular matrix disassembly; P:negative regulation of extracellular matrix organization; P:positive regulation of cell cycle arrest; P:positive regulation of execution phase of apoptosis; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of collagen catabolic process; P:regulation of fibrinolysis; scaffold9 indexed_genome mRNA 42669572 42725373 . - . ID=transcript_2492;Q9BYX4 Q2NKL6 Q6DC96 Q86X56 Q96MX8 Q9H3G6,Interferon-induced helicase C domain-containing protein 1 {ECO:0000305},Clinically amyopathic dermatomyositis autoantigen 140 kDa;Helicase with 2 CARD domains;Interferon-induced with helicase C domain protein 1;Melanoma differentiation-associated protein 5;Murabutide down-regulated protein;RIG-I-like receptor 2;RNA helicase-DEAD box protein 116;, PF16739;PF00271;PF04851;PF18119;PF11648;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0003677;GO:0003725;GO:0042802;GO:0043021;GO:0003724;GO:0003727;GO:0008270;GO:0071360;GO:0039528;GO:0051607;GO:0009597;GO:0045087;GO:0039530;GO:0032480;GO:0032727;GO:0032728;GO:0032755;GO:0060760;GO:0032760;GO:0016579;GO:0016925;GO:0034344;GO:0009615;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:DNA binding; F:double-stranded RNA binding; F:identical protein binding; F:ribonucleoprotein complex binding; F:RNA helicase activity; F:single-stranded RNA binding; F:zinc ion binding;, P:cellular response to exogenous dsRNA; P:cytoplasmic pattern recognition receptor signaling pathway in response to virus; P:defense response to virus; P:detection of virus; P:innate immune response; P:MDA-5 signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of response to cytokine stimulus; P:positive regulation of tumor necrosis factor production; P:protein deubiquitination; P:protein sumoylation; P:regulation of type III interferon production; P:response to virus; P:viral process;|Q9BYX4 Q2NKL6 Q6DC96 Q86X56 Q96MX8 Q9H3G6,Interferon-induced helicase C domain-containing protein 1 {ECO:0000305},Clinically amyopathic dermatomyositis autoantigen 140 kDa;Helicase with 2 CARD domains;Interferon-induced with helicase C domain protein 1;Melanoma differentiation-associated protein 5;Murabutide down-regulated protein;RIG-I-like receptor 2;RNA helicase-DEAD box protein 116;, PF16739;PF00271;PF04851;PF18119;PF11648;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0003677;GO:0003725;GO:0042802;GO:0043021;GO:0003724;GO:0003727;GO:0008270;GO:0071360;GO:0039528;GO:0051607;GO:0009597;GO:0045087;GO:0039530;GO:0032480;GO:0032727;GO:0032728;GO:0032755;GO:0060760;GO:0032760;GO:0016579;GO:0016925;GO:0034344;GO:0009615;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:DNA binding; F:double-stranded RNA binding; F:identical protein binding; F:ribonucleoprotein complex binding; F:RNA helicase activity; F:single-stranded RNA binding; F:zinc ion binding;, P:cellular response to exogenous dsRNA; P:cytoplasmic pattern recognition receptor signaling pathway in response to virus; P:defense response to virus; P:detection of virus; P:innate immune response; P:MDA-5 signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of response to cytokine stimulus; P:positive regulation of tumor necrosis factor production; P:protein deubiquitination; P:protein sumoylation; P:regulation of type III interferon production; P:response to virus; P:viral process; scaffold9 indexed_genome mRNA 42753028 42769781 . + . ID=transcript_2493;P28676 B2R5X3 Q53TB5 Q59EP3,Grancalcin,, PF13833;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0005509;GO:0046982;GO:0042803;GO:0061025;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:calcium ion binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:membrane fusion; P:neutrophil degranulation;|P28676 B2R5X3 Q53TB5 Q59EP3,Grancalcin,, PF13833;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0005509;GO:0046982;GO:0042803;GO:0061025;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:calcium ion binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:membrane fusion; P:neutrophil degranulation;|P28676 B2R5X3 Q53TB5 Q59EP3,Grancalcin,, PF13833;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0005509;GO:0046982;GO:0042803;GO:0061025;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:calcium ion binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:membrane fusion; P:neutrophil degranulation; scaffold9 indexed_genome mRNA 44023151 44026594 . + . ID=transcript_2494;Q5HY92 B3KWM0 Q9H6M5 Q9NVZ9,Fidgetin,, PF00004;PF09336;, GO:0005737;GO:0005874;GO:0005815;GO:0016363;GO:0005634;GO:0005524;GO:0016887;GO:0008568;GO:0008022;GO:0007049;GO:0051301;GO:0031122;, C:cytoplasm; C:microtubule; C:microtubule organizing center; C:nuclear matrix; C:nucleus;, F:ATP binding; F:ATPase activity; F:microtubule-severing ATPase activity; F:protein C-terminus binding;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization;|Q5HY92 B3KWM0 Q9H6M5 Q9NVZ9,Fidgetin,, PF00004;PF09336;, GO:0005737;GO:0005874;GO:0005815;GO:0016363;GO:0005634;GO:0005524;GO:0016887;GO:0008568;GO:0008022;GO:0007049;GO:0051301;GO:0031122;, C:cytoplasm; C:microtubule; C:microtubule organizing center; C:nuclear matrix; C:nucleus;, F:ATP binding; F:ATPase activity; F:microtubule-severing ATPase activity; F:protein C-terminus binding;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; scaffold9 indexed_genome mRNA 44026696 44027974 . - . ID=transcript_2495;Q5HY92 B3KWM0 Q9H6M5 Q9NVZ9,Fidgetin,, PF00004;PF09336;, GO:0005737;GO:0005874;GO:0005815;GO:0016363;GO:0005634;GO:0005524;GO:0016887;GO:0008568;GO:0008022;GO:0007049;GO:0051301;GO:0031122;, C:cytoplasm; C:microtubule; C:microtubule organizing center; C:nuclear matrix; C:nucleus;, F:ATP binding; F:ATPase activity; F:microtubule-severing ATPase activity; F:protein C-terminus binding;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; scaffold9 indexed_genome mRNA 44916795 44928146 . - . ID=transcript_2496;Q14449 B7Z7F9 Q7Z6I1,Growth factor receptor-bound protein 14,GRB14 adapter protein;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0010008;GO:0043231;GO:0005886;GO:0030674;GO:0030971;GO:0008286;GO:0050900;GO:0046627;GO:0007165;, C:cytoplasm; C:cytosol; C:endosome membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:protein-macromolecule adaptor activity; F:receptor tyrosine kinase binding;, P:insulin receptor signaling pathway; P:leukocyte migration; P:negative regulation of insulin receptor signaling pathway; P:signal transduction;|Q14449 B7Z7F9 Q7Z6I1,Growth factor receptor-bound protein 14,GRB14 adapter protein;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0010008;GO:0043231;GO:0005886;GO:0030674;GO:0030971;GO:0008286;GO:0050900;GO:0046627;GO:0007165;, C:cytoplasm; C:cytosol; C:endosome membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:protein-macromolecule adaptor activity; F:receptor tyrosine kinase binding;, P:insulin receptor signaling pathway; P:leukocyte migration; P:negative regulation of insulin receptor signaling pathway; P:signal transduction;|Q14449 B7Z7F9 Q7Z6I1,Growth factor receptor-bound protein 14,GRB14 adapter protein;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0010008;GO:0043231;GO:0005886;GO:0030674;GO:0030971;GO:0008286;GO:0050900;GO:0046627;GO:0007165;, C:cytoplasm; C:cytosol; C:endosome membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:protein-macromolecule adaptor activity; F:receptor tyrosine kinase binding;, P:insulin receptor signaling pathway; P:leukocyte migration; P:negative regulation of insulin receptor signaling pathway; P:signal transduction;|Q14449 B7Z7F9 Q7Z6I1,Growth factor receptor-bound protein 14,GRB14 adapter protein;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0010008;GO:0043231;GO:0005886;GO:0030674;GO:0030971;GO:0008286;GO:0050900;GO:0046627;GO:0007165;, C:cytoplasm; C:cytosol; C:endosome membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:protein-macromolecule adaptor activity; F:receptor tyrosine kinase binding;, P:insulin receptor signaling pathway; P:leukocyte migration; P:negative regulation of insulin receptor signaling pathway; P:signal transduction; scaffold9 indexed_genome mRNA 45078861 45084690 . - . ID=transcript_2497;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold9 indexed_genome mRNA 45109508 45116653 . - . ID=transcript_2498;Q53SF7 A6NMZ3 Q6IQ33 Q7Z3I6 Q9BRH4 Q9UG88 Q9Y2I3,Cordon-bleu protein-like 1 {ECO:0000305},, PF09469;, GO:0070062;GO:0003785;GO:0045296;, C:extracellular exosome;, F:actin monomer binding; F:cadherin binding; scaffold9 indexed_genome mRNA 45116658 45155880 . + . ID=transcript_2499;Q53SF7 A6NMZ3 Q6IQ33 Q7Z3I6 Q9BRH4 Q9UG88 Q9Y2I3,Cordon-bleu protein-like 1 {ECO:0000305},, PF09469;, GO:0070062;GO:0003785;GO:0045296;, C:extracellular exosome;, F:actin monomer binding; F:cadherin binding;|Q53SF7 A6NMZ3 Q6IQ33 Q7Z3I6 Q9BRH4 Q9UG88 Q9Y2I3,Cordon-bleu protein-like 1 {ECO:0000305},, PF09469;, GO:0070062;GO:0003785;GO:0045296;, C:extracellular exosome;, F:actin monomer binding; F:cadherin binding;|Q53SF7 A6NMZ3 Q6IQ33 Q7Z3I6 Q9BRH4 Q9UG88 Q9Y2I3,Cordon-bleu protein-like 1 {ECO:0000305},, PF09469;, GO:0070062;GO:0003785;GO:0045296;, C:extracellular exosome;, F:actin monomer binding; F:cadherin binding;|Q53SF7 A6NMZ3 Q6IQ33 Q7Z3I6 Q9BRH4 Q9UG88 Q9Y2I3,Cordon-bleu protein-like 1 {ECO:0000305},, PF09469;, GO:0070062;GO:0003785;GO:0045296;, C:extracellular exosome;, F:actin monomer binding; F:cadherin binding; scaffold9 indexed_genome mRNA 45348114 45402319 . - . ID=transcript_2500;Q08AI6 B4DF99 Q8N887,Putative sodium-coupled neutral amino acid transporter 11,Solute carrier family 38 member 11;, PF01490;, GO:0016021;GO:0015171;GO:0003333;GO:0006814;, C:integral component of membrane;, F:amino acid transmembrane transporter activity;, P:amino acid transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 45557040 45562492 . - . ID=transcript_2501;Q9NY46 Q16142 Q53SX0 Q9BZB3 Q9C006 Q9NYK2 Q9P2J1 Q9UPD1 Q9Y6P4,Sodium channel protein type 3 subunit alpha,Sodium channel protein brain III subunit alpha;Sodium channel protein type III subunit alpha;Voltage-gated sodium channel subtype III;Voltage-gated sodium channel subunit alpha Nav1.3;, PF00520;PF06512;PF11933;, GO:0030424;GO:0005737;GO:0001518;GO:0005244;GO:0005248;GO:0086010;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:cytoplasm; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 45709187 45758835 . + . ID=transcript_2502;Q99250 A6NC14 A6NIQ5 Q14472 Q53T77 Q9BZC9 Q9BZD0,Sodium channel protein type 2 subunit alpha,HBSC II;Sodium channel protein brain II subunit alpha;Sodium channel protein type II subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.2;, PF00520;PF06512;PF11933;, GO:0030424;GO:0098978;GO:0005887;GO:0099056;GO:0014704;GO:0031226;GO:0016020;GO:0033268;GO:0033270;GO:0005886;GO:0034706;GO:0030315;GO:0001518;GO:0005244;GO:0005248;GO:0071456;GO:0008627;GO:0086010;GO:0007613;GO:0042552;GO:0007399;GO:0051402;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intercalated disc; C:intrinsic component of plasma membrane; C:membrane; C:node of Ranvier; C:paranode region of axon; C:plasma membrane; C:sodium channel complex; C:T-tubule; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cellular response to hypoxia; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:membrane depolarization during action potential; P:memory; P:myelination; P:nervous system development; P:neuron apoptotic process; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|Q99250 A6NC14 A6NIQ5 Q14472 Q53T77 Q9BZC9 Q9BZD0,Sodium channel protein type 2 subunit alpha,HBSC II;Sodium channel protein brain II subunit alpha;Sodium channel protein type II subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.2;, PF00520;PF06512;PF11933;, GO:0030424;GO:0098978;GO:0005887;GO:0099056;GO:0014704;GO:0031226;GO:0016020;GO:0033268;GO:0033270;GO:0005886;GO:0034706;GO:0030315;GO:0001518;GO:0005244;GO:0005248;GO:0071456;GO:0008627;GO:0086010;GO:0007613;GO:0042552;GO:0007399;GO:0051402;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intercalated disc; C:intrinsic component of plasma membrane; C:membrane; C:node of Ranvier; C:paranode region of axon; C:plasma membrane; C:sodium channel complex; C:T-tubule; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cellular response to hypoxia; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:membrane depolarization during action potential; P:memory; P:myelination; P:nervous system development; P:neuron apoptotic process; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|Q99250 A6NC14 A6NIQ5 Q14472 Q53T77 Q9BZC9 Q9BZD0,Sodium channel protein type 2 subunit alpha,HBSC II;Sodium channel protein brain II subunit alpha;Sodium channel protein type II subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.2;, PF00520;PF06512;PF11933;, GO:0030424;GO:0098978;GO:0005887;GO:0099056;GO:0014704;GO:0031226;GO:0016020;GO:0033268;GO:0033270;GO:0005886;GO:0034706;GO:0030315;GO:0001518;GO:0005244;GO:0005248;GO:0071456;GO:0008627;GO:0086010;GO:0007613;GO:0042552;GO:0007399;GO:0051402;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intercalated disc; C:intrinsic component of plasma membrane; C:membrane; C:node of Ranvier; C:paranode region of axon; C:plasma membrane; C:sodium channel complex; C:T-tubule; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cellular response to hypoxia; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:membrane depolarization during action potential; P:memory; P:myelination; P:nervous system development; P:neuron apoptotic process; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 45763035 45778584 . + . ID=transcript_2503;Q99250 A6NC14 A6NIQ5 Q14472 Q53T77 Q9BZC9 Q9BZD0,Sodium channel protein type 2 subunit alpha,HBSC II;Sodium channel protein brain II subunit alpha;Sodium channel protein type II subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.2;, PF00520;PF06512;PF11933;, GO:0030424;GO:0098978;GO:0005887;GO:0099056;GO:0014704;GO:0031226;GO:0016020;GO:0033268;GO:0033270;GO:0005886;GO:0034706;GO:0030315;GO:0001518;GO:0005244;GO:0005248;GO:0071456;GO:0008627;GO:0086010;GO:0007613;GO:0042552;GO:0007399;GO:0051402;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intercalated disc; C:intrinsic component of plasma membrane; C:membrane; C:node of Ranvier; C:paranode region of axon; C:plasma membrane; C:sodium channel complex; C:T-tubule; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cellular response to hypoxia; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:membrane depolarization during action potential; P:memory; P:myelination; P:nervous system development; P:neuron apoptotic process; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|Q99250 A6NC14 A6NIQ5 Q14472 Q53T77 Q9BZC9 Q9BZD0,Sodium channel protein type 2 subunit alpha,HBSC II;Sodium channel protein brain II subunit alpha;Sodium channel protein type II subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.2;, PF00520;PF06512;PF11933;, GO:0030424;GO:0098978;GO:0005887;GO:0099056;GO:0014704;GO:0031226;GO:0016020;GO:0033268;GO:0033270;GO:0005886;GO:0034706;GO:0030315;GO:0001518;GO:0005244;GO:0005248;GO:0071456;GO:0008627;GO:0086010;GO:0007613;GO:0042552;GO:0007399;GO:0051402;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intercalated disc; C:intrinsic component of plasma membrane; C:membrane; C:node of Ranvier; C:paranode region of axon; C:plasma membrane; C:sodium channel complex; C:T-tubule; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cellular response to hypoxia; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:membrane depolarization during action potential; P:memory; P:myelination; P:nervous system development; P:neuron apoptotic process; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|Q99250 A6NC14 A6NIQ5 Q14472 Q53T77 Q9BZC9 Q9BZD0,Sodium channel protein type 2 subunit alpha,HBSC II;Sodium channel protein brain II subunit alpha;Sodium channel protein type II subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.2;, PF00520;PF06512;PF11933;, GO:0030424;GO:0098978;GO:0005887;GO:0099056;GO:0014704;GO:0031226;GO:0016020;GO:0033268;GO:0033270;GO:0005886;GO:0034706;GO:0030315;GO:0001518;GO:0005244;GO:0005248;GO:0071456;GO:0008627;GO:0086010;GO:0007613;GO:0042552;GO:0007399;GO:0051402;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intercalated disc; C:intrinsic component of plasma membrane; C:membrane; C:node of Ranvier; C:paranode region of axon; C:plasma membrane; C:sodium channel complex; C:T-tubule; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cellular response to hypoxia; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:membrane depolarization during action potential; P:memory; P:myelination; P:nervous system development; P:neuron apoptotic process; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 45789965 45795633 . - . ID=transcript_2504;Q99250 A6NC14 A6NIQ5 Q14472 Q53T77 Q9BZC9 Q9BZD0,Sodium channel protein type 2 subunit alpha,HBSC II;Sodium channel protein brain II subunit alpha;Sodium channel protein type II subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.2;, PF00520;PF06512;PF11933;, GO:0030424;GO:0098978;GO:0005887;GO:0099056;GO:0014704;GO:0031226;GO:0016020;GO:0033268;GO:0033270;GO:0005886;GO:0034706;GO:0030315;GO:0001518;GO:0005244;GO:0005248;GO:0071456;GO:0008627;GO:0086010;GO:0007613;GO:0042552;GO:0007399;GO:0051402;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intercalated disc; C:intrinsic component of plasma membrane; C:membrane; C:node of Ranvier; C:paranode region of axon; C:plasma membrane; C:sodium channel complex; C:T-tubule; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cellular response to hypoxia; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:membrane depolarization during action potential; P:memory; P:myelination; P:nervous system development; P:neuron apoptotic process; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|Q99250 A6NC14 A6NIQ5 Q14472 Q53T77 Q9BZC9 Q9BZD0,Sodium channel protein type 2 subunit alpha,HBSC II;Sodium channel protein brain II subunit alpha;Sodium channel protein type II subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.2;, PF00520;PF06512;PF11933;, GO:0030424;GO:0098978;GO:0005887;GO:0099056;GO:0014704;GO:0031226;GO:0016020;GO:0033268;GO:0033270;GO:0005886;GO:0034706;GO:0030315;GO:0001518;GO:0005244;GO:0005248;GO:0071456;GO:0008627;GO:0086010;GO:0007613;GO:0042552;GO:0007399;GO:0051402;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intercalated disc; C:intrinsic component of plasma membrane; C:membrane; C:node of Ranvier; C:paranode region of axon; C:plasma membrane; C:sodium channel complex; C:T-tubule; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cellular response to hypoxia; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:membrane depolarization during action potential; P:memory; P:myelination; P:nervous system development; P:neuron apoptotic process; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 46100990 46124615 . - . ID=transcript_2505;Q14435 Q53TG9 Q7Z476,Polypeptide N-acetylgalactosaminyltransferase 3,Polypeptide GalNAc transferase 3;Protein-UDP acetylgalactosaminyltransferase 3;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3;, PF00535;PF00652;, GO:0070062;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0005509;GO:0030246;GO:0030145;GO:0004653;GO:0005975;GO:0008543;GO:0016266;GO:0018242;GO:0018243;, C:extracellular exosome; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:fibroblast growth factor receptor signaling pathway; P:O-glycan processing; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine; scaffold9 indexed_genome mRNA 46124635 46152599 . - . ID=transcript_2506;Q14435 Q53TG9 Q7Z476,Polypeptide N-acetylgalactosaminyltransferase 3,Polypeptide GalNAc transferase 3;Protein-UDP acetylgalactosaminyltransferase 3;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3;, PF00535;PF00652;, GO:0070062;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0005509;GO:0030246;GO:0030145;GO:0004653;GO:0005975;GO:0008543;GO:0016266;GO:0018242;GO:0018243;, C:extracellular exosome; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:fibroblast growth factor receptor signaling pathway; P:O-glycan processing; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine; scaffold9 indexed_genome mRNA 46232124 46260394 . - . ID=transcript_2507;Q7Z4L5 A8MUZ3 Q3LIE4 Q53T84 Q6P4A1 Q6PIF5 Q8NCN3 Q96MA4 Q9HAK8,Tetratricopeptide repeat protein 21B {ECO:0000305},Intraflagellar transport 139 homolog {ECO:0000305};, PF13181;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0035721;GO:0035735;GO:0061512;GO:1905799;GO:0006357;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A;, , P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:protein localization to cilium; P:regulation of intraciliary retrograde transport; P:regulation of transcription by RNA polymerase II;|Q7Z4L5 A8MUZ3 Q3LIE4 Q53T84 Q6P4A1 Q6PIF5 Q8NCN3 Q96MA4 Q9HAK8,Tetratricopeptide repeat protein 21B {ECO:0000305},Intraflagellar transport 139 homolog {ECO:0000305};, PF13181;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0035721;GO:0035735;GO:0061512;GO:1905799;GO:0006357;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A;, , P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:protein localization to cilium; P:regulation of intraciliary retrograde transport; P:regulation of transcription by RNA polymerase II;|Q7Z4L5 A8MUZ3 Q3LIE4 Q53T84 Q6P4A1 Q6PIF5 Q8NCN3 Q96MA4 Q9HAK8,Tetratricopeptide repeat protein 21B {ECO:0000305},Intraflagellar transport 139 homolog {ECO:0000305};, PF13181;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0035721;GO:0035735;GO:0061512;GO:1905799;GO:0006357;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A;, , P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:protein localization to cilium; P:regulation of intraciliary retrograde transport; P:regulation of transcription by RNA polymerase II;|Q7Z4L5 A8MUZ3 Q3LIE4 Q53T84 Q6P4A1 Q6PIF5 Q8NCN3 Q96MA4 Q9HAK8,Tetratricopeptide repeat protein 21B {ECO:0000305},Intraflagellar transport 139 homolog {ECO:0000305};, PF13181;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0035721;GO:0035735;GO:0061512;GO:1905799;GO:0006357;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A;, , P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:protein localization to cilium; P:regulation of intraciliary retrograde transport; P:regulation of transcription by RNA polymerase II;|Q7Z4L5 A8MUZ3 Q3LIE4 Q53T84 Q6P4A1 Q6PIF5 Q8NCN3 Q96MA4 Q9HAK8,Tetratricopeptide repeat protein 21B {ECO:0000305},Intraflagellar transport 139 homolog {ECO:0000305};, PF13181;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0035721;GO:0035735;GO:0061512;GO:1905799;GO:0006357;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A;, , P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:protein localization to cilium; P:regulation of intraciliary retrograde transport; P:regulation of transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 46272517 46322876 . - . ID=transcript_2508;Q7Z4L5 A8MUZ3 Q3LIE4 Q53T84 Q6P4A1 Q6PIF5 Q8NCN3 Q96MA4 Q9HAK8,Tetratricopeptide repeat protein 21B {ECO:0000305},Intraflagellar transport 139 homolog {ECO:0000305};, PF13181;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0035721;GO:0035735;GO:0061512;GO:1905799;GO:0006357;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A;, , P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:protein localization to cilium; P:regulation of intraciliary retrograde transport; P:regulation of transcription by RNA polymerase II;|Q7Z4L5 A8MUZ3 Q3LIE4 Q53T84 Q6P4A1 Q6PIF5 Q8NCN3 Q96MA4 Q9HAK8,Tetratricopeptide repeat protein 21B {ECO:0000305},Intraflagellar transport 139 homolog {ECO:0000305};, PF13181;, GO:0097542;GO:0005929;GO:0005737;GO:0005856;GO:0030991;GO:0035721;GO:0035735;GO:0061512;GO:1905799;GO:0006357;, C:ciliary tip; C:cilium; C:cytoplasm; C:cytoskeleton; C:intraciliary transport particle A;, , P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:protein localization to cilium; P:regulation of intraciliary retrograde transport; P:regulation of transcription by RNA polymerase II; scaffold9 indexed_genome mRNA 46328974 46346737 . + . ID=transcript_2509;P35498 E9PG49 Q16172 Q585T7 Q8IUJ6 Q96LA3 Q9C008,Sodium channel protein type 1 subunit alpha,Sodium channel protein brain I subunit alpha;Sodium channel protein type I subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.1;, PF00520;PF06512;PF11933;, GO:0030424;GO:0016604;GO:0005654;GO:0005886;GO:0001518;GO:0030018;GO:0005244;GO:0005248;GO:0086002;GO:0050966;GO:0086010;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:nuclear body; C:nucleoplasm; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cardiac muscle cell action potential involved in contraction; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|P35498 E9PG49 Q16172 Q585T7 Q8IUJ6 Q96LA3 Q9C008,Sodium channel protein type 1 subunit alpha,Sodium channel protein brain I subunit alpha;Sodium channel protein type I subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.1;, PF00520;PF06512;PF11933;, GO:0030424;GO:0016604;GO:0005654;GO:0005886;GO:0001518;GO:0030018;GO:0005244;GO:0005248;GO:0086002;GO:0050966;GO:0086010;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:nuclear body; C:nucleoplasm; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cardiac muscle cell action potential involved in contraction; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|P35498 E9PG49 Q16172 Q585T7 Q8IUJ6 Q96LA3 Q9C008,Sodium channel protein type 1 subunit alpha,Sodium channel protein brain I subunit alpha;Sodium channel protein type I subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.1;, PF00520;PF06512;PF11933;, GO:0030424;GO:0016604;GO:0005654;GO:0005886;GO:0001518;GO:0030018;GO:0005244;GO:0005248;GO:0086002;GO:0050966;GO:0086010;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:nuclear body; C:nucleoplasm; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cardiac muscle cell action potential involved in contraction; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|P35498 E9PG49 Q16172 Q585T7 Q8IUJ6 Q96LA3 Q9C008,Sodium channel protein type 1 subunit alpha,Sodium channel protein brain I subunit alpha;Sodium channel protein type I subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.1;, PF00520;PF06512;PF11933;, GO:0030424;GO:0016604;GO:0005654;GO:0005886;GO:0001518;GO:0030018;GO:0005244;GO:0005248;GO:0086002;GO:0050966;GO:0086010;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:nuclear body; C:nucleoplasm; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cardiac muscle cell action potential involved in contraction; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|P35498 E9PG49 Q16172 Q585T7 Q8IUJ6 Q96LA3 Q9C008,Sodium channel protein type 1 subunit alpha,Sodium channel protein brain I subunit alpha;Sodium channel protein type I subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.1;, PF00520;PF06512;PF11933;, GO:0030424;GO:0016604;GO:0005654;GO:0005886;GO:0001518;GO:0030018;GO:0005244;GO:0005248;GO:0086002;GO:0050966;GO:0086010;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:nuclear body; C:nucleoplasm; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cardiac muscle cell action potential involved in contraction; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|Q59H93 Q75RX9 Q75RY0 Q86UR3 Q8IZC9 Q96J69,Sodium channel protein type 5 subunit alpha,Sodium channel protein cardiac muscle subunit alpha;Sodium channel protein type V subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.5;hH1 {ECO:0000303|PubMed:1309946};, PF00520;PF06512;PF11933;, GO:0005901;GO:0009986;GO:0005783;GO:0016021;GO:0014704;GO:0016328;GO:0005730;GO:0005654;GO:0048471;GO:0005886;GO:0042383;GO:0030315;GO:0001518;GO:0030018;GO:0030506;GO:0005516;GO:0019899;GO:0017134;GO:0044325;GO:0050998;GO:0019904;GO:0019901;GO:0097110;GO:0031625;GO:0005244;GO:0005248;GO:0086060;GO:0086061;GO:0086006;GO:0086062;GO:0086063;GO:0086014;GO:0086016;GO:0086067;GO:0003360;GO:0086043;GO:0061337;GO:0086002;GO:0060048;GO:0003231;GO:0071277;GO:0021549;GO:0051899;GO:0086010;GO:0098912;GO:0086045;GO:0086048;GO:0086012;GO:0086047;GO:0086046;GO:0019228;GO:0042475;GO:0045760;GO:0050679;GO:0010765;GO:0060371;GO:0060372;GO:0086004;GO:0002027;GO:0086091;GO:1902305;GO:0060373;GO:0060307;GO:0014894;GO:0086015;GO:0035725;GO:0006814;GO:0021537;GO:0086005;, C:caveola; C:cell surface; C:endoplasmic reticulum; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:T-tubule; C:voltage-gated sodium channel complex; C:Z disc;, F:ankyrin binding; F:calmodulin binding; F:enzyme binding; F:fibroblast growth factor binding; F:ion channel binding; F:nitric-oxide synthase binding; F:protein domain specific binding; F:protein kinase binding; F:scaffold protein binding; F:ubiquitin protein ligase binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity; F:voltage-gated sodium channel activity involved in AV node cell action potential; F:voltage-gated sodium channel activity involved in bundle of His cell action potential; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; F:voltage-gated sodium channel activity involved in Purkinje myocyte action potential; F:voltage-gated sodium channel activity involved in SA node cell action potential;, P:atrial cardiac muscle cell action potential; P:AV node cell action potential; P:AV node cell to bundle of His cell communication; P:brainstem development; P:bundle of His cell action potential; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:cardiac ventricle development; P:cellular response to calcium ion; P:cerebellum development; P:membrane depolarization; P:membrane depolarization during action potential; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during bundle of His cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:odontogenesis of dentin-containing tooth; P:positive regulation of action potential; P:positive regulation of epithelial cell proliferation; P:positive regulation of sodium ion transport; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of cardiac muscle cell contraction; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:response to denervation involved in regulation of muscle adaptation; P:SA node cell action potential; P:sodium ion transmembrane transport; P:sodium ion transport; P:telencephalon development; P:ventricular cardiac muscle cell action potential;|P35498 E9PG49 Q16172 Q585T7 Q8IUJ6 Q96LA3 Q9C008,Sodium channel protein type 1 subunit alpha,Sodium channel protein brain I subunit alpha;Sodium channel protein type I subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.1;, PF00520;PF06512;PF11933;, GO:0030424;GO:0016604;GO:0005654;GO:0005886;GO:0001518;GO:0030018;GO:0005244;GO:0005248;GO:0086002;GO:0050966;GO:0086010;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:nuclear body; C:nucleoplasm; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cardiac muscle cell action potential involved in contraction; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 46350554 46470345 . - . ID=transcript_2510;P35498 E9PG49 Q16172 Q585T7 Q8IUJ6 Q96LA3 Q9C008,Sodium channel protein type 1 subunit alpha,Sodium channel protein brain I subunit alpha;Sodium channel protein type I subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.1;, PF00520;PF06512;PF11933;, GO:0030424;GO:0016604;GO:0005654;GO:0005886;GO:0001518;GO:0030018;GO:0005244;GO:0005248;GO:0086002;GO:0050966;GO:0086010;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:nuclear body; C:nucleoplasm; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cardiac muscle cell action potential involved in contraction; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|P35498 E9PG49 Q16172 Q585T7 Q8IUJ6 Q96LA3 Q9C008,Sodium channel protein type 1 subunit alpha,Sodium channel protein brain I subunit alpha;Sodium channel protein type I subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.1;, PF00520;PF06512;PF11933;, GO:0030424;GO:0016604;GO:0005654;GO:0005886;GO:0001518;GO:0030018;GO:0005244;GO:0005248;GO:0086002;GO:0050966;GO:0086010;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:nuclear body; C:nucleoplasm; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cardiac muscle cell action potential involved in contraction; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|P35498 E9PG49 Q16172 Q585T7 Q8IUJ6 Q96LA3 Q9C008,Sodium channel protein type 1 subunit alpha,Sodium channel protein brain I subunit alpha;Sodium channel protein type I subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.1;, PF00520;PF06512;PF11933;, GO:0030424;GO:0016604;GO:0005654;GO:0005886;GO:0001518;GO:0030018;GO:0005244;GO:0005248;GO:0086002;GO:0050966;GO:0086010;GO:0019228;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:nuclear body; C:nucleoplasm; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:cardiac muscle cell action potential involved in contraction; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 46541947 46542542 . - . ID=transcript_2511;Q15858 A1BUH5 Q6B4R9 Q6B4S0 Q6B4S1 Q70HX1 Q70HX2 Q8WTU1 Q8WWN4,Sodium channel protein type 9 subunit alpha {ECO:0000305},Neuroendocrine sodium channel {ECO:0000303|PubMed:7720699};Peripheral sodium channel 1;Sodium channel protein type IX subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.7;, PF00520;PF06512;PF11933;, GO:0030424;GO:0005887;GO:0001518;GO:0031402;GO:0005244;GO:0005248;GO:0048266;GO:0006954;GO:0086010;GO:0019228;GO:0009791;GO:0034765;GO:0009636;GO:0019233;GO:0035725;GO:0006814;, C:axon; C:integral component of plasma membrane; C:voltage-gated sodium channel complex;, F:sodium ion binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:behavioral response to pain; P:inflammatory response; P:membrane depolarization during action potential; P:neuronal action potential; P:post-embryonic development; P:regulation of ion transmembrane transport; P:response to toxic substance; P:sensory perception of pain; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 46601875 46602474 . + . ID=transcript_2512;Q15858 A1BUH5 Q6B4R9 Q6B4S0 Q6B4S1 Q70HX1 Q70HX2 Q8WTU1 Q8WWN4,Sodium channel protein type 9 subunit alpha {ECO:0000305},Neuroendocrine sodium channel {ECO:0000303|PubMed:7720699};Peripheral sodium channel 1;Sodium channel protein type IX subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.7;, PF00520;PF06512;PF11933;, GO:0030424;GO:0005887;GO:0001518;GO:0031402;GO:0005244;GO:0005248;GO:0048266;GO:0006954;GO:0086010;GO:0019228;GO:0009791;GO:0034765;GO:0009636;GO:0019233;GO:0035725;GO:0006814;, C:axon; C:integral component of plasma membrane; C:voltage-gated sodium channel complex;, F:sodium ion binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:behavioral response to pain; P:inflammatory response; P:membrane depolarization during action potential; P:neuronal action potential; P:post-embryonic development; P:regulation of ion transmembrane transport; P:response to toxic substance; P:sensory perception of pain; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 46604435 46632476 . + . ID=transcript_2513;Q15858 A1BUH5 Q6B4R9 Q6B4S0 Q6B4S1 Q70HX1 Q70HX2 Q8WTU1 Q8WWN4,Sodium channel protein type 9 subunit alpha {ECO:0000305},Neuroendocrine sodium channel {ECO:0000303|PubMed:7720699};Peripheral sodium channel 1;Sodium channel protein type IX subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.7;, PF00520;PF06512;PF11933;, GO:0030424;GO:0005887;GO:0001518;GO:0031402;GO:0005244;GO:0005248;GO:0048266;GO:0006954;GO:0086010;GO:0019228;GO:0009791;GO:0034765;GO:0009636;GO:0019233;GO:0035725;GO:0006814;, C:axon; C:integral component of plasma membrane; C:voltage-gated sodium channel complex;, F:sodium ion binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:behavioral response to pain; P:inflammatory response; P:membrane depolarization during action potential; P:neuronal action potential; P:post-embryonic development; P:regulation of ion transmembrane transport; P:response to toxic substance; P:sensory perception of pain; P:sodium ion transmembrane transport; P:sodium ion transport;|Q15858 A1BUH5 Q6B4R9 Q6B4S0 Q6B4S1 Q70HX1 Q70HX2 Q8WTU1 Q8WWN4,Sodium channel protein type 9 subunit alpha {ECO:0000305},Neuroendocrine sodium channel {ECO:0000303|PubMed:7720699};Peripheral sodium channel 1;Sodium channel protein type IX subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.7;, PF00520;PF06512;PF11933;, GO:0030424;GO:0005887;GO:0001518;GO:0031402;GO:0005244;GO:0005248;GO:0048266;GO:0006954;GO:0086010;GO:0019228;GO:0009791;GO:0034765;GO:0009636;GO:0019233;GO:0035725;GO:0006814;, C:axon; C:integral component of plasma membrane; C:voltage-gated sodium channel complex;, F:sodium ion binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:behavioral response to pain; P:inflammatory response; P:membrane depolarization during action potential; P:neuronal action potential; P:post-embryonic development; P:regulation of ion transmembrane transport; P:response to toxic substance; P:sensory perception of pain; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 46724066 46725903 . + . ID=transcript_2514;Q01118,Sodium channel protein type 7 subunit alpha,Putative voltage-gated sodium channel subunit alpha Nax;Sodium channel protein cardiac and skeletal muscle subunit alpha;Sodium channel protein type VII subunit alpha;, PF00520;PF06512;, GO:0030424;GO:0097386;GO:0001518;GO:0005244;GO:0005248;GO:0086010;GO:0006936;GO:0019228;GO:0034765;GO:0009617;GO:0055078;GO:0035725;GO:0006814;, C:axon; C:glial cell projection; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:membrane depolarization during action potential; P:muscle contraction; P:neuronal action potential; P:regulation of ion transmembrane transport; P:response to bacterium; P:sodium ion homeostasis; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 46749672 46750192 . + . ID=transcript_2515;Q01118,Sodium channel protein type 7 subunit alpha,Putative voltage-gated sodium channel subunit alpha Nax;Sodium channel protein cardiac and skeletal muscle subunit alpha;Sodium channel protein type VII subunit alpha;, PF00520;PF06512;, GO:0030424;GO:0097386;GO:0001518;GO:0005244;GO:0005248;GO:0086010;GO:0006936;GO:0019228;GO:0034765;GO:0009617;GO:0055078;GO:0035725;GO:0006814;, C:axon; C:glial cell projection; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:membrane depolarization during action potential; P:muscle contraction; P:neuronal action potential; P:regulation of ion transmembrane transport; P:response to bacterium; P:sodium ion homeostasis; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold9 indexed_genome mRNA 47499575 47524173 . + . ID=transcript_2516;Q8N1M9 Q8N3R5 Q8TBV6,Xin actin-binding repeat-containing protein 2,Beta-xin;Cardiomyopathy-associated protein 3;Xeplin;, PF08043;, GO:0030054;GO:0051015;GO:0030036;GO:0007507;, C:cell junction;, F:actin filament binding;, P:actin cytoskeleton organization; P:heart development; scaffold9 indexed_genome mRNA 47524233 47541890 . + . ID=transcript_2517;Q8N1M9 Q8N3R5 Q8TBV6,Xin actin-binding repeat-containing protein 2,Beta-xin;Cardiomyopathy-associated protein 3;Xeplin;, PF08043;, GO:0030054;GO:0051015;GO:0030036;GO:0007507;, C:cell junction;, F:actin filament binding;, P:actin cytoskeleton organization; P:heart development;|Q9BT23 D3DU16 Q96S91,LIM domain-containing protein 2 {ECO:0000305},, PF00412;, GO:0005829;GO:0005654;GO:0046872;, C:cytosol; C:nucleoplasm;, F:metal ion binding; scaffold9 indexed_genome mRNA 47589720 48187292 . + . ID=transcript_2518;Q9Y5Z6 D3DPB8 Q53SS2,Beta-1,3-galactosyltransferase 1 {ECO:0000305},UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1;, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0047275;GO:0008532;GO:0008499;GO:0006682;GO:0030259;GO:0009312;GO:0030311;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity;, P:galactosylceramide biosynthetic process; P:lipid glycosylation; P:oligosaccharide biosynthetic process; P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation;|Q9Y5Z6 D3DPB8 Q53SS2,Beta-1,3-galactosyltransferase 1 {ECO:0000305},UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1;, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0047275;GO:0008532;GO:0008499;GO:0006682;GO:0030259;GO:0009312;GO:0030311;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity;, P:galactosylceramide biosynthetic process; P:lipid glycosylation; P:oligosaccharide biosynthetic process; P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation; scaffold9 indexed_genome mRNA 48296204 48297110 . - . ID=transcript_2519;Q9UEW8 O14774 Q53S90 Q53SL7 Q53SS1 Q9UER4 X5D9C8,STE20/SPS1-related proline-alanine-rich protein kinase,DCHT;Serine/threonine-protein kinase 39;, PF12202;PF00069;, GO:0016324;GO:0016323;GO:0005856;GO:0005829;GO:0019898;GO:0043231;GO:0005654;GO:0005524;GO:0016301;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0000187;GO:0071476;GO:1990869;GO:0038146;GO:0035556;GO:0050801;GO:0036438;GO:1905408;GO:0090188;GO:1901380;GO:1901017;GO:2000650;GO:0018105;GO:0018107;GO:0032414;GO:0043268;GO:0010820;GO:0046777;GO:0006468;GO:0008217;GO:0050727;GO:0007165;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoskeleton; C:cytosol; C:extrinsic component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:cellular hypotonic response; P:cellular response to chemokine; P:chemokine (C-X-C motif) ligand 12 signaling pathway; P:intracellular signal transduction; P:ion homeostasis; P:maintenance of lens transparency; P:negative regulation of creatine transmembrane transporter activity; P:negative regulation of pancreatic juice secretion; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of sodium ion transmembrane transporter activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:positive regulation of T cell chemotaxis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of blood pressure; P:regulation of inflammatory response; P:signal transduction; scaffold9 indexed_genome mRNA 48771207 49104423 . + . ID=transcript_2520;Q6ZMG9 Q32M63 Q8N617,Ceramide synthase 6 {ECO:0000305},LAG1 longevity assurance homolog 6 {ECO:0000250|UniProtKB:Q8C172};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0006954;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:inflammatory response; P:sphingolipid biosynthetic process; scaffold9 indexed_genome mRNA 49130171 49193978 . + . ID=transcript_2521;Q8IVI9 A8K2I9 B3KSF5 E7EPT9 Q27HG3 Q53S62 Q96CJ9,Nostrin,BM247 homolog;Nitric oxide synthase traffic inducer;Nitric oxide synthase trafficker;eNOS-trafficking inducer;, PF00611;PF14604;, GO:0005856;GO:0030666;GO:0005634;GO:0005886;GO:0003677;GO:0006897;GO:0045892;GO:0050999;GO:0007165;, C:cytoskeleton; C:endocytic vesicle membrane; C:nucleus; C:plasma membrane;, F:DNA binding;, P:endocytosis; P:negative regulation of transcription, DNA-templated; P:regulation of nitric-oxide synthase activity; P:signal transduction;|Q8IVI9 A8K2I9 B3KSF5 E7EPT9 Q27HG3 Q53S62 Q96CJ9,Nostrin,BM247 homolog;Nitric oxide synthase traffic inducer;Nitric oxide synthase trafficker;eNOS-trafficking inducer;, PF00611;PF14604;, GO:0005856;GO:0030666;GO:0005634;GO:0005886;GO:0003677;GO:0006897;GO:0045892;GO:0050999;GO:0007165;, C:cytoskeleton; C:endocytic vesicle membrane; C:nucleus; C:plasma membrane;, F:DNA binding;, P:endocytosis; P:negative regulation of transcription, DNA-templated; P:regulation of nitric-oxide synthase activity; P:signal transduction;|Q8IVI9 A8K2I9 B3KSF5 E7EPT9 Q27HG3 Q53S62 Q96CJ9,Nostrin,BM247 homolog;Nitric oxide synthase traffic inducer;Nitric oxide synthase trafficker;eNOS-trafficking inducer;, PF00611;PF14604;, GO:0005856;GO:0030666;GO:0005634;GO:0005886;GO:0003677;GO:0006897;GO:0045892;GO:0050999;GO:0007165;, C:cytoskeleton; C:endocytic vesicle membrane; C:nucleus; C:plasma membrane;, F:DNA binding;, P:endocytosis; P:negative regulation of transcription, DNA-templated; P:regulation of nitric-oxide synthase activity; P:signal transduction; scaffold9 indexed_genome mRNA 49200483 49212701 . - . ID=transcript_2522;Q9HBM1 A8K4X8 D3DPC0,Kinetochore protein Spc25,, PF08234;, GO:0000777;GO:0005829;GO:0031262;GO:0005634;GO:0051301;GO:0007059;GO:0007052;, C:condensed chromosome kinetochore; C:cytosol; C:Ndc80 complex; C:nucleus;, , P:cell division; P:chromosome segregation; P:mitotic spindle organization; scaffold9 indexed_genome mRNA 49243226 49330573 . - . ID=transcript_2523;O95342 Q53TL2 Q9UNB2,Bile salt export pump {ECO:0000303|Ref.2},ATP-binding cassette sub-family B member 11;, PF00664;PF00005;, GO:0016324;GO:0009986;GO:0005768;GO:0070062;GO:0016021;GO:0046581;GO:0046691;GO:0005886;GO:0055037;GO:0055038;GO:0015432;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015125;GO:0015126;GO:0015721;GO:0006699;GO:0008206;GO:0015722;GO:0042632;GO:0046618;GO:0017144;GO:0006855;GO:0006631;GO:0055088;GO:0055091;GO:0120189;GO:0016567;GO:1904251;GO:0031998;GO:0055085;, C:apical plasma membrane; C:cell surface; C:endosome; C:extracellular exosome; C:integral component of membrane; C:intercellular canaliculus; C:intracellular canaliculus; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:ABC-type bile acid transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bile acid transmembrane transporter activity; F:canalicular bile acid transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:bile acid metabolic process; P:canalicular bile acid transport; P:cholesterol homeostasis; P:drug export; P:drug metabolic process; P:drug transmembrane transport; P:fatty acid metabolic process; P:lipid homeostasis; P:phospholipid homeostasis; P:positive regulation of bile acid secretion; P:protein ubiquitination; P:regulation of bile acid metabolic process; P:regulation of fatty acid beta-oxidation; P:transmembrane transport;|O95342 Q53TL2 Q9UNB2,Bile salt export pump {ECO:0000303|Ref.2},ATP-binding cassette sub-family B member 11;, PF00664;PF00005;, GO:0016324;GO:0009986;GO:0005768;GO:0070062;GO:0016021;GO:0046581;GO:0046691;GO:0005886;GO:0055037;GO:0055038;GO:0015432;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015125;GO:0015126;GO:0015721;GO:0006699;GO:0008206;GO:0015722;GO:0042632;GO:0046618;GO:0017144;GO:0006855;GO:0006631;GO:0055088;GO:0055091;GO:0120189;GO:0016567;GO:1904251;GO:0031998;GO:0055085;, C:apical plasma membrane; C:cell surface; C:endosome; C:extracellular exosome; C:integral component of membrane; C:intercellular canaliculus; C:intracellular canaliculus; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:ABC-type bile acid transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bile acid transmembrane transporter activity; F:canalicular bile acid transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:bile acid metabolic process; P:canalicular bile acid transport; P:cholesterol homeostasis; P:drug export; P:drug metabolic process; P:drug transmembrane transport; P:fatty acid metabolic process; P:lipid homeostasis; P:phospholipid homeostasis; P:positive regulation of bile acid secretion; P:protein ubiquitination; P:regulation of bile acid metabolic process; P:regulation of fatty acid beta-oxidation; P:transmembrane transport;|O95342 Q53TL2 Q9UNB2,Bile salt export pump {ECO:0000303|Ref.2},ATP-binding cassette sub-family B member 11;, PF00664;PF00005;, GO:0016324;GO:0009986;GO:0005768;GO:0070062;GO:0016021;GO:0046581;GO:0046691;GO:0005886;GO:0055037;GO:0055038;GO:0015432;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015125;GO:0015126;GO:0015721;GO:0006699;GO:0008206;GO:0015722;GO:0042632;GO:0046618;GO:0017144;GO:0006855;GO:0006631;GO:0055088;GO:0055091;GO:0120189;GO:0016567;GO:1904251;GO:0031998;GO:0055085;, C:apical plasma membrane; C:cell surface; C:endosome; C:extracellular exosome; C:integral component of membrane; C:intercellular canaliculus; C:intracellular canaliculus; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:ABC-type bile acid transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bile acid transmembrane transporter activity; F:canalicular bile acid transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:bile acid metabolic process; P:canalicular bile acid transport; P:cholesterol homeostasis; P:drug export; P:drug metabolic process; P:drug transmembrane transport; P:fatty acid metabolic process; P:lipid homeostasis; P:phospholipid homeostasis; P:positive regulation of bile acid secretion; P:protein ubiquitination; P:regulation of bile acid metabolic process; P:regulation of fatty acid beta-oxidation; P:transmembrane transport;|O95342 Q53TL2 Q9UNB2,Bile salt export pump {ECO:0000303|Ref.2},ATP-binding cassette sub-family B member 11;, PF00664;PF00005;, GO:0016324;GO:0009986;GO:0005768;GO:0070062;GO:0016021;GO:0046581;GO:0046691;GO:0005886;GO:0055037;GO:0055038;GO:0015432;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015125;GO:0015126;GO:0015721;GO:0006699;GO:0008206;GO:0015722;GO:0042632;GO:0046618;GO:0017144;GO:0006855;GO:0006631;GO:0055088;GO:0055091;GO:0120189;GO:0016567;GO:1904251;GO:0031998;GO:0055085;, C:apical plasma membrane; C:cell surface; C:endosome; C:extracellular exosome; C:integral component of membrane; C:intercellular canaliculus; C:intracellular canaliculus; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:ABC-type bile acid transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bile acid transmembrane transporter activity; F:canalicular bile acid transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:bile acid metabolic process; P:canalicular bile acid transport; P:cholesterol homeostasis; P:drug export; P:drug metabolic process; P:drug transmembrane transport; P:fatty acid metabolic process; P:lipid homeostasis; P:phospholipid homeostasis; P:positive regulation of bile acid secretion; P:protein ubiquitination; P:regulation of bile acid metabolic process; P:regulation of fatty acid beta-oxidation; P:transmembrane transport;|O95342 Q53TL2 Q9UNB2,Bile salt export pump {ECO:0000303|Ref.2},ATP-binding cassette sub-family B member 11;, PF00664;PF00005;, GO:0016324;GO:0009986;GO:0005768;GO:0070062;GO:0016021;GO:0046581;GO:0046691;GO:0005886;GO:0055037;GO:0055038;GO:0015432;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015125;GO:0015126;GO:0015721;GO:0006699;GO:0008206;GO:0015722;GO:0042632;GO:0046618;GO:0017144;GO:0006855;GO:0006631;GO:0055088;GO:0055091;GO:0120189;GO:0016567;GO:1904251;GO:0031998;GO:0055085;, C:apical plasma membrane; C:cell surface; C:endosome; C:extracellular exosome; C:integral component of membrane; C:intercellular canaliculus; C:intracellular canaliculus; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:ABC-type bile acid transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bile acid transmembrane transporter activity; F:canalicular bile acid transmembrane transporter activity;, P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:bile acid metabolic process; P:canalicular bile acid transport; P:cholesterol homeostasis; P:drug export; P:drug metabolic process; P:drug transmembrane transport; P:fatty acid metabolic process; P:lipid homeostasis; P:phospholipid homeostasis; P:positive regulation of bile acid secretion; P:protein ubiquitination; P:regulation of bile acid metabolic process; P:regulation of fatty acid beta-oxidation; P:transmembrane transport; scaffold9 indexed_genome mRNA 49370252 49396825 . + . ID=transcript_2524;Q9BPW9 B7Z416 D3DPC1 Q5RKX1 Q9NRA9 Q9NRB0,Dehydrogenase/reductase SDR family member 9,3-alpha hydroxysteroid dehydrogenase;NADP-dependent retinol dehydrogenase/reductase;RDH-E2;RDHL;Retinol dehydrogenase 15;Short chain dehydrogenase/reductase family 9C member 4 {ECO:0000303|PubMed:19027726};Short-chain dehydrogenase/reductase retSDR8;Tracheobronchial epithelial cell-specific retinol dehydrogenase {ECO:0000303|PubMed:11304534};, PF00106;, GO:0005789;GO:0030176;GO:0004022;GO:0047044;GO:0047023;GO:0016854;GO:0004745;GO:0047035;GO:0042904;GO:0008209;GO:0030855;GO:0042448;GO:0042572;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:alcohol dehydrogenase (NAD+) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:racemase and epimerase activity; F:retinol dehydrogenase activity; F:testosterone dehydrogenase (NAD+) activity;, P:9-cis-retinoic acid biosynthetic process; P:androgen metabolic process; P:epithelial cell differentiation; P:progesterone metabolic process; P:retinol metabolic process; scaffold9 indexed_genome mRNA 49464333 49466375 . - . ID=transcript_2525;P98164 O00711 Q16215,Low-density lipoprotein receptor-related protein 2,Glycoprotein 330;Megalin;, PF12662;PF07645;PF00057;PF00058;, GO:0016324;GO:0030424;GO:0031526;GO:0030669;GO:0005905;GO:0030425;GO:0005783;GO:0031904;GO:0009897;GO:0070062;GO:0005794;GO:0016021;GO:0005765;GO:0005764;GO:0005886;GO:0043235;GO:0005509;GO:0051087;GO:0042562;GO:0031994;GO:0140318;GO:0017124;GO:0097242;GO:0035904;GO:0008283;GO:0071363;GO:0060982;GO:0006897;GO:1904447;GO:0030900;GO:0001822;GO:0006629;GO:0008584;GO:0061024;GO:0030001;GO:0043066;GO:0030514;GO:0001843;GO:0140058;GO:0003148;GO:1905167;GO:0050769;GO:0070447;GO:0051897;GO:0015031;GO:0061156;GO:0006898;GO:0044321;GO:0001523;GO:0003139;GO:0007605;GO:0045056;GO:0150104;GO:0060068;GO:0003223;GO:0003281;GO:0042359;, C:apical plasma membrane; C:axon; C:brush border membrane; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:dendrite; C:endoplasmic reticulum; C:endosome lumen; C:external side of plasma membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:chaperone binding; F:hormone binding; F:insulin-like growth factor I binding; F:protein transporter activity; F:SH3 domain binding;, P:amyloid-beta clearance; P:aorta development; P:cell population proliferation; P:cellular response to growth factor stimulus; P:coronary artery morphogenesis; P:endocytosis; P:folate import across plasma membrane; P:forebrain development; P:kidney development; P:lipid metabolic process; P:male gonad development; P:membrane organization; P:metal ion transport; P:negative regulation of apoptotic process; P:negative regulation of BMP signaling pathway; P:neural tube closure; P:neuron projection arborization; P:outflow tract septum morphogenesis; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of neurogenesis; P:positive regulation of oligodendrocyte progenitor proliferation; P:positive regulation of protein kinase B signaling; P:protein transport; P:pulmonary artery morphogenesis; P:receptor-mediated endocytosis; P:response to leptin; P:retinoid metabolic process; P:secondary heart field specification; P:sensory perception of sound; P:transcytosis; P:transport across blood-brain barrier; P:vagina development; P:ventricular compact myocardium morphogenesis; P:ventricular septum development; P:vitamin D metabolic process; scaffold9 indexed_genome mRNA 49687151 49707345 . + . ID=transcript_2526;Q8N3I7 D3DPC3 Q6PKN0,Bardet-Biedl syndrome 5 protein,, PF07289;, GO:0005930;GO:0034464;GO:0034451;GO:0036064;GO:0060170;GO:0005829;GO:0032266;GO:0001103;GO:0060271;GO:0001947;GO:0046907;GO:0032402;GO:0044458;GO:0015031;GO:0050896;GO:0007601;, C:axoneme; C:BBSome; C:centriolar satellite; C:ciliary basal body; C:ciliary membrane; C:cytosol;, F:phosphatidylinositol-3-phosphate binding; F:RNA polymerase II repressing transcription factor binding;, P:cilium assembly; P:heart looping; P:intracellular transport; P:melanosome transport; P:motile cilium assembly; P:protein transport; P:response to stimulus; P:visual perception;|Q8N3I7 D3DPC3 Q6PKN0,Bardet-Biedl syndrome 5 protein,, PF07289;, GO:0005930;GO:0034464;GO:0034451;GO:0036064;GO:0060170;GO:0005829;GO:0032266;GO:0001103;GO:0060271;GO:0001947;GO:0046907;GO:0032402;GO:0044458;GO:0015031;GO:0050896;GO:0007601;, C:axoneme; C:BBSome; C:centriolar satellite; C:ciliary basal body; C:ciliary membrane; C:cytosol;, F:phosphatidylinositol-3-phosphate binding; F:RNA polymerase II repressing transcription factor binding;, P:cilium assembly; P:heart looping; P:intracellular transport; P:melanosome transport; P:motile cilium assembly; P:protein transport; P:response to stimulus; P:visual perception;|Q8N3I7 D3DPC3 Q6PKN0,Bardet-Biedl syndrome 5 protein,, PF07289;, GO:0005930;GO:0034464;GO:0034451;GO:0036064;GO:0060170;GO:0005829;GO:0032266;GO:0001103;GO:0060271;GO:0001947;GO:0046907;GO:0032402;GO:0044458;GO:0015031;GO:0050896;GO:0007601;, C:axoneme; C:BBSome; C:centriolar satellite; C:ciliary basal body; C:ciliary membrane; C:cytosol;, F:phosphatidylinositol-3-phosphate binding; F:RNA polymerase II repressing transcription factor binding;, P:cilium assembly; P:heart looping; P:intracellular transport; P:melanosome transport; P:motile cilium assembly; P:protein transport; P:response to stimulus; P:visual perception; scaffold9 indexed_genome mRNA 49709176 49725332 . + . ID=transcript_2527;O60662 Q53R42,Kelch-like protein 41,Kel-like protein 23;Kelch repeat and BTB domain-containing protein 10;Kelch-related protein 1;Sarcosin;, PF07707;PF00651;PF01344;, GO:0031463;GO:0005737;GO:0005856;GO:0005829;GO:0005789;GO:0031430;GO:0005654;GO:0005886;GO:0031143;GO:0001726;GO:0033017;GO:0030239;GO:0043687;GO:0016567;GO:0031275;GO:0045661;GO:2000291;GO:2001014;GO:0045214;GO:0035914;GO:0048741;GO:0006941;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum membrane; C:M band; C:nucleoplasm; C:plasma membrane; C:pseudopodium; C:ruffle; C:sarcoplasmic reticulum membrane;, , P:myofibril assembly; P:post-translational protein modification; P:protein ubiquitination; P:regulation of lateral pseudopodium assembly; P:regulation of myoblast differentiation; P:regulation of myoblast proliferation; P:regulation of skeletal muscle cell differentiation; P:sarcomere organization; P:skeletal muscle cell differentiation; P:skeletal muscle fiber development; P:striated muscle contraction; scaffold9 indexed_genome mRNA 49727354 49762132 . - . ID=transcript_2528;Q53R41 Q8N583 Q8TEA9 Q96JM5 Q96N71 Q9H6T4,FAST kinase domain-containing protein 1, mitochondrial,, PF06743;PF08368;PF08373;, GO:0005739;GO:0003723;GO:0000959;GO:0044528;, C:mitochondrion;, F:RNA binding;, P:mitochondrial RNA metabolic process; P:regulation of mitochondrial mRNA stability;|Q53R41 Q8N583 Q8TEA9 Q96JM5 Q96N71 Q9H6T4,FAST kinase domain-containing protein 1, mitochondrial,, PF06743;PF08368;PF08373;, GO:0005739;GO:0003723;GO:0000959;GO:0044528;, C:mitochondrion;, F:RNA binding;, P:mitochondrial RNA metabolic process; P:regulation of mitochondrial mRNA stability;|Q53R41 Q8N583 Q8TEA9 Q96JM5 Q96N71 Q9H6T4,FAST kinase domain-containing protein 1, mitochondrial,, PF06743;PF08368;PF08373;, GO:0005739;GO:0003723;GO:0000959;GO:0044528;, C:mitochondrion;, F:RNA binding;, P:mitochondrial RNA metabolic process; P:regulation of mitochondrial mRNA stability;|Q53R41 Q8N583 Q8TEA9 Q96JM5 Q96N71 Q9H6T4,FAST kinase domain-containing protein 1, mitochondrial,, PF06743;PF08368;PF08373;, GO:0005739;GO:0003723;GO:0000959;GO:0044528;, C:mitochondrion;, F:RNA binding;, P:mitochondrial RNA metabolic process; P:regulation of mitochondrial mRNA stability; scaffold9 indexed_genome mRNA 49766365 49806558 . + . ID=transcript_2529;Q13427 D3DPC5 D3DPC6 O00706 Q53R40 Q53SN4 Q96DG9,Peptidyl-prolyl cis-trans isomerase G,CASP10;Clk-associating RS-cyclophilin;Cyclophilin G;Rotamase G;, PF00160;, GO:0005737;GO:0005829;GO:0043231;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0016018;GO:0003755;GO:0003723;GO:0006457;GO:0000413;GO:0008380;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:protein folding; P:protein peptidyl-prolyl isomerization; P:RNA splicing;|Q13427 D3DPC5 D3DPC6 O00706 Q53R40 Q53SN4 Q96DG9,Peptidyl-prolyl cis-trans isomerase G,CASP10;Clk-associating RS-cyclophilin;Cyclophilin G;Rotamase G;, PF00160;, GO:0005737;GO:0005829;GO:0043231;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0016018;GO:0003755;GO:0003723;GO:0006457;GO:0000413;GO:0008380;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:protein folding; P:protein peptidyl-prolyl isomerization; P:RNA splicing;|Q13427 D3DPC5 D3DPC6 O00706 Q53R40 Q53SN4 Q96DG9,Peptidyl-prolyl cis-trans isomerase G,CASP10;Clk-associating RS-cyclophilin;Cyclophilin G;Rotamase G;, PF00160;, GO:0005737;GO:0005829;GO:0043231;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0016018;GO:0003755;GO:0003723;GO:0006457;GO:0000413;GO:0008380;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:protein folding; P:protein peptidyl-prolyl isomerization; P:RNA splicing;|Q13427 D3DPC5 D3DPC6 O00706 Q53R40 Q53SN4 Q96DG9,Peptidyl-prolyl cis-trans isomerase G,CASP10;Clk-associating RS-cyclophilin;Cyclophilin G;Rotamase G;, PF00160;, GO:0005737;GO:0005829;GO:0043231;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0016018;GO:0003755;GO:0003723;GO:0006457;GO:0000413;GO:0008380;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:protein folding; P:protein peptidyl-prolyl isomerization; P:RNA splicing; scaffold9 indexed_genome mRNA 49807394 49819402 . - . ID=transcript_2530;Q0VFZ6 Q6PJF6,Coiled-coil domain-containing protein 173,, PF13868; scaffold9 indexed_genome mRNA 49822221 49822926 . - . ID=transcript_2531;Q0VFZ6 Q6PJF6,Coiled-coil domain-containing protein 173,, PF13868; scaffold9 indexed_genome mRNA 49830642 49833485 . + . ID=transcript_2532;Q8TCD6 B2RC30 D3DPC7,Pyridoxal phosphate phosphatase PHOSPHO2,, PF06888;, GO:0046872;GO:0016791;GO:0033883;, , F:metal ion binding; F:phosphatase activity; F:pyridoxal phosphatase activity; scaffold9 indexed_genome mRNA 49855564 49878963 . + . ID=transcript_2533;Q8NBE8 Q8N9B9 Q96FT8,Kelch-like protein 23,, PF07707;PF00651;PF01344;|Q8NBE8 Q8N9B9 Q96FT8,Kelch-like protein 23,, PF07707;PF00651;PF01344;|Q8NBE8 Q8N9B9 Q96FT8,Kelch-like protein 23,, PF07707;PF00651;PF01344; scaffold9 indexed_genome mRNA 49898389 49916426 . + . ID=transcript_2534;P05455 Q15367 Q53XJ4,Lupus La protein,La autoantigen;La ribonucleoprotein;Sjoegren syndrome type B antigen;, PF05383;PF00076;PF08777;, GO:0000781;GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0008266;GO:0003723;GO:1990825;GO:0000049;GO:0008334;GO:0075522;GO:0071045;GO:1903608;GO:0042780;GO:0001682;GO:0006409;GO:0006400;GO:0008033;, C:chromosome, telomeric region; C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:poly(U) RNA binding; F:RNA binding; F:sequence-specific mRNA binding; F:tRNA binding;, P:histone mRNA metabolic process; P:IRES-dependent viral translational initiation; P:nuclear histone mRNA catabolic process; P:protein localization to cytoplasmic stress granule; P:tRNA 3'-end processing; P:tRNA 5'-leader removal; P:tRNA export from nucleus; P:tRNA modification; P:tRNA processing;|P05455 Q15367 Q53XJ4,Lupus La protein,La autoantigen;La ribonucleoprotein;Sjoegren syndrome type B antigen;, PF05383;PF00076;PF08777;, GO:0000781;GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0008266;GO:0003723;GO:1990825;GO:0000049;GO:0008334;GO:0075522;GO:0071045;GO:1903608;GO:0042780;GO:0001682;GO:0006409;GO:0006400;GO:0008033;, C:chromosome, telomeric region; C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:poly(U) RNA binding; F:RNA binding; F:sequence-specific mRNA binding; F:tRNA binding;, P:histone mRNA metabolic process; P:IRES-dependent viral translational initiation; P:nuclear histone mRNA catabolic process; P:protein localization to cytoplasmic stress granule; P:tRNA 3'-end processing; P:tRNA 5'-leader removal; P:tRNA export from nucleus; P:tRNA modification; P:tRNA processing;|P05455 Q15367 Q53XJ4,Lupus La protein,La autoantigen;La ribonucleoprotein;Sjoegren syndrome type B antigen;, PF05383;PF00076;PF08777;, GO:0000781;GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0008266;GO:0003723;GO:1990825;GO:0000049;GO:0008334;GO:0075522;GO:0071045;GO:1903608;GO:0042780;GO:0001682;GO:0006409;GO:0006400;GO:0008033;, C:chromosome, telomeric region; C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:poly(U) RNA binding; F:RNA binding; F:sequence-specific mRNA binding; F:tRNA binding;, P:histone mRNA metabolic process; P:IRES-dependent viral translational initiation; P:nuclear histone mRNA catabolic process; P:protein localization to cytoplasmic stress granule; P:tRNA 3'-end processing; P:tRNA 5'-leader removal; P:tRNA export from nucleus; P:tRNA modification; P:tRNA processing;|P05455 Q15367 Q53XJ4,Lupus La protein,La autoantigen;La ribonucleoprotein;Sjoegren syndrome type B antigen;, PF05383;PF00076;PF08777;, GO:0000781;GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0008266;GO:0003723;GO:1990825;GO:0000049;GO:0008334;GO:0075522;GO:0071045;GO:1903608;GO:0042780;GO:0001682;GO:0006409;GO:0006400;GO:0008033;, C:chromosome, telomeric region; C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:poly(U) RNA binding; F:RNA binding; F:sequence-specific mRNA binding; F:tRNA binding;, P:histone mRNA metabolic process; P:IRES-dependent viral translational initiation; P:nuclear histone mRNA catabolic process; P:protein localization to cytoplasmic stress granule; P:tRNA 3'-end processing; P:tRNA 5'-leader removal; P:tRNA export from nucleus; P:tRNA modification; P:tRNA processing;|P05455 Q15367 Q53XJ4,Lupus La protein,La autoantigen;La ribonucleoprotein;Sjoegren syndrome type B antigen;, PF05383;PF00076;PF08777;, GO:0000781;GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0008266;GO:0003723;GO:1990825;GO:0000049;GO:0008334;GO:0075522;GO:0071045;GO:1903608;GO:0042780;GO:0001682;GO:0006409;GO:0006400;GO:0008033;, C:chromosome, telomeric region; C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:poly(U) RNA binding; F:RNA binding; F:sequence-specific mRNA binding; F:tRNA binding;, P:histone mRNA metabolic process; P:IRES-dependent viral translational initiation; P:nuclear histone mRNA catabolic process; P:protein localization to cytoplasmic stress granule; P:tRNA 3'-end processing; P:tRNA 5'-leader removal; P:tRNA export from nucleus; P:tRNA modification; P:tRNA processing;|Q9NRN9 D3DPC9 Q9NVX1,rRNA N6-adenosine-methyltransferase METTL5 {ECO:0000305},Methyltransferase-like protein 5 {ECO:0000303|PubMed:31328227};, PF05175;, GO:0042995;GO:0005634;GO:0098794;GO:0098793;GO:0003676;GO:0008988;GO:1904047;GO:0045727;GO:0031167;GO:0048863;, C:cell projection; C:nucleus; C:postsynapse; C:presynapse;, F:nucleic acid binding; F:rRNA (adenine-N6-)-methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:positive regulation of translation; P:rRNA methylation; P:stem cell differentiation;|Q9NRN9 D3DPC9 Q9NVX1,rRNA N6-adenosine-methyltransferase METTL5 {ECO:0000305},Methyltransferase-like protein 5 {ECO:0000303|PubMed:31328227};, PF05175;, GO:0042995;GO:0005634;GO:0098794;GO:0098793;GO:0003676;GO:0008988;GO:1904047;GO:0045727;GO:0031167;GO:0048863;, C:cell projection; C:nucleus; C:postsynapse; C:presynapse;, F:nucleic acid binding; F:rRNA (adenine-N6-)-methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:positive regulation of translation; P:rRNA methylation; P:stem cell differentiation; scaffold9 indexed_genome mRNA 49928890 49930335 . - . ID=transcript_2535;P07355 Q567R4 Q6N0B3 Q8TBV2 Q96DD5 Q9UDH8,Annexin A2,Annexin II;Annexin-2;Calpactin I heavy chain;Calpactin-1 heavy chain;Chromobindin-8;Lipocortin II;Placental anticoagulant protein IV;Protein I;p36;, PF00191;, GO:0005912;GO:1990665;GO:0035578;GO:0005604;GO:0016323;GO:0009986;GO:0062023;GO:0005737;GO:0005768;GO:0070062;GO:0005576;GO:0005615;GO:0031902;GO:0005811;GO:0005765;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:1990667;GO:0005886;GO:0031982;GO:0098641;GO:0005262;GO:0005509;GO:0005544;GO:0048306;GO:0008092;GO:0042802;GO:0005546;GO:0001786;GO:0019834;GO:0002020;GO:0003723;GO:0044548;GO:0004867;GO:0046790;GO:0001525;GO:0052362;GO:0035722;GO:0001765;GO:0052405;GO:0044147;GO:0032804;GO:0043312;GO:0036035;GO:1905581;GO:1905597;GO:1905599;GO:0001921;GO:1905602;GO:0044090;GO:0031340;GO:0006900;GO:0016032;, C:adherens junction; C:AnxA2-p11 complex; C:azurophil granule lumen; C:basement membrane; C:basolateral plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:late endosome membrane; C:lipid droplet; C:lysosomal membrane; C:melanosome; C:membrane; C:midbody; C:nucleus; C:PCSK9-AnxA2 complex; C:plasma membrane; C:vesicle;, F:cadherin binding involved in cell-cell adhesion; F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:cytoskeletal protein binding; F:identical protein binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:phospholipase A2 inhibitor activity; F:protease binding; F:RNA binding; F:S100 protein binding; F:serine-type endopeptidase inhibitor activity; F:virion binding;, P:angiogenesis; P:catabolism by host of symbiont protein; P:interleukin-12-mediated signaling pathway; P:membrane raft assembly; P:negative regulation by host of symbiont molecular function; P:negative regulation of development of symbiont involved in interaction with host; P:negative regulation of low-density lipoprotein particle receptor catabolic process; P:neutrophil degranulation; P:osteoclast development; P:positive regulation of low-density lipoprotein particle clearance; P:positive regulation of low-density lipoprotein particle receptor binding; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of receptor recycling; P:positive regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of vacuole organization; P:positive regulation of vesicle fusion; P:vesicle budding from membrane; P:viral process; scaffold9 indexed_genome mRNA 49938363 50123753 . + . ID=transcript_2536;Q6ZT12 B4DZR7 Q2KHN5 Q6ZR55 Q6ZSC2 Q8IVE7 Q8ND96,E3 ubiquitin-protein ligase UBR3,N-recognin-3;RING-type E3 ubiquitin transferase UBR3;Ubiquitin-protein ligase E3-alpha-3;Ubiquitin-protein ligase E3-alpha-III;Zinc finger protein 650;, PF18995;PF02207;, GO:0005737;GO:0016021;GO:0000151;GO:0061630;GO:0004842;GO:0008270;GO:0009792;GO:0016567;GO:0007608;GO:0001967;GO:0006511;GO:0071596;, C:cytoplasm; C:integral component of membrane; C:ubiquitin ligase complex;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:embryo development ending in birth or egg hatching; P:protein ubiquitination; P:sensory perception of smell; P:suckling behavior; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q6ZT12 B4DZR7 Q2KHN5 Q6ZR55 Q6ZSC2 Q8IVE7 Q8ND96,E3 ubiquitin-protein ligase UBR3,N-recognin-3;RING-type E3 ubiquitin transferase UBR3;Ubiquitin-protein ligase E3-alpha-3;Ubiquitin-protein ligase E3-alpha-III;Zinc finger protein 650;, PF18995;PF02207;, GO:0005737;GO:0016021;GO:0000151;GO:0061630;GO:0004842;GO:0008270;GO:0009792;GO:0016567;GO:0007608;GO:0001967;GO:0006511;GO:0071596;, C:cytoplasm; C:integral component of membrane; C:ubiquitin ligase complex;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:embryo development ending in birth or egg hatching; P:protein ubiquitination; P:sensory perception of smell; P:suckling behavior; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q6ZT12 B4DZR7 Q2KHN5 Q6ZR55 Q6ZSC2 Q8IVE7 Q8ND96,E3 ubiquitin-protein ligase UBR3,N-recognin-3;RING-type E3 ubiquitin transferase UBR3;Ubiquitin-protein ligase E3-alpha-3;Ubiquitin-protein ligase E3-alpha-III;Zinc finger protein 650;, PF18995;PF02207;, GO:0005737;GO:0016021;GO:0000151;GO:0061630;GO:0004842;GO:0008270;GO:0009792;GO:0016567;GO:0007608;GO:0001967;GO:0006511;GO:0071596;, C:cytoplasm; C:integral component of membrane; C:ubiquitin ligase complex;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:embryo development ending in birth or egg hatching; P:protein ubiquitination; P:sensory perception of smell; P:suckling behavior; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; scaffold9 indexed_genome mRNA 50123789 50131961 . + . ID=transcript_2537;Q6ZT12 B4DZR7 Q2KHN5 Q6ZR55 Q6ZSC2 Q8IVE7 Q8ND96,E3 ubiquitin-protein ligase UBR3,N-recognin-3;RING-type E3 ubiquitin transferase UBR3;Ubiquitin-protein ligase E3-alpha-3;Ubiquitin-protein ligase E3-alpha-III;Zinc finger protein 650;, PF18995;PF02207;, GO:0005737;GO:0016021;GO:0000151;GO:0061630;GO:0004842;GO:0008270;GO:0009792;GO:0016567;GO:0007608;GO:0001967;GO:0006511;GO:0071596;, C:cytoplasm; C:integral component of membrane; C:ubiquitin ligase complex;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:embryo development ending in birth or egg hatching; P:protein ubiquitination; P:sensory perception of smell; P:suckling behavior; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; scaffold9 indexed_genome mRNA 50732525 50787784 . + . ID=transcript_2538;A1L162 A7E2T7,Glutamate-rich protein 2 scaffold9 indexed_genome mRNA 50808898 50842777 . + . ID=transcript_2539;Q99259 Q49AK1 Q53TQ7 Q9BU91 Q9UHH4,Glutamate decarboxylase 1,67 kDa glutamic acid decarboxylase;Glutamate decarboxylase 67 kDa isoform;, PF00282;, GO:0043679;GO:0005938;GO:0061202;GO:0060077;GO:0005886;GO:0048786;GO:0012506;GO:0016595;GO:0004351;GO:0047485;GO:0044877;GO:0030170;GO:0007268;GO:0009449;GO:0006538;GO:0006540;GO:0035641;GO:0042136;GO:0007269;GO:0018352;GO:0042493;GO:0035176;, C:axon terminus; C:cell cortex; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:inhibitory synapse; C:plasma membrane; C:presynaptic active zone; C:vesicle membrane;, F:glutamate binding; F:glutamate decarboxylase activity; F:protein N-terminus binding; F:protein-containing complex binding; F:pyridoxal phosphate binding;, P:chemical synaptic transmission; P:gamma-aminobutyric acid biosynthetic process; P:glutamate catabolic process; P:glutamate decarboxylation to succinate; P:locomotory exploration behavior; P:neurotransmitter biosynthetic process; P:neurotransmitter secretion; P:protein-pyridoxal-5-phosphate linkage; P:response to drug; P:social behavior;|Q99259 Q49AK1 Q53TQ7 Q9BU91 Q9UHH4,Glutamate decarboxylase 1,67 kDa glutamic acid decarboxylase;Glutamate decarboxylase 67 kDa isoform;, PF00282;, GO:0043679;GO:0005938;GO:0061202;GO:0060077;GO:0005886;GO:0048786;GO:0012506;GO:0016595;GO:0004351;GO:0047485;GO:0044877;GO:0030170;GO:0007268;GO:0009449;GO:0006538;GO:0006540;GO:0035641;GO:0042136;GO:0007269;GO:0018352;GO:0042493;GO:0035176;, C:axon terminus; C:cell cortex; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:inhibitory synapse; C:plasma membrane; C:presynaptic active zone; C:vesicle membrane;, F:glutamate binding; F:glutamate decarboxylase activity; F:protein N-terminus binding; F:protein-containing complex binding; F:pyridoxal phosphate binding;, P:chemical synaptic transmission; P:gamma-aminobutyric acid biosynthetic process; P:glutamate catabolic process; P:glutamate decarboxylation to succinate; P:locomotory exploration behavior; P:neurotransmitter biosynthetic process; P:neurotransmitter secretion; P:protein-pyridoxal-5-phosphate linkage; P:response to drug; P:social behavior;|Q99259 Q49AK1 Q53TQ7 Q9BU91 Q9UHH4,Glutamate decarboxylase 1,67 kDa glutamic acid decarboxylase;Glutamate decarboxylase 67 kDa isoform;, PF00282;, GO:0043679;GO:0005938;GO:0061202;GO:0060077;GO:0005886;GO:0048786;GO:0012506;GO:0016595;GO:0004351;GO:0047485;GO:0044877;GO:0030170;GO:0007268;GO:0009449;GO:0006538;GO:0006540;GO:0035641;GO:0042136;GO:0007269;GO:0018352;GO:0042493;GO:0035176;, C:axon terminus; C:cell cortex; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:inhibitory synapse; C:plasma membrane; C:presynaptic active zone; C:vesicle membrane;, F:glutamate binding; F:glutamate decarboxylase activity; F:protein N-terminus binding; F:protein-containing complex binding; F:pyridoxal phosphate binding;, P:chemical synaptic transmission; P:gamma-aminobutyric acid biosynthetic process; P:glutamate catabolic process; P:glutamate decarboxylation to succinate; P:locomotory exploration behavior; P:neurotransmitter biosynthetic process; P:neurotransmitter secretion; P:protein-pyridoxal-5-phosphate linkage; P:response to drug; P:social behavior;|Q99259 Q49AK1 Q53TQ7 Q9BU91 Q9UHH4,Glutamate decarboxylase 1,67 kDa glutamic acid decarboxylase;Glutamate decarboxylase 67 kDa isoform;, PF00282;, GO:0043679;GO:0005938;GO:0061202;GO:0060077;GO:0005886;GO:0048786;GO:0012506;GO:0016595;GO:0004351;GO:0047485;GO:0044877;GO:0030170;GO:0007268;GO:0009449;GO:0006538;GO:0006540;GO:0035641;GO:0042136;GO:0007269;GO:0018352;GO:0042493;GO:0035176;, C:axon terminus; C:cell cortex; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:inhibitory synapse; C:plasma membrane; C:presynaptic active zone; C:vesicle membrane;, F:glutamate binding; F:glutamate decarboxylase activity; F:protein N-terminus binding; F:protein-containing complex binding; F:pyridoxal phosphate binding;, P:chemical synaptic transmission; P:gamma-aminobutyric acid biosynthetic process; P:glutamate catabolic process; P:glutamate decarboxylation to succinate; P:locomotory exploration behavior; P:neurotransmitter biosynthetic process; P:neurotransmitter secretion; P:protein-pyridoxal-5-phosphate linkage; P:response to drug; P:social behavior; scaffold9 indexed_genome mRNA 50842814 50844346 . - . ID=transcript_2540;Q99259 Q49AK1 Q53TQ7 Q9BU91 Q9UHH4,Glutamate decarboxylase 1,67 kDa glutamic acid decarboxylase;Glutamate decarboxylase 67 kDa isoform;, PF00282;, GO:0043679;GO:0005938;GO:0061202;GO:0060077;GO:0005886;GO:0048786;GO:0012506;GO:0016595;GO:0004351;GO:0047485;GO:0044877;GO:0030170;GO:0007268;GO:0009449;GO:0006538;GO:0006540;GO:0035641;GO:0042136;GO:0007269;GO:0018352;GO:0042493;GO:0035176;, C:axon terminus; C:cell cortex; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:inhibitory synapse; C:plasma membrane; C:presynaptic active zone; C:vesicle membrane;, F:glutamate binding; F:glutamate decarboxylase activity; F:protein N-terminus binding; F:protein-containing complex binding; F:pyridoxal phosphate binding;, P:chemical synaptic transmission; P:gamma-aminobutyric acid biosynthetic process; P:glutamate catabolic process; P:glutamate decarboxylation to succinate; P:locomotory exploration behavior; P:neurotransmitter biosynthetic process; P:neurotransmitter secretion; P:protein-pyridoxal-5-phosphate linkage; P:response to drug; P:social behavior; scaffold9 indexed_genome mRNA 50893400 50923207 . + . ID=transcript_2541;Q9H8Y8 B4DKT0 Q53TE3 Q96I74 Q96K84 Q9H946 Q9UFW4,Golgi reassembly-stacking protein 2,Golgi phosphoprotein 6;Golgi reassembly-stacking protein of 55 kDa;p59;, PF04495;, GO:0005789;GO:0005794;GO:0000139;GO:0016020;GO:0030154;GO:0061951;GO:0007030;GO:0070925;GO:0006996;GO:0034976;GO:0007283;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:membrane;, , P:cell differentiation; P:establishment of protein localization to plasma membrane; P:Golgi organization; P:organelle assembly; P:organelle organization; P:response to endoplasmic reticulum stress; P:spermatogenesis;|Q9H8Y8 B4DKT0 Q53TE3 Q96I74 Q96K84 Q9H946 Q9UFW4,Golgi reassembly-stacking protein 2,Golgi phosphoprotein 6;Golgi reassembly-stacking protein of 55 kDa;p59;, PF04495;, GO:0005789;GO:0005794;GO:0000139;GO:0016020;GO:0030154;GO:0061951;GO:0007030;GO:0070925;GO:0006996;GO:0034976;GO:0007283;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:membrane;, , P:cell differentiation; P:establishment of protein localization to plasma membrane; P:Golgi organization; P:organelle assembly; P:organelle organization; P:response to endoplasmic reticulum stress; P:spermatogenesis;|Q9H8Y8 B4DKT0 Q53TE3 Q96I74 Q96K84 Q9H946 Q9UFW4,Golgi reassembly-stacking protein 2,Golgi phosphoprotein 6;Golgi reassembly-stacking protein of 55 kDa;p59;, PF04495;, GO:0005789;GO:0005794;GO:0000139;GO:0016020;GO:0030154;GO:0061951;GO:0007030;GO:0070925;GO:0006996;GO:0034976;GO:0007283;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:membrane;, , P:cell differentiation; P:establishment of protein localization to plasma membrane; P:Golgi organization; P:organelle assembly; P:organelle organization; P:response to endoplasmic reticulum stress; P:spermatogenesis; scaffold9 indexed_genome mRNA 50987226 51171986 . - . ID=transcript_2542;Q9UKI8 B3KR15 B4DX87 Q14150 Q8N591 Q9NYH2 Q9Y4F6,Serine/threonine-protein kinase tousled-like 1,PKU-beta;Tousled-like kinase 1;, PF00069;, GO:0005654;GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0006974;GO:0006325;GO:0007059;GO:0006886;GO:0035556;GO:0018105;GO:0006468;GO:0001672;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromosome segregation; P:intracellular protein transport; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of chromatin assembly or disassembly;|Q9UKI8 B3KR15 B4DX87 Q14150 Q8N591 Q9NYH2 Q9Y4F6,Serine/threonine-protein kinase tousled-like 1,PKU-beta;Tousled-like kinase 1;, PF00069;, GO:0005654;GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0006974;GO:0006325;GO:0007059;GO:0006886;GO:0035556;GO:0018105;GO:0006468;GO:0001672;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromosome segregation; P:intracellular protein transport; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of chromatin assembly or disassembly;|Q9UKI8 B3KR15 B4DX87 Q14150 Q8N591 Q9NYH2 Q9Y4F6,Serine/threonine-protein kinase tousled-like 1,PKU-beta;Tousled-like kinase 1;, PF00069;, GO:0005654;GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0006974;GO:0006325;GO:0007059;GO:0006886;GO:0035556;GO:0018105;GO:0006468;GO:0001672;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromosome segregation; P:intracellular protein transport; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of chromatin assembly or disassembly;|Q9UKI8 B3KR15 B4DX87 Q14150 Q8N591 Q9NYH2 Q9Y4F6,Serine/threonine-protein kinase tousled-like 1,PKU-beta;Tousled-like kinase 1;, PF00069;, GO:0005654;GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0006974;GO:0006325;GO:0007059;GO:0006886;GO:0035556;GO:0018105;GO:0006468;GO:0001672;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromosome segregation; P:intracellular protein transport; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of chromatin assembly or disassembly; scaffold9 indexed_genome mRNA 51330882 51349257 . - . ID=transcript_2543;Q9H825 Q53TM9 Q53TQ0,mRNA N(3)-methylcytidine methyltransferase METTL8 {ECO:0000305},Methyltransferase-like protein 8 {ECO:0000305};, PF13649;, GO:0005737;GO:0005634;GO:0008174;GO:0052735;GO:0080009;, C:cytoplasm; C:nucleus;, F:mRNA methyltransferase activity; F:tRNA (cytosine-3-)-methyltransferase activity;, P:mRNA methylation; scaffold9 indexed_genome mRNA 51417952 51452889 . + . ID=transcript_2544;Q5H9S7 B2RTW5 Q53TN3 Q9H908,DDB1- and CUL4-associated factor 17,, PF15802;, GO:0080008;GO:0005829;GO:0016021;GO:0005730;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytosol; C:integral component of membrane; C:nucleolus; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q5H9S7 B2RTW5 Q53TN3 Q9H908,DDB1- and CUL4-associated factor 17,, PF15802;, GO:0080008;GO:0005829;GO:0016021;GO:0005730;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytosol; C:integral component of membrane; C:nucleolus; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q5H9S7 B2RTW5 Q53TN3 Q9H908,DDB1- and CUL4-associated factor 17,, PF15802;, GO:0080008;GO:0005829;GO:0016021;GO:0005730;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytosol; C:integral component of membrane; C:nucleolus; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q5H9S7 B2RTW5 Q53TN3 Q9H908,DDB1- and CUL4-associated factor 17,, PF15802;, GO:0080008;GO:0005829;GO:0016021;GO:0005730;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytosol; C:integral component of membrane; C:nucleolus; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination; scaffold9 indexed_genome mRNA 51501151 51543094 . + . ID=transcript_2545;Q53TN4 B2RE79 B4DWD7 Q6KC16 Q6KC17 Q6P147 Q6ZR51 Q9H0Q8 Q9H5G5,Plasma membrane ascorbate-dependent reductase CYBRD1 {ECO:0000305|PubMed:17068337, ECO:0000305|PubMed:30272000},Cytochrome b reductase 1 {ECO:0000312|HGNC:HGNC:20797};Duodenal cytochrome b {ECO:0000303|PubMed:12949720};Ferric-chelate reductase 3;, PF03188;, GO:0016324;GO:0031526;GO:0070062;GO:0016021;GO:0005765;GO:0005886;GO:0000293;GO:0042802;GO:0046872;GO:0016491;GO:0016722;GO:0140571;GO:0140575;GO:0006879;GO:0033215;GO:0010039;, C:apical plasma membrane; C:brush border membrane; C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane;, F:ferric-chelate reductase activity; F:identical protein binding; F:metal ion binding; F:oxidoreductase activity; F:oxidoreductase activity, oxidizing metal ions; F:transmembrane ascorbate ferrireductase activity; F:transmembrane monodehydroascorbate reductase activity;, P:cellular iron ion homeostasis; P:reductive iron assimilation; P:response to iron ion;|Q53TN4 B2RE79 B4DWD7 Q6KC16 Q6KC17 Q6P147 Q6ZR51 Q9H0Q8 Q9H5G5,Plasma membrane ascorbate-dependent reductase CYBRD1 {ECO:0000305|PubMed:17068337, ECO:0000305|PubMed:30272000},Cytochrome b reductase 1 {ECO:0000312|HGNC:HGNC:20797};Duodenal cytochrome b {ECO:0000303|PubMed:12949720};Ferric-chelate reductase 3;, PF03188;, GO:0016324;GO:0031526;GO:0070062;GO:0016021;GO:0005765;GO:0005886;GO:0000293;GO:0042802;GO:0046872;GO:0016491;GO:0016722;GO:0140571;GO:0140575;GO:0006879;GO:0033215;GO:0010039;, C:apical plasma membrane; C:brush border membrane; C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane;, F:ferric-chelate reductase activity; F:identical protein binding; F:metal ion binding; F:oxidoreductase activity; F:oxidoreductase activity, oxidizing metal ions; F:transmembrane ascorbate ferrireductase activity; F:transmembrane monodehydroascorbate reductase activity;, P:cellular iron ion homeostasis; P:reductive iron assimilation; P:response to iron ion;|Q53TN4 B2RE79 B4DWD7 Q6KC16 Q6KC17 Q6P147 Q6ZR51 Q9H0Q8 Q9H5G5,Plasma membrane ascorbate-dependent reductase CYBRD1 {ECO:0000305|PubMed:17068337, ECO:0000305|PubMed:30272000},Cytochrome b reductase 1 {ECO:0000312|HGNC:HGNC:20797};Duodenal cytochrome b {ECO:0000303|PubMed:12949720};Ferric-chelate reductase 3;, PF03188;, GO:0016324;GO:0031526;GO:0070062;GO:0016021;GO:0005765;GO:0005886;GO:0000293;GO:0042802;GO:0046872;GO:0016491;GO:0016722;GO:0140571;GO:0140575;GO:0006879;GO:0033215;GO:0010039;, C:apical plasma membrane; C:brush border membrane; C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane;, F:ferric-chelate reductase activity; F:identical protein binding; F:metal ion binding; F:oxidoreductase activity; F:oxidoreductase activity, oxidizing metal ions; F:transmembrane ascorbate ferrireductase activity; F:transmembrane monodehydroascorbate reductase activity;, P:cellular iron ion homeostasis; P:reductive iron assimilation; P:response to iron ion; scaffold9 indexed_genome mRNA 51631462 51685846 . + . ID=transcript_2546;Q96NG7 Q96S87 Q9BXZ5 Q9NT58,Cytoplasmic dynein 1 intermediate chain 2,Cytoplasmic dynein intermediate chain 2;Dynein intermediate chain 2, cytosolic;, PF11540;PF00400;, GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005874;GO:0031982;GO:0045504;GO:0045503;GO:0003777;GO:0035973;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0007018;GO:0007052;GO:0010389;GO:0010970;GO:0019058;, C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:microtubule; C:vesicle;, F:dynein heavy chain binding; F:dynein light chain binding; F:microtubule motor activity;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:microtubule-based movement; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle; P:transport along microtubule; P:viral life cycle;|Q96NG7 Q96S87 Q9BXZ5 Q9NT58,Cytoplasmic dynein 1 intermediate chain 2,Cytoplasmic dynein intermediate chain 2;Dynein intermediate chain 2, cytosolic;, PF11540;PF00400;, GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005874;GO:0031982;GO:0045504;GO:0045503;GO:0003777;GO:0035973;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0007018;GO:0007052;GO:0010389;GO:0010970;GO:0019058;, C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:microtubule; C:vesicle;, F:dynein heavy chain binding; F:dynein light chain binding; F:microtubule motor activity;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:microtubule-based movement; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle; P:transport along microtubule; P:viral life cycle;|O14576 B4DME3 F5H050 G5E9K1 Q8TBF7 Q9Y2X1,Cytoplasmic dynein 1 intermediate chain 1,Cytoplasmic dynein intermediate chain 1;Dynein intermediate chain 1, cytosolic;, PF11540;PF00400;, GO:0000777;GO:0005737;GO:0005868;GO:0036464;GO:0005829;GO:0000776;GO:0005874;GO:0005634;GO:0048471;GO:0055037;GO:0000922;GO:0031982;GO:0045504;GO:0045503;GO:0008017;GO:0003777;GO:0003774;GO:0030507;GO:0035973;GO:0019886;GO:0006888;GO:0007018;GO:0007052;GO:0010970;GO:0047496;GO:0019058;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic dynein complex; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:kinetochore; C:microtubule; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome; C:spindle pole; C:vesicle;, F:dynein heavy chain binding; F:dynein light chain binding; F:microtubule binding; F:microtubule motor activity; F:motor activity; F:spectrin binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule-based movement; P:mitotic spindle organization; P:transport along microtubule; P:vesicle transport along microtubule; P:viral life cycle;|Q96NG7 Q96S87 Q9BXZ5 Q9NT58,Cytoplasmic dynein 1 intermediate chain 2,Cytoplasmic dynein intermediate chain 2;Dynein intermediate chain 2, cytosolic;, PF11540;PF00400;, GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005874;GO:0031982;GO:0045504;GO:0045503;GO:0003777;GO:0035973;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0007018;GO:0007052;GO:0010389;GO:0010970;GO:0019058;, C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:microtubule; C:vesicle;, F:dynein heavy chain binding; F:dynein light chain binding; F:microtubule motor activity;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:microtubule-based movement; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle; P:transport along microtubule; P:viral life cycle;|Q96NG7 Q96S87 Q9BXZ5 Q9NT58,Cytoplasmic dynein 1 intermediate chain 2,Cytoplasmic dynein intermediate chain 2;Dynein intermediate chain 2, cytosolic;, PF11540;PF00400;, GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005874;GO:0031982;GO:0045504;GO:0045503;GO:0003777;GO:0035973;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0007018;GO:0007052;GO:0010389;GO:0010970;GO:0019058;, C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:microtubule; C:vesicle;, F:dynein heavy chain binding; F:dynein light chain binding; F:microtubule motor activity;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:microtubule-based movement; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle; P:transport along microtubule; P:viral life cycle;|Q96NG7 Q96S87 Q9BXZ5 Q9NT58,Cytoplasmic dynein 1 intermediate chain 2,Cytoplasmic dynein intermediate chain 2;Dynein intermediate chain 2, cytosolic;, PF11540;PF00400;, GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005874;GO:0031982;GO:0045504;GO:0045503;GO:0003777;GO:0035973;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0007018;GO:0007052;GO:0010389;GO:0010970;GO:0019058;, C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:microtubule; C:vesicle;, F:dynein heavy chain binding; F:dynein light chain binding; F:microtubule motor activity;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:microtubule-based movement; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle; P:transport along microtubule; P:viral life cycle;|Q96NG7 Q96S87 Q9BXZ5 Q9NT58,Cytoplasmic dynein 1 intermediate chain 2,Cytoplasmic dynein intermediate chain 2;Dynein intermediate chain 2, cytosolic;, PF11540;PF00400;, GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005874;GO:0031982;GO:0045504;GO:0045503;GO:0003777;GO:0035973;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0007018;GO:0007052;GO:0010389;GO:0010970;GO:0019058;, C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:microtubule; C:vesicle;, F:dynein heavy chain binding; F:dynein light chain binding; F:microtubule motor activity;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:microtubule-based movement; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle; P:transport along microtubule; P:viral life cycle;|Q96NG7 Q96S87 Q9BXZ5 Q9NT58,Cytoplasmic dynein 1 intermediate chain 2,Cytoplasmic dynein intermediate chain 2;Dynein intermediate chain 2, cytosolic;, PF11540;PF00400;, GO:0005813;GO:0005737;GO:0005868;GO:0005829;GO:0005874;GO:0031982;GO:0045504;GO:0045503;GO:0003777;GO:0035973;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0007018;GO:0007052;GO:0010389;GO:0010970;GO:0019058;, C:centrosome; C:cytoplasm; C:cytoplasmic dynein complex; C:cytosol; C:microtubule; C:vesicle;, F:dynein heavy chain binding; F:dynein light chain binding; F:microtubule motor activity;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:microtubule-based movement; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle; P:transport along microtubule; P:viral life cycle; scaffold9 indexed_genome mRNA 51712862 51720642 . - . ID=transcript_2547;O75746 B3KR64 Q96AM8,Calcium-binding mitochondrial carrier protein Aralar1,Mitochondrial aspartate glutamate carrier 1;Solute carrier family 25 member 12;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005509;GO:0042802;GO:0015183;GO:0005313;GO:0022857;GO:0009066;GO:0015810;GO:0006094;GO:0006537;GO:0015813;GO:0043490;GO:1904024;GO:2001171;GO:0010907;GO:0031643;GO:0051592;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:identical protein binding; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:transmembrane transporter activity;, P:aspartate family amino acid metabolic process; P:aspartate transmembrane transport; P:gluconeogenesis; P:glutamate biosynthetic process; P:L-glutamate transmembrane transport; P:malate-aspartate shuttle; P:negative regulation of glucose catabolic process to lactate via pyruvate; P:positive regulation of ATP biosynthetic process; P:positive regulation of glucose metabolic process; P:positive regulation of myelination; P:response to calcium ion; scaffold9 indexed_genome mRNA 51721617 51817312 . - . ID=transcript_2548;O75746 B3KR64 Q96AM8,Calcium-binding mitochondrial carrier protein Aralar1,Mitochondrial aspartate glutamate carrier 1;Solute carrier family 25 member 12;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005509;GO:0042802;GO:0015183;GO:0005313;GO:0022857;GO:0009066;GO:0015810;GO:0006094;GO:0006537;GO:0015813;GO:0043490;GO:1904024;GO:2001171;GO:0010907;GO:0031643;GO:0051592;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:identical protein binding; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:transmembrane transporter activity;, P:aspartate family amino acid metabolic process; P:aspartate transmembrane transport; P:gluconeogenesis; P:glutamate biosynthetic process; P:L-glutamate transmembrane transport; P:malate-aspartate shuttle; P:negative regulation of glucose catabolic process to lactate via pyruvate; P:positive regulation of ATP biosynthetic process; P:positive regulation of glucose metabolic process; P:positive regulation of myelination; P:response to calcium ion;|O75746 B3KR64 Q96AM8,Calcium-binding mitochondrial carrier protein Aralar1,Mitochondrial aspartate glutamate carrier 1;Solute carrier family 25 member 12;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005509;GO:0042802;GO:0015183;GO:0005313;GO:0022857;GO:0009066;GO:0015810;GO:0006094;GO:0006537;GO:0015813;GO:0043490;GO:1904024;GO:2001171;GO:0010907;GO:0031643;GO:0051592;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:identical protein binding; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:transmembrane transporter activity;, P:aspartate family amino acid metabolic process; P:aspartate transmembrane transport; P:gluconeogenesis; P:glutamate biosynthetic process; P:L-glutamate transmembrane transport; P:malate-aspartate shuttle; P:negative regulation of glucose catabolic process to lactate via pyruvate; P:positive regulation of ATP biosynthetic process; P:positive regulation of glucose metabolic process; P:positive regulation of myelination; P:response to calcium ion;|O75746 B3KR64 Q96AM8,Calcium-binding mitochondrial carrier protein Aralar1,Mitochondrial aspartate glutamate carrier 1;Solute carrier family 25 member 12;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005509;GO:0042802;GO:0015183;GO:0005313;GO:0022857;GO:0009066;GO:0015810;GO:0006094;GO:0006537;GO:0015813;GO:0043490;GO:1904024;GO:2001171;GO:0010907;GO:0031643;GO:0051592;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:identical protein binding; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:transmembrane transporter activity;, P:aspartate family amino acid metabolic process; P:aspartate transmembrane transport; P:gluconeogenesis; P:glutamate biosynthetic process; P:L-glutamate transmembrane transport; P:malate-aspartate shuttle; P:negative regulation of glucose catabolic process to lactate via pyruvate; P:positive regulation of ATP biosynthetic process; P:positive regulation of glucose metabolic process; P:positive regulation of myelination; P:response to calcium ion; scaffold9 indexed_genome mRNA 51861639 51894863 . + . ID=transcript_2549;O14929 Q49A44 Q53QF0 Q53SU4 Q6P594 Q8WWB9,Histone acetyltransferase type B catalytic subunit,Histone acetyltransferase 1;, PF10394;, GO:0000785;GO:0000781;GO:0005737;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0010485;GO:0004402;GO:0042393;GO:0006348;GO:0006323;GO:0006335;GO:0006336;GO:0043967;GO:0006475;GO:0007584;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding;, P:chromatin silencing at telomere; P:DNA packaging; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:histone H4 acetylation; P:internal protein amino acid acetylation; P:response to nutrient;|O14929 Q49A44 Q53QF0 Q53SU4 Q6P594 Q8WWB9,Histone acetyltransferase type B catalytic subunit,Histone acetyltransferase 1;, PF10394;, GO:0000785;GO:0000781;GO:0005737;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0010485;GO:0004402;GO:0042393;GO:0006348;GO:0006323;GO:0006335;GO:0006336;GO:0043967;GO:0006475;GO:0007584;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding;, P:chromatin silencing at telomere; P:DNA packaging; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:histone H4 acetylation; P:internal protein amino acid acetylation; P:response to nutrient;|O14929 Q49A44 Q53QF0 Q53SU4 Q6P594 Q8WWB9,Histone acetyltransferase type B catalytic subunit,Histone acetyltransferase 1;, PF10394;, GO:0000785;GO:0000781;GO:0005737;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0010485;GO:0004402;GO:0042393;GO:0006348;GO:0006323;GO:0006335;GO:0006336;GO:0043967;GO:0006475;GO:0007584;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding;, P:chromatin silencing at telomere; P:DNA packaging; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:histone H4 acetylation; P:internal protein amino acid acetylation; P:response to nutrient; scaffold9 indexed_genome mRNA 51910117 51981118 . + . ID=transcript_2550;Q6UB28 Q1WNX3,Methionine aminopeptidase 1D, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03174},Methionyl aminopeptidase type 1D, mitochondrial;Peptidase M 1D {ECO:0000255|HAMAP-Rule:MF_03174};, PF00557;, GO:0005739;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0031365;GO:0018206;GO:0070084;, C:mitochondrion;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal;|Q6UB28 Q1WNX3,Methionine aminopeptidase 1D, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03174},Methionyl aminopeptidase type 1D, mitochondrial;Peptidase M 1D {ECO:0000255|HAMAP-Rule:MF_03174};, PF00557;, GO:0005739;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0031365;GO:0018206;GO:0070084;, C:mitochondrion;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal;|Q6UB28 Q1WNX3,Methionine aminopeptidase 1D, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03174},Methionyl aminopeptidase type 1D, mitochondrial;Peptidase M 1D {ECO:0000255|HAMAP-Rule:MF_03174};, PF00557;, GO:0005739;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0031365;GO:0018206;GO:0070084;, C:mitochondrion;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal;|Q6UB28 Q1WNX3,Methionine aminopeptidase 1D, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03174},Methionyl aminopeptidase type 1D, mitochondrial;Peptidase M 1D {ECO:0000255|HAMAP-Rule:MF_03174};, PF00557;, GO:0005739;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0031365;GO:0018206;GO:0070084;, C:mitochondrion;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal;|Q6UB28 Q1WNX3,Methionine aminopeptidase 1D, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03174},Methionyl aminopeptidase type 1D, mitochondrial;Peptidase M 1D {ECO:0000255|HAMAP-Rule:MF_03174};, PF00557;, GO:0005739;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0031365;GO:0018206;GO:0070084;, C:mitochondrion;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal;|Q6UB28 Q1WNX3,Methionine aminopeptidase 1D, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03174},Methionyl aminopeptidase type 1D, mitochondrial;Peptidase M 1D {ECO:0000255|HAMAP-Rule:MF_03174};, PF00557;, GO:0005739;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0031365;GO:0018206;GO:0070084;, C:mitochondrion;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal; scaffold9 indexed_genome mRNA 52315089 52360095 . + . ID=transcript_2551;Q16508 Q53RX7 Q59HB7 Q86VL6 Q9UCT1 Q9UN03,Integrin alpha-6,CD49 antigen-like family member F;VLA-6;, PF01839;PF08441;, GO:0005912;GO:0009986;GO:0030175;GO:0005925;GO:0034676;GO:0005886;GO:0045296;GO:0031994;GO:0043236;GO:0046872;GO:0038132;GO:0044877;GO:0098609;GO:0031589;GO:0007044;GO:0071407;GO:0030199;GO:0010668;GO:0030198;GO:0031581;GO:0007229;GO:0050900;GO:0035878;GO:2001237;GO:0043065;GO:0030335;GO:0010811;GO:0043547;GO:0010976;GO:0042327;GO:0045944;GO:0043589;, C:adherens junction; C:cell surface; C:filopodium; C:focal adhesion; C:integrin alpha6-beta4 complex; C:plasma membrane;, F:cadherin binding; F:insulin-like growth factor I binding; F:laminin binding; F:metal ion binding; F:neuregulin binding; F:protein-containing complex binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:cell-substrate junction assembly; P:cellular response to organic cyclic compound; P:collagen fibril organization; P:ectodermal cell differentiation; P:extracellular matrix organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:leukocyte migration; P:nail development; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:skin morphogenesis;|Q16508 Q53RX7 Q59HB7 Q86VL6 Q9UCT1 Q9UN03,Integrin alpha-6,CD49 antigen-like family member F;VLA-6;, PF01839;PF08441;, GO:0005912;GO:0009986;GO:0030175;GO:0005925;GO:0034676;GO:0005886;GO:0045296;GO:0031994;GO:0043236;GO:0046872;GO:0038132;GO:0044877;GO:0098609;GO:0031589;GO:0007044;GO:0071407;GO:0030199;GO:0010668;GO:0030198;GO:0031581;GO:0007229;GO:0050900;GO:0035878;GO:2001237;GO:0043065;GO:0030335;GO:0010811;GO:0043547;GO:0010976;GO:0042327;GO:0045944;GO:0043589;, C:adherens junction; C:cell surface; C:filopodium; C:focal adhesion; C:integrin alpha6-beta4 complex; C:plasma membrane;, F:cadherin binding; F:insulin-like growth factor I binding; F:laminin binding; F:metal ion binding; F:neuregulin binding; F:protein-containing complex binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:cell-substrate junction assembly; P:cellular response to organic cyclic compound; P:collagen fibril organization; P:ectodermal cell differentiation; P:extracellular matrix organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:leukocyte migration; P:nail development; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:skin morphogenesis; scaffold9 indexed_genome mRNA 52382648 52428353 . + . ID=transcript_2552;Q15118 B2R6T1 B7Z937 D3DPD8 E9PD65 Q308M4,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial,Pyruvate dehydrogenase kinase isoform 1;, PF10436;PF02518;, GO:0005759;GO:0005967;GO:0005739;GO:0005524;GO:0004672;GO:0004740;GO:0008283;GO:0006006;GO:0097411;GO:0008631;GO:0006468;GO:0010510;GO:0010906;, C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion;, F:ATP binding; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cell population proliferation; P:glucose metabolic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:protein phosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of glucose metabolic process;|Q15118 B2R6T1 B7Z937 D3DPD8 E9PD65 Q308M4,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial,Pyruvate dehydrogenase kinase isoform 1;, PF10436;PF02518;, GO:0005759;GO:0005967;GO:0005739;GO:0005524;GO:0004672;GO:0004740;GO:0008283;GO:0006006;GO:0097411;GO:0008631;GO:0006468;GO:0010510;GO:0010906;, C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion;, F:ATP binding; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cell population proliferation; P:glucose metabolic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:protein phosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of glucose metabolic process;|Q15118 B2R6T1 B7Z937 D3DPD8 E9PD65 Q308M4,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial,Pyruvate dehydrogenase kinase isoform 1;, PF10436;PF02518;, GO:0005759;GO:0005967;GO:0005739;GO:0005524;GO:0004672;GO:0004740;GO:0008283;GO:0006006;GO:0097411;GO:0008631;GO:0006468;GO:0010510;GO:0010906;, C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion;, F:ATP binding; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cell population proliferation; P:glucose metabolic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:protein phosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of glucose metabolic process;|Q15118 B2R6T1 B7Z937 D3DPD8 E9PD65 Q308M4,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial,Pyruvate dehydrogenase kinase isoform 1;, PF10436;PF02518;, GO:0005759;GO:0005967;GO:0005739;GO:0005524;GO:0004672;GO:0004740;GO:0008283;GO:0006006;GO:0097411;GO:0008631;GO:0006468;GO:0010510;GO:0010906;, C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion;, F:ATP binding; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cell population proliferation; P:glucose metabolic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:protein phosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of glucose metabolic process; scaffold9 indexed_genome mRNA 52509820 52822613 . + . ID=transcript_2553;Q8WZA2 B2R7R3 B7Z283 B7Z3T6 B7Z912 O95636 Q8IXK6 Q8TAA4,Rap guanine nucleotide exchange factor 4,Exchange factor directly activated by cAMP 2;Exchange protein directly activated by cAMP 2;cAMP-regulated guanine nucleotide exchange factor II;, PF00027;PF00610;PF00617;PF00618;, GO:0005829;GO:0098686;GO:0016020;GO:0005886;GO:0030552;GO:0005085;GO:0031267;GO:0002250;GO:0017156;GO:0019933;GO:0007186;GO:0030073;GO:0017157;GO:0050796;GO:0098693;GO:0007264;, C:cytosol; C:hippocampal mossy fiber to CA3 synapse; C:membrane; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:adaptive immune response; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:insulin secretion; P:regulation of exocytosis; P:regulation of insulin secretion; P:regulation of synaptic vesicle cycle; P:small GTPase mediated signal transduction;|Q8WZA2 B2R7R3 B7Z283 B7Z3T6 B7Z912 O95636 Q8IXK6 Q8TAA4,Rap guanine nucleotide exchange factor 4,Exchange factor directly activated by cAMP 2;Exchange protein directly activated by cAMP 2;cAMP-regulated guanine nucleotide exchange factor II;, PF00027;PF00610;PF00617;PF00618;, GO:0005829;GO:0098686;GO:0016020;GO:0005886;GO:0030552;GO:0005085;GO:0031267;GO:0002250;GO:0017156;GO:0019933;GO:0007186;GO:0030073;GO:0017157;GO:0050796;GO:0098693;GO:0007264;, C:cytosol; C:hippocampal mossy fiber to CA3 synapse; C:membrane; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:adaptive immune response; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:insulin secretion; P:regulation of exocytosis; P:regulation of insulin secretion; P:regulation of synaptic vesicle cycle; P:small GTPase mediated signal transduction;|Q8WZA2 B2R7R3 B7Z283 B7Z3T6 B7Z912 O95636 Q8IXK6 Q8TAA4,Rap guanine nucleotide exchange factor 4,Exchange factor directly activated by cAMP 2;Exchange protein directly activated by cAMP 2;cAMP-regulated guanine nucleotide exchange factor II;, PF00027;PF00610;PF00617;PF00618;, GO:0005829;GO:0098686;GO:0016020;GO:0005886;GO:0030552;GO:0005085;GO:0031267;GO:0002250;GO:0017156;GO:0019933;GO:0007186;GO:0030073;GO:0017157;GO:0050796;GO:0098693;GO:0007264;, C:cytosol; C:hippocampal mossy fiber to CA3 synapse; C:membrane; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:adaptive immune response; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:insulin secretion; P:regulation of exocytosis; P:regulation of insulin secretion; P:regulation of synaptic vesicle cycle; P:small GTPase mediated signal transduction;|Q8WZA2 B2R7R3 B7Z283 B7Z3T6 B7Z912 O95636 Q8IXK6 Q8TAA4,Rap guanine nucleotide exchange factor 4,Exchange factor directly activated by cAMP 2;Exchange protein directly activated by cAMP 2;cAMP-regulated guanine nucleotide exchange factor II;, PF00027;PF00610;PF00617;PF00618;, GO:0005829;GO:0098686;GO:0016020;GO:0005886;GO:0030552;GO:0005085;GO:0031267;GO:0002250;GO:0017156;GO:0019933;GO:0007186;GO:0030073;GO:0017157;GO:0050796;GO:0098693;GO:0007264;, C:cytosol; C:hippocampal mossy fiber to CA3 synapse; C:membrane; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:adaptive immune response; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:insulin secretion; P:regulation of exocytosis; P:regulation of insulin secretion; P:regulation of synaptic vesicle cycle; P:small GTPase mediated signal transduction;|Q8WZA2 B2R7R3 B7Z283 B7Z3T6 B7Z912 O95636 Q8IXK6 Q8TAA4,Rap guanine nucleotide exchange factor 4,Exchange factor directly activated by cAMP 2;Exchange protein directly activated by cAMP 2;cAMP-regulated guanine nucleotide exchange factor II;, PF00027;PF00610;PF00617;PF00618;, GO:0005829;GO:0098686;GO:0016020;GO:0005886;GO:0030552;GO:0005085;GO:0031267;GO:0002250;GO:0017156;GO:0019933;GO:0007186;GO:0030073;GO:0017157;GO:0050796;GO:0098693;GO:0007264;, C:cytosol; C:hippocampal mossy fiber to CA3 synapse; C:membrane; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:adaptive immune response; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:insulin secretion; P:regulation of exocytosis; P:regulation of insulin secretion; P:regulation of synaptic vesicle cycle; P:small GTPase mediated signal transduction;|Q8WZA2 B2R7R3 B7Z283 B7Z3T6 B7Z912 O95636 Q8IXK6 Q8TAA4,Rap guanine nucleotide exchange factor 4,Exchange factor directly activated by cAMP 2;Exchange protein directly activated by cAMP 2;cAMP-regulated guanine nucleotide exchange factor II;, PF00027;PF00610;PF00617;PF00618;, GO:0005829;GO:0098686;GO:0016020;GO:0005886;GO:0030552;GO:0005085;GO:0031267;GO:0002250;GO:0017156;GO:0019933;GO:0007186;GO:0030073;GO:0017157;GO:0050796;GO:0098693;GO:0007264;, C:cytosol; C:hippocampal mossy fiber to CA3 synapse; C:membrane; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:adaptive immune response; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:insulin secretion; P:regulation of exocytosis; P:regulation of insulin secretion; P:regulation of synaptic vesicle cycle; P:small GTPase mediated signal transduction; scaffold9 indexed_genome mRNA 52876208 52980443 . + . ID=transcript_2554;Q9NYE9,Mitogen-activated protein kinase kinase kinase 20 {ECO:0000312|HGNC:HGNC:17797},Human cervical cancer suppressor gene 4 protein;Leucine zipper- and sterile alpha motif-containing kinase;MLK-like mitogen-activated protein triple kinase;Mitogen-activated protein kinase kinase kinase MLT;Mixed lineage kinase-related kinase;Sterile alpha motif- and leucine zipper-containing kinase AZK;, PF07714;PF00536;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0000287;GO:0004709;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0007257;GO:0000186;GO:0007050;GO:0008219;GO:0030154;GO:0071480;GO:0007010;GO:0000077;GO:0042733;GO:0060173;GO:0043065;GO:1904291;GO:0006468;GO:0051403;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase kinase kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:activation of JUN kinase activity; P:activation of MAPKK activity; P:cell cycle arrest; P:cell death; P:cell differentiation; P:cellular response to gamma radiation; P:cytoskeleton organization; P:DNA damage checkpoint; P:embryonic digit morphogenesis; P:limb development; P:positive regulation of apoptotic process; P:positive regulation of mitotic DNA damage checkpoint; P:protein phosphorylation; P:stress-activated MAPK cascade; scaffold9 indexed_genome mRNA 52987924 53023818 . + . ID=transcript_2555;Q9NYE9,Mitogen-activated protein kinase kinase kinase 20 {ECO:0000312|HGNC:HGNC:17797},Human cervical cancer suppressor gene 4 protein;Leucine zipper- and sterile alpha motif-containing kinase;MLK-like mitogen-activated protein triple kinase;Mitogen-activated protein kinase kinase kinase MLT;Mixed lineage kinase-related kinase;Sterile alpha motif- and leucine zipper-containing kinase AZK;, PF07714;PF00536;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0000287;GO:0004709;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0007257;GO:0000186;GO:0007050;GO:0008219;GO:0030154;GO:0071480;GO:0007010;GO:0000077;GO:0042733;GO:0060173;GO:0043065;GO:1904291;GO:0006468;GO:0051403;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase kinase kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:activation of JUN kinase activity; P:activation of MAPKK activity; P:cell cycle arrest; P:cell death; P:cell differentiation; P:cellular response to gamma radiation; P:cytoskeleton organization; P:DNA damage checkpoint; P:embryonic digit morphogenesis; P:limb development; P:positive regulation of apoptotic process; P:positive regulation of mitotic DNA damage checkpoint; P:protein phosphorylation; P:stress-activated MAPK cascade; scaffold9 indexed_genome mRNA 53073510 53086484 . + . ID=transcript_2556;Q96SP5,Cell division cycle-associated protein 7,Protein JPO1;, PF10497;, GO:0005829;GO:0005654;GO:0005634;GO:0006915;GO:0042127;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, , P:apoptotic process; P:regulation of cell population proliferation; P:regulation of transcription, DNA-templated; scaffold9 indexed_genome mRNA 53542392 53549300 . - . ID=transcript_2557;Q02447 A0AVL9 B4E2B7 Q69B26 Q69B27 Q8TD56 Q8WWU4 Q9BQR1,Transcription factor Sp3,SPR-2;, PF00096;, GO:0000785;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0017053;GO:0003682;GO:0000987;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:1990837;GO:0030183;GO:0060216;GO:0048596;GO:0001892;GO:0060136;GO:0048706;GO:0043353;GO:0030851;GO:0001889;GO:0030324;GO:0030219;GO:0030224;GO:0001779;GO:0045892;GO:0001503;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0030217;GO:0001829;, C:chromatin; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex; C:transcription repressor complex;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:B cell differentiation; P:definitive hemopoiesis; P:embryonic camera-type eye morphogenesis; P:embryonic placenta development; P:embryonic process involved in female pregnancy; P:embryonic skeletal system development; P:enucleate erythrocyte differentiation; P:granulocyte differentiation; P:liver development; P:lung development; P:megakaryocyte differentiation; P:monocyte differentiation; P:natural killer cell differentiation; P:negative regulation of transcription, DNA-templated; P:ossification; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:T cell differentiation; P:trophectodermal cell differentiation;|Q02447 A0AVL9 B4E2B7 Q69B26 Q69B27 Q8TD56 Q8WWU4 Q9BQR1,Transcription factor Sp3,SPR-2;, PF00096;, GO:0000785;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0017053;GO:0003682;GO:0000987;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:1990837;GO:0030183;GO:0060216;GO:0048596;GO:0001892;GO:0060136;GO:0048706;GO:0043353;GO:0030851;GO:0001889;GO:0030324;GO:0030219;GO:0030224;GO:0001779;GO:0045892;GO:0001503;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0030217;GO:0001829;, C:chromatin; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex; C:transcription repressor complex;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:B cell differentiation; P:definitive hemopoiesis; P:embryonic camera-type eye morphogenesis; P:embryonic placenta development; P:embryonic process involved in female pregnancy; P:embryonic skeletal system development; P:enucleate erythrocyte differentiation; P:granulocyte differentiation; P:liver development; P:lung development; P:megakaryocyte differentiation; P:monocyte differentiation; P:natural killer cell differentiation; P:negative regulation of transcription, DNA-templated; P:ossification; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:T cell differentiation; P:trophectodermal cell differentiation; scaffold9 indexed_genome mRNA 53550426 53588224 . - . ID=transcript_2558;Q02447 A0AVL9 B4E2B7 Q69B26 Q69B27 Q8TD56 Q8WWU4 Q9BQR1,Transcription factor Sp3,SPR-2;, PF00096;, GO:0000785;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0017053;GO:0003682;GO:0000987;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:1990837;GO:0030183;GO:0060216;GO:0048596;GO:0001892;GO:0060136;GO:0048706;GO:0043353;GO:0030851;GO:0001889;GO:0030324;GO:0030219;GO:0030224;GO:0001779;GO:0045892;GO:0001503;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0030217;GO:0001829;, C:chromatin; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex; C:transcription repressor complex;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:B cell differentiation; P:definitive hemopoiesis; P:embryonic camera-type eye morphogenesis; P:embryonic placenta development; P:embryonic process involved in female pregnancy; P:embryonic skeletal system development; P:enucleate erythrocyte differentiation; P:granulocyte differentiation; P:liver development; P:lung development; P:megakaryocyte differentiation; P:monocyte differentiation; P:natural killer cell differentiation; P:negative regulation of transcription, DNA-templated; P:ossification; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:T cell differentiation; P:trophectodermal cell differentiation;|Q02447 A0AVL9 B4E2B7 Q69B26 Q69B27 Q8TD56 Q8WWU4 Q9BQR1,Transcription factor Sp3,SPR-2;, PF00096;, GO:0000785;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0017053;GO:0003682;GO:0000987;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:1990837;GO:0030183;GO:0060216;GO:0048596;GO:0001892;GO:0060136;GO:0048706;GO:0043353;GO:0030851;GO:0001889;GO:0030324;GO:0030219;GO:0030224;GO:0001779;GO:0045892;GO:0001503;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0030217;GO:0001829;, C:chromatin; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex; C:transcription repressor complex;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:B cell differentiation; P:definitive hemopoiesis; P:embryonic camera-type eye morphogenesis; P:embryonic placenta development; P:embryonic process involved in female pregnancy; P:embryonic skeletal system development; P:enucleate erythrocyte differentiation; P:granulocyte differentiation; P:liver development; P:lung development; P:megakaryocyte differentiation; P:monocyte differentiation; P:natural killer cell differentiation; P:negative regulation of transcription, DNA-templated; P:ossification; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:T cell differentiation; P:trophectodermal cell differentiation; scaffold9 indexed_genome mRNA 53704359 53860049 . - . ID=transcript_2559;Q9NTK5 D7EHM2 Q5BJD7 Q8NCI8 Q96CU1 Q96SV2 Q9P1D3 Q9UNY9 Q9Y6G4,Obg-like ATPase 1 {ECO:0000255|HAMAP-Rule:MF_03167},DNA damage-regulated overexpressed in cancer 45;GTP-binding protein 9;, PF01926;PF06071;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0031093;GO:0005524;GO:0016887;GO:0045296;GO:0005525;GO:0046872;GO:0043023;GO:0043022;GO:0046034;GO:0002576;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:platelet alpha granule lumen;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:GTP binding; F:metal ion binding; F:ribosomal large subunit binding; F:ribosome binding;, P:ATP metabolic process; P:platelet degranulation;|Q9NTK5 D7EHM2 Q5BJD7 Q8NCI8 Q96CU1 Q96SV2 Q9P1D3 Q9UNY9 Q9Y6G4,Obg-like ATPase 1 {ECO:0000255|HAMAP-Rule:MF_03167},DNA damage-regulated overexpressed in cancer 45;GTP-binding protein 9;, PF01926;PF06071;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0031093;GO:0005524;GO:0016887;GO:0045296;GO:0005525;GO:0046872;GO:0043023;GO:0043022;GO:0046034;GO:0002576;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:platelet alpha granule lumen;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:GTP binding; F:metal ion binding; F:ribosomal large subunit binding; F:ribosome binding;, P:ATP metabolic process; P:platelet degranulation;|Q9NTK5 D7EHM2 Q5BJD7 Q8NCI8 Q96CU1 Q96SV2 Q9P1D3 Q9UNY9 Q9Y6G4,Obg-like ATPase 1 {ECO:0000255|HAMAP-Rule:MF_03167},DNA damage-regulated overexpressed in cancer 45;GTP-binding protein 9;, PF01926;PF06071;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0031093;GO:0005524;GO:0016887;GO:0045296;GO:0005525;GO:0046872;GO:0043023;GO:0043022;GO:0046034;GO:0002576;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:platelet alpha granule lumen;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:GTP binding; F:metal ion binding; F:ribosomal large subunit binding; F:ribosome binding;, P:ATP metabolic process; P:platelet degranulation; scaffold9 indexed_genome mRNA 53949471 53981089 . - . ID=transcript_2560;Q86X95 A6NFI6 A8K8M4 O95367 Q12804 Q4G1B9 Q6PJI4 Q8IWI2,Corepressor interacting with RBPJ 1,CBF1-interacting corepressor;Recepin;, PF10197;, GO:0005737;GO:0005815;GO:0016607;GO:0005634;GO:0032991;GO:0042826;GO:0019901;GO:0044877;GO:0003714;GO:0001701;GO:0006397;GO:0000122;GO:0045892;GO:0008380;, C:cytoplasm; C:microtubule organizing center; C:nuclear speck; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:protein kinase binding; F:protein-containing complex binding; F:transcription corepressor activity;, P:in utero embryonic development; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:RNA splicing;|Q86X95 A6NFI6 A8K8M4 O95367 Q12804 Q4G1B9 Q6PJI4 Q8IWI2,Corepressor interacting with RBPJ 1,CBF1-interacting corepressor;Recepin;, PF10197;, GO:0005737;GO:0005815;GO:0016607;GO:0005634;GO:0032991;GO:0042826;GO:0019901;GO:0044877;GO:0003714;GO:0001701;GO:0006397;GO:0000122;GO:0045892;GO:0008380;, C:cytoplasm; C:microtubule organizing center; C:nuclear speck; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:protein kinase binding; F:protein-containing complex binding; F:transcription corepressor activity;, P:in utero embryonic development; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:RNA splicing;|Q86X95 A6NFI6 A8K8M4 O95367 Q12804 Q4G1B9 Q6PJI4 Q8IWI2,Corepressor interacting with RBPJ 1,CBF1-interacting corepressor;Recepin;, PF10197;, GO:0005737;GO:0005815;GO:0016607;GO:0005634;GO:0032991;GO:0042826;GO:0019901;GO:0044877;GO:0003714;GO:0001701;GO:0006397;GO:0000122;GO:0045892;GO:0008380;, C:cytoplasm; C:microtubule organizing center; C:nuclear speck; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:protein kinase binding; F:protein-containing complex binding; F:transcription corepressor activity;, P:in utero embryonic development; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:RNA splicing; scaffold9 indexed_genome mRNA 53991379 54068391 . - . ID=transcript_2561;Q0VDG4 B4DI11 C9JPC1 D3DPE0 Q7L1C5 Q9H5R5,Secernin-3,, PF03577;, GO:0070004;GO:0016805;, , F:cysteine-type exopeptidase activity; F:dipeptidase activity;|Q0VDG4 B4DI11 C9JPC1 D3DPE0 Q7L1C5 Q9H5R5,Secernin-3,, PF03577;, GO:0070004;GO:0016805;, , F:cysteine-type exopeptidase activity; F:dipeptidase activity;|Q0VDG4 B4DI11 C9JPC1 D3DPE0 Q7L1C5 Q9H5R5,Secernin-3,, PF03577;, GO:0070004;GO:0016805;, , F:cysteine-type exopeptidase activity; F:dipeptidase activity;|Q8N639 Q8N8K3 Q96MV6,Integral membrane protein GPR155,G-protein coupled receptor PGR22;, PF00610;PF03547;, GO:0070062;GO:0016021;GO:0050890;GO:0035556;GO:0055085;, C:extracellular exosome; C:integral component of membrane;, , P:cognition; P:intracellular signal transduction; P:transmembrane transport;|Q8N639 Q8N8K3 Q96MV6,Integral membrane protein GPR155,G-protein coupled receptor PGR22;, PF00610;PF03547;, GO:0070062;GO:0016021;GO:0050890;GO:0035556;GO:0055085;, C:extracellular exosome; C:integral component of membrane;, , P:cognition; P:intracellular signal transduction; P:transmembrane transport;|Q8N639 Q8N8K3 Q96MV6,Integral membrane protein GPR155,G-protein coupled receptor PGR22;, PF00610;PF03547;, GO:0070062;GO:0016021;GO:0050890;GO:0035556;GO:0055085;, C:extracellular exosome; C:integral component of membrane;, , P:cognition; P:intracellular signal transduction; P:transmembrane transport;|Q8N639 Q8N8K3 Q96MV6,Integral membrane protein GPR155,G-protein coupled receptor PGR22;, PF00610;PF03547;, GO:0070062;GO:0016021;GO:0050890;GO:0035556;GO:0055085;, C:extracellular exosome; C:integral component of membrane;, , P:cognition; P:intracellular signal transduction; P:transmembrane transport;|Q8N639 Q8N8K3 Q96MV6,Integral membrane protein GPR155,G-protein coupled receptor PGR22;, PF00610;PF03547;, GO:0070062;GO:0016021;GO:0050890;GO:0035556;GO:0055085;, C:extracellular exosome; C:integral component of membrane;, , P:cognition; P:intracellular signal transduction; P:transmembrane transport;|Q8N639 Q8N8K3 Q96MV6,Integral membrane protein GPR155,G-protein coupled receptor PGR22;, PF00610;PF03547;, GO:0070062;GO:0016021;GO:0050890;GO:0035556;GO:0055085;, C:extracellular exosome; C:integral component of membrane;, , P:cognition; P:intracellular signal transduction; P:transmembrane transport; scaffold9 indexed_genome mRNA 54126937 54155023 . - . ID=transcript_2562;O43516 B8ZZM1 D3DPE4 Q15220 Q53TA9 Q6MZU9 Q9BU37 Q9UNP1,WAS/WASL-interacting protein family member 1,Protein PRPL-2;Wiskott-Aldrich syndrome protein-interacting protein;, PF02205;, GO:0015629;GO:0005884;GO:0031410;GO:0005829;GO:0001726;GO:0003779;GO:0005522;GO:0017124;GO:0030048;GO:0008154;GO:0038096;GO:0065003;GO:0051707;, C:actin cytoskeleton; C:actin filament; C:cytoplasmic vesicle; C:cytosol; C:ruffle;, F:actin binding; F:profilin binding; F:SH3 domain binding;, P:actin filament-based movement; P:actin polymerization or depolymerization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:protein-containing complex assembly; P:response to other organism;|O43516 B8ZZM1 D3DPE4 Q15220 Q53TA9 Q6MZU9 Q9BU37 Q9UNP1,WAS/WASL-interacting protein family member 1,Protein PRPL-2;Wiskott-Aldrich syndrome protein-interacting protein;, PF02205;, GO:0015629;GO:0005884;GO:0031410;GO:0005829;GO:0001726;GO:0003779;GO:0005522;GO:0017124;GO:0030048;GO:0008154;GO:0038096;GO:0065003;GO:0051707;, C:actin cytoskeleton; C:actin filament; C:cytoplasmic vesicle; C:cytosol; C:ruffle;, F:actin binding; F:profilin binding; F:SH3 domain binding;, P:actin filament-based movement; P:actin polymerization or depolymerization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:protein-containing complex assembly; P:response to other organism; scaffold9 indexed_genome mRNA 54340668 54387687 . - . ID=transcript_2563;P15882 A8K1M6 B3KNU6 B4DV19 Q53SD6 Q53SH5 Q96FB0,N-chimaerin,A-chimaerin;Alpha-chimerin;N-chimerin;Rho GTPase-activating protein 2;, PF00130;PF00620;PF00017;, GO:0005829;GO:0046875;GO:0005096;GO:0046872;GO:0048013;GO:0035556;GO:0008045;GO:0050770;GO:0043087;GO:0051056;, C:cytosol;, F:ephrin receptor binding; F:GTPase activator activity; F:metal ion binding;, P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:motor neuron axon guidance; P:regulation of axonogenesis; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|P15882 A8K1M6 B3KNU6 B4DV19 Q53SD6 Q53SH5 Q96FB0,N-chimaerin,A-chimaerin;Alpha-chimerin;N-chimerin;Rho GTPase-activating protein 2;, PF00130;PF00620;PF00017;, GO:0005829;GO:0046875;GO:0005096;GO:0046872;GO:0048013;GO:0035556;GO:0008045;GO:0050770;GO:0043087;GO:0051056;, C:cytosol;, F:ephrin receptor binding; F:GTPase activator activity; F:metal ion binding;, P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:motor neuron axon guidance; P:regulation of axonogenesis; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|P15882 A8K1M6 B3KNU6 B4DV19 Q53SD6 Q53SH5 Q96FB0,N-chimaerin,A-chimaerin;Alpha-chimerin;N-chimerin;Rho GTPase-activating protein 2;, PF00130;PF00620;PF00017;, GO:0005829;GO:0046875;GO:0005096;GO:0046872;GO:0048013;GO:0035556;GO:0008045;GO:0050770;GO:0043087;GO:0051056;, C:cytosol;, F:ephrin receptor binding; F:GTPase activator activity; F:metal ion binding;, P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:motor neuron axon guidance; P:regulation of axonogenesis; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold9 indexed_genome mRNA 54422140 54541975 . - . ID=transcript_2564;P15882 A8K1M6 B3KNU6 B4DV19 Q53SD6 Q53SH5 Q96FB0,N-chimaerin,A-chimaerin;Alpha-chimerin;N-chimerin;Rho GTPase-activating protein 2;, PF00130;PF00620;PF00017;, GO:0005829;GO:0046875;GO:0005096;GO:0046872;GO:0048013;GO:0035556;GO:0008045;GO:0050770;GO:0043087;GO:0051056;, C:cytosol;, F:ephrin receptor binding; F:GTPase activator activity; F:metal ion binding;, P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:motor neuron axon guidance; P:regulation of axonogenesis; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold9 indexed_genome mRNA 54595175 54597715 . + . ID=transcript_2565;Q4ZFU9 Q53RY2 Q8TAR1 Q96JT8,Cyclic AMP-dependent transcription factor ATF-2,Activating transcription factor 2;Cyclic AMP-responsive element-binding protein 2;HB16;cAMP response element-binding protein CRE-BP1;, PF00170;, GO:0000785;GO:0005737;GO:1902562;GO:0005741;GO:0005654;GO:0005634;GO:0035861;GO:0035497;GO:0008140;GO:0003682;GO:0000987;GO:0001228;GO:0003700;GO:0000981;GO:0044013;GO:0010485;GO:0046872;GO:0019901;GO:0044877;GO:0001102;GO:0000978;GO:0000977;GO:1990837;GO:0060612;GO:0097186;GO:0034198;GO:0006974;GO:0045444;GO:0043969;GO:0043967;GO:0031573;GO:0016525;GO:0050680;GO:0000122;GO:0003151;GO:0110024;GO:0051091;GO:0010628;GO:1902110;GO:0043525;GO:0045944;GO:0032915;GO:0051090;GO:0006357;GO:0006355;GO:0006970;GO:0009414;, C:chromatin; C:cytoplasm; C:H4 histone acetyltransferase complex; C:mitochondrial outer membrane; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:cAMP response element binding; F:cAMP response element binding protein binding; F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:H2B histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:metal ion binding; F:protein kinase binding; F:protein-containing complex binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adipose tissue development; P:amelogenesis; P:cellular response to amino acid starvation; P:cellular response to DNA damage stimulus; P:fat cell differentiation; P:histone H2B acetylation; P:histone H4 acetylation; P:intra-S DNA damage checkpoint; P:negative regulation of angiogenesis; P:negative regulation of epithelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:outflow tract morphogenesis; P:positive regulation of cardiac muscle myoblast proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression; P:positive regulation of mitochondrial membrane permeability involved in apoptotic process; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta2 production; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to osmotic stress; P:response to water deprivation; scaffold9 indexed_genome mRNA 54602849 54604039 . + . ID=transcript_2566;Q4ZFU9 Q53RY2 Q8TAR1 Q96JT8,Cyclic AMP-dependent transcription factor ATF-2,Activating transcription factor 2;Cyclic AMP-responsive element-binding protein 2;HB16;cAMP response element-binding protein CRE-BP1;, PF00170;, GO:0000785;GO:0005737;GO:1902562;GO:0005741;GO:0005654;GO:0005634;GO:0035861;GO:0035497;GO:0008140;GO:0003682;GO:0000987;GO:0001228;GO:0003700;GO:0000981;GO:0044013;GO:0010485;GO:0046872;GO:0019901;GO:0044877;GO:0001102;GO:0000978;GO:0000977;GO:1990837;GO:0060612;GO:0097186;GO:0034198;GO:0006974;GO:0045444;GO:0043969;GO:0043967;GO:0031573;GO:0016525;GO:0050680;GO:0000122;GO:0003151;GO:0110024;GO:0051091;GO:0010628;GO:1902110;GO:0043525;GO:0045944;GO:0032915;GO:0051090;GO:0006357;GO:0006355;GO:0006970;GO:0009414;, C:chromatin; C:cytoplasm; C:H4 histone acetyltransferase complex; C:mitochondrial outer membrane; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:cAMP response element binding; F:cAMP response element binding protein binding; F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:H2B histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:metal ion binding; F:protein kinase binding; F:protein-containing complex binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adipose tissue development; P:amelogenesis; P:cellular response to amino acid starvation; P:cellular response to DNA damage stimulus; P:fat cell differentiation; P:histone H2B acetylation; P:histone H4 acetylation; P:intra-S DNA damage checkpoint; P:negative regulation of angiogenesis; P:negative regulation of epithelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:outflow tract morphogenesis; P:positive regulation of cardiac muscle myoblast proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression; P:positive regulation of mitochondrial membrane permeability involved in apoptotic process; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta2 production; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to osmotic stress; P:response to water deprivation; scaffold9 indexed_genome mRNA 54612704 54673224 . - . ID=transcript_2567;Q4ZFU9 Q53RY2 Q8TAR1 Q96JT8,Cyclic AMP-dependent transcription factor ATF-2,Activating transcription factor 2;Cyclic AMP-responsive element-binding protein 2;HB16;cAMP response element-binding protein CRE-BP1;, PF00170;, GO:0000785;GO:0005737;GO:1902562;GO:0005741;GO:0005654;GO:0005634;GO:0035861;GO:0035497;GO:0008140;GO:0003682;GO:0000987;GO:0001228;GO:0003700;GO:0000981;GO:0044013;GO:0010485;GO:0046872;GO:0019901;GO:0044877;GO:0001102;GO:0000978;GO:0000977;GO:1990837;GO:0060612;GO:0097186;GO:0034198;GO:0006974;GO:0045444;GO:0043969;GO:0043967;GO:0031573;GO:0016525;GO:0050680;GO:0000122;GO:0003151;GO:0110024;GO:0051091;GO:0010628;GO:1902110;GO:0043525;GO:0045944;GO:0032915;GO:0051090;GO:0006357;GO:0006355;GO:0006970;GO:0009414;, C:chromatin; C:cytoplasm; C:H4 histone acetyltransferase complex; C:mitochondrial outer membrane; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:cAMP response element binding; F:cAMP response element binding protein binding; F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:H2B histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:metal ion binding; F:protein kinase binding; F:protein-containing complex binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adipose tissue development; P:amelogenesis; P:cellular response to amino acid starvation; P:cellular response to DNA damage stimulus; P:fat cell differentiation; P:histone H2B acetylation; P:histone H4 acetylation; P:intra-S DNA damage checkpoint; P:negative regulation of angiogenesis; P:negative regulation of epithelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:outflow tract morphogenesis; P:positive regulation of cardiac muscle myoblast proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression; P:positive regulation of mitochondrial membrane permeability involved in apoptotic process; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta2 production; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to osmotic stress; P:response to water deprivation; scaffold9 indexed_genome mRNA 54684949 54690899 . - . ID=transcript_2568;P48201 B2R4Z0 D3DPF0 Q4ZFX7,ATP synthase F(0) complex subunit C3, mitochondrial {ECO:0000305},ATP synthase lipid-binding protein;ATP synthase membrane subunit c locus 3 {ECO:0000312|HGNC:HGNC:843};ATP synthase proteolipid P3;ATP synthase proton-transporting mitochondrial F(0) complex subunit C3;ATPase protein 9;ATPase subunit c;, PF00137;, GO:0016021;GO:0005741;GO:0000276;GO:0045263;GO:0008289;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:proton-transporting ATP synthase complex, coupling factor F(o);, F:lipid binding; F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport;|Q06055 B3KQQ6,ATP synthase F(0) complex subunit C2, mitochondrial {ECO:0000305},ATP synthase lipid-binding protein;ATP synthase membrane subunit c locus 2 {ECO:0000312|HGNC:HGNC:842};ATP synthase proteolipid P2;ATP synthase proton-transporting mitochondrial F(0) complex subunit C2;ATPase protein 9;ATPase subunit c;, PF00137;, GO:0016021;GO:0005741;GO:0000276;GO:0045263;GO:0008289;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:proton-transporting ATP synthase complex, coupling factor F(o);, F:lipid binding; F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport;|P48201 B2R4Z0 D3DPF0 Q4ZFX7,ATP synthase F(0) complex subunit C3, mitochondrial {ECO:0000305},ATP synthase lipid-binding protein;ATP synthase membrane subunit c locus 3 {ECO:0000312|HGNC:HGNC:843};ATP synthase proteolipid P3;ATP synthase proton-transporting mitochondrial F(0) complex subunit C3;ATPase protein 9;ATPase subunit c;, PF00137;, GO:0016021;GO:0005741;GO:0000276;GO:0045263;GO:0008289;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:proton-transporting ATP synthase complex, coupling factor F(o);, F:lipid binding; F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; scaffold9 indexed_genome mRNA 55337975 55431121 . - . ID=transcript_2569;Q9C0E8 B7ZLA8 Q2M2V8 Q2YD99 Q658W8 Q8N5V9 Q96MS5,Endoplasmic reticulum junction formation protein lunapark {ECO:0000305},ER junction formation factor lunapark {ECO:0000312|HGNC:HGNC:21610};, PF10058;, GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0030176;GO:0016021;GO:0005654;GO:0042802;GO:0046872;GO:0007596;GO:0042733;GO:0035115;GO:0007029;GO:0071788;GO:0071786;GO:0060173;GO:1903373;GO:0032330;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm;, F:identical protein binding; F:metal ion binding;, P:blood coagulation; P:embryonic digit morphogenesis; P:embryonic forelimb morphogenesis; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network maintenance; P:endoplasmic reticulum tubular network organization; P:limb development; P:positive regulation of endoplasmic reticulum tubular network organization; P:regulation of chondrocyte differentiation;|Q9C0E8 B7ZLA8 Q2M2V8 Q2YD99 Q658W8 Q8N5V9 Q96MS5,Endoplasmic reticulum junction formation protein lunapark {ECO:0000305},ER junction formation factor lunapark {ECO:0000312|HGNC:HGNC:21610};, PF10058;, GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0030176;GO:0016021;GO:0005654;GO:0042802;GO:0046872;GO:0007596;GO:0042733;GO:0035115;GO:0007029;GO:0071788;GO:0071786;GO:0060173;GO:1903373;GO:0032330;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm;, F:identical protein binding; F:metal ion binding;, P:blood coagulation; P:embryonic digit morphogenesis; P:embryonic forelimb morphogenesis; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network maintenance; P:endoplasmic reticulum tubular network organization; P:limb development; P:positive regulation of endoplasmic reticulum tubular network organization; P:regulation of chondrocyte differentiation;|Q9C0E8 B7ZLA8 Q2M2V8 Q2YD99 Q658W8 Q8N5V9 Q96MS5,Endoplasmic reticulum junction formation protein lunapark {ECO:0000305},ER junction formation factor lunapark {ECO:0000312|HGNC:HGNC:21610};, PF10058;, GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0030176;GO:0016021;GO:0005654;GO:0042802;GO:0046872;GO:0007596;GO:0042733;GO:0035115;GO:0007029;GO:0071788;GO:0071786;GO:0060173;GO:1903373;GO:0032330;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm;, F:identical protein binding; F:metal ion binding;, P:blood coagulation; P:embryonic digit morphogenesis; P:embryonic forelimb morphogenesis; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network maintenance; P:endoplasmic reticulum tubular network organization; P:limb development; P:positive regulation of endoplasmic reticulum tubular network organization; P:regulation of chondrocyte differentiation;|Q9C0E8 B7ZLA8 Q2M2V8 Q2YD99 Q658W8 Q8N5V9 Q96MS5,Endoplasmic reticulum junction formation protein lunapark {ECO:0000305},ER junction formation factor lunapark {ECO:0000312|HGNC:HGNC:21610};, PF10058;, GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0030176;GO:0016021;GO:0005654;GO:0042802;GO:0046872;GO:0007596;GO:0042733;GO:0035115;GO:0007029;GO:0071788;GO:0071786;GO:0060173;GO:1903373;GO:0032330;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm;, F:identical protein binding; F:metal ion binding;, P:blood coagulation; P:embryonic digit morphogenesis; P:embryonic forelimb morphogenesis; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network maintenance; P:endoplasmic reticulum tubular network organization; P:limb development; P:positive regulation of endoplasmic reticulum tubular network organization; P:regulation of chondrocyte differentiation;|Q9C0E8 B7ZLA8 Q2M2V8 Q2YD99 Q658W8 Q8N5V9 Q96MS5,Endoplasmic reticulum junction formation protein lunapark {ECO:0000305},ER junction formation factor lunapark {ECO:0000312|HGNC:HGNC:21610};, PF10058;, GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0030176;GO:0016021;GO:0005654;GO:0042802;GO:0046872;GO:0007596;GO:0042733;GO:0035115;GO:0007029;GO:0071788;GO:0071786;GO:0060173;GO:1903373;GO:0032330;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm;, F:identical protein binding; F:metal ion binding;, P:blood coagulation; P:embryonic digit morphogenesis; P:embryonic forelimb morphogenesis; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network maintenance; P:endoplasmic reticulum tubular network organization; P:limb development; P:positive regulation of endoplasmic reticulum tubular network organization; P:regulation of chondrocyte differentiation; scaffold10 indexed_genome mRNA 8879 13369 . - . ID=transcript_2570;O43861 O60872 Q08AD8 Q08AD9,Probable phospholipid-transporting ATPase IIB,ATPase class II type 9B;, PF16212;PF16209;, GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0006897;GO:0045332;GO:0006890;, C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:endocytosis; P:phospholipid translocation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O43861 O60872 Q08AD8 Q08AD9,Probable phospholipid-transporting ATPase IIB,ATPase class II type 9B;, PF16212;PF16209;, GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0006897;GO:0045332;GO:0006890;, C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:endocytosis; P:phospholipid translocation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O43861 O60872 Q08AD8 Q08AD9,Probable phospholipid-transporting ATPase IIB,ATPase class II type 9B;, PF16212;PF16209;, GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0006897;GO:0045332;GO:0006890;, C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:endocytosis; P:phospholipid translocation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold10 indexed_genome mRNA 13446 169407 . - . ID=transcript_2571;O43861 O60872 Q08AD8 Q08AD9,Probable phospholipid-transporting ATPase IIB,ATPase class II type 9B;, PF16212;PF16209;, GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0006897;GO:0045332;GO:0006890;, C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:endocytosis; P:phospholipid translocation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O43861 O60872 Q08AD8 Q08AD9,Probable phospholipid-transporting ATPase IIB,ATPase class II type 9B;, PF16212;PF16209;, GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0006897;GO:0045332;GO:0006890;, C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:endocytosis; P:phospholipid translocation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O43861 O60872 Q08AD8 Q08AD9,Probable phospholipid-transporting ATPase IIB,ATPase class II type 9B;, PF16212;PF16209;, GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0006897;GO:0045332;GO:0006890;, C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:endocytosis; P:phospholipid translocation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O43861 O60872 Q08AD8 Q08AD9,Probable phospholipid-transporting ATPase IIB,ATPase class II type 9B;, PF16212;PF16209;, GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0006897;GO:0045332;GO:0006890;, C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:endocytosis; P:phospholipid translocation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O43861 O60872 Q08AD8 Q08AD9,Probable phospholipid-transporting ATPase IIB,ATPase class II type 9B;, PF16212;PF16209;, GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0006897;GO:0045332;GO:0006890;, C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:endocytosis; P:phospholipid translocation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O43861 O60872 Q08AD8 Q08AD9,Probable phospholipid-transporting ATPase IIB,ATPase class II type 9B;, PF16212;PF16209;, GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0006897;GO:0045332;GO:0006890;, C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:endocytosis; P:phospholipid translocation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O43861 O60872 Q08AD8 Q08AD9,Probable phospholipid-transporting ATPase IIB,ATPase class II type 9B;, PF16212;PF16209;, GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0006897;GO:0045332;GO:0006890;, C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:endocytosis; P:phospholipid translocation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold10 indexed_genome mRNA 1349653 1383518 . + . ID=transcript_2572;Q15338 Q15339 Q15340 Q59GX3 Q65ZS4 Q6AI64 Q6FH37 Q6FI04 Q6PK23,Myelin basic protein,Myelin A1 protein;Myelin membrane encephalitogenic protein;, PF01669;, GO:0071944;GO:0009986;GO:0043218;GO:0005829;GO:0033269;GO:0043209;GO:0043025;GO:0005634;GO:0005886;GO:0032991;GO:0045202;GO:0005516;GO:0002020;GO:0019911;GO:0008366;GO:0007417;GO:0007268;GO:0006955;GO:0035633;GO:0000165;GO:0061024;GO:0042552;GO:0034115;GO:0007399;GO:2000343;GO:0032755;GO:1904685;GO:0009636;GO:0007605;GO:0021762;, C:cell periphery; C:cell surface; C:compact myelin; C:cytosol; C:internode region of axon; C:myelin sheath; C:neuronal cell body; C:nucleus; C:plasma membrane; C:protein-containing complex; C:synapse;, F:calmodulin binding; F:protease binding; F:structural constituent of myelin sheath;, P:axon ensheathment; P:central nervous system development; P:chemical synaptic transmission; P:immune response; P:maintenance of blood-brain barrier; P:MAPK cascade; P:membrane organization; P:myelination; P:negative regulation of heterotypic cell-cell adhesion; P:nervous system development; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of interleukin-6 production; P:positive regulation of metalloendopeptidase activity; P:response to toxic substance; P:sensory perception of sound; P:substantia nigra development;|Q15338 Q15339 Q15340 Q59GX3 Q65ZS4 Q6AI64 Q6FH37 Q6FI04 Q6PK23,Myelin basic protein,Myelin A1 protein;Myelin membrane encephalitogenic protein;, PF01669;, GO:0071944;GO:0009986;GO:0043218;GO:0005829;GO:0033269;GO:0043209;GO:0043025;GO:0005634;GO:0005886;GO:0032991;GO:0045202;GO:0005516;GO:0002020;GO:0019911;GO:0008366;GO:0007417;GO:0007268;GO:0006955;GO:0035633;GO:0000165;GO:0061024;GO:0042552;GO:0034115;GO:0007399;GO:2000343;GO:0032755;GO:1904685;GO:0009636;GO:0007605;GO:0021762;, C:cell periphery; C:cell surface; C:compact myelin; C:cytosol; C:internode region of axon; C:myelin sheath; C:neuronal cell body; C:nucleus; C:plasma membrane; C:protein-containing complex; C:synapse;, F:calmodulin binding; F:protease binding; F:structural constituent of myelin sheath;, P:axon ensheathment; P:central nervous system development; P:chemical synaptic transmission; P:immune response; P:maintenance of blood-brain barrier; P:MAPK cascade; P:membrane organization; P:myelination; P:negative regulation of heterotypic cell-cell adhesion; P:nervous system development; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of interleukin-6 production; P:positive regulation of metalloendopeptidase activity; P:response to toxic substance; P:sensory perception of sound; P:substantia nigra development;|Q15338 Q15339 Q15340 Q59GX3 Q65ZS4 Q6AI64 Q6FH37 Q6FI04 Q6PK23,Myelin basic protein,Myelin A1 protein;Myelin membrane encephalitogenic protein;, PF01669;, GO:0071944;GO:0009986;GO:0043218;GO:0005829;GO:0033269;GO:0043209;GO:0043025;GO:0005634;GO:0005886;GO:0032991;GO:0045202;GO:0005516;GO:0002020;GO:0019911;GO:0008366;GO:0007417;GO:0007268;GO:0006955;GO:0035633;GO:0000165;GO:0061024;GO:0042552;GO:0034115;GO:0007399;GO:2000343;GO:0032755;GO:1904685;GO:0009636;GO:0007605;GO:0021762;, C:cell periphery; C:cell surface; C:compact myelin; C:cytosol; C:internode region of axon; C:myelin sheath; C:neuronal cell body; C:nucleus; C:plasma membrane; C:protein-containing complex; C:synapse;, F:calmodulin binding; F:protease binding; F:structural constituent of myelin sheath;, P:axon ensheathment; P:central nervous system development; P:chemical synaptic transmission; P:immune response; P:maintenance of blood-brain barrier; P:MAPK cascade; P:membrane organization; P:myelination; P:negative regulation of heterotypic cell-cell adhesion; P:nervous system development; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of interleukin-6 production; P:positive regulation of metalloendopeptidase activity; P:response to toxic substance; P:sensory perception of sound; P:substantia nigra development;|Q15338 Q15339 Q15340 Q59GX3 Q65ZS4 Q6AI64 Q6FH37 Q6FI04 Q6PK23,Myelin basic protein,Myelin A1 protein;Myelin membrane encephalitogenic protein;, PF01669;, GO:0071944;GO:0009986;GO:0043218;GO:0005829;GO:0033269;GO:0043209;GO:0043025;GO:0005634;GO:0005886;GO:0032991;GO:0045202;GO:0005516;GO:0002020;GO:0019911;GO:0008366;GO:0007417;GO:0007268;GO:0006955;GO:0035633;GO:0000165;GO:0061024;GO:0042552;GO:0034115;GO:0007399;GO:2000343;GO:0032755;GO:1904685;GO:0009636;GO:0007605;GO:0021762;, C:cell periphery; C:cell surface; C:compact myelin; C:cytosol; C:internode region of axon; C:myelin sheath; C:neuronal cell body; C:nucleus; C:plasma membrane; C:protein-containing complex; C:synapse;, F:calmodulin binding; F:protease binding; F:structural constituent of myelin sheath;, P:axon ensheathment; P:central nervous system development; P:chemical synaptic transmission; P:immune response; P:maintenance of blood-brain barrier; P:MAPK cascade; P:membrane organization; P:myelination; P:negative regulation of heterotypic cell-cell adhesion; P:nervous system development; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of interleukin-6 production; P:positive regulation of metalloendopeptidase activity; P:response to toxic substance; P:sensory perception of sound; P:substantia nigra development; scaffold10 indexed_genome mRNA 1391080 1394652 . + . ID=transcript_2573;Q9UL36 B2RTX9 Q9UL37,Zinc finger protein 236,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0071333;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II;|Q9UL36 B2RTX9 Q9UL37,Zinc finger protein 236,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0071333;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II;|Q9UL36 B2RTX9 Q9UL37,Zinc finger protein 236,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0071333;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 1395933 1406589 . + . ID=transcript_2574;Q9UL36 B2RTX9 Q9UL37,Zinc finger protein 236,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0071333;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II;|Q9UL36 B2RTX9 Q9UL37,Zinc finger protein 236,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0071333;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II;|Q9UL36 B2RTX9 Q9UL37,Zinc finger protein 236,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0071333;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 1406644 1445143 . - . ID=transcript_2575;Q9UL36 B2RTX9 Q9UL37,Zinc finger protein 236,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0071333;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II;|Q9UL36 B2RTX9 Q9UL37,Zinc finger protein 236,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0071333;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 1659396 1712847 . + . ID=transcript_2576;Q92618,Zinc finger protein 516 {ECO:0000312|HGNC:HGNC:28990},, PF00096;, GO:0005634;GO:0033613;GO:0000987;GO:0000981;GO:0046872;GO:0000978;GO:0060612;GO:0050873;GO:0120162;GO:0045893;GO:0006355;GO:0009409;, C:nucleus;, F:activating transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adipose tissue development; P:brown fat cell differentiation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:response to cold; scaffold10 indexed_genome mRNA 2434004 2440577 . - . ID=transcript_2577;Q6ZSZ6 O60534 Q4LE29 Q53EU4,Teashirt homolog 1,Antigen NY-CO-33;Serologically defined colon cancer antigen 33;, , GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0009952;GO:0042474;GO:0006357;GO:0060023;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:anterior/posterior pattern specification; P:middle ear morphogenesis; P:regulation of transcription by RNA polymerase II; P:soft palate development; scaffold10 indexed_genome mRNA 2529069 2534260 . - . ID=transcript_2578;Q8N4Q0 A8KA15 B4DZ91,Prostaglandin reductase 3,Zinc-binding alcohol dehydrogenase domain-containing protein 2;, PF08240;PF00107;, GO:0005777;GO:0036132;GO:0047522;GO:0008270;GO:0045599;, C:peroxisome;, F:13-prostaglandin reductase activity; F:15-oxoprostaglandin 13-oxidase activity; F:zinc ion binding;, P:negative regulation of fat cell differentiation; scaffold10 indexed_genome mRNA 2619321 2983139 . - . ID=transcript_2579;Q9C0G0 B5MD54 Q96MY0 Q9H8A1 Q9NXD4 Q9NXD7,Zinc finger protein 407,, PF00096;, GO:0005634;GO:0003677;GO:0008270;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:zinc ion binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold10 indexed_genome mRNA 2983328 2984282 . - . ID=transcript_2580;Q9C0G0 B5MD54 Q96MY0 Q9H8A1 Q9NXD4 Q9NXD7,Zinc finger protein 407,, PF00096;, GO:0005634;GO:0003677;GO:0008270;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:zinc ion binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold10 indexed_genome mRNA 3019408 3044361 . - . ID=transcript_2581;Q96KN2 Q14D40 Q17S05 Q2TBG0 Q6UWK2 Q9BT98,Beta-Ala-His dipeptidase,CNDP dipeptidase 1;Carnosine dipeptidase 1;Glutamate carboxypeptidase-like protein 2;Serum carnosinase;, PF07687;PF01546;, GO:0005829;GO:0005576;GO:0004180;GO:0016805;GO:0046872;GO:0070573;GO:0008233;GO:0006508;GO:0032268;, C:cytosol; C:extracellular region;, F:carboxypeptidase activity; F:dipeptidase activity; F:metal ion binding; F:metallodipeptidase activity; F:peptidase activity;, P:proteolysis; P:regulation of cellular protein metabolic process;|Q96KN2 Q14D40 Q17S05 Q2TBG0 Q6UWK2 Q9BT98,Beta-Ala-His dipeptidase,CNDP dipeptidase 1;Carnosine dipeptidase 1;Glutamate carboxypeptidase-like protein 2;Serum carnosinase;, PF07687;PF01546;, GO:0005829;GO:0005576;GO:0004180;GO:0016805;GO:0046872;GO:0070573;GO:0008233;GO:0006508;GO:0032268;, C:cytosol; C:extracellular region;, F:carboxypeptidase activity; F:dipeptidase activity; F:metal ion binding; F:metallodipeptidase activity; F:peptidase activity;, P:proteolysis; P:regulation of cellular protein metabolic process;|Q96KN2 Q14D40 Q17S05 Q2TBG0 Q6UWK2 Q9BT98,Beta-Ala-His dipeptidase,CNDP dipeptidase 1;Carnosine dipeptidase 1;Glutamate carboxypeptidase-like protein 2;Serum carnosinase;, PF07687;PF01546;, GO:0005829;GO:0005576;GO:0004180;GO:0016805;GO:0046872;GO:0070573;GO:0008233;GO:0006508;GO:0032268;, C:cytosol; C:extracellular region;, F:carboxypeptidase activity; F:dipeptidase activity; F:metal ion binding; F:metallodipeptidase activity; F:peptidase activity;, P:proteolysis; P:regulation of cellular protein metabolic process;|Q96KN2 Q14D40 Q17S05 Q2TBG0 Q6UWK2 Q9BT98,Beta-Ala-His dipeptidase,CNDP dipeptidase 1;Carnosine dipeptidase 1;Glutamate carboxypeptidase-like protein 2;Serum carnosinase;, PF07687;PF01546;, GO:0005829;GO:0005576;GO:0004180;GO:0016805;GO:0046872;GO:0070573;GO:0008233;GO:0006508;GO:0032268;, C:cytosol; C:extracellular region;, F:carboxypeptidase activity; F:dipeptidase activity; F:metal ion binding; F:metallodipeptidase activity; F:peptidase activity;, P:proteolysis; P:regulation of cellular protein metabolic process; scaffold10 indexed_genome mRNA 3050736 3062967 . - . ID=transcript_2582;Q96KP4 B3KUG4 Q8WY59 Q9BQ94 Q9NVB4 V9HWE5,Cytosolic non-specific dipeptidase,CNDP dipeptidase 2;Carnosine dipeptidase II {ECO:0000303|PubMed:25964343};Epididymis secretory protein Li 13 {ECO:0000312|EMBL:ACJ13654.1};Glutamate carboxypeptidase-like protein 1;Peptidase A;, PF07687;PF01546;, GO:0005829;GO:0070062;GO:0005654;GO:0103046;GO:0004180;GO:0016805;GO:0046872;GO:0070573;GO:0008233;GO:0006750;GO:0006508;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:alanylglutamate dipeptidase activity; F:carboxypeptidase activity; F:dipeptidase activity; F:metal ion binding; F:metallodipeptidase activity; F:peptidase activity;, P:glutathione biosynthetic process; P:proteolysis;|Q96KP4 B3KUG4 Q8WY59 Q9BQ94 Q9NVB4 V9HWE5,Cytosolic non-specific dipeptidase,CNDP dipeptidase 2;Carnosine dipeptidase II {ECO:0000303|PubMed:25964343};Epididymis secretory protein Li 13 {ECO:0000312|EMBL:ACJ13654.1};Glutamate carboxypeptidase-like protein 1;Peptidase A;, PF07687;PF01546;, GO:0005829;GO:0070062;GO:0005654;GO:0103046;GO:0004180;GO:0016805;GO:0046872;GO:0070573;GO:0008233;GO:0006750;GO:0006508;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:alanylglutamate dipeptidase activity; F:carboxypeptidase activity; F:dipeptidase activity; F:metal ion binding; F:metallodipeptidase activity; F:peptidase activity;, P:glutathione biosynthetic process; P:proteolysis;|Q96KP4 B3KUG4 Q8WY59 Q9BQ94 Q9NVB4 V9HWE5,Cytosolic non-specific dipeptidase,CNDP dipeptidase 2;Carnosine dipeptidase II {ECO:0000303|PubMed:25964343};Epididymis secretory protein Li 13 {ECO:0000312|EMBL:ACJ13654.1};Glutamate carboxypeptidase-like protein 1;Peptidase A;, PF07687;PF01546;, GO:0005829;GO:0070062;GO:0005654;GO:0103046;GO:0004180;GO:0016805;GO:0046872;GO:0070573;GO:0008233;GO:0006750;GO:0006508;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:alanylglutamate dipeptidase activity; F:carboxypeptidase activity; F:dipeptidase activity; F:metal ion binding; F:metallodipeptidase activity; F:peptidase activity;, P:glutathione biosynthetic process; P:proteolysis;|Q96KP4 B3KUG4 Q8WY59 Q9BQ94 Q9NVB4 V9HWE5,Cytosolic non-specific dipeptidase,CNDP dipeptidase 2;Carnosine dipeptidase II {ECO:0000303|PubMed:25964343};Epididymis secretory protein Li 13 {ECO:0000312|EMBL:ACJ13654.1};Glutamate carboxypeptidase-like protein 1;Peptidase A;, PF07687;PF01546;, GO:0005829;GO:0070062;GO:0005654;GO:0103046;GO:0004180;GO:0016805;GO:0046872;GO:0070573;GO:0008233;GO:0006750;GO:0006508;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:alanylglutamate dipeptidase activity; F:carboxypeptidase activity; F:dipeptidase activity; F:metal ion binding; F:metallodipeptidase activity; F:peptidase activity;, P:glutathione biosynthetic process; P:proteolysis;|Q96KP4 B3KUG4 Q8WY59 Q9BQ94 Q9NVB4 V9HWE5,Cytosolic non-specific dipeptidase,CNDP dipeptidase 2;Carnosine dipeptidase II {ECO:0000303|PubMed:25964343};Epididymis secretory protein Li 13 {ECO:0000312|EMBL:ACJ13654.1};Glutamate carboxypeptidase-like protein 1;Peptidase A;, PF07687;PF01546;, GO:0005829;GO:0070062;GO:0005654;GO:0103046;GO:0004180;GO:0016805;GO:0046872;GO:0070573;GO:0008233;GO:0006750;GO:0006508;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:alanylglutamate dipeptidase activity; F:carboxypeptidase activity; F:dipeptidase activity; F:metal ion binding; F:metallodipeptidase activity; F:peptidase activity;, P:glutathione biosynthetic process; P:proteolysis; scaffold10 indexed_genome mRNA 3205871 3245502 . + . ID=transcript_2583;P00167 A8MV91 F8WEU4 Q6IB14,Cytochrome b5,Microsomal cytochrome b5 type A;, PF00173;, GO:0005829;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005741;GO:0004129;GO:0009055;GO:0019899;GO:0020037;GO:0046872;GO:0019852;GO:0045048;GO:0046686;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane;, F:cytochrome-c oxidase activity; F:electron transfer activity; F:enzyme binding; F:heme binding; F:metal ion binding;, P:L-ascorbic acid metabolic process; P:protein insertion into ER membrane; P:response to cadmium ion; scaffold10 indexed_genome mRNA 3245890 3248146 . + . ID=transcript_2584;P00167 A8MV91 F8WEU4 Q6IB14,Cytochrome b5,Microsomal cytochrome b5 type A;, PF00173;, GO:0005829;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005741;GO:0004129;GO:0009055;GO:0019899;GO:0020037;GO:0046872;GO:0019852;GO:0045048;GO:0046686;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane;, F:cytochrome-c oxidase activity; F:electron transfer activity; F:enzyme binding; F:heme binding; F:metal ion binding;, P:L-ascorbic acid metabolic process; P:protein insertion into ER membrane; P:response to cadmium ion; scaffold10 indexed_genome mRNA 3306318 3349040 . - . ID=transcript_2585;Q8NCQ5 B3KST3,F-box only protein 15,, PF12937;, GO:0005829;GO:0043687;GO:0000209;, C:cytosol;, , P:post-translational protein modification; P:protein polyubiquitination;|Q9BVV7 Q9P010,Mitochondrial import inner membrane translocase subunit Tim21,TIM21-like protein, mitochondrial;, PF08294;, GO:0016021;GO:0005744;GO:0033617;GO:0032981;GO:0030150;, C:integral component of membrane; C:TIM23 mitochondrial import inner membrane translocase complex;, , P:mitochondrial cytochrome c oxidase assembly; P:mitochondrial respiratory chain complex I assembly; P:protein import into mitochondrial matrix; scaffold10 indexed_genome mRNA 4189797 4192482 . + . ID=transcript_2586;Q8TDF5 Q86W85 Q8ND78 Q8TDF4,Neuropilin and tolloid-like protein 1,Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1;, PF00431;PF00057;, GO:0060076;GO:0005576;GO:0098978;GO:0099061;GO:0014069;GO:0098839;GO:0035255;GO:0007613;GO:2000463;GO:0097120;GO:2000312;GO:0048169;GO:0008542;, C:excitatory synapse; C:extracellular region; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:ionotropic glutamate receptor binding;, P:memory; P:positive regulation of excitatory postsynaptic potential; P:receptor localization to synapse; P:regulation of kainate selective glutamate receptor activity; P:regulation of long-term neuronal synaptic plasticity; P:visual learning; scaffold10 indexed_genome mRNA 5924034 5949636 . - . ID=transcript_2587;O14544 Q8WUM3,Suppressor of cytokine signaling 6,Cytokine-inducible SH2 protein 4;Suppressor of cytokine signaling 4;, PF00017;PF07525;, GO:0005737;GO:0005829;GO:0001772;GO:0005942;GO:0046935;GO:0019221;GO:0006952;GO:0035556;GO:0009968;GO:0050868;GO:0046854;GO:0043687;GO:0010498;GO:0016567;GO:0007259;GO:0040008;, C:cytoplasm; C:cytosol; C:immunological synapse; C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase regulator activity;, P:cytokine-mediated signaling pathway; P:defense response; P:intracellular signal transduction; P:negative regulation of signal transduction; P:negative regulation of T cell activation; P:phosphatidylinositol phosphorylation; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein ubiquitination; P:receptor signaling pathway via JAK-STAT; P:regulation of growth; scaffold10 indexed_genome mRNA 6017602 6032385 . + . ID=transcript_2588;Q86VV8 Q68CS9 Q6ZRL8 Q6ZTK3 Q86TG4 Q8N8N8 Q8TBQ4 Q96IN9 Q9UFJ4,Rotatin,, PF14726;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0007099;GO:0010457;GO:0032053;GO:0007368;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm;, , P:centriole replication; P:centriole-centriole cohesion; P:ciliary basal body organization; P:determination of left/right symmetry; scaffold10 indexed_genome mRNA 6034238 6145591 . + . ID=transcript_2589;Q86VV8 Q68CS9 Q6ZRL8 Q6ZTK3 Q86TG4 Q8N8N8 Q8TBQ4 Q96IN9 Q9UFJ4,Rotatin,, PF14726;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0007099;GO:0010457;GO:0032053;GO:0007368;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm;, , P:centriole replication; P:centriole-centriole cohesion; P:ciliary basal body organization; P:determination of left/right symmetry;|Q86VV8 Q68CS9 Q6ZRL8 Q6ZTK3 Q86TG4 Q8N8N8 Q8TBQ4 Q96IN9 Q9UFJ4,Rotatin,, PF14726;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0007099;GO:0010457;GO:0032053;GO:0007368;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm;, , P:centriole replication; P:centriole-centriole cohesion; P:ciliary basal body organization; P:determination of left/right symmetry;|Q86VV8 Q68CS9 Q6ZRL8 Q6ZTK3 Q86TG4 Q8N8N8 Q8TBQ4 Q96IN9 Q9UFJ4,Rotatin,, PF14726;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0007099;GO:0010457;GO:0032053;GO:0007368;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm;, , P:centriole replication; P:centriole-centriole cohesion; P:ciliary basal body organization; P:determination of left/right symmetry; scaffold10 indexed_genome mRNA 6194358 6263588 . + . ID=transcript_2590;Q15762 B2R818,CD226 antigen,DNAX accessory molecule 1;, PF07686;, GO:0009986;GO:0009897;GO:0005887;GO:0045121;GO:0005886;GO:0050839;GO:0005178;GO:0019901;GO:0007155;GO:0008037;GO:0060369;GO:0002891;GO:0032729;GO:0033005;GO:0002729;GO:0045954;GO:0002860;GO:0050862;GO:0050776;GO:0007165;, C:cell surface; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane;, F:cell adhesion molecule binding; F:integrin binding; F:protein kinase binding;, P:cell adhesion; P:cell recognition; P:positive regulation of Fc receptor mediated stimulatory signaling pathway; P:positive regulation of immunoglobulin mediated immune response; P:positive regulation of interferon-gamma production; P:positive regulation of mast cell activation; P:positive regulation of natural killer cell cytokine production; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:positive regulation of T cell receptor signaling pathway; P:regulation of immune response; P:signal transduction; scaffold10 indexed_genome mRNA 6955544 7177045 . - . ID=transcript_2591;Q68D86 A1A4H1 Q7Z467 Q8NDK7 Q9H5C1,Coiled-coil domain-containing protein 102B scaffold10 indexed_genome mRNA 7231888 7273295 . + . ID=transcript_2592;Q96JJ7 B3KV75 Q52LT7 Q8N5J0 Q9NWJ9,Protein disulfide-isomerase TMX3,Thioredoxin domain-containing protein 10;Thioredoxin-related transmembrane protein 3;, PF00085;, GO:0009986;GO:0005789;GO:0016021;GO:0005886;GO:0031092;GO:0003756;GO:0016972;GO:0018171;GO:0002576;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:platelet alpha granule membrane;, F:protein disulfide isomerase activity; F:thiol oxidase activity;, P:peptidyl-cysteine oxidation; P:platelet degranulation;|Q96JJ7 B3KV75 Q52LT7 Q8N5J0 Q9NWJ9,Protein disulfide-isomerase TMX3,Thioredoxin domain-containing protein 10;Thioredoxin-related transmembrane protein 3;, PF00085;, GO:0009986;GO:0005789;GO:0016021;GO:0005886;GO:0031092;GO:0003756;GO:0016972;GO:0018171;GO:0002576;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:platelet alpha granule membrane;, F:protein disulfide isomerase activity; F:thiol oxidase activity;, P:peptidyl-cysteine oxidation; P:platelet degranulation;|Q96JJ7 B3KV75 Q52LT7 Q8N5J0 Q9NWJ9,Protein disulfide-isomerase TMX3,Thioredoxin domain-containing protein 10;Thioredoxin-related transmembrane protein 3;, PF00085;, GO:0009986;GO:0005789;GO:0016021;GO:0005886;GO:0031092;GO:0003756;GO:0016972;GO:0018171;GO:0002576;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:platelet alpha granule membrane;, F:protein disulfide isomerase activity; F:thiol oxidase activity;, P:peptidyl-cysteine oxidation; P:platelet degranulation;|Q96JJ7 B3KV75 Q52LT7 Q8N5J0 Q9NWJ9,Protein disulfide-isomerase TMX3,Thioredoxin domain-containing protein 10;Thioredoxin-related transmembrane protein 3;, PF00085;, GO:0009986;GO:0005789;GO:0016021;GO:0005886;GO:0031092;GO:0003756;GO:0016972;GO:0018171;GO:0002576;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:platelet alpha granule membrane;, F:protein disulfide isomerase activity; F:thiol oxidase activity;, P:peptidyl-cysteine oxidation; P:platelet degranulation;|Q96JJ7 B3KV75 Q52LT7 Q8N5J0 Q9NWJ9,Protein disulfide-isomerase TMX3,Thioredoxin domain-containing protein 10;Thioredoxin-related transmembrane protein 3;, PF00085;, GO:0009986;GO:0005789;GO:0016021;GO:0005886;GO:0031092;GO:0003756;GO:0016972;GO:0018171;GO:0002576;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:platelet alpha granule membrane;, F:protein disulfide isomerase activity; F:thiol oxidase activity;, P:peptidyl-cysteine oxidation; P:platelet degranulation;|Q96JJ7 B3KV75 Q52LT7 Q8N5J0 Q9NWJ9,Protein disulfide-isomerase TMX3,Thioredoxin domain-containing protein 10;Thioredoxin-related transmembrane protein 3;, PF00085;, GO:0009986;GO:0005789;GO:0016021;GO:0005886;GO:0031092;GO:0003756;GO:0016972;GO:0018171;GO:0002576;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:platelet alpha granule membrane;, F:protein disulfide isomerase activity; F:thiol oxidase activity;, P:peptidyl-cysteine oxidation; P:platelet degranulation; scaffold10 indexed_genome mRNA 8141358 8152821 . - . ID=transcript_2593;Q8IZU8 Q17RH1 Q6P5Z3,Dermatan-sulfate epimerase-like protein,, PF00685;, GO:0000139;GO:0016021;GO:0047757;GO:0008146;GO:0030204;GO:0030208;GO:0030205;, C:Golgi membrane; C:integral component of membrane;, F:chondroitin-glucuronate 5-epimerase activity; F:sulfotransferase activity;, P:chondroitin sulfate metabolic process; P:dermatan sulfate biosynthetic process; P:dermatan sulfate metabolic process; scaffold10 indexed_genome mRNA 8792659 8837980 . + . ID=transcript_2594;Q9H159 B4E1V5 F5H1K0,Cadherin-19,, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0016021;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold10 indexed_genome mRNA 9333417 9341476 . - . ID=transcript_2595;Q9ULB5 Q9H157,Cadherin-7,, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098609;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold10 indexed_genome mRNA 9349489 9472013 . - . ID=transcript_2596;Q9ULB5 Q9H157,Cadherin-7,, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098609;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development;|Q9ULB5 Q9H157,Cadherin-7,, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098609;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development;|Q9ULB5 Q9H157,Cadherin-7,, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098609;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold10 indexed_genome mRNA 10892570 10893422 . + . ID=transcript_2597;P05120 Q96E96,Plasminogen activator inhibitor 2,Monocyte Arg-serpin;Placental plasminogen activator inhibitor;Serpin B2;Urokinase inhibitor;, PF00079;, GO:0005737;GO:0005576;GO:0005615;GO:0005886;GO:0004867;GO:0042730;GO:0035722;GO:0043066;GO:0010951;GO:0042060;, C:cytoplasm; C:extracellular region; C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase inhibitor activity;, P:fibrinolysis; P:interleukin-12-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of endopeptidase activity; P:wound healing; scaffold10 indexed_genome mRNA 11060027 11070552 . + . ID=transcript_2598;Q9H2B2 B4DEU3 Q9P2K4,Synaptotagmin-4,Synaptotagmin IV;, PF00168;, GO:0097449;GO:0030424;GO:0032127;GO:0070382;GO:0030173;GO:0030285;GO:0098675;GO:0044306;GO:0043025;GO:0098992;GO:0005886;GO:0045202;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0046982;GO:0042803;GO:0000149;GO:0017075;GO:0030348;GO:0007420;GO:0017156;GO:0030154;GO:0071277;GO:0099519;GO:0045955;GO:0033604;GO:1905414;GO:0046929;GO:0031339;GO:0045956;GO:1903861;GO:0017158;GO:0014059;GO:0030100;GO:0061792;GO:0006906;GO:0061782;GO:0016192;, C:astrocyte projection; C:axon; C:dense core granule membrane; C:exocytic vesicle; C:integral component of Golgi membrane; C:integral component of synaptic vesicle membrane; C:intrinsic component of neuronal dense core vesicle membrane; C:neuron projection terminus; C:neuronal cell body; C:neuronal dense core vesicle; C:plasma membrane; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SNARE binding; F:syntaxin-1 binding; F:syntaxin-3 binding;, P:brain development; P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:dense core granule cytoskeletal transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of catecholamine secretion; P:negative regulation of dense core granule exocytosis; P:negative regulation of neurotransmitter secretion; P:negative regulation of vesicle fusion; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of dendrite extension; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of endocytosis; P:secretory granule maturation; P:vesicle fusion; P:vesicle fusion with vesicle; P:vesicle-mediated transport;|Q9H2B2 B4DEU3 Q9P2K4,Synaptotagmin-4,Synaptotagmin IV;, PF00168;, GO:0097449;GO:0030424;GO:0032127;GO:0070382;GO:0030173;GO:0030285;GO:0098675;GO:0044306;GO:0043025;GO:0098992;GO:0005886;GO:0045202;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0046982;GO:0042803;GO:0000149;GO:0017075;GO:0030348;GO:0007420;GO:0017156;GO:0030154;GO:0071277;GO:0099519;GO:0045955;GO:0033604;GO:1905414;GO:0046929;GO:0031339;GO:0045956;GO:1903861;GO:0017158;GO:0014059;GO:0030100;GO:0061792;GO:0006906;GO:0061782;GO:0016192;, C:astrocyte projection; C:axon; C:dense core granule membrane; C:exocytic vesicle; C:integral component of Golgi membrane; C:integral component of synaptic vesicle membrane; C:intrinsic component of neuronal dense core vesicle membrane; C:neuron projection terminus; C:neuronal cell body; C:neuronal dense core vesicle; C:plasma membrane; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SNARE binding; F:syntaxin-1 binding; F:syntaxin-3 binding;, P:brain development; P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:dense core granule cytoskeletal transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of catecholamine secretion; P:negative regulation of dense core granule exocytosis; P:negative regulation of neurotransmitter secretion; P:negative regulation of vesicle fusion; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of dendrite extension; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of endocytosis; P:secretory granule maturation; P:vesicle fusion; P:vesicle fusion with vesicle; P:vesicle-mediated transport;|Q9H2B2 B4DEU3 Q9P2K4,Synaptotagmin-4,Synaptotagmin IV;, PF00168;, GO:0097449;GO:0030424;GO:0032127;GO:0070382;GO:0030173;GO:0030285;GO:0098675;GO:0044306;GO:0043025;GO:0098992;GO:0005886;GO:0045202;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0046982;GO:0042803;GO:0000149;GO:0017075;GO:0030348;GO:0007420;GO:0017156;GO:0030154;GO:0071277;GO:0099519;GO:0045955;GO:0033604;GO:1905414;GO:0046929;GO:0031339;GO:0045956;GO:1903861;GO:0017158;GO:0014059;GO:0030100;GO:0061792;GO:0006906;GO:0061782;GO:0016192;, C:astrocyte projection; C:axon; C:dense core granule membrane; C:exocytic vesicle; C:integral component of Golgi membrane; C:integral component of synaptic vesicle membrane; C:intrinsic component of neuronal dense core vesicle membrane; C:neuron projection terminus; C:neuronal cell body; C:neuronal dense core vesicle; C:plasma membrane; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SNARE binding; F:syntaxin-1 binding; F:syntaxin-3 binding;, P:brain development; P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:dense core granule cytoskeletal transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of catecholamine secretion; P:negative regulation of dense core granule exocytosis; P:negative regulation of neurotransmitter secretion; P:negative regulation of vesicle fusion; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of dendrite extension; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of endocytosis; P:secretory granule maturation; P:vesicle fusion; P:vesicle fusion with vesicle; P:vesicle-mediated transport; scaffold10 indexed_genome mRNA 12226090 12226704 . - . ID=transcript_2599;Q71UM5 Q9BTJ1,40S ribosomal protein S27-like,Small ribosomal subunit protein eS27-like;, PF01667;, GO:0022627;GO:0005634;GO:0008656;GO:0046872;GO:0003723;GO:0003735;GO:0008494;GO:0006919;GO:0006978;GO:0042771;GO:0031571;GO:0045727;GO:0000028;GO:0006412;, C:cytosolic small ribosomal subunit; C:nucleus;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:metal ion binding; F:RNA binding; F:structural constituent of ribosome; F:translation activator activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic G1 DNA damage checkpoint; P:positive regulation of translation; P:ribosomal small subunit assembly; P:translation; scaffold10 indexed_genome mRNA 12229679 12396075 . - . ID=transcript_2600;Q8NEB9 Q15134,Phosphatidylinositol 3-kinase catalytic subunit type 3,Phosphatidylinositol 3-kinase p100 subunit;Phosphoinositide-3-kinase class 3;hVps34;, PF00454;PF00792;PF00613;, GO:0044754;GO:0005930;GO:0005737;GO:0005829;GO:0005768;GO:0005770;GO:0016020;GO:0030496;GO:0005777;GO:0030670;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0016303;GO:0005524;GO:0016301;GO:0052742;GO:0000045;GO:0006914;GO:0030242;GO:0007049;GO:0051301;GO:0042149;GO:0045022;GO:0006897;GO:0016236;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0006497;GO:0032465;GO:0034162;, C:autolysosome; C:axoneme; C:cytoplasm; C:cytosol; C:endosome; C:late endosome; C:membrane; C:midbody; C:peroxisome; C:phagocytic vesicle membrane; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:autophagosome assembly; P:autophagy; P:autophagy of peroxisome; P:cell cycle; P:cell division; P:cellular response to glucose starvation; P:early endosome to late endosome transport; P:endocytosis; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein lipidation; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway;|Q8NEB9 Q15134,Phosphatidylinositol 3-kinase catalytic subunit type 3,Phosphatidylinositol 3-kinase p100 subunit;Phosphoinositide-3-kinase class 3;hVps34;, PF00454;PF00792;PF00613;, GO:0044754;GO:0005930;GO:0005737;GO:0005829;GO:0005768;GO:0005770;GO:0016020;GO:0030496;GO:0005777;GO:0030670;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0016303;GO:0005524;GO:0016301;GO:0052742;GO:0000045;GO:0006914;GO:0030242;GO:0007049;GO:0051301;GO:0042149;GO:0045022;GO:0006897;GO:0016236;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0006497;GO:0032465;GO:0034162;, C:autolysosome; C:axoneme; C:cytoplasm; C:cytosol; C:endosome; C:late endosome; C:membrane; C:midbody; C:peroxisome; C:phagocytic vesicle membrane; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:autophagosome assembly; P:autophagy; P:autophagy of peroxisome; P:cell cycle; P:cell division; P:cellular response to glucose starvation; P:early endosome to late endosome transport; P:endocytosis; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein lipidation; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway;|Q8NEB9 Q15134,Phosphatidylinositol 3-kinase catalytic subunit type 3,Phosphatidylinositol 3-kinase p100 subunit;Phosphoinositide-3-kinase class 3;hVps34;, PF00454;PF00792;PF00613;, GO:0044754;GO:0005930;GO:0005737;GO:0005829;GO:0005768;GO:0005770;GO:0016020;GO:0030496;GO:0005777;GO:0030670;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0016303;GO:0005524;GO:0016301;GO:0052742;GO:0000045;GO:0006914;GO:0030242;GO:0007049;GO:0051301;GO:0042149;GO:0045022;GO:0006897;GO:0016236;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0006497;GO:0032465;GO:0034162;, C:autolysosome; C:axoneme; C:cytoplasm; C:cytosol; C:endosome; C:late endosome; C:membrane; C:midbody; C:peroxisome; C:phagocytic vesicle membrane; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:autophagosome assembly; P:autophagy; P:autophagy of peroxisome; P:cell cycle; P:cell division; P:cellular response to glucose starvation; P:early endosome to late endosome transport; P:endocytosis; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein lipidation; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway;|Q8NEB9 Q15134,Phosphatidylinositol 3-kinase catalytic subunit type 3,Phosphatidylinositol 3-kinase p100 subunit;Phosphoinositide-3-kinase class 3;hVps34;, PF00454;PF00792;PF00613;, GO:0044754;GO:0005930;GO:0005737;GO:0005829;GO:0005768;GO:0005770;GO:0016020;GO:0030496;GO:0005777;GO:0030670;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0016303;GO:0005524;GO:0016301;GO:0052742;GO:0000045;GO:0006914;GO:0030242;GO:0007049;GO:0051301;GO:0042149;GO:0045022;GO:0006897;GO:0016236;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0006497;GO:0032465;GO:0034162;, C:autolysosome; C:axoneme; C:cytoplasm; C:cytosol; C:endosome; C:late endosome; C:membrane; C:midbody; C:peroxisome; C:phagocytic vesicle membrane; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:autophagosome assembly; P:autophagy; P:autophagy of peroxisome; P:cell cycle; P:cell division; P:cellular response to glucose starvation; P:early endosome to late endosome transport; P:endocytosis; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein lipidation; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway;|Q8NEB9 Q15134,Phosphatidylinositol 3-kinase catalytic subunit type 3,Phosphatidylinositol 3-kinase p100 subunit;Phosphoinositide-3-kinase class 3;hVps34;, PF00454;PF00792;PF00613;, GO:0044754;GO:0005930;GO:0005737;GO:0005829;GO:0005768;GO:0005770;GO:0016020;GO:0030496;GO:0005777;GO:0030670;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0016303;GO:0005524;GO:0016301;GO:0052742;GO:0000045;GO:0006914;GO:0030242;GO:0007049;GO:0051301;GO:0042149;GO:0045022;GO:0006897;GO:0016236;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0006497;GO:0032465;GO:0034162;, C:autolysosome; C:axoneme; C:cytoplasm; C:cytosol; C:endosome; C:late endosome; C:membrane; C:midbody; C:peroxisome; C:phagocytic vesicle membrane; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:autophagosome assembly; P:autophagy; P:autophagy of peroxisome; P:cell cycle; P:cell division; P:cellular response to glucose starvation; P:early endosome to late endosome transport; P:endocytosis; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein lipidation; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway; scaffold10 indexed_genome mRNA 17461241 17756746 . + . ID=transcript_2601;Q9BZC1 Q59EN7 Q86XB9 Q8N2M6 Q9BQ96 Q9NR84 Q9NR85,CUGBP Elav-like family member 4,Bruno-like protein 4;CUG-BP- and ETR-3-like factor 4;RNA-binding protein BRUNOL-4;, PF00076;, GO:0005737;GO:0005654;GO:0005634;GO:1990904;GO:0042835;GO:0003729;GO:0036002;GO:0003723;GO:0000900;GO:0000380;GO:0009792;GO:0007281;GO:0001701;GO:0006376;GO:0090394;GO:0048025;GO:0048026;GO:0000381;GO:1902866;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:BRE binding; F:mRNA binding; F:pre-mRNA binding; F:RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:alternative mRNA splicing, via spliceosome; P:embryo development ending in birth or egg hatching; P:germ cell development; P:in utero embryonic development; P:mRNA splice site selection; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of retina development in camera-type eye;|Q9BZC1 Q59EN7 Q86XB9 Q8N2M6 Q9BQ96 Q9NR84 Q9NR85,CUGBP Elav-like family member 4,Bruno-like protein 4;CUG-BP- and ETR-3-like factor 4;RNA-binding protein BRUNOL-4;, PF00076;, GO:0005737;GO:0005654;GO:0005634;GO:1990904;GO:0042835;GO:0003729;GO:0036002;GO:0003723;GO:0000900;GO:0000380;GO:0009792;GO:0007281;GO:0001701;GO:0006376;GO:0090394;GO:0048025;GO:0048026;GO:0000381;GO:1902866;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:BRE binding; F:mRNA binding; F:pre-mRNA binding; F:RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:alternative mRNA splicing, via spliceosome; P:embryo development ending in birth or egg hatching; P:germ cell development; P:in utero embryonic development; P:mRNA splice site selection; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of retina development in camera-type eye; scaffold10 indexed_genome mRNA 17805343 17807169 . + . ID=transcript_2602;Q86T90 Q05DL0 Q49AG6 Q9P2L8,Protein hinderin {ECO:0000303|PubMed:15656913},, PF15369; scaffold10 indexed_genome mRNA 17946019 18197951 . - . ID=transcript_2603;Q86T90 Q05DL0 Q49AG6 Q9P2L8,Protein hinderin {ECO:0000303|PubMed:15656913},, PF15369; scaffold10 indexed_genome mRNA 18228119 18268402 . + . ID=transcript_2604;Q68CL5 B4DIX2 K7EIJ9 Q4KN59 Q8WTU3 Q96BT9 Q9Y435,Tubulin polyglutamylase complex subunit 2,, , GO:0005737;GO:0005874;GO:0018095;, C:cytoplasm; C:microtubule;, , P:protein polyglutamylation; scaffold10 indexed_genome mRNA 18291541 18564310 . - . ID=transcript_2605;Q9H6G7,FH1/FH2 domain-containing protein 3,Formactin-2;Formin homolog overexpressed in spleen 2;, PF02181;PF18382;, GO:0005737;GO:0005856;GO:0005865;GO:0030018;GO:0051015;GO:0051639;GO:0055003;GO:0030866;GO:0030837;GO:0045214;, C:cytoplasm; C:cytoskeleton; C:striated muscle thin filament; C:Z disc;, F:actin filament binding;, P:actin filament network formation; P:cardiac myofibril assembly; P:cortical actin cytoskeleton organization; P:negative regulation of actin filament polymerization; P:sarcomere organization; scaffold10 indexed_genome mRNA 18838178 18893374 . - . ID=transcript_2606;Q96EN8 Q53GP5 Q8N3A4 Q9NWM7,Molybdenum cofactor sulfurase {ECO:0000255|HAMAP-Rule:MF_03050},Molybdenum cofactor sulfurtransferase {ECO:0000255|HAMAP-Rule:MF_03050};, PF00266;PF03473;PF03476;, GO:0005829;GO:0016829;GO:0008265;GO:0102867;GO:0030151;GO:0030170;GO:0006777;GO:0032324;GO:0043545;, C:cytosol;, F:lyase activity; F:Mo-molybdopterin cofactor sulfurase activity; F:molybdenum cofactor sulfurtransferase activity; F:molybdenum ion binding; F:pyridoxal phosphate binding;, P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor metabolic process; scaffold10 indexed_genome mRNA 18911626 18960215 . - . ID=transcript_2607;Q96GV4 Q96PI7 Q9H9N0 Q9NV81,Elongator complex protein 2,SHINC-2;STAT3-interacting protein 1;, PF00400;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0008023;GO:0019901;GO:0046425;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:protein kinase binding;, P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96GV4 Q96PI7 Q9H9N0 Q9NV81,Elongator complex protein 2,SHINC-2;STAT3-interacting protein 1;, PF00400;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0008023;GO:0019901;GO:0046425;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:protein kinase binding;, P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96GV4 Q96PI7 Q9H9N0 Q9NV81,Elongator complex protein 2,SHINC-2;STAT3-interacting protein 1;, PF00400;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0008023;GO:0019901;GO:0046425;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:protein kinase binding;, P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96GV4 Q96PI7 Q9H9N0 Q9NV81,Elongator complex protein 2,SHINC-2;STAT3-interacting protein 1;, PF00400;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0008023;GO:0019901;GO:0046425;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:protein kinase binding;, P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96GV4 Q96PI7 Q9H9N0 Q9NV81,Elongator complex protein 2,SHINC-2;STAT3-interacting protein 1;, PF00400;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0008023;GO:0019901;GO:0046425;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:protein kinase binding;, P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96GV4 Q96PI7 Q9H9N0 Q9NV81,Elongator complex protein 2,SHINC-2;STAT3-interacting protein 1;, PF00400;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0008023;GO:0019901;GO:0046425;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:protein kinase binding;, P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96GV4 Q96PI7 Q9H9N0 Q9NV81,Elongator complex protein 2,SHINC-2;STAT3-interacting protein 1;, PF00400;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0008023;GO:0019901;GO:0046425;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:protein kinase binding;, P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96GV4 Q96PI7 Q9H9N0 Q9NV81,Elongator complex protein 2,SHINC-2;STAT3-interacting protein 1;, PF00400;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0008023;GO:0019901;GO:0046425;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:protein kinase binding;, P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96GV4 Q96PI7 Q9H9N0 Q9NV81,Elongator complex protein 2,SHINC-2;STAT3-interacting protein 1;, PF00400;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0008023;GO:0019901;GO:0046425;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:protein kinase binding;, P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification; scaffold10 indexed_genome mRNA 18972355 18991105 . + . ID=transcript_2608;Q13433 B4DR49 B4E224 Q8IXR3 Q96HP5,Zinc transporter ZIP6,Estrogen-regulated protein LIV-1;Solute carrier family 39 member 6;Zrt- and Irt-like protein 6;, PF02535;, GO:0009986;GO:0005783;GO:0005887;GO:0031258;GO:0005886;GO:0005385;GO:0006882;GO:0071578;GO:0071577;, C:cell surface; C:endoplasmic reticulum; C:integral component of plasma membrane; C:lamellipodium membrane; C:plasma membrane;, F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport;|Q13433 B4DR49 B4E224 Q8IXR3 Q96HP5,Zinc transporter ZIP6,Estrogen-regulated protein LIV-1;Solute carrier family 39 member 6;Zrt- and Irt-like protein 6;, PF02535;, GO:0009986;GO:0005783;GO:0005887;GO:0031258;GO:0005886;GO:0005385;GO:0006882;GO:0071578;GO:0071577;, C:cell surface; C:endoplasmic reticulum; C:integral component of plasma membrane; C:lamellipodium membrane; C:plasma membrane;, F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport;|Q13433 B4DR49 B4E224 Q8IXR3 Q96HP5,Zinc transporter ZIP6,Estrogen-regulated protein LIV-1;Solute carrier family 39 member 6;Zrt- and Irt-like protein 6;, PF02535;, GO:0009986;GO:0005783;GO:0005887;GO:0031258;GO:0005886;GO:0005385;GO:0006882;GO:0071578;GO:0071577;, C:cell surface; C:endoplasmic reticulum; C:integral component of plasma membrane; C:lamellipodium membrane; C:plasma membrane;, F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport; scaffold10 indexed_genome mRNA 19018097 19051952 . + . ID=transcript_2609;Q96P16 A8KA42 B2RBA3 Q7Z5G8 Q96FY9 Q9NVL4,Regulation of nuclear pre-mRNA domain-containing protein 1A,Cyclin-dependent kinase inhibitor 2B-related protein;p15INK4B-related protein;, PF04818;PF16566;, GO:0005654;GO:0016591;GO:0042802;GO:0000993;GO:0070940;GO:0031124;GO:0042795;, C:nucleoplasm; C:RNA polymerase II, holoenzyme;, F:identical protein binding; F:RNA polymerase II complex binding;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:mRNA 3'-end processing; P:snRNA transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 19061610 19062161 . - . ID=transcript_2610;Q9NR30 B2RDL0 Q13436 Q5VX41 Q68D35,Nucleolar RNA helicase 2 {ECO:0000305},DEAD box protein 21;Gu-alpha;Nucleolar RNA helicase Gu;Nucleolar RNA helicase II;RH II/Gu;, PF00270;PF08152;PF00271;, GO:0005694;GO:0005829;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0097322;GO:0005524;GO:0003725;GO:0042802;GO:0035198;GO:0003723;GO:0003724;GO:0019843;GO:0030515;GO:0051607;GO:0045087;GO:0001649;GO:0045815;GO:0043123;GO:0002735;GO:0062176;GO:0043330;GO:0006364;GO:0006366;, C:chromosome; C:cytosol; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:7SK snRNA binding; F:ATP binding; F:double-stranded RNA binding; F:identical protein binding; F:miRNA binding; F:RNA binding; F:RNA helicase activity; F:rRNA binding; F:snoRNA binding;, P:defense response to virus; P:innate immune response; P:osteoblast differentiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of myeloid dendritic cell cytokine production; P:R-loop disassembly; P:response to exogenous dsRNA; P:rRNA processing; P:transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 19079846 19083701 . - . ID=transcript_2611;Q96P16 A8KA42 B2RBA3 Q7Z5G8 Q96FY9 Q9NVL4,Regulation of nuclear pre-mRNA domain-containing protein 1A,Cyclin-dependent kinase inhibitor 2B-related protein;p15INK4B-related protein;, PF04818;PF16566;, GO:0005654;GO:0016591;GO:0042802;GO:0000993;GO:0070940;GO:0031124;GO:0042795;, C:nucleoplasm; C:RNA polymerase II, holoenzyme;, F:identical protein binding; F:RNA polymerase II complex binding;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:mRNA 3'-end processing; P:snRNA transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 19098122 19108839 . - . ID=transcript_2612;Q32NC0 Q6GW03 Q9BXV6 Q9BXW2,UPF0711 protein C18orf21,HBV X-transactivated gene 13 protein;HBV XAg-transactivated protein 13;, PF15719;|Q32NC0 Q6GW03 Q9BXV6 Q9BXW2,UPF0711 protein C18orf21,HBV X-transactivated gene 13 protein;HBV XAg-transactivated protein 13;, PF15719; scaffold10 indexed_genome mRNA 19322935 19395628 . - . ID=transcript_2613;Q10472 Q86TJ7 Q9UM86,Polypeptide N-acetylgalactosaminyltransferase 1,Polypeptide GalNAc transferase 1;Protein-UDP acetylgalactosaminyltransferase 1;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1;, PF00535;PF00652;, GO:0005789;GO:0033116;GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0030246;GO:0030145;GO:0004653;GO:0016266;GO:0006493;GO:0018242;GO:0018243;GO:0019082;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm;, F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine; P:viral protein processing;|Q10472 Q86TJ7 Q9UM86,Polypeptide N-acetylgalactosaminyltransferase 1,Polypeptide GalNAc transferase 1;Protein-UDP acetylgalactosaminyltransferase 1;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1;, PF00535;PF00652;, GO:0005789;GO:0033116;GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0030246;GO:0030145;GO:0004653;GO:0016266;GO:0006493;GO:0018242;GO:0018243;GO:0019082;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm;, F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine; P:viral protein processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q10472 Q86TJ7 Q9UM86,Polypeptide N-acetylgalactosaminyltransferase 1,Polypeptide GalNAc transferase 1;Protein-UDP acetylgalactosaminyltransferase 1;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1;, PF00535;PF00652;, GO:0005789;GO:0033116;GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0030246;GO:0030145;GO:0004653;GO:0016266;GO:0006493;GO:0018242;GO:0018243;GO:0019082;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm;, F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine; P:viral protein processing; scaffold10 indexed_genome mRNA 19526845 19550483 . + . ID=transcript_2614;Q6PI98 B4DUI4 E9PCS7 Q86WR1 Q8N994,INO80 complex subunit C,IES6 homolog;, PF08265;, GO:0031011;GO:0071339;GO:0005654;GO:0006338;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:MLL1 complex; C:nucleoplasm;, , P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q6PI98 B4DUI4 E9PCS7 Q86WR1 Q8N994,INO80 complex subunit C,IES6 homolog;, PF08265;, GO:0031011;GO:0071339;GO:0005654;GO:0006338;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:MLL1 complex; C:nucleoplasm;, , P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q6PI98 B4DUI4 E9PCS7 Q86WR1 Q8N994,INO80 complex subunit C,IES6 homolog;, PF08265;, GO:0031011;GO:0071339;GO:0005654;GO:0006338;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:MLL1 complex; C:nucleoplasm;, , P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:protein deubiquitination; scaffold10 indexed_genome mRNA 19621825 19624117 . + . ID=transcript_2615;Q96N95 A1L3V0 Q8NF98 Q8TD80,Zinc finger protein 396,Zinc finger and SCAN domain-containing protein 14;, PF02023;PF00096;, GO:0000785;GO:0005737;GO:0005634;GO:0000981;GO:0046872;GO:0046982;GO:0042803;GO:0000978;GO:1990837;GO:0045892;GO:0006357;, C:chromatin; C:cytoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 19638057 19649366 . + . ID=transcript_2616;P17028 O14754 Q53YE4 Q6ICR5 Q8IZN4,Zinc finger protein 24,Retinoic acid suppression protein A;Zinc finger and SCAN domain-containing protein 3;Zinc finger protein 191;Zinc finger protein KOX17;, PF02023;PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0043565;GO:0042552;GO:0045892;GO:0045944;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:myelination; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P17028 O14754 Q53YE4 Q6ICR5 Q8IZN4,Zinc finger protein 24,Retinoic acid suppression protein A;Zinc finger and SCAN domain-containing protein 3;Zinc finger protein 191;Zinc finger protein KOX17;, PF02023;PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0043565;GO:0042552;GO:0045892;GO:0045944;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:myelination; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P17028 O14754 Q53YE4 Q6ICR5 Q8IZN4,Zinc finger protein 24,Retinoic acid suppression protein A;Zinc finger and SCAN domain-containing protein 3;Zinc finger protein 191;Zinc finger protein KOX17;, PF02023;PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0043565;GO:0042552;GO:0045892;GO:0045944;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:myelination; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 19666523 19668829 . + . ID=transcript_2617;Q8TAQ5 B2RDY6 Q96ML5,Zinc finger protein 420,, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0042981;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of apoptotic process; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 19693534 19696608 . + . ID=transcript_2618;Q86W11 B4E0N0 Q6ZNB3 Q96PN3,Zinc finger and SCAN domain-containing protein 30,ZNF-WYM;Zinc finger protein 397 opposite strand;Zinc finger protein 397OS;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 19699217 19706727 . - . ID=transcript_2619;Q86W11 B4E0N0 Q6ZNB3 Q96PN3,Zinc finger and SCAN domain-containing protein 30,ZNF-WYM;Zinc finger protein 397 opposite strand;Zinc finger protein 397OS;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 19707332 19712927 . + . ID=transcript_2620;Q8NF99 Q9BRM2,Zinc finger protein 397,Zinc finger and SCAN domain-containing protein 15;Zinc finger protein 47;, PF02023;PF00096;, GO:0005737;GO:0005829;GO:0015630;GO:0005730;GO:0005634;GO:0005886;GO:0000981;GO:0046872;GO:0046982;GO:0042803;GO:0000978;GO:0045892;GO:0006357;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleolus; C:nucleus; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 19713453 19715131 . - . ID=transcript_2621;Q8NF99 Q9BRM2,Zinc finger protein 397,Zinc finger and SCAN domain-containing protein 15;Zinc finger protein 47;, PF02023;PF00096;, GO:0005737;GO:0005829;GO:0015630;GO:0005730;GO:0005634;GO:0005886;GO:0000981;GO:0046872;GO:0046982;GO:0042803;GO:0000978;GO:0045892;GO:0006357;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleolus; C:nucleus; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 19978936 19979868 . + . ID=transcript_2622;Q15555 B2RE21 B3KR39 B4DJV4 B7Z2L3 E9PHR3 F5H1V8 G5E9I6 Q9UQ33,Microtubule-associated protein RP/EB family member 2,APC-binding protein EB2;End-binding protein 2;, PF00307;PF03271;, GO:0005737;GO:0005881;GO:0005925;GO:0015630;GO:0005815;GO:0035371;GO:0051233;GO:0042802;GO:0008017;GO:0051010;GO:0019901;GO:0051301;GO:0032014;GO:0120183;GO:0043547;GO:0051549;GO:1904825;GO:0031110;GO:0051225;, C:cytoplasm; C:cytoplasmic microtubule; C:focal adhesion; C:microtubule cytoskeleton; C:microtubule organizing center; C:microtubule plus-end; C:spindle midzone;, F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding;, P:cell division; P:positive regulation of ARF protein signal transduction; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:protein localization to microtubule plus-end; P:regulation of microtubule polymerization or depolymerization; P:spindle assembly; scaffold10 indexed_genome mRNA 20042914 20062061 . - . ID=transcript_2623;Q59GK7 Q9BS59,Dystrobrevin alpha,Alpha-dystrobrevin;Dystrophin-related protein 3;, PF09068;PF09069;PF00569;, GO:0030054;GO:0005737;GO:0045111;GO:0005654;GO:0005886;GO:0032991;GO:0045202;GO:0008270;GO:0007268;GO:0007274;GO:0007165;GO:0006941;GO:0099536;, C:cell junction; C:cytoplasm; C:intermediate filament cytoskeleton; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:zinc ion binding;, P:chemical synaptic transmission; P:neuromuscular synaptic transmission; P:signal transduction; P:striated muscle contraction; P:synaptic signaling;|Q59GK7 Q9BS59,Dystrobrevin alpha,Alpha-dystrobrevin;Dystrophin-related protein 3;, PF09068;PF09069;PF00569;, GO:0030054;GO:0005737;GO:0045111;GO:0005654;GO:0005886;GO:0032991;GO:0045202;GO:0008270;GO:0007268;GO:0007274;GO:0007165;GO:0006941;GO:0099536;, C:cell junction; C:cytoplasm; C:intermediate filament cytoskeleton; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:zinc ion binding;, P:chemical synaptic transmission; P:neuromuscular synaptic transmission; P:signal transduction; P:striated muscle contraction; P:synaptic signaling;|Q59GK7 Q9BS59,Dystrobrevin alpha,Alpha-dystrobrevin;Dystrophin-related protein 3;, PF09068;PF09069;PF00569;, GO:0030054;GO:0005737;GO:0045111;GO:0005654;GO:0005886;GO:0032991;GO:0045202;GO:0008270;GO:0007268;GO:0007274;GO:0007165;GO:0006941;GO:0099536;, C:cell junction; C:cytoplasm; C:intermediate filament cytoskeleton; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:zinc ion binding;, P:chemical synaptic transmission; P:neuromuscular synaptic transmission; P:signal transduction; P:striated muscle contraction; P:synaptic signaling; scaffold10 indexed_genome mRNA 20064106 20337774 . - . ID=transcript_2624;Q59GK7 Q9BS59,Dystrobrevin alpha,Alpha-dystrobrevin;Dystrophin-related protein 3;, PF09068;PF09069;PF00569;, GO:0030054;GO:0005737;GO:0045111;GO:0005654;GO:0005886;GO:0032991;GO:0045202;GO:0008270;GO:0007268;GO:0007274;GO:0007165;GO:0006941;GO:0099536;, C:cell junction; C:cytoplasm; C:intermediate filament cytoskeleton; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:zinc ion binding;, P:chemical synaptic transmission; P:neuromuscular synaptic transmission; P:signal transduction; P:striated muscle contraction; P:synaptic signaling;|Q59GK7 Q9BS59,Dystrobrevin alpha,Alpha-dystrobrevin;Dystrophin-related protein 3;, PF09068;PF09069;PF00569;, GO:0030054;GO:0005737;GO:0045111;GO:0005654;GO:0005886;GO:0032991;GO:0045202;GO:0008270;GO:0007268;GO:0007274;GO:0007165;GO:0006941;GO:0099536;, C:cell junction; C:cytoplasm; C:intermediate filament cytoskeleton; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:zinc ion binding;, P:chemical synaptic transmission; P:neuromuscular synaptic transmission; P:signal transduction; P:striated muscle contraction; P:synaptic signaling;|Q59GK7 Q9BS59,Dystrobrevin alpha,Alpha-dystrobrevin;Dystrophin-related protein 3;, PF09068;PF09069;PF00569;, GO:0030054;GO:0005737;GO:0045111;GO:0005654;GO:0005886;GO:0032991;GO:0045202;GO:0008270;GO:0007268;GO:0007274;GO:0007165;GO:0006941;GO:0099536;, C:cell junction; C:cytoplasm; C:intermediate filament cytoskeleton; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:zinc ion binding;, P:chemical synaptic transmission; P:neuromuscular synaptic transmission; P:signal transduction; P:striated muscle contraction; P:synaptic signaling;|Q59GK7 Q9BS59,Dystrobrevin alpha,Alpha-dystrobrevin;Dystrophin-related protein 3;, PF09068;PF09069;PF00569;, GO:0030054;GO:0005737;GO:0045111;GO:0005654;GO:0005886;GO:0032991;GO:0045202;GO:0008270;GO:0007268;GO:0007274;GO:0007165;GO:0006941;GO:0099536;, C:cell junction; C:cytoplasm; C:intermediate filament cytoskeleton; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:zinc ion binding;, P:chemical synaptic transmission; P:neuromuscular synaptic transmission; P:signal transduction; P:striated muscle contraction; P:synaptic signaling; scaffold10 indexed_genome mRNA 20716035 21149474 . + . ID=transcript_2625;O94818 B4DSQ0 B7Z3Z7 F5H1E3 Q6IBS2 Q9BWF1,Nucleolar protein 4,Nucleolar-localized protein;, , GO:0005730;GO:0003723;, C:nucleolus;, F:RNA binding; scaffold10 indexed_genome mRNA 21250353 21251313 . - . ID=transcript_2626;Q9C0F0 Q6ZMX6 Q96MU3 Q9UFC5,Putative Polycomb group protein ASXL3,Additional sex combs-like protein 3;, PF13919;PF05066;PF13922;, GO:0035517;GO:0003682;GO:0003677;GO:0046872;GO:0042975;GO:0009887;GO:0051055;GO:0045944;GO:0006351;, C:PR-DUB complex;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:peroxisome proliferator activated receptor binding;, P:animal organ morphogenesis; P:negative regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold10 indexed_genome mRNA 21252393 21253020 . + . ID=transcript_2627;Q9C0F0 Q6ZMX6 Q96MU3 Q9UFC5,Putative Polycomb group protein ASXL3,Additional sex combs-like protein 3;, PF13919;PF05066;PF13922;, GO:0035517;GO:0003682;GO:0003677;GO:0046872;GO:0042975;GO:0009887;GO:0051055;GO:0045944;GO:0006351;, C:PR-DUB complex;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:peroxisome proliferator activated receptor binding;, P:animal organ morphogenesis; P:negative regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold10 indexed_genome mRNA 21257313 21257854 . + . ID=transcript_2628;Q9C0F0 Q6ZMX6 Q96MU3 Q9UFC5,Putative Polycomb group protein ASXL3,Additional sex combs-like protein 3;, PF13919;PF05066;PF13922;, GO:0035517;GO:0003682;GO:0003677;GO:0046872;GO:0042975;GO:0009887;GO:0051055;GO:0045944;GO:0006351;, C:PR-DUB complex;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:peroxisome proliferator activated receptor binding;, P:animal organ morphogenesis; P:negative regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold10 indexed_genome mRNA 21259031 21331314 . - . ID=transcript_2629;Q9C0F0 Q6ZMX6 Q96MU3 Q9UFC5,Putative Polycomb group protein ASXL3,Additional sex combs-like protein 3;, PF13919;PF05066;PF13922;, GO:0035517;GO:0003682;GO:0003677;GO:0046872;GO:0042975;GO:0009887;GO:0051055;GO:0045944;GO:0006351;, C:PR-DUB complex;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:peroxisome proliferator activated receptor binding;, P:animal organ morphogenesis; P:negative regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold10 indexed_genome mRNA 22131327 22131855 . + . ID=transcript_2630;Q9P2G3 A6NNW1 B4DHA0 Q8WU41,Kelch-like protein 14,Protein interactor of Torsin-1A;, PF07707;PF00651;PF01344;, GO:0015629;GO:0016235;GO:0005829;GO:0005783;GO:0005789;GO:0043005;GO:0043025;, C:actin cytoskeleton; C:aggresome; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:neuron projection; C:neuronal cell body; scaffold10 indexed_genome mRNA 22235203 22238018 . + . ID=transcript_2631;Q9P2G3 A6NNW1 B4DHA0 Q8WU41,Kelch-like protein 14,Protein interactor of Torsin-1A;, PF07707;PF00651;PF01344;, GO:0015629;GO:0016235;GO:0005829;GO:0005783;GO:0005789;GO:0043005;GO:0043025;, C:actin cytoskeleton; C:aggresome; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:neuron projection; C:neuronal cell body; scaffold10 indexed_genome mRNA 22664710 22668056 . - . ID=transcript_2632;Q9H706 Q0VAG3 Q0VAG4 Q8ND03 Q9BSF5,GRB2-associated and regulator of MAPK protein 1,GRB2-associated and regulator of MAPK1;, PF12736;, GO:0005886;GO:0070064;GO:0071364;GO:0007173;GO:0051781;GO:0008284;GO:0070374;, C:plasma membrane;, F:proline-rich region binding;, P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade;|Q9H706 Q0VAG3 Q0VAG4 Q8ND03 Q9BSF5,GRB2-associated and regulator of MAPK protein 1,GRB2-associated and regulator of MAPK1;, PF12736;, GO:0005886;GO:0070064;GO:0071364;GO:0007173;GO:0051781;GO:0008284;GO:0070374;, C:plasma membrane;, F:proline-rich region binding;, P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; scaffold10 indexed_genome mRNA 22720936 22757405 . - . ID=transcript_2633;Q16820 B7ZM35 B9EGL6 Q670J1,Meprin A subunit beta,Endopeptidase-2;Meprin B;N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit beta;PABA peptide hydrolase;PPH beta;, PF01400;PF00629;, GO:0005576;GO:0005887;GO:0017090;GO:0042802;GO:0004222;GO:0008270;GO:0006954;GO:1901998;, C:extracellular region; C:integral component of plasma membrane; C:meprin A complex;, F:identical protein binding; F:metalloendopeptidase activity; F:zinc ion binding;, P:inflammatory response; P:toxin transport; scaffold10 indexed_genome mRNA 22810088 22810693 . - . ID=transcript_2634;Q8WVD3 B2RE17 Q9H8K2 Q9UF87 Q9UKI6,E3 ubiquitin-protein ligase RNF138 {ECO:0000305},Nemo-like kinase-associated RING finger protein {ECO:0000303|PubMed:16714285};RING finger protein 138 {ECO:0000305};RING-type E3 ubiquitin transferase RNF138 {ECO:0000305};, PF05605;PF18574;, GO:0005634;GO:0035861;GO:0046872;GO:0019901;GO:0003697;GO:0061630;GO:1990830;GO:0010792;GO:0000724;GO:0016567;GO:0016055;, C:nucleus; C:site of double-strand break;, F:metal ion binding; F:protein kinase binding; F:single-stranded DNA binding; F:ubiquitin protein ligase activity;, P:cellular response to leukemia inhibitory factor; P:DNA double-strand break processing involved in repair via single-strand annealing; P:double-strand break repair via homologous recombination; P:protein ubiquitination; P:Wnt signaling pathway; scaffold10 indexed_genome mRNA 22824779 22827069 . - . ID=transcript_2635;Q8WVD3 B2RE17 Q9H8K2 Q9UF87 Q9UKI6,E3 ubiquitin-protein ligase RNF138 {ECO:0000305},Nemo-like kinase-associated RING finger protein {ECO:0000303|PubMed:16714285};RING finger protein 138 {ECO:0000305};RING-type E3 ubiquitin transferase RNF138 {ECO:0000305};, PF05605;PF18574;, GO:0005634;GO:0035861;GO:0046872;GO:0019901;GO:0003697;GO:0061630;GO:1990830;GO:0010792;GO:0000724;GO:0016567;GO:0016055;, C:nucleus; C:site of double-strand break;, F:metal ion binding; F:protein kinase binding; F:single-stranded DNA binding; F:ubiquitin protein ligase activity;, P:cellular response to leukemia inhibitory factor; P:DNA double-strand break processing involved in repair via single-strand annealing; P:double-strand break repair via homologous recombination; P:protein ubiquitination; P:Wnt signaling pathway; scaffold10 indexed_genome mRNA 22870728 22910707 . - . ID=transcript_2636;Q96EQ8 Q9NX39,E3 ubiquitin-protein ligase RNF125 {ECO:0000305},RING finger protein 125 {ECO:0000312|HGNC:HGNC:21150};T-cell RING activation protein 1 {ECO:0000303|PubMed:12974981};, PF05605;PF18574;, GO:0000139;GO:0043231;GO:0034098;GO:0002039;GO:0031624;GO:0061630;GO:0008270;GO:0002250;GO:1990830;GO:0039536;GO:0032480;GO:0000209;GO:0006511;, C:Golgi membrane; C:intracellular membrane-bounded organelle; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:p53 binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:adaptive immune response; P:cellular response to leukemia inhibitory factor; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold10 indexed_genome mRNA 22971041 22971848 . + . ID=transcript_2637;P61570,Endogenous retrovirus group K member 25 Env polyprotein,Envelope polyprotein;HERV-K_11q22.1 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity; scaffold10 indexed_genome mRNA 22988534 23073114 . + . ID=transcript_2638;Q9Y2L5 A0JP15 B3KME5 Q9H0L2,Trafficking protein particle complex subunit 8,Protein TRS85 homolog;, PF12739;, GO:0031410;GO:0005829;GO:0000407;GO:0030008;GO:1990072;GO:0030242;GO:0006888;GO:0007030;GO:0034497;, C:cytoplasmic vesicle; C:cytosol; C:phagophore assembly site; C:TRAPP complex; C:TRAPPIII protein complex;, , P:autophagy of peroxisome; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein localization to phagophore assembly site;|Q9Y2L5 A0JP15 B3KME5 Q9H0L2,Trafficking protein particle complex subunit 8,Protein TRS85 homolog;, PF12739;, GO:0031410;GO:0005829;GO:0000407;GO:0030008;GO:1990072;GO:0030242;GO:0006888;GO:0007030;GO:0034497;, C:cytoplasmic vesicle; C:cytosol; C:phagophore assembly site; C:TRAPP complex; C:TRAPPIII protein complex;, , P:autophagy of peroxisome; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein localization to phagophore assembly site;|Q9Y2L5 A0JP15 B3KME5 Q9H0L2,Trafficking protein particle complex subunit 8,Protein TRS85 homolog;, PF12739;, GO:0031410;GO:0005829;GO:0000407;GO:0030008;GO:1990072;GO:0030242;GO:0006888;GO:0007030;GO:0034497;, C:cytoplasmic vesicle; C:cytosol; C:phagophore assembly site; C:TRAPP complex; C:TRAPPIII protein complex;, , P:autophagy of peroxisome; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein localization to phagophore assembly site;|Q9Y2L5 A0JP15 B3KME5 Q9H0L2,Trafficking protein particle complex subunit 8,Protein TRS85 homolog;, PF12739;, GO:0031410;GO:0005829;GO:0000407;GO:0030008;GO:1990072;GO:0030242;GO:0006888;GO:0007030;GO:0034497;, C:cytoplasmic vesicle; C:cytosol; C:phagophore assembly site; C:TRAPP complex; C:TRAPPIII protein complex;, , P:autophagy of peroxisome; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:protein localization to phagophore assembly site; scaffold10 indexed_genome mRNA 23176909 23245169 . + . ID=transcript_2639;Q9UBX8 O60514 Q6NT09,Beta-1,4-galactosyltransferase 6 {ECO:0000305},Glucosylceramide beta-1,4-galactosyltransferase;Lactosylceramide synthase {ECO:0000303|PubMed:24498430};UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6;UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:3099851};UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6;, PF02709;PF13733;, GO:0032580;GO:0000139;GO:0016021;GO:0008378;GO:0046872;GO:0008489;GO:0005975;GO:0022010;GO:0021955;GO:0010706;GO:0018146;GO:0001572;GO:0042551;GO:0006486;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:galactosyltransferase activity; F:metal ion binding; F:UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity;, P:carbohydrate metabolic process; P:central nervous system myelination; P:central nervous system neuron axonogenesis; P:ganglioside biosynthetic process via lactosylceramide; P:keratan sulfate biosynthetic process; P:lactosylceramide biosynthetic process; P:neuron maturation; P:protein glycosylation;|Q9UBX8 O60514 Q6NT09,Beta-1,4-galactosyltransferase 6 {ECO:0000305},Glucosylceramide beta-1,4-galactosyltransferase;Lactosylceramide synthase {ECO:0000303|PubMed:24498430};UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6;UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:3099851};UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6;, PF02709;PF13733;, GO:0032580;GO:0000139;GO:0016021;GO:0008378;GO:0046872;GO:0008489;GO:0005975;GO:0022010;GO:0021955;GO:0010706;GO:0018146;GO:0001572;GO:0042551;GO:0006486;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:galactosyltransferase activity; F:metal ion binding; F:UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity;, P:carbohydrate metabolic process; P:central nervous system myelination; P:central nervous system neuron axonogenesis; P:ganglioside biosynthetic process via lactosylceramide; P:keratan sulfate biosynthetic process; P:lactosylceramide biosynthetic process; P:neuron maturation; P:protein glycosylation; scaffold10 indexed_genome mRNA 23251573 23267063 . - . ID=transcript_2640;P02766 Q549C7 Q6IB96 Q9UBZ6 Q9UCM9,Transthyretin,ATTR;Prealbumin;TBPA;, PF00576;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:0032991;GO:0005179;GO:0042802;GO:0044877;GO:0070324;GO:1990000;GO:0030198;GO:0043312;GO:0006144;GO:0001523;GO:0042572;GO:0070327;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:protein-containing complex;, F:hormone activity; F:identical protein binding; F:protein-containing complex binding; F:thyroid hormone binding;, P:amyloid fibril formation; P:extracellular matrix organization; P:neutrophil degranulation; P:purine nucleobase metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:thyroid hormone transport;|P02766 Q549C7 Q6IB96 Q9UBZ6 Q9UCM9,Transthyretin,ATTR;Prealbumin;TBPA;, PF00576;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:0032991;GO:0005179;GO:0042802;GO:0044877;GO:0070324;GO:1990000;GO:0030198;GO:0043312;GO:0006144;GO:0001523;GO:0042572;GO:0070327;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:protein-containing complex;, F:hormone activity; F:identical protein binding; F:protein-containing complex binding; F:thyroid hormone binding;, P:amyloid fibril formation; P:extracellular matrix organization; P:neutrophil degranulation; P:purine nucleobase metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:thyroid hormone transport; scaffold10 indexed_genome mRNA 23314356 23345809 . + . ID=transcript_2641;Q14126 Q4KKU6,Desmoglein-2,Cadherin family member 5;HDGC;, PF00028;, GO:0016324;GO:0030054;GO:0009986;GO:0005911;GO:0001533;GO:0030057;GO:0070062;GO:0016021;GO:0014704;GO:0043231;GO:0016328;GO:0005886;GO:0005509;GO:0050839;GO:0086083;GO:0086073;GO:0007155;GO:0098609;GO:0070268;GO:0002934;GO:0007156;GO:0031424;GO:0060135;GO:0003165;GO:0086091;GO:0098911;GO:0032570;, C:apical plasma membrane; C:cell junction; C:cell surface; C:cell-cell junction; C:cornified envelope; C:desmosome; C:extracellular exosome; C:integral component of membrane; C:intercalated disc; C:intracellular membrane-bounded organelle; C:lateral plasma membrane; C:plasma membrane;, F:calcium ion binding; F:cell adhesion molecule binding; F:cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication;, P:bundle of His cell-Purkinje myocyte adhesion involved in cell communication; P:cell adhesion; P:cell-cell adhesion; P:cornification; P:desmosome organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinization; P:maternal process involved in female pregnancy; P:Purkinje myocyte development; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell action potential; P:response to progesterone;|Q14126 Q4KKU6,Desmoglein-2,Cadherin family member 5;HDGC;, PF00028;, GO:0016324;GO:0030054;GO:0009986;GO:0005911;GO:0001533;GO:0030057;GO:0070062;GO:0016021;GO:0014704;GO:0043231;GO:0016328;GO:0005886;GO:0005509;GO:0050839;GO:0086083;GO:0086073;GO:0007155;GO:0098609;GO:0070268;GO:0002934;GO:0007156;GO:0031424;GO:0060135;GO:0003165;GO:0086091;GO:0098911;GO:0032570;, C:apical plasma membrane; C:cell junction; C:cell surface; C:cell-cell junction; C:cornified envelope; C:desmosome; C:extracellular exosome; C:integral component of membrane; C:intercalated disc; C:intracellular membrane-bounded organelle; C:lateral plasma membrane; C:plasma membrane;, F:calcium ion binding; F:cell adhesion molecule binding; F:cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication;, P:bundle of His cell-Purkinje myocyte adhesion involved in cell communication; P:cell adhesion; P:cell-cell adhesion; P:cornification; P:desmosome organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinization; P:maternal process involved in female pregnancy; P:Purkinje myocyte development; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell action potential; P:response to progesterone; scaffold10 indexed_genome mRNA 23384379 23385163 . + . ID=transcript_2642;P32926 A8K2V2,Desmoglein-3,130 kDa pemphigus vulgaris antigen;Cadherin family member 6;, PF00028;PF01049;, GO:0005911;GO:0001533;GO:0005829;GO:0030057;GO:0070062;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0070268;GO:0007156;GO:0031424;, C:cell-cell junction; C:cornified envelope; C:cytosol; C:desmosome; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cornification; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinization; scaffold10 indexed_genome mRNA 23716325 23749397 . + . ID=transcript_2643;Q02487,Desmocollin-2 {ECO:0000303|PubMed:28256248},Cadherin family member 2;Desmocollin-3;Desmosomal glycoprotein II;Desmosomal glycoprotein III;, PF00028;PF01049;PF08758;, GO:0005912;GO:0005911;GO:0001533;GO:0031410;GO:0030057;GO:0070062;GO:0016021;GO:0014704;GO:0005886;GO:0005509;GO:0086083;GO:0086073;GO:0086042;GO:0007155;GO:0098609;GO:0009267;GO:0070268;GO:0007156;GO:0031424;GO:0086091;GO:0098911;, C:adherens junction; C:cell-cell junction; C:cornified envelope; C:cytoplasmic vesicle; C:desmosome; C:extracellular exosome; C:integral component of membrane; C:intercalated disc; C:plasma membrane;, F:calcium ion binding; F:cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication;, P:bundle of His cell-Purkinje myocyte adhesion involved in cell communication; P:cardiac muscle cell-cardiac muscle cell adhesion; P:cell adhesion; P:cell-cell adhesion; P:cellular response to starvation; P:cornification; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinization; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell action potential; scaffold10 indexed_genome mRNA 26388224 26389698 . + . ID=transcript_2644;P19022 A8MWK3 B0YIY6 Q14923 Q8N173,Cadherin-2,CDw325;Neural cadherin;, PF00028;PF01049;PF08758;, GO:0005912;GO:0045177;GO:0016324;GO:0016327;GO:0016323;GO:0016342;GO:0030054;GO:0009986;GO:0005911;GO:0062023;GO:0005737;GO:0005788;GO:0005916;GO:0005925;GO:0005887;GO:0099060;GO:0099059;GO:0014704;GO:0030027;GO:0043005;GO:0005886;GO:0044853;GO:0014069;GO:0042383;GO:0045294;GO:0008013;GO:0045296;GO:0005509;GO:0045295;GO:0042802;GO:0019901;GO:0019903;GO:0034332;GO:0048514;GO:0007420;GO:0048854;GO:0016339;GO:0007155;GO:0098609;GO:0044331;GO:0098742;GO:0007043;GO:0044267;GO:0021987;GO:0035995;GO:0010001;GO:0007157;GO:0048872;GO:0007156;GO:0090497;GO:0090090;GO:0014032;GO:0060563;GO:0097118;GO:0097150;GO:0043410;GO:0051149;GO:2000809;GO:0043687;GO:0072659;GO:0060019;GO:0050770;GO:0070445;GO:1902897;GO:0051966;GO:0051146;GO:0007416;GO:0003323;, C:adherens junction; C:apical part of cell; C:apical plasma membrane; C:apicolateral plasma membrane; C:basolateral plasma membrane; C:catenin complex; C:cell junction; C:cell surface; C:cell-cell junction; C:collagen-containing extracellular matrix; C:cytoplasm; C:endoplasmic reticulum lumen; C:fascia adherens; C:focal adhesion; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:integral component of presynaptic active zone membrane; C:intercalated disc; C:lamellipodium; C:neuron projection; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:sarcolemma;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:calcium ion binding; F:gamma-catenin binding; F:identical protein binding; F:protein kinase binding; F:protein phosphatase binding;, P:adherens junction organization; P:blood vessel morphogenesis; P:brain development; P:brain morphogenesis; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:cellular protein metabolic process; P:cerebral cortex development; P:detection of muscle stretch; P:glial cell differentiation; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homeostasis of number of cells; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:mesenchymal cell migration; P:negative regulation of canonical Wnt signaling pathway; P:neural crest cell development; P:neuroepithelial cell differentiation; P:neuroligin clustering involved in postsynaptic membrane assembly; P:neuronal stem cell population maintenance; P:positive regulation of MAPK cascade; P:positive regulation of muscle cell differentiation; P:positive regulation of synaptic vesicle clustering; P:post-translational protein modification; P:protein localization to plasma membrane; P:radial glial cell differentiation; P:regulation of axonogenesis; P:regulation of oligodendrocyte progenitor proliferation; P:regulation of postsynaptic density protein 95 clustering; P:regulation of synaptic transmission, glutamatergic; P:striated muscle cell differentiation; P:synapse assembly; P:type B pancreatic cell development; scaffold10 indexed_genome mRNA 27394439 27405659 . + . ID=transcript_2645;P55087 P78564,Aquaporin-4,Mercurial-insensitive water channel {ECO:0000303|PubMed:7559426};WCH4;, PF00230;, GO:0097450;GO:0016323;GO:0005737;GO:0010008;GO:0009897;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0042383;GO:0042802;GO:0015250;GO:0071346;GO:0009992;GO:0090660;GO:0050891;GO:0051289;GO:0003091;GO:0030104;GO:0006833;, C:astrocyte end-foot; C:basolateral plasma membrane; C:cytoplasm; C:endosome membrane; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:sarcolemma;, F:identical protein binding; F:water channel activity;, P:cellular response to interferon-gamma; P:cellular water homeostasis; P:cerebrospinal fluid circulation; P:multicellular organismal water homeostasis; P:protein homotetramerization; P:renal water homeostasis; P:water homeostasis; P:water transport; scaffold10 indexed_genome mRNA 27714116 27808914 . + . ID=transcript_2646;Q719H9 A8K1F5,BTB/POZ domain-containing protein KCTD1,Potassium channel tetramerization domain-containing protein 1;, PF02214;, GO:0034451;GO:0005829;GO:0045171;GO:0005730;GO:0005654;GO:0005634;GO:0042802;GO:0003714;GO:0008134;GO:0000122;GO:0045892;GO:0051260;, C:centriolar satellite; C:cytosol; C:intercellular bridge; C:nucleolus; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:transcription corepressor activity; F:transcription factor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein homooligomerization; scaffold10 indexed_genome mRNA 27866571 27937009 . - . ID=transcript_2647;Q92750 Q29YA4 Q29YA5,Transcription initiation factor TFIID subunit 4B,Transcription initiation factor TFIID 105 kDa subunit;, PF05236;PF07531;, GO:0005737;GO:0001650;GO:0005654;GO:0005669;GO:0003677;GO:0051059;GO:0046982;GO:0016251;GO:0048477;GO:1901796;GO:0007283;GO:0006366;GO:0006367;, C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:NF-kappaB binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity;, P:oogenesis; P:regulation of signal transduction by p53 class mediator; P:spermatogenesis; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q92750 Q29YA4 Q29YA5,Transcription initiation factor TFIID subunit 4B,Transcription initiation factor TFIID 105 kDa subunit;, PF05236;PF07531;, GO:0005737;GO:0001650;GO:0005654;GO:0005669;GO:0003677;GO:0051059;GO:0046982;GO:0016251;GO:0048477;GO:1901796;GO:0007283;GO:0006366;GO:0006367;, C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:NF-kappaB binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity;, P:oogenesis; P:regulation of signal transduction by p53 class mediator; P:spermatogenesis; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold10 indexed_genome mRNA 27939318 27955825 . - . ID=transcript_2648;Q92750 Q29YA4 Q29YA5,Transcription initiation factor TFIID subunit 4B,Transcription initiation factor TFIID 105 kDa subunit;, PF05236;PF07531;, GO:0005737;GO:0001650;GO:0005654;GO:0005669;GO:0003677;GO:0051059;GO:0046982;GO:0016251;GO:0048477;GO:1901796;GO:0007283;GO:0006366;GO:0006367;, C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:transcription factor TFIID complex;, F:DNA binding; F:NF-kappaB binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity;, P:oogenesis; P:regulation of signal transduction by p53 class mediator; P:spermatogenesis; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold10 indexed_genome mRNA 28013006 28086374 . + . ID=transcript_2649;Q15532 B0YJ95 Q16404 Q4VAX1 Q9BXC6,Protein SSXT,Protein SYT;Synovial sarcoma translocated to X chromosome protein;, PF05030;, GO:0015630;GO:0071564;GO:0005634;GO:0016514;GO:0030374;GO:0000902;GO:0048013;GO:0035556;GO:0000226;GO:0097150;GO:0045944;GO:0042493;, C:microtubule cytoskeleton; C:npBAF complex; C:nucleus; C:SWI/SNF complex;, F:nuclear receptor coactivator activity;, P:cell morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:neuronal stem cell population maintenance; P:positive regulation of transcription by RNA polymerase II; P:response to drug;|Q14258,E3 ubiquitin/ISG15 ligase TRIM25,Estrogen-responsive finger protein {ECO:0000303|PubMed:8248217};RING finger protein 147;RING-type E3 ubiquitin transferase;RING-type E3 ubiquitin transferase TRIM25 {ECO:0000305};Tripartite motif-containing protein 25;Ubiquitin/ISG15-conjugating enzyme TRIM25;Zinc finger protein 147;, PF13765;PF00622;, GO:0010494;GO:0005829;GO:0016604;GO:0005654;GO:0045296;GO:0016874;GO:0046872;GO:0039552;GO:0003723;GO:0003713;GO:0061630;GO:1990830;GO:0051607;GO:0045087;GO:0060333;GO:0032480;GO:0046597;GO:1902187;GO:0051091;GO:0043123;GO:0051092;GO:0006513;GO:0032880;GO:0046596;GO:1902186;GO:0043627;GO:0033280;GO:0019985;GO:0030433;GO:0006511;GO:0016032;, C:cytoplasmic stress granule; C:cytosol; C:nuclear body; C:nucleoplasm;, F:cadherin binding; F:ligase activity; F:metal ion binding; F:RIG-I binding; F:RNA binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity;, P:cellular response to leukemia inhibitory factor; P:defense response to virus; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of type I interferon production; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein monoubiquitination; P:regulation of protein localization; P:regulation of viral entry into host cell; P:regulation of viral release from host cell; P:response to estrogen; P:response to vitamin D; P:translesion synthesis; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold10 indexed_genome mRNA 28826200 28974200 . + . ID=transcript_2650;Q96K83 A3QVP7 B0YJB7 Q8IXI0 Q8TES6 Q9C065 Q9HAL5 Q9UFK4,Zinc finger protein 521,Early hematopoietic zinc finger protein;LYST-interacting protein 3;, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0019904;GO:0000978;GO:0048663;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:neuron fate commitment; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 29506135 29520903 . - . ID=transcript_2651;Q9H3N8 B0YJ19 B2KJ48 Q4G0I6 Q9GZQ0,Histamine H4 receptor,AXOR35;G-protein coupled receptor 105;GPRv53;Pfi-013;SP9144;, PF00001;, GO:0030425;GO:0005887;GO:0005886;GO:0045202;GO:0016907;GO:0004993;GO:0004969;GO:0030594;GO:0007197;GO:0007268;GO:0007186;GO:0007187;GO:0006954;GO:0007204;GO:0043408;, C:dendrite; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:G protein-coupled acetylcholine receptor activity; F:G protein-coupled serotonin receptor activity; F:histamine receptor activity; F:neurotransmitter receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway; P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:inflammatory response; P:positive regulation of cytosolic calcium ion concentration; P:regulation of MAPK cascade; scaffold10 indexed_genome mRNA 29550405 29577667 . - . ID=transcript_2652;Q9P2X3 A8MXG0 Q49AM0 Q9H2X4,Protein IMPACT,Imprinted and ancient gene protein homolog;, PF05773;PF01205;, GO:0005737;GO:0005844;GO:0003779;GO:0071468;GO:0034198;GO:0072755;GO:0042149;GO:0070301;GO:1990253;GO:0071494;GO:0140469;GO:0060548;GO:0031953;GO:0001933;GO:0031333;GO:0000122;GO:0097201;GO:1990138;GO:0045666;GO:0071264;GO:0006446;, C:cytoplasm; C:polysome;, F:actin binding;, P:cellular response to acidic pH; P:cellular response to amino acid starvation; P:cellular response to benomyl; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to leucine starvation; P:cellular response to UV-C; P:GCN2-mediated signaling; P:negative regulation of cell death; P:negative regulation of protein autophosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; P:neuron projection extension; P:positive regulation of neuron differentiation; P:positive regulation of translational initiation in response to starvation; P:regulation of translational initiation;|Q9P2X3 A8MXG0 Q49AM0 Q9H2X4,Protein IMPACT,Imprinted and ancient gene protein homolog;, PF05773;PF01205;, GO:0005737;GO:0005844;GO:0003779;GO:0071468;GO:0034198;GO:0072755;GO:0042149;GO:0070301;GO:1990253;GO:0071494;GO:0140469;GO:0060548;GO:0031953;GO:0001933;GO:0031333;GO:0000122;GO:0097201;GO:1990138;GO:0045666;GO:0071264;GO:0006446;, C:cytoplasm; C:polysome;, F:actin binding;, P:cellular response to acidic pH; P:cellular response to amino acid starvation; P:cellular response to benomyl; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to leucine starvation; P:cellular response to UV-C; P:GCN2-mediated signaling; P:negative regulation of cell death; P:negative regulation of protein autophosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; P:neuron projection extension; P:positive regulation of neuron differentiation; P:positive regulation of translational initiation in response to starvation; P:regulation of translational initiation;|Q9P2X3 A8MXG0 Q49AM0 Q9H2X4,Protein IMPACT,Imprinted and ancient gene protein homolog;, PF05773;PF01205;, GO:0005737;GO:0005844;GO:0003779;GO:0071468;GO:0034198;GO:0072755;GO:0042149;GO:0070301;GO:1990253;GO:0071494;GO:0140469;GO:0060548;GO:0031953;GO:0001933;GO:0031333;GO:0000122;GO:0097201;GO:1990138;GO:0045666;GO:0071264;GO:0006446;, C:cytoplasm; C:polysome;, F:actin binding;, P:cellular response to acidic pH; P:cellular response to amino acid starvation; P:cellular response to benomyl; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to leucine starvation; P:cellular response to UV-C; P:GCN2-mediated signaling; P:negative regulation of cell death; P:negative regulation of protein autophosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; P:neuron projection extension; P:positive regulation of neuron differentiation; P:positive regulation of translational initiation in response to starvation; P:regulation of translational initiation; scaffold10 indexed_genome mRNA 29675918 29677006 . + . ID=transcript_2653;Q9BXW6 B7Z7D3 Q9BZF5 Q9NW87,Oxysterol-binding protein-related protein 1,, PF12796;PF01237;, GO:0005829;GO:0005768;GO:0070062;GO:0043231;GO:0005770;GO:0016020;GO:0044232;GO:0015485;GO:0005543;GO:0032934;GO:0015248;GO:0019886;GO:0006699;GO:0008203;GO:0016192;, C:cytosol; C:endosome; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:late endosome; C:membrane; C:organelle membrane contact site;, F:cholesterol binding; F:phospholipid binding; F:sterol binding; F:sterol transporter activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:bile acid biosynthetic process; P:cholesterol metabolic process; P:vesicle-mediated transport; scaffold10 indexed_genome mRNA 29678906 29682641 . - . ID=transcript_2654;Q9BXW6 B7Z7D3 Q9BZF5 Q9NW87,Oxysterol-binding protein-related protein 1,, PF12796;PF01237;, GO:0005829;GO:0005768;GO:0070062;GO:0043231;GO:0005770;GO:0016020;GO:0044232;GO:0015485;GO:0005543;GO:0032934;GO:0015248;GO:0019886;GO:0006699;GO:0008203;GO:0016192;, C:cytosol; C:endosome; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:late endosome; C:membrane; C:organelle membrane contact site;, F:cholesterol binding; F:phospholipid binding; F:sterol binding; F:sterol transporter activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:bile acid biosynthetic process; P:cholesterol metabolic process; P:vesicle-mediated transport; scaffold10 indexed_genome mRNA 29840799 29954772 . + . ID=transcript_2655;O75952 B2R857 Q8WXW5 Q9HAY3 Q9HAY4 Q9HAY5 Q9HCY9,Calcium-binding tyrosine phosphorylation-regulated protein,Calcium-binding protein 86;Cancer/testis antigen 88;Fibrousheathin II;Fibrousheathin-2;Testis-specific calcium-binding protein CBP86;, PF02197;, GO:0005737;GO:0005856;GO:0005829;GO:0005576;GO:0031514;GO:0005654;GO:0005634;GO:0097229;GO:0035686;GO:0097228;GO:0005509;GO:0019899;GO:0017124;GO:0003351;GO:0048240;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular region; C:motile cilium; C:nucleoplasm; C:nucleus; C:sperm end piece; C:sperm fibrous sheath; C:sperm principal piece;, F:calcium ion binding; F:enzyme binding; F:SH3 domain binding;, P:epithelial cilium movement involved in extracellular fluid movement; P:sperm capacitation;|O75952 B2R857 Q8WXW5 Q9HAY3 Q9HAY4 Q9HAY5 Q9HCY9,Calcium-binding tyrosine phosphorylation-regulated protein,Calcium-binding protein 86;Cancer/testis antigen 88;Fibrousheathin II;Fibrousheathin-2;Testis-specific calcium-binding protein CBP86;, PF02197;, GO:0005737;GO:0005856;GO:0005829;GO:0005576;GO:0031514;GO:0005654;GO:0005634;GO:0097229;GO:0035686;GO:0097228;GO:0005509;GO:0019899;GO:0017124;GO:0003351;GO:0048240;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular region; C:motile cilium; C:nucleoplasm; C:nucleus; C:sperm end piece; C:sperm fibrous sheath; C:sperm principal piece;, F:calcium ion binding; F:enzyme binding; F:SH3 domain binding;, P:epithelial cilium movement involved in extracellular fluid movement; P:sperm capacitation;|O75952 B2R857 Q8WXW5 Q9HAY3 Q9HAY4 Q9HAY5 Q9HCY9,Calcium-binding tyrosine phosphorylation-regulated protein,Calcium-binding protein 86;Cancer/testis antigen 88;Fibrousheathin II;Fibrousheathin-2;Testis-specific calcium-binding protein CBP86;, PF02197;, GO:0005737;GO:0005856;GO:0005829;GO:0005576;GO:0031514;GO:0005654;GO:0005634;GO:0097229;GO:0035686;GO:0097228;GO:0005509;GO:0019899;GO:0017124;GO:0003351;GO:0048240;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular region; C:motile cilium; C:nucleoplasm; C:nucleus; C:sperm end piece; C:sperm fibrous sheath; C:sperm principal piece;, F:calcium ion binding; F:enzyme binding; F:SH3 domain binding;, P:epithelial cilium movement involved in extracellular fluid movement; P:sperm capacitation;|O75952 B2R857 Q8WXW5 Q9HAY3 Q9HAY4 Q9HAY5 Q9HCY9,Calcium-binding tyrosine phosphorylation-regulated protein,Calcium-binding protein 86;Cancer/testis antigen 88;Fibrousheathin II;Fibrousheathin-2;Testis-specific calcium-binding protein CBP86;, PF02197;, GO:0005737;GO:0005856;GO:0005829;GO:0005576;GO:0031514;GO:0005654;GO:0005634;GO:0097229;GO:0035686;GO:0097228;GO:0005509;GO:0019899;GO:0017124;GO:0003351;GO:0048240;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular region; C:motile cilium; C:nucleoplasm; C:nucleus; C:sperm end piece; C:sperm fibrous sheath; C:sperm principal piece;, F:calcium ion binding; F:enzyme binding; F:SH3 domain binding;, P:epithelial cilium movement involved in extracellular fluid movement; P:sperm capacitation;|O75952 B2R857 Q8WXW5 Q9HAY3 Q9HAY4 Q9HAY5 Q9HCY9,Calcium-binding tyrosine phosphorylation-regulated protein,Calcium-binding protein 86;Cancer/testis antigen 88;Fibrousheathin II;Fibrousheathin-2;Testis-specific calcium-binding protein CBP86;, PF02197;, GO:0005737;GO:0005856;GO:0005829;GO:0005576;GO:0031514;GO:0005654;GO:0005634;GO:0097229;GO:0035686;GO:0097228;GO:0005509;GO:0019899;GO:0017124;GO:0003351;GO:0048240;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular region; C:motile cilium; C:nucleoplasm; C:nucleus; C:sperm end piece; C:sperm fibrous sheath; C:sperm principal piece;, F:calcium ion binding; F:enzyme binding; F:SH3 domain binding;, P:epithelial cilium movement involved in extracellular fluid movement; P:sperm capacitation;|Q8N584 B7WP63 J3QRR1 Q0VAJ2 Q8N284,Tetratricopeptide repeat protein 39C,, PF10300;, GO:0060271;GO:0032474;, , , P:cilium assembly; P:otolith morphogenesis;|Q8N584 B7WP63 J3QRR1 Q0VAJ2 Q8N284,Tetratricopeptide repeat protein 39C,, PF10300;, GO:0060271;GO:0032474;, , , P:cilium assembly; P:otolith morphogenesis;|Q8N584 B7WP63 J3QRR1 Q0VAJ2 Q8N284,Tetratricopeptide repeat protein 39C,, PF10300;, GO:0060271;GO:0032474;, , , P:cilium assembly; P:otolith morphogenesis; scaffold10 indexed_genome mRNA 30000565 30081742 . - . ID=transcript_2656;Q16787 B0YJ33 Q13679 Q13680 Q6VU67 Q6VU68 Q6VU69 Q76E14 Q96TG0,Laminin subunit alpha-3,Epiligrin 170 kDa subunit;Epiligrin subunit alpha;Kalinin subunit alpha;Laminin-5 subunit alpha;Laminin-6 subunit alpha;Laminin-7 subunit alpha;Nicein subunit alpha;, PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005610;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0007411;GO:0016477;GO:0098609;GO:0030199;GO:0035987;GO:0008544;GO:0030198;GO:0031581;GO:0007229;GO:0001738;GO:0030155;GO:0030334;GO:0045995;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:laminin-5 complex;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:axon guidance; P:cell migration; P:cell-cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:morphogenesis of a polarized epithelium; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:tissue development;|Q16787 B0YJ33 Q13679 Q13680 Q6VU67 Q6VU68 Q6VU69 Q76E14 Q96TG0,Laminin subunit alpha-3,Epiligrin 170 kDa subunit;Epiligrin subunit alpha;Kalinin subunit alpha;Laminin-5 subunit alpha;Laminin-6 subunit alpha;Laminin-7 subunit alpha;Nicein subunit alpha;, PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005610;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0007411;GO:0016477;GO:0098609;GO:0030199;GO:0035987;GO:0008544;GO:0030198;GO:0031581;GO:0007229;GO:0001738;GO:0030155;GO:0030334;GO:0045995;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:laminin-5 complex;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:axon guidance; P:cell migration; P:cell-cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:morphogenesis of a polarized epithelium; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:tissue development; scaffold10 indexed_genome mRNA 30087498 30107355 . - . ID=transcript_2657;Q16787 B0YJ33 Q13679 Q13680 Q6VU67 Q6VU68 Q6VU69 Q76E14 Q96TG0,Laminin subunit alpha-3,Epiligrin 170 kDa subunit;Epiligrin subunit alpha;Kalinin subunit alpha;Laminin-5 subunit alpha;Laminin-6 subunit alpha;Laminin-7 subunit alpha;Nicein subunit alpha;, PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005610;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0007411;GO:0016477;GO:0098609;GO:0030199;GO:0035987;GO:0008544;GO:0030198;GO:0031581;GO:0007229;GO:0001738;GO:0030155;GO:0030334;GO:0045995;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:laminin-5 complex;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:axon guidance; P:cell migration; P:cell-cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:morphogenesis of a polarized epithelium; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:tissue development; scaffold10 indexed_genome mRNA 30112182 30122705 . - . ID=transcript_2658;Q16787 B0YJ33 Q13679 Q13680 Q6VU67 Q6VU68 Q6VU69 Q76E14 Q96TG0,Laminin subunit alpha-3,Epiligrin 170 kDa subunit;Epiligrin subunit alpha;Kalinin subunit alpha;Laminin-5 subunit alpha;Laminin-6 subunit alpha;Laminin-7 subunit alpha;Nicein subunit alpha;, PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005610;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0007411;GO:0016477;GO:0098609;GO:0030199;GO:0035987;GO:0008544;GO:0030198;GO:0031581;GO:0007229;GO:0001738;GO:0030155;GO:0030334;GO:0045995;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:laminin-5 complex;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:axon guidance; P:cell migration; P:cell-cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:morphogenesis of a polarized epithelium; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:tissue development; scaffold10 indexed_genome mRNA 30155553 30159164 . - . ID=transcript_2659;Q16787 B0YJ33 Q13679 Q13680 Q6VU67 Q6VU68 Q6VU69 Q76E14 Q96TG0,Laminin subunit alpha-3,Epiligrin 170 kDa subunit;Epiligrin subunit alpha;Kalinin subunit alpha;Laminin-5 subunit alpha;Laminin-6 subunit alpha;Laminin-7 subunit alpha;Nicein subunit alpha;, PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005610;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0007411;GO:0016477;GO:0098609;GO:0030199;GO:0035987;GO:0008544;GO:0030198;GO:0031581;GO:0007229;GO:0001738;GO:0030155;GO:0030334;GO:0045995;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:laminin-5 complex;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:axon guidance; P:cell migration; P:cell-cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:morphogenesis of a polarized epithelium; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:tissue development; scaffold10 indexed_genome mRNA 30277032 30326348 . + . ID=transcript_2660;Q8N6D5 B2R972 Q6ZWE8 Q96LU9,Ankyrin repeat domain-containing protein 29,, PF00023;PF12796;|Q8N6D5 B2R972 Q6ZWE8 Q96LU9,Ankyrin repeat domain-containing protein 29,, PF00023;PF12796;|Q8N6D5 B2R972 Q6ZWE8 Q96LU9,Ankyrin repeat domain-containing protein 29,, PF00023;PF12796;|Q8N6D5 B2R972 Q6ZWE8 Q96LU9,Ankyrin repeat domain-containing protein 29,, PF00023;PF12796;|Q8N6D5 B2R972 Q6ZWE8 Q96LU9,Ankyrin repeat domain-containing protein 29,, PF00023;PF12796; scaffold10 indexed_genome mRNA 30343285 30370869 . + . ID=transcript_2661;O15118 B4DET3 Q9P130,NPC intracellular cholesterol transporter 1 {ECO:0000312|HGNC:HGNC:7897},Niemann-Pick C1 protein {ECO:0000303|PubMed:9211849};, PF16414;PF02460;PF12349;, GO:0005783;GO:0070062;GO:0005576;GO:0005794;GO:1905103;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0045121;GO:0005635;GO:0048471;GO:0015485;GO:0038023;GO:0015248;GO:0004888;GO:0001618;GO:0007628;GO:0006914;GO:0008206;GO:0071404;GO:0071383;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0006897;GO:0090150;GO:0010467;GO:0032367;GO:0034383;GO:0007041;GO:0031579;GO:0060548;GO:0016242;GO:0006486;GO:0046686;GO:0042493;GO:0046718;, C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:integral component of lysosomal membrane; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:membrane raft; C:nuclear envelope; C:perinuclear region of cytoplasm;, F:cholesterol binding; F:signaling receptor activity; F:sterol transporter activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:adult walking behavior; P:autophagy; P:bile acid metabolic process; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to steroid hormone stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:endocytosis; P:establishment of protein localization to membrane; P:gene expression; P:intracellular cholesterol transport; P:low-density lipoprotein particle clearance; P:lysosomal transport; P:membrane raft organization; P:negative regulation of cell death; P:negative regulation of macroautophagy; P:protein glycosylation; P:response to cadmium ion; P:response to drug; P:viral entry into host cell; scaffold10 indexed_genome mRNA 30372532 30373916 . + . ID=transcript_2662;O15118 B4DET3 Q9P130,NPC intracellular cholesterol transporter 1 {ECO:0000312|HGNC:HGNC:7897},Niemann-Pick C1 protein {ECO:0000303|PubMed:9211849};, PF16414;PF02460;PF12349;, GO:0005783;GO:0070062;GO:0005576;GO:0005794;GO:1905103;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0045121;GO:0005635;GO:0048471;GO:0015485;GO:0038023;GO:0015248;GO:0004888;GO:0001618;GO:0007628;GO:0006914;GO:0008206;GO:0071404;GO:0071383;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0006897;GO:0090150;GO:0010467;GO:0032367;GO:0034383;GO:0007041;GO:0031579;GO:0060548;GO:0016242;GO:0006486;GO:0046686;GO:0042493;GO:0046718;, C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:integral component of lysosomal membrane; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:membrane raft; C:nuclear envelope; C:perinuclear region of cytoplasm;, F:cholesterol binding; F:signaling receptor activity; F:sterol transporter activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:adult walking behavior; P:autophagy; P:bile acid metabolic process; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to steroid hormone stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:endocytosis; P:establishment of protein localization to membrane; P:gene expression; P:intracellular cholesterol transport; P:low-density lipoprotein particle clearance; P:lysosomal transport; P:membrane raft organization; P:negative regulation of cell death; P:negative regulation of macroautophagy; P:protein glycosylation; P:response to cadmium ion; P:response to drug; P:viral entry into host cell; scaffold10 indexed_genome mRNA 30378777 30379690 . - . ID=transcript_2663;O15118 B4DET3 Q9P130,NPC intracellular cholesterol transporter 1 {ECO:0000312|HGNC:HGNC:7897},Niemann-Pick C1 protein {ECO:0000303|PubMed:9211849};, PF16414;PF02460;PF12349;, GO:0005783;GO:0070062;GO:0005576;GO:0005794;GO:1905103;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0045121;GO:0005635;GO:0048471;GO:0015485;GO:0038023;GO:0015248;GO:0004888;GO:0001618;GO:0007628;GO:0006914;GO:0008206;GO:0071404;GO:0071383;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0006897;GO:0090150;GO:0010467;GO:0032367;GO:0034383;GO:0007041;GO:0031579;GO:0060548;GO:0016242;GO:0006486;GO:0046686;GO:0042493;GO:0046718;, C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:integral component of lysosomal membrane; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:membrane raft; C:nuclear envelope; C:perinuclear region of cytoplasm;, F:cholesterol binding; F:signaling receptor activity; F:sterol transporter activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:adult walking behavior; P:autophagy; P:bile acid metabolic process; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to steroid hormone stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:endocytosis; P:establishment of protein localization to membrane; P:gene expression; P:intracellular cholesterol transport; P:low-density lipoprotein particle clearance; P:lysosomal transport; P:membrane raft organization; P:negative regulation of cell death; P:negative regulation of macroautophagy; P:protein glycosylation; P:response to cadmium ion; P:response to drug; P:viral entry into host cell; scaffold10 indexed_genome mRNA 30380335 30381221 . - . ID=transcript_2664;O15118 B4DET3 Q9P130,NPC intracellular cholesterol transporter 1 {ECO:0000312|HGNC:HGNC:7897},Niemann-Pick C1 protein {ECO:0000303|PubMed:9211849};, PF16414;PF02460;PF12349;, GO:0005783;GO:0070062;GO:0005576;GO:0005794;GO:1905103;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0045121;GO:0005635;GO:0048471;GO:0015485;GO:0038023;GO:0015248;GO:0004888;GO:0001618;GO:0007628;GO:0006914;GO:0008206;GO:0071404;GO:0071383;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0006897;GO:0090150;GO:0010467;GO:0032367;GO:0034383;GO:0007041;GO:0031579;GO:0060548;GO:0016242;GO:0006486;GO:0046686;GO:0042493;GO:0046718;, C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:integral component of lysosomal membrane; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:membrane raft; C:nuclear envelope; C:perinuclear region of cytoplasm;, F:cholesterol binding; F:signaling receptor activity; F:sterol transporter activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:adult walking behavior; P:autophagy; P:bile acid metabolic process; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to steroid hormone stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:endocytosis; P:establishment of protein localization to membrane; P:gene expression; P:intracellular cholesterol transport; P:low-density lipoprotein particle clearance; P:lysosomal transport; P:membrane raft organization; P:negative regulation of cell death; P:negative regulation of macroautophagy; P:protein glycosylation; P:response to cadmium ion; P:response to drug; P:viral entry into host cell; scaffold10 indexed_genome mRNA 30387971 30413761 . - . ID=transcript_2665;Q96DM3 Q9BU17 Q9Y5M0,Regulator of MON1-CCZ1 complex {ECO:0000303|PubMed:29038162},Colon cancer-associated protein Mic1;WD repeat-containing protein 98 {ECO:0000305};, PF07035;, GO:0031902;GO:0005765;GO:0035658;GO:0006914;GO:0010506;, C:late endosome membrane; C:lysosomal membrane; C:Mon1-Ccz1 complex;, , P:autophagy; P:regulation of autophagy;|Q96DM3 Q9BU17 Q9Y5M0,Regulator of MON1-CCZ1 complex {ECO:0000303|PubMed:29038162},Colon cancer-associated protein Mic1;WD repeat-containing protein 98 {ECO:0000305};, PF07035;, GO:0031902;GO:0005765;GO:0035658;GO:0006914;GO:0010506;, C:late endosome membrane; C:lysosomal membrane; C:Mon1-Ccz1 complex;, , P:autophagy; P:regulation of autophagy;|Q96DM3 Q9BU17 Q9Y5M0,Regulator of MON1-CCZ1 complex {ECO:0000303|PubMed:29038162},Colon cancer-associated protein Mic1;WD repeat-containing protein 98 {ECO:0000305};, PF07035;, GO:0031902;GO:0005765;GO:0035658;GO:0006914;GO:0010506;, C:late endosome membrane; C:lysosomal membrane; C:Mon1-Ccz1 complex;, , P:autophagy; P:regulation of autophagy; scaffold10 indexed_genome mRNA 30431937 30453715 . - . ID=transcript_2666;O14730 Q8IXN9,Serine/threonine-protein kinase RIO3,RIO kinase 3;sudD homolog;, , GO:0005829;GO:0030688;GO:0005524;GO:0089720;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:1990786;GO:0071359;GO:0098586;GO:0007059;GO:0051607;GO:0045087;GO:0030490;GO:0043124;GO:0039534;GO:0031333;GO:0045089;GO:0032728;, C:cytosol; C:preribosome, small subunit precursor;, F:ATP binding; F:caspase binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to dsDNA; P:cellular response to dsRNA; P:cellular response to virus; P:chromosome segregation; P:defense response to virus; P:innate immune response; P:maturation of SSU-rRNA; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MDA-5 signaling pathway; P:negative regulation of protein-containing complex assembly; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production;|O14730 Q8IXN9,Serine/threonine-protein kinase RIO3,RIO kinase 3;sudD homolog;, , GO:0005829;GO:0030688;GO:0005524;GO:0089720;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:1990786;GO:0071359;GO:0098586;GO:0007059;GO:0051607;GO:0045087;GO:0030490;GO:0043124;GO:0039534;GO:0031333;GO:0045089;GO:0032728;, C:cytosol; C:preribosome, small subunit precursor;, F:ATP binding; F:caspase binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to dsDNA; P:cellular response to dsRNA; P:cellular response to virus; P:chromosome segregation; P:defense response to virus; P:innate immune response; P:maturation of SSU-rRNA; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MDA-5 signaling pathway; P:negative regulation of protein-containing complex assembly; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production;|O14730 Q8IXN9,Serine/threonine-protein kinase RIO3,RIO kinase 3;sudD homolog;, , GO:0005829;GO:0030688;GO:0005524;GO:0089720;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:1990786;GO:0071359;GO:0098586;GO:0007059;GO:0051607;GO:0045087;GO:0030490;GO:0043124;GO:0039534;GO:0031333;GO:0045089;GO:0032728;, C:cytosol; C:preribosome, small subunit precursor;, F:ATP binding; F:caspase binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to dsDNA; P:cellular response to dsRNA; P:cellular response to virus; P:chromosome segregation; P:defense response to virus; P:innate immune response; P:maturation of SSU-rRNA; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MDA-5 signaling pathway; P:negative regulation of protein-containing complex assembly; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production;|O14730 Q8IXN9,Serine/threonine-protein kinase RIO3,RIO kinase 3;sudD homolog;, , GO:0005829;GO:0030688;GO:0005524;GO:0089720;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:1990786;GO:0071359;GO:0098586;GO:0007059;GO:0051607;GO:0045087;GO:0030490;GO:0043124;GO:0039534;GO:0031333;GO:0045089;GO:0032728;, C:cytosol; C:preribosome, small subunit precursor;, F:ATP binding; F:caspase binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to dsDNA; P:cellular response to dsRNA; P:cellular response to virus; P:chromosome segregation; P:defense response to virus; P:innate immune response; P:maturation of SSU-rRNA; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MDA-5 signaling pathway; P:negative regulation of protein-containing complex assembly; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; scaffold10 indexed_genome mRNA 30454006 30562949 . + . ID=transcript_2667;Q24JQ0 I0J130 Q6ZTS7 Q6ZW41,Transmembrane protein 241,, , GO:0005794;GO:0016021;GO:0015297;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity;|Q24JQ0 I0J130 Q6ZTS7 Q6ZW41,Transmembrane protein 241,, , GO:0005794;GO:0016021;GO:0015297;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity;|Q24JQ0 I0J130 Q6ZTS7 Q6ZW41,Transmembrane protein 241,, , GO:0005794;GO:0016021;GO:0015297;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity; scaffold10 indexed_genome mRNA 30587900 30611017 . - . ID=transcript_2668;Q8TDN4 B4DK60 Q8N3Y8 Q8NA22 Q9BTG1,CDK5 and ABL1 enzyme substrate 1,Interactor with CDK3 1;, PF00134;, GO:0005829;GO:0005634;GO:0007049;GO:0051301;GO:0051726;, C:cytosol; C:nucleus;, , P:cell cycle; P:cell division; P:regulation of cell cycle; scaffold10 indexed_genome mRNA 30752784 30844338 . + . ID=transcript_2669;Q99708 A6NKN2 A8K8W6 E7ETY1 O75371 Q8NHQ3,DNA endonuclease RBBP8,CtBP-interacting protein;Retinoblastoma-binding protein 8;Retinoblastoma-interacting protein and myosin-like;Sporulation in the absence of SPO11 protein 2 homolog;, PF10482;PF08573;, GO:0043231;GO:0005654;GO:0005634;GO:0035861;GO:0017053;GO:0003684;GO:0000406;GO:0003690;GO:0070336;GO:0042802;GO:0001103;GO:0003697;GO:0000014;GO:0003714;GO:0000403;GO:0051301;GO:0000729;GO:0010792;GO:0006281;GO:0006260;GO:0000724;GO:0051321;GO:0070317;GO:1901796;GO:0006357;, C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:transcription repressor complex;, F:damaged DNA binding; F:double-strand/single-strand DNA junction binding; F:double-stranded DNA binding; F:flap-structured DNA binding; F:identical protein binding; F:RNA polymerase II repressing transcription factor binding; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:transcription corepressor activity; F:Y-form DNA binding;, P:cell division; P:DNA double-strand break processing; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:meiotic cell cycle; P:negative regulation of G0 to G1 transition; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q99708 A6NKN2 A8K8W6 E7ETY1 O75371 Q8NHQ3,DNA endonuclease RBBP8,CtBP-interacting protein;Retinoblastoma-binding protein 8;Retinoblastoma-interacting protein and myosin-like;Sporulation in the absence of SPO11 protein 2 homolog;, PF10482;PF08573;, GO:0043231;GO:0005654;GO:0005634;GO:0035861;GO:0017053;GO:0003684;GO:0000406;GO:0003690;GO:0070336;GO:0042802;GO:0001103;GO:0003697;GO:0000014;GO:0003714;GO:0000403;GO:0051301;GO:0000729;GO:0010792;GO:0006281;GO:0006260;GO:0000724;GO:0051321;GO:0070317;GO:1901796;GO:0006357;, C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:transcription repressor complex;, F:damaged DNA binding; F:double-strand/single-strand DNA junction binding; F:double-stranded DNA binding; F:flap-structured DNA binding; F:identical protein binding; F:RNA polymerase II repressing transcription factor binding; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:transcription corepressor activity; F:Y-form DNA binding;, P:cell division; P:DNA double-strand break processing; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:meiotic cell cycle; P:negative regulation of G0 to G1 transition; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q99708 A6NKN2 A8K8W6 E7ETY1 O75371 Q8NHQ3,DNA endonuclease RBBP8,CtBP-interacting protein;Retinoblastoma-binding protein 8;Retinoblastoma-interacting protein and myosin-like;Sporulation in the absence of SPO11 protein 2 homolog;, PF10482;PF08573;, GO:0043231;GO:0005654;GO:0005634;GO:0035861;GO:0017053;GO:0003684;GO:0000406;GO:0003690;GO:0070336;GO:0042802;GO:0001103;GO:0003697;GO:0000014;GO:0003714;GO:0000403;GO:0051301;GO:0000729;GO:0010792;GO:0006281;GO:0006260;GO:0000724;GO:0051321;GO:0070317;GO:1901796;GO:0006357;, C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:transcription repressor complex;, F:damaged DNA binding; F:double-strand/single-strand DNA junction binding; F:double-stranded DNA binding; F:flap-structured DNA binding; F:identical protein binding; F:RNA polymerase II repressing transcription factor binding; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:transcription corepressor activity; F:Y-form DNA binding;, P:cell division; P:DNA double-strand break processing; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:meiotic cell cycle; P:negative regulation of G0 to G1 transition; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q99708 A6NKN2 A8K8W6 E7ETY1 O75371 Q8NHQ3,DNA endonuclease RBBP8,CtBP-interacting protein;Retinoblastoma-binding protein 8;Retinoblastoma-interacting protein and myosin-like;Sporulation in the absence of SPO11 protein 2 homolog;, PF10482;PF08573;, GO:0043231;GO:0005654;GO:0005634;GO:0035861;GO:0017053;GO:0003684;GO:0000406;GO:0003690;GO:0070336;GO:0042802;GO:0001103;GO:0003697;GO:0000014;GO:0003714;GO:0000403;GO:0051301;GO:0000729;GO:0010792;GO:0006281;GO:0006260;GO:0000724;GO:0051321;GO:0070317;GO:1901796;GO:0006357;, C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:transcription repressor complex;, F:damaged DNA binding; F:double-strand/single-strand DNA junction binding; F:double-stranded DNA binding; F:flap-structured DNA binding; F:identical protein binding; F:RNA polymerase II repressing transcription factor binding; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:transcription corepressor activity; F:Y-form DNA binding;, P:cell division; P:DNA double-strand break processing; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:meiotic cell cycle; P:negative regulation of G0 to G1 transition; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 31462743 31463565 . + . ID=transcript_2670;Q92908 B0YJ17 P78327,Transcription factor GATA-6,GATA-binding factor 6;, PF00320;PF05349;, GO:0000785;GO:0031965;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0003700;GO:0000981;GO:0019901;GO:0000978;GO:0001103;GO:1990837;GO:0008134;GO:0000976;GO:0008270;GO:0048645;GO:0007596;GO:0055007;GO:0014898;GO:0060947;GO:0045165;GO:0044267;GO:0071773;GO:0071371;GO:0071456;GO:0060486;GO:0007493;GO:0030855;GO:0001701;GO:0060575;GO:0001889;GO:0060430;GO:0008584;GO:0043066;GO:1904003;GO:0000122;GO:0045892;GO:0032911;GO:0032912;GO:0003148;GO:0003310;GO:0006644;GO:0045766;GO:0060045;GO:0110024;GO:0051891;GO:0071158;GO:0045944;GO:0045893;GO:1901390;GO:0002759;GO:0006357;GO:0042493;GO:0043627;GO:0070848;GO:0032526;GO:0001949;GO:0098773;GO:0051145;GO:0035239;GO:0003309;GO:0060510;, C:chromatin; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:animal organ formation; P:blood coagulation; P:cardiac muscle cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cardiac vascular smooth muscle cell differentiation; P:cell fate commitment; P:cellular protein metabolic process; P:cellular response to BMP stimulus; P:cellular response to gonadotropin stimulus; P:cellular response to hypoxia; P:club cell differentiation; P:endodermal cell fate determination; P:epithelial cell differentiation; P:in utero embryonic development; P:intestinal epithelial cell differentiation; P:liver development; P:lung saccule development; P:male gonad development; P:negative regulation of apoptotic process; P:negative regulation of sebum secreting cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta1 production; P:negative regulation of transforming growth factor beta2 production; P:outflow tract septum morphogenesis; P:pancreatic A cell differentiation; P:phospholipid metabolic process; P:positive regulation of angiogenesis; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cardiac muscle myoblast proliferation; P:positive regulation of cardioblast differentiation; P:positive regulation of cell cycle arrest; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta activation; P:regulation of antimicrobial humoral response; P:regulation of transcription by RNA polymerase II; P:response to drug; P:response to estrogen; P:response to growth factor; P:response to retinoic acid; P:sebaceous gland cell differentiation; P:skin epidermis development; P:smooth muscle cell differentiation; P:tube morphogenesis; P:type B pancreatic cell differentiation; P:type II pneumocyte differentiation; scaffold10 indexed_genome mRNA 31691757 31770880 . - . ID=transcript_2671;Q86YT6 B0YJ38 Q2TB37 Q68D01 Q6YI51 Q8NBY0 Q8TCB5 Q8TCL7 Q9P2M3,E3 ubiquitin-protein ligase MIB1,DAPK-interacting protein 1;Mind bomb homolog 1;RING-type E3 ubiquitin transferase MIB1 {ECO:0000305};Zinc finger ZZ type with ankyrin repeat domain protein 2;, PF12796;PF06701;PF18346;PF00569;, GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005886;GO:0014069;GO:0004842;GO:0008270;GO:0001568;GO:0006897;GO:0001947;GO:0001701;GO:0045665;GO:0001841;GO:0007219;GO:0045807;GO:0016567;GO:0001756;GO:0006511;, C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:plasma membrane; C:postsynaptic density;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:blood vessel development; P:endocytosis; P:heart looping; P:in utero embryonic development; P:negative regulation of neuron differentiation; P:neural tube formation; P:Notch signaling pathway; P:positive regulation of endocytosis; P:protein ubiquitination; P:somitogenesis; P:ubiquitin-dependent protein catabolic process;|Q86YT6 B0YJ38 Q2TB37 Q68D01 Q6YI51 Q8NBY0 Q8TCB5 Q8TCL7 Q9P2M3,E3 ubiquitin-protein ligase MIB1,DAPK-interacting protein 1;Mind bomb homolog 1;RING-type E3 ubiquitin transferase MIB1 {ECO:0000305};Zinc finger ZZ type with ankyrin repeat domain protein 2;, PF12796;PF06701;PF18346;PF00569;, GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005886;GO:0014069;GO:0004842;GO:0008270;GO:0001568;GO:0006897;GO:0001947;GO:0001701;GO:0045665;GO:0001841;GO:0007219;GO:0045807;GO:0016567;GO:0001756;GO:0006511;, C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:plasma membrane; C:postsynaptic density;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:blood vessel development; P:endocytosis; P:heart looping; P:in utero embryonic development; P:negative regulation of neuron differentiation; P:neural tube formation; P:Notch signaling pathway; P:positive regulation of endocytosis; P:protein ubiquitination; P:somitogenesis; P:ubiquitin-dependent protein catabolic process; scaffold10 indexed_genome mRNA 31816326 31876510 . + . ID=transcript_2672;Q8WU67 B0YIV0 B7Z5C2 O43411,Phospholipase ABHD3 {ECO:0000305},Abhydrolase domain-containing protein 3 {ECO:0000305};, PF00561;, GO:0016021;GO:0005886;GO:0052740;GO:0008126;GO:0047372;GO:0052739;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0034338;GO:0044255;GO:0051792;GO:0051793;GO:0006656;GO:0046470;, C:integral component of membrane; C:plasma membrane;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:acetylesterase activity; F:acylglycerol lipase activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:short-chain carboxylesterase activity;, P:cellular lipid metabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylcholine metabolic process;|P08708 B2R4U4 P0CW22,40S ribosomal protein S17 {ECO:0000305},Small ribosomal subunit protein eS17 {ECO:0000303|PubMed:24524803};, PF00833;, GO:0005829;GO:0022627;GO:0005925;GO:0016020;GO:0005654;GO:0005840;GO:0003723;GO:0003735;GO:0034101;GO:0000184;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:focal adhesion; C:membrane; C:nucleoplasm; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:erythrocyte homeostasis; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q8WU67 B0YIV0 B7Z5C2 O43411,Phospholipase ABHD3 {ECO:0000305},Abhydrolase domain-containing protein 3 {ECO:0000305};, PF00561;, GO:0016021;GO:0005886;GO:0052740;GO:0008126;GO:0047372;GO:0052739;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0034338;GO:0044255;GO:0051792;GO:0051793;GO:0006656;GO:0046470;, C:integral component of membrane; C:plasma membrane;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:acetylesterase activity; F:acylglycerol lipase activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:short-chain carboxylesterase activity;, P:cellular lipid metabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylcholine metabolic process;|Q8WU67 B0YIV0 B7Z5C2 O43411,Phospholipase ABHD3 {ECO:0000305},Abhydrolase domain-containing protein 3 {ECO:0000305};, PF00561;, GO:0016021;GO:0005886;GO:0052740;GO:0008126;GO:0047372;GO:0052739;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0034338;GO:0044255;GO:0051792;GO:0051793;GO:0006656;GO:0046470;, C:integral component of membrane; C:plasma membrane;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:acetylesterase activity; F:acylglycerol lipase activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:short-chain carboxylesterase activity;, P:cellular lipid metabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylcholine metabolic process;|Q8WU67 B0YIV0 B7Z5C2 O43411,Phospholipase ABHD3 {ECO:0000305},Abhydrolase domain-containing protein 3 {ECO:0000305};, PF00561;, GO:0016021;GO:0005886;GO:0052740;GO:0008126;GO:0047372;GO:0052739;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0034338;GO:0044255;GO:0051792;GO:0051793;GO:0006656;GO:0046470;, C:integral component of membrane; C:plasma membrane;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:acetylesterase activity; F:acylglycerol lipase activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:short-chain carboxylesterase activity;, P:cellular lipid metabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylcholine metabolic process;|Q8WU67 B0YIV0 B7Z5C2 O43411,Phospholipase ABHD3 {ECO:0000305},Abhydrolase domain-containing protein 3 {ECO:0000305};, PF00561;, GO:0016021;GO:0005886;GO:0052740;GO:0008126;GO:0047372;GO:0052739;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0034338;GO:0044255;GO:0051792;GO:0051793;GO:0006656;GO:0046470;, C:integral component of membrane; C:plasma membrane;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:acetylesterase activity; F:acylglycerol lipase activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:short-chain carboxylesterase activity;, P:cellular lipid metabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylcholine metabolic process; scaffold10 indexed_genome mRNA 31886300 31920115 . + . ID=transcript_2673;P62314 B5BTZ1 P13641,Small nuclear ribonucleoprotein Sm D1,Sm-D autoantigen;snRNP core protein D1;, PF01423;, GO:0071013;GO:0000243;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0034715;GO:0071011;GO:0030532;GO:0034719;GO:0097526;GO:0005685;GO:0005689;GO:0005686;GO:0071007;GO:0071005;GO:0005687;GO:0046540;GO:0005682;GO:0003723;GO:1990446;GO:0051170;GO:0000398;GO:0008380;GO:0000245;GO:0000387;, C:catalytic step 2 spliceosome; C:commitment complex; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:precatalytic spliceosome; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal tri-snRNP complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:RNA binding; F:U1 snRNP binding;, P:import into nucleus; P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly;|P62314 B5BTZ1 P13641,Small nuclear ribonucleoprotein Sm D1,Sm-D autoantigen;snRNP core protein D1;, PF01423;, GO:0071013;GO:0000243;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0034715;GO:0071011;GO:0030532;GO:0034719;GO:0097526;GO:0005685;GO:0005689;GO:0005686;GO:0071007;GO:0071005;GO:0005687;GO:0046540;GO:0005682;GO:0003723;GO:1990446;GO:0051170;GO:0000398;GO:0008380;GO:0000245;GO:0000387;, C:catalytic step 2 spliceosome; C:commitment complex; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:precatalytic spliceosome; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal tri-snRNP complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:RNA binding; F:U1 snRNP binding;, P:import into nucleus; P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly;|Q5FWF5 B0YJ11 B0YJ12 Q69YG4 Q69YS3 Q6IMD7 Q8N3Z5 Q8NBG2 Q96PX7,N-acetyltransferase ESCO1,CTF7 homolog 1;Establishment factor-like protein 1 {ECO:0000303|PubMed:14576321};Establishment of cohesion 1 homolog 1;, PF13880;PF13878;, GO:0000785;GO:0005694;GO:0005654;GO:0016407;GO:0042802;GO:0008080;GO:0061733;GO:0008270;GO:0018394;GO:0034421;GO:0006275;GO:0007062;, C:chromatin; C:chromosome; C:nucleoplasm;, F:acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:peptide-lysine-N-acetyltransferase activity; F:zinc ion binding;, P:peptidyl-lysine acetylation; P:post-translational protein acetylation; P:regulation of DNA replication; P:sister chromatid cohesion;|Q5FWF5 B0YJ11 B0YJ12 Q69YG4 Q69YS3 Q6IMD7 Q8N3Z5 Q8NBG2 Q96PX7,N-acetyltransferase ESCO1,CTF7 homolog 1;Establishment factor-like protein 1 {ECO:0000303|PubMed:14576321};Establishment of cohesion 1 homolog 1;, PF13880;PF13878;, GO:0000785;GO:0005694;GO:0005654;GO:0016407;GO:0042802;GO:0008080;GO:0061733;GO:0008270;GO:0018394;GO:0034421;GO:0006275;GO:0007062;, C:chromatin; C:chromosome; C:nucleoplasm;, F:acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:peptide-lysine-N-acetyltransferase activity; F:zinc ion binding;, P:peptidyl-lysine acetylation; P:post-translational protein acetylation; P:regulation of DNA replication; P:sister chromatid cohesion; scaffold10 indexed_genome mRNA 31921168 31945834 . + . ID=transcript_2674;Q5FWF5 B0YJ11 B0YJ12 Q69YG4 Q69YS3 Q6IMD7 Q8N3Z5 Q8NBG2 Q96PX7,N-acetyltransferase ESCO1,CTF7 homolog 1;Establishment factor-like protein 1 {ECO:0000303|PubMed:14576321};Establishment of cohesion 1 homolog 1;, PF13880;PF13878;, GO:0000785;GO:0005694;GO:0005654;GO:0016407;GO:0042802;GO:0008080;GO:0061733;GO:0008270;GO:0018394;GO:0034421;GO:0006275;GO:0007062;, C:chromatin; C:chromosome; C:nucleoplasm;, F:acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:peptide-lysine-N-acetyltransferase activity; F:zinc ion binding;, P:peptidyl-lysine acetylation; P:post-translational protein acetylation; P:regulation of DNA replication; P:sister chromatid cohesion;|Q5FWF5 B0YJ11 B0YJ12 Q69YG4 Q69YS3 Q6IMD7 Q8N3Z5 Q8NBG2 Q96PX7,N-acetyltransferase ESCO1,CTF7 homolog 1;Establishment factor-like protein 1 {ECO:0000303|PubMed:14576321};Establishment of cohesion 1 homolog 1;, PF13880;PF13878;, GO:0000785;GO:0005694;GO:0005654;GO:0016407;GO:0042802;GO:0008080;GO:0061733;GO:0008270;GO:0018394;GO:0034421;GO:0006275;GO:0007062;, C:chromatin; C:chromosome; C:nucleoplasm;, F:acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:peptide-lysine-N-acetyltransferase activity; F:zinc ion binding;, P:peptidyl-lysine acetylation; P:post-translational protein acetylation; P:regulation of DNA replication; P:sister chromatid cohesion;|Q5FWF5 B0YJ11 B0YJ12 Q69YG4 Q69YS3 Q6IMD7 Q8N3Z5 Q8NBG2 Q96PX7,N-acetyltransferase ESCO1,CTF7 homolog 1;Establishment factor-like protein 1 {ECO:0000303|PubMed:14576321};Establishment of cohesion 1 homolog 1;, PF13880;PF13878;, GO:0000785;GO:0005694;GO:0005654;GO:0016407;GO:0042802;GO:0008080;GO:0061733;GO:0008270;GO:0018394;GO:0034421;GO:0006275;GO:0007062;, C:chromatin; C:chromosome; C:nucleoplasm;, F:acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:peptide-lysine-N-acetyltransferase activity; F:zinc ion binding;, P:peptidyl-lysine acetylation; P:post-translational protein acetylation; P:regulation of DNA replication; P:sister chromatid cohesion; scaffold10 indexed_genome mRNA 31948219 32016198 . + . ID=transcript_2675;Q9C091 A4QN17 Q9H8F1,GREB1-like protein,Growth regulation by estrogen in breast cancer 1-like protein;, PF15782;, GO:0016021;GO:0001822;GO:0007275;, C:integral component of membrane;, , P:kidney development; P:multicellular organism development;|Q9C091 A4QN17 Q9H8F1,GREB1-like protein,Growth regulation by estrogen in breast cancer 1-like protein;, PF15782;, GO:0016021;GO:0001822;GO:0007275;, C:integral component of membrane;, , P:kidney development; P:multicellular organism development;|Q9C091 A4QN17 Q9H8F1,GREB1-like protein,Growth regulation by estrogen in breast cancer 1-like protein;, PF15782;, GO:0016021;GO:0001822;GO:0007275;, C:integral component of membrane;, , P:kidney development; P:multicellular organism development;|Q9C091 A4QN17 Q9H8F1,GREB1-like protein,Growth regulation by estrogen in breast cancer 1-like protein;, PF15782;, GO:0016021;GO:0001822;GO:0007275;, C:integral component of membrane;, , P:kidney development; P:multicellular organism development; scaffold10 indexed_genome mRNA 32040650 32071210 . - . ID=transcript_2676;Q9C091 A4QN17 Q9H8F1,GREB1-like protein,Growth regulation by estrogen in breast cancer 1-like protein;, PF15782;, GO:0016021;GO:0001822;GO:0007275;, C:integral component of membrane;, , P:kidney development; P:multicellular organism development; scaffold10 indexed_genome mRNA 32300330 32421730 . + . ID=transcript_2677;Q13464 B0YJ91 Q2KHM4 Q59GZ4,Rho-associated protein kinase 1,Renal carcinoma antigen NY-REN-35;Rho-associated, coiled-coil-containing protein kinase 1;Rho-associated, coiled-coil-containing protein kinase I;p160 ROCK-1;, PF00069;PF08912;, GO:0032059;GO:0005814;GO:0005737;GO:0010494;GO:0005856;GO:0005829;GO:0005576;GO:0000139;GO:0030027;GO:0005886;GO:0001726;GO:0034774;GO:0019828;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0072518;GO:0031267;GO:0048156;GO:0050321;GO:0030036;GO:0031032;GO:0003180;GO:0006915;GO:0097746;GO:0030866;GO:0048598;GO:0048013;GO:0007186;GO:0090521;GO:0007249;GO:0007159;GO:0050900;GO:0050901;GO:0022614;GO:0000281;GO:0061157;GO:0051451;GO:1902992;GO:1902430;GO:0016525;GO:1903347;GO:0070168;GO:0051045;GO:0035509;GO:0042326;GO:0032091;GO:0140058;GO:0031175;GO:0043312;GO:0018105;GO:0018107;GO:1900223;GO:0010508;GO:0010613;GO:1905205;GO:0051894;GO:0010628;GO:0043410;GO:0072659;GO:0006468;GO:0032956;GO:1902003;GO:0110061;GO:0010506;GO:0030155;GO:1901888;GO:0030334;GO:2000145;GO:2000114;GO:1903140;GO:0051893;GO:0045616;GO:0070507;GO:0045664;GO:0051492;GO:1900242;GO:1990776;GO:0071559;GO:0007266;GO:0007165;GO:0006939;GO:0048010;, C:bleb; C:centriole; C:cytoplasm; C:cytoplasmic stress granule; C:cytoskeleton; C:cytosol; C:extracellular region; C:Golgi membrane; C:lamellipodium; C:plasma membrane; C:ruffle; C:secretory granule lumen;, F:aspartic-type endopeptidase inhibitor activity; F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:Rho-dependent protein serine/threonine kinase activity; F:small GTPase binding; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:aortic valve morphogenesis; P:apoptotic process; P:blood vessel diameter maintenance; P:cortical actin cytoskeleton organization; P:embryonic morphogenesis; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glomerular visceral epithelial cell migration; P:I-kappaB kinase/NF-kappaB signaling; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:membrane to membrane docking; P:mitotic cytokinesis; P:mRNA destabilization; P:myoblast migration; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of amyloid-beta formation; P:negative regulation of angiogenesis; P:negative regulation of bicellular tight junction assembly; P:negative regulation of biomineral tissue development; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of myosin-light-chain-phosphatase activity; P:negative regulation of phosphorylation; P:negative regulation of protein binding; P:neuron projection arborization; P:neuron projection development; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of amyloid-beta clearance; P:positive regulation of autophagy; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of connective tissue replacement; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of MAPK cascade; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of amyloid-beta formation; P:regulation of angiotensin-activated signaling pathway; P:regulation of autophagy; P:regulation of cell adhesion; P:regulation of cell junction assembly; P:regulation of cell migration; P:regulation of cell motility; P:regulation of establishment of cell polarity; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of keratinocyte differentiation; P:regulation of microtubule cytoskeleton organization; P:regulation of neuron differentiation; P:regulation of stress fiber assembly; P:regulation of synaptic vesicle endocytosis; P:response to angiotensin; P:response to transforming growth factor beta; P:Rho protein signal transduction; P:signal transduction; P:smooth muscle contraction; P:vascular endothelial growth factor receptor signaling pathway;|Q13464 B0YJ91 Q2KHM4 Q59GZ4,Rho-associated protein kinase 1,Renal carcinoma antigen NY-REN-35;Rho-associated, coiled-coil-containing protein kinase 1;Rho-associated, coiled-coil-containing protein kinase I;p160 ROCK-1;, PF00069;PF08912;, GO:0032059;GO:0005814;GO:0005737;GO:0010494;GO:0005856;GO:0005829;GO:0005576;GO:0000139;GO:0030027;GO:0005886;GO:0001726;GO:0034774;GO:0019828;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0072518;GO:0031267;GO:0048156;GO:0050321;GO:0030036;GO:0031032;GO:0003180;GO:0006915;GO:0097746;GO:0030866;GO:0048598;GO:0048013;GO:0007186;GO:0090521;GO:0007249;GO:0007159;GO:0050900;GO:0050901;GO:0022614;GO:0000281;GO:0061157;GO:0051451;GO:1902992;GO:1902430;GO:0016525;GO:1903347;GO:0070168;GO:0051045;GO:0035509;GO:0042326;GO:0032091;GO:0140058;GO:0031175;GO:0043312;GO:0018105;GO:0018107;GO:1900223;GO:0010508;GO:0010613;GO:1905205;GO:0051894;GO:0010628;GO:0043410;GO:0072659;GO:0006468;GO:0032956;GO:1902003;GO:0110061;GO:0010506;GO:0030155;GO:1901888;GO:0030334;GO:2000145;GO:2000114;GO:1903140;GO:0051893;GO:0045616;GO:0070507;GO:0045664;GO:0051492;GO:1900242;GO:1990776;GO:0071559;GO:0007266;GO:0007165;GO:0006939;GO:0048010;, C:bleb; C:centriole; C:cytoplasm; C:cytoplasmic stress granule; C:cytoskeleton; C:cytosol; C:extracellular region; C:Golgi membrane; C:lamellipodium; C:plasma membrane; C:ruffle; C:secretory granule lumen;, F:aspartic-type endopeptidase inhibitor activity; F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:Rho-dependent protein serine/threonine kinase activity; F:small GTPase binding; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:aortic valve morphogenesis; P:apoptotic process; P:blood vessel diameter maintenance; P:cortical actin cytoskeleton organization; P:embryonic morphogenesis; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glomerular visceral epithelial cell migration; P:I-kappaB kinase/NF-kappaB signaling; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:membrane to membrane docking; P:mitotic cytokinesis; P:mRNA destabilization; P:myoblast migration; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of amyloid-beta formation; P:negative regulation of angiogenesis; P:negative regulation of bicellular tight junction assembly; P:negative regulation of biomineral tissue development; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of myosin-light-chain-phosphatase activity; P:negative regulation of phosphorylation; P:negative regulation of protein binding; P:neuron projection arborization; P:neuron projection development; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of amyloid-beta clearance; P:positive regulation of autophagy; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of connective tissue replacement; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of MAPK cascade; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of amyloid-beta formation; P:regulation of angiotensin-activated signaling pathway; P:regulation of autophagy; P:regulation of cell adhesion; P:regulation of cell junction assembly; P:regulation of cell migration; P:regulation of cell motility; P:regulation of establishment of cell polarity; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of keratinocyte differentiation; P:regulation of microtubule cytoskeleton organization; P:regulation of neuron differentiation; P:regulation of stress fiber assembly; P:regulation of synaptic vesicle endocytosis; P:response to angiotensin; P:response to transforming growth factor beta; P:Rho protein signal transduction; P:signal transduction; P:smooth muscle contraction; P:vascular endothelial growth factor receptor signaling pathway;|Q13464 B0YJ91 Q2KHM4 Q59GZ4,Rho-associated protein kinase 1,Renal carcinoma antigen NY-REN-35;Rho-associated, coiled-coil-containing protein kinase 1;Rho-associated, coiled-coil-containing protein kinase I;p160 ROCK-1;, PF00069;PF08912;, GO:0032059;GO:0005814;GO:0005737;GO:0010494;GO:0005856;GO:0005829;GO:0005576;GO:0000139;GO:0030027;GO:0005886;GO:0001726;GO:0034774;GO:0019828;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0072518;GO:0031267;GO:0048156;GO:0050321;GO:0030036;GO:0031032;GO:0003180;GO:0006915;GO:0097746;GO:0030866;GO:0048598;GO:0048013;GO:0007186;GO:0090521;GO:0007249;GO:0007159;GO:0050900;GO:0050901;GO:0022614;GO:0000281;GO:0061157;GO:0051451;GO:1902992;GO:1902430;GO:0016525;GO:1903347;GO:0070168;GO:0051045;GO:0035509;GO:0042326;GO:0032091;GO:0140058;GO:0031175;GO:0043312;GO:0018105;GO:0018107;GO:1900223;GO:0010508;GO:0010613;GO:1905205;GO:0051894;GO:0010628;GO:0043410;GO:0072659;GO:0006468;GO:0032956;GO:1902003;GO:0110061;GO:0010506;GO:0030155;GO:1901888;GO:0030334;GO:2000145;GO:2000114;GO:1903140;GO:0051893;GO:0045616;GO:0070507;GO:0045664;GO:0051492;GO:1900242;GO:1990776;GO:0071559;GO:0007266;GO:0007165;GO:0006939;GO:0048010;, C:bleb; C:centriole; C:cytoplasm; C:cytoplasmic stress granule; C:cytoskeleton; C:cytosol; C:extracellular region; C:Golgi membrane; C:lamellipodium; C:plasma membrane; C:ruffle; C:secretory granule lumen;, F:aspartic-type endopeptidase inhibitor activity; F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:Rho-dependent protein serine/threonine kinase activity; F:small GTPase binding; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:aortic valve morphogenesis; P:apoptotic process; P:blood vessel diameter maintenance; P:cortical actin cytoskeleton organization; P:embryonic morphogenesis; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glomerular visceral epithelial cell migration; P:I-kappaB kinase/NF-kappaB signaling; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:membrane to membrane docking; P:mitotic cytokinesis; P:mRNA destabilization; P:myoblast migration; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of amyloid-beta formation; P:negative regulation of angiogenesis; P:negative regulation of bicellular tight junction assembly; P:negative regulation of biomineral tissue development; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of myosin-light-chain-phosphatase activity; P:negative regulation of phosphorylation; P:negative regulation of protein binding; P:neuron projection arborization; P:neuron projection development; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of amyloid-beta clearance; P:positive regulation of autophagy; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of connective tissue replacement; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of MAPK cascade; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of amyloid-beta formation; P:regulation of angiotensin-activated signaling pathway; P:regulation of autophagy; P:regulation of cell adhesion; P:regulation of cell junction assembly; P:regulation of cell migration; P:regulation of cell motility; P:regulation of establishment of cell polarity; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of keratinocyte differentiation; P:regulation of microtubule cytoskeleton organization; P:regulation of neuron differentiation; P:regulation of stress fiber assembly; P:regulation of synaptic vesicle endocytosis; P:response to angiotensin; P:response to transforming growth factor beta; P:Rho protein signal transduction; P:signal transduction; P:smooth muscle contraction; P:vascular endothelial growth factor receptor signaling pathway;|Q13464 B0YJ91 Q2KHM4 Q59GZ4,Rho-associated protein kinase 1,Renal carcinoma antigen NY-REN-35;Rho-associated, coiled-coil-containing protein kinase 1;Rho-associated, coiled-coil-containing protein kinase I;p160 ROCK-1;, PF00069;PF08912;, GO:0032059;GO:0005814;GO:0005737;GO:0010494;GO:0005856;GO:0005829;GO:0005576;GO:0000139;GO:0030027;GO:0005886;GO:0001726;GO:0034774;GO:0019828;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0072518;GO:0031267;GO:0048156;GO:0050321;GO:0030036;GO:0031032;GO:0003180;GO:0006915;GO:0097746;GO:0030866;GO:0048598;GO:0048013;GO:0007186;GO:0090521;GO:0007249;GO:0007159;GO:0050900;GO:0050901;GO:0022614;GO:0000281;GO:0061157;GO:0051451;GO:1902992;GO:1902430;GO:0016525;GO:1903347;GO:0070168;GO:0051045;GO:0035509;GO:0042326;GO:0032091;GO:0140058;GO:0031175;GO:0043312;GO:0018105;GO:0018107;GO:1900223;GO:0010508;GO:0010613;GO:1905205;GO:0051894;GO:0010628;GO:0043410;GO:0072659;GO:0006468;GO:0032956;GO:1902003;GO:0110061;GO:0010506;GO:0030155;GO:1901888;GO:0030334;GO:2000145;GO:2000114;GO:1903140;GO:0051893;GO:0045616;GO:0070507;GO:0045664;GO:0051492;GO:1900242;GO:1990776;GO:0071559;GO:0007266;GO:0007165;GO:0006939;GO:0048010;, C:bleb; C:centriole; C:cytoplasm; C:cytoplasmic stress granule; C:cytoskeleton; C:cytosol; C:extracellular region; C:Golgi membrane; C:lamellipodium; C:plasma membrane; C:ruffle; C:secretory granule lumen;, F:aspartic-type endopeptidase inhibitor activity; F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:Rho-dependent protein serine/threonine kinase activity; F:small GTPase binding; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:aortic valve morphogenesis; P:apoptotic process; P:blood vessel diameter maintenance; P:cortical actin cytoskeleton organization; P:embryonic morphogenesis; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glomerular visceral epithelial cell migration; P:I-kappaB kinase/NF-kappaB signaling; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:membrane to membrane docking; P:mitotic cytokinesis; P:mRNA destabilization; P:myoblast migration; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of amyloid-beta formation; P:negative regulation of angiogenesis; P:negative regulation of bicellular tight junction assembly; P:negative regulation of biomineral tissue development; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of myosin-light-chain-phosphatase activity; P:negative regulation of phosphorylation; P:negative regulation of protein binding; P:neuron projection arborization; P:neuron projection development; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of amyloid-beta clearance; P:positive regulation of autophagy; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of connective tissue replacement; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of MAPK cascade; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of amyloid-beta formation; P:regulation of angiotensin-activated signaling pathway; P:regulation of autophagy; P:regulation of cell adhesion; P:regulation of cell junction assembly; P:regulation of cell migration; P:regulation of cell motility; P:regulation of establishment of cell polarity; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of keratinocyte differentiation; P:regulation of microtubule cytoskeleton organization; P:regulation of neuron differentiation; P:regulation of stress fiber assembly; P:regulation of synaptic vesicle endocytosis; P:response to angiotensin; P:response to transforming growth factor beta; P:Rho protein signal transduction; P:signal transduction; P:smooth muscle contraction; P:vascular endothelial growth factor receptor signaling pathway;|Q13464 B0YJ91 Q2KHM4 Q59GZ4,Rho-associated protein kinase 1,Renal carcinoma antigen NY-REN-35;Rho-associated, coiled-coil-containing protein kinase 1;Rho-associated, coiled-coil-containing protein kinase I;p160 ROCK-1;, PF00069;PF08912;, GO:0032059;GO:0005814;GO:0005737;GO:0010494;GO:0005856;GO:0005829;GO:0005576;GO:0000139;GO:0030027;GO:0005886;GO:0001726;GO:0034774;GO:0019828;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0072518;GO:0031267;GO:0048156;GO:0050321;GO:0030036;GO:0031032;GO:0003180;GO:0006915;GO:0097746;GO:0030866;GO:0048598;GO:0048013;GO:0007186;GO:0090521;GO:0007249;GO:0007159;GO:0050900;GO:0050901;GO:0022614;GO:0000281;GO:0061157;GO:0051451;GO:1902992;GO:1902430;GO:0016525;GO:1903347;GO:0070168;GO:0051045;GO:0035509;GO:0042326;GO:0032091;GO:0140058;GO:0031175;GO:0043312;GO:0018105;GO:0018107;GO:1900223;GO:0010508;GO:0010613;GO:1905205;GO:0051894;GO:0010628;GO:0043410;GO:0072659;GO:0006468;GO:0032956;GO:1902003;GO:0110061;GO:0010506;GO:0030155;GO:1901888;GO:0030334;GO:2000145;GO:2000114;GO:1903140;GO:0051893;GO:0045616;GO:0070507;GO:0045664;GO:0051492;GO:1900242;GO:1990776;GO:0071559;GO:0007266;GO:0007165;GO:0006939;GO:0048010;, C:bleb; C:centriole; C:cytoplasm; C:cytoplasmic stress granule; C:cytoskeleton; C:cytosol; C:extracellular region; C:Golgi membrane; C:lamellipodium; C:plasma membrane; C:ruffle; C:secretory granule lumen;, F:aspartic-type endopeptidase inhibitor activity; F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:Rho-dependent protein serine/threonine kinase activity; F:small GTPase binding; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:aortic valve morphogenesis; P:apoptotic process; P:blood vessel diameter maintenance; P:cortical actin cytoskeleton organization; P:embryonic morphogenesis; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glomerular visceral epithelial cell migration; P:I-kappaB kinase/NF-kappaB signaling; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:membrane to membrane docking; P:mitotic cytokinesis; P:mRNA destabilization; P:myoblast migration; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of amyloid-beta formation; P:negative regulation of angiogenesis; P:negative regulation of bicellular tight junction assembly; P:negative regulation of biomineral tissue development; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of myosin-light-chain-phosphatase activity; P:negative regulation of phosphorylation; P:negative regulation of protein binding; P:neuron projection arborization; P:neuron projection development; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of amyloid-beta clearance; P:positive regulation of autophagy; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of connective tissue replacement; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of MAPK cascade; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of amyloid-beta formation; P:regulation of angiotensin-activated signaling pathway; P:regulation of autophagy; P:regulation of cell adhesion; P:regulation of cell junction assembly; P:regulation of cell migration; P:regulation of cell motility; P:regulation of establishment of cell polarity; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of keratinocyte differentiation; P:regulation of microtubule cytoskeleton organization; P:regulation of neuron differentiation; P:regulation of stress fiber assembly; P:regulation of synaptic vesicle endocytosis; P:response to angiotensin; P:response to transforming growth factor beta; P:Rho protein signal transduction; P:signal transduction; P:smooth muscle contraction; P:vascular endothelial growth factor receptor signaling pathway;|Q13464 B0YJ91 Q2KHM4 Q59GZ4,Rho-associated protein kinase 1,Renal carcinoma antigen NY-REN-35;Rho-associated, coiled-coil-containing protein kinase 1;Rho-associated, coiled-coil-containing protein kinase I;p160 ROCK-1;, PF00069;PF08912;, GO:0032059;GO:0005814;GO:0005737;GO:0010494;GO:0005856;GO:0005829;GO:0005576;GO:0000139;GO:0030027;GO:0005886;GO:0001726;GO:0034774;GO:0019828;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0072518;GO:0031267;GO:0048156;GO:0050321;GO:0030036;GO:0031032;GO:0003180;GO:0006915;GO:0097746;GO:0030866;GO:0048598;GO:0048013;GO:0007186;GO:0090521;GO:0007249;GO:0007159;GO:0050900;GO:0050901;GO:0022614;GO:0000281;GO:0061157;GO:0051451;GO:1902992;GO:1902430;GO:0016525;GO:1903347;GO:0070168;GO:0051045;GO:0035509;GO:0042326;GO:0032091;GO:0140058;GO:0031175;GO:0043312;GO:0018105;GO:0018107;GO:1900223;GO:0010508;GO:0010613;GO:1905205;GO:0051894;GO:0010628;GO:0043410;GO:0072659;GO:0006468;GO:0032956;GO:1902003;GO:0110061;GO:0010506;GO:0030155;GO:1901888;GO:0030334;GO:2000145;GO:2000114;GO:1903140;GO:0051893;GO:0045616;GO:0070507;GO:0045664;GO:0051492;GO:1900242;GO:1990776;GO:0071559;GO:0007266;GO:0007165;GO:0006939;GO:0048010;, C:bleb; C:centriole; C:cytoplasm; C:cytoplasmic stress granule; C:cytoskeleton; C:cytosol; C:extracellular region; C:Golgi membrane; C:lamellipodium; C:plasma membrane; C:ruffle; C:secretory granule lumen;, F:aspartic-type endopeptidase inhibitor activity; F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:Rho-dependent protein serine/threonine kinase activity; F:small GTPase binding; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:aortic valve morphogenesis; P:apoptotic process; P:blood vessel diameter maintenance; P:cortical actin cytoskeleton organization; P:embryonic morphogenesis; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glomerular visceral epithelial cell migration; P:I-kappaB kinase/NF-kappaB signaling; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:membrane to membrane docking; P:mitotic cytokinesis; P:mRNA destabilization; P:myoblast migration; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of amyloid-beta formation; P:negative regulation of angiogenesis; P:negative regulation of bicellular tight junction assembly; P:negative regulation of biomineral tissue development; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of myosin-light-chain-phosphatase activity; P:negative regulation of phosphorylation; P:negative regulation of protein binding; P:neuron projection arborization; P:neuron projection development; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of amyloid-beta clearance; P:positive regulation of autophagy; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of connective tissue replacement; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of MAPK cascade; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of amyloid-beta formation; P:regulation of angiotensin-activated signaling pathway; P:regulation of autophagy; P:regulation of cell adhesion; P:regulation of cell junction assembly; P:regulation of cell migration; P:regulation of cell motility; P:regulation of establishment of cell polarity; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of keratinocyte differentiation; P:regulation of microtubule cytoskeleton organization; P:regulation of neuron differentiation; P:regulation of stress fiber assembly; P:regulation of synaptic vesicle endocytosis; P:response to angiotensin; P:response to transforming growth factor beta; P:Rho protein signal transduction; P:signal transduction; P:smooth muscle contraction; P:vascular endothelial growth factor receptor signaling pathway;|Q9UJ21,Sodium/potassium-transporting ATPase subunit alpha-1,Sodium pump subunit alpha-1;, PF00689;PF00690;, GO:0016324;GO:0016323;GO:0005901;GO:0005783;GO:0005768;GO:0070062;GO:1903561;GO:0005794;GO:0016021;GO:0014704;GO:0016328;GO:0042470;GO:0016020;GO:0045121;GO:0031090;GO:0060342;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0043531;GO:0030506;GO:0005524;GO:0051087;GO:0005391;GO:0016791;GO:0043548;GO:0030955;GO:0008556;GO:0019904;GO:0046982;GO:0019901;GO:0031402;GO:1990239;GO:0086002;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0060081;GO:0086009;GO:0086013;GO:0031947;GO:0045822;GO:0045823;GO:0045989;GO:1990573;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0002028;GO:0002026;GO:0055119;GO:0042493;GO:1903416;GO:0036376;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:melanosome; C:membrane; C:membrane raft; C:organelle membrane; C:photoreceptor inner segment membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ADP binding; F:ankyrin binding; F:ATP binding; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:phosphatidylinositol 3-kinase binding; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:sodium ion binding; F:steroid hormone binding;, P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:membrane hyperpolarization; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of glucocorticoid biosynthetic process; P:negative regulation of heart contraction; P:positive regulation of heart contraction; P:positive regulation of striated muscle contraction; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to drug; P:response to glycoside; P:sodium ion export across plasma membrane; scaffold10 indexed_genome mRNA 32429145 32511193 . + . ID=transcript_2678;P54578 B7Z4N8 J3QRZ5 Q53XY5,Ubiquitin carboxyl-terminal hydrolase 14,Deubiquitinating enzyme 14;Ubiquitin thioesterase 14;Ubiquitin-specific-processing protease 14;, PF00443;, GO:0009986;GO:0031410;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0000502;GO:0004197;GO:0004866;GO:0070628;GO:0004843;GO:0045087;GO:1903070;GO:0016579;GO:0050920;GO:0061136;GO:0006511;, C:cell surface; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:proteasome complex;, F:cysteine-type endopeptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of chemotaxis; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|P54578 B7Z4N8 J3QRZ5 Q53XY5,Ubiquitin carboxyl-terminal hydrolase 14,Deubiquitinating enzyme 14;Ubiquitin thioesterase 14;Ubiquitin-specific-processing protease 14;, PF00443;, GO:0009986;GO:0031410;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0000502;GO:0004197;GO:0004866;GO:0070628;GO:0004843;GO:0045087;GO:1903070;GO:0016579;GO:0050920;GO:0061136;GO:0006511;, C:cell surface; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:proteasome complex;, F:cysteine-type endopeptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of chemotaxis; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|P54578 B7Z4N8 J3QRZ5 Q53XY5,Ubiquitin carboxyl-terminal hydrolase 14,Deubiquitinating enzyme 14;Ubiquitin thioesterase 14;Ubiquitin-specific-processing protease 14;, PF00443;, GO:0009986;GO:0031410;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0000502;GO:0004197;GO:0004866;GO:0070628;GO:0004843;GO:0045087;GO:1903070;GO:0016579;GO:0050920;GO:0061136;GO:0006511;, C:cell surface; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:proteasome complex;, F:cysteine-type endopeptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of chemotaxis; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|P54578 B7Z4N8 J3QRZ5 Q53XY5,Ubiquitin carboxyl-terminal hydrolase 14,Deubiquitinating enzyme 14;Ubiquitin thioesterase 14;Ubiquitin-specific-processing protease 14;, PF00443;, GO:0009986;GO:0031410;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0000502;GO:0004197;GO:0004866;GO:0070628;GO:0004843;GO:0045087;GO:1903070;GO:0016579;GO:0050920;GO:0061136;GO:0006511;, C:cell surface; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:proteasome complex;, F:cysteine-type endopeptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of chemotaxis; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|P54578 B7Z4N8 J3QRZ5 Q53XY5,Ubiquitin carboxyl-terminal hydrolase 14,Deubiquitinating enzyme 14;Ubiquitin thioesterase 14;Ubiquitin-specific-processing protease 14;, PF00443;, GO:0009986;GO:0031410;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0000502;GO:0004197;GO:0004866;GO:0070628;GO:0004843;GO:0045087;GO:1903070;GO:0016579;GO:0050920;GO:0061136;GO:0006511;, C:cell surface; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:proteasome complex;, F:cysteine-type endopeptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of chemotaxis; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|P54578 B7Z4N8 J3QRZ5 Q53XY5,Ubiquitin carboxyl-terminal hydrolase 14,Deubiquitinating enzyme 14;Ubiquitin thioesterase 14;Ubiquitin-specific-processing protease 14;, PF00443;, GO:0009986;GO:0031410;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0000502;GO:0004197;GO:0004866;GO:0070628;GO:0004843;GO:0045087;GO:1903070;GO:0016579;GO:0050920;GO:0061136;GO:0006511;, C:cell surface; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:proteasome complex;, F:cysteine-type endopeptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of chemotaxis; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|P54578 B7Z4N8 J3QRZ5 Q53XY5,Ubiquitin carboxyl-terminal hydrolase 14,Deubiquitinating enzyme 14;Ubiquitin thioesterase 14;Ubiquitin-specific-processing protease 14;, PF00443;, GO:0009986;GO:0031410;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0000502;GO:0004197;GO:0004866;GO:0070628;GO:0004843;GO:0045087;GO:1903070;GO:0016579;GO:0050920;GO:0061136;GO:0006511;, C:cell surface; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:proteasome complex;, F:cysteine-type endopeptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of chemotaxis; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q96FV9 B2RBP6 Q15219 Q64I72 Q64I73,THO complex subunit 1,Nuclear matrix protein p84;hTREX84;, PF00531;PF11957;, GO:0005737;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003677;GO:0003723;GO:0006915;GO:0031124;GO:0006406;GO:2000002;GO:0048297;GO:0032786;GO:0000018;GO:0032784;GO:0031297;GO:0006405;GO:0006396;GO:0008380;GO:0007165;GO:0046784;, C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:negative regulation of isotype switching to IgA isotypes; P:positive regulation of DNA-templated transcription, elongation; P:regulation of DNA recombination; P:regulation of DNA-templated transcription, elongation; P:replication fork processing; P:RNA export from nucleus; P:RNA processing; P:RNA splicing; P:signal transduction; P:viral mRNA export from host cell nucleus;|Q96FV9 B2RBP6 Q15219 Q64I72 Q64I73,THO complex subunit 1,Nuclear matrix protein p84;hTREX84;, PF00531;PF11957;, GO:0005737;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003677;GO:0003723;GO:0006915;GO:0031124;GO:0006406;GO:2000002;GO:0048297;GO:0032786;GO:0000018;GO:0032784;GO:0031297;GO:0006405;GO:0006396;GO:0008380;GO:0007165;GO:0046784;, C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:negative regulation of isotype switching to IgA isotypes; P:positive regulation of DNA-templated transcription, elongation; P:regulation of DNA recombination; P:regulation of DNA-templated transcription, elongation; P:replication fork processing; P:RNA export from nucleus; P:RNA processing; P:RNA splicing; P:signal transduction; P:viral mRNA export from host cell nucleus;|Q96FV9 B2RBP6 Q15219 Q64I72 Q64I73,THO complex subunit 1,Nuclear matrix protein p84;hTREX84;, PF00531;PF11957;, GO:0005737;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003677;GO:0003723;GO:0006915;GO:0031124;GO:0006406;GO:2000002;GO:0048297;GO:0032786;GO:0000018;GO:0032784;GO:0031297;GO:0006405;GO:0006396;GO:0008380;GO:0007165;GO:0046784;, C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:negative regulation of isotype switching to IgA isotypes; P:positive regulation of DNA-templated transcription, elongation; P:regulation of DNA recombination; P:regulation of DNA-templated transcription, elongation; P:replication fork processing; P:RNA export from nucleus; P:RNA processing; P:RNA splicing; P:signal transduction; P:viral mRNA export from host cell nucleus;|Q96FV9 B2RBP6 Q15219 Q64I72 Q64I73,THO complex subunit 1,Nuclear matrix protein p84;hTREX84;, PF00531;PF11957;, GO:0005737;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003677;GO:0003723;GO:0006915;GO:0031124;GO:0006406;GO:2000002;GO:0048297;GO:0032786;GO:0000018;GO:0032784;GO:0031297;GO:0006405;GO:0006396;GO:0008380;GO:0007165;GO:0046784;, C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:negative regulation of isotype switching to IgA isotypes; P:positive regulation of DNA-templated transcription, elongation; P:regulation of DNA recombination; P:regulation of DNA-templated transcription, elongation; P:replication fork processing; P:RNA export from nucleus; P:RNA processing; P:RNA splicing; P:signal transduction; P:viral mRNA export from host cell nucleus;|Q96FV9 B2RBP6 Q15219 Q64I72 Q64I73,THO complex subunit 1,Nuclear matrix protein p84;hTREX84;, PF00531;PF11957;, GO:0005737;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003677;GO:0003723;GO:0006915;GO:0031124;GO:0006406;GO:2000002;GO:0048297;GO:0032786;GO:0000018;GO:0032784;GO:0031297;GO:0006405;GO:0006396;GO:0008380;GO:0007165;GO:0046784;, C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:negative regulation of isotype switching to IgA isotypes; P:positive regulation of DNA-templated transcription, elongation; P:regulation of DNA recombination; P:regulation of DNA-templated transcription, elongation; P:replication fork processing; P:RNA export from nucleus; P:RNA processing; P:RNA splicing; P:signal transduction; P:viral mRNA export from host cell nucleus;|Q96FV9 B2RBP6 Q15219 Q64I72 Q64I73,THO complex subunit 1,Nuclear matrix protein p84;hTREX84;, PF00531;PF11957;, GO:0005737;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003677;GO:0003723;GO:0006915;GO:0031124;GO:0006406;GO:2000002;GO:0048297;GO:0032786;GO:0000018;GO:0032784;GO:0031297;GO:0006405;GO:0006396;GO:0008380;GO:0007165;GO:0046784;, C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:negative regulation of isotype switching to IgA isotypes; P:positive regulation of DNA-templated transcription, elongation; P:regulation of DNA recombination; P:regulation of DNA-templated transcription, elongation; P:replication fork processing; P:RNA export from nucleus; P:RNA processing; P:RNA splicing; P:signal transduction; P:viral mRNA export from host cell nucleus; scaffold10 indexed_genome mRNA 32535647 32718315 . - . ID=transcript_2679;Q5KU26 Q6P9F2 Q8TCR2 Q8WZA4 Q9BY85 Q9BYH7,Collectin-12,Collectin placenta protein 1;Nurse cell scavenger receptor 2;Scavenger receptor class A member 4;Scavenger receptor with C-type lectin;, PF01391;PF00059;, GO:0005581;GO:0030666;GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0005534;GO:0030169;GO:0046872;GO:0038187;GO:0005044;GO:0009756;GO:0071360;GO:0006952;GO:0042742;GO:0045087;GO:0006910;GO:0060355;GO:0006898;GO:0050776;GO:0034138;, C:collagen trimer; C:endocytic vesicle membrane; C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:galactose binding; F:low-density lipoprotein particle binding; F:metal ion binding; F:pattern recognition receptor activity; F:scavenger receptor activity;, P:carbohydrate mediated signaling; P:cellular response to exogenous dsRNA; P:defense response; P:defense response to bacterium; P:innate immune response; P:phagocytosis, recognition; P:positive regulation of cell adhesion molecule production; P:receptor-mediated endocytosis; P:regulation of immune response; P:toll-like receptor 3 signaling pathway;|Q5KU26 Q6P9F2 Q8TCR2 Q8WZA4 Q9BY85 Q9BYH7,Collectin-12,Collectin placenta protein 1;Nurse cell scavenger receptor 2;Scavenger receptor class A member 4;Scavenger receptor with C-type lectin;, PF01391;PF00059;, GO:0005581;GO:0030666;GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0005534;GO:0030169;GO:0046872;GO:0038187;GO:0005044;GO:0009756;GO:0071360;GO:0006952;GO:0042742;GO:0045087;GO:0006910;GO:0060355;GO:0006898;GO:0050776;GO:0034138;, C:collagen trimer; C:endocytic vesicle membrane; C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:galactose binding; F:low-density lipoprotein particle binding; F:metal ion binding; F:pattern recognition receptor activity; F:scavenger receptor activity;, P:carbohydrate mediated signaling; P:cellular response to exogenous dsRNA; P:defense response; P:defense response to bacterium; P:innate immune response; P:phagocytosis, recognition; P:positive regulation of cell adhesion molecule production; P:receptor-mediated endocytosis; P:regulation of immune response; P:toll-like receptor 3 signaling pathway; scaffold10 indexed_genome mRNA 32839790 32872099 . + . ID=transcript_2680;P04818 Q8WYK3 Q8WYK4,Thymidylate synthase,, PF00303;, GO:0005737;GO:0005829;GO:0005743;GO:0005759;GO:0005739;GO:0005730;GO:0005634;GO:0008144;GO:0005542;GO:0042803;GO:1990825;GO:0004799;GO:0000900;GO:0007568;GO:0051216;GO:0007623;GO:0048589;GO:0071897;GO:0006231;GO:0006235;GO:0060574;GO:0097421;GO:0032259;GO:0019048;GO:0017148;GO:0015949;GO:0000083;GO:0034097;GO:0042493;GO:0045471;GO:0051593;GO:0051384;GO:0046683;GO:0032570;GO:0009636;GO:0033189;GO:0035999;GO:0019860;, C:cytoplasm; C:cytosol; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleolus; C:nucleus;, F:drug binding; F:folic acid binding; F:protein homodimerization activity; F:sequence-specific mRNA binding; F:thymidylate synthase activity; F:translation repressor activity, mRNA regulatory element binding;, P:aging; P:cartilage development; P:circadian rhythm; P:developmental growth; P:DNA biosynthetic process; P:dTMP biosynthetic process; P:dTTP biosynthetic process; P:intestinal epithelial cell maturation; P:liver regeneration; P:methylation; P:modulation by virus of host process; P:negative regulation of translation; P:nucleobase-containing small molecule interconversion; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:response to cytokine; P:response to drug; P:response to ethanol; P:response to folic acid; P:response to glucocorticoid; P:response to organophosphorus; P:response to progesterone; P:response to toxic substance; P:response to vitamin A; P:tetrahydrofolate interconversion; P:uracil metabolic process;|Q6ZS08 Q9HAS5 Q9HAS6,Mitochondrial enolase superfamily member 1,Antisense RNA to thymidylate synthase;L-fuconate dehydratase;, PF13378;PF02746;, GO:0005739;GO:0016836;GO:0016853;GO:0050023;GO:0000287;GO:0016052;GO:0009063;GO:0044275;, C:mitochondrion;, F:hydro-lyase activity; F:isomerase activity; F:L-fuconate dehydratase activity; F:magnesium ion binding;, P:carbohydrate catabolic process; P:cellular amino acid catabolic process; P:cellular carbohydrate catabolic process;|Q6ZS08 Q9HAS5 Q9HAS6,Mitochondrial enolase superfamily member 1,Antisense RNA to thymidylate synthase;L-fuconate dehydratase;, PF13378;PF02746;, GO:0005739;GO:0016836;GO:0016853;GO:0050023;GO:0000287;GO:0016052;GO:0009063;GO:0044275;, C:mitochondrion;, F:hydro-lyase activity; F:isomerase activity; F:L-fuconate dehydratase activity; F:magnesium ion binding;, P:carbohydrate catabolic process; P:cellular amino acid catabolic process; P:cellular carbohydrate catabolic process;|Q6ZS08 Q9HAS5 Q9HAS6,Mitochondrial enolase superfamily member 1,Antisense RNA to thymidylate synthase;L-fuconate dehydratase;, PF13378;PF02746;, GO:0005739;GO:0016836;GO:0016853;GO:0050023;GO:0000287;GO:0016052;GO:0009063;GO:0044275;, C:mitochondrion;, F:hydro-lyase activity; F:isomerase activity; F:L-fuconate dehydratase activity; F:magnesium ion binding;, P:carbohydrate catabolic process; P:cellular amino acid catabolic process; P:cellular carbohydrate catabolic process;|Q6ZS08 Q9HAS5 Q9HAS6,Mitochondrial enolase superfamily member 1,Antisense RNA to thymidylate synthase;L-fuconate dehydratase;, PF13378;PF02746;, GO:0005739;GO:0016836;GO:0016853;GO:0050023;GO:0000287;GO:0016052;GO:0009063;GO:0044275;, C:mitochondrion;, F:hydro-lyase activity; F:isomerase activity; F:L-fuconate dehydratase activity; F:magnesium ion binding;, P:carbohydrate catabolic process; P:cellular amino acid catabolic process; P:cellular carbohydrate catabolic process; scaffold10 indexed_genome mRNA 32877717 32942782 . - . ID=transcript_2681;P07947 A6NLB3 D3DUH1,Tyrosine-protein kinase Yes,Proto-oncogene c-Yes;p61-Yes;, PF07714;PF00017;PF00018;, GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0005794;GO:0005815;GO:0005886;GO:0005524;GO:0019899;GO:0044325;GO:0004715;GO:0001784;GO:0004713;GO:0005102;GO:0004714;GO:0030154;GO:0006464;GO:0048013;GO:0038096;GO:0045087;GO:0050900;GO:0002862;GO:0043114;GO:0031295;GO:0007169;, C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:microtubule organizing center; C:plasma membrane;, F:ATP binding; F:enzyme binding; F:ion channel binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:cellular protein modification process; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:innate immune response; P:leukocyte migration; P:negative regulation of inflammatory response to antigenic stimulus; P:regulation of vascular permeability; P:T cell costimulation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P07947 A6NLB3 D3DUH1,Tyrosine-protein kinase Yes,Proto-oncogene c-Yes;p61-Yes;, PF07714;PF00017;PF00018;, GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0005794;GO:0005815;GO:0005886;GO:0005524;GO:0019899;GO:0044325;GO:0004715;GO:0001784;GO:0004713;GO:0005102;GO:0004714;GO:0030154;GO:0006464;GO:0048013;GO:0038096;GO:0045087;GO:0050900;GO:0002862;GO:0043114;GO:0031295;GO:0007169;, C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:microtubule organizing center; C:plasma membrane;, F:ATP binding; F:enzyme binding; F:ion channel binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:cellular protein modification process; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:innate immune response; P:leukocyte migration; P:negative regulation of inflammatory response to antigenic stimulus; P:regulation of vascular permeability; P:T cell costimulation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P07947 A6NLB3 D3DUH1,Tyrosine-protein kinase Yes,Proto-oncogene c-Yes;p61-Yes;, PF07714;PF00017;PF00018;, GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0005794;GO:0005815;GO:0005886;GO:0005524;GO:0019899;GO:0044325;GO:0004715;GO:0001784;GO:0004713;GO:0005102;GO:0004714;GO:0030154;GO:0006464;GO:0048013;GO:0038096;GO:0045087;GO:0050900;GO:0002862;GO:0043114;GO:0031295;GO:0007169;, C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:microtubule organizing center; C:plasma membrane;, F:ATP binding; F:enzyme binding; F:ion channel binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:cellular protein modification process; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:innate immune response; P:leukocyte migration; P:negative regulation of inflammatory response to antigenic stimulus; P:regulation of vascular permeability; P:T cell costimulation; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold10 indexed_genome mRNA 33016145 33016721 . - . ID=transcript_2682;P18509 B2R7N4 Q52LQ0,Pituitary adenylate cyclase-activating polypeptide,, PF00123;, GO:0005576;GO:0005615;GO:0043005;GO:0043204;GO:0043195;GO:0005184;GO:0051428;GO:0016521;GO:0031858;GO:0005102;GO:0007190;GO:0007189;GO:0046034;GO:0001662;GO:0019933;GO:0007267;GO:0071385;GO:0007565;GO:0007186;GO:0001821;GO:0030073;GO:0002865;GO:0002878;GO:0060253;GO:0034260;GO:0002862;GO:0010656;GO:0043267;GO:0031175;GO:0007218;GO:0001541;GO:0021983;GO:0043950;GO:0008284;GO:0071651;GO:0120162;GO:0007204;GO:0070374;GO:0060124;GO:0043547;GO:0032755;GO:0010976;GO:0045860;GO:0090274;GO:0051968;GO:0045944;GO:0008277;GO:0070445;GO:0060078;GO:0032880;GO:0045471;GO:0042594;GO:0019233;, C:extracellular region; C:extracellular space; C:neuron projection; C:perikaryon; C:terminal bouton;, F:neuropeptide hormone activity; F:peptide hormone receptor binding; F:pituitary adenylate cyclase activating polypeptide activity; F:pituitary adenylate cyclase-activating polypeptide receptor binding; F:signaling receptor binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:ATP metabolic process; P:behavioral fear response; P:cAMP-mediated signaling; P:cell-cell signaling; P:cellular response to glucocorticoid stimulus; P:female pregnancy; P:G protein-coupled receptor signaling pathway; P:histamine secretion; P:insulin secretion; P:negative regulation of acute inflammatory response to antigenic stimulus; P:negative regulation of acute inflammatory response to non-antigenic stimulus; P:negative regulation of glial cell proliferation; P:negative regulation of GTPase activity; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of muscle cell apoptotic process; P:negative regulation of potassium ion transport; P:neuron projection development; P:neuropeptide signaling pathway; P:ovarian follicle development; P:pituitary gland development; P:positive regulation of cAMP-mediated signaling; P:positive regulation of cell population proliferation; P:positive regulation of chemokine (C-C motif) ligand 5 production; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of growth hormone secretion; P:positive regulation of GTPase activity; P:positive regulation of interleukin-6 production; P:positive regulation of neuron projection development; P:positive regulation of protein kinase activity; P:positive regulation of somatostatin secretion; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of transcription by RNA polymerase II; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of oligodendrocyte progenitor proliferation; P:regulation of postsynaptic membrane potential; P:regulation of protein localization; P:response to ethanol; P:response to starvation; P:sensory perception of pain; scaffold10 indexed_genome mRNA 34028344 34054804 . - . ID=transcript_2683;Q8N3J2 B2RNA1 Q2TAA7 Q9H5U9,N(6)-adenine-specific methyltransferase METTL4 {ECO:0000305},Methyltransferase-like protein 4 {ECO:0000305};N(6)-adenine-specific DNA methyltransferase METTL4 {ECO:0000305};snRNA (2'-O-methyladenosine-N(6)-)-methyltransferase METTL4 {ECO:0000305};, PF05063;, GO:0005829;GO:0005759;GO:0005634;GO:0008168;GO:0003676;GO:0008173;GO:0009007;GO:0106347;GO:0006325;GO:0032775;GO:1902275;GO:0090296;GO:1903108;GO:0043484;GO:0120049;, C:cytosol; C:mitochondrial matrix; C:nucleus;, F:methyltransferase activity; F:nucleic acid binding; F:RNA methyltransferase activity; F:site-specific DNA-methyltransferase (adenine-specific) activity; F:U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity;, P:chromatin organization; P:DNA methylation on adenine; P:regulation of chromatin organization; P:regulation of mitochondrial DNA replication; P:regulation of mitochondrial transcription; P:regulation of RNA splicing; P:snRNA (adenine-N6)-methylation; scaffold10 indexed_genome mRNA 34086348 34090748 . + . ID=transcript_2684;O14777 Q6PJX2,Kinetochore protein NDC80 homolog,Highly expressed in cancer protein;Kinetochore protein Hec1;Kinetochore-associated protein 2;Retinoblastoma-associated protein HEC;, PF18077;PF03801;, GO:0005813;GO:0000775;GO:0000777;GO:0000778;GO:0000942;GO:0005829;GO:0000776;GO:0016020;GO:0031262;GO:0005654;GO:0005634;GO:0042802;GO:0051315;GO:0008608;GO:0051301;GO:0051298;GO:0007059;GO:0000132;GO:0051383;GO:0051310;GO:0000278;GO:0000070;GO:0007052;GO:0090267;GO:1905342;, C:centrosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:condensed nuclear chromosome kinetochore; C:condensed nuclear chromosome outer kinetochore; C:cytosol; C:kinetochore; C:membrane; C:Ndc80 complex; C:nucleoplasm; C:nucleus;, F:identical protein binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:attachment of spindle microtubules to kinetochore; P:cell division; P:centrosome duplication; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:kinetochore organization; P:metaphase plate congression; P:mitotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:positive regulation of protein localization to kinetochore; scaffold10 indexed_genome mRNA 34127017 34250570 . + . ID=transcript_2685;A6NHR9 O75141 Q6AHX6 Q6ZTQ8 Q9H6Q2 Q9UG39,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 {ECO:0000250|UniProtKB:Q6P5D8},, PF06470;, GO:0001740;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0042803;GO:0009048;GO:0006302;GO:0070868;GO:0060821;GO:0060820;GO:2000042;GO:0043584;GO:0045739;GO:2001034;, C:Barr body; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:protein homodimerization activity;, P:dosage compensation by inactivation of X chromosome; P:double-strand break repair; P:heterochromatin organization involved in chromatin silencing; P:inactivation of X chromosome by DNA methylation; P:inactivation of X chromosome by heterochromatin assembly; P:negative regulation of double-strand break repair via homologous recombination; P:nose development; P:positive regulation of DNA repair; P:positive regulation of double-strand break repair via nonhomologous end joining;|A6NHR9 O75141 Q6AHX6 Q6ZTQ8 Q9H6Q2 Q9UG39,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 {ECO:0000250|UniProtKB:Q6P5D8},, PF06470;, GO:0001740;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0042803;GO:0009048;GO:0006302;GO:0070868;GO:0060821;GO:0060820;GO:2000042;GO:0043584;GO:0045739;GO:2001034;, C:Barr body; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:protein homodimerization activity;, P:dosage compensation by inactivation of X chromosome; P:double-strand break repair; P:heterochromatin organization involved in chromatin silencing; P:inactivation of X chromosome by DNA methylation; P:inactivation of X chromosome by heterochromatin assembly; P:negative regulation of double-strand break repair via homologous recombination; P:nose development; P:positive regulation of DNA repair; P:positive regulation of double-strand break repair via nonhomologous end joining;|A6NHR9 O75141 Q6AHX6 Q6ZTQ8 Q9H6Q2 Q9UG39,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 {ECO:0000250|UniProtKB:Q6P5D8},, PF06470;, GO:0001740;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0042803;GO:0009048;GO:0006302;GO:0070868;GO:0060821;GO:0060820;GO:2000042;GO:0043584;GO:0045739;GO:2001034;, C:Barr body; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:protein homodimerization activity;, P:dosage compensation by inactivation of X chromosome; P:double-strand break repair; P:heterochromatin organization involved in chromatin silencing; P:inactivation of X chromosome by DNA methylation; P:inactivation of X chromosome by heterochromatin assembly; P:negative regulation of double-strand break repair via homologous recombination; P:nose development; P:positive regulation of DNA repair; P:positive regulation of double-strand break repair via nonhomologous end joining;|A6NHR9 O75141 Q6AHX6 Q6ZTQ8 Q9H6Q2 Q9UG39,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 {ECO:0000250|UniProtKB:Q6P5D8},, PF06470;, GO:0001740;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0042803;GO:0009048;GO:0006302;GO:0070868;GO:0060821;GO:0060820;GO:2000042;GO:0043584;GO:0045739;GO:2001034;, C:Barr body; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:protein homodimerization activity;, P:dosage compensation by inactivation of X chromosome; P:double-strand break repair; P:heterochromatin organization involved in chromatin silencing; P:inactivation of X chromosome by DNA methylation; P:inactivation of X chromosome by heterochromatin assembly; P:negative regulation of double-strand break repair via homologous recombination; P:nose development; P:positive regulation of DNA repair; P:positive regulation of double-strand break repair via nonhomologous end joining;|A6NHR9 O75141 Q6AHX6 Q6ZTQ8 Q9H6Q2 Q9UG39,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 {ECO:0000250|UniProtKB:Q6P5D8},, PF06470;, GO:0001740;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0042803;GO:0009048;GO:0006302;GO:0070868;GO:0060821;GO:0060820;GO:2000042;GO:0043584;GO:0045739;GO:2001034;, C:Barr body; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:protein homodimerization activity;, P:dosage compensation by inactivation of X chromosome; P:double-strand break repair; P:heterochromatin organization involved in chromatin silencing; P:inactivation of X chromosome by DNA methylation; P:inactivation of X chromosome by heterochromatin assembly; P:negative regulation of double-strand break repair via homologous recombination; P:nose development; P:positive regulation of DNA repair; P:positive regulation of double-strand break repair via nonhomologous end joining; scaffold10 indexed_genome mRNA 34270296 34326025 . + . ID=transcript_2686;Q9BXX0 B2RMY3 Q8NBH3 Q96JQ4,EMILIN-2,Elastin microfibril interface-located protein 2;Protein FOAP-10;, PF00386;PF07546;, GO:0005581;GO:0062023;GO:0005576;GO:0030023;GO:0007155;, C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular region;, F:extracellular matrix constituent conferring elasticity;, P:cell adhesion; scaffold10 indexed_genome mRNA 34328270 34362937 . - . ID=transcript_2687;Q92539 A7MD25 D3DUH3,Phosphatidate phosphatase LPIN2 {ECO:0000305},Lipin-2 {ECO:0000250|UniProtKB:Q99PI5};, PF16876;PF04571;PF08235;, GO:0005829;GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006629;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:cytosol; C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process;|Q92539 A7MD25 D3DUH3,Phosphatidate phosphatase LPIN2 {ECO:0000305},Lipin-2 {ECO:0000250|UniProtKB:Q99PI5};, PF16876;PF04571;PF08235;, GO:0005829;GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006629;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:cytosol; C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process;|Q92539 A7MD25 D3DUH3,Phosphatidate phosphatase LPIN2 {ECO:0000305},Lipin-2 {ECO:0000250|UniProtKB:Q99PI5};, PF16876;PF04571;PF08235;, GO:0005829;GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006629;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:cytosol; C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process;|Q92539 A7MD25 D3DUH3,Phosphatidate phosphatase LPIN2 {ECO:0000305},Lipin-2 {ECO:0000250|UniProtKB:Q99PI5};, PF16876;PF04571;PF08235;, GO:0005829;GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006629;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:cytosol; C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process; scaffold10 indexed_genome mRNA 34448639 34567740 . - . ID=transcript_2688;P52179 Q14BD6 Q6H969 Q6ZUU0,Myomesin-1,190 kDa connectin-associated protein;190 kDa titin-associated protein;Myomesin family member 1;, PF00041;PF07679;, GO:0031430;GO:0005863;GO:0051015;GO:0042802;GO:0019900;GO:0042803;GO:0008307;GO:0002074;GO:0006936;GO:0010628;GO:0050714;GO:0010737;, C:M band; C:striated muscle myosin thick filament;, F:actin filament binding; F:identical protein binding; F:kinase binding; F:protein homodimerization activity; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling;|P52179 Q14BD6 Q6H969 Q6ZUU0,Myomesin-1,190 kDa connectin-associated protein;190 kDa titin-associated protein;Myomesin family member 1;, PF00041;PF07679;, GO:0031430;GO:0005863;GO:0051015;GO:0042802;GO:0019900;GO:0042803;GO:0008307;GO:0002074;GO:0006936;GO:0010628;GO:0050714;GO:0010737;, C:M band; C:striated muscle myosin thick filament;, F:actin filament binding; F:identical protein binding; F:kinase binding; F:protein homodimerization activity; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling;|P52179 Q14BD6 Q6H969 Q6ZUU0,Myomesin-1,190 kDa connectin-associated protein;190 kDa titin-associated protein;Myomesin family member 1;, PF00041;PF07679;, GO:0031430;GO:0005863;GO:0051015;GO:0042802;GO:0019900;GO:0042803;GO:0008307;GO:0002074;GO:0006936;GO:0010628;GO:0050714;GO:0010737;, C:M band; C:striated muscle myosin thick filament;, F:actin filament binding; F:identical protein binding; F:kinase binding; F:protein homodimerization activity; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling;|P52179 Q14BD6 Q6H969 Q6ZUU0,Myomesin-1,190 kDa connectin-associated protein;190 kDa titin-associated protein;Myomesin family member 1;, PF00041;PF07679;, GO:0031430;GO:0005863;GO:0051015;GO:0042802;GO:0019900;GO:0042803;GO:0008307;GO:0002074;GO:0006936;GO:0010628;GO:0050714;GO:0010737;, C:M band; C:striated muscle myosin thick filament;, F:actin filament binding; F:identical protein binding; F:kinase binding; F:protein homodimerization activity; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling;|P52179 Q14BD6 Q6H969 Q6ZUU0,Myomesin-1,190 kDa connectin-associated protein;190 kDa titin-associated protein;Myomesin family member 1;, PF00041;PF07679;, GO:0031430;GO:0005863;GO:0051015;GO:0042802;GO:0019900;GO:0042803;GO:0008307;GO:0002074;GO:0006936;GO:0010628;GO:0050714;GO:0010737;, C:M band; C:striated muscle myosin thick filament;, F:actin filament binding; F:identical protein binding; F:kinase binding; F:protein homodimerization activity; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling;|P52179 Q14BD6 Q6H969 Q6ZUU0,Myomesin-1,190 kDa connectin-associated protein;190 kDa titin-associated protein;Myomesin family member 1;, PF00041;PF07679;, GO:0031430;GO:0005863;GO:0051015;GO:0042802;GO:0019900;GO:0042803;GO:0008307;GO:0002074;GO:0006936;GO:0010628;GO:0050714;GO:0010737;, C:M band; C:striated muscle myosin thick filament;, F:actin filament binding; F:identical protein binding; F:kinase binding; F:protein homodimerization activity; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; scaffold10 indexed_genome mRNA 34586038 34602348 . + . ID=transcript_2689;O14950 D3DUH6 Q13182 Q7Z5Z4,Myosin regulatory light chain 12B,MLC-2A;Myosin regulatory light chain 2-B, smooth muscle isoform;Myosin regulatory light chain 20 kDa;Myosin regulatory light chain MRLC2;SHUJUN-1;, PF08976;PF13405;, GO:0099738;GO:0005829;GO:0070062;GO:0016459;GO:0005509;GO:0006936;, C:cell cortex region; C:cytosol; C:extracellular exosome; C:myosin complex;, F:calcium ion binding;, P:muscle contraction; scaffold10 indexed_genome mRNA 34698596 34706245 . + . ID=transcript_2690;Q15583 A6NE42 A6NLU7 F8VZB6 Q6ICR0 Q8N5X9 Q9NRS0,Homeobox protein TGIF1,5'-TG-3'-interacting factor 1;, PF05920;, GO:0000785;GO:0005654;GO:0070410;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0071363;GO:0000122;GO:0006357;GO:0042493;, C:chromatin; C:nucleoplasm;, F:co-SMAD binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to growth factor stimulus; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to drug; scaffold10 indexed_genome mRNA 34790108 34790698 . - . ID=transcript_2691;Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold10 indexed_genome mRNA 34864594 35041420 . - . ID=transcript_2692;O14490 A8MWN8 B2RMU8 B7WPA1 B7Z2H2 B7Z2I2 B7Z9Y4 O14489 P78335,Disks large-associated protein 1,Guanylate kinase-associated protein;PSD-95/SAP90-binding protein 1;SAP90/PSD-95-associated protein 1;, PF03359;, GO:0098978;GO:0005886;GO:0014069;GO:0099572;GO:0060090;GO:0044877;GO:0007268;GO:0098962;, C:glutamatergic synapse; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization;, F:molecular adaptor activity; F:protein-containing complex binding;, P:chemical synaptic transmission; P:regulation of postsynaptic neurotransmitter receptor activity; scaffold10 indexed_genome mRNA 35846316 35879328 . - . ID=transcript_2693;P0CW23,A-kinase anchor protein inhibitor 1,, PF10470;, GO:0051018;GO:0008104;, , F:protein kinase A binding;, P:protein localization; scaffold10 indexed_genome mRNA 35914388 35919966 . - . ID=transcript_2694;O43829 O00403 Q2TB80,Zinc finger and BTB domain-containing protein 14,Zinc finger protein 161 homolog;Zinc finger protein 478;Zinc finger protein 5 homolog;, PF00651;PF00096;, GO:0016235;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0003279;GO:0060976;GO:0003170;GO:0001822;GO:0000122;GO:0045892;GO:0006357;, C:aggresome; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cardiac septum development; P:coronary vasculature development; P:heart valve development; P:kidney development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 35977774 35987525 . - . ID=transcript_2695;Q9Y2J2 B7Z4I5 F5GX05 O95713 Q9BRP5,Band 4.1-like protein 3,4.1B;Differentially expressed in adenocarcinoma of the lung protein 1;Erythrocyte membrane protein band 4.1-like 3 {ECO:0000312|HGNC:HGNC:3380};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0030054;GO:0005911;GO:0005856;GO:0005829;GO:0044224;GO:0033270;GO:0005886;GO:0003779;GO:0106006;GO:0005200;GO:0031032;GO:0006915;GO:0030866;GO:0030865;GO:0043217;GO:0048812;GO:0030913;GO:0071205;GO:0002175;GO:0072659;GO:0001558;GO:0008360;, C:cell junction; C:cell-cell junction; C:cytoskeleton; C:cytosol; C:juxtaparanode region of axon; C:paranode region of axon; C:plasma membrane;, F:actin binding; F:cytoskeletal protein-membrane anchor activity; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:apoptotic process; P:cortical actin cytoskeleton organization; P:cortical cytoskeleton organization; P:myelin maintenance; P:neuron projection morphogenesis; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:protein localization to plasma membrane; P:regulation of cell growth; P:regulation of cell shape;|Q9Y2J2 B7Z4I5 F5GX05 O95713 Q9BRP5,Band 4.1-like protein 3,4.1B;Differentially expressed in adenocarcinoma of the lung protein 1;Erythrocyte membrane protein band 4.1-like 3 {ECO:0000312|HGNC:HGNC:3380};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0030054;GO:0005911;GO:0005856;GO:0005829;GO:0044224;GO:0033270;GO:0005886;GO:0003779;GO:0106006;GO:0005200;GO:0031032;GO:0006915;GO:0030866;GO:0030865;GO:0043217;GO:0048812;GO:0030913;GO:0071205;GO:0002175;GO:0072659;GO:0001558;GO:0008360;, C:cell junction; C:cell-cell junction; C:cytoskeleton; C:cytosol; C:juxtaparanode region of axon; C:paranode region of axon; C:plasma membrane;, F:actin binding; F:cytoskeletal protein-membrane anchor activity; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:apoptotic process; P:cortical actin cytoskeleton organization; P:cortical cytoskeleton organization; P:myelin maintenance; P:neuron projection morphogenesis; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:protein localization to plasma membrane; P:regulation of cell growth; P:regulation of cell shape;|Q9Y2J2 B7Z4I5 F5GX05 O95713 Q9BRP5,Band 4.1-like protein 3,4.1B;Differentially expressed in adenocarcinoma of the lung protein 1;Erythrocyte membrane protein band 4.1-like 3 {ECO:0000312|HGNC:HGNC:3380};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0030054;GO:0005911;GO:0005856;GO:0005829;GO:0044224;GO:0033270;GO:0005886;GO:0003779;GO:0106006;GO:0005200;GO:0031032;GO:0006915;GO:0030866;GO:0030865;GO:0043217;GO:0048812;GO:0030913;GO:0071205;GO:0002175;GO:0072659;GO:0001558;GO:0008360;, C:cell junction; C:cell-cell junction; C:cytoskeleton; C:cytosol; C:juxtaparanode region of axon; C:paranode region of axon; C:plasma membrane;, F:actin binding; F:cytoskeletal protein-membrane anchor activity; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:apoptotic process; P:cortical actin cytoskeleton organization; P:cortical cytoskeleton organization; P:myelin maintenance; P:neuron projection morphogenesis; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:protein localization to plasma membrane; P:regulation of cell growth; P:regulation of cell shape;|Q9Y2J2 B7Z4I5 F5GX05 O95713 Q9BRP5,Band 4.1-like protein 3,4.1B;Differentially expressed in adenocarcinoma of the lung protein 1;Erythrocyte membrane protein band 4.1-like 3 {ECO:0000312|HGNC:HGNC:3380};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0030054;GO:0005911;GO:0005856;GO:0005829;GO:0044224;GO:0033270;GO:0005886;GO:0003779;GO:0106006;GO:0005200;GO:0031032;GO:0006915;GO:0030866;GO:0030865;GO:0043217;GO:0048812;GO:0030913;GO:0071205;GO:0002175;GO:0072659;GO:0001558;GO:0008360;, C:cell junction; C:cell-cell junction; C:cytoskeleton; C:cytosol; C:juxtaparanode region of axon; C:paranode region of axon; C:plasma membrane;, F:actin binding; F:cytoskeletal protein-membrane anchor activity; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:apoptotic process; P:cortical actin cytoskeleton organization; P:cortical cytoskeleton organization; P:myelin maintenance; P:neuron projection morphogenesis; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:protein localization to plasma membrane; P:regulation of cell growth; P:regulation of cell shape;|Q9Y2J2 B7Z4I5 F5GX05 O95713 Q9BRP5,Band 4.1-like protein 3,4.1B;Differentially expressed in adenocarcinoma of the lung protein 1;Erythrocyte membrane protein band 4.1-like 3 {ECO:0000312|HGNC:HGNC:3380};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0030054;GO:0005911;GO:0005856;GO:0005829;GO:0044224;GO:0033270;GO:0005886;GO:0003779;GO:0106006;GO:0005200;GO:0031032;GO:0006915;GO:0030866;GO:0030865;GO:0043217;GO:0048812;GO:0030913;GO:0071205;GO:0002175;GO:0072659;GO:0001558;GO:0008360;, C:cell junction; C:cell-cell junction; C:cytoskeleton; C:cytosol; C:juxtaparanode region of axon; C:paranode region of axon; C:plasma membrane;, F:actin binding; F:cytoskeletal protein-membrane anchor activity; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:apoptotic process; P:cortical actin cytoskeleton organization; P:cortical cytoskeleton organization; P:myelin maintenance; P:neuron projection morphogenesis; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:protein localization to plasma membrane; P:regulation of cell growth; P:regulation of cell shape; scaffold10 indexed_genome mRNA 35989457 36207596 . - . ID=transcript_2696;Q9Y2J2 B7Z4I5 F5GX05 O95713 Q9BRP5,Band 4.1-like protein 3,4.1B;Differentially expressed in adenocarcinoma of the lung protein 1;Erythrocyte membrane protein band 4.1-like 3 {ECO:0000312|HGNC:HGNC:3380};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0030054;GO:0005911;GO:0005856;GO:0005829;GO:0044224;GO:0033270;GO:0005886;GO:0003779;GO:0106006;GO:0005200;GO:0031032;GO:0006915;GO:0030866;GO:0030865;GO:0043217;GO:0048812;GO:0030913;GO:0071205;GO:0002175;GO:0072659;GO:0001558;GO:0008360;, C:cell junction; C:cell-cell junction; C:cytoskeleton; C:cytosol; C:juxtaparanode region of axon; C:paranode region of axon; C:plasma membrane;, F:actin binding; F:cytoskeletal protein-membrane anchor activity; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:apoptotic process; P:cortical actin cytoskeleton organization; P:cortical cytoskeleton organization; P:myelin maintenance; P:neuron projection morphogenesis; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:protein localization to plasma membrane; P:regulation of cell growth; P:regulation of cell shape;|Q9Y2J2 B7Z4I5 F5GX05 O95713 Q9BRP5,Band 4.1-like protein 3,4.1B;Differentially expressed in adenocarcinoma of the lung protein 1;Erythrocyte membrane protein band 4.1-like 3 {ECO:0000312|HGNC:HGNC:3380};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0030054;GO:0005911;GO:0005856;GO:0005829;GO:0044224;GO:0033270;GO:0005886;GO:0003779;GO:0106006;GO:0005200;GO:0031032;GO:0006915;GO:0030866;GO:0030865;GO:0043217;GO:0048812;GO:0030913;GO:0071205;GO:0002175;GO:0072659;GO:0001558;GO:0008360;, C:cell junction; C:cell-cell junction; C:cytoskeleton; C:cytosol; C:juxtaparanode region of axon; C:paranode region of axon; C:plasma membrane;, F:actin binding; F:cytoskeletal protein-membrane anchor activity; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:apoptotic process; P:cortical actin cytoskeleton organization; P:cortical cytoskeleton organization; P:myelin maintenance; P:neuron projection morphogenesis; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:protein localization to plasma membrane; P:regulation of cell growth; P:regulation of cell shape;|Q9Y2J2 B7Z4I5 F5GX05 O95713 Q9BRP5,Band 4.1-like protein 3,4.1B;Differentially expressed in adenocarcinoma of the lung protein 1;Erythrocyte membrane protein band 4.1-like 3 {ECO:0000312|HGNC:HGNC:3380};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0030054;GO:0005911;GO:0005856;GO:0005829;GO:0044224;GO:0033270;GO:0005886;GO:0003779;GO:0106006;GO:0005200;GO:0031032;GO:0006915;GO:0030866;GO:0030865;GO:0043217;GO:0048812;GO:0030913;GO:0071205;GO:0002175;GO:0072659;GO:0001558;GO:0008360;, C:cell junction; C:cell-cell junction; C:cytoskeleton; C:cytosol; C:juxtaparanode region of axon; C:paranode region of axon; C:plasma membrane;, F:actin binding; F:cytoskeletal protein-membrane anchor activity; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:apoptotic process; P:cortical actin cytoskeleton organization; P:cortical cytoskeleton organization; P:myelin maintenance; P:neuron projection morphogenesis; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:protein localization to plasma membrane; P:regulation of cell growth; P:regulation of cell shape; scaffold10 indexed_genome mRNA 36959033 36975029 . + . ID=transcript_2697;Q9P2N2 A8MQB7 A8MU88 Q6P160 Q8N4T3 Q9NW53,Rho GTPase-activating protein 28,Rho-type GTPase-activating protein 28;, PF00620;, GO:0005737;GO:0005829;GO:0005096;GO:1904425;GO:0051497;GO:0030833;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol;, F:GTPase activator activity;, P:negative regulation of GTP binding; P:negative regulation of stress fiber assembly; P:regulation of actin filament polymerization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold10 indexed_genome mRNA 36983434 36997690 . + . ID=transcript_2698;Q9P2N2 A8MQB7 A8MU88 Q6P160 Q8N4T3 Q9NW53,Rho GTPase-activating protein 28,Rho-type GTPase-activating protein 28;, PF00620;, GO:0005737;GO:0005829;GO:0005096;GO:1904425;GO:0051497;GO:0030833;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol;, F:GTPase activator activity;, P:negative regulation of GTP binding; P:negative regulation of stress fiber assembly; P:regulation of actin filament polymerization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold10 indexed_genome mRNA 37011462 37043883 . - . ID=transcript_2699;P25391,Laminin subunit alpha-1,Laminin A chain;Laminin-1 subunit alpha;Laminin-3 subunit alpha;S-laminin subunit alpha;, PF00052;PF00053;PF00054;PF06008;PF06009;PF00055;, GO:0005604;GO:0005911;GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0005606;GO:0005608;GO:0016020;GO:0005201;GO:0043208;GO:0008022;GO:0005102;GO:0009887;GO:0007411;GO:0048514;GO:0060445;GO:0043010;GO:0007155;GO:0007166;GO:0060441;GO:0045198;GO:0030198;GO:0002011;GO:0006468;GO:0030155;GO:0030334;GO:0045995;GO:0061304;GO:0009888;, C:basement membrane; C:cell-cell junction; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:laminin-1 complex; C:laminin-3 complex; C:membrane;, F:extracellular matrix structural constituent; F:glycosphingolipid binding; F:protein C-terminus binding; F:signaling receptor binding;, P:animal organ morphogenesis; P:axon guidance; P:blood vessel morphogenesis; P:branching involved in salivary gland morphogenesis; P:camera-type eye development; P:cell adhesion; P:cell surface receptor signaling pathway; P:epithelial tube branching involved in lung morphogenesis; P:establishment of epithelial cell apical/basal polarity; P:extracellular matrix organization; P:morphogenesis of an epithelial sheet; P:protein phosphorylation; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:retinal blood vessel morphogenesis; P:tissue development; scaffold10 indexed_genome mRNA 37047057 37060272 . - . ID=transcript_2700;P25391,Laminin subunit alpha-1,Laminin A chain;Laminin-1 subunit alpha;Laminin-3 subunit alpha;S-laminin subunit alpha;, PF00052;PF00053;PF00054;PF06008;PF06009;PF00055;, GO:0005604;GO:0005911;GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0005606;GO:0005608;GO:0016020;GO:0005201;GO:0043208;GO:0008022;GO:0005102;GO:0009887;GO:0007411;GO:0048514;GO:0060445;GO:0043010;GO:0007155;GO:0007166;GO:0060441;GO:0045198;GO:0030198;GO:0002011;GO:0006468;GO:0030155;GO:0030334;GO:0045995;GO:0061304;GO:0009888;, C:basement membrane; C:cell-cell junction; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:laminin-1 complex; C:laminin-3 complex; C:membrane;, F:extracellular matrix structural constituent; F:glycosphingolipid binding; F:protein C-terminus binding; F:signaling receptor binding;, P:animal organ morphogenesis; P:axon guidance; P:blood vessel morphogenesis; P:branching involved in salivary gland morphogenesis; P:camera-type eye development; P:cell adhesion; P:cell surface receptor signaling pathway; P:epithelial tube branching involved in lung morphogenesis; P:establishment of epithelial cell apical/basal polarity; P:extracellular matrix organization; P:morphogenesis of an epithelial sheet; P:protein phosphorylation; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:retinal blood vessel morphogenesis; P:tissue development; scaffold10 indexed_genome mRNA 37060409 37080733 . - . ID=transcript_2701;P25391,Laminin subunit alpha-1,Laminin A chain;Laminin-1 subunit alpha;Laminin-3 subunit alpha;S-laminin subunit alpha;, PF00052;PF00053;PF00054;PF06008;PF06009;PF00055;, GO:0005604;GO:0005911;GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0005606;GO:0005608;GO:0016020;GO:0005201;GO:0043208;GO:0008022;GO:0005102;GO:0009887;GO:0007411;GO:0048514;GO:0060445;GO:0043010;GO:0007155;GO:0007166;GO:0060441;GO:0045198;GO:0030198;GO:0002011;GO:0006468;GO:0030155;GO:0030334;GO:0045995;GO:0061304;GO:0009888;, C:basement membrane; C:cell-cell junction; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:laminin-1 complex; C:laminin-3 complex; C:membrane;, F:extracellular matrix structural constituent; F:glycosphingolipid binding; F:protein C-terminus binding; F:signaling receptor binding;, P:animal organ morphogenesis; P:axon guidance; P:blood vessel morphogenesis; P:branching involved in salivary gland morphogenesis; P:camera-type eye development; P:cell adhesion; P:cell surface receptor signaling pathway; P:epithelial tube branching involved in lung morphogenesis; P:establishment of epithelial cell apical/basal polarity; P:extracellular matrix organization; P:morphogenesis of an epithelial sheet; P:protein phosphorylation; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:retinal blood vessel morphogenesis; P:tissue development;|P25391,Laminin subunit alpha-1,Laminin A chain;Laminin-1 subunit alpha;Laminin-3 subunit alpha;S-laminin subunit alpha;, PF00052;PF00053;PF00054;PF06008;PF06009;PF00055;, GO:0005604;GO:0005911;GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0005606;GO:0005608;GO:0016020;GO:0005201;GO:0043208;GO:0008022;GO:0005102;GO:0009887;GO:0007411;GO:0048514;GO:0060445;GO:0043010;GO:0007155;GO:0007166;GO:0060441;GO:0045198;GO:0030198;GO:0002011;GO:0006468;GO:0030155;GO:0030334;GO:0045995;GO:0061304;GO:0009888;, C:basement membrane; C:cell-cell junction; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:laminin-1 complex; C:laminin-3 complex; C:membrane;, F:extracellular matrix structural constituent; F:glycosphingolipid binding; F:protein C-terminus binding; F:signaling receptor binding;, P:animal organ morphogenesis; P:axon guidance; P:blood vessel morphogenesis; P:branching involved in salivary gland morphogenesis; P:camera-type eye development; P:cell adhesion; P:cell surface receptor signaling pathway; P:epithelial tube branching involved in lung morphogenesis; P:establishment of epithelial cell apical/basal polarity; P:extracellular matrix organization; P:morphogenesis of an epithelial sheet; P:protein phosphorylation; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:retinal blood vessel morphogenesis; P:tissue development; scaffold10 indexed_genome mRNA 37081358 37091206 . - . ID=transcript_2702;P25391,Laminin subunit alpha-1,Laminin A chain;Laminin-1 subunit alpha;Laminin-3 subunit alpha;S-laminin subunit alpha;, PF00052;PF00053;PF00054;PF06008;PF06009;PF00055;, GO:0005604;GO:0005911;GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0005606;GO:0005608;GO:0016020;GO:0005201;GO:0043208;GO:0008022;GO:0005102;GO:0009887;GO:0007411;GO:0048514;GO:0060445;GO:0043010;GO:0007155;GO:0007166;GO:0060441;GO:0045198;GO:0030198;GO:0002011;GO:0006468;GO:0030155;GO:0030334;GO:0045995;GO:0061304;GO:0009888;, C:basement membrane; C:cell-cell junction; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:laminin-1 complex; C:laminin-3 complex; C:membrane;, F:extracellular matrix structural constituent; F:glycosphingolipid binding; F:protein C-terminus binding; F:signaling receptor binding;, P:animal organ morphogenesis; P:axon guidance; P:blood vessel morphogenesis; P:branching involved in salivary gland morphogenesis; P:camera-type eye development; P:cell adhesion; P:cell surface receptor signaling pathway; P:epithelial tube branching involved in lung morphogenesis; P:establishment of epithelial cell apical/basal polarity; P:extracellular matrix organization; P:morphogenesis of an epithelial sheet; P:protein phosphorylation; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:retinal blood vessel morphogenesis; P:tissue development; scaffold10 indexed_genome mRNA 37091232 37115490 . - . ID=transcript_2703;P25391,Laminin subunit alpha-1,Laminin A chain;Laminin-1 subunit alpha;Laminin-3 subunit alpha;S-laminin subunit alpha;, PF00052;PF00053;PF00054;PF06008;PF06009;PF00055;, GO:0005604;GO:0005911;GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0005606;GO:0005608;GO:0016020;GO:0005201;GO:0043208;GO:0008022;GO:0005102;GO:0009887;GO:0007411;GO:0048514;GO:0060445;GO:0043010;GO:0007155;GO:0007166;GO:0060441;GO:0045198;GO:0030198;GO:0002011;GO:0006468;GO:0030155;GO:0030334;GO:0045995;GO:0061304;GO:0009888;, C:basement membrane; C:cell-cell junction; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:laminin-1 complex; C:laminin-3 complex; C:membrane;, F:extracellular matrix structural constituent; F:glycosphingolipid binding; F:protein C-terminus binding; F:signaling receptor binding;, P:animal organ morphogenesis; P:axon guidance; P:blood vessel morphogenesis; P:branching involved in salivary gland morphogenesis; P:camera-type eye development; P:cell adhesion; P:cell surface receptor signaling pathway; P:epithelial tube branching involved in lung morphogenesis; P:establishment of epithelial cell apical/basal polarity; P:extracellular matrix organization; P:morphogenesis of an epithelial sheet; P:protein phosphorylation; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:retinal blood vessel morphogenesis; P:tissue development; scaffold10 indexed_genome mRNA 37190740 37193073 . + . ID=transcript_2704;A6NM36,Leucine-rich repeat-containing protein 30,, PF13855;, GO:0005737;GO:0043231;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle;, F:protein serine/threonine phosphatase activity;, P:signal transduction; scaffold10 indexed_genome mRNA 37988537 38018166 . + . ID=transcript_2705;P28827 A7MBN1 D3DUH8 J3QL11,Receptor-type tyrosine-protein phosphatase mu,, PF00041;PF00047;PF00629;PF18861;PF00102;, GO:0005912;GO:0005911;GO:0005737;GO:0005887;GO:0030027;GO:0048471;GO:0005886;GO:0045296;GO:0042802;GO:0004725;GO:0005001;GO:0007156;GO:0016525;GO:0010596;GO:0001937;GO:0031175;GO:0006470;GO:0042493;GO:0010842;GO:0031290;GO:0007165;, C:adherens junction; C:cell-cell junction; C:cytoplasm; C:integral component of plasma membrane; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cadherin binding; F:identical protein binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:neuron projection development; P:protein dephosphorylation; P:response to drug; P:retina layer formation; P:retinal ganglion cell axon guidance; P:signal transduction;|P28827 A7MBN1 D3DUH8 J3QL11,Receptor-type tyrosine-protein phosphatase mu,, PF00041;PF00047;PF00629;PF18861;PF00102;, GO:0005912;GO:0005911;GO:0005737;GO:0005887;GO:0030027;GO:0048471;GO:0005886;GO:0045296;GO:0042802;GO:0004725;GO:0005001;GO:0007156;GO:0016525;GO:0010596;GO:0001937;GO:0031175;GO:0006470;GO:0042493;GO:0010842;GO:0031290;GO:0007165;, C:adherens junction; C:cell-cell junction; C:cytoplasm; C:integral component of plasma membrane; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cadherin binding; F:identical protein binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:neuron projection development; P:protein dephosphorylation; P:response to drug; P:retina layer formation; P:retinal ganglion cell axon guidance; P:signal transduction;|P28827 A7MBN1 D3DUH8 J3QL11,Receptor-type tyrosine-protein phosphatase mu,, PF00041;PF00047;PF00629;PF18861;PF00102;, GO:0005912;GO:0005911;GO:0005737;GO:0005887;GO:0030027;GO:0048471;GO:0005886;GO:0045296;GO:0042802;GO:0004725;GO:0005001;GO:0007156;GO:0016525;GO:0010596;GO:0001937;GO:0031175;GO:0006470;GO:0042493;GO:0010842;GO:0031290;GO:0007165;, C:adherens junction; C:cell-cell junction; C:cytoplasm; C:integral component of plasma membrane; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cadherin binding; F:identical protein binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:neuron projection development; P:protein dephosphorylation; P:response to drug; P:retina layer formation; P:retinal ganglion cell axon guidance; P:signal transduction;|P28827 A7MBN1 D3DUH8 J3QL11,Receptor-type tyrosine-protein phosphatase mu,, PF00041;PF00047;PF00629;PF18861;PF00102;, GO:0005912;GO:0005911;GO:0005737;GO:0005887;GO:0030027;GO:0048471;GO:0005886;GO:0045296;GO:0042802;GO:0004725;GO:0005001;GO:0007156;GO:0016525;GO:0010596;GO:0001937;GO:0031175;GO:0006470;GO:0042493;GO:0010842;GO:0031290;GO:0007165;, C:adherens junction; C:cell-cell junction; C:cytoplasm; C:integral component of plasma membrane; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cadherin binding; F:identical protein binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:neuron projection development; P:protein dephosphorylation; P:response to drug; P:retina layer formation; P:retinal ganglion cell axon guidance; P:signal transduction; scaffold10 indexed_genome mRNA 38117943 38118953 . + . ID=transcript_2706;Q6IQ22 A6NEF5 Q4KMQ3,Ras-related protein Rab-12,, PF00071;, GO:0005776;GO:0005829;GO:0005768;GO:0005794;GO:0000139;GO:0032593;GO:0005765;GO:0005764;GO:0005886;GO:0055037;GO:0055038;GO:0008021;GO:0019003;GO:0005525;GO:0003924;GO:0006914;GO:0044257;GO:0032869;GO:0008333;GO:0072659;GO:0009306;GO:0032482;GO:0017157;GO:0006904;, C:autophagosome; C:cytosol; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:insulin-responsive compartment; C:lysosomal membrane; C:lysosome; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:synaptic vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:autophagy; P:cellular protein catabolic process; P:cellular response to insulin stimulus; P:endosome to lysosome transport; P:protein localization to plasma membrane; P:protein secretion; P:Rab protein signal transduction; P:regulation of exocytosis; P:vesicle docking involved in exocytosis; scaffold10 indexed_genome mRNA 38121329 38127049 . + . ID=transcript_2707;Q6IQ22 A6NEF5 Q4KMQ3,Ras-related protein Rab-12,, PF00071;, GO:0005776;GO:0005829;GO:0005768;GO:0005794;GO:0000139;GO:0032593;GO:0005765;GO:0005764;GO:0005886;GO:0055037;GO:0055038;GO:0008021;GO:0019003;GO:0005525;GO:0003924;GO:0006914;GO:0044257;GO:0032869;GO:0008333;GO:0072659;GO:0009306;GO:0032482;GO:0017157;GO:0006904;, C:autophagosome; C:cytosol; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:insulin-responsive compartment; C:lysosomal membrane; C:lysosome; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:synaptic vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:autophagy; P:cellular protein catabolic process; P:cellular response to insulin stimulus; P:endosome to lysosome transport; P:protein localization to plasma membrane; P:protein secretion; P:Rab protein signal transduction; P:regulation of exocytosis; P:vesicle docking involved in exocytosis;|Q6IQ22 A6NEF5 Q4KMQ3,Ras-related protein Rab-12,, PF00071;, GO:0005776;GO:0005829;GO:0005768;GO:0005794;GO:0000139;GO:0032593;GO:0005765;GO:0005764;GO:0005886;GO:0055037;GO:0055038;GO:0008021;GO:0019003;GO:0005525;GO:0003924;GO:0006914;GO:0044257;GO:0032869;GO:0008333;GO:0072659;GO:0009306;GO:0032482;GO:0017157;GO:0006904;, C:autophagosome; C:cytosol; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:insulin-responsive compartment; C:lysosomal membrane; C:lysosome; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:synaptic vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:autophagy; P:cellular protein catabolic process; P:cellular response to insulin stimulus; P:endosome to lysosome transport; P:protein localization to plasma membrane; P:protein secretion; P:Rab protein signal transduction; P:regulation of exocytosis; P:vesicle docking involved in exocytosis; scaffold10 indexed_genome mRNA 38177814 38279810 . + . ID=transcript_2708;Q9Y4B5 E9PAY7 Q6ZMQ9 Q8IWA9,Microtubule cross-linking factor 1,Coiled-coil domain-containing protein 165;PAR-1-interacting protein;SOGA family member 2;, PF14818;PF11365;, GO:0016324;GO:0016327;GO:0005737;GO:0005856;GO:0005615;GO:0016328;GO:0097427;GO:0030496;GO:0000922;GO:0008017;GO:0042803;GO:0003723;GO:0045197;GO:0001578;GO:2000576;GO:0090314;GO:0010506;, C:apical plasma membrane; C:apicolateral plasma membrane; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:lateral plasma membrane; C:microtubule bundle; C:midbody; C:spindle pole;, F:microtubule binding; F:protein homodimerization activity; F:RNA binding;, P:establishment or maintenance of epithelial cell apical/basal polarity; P:microtubule bundle formation; P:positive regulation of microtubule motor activity; P:positive regulation of protein targeting to membrane; P:regulation of autophagy;|Q9Y4B5 E9PAY7 Q6ZMQ9 Q8IWA9,Microtubule cross-linking factor 1,Coiled-coil domain-containing protein 165;PAR-1-interacting protein;SOGA family member 2;, PF14818;PF11365;, GO:0016324;GO:0016327;GO:0005737;GO:0005856;GO:0005615;GO:0016328;GO:0097427;GO:0030496;GO:0000922;GO:0008017;GO:0042803;GO:0003723;GO:0045197;GO:0001578;GO:2000576;GO:0090314;GO:0010506;, C:apical plasma membrane; C:apicolateral plasma membrane; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:lateral plasma membrane; C:microtubule bundle; C:midbody; C:spindle pole;, F:microtubule binding; F:protein homodimerization activity; F:RNA binding;, P:establishment or maintenance of epithelial cell apical/basal polarity; P:microtubule bundle formation; P:positive regulation of microtubule motor activity; P:positive regulation of protein targeting to membrane; P:regulation of autophagy;|Q9Y4B5 E9PAY7 Q6ZMQ9 Q8IWA9,Microtubule cross-linking factor 1,Coiled-coil domain-containing protein 165;PAR-1-interacting protein;SOGA family member 2;, PF14818;PF11365;, GO:0016324;GO:0016327;GO:0005737;GO:0005856;GO:0005615;GO:0016328;GO:0097427;GO:0030496;GO:0000922;GO:0008017;GO:0042803;GO:0003723;GO:0045197;GO:0001578;GO:2000576;GO:0090314;GO:0010506;, C:apical plasma membrane; C:apicolateral plasma membrane; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:lateral plasma membrane; C:microtubule bundle; C:midbody; C:spindle pole;, F:microtubule binding; F:protein homodimerization activity; F:RNA binding;, P:establishment or maintenance of epithelial cell apical/basal polarity; P:microtubule bundle formation; P:positive regulation of microtubule motor activity; P:positive regulation of protein targeting to membrane; P:regulation of autophagy;|Q9Y4B5 E9PAY7 Q6ZMQ9 Q8IWA9,Microtubule cross-linking factor 1,Coiled-coil domain-containing protein 165;PAR-1-interacting protein;SOGA family member 2;, PF14818;PF11365;, GO:0016324;GO:0016327;GO:0005737;GO:0005856;GO:0005615;GO:0016328;GO:0097427;GO:0030496;GO:0000922;GO:0008017;GO:0042803;GO:0003723;GO:0045197;GO:0001578;GO:2000576;GO:0090314;GO:0010506;, C:apical plasma membrane; C:apicolateral plasma membrane; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:lateral plasma membrane; C:microtubule bundle; C:midbody; C:spindle pole;, F:microtubule binding; F:protein homodimerization activity; F:RNA binding;, P:establishment or maintenance of epithelial cell apical/basal polarity; P:microtubule bundle formation; P:positive regulation of microtubule motor activity; P:positive regulation of protein targeting to membrane; P:regulation of autophagy; scaffold10 indexed_genome mRNA 38453000 38454594 . + . ID=transcript_2709;P19404 Q9BV41,NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial,NADH-ubiquinone oxidoreductase 24 kDa subunit;, , GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0051537;GO:0009055;GO:0046872;GO:0008137;GO:0048738;GO:0006120;GO:0032981;GO:0007399;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:cardiac muscle tissue development; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:nervous system development; scaffold10 indexed_genome mRNA 38454726 38456693 . - . ID=transcript_2710;P19404 Q9BV41,NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial,NADH-ubiquinone oxidoreductase 24 kDa subunit;, , GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0051537;GO:0009055;GO:0046872;GO:0008137;GO:0048738;GO:0006120;GO:0032981;GO:0007399;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:cardiac muscle tissue development; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:nervous system development;|P19404 Q9BV41,NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial,NADH-ubiquinone oxidoreductase 24 kDa subunit;, , GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0051537;GO:0009055;GO:0046872;GO:0008137;GO:0048738;GO:0006120;GO:0032981;GO:0007399;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:cardiac muscle tissue development; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:nervous system development; scaffold10 indexed_genome mRNA 38456848 38462146 . + . ID=transcript_2711;P19404 Q9BV41,NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial,NADH-ubiquinone oxidoreductase 24 kDa subunit;, , GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0051537;GO:0009055;GO:0046872;GO:0008137;GO:0048738;GO:0006120;GO:0032981;GO:0007399;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:cardiac muscle tissue development; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:nervous system development;|P19404 Q9BV41,NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial,NADH-ubiquinone oxidoreductase 24 kDa subunit;, , GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0051537;GO:0009055;GO:0046872;GO:0008137;GO:0048738;GO:0006120;GO:0032981;GO:0007399;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:cardiac muscle tissue development; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:nervous system development; scaffold10 indexed_genome mRNA 38542293 38564393 . + . ID=transcript_2712;Q6UB98 O94951 Q658K1 Q6QMF7 Q9H231 Q9H784,Ankyrin repeat domain-containing protein 12,Ankyrin repeat-containing cofactor 2;GAC-1 protein;, PF00023;PF12796;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q6UB98 O94951 Q658K1 Q6QMF7 Q9H231 Q9H784,Ankyrin repeat domain-containing protein 12,Ankyrin repeat-containing cofactor 2;GAC-1 protein;, PF00023;PF12796;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q6UB98 O94951 Q658K1 Q6QMF7 Q9H231 Q9H784,Ankyrin repeat domain-containing protein 12,Ankyrin repeat-containing cofactor 2;GAC-1 protein;, PF00023;PF12796;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q6UB98 O94951 Q658K1 Q6QMF7 Q9H231 Q9H784,Ankyrin repeat domain-containing protein 12,Ankyrin repeat-containing cofactor 2;GAC-1 protein;, PF00023;PF12796;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q6UB98 O94951 Q658K1 Q6QMF7 Q9H231 Q9H784,Ankyrin repeat domain-containing protein 12,Ankyrin repeat-containing cofactor 2;GAC-1 protein;, PF00023;PF12796;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q6UB98 O94951 Q658K1 Q6QMF7 Q9H231 Q9H784,Ankyrin repeat domain-containing protein 12,Ankyrin repeat-containing cofactor 2;GAC-1 protein;, PF00023;PF12796;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold10 indexed_genome mRNA 38595920 38596561 . - . ID=transcript_2713;Q9GZX9 B2RE08 D3DUH9 Q8NBI7 Q96K46,Twisted gastrulation protein homolog 1,, PF04668;, GO:0005615;GO:0050431;GO:0030509;GO:0043010;GO:0030154;GO:0030900;GO:0030097;GO:0001707;GO:0030514;GO:2000515;GO:2000562;GO:0001818;GO:0045668;GO:0001503;GO:0030513;GO:0010862;GO:0030510;GO:0007435;GO:0007179;, C:extracellular space;, F:transforming growth factor beta binding;, P:BMP signaling pathway; P:camera-type eye development; P:cell differentiation; P:forebrain development; P:hemopoiesis; P:mesoderm formation; P:negative regulation of BMP signaling pathway; P:negative regulation of CD4-positive, alpha-beta T cell activation; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of cytokine production; P:negative regulation of osteoblast differentiation; P:ossification; P:positive regulation of BMP signaling pathway; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:regulation of BMP signaling pathway; P:salivary gland morphogenesis; P:transforming growth factor beta receptor signaling pathway; scaffold10 indexed_genome mRNA 38660362 38679598 . + . ID=transcript_2714;Q15311 D3DUI0,RalA-binding protein 1,76 kDa Ral-interacting protein;Dinitrophenyl S-glutathione ATPase;Ral-interacting protein 1;, PF00620;, GO:0005829;GO:0016020;GO:0042626;GO:0005096;GO:0031267;GO:0022857;GO:0042910;GO:0006935;GO:1900753;GO:0006897;GO:0043547;GO:0043087;GO:0051056;GO:0007264;GO:0055085;GO:1990961;, C:cytosol; C:membrane;, F:ATPase-coupled transmembrane transporter activity; F:GTPase activator activity; F:small GTPase binding; F:transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:chemotaxis; P:doxorubicin transport; P:endocytosis; P:positive regulation of GTPase activity; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; P:transmembrane transport; P:xenobiotic detoxification by transmembrane export across the plasma membrane; scaffold10 indexed_genome mRNA 38691297 38722876 . - . ID=transcript_2715;Q8TF05 Q99774 Q9UNQ7,Serine/threonine-protein phosphatase 4 regulatory subunit 1,, PF02985;PF15017;, GO:0030289;GO:0008287;GO:0019888;GO:0006470;GO:0006468;GO:0007165;, C:protein phosphatase 4 complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:protein dephosphorylation; P:protein phosphorylation; P:signal transduction;|Q8TF05 Q99774 Q9UNQ7,Serine/threonine-protein phosphatase 4 regulatory subunit 1,, PF02985;PF15017;, GO:0030289;GO:0008287;GO:0019888;GO:0006470;GO:0006468;GO:0007165;, C:protein phosphatase 4 complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:protein dephosphorylation; P:protein phosphorylation; P:signal transduction;|Q8TF05 Q99774 Q9UNQ7,Serine/threonine-protein phosphatase 4 regulatory subunit 1,, PF02985;PF15017;, GO:0030289;GO:0008287;GO:0019888;GO:0006470;GO:0006468;GO:0007165;, C:protein phosphatase 4 complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:protein dephosphorylation; P:protein phosphorylation; P:signal transduction; scaffold10 indexed_genome mRNA 38824550 38904653 . + . ID=transcript_2716;Q13636 B2RBT7 Q15770 Q9HC00,Ras-related protein Rab-31,Ras-related protein Rab-22B;, PF00071;, GO:0005829;GO:0005769;GO:0031901;GO:0036186;GO:0012505;GO:0001891;GO:0045335;GO:0005886;GO:0030667;GO:0032588;GO:0019003;GO:0005525;GO:0003924;GO:0032869;GO:0043001;GO:0006886;GO:0043312;GO:0090382;GO:0060100;GO:0031623;GO:0045055;, C:cytosol; C:early endosome; C:early endosome membrane; C:early phagosome membrane; C:endomembrane system; C:phagocytic cup; C:phagocytic vesicle; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:cellular response to insulin stimulus; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:neutrophil degranulation; P:phagosome maturation; P:positive regulation of phagocytosis, engulfment; P:receptor internalization; P:regulated exocytosis; scaffold10 indexed_genome mRNA 38956393 38978550 . + . ID=transcript_2717;Q9P0L0 A6NDZ0 D3DUI3 O75453 Q5U0E7 Q9UBZ2,Vesicle-associated membrane protein-associated protein A,33 kDa VAMP-associated protein;, PF00635;, GO:0035577;GO:0005923;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0005886;GO:0031982;GO:0045296;GO:0033149;GO:0008017;GO:0019904;GO:0046982;GO:0008219;GO:0090114;GO:0006888;GO:0061025;GO:0044828;GO:0031175;GO:0043312;GO:0044829;GO:0044791;GO:0043123;GO:0045048;GO:0070972;GO:0030148;GO:0016032;, C:azurophil granule membrane; C:bicellular tight junction; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane; C:plasma membrane; C:vesicle;, F:cadherin binding; F:FFAT motif binding; F:microtubule binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell death; P:COPII-coated vesicle budding; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane fusion; P:negative regulation by host of viral genome replication; P:neuron projection development; P:neutrophil degranulation; P:positive regulation by host of viral genome replication; P:positive regulation by host of viral release from host cell; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein insertion into ER membrane; P:protein localization to endoplasmic reticulum; P:sphingolipid biosynthetic process; P:viral process;|Q9P0L0 A6NDZ0 D3DUI3 O75453 Q5U0E7 Q9UBZ2,Vesicle-associated membrane protein-associated protein A,33 kDa VAMP-associated protein;, PF00635;, GO:0035577;GO:0005923;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0005886;GO:0031982;GO:0045296;GO:0033149;GO:0008017;GO:0019904;GO:0046982;GO:0008219;GO:0090114;GO:0006888;GO:0061025;GO:0044828;GO:0031175;GO:0043312;GO:0044829;GO:0044791;GO:0043123;GO:0045048;GO:0070972;GO:0030148;GO:0016032;, C:azurophil granule membrane; C:bicellular tight junction; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane; C:plasma membrane; C:vesicle;, F:cadherin binding; F:FFAT motif binding; F:microtubule binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell death; P:COPII-coated vesicle budding; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane fusion; P:negative regulation by host of viral genome replication; P:neuron projection development; P:neutrophil degranulation; P:positive regulation by host of viral genome replication; P:positive regulation by host of viral release from host cell; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein insertion into ER membrane; P:protein localization to endoplasmic reticulum; P:sphingolipid biosynthetic process; P:viral process;|Q9P0L0 A6NDZ0 D3DUI3 O75453 Q5U0E7 Q9UBZ2,Vesicle-associated membrane protein-associated protein A,33 kDa VAMP-associated protein;, PF00635;, GO:0035577;GO:0005923;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0005886;GO:0031982;GO:0045296;GO:0033149;GO:0008017;GO:0019904;GO:0046982;GO:0008219;GO:0090114;GO:0006888;GO:0061025;GO:0044828;GO:0031175;GO:0043312;GO:0044829;GO:0044791;GO:0043123;GO:0045048;GO:0070972;GO:0030148;GO:0016032;, C:azurophil granule membrane; C:bicellular tight junction; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane; C:plasma membrane; C:vesicle;, F:cadherin binding; F:FFAT motif binding; F:microtubule binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell death; P:COPII-coated vesicle budding; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane fusion; P:negative regulation by host of viral genome replication; P:neuron projection development; P:neutrophil degranulation; P:positive regulation by host of viral genome replication; P:positive regulation by host of viral release from host cell; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein insertion into ER membrane; P:protein localization to endoplasmic reticulum; P:sphingolipid biosynthetic process; P:viral process;|Q9P0L0 A6NDZ0 D3DUI3 O75453 Q5U0E7 Q9UBZ2,Vesicle-associated membrane protein-associated protein A,33 kDa VAMP-associated protein;, PF00635;, GO:0035577;GO:0005923;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0005886;GO:0031982;GO:0045296;GO:0033149;GO:0008017;GO:0019904;GO:0046982;GO:0008219;GO:0090114;GO:0006888;GO:0061025;GO:0044828;GO:0031175;GO:0043312;GO:0044829;GO:0044791;GO:0043123;GO:0045048;GO:0070972;GO:0030148;GO:0016032;, C:azurophil granule membrane; C:bicellular tight junction; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane; C:plasma membrane; C:vesicle;, F:cadherin binding; F:FFAT motif binding; F:microtubule binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell death; P:COPII-coated vesicle budding; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane fusion; P:negative regulation by host of viral genome replication; P:neuron projection development; P:neutrophil degranulation; P:positive regulation by host of viral genome replication; P:positive regulation by host of viral release from host cell; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein insertion into ER membrane; P:protein localization to endoplasmic reticulum; P:sphingolipid biosynthetic process; P:viral process; scaffold10 indexed_genome mRNA 39197257 39216925 . + . ID=transcript_2718;Q8J025 B4DUQ0 B4DZT0 Q71M25,Protein APCDD1,Adenomatosis polyposis coli down-regulated 1 protein;, PF14921;, GO:0005887;GO:0005886;GO:0042802;GO:0017147;GO:0001942;GO:0030178;GO:0016055;, C:integral component of plasma membrane; C:plasma membrane;, F:identical protein binding; F:Wnt-protein binding;, P:hair follicle development; P:negative regulation of Wnt signaling pathway; P:Wnt signaling pathway;|Q8J025 B4DUQ0 B4DZT0 Q71M25,Protein APCDD1,Adenomatosis polyposis coli down-regulated 1 protein;, PF14921;, GO:0005887;GO:0005886;GO:0042802;GO:0017147;GO:0001942;GO:0030178;GO:0016055;, C:integral component of plasma membrane; C:plasma membrane;, F:identical protein binding; F:Wnt-protein binding;, P:hair follicle development; P:negative regulation of Wnt signaling pathway; P:Wnt signaling pathway; scaffold10 indexed_genome mRNA 39237267 39248536 . + . ID=transcript_2719;Q99747 B4DFC9 Q9BUV1,Gamma-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein gamma;, , GO:0070062;GO:0005765;GO:0005739;GO:0031201;GO:0045202;GO:0005774;GO:0005483;GO:0019905;GO:0006891;GO:0006886;GO:0061025;GO:0050821;GO:0065003;, C:extracellular exosome; C:lysosomal membrane; C:mitochondrion; C:SNARE complex; C:synapse; C:vacuolar membrane;, F:soluble NSF attachment protein activity; F:syntaxin binding;, P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane fusion; P:protein stabilization; P:protein-containing complex assembly;|Q99747 B4DFC9 Q9BUV1,Gamma-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein gamma;, , GO:0070062;GO:0005765;GO:0005739;GO:0031201;GO:0045202;GO:0005774;GO:0005483;GO:0019905;GO:0006891;GO:0006886;GO:0061025;GO:0050821;GO:0065003;, C:extracellular exosome; C:lysosomal membrane; C:mitochondrion; C:SNARE complex; C:synapse; C:vacuolar membrane;, F:soluble NSF attachment protein activity; F:syntaxin binding;, P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane fusion; P:protein stabilization; P:protein-containing complex assembly;|Q99747 B4DFC9 Q9BUV1,Gamma-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein gamma;, , GO:0070062;GO:0005765;GO:0005739;GO:0031201;GO:0045202;GO:0005774;GO:0005483;GO:0019905;GO:0006891;GO:0006886;GO:0061025;GO:0050821;GO:0065003;, C:extracellular exosome; C:lysosomal membrane; C:mitochondrion; C:SNARE complex; C:synapse; C:vacuolar membrane;, F:soluble NSF attachment protein activity; F:syntaxin binding;, P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane fusion; P:protein stabilization; P:protein-containing complex assembly;|Q99747 B4DFC9 Q9BUV1,Gamma-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein gamma;, , GO:0070062;GO:0005765;GO:0005739;GO:0031201;GO:0045202;GO:0005774;GO:0005483;GO:0019905;GO:0006891;GO:0006886;GO:0061025;GO:0050821;GO:0065003;, C:extracellular exosome; C:lysosomal membrane; C:mitochondrion; C:SNARE complex; C:synapse; C:vacuolar membrane;, F:soluble NSF attachment protein activity; F:syntaxin binding;, P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane fusion; P:protein stabilization; P:protein-containing complex assembly; scaffold10 indexed_genome mRNA 39259224 39263564 . - . ID=transcript_2720;Q9H5I5 B7Z812 M4GPJ9 Q6ZS91 Q8N787 Q8NAR6 Q9H5R4,Piezo-type mechanosensitive ion channel component 2,Protein FAM38B;, PF15917;PF12166;, GO:0016021;GO:0016020;GO:0005886;GO:0005261;GO:0008381;GO:0006812;GO:0071260;GO:0050982;GO:0050974;GO:0042391;GO:0009612;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:cation channel activity; F:mechanosensitive ion channel activity;, P:cation transport; P:cellular response to mechanical stimulus; P:detection of mechanical stimulus; P:detection of mechanical stimulus involved in sensory perception; P:regulation of membrane potential; P:response to mechanical stimulus; scaffold10 indexed_genome mRNA 39278906 39292675 . - . ID=transcript_2721;Q9H5I5 B7Z812 M4GPJ9 Q6ZS91 Q8N787 Q8NAR6 Q9H5R4,Piezo-type mechanosensitive ion channel component 2,Protein FAM38B;, PF15917;PF12166;, GO:0016021;GO:0016020;GO:0005886;GO:0005261;GO:0008381;GO:0006812;GO:0071260;GO:0050982;GO:0050974;GO:0042391;GO:0009612;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:cation channel activity; F:mechanosensitive ion channel activity;, P:cation transport; P:cellular response to mechanical stimulus; P:detection of mechanical stimulus; P:detection of mechanical stimulus involved in sensory perception; P:regulation of membrane potential; P:response to mechanical stimulus; scaffold10 indexed_genome mRNA 39763530 39767649 . - . ID=transcript_2722;Q7LBR1 Q96E89 Q9HD41,Charged multivesicular body protein 1b,CHMP1.5;Chromatin-modifying protein 1b;Vacuolar protein sorting-associated protein 46-2;, PF03357;, GO:0005829;GO:0010008;GO:0000815;GO:0070062;GO:0031902;GO:0030117;GO:0030496;GO:0005771;GO:0005654;GO:0042802;GO:0019904;GO:0051301;GO:0032509;GO:1904903;GO:0045184;GO:0045324;GO:0061952;GO:0007080;GO:0036258;GO:0006997;GO:0015031;GO:0010824;GO:1901673;GO:0039702;, C:cytosol; C:endosome membrane; C:ESCRT III complex; C:extracellular exosome; C:late endosome membrane; C:membrane coat; C:midbody; C:multivesicular body; C:nucleoplasm;, F:identical protein binding; F:protein domain specific binding;, P:cell division; P:endosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:establishment of protein localization; P:late endosome to vacuole transport; P:midbody abscission; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:nucleus organization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:viral budding via host ESCRT complex; scaffold10 indexed_genome mRNA 39772512 39775568 . + . ID=transcript_2723;P38405 B7ZA26 Q86XU3,Guanine nucleotide-binding protein G(olf) subunit alpha,Adenylate cyclase-stimulating G alpha protein, olfactory type;, PF00503;, GO:0070062;GO:0005834;GO:0005886;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007191;GO:0007189;GO:0007193;GO:0007188;GO:0007606;GO:0007165;, C:extracellular exosome; C:heterotrimeric G-protein complex; C:plasma membrane;, F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:sensory perception of chemical stimulus; P:signal transduction; scaffold10 indexed_genome mRNA 39775582 39791189 . - . ID=transcript_2724;Q8TAD6 Q8TE26 Q8WZ32 Q9BU58 Q9H958 Q9HAI4,Metallophosphoesterase 1 {ECO:0000305},Post-GPI attachment to proteins factor 5 {ECO:0000303|PubMed:29374258};, PF00149;, GO:0005801;GO:0070971;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0005654;GO:0034235;GO:0062050;GO:0030145;GO:0006888;GO:0006506;, C:cis-Golgi network; C:endoplasmic reticulum exit site; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm;, F:GPI anchor binding; F:GPI-mannose ethanolamine phosphate phosphodiesterase activity; F:manganese ion binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:GPI anchor biosynthetic process;|Q8TAD6 Q8TE26 Q8WZ32 Q9BU58 Q9H958 Q9HAI4,Metallophosphoesterase 1 {ECO:0000305},Post-GPI attachment to proteins factor 5 {ECO:0000303|PubMed:29374258};, PF00149;, GO:0005801;GO:0070971;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0005654;GO:0034235;GO:0062050;GO:0030145;GO:0006888;GO:0006506;, C:cis-Golgi network; C:endoplasmic reticulum exit site; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm;, F:GPI anchor binding; F:GPI-mannose ethanolamine phosphate phosphodiesterase activity; F:manganese ion binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:GPI anchor biosynthetic process;|Q8TAD6 Q8TE26 Q8WZ32 Q9BU58 Q9H958 Q9HAI4,Metallophosphoesterase 1 {ECO:0000305},Post-GPI attachment to proteins factor 5 {ECO:0000303|PubMed:29374258};, PF00149;, GO:0005801;GO:0070971;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0005654;GO:0034235;GO:0062050;GO:0030145;GO:0006888;GO:0006506;, C:cis-Golgi network; C:endoplasmic reticulum exit site; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm;, F:GPI anchor binding; F:GPI-mannose ethanolamine phosphate phosphodiesterase activity; F:manganese ion binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:GPI anchor biosynthetic process;|Q8TAD6 Q8TE26 Q8WZ32 Q9BU58 Q9H958 Q9HAI4,Metallophosphoesterase 1 {ECO:0000305},Post-GPI attachment to proteins factor 5 {ECO:0000303|PubMed:29374258};, PF00149;, GO:0005801;GO:0070971;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0005654;GO:0034235;GO:0062050;GO:0030145;GO:0006888;GO:0006506;, C:cis-Golgi network; C:endoplasmic reticulum exit site; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm;, F:GPI anchor binding; F:GPI-mannose ethanolamine phosphate phosphodiesterase activity; F:manganese ion binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:GPI anchor biosynthetic process;|Q8TAD6 Q8TE26 Q8WZ32 Q9BU58 Q9H958 Q9HAI4,Metallophosphoesterase 1 {ECO:0000305},Post-GPI attachment to proteins factor 5 {ECO:0000303|PubMed:29374258};, PF00149;, GO:0005801;GO:0070971;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0005654;GO:0034235;GO:0062050;GO:0030145;GO:0006888;GO:0006506;, C:cis-Golgi network; C:endoplasmic reticulum exit site; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm;, F:GPI anchor binding; F:GPI-mannose ethanolamine phosphate phosphodiesterase activity; F:manganese ion binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:GPI anchor biosynthetic process; scaffold10 indexed_genome mRNA 39811871 39828894 . + . ID=transcript_2725;O14732 B0YJ29 Q9UJT3,Inositol monophosphatase 2,Inositol-1(or 4)-monophosphatase 2;Myo-inositol monophosphatase A2;, PF00459;, GO:0005737;GO:0005829;GO:0008934;GO:0052832;GO:0052833;GO:0046872;GO:0042803;GO:0006021;GO:0006020;GO:0046855;GO:0043647;GO:0006796;GO:0046854;GO:0007165;, C:cytoplasm; C:cytosol;, F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:metal ion binding; F:protein homodimerization activity;, P:inositol biosynthetic process; P:inositol metabolic process; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphate-containing compound metabolic process; P:phosphatidylinositol phosphorylation; P:signal transduction; scaffold10 indexed_genome mRNA 39834310 39846100 . + . ID=transcript_2726;O60543 B0YIY7 Q6UPR7,Cell death activator CIDE-A,Cell death-inducing DFFA-like effector A;, PF02017;, GO:0005737;GO:0005829;GO:0005811;GO:0005740;GO:0005739;GO:0005634;GO:0042803;GO:0006915;GO:0008219;GO:0070417;GO:0034389;GO:0006629;GO:0019915;GO:0120163;GO:0001818;GO:1900118;GO:0050995;GO:0030512;GO:0032720;GO:0010890;GO:1902510;GO:0042981;GO:0035634;GO:0001659;, C:cytoplasm; C:cytosol; C:lipid droplet; C:mitochondrial envelope; C:mitochondrion; C:nucleus;, F:protein homodimerization activity;, P:apoptotic process; P:cell death; P:cellular response to cold; P:lipid droplet organization; P:lipid metabolic process; P:lipid storage; P:negative regulation of cold-induced thermogenesis; P:negative regulation of cytokine production; P:negative regulation of execution phase of apoptosis; P:negative regulation of lipid catabolic process; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:positive regulation of sequestering of triglyceride; P:regulation of apoptotic DNA fragmentation; P:regulation of apoptotic process; P:response to stilbenoid; P:temperature homeostasis; scaffold10 indexed_genome mRNA 39856717 39863346 . + . ID=transcript_2727;Q9BUF5 B3KM76 Q9HA42,Tubulin beta-6 chain,Tubulin beta class V;, PF00091;PF03953;, GO:0005737;GO:0070062;GO:0005874;GO:0005634;GO:0005525;GO:0003924;GO:0005200;GO:0000226;GO:0000278;, C:cytoplasm; C:extracellular exosome; C:microtubule; C:nucleus;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q9BUF5 B3KM76 Q9HA42,Tubulin beta-6 chain,Tubulin beta class V;, PF00091;PF03953;, GO:0005737;GO:0070062;GO:0005874;GO:0005634;GO:0005525;GO:0003924;GO:0005200;GO:0000226;GO:0000278;, C:cytoplasm; C:extracellular exosome; C:microtubule; C:nucleus;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:microtubule cytoskeleton organization; P:mitotic cell cycle; scaffold10 indexed_genome mRNA 39864950 39879582 . - . ID=transcript_2728;Q9Y4W6 Q6P1L0,AFG3-like protein 2 {ECO:0000305},Paraplegin-like protein;, PF00004;PF17862;PF06480;PF01434;, GO:0005745;GO:0005743;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008237;GO:0051082;GO:0008270;GO:0007409;GO:0036444;GO:0042407;GO:0033619;GO:0051560;GO:0006851;GO:0008053;GO:0034982;GO:0048747;GO:0042552;GO:0021675;GO:0007528;GO:0016540;GO:0016485;GO:0065003;GO:0006508;GO:0040014;GO:0060013;, C:m-AAA complex; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:axonogenesis; P:calcium import into the mitochondrion; P:cristae formation; P:membrane protein proteolysis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial protein processing; P:muscle fiber development; P:myelination; P:nerve development; P:neuromuscular junction development; P:protein autoprocessing; P:protein processing; P:protein-containing complex assembly; P:proteolysis; P:regulation of multicellular organism growth; P:righting reflex;|Q9Y4W6 Q6P1L0,AFG3-like protein 2 {ECO:0000305},Paraplegin-like protein;, PF00004;PF17862;PF06480;PF01434;, GO:0005745;GO:0005743;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008237;GO:0051082;GO:0008270;GO:0007409;GO:0036444;GO:0042407;GO:0033619;GO:0051560;GO:0006851;GO:0008053;GO:0034982;GO:0048747;GO:0042552;GO:0021675;GO:0007528;GO:0016540;GO:0016485;GO:0065003;GO:0006508;GO:0040014;GO:0060013;, C:m-AAA complex; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:axonogenesis; P:calcium import into the mitochondrion; P:cristae formation; P:membrane protein proteolysis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial protein processing; P:muscle fiber development; P:myelination; P:nerve development; P:neuromuscular junction development; P:protein autoprocessing; P:protein processing; P:protein-containing complex assembly; P:proteolysis; P:regulation of multicellular organism growth; P:righting reflex;|Q9Y4W6 Q6P1L0,AFG3-like protein 2 {ECO:0000305},Paraplegin-like protein;, PF00004;PF17862;PF06480;PF01434;, GO:0005745;GO:0005743;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008237;GO:0051082;GO:0008270;GO:0007409;GO:0036444;GO:0042407;GO:0033619;GO:0051560;GO:0006851;GO:0008053;GO:0034982;GO:0048747;GO:0042552;GO:0021675;GO:0007528;GO:0016540;GO:0016485;GO:0065003;GO:0006508;GO:0040014;GO:0060013;, C:m-AAA complex; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:axonogenesis; P:calcium import into the mitochondrion; P:cristae formation; P:membrane protein proteolysis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial protein processing; P:muscle fiber development; P:myelination; P:nerve development; P:neuromuscular junction development; P:protein autoprocessing; P:protein processing; P:protein-containing complex assembly; P:proteolysis; P:regulation of multicellular organism growth; P:righting reflex;|Q9Y4W6 Q6P1L0,AFG3-like protein 2 {ECO:0000305},Paraplegin-like protein;, PF00004;PF17862;PF06480;PF01434;, GO:0005745;GO:0005743;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008237;GO:0051082;GO:0008270;GO:0007409;GO:0036444;GO:0042407;GO:0033619;GO:0051560;GO:0006851;GO:0008053;GO:0034982;GO:0048747;GO:0042552;GO:0021675;GO:0007528;GO:0016540;GO:0016485;GO:0065003;GO:0006508;GO:0040014;GO:0060013;, C:m-AAA complex; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:axonogenesis; P:calcium import into the mitochondrion; P:cristae formation; P:membrane protein proteolysis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial protein processing; P:muscle fiber development; P:myelination; P:nerve development; P:neuromuscular junction development; P:protein autoprocessing; P:protein processing; P:protein-containing complex assembly; P:proteolysis; P:regulation of multicellular organism growth; P:righting reflex; scaffold10 indexed_genome mRNA 39921919 39937792 . + . ID=transcript_2729;Q96N28 B0YJ10 B4E0C9 D3DUJ1 Q6AHX2,PRELI domain containing protein 3A,Protein slowmo homolog 1;, PF04707;, GO:0005758;GO:1990050;GO:0015914;, C:mitochondrial intermembrane space;, F:phosphatidic acid transfer activity;, P:phospholipid transport;|Q96N28 B0YJ10 B4E0C9 D3DUJ1 Q6AHX2,PRELI domain containing protein 3A,Protein slowmo homolog 1;, PF04707;, GO:0005758;GO:1990050;GO:0015914;, C:mitochondrial intermembrane space;, F:phosphatidic acid transfer activity;, P:phospholipid transport; scaffold10 indexed_genome mRNA 39941463 39959721 . - . ID=transcript_2730;Q08AE8 A8K2B5 J3KQ50 J3KQR5 Q1RMD4 Q8NDP1 Q9NQ71 Q9ULT4,Protein spire homolog 1,, PF16474;, GO:0005938;GO:0030659;GO:0005856;GO:0005829;GO:0031307;GO:0005654;GO:0048471;GO:0005886;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0090141;GO:0015031;GO:0016192;, C:cell cortex; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:integral component of mitochondrial outer membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:positive regulation of mitochondrial fission; P:protein transport; P:vesicle-mediated transport;|Q08AE8 A8K2B5 J3KQ50 J3KQR5 Q1RMD4 Q8NDP1 Q9NQ71 Q9ULT4,Protein spire homolog 1,, PF16474;, GO:0005938;GO:0030659;GO:0005856;GO:0005829;GO:0031307;GO:0005654;GO:0048471;GO:0005886;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0090141;GO:0015031;GO:0016192;, C:cell cortex; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:integral component of mitochondrial outer membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:positive regulation of mitochondrial fission; P:protein transport; P:vesicle-mediated transport;|Q08AE8 A8K2B5 J3KQ50 J3KQR5 Q1RMD4 Q8NDP1 Q9NQ71 Q9ULT4,Protein spire homolog 1,, PF16474;, GO:0005938;GO:0030659;GO:0005856;GO:0005829;GO:0031307;GO:0005654;GO:0048471;GO:0005886;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0090141;GO:0015031;GO:0016192;, C:cell cortex; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:integral component of mitochondrial outer membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:positive regulation of mitochondrial fission; P:protein transport; P:vesicle-mediated transport;|Q08AE8 A8K2B5 J3KQ50 J3KQR5 Q1RMD4 Q8NDP1 Q9NQ71 Q9ULT4,Protein spire homolog 1,, PF16474;, GO:0005938;GO:0030659;GO:0005856;GO:0005829;GO:0031307;GO:0005654;GO:0048471;GO:0005886;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0090141;GO:0015031;GO:0016192;, C:cell cortex; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:integral component of mitochondrial outer membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:positive regulation of mitochondrial fission; P:protein transport; P:vesicle-mediated transport; scaffold10 indexed_genome mRNA 39960186 40091052 . - . ID=transcript_2731;Q08AE8 A8K2B5 J3KQ50 J3KQR5 Q1RMD4 Q8NDP1 Q9NQ71 Q9ULT4,Protein spire homolog 1,, PF16474;, GO:0005938;GO:0030659;GO:0005856;GO:0005829;GO:0031307;GO:0005654;GO:0048471;GO:0005886;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0090141;GO:0015031;GO:0016192;, C:cell cortex; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:integral component of mitochondrial outer membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:positive regulation of mitochondrial fission; P:protein transport; P:vesicle-mediated transport;|Q08AE8 A8K2B5 J3KQ50 J3KQR5 Q1RMD4 Q8NDP1 Q9NQ71 Q9ULT4,Protein spire homolog 1,, PF16474;, GO:0005938;GO:0030659;GO:0005856;GO:0005829;GO:0031307;GO:0005654;GO:0048471;GO:0005886;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0090141;GO:0015031;GO:0016192;, C:cell cortex; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:integral component of mitochondrial outer membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:positive regulation of mitochondrial fission; P:protein transport; P:vesicle-mediated transport; scaffold10 indexed_genome mRNA 40110060 40140403 . - . ID=transcript_2732;Q8TAP6 B0YJB2 B4DXG5 B4DZW1 Q658N5 Q9H9U7,Centrosomal protein of 76 kDa,, PF15627;, GO:0005814;GO:0005813;GO:0005829;GO:0032991;GO:0097711;GO:0000086;GO:0046599;GO:0010389;, C:centriole; C:centrosome; C:cytosol; C:protein-containing complex;, , P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of centriole replication; P:regulation of G2/M transition of mitotic cell cycle;|Q8TAP6 B0YJB2 B4DXG5 B4DZW1 Q658N5 Q9H9U7,Centrosomal protein of 76 kDa,, PF15627;, GO:0005814;GO:0005813;GO:0005829;GO:0032991;GO:0097711;GO:0000086;GO:0046599;GO:0010389;, C:centriole; C:centrosome; C:cytosol; C:protein-containing complex;, , P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of centriole replication; P:regulation of G2/M transition of mitotic cell cycle;|Q969U7 B0YJB3 Q6IAH4 Q9NRV1 V9GYH7,Proteasome assembly chaperone 2,Hepatocellular carcinoma-susceptibility protein 3;Tumor necrosis factor superfamily member 5-induced protein 1;, PF09754;, GO:0101031;GO:0005829;GO:0005634;GO:0060090;GO:0051131;GO:0007094;GO:0043066;GO:0043248;, C:chaperone complex; C:cytosol; C:nucleus;, F:molecular adaptor activity;, P:chaperone-mediated protein complex assembly; P:mitotic spindle assembly checkpoint; P:negative regulation of apoptotic process; P:proteasome assembly;|Q969U7 B0YJB3 Q6IAH4 Q9NRV1 V9GYH7,Proteasome assembly chaperone 2,Hepatocellular carcinoma-susceptibility protein 3;Tumor necrosis factor superfamily member 5-induced protein 1;, PF09754;, GO:0101031;GO:0005829;GO:0005634;GO:0060090;GO:0051131;GO:0007094;GO:0043066;GO:0043248;, C:chaperone complex; C:cytosol; C:nucleus;, F:molecular adaptor activity;, P:chaperone-mediated protein complex assembly; P:mitotic spindle assembly checkpoint; P:negative regulation of apoptotic process; P:proteasome assembly;|Q969U7 B0YJB3 Q6IAH4 Q9NRV1 V9GYH7,Proteasome assembly chaperone 2,Hepatocellular carcinoma-susceptibility protein 3;Tumor necrosis factor superfamily member 5-induced protein 1;, PF09754;, GO:0101031;GO:0005829;GO:0005634;GO:0060090;GO:0051131;GO:0007094;GO:0043066;GO:0043248;, C:chaperone complex; C:cytosol; C:nucleus;, F:molecular adaptor activity;, P:chaperone-mediated protein complex assembly; P:mitotic spindle assembly checkpoint; P:negative regulation of apoptotic process; P:proteasome assembly;|Q969U7 B0YJB3 Q6IAH4 Q9NRV1 V9GYH7,Proteasome assembly chaperone 2,Hepatocellular carcinoma-susceptibility protein 3;Tumor necrosis factor superfamily member 5-induced protein 1;, PF09754;, GO:0101031;GO:0005829;GO:0005634;GO:0060090;GO:0051131;GO:0007094;GO:0043066;GO:0043248;, C:chaperone complex; C:cytosol; C:nucleus;, F:molecular adaptor activity;, P:chaperone-mediated protein complex assembly; P:mitotic spindle assembly checkpoint; P:negative regulation of apoptotic process; P:proteasome assembly;|Q969U7 B0YJB3 Q6IAH4 Q9NRV1 V9GYH7,Proteasome assembly chaperone 2,Hepatocellular carcinoma-susceptibility protein 3;Tumor necrosis factor superfamily member 5-induced protein 1;, PF09754;, GO:0101031;GO:0005829;GO:0005634;GO:0060090;GO:0051131;GO:0007094;GO:0043066;GO:0043248;, C:chaperone complex; C:cytosol; C:nucleus;, F:molecular adaptor activity;, P:chaperone-mediated protein complex assembly; P:mitotic spindle assembly checkpoint; P:negative regulation of apoptotic process; P:proteasome assembly;|Q969U7 B0YJB3 Q6IAH4 Q9NRV1 V9GYH7,Proteasome assembly chaperone 2,Hepatocellular carcinoma-susceptibility protein 3;Tumor necrosis factor superfamily member 5-induced protein 1;, PF09754;, GO:0101031;GO:0005829;GO:0005634;GO:0060090;GO:0051131;GO:0007094;GO:0043066;GO:0043248;, C:chaperone complex; C:cytosol; C:nucleus;, F:molecular adaptor activity;, P:chaperone-mediated protein complex assembly; P:mitotic spindle assembly checkpoint; P:negative regulation of apoptotic process; P:proteasome assembly; scaffold10 indexed_genome mRNA 40152742 40226596 . + . ID=transcript_2733;P17706 A8K955 A8MXU3 K7ENG3 Q96AU5 Q96HR2,Tyrosine-protein phosphatase non-receptor type 2,T-cell protein-tyrosine phosphatase;, PF00102;, GO:0005829;GO:0005783;GO:0005793;GO:0005654;GO:0005634;GO:0005886;GO:0005178;GO:0004726;GO:0019901;GO:0004725;GO:0030971;GO:0097677;GO:0019905;GO:0030183;GO:0071345;GO:0030218;GO:0042593;GO:0008286;GO:0008285;GO:0050922;GO:0042059;GO:0070373;GO:0050728;GO:0046627;GO:0060336;GO:1902206;GO:1902215;GO:0070104;GO:0010888;GO:1902227;GO:0045650;GO:2000587;GO:1902233;GO:0061099;GO:0050860;GO:0000122;GO:0010804;GO:0060339;GO:0042532;GO:0035335;GO:1902237;GO:0045722;GO:1903899;GO:1902202;GO:0060334;GO:0030217;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:integrin binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:STAT family protein binding; F:syntaxin binding;, P:B cell differentiation; P:cellular response to cytokine stimulus; P:erythrocyte differentiation; P:glucose homeostasis; P:insulin receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of chemotaxis; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of inflammatory response; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of interleukin-2-mediated signaling pathway; P:negative regulation of interleukin-4-mediated signaling pathway; P:negative regulation of interleukin-6-mediated signaling pathway; P:negative regulation of lipid storage; P:negative regulation of macrophage colony-stimulating factor signaling pathway; P:negative regulation of macrophage differentiation; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of positive thymic T cell selection; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:negative regulation of type I interferon-mediated signaling pathway; P:negative regulation of tyrosine phosphorylation of STAT protein; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of gluconeogenesis; P:positive regulation of PERK-mediated unfolded protein response; P:regulation of hepatocyte growth factor receptor signaling pathway; P:regulation of interferon-gamma-mediated signaling pathway; P:T cell differentiation;|P17706 A8K955 A8MXU3 K7ENG3 Q96AU5 Q96HR2,Tyrosine-protein phosphatase non-receptor type 2,T-cell protein-tyrosine phosphatase;, PF00102;, GO:0005829;GO:0005783;GO:0005793;GO:0005654;GO:0005634;GO:0005886;GO:0005178;GO:0004726;GO:0019901;GO:0004725;GO:0030971;GO:0097677;GO:0019905;GO:0030183;GO:0071345;GO:0030218;GO:0042593;GO:0008286;GO:0008285;GO:0050922;GO:0042059;GO:0070373;GO:0050728;GO:0046627;GO:0060336;GO:1902206;GO:1902215;GO:0070104;GO:0010888;GO:1902227;GO:0045650;GO:2000587;GO:1902233;GO:0061099;GO:0050860;GO:0000122;GO:0010804;GO:0060339;GO:0042532;GO:0035335;GO:1902237;GO:0045722;GO:1903899;GO:1902202;GO:0060334;GO:0030217;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:integrin binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:STAT family protein binding; F:syntaxin binding;, P:B cell differentiation; P:cellular response to cytokine stimulus; P:erythrocyte differentiation; P:glucose homeostasis; P:insulin receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of chemotaxis; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of inflammatory response; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of interleukin-2-mediated signaling pathway; P:negative regulation of interleukin-4-mediated signaling pathway; P:negative regulation of interleukin-6-mediated signaling pathway; P:negative regulation of lipid storage; P:negative regulation of macrophage colony-stimulating factor signaling pathway; P:negative regulation of macrophage differentiation; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of positive thymic T cell selection; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:negative regulation of type I interferon-mediated signaling pathway; P:negative regulation of tyrosine phosphorylation of STAT protein; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of gluconeogenesis; P:positive regulation of PERK-mediated unfolded protein response; P:regulation of hepatocyte growth factor receptor signaling pathway; P:regulation of interferon-gamma-mediated signaling pathway; P:T cell differentiation; scaffold10 indexed_genome mRNA 40268725 40288398 . + . ID=transcript_2734;Q96EE3 A8K5B1 Q8NFU6 Q96MH3 Q9C069,Nucleoporin SEH1 {ECO:0000305},GATOR complex protein SEH1 {ECO:0000305};Nup107-160 subcomplex subunit SEH1;SEC13-like protein;, PF00400;, GO:0000777;GO:0005829;GO:0061700;GO:0043657;GO:0005765;GO:0005635;GO:0031080;GO:0035859;GO:0005198;GO:0051315;GO:0051301;GO:0034629;GO:0034198;GO:0050830;GO:0075733;GO:0007080;GO:0007084;GO:0007052;GO:0006406;GO:0006999;GO:0032008;GO:1904263;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:GATOR2 complex; C:host cell; C:lysosomal membrane; C:nuclear envelope; C:nuclear pore outer ring; C:Seh1-associated complex;, F:structural molecule activity;, P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:cellular protein-containing complex localization; P:cellular response to amino acid starvation; P:defense response to Gram-positive bacterium; P:intracellular transport of virus; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nuclear pore organization; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold10 indexed_genome mRNA 40304751 40316457 . + . ID=transcript_2735;Q8TEP8 A0A060A9S4 B7ZMF0 E9PF99 Q8WYT8 Q9H0F4 Q9NW27,Centrosomal protein of 192 kDa {ECO:0000305},, , GO:0005814;GO:0005813;GO:0005829;GO:0000242;GO:0019902;GO:0051298;GO:0090222;GO:0097711;GO:0000086;GO:0090307;GO:0010923;GO:0071539;GO:0010389;GO:0009617;, C:centriole; C:centrosome; C:cytosol; C:pericentriolar material;, F:phosphatase binding;, P:centrosome duplication; P:centrosome-templated microtubule nucleation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:mitotic spindle assembly; P:negative regulation of phosphatase activity; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; P:response to bacterium; scaffold10 indexed_genome mRNA 40316462 40368304 . + . ID=transcript_2736;Q8TEP8 A0A060A9S4 B7ZMF0 E9PF99 Q8WYT8 Q9H0F4 Q9NW27,Centrosomal protein of 192 kDa {ECO:0000305},, , GO:0005814;GO:0005813;GO:0005829;GO:0000242;GO:0019902;GO:0051298;GO:0090222;GO:0097711;GO:0000086;GO:0090307;GO:0010923;GO:0071539;GO:0010389;GO:0009617;, C:centriole; C:centrosome; C:cytosol; C:pericentriolar material;, F:phosphatase binding;, P:centrosome duplication; P:centrosome-templated microtubule nucleation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:mitotic spindle assembly; P:negative regulation of phosphatase activity; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; P:response to bacterium;|Q8TEP8 A0A060A9S4 B7ZMF0 E9PF99 Q8WYT8 Q9H0F4 Q9NW27,Centrosomal protein of 192 kDa {ECO:0000305},, , GO:0005814;GO:0005813;GO:0005829;GO:0000242;GO:0019902;GO:0051298;GO:0090222;GO:0097711;GO:0000086;GO:0090307;GO:0010923;GO:0071539;GO:0010389;GO:0009617;, C:centriole; C:centrosome; C:cytosol; C:pericentriolar material;, F:phosphatase binding;, P:centrosome duplication; P:centrosome-templated microtubule nucleation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:mitotic spindle assembly; P:negative regulation of phosphatase activity; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; P:response to bacterium;|Q8TEP8 A0A060A9S4 B7ZMF0 E9PF99 Q8WYT8 Q9H0F4 Q9NW27,Centrosomal protein of 192 kDa {ECO:0000305},, , GO:0005814;GO:0005813;GO:0005829;GO:0000242;GO:0019902;GO:0051298;GO:0090222;GO:0097711;GO:0000086;GO:0090307;GO:0010923;GO:0071539;GO:0010389;GO:0009617;, C:centriole; C:centrosome; C:cytosol; C:pericentriolar material;, F:phosphatase binding;, P:centrosome duplication; P:centrosome-templated microtubule nucleation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:mitotic spindle assembly; P:negative regulation of phosphatase activity; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; P:response to bacterium; scaffold10 indexed_genome mRNA 40526743 40546423 . + . ID=transcript_2737;O15165 B3KNT9 E9PAY9 K7EN38 O15166 O15167 O15168 Q5U646 Q6NXP3,Low-density lipoprotein receptor class A domain-containing protein 4,, PF00057;, GO:0031901;GO:0000139;GO:0016021;GO:0043231;GO:0070412;GO:0030336;GO:0010719;GO:0060394;GO:0010991;GO:0030512;, C:early endosome membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:R-SMAD binding;, P:negative regulation of cell migration; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of SMAD protein complex assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; scaffold10 indexed_genome mRNA 40550912 40586946 . + . ID=transcript_2738;Q96ND0 D3DUJ4,Protein FAM210A,, PF06916;, GO:0005737;GO:0016021;GO:0005739;, C:cytoplasm; C:integral component of membrane; C:mitochondrion;|Q96ND0 D3DUJ4,Protein FAM210A,, PF06916;, GO:0005737;GO:0016021;GO:0005739;, C:cytoplasm; C:integral component of membrane; C:mitochondrion;|Q96ND0 D3DUJ4,Protein FAM210A,, PF06916;, GO:0005737;GO:0016021;GO:0005739;, C:cytoplasm; C:integral component of membrane; C:mitochondrion;|O43148 B0YJ90 D3DUJ5 O94996 Q9UIJ9,mRNA cap guanine-N7 methyltransferase,RG7MT1;mRNA (guanine-N(7)-)-methyltransferase;mRNA cap methyltransferase;, PF03291;, GO:0001650;GO:0005845;GO:0031533;GO:0005654;GO:0005634;GO:0043235;GO:0004482;GO:0003723;GO:0006370;GO:1990830;GO:0006366;, C:fibrillar center; C:mRNA cap binding complex; C:mRNA cap methyltransferase complex; C:nucleoplasm; C:nucleus; C:receptor complex;, F:mRNA (guanine-N7-)-methyltransferase activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:cellular response to leukemia inhibitory factor; P:transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 41273342 41536534 . + . ID=transcript_2739;Q9Y6X0 A6H8W5 Q6P6C3 Q9UEF3,SET-binding protein,, , GO:0005829;GO:0016604;GO:0005654;GO:0003677;, C:cytosol; C:nuclear body; C:nucleoplasm;, F:DNA binding; scaffold10 indexed_genome mRNA 41645726 41649615 . - . ID=transcript_2740;Q9Y6X0 A6H8W5 Q6P6C3 Q9UEF3,SET-binding protein,, , GO:0005829;GO:0016604;GO:0005654;GO:0003677;, C:cytosol; C:nuclear body; C:nucleoplasm;, F:DNA binding; scaffold10 indexed_genome mRNA 42414233 42417266 . + . ID=transcript_2741;Q9NVT9 B4E2W7 Q9H018 Q9H820,Armadillo repeat-containing protein 1,, PF00514;, GO:0005829;GO:0005741;GO:0005739;GO:0046872;GO:0048312;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:metal ion binding;, P:intracellular distribution of mitochondria; scaffold10 indexed_genome mRNA 42500630 42614564 . - . ID=transcript_2742;Q9HCE0 A2BDF3 Q9H8C8,Ectopic P granules protein 5 homolog,, , GO:0005737;GO:0005764;GO:0048471;GO:0097352;GO:1990786;GO:0032456;GO:0008333;GO:0006862;GO:0034162;, C:cytoplasm; C:lysosome; C:perinuclear region of cytoplasm;, , P:autophagosome maturation; P:cellular response to dsDNA; P:endocytic recycling; P:endosome to lysosome transport; P:nucleotide transport; P:toll-like receptor 9 signaling pathway;|Q9HCE0 A2BDF3 Q9H8C8,Ectopic P granules protein 5 homolog,, , GO:0005737;GO:0005764;GO:0048471;GO:0097352;GO:1990786;GO:0032456;GO:0008333;GO:0006862;GO:0034162;, C:cytoplasm; C:lysosome; C:perinuclear region of cytoplasm;, , P:autophagosome maturation; P:cellular response to dsDNA; P:endocytic recycling; P:endosome to lysosome transport; P:nucleotide transport; P:toll-like receptor 9 signaling pathway;|Q9HCE0 A2BDF3 Q9H8C8,Ectopic P granules protein 5 homolog,, , GO:0005737;GO:0005764;GO:0048471;GO:0097352;GO:1990786;GO:0032456;GO:0008333;GO:0006862;GO:0034162;, C:cytoplasm; C:lysosome; C:perinuclear region of cytoplasm;, , P:autophagosome maturation; P:cellular response to dsDNA; P:endocytic recycling; P:endosome to lysosome transport; P:nucleotide transport; P:toll-like receptor 9 signaling pathway;|Q9HCE0 A2BDF3 Q9H8C8,Ectopic P granules protein 5 homolog,, , GO:0005737;GO:0005764;GO:0048471;GO:0097352;GO:1990786;GO:0032456;GO:0008333;GO:0006862;GO:0034162;, C:cytoplasm; C:lysosome; C:perinuclear region of cytoplasm;, , P:autophagosome maturation; P:cellular response to dsDNA; P:endocytic recycling; P:endosome to lysosome transport; P:nucleotide transport; P:toll-like receptor 9 signaling pathway; scaffold10 indexed_genome mRNA 42652746 42738294 . - . ID=transcript_2743;Q9H939,Proline-serine-threonine phosphatase-interacting protein 2,, PF00611;, GO:0005884;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0051015;GO:0030041;GO:0016477;, C:actin filament; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:actin filament binding;, P:actin filament polymerization; P:cell migration; scaffold10 indexed_genome mRNA 42762961 42763493 . + . ID=transcript_2744;Q9BTV8,ATP synthase subunit alpha, mitochondrial {ECO:0000305},ATP synthase F1 subunit alpha {ECO:0000312|HGNC:HGNC:823};, PF00006;PF00306;PF02874;, GO:0070062;GO:0016020;GO:0005743;GO:0005759;GO:0005753;GO:0005739;GO:0005886;GO:0045259;GO:0045261;GO:0043531;GO:0043532;GO:0005524;GO:0042288;GO:0046933;GO:0003723;GO:0006754;GO:0015986;GO:0042407;GO:0006629;GO:0042776;GO:0001937;GO:0043536;, C:extracellular exosome; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrion; C:plasma membrane; C:proton-transporting ATP synthase complex; C:proton-transporting ATP synthase complex, catalytic core F(1);, F:ADP binding; F:angiostatin binding; F:ATP binding; F:MHC class I protein binding; F:proton-transporting ATP synthase activity, rotational mechanism; F:RNA binding;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:lipid metabolic process; P:mitochondrial ATP synthesis coupled proton transport; P:negative regulation of endothelial cell proliferation; P:positive regulation of blood vessel endothelial cell migration; scaffold10 indexed_genome mRNA 42764059 42765006 . + . ID=transcript_2745;Q9BTV8,ATP synthase subunit alpha, mitochondrial {ECO:0000305},ATP synthase F1 subunit alpha {ECO:0000312|HGNC:HGNC:823};, PF00006;PF00306;PF02874;, GO:0070062;GO:0016020;GO:0005743;GO:0005759;GO:0005753;GO:0005739;GO:0005886;GO:0045259;GO:0045261;GO:0043531;GO:0043532;GO:0005524;GO:0042288;GO:0046933;GO:0003723;GO:0006754;GO:0015986;GO:0042407;GO:0006629;GO:0042776;GO:0001937;GO:0043536;, C:extracellular exosome; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrion; C:plasma membrane; C:proton-transporting ATP synthase complex; C:proton-transporting ATP synthase complex, catalytic core F(1);, F:ADP binding; F:angiostatin binding; F:ATP binding; F:MHC class I protein binding; F:proton-transporting ATP synthase activity, rotational mechanism; F:RNA binding;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:lipid metabolic process; P:mitochondrial ATP synthesis coupled proton transport; P:negative regulation of endothelial cell proliferation; P:positive regulation of blood vessel endothelial cell migration; scaffold10 indexed_genome mRNA 42776156 42785525 . + . ID=transcript_2746;Q96CS2 B2RDM7 Q8N837,HAUS augmin-like complex subunit 1,Coiled-coil domain-containing protein 5;Enhancer of invasion-cluster;, , GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0000922;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule; C:spindle pole;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q96CS2 B2RDM7 Q8N837,HAUS augmin-like complex subunit 1,Coiled-coil domain-containing protein 5;Enhancer of invasion-cluster;, , GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0000922;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule; C:spindle pole;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q96CS2 B2RDM7 Q8N837,HAUS augmin-like complex subunit 1,Coiled-coil domain-containing protein 5;Enhancer of invasion-cluster;, , GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0000922;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule; C:spindle pole;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q96CS2 B2RDM7 Q8N837,HAUS augmin-like complex subunit 1,Coiled-coil domain-containing protein 5;Enhancer of invasion-cluster;, , GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0000922;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule; C:spindle pole;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold10 indexed_genome mRNA 42826985 42908158 . + . ID=transcript_2747;Q96B23 A8K123 A8KAB6 Q5BIX2 Q5XG78 Q6N058 Q86TB5 Q8TCQ5,Uncharacterized protein C18orf25,ARKadia-like protein 1 {ECO:0000303|PubMed:15722956};, PF15303;, GO:0061630;GO:0006511;, , F:ubiquitin protein ligase activity;, P:ubiquitin-dependent protein catabolic process;|Q96B23 A8K123 A8KAB6 Q5BIX2 Q5XG78 Q6N058 Q86TB5 Q8TCQ5,Uncharacterized protein C18orf25,ARKadia-like protein 1 {ECO:0000303|PubMed:15722956};, PF15303;, GO:0061630;GO:0006511;, , F:ubiquitin protein ligase activity;, P:ubiquitin-dependent protein catabolic process;|Q96B23 A8K123 A8KAB6 Q5BIX2 Q5XG78 Q6N058 Q86TB5 Q8TCQ5,Uncharacterized protein C18orf25,ARKadia-like protein 1 {ECO:0000303|PubMed:15722956};, PF15303;, GO:0061630;GO:0006511;, , F:ubiquitin protein ligase activity;, P:ubiquitin-dependent protein catabolic process; scaffold10 indexed_genome mRNA 42977033 42978697 . - . ID=transcript_2748;Q6ZSG1 B3KVD1,E3 ubiquitin-protein ligase RNF165 {ECO:0000305},RING finger protein 165 {ECO:0000312|HGNC:HGNC:31696};, PF13639;, GO:0005634;GO:0032991;GO:0061630;GO:0008270;GO:0035136;GO:0060384;GO:0008045;GO:0010259;GO:0061061;GO:0030513;GO:0030163;GO:0000209;, C:nucleus; C:protein-containing complex;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:forelimb morphogenesis; P:innervation; P:motor neuron axon guidance; P:multicellular organism aging; P:muscle structure development; P:positive regulation of BMP signaling pathway; P:protein catabolic process; P:protein polyubiquitination; scaffold10 indexed_genome mRNA 43064771 43080806 . + . ID=transcript_2749;Q6ZSG1 B3KVD1,E3 ubiquitin-protein ligase RNF165 {ECO:0000305},RING finger protein 165 {ECO:0000312|HGNC:HGNC:31696};, PF13639;, GO:0005634;GO:0032991;GO:0061630;GO:0008270;GO:0035136;GO:0060384;GO:0008045;GO:0010259;GO:0061061;GO:0030513;GO:0030163;GO:0000209;, C:nucleus; C:protein-containing complex;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:forelimb morphogenesis; P:innervation; P:motor neuron axon guidance; P:multicellular organism aging; P:muscle structure development; P:positive regulation of BMP signaling pathway; P:protein catabolic process; P:protein polyubiquitination; scaffold10 indexed_genome mRNA 43090471 43127072 . - . ID=transcript_2750;Q8IVV2 B7WNN3 B7WNT1 B7WPI9 H7BZ41 Q6ZRY7 Q86WW9 Q96DL7,Lipoxygenase homology domain-containing protein 1,, PF01477;, GO:0032420;GO:0004096;GO:0020037;GO:0007605;, C:stereocilium;, F:catalase activity; F:heme binding;, P:sensory perception of sound;|Q8IVV2 B7WNN3 B7WNT1 B7WPI9 H7BZ41 Q6ZRY7 Q86WW9 Q96DL7,Lipoxygenase homology domain-containing protein 1,, PF01477;, GO:0032420;GO:0004096;GO:0020037;GO:0007605;, C:stereocilium;, F:catalase activity; F:heme binding;, P:sensory perception of sound;|Q8IVV2 B7WNN3 B7WNT1 B7WPI9 H7BZ41 Q6ZRY7 Q86WW9 Q96DL7,Lipoxygenase homology domain-containing protein 1,, PF01477;, GO:0032420;GO:0004096;GO:0020037;GO:0007605;, C:stereocilium;, F:catalase activity; F:heme binding;, P:sensory perception of sound; scaffold10 indexed_genome mRNA 43147391 43149440 . - . ID=transcript_2751;Q8IVV2 B7WNN3 B7WNT1 B7WPI9 H7BZ41 Q6ZRY7 Q86WW9 Q96DL7,Lipoxygenase homology domain-containing protein 1,, PF01477;, GO:0032420;GO:0004096;GO:0020037;GO:0007605;, C:stereocilium;, F:catalase activity; F:heme binding;, P:sensory perception of sound; scaffold10 indexed_genome mRNA 43149466 43204841 . - . ID=transcript_2752;Q8IVV2 B7WNN3 B7WNT1 B7WPI9 H7BZ41 Q6ZRY7 Q86WW9 Q96DL7,Lipoxygenase homology domain-containing protein 1,, PF01477;, GO:0032420;GO:0004096;GO:0020037;GO:0007605;, C:stereocilium;, F:catalase activity; F:heme binding;, P:sensory perception of sound; scaffold10 indexed_genome mRNA 43227877 43244495 . - . ID=transcript_2753;O15466 B7Z1K9 Q6IAW7,Alpha-2,8-sialyltransferase 8E {ECO:0000305},Sialyltransferase 8E;Sialyltransferase St8Sia V;, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0008373;GO:0005975;GO:0006688;GO:0006491;GO:0009311;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:sialyltransferase activity;, P:carbohydrate metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation;|O15466 B7Z1K9 Q6IAW7,Alpha-2,8-sialyltransferase 8E {ECO:0000305},Sialyltransferase 8E;Sialyltransferase St8Sia V;, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0008373;GO:0005975;GO:0006688;GO:0006491;GO:0009311;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:sialyltransferase activity;, P:carbohydrate metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation; scaffold10 indexed_genome mRNA 43245417 43246396 . - . ID=transcript_2754;O15466 B7Z1K9 Q6IAW7,Alpha-2,8-sialyltransferase 8E {ECO:0000305},Sialyltransferase 8E;Sialyltransferase St8Sia V;, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0008373;GO:0005975;GO:0006688;GO:0006491;GO:0009311;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:sialyltransferase activity;, P:carbohydrate metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation; scaffold10 indexed_genome mRNA 43248902 43275920 . - . ID=transcript_2755;O15466 B7Z1K9 Q6IAW7,Alpha-2,8-sialyltransferase 8E {ECO:0000305},Sialyltransferase 8E;Sialyltransferase St8Sia V;, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0008373;GO:0005975;GO:0006688;GO:0006491;GO:0009311;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:sialyltransferase activity;, P:carbohydrate metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation;|O15466 B7Z1K9 Q6IAW7,Alpha-2,8-sialyltransferase 8E {ECO:0000305},Sialyltransferase 8E;Sialyltransferase St8Sia V;, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0008373;GO:0005975;GO:0006688;GO:0006491;GO:0009311;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:sialyltransferase activity;, P:carbohydrate metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation;|O15466 B7Z1K9 Q6IAW7,Alpha-2,8-sialyltransferase 8E {ECO:0000305},Sialyltransferase 8E;Sialyltransferase St8Sia V;, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0008373;GO:0005975;GO:0006688;GO:0006491;GO:0009311;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:sialyltransferase activity;, P:carbohydrate metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation; scaffold10 indexed_genome mRNA 43348329 43404389 . + . ID=transcript_2756;O75928 O75927 Q96BT5 Q96KE3,E3 SUMO-protein ligase PIAS2,Androgen receptor-interacting protein 3;DAB2-interacting protein;E3 SUMO-protein transferase PIAS2 {ECO:0000305};Msx-interacting zinc finger protein;PIAS-NY protein;Protein inhibitor of activated STAT x;Protein inhibitor of activated STAT2;, PF14324;PF02891;, GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0008134;GO:0031625;GO:0008270;GO:0060766;GO:0043433;GO:0016925;GO:0006357;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:negative regulation of androgen receptor signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:protein sumoylation; P:regulation of transcription by RNA polymerase II;|O75928 O75927 Q96BT5 Q96KE3,E3 SUMO-protein ligase PIAS2,Androgen receptor-interacting protein 3;DAB2-interacting protein;E3 SUMO-protein transferase PIAS2 {ECO:0000305};Msx-interacting zinc finger protein;PIAS-NY protein;Protein inhibitor of activated STAT x;Protein inhibitor of activated STAT2;, PF14324;PF02891;, GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0008134;GO:0031625;GO:0008270;GO:0060766;GO:0043433;GO:0016925;GO:0006357;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:negative regulation of androgen receptor signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:protein sumoylation; P:regulation of transcription by RNA polymerase II;|P62851 B2R4M7 P25111,40S ribosomal protein S25,Small ribosomal subunit protein eS25 {ECO:0000303|PubMed:24524803};, PF03297;, GO:0005829;GO:0022627;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0014069;GO:0005840;GO:0015935;GO:0003723;GO:0003735;GO:0000184;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic density; C:ribosome; C:small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|O75928 O75927 Q96BT5 Q96KE3,E3 SUMO-protein ligase PIAS2,Androgen receptor-interacting protein 3;DAB2-interacting protein;E3 SUMO-protein transferase PIAS2 {ECO:0000305};Msx-interacting zinc finger protein;PIAS-NY protein;Protein inhibitor of activated STAT x;Protein inhibitor of activated STAT2;, PF14324;PF02891;, GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0008134;GO:0031625;GO:0008270;GO:0060766;GO:0043433;GO:0016925;GO:0006357;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:negative regulation of androgen receptor signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:protein sumoylation; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 43567754 43568839 . + . ID=transcript_2757;Q8IYT4,Katanin p60 ATPase-containing subunit A-like 2 {ECO:0000255|HAMAP-Rule:MF_03025},p60 katanin-like 2 {ECO:0000255|HAMAP-Rule:MF_03025};, PF00004;PF17862;PF08513;, GO:0005737;GO:0005874;GO:0005634;GO:0005819;GO:0000922;GO:0005524;GO:0016887;GO:0016853;GO:0008017;GO:0008568;GO:0031122;, C:cytoplasm; C:microtubule; C:nucleus; C:spindle; C:spindle pole;, F:ATP binding; F:ATPase activity; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity;, P:cytoplasmic microtubule organization; scaffold10 indexed_genome mRNA 43572871 43622827 . - . ID=transcript_2758;Q9H0R4 A8K7T3 Q96NV4,Haloacid dehalogenase-like hydrolase domain-containing protein 2,, PF13344;, GO:0070062;GO:0019899;GO:0046872;GO:0016791;GO:0016311;, C:extracellular exosome;, F:enzyme binding; F:metal ion binding; F:phosphatase activity;, P:dephosphorylation;|Q9H0R4 A8K7T3 Q96NV4,Haloacid dehalogenase-like hydrolase domain-containing protein 2,, PF13344;, GO:0070062;GO:0019899;GO:0046872;GO:0016791;GO:0016311;, C:extracellular exosome;, F:enzyme binding; F:metal ion binding; F:phosphatase activity;, P:dephosphorylation;|Q9H0R4 A8K7T3 Q96NV4,Haloacid dehalogenase-like hydrolase domain-containing protein 2,, PF13344;, GO:0070062;GO:0019899;GO:0046872;GO:0016791;GO:0016311;, C:extracellular exosome;, F:enzyme binding; F:metal ion binding; F:phosphatase activity;, P:dephosphorylation; scaffold10 indexed_genome mRNA 43629498 43644798 . - . ID=transcript_2759;Q9Y5U9,Immediate early response 3-interacting protein 1 {ECO:0000305},, PF08571;, GO:0030134;GO:0005783;GO:0005789;GO:0005794;GO:0030173;GO:0016020;GO:0007420;GO:0006888;GO:0035265;GO:0003331;GO:0050714;GO:2000269;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of Golgi membrane; C:membrane;, , P:brain development; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:organ growth; P:positive regulation of extracellular matrix constituent secretion; P:positive regulation of protein secretion; P:regulation of fibroblast apoptotic process;|Q9Y5U9,Immediate early response 3-interacting protein 1 {ECO:0000305},, PF08571;, GO:0030134;GO:0005783;GO:0005789;GO:0005794;GO:0030173;GO:0016020;GO:0007420;GO:0006888;GO:0035265;GO:0003331;GO:0050714;GO:2000269;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of Golgi membrane; C:membrane;, , P:brain development; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:organ growth; P:positive regulation of extracellular matrix constituent secretion; P:positive regulation of protein secretion; P:regulation of fibroblast apoptotic process;|Q9Y5U9,Immediate early response 3-interacting protein 1 {ECO:0000305},, PF08571;, GO:0030134;GO:0005783;GO:0005789;GO:0005794;GO:0030173;GO:0016020;GO:0007420;GO:0006888;GO:0035265;GO:0003331;GO:0050714;GO:2000269;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of Golgi membrane; C:membrane;, , P:brain development; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:organ growth; P:positive regulation of extracellular matrix constituent secretion; P:positive regulation of protein secretion; P:regulation of fibroblast apoptotic process; scaffold10 indexed_genome mRNA 43675551 43713724 . - . ID=transcript_2760;Q2VWA4,SKI family transcriptional corepressor 2,Functional Smad-suppressing element on chromosome 18;LBX1 corepressor 1-like protein;Ladybird homeobox corepressor 1-like protein;, PF08782;PF02437;, GO:0005737;GO:0005634;GO:0005667;GO:0000981;GO:0000978;GO:1990837;GO:0046332;GO:0030514;GO:0000122;GO:0030512;GO:0006355;, C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SMAD binding;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of transcription, DNA-templated; scaffold10 indexed_genome mRNA 44247165 44277607 . - . ID=transcript_2761;Q15796,Mothers against decapentaplegic homolog 2,JV18-1;Mad-related protein 2;SMAD family member 2;, PF03165;PF03166;, GO:0032444;GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0032991;GO:0071141;GO:0005667;GO:0033613;GO:0003682;GO:0000987;GO:0070410;GO:0097718;GO:0001228;GO:0003700;GO:0000981;GO:0003690;GO:0070411;GO:0046872;GO:0019902;GO:0070412;GO:0000978;GO:0046332;GO:0048156;GO:0008134;GO:0005160;GO:0034713;GO:0031625;GO:0032924;GO:0030325;GO:0009653;GO:0009952;GO:0030509;GO:0030154;GO:0045165;GO:0007182;GO:0048701;GO:0048617;GO:0001706;GO:0007369;GO:0001701;GO:0030073;GO:0035556;GO:0030324;GO:0001707;GO:0008285;GO:0000122;GO:0045892;GO:0030512;GO:0038092;GO:0035265;GO:0031016;GO:0048340;GO:0060039;GO:0030513;GO:0010718;GO:1900224;GO:0045944;GO:0045893;GO:0009791;GO:0031053;GO:0016579;GO:0051098;GO:0017015;GO:0070723;GO:0009749;GO:0062009;GO:0023019;GO:0007183;GO:0060395;GO:0035019;GO:0007179;GO:0001657;GO:0042060;GO:0007352;, C:activin responsive factor complex; C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SMAD protein complex; C:transcription regulator complex;, F:activating transcription factor binding; F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:co-SMAD binding; F:disordered domain specific binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:I-SMAD binding; F:metal ion binding; F:phosphatase binding; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:SMAD binding; F:tau protein binding; F:transcription factor binding; F:transforming growth factor beta receptor binding; F:type I transforming growth factor beta receptor binding; F:ubiquitin protein ligase binding;, P:activin receptor signaling pathway; P:adrenal gland development; P:anatomical structure morphogenesis; P:anterior/posterior pattern specification; P:BMP signaling pathway; P:cell differentiation; P:cell fate commitment; P:common-partner SMAD protein phosphorylation; P:embryonic cranial skeleton morphogenesis; P:embryonic foregut morphogenesis; P:endoderm formation; P:gastrulation; P:in utero embryonic development; P:insulin secretion; P:intracellular signal transduction; P:lung development; P:mesoderm formation; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:nodal signaling pathway; P:organ growth; P:pancreas development; P:paraxial mesoderm morphogenesis; P:pericardium development; P:positive regulation of BMP signaling pathway; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:post-embryonic development; P:primary miRNA processing; P:protein deubiquitination; P:regulation of binding; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to cholesterol; P:response to glucose; P:secondary palate development; P:signal transduction involved in regulation of gene expression; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:somatic stem cell population maintenance; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development; P:wound healing; P:zygotic specification of dorsal/ventral axis; scaffold10 indexed_genome mRNA 44456202 44470184 . - . ID=transcript_2762;A1YPR0 O73453,Zinc finger and BTB domain-containing protein 7C,Affected by papillomavirus DNA integration in ME180 cells protein 1;Zinc finger and BTB domain-containing protein 36;Zinc finger protein 857C;, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0008285;GO:0045600;GO:0045944;GO:1903025;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of transcription by RNA polymerase II;|A1YPR0 O73453,Zinc finger and BTB domain-containing protein 7C,Affected by papillomavirus DNA integration in ME180 cells protein 1;Zinc finger and BTB domain-containing protein 36;Zinc finger protein 857C;, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0008285;GO:0045600;GO:0045944;GO:1903025;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 44967056 45184698 . + . ID=transcript_2763;O43310 B3KTR8 Q8IVD5,CBP80/20-dependent translation initiation factor,, PF02854;, GO:0005829;GO:0048471;GO:0003723;GO:0008494;GO:0000184;GO:0006446;, C:cytosol; C:perinuclear region of cytoplasm;, F:RNA binding; F:translation activator activity;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translational initiation;|O43310 B3KTR8 Q8IVD5,CBP80/20-dependent translation initiation factor,, PF02854;, GO:0005829;GO:0048471;GO:0003723;GO:0008494;GO:0000184;GO:0006446;, C:cytosol; C:perinuclear region of cytoplasm;, F:RNA binding; F:translation activator activity;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translational initiation;|O43310 B3KTR8 Q8IVD5,CBP80/20-dependent translation initiation factor,, PF02854;, GO:0005829;GO:0048471;GO:0003723;GO:0008494;GO:0000184;GO:0006446;, C:cytosol; C:perinuclear region of cytoplasm;, F:RNA binding; F:translation activator activity;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translational initiation; scaffold10 indexed_genome mRNA 45184795 45185457 . - . ID=transcript_2764;O43310 B3KTR8 Q8IVD5,CBP80/20-dependent translation initiation factor,, PF02854;, GO:0005829;GO:0048471;GO:0003723;GO:0008494;GO:0000184;GO:0006446;, C:cytosol; C:perinuclear region of cytoplasm;, F:RNA binding; F:translation activator activity;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translational initiation; scaffold10 indexed_genome mRNA 45278227 45282928 . + . ID=transcript_2765;O43310 B3KTR8 Q8IVD5,CBP80/20-dependent translation initiation factor,, PF02854;, GO:0005829;GO:0048471;GO:0003723;GO:0008494;GO:0000184;GO:0006446;, C:cytosol; C:perinuclear region of cytoplasm;, F:RNA binding; F:translation activator activity;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translational initiation; scaffold10 indexed_genome mRNA 45335725 45362193 . - . ID=transcript_2766;O15105 B7Z773 K7EQ10 O14740 Q6DK23,Mothers against decapentaplegic homolog 7,Mothers against decapentaplegic homolog 8;SMAD family member 7;, PF03165;PF03166;, GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0001650;GO:0071144;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0048185;GO:0008013;GO:0005518;GO:0003677;GO:0070411;GO:0046872;GO:0140416;GO:0034713;GO:0031625;GO:0034333;GO:0009653;GO:0048844;GO:0030509;GO:0030154;GO:0034629;GO:1990830;GO:0071560;GO:0030514;GO:0030336;GO:1902731;GO:0043433;GO:0010719;GO:0030279;GO:0060394;GO:0033137;GO:0010801;GO:0031397;GO:0002725;GO:2000320;GO:2000317;GO:0010944;GO:0000122;GO:0030512;GO:0051444;GO:0060389;GO:0022409;GO:1903043;GO:0032436;GO:0031398;GO:0045944;GO:0016579;GO:0050821;GO:0032925;GO:0055117;GO:0010717;GO:0017015;GO:0060373;GO:0034616;GO:0060395;GO:0007179;GO:0001657;GO:0055010;GO:0060412;, C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:fibrillar center; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:activin binding; F:beta-catenin binding; F:collagen binding; F:DNA binding; F:I-SMAD binding; F:metal ion binding; F:transcription regulator inhibitor activity; F:type I transforming growth factor beta receptor binding; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:anatomical structure morphogenesis; P:artery morphogenesis; P:BMP signaling pathway; P:cell differentiation; P:cellular protein-containing complex localization; P:cellular response to leukemia inhibitory factor; P:cellular response to transforming growth factor beta stimulus; P:negative regulation of BMP signaling pathway; P:negative regulation of cell migration; P:negative regulation of chondrocyte proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ossification; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein ubiquitination; P:negative regulation of T cell cytokine production; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of T-helper 17 type immune response; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of ubiquitin-protein transferase activity; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of cell-cell adhesion; P:positive regulation of chondrocyte hypertrophy; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein stabilization; P:regulation of activin receptor signaling pathway; P:regulation of cardiac muscle contraction; P:regulation of epithelial to mesenchymal transition; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:response to laminar fluid shear stress; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular septum morphogenesis;|O15105 B7Z773 K7EQ10 O14740 Q6DK23,Mothers against decapentaplegic homolog 7,Mothers against decapentaplegic homolog 8;SMAD family member 7;, PF03165;PF03166;, GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0001650;GO:0071144;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0048185;GO:0008013;GO:0005518;GO:0003677;GO:0070411;GO:0046872;GO:0140416;GO:0034713;GO:0031625;GO:0034333;GO:0009653;GO:0048844;GO:0030509;GO:0030154;GO:0034629;GO:1990830;GO:0071560;GO:0030514;GO:0030336;GO:1902731;GO:0043433;GO:0010719;GO:0030279;GO:0060394;GO:0033137;GO:0010801;GO:0031397;GO:0002725;GO:2000320;GO:2000317;GO:0010944;GO:0000122;GO:0030512;GO:0051444;GO:0060389;GO:0022409;GO:1903043;GO:0032436;GO:0031398;GO:0045944;GO:0016579;GO:0050821;GO:0032925;GO:0055117;GO:0010717;GO:0017015;GO:0060373;GO:0034616;GO:0060395;GO:0007179;GO:0001657;GO:0055010;GO:0060412;, C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:fibrillar center; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:activin binding; F:beta-catenin binding; F:collagen binding; F:DNA binding; F:I-SMAD binding; F:metal ion binding; F:transcription regulator inhibitor activity; F:type I transforming growth factor beta receptor binding; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:anatomical structure morphogenesis; P:artery morphogenesis; P:BMP signaling pathway; P:cell differentiation; P:cellular protein-containing complex localization; P:cellular response to leukemia inhibitory factor; P:cellular response to transforming growth factor beta stimulus; P:negative regulation of BMP signaling pathway; P:negative regulation of cell migration; P:negative regulation of chondrocyte proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ossification; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein ubiquitination; P:negative regulation of T cell cytokine production; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of T-helper 17 type immune response; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of ubiquitin-protein transferase activity; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of cell-cell adhesion; P:positive regulation of chondrocyte hypertrophy; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein stabilization; P:regulation of activin receptor signaling pathway; P:regulation of cardiac muscle contraction; P:regulation of epithelial to mesenchymal transition; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:response to laminar fluid shear stress; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular septum morphogenesis;|O15105 B7Z773 K7EQ10 O14740 Q6DK23,Mothers against decapentaplegic homolog 7,Mothers against decapentaplegic homolog 8;SMAD family member 7;, PF03165;PF03166;, GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0001650;GO:0071144;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0048185;GO:0008013;GO:0005518;GO:0003677;GO:0070411;GO:0046872;GO:0140416;GO:0034713;GO:0031625;GO:0034333;GO:0009653;GO:0048844;GO:0030509;GO:0030154;GO:0034629;GO:1990830;GO:0071560;GO:0030514;GO:0030336;GO:1902731;GO:0043433;GO:0010719;GO:0030279;GO:0060394;GO:0033137;GO:0010801;GO:0031397;GO:0002725;GO:2000320;GO:2000317;GO:0010944;GO:0000122;GO:0030512;GO:0051444;GO:0060389;GO:0022409;GO:1903043;GO:0032436;GO:0031398;GO:0045944;GO:0016579;GO:0050821;GO:0032925;GO:0055117;GO:0010717;GO:0017015;GO:0060373;GO:0034616;GO:0060395;GO:0007179;GO:0001657;GO:0055010;GO:0060412;, C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:fibrillar center; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:activin binding; F:beta-catenin binding; F:collagen binding; F:DNA binding; F:I-SMAD binding; F:metal ion binding; F:transcription regulator inhibitor activity; F:type I transforming growth factor beta receptor binding; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:anatomical structure morphogenesis; P:artery morphogenesis; P:BMP signaling pathway; P:cell differentiation; P:cellular protein-containing complex localization; P:cellular response to leukemia inhibitory factor; P:cellular response to transforming growth factor beta stimulus; P:negative regulation of BMP signaling pathway; P:negative regulation of cell migration; P:negative regulation of chondrocyte proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ossification; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein ubiquitination; P:negative regulation of T cell cytokine production; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of T-helper 17 type immune response; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of ubiquitin-protein transferase activity; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of cell-cell adhesion; P:positive regulation of chondrocyte hypertrophy; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein stabilization; P:regulation of activin receptor signaling pathway; P:regulation of cardiac muscle contraction; P:regulation of epithelial to mesenchymal transition; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:response to laminar fluid shear stress; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular septum morphogenesis; scaffold10 indexed_genome mRNA 45457427 45783294 . - . ID=transcript_2767;Q7RTS9 A8K5I8 B2RCF9 B4DKI7 Q3ZTS8 Q6P2P5 Q8N2M0 Q9BVE9 Q9NPU7,Dymeclin,Dyggve-Melchior-Clausen syndrome protein;, , GO:0005737;GO:0005794;GO:0016020;GO:0019899;GO:0060348;GO:0007030;, C:cytoplasm; C:Golgi apparatus; C:membrane;, F:enzyme binding;, P:bone development; P:Golgi organization; scaffold10 indexed_genome mRNA 45860437 45867318 . - . ID=transcript_2768;Q8TCD1,UPF0729 protein C18orf32,Putative NF-kappa-B-activating protein 200;, PF14975;, GO:0005783;GO:0005811;GO:0043123;, C:endoplasmic reticulum; C:lipid droplet;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q8TCD1,UPF0729 protein C18orf32,Putative NF-kappa-B-activating protein 200;, PF14975;, GO:0005783;GO:0005811;GO:0043123;, C:endoplasmic reticulum; C:lipid droplet;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q8TCD1,UPF0729 protein C18orf32,Putative NF-kappa-B-activating protein 200;, PF14975;, GO:0005783;GO:0005811;GO:0043123;, C:endoplasmic reticulum; C:lipid droplet;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold10 indexed_genome mRNA 45869777 45872830 . - . ID=transcript_2769;P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold10 indexed_genome mRNA 45914772 45940172 . + . ID=transcript_2770;Q9Y5X9 B0LPG6 Q6P9C8 Q6UW82,Endothelial lipase,Endothelial cell-derived lipase;Phospholipase A1;, PF00151;PF01477;, GO:0009986;GO:0005769;GO:0005576;GO:0005615;GO:0005794;GO:0052740;GO:0008201;GO:0016298;GO:0004465;GO:0052739;GO:0008970;GO:0004620;GO:0004806;GO:0008283;GO:0042632;GO:0006633;GO:0034375;GO:0016042;GO:0006629;GO:0009395;GO:0055091;GO:0032376;GO:0010983;GO:0050746;GO:0007584;GO:0043691;GO:0019433;, C:cell surface; C:early endosome; C:extracellular region; C:extracellular space; C:Golgi apparatus;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:heparin binding; F:lipase activity; F:lipoprotein lipase activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase activity; F:triglyceride lipase activity;, P:cell population proliferation; P:cholesterol homeostasis; P:fatty acid biosynthetic process; P:high-density lipoprotein particle remodeling; P:lipid catabolic process; P:lipid metabolic process; P:phospholipid catabolic process; P:phospholipid homeostasis; P:positive regulation of cholesterol transport; P:positive regulation of high-density lipoprotein particle clearance; P:regulation of lipoprotein metabolic process; P:response to nutrient; P:reverse cholesterol transport; P:triglyceride catabolic process; scaffold10 indexed_genome mRNA 46135723 46189264 . - . ID=transcript_2771;P42765 Q9BUT6,3-ketoacyl-CoA thiolase, mitochondrial {ECO:0000305},Acetyl-CoA acetyltransferase {ECO:0000305};Acetyl-CoA acyltransferase;Acyl-CoA hydrolase, mitochondrial {ECO:0000305};Beta-ketothiolase;Mitochondrial 3-oxoacyl-CoA thiolase;T1;, PF02803;PF00108;, GO:0005759;GO:0005739;GO:0003985;GO:0003988;GO:0003986;GO:0047617;GO:0102991;GO:0016290;GO:0003723;GO:0071456;GO:0006695;GO:0006635;GO:1902109;GO:1901029;, C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA C-acetyltransferase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:RNA binding;, P:cellular response to hypoxia; P:cholesterol biosynthetic process; P:fatty acid beta-oxidation; P:negative regulation of mitochondrial membrane permeability involved in apoptotic process; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;|P42765 Q9BUT6,3-ketoacyl-CoA thiolase, mitochondrial {ECO:0000305},Acetyl-CoA acetyltransferase {ECO:0000305};Acetyl-CoA acyltransferase;Acyl-CoA hydrolase, mitochondrial {ECO:0000305};Beta-ketothiolase;Mitochondrial 3-oxoacyl-CoA thiolase;T1;, PF02803;PF00108;, GO:0005759;GO:0005739;GO:0003985;GO:0003988;GO:0003986;GO:0047617;GO:0102991;GO:0016290;GO:0003723;GO:0071456;GO:0006695;GO:0006635;GO:1902109;GO:1901029;, C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA C-acetyltransferase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:RNA binding;, P:cellular response to hypoxia; P:cholesterol biosynthetic process; P:fatty acid beta-oxidation; P:negative regulation of mitochondrial membrane permeability involved in apoptotic process; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;|P42765 Q9BUT6,3-ketoacyl-CoA thiolase, mitochondrial {ECO:0000305},Acetyl-CoA acetyltransferase {ECO:0000305};Acetyl-CoA acyltransferase;Acyl-CoA hydrolase, mitochondrial {ECO:0000305};Beta-ketothiolase;Mitochondrial 3-oxoacyl-CoA thiolase;T1;, PF02803;PF00108;, GO:0005759;GO:0005739;GO:0003985;GO:0003988;GO:0003986;GO:0047617;GO:0102991;GO:0016290;GO:0003723;GO:0071456;GO:0006695;GO:0006635;GO:1902109;GO:1901029;, C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA C-acetyltransferase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:RNA binding;, P:cellular response to hypoxia; P:cholesterol biosynthetic process; P:fatty acid beta-oxidation; P:negative regulation of mitochondrial membrane permeability involved in apoptotic process; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;|P42765 Q9BUT6,3-ketoacyl-CoA thiolase, mitochondrial {ECO:0000305},Acetyl-CoA acetyltransferase {ECO:0000305};Acetyl-CoA acyltransferase;Acyl-CoA hydrolase, mitochondrial {ECO:0000305};Beta-ketothiolase;Mitochondrial 3-oxoacyl-CoA thiolase;T1;, PF02803;PF00108;, GO:0005759;GO:0005739;GO:0003985;GO:0003988;GO:0003986;GO:0047617;GO:0102991;GO:0016290;GO:0003723;GO:0071456;GO:0006695;GO:0006635;GO:1902109;GO:1901029;, C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA C-acetyltransferase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:RNA binding;, P:cellular response to hypoxia; P:cholesterol biosynthetic process; P:fatty acid beta-oxidation; P:negative regulation of mitochondrial membrane permeability involved in apoptotic process; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; scaffold10 indexed_genome mRNA 46200056 46394250 . - . ID=transcript_2772;Q9ULV0 B0I1R3 Q0P656 Q9H6Y6,Unconventional myosin-Vb,, PF01843;PF00612;PF00063;, GO:0015629;GO:0045179;GO:0005737;GO:0030659;GO:0070062;GO:0016459;GO:0032991;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0031267;GO:0007015;GO:0016197;GO:0015031;GO:0003091;GO:0030050;GO:0016192;, C:actin cytoskeleton; C:apical cortex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:myosin complex; C:protein-containing complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:small GTPase binding;, P:actin filament organization; P:endosomal transport; P:protein transport; P:renal water homeostasis; P:vesicle transport along actin filament; P:vesicle-mediated transport;|Q9ULV0 B0I1R3 Q0P656 Q9H6Y6,Unconventional myosin-Vb,, PF01843;PF00612;PF00063;, GO:0015629;GO:0045179;GO:0005737;GO:0030659;GO:0070062;GO:0016459;GO:0032991;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0031267;GO:0007015;GO:0016197;GO:0015031;GO:0003091;GO:0030050;GO:0016192;, C:actin cytoskeleton; C:apical cortex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:myosin complex; C:protein-containing complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:small GTPase binding;, P:actin filament organization; P:endosomal transport; P:protein transport; P:renal water homeostasis; P:vesicle transport along actin filament; P:vesicle-mediated transport; scaffold10 indexed_genome mRNA 46566487 46584471 . - . ID=transcript_2773;Q96M91 B4DXT1,Cilia- and flagella-associated protein 53 {ECO:0000312|HGNC:HGNC:26530},Coiled-coil domain-containing protein 11 {ECO:0000312|HGNC:HGNC:26530};, PF13868;, GO:0005929;GO:0005576;GO:0060271;GO:0003341;GO:0007368;GO:0060287;, C:cilium; C:extracellular region;, , P:cilium assembly; P:cilium movement; P:determination of left/right symmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; scaffold10 indexed_genome mRNA 46596337 46619918 . + . ID=transcript_2774;Q96M91 B4DXT1,Cilia- and flagella-associated protein 53 {ECO:0000312|HGNC:HGNC:26530},Coiled-coil domain-containing protein 11 {ECO:0000312|HGNC:HGNC:26530};, PF13868;, GO:0005929;GO:0005576;GO:0060271;GO:0003341;GO:0007368;GO:0060287;, C:cilium; C:extracellular region;, , P:cilium assembly; P:cilium movement; P:determination of left/right symmetry; P:epithelial cilium movement involved in determination of left/right asymmetry;|Q96M91 B4DXT1,Cilia- and flagella-associated protein 53 {ECO:0000312|HGNC:HGNC:26530},Coiled-coil domain-containing protein 11 {ECO:0000312|HGNC:HGNC:26530};, PF13868;, GO:0005929;GO:0005576;GO:0060271;GO:0003341;GO:0007368;GO:0060287;, C:cilium; C:extracellular region;, , P:cilium assembly; P:cilium movement; P:determination of left/right symmetry; P:epithelial cilium movement involved in determination of left/right asymmetry;|Q96M91 B4DXT1,Cilia- and flagella-associated protein 53 {ECO:0000312|HGNC:HGNC:26530},Coiled-coil domain-containing protein 11 {ECO:0000312|HGNC:HGNC:26530};, PF13868;, GO:0005929;GO:0005576;GO:0060271;GO:0003341;GO:0007368;GO:0060287;, C:cilium; C:extracellular region;, , P:cilium assembly; P:cilium movement; P:determination of left/right symmetry; P:epithelial cilium movement involved in determination of left/right asymmetry;|Q7Z7B5 Q8N4W4 Q9UNZ6 Q9UNZ7 Q9UNZ8 Q9UNZ9,Methyl-CpG-binding domain protein 1 {ECO:0000305},CXXC-type zinc finger protein 3;Methyl-CpG-binding protein MBD1;Protein containing methyl-CpG-binding domain 1;, PF01429;PF02008;, GO:0005694;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0010385;GO:0008327;GO:0045322;GO:0008270;GO:0045892;GO:0006366;, C:chromosome; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded methylated DNA binding; F:methyl-CpG binding; F:unmethylated CpG binding; F:zinc ion binding;, P:negative regulation of transcription, DNA-templated; P:transcription by RNA polymerase II;|Q7Z7B5 Q8N4W4 Q9UNZ6 Q9UNZ7 Q9UNZ8 Q9UNZ9,Methyl-CpG-binding domain protein 1 {ECO:0000305},CXXC-type zinc finger protein 3;Methyl-CpG-binding protein MBD1;Protein containing methyl-CpG-binding domain 1;, PF01429;PF02008;, GO:0005694;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0010385;GO:0008327;GO:0045322;GO:0008270;GO:0045892;GO:0006366;, C:chromosome; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded methylated DNA binding; F:methyl-CpG binding; F:unmethylated CpG binding; F:zinc ion binding;, P:negative regulation of transcription, DNA-templated; P:transcription by RNA polymerase II;|Q7Z7B5 Q8N4W4 Q9UNZ6 Q9UNZ7 Q9UNZ8 Q9UNZ9,Methyl-CpG-binding domain protein 1 {ECO:0000305},CXXC-type zinc finger protein 3;Methyl-CpG-binding protein MBD1;Protein containing methyl-CpG-binding domain 1;, PF01429;PF02008;, GO:0005694;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0010385;GO:0008327;GO:0045322;GO:0008270;GO:0045892;GO:0006366;, C:chromosome; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded methylated DNA binding; F:methyl-CpG binding; F:unmethylated CpG binding; F:zinc ion binding;, P:negative regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 46649349 46654314 . - . ID=transcript_2775;Q9P0U4 B2RC03 Q8N2W4 Q96BC8 Q9P2V7,CXXC-type zinc finger protein 1,CpG-binding protein;PHD finger and CXXC domain-containing protein 1;, PF00628;PF12269;PF02008;, GO:0005829;GO:0035097;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0000987;GO:0035064;GO:0045322;GO:0008270;GO:0051568;GO:0036498;GO:0045893;GO:0006355;, C:cytosol; C:histone methyltransferase complex; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:cis-regulatory region sequence-specific DNA binding; F:methylated histone binding; F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 methylation; P:IRE1-mediated unfolded protein response; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9P0U4 B2RC03 Q8N2W4 Q96BC8 Q9P2V7,CXXC-type zinc finger protein 1,CpG-binding protein;PHD finger and CXXC domain-containing protein 1;, PF00628;PF12269;PF02008;, GO:0005829;GO:0035097;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0000987;GO:0035064;GO:0045322;GO:0008270;GO:0051568;GO:0036498;GO:0045893;GO:0006355;, C:cytosol; C:histone methyltransferase complex; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:cis-regulatory region sequence-specific DNA binding; F:methylated histone binding; F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 methylation; P:IRE1-mediated unfolded protein response; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9P0U4 B2RC03 Q8N2W4 Q96BC8 Q9P2V7,CXXC-type zinc finger protein 1,CpG-binding protein;PHD finger and CXXC domain-containing protein 1;, PF00628;PF12269;PF02008;, GO:0005829;GO:0035097;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0000987;GO:0035064;GO:0045322;GO:0008270;GO:0051568;GO:0036498;GO:0045893;GO:0006355;, C:cytosol; C:histone methyltransferase complex; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:cis-regulatory region sequence-specific DNA binding; F:methylated histone binding; F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 methylation; P:IRE1-mediated unfolded protein response; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9P0U4 B2RC03 Q8N2W4 Q96BC8 Q9P2V7,CXXC-type zinc finger protein 1,CpG-binding protein;PHD finger and CXXC domain-containing protein 1;, PF00628;PF12269;PF02008;, GO:0005829;GO:0035097;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0000987;GO:0035064;GO:0045322;GO:0008270;GO:0051568;GO:0036498;GO:0045893;GO:0006355;, C:cytosol; C:histone methyltransferase complex; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:cis-regulatory region sequence-specific DNA binding; F:methylated histone binding; F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 methylation; P:IRE1-mediated unfolded protein response; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9P0U4 B2RC03 Q8N2W4 Q96BC8 Q9P2V7,CXXC-type zinc finger protein 1,CpG-binding protein;PHD finger and CXXC domain-containing protein 1;, PF00628;PF12269;PF02008;, GO:0005829;GO:0035097;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0000987;GO:0035064;GO:0045322;GO:0008270;GO:0051568;GO:0036498;GO:0045893;GO:0006355;, C:cytosol; C:histone methyltransferase complex; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:cis-regulatory region sequence-specific DNA binding; F:methylated histone binding; F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 methylation; P:IRE1-mediated unfolded protein response; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9P0U4 B2RC03 Q8N2W4 Q96BC8 Q9P2V7,CXXC-type zinc finger protein 1,CpG-binding protein;PHD finger and CXXC domain-containing protein 1;, PF00628;PF12269;PF02008;, GO:0005829;GO:0035097;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0000987;GO:0035064;GO:0045322;GO:0008270;GO:0051568;GO:0036498;GO:0045893;GO:0006355;, C:cytosol; C:histone methyltransferase complex; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:cis-regulatory region sequence-specific DNA binding; F:methylated histone binding; F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 methylation; P:IRE1-mediated unfolded protein response; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9P0U4 B2RC03 Q8N2W4 Q96BC8 Q9P2V7,CXXC-type zinc finger protein 1,CpG-binding protein;PHD finger and CXXC domain-containing protein 1;, PF00628;PF12269;PF02008;, GO:0005829;GO:0035097;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0000987;GO:0035064;GO:0045322;GO:0008270;GO:0051568;GO:0036498;GO:0045893;GO:0006355;, C:cytosol; C:histone methyltransferase complex; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:cis-regulatory region sequence-specific DNA binding; F:methylated histone binding; F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 methylation; P:IRE1-mediated unfolded protein response; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold10 indexed_genome mRNA 46687211 46688338 . - . ID=transcript_2776;P63208 D3DQ97 D3DQ98 P34991 Q8TAY2,S-phase kinase-associated protein 1,Cyclin-A/CDK2-associated protein p19;Organ of Corti protein 2;Organ of Corti protein II;RNA polymerase II elongation factor-like protein;SIII;Transcription elongation factor B polypeptide 1-like;p19skp1;, PF01466;PF03931;, GO:0005813;GO:0031467;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0008013;GO:0097602;GO:1990444;GO:0019904;GO:1990756;GO:0006879;GO:0038095;GO:0000086;GO:0035518;GO:0070498;GO:0051457;GO:0010972;GO:0038061;GO:1904668;GO:0043687;GO:0070936;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:cullin family protein binding; F:F-box domain binding; F:protein domain specific binding; F:ubiquitin ligase-substrate adaptor activity;, P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:histone H2A monoubiquitination; P:interleukin-1-mediated signaling pathway; P:maintenance of protein location in nucleus; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway; scaffold10 indexed_genome mRNA 46915135 46916470 . - . ID=transcript_2777;P31152 A1A4C4 Q0VG04,Mitogen-activated protein kinase 4,Extracellular signal-regulated kinase 4;MAP kinase isoform p63;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004707;GO:0046982;GO:0042803;GO:0019901;GO:0106310;GO:0106311;GO:0007049;GO:0035556;GO:0006468;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:intracellular signal transduction; P:protein phosphorylation; P:regulation of gene expression; scaffold10 indexed_genome mRNA 47016109 47018636 . + . ID=transcript_2778;Q9BYG7 B7Z2I5 B7Z3B2 E9PAT5 E9PBI3 K7EKJ8 Q8N6K5,Protein maestro,Male-specific transcription in the developing reproductive organs;Protein B29;, , GO:0005730;, C:nucleolus; scaffold10 indexed_genome mRNA 47022439 47034601 . - . ID=transcript_2779;Q9BYG7 B7Z2I5 B7Z3B2 E9PAT5 E9PBI3 K7EKJ8 Q8N6K5,Protein maestro,Male-specific transcription in the developing reproductive organs;Protein B29;, , GO:0005730;, C:nucleolus; scaffold10 indexed_genome mRNA 47094182 47168419 . + . ID=transcript_2780;P23368 B2R8J2 Q9BWL6 Q9BYG1 Q9H4B2,NAD-dependent malic enzyme, mitochondrial,Malic enzyme 2;, PF00390;PF03949;, GO:0043231;GO:0005759;GO:0005739;GO:0009055;GO:0004471;GO:0004473;GO:0004470;GO:0046872;GO:0051287;GO:0008948;GO:0006108;GO:0006090;GO:1902031;GO:0006099;, C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:malate dehydrogenase (decarboxylating) (NAD+) activity; F:malate dehydrogenase (decarboxylating) (NADP+) activity; F:malic enzyme activity; F:metal ion binding; F:NAD binding; F:oxaloacetate decarboxylase activity;, P:malate metabolic process; P:pyruvate metabolic process; P:regulation of NADP metabolic process; P:tricarboxylic acid cycle;|P23368 B2R8J2 Q9BWL6 Q9BYG1 Q9H4B2,NAD-dependent malic enzyme, mitochondrial,Malic enzyme 2;, PF00390;PF03949;, GO:0043231;GO:0005759;GO:0005739;GO:0009055;GO:0004471;GO:0004473;GO:0004470;GO:0046872;GO:0051287;GO:0008948;GO:0006108;GO:0006090;GO:1902031;GO:0006099;, C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:malate dehydrogenase (decarboxylating) (NAD+) activity; F:malate dehydrogenase (decarboxylating) (NADP+) activity; F:malic enzyme activity; F:metal ion binding; F:NAD binding; F:oxaloacetate decarboxylase activity;, P:malate metabolic process; P:pyruvate metabolic process; P:regulation of NADP metabolic process; P:tricarboxylic acid cycle;|P23368 B2R8J2 Q9BWL6 Q9BYG1 Q9H4B2,NAD-dependent malic enzyme, mitochondrial,Malic enzyme 2;, PF00390;PF03949;, GO:0043231;GO:0005759;GO:0005739;GO:0009055;GO:0004471;GO:0004473;GO:0004470;GO:0046872;GO:0051287;GO:0008948;GO:0006108;GO:0006090;GO:1902031;GO:0006099;, C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:malate dehydrogenase (decarboxylating) (NAD+) activity; F:malate dehydrogenase (decarboxylating) (NADP+) activity; F:malic enzyme activity; F:metal ion binding; F:NAD binding; F:oxaloacetate decarboxylase activity;, P:malate metabolic process; P:pyruvate metabolic process; P:regulation of NADP metabolic process; P:tricarboxylic acid cycle;|P23368 B2R8J2 Q9BWL6 Q9BYG1 Q9H4B2,NAD-dependent malic enzyme, mitochondrial,Malic enzyme 2;, PF00390;PF03949;, GO:0043231;GO:0005759;GO:0005739;GO:0009055;GO:0004471;GO:0004473;GO:0004470;GO:0046872;GO:0051287;GO:0008948;GO:0006108;GO:0006090;GO:1902031;GO:0006099;, C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:malate dehydrogenase (decarboxylating) (NAD+) activity; F:malate dehydrogenase (decarboxylating) (NADP+) activity; F:malic enzyme activity; F:metal ion binding; F:NAD binding; F:oxaloacetate decarboxylase activity;, P:malate metabolic process; P:pyruvate metabolic process; P:regulation of NADP metabolic process; P:tricarboxylic acid cycle; scaffold10 indexed_genome mRNA 47174263 47186395 . + . ID=transcript_2781;Q9H777 Q9NS99,Zinc phosphodiesterase ELAC protein 1,Deleted in Ma29;ElaC homolog protein 1;Ribonuclease Z 1;tRNA 3 endonuclease 1;tRNase Z 1;, PF00753;PF12706;, GO:0005829;GO:0005654;GO:0005634;GO:0042781;GO:0046872;, C:cytosol; C:nucleoplasm; C:nucleus;, F:3'-tRNA processing endoribonuclease activity; F:metal ion binding;|Q9H777 Q9NS99,Zinc phosphodiesterase ELAC protein 1,Deleted in Ma29;ElaC homolog protein 1;Ribonuclease Z 1;tRNA 3 endonuclease 1;tRNase Z 1;, PF00753;PF12706;, GO:0005829;GO:0005654;GO:0005634;GO:0042781;GO:0046872;, C:cytosol; C:nucleoplasm; C:nucleus;, F:3'-tRNA processing endoribonuclease activity; F:metal ion binding; scaffold10 indexed_genome mRNA 47254253 47289510 . - . ID=transcript_2782;Q13485 A8K405,Mothers against decapentaplegic homolog 4,Deletion target in pancreatic carcinoma 4;SMAD family member 4;, PF03165;PF03166;, GO:0032444;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0071141;GO:0005667;GO:0003682;GO:0005518;GO:0001228;GO:0000981;GO:0070411;GO:0042802;GO:0046872;GO:0042803;GO:0070412;GO:0000978;GO:0001085;GO:0043199;GO:0001223;GO:0140537;GO:0000976;GO:0009653;GO:0036302;GO:0003190;GO:0007411;GO:0030509;GO:0003360;GO:0001658;GO:0030154;GO:0008283;GO:0006879;GO:0071773;GO:0048589;GO:0042733;GO:0060956;GO:0042118;GO:0003198;GO:0061040;GO:0048859;GO:0001702;GO:0001701;GO:0070102;GO:0035556;GO:0003220;GO:0048382;GO:0072133;GO:0030514;GO:0010614;GO:1905305;GO:0060548;GO:0030308;GO:0008285;GO:0070373;GO:0000122;GO:0045892;GO:0072134;GO:0014033;GO:0048663;GO:0003148;GO:0001541;GO:0030513;GO:0003251;GO:0010718;GO:0046881;GO:0051571;GO:2000617;GO:0033686;GO:0010862;GO:1902895;GO:0060391;GO:0045944;GO:1901522;GO:0045893;GO:0030511;GO:0016579;GO:0051098;GO:0051797;GO:0017015;GO:0032909;GO:0001666;GO:0071559;GO:0048733;GO:0062009;GO:0072520;GO:0007338;GO:0007183;GO:0060395;GO:0035019;GO:0032525;GO:0007283;GO:0007179;GO:0060065;GO:0060412;, C:activin responsive factor complex; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:SMAD protein complex; C:transcription regulator complex;, F:chromatin binding; F:collagen binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sulfate binding; F:transcription coactivator binding; F:transcription regulator activator activity; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:atrioventricular canal development; P:atrioventricular valve formation; P:axon guidance; P:BMP signaling pathway; P:brainstem development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation; P:cell population proliferation; P:cellular iron ion homeostasis; P:cellular response to BMP stimulus; P:developmental growth; P:embryonic digit morphogenesis; P:endocardial cell differentiation; P:endothelial cell activation; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:female gonad morphogenesis; P:formation of anatomical boundary; P:gastrulation with mouth forming second; P:in utero embryonic development; P:interleukin-6-mediated signaling pathway; P:intracellular signal transduction; P:left ventricular cardiac muscle tissue morphogenesis; P:mesendoderm development; P:metanephric mesenchyme morphogenesis; P:negative regulation of BMP signaling pathway; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cardiac myofibril assembly; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nephrogenic mesenchyme morphogenesis; P:neural crest cell differentiation; P:neuron fate commitment; P:outflow tract septum morphogenesis; P:ovarian follicle development; P:positive regulation of BMP signaling pathway; P:positive regulation of cell proliferation involved in heart valve morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of follicle-stimulating hormone secretion; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of luteinizing hormone secretion; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein deubiquitination; P:regulation of binding; P:regulation of hair follicle development; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to transforming growth factor beta; P:sebaceous gland development; P:secondary palate development; P:seminiferous tubule development; P:single fertilization; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:somatic stem cell population maintenance; P:somite rostral/caudal axis specification; P:spermatogenesis; P:transforming growth factor beta receptor signaling pathway; P:uterus development; P:ventricular septum morphogenesis;|Q13485 A8K405,Mothers against decapentaplegic homolog 4,Deletion target in pancreatic carcinoma 4;SMAD family member 4;, PF03165;PF03166;, GO:0032444;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0071141;GO:0005667;GO:0003682;GO:0005518;GO:0001228;GO:0000981;GO:0070411;GO:0042802;GO:0046872;GO:0042803;GO:0070412;GO:0000978;GO:0001085;GO:0043199;GO:0001223;GO:0140537;GO:0000976;GO:0009653;GO:0036302;GO:0003190;GO:0007411;GO:0030509;GO:0003360;GO:0001658;GO:0030154;GO:0008283;GO:0006879;GO:0071773;GO:0048589;GO:0042733;GO:0060956;GO:0042118;GO:0003198;GO:0061040;GO:0048859;GO:0001702;GO:0001701;GO:0070102;GO:0035556;GO:0003220;GO:0048382;GO:0072133;GO:0030514;GO:0010614;GO:1905305;GO:0060548;GO:0030308;GO:0008285;GO:0070373;GO:0000122;GO:0045892;GO:0072134;GO:0014033;GO:0048663;GO:0003148;GO:0001541;GO:0030513;GO:0003251;GO:0010718;GO:0046881;GO:0051571;GO:2000617;GO:0033686;GO:0010862;GO:1902895;GO:0060391;GO:0045944;GO:1901522;GO:0045893;GO:0030511;GO:0016579;GO:0051098;GO:0051797;GO:0017015;GO:0032909;GO:0001666;GO:0071559;GO:0048733;GO:0062009;GO:0072520;GO:0007338;GO:0007183;GO:0060395;GO:0035019;GO:0032525;GO:0007283;GO:0007179;GO:0060065;GO:0060412;, C:activin responsive factor complex; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:SMAD protein complex; C:transcription regulator complex;, F:chromatin binding; F:collagen binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sulfate binding; F:transcription coactivator binding; F:transcription regulator activator activity; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:atrioventricular canal development; P:atrioventricular valve formation; P:axon guidance; P:BMP signaling pathway; P:brainstem development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation; P:cell population proliferation; P:cellular iron ion homeostasis; P:cellular response to BMP stimulus; P:developmental growth; P:embryonic digit morphogenesis; P:endocardial cell differentiation; P:endothelial cell activation; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:female gonad morphogenesis; P:formation of anatomical boundary; P:gastrulation with mouth forming second; P:in utero embryonic development; P:interleukin-6-mediated signaling pathway; P:intracellular signal transduction; P:left ventricular cardiac muscle tissue morphogenesis; P:mesendoderm development; P:metanephric mesenchyme morphogenesis; P:negative regulation of BMP signaling pathway; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cardiac myofibril assembly; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nephrogenic mesenchyme morphogenesis; P:neural crest cell differentiation; P:neuron fate commitment; P:outflow tract septum morphogenesis; P:ovarian follicle development; P:positive regulation of BMP signaling pathway; P:positive regulation of cell proliferation involved in heart valve morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of follicle-stimulating hormone secretion; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of luteinizing hormone secretion; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein deubiquitination; P:regulation of binding; P:regulation of hair follicle development; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to transforming growth factor beta; P:sebaceous gland development; P:secondary palate development; P:seminiferous tubule development; P:single fertilization; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:somatic stem cell population maintenance; P:somite rostral/caudal axis specification; P:spermatogenesis; P:transforming growth factor beta receptor signaling pathway; P:uterus development; P:ventricular septum morphogenesis;|Q13485 A8K405,Mothers against decapentaplegic homolog 4,Deletion target in pancreatic carcinoma 4;SMAD family member 4;, PF03165;PF03166;, GO:0032444;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0071141;GO:0005667;GO:0003682;GO:0005518;GO:0001228;GO:0000981;GO:0070411;GO:0042802;GO:0046872;GO:0042803;GO:0070412;GO:0000978;GO:0001085;GO:0043199;GO:0001223;GO:0140537;GO:0000976;GO:0009653;GO:0036302;GO:0003190;GO:0007411;GO:0030509;GO:0003360;GO:0001658;GO:0030154;GO:0008283;GO:0006879;GO:0071773;GO:0048589;GO:0042733;GO:0060956;GO:0042118;GO:0003198;GO:0061040;GO:0048859;GO:0001702;GO:0001701;GO:0070102;GO:0035556;GO:0003220;GO:0048382;GO:0072133;GO:0030514;GO:0010614;GO:1905305;GO:0060548;GO:0030308;GO:0008285;GO:0070373;GO:0000122;GO:0045892;GO:0072134;GO:0014033;GO:0048663;GO:0003148;GO:0001541;GO:0030513;GO:0003251;GO:0010718;GO:0046881;GO:0051571;GO:2000617;GO:0033686;GO:0010862;GO:1902895;GO:0060391;GO:0045944;GO:1901522;GO:0045893;GO:0030511;GO:0016579;GO:0051098;GO:0051797;GO:0017015;GO:0032909;GO:0001666;GO:0071559;GO:0048733;GO:0062009;GO:0072520;GO:0007338;GO:0007183;GO:0060395;GO:0035019;GO:0032525;GO:0007283;GO:0007179;GO:0060065;GO:0060412;, C:activin responsive factor complex; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:SMAD protein complex; C:transcription regulator complex;, F:chromatin binding; F:collagen binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sulfate binding; F:transcription coactivator binding; F:transcription regulator activator activity; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:atrioventricular canal development; P:atrioventricular valve formation; P:axon guidance; P:BMP signaling pathway; P:brainstem development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation; P:cell population proliferation; P:cellular iron ion homeostasis; P:cellular response to BMP stimulus; P:developmental growth; P:embryonic digit morphogenesis; P:endocardial cell differentiation; P:endothelial cell activation; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:female gonad morphogenesis; P:formation of anatomical boundary; P:gastrulation with mouth forming second; P:in utero embryonic development; P:interleukin-6-mediated signaling pathway; P:intracellular signal transduction; P:left ventricular cardiac muscle tissue morphogenesis; P:mesendoderm development; P:metanephric mesenchyme morphogenesis; P:negative regulation of BMP signaling pathway; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cardiac myofibril assembly; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nephrogenic mesenchyme morphogenesis; P:neural crest cell differentiation; P:neuron fate commitment; P:outflow tract septum morphogenesis; P:ovarian follicle development; P:positive regulation of BMP signaling pathway; P:positive regulation of cell proliferation involved in heart valve morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of follicle-stimulating hormone secretion; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of luteinizing hormone secretion; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein deubiquitination; P:regulation of binding; P:regulation of hair follicle development; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to transforming growth factor beta; P:sebaceous gland development; P:secondary palate development; P:seminiferous tubule development; P:single fertilization; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:somatic stem cell population maintenance; P:somite rostral/caudal axis specification; P:spermatogenesis; P:transforming growth factor beta receptor signaling pathway; P:uterus development; P:ventricular septum morphogenesis;|Q13485 A8K405,Mothers against decapentaplegic homolog 4,Deletion target in pancreatic carcinoma 4;SMAD family member 4;, PF03165;PF03166;, GO:0032444;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0071141;GO:0005667;GO:0003682;GO:0005518;GO:0001228;GO:0000981;GO:0070411;GO:0042802;GO:0046872;GO:0042803;GO:0070412;GO:0000978;GO:0001085;GO:0043199;GO:0001223;GO:0140537;GO:0000976;GO:0009653;GO:0036302;GO:0003190;GO:0007411;GO:0030509;GO:0003360;GO:0001658;GO:0030154;GO:0008283;GO:0006879;GO:0071773;GO:0048589;GO:0042733;GO:0060956;GO:0042118;GO:0003198;GO:0061040;GO:0048859;GO:0001702;GO:0001701;GO:0070102;GO:0035556;GO:0003220;GO:0048382;GO:0072133;GO:0030514;GO:0010614;GO:1905305;GO:0060548;GO:0030308;GO:0008285;GO:0070373;GO:0000122;GO:0045892;GO:0072134;GO:0014033;GO:0048663;GO:0003148;GO:0001541;GO:0030513;GO:0003251;GO:0010718;GO:0046881;GO:0051571;GO:2000617;GO:0033686;GO:0010862;GO:1902895;GO:0060391;GO:0045944;GO:1901522;GO:0045893;GO:0030511;GO:0016579;GO:0051098;GO:0051797;GO:0017015;GO:0032909;GO:0001666;GO:0071559;GO:0048733;GO:0062009;GO:0072520;GO:0007338;GO:0007183;GO:0060395;GO:0035019;GO:0032525;GO:0007283;GO:0007179;GO:0060065;GO:0060412;, C:activin responsive factor complex; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:SMAD protein complex; C:transcription regulator complex;, F:chromatin binding; F:collagen binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sulfate binding; F:transcription coactivator binding; F:transcription regulator activator activity; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:atrioventricular canal development; P:atrioventricular valve formation; P:axon guidance; P:BMP signaling pathway; P:brainstem development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation; P:cell population proliferation; P:cellular iron ion homeostasis; P:cellular response to BMP stimulus; P:developmental growth; P:embryonic digit morphogenesis; P:endocardial cell differentiation; P:endothelial cell activation; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:female gonad morphogenesis; P:formation of anatomical boundary; P:gastrulation with mouth forming second; P:in utero embryonic development; P:interleukin-6-mediated signaling pathway; P:intracellular signal transduction; P:left ventricular cardiac muscle tissue morphogenesis; P:mesendoderm development; P:metanephric mesenchyme morphogenesis; P:negative regulation of BMP signaling pathway; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cardiac myofibril assembly; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nephrogenic mesenchyme morphogenesis; P:neural crest cell differentiation; P:neuron fate commitment; P:outflow tract septum morphogenesis; P:ovarian follicle development; P:positive regulation of BMP signaling pathway; P:positive regulation of cell proliferation involved in heart valve morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of follicle-stimulating hormone secretion; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of luteinizing hormone secretion; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein deubiquitination; P:regulation of binding; P:regulation of hair follicle development; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to transforming growth factor beta; P:sebaceous gland development; P:secondary palate development; P:seminiferous tubule development; P:single fertilization; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:somatic stem cell population maintenance; P:somite rostral/caudal axis specification; P:spermatogenesis; P:transforming growth factor beta receptor signaling pathway; P:uterus development; P:ventricular septum morphogenesis;|Q13485 A8K405,Mothers against decapentaplegic homolog 4,Deletion target in pancreatic carcinoma 4;SMAD family member 4;, PF03165;PF03166;, GO:0032444;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0005654;GO:0005634;GO:0071141;GO:0005667;GO:0003682;GO:0005518;GO:0001228;GO:0000981;GO:0070411;GO:0042802;GO:0046872;GO:0042803;GO:0070412;GO:0000978;GO:0001085;GO:0043199;GO:0001223;GO:0140537;GO:0000976;GO:0009653;GO:0036302;GO:0003190;GO:0007411;GO:0030509;GO:0003360;GO:0001658;GO:0030154;GO:0008283;GO:0006879;GO:0071773;GO:0048589;GO:0042733;GO:0060956;GO:0042118;GO:0003198;GO:0061040;GO:0048859;GO:0001702;GO:0001701;GO:0070102;GO:0035556;GO:0003220;GO:0048382;GO:0072133;GO:0030514;GO:0010614;GO:1905305;GO:0060548;GO:0030308;GO:0008285;GO:0070373;GO:0000122;GO:0045892;GO:0072134;GO:0014033;GO:0048663;GO:0003148;GO:0001541;GO:0030513;GO:0003251;GO:0010718;GO:0046881;GO:0051571;GO:2000617;GO:0033686;GO:0010862;GO:1902895;GO:0060391;GO:0045944;GO:1901522;GO:0045893;GO:0030511;GO:0016579;GO:0051098;GO:0051797;GO:0017015;GO:0032909;GO:0001666;GO:0071559;GO:0048733;GO:0062009;GO:0072520;GO:0007338;GO:0007183;GO:0060395;GO:0035019;GO:0032525;GO:0007283;GO:0007179;GO:0060065;GO:0060412;, C:activin responsive factor complex; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:nucleoplasm; C:nucleus; C:SMAD protein complex; C:transcription regulator complex;, F:chromatin binding; F:collagen binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sulfate binding; F:transcription coactivator binding; F:transcription regulator activator activity; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:atrioventricular canal development; P:atrioventricular valve formation; P:axon guidance; P:BMP signaling pathway; P:brainstem development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation; P:cell population proliferation; P:cellular iron ion homeostasis; P:cellular response to BMP stimulus; P:developmental growth; P:embryonic digit morphogenesis; P:endocardial cell differentiation; P:endothelial cell activation; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:female gonad morphogenesis; P:formation of anatomical boundary; P:gastrulation with mouth forming second; P:in utero embryonic development; P:interleukin-6-mediated signaling pathway; P:intracellular signal transduction; P:left ventricular cardiac muscle tissue morphogenesis; P:mesendoderm development; P:metanephric mesenchyme morphogenesis; P:negative regulation of BMP signaling pathway; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cardiac myofibril assembly; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nephrogenic mesenchyme morphogenesis; P:neural crest cell differentiation; P:neuron fate commitment; P:outflow tract septum morphogenesis; P:ovarian follicle development; P:positive regulation of BMP signaling pathway; P:positive regulation of cell proliferation involved in heart valve morphogenesis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of follicle-stimulating hormone secretion; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of luteinizing hormone secretion; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein deubiquitination; P:regulation of binding; P:regulation of hair follicle development; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to transforming growth factor beta; P:sebaceous gland development; P:secondary palate development; P:seminiferous tubule development; P:single fertilization; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:somatic stem cell population maintenance; P:somite rostral/caudal axis specification; P:spermatogenesis; P:transforming growth factor beta receptor signaling pathway; P:uterus development; P:ventricular septum morphogenesis; scaffold10 indexed_genome mRNA 48988721 49444024 . + . ID=transcript_2783;P43146,Netrin receptor DCC,Colorectal cancer suppressor;Immunoglobulin superfamily DCC subclass member 1;Tumor suppressor protein DCC;, PF00041;PF07679;PF06583;, GO:0030424;GO:0005829;GO:0099061;GO:0005886;GO:0098685;GO:0005042;GO:0004888;GO:0033564;GO:0006915;GO:0007411;GO:0007409;GO:0033563;GO:0097192;GO:0048671;GO:2000171;GO:1902842;GO:0010977;GO:0001764;GO:0099170;GO:1901214;GO:0021965;, C:axon; C:cytosol; C:integral component of postsynaptic density membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:netrin receptor activity; F:transmembrane signaling receptor activity;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:axonogenesis; P:dorsal/ventral axon guidance; P:extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of collateral sprouting; P:negative regulation of dendrite development; P:negative regulation of netrin-activated signaling pathway; P:negative regulation of neuron projection development; P:neuron migration; P:postsynaptic modulation of chemical synaptic transmission; P:regulation of neuron death; P:spinal cord ventral commissure morphogenesis; scaffold10 indexed_genome mRNA 49495594 49655484 . + . ID=transcript_2784;P43146,Netrin receptor DCC,Colorectal cancer suppressor;Immunoglobulin superfamily DCC subclass member 1;Tumor suppressor protein DCC;, PF00041;PF07679;PF06583;, GO:0030424;GO:0005829;GO:0099061;GO:0005886;GO:0098685;GO:0005042;GO:0004888;GO:0033564;GO:0006915;GO:0007411;GO:0007409;GO:0033563;GO:0097192;GO:0048671;GO:2000171;GO:1902842;GO:0010977;GO:0001764;GO:0099170;GO:1901214;GO:0021965;, C:axon; C:cytosol; C:integral component of postsynaptic density membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:netrin receptor activity; F:transmembrane signaling receptor activity;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:axonogenesis; P:dorsal/ventral axon guidance; P:extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of collateral sprouting; P:negative regulation of dendrite development; P:negative regulation of netrin-activated signaling pathway; P:negative regulation of neuron projection development; P:neuron migration; P:postsynaptic modulation of chemical synaptic transmission; P:regulation of neuron death; P:spinal cord ventral commissure morphogenesis; scaffold10 indexed_genome mRNA 50153878 50221545 . - . ID=transcript_2785;O95983 A8K4B7 D6W5Z2 Q6PIL9 Q6PJZ9 Q86XF4,Methyl-CpG-binding domain protein 3,Methyl-CpG-binding protein MBD3;, PF01429;PF14048;PF16564;, GO:0000785;GO:0005737;GO:0000792;GO:0005654;GO:0016581;GO:0032991;GO:0003682;GO:0003677;GO:0008327;GO:0007568;GO:0043044;GO:0007420;GO:0006346;GO:0048568;GO:0007507;GO:0016573;GO:0001701;GO:0000122;GO:0044030;GO:1901796;GO:0032355;GO:0031667;GO:0009888;, C:chromatin; C:cytoplasm; C:heterochromatin; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:methyl-CpG binding;, P:aging; P:ATP-dependent chromatin remodeling; P:brain development; P:DNA methylation-dependent heterochromatin assembly; P:embryonic organ development; P:heart development; P:histone acetylation; P:in utero embryonic development; P:negative regulation of transcription by RNA polymerase II; P:regulation of DNA methylation; P:regulation of signal transduction by p53 class mediator; P:response to estradiol; P:response to nutrient levels; P:tissue development;|Q9UBB5 O95242 Q9UIS8,Methyl-CpG-binding domain protein 2 {ECO:0000305},Demethylase;Methyl-CpG-binding protein MBD2;, PF01429;PF14048;PF16564;, GO:0000785;GO:0005829;GO:0000792;GO:0000118;GO:0005654;GO:0005634;GO:0032991;GO:0070742;GO:0003682;GO:0008327;GO:0003729;GO:0019904;GO:0003696;GO:0035197;GO:0007568;GO:0043044;GO:0034622;GO:0071407;GO:0006346;GO:0048568;GO:0007507;GO:0042711;GO:0000122;GO:0045892;GO:0035563;GO:0030177;GO:0000183;GO:0042127;GO:0044030;GO:0032355;GO:0009612;GO:0031667;, C:chromatin; C:cytosol; C:heterochromatin; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:C2H2 zinc finger domain binding; F:chromatin binding; F:methyl-CpG binding; F:mRNA binding; F:protein domain specific binding; F:satellite DNA binding; F:siRNA binding;, P:aging; P:ATP-dependent chromatin remodeling; P:cellular protein-containing complex assembly; P:cellular response to organic cyclic compound; P:DNA methylation-dependent heterochromatin assembly; P:embryonic organ development; P:heart development; P:maternal behavior; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin binding; P:positive regulation of Wnt signaling pathway; P:rDNA heterochromatin assembly; P:regulation of cell population proliferation; P:regulation of DNA methylation; P:response to estradiol; P:response to mechanical stimulus; P:response to nutrient levels; scaffold10 indexed_genome mRNA 50263979 50268083 . + . ID=transcript_2786;Q9UNA4 Q8N590 Q9H0S1 Q9NYH6,DNA polymerase iota,Eta2;RAD30 homolog B;, PF00817;PF11799;, GO:0036464;GO:0016607;GO:0005654;GO:0003684;GO:0003887;GO:0046872;GO:0006281;GO:0006260;GO:0042276;GO:0019985;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:translesion synthesis; scaffold10 indexed_genome mRNA 50268129 50290796 . + . ID=transcript_2787;Q9UNA4 Q8N590 Q9H0S1 Q9NYH6,DNA polymerase iota,Eta2;RAD30 homolog B;, PF00817;PF11799;, GO:0036464;GO:0016607;GO:0005654;GO:0003684;GO:0003887;GO:0046872;GO:0006281;GO:0006260;GO:0042276;GO:0019985;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:translesion synthesis;|Q9UNA4 Q8N590 Q9H0S1 Q9NYH6,DNA polymerase iota,Eta2;RAD30 homolog B;, PF00817;PF11799;, GO:0036464;GO:0016607;GO:0005654;GO:0003684;GO:0003887;GO:0046872;GO:0006281;GO:0006260;GO:0042276;GO:0019985;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:translesion synthesis;|Q9UNA4 Q8N590 Q9H0S1 Q9NYH6,DNA polymerase iota,Eta2;RAD30 homolog B;, PF00817;PF11799;, GO:0036464;GO:0016607;GO:0005654;GO:0003684;GO:0003887;GO:0046872;GO:0006281;GO:0006260;GO:0042276;GO:0019985;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:translesion synthesis;|Q9UNA4 Q8N590 Q9H0S1 Q9NYH6,DNA polymerase iota,Eta2;RAD30 homolog B;, PF00817;PF11799;, GO:0036464;GO:0016607;GO:0005654;GO:0003684;GO:0003887;GO:0046872;GO:0006281;GO:0006260;GO:0042276;GO:0019985;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:translesion synthesis;|Q9UNA4 Q8N590 Q9H0S1 Q9NYH6,DNA polymerase iota,Eta2;RAD30 homolog B;, PF00817;PF11799;, GO:0036464;GO:0016607;GO:0005654;GO:0003684;GO:0003887;GO:0046872;GO:0006281;GO:0006260;GO:0042276;GO:0019985;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:translesion synthesis;|Q9UNA4 Q8N590 Q9H0S1 Q9NYH6,DNA polymerase iota,Eta2;RAD30 homolog B;, PF00817;PF11799;, GO:0036464;GO:0016607;GO:0005654;GO:0003684;GO:0003887;GO:0046872;GO:0006281;GO:0006260;GO:0042276;GO:0019985;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:translesion synthesis;|Q9UNA4 Q8N590 Q9H0S1 Q9NYH6,DNA polymerase iota,Eta2;RAD30 homolog B;, PF00817;PF11799;, GO:0036464;GO:0016607;GO:0005654;GO:0003684;GO:0003887;GO:0046872;GO:0006281;GO:0006260;GO:0042276;GO:0019985;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:translesion synthesis; scaffold10 indexed_genome mRNA 50293590 50294247 . - . ID=transcript_2788;P59095,StAR-related lipid transfer protein 6,START domain-containing protein 6;, PF01852;, GO:0008289;GO:0006869;, , F:lipid binding;, P:lipid transport; scaffold10 indexed_genome mRNA 50300778 50302185 . + . ID=transcript_2789;P59095,StAR-related lipid transfer protein 6,START domain-containing protein 6;, PF01852;, GO:0008289;GO:0006869;, , F:lipid binding;, P:lipid transport; scaffold10 indexed_genome mRNA 50303444 50312589 . - . ID=transcript_2790;P59095,StAR-related lipid transfer protein 6,START domain-containing protein 6;, PF01852;, GO:0008289;GO:0006869;, , F:lipid binding;, P:lipid transport;|P59095,StAR-related lipid transfer protein 6,START domain-containing protein 6;, PF01852;, GO:0008289;GO:0006869;, , F:lipid binding;, P:lipid transport; scaffold10 indexed_genome mRNA 50316417 50332075 . + . ID=transcript_2791;Q8IYD9 I7HFJ6 Q6MZU3 Q6ZTL6,Lung adenoma susceptibility protein 2,, PF15792;, GO:0005576;GO:0008285;, C:extracellular region;, , P:negative regulation of cell population proliferation;|Q8IYD9 I7HFJ6 Q6MZU3 Q6ZTL6,Lung adenoma susceptibility protein 2,, PF15792;, GO:0005576;GO:0008285;, C:extracellular region;, , P:negative regulation of cell population proliferation;|Q8IYD9 I7HFJ6 Q6MZU3 Q6ZTL6,Lung adenoma susceptibility protein 2,, PF15792;, GO:0005576;GO:0008285;, C:extracellular region;, , P:negative regulation of cell population proliferation; scaffold10 indexed_genome mRNA 50731804 50793301 . + . ID=transcript_2792;O00194 B2RAB0 Q9BZB6,Ras-related protein Rab-27B,C25KG;, PF00071;, GO:0098993;GO:0016324;GO:1904115;GO:0070062;GO:0005795;GO:0005770;GO:0042470;GO:0032585;GO:0005886;GO:0031088;GO:0030141;GO:0030140;GO:0042589;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019904;GO:0099641;GO:0032402;GO:0071985;GO:0002576;GO:0045921;GO:0048488;, C:anchored component of synaptic vesicle membrane; C:apical plasma membrane; C:axon cytoplasm; C:extracellular exosome; C:Golgi stack; C:late endosome; C:melanosome; C:multivesicular body membrane; C:plasma membrane; C:platelet dense granule membrane; C:secretory granule; C:trans-Golgi network transport vesicle; C:zymogen granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding; F:protein domain specific binding;, P:anterograde axonal protein transport; P:melanosome transport; P:multivesicular body sorting pathway; P:platelet degranulation; P:positive regulation of exocytosis; P:synaptic vesicle endocytosis; scaffold10 indexed_genome mRNA 51112581 51499808 . + . ID=transcript_2793;H3BPQ1 Q08AP2 Q08AP3 Q15439 Q15440 Q15441,Transcription factor 4,Class B basic helix-loop-helix protein 19;Immunoglobulin transcription factor 2;SL3-3 enhancer factor 2;, PF00010;, GO:1990907;GO:0070369;GO:0000785;GO:0005634;GO:0005667;GO:0008013;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0042802;GO:0008022;GO:0046982;GO:0000978;GO:1990837;GO:0001093;GO:0030154;GO:0007399;GO:0045666;GO:0045944;GO:0045893;GO:0065004;GO:0006357;, C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:chromatin; C:nucleus; C:transcription regulator complex;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:identical protein binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:TFIIB-class transcription factor binding;, P:cell differentiation; P:nervous system development; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein-DNA complex assembly; P:regulation of transcription by RNA polymerase II;|H3BPQ1 Q08AP2 Q08AP3 Q15439 Q15440 Q15441,Transcription factor 4,Class B basic helix-loop-helix protein 19;Immunoglobulin transcription factor 2;SL3-3 enhancer factor 2;, PF00010;, GO:1990907;GO:0070369;GO:0000785;GO:0005634;GO:0005667;GO:0008013;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0042802;GO:0008022;GO:0046982;GO:0000978;GO:1990837;GO:0001093;GO:0030154;GO:0007399;GO:0045666;GO:0045944;GO:0045893;GO:0065004;GO:0006357;, C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:chromatin; C:nucleus; C:transcription regulator complex;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:identical protein binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:TFIIB-class transcription factor binding;, P:cell differentiation; P:nervous system development; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein-DNA complex assembly; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 52400506 52432446 . - . ID=transcript_2794;O43396,Thioredoxin-like protein 1,32 kDa thioredoxin-related protein;, PF06201;PF00085;, GO:0005737;GO:0005829;GO:0005634;GO:0000502;GO:0015036;, C:cytoplasm; C:cytosol; C:nucleus; C:proteasome complex;, F:disulfide oxidoreductase activity;|O43396,Thioredoxin-like protein 1,32 kDa thioredoxin-related protein;, PF06201;PF00085;, GO:0005737;GO:0005829;GO:0005634;GO:0000502;GO:0015036;, C:cytoplasm; C:cytosol; C:nucleus; C:proteasome complex;, F:disulfide oxidoreductase activity; scaffold10 indexed_genome mRNA 52486007 52802455 . + . ID=transcript_2795;Q9Y4E6 A7E2C8 Q86UX5 Q86VP2 Q96PS7,WD repeat-containing protein 7,Rabconnectin-3 beta;TGF-beta resistance-associated protein TRAG;, PF00400;, GO:0008021;, C:synaptic vesicle; scaffold10 indexed_genome mRNA 53051364 53064855 . + . ID=transcript_2796;O43173 A8K0F2 Q6B085 Q9NS41,Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase,Alpha-2,8-sialyltransferase 8C;Alpha-2,8-sialyltransferase III;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3;Sialyltransferase 8C;Sialyltransferase St8Sia III {ECO:0000303|PubMed:9826427};, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0042802;GO:0033691;GO:0008373;GO:0001574;GO:0009100;GO:0006688;GO:0006491;GO:0009311;GO:0006486;GO:1990743;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:identical protein binding; F:sialic acid binding; F:sialyltransferase activity;, P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation; P:protein sialylation;|O43173 A8K0F2 Q6B085 Q9NS41,Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase,Alpha-2,8-sialyltransferase 8C;Alpha-2,8-sialyltransferase III;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3;Sialyltransferase 8C;Sialyltransferase St8Sia III {ECO:0000303|PubMed:9826427};, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0042802;GO:0033691;GO:0008373;GO:0001574;GO:0009100;GO:0006688;GO:0006491;GO:0009311;GO:0006486;GO:1990743;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:identical protein binding; F:sialic acid binding; F:sialyltransferase activity;, P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation; P:protein sialylation;|O43173 A8K0F2 Q6B085 Q9NS41,Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase,Alpha-2,8-sialyltransferase 8C;Alpha-2,8-sialyltransferase III;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3;Sialyltransferase 8C;Sialyltransferase St8Sia III {ECO:0000303|PubMed:9826427};, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0042802;GO:0033691;GO:0008373;GO:0001574;GO:0009100;GO:0006688;GO:0006491;GO:0009311;GO:0006486;GO:1990743;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:identical protein binding; F:sialic acid binding; F:sialyltransferase activity;, P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation; P:protein sialylation;|O43173 A8K0F2 Q6B085 Q9NS41,Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase,Alpha-2,8-sialyltransferase 8C;Alpha-2,8-sialyltransferase III;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3;Sialyltransferase 8C;Sialyltransferase St8Sia III {ECO:0000303|PubMed:9826427};, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0042802;GO:0033691;GO:0008373;GO:0001574;GO:0009100;GO:0006688;GO:0006491;GO:0009311;GO:0006486;GO:1990743;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:identical protein binding; F:sialic acid binding; F:sialyltransferase activity;, P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation; P:protein sialylation;|O43173 A8K0F2 Q6B085 Q9NS41,Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase,Alpha-2,8-sialyltransferase 8C;Alpha-2,8-sialyltransferase III;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3;Sialyltransferase 8C;Sialyltransferase St8Sia III {ECO:0000303|PubMed:9826427};, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0042802;GO:0033691;GO:0008373;GO:0001574;GO:0009100;GO:0006688;GO:0006491;GO:0009311;GO:0006486;GO:1990743;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:identical protein binding; F:sialic acid binding; F:sialyltransferase activity;, P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation; P:protein sialylation; scaffold10 indexed_genome mRNA 53124843 53168883 . + . ID=transcript_2797;O95948,One cut domain family member 2,Hepatocyte nuclear factor 6-beta;One cut homeobox 2;Transcription factor ONECUT-2;, PF02376;PF00046;, GO:0015629;GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0009887;GO:0045165;GO:0060271;GO:0031018;GO:0002064;GO:0001889;GO:0030512;GO:0048935;GO:0030335;GO:0045944;GO:0001952;GO:0006357;, C:actin cytoskeleton; C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ morphogenesis; P:cell fate commitment; P:cilium assembly; P:endocrine pancreas development; P:epithelial cell development; P:liver development; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peripheral nervous system neuron development; P:positive regulation of cell migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell-matrix adhesion; P:regulation of transcription by RNA polymerase II; scaffold10 indexed_genome mRNA 53221625 53257402 . - . ID=transcript_2798;P22830 A8KA72 Q8IXN1 Q8NAN0,Ferrochelatase, mitochondrial,Heme synthase;Protoheme ferro-lyase;, PF00762;, GO:0005743;GO:0005759;GO:0005739;GO:0051537;GO:0004325;GO:0008198;GO:0071549;GO:0006091;GO:0006783;GO:0046501;GO:0046685;GO:0042493;GO:0045471;GO:0017085;GO:0010288;GO:0009416;GO:0051597;GO:0070541;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:ferrochelatase activity; F:ferrous iron binding;, P:cellular response to dexamethasone stimulus; P:generation of precursor metabolites and energy; P:heme biosynthetic process; P:protoporphyrinogen IX metabolic process; P:response to arsenic-containing substance; P:response to drug; P:response to ethanol; P:response to insecticide; P:response to lead ion; P:response to light stimulus; P:response to methylmercury; P:response to platinum ion;|P22830 A8KA72 Q8IXN1 Q8NAN0,Ferrochelatase, mitochondrial,Heme synthase;Protoheme ferro-lyase;, PF00762;, GO:0005743;GO:0005759;GO:0005739;GO:0051537;GO:0004325;GO:0008198;GO:0071549;GO:0006091;GO:0006783;GO:0046501;GO:0046685;GO:0042493;GO:0045471;GO:0017085;GO:0010288;GO:0009416;GO:0051597;GO:0070541;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:ferrochelatase activity; F:ferrous iron binding;, P:cellular response to dexamethasone stimulus; P:generation of precursor metabolites and energy; P:heme biosynthetic process; P:protoporphyrinogen IX metabolic process; P:response to arsenic-containing substance; P:response to drug; P:response to ethanol; P:response to insecticide; P:response to lead ion; P:response to light stimulus; P:response to methylmercury; P:response to platinum ion;|P22830 A8KA72 Q8IXN1 Q8NAN0,Ferrochelatase, mitochondrial,Heme synthase;Protoheme ferro-lyase;, PF00762;, GO:0005743;GO:0005759;GO:0005739;GO:0051537;GO:0004325;GO:0008198;GO:0071549;GO:0006091;GO:0006783;GO:0046501;GO:0046685;GO:0042493;GO:0045471;GO:0017085;GO:0010288;GO:0009416;GO:0051597;GO:0070541;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:ferrochelatase activity; F:ferrous iron binding;, P:cellular response to dexamethasone stimulus; P:generation of precursor metabolites and energy; P:heme biosynthetic process; P:protoporphyrinogen IX metabolic process; P:response to arsenic-containing substance; P:response to drug; P:response to ethanol; P:response to insecticide; P:response to lead ion; P:response to light stimulus; P:response to methylmercury; P:response to platinum ion; scaffold10 indexed_genome mRNA 53268268 53284119 . - . ID=transcript_2799;O43776 B4DG16 Q53GU6,Asparagine--tRNA ligase, cytoplasmic,Asparaginyl-tRNA synthetase;Asparaginyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:7643};, PF00152;PF01336;, GO:0005737;GO:0005829;GO:0070062;GO:0004816;GO:0005524;GO:0031728;GO:0003676;GO:0046983;GO:0006421;GO:0016477;GO:0006418;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:asparagine-tRNA ligase activity; F:ATP binding; F:CCR3 chemokine receptor binding; F:nucleic acid binding; F:protein dimerization activity;, P:asparaginyl-tRNA aminoacylation; P:cell migration; P:tRNA aminoacylation for protein translation;|O43776 B4DG16 Q53GU6,Asparagine--tRNA ligase, cytoplasmic,Asparaginyl-tRNA synthetase;Asparaginyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:7643};, PF00152;PF01336;, GO:0005737;GO:0005829;GO:0070062;GO:0004816;GO:0005524;GO:0031728;GO:0003676;GO:0046983;GO:0006421;GO:0016477;GO:0006418;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:asparagine-tRNA ligase activity; F:ATP binding; F:CCR3 chemokine receptor binding; F:nucleic acid binding; F:protein dimerization activity;, P:asparaginyl-tRNA aminoacylation; P:cell migration; P:tRNA aminoacylation for protein translation;|O43776 B4DG16 Q53GU6,Asparagine--tRNA ligase, cytoplasmic,Asparaginyl-tRNA synthetase;Asparaginyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:7643};, PF00152;PF01336;, GO:0005737;GO:0005829;GO:0070062;GO:0004816;GO:0005524;GO:0031728;GO:0003676;GO:0046983;GO:0006421;GO:0016477;GO:0006418;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:asparagine-tRNA ligase activity; F:ATP binding; F:CCR3 chemokine receptor binding; F:nucleic acid binding; F:protein dimerization activity;, P:asparaginyl-tRNA aminoacylation; P:cell migration; P:tRNA aminoacylation for protein translation;|O43776 B4DG16 Q53GU6,Asparagine--tRNA ligase, cytoplasmic,Asparaginyl-tRNA synthetase;Asparaginyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:7643};, PF00152;PF01336;, GO:0005737;GO:0005829;GO:0070062;GO:0004816;GO:0005524;GO:0031728;GO:0003676;GO:0046983;GO:0006421;GO:0016477;GO:0006418;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:asparagine-tRNA ligase activity; F:ATP binding; F:CCR3 chemokine receptor binding; F:nucleic acid binding; F:protein dimerization activity;, P:asparaginyl-tRNA aminoacylation; P:cell migration; P:tRNA aminoacylation for protein translation;|O43776 B4DG16 Q53GU6,Asparagine--tRNA ligase, cytoplasmic,Asparaginyl-tRNA synthetase;Asparaginyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:7643};, PF00152;PF01336;, GO:0005737;GO:0005829;GO:0070062;GO:0004816;GO:0005524;GO:0031728;GO:0003676;GO:0046983;GO:0006421;GO:0016477;GO:0006418;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:asparagine-tRNA ligase activity; F:ATP binding; F:CCR3 chemokine receptor binding; F:nucleic acid binding; F:protein dimerization activity;, P:asparaginyl-tRNA aminoacylation; P:cell migration; P:tRNA aminoacylation for protein translation; scaffold10 indexed_genome mRNA 53288777 53356360 . - . ID=transcript_2800;O43520 Q9BTP8,Phospholipid-transporting ATPase IC {ECO:0000305},ATPase class I type 8B member 1;Familial intrahepatic cholestasis type 1;P4-ATPase flippase complex alpha subunit ATP8B1;, PF16212;PF16209;, GO:0016324;GO:0031526;GO:0005829;GO:0005783;GO:0005794;GO:0005887;GO:0016604;GO:0005654;GO:1990531;GO:0005886;GO:0032420;GO:0005802;GO:0005524;GO:0140326;GO:1901612;GO:0000287;GO:0140345;GO:0140346;GO:0045176;GO:0015721;GO:0008206;GO:0006855;GO:0007030;GO:0060119;GO:0034220;GO:0045892;GO:0045332;GO:2001225;GO:0032534;GO:1903729;GO:0007605;GO:0021650;, C:apical plasma membrane; C:brush border membrane; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear body; C:nucleoplasm; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:stereocilium; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:cardiolipin binding; F:magnesium ion binding; F:phosphatidylcholine flippase activity; F:phosphatidylserine flippase activity;, P:apical protein localization; P:bile acid and bile salt transport; P:bile acid metabolic process; P:drug transmembrane transport; P:Golgi organization; P:inner ear receptor cell development; P:ion transmembrane transport; P:negative regulation of transcription, DNA-templated; P:phospholipid translocation; P:regulation of chloride transport; P:regulation of microvillus assembly; P:regulation of plasma membrane organization; P:sensory perception of sound; P:vestibulocochlear nerve formation;|O43520 Q9BTP8,Phospholipid-transporting ATPase IC {ECO:0000305},ATPase class I type 8B member 1;Familial intrahepatic cholestasis type 1;P4-ATPase flippase complex alpha subunit ATP8B1;, PF16212;PF16209;, GO:0016324;GO:0031526;GO:0005829;GO:0005783;GO:0005794;GO:0005887;GO:0016604;GO:0005654;GO:1990531;GO:0005886;GO:0032420;GO:0005802;GO:0005524;GO:0140326;GO:1901612;GO:0000287;GO:0140345;GO:0140346;GO:0045176;GO:0015721;GO:0008206;GO:0006855;GO:0007030;GO:0060119;GO:0034220;GO:0045892;GO:0045332;GO:2001225;GO:0032534;GO:1903729;GO:0007605;GO:0021650;, C:apical plasma membrane; C:brush border membrane; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear body; C:nucleoplasm; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:stereocilium; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:cardiolipin binding; F:magnesium ion binding; F:phosphatidylcholine flippase activity; F:phosphatidylserine flippase activity;, P:apical protein localization; P:bile acid and bile salt transport; P:bile acid metabolic process; P:drug transmembrane transport; P:Golgi organization; P:inner ear receptor cell development; P:ion transmembrane transport; P:negative regulation of transcription, DNA-templated; P:phospholipid translocation; P:regulation of chloride transport; P:regulation of microvillus assembly; P:regulation of plasma membrane organization; P:sensory perception of sound; P:vestibulocochlear nerve formation;|O43520 Q9BTP8,Phospholipid-transporting ATPase IC {ECO:0000305},ATPase class I type 8B member 1;Familial intrahepatic cholestasis type 1;P4-ATPase flippase complex alpha subunit ATP8B1;, PF16212;PF16209;, GO:0016324;GO:0031526;GO:0005829;GO:0005783;GO:0005794;GO:0005887;GO:0016604;GO:0005654;GO:1990531;GO:0005886;GO:0032420;GO:0005802;GO:0005524;GO:0140326;GO:1901612;GO:0000287;GO:0140345;GO:0140346;GO:0045176;GO:0015721;GO:0008206;GO:0006855;GO:0007030;GO:0060119;GO:0034220;GO:0045892;GO:0045332;GO:2001225;GO:0032534;GO:1903729;GO:0007605;GO:0021650;, C:apical plasma membrane; C:brush border membrane; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear body; C:nucleoplasm; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:stereocilium; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:cardiolipin binding; F:magnesium ion binding; F:phosphatidylcholine flippase activity; F:phosphatidylserine flippase activity;, P:apical protein localization; P:bile acid and bile salt transport; P:bile acid metabolic process; P:drug transmembrane transport; P:Golgi organization; P:inner ear receptor cell development; P:ion transmembrane transport; P:negative regulation of transcription, DNA-templated; P:phospholipid translocation; P:regulation of chloride transport; P:regulation of microvillus assembly; P:regulation of plasma membrane organization; P:sensory perception of sound; P:vestibulocochlear nerve formation;|O43520 Q9BTP8,Phospholipid-transporting ATPase IC {ECO:0000305},ATPase class I type 8B member 1;Familial intrahepatic cholestasis type 1;P4-ATPase flippase complex alpha subunit ATP8B1;, PF16212;PF16209;, GO:0016324;GO:0031526;GO:0005829;GO:0005783;GO:0005794;GO:0005887;GO:0016604;GO:0005654;GO:1990531;GO:0005886;GO:0032420;GO:0005802;GO:0005524;GO:0140326;GO:1901612;GO:0000287;GO:0140345;GO:0140346;GO:0045176;GO:0015721;GO:0008206;GO:0006855;GO:0007030;GO:0060119;GO:0034220;GO:0045892;GO:0045332;GO:2001225;GO:0032534;GO:1903729;GO:0007605;GO:0021650;, C:apical plasma membrane; C:brush border membrane; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear body; C:nucleoplasm; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:stereocilium; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:cardiolipin binding; F:magnesium ion binding; F:phosphatidylcholine flippase activity; F:phosphatidylserine flippase activity;, P:apical protein localization; P:bile acid and bile salt transport; P:bile acid metabolic process; P:drug transmembrane transport; P:Golgi organization; P:inner ear receptor cell development; P:ion transmembrane transport; P:negative regulation of transcription, DNA-templated; P:phospholipid translocation; P:regulation of chloride transport; P:regulation of microvillus assembly; P:regulation of plasma membrane organization; P:sensory perception of sound; P:vestibulocochlear nerve formation;|O43520 Q9BTP8,Phospholipid-transporting ATPase IC {ECO:0000305},ATPase class I type 8B member 1;Familial intrahepatic cholestasis type 1;P4-ATPase flippase complex alpha subunit ATP8B1;, PF16212;PF16209;, GO:0016324;GO:0031526;GO:0005829;GO:0005783;GO:0005794;GO:0005887;GO:0016604;GO:0005654;GO:1990531;GO:0005886;GO:0032420;GO:0005802;GO:0005524;GO:0140326;GO:1901612;GO:0000287;GO:0140345;GO:0140346;GO:0045176;GO:0015721;GO:0008206;GO:0006855;GO:0007030;GO:0060119;GO:0034220;GO:0045892;GO:0045332;GO:2001225;GO:0032534;GO:1903729;GO:0007605;GO:0021650;, C:apical plasma membrane; C:brush border membrane; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear body; C:nucleoplasm; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:stereocilium; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:cardiolipin binding; F:magnesium ion binding; F:phosphatidylcholine flippase activity; F:phosphatidylserine flippase activity;, P:apical protein localization; P:bile acid and bile salt transport; P:bile acid metabolic process; P:drug transmembrane transport; P:Golgi organization; P:inner ear receptor cell development; P:ion transmembrane transport; P:negative regulation of transcription, DNA-templated; P:phospholipid translocation; P:regulation of chloride transport; P:regulation of microvillus assembly; P:regulation of plasma membrane organization; P:sensory perception of sound; P:vestibulocochlear nerve formation; scaffold10 indexed_genome mRNA 53798201 53953300 . + . ID=transcript_2801;Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis;|Q9H2W4 Q9NT88,E3 ubiquitin-protein ligase NEDD4-like,HECT-type E3 ubiquitin transferase NED4L;NEDD4.2;Nedd4-2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005771;GO:0005654;GO:0044325;GO:0019870;GO:0015459;GO:0019871;GO:0017080;GO:0061630;GO:0004842;GO:0030154;GO:0006883;GO:0007588;GO:0034220;GO:1901380;GO:1901017;GO:2000009;GO:1902306;GO:2000650;GO:0000122;GO:2001288;GO:1903861;GO:0045807;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0048814;GO:0034765;GO:0003254;GO:0042391;GO:0060306;GO:1901016;GO:0042176;GO:0031647;GO:0010038;GO:0006814;GO:0006511;GO:0086005;GO:0019058;GO:0030104;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:multivesicular body; C:nucleoplasm;, F:ion channel binding; F:potassium channel inhibitor activity; F:potassium channel regulator activity; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell differentiation; P:cellular sodium ion homeostasis; P:excretion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of dendrite extension; P:positive regulation of endocytosis; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of ion transmembrane transport; P:regulation of membrane depolarization; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transporter activity; P:regulation of protein catabolic process; P:regulation of protein stability; P:response to metal ion; P:sodium ion transport; P:ubiquitin-dependent protein catabolic process; P:ventricular cardiac muscle cell action potential; P:viral life cycle; P:water homeostasis; scaffold10 indexed_genome mRNA 54014688 54146182 . - . ID=transcript_2802;Q86TB3 Q6ZUX0 Q8NAT5 Q96L95,Alpha-protein kinase 2 {ECO:0000305},Heart alpha-protein kinase {ECO:0000303|PubMed:10021370};, PF02816;PF07679;, GO:0016323;GO:0005524;GO:0106310;GO:0106311;GO:0055013;GO:1905223;GO:0030010;GO:0003007;GO:0003308;GO:0042981;GO:0010468;, C:basolateral plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell development; P:epicardium morphogenesis; P:establishment of cell polarity; P:heart morphogenesis; P:negative regulation of Wnt signaling pathway involved in heart development; P:regulation of apoptotic process; P:regulation of gene expression;|Q86TB3 Q6ZUX0 Q8NAT5 Q96L95,Alpha-protein kinase 2 {ECO:0000305},Heart alpha-protein kinase {ECO:0000303|PubMed:10021370};, PF02816;PF07679;, GO:0016323;GO:0005524;GO:0106310;GO:0106311;GO:0055013;GO:1905223;GO:0030010;GO:0003007;GO:0003308;GO:0042981;GO:0010468;, C:basolateral plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell development; P:epicardium morphogenesis; P:establishment of cell polarity; P:heart morphogenesis; P:negative regulation of Wnt signaling pathway involved in heart development; P:regulation of apoptotic process; P:regulation of gene expression; scaffold10 indexed_genome mRNA 54210949 54242579 . + . ID=transcript_2803;Q9UDY8 Q9NTB7 Q9ULX4,Mucosa-associated lymphoid tissue lymphoma translocation protein 1,MALT lymphoma-associated translocation;Paracaspase;, PF13895;PF18703;, GO:0032449;GO:0005737;GO:0005829;GO:0001650;GO:0005634;GO:0048471;GO:0002096;GO:0032991;GO:0004197;GO:0004175;GO:0042802;GO:0008233;GO:0002020;GO:0043621;GO:0004842;GO:0007250;GO:0042113;GO:0001923;GO:0006952;GO:0038095;GO:0045087;GO:0031663;GO:0043066;GO:0051168;GO:0043280;GO:0043123;GO:0032731;GO:0032743;GO:0051092;GO:0031398;GO:0002726;GO:2000321;GO:0006508;GO:0051603;GO:0042981;GO:0050856;GO:0009620;GO:0002223;GO:0042098;GO:0050852;, C:CBM complex; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleus; C:perinuclear region of cytoplasm; C:polkadots; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:peptidase activity; F:protease binding; F:protein self-association; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:B cell activation; P:B-1 B cell differentiation; P:defense response; P:Fc-epsilon receptor signaling pathway; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nuclear export; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-2 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein ubiquitination; P:positive regulation of T cell cytokine production; P:positive regulation of T-helper 17 cell differentiation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of apoptotic process; P:regulation of T cell receptor signaling pathway; P:response to fungus; P:stimulatory C-type lectin receptor signaling pathway; P:T cell proliferation; P:T cell receptor signaling pathway;|Q9UDY8 Q9NTB7 Q9ULX4,Mucosa-associated lymphoid tissue lymphoma translocation protein 1,MALT lymphoma-associated translocation;Paracaspase;, PF13895;PF18703;, GO:0032449;GO:0005737;GO:0005829;GO:0001650;GO:0005634;GO:0048471;GO:0002096;GO:0032991;GO:0004197;GO:0004175;GO:0042802;GO:0008233;GO:0002020;GO:0043621;GO:0004842;GO:0007250;GO:0042113;GO:0001923;GO:0006952;GO:0038095;GO:0045087;GO:0031663;GO:0043066;GO:0051168;GO:0043280;GO:0043123;GO:0032731;GO:0032743;GO:0051092;GO:0031398;GO:0002726;GO:2000321;GO:0006508;GO:0051603;GO:0042981;GO:0050856;GO:0009620;GO:0002223;GO:0042098;GO:0050852;, C:CBM complex; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleus; C:perinuclear region of cytoplasm; C:polkadots; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:peptidase activity; F:protease binding; F:protein self-association; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:B cell activation; P:B-1 B cell differentiation; P:defense response; P:Fc-epsilon receptor signaling pathway; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nuclear export; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-2 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein ubiquitination; P:positive regulation of T cell cytokine production; P:positive regulation of T-helper 17 cell differentiation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of apoptotic process; P:regulation of T cell receptor signaling pathway; P:response to fungus; P:stimulatory C-type lectin receptor signaling pathway; P:T cell proliferation; P:T cell receptor signaling pathway;|Q9UDY8 Q9NTB7 Q9ULX4,Mucosa-associated lymphoid tissue lymphoma translocation protein 1,MALT lymphoma-associated translocation;Paracaspase;, PF13895;PF18703;, GO:0032449;GO:0005737;GO:0005829;GO:0001650;GO:0005634;GO:0048471;GO:0002096;GO:0032991;GO:0004197;GO:0004175;GO:0042802;GO:0008233;GO:0002020;GO:0043621;GO:0004842;GO:0007250;GO:0042113;GO:0001923;GO:0006952;GO:0038095;GO:0045087;GO:0031663;GO:0043066;GO:0051168;GO:0043280;GO:0043123;GO:0032731;GO:0032743;GO:0051092;GO:0031398;GO:0002726;GO:2000321;GO:0006508;GO:0051603;GO:0042981;GO:0050856;GO:0009620;GO:0002223;GO:0042098;GO:0050852;, C:CBM complex; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleus; C:perinuclear region of cytoplasm; C:polkadots; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:peptidase activity; F:protease binding; F:protein self-association; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:B cell activation; P:B-1 B cell differentiation; P:defense response; P:Fc-epsilon receptor signaling pathway; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nuclear export; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-2 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein ubiquitination; P:positive regulation of T cell cytokine production; P:positive regulation of T-helper 17 cell differentiation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of apoptotic process; P:regulation of T cell receptor signaling pathway; P:response to fungus; P:stimulatory C-type lectin receptor signaling pathway; P:T cell proliferation; P:T cell receptor signaling pathway;|Q9UDY8 Q9NTB7 Q9ULX4,Mucosa-associated lymphoid tissue lymphoma translocation protein 1,MALT lymphoma-associated translocation;Paracaspase;, PF13895;PF18703;, GO:0032449;GO:0005737;GO:0005829;GO:0001650;GO:0005634;GO:0048471;GO:0002096;GO:0032991;GO:0004197;GO:0004175;GO:0042802;GO:0008233;GO:0002020;GO:0043621;GO:0004842;GO:0007250;GO:0042113;GO:0001923;GO:0006952;GO:0038095;GO:0045087;GO:0031663;GO:0043066;GO:0051168;GO:0043280;GO:0043123;GO:0032731;GO:0032743;GO:0051092;GO:0031398;GO:0002726;GO:2000321;GO:0006508;GO:0051603;GO:0042981;GO:0050856;GO:0009620;GO:0002223;GO:0042098;GO:0050852;, C:CBM complex; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleus; C:perinuclear region of cytoplasm; C:polkadots; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:peptidase activity; F:protease binding; F:protein self-association; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:B cell activation; P:B-1 B cell differentiation; P:defense response; P:Fc-epsilon receptor signaling pathway; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nuclear export; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-2 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein ubiquitination; P:positive regulation of T cell cytokine production; P:positive regulation of T-helper 17 cell differentiation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of apoptotic process; P:regulation of T cell receptor signaling pathway; P:response to fungus; P:stimulatory C-type lectin receptor signaling pathway; P:T cell proliferation; P:T cell receptor signaling pathway;|Q9UDY8 Q9NTB7 Q9ULX4,Mucosa-associated lymphoid tissue lymphoma translocation protein 1,MALT lymphoma-associated translocation;Paracaspase;, PF13895;PF18703;, GO:0032449;GO:0005737;GO:0005829;GO:0001650;GO:0005634;GO:0048471;GO:0002096;GO:0032991;GO:0004197;GO:0004175;GO:0042802;GO:0008233;GO:0002020;GO:0043621;GO:0004842;GO:0007250;GO:0042113;GO:0001923;GO:0006952;GO:0038095;GO:0045087;GO:0031663;GO:0043066;GO:0051168;GO:0043280;GO:0043123;GO:0032731;GO:0032743;GO:0051092;GO:0031398;GO:0002726;GO:2000321;GO:0006508;GO:0051603;GO:0042981;GO:0050856;GO:0009620;GO:0002223;GO:0042098;GO:0050852;, C:CBM complex; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleus; C:perinuclear region of cytoplasm; C:polkadots; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:peptidase activity; F:protease binding; F:protein self-association; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:B cell activation; P:B-1 B cell differentiation; P:defense response; P:Fc-epsilon receptor signaling pathway; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nuclear export; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-2 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein ubiquitination; P:positive regulation of T cell cytokine production; P:positive regulation of T-helper 17 cell differentiation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of apoptotic process; P:regulation of T cell receptor signaling pathway; P:response to fungus; P:stimulatory C-type lectin receptor signaling pathway; P:T cell proliferation; P:T cell receptor signaling pathway;|Q9UDY8 Q9NTB7 Q9ULX4,Mucosa-associated lymphoid tissue lymphoma translocation protein 1,MALT lymphoma-associated translocation;Paracaspase;, PF13895;PF18703;, GO:0032449;GO:0005737;GO:0005829;GO:0001650;GO:0005634;GO:0048471;GO:0002096;GO:0032991;GO:0004197;GO:0004175;GO:0042802;GO:0008233;GO:0002020;GO:0043621;GO:0004842;GO:0007250;GO:0042113;GO:0001923;GO:0006952;GO:0038095;GO:0045087;GO:0031663;GO:0043066;GO:0051168;GO:0043280;GO:0043123;GO:0032731;GO:0032743;GO:0051092;GO:0031398;GO:0002726;GO:2000321;GO:0006508;GO:0051603;GO:0042981;GO:0050856;GO:0009620;GO:0002223;GO:0042098;GO:0050852;, C:CBM complex; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleus; C:perinuclear region of cytoplasm; C:polkadots; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:peptidase activity; F:protease binding; F:protein self-association; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:B cell activation; P:B-1 B cell differentiation; P:defense response; P:Fc-epsilon receptor signaling pathway; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nuclear export; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-2 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein ubiquitination; P:positive regulation of T cell cytokine production; P:positive regulation of T-helper 17 cell differentiation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of apoptotic process; P:regulation of T cell receptor signaling pathway; P:response to fungus; P:stimulatory C-type lectin receptor signaling pathway; P:T cell proliferation; P:T cell receptor signaling pathway; scaffold11 indexed_genome mRNA 632 1323 . + . ID=transcript_2804;Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport; scaffold11 indexed_genome mRNA 214908 233808 . - . ID=transcript_2805;Q8IY95 Q7Z3A1 Q8N928,Transmembrane protein 192,, PF14802;, GO:0005768;GO:0016021;GO:0005770;GO:0005765;GO:0005764;GO:0005654;GO:0048471;GO:0042803;, C:endosome; C:integral component of membrane; C:late endosome; C:lysosomal membrane; C:lysosome; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; scaffold11 indexed_genome mRNA 385172 514536 . + . ID=transcript_2806;O95198 A6NCM7 B2RD18 B4DFH7 F5H6M3 Q8N484 Q8TBH5,Kelch-like protein 2,Actin-binding protein Mayven;, PF07707;PF00651;PF01344;, GO:0015629;GO:0031463;GO:0005737;GO:0005829;GO:0030027;GO:0001726;GO:0003779;GO:0042802;GO:0043687;GO:0016567;, C:actin cytoskeleton; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:lamellipodium; C:ruffle;, F:actin binding; F:identical protein binding;, P:post-translational protein modification; P:protein ubiquitination; scaffold11 indexed_genome mRNA 514549 537555 . + . ID=transcript_2807;O95198 A6NCM7 B2RD18 B4DFH7 F5H6M3 Q8N484 Q8TBH5,Kelch-like protein 2,Actin-binding protein Mayven;, PF07707;PF00651;PF01344;, GO:0015629;GO:0031463;GO:0005737;GO:0005829;GO:0030027;GO:0001726;GO:0003779;GO:0042802;GO:0043687;GO:0016567;, C:actin cytoskeleton; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:lamellipodium; C:ruffle;, F:actin binding; F:identical protein binding;, P:post-translational protein modification; P:protein ubiquitination;|O95198 A6NCM7 B2RD18 B4DFH7 F5H6M3 Q8N484 Q8TBH5,Kelch-like protein 2,Actin-binding protein Mayven;, PF07707;PF00651;PF01344;, GO:0015629;GO:0031463;GO:0005737;GO:0005829;GO:0030027;GO:0001726;GO:0003779;GO:0042802;GO:0043687;GO:0016567;, C:actin cytoskeleton; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:lamellipodium; C:ruffle;, F:actin binding; F:identical protein binding;, P:post-translational protein modification; P:protein ubiquitination;|O95198 A6NCM7 B2RD18 B4DFH7 F5H6M3 Q8N484 Q8TBH5,Kelch-like protein 2,Actin-binding protein Mayven;, PF07707;PF00651;PF01344;, GO:0015629;GO:0031463;GO:0005737;GO:0005829;GO:0030027;GO:0001726;GO:0003779;GO:0042802;GO:0043687;GO:0016567;, C:actin cytoskeleton; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:lamellipodium; C:ruffle;, F:actin binding; F:identical protein binding;, P:post-translational protein modification; P:protein ubiquitination;|O95198 A6NCM7 B2RD18 B4DFH7 F5H6M3 Q8N484 Q8TBH5,Kelch-like protein 2,Actin-binding protein Mayven;, PF07707;PF00651;PF01344;, GO:0015629;GO:0031463;GO:0005737;GO:0005829;GO:0030027;GO:0001726;GO:0003779;GO:0042802;GO:0043687;GO:0016567;, C:actin cytoskeleton; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:lamellipodium; C:ruffle;, F:actin binding; F:identical protein binding;, P:post-translational protein modification; P:protein ubiquitination;|O95198 A6NCM7 B2RD18 B4DFH7 F5H6M3 Q8N484 Q8TBH5,Kelch-like protein 2,Actin-binding protein Mayven;, PF07707;PF00651;PF01344;, GO:0015629;GO:0031463;GO:0005737;GO:0005829;GO:0030027;GO:0001726;GO:0003779;GO:0042802;GO:0043687;GO:0016567;, C:actin cytoskeleton; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:lamellipodium; C:ruffle;, F:actin binding; F:identical protein binding;, P:post-translational protein modification; P:protein ubiquitination;|O95198 A6NCM7 B2RD18 B4DFH7 F5H6M3 Q8N484 Q8TBH5,Kelch-like protein 2,Actin-binding protein Mayven;, PF07707;PF00651;PF01344;, GO:0015629;GO:0031463;GO:0005737;GO:0005829;GO:0030027;GO:0001726;GO:0003779;GO:0042802;GO:0043687;GO:0016567;, C:actin cytoskeleton; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:lamellipodium; C:ruffle;, F:actin binding; F:identical protein binding;, P:post-translational protein modification; P:protein ubiquitination;|O95198 A6NCM7 B2RD18 B4DFH7 F5H6M3 Q8N484 Q8TBH5,Kelch-like protein 2,Actin-binding protein Mayven;, PF07707;PF00651;PF01344;, GO:0015629;GO:0031463;GO:0005737;GO:0005829;GO:0030027;GO:0001726;GO:0003779;GO:0042802;GO:0043687;GO:0016567;, C:actin cytoskeleton; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:lamellipodium; C:ruffle;, F:actin binding; F:identical protein binding;, P:post-translational protein modification; P:protein ubiquitination;|O95198 A6NCM7 B2RD18 B4DFH7 F5H6M3 Q8N484 Q8TBH5,Kelch-like protein 2,Actin-binding protein Mayven;, PF07707;PF00651;PF01344;, GO:0015629;GO:0031463;GO:0005737;GO:0005829;GO:0030027;GO:0001726;GO:0003779;GO:0042802;GO:0043687;GO:0016567;, C:actin cytoskeleton; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:lamellipodium; C:ruffle;, F:actin binding; F:identical protein binding;, P:post-translational protein modification; P:protein ubiquitination; scaffold11 indexed_genome mRNA 542716 559227 . + . ID=transcript_2808;Q15800 A8K8Q3 A8MYF6 D3DP32 Q32Q24,Methylsterol monooxygenase 1 {ECO:0000303|PubMed:23583456},C-4 methylsterol oxidase {ECO:0000303|PubMed:23583456};Sterol-C4-methyl oxidase {ECO:0000303|PubMed:21285510};, PF04116;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0000254;GO:0005506;GO:0016491;GO:0006695;GO:0006631;GO:0008202;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:C-4 methylsterol oxidase activity; F:iron ion binding; F:oxidoreductase activity;, P:cholesterol biosynthetic process; P:fatty acid metabolic process; P:steroid metabolic process; P:sterol biosynthetic process;|Q15800 A8K8Q3 A8MYF6 D3DP32 Q32Q24,Methylsterol monooxygenase 1 {ECO:0000303|PubMed:23583456},C-4 methylsterol oxidase {ECO:0000303|PubMed:23583456};Sterol-C4-methyl oxidase {ECO:0000303|PubMed:21285510};, PF04116;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0000254;GO:0005506;GO:0016491;GO:0006695;GO:0006631;GO:0008202;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:C-4 methylsterol oxidase activity; F:iron ion binding; F:oxidoreductase activity;, P:cholesterol biosynthetic process; P:fatty acid metabolic process; P:steroid metabolic process; P:sterol biosynthetic process;|Q15800 A8K8Q3 A8MYF6 D3DP32 Q32Q24,Methylsterol monooxygenase 1 {ECO:0000303|PubMed:23583456},C-4 methylsterol oxidase {ECO:0000303|PubMed:23583456};Sterol-C4-methyl oxidase {ECO:0000303|PubMed:21285510};, PF04116;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0000254;GO:0005506;GO:0016491;GO:0006695;GO:0006631;GO:0008202;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:C-4 methylsterol oxidase activity; F:iron ion binding; F:oxidoreductase activity;, P:cholesterol biosynthetic process; P:fatty acid metabolic process; P:steroid metabolic process; P:sterol biosynthetic process;|Q15800 A8K8Q3 A8MYF6 D3DP32 Q32Q24,Methylsterol monooxygenase 1 {ECO:0000303|PubMed:23583456},C-4 methylsterol oxidase {ECO:0000303|PubMed:23583456};Sterol-C4-methyl oxidase {ECO:0000303|PubMed:21285510};, PF04116;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0000254;GO:0005506;GO:0016491;GO:0006695;GO:0006631;GO:0008202;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:C-4 methylsterol oxidase activity; F:iron ion binding; F:oxidoreductase activity;, P:cholesterol biosynthetic process; P:fatty acid metabolic process; P:steroid metabolic process; P:sterol biosynthetic process;|Q15800 A8K8Q3 A8MYF6 D3DP32 Q32Q24,Methylsterol monooxygenase 1 {ECO:0000303|PubMed:23583456},C-4 methylsterol oxidase {ECO:0000303|PubMed:23583456};Sterol-C4-methyl oxidase {ECO:0000303|PubMed:21285510};, PF04116;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0000254;GO:0005506;GO:0016491;GO:0006695;GO:0006631;GO:0008202;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:C-4 methylsterol oxidase activity; F:iron ion binding; F:oxidoreductase activity;, P:cholesterol biosynthetic process; P:fatty acid metabolic process; P:steroid metabolic process; P:sterol biosynthetic process; scaffold11 indexed_genome mRNA 597947 754431 . - . ID=transcript_2809;P16870 A8K4N1 B3KR42 B4DFN4 D3DP33 Q9UIU9,Carboxypeptidase E,Carboxypeptidase H;Enkephalin convertase;Prohormone-processing carboxypeptidase;, PF00246;, GO:0070062;GO:0005615;GO:0005794;GO:0005634;GO:0005886;GO:0030658;GO:0004180;GO:0050839;GO:0004181;GO:0042043;GO:0008270;GO:0003214;GO:0006464;GO:0007218;GO:0006518;GO:0072657;GO:0016485;GO:0016055;, C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:nucleus; C:plasma membrane; C:transport vesicle membrane;, F:carboxypeptidase activity; F:cell adhesion molecule binding; F:metallocarboxypeptidase activity; F:neurexin family protein binding; F:zinc ion binding;, P:cardiac left ventricle morphogenesis; P:cellular protein modification process; P:neuropeptide signaling pathway; P:peptide metabolic process; P:protein localization to membrane; P:protein processing; P:Wnt signaling pathway;|P16870 A8K4N1 B3KR42 B4DFN4 D3DP33 Q9UIU9,Carboxypeptidase E,Carboxypeptidase H;Enkephalin convertase;Prohormone-processing carboxypeptidase;, PF00246;, GO:0070062;GO:0005615;GO:0005794;GO:0005634;GO:0005886;GO:0030658;GO:0004180;GO:0050839;GO:0004181;GO:0042043;GO:0008270;GO:0003214;GO:0006464;GO:0007218;GO:0006518;GO:0072657;GO:0016485;GO:0016055;, C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:nucleus; C:plasma membrane; C:transport vesicle membrane;, F:carboxypeptidase activity; F:cell adhesion molecule binding; F:metallocarboxypeptidase activity; F:neurexin family protein binding; F:zinc ion binding;, P:cardiac left ventricle morphogenesis; P:cellular protein modification process; P:neuropeptide signaling pathway; P:peptide metabolic process; P:protein localization to membrane; P:protein processing; P:Wnt signaling pathway; scaffold11 indexed_genome mRNA 1477535 1760295 . - . ID=transcript_2810;O43897 B2RMU2 Q96AN3 Q9NQS4,Tolloid-like protein 1,, PF01400;PF00431;PF07645;, GO:0005576;GO:0005509;GO:0004222;GO:0008270;GO:0030154;GO:0030199;GO:0022617;GO:0001501;, C:extracellular region;, F:calcium ion binding; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:skeletal system development;|O43897 B2RMU2 Q96AN3 Q9NQS4,Tolloid-like protein 1,, PF01400;PF00431;PF07645;, GO:0005576;GO:0005509;GO:0004222;GO:0008270;GO:0030154;GO:0030199;GO:0022617;GO:0001501;, C:extracellular region;, F:calcium ion binding; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:skeletal system development;|O43897 B2RMU2 Q96AN3 Q9NQS4,Tolloid-like protein 1,, PF01400;PF00431;PF07645;, GO:0005576;GO:0005509;GO:0004222;GO:0008270;GO:0030154;GO:0030199;GO:0022617;GO:0001501;, C:extracellular region;, F:calcium ion binding; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:skeletal system development;|O43897 B2RMU2 Q96AN3 Q9NQS4,Tolloid-like protein 1,, PF01400;PF00431;PF07645;, GO:0005576;GO:0005509;GO:0004222;GO:0008270;GO:0030154;GO:0030199;GO:0022617;GO:0001501;, C:extracellular region;, F:calcium ion binding; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:skeletal system development;|O43897 B2RMU2 Q96AN3 Q9NQS4,Tolloid-like protein 1,, PF01400;PF00431;PF07645;, GO:0005576;GO:0005509;GO:0004222;GO:0008270;GO:0030154;GO:0030199;GO:0022617;GO:0001501;, C:extracellular region;, F:calcium ion binding; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:skeletal system development; scaffold11 indexed_genome mRNA 1834408 1884031 . + . ID=transcript_2811;Q49MG5 Q4W5I7 Q68DU1 Q9H781 Q9H7B6,Microtubule-associated protein 9,Aster-associated protein;, , GO:0000235;GO:0030424;GO:0005737;GO:0072686;GO:1990023;GO:0051233;GO:0008017;GO:0000281;GO:0090307;GO:0046602;GO:1902412;GO:0060236;, C:astral microtubule; C:axon; C:cytoplasm; C:mitotic spindle; C:mitotic spindle midzone; C:spindle midzone;, F:microtubule binding;, P:mitotic cytokinesis; P:mitotic spindle assembly; P:regulation of mitotic centrosome separation; P:regulation of mitotic cytokinesis; P:regulation of mitotic spindle organization;|Q49MG5 Q4W5I7 Q68DU1 Q9H781 Q9H7B6,Microtubule-associated protein 9,Aster-associated protein;, , GO:0000235;GO:0030424;GO:0005737;GO:0072686;GO:1990023;GO:0051233;GO:0008017;GO:0000281;GO:0090307;GO:0046602;GO:1902412;GO:0060236;, C:astral microtubule; C:axon; C:cytoplasm; C:mitotic spindle; C:mitotic spindle midzone; C:spindle midzone;, F:microtubule binding;, P:mitotic cytokinesis; P:mitotic spindle assembly; P:regulation of mitotic centrosome separation; P:regulation of mitotic cytokinesis; P:regulation of mitotic spindle organization;|Q49MG5 Q4W5I7 Q68DU1 Q9H781 Q9H7B6,Microtubule-associated protein 9,Aster-associated protein;, , GO:0000235;GO:0030424;GO:0005737;GO:0072686;GO:1990023;GO:0051233;GO:0008017;GO:0000281;GO:0090307;GO:0046602;GO:1902412;GO:0060236;, C:astral microtubule; C:axon; C:cytoplasm; C:mitotic spindle; C:mitotic spindle midzone; C:spindle midzone;, F:microtubule binding;, P:mitotic cytokinesis; P:mitotic spindle assembly; P:regulation of mitotic centrosome separation; P:regulation of mitotic cytokinesis; P:regulation of mitotic spindle organization;|Q49MG5 Q4W5I7 Q68DU1 Q9H781 Q9H7B6,Microtubule-associated protein 9,Aster-associated protein;, , GO:0000235;GO:0030424;GO:0005737;GO:0072686;GO:1990023;GO:0051233;GO:0008017;GO:0000281;GO:0090307;GO:0046602;GO:1902412;GO:0060236;, C:astral microtubule; C:axon; C:cytoplasm; C:mitotic spindle; C:mitotic spindle midzone; C:spindle midzone;, F:microtubule binding;, P:mitotic cytokinesis; P:mitotic spindle assembly; P:regulation of mitotic centrosome separation; P:regulation of mitotic cytokinesis; P:regulation of mitotic spindle organization; scaffold11 indexed_genome mRNA 2494810 2495587 . - . ID=transcript_2812;Q8TBY0 B3KWU8 B4DZ27,Probable RNA-binding protein 46,Cancer/testis antigen 68;RNA-binding motif protein 46;, PF00076;, GO:0005634;GO:0003729;GO:0003723;GO:0048255;GO:0001829;, C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA stabilization; P:trophectodermal cell differentiation; scaffold11 indexed_genome mRNA 2593844 2602394 . - . ID=transcript_2813;O95237 A8K983 Q8N716,Lecithin retinol acyltransferase {ECO:0000305},Phosphatidylcholine--retinol O-acyltransferase;, PF04970;, GO:0005783;GO:0005789;GO:0016021;GO:0005771;GO:0048471;GO:0005791;GO:0102279;GO:0047173;GO:0001972;GO:0019841;GO:0016746;GO:1990830;GO:0032370;GO:0009617;GO:0032526;GO:0033189;GO:0001523;GO:0042572;GO:0007601;GO:0006776;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:multivesicular body; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum;, F:lecithin:11-cis retinol acyltransferase activity; F:phosphatidylcholine-retinol O-acyltransferase activity; F:retinoic acid binding; F:retinol binding; F:transferase activity, transferring acyl groups;, P:cellular response to leukemia inhibitory factor; P:positive regulation of lipid transport; P:response to bacterium; P:response to retinoic acid; P:response to vitamin A; P:retinoid metabolic process; P:retinol metabolic process; P:visual perception; P:vitamin A metabolic process;|O95237 A8K983 Q8N716,Lecithin retinol acyltransferase {ECO:0000305},Phosphatidylcholine--retinol O-acyltransferase;, PF04970;, GO:0005783;GO:0005789;GO:0016021;GO:0005771;GO:0048471;GO:0005791;GO:0102279;GO:0047173;GO:0001972;GO:0019841;GO:0016746;GO:1990830;GO:0032370;GO:0009617;GO:0032526;GO:0033189;GO:0001523;GO:0042572;GO:0007601;GO:0006776;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:multivesicular body; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum;, F:lecithin:11-cis retinol acyltransferase activity; F:phosphatidylcholine-retinol O-acyltransferase activity; F:retinoic acid binding; F:retinol binding; F:transferase activity, transferring acyl groups;, P:cellular response to leukemia inhibitory factor; P:positive regulation of lipid transport; P:response to bacterium; P:response to retinoic acid; P:response to vitamin A; P:retinoid metabolic process; P:retinol metabolic process; P:visual perception; P:vitamin A metabolic process; scaffold11 indexed_genome mRNA 2772485 2780688 . + . ID=transcript_2814;Q9UCF3,Fibrinogen gamma chain,, PF08702;PF00147;, GO:0072562;GO:0009986;GO:0062023;GO:0005788;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0050839;GO:0005201;GO:0046872;GO:0005102;GO:0005198;GO:0007596;GO:0072378;GO:0007160;GO:0044267;GO:0034622;GO:0030198;GO:0042730;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0043687;GO:0051258;GO:0009306;GO:0051592;GO:0002224;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen;, F:cell adhesion molecule binding; F:extracellular matrix structural constituent; F:metal ion binding; F:signaling receptor binding; F:structural molecule activity;, P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cell-matrix adhesion; P:cellular protein metabolic process; P:cellular protein-containing complex assembly; P:extracellular matrix organization; P:fibrinolysis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:post-translational protein modification; P:protein polymerization; P:protein secretion; P:response to calcium ion; P:toll-like receptor signaling pathway;|Q9UCF3,Fibrinogen gamma chain,, PF08702;PF00147;, GO:0072562;GO:0009986;GO:0062023;GO:0005788;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0050839;GO:0005201;GO:0046872;GO:0005102;GO:0005198;GO:0007596;GO:0072378;GO:0007160;GO:0044267;GO:0034622;GO:0030198;GO:0042730;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0043687;GO:0051258;GO:0009306;GO:0051592;GO:0002224;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen;, F:cell adhesion molecule binding; F:extracellular matrix structural constituent; F:metal ion binding; F:signaling receptor binding; F:structural molecule activity;, P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cell-matrix adhesion; P:cellular protein metabolic process; P:cellular protein-containing complex assembly; P:extracellular matrix organization; P:fibrinolysis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:post-translational protein modification; P:protein polymerization; P:protein secretion; P:response to calcium ion; P:toll-like receptor signaling pathway;|Q9UCF3,Fibrinogen gamma chain,, PF08702;PF00147;, GO:0072562;GO:0009986;GO:0062023;GO:0005788;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0050839;GO:0005201;GO:0046872;GO:0005102;GO:0005198;GO:0007596;GO:0072378;GO:0007160;GO:0044267;GO:0034622;GO:0030198;GO:0042730;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0043687;GO:0051258;GO:0009306;GO:0051592;GO:0002224;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen;, F:cell adhesion molecule binding; F:extracellular matrix structural constituent; F:metal ion binding; F:signaling receptor binding; F:structural molecule activity;, P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cell-matrix adhesion; P:cellular protein metabolic process; P:cellular protein-containing complex assembly; P:extracellular matrix organization; P:fibrinolysis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:post-translational protein modification; P:protein polymerization; P:protein secretion; P:response to calcium ion; P:toll-like receptor signaling pathway;|Q9UCF3,Fibrinogen gamma chain,, PF08702;PF00147;, GO:0072562;GO:0009986;GO:0062023;GO:0005788;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0050839;GO:0005201;GO:0046872;GO:0005102;GO:0005198;GO:0007596;GO:0072378;GO:0007160;GO:0044267;GO:0034622;GO:0030198;GO:0042730;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0043687;GO:0051258;GO:0009306;GO:0051592;GO:0002224;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen;, F:cell adhesion molecule binding; F:extracellular matrix structural constituent; F:metal ion binding; F:signaling receptor binding; F:structural molecule activity;, P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cell-matrix adhesion; P:cellular protein metabolic process; P:cellular protein-containing complex assembly; P:extracellular matrix organization; P:fibrinolysis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:post-translational protein modification; P:protein polymerization; P:protein secretion; P:response to calcium ion; P:toll-like receptor signaling pathway;|Q9UCF3,Fibrinogen gamma chain,, PF08702;PF00147;, GO:0072562;GO:0009986;GO:0062023;GO:0005788;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0050839;GO:0005201;GO:0046872;GO:0005102;GO:0005198;GO:0007596;GO:0072378;GO:0007160;GO:0044267;GO:0034622;GO:0030198;GO:0042730;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0043687;GO:0051258;GO:0009306;GO:0051592;GO:0002224;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen;, F:cell adhesion molecule binding; F:extracellular matrix structural constituent; F:metal ion binding; F:signaling receptor binding; F:structural molecule activity;, P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cell-matrix adhesion; P:cellular protein metabolic process; P:cellular protein-containing complex assembly; P:extracellular matrix organization; P:fibrinolysis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:post-translational protein modification; P:protein polymerization; P:protein secretion; P:response to calcium ion; P:toll-like receptor signaling pathway;|Q9UCF3,Fibrinogen gamma chain,, PF08702;PF00147;, GO:0072562;GO:0009986;GO:0062023;GO:0005788;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0050839;GO:0005201;GO:0046872;GO:0005102;GO:0005198;GO:0007596;GO:0072378;GO:0007160;GO:0044267;GO:0034622;GO:0030198;GO:0042730;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0043687;GO:0051258;GO:0009306;GO:0051592;GO:0002224;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen;, F:cell adhesion molecule binding; F:extracellular matrix structural constituent; F:metal ion binding; F:signaling receptor binding; F:structural molecule activity;, P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cell-matrix adhesion; P:cellular protein metabolic process; P:cellular protein-containing complex assembly; P:extracellular matrix organization; P:fibrinolysis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:post-translational protein modification; P:protein polymerization; P:protein secretion; P:response to calcium ion; P:toll-like receptor signaling pathway; scaffold11 indexed_genome mRNA 2797713 2803165 . + . ID=transcript_2815;P02671 A8K3E4 D3DP14 D3DP15 Q4QQH7 Q9BX62 Q9UCH2,Fibrinogen alpha chain,, PF08702;PF12160;PF00147;, GO:0072562;GO:0005938;GO:0009986;GO:0062023;GO:0005788;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0045202;GO:0005201;GO:0046872;GO:0005102;GO:0005198;GO:0002250;GO:1990000;GO:0007596;GO:0072377;GO:0072378;GO:0007160;GO:0044267;GO:0034622;GO:0030198;GO:0042730;GO:0043152;GO:0045087;GO:2000261;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0043687;GO:0051258;GO:0065003;GO:0051592;GO:0002224;, C:blood microparticle; C:cell cortex; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen; C:synapse;, F:extracellular matrix structural constituent; F:metal ion binding; F:signaling receptor binding; F:structural molecule activity;, P:adaptive immune response; P:amyloid fibril formation; P:blood coagulation; P:blood coagulation, common pathway; P:blood coagulation, fibrin clot formation; P:cell-matrix adhesion; P:cellular protein metabolic process; P:cellular protein-containing complex assembly; P:extracellular matrix organization; P:fibrinolysis; P:induction of bacterial agglutination; P:innate immune response; P:negative regulation of blood coagulation, common pathway; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:post-translational protein modification; P:protein polymerization; P:protein-containing complex assembly; P:response to calcium ion; P:toll-like receptor signaling pathway; scaffold11 indexed_genome mRNA 2822621 2838356 . - . ID=transcript_2816;P02675 A0JLR9 B2R7G3 Q32Q65 Q3KPF2,Fibrinogen beta chain,, PF08702;PF00147;, GO:0072562;GO:0005938;GO:0009986;GO:0062023;GO:0005783;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0045202;GO:0051087;GO:0005201;GO:0005102;GO:0005198;GO:0002250;GO:0007596;GO:0072378;GO:0007155;GO:0007160;GO:0034622;GO:0071347;GO:0044320;GO:0030198;GO:0042730;GO:0043152;GO:0045087;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0051258;GO:0051592;GO:0002224;, C:blood microparticle; C:cell cortex; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen; C:synapse;, F:chaperone binding; F:extracellular matrix structural constituent; F:signaling receptor binding; F:structural molecule activity;, P:adaptive immune response; P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cell adhesion; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:cellular response to interleukin-1; P:cellular response to leptin stimulus; P:extracellular matrix organization; P:fibrinolysis; P:induction of bacterial agglutination; P:innate immune response; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:protein polymerization; P:response to calcium ion; P:toll-like receptor signaling pathway;|P02675 A0JLR9 B2R7G3 Q32Q65 Q3KPF2,Fibrinogen beta chain,, PF08702;PF00147;, GO:0072562;GO:0005938;GO:0009986;GO:0062023;GO:0005783;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0045202;GO:0051087;GO:0005201;GO:0005102;GO:0005198;GO:0002250;GO:0007596;GO:0072378;GO:0007155;GO:0007160;GO:0034622;GO:0071347;GO:0044320;GO:0030198;GO:0042730;GO:0043152;GO:0045087;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0051258;GO:0051592;GO:0002224;, C:blood microparticle; C:cell cortex; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen; C:synapse;, F:chaperone binding; F:extracellular matrix structural constituent; F:signaling receptor binding; F:structural molecule activity;, P:adaptive immune response; P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cell adhesion; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:cellular response to interleukin-1; P:cellular response to leptin stimulus; P:extracellular matrix organization; P:fibrinolysis; P:induction of bacterial agglutination; P:innate immune response; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:protein polymerization; P:response to calcium ion; P:toll-like receptor signaling pathway;|P02675 A0JLR9 B2R7G3 Q32Q65 Q3KPF2,Fibrinogen beta chain,, PF08702;PF00147;, GO:0072562;GO:0005938;GO:0009986;GO:0062023;GO:0005783;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0045202;GO:0051087;GO:0005201;GO:0005102;GO:0005198;GO:0002250;GO:0007596;GO:0072378;GO:0007155;GO:0007160;GO:0034622;GO:0071347;GO:0044320;GO:0030198;GO:0042730;GO:0043152;GO:0045087;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0051258;GO:0051592;GO:0002224;, C:blood microparticle; C:cell cortex; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen; C:synapse;, F:chaperone binding; F:extracellular matrix structural constituent; F:signaling receptor binding; F:structural molecule activity;, P:adaptive immune response; P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cell adhesion; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:cellular response to interleukin-1; P:cellular response to leptin stimulus; P:extracellular matrix organization; P:fibrinolysis; P:induction of bacterial agglutination; P:innate immune response; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:protein polymerization; P:response to calcium ion; P:toll-like receptor signaling pathway;|P02675 A0JLR9 B2R7G3 Q32Q65 Q3KPF2,Fibrinogen beta chain,, PF08702;PF00147;, GO:0072562;GO:0005938;GO:0009986;GO:0062023;GO:0005783;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005577;GO:0005886;GO:0031091;GO:0031093;GO:0045202;GO:0051087;GO:0005201;GO:0005102;GO:0005198;GO:0002250;GO:0007596;GO:0072378;GO:0007155;GO:0007160;GO:0034622;GO:0071347;GO:0044320;GO:0030198;GO:0042730;GO:0043152;GO:0045087;GO:2000352;GO:1902042;GO:0031639;GO:0070527;GO:0002576;GO:0070374;GO:0045921;GO:0034116;GO:0090277;GO:0050714;GO:1900026;GO:0045907;GO:0051258;GO:0051592;GO:0002224;, C:blood microparticle; C:cell cortex; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:fibrinogen complex; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen; C:synapse;, F:chaperone binding; F:extracellular matrix structural constituent; F:signaling receptor binding; F:structural molecule activity;, P:adaptive immune response; P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cell adhesion; P:cell-matrix adhesion; P:cellular protein-containing complex assembly; P:cellular response to interleukin-1; P:cellular response to leptin stimulus; P:extracellular matrix organization; P:fibrinolysis; P:induction of bacterial agglutination; P:innate immune response; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:plasminogen activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of peptide hormone secretion; P:positive regulation of protein secretion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vasoconstriction; P:protein polymerization; P:response to calcium ion; P:toll-like receptor signaling pathway; scaffold11 indexed_genome mRNA 2839083 2855550 . + . ID=transcript_2817;O43660 B3KMK4 Q3KQY5 Q8WUD8,Pleiotropic regulator 1,, PF00400;, GO:0071013;GO:0080008;GO:0001650;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0000974;GO:0071007;GO:0000398;GO:1900087;GO:0034504;, C:catalytic step 2 spliceosome; C:Cul4-RING E3 ubiquitin ligase complex; C:fibrillar center; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:U2-type catalytic step 2 spliceosome;, , P:mRNA splicing, via spliceosome; P:positive regulation of G1/S transition of mitotic cell cycle; P:protein localization to nucleus;|O43660 B3KMK4 Q3KQY5 Q8WUD8,Pleiotropic regulator 1,, PF00400;, GO:0071013;GO:0080008;GO:0001650;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0000974;GO:0071007;GO:0000398;GO:1900087;GO:0034504;, C:catalytic step 2 spliceosome; C:Cul4-RING E3 ubiquitin ligase complex; C:fibrillar center; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:U2-type catalytic step 2 spliceosome;, , P:mRNA splicing, via spliceosome; P:positive regulation of G1/S transition of mitotic cell cycle; P:protein localization to nucleus; scaffold11 indexed_genome mRNA 3703818 3712758 . + . ID=transcript_2818;Q96HF1 B3KQR2 O14778 Q9HAP5,Secreted frizzled-related protein 2,Secreted apoptosis-related protein 1;, PF01392;PF01759;, GO:0062023;GO:0005615;GO:0061133;GO:0001968;GO:0005178;GO:0048018;GO:0017147;GO:0006915;GO:0060349;GO:0001569;GO:0060070;GO:0003214;GO:0007267;GO:0031668;GO:0071481;GO:0002063;GO:0030199;GO:0060028;GO:0048546;GO:0042733;GO:0071425;GO:0008584;GO:0030514;GO:0090090;GO:0010667;GO:0030308;GO:0030336;GO:0008285;GO:0043154;GO:0061185;GO:0050680;GO:0010719;GO:1902042;GO:0010629;GO:1902230;GO:0043508;GO:0042662;GO:0050732;GO:2000041;GO:0045892;GO:0030178;GO:0003151;GO:0090179;GO:0045766;GO:0043065;GO:0090263;GO:0033630;GO:0030307;GO:0008284;GO:0045600;GO:0045669;GO:0033138;GO:0045944;GO:0036342;GO:1904956;GO:0010975;GO:2000035;GO:0042493;GO:0007584;GO:0061056;GO:0090244;, C:collagen-containing extracellular matrix; C:extracellular space;, F:endopeptidase activator activity; F:fibronectin binding; F:integrin binding; F:receptor ligand activity; F:Wnt-protein binding;, P:apoptotic process; P:bone morphogenesis; P:branching involved in blood vessel morphogenesis; P:canonical Wnt signaling pathway; P:cardiac left ventricle morphogenesis; P:cell-cell signaling; P:cellular response to extracellular stimulus; P:cellular response to X-ray; P:chondrocyte development; P:collagen fibril organization; P:convergent extension involved in axis elongation; P:digestive tract morphogenesis; P:embryonic digit morphogenesis; P:hematopoietic stem cell proliferation; P:male gonad development; P:negative regulation of BMP signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dermatome development; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of gene expression; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of JUN kinase activity; P:negative regulation of mesodermal cell fate specification; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of planar cell polarity pathway involved in axis elongation; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:outflow tract morphogenesis; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:post-anal tail morphogenesis; P:regulation of midbrain dopaminergic neuron differentiation; P:regulation of neuron projection development; P:regulation of stem cell division; P:response to drug; P:response to nutrient; P:sclerotome development; P:Wnt signaling pathway involved in somitogenesis;|Q96HF1 B3KQR2 O14778 Q9HAP5,Secreted frizzled-related protein 2,Secreted apoptosis-related protein 1;, PF01392;PF01759;, GO:0062023;GO:0005615;GO:0061133;GO:0001968;GO:0005178;GO:0048018;GO:0017147;GO:0006915;GO:0060349;GO:0001569;GO:0060070;GO:0003214;GO:0007267;GO:0031668;GO:0071481;GO:0002063;GO:0030199;GO:0060028;GO:0048546;GO:0042733;GO:0071425;GO:0008584;GO:0030514;GO:0090090;GO:0010667;GO:0030308;GO:0030336;GO:0008285;GO:0043154;GO:0061185;GO:0050680;GO:0010719;GO:1902042;GO:0010629;GO:1902230;GO:0043508;GO:0042662;GO:0050732;GO:2000041;GO:0045892;GO:0030178;GO:0003151;GO:0090179;GO:0045766;GO:0043065;GO:0090263;GO:0033630;GO:0030307;GO:0008284;GO:0045600;GO:0045669;GO:0033138;GO:0045944;GO:0036342;GO:1904956;GO:0010975;GO:2000035;GO:0042493;GO:0007584;GO:0061056;GO:0090244;, C:collagen-containing extracellular matrix; C:extracellular space;, F:endopeptidase activator activity; F:fibronectin binding; F:integrin binding; F:receptor ligand activity; F:Wnt-protein binding;, P:apoptotic process; P:bone morphogenesis; P:branching involved in blood vessel morphogenesis; P:canonical Wnt signaling pathway; P:cardiac left ventricle morphogenesis; P:cell-cell signaling; P:cellular response to extracellular stimulus; P:cellular response to X-ray; P:chondrocyte development; P:collagen fibril organization; P:convergent extension involved in axis elongation; P:digestive tract morphogenesis; P:embryonic digit morphogenesis; P:hematopoietic stem cell proliferation; P:male gonad development; P:negative regulation of BMP signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dermatome development; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of gene expression; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of JUN kinase activity; P:negative regulation of mesodermal cell fate specification; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of planar cell polarity pathway involved in axis elongation; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:outflow tract morphogenesis; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:post-anal tail morphogenesis; P:regulation of midbrain dopaminergic neuron differentiation; P:regulation of neuron projection development; P:regulation of stem cell division; P:response to drug; P:response to nutrient; P:sclerotome development; P:Wnt signaling pathway involved in somitogenesis; scaffold11 indexed_genome mRNA 3753695 3802261 . + . ID=transcript_2819;Q8N4F7 C9JL66 Q8NB61,RING finger protein 175,, , GO:0005789;GO:0000139;GO:0016021;GO:0046872;GO:0061630;GO:0030968;GO:0030433;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:endoplasmic reticulum unfolded protein response; P:ubiquitin-dependent ERAD pathway; scaffold11 indexed_genome mRNA 3804975 3808604 . - . ID=transcript_2820;O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00,Toll-like receptor 2,Toll/interleukin-1 receptor-like protein 4;, PF13855;PF01463;PF01582;, GO:0044297;GO:0042995;GO:0009986;GO:0005737;GO:0005794;GO:0005887;GO:0031226;GO:0045121;GO:0030670;GO:0005886;GO:0030667;GO:0035354;GO:0001540;GO:0042802;GO:0001530;GO:0001875;GO:0050135;GO:0061809;GO:0038187;GO:0042834;GO:0044877;GO:0038023;GO:0035325;GO:0004888;GO:0042497;GO:0006915;GO:0001775;GO:0071221;GO:0071726;GO:0071346;GO:0071223;GO:0071727;GO:0032289;GO:0050830;GO:0042496;GO:0042495;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0032613;GO:0007612;GO:0006691;GO:0014005;GO:0001774;GO:0052031;GO:0002755;GO:0008285;GO:0050765;GO:0051964;GO:0043312;GO:0046209;GO:1903974;GO:0032722;GO:0010628;GO:0050729;GO:0032728;GO:0032733;GO:0032735;GO:0032741;GO:0032755;GO:0032757;GO:1904466;GO:0051092;GO:1901224;GO:0051770;GO:0048714;GO:0034123;GO:0045944;GO:0032760;GO:0030177;GO:0070542;GO:0001666;GO:0032868;GO:0032570;GO:0009636;GO:0007165;GO:0034134;GO:0002224;GO:0038123;GO:0038124;, C:cell body; C:cell projection; C:cell surface; C:cytoplasm; C:Golgi apparatus; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:membrane raft; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:Toll-like receptor 1-Toll-like receptor 2 protein complex;, F:amyloid-beta binding; F:identical protein binding; F:lipopolysaccharide binding; F:lipopolysaccharide immune receptor activity; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:pattern recognition receptor activity; F:peptidoglycan binding; F:protein-containing complex binding; F:signaling receptor activity; F:Toll-like receptor binding; F:transmembrane signaling receptor activity; F:triacyl lipopeptide binding;, P:apoptotic process; P:cell activation; P:cellular response to bacterial lipopeptide; P:cellular response to diacyl bacterial lipopeptide; P:cellular response to interferon-gamma; P:cellular response to lipoteichoic acid; P:cellular response to triacyl bacterial lipopeptide; P:central nervous system myelin formation; P:defense response to Gram-positive bacterium; P:detection of diacyl bacterial lipopeptide; P:detection of triacyl bacterial lipopeptide; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-10 production; P:learning; P:leukotriene metabolic process; P:microglia development; P:microglial cell activation; P:modulation by symbiont of host defense response; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of phagocytosis; P:negative regulation of synapse assembly; P:neutrophil degranulation; P:nitric oxide metabolic process; P:positive regulation of cellular response to macrophage colony-stimulating factor stimulus; P:positive regulation of chemokine production; P:positive regulation of gene expression; P:positive regulation of inflammatory response; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-18 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of matrix metallopeptidase secretion; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of toll-like receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of Wnt signaling pathway; P:response to fatty acid; P:response to hypoxia; P:response to insulin; P:response to progesterone; P:response to toxic substance; P:signal transduction; P:toll-like receptor 2 signaling pathway; P:toll-like receptor signaling pathway; P:toll-like receptor TLR1:TLR2 signaling pathway; P:toll-like receptor TLR6:TLR2 signaling pathway; scaffold11 indexed_genome mRNA 3846035 3894119 . - . ID=transcript_2821;A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway;|A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway;|A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway;|A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway;|A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway;|A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway;|A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway;|P51531 B1ALG3 B1ALG4 D3DRH4 D3DRH5,Probable global transcription activator SNF2L2,ATP-dependent helicase SMARCA2;BRG1-associated factor 190B;Protein brahma homolog;SNF2-alpha;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 {ECO:0000312|HGNC:HGNC:11098};, PF07533;PF00439;PF00271;PF07529;PF08880;PF14619;PF00176;, GO:0000785;GO:0045111;GO:0043231;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0005524;GO:0003682;GO:0003677;GO:0008094;GO:0004386;GO:0042393;GO:0070615;GO:0003713;GO:0000976;GO:0043044;GO:0006338;GO:0030308;GO:0008285;GO:0000122;GO:0045892;GO:0007399;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0007286;, C:chromatin; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:histone binding; F:nucleosome-dependent ATPase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatid development;|A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway;|A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway;|A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway; scaffold11 indexed_genome mRNA 3894198 3897194 . - . ID=transcript_2822;A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7,Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146},, PF12371;, GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;, C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway; scaffold11 indexed_genome mRNA 3998114 4004663 . - . ID=transcript_2823;Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1,Tripartite motif-containing protein 2,E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process;|Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1,Tripartite motif-containing protein 2,E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process;|Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1,Tripartite motif-containing protein 2,E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process; scaffold11 indexed_genome mRNA 4006307 4009134 . + . ID=transcript_2824;Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1,Tripartite motif-containing protein 2,E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process; scaffold11 indexed_genome mRNA 4009158 4176876 . - . ID=transcript_2825;Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1,Tripartite motif-containing protein 2,E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process;|Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1,Tripartite motif-containing protein 2,E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process;|Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1,Tripartite motif-containing protein 2,E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process;|Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1,Tripartite motif-containing protein 2,E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process;|Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1,Tripartite motif-containing protein 2,E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process; scaffold11 indexed_genome mRNA 4352770 4388407 . - . ID=transcript_2826;Q9C0D6,FH2 domain-containing protein 1,Inverted formin-1 {ECO:0000303|PubMed:18815276};, PF02181;, GO:0005929;GO:0005881;GO:0005794;GO:0005874;GO:0003779;GO:0008017;GO:0060271;GO:0090161;GO:0043149;, C:cilium; C:cytoplasmic microtubule; C:Golgi apparatus; C:microtubule;, F:actin binding; F:microtubule binding;, P:cilium assembly; P:Golgi ribbon formation; P:stress fiber assembly; scaffold11 indexed_genome mRNA 4405167 4466681 . - . ID=transcript_2827;P53367 B4DS69 Q2M2X4 Q3SYL4 Q9Y2X6,Arfaptin-1,ADP-ribosylation factor-interacting protein 1;, PF06456;, GO:0005829;GO:0000139;GO:0032588;GO:0070273;GO:0005543;GO:0019904;GO:0006886;GO:1905280;GO:0034315;GO:0050708;, C:cytosol; C:Golgi membrane; C:trans-Golgi network membrane;, F:phosphatidylinositol-4-phosphate binding; F:phospholipid binding; F:protein domain specific binding;, P:intracellular protein transport; P:negative regulation of retrograde transport, endosome to Golgi; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of protein secretion;|P53367 B4DS69 Q2M2X4 Q3SYL4 Q9Y2X6,Arfaptin-1,ADP-ribosylation factor-interacting protein 1;, PF06456;, GO:0005829;GO:0000139;GO:0032588;GO:0070273;GO:0005543;GO:0019904;GO:0006886;GO:1905280;GO:0034315;GO:0050708;, C:cytosol; C:Golgi membrane; C:trans-Golgi network membrane;, F:phosphatidylinositol-4-phosphate binding; F:phospholipid binding; F:protein domain specific binding;, P:intracellular protein transport; P:negative regulation of retrograde transport, endosome to Golgi; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of protein secretion; scaffold11 indexed_genome mRNA 4485154 4507620 . - . ID=transcript_2828;P53367 B4DS69 Q2M2X4 Q3SYL4 Q9Y2X6,Arfaptin-1,ADP-ribosylation factor-interacting protein 1;, PF06456;, GO:0005829;GO:0000139;GO:0032588;GO:0070273;GO:0005543;GO:0019904;GO:0006886;GO:1905280;GO:0034315;GO:0050708;, C:cytosol; C:Golgi membrane; C:trans-Golgi network membrane;, F:phosphatidylinositol-4-phosphate binding; F:phospholipid binding; F:protein domain specific binding;, P:intracellular protein transport; P:negative regulation of retrograde transport, endosome to Golgi; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of protein secretion; scaffold11 indexed_genome mRNA 4629969 4680929 . + . ID=transcript_2829;Q6P9G4 Q8WUT7 Q96MQ8,Transmembrane protein 154,, PF15102;, GO:0016021;, C:integral component of membrane; scaffold11 indexed_genome mRNA 4762267 4982976 . - . ID=transcript_2830;Q969H0 B7ZLP9 Q68DR0 Q96A16 Q96LE0 Q96RI2 Q9NUX6,F-box/WD repeat-containing protein 7 {ECO:0000305},Archipelago homolog {ECO:0000303|PubMed:11565033};F-box and WD-40 domain-containing protein 7 {ECO:0000305};F-box protein FBX30 {ECO:0000305|PubMed:10531037};SEL-10 {ECO:0000303|PubMed:12354302};hCdc4 {ECO:0000303|PubMed:11565034};, PF12937;PF00400;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990452;GO:0048471;GO:0032991;GO:0019005;GO:0030332;GO:0042802;GO:0050816;GO:0030674;GO:0043130;GO:0031625;GO:0097027;GO:0006974;GO:0034644;GO:0055088;GO:0030324;GO:0010629;GO:2000346;GO:0045746;GO:2001205;GO:1903026;GO:2000639;GO:0010868;GO:0007219;GO:0045741;GO:0070374;GO:1903378;GO:1901800;GO:1903955;GO:0031398;GO:2000060;GO:0051443;GO:0043687;GO:0043161;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:1903146;GO:1902806;GO:0090049;GO:0042752;GO:0010883;GO:0032880;GO:0048511;GO:0031146;GO:0007062;GO:0010992;GO:0001944;GO:0001570;GO:0016032;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:perinuclear region of cytoplasm; C:protein-containing complex; C:SCF ubiquitin ligase complex;, F:cyclin binding; F:identical protein binding; F:phosphothreonine residue binding; F:protein-macromolecule adaptor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:lipid homeostasis; P:lung development; P:negative regulation of gene expression; P:negative regulation of hepatocyte proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of osteoclast development; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of SREBP signaling pathway; P:negative regulation of triglyceride biosynthetic process; P:Notch signaling pathway; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle G1/S phase transition; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of circadian rhythm; P:regulation of lipid storage; P:regulation of protein localization; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:sister chromatid cohesion; P:ubiquitin recycling; P:vasculature development; P:vasculogenesis; P:viral process;|Q969H0 B7ZLP9 Q68DR0 Q96A16 Q96LE0 Q96RI2 Q9NUX6,F-box/WD repeat-containing protein 7 {ECO:0000305},Archipelago homolog {ECO:0000303|PubMed:11565033};F-box and WD-40 domain-containing protein 7 {ECO:0000305};F-box protein FBX30 {ECO:0000305|PubMed:10531037};SEL-10 {ECO:0000303|PubMed:12354302};hCdc4 {ECO:0000303|PubMed:11565034};, PF12937;PF00400;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990452;GO:0048471;GO:0032991;GO:0019005;GO:0030332;GO:0042802;GO:0050816;GO:0030674;GO:0043130;GO:0031625;GO:0097027;GO:0006974;GO:0034644;GO:0055088;GO:0030324;GO:0010629;GO:2000346;GO:0045746;GO:2001205;GO:1903026;GO:2000639;GO:0010868;GO:0007219;GO:0045741;GO:0070374;GO:1903378;GO:1901800;GO:1903955;GO:0031398;GO:2000060;GO:0051443;GO:0043687;GO:0043161;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:1903146;GO:1902806;GO:0090049;GO:0042752;GO:0010883;GO:0032880;GO:0048511;GO:0031146;GO:0007062;GO:0010992;GO:0001944;GO:0001570;GO:0016032;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:perinuclear region of cytoplasm; C:protein-containing complex; C:SCF ubiquitin ligase complex;, F:cyclin binding; F:identical protein binding; F:phosphothreonine residue binding; F:protein-macromolecule adaptor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:lipid homeostasis; P:lung development; P:negative regulation of gene expression; P:negative regulation of hepatocyte proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of osteoclast development; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of SREBP signaling pathway; P:negative regulation of triglyceride biosynthetic process; P:Notch signaling pathway; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle G1/S phase transition; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of circadian rhythm; P:regulation of lipid storage; P:regulation of protein localization; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:sister chromatid cohesion; P:ubiquitin recycling; P:vasculature development; P:vasculogenesis; P:viral process;|Q969H0 B7ZLP9 Q68DR0 Q96A16 Q96LE0 Q96RI2 Q9NUX6,F-box/WD repeat-containing protein 7 {ECO:0000305},Archipelago homolog {ECO:0000303|PubMed:11565033};F-box and WD-40 domain-containing protein 7 {ECO:0000305};F-box protein FBX30 {ECO:0000305|PubMed:10531037};SEL-10 {ECO:0000303|PubMed:12354302};hCdc4 {ECO:0000303|PubMed:11565034};, PF12937;PF00400;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990452;GO:0048471;GO:0032991;GO:0019005;GO:0030332;GO:0042802;GO:0050816;GO:0030674;GO:0043130;GO:0031625;GO:0097027;GO:0006974;GO:0034644;GO:0055088;GO:0030324;GO:0010629;GO:2000346;GO:0045746;GO:2001205;GO:1903026;GO:2000639;GO:0010868;GO:0007219;GO:0045741;GO:0070374;GO:1903378;GO:1901800;GO:1903955;GO:0031398;GO:2000060;GO:0051443;GO:0043687;GO:0043161;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:1903146;GO:1902806;GO:0090049;GO:0042752;GO:0010883;GO:0032880;GO:0048511;GO:0031146;GO:0007062;GO:0010992;GO:0001944;GO:0001570;GO:0016032;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:perinuclear region of cytoplasm; C:protein-containing complex; C:SCF ubiquitin ligase complex;, F:cyclin binding; F:identical protein binding; F:phosphothreonine residue binding; F:protein-macromolecule adaptor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:lipid homeostasis; P:lung development; P:negative regulation of gene expression; P:negative regulation of hepatocyte proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of osteoclast development; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of SREBP signaling pathway; P:negative regulation of triglyceride biosynthetic process; P:Notch signaling pathway; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle G1/S phase transition; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of circadian rhythm; P:regulation of lipid storage; P:regulation of protein localization; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:sister chromatid cohesion; P:ubiquitin recycling; P:vasculature development; P:vasculogenesis; P:viral process; scaffold11 indexed_genome mRNA 4983008 4996036 . + . ID=transcript_2831;Q969H0 B7ZLP9 Q68DR0 Q96A16 Q96LE0 Q96RI2 Q9NUX6,F-box/WD repeat-containing protein 7 {ECO:0000305},Archipelago homolog {ECO:0000303|PubMed:11565033};F-box and WD-40 domain-containing protein 7 {ECO:0000305};F-box protein FBX30 {ECO:0000305|PubMed:10531037};SEL-10 {ECO:0000303|PubMed:12354302};hCdc4 {ECO:0000303|PubMed:11565034};, PF12937;PF00400;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990452;GO:0048471;GO:0032991;GO:0019005;GO:0030332;GO:0042802;GO:0050816;GO:0030674;GO:0043130;GO:0031625;GO:0097027;GO:0006974;GO:0034644;GO:0055088;GO:0030324;GO:0010629;GO:2000346;GO:0045746;GO:2001205;GO:1903026;GO:2000639;GO:0010868;GO:0007219;GO:0045741;GO:0070374;GO:1903378;GO:1901800;GO:1903955;GO:0031398;GO:2000060;GO:0051443;GO:0043687;GO:0043161;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:1903146;GO:1902806;GO:0090049;GO:0042752;GO:0010883;GO:0032880;GO:0048511;GO:0031146;GO:0007062;GO:0010992;GO:0001944;GO:0001570;GO:0016032;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:perinuclear region of cytoplasm; C:protein-containing complex; C:SCF ubiquitin ligase complex;, F:cyclin binding; F:identical protein binding; F:phosphothreonine residue binding; F:protein-macromolecule adaptor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:lipid homeostasis; P:lung development; P:negative regulation of gene expression; P:negative regulation of hepatocyte proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of osteoclast development; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of SREBP signaling pathway; P:negative regulation of triglyceride biosynthetic process; P:Notch signaling pathway; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle G1/S phase transition; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of circadian rhythm; P:regulation of lipid storage; P:regulation of protein localization; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:sister chromatid cohesion; P:ubiquitin recycling; P:vasculature development; P:vasculogenesis; P:viral process;|Q969H0 B7ZLP9 Q68DR0 Q96A16 Q96LE0 Q96RI2 Q9NUX6,F-box/WD repeat-containing protein 7 {ECO:0000305},Archipelago homolog {ECO:0000303|PubMed:11565033};F-box and WD-40 domain-containing protein 7 {ECO:0000305};F-box protein FBX30 {ECO:0000305|PubMed:10531037};SEL-10 {ECO:0000303|PubMed:12354302};hCdc4 {ECO:0000303|PubMed:11565034};, PF12937;PF00400;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990452;GO:0048471;GO:0032991;GO:0019005;GO:0030332;GO:0042802;GO:0050816;GO:0030674;GO:0043130;GO:0031625;GO:0097027;GO:0006974;GO:0034644;GO:0055088;GO:0030324;GO:0010629;GO:2000346;GO:0045746;GO:2001205;GO:1903026;GO:2000639;GO:0010868;GO:0007219;GO:0045741;GO:0070374;GO:1903378;GO:1901800;GO:1903955;GO:0031398;GO:2000060;GO:0051443;GO:0043687;GO:0043161;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:1903146;GO:1902806;GO:0090049;GO:0042752;GO:0010883;GO:0032880;GO:0048511;GO:0031146;GO:0007062;GO:0010992;GO:0001944;GO:0001570;GO:0016032;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:perinuclear region of cytoplasm; C:protein-containing complex; C:SCF ubiquitin ligase complex;, F:cyclin binding; F:identical protein binding; F:phosphothreonine residue binding; F:protein-macromolecule adaptor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:lipid homeostasis; P:lung development; P:negative regulation of gene expression; P:negative regulation of hepatocyte proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of osteoclast development; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of SREBP signaling pathway; P:negative regulation of triglyceride biosynthetic process; P:Notch signaling pathway; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle G1/S phase transition; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of circadian rhythm; P:regulation of lipid storage; P:regulation of protein localization; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:sister chromatid cohesion; P:ubiquitin recycling; P:vasculature development; P:vasculogenesis; P:viral process;|Q969H0 B7ZLP9 Q68DR0 Q96A16 Q96LE0 Q96RI2 Q9NUX6,F-box/WD repeat-containing protein 7 {ECO:0000305},Archipelago homolog {ECO:0000303|PubMed:11565033};F-box and WD-40 domain-containing protein 7 {ECO:0000305};F-box protein FBX30 {ECO:0000305|PubMed:10531037};SEL-10 {ECO:0000303|PubMed:12354302};hCdc4 {ECO:0000303|PubMed:11565034};, PF12937;PF00400;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990452;GO:0048471;GO:0032991;GO:0019005;GO:0030332;GO:0042802;GO:0050816;GO:0030674;GO:0043130;GO:0031625;GO:0097027;GO:0006974;GO:0034644;GO:0055088;GO:0030324;GO:0010629;GO:2000346;GO:0045746;GO:2001205;GO:1903026;GO:2000639;GO:0010868;GO:0007219;GO:0045741;GO:0070374;GO:1903378;GO:1901800;GO:1903955;GO:0031398;GO:2000060;GO:0051443;GO:0043687;GO:0043161;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:1903146;GO:1902806;GO:0090049;GO:0042752;GO:0010883;GO:0032880;GO:0048511;GO:0031146;GO:0007062;GO:0010992;GO:0001944;GO:0001570;GO:0016032;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:perinuclear region of cytoplasm; C:protein-containing complex; C:SCF ubiquitin ligase complex;, F:cyclin binding; F:identical protein binding; F:phosphothreonine residue binding; F:protein-macromolecule adaptor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:lipid homeostasis; P:lung development; P:negative regulation of gene expression; P:negative regulation of hepatocyte proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of osteoclast development; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of SREBP signaling pathway; P:negative regulation of triglyceride biosynthetic process; P:Notch signaling pathway; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle G1/S phase transition; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of circadian rhythm; P:regulation of lipid storage; P:regulation of protein localization; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:sister chromatid cohesion; P:ubiquitin recycling; P:vasculature development; P:vasculogenesis; P:viral process;|Q969H0 B7ZLP9 Q68DR0 Q96A16 Q96LE0 Q96RI2 Q9NUX6,F-box/WD repeat-containing protein 7 {ECO:0000305},Archipelago homolog {ECO:0000303|PubMed:11565033};F-box and WD-40 domain-containing protein 7 {ECO:0000305};F-box protein FBX30 {ECO:0000305|PubMed:10531037};SEL-10 {ECO:0000303|PubMed:12354302};hCdc4 {ECO:0000303|PubMed:11565034};, PF12937;PF00400;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990452;GO:0048471;GO:0032991;GO:0019005;GO:0030332;GO:0042802;GO:0050816;GO:0030674;GO:0043130;GO:0031625;GO:0097027;GO:0006974;GO:0034644;GO:0055088;GO:0030324;GO:0010629;GO:2000346;GO:0045746;GO:2001205;GO:1903026;GO:2000639;GO:0010868;GO:0007219;GO:0045741;GO:0070374;GO:1903378;GO:1901800;GO:1903955;GO:0031398;GO:2000060;GO:0051443;GO:0043687;GO:0043161;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:1903146;GO:1902806;GO:0090049;GO:0042752;GO:0010883;GO:0032880;GO:0048511;GO:0031146;GO:0007062;GO:0010992;GO:0001944;GO:0001570;GO:0016032;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:perinuclear region of cytoplasm; C:protein-containing complex; C:SCF ubiquitin ligase complex;, F:cyclin binding; F:identical protein binding; F:phosphothreonine residue binding; F:protein-macromolecule adaptor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:lipid homeostasis; P:lung development; P:negative regulation of gene expression; P:negative regulation of hepatocyte proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of osteoclast development; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of SREBP signaling pathway; P:negative regulation of triglyceride biosynthetic process; P:Notch signaling pathway; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle G1/S phase transition; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of circadian rhythm; P:regulation of lipid storage; P:regulation of protein localization; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:sister chromatid cohesion; P:ubiquitin recycling; P:vasculature development; P:vasculogenesis; P:viral process;|Q969H0 B7ZLP9 Q68DR0 Q96A16 Q96LE0 Q96RI2 Q9NUX6,F-box/WD repeat-containing protein 7 {ECO:0000305},Archipelago homolog {ECO:0000303|PubMed:11565033};F-box and WD-40 domain-containing protein 7 {ECO:0000305};F-box protein FBX30 {ECO:0000305|PubMed:10531037};SEL-10 {ECO:0000303|PubMed:12354302};hCdc4 {ECO:0000303|PubMed:11565034};, PF12937;PF00400;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990452;GO:0048471;GO:0032991;GO:0019005;GO:0030332;GO:0042802;GO:0050816;GO:0030674;GO:0043130;GO:0031625;GO:0097027;GO:0006974;GO:0034644;GO:0055088;GO:0030324;GO:0010629;GO:2000346;GO:0045746;GO:2001205;GO:1903026;GO:2000639;GO:0010868;GO:0007219;GO:0045741;GO:0070374;GO:1903378;GO:1901800;GO:1903955;GO:0031398;GO:2000060;GO:0051443;GO:0043687;GO:0043161;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:1903146;GO:1902806;GO:0090049;GO:0042752;GO:0010883;GO:0032880;GO:0048511;GO:0031146;GO:0007062;GO:0010992;GO:0001944;GO:0001570;GO:0016032;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:perinuclear region of cytoplasm; C:protein-containing complex; C:SCF ubiquitin ligase complex;, F:cyclin binding; F:identical protein binding; F:phosphothreonine residue binding; F:protein-macromolecule adaptor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:lipid homeostasis; P:lung development; P:negative regulation of gene expression; P:negative regulation of hepatocyte proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of osteoclast development; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of SREBP signaling pathway; P:negative regulation of triglyceride biosynthetic process; P:Notch signaling pathway; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle G1/S phase transition; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of circadian rhythm; P:regulation of lipid storage; P:regulation of protein localization; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:sister chromatid cohesion; P:ubiquitin recycling; P:vasculature development; P:vasculogenesis; P:viral process;|Q969H0 B7ZLP9 Q68DR0 Q96A16 Q96LE0 Q96RI2 Q9NUX6,F-box/WD repeat-containing protein 7 {ECO:0000305},Archipelago homolog {ECO:0000303|PubMed:11565033};F-box and WD-40 domain-containing protein 7 {ECO:0000305};F-box protein FBX30 {ECO:0000305|PubMed:10531037};SEL-10 {ECO:0000303|PubMed:12354302};hCdc4 {ECO:0000303|PubMed:11565034};, PF12937;PF00400;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990452;GO:0048471;GO:0032991;GO:0019005;GO:0030332;GO:0042802;GO:0050816;GO:0030674;GO:0043130;GO:0031625;GO:0097027;GO:0006974;GO:0034644;GO:0055088;GO:0030324;GO:0010629;GO:2000346;GO:0045746;GO:2001205;GO:1903026;GO:2000639;GO:0010868;GO:0007219;GO:0045741;GO:0070374;GO:1903378;GO:1901800;GO:1903955;GO:0031398;GO:2000060;GO:0051443;GO:0043687;GO:0043161;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:1903146;GO:1902806;GO:0090049;GO:0042752;GO:0010883;GO:0032880;GO:0048511;GO:0031146;GO:0007062;GO:0010992;GO:0001944;GO:0001570;GO:0016032;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:perinuclear region of cytoplasm; C:protein-containing complex; C:SCF ubiquitin ligase complex;, F:cyclin binding; F:identical protein binding; F:phosphothreonine residue binding; F:protein-macromolecule adaptor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:lipid homeostasis; P:lung development; P:negative regulation of gene expression; P:negative regulation of hepatocyte proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of osteoclast development; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of SREBP signaling pathway; P:negative regulation of triglyceride biosynthetic process; P:Notch signaling pathway; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle G1/S phase transition; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of circadian rhythm; P:regulation of lipid storage; P:regulation of protein localization; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:sister chromatid cohesion; P:ubiquitin recycling; P:vasculature development; P:vasculogenesis; P:viral process; scaffold11 indexed_genome mRNA 5618583 5718847 . + . ID=transcript_2832;O75879 Q4W5M8 Q53GP4 Q9P0S6 Q9Y2B8,Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03147},Cytochrome c oxidase assembly factor PET112 homolog;, PF02934;PF02637;, GO:0030956;GO:0005739;GO:0005524;GO:0050567;GO:0070681;GO:0032543;, C:glutamyl-tRNA(Gln) amidotransferase complex; C:mitochondrion;, F:ATP binding; F:glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity;, P:glutaminyl-tRNAGln biosynthesis via transamidation; P:mitochondrial translation;|O75879 Q4W5M8 Q53GP4 Q9P0S6 Q9Y2B8,Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03147},Cytochrome c oxidase assembly factor PET112 homolog;, PF02934;PF02637;, GO:0030956;GO:0005739;GO:0005524;GO:0050567;GO:0070681;GO:0032543;, C:glutamyl-tRNA(Gln) amidotransferase complex; C:mitochondrion;, F:ATP binding; F:glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity;, P:glutaminyl-tRNAGln biosynthesis via transamidation; P:mitochondrial translation;|O75879 Q4W5M8 Q53GP4 Q9P0S6 Q9Y2B8,Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03147},Cytochrome c oxidase assembly factor PET112 homolog;, PF02934;PF02637;, GO:0030956;GO:0005739;GO:0005524;GO:0050567;GO:0070681;GO:0032543;, C:glutamyl-tRNA(Gln) amidotransferase complex; C:mitochondrion;, F:ATP binding; F:glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity;, P:glutaminyl-tRNAGln biosynthesis via transamidation; P:mitochondrial translation; scaffold11 indexed_genome mRNA 5718883 6033007 . - . ID=transcript_2833;Q05DH4 Q6ZUS2,Protein FAM160A1,, PF10257;|Q05DH4 Q6ZUS2,Protein FAM160A1,, PF10257; scaffold11 indexed_genome mRNA 6263410 6314350 . + . ID=transcript_2834;Q5HYK7 B7Z296 Q08EK1 Q32N10 Q5U3B8 Q86XB3 Q8N5E7 Q9UFC8,SH3 domain-containing protein 19,ADAM-binding protein Eve-1;EEN-binding protein;, PF00018;PF07653;PF14604;, GO:0005829;GO:0005654;GO:0005886;GO:0070064;GO:0007010;GO:0051044;GO:0006892;GO:0022604;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:proline-rich region binding;, P:cytoskeleton organization; P:positive regulation of membrane protein ectodomain proteolysis; P:post-Golgi vesicle-mediated transport; P:regulation of cell morphogenesis;|Q5HYK7 B7Z296 Q08EK1 Q32N10 Q5U3B8 Q86XB3 Q8N5E7 Q9UFC8,SH3 domain-containing protein 19,ADAM-binding protein Eve-1;EEN-binding protein;, PF00018;PF07653;PF14604;, GO:0005829;GO:0005654;GO:0005886;GO:0070064;GO:0007010;GO:0051044;GO:0006892;GO:0022604;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:proline-rich region binding;, P:cytoskeleton organization; P:positive regulation of membrane protein ectodomain proteolysis; P:post-Golgi vesicle-mediated transport; P:regulation of cell morphogenesis; scaffold11 indexed_genome mRNA 6331261 6334275 . + . ID=transcript_2835;P61247 B2R4D4 D3DP05 P33443 P49241,40S ribosomal protein S3a {ECO:0000255|HAMAP-Rule:MF_03122},Small ribosomal subunit protein eS1 {ECO:0000303|PubMed:24524803};v-fos transformation effector protein;, PF01015;, GO:0005737;GO:0005829;GO:0022627;GO:0005783;GO:0070062;GO:0005925;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0048027;GO:0003723;GO:0003735;GO:0030154;GO:0043066;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 5'-UTR binding; F:RNA binding; F:structural constituent of ribosome;, P:cell differentiation; P:negative regulation of apoptotic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P61247 B2R4D4 D3DP05 P33443 P49241,40S ribosomal protein S3a {ECO:0000255|HAMAP-Rule:MF_03122},Small ribosomal subunit protein eS1 {ECO:0000303|PubMed:24524803};v-fos transformation effector protein;, PF01015;, GO:0005737;GO:0005829;GO:0022627;GO:0005783;GO:0070062;GO:0005925;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0048027;GO:0003723;GO:0003735;GO:0030154;GO:0043066;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 5'-UTR binding; F:RNA binding; F:structural constituent of ribosome;, P:cell differentiation; P:negative regulation of apoptotic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold11 indexed_genome mRNA 6414809 7142134 . + . ID=transcript_2836;P50851 Q4W5J4 Q4W5L6 Q8NFQ0 Q9H2U3 Q9H2U4,Lipopolysaccharide-responsive and beige-like anchor protein,Beige-like protein;CDC4-like protein;, PF02138;PF06469;PF15787;PF14844;, GO:0005829;GO:0005783;GO:0005794;GO:0016021;GO:0005764;GO:0016020;GO:0005886;GO:0019901;GO:0008104;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:lysosome; C:membrane; C:plasma membrane;, F:protein kinase binding;, P:protein localization;|Q8WWW0 A8K1E6 Q5SY32 Q8WWV9 Q8WXF4 Q9BT99,Ras association domain-containing protein 5,New ras effector 1;Regulator for cell adhesion and polarization enriched in lymphoid tissues;, PF00130;PF16517;PF00788;, GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0046872;GO:0031267;GO:0006915;GO:0035556;GO:0008285;GO:0031398;GO:0042981;GO:1900180;GO:0007165;, C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:metal ion binding; F:small GTPase binding;, P:apoptotic process; P:intracellular signal transduction; P:negative regulation of cell population proliferation; P:positive regulation of protein ubiquitination; P:regulation of apoptotic process; P:regulation of protein localization to nucleus; P:signal transduction; scaffold11 indexed_genome mRNA 7150018 7331655 . - . ID=transcript_2837;Q8N568 C9J5Q9 Q59GC8 Q8N399,Serine/threonine-protein kinase DCLK2,CaMK-like CREB regulatory kinase 2;Doublecortin domain-containing protein 3B;Doublecortin-like and CAM kinase-like 2;Doublecortin-like kinase 2;, PF03607;PF00069;, GO:0005737;GO:0005856;GO:0005524;GO:0106310;GO:0106311;GO:0035556;GO:0000226;, C:cytoplasm; C:cytoskeleton;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:microtubule cytoskeleton organization;|Q8N568 C9J5Q9 Q59GC8 Q8N399,Serine/threonine-protein kinase DCLK2,CaMK-like CREB regulatory kinase 2;Doublecortin domain-containing protein 3B;Doublecortin-like and CAM kinase-like 2;Doublecortin-like kinase 2;, PF03607;PF00069;, GO:0005737;GO:0005856;GO:0005524;GO:0106310;GO:0106311;GO:0035556;GO:0000226;, C:cytoplasm; C:cytoskeleton;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:microtubule cytoskeleton organization;|Q8N568 C9J5Q9 Q59GC8 Q8N399,Serine/threonine-protein kinase DCLK2,CaMK-like CREB regulatory kinase 2;Doublecortin domain-containing protein 3B;Doublecortin-like and CAM kinase-like 2;Doublecortin-like kinase 2;, PF03607;PF00069;, GO:0005737;GO:0005856;GO:0005524;GO:0106310;GO:0106311;GO:0035556;GO:0000226;, C:cytoplasm; C:cytoskeleton;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:microtubule cytoskeleton organization;|Q8N568 C9J5Q9 Q59GC8 Q8N399,Serine/threonine-protein kinase DCLK2,CaMK-like CREB regulatory kinase 2;Doublecortin domain-containing protein 3B;Doublecortin-like and CAM kinase-like 2;Doublecortin-like kinase 2;, PF03607;PF00069;, GO:0005737;GO:0005856;GO:0005524;GO:0106310;GO:0106311;GO:0035556;GO:0000226;, C:cytoplasm; C:cytoskeleton;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:microtubule cytoskeleton organization; scaffold11 indexed_genome mRNA 9068165 9485075 . + . ID=transcript_2838;P08235 B0ZBF5 B0ZBF7 Q2NKL1 Q96KQ8 Q96KQ9,Mineralocorticoid receptor,Nuclear receptor subfamily 3 group C member 2;, PF00104;PF00105;, GO:0000785;GO:0005829;GO:0005789;GO:0005654;GO:0043235;GO:0003700;GO:0000981;GO:0004879;GO:0000978;GO:1990837;GO:0005496;GO:0003707;GO:0008270;GO:0030518;GO:1901224;GO:0006357;GO:0007165;GO:0006367;, C:chromatin; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:receptor complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:intracellular steroid hormone receptor signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; scaffold11 indexed_genome mRNA 9491745 9769129 . - . ID=transcript_2839;A1A4S6 A1L0S5 Q2VPC4 Q2VPC5 Q96EV3 Q96S75,Rho GTPase-activating protein 10,GTPase regulator associated with focal adhesion kinase 2;Graf-related protein 2;Rho-type GTPase-activating protein 10;, PF00169;PF00620;PF14604;, GO:0005829;GO:0048471;GO:0005886;GO:0005096;GO:0007010;GO:0043066;GO:0051056;GO:0007165;, C:cytosol; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:cytoskeleton organization; P:negative regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold11 indexed_genome mRNA 9922963 9982601 . + . ID=transcript_2840;Q6P2P2 A8KA39 B3KU92 Q6ZR58 Q8N383 Q9BT55 Q9NT98,Protein arginine N-methyltransferase 9,Protein arginine N-methyltransferase 10;, , GO:0005737;GO:0016274;GO:0035241;GO:0035243;GO:0006397;, C:cytoplasm;, F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity;, P:mRNA processing;|Q6P2P2 A8KA39 B3KU92 Q6ZR58 Q8N383 Q9BT55 Q9NT98,Protein arginine N-methyltransferase 9,Protein arginine N-methyltransferase 10;, , GO:0005737;GO:0016274;GO:0035241;GO:0035243;GO:0006397;, C:cytoplasm;, F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity;, P:mRNA processing;|Q6P2P2 A8KA39 B3KU92 Q6ZR58 Q8N383 Q9BT55 Q9NT98,Protein arginine N-methyltransferase 9,Protein arginine N-methyltransferase 10;, , GO:0005737;GO:0016274;GO:0035241;GO:0035243;GO:0006397;, C:cytoplasm;, F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity;, P:mRNA processing;|Q6P2P2 A8KA39 B3KU92 Q6ZR58 Q8N383 Q9BT55 Q9NT98,Protein arginine N-methyltransferase 9,Protein arginine N-methyltransferase 10;, , GO:0005737;GO:0016274;GO:0035241;GO:0035243;GO:0006397;, C:cytoplasm;, F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity;, P:mRNA processing;|Q6P2P2 A8KA39 B3KU92 Q6ZR58 Q8N383 Q9BT55 Q9NT98,Protein arginine N-methyltransferase 9,Protein arginine N-methyltransferase 10;, , GO:0005737;GO:0016274;GO:0035241;GO:0035243;GO:0006397;, C:cytoplasm;, F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity;, P:mRNA processing;|Q9NVA4 D3DP04 Q86X84 Q969I7 Q9NXM2,Transmembrane protein 184C,Transmembrane protein 34;, PF03619;, GO:0016021;, C:integral component of membrane;|Q9NVA4 D3DP04 Q86X84 Q969I7 Q9NXM2,Transmembrane protein 184C,Transmembrane protein 34;, PF03619;, GO:0016021;, C:integral component of membrane; scaffold11 indexed_genome mRNA 10064501 10140255 . - . ID=transcript_2841;Q8TBH2,Endothelin-1 receptor {ECO:0000305},Endothelin receptor type A {ECO:0000312|HGNC:HGNC:3179};, PF00001;, GO:0005887;GO:0005886;GO:0004962;GO:0004435;GO:0007190;GO:0007202;GO:0007193;GO:0014824;GO:0001569;GO:0008283;GO:0048484;GO:0007186;GO:0060322;GO:0007507;GO:0001701;GO:0014032;GO:0007204;GO:0008217;GO:0010827;GO:0007585;GO:0001666;GO:0007165;GO:0006939;GO:0042310;, C:integral component of plasma membrane; C:plasma membrane;, F:endothelin receptor activity; F:phosphatidylinositol phospholipase C activity;, P:activation of adenylate cyclase activity; P:activation of phospholipase C activity; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:artery smooth muscle contraction; P:branching involved in blood vessel morphogenesis; P:cell population proliferation; P:enteric nervous system development; P:G protein-coupled receptor signaling pathway; P:head development; P:heart development; P:in utero embryonic development; P:neural crest cell development; P:positive regulation of cytosolic calcium ion concentration; P:regulation of blood pressure; P:regulation of glucose transmembrane transport; P:respiratory gaseous exchange by respiratory system; P:response to hypoxia; P:signal transduction; P:smooth muscle contraction; P:vasoconstriction; scaffold11 indexed_genome mRNA 10709521 10953788 . + . ID=transcript_2842;Q8NA56 A4GU95 Q9BXB6,Tetratricopeptide repeat protein 29,Protein TBPP2A;Testis development protein NYD-SP14;, , GO:0005737;GO:0005856;GO:0036126;GO:0003341;GO:0044782;, C:cytoplasm; C:cytoskeleton; C:sperm flagellum;, , P:cilium movement; P:cilium organization; scaffold11 indexed_genome mRNA 11106629 11395695 . + . ID=transcript_2843;Q8NBP8 Q9H0M9,Sodium/bile acid cotransporter 7,Na(+)/bile acid cotransporter 7;Solute carrier family 10 member 7;, PF13593;, GO:0005801;GO:0005783;GO:0005789;GO:0005794;GO:0005797;GO:0000139;GO:0016021;GO:0031226;GO:0005886;GO:0005802;GO:0015125;GO:0015293;GO:0060348;GO:0006874;GO:0034436;GO:0048193;GO:0030210;GO:0006814;, C:cis-Golgi network; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi membrane; C:integral component of membrane; C:intrinsic component of plasma membrane; C:plasma membrane; C:trans-Golgi network;, F:bile acid transmembrane transporter activity; F:symporter activity;, P:bone development; P:cellular calcium ion homeostasis; P:glycoprotein transport; P:Golgi vesicle transport; P:heparin biosynthetic process; P:sodium ion transport; scaffold11 indexed_genome mRNA 11420331 11426873 . - . ID=transcript_2844;A0A1B0GV85,Reelin domain-containing protein 1 {ECO:0000305},, PF02014;, GO:0016021;, C:integral component of membrane; scaffold11 indexed_genome mRNA 11426901 11432705 . - . ID=transcript_2845;A0A1B0GV85,Reelin domain-containing protein 1 {ECO:0000305},, PF02014;, GO:0016021;, C:integral component of membrane; scaffold11 indexed_genome mRNA 11456884 11472020 . - . ID=transcript_2846;P62312 Q4W5J5 Q9Y4Y8,U6 snRNA-associated Sm-like protein LSm6,, PF01423;, GO:0005737;GO:0005829;GO:0120115;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0030532;GO:0005732;GO:0071005;GO:0046540;GO:0005688;GO:0046982;GO:0003723;GO:0043928;GO:0030490;GO:0006402;GO:0000398;GO:0008380;GO:0008033;, C:cytoplasm; C:cytosol; C:Lsm2-8 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:small nuclear ribonucleoprotein complex; C:sno(s)RNA-containing ribonucleoprotein complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:protein heterodimerization activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:maturation of SSU-rRNA; P:mRNA catabolic process; P:mRNA splicing, via spliceosome; P:RNA splicing; P:tRNA processing;|P62312 Q4W5J5 Q9Y4Y8,U6 snRNA-associated Sm-like protein LSm6,, PF01423;, GO:0005737;GO:0005829;GO:0120115;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0030532;GO:0005732;GO:0071005;GO:0046540;GO:0005688;GO:0046982;GO:0003723;GO:0043928;GO:0030490;GO:0006402;GO:0000398;GO:0008380;GO:0008033;, C:cytoplasm; C:cytosol; C:Lsm2-8 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:small nuclear ribonucleoprotein complex; C:sno(s)RNA-containing ribonucleoprotein complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:protein heterodimerization activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:maturation of SSU-rRNA; P:mRNA catabolic process; P:mRNA splicing, via spliceosome; P:RNA splicing; P:tRNA processing;|P62312 Q4W5J5 Q9Y4Y8,U6 snRNA-associated Sm-like protein LSm6,, PF01423;, GO:0005737;GO:0005829;GO:0120115;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0030532;GO:0005732;GO:0071005;GO:0046540;GO:0005688;GO:0046982;GO:0003723;GO:0043928;GO:0030490;GO:0006402;GO:0000398;GO:0008380;GO:0008033;, C:cytoplasm; C:cytosol; C:Lsm2-8 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:small nuclear ribonucleoprotein complex; C:sno(s)RNA-containing ribonucleoprotein complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:protein heterodimerization activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:maturation of SSU-rRNA; P:mRNA catabolic process; P:mRNA splicing, via spliceosome; P:RNA splicing; P:tRNA processing; scaffold11 indexed_genome mRNA 11703153 11846862 . + . ID=transcript_2847;Q17R98 B7ZL52 Q7Z4S7 Q8N279,Zinc finger protein 827,, PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression;|Q17R98 B7ZL52 Q7Z4S7 Q8N279,Zinc finger protein 827,, PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression;|Q17R98 B7ZL52 Q7Z4S7 Q8N279,Zinc finger protein 827,, PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold11 indexed_genome mRNA 11848817 11851685 . + . ID=transcript_2848;Q13127 A2RUE0 B9EGJ0 Q12956 Q12957 Q13134 Q59ER1 Q8IWI3,RE1-silencing transcription factor,Neural-restrictive silencer factor;X2 box repressor;, , GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0003700;GO:0001227;GO:0042802;GO:0046872;GO:0000978;GO:0008134;GO:0000976;GO:0060088;GO:0060379;GO:0035690;GO:0071257;GO:0071385;GO:0050910;GO:0070933;GO:0099563;GO:0043922;GO:0032348;GO:2000798;GO:0045955;GO:0008285;GO:2000065;GO:2000706;GO:0010629;GO:0046676;GO:2000740;GO:0050768;GO:0045665;GO:1903204;GO:0000122;GO:2000678;GO:0045892;GO:0050885;GO:0097150;GO:0043065;GO:0043280;GO:0010628;GO:0045666;GO:1903223;GO:1902459;GO:0045944;GO:0045893;GO:0000381;GO:0010468;GO:0045667;GO:1903203;GO:0006355;GO:0001666;GO:0002931;GO:0035019;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:auditory receptor cell stereocilium organization; P:cardiac muscle cell myoblast differentiation; P:cellular response to drug; P:cellular response to electrical stimulus; P:cellular response to glucocorticoid stimulus; P:detection of mechanical stimulus involved in sensory perception of sound; P:histone H4 deacetylation; P:modification of synaptic structure; P:negative regulation by host of viral transcription; P:negative regulation of aldosterone biosynthetic process; P:negative regulation of amniotic stem cell differentiation; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of cell population proliferation; P:negative regulation of cortisol biosynthetic process; P:negative regulation of dense core granule biogenesis; P:negative regulation of gene expression; P:negative regulation of insulin secretion; P:negative regulation of mesenchymal stem cell differentiation; P:negative regulation of neurogenesis; P:negative regulation of neuron differentiation; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:neuromuscular process controlling balance; P:neuronal stem cell population maintenance; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:positive regulation of oxidative stress-induced neuron death; P:positive regulation of stem cell population maintenance; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of osteoblast differentiation; P:regulation of oxidative stress-induced neuron death; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:response to ischemia; P:somatic stem cell population maintenance; scaffold11 indexed_genome mRNA 11919187 11944843 . - . ID=transcript_2849;Q8IVH4 B3KX40 Q495G7,Methylmalonic aciduria type A protein, mitochondrial {ECO:0000305},, , GO:0005737;GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0042802;GO:0042803;GO:0009235;GO:0019626;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:protein homodimerization activity;, P:cobalamin metabolic process; P:short-chain fatty acid catabolic process;|Q8IVH4 B3KX40 Q495G7,Methylmalonic aciduria type A protein, mitochondrial {ECO:0000305},, , GO:0005737;GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0042802;GO:0042803;GO:0009235;GO:0019626;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:protein homodimerization activity;, P:cobalamin metabolic process; P:short-chain fatty acid catabolic process;|Q8IVH4 B3KX40 Q495G7,Methylmalonic aciduria type A protein, mitochondrial {ECO:0000305},, , GO:0005737;GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0042802;GO:0042803;GO:0009235;GO:0019626;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:protein homodimerization activity;, P:cobalamin metabolic process; P:short-chain fatty acid catabolic process; scaffold11 indexed_genome mRNA 12019334 12021023 . + . ID=transcript_2850;Q15797 A8KAJ0 D3DNZ9 Q16636 Q9UFT8,Mothers against decapentaplegic homolog 1,JV4-1;Mad-related protein 1;SMAD family member 1;Transforming growth factor-beta-signaling protein 1;, PF03165;PF03166;, GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0016021;GO:0005637;GO:0005654;GO:0005634;GO:0032991;GO:0071141;GO:0070410;GO:0017151;GO:0001228;GO:0003700;GO:0000981;GO:0070411;GO:0042802;GO:0046872;GO:0070878;GO:0019901;GO:0000978;GO:0009653;GO:0030509;GO:0060348;GO:0060038;GO:0051216;GO:0030154;GO:0071407;GO:0009880;GO:0007276;GO:0030902;GO:0042592;GO:0006954;GO:0000165;GO:0001710;GO:0030901;GO:0030514;GO:0008285;GO:0002051;GO:0061036;GO:0010628;GO:0045669;GO:1902895;GO:1903672;GO:0045944;GO:1901522;GO:0031053;GO:0016579;GO:0006468;GO:0007165;GO:0007183;GO:0060395;GO:0007179;GO:0001657;, C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:integral component of membrane; C:nuclear inner membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SMAD protein complex;, F:co-SMAD binding; F:DEAD/H-box RNA helicase binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:identical protein binding; F:metal ion binding; F:primary miRNA binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:BMP signaling pathway; P:bone development; P:cardiac muscle cell proliferation; P:cartilage development; P:cell differentiation; P:cellular response to organic cyclic compound; P:embryonic pattern specification; P:gamete generation; P:hindbrain development; P:homeostatic process; P:inflammatory response; P:MAPK cascade; P:mesodermal cell fate commitment; P:midbrain development; P:negative regulation of BMP signaling pathway; P:negative regulation of cell population proliferation; P:osteoblast fate commitment; P:positive regulation of cartilage development; P:positive regulation of gene expression; P:positive regulation of osteoblast differentiation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:primary miRNA processing; P:protein deubiquitination; P:protein phosphorylation; P:signal transduction; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development; scaffold11 indexed_genome mRNA 12024465 12059440 . - . ID=transcript_2851;Q15797 A8KAJ0 D3DNZ9 Q16636 Q9UFT8,Mothers against decapentaplegic homolog 1,JV4-1;Mad-related protein 1;SMAD family member 1;Transforming growth factor-beta-signaling protein 1;, PF03165;PF03166;, GO:0000785;GO:0005737;GO:0005829;GO:0071144;GO:0016021;GO:0005637;GO:0005654;GO:0005634;GO:0032991;GO:0071141;GO:0070410;GO:0017151;GO:0001228;GO:0003700;GO:0000981;GO:0070411;GO:0042802;GO:0046872;GO:0070878;GO:0019901;GO:0000978;GO:0009653;GO:0030509;GO:0060348;GO:0060038;GO:0051216;GO:0030154;GO:0071407;GO:0009880;GO:0007276;GO:0030902;GO:0042592;GO:0006954;GO:0000165;GO:0001710;GO:0030901;GO:0030514;GO:0008285;GO:0002051;GO:0061036;GO:0010628;GO:0045669;GO:1902895;GO:1903672;GO:0045944;GO:1901522;GO:0031053;GO:0016579;GO:0006468;GO:0007165;GO:0007183;GO:0060395;GO:0007179;GO:0001657;, C:chromatin; C:cytoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:integral component of membrane; C:nuclear inner membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SMAD protein complex;, F:co-SMAD binding; F:DEAD/H-box RNA helicase binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:identical protein binding; F:metal ion binding; F:primary miRNA binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:BMP signaling pathway; P:bone development; P:cardiac muscle cell proliferation; P:cartilage development; P:cell differentiation; P:cellular response to organic cyclic compound; P:embryonic pattern specification; P:gamete generation; P:hindbrain development; P:homeostatic process; P:inflammatory response; P:MAPK cascade; P:mesodermal cell fate commitment; P:midbrain development; P:negative regulation of BMP signaling pathway; P:negative regulation of cell population proliferation; P:osteoblast fate commitment; P:positive regulation of cartilage development; P:positive regulation of gene expression; P:positive regulation of osteoblast differentiation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:primary miRNA processing; P:protein deubiquitination; P:protein phosphorylation; P:signal transduction; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development; scaffold11 indexed_genome mRNA 12388115 12461390 . + . ID=transcript_2852;Q01804 B4DYS4 Q147U2 Q1ZYK1 Q6PG39 Q96MQ5 Q9NT94 Q9UPV6,OTU domain-containing protein 4,HIV-1-induced protein HIN-1 {ECO:0000303|PubMed:1475186};, PF02338;, GO:0005829;GO:0005634;GO:0008234;GO:0061578;GO:0060090;GO:0003723;GO:0004843;GO:0045087;GO:2000660;GO:0034122;GO:1901537;GO:0016579;GO:0071108;GO:0070536;GO:1903093;, C:cytosol; C:nucleus;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:molecular adaptor activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of interleukin-1-mediated signaling pathway; P:negative regulation of toll-like receptor signaling pathway; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of protein K48-linked deubiquitination;|Q01804 B4DYS4 Q147U2 Q1ZYK1 Q6PG39 Q96MQ5 Q9NT94 Q9UPV6,OTU domain-containing protein 4,HIV-1-induced protein HIN-1 {ECO:0000303|PubMed:1475186};, PF02338;, GO:0005829;GO:0005634;GO:0008234;GO:0061578;GO:0060090;GO:0003723;GO:0004843;GO:0045087;GO:2000660;GO:0034122;GO:1901537;GO:0016579;GO:0071108;GO:0070536;GO:1903093;, C:cytosol; C:nucleus;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:molecular adaptor activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of interleukin-1-mediated signaling pathway; P:negative regulation of toll-like receptor signaling pathway; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of protein K48-linked deubiquitination;|Q01804 B4DYS4 Q147U2 Q1ZYK1 Q6PG39 Q96MQ5 Q9NT94 Q9UPV6,OTU domain-containing protein 4,HIV-1-induced protein HIN-1 {ECO:0000303|PubMed:1475186};, PF02338;, GO:0005829;GO:0005634;GO:0008234;GO:0061578;GO:0060090;GO:0003723;GO:0004843;GO:0045087;GO:2000660;GO:0034122;GO:1901537;GO:0016579;GO:0071108;GO:0070536;GO:1903093;, C:cytosol; C:nucleus;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:molecular adaptor activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of interleukin-1-mediated signaling pathway; P:negative regulation of toll-like receptor signaling pathway; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of protein K48-linked deubiquitination;|Q01804 B4DYS4 Q147U2 Q1ZYK1 Q6PG39 Q96MQ5 Q9NT94 Q9UPV6,OTU domain-containing protein 4,HIV-1-induced protein HIN-1 {ECO:0000303|PubMed:1475186};, PF02338;, GO:0005829;GO:0005634;GO:0008234;GO:0061578;GO:0060090;GO:0003723;GO:0004843;GO:0045087;GO:2000660;GO:0034122;GO:1901537;GO:0016579;GO:0071108;GO:0070536;GO:1903093;, C:cytosol; C:nucleus;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:molecular adaptor activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of interleukin-1-mediated signaling pathway; P:negative regulation of toll-like receptor signaling pathway; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of protein K48-linked deubiquitination;|Q01804 B4DYS4 Q147U2 Q1ZYK1 Q6PG39 Q96MQ5 Q9NT94 Q9UPV6,OTU domain-containing protein 4,HIV-1-induced protein HIN-1 {ECO:0000303|PubMed:1475186};, PF02338;, GO:0005829;GO:0005634;GO:0008234;GO:0061578;GO:0060090;GO:0003723;GO:0004843;GO:0045087;GO:2000660;GO:0034122;GO:1901537;GO:0016579;GO:0071108;GO:0070536;GO:1903093;, C:cytosol; C:nucleus;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:molecular adaptor activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of interleukin-1-mediated signaling pathway; P:negative regulation of toll-like receptor signaling pathway; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of protein K48-linked deubiquitination;|Q01804 B4DYS4 Q147U2 Q1ZYK1 Q6PG39 Q96MQ5 Q9NT94 Q9UPV6,OTU domain-containing protein 4,HIV-1-induced protein HIN-1 {ECO:0000303|PubMed:1475186};, PF02338;, GO:0005829;GO:0005634;GO:0008234;GO:0061578;GO:0060090;GO:0003723;GO:0004843;GO:0045087;GO:2000660;GO:0034122;GO:1901537;GO:0016579;GO:0071108;GO:0070536;GO:1903093;, C:cytosol; C:nucleus;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:molecular adaptor activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of interleukin-1-mediated signaling pathway; P:negative regulation of toll-like receptor signaling pathway; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of protein K48-linked deubiquitination;|Q01804 B4DYS4 Q147U2 Q1ZYK1 Q6PG39 Q96MQ5 Q9NT94 Q9UPV6,OTU domain-containing protein 4,HIV-1-induced protein HIN-1 {ECO:0000303|PubMed:1475186};, PF02338;, GO:0005829;GO:0005634;GO:0008234;GO:0061578;GO:0060090;GO:0003723;GO:0004843;GO:0045087;GO:2000660;GO:0034122;GO:1901537;GO:0016579;GO:0071108;GO:0070536;GO:1903093;, C:cytosol; C:nucleus;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:molecular adaptor activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of interleukin-1-mediated signaling pathway; P:negative regulation of toll-like receptor signaling pathway; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of protein K48-linked deubiquitination;|P61221 O88793 Q13181 Q13864 Q6NR76 Q96AL0 Q96B10 Q99K66,ATP-binding cassette sub-family E member 1,2'-5'-oligoadenylate-binding protein;HuHP68;RNase L inhibitor;Ribonuclease 4 inhibitor;, PF00005;PF00037;PF04068;, GO:0005737;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0051539;GO:0005524;GO:0016887;GO:0060698;GO:0005506;GO:0043024;GO:0051607;GO:0060702;GO:0006417;GO:0060338;GO:0000054;GO:0006413;GO:0006415;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:endoribonuclease inhibitor activity; F:iron ion binding; F:ribosomal small subunit binding;, P:defense response to virus; P:negative regulation of endoribonuclease activity; P:regulation of translation; P:regulation of type I interferon-mediated signaling pathway; P:ribosomal subunit export from nucleus; P:translational initiation; P:translational termination; P:viral process;|P61221 O88793 Q13181 Q13864 Q6NR76 Q96AL0 Q96B10 Q99K66,ATP-binding cassette sub-family E member 1,2'-5'-oligoadenylate-binding protein;HuHP68;RNase L inhibitor;Ribonuclease 4 inhibitor;, PF00005;PF00037;PF04068;, GO:0005737;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0051539;GO:0005524;GO:0016887;GO:0060698;GO:0005506;GO:0043024;GO:0051607;GO:0060702;GO:0006417;GO:0060338;GO:0000054;GO:0006413;GO:0006415;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:endoribonuclease inhibitor activity; F:iron ion binding; F:ribosomal small subunit binding;, P:defense response to virus; P:negative regulation of endoribonuclease activity; P:regulation of translation; P:regulation of type I interferon-mediated signaling pathway; P:ribosomal subunit export from nucleus; P:translational initiation; P:translational termination; P:viral process;|P61221 O88793 Q13181 Q13864 Q6NR76 Q96AL0 Q96B10 Q99K66,ATP-binding cassette sub-family E member 1,2'-5'-oligoadenylate-binding protein;HuHP68;RNase L inhibitor;Ribonuclease 4 inhibitor;, PF00005;PF00037;PF04068;, GO:0005737;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0051539;GO:0005524;GO:0016887;GO:0060698;GO:0005506;GO:0043024;GO:0051607;GO:0060702;GO:0006417;GO:0060338;GO:0000054;GO:0006413;GO:0006415;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:endoribonuclease inhibitor activity; F:iron ion binding; F:ribosomal small subunit binding;, P:defense response to virus; P:negative regulation of endoribonuclease activity; P:regulation of translation; P:regulation of type I interferon-mediated signaling pathway; P:ribosomal subunit export from nucleus; P:translational initiation; P:translational termination; P:viral process;|P61221 O88793 Q13181 Q13864 Q6NR76 Q96AL0 Q96B10 Q99K66,ATP-binding cassette sub-family E member 1,2'-5'-oligoadenylate-binding protein;HuHP68;RNase L inhibitor;Ribonuclease 4 inhibitor;, PF00005;PF00037;PF04068;, GO:0005737;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0051539;GO:0005524;GO:0016887;GO:0060698;GO:0005506;GO:0043024;GO:0051607;GO:0060702;GO:0006417;GO:0060338;GO:0000054;GO:0006413;GO:0006415;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:endoribonuclease inhibitor activity; F:iron ion binding; F:ribosomal small subunit binding;, P:defense response to virus; P:negative regulation of endoribonuclease activity; P:regulation of translation; P:regulation of type I interferon-mediated signaling pathway; P:ribosomal subunit export from nucleus; P:translational initiation; P:translational termination; P:viral process;|P61221 O88793 Q13181 Q13864 Q6NR76 Q96AL0 Q96B10 Q99K66,ATP-binding cassette sub-family E member 1,2'-5'-oligoadenylate-binding protein;HuHP68;RNase L inhibitor;Ribonuclease 4 inhibitor;, PF00005;PF00037;PF04068;, GO:0005737;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0051539;GO:0005524;GO:0016887;GO:0060698;GO:0005506;GO:0043024;GO:0051607;GO:0060702;GO:0006417;GO:0060338;GO:0000054;GO:0006413;GO:0006415;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:endoribonuclease inhibitor activity; F:iron ion binding; F:ribosomal small subunit binding;, P:defense response to virus; P:negative regulation of endoribonuclease activity; P:regulation of translation; P:regulation of type I interferon-mediated signaling pathway; P:ribosomal subunit export from nucleus; P:translational initiation; P:translational termination; P:viral process;|P61221 O88793 Q13181 Q13864 Q6NR76 Q96AL0 Q96B10 Q99K66,ATP-binding cassette sub-family E member 1,2'-5'-oligoadenylate-binding protein;HuHP68;RNase L inhibitor;Ribonuclease 4 inhibitor;, PF00005;PF00037;PF04068;, GO:0005737;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0051539;GO:0005524;GO:0016887;GO:0060698;GO:0005506;GO:0043024;GO:0051607;GO:0060702;GO:0006417;GO:0060338;GO:0000054;GO:0006413;GO:0006415;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:endoribonuclease inhibitor activity; F:iron ion binding; F:ribosomal small subunit binding;, P:defense response to virus; P:negative regulation of endoribonuclease activity; P:regulation of translation; P:regulation of type I interferon-mediated signaling pathway; P:ribosomal subunit export from nucleus; P:translational initiation; P:translational termination; P:viral process; scaffold11 indexed_genome mRNA 12461476 12539168 . + . ID=transcript_2853;Q9UM13 D3DNZ7 Q2V500 Q9UG51 Q9Y5R0,Anaphase-promoting complex subunit 10,Cyclosome subunit 10;, PF03256;, GO:0005680;GO:0005829;GO:0005654;GO:0031145;GO:0007049;GO:0051301;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold11 indexed_genome mRNA 12710757 12813924 . - . ID=transcript_2854;Q96QV1 Q6PK09 Q8NCI7 Q9BXK3 Q9H1J4 Q9H7E7,Hedgehog-interacting protein,, PF03024;PF07995;, GO:0009986;GO:0060170;GO:0005737;GO:0005576;GO:0005887;GO:0005634;GO:0003824;GO:0097108;GO:0008270;GO:0009953;GO:0060441;GO:0043066;GO:0009968;GO:0045879;GO:0007405;GO:0040036;GO:0007165;GO:0048705;, C:cell surface; C:ciliary membrane; C:cytoplasm; C:extracellular region; C:integral component of plasma membrane; C:nucleus;, F:catalytic activity; F:hedgehog family protein binding; F:zinc ion binding;, P:dorsal/ventral pattern formation; P:epithelial tube branching involved in lung morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of signal transduction; P:negative regulation of smoothened signaling pathway; P:neuroblast proliferation; P:regulation of fibroblast growth factor receptor signaling pathway; P:signal transduction; P:skeletal system morphogenesis; scaffold11 indexed_genome mRNA 13479318 13516937 . - . ID=transcript_2855;O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,Sucrose nonfermenting protein 2 homolog;, PF09110;PF00271;PF09111;PF00176;, GO:0005677;GO:0000793;GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0031213;GO:0005524;GO:0016887;GO:0003677;GO:0008094;GO:0004386;GO:0031491;GO:0070615;GO:0043044;GO:1990830;GO:0034080;GO:0006338;GO:0006352;GO:0006302;GO:0006334;GO:0016584;GO:0045815;GO:0045944;GO:0000183;GO:0006357;, C:chromatin silencing complex; C:condensed chromosome; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex; C:RSF complex;, F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity;, P:ATP-dependent chromatin remodeling; P:cellular response to leukemia inhibitory factor; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA-templated transcription, initiation; P:double-strand break repair; P:nucleosome assembly; P:nucleosome positioning; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:regulation of transcription by RNA polymerase II;|O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,Sucrose nonfermenting protein 2 homolog;, PF09110;PF00271;PF09111;PF00176;, GO:0005677;GO:0000793;GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0031213;GO:0005524;GO:0016887;GO:0003677;GO:0008094;GO:0004386;GO:0031491;GO:0070615;GO:0043044;GO:1990830;GO:0034080;GO:0006338;GO:0006352;GO:0006302;GO:0006334;GO:0016584;GO:0045815;GO:0045944;GO:0000183;GO:0006357;, C:chromatin silencing complex; C:condensed chromosome; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex; C:RSF complex;, F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity;, P:ATP-dependent chromatin remodeling; P:cellular response to leukemia inhibitory factor; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA-templated transcription, initiation; P:double-strand break repair; P:nucleosome assembly; P:nucleosome positioning; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:regulation of transcription by RNA polymerase II;|O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,Sucrose nonfermenting protein 2 homolog;, PF09110;PF00271;PF09111;PF00176;, GO:0005677;GO:0000793;GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0031213;GO:0005524;GO:0016887;GO:0003677;GO:0008094;GO:0004386;GO:0031491;GO:0070615;GO:0043044;GO:1990830;GO:0034080;GO:0006338;GO:0006352;GO:0006302;GO:0006334;GO:0016584;GO:0045815;GO:0045944;GO:0000183;GO:0006357;, C:chromatin silencing complex; C:condensed chromosome; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex; C:RSF complex;, F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity;, P:ATP-dependent chromatin remodeling; P:cellular response to leukemia inhibitory factor; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA-templated transcription, initiation; P:double-strand break repair; P:nucleosome assembly; P:nucleosome positioning; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:regulation of transcription by RNA polymerase II;|O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,Sucrose nonfermenting protein 2 homolog;, PF09110;PF00271;PF09111;PF00176;, GO:0005677;GO:0000793;GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0031213;GO:0005524;GO:0016887;GO:0003677;GO:0008094;GO:0004386;GO:0031491;GO:0070615;GO:0043044;GO:1990830;GO:0034080;GO:0006338;GO:0006352;GO:0006302;GO:0006334;GO:0016584;GO:0045815;GO:0045944;GO:0000183;GO:0006357;, C:chromatin silencing complex; C:condensed chromosome; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex; C:RSF complex;, F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity;, P:ATP-dependent chromatin remodeling; P:cellular response to leukemia inhibitory factor; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA-templated transcription, initiation; P:double-strand break repair; P:nucleosome assembly; P:nucleosome positioning; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:regulation of transcription by RNA polymerase II;|P28370 Q5JV41 Q5JV42,Probable global transcription activator SNF2L1,ATP-dependent helicase SMARCA1;Nucleosome-remodeling factor subunit SNF2L;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1;, PF13892;PF09110;PF00271;PF09111;PF00176;, GO:0090537;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0036310;GO:0005524;GO:0003677;GO:0004386;GO:0031491;GO:0070615;GO:0008134;GO:0043044;GO:0007420;GO:0006338;GO:0030182;GO:0045944;GO:0045893;, C:CERF complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex;, F:annealing helicase activity; F:ATP binding; F:DNA binding; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:chromatin remodeling; P:neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated;|O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,Sucrose nonfermenting protein 2 homolog;, PF09110;PF00271;PF09111;PF00176;, GO:0005677;GO:0000793;GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0031213;GO:0005524;GO:0016887;GO:0003677;GO:0008094;GO:0004386;GO:0031491;GO:0070615;GO:0043044;GO:1990830;GO:0034080;GO:0006338;GO:0006352;GO:0006302;GO:0006334;GO:0016584;GO:0045815;GO:0045944;GO:0000183;GO:0006357;, C:chromatin silencing complex; C:condensed chromosome; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex; C:RSF complex;, F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity;, P:ATP-dependent chromatin remodeling; P:cellular response to leukemia inhibitory factor; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA-templated transcription, initiation; P:double-strand break repair; P:nucleosome assembly; P:nucleosome positioning; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:regulation of transcription by RNA polymerase II;|O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,Sucrose nonfermenting protein 2 homolog;, PF09110;PF00271;PF09111;PF00176;, GO:0005677;GO:0000793;GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0031213;GO:0005524;GO:0016887;GO:0003677;GO:0008094;GO:0004386;GO:0031491;GO:0070615;GO:0043044;GO:1990830;GO:0034080;GO:0006338;GO:0006352;GO:0006302;GO:0006334;GO:0016584;GO:0045815;GO:0045944;GO:0000183;GO:0006357;, C:chromatin silencing complex; C:condensed chromosome; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex; C:RSF complex;, F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity;, P:ATP-dependent chromatin remodeling; P:cellular response to leukemia inhibitory factor; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA-templated transcription, initiation; P:double-strand break repair; P:nucleosome assembly; P:nucleosome positioning; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 13540412 13666950 . - . ID=transcript_2856;Q13480 A8K152 Q4W5G2 Q6P1W2,GRB2-associated-binding protein 1,GRB2-associated binder 1;Growth factor receptor bound protein 2-associated protein 1;, PF00169;, GO:0005911;GO:0005829;GO:0031532;GO:0001525;GO:0007411;GO:0090668;GO:0007173;GO:0038128;GO:0008286;GO:0045766;GO:0038089;GO:0014068;GO:0051897;GO:0035728;GO:0038084;, C:cell-cell junction; C:cytosol;, , P:actin cytoskeleton reorganization; P:angiogenesis; P:axon guidance; P:endothelial cell chemotaxis to vascular endothelial growth factor; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:insulin receptor signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:response to hepatocyte growth factor; P:vascular endothelial growth factor signaling pathway;|Q13480 A8K152 Q4W5G2 Q6P1W2,GRB2-associated-binding protein 1,GRB2-associated binder 1;Growth factor receptor bound protein 2-associated protein 1;, PF00169;, GO:0005911;GO:0005829;GO:0031532;GO:0001525;GO:0007411;GO:0090668;GO:0007173;GO:0038128;GO:0008286;GO:0045766;GO:0038089;GO:0014068;GO:0051897;GO:0035728;GO:0038084;, C:cell-cell junction; C:cytosol;, , P:actin cytoskeleton reorganization; P:angiogenesis; P:axon guidance; P:endothelial cell chemotaxis to vascular endothelial growth factor; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:insulin receptor signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:response to hepatocyte growth factor; P:vascular endothelial growth factor signaling pathway;|Q13480 A8K152 Q4W5G2 Q6P1W2,GRB2-associated-binding protein 1,GRB2-associated binder 1;Growth factor receptor bound protein 2-associated protein 1;, PF00169;, GO:0005911;GO:0005829;GO:0031532;GO:0001525;GO:0007411;GO:0090668;GO:0007173;GO:0038128;GO:0008286;GO:0045766;GO:0038089;GO:0014068;GO:0051897;GO:0035728;GO:0038084;, C:cell-cell junction; C:cytosol;, , P:actin cytoskeleton reorganization; P:angiogenesis; P:axon guidance; P:endothelial cell chemotaxis to vascular endothelial growth factor; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:insulin receptor signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:response to hepatocyte growth factor; P:vascular endothelial growth factor signaling pathway;|Q13480 A8K152 Q4W5G2 Q6P1W2,GRB2-associated-binding protein 1,GRB2-associated binder 1;Growth factor receptor bound protein 2-associated protein 1;, PF00169;, GO:0005911;GO:0005829;GO:0031532;GO:0001525;GO:0007411;GO:0090668;GO:0007173;GO:0038128;GO:0008286;GO:0045766;GO:0038089;GO:0014068;GO:0051897;GO:0035728;GO:0038084;, C:cell-cell junction; C:cytosol;, , P:actin cytoskeleton reorganization; P:angiogenesis; P:axon guidance; P:endothelial cell chemotaxis to vascular endothelial growth factor; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:insulin receptor signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:response to hepatocyte growth factor; P:vascular endothelial growth factor signaling pathway;|Q13480 A8K152 Q4W5G2 Q6P1W2,GRB2-associated-binding protein 1,GRB2-associated binder 1;Growth factor receptor bound protein 2-associated protein 1;, PF00169;, GO:0005911;GO:0005829;GO:0031532;GO:0001525;GO:0007411;GO:0090668;GO:0007173;GO:0038128;GO:0008286;GO:0045766;GO:0038089;GO:0014068;GO:0051897;GO:0035728;GO:0038084;, C:cell-cell junction; C:cytosol;, , P:actin cytoskeleton reorganization; P:angiogenesis; P:axon guidance; P:endothelial cell chemotaxis to vascular endothelial growth factor; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:insulin receptor signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:response to hepatocyte growth factor; P:vascular endothelial growth factor signaling pathway; scaffold11 indexed_genome mRNA 13795700 13802982 . - . ID=transcript_2857;Q8NB14 B3KX93 Q3ZCV1 Q8NDF5 Q96DK6 Q96PZ6 Q9BY55,Ubiquitin carboxyl-terminal hydrolase 38,Deubiquitinating enzyme 38;HP43.8KD;Ubiquitin thioesterase 38;Ubiquitin-specific-processing protease 38;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold11 indexed_genome mRNA 13811027 13829881 . - . ID=transcript_2858;Q8NB14 B3KX93 Q3ZCV1 Q8NDF5 Q96DK6 Q96PZ6 Q9BY55,Ubiquitin carboxyl-terminal hydrolase 38,Deubiquitinating enzyme 38;HP43.8KD;Ubiquitin thioesterase 38;Ubiquitin-specific-processing protease 38;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8NB14 B3KX93 Q3ZCV1 Q8NDF5 Q96DK6 Q96PZ6 Q9BY55,Ubiquitin carboxyl-terminal hydrolase 38,Deubiquitinating enzyme 38;HP43.8KD;Ubiquitin thioesterase 38;Ubiquitin-specific-processing protease 38;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8NB14 B3KX93 Q3ZCV1 Q8NDF5 Q96DK6 Q96PZ6 Q9BY55,Ubiquitin carboxyl-terminal hydrolase 38,Deubiquitinating enzyme 38;HP43.8KD;Ubiquitin thioesterase 38;Ubiquitin-specific-processing protease 38;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold11 indexed_genome mRNA 14496866 14881750 . + . ID=transcript_2859;O15327 Q2TAI2 Q5XLE7 Q6IN59 Q6PJB4,Inositol polyphosphate 4-phosphatase type II,Type II inositol 3,4-bisphosphate 4-phosphatase;, , GO:0005737;GO:0005829;GO:0017161;GO:0052828;GO:0016316;GO:0034597;GO:0043647;GO:0006661;GO:0007165;, C:cytoplasm; C:cytosol;, F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;, P:inositol phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:signal transduction; scaffold11 indexed_genome mRNA 15067216 15165417 . - . ID=transcript_2860;P40933 D3DNZ2 O00440 O43512 Q495Z8 Q6FGX7 Q93058 Q9UBA3,Interleukin-15,, PF02372;, GO:0009986;GO:0005737;GO:0005829;GO:0005768;GO:0005576;GO:0005615;GO:0005794;GO:0016607;GO:0005654;GO:0005125;GO:0005126;GO:0007568;GO:0048469;GO:0007267;GO:0071305;GO:0045062;GO:0030212;GO:0006955;GO:0006954;GO:0035723;GO:0048535;GO:0030225;GO:0120163;GO:0048662;GO:0042119;GO:0001866;GO:0008284;GO:0001819;GO:0050778;GO:0050729;GO:0032740;GO:0032825;GO:0032819;GO:0050731;GO:0050766;GO:1904100;GO:0042102;GO:0034105;GO:0042531;GO:0050691;GO:0045580;GO:0007165;GO:0014732;GO:0007260;, C:cell surface; C:cytoplasm; C:cytosol; C:endosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm;, F:cytokine activity; F:cytokine receptor binding;, P:aging; P:cell maturation; P:cell-cell signaling; P:cellular response to vitamin D; P:extrathymic T cell selection; P:hyaluronan metabolic process; P:immune response; P:inflammatory response; P:interleukin-15-mediated signaling pathway; P:lymph node development; P:macrophage differentiation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of smooth muscle cell proliferation; P:neutrophil activation; P:NK T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of cytokine production; P:positive regulation of immune response; P:positive regulation of inflammatory response; P:positive regulation of interleukin-17 production; P:positive regulation of natural killer cell differentiation; P:positive regulation of natural killer cell proliferation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:positive regulation of protein O-linked glycosylation; P:positive regulation of T cell proliferation; P:positive regulation of tissue remodeling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of defense response to virus by host; P:regulation of T cell differentiation; P:signal transduction; P:skeletal muscle atrophy; P:tyrosine phosphorylation of STAT protein;|P40933 D3DNZ2 O00440 O43512 Q495Z8 Q6FGX7 Q93058 Q9UBA3,Interleukin-15,, PF02372;, GO:0009986;GO:0005737;GO:0005829;GO:0005768;GO:0005576;GO:0005615;GO:0005794;GO:0016607;GO:0005654;GO:0005125;GO:0005126;GO:0007568;GO:0048469;GO:0007267;GO:0071305;GO:0045062;GO:0030212;GO:0006955;GO:0006954;GO:0035723;GO:0048535;GO:0030225;GO:0120163;GO:0048662;GO:0042119;GO:0001866;GO:0008284;GO:0001819;GO:0050778;GO:0050729;GO:0032740;GO:0032825;GO:0032819;GO:0050731;GO:0050766;GO:1904100;GO:0042102;GO:0034105;GO:0042531;GO:0050691;GO:0045580;GO:0007165;GO:0014732;GO:0007260;, C:cell surface; C:cytoplasm; C:cytosol; C:endosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm;, F:cytokine activity; F:cytokine receptor binding;, P:aging; P:cell maturation; P:cell-cell signaling; P:cellular response to vitamin D; P:extrathymic T cell selection; P:hyaluronan metabolic process; P:immune response; P:inflammatory response; P:interleukin-15-mediated signaling pathway; P:lymph node development; P:macrophage differentiation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of smooth muscle cell proliferation; P:neutrophil activation; P:NK T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of cytokine production; P:positive regulation of immune response; P:positive regulation of inflammatory response; P:positive regulation of interleukin-17 production; P:positive regulation of natural killer cell differentiation; P:positive regulation of natural killer cell proliferation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:positive regulation of protein O-linked glycosylation; P:positive regulation of T cell proliferation; P:positive regulation of tissue remodeling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of defense response to virus by host; P:regulation of T cell differentiation; P:signal transduction; P:skeletal muscle atrophy; P:tyrosine phosphorylation of STAT protein; scaffold11 indexed_genome mRNA 15517068 15535760 . - . ID=transcript_2861;Q9Y3S2 B2RDA3,Zinc finger protein 330,Nucleolar autoantigen 36;Nucleolar cysteine-rich protein;, PF06524;, GO:0000775;GO:0030496;GO:0005730;GO:0005634;GO:0046872;GO:0008270;, C:chromosome, centromeric region; C:midbody; C:nucleolus; C:nucleus;, F:metal ion binding; F:zinc ion binding;|Q9Y3S2 B2RDA3,Zinc finger protein 330,Nucleolar autoantigen 36;Nucleolar cysteine-rich protein;, PF06524;, GO:0000775;GO:0030496;GO:0005730;GO:0005634;GO:0046872;GO:0008270;, C:chromosome, centromeric region; C:midbody; C:nucleolus; C:nucleus;, F:metal ion binding; F:zinc ion binding;|Q9Y3S2 B2RDA3,Zinc finger protein 330,Nucleolar autoantigen 36;Nucleolar cysteine-rich protein;, PF06524;, GO:0000775;GO:0030496;GO:0005730;GO:0005634;GO:0046872;GO:0008270;, C:chromosome, centromeric region; C:midbody; C:nucleolus; C:nucleus;, F:metal ion binding; F:zinc ion binding;|Q9Y3S2 B2RDA3,Zinc finger protein 330,Nucleolar autoantigen 36;Nucleolar cysteine-rich protein;, PF06524;, GO:0000775;GO:0030496;GO:0005730;GO:0005634;GO:0046872;GO:0008270;, C:chromosome, centromeric region; C:midbody; C:nucleolus; C:nucleus;, F:metal ion binding; F:zinc ion binding;|Q9Y3S2 B2RDA3,Zinc finger protein 330,Nucleolar autoantigen 36;Nucleolar cysteine-rich protein;, PF06524;, GO:0000775;GO:0030496;GO:0005730;GO:0005634;GO:0046872;GO:0008270;, C:chromosome, centromeric region; C:midbody; C:nucleolus; C:nucleus;, F:metal ion binding; F:zinc ion binding;|Q9Y3S2 B2RDA3,Zinc finger protein 330,Nucleolar autoantigen 36;Nucleolar cysteine-rich protein;, PF06524;, GO:0000775;GO:0030496;GO:0005730;GO:0005634;GO:0046872;GO:0008270;, C:chromosome, centromeric region; C:midbody; C:nucleolus; C:nucleus;, F:metal ion binding; F:zinc ion binding; scaffold11 indexed_genome mRNA 15626292 15837656 . + . ID=transcript_2862;Q9ULK6 Q3T1D0 Q6ZNW6,RING finger protein 150,, PF02225;PF13639;, GO:0005737;GO:0016021;GO:0046872;GO:0061630;GO:0006511;, C:cytoplasm; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:ubiquitin-dependent protein catabolic process; scaffold11 indexed_genome mRNA 15879573 15882390 . + . ID=transcript_2863;Q9ULK6 Q3T1D0 Q6ZNW6,RING finger protein 150,, PF02225;PF13639;, GO:0005737;GO:0016021;GO:0046872;GO:0061630;GO:0006511;, C:cytoplasm; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:ubiquitin-dependent protein catabolic process; scaffold11 indexed_genome mRNA 15949815 15950735 . + . ID=transcript_2864;C9JTH3 C9JY50 Q96SL9 Q9BQI8,UAP56-interacting factor,Forty-two-three domain-containing protein 1;, , GO:0016607;GO:0005654;GO:0003729;GO:0003723;GO:0006406;, C:nuclear speck; C:nucleoplasm;, F:mRNA binding; F:RNA binding;, P:mRNA export from nucleus; scaffold11 indexed_genome mRNA 15965793 16110064 . + . ID=transcript_2865;Q6ZT07 A6H8U8 D3DNZ1 O94958,TBC1 domain family member 9,TBC1 domain family member 9A;, PF02893;PF00566;, GO:0005509;GO:0005096;GO:0090630;GO:0006886;, , F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; scaffold11 indexed_genome mRNA 16143664 16169392 . - . ID=transcript_2866;Q8IZ81 B2R712 D3DNZ0,ELMO domain-containing protein 2,, PF04727;, GO:0016020;GO:0005096;GO:0051607;GO:0050688;, C:membrane;, F:GTPase activator activity;, P:defense response to virus; P:regulation of defense response to virus;|Q8IZ81 B2R712 D3DNZ0,ELMO domain-containing protein 2,, PF04727;, GO:0016020;GO:0005096;GO:0051607;GO:0050688;, C:membrane;, F:GTPase activator activity;, P:defense response to virus; P:regulation of defense response to virus;|Q8IZ81 B2R712 D3DNZ0,ELMO domain-containing protein 2,, PF04727;, GO:0016020;GO:0005096;GO:0051607;GO:0050688;, C:membrane;, F:GTPase activator activity;, P:defense response to virus; P:regulation of defense response to virus;|Q8IZ81 B2R712 D3DNZ0,ELMO domain-containing protein 2,, PF04727;, GO:0016020;GO:0005096;GO:0051607;GO:0050688;, C:membrane;, F:GTPase activator activity;, P:defense response to virus; P:regulation of defense response to virus; scaffold11 indexed_genome mRNA 16234494 16258982 . + . ID=transcript_2867;O14967 B3KS90 B4DXV8 D3DNY8,Calmegin,, PF00262;, GO:0005783;GO:0005789;GO:0016021;GO:0005635;GO:0005509;GO:0044183;GO:0051082;GO:0007339;GO:0030968;GO:0006457;GO:0065003;GO:0007338;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, F:calcium ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:protein-containing complex assembly; P:single fertilization;|O14967 B3KS90 B4DXV8 D3DNY8,Calmegin,, PF00262;, GO:0005783;GO:0005789;GO:0016021;GO:0005635;GO:0005509;GO:0044183;GO:0051082;GO:0007339;GO:0030968;GO:0006457;GO:0065003;GO:0007338;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, F:calcium ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:protein-containing complex assembly; P:single fertilization;|O14967 B3KS90 B4DXV8 D3DNY8,Calmegin,, PF00262;, GO:0005783;GO:0005789;GO:0016021;GO:0005635;GO:0005509;GO:0044183;GO:0051082;GO:0007339;GO:0030968;GO:0006457;GO:0065003;GO:0007338;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, F:calcium ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:protein-containing complex assembly; P:single fertilization;|O14967 B3KS90 B4DXV8 D3DNY8,Calmegin,, PF00262;, GO:0005783;GO:0005789;GO:0016021;GO:0005635;GO:0005509;GO:0044183;GO:0051082;GO:0007339;GO:0030968;GO:0006457;GO:0065003;GO:0007338;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, F:calcium ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:protein-containing complex assembly; P:single fertilization;|O14967 B3KS90 B4DXV8 D3DNY8,Calmegin,, PF00262;, GO:0005783;GO:0005789;GO:0016021;GO:0005635;GO:0005509;GO:0044183;GO:0051082;GO:0007339;GO:0030968;GO:0006457;GO:0065003;GO:0007338;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, F:calcium ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:protein-containing complex assembly; P:single fertilization; scaffold11 indexed_genome mRNA 16259622 16278320 . + . ID=transcript_2868;O14967 B3KS90 B4DXV8 D3DNY8,Calmegin,, PF00262;, GO:0005783;GO:0005789;GO:0016021;GO:0005635;GO:0005509;GO:0044183;GO:0051082;GO:0007339;GO:0030968;GO:0006457;GO:0065003;GO:0007338;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, F:calcium ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:protein-containing complex assembly; P:single fertilization;|O14967 B3KS90 B4DXV8 D3DNY8,Calmegin,, PF00262;, GO:0005783;GO:0005789;GO:0016021;GO:0005635;GO:0005509;GO:0044183;GO:0051082;GO:0007339;GO:0030968;GO:0006457;GO:0065003;GO:0007338;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, F:calcium ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:protein-containing complex assembly; P:single fertilization;|O14967 B3KS90 B4DXV8 D3DNY8,Calmegin,, PF00262;, GO:0005783;GO:0005789;GO:0016021;GO:0005635;GO:0005509;GO:0044183;GO:0051082;GO:0007339;GO:0030968;GO:0006457;GO:0065003;GO:0007338;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, F:calcium ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:protein-containing complex assembly; P:single fertilization;|O14967 B3KS90 B4DXV8 D3DNY8,Calmegin,, PF00262;, GO:0005783;GO:0005789;GO:0016021;GO:0005635;GO:0005509;GO:0044183;GO:0051082;GO:0007339;GO:0030968;GO:0006457;GO:0065003;GO:0007338;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, F:calcium ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:protein-containing complex assembly; P:single fertilization; scaffold11 indexed_genome mRNA 16284194 16295429 . - . ID=transcript_2869;Q9UIL1 B7WPH7 D3DNY7 E9PB65 Q6P5T9 Q7L2Y0 Q7Z4P2 Q96JY9 Q9BZB2,Short coiled-coil protein,, PF10224;, GO:0005829;GO:0005794;GO:0000139;GO:0005654;GO:0016239;GO:0061635;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm;, , P:positive regulation of macroautophagy; P:regulation of protein complex stability;|Q9UIL1 B7WPH7 D3DNY7 E9PB65 Q6P5T9 Q7L2Y0 Q7Z4P2 Q96JY9 Q9BZB2,Short coiled-coil protein,, PF10224;, GO:0005829;GO:0005794;GO:0000139;GO:0005654;GO:0016239;GO:0061635;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm;, , P:positive regulation of macroautophagy; P:regulation of protein complex stability; scaffold11 indexed_genome mRNA 16503111 16771890 . + . ID=transcript_2870;Q96JK9 B2RNU9 B3KVV7 E7EVW8,Mastermind-like protein 3,, PF09596;, GO:0016607;GO:0005654;GO:0005634;GO:0003713;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0006367;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity;, P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:transcription initiation from RNA polymerase II promoter; scaffold11 indexed_genome mRNA 16772050 16947806 . + . ID=transcript_2871;Q96JK9 B2RNU9 B3KVV7 E7EVW8,Mastermind-like protein 3,, PF09596;, GO:0016607;GO:0005654;GO:0005634;GO:0003713;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0006367;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity;, P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:transcription initiation from RNA polymerase II promoter;|Q96JK9 B2RNU9 B3KVV7 E7EVW8,Mastermind-like protein 3,, PF09596;, GO:0016607;GO:0005654;GO:0005634;GO:0003713;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0006367;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity;, P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:transcription initiation from RNA polymerase II promoter; scaffold11 indexed_genome mRNA 16952483 16981164 . - . ID=transcript_2872;Q99735 D6RBB5 Q7Z5B8,Microsomal glutathione S-transferase 2,Glutathione peroxidase MGST2 {ECO:0000305};Leukotriene C4 synthase MGST2 {ECO:0000305};Microsomal glutathione S-transferase II {ECO:0000303|PubMed:8703034};, PF01124;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005635;GO:0005886;GO:0008047;GO:0043295;GO:0004602;GO:0004364;GO:0042802;GO:0004464;GO:0046222;GO:0006750;GO:1901687;GO:0019370;GO:0006629;GO:0046466;GO:0050729;GO:0032496;GO:0010243;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope; C:plasma membrane;, F:enzyme activator activity; F:glutathione binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:identical protein binding; F:leukotriene-C4 synthase activity;, P:aflatoxin metabolic process; P:glutathione biosynthetic process; P:glutathione derivative biosynthetic process; P:leukotriene biosynthetic process; P:lipid metabolic process; P:membrane lipid catabolic process; P:positive regulation of inflammatory response; P:response to lipopolysaccharide; P:response to organonitrogen compound; scaffold11 indexed_genome mRNA 17085583 17147079 . + . ID=transcript_2873;Q8WTS6 B5WWL3 Q0VAH3 Q4W5A9 Q9C0E6,Histone-lysine N-methyltransferase SETD7,Histone H3-K4 methyltransferase SETD7;Lysine N-methyltransferase 7;SET domain-containing protein 7;SET7/9;, PF02493;PF00856;, GO:0005694;GO:0005730;GO:0005654;GO:0003682;GO:0018024;GO:0002039;GO:0016279;GO:0006974;GO:0006325;GO:0070828;GO:0018027;GO:0018026;GO:0045893;GO:0051570;GO:0045471;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:chromatin binding; F:histone-lysine N-methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:heterochromatin organization; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of transcription, DNA-templated; P:regulation of histone H3-K9 methylation; P:response to ethanol;|Q8WTS6 B5WWL3 Q0VAH3 Q4W5A9 Q9C0E6,Histone-lysine N-methyltransferase SETD7,Histone H3-K4 methyltransferase SETD7;Lysine N-methyltransferase 7;SET domain-containing protein 7;SET7/9;, PF02493;PF00856;, GO:0005694;GO:0005730;GO:0005654;GO:0003682;GO:0018024;GO:0002039;GO:0016279;GO:0006974;GO:0006325;GO:0070828;GO:0018027;GO:0018026;GO:0045893;GO:0051570;GO:0045471;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:chromatin binding; F:histone-lysine N-methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:heterochromatin organization; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of transcription, DNA-templated; P:regulation of histone H3-K9 methylation; P:response to ethanol; scaffold11 indexed_genome mRNA 17248067 17317793 . - . ID=transcript_2874;Q9BXJ9 D3DNY6 Q52LG9 Q8IWH4 Q8NEV2 Q9H8P6,N-alpha-acetyltransferase 15, NatA auxiliary subunit,Gastric cancer antigen Ga19;N-terminal acetyltransferase;NMDA receptor-regulated protein 1;Protein tubedown-1;Tbdn100;, PF12569;PF13181;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0031415;GO:0016604;GO:0005634;GO:0005667;GO:0043022;GO:0003723;GO:0001525;GO:0030154;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:NatA complex; C:nuclear body; C:nucleus; C:transcription regulator complex;, F:ribosome binding; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q9BXJ9 D3DNY6 Q52LG9 Q8IWH4 Q8NEV2 Q9H8P6,N-alpha-acetyltransferase 15, NatA auxiliary subunit,Gastric cancer antigen Ga19;N-terminal acetyltransferase;NMDA receptor-regulated protein 1;Protein tubedown-1;Tbdn100;, PF12569;PF13181;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0031415;GO:0016604;GO:0005634;GO:0005667;GO:0043022;GO:0003723;GO:0001525;GO:0030154;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:NatA complex; C:nuclear body; C:nucleus; C:transcription regulator complex;, F:ribosome binding; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q9BXJ9 D3DNY6 Q52LG9 Q8IWH4 Q8NEV2 Q9H8P6,N-alpha-acetyltransferase 15, NatA auxiliary subunit,Gastric cancer antigen Ga19;N-terminal acetyltransferase;NMDA receptor-regulated protein 1;Protein tubedown-1;Tbdn100;, PF12569;PF13181;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0031415;GO:0016604;GO:0005634;GO:0005667;GO:0043022;GO:0003723;GO:0001525;GO:0030154;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:NatA complex; C:nuclear body; C:nucleus; C:transcription regulator complex;, F:ribosome binding; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q9BXJ9 D3DNY6 Q52LG9 Q8IWH4 Q8NEV2 Q9H8P6,N-alpha-acetyltransferase 15, NatA auxiliary subunit,Gastric cancer antigen Ga19;N-terminal acetyltransferase;NMDA receptor-regulated protein 1;Protein tubedown-1;Tbdn100;, PF12569;PF13181;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0031415;GO:0016604;GO:0005634;GO:0005667;GO:0043022;GO:0003723;GO:0001525;GO:0030154;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:NatA complex; C:nuclear body; C:nucleus; C:transcription regulator complex;, F:ribosome binding; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q9BXJ9 D3DNY6 Q52LG9 Q8IWH4 Q8NEV2 Q9H8P6,N-alpha-acetyltransferase 15, NatA auxiliary subunit,Gastric cancer antigen Ga19;N-terminal acetyltransferase;NMDA receptor-regulated protein 1;Protein tubedown-1;Tbdn100;, PF12569;PF13181;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0031415;GO:0016604;GO:0005634;GO:0005667;GO:0043022;GO:0003723;GO:0001525;GO:0030154;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:NatA complex; C:nuclear body; C:nucleus; C:transcription regulator complex;, F:ribosome binding; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q9BXJ9 D3DNY6 Q52LG9 Q8IWH4 Q8NEV2 Q9H8P6,N-alpha-acetyltransferase 15, NatA auxiliary subunit,Gastric cancer antigen Ga19;N-terminal acetyltransferase;NMDA receptor-regulated protein 1;Protein tubedown-1;Tbdn100;, PF12569;PF13181;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0031415;GO:0016604;GO:0005634;GO:0005667;GO:0043022;GO:0003723;GO:0001525;GO:0030154;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:NatA complex; C:nuclear body; C:nucleus; C:transcription regulator complex;, F:ribosome binding; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q9BXJ9 D3DNY6 Q52LG9 Q8IWH4 Q8NEV2 Q9H8P6,N-alpha-acetyltransferase 15, NatA auxiliary subunit,Gastric cancer antigen Ga19;N-terminal acetyltransferase;NMDA receptor-regulated protein 1;Protein tubedown-1;Tbdn100;, PF12569;PF13181;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0031415;GO:0016604;GO:0005634;GO:0005667;GO:0043022;GO:0003723;GO:0001525;GO:0030154;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:NatA complex; C:nuclear body; C:nucleus; C:transcription regulator complex;, F:ribosome binding; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q9BXJ9 D3DNY6 Q52LG9 Q8IWH4 Q8NEV2 Q9H8P6,N-alpha-acetyltransferase 15, NatA auxiliary subunit,Gastric cancer antigen Ga19;N-terminal acetyltransferase;NMDA receptor-regulated protein 1;Protein tubedown-1;Tbdn100;, PF12569;PF13181;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0031415;GO:0016604;GO:0005634;GO:0005667;GO:0043022;GO:0003723;GO:0001525;GO:0030154;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:NatA complex; C:nuclear body; C:nucleus; C:transcription regulator complex;, F:ribosome binding; F:RNA binding;, P:angiogenesis; P:cell differentiation; P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization; scaffold11 indexed_genome mRNA 17325199 17334789 . - . ID=transcript_2875;O43677 A8K532 Q3MIJ9,NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial,Complex I-KFYI;NADH-ubiquinone oxidoreductase KFYI subunit;, PF15088;, GO:0016021;GO:0005743;GO:0005747;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O43677 A8K532 Q3MIJ9,NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial,Complex I-KFYI;NADH-ubiquinone oxidoreductase KFYI subunit;, PF15088;, GO:0016021;GO:0005743;GO:0005747;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold11 indexed_genome mRNA 17445166 17448427 . + . ID=transcript_2876;Q15723 E9PCX3 Q15724 Q15725 Q6P1K5,ETS-related transcription factor Elf-2,E74-like factor 2;New ETS-related factor;, PF12310;PF00178;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0045892;GO:0045893;GO:0050855;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 17462590 17514309 . + . ID=transcript_2877;Q15723 E9PCX3 Q15724 Q15725 Q6P1K5,ETS-related transcription factor Elf-2,E74-like factor 2;New ETS-related factor;, PF12310;PF00178;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0045892;GO:0045893;GO:0050855;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q15723 E9PCX3 Q15724 Q15725 Q6P1K5,ETS-related transcription factor Elf-2,E74-like factor 2;New ETS-related factor;, PF12310;PF00178;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0045892;GO:0045893;GO:0050855;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q15723 E9PCX3 Q15724 Q15725 Q6P1K5,ETS-related transcription factor Elf-2,E74-like factor 2;New ETS-related factor;, PF12310;PF00178;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0045892;GO:0045893;GO:0050855;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q15723 E9PCX3 Q15724 Q15725 Q6P1K5,ETS-related transcription factor Elf-2,E74-like factor 2;New ETS-related factor;, PF12310;PF00178;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0045892;GO:0045893;GO:0050855;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q15723 E9PCX3 Q15724 Q15725 Q6P1K5,ETS-related transcription factor Elf-2,E74-like factor 2;New ETS-related factor;, PF12310;PF00178;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0045892;GO:0045893;GO:0050855;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q15723 E9PCX3 Q15724 Q15725 Q6P1K5,ETS-related transcription factor Elf-2,E74-like factor 2;New ETS-related factor;, PF12310;PF00178;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0045892;GO:0045893;GO:0050855;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q15723 E9PCX3 Q15724 Q15725 Q6P1K5,ETS-related transcription factor Elf-2,E74-like factor 2;New ETS-related factor;, PF12310;PF00178;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0045892;GO:0045893;GO:0050855;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 17521994 17540781 . - . ID=transcript_2878;Q9UK39 D3DNY5 Q14D51 Q9HD93 Q9HD94 Q9HD95,Nocturnin {ECO:0000312|HGNC:HGNC:14254},Carbon catabolite repression 4-like protein;, PF03372;, GO:0005737;GO:0005739;GO:0005654;GO:0005634;GO:0000932;GO:0048471;GO:0000175;GO:0046872;GO:0003729;GO:0019178;GO:0102757;GO:0004535;GO:0032922;GO:0007623;GO:0000290;GO:0048255;GO:0006739;GO:0010629;GO:0045668;GO:0033962;GO:0045600;GO:0042752;GO:0045995;GO:0009991;GO:0032496;GO:0006366;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:nucleus; C:P-body; C:perinuclear region of cytoplasm;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:mRNA binding; F:NADP phosphatase activity; F:NADPH phosphatase activity; F:poly(A)-specific ribonuclease activity;, P:circadian regulation of gene expression; P:circadian rhythm; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:mRNA stabilization; P:NADP metabolic process; P:negative regulation of gene expression; P:negative regulation of osteoblast differentiation; P:P-body assembly; P:positive regulation of fat cell differentiation; P:regulation of circadian rhythm; P:regulation of embryonic development; P:response to extracellular stimulus; P:response to lipopolysaccharide; P:transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 18332493 18394557 . + . ID=transcript_2879;Q9UPY5 A8K2U4,Cystine/glutamate transporter,Amino acid transport system xc-;Calcium channel blocker resistance protein CCBR1;Solute carrier family 7 member 11;xCT;, PF13520;, GO:0045177;GO:0097449;GO:0031526;GO:0009986;GO:0005856;GO:0016021;GO:0005886;GO:0005791;GO:0015327;GO:0015179;GO:0030534;GO:0006865;GO:0034599;GO:0140206;GO:0090461;GO:0006749;GO:0034775;GO:0098712;GO:0070306;GO:0050900;GO:0060173;GO:0048286;GO:0050804;GO:1903204;GO:0070527;GO:1904717;GO:0042127;GO:1901494;GO:2000211;GO:1903786;GO:0048021;GO:0033029;GO:0051223;GO:0050807;GO:0035094;GO:0014070;GO:0051775;GO:0009636;GO:0021756;GO:0021591;GO:0008542;, C:apical part of cell; C:astrocyte projection; C:brush border membrane; C:cell surface; C:cytoskeleton; C:integral component of membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:cystine:glutamate antiporter activity; F:L-amino acid transmembrane transporter activity;, P:adult behavior; P:amino acid transport; P:cellular response to oxidative stress; P:dipeptide import across plasma membrane; P:glutamate homeostasis; P:glutathione metabolic process; P:glutathione transmembrane transport; P:L-glutamate import across plasma membrane; P:lens fiber cell differentiation; P:leukocyte migration; P:limb development; P:lung alveolus development; P:modulation of chemical synaptic transmission; P:negative regulation of oxidative stress-induced neuron death; P:platelet aggregation; P:regulation of AMPA glutamate receptor clustering; P:regulation of cell population proliferation; P:regulation of cysteine metabolic process; P:regulation of glutamate metabolic process; P:regulation of glutathione biosynthetic process; P:regulation of melanin biosynthetic process; P:regulation of neutrophil apoptotic process; P:regulation of protein transport; P:regulation of synapse organization; P:response to nicotine; P:response to organic cyclic compound; P:response to redox state; P:response to toxic substance; P:striatum development; P:ventricular system development; P:visual learning; scaffold11 indexed_genome mRNA 19161514 19175553 . + . ID=transcript_2880;Q9HCL0 A8K7K3 B7ZKT1 Q52LS2,Protocadherin-18,, PF00028;PF08266;, GO:0005887;GO:0005509;GO:0007420;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:brain development; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold11 indexed_genome mRNA 22698813 22699955 . - . ID=transcript_2881;P0CB38,Polyadenylate-binding protein 4-like,, PF00076;, GO:0010494;GO:0005829;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;, C:cytoplasmic stress granule; C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding; scaffold11 indexed_genome mRNA 23550226 23591141 . - . ID=transcript_2882;Q9P2E7 Q4W5F6 Q96SF0,Protocadherin-10,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9P2E7 Q4W5F6 Q96SF0,Protocadherin-10,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9P2E7 Q4W5F6 Q96SF0,Protocadherin-10,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold11 indexed_genome mRNA 23591144 23592597 . - . ID=transcript_2883;Q9P2E7 Q4W5F6 Q96SF0,Protocadherin-10,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold11 indexed_genome mRNA 26847314 26865322 . - . ID=transcript_2884;Q8N1A6 D3DNY2 Q6PJF3 Q8NBC5,UPF0462 protein C4orf33 scaffold11 indexed_genome mRNA 26866308 27091018 . + . ID=transcript_2885;Q96NL6 A4QN04 Q0VAH2 Q6P2M4,Sodium channel and clathrin linker 1,Sodium channel-associated protein 1;, , GO:0005814;GO:0005813;GO:0097539;GO:0071439;GO:0005829;GO:0030276;GO:0008022;GO:0017080;GO:0097711;GO:0060271;GO:0045162;, C:centriole; C:centrosome; C:ciliary transition fiber; C:clathrin complex; C:cytosol;, F:clathrin binding; F:protein C-terminus binding; F:sodium channel regulator activity;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:clustering of voltage-gated sodium channels; scaffold11 indexed_genome mRNA 27101066 27106698 . + . ID=transcript_2886;Q6IE81 D3DNY0 D3DNY1 Q4W5D5 Q6ZSL7 Q8NC41 Q96JL8 Q96SQ1 Q9H692,Protein Jade-1,Jade family PHD finger protein 1;PHD finger protein 17;, PF10513;, GO:0005694;GO:0036064;GO:0005737;GO:0005829;GO:0000123;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0003713;GO:0006915;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0090090;GO:0030308;GO:2000134;, C:chromosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:transcription coactivator activity;, P:apoptotic process; P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; scaffold11 indexed_genome mRNA 27107126 27110114 . + . ID=transcript_2887;Q6IE81 D3DNY0 D3DNY1 Q4W5D5 Q6ZSL7 Q8NC41 Q96JL8 Q96SQ1 Q9H692,Protein Jade-1,Jade family PHD finger protein 1;PHD finger protein 17;, PF10513;, GO:0005694;GO:0036064;GO:0005737;GO:0005829;GO:0000123;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0003713;GO:0006915;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0090090;GO:0030308;GO:2000134;, C:chromosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:transcription coactivator activity;, P:apoptotic process; P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; scaffold11 indexed_genome mRNA 27113167 27165808 . - . ID=transcript_2888;Q6IE81 D3DNY0 D3DNY1 Q4W5D5 Q6ZSL7 Q8NC41 Q96JL8 Q96SQ1 Q9H692,Protein Jade-1,Jade family PHD finger protein 1;PHD finger protein 17;, PF10513;, GO:0005694;GO:0036064;GO:0005737;GO:0005829;GO:0000123;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0003713;GO:0006915;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0090090;GO:0030308;GO:2000134;, C:chromosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:transcription coactivator activity;, P:apoptotic process; P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle;|Q6IE81 D3DNY0 D3DNY1 Q4W5D5 Q6ZSL7 Q8NC41 Q96JL8 Q96SQ1 Q9H692,Protein Jade-1,Jade family PHD finger protein 1;PHD finger protein 17;, PF10513;, GO:0005694;GO:0036064;GO:0005737;GO:0005829;GO:0000123;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0003713;GO:0006915;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0090090;GO:0030308;GO:2000134;, C:chromosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:transcription coactivator activity;, P:apoptotic process; P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle;|Q6IE81 D3DNY0 D3DNY1 Q4W5D5 Q6ZSL7 Q8NC41 Q96JL8 Q96SQ1 Q9H692,Protein Jade-1,Jade family PHD finger protein 1;PHD finger protein 17;, PF10513;, GO:0005694;GO:0036064;GO:0005737;GO:0005829;GO:0000123;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0003713;GO:0006915;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0090090;GO:0030308;GO:2000134;, C:chromosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:transcription coactivator activity;, P:apoptotic process; P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; scaffold11 indexed_genome mRNA 27601298 27617338 . + . ID=transcript_2889;O15173 Q569H1,Membrane-associated progesterone receptor component 2 {ECO:0000305},Progesterone membrane-binding protein;Steroid receptor protein DG6;, PF00173;, GO:0012505;GO:0005783;GO:0016021;GO:0016020;GO:0005635;GO:0020037;GO:0015232;GO:0005496;GO:0003707;GO:0060612;, C:endomembrane system; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:nuclear envelope;, F:heme binding; F:heme transmembrane transporter activity; F:steroid binding; F:steroid hormone receptor activity;, P:adipose tissue development;|O15173 Q569H1,Membrane-associated progesterone receptor component 2 {ECO:0000305},Progesterone membrane-binding protein;Steroid receptor protein DG6;, PF00173;, GO:0012505;GO:0005783;GO:0016021;GO:0016020;GO:0005635;GO:0020037;GO:0015232;GO:0005496;GO:0003707;GO:0060612;, C:endomembrane system; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:nuclear envelope;, F:heme binding; F:heme transmembrane transporter activity; F:steroid binding; F:steroid hormone receptor activity;, P:adipose tissue development; scaffold11 indexed_genome mRNA 27665957 27772826 . - . ID=transcript_2890;Q8N7H4 Q8NAF2 Q9H5E7 Q9NW12,La-related protein 1B,La ribonucleoprotein domain family member 1B;La ribonucleoprotein domain family member 2;La-related protein 2;, PF05383;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|Q8N7H4 Q8NAF2 Q9H5E7 Q9NW12,La-related protein 1B,La ribonucleoprotein domain family member 1B;La ribonucleoprotein domain family member 2;La-related protein 2;, PF05383;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|Q8N7H4 Q8NAF2 Q9H5E7 Q9NW12,La-related protein 1B,La ribonucleoprotein domain family member 1B;La ribonucleoprotein domain family member 2;La-related protein 2;, PF05383;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|P55039 B2R8G5 Q53Y50 Q9BWB2,Developmentally-regulated GTP-binding protein 2,Translation factor GTPase DRG2;, PF01926;PF16897;PF02824;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0002181;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding;, P:cytoplasmic translation; P:signal transduction;|Q8N7H4 Q8NAF2 Q9H5E7 Q9NW12,La-related protein 1B,La ribonucleoprotein domain family member 1B;La ribonucleoprotein domain family member 2;La-related protein 2;, PF05383;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|Q8N7H4 Q8NAF2 Q9H5E7 Q9NW12,La-related protein 1B,La ribonucleoprotein domain family member 1B;La ribonucleoprotein domain family member 2;La-related protein 2;, PF05383;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding; scaffold11 indexed_genome mRNA 27783088 27783639 . - . ID=transcript_2891;Q8N7H4 Q8NAF2 Q9H5E7 Q9NW12,La-related protein 1B,La ribonucleoprotein domain family member 1B;La ribonucleoprotein domain family member 2;La-related protein 2;, PF05383;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding; scaffold11 indexed_genome mRNA 27835960 27873106 . - . ID=transcript_2892;Q0P651 A1A4W8 A1A4W9 Q9H7A7,Protein ABHD18 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 18 {ECO:0000305};, PF09752;, GO:0005576;, C:extracellular region;|Q0P651 A1A4W8 A1A4W9 Q9H7A7,Protein ABHD18 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 18 {ECO:0000305};, PF09752;, GO:0005576;, C:extracellular region;|Q0P651 A1A4W8 A1A4W9 Q9H7A7,Protein ABHD18 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 18 {ECO:0000305};, PF09752;, GO:0005576;, C:extracellular region;|Q7Z3B0 B9EJC4,Small integral membrane protein 15,, PF15086;, GO:0016021;, C:integral component of membrane;|Q0P651 A1A4W8 A1A4W9 Q9H7A7,Protein ABHD18 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 18 {ECO:0000305};, PF09752;, GO:0005576;, C:extracellular region;|Q0P651 A1A4W8 A1A4W9 Q9H7A7,Protein ABHD18 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 18 {ECO:0000305};, PF09752;, GO:0005576;, C:extracellular region;|Q0P651 A1A4W8 A1A4W9 Q9H7A7,Protein ABHD18 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 18 {ECO:0000305};, PF09752;, GO:0005576;, C:extracellular region; scaffold11 indexed_genome mRNA 27873660 27912471 . + . ID=transcript_2893;Q8NHS3 B2RDM1 B7Z205 Q8N2P3,Major facilitator superfamily domain-containing protein 8,Ceroid-lipofuscinosis neuronal protein 7;, PF07690;, GO:0016021;GO:0005765;GO:0022857;GO:0097352;GO:0007040;GO:0048666;GO:0010506;GO:1905165;GO:0038202;, C:integral component of membrane; C:lysosomal membrane;, F:transmembrane transporter activity;, P:autophagosome maturation; P:lysosome organization; P:neuron development; P:regulation of autophagy; P:regulation of lysosomal protein catabolic process; P:TORC1 signaling;|Q8NHS3 B2RDM1 B7Z205 Q8N2P3,Major facilitator superfamily domain-containing protein 8,Ceroid-lipofuscinosis neuronal protein 7;, PF07690;, GO:0016021;GO:0005765;GO:0022857;GO:0097352;GO:0007040;GO:0048666;GO:0010506;GO:1905165;GO:0038202;, C:integral component of membrane; C:lysosomal membrane;, F:transmembrane transporter activity;, P:autophagosome maturation; P:lysosome organization; P:neuron development; P:regulation of autophagy; P:regulation of lysosomal protein catabolic process; P:TORC1 signaling;|Q8NHS3 B2RDM1 B7Z205 Q8N2P3,Major facilitator superfamily domain-containing protein 8,Ceroid-lipofuscinosis neuronal protein 7;, PF07690;, GO:0016021;GO:0005765;GO:0022857;GO:0097352;GO:0007040;GO:0048666;GO:0010506;GO:1905165;GO:0038202;, C:integral component of membrane; C:lysosomal membrane;, F:transmembrane transporter activity;, P:autophagosome maturation; P:lysosome organization; P:neuron development; P:regulation of autophagy; P:regulation of lysosomal protein catabolic process; P:TORC1 signaling;|Q8NHS3 B2RDM1 B7Z205 Q8N2P3,Major facilitator superfamily domain-containing protein 8,Ceroid-lipofuscinosis neuronal protein 7;, PF07690;, GO:0016021;GO:0005765;GO:0022857;GO:0097352;GO:0007040;GO:0048666;GO:0010506;GO:1905165;GO:0038202;, C:integral component of membrane; C:lysosomal membrane;, F:transmembrane transporter activity;, P:autophagosome maturation; P:lysosome organization; P:neuron development; P:regulation of autophagy; P:regulation of lysosomal protein catabolic process; P:TORC1 signaling;|Q8NHS3 B2RDM1 B7Z205 Q8N2P3,Major facilitator superfamily domain-containing protein 8,Ceroid-lipofuscinosis neuronal protein 7;, PF07690;, GO:0016021;GO:0005765;GO:0022857;GO:0097352;GO:0007040;GO:0048666;GO:0010506;GO:1905165;GO:0038202;, C:integral component of membrane; C:lysosomal membrane;, F:transmembrane transporter activity;, P:autophagosome maturation; P:lysosome organization; P:neuron development; P:regulation of autophagy; P:regulation of lysosomal protein catabolic process; P:TORC1 signaling; scaffold11 indexed_genome mRNA 27915278 27919668 . + . ID=transcript_2894;O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation;|O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation;|O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation;|O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation; scaffold11 indexed_genome mRNA 27920516 27922771 . - . ID=transcript_2895;O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation;|O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation;|O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation; scaffold11 indexed_genome mRNA 27922830 27933208 . + . ID=transcript_2896;O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation;|O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation;|O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation;|O00444 B2RAL0 B7Z837 B7Z8G7 Q8IYF0 Q96Q95 Q9UD84 Q9UDE2,Serine/threonine-protein kinase PLK4,Polo-like kinase 4;Serine/threonine-protein kinase 18;Serine/threonine-protein kinase Sak;, PF00069;PF18190;PF18409;, GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0005829;GO:0098536;GO:0005730;GO:0005634;GO:0000922;GO:0001741;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007099;GO:0097711;GO:0060271;GO:0098535;GO:0000086;GO:0000278;GO:0046601;GO:0006468;GO:0032465;GO:0010389;GO:0060707;, C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:cytosol; C:deuterosome; C:nucleolus; C:nucleus; C:spindle pole; C:XY body;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:centriole replication; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:positive regulation of centriole replication; P:protein phosphorylation; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:trophoblast giant cell differentiation; scaffold11 indexed_genome mRNA 27933326 28010008 . - . ID=transcript_2897;O95757 A2ICT2 Q4W5M5 Q8IWA2,Heat shock 70 kDa protein 4L,Heat shock 70-related protein APG-1;Heat-shock protein family A member 4-like protein;Osmotic stress protein 94;, PF00012;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0016887;GO:0006457;GO:0006986;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:ATPase activity;, P:protein folding; P:response to unfolded protein;|O95757 A2ICT2 Q4W5M5 Q8IWA2,Heat shock 70 kDa protein 4L,Heat shock 70-related protein APG-1;Heat-shock protein family A member 4-like protein;Osmotic stress protein 94;, PF00012;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0016887;GO:0006457;GO:0006986;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:ATPase activity;, P:protein folding; P:response to unfolded protein;|O95757 A2ICT2 Q4W5M5 Q8IWA2,Heat shock 70 kDa protein 4L,Heat shock 70-related protein APG-1;Heat-shock protein family A member 4-like protein;Osmotic stress protein 94;, PF00012;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0016887;GO:0006457;GO:0006986;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:ATPase activity;, P:protein folding; P:response to unfolded protein;|O95757 A2ICT2 Q4W5M5 Q8IWA2,Heat shock 70 kDa protein 4L,Heat shock 70-related protein APG-1;Heat-shock protein family A member 4-like protein;Osmotic stress protein 94;, PF00012;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0016887;GO:0006457;GO:0006986;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:ATPase activity;, P:protein folding; P:response to unfolded protein;|O95757 A2ICT2 Q4W5M5 Q8IWA2,Heat shock 70 kDa protein 4L,Heat shock 70-related protein APG-1;Heat-shock protein family A member 4-like protein;Osmotic stress protein 94;, PF00012;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0016887;GO:0006457;GO:0006986;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:ATPase activity;, P:protein folding; P:response to unfolded protein;|O95757 A2ICT2 Q4W5M5 Q8IWA2,Heat shock 70 kDa protein 4L,Heat shock 70-related protein APG-1;Heat-shock protein family A member 4-like protein;Osmotic stress protein 94;, PF00012;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0016887;GO:0006457;GO:0006986;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:ATPase activity;, P:protein folding; P:response to unfolded protein; scaffold11 indexed_genome mRNA 28047652 28060316 . - . ID=transcript_2898;Q9ULD6 A1L4N5 D6RAE6 D6RBT4 Q4W5I8 Q86V55,Protein inturned,Inturned planar cell polarity effector homolog;PDZ domain-containing protein 6;, PF19031;PF19032;PF19033;, GO:0009986;GO:0036064;GO:0005737;GO:0031514;GO:0060271;GO:0042733;GO:0001736;GO:0031069;GO:0030216;GO:0060173;GO:0044458;GO:0051782;GO:0010839;GO:0007399;GO:0021915;GO:1905515;GO:0045880;GO:0030278;GO:0008589;GO:0060021;GO:0021513;GO:0043587;GO:0016192;, C:cell surface; C:ciliary basal body; C:cytoplasm; C:motile cilium;, , P:cilium assembly; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:hair follicle morphogenesis; P:keratinocyte differentiation; P:limb development; P:motile cilium assembly; P:negative regulation of cell division; P:negative regulation of keratinocyte proliferation; P:nervous system development; P:neural tube development; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:regulation of ossification; P:regulation of smoothened signaling pathway; P:roof of mouth development; P:spinal cord dorsal/ventral patterning; P:tongue morphogenesis; P:vesicle-mediated transport;|Q9ULD6 A1L4N5 D6RAE6 D6RBT4 Q4W5I8 Q86V55,Protein inturned,Inturned planar cell polarity effector homolog;PDZ domain-containing protein 6;, PF19031;PF19032;PF19033;, GO:0009986;GO:0036064;GO:0005737;GO:0031514;GO:0060271;GO:0042733;GO:0001736;GO:0031069;GO:0030216;GO:0060173;GO:0044458;GO:0051782;GO:0010839;GO:0007399;GO:0021915;GO:1905515;GO:0045880;GO:0030278;GO:0008589;GO:0060021;GO:0021513;GO:0043587;GO:0016192;, C:cell surface; C:ciliary basal body; C:cytoplasm; C:motile cilium;, , P:cilium assembly; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:hair follicle morphogenesis; P:keratinocyte differentiation; P:limb development; P:motile cilium assembly; P:negative regulation of cell division; P:negative regulation of keratinocyte proliferation; P:nervous system development; P:neural tube development; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:regulation of ossification; P:regulation of smoothened signaling pathway; P:roof of mouth development; P:spinal cord dorsal/ventral patterning; P:tongue morphogenesis; P:vesicle-mediated transport;|Q9ULD6 A1L4N5 D6RAE6 D6RBT4 Q4W5I8 Q86V55,Protein inturned,Inturned planar cell polarity effector homolog;PDZ domain-containing protein 6;, PF19031;PF19032;PF19033;, GO:0009986;GO:0036064;GO:0005737;GO:0031514;GO:0060271;GO:0042733;GO:0001736;GO:0031069;GO:0030216;GO:0060173;GO:0044458;GO:0051782;GO:0010839;GO:0007399;GO:0021915;GO:1905515;GO:0045880;GO:0030278;GO:0008589;GO:0060021;GO:0021513;GO:0043587;GO:0016192;, C:cell surface; C:ciliary basal body; C:cytoplasm; C:motile cilium;, , P:cilium assembly; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:hair follicle morphogenesis; P:keratinocyte differentiation; P:limb development; P:motile cilium assembly; P:negative regulation of cell division; P:negative regulation of keratinocyte proliferation; P:nervous system development; P:neural tube development; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:regulation of ossification; P:regulation of smoothened signaling pathway; P:roof of mouth development; P:spinal cord dorsal/ventral patterning; P:tongue morphogenesis; P:vesicle-mediated transport;|Q9ULD6 A1L4N5 D6RAE6 D6RBT4 Q4W5I8 Q86V55,Protein inturned,Inturned planar cell polarity effector homolog;PDZ domain-containing protein 6;, PF19031;PF19032;PF19033;, GO:0009986;GO:0036064;GO:0005737;GO:0031514;GO:0060271;GO:0042733;GO:0001736;GO:0031069;GO:0030216;GO:0060173;GO:0044458;GO:0051782;GO:0010839;GO:0007399;GO:0021915;GO:1905515;GO:0045880;GO:0030278;GO:0008589;GO:0060021;GO:0021513;GO:0043587;GO:0016192;, C:cell surface; C:ciliary basal body; C:cytoplasm; C:motile cilium;, , P:cilium assembly; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:hair follicle morphogenesis; P:keratinocyte differentiation; P:limb development; P:motile cilium assembly; P:negative regulation of cell division; P:negative regulation of keratinocyte proliferation; P:nervous system development; P:neural tube development; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:regulation of ossification; P:regulation of smoothened signaling pathway; P:roof of mouth development; P:spinal cord dorsal/ventral patterning; P:tongue morphogenesis; P:vesicle-mediated transport;|Q9ULD6 A1L4N5 D6RAE6 D6RBT4 Q4W5I8 Q86V55,Protein inturned,Inturned planar cell polarity effector homolog;PDZ domain-containing protein 6;, PF19031;PF19032;PF19033;, GO:0009986;GO:0036064;GO:0005737;GO:0031514;GO:0060271;GO:0042733;GO:0001736;GO:0031069;GO:0030216;GO:0060173;GO:0044458;GO:0051782;GO:0010839;GO:0007399;GO:0021915;GO:1905515;GO:0045880;GO:0030278;GO:0008589;GO:0060021;GO:0021513;GO:0043587;GO:0016192;, C:cell surface; C:ciliary basal body; C:cytoplasm; C:motile cilium;, , P:cilium assembly; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:hair follicle morphogenesis; P:keratinocyte differentiation; P:limb development; P:motile cilium assembly; P:negative regulation of cell division; P:negative regulation of keratinocyte proliferation; P:nervous system development; P:neural tube development; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:regulation of ossification; P:regulation of smoothened signaling pathway; P:roof of mouth development; P:spinal cord dorsal/ventral patterning; P:tongue morphogenesis; P:vesicle-mediated transport; scaffold11 indexed_genome mRNA 28061747 28117242 . - . ID=transcript_2899;Q9ULD6 A1L4N5 D6RAE6 D6RBT4 Q4W5I8 Q86V55,Protein inturned,Inturned planar cell polarity effector homolog;PDZ domain-containing protein 6;, PF19031;PF19032;PF19033;, GO:0009986;GO:0036064;GO:0005737;GO:0031514;GO:0060271;GO:0042733;GO:0001736;GO:0031069;GO:0030216;GO:0060173;GO:0044458;GO:0051782;GO:0010839;GO:0007399;GO:0021915;GO:1905515;GO:0045880;GO:0030278;GO:0008589;GO:0060021;GO:0021513;GO:0043587;GO:0016192;, C:cell surface; C:ciliary basal body; C:cytoplasm; C:motile cilium;, , P:cilium assembly; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:hair follicle morphogenesis; P:keratinocyte differentiation; P:limb development; P:motile cilium assembly; P:negative regulation of cell division; P:negative regulation of keratinocyte proliferation; P:nervous system development; P:neural tube development; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:regulation of ossification; P:regulation of smoothened signaling pathway; P:roof of mouth development; P:spinal cord dorsal/ventral patterning; P:tongue morphogenesis; P:vesicle-mediated transport;|Q9ULD6 A1L4N5 D6RAE6 D6RBT4 Q4W5I8 Q86V55,Protein inturned,Inturned planar cell polarity effector homolog;PDZ domain-containing protein 6;, PF19031;PF19032;PF19033;, GO:0009986;GO:0036064;GO:0005737;GO:0031514;GO:0060271;GO:0042733;GO:0001736;GO:0031069;GO:0030216;GO:0060173;GO:0044458;GO:0051782;GO:0010839;GO:0007399;GO:0021915;GO:1905515;GO:0045880;GO:0030278;GO:0008589;GO:0060021;GO:0021513;GO:0043587;GO:0016192;, C:cell surface; C:ciliary basal body; C:cytoplasm; C:motile cilium;, , P:cilium assembly; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:hair follicle morphogenesis; P:keratinocyte differentiation; P:limb development; P:motile cilium assembly; P:negative regulation of cell division; P:negative regulation of keratinocyte proliferation; P:nervous system development; P:neural tube development; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:regulation of ossification; P:regulation of smoothened signaling pathway; P:roof of mouth development; P:spinal cord dorsal/ventral patterning; P:tongue morphogenesis; P:vesicle-mediated transport;|Q9ULD6 A1L4N5 D6RAE6 D6RBT4 Q4W5I8 Q86V55,Protein inturned,Inturned planar cell polarity effector homolog;PDZ domain-containing protein 6;, PF19031;PF19032;PF19033;, GO:0009986;GO:0036064;GO:0005737;GO:0031514;GO:0060271;GO:0042733;GO:0001736;GO:0031069;GO:0030216;GO:0060173;GO:0044458;GO:0051782;GO:0010839;GO:0007399;GO:0021915;GO:1905515;GO:0045880;GO:0030278;GO:0008589;GO:0060021;GO:0021513;GO:0043587;GO:0016192;, C:cell surface; C:ciliary basal body; C:cytoplasm; C:motile cilium;, , P:cilium assembly; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:hair follicle morphogenesis; P:keratinocyte differentiation; P:limb development; P:motile cilium assembly; P:negative regulation of cell division; P:negative regulation of keratinocyte proliferation; P:nervous system development; P:neural tube development; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:regulation of ossification; P:regulation of smoothened signaling pathway; P:roof of mouth development; P:spinal cord dorsal/ventral patterning; P:tongue morphogenesis; P:vesicle-mediated transport;|Q9ULD6 A1L4N5 D6RAE6 D6RBT4 Q4W5I8 Q86V55,Protein inturned,Inturned planar cell polarity effector homolog;PDZ domain-containing protein 6;, PF19031;PF19032;PF19033;, GO:0009986;GO:0036064;GO:0005737;GO:0031514;GO:0060271;GO:0042733;GO:0001736;GO:0031069;GO:0030216;GO:0060173;GO:0044458;GO:0051782;GO:0010839;GO:0007399;GO:0021915;GO:1905515;GO:0045880;GO:0030278;GO:0008589;GO:0060021;GO:0021513;GO:0043587;GO:0016192;, C:cell surface; C:ciliary basal body; C:cytoplasm; C:motile cilium;, , P:cilium assembly; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:hair follicle morphogenesis; P:keratinocyte differentiation; P:limb development; P:motile cilium assembly; P:negative regulation of cell division; P:negative regulation of keratinocyte proliferation; P:nervous system development; P:neural tube development; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:regulation of ossification; P:regulation of smoothened signaling pathway; P:roof of mouth development; P:spinal cord dorsal/ventral patterning; P:tongue morphogenesis; P:vesicle-mediated transport;|Q9ULD6 A1L4N5 D6RAE6 D6RBT4 Q4W5I8 Q86V55,Protein inturned,Inturned planar cell polarity effector homolog;PDZ domain-containing protein 6;, PF19031;PF19032;PF19033;, GO:0009986;GO:0036064;GO:0005737;GO:0031514;GO:0060271;GO:0042733;GO:0001736;GO:0031069;GO:0030216;GO:0060173;GO:0044458;GO:0051782;GO:0010839;GO:0007399;GO:0021915;GO:1905515;GO:0045880;GO:0030278;GO:0008589;GO:0060021;GO:0021513;GO:0043587;GO:0016192;, C:cell surface; C:ciliary basal body; C:cytoplasm; C:motile cilium;, , P:cilium assembly; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:hair follicle morphogenesis; P:keratinocyte differentiation; P:limb development; P:motile cilium assembly; P:negative regulation of cell division; P:negative regulation of keratinocyte proliferation; P:nervous system development; P:neural tube development; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:regulation of ossification; P:regulation of smoothened signaling pathway; P:roof of mouth development; P:spinal cord dorsal/ventral patterning; P:tongue morphogenesis; P:vesicle-mediated transport; scaffold11 indexed_genome mRNA 30246209 30271009 . - . ID=transcript_2900;Q6V0I7 A8K5Z6 B5MDG4 Q3LIA6 Q8TCK7 Q9H5T6,Protocadherin Fat 4,Cadherin family member 14;FAT tumor suppressor homolog 4;Fat-like cadherin protein FAT-J;, PF00028;PF07645;PF02210;, GO:0045177;GO:0070062;GO:0016021;GO:0005886;GO:0005509;GO:0001658;GO:0098609;GO:0021987;GO:0072137;GO:0048565;GO:0008543;GO:0003007;GO:0007157;GO:0035329;GO:0007156;GO:0060122;GO:0022008;GO:0007219;GO:0043931;GO:0007009;GO:0072307;, C:apical part of cell; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:branching involved in ureteric bud morphogenesis; P:cell-cell adhesion; P:cerebral cortex development; P:condensed mesenchymal cell proliferation; P:digestive tract development; P:fibroblast growth factor receptor signaling pathway; P:heart morphogenesis; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:hippo signaling; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear receptor cell stereocilium organization; P:neurogenesis; P:Notch signaling pathway; P:ossification involved in bone maturation; P:plasma membrane organization; P:regulation of metanephric nephron tubule epithelial cell differentiation; scaffold11 indexed_genome mRNA 30284345 30284927 . + . ID=transcript_2901;Q6V0I7 A8K5Z6 B5MDG4 Q3LIA6 Q8TCK7 Q9H5T6,Protocadherin Fat 4,Cadherin family member 14;FAT tumor suppressor homolog 4;Fat-like cadherin protein FAT-J;, PF00028;PF07645;PF02210;, GO:0045177;GO:0070062;GO:0016021;GO:0005886;GO:0005509;GO:0001658;GO:0098609;GO:0021987;GO:0072137;GO:0048565;GO:0008543;GO:0003007;GO:0007157;GO:0035329;GO:0007156;GO:0060122;GO:0022008;GO:0007219;GO:0043931;GO:0007009;GO:0072307;, C:apical part of cell; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:branching involved in ureteric bud morphogenesis; P:cell-cell adhesion; P:cerebral cortex development; P:condensed mesenchymal cell proliferation; P:digestive tract development; P:fibroblast growth factor receptor signaling pathway; P:heart morphogenesis; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:hippo signaling; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear receptor cell stereocilium organization; P:neurogenesis; P:Notch signaling pathway; P:ossification involved in bone maturation; P:plasma membrane organization; P:regulation of metanephric nephron tubule epithelial cell differentiation; scaffold11 indexed_genome mRNA 30986566 30995065 . + . ID=transcript_2902;Q9ULJ7 A8K4V3 B4DHJ6 E9PDW0 Q6N064 Q6ZSE6,Ankyrin repeat domain-containing protein 50,, PF00023;PF12796;, GO:0005768;GO:0015031;GO:1990126;, C:endosome;, , P:protein transport; P:retrograde transport, endosome to plasma membrane; scaffold11 indexed_genome mRNA 32197119 32198676 . + . ID=transcript_2903;Q8NB90 C9JT97 Q86XW1 Q8NI20 Q8TDL7,ATPase family protein 2 homolog {ECO:0000305},Spermatogenesis-associated factor protein;Spermatogenesis-associated protein 5;, PF00004;PF17862;, GO:0005737;GO:0005739;GO:0005819;GO:0005524;GO:0016887;GO:0007420;GO:0030154;GO:0007283;, C:cytoplasm; C:mitochondrion; C:spindle;, F:ATP binding; F:ATPase activity;, P:brain development; P:cell differentiation; P:spermatogenesis;|Q8NB90 C9JT97 Q86XW1 Q8NI20 Q8TDL7,ATPase family protein 2 homolog {ECO:0000305},Spermatogenesis-associated factor protein;Spermatogenesis-associated protein 5;, PF00004;PF17862;, GO:0005737;GO:0005739;GO:0005819;GO:0005524;GO:0016887;GO:0007420;GO:0030154;GO:0007283;, C:cytoplasm; C:mitochondrion; C:spindle;, F:ATP binding; F:ATPase activity;, P:brain development; P:cell differentiation; P:spermatogenesis; scaffold11 indexed_genome mRNA 32422745 32527072 . - . ID=transcript_2904;Q8NB90 C9JT97 Q86XW1 Q8NI20 Q8TDL7,ATPase family protein 2 homolog {ECO:0000305},Spermatogenesis-associated factor protein;Spermatogenesis-associated protein 5;, PF00004;PF17862;, GO:0005737;GO:0005739;GO:0005819;GO:0005524;GO:0016887;GO:0007420;GO:0030154;GO:0007283;, C:cytoplasm; C:mitochondrion; C:spindle;, F:ATP binding; F:ATPase activity;, P:brain development; P:cell differentiation; P:spermatogenesis;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold11 indexed_genome mRNA 32527772 32595955 . + . ID=transcript_2905;P53370 A8K756 O95097 Q9UQD9,Nucleoside diphosphate-linked moiety X motif 6,Antisense basic fibroblast growth factor;Protein GFG;, PF00293;PF18290;, GO:0005737;GO:0005739;GO:0005634;GO:0047631;GO:0051287;GO:0035529;GO:0045786;GO:0008285;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:ADP-ribose diphosphatase activity; F:NAD binding; F:NADH pyrophosphatase activity;, P:negative regulation of cell cycle; P:negative regulation of cell population proliferation;|P53370 A8K756 O95097 Q9UQD9,Nucleoside diphosphate-linked moiety X motif 6,Antisense basic fibroblast growth factor;Protein GFG;, PF00293;PF18290;, GO:0005737;GO:0005739;GO:0005634;GO:0047631;GO:0051287;GO:0035529;GO:0045786;GO:0008285;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:ADP-ribose diphosphatase activity; F:NAD binding; F:NADH pyrophosphatase activity;, P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; scaffold11 indexed_genome mRNA 32596762 32606690 . + . ID=transcript_2906;Q9UCS5 Q9UCS6,Fibroblast growth factor 2,Basic fibroblast growth factor;Heparin-binding growth factor 2;, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005634;GO:0042056;GO:0019956;GO:0005125;GO:0005104;GO:0008083;GO:0008201;GO:0042802;GO:0005178;GO:0030374;GO:0090722;GO:0000187;GO:0009887;GO:0001658;GO:0030154;GO:0002042;GO:0006935;GO:0060591;GO:0019221;GO:0048598;GO:0030198;GO:0008543;GO:0014843;GO:0030214;GO:0032958;GO:0030324;GO:0000165;GO:0043537;GO:0060548;GO:0040037;GO:0010764;GO:0010629;GO:0061045;GO:0007399;GO:0038001;GO:0006661;GO:0045766;GO:0043536;GO:0060045;GO:0051781;GO:0042660;GO:0090050;GO:0008284;GO:2000573;GO:2001028;GO:2000546;GO:0010595;GO:0001938;GO:0050679;GO:1905278;GO:0070374;GO:0010628;GO:1902748;GO:0043406;GO:0043410;GO:0043552;GO:0014068;GO:0010863;GO:1902895;GO:0051897;GO:0001934;GO:1903672;GO:0045944;GO:0045893;GO:1904707;GO:1905564;GO:0007265;GO:0045765;GO:1903587;GO:0030334;GO:0090049;GO:2000544;GO:0051209;GO:0007165;GO:0035019;GO:0072089;GO:0042060;, C:cytoplasm; C:extracellular region; C:extracellular space; C:nucleus;, F:chemoattractant activity; F:chemokine binding; F:cytokine activity; F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparin binding; F:identical protein binding; F:integrin binding; F:nuclear receptor coactivator activity; F:receptor-receptor interaction;, P:activation of MAPK activity; P:animal organ morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cell differentiation; P:cell migration involved in sprouting angiogenesis; P:chemotaxis; P:chondroblast differentiation; P:cytokine-mediated signaling pathway; P:embryonic morphogenesis; P:extracellular matrix organization; P:fibroblast growth factor receptor signaling pathway; P:growth factor dependent regulation of skeletal muscle satellite cell proliferation; P:hyaluronan catabolic process; P:inositol phosphate biosynthetic process; P:lung development; P:MAPK cascade; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell death; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of fibroblast migration; P:negative regulation of gene expression; P:negative regulation of wound healing; P:nervous system development; P:paracrine signaling; P:phosphatidylinositol biosynthetic process; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell division; P:positive regulation of cell fate specification; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of lens fiber cell differentiation; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of vascular endothelial cell proliferation; P:Ras protein signal transduction; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:regulation of cell migration; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of endothelial cell chemotaxis to fibroblast growth factor; P:release of sequestered calcium ion into cytosol; P:signal transduction; P:somatic stem cell population maintenance; P:stem cell proliferation; P:wound healing; scaffold11 indexed_genome mRNA 32607166 32614176 . + . ID=transcript_2907;Q9UCS5 Q9UCS6,Fibroblast growth factor 2,Basic fibroblast growth factor;Heparin-binding growth factor 2;, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005634;GO:0042056;GO:0019956;GO:0005125;GO:0005104;GO:0008083;GO:0008201;GO:0042802;GO:0005178;GO:0030374;GO:0090722;GO:0000187;GO:0009887;GO:0001658;GO:0030154;GO:0002042;GO:0006935;GO:0060591;GO:0019221;GO:0048598;GO:0030198;GO:0008543;GO:0014843;GO:0030214;GO:0032958;GO:0030324;GO:0000165;GO:0043537;GO:0060548;GO:0040037;GO:0010764;GO:0010629;GO:0061045;GO:0007399;GO:0038001;GO:0006661;GO:0045766;GO:0043536;GO:0060045;GO:0051781;GO:0042660;GO:0090050;GO:0008284;GO:2000573;GO:2001028;GO:2000546;GO:0010595;GO:0001938;GO:0050679;GO:1905278;GO:0070374;GO:0010628;GO:1902748;GO:0043406;GO:0043410;GO:0043552;GO:0014068;GO:0010863;GO:1902895;GO:0051897;GO:0001934;GO:1903672;GO:0045944;GO:0045893;GO:1904707;GO:1905564;GO:0007265;GO:0045765;GO:1903587;GO:0030334;GO:0090049;GO:2000544;GO:0051209;GO:0007165;GO:0035019;GO:0072089;GO:0042060;, C:cytoplasm; C:extracellular region; C:extracellular space; C:nucleus;, F:chemoattractant activity; F:chemokine binding; F:cytokine activity; F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparin binding; F:identical protein binding; F:integrin binding; F:nuclear receptor coactivator activity; F:receptor-receptor interaction;, P:activation of MAPK activity; P:animal organ morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cell differentiation; P:cell migration involved in sprouting angiogenesis; P:chemotaxis; P:chondroblast differentiation; P:cytokine-mediated signaling pathway; P:embryonic morphogenesis; P:extracellular matrix organization; P:fibroblast growth factor receptor signaling pathway; P:growth factor dependent regulation of skeletal muscle satellite cell proliferation; P:hyaluronan catabolic process; P:inositol phosphate biosynthetic process; P:lung development; P:MAPK cascade; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell death; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of fibroblast migration; P:negative regulation of gene expression; P:negative regulation of wound healing; P:nervous system development; P:paracrine signaling; P:phosphatidylinositol biosynthetic process; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell division; P:positive regulation of cell fate specification; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of lens fiber cell differentiation; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of vascular endothelial cell proliferation; P:Ras protein signal transduction; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:regulation of cell migration; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of endothelial cell chemotaxis to fibroblast growth factor; P:release of sequestered calcium ion into cytosol; P:signal transduction; P:somatic stem cell population maintenance; P:stem cell proliferation; P:wound healing; scaffold11 indexed_genome mRNA 32723931 32728371 . + . ID=transcript_2908;Q6ZW61 D3DNX5 Q7Z342 Q7Z482 Q8NAB8,Bardet-Biedl syndrome 12 protein,, PF00118;, GO:0005929;GO:0005524;GO:0016887;GO:0051131;GO:0042755;GO:0042073;GO:0045599;GO:0045494;, C:cilium;, F:ATP binding; F:ATPase activity;, P:chaperone-mediated protein complex assembly; P:eating behavior; P:intraciliary transport; P:negative regulation of fat cell differentiation; P:photoreceptor cell maintenance; scaffold11 indexed_genome mRNA 32733807 32737274 . + . ID=transcript_2909;Q12798 B2R536,Centrin-1 {ECO:0000305},Caltractin isoform 2;, PF13499;, GO:0005814;GO:0005813;GO:0005829;GO:0032391;GO:0000922;GO:0005509;GO:0035973;GO:0051301;GO:0007099;GO:0000278;GO:0006289;, C:centriole; C:centrosome; C:cytosol; C:photoreceptor connecting cilium; C:spindle pole;, F:calcium ion binding;, P:aggrephagy; P:cell division; P:centriole replication; P:mitotic cell cycle; P:nucleotide-excision repair; scaffold11 indexed_genome mRNA 33024261 33046136 . - . ID=transcript_2910;Q96M93 A6NKN4 B7WPB0 D3DNX2 Q8IWG6 Q8NA06,Adenosine deaminase domain-containing protein 1,Testis nuclear RNA-binding protein;, PF02137;PF00035;, GO:0005737;GO:0005730;GO:0003726;GO:0003725;GO:0008251;GO:0006382;GO:0007275;GO:0006396;GO:0007286;, C:cytoplasm; C:nucleolus;, F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:multicellular organism development; P:RNA processing; P:spermatid development; scaffold11 indexed_genome mRNA 33060734 33073022 . - . ID=transcript_2911;Q96M93 A6NKN4 B7WPB0 D3DNX2 Q8IWG6 Q8NA06,Adenosine deaminase domain-containing protein 1,Testis nuclear RNA-binding protein;, PF02137;PF00035;, GO:0005737;GO:0005730;GO:0003726;GO:0003725;GO:0008251;GO:0006382;GO:0007275;GO:0006396;GO:0007286;, C:cytoplasm; C:nucleolus;, F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:multicellular organism development; P:RNA processing; P:spermatid development; scaffold11 indexed_genome mRNA 33082783 33114639 . + . ID=transcript_2912;Q9NTC3 Q9NTI4 Q9P2H6 Q9UPP3,Transmembrane protein KIAA1109 {ECO:0000305},Fragile site-associated protein;, PF10479;, GO:0016021;GO:0016020;GO:0005634;GO:0098793;GO:0032456;GO:0016197;GO:0006909;GO:0001558;GO:0030856;GO:0048488;, C:integral component of membrane; C:membrane; C:nucleus; C:presynapse;, , P:endocytic recycling; P:endosomal transport; P:phagocytosis; P:regulation of cell growth; P:regulation of epithelial cell differentiation; P:synaptic vesicle endocytosis;|Q9NTC3 Q9NTI4 Q9P2H6 Q9UPP3,Transmembrane protein KIAA1109 {ECO:0000305},Fragile site-associated protein;, PF10479;, GO:0016021;GO:0016020;GO:0005634;GO:0098793;GO:0032456;GO:0016197;GO:0006909;GO:0001558;GO:0030856;GO:0048488;, C:integral component of membrane; C:membrane; C:nucleus; C:presynapse;, , P:endocytic recycling; P:endosomal transport; P:phagocytosis; P:regulation of cell growth; P:regulation of epithelial cell differentiation; P:synaptic vesicle endocytosis;|Q9NTC3 Q9NTI4 Q9P2H6 Q9UPP3,Transmembrane protein KIAA1109 {ECO:0000305},Fragile site-associated protein;, PF10479;, GO:0016021;GO:0016020;GO:0005634;GO:0098793;GO:0032456;GO:0016197;GO:0006909;GO:0001558;GO:0030856;GO:0048488;, C:integral component of membrane; C:membrane; C:nucleus; C:presynapse;, , P:endocytic recycling; P:endosomal transport; P:phagocytosis; P:regulation of cell growth; P:regulation of epithelial cell differentiation; P:synaptic vesicle endocytosis;|Q9NTC3 Q9NTI4 Q9P2H6 Q9UPP3,Transmembrane protein KIAA1109 {ECO:0000305},Fragile site-associated protein;, PF10479;, GO:0016021;GO:0016020;GO:0005634;GO:0098793;GO:0032456;GO:0016197;GO:0006909;GO:0001558;GO:0030856;GO:0048488;, C:integral component of membrane; C:membrane; C:nucleus; C:presynapse;, , P:endocytic recycling; P:endosomal transport; P:phagocytosis; P:regulation of cell growth; P:regulation of epithelial cell differentiation; P:synaptic vesicle endocytosis;|Q9NTC3 Q9NTI4 Q9P2H6 Q9UPP3,Transmembrane protein KIAA1109 {ECO:0000305},Fragile site-associated protein;, PF10479;, GO:0016021;GO:0016020;GO:0005634;GO:0098793;GO:0032456;GO:0016197;GO:0006909;GO:0001558;GO:0030856;GO:0048488;, C:integral component of membrane; C:membrane; C:nucleus; C:presynapse;, , P:endocytic recycling; P:endosomal transport; P:phagocytosis; P:regulation of cell growth; P:regulation of epithelial cell differentiation; P:synaptic vesicle endocytosis;|Q9NTC3 Q9NTI4 Q9P2H6 Q9UPP3,Transmembrane protein KIAA1109 {ECO:0000305},Fragile site-associated protein;, PF10479;, GO:0016021;GO:0016020;GO:0005634;GO:0098793;GO:0032456;GO:0016197;GO:0006909;GO:0001558;GO:0030856;GO:0048488;, C:integral component of membrane; C:membrane; C:nucleus; C:presynapse;, , P:endocytic recycling; P:endosomal transport; P:phagocytosis; P:regulation of cell growth; P:regulation of epithelial cell differentiation; P:synaptic vesicle endocytosis;|Q9NTC3 Q9NTI4 Q9P2H6 Q9UPP3,Transmembrane protein KIAA1109 {ECO:0000305},Fragile site-associated protein;, PF10479;, GO:0016021;GO:0016020;GO:0005634;GO:0098793;GO:0032456;GO:0016197;GO:0006909;GO:0001558;GO:0030856;GO:0048488;, C:integral component of membrane; C:membrane; C:nucleus; C:presynapse;, , P:endocytic recycling; P:endosomal transport; P:phagocytosis; P:regulation of cell growth; P:regulation of epithelial cell differentiation; P:synaptic vesicle endocytosis;|Q9NTC3 Q9NTI4 Q9P2H6 Q9UPP3,Transmembrane protein KIAA1109 {ECO:0000305},Fragile site-associated protein;, PF10479;, GO:0016021;GO:0016020;GO:0005634;GO:0098793;GO:0032456;GO:0016197;GO:0006909;GO:0001558;GO:0030856;GO:0048488;, C:integral component of membrane; C:membrane; C:nucleus; C:presynapse;, , P:endocytic recycling; P:endosomal transport; P:phagocytosis; P:regulation of cell growth; P:regulation of epithelial cell differentiation; P:synaptic vesicle endocytosis; scaffold11 indexed_genome mRNA 33116384 33280996 . - . ID=transcript_2913;Q9NTC3 Q9NTI4 Q9P2H6 Q9UPP3,Transmembrane protein KIAA1109 {ECO:0000305},Fragile site-associated protein;, PF10479;, GO:0016021;GO:0016020;GO:0005634;GO:0098793;GO:0032456;GO:0016197;GO:0006909;GO:0001558;GO:0030856;GO:0048488;, C:integral component of membrane; C:membrane; C:nucleus; C:presynapse;, , P:endocytic recycling; P:endosomal transport; P:phagocytosis; P:regulation of cell growth; P:regulation of epithelial cell differentiation; P:synaptic vesicle endocytosis;|Q9NTC3 Q9NTI4 Q9P2H6 Q9UPP3,Transmembrane protein KIAA1109 {ECO:0000305},Fragile site-associated protein;, PF10479;, GO:0016021;GO:0016020;GO:0005634;GO:0098793;GO:0032456;GO:0016197;GO:0006909;GO:0001558;GO:0030856;GO:0048488;, C:integral component of membrane; C:membrane; C:nucleus; C:presynapse;, , P:endocytic recycling; P:endosomal transport; P:phagocytosis; P:regulation of cell growth; P:regulation of epithelial cell differentiation; P:synaptic vesicle endocytosis; scaffold11 indexed_genome mRNA 33465337 33536660 . + . ID=transcript_2914;Q13507 A7VJS1 E9PCJ9 O00593 Q15660 Q52M35 Q5G1L5,Short transient receptor potential channel 3,Transient receptor protein 3;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0005262;GO:0070679;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0007602;GO:0030168;GO:0010524;GO:1903244;GO:0051480;GO:0033198;GO:0051592;GO:0007338;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:calcium channel activity; F:inositol 1,4,5 trisphosphate binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:phototransduction; P:platelet activation; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cardiac muscle hypertrophy in response to stress; P:regulation of cytosolic calcium ion concentration; P:response to ATP; P:response to calcium ion; P:single fertilization;|Q13507 A7VJS1 E9PCJ9 O00593 Q15660 Q52M35 Q5G1L5,Short transient receptor potential channel 3,Transient receptor protein 3;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0005262;GO:0070679;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0007602;GO:0030168;GO:0010524;GO:1903244;GO:0051480;GO:0033198;GO:0051592;GO:0007338;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:calcium channel activity; F:inositol 1,4,5 trisphosphate binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:phototransduction; P:platelet activation; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cardiac muscle hypertrophy in response to stress; P:regulation of cytosolic calcium ion concentration; P:response to ATP; P:response to calcium ion; P:single fertilization;|Q13507 A7VJS1 E9PCJ9 O00593 Q15660 Q52M35 Q5G1L5,Short transient receptor potential channel 3,Transient receptor protein 3;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0005262;GO:0070679;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0007602;GO:0030168;GO:0010524;GO:1903244;GO:0051480;GO:0033198;GO:0051592;GO:0007338;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:calcium channel activity; F:inositol 1,4,5 trisphosphate binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:phototransduction; P:platelet activation; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cardiac muscle hypertrophy in response to stress; P:regulation of cytosolic calcium ion concentration; P:response to ATP; P:response to calcium ion; P:single fertilization;|Q13507 A7VJS1 E9PCJ9 O00593 Q15660 Q52M35 Q5G1L5,Short transient receptor potential channel 3,Transient receptor protein 3;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0005262;GO:0070679;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0007602;GO:0030168;GO:0010524;GO:1903244;GO:0051480;GO:0033198;GO:0051592;GO:0007338;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:calcium channel activity; F:inositol 1,4,5 trisphosphate binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:phototransduction; P:platelet activation; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cardiac muscle hypertrophy in response to stress; P:regulation of cytosolic calcium ion concentration; P:response to ATP; P:response to calcium ion; P:single fertilization;|Q13507 A7VJS1 E9PCJ9 O00593 Q15660 Q52M35 Q5G1L5,Short transient receptor potential channel 3,Transient receptor protein 3;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0005262;GO:0070679;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0007602;GO:0030168;GO:0010524;GO:1903244;GO:0051480;GO:0033198;GO:0051592;GO:0007338;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:calcium channel activity; F:inositol 1,4,5 trisphosphate binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:phototransduction; P:platelet activation; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cardiac muscle hypertrophy in response to stress; P:regulation of cytosolic calcium ion concentration; P:response to ATP; P:response to calcium ion; P:single fertilization; scaffold11 indexed_genome mRNA 34241281 34817154 . + . ID=transcript_2915;Q8N475 E9PCP6 Q9NSW7 Q9ULF7,Follistatin-related protein 5,Follistatin-like protein 5;, PF07648;, GO:0005576;GO:0005509;GO:0030154;GO:0007275;, C:extracellular region;, F:calcium ion binding;, P:cell differentiation; P:multicellular organism development;|Q8N475 E9PCP6 Q9NSW7 Q9ULF7,Follistatin-related protein 5,Follistatin-like protein 5;, PF07648;, GO:0005576;GO:0005509;GO:0030154;GO:0007275;, C:extracellular region;, F:calcium ion binding;, P:cell differentiation; P:multicellular organism development;|Q8N475 E9PCP6 Q9NSW7 Q9ULF7,Follistatin-related protein 5,Follistatin-like protein 5;, PF07648;, GO:0005576;GO:0005509;GO:0030154;GO:0007275;, C:extracellular region;, F:calcium ion binding;, P:cell differentiation; P:multicellular organism development; scaffold11 indexed_genome mRNA 37037095 37174268 . - . ID=transcript_2916;Q9Y4G8 D3DP27,Rap guanine nucleotide exchange factor 2,Cyclic nucleotide ras GEF;Neural RAP guanine nucleotide exchange protein;PDZ domain-containing guanine nucleotide exchange factor 1;RA-GEF-1;Ras/Rap1-associating GEF-1;, PF00595;PF00788;PF00617;PF00618;, GO:0016324;GO:0005923;GO:0005911;GO:0005737;GO:0005829;GO:0030139;GO:0005887;GO:0005770;GO:0016020;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0032991;GO:0045202;GO:0031697;GO:0005509;GO:0030552;GO:0019992;GO:0005096;GO:0005085;GO:0030165;GO:0070300;GO:0050699;GO:0071880;GO:0001568;GO:0031547;GO:0019933;GO:0071320;GO:0071321;GO:1990090;GO:0061028;GO:0090557;GO:0021884;GO:0007186;GO:0035556;GO:0000165;GO:0030033;GO:0008285;GO:0050774;GO:0048022;GO:0038180;GO:0001764;GO:0031175;GO:0007218;GO:2000481;GO:0043950;GO:2000670;GO:0070374;GO:0043547;GO:2001224;GO:0010976;GO:0032092;GO:0045860;GO:2001214;GO:0072659;GO:0032486;GO:1901888;GO:0048167;GO:0007264;GO:0021591;, C:apical plasma membrane; C:bicellular tight junction; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endocytic vesicle; C:integral component of plasma membrane; C:late endosome; C:membrane; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:beta-1 adrenergic receptor binding; F:calcium ion binding; F:cAMP binding; F:diacylglycerol binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:phosphatidic acid binding; F:WW domain binding;, P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:blood vessel development; P:brain-derived neurotrophic factor receptor signaling pathway; P:cAMP-mediated signaling; P:cellular response to cAMP; P:cellular response to cGMP; P:cellular response to nerve growth factor stimulus; P:establishment of endothelial barrier; P:establishment of endothelial intestinal barrier; P:forebrain neuron development; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:microvillus assembly; P:negative regulation of cell population proliferation; P:negative regulation of dendrite morphogenesis; P:negative regulation of melanin biosynthetic process; P:nerve growth factor signaling pathway; P:neuron migration; P:neuron projection development; P:neuropeptide signaling pathway; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-mediated signaling; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of neuron migration; P:positive regulation of neuron projection development; P:positive regulation of protein binding; P:positive regulation of protein kinase activity; P:positive regulation of vasculogenesis; P:protein localization to plasma membrane; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of synaptic plasticity; P:small GTPase mediated signal transduction; P:ventricular system development;|Q9Y4G8 D3DP27,Rap guanine nucleotide exchange factor 2,Cyclic nucleotide ras GEF;Neural RAP guanine nucleotide exchange protein;PDZ domain-containing guanine nucleotide exchange factor 1;RA-GEF-1;Ras/Rap1-associating GEF-1;, PF00595;PF00788;PF00617;PF00618;, GO:0016324;GO:0005923;GO:0005911;GO:0005737;GO:0005829;GO:0030139;GO:0005887;GO:0005770;GO:0016020;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0032991;GO:0045202;GO:0031697;GO:0005509;GO:0030552;GO:0019992;GO:0005096;GO:0005085;GO:0030165;GO:0070300;GO:0050699;GO:0071880;GO:0001568;GO:0031547;GO:0019933;GO:0071320;GO:0071321;GO:1990090;GO:0061028;GO:0090557;GO:0021884;GO:0007186;GO:0035556;GO:0000165;GO:0030033;GO:0008285;GO:0050774;GO:0048022;GO:0038180;GO:0001764;GO:0031175;GO:0007218;GO:2000481;GO:0043950;GO:2000670;GO:0070374;GO:0043547;GO:2001224;GO:0010976;GO:0032092;GO:0045860;GO:2001214;GO:0072659;GO:0032486;GO:1901888;GO:0048167;GO:0007264;GO:0021591;, C:apical plasma membrane; C:bicellular tight junction; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endocytic vesicle; C:integral component of plasma membrane; C:late endosome; C:membrane; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:beta-1 adrenergic receptor binding; F:calcium ion binding; F:cAMP binding; F:diacylglycerol binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:phosphatidic acid binding; F:WW domain binding;, P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:blood vessel development; P:brain-derived neurotrophic factor receptor signaling pathway; P:cAMP-mediated signaling; P:cellular response to cAMP; P:cellular response to cGMP; P:cellular response to nerve growth factor stimulus; P:establishment of endothelial barrier; P:establishment of endothelial intestinal barrier; P:forebrain neuron development; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:microvillus assembly; P:negative regulation of cell population proliferation; P:negative regulation of dendrite morphogenesis; P:negative regulation of melanin biosynthetic process; P:nerve growth factor signaling pathway; P:neuron migration; P:neuron projection development; P:neuropeptide signaling pathway; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-mediated signaling; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of neuron migration; P:positive regulation of neuron projection development; P:positive regulation of protein binding; P:positive regulation of protein kinase activity; P:positive regulation of vasculogenesis; P:protein localization to plasma membrane; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of synaptic plasticity; P:small GTPase mediated signal transduction; P:ventricular system development;|Q9Y4G8 D3DP27,Rap guanine nucleotide exchange factor 2,Cyclic nucleotide ras GEF;Neural RAP guanine nucleotide exchange protein;PDZ domain-containing guanine nucleotide exchange factor 1;RA-GEF-1;Ras/Rap1-associating GEF-1;, PF00595;PF00788;PF00617;PF00618;, GO:0016324;GO:0005923;GO:0005911;GO:0005737;GO:0005829;GO:0030139;GO:0005887;GO:0005770;GO:0016020;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0032991;GO:0045202;GO:0031697;GO:0005509;GO:0030552;GO:0019992;GO:0005096;GO:0005085;GO:0030165;GO:0070300;GO:0050699;GO:0071880;GO:0001568;GO:0031547;GO:0019933;GO:0071320;GO:0071321;GO:1990090;GO:0061028;GO:0090557;GO:0021884;GO:0007186;GO:0035556;GO:0000165;GO:0030033;GO:0008285;GO:0050774;GO:0048022;GO:0038180;GO:0001764;GO:0031175;GO:0007218;GO:2000481;GO:0043950;GO:2000670;GO:0070374;GO:0043547;GO:2001224;GO:0010976;GO:0032092;GO:0045860;GO:2001214;GO:0072659;GO:0032486;GO:1901888;GO:0048167;GO:0007264;GO:0021591;, C:apical plasma membrane; C:bicellular tight junction; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endocytic vesicle; C:integral component of plasma membrane; C:late endosome; C:membrane; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:beta-1 adrenergic receptor binding; F:calcium ion binding; F:cAMP binding; F:diacylglycerol binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:phosphatidic acid binding; F:WW domain binding;, P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:blood vessel development; P:brain-derived neurotrophic factor receptor signaling pathway; P:cAMP-mediated signaling; P:cellular response to cAMP; P:cellular response to cGMP; P:cellular response to nerve growth factor stimulus; P:establishment of endothelial barrier; P:establishment of endothelial intestinal barrier; P:forebrain neuron development; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:microvillus assembly; P:negative regulation of cell population proliferation; P:negative regulation of dendrite morphogenesis; P:negative regulation of melanin biosynthetic process; P:nerve growth factor signaling pathway; P:neuron migration; P:neuron projection development; P:neuropeptide signaling pathway; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-mediated signaling; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of neuron migration; P:positive regulation of neuron projection development; P:positive regulation of protein binding; P:positive regulation of protein kinase activity; P:positive regulation of vasculogenesis; P:protein localization to plasma membrane; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of synaptic plasticity; P:small GTPase mediated signal transduction; P:ventricular system development;|Q9Y4G8 D3DP27,Rap guanine nucleotide exchange factor 2,Cyclic nucleotide ras GEF;Neural RAP guanine nucleotide exchange protein;PDZ domain-containing guanine nucleotide exchange factor 1;RA-GEF-1;Ras/Rap1-associating GEF-1;, PF00595;PF00788;PF00617;PF00618;, GO:0016324;GO:0005923;GO:0005911;GO:0005737;GO:0005829;GO:0030139;GO:0005887;GO:0005770;GO:0016020;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0032991;GO:0045202;GO:0031697;GO:0005509;GO:0030552;GO:0019992;GO:0005096;GO:0005085;GO:0030165;GO:0070300;GO:0050699;GO:0071880;GO:0001568;GO:0031547;GO:0019933;GO:0071320;GO:0071321;GO:1990090;GO:0061028;GO:0090557;GO:0021884;GO:0007186;GO:0035556;GO:0000165;GO:0030033;GO:0008285;GO:0050774;GO:0048022;GO:0038180;GO:0001764;GO:0031175;GO:0007218;GO:2000481;GO:0043950;GO:2000670;GO:0070374;GO:0043547;GO:2001224;GO:0010976;GO:0032092;GO:0045860;GO:2001214;GO:0072659;GO:0032486;GO:1901888;GO:0048167;GO:0007264;GO:0021591;, C:apical plasma membrane; C:bicellular tight junction; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endocytic vesicle; C:integral component of plasma membrane; C:late endosome; C:membrane; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:beta-1 adrenergic receptor binding; F:calcium ion binding; F:cAMP binding; F:diacylglycerol binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:phosphatidic acid binding; F:WW domain binding;, P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:blood vessel development; P:brain-derived neurotrophic factor receptor signaling pathway; P:cAMP-mediated signaling; P:cellular response to cAMP; P:cellular response to cGMP; P:cellular response to nerve growth factor stimulus; P:establishment of endothelial barrier; P:establishment of endothelial intestinal barrier; P:forebrain neuron development; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:microvillus assembly; P:negative regulation of cell population proliferation; P:negative regulation of dendrite morphogenesis; P:negative regulation of melanin biosynthetic process; P:nerve growth factor signaling pathway; P:neuron migration; P:neuron projection development; P:neuropeptide signaling pathway; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-mediated signaling; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of neuron migration; P:positive regulation of neuron projection development; P:positive regulation of protein binding; P:positive regulation of protein kinase activity; P:positive regulation of vasculogenesis; P:protein localization to plasma membrane; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of synaptic plasticity; P:small GTPase mediated signal transduction; P:ventricular system development; scaffold11 indexed_genome mRNA 37498226 37587279 . + . ID=transcript_2917;Q9P278 Q05DC3 Q96I31 Q9H994,Folliculin-interacting protein 2 {ECO:0000303|PubMed:18663353},FNIP1-like protein {ECO:0000303|PubMed:18663353};O6-methylguanine-induced apoptosis 1 protein {ECO:0000303|PubMed:19137017};, PF14638;PF14637;PF14636;, GO:0034451;GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0008630;GO:0000122;GO:0033138;GO:0031334;GO:0006468;GO:0001932;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding;, P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein-containing complex assembly; P:protein phosphorylation; P:regulation of protein phosphorylation;|Q9P278 Q05DC3 Q96I31 Q9H994,Folliculin-interacting protein 2 {ECO:0000303|PubMed:18663353},FNIP1-like protein {ECO:0000303|PubMed:18663353};O6-methylguanine-induced apoptosis 1 protein {ECO:0000303|PubMed:19137017};, PF14638;PF14637;PF14636;, GO:0034451;GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0008630;GO:0000122;GO:0033138;GO:0031334;GO:0006468;GO:0001932;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding;, P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein-containing complex assembly; P:protein phosphorylation; P:regulation of protein phosphorylation;|Q9P278 Q05DC3 Q96I31 Q9H994,Folliculin-interacting protein 2 {ECO:0000303|PubMed:18663353},FNIP1-like protein {ECO:0000303|PubMed:18663353};O6-methylguanine-induced apoptosis 1 protein {ECO:0000303|PubMed:19137017};, PF14638;PF14637;PF14636;, GO:0034451;GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0008630;GO:0000122;GO:0033138;GO:0031334;GO:0006468;GO:0001932;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding;, P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein-containing complex assembly; P:protein phosphorylation; P:regulation of protein phosphorylation;|Q9P278 Q05DC3 Q96I31 Q9H994,Folliculin-interacting protein 2 {ECO:0000303|PubMed:18663353},FNIP1-like protein {ECO:0000303|PubMed:18663353};O6-methylguanine-induced apoptosis 1 protein {ECO:0000303|PubMed:19137017};, PF14638;PF14637;PF14636;, GO:0034451;GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0008630;GO:0000122;GO:0033138;GO:0031334;GO:0006468;GO:0001932;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding;, P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein-containing complex assembly; P:protein phosphorylation; P:regulation of protein phosphorylation;|Q9P278 Q05DC3 Q96I31 Q9H994,Folliculin-interacting protein 2 {ECO:0000303|PubMed:18663353},FNIP1-like protein {ECO:0000303|PubMed:18663353};O6-methylguanine-induced apoptosis 1 protein {ECO:0000303|PubMed:19137017};, PF14638;PF14637;PF14636;, GO:0034451;GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0008630;GO:0000122;GO:0033138;GO:0031334;GO:0006468;GO:0001932;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding;, P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein-containing complex assembly; P:protein phosphorylation; P:regulation of protein phosphorylation; scaffold11 indexed_genome mRNA 37663396 37717555 . + . ID=transcript_2918;Q08752 B2R9V2,Peptidyl-prolyl cis-trans isomerase D {ECO:0000305|PubMed:11350175, ECO:0000305|PubMed:20676357},40 kDa peptidyl-prolyl cis-trans isomerase;Cyclophilin-40 {ECO:0000303|PubMed:8509368};Cyclophilin-related protein;Rotamase D {ECO:0000305|PubMed:11350175, ECO:0000305|PubMed:20676357};, PF00160;PF13176;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0016018;GO:0030331;GO:0031072;GO:0030544;GO:0051879;GO:0003755;GO:0008134;GO:0006915;GO:0071492;GO:0061077;GO:0034389;GO:0000122;GO:0043065;GO:0050714;GO:0045070;GO:0006457;GO:0000413;GO:0015031;GO:0065003;GO:0019076;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cyclosporin A binding; F:estrogen receptor binding; F:heat shock protein binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:peptidyl-prolyl cis-trans isomerase activity; F:transcription factor binding;, P:apoptotic process; P:cellular response to UV-A; P:chaperone-mediated protein folding; P:lipid droplet organization; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of protein secretion; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein transport; P:protein-containing complex assembly; P:viral release from host cell;|Q08752 B2R9V2,Peptidyl-prolyl cis-trans isomerase D {ECO:0000305|PubMed:11350175, ECO:0000305|PubMed:20676357},40 kDa peptidyl-prolyl cis-trans isomerase;Cyclophilin-40 {ECO:0000303|PubMed:8509368};Cyclophilin-related protein;Rotamase D {ECO:0000305|PubMed:11350175, ECO:0000305|PubMed:20676357};, PF00160;PF13176;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0016018;GO:0030331;GO:0031072;GO:0030544;GO:0051879;GO:0003755;GO:0008134;GO:0006915;GO:0071492;GO:0061077;GO:0034389;GO:0000122;GO:0043065;GO:0050714;GO:0045070;GO:0006457;GO:0000413;GO:0015031;GO:0065003;GO:0019076;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cyclosporin A binding; F:estrogen receptor binding; F:heat shock protein binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:peptidyl-prolyl cis-trans isomerase activity; F:transcription factor binding;, P:apoptotic process; P:cellular response to UV-A; P:chaperone-mediated protein folding; P:lipid droplet organization; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of protein secretion; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein transport; P:protein-containing complex assembly; P:viral release from host cell;|Q08752 B2R9V2,Peptidyl-prolyl cis-trans isomerase D {ECO:0000305|PubMed:11350175, ECO:0000305|PubMed:20676357},40 kDa peptidyl-prolyl cis-trans isomerase;Cyclophilin-40 {ECO:0000303|PubMed:8509368};Cyclophilin-related protein;Rotamase D {ECO:0000305|PubMed:11350175, ECO:0000305|PubMed:20676357};, PF00160;PF13176;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0016018;GO:0030331;GO:0031072;GO:0030544;GO:0051879;GO:0003755;GO:0008134;GO:0006915;GO:0071492;GO:0061077;GO:0034389;GO:0000122;GO:0043065;GO:0050714;GO:0045070;GO:0006457;GO:0000413;GO:0015031;GO:0065003;GO:0019076;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cyclosporin A binding; F:estrogen receptor binding; F:heat shock protein binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:peptidyl-prolyl cis-trans isomerase activity; F:transcription factor binding;, P:apoptotic process; P:cellular response to UV-A; P:chaperone-mediated protein folding; P:lipid droplet organization; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of protein secretion; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein transport; P:protein-containing complex assembly; P:viral release from host cell;|Q16134 B4E3R9 J3KND9 Q7Z347,Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial,Electron-transferring-flavoprotein dehydrogenase;, , GO:0031305;GO:0005759;GO:0031966;GO:0051539;GO:0009055;GO:0004174;GO:0050660;GO:0046872;GO:0016491;GO:0043783;GO:0048038;GO:0048039;GO:0022900;GO:0033539;GO:0022904;GO:0006979;, C:integral component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane;, F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:electron-transferring-flavoprotein dehydrogenase activity; F:flavin adenine dinucleotide binding; F:metal ion binding; F:oxidoreductase activity; F:oxidoreductase activity, oxidizing metal ions with flavin as acceptor; F:quinone binding; F:ubiquinone binding;, P:electron transport chain; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:respiratory electron transport chain; P:response to oxidative stress;|Q16134 B4E3R9 J3KND9 Q7Z347,Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial,Electron-transferring-flavoprotein dehydrogenase;, , GO:0031305;GO:0005759;GO:0031966;GO:0051539;GO:0009055;GO:0004174;GO:0050660;GO:0046872;GO:0016491;GO:0043783;GO:0048038;GO:0048039;GO:0022900;GO:0033539;GO:0022904;GO:0006979;, C:integral component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane;, F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:electron-transferring-flavoprotein dehydrogenase activity; F:flavin adenine dinucleotide binding; F:metal ion binding; F:oxidoreductase activity; F:oxidoreductase activity, oxidizing metal ions with flavin as acceptor; F:quinone binding; F:ubiquinone binding;, P:electron transport chain; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:respiratory electron transport chain; P:response to oxidative stress;|Q16134 B4E3R9 J3KND9 Q7Z347,Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial,Electron-transferring-flavoprotein dehydrogenase;, , GO:0031305;GO:0005759;GO:0031966;GO:0051539;GO:0009055;GO:0004174;GO:0050660;GO:0046872;GO:0016491;GO:0043783;GO:0048038;GO:0048039;GO:0022900;GO:0033539;GO:0022904;GO:0006979;, C:integral component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane;, F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:electron-transferring-flavoprotein dehydrogenase activity; F:flavin adenine dinucleotide binding; F:metal ion binding; F:oxidoreductase activity; F:oxidoreductase activity, oxidizing metal ions with flavin as acceptor; F:quinone binding; F:ubiquinone binding;, P:electron transport chain; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:respiratory electron transport chain; P:response to oxidative stress;|Q8IYS8 B3KXU4 Q8WW13,Biorientation of chromosomes in cell division protein 1-like 2 {ECO:0000305},Biorientation of chromosomes in cell division protein 1 pseudogene {ECO:0000305};Protein FAM44C {ECO:0000305};, , GO:0005813;GO:0000940;GO:0005737;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0007049;GO:0051301;GO:0032515;, C:centrosome; C:condensed chromosome outer kinetochore; C:cytoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cell cycle; P:cell division; P:negative regulation of phosphoprotein phosphatase activity; scaffold11 indexed_genome mRNA 37717686 37720134 . + . ID=transcript_2919;Q504U0 B3KNH7,Renal cancer differentiation gene 1 protein {ECO:0000303|PubMed:25059753},, PF15725;, GO:0005737;, C:cytoplasm;|Q504U0 B3KNH7,Renal cancer differentiation gene 1 protein {ECO:0000303|PubMed:25059753},, PF15725;, GO:0005737;, C:cytoplasm;|Q504U0 B3KNH7,Renal cancer differentiation gene 1 protein {ECO:0000303|PubMed:25059753},, PF15725;, GO:0005737;, C:cytoplasm; scaffold11 indexed_genome mRNA 37725563 37727245 . + . ID=transcript_2920;Q9HBX9 B4DHD1 B4DTV2 Q2M215 Q3KU24 Q3KU25 Q3KU26,Relaxin receptor 1,Leucine-rich repeat-containing G-protein coupled receptor 7;Relaxin family peptide receptor 1;, PF00001;PF00057;PF13855;, GO:0005887;GO:0005886;GO:0008528;GO:0004930;GO:0046872;GO:0007190;GO:0007189;GO:0007186;GO:0009755;GO:0002862;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:metal ion binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hormone-mediated signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; scaffold11 indexed_genome mRNA 38037893 38085386 . - . ID=transcript_2921;Q7Z5S9 D3DP24 Q49A05 Q9NUT3,Transmembrane protein 144,, PF07857;, GO:0016021;GO:0015144;, C:integral component of membrane;, F:carbohydrate transmembrane transporter activity; scaffold11 indexed_genome mRNA 38137246 38201775 . + . ID=transcript_2922;Q6UWH4 Q498Z3 Q6IAF9 Q6ZMF2 Q86XL0,Golgi-associated kinase 1B {ECO:0000305},Expressed in nerve and epithelium during development;Protein FAM198B;, PF15051;, GO:0005794;GO:0000139;GO:0016021;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; scaffold11 indexed_genome mRNA 38953550 38963327 . - . ID=transcript_2923;P42262 A8MT92 I6L997 Q96FP6,Glutamate receptor 2 {ECO:0000305},AMPA-selective glutamate receptor 2;GluR-B;GluR-K2;Glutamate receptor ionotropic, AMPA 2;, PF01094;PF00060;PF10613;, GO:0032281;GO:0032279;GO:0030425;GO:0043197;GO:0030666;GO:0005789;GO:0060076;GO:0009897;GO:0005887;GO:0043025;GO:0005886;GO:0098794;GO:0014069;GO:0098839;GO:0098843;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0035235;GO:2000310;GO:0007165;GO:0035249;, C:AMPA glutamate receptor complex; C:asymmetric synapse; C:dendrite; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:excitatory synapse; C:external side of plasma membrane; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic endocytic zone;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:ionotropic glutamate receptor signaling pathway; P:regulation of NMDA receptor activity; P:signal transduction; P:synaptic transmission, glutamatergic;|P42262 A8MT92 I6L997 Q96FP6,Glutamate receptor 2 {ECO:0000305},AMPA-selective glutamate receptor 2;GluR-B;GluR-K2;Glutamate receptor ionotropic, AMPA 2;, PF01094;PF00060;PF10613;, GO:0032281;GO:0032279;GO:0030425;GO:0043197;GO:0030666;GO:0005789;GO:0060076;GO:0009897;GO:0005887;GO:0043025;GO:0005886;GO:0098794;GO:0014069;GO:0098839;GO:0098843;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0035235;GO:2000310;GO:0007165;GO:0035249;, C:AMPA glutamate receptor complex; C:asymmetric synapse; C:dendrite; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:excitatory synapse; C:external side of plasma membrane; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic endocytic zone;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:ionotropic glutamate receptor signaling pathway; P:regulation of NMDA receptor activity; P:signal transduction; P:synaptic transmission, glutamatergic;|P42262 A8MT92 I6L997 Q96FP6,Glutamate receptor 2 {ECO:0000305},AMPA-selective glutamate receptor 2;GluR-B;GluR-K2;Glutamate receptor ionotropic, AMPA 2;, PF01094;PF00060;PF10613;, GO:0032281;GO:0032279;GO:0030425;GO:0043197;GO:0030666;GO:0005789;GO:0060076;GO:0009897;GO:0005887;GO:0043025;GO:0005886;GO:0098794;GO:0014069;GO:0098839;GO:0098843;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0035235;GO:2000310;GO:0007165;GO:0035249;, C:AMPA glutamate receptor complex; C:asymmetric synapse; C:dendrite; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:excitatory synapse; C:external side of plasma membrane; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic endocytic zone;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:ionotropic glutamate receptor signaling pathway; P:regulation of NMDA receptor activity; P:signal transduction; P:synaptic transmission, glutamatergic; scaffold11 indexed_genome mRNA 38994943 39136209 . - . ID=transcript_2924;P42262 A8MT92 I6L997 Q96FP6,Glutamate receptor 2 {ECO:0000305},AMPA-selective glutamate receptor 2;GluR-B;GluR-K2;Glutamate receptor ionotropic, AMPA 2;, PF01094;PF00060;PF10613;, GO:0032281;GO:0032279;GO:0030425;GO:0043197;GO:0030666;GO:0005789;GO:0060076;GO:0009897;GO:0005887;GO:0043025;GO:0005886;GO:0098794;GO:0014069;GO:0098839;GO:0098843;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0035235;GO:2000310;GO:0007165;GO:0035249;, C:AMPA glutamate receptor complex; C:asymmetric synapse; C:dendrite; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:excitatory synapse; C:external side of plasma membrane; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic endocytic zone;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:ionotropic glutamate receptor signaling pathway; P:regulation of NMDA receptor activity; P:signal transduction; P:synaptic transmission, glutamatergic;|P42261 B7Z2S0 B7Z2W8 B7Z3F6 B7Z9G9 D3DQI4 E7ESV8 Q2NKM6,Glutamate receptor 1,AMPA-selective glutamate receptor 1;GluR-A;GluR-K1;Glutamate receptor ionotropic, AMPA 1;, PF01094;PF00060;PF10613;, GO:0032281;GO:0044308;GO:0009986;GO:0030425;GO:0043197;GO:0032591;GO:0031901;GO:0030666;GO:0005789;GO:0033116;GO:0012507;GO:0060076;GO:0098978;GO:0099061;GO:0044309;GO:0043025;GO:0099544;GO:0005886;GO:0014069;GO:0055037;GO:0055038;GO:0097060;GO:0030672;GO:0004971;GO:0001540;GO:0008066;GO:0015276;GO:0099583;GO:0030165;GO:0038023;GO:1904315;GO:0071242;GO:0007268;GO:0048208;GO:0006888;GO:0007616;GO:0060292;GO:0031623;GO:2000310;GO:0007165;, C:AMPA glutamate receptor complex; C:axonal spine; C:cell surface; C:dendrite; C:dendritic spine; C:dendritic spine membrane; C:early endosome membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:excitatory synapse; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:neuron spine; C:neuronal cell body; C:perisynaptic space; C:plasma membrane; C:postsynaptic density; C:recycling endosome; C:recycling endosome membrane; C:synaptic membrane; C:synaptic vesicle membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:glutamate receptor activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to ammonium ion; P:chemical synaptic transmission; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:long-term memory; P:long-term synaptic depression; P:receptor internalization; P:regulation of NMDA receptor activity; P:signal transduction; scaffold11 indexed_genome mRNA 39183302 39277735 . - . ID=transcript_2925;P48167 A8K3K2 D3DP23 F5GWE1,Glycine receptor subunit beta,Glycine receptor 58 kDa subunit;, PF02931;PF02932;, GO:0005737;GO:0030425;GO:0098982;GO:0016935;GO:0098690;GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0016934;GO:0016933;GO:0016594;GO:0030594;GO:0044877;GO:0004888;GO:1904315;GO:0007340;GO:0007628;GO:0007268;GO:1902476;GO:0097112;GO:0034220;GO:0006811;GO:0007399;GO:0050877;GO:0007218;GO:0042391;GO:0043200;GO:0060013;GO:0007165;GO:0001964;GO:0060012;GO:0007601;, C:cytoplasm; C:dendrite; C:GABA-ergic synapse; C:glycine-gated chloride channel complex; C:glycinergic synapse; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:extracellularly glycine-gated chloride channel activity; F:extracellularly glycine-gated ion channel activity; F:glycine binding; F:neurotransmitter receptor activity; F:protein-containing complex binding; F:transmembrane signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:acrosome reaction; P:adult walking behavior; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid receptor clustering; P:ion transmembrane transport; P:ion transport; P:nervous system development; P:nervous system process; P:neuropeptide signaling pathway; P:regulation of membrane potential; P:response to amino acid; P:righting reflex; P:signal transduction; P:startle response; P:synaptic transmission, glycinergic; P:visual perception; scaffold11 indexed_genome mRNA 39366599 39626927 . + . ID=transcript_2926;Q9NRA1 B4DU34 B9EGR8 Q4W5M9 Q9UL22,Platelet-derived growth factor C,Fallotein;Spinal cord-derived growth factor;VEGF-E;, PF00431;PF00341;, GO:0009986;GO:0005829;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0000139;GO:0005634;GO:0005886;GO:0008083;GO:0070851;GO:0005161;GO:0042803;GO:0007171;GO:0009887;GO:0060348;GO:0071230;GO:0007417;GO:0048565;GO:0048568;GO:0048008;GO:0051781;GO:0030335;GO:0008284;GO:0120162;GO:0070374;GO:0048146;GO:0043406;GO:0014068;GO:0031954;GO:0050730;, C:cell surface; C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi membrane; C:nucleus; C:plasma membrane;, F:growth factor activity; F:growth factor receptor binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity;, P:activation of transmembrane receptor protein tyrosine kinase activity; P:animal organ morphogenesis; P:bone development; P:cellular response to amino acid stimulus; P:central nervous system development; P:digestive tract development; P:embryonic organ development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of MAP kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein autophosphorylation; P:regulation of peptidyl-tyrosine phosphorylation;|Q9NRA1 B4DU34 B9EGR8 Q4W5M9 Q9UL22,Platelet-derived growth factor C,Fallotein;Spinal cord-derived growth factor;VEGF-E;, PF00431;PF00341;, GO:0009986;GO:0005829;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0000139;GO:0005634;GO:0005886;GO:0008083;GO:0070851;GO:0005161;GO:0042803;GO:0007171;GO:0009887;GO:0060348;GO:0071230;GO:0007417;GO:0048565;GO:0048568;GO:0048008;GO:0051781;GO:0030335;GO:0008284;GO:0120162;GO:0070374;GO:0048146;GO:0043406;GO:0014068;GO:0031954;GO:0050730;, C:cell surface; C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi membrane; C:nucleus; C:plasma membrane;, F:growth factor activity; F:growth factor receptor binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity;, P:activation of transmembrane receptor protein tyrosine kinase activity; P:animal organ morphogenesis; P:bone development; P:cellular response to amino acid stimulus; P:central nervous system development; P:digestive tract development; P:embryonic organ development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of MAP kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein autophosphorylation; P:regulation of peptidyl-tyrosine phosphorylation;|Q9NRA1 B4DU34 B9EGR8 Q4W5M9 Q9UL22,Platelet-derived growth factor C,Fallotein;Spinal cord-derived growth factor;VEGF-E;, PF00431;PF00341;, GO:0009986;GO:0005829;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0000139;GO:0005634;GO:0005886;GO:0008083;GO:0070851;GO:0005161;GO:0042803;GO:0007171;GO:0009887;GO:0060348;GO:0071230;GO:0007417;GO:0048565;GO:0048568;GO:0048008;GO:0051781;GO:0030335;GO:0008284;GO:0120162;GO:0070374;GO:0048146;GO:0043406;GO:0014068;GO:0031954;GO:0050730;, C:cell surface; C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi membrane; C:nucleus; C:plasma membrane;, F:growth factor activity; F:growth factor receptor binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity;, P:activation of transmembrane receptor protein tyrosine kinase activity; P:animal organ morphogenesis; P:bone development; P:cellular response to amino acid stimulus; P:central nervous system development; P:digestive tract development; P:embryonic organ development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of MAP kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein autophosphorylation; P:regulation of peptidyl-tyrosine phosphorylation; scaffold11 indexed_genome mRNA 40396652 40426139 . + . ID=transcript_2927;P43234,Cathepsin O,, PF00112;, GO:0005615;GO:0005764;GO:0004197;GO:0006508;GO:0051603;, C:extracellular space; C:lysosome;, F:cysteine-type endopeptidase activity;, P:proteolysis; P:proteolysis involved in cellular protein catabolic process;|P43234,Cathepsin O,, PF00112;, GO:0005615;GO:0005764;GO:0004197;GO:0006508;GO:0051603;, C:extracellular space; C:lysosome;, F:cysteine-type endopeptidase activity;, P:proteolysis; P:proteolysis involved in cellular protein catabolic process;|P43234,Cathepsin O,, PF00112;, GO:0005615;GO:0005764;GO:0004197;GO:0006508;GO:0051603;, C:extracellular space; C:lysosome;, F:cysteine-type endopeptidase activity;, P:proteolysis; P:proteolysis involved in cellular protein catabolic process; scaffold11 indexed_genome mRNA 40433583 40451610 . - . ID=transcript_2928;P48775 A8K053,Tryptophan 2,3-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03020},Tryptamin 2,3-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03020};Tryptophan oxygenase {ECO:0000255|HAMAP-Rule:MF_03020};Tryptophan pyrrolase {ECO:0000255|HAMAP-Rule:MF_03020};Tryptophanase {ECO:0000255|HAMAP-Rule:MF_03020};, PF03301;, GO:0005829;GO:0016597;GO:0020037;GO:0042802;GO:0046872;GO:0019825;GO:0004833;GO:0051289;GO:1904842;GO:0006569;GO:0019442;GO:0019441;, C:cytosol;, F:amino acid binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:oxygen binding; F:tryptophan 2,3-dioxygenase activity;, P:protein homotetramerization; P:response to nitroglycerin; P:tryptophan catabolic process; P:tryptophan catabolic process to acetyl-CoA; P:tryptophan catabolic process to kynurenine;|P48775 A8K053,Tryptophan 2,3-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03020},Tryptamin 2,3-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03020};Tryptophan oxygenase {ECO:0000255|HAMAP-Rule:MF_03020};Tryptophan pyrrolase {ECO:0000255|HAMAP-Rule:MF_03020};Tryptophanase {ECO:0000255|HAMAP-Rule:MF_03020};, PF03301;, GO:0005829;GO:0016597;GO:0020037;GO:0042802;GO:0046872;GO:0019825;GO:0004833;GO:0051289;GO:1904842;GO:0006569;GO:0019442;GO:0019441;, C:cytosol;, F:amino acid binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:oxygen binding; F:tryptophan 2,3-dioxygenase activity;, P:protein homotetramerization; P:response to nitroglycerin; P:tryptophan catabolic process; P:tryptophan catabolic process to acetyl-CoA; P:tryptophan catabolic process to kynurenine;|P48775 A8K053,Tryptophan 2,3-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03020},Tryptamin 2,3-dioxygenase {ECO:0000255|HAMAP-Rule:MF_03020};Tryptophan oxygenase {ECO:0000255|HAMAP-Rule:MF_03020};Tryptophan pyrrolase {ECO:0000255|HAMAP-Rule:MF_03020};Tryptophanase {ECO:0000255|HAMAP-Rule:MF_03020};, PF03301;, GO:0005829;GO:0016597;GO:0020037;GO:0042802;GO:0046872;GO:0019825;GO:0004833;GO:0051289;GO:1904842;GO:0006569;GO:0019442;GO:0019441;, C:cytosol;, F:amino acid binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:oxygen binding; F:tryptophan 2,3-dioxygenase activity;, P:protein homotetramerization; P:response to nitroglycerin; P:tryptophan catabolic process; P:tryptophan catabolic process to acetyl-CoA; P:tryptophan catabolic process to kynurenine; scaffold11 indexed_genome mRNA 40539385 40591530 . - . ID=transcript_2929;Q02153 B7Z426 Q86WY5,Guanylate cyclase soluble subunit beta-1 {ECO:0000305},Guanylate cyclase soluble subunit beta-3 {ECO:0000303|PubMed:1352257};Soluble guanylate cyclase small subunit;, PF00211;PF07700;PF07701;, GO:0008074;GO:0048786;GO:0005525;GO:0004383;GO:0020037;GO:0046872;GO:0038023;GO:0008015;GO:0071732;GO:0006182;GO:0019934;GO:0007263;GO:0038060;GO:0099555;, C:guanylate cyclase complex, soluble; C:presynaptic active zone;, F:GTP binding; F:guanylate cyclase activity; F:heme binding; F:metal ion binding; F:signaling receptor activity;, P:blood circulation; P:cellular response to nitric oxide; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:nitric oxide mediated signal transduction; P:nitric oxide-cGMP-mediated signaling pathway; P:trans-synaptic signaling by nitric oxide, modulating synaptic transmission;|Q02153 B7Z426 Q86WY5,Guanylate cyclase soluble subunit beta-1 {ECO:0000305},Guanylate cyclase soluble subunit beta-3 {ECO:0000303|PubMed:1352257};Soluble guanylate cyclase small subunit;, PF00211;PF07700;PF07701;, GO:0008074;GO:0048786;GO:0005525;GO:0004383;GO:0020037;GO:0046872;GO:0038023;GO:0008015;GO:0071732;GO:0006182;GO:0019934;GO:0007263;GO:0038060;GO:0099555;, C:guanylate cyclase complex, soluble; C:presynaptic active zone;, F:GTP binding; F:guanylate cyclase activity; F:heme binding; F:metal ion binding; F:signaling receptor activity;, P:blood circulation; P:cellular response to nitric oxide; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:nitric oxide mediated signal transduction; P:nitric oxide-cGMP-mediated signaling pathway; P:trans-synaptic signaling by nitric oxide, modulating synaptic transmission;|Q02153 B7Z426 Q86WY5,Guanylate cyclase soluble subunit beta-1 {ECO:0000305},Guanylate cyclase soluble subunit beta-3 {ECO:0000303|PubMed:1352257};Soluble guanylate cyclase small subunit;, PF00211;PF07700;PF07701;, GO:0008074;GO:0048786;GO:0005525;GO:0004383;GO:0020037;GO:0046872;GO:0038023;GO:0008015;GO:0071732;GO:0006182;GO:0019934;GO:0007263;GO:0038060;GO:0099555;, C:guanylate cyclase complex, soluble; C:presynaptic active zone;, F:GTP binding; F:guanylate cyclase activity; F:heme binding; F:metal ion binding; F:signaling receptor activity;, P:blood circulation; P:cellular response to nitric oxide; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:nitric oxide mediated signal transduction; P:nitric oxide-cGMP-mediated signaling pathway; P:trans-synaptic signaling by nitric oxide, modulating synaptic transmission; scaffold11 indexed_genome mRNA 40620263 40685825 . - . ID=transcript_2930;Q02108 D3DP19 D6RDW3 O43843 Q8TAH3,Guanylate cyclase soluble subunit alpha-1 {ECO:0000305},Guanylate cyclase soluble subunit alpha-3 {ECO:0000303|PubMed:1352257};Soluble guanylate cyclase large subunit;, PF00211;PF07700;PF07701;, GO:0098982;GO:0098978;GO:0008074;GO:0005525;GO:0004383;GO:0020037;GO:0038023;GO:0008015;GO:0006182;GO:0007263;GO:0010750;GO:0008217;GO:0060087;GO:0098925;, C:GABA-ergic synapse; C:glutamatergic synapse; C:guanylate cyclase complex, soluble;, F:GTP binding; F:guanylate cyclase activity; F:heme binding; F:signaling receptor activity;, P:blood circulation; P:cGMP biosynthetic process; P:nitric oxide mediated signal transduction; P:positive regulation of nitric oxide mediated signal transduction; P:regulation of blood pressure; P:relaxation of vascular associated smooth muscle; P:retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission; scaffold11 indexed_genome mRNA 40972772 40986816 . - . ID=transcript_2931;Q6PF04 Q96SS9,Zinc finger protein 613,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q86T29 B3KVG4 D3DXJ0 Q86T91,Zinc finger protein 605,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q86T29 B3KVG4 D3DXJ0 Q86T91,Zinc finger protein 605,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q86T29 B3KVG4 D3DXJ0 Q86T91,Zinc finger protein 605,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 41004086 41026074 . + . ID=transcript_2932;P17031 Q86X57 Q9NWL3,Zinc finger protein 26,Zinc finger protein KOX20;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 41062482 41069747 . + . ID=transcript_2933;P51523 B2RAK5 D3DXJ1 Q3ZCV9 Q5D057 Q86XU8 Q9NNX7 Q9UC17 Q9UC18,Zinc finger protein 84,Zinc finger protein HPF2;, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II;|P51523 B2RAK5 D3DXJ1 Q3ZCV9 Q5D057 Q86XU8 Q9NNX7 Q9UC17 Q9UC18,Zinc finger protein 84,Zinc finger protein HPF2;, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 41094211 41109275 . + . ID=transcript_2934;P52738 D3DXJ3 Q05CP6 Q8IV75,Zinc finger protein 140,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P52738 D3DXJ3 Q05CP6 Q8IV75,Zinc finger protein 140,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 41119913 41131871 . - . ID=transcript_2935;A8MT65,Zinc finger protein 891,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 41131993 41149504 . + . ID=transcript_2936;P21506 B2RBS1 Q8TC91,Zinc finger protein 10,Zinc finger protein KOX1;, PF01352;PF00096;, GO:0005634;GO:0032991;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus; C:protein-containing complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 41164503 41197626 . + . ID=transcript_2937;Q14587 Q8TDG8 Q96RH4 Q9BZJ9,Zinc finger protein 268,Zinc finger protein HZF3;, PF01352;PF00096;, GO:0015629;GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0046872;GO:0000978;GO:0030154;GO:0071356;GO:0043066;GO:0071157;GO:0008285;GO:0000122;GO:0043065;GO:0045597;GO:0030335;GO:0008284;GO:1901224;GO:0045732;GO:0090073;GO:0001934;GO:0045944;GO:0007346;GO:0043497;GO:0006357;GO:0006355;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell differentiation; P:cellular response to tumor necrosis factor; P:negative regulation of apoptotic process; P:negative regulation of cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein catabolic process; P:positive regulation of protein homodimerization activity; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of mitotic cell cycle; P:regulation of protein heterodimerization activity; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q14587 Q8TDG8 Q96RH4 Q9BZJ9,Zinc finger protein 268,Zinc finger protein HZF3;, PF01352;PF00096;, GO:0015629;GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0046872;GO:0000978;GO:0030154;GO:0071356;GO:0043066;GO:0071157;GO:0008285;GO:0000122;GO:0043065;GO:0045597;GO:0030335;GO:0008284;GO:1901224;GO:0045732;GO:0090073;GO:0001934;GO:0045944;GO:0007346;GO:0043497;GO:0006357;GO:0006355;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell differentiation; P:cellular response to tumor necrosis factor; P:negative regulation of apoptotic process; P:negative regulation of cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein catabolic process; P:positive regulation of protein homodimerization activity; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of mitotic cell cycle; P:regulation of protein heterodimerization activity; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold11 indexed_genome mRNA 41274866 41279734 . + . ID=transcript_2938;Q14587 Q8TDG8 Q96RH4 Q9BZJ9,Zinc finger protein 268,Zinc finger protein HZF3;, PF01352;PF00096;, GO:0015629;GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0046872;GO:0000978;GO:0030154;GO:0071356;GO:0043066;GO:0071157;GO:0008285;GO:0000122;GO:0043065;GO:0045597;GO:0030335;GO:0008284;GO:1901224;GO:0045732;GO:0090073;GO:0001934;GO:0045944;GO:0007346;GO:0043497;GO:0006357;GO:0006355;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell differentiation; P:cellular response to tumor necrosis factor; P:negative regulation of apoptotic process; P:negative regulation of cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein catabolic process; P:positive regulation of protein homodimerization activity; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of mitotic cell cycle; P:regulation of protein heterodimerization activity; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold11 indexed_genome mRNA 41282750 41312703 . - . ID=transcript_2939;Q14587 Q8TDG8 Q96RH4 Q9BZJ9,Zinc finger protein 268,Zinc finger protein HZF3;, PF01352;PF00096;, GO:0015629;GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0046872;GO:0000978;GO:0030154;GO:0071356;GO:0043066;GO:0071157;GO:0008285;GO:0000122;GO:0043065;GO:0045597;GO:0030335;GO:0008284;GO:1901224;GO:0045732;GO:0090073;GO:0001934;GO:0045944;GO:0007346;GO:0043497;GO:0006357;GO:0006355;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell differentiation; P:cellular response to tumor necrosis factor; P:negative regulation of apoptotic process; P:negative regulation of cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein catabolic process; P:positive regulation of protein homodimerization activity; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of mitotic cell cycle; P:regulation of protein heterodimerization activity; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold11 indexed_genome mRNA 41327222 41370018 . + . ID=transcript_2940;Q08378 A5PKX6 O43241 Q6P9C7 Q86XW3 Q8TDA9 Q8WZA3,Golgin subfamily A member 3,Golgi complex-associated protein of 170 kDa;Golgin-160;, , GO:0005829;GO:0090498;GO:0005794;GO:0032580;GO:0000139;GO:0016020;GO:0005730;GO:0005654;GO:0045296;GO:0007283;, C:cytosol; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:membrane; C:nucleolus; C:nucleoplasm;, F:cadherin binding;, P:spermatogenesis;|Q08378 A5PKX6 O43241 Q6P9C7 Q86XW3 Q8TDA9 Q8WZA3,Golgin subfamily A member 3,Golgi complex-associated protein of 170 kDa;Golgin-160;, , GO:0005829;GO:0090498;GO:0005794;GO:0032580;GO:0000139;GO:0016020;GO:0005730;GO:0005654;GO:0045296;GO:0007283;, C:cytosol; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:membrane; C:nucleolus; C:nucleoplasm;, F:cadherin binding;, P:spermatogenesis;|Q08378 A5PKX6 O43241 Q6P9C7 Q86XW3 Q8TDA9 Q8WZA3,Golgin subfamily A member 3,Golgi complex-associated protein of 170 kDa;Golgin-160;, , GO:0005829;GO:0090498;GO:0005794;GO:0032580;GO:0000139;GO:0016020;GO:0005730;GO:0005654;GO:0045296;GO:0007283;, C:cytosol; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:membrane; C:nucleolus; C:nucleoplasm;, F:cadherin binding;, P:spermatogenesis;|Q08378 A5PKX6 O43241 Q6P9C7 Q86XW3 Q8TDA9 Q8WZA3,Golgin subfamily A member 3,Golgi complex-associated protein of 170 kDa;Golgin-160;, , GO:0005829;GO:0090498;GO:0005794;GO:0032580;GO:0000139;GO:0016020;GO:0005730;GO:0005654;GO:0045296;GO:0007283;, C:cytosol; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:membrane; C:nucleolus; C:nucleoplasm;, F:cadherin binding;, P:spermatogenesis;|Q08378 A5PKX6 O43241 Q6P9C7 Q86XW3 Q8TDA9 Q8WZA3,Golgin subfamily A member 3,Golgi complex-associated protein of 170 kDa;Golgin-160;, , GO:0005829;GO:0090498;GO:0005794;GO:0032580;GO:0000139;GO:0016020;GO:0005730;GO:0005654;GO:0045296;GO:0007283;, C:cytosol; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:membrane; C:nucleolus; C:nucleoplasm;, F:cadherin binding;, P:spermatogenesis;|Q08378 A5PKX6 O43241 Q6P9C7 Q86XW3 Q8TDA9 Q8WZA3,Golgin subfamily A member 3,Golgi complex-associated protein of 170 kDa;Golgin-160;, , GO:0005829;GO:0090498;GO:0005794;GO:0032580;GO:0000139;GO:0016020;GO:0005730;GO:0005654;GO:0045296;GO:0007283;, C:cytosol; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:membrane; C:nucleolus; C:nucleoplasm;, F:cadherin binding;, P:spermatogenesis;|Q08378 A5PKX6 O43241 Q6P9C7 Q86XW3 Q8TDA9 Q8WZA3,Golgin subfamily A member 3,Golgi complex-associated protein of 170 kDa;Golgin-160;, , GO:0005829;GO:0090498;GO:0005794;GO:0032580;GO:0000139;GO:0016020;GO:0005730;GO:0005654;GO:0045296;GO:0007283;, C:cytosol; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:membrane; C:nucleolus; C:nucleoplasm;, F:cadherin binding;, P:spermatogenesis; scaffold11 indexed_genome mRNA 41385440 41415744 . + . ID=transcript_2941;Q86XL3 A8KAG3 B3KN97 B3KSF8 O75176 Q6P6A5 Q8TAZ9 Q96DH4,Ankyrin repeat and LEM domain-containing protein 2,LEM domain-containing protein 4;, PF01693;PF03020;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0051721;GO:0019888;GO:0051301;GO:0007417;GO:0007084;GO:0043066;GO:0042326;GO:0035307;GO:0050790;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity;, P:cell division; P:central nervous system development; P:mitotic nuclear envelope reassembly; P:negative regulation of apoptotic process; P:negative regulation of phosphorylation; P:positive regulation of protein dephosphorylation; P:regulation of catalytic activity;|Q86XL3 A8KAG3 B3KN97 B3KSF8 O75176 Q6P6A5 Q8TAZ9 Q96DH4,Ankyrin repeat and LEM domain-containing protein 2,LEM domain-containing protein 4;, PF01693;PF03020;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0051721;GO:0019888;GO:0051301;GO:0007417;GO:0007084;GO:0043066;GO:0042326;GO:0035307;GO:0050790;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity;, P:cell division; P:central nervous system development; P:mitotic nuclear envelope reassembly; P:negative regulation of apoptotic process; P:negative regulation of phosphorylation; P:positive regulation of protein dephosphorylation; P:regulation of catalytic activity;|Q86XL3 A8KAG3 B3KN97 B3KSF8 O75176 Q6P6A5 Q8TAZ9 Q96DH4,Ankyrin repeat and LEM domain-containing protein 2,LEM domain-containing protein 4;, PF01693;PF03020;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0051721;GO:0019888;GO:0051301;GO:0007417;GO:0007084;GO:0043066;GO:0042326;GO:0035307;GO:0050790;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity;, P:cell division; P:central nervous system development; P:mitotic nuclear envelope reassembly; P:negative regulation of apoptotic process; P:negative regulation of phosphorylation; P:positive regulation of protein dephosphorylation; P:regulation of catalytic activity;|Q86XL3 A8KAG3 B3KN97 B3KSF8 O75176 Q6P6A5 Q8TAZ9 Q96DH4,Ankyrin repeat and LEM domain-containing protein 2,LEM domain-containing protein 4;, PF01693;PF03020;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0051721;GO:0019888;GO:0051301;GO:0007417;GO:0007084;GO:0043066;GO:0042326;GO:0035307;GO:0050790;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity;, P:cell division; P:central nervous system development; P:mitotic nuclear envelope reassembly; P:negative regulation of apoptotic process; P:negative regulation of phosphorylation; P:positive regulation of protein dephosphorylation; P:regulation of catalytic activity; scaffold11 indexed_genome mRNA 41415865 41419938 . - . ID=transcript_2942;Q96HS1 A9LN06 C9IZY7 Q96JB0,Serine/threonine-protein phosphatase PGAM5, mitochondrial,Bcl-XL-binding protein v68;Phosphoglycerate mutase family member 5;, PF00300;, GO:0016021;GO:0005741;GO:0005739;GO:0005096;GO:0016791;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0016236;GO:0070266;GO:0120163;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTPase activator activity; F:phosphatase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding;, P:macroautophagy; P:necroptotic process; P:negative regulation of cold-induced thermogenesis;|Q96HS1 A9LN06 C9IZY7 Q96JB0,Serine/threonine-protein phosphatase PGAM5, mitochondrial,Bcl-XL-binding protein v68;Phosphoglycerate mutase family member 5;, PF00300;, GO:0016021;GO:0005741;GO:0005739;GO:0005096;GO:0016791;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0016236;GO:0070266;GO:0120163;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTPase activator activity; F:phosphatase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding;, P:macroautophagy; P:necroptotic process; P:negative regulation of cold-induced thermogenesis;|Q96HS1 A9LN06 C9IZY7 Q96JB0,Serine/threonine-protein phosphatase PGAM5, mitochondrial,Bcl-XL-binding protein v68;Phosphoglycerate mutase family member 5;, PF00300;, GO:0016021;GO:0005741;GO:0005739;GO:0005096;GO:0016791;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0016236;GO:0070266;GO:0120163;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTPase activator activity; F:phosphatase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding;, P:macroautophagy; P:necroptotic process; P:negative regulation of cold-induced thermogenesis; scaffold11 indexed_genome mRNA 41426442 41439257 . - . ID=transcript_2943;Q9NR77,Peroxisomal membrane protein 2,22 kDa peroxisomal membrane protein;, PF04117;, GO:0005737;GO:0005829;GO:0016021;GO:0016020;GO:0005739;GO:0005778;GO:0032991;GO:0045046;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrion; C:peroxisomal membrane; C:protein-containing complex;, , P:protein import into peroxisome membrane;|Q9NR77,Peroxisomal membrane protein 2,22 kDa peroxisomal membrane protein;, PF04117;, GO:0005737;GO:0005829;GO:0016021;GO:0016020;GO:0005739;GO:0005778;GO:0032991;GO:0045046;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrion; C:peroxisomal membrane; C:protein-containing complex;, , P:protein import into peroxisome membrane;|Q9NR77,Peroxisomal membrane protein 2,22 kDa peroxisomal membrane protein;, PF04117;, GO:0005737;GO:0005829;GO:0016021;GO:0016020;GO:0005739;GO:0005778;GO:0032991;GO:0045046;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrion; C:peroxisomal membrane; C:protein-containing complex;, , P:protein import into peroxisome membrane; scaffold11 indexed_genome mRNA 41491050 41492752 . + . ID=transcript_2944;Q07864 Q13533 Q86VH9,DNA polymerase epsilon catalytic subunit A,3'-5' exodeoxyribonuclease {ECO:0000305};DNA polymerase II subunit A;, PF00136;PF03104;PF08490;, GO:0008622;GO:0005654;GO:0005634;GO:0005886;GO:0051539;GO:0003682;GO:0003677;GO:0003887;GO:0000166;GO:0008310;GO:0008270;GO:0006287;GO:0006260;GO:0006270;GO:0045004;GO:0000731;GO:0048568;GO:0000082;GO:0006272;GO:0000278;GO:0006297;, C:epsilon DNA polymerase complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:4 iron, 4 sulfur cluster binding; F:chromatin binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:nucleotide binding; F:single-stranded DNA 3'-5' exodeoxyribonuclease activity; F:zinc ion binding;, P:base-excision repair, gap-filling; P:DNA replication; P:DNA replication initiation; P:DNA replication proofreading; P:DNA synthesis involved in DNA repair; P:embryonic organ development; P:G1/S transition of mitotic cell cycle; P:leading strand elongation; P:mitotic cell cycle; P:nucleotide-excision repair, DNA gap filling; scaffold11 indexed_genome mRNA 41529006 41600844 . - . ID=transcript_2945;Q9HCM7 Q86XQ1,Fibrosin-1-like protein,AUTS2-like protein;HBV X-transactivated gene 9 protein;HBV XAg-transactivated protein 9;, PF15336;, GO:0003723;, , F:RNA binding;|Q9HCM7 Q86XQ1,Fibrosin-1-like protein,AUTS2-like protein;HBV X-transactivated gene 9 protein;HBV XAg-transactivated protein 9;, PF15336;, GO:0003723;, , F:RNA binding;|Q9HCM7 Q86XQ1,Fibrosin-1-like protein,AUTS2-like protein;HBV X-transactivated gene 9 protein;HBV XAg-transactivated protein 9;, PF15336;, GO:0003723;, , F:RNA binding;|Q9HCM7 Q86XQ1,Fibrosin-1-like protein,AUTS2-like protein;HBV X-transactivated gene 9 protein;HBV XAg-transactivated protein 9;, PF15336;, GO:0003723;, , F:RNA binding;|Q9HCM7 Q86XQ1,Fibrosin-1-like protein,AUTS2-like protein;HBV X-transactivated gene 9 protein;HBV XAg-transactivated protein 9;, PF15336;, GO:0003723;, , F:RNA binding;|Q9HCM7 Q86XQ1,Fibrosin-1-like protein,AUTS2-like protein;HBV X-transactivated gene 9 protein;HBV XAg-transactivated protein 9;, PF15336;, GO:0003723;, , F:RNA binding;|Q9HCM7 Q86XQ1,Fibrosin-1-like protein,AUTS2-like protein;HBV X-transactivated gene 9 protein;HBV XAg-transactivated protein 9;, PF15336;, GO:0003723;, , F:RNA binding; scaffold11 indexed_genome mRNA 41771834 41890973 . + . ID=transcript_2946;Q9HCQ5 Q52LR8 Q6NT54 Q8NFR1,Polypeptide N-acetylgalactosaminyltransferase 9,Polypeptide GalNAc transferase 9;Protein-UDP acetylgalactosaminyltransferase 9;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;GO:0006493;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation;|Q9HCQ5 Q52LR8 Q6NT54 Q8NFR1,Polypeptide N-acetylgalactosaminyltransferase 9,Polypeptide GalNAc transferase 9;Protein-UDP acetylgalactosaminyltransferase 9;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;GO:0006493;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation;|Q9HCQ5 Q52LR8 Q6NT54 Q8NFR1,Polypeptide N-acetylgalactosaminyltransferase 9,Polypeptide GalNAc transferase 9;Protein-UDP acetylgalactosaminyltransferase 9;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;GO:0006493;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation; scaffold11 indexed_genome mRNA 41938386 41943664 . - . ID=transcript_2947;Q9BVI4 Q8N2S5 Q96I14,Nucleolar complex protein 4 homolog,NOC4-like protein;Nucleolar complex-associated protein 4-like protein;, PF03914;, GO:0016021;GO:0030692;GO:0031965;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:integral component of membrane; C:Noc4p-Nop14p complex; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing; scaffold11 indexed_genome mRNA 41948983 41952923 . + . ID=transcript_2948;Q8N8A6 A8MPT9 Q5CZ71 Q8IXK5 Q96ED1,ATP-dependent RNA helicase DDX51,DEAD box protein 51;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0006364;, C:membrane; C:nucleolus; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:rRNA processing; scaffold11 indexed_genome mRNA 41953141 41955178 . + . ID=transcript_2949;Q8N8A6 A8MPT9 Q5CZ71 Q8IXK5 Q96ED1,ATP-dependent RNA helicase DDX51,DEAD box protein 51;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0006364;, C:membrane; C:nucleolus; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:rRNA processing; scaffold11 indexed_genome mRNA 41958943 41969134 . - . ID=transcript_2950;Q9UET6 B2RCJ0 O75670,Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03162},2'-O-ribose RNA methyltransferase TRM7 homolog {ECO:0000255|HAMAP-Rule:MF_03162};Protein ftsJ homolog 1 {ECO:0000255|HAMAP-Rule:MF_03162};, PF01728;, GO:0005737;GO:0005829;GO:0008173;GO:0052666;GO:0009020;GO:0008175;GO:0002181;GO:0001510;GO:0030488;GO:0006400;GO:0002128;, C:cytoplasm; C:cytosol;, F:RNA methyltransferase activity; F:tRNA (cytosine-2'-O-)-methyltransferase activity; F:tRNA (guanosine-2'-O-)-methyltransferase activity; F:tRNA methyltransferase activity;, P:cytoplasmic translation; P:RNA methylation; P:tRNA methylation; P:tRNA modification; P:tRNA nucleoside ribose methylation; scaffold11 indexed_genome mRNA 41972453 42078268 . - . ID=transcript_2951;Q96L91 O15411 Q6P2F5 Q8N8Q7 Q8NE05 Q96JK7 Q9P230,E1A-binding protein p400,CAG repeat protein 32;Domino homolog;Trinucleotide repeat-containing gene 12 protein;p400 kDa SWI2/SNF2-related protein;, PF15790;PF00271;PF07529;PF00176;, GO:0035267;GO:0016607;GO:0005654;GO:0000812;GO:0005524;GO:0003682;GO:0003677;GO:0004386;GO:0070615;GO:1990405;GO:0043968;GO:0043967;, C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Swr1 complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:helicase activity; F:nucleosome-dependent ATPase activity; F:protein antigen binding;, P:histone H2A acetylation; P:histone H4 acetylation;|Q96L91 O15411 Q6P2F5 Q8N8Q7 Q8NE05 Q96JK7 Q9P230,E1A-binding protein p400,CAG repeat protein 32;Domino homolog;Trinucleotide repeat-containing gene 12 protein;p400 kDa SWI2/SNF2-related protein;, PF15790;PF00271;PF07529;PF00176;, GO:0035267;GO:0016607;GO:0005654;GO:0000812;GO:0005524;GO:0003682;GO:0003677;GO:0004386;GO:0070615;GO:1990405;GO:0043968;GO:0043967;, C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Swr1 complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:helicase activity; F:nucleosome-dependent ATPase activity; F:protein antigen binding;, P:histone H2A acetylation; P:histone H4 acetylation;|Q96L91 O15411 Q6P2F5 Q8N8Q7 Q8NE05 Q96JK7 Q9P230,E1A-binding protein p400,CAG repeat protein 32;Domino homolog;Trinucleotide repeat-containing gene 12 protein;p400 kDa SWI2/SNF2-related protein;, PF15790;PF00271;PF07529;PF00176;, GO:0035267;GO:0016607;GO:0005654;GO:0000812;GO:0005524;GO:0003682;GO:0003677;GO:0004386;GO:0070615;GO:1990405;GO:0043968;GO:0043967;, C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Swr1 complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:helicase activity; F:nucleosome-dependent ATPase activity; F:protein antigen binding;, P:histone H2A acetylation; P:histone H4 acetylation;|Q96L91 O15411 Q6P2F5 Q8N8Q7 Q8NE05 Q96JK7 Q9P230,E1A-binding protein p400,CAG repeat protein 32;Domino homolog;Trinucleotide repeat-containing gene 12 protein;p400 kDa SWI2/SNF2-related protein;, PF15790;PF00271;PF07529;PF00176;, GO:0035267;GO:0016607;GO:0005654;GO:0000812;GO:0005524;GO:0003682;GO:0003677;GO:0004386;GO:0070615;GO:1990405;GO:0043968;GO:0043967;, C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Swr1 complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:helicase activity; F:nucleosome-dependent ATPase activity; F:protein antigen binding;, P:histone H2A acetylation; P:histone H4 acetylation; scaffold11 indexed_genome mRNA 42086093 42095959 . - . ID=transcript_2952;Q9Y606 A8K877 B3KQC1 Q8WYT2 Q9BU44,tRNA pseudouridine synthase A,tRNA pseudouridine(38-40) synthase;tRNA pseudouridylate synthase I;tRNA-uridine isomerase I;, PF01416;, GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0009982;GO:0003723;GO:0002153;GO:0000049;GO:0106029;GO:0070902;GO:1990481;GO:0031119;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:pseudouridine synthase activity; F:RNA binding; F:steroid receptor RNA activator RNA binding; F:tRNA binding; F:tRNA pseudouridine synthase activity;, P:mitochondrial tRNA pseudouridine synthesis; P:mRNA pseudouridine synthesis; P:tRNA pseudouridine synthesis;|Q9Y606 A8K877 B3KQC1 Q8WYT2 Q9BU44,tRNA pseudouridine synthase A,tRNA pseudouridine(38-40) synthase;tRNA pseudouridylate synthase I;tRNA-uridine isomerase I;, PF01416;, GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0009982;GO:0003723;GO:0002153;GO:0000049;GO:0106029;GO:0070902;GO:1990481;GO:0031119;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:pseudouridine synthase activity; F:RNA binding; F:steroid receptor RNA activator RNA binding; F:tRNA binding; F:tRNA pseudouridine synthase activity;, P:mitochondrial tRNA pseudouridine synthesis; P:mRNA pseudouridine synthesis; P:tRNA pseudouridine synthesis;|Q9Y606 A8K877 B3KQC1 Q8WYT2 Q9BU44,tRNA pseudouridine synthase A,tRNA pseudouridine(38-40) synthase;tRNA pseudouridylate synthase I;tRNA-uridine isomerase I;, PF01416;, GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0009982;GO:0003723;GO:0002153;GO:0000049;GO:0106029;GO:0070902;GO:1990481;GO:0031119;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:pseudouridine synthase activity; F:RNA binding; F:steroid receptor RNA activator RNA binding; F:tRNA binding; F:tRNA pseudouridine synthase activity;, P:mitochondrial tRNA pseudouridine synthesis; P:mRNA pseudouridine synthesis; P:tRNA pseudouridine synthesis; scaffold11 indexed_genome mRNA 42100207 42123194 . - . ID=transcript_2953;O75385 Q9UQ28,Serine/threonine-protein kinase ULK1 {ECO:0000305},Autophagy-related protein 1 homolog;Unc-51-like kinase 1;, PF12063;PF00069;, GO:1990316;GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0005789;GO:0097635;GO:0097629;GO:0097632;GO:0005741;GO:0034045;GO:0055037;GO:0005524;GO:0051020;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031267;GO:0000045;GO:0006914;GO:0048675;GO:0031669;GO:0016236;GO:0031333;GO:0031175;GO:0031102;GO:0018105;GO:0018107;GO:0075044;GO:2000786;GO:0010508;GO:0046777;GO:0008104;GO:0006468;GO:0016241;GO:0042594;GO:0007165;, C:Atg1/ULK1 kinase complex; C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of autophagosome membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondrial outer membrane; C:phagophore assembly site membrane; C:recycling endosome;, F:ATP binding; F:GTPase binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:small GTPase binding;, P:autophagosome assembly; P:autophagy; P:axon extension; P:cellular response to nutrient levels; P:macroautophagy; P:negative regulation of protein-containing complex assembly; P:neuron projection development; P:neuron projection regeneration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation by symbiont of host autophagy; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:protein autophosphorylation; P:protein localization; P:protein phosphorylation; P:regulation of macroautophagy; P:response to starvation; P:signal transduction;|O75385 Q9UQ28,Serine/threonine-protein kinase ULK1 {ECO:0000305},Autophagy-related protein 1 homolog;Unc-51-like kinase 1;, PF12063;PF00069;, GO:1990316;GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0005789;GO:0097635;GO:0097629;GO:0097632;GO:0005741;GO:0034045;GO:0055037;GO:0005524;GO:0051020;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031267;GO:0000045;GO:0006914;GO:0048675;GO:0031669;GO:0016236;GO:0031333;GO:0031175;GO:0031102;GO:0018105;GO:0018107;GO:0075044;GO:2000786;GO:0010508;GO:0046777;GO:0008104;GO:0006468;GO:0016241;GO:0042594;GO:0007165;, C:Atg1/ULK1 kinase complex; C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of autophagosome membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondrial outer membrane; C:phagophore assembly site membrane; C:recycling endosome;, F:ATP binding; F:GTPase binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:small GTPase binding;, P:autophagosome assembly; P:autophagy; P:axon extension; P:cellular response to nutrient levels; P:macroautophagy; P:negative regulation of protein-containing complex assembly; P:neuron projection development; P:neuron projection regeneration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation by symbiont of host autophagy; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:protein autophosphorylation; P:protein localization; P:protein phosphorylation; P:regulation of macroautophagy; P:response to starvation; P:signal transduction;|O75385 Q9UQ28,Serine/threonine-protein kinase ULK1 {ECO:0000305},Autophagy-related protein 1 homolog;Unc-51-like kinase 1;, PF12063;PF00069;, GO:1990316;GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0005789;GO:0097635;GO:0097629;GO:0097632;GO:0005741;GO:0034045;GO:0055037;GO:0005524;GO:0051020;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031267;GO:0000045;GO:0006914;GO:0048675;GO:0031669;GO:0016236;GO:0031333;GO:0031175;GO:0031102;GO:0018105;GO:0018107;GO:0075044;GO:2000786;GO:0010508;GO:0046777;GO:0008104;GO:0006468;GO:0016241;GO:0042594;GO:0007165;, C:Atg1/ULK1 kinase complex; C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of autophagosome membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondrial outer membrane; C:phagophore assembly site membrane; C:recycling endosome;, F:ATP binding; F:GTPase binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:small GTPase binding;, P:autophagosome assembly; P:autophagy; P:axon extension; P:cellular response to nutrient levels; P:macroautophagy; P:negative regulation of protein-containing complex assembly; P:neuron projection development; P:neuron projection regeneration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation by symbiont of host autophagy; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:protein autophosphorylation; P:protein localization; P:protein phosphorylation; P:regulation of macroautophagy; P:response to starvation; P:signal transduction;|O75385 Q9UQ28,Serine/threonine-protein kinase ULK1 {ECO:0000305},Autophagy-related protein 1 homolog;Unc-51-like kinase 1;, PF12063;PF00069;, GO:1990316;GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0005789;GO:0097635;GO:0097629;GO:0097632;GO:0005741;GO:0034045;GO:0055037;GO:0005524;GO:0051020;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031267;GO:0000045;GO:0006914;GO:0048675;GO:0031669;GO:0016236;GO:0031333;GO:0031175;GO:0031102;GO:0018105;GO:0018107;GO:0075044;GO:2000786;GO:0010508;GO:0046777;GO:0008104;GO:0006468;GO:0016241;GO:0042594;GO:0007165;, C:Atg1/ULK1 kinase complex; C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of autophagosome membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondrial outer membrane; C:phagophore assembly site membrane; C:recycling endosome;, F:ATP binding; F:GTPase binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:small GTPase binding;, P:autophagosome assembly; P:autophagy; P:axon extension; P:cellular response to nutrient levels; P:macroautophagy; P:negative regulation of protein-containing complex assembly; P:neuron projection development; P:neuron projection regeneration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation by symbiont of host autophagy; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:protein autophosphorylation; P:protein localization; P:protein phosphorylation; P:regulation of macroautophagy; P:response to starvation; P:signal transduction;|O75385 Q9UQ28,Serine/threonine-protein kinase ULK1 {ECO:0000305},Autophagy-related protein 1 homolog;Unc-51-like kinase 1;, PF12063;PF00069;, GO:1990316;GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0005789;GO:0097635;GO:0097629;GO:0097632;GO:0005741;GO:0034045;GO:0055037;GO:0005524;GO:0051020;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031267;GO:0000045;GO:0006914;GO:0048675;GO:0031669;GO:0016236;GO:0031333;GO:0031175;GO:0031102;GO:0018105;GO:0018107;GO:0075044;GO:2000786;GO:0010508;GO:0046777;GO:0008104;GO:0006468;GO:0016241;GO:0042594;GO:0007165;, C:Atg1/ULK1 kinase complex; C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of autophagosome membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondrial outer membrane; C:phagophore assembly site membrane; C:recycling endosome;, F:ATP binding; F:GTPase binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:small GTPase binding;, P:autophagosome assembly; P:autophagy; P:axon extension; P:cellular response to nutrient levels; P:macroautophagy; P:negative regulation of protein-containing complex assembly; P:neuron projection development; P:neuron projection regeneration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation by symbiont of host autophagy; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:protein autophosphorylation; P:protein localization; P:protein phosphorylation; P:regulation of macroautophagy; P:response to starvation; P:signal transduction;|O75385 Q9UQ28,Serine/threonine-protein kinase ULK1 {ECO:0000305},Autophagy-related protein 1 homolog;Unc-51-like kinase 1;, PF12063;PF00069;, GO:1990316;GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0005789;GO:0097635;GO:0097629;GO:0097632;GO:0005741;GO:0034045;GO:0055037;GO:0005524;GO:0051020;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031267;GO:0000045;GO:0006914;GO:0048675;GO:0031669;GO:0016236;GO:0031333;GO:0031175;GO:0031102;GO:0018105;GO:0018107;GO:0075044;GO:2000786;GO:0010508;GO:0046777;GO:0008104;GO:0006468;GO:0016241;GO:0042594;GO:0007165;, C:Atg1/ULK1 kinase complex; C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of autophagosome membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondrial outer membrane; C:phagophore assembly site membrane; C:recycling endosome;, F:ATP binding; F:GTPase binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:small GTPase binding;, P:autophagosome assembly; P:autophagy; P:axon extension; P:cellular response to nutrient levels; P:macroautophagy; P:negative regulation of protein-containing complex assembly; P:neuron projection development; P:neuron projection regeneration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation by symbiont of host autophagy; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:protein autophosphorylation; P:protein localization; P:protein phosphorylation; P:regulation of macroautophagy; P:response to starvation; P:signal transduction;|O75385 Q9UQ28,Serine/threonine-protein kinase ULK1 {ECO:0000305},Autophagy-related protein 1 homolog;Unc-51-like kinase 1;, PF12063;PF00069;, GO:1990316;GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0005789;GO:0097635;GO:0097629;GO:0097632;GO:0005741;GO:0034045;GO:0055037;GO:0005524;GO:0051020;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031267;GO:0000045;GO:0006914;GO:0048675;GO:0031669;GO:0016236;GO:0031333;GO:0031175;GO:0031102;GO:0018105;GO:0018107;GO:0075044;GO:2000786;GO:0010508;GO:0046777;GO:0008104;GO:0006468;GO:0016241;GO:0042594;GO:0007165;, C:Atg1/ULK1 kinase complex; C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of autophagosome membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondrial outer membrane; C:phagophore assembly site membrane; C:recycling endosome;, F:ATP binding; F:GTPase binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:small GTPase binding;, P:autophagosome assembly; P:autophagy; P:axon extension; P:cellular response to nutrient levels; P:macroautophagy; P:negative regulation of protein-containing complex assembly; P:neuron projection development; P:neuron projection regeneration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation by symbiont of host autophagy; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:protein autophosphorylation; P:protein localization; P:protein phosphorylation; P:regulation of macroautophagy; P:response to starvation; P:signal transduction;|O75385 Q9UQ28,Serine/threonine-protein kinase ULK1 {ECO:0000305},Autophagy-related protein 1 homolog;Unc-51-like kinase 1;, PF12063;PF00069;, GO:1990316;GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0005789;GO:0097635;GO:0097629;GO:0097632;GO:0005741;GO:0034045;GO:0055037;GO:0005524;GO:0051020;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031267;GO:0000045;GO:0006914;GO:0048675;GO:0031669;GO:0016236;GO:0031333;GO:0031175;GO:0031102;GO:0018105;GO:0018107;GO:0075044;GO:2000786;GO:0010508;GO:0046777;GO:0008104;GO:0006468;GO:0016241;GO:0042594;GO:0007165;, C:Atg1/ULK1 kinase complex; C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of autophagosome membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondrial outer membrane; C:phagophore assembly site membrane; C:recycling endosome;, F:ATP binding; F:GTPase binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:small GTPase binding;, P:autophagosome assembly; P:autophagy; P:axon extension; P:cellular response to nutrient levels; P:macroautophagy; P:negative regulation of protein-containing complex assembly; P:neuron projection development; P:neuron projection regeneration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation by symbiont of host autophagy; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:protein autophosphorylation; P:protein localization; P:protein phosphorylation; P:regulation of macroautophagy; P:response to starvation; P:signal transduction;|O75385 Q9UQ28,Serine/threonine-protein kinase ULK1 {ECO:0000305},Autophagy-related protein 1 homolog;Unc-51-like kinase 1;, PF12063;PF00069;, GO:1990316;GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0005789;GO:0097635;GO:0097629;GO:0097632;GO:0005741;GO:0034045;GO:0055037;GO:0005524;GO:0051020;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031267;GO:0000045;GO:0006914;GO:0048675;GO:0031669;GO:0016236;GO:0031333;GO:0031175;GO:0031102;GO:0018105;GO:0018107;GO:0075044;GO:2000786;GO:0010508;GO:0046777;GO:0008104;GO:0006468;GO:0016241;GO:0042594;GO:0007165;, C:Atg1/ULK1 kinase complex; C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of autophagosome membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondrial outer membrane; C:phagophore assembly site membrane; C:recycling endosome;, F:ATP binding; F:GTPase binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:small GTPase binding;, P:autophagosome assembly; P:autophagy; P:axon extension; P:cellular response to nutrient levels; P:macroautophagy; P:negative regulation of protein-containing complex assembly; P:neuron projection development; P:neuron projection regeneration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation by symbiont of host autophagy; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:protein autophosphorylation; P:protein localization; P:protein phosphorylation; P:regulation of macroautophagy; P:response to starvation; P:signal transduction;|O75385 Q9UQ28,Serine/threonine-protein kinase ULK1 {ECO:0000305},Autophagy-related protein 1 homolog;Unc-51-like kinase 1;, PF12063;PF00069;, GO:1990316;GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0005789;GO:0097635;GO:0097629;GO:0097632;GO:0005741;GO:0034045;GO:0055037;GO:0005524;GO:0051020;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031267;GO:0000045;GO:0006914;GO:0048675;GO:0031669;GO:0016236;GO:0031333;GO:0031175;GO:0031102;GO:0018105;GO:0018107;GO:0075044;GO:2000786;GO:0010508;GO:0046777;GO:0008104;GO:0006468;GO:0016241;GO:0042594;GO:0007165;, C:Atg1/ULK1 kinase complex; C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of autophagosome membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondrial outer membrane; C:phagophore assembly site membrane; C:recycling endosome;, F:ATP binding; F:GTPase binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:small GTPase binding;, P:autophagosome assembly; P:autophagy; P:axon extension; P:cellular response to nutrient levels; P:macroautophagy; P:negative regulation of protein-containing complex assembly; P:neuron projection development; P:neuron projection regeneration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation by symbiont of host autophagy; P:positive regulation of autophagosome assembly; P:positive regulation of autophagy; P:protein autophosphorylation; P:protein localization; P:protein phosphorylation; P:regulation of macroautophagy; P:response to starvation; P:signal transduction; scaffold11 indexed_genome mRNA 42163929 42168854 . - . ID=transcript_2954;Q9ULZ9 Q14850,Matrix metalloproteinase-17,Membrane-type matrix metalloproteinase 4;Membrane-type-4 matrix metalloproteinase;, PF00045;PF00413;PF01471;, GO:0031225;GO:0031012;GO:0005576;GO:0005886;GO:0008047;GO:0070006;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0006508;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:plasma membrane;, F:enzyme activator activity; F:metalloaminopeptidase activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:proteolysis;|Q9ULZ9 Q14850,Matrix metalloproteinase-17,Membrane-type matrix metalloproteinase 4;Membrane-type-4 matrix metalloproteinase;, PF00045;PF00413;PF01471;, GO:0031225;GO:0031012;GO:0005576;GO:0005886;GO:0008047;GO:0070006;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0006508;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:plasma membrane;, F:enzyme activator activity; F:metalloaminopeptidase activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:proteolysis; scaffold11 indexed_genome mRNA 42169225 42186989 . - . ID=transcript_2955;Q9ULZ9 Q14850,Matrix metalloproteinase-17,Membrane-type matrix metalloproteinase 4;Membrane-type-4 matrix metalloproteinase;, PF00045;PF00413;PF01471;, GO:0031225;GO:0031012;GO:0005576;GO:0005886;GO:0008047;GO:0070006;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0006508;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:plasma membrane;, F:enzyme activator activity; F:metalloaminopeptidase activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:proteolysis;|Q9ULZ9 Q14850,Matrix metalloproteinase-17,Membrane-type matrix metalloproteinase 4;Membrane-type-4 matrix metalloproteinase;, PF00045;PF00413;PF01471;, GO:0031225;GO:0031012;GO:0005576;GO:0005886;GO:0008047;GO:0070006;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0006508;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:plasma membrane;, F:enzyme activator activity; F:metalloaminopeptidase activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:proteolysis; scaffold11 indexed_genome mRNA 42204189 42206532 . - . ID=transcript_2956;Q12872 B2RN45 B7ZM97 F5H6B8 Q6PJF7,Splicing factor, suppressor of white-apricot homolog,Splicing factor, arginine/serine-rich 8;Suppressor of white apricot protein homolog;, PF09750;PF01805;, GO:0005634;GO:0003723;GO:0000380;GO:0000395;GO:0048025;, C:nucleus;, F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 5'-splice site recognition; P:negative regulation of mRNA splicing, via spliceosome;|Q12872 B2RN45 B7ZM97 F5H6B8 Q6PJF7,Splicing factor, suppressor of white-apricot homolog,Splicing factor, arginine/serine-rich 8;Suppressor of white apricot protein homolog;, PF09750;PF01805;, GO:0005634;GO:0003723;GO:0000380;GO:0000395;GO:0048025;, C:nucleus;, F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 5'-splice site recognition; P:negative regulation of mRNA splicing, via spliceosome; scaffold11 indexed_genome mRNA 42208623 42214664 . + . ID=transcript_2957;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold11 indexed_genome mRNA 42217827 42284199 . + . ID=transcript_2958;Q12872 B2RN45 B7ZM97 F5H6B8 Q6PJF7,Splicing factor, suppressor of white-apricot homolog,Splicing factor, arginine/serine-rich 8;Suppressor of white apricot protein homolog;, PF09750;PF01805;, GO:0005634;GO:0003723;GO:0000380;GO:0000395;GO:0048025;, C:nucleus;, F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 5'-splice site recognition; P:negative regulation of mRNA splicing, via spliceosome;|Q12872 B2RN45 B7ZM97 F5H6B8 Q6PJF7,Splicing factor, suppressor of white-apricot homolog,Splicing factor, arginine/serine-rich 8;Suppressor of white apricot protein homolog;, PF09750;PF01805;, GO:0005634;GO:0003723;GO:0000380;GO:0000395;GO:0048025;, C:nucleus;, F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 5'-splice site recognition; P:negative regulation of mRNA splicing, via spliceosome;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q12872 B2RN45 B7ZM97 F5H6B8 Q6PJF7,Splicing factor, suppressor of white-apricot homolog,Splicing factor, arginine/serine-rich 8;Suppressor of white apricot protein homolog;, PF09750;PF01805;, GO:0005634;GO:0003723;GO:0000380;GO:0000395;GO:0048025;, C:nucleus;, F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 5'-splice site recognition; P:negative regulation of mRNA splicing, via spliceosome; scaffold11 indexed_genome mRNA 42906204 42916507 . - . ID=transcript_2959;Q6QNK2 B2CKK9 B7ZLF7 Q2M1L3 Q6ZMQ1 Q7Z7M2 Q86SM4,Adhesion G-protein coupled receptor D1 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 133;G-protein coupled receptor PGR25;, PF00002;PF01825;, GO:0016021;GO:0005887;GO:0005654;GO:0005886;GO:0004930;GO:0007189;GO:0007166;GO:0007186;, C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold11 indexed_genome mRNA 42936321 43022444 . - . ID=transcript_2960;Q6QNK2 B2CKK9 B7ZLF7 Q2M1L3 Q6ZMQ1 Q7Z7M2 Q86SM4,Adhesion G-protein coupled receptor D1 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 133;G-protein coupled receptor PGR25;, PF00002;PF01825;, GO:0016021;GO:0005887;GO:0005654;GO:0005886;GO:0004930;GO:0007189;GO:0007166;GO:0007186;, C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold11 indexed_genome mRNA 43055376 43087089 . - . ID=transcript_2961;Q6QNK2 B2CKK9 B7ZLF7 Q2M1L3 Q6ZMQ1 Q7Z7M2 Q86SM4,Adhesion G-protein coupled receptor D1 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 133;G-protein coupled receptor PGR25;, PF00002;PF01825;, GO:0016021;GO:0005887;GO:0005654;GO:0005886;GO:0004930;GO:0007189;GO:0007166;GO:0007186;, C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold11 indexed_genome mRNA 43162935 43168199 . - . ID=transcript_2962;Q9CWI7 Q9CZA2 Q9UDJ5 Q9UEU9,GTP-binding nuclear protein Ran,Androgen receptor-associated protein 24 {ECO:0000303|PubMed:10400640};GTPase Ran;Ras-like protein TC4 {ECO:0000303|PubMed:2108320, ECO:0000303|PubMed:8276887, ECO:0000303|PubMed:8421051};Ras-related nuclear protein;, PF00071;, GO:0005814;GO:0005737;GO:0005829;GO:0070062;GO:0043657;GO:0042470;GO:0016020;GO:0030496;GO:0005635;GO:0005643;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0055037;GO:0042565;GO:0045296;GO:0003682;GO:0019003;GO:0005525;GO:0003924;GO:0000287;GO:0046982;GO:0003723;GO:0051301;GO:0006259;GO:0046039;GO:0075733;GO:0010586;GO:0000278;GO:0007084;GO:0000070;GO:0007052;GO:0032092;GO:0042307;GO:0035281;GO:0006611;GO:0006606;GO:1902570;GO:0045540;GO:0000055;GO:0000056;GO:0000054;GO:0061015;GO:0006409;GO:0016032;, C:centriole; C:cytoplasm; C:cytosol; C:extracellular exosome; C:host cell; C:melanosome; C:membrane; C:midbody; C:nuclear envelope; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:recycling endosome; C:RNA nuclear export complex;, F:cadherin binding; F:chromatin binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:magnesium ion binding; F:protein heterodimerization activity; F:RNA binding;, P:cell division; P:DNA metabolic process; P:GTP metabolic process; P:intracellular transport of virus; P:miRNA metabolic process; P:mitotic cell cycle; P:mitotic nuclear envelope reassembly; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:pre-miRNA export from nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein localization to nucleolus; P:regulation of cholesterol biosynthetic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:snRNA import into nucleus; P:tRNA export from nucleus; P:viral process;|Q9CWI7 Q9CZA2 Q9UDJ5 Q9UEU9,GTP-binding nuclear protein Ran,Androgen receptor-associated protein 24 {ECO:0000303|PubMed:10400640};GTPase Ran;Ras-like protein TC4 {ECO:0000303|PubMed:2108320, ECO:0000303|PubMed:8276887, ECO:0000303|PubMed:8421051};Ras-related nuclear protein;, PF00071;, GO:0005814;GO:0005737;GO:0005829;GO:0070062;GO:0043657;GO:0042470;GO:0016020;GO:0030496;GO:0005635;GO:0005643;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0055037;GO:0042565;GO:0045296;GO:0003682;GO:0019003;GO:0005525;GO:0003924;GO:0000287;GO:0046982;GO:0003723;GO:0051301;GO:0006259;GO:0046039;GO:0075733;GO:0010586;GO:0000278;GO:0007084;GO:0000070;GO:0007052;GO:0032092;GO:0042307;GO:0035281;GO:0006611;GO:0006606;GO:1902570;GO:0045540;GO:0000055;GO:0000056;GO:0000054;GO:0061015;GO:0006409;GO:0016032;, C:centriole; C:cytoplasm; C:cytosol; C:extracellular exosome; C:host cell; C:melanosome; C:membrane; C:midbody; C:nuclear envelope; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:recycling endosome; C:RNA nuclear export complex;, F:cadherin binding; F:chromatin binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:magnesium ion binding; F:protein heterodimerization activity; F:RNA binding;, P:cell division; P:DNA metabolic process; P:GTP metabolic process; P:intracellular transport of virus; P:miRNA metabolic process; P:mitotic cell cycle; P:mitotic nuclear envelope reassembly; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:pre-miRNA export from nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein localization to nucleolus; P:regulation of cholesterol biosynthetic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:snRNA import into nucleus; P:tRNA export from nucleus; P:viral process; scaffold11 indexed_genome mRNA 43197843 43235737 . + . ID=transcript_2963;P32856 Q86VW8,Syntaxin-2,Epimorphin;, PF05739;PF00804;, GO:0016323;GO:0012505;GO:0005615;GO:0016021;GO:0043231;GO:0030027;GO:0005886;GO:0048787;GO:0032991;GO:0031201;GO:0008021;GO:0048306;GO:0042802;GO:0005484;GO:0000149;GO:0005198;GO:0007340;GO:0009887;GO:0030154;GO:0034599;GO:1903575;GO:0007398;GO:0006887;GO:0006886;GO:0007165;GO:0031629;GO:0048278;GO:0006906;, C:basolateral plasma membrane; C:endomembrane system; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lamellipodium; C:plasma membrane; C:presynaptic active zone membrane; C:protein-containing complex; C:SNARE complex; C:synaptic vesicle;, F:calcium-dependent protein binding; F:identical protein binding; F:SNAP receptor activity; F:SNARE binding; F:structural molecule activity;, P:acrosome reaction; P:animal organ morphogenesis; P:cell differentiation; P:cellular response to oxidative stress; P:cornified envelope assembly; P:ectoderm development; P:exocytosis; P:intracellular protein transport; P:signal transduction; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle fusion;|P32856 Q86VW8,Syntaxin-2,Epimorphin;, PF05739;PF00804;, GO:0016323;GO:0012505;GO:0005615;GO:0016021;GO:0043231;GO:0030027;GO:0005886;GO:0048787;GO:0032991;GO:0031201;GO:0008021;GO:0048306;GO:0042802;GO:0005484;GO:0000149;GO:0005198;GO:0007340;GO:0009887;GO:0030154;GO:0034599;GO:1903575;GO:0007398;GO:0006887;GO:0006886;GO:0007165;GO:0031629;GO:0048278;GO:0006906;, C:basolateral plasma membrane; C:endomembrane system; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lamellipodium; C:plasma membrane; C:presynaptic active zone membrane; C:protein-containing complex; C:SNARE complex; C:synaptic vesicle;, F:calcium-dependent protein binding; F:identical protein binding; F:SNAP receptor activity; F:SNARE binding; F:structural molecule activity;, P:acrosome reaction; P:animal organ morphogenesis; P:cell differentiation; P:cellular response to oxidative stress; P:cornified envelope assembly; P:ectoderm development; P:exocytosis; P:intracellular protein transport; P:signal transduction; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle fusion; scaffold11 indexed_genome mRNA 43528010 43542286 . + . ID=transcript_2964;O15034 Q96ID2,RIMS-binding protein 2,, PF07653;PF14604;, GO:0005886;GO:0045202;GO:0010923;GO:0007274;, C:plasma membrane; C:synapse;, , P:negative regulation of phosphatase activity; P:neuromuscular synaptic transmission; scaffold11 indexed_genome mRNA 43543543 43560743 . + . ID=transcript_2965;O15034 Q96ID2,RIMS-binding protein 2,, PF07653;PF14604;, GO:0005886;GO:0045202;GO:0010923;GO:0007274;, C:plasma membrane; C:synapse;, , P:negative regulation of phosphatase activity; P:neuromuscular synaptic transmission; scaffold11 indexed_genome mRNA 43560879 43577510 . + . ID=transcript_2966;O15034 Q96ID2,RIMS-binding protein 2,, PF07653;PF14604;, GO:0005886;GO:0045202;GO:0010923;GO:0007274;, C:plasma membrane; C:synapse;, , P:negative regulation of phosphatase activity; P:neuromuscular synaptic transmission; scaffold11 indexed_genome mRNA 45102912 45120275 . + . ID=transcript_2967;Q8N697 A6H8Y9 B3KTK1 Q71M34 Q7Z5F8 Q8TAH0,Solute carrier family 15 member 4 {ECO:0000305},Peptide transporter 4 {ECO:0000303|Ref.2};Peptide/histidine transporter 1 {ECO:0000303|PubMed:16289537, ECO:0000303|PubMed:29224352};, PF00854;, GO:0031901;GO:0036020;GO:0031303;GO:1905103;GO:0005765;GO:0005886;GO:0035579;GO:0071916;GO:0005290;GO:0015333;GO:0015647;GO:0140206;GO:0015817;GO:0045087;GO:0006811;GO:0089708;GO:0033023;GO:0043312;GO:0015835;GO:0045089;GO:0070430;GO:0070434;GO:0034157;GO:0034161;GO:0034165;GO:0015031;GO:0048302;GO:0070424;, C:early endosome membrane; C:endolysosome membrane; C:integral component of endosome membrane; C:integral component of lysosomal membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane;, F:dipeptide transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:peptide:proton symporter activity; F:peptidoglycan transmembrane transporter activity;, P:dipeptide import across plasma membrane; P:histidine transport; P:innate immune response; P:ion transport; P:L-histidine transmembrane export from vacuole; P:mast cell homeostasis; P:neutrophil degranulation; P:peptidoglycan transport; P:positive regulation of innate immune response; P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:positive regulation of toll-like receptor 9 signaling pathway; P:protein transport; P:regulation of isotype switching to IgG isotypes; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway;|Q8N697 A6H8Y9 B3KTK1 Q71M34 Q7Z5F8 Q8TAH0,Solute carrier family 15 member 4 {ECO:0000305},Peptide transporter 4 {ECO:0000303|Ref.2};Peptide/histidine transporter 1 {ECO:0000303|PubMed:16289537, ECO:0000303|PubMed:29224352};, PF00854;, GO:0031901;GO:0036020;GO:0031303;GO:1905103;GO:0005765;GO:0005886;GO:0035579;GO:0071916;GO:0005290;GO:0015333;GO:0015647;GO:0140206;GO:0015817;GO:0045087;GO:0006811;GO:0089708;GO:0033023;GO:0043312;GO:0015835;GO:0045089;GO:0070430;GO:0070434;GO:0034157;GO:0034161;GO:0034165;GO:0015031;GO:0048302;GO:0070424;, C:early endosome membrane; C:endolysosome membrane; C:integral component of endosome membrane; C:integral component of lysosomal membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane;, F:dipeptide transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:peptide:proton symporter activity; F:peptidoglycan transmembrane transporter activity;, P:dipeptide import across plasma membrane; P:histidine transport; P:innate immune response; P:ion transport; P:L-histidine transmembrane export from vacuole; P:mast cell homeostasis; P:neutrophil degranulation; P:peptidoglycan transport; P:positive regulation of innate immune response; P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:positive regulation of toll-like receptor 9 signaling pathway; P:protein transport; P:regulation of isotype switching to IgG isotypes; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway;|Q8N697 A6H8Y9 B3KTK1 Q71M34 Q7Z5F8 Q8TAH0,Solute carrier family 15 member 4 {ECO:0000305},Peptide transporter 4 {ECO:0000303|Ref.2};Peptide/histidine transporter 1 {ECO:0000303|PubMed:16289537, ECO:0000303|PubMed:29224352};, PF00854;, GO:0031901;GO:0036020;GO:0031303;GO:1905103;GO:0005765;GO:0005886;GO:0035579;GO:0071916;GO:0005290;GO:0015333;GO:0015647;GO:0140206;GO:0015817;GO:0045087;GO:0006811;GO:0089708;GO:0033023;GO:0043312;GO:0015835;GO:0045089;GO:0070430;GO:0070434;GO:0034157;GO:0034161;GO:0034165;GO:0015031;GO:0048302;GO:0070424;, C:early endosome membrane; C:endolysosome membrane; C:integral component of endosome membrane; C:integral component of lysosomal membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane;, F:dipeptide transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:peptide:proton symporter activity; F:peptidoglycan transmembrane transporter activity;, P:dipeptide import across plasma membrane; P:histidine transport; P:innate immune response; P:ion transport; P:L-histidine transmembrane export from vacuole; P:mast cell homeostasis; P:neutrophil degranulation; P:peptidoglycan transport; P:positive regulation of innate immune response; P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:positive regulation of toll-like receptor 9 signaling pathway; P:protein transport; P:regulation of isotype switching to IgG isotypes; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway;|Q8N697 A6H8Y9 B3KTK1 Q71M34 Q7Z5F8 Q8TAH0,Solute carrier family 15 member 4 {ECO:0000305},Peptide transporter 4 {ECO:0000303|Ref.2};Peptide/histidine transporter 1 {ECO:0000303|PubMed:16289537, ECO:0000303|PubMed:29224352};, PF00854;, GO:0031901;GO:0036020;GO:0031303;GO:1905103;GO:0005765;GO:0005886;GO:0035579;GO:0071916;GO:0005290;GO:0015333;GO:0015647;GO:0140206;GO:0015817;GO:0045087;GO:0006811;GO:0089708;GO:0033023;GO:0043312;GO:0015835;GO:0045089;GO:0070430;GO:0070434;GO:0034157;GO:0034161;GO:0034165;GO:0015031;GO:0048302;GO:0070424;, C:early endosome membrane; C:endolysosome membrane; C:integral component of endosome membrane; C:integral component of lysosomal membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane;, F:dipeptide transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:peptide:proton symporter activity; F:peptidoglycan transmembrane transporter activity;, P:dipeptide import across plasma membrane; P:histidine transport; P:innate immune response; P:ion transport; P:L-histidine transmembrane export from vacuole; P:mast cell homeostasis; P:neutrophil degranulation; P:peptidoglycan transport; P:positive regulation of innate immune response; P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:positive regulation of toll-like receptor 9 signaling pathway; P:protein transport; P:regulation of isotype switching to IgG isotypes; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway;|Q8N697 A6H8Y9 B3KTK1 Q71M34 Q7Z5F8 Q8TAH0,Solute carrier family 15 member 4 {ECO:0000305},Peptide transporter 4 {ECO:0000303|Ref.2};Peptide/histidine transporter 1 {ECO:0000303|PubMed:16289537, ECO:0000303|PubMed:29224352};, PF00854;, GO:0031901;GO:0036020;GO:0031303;GO:1905103;GO:0005765;GO:0005886;GO:0035579;GO:0071916;GO:0005290;GO:0015333;GO:0015647;GO:0140206;GO:0015817;GO:0045087;GO:0006811;GO:0089708;GO:0033023;GO:0043312;GO:0015835;GO:0045089;GO:0070430;GO:0070434;GO:0034157;GO:0034161;GO:0034165;GO:0015031;GO:0048302;GO:0070424;, C:early endosome membrane; C:endolysosome membrane; C:integral component of endosome membrane; C:integral component of lysosomal membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane;, F:dipeptide transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:peptide:proton symporter activity; F:peptidoglycan transmembrane transporter activity;, P:dipeptide import across plasma membrane; P:histidine transport; P:innate immune response; P:ion transport; P:L-histidine transmembrane export from vacuole; P:mast cell homeostasis; P:neutrophil degranulation; P:peptidoglycan transport; P:positive regulation of innate immune response; P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:positive regulation of toll-like receptor 9 signaling pathway; P:protein transport; P:regulation of isotype switching to IgG isotypes; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; scaffold11 indexed_genome mRNA 45194205 45203340 . + . ID=transcript_2968;Q8N3T6 Q69YX8,Transmembrane protein 132C,, PF16070;PF15706;PF15705;, GO:0016021;, C:integral component of membrane;|Q8N3T6 Q69YX8,Transmembrane protein 132C,, PF16070;PF15706;PF15705;, GO:0016021;, C:integral component of membrane; scaffold11 indexed_genome mRNA 46984954 46987218 . - . ID=transcript_2969;Q14DG7 A2RRG8 Q8NA73 Q96JN9 Q96PY1,Transmembrane protein 132B,, PF16070;PF15706;PF15705;, GO:0016021;, C:integral component of membrane; scaffold11 indexed_genome mRNA 46987224 47020460 . - . ID=transcript_2970;Q14DG7 A2RRG8 Q8NA73 Q96JN9 Q96PY1,Transmembrane protein 132B,, PF16070;PF15706;PF15705;, GO:0016021;, C:integral component of membrane; scaffold11 indexed_genome mRNA 47389407 47677843 . + . ID=transcript_2971;O94989 A8K6G1 Q8N449 Q9H8B4,Rho guanine nucleotide exchange factor 15,Ephexin-5;Vsm-RhoGEF;, PF00621;, GO:0005737;GO:0030425;GO:0005096;GO:0005085;GO:0090630;GO:2000297;GO:0051496;GO:0050790;GO:0061299;, C:cytoplasm; C:dendrite;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:negative regulation of synapse maturation; P:positive regulation of stress fiber assembly; P:regulation of catalytic activity; P:retina vasculature morphogenesis in camera-type eye;|Q86V21 Q49AB9 Q49AC3 Q658Q8 Q8IWD2 Q8NEW5 Q9BSJ9 Q9H829 Q9HA19,Acetoacetyl-CoA synthetase,Acyl-CoA synthetase family member 1;Protein sur-5 homolog;, PF16177;PF00501;, GO:0005829;GO:0030729;GO:0005524;GO:0047760;GO:0060612;GO:0071397;GO:0071333;GO:0071394;GO:0006631;GO:0046951;GO:0001889;GO:0032024;GO:0042493;GO:0045471;GO:0007584;GO:0034201;GO:0014074;GO:0042594;GO:0050872;, C:cytosol;, F:acetoacetate-CoA ligase activity; F:ATP binding; F:butyrate-CoA ligase activity;, P:adipose tissue development; P:cellular response to cholesterol; P:cellular response to glucose stimulus; P:cellular response to testosterone stimulus; P:fatty acid metabolic process; P:ketone body biosynthetic process; P:liver development; P:positive regulation of insulin secretion; P:response to drug; P:response to ethanol; P:response to nutrient; P:response to oleic acid; P:response to purine-containing compound; P:response to starvation; P:white fat cell differentiation;|Q86V21 Q49AB9 Q49AC3 Q658Q8 Q8IWD2 Q8NEW5 Q9BSJ9 Q9H829 Q9HA19,Acetoacetyl-CoA synthetase,Acyl-CoA synthetase family member 1;Protein sur-5 homolog;, PF16177;PF00501;, GO:0005829;GO:0030729;GO:0005524;GO:0047760;GO:0060612;GO:0071397;GO:0071333;GO:0071394;GO:0006631;GO:0046951;GO:0001889;GO:0032024;GO:0042493;GO:0045471;GO:0007584;GO:0034201;GO:0014074;GO:0042594;GO:0050872;, C:cytosol;, F:acetoacetate-CoA ligase activity; F:ATP binding; F:butyrate-CoA ligase activity;, P:adipose tissue development; P:cellular response to cholesterol; P:cellular response to glucose stimulus; P:cellular response to testosterone stimulus; P:fatty acid metabolic process; P:ketone body biosynthetic process; P:liver development; P:positive regulation of insulin secretion; P:response to drug; P:response to ethanol; P:response to nutrient; P:response to oleic acid; P:response to purine-containing compound; P:response to starvation; P:white fat cell differentiation;|Q86V21 Q49AB9 Q49AC3 Q658Q8 Q8IWD2 Q8NEW5 Q9BSJ9 Q9H829 Q9HA19,Acetoacetyl-CoA synthetase,Acyl-CoA synthetase family member 1;Protein sur-5 homolog;, PF16177;PF00501;, GO:0005829;GO:0030729;GO:0005524;GO:0047760;GO:0060612;GO:0071397;GO:0071333;GO:0071394;GO:0006631;GO:0046951;GO:0001889;GO:0032024;GO:0042493;GO:0045471;GO:0007584;GO:0034201;GO:0014074;GO:0042594;GO:0050872;, C:cytosol;, F:acetoacetate-CoA ligase activity; F:ATP binding; F:butyrate-CoA ligase activity;, P:adipose tissue development; P:cellular response to cholesterol; P:cellular response to glucose stimulus; P:cellular response to testosterone stimulus; P:fatty acid metabolic process; P:ketone body biosynthetic process; P:liver development; P:positive regulation of insulin secretion; P:response to drug; P:response to ethanol; P:response to nutrient; P:response to oleic acid; P:response to purine-containing compound; P:response to starvation; P:white fat cell differentiation;|Q8WY22 Q8WY23,BRI3-binding protein,Cervical cancer 1 proto-oncogene-binding protein KG19;HCCRBP-1;, , GO:0016021;GO:0005741;GO:0005739;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;|Q8WY22 Q8WY23,BRI3-binding protein,Cervical cancer 1 proto-oncogene-binding protein KG19;HCCRBP-1;, , GO:0016021;GO:0005741;GO:0005739;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;|Q8WY22 Q8WY23,BRI3-binding protein,Cervical cancer 1 proto-oncogene-binding protein KG19;HCCRBP-1;, , GO:0016021;GO:0005741;GO:0005739;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;|Q8IY37 Q9BUI7 Q9P211,Probable ATP-dependent RNA helicase DHX37,DEAH box protein 37;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0031965;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;GO:0034511;GO:0007420;GO:0000462;GO:2000020;GO:0042255;GO:0042254;GO:0006364;, C:cytoplasm; C:nuclear membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:U3 snoRNA binding;, P:brain development; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of male gonad development; P:ribosome assembly; P:ribosome biogenesis; P:rRNA processing;|Q8IY37 Q9BUI7 Q9P211,Probable ATP-dependent RNA helicase DHX37,DEAH box protein 37;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0031965;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;GO:0034511;GO:0007420;GO:0000462;GO:2000020;GO:0042255;GO:0042254;GO:0006364;, C:cytoplasm; C:nuclear membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:U3 snoRNA binding;, P:brain development; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of male gonad development; P:ribosome assembly; P:ribosome biogenesis; P:rRNA processing;|Q8IY37 Q9BUI7 Q9P211,Probable ATP-dependent RNA helicase DHX37,DEAH box protein 37;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0031965;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;GO:0034511;GO:0007420;GO:0000462;GO:2000020;GO:0042255;GO:0042254;GO:0006364;, C:cytoplasm; C:nuclear membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:U3 snoRNA binding;, P:brain development; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of male gonad development; P:ribosome assembly; P:ribosome biogenesis; P:rRNA processing;|Q8IY37 Q9BUI7 Q9P211,Probable ATP-dependent RNA helicase DHX37,DEAH box protein 37;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0031965;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;GO:0034511;GO:0007420;GO:0000462;GO:2000020;GO:0042255;GO:0042254;GO:0006364;, C:cytoplasm; C:nuclear membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:U3 snoRNA binding;, P:brain development; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of male gonad development; P:ribosome assembly; P:ribosome biogenesis; P:rRNA processing;|Q8IY37 Q9BUI7 Q9P211,Probable ATP-dependent RNA helicase DHX37,DEAH box protein 37;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0031965;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;GO:0034511;GO:0007420;GO:0000462;GO:2000020;GO:0042255;GO:0042254;GO:0006364;, C:cytoplasm; C:nuclear membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:U3 snoRNA binding;, P:brain development; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of male gonad development; P:ribosome assembly; P:ribosome biogenesis; P:rRNA processing;|Q8IY37 Q9BUI7 Q9P211,Probable ATP-dependent RNA helicase DHX37,DEAH box protein 37;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0031965;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;GO:0034511;GO:0007420;GO:0000462;GO:2000020;GO:0042255;GO:0042254;GO:0006364;, C:cytoplasm; C:nuclear membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:U3 snoRNA binding;, P:brain development; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of male gonad development; P:ribosome assembly; P:ribosome biogenesis; P:rRNA processing;|Q8IY37 Q9BUI7 Q9P211,Probable ATP-dependent RNA helicase DHX37,DEAH box protein 37;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0031965;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;GO:0034511;GO:0007420;GO:0000462;GO:2000020;GO:0042255;GO:0042254;GO:0006364;, C:cytoplasm; C:nuclear membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:U3 snoRNA binding;, P:brain development; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of male gonad development; P:ribosome assembly; P:ribosome biogenesis; P:rRNA processing;|Q91887 Q91888 Q9BWD6 Q9BX98 Q9UEF2 Q9UEG1 Q9UEK8 Q9UPK7,Polyubiquitin-B,, PF00240;, GO:0005737;GO:0005829;GO:0030666;GO:0005789;GO:0010008;GO:0070062;GO:0005615;GO:0043657;GO:0005741;GO:0005739;GO:0043005;GO:0043025;GO:0005654;GO:0005634;GO:0005886;GO:0031982;GO:0031386;GO:0031625;GO:0000187;GO:0035973;GO:1990000;GO:0031145;GO:0019221;GO:0002753;GO:0042769;GO:1904380;GO:0016197;GO:0097009;GO:0070987;GO:0042276;GO:0060613;GO:0008585;GO:0007144;GO:0070911;GO:0021888;GO:0007249;GO:0070498;GO:0036297;GO:0075733;GO:0007254;GO:0007141;GO:0061024;GO:0047497;GO:0019941;GO:0052031;GO:0002755;GO:0002756;GO:0043066;GO:0000122;GO:0030512;GO:0048812;GO:0070423;GO:0000715;GO:0000717;GO:0006297;GO:0033683;GO:0006296;GO:0006294;GO:0043065;GO:1902255;GO:0051092;GO:1902527;GO:0031398;GO:0045944;GO:0036388;GO:0016579;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:0051881;GO:0043488;GO:1901214;GO:0061136;GO:0061418;GO:0072520;GO:0051403;GO:0006283;GO:0007179;GO:0019985;GO:0055085;GO:0035666;GO:0019058;GO:0019081;GO:0019068;GO:0016055;, C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:host cell; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle;, F:protein tag; F:ubiquitin protein ligase binding;, P:activation of MAPK activity; P:aggrephagy; P:amyloid fibril formation; P:anaphase-promoting complex-dependent catabolic process; P:cytokine-mediated signaling pathway; P:cytoplasmic pattern recognition receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:endoplasmic reticulum mannose trimming; P:endosomal transport; P:energy homeostasis; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:fat pad development; P:female gonad development; P:female meiosis I; P:global genome nucleotide-excision repair; P:hypothalamus gonadotrophin-releasing hormone neuron development; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:interstrand cross-link repair; P:intracellular transport of virus; P:JNK cascade; P:male meiosis I; P:membrane organization; P:mitochondrion transport along microtubule; P:modification-dependent protein catabolic process; P:modulation by symbiont of host defense response; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron projection morphogenesis; P:nucleotide-binding oligomerization domain containing signaling pathway; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein monoubiquitination; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly; P:protein deubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitochondrial membrane potential; P:regulation of mRNA stability; P:regulation of neuron death; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:seminiferous tubule development; P:stress-activated MAPK cascade; P:transcription-coupled nucleotide-excision repair; P:transforming growth factor beta receptor signaling pathway; P:translesion synthesis; P:transmembrane transport; P:TRIF-dependent toll-like receptor signaling pathway; P:viral life cycle; P:viral translation; P:virion assembly; P:Wnt signaling pathway;|Q8WYN8 Q91887 Q91888 Q9BWD6 Q9BX98 Q9UEF2 Q9UEG1 Q9UEK8 Q9UPK7,Ubiquitin-60S ribosomal protein L40,CEP52;Ubiquitin A-52 residue ribosomal protein fusion product 1;, PF01020;PF00240;, GO:0005737;GO:0005829;GO:0022625;GO:0022627;GO:0030666;GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005615;GO:0043657;GO:0005765;GO:0005741;GO:0005654;GO:0005634;GO:0005886;GO:0031982;GO:0031386;GO:0003735;GO:0031625;GO:0000187;GO:0035973;GO:1990000;GO:0031145;GO:0006464;GO:0019221;GO:0002753;GO:0042769;GO:1904380;GO:0016197;GO:0070987;GO:0042276;GO:0070911;GO:0007249;GO:0070498;GO:0036297;GO:0075733;GO:0007254;GO:0061024;GO:0019941;GO:0052031;GO:0002755;GO:0002756;GO:0043066;GO:0000122;GO:0030512;GO:0000184;GO:0070423;GO:0000715;GO:0000717;GO:0006297;GO:0033683;GO:0006296;GO:0006294;GO:0043065;GO:0051092;GO:0045944;GO:0036388;GO:0016579;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:0043488;GO:0061418;GO:0006364;GO:0006614;GO:0051403;GO:0006283;GO:0007179;GO:0006412;GO:0006413;GO:0019985;GO:0055085;GO:0035666;GO:0019058;GO:0019083;GO:0019081;GO:0019068;GO:0016055;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:cytosolic small ribosomal subunit; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:host cell; C:lysosomal membrane; C:mitochondrial outer membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle;, F:protein tag; F:structural constituent of ribosome; F:ubiquitin protein ligase binding;, P:activation of MAPK activity; P:aggrephagy; P:amyloid fibril formation; P:anaphase-promoting complex-dependent catabolic process; P:cellular protein modification process; P:cytokine-mediated signaling pathway; P:cytoplasmic pattern recognition receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:endoplasmic reticulum mannose trimming; P:endosomal transport; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:global genome nucleotide-excision repair; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:interstrand cross-link repair; P:intracellular transport of virus; P:JNK cascade; P:membrane organization; P:modification-dependent protein catabolic process; P:modulation by symbiont of host defense response; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nucleotide-binding oligomerization domain containing signaling pathway; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly; P:protein deubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:stress-activated MAPK cascade; P:transcription-coupled nucleotide-excision repair; P:transforming growth factor beta receptor signaling pathway; P:translation; P:translational initiation; P:translesion synthesis; P:transmembrane transport; P:TRIF-dependent toll-like receptor signaling pathway; P:viral life cycle; P:viral transcription; P:viral translation; P:virion assembly; P:Wnt signaling pathway;|Q8WTV0 F8W8N0 Q14016 Q52LZ5 Q6KFX4,Scavenger receptor class B member 1,CD36 and LIMPII analogous 1;CD36 antigen-like 1;Collagen type I receptor, thrombospondin receptor-like 1;SR-BI;, PF01130;, GO:0005901;GO:0009986;GO:0005737;GO:0030666;GO:0070062;GO:0005887;GO:0043231;GO:0005765;GO:0005764;GO:0031528;GO:0005886;GO:0005545;GO:0001540;GO:0034186;GO:0034185;GO:0008035;GO:0070506;GO:0042802;GO:0008289;GO:0001530;GO:0001875;GO:0030169;GO:0001786;GO:0005044;GO:0005215;GO:0001618;GO:0044406;GO:0006702;GO:0043534;GO:0006707;GO:0033344;GO:0042632;GO:0070508;GO:0032497;GO:0001935;GO:0034384;GO:0034375;GO:0050892;GO:0015920;GO:0034383;GO:0015914;GO:0034381;GO:0010886;GO:0010595;GO:0051000;GO:0010867;GO:0006898;GO:0043654;GO:0050764;GO:0010899;GO:0043691;GO:0070328;GO:0035461;GO:0042060;, C:caveola; C:cell surface; C:cytoplasm; C:endocytic vesicle membrane; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:microvillus membrane; C:plasma membrane;, F:1-phosphatidylinositol binding; F:amyloid-beta binding; F:apolipoprotein A-I binding; F:apolipoprotein binding; F:high-density lipoprotein particle binding; F:high-density lipoprotein particle receptor activity; F:identical protein binding; F:lipid binding; F:lipopolysaccharide binding; F:lipopolysaccharide immune receptor activity; F:low-density lipoprotein particle binding; F:phosphatidylserine binding; F:scavenger receptor activity; F:transporter activity; F:virus receptor activity;, P:adhesion of symbiont to host; P:androgen biosynthetic process; P:blood vessel endothelial cell migration; P:cholesterol catabolic process; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol import; P:detection of lipopolysaccharide; P:endothelial cell proliferation; P:high-density lipoprotein particle clearance; P:high-density lipoprotein particle remodeling; P:intestinal absorption; P:lipopolysaccharide transport; P:low-density lipoprotein particle clearance; P:phospholipid transport; P:plasma lipoprotein particle clearance; P:positive regulation of cholesterol storage; P:positive regulation of endothelial cell migration; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of triglyceride biosynthetic process; P:receptor-mediated endocytosis; P:recognition of apoptotic cell; P:regulation of phagocytosis; P:regulation of phosphatidylcholine catabolic process; P:reverse cholesterol transport; P:triglyceride homeostasis; P:vitamin transmembrane transport; P:wound healing;|Q8WTV0 F8W8N0 Q14016 Q52LZ5 Q6KFX4,Scavenger receptor class B member 1,CD36 and LIMPII analogous 1;CD36 antigen-like 1;Collagen type I receptor, thrombospondin receptor-like 1;SR-BI;, PF01130;, GO:0005901;GO:0009986;GO:0005737;GO:0030666;GO:0070062;GO:0005887;GO:0043231;GO:0005765;GO:0005764;GO:0031528;GO:0005886;GO:0005545;GO:0001540;GO:0034186;GO:0034185;GO:0008035;GO:0070506;GO:0042802;GO:0008289;GO:0001530;GO:0001875;GO:0030169;GO:0001786;GO:0005044;GO:0005215;GO:0001618;GO:0044406;GO:0006702;GO:0043534;GO:0006707;GO:0033344;GO:0042632;GO:0070508;GO:0032497;GO:0001935;GO:0034384;GO:0034375;GO:0050892;GO:0015920;GO:0034383;GO:0015914;GO:0034381;GO:0010886;GO:0010595;GO:0051000;GO:0010867;GO:0006898;GO:0043654;GO:0050764;GO:0010899;GO:0043691;GO:0070328;GO:0035461;GO:0042060;, C:caveola; C:cell surface; C:cytoplasm; C:endocytic vesicle membrane; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:microvillus membrane; C:plasma membrane;, F:1-phosphatidylinositol binding; F:amyloid-beta binding; F:apolipoprotein A-I binding; F:apolipoprotein binding; F:high-density lipoprotein particle binding; F:high-density lipoprotein particle receptor activity; F:identical protein binding; F:lipid binding; F:lipopolysaccharide binding; F:lipopolysaccharide immune receptor activity; F:low-density lipoprotein particle binding; F:phosphatidylserine binding; F:scavenger receptor activity; F:transporter activity; F:virus receptor activity;, P:adhesion of symbiont to host; P:androgen biosynthetic process; P:blood vessel endothelial cell migration; P:cholesterol catabolic process; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol import; P:detection of lipopolysaccharide; P:endothelial cell proliferation; P:high-density lipoprotein particle clearance; P:high-density lipoprotein particle remodeling; P:intestinal absorption; P:lipopolysaccharide transport; P:low-density lipoprotein particle clearance; P:phospholipid transport; P:plasma lipoprotein particle clearance; P:positive regulation of cholesterol storage; P:positive regulation of endothelial cell migration; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of triglyceride biosynthetic process; P:receptor-mediated endocytosis; P:recognition of apoptotic cell; P:regulation of phagocytosis; P:regulation of phosphatidylcholine catabolic process; P:reverse cholesterol transport; P:triglyceride homeostasis; P:vitamin transmembrane transport; P:wound healing;|Q8WTV0 F8W8N0 Q14016 Q52LZ5 Q6KFX4,Scavenger receptor class B member 1,CD36 and LIMPII analogous 1;CD36 antigen-like 1;Collagen type I receptor, thrombospondin receptor-like 1;SR-BI;, PF01130;, GO:0005901;GO:0009986;GO:0005737;GO:0030666;GO:0070062;GO:0005887;GO:0043231;GO:0005765;GO:0005764;GO:0031528;GO:0005886;GO:0005545;GO:0001540;GO:0034186;GO:0034185;GO:0008035;GO:0070506;GO:0042802;GO:0008289;GO:0001530;GO:0001875;GO:0030169;GO:0001786;GO:0005044;GO:0005215;GO:0001618;GO:0044406;GO:0006702;GO:0043534;GO:0006707;GO:0033344;GO:0042632;GO:0070508;GO:0032497;GO:0001935;GO:0034384;GO:0034375;GO:0050892;GO:0015920;GO:0034383;GO:0015914;GO:0034381;GO:0010886;GO:0010595;GO:0051000;GO:0010867;GO:0006898;GO:0043654;GO:0050764;GO:0010899;GO:0043691;GO:0070328;GO:0035461;GO:0042060;, C:caveola; C:cell surface; C:cytoplasm; C:endocytic vesicle membrane; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:microvillus membrane; C:plasma membrane;, F:1-phosphatidylinositol binding; F:amyloid-beta binding; F:apolipoprotein A-I binding; F:apolipoprotein binding; F:high-density lipoprotein particle binding; F:high-density lipoprotein particle receptor activity; F:identical protein binding; F:lipid binding; F:lipopolysaccharide binding; F:lipopolysaccharide immune receptor activity; F:low-density lipoprotein particle binding; F:phosphatidylserine binding; F:scavenger receptor activity; F:transporter activity; F:virus receptor activity;, P:adhesion of symbiont to host; P:androgen biosynthetic process; P:blood vessel endothelial cell migration; P:cholesterol catabolic process; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol import; P:detection of lipopolysaccharide; P:endothelial cell proliferation; P:high-density lipoprotein particle clearance; P:high-density lipoprotein particle remodeling; P:intestinal absorption; P:lipopolysaccharide transport; P:low-density lipoprotein particle clearance; P:phospholipid transport; P:plasma lipoprotein particle clearance; P:positive regulation of cholesterol storage; P:positive regulation of endothelial cell migration; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of triglyceride biosynthetic process; P:receptor-mediated endocytosis; P:recognition of apoptotic cell; P:regulation of phagocytosis; P:regulation of phosphatidylcholine catabolic process; P:reverse cholesterol transport; P:triglyceride homeostasis; P:vitamin transmembrane transport; P:wound healing; scaffold11 indexed_genome mRNA 47917883 48060789 . + . ID=transcript_2972;Q9Y618 O00613 O15416 O15421 Q13354 Q56D06 Q59GM0 Q9Y5U0,Nuclear receptor corepressor 2 {ECO:0000305},CTG repeat protein 26;SMAP270;Silencing mediator of retinoic acid and thyroid hormone receptor {ECO:0000305};T3 receptor-associating factor;Thyroid-, retinoic-acid-receptor-associated corepressor;, PF15784;PF00249;, GO:0000785;GO:0000118;GO:0016020;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0035259;GO:0042826;GO:0005112;GO:0035257;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003714;GO:0044849;GO:0030522;GO:0007595;GO:0060766;GO:1903799;GO:0000122;GO:0045892;GO:0010565;GO:0019216;GO:0032355;GO:0010243;GO:0006367;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:glucocorticoid receptor binding; F:histone deacetylase binding; F:Notch binding; F:nuclear hormone receptor binding; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity;, P:estrous cycle; P:intracellular receptor signaling pathway; P:lactation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of cellular ketone metabolic process; P:regulation of lipid metabolic process; P:response to estradiol; P:response to organonitrogen compound; P:transcription initiation from RNA polymerase II promoter;|Q9Y618 O00613 O15416 O15421 Q13354 Q56D06 Q59GM0 Q9Y5U0,Nuclear receptor corepressor 2 {ECO:0000305},CTG repeat protein 26;SMAP270;Silencing mediator of retinoic acid and thyroid hormone receptor {ECO:0000305};T3 receptor-associating factor;Thyroid-, retinoic-acid-receptor-associated corepressor;, PF15784;PF00249;, GO:0000785;GO:0000118;GO:0016020;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0035259;GO:0042826;GO:0005112;GO:0035257;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003714;GO:0044849;GO:0030522;GO:0007595;GO:0060766;GO:1903799;GO:0000122;GO:0045892;GO:0010565;GO:0019216;GO:0032355;GO:0010243;GO:0006367;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:glucocorticoid receptor binding; F:histone deacetylase binding; F:Notch binding; F:nuclear hormone receptor binding; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity;, P:estrous cycle; P:intracellular receptor signaling pathway; P:lactation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of cellular ketone metabolic process; P:regulation of lipid metabolic process; P:response to estradiol; P:response to organonitrogen compound; P:transcription initiation from RNA polymerase II promoter; scaffold11 indexed_genome mRNA 48070790 48073752 . + . ID=transcript_2973;Q9Y618 O00613 O15416 O15421 Q13354 Q56D06 Q59GM0 Q9Y5U0,Nuclear receptor corepressor 2 {ECO:0000305},CTG repeat protein 26;SMAP270;Silencing mediator of retinoic acid and thyroid hormone receptor {ECO:0000305};T3 receptor-associating factor;Thyroid-, retinoic-acid-receptor-associated corepressor;, PF15784;PF00249;, GO:0000785;GO:0000118;GO:0016020;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0035259;GO:0042826;GO:0005112;GO:0035257;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003714;GO:0044849;GO:0030522;GO:0007595;GO:0060766;GO:1903799;GO:0000122;GO:0045892;GO:0010565;GO:0019216;GO:0032355;GO:0010243;GO:0006367;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:glucocorticoid receptor binding; F:histone deacetylase binding; F:Notch binding; F:nuclear hormone receptor binding; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity;, P:estrous cycle; P:intracellular receptor signaling pathway; P:lactation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of cellular ketone metabolic process; P:regulation of lipid metabolic process; P:response to estradiol; P:response to organonitrogen compound; P:transcription initiation from RNA polymerase II promoter; scaffold11 indexed_genome mRNA 48090110 48134038 . + . ID=transcript_2974;Q9Y618 O00613 O15416 O15421 Q13354 Q56D06 Q59GM0 Q9Y5U0,Nuclear receptor corepressor 2 {ECO:0000305},CTG repeat protein 26;SMAP270;Silencing mediator of retinoic acid and thyroid hormone receptor {ECO:0000305};T3 receptor-associating factor;Thyroid-, retinoic-acid-receptor-associated corepressor;, PF15784;PF00249;, GO:0000785;GO:0000118;GO:0016020;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0035259;GO:0042826;GO:0005112;GO:0035257;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003714;GO:0044849;GO:0030522;GO:0007595;GO:0060766;GO:1903799;GO:0000122;GO:0045892;GO:0010565;GO:0019216;GO:0032355;GO:0010243;GO:0006367;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:glucocorticoid receptor binding; F:histone deacetylase binding; F:Notch binding; F:nuclear hormone receptor binding; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity;, P:estrous cycle; P:intracellular receptor signaling pathway; P:lactation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of cellular ketone metabolic process; P:regulation of lipid metabolic process; P:response to estradiol; P:response to organonitrogen compound; P:transcription initiation from RNA polymerase II promoter;|Q9Y618 O00613 O15416 O15421 Q13354 Q56D06 Q59GM0 Q9Y5U0,Nuclear receptor corepressor 2 {ECO:0000305},CTG repeat protein 26;SMAP270;Silencing mediator of retinoic acid and thyroid hormone receptor {ECO:0000305};T3 receptor-associating factor;Thyroid-, retinoic-acid-receptor-associated corepressor;, PF15784;PF00249;, GO:0000785;GO:0000118;GO:0016020;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0035259;GO:0042826;GO:0005112;GO:0035257;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003714;GO:0044849;GO:0030522;GO:0007595;GO:0060766;GO:1903799;GO:0000122;GO:0045892;GO:0010565;GO:0019216;GO:0032355;GO:0010243;GO:0006367;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:glucocorticoid receptor binding; F:histone deacetylase binding; F:Notch binding; F:nuclear hormone receptor binding; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity;, P:estrous cycle; P:intracellular receptor signaling pathway; P:lactation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of cellular ketone metabolic process; P:regulation of lipid metabolic process; P:response to estradiol; P:response to organonitrogen compound; P:transcription initiation from RNA polymerase II promoter;|Q9Y618 O00613 O15416 O15421 Q13354 Q56D06 Q59GM0 Q9Y5U0,Nuclear receptor corepressor 2 {ECO:0000305},CTG repeat protein 26;SMAP270;Silencing mediator of retinoic acid and thyroid hormone receptor {ECO:0000305};T3 receptor-associating factor;Thyroid-, retinoic-acid-receptor-associated corepressor;, PF15784;PF00249;, GO:0000785;GO:0000118;GO:0016020;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0035259;GO:0042826;GO:0005112;GO:0035257;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003714;GO:0044849;GO:0030522;GO:0007595;GO:0060766;GO:1903799;GO:0000122;GO:0045892;GO:0010565;GO:0019216;GO:0032355;GO:0010243;GO:0006367;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:glucocorticoid receptor binding; F:histone deacetylase binding; F:Notch binding; F:nuclear hormone receptor binding; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity;, P:estrous cycle; P:intracellular receptor signaling pathway; P:lactation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of cellular ketone metabolic process; P:regulation of lipid metabolic process; P:response to estradiol; P:response to organonitrogen compound; P:transcription initiation from RNA polymerase II promoter;|Q9Y618 O00613 O15416 O15421 Q13354 Q56D06 Q59GM0 Q9Y5U0,Nuclear receptor corepressor 2 {ECO:0000305},CTG repeat protein 26;SMAP270;Silencing mediator of retinoic acid and thyroid hormone receptor {ECO:0000305};T3 receptor-associating factor;Thyroid-, retinoic-acid-receptor-associated corepressor;, PF15784;PF00249;, GO:0000785;GO:0000118;GO:0016020;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0035259;GO:0042826;GO:0005112;GO:0035257;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003714;GO:0044849;GO:0030522;GO:0007595;GO:0060766;GO:1903799;GO:0000122;GO:0045892;GO:0010565;GO:0019216;GO:0032355;GO:0010243;GO:0006367;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:glucocorticoid receptor binding; F:histone deacetylase binding; F:Notch binding; F:nuclear hormone receptor binding; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity;, P:estrous cycle; P:intracellular receptor signaling pathway; P:lactation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of cellular ketone metabolic process; P:regulation of lipid metabolic process; P:response to estradiol; P:response to organonitrogen compound; P:transcription initiation from RNA polymerase II promoter;|Q9Y618 O00613 O15416 O15421 Q13354 Q56D06 Q59GM0 Q9Y5U0,Nuclear receptor corepressor 2 {ECO:0000305},CTG repeat protein 26;SMAP270;Silencing mediator of retinoic acid and thyroid hormone receptor {ECO:0000305};T3 receptor-associating factor;Thyroid-, retinoic-acid-receptor-associated corepressor;, PF15784;PF00249;, GO:0000785;GO:0000118;GO:0016020;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0035259;GO:0042826;GO:0005112;GO:0035257;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003714;GO:0044849;GO:0030522;GO:0007595;GO:0060766;GO:1903799;GO:0000122;GO:0045892;GO:0010565;GO:0019216;GO:0032355;GO:0010243;GO:0006367;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:glucocorticoid receptor binding; F:histone deacetylase binding; F:Notch binding; F:nuclear hormone receptor binding; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity;, P:estrous cycle; P:intracellular receptor signaling pathway; P:lactation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of cellular ketone metabolic process; P:regulation of lipid metabolic process; P:response to estradiol; P:response to organonitrogen compound; P:transcription initiation from RNA polymerase II promoter;|Q9Y618 O00613 O15416 O15421 Q13354 Q56D06 Q59GM0 Q9Y5U0,Nuclear receptor corepressor 2 {ECO:0000305},CTG repeat protein 26;SMAP270;Silencing mediator of retinoic acid and thyroid hormone receptor {ECO:0000305};T3 receptor-associating factor;Thyroid-, retinoic-acid-receptor-associated corepressor;, PF15784;PF00249;, GO:0000785;GO:0000118;GO:0016020;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0035259;GO:0042826;GO:0005112;GO:0035257;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003714;GO:0044849;GO:0030522;GO:0007595;GO:0060766;GO:1903799;GO:0000122;GO:0045892;GO:0010565;GO:0019216;GO:0032355;GO:0010243;GO:0006367;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:glucocorticoid receptor binding; F:histone deacetylase binding; F:Notch binding; F:nuclear hormone receptor binding; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity;, P:estrous cycle; P:intracellular receptor signaling pathway; P:lactation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of cellular ketone metabolic process; P:regulation of lipid metabolic process; P:response to estradiol; P:response to organonitrogen compound; P:transcription initiation from RNA polymerase II promoter; scaffold11 indexed_genome mRNA 48386038 48390681 . - . ID=transcript_2975;Q8N3J9 B3KP97 Q15914 Q3ZCQ7,Zinc finger protein 664,Zinc finger protein 176 {ECO:0000312|HGNC:HGNC:25406};Zinc finger protein from organ of Corti;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold11 indexed_genome mRNA 48429322 48463324 . + . ID=transcript_2976;Q53HC0 B3KNQ0 Q9H697,Coiled-coil domain-containing protein 92,Limkain beta-2;, PF14916;, GO:0005814;GO:0005813;GO:0005737;GO:0043231;GO:0005654;GO:0042802;, C:centriole; C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:identical protein binding;|Q53HC0 B3KNQ0 Q9H697,Coiled-coil domain-containing protein 92,Limkain beta-2;, PF14916;, GO:0005814;GO:0005813;GO:0005737;GO:0043231;GO:0005654;GO:0042802;, C:centriole; C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:identical protein binding;|Q53HC0 B3KNQ0 Q9H697,Coiled-coil domain-containing protein 92,Limkain beta-2;, PF14916;, GO:0005814;GO:0005813;GO:0005737;GO:0043231;GO:0005654;GO:0042802;, C:centriole; C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:identical protein binding;|Q53HC0 B3KNQ0 Q9H697,Coiled-coil domain-containing protein 92,Limkain beta-2;, PF14916;, GO:0005814;GO:0005813;GO:0005737;GO:0043231;GO:0005654;GO:0042802;, C:centriole; C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:identical protein binding; scaffold11 indexed_genome mRNA 48464768 48467948 . - . ID=transcript_2977;Q8IVF4 C9JMF5 O95495 Q6ZUC9 Q6ZUP6 Q8N761,Dynein heavy chain 10, axonemal,Axonemal beta dynein heavy chain 10;Ciliary dynein heavy chain 10;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005930;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0007018;, C:axoneme; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:microtubule-based movement; scaffold11 indexed_genome mRNA 48470970 48476714 . - . ID=transcript_2978;Q8IVF4 C9JMF5 O95495 Q6ZUC9 Q6ZUP6 Q8N761,Dynein heavy chain 10, axonemal,Axonemal beta dynein heavy chain 10;Ciliary dynein heavy chain 10;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005930;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0007018;, C:axoneme; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:microtubule-based movement;|Q8IVF4 C9JMF5 O95495 Q6ZUC9 Q6ZUP6 Q8N761,Dynein heavy chain 10, axonemal,Axonemal beta dynein heavy chain 10;Ciliary dynein heavy chain 10;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005930;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0007018;, C:axoneme; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:microtubule-based movement; scaffold11 indexed_genome mRNA 48619032 48659173 . - . ID=transcript_2979;Q9Y487 A8K026 Q6NUM0,V-type proton ATPase 116 kDa subunit a2,Lysosomal H(+)-transporting ATPase V0 subunit a2;TJ6;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2;, PF01496;, GO:0001669;GO:0010008;GO:0016021;GO:0005765;GO:0048471;GO:0030670;GO:0005886;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0006879;GO:0036295;GO:0006955;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;GO:0007035;, C:acrosomal vesicle; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:immune response; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification;|Q9Y487 A8K026 Q6NUM0,V-type proton ATPase 116 kDa subunit a2,Lysosomal H(+)-transporting ATPase V0 subunit a2;TJ6;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2;, PF01496;, GO:0001669;GO:0010008;GO:0016021;GO:0005765;GO:0048471;GO:0030670;GO:0005886;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0006879;GO:0036295;GO:0006955;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;GO:0007035;, C:acrosomal vesicle; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:immune response; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification;|Q9Y487 A8K026 Q6NUM0,V-type proton ATPase 116 kDa subunit a2,Lysosomal H(+)-transporting ATPase V0 subunit a2;TJ6;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2;, PF01496;, GO:0001669;GO:0010008;GO:0016021;GO:0005765;GO:0048471;GO:0030670;GO:0005886;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0006879;GO:0036295;GO:0006955;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;GO:0007035;, C:acrosomal vesicle; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:immune response; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification;|Q9Y487 A8K026 Q6NUM0,V-type proton ATPase 116 kDa subunit a2,Lysosomal H(+)-transporting ATPase V0 subunit a2;TJ6;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2;, PF01496;, GO:0001669;GO:0010008;GO:0016021;GO:0005765;GO:0048471;GO:0030670;GO:0005886;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0006879;GO:0036295;GO:0006955;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;GO:0007035;, C:acrosomal vesicle; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:immune response; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification;|Q9Y487 A8K026 Q6NUM0,V-type proton ATPase 116 kDa subunit a2,Lysosomal H(+)-transporting ATPase V0 subunit a2;TJ6;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2;, PF01496;, GO:0001669;GO:0010008;GO:0016021;GO:0005765;GO:0048471;GO:0030670;GO:0005886;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0006879;GO:0036295;GO:0006955;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;GO:0007035;, C:acrosomal vesicle; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:immune response; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification;|Q9Y487 A8K026 Q6NUM0,V-type proton ATPase 116 kDa subunit a2,Lysosomal H(+)-transporting ATPase V0 subunit a2;TJ6;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2;, PF01496;, GO:0001669;GO:0010008;GO:0016021;GO:0005765;GO:0048471;GO:0030670;GO:0005886;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0006879;GO:0036295;GO:0006955;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;GO:0007035;, C:acrosomal vesicle; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:immune response; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification; scaffold11 indexed_genome mRNA 48669108 48689426 . - . ID=transcript_2980;Q96GX1 A8K7Y8 B3KPW5 Q9H966,Tectonic-2,, PF07773;, GO:0060170;GO:0005737;GO:0005856;GO:0016021;GO:0036038;GO:0097711;GO:0060271;GO:1904491;GO:0007224;, C:ciliary membrane; C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:protein localization to ciliary transition zone; P:smoothened signaling pathway;|Q96GX1 A8K7Y8 B3KPW5 Q9H966,Tectonic-2,, PF07773;, GO:0060170;GO:0005737;GO:0005856;GO:0016021;GO:0036038;GO:0097711;GO:0060271;GO:1904491;GO:0007224;, C:ciliary membrane; C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:protein localization to ciliary transition zone; P:smoothened signaling pathway;|Q96GX1 A8K7Y8 B3KPW5 Q9H966,Tectonic-2,, PF07773;, GO:0060170;GO:0005737;GO:0005856;GO:0016021;GO:0036038;GO:0097711;GO:0060271;GO:1904491;GO:0007224;, C:ciliary membrane; C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:protein localization to ciliary transition zone; P:smoothened signaling pathway; scaffold11 indexed_genome mRNA 48696761 48699187 . + . ID=transcript_2981;Q96GX1 A8K7Y8 B3KPW5 Q9H966,Tectonic-2,, PF07773;, GO:0060170;GO:0005737;GO:0005856;GO:0016021;GO:0036038;GO:0097711;GO:0060271;GO:1904491;GO:0007224;, C:ciliary membrane; C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:protein localization to ciliary transition zone; P:smoothened signaling pathway;|Q96GX1 A8K7Y8 B3KPW5 Q9H966,Tectonic-2,, PF07773;, GO:0060170;GO:0005737;GO:0005856;GO:0016021;GO:0036038;GO:0097711;GO:0060271;GO:1904491;GO:0007224;, C:ciliary membrane; C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:protein localization to ciliary transition zone; P:smoothened signaling pathway; scaffold11 indexed_genome mRNA 48701027 48721466 . - . ID=transcript_2982;Q13889 B2R819 B4DNZ6 Q7L0G0 Q96AT7,General transcription factor IIH subunit 3,Basic transcription factor 2 34 kDa subunit;General transcription factor IIH polypeptide 3;TFIIH basal transcription factor complex p34 subunit {ECO:0000303|PubMed:8194529};, PF03850;, GO:0000438;GO:0005654;GO:0005634;GO:0005669;GO:0000439;GO:0005675;GO:0097550;GO:0046872;GO:0047485;GO:0016251;GO:0006370;GO:0006281;GO:0070911;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:core TFIIH complex portion of holo TFIIH complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex; C:transcription preinitiation complex;, F:metal ion binding; F:protein N-terminus binding; F:RNA polymerase II general transcription initiation factor activity;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|Q13889 B2R819 B4DNZ6 Q7L0G0 Q96AT7,General transcription factor IIH subunit 3,Basic transcription factor 2 34 kDa subunit;General transcription factor IIH polypeptide 3;TFIIH basal transcription factor complex p34 subunit {ECO:0000303|PubMed:8194529};, PF03850;, GO:0000438;GO:0005654;GO:0005634;GO:0005669;GO:0000439;GO:0005675;GO:0097550;GO:0046872;GO:0047485;GO:0016251;GO:0006370;GO:0006281;GO:0070911;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:core TFIIH complex portion of holo TFIIH complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex; C:transcription preinitiation complex;, F:metal ion binding; F:protein N-terminus binding; F:RNA polymerase II general transcription initiation factor activity;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|Q13889 B2R819 B4DNZ6 Q7L0G0 Q96AT7,General transcription factor IIH subunit 3,Basic transcription factor 2 34 kDa subunit;General transcription factor IIH polypeptide 3;TFIIH basal transcription factor complex p34 subunit {ECO:0000303|PubMed:8194529};, PF03850;, GO:0000438;GO:0005654;GO:0005634;GO:0005669;GO:0000439;GO:0005675;GO:0097550;GO:0046872;GO:0047485;GO:0016251;GO:0006370;GO:0006281;GO:0070911;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:core TFIIH complex portion of holo TFIIH complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex; C:transcription preinitiation complex;, F:metal ion binding; F:protein N-terminus binding; F:RNA polymerase II general transcription initiation factor activity;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|Q13889 B2R819 B4DNZ6 Q7L0G0 Q96AT7,General transcription factor IIH subunit 3,Basic transcription factor 2 34 kDa subunit;General transcription factor IIH polypeptide 3;TFIIH basal transcription factor complex p34 subunit {ECO:0000303|PubMed:8194529};, PF03850;, GO:0000438;GO:0005654;GO:0005634;GO:0005669;GO:0000439;GO:0005675;GO:0097550;GO:0046872;GO:0047485;GO:0016251;GO:0006370;GO:0006281;GO:0070911;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:core TFIIH complex portion of holo TFIIH complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex; C:transcription preinitiation complex;, F:metal ion binding; F:protein N-terminus binding; F:RNA polymerase II general transcription initiation factor activity;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; scaffold11 indexed_genome mRNA 48721805 48733901 . + . ID=transcript_2983;Q14232 A6NLY9 B4DGX0 Q3SXP4,Translation initiation factor eIF-2B subunit alpha,eIF-2B GDP-GTP exchange factor subunit alpha;, PF01008;, GO:0005737;GO:0005829;GO:0005851;GO:0016020;GO:0005886;GO:0042802;GO:0003743;GO:0014003;GO:0050790;GO:0006446;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex; C:membrane; C:plasma membrane;, F:identical protein binding; F:translation initiation factor activity;, P:oligodendrocyte development; P:regulation of catalytic activity; P:regulation of translational initiation; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|Q14232 A6NLY9 B4DGX0 Q3SXP4,Translation initiation factor eIF-2B subunit alpha,eIF-2B GDP-GTP exchange factor subunit alpha;, PF01008;, GO:0005737;GO:0005829;GO:0005851;GO:0016020;GO:0005886;GO:0042802;GO:0003743;GO:0014003;GO:0050790;GO:0006446;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex; C:membrane; C:plasma membrane;, F:identical protein binding; F:translation initiation factor activity;, P:oligodendrocyte development; P:regulation of catalytic activity; P:regulation of translational initiation; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation; scaffold11 indexed_genome mRNA 48733904 48745022 . + . ID=transcript_2984;Q8NHQ9 Q658L6 Q8IYH0 Q9HCH7,ATP-dependent RNA helicase DDX55,DEAD box protein 55;, PF00270;PF13959;PF00271;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q8NHQ9 Q658L6 Q8IYH0 Q9HCH7,ATP-dependent RNA helicase DDX55,DEAD box protein 55;, PF00270;PF13959;PF00271;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q8NHQ9 Q658L6 Q8IYH0 Q9HCH7,ATP-dependent RNA helicase DDX55,DEAD box protein 55;, PF00270;PF13959;PF00271;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q8NHQ9 Q658L6 Q8IYH0 Q9HCH7,ATP-dependent RNA helicase DDX55,DEAD box protein 55;, PF00270;PF13959;PF00271;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q8NHQ9 Q658L6 Q8IYH0 Q9HCH7,ATP-dependent RNA helicase DDX55,DEAD box protein 55;, PF00270;PF13959;PF00271;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity; scaffold11 indexed_genome mRNA 48755518 48763943 . - . ID=transcript_2985;Q15363,Transmembrane emp24 domain-containing protein 2,Membrane protein p24A;p24;p24 family protein beta-1;, PF01105;, GO:0030137;GO:0030663;GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0043231;GO:0030133;GO:0042589;GO:0048205;GO:0048208;GO:0090158;GO:0006888;GO:0007030;GO:0001947;GO:0006886;GO:0060716;GO:0001893;GO:0035264;GO:1903912;GO:0034260;GO:0001843;GO:0036499;GO:0010628;GO:0036342;GO:0072659;GO:2000638;GO:0006890;GO:0032525;GO:0035459;, C:COPI-coated vesicle; C:COPI-coated vesicle membrane; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:transport vesicle; C:zymogen granule membrane;, , P:COPI coating of Golgi vesicle; P:COPII vesicle coating; P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:heart looping; P:intracellular protein transport; P:labyrinthine layer blood vessel development; P:maternal placenta development; P:multicellular organism growth; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of GTPase activity; P:neural tube closure; P:PERK-mediated unfolded protein response; P:positive regulation of gene expression; P:post-anal tail morphogenesis; P:protein localization to plasma membrane; P:regulation of SREBP signaling pathway; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:somite rostral/caudal axis specification; P:vesicle cargo loading;|Q15363,Transmembrane emp24 domain-containing protein 2,Membrane protein p24A;p24;p24 family protein beta-1;, PF01105;, GO:0030137;GO:0030663;GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0043231;GO:0030133;GO:0042589;GO:0048205;GO:0048208;GO:0090158;GO:0006888;GO:0007030;GO:0001947;GO:0006886;GO:0060716;GO:0001893;GO:0035264;GO:1903912;GO:0034260;GO:0001843;GO:0036499;GO:0010628;GO:0036342;GO:0072659;GO:2000638;GO:0006890;GO:0032525;GO:0035459;, C:COPI-coated vesicle; C:COPI-coated vesicle membrane; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:transport vesicle; C:zymogen granule membrane;, , P:COPI coating of Golgi vesicle; P:COPII vesicle coating; P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:heart looping; P:intracellular protein transport; P:labyrinthine layer blood vessel development; P:maternal placenta development; P:multicellular organism growth; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of GTPase activity; P:neural tube closure; P:PERK-mediated unfolded protein response; P:positive regulation of gene expression; P:post-anal tail morphogenesis; P:protein localization to plasma membrane; P:regulation of SREBP signaling pathway; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:somite rostral/caudal axis specification; P:vesicle cargo loading;|Q15363,Transmembrane emp24 domain-containing protein 2,Membrane protein p24A;p24;p24 family protein beta-1;, PF01105;, GO:0030137;GO:0030663;GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0043231;GO:0030133;GO:0042589;GO:0048205;GO:0048208;GO:0090158;GO:0006888;GO:0007030;GO:0001947;GO:0006886;GO:0060716;GO:0001893;GO:0035264;GO:1903912;GO:0034260;GO:0001843;GO:0036499;GO:0010628;GO:0036342;GO:0072659;GO:2000638;GO:0006890;GO:0032525;GO:0035459;, C:COPI-coated vesicle; C:COPI-coated vesicle membrane; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:transport vesicle; C:zymogen granule membrane;, , P:COPI coating of Golgi vesicle; P:COPII vesicle coating; P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:heart looping; P:intracellular protein transport; P:labyrinthine layer blood vessel development; P:maternal placenta development; P:multicellular organism growth; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of GTPase activity; P:neural tube closure; P:PERK-mediated unfolded protein response; P:positive regulation of gene expression; P:post-anal tail morphogenesis; P:protein localization to plasma membrane; P:regulation of SREBP signaling pathway; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:somite rostral/caudal axis specification; P:vesicle cargo loading;|Q15363,Transmembrane emp24 domain-containing protein 2,Membrane protein p24A;p24;p24 family protein beta-1;, PF01105;, GO:0030137;GO:0030663;GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0043231;GO:0030133;GO:0042589;GO:0048205;GO:0048208;GO:0090158;GO:0006888;GO:0007030;GO:0001947;GO:0006886;GO:0060716;GO:0001893;GO:0035264;GO:1903912;GO:0034260;GO:0001843;GO:0036499;GO:0010628;GO:0036342;GO:0072659;GO:2000638;GO:0006890;GO:0032525;GO:0035459;, C:COPI-coated vesicle; C:COPI-coated vesicle membrane; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:transport vesicle; C:zymogen granule membrane;, , P:COPI coating of Golgi vesicle; P:COPII vesicle coating; P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:heart looping; P:intracellular protein transport; P:labyrinthine layer blood vessel development; P:maternal placenta development; P:multicellular organism growth; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of GTPase activity; P:neural tube closure; P:PERK-mediated unfolded protein response; P:positive regulation of gene expression; P:post-anal tail morphogenesis; P:protein localization to plasma membrane; P:regulation of SREBP signaling pathway; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:somite rostral/caudal axis specification; P:vesicle cargo loading; scaffold11 indexed_genome mRNA 48790468 48833261 . + . ID=transcript_2986;Q5EBL4 Q66K36 Q8N1M0,RILP-like protein 1,Rab-interacting lysosomal-like protein 1;, PF09744;PF11461;, GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0046983;GO:0060271;GO:0003382;GO:1903445;GO:1901214;, C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:protein dimerization activity;, P:cilium assembly; P:epithelial cell morphogenesis; P:protein transport from ciliary membrane to plasma membrane; P:regulation of neuron death;|Q5EBL4 Q66K36 Q8N1M0,RILP-like protein 1,Rab-interacting lysosomal-like protein 1;, PF09744;PF11461;, GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0046983;GO:0060271;GO:0003382;GO:1903445;GO:1901214;, C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:protein dimerization activity;, P:cilium assembly; P:epithelial cell morphogenesis; P:protein transport from ciliary membrane to plasma membrane; P:regulation of neuron death;|Q5EBL4 Q66K36 Q8N1M0,RILP-like protein 1,Rab-interacting lysosomal-like protein 1;, PF09744;PF11461;, GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0046983;GO:0060271;GO:0003382;GO:1903445;GO:1901214;, C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:protein dimerization activity;, P:cilium assembly; P:epithelial cell morphogenesis; P:protein transport from ciliary membrane to plasma membrane; P:regulation of neuron death; scaffold11 indexed_genome mRNA 48835967 48839398 . - . ID=transcript_2987;Q16560 A8K262 Q5XKN9,U11/U12 small nuclear ribonucleoprotein 35 kDa protein,Protein HM-1;U1 snRNP-binding protein homolog;, PF00076;, GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0003729;GO:0017069;GO:0000398;GO:0008380;, C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex;, F:mRNA binding; F:snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; scaffold11 indexed_genome mRNA 48855956 48882664 . + . ID=transcript_2988;Q969X0,RILP-like protein 2,Rab-interacting lysosomal protein-like 2;p40phox-binding protein;, PF11461;, GO:0005813;GO:0036064;GO:0005929;GO:0005737;GO:0005829;GO:0016020;GO:0042802;GO:0046983;GO:0060271;GO:0003382;GO:1903445;, C:centrosome; C:ciliary basal body; C:cilium; C:cytoplasm; C:cytosol; C:membrane;, F:identical protein binding; F:protein dimerization activity;, P:cilium assembly; P:epithelial cell morphogenesis; P:protein transport from ciliary membrane to plasma membrane; scaffold11 indexed_genome mRNA 48887828 48888574 . + . ID=transcript_2989;Q9NQR1 A8K9D0 Q86W83 Q8TD09,N-lysine methyltransferase KMT5A {ECO:0000305},H4-K20-HMTase KMT5A;Histone-lysine N-methyltransferase KMT5A;Lysine N-methyltransferase 5A;Lysine-specific methylase 5A {ECO:0000312|HGNC:HGNC:29489};PR/SET domain-containing protein 07;SET domain-containing protein 8;, PF00856;, GO:0005694;GO:0005829;GO:0005654;GO:0018024;GO:0002039;GO:0016279;GO:0003714;GO:0051301;GO:0034770;GO:0007076;GO:0000122;GO:0045892;GO:0018026;GO:0043516;GO:1901796;, C:chromosome; C:cytosol; C:nucleoplasm;, F:histone-lysine N-methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:transcription corepressor activity;, P:cell division; P:histone H4-K20 methylation; P:mitotic chromosome condensation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine monomethylation; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of signal transduction by p53 class mediator; scaffold11 indexed_genome mRNA 48891185 48893129 . - . ID=transcript_2990;Q9NQR1 A8K9D0 Q86W83 Q8TD09,N-lysine methyltransferase KMT5A {ECO:0000305},H4-K20-HMTase KMT5A;Histone-lysine N-methyltransferase KMT5A;Lysine N-methyltransferase 5A;Lysine-specific methylase 5A {ECO:0000312|HGNC:HGNC:29489};PR/SET domain-containing protein 07;SET domain-containing protein 8;, PF00856;, GO:0005694;GO:0005829;GO:0005654;GO:0018024;GO:0002039;GO:0016279;GO:0003714;GO:0051301;GO:0034770;GO:0007076;GO:0000122;GO:0045892;GO:0018026;GO:0043516;GO:1901796;, C:chromosome; C:cytosol; C:nucleoplasm;, F:histone-lysine N-methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:transcription corepressor activity;, P:cell division; P:histone H4-K20 methylation; P:mitotic chromosome condensation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine monomethylation; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of signal transduction by p53 class mediator; scaffold11 indexed_genome mRNA 48924490 48975654 . + . ID=transcript_2991;A3KN83 Q05C06 Q3ZTS3 Q9H3T8 Q9NVB2,Protein strawberry notch homolog 1,Monocyte protein 3;, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:regulation of transcription, DNA-templated; scaffold11 indexed_genome mRNA 49000846 49007536 . + . ID=transcript_2992;O14519 F5GYA4,Cyclin-dependent kinase 2-associated protein 1,Deleted in oral cancer 1;Putative oral cancer suppressor;, PF09806;, GO:0005829;GO:0005654;GO:0005634;GO:0048471;GO:0070182;GO:0007049;GO:0006261;GO:0001934;, C:cytosol; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA polymerase binding;, P:cell cycle; P:DNA-dependent DNA replication; P:positive regulation of protein phosphorylation;|O14519 F5GYA4,Cyclin-dependent kinase 2-associated protein 1,Deleted in oral cancer 1;Putative oral cancer suppressor;, PF09806;, GO:0005829;GO:0005654;GO:0005634;GO:0048471;GO:0070182;GO:0007049;GO:0006261;GO:0001934;, C:cytosol; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA polymerase binding;, P:cell cycle; P:DNA-dependent DNA replication; P:positive regulation of protein phosphorylation;|O14519 F5GYA4,Cyclin-dependent kinase 2-associated protein 1,Deleted in oral cancer 1;Putative oral cancer suppressor;, PF09806;, GO:0005829;GO:0005654;GO:0005634;GO:0048471;GO:0070182;GO:0007049;GO:0006261;GO:0001934;, C:cytosol; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA polymerase binding;, P:cell cycle; P:DNA-dependent DNA replication; P:positive regulation of protein phosphorylation;|O14519 F5GYA4,Cyclin-dependent kinase 2-associated protein 1,Deleted in oral cancer 1;Putative oral cancer suppressor;, PF09806;, GO:0005829;GO:0005654;GO:0005634;GO:0048471;GO:0070182;GO:0007049;GO:0006261;GO:0001934;, C:cytosol; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA polymerase binding;, P:cell cycle; P:DNA-dependent DNA replication; P:positive regulation of protein phosphorylation; scaffold11 indexed_genome mRNA 49008119 49011700 . - . ID=transcript_2993;Q9H3J6 Q8WUC6,Probable peptide chain release factor C12orf65, mitochondrial,, PF00472;, GO:0005762;GO:0005739;GO:0003747;, C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:translation release factor activity;|Q9H3J6 Q8WUC6,Probable peptide chain release factor C12orf65, mitochondrial,, PF00472;, GO:0005762;GO:0005739;GO:0003747;, C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:translation release factor activity; scaffold11 indexed_genome mRNA 49021837 49064412 . + . ID=transcript_2994;Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane;|Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane;|Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane;|Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane;|Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane;|Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane; scaffold11 indexed_genome mRNA 49067349 49076710 . - . ID=transcript_2995;Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane;|Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane;|Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane;|Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane;|Q99550 A1L486 A6NEE2 B3KR87 Q9H976 U3KQ28,M-phase phosphoprotein 9,, , GO:0005814;GO:0005794;GO:0000139;GO:0016020;, C:centriole; C:Golgi apparatus; C:Golgi membrane; C:membrane; scaffold11 indexed_genome mRNA 49201212 49235846 . + . ID=transcript_2996;Q9BZ72 Q9P271,Membrane-associated phosphatidylinositol transfer protein 2,Phosphatidylinositol transfer protein, membrane-associated 2;Pyk2 N-terminal domain-interacting receptor 3;, PF02862;PF02121;, GO:0044297;GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0005509;GO:0031210;GO:0008525;GO:0035091;GO:0008526;GO:0030971;GO:0006661;GO:0048015;, C:cell body; C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:calcium ion binding; F:phosphatidylcholine binding; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:receptor tyrosine kinase binding;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol-mediated signaling;|Q9BZ72 Q9P271,Membrane-associated phosphatidylinositol transfer protein 2,Phosphatidylinositol transfer protein, membrane-associated 2;Pyk2 N-terminal domain-interacting receptor 3;, PF02862;PF02121;, GO:0044297;GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0005509;GO:0031210;GO:0008525;GO:0035091;GO:0008526;GO:0030971;GO:0006661;GO:0048015;, C:cell body; C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:calcium ion binding; F:phosphatidylcholine binding; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:receptor tyrosine kinase binding;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol-mediated signaling;|Q9BZ72 Q9P271,Membrane-associated phosphatidylinositol transfer protein 2,Phosphatidylinositol transfer protein, membrane-associated 2;Pyk2 N-terminal domain-interacting receptor 3;, PF02862;PF02121;, GO:0044297;GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0005509;GO:0031210;GO:0008525;GO:0035091;GO:0008526;GO:0030971;GO:0006661;GO:0048015;, C:cell body; C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:calcium ion binding; F:phosphatidylcholine binding; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:receptor tyrosine kinase binding;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol-mediated signaling;|Q9BZ72 Q9P271,Membrane-associated phosphatidylinositol transfer protein 2,Phosphatidylinositol transfer protein, membrane-associated 2;Pyk2 N-terminal domain-interacting receptor 3;, PF02862;PF02121;, GO:0044297;GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0005509;GO:0031210;GO:0008525;GO:0035091;GO:0008526;GO:0030971;GO:0006661;GO:0048015;, C:cell body; C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:calcium ion binding; F:phosphatidylcholine binding; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:receptor tyrosine kinase binding;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol-mediated signaling; scaffold11 indexed_genome mRNA 49244583 49247626 . - . ID=transcript_2997;Q66PJ3 A4UCR8 B3V0L0 B3V0L1 Q4F966 Q504R8 Q96BI2 Q9NR05 Q9P2R9,ADP-ribosylation factor-like protein 6-interacting protein 4,HSP-975;HSVI-binding protein;SR-15;SRp25;Splicing factor SRrp37;, PF10500;, GO:0016607;GO:0005730;GO:0005634;GO:0003723;GO:0006397;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleus;, F:RNA binding;, P:mRNA processing; P:RNA splicing;|Q66PJ3 A4UCR8 B3V0L0 B3V0L1 Q4F966 Q504R8 Q96BI2 Q9NR05 Q9P2R9,ADP-ribosylation factor-like protein 6-interacting protein 4,HSP-975;HSVI-binding protein;SR-15;SRp25;Splicing factor SRrp37;, PF10500;, GO:0016607;GO:0005730;GO:0005634;GO:0003723;GO:0006397;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleus;, F:RNA binding;, P:mRNA processing; P:RNA splicing; scaffold11 indexed_genome mRNA 49249315 49251721 . - . ID=transcript_2998;Q6N063 B3KT24 Q4KN13 Q6N023 Q9H8K6,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,, , GO:0051213;GO:0005506;GO:0031418;GO:0016705;, , F:dioxygenase activity; F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;|Q6N063 B3KT24 Q4KN13 Q6N023 Q9H8K6,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,, , GO:0051213;GO:0005506;GO:0031418;GO:0016705;, , F:dioxygenase activity; F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; scaffold11 indexed_genome mRNA 49260750 49288733 . + . ID=transcript_2999;Q9NP78 B4E2J0 Q5W9G7 Q769F3 Q769F4 Q96AB1 Q9P208,ATP-binding cassette sub-family B member 9,ATP-binding cassette transporter 9;TAP-like protein;, PF00664;PF00005;, GO:0030176;GO:0016021;GO:0043231;GO:0005765;GO:0005764;GO:0042824;GO:0015433;GO:0015440;GO:0005524;GO:0016887;GO:0042626;GO:0042803;GO:0046978;GO:0022857;GO:0019885;GO:0015833;GO:0015031;GO:0055085;, C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:MHC class I peptide loading complex;, F:ABC-type peptide antigen transporter activity; F:ABC-type peptide transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:protein homodimerization activity; F:TAP1 binding; F:transmembrane transporter activity;, P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:peptide transport; P:protein transport; P:transmembrane transport;|Q9NP78 B4E2J0 Q5W9G7 Q769F3 Q769F4 Q96AB1 Q9P208,ATP-binding cassette sub-family B member 9,ATP-binding cassette transporter 9;TAP-like protein;, PF00664;PF00005;, GO:0030176;GO:0016021;GO:0043231;GO:0005765;GO:0005764;GO:0042824;GO:0015433;GO:0015440;GO:0005524;GO:0016887;GO:0042626;GO:0042803;GO:0046978;GO:0022857;GO:0019885;GO:0015833;GO:0015031;GO:0055085;, C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:MHC class I peptide loading complex;, F:ABC-type peptide antigen transporter activity; F:ABC-type peptide transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:protein homodimerization activity; F:TAP1 binding; F:transmembrane transporter activity;, P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:peptide transport; P:protein transport; P:transmembrane transport;|Q9NP78 B4E2J0 Q5W9G7 Q769F3 Q769F4 Q96AB1 Q9P208,ATP-binding cassette sub-family B member 9,ATP-binding cassette transporter 9;TAP-like protein;, PF00664;PF00005;, GO:0030176;GO:0016021;GO:0043231;GO:0005765;GO:0005764;GO:0042824;GO:0015433;GO:0015440;GO:0005524;GO:0016887;GO:0042626;GO:0042803;GO:0046978;GO:0022857;GO:0019885;GO:0015833;GO:0015031;GO:0055085;, C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:MHC class I peptide loading complex;, F:ABC-type peptide antigen transporter activity; F:ABC-type peptide transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:protein homodimerization activity; F:TAP1 binding; F:transmembrane transporter activity;, P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:peptide transport; P:protein transport; P:transmembrane transport; scaffold11 indexed_genome mRNA 49318807 49363238 . + . ID=transcript_3000;Q9H9H4,Vacuolar protein sorting-associated protein 37B,ESCRT-I complex subunit VPS37B;, PF07200;, GO:0005737;GO:0005768;GO:0010008;GO:0000813;GO:0070062;GO:0043657;GO:0043231;GO:0031902;GO:0030496;GO:0005886;GO:0048306;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:1903774;GO:1902188;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;, C:cytoplasm; C:endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:midbody; C:plasma membrane;, F:calcium-dependent protein binding;, P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral release from host cell; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle;|Q9H9H4,Vacuolar protein sorting-associated protein 37B,ESCRT-I complex subunit VPS37B;, PF07200;, GO:0005737;GO:0005768;GO:0010008;GO:0000813;GO:0070062;GO:0043657;GO:0043231;GO:0031902;GO:0030496;GO:0005886;GO:0048306;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:1903774;GO:1902188;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;, C:cytoplasm; C:endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:midbody; C:plasma membrane;, F:calcium-dependent protein binding;, P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral release from host cell; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle;|O75146 A6NHQ6 Q6NXG8 Q9UED9,Huntingtin-interacting protein 1-related protein,Huntingtin-interacting protein 12;, PF07651;PF16515;PF01608;, GO:0016324;GO:0005938;GO:0005905;GO:0030136;GO:0030665;GO:0005856;GO:0005829;GO:0032839;GO:0043197;GO:0043231;GO:0005739;GO:0043025;GO:0048471;GO:0005886;GO:0014069;GO:0032587;GO:0097060;GO:0051015;GO:0035615;GO:0030276;GO:0032051;GO:0042802;GO:0035091;GO:0005547;GO:0043325;GO:0080025;GO:0005546;GO:0046982;GO:0042803;GO:0017124;GO:0007015;GO:0006919;GO:0006915;GO:0048268;GO:0055123;GO:0061024;GO:0030837;GO:0043066;GO:0034316;GO:0043065;GO:1905445;GO:0045742;GO:1901030;GO:2000588;GO:0032092;GO:0048260;GO:0050821;GO:0006898;GO:0032956;GO:2000369;GO:0030100;GO:0060453;, C:apical plasma membrane; C:cell cortex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:intracellular membrane-bounded organelle; C:mitochondrion; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:ruffle membrane; C:synaptic membrane;, F:actin filament binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SH3 domain binding;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:clathrin coat assembly; P:digestive system development; P:membrane organization; P:negative regulation of actin filament polymerization; P:negative regulation of apoptotic process; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of apoptotic process; P:positive regulation of clathrin coat assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein binding; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of clathrin-dependent endocytosis; P:regulation of endocytosis; P:regulation of gastric acid secretion;|O75146 A6NHQ6 Q6NXG8 Q9UED9,Huntingtin-interacting protein 1-related protein,Huntingtin-interacting protein 12;, PF07651;PF16515;PF01608;, GO:0016324;GO:0005938;GO:0005905;GO:0030136;GO:0030665;GO:0005856;GO:0005829;GO:0032839;GO:0043197;GO:0043231;GO:0005739;GO:0043025;GO:0048471;GO:0005886;GO:0014069;GO:0032587;GO:0097060;GO:0051015;GO:0035615;GO:0030276;GO:0032051;GO:0042802;GO:0035091;GO:0005547;GO:0043325;GO:0080025;GO:0005546;GO:0046982;GO:0042803;GO:0017124;GO:0007015;GO:0006919;GO:0006915;GO:0048268;GO:0055123;GO:0061024;GO:0030837;GO:0043066;GO:0034316;GO:0043065;GO:1905445;GO:0045742;GO:1901030;GO:2000588;GO:0032092;GO:0048260;GO:0050821;GO:0006898;GO:0032956;GO:2000369;GO:0030100;GO:0060453;, C:apical plasma membrane; C:cell cortex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:intracellular membrane-bounded organelle; C:mitochondrion; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:ruffle membrane; C:synaptic membrane;, F:actin filament binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SH3 domain binding;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:clathrin coat assembly; P:digestive system development; P:membrane organization; P:negative regulation of actin filament polymerization; P:negative regulation of apoptotic process; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of apoptotic process; P:positive regulation of clathrin coat assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein binding; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of clathrin-dependent endocytosis; P:regulation of endocytosis; P:regulation of gastric acid secretion;|O75146 A6NHQ6 Q6NXG8 Q9UED9,Huntingtin-interacting protein 1-related protein,Huntingtin-interacting protein 12;, PF07651;PF16515;PF01608;, GO:0016324;GO:0005938;GO:0005905;GO:0030136;GO:0030665;GO:0005856;GO:0005829;GO:0032839;GO:0043197;GO:0043231;GO:0005739;GO:0043025;GO:0048471;GO:0005886;GO:0014069;GO:0032587;GO:0097060;GO:0051015;GO:0035615;GO:0030276;GO:0032051;GO:0042802;GO:0035091;GO:0005547;GO:0043325;GO:0080025;GO:0005546;GO:0046982;GO:0042803;GO:0017124;GO:0007015;GO:0006919;GO:0006915;GO:0048268;GO:0055123;GO:0061024;GO:0030837;GO:0043066;GO:0034316;GO:0043065;GO:1905445;GO:0045742;GO:1901030;GO:2000588;GO:0032092;GO:0048260;GO:0050821;GO:0006898;GO:0032956;GO:2000369;GO:0030100;GO:0060453;, C:apical plasma membrane; C:cell cortex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:intracellular membrane-bounded organelle; C:mitochondrion; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:ruffle membrane; C:synaptic membrane;, F:actin filament binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SH3 domain binding;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:clathrin coat assembly; P:digestive system development; P:membrane organization; P:negative regulation of actin filament polymerization; P:negative regulation of apoptotic process; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of apoptotic process; P:positive regulation of clathrin coat assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein binding; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of clathrin-dependent endocytosis; P:regulation of endocytosis; P:regulation of gastric acid secretion;|O75146 A6NHQ6 Q6NXG8 Q9UED9,Huntingtin-interacting protein 1-related protein,Huntingtin-interacting protein 12;, PF07651;PF16515;PF01608;, GO:0016324;GO:0005938;GO:0005905;GO:0030136;GO:0030665;GO:0005856;GO:0005829;GO:0032839;GO:0043197;GO:0043231;GO:0005739;GO:0043025;GO:0048471;GO:0005886;GO:0014069;GO:0032587;GO:0097060;GO:0051015;GO:0035615;GO:0030276;GO:0032051;GO:0042802;GO:0035091;GO:0005547;GO:0043325;GO:0080025;GO:0005546;GO:0046982;GO:0042803;GO:0017124;GO:0007015;GO:0006919;GO:0006915;GO:0048268;GO:0055123;GO:0061024;GO:0030837;GO:0043066;GO:0034316;GO:0043065;GO:1905445;GO:0045742;GO:1901030;GO:2000588;GO:0032092;GO:0048260;GO:0050821;GO:0006898;GO:0032956;GO:2000369;GO:0030100;GO:0060453;, C:apical plasma membrane; C:cell cortex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:intracellular membrane-bounded organelle; C:mitochondrion; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:ruffle membrane; C:synaptic membrane;, F:actin filament binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SH3 domain binding;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:clathrin coat assembly; P:digestive system development; P:membrane organization; P:negative regulation of actin filament polymerization; P:negative regulation of apoptotic process; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of apoptotic process; P:positive regulation of clathrin coat assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein binding; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of clathrin-dependent endocytosis; P:regulation of endocytosis; P:regulation of gastric acid secretion;|O75146 A6NHQ6 Q6NXG8 Q9UED9,Huntingtin-interacting protein 1-related protein,Huntingtin-interacting protein 12;, PF07651;PF16515;PF01608;, GO:0016324;GO:0005938;GO:0005905;GO:0030136;GO:0030665;GO:0005856;GO:0005829;GO:0032839;GO:0043197;GO:0043231;GO:0005739;GO:0043025;GO:0048471;GO:0005886;GO:0014069;GO:0032587;GO:0097060;GO:0051015;GO:0035615;GO:0030276;GO:0032051;GO:0042802;GO:0035091;GO:0005547;GO:0043325;GO:0080025;GO:0005546;GO:0046982;GO:0042803;GO:0017124;GO:0007015;GO:0006919;GO:0006915;GO:0048268;GO:0055123;GO:0061024;GO:0030837;GO:0043066;GO:0034316;GO:0043065;GO:1905445;GO:0045742;GO:1901030;GO:2000588;GO:0032092;GO:0048260;GO:0050821;GO:0006898;GO:0032956;GO:2000369;GO:0030100;GO:0060453;, C:apical plasma membrane; C:cell cortex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:intracellular membrane-bounded organelle; C:mitochondrion; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:ruffle membrane; C:synaptic membrane;, F:actin filament binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SH3 domain binding;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:clathrin coat assembly; P:digestive system development; P:membrane organization; P:negative regulation of actin filament polymerization; P:negative regulation of apoptotic process; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of apoptotic process; P:positive regulation of clathrin coat assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein binding; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of clathrin-dependent endocytosis; P:regulation of endocytosis; P:regulation of gastric acid secretion;|O75146 A6NHQ6 Q6NXG8 Q9UED9,Huntingtin-interacting protein 1-related protein,Huntingtin-interacting protein 12;, PF07651;PF16515;PF01608;, GO:0016324;GO:0005938;GO:0005905;GO:0030136;GO:0030665;GO:0005856;GO:0005829;GO:0032839;GO:0043197;GO:0043231;GO:0005739;GO:0043025;GO:0048471;GO:0005886;GO:0014069;GO:0032587;GO:0097060;GO:0051015;GO:0035615;GO:0030276;GO:0032051;GO:0042802;GO:0035091;GO:0005547;GO:0043325;GO:0080025;GO:0005546;GO:0046982;GO:0042803;GO:0017124;GO:0007015;GO:0006919;GO:0006915;GO:0048268;GO:0055123;GO:0061024;GO:0030837;GO:0043066;GO:0034316;GO:0043065;GO:1905445;GO:0045742;GO:1901030;GO:2000588;GO:0032092;GO:0048260;GO:0050821;GO:0006898;GO:0032956;GO:2000369;GO:0030100;GO:0060453;, C:apical plasma membrane; C:cell cortex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:intracellular membrane-bounded organelle; C:mitochondrion; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:ruffle membrane; C:synaptic membrane;, F:actin filament binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SH3 domain binding;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:clathrin coat assembly; P:digestive system development; P:membrane organization; P:negative regulation of actin filament polymerization; P:negative regulation of apoptotic process; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of apoptotic process; P:positive regulation of clathrin coat assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein binding; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of clathrin-dependent endocytosis; P:regulation of endocytosis; P:regulation of gastric acid secretion;|O75146 A6NHQ6 Q6NXG8 Q9UED9,Huntingtin-interacting protein 1-related protein,Huntingtin-interacting protein 12;, PF07651;PF16515;PF01608;, GO:0016324;GO:0005938;GO:0005905;GO:0030136;GO:0030665;GO:0005856;GO:0005829;GO:0032839;GO:0043197;GO:0043231;GO:0005739;GO:0043025;GO:0048471;GO:0005886;GO:0014069;GO:0032587;GO:0097060;GO:0051015;GO:0035615;GO:0030276;GO:0032051;GO:0042802;GO:0035091;GO:0005547;GO:0043325;GO:0080025;GO:0005546;GO:0046982;GO:0042803;GO:0017124;GO:0007015;GO:0006919;GO:0006915;GO:0048268;GO:0055123;GO:0061024;GO:0030837;GO:0043066;GO:0034316;GO:0043065;GO:1905445;GO:0045742;GO:1901030;GO:2000588;GO:0032092;GO:0048260;GO:0050821;GO:0006898;GO:0032956;GO:2000369;GO:0030100;GO:0060453;, C:apical plasma membrane; C:cell cortex; C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:intracellular membrane-bounded organelle; C:mitochondrion; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:ruffle membrane; C:synaptic membrane;, F:actin filament binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SH3 domain binding;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:clathrin coat assembly; P:digestive system development; P:membrane organization; P:negative regulation of actin filament polymerization; P:negative regulation of apoptotic process; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of apoptotic process; P:positive regulation of clathrin coat assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein binding; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of clathrin-dependent endocytosis; P:regulation of endocytosis; P:regulation of gastric acid secretion; scaffold11 indexed_genome mRNA 49388262 49406136 . - . ID=transcript_3001;Q6P9F0 A8K8V1 B3KUP3 Q6ZVF2 Q86VJ0 Q9BYZ5,Coiled-coil domain-containing protein 62,Protein TSP-NY;Protein aaa;, , GO:0005737;GO:0005654;GO:0005634;GO:0005886;GO:0030331;GO:0030374;GO:0001835;GO:0071392;GO:0045944;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:estrogen receptor binding; F:nuclear receptor coactivator activity;, P:blastocyst hatching; P:cellular response to estradiol stimulus; P:positive regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 49406552 49407079 . + . ID=transcript_3002;Q6P9F0 A8K8V1 B3KUP3 Q6ZVF2 Q86VJ0 Q9BYZ5,Coiled-coil domain-containing protein 62,Protein TSP-NY;Protein aaa;, , GO:0005737;GO:0005654;GO:0005634;GO:0005886;GO:0030331;GO:0030374;GO:0001835;GO:0071392;GO:0045944;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:estrogen receptor binding; F:nuclear receptor coactivator activity;, P:blastocyst hatching; P:cellular response to estradiol stimulus; P:positive regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 49408537 49415442 . - . ID=transcript_3003;Q6P9F0 A8K8V1 B3KUP3 Q6ZVF2 Q86VJ0 Q9BYZ5,Coiled-coil domain-containing protein 62,Protein TSP-NY;Protein aaa;, , GO:0005737;GO:0005654;GO:0005634;GO:0005886;GO:0030331;GO:0030374;GO:0001835;GO:0071392;GO:0045944;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:estrogen receptor binding; F:nuclear receptor coactivator activity;, P:blastocyst hatching; P:cellular response to estradiol stimulus; P:positive regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 49416649 49425162 . - . ID=transcript_3004;Q6P9F0 A8K8V1 B3KUP3 Q6ZVF2 Q86VJ0 Q9BYZ5,Coiled-coil domain-containing protein 62,Protein TSP-NY;Protein aaa;, , GO:0005737;GO:0005654;GO:0005634;GO:0005886;GO:0030331;GO:0030374;GO:0001835;GO:0071392;GO:0045944;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:estrogen receptor binding; F:nuclear receptor coactivator activity;, P:blastocyst hatching; P:cellular response to estradiol stimulus; P:positive regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 49430601 49442283 . - . ID=transcript_3005;O43583 Q9H3U6 Q9UKZ0,Density-regulated protein,Protein DRP1;Smooth muscle cell-associated protein 3;, PF01253;, GO:0003729;GO:0003743;GO:0001731;GO:0075522;GO:0032790;GO:0002188;, , F:mRNA binding; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:IRES-dependent viral translational initiation; P:ribosome disassembly; P:translation reinitiation;|O43583 Q9H3U6 Q9UKZ0,Density-regulated protein,Protein DRP1;Smooth muscle cell-associated protein 3;, PF01253;, GO:0003729;GO:0003743;GO:0001731;GO:0075522;GO:0032790;GO:0002188;, , F:mRNA binding; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:IRES-dependent viral translational initiation; P:ribosome disassembly; P:translation reinitiation;|P27635 A3KQT0 D3DWW6 Q16470 Q2HXT7 Q53FH7 Q6FGN8 Q8TDA5,60S ribosomal protein L10 {ECO:0000305},Laminin receptor homolog;Large ribosomal subunit protein uL16 {ECO:0000303|PubMed:24524803};Protein QM;Ribosomal protein L10 {ECO:0000312|HGNC:HGNC:10298};Tumor suppressor QM;, PF00252;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0005634;GO:0032991;GO:0003723;GO:0003735;GO:0045182;GO:1990403;GO:0043066;GO:0000122;GO:0000184;GO:0006417;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane; C:nucleus; C:protein-containing complex;, F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:embryonic brain development; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|O43583 Q9H3U6 Q9UKZ0,Density-regulated protein,Protein DRP1;Smooth muscle cell-associated protein 3;, PF01253;, GO:0003729;GO:0003743;GO:0001731;GO:0075522;GO:0032790;GO:0002188;, , F:mRNA binding; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:IRES-dependent viral translational initiation; P:ribosome disassembly; P:translation reinitiation; scaffold11 indexed_genome mRNA 49487160 49488920 . + . ID=transcript_3006;Q8TDS4 A0PJL5 A7LGG3,Hydroxycarboxylic acid receptor 2,G-protein coupled receptor 109A;G-protein coupled receptor HM74A;Niacin receptor 1;Nicotinic acid receptor;, PF00001;, GO:0030054;GO:0016021;GO:0005886;GO:0070553;GO:0007186;GO:0050995;GO:0001781;GO:0070165;GO:0033031;, C:cell junction; C:integral component of membrane; C:plasma membrane;, F:nicotinic acid receptor activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of lipid catabolic process; P:neutrophil apoptotic process; P:positive regulation of adiponectin secretion; P:positive regulation of neutrophil apoptotic process;|P49019 A8K4G5 B2R830 E9PI97 Q8NGE4,Hydroxycarboxylic acid receptor 3,G-protein coupled receptor 109B;G-protein coupled receptor HM74;G-protein coupled receptor HM74B;Niacin receptor 2;Nicotinic acid receptor 2;, PF00001;, GO:0030054;GO:0005887;GO:0005886;GO:0004930;GO:0007186;, C:cell junction; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; scaffold11 indexed_genome mRNA 49557476 49566355 . - . ID=transcript_3007;P50748 A7E2C4 B3KSG2,Kinetochore-associated protein 1,Rough deal homolog;, PF10493;, GO:0015629;GO:0000777;GO:0005829;GO:0005828;GO:0005634;GO:0005886;GO:1990423;GO:0000922;GO:0051301;GO:0007094;GO:0007052;GO:0065003;GO:0007096;, C:actin cytoskeleton; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore microtubule; C:nucleus; C:plasma membrane; C:RZZ complex; C:spindle pole;, , P:cell division; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein-containing complex assembly; P:regulation of exit from mitosis; scaffold11 indexed_genome mRNA 49583820 49586755 . - . ID=transcript_3008;P50748 A7E2C4 B3KSG2,Kinetochore-associated protein 1,Rough deal homolog;, PF10493;, GO:0015629;GO:0000777;GO:0005829;GO:0005828;GO:0005634;GO:0005886;GO:1990423;GO:0000922;GO:0051301;GO:0007094;GO:0007052;GO:0065003;GO:0007096;, C:actin cytoskeleton; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore microtubule; C:nucleus; C:plasma membrane; C:RZZ complex; C:spindle pole;, , P:cell division; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein-containing complex assembly; P:regulation of exit from mitosis; scaffold11 indexed_genome mRNA 49619654 49631293 . + . ID=transcript_3009;Q7L4I2 Q6N040 Q6NW16 Q9H864,Arginine/serine-rich coiled-coil protein 2,, PF15477;, GO:0003723;, , F:RNA binding;|Q7L4I2 Q6N040 Q6NW16 Q9H864,Arginine/serine-rich coiled-coil protein 2,, PF15477;, GO:0003723;, , F:RNA binding;|Q7L4I2 Q6N040 Q6NW16 Q9H864,Arginine/serine-rich coiled-coil protein 2,, PF15477;, GO:0003723;, , F:RNA binding;|Q7L4I2 Q6N040 Q6NW16 Q9H864,Arginine/serine-rich coiled-coil protein 2,, PF15477;, GO:0003723;, , F:RNA binding;|Q7L4I2 Q6N040 Q6NW16 Q9H864,Arginine/serine-rich coiled-coil protein 2,, PF15477;, GO:0003723;, , F:RNA binding;|Q7L4I2 Q6N040 Q6NW16 Q9H864,Arginine/serine-rich coiled-coil protein 2,, PF15477;, GO:0003723;, , F:RNA binding; scaffold11 indexed_genome mRNA 49637098 49649608 . + . ID=transcript_3010;Q6NZY4 Q7L2P6 Q8N2K5 Q96SK7 Q9NSS2 Q9NSS3,Zinc finger CCHC domain-containing protein 8,TRAMP-like complex RNA-binding factor ZCCHC8;, PF04046;PF00098;, GO:0071013;GO:0016604;GO:0005654;GO:0005634;GO:0031499;GO:0003723;GO:0008270;GO:0000398;GO:0034470;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:ncRNA processing; P:snRNA catabolic process;|Q6NZY4 Q7L2P6 Q8N2K5 Q96SK7 Q9NSS2 Q9NSS3,Zinc finger CCHC domain-containing protein 8,TRAMP-like complex RNA-binding factor ZCCHC8;, PF04046;PF00098;, GO:0071013;GO:0016604;GO:0005654;GO:0005634;GO:0031499;GO:0003723;GO:0008270;GO:0000398;GO:0034470;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:ncRNA processing; P:snRNA catabolic process;|Q6NZY4 Q7L2P6 Q8N2K5 Q96SK7 Q9NSS2 Q9NSS3,Zinc finger CCHC domain-containing protein 8,TRAMP-like complex RNA-binding factor ZCCHC8;, PF04046;PF00098;, GO:0071013;GO:0016604;GO:0005654;GO:0005634;GO:0031499;GO:0003723;GO:0008270;GO:0000398;GO:0034470;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:ncRNA processing; P:snRNA catabolic process;|Q6NZY4 Q7L2P6 Q8N2K5 Q96SK7 Q9NSS2 Q9NSS3,Zinc finger CCHC domain-containing protein 8,TRAMP-like complex RNA-binding factor ZCCHC8;, PF04046;PF00098;, GO:0071013;GO:0016604;GO:0005654;GO:0005634;GO:0031499;GO:0003723;GO:0008270;GO:0000398;GO:0034470;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:ncRNA processing; P:snRNA catabolic process;|Q6NZY4 Q7L2P6 Q8N2K5 Q96SK7 Q9NSS2 Q9NSS3,Zinc finger CCHC domain-containing protein 8,TRAMP-like complex RNA-binding factor ZCCHC8;, PF04046;PF00098;, GO:0071013;GO:0016604;GO:0005654;GO:0005634;GO:0031499;GO:0003723;GO:0008270;GO:0000398;GO:0034470;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:ncRNA processing; P:snRNA catabolic process;|Q6NZY4 Q7L2P6 Q8N2K5 Q96SK7 Q9NSS2 Q9NSS3,Zinc finger CCHC domain-containing protein 8,TRAMP-like complex RNA-binding factor ZCCHC8;, PF04046;PF00098;, GO:0071013;GO:0016604;GO:0005654;GO:0005634;GO:0031499;GO:0003723;GO:0008270;GO:0000398;GO:0034470;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:ncRNA processing; P:snRNA catabolic process; scaffold11 indexed_genome mRNA 49650097 49659981 . + . ID=transcript_3011;Q6NZY4 Q7L2P6 Q8N2K5 Q96SK7 Q9NSS2 Q9NSS3,Zinc finger CCHC domain-containing protein 8,TRAMP-like complex RNA-binding factor ZCCHC8;, PF04046;PF00098;, GO:0071013;GO:0016604;GO:0005654;GO:0005634;GO:0031499;GO:0003723;GO:0008270;GO:0000398;GO:0034470;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:ncRNA processing; P:snRNA catabolic process;|Q6NZY4 Q7L2P6 Q8N2K5 Q96SK7 Q9NSS2 Q9NSS3,Zinc finger CCHC domain-containing protein 8,TRAMP-like complex RNA-binding factor ZCCHC8;, PF04046;PF00098;, GO:0071013;GO:0016604;GO:0005654;GO:0005634;GO:0031499;GO:0003723;GO:0008270;GO:0000398;GO:0034470;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:ncRNA processing; P:snRNA catabolic process;|Q6NZY4 Q7L2P6 Q8N2K5 Q96SK7 Q9NSS2 Q9NSS3,Zinc finger CCHC domain-containing protein 8,TRAMP-like complex RNA-binding factor ZCCHC8;, PF04046;PF00098;, GO:0071013;GO:0016604;GO:0005654;GO:0005634;GO:0031499;GO:0003723;GO:0008270;GO:0000398;GO:0034470;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:ncRNA processing; P:snRNA catabolic process; scaffold11 indexed_genome mRNA 49719035 49731456 . + . ID=transcript_3012;P30622 A0AVD3 Q17RS4 Q29RG0,CAP-Gly domain-containing linker protein 1,Cytoplasmic linker protein 1;Cytoplasmic linker protein 170 alpha-2;Reed-Sternberg intermediate filament-associated protein;Restin;, PF01302;PF16641;, GO:0005813;GO:0005737;GO:0030659;GO:0005829;GO:0005882;GO:0000776;GO:0005874;GO:0015630;GO:0005634;GO:0001726;GO:0042802;GO:0008017;GO:0051010;GO:0015631;GO:0008270;GO:0031122;GO:0001578;GO:0000278;GO:0007052;GO:0031116;, C:centrosome; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:intermediate filament; C:kinetochore; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:ruffle;, F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:tubulin binding; F:zinc ion binding;, P:cytoplasmic microtubule organization; P:microtubule bundle formation; P:mitotic cell cycle; P:mitotic spindle organization; P:positive regulation of microtubule polymerization; scaffold11 indexed_genome mRNA 49736167 49740158 . + . ID=transcript_3013;P30622 A0AVD3 Q17RS4 Q29RG0,CAP-Gly domain-containing linker protein 1,Cytoplasmic linker protein 1;Cytoplasmic linker protein 170 alpha-2;Reed-Sternberg intermediate filament-associated protein;Restin;, PF01302;PF16641;, GO:0005813;GO:0005737;GO:0030659;GO:0005829;GO:0005882;GO:0000776;GO:0005874;GO:0015630;GO:0005634;GO:0001726;GO:0042802;GO:0008017;GO:0051010;GO:0015631;GO:0008270;GO:0031122;GO:0001578;GO:0000278;GO:0007052;GO:0031116;, C:centrosome; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:intermediate filament; C:kinetochore; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:ruffle;, F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:tubulin binding; F:zinc ion binding;, P:cytoplasmic microtubule organization; P:microtubule bundle formation; P:mitotic cell cycle; P:mitotic spindle organization; P:positive regulation of microtubule polymerization; scaffold11 indexed_genome mRNA 49748022 49750134 . + . ID=transcript_3014;P30622 A0AVD3 Q17RS4 Q29RG0,CAP-Gly domain-containing linker protein 1,Cytoplasmic linker protein 1;Cytoplasmic linker protein 170 alpha-2;Reed-Sternberg intermediate filament-associated protein;Restin;, PF01302;PF16641;, GO:0005813;GO:0005737;GO:0030659;GO:0005829;GO:0005882;GO:0000776;GO:0005874;GO:0015630;GO:0005634;GO:0001726;GO:0042802;GO:0008017;GO:0051010;GO:0015631;GO:0008270;GO:0031122;GO:0001578;GO:0000278;GO:0007052;GO:0031116;, C:centrosome; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:intermediate filament; C:kinetochore; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:ruffle;, F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:tubulin binding; F:zinc ion binding;, P:cytoplasmic microtubule organization; P:microtubule bundle formation; P:mitotic cell cycle; P:mitotic spindle organization; P:positive regulation of microtubule polymerization; scaffold11 indexed_genome mRNA 49757732 49791723 . + . ID=transcript_3015;P30622 A0AVD3 Q17RS4 Q29RG0,CAP-Gly domain-containing linker protein 1,Cytoplasmic linker protein 1;Cytoplasmic linker protein 170 alpha-2;Reed-Sternberg intermediate filament-associated protein;Restin;, PF01302;PF16641;, GO:0005813;GO:0005737;GO:0030659;GO:0005829;GO:0005882;GO:0000776;GO:0005874;GO:0015630;GO:0005634;GO:0001726;GO:0042802;GO:0008017;GO:0051010;GO:0015631;GO:0008270;GO:0031122;GO:0001578;GO:0000278;GO:0007052;GO:0031116;, C:centrosome; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:intermediate filament; C:kinetochore; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:ruffle;, F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:tubulin binding; F:zinc ion binding;, P:cytoplasmic microtubule organization; P:microtubule bundle formation; P:mitotic cell cycle; P:mitotic spindle organization; P:positive regulation of microtubule polymerization;|P30622 A0AVD3 Q17RS4 Q29RG0,CAP-Gly domain-containing linker protein 1,Cytoplasmic linker protein 1;Cytoplasmic linker protein 170 alpha-2;Reed-Sternberg intermediate filament-associated protein;Restin;, PF01302;PF16641;, GO:0005813;GO:0005737;GO:0030659;GO:0005829;GO:0005882;GO:0000776;GO:0005874;GO:0015630;GO:0005634;GO:0001726;GO:0042802;GO:0008017;GO:0051010;GO:0015631;GO:0008270;GO:0031122;GO:0001578;GO:0000278;GO:0007052;GO:0031116;, C:centrosome; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:intermediate filament; C:kinetochore; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:ruffle;, F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:tubulin binding; F:zinc ion binding;, P:cytoplasmic microtubule organization; P:microtubule bundle formation; P:mitotic cell cycle; P:mitotic spindle organization; P:positive regulation of microtubule polymerization;|P30622 A0AVD3 Q17RS4 Q29RG0,CAP-Gly domain-containing linker protein 1,Cytoplasmic linker protein 1;Cytoplasmic linker protein 170 alpha-2;Reed-Sternberg intermediate filament-associated protein;Restin;, PF01302;PF16641;, GO:0005813;GO:0005737;GO:0030659;GO:0005829;GO:0005882;GO:0000776;GO:0005874;GO:0015630;GO:0005634;GO:0001726;GO:0042802;GO:0008017;GO:0051010;GO:0015631;GO:0008270;GO:0031122;GO:0001578;GO:0000278;GO:0007052;GO:0031116;, C:centrosome; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:intermediate filament; C:kinetochore; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:ruffle;, F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:tubulin binding; F:zinc ion binding;, P:cytoplasmic microtubule organization; P:microtubule bundle formation; P:mitotic cell cycle; P:mitotic spindle organization; P:positive regulation of microtubule polymerization;|P30622 A0AVD3 Q17RS4 Q29RG0,CAP-Gly domain-containing linker protein 1,Cytoplasmic linker protein 1;Cytoplasmic linker protein 170 alpha-2;Reed-Sternberg intermediate filament-associated protein;Restin;, PF01302;PF16641;, GO:0005813;GO:0005737;GO:0030659;GO:0005829;GO:0005882;GO:0000776;GO:0005874;GO:0015630;GO:0005634;GO:0001726;GO:0042802;GO:0008017;GO:0051010;GO:0015631;GO:0008270;GO:0031122;GO:0001578;GO:0000278;GO:0007052;GO:0031116;, C:centrosome; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:intermediate filament; C:kinetochore; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:ruffle;, F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:tubulin binding; F:zinc ion binding;, P:cytoplasmic microtubule organization; P:microtubule bundle formation; P:mitotic cell cycle; P:mitotic spindle organization; P:positive regulation of microtubule polymerization; scaffold11 indexed_genome mRNA 49802043 49827377 . + . ID=transcript_3016;Q96AX1 Q547V4 Q9H5Q0,Vacuolar protein sorting-associated protein 33A,, PF00995;, GO:0005776;GO:0030136;GO:0033263;GO:0005769;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0097352;GO:0008333;GO:0006886;GO:0032418;GO:0032400;GO:0030220;GO:0048070;GO:0035751;GO:0016192;, C:autophagosome; C:clathrin-coated vesicle; C:CORVET complex; C:early endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, , P:autophagosome maturation; P:endosome to lysosome transport; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:platelet formation; P:regulation of developmental pigmentation; P:regulation of lysosomal lumen pH; P:vesicle-mediated transport;|Q96AX1 Q547V4 Q9H5Q0,Vacuolar protein sorting-associated protein 33A,, PF00995;, GO:0005776;GO:0030136;GO:0033263;GO:0005769;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0097352;GO:0008333;GO:0006886;GO:0032418;GO:0032400;GO:0030220;GO:0048070;GO:0035751;GO:0016192;, C:autophagosome; C:clathrin-coated vesicle; C:CORVET complex; C:early endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, , P:autophagosome maturation; P:endosome to lysosome transport; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:platelet formation; P:regulation of developmental pigmentation; P:regulation of lysosomal lumen pH; P:vesicle-mediated transport;|Q96AX1 Q547V4 Q9H5Q0,Vacuolar protein sorting-associated protein 33A,, PF00995;, GO:0005776;GO:0030136;GO:0033263;GO:0005769;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0097352;GO:0008333;GO:0006886;GO:0032418;GO:0032400;GO:0030220;GO:0048070;GO:0035751;GO:0016192;, C:autophagosome; C:clathrin-coated vesicle; C:CORVET complex; C:early endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, , P:autophagosome maturation; P:endosome to lysosome transport; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:platelet formation; P:regulation of developmental pigmentation; P:regulation of lysosomal lumen pH; P:vesicle-mediated transport;|Q96AX1 Q547V4 Q9H5Q0,Vacuolar protein sorting-associated protein 33A,, PF00995;, GO:0005776;GO:0030136;GO:0033263;GO:0005769;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0097352;GO:0008333;GO:0006886;GO:0032418;GO:0032400;GO:0030220;GO:0048070;GO:0035751;GO:0016192;, C:autophagosome; C:clathrin-coated vesicle; C:CORVET complex; C:early endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, , P:autophagosome maturation; P:endosome to lysosome transport; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:platelet formation; P:regulation of developmental pigmentation; P:regulation of lysosomal lumen pH; P:vesicle-mediated transport; scaffold11 indexed_genome mRNA 49827570 49833638 . + . ID=transcript_3017;Q96AX1 Q547V4 Q9H5Q0,Vacuolar protein sorting-associated protein 33A,, PF00995;, GO:0005776;GO:0030136;GO:0033263;GO:0005769;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0097352;GO:0008333;GO:0006886;GO:0032418;GO:0032400;GO:0030220;GO:0048070;GO:0035751;GO:0016192;, C:autophagosome; C:clathrin-coated vesicle; C:CORVET complex; C:early endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, , P:autophagosome maturation; P:endosome to lysosome transport; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:platelet formation; P:regulation of developmental pigmentation; P:regulation of lysosomal lumen pH; P:vesicle-mediated transport;|Q96AX1 Q547V4 Q9H5Q0,Vacuolar protein sorting-associated protein 33A,, PF00995;, GO:0005776;GO:0030136;GO:0033263;GO:0005769;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0097352;GO:0008333;GO:0006886;GO:0032418;GO:0032400;GO:0030220;GO:0048070;GO:0035751;GO:0016192;, C:autophagosome; C:clathrin-coated vesicle; C:CORVET complex; C:early endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, , P:autophagosome maturation; P:endosome to lysosome transport; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:platelet formation; P:regulation of developmental pigmentation; P:regulation of lysosomal lumen pH; P:vesicle-mediated transport; scaffold11 indexed_genome mRNA 49836812 49900713 . + . ID=transcript_3018;Q9NR28 B2RDQ0 Q6W3F3 Q96LV0 Q9BT11 Q9HAV6,Diablo homolog, mitochondrial,Direct IAP-binding protein with low pI;Second mitochondria-derived activator of caspase;, PF09057;, GO:0035631;GO:0009898;GO:0005829;GO:0005758;GO:0005739;GO:0006919;GO:0008635;GO:0006915;GO:0008625;GO:0097193;GO:0008631;GO:0051402;GO:0043065;, C:CD40 receptor complex; C:cytoplasmic side of plasma membrane; C:cytosol; C:mitochondrial intermembrane space; C:mitochondrion;, , P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:apoptotic process; P:extrinsic apoptotic signaling pathway via death domain receptors; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:neuron apoptotic process; P:positive regulation of apoptotic process;|Q9NR28 B2RDQ0 Q6W3F3 Q96LV0 Q9BT11 Q9HAV6,Diablo homolog, mitochondrial,Direct IAP-binding protein with low pI;Second mitochondria-derived activator of caspase;, PF09057;, GO:0035631;GO:0009898;GO:0005829;GO:0005758;GO:0005739;GO:0006919;GO:0008635;GO:0006915;GO:0008625;GO:0097193;GO:0008631;GO:0051402;GO:0043065;, C:CD40 receptor complex; C:cytoplasmic side of plasma membrane; C:cytosol; C:mitochondrial intermembrane space; C:mitochondrion;, , P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:apoptotic process; P:extrinsic apoptotic signaling pathway via death domain receptors; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:neuron apoptotic process; P:positive regulation of apoptotic process;|Q9NR28 B2RDQ0 Q6W3F3 Q96LV0 Q9BT11 Q9HAV6,Diablo homolog, mitochondrial,Direct IAP-binding protein with low pI;Second mitochondria-derived activator of caspase;, PF09057;, GO:0035631;GO:0009898;GO:0005829;GO:0005758;GO:0005739;GO:0006919;GO:0008635;GO:0006915;GO:0008625;GO:0097193;GO:0008631;GO:0051402;GO:0043065;, C:CD40 receptor complex; C:cytoplasmic side of plasma membrane; C:cytosol; C:mitochondrial intermembrane space; C:mitochondrion;, , P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:apoptotic process; P:extrinsic apoptotic signaling pathway via death domain receptors; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:neuron apoptotic process; P:positive regulation of apoptotic process; scaffold11 indexed_genome mRNA 49900860 49901818 . - . ID=transcript_3019;Q9C0J1 Q8N5W4 Q8N934 Q8ND21 Q8WWR5 Q8WY02 Q96QH5,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 4,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4;, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0008457;GO:0008532;GO:0018146;GO:0016266;GO:0030311;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity;, P:keratan sulfate biosynthetic process; P:O-glycan processing; P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation; scaffold11 indexed_genome mRNA 49950476 50008632 . + . ID=transcript_3020;Q9HAP2 A7MBN0 O94945 Q7LC47 Q8IXP1 Q8TAH9 Q8WVQ0 Q8WYA5,MLX-interacting protein,Class E basic helix-loop-helix protein 36;Transcriptional activator MondoA;, PF00010;, GO:0000785;GO:0005741;GO:0005634;GO:0001228;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0045944;GO:0006357;, C:chromatin; C:mitochondrial outer membrane; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9HAP2 A7MBN0 O94945 Q7LC47 Q8IXP1 Q8TAH9 Q8WVQ0 Q8WYA5,MLX-interacting protein,Class E basic helix-loop-helix protein 36;Transcriptional activator MondoA;, PF00010;, GO:0000785;GO:0005741;GO:0005634;GO:0001228;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0045944;GO:0006357;, C:chromatin; C:mitochondrial outer membrane; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9HAP2 A7MBN0 O94945 Q7LC47 Q8IXP1 Q8TAH9 Q8WVQ0 Q8WYA5,MLX-interacting protein,Class E basic helix-loop-helix protein 36;Transcriptional activator MondoA;, PF00010;, GO:0000785;GO:0005741;GO:0005634;GO:0001228;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0045944;GO:0006357;, C:chromatin; C:mitochondrial outer membrane; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9HAP2 A7MBN0 O94945 Q7LC47 Q8IXP1 Q8TAH9 Q8WVQ0 Q8WYA5,MLX-interacting protein,Class E basic helix-loop-helix protein 36;Transcriptional activator MondoA;, PF00010;, GO:0000785;GO:0005741;GO:0005634;GO:0001228;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0045944;GO:0006357;, C:chromatin; C:mitochondrial outer membrane; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9HAP2 A7MBN0 O94945 Q7LC47 Q8IXP1 Q8TAH9 Q8WVQ0 Q8WYA5,MLX-interacting protein,Class E basic helix-loop-helix protein 36;Transcriptional activator MondoA;, PF00010;, GO:0000785;GO:0005741;GO:0005634;GO:0001228;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0045944;GO:0006357;, C:chromatin; C:mitochondrial outer membrane; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9HAP2 A7MBN0 O94945 Q7LC47 Q8IXP1 Q8TAH9 Q8WVQ0 Q8WYA5,MLX-interacting protein,Class E basic helix-loop-helix protein 36;Transcriptional activator MondoA;, PF00010;, GO:0000785;GO:0005741;GO:0005634;GO:0001228;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0045944;GO:0006357;, C:chromatin; C:mitochondrial outer membrane; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9HAP2 A7MBN0 O94945 Q7LC47 Q8IXP1 Q8TAH9 Q8WVQ0 Q8WYA5,MLX-interacting protein,Class E basic helix-loop-helix protein 36;Transcriptional activator MondoA;, PF00010;, GO:0000785;GO:0005741;GO:0005634;GO:0001228;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0045944;GO:0006357;, C:chromatin; C:mitochondrial outer membrane; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold11 indexed_genome mRNA 50037465 50051022 . - . ID=transcript_3021;Q4VC05 B4DJN6 B7ZB21 Q13843 Q14CT7,B-cell CLL/lymphoma 7 protein family member A,, PF04714;, GO:0045892;, , , P:negative regulation of transcription, DNA-templated;|Q4VC05 B4DJN6 B7ZB21 Q13843 Q14CT7,B-cell CLL/lymphoma 7 protein family member A,, PF04714;, GO:0045892;, , , P:negative regulation of transcription, DNA-templated; scaffold11 indexed_genome mRNA 50080316 50140009 . - . ID=transcript_3022;Q8TBY9 C9J1W2 Q8IYA3 Q8N898 Q8NDE7,Cilia- and flagella-associated protein 251 {ECO:0000305},WD repeat-containing protein 66 {ECO:0000312|HGNC:HGNC:28506};, PF00400;, GO:0005930;GO:0031514;GO:0036126;GO:0003341;GO:0030317;, C:axoneme; C:motile cilium; C:sperm flagellum;, , P:cilium movement; P:flagellated sperm motility;|Q8TBY9 C9J1W2 Q8IYA3 Q8N898 Q8NDE7,Cilia- and flagella-associated protein 251 {ECO:0000305},WD repeat-containing protein 66 {ECO:0000312|HGNC:HGNC:28506};, PF00400;, GO:0005930;GO:0031514;GO:0036126;GO:0003341;GO:0030317;, C:axoneme; C:motile cilium; C:sperm flagellum;, , P:cilium movement; P:flagellated sperm motility;|Q8TBY9 C9J1W2 Q8IYA3 Q8N898 Q8NDE7,Cilia- and flagella-associated protein 251 {ECO:0000305},WD repeat-containing protein 66 {ECO:0000312|HGNC:HGNC:28506};, PF00400;, GO:0005930;GO:0031514;GO:0036126;GO:0003341;GO:0030317;, C:axoneme; C:motile cilium; C:sperm flagellum;, , P:cilium movement; P:flagellated sperm motility; scaffold11 indexed_genome mRNA 50142578 50150973 . - . ID=transcript_3023;Q8TBY9 C9J1W2 Q8IYA3 Q8N898 Q8NDE7,Cilia- and flagella-associated protein 251 {ECO:0000305},WD repeat-containing protein 66 {ECO:0000312|HGNC:HGNC:28506};, PF00400;, GO:0005930;GO:0031514;GO:0036126;GO:0003341;GO:0030317;, C:axoneme; C:motile cilium; C:sperm flagellum;, , P:cilium movement; P:flagellated sperm motility; scaffold11 indexed_genome mRNA 50153904 50170276 . - . ID=transcript_3024;O00233 B2RD35 G3V1Q6 Q9BQ42,26S proteasome non-ATPase regulatory subunit 9,26S proteasome regulatory subunit p27;, PF18265;PF17820;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005838;GO:0043425;GO:0003713;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0046676;GO:0038061;GO:0090263;GO:0032024;GO:0045893;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome regulatory particle;, F:bHLH transcription factor binding; F:transcription coactivator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of insulin secretion; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of insulin secretion; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00233 B2RD35 G3V1Q6 Q9BQ42,26S proteasome non-ATPase regulatory subunit 9,26S proteasome regulatory subunit p27;, PF18265;PF17820;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005838;GO:0043425;GO:0003713;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0046676;GO:0038061;GO:0090263;GO:0032024;GO:0045893;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome regulatory particle;, F:bHLH transcription factor binding; F:transcription coactivator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of insulin secretion; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of insulin secretion; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00233 B2RD35 G3V1Q6 Q9BQ42,26S proteasome non-ATPase regulatory subunit 9,26S proteasome regulatory subunit p27;, PF18265;PF17820;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005838;GO:0043425;GO:0003713;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0046676;GO:0038061;GO:0090263;GO:0032024;GO:0045893;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome regulatory particle;, F:bHLH transcription factor binding; F:transcription coactivator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of insulin secretion; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of insulin secretion; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00233 B2RD35 G3V1Q6 Q9BQ42,26S proteasome non-ATPase regulatory subunit 9,26S proteasome regulatory subunit p27;, PF18265;PF17820;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005838;GO:0043425;GO:0003713;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0046676;GO:0038061;GO:0090263;GO:0032024;GO:0045893;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome regulatory particle;, F:bHLH transcription factor binding; F:transcription coactivator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of insulin secretion; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of insulin secretion; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00233 B2RD35 G3V1Q6 Q9BQ42,26S proteasome non-ATPase regulatory subunit 9,26S proteasome regulatory subunit p27;, PF18265;PF17820;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005838;GO:0043425;GO:0003713;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0046676;GO:0038061;GO:0090263;GO:0032024;GO:0045893;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome regulatory particle;, F:bHLH transcription factor binding; F:transcription coactivator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of insulin secretion; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of insulin secretion; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold11 indexed_genome mRNA 50190988 50204952 . + . ID=transcript_3025;P32754 A8K461 B3KQ63 Q13234,4-hydroxyphenylpyruvate dioxygenase,4-hydroxyphenylpyruvic acid oxidase;, PF00903;, GO:0005829;GO:0005789;GO:0070062;GO:0000139;GO:0003868;GO:0046872;GO:0006559;GO:0006572;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi membrane;, F:4-hydroxyphenylpyruvate dioxygenase activity; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|P32754 A8K461 B3KQ63 Q13234,4-hydroxyphenylpyruvate dioxygenase,4-hydroxyphenylpyruvic acid oxidase;, PF00903;, GO:0005829;GO:0005789;GO:0070062;GO:0000139;GO:0003868;GO:0046872;GO:0006559;GO:0006572;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi membrane;, F:4-hydroxyphenylpyruvate dioxygenase activity; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|P32754 A8K461 B3KQ63 Q13234,4-hydroxyphenylpyruvate dioxygenase,4-hydroxyphenylpyruvic acid oxidase;, PF00903;, GO:0005829;GO:0005789;GO:0070062;GO:0000139;GO:0003868;GO:0046872;GO:0006559;GO:0006572;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi membrane;, F:4-hydroxyphenylpyruvate dioxygenase activity; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|P32754 A8K461 B3KQ63 Q13234,4-hydroxyphenylpyruvate dioxygenase,4-hydroxyphenylpyruvic acid oxidase;, PF00903;, GO:0005829;GO:0005789;GO:0070062;GO:0000139;GO:0003868;GO:0046872;GO:0006559;GO:0006572;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi membrane;, F:4-hydroxyphenylpyruvate dioxygenase activity; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|P32754 A8K461 B3KQ63 Q13234,4-hydroxyphenylpyruvate dioxygenase,4-hydroxyphenylpyruvic acid oxidase;, PF00903;, GO:0005829;GO:0005789;GO:0070062;GO:0000139;GO:0003868;GO:0046872;GO:0006559;GO:0006572;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi membrane;, F:4-hydroxyphenylpyruvate dioxygenase activity; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process; scaffold11 indexed_genome mRNA 50205685 50218923 . - . ID=transcript_3026;Q9UPS6 F6MFW1,Histone-lysine N-methyltransferase SETD1B,Lysine N-methyltransferase 2G;SET domain-containing protein 1B;, PF11764;PF00076;PF00856;, GO:0005694;GO:0035097;GO:0016607;GO:0005654;GO:0048188;GO:0018024;GO:0003723;GO:0044648;GO:0051568;GO:0097692;GO:0080182;, C:chromosome; C:histone methyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Set1C/COMPASS complex;, F:histone-lysine N-methyltransferase activity; F:RNA binding;, P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation;|Q9UPS6 F6MFW1,Histone-lysine N-methyltransferase SETD1B,Lysine N-methyltransferase 2G;SET domain-containing protein 1B;, PF11764;PF00076;PF00856;, GO:0005694;GO:0035097;GO:0016607;GO:0005654;GO:0048188;GO:0018024;GO:0003723;GO:0044648;GO:0051568;GO:0097692;GO:0080182;, C:chromosome; C:histone methyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Set1C/COMPASS complex;, F:histone-lysine N-methyltransferase activity; F:RNA binding;, P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation;|Q9UPS6 F6MFW1,Histone-lysine N-methyltransferase SETD1B,Lysine N-methyltransferase 2G;SET domain-containing protein 1B;, PF11764;PF00076;PF00856;, GO:0005694;GO:0035097;GO:0016607;GO:0005654;GO:0048188;GO:0018024;GO:0003723;GO:0044648;GO:0051568;GO:0097692;GO:0080182;, C:chromosome; C:histone methyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Set1C/COMPASS complex;, F:histone-lysine N-methyltransferase activity; F:RNA binding;, P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; scaffold11 indexed_genome mRNA 50219018 50223433 . - . ID=transcript_3027;Q9UPS6 F6MFW1,Histone-lysine N-methyltransferase SETD1B,Lysine N-methyltransferase 2G;SET domain-containing protein 1B;, PF11764;PF00076;PF00856;, GO:0005694;GO:0035097;GO:0016607;GO:0005654;GO:0048188;GO:0018024;GO:0003723;GO:0044648;GO:0051568;GO:0097692;GO:0080182;, C:chromosome; C:histone methyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Set1C/COMPASS complex;, F:histone-lysine N-methyltransferase activity; F:RNA binding;, P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; scaffold12 indexed_genome mRNA 7367 91420 . - . ID=transcript_3028;Q9UBF2 A6NH74 Q2NLA0 Q54AC3 Q8WVW8,Coatomer subunit gamma-2,Gamma-2-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0000139;GO:0030426;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:growth cone; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9UBF2 A6NH74 Q2NLA0 Q54AC3 Q8WVW8,Coatomer subunit gamma-2,Gamma-2-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0000139;GO:0030426;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:growth cone; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9UBF2 A6NH74 Q2NLA0 Q54AC3 Q8WVW8,Coatomer subunit gamma-2,Gamma-2-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0000139;GO:0030426;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:growth cone; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9UBF2 A6NH74 Q2NLA0 Q54AC3 Q8WVW8,Coatomer subunit gamma-2,Gamma-2-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0000139;GO:0030426;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:growth cone; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9UBF2 A6NH74 Q2NLA0 Q54AC3 Q8WVW8,Coatomer subunit gamma-2,Gamma-2-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0000139;GO:0030426;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:growth cone; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold12 indexed_genome mRNA 760555 894013 . + . ID=transcript_3029;Q9UL63 A4D1M8 A6NG43 Q9NSK4 Q9NUS8,Muskelin,, PF01344;PF06588;, GO:0005938;GO:0005737;GO:0005829;GO:0005654;GO:0098794;GO:0001726;GO:0000151;GO:0042802;GO:0042803;GO:0031532;GO:0007160;GO:0008360;GO:0002090;GO:0007165;, C:cell cortex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:postsynapse; C:ruffle; C:ubiquitin ligase complex;, F:identical protein binding; F:protein homodimerization activity;, P:actin cytoskeleton reorganization; P:cell-matrix adhesion; P:regulation of cell shape; P:regulation of receptor internalization; P:signal transduction;|Q9UL63 A4D1M8 A6NG43 Q9NSK4 Q9NUS8,Muskelin,, PF01344;PF06588;, GO:0005938;GO:0005737;GO:0005829;GO:0005654;GO:0098794;GO:0001726;GO:0000151;GO:0042802;GO:0042803;GO:0031532;GO:0007160;GO:0008360;GO:0002090;GO:0007165;, C:cell cortex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:postsynapse; C:ruffle; C:ubiquitin ligase complex;, F:identical protein binding; F:protein homodimerization activity;, P:actin cytoskeleton reorganization; P:cell-matrix adhesion; P:regulation of cell shape; P:regulation of receptor internalization; P:signal transduction;|Q9UL63 A4D1M8 A6NG43 Q9NSK4 Q9NUS8,Muskelin,, PF01344;PF06588;, GO:0005938;GO:0005737;GO:0005829;GO:0005654;GO:0098794;GO:0001726;GO:0000151;GO:0042802;GO:0042803;GO:0031532;GO:0007160;GO:0008360;GO:0002090;GO:0007165;, C:cell cortex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:postsynapse; C:ruffle; C:ubiquitin ligase complex;, F:identical protein binding; F:protein homodimerization activity;, P:actin cytoskeleton reorganization; P:cell-matrix adhesion; P:regulation of cell shape; P:regulation of receptor internalization; P:signal transduction;|Q9UL63 A4D1M8 A6NG43 Q9NSK4 Q9NUS8,Muskelin,, PF01344;PF06588;, GO:0005938;GO:0005737;GO:0005829;GO:0005654;GO:0098794;GO:0001726;GO:0000151;GO:0042802;GO:0042803;GO:0031532;GO:0007160;GO:0008360;GO:0002090;GO:0007165;, C:cell cortex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:postsynapse; C:ruffle; C:ubiquitin ligase complex;, F:identical protein binding; F:protein homodimerization activity;, P:actin cytoskeleton reorganization; P:cell-matrix adhesion; P:regulation of cell shape; P:regulation of receptor internalization; P:signal transduction; scaffold12 indexed_genome mRNA 894703 946845 . - . ID=transcript_3030;O00592 A6NHX8 Q52LZ7 Q53ER6,Podocalyxin,GCTM-2 antigen;Gp200;Podocalyxin-like protein 1;, PF06365;, GO:0016324;GO:0034451;GO:0005737;GO:0070062;GO:0005615;GO:0030175;GO:0005887;GO:0043231;GO:0030027;GO:0045121;GO:0031528;GO:0005730;GO:0005886;GO:0001726;GO:0036057;GO:0007155;GO:0016477;GO:0072175;GO:0072015;GO:0007162;GO:0022408;GO:0030335;GO:0033634;GO:0032534;, C:apical plasma membrane; C:centriolar satellite; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:filopodium; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lamellipodium; C:membrane raft; C:microvillus membrane; C:nucleolus; C:plasma membrane; C:ruffle; C:slit diaphragm;, , P:cell adhesion; P:cell migration; P:epithelial tube formation; P:glomerular visceral epithelial cell development; P:negative regulation of cell adhesion; P:negative regulation of cell-cell adhesion; P:positive regulation of cell migration; P:positive regulation of cell-cell adhesion mediated by integrin; P:regulation of microvillus assembly; scaffold12 indexed_genome mRNA 1424038 1442681 . - . ID=transcript_3031;Q9HCM2 A4D1N6 E9PAM2 Q6UWC6 Q6ZW89 Q8N969 Q8ND00 Q8NEN3 Q9NTD4,Plexin-A4,, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005887;GO:0005886;GO:0002116;GO:0017154;GO:0021960;GO:0021793;GO:0021612;GO:0021615;GO:0007162;GO:0050772;GO:0021784;GO:0048841;GO:0030334;GO:0008360;GO:0043087;GO:0050923;GO:0071526;GO:1902287;GO:0048485;GO:0021637;GO:0021644;, C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:anterior commissure morphogenesis; P:chemorepulsion of branchiomotor axon; P:facial nerve structural organization; P:glossopharyngeal nerve morphogenesis; P:negative regulation of cell adhesion; P:positive regulation of axonogenesis; P:postganglionic parasympathetic fiber development; P:regulation of axon extension involved in axon guidance; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of negative chemotaxis; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:sympathetic nervous system development; P:trigeminal nerve structural organization; P:vagus nerve morphogenesis; scaffold12 indexed_genome mRNA 1455299 1890565 . - . ID=transcript_3032;Q9HCM2 A4D1N6 E9PAM2 Q6UWC6 Q6ZW89 Q8N969 Q8ND00 Q8NEN3 Q9NTD4,Plexin-A4,, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005887;GO:0005886;GO:0002116;GO:0017154;GO:0021960;GO:0021793;GO:0021612;GO:0021615;GO:0007162;GO:0050772;GO:0021784;GO:0048841;GO:0030334;GO:0008360;GO:0043087;GO:0050923;GO:0071526;GO:1902287;GO:0048485;GO:0021637;GO:0021644;, C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:anterior commissure morphogenesis; P:chemorepulsion of branchiomotor axon; P:facial nerve structural organization; P:glossopharyngeal nerve morphogenesis; P:negative regulation of cell adhesion; P:positive regulation of axonogenesis; P:postganglionic parasympathetic fiber development; P:regulation of axon extension involved in axon guidance; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of negative chemotaxis; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:sympathetic nervous system development; P:trigeminal nerve structural organization; P:vagus nerve morphogenesis; scaffold12 indexed_genome mRNA 2090750 2372946 . - . ID=transcript_3033;Q9NX63,MICOS complex subunit MIC19,Coiled-coil-helix-coiled-coil-helix domain-containing protein 3;, , GO:0070062;GO:0140275;GO:0061617;GO:0005743;GO:0005739;GO:0005634;GO:0001401;GO:0060090;GO:0019902;GO:0042407;GO:0007007;GO:0008053;, C:extracellular exosome; C:MIB complex; C:MICOS complex; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus; C:SAM complex;, F:molecular adaptor activity; F:phosphatase binding;, P:cristae formation; P:inner mitochondrial membrane organization; P:mitochondrial fusion; scaffold12 indexed_genome mRNA 2576861 3331833 . + . ID=transcript_3034;Q96A65 E9PED2 Q541U8 Q9C0G4 Q9H9K0 Q9P102,Exocyst complex component 4,Exocyst complex component Sec8;, PF04048;, GO:0005737;GO:0005829;GO:0000145;GO:0090543;GO:0032584;GO:0016020;GO:0005902;GO:0035748;GO:0005886;GO:0045202;GO:0030165;GO:0047485;GO:0031267;GO:0007268;GO:0060271;GO:0006887;GO:0006893;GO:0048341;GO:0006612;GO:0016241;GO:0006904;GO:0090522;, C:cytoplasm; C:cytosol; C:exocyst; C:Flemming body; C:growth cone membrane; C:membrane; C:microvillus; C:myelin sheath abaxonal region; C:plasma membrane; C:synapse;, F:PDZ domain binding; F:protein N-terminus binding; F:small GTPase binding;, P:chemical synaptic transmission; P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:paraxial mesoderm formation; P:protein targeting to membrane; P:regulation of macroautophagy; P:vesicle docking involved in exocytosis; P:vesicle tethering involved in exocytosis; scaffold12 indexed_genome mRNA 3474481 3546670 . + . ID=transcript_3035;Q969S0 A4D1P3 A6NNS4 Q53GQ7 Q8TCU7 Q96K33,UDP-xylose and UDP-N-acetylglucosamine transporter,Solute carrier family 35 member B4;YEA4 homolog;, PF08449;, GO:0005783;GO:0005794;GO:0000139;GO:0030176;GO:0030173;GO:0022857;GO:0005462;GO:0005464;GO:0008643;GO:0006111;GO:1990569;GO:0015790;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:transmembrane transporter activity; F:UDP-N-acetylglucosamine transmembrane transporter activity; F:UDP-xylose transmembrane transporter activity;, P:carbohydrate transport; P:regulation of gluconeogenesis; P:UDP-N-acetylglucosamine transmembrane transport; P:UDP-xylose transmembrane transport;|Q969S0 A4D1P3 A6NNS4 Q53GQ7 Q8TCU7 Q96K33,UDP-xylose and UDP-N-acetylglucosamine transporter,Solute carrier family 35 member B4;YEA4 homolog;, PF08449;, GO:0005783;GO:0005794;GO:0000139;GO:0030176;GO:0030173;GO:0022857;GO:0005462;GO:0005464;GO:0008643;GO:0006111;GO:1990569;GO:0015790;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:transmembrane transporter activity; F:UDP-N-acetylglucosamine transmembrane transporter activity; F:UDP-xylose transmembrane transporter activity;, P:carbohydrate transport; P:regulation of gluconeogenesis; P:UDP-N-acetylglucosamine transmembrane transport; P:UDP-xylose transmembrane transport; scaffold12 indexed_genome mRNA 3677214 3680407 . - . ID=transcript_3036;P15121 B2R8N3 Q5U031 Q6FGA4 Q6ICP2 Q9BS21 Q9UCI9,Aldo-keto reductase family 1 member B1,Aldehyde reductase;Aldose reductase;, PF00248;, GO:0005829;GO:0070062;GO:0005615;GO:0042629;GO:0005654;GO:0033010;GO:0048471;GO:0032838;GO:0043220;GO:0097454;GO:0004032;GO:0047655;GO:0047834;GO:0009055;GO:0043795;GO:0047956;GO:0052650;GO:0036130;GO:0001758;GO:0006700;GO:0005975;GO:0071475;GO:0097238;GO:1901653;GO:0044597;GO:0044598;GO:0002070;GO:0046370;GO:0072061;GO:0060135;GO:0072205;GO:0018931;GO:0043066;GO:0042415;GO:0046427;GO:0048661;GO:0035809;GO:0003091;GO:0097066;GO:0009414;GO:0001523;GO:0006061;GO:0031098;GO:0001894;, C:cytosol; C:extracellular exosome; C:extracellular space; C:mast cell granule; C:nucleoplasm; C:paranodal junction; C:perinuclear region of cytoplasm; C:plasma membrane bounded cell projection cytoplasm; C:Schmidt-Lanterman incisure; C:Schwann cell microvillus;, F:alditol:NADP+ 1-oxidoreductase activity; F:allyl-alcohol dehydrogenase activity; F:D-threo-aldose 1-dehydrogenase activity; F:electron transfer activity; F:glyceraldehyde oxidoreductase activity; F:glycerol dehydrogenase [NADP+] activity; F:NADP-retinol dehydrogenase activity; F:prostaglandin H2 endoperoxidase reductase activity; F:retinal dehydrogenase activity;, P:C21-steroid hormone biosynthetic process; P:carbohydrate metabolic process; P:cellular hyperosmotic salinity response; P:cellular response to methylglyoxal; P:cellular response to peptide; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:epithelial cell maturation; P:fructose biosynthetic process; P:inner medullary collecting duct development; P:maternal process involved in female pregnancy; P:metanephric collecting duct development; P:naphthalene metabolic process; P:negative regulation of apoptotic process; P:norepinephrine metabolic process; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of smooth muscle cell proliferation; P:regulation of urine volume; P:renal water homeostasis; P:response to thyroid hormone; P:response to water deprivation; P:retinoid metabolic process; P:sorbitol biosynthetic process; P:stress-activated protein kinase signaling cascade; P:tissue homeostasis; scaffold12 indexed_genome mRNA 3863948 3896818 . + . ID=transcript_3037;P07738 A4D1N9,Bisphosphoglycerate mutase,2,3-bisphosphoglycerate mutase, erythrocyte;2,3-bisphosphoglycerate synthase;2,3-diphosphoglycerate mutase;BPG-dependent PGAM;, PF00300;, GO:0005829;GO:0070062;GO:0004082;GO:0016787;GO:0004619;GO:1901136;GO:0005975;GO:0048821;GO:0006096;GO:0007585;, C:cytosol; C:extracellular exosome;, F:bisphosphoglycerate mutase activity; F:hydrolase activity; F:phosphoglycerate mutase activity;, P:carbohydrate derivative catabolic process; P:carbohydrate metabolic process; P:erythrocyte development; P:glycolytic process; P:respiratory gaseous exchange by respiratory system; scaffold12 indexed_genome mRNA 4172043 4211222 . + . ID=transcript_3038;Q05682 A8K0X1 Q13978 Q13979 Q14741 Q14742 Q9UD91,Caldesmon,, PF02029;, GO:0030478;GO:0015629;GO:0005856;GO:0005829;GO:0030016;GO:0005886;GO:0003779;GO:0045296;GO:0005516;GO:0017022;GO:0005523;GO:0006936;, C:actin cap; C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:myofibril; C:plasma membrane;, F:actin binding; F:cadherin binding; F:calmodulin binding; F:myosin binding; F:tropomyosin binding;, P:muscle contraction;|Q05682 A8K0X1 Q13978 Q13979 Q14741 Q14742 Q9UD91,Caldesmon,, PF02029;, GO:0030478;GO:0015629;GO:0005856;GO:0005829;GO:0030016;GO:0005886;GO:0003779;GO:0045296;GO:0005516;GO:0017022;GO:0005523;GO:0006936;, C:actin cap; C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:myofibril; C:plasma membrane;, F:actin binding; F:cadherin binding; F:calmodulin binding; F:myosin binding; F:tropomyosin binding;, P:muscle contraction;|Q05682 A8K0X1 Q13978 Q13979 Q14741 Q14742 Q9UD91,Caldesmon,, PF02029;, GO:0030478;GO:0015629;GO:0005856;GO:0005829;GO:0030016;GO:0005886;GO:0003779;GO:0045296;GO:0005516;GO:0017022;GO:0005523;GO:0006936;, C:actin cap; C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:myofibril; C:plasma membrane;, F:actin binding; F:cadherin binding; F:calmodulin binding; F:myosin binding; F:tropomyosin binding;, P:muscle contraction;|Q05682 A8K0X1 Q13978 Q13979 Q14741 Q14742 Q9UD91,Caldesmon,, PF02029;, GO:0030478;GO:0015629;GO:0005856;GO:0005829;GO:0030016;GO:0005886;GO:0003779;GO:0045296;GO:0005516;GO:0017022;GO:0005523;GO:0006936;, C:actin cap; C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:myofibril; C:plasma membrane;, F:actin binding; F:cadherin binding; F:calmodulin binding; F:myosin binding; F:tropomyosin binding;, P:muscle contraction;|Q05682 A8K0X1 Q13978 Q13979 Q14741 Q14742 Q9UD91,Caldesmon,, PF02029;, GO:0030478;GO:0015629;GO:0005856;GO:0005829;GO:0030016;GO:0005886;GO:0003779;GO:0045296;GO:0005516;GO:0017022;GO:0005523;GO:0006936;, C:actin cap; C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:myofibril; C:plasma membrane;, F:actin binding; F:cadherin binding; F:calmodulin binding; F:myosin binding; F:tropomyosin binding;, P:muscle contraction; scaffold12 indexed_genome mRNA 4218147 4249020 . + . ID=transcript_3039;Q8NEM8 B7Z827 Q9H965,Cytosolic carboxypeptidase 3,ATP/GTP-binding protein-like 3;, PF18027;PF00246;, GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation; scaffold12 indexed_genome mRNA 4251631 4252359 . + . ID=transcript_3040;Q8NEM8 B7Z827 Q9H965,Cytosolic carboxypeptidase 3,ATP/GTP-binding protein-like 3;, PF18027;PF00246;, GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation; scaffold12 indexed_genome mRNA 4252821 4313144 . + . ID=transcript_3041;Q8NEM8 B7Z827 Q9H965,Cytosolic carboxypeptidase 3,ATP/GTP-binding protein-like 3;, PF18027;PF00246;, GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation;|Q8NEM8 B7Z827 Q9H965,Cytosolic carboxypeptidase 3,ATP/GTP-binding protein-like 3;, PF18027;PF00246;, GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation;|Q8NEM8 B7Z827 Q9H965,Cytosolic carboxypeptidase 3,ATP/GTP-binding protein-like 3;, PF18027;PF00246;, GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation;|Q8NEM8 B7Z827 Q9H965,Cytosolic carboxypeptidase 3,ATP/GTP-binding protein-like 3;, PF18027;PF00246;, GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation; scaffold12 indexed_genome mRNA 4345797 4358130 . - . ID=transcript_3042;Q9H9B6 Q9NVG7 Q9NZY6,WD repeat-containing protein 91 {ECO:0000312|HGNC:HGNC:24997},, PF00400;, GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0035014;GO:0045022;GO:1903362;GO:0043551;, C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane;, F:phosphatidylinositol 3-kinase regulator activity;, P:early endosome to late endosome transport; P:regulation of cellular protein catabolic process; P:regulation of phosphatidylinositol 3-kinase activity;|Q9H9B6 Q9NVG7 Q9NZY6,WD repeat-containing protein 91 {ECO:0000312|HGNC:HGNC:24997},, PF00400;, GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0035014;GO:0045022;GO:1903362;GO:0043551;, C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane;, F:phosphatidylinositol 3-kinase regulator activity;, P:early endosome to late endosome transport; P:regulation of cellular protein catabolic process; P:regulation of phosphatidylinositol 3-kinase activity;|Q9H9B6 Q9NVG7 Q9NZY6,WD repeat-containing protein 91 {ECO:0000312|HGNC:HGNC:24997},, PF00400;, GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0035014;GO:0045022;GO:1903362;GO:0043551;, C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane;, F:phosphatidylinositol 3-kinase regulator activity;, P:early endosome to late endosome transport; P:regulation of cellular protein catabolic process; P:regulation of phosphatidylinositol 3-kinase activity;|Q9H9B6 Q9NVG7 Q9NZY6,WD repeat-containing protein 91 {ECO:0000312|HGNC:HGNC:24997},, PF00400;, GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0035014;GO:0045022;GO:1903362;GO:0043551;, C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane;, F:phosphatidylinositol 3-kinase regulator activity;, P:early endosome to late endosome transport; P:regulation of cellular protein catabolic process; P:regulation of phosphatidylinositol 3-kinase activity;|Q9H9B6 Q9NVG7 Q9NZY6,WD repeat-containing protein 91 {ECO:0000312|HGNC:HGNC:24997},, PF00400;, GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0035014;GO:0045022;GO:1903362;GO:0043551;, C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane;, F:phosphatidylinositol 3-kinase regulator activity;, P:early endosome to late endosome transport; P:regulation of cellular protein catabolic process; P:regulation of phosphatidylinositol 3-kinase activity; scaffold12 indexed_genome mRNA 4365803 4370734 . + . ID=transcript_3043;Q9H9B6 Q9NVG7 Q9NZY6,WD repeat-containing protein 91 {ECO:0000312|HGNC:HGNC:24997},, PF00400;, GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0035014;GO:0045022;GO:1903362;GO:0043551;, C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane;, F:phosphatidylinositol 3-kinase regulator activity;, P:early endosome to late endosome transport; P:regulation of cellular protein catabolic process; P:regulation of phosphatidylinositol 3-kinase activity;|Q9H9B6 Q9NVG7 Q9NZY6,WD repeat-containing protein 91 {ECO:0000312|HGNC:HGNC:24997},, PF00400;, GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0035014;GO:0045022;GO:1903362;GO:0043551;, C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane;, F:phosphatidylinositol 3-kinase regulator activity;, P:early endosome to late endosome transport; P:regulation of cellular protein catabolic process; P:regulation of phosphatidylinositol 3-kinase activity;|Q9H9B6 Q9NVG7 Q9NZY6,WD repeat-containing protein 91 {ECO:0000312|HGNC:HGNC:24997},, PF00400;, GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0035014;GO:0045022;GO:1903362;GO:0043551;, C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane;, F:phosphatidylinositol 3-kinase regulator activity;, P:early endosome to late endosome transport; P:regulation of cellular protein catabolic process; P:regulation of phosphatidylinositol 3-kinase activity;|Q9H9B6 Q9NVG7 Q9NZY6,WD repeat-containing protein 91 {ECO:0000312|HGNC:HGNC:24997},, PF00400;, GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0035014;GO:0045022;GO:1903362;GO:0043551;, C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane;, F:phosphatidylinositol 3-kinase regulator activity;, P:early endosome to late endosome transport; P:regulation of cellular protein catabolic process; P:regulation of phosphatidylinositol 3-kinase activity; scaffold12 indexed_genome mRNA 4390459 4394708 . + . ID=transcript_3044;Q7Z7C7,Stimulated by retinoic acid gene 8 protein homolog {ECO:0000305},, , GO:0005737;GO:0005634;GO:0046983;GO:0090427;GO:0071300;GO:0006260;GO:0051321;GO:0048477;GO:0006357;GO:0007283;, C:cytoplasm; C:nucleus;, F:protein dimerization activity;, P:activation of meiosis; P:cellular response to retinoic acid; P:DNA replication; P:meiotic cell cycle; P:oogenesis; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold12 indexed_genome mRNA 4524004 4567558 . - . ID=transcript_3045;Q9NZN6,CCR4-NOT transcription complex subunit 4,CCR4-associated factor 4;E3 ubiquitin-protein ligase CNOT4;Potential transcriptional repressor NOT4Hp;RING-type E3 ubiquitin transferase CNOT4 {ECO:0000305};, PF00076;, GO:0030014;GO:0005829;GO:0005634;GO:0046872;GO:0003723;GO:0004842;GO:0006977;GO:0000289;GO:0051865;GO:0016567;GO:0045652;GO:0006511;, C:CCR4-NOT complex; C:cytosol; C:nucleus;, F:metal ion binding; F:RNA binding; F:ubiquitin-protein transferase activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:nuclear-transcribed mRNA poly(A) tail shortening; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of megakaryocyte differentiation; P:ubiquitin-dependent protein catabolic process; scaffold12 indexed_genome mRNA 4700107 4776350 . + . ID=transcript_3046;Q92621 A6H8X3 Q86YC1,Nuclear pore complex protein Nup205,205 kDa nucleoporin;Nucleoporin Nup205;, PF11894;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0051292;GO:0006999;GO:0006913;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear pore complex assembly; P:nuclear pore organization; P:nucleocytoplasmic transport; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q92621 A6H8X3 Q86YC1,Nuclear pore complex protein Nup205,205 kDa nucleoporin;Nucleoporin Nup205;, PF11894;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0051292;GO:0006999;GO:0006913;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear pore complex assembly; P:nuclear pore organization; P:nucleocytoplasmic transport; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold12 indexed_genome mRNA 4791017 4794574 . - . ID=transcript_3047;E0CX11,Short transmembrane mitochondrial protein 1 {ECO:0000303|PubMed:23073385},, PF15054;, GO:0016021;GO:0005758;GO:0005741;GO:0005746;GO:0045087;GO:0032731;GO:1900227;, C:integral component of membrane; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrial respirasome;, , P:innate immune response; P:positive regulation of interleukin-1 beta production; P:positive regulation of NLRP3 inflammasome complex assembly; scaffold12 indexed_genome mRNA 4845181 4846819 . + . ID=transcript_3048;Q6UWF9 B2RP85,Protein FAM180A,, PF15173;, GO:0005576;, C:extracellular region; scaffold12 indexed_genome mRNA 5045317 5116129 . - . ID=transcript_3049;P58546,Myotrophin,Protein V-1;, PF12796;, GO:0030424;GO:0005737;GO:0005829;GO:0008290;GO:0005634;GO:0048471;GO:0043565;GO:0006584;GO:0071260;GO:0021707;GO:0030182;GO:0010613;GO:0030307;GO:0010557;GO:0051092;GO:0051247;GO:2000812;GO:0008361;GO:0016202;GO:0006417;GO:0043403;GO:0051146;, C:axon; C:cytoplasm; C:cytosol; C:F-actin capping protein complex; C:nucleus; C:perinuclear region of cytoplasm;, F:sequence-specific DNA binding;, P:catecholamine metabolic process; P:cellular response to mechanical stimulus; P:cerebellar granule cell differentiation; P:neuron differentiation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell growth; P:positive regulation of macromolecule biosynthetic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein metabolic process; P:regulation of barbed-end actin filament capping; P:regulation of cell size; P:regulation of striated muscle tissue development; P:regulation of translation; P:skeletal muscle tissue regeneration; P:striated muscle cell differentiation; scaffold12 indexed_genome mRNA 5840421 5993739 . + . ID=transcript_3050;P08172 Q4VBK6 Q9P1X9,Muscarinic acetylcholine receptor M2,, PF00001;, GO:0030669;GO:0030425;GO:0016021;GO:0005887;GO:0005886;GO:0045211;GO:0045202;GO:1990763;GO:0016907;GO:0004993;GO:0030594;GO:0007197;GO:0007188;GO:0007268;GO:0007213;GO:0007186;GO:0007187;GO:0061024;GO:0007399;GO:0007207;GO:0008016;GO:0006940;GO:0009615;, C:clathrin-coated endocytic vesicle membrane; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:arrestin family protein binding; F:G protein-coupled acetylcholine receptor activity; F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:chemical synaptic transmission; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:membrane organization; P:nervous system development; P:phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway; P:regulation of heart contraction; P:regulation of smooth muscle contraction; P:response to virus; scaffold12 indexed_genome mRNA 6115750 6216020 . - . ID=transcript_3051;P21246 Q5U0B0 Q6ICQ5 Q9UCC6,Pleiotrophin {ECO:0000303|PubMed:1457401, ECO:0000303|PubMed:2270483},Heparin-binding brain mitogen {ECO:0000303|PubMed:2388713};Heparin-binding growth factor 8 {ECO:0000250|UniProtKB:P21782};Heparin-binding growth-associated molecule {ECO:0000250|UniProtKB:P63090};Heparin-binding neurite outgrowth-promoting factor {ECO:0000303|PubMed:8484754};Heparin-binding neurite outgrowth-promoting factor 1 {ECO:0000303|PubMed:1768439};Osteoblast-specific factor 1 {ECO:0000303|PubMed:1701634};, PF01091;PF05196;, GO:0005604;GO:0009986;GO:0005783;GO:0005576;GO:0005615;GO:0031594;GO:0048471;GO:0005886;GO:0098794;GO:0098793;GO:0032991;GO:0035374;GO:0035373;GO:0008083;GO:1904399;GO:0008201;GO:0005178;GO:0019901;GO:0004864;GO:0045545;GO:0038085;GO:0030282;GO:0071456;GO:0036120;GO:0034644;GO:0071305;GO:0021549;GO:0046697;GO:0140059;GO:0031104;GO:0045446;GO:0044849;GO:0007507;GO:0007229;GO:0007612;GO:0002232;GO:0001889;GO:0060291;GO:0030324;GO:0007613;GO:0016525;GO:0030336;GO:0050680;GO:0060253;GO:1900272;GO:0045837;GO:0072201;GO:0007406;GO:1904397;GO:0007399;GO:0048477;GO:0043932;GO:0043065;GO:0048680;GO:0030501;GO:0051781;GO:0008284;GO:0010811;GO:1900006;GO:2000347;GO:0002690;GO:0010976;GO:0048714;GO:0045778;GO:1904395;GO:2000738;GO:0043113;GO:0008360;GO:0010594;GO:1903706;GO:0031641;GO:2000036;GO:0048167;GO:0014823;GO:0010996;GO:1904391;GO:0042493;GO:0032355;GO:1904373;GO:1990089;GO:0032570;GO:0060221;GO:1904389;GO:0021510;GO:0021794;GO:0042246;GO:0007185;, C:basement membrane; C:cell surface; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:neuromuscular junction; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:presynapse; C:protein-containing complex;, F:chondroitin sulfate binding; F:chondroitin sulfate proteoglycan binding; F:growth factor activity; F:heparan sulfate binding; F:heparin binding; F:integrin binding; F:protein kinase binding; F:protein phosphatase inhibitor activity; F:syndecan binding; F:vascular endothelial growth factor binding;, P:bone mineralization; P:cellular response to hypoxia; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to UV; P:cellular response to vitamin D; P:cerebellum development; P:decidualization; P:dendrite arborization; P:dendrite regeneration; P:endothelial cell differentiation; P:estrous cycle; P:heart development; P:integrin-mediated signaling pathway; P:learning; P:leukocyte chemotaxis involved in inflammatory response; P:liver development; P:long-term synaptic potentiation; P:lung development; P:memory; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of glial cell proliferation; P:negative regulation of long-term synaptic potentiation; P:negative regulation of membrane potential; P:negative regulation of mesenchymal cell proliferation; P:negative regulation of neuroblast proliferation; P:negative regulation of neuromuscular junction development; P:nervous system development; P:oogenesis; P:ossification involved in bone remodeling; P:positive regulation of apoptotic process; P:positive regulation of axon regeneration; P:positive regulation of bone mineralization; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of cell-substrate adhesion; P:positive regulation of dendrite development; P:positive regulation of hepatocyte proliferation; P:positive regulation of leukocyte chemotaxis; P:positive regulation of neuron projection development; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of ossification; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; P:positive regulation of stem cell differentiation; P:receptor clustering; P:regulation of cell shape; P:regulation of endothelial cell migration; P:regulation of hemopoiesis; P:regulation of myelination; P:regulation of stem cell population maintenance; P:regulation of synaptic plasticity; P:response to activity; P:response to auditory stimulus; P:response to ciliary neurotrophic factor; P:response to drug; P:response to estradiol; P:response to kainic acid; P:response to nerve growth factor; P:response to progesterone; P:retinal rod cell differentiation; P:rod bipolar cell differentiation; P:spinal cord development; P:thalamus development; P:tissue regeneration; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; scaffold12 indexed_genome mRNA 6276872 6556400 . - . ID=transcript_3052;O75912 A4D1Q9 Q9NZ49,Diacylglycerol kinase iota {ECO:0000303|PubMed:9830018},, PF12796;PF00130;PF00609;PF00781;, GO:0030424;GO:0005737;GO:0005829;GO:0043197;GO:0005634;GO:0005886;GO:0014069;GO:0032991;GO:0045202;GO:0097060;GO:0030672;GO:0005524;GO:0004143;GO:0046872;GO:0003951;GO:0046339;GO:0035556;GO:0046834;GO:0030168;GO:0007205;GO:0051966;, C:axon; C:cytoplasm; C:cytosol; C:dendritic spine; C:nucleus; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:synapse; C:synaptic membrane; C:synaptic vesicle membrane;, F:ATP binding; F:diacylglycerol kinase activity; F:metal ion binding; F:NAD+ kinase activity;, P:diacylglycerol metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, glutamatergic; scaffold12 indexed_genome mRNA 6801513 6832511 . - . ID=transcript_3053;Q70SY1 Q6P454 Q6ZMR6,Cyclic AMP-responsive element-binding protein 3-like protein 2,BBF2 human homolog on chromosome 7;, PF00170;, GO:0000785;GO:0005783;GO:0005789;GO:0016021;GO:0005654;GO:0005634;GO:0097038;GO:0035497;GO:0001228;GO:0000981;GO:0000976;GO:0051216;GO:0002062;GO:0006888;GO:0030968;GO:0010976;GO:0045893;GO:0006357;GO:0034976;GO:0009611;, C:chromatin; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm; C:nucleus; C:perinuclear endoplasmic reticulum;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:transcription regulatory region sequence-specific DNA binding;, P:cartilage development; P:chondrocyte differentiation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum unfolded protein response; P:positive regulation of neuron projection development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to endoplasmic reticulum stress; P:response to wounding; scaffold12 indexed_genome mRNA 6850452 6928225 . - . ID=transcript_3054;Q70SY1 Q6P454 Q6ZMR6,Cyclic AMP-responsive element-binding protein 3-like protein 2,BBF2 human homolog on chromosome 7;, PF00170;, GO:0000785;GO:0005783;GO:0005789;GO:0016021;GO:0005654;GO:0005634;GO:0097038;GO:0035497;GO:0001228;GO:0000981;GO:0000976;GO:0051216;GO:0002062;GO:0006888;GO:0030968;GO:0010976;GO:0045893;GO:0006357;GO:0034976;GO:0009611;, C:chromatin; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm; C:nucleus; C:perinuclear endoplasmic reticulum;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:transcription regulatory region sequence-specific DNA binding;, P:cartilage development; P:chondrocyte differentiation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum unfolded protein response; P:positive regulation of neuron projection development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to endoplasmic reticulum stress; P:response to wounding; scaffold12 indexed_genome mRNA 6974413 7034172 . + . ID=transcript_3055;P51857 A1L4P6 A8K060 B4DPN3 B4DPN8,Aldo-keto reductase family 1 member D1,3-oxo-5-beta-steroid 4-dehydrogenase;Delta(4)-3-ketosteroid 5-beta-reductase;Delta(4)-3-oxosteroid 5-beta-reductase;, PF00248;, GO:0005829;GO:0004032;GO:0047834;GO:0047787;GO:0047086;GO:0005496;GO:0016229;GO:0008209;GO:0006699;GO:0030573;GO:0008207;GO:0006707;GO:0007586;GO:0008202;, C:cytosol;, F:alditol:NADP+ 1-oxidoreductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:ketosteroid monooxygenase activity; F:steroid binding; F:steroid dehydrogenase activity;, P:androgen metabolic process; P:bile acid biosynthetic process; P:bile acid catabolic process; P:C21-steroid hormone metabolic process; P:cholesterol catabolic process; P:digestion; P:steroid metabolic process;|P51857 A1L4P6 A8K060 B4DPN3 B4DPN8,Aldo-keto reductase family 1 member D1,3-oxo-5-beta-steroid 4-dehydrogenase;Delta(4)-3-ketosteroid 5-beta-reductase;Delta(4)-3-oxosteroid 5-beta-reductase;, PF00248;, GO:0005829;GO:0004032;GO:0047834;GO:0047787;GO:0047086;GO:0005496;GO:0016229;GO:0008209;GO:0006699;GO:0030573;GO:0008207;GO:0006707;GO:0007586;GO:0008202;, C:cytosol;, F:alditol:NADP+ 1-oxidoreductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:ketosteroid monooxygenase activity; F:steroid binding; F:steroid dehydrogenase activity;, P:androgen metabolic process; P:bile acid biosynthetic process; P:bile acid catabolic process; P:C21-steroid hormone metabolic process; P:cholesterol catabolic process; P:digestion; P:steroid metabolic process; scaffold12 indexed_genome mRNA 7384306 7450075 . + . ID=transcript_3056;O15164 A4D1R7 A4D1R8 O95854,Transcription intermediary factor 1-alpha,E3 ubiquitin-protein ligase TRIM24;RING finger protein 82;RING-type E3 ubiquitin transferase TIF1-alpha {ECO:0000305};Tripartite motif-containing protein 24;, PF00439;PF00628;PF00643;, GO:0005829;GO:0000791;GO:0005654;GO:0005634;GO:0005726;GO:0003682;GO:0034056;GO:0070577;GO:0016922;GO:0002039;GO:0004672;GO:0005102;GO:0003713;GO:0061630;GO:0008270;GO:0055074;GO:0071391;GO:0008285;GO:0045892;GO:0046777;GO:0030163;GO:0016567;GO:0042981;GO:0031647;GO:1901796;GO:0070562;GO:0006366;, C:cytosol; C:euchromatin; C:nucleoplasm; C:nucleus; C:perichromatin fibrils;, F:chromatin binding; F:estrogen response element binding; F:lysine-acetylated histone binding; F:nuclear receptor binding; F:p53 binding; F:protein kinase activity; F:signaling receptor binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:calcium ion homeostasis; P:cellular response to estrogen stimulus; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein catabolic process; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of protein stability; P:regulation of signal transduction by p53 class mediator; P:regulation of vitamin D receptor signaling pathway; P:transcription by RNA polymerase II;|O15164 A4D1R7 A4D1R8 O95854,Transcription intermediary factor 1-alpha,E3 ubiquitin-protein ligase TRIM24;RING finger protein 82;RING-type E3 ubiquitin transferase TIF1-alpha {ECO:0000305};Tripartite motif-containing protein 24;, PF00439;PF00628;PF00643;, GO:0005829;GO:0000791;GO:0005654;GO:0005634;GO:0005726;GO:0003682;GO:0034056;GO:0070577;GO:0016922;GO:0002039;GO:0004672;GO:0005102;GO:0003713;GO:0061630;GO:0008270;GO:0055074;GO:0071391;GO:0008285;GO:0045892;GO:0046777;GO:0030163;GO:0016567;GO:0042981;GO:0031647;GO:1901796;GO:0070562;GO:0006366;, C:cytosol; C:euchromatin; C:nucleoplasm; C:nucleus; C:perichromatin fibrils;, F:chromatin binding; F:estrogen response element binding; F:lysine-acetylated histone binding; F:nuclear receptor binding; F:p53 binding; F:protein kinase activity; F:signaling receptor binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:calcium ion homeostasis; P:cellular response to estrogen stimulus; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein catabolic process; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of protein stability; P:regulation of signal transduction by p53 class mediator; P:regulation of vitamin D receptor signaling pathway; P:transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 7460255 7508941 . - . ID=transcript_3057;Q8N434,Putative transporter SVOPL,SV2-related protein-like;SVOP-like protein;, PF07690;PF00083;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold12 indexed_genome mRNA 7534904 7546440 . - . ID=transcript_3058;Q8N434,Putative transporter SVOPL,SV2-related protein-like;SVOP-like protein;, PF07690;PF00083;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold12 indexed_genome mRNA 7638091 7713830 . - . ID=transcript_3059;B6HY65 B6HY66 Q5BJD6 Q8IY15 Q9H0M3,UPF0606 protein KIAA1549,, PF12877;, GO:0016021;GO:0032391;GO:0005886;, C:integral component of membrane; C:photoreceptor connecting cilium; C:plasma membrane;|B6HY65 B6HY66 Q5BJD6 Q8IY15 Q9H0M3,UPF0606 protein KIAA1549,, PF12877;, GO:0016021;GO:0032391;GO:0005886;, C:integral component of membrane; C:photoreceptor connecting cilium; C:plasma membrane; scaffold12 indexed_genome mRNA 7786817 7796359 . - . ID=transcript_3060;Q96H79 Q8WUD9,Zinc finger CCCH-type antiviral protein 1-like,, PF18606;, GO:0005829;, C:cytosol; scaffold12 indexed_genome mRNA 7799919 7856363 . - . ID=transcript_3061;Q7Z2W4 A4D1R2 A4D1S4 Q8IW57 Q8TAJ3 Q96N79 Q9H8R9 Q9P0Y7,Zinc finger CCCH-type antiviral protein 1,ADP-ribosyltransferase diphtheria toxin-like 13 {ECO:0000303|PubMed:20106667};Inactive Poly [ADP-ribose] polymerase 13 {ECO:0000305};Zinc finger CCCH domain-containing protein 2;Zinc finger antiviral protein;, PF18606;PF00644;PF02825;PF18633;, GO:0005737;GO:0005829;GO:0005634;GO:0045296;GO:0046872;GO:0003723;GO:0051607;GO:0045087;GO:0045071;GO:0043123;GO:0032727;GO:0032728;GO:0061014;GO:1900246;GO:0006471;GO:0009615;, C:cytoplasm; C:cytosol; C:nucleus;, F:cadherin binding; F:metal ion binding; F:RNA binding;, P:defense response to virus; P:innate immune response; P:negative regulation of viral genome replication; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of mRNA catabolic process; P:positive regulation of RIG-I signaling pathway; P:protein ADP-ribosylation; P:response to virus;|Q7Z2W4 A4D1R2 A4D1S4 Q8IW57 Q8TAJ3 Q96N79 Q9H8R9 Q9P0Y7,Zinc finger CCCH-type antiviral protein 1,ADP-ribosyltransferase diphtheria toxin-like 13 {ECO:0000303|PubMed:20106667};Inactive Poly [ADP-ribose] polymerase 13 {ECO:0000305};Zinc finger CCCH domain-containing protein 2;Zinc finger antiviral protein;, PF18606;PF00644;PF02825;PF18633;, GO:0005737;GO:0005829;GO:0005634;GO:0045296;GO:0046872;GO:0003723;GO:0051607;GO:0045087;GO:0045071;GO:0043123;GO:0032727;GO:0032728;GO:0061014;GO:1900246;GO:0006471;GO:0009615;, C:cytoplasm; C:cytosol; C:nucleus;, F:cadherin binding; F:metal ion binding; F:RNA binding;, P:defense response to virus; P:innate immune response; P:negative regulation of viral genome replication; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of mRNA catabolic process; P:positive regulation of RIG-I signaling pathway; P:protein ADP-ribosylation; P:response to virus;|Q7Z2W4 A4D1R2 A4D1S4 Q8IW57 Q8TAJ3 Q96N79 Q9H8R9 Q9P0Y7,Zinc finger CCCH-type antiviral protein 1,ADP-ribosyltransferase diphtheria toxin-like 13 {ECO:0000303|PubMed:20106667};Inactive Poly [ADP-ribose] polymerase 13 {ECO:0000305};Zinc finger CCCH domain-containing protein 2;Zinc finger antiviral protein;, PF18606;PF00644;PF02825;PF18633;, GO:0005737;GO:0005829;GO:0005634;GO:0045296;GO:0046872;GO:0003723;GO:0051607;GO:0045087;GO:0045071;GO:0043123;GO:0032727;GO:0032728;GO:0061014;GO:1900246;GO:0006471;GO:0009615;, C:cytoplasm; C:cytosol; C:nucleus;, F:cadherin binding; F:metal ion binding; F:RNA binding;, P:defense response to virus; P:innate immune response; P:negative regulation of viral genome replication; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of mRNA catabolic process; P:positive regulation of RIG-I signaling pathway; P:protein ADP-ribosylation; P:response to virus; scaffold12 indexed_genome mRNA 7877760 7916684 . + . ID=transcript_3062;A0AVF1 A4D1S3 B7Z5M0 C9J2N7 F8W724 Q9H9S8 Q9NTC0,Intraflagellar transport protein 56 {ECO:0000250|UniProtKB:Q8BS45},Tetratricopeptide repeat protein 26 {ECO:0000312|HGNC:HGNC:21882};, , GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0030992;GO:0120170;GO:0035082;GO:0060271;GO:0035720;GO:0042073;GO:0035735;GO:1905198;GO:0061512;GO:0007224;, C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:intraciliary transport particle B;, F:intraciliary transport particle B binding;, P:axoneme assembly; P:cilium assembly; P:intraciliary anterograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:manchette assembly; P:protein localization to cilium; P:smoothened signaling pathway;|A0AVF1 A4D1S3 B7Z5M0 C9J2N7 F8W724 Q9H9S8 Q9NTC0,Intraflagellar transport protein 56 {ECO:0000250|UniProtKB:Q8BS45},Tetratricopeptide repeat protein 26 {ECO:0000312|HGNC:HGNC:21882};, , GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0030992;GO:0120170;GO:0035082;GO:0060271;GO:0035720;GO:0042073;GO:0035735;GO:1905198;GO:0061512;GO:0007224;, C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:intraciliary transport particle B;, F:intraciliary transport particle B binding;, P:axoneme assembly; P:cilium assembly; P:intraciliary anterograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:manchette assembly; P:protein localization to cilium; P:smoothened signaling pathway; scaffold12 indexed_genome mRNA 8027526 8033146 . + . ID=transcript_3063;Q96HJ9 B7Z4Q3 Q75M90 Q9P0B3,Protein FMC1 homolog,ATP synthase assembly factor FMC1, mitochondrial {ECO:0000312|HGNC:HGNC:26946};Formation of mitochondrial complex V assembly factor 1 homolog {ECO:0000312|HGNC:HGNC:26946};, , GO:0005739;GO:0033615;GO:0050995;GO:0061469;, C:mitochondrion;, , P:mitochondrial proton-transporting ATP synthase complex assembly; P:negative regulation of lipid catabolic process; P:regulation of type B pancreatic cell proliferation;|Q96HJ9 B7Z4Q3 Q75M90 Q9P0B3,Protein FMC1 homolog,ATP synthase assembly factor FMC1, mitochondrial {ECO:0000312|HGNC:HGNC:26946};Formation of mitochondrial complex V assembly factor 1 homolog {ECO:0000312|HGNC:HGNC:26946};, , GO:0005739;GO:0033615;GO:0050995;GO:0061469;, C:mitochondrion;, , P:mitochondrial proton-transporting ATP synthase complex assembly; P:negative regulation of lipid catabolic process; P:regulation of type B pancreatic cell proliferation; scaffold12 indexed_genome mRNA 8040560 8042379 . + . ID=transcript_3064;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold12 indexed_genome mRNA 8043997 8045825 . - . ID=transcript_3065;Q9Y383 B7Z500 Q8IUP9 Q9NVL3 Q9NVN7 Q9UQN1,Putative RNA-binding protein Luc7-like 2,, PF03194;, GO:0016607;GO:0005685;GO:0071004;GO:0019899;GO:0003729;GO:0003723;GO:0006376;, C:nuclear speck; C:U1 snRNP; C:U2-type prespliceosome;, F:enzyme binding; F:mRNA binding; F:RNA binding;, P:mRNA splice site selection; scaffold12 indexed_genome mRNA 8058009 8109041 . - . ID=transcript_3066;Q9Y383 B7Z500 Q8IUP9 Q9NVL3 Q9NVN7 Q9UQN1,Putative RNA-binding protein Luc7-like 2,, PF03194;, GO:0016607;GO:0005685;GO:0071004;GO:0019899;GO:0003729;GO:0003723;GO:0006376;, C:nuclear speck; C:U1 snRNP; C:U2-type prespliceosome;, F:enzyme binding; F:mRNA binding; F:RNA binding;, P:mRNA splice site selection;|Q9Y383 B7Z500 Q8IUP9 Q9NVL3 Q9NVN7 Q9UQN1,Putative RNA-binding protein Luc7-like 2,, PF03194;, GO:0016607;GO:0005685;GO:0071004;GO:0019899;GO:0003729;GO:0003723;GO:0006376;, C:nuclear speck; C:U1 snRNP; C:U2-type prespliceosome;, F:enzyme binding; F:mRNA binding; F:RNA binding;, P:mRNA splice site selection; scaffold12 indexed_genome mRNA 8179998 8185924 . + . ID=transcript_3067;P0C7M8,C-type lectin domain family 2 member L,, PF00059;, GO:0016021;GO:0030246;, C:integral component of membrane;, F:carbohydrate binding;|P0C7M8,C-type lectin domain family 2 member L,, PF00059;, GO:0016021;GO:0030246;, C:integral component of membrane;, F:carbohydrate binding;|P0C7M8,C-type lectin domain family 2 member L,, PF00059;, GO:0016021;GO:0030246;, C:integral component of membrane;, F:carbohydrate binding; scaffold12 indexed_genome mRNA 8206502 8340777 . - . ID=transcript_3068;Q9H2X6 Q75MR7 Q8WWI4 Q9H2Y1,Homeodomain-interacting protein kinase 2,, PF00069;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0090575;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0001102;GO:0046332;GO:0003713;GO:0003714;GO:0046790;GO:0007628;GO:0009952;GO:0071456;GO:0006978;GO:0048596;GO:0060059;GO:0030218;GO:0001654;GO:0097193;GO:0042771;GO:0061072;GO:0060235;GO:0019048;GO:0030514;GO:0043524;GO:0000122;GO:2000059;GO:0030182;GO:0018105;GO:0018107;GO:0030578;GO:0045766;GO:0008284;GO:0043388;GO:0051091;GO:0046330;GO:0032092;GO:0001934;GO:0045944;GO:0045893;GO:0030511;GO:0006468;GO:0051726;GO:1901796;GO:0010842;GO:0060395;GO:0007224;GO:0007179;GO:0050882;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:RNA polymerase II transcription regulator complex;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:RNA polymerase II activating transcription factor binding; F:SMAD binding; F:transcription coactivator activity; F:transcription corepressor activity; F:virion binding;, P:adult walking behavior; P:anterior/posterior pattern specification; P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:embryonic camera-type eye morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:erythrocyte differentiation; P:eye development; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:iris morphogenesis; P:lens induction in camera-type eye; P:modulation by virus of host process; P:negative regulation of BMP signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:neuron differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:PML body organization; P:positive regulation of angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of DNA binding; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of JNK cascade; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein phosphorylation; P:regulation of cell cycle; P:regulation of signal transduction by p53 class mediator; P:retina layer formation; P:SMAD protein signal transduction; P:smoothened signaling pathway; P:transforming growth factor beta receptor signaling pathway; P:voluntary musculoskeletal movement; scaffold12 indexed_genome mRNA 8463965 8627492 . + . ID=transcript_3069;Q9HD84,Thromboxane-A synthase,Cytochrome P450 5A1;Hydroperoxy icosatetraenoate dehydratase {ECO:0000305};, PF00067;, GO:0005789;GO:0016021;GO:0036134;GO:0020037;GO:0106256;GO:0005506;GO:0004497;GO:0016705;GO:0004796;GO:0019371;GO:0006690;GO:0001516;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:12-hydroxyheptadecatrienoic acid synthase activity; F:heme binding; F:hydroperoxy icosatetraenoate dehydratase activity; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:thromboxane-A synthase activity;, P:cyclooxygenase pathway; P:icosanoid metabolic process; P:prostaglandin biosynthetic process; scaffold12 indexed_genome mRNA 8685482 8727166 . - . ID=transcript_3070;Q6ZMT4 A4D1S9 C9JJH9 C9JQU2 Q6MZL8 Q9C0E5,Lysine-specific demethylase 7A,JmjC domain-containing histone demethylation protein 1D;Lysine-specific demethylase 7;, PF17811;PF02373;PF00628;, GO:0005730;GO:0005654;GO:0005634;GO:0016706;GO:0032452;GO:0071558;GO:0051864;GO:0032454;GO:0035575;GO:0005506;GO:0035064;GO:0003712;GO:0008270;GO:0071557;GO:0070544;GO:0033169;GO:0035574;GO:0030901;GO:0045893;GO:0006482;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:histone demethylase activity; F:histone demethylase activity (H3-K27 specific); F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:histone demethylase activity (H4-K20 specific); F:iron ion binding; F:methylated histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:histone H3-K27 demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:histone H4-K20 demethylation; P:midbrain development; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 8911425 8916420 . + . ID=transcript_3071;Q8NCC5 Q6PIU7 Q86SS4 Q9BQG7,Sugar phosphate exchanger 3,Solute carrier family 37 member 3;, PF07690;, GO:0030176;GO:0022857;GO:0008643;GO:0015712;, C:integral component of endoplasmic reticulum membrane;, F:transmembrane transporter activity;, P:carbohydrate transport; P:hexose phosphate transport;|Q8NCC5 Q6PIU7 Q86SS4 Q9BQG7,Sugar phosphate exchanger 3,Solute carrier family 37 member 3;, PF07690;, GO:0030176;GO:0022857;GO:0008643;GO:0015712;, C:integral component of endoplasmic reticulum membrane;, F:transmembrane transporter activity;, P:carbohydrate transport; P:hexose phosphate transport; scaffold12 indexed_genome mRNA 8993699 9020463 . - . ID=transcript_3072;Q9UHC7 A4D1T7 B3KXB4 Q256Y7 Q59G11 Q6GSF1 Q9H0G0 Q9UEZ7 Q9UHW2,E3 ubiquitin-protein ligase makorin-1,RING finger protein 61;RING-type E3 ubiquitin transferase makorin-1 {ECO:0000305};, PF15815;PF00097;PF00642;PF18044;, GO:0005829;GO:0046872;GO:0003723;GO:0061630;GO:0000209;GO:0016567;, C:cytosol;, F:metal ion binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:protein ubiquitination;|Q9UHC7 A4D1T7 B3KXB4 Q256Y7 Q59G11 Q6GSF1 Q9H0G0 Q9UEZ7 Q9UHW2,E3 ubiquitin-protein ligase makorin-1,RING finger protein 61;RING-type E3 ubiquitin transferase makorin-1 {ECO:0000305};, PF15815;PF00097;PF00642;PF18044;, GO:0005829;GO:0046872;GO:0003723;GO:0061630;GO:0000209;GO:0016567;, C:cytosol;, F:metal ion binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:protein ubiquitination;|Q9UHC7 A4D1T7 B3KXB4 Q256Y7 Q59G11 Q6GSF1 Q9H0G0 Q9UEZ7 Q9UHW2,E3 ubiquitin-protein ligase makorin-1,RING finger protein 61;RING-type E3 ubiquitin transferase makorin-1 {ECO:0000305};, PF15815;PF00097;PF00642;PF18044;, GO:0005829;GO:0046872;GO:0003723;GO:0061630;GO:0000209;GO:0016567;, C:cytosol;, F:metal ion binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:protein ubiquitination;|Q9UHC7 A4D1T7 B3KXB4 Q256Y7 Q59G11 Q6GSF1 Q9H0G0 Q9UEZ7 Q9UHW2,E3 ubiquitin-protein ligase makorin-1,RING finger protein 61;RING-type E3 ubiquitin transferase makorin-1 {ECO:0000305};, PF15815;PF00097;PF00642;PF18044;, GO:0005829;GO:0046872;GO:0003723;GO:0061630;GO:0000209;GO:0016567;, C:cytosol;, F:metal ion binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:protein ubiquitination; scaffold12 indexed_genome mRNA 9050312 9119011 . - . ID=transcript_3073;Q9ULE3 C9JUI3 Q1RMD5 Q86XY0,DENN domain-containing protein 2A,, PF03455;PF02141;PF03456;, GO:0015629;GO:0005829;GO:0005085;GO:0015031;GO:0042147;, C:actin cytoskeleton; C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:protein transport; P:retrograde transport, endosome to Golgi;|Q9ULE3 C9JUI3 Q1RMD5 Q86XY0,DENN domain-containing protein 2A,, PF03455;PF02141;PF03456;, GO:0015629;GO:0005829;GO:0005085;GO:0015031;GO:0042147;, C:actin cytoskeleton; C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:protein transport; P:retrograde transport, endosome to Golgi;|Q68D51 B1AL26 Q5TCX6 Q6P3R3,DENN domain-containing protein 2C,, PF03455;PF02141;PF03456;, GO:0005654;GO:0005085;, C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity; scaffold12 indexed_genome mRNA 9166023 9180940 . + . ID=transcript_3074;Q7Z695 Q96CN6 Q9Y6T5,Uncharacterized aarF domain-containing protein kinase 2,, PF03109;, GO:0016021;GO:0005524;GO:0004674;, C:integral component of membrane;, F:ATP binding; F:protein serine/threonine kinase activity;|Q7Z695 Q96CN6 Q9Y6T5,Uncharacterized aarF domain-containing protein kinase 2,, PF03109;, GO:0016021;GO:0005524;GO:0004674;, C:integral component of membrane;, F:ATP binding; F:protein serine/threonine kinase activity;|Q7Z695 Q96CN6 Q9Y6T5,Uncharacterized aarF domain-containing protein kinase 2,, PF03109;, GO:0016021;GO:0005524;GO:0004674;, C:integral component of membrane;, F:ATP binding; F:protein serine/threonine kinase activity;|Q7Z695 Q96CN6 Q9Y6T5,Uncharacterized aarF domain-containing protein kinase 2,, PF03109;, GO:0016021;GO:0005524;GO:0004674;, C:integral component of membrane;, F:ATP binding; F:protein serine/threonine kinase activity;|Q7Z695 Q96CN6 Q9Y6T5,Uncharacterized aarF domain-containing protein kinase 2,, PF03109;, GO:0016021;GO:0005524;GO:0004674;, C:integral component of membrane;, F:ATP binding; F:protein serine/threonine kinase activity;|Q7Z695 Q96CN6 Q9Y6T5,Uncharacterized aarF domain-containing protein kinase 2,, PF03109;, GO:0016021;GO:0005524;GO:0004674;, C:integral component of membrane;, F:ATP binding; F:protein serine/threonine kinase activity; scaffold12 indexed_genome mRNA 9185864 9202447 . + . ID=transcript_3075;O95178 Q6FGI6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial,Complex I-AGGG;NADH-ubiquinone oxidoreductase AGGG subunit;, PF14813;, GO:0005743;GO:0005747;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold12 indexed_genome mRNA 9204857 9270843 . - . ID=transcript_3076;Q3MIN6 Q9UDP8 Q9Y6T3,Serine/threonine-protein kinase B-raf {ECO:0000305},Proto-oncogene B-Raf;p94;v-Raf murine sarcoma viral oncogene homolog B1;, PF00130;PF07714;PF02196;, GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005524;GO:0005509;GO:0042802;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:0000186;GO:0009887;GO:0071277;GO:0007173;GO:0090150;GO:0000165;GO:0043066;GO:0070374;GO:0010628;GO:0010828;GO:0033138;GO:0006468;GO:0070413;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:identical protein binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding;, P:activation of MAPKK activity; P:animal organ morphogenesis; P:cellular response to calcium ion; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization to membrane; P:MAPK cascade; P:negative regulation of apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of glucose transmembrane transport; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:trehalose metabolism in response to stress; scaffold12 indexed_genome mRNA 9282762 9358040 . - . ID=transcript_3077;Q3MIN6 Q9UDP8 Q9Y6T3,Serine/threonine-protein kinase B-raf {ECO:0000305},Proto-oncogene B-Raf;p94;v-Raf murine sarcoma viral oncogene homolog B1;, PF00130;PF07714;PF02196;, GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005524;GO:0005509;GO:0042802;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:0000186;GO:0009887;GO:0071277;GO:0007173;GO:0090150;GO:0000165;GO:0043066;GO:0070374;GO:0010628;GO:0010828;GO:0033138;GO:0006468;GO:0070413;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:identical protein binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding;, P:activation of MAPKK activity; P:animal organ morphogenesis; P:cellular response to calcium ion; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization to membrane; P:MAPK cascade; P:negative regulation of apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of glucose transmembrane transport; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:trehalose metabolism in response to stress;|Q3MIN6 Q9UDP8 Q9Y6T3,Serine/threonine-protein kinase B-raf {ECO:0000305},Proto-oncogene B-Raf;p94;v-Raf murine sarcoma viral oncogene homolog B1;, PF00130;PF07714;PF02196;, GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005524;GO:0005509;GO:0042802;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:0000186;GO:0009887;GO:0071277;GO:0007173;GO:0090150;GO:0000165;GO:0043066;GO:0070374;GO:0010628;GO:0010828;GO:0033138;GO:0006468;GO:0070413;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:identical protein binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding;, P:activation of MAPKK activity; P:animal organ morphogenesis; P:cellular response to calcium ion; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization to membrane; P:MAPK cascade; P:negative regulation of apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of glucose transmembrane transport; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:trehalose metabolism in response to stress; scaffold12 indexed_genome mRNA 9403151 9414436 . - . ID=transcript_3078;Q9Y291,28S ribosomal protein S33, mitochondrial,Mitochondrial small ribosomal subunit protein mS33 {ECO:0000303|PubMed:25838379};, PF08293;, GO:0005743;GO:0005763;GO:0005739;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold12 indexed_genome mRNA 9455846 9456539 . + . ID=transcript_3079;H3BS89,Transmembrane protein 178B,, PF13903;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane; scaffold12 indexed_genome mRNA 9984433 9986314 . + . ID=transcript_3080;Q53H12 Q75KN1 Q96GC3 Q9NP48,Acylglycerol kinase, mitochondrial {ECO:0000303|PubMed:15939762},Multiple substrate lipid kinase {ECO:0000303|PubMed:16269826};, PF00781;, GO:0005737;GO:0005829;GO:0031305;GO:0043231;GO:0016020;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0042721;GO:0047620;GO:0005524;GO:0001729;GO:0017050;GO:0004143;GO:0102773;GO:0001727;GO:0003951;GO:0046513;GO:0046474;GO:0016310;GO:0045039;GO:0006665;GO:0046512;, C:cytoplasm; C:cytosol; C:integral component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:TIM22 mitochondrial import inner membrane insertion complex;, F:acylglycerol kinase activity; F:ATP binding; F:ceramide kinase activity; F:D-erythro-sphingosine kinase activity; F:diacylglycerol kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:NAD+ kinase activity;, P:ceramide biosynthetic process; P:glycerophospholipid biosynthetic process; P:phosphorylation; P:protein insertion into mitochondrial inner membrane; P:sphingolipid metabolic process; P:sphingosine biosynthetic process; scaffold12 indexed_genome mRNA 9986367 9989813 . + . ID=transcript_3081;Q53H12 Q75KN1 Q96GC3 Q9NP48,Acylglycerol kinase, mitochondrial {ECO:0000303|PubMed:15939762},Multiple substrate lipid kinase {ECO:0000303|PubMed:16269826};, PF00781;, GO:0005737;GO:0005829;GO:0031305;GO:0043231;GO:0016020;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0042721;GO:0047620;GO:0005524;GO:0001729;GO:0017050;GO:0004143;GO:0102773;GO:0001727;GO:0003951;GO:0046513;GO:0046474;GO:0016310;GO:0045039;GO:0006665;GO:0046512;, C:cytoplasm; C:cytosol; C:integral component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:TIM22 mitochondrial import inner membrane insertion complex;, F:acylglycerol kinase activity; F:ATP binding; F:ceramide kinase activity; F:D-erythro-sphingosine kinase activity; F:diacylglycerol kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:NAD+ kinase activity;, P:ceramide biosynthetic process; P:glycerophospholipid biosynthetic process; P:phosphorylation; P:protein insertion into mitochondrial inner membrane; P:sphingolipid metabolic process; P:sphingosine biosynthetic process;|Q53H12 Q75KN1 Q96GC3 Q9NP48,Acylglycerol kinase, mitochondrial {ECO:0000303|PubMed:15939762},Multiple substrate lipid kinase {ECO:0000303|PubMed:16269826};, PF00781;, GO:0005737;GO:0005829;GO:0031305;GO:0043231;GO:0016020;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0042721;GO:0047620;GO:0005524;GO:0001729;GO:0017050;GO:0004143;GO:0102773;GO:0001727;GO:0003951;GO:0046513;GO:0046474;GO:0016310;GO:0045039;GO:0006665;GO:0046512;, C:cytoplasm; C:cytosol; C:integral component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:TIM22 mitochondrial import inner membrane insertion complex;, F:acylglycerol kinase activity; F:ATP binding; F:ceramide kinase activity; F:D-erythro-sphingosine kinase activity; F:diacylglycerol kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:NAD+ kinase activity;, P:ceramide biosynthetic process; P:glycerophospholipid biosynthetic process; P:phosphorylation; P:protein insertion into mitochondrial inner membrane; P:sphingolipid metabolic process; P:sphingosine biosynthetic process;|Q53H12 Q75KN1 Q96GC3 Q9NP48,Acylglycerol kinase, mitochondrial {ECO:0000303|PubMed:15939762},Multiple substrate lipid kinase {ECO:0000303|PubMed:16269826};, PF00781;, GO:0005737;GO:0005829;GO:0031305;GO:0043231;GO:0016020;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0042721;GO:0047620;GO:0005524;GO:0001729;GO:0017050;GO:0004143;GO:0102773;GO:0001727;GO:0003951;GO:0046513;GO:0046474;GO:0016310;GO:0045039;GO:0006665;GO:0046512;, C:cytoplasm; C:cytosol; C:integral component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:TIM22 mitochondrial import inner membrane insertion complex;, F:acylglycerol kinase activity; F:ATP binding; F:ceramide kinase activity; F:D-erythro-sphingosine kinase activity; F:diacylglycerol kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:NAD+ kinase activity;, P:ceramide biosynthetic process; P:glycerophospholipid biosynthetic process; P:phosphorylation; P:protein insertion into mitochondrial inner membrane; P:sphingolipid metabolic process; P:sphingosine biosynthetic process; scaffold12 indexed_genome mRNA 9998015 10047391 . - . ID=transcript_3082;A4D1U4 Q9ULS3,DENN domain-containing protein 11 {ECO:0000305},Protein LCHN;, PF09804;, GO:0005737;GO:0005085;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity;|A4D1U4 Q9ULS3,DENN domain-containing protein 11 {ECO:0000305},Protein LCHN;, PF09804;, GO:0005737;GO:0005085;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity;|A4D1U4 Q9ULS3,DENN domain-containing protein 11 {ECO:0000305},Protein LCHN;, PF09804;, GO:0005737;GO:0005085;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity; scaffold12 indexed_genome mRNA 10092454 10099488 . + . ID=transcript_3083;Q04837,Single-stranded DNA-binding protein, mitochondrial,PWP1-interacting protein 17;, PF00436;, GO:0070062;GO:0005759;GO:0042645;GO:0005739;GO:0009295;GO:0005634;GO:0003682;GO:0042802;GO:0003723;GO:0003697;GO:0006268;GO:0006264;GO:0070584;GO:0007005;GO:1905776;GO:0051096;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoid; C:nucleus;, F:chromatin binding; F:identical protein binding; F:RNA binding; F:single-stranded DNA binding;, P:DNA unwinding involved in DNA replication; P:mitochondrial DNA replication; P:mitochondrion morphogenesis; P:mitochondrion organization; P:positive regulation of DNA helicase activity; P:positive regulation of helicase activity;|Q04837,Single-stranded DNA-binding protein, mitochondrial,PWP1-interacting protein 17;, PF00436;, GO:0070062;GO:0005759;GO:0042645;GO:0005739;GO:0009295;GO:0005634;GO:0003682;GO:0042802;GO:0003723;GO:0003697;GO:0006268;GO:0006264;GO:0070584;GO:0007005;GO:1905776;GO:0051096;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoid; C:nucleus;, F:chromatin binding; F:identical protein binding; F:RNA binding; F:single-stranded DNA binding;, P:DNA unwinding involved in DNA replication; P:mitochondrial DNA replication; P:mitochondrion morphogenesis; P:mitochondrion organization; P:positive regulation of DNA helicase activity; P:positive regulation of helicase activity;|Q04837,Single-stranded DNA-binding protein, mitochondrial,PWP1-interacting protein 17;, PF00436;, GO:0070062;GO:0005759;GO:0042645;GO:0005739;GO:0009295;GO:0005634;GO:0003682;GO:0042802;GO:0003723;GO:0003697;GO:0006268;GO:0006264;GO:0070584;GO:0007005;GO:1905776;GO:0051096;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoid; C:nucleus;, F:chromatin binding; F:identical protein binding; F:RNA binding; F:single-stranded DNA binding;, P:DNA unwinding involved in DNA replication; P:mitochondrial DNA replication; P:mitochondrion morphogenesis; P:mitochondrion organization; P:positive regulation of DNA helicase activity; P:positive regulation of helicase activity; scaffold12 indexed_genome mRNA 10317484 10344772 . + . ID=transcript_3084;O43451 Q0VAX6 Q75ME7 Q86UM5,Maltase-glucoamylase, intestinal,, PF01055;PF16863;PF00088;, GO:0016324;GO:0070062;GO:0101003;GO:0016021;GO:0005886;GO:0070821;GO:0004558;GO:0030246;GO:0003824;GO:0004339;GO:0004553;GO:0032450;GO:0043312;GO:0044245;GO:0005983;, C:apical plasma membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:plasma membrane; C:tertiary granule membrane;, F:alpha-1,4-glucosidase activity; F:carbohydrate binding; F:catalytic activity; F:glucan 1,4-alpha-glucosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:neutrophil degranulation; P:polysaccharide digestion; P:starch catabolic process;|O43451 Q0VAX6 Q75ME7 Q86UM5,Maltase-glucoamylase, intestinal,, PF01055;PF16863;PF00088;, GO:0016324;GO:0070062;GO:0101003;GO:0016021;GO:0005886;GO:0070821;GO:0004558;GO:0030246;GO:0003824;GO:0004339;GO:0004553;GO:0032450;GO:0043312;GO:0044245;GO:0005983;, C:apical plasma membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:plasma membrane; C:tertiary granule membrane;, F:alpha-1,4-glucosidase activity; F:carbohydrate binding; F:catalytic activity; F:glucan 1,4-alpha-glucosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:neutrophil degranulation; P:polysaccharide digestion; P:starch catabolic process; scaffold12 indexed_genome mRNA 10356161 10398368 . + . ID=transcript_3085;O43451 Q0VAX6 Q75ME7 Q86UM5,Maltase-glucoamylase, intestinal,, PF01055;PF16863;PF00088;, GO:0016324;GO:0070062;GO:0101003;GO:0016021;GO:0005886;GO:0070821;GO:0004558;GO:0030246;GO:0003824;GO:0004339;GO:0004553;GO:0032450;GO:0043312;GO:0044245;GO:0005983;, C:apical plasma membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:plasma membrane; C:tertiary granule membrane;, F:alpha-1,4-glucosidase activity; F:carbohydrate binding; F:catalytic activity; F:glucan 1,4-alpha-glucosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:neutrophil degranulation; P:polysaccharide digestion; P:starch catabolic process; scaffold12 indexed_genome mRNA 10878994 10885427 . + . ID=transcript_3086;Q8NHM4,Putative trypsin-6,Serine protease 3 pseudogene 2;Trypsinogen C;, PF00089;, GO:0005615;GO:0046872;GO:0004252;GO:0043542;GO:0006508;, C:extracellular space;, F:metal ion binding; F:serine-type endopeptidase activity;, P:endothelial cell migration; P:proteolysis; scaffold12 indexed_genome mRNA 10966098 10967175 . + . ID=transcript_3087;O15197 A4D2I7 A8CDT5 D3DXD3 Q2TB23 Q2TB24,Ephrin type-B receptor 6,HEP;Tyrosine-protein kinase-defective receptor EPH-6;, PF14575;PF01404;PF07699;PF00041;PF07714;PF07647;, GO:0005829;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0005003;GO:0038023;GO:0004714;GO:0005005;GO:0007411;GO:0021952;GO:0048013;GO:0007275;GO:0033674;GO:0007169;, C:cytosol; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ephrin receptor activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:central nervous system projection neuron axonogenesis; P:ephrin receptor signaling pathway; P:multicellular organism development; P:positive regulation of kinase activity; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold12 indexed_genome mRNA 10967451 10971569 . - . ID=transcript_3088;Q9H1D0 A4D2I8 Q8TDL3 Q8WXR8 Q96LC5 Q9H1D1 Q9H296,Transient receptor potential cation channel subfamily V member 6,CaT-like {ECO:0000303|PubMed:11278579};Calcium transport protein 1 {ECO:0000303|PubMed:11097838};Epithelial calcium channel 2;, PF00023;PF12796;PF00520;, GO:0034704;GO:0005887;GO:0005886;GO:0005262;GO:0005516;GO:0042802;GO:0005216;GO:0046872;GO:0055074;GO:0098703;GO:0070588;GO:0006816;GO:0035898;GO:0017158;GO:0051592;, C:calcium channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:calcium channel activity; F:calmodulin binding; F:identical protein binding; F:ion channel activity; F:metal ion binding;, P:calcium ion homeostasis; P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:calcium ion transport; P:parathyroid hormone secretion; P:regulation of calcium ion-dependent exocytosis; P:response to calcium ion; scaffold12 indexed_genome mRNA 11380842 11388124 . + . ID=transcript_3089;Q9Y2Q3 B4DIH1 B4DSY2 Q6P4H0 Q7Z520 Q9P1S4,Glutathione S-transferase kappa 1,GST 13-13;GST class-kappa;GSTK1-1;Glutathione S-transferase subunit 13;, PF01323;, GO:0005829;GO:0070062;GO:0016020;GO:0005759;GO:0005739;GO:0005782;GO:0005777;GO:0004602;GO:0004364;GO:0030855;GO:1901687;GO:0006749;GO:0008104;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:glutathione peroxidase activity; F:glutathione transferase activity;, P:epithelial cell differentiation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:protein localization;|Q9Y2Q3 B4DIH1 B4DSY2 Q6P4H0 Q7Z520 Q9P1S4,Glutathione S-transferase kappa 1,GST 13-13;GST class-kappa;GSTK1-1;Glutathione S-transferase subunit 13;, PF01323;, GO:0005829;GO:0070062;GO:0016020;GO:0005759;GO:0005739;GO:0005782;GO:0005777;GO:0004602;GO:0004364;GO:0030855;GO:1901687;GO:0006749;GO:0008104;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:glutathione peroxidase activity; F:glutathione transferase activity;, P:epithelial cell differentiation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:protein localization;|Q9Y2Q3 B4DIH1 B4DSY2 Q6P4H0 Q7Z520 Q9P1S4,Glutathione S-transferase kappa 1,GST 13-13;GST class-kappa;GSTK1-1;Glutathione S-transferase subunit 13;, PF01323;, GO:0005829;GO:0070062;GO:0016020;GO:0005759;GO:0005739;GO:0005782;GO:0005777;GO:0004602;GO:0004364;GO:0030855;GO:1901687;GO:0006749;GO:0008104;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:glutathione peroxidase activity; F:glutathione transferase activity;, P:epithelial cell differentiation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:protein localization;|Q9Y2Q3 B4DIH1 B4DSY2 Q6P4H0 Q7Z520 Q9P1S4,Glutathione S-transferase kappa 1,GST 13-13;GST class-kappa;GSTK1-1;Glutathione S-transferase subunit 13;, PF01323;, GO:0005829;GO:0070062;GO:0016020;GO:0005759;GO:0005739;GO:0005782;GO:0005777;GO:0004602;GO:0004364;GO:0030855;GO:1901687;GO:0006749;GO:0008104;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:glutathione peroxidase activity; F:glutathione transferase activity;, P:epithelial cell differentiation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:protein localization; scaffold12 indexed_genome mRNA 11406843 11409100 . + . ID=transcript_3090;Q8IV31 B2RCL5 D3DXD4 Q6ZME2 Q8NC22 Q96AU8,Transmembrane protein 139,, , GO:0016021;, C:integral component of membrane; scaffold12 indexed_genome mRNA 11411464 11430928 . + . ID=transcript_3091;Q9BZK9 Q9BZL0,Caspase-2,Neural precursor cell expressed developmentally down-regulated protein 2;Protease ICH-1;, PF00619;, GO:0005737;GO:0005829;GO:0016020;GO:0005739;GO:0005634;GO:0004197;GO:0097153;GO:0097199;GO:0097200;GO:0019899;GO:0042802;GO:0019904;GO:0006919;GO:0007568;GO:0006915;GO:0097190;GO:0007420;GO:0071260;GO:0006977;GO:0035234;GO:0097194;GO:0097192;GO:0008630;GO:0001554;GO:0043066;GO:0003407;GO:0043065;GO:2001235;GO:0043525;GO:0016485;GO:0042981;, C:cytoplasm; C:cytosol; C:membrane; C:mitochondrion; C:nucleus;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:enzyme binding; F:identical protein binding; F:protein domain specific binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:aging; P:apoptotic process; P:apoptotic signaling pathway; P:brain development; P:cellular response to mechanical stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:ectopic germ cell programmed cell death; P:execution phase of apoptosis; P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:luteolysis; P:negative regulation of apoptotic process; P:neural retina development; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:protein processing; P:regulation of apoptotic process;|Q9BZK9 Q9BZL0,Caspase-2,Neural precursor cell expressed developmentally down-regulated protein 2;Protease ICH-1;, PF00619;, GO:0005737;GO:0005829;GO:0016020;GO:0005739;GO:0005634;GO:0004197;GO:0097153;GO:0097199;GO:0097200;GO:0019899;GO:0042802;GO:0019904;GO:0006919;GO:0007568;GO:0006915;GO:0097190;GO:0007420;GO:0071260;GO:0006977;GO:0035234;GO:0097194;GO:0097192;GO:0008630;GO:0001554;GO:0043066;GO:0003407;GO:0043065;GO:2001235;GO:0043525;GO:0016485;GO:0042981;, C:cytoplasm; C:cytosol; C:membrane; C:mitochondrion; C:nucleus;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:enzyme binding; F:identical protein binding; F:protein domain specific binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:aging; P:apoptotic process; P:apoptotic signaling pathway; P:brain development; P:cellular response to mechanical stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:ectopic germ cell programmed cell death; P:execution phase of apoptosis; P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:luteolysis; P:negative regulation of apoptotic process; P:neural retina development; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:protein processing; P:regulation of apoptotic process;|Q9BZK9 Q9BZL0,Caspase-2,Neural precursor cell expressed developmentally down-regulated protein 2;Protease ICH-1;, PF00619;, GO:0005737;GO:0005829;GO:0016020;GO:0005739;GO:0005634;GO:0004197;GO:0097153;GO:0097199;GO:0097200;GO:0019899;GO:0042802;GO:0019904;GO:0006919;GO:0007568;GO:0006915;GO:0097190;GO:0007420;GO:0071260;GO:0006977;GO:0035234;GO:0097194;GO:0097192;GO:0008630;GO:0001554;GO:0043066;GO:0003407;GO:0043065;GO:2001235;GO:0043525;GO:0016485;GO:0042981;, C:cytoplasm; C:cytosol; C:membrane; C:mitochondrion; C:nucleus;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:enzyme binding; F:identical protein binding; F:protein domain specific binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:aging; P:apoptotic process; P:apoptotic signaling pathway; P:brain development; P:cellular response to mechanical stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:ectopic germ cell programmed cell death; P:execution phase of apoptosis; P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:luteolysis; P:negative regulation of apoptotic process; P:neural retina development; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:protein processing; P:regulation of apoptotic process; scaffold12 indexed_genome mRNA 11435282 11475785 . + . ID=transcript_3092;P35523 A4D2H5 Q2M202,Chloride channel protein 1,Chloride channel protein, skeletal muscle;, PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0042383;GO:0042803;GO:0005247;GO:1902476;GO:0006821;GO:0034220;GO:0006936;GO:0019227;GO:0034765;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane; C:sarcolemma;, F:protein homodimerization activity; F:voltage-gated chloride channel activity;, P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:muscle contraction; P:neuronal action potential propagation; P:regulation of ion transmembrane transport;|P35523 A4D2H5 Q2M202,Chloride channel protein 1,Chloride channel protein, skeletal muscle;, PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0042383;GO:0042803;GO:0005247;GO:1902476;GO:0006821;GO:0034220;GO:0006936;GO:0019227;GO:0034765;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane; C:sarcolemma;, F:protein homodimerization activity; F:voltage-gated chloride channel activity;, P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:muscle contraction; P:neuronal action potential propagation; P:regulation of ion transmembrane transport;|P35523 A4D2H5 Q2M202,Chloride channel protein 1,Chloride channel protein, skeletal muscle;, PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0042383;GO:0042803;GO:0005247;GO:1902476;GO:0006821;GO:0034220;GO:0006936;GO:0019227;GO:0034765;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane; C:sarcolemma;, F:protein homodimerization activity; F:voltage-gated chloride channel activity;, P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:muscle contraction; P:neuronal action potential propagation; P:regulation of ion transmembrane transport;|P35523 A4D2H5 Q2M202,Chloride channel protein 1,Chloride channel protein, skeletal muscle;, PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0042383;GO:0042803;GO:0005247;GO:1902476;GO:0006821;GO:0034220;GO:0006936;GO:0019227;GO:0034765;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane; C:sarcolemma;, F:protein homodimerization activity; F:voltage-gated chloride channel activity;, P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:muscle contraction; P:neuronal action potential propagation; P:regulation of ion transmembrane transport;|P35523 A4D2H5 Q2M202,Chloride channel protein 1,Chloride channel protein, skeletal muscle;, PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0042383;GO:0042803;GO:0005247;GO:1902476;GO:0006821;GO:0034220;GO:0006936;GO:0019227;GO:0034765;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane; C:sarcolemma;, F:protein homodimerization activity; F:voltage-gated chloride channel activity;, P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:muscle contraction; P:neuronal action potential propagation; P:regulation of ion transmembrane transport; scaffold12 indexed_genome mRNA 11476989 11481872 . - . ID=transcript_3093;Q86XD5 A4D2H6 A6NDW3 A8K605 B8ZZN2 D3DXE3 J3KQX2 Q7L0D6 Q86T97,Protein FAM131B,, PF15010;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q86XD5 A4D2H6 A6NDW3 A8K605 B8ZZN2 D3DXE3 J3KQX2 Q7L0D6 Q86T97,Protein FAM131B,, PF15010;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q86XD5 A4D2H6 A6NDW3 A8K605 B8ZZN2 D3DXE3 J3KQX2 Q7L0D6 Q86T97,Protein FAM131B,, PF15010;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold12 indexed_genome mRNA 11528892 11529415 . + . ID=transcript_3094;Q15942 A4D2G6 B4DQX7 Q6I9S4,Zyxin,Zyxin-2;, PF00412;, GO:0015629;GO:0005912;GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0045335;GO:0005886;GO:0001725;GO:0046872;GO:0003723;GO:0007267;GO:0007160;GO:0071346;GO:0007229;GO:0050727;GO:0007165;GO:0043149;GO:0007179;GO:0016032;, C:actin cytoskeleton; C:adherens junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:phagocytic vesicle; C:plasma membrane; C:stress fiber;, F:metal ion binding; F:RNA binding;, P:cell-cell signaling; P:cell-matrix adhesion; P:cellular response to interferon-gamma; P:integrin-mediated signaling pathway; P:regulation of inflammatory response; P:signal transduction; P:stress fiber assembly; P:transforming growth factor beta receptor signaling pathway; P:viral process; scaffold12 indexed_genome mRNA 11529606 11530212 . + . ID=transcript_3095;Q15942 A4D2G6 B4DQX7 Q6I9S4,Zyxin,Zyxin-2;, PF00412;, GO:0015629;GO:0005912;GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0045335;GO:0005886;GO:0001725;GO:0046872;GO:0003723;GO:0007267;GO:0007160;GO:0071346;GO:0007229;GO:0050727;GO:0007165;GO:0043149;GO:0007179;GO:0016032;, C:actin cytoskeleton; C:adherens junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:phagocytic vesicle; C:plasma membrane; C:stress fiber;, F:metal ion binding; F:RNA binding;, P:cell-cell signaling; P:cell-matrix adhesion; P:cellular response to interferon-gamma; P:integrin-mediated signaling pathway; P:regulation of inflammatory response; P:signal transduction; P:stress fiber assembly; P:transforming growth factor beta receptor signaling pathway; P:viral process; scaffold12 indexed_genome mRNA 11534734 11537643 . + . ID=transcript_3096;Q15942 A4D2G6 B4DQX7 Q6I9S4,Zyxin,Zyxin-2;, PF00412;, GO:0015629;GO:0005912;GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0045335;GO:0005886;GO:0001725;GO:0046872;GO:0003723;GO:0007267;GO:0007160;GO:0071346;GO:0007229;GO:0050727;GO:0007165;GO:0043149;GO:0007179;GO:0016032;, C:actin cytoskeleton; C:adherens junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:phagocytic vesicle; C:plasma membrane; C:stress fiber;, F:metal ion binding; F:RNA binding;, P:cell-cell signaling; P:cell-matrix adhesion; P:cellular response to interferon-gamma; P:integrin-mediated signaling pathway; P:regulation of inflammatory response; P:signal transduction; P:stress fiber assembly; P:transforming growth factor beta receptor signaling pathway; P:viral process;|Q15942 A4D2G6 B4DQX7 Q6I9S4,Zyxin,Zyxin-2;, PF00412;, GO:0015629;GO:0005912;GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0045335;GO:0005886;GO:0001725;GO:0046872;GO:0003723;GO:0007267;GO:0007160;GO:0071346;GO:0007229;GO:0050727;GO:0007165;GO:0043149;GO:0007179;GO:0016032;, C:actin cytoskeleton; C:adherens junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:phagocytic vesicle; C:plasma membrane; C:stress fiber;, F:metal ion binding; F:RNA binding;, P:cell-cell signaling; P:cell-matrix adhesion; P:cellular response to interferon-gamma; P:integrin-mediated signaling pathway; P:regulation of inflammatory response; P:signal transduction; P:stress fiber assembly; P:transforming growth factor beta receptor signaling pathway; P:viral process;|Q15942 A4D2G6 B4DQX7 Q6I9S4,Zyxin,Zyxin-2;, PF00412;, GO:0015629;GO:0005912;GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0045335;GO:0005886;GO:0001725;GO:0046872;GO:0003723;GO:0007267;GO:0007160;GO:0071346;GO:0007229;GO:0050727;GO:0007165;GO:0043149;GO:0007179;GO:0016032;, C:actin cytoskeleton; C:adherens junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:phagocytic vesicle; C:plasma membrane; C:stress fiber;, F:metal ion binding; F:RNA binding;, P:cell-cell signaling; P:cell-matrix adhesion; P:cellular response to interferon-gamma; P:integrin-mediated signaling pathway; P:regulation of inflammatory response; P:signal transduction; P:stress fiber assembly; P:transforming growth factor beta receptor signaling pathway; P:viral process; scaffold12 indexed_genome mRNA 11538075 11543288 . - . ID=transcript_3097;P21709 A1L3V3 B5A966 B5A967 Q15405,Ephrin type-A receptor 1,EPH tyrosine kinase;EPH tyrosine kinase 1;Erythropoietin-producing hepatoma receptor;Tyrosine-protein kinase receptor EPH;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0001968;GO:0004672;GO:0019901;GO:0004714;GO:0005005;GO:0090630;GO:0001525;GO:0007411;GO:0007166;GO:0048013;GO:0007275;GO:0030336;GO:0006469;GO:0018108;GO:0045766;GO:0030335;GO:0008284;GO:0001954;GO:0033674;GO:0051496;GO:0046777;GO:0043087;GO:0035019;GO:0034446;GO:0007169;, C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibronectin binding; F:protein kinase activity; F:protein kinase binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:activation of GTPase activity; P:angiogenesis; P:axon guidance; P:cell surface receptor signaling pathway; P:ephrin receptor signaling pathway; P:multicellular organism development; P:negative regulation of cell migration; P:negative regulation of protein kinase activity; P:peptidyl-tyrosine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of kinase activity; P:positive regulation of stress fiber assembly; P:protein autophosphorylation; P:regulation of GTPase activity; P:somatic stem cell population maintenance; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold12 indexed_genome mRNA 11544117 11544679 . + . ID=transcript_3098;P21709 A1L3V3 B5A966 B5A967 Q15405,Ephrin type-A receptor 1,EPH tyrosine kinase;EPH tyrosine kinase 1;Erythropoietin-producing hepatoma receptor;Tyrosine-protein kinase receptor EPH;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0001968;GO:0004672;GO:0019901;GO:0004714;GO:0005005;GO:0090630;GO:0001525;GO:0007411;GO:0007166;GO:0048013;GO:0007275;GO:0030336;GO:0006469;GO:0018108;GO:0045766;GO:0030335;GO:0008284;GO:0001954;GO:0033674;GO:0051496;GO:0046777;GO:0043087;GO:0035019;GO:0034446;GO:0007169;, C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibronectin binding; F:protein kinase activity; F:protein kinase binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:activation of GTPase activity; P:angiogenesis; P:axon guidance; P:cell surface receptor signaling pathway; P:ephrin receptor signaling pathway; P:multicellular organism development; P:negative regulation of cell migration; P:negative regulation of protein kinase activity; P:peptidyl-tyrosine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of kinase activity; P:positive regulation of stress fiber assembly; P:protein autophosphorylation; P:regulation of GTPase activity; P:somatic stem cell population maintenance; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold12 indexed_genome mRNA 11547350 11552452 . - . ID=transcript_3099;P21709 A1L3V3 B5A966 B5A967 Q15405,Ephrin type-A receptor 1,EPH tyrosine kinase;EPH tyrosine kinase 1;Erythropoietin-producing hepatoma receptor;Tyrosine-protein kinase receptor EPH;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0001968;GO:0004672;GO:0019901;GO:0004714;GO:0005005;GO:0090630;GO:0001525;GO:0007411;GO:0007166;GO:0048013;GO:0007275;GO:0030336;GO:0006469;GO:0018108;GO:0045766;GO:0030335;GO:0008284;GO:0001954;GO:0033674;GO:0051496;GO:0046777;GO:0043087;GO:0035019;GO:0034446;GO:0007169;, C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibronectin binding; F:protein kinase activity; F:protein kinase binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:activation of GTPase activity; P:angiogenesis; P:axon guidance; P:cell surface receptor signaling pathway; P:ephrin receptor signaling pathway; P:multicellular organism development; P:negative regulation of cell migration; P:negative regulation of protein kinase activity; P:peptidyl-tyrosine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of kinase activity; P:positive regulation of stress fiber assembly; P:protein autophosphorylation; P:regulation of GTPase activity; P:somatic stem cell population maintenance; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold12 indexed_genome mRNA 11765245 11794701 . - . ID=transcript_3100;Q9Y4C2 A8K6E0 Q75KM8 Q75KM9 Q7L665 Q9BW63,TRPM8 channel-associated factor 1 {ECO:0000303|PubMed:25559186},TRP channel-associated factor 1 {ECO:0000303|PubMed:25559186};, PF17291;PF13402;, GO:0005886;GO:0044325;GO:0030336;GO:1901529;GO:0090314;GO:0010359;, C:plasma membrane;, F:ion channel binding;, P:negative regulation of cell migration; P:positive regulation of anion channel activity; P:positive regulation of protein targeting to membrane; P:regulation of anion channel activity;|Q9Y4C2 A8K6E0 Q75KM8 Q75KM9 Q7L665 Q9BW63,TRPM8 channel-associated factor 1 {ECO:0000303|PubMed:25559186},TRP channel-associated factor 1 {ECO:0000303|PubMed:25559186};, PF17291;PF13402;, GO:0005886;GO:0044325;GO:0030336;GO:1901529;GO:0090314;GO:0010359;, C:plasma membrane;, F:ion channel binding;, P:negative regulation of cell migration; P:positive regulation of anion channel activity; P:positive regulation of protein targeting to membrane; P:regulation of anion channel activity; scaffold12 indexed_genome mRNA 12243346 12244189 . + . ID=transcript_3101;A5YM69 Q6ZUI2,Rho guanine nucleotide exchange factor 35,Rho guanine nucleotide exchange factor 5-like protein;, PF15441; scaffold12 indexed_genome mRNA 12244469 12245408 . + . ID=transcript_3102;Q12774 A6NNJ2 Q6ZML7,Rho guanine nucleotide exchange factor 5,Ephexin-3;Guanine nucleotide regulatory protein TIM;Oncogene TIM;Transforming immortalized mammary oncogene;p60 TIM;, PF15441;PF00621;PF14604;, GO:0030054;GO:0071944;GO:0042995;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0002102;GO:0005525;GO:0005085;GO:0008289;GO:0090630;GO:0007186;GO:0035556;GO:0043065;GO:0051091;GO:0043507;GO:1904591;GO:0051496;GO:0032956;GO:0051493;GO:0043087;GO:0051056;, C:cell junction; C:cell periphery; C:cell projection; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:podosome;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of JUN kinase activity; P:positive regulation of protein import; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cytoskeleton organization; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold12 indexed_genome mRNA 12245803 12264491 . - . ID=transcript_3103;Q12774 A6NNJ2 Q6ZML7,Rho guanine nucleotide exchange factor 5,Ephexin-3;Guanine nucleotide regulatory protein TIM;Oncogene TIM;Transforming immortalized mammary oncogene;p60 TIM;, PF15441;PF00621;PF14604;, GO:0030054;GO:0071944;GO:0042995;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0002102;GO:0005525;GO:0005085;GO:0008289;GO:0090630;GO:0007186;GO:0035556;GO:0043065;GO:0051091;GO:0043507;GO:1904591;GO:0051496;GO:0032956;GO:0051493;GO:0043087;GO:0051056;, C:cell junction; C:cell periphery; C:cell projection; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:podosome;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of JUN kinase activity; P:positive regulation of protein import; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cytoskeleton organization; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q12774 A6NNJ2 Q6ZML7,Rho guanine nucleotide exchange factor 5,Ephexin-3;Guanine nucleotide regulatory protein TIM;Oncogene TIM;Transforming immortalized mammary oncogene;p60 TIM;, PF15441;PF00621;PF14604;, GO:0030054;GO:0071944;GO:0042995;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0002102;GO:0005525;GO:0005085;GO:0008289;GO:0090630;GO:0007186;GO:0035556;GO:0043065;GO:0051091;GO:0043507;GO:1904591;GO:0051496;GO:0032956;GO:0051493;GO:0043087;GO:0051056;, C:cell junction; C:cell periphery; C:cell projection; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:podosome;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of JUN kinase activity; P:positive regulation of protein import; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cytoskeleton organization; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold12 indexed_genome mRNA 12327457 12699999 . - . ID=transcript_3104;Q9H3S4 A8K0T7 D3DWG0 I6L9B8 Q6NUR5 Q9H602,Thiamin pyrophosphokinase 1,Placental protein 20;Thiamine pyrophosphokinase 1;, PF04265;PF04263;, GO:0005829;GO:0005524;GO:0042802;GO:0016301;GO:0030975;GO:0004788;GO:0009229;GO:0006772;GO:0042723;, C:cytosol;, F:ATP binding; F:identical protein binding; F:kinase activity; F:thiamine binding; F:thiamine diphosphokinase activity;, P:thiamine diphosphate biosynthetic process; P:thiamine metabolic process; P:thiamine-containing compound metabolic process; scaffold12 indexed_genome mRNA 16305640 16359640 . + . ID=transcript_3105;Q13616 D3DWG3 O60719 Q08AL6 Q8IYW1,Cullin-1,, PF00888;PF10557;, GO:0031461;GO:0005829;GO:0005654;GO:1990452;GO:0005886;GO:0019005;GO:0031625;GO:0004842;GO:0009887;GO:0008283;GO:0006879;GO:0038095;GO:0000082;GO:0000086;GO:0070498;GO:0097193;GO:0010972;GO:0038061;GO:0043687;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:plasma membrane; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:animal organ morphogenesis; P:cell population proliferation; P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway;|Q13616 D3DWG3 O60719 Q08AL6 Q8IYW1,Cullin-1,, PF00888;PF10557;, GO:0031461;GO:0005829;GO:0005654;GO:1990452;GO:0005886;GO:0019005;GO:0031625;GO:0004842;GO:0009887;GO:0008283;GO:0006879;GO:0038095;GO:0000082;GO:0000086;GO:0070498;GO:0097193;GO:0010972;GO:0038061;GO:0043687;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:plasma membrane; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:animal organ morphogenesis; P:cell population proliferation; P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway;|Q13616 D3DWG3 O60719 Q08AL6 Q8IYW1,Cullin-1,, PF00888;PF10557;, GO:0031461;GO:0005829;GO:0005654;GO:1990452;GO:0005886;GO:0019005;GO:0031625;GO:0004842;GO:0009887;GO:0008283;GO:0006879;GO:0038095;GO:0000082;GO:0000086;GO:0070498;GO:0097193;GO:0010972;GO:0038061;GO:0043687;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:plasma membrane; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:animal organ morphogenesis; P:cell population proliferation; P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway;|Q13616 D3DWG3 O60719 Q08AL6 Q8IYW1,Cullin-1,, PF00888;PF10557;, GO:0031461;GO:0005829;GO:0005654;GO:1990452;GO:0005886;GO:0019005;GO:0031625;GO:0004842;GO:0009887;GO:0008283;GO:0006879;GO:0038095;GO:0000082;GO:0000086;GO:0070498;GO:0097193;GO:0010972;GO:0038061;GO:0043687;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:plasma membrane; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:animal organ morphogenesis; P:cell population proliferation; P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway;|Q13616 D3DWG3 O60719 Q08AL6 Q8IYW1,Cullin-1,, PF00888;PF10557;, GO:0031461;GO:0005829;GO:0005654;GO:1990452;GO:0005886;GO:0019005;GO:0031625;GO:0004842;GO:0009887;GO:0008283;GO:0006879;GO:0038095;GO:0000082;GO:0000086;GO:0070498;GO:0097193;GO:0010972;GO:0038061;GO:0043687;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:plasma membrane; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:animal organ morphogenesis; P:cell population proliferation; P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway;|Q13616 D3DWG3 O60719 Q08AL6 Q8IYW1,Cullin-1,, PF00888;PF10557;, GO:0031461;GO:0005829;GO:0005654;GO:1990452;GO:0005886;GO:0019005;GO:0031625;GO:0004842;GO:0009887;GO:0008283;GO:0006879;GO:0038095;GO:0000082;GO:0000086;GO:0070498;GO:0097193;GO:0010972;GO:0038061;GO:0043687;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:plasma membrane; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:animal organ morphogenesis; P:cell population proliferation; P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway;|Q13616 D3DWG3 O60719 Q08AL6 Q8IYW1,Cullin-1,, PF00888;PF10557;, GO:0031461;GO:0005829;GO:0005654;GO:1990452;GO:0005886;GO:0019005;GO:0031625;GO:0004842;GO:0009887;GO:0008283;GO:0006879;GO:0038095;GO:0000082;GO:0000086;GO:0070498;GO:0097193;GO:0010972;GO:0038061;GO:0043687;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; C:plasma membrane; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:animal organ morphogenesis; P:cell population proliferation; P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway; scaffold12 indexed_genome mRNA 16364758 16374183 . - . ID=transcript_3106;Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle;|Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle;|Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle;|Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle;|Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle;|Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle; scaffold12 indexed_genome mRNA 16374228 16397964 . - . ID=transcript_3107;Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle;|Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle;|Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle;|Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle; scaffold12 indexed_genome mRNA 16545864 16573718 . - . ID=transcript_3108;P13667 A8K4K6 Q549T6,Protein disulfide-isomerase A4,Endoplasmic reticulum resident protein 70;Endoplasmic reticulum resident protein 72;, PF00085;, GO:0009986;GO:0005783;GO:0005788;GO:0005615;GO:0042470;GO:0015037;GO:0003756;GO:0003723;GO:0061077;GO:0006457;GO:0009306;GO:0034976;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:melanosome;, F:peptide disulfide oxidoreductase activity; F:protein disulfide isomerase activity; F:RNA binding;, P:chaperone-mediated protein folding; P:protein folding; P:protein secretion; P:response to endoplasmic reticulum stress; scaffold12 indexed_genome mRNA 16646916 16648778 . - . ID=transcript_3109;Q96F85 B2R4D0 Q49AN4 Q9UFZ0,CB1 cannabinoid receptor-interacting protein 1,, PF15043;, GO:0005737;GO:0005886;GO:0008022;GO:0031718;GO:2000272;GO:0010469;, C:cytoplasm; C:plasma membrane;, F:protein C-terminus binding; F:type 1 cannabinoid receptor binding;, P:negative regulation of signaling receptor activity; P:regulation of signaling receptor activity; scaffold12 indexed_genome mRNA 16727078 16752953 . + . ID=transcript_3110;P08567 B2R9E8 Q53SU8 Q6FGM8 Q6FGQ1 Q8WV81,Pleckstrin,Platelet 47 kDa protein;, PF00610;PF00169;, GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0005886;GO:0032587;GO:0043325;GO:0042803;GO:0005080;GO:0031532;GO:0030030;GO:0030866;GO:0002244;GO:0007229;GO:0050849;GO:0045744;GO:0010920;GO:0046488;GO:0030845;GO:0070527;GO:0002576;GO:0032233;GO:0030836;GO:0010925;GO:0033625;GO:0010572;GO:0070528;GO:0070560;GO:0060305;GO:0031529;GO:0070493;GO:0006904;, C:cytoplasm; C:cytosol; C:extracellular region; C:membrane; C:plasma membrane; C:ruffle membrane;, F:phosphatidylinositol-3,4-bisphosphate binding; F:protein homodimerization activity; F:protein kinase C binding;, P:actin cytoskeleton reorganization; P:cell projection organization; P:cortical actin cytoskeleton organization; P:hematopoietic progenitor cell differentiation; P:integrin-mediated signaling pathway; P:negative regulation of calcium-mediated signaling; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of inositol phosphate biosynthetic process; P:phosphatidylinositol metabolic process; P:phospholipase C-inhibiting G protein-coupled receptor signaling pathway; P:platelet aggregation; P:platelet degranulation; P:positive regulation of actin filament bundle assembly; P:positive regulation of actin filament depolymerization; P:positive regulation of inositol-polyphosphate 5-phosphatase activity; P:positive regulation of integrin activation; P:positive regulation of platelet activation; P:protein kinase C signaling; P:protein secretion by platelet; P:regulation of cell diameter; P:ruffle organization; P:thrombin-activated receptor signaling pathway; P:vesicle docking involved in exocytosis; scaffold12 indexed_genome mRNA 16807560 16811724 . - . ID=transcript_3111;Q5FWF7,F-box only protein 48,, PF12937;, GO:0019005;GO:0031146;, C:SCF ubiquitin ligase complex;, , P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q5FWF7,F-box only protein 48,, PF12937;, GO:0019005;GO:0031146;, C:SCF ubiquitin ligase complex;, , P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold12 indexed_genome mRNA 16812946 16905110 . + . ID=transcript_3112;Q8IW19 A8K476 Q53P47 Q53PB9 Q53QU0,Aprataxin and PNK-like factor,Apurinic-apyrimidinic endonuclease APLF;PNK and APTX-like FHA domain-containing protein;XRCC1-interacting protein 1;, PF17913;PF10283;, GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0008408;GO:0003906;GO:0004520;GO:0046872;GO:0000166;GO:0006974;GO:0006302;GO:0051106;GO:0000012;, C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:3'-5' exonuclease activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:endodeoxyribonuclease activity; F:metal ion binding; F:nucleotide binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:positive regulation of DNA ligation; P:single strand break repair;|Q8IW19 A8K476 Q53P47 Q53PB9 Q53QU0,Aprataxin and PNK-like factor,Apurinic-apyrimidinic endonuclease APLF;PNK and APTX-like FHA domain-containing protein;XRCC1-interacting protein 1;, PF17913;PF10283;, GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0008408;GO:0003906;GO:0004520;GO:0046872;GO:0000166;GO:0006974;GO:0006302;GO:0051106;GO:0000012;, C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:3'-5' exonuclease activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:endodeoxyribonuclease activity; F:metal ion binding; F:nucleotide binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:positive regulation of DNA ligation; P:single strand break repair; scaffold12 indexed_genome mRNA 17075249 17109439 . + . ID=transcript_3113;P42331 A8K2Y1 B7Z498 E9PFQ7 G5E9G2 Q8IXQ2,Rho GTPase-activating protein 25,Rho-type GTPase-activating protein 25;, PF00169;PF00620;, GO:0005829;GO:0001891;GO:0005096;GO:0007015;GO:0090630;GO:0051058;GO:0006911;GO:0051056;GO:0007165;, C:cytosol; C:phagocytic cup;, F:GTPase activator activity;, P:actin filament organization; P:activation of GTPase activity; P:negative regulation of small GTPase mediated signal transduction; P:phagocytosis, engulfment; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold12 indexed_genome mRNA 17112996 17122614 . + . ID=transcript_3114;P42331 A8K2Y1 B7Z498 E9PFQ7 G5E9G2 Q8IXQ2,Rho GTPase-activating protein 25,Rho-type GTPase-activating protein 25;, PF00169;PF00620;, GO:0005829;GO:0001891;GO:0005096;GO:0007015;GO:0090630;GO:0051058;GO:0006911;GO:0051056;GO:0007165;, C:cytosol; C:phagocytic cup;, F:GTPase activator activity;, P:actin filament organization; P:activation of GTPase activity; P:negative regulation of small GTPase mediated signal transduction; P:phagocytosis, engulfment; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|P42331 A8K2Y1 B7Z498 E9PFQ7 G5E9G2 Q8IXQ2,Rho GTPase-activating protein 25,Rho-type GTPase-activating protein 25;, PF00169;PF00620;, GO:0005829;GO:0001891;GO:0005096;GO:0007015;GO:0090630;GO:0051058;GO:0006911;GO:0051056;GO:0007165;, C:cytosol; C:phagocytic cup;, F:GTPase activator activity;, P:actin filament organization; P:activation of GTPase activity; P:negative regulation of small GTPase mediated signal transduction; P:phagocytosis, engulfment; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold12 indexed_genome mRNA 17152834 17153841 . - . ID=transcript_3115;O95393 Q53R17 Q6NTE0,Bone morphogenetic protein 10,, PF00019;PF00688;, GO:0009986;GO:0005737;GO:0005576;GO:0005615;GO:0030018;GO:0005125;GO:0008083;GO:0005179;GO:0033612;GO:0031433;GO:0032924;GO:0007512;GO:0055009;GO:0030509;GO:0060038;GO:0007155;GO:0060347;GO:0001822;GO:0010614;GO:0030308;GO:0030336;GO:0010596;GO:0060389;GO:0060045;GO:0010613;GO:0061036;GO:2000138;GO:0010862;GO:0060298;GO:0045893;GO:0055117;GO:1903242;GO:0045214;GO:0060395;GO:0055015;GO:0055010;, C:cell surface; C:cytoplasm; C:extracellular region; C:extracellular space; C:Z disc;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:receptor serine/threonine kinase binding; F:telethonin binding;, P:activin receptor signaling pathway; P:adult heart development; P:atrial cardiac muscle tissue morphogenesis; P:BMP signaling pathway; P:cardiac muscle cell proliferation; P:cell adhesion; P:heart trabecula formation; P:kidney development; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of endothelial cell migration; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cartilage development; P:positive regulation of cell proliferation involved in heart morphogenesis; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of sarcomere organization; P:positive regulation of transcription, DNA-templated; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle hypertrophy in response to stress; P:sarcomere organization; P:SMAD protein signal transduction; P:ventricular cardiac muscle cell development; P:ventricular cardiac muscle tissue morphogenesis; scaffold12 indexed_genome mRNA 17308184 17541726 . + . ID=transcript_3116;Q9H6X2 A8K7U8 J7K7G4 J7KF88 Q4ZFV6 Q53QD8 Q96P02 Q9NVP3,Anthrax toxin receptor 1,Tumor endothelial marker 8;, PF05586;PF05587;PF00092;, GO:0009986;GO:0010008;GO:0009897;GO:0031527;GO:0016021;GO:0031258;GO:0005886;GO:0051015;GO:0005518;GO:0046872;GO:0004888;GO:0031532;GO:0001568;GO:1901202;GO:1905050;GO:0022414;GO:0034446;GO:1901998;, C:cell surface; C:endosome membrane; C:external side of plasma membrane; C:filopodium membrane; C:integral component of membrane; C:lamellipodium membrane; C:plasma membrane;, F:actin filament binding; F:collagen binding; F:metal ion binding; F:transmembrane signaling receptor activity;, P:actin cytoskeleton reorganization; P:blood vessel development; P:negative regulation of extracellular matrix assembly; P:positive regulation of metallopeptidase activity; P:reproductive process; P:substrate adhesion-dependent cell spreading; P:toxin transport;|Q9H6X2 A8K7U8 J7K7G4 J7KF88 Q4ZFV6 Q53QD8 Q96P02 Q9NVP3,Anthrax toxin receptor 1,Tumor endothelial marker 8;, PF05586;PF05587;PF00092;, GO:0009986;GO:0010008;GO:0009897;GO:0031527;GO:0016021;GO:0031258;GO:0005886;GO:0051015;GO:0005518;GO:0046872;GO:0004888;GO:0031532;GO:0001568;GO:1901202;GO:1905050;GO:0022414;GO:0034446;GO:1901998;, C:cell surface; C:endosome membrane; C:external side of plasma membrane; C:filopodium membrane; C:integral component of membrane; C:lamellipodium membrane; C:plasma membrane;, F:actin filament binding; F:collagen binding; F:metal ion binding; F:transmembrane signaling receptor activity;, P:actin cytoskeleton reorganization; P:blood vessel development; P:negative regulation of extracellular matrix assembly; P:positive regulation of metallopeptidase activity; P:reproductive process; P:substrate adhesion-dependent cell spreading; P:toxin transport; scaffold12 indexed_genome mRNA 17629333 17685010 . - . ID=transcript_3117;Q06210 Q53QE6 Q9BXF8,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1,D-fructose-6-phosphate amidotransferase 1;Glutamine:fructose-6-phosphate amidotransferase 1;Hexosephosphate aminotransferase 1;, PF01380;, GO:0005829;GO:0070062;GO:0097367;GO:0004360;GO:0032922;GO:0006112;GO:0006002;GO:0006541;GO:0036498;GO:0006487;GO:0006048;GO:0006047;, C:cytosol; C:extracellular exosome;, F:carbohydrate derivative binding; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity;, P:circadian regulation of gene expression; P:energy reserve metabolic process; P:fructose 6-phosphate metabolic process; P:glutamine metabolic process; P:IRE1-mediated unfolded protein response; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine biosynthetic process; P:UDP-N-acetylglucosamine metabolic process;|Q06210 Q53QE6 Q9BXF8,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1,D-fructose-6-phosphate amidotransferase 1;Glutamine:fructose-6-phosphate amidotransferase 1;Hexosephosphate aminotransferase 1;, PF01380;, GO:0005829;GO:0070062;GO:0097367;GO:0004360;GO:0032922;GO:0006112;GO:0006002;GO:0006541;GO:0036498;GO:0006487;GO:0006048;GO:0006047;, C:cytosol; C:extracellular exosome;, F:carbohydrate derivative binding; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity;, P:circadian regulation of gene expression; P:energy reserve metabolic process; P:fructose 6-phosphate metabolic process; P:glutamine metabolic process; P:IRE1-mediated unfolded protein response; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine biosynthetic process; P:UDP-N-acetylglucosamine metabolic process; scaffold12 indexed_genome mRNA 17702889 17728100 . - . ID=transcript_3118;Q9UMS0 B4DUL9 Q53QE5 Q6VNZ8 Q7Z5B1 Q7Z5B2 Q9Y322,NFU1 iron-sulfur cluster scaffold homolog, mitochondrial,HIRA-interacting protein 5 {ECO:0000303|PubMed:11342215};, PF08712;PF01106;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0051539;GO:0005506;GO:0016226;GO:0097428;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:iron ion binding;, P:iron-sulfur cluster assembly; P:protein maturation by iron-sulfur cluster transfer; scaffold12 indexed_genome mRNA 17746494 17866881 . + . ID=transcript_3119;Q6ZSR9,Uncharacterized protein FLJ45252,, PF15282;|Q2M2I8 Q4ZFZ3 Q53RX6 Q9UPV4,AP2-associated protein kinase 1,Adaptor-associated kinase 1;, PF00069;, GO:0031252;GO:0005905;GO:0030136;GO:0005737;GO:0005829;GO:0019897;GO:0043195;GO:0035612;GO:0005524;GO:0005112;GO:0106310;GO:0004674;GO:0106311;GO:0006897;GO:0061024;GO:0045747;GO:0046777;GO:0006468;GO:0050821;GO:2000369;GO:0032880;, C:cell leading edge; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extrinsic component of plasma membrane; C:terminal bouton;, F:AP-2 adaptor complex binding; F:ATP binding; F:Notch binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:endocytosis; P:membrane organization; P:positive regulation of Notch signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of clathrin-dependent endocytosis; P:regulation of protein localization;|Q2M2I8 Q4ZFZ3 Q53RX6 Q9UPV4,AP2-associated protein kinase 1,Adaptor-associated kinase 1;, PF00069;, GO:0031252;GO:0005905;GO:0030136;GO:0005737;GO:0005829;GO:0019897;GO:0043195;GO:0035612;GO:0005524;GO:0005112;GO:0106310;GO:0004674;GO:0106311;GO:0006897;GO:0061024;GO:0045747;GO:0046777;GO:0006468;GO:0050821;GO:2000369;GO:0032880;, C:cell leading edge; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extrinsic component of plasma membrane; C:terminal bouton;, F:AP-2 adaptor complex binding; F:ATP binding; F:Notch binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:endocytosis; P:membrane organization; P:positive regulation of Notch signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of clathrin-dependent endocytosis; P:regulation of protein localization;|Q2M2I8 Q4ZFZ3 Q53RX6 Q9UPV4,AP2-associated protein kinase 1,Adaptor-associated kinase 1;, PF00069;, GO:0031252;GO:0005905;GO:0030136;GO:0005737;GO:0005829;GO:0019897;GO:0043195;GO:0035612;GO:0005524;GO:0005112;GO:0106310;GO:0004674;GO:0106311;GO:0006897;GO:0061024;GO:0045747;GO:0046777;GO:0006468;GO:0050821;GO:2000369;GO:0032880;, C:cell leading edge; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extrinsic component of plasma membrane; C:terminal bouton;, F:AP-2 adaptor complex binding; F:ATP binding; F:Notch binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:endocytosis; P:membrane organization; P:positive regulation of Notch signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of clathrin-dependent endocytosis; P:regulation of protein localization;|Q2M2I8 Q4ZFZ3 Q53RX6 Q9UPV4,AP2-associated protein kinase 1,Adaptor-associated kinase 1;, PF00069;, GO:0031252;GO:0005905;GO:0030136;GO:0005737;GO:0005829;GO:0019897;GO:0043195;GO:0035612;GO:0005524;GO:0005112;GO:0106310;GO:0004674;GO:0106311;GO:0006897;GO:0061024;GO:0045747;GO:0046777;GO:0006468;GO:0050821;GO:2000369;GO:0032880;, C:cell leading edge; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extrinsic component of plasma membrane; C:terminal bouton;, F:AP-2 adaptor complex binding; F:ATP binding; F:Notch binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:endocytosis; P:membrane organization; P:positive regulation of Notch signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of clathrin-dependent endocytosis; P:regulation of protein localization;|Q2M2I8 Q4ZFZ3 Q53RX6 Q9UPV4,AP2-associated protein kinase 1,Adaptor-associated kinase 1;, PF00069;, GO:0031252;GO:0005905;GO:0030136;GO:0005737;GO:0005829;GO:0019897;GO:0043195;GO:0035612;GO:0005524;GO:0005112;GO:0106310;GO:0004674;GO:0106311;GO:0006897;GO:0061024;GO:0045747;GO:0046777;GO:0006468;GO:0050821;GO:2000369;GO:0032880;, C:cell leading edge; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extrinsic component of plasma membrane; C:terminal bouton;, F:AP-2 adaptor complex binding; F:ATP binding; F:Notch binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:endocytosis; P:membrane organization; P:positive regulation of Notch signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of clathrin-dependent endocytosis; P:regulation of protein localization; scaffold12 indexed_genome mRNA 18029641 18055217 . + . ID=transcript_3120;P09525 B4DDF9 Q96F33 Q9BWK1,Annexin A4,35-beta calcimedin;Annexin IV;Annexin-4;Carbohydrate-binding protein p33/p41;Chromobindin-4;Endonexin I;Lipocortin IV;P32.5;PP4-X;Placental anticoagulant protein II;Protein II;, PF00191;, GO:0009986;GO:0062023;GO:0005737;GO:0070062;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:0012506;GO:0005509;GO:0005544;GO:0048306;GO:0042802;GO:0051059;GO:0004859;GO:0030855;GO:0043066;GO:0032717;GO:0032088;GO:0007219;GO:0006357;GO:0007165;, C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:identical protein binding; F:NF-kappaB binding; F:phospholipase inhibitor activity;, P:epithelial cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of interleukin-8 production; P:negative regulation of NF-kappaB transcription factor activity; P:Notch signaling pathway; P:regulation of transcription by RNA polymerase II; P:signal transduction;|P09525 B4DDF9 Q96F33 Q9BWK1,Annexin A4,35-beta calcimedin;Annexin IV;Annexin-4;Carbohydrate-binding protein p33/p41;Chromobindin-4;Endonexin I;Lipocortin IV;P32.5;PP4-X;Placental anticoagulant protein II;Protein II;, PF00191;, GO:0009986;GO:0062023;GO:0005737;GO:0070062;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:0012506;GO:0005509;GO:0005544;GO:0048306;GO:0042802;GO:0051059;GO:0004859;GO:0030855;GO:0043066;GO:0032717;GO:0032088;GO:0007219;GO:0006357;GO:0007165;, C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:identical protein binding; F:NF-kappaB binding; F:phospholipase inhibitor activity;, P:epithelial cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of interleukin-8 production; P:negative regulation of NF-kappaB transcription factor activity; P:Notch signaling pathway; P:regulation of transcription by RNA polymerase II; P:signal transduction; scaffold12 indexed_genome mRNA 18058114 18105508 . + . ID=transcript_3121;Q96IK5 Q9H826 Q9H8V7 Q9H927,Germ cell-less protein-like 1,Spermatogenesis-associated protein 29;, PF07707;PF00651;, GO:0016363;GO:0005634;GO:0042802;GO:0007281;GO:0007275;GO:0007283;, C:nuclear matrix; C:nucleus;, F:identical protein binding;, P:germ cell development; P:multicellular organism development; P:spermatogenesis;|Q96IK5 Q9H826 Q9H8V7 Q9H927,Germ cell-less protein-like 1,Spermatogenesis-associated protein 29;, PF07707;PF00651;, GO:0016363;GO:0005634;GO:0042802;GO:0007281;GO:0007275;GO:0007283;, C:nuclear matrix; C:nucleus;, F:identical protein binding;, P:germ cell development; P:multicellular organism development; P:spermatogenesis;|Q8NEA9 B2RDW6 Q2VIQ8 Q8TC88 Q8TC89,Germ cell-less protein-like 2 {ECO:0000305},Germ cell-less protein-like 1-like;, PF00651;, GO:0016363;GO:0005634;GO:0097602;GO:0007281;GO:0007275;GO:0016567;GO:0007283;, C:nuclear matrix; C:nucleus;, F:cullin family protein binding;, P:germ cell development; P:multicellular organism development; P:protein ubiquitination; P:spermatogenesis; scaffold12 indexed_genome mRNA 18108572 18115993 . + . ID=transcript_3122;Q8WVK2 Q15410,U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein,Nucleic acid-binding protein RY-1;U4/U6.U5 tri-snRNP-associated 27 kDa protein;U4/U6.U5 tri-snRNP-associated protein 3;, PF08648;, GO:0005654;GO:0003676;GO:0000398;, C:nucleoplasm;, F:nucleic acid binding;, P:mRNA splicing, via spliceosome;|Q8WVK2 Q15410,U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein,Nucleic acid-binding protein RY-1;U4/U6.U5 tri-snRNP-associated 27 kDa protein;U4/U6.U5 tri-snRNP-associated protein 3;, PF08648;, GO:0005654;GO:0003676;GO:0000398;, C:nucleoplasm;, F:nucleic acid binding;, P:mRNA splicing, via spliceosome;|Q8WVK2 Q15410,U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein,Nucleic acid-binding protein RY-1;U4/U6.U5 tri-snRNP-associated 27 kDa protein;U4/U6.U5 tri-snRNP-associated protein 3;, PF08648;, GO:0005654;GO:0003676;GO:0000398;, C:nucleoplasm;, F:nucleic acid binding;, P:mRNA splicing, via spliceosome; scaffold12 indexed_genome mRNA 18125711 18147830 . + . ID=transcript_3123;Q05195 B2R6V8 B7ZLI6 D6W5G2 Q6FI41,Max dimerization protein 1,Protein MAD;, PF00010;, GO:0000785;GO:0005829;GO:0005739;GO:0005654;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:0000122;GO:0006357;, C:chromatin; C:cytosol; C:mitochondrion; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q05195 B2R6V8 B7ZLI6 D6W5G2 Q6FI41,Max dimerization protein 1,Protein MAD;, PF00010;, GO:0000785;GO:0005829;GO:0005739;GO:0005654;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:0000122;GO:0006357;, C:chromatin; C:cytosol; C:mitochondrion; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 18271251 18272676 . + . ID=transcript_3124;Q15365 Q13157 Q14975,Poly(rC)-binding protein 1,Alpha-CP1;Heterogeneous nuclear ribonucleoprotein E1;Nucleic acid-binding protein SUB2.3;, PF00013;, GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0045296;GO:0000981;GO:0003729;GO:0003723;GO:0098847;GO:0003697;GO:0000398;GO:0045944;GO:0010468;GO:0051252;GO:0016070;GO:0039694;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cadherin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:mRNA binding; F:RNA binding; F:sequence-specific single stranded DNA binding; F:single-stranded DNA binding;, P:mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA metabolic process; P:viral RNA genome replication; scaffold12 indexed_genome mRNA 18333571 18370876 . - . ID=transcript_3125;Q9NWW7 D6W5G3 Q9H629,Uncharacterized protein C2orf42,, PF14952;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus; scaffold12 indexed_genome mRNA 18373698 18412504 . - . ID=transcript_3126;P31483 Q53SS9 Q96B58,Nucleolysin TIA-1 isoform p40,RNA-binding protein TIA-1;T-cell-restricted intracellular antigen-1;p40-TIA-1;, PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0097165;GO:0005654;GO:0005634;GO:1990904;GO:0035925;GO:0008143;GO:0003723;GO:0006915;GO:0008543;GO:0001818;GO:0017148;GO:1904037;GO:1903608;GO:0048024;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:poly(A) binding; F:RNA binding;, P:apoptotic process; P:fibroblast growth factor receptor signaling pathway; P:negative regulation of cytokine production; P:negative regulation of translation; P:positive regulation of epithelial cell apoptotic process; P:protein localization to cytoplasmic stress granule; P:regulation of mRNA splicing, via spliceosome;|P31483 Q53SS9 Q96B58,Nucleolysin TIA-1 isoform p40,RNA-binding protein TIA-1;T-cell-restricted intracellular antigen-1;p40-TIA-1;, PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0097165;GO:0005654;GO:0005634;GO:1990904;GO:0035925;GO:0008143;GO:0003723;GO:0006915;GO:0008543;GO:0001818;GO:0017148;GO:1904037;GO:1903608;GO:0048024;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:poly(A) binding; F:RNA binding;, P:apoptotic process; P:fibroblast growth factor receptor signaling pathway; P:negative regulation of cytokine production; P:negative regulation of translation; P:positive regulation of epithelial cell apoptotic process; P:protein localization to cytoplasmic stress granule; P:regulation of mRNA splicing, via spliceosome;|P31483 Q53SS9 Q96B58,Nucleolysin TIA-1 isoform p40,RNA-binding protein TIA-1;T-cell-restricted intracellular antigen-1;p40-TIA-1;, PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0097165;GO:0005654;GO:0005634;GO:1990904;GO:0035925;GO:0008143;GO:0003723;GO:0006915;GO:0008543;GO:0001818;GO:0017148;GO:1904037;GO:1903608;GO:0048024;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:poly(A) binding; F:RNA binding;, P:apoptotic process; P:fibroblast growth factor receptor signaling pathway; P:negative regulation of cytokine production; P:negative regulation of translation; P:positive regulation of epithelial cell apoptotic process; P:protein localization to cytoplasmic stress granule; P:regulation of mRNA splicing, via spliceosome;|P31483 Q53SS9 Q96B58,Nucleolysin TIA-1 isoform p40,RNA-binding protein TIA-1;T-cell-restricted intracellular antigen-1;p40-TIA-1;, PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0097165;GO:0005654;GO:0005634;GO:1990904;GO:0035925;GO:0008143;GO:0003723;GO:0006915;GO:0008543;GO:0001818;GO:0017148;GO:1904037;GO:1903608;GO:0048024;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:poly(A) binding; F:RNA binding;, P:apoptotic process; P:fibroblast growth factor receptor signaling pathway; P:negative regulation of cytokine production; P:negative regulation of translation; P:positive regulation of epithelial cell apoptotic process; P:protein localization to cytoplasmic stress granule; P:regulation of mRNA splicing, via spliceosome;|Q01085 A8K3T0 A8K4L9,Nucleolysin TIAR,TIA-1-related protein;, PF00076;, GO:0005737;GO:0010494;GO:0005764;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003723;GO:0006915;GO:0006952;GO:0008543;GO:0006357;, C:cytoplasm; C:cytoplasmic stress granule; C:lysosome; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:defense response; P:fibroblast growth factor receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|P31483 Q53SS9 Q96B58,Nucleolysin TIA-1 isoform p40,RNA-binding protein TIA-1;T-cell-restricted intracellular antigen-1;p40-TIA-1;, PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0097165;GO:0005654;GO:0005634;GO:1990904;GO:0035925;GO:0008143;GO:0003723;GO:0006915;GO:0008543;GO:0001818;GO:0017148;GO:1904037;GO:1903608;GO:0048024;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:poly(A) binding; F:RNA binding;, P:apoptotic process; P:fibroblast growth factor receptor signaling pathway; P:negative regulation of cytokine production; P:negative regulation of translation; P:positive regulation of epithelial cell apoptotic process; P:protein localization to cytoplasmic stress granule; P:regulation of mRNA splicing, via spliceosome;|P31483 Q53SS9 Q96B58,Nucleolysin TIA-1 isoform p40,RNA-binding protein TIA-1;T-cell-restricted intracellular antigen-1;p40-TIA-1;, PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0097165;GO:0005654;GO:0005634;GO:1990904;GO:0035925;GO:0008143;GO:0003723;GO:0006915;GO:0008543;GO:0001818;GO:0017148;GO:1904037;GO:1903608;GO:0048024;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:poly(A) binding; F:RNA binding;, P:apoptotic process; P:fibroblast growth factor receptor signaling pathway; P:negative regulation of cytokine production; P:negative regulation of translation; P:positive regulation of epithelial cell apoptotic process; P:protein localization to cytoplasmic stress granule; P:regulation of mRNA splicing, via spliceosome;|P31483 Q53SS9 Q96B58,Nucleolysin TIA-1 isoform p40,RNA-binding protein TIA-1;T-cell-restricted intracellular antigen-1;p40-TIA-1;, PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0097165;GO:0005654;GO:0005634;GO:1990904;GO:0035925;GO:0008143;GO:0003723;GO:0006915;GO:0008543;GO:0001818;GO:0017148;GO:1904037;GO:1903608;GO:0048024;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:poly(A) binding; F:RNA binding;, P:apoptotic process; P:fibroblast growth factor receptor signaling pathway; P:negative regulation of cytokine production; P:negative regulation of translation; P:positive regulation of epithelial cell apoptotic process; P:protein localization to cytoplasmic stress granule; P:regulation of mRNA splicing, via spliceosome; scaffold12 indexed_genome mRNA 18446798 18447657 . - . ID=transcript_3127;Q9UHG3 B2RB14 B7Z9P8 O94982 Q8N4N5 Q96QM8,Prenylcysteine oxidase 1,Prenylcysteine lyase;, PF07156;, GO:0070062;GO:0005764;GO:0005886;GO:0034361;GO:0008555;GO:0001735;GO:0030327;GO:0030328;, C:extracellular exosome; C:lysosome; C:plasma membrane; C:very-low-density lipoprotein particle;, F:ATPase-coupled chloride transmembrane transporter activity; F:prenylcysteine oxidase activity;, P:prenylated protein catabolic process; P:prenylcysteine catabolic process; scaffold12 indexed_genome mRNA 18463908 18464562 . + . ID=transcript_3128;A8MWD9,Putative small nuclear ribonucleoprotein G-like protein 15,, PF01423;, GO:0071013;GO:0043186;GO:0071011;GO:1990904;GO:0034719;GO:0097526;GO:0005685;GO:0005689;GO:0005686;GO:0071004;GO:0005687;GO:0005682;GO:0003723;GO:0000398;GO:0000387;, C:catalytic step 2 spliceosome; C:P granule; C:precatalytic spliceosome; C:ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal tri-snRNP complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type prespliceosome; C:U4 snRNP; C:U5 snRNP;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:spliceosomal snRNP assembly; scaffold12 indexed_genome mRNA 18515618 18542850 . - . ID=transcript_3129;Q9NZN3 B4DFR5 D6W574 Q8N514 Q9NZB3,EH domain-containing protein 3 {ECO:0000305},PAST homolog 3 {ECO:0000305};, PF18150;PF00350;PF12763;PF16880;, GO:0020018;GO:0005737;GO:0005829;GO:0005769;GO:0030139;GO:0010008;GO:0005925;GO:0043231;GO:0005634;GO:0048471;GO:0055038;GO:0005524;GO:0005509;GO:0005525;GO:0003676;GO:0007596;GO:0060271;GO:0034498;GO:0032456;GO:0006897;GO:0016197;GO:0090160;GO:1901387;GO:0051260;GO:0072659;GO:0015031;GO:0001881;GO:1903779;GO:0086036;GO:0055117;GO:1903358;, C:ciliary pocket membrane; C:cytoplasm; C:cytosol; C:early endosome; C:endocytic vesicle; C:endosome membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome membrane;, F:ATP binding; F:calcium ion binding; F:GTP binding; F:nucleic acid binding;, P:blood coagulation; P:cilium assembly; P:early endosome to Golgi transport; P:endocytic recycling; P:endocytosis; P:endosomal transport; P:Golgi to lysosome transport; P:positive regulation of voltage-gated calcium channel activity; P:protein homooligomerization; P:protein localization to plasma membrane; P:protein transport; P:receptor recycling; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction; P:regulation of Golgi organization;|Q9NZN3 B4DFR5 D6W574 Q8N514 Q9NZB3,EH domain-containing protein 3 {ECO:0000305},PAST homolog 3 {ECO:0000305};, PF18150;PF00350;PF12763;PF16880;, GO:0020018;GO:0005737;GO:0005829;GO:0005769;GO:0030139;GO:0010008;GO:0005925;GO:0043231;GO:0005634;GO:0048471;GO:0055038;GO:0005524;GO:0005509;GO:0005525;GO:0003676;GO:0007596;GO:0060271;GO:0034498;GO:0032456;GO:0006897;GO:0016197;GO:0090160;GO:1901387;GO:0051260;GO:0072659;GO:0015031;GO:0001881;GO:1903779;GO:0086036;GO:0055117;GO:1903358;, C:ciliary pocket membrane; C:cytoplasm; C:cytosol; C:early endosome; C:endocytic vesicle; C:endosome membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome membrane;, F:ATP binding; F:calcium ion binding; F:GTP binding; F:nucleic acid binding;, P:blood coagulation; P:cilium assembly; P:early endosome to Golgi transport; P:endocytic recycling; P:endocytosis; P:endosomal transport; P:Golgi to lysosome transport; P:positive regulation of voltage-gated calcium channel activity; P:protein homooligomerization; P:protein localization to plasma membrane; P:protein transport; P:receptor recycling; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction; P:regulation of Golgi organization;|Q9NZN3 B4DFR5 D6W574 Q8N514 Q9NZB3,EH domain-containing protein 3 {ECO:0000305},PAST homolog 3 {ECO:0000305};, PF18150;PF00350;PF12763;PF16880;, GO:0020018;GO:0005737;GO:0005829;GO:0005769;GO:0030139;GO:0010008;GO:0005925;GO:0043231;GO:0005634;GO:0048471;GO:0055038;GO:0005524;GO:0005509;GO:0005525;GO:0003676;GO:0007596;GO:0060271;GO:0034498;GO:0032456;GO:0006897;GO:0016197;GO:0090160;GO:1901387;GO:0051260;GO:0072659;GO:0015031;GO:0001881;GO:1903779;GO:0086036;GO:0055117;GO:1903358;, C:ciliary pocket membrane; C:cytoplasm; C:cytosol; C:early endosome; C:endocytic vesicle; C:endosome membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome membrane;, F:ATP binding; F:calcium ion binding; F:GTP binding; F:nucleic acid binding;, P:blood coagulation; P:cilium assembly; P:early endosome to Golgi transport; P:endocytic recycling; P:endocytosis; P:endosomal transport; P:Golgi to lysosome transport; P:positive regulation of voltage-gated calcium channel activity; P:protein homooligomerization; P:protein localization to plasma membrane; P:protein transport; P:receptor recycling; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction; P:regulation of Golgi organization; scaffold12 indexed_genome mRNA 18813387 18864191 . + . ID=transcript_3130;Q96FL9 B3KV89 Q4ZG75 Q53SU1 Q53TJ0 Q8IVI4 Q9BRH1 Q9H827 Q9H9J8,Polypeptide N-acetylgalactosaminyltransferase 14,Polypeptide GalNAc transferase 14;Protein-UDP acetylgalactosaminyltransferase 14;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; scaffold12 indexed_genome mRNA 19094810 19278609 . - . ID=transcript_3131;Q6UWP7 A6H8Z7 Q8N1Q7,Lysocardiolipin acyltransferase 1,1-acylglycerol-3-phosphate O-acyltransferase 8 {ECO:0000303|PubMed:16620771};Acyl-CoA:lysocardiolipin acyltransferase 1;, PF16076;PF01553;, GO:0005829;GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003841;GO:0016746;GO:0035965;GO:0016024;GO:0007275;GO:0006654;GO:0036149;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:cardiolipin acyl-chain remodeling; P:CDP-diacylglycerol biosynthetic process; P:multicellular organism development; P:phosphatidic acid biosynthetic process; P:phosphatidylinositol acyl-chain remodeling; scaffold12 indexed_genome mRNA 19463522 19490140 . - . ID=transcript_3132;Q53QV2 B2RBC2 Q9H0Q1,Protein LBH {ECO:0000305},Limb bud and heart development protein homolog {ECO:0000305};, PF15317;, GO:0005737;GO:0005634;GO:0032991;GO:0007275;GO:0045892;GO:0045893;GO:0043408;, C:cytoplasm; C:nucleus; C:protein-containing complex;, , P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of MAPK cascade;|Q53QV2 B2RBC2 Q9H0Q1,Protein LBH {ECO:0000305},Limb bud and heart development protein homolog {ECO:0000305};, PF15317;, GO:0005737;GO:0005634;GO:0032991;GO:0007275;GO:0045892;GO:0045893;GO:0043408;, C:cytoplasm; C:nucleus; C:protein-containing complex;, , P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of MAPK cascade; scaffold12 indexed_genome mRNA 19551558 19555164 . - . ID=transcript_3133;P62699 D6W568 Q65Z97 Q8R174 Q9D6M1 Q9UMX7 Q9Y3C9,Protein yippee-like 5,, PF03226;, GO:0005576;GO:1904813;GO:0005815;GO:0030496;GO:0097431;GO:0005634;GO:1904724;GO:0000151;GO:0046872;GO:0008283;GO:0043312;, C:extracellular region; C:ficolin-1-rich granule lumen; C:microtubule organizing center; C:midbody; C:mitotic spindle pole; C:nucleus; C:tertiary granule lumen; C:ubiquitin ligase complex;, F:metal ion binding;, P:cell population proliferation; P:neutrophil degranulation; scaffold12 indexed_genome mRNA 20505183 20512524 . - . ID=transcript_3134;Q8N3C7 A0AV10 B2RMQ3 B7Z7N8 Q7Z4U3 Q96BR7 Q96MA5 Q9H7C0,CAP-Gly domain-containing linker protein 4,Restin-like protein 2;, PF12796;PF01302;, GO:0005737;GO:0043231;GO:0035371;GO:0005634;GO:0051010;GO:0031122;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:microtubule plus-end; C:nucleus;, F:microtubule plus-end binding;, P:cytoplasmic microtubule organization; scaffold12 indexed_genome mRNA 20512542 20583712 . - . ID=transcript_3135;Q8N3C7 A0AV10 B2RMQ3 B7Z7N8 Q7Z4U3 Q96BR7 Q96MA5 Q9H7C0,CAP-Gly domain-containing linker protein 4,Restin-like protein 2;, PF12796;PF01302;, GO:0005737;GO:0043231;GO:0035371;GO:0005634;GO:0051010;GO:0031122;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:microtubule plus-end; C:nucleus;, F:microtubule plus-end binding;, P:cytoplasmic microtubule organization; scaffold12 indexed_genome mRNA 20651482 20655800 . - . ID=transcript_3136;Q6ZUX3 Q6ZUF5,TOG array regulator of axonemal microtubules protein 2 {ECO:0000312|HGNC:HGNC:33715},Crescerin-2 {ECO:0000305};, PF12348;, GO:0005929;GO:0005881;GO:0005815;GO:0072686;GO:0005876;GO:0008017;GO:0000226;GO:0090307;, C:cilium; C:cytoplasmic microtubule; C:microtubule organizing center; C:mitotic spindle; C:spindle microtubule;, F:microtubule binding;, P:microtubule cytoskeleton organization; P:mitotic spindle assembly; scaffold12 indexed_genome mRNA 20707865 20720555 . + . ID=transcript_3137;Q15061 Q15395 Q92577,WD repeat-containing protein 43,U3 small nucleolar RNA-associated protein 5 homolog;, PF04003;PF00400;, GO:0000785;GO:0001650;GO:0005730;GO:0005654;GO:0003723;GO:0000993;GO:0003711;GO:2000234;GO:0045943;GO:2000036;GO:0034243;GO:0006364;, C:chromatin; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:RNA polymerase II complex binding; F:transcription elongation regulator activity;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:regulation of stem cell population maintenance; P:regulation of transcription elongation from RNA polymerase II promoter; P:rRNA processing;|Q15061 Q15395 Q92577,WD repeat-containing protein 43,U3 small nucleolar RNA-associated protein 5 homolog;, PF04003;PF00400;, GO:0000785;GO:0001650;GO:0005730;GO:0005654;GO:0003723;GO:0000993;GO:0003711;GO:2000234;GO:0045943;GO:2000036;GO:0034243;GO:0006364;, C:chromatin; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:RNA polymerase II complex binding; F:transcription elongation regulator activity;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:regulation of stem cell population maintenance; P:regulation of transcription elongation from RNA polymerase II promoter; P:rRNA processing;|Q15061 Q15395 Q92577,WD repeat-containing protein 43,U3 small nucleolar RNA-associated protein 5 homolog;, PF04003;PF00400;, GO:0000785;GO:0001650;GO:0005730;GO:0005654;GO:0003723;GO:0000993;GO:0003711;GO:2000234;GO:0045943;GO:2000036;GO:0034243;GO:0006364;, C:chromatin; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:RNA polymerase II complex binding; F:transcription elongation regulator activity;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:regulation of stem cell population maintenance; P:regulation of transcription elongation from RNA polymerase II promoter; P:rRNA processing;|Q15061 Q15395 Q92577,WD repeat-containing protein 43,U3 small nucleolar RNA-associated protein 5 homolog;, PF04003;PF00400;, GO:0000785;GO:0001650;GO:0005730;GO:0005654;GO:0003723;GO:0000993;GO:0003711;GO:2000234;GO:0045943;GO:2000036;GO:0034243;GO:0006364;, C:chromatin; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:RNA polymerase II complex binding; F:transcription elongation regulator activity;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:regulation of stem cell population maintenance; P:regulation of transcription elongation from RNA polymerase II promoter; P:rRNA processing;|Q15061 Q15395 Q92577,WD repeat-containing protein 43,U3 small nucleolar RNA-associated protein 5 homolog;, PF04003;PF00400;, GO:0000785;GO:0001650;GO:0005730;GO:0005654;GO:0003723;GO:0000993;GO:0003711;GO:2000234;GO:0045943;GO:2000036;GO:0034243;GO:0006364;, C:chromatin; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:RNA polymerase II complex binding; F:transcription elongation regulator activity;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:regulation of stem cell population maintenance; P:regulation of transcription elongation from RNA polymerase II promoter; P:rRNA processing; scaffold12 indexed_genome mRNA 20758463 20771326 . + . ID=transcript_3138;Q9BVS5 Q9H0Q9 Q9NWS7,tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial,mRNA methyladenosine-N(1)-methyltransferase {ECO:0000303|PubMed:29107537};, PF08704;, GO:0005759;GO:0005739;GO:0031515;GO:0061953;GO:0016433;GO:0016429;GO:0070901;GO:0080009;GO:0051260;GO:0030488;, C:mitochondrial matrix; C:mitochondrion; C:tRNA (m1A) methyltransferase complex;, F:mRNA (adenine-N1-)-methyltransferase activity; F:rRNA (adenine) methyltransferase activity; F:tRNA (adenine-N1-)-methyltransferase activity;, P:mitochondrial tRNA methylation; P:mRNA methylation; P:protein homooligomerization; P:tRNA methylation;|Q9BVS5 Q9H0Q9 Q9NWS7,tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial,mRNA methyladenosine-N(1)-methyltransferase {ECO:0000303|PubMed:29107537};, PF08704;, GO:0005759;GO:0005739;GO:0031515;GO:0061953;GO:0016433;GO:0016429;GO:0070901;GO:0080009;GO:0051260;GO:0030488;, C:mitochondrial matrix; C:mitochondrion; C:tRNA (m1A) methyltransferase complex;, F:mRNA (adenine-N1-)-methyltransferase activity; F:rRNA (adenine) methyltransferase activity; F:tRNA (adenine-N1-)-methyltransferase activity;, P:mitochondrial tRNA methylation; P:mRNA methylation; P:protein homooligomerization; P:tRNA methylation;|Q9BVS5 Q9H0Q9 Q9NWS7,tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial,mRNA methyladenosine-N(1)-methyltransferase {ECO:0000303|PubMed:29107537};, PF08704;, GO:0005759;GO:0005739;GO:0031515;GO:0061953;GO:0016433;GO:0016429;GO:0070901;GO:0080009;GO:0051260;GO:0030488;, C:mitochondrial matrix; C:mitochondrion; C:tRNA (m1A) methyltransferase complex;, F:mRNA (adenine-N1-)-methyltransferase activity; F:rRNA (adenine) methyltransferase activity; F:tRNA (adenine-N1-)-methyltransferase activity;, P:mitochondrial tRNA methylation; P:mRNA methylation; P:protein homooligomerization; P:tRNA methylation; scaffold12 indexed_genome mRNA 20789485 20808914 . - . ID=transcript_3139;Q5MJ70 Q53R05 Q5MJ69,Speedy protein A,Rapid inducer of G2/M progression in oocytes A;Speedy-1;, PF11357;, GO:0005654;GO:0005634;GO:0030295;GO:0019901;GO:0006974;GO:0000082;GO:0007140;GO:0007275;GO:0008284;GO:0045737;GO:0045860;, C:nucleoplasm; C:nucleus;, F:protein kinase activator activity; F:protein kinase binding;, P:cellular response to DNA damage stimulus; P:G1/S transition of mitotic cell cycle; P:male meiotic nuclear division; P:multicellular organism development; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of protein kinase activity;|Q5MJ70 Q53R05 Q5MJ69,Speedy protein A,Rapid inducer of G2/M progression in oocytes A;Speedy-1;, PF11357;, GO:0005654;GO:0005634;GO:0030295;GO:0019901;GO:0006974;GO:0000082;GO:0007140;GO:0007275;GO:0008284;GO:0045737;GO:0045860;, C:nucleoplasm; C:nucleus;, F:protein kinase activator activity; F:protein kinase binding;, P:cellular response to DNA damage stimulus; P:G1/S transition of mitotic cell cycle; P:male meiotic nuclear division; P:multicellular organism development; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of protein kinase activity;|Q5MJ70 Q53R05 Q5MJ69,Speedy protein A,Rapid inducer of G2/M progression in oocytes A;Speedy-1;, PF11357;, GO:0005654;GO:0005634;GO:0030295;GO:0019901;GO:0006974;GO:0000082;GO:0007140;GO:0007275;GO:0008284;GO:0045737;GO:0045860;, C:nucleoplasm; C:nucleus;, F:protein kinase activator activity; F:protein kinase binding;, P:cellular response to DNA damage stimulus; P:G1/S transition of mitotic cell cycle; P:male meiotic nuclear division; P:multicellular organism development; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of protein kinase activity; scaffold12 indexed_genome mRNA 20828260 20833842 . + . ID=transcript_3140;P62140 B2R5V4 D6W565 P37140 Q5U087 Q6FG45,Serine/threonine-protein phosphatase PP1-beta catalytic subunit,, PF00149;PF16891;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0042587;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0000164;GO:0072357;GO:0046872;GO:0017018;GO:0050115;GO:0016791;GO:0019901;GO:0106306;GO:0004722;GO:0106307;GO:0051301;GO:0032922;GO:0043153;GO:0000086;GO:0005977;GO:0000165;GO:0006470;GO:0030155;GO:0042752;GO:0005979;GO:0005981;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:glycogen granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein phosphatase type 1 complex; C:PTW/PP1 phosphatase complex;, F:metal ion binding; F:myosin phosphatase activity; F:myosin-light-chain-phosphatase activity; F:phosphatase activity; F:protein kinase binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:cell division; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:glycogen metabolic process; P:MAPK cascade; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of circadian rhythm; P:regulation of glycogen biosynthetic process; P:regulation of glycogen catabolic process;|P62140 B2R5V4 D6W565 P37140 Q5U087 Q6FG45,Serine/threonine-protein phosphatase PP1-beta catalytic subunit,, PF00149;PF16891;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0042587;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0000164;GO:0072357;GO:0046872;GO:0017018;GO:0050115;GO:0016791;GO:0019901;GO:0106306;GO:0004722;GO:0106307;GO:0051301;GO:0032922;GO:0043153;GO:0000086;GO:0005977;GO:0000165;GO:0006470;GO:0030155;GO:0042752;GO:0005979;GO:0005981;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:glycogen granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein phosphatase type 1 complex; C:PTW/PP1 phosphatase complex;, F:metal ion binding; F:myosin phosphatase activity; F:myosin-light-chain-phosphatase activity; F:phosphatase activity; F:protein kinase binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:cell division; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:glycogen metabolic process; P:MAPK cascade; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of circadian rhythm; P:regulation of glycogen biosynthetic process; P:regulation of glycogen catabolic process; scaffold12 indexed_genome mRNA 21172704 21195643 . + . ID=transcript_3141;P15408 B2RD58 B3KP27 B4DYV4 Q6FG46,Fos-related antigen 2,, PF00170;, GO:0000785;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000977;GO:0008219;GO:0003334;GO:0048146;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell death; P:keratinocyte development; P:positive regulation of fibroblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P15408 B2RD58 B3KP27 B4DYV4 Q6FG46,Fos-related antigen 2,, PF00170;, GO:0000785;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000977;GO:0008219;GO:0003334;GO:0048146;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell death; P:keratinocyte development; P:positive regulation of fibroblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P15408 B2RD58 B3KP27 B4DYV4 Q6FG46,Fos-related antigen 2,, PF00170;, GO:0000785;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000977;GO:0008219;GO:0003334;GO:0048146;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell death; P:keratinocyte development; P:positive regulation of fibroblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P15408 B2RD58 B3KP27 B4DYV4 Q6FG46,Fos-related antigen 2,, PF00170;, GO:0000785;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000977;GO:0008219;GO:0003334;GO:0048146;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell death; P:keratinocyte development; P:positive regulation of fibroblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 21525357 21526522 . - . ID=transcript_3142;Q9NXR7 A8K4X1 D6W562 D6W563 Q13880 Q4ZFX8 Q53SD0 Q969X9 Q96P06,BRISC and BRCA1-A complex member 2 {ECO:0000312|HGNC:HGNC:1106},BRCA1-A complex subunit BRE;BRCA1/BRCA2-containing complex subunit 45 {ECO:0000303|PubMed:14636569};Brain and reproductive organ-expressed protein {ECO:0000303|PubMed:7826398};, PF06113;, GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0000152;GO:0005654;GO:0005634;GO:0000268;GO:0031593;GO:0005164;GO:0006915;GO:0007049;GO:0051301;GO:0006974;GO:0006325;GO:0006302;GO:0006303;GO:0043066;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0007165;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear ubiquitin ligase complex; C:nucleoplasm; C:nucleus;, F:peroxisome targeting sequence binding; F:polyubiquitin modification-dependent protein binding; F:tumor necrosis factor receptor binding;, P:apoptotic process; P:cell cycle; P:cell division; P:cellular response to DNA damage stimulus; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of apoptotic process; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in G2 DNA damage checkpoint; scaffold12 indexed_genome mRNA 21650979 21699851 . + . ID=transcript_3143;Q9H477 A9UK04 B4DV96,Ribokinase {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000303|PubMed:17585908},, PF00294;, GO:0005829;GO:0005634;GO:0005524;GO:0042802;GO:0046872;GO:0004747;GO:0019303;GO:0006098;, C:cytosol; C:nucleus;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:ribokinase activity;, P:D-ribose catabolic process; P:pentose-phosphate shunt; scaffold12 indexed_genome mRNA 21699889 21747704 . + . ID=transcript_3144;Q9H477 A9UK04 B4DV96,Ribokinase {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000303|PubMed:17585908},, PF00294;, GO:0005829;GO:0005634;GO:0005524;GO:0042802;GO:0046872;GO:0004747;GO:0019303;GO:0006098;, C:cytosol; C:nucleus;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:ribokinase activity;, P:D-ribose catabolic process; P:pentose-phosphate shunt;|Q9H477 A9UK04 B4DV96,Ribokinase {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000303|PubMed:17585908},, PF00294;, GO:0005829;GO:0005634;GO:0005524;GO:0042802;GO:0046872;GO:0004747;GO:0019303;GO:0006098;, C:cytosol; C:nucleus;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:ribokinase activity;, P:D-ribose catabolic process; P:pentose-phosphate shunt; scaffold12 indexed_genome mRNA 21748325 21758025 . - . ID=transcript_3145;O75394 Q53RZ6 Q5FVE3 Q96Q50,39S ribosomal protein L33, mitochondrial,Mitochondrial large ribosomal subunit protein bL33m {ECO:0000303|PubMed:25278503};, PF00471;, GO:0005743;GO:0005762;GO:0005739;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|O75394 Q53RZ6 Q5FVE3 Q96Q50,39S ribosomal protein L33, mitochondrial,Mitochondrial large ribosomal subunit protein bL33m {ECO:0000303|PubMed:25278503};, PF00471;, GO:0005743;GO:0005762;GO:0005739;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|O75394 Q53RZ6 Q5FVE3 Q96Q50,39S ribosomal protein L33, mitochondrial,Mitochondrial large ribosomal subunit protein bL33m {ECO:0000303|PubMed:25278503};, PF00471;, GO:0005743;GO:0005762;GO:0005739;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold12 indexed_genome mRNA 21822698 21852685 . - . ID=transcript_3146;Q9BWU0 A6NJ39 Q4KMT1 Q4KMX0 Q7Z5Q9 Q9NVN2,Kanadaptin,Human lung cancer oncogene 3 protein;Kidney anion exchanger adapter protein;Solute carrier family 4 anion exchanger member 1 adapter protein;, PF00498;, GO:0005737;GO:0043231;GO:0005654;GO:0005886;GO:0003729;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:mRNA binding;|Q9BWU0 A6NJ39 Q4KMT1 Q4KMX0 Q7Z5Q9 Q9NVN2,Kanadaptin,Human lung cancer oncogene 3 protein;Kidney anion exchanger adapter protein;Solute carrier family 4 anion exchanger member 1 adapter protein;, PF00498;, GO:0005737;GO:0043231;GO:0005654;GO:0005886;GO:0003729;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:mRNA binding; scaffold12 indexed_genome mRNA 21852752 21891490 . + . ID=transcript_3147;O94864 B4E3W3 Q6IB21 Q9H2T6,STAGA complex 65 subunit gamma,Adenocarcinoma antigen ART1;SPTF-associated factor 65 gamma;Suppressor of Ty 7-like;, PF07524;, GO:0005654;GO:0005634;GO:0030914;GO:0004402;GO:0046982;GO:0003713;GO:0043966;GO:0051457;, C:nucleoplasm; C:nucleus; C:STAGA complex;, F:histone acetyltransferase activity; F:protein heterodimerization activity; F:transcription coactivator activity;, P:histone H3 acetylation; P:maintenance of protein location in nucleus;|O94864 B4E3W3 Q6IB21 Q9H2T6,STAGA complex 65 subunit gamma,Adenocarcinoma antigen ART1;SPTF-associated factor 65 gamma;Suppressor of Ty 7-like;, PF07524;, GO:0005654;GO:0005634;GO:0030914;GO:0004402;GO:0046982;GO:0003713;GO:0043966;GO:0051457;, C:nucleoplasm; C:nucleus; C:STAGA complex;, F:histone acetyltransferase activity; F:protein heterodimerization activity; F:transcription coactivator activity;, P:histone H3 acetylation; P:maintenance of protein location in nucleus;|O94864 B4E3W3 Q6IB21 Q9H2T6,STAGA complex 65 subunit gamma,Adenocarcinoma antigen ART1;SPTF-associated factor 65 gamma;Suppressor of Ty 7-like;, PF07524;, GO:0005654;GO:0005634;GO:0030914;GO:0004402;GO:0046982;GO:0003713;GO:0043966;GO:0051457;, C:nucleoplasm; C:nucleus; C:STAGA complex;, F:histone acetyltransferase activity; F:protein heterodimerization activity; F:transcription coactivator activity;, P:histone H3 acetylation; P:maintenance of protein location in nucleus;|O94864 B4E3W3 Q6IB21 Q9H2T6,STAGA complex 65 subunit gamma,Adenocarcinoma antigen ART1;SPTF-associated factor 65 gamma;Suppressor of Ty 7-like;, PF07524;, GO:0005654;GO:0005634;GO:0030914;GO:0004402;GO:0046982;GO:0003713;GO:0043966;GO:0051457;, C:nucleoplasm; C:nucleus; C:STAGA complex;, F:histone acetyltransferase activity; F:protein heterodimerization activity; F:transcription coactivator activity;, P:histone H3 acetylation; P:maintenance of protein location in nucleus;|O94864 B4E3W3 Q6IB21 Q9H2T6,STAGA complex 65 subunit gamma,Adenocarcinoma antigen ART1;SPTF-associated factor 65 gamma;Suppressor of Ty 7-like;, PF07524;, GO:0005654;GO:0005634;GO:0030914;GO:0004402;GO:0046982;GO:0003713;GO:0043966;GO:0051457;, C:nucleoplasm; C:nucleus; C:STAGA complex;, F:histone acetyltransferase activity; F:protein heterodimerization activity; F:transcription coactivator activity;, P:histone H3 acetylation; P:maintenance of protein location in nucleus;|O94864 B4E3W3 Q6IB21 Q9H2T6,STAGA complex 65 subunit gamma,Adenocarcinoma antigen ART1;SPTF-associated factor 65 gamma;Suppressor of Ty 7-like;, PF07524;, GO:0005654;GO:0005634;GO:0030914;GO:0004402;GO:0046982;GO:0003713;GO:0043966;GO:0051457;, C:nucleoplasm; C:nucleus; C:STAGA complex;, F:histone acetyltransferase activity; F:protein heterodimerization activity; F:transcription coactivator activity;, P:histone H3 acetylation; P:maintenance of protein location in nucleus;|Q9HCN4 B4DQJ5 B4DQM4 B4DXU4 B5MBZ5 O76004,GPN-loop GTPase 1 {ECO:0000303|PubMed:20855544},MBD2-interacting protein;RNAPII-associated protein 4 {ECO:0000303|PubMed:20855544};XPA-binding protein 1 {ECO:0000303|PubMed:11058119};, PF03029;, GO:0005829;GO:0005739;GO:0005654;GO:0005525;GO:0003924;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:GTPase activity;|Q9HCN4 B4DQJ5 B4DQM4 B4DXU4 B5MBZ5 O76004,GPN-loop GTPase 1 {ECO:0000303|PubMed:20855544},MBD2-interacting protein;RNAPII-associated protein 4 {ECO:0000303|PubMed:20855544};XPA-binding protein 1 {ECO:0000303|PubMed:11058119};, PF03029;, GO:0005829;GO:0005739;GO:0005654;GO:0005525;GO:0003924;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:GTPase activity;|Q9HCN4 B4DQJ5 B4DQM4 B4DXU4 B5MBZ5 O76004,GPN-loop GTPase 1 {ECO:0000303|PubMed:20855544},MBD2-interacting protein;RNAPII-associated protein 4 {ECO:0000303|PubMed:20855544};XPA-binding protein 1 {ECO:0000303|PubMed:11058119};, PF03029;, GO:0005829;GO:0005739;GO:0005654;GO:0005525;GO:0003924;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:GTPase activity; scaffold12 indexed_genome mRNA 21893251 21894419 . + . ID=transcript_3148;Q6ZUS5 B3KW66 J3KQZ8 Q9H8G6,Coiled-coil domain-containing protein 121,, PF14988; scaffold12 indexed_genome mRNA 21899135 21927960 . - . ID=transcript_3149;Q96ME7 B4DSM5 Q53RZ7 Q86XK6 Q96JM0,Zinc finger protein 512,, PF00096;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q96ME7 B4DSM5 Q53RZ7 Q86XK6 Q96JM0,Zinc finger protein 512,, PF00096;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q96ME7 B4DSM5 Q53RZ7 Q86XK6 Q96JM0,Zinc finger protein 512,, PF00096;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding; scaffold12 indexed_genome mRNA 22009397 22011890 . + . ID=transcript_3150;Q9H6D8 D6W560,Fibronectin type III domain-containing protein 4,Fibronectin type III repeat-containing protein 1;, PF00041;, GO:0005783;GO:0005576;GO:0005615;GO:0016021;GO:0005886;GO:0050728;GO:0071559;, C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of inflammatory response; P:response to transforming growth factor beta;|Q9H6D8 D6W560,Fibronectin type III domain-containing protein 4,Fibronectin type III repeat-containing protein 1;, PF00041;, GO:0005783;GO:0005576;GO:0005615;GO:0016021;GO:0005886;GO:0050728;GO:0071559;, C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of inflammatory response; P:response to transforming growth factor beta; scaffold12 indexed_genome mRNA 22013072 22049808 . + . ID=transcript_3151;Q9UG01 A5PKZ0 B2RNU5 Q86X44 Q96HW4 Q9UFJ9 Q9ULP1,Intraflagellar transport protein 172 homolog,, PF00400;, GO:0005930;GO:0036064;GO:0097542;GO:0005929;GO:1903561;GO:0030992;GO:0097598;GO:0097225;GO:0097228;GO:0060348;GO:0007420;GO:0060271;GO:0031122;GO:0009953;GO:0048596;GO:0008544;GO:0001947;GO:0061525;GO:0042073;GO:0035735;GO:0070986;GO:0060173;GO:0050680;GO:0045879;GO:0001843;GO:1905515;GO:0007219;GO:0045880;GO:0016485;GO:0060021;GO:0007224;GO:0021522;, C:axoneme; C:ciliary basal body; C:ciliary tip; C:cilium; C:extracellular vesicle; C:intraciliary transport particle B; C:sperm cytoplasmic droplet; C:sperm midpiece; C:sperm principal piece;, , P:bone development; P:brain development; P:cilium assembly; P:cytoplasmic microtubule organization; P:dorsal/ventral pattern formation; P:embryonic camera-type eye morphogenesis; P:epidermis development; P:heart looping; P:hindgut development; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right axis specification; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein processing; P:roof of mouth development; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation;|Q9UG01 A5PKZ0 B2RNU5 Q86X44 Q96HW4 Q9UFJ9 Q9ULP1,Intraflagellar transport protein 172 homolog,, PF00400;, GO:0005930;GO:0036064;GO:0097542;GO:0005929;GO:1903561;GO:0030992;GO:0097598;GO:0097225;GO:0097228;GO:0060348;GO:0007420;GO:0060271;GO:0031122;GO:0009953;GO:0048596;GO:0008544;GO:0001947;GO:0061525;GO:0042073;GO:0035735;GO:0070986;GO:0060173;GO:0050680;GO:0045879;GO:0001843;GO:1905515;GO:0007219;GO:0045880;GO:0016485;GO:0060021;GO:0007224;GO:0021522;, C:axoneme; C:ciliary basal body; C:ciliary tip; C:cilium; C:extracellular vesicle; C:intraciliary transport particle B; C:sperm cytoplasmic droplet; C:sperm midpiece; C:sperm principal piece;, , P:bone development; P:brain development; P:cilium assembly; P:cytoplasmic microtubule organization; P:dorsal/ventral pattern formation; P:embryonic camera-type eye morphogenesis; P:epidermis development; P:heart looping; P:hindgut development; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right axis specification; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein processing; P:roof of mouth development; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation;|Q9UG01 A5PKZ0 B2RNU5 Q86X44 Q96HW4 Q9UFJ9 Q9ULP1,Intraflagellar transport protein 172 homolog,, PF00400;, GO:0005930;GO:0036064;GO:0097542;GO:0005929;GO:1903561;GO:0030992;GO:0097598;GO:0097225;GO:0097228;GO:0060348;GO:0007420;GO:0060271;GO:0031122;GO:0009953;GO:0048596;GO:0008544;GO:0001947;GO:0061525;GO:0042073;GO:0035735;GO:0070986;GO:0060173;GO:0050680;GO:0045879;GO:0001843;GO:1905515;GO:0007219;GO:0045880;GO:0016485;GO:0060021;GO:0007224;GO:0021522;, C:axoneme; C:ciliary basal body; C:ciliary tip; C:cilium; C:extracellular vesicle; C:intraciliary transport particle B; C:sperm cytoplasmic droplet; C:sperm midpiece; C:sperm principal piece;, , P:bone development; P:brain development; P:cilium assembly; P:cytoplasmic microtubule organization; P:dorsal/ventral pattern formation; P:embryonic camera-type eye morphogenesis; P:epidermis development; P:heart looping; P:hindgut development; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right axis specification; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein processing; P:roof of mouth development; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation;|Q9UG01 A5PKZ0 B2RNU5 Q86X44 Q96HW4 Q9UFJ9 Q9ULP1,Intraflagellar transport protein 172 homolog,, PF00400;, GO:0005930;GO:0036064;GO:0097542;GO:0005929;GO:1903561;GO:0030992;GO:0097598;GO:0097225;GO:0097228;GO:0060348;GO:0007420;GO:0060271;GO:0031122;GO:0009953;GO:0048596;GO:0008544;GO:0001947;GO:0061525;GO:0042073;GO:0035735;GO:0070986;GO:0060173;GO:0050680;GO:0045879;GO:0001843;GO:1905515;GO:0007219;GO:0045880;GO:0016485;GO:0060021;GO:0007224;GO:0021522;, C:axoneme; C:ciliary basal body; C:ciliary tip; C:cilium; C:extracellular vesicle; C:intraciliary transport particle B; C:sperm cytoplasmic droplet; C:sperm midpiece; C:sperm principal piece;, , P:bone development; P:brain development; P:cilium assembly; P:cytoplasmic microtubule organization; P:dorsal/ventral pattern formation; P:embryonic camera-type eye morphogenesis; P:epidermis development; P:heart looping; P:hindgut development; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right axis specification; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein processing; P:roof of mouth development; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation;|Q9UG01 A5PKZ0 B2RNU5 Q86X44 Q96HW4 Q9UFJ9 Q9ULP1,Intraflagellar transport protein 172 homolog,, PF00400;, GO:0005930;GO:0036064;GO:0097542;GO:0005929;GO:1903561;GO:0030992;GO:0097598;GO:0097225;GO:0097228;GO:0060348;GO:0007420;GO:0060271;GO:0031122;GO:0009953;GO:0048596;GO:0008544;GO:0001947;GO:0061525;GO:0042073;GO:0035735;GO:0070986;GO:0060173;GO:0050680;GO:0045879;GO:0001843;GO:1905515;GO:0007219;GO:0045880;GO:0016485;GO:0060021;GO:0007224;GO:0021522;, C:axoneme; C:ciliary basal body; C:ciliary tip; C:cilium; C:extracellular vesicle; C:intraciliary transport particle B; C:sperm cytoplasmic droplet; C:sperm midpiece; C:sperm principal piece;, , P:bone development; P:brain development; P:cilium assembly; P:cytoplasmic microtubule organization; P:dorsal/ventral pattern formation; P:embryonic camera-type eye morphogenesis; P:epidermis development; P:heart looping; P:hindgut development; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right axis specification; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein processing; P:roof of mouth development; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation;|Q9UG01 A5PKZ0 B2RNU5 Q86X44 Q96HW4 Q9UFJ9 Q9ULP1,Intraflagellar transport protein 172 homolog,, PF00400;, GO:0005930;GO:0036064;GO:0097542;GO:0005929;GO:1903561;GO:0030992;GO:0097598;GO:0097225;GO:0097228;GO:0060348;GO:0007420;GO:0060271;GO:0031122;GO:0009953;GO:0048596;GO:0008544;GO:0001947;GO:0061525;GO:0042073;GO:0035735;GO:0070986;GO:0060173;GO:0050680;GO:0045879;GO:0001843;GO:1905515;GO:0007219;GO:0045880;GO:0016485;GO:0060021;GO:0007224;GO:0021522;, C:axoneme; C:ciliary basal body; C:ciliary tip; C:cilium; C:extracellular vesicle; C:intraciliary transport particle B; C:sperm cytoplasmic droplet; C:sperm midpiece; C:sperm principal piece;, , P:bone development; P:brain development; P:cilium assembly; P:cytoplasmic microtubule organization; P:dorsal/ventral pattern formation; P:embryonic camera-type eye morphogenesis; P:epidermis development; P:heart looping; P:hindgut development; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right axis specification; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein processing; P:roof of mouth development; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation;|Q9UG01 A5PKZ0 B2RNU5 Q86X44 Q96HW4 Q9UFJ9 Q9ULP1,Intraflagellar transport protein 172 homolog,, PF00400;, GO:0005930;GO:0036064;GO:0097542;GO:0005929;GO:1903561;GO:0030992;GO:0097598;GO:0097225;GO:0097228;GO:0060348;GO:0007420;GO:0060271;GO:0031122;GO:0009953;GO:0048596;GO:0008544;GO:0001947;GO:0061525;GO:0042073;GO:0035735;GO:0070986;GO:0060173;GO:0050680;GO:0045879;GO:0001843;GO:1905515;GO:0007219;GO:0045880;GO:0016485;GO:0060021;GO:0007224;GO:0021522;, C:axoneme; C:ciliary basal body; C:ciliary tip; C:cilium; C:extracellular vesicle; C:intraciliary transport particle B; C:sperm cytoplasmic droplet; C:sperm midpiece; C:sperm principal piece;, , P:bone development; P:brain development; P:cilium assembly; P:cytoplasmic microtubule organization; P:dorsal/ventral pattern formation; P:embryonic camera-type eye morphogenesis; P:epidermis development; P:heart looping; P:hindgut development; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right axis specification; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein processing; P:roof of mouth development; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation;|Q9UG01 A5PKZ0 B2RNU5 Q86X44 Q96HW4 Q9UFJ9 Q9ULP1,Intraflagellar transport protein 172 homolog,, PF00400;, GO:0005930;GO:0036064;GO:0097542;GO:0005929;GO:1903561;GO:0030992;GO:0097598;GO:0097225;GO:0097228;GO:0060348;GO:0007420;GO:0060271;GO:0031122;GO:0009953;GO:0048596;GO:0008544;GO:0001947;GO:0061525;GO:0042073;GO:0035735;GO:0070986;GO:0060173;GO:0050680;GO:0045879;GO:0001843;GO:1905515;GO:0007219;GO:0045880;GO:0016485;GO:0060021;GO:0007224;GO:0021522;, C:axoneme; C:ciliary basal body; C:ciliary tip; C:cilium; C:extracellular vesicle; C:intraciliary transport particle B; C:sperm cytoplasmic droplet; C:sperm midpiece; C:sperm principal piece;, , P:bone development; P:brain development; P:cilium assembly; P:cytoplasmic microtubule organization; P:dorsal/ventral pattern formation; P:embryonic camera-type eye morphogenesis; P:epidermis development; P:heart looping; P:hindgut development; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right axis specification; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein processing; P:roof of mouth development; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation;|Q9UG01 A5PKZ0 B2RNU5 Q86X44 Q96HW4 Q9UFJ9 Q9ULP1,Intraflagellar transport protein 172 homolog,, PF00400;, GO:0005930;GO:0036064;GO:0097542;GO:0005929;GO:1903561;GO:0030992;GO:0097598;GO:0097225;GO:0097228;GO:0060348;GO:0007420;GO:0060271;GO:0031122;GO:0009953;GO:0048596;GO:0008544;GO:0001947;GO:0061525;GO:0042073;GO:0035735;GO:0070986;GO:0060173;GO:0050680;GO:0045879;GO:0001843;GO:1905515;GO:0007219;GO:0045880;GO:0016485;GO:0060021;GO:0007224;GO:0021522;, C:axoneme; C:ciliary basal body; C:ciliary tip; C:cilium; C:extracellular vesicle; C:intraciliary transport particle B; C:sperm cytoplasmic droplet; C:sperm midpiece; C:sperm principal piece;, , P:bone development; P:brain development; P:cilium assembly; P:cytoplasmic microtubule organization; P:dorsal/ventral pattern formation; P:embryonic camera-type eye morphogenesis; P:epidermis development; P:heart looping; P:hindgut development; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right axis specification; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein processing; P:roof of mouth development; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation;|Q9UG01 A5PKZ0 B2RNU5 Q86X44 Q96HW4 Q9UFJ9 Q9ULP1,Intraflagellar transport protein 172 homolog,, PF00400;, GO:0005930;GO:0036064;GO:0097542;GO:0005929;GO:1903561;GO:0030992;GO:0097598;GO:0097225;GO:0097228;GO:0060348;GO:0007420;GO:0060271;GO:0031122;GO:0009953;GO:0048596;GO:0008544;GO:0001947;GO:0061525;GO:0042073;GO:0035735;GO:0070986;GO:0060173;GO:0050680;GO:0045879;GO:0001843;GO:1905515;GO:0007219;GO:0045880;GO:0016485;GO:0060021;GO:0007224;GO:0021522;, C:axoneme; C:ciliary basal body; C:ciliary tip; C:cilium; C:extracellular vesicle; C:intraciliary transport particle B; C:sperm cytoplasmic droplet; C:sperm midpiece; C:sperm principal piece;, , P:bone development; P:brain development; P:cilium assembly; P:cytoplasmic microtubule organization; P:dorsal/ventral pattern formation; P:embryonic camera-type eye morphogenesis; P:epidermis development; P:heart looping; P:hindgut development; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:left/right axis specification; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein processing; P:roof of mouth development; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation; scaffold12 indexed_genome mRNA 22049875 22063906 . - . ID=transcript_3152;Q53RY4 B7ZL49 Q6UW42 Q8IWS5,Keratinocyte-associated protein 3,, PF12304;, GO:0016021;, C:integral component of membrane;|Q53RY4 B7ZL49 Q6UW42 Q8IWS5,Keratinocyte-associated protein 3,, PF12304;, GO:0016021;, C:integral component of membrane;|Q9UHY1 B3KV40 D6W558 Q53FZ5 Q96SU3,Nuclear receptor-binding protein,, PF07714;, GO:0005938;GO:0005737;GO:0012505;GO:0030027;GO:0016020;GO:0005654;GO:0005524;GO:0042803;GO:0006888;GO:0035556;GO:0006468;GO:0006367;, C:cell cortex; C:cytoplasm; C:endomembrane system; C:lamellipodium; C:membrane; C:nucleoplasm;, F:ATP binding; F:protein homodimerization activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular signal transduction; P:protein phosphorylation; P:transcription initiation from RNA polymerase II promoter;|Q9UHY1 B3KV40 D6W558 Q53FZ5 Q96SU3,Nuclear receptor-binding protein,, PF07714;, GO:0005938;GO:0005737;GO:0012505;GO:0030027;GO:0016020;GO:0005654;GO:0005524;GO:0042803;GO:0006888;GO:0035556;GO:0006468;GO:0006367;, C:cell cortex; C:cytoplasm; C:endomembrane system; C:lamellipodium; C:membrane; C:nucleoplasm;, F:ATP binding; F:protein homodimerization activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular signal transduction; P:protein phosphorylation; P:transcription initiation from RNA polymerase II promoter;|Q9UHY1 B3KV40 D6W558 Q53FZ5 Q96SU3,Nuclear receptor-binding protein,, PF07714;, GO:0005938;GO:0005737;GO:0012505;GO:0030027;GO:0016020;GO:0005654;GO:0005524;GO:0042803;GO:0006888;GO:0035556;GO:0006468;GO:0006367;, C:cell cortex; C:cytoplasm; C:endomembrane system; C:lamellipodium; C:membrane; C:nucleoplasm;, F:ATP binding; F:protein homodimerization activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular signal transduction; P:protein phosphorylation; P:transcription initiation from RNA polymerase II promoter;|Q13765 A8MTN7 B2R4P8 F8VU71 Q3KQV4 Q53A18 Q53G46,Nascent polypeptide-associated complex subunit alpha,Alpha-NAC;, PF19026;PF01849;, GO:0005737;GO:0070062;GO:0005854;GO:0005634;GO:0003677;GO:0003713;GO:0003231;GO:0061384;GO:0010664;GO:1901227;GO:2000138;GO:0048633;GO:1901228;GO:0015031;GO:0048742;GO:0043403;GO:0006412;GO:0042060;, C:cytoplasm; C:extracellular exosome; C:nascent polypeptide-associated complex; C:nucleus;, F:DNA binding; F:transcription coactivator activity;, P:cardiac ventricle development; P:heart trabecula morphogenesis; P:negative regulation of striated muscle cell apoptotic process; P:negative regulation of transcription from RNA polymerase II promoter involved in heart development; P:positive regulation of cell proliferation involved in heart morphogenesis; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; P:protein transport; P:regulation of skeletal muscle fiber development; P:skeletal muscle tissue regeneration; P:translation; P:wound healing;|Q9UHY1 B3KV40 D6W558 Q53FZ5 Q96SU3,Nuclear receptor-binding protein,, PF07714;, GO:0005938;GO:0005737;GO:0012505;GO:0030027;GO:0016020;GO:0005654;GO:0005524;GO:0042803;GO:0006888;GO:0035556;GO:0006468;GO:0006367;, C:cell cortex; C:cytoplasm; C:endomembrane system; C:lamellipodium; C:membrane; C:nucleoplasm;, F:ATP binding; F:protein homodimerization activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular signal transduction; P:protein phosphorylation; P:transcription initiation from RNA polymerase II promoter; scaffold12 indexed_genome mRNA 22078693 22097666 . + . ID=transcript_3153;O15355,Protein phosphatase 1G,Protein phosphatase 1C;Protein phosphatase 2C isoform gamma;Protein phosphatase magnesium-dependent 1 gamma;, PF00481;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0004724;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0007050;GO:0035970;GO:0006470;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:cell cycle arrest; P:peptidyl-threonine dephosphorylation; P:protein dephosphorylation;|O15355,Protein phosphatase 1G,Protein phosphatase 1C;Protein phosphatase 2C isoform gamma;Protein phosphatase magnesium-dependent 1 gamma;, PF00481;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0004724;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0007050;GO:0035970;GO:0006470;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:cell cycle arrest; P:peptidyl-threonine dephosphorylation; P:protein dephosphorylation;|O15355,Protein phosphatase 1G,Protein phosphatase 1C;Protein phosphatase 2C isoform gamma;Protein phosphatase magnesium-dependent 1 gamma;, PF00481;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0004724;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0007050;GO:0035970;GO:0006470;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:cell cycle arrest; P:peptidyl-threonine dephosphorylation; P:protein dephosphorylation; scaffold12 indexed_genome mRNA 22098462 22107435 . - . ID=transcript_3154;Q8N8E2 A8K3S5 B7WP71 Q3ZCU1 Q68CJ1 Q86UZ3 Q8NDL8 Q96ML3,Zinc finger protein 513,, PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0000976;GO:0045944;GO:0010468;GO:0050896;GO:0060041;GO:0007601;, C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:response to stimulus; P:retina development in camera-type eye; P:visual perception;|Q15036 B4DQM7 Q53HN7 Q6IAS3,Sorting nexin-17,, PF00787;PF18116;, GO:0031410;GO:0030659;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0005794;GO:0043231;GO:0016020;GO:0032991;GO:0050750;GO:0035091;GO:0008022;GO:0005102;GO:0035904;GO:0003279;GO:0006707;GO:0060976;GO:0032456;GO:0016197;GO:0006886;GO:0001822;GO:0006898;GO:0030100;GO:1990126;GO:0007165;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:protein-containing complex;, F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:signaling receptor binding;, P:aorta development; P:cardiac septum development; P:cholesterol catabolic process; P:coronary vasculature development; P:endocytic recycling; P:endosomal transport; P:intracellular protein transport; P:kidney development; P:receptor-mediated endocytosis; P:regulation of endocytosis; P:retrograde transport, endosome to plasma membrane; P:signal transduction;|Q15036 B4DQM7 Q53HN7 Q6IAS3,Sorting nexin-17,, PF00787;PF18116;, GO:0031410;GO:0030659;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0005794;GO:0043231;GO:0016020;GO:0032991;GO:0050750;GO:0035091;GO:0008022;GO:0005102;GO:0035904;GO:0003279;GO:0006707;GO:0060976;GO:0032456;GO:0016197;GO:0006886;GO:0001822;GO:0006898;GO:0030100;GO:1990126;GO:0007165;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:protein-containing complex;, F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:signaling receptor binding;, P:aorta development; P:cardiac septum development; P:cholesterol catabolic process; P:coronary vasculature development; P:endocytic recycling; P:endosomal transport; P:intracellular protein transport; P:kidney development; P:receptor-mediated endocytosis; P:regulation of endocytosis; P:retrograde transport, endosome to plasma membrane; P:signal transduction;|Q15036 B4DQM7 Q53HN7 Q6IAS3,Sorting nexin-17,, PF00787;PF18116;, GO:0031410;GO:0030659;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0005794;GO:0043231;GO:0016020;GO:0032991;GO:0050750;GO:0035091;GO:0008022;GO:0005102;GO:0035904;GO:0003279;GO:0006707;GO:0060976;GO:0032456;GO:0016197;GO:0006886;GO:0001822;GO:0006898;GO:0030100;GO:1990126;GO:0007165;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:protein-containing complex;, F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:signaling receptor binding;, P:aorta development; P:cardiac septum development; P:cholesterol catabolic process; P:coronary vasculature development; P:endocytic recycling; P:endosomal transport; P:intracellular protein transport; P:kidney development; P:receptor-mediated endocytosis; P:regulation of endocytosis; P:retrograde transport, endosome to plasma membrane; P:signal transduction; scaffold12 indexed_genome mRNA 22108879 22115548 . + . ID=transcript_3155;Q9UI10 Q53RY7 Q5BJF4 Q9BUV9 Q9UBG4 Q9UIQ9 Q9UJ95,Translation initiation factor eIF-2B subunit delta,eIF-2B GDP-GTP exchange factor subunit delta;, PF01008;, GO:0005737;GO:0005829;GO:0005851;GO:0003743;GO:0031369;GO:0042552;GO:0014003;GO:0001541;GO:0050790;GO:0006417;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex;, F:translation initiation factor activity; F:translation initiation factor binding;, P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:regulation of catalytic activity; P:regulation of translation; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|Q9UI10 Q53RY7 Q5BJF4 Q9BUV9 Q9UBG4 Q9UIQ9 Q9UJ95,Translation initiation factor eIF-2B subunit delta,eIF-2B GDP-GTP exchange factor subunit delta;, PF01008;, GO:0005737;GO:0005829;GO:0005851;GO:0003743;GO:0031369;GO:0042552;GO:0014003;GO:0001541;GO:0050790;GO:0006417;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex;, F:translation initiation factor activity; F:translation initiation factor binding;, P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:regulation of catalytic activity; P:regulation of translation; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|Q9UI10 Q53RY7 Q5BJF4 Q9BUV9 Q9UBG4 Q9UIQ9 Q9UJ95,Translation initiation factor eIF-2B subunit delta,eIF-2B GDP-GTP exchange factor subunit delta;, PF01008;, GO:0005737;GO:0005829;GO:0005851;GO:0003743;GO:0031369;GO:0042552;GO:0014003;GO:0001541;GO:0050790;GO:0006417;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex;, F:translation initiation factor activity; F:translation initiation factor binding;, P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:regulation of catalytic activity; P:regulation of translation; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation; scaffold12 indexed_genome mRNA 22116338 22136163 . + . ID=transcript_3156;Q8WUA4 D6W557 Q16632 Q9BWI7,General transcription factor 3C polypeptide 2,TF3C-beta;Transcription factor IIIC 110 kDa subunit;Transcription factor IIIC subunit beta;, PF00400;, GO:0005654;GO:0000127;GO:0042791;GO:0006383;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, , P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III;|Q8WUA4 D6W557 Q16632 Q9BWI7,General transcription factor 3C polypeptide 2,TF3C-beta;Transcription factor IIIC 110 kDa subunit;Transcription factor IIIC subunit beta;, PF00400;, GO:0005654;GO:0000127;GO:0042791;GO:0006383;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, , P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III;|Q8WUA4 D6W557 Q16632 Q9BWI7,General transcription factor 3C polypeptide 2,TF3C-beta;Transcription factor IIIC 110 kDa subunit;Transcription factor IIIC subunit beta;, PF00400;, GO:0005654;GO:0000127;GO:0042791;GO:0006383;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, , P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III;|Q8WUA4 D6W557 Q16632 Q9BWI7,General transcription factor 3C polypeptide 2,TF3C-beta;Transcription factor IIIC 110 kDa subunit;Transcription factor IIIC subunit beta;, PF00400;, GO:0005654;GO:0000127;GO:0042791;GO:0006383;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, , P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III;|Q8WUA4 D6W557 Q16632 Q9BWI7,General transcription factor 3C polypeptide 2,TF3C-beta;Transcription factor IIIC 110 kDa subunit;Transcription factor IIIC subunit beta;, PF00400;, GO:0005654;GO:0000127;GO:0042791;GO:0006383;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, , P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III;|Q8WUA4 D6W557 Q16632 Q9BWI7,General transcription factor 3C polypeptide 2,TF3C-beta;Transcription factor IIIC 110 kDa subunit;Transcription factor IIIC subunit beta;, PF00400;, GO:0005654;GO:0000127;GO:0042791;GO:0006383;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, , P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III;|Q8WUA4 D6W557 Q16632 Q9BWI7,General transcription factor 3C polypeptide 2,TF3C-beta;Transcription factor IIIC 110 kDa subunit;Transcription factor IIIC subunit beta;, PF00400;, GO:0005654;GO:0000127;GO:0042791;GO:0006383;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, , P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III;|Q8WUA4 D6W557 Q16632 Q9BWI7,General transcription factor 3C polypeptide 2,TF3C-beta;Transcription factor IIIC 110 kDa subunit;Transcription factor IIIC subunit beta;, PF00400;, GO:0005654;GO:0000127;GO:0042791;GO:0006383;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, , P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III; scaffold12 indexed_genome mRNA 22145348 22172315 . - . ID=transcript_3157;P39210 D6W555 Q53SY2 Q96B08,Protein Mpv17,, PF04117;, GO:0005737;GO:0005829;GO:0016021;GO:0005743;GO:0005739;GO:0005778;GO:0005777;GO:0015267;GO:0034614;GO:0032836;GO:0042592;GO:0048839;GO:0000002;GO:0008104;GO:1901858;GO:2000377;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:peroxisomal membrane; C:peroxisome;, F:channel activity;, P:cellular response to reactive oxygen species; P:glomerular basement membrane development; P:homeostatic process; P:inner ear development; P:mitochondrial genome maintenance; P:protein localization; P:regulation of mitochondrial DNA metabolic process; P:regulation of reactive oxygen species metabolic process;|Q9BYV2 A5D8T7 Q53SY4 Q9BYV3,Tripartite motif-containing protein 54,Muscle-specific RING finger protein;Muscle-specific RING finger protein 3;RING finger protein 30;, PF00643;PF13445;, GO:0005737;GO:0005874;GO:0005875;GO:0030018;GO:0008017;GO:0061630;GO:0008270;GO:0030154;GO:0007017;GO:0007275;GO:0007026;GO:0016567;GO:0007165;, C:cytoplasm; C:microtubule; C:microtubule associated complex; C:Z disc;, F:microtubule binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cell differentiation; P:microtubule-based process; P:multicellular organism development; P:negative regulation of microtubule depolymerization; P:protein ubiquitination; P:signal transduction;|Q9BYV2 A5D8T7 Q53SY4 Q9BYV3,Tripartite motif-containing protein 54,Muscle-specific RING finger protein;Muscle-specific RING finger protein 3;RING finger protein 30;, PF00643;PF13445;, GO:0005737;GO:0005874;GO:0005875;GO:0030018;GO:0008017;GO:0061630;GO:0008270;GO:0030154;GO:0007017;GO:0007275;GO:0007026;GO:0016567;GO:0007165;, C:cytoplasm; C:microtubule; C:microtubule associated complex; C:Z disc;, F:microtubule binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cell differentiation; P:microtubule-based process; P:multicellular organism development; P:negative regulation of microtubule depolymerization; P:protein ubiquitination; P:signal transduction; scaffold12 indexed_genome mRNA 22195076 22198834 . + . ID=transcript_3158;Q99726 Q8TC03,Zinc transporter 3,Solute carrier family 30 member 3;, PF01545;, GO:0005737;GO:0005768;GO:0098978;GO:0097457;GO:0098686;GO:0005887;GO:0030285;GO:0005770;GO:0031902;GO:0005765;GO:0016020;GO:0043005;GO:0005886;GO:0008021;GO:0005385;GO:0051050;GO:0061088;GO:0010043;GO:0099180;GO:0071577;, C:cytoplasm; C:endosome; C:glutamatergic synapse; C:hippocampal mossy fiber; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:neuron projection; C:plasma membrane; C:synaptic vesicle;, F:zinc ion transmembrane transporter activity;, P:positive regulation of transport; P:regulation of sequestering of zinc ion; P:response to zinc ion; P:zinc ion import into synaptic vesicle; P:zinc ion transmembrane transport; scaffold12 indexed_genome mRNA 22208744 22226410 . - . ID=transcript_3159;P27708 D6W552 Q6P0Q0 Q96CK3,CAD protein,, PF01979;PF02786;PF02787;PF00988;PF00117;PF02142;PF00185;PF02729;, GO:0042995;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0043195;GO:0070335;GO:0004070;GO:0005524;GO:0004088;GO:0004151;GO:0019899;GO:0042802;GO:0004672;GO:0008270;GO:0006207;GO:0044205;GO:0031100;GO:0035690;GO:0071364;GO:0019240;GO:0017144;GO:0007565;GO:0006541;GO:0007507;GO:0007595;GO:0001889;GO:0006807;GO:0018107;GO:0046777;GO:0046134;GO:0014075;GO:0031000;GO:0051414;GO:0032868;GO:0042594;GO:0033574;GO:0006228;, C:cell projection; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:terminal bouton;, F:aspartate binding; F:aspartate carbamoyltransferase activity; F:ATP binding; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:dihydroorotase activity; F:enzyme binding; F:identical protein binding; F:protein kinase activity; F:zinc ion binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:animal organ regeneration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:citrulline biosynthetic process; P:drug metabolic process; P:female pregnancy; P:glutamine metabolic process; P:heart development; P:lactation; P:liver development; P:nitrogen compound metabolic process; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:pyrimidine nucleoside biosynthetic process; P:response to amine; P:response to caffeine; P:response to cortisol; P:response to insulin; P:response to starvation; P:response to testosterone; P:UTP biosynthetic process;|P27708 D6W552 Q6P0Q0 Q96CK3,CAD protein,, PF01979;PF02786;PF02787;PF00988;PF00117;PF02142;PF00185;PF02729;, GO:0042995;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0043195;GO:0070335;GO:0004070;GO:0005524;GO:0004088;GO:0004151;GO:0019899;GO:0042802;GO:0004672;GO:0008270;GO:0006207;GO:0044205;GO:0031100;GO:0035690;GO:0071364;GO:0019240;GO:0017144;GO:0007565;GO:0006541;GO:0007507;GO:0007595;GO:0001889;GO:0006807;GO:0018107;GO:0046777;GO:0046134;GO:0014075;GO:0031000;GO:0051414;GO:0032868;GO:0042594;GO:0033574;GO:0006228;, C:cell projection; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:terminal bouton;, F:aspartate binding; F:aspartate carbamoyltransferase activity; F:ATP binding; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:dihydroorotase activity; F:enzyme binding; F:identical protein binding; F:protein kinase activity; F:zinc ion binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:animal organ regeneration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:citrulline biosynthetic process; P:drug metabolic process; P:female pregnancy; P:glutamine metabolic process; P:heart development; P:lactation; P:liver development; P:nitrogen compound metabolic process; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:pyrimidine nucleoside biosynthetic process; P:response to amine; P:response to caffeine; P:response to cortisol; P:response to insulin; P:response to starvation; P:response to testosterone; P:UTP biosynthetic process;|P27708 D6W552 Q6P0Q0 Q96CK3,CAD protein,, PF01979;PF02786;PF02787;PF00988;PF00117;PF02142;PF00185;PF02729;, GO:0042995;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0043195;GO:0070335;GO:0004070;GO:0005524;GO:0004088;GO:0004151;GO:0019899;GO:0042802;GO:0004672;GO:0008270;GO:0006207;GO:0044205;GO:0031100;GO:0035690;GO:0071364;GO:0019240;GO:0017144;GO:0007565;GO:0006541;GO:0007507;GO:0007595;GO:0001889;GO:0006807;GO:0018107;GO:0046777;GO:0046134;GO:0014075;GO:0031000;GO:0051414;GO:0032868;GO:0042594;GO:0033574;GO:0006228;, C:cell projection; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:terminal bouton;, F:aspartate binding; F:aspartate carbamoyltransferase activity; F:ATP binding; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:dihydroorotase activity; F:enzyme binding; F:identical protein binding; F:protein kinase activity; F:zinc ion binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:animal organ regeneration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:citrulline biosynthetic process; P:drug metabolic process; P:female pregnancy; P:glutamine metabolic process; P:heart development; P:lactation; P:liver development; P:nitrogen compound metabolic process; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:pyrimidine nucleoside biosynthetic process; P:response to amine; P:response to caffeine; P:response to cortisol; P:response to insulin; P:response to starvation; P:response to testosterone; P:UTP biosynthetic process;|P27708 D6W552 Q6P0Q0 Q96CK3,CAD protein,, PF01979;PF02786;PF02787;PF00988;PF00117;PF02142;PF00185;PF02729;, GO:0042995;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0043195;GO:0070335;GO:0004070;GO:0005524;GO:0004088;GO:0004151;GO:0019899;GO:0042802;GO:0004672;GO:0008270;GO:0006207;GO:0044205;GO:0031100;GO:0035690;GO:0071364;GO:0019240;GO:0017144;GO:0007565;GO:0006541;GO:0007507;GO:0007595;GO:0001889;GO:0006807;GO:0018107;GO:0046777;GO:0046134;GO:0014075;GO:0031000;GO:0051414;GO:0032868;GO:0042594;GO:0033574;GO:0006228;, C:cell projection; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:terminal bouton;, F:aspartate binding; F:aspartate carbamoyltransferase activity; F:ATP binding; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:dihydroorotase activity; F:enzyme binding; F:identical protein binding; F:protein kinase activity; F:zinc ion binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:animal organ regeneration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:citrulline biosynthetic process; P:drug metabolic process; P:female pregnancy; P:glutamine metabolic process; P:heart development; P:lactation; P:liver development; P:nitrogen compound metabolic process; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:pyrimidine nucleoside biosynthetic process; P:response to amine; P:response to caffeine; P:response to cortisol; P:response to insulin; P:response to starvation; P:response to testosterone; P:UTP biosynthetic process;|P27708 D6W552 Q6P0Q0 Q96CK3,CAD protein,, PF01979;PF02786;PF02787;PF00988;PF00117;PF02142;PF00185;PF02729;, GO:0042995;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0043195;GO:0070335;GO:0004070;GO:0005524;GO:0004088;GO:0004151;GO:0019899;GO:0042802;GO:0004672;GO:0008270;GO:0006207;GO:0044205;GO:0031100;GO:0035690;GO:0071364;GO:0019240;GO:0017144;GO:0007565;GO:0006541;GO:0007507;GO:0007595;GO:0001889;GO:0006807;GO:0018107;GO:0046777;GO:0046134;GO:0014075;GO:0031000;GO:0051414;GO:0032868;GO:0042594;GO:0033574;GO:0006228;, C:cell projection; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:terminal bouton;, F:aspartate binding; F:aspartate carbamoyltransferase activity; F:ATP binding; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:dihydroorotase activity; F:enzyme binding; F:identical protein binding; F:protein kinase activity; F:zinc ion binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:animal organ regeneration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:citrulline biosynthetic process; P:drug metabolic process; P:female pregnancy; P:glutamine metabolic process; P:heart development; P:lactation; P:liver development; P:nitrogen compound metabolic process; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:pyrimidine nucleoside biosynthetic process; P:response to amine; P:response to caffeine; P:response to cortisol; P:response to insulin; P:response to starvation; P:response to testosterone; P:UTP biosynthetic process;|P27708 D6W552 Q6P0Q0 Q96CK3,CAD protein,, PF01979;PF02786;PF02787;PF00988;PF00117;PF02142;PF00185;PF02729;, GO:0042995;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0043195;GO:0070335;GO:0004070;GO:0005524;GO:0004088;GO:0004151;GO:0019899;GO:0042802;GO:0004672;GO:0008270;GO:0006207;GO:0044205;GO:0031100;GO:0035690;GO:0071364;GO:0019240;GO:0017144;GO:0007565;GO:0006541;GO:0007507;GO:0007595;GO:0001889;GO:0006807;GO:0018107;GO:0046777;GO:0046134;GO:0014075;GO:0031000;GO:0051414;GO:0032868;GO:0042594;GO:0033574;GO:0006228;, C:cell projection; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:terminal bouton;, F:aspartate binding; F:aspartate carbamoyltransferase activity; F:ATP binding; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:dihydroorotase activity; F:enzyme binding; F:identical protein binding; F:protein kinase activity; F:zinc ion binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:animal organ regeneration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:citrulline biosynthetic process; P:drug metabolic process; P:female pregnancy; P:glutamine metabolic process; P:heart development; P:lactation; P:liver development; P:nitrogen compound metabolic process; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:pyrimidine nucleoside biosynthetic process; P:response to amine; P:response to caffeine; P:response to cortisol; P:response to insulin; P:response to starvation; P:response to testosterone; P:UTP biosynthetic process; scaffold12 indexed_genome mRNA 22226596 22230507 . - . ID=transcript_3160;P27708 D6W552 Q6P0Q0 Q96CK3,CAD protein,, PF01979;PF02786;PF02787;PF00988;PF00117;PF02142;PF00185;PF02729;, GO:0042995;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0043195;GO:0070335;GO:0004070;GO:0005524;GO:0004088;GO:0004151;GO:0019899;GO:0042802;GO:0004672;GO:0008270;GO:0006207;GO:0044205;GO:0031100;GO:0035690;GO:0071364;GO:0019240;GO:0017144;GO:0007565;GO:0006541;GO:0007507;GO:0007595;GO:0001889;GO:0006807;GO:0018107;GO:0046777;GO:0046134;GO:0014075;GO:0031000;GO:0051414;GO:0032868;GO:0042594;GO:0033574;GO:0006228;, C:cell projection; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:terminal bouton;, F:aspartate binding; F:aspartate carbamoyltransferase activity; F:ATP binding; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:dihydroorotase activity; F:enzyme binding; F:identical protein binding; F:protein kinase activity; F:zinc ion binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:animal organ regeneration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:citrulline biosynthetic process; P:drug metabolic process; P:female pregnancy; P:glutamine metabolic process; P:heart development; P:lactation; P:liver development; P:nitrogen compound metabolic process; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:pyrimidine nucleoside biosynthetic process; P:response to amine; P:response to caffeine; P:response to cortisol; P:response to insulin; P:response to starvation; P:response to testosterone; P:UTP biosynthetic process;|P27708 D6W552 Q6P0Q0 Q96CK3,CAD protein,, PF01979;PF02786;PF02787;PF00988;PF00117;PF02142;PF00185;PF02729;, GO:0042995;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0043195;GO:0070335;GO:0004070;GO:0005524;GO:0004088;GO:0004151;GO:0019899;GO:0042802;GO:0004672;GO:0008270;GO:0006207;GO:0044205;GO:0031100;GO:0035690;GO:0071364;GO:0019240;GO:0017144;GO:0007565;GO:0006541;GO:0007507;GO:0007595;GO:0001889;GO:0006807;GO:0018107;GO:0046777;GO:0046134;GO:0014075;GO:0031000;GO:0051414;GO:0032868;GO:0042594;GO:0033574;GO:0006228;, C:cell projection; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:terminal bouton;, F:aspartate binding; F:aspartate carbamoyltransferase activity; F:ATP binding; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:dihydroorotase activity; F:enzyme binding; F:identical protein binding; F:protein kinase activity; F:zinc ion binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:animal organ regeneration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:citrulline biosynthetic process; P:drug metabolic process; P:female pregnancy; P:glutamine metabolic process; P:heart development; P:lactation; P:liver development; P:nitrogen compound metabolic process; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:pyrimidine nucleoside biosynthetic process; P:response to amine; P:response to caffeine; P:response to cortisol; P:response to insulin; P:response to starvation; P:response to testosterone; P:UTP biosynthetic process; scaffold12 indexed_genome mRNA 22230536 22234641 . - . ID=transcript_3161;Q6UW56 A8C1S2 A8K779 Q96FF6 Q96RT2 Q9Y2R7 Q9Y5L7,All-trans retinoic acid-induced differentiation factor,Apoptosis-related protein 3;p18;, , GO:0016021;GO:0005765;GO:0005635;GO:0048471;GO:0005886;GO:0030154;GO:1903363;GO:0033689;GO:0030501;GO:0045669;GO:0010468;, C:integral component of membrane; C:lysosomal membrane; C:nuclear envelope; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:cell differentiation; P:negative regulation of cellular protein catabolic process; P:negative regulation of osteoblast proliferation; P:positive regulation of bone mineralization; P:positive regulation of osteoblast differentiation; P:regulation of gene expression;|Q6UW56 A8C1S2 A8K779 Q96FF6 Q96RT2 Q9Y2R7 Q9Y5L7,All-trans retinoic acid-induced differentiation factor,Apoptosis-related protein 3;p18;, , GO:0016021;GO:0005765;GO:0005635;GO:0048471;GO:0005886;GO:0030154;GO:1903363;GO:0033689;GO:0030501;GO:0045669;GO:0010468;, C:integral component of membrane; C:lysosomal membrane; C:nuclear envelope; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:cell differentiation; P:negative regulation of cellular protein catabolic process; P:negative regulation of osteoblast proliferation; P:positive regulation of bone mineralization; P:positive regulation of osteoblast differentiation; P:regulation of gene expression;|Q6UW56 A8C1S2 A8K779 Q96FF6 Q96RT2 Q9Y2R7 Q9Y5L7,All-trans retinoic acid-induced differentiation factor,Apoptosis-related protein 3;p18;, , GO:0016021;GO:0005765;GO:0005635;GO:0048471;GO:0005886;GO:0030154;GO:1903363;GO:0033689;GO:0030501;GO:0045669;GO:0010468;, C:integral component of membrane; C:lysosomal membrane; C:nuclear envelope; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:cell differentiation; P:negative regulation of cellular protein catabolic process; P:negative regulation of osteoblast proliferation; P:positive regulation of bone mineralization; P:positive regulation of osteoblast differentiation; P:regulation of gene expression; scaffold12 indexed_genome mRNA 22235493 22247433 . + . ID=transcript_3162;Q9Y289 B2RB85 D6W549 Q969Y5,Sodium-dependent multivitamin transporter,Solute carrier family 5 member 6;, PF00474;, GO:0016324;GO:0009925;GO:0016323;GO:0031526;GO:0005887;GO:0016020;GO:0005886;GO:0012506;GO:0015225;GO:0015233;GO:0008523;GO:0015293;GO:1905135;GO:0006768;GO:0015878;GO:0015939;GO:0015887;GO:0006814;GO:0055085;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle membrane;, F:biotin transmembrane transporter activity; F:pantothenate transmembrane transporter activity; F:sodium-dependent multivitamin transmembrane transporter activity; F:symporter activity;, P:biotin import across plasma membrane; P:biotin metabolic process; P:biotin transport; P:pantothenate metabolic process; P:pantothenate transmembrane transport; P:sodium ion transport; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y289 B2RB85 D6W549 Q969Y5,Sodium-dependent multivitamin transporter,Solute carrier family 5 member 6;, PF00474;, GO:0016324;GO:0009925;GO:0016323;GO:0031526;GO:0005887;GO:0016020;GO:0005886;GO:0012506;GO:0015225;GO:0015233;GO:0008523;GO:0015293;GO:1905135;GO:0006768;GO:0015878;GO:0015939;GO:0015887;GO:0006814;GO:0055085;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle membrane;, F:biotin transmembrane transporter activity; F:pantothenate transmembrane transporter activity; F:sodium-dependent multivitamin transmembrane transporter activity; F:symporter activity;, P:biotin import across plasma membrane; P:biotin metabolic process; P:biotin transport; P:pantothenate metabolic process; P:pantothenate transmembrane transport; P:sodium ion transport; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y289 B2RB85 D6W549 Q969Y5,Sodium-dependent multivitamin transporter,Solute carrier family 5 member 6;, PF00474;, GO:0016324;GO:0009925;GO:0016323;GO:0031526;GO:0005887;GO:0016020;GO:0005886;GO:0012506;GO:0015225;GO:0015233;GO:0008523;GO:0015293;GO:1905135;GO:0006768;GO:0015878;GO:0015939;GO:0015887;GO:0006814;GO:0055085;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle membrane;, F:biotin transmembrane transporter activity; F:pantothenate transmembrane transporter activity; F:sodium-dependent multivitamin transmembrane transporter activity; F:symporter activity;, P:biotin import across plasma membrane; P:biotin metabolic process; P:biotin transport; P:pantothenate metabolic process; P:pantothenate transmembrane transport; P:sodium ion transport; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y289 B2RB85 D6W549 Q969Y5,Sodium-dependent multivitamin transporter,Solute carrier family 5 member 6;, PF00474;, GO:0016324;GO:0009925;GO:0016323;GO:0031526;GO:0005887;GO:0016020;GO:0005886;GO:0012506;GO:0015225;GO:0015233;GO:0008523;GO:0015293;GO:1905135;GO:0006768;GO:0015878;GO:0015939;GO:0015887;GO:0006814;GO:0055085;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle membrane;, F:biotin transmembrane transporter activity; F:pantothenate transmembrane transporter activity; F:sodium-dependent multivitamin transmembrane transporter activity; F:symporter activity;, P:biotin import across plasma membrane; P:biotin metabolic process; P:biotin transport; P:pantothenate metabolic process; P:pantothenate transmembrane transport; P:sodium ion transport; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y289 B2RB85 D6W549 Q969Y5,Sodium-dependent multivitamin transporter,Solute carrier family 5 member 6;, PF00474;, GO:0016324;GO:0009925;GO:0016323;GO:0031526;GO:0005887;GO:0016020;GO:0005886;GO:0012506;GO:0015225;GO:0015233;GO:0008523;GO:0015293;GO:1905135;GO:0006768;GO:0015878;GO:0015939;GO:0015887;GO:0006814;GO:0055085;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle membrane;, F:biotin transmembrane transporter activity; F:pantothenate transmembrane transporter activity; F:sodium-dependent multivitamin transmembrane transporter activity; F:symporter activity;, P:biotin import across plasma membrane; P:biotin metabolic process; P:biotin transport; P:pantothenate metabolic process; P:pantothenate transmembrane transport; P:sodium ion transport; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y289 B2RB85 D6W549 Q969Y5,Sodium-dependent multivitamin transporter,Solute carrier family 5 member 6;, PF00474;, GO:0016324;GO:0009925;GO:0016323;GO:0031526;GO:0005887;GO:0016020;GO:0005886;GO:0012506;GO:0015225;GO:0015233;GO:0008523;GO:0015293;GO:1905135;GO:0006768;GO:0015878;GO:0015939;GO:0015887;GO:0006814;GO:0055085;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle membrane;, F:biotin transmembrane transporter activity; F:pantothenate transmembrane transporter activity; F:sodium-dependent multivitamin transmembrane transporter activity; F:symporter activity;, P:biotin import across plasma membrane; P:biotin metabolic process; P:biotin transport; P:pantothenate metabolic process; P:pantothenate transmembrane transport; P:sodium ion transport; P:transmembrane transport; P:transport across blood-brain barrier; scaffold12 indexed_genome mRNA 22319935 22325042 . + . ID=transcript_3163;Q9HCU5 Q53SZ8 Q9UH94,Prolactin regulatory element-binding protein,Mammalian guanine nucleotide exchange factor mSec12;, PF00400;, GO:0070971;GO:0005789;GO:0030176;GO:0016020;GO:0005634;GO:0003677;GO:0005096;GO:0051020;GO:0005085;GO:0048208;GO:0006888;GO:0036498;GO:0032527;GO:0009306;GO:0003400;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nucleus;, F:DNA binding; F:GTPase activator activity; F:GTPase binding; F:guanyl-nucleotide exchange factor activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein exit from endoplasmic reticulum; P:protein secretion; P:regulation of COPII vesicle coating;|Q9HCU5 Q53SZ8 Q9UH94,Prolactin regulatory element-binding protein,Mammalian guanine nucleotide exchange factor mSec12;, PF00400;, GO:0070971;GO:0005789;GO:0030176;GO:0016020;GO:0005634;GO:0003677;GO:0005096;GO:0051020;GO:0005085;GO:0048208;GO:0006888;GO:0036498;GO:0032527;GO:0009306;GO:0003400;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nucleus;, F:DNA binding; F:GTPase activator activity; F:GTPase binding; F:guanyl-nucleotide exchange factor activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein exit from endoplasmic reticulum; P:protein secretion; P:regulation of COPII vesicle coating;|Q9HCU5 Q53SZ8 Q9UH94,Prolactin regulatory element-binding protein,Mammalian guanine nucleotide exchange factor mSec12;, PF00400;, GO:0070971;GO:0005789;GO:0030176;GO:0016020;GO:0005634;GO:0003677;GO:0005096;GO:0051020;GO:0005085;GO:0048208;GO:0006888;GO:0036498;GO:0032527;GO:0009306;GO:0003400;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nucleus;, F:DNA binding; F:GTPase activator activity; F:GTPase binding; F:guanyl-nucleotide exchange factor activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein exit from endoplasmic reticulum; P:protein secretion; P:regulation of COPII vesicle coating;|Q9HCU5 Q53SZ8 Q9UH94,Prolactin regulatory element-binding protein,Mammalian guanine nucleotide exchange factor mSec12;, PF00400;, GO:0070971;GO:0005789;GO:0030176;GO:0016020;GO:0005634;GO:0003677;GO:0005096;GO:0051020;GO:0005085;GO:0048208;GO:0006888;GO:0036498;GO:0032527;GO:0009306;GO:0003400;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nucleus;, F:DNA binding; F:GTPase activator activity; F:GTPase binding; F:guanyl-nucleotide exchange factor activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein exit from endoplasmic reticulum; P:protein secretion; P:regulation of COPII vesicle coating;|Q9HCU5 Q53SZ8 Q9UH94,Prolactin regulatory element-binding protein,Mammalian guanine nucleotide exchange factor mSec12;, PF00400;, GO:0070971;GO:0005789;GO:0030176;GO:0016020;GO:0005634;GO:0003677;GO:0005096;GO:0051020;GO:0005085;GO:0048208;GO:0006888;GO:0036498;GO:0032527;GO:0009306;GO:0003400;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nucleus;, F:DNA binding; F:GTPase activator activity; F:GTPase binding; F:guanyl-nucleotide exchange factor activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein exit from endoplasmic reticulum; P:protein secretion; P:regulation of COPII vesicle coating; scaffold12 indexed_genome mRNA 22325110 22326147 . - . ID=transcript_3164;Q96SE0 B3KSF6 E9PDR9 Q05BY3 Q53SZ1 Q8IXQ7,Protein ABHD1 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 1 {ECO:0000305};Lung alpha/beta hydrolase 1;, PF00561;, GO:0016021;GO:0008126;GO:0047372;GO:0034338;GO:0044255;GO:0051792;GO:0051793;, C:integral component of membrane;, F:acetylesterase activity; F:acylglycerol lipase activity; F:short-chain carboxylesterase activity;, P:cellular lipid metabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty acid catabolic process; scaffold12 indexed_genome mRNA 22353056 22360181 . + . ID=transcript_3165;Q99674 A6NHV7 B4DXY8 B5MCB7 B5MCC9 B5MCP5 E7EU99 Q8N4B7,Cell growth regulator with EF hand domain protein 1 {ECO:0000305},Cell growth regulatory gene 11 protein;Hydrophobestin;, , GO:0005576;GO:0005509;GO:0007155;GO:0007050;GO:0008285;, C:extracellular region;, F:calcium ion binding;, P:cell adhesion; P:cell cycle arrest; P:negative regulation of cell population proliferation;|Q99674 A6NHV7 B4DXY8 B5MCB7 B5MCC9 B5MCP5 E7EU99 Q8N4B7,Cell growth regulator with EF hand domain protein 1 {ECO:0000305},Cell growth regulatory gene 11 protein;Hydrophobestin;, , GO:0005576;GO:0005509;GO:0007155;GO:0007050;GO:0008285;, C:extracellular region;, F:calcium ion binding;, P:cell adhesion; P:cell cycle arrest; P:negative regulation of cell population proliferation;|Q99674 A6NHV7 B4DXY8 B5MCB7 B5MCC9 B5MCP5 E7EU99 Q8N4B7,Cell growth regulator with EF hand domain protein 1 {ECO:0000305},Cell growth regulatory gene 11 protein;Hydrophobestin;, , GO:0005576;GO:0005509;GO:0007155;GO:0007050;GO:0008285;, C:extracellular region;, F:calcium ion binding;, P:cell adhesion; P:cell cycle arrest; P:negative regulation of cell population proliferation;|P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1,Ketohexokinase {ECO:0000312|HGNC:HGNC:6315},Hepatic fructokinase;, PF00294;, GO:0005737;GO:0005829;GO:0070062;GO:0005524;GO:0004454;GO:0061624;GO:0006000;GO:0070873;GO:0009750;GO:0009749;GO:0032868;GO:0009744;GO:0010043;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:ATP binding; F:ketohexokinase activity;, P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:fructose metabolic process; P:regulation of glycogen metabolic process; P:response to fructose; P:response to glucose; P:response to insulin; P:response to sucrose; P:response to zinc ion; scaffold12 indexed_genome mRNA 22360880 22372072 . - . ID=transcript_3166;P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1,Ketohexokinase {ECO:0000312|HGNC:HGNC:6315},Hepatic fructokinase;, PF00294;, GO:0005737;GO:0005829;GO:0070062;GO:0005524;GO:0004454;GO:0061624;GO:0006000;GO:0070873;GO:0009750;GO:0009749;GO:0032868;GO:0009744;GO:0010043;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:ATP binding; F:ketohexokinase activity;, P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:fructose metabolic process; P:regulation of glycogen metabolic process; P:response to fructose; P:response to glucose; P:response to insulin; P:response to sucrose; P:response to zinc ion;|P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1,Ketohexokinase {ECO:0000312|HGNC:HGNC:6315},Hepatic fructokinase;, PF00294;, GO:0005737;GO:0005829;GO:0070062;GO:0005524;GO:0004454;GO:0061624;GO:0006000;GO:0070873;GO:0009750;GO:0009749;GO:0032868;GO:0009744;GO:0010043;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:ATP binding; F:ketohexokinase activity;, P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:fructose metabolic process; P:regulation of glycogen metabolic process; P:response to fructose; P:response to glucose; P:response to insulin; P:response to sucrose; P:response to zinc ion;|P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1,Ketohexokinase {ECO:0000312|HGNC:HGNC:6315},Hepatic fructokinase;, PF00294;, GO:0005737;GO:0005829;GO:0070062;GO:0005524;GO:0004454;GO:0061624;GO:0006000;GO:0070873;GO:0009750;GO:0009749;GO:0032868;GO:0009744;GO:0010043;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:ATP binding; F:ketohexokinase activity;, P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:fructose metabolic process; P:regulation of glycogen metabolic process; P:response to fructose; P:response to glucose; P:response to insulin; P:response to sucrose; P:response to zinc ion; scaffold12 indexed_genome mRNA 22372392 22389639 . - . ID=transcript_3167;Q9Y6C2 A0A0C4DFX3 A5PL03 H0Y7A0 Q53SY9 Q96G58 Q96IH6 Q9UG76,EMILIN-1,Elastin microfibril interface-located protein 1;, PF00386;PF01391;PF07546;, GO:0005581;GO:0062023;GO:1990971;GO:0070062;GO:0005576;GO:0005615;GO:0034668;GO:0030023;GO:0042802;GO:0098640;GO:0003180;GO:0007155;GO:0016477;GO:0007160;GO:0048251;GO:0016525;GO:0050866;GO:0032966;GO:1904027;GO:0070373;GO:0010629;GO:1905522;GO:0060394;GO:0030512;GO:0030948;GO:0010811;GO:1901203;GO:0010628;, C:collagen trimer; C:collagen-containing extracellular matrix; C:EMILIN complex; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integrin alpha4-beta1 complex;, F:extracellular matrix constituent conferring elasticity; F:identical protein binding; F:integrin binding involved in cell-matrix adhesion;, P:aortic valve morphogenesis; P:cell adhesion; P:cell migration; P:cell-matrix adhesion; P:elastic fiber assembly; P:negative regulation of angiogenesis; P:negative regulation of cell activation; P:negative regulation of collagen biosynthetic process; P:negative regulation of collagen fibril organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of macrophage migration; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of cell-substrate adhesion; P:positive regulation of extracellular matrix assembly; P:positive regulation of gene expression;|Q9Y6C2 A0A0C4DFX3 A5PL03 H0Y7A0 Q53SY9 Q96G58 Q96IH6 Q9UG76,EMILIN-1,Elastin microfibril interface-located protein 1;, PF00386;PF01391;PF07546;, GO:0005581;GO:0062023;GO:1990971;GO:0070062;GO:0005576;GO:0005615;GO:0034668;GO:0030023;GO:0042802;GO:0098640;GO:0003180;GO:0007155;GO:0016477;GO:0007160;GO:0048251;GO:0016525;GO:0050866;GO:0032966;GO:1904027;GO:0070373;GO:0010629;GO:1905522;GO:0060394;GO:0030512;GO:0030948;GO:0010811;GO:1901203;GO:0010628;, C:collagen trimer; C:collagen-containing extracellular matrix; C:EMILIN complex; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integrin alpha4-beta1 complex;, F:extracellular matrix constituent conferring elasticity; F:identical protein binding; F:integrin binding involved in cell-matrix adhesion;, P:aortic valve morphogenesis; P:cell adhesion; P:cell migration; P:cell-matrix adhesion; P:elastic fiber assembly; P:negative regulation of angiogenesis; P:negative regulation of cell activation; P:negative regulation of collagen biosynthetic process; P:negative regulation of collagen fibril organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of macrophage migration; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of cell-substrate adhesion; P:positive regulation of extracellular matrix assembly; P:positive regulation of gene expression;|P0C6T2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4,, PF10215;, GO:0016021;GO:0008250;GO:0018279;, C:integral component of membrane; C:oligosaccharyltransferase complex;, , P:protein N-linked glycosylation via asparagine; scaffold12 indexed_genome mRNA 22389959 22390481 . - . ID=transcript_3168;Q9H8P8,Cytosolic carboxypeptidase-like protein 5,ATP/GTP-binding protein-like 5;, PF18027;PF00246;, GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0030496;GO:0072686;GO:0005634;GO:0004181;GO:0015631;GO:0008270;GO:0051607;GO:0035611;GO:0035608;, C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle; C:nucleus;, F:metallocarboxypeptidase activity; F:tubulin binding; F:zinc ion binding;, P:defense response to virus; P:protein branching point deglutamylation; P:protein deglutamylation; scaffold12 indexed_genome mRNA 22398549 22405787 . - . ID=transcript_3169;Q9H8P8,Cytosolic carboxypeptidase-like protein 5,ATP/GTP-binding protein-like 5;, PF18027;PF00246;, GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0030496;GO:0072686;GO:0005634;GO:0004181;GO:0015631;GO:0008270;GO:0051607;GO:0035611;GO:0035608;, C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle; C:nucleus;, F:metallocarboxypeptidase activity; F:tubulin binding; F:zinc ion binding;, P:defense response to virus; P:protein branching point deglutamylation; P:protein deglutamylation;|Q9H8P8,Cytosolic carboxypeptidase-like protein 5,ATP/GTP-binding protein-like 5;, PF18027;PF00246;, GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0030496;GO:0072686;GO:0005634;GO:0004181;GO:0015631;GO:0008270;GO:0051607;GO:0035611;GO:0035608;, C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle; C:nucleus;, F:metallocarboxypeptidase activity; F:tubulin binding; F:zinc ion binding;, P:defense response to virus; P:protein branching point deglutamylation; P:protein deglutamylation; scaffold12 indexed_genome mRNA 22414386 22417407 . - . ID=transcript_3170;Q9NXH2,Transmembrane protein 214,, PF10151;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0006915;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:apoptotic process;|Q9NXH2,Transmembrane protein 214,, PF10151;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0006915;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:apoptotic process; scaffold12 indexed_genome mRNA 22418844 22419750 . + . ID=transcript_3171;Q9UPY8 B7WPK5 O00265 Q6FHB0 Q6FI15 Q9BZP7 Q9BZP8,Microtubule-associated protein RP/EB family member 3,EB1 protein family member 3;End-binding protein 3;RP3;, PF00307;PF03271;, GO:0005737;GO:0015630;GO:0005815;GO:0035371;GO:0030496;GO:1905721;GO:0048471;GO:0051233;GO:0042802;GO:0008017;GO:0051010;GO:0008022;GO:0019901;GO:0051301;GO:0045737;GO:1903033;GO:0045860;GO:0045893;GO:0008104;GO:1904825;GO:0031113;GO:0031110;GO:0051225;, C:cytoplasm; C:microtubule cytoskeleton; C:microtubule organizing center; C:microtubule plus-end; C:midbody; C:mitotic spindle astral microtubule end; C:perinuclear region of cytoplasm; C:spindle midzone;, F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:protein C-terminus binding; F:protein kinase binding;, P:cell division; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of microtubule plus-end binding; P:positive regulation of protein kinase activity; P:positive regulation of transcription, DNA-templated; P:protein localization; P:protein localization to microtubule plus-end; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:spindle assembly; scaffold12 indexed_genome mRNA 22492108 22578522 . - . ID=transcript_3172;Q9BPU6 Q8TCL6 Q9NQC4 Q9NRY9,Dihydropyrimidinase-related protein 5,CRMP3-associated molecule;Collapsin response mediator protein 5;UNC33-like phosphoprotein 6;, PF01979;, GO:0005829;GO:0030425;GO:0043025;GO:0016810;GO:0008017;GO:0007411;GO:0007399;GO:0007165;, C:cytosol; C:dendrite; C:neuronal cell body;, F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:microtubule binding;, P:axon guidance; P:nervous system development; P:signal transduction;|Q9BPU6 Q8TCL6 Q9NQC4 Q9NRY9,Dihydropyrimidinase-related protein 5,CRMP3-associated molecule;Collapsin response mediator protein 5;UNC33-like phosphoprotein 6;, PF01979;, GO:0005829;GO:0030425;GO:0043025;GO:0016810;GO:0008017;GO:0007411;GO:0007399;GO:0007165;, C:cytosol; C:dendrite; C:neuronal cell body;, F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:microtubule binding;, P:axon guidance; P:nervous system development; P:signal transduction; scaffold12 indexed_genome mRNA 22610737 22626996 . - . ID=transcript_3173;Q8N357 D6W543 Q53GK2 Q8NBX6 Q9NWX0,Solute carrier family 35 member F6,ANT2-binding protein;Transport and Golgi organization 9 homolog;, PF06027;, GO:0005829;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0005739;GO:0005654;GO:0022857;GO:1901029;GO:0008284;, C:cytosol; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:mitochondrion; C:nucleoplasm;, F:transmembrane transporter activity;, P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of cell population proliferation; scaffold12 indexed_genome mRNA 22794288 22794827 . - . ID=transcript_3174;A6NJV1,Protein FAM166C {ECO:0000305},Family with sequence similarity 166 member C {ECO:0000312|HGNC:HGNC:27938};, PF10629;, GO:0005634;, C:nucleus; scaffold12 indexed_genome mRNA 22901467 22933297 . - . ID=transcript_3175;Q96MC2 A8K1N8 Q53R91 Q53TA3 Q8NDI5,Dynein regulatory complex protein 1,Coiled-coil domain-containing protein 164;, PF14772;PF14775;, GO:0005858;GO:0005930;GO:0005829;GO:0031514;GO:0070286;GO:0060285;GO:0007368;GO:0007507;GO:0003352;, C:axonemal dynein complex; C:axoneme; C:cytosol; C:motile cilium;, , P:axonemal dynein complex assembly; P:cilium-dependent cell motility; P:determination of left/right symmetry; P:heart development; P:regulation of cilium movement;|Q96MC2 A8K1N8 Q53R91 Q53TA3 Q8NDI5,Dynein regulatory complex protein 1,Coiled-coil domain-containing protein 164;, PF14772;PF14775;, GO:0005858;GO:0005930;GO:0005829;GO:0031514;GO:0070286;GO:0060285;GO:0007368;GO:0007507;GO:0003352;, C:axonemal dynein complex; C:axoneme; C:cytosol; C:motile cilium;, , P:axonemal dynein complex assembly; P:cilium-dependent cell motility; P:determination of left/right symmetry; P:heart development; P:regulation of cilium movement; scaffold12 indexed_genome mRNA 22939868 22952595 . - . ID=transcript_3176;Q9C0D9 Q63ZE3,Ethanolaminephosphotransferase 1 {ECO:0000305},Selenoprotein I {ECO:0000303|PubMed:27645994, ECO:0000312|HGNC:HGNC:29361};, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0004307;GO:0046872;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:phosphatidylethanolamine biosynthetic process;|Q9C0D9 Q63ZE3,Ethanolaminephosphotransferase 1 {ECO:0000305},Selenoprotein I {ECO:0000303|PubMed:27645994, ECO:0000312|HGNC:HGNC:29361};, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0004307;GO:0046872;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:phosphatidylethanolamine biosynthetic process;|Q9C0D9 Q63ZE3,Ethanolaminephosphotransferase 1 {ECO:0000305},Selenoprotein I {ECO:0000303|PubMed:27645994, ECO:0000312|HGNC:HGNC:29361};, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0004307;GO:0046872;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:phosphatidylethanolamine biosynthetic process;|Q9C0D9 Q63ZE3,Ethanolaminephosphotransferase 1 {ECO:0000305},Selenoprotein I {ECO:0000303|PubMed:27645994, ECO:0000312|HGNC:HGNC:29361};, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0004307;GO:0046872;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:phosphatidylethanolamine biosynthetic process;|Q9C0D9 Q63ZE3,Ethanolaminephosphotransferase 1 {ECO:0000305},Selenoprotein I {ECO:0000303|PubMed:27645994, ECO:0000312|HGNC:HGNC:29361};, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0004307;GO:0046872;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:phosphatidylethanolamine biosynthetic process; scaffold12 indexed_genome mRNA 22957254 22984728 . - . ID=transcript_3177;Q9C0D9 Q63ZE3,Ethanolaminephosphotransferase 1 {ECO:0000305},Selenoprotein I {ECO:0000303|PubMed:27645994, ECO:0000312|HGNC:HGNC:29361};, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0004307;GO:0046872;GO:0006646;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:ethanolaminephosphotransferase activity; F:metal ion binding;, P:phosphatidylethanolamine biosynthetic process; scaffold12 indexed_genome mRNA 23013228 23014527 . + . ID=transcript_3178;Q8IZF5 B4DF15 E9PEV1 Q53TA5 Q6UXT7 Q6UXX3 Q86SL7 Q8IXD8 Q8TDT3,Adhesion G-protein coupled receptor F3,G-protein coupled receptor 113;G-protein coupled receptor PGR23;, PF00002;PF01825;, GO:0016021;GO:0004930;GO:0007166;GO:0007186;, C:integral component of membrane;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold12 indexed_genome mRNA 23014978 23049062 . - . ID=transcript_3179;P55084 B2RB16 B4E2W0 O14969 Q53TA6 Q96C77 Q9H3F5 Q9T2V8,Trifunctional enzyme subunit beta, mitochondrial,TP-beta;, PF02803;PF00108;, GO:0005783;GO:0005740;GO:0005743;GO:0042645;GO:0005741;GO:0005739;GO:0003857;GO:0003988;GO:0050633;GO:0004300;GO:0003723;GO:0035965;GO:0006635;, C:endoplasmic reticulum; C:mitochondrial envelope; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrion;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:enoyl-CoA hydratase activity; F:RNA binding;, P:cardiolipin acyl-chain remodeling; P:fatty acid beta-oxidation; scaffold12 indexed_genome mRNA 23049220 23090878 . + . ID=transcript_3180;P40939 B2R7L4 B4DYP2 Q16679 Q53T69 Q53TA2 Q96GT7 Q9UQC5,Trifunctional enzyme subunit alpha, mitochondrial,78 kDa gastrin-binding protein;Monolysocardiolipin acyltransferase {ECO:0000305|PubMed:23152787};TP-alpha;, PF00725;PF02737;PF00378;, GO:0016507;GO:0005743;GO:0042645;GO:0005739;GO:0003857;GO:0003985;GO:0004300;GO:0016509;GO:0070403;GO:0035965;GO:0006635;, C:mitochondrial fatty acid beta-oxidation multienzyme complex; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:acetyl-CoA C-acetyltransferase activity; F:enoyl-CoA hydratase activity; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; F:NAD+ binding;, P:cardiolipin acyl-chain remodeling; P:fatty acid beta-oxidation;|P40939 B2R7L4 B4DYP2 Q16679 Q53T69 Q53TA2 Q96GT7 Q9UQC5,Trifunctional enzyme subunit alpha, mitochondrial,78 kDa gastrin-binding protein;Monolysocardiolipin acyltransferase {ECO:0000305|PubMed:23152787};TP-alpha;, PF00725;PF02737;PF00378;, GO:0016507;GO:0005743;GO:0042645;GO:0005739;GO:0003857;GO:0003985;GO:0004300;GO:0016509;GO:0070403;GO:0035965;GO:0006635;, C:mitochondrial fatty acid beta-oxidation multienzyme complex; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:acetyl-CoA C-acetyltransferase activity; F:enoyl-CoA hydratase activity; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; F:NAD+ binding;, P:cardiolipin acyl-chain remodeling; P:fatty acid beta-oxidation;|P40939 B2R7L4 B4DYP2 Q16679 Q53T69 Q53TA2 Q96GT7 Q9UQC5,Trifunctional enzyme subunit alpha, mitochondrial,78 kDa gastrin-binding protein;Monolysocardiolipin acyltransferase {ECO:0000305|PubMed:23152787};TP-alpha;, PF00725;PF02737;PF00378;, GO:0016507;GO:0005743;GO:0042645;GO:0005739;GO:0003857;GO:0003985;GO:0004300;GO:0016509;GO:0070403;GO:0035965;GO:0006635;, C:mitochondrial fatty acid beta-oxidation multienzyme complex; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:acetyl-CoA C-acetyltransferase activity; F:enoyl-CoA hydratase activity; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; F:NAD+ binding;, P:cardiolipin acyl-chain remodeling; P:fatty acid beta-oxidation;|P40939 B2R7L4 B4DYP2 Q16679 Q53T69 Q53TA2 Q96GT7 Q9UQC5,Trifunctional enzyme subunit alpha, mitochondrial,78 kDa gastrin-binding protein;Monolysocardiolipin acyltransferase {ECO:0000305|PubMed:23152787};TP-alpha;, PF00725;PF02737;PF00378;, GO:0016507;GO:0005743;GO:0042645;GO:0005739;GO:0003857;GO:0003985;GO:0004300;GO:0016509;GO:0070403;GO:0035965;GO:0006635;, C:mitochondrial fatty acid beta-oxidation multienzyme complex; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:acetyl-CoA C-acetyltransferase activity; F:enoyl-CoA hydratase activity; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; F:NAD+ binding;, P:cardiolipin acyl-chain remodeling; P:fatty acid beta-oxidation;|P40939 B2R7L4 B4DYP2 Q16679 Q53T69 Q53TA2 Q96GT7 Q9UQC5,Trifunctional enzyme subunit alpha, mitochondrial,78 kDa gastrin-binding protein;Monolysocardiolipin acyltransferase {ECO:0000305|PubMed:23152787};TP-alpha;, PF00725;PF02737;PF00378;, GO:0016507;GO:0005743;GO:0042645;GO:0005739;GO:0003857;GO:0003985;GO:0004300;GO:0016509;GO:0070403;GO:0035965;GO:0006635;, C:mitochondrial fatty acid beta-oxidation multienzyme complex; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:acetyl-CoA C-acetyltransferase activity; F:enoyl-CoA hydratase activity; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; F:NAD+ binding;, P:cardiolipin acyl-chain remodeling; P:fatty acid beta-oxidation;|P40939 B2R7L4 B4DYP2 Q16679 Q53T69 Q53TA2 Q96GT7 Q9UQC5,Trifunctional enzyme subunit alpha, mitochondrial,78 kDa gastrin-binding protein;Monolysocardiolipin acyltransferase {ECO:0000305|PubMed:23152787};TP-alpha;, PF00725;PF02737;PF00378;, GO:0016507;GO:0005743;GO:0042645;GO:0005739;GO:0003857;GO:0003985;GO:0004300;GO:0016509;GO:0070403;GO:0035965;GO:0006635;, C:mitochondrial fatty acid beta-oxidation multienzyme complex; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:acetyl-CoA C-acetyltransferase activity; F:enoyl-CoA hydratase activity; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; F:NAD+ binding;, P:cardiolipin acyl-chain remodeling; P:fatty acid beta-oxidation; scaffold12 indexed_genome mRNA 23092253 23095772 . + . ID=transcript_3181;Q75VX8 B5MC97 B7WNK9 Q8NF27 Q9UIK8,GRB2-associated and regulator of MAPK protein 2,GRB2-associated and regulator of MAPK1-like;, PF12736;|Q75VX8 B5MC97 B7WNK9 Q8NF27 Q9UIK8,GRB2-associated and regulator of MAPK protein 2,GRB2-associated and regulator of MAPK1-like;, PF12736; scaffold12 indexed_genome mRNA 23135527 23199888 . - . ID=transcript_3182;P61026 D6W538 O88386 Q6IA52 Q9D7X6 Q9H0T3,Ras-related protein Rab-10,, PF00071;, GO:0005912;GO:0005929;GO:0030659;GO:0005856;GO:0005829;GO:0005789;GO:0071782;GO:0005768;GO:0070382;GO:0070062;GO:0005925;GO:0005794;GO:0000139;GO:0032593;GO:0048471;GO:0030670;GO:0005886;GO:0055037;GO:0055038;GO:0030667;GO:0008021;GO:0005802;GO:0098641;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019882;GO:0007409;GO:0032869;GO:0071786;GO:0016197;GO:0045200;GO:0097051;GO:0090150;GO:0043001;GO:0006893;GO:0043312;GO:0030859;GO:1903361;GO:0072659;GO:0009306;GO:0045055;GO:0017157;GO:0006904;GO:0016192;, C:adherens junction; C:cilium; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endosome; C:exocytic vesicle; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:Golgi membrane; C:insulin-responsive compartment; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:secretory granule membrane; C:synaptic vesicle; C:trans-Golgi network;, F:cadherin binding involved in cell-cell adhesion; F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding;, P:antigen processing and presentation; P:axonogenesis; P:cellular response to insulin stimulus; P:endoplasmic reticulum tubular network organization; P:endosomal transport; P:establishment of neuroblast polarity; P:establishment of protein localization to endoplasmic reticulum membrane; P:establishment of protein localization to membrane; P:Golgi to plasma membrane protein transport; P:Golgi to plasma membrane transport; P:neutrophil degranulation; P:polarized epithelial cell differentiation; P:protein localization to basolateral plasma membrane; P:protein localization to plasma membrane; P:protein secretion; P:regulated exocytosis; P:regulation of exocytosis; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|P61026 D6W538 O88386 Q6IA52 Q9D7X6 Q9H0T3,Ras-related protein Rab-10,, PF00071;, GO:0005912;GO:0005929;GO:0030659;GO:0005856;GO:0005829;GO:0005789;GO:0071782;GO:0005768;GO:0070382;GO:0070062;GO:0005925;GO:0005794;GO:0000139;GO:0032593;GO:0048471;GO:0030670;GO:0005886;GO:0055037;GO:0055038;GO:0030667;GO:0008021;GO:0005802;GO:0098641;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019882;GO:0007409;GO:0032869;GO:0071786;GO:0016197;GO:0045200;GO:0097051;GO:0090150;GO:0043001;GO:0006893;GO:0043312;GO:0030859;GO:1903361;GO:0072659;GO:0009306;GO:0045055;GO:0017157;GO:0006904;GO:0016192;, C:adherens junction; C:cilium; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endosome; C:exocytic vesicle; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:Golgi membrane; C:insulin-responsive compartment; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:secretory granule membrane; C:synaptic vesicle; C:trans-Golgi network;, F:cadherin binding involved in cell-cell adhesion; F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding;, P:antigen processing and presentation; P:axonogenesis; P:cellular response to insulin stimulus; P:endoplasmic reticulum tubular network organization; P:endosomal transport; P:establishment of neuroblast polarity; P:establishment of protein localization to endoplasmic reticulum membrane; P:establishment of protein localization to membrane; P:Golgi to plasma membrane protein transport; P:Golgi to plasma membrane transport; P:neutrophil degranulation; P:polarized epithelial cell differentiation; P:protein localization to basolateral plasma membrane; P:protein localization to plasma membrane; P:protein secretion; P:regulated exocytosis; P:regulation of exocytosis; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport; scaffold12 indexed_genome mRNA 23245334 23276417 . + . ID=transcript_3183;O14782 O43544 Q4ZG18 Q53SX5 Q562F7,Kinesin-like protein KIF3C,, PF00225;, GO:0097542;GO:0005929;GO:0005829;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0035735;GO:0007018;GO:0072384;GO:0006890;, C:ciliary tip; C:cilium; C:cytosol; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:organelle transport along microtubule; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O14782 O43544 Q4ZG18 Q53SX5 Q562F7,Kinesin-like protein KIF3C,, PF00225;, GO:0097542;GO:0005929;GO:0005829;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0035735;GO:0007018;GO:0072384;GO:0006890;, C:ciliary tip; C:cilium; C:cytosol; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:organelle transport along microtubule; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O14782 O43544 Q4ZG18 Q53SX5 Q562F7,Kinesin-like protein KIF3C,, PF00225;, GO:0097542;GO:0005929;GO:0005829;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0035735;GO:0007018;GO:0072384;GO:0006890;, C:ciliary tip; C:cilium; C:cytosol; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:organelle transport along microtubule; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold12 indexed_genome mRNA 23386917 23424020 . + . ID=transcript_3184;Q76L83 Q53TC9 Q5H9U4 Q76L81 Q86XM1 Q9C0H8 Q9NV67,Putative Polycomb group protein ASXL2,Additional sex combs-like protein 2;, PF13919;PF05066;PF13922;, GO:0005654;GO:0035517;GO:0003682;GO:0003677;GO:0046872;GO:0042975;GO:0009887;GO:0045600;GO:0010884;GO:0035360;GO:0045944;GO:0016579;GO:0006351;, C:nucleoplasm; C:PR-DUB complex;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:peroxisome proliferator activated receptor binding;, P:animal organ morphogenesis; P:positive regulation of fat cell differentiation; P:positive regulation of lipid storage; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:transcription, DNA-templated; scaffold12 indexed_genome mRNA 23516543 23679300 . + . ID=transcript_3185;Q9UE14 Q9UE15 Q9UE16,Dystrobrevin beta,Beta-dystrobrevin;, PF09068;PF09069;PF00569;, GO:0005737;GO:0005886;GO:0045202;GO:0008270;GO:0099536;, C:cytoplasm; C:plasma membrane; C:synapse;, F:zinc ion binding;, P:synaptic signaling;|Q9UE14 Q9UE15 Q9UE16,Dystrobrevin beta,Beta-dystrobrevin;, PF09068;PF09069;PF00569;, GO:0005737;GO:0005886;GO:0045202;GO:0008270;GO:0099536;, C:cytoplasm; C:plasma membrane; C:synapse;, F:zinc ion binding;, P:synaptic signaling;|Q59GK7 Q9BS59,Dystrobrevin alpha,Alpha-dystrobrevin;Dystrophin-related protein 3;, PF09068;PF09069;PF00569;, GO:0030054;GO:0005737;GO:0045111;GO:0005654;GO:0005886;GO:0032991;GO:0045202;GO:0008270;GO:0007268;GO:0007274;GO:0007165;GO:0006941;GO:0099536;, C:cell junction; C:cytoplasm; C:intermediate filament cytoskeleton; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:synapse;, F:zinc ion binding;, P:chemical synaptic transmission; P:neuromuscular synaptic transmission; P:signal transduction; P:striated muscle contraction; P:synaptic signaling; scaffold12 indexed_genome mRNA 23701671 23714363 . - . ID=transcript_3186;Q9UE14 Q9UE15 Q9UE16,Dystrobrevin beta,Beta-dystrobrevin;, PF09068;PF09069;PF00569;, GO:0005737;GO:0005886;GO:0045202;GO:0008270;GO:0099536;, C:cytoplasm; C:plasma membrane; C:synapse;, F:zinc ion binding;, P:synaptic signaling;|Q9UE14 Q9UE15 Q9UE16,Dystrobrevin beta,Beta-dystrobrevin;, PF09068;PF09069;PF00569;, GO:0005737;GO:0005886;GO:0045202;GO:0008270;GO:0099536;, C:cytoplasm; C:plasma membrane; C:synapse;, F:zinc ion binding;, P:synaptic signaling;|Q9UE14 Q9UE15 Q9UE16,Dystrobrevin beta,Beta-dystrobrevin;, PF09068;PF09069;PF00569;, GO:0005737;GO:0005886;GO:0045202;GO:0008270;GO:0099536;, C:cytoplasm; C:plasma membrane; C:synapse;, F:zinc ion binding;, P:synaptic signaling; scaffold12 indexed_genome mRNA 23780923 23847802 . + . ID=transcript_3187;Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis;|Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis;|Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis;|Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis;|Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis;|Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis;|Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis; scaffold12 indexed_genome mRNA 23848228 23848842 . + . ID=transcript_3188;Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis; scaffold12 indexed_genome mRNA 23850789 23853673 . + . ID=transcript_3189;Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis;|Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis;|Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis;|Q9Y6K1 E9PEB8 Q86TE8 Q86XF5 Q8IZV0 Q8WXU9,DNA (cytosine-5)-methyltransferase 3A,DNA methyltransferase HsaIIIA;, PF17980;PF00145;PF00855;, GO:0000775;GO:0005737;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0001741;GO:0003682;GO:0003886;GO:0003677;GO:0042802;GO:0046872;GO:0000978;GO:0003714;GO:0008134;GO:0007568;GO:0071230;GO:0071361;GO:0071456;GO:0006306;GO:0043045;GO:0043046;GO:0006346;GO:0097284;GO:0000278;GO:0045814;GO:0000122;GO:0030182;GO:0010942;GO:0006349;GO:0042220;GO:0042493;GO:0032355;GO:0010212;GO:0010288;GO:0009636;GO:0033189;GO:0007283;, C:chromosome, centromeric region; C:cytoplasm; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:XY body;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:aging; P:cellular response to amino acid stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:DNA methylation; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:DNA methylation-dependent heterochromatin assembly; P:hepatocyte apoptotic process; P:mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:positive regulation of cell death; P:regulation of gene expression by genetic imprinting; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to ionizing radiation; P:response to lead ion; P:response to toxic substance; P:response to vitamin A; P:spermatogenesis; scaffold12 indexed_genome mRNA 23908303 23909109 . + . ID=transcript_3190;P01189 P78442 Q53T23 Q9UD39 Q9UD40,Pro-opiomelanocortin,Corticotropin-lipotropin;, PF00976;PF08384;PF08035;, GO:0005737;GO:0005576;GO:0005615;GO:0005782;GO:0030141;GO:0034774;GO:0001664;GO:0005179;GO:0005102;GO:0070996;GO:0031781;GO:0031782;GO:0061844;GO:0007267;GO:0033059;GO:0019221;GO:0007186;GO:0006091;GO:0042593;GO:0031640;GO:0035821;GO:0002862;GO:0032720;GO:0007218;GO:0070965;GO:0045944;GO:0032098;GO:0008217;GO:2000852;GO:0070873;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space; C:peroxisomal matrix; C:secretory granule; C:secretory granule lumen;, F:G protein-coupled receptor binding; F:hormone activity; F:signaling receptor binding; F:type 1 melanocortin receptor binding; F:type 3 melanocortin receptor binding; F:type 4 melanocortin receptor binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell-cell signaling; P:cellular pigmentation; P:cytokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:killing of cells of other organism; P:modulation of process of other organism; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of tumor necrosis factor production; P:neuropeptide signaling pathway; P:positive regulation of neutrophil mediated killing of fungus; P:positive regulation of transcription by RNA polymerase II; P:regulation of appetite; P:regulation of blood pressure; P:regulation of corticosterone secretion; P:regulation of glycogen metabolic process; P:signal transduction; scaffold12 indexed_genome mRNA 23914805 24007351 . - . ID=transcript_3191;Q9Y2G0 B7WPL8 Q86XU6,Protein EFR3 homolog B {ECO:0000305},, , GO:0015629;GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:actin cytoskeleton; C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q9Y2G0 B7WPL8 Q86XU6,Protein EFR3 homolog B {ECO:0000305},, , GO:0015629;GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:actin cytoskeleton; C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q9Y2G0 B7WPL8 Q86XU6,Protein EFR3 homolog B {ECO:0000305},, , GO:0015629;GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:actin cytoskeleton; C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q9Y2G0 B7WPL8 Q86XU6,Protein EFR3 homolog B {ECO:0000305},, , GO:0015629;GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:actin cytoskeleton; C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane; scaffold12 indexed_genome mRNA 24048032 24088045 . + . ID=transcript_3192;Q9NZQ0 Q5JV88 Q86Y24,DnaJ homolog subfamily C member 27,Rab and DnaJ domain-containing protein;, PF00226;PF00071;, GO:0005634;GO:0005525;GO:0003924;GO:0006886;GO:0070374;GO:0071701;, C:nucleus;, F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:positive regulation of ERK1 and ERK2 cascade; P:regulation of MAPK export from nucleus; scaffold12 indexed_genome mRNA 24177901 24197513 . + . ID=transcript_3193;O60266 B3KT86 Q53T54 Q9UDB1,Adenylate cyclase type 3,ATP pyrophosphate-lyase 3;Adenylate cyclase type III;Adenylate cyclase, olfactive type;Adenylyl cyclase 3 {ECO:0000305};, PF16214;PF00211;, GO:0005929;GO:0005737;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0005516;GO:0046872;GO:0007340;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0030317;GO:0007186;GO:0002862;GO:0008355;GO:0003091;GO:0007608;GO:0007165;GO:0007338;, C:cilium; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:calmodulin binding; F:metal ion binding;, P:acrosome reaction; P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:flagellated sperm motility; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:olfactory learning; P:renal water homeostasis; P:sensory perception of smell; P:signal transduction; P:single fertilization;|O60266 B3KT86 Q53T54 Q9UDB1,Adenylate cyclase type 3,ATP pyrophosphate-lyase 3;Adenylate cyclase type III;Adenylate cyclase, olfactive type;Adenylyl cyclase 3 {ECO:0000305};, PF16214;PF00211;, GO:0005929;GO:0005737;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0005516;GO:0046872;GO:0007340;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0030317;GO:0007186;GO:0002862;GO:0008355;GO:0003091;GO:0007608;GO:0007165;GO:0007338;, C:cilium; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:calmodulin binding; F:metal ion binding;, P:acrosome reaction; P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:flagellated sperm motility; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:olfactory learning; P:renal water homeostasis; P:sensory perception of smell; P:signal transduction; P:single fertilization;|O60266 B3KT86 Q53T54 Q9UDB1,Adenylate cyclase type 3,ATP pyrophosphate-lyase 3;Adenylate cyclase type III;Adenylate cyclase, olfactive type;Adenylyl cyclase 3 {ECO:0000305};, PF16214;PF00211;, GO:0005929;GO:0005737;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0005516;GO:0046872;GO:0007340;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0030317;GO:0007186;GO:0002862;GO:0008355;GO:0003091;GO:0007608;GO:0007165;GO:0007338;, C:cilium; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:calmodulin binding; F:metal ion binding;, P:acrosome reaction; P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:flagellated sperm motility; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:olfactory learning; P:renal water homeostasis; P:sensory perception of smell; P:signal transduction; P:single fertilization;|O60266 B3KT86 Q53T54 Q9UDB1,Adenylate cyclase type 3,ATP pyrophosphate-lyase 3;Adenylate cyclase type III;Adenylate cyclase, olfactive type;Adenylyl cyclase 3 {ECO:0000305};, PF16214;PF00211;, GO:0005929;GO:0005737;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0005516;GO:0046872;GO:0007340;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0030317;GO:0007186;GO:0002862;GO:0008355;GO:0003091;GO:0007608;GO:0007165;GO:0007338;, C:cilium; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:calmodulin binding; F:metal ion binding;, P:acrosome reaction; P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:flagellated sperm motility; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:olfactory learning; P:renal water homeostasis; P:sensory perception of smell; P:signal transduction; P:single fertilization;|O60266 B3KT86 Q53T54 Q9UDB1,Adenylate cyclase type 3,ATP pyrophosphate-lyase 3;Adenylate cyclase type III;Adenylate cyclase, olfactive type;Adenylyl cyclase 3 {ECO:0000305};, PF16214;PF00211;, GO:0005929;GO:0005737;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0005516;GO:0046872;GO:0007340;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0030317;GO:0007186;GO:0002862;GO:0008355;GO:0003091;GO:0007608;GO:0007165;GO:0007338;, C:cilium; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:calmodulin binding; F:metal ion binding;, P:acrosome reaction; P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:flagellated sperm motility; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:olfactory learning; P:renal water homeostasis; P:sensory perception of smell; P:signal transduction; P:single fertilization;|O60266 B3KT86 Q53T54 Q9UDB1,Adenylate cyclase type 3,ATP pyrophosphate-lyase 3;Adenylate cyclase type III;Adenylate cyclase, olfactive type;Adenylyl cyclase 3 {ECO:0000305};, PF16214;PF00211;, GO:0005929;GO:0005737;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0005516;GO:0046872;GO:0007340;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0030317;GO:0007186;GO:0002862;GO:0008355;GO:0003091;GO:0007608;GO:0007165;GO:0007338;, C:cilium; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:calmodulin binding; F:metal ion binding;, P:acrosome reaction; P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:flagellated sperm motility; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:olfactory learning; P:renal water homeostasis; P:sensory perception of smell; P:signal transduction; P:single fertilization;|O60266 B3KT86 Q53T54 Q9UDB1,Adenylate cyclase type 3,ATP pyrophosphate-lyase 3;Adenylate cyclase type III;Adenylate cyclase, olfactive type;Adenylyl cyclase 3 {ECO:0000305};, PF16214;PF00211;, GO:0005929;GO:0005737;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0005516;GO:0046872;GO:0007340;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0030317;GO:0007186;GO:0002862;GO:0008355;GO:0003091;GO:0007608;GO:0007165;GO:0007338;, C:cilium; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:calmodulin binding; F:metal ion binding;, P:acrosome reaction; P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:flagellated sperm motility; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:olfactory learning; P:renal water homeostasis; P:sensory perception of smell; P:signal transduction; P:single fertilization;|O60266 B3KT86 Q53T54 Q9UDB1,Adenylate cyclase type 3,ATP pyrophosphate-lyase 3;Adenylate cyclase type III;Adenylate cyclase, olfactive type;Adenylyl cyclase 3 {ECO:0000305};, PF16214;PF00211;, GO:0005929;GO:0005737;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0005516;GO:0046872;GO:0007340;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0030317;GO:0007186;GO:0002862;GO:0008355;GO:0003091;GO:0007608;GO:0007165;GO:0007338;, C:cilium; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:calmodulin binding; F:metal ion binding;, P:acrosome reaction; P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:flagellated sperm motility; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:olfactory learning; P:renal water homeostasis; P:sensory perception of smell; P:signal transduction; P:single fertilization; scaffold12 indexed_genome mRNA 24197527 24214146 . - . ID=transcript_3194;Q9BU64 B2RDC0 D6W536 Q53T55 Q96JV3,Centromere protein O,Interphase centromere complex protein 36;, PF09496;, GO:0000778;GO:0005829;GO:0031511;GO:0016604;GO:0005654;GO:0034080;GO:0007052;, C:condensed nuclear chromosome kinetochore; C:cytosol; C:Mis6-Sim4 complex; C:nuclear body; C:nucleoplasm;, , P:CENP-A containing nucleosome assembly; P:mitotic spindle organization; scaffold12 indexed_genome mRNA 24227928 24330480 . - . ID=transcript_3195;Q7KYV3,Nuclear receptor coactivator 1,Class E basic helix-loop-helix protein 74;Protein Hin-2;RIP160;Renal carcinoma antigen NY-REN-52;Steroid receptor coactivator 1;, PF07469;PF00010;PF08815;PF00989;PF08832;, GO:0000785;GO:0005829;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0017162;GO:0003682;GO:0019899;GO:0030331;GO:0004402;GO:0035257;GO:0016922;GO:0030374;GO:0033142;GO:0046983;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003713;GO:0015721;GO:0032870;GO:1904017;GO:0021549;GO:0021987;GO:0044849;GO:0021766;GO:0043967;GO:0021854;GO:0030522;GO:0060713;GO:0007595;GO:0008584;GO:0060179;GO:0043065;GO:0045925;GO:0045666;GO:0045944;GO:0000435;GO:0045893;GO:2001038;GO:0019216;GO:0002155;GO:0032355;GO:0032570;GO:0032526;, C:chromatin; C:cytosol; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:aryl hydrocarbon receptor binding; F:chromatin binding; F:enzyme binding; F:estrogen receptor binding; F:histone acetyltransferase activity; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:progesterone receptor binding; F:protein dimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:bile acid and bile salt transport; P:cellular response to hormone stimulus; P:cellular response to Thyroglobulin triiodothyronine; P:cerebellum development; P:cerebral cortex development; P:estrous cycle; P:hippocampus development; P:histone H4 acetylation; P:hypothalamus development; P:intracellular receptor signaling pathway; P:labyrinthine layer morphogenesis; P:lactation; P:male gonad development; P:male mating behavior; P:positive regulation of apoptotic process; P:positive regulation of female receptivity; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter by galactose; P:positive regulation of transcription, DNA-templated; P:regulation of cellular response to drug; P:regulation of lipid metabolic process; P:regulation of thyroid hormone mediated signaling pathway; P:response to estradiol; P:response to progesterone; P:response to retinoic acid;|Q7KYV3,Nuclear receptor coactivator 1,Class E basic helix-loop-helix protein 74;Protein Hin-2;RIP160;Renal carcinoma antigen NY-REN-52;Steroid receptor coactivator 1;, PF07469;PF00010;PF08815;PF00989;PF08832;, GO:0000785;GO:0005829;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0017162;GO:0003682;GO:0019899;GO:0030331;GO:0004402;GO:0035257;GO:0016922;GO:0030374;GO:0033142;GO:0046983;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003713;GO:0015721;GO:0032870;GO:1904017;GO:0021549;GO:0021987;GO:0044849;GO:0021766;GO:0043967;GO:0021854;GO:0030522;GO:0060713;GO:0007595;GO:0008584;GO:0060179;GO:0043065;GO:0045925;GO:0045666;GO:0045944;GO:0000435;GO:0045893;GO:2001038;GO:0019216;GO:0002155;GO:0032355;GO:0032570;GO:0032526;, C:chromatin; C:cytosol; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:aryl hydrocarbon receptor binding; F:chromatin binding; F:enzyme binding; F:estrogen receptor binding; F:histone acetyltransferase activity; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:progesterone receptor binding; F:protein dimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:bile acid and bile salt transport; P:cellular response to hormone stimulus; P:cellular response to Thyroglobulin triiodothyronine; P:cerebellum development; P:cerebral cortex development; P:estrous cycle; P:hippocampus development; P:histone H4 acetylation; P:hypothalamus development; P:intracellular receptor signaling pathway; P:labyrinthine layer morphogenesis; P:lactation; P:male gonad development; P:male mating behavior; P:positive regulation of apoptotic process; P:positive regulation of female receptivity; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter by galactose; P:positive regulation of transcription, DNA-templated; P:regulation of cellular response to drug; P:regulation of lipid metabolic process; P:regulation of thyroid hormone mediated signaling pathway; P:response to estradiol; P:response to progesterone; P:response to retinoic acid;|Q7KYV3,Nuclear receptor coactivator 1,Class E basic helix-loop-helix protein 74;Protein Hin-2;RIP160;Renal carcinoma antigen NY-REN-52;Steroid receptor coactivator 1;, PF07469;PF00010;PF08815;PF00989;PF08832;, GO:0000785;GO:0005829;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0017162;GO:0003682;GO:0019899;GO:0030331;GO:0004402;GO:0035257;GO:0016922;GO:0030374;GO:0033142;GO:0046983;GO:0047485;GO:0044877;GO:0046965;GO:0000977;GO:0003713;GO:0015721;GO:0032870;GO:1904017;GO:0021549;GO:0021987;GO:0044849;GO:0021766;GO:0043967;GO:0021854;GO:0030522;GO:0060713;GO:0007595;GO:0008584;GO:0060179;GO:0043065;GO:0045925;GO:0045666;GO:0045944;GO:0000435;GO:0045893;GO:2001038;GO:0019216;GO:0002155;GO:0032355;GO:0032570;GO:0032526;, C:chromatin; C:cytosol; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:aryl hydrocarbon receptor binding; F:chromatin binding; F:enzyme binding; F:estrogen receptor binding; F:histone acetyltransferase activity; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:progesterone receptor binding; F:protein dimerization activity; F:protein N-terminus binding; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:bile acid and bile salt transport; P:cellular response to hormone stimulus; P:cellular response to Thyroglobulin triiodothyronine; P:cerebellum development; P:cerebral cortex development; P:estrous cycle; P:hippocampus development; P:histone H4 acetylation; P:hypothalamus development; P:intracellular receptor signaling pathway; P:labyrinthine layer morphogenesis; P:lactation; P:male gonad development; P:male mating behavior; P:positive regulation of apoptotic process; P:positive regulation of female receptivity; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter by galactose; P:positive regulation of transcription, DNA-templated; P:regulation of cellular response to drug; P:regulation of lipid metabolic process; P:regulation of thyroid hormone mediated signaling pathway; P:response to estradiol; P:response to progesterone; P:response to retinoic acid; scaffold12 indexed_genome mRNA 24649009 24649687 . + . ID=transcript_3196;Q9NZM3 O95062 Q15812 Q9HAK4 Q9NXE6 Q9NYG0 Q9NZM2 Q9ULG4,Intersectin-2,SH3 domain-containing protein 1B;SH3P18;SH3P18-like WASP-associated protein;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0005813;GO:0005905;GO:0005737;GO:0070062;GO:0098793;GO:0005509;GO:0005085;GO:0060090;GO:0030154;GO:0150007;GO:0006897;GO:0016197;GO:1903861;GO:0016032;, C:centrosome; C:clathrin-coated pit; C:cytoplasm; C:extracellular exosome; C:presynapse;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:cell differentiation; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:positive regulation of dendrite extension; P:viral process; scaffold12 indexed_genome mRNA 24653066 24656266 . + . ID=transcript_3197;Q9NZM3 O95062 Q15812 Q9HAK4 Q9NXE6 Q9NYG0 Q9NZM2 Q9ULG4,Intersectin-2,SH3 domain-containing protein 1B;SH3P18;SH3P18-like WASP-associated protein;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0005813;GO:0005905;GO:0005737;GO:0070062;GO:0098793;GO:0005509;GO:0005085;GO:0060090;GO:0030154;GO:0150007;GO:0006897;GO:0016197;GO:1903861;GO:0016032;, C:centrosome; C:clathrin-coated pit; C:cytoplasm; C:extracellular exosome; C:presynapse;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:cell differentiation; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:positive regulation of dendrite extension; P:viral process; scaffold12 indexed_genome mRNA 24676993 24685891 . + . ID=transcript_3198;Q9NZM3 O95062 Q15812 Q9HAK4 Q9NXE6 Q9NYG0 Q9NZM2 Q9ULG4,Intersectin-2,SH3 domain-containing protein 1B;SH3P18;SH3P18-like WASP-associated protein;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0005813;GO:0005905;GO:0005737;GO:0070062;GO:0098793;GO:0005509;GO:0005085;GO:0060090;GO:0030154;GO:0150007;GO:0006897;GO:0016197;GO:1903861;GO:0016032;, C:centrosome; C:clathrin-coated pit; C:cytoplasm; C:extracellular exosome; C:presynapse;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:cell differentiation; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:positive regulation of dendrite extension; P:viral process;|Q9NZM3 O95062 Q15812 Q9HAK4 Q9NXE6 Q9NYG0 Q9NZM2 Q9ULG4,Intersectin-2,SH3 domain-containing protein 1B;SH3P18;SH3P18-like WASP-associated protein;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0005813;GO:0005905;GO:0005737;GO:0070062;GO:0098793;GO:0005509;GO:0005085;GO:0060090;GO:0030154;GO:0150007;GO:0006897;GO:0016197;GO:1903861;GO:0016032;, C:centrosome; C:clathrin-coated pit; C:cytoplasm; C:extracellular exosome; C:presynapse;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:cell differentiation; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:positive regulation of dendrite extension; P:viral process;|Q9NZM3 O95062 Q15812 Q9HAK4 Q9NXE6 Q9NYG0 Q9NZM2 Q9ULG4,Intersectin-2,SH3 domain-containing protein 1B;SH3P18;SH3P18-like WASP-associated protein;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0005813;GO:0005905;GO:0005737;GO:0070062;GO:0098793;GO:0005509;GO:0005085;GO:0060090;GO:0030154;GO:0150007;GO:0006897;GO:0016197;GO:1903861;GO:0016032;, C:centrosome; C:clathrin-coated pit; C:cytoplasm; C:extracellular exosome; C:presynapse;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:cell differentiation; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:positive regulation of dendrite extension; P:viral process;|Q9NZM3 O95062 Q15812 Q9HAK4 Q9NXE6 Q9NYG0 Q9NZM2 Q9ULG4,Intersectin-2,SH3 domain-containing protein 1B;SH3P18;SH3P18-like WASP-associated protein;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0005813;GO:0005905;GO:0005737;GO:0070062;GO:0098793;GO:0005509;GO:0005085;GO:0060090;GO:0030154;GO:0150007;GO:0006897;GO:0016197;GO:1903861;GO:0016032;, C:centrosome; C:clathrin-coated pit; C:cytoplasm; C:extracellular exosome; C:presynapse;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:cell differentiation; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:positive regulation of dendrite extension; P:viral process;|Q9NZM3 O95062 Q15812 Q9HAK4 Q9NXE6 Q9NYG0 Q9NZM2 Q9ULG4,Intersectin-2,SH3 domain-containing protein 1B;SH3P18;SH3P18-like WASP-associated protein;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0005813;GO:0005905;GO:0005737;GO:0070062;GO:0098793;GO:0005509;GO:0005085;GO:0060090;GO:0030154;GO:0150007;GO:0006897;GO:0016197;GO:1903861;GO:0016032;, C:centrosome; C:clathrin-coated pit; C:cytoplasm; C:extracellular exosome; C:presynapse;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:cell differentiation; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:positive regulation of dendrite extension; P:viral process;|Q9NZM3 O95062 Q15812 Q9HAK4 Q9NXE6 Q9NYG0 Q9NZM2 Q9ULG4,Intersectin-2,SH3 domain-containing protein 1B;SH3P18;SH3P18-like WASP-associated protein;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0005813;GO:0005905;GO:0005737;GO:0070062;GO:0098793;GO:0005509;GO:0005085;GO:0060090;GO:0030154;GO:0150007;GO:0006897;GO:0016197;GO:1903861;GO:0016032;, C:centrosome; C:clathrin-coated pit; C:cytoplasm; C:extracellular exosome; C:presynapse;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:cell differentiation; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:positive regulation of dendrite extension; P:viral process; scaffold12 indexed_genome mRNA 24687850 24696967 . - . ID=transcript_3199;P0C875 A0A087WZA1,Protein FAM228B scaffold12 indexed_genome mRNA 24700215 24700924 . + . ID=transcript_3200;Q86W67,Protein FAM228A scaffold12 indexed_genome mRNA 24706177 24715523 . + . ID=transcript_3201;P0C875 A0A087WZA1,Protein FAM228B|P0C875 A0A087WZA1,Protein FAM228B scaffold12 indexed_genome mRNA 24715845 24716583 . + . ID=transcript_3202;P0C875 A0A087WZA1,Protein FAM228B scaffold12 indexed_genome mRNA 24716666 24726206 . - . ID=transcript_3203;P0C875 A0A087WZA1,Protein FAM228B|P0C875 A0A087WZA1,Protein FAM228B|P0C875 A0A087WZA1,Protein FAM228B|P0C875 A0A087WZA1,Protein FAM228B|P0C875 A0A087WZA1,Protein FAM228B|P0C875 A0A087WZA1,Protein FAM228B scaffold12 indexed_genome mRNA 24735220 24754309 . + . ID=transcript_3204;Q53FA7 D6W533 O14679 O14685 Q38G78 Q6JLE7 Q9BWB8,Quinone oxidoreductase PIG3,Tumor protein p53-inducible protein 3;p53-induced gene 3 protein;, PF08240;PF00107;, GO:0005829;GO:0070402;GO:0003960;GO:0042803;GO:0048038;GO:0006739;GO:0042981;, C:cytosol;, F:NADPH binding; F:NADPH:quinone reductase activity; F:protein homodimerization activity; F:quinone binding;, P:NADP metabolic process; P:regulation of apoptotic process;|Q53FA7 D6W533 O14679 O14685 Q38G78 Q6JLE7 Q9BWB8,Quinone oxidoreductase PIG3,Tumor protein p53-inducible protein 3;p53-induced gene 3 protein;, PF08240;PF00107;, GO:0005829;GO:0070402;GO:0003960;GO:0042803;GO:0048038;GO:0006739;GO:0042981;, C:cytosol;, F:NADPH binding; F:NADPH:quinone reductase activity; F:protein homodimerization activity; F:quinone binding;, P:NADP metabolic process; P:regulation of apoptotic process;|Q53FA7 D6W533 O14679 O14685 Q38G78 Q6JLE7 Q9BWB8,Quinone oxidoreductase PIG3,Tumor protein p53-inducible protein 3;p53-induced gene 3 protein;, PF08240;PF00107;, GO:0005829;GO:0070402;GO:0003960;GO:0042803;GO:0048038;GO:0006739;GO:0042981;, C:cytosol;, F:NADPH binding; F:NADPH:quinone reductase activity; F:protein homodimerization activity; F:quinone binding;, P:NADP metabolic process; P:regulation of apoptotic process;|Q9H9Z2,Protein lin-28 homolog A,Zinc finger CCHC domain-containing protein 1;, PF00313;PF00098;, GO:0005737;GO:0010494;GO:0005829;GO:0005730;GO:0005634;GO:0000932;GO:0005844;GO:1990904;GO:0005791;GO:0002151;GO:0035198;GO:1905538;GO:0003723;GO:1990825;GO:0031369;GO:0008270;GO:0071333;GO:0007281;GO:0010587;GO:0045686;GO:0017148;GO:1901724;GO:2000767;GO:0045666;GO:1903800;GO:0051897;GO:0032008;GO:0031054;GO:0071076;GO:0031123;GO:0035019;GO:0048863;GO:0019827;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleolus; C:nucleus; C:P-body; C:polysome; C:ribonucleoprotein complex; C:rough endoplasmic reticulum;, F:G-quadruplex RNA binding; F:miRNA binding; F:polysome binding; F:RNA binding; F:sequence-specific mRNA binding; F:translation initiation factor binding; F:zinc ion binding;, P:cellular response to glucose stimulus; P:germ cell development; P:miRNA catabolic process; P:negative regulation of glial cell differentiation; P:negative regulation of translation; P:positive regulation of cell proliferation involved in kidney development; P:positive regulation of cytoplasmic translation; P:positive regulation of neuron differentiation; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein kinase B signaling; P:positive regulation of TOR signaling; P:pre-miRNA processing; P:RNA 3' uridylation; P:RNA 3'-end processing; P:somatic stem cell population maintenance; P:stem cell differentiation; P:stem cell population maintenance;|Q53FA7 D6W533 O14679 O14685 Q38G78 Q6JLE7 Q9BWB8,Quinone oxidoreductase PIG3,Tumor protein p53-inducible protein 3;p53-induced gene 3 protein;, PF08240;PF00107;, GO:0005829;GO:0070402;GO:0003960;GO:0042803;GO:0048038;GO:0006739;GO:0042981;, C:cytosol;, F:NADPH binding; F:NADPH:quinone reductase activity; F:protein homodimerization activity; F:quinone binding;, P:NADP metabolic process; P:regulation of apoptotic process;|Q9Y3B4 Q53TM1,Splicing factor 3B subunit 6,Pre-mRNA branch site protein p14;SF3b 14 kDa subunit;Spliceosome-associated protein, 14-kDa;Splicing factor 3b, subunit 6, 14kDa;, PF00076;, GO:0071013;GO:0005654;GO:0005634;GO:0071011;GO:0005689;GO:0005686;GO:0005684;GO:0003729;GO:0003723;GO:0001825;GO:0000398;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type spliceosomal complex;, F:mRNA binding; F:RNA binding;, P:blastocyst formation; P:mRNA splicing, via spliceosome;|Q9Y3B4 Q53TM1,Splicing factor 3B subunit 6,Pre-mRNA branch site protein p14;SF3b 14 kDa subunit;Spliceosome-associated protein, 14-kDa;Splicing factor 3b, subunit 6, 14kDa;, PF00076;, GO:0071013;GO:0005654;GO:0005634;GO:0071011;GO:0005689;GO:0005686;GO:0005684;GO:0003729;GO:0003723;GO:0001825;GO:0000398;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type spliceosomal complex;, F:mRNA binding; F:RNA binding;, P:blastocyst formation; P:mRNA splicing, via spliceosome; scaffold12 indexed_genome mRNA 24758642 24769486 . - . ID=transcript_3205;P68106 Q13664 Q16645 Q53TM2 Q9BQ40,Peptidyl-prolyl cis-trans isomerase FKBP1B,12.6 kDa FK506-binding protein;FK506-binding protein 1B;Immunophilin FKBP12.6;Rotamase;h-FKBP-12;, PF00254;, GO:0034704;GO:0005737;GO:0005829;GO:0016020;GO:0033017;GO:0030018;GO:0019855;GO:0030551;GO:0005528;GO:0044325;GO:0003755;GO:0005102;GO:0006458;GO:0035584;GO:0086064;GO:0061077;GO:0030073;GO:0034220;GO:0010459;GO:0061179;GO:0032515;GO:0051280;GO:0060315;GO:0019227;GO:0048680;GO:0051284;GO:0022417;GO:0000413;GO:0042026;GO:1903779;GO:0010881;GO:0051480;GO:0010880;GO:0060314;GO:0051209;GO:0009749;GO:0042542;GO:0051775;GO:0033197;GO:0006939;GO:0042098;, C:calcium channel complex; C:cytoplasm; C:cytosol; C:membrane; C:sarcoplasmic reticulum membrane; C:Z disc;, F:calcium channel inhibitor activity; F:cyclic nucleotide binding; F:FK506 binding; F:ion channel binding; F:peptidyl-prolyl cis-trans isomerase activity; F:signaling receptor binding;, P:'de novo' protein folding; P:calcium-mediated signaling using intracellular calcium source; P:cell communication by electrical coupling involved in cardiac conduction; P:chaperone-mediated protein folding; P:insulin secretion; P:ion transmembrane transport; P:negative regulation of heart rate; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of release of sequestered calcium ion into cytosol; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:neuronal action potential propagation; P:positive regulation of axon regeneration; P:positive regulation of sequestering of calcium ion; P:protein maturation by protein folding; P:protein peptidyl-prolyl isomerization; P:protein refolding; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:release of sequestered calcium ion into cytosol; P:response to glucose; P:response to hydrogen peroxide; P:response to redox state; P:response to vitamin E; P:smooth muscle contraction; P:T cell proliferation;|P68106 Q13664 Q16645 Q53TM2 Q9BQ40,Peptidyl-prolyl cis-trans isomerase FKBP1B,12.6 kDa FK506-binding protein;FK506-binding protein 1B;Immunophilin FKBP12.6;Rotamase;h-FKBP-12;, PF00254;, GO:0034704;GO:0005737;GO:0005829;GO:0016020;GO:0033017;GO:0030018;GO:0019855;GO:0030551;GO:0005528;GO:0044325;GO:0003755;GO:0005102;GO:0006458;GO:0035584;GO:0086064;GO:0061077;GO:0030073;GO:0034220;GO:0010459;GO:0061179;GO:0032515;GO:0051280;GO:0060315;GO:0019227;GO:0048680;GO:0051284;GO:0022417;GO:0000413;GO:0042026;GO:1903779;GO:0010881;GO:0051480;GO:0010880;GO:0060314;GO:0051209;GO:0009749;GO:0042542;GO:0051775;GO:0033197;GO:0006939;GO:0042098;, C:calcium channel complex; C:cytoplasm; C:cytosol; C:membrane; C:sarcoplasmic reticulum membrane; C:Z disc;, F:calcium channel inhibitor activity; F:cyclic nucleotide binding; F:FK506 binding; F:ion channel binding; F:peptidyl-prolyl cis-trans isomerase activity; F:signaling receptor binding;, P:'de novo' protein folding; P:calcium-mediated signaling using intracellular calcium source; P:cell communication by electrical coupling involved in cardiac conduction; P:chaperone-mediated protein folding; P:insulin secretion; P:ion transmembrane transport; P:negative regulation of heart rate; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of release of sequestered calcium ion into cytosol; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:neuronal action potential propagation; P:positive regulation of axon regeneration; P:positive regulation of sequestering of calcium ion; P:protein maturation by protein folding; P:protein peptidyl-prolyl isomerization; P:protein refolding; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:release of sequestered calcium ion into cytosol; P:response to glucose; P:response to hydrogen peroxide; P:response to redox state; P:response to vitamin E; P:smooth muscle contraction; P:T cell proliferation; scaffold12 indexed_genome mRNA 24771263 24786451 . + . ID=transcript_3206;Q9H6R7 D6W532 Q8IYK0 Q9HBP5,WD repeat and coiled-coil-containing protein {ECO:0000305},, PF15390;, GO:0019900;GO:0051259;, , F:kinase binding;, P:protein complex oligomerization;|Q9H6R7 D6W532 Q8IYK0 Q9HBP5,WD repeat and coiled-coil-containing protein {ECO:0000305},, PF15390;, GO:0019900;GO:0051259;, , F:kinase binding;, P:protein complex oligomerization;|Q9H6R7 D6W532 Q8IYK0 Q9HBP5,WD repeat and coiled-coil-containing protein {ECO:0000305},, PF15390;, GO:0019900;GO:0051259;, , F:kinase binding;, P:protein complex oligomerization;|Q9H6R7 D6W532 Q8IYK0 Q9HBP5,WD repeat and coiled-coil-containing protein {ECO:0000305},, PF15390;, GO:0019900;GO:0051259;, , F:kinase binding;, P:protein complex oligomerization; scaffold12 indexed_genome mRNA 24798759 24801927 . - . ID=transcript_3207;A6NFX1 B5MC32 J3KNU6,Major facilitator superfamily domain-containing protein 2B {ECO:0000305},, , GO:0005887;GO:0046624;GO:0015293;GO:0008643;GO:0006869;GO:0071702;, C:integral component of plasma membrane;, F:sphingolipid transporter activity; F:symporter activity;, P:carbohydrate transport; P:lipid transport; P:organic substance transport; scaffold12 indexed_genome mRNA 24849032 24945490 . + . ID=transcript_3208;Q9ULI0 B9ZVQ5 Q6ZNA6 Q8N9E7,ATPase family AAA domain-containing protein 2B,, PF00004;PF17862;PF00439;, GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0042393;GO:0070577;GO:0031936;GO:0045944;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:histone binding; F:lysine-acetylated histone binding;, P:negative regulation of chromatin silencing; P:positive regulation of transcription by RNA polymerase II;|Q9ULI0 B9ZVQ5 Q6ZNA6 Q8N9E7,ATPase family AAA domain-containing protein 2B,, PF00004;PF17862;PF00439;, GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0042393;GO:0070577;GO:0031936;GO:0045944;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:histone binding; F:lysine-acetylated histone binding;, P:negative regulation of chromatin silencing; P:positive regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 24947140 24971882 . + . ID=transcript_3209;Q9ULI0 B9ZVQ5 Q6ZNA6 Q8N9E7,ATPase family AAA domain-containing protein 2B,, PF00004;PF17862;PF00439;, GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0042393;GO:0070577;GO:0031936;GO:0045944;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:histone binding; F:lysine-acetylated histone binding;, P:negative regulation of chromatin silencing; P:positive regulation of transcription by RNA polymerase II;|Q9ULI0 B9ZVQ5 Q6ZNA6 Q8N9E7,ATPase family AAA domain-containing protein 2B,, PF00004;PF17862;PF00439;, GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0042393;GO:0070577;GO:0031936;GO:0045944;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:histone binding; F:lysine-acetylated histone binding;, P:negative regulation of chromatin silencing; P:positive regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 24997405 25024331 . + . ID=transcript_3210;Q96CT2 Q8N388 Q96BF0 Q96PW7,Kelch-like protein 29,Kelch repeat and BTB domain-containing protein 9;, PF07707;PF00651;PF01344;|Q96CT2 Q8N388 Q96BF0 Q96PW7,Kelch-like protein 29,Kelch repeat and BTB domain-containing protein 9;, PF07707;PF00651;PF01344; scaffold12 indexed_genome mRNA 25066343 25068655 . - . ID=transcript_3211;Q96CT2 Q8N388 Q96BF0 Q96PW7,Kelch-like protein 29,Kelch repeat and BTB domain-containing protein 9;, PF07707;PF00651;PF01344; scaffold12 indexed_genome mRNA 25142637 25325357 . - . ID=transcript_3212;Q96CT2 Q8N388 Q96BF0 Q96PW7,Kelch-like protein 29,Kelch repeat and BTB domain-containing protein 9;, PF07707;PF00651;PF01344; scaffold12 indexed_genome mRNA 27520843 27566197 . + . ID=transcript_3213;Q13788 Q4ZG63 Q53QC8 Q7Z600 Q9UMN0,Apolipoprotein B-100,, PF12491;PF06448;PF09172;PF01347;, GO:0042627;GO:0034360;GO:0030669;GO:0005737;GO:0005829;GO:0005769;GO:0071682;GO:0070971;GO:0005788;GO:0005789;GO:0031904;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0034363;GO:0043231;GO:0005811;GO:0034362;GO:0043202;GO:0034359;GO:0043025;GO:0005886;GO:0005790;GO:0034361;GO:0031983;GO:0120020;GO:0008201;GO:0035473;GO:0050750;GO:0005543;GO:0048844;GO:0044267;GO:0071379;GO:0071356;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0034378;GO:0034382;GO:0034371;GO:0009566;GO:0030317;GO:0001701;GO:0050900;GO:0042158;GO:0042159;GO:0042953;GO:0034383;GO:0034374;GO:0061024;GO:0007399;GO:0010886;GO:0010628;GO:0010884;GO:0010744;GO:0009791;GO:0043687;GO:0006898;GO:0045540;GO:0009743;GO:0032355;GO:0032496;GO:0010269;GO:0009615;GO:0001523;GO:0007283;GO:0002224;GO:0019433;GO:0006642;GO:0034379;GO:0034447;, C:chylomicron; C:chylomicron remnant; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytosol; C:early endosome; C:endocytic vesicle lumen; C:endoplasmic reticulum exit site; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endosome lumen; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:intermediate-density lipoprotein particle; C:intracellular membrane-bounded organelle; C:lipid droplet; C:low-density lipoprotein particle; C:lysosomal lumen; C:mature chylomicron; C:neuronal cell body; C:plasma membrane; C:smooth endoplasmic reticulum; C:very-low-density lipoprotein particle; C:vesicle lumen;, F:cholesterol transfer activity; F:heparin binding; F:lipase binding; F:low-density lipoprotein particle receptor binding; F:phospholipid binding;, P:artery morphogenesis; P:cellular protein metabolic process; P:cellular response to prostaglandin stimulus; P:cellular response to tumor necrosis factor; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:chylomicron assembly; P:chylomicron remnant clearance; P:chylomicron remodeling; P:fertilization; P:flagellated sperm motility; P:in utero embryonic development; P:leukocyte migration; P:lipoprotein biosynthetic process; P:lipoprotein catabolic process; P:lipoprotein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle remodeling; P:membrane organization; P:nervous system development; P:positive regulation of cholesterol storage; P:positive regulation of gene expression; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:post-embryonic development; P:post-translational protein modification; P:receptor-mediated endocytosis; P:regulation of cholesterol biosynthetic process; P:response to carbohydrate; P:response to estradiol; P:response to lipopolysaccharide; P:response to selenium ion; P:response to virus; P:retinoid metabolic process; P:spermatogenesis; P:toll-like receptor signaling pathway; P:triglyceride catabolic process; P:triglyceride mobilization; P:very-low-density lipoprotein particle assembly; P:very-low-density lipoprotein particle clearance;|Q13788 Q4ZG63 Q53QC8 Q7Z600 Q9UMN0,Apolipoprotein B-100,, PF12491;PF06448;PF09172;PF01347;, GO:0042627;GO:0034360;GO:0030669;GO:0005737;GO:0005829;GO:0005769;GO:0071682;GO:0070971;GO:0005788;GO:0005789;GO:0031904;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0034363;GO:0043231;GO:0005811;GO:0034362;GO:0043202;GO:0034359;GO:0043025;GO:0005886;GO:0005790;GO:0034361;GO:0031983;GO:0120020;GO:0008201;GO:0035473;GO:0050750;GO:0005543;GO:0048844;GO:0044267;GO:0071379;GO:0071356;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0034378;GO:0034382;GO:0034371;GO:0009566;GO:0030317;GO:0001701;GO:0050900;GO:0042158;GO:0042159;GO:0042953;GO:0034383;GO:0034374;GO:0061024;GO:0007399;GO:0010886;GO:0010628;GO:0010884;GO:0010744;GO:0009791;GO:0043687;GO:0006898;GO:0045540;GO:0009743;GO:0032355;GO:0032496;GO:0010269;GO:0009615;GO:0001523;GO:0007283;GO:0002224;GO:0019433;GO:0006642;GO:0034379;GO:0034447;, C:chylomicron; C:chylomicron remnant; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytosol; C:early endosome; C:endocytic vesicle lumen; C:endoplasmic reticulum exit site; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endosome lumen; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:intermediate-density lipoprotein particle; C:intracellular membrane-bounded organelle; C:lipid droplet; C:low-density lipoprotein particle; C:lysosomal lumen; C:mature chylomicron; C:neuronal cell body; C:plasma membrane; C:smooth endoplasmic reticulum; C:very-low-density lipoprotein particle; C:vesicle lumen;, F:cholesterol transfer activity; F:heparin binding; F:lipase binding; F:low-density lipoprotein particle receptor binding; F:phospholipid binding;, P:artery morphogenesis; P:cellular protein metabolic process; P:cellular response to prostaglandin stimulus; P:cellular response to tumor necrosis factor; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:chylomicron assembly; P:chylomicron remnant clearance; P:chylomicron remodeling; P:fertilization; P:flagellated sperm motility; P:in utero embryonic development; P:leukocyte migration; P:lipoprotein biosynthetic process; P:lipoprotein catabolic process; P:lipoprotein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle remodeling; P:membrane organization; P:nervous system development; P:positive regulation of cholesterol storage; P:positive regulation of gene expression; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:post-embryonic development; P:post-translational protein modification; P:receptor-mediated endocytosis; P:regulation of cholesterol biosynthetic process; P:response to carbohydrate; P:response to estradiol; P:response to lipopolysaccharide; P:response to selenium ion; P:response to virus; P:retinoid metabolic process; P:spermatogenesis; P:toll-like receptor signaling pathway; P:triglyceride catabolic process; P:triglyceride mobilization; P:very-low-density lipoprotein particle assembly; P:very-low-density lipoprotein particle clearance; scaffold12 indexed_genome mRNA 27718314 27822157 . + . ID=transcript_3214;Q9H6V9 B7ZA47 B7ZAJ5 D6W530 E7ESN0 Q53T37 Q53T58,Lipid droplet-associated hydrolase {ECO:0000312|HGNC:HGNC:26145},Lipid droplet-associated serine hydrolase {ECO:0000303|PubMed:24357060};, PF10230;, GO:0005783;GO:0005811;GO:0016298;GO:0016042;GO:0019915;, C:endoplasmic reticulum; C:lipid droplet;, F:lipase activity;, P:lipid catabolic process; P:lipid storage; scaffold12 indexed_genome mRNA 28031962 28034416 . - . ID=transcript_3215;P62745 B2R692 P01121 Q5U0H6 Q7RTN5 Q7RTR9 Q9CUV7,Rho-related GTP-binding protein RhoB,Rho cDNA clone 6;, PF00071;, GO:0005938;GO:0042995;GO:0032154;GO:0031410;GO:0005856;GO:0005829;GO:0005769;GO:0010008;GO:0070062;GO:0005925;GO:0043231;GO:0031902;GO:0005634;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0001525;GO:0006915;GO:0007155;GO:0030154;GO:0016477;GO:0070301;GO:0071479;GO:0030865;GO:0008333;GO:0061154;GO:0007163;GO:0007186;GO:0006886;GO:0000281;GO:0045786;GO:0030336;GO:0045766;GO:0043065;GO:0010595;GO:0032956;GO:0030334;GO:0008360;GO:0051056;GO:0007266;, C:cell cortex; C:cell projection; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:early endosome; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:nucleus; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:angiogenesis; P:apoptotic process; P:cell adhesion; P:cell differentiation; P:cell migration; P:cellular response to hydrogen peroxide; P:cellular response to ionizing radiation; P:cortical cytoskeleton organization; P:endosome to lysosome transport; P:endothelial tube morphogenesis; P:establishment or maintenance of cell polarity; P:G protein-coupled receptor signaling pathway; P:intracellular protein transport; P:mitotic cytokinesis; P:negative regulation of cell cycle; P:negative regulation of cell migration; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of endothelial cell migration; P:regulation of actin cytoskeleton organization; P:regulation of cell migration; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold12 indexed_genome mRNA 28145071 28174503 . + . ID=transcript_3216;Q8TB72 B3KSL0 B4E2B6 D6W527 O00234 Q53TV7 Q8WY43 Q9HAN2,Pumilio homolog 2,, PF00806;, GO:0005737;GO:0010494;GO:0005829;GO:0031965;GO:0048471;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:2000637;GO:1900246;GO:0010608;GO:0035196;GO:0051983;GO:0060964;GO:0043488;GO:0006417;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm;, F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:positive regulation of gene silencing by miRNA; P:positive regulation of RIG-I signaling pathway; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of chromosome segregation; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of translation; P:stress granule assembly; scaffold12 indexed_genome mRNA 28183453 28219404 . - . ID=transcript_3217;Q8TB72 B3KSL0 B4E2B6 D6W527 O00234 Q53TV7 Q8WY43 Q9HAN2,Pumilio homolog 2,, PF00806;, GO:0005737;GO:0010494;GO:0005829;GO:0031965;GO:0048471;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:2000637;GO:1900246;GO:0010608;GO:0035196;GO:0051983;GO:0060964;GO:0043488;GO:0006417;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm;, F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:positive regulation of gene silencing by miRNA; P:positive regulation of RIG-I signaling pathway; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of chromosome segregation; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of translation; P:stress granule assembly;|Q8TB72 B3KSL0 B4E2B6 D6W527 O00234 Q53TV7 Q8WY43 Q9HAN2,Pumilio homolog 2,, PF00806;, GO:0005737;GO:0010494;GO:0005829;GO:0031965;GO:0048471;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:2000637;GO:1900246;GO:0010608;GO:0035196;GO:0051983;GO:0060964;GO:0043488;GO:0006417;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm;, F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:positive regulation of gene silencing by miRNA; P:positive regulation of RIG-I signaling pathway; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of chromosome segregation; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of translation; P:stress granule assembly;|Q8TB72 B3KSL0 B4E2B6 D6W527 O00234 Q53TV7 Q8WY43 Q9HAN2,Pumilio homolog 2,, PF00806;, GO:0005737;GO:0010494;GO:0005829;GO:0031965;GO:0048471;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:2000637;GO:1900246;GO:0010608;GO:0035196;GO:0051983;GO:0060964;GO:0043488;GO:0006417;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm;, F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:positive regulation of gene silencing by miRNA; P:positive regulation of RIG-I signaling pathway; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of chromosome segregation; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of translation; P:stress granule assembly; scaffold12 indexed_genome mRNA 28259488 28264011 . + . ID=transcript_3218;P18827 D6W523 Q53QV0 Q546D3 Q96HB7,Syndecan-1,, PF01034;, GO:0009986;GO:0009897;GO:0070062;GO:0005796;GO:0005887;GO:0043202;GO:0005886;GO:0032991;GO:0042802;GO:0008022;GO:0060070;GO:0016477;GO:0019221;GO:0006024;GO:0006027;GO:0006954;GO:0050900;GO:0048627;GO:0042476;GO:1903543;GO:1903553;GO:0051592;GO:0051591;GO:0051384;GO:0042542;GO:0009636;GO:0001523;GO:0060009;GO:0055002;GO:0001657;GO:0042060;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:Golgi lumen; C:integral component of plasma membrane; C:lysosomal lumen; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:protein C-terminus binding;, P:canonical Wnt signaling pathway; P:cell migration; P:cytokine-mediated signaling pathway; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inflammatory response; P:leukocyte migration; P:myoblast development; P:odontogenesis; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:response to calcium ion; P:response to cAMP; P:response to glucocorticoid; P:response to hydrogen peroxide; P:response to toxic substance; P:retinoid metabolic process; P:Sertoli cell development; P:striated muscle cell development; P:ureteric bud development; P:wound healing;|P18827 D6W523 Q53QV0 Q546D3 Q96HB7,Syndecan-1,, PF01034;, GO:0009986;GO:0009897;GO:0070062;GO:0005796;GO:0005887;GO:0043202;GO:0005886;GO:0032991;GO:0042802;GO:0008022;GO:0060070;GO:0016477;GO:0019221;GO:0006024;GO:0006027;GO:0006954;GO:0050900;GO:0048627;GO:0042476;GO:1903543;GO:1903553;GO:0051592;GO:0051591;GO:0051384;GO:0042542;GO:0009636;GO:0001523;GO:0060009;GO:0055002;GO:0001657;GO:0042060;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:Golgi lumen; C:integral component of plasma membrane; C:lysosomal lumen; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:protein C-terminus binding;, P:canonical Wnt signaling pathway; P:cell migration; P:cytokine-mediated signaling pathway; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inflammatory response; P:leukocyte migration; P:myoblast development; P:odontogenesis; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:response to calcium ion; P:response to cAMP; P:response to glucocorticoid; P:response to hydrogen peroxide; P:response to toxic substance; P:retinoid metabolic process; P:Sertoli cell development; P:striated muscle cell development; P:ureteric bud development; P:wound healing; scaffold12 indexed_genome mRNA 28401031 28416979 . + . ID=transcript_3219;Q15012 Q6UW22,Lysosomal-associated transmembrane protein 4A,Golgi 4-transmembrane-spanning transporter MTP;, PF03821;, GO:0005794;GO:0016021;GO:0031902;GO:0005765;, C:Golgi apparatus; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane;|Q15012 Q6UW22,Lysosomal-associated transmembrane protein 4A,Golgi 4-transmembrane-spanning transporter MTP;, PF03821;, GO:0005794;GO:0016021;GO:0031902;GO:0005765;, C:Golgi apparatus; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane;|Q15012 Q6UW22,Lysosomal-associated transmembrane protein 4A,Golgi 4-transmembrane-spanning transporter MTP;, PF03821;, GO:0005794;GO:0016021;GO:0031902;GO:0005765;, C:Golgi apparatus; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane;|Q15012 Q6UW22,Lysosomal-associated transmembrane protein 4A,Golgi 4-transmembrane-spanning transporter MTP;, PF03821;, GO:0005794;GO:0016021;GO:0031902;GO:0005765;, C:Golgi apparatus; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane;|Q15012 Q6UW22,Lysosomal-associated transmembrane protein 4A,Golgi 4-transmembrane-spanning transporter MTP;, PF03821;, GO:0005794;GO:0016021;GO:0031902;GO:0005765;, C:Golgi apparatus; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; scaffold12 indexed_genome mRNA 28446593 28474506 . + . ID=transcript_3220;Q9P2L0 B3KVI5 Q4ZG01 Q8NE11,WD repeat-containing protein 35 {ECO:0000305},Intraflagellar transport protein 121 homolog;, PF12894;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0071333;GO:1990830;GO:1905705;GO:0071356;GO:0060271;GO:0035721;GO:0042073;GO:0035735;GO:0097421;GO:0010629;GO:0045019;GO:0043065;GO:0043280;GO:0090200;GO:0061512;GO:0032496;GO:0009636;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A;, , P:cellular response to glucose stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to paclitaxel; P:cellular response to tumor necrosis factor; P:cilium assembly; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:liver regeneration; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of release of cytochrome c from mitochondria; P:protein localization to cilium; P:response to lipopolysaccharide; P:response to toxic substance;|Q9P2L0 B3KVI5 Q4ZG01 Q8NE11,WD repeat-containing protein 35 {ECO:0000305},Intraflagellar transport protein 121 homolog;, PF12894;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0071333;GO:1990830;GO:1905705;GO:0071356;GO:0060271;GO:0035721;GO:0042073;GO:0035735;GO:0097421;GO:0010629;GO:0045019;GO:0043065;GO:0043280;GO:0090200;GO:0061512;GO:0032496;GO:0009636;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A;, , P:cellular response to glucose stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to paclitaxel; P:cellular response to tumor necrosis factor; P:cilium assembly; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:liver regeneration; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of release of cytochrome c from mitochondria; P:protein localization to cilium; P:response to lipopolysaccharide; P:response to toxic substance; scaffold12 indexed_genome mRNA 28477678 28499610 . + . ID=transcript_3221;Q9P2L0 B3KVI5 Q4ZG01 Q8NE11,WD repeat-containing protein 35 {ECO:0000305},Intraflagellar transport protein 121 homolog;, PF12894;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0071333;GO:1990830;GO:1905705;GO:0071356;GO:0060271;GO:0035721;GO:0042073;GO:0035735;GO:0097421;GO:0010629;GO:0045019;GO:0043065;GO:0043280;GO:0090200;GO:0061512;GO:0032496;GO:0009636;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A;, , P:cellular response to glucose stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to paclitaxel; P:cellular response to tumor necrosis factor; P:cilium assembly; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:liver regeneration; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of release of cytochrome c from mitochondria; P:protein localization to cilium; P:response to lipopolysaccharide; P:response to toxic substance;|Q9P2L0 B3KVI5 Q4ZG01 Q8NE11,WD repeat-containing protein 35 {ECO:0000305},Intraflagellar transport protein 121 homolog;, PF12894;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0071333;GO:1990830;GO:1905705;GO:0071356;GO:0060271;GO:0035721;GO:0042073;GO:0035735;GO:0097421;GO:0010629;GO:0045019;GO:0043065;GO:0043280;GO:0090200;GO:0061512;GO:0032496;GO:0009636;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A;, , P:cellular response to glucose stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to paclitaxel; P:cellular response to tumor necrosis factor; P:cilium assembly; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:liver regeneration; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of release of cytochrome c from mitochondria; P:protein localization to cilium; P:response to lipopolysaccharide; P:response to toxic substance;|Q9P2L0 B3KVI5 Q4ZG01 Q8NE11,WD repeat-containing protein 35 {ECO:0000305},Intraflagellar transport protein 121 homolog;, PF12894;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0071333;GO:1990830;GO:1905705;GO:0071356;GO:0060271;GO:0035721;GO:0042073;GO:0035735;GO:0097421;GO:0010629;GO:0045019;GO:0043065;GO:0043280;GO:0090200;GO:0061512;GO:0032496;GO:0009636;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A;, , P:cellular response to glucose stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to paclitaxel; P:cellular response to tumor necrosis factor; P:cilium assembly; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:liver regeneration; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of release of cytochrome c from mitochondria; P:protein localization to cilium; P:response to lipopolysaccharide; P:response to toxic substance;|Q9P2L0 B3KVI5 Q4ZG01 Q8NE11,WD repeat-containing protein 35 {ECO:0000305},Intraflagellar transport protein 121 homolog;, PF12894;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0071333;GO:1990830;GO:1905705;GO:0071356;GO:0060271;GO:0035721;GO:0042073;GO:0035735;GO:0097421;GO:0010629;GO:0045019;GO:0043065;GO:0043280;GO:0090200;GO:0061512;GO:0032496;GO:0009636;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A;, , P:cellular response to glucose stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to paclitaxel; P:cellular response to tumor necrosis factor; P:cilium assembly; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:liver regeneration; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of release of cytochrome c from mitochondria; P:protein localization to cilium; P:response to lipopolysaccharide; P:response to toxic substance;|Q9P2L0 B3KVI5 Q4ZG01 Q8NE11,WD repeat-containing protein 35 {ECO:0000305},Intraflagellar transport protein 121 homolog;, PF12894;, GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0071333;GO:1990830;GO:1905705;GO:0071356;GO:0060271;GO:0035721;GO:0042073;GO:0035735;GO:0097421;GO:0010629;GO:0045019;GO:0043065;GO:0043280;GO:0090200;GO:0061512;GO:0032496;GO:0009636;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A;, , P:cellular response to glucose stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to paclitaxel; P:cellular response to tumor necrosis factor; P:cilium assembly; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:liver regeneration; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of release of cytochrome c from mitochondria; P:protein localization to cilium; P:response to lipopolysaccharide; P:response to toxic substance; scaffold12 indexed_genome mRNA 28504417 28511318 . + . ID=transcript_3222;Q5I0X7,Tetratricopeptide repeat protein 32,, PF00515;|Q5I0X7,Tetratricopeptide repeat protein 32,, PF00515;|Q5I0X7,Tetratricopeptide repeat protein 32,, PF00515; scaffold12 indexed_genome mRNA 29010279 29011964 . + . ID=transcript_3223;Q8TAX0 B3KV97 D6W521,Protein odd-skipped-related 1,, PF00096;, GO:0000785;GO:0005829;GO:0019898;GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0030154;GO:0072111;GO:0071300;GO:0002062;GO:0042733;GO:0035115;GO:0035116;GO:0072498;GO:0060272;GO:0036023;GO:0008406;GO:0007507;GO:0048389;GO:0072143;GO:0072180;GO:0001823;GO:0090094;GO:0072207;GO:0072239;GO:0072259;GO:0072162;GO:0072075;GO:0072133;GO:0072234;GO:0072208;GO:0042474;GO:0043066;GO:1905408;GO:0030857;GO:0072183;GO:2000650;GO:0000122;GO:0042476;GO:0072268;GO:0030501;GO:0050679;GO:2000543;GO:0010628;GO:0045944;GO:0072166;GO:0048793;GO:0006357;GO:0072184;GO:0060021;GO:0072168;GO:0072169;GO:0048863;GO:0072190;GO:0001657;GO:0001655;, C:chromatin; C:cytosol; C:extrinsic component of membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:cell proliferation involved in kidney development; P:cellular response to retinoic acid; P:chondrocyte differentiation; P:embryonic digit morphogenesis; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:embryonic skeletal joint development; P:embryonic skeletal joint morphogenesis; P:embryonic skeletal limb joint morphogenesis; P:gonad development; P:heart development; P:intermediate mesoderm development; P:mesangial cell development; P:mesonephric duct morphogenesis; P:mesonephros development; P:metanephric cap mesenchymal cell proliferation involved in metanephros development; P:metanephric epithelium development; P:metanephric glomerulus vasculature development; P:metanephric interstitial fibroblast development; P:metanephric mesenchymal cell differentiation; P:metanephric mesenchyme development; P:metanephric mesenchyme morphogenesis; P:metanephric nephron tubule development; P:metanephric smooth muscle tissue development; P:middle ear morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of creatine transmembrane transporter activity; P:negative regulation of epithelial cell differentiation; P:negative regulation of nephron tubule epithelial cell differentiation; P:negative regulation of sodium ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis; P:pattern specification involved in metanephros development; P:positive regulation of bone mineralization; P:positive regulation of epithelial cell proliferation; P:positive regulation of gastrulation; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:posterior mesonephric tubule development; P:pronephros development; P:regulation of transcription by RNA polymerase II; P:renal vesicle progenitor cell differentiation; P:roof of mouth development; P:specification of anterior mesonephric tubule identity; P:specification of posterior mesonephric tubule identity; P:stem cell differentiation; P:ureter urothelium development; P:ureteric bud development; P:urogenital system development; scaffold12 indexed_genome mRNA 29733918 29740889 . + . ID=transcript_3224;Q9HBH5,Retinol dehydrogenase 14 {ECO:0000305},Alcohol dehydrogenase PAN2 {ECO:0000303|PubMed:12435598};Short chain dehydrogenase/reductase family 7C member 4;, PF00106;, GO:0005829;GO:0005783;GO:0005789;GO:0005765;GO:0016020;GO:0005654;GO:0005634;GO:0102354;GO:0052650;GO:0001649;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:lysosomal membrane; C:membrane; C:nucleoplasm; C:nucleus;, F:11-cis-retinol dehydrogenase activity; F:NADP-retinol dehydrogenase activity;, P:osteoblast differentiation; scaffold12 indexed_genome mRNA 30250193 30275637 . - . ID=transcript_3225;Q9BQ31 D6W520 O43651 Q4ZFY1 Q96B56,Potassium voltage-gated channel subfamily S member 3,Delayed-rectifier K(+) channel alpha subunit 3;Voltage-gated potassium channel subunit Kv9.3;, PF02214;PF00520;, GO:0005829;GO:0005794;GO:0016021;GO:0005886;GO:0008076;GO:0005251;GO:0015459;GO:0005249;GO:0071805;GO:0006813;GO:0051260;GO:0050796;GO:0034765;, C:cytosol; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:potassium channel regulator activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; scaffold12 indexed_genome mRNA 30408651 30476967 . + . ID=transcript_3226;Q96SB8 A8K8Q6 D6W518 Q05BV4 Q9H0X3 Q9H6M0,Structural maintenance of chromosomes protein 6,, PF02463;, GO:0000775;GO:0000781;GO:0035061;GO:0097431;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0000803;GO:0035861;GO:0030915;GO:0005524;GO:0031625;GO:0006974;GO:0090398;GO:0006281;GO:0051984;GO:0000722;, C:chromosome, centromeric region; C:chromosome, telomeric region; C:interchromatin granule; C:mitotic spindle pole; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body; C:sex chromosome; C:site of double-strand break; C:Smc5-Smc6 complex;, F:ATP binding; F:ubiquitin protein ligase binding;, P:cellular response to DNA damage stimulus; P:cellular senescence; P:DNA repair; P:positive regulation of chromosome segregation; P:telomere maintenance via recombination;|Q96SB8 A8K8Q6 D6W518 Q05BV4 Q9H0X3 Q9H6M0,Structural maintenance of chromosomes protein 6,, PF02463;, GO:0000775;GO:0000781;GO:0035061;GO:0097431;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0000803;GO:0035861;GO:0030915;GO:0005524;GO:0031625;GO:0006974;GO:0090398;GO:0006281;GO:0051984;GO:0000722;, C:chromosome, centromeric region; C:chromosome, telomeric region; C:interchromatin granule; C:mitotic spindle pole; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body; C:sex chromosome; C:site of double-strand break; C:Smc5-Smc6 complex;, F:ATP binding; F:ubiquitin protein ligase binding;, P:cellular response to DNA damage stimulus; P:cellular senescence; P:DNA repair; P:positive regulation of chromosome segregation; P:telomere maintenance via recombination;|Q96SB8 A8K8Q6 D6W518 Q05BV4 Q9H0X3 Q9H6M0,Structural maintenance of chromosomes protein 6,, PF02463;, GO:0000775;GO:0000781;GO:0035061;GO:0097431;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0000803;GO:0035861;GO:0030915;GO:0005524;GO:0031625;GO:0006974;GO:0090398;GO:0006281;GO:0051984;GO:0000722;, C:chromosome, centromeric region; C:chromosome, telomeric region; C:interchromatin granule; C:mitotic spindle pole; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body; C:sex chromosome; C:site of double-strand break; C:Smc5-Smc6 complex;, F:ATP binding; F:ubiquitin protein ligase binding;, P:cellular response to DNA damage stimulus; P:cellular senescence; P:DNA repair; P:positive regulation of chromosome segregation; P:telomere maintenance via recombination;|Q96SB8 A8K8Q6 D6W518 Q05BV4 Q9H0X3 Q9H6M0,Structural maintenance of chromosomes protein 6,, PF02463;, GO:0000775;GO:0000781;GO:0035061;GO:0097431;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0000803;GO:0035861;GO:0030915;GO:0005524;GO:0031625;GO:0006974;GO:0090398;GO:0006281;GO:0051984;GO:0000722;, C:chromosome, centromeric region; C:chromosome, telomeric region; C:interchromatin granule; C:mitotic spindle pole; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body; C:sex chromosome; C:site of double-strand break; C:Smc5-Smc6 complex;, F:ATP binding; F:ubiquitin protein ligase binding;, P:cellular response to DNA damage stimulus; P:cellular senescence; P:DNA repair; P:positive regulation of chromosome segregation; P:telomere maintenance via recombination; scaffold12 indexed_genome mRNA 30488886 30601231 . - . ID=transcript_3227;P62760 D6W515 P28677 P29103 P42323 Q9UM20,Visinin-like protein 1,Hippocalcin-like protein 3;, PF00036;PF13499;, GO:0005829;GO:0016020;GO:0005509;GO:0046676;GO:0045921;GO:0035774;, C:cytosol; C:membrane;, F:calcium ion binding;, P:negative regulation of insulin secretion; P:positive regulation of exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|P62760 D6W515 P28677 P29103 P42323 Q9UM20,Visinin-like protein 1,Hippocalcin-like protein 3;, PF00036;PF13499;, GO:0005829;GO:0016020;GO:0005509;GO:0046676;GO:0045921;GO:0035774;, C:cytosol; C:membrane;, F:calcium ion binding;, P:negative regulation of insulin secretion; P:positive regulation of exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; scaffold12 indexed_genome mRNA 31409564 31426551 . + . ID=transcript_3228;Q9H0Q0 B3KNZ1 Q53QW2,CYFIP-related Rac1 interactor A {ECO:0000305},Protein CYRIA;, PF07159;, GO:0016020;GO:0031267;GO:0030833;, C:membrane;, F:small GTPase binding;, P:regulation of actin filament polymerization;|Q9H0Q0 B3KNZ1 Q53QW2,CYFIP-related Rac1 interactor A {ECO:0000305},Protein CYRIA;, PF07159;, GO:0016020;GO:0031267;GO:0030833;, C:membrane;, F:small GTPase binding;, P:regulation of actin filament polymerization;|Q9H0Q0 B3KNZ1 Q53QW2,CYFIP-related Rac1 interactor A {ECO:0000305},Protein CYRIA;, PF07159;, GO:0016020;GO:0031267;GO:0030833;, C:membrane;, F:small GTPase binding;, P:regulation of actin filament polymerization;|Q9H0Q0 B3KNZ1 Q53QW2,CYFIP-related Rac1 interactor A {ECO:0000305},Protein CYRIA;, PF07159;, GO:0016020;GO:0031267;GO:0030833;, C:membrane;, F:small GTPase binding;, P:regulation of actin filament polymerization; scaffold12 indexed_genome mRNA 31927112 31928360 . + . ID=transcript_3229;P04198 Q53XS5 Q6LDT9,N-myc proto-oncogene protein,Class E basic helix-loop-helix protein 37;, PF00010;PF01056;, GO:0000785;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0019900;GO:0046983;GO:0000978;GO:1990837;GO:0010629;GO:0010628;GO:1903800;GO:0045944;GO:0045893;GO:0006357;, C:chromatin; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:kinase binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 32194564 32233235 . + . ID=transcript_3230;Q92499 B4DME8 B4DPN6,ATP-dependent RNA helicase DDX1,DEAD box protein 1;DEAD box protein retinoblastoma;, PF00270;PF00271;PF00622;, GO:0071920;GO:0005737;GO:0010494;GO:0005829;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:1990904;GO:0072669;GO:0005524;GO:0003682;GO:0003677;GO:0033677;GO:0004527;GO:0004386;GO:0004518;GO:0008143;GO:0003723;GO:0003724;GO:0003712;GO:0051607;GO:0032508;GO:0006302;GO:0045087;GO:0007275;GO:0090305;GO:0043123;GO:1903608;GO:0006446;GO:0000245;GO:0006388;GO:0016032;, C:cleavage body; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:tRNA-splicing ligase complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA/RNA helicase activity; F:exonuclease activity; F:helicase activity; F:nuclease activity; F:poly(A) binding; F:RNA binding; F:RNA helicase activity; F:transcription coregulator activity;, P:defense response to virus; P:DNA duplex unwinding; P:double-strand break repair; P:innate immune response; P:multicellular organism development; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein localization to cytoplasmic stress granule; P:regulation of translational initiation; P:spliceosomal complex assembly; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:viral process;|Q92499 B4DME8 B4DPN6,ATP-dependent RNA helicase DDX1,DEAD box protein 1;DEAD box protein retinoblastoma;, PF00270;PF00271;PF00622;, GO:0071920;GO:0005737;GO:0010494;GO:0005829;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:1990904;GO:0072669;GO:0005524;GO:0003682;GO:0003677;GO:0033677;GO:0004527;GO:0004386;GO:0004518;GO:0008143;GO:0003723;GO:0003724;GO:0003712;GO:0051607;GO:0032508;GO:0006302;GO:0045087;GO:0007275;GO:0090305;GO:0043123;GO:1903608;GO:0006446;GO:0000245;GO:0006388;GO:0016032;, C:cleavage body; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:tRNA-splicing ligase complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA/RNA helicase activity; F:exonuclease activity; F:helicase activity; F:nuclease activity; F:poly(A) binding; F:RNA binding; F:RNA helicase activity; F:transcription coregulator activity;, P:defense response to virus; P:DNA duplex unwinding; P:double-strand break repair; P:innate immune response; P:multicellular organism development; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein localization to cytoplasmic stress granule; P:regulation of translational initiation; P:spliceosomal complex assembly; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:viral process;|Q92499 B4DME8 B4DPN6,ATP-dependent RNA helicase DDX1,DEAD box protein 1;DEAD box protein retinoblastoma;, PF00270;PF00271;PF00622;, GO:0071920;GO:0005737;GO:0010494;GO:0005829;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:1990904;GO:0072669;GO:0005524;GO:0003682;GO:0003677;GO:0033677;GO:0004527;GO:0004386;GO:0004518;GO:0008143;GO:0003723;GO:0003724;GO:0003712;GO:0051607;GO:0032508;GO:0006302;GO:0045087;GO:0007275;GO:0090305;GO:0043123;GO:1903608;GO:0006446;GO:0000245;GO:0006388;GO:0016032;, C:cleavage body; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:tRNA-splicing ligase complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA/RNA helicase activity; F:exonuclease activity; F:helicase activity; F:nuclease activity; F:poly(A) binding; F:RNA binding; F:RNA helicase activity; F:transcription coregulator activity;, P:defense response to virus; P:DNA duplex unwinding; P:double-strand break repair; P:innate immune response; P:multicellular organism development; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein localization to cytoplasmic stress granule; P:regulation of translational initiation; P:spliceosomal complex assembly; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:viral process;|Q92499 B4DME8 B4DPN6,ATP-dependent RNA helicase DDX1,DEAD box protein 1;DEAD box protein retinoblastoma;, PF00270;PF00271;PF00622;, GO:0071920;GO:0005737;GO:0010494;GO:0005829;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:1990904;GO:0072669;GO:0005524;GO:0003682;GO:0003677;GO:0033677;GO:0004527;GO:0004386;GO:0004518;GO:0008143;GO:0003723;GO:0003724;GO:0003712;GO:0051607;GO:0032508;GO:0006302;GO:0045087;GO:0007275;GO:0090305;GO:0043123;GO:1903608;GO:0006446;GO:0000245;GO:0006388;GO:0016032;, C:cleavage body; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:tRNA-splicing ligase complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA/RNA helicase activity; F:exonuclease activity; F:helicase activity; F:nuclease activity; F:poly(A) binding; F:RNA binding; F:RNA helicase activity; F:transcription coregulator activity;, P:defense response to virus; P:DNA duplex unwinding; P:double-strand break repair; P:innate immune response; P:multicellular organism development; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein localization to cytoplasmic stress granule; P:regulation of translational initiation; P:spliceosomal complex assembly; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:viral process;|Q92499 B4DME8 B4DPN6,ATP-dependent RNA helicase DDX1,DEAD box protein 1;DEAD box protein retinoblastoma;, PF00270;PF00271;PF00622;, GO:0071920;GO:0005737;GO:0010494;GO:0005829;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:1990904;GO:0072669;GO:0005524;GO:0003682;GO:0003677;GO:0033677;GO:0004527;GO:0004386;GO:0004518;GO:0008143;GO:0003723;GO:0003724;GO:0003712;GO:0051607;GO:0032508;GO:0006302;GO:0045087;GO:0007275;GO:0090305;GO:0043123;GO:1903608;GO:0006446;GO:0000245;GO:0006388;GO:0016032;, C:cleavage body; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:tRNA-splicing ligase complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA/RNA helicase activity; F:exonuclease activity; F:helicase activity; F:nuclease activity; F:poly(A) binding; F:RNA binding; F:RNA helicase activity; F:transcription coregulator activity;, P:defense response to virus; P:DNA duplex unwinding; P:double-strand break repair; P:innate immune response; P:multicellular organism development; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein localization to cytoplasmic stress granule; P:regulation of translational initiation; P:spliceosomal complex assembly; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:viral process; scaffold12 indexed_genome mRNA 32253517 32567427 . + . ID=transcript_3231;A2RRP1 O95790 Q2VPJ7 Q53TK6 Q86V39 Q8NFY8 Q9Y3W5,Neuroblastoma-amplified sequence,Neuroblastoma-amplified gene protein;, PF15492;PF08314;, GO:0005829;GO:0070939;GO:0005783;GO:0005789;GO:0016020;GO:0000149;GO:2000623;GO:0000956;GO:0015031;GO:0006890;, C:cytosol; C:Dsl1/NZR complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane;, F:SNARE binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA catabolic process; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|A2RRP1 O95790 Q2VPJ7 Q53TK6 Q86V39 Q8NFY8 Q9Y3W5,Neuroblastoma-amplified sequence,Neuroblastoma-amplified gene protein;, PF15492;PF08314;, GO:0005829;GO:0070939;GO:0005783;GO:0005789;GO:0016020;GO:0000149;GO:2000623;GO:0000956;GO:0015031;GO:0006890;, C:cytosol; C:Dsl1/NZR complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane;, F:SNARE binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA catabolic process; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|A2RRP1 O95790 Q2VPJ7 Q53TK6 Q86V39 Q8NFY8 Q9Y3W5,Neuroblastoma-amplified sequence,Neuroblastoma-amplified gene protein;, PF15492;PF08314;, GO:0005829;GO:0070939;GO:0005783;GO:0005789;GO:0016020;GO:0000149;GO:2000623;GO:0000956;GO:0015031;GO:0006890;, C:cytosol; C:Dsl1/NZR complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane;, F:SNARE binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA catabolic process; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold12 indexed_genome mRNA 33016305 33016890 . + . ID=transcript_3232;Q96KN4 A6NP76 Q86UZ2 Q8NAH7 Q8TAM5,Protein LRATD1 {ECO:0000305},LRAT domain-containing 1 {ECO:0000312|HGNC:HGNC:20743};Neurologic sensory protein 1;Protein FAM84A;, PF04970;, GO:0005737;GO:0000902;GO:0048870;, C:cytoplasm;, , P:cell morphogenesis; P:cell motility; scaffold12 indexed_genome mRNA 34349923 34378445 . - . ID=transcript_3233;Q92519 B2R851 D6W510,Tribbles homolog 2,, PF00069;, GO:0005737;GO:0005856;GO:0005634;GO:0031434;GO:0004860;GO:0008134;GO:0031625;GO:0055106;GO:0045599;GO:0032693;GO:0006469;GO:0032436;GO:0006468;GO:0043405;, C:cytoplasm; C:cytoskeleton; C:nucleus;, F:mitogen-activated protein kinase kinase binding; F:protein kinase inhibitor activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase regulator activity;, P:negative regulation of fat cell differentiation; P:negative regulation of interleukin-10 production; P:negative regulation of protein kinase activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein phosphorylation; P:regulation of MAP kinase activity; scaffold12 indexed_genome mRNA 35155317 35210379 . - . ID=transcript_3234;F5GY24 Q53T25,Phosphatidate phosphatase LPIN1 {ECO:0000305},Lipin-1 {ECO:0000250|UniProtKB:Q91ZP3};, PF16876;PF04571;PF08235;, GO:0005737;GO:0005829;GO:0005789;GO:0005741;GO:0005635;GO:0031965;GO:0005654;GO:0005634;GO:0008195;GO:0003713;GO:0031100;GO:0044255;GO:0032869;GO:0009062;GO:0007077;GO:0046473;GO:0006656;GO:0006646;GO:0120162;GO:0045944;GO:0019432;GO:0006642;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:nuclear envelope; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:animal organ regeneration; P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:mitotic nuclear envelope disassembly; P:phosphatidic acid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process; P:triglyceride mobilization; scaffold12 indexed_genome mRNA 35293256 35300917 . + . ID=transcript_3235;O95665 Q53QQ5 Q57Z87 Q8IY58 Q8TBH6,Neurotensin receptor type 2,Levocabastine-sensitive neurotensin receptor;, PF00001;, GO:0005887;GO:0005886;GO:0016492;GO:0004930;GO:0007166;GO:0007186;GO:0007200;GO:0042391;GO:0007600;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled neurotensin receptor activity; F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:regulation of membrane potential; P:sensory perception; scaffold12 indexed_genome mRNA 35308303 35310227 . - . ID=transcript_3236;Q4ZG55 A6NHD0 A6NKN0 B5MDA9 O60321 Q7Z5S2 Q9H2Q6 Q9H2Q7 Q9H2Q8,Protein GREB1,Gene regulated in breast cancer 1 protein;, PF15782;, GO:0070062;GO:0016021;GO:0005654;GO:0007275;, C:extracellular exosome; C:integral component of membrane; C:nucleoplasm;, , P:multicellular organism development; scaffold12 indexed_genome mRNA 35311036 35315674 . - . ID=transcript_3237;Q4ZG55 A6NHD0 A6NKN0 B5MDA9 O60321 Q7Z5S2 Q9H2Q6 Q9H2Q7 Q9H2Q8,Protein GREB1,Gene regulated in breast cancer 1 protein;, PF15782;, GO:0070062;GO:0016021;GO:0005654;GO:0007275;, C:extracellular exosome; C:integral component of membrane; C:nucleoplasm;, , P:multicellular organism development; scaffold12 indexed_genome mRNA 35474743 35475730 . - . ID=transcript_3238;O75461 A8K2Z8 G5E936 O60544 Q53QY9 Q6Q9Z6 Q7Z2H6,Transcription factor E2F6 {ECO:0000305},, PF16421;PF02319;, GO:0000785;GO:0071339;GO:0005654;GO:0005634;GO:0090575;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:0070317;GO:0000122;GO:0006357;GO:0000083;, C:chromatin; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; scaffold12 indexed_genome mRNA 35476909 35478299 . - . ID=transcript_3239;O75461 A8K2Z8 G5E936 O60544 Q53QY9 Q6Q9Z6 Q7Z2H6,Transcription factor E2F6 {ECO:0000305},, PF16421;PF02319;, GO:0000785;GO:0071339;GO:0005654;GO:0005634;GO:0090575;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:0070317;GO:0000122;GO:0006357;GO:0000083;, C:chromatin; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; scaffold12 indexed_genome mRNA 35621295 35702969 . + . ID=transcript_3240;O75116 Q53QZ0 Q53SJ7 Q9UQN5,Rho-associated protein kinase 2,Rho kinase 2;Rho-associated, coiled-coil-containing protein kinase 2;Rho-associated, coiled-coil-containing protein kinase II;p164 ROCK-2;, PF00069;PF08912;, GO:0005813;GO:0005737;GO:0036464;GO:0005856;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0072518;GO:0003723;GO:0031267;GO:0005198;GO:0048156;GO:0050321;GO:0031032;GO:0003180;GO:0097746;GO:1905145;GO:0071394;GO:0051298;GO:0030866;GO:0048598;GO:0048013;GO:0007186;GO:0007249;GO:0000281;GO:0061157;GO:0016525;GO:1903347;GO:0070168;GO:0010629;GO:0035509;GO:0045019;GO:0150033;GO:0018105;GO:0018107;GO:1902993;GO:1902004;GO:1902961;GO:0010613;GO:0030335;GO:0010825;GO:0032723;GO:1905205;GO:0010595;GO:0090271;GO:0010628;GO:0043410;GO:1902966;GO:0001934;GO:0051496;GO:0072659;GO:0006468;GO:0032956;GO:0110061;GO:0030155;GO:1901888;GO:2000145;GO:1900037;GO:0042752;GO:2000114;GO:1903140;GO:0051893;GO:0045616;GO:0031644;GO:0051246;GO:0051492;GO:1990776;GO:0002931;GO:0071559;GO:0007266;GO:0048511;GO:0006939;GO:0048010;GO:0039694;, C:centrosome; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoskeleton; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:Rho-dependent protein serine/threonine kinase activity; F:RNA binding; F:small GTPase binding; F:structural molecule activity; F:tau protein binding; F:tau-protein kinase activity;, P:actomyosin structure organization; P:aortic valve morphogenesis; P:blood vessel diameter maintenance; P:cellular response to acetylcholine; P:cellular response to testosterone stimulus; P:centrosome duplication; P:cortical actin cytoskeleton organization; P:embryonic morphogenesis; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:mitotic cytokinesis; P:mRNA destabilization; P:negative regulation of angiogenesis; P:negative regulation of bicellular tight junction assembly; P:negative regulation of biomineral tissue development; P:negative regulation of gene expression; P:negative regulation of myosin-light-chain-phosphatase activity; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of protein localization to lysosome; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of amyloid precursor protein catabolic process; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell migration; P:positive regulation of centrosome duplication; P:positive regulation of connective tissue growth factor production; P:positive regulation of connective tissue replacement; P:positive regulation of endothelial cell migration; P:positive regulation of fibroblast growth factor production; P:positive regulation of gene expression; P:positive regulation of MAPK cascade; P:positive regulation of protein localization to early endosome; P:positive regulation of protein phosphorylation; P:positive regulation of stress fiber assembly; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of angiotensin-activated signaling pathway; P:regulation of cell adhesion; P:regulation of cell junction assembly; P:regulation of cell motility; P:regulation of cellular response to hypoxia; P:regulation of circadian rhythm; P:regulation of establishment of cell polarity; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of keratinocyte differentiation; P:regulation of nervous system process; P:regulation of protein metabolic process; P:regulation of stress fiber assembly; P:response to angiotensin; P:response to ischemia; P:response to transforming growth factor beta; P:Rho protein signal transduction; P:rhythmic process; P:smooth muscle contraction; P:vascular endothelial growth factor receptor signaling pathway; P:viral RNA genome replication; scaffold12 indexed_genome mRNA 35706748 35719760 . - . ID=transcript_3241;Q8N755 B2R8K1 B4DWA4,Solute carrier family 66 member 3 {ECO:0000305},PQ-loop repeat-containing protein 3 {ECO:0000305};, PF04193;, GO:0016021;, C:integral component of membrane; scaffold12 indexed_genome mRNA 35945709 36033227 . + . ID=transcript_3242;Q15084 B3KY95 B5MCQ5 B7Z254 B7Z4M8 F8WA83 Q53RC7 Q6ZSH5 Q99778,Protein disulfide-isomerase A6,Endoplasmic reticulum protein 5;Protein disulfide isomerase P5;Thioredoxin domain-containing protein 7;, PF00085;, GO:0005829;GO:0005783;GO:0034663;GO:0005788;GO:0005789;GO:0005793;GO:0070062;GO:0005615;GO:0042470;GO:0005886;GO:0015037;GO:0003756;GO:0044267;GO:0036498;GO:0043687;GO:0006457;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular space; C:melanosome; C:plasma membrane;, F:peptide disulfide oxidoreductase activity; F:protein disulfide isomerase activity;, P:cellular protein metabolic process; P:IRE1-mediated unfolded protein response; P:post-translational protein modification; P:protein folding;|Q15084 B3KY95 B5MCQ5 B7Z254 B7Z4M8 F8WA83 Q53RC7 Q6ZSH5 Q99778,Protein disulfide-isomerase A6,Endoplasmic reticulum protein 5;Protein disulfide isomerase P5;Thioredoxin domain-containing protein 7;, PF00085;, GO:0005829;GO:0005783;GO:0034663;GO:0005788;GO:0005789;GO:0005793;GO:0070062;GO:0005615;GO:0042470;GO:0005886;GO:0015037;GO:0003756;GO:0044267;GO:0036498;GO:0043687;GO:0006457;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular space; C:melanosome; C:plasma membrane;, F:peptide disulfide oxidoreductase activity; F:protein disulfide isomerase activity;, P:cellular protein metabolic process; P:IRE1-mediated unfolded protein response; P:post-translational protein modification; P:protein folding;|Q15084 B3KY95 B5MCQ5 B7Z254 B7Z4M8 F8WA83 Q53RC7 Q6ZSH5 Q99778,Protein disulfide-isomerase A6,Endoplasmic reticulum protein 5;Protein disulfide isomerase P5;Thioredoxin domain-containing protein 7;, PF00085;, GO:0005829;GO:0005783;GO:0034663;GO:0005788;GO:0005789;GO:0005793;GO:0070062;GO:0005615;GO:0042470;GO:0005886;GO:0015037;GO:0003756;GO:0044267;GO:0036498;GO:0043687;GO:0006457;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular space; C:melanosome; C:plasma membrane;, F:peptide disulfide oxidoreductase activity; F:protein disulfide isomerase activity;, P:cellular protein metabolic process; P:IRE1-mediated unfolded protein response; P:post-translational protein modification; P:protein folding;|Q8NEY4 Q96EL8,V-type proton ATPase subunit C 2,Vacuolar proton pump subunit C 2;, PF03223;, GO:0005829;GO:0070062;GO:0005765;GO:0000221;GO:0042802;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:0030177;GO:0016241;GO:0033572;, C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:vacuolar proton-transporting V-type ATPase, V1 domain;, F:identical protein binding; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:positive regulation of Wnt signaling pathway; P:regulation of macroautophagy; P:transferrin transport;|Q8NEY4 Q96EL8,V-type proton ATPase subunit C 2,Vacuolar proton pump subunit C 2;, PF03223;, GO:0005829;GO:0070062;GO:0005765;GO:0000221;GO:0042802;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:0030177;GO:0016241;GO:0033572;, C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:vacuolar proton-transporting V-type ATPase, V1 domain;, F:identical protein binding; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:positive regulation of Wnt signaling pathway; P:regulation of macroautophagy; P:transferrin transport; scaffold12 indexed_genome mRNA 36072896 36151752 . + . ID=transcript_3243;Q9BSC4 A8K3R5 B4DLV0 Q53RC9 Q96TA5 Q9H7Y7 Q9H855,Nucleolar protein 10,, PF08159;, GO:0005730;GO:0032040;GO:0003723;GO:0000462;, C:nucleolus; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q9BSC4 A8K3R5 B4DLV0 Q53RC9 Q96TA5 Q9H7Y7 Q9H855,Nucleolar protein 10,, PF08159;, GO:0005730;GO:0032040;GO:0003723;GO:0000462;, C:nucleolus; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q9BSC4 A8K3R5 B4DLV0 Q53RC9 Q96TA5 Q9H7Y7 Q9H855,Nucleolar protein 10,, PF08159;, GO:0005730;GO:0032040;GO:0003723;GO:0000462;, C:nucleolus; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); scaffold12 indexed_genome mRNA 36283084 36287700 . + . ID=transcript_3244;P11926 Q53TU3 Q6LDS9,Ornithine decarboxylase,, PF02784;PF00278;, GO:0005737;GO:0005829;GO:0048471;GO:0004586;GO:0042803;GO:0006595;GO:0033387;GO:0006521;GO:0042176;GO:0009615;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ornithine decarboxylase activity; F:protein homodimerization activity;, P:polyamine metabolic process; P:putrescine biosynthetic process from ornithine; P:regulation of cellular amino acid metabolic process; P:regulation of protein catabolic process; P:response to virus;|P11926 Q53TU3 Q6LDS9,Ornithine decarboxylase,, PF02784;PF00278;, GO:0005737;GO:0005829;GO:0048471;GO:0004586;GO:0042803;GO:0006595;GO:0033387;GO:0006521;GO:0042176;GO:0009615;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ornithine decarboxylase activity; F:protein homodimerization activity;, P:polyamine metabolic process; P:putrescine biosynthetic process from ornithine; P:regulation of cellular amino acid metabolic process; P:regulation of protein catabolic process; P:response to virus;|P11926 Q53TU3 Q6LDS9,Ornithine decarboxylase,, PF02784;PF00278;, GO:0005737;GO:0005829;GO:0048471;GO:0004586;GO:0042803;GO:0006595;GO:0033387;GO:0006521;GO:0042176;GO:0009615;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:ornithine decarboxylase activity; F:protein homodimerization activity;, P:polyamine metabolic process; P:putrescine biosynthetic process from ornithine; P:regulation of cellular amino acid metabolic process; P:regulation of protein catabolic process; P:response to virus; scaffold12 indexed_genome mRNA 36296308 36300853 . - . ID=transcript_3245;P37235 Q969S5,Hippocalcin-like protein 1,Calcium-binding protein BDR-1;HLP2;Visinin-like protein 3;, PF13499;PF13833;, GO:0016020;GO:0005509;, C:membrane;, F:calcium ion binding;|P84074 B2R9T3 D3DPQ7 P32076 P41211 P70510,Neuron-specific calcium-binding protein hippocalcin {ECO:0000305},Calcium-binding protein BDR-2;, PF13499;PF13833;, GO:0030424;GO:0005737;GO:0005829;GO:0032839;GO:0032590;GO:0044327;GO:0019898;GO:0098978;GO:0032809;GO:0043204;GO:0003779;GO:0005509;GO:0042802;GO:0019900;GO:0031584;GO:0007420;GO:0019722;GO:0071277;GO:0071257;GO:1904009;GO:0048839;GO:0031283;GO:0045762;GO:0090314;GO:0099149;GO:1901385;GO:1904010;GO:1901986;GO:1902065;GO:0060041;, C:axon; C:cytoplasm; C:cytosol; C:dendrite cytoplasm; C:dendrite membrane; C:dendritic spine head; C:extrinsic component of membrane; C:glutamatergic synapse; C:neuronal cell body membrane; C:perikaryon;, F:actin binding; F:calcium ion binding; F:identical protein binding; F:kinase binding;, P:activation of phospholipase D activity; P:brain development; P:calcium-mediated signaling; P:cellular response to calcium ion; P:cellular response to electrical stimulus; P:cellular response to monosodium glutamate; P:inner ear development; P:negative regulation of guanylate cyclase activity; P:positive regulation of adenylate cyclase activity; P:positive regulation of protein targeting to membrane; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of voltage-gated calcium channel activity; P:response to Aroclor 1254; P:response to ketamine; P:response to L-glutamate; P:retina development in camera-type eye; scaffold12 indexed_genome mRNA 36566214 36573592 . - . ID=transcript_3246;P31350 B2R9B5 J3KP43 Q5WRU7,Ribonucleoside-diphosphate reductase subunit M2,Ribonucleotide reductase small chain;Ribonucleotide reductase small subunit;, PF00268;, GO:0005829;GO:0046872;GO:0004748;GO:0009263;GO:0006260;GO:0070317;GO:0015949;GO:0000083;, C:cytosol;, F:metal ion binding; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor;, P:deoxyribonucleotide biosynthetic process; P:DNA replication; P:negative regulation of G0 to G1 transition; P:nucleobase-containing small molecule interconversion; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; scaffold12 indexed_genome mRNA 36620866 36641532 . + . ID=transcript_3247;O14901 B4DZE7 Q9EPF4,Krueppel-like factor 11,Transforming growth factor-beta-inducible early growth response protein 2;, PF00096;, GO:0000785;GO:0005829;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0000976;GO:0006915;GO:1901653;GO:0008285;GO:0000122;GO:0043065;GO:0006357;GO:0000083;, C:chromatin; C:cytosol; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to peptide; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|O14901 B4DZE7 Q9EPF4,Krueppel-like factor 11,Transforming growth factor-beta-inducible early growth response protein 2;, PF00096;, GO:0000785;GO:0005829;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0000976;GO:0006915;GO:1901653;GO:0008285;GO:0000122;GO:0043065;GO:0006357;GO:0000083;, C:chromatin; C:cytosol; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to peptide; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|O14901 B4DZE7 Q9EPF4,Krueppel-like factor 11,Transforming growth factor-beta-inducible early growth response protein 2;, PF00096;, GO:0000785;GO:0005829;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0000976;GO:0006915;GO:1901653;GO:0008285;GO:0000122;GO:0043065;GO:0006357;GO:0000083;, C:chromatin; C:cytosol; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to peptide; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|O14901 B4DZE7 Q9EPF4,Krueppel-like factor 11,Transforming growth factor-beta-inducible early growth response protein 2;, PF00096;, GO:0000785;GO:0005829;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0000976;GO:0006915;GO:1901653;GO:0008285;GO:0000122;GO:0043065;GO:0006357;GO:0000083;, C:chromatin; C:cytosol; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to peptide; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; scaffold12 indexed_genome mRNA 36686668 36730000 . - . ID=transcript_3248;Q9NZI5 A6NLA4 B2R7E4 B5MEC2 Q53T93 Q6NWN7 Q6NWN8 Q6NWN9 Q8NI33,Grainyhead-like protein 1 homolog {ECO:0000312|HGNC:HGNC:17923},Mammalian grainyhead;NH32;Transcription factor CP2-like 2;Transcription factor LBP-32;, PF04516;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0031490;GO:0001228;GO:0000981;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0002934;GO:0008544;GO:0061436;GO:0045944;GO:0045616;GO:0019222;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:desmosome organization; P:epidermis development; P:establishment of skin barrier; P:positive regulation of transcription by RNA polymerase II; P:regulation of keratinocyte differentiation; P:regulation of metabolic process; P:regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 36761117 36814628 . - . ID=transcript_3249;Q53T94 B4DI42 F8WD72 Q15574 Q8WVC3,TATA box-binding protein-associated factor RNA polymerase I subunit B,RNA polymerase I-specific TBP-associated factor 63 kDa;TATA box-binding protein-associated factor 1B;Transcription initiation factor SL1/TIF-IB subunit B;, PF11781;, GO:0005730;GO:0005654;GO:0005634;GO:0070860;GO:0005668;GO:0046872;GO:0001164;GO:0017025;GO:0042790;GO:0045815;GO:0001188;GO:0006363;GO:0006361;GO:0006351;, C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase I core factor complex; C:RNA polymerase transcription factor SL1 complex;, F:metal ion binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:TBP-class protein binding;, P:nucleolar large rRNA transcription by RNA polymerase I; P:positive regulation of gene expression, epigenetic; P:RNA polymerase I preinitiation complex assembly; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; P:transcription, DNA-templated;|Q53T94 B4DI42 F8WD72 Q15574 Q8WVC3,TATA box-binding protein-associated factor RNA polymerase I subunit B,RNA polymerase I-specific TBP-associated factor 63 kDa;TATA box-binding protein-associated factor 1B;Transcription initiation factor SL1/TIF-IB subunit B;, PF11781;, GO:0005730;GO:0005654;GO:0005634;GO:0070860;GO:0005668;GO:0046872;GO:0001164;GO:0017025;GO:0042790;GO:0045815;GO:0001188;GO:0006363;GO:0006361;GO:0006351;, C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase I core factor complex; C:RNA polymerase transcription factor SL1 complex;, F:metal ion binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:TBP-class protein binding;, P:nucleolar large rRNA transcription by RNA polymerase I; P:positive regulation of gene expression, epigenetic; P:RNA polymerase I preinitiation complex assembly; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; P:transcription, DNA-templated;|Q53T94 B4DI42 F8WD72 Q15574 Q8WVC3,TATA box-binding protein-associated factor RNA polymerase I subunit B,RNA polymerase I-specific TBP-associated factor 63 kDa;TATA box-binding protein-associated factor 1B;Transcription initiation factor SL1/TIF-IB subunit B;, PF11781;, GO:0005730;GO:0005654;GO:0005634;GO:0070860;GO:0005668;GO:0046872;GO:0001164;GO:0017025;GO:0042790;GO:0045815;GO:0001188;GO:0006363;GO:0006361;GO:0006351;, C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase I core factor complex; C:RNA polymerase transcription factor SL1 complex;, F:metal ion binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:TBP-class protein binding;, P:nucleolar large rRNA transcription by RNA polymerase I; P:positive regulation of gene expression, epigenetic; P:RNA polymerase I preinitiation complex assembly; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; P:transcription, DNA-templated;|Q53T94 B4DI42 F8WD72 Q15574 Q8WVC3,TATA box-binding protein-associated factor RNA polymerase I subunit B,RNA polymerase I-specific TBP-associated factor 63 kDa;TATA box-binding protein-associated factor 1B;Transcription initiation factor SL1/TIF-IB subunit B;, PF11781;, GO:0005730;GO:0005654;GO:0005634;GO:0070860;GO:0005668;GO:0046872;GO:0001164;GO:0017025;GO:0042790;GO:0045815;GO:0001188;GO:0006363;GO:0006361;GO:0006351;, C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase I core factor complex; C:RNA polymerase transcription factor SL1 complex;, F:metal ion binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:TBP-class protein binding;, P:nucleolar large rRNA transcription by RNA polymerase I; P:positive regulation of gene expression, epigenetic; P:RNA polymerase I preinitiation complex assembly; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; P:transcription, DNA-templated;|Q53T94 B4DI42 F8WD72 Q15574 Q8WVC3,TATA box-binding protein-associated factor RNA polymerase I subunit B,RNA polymerase I-specific TBP-associated factor 63 kDa;TATA box-binding protein-associated factor 1B;Transcription initiation factor SL1/TIF-IB subunit B;, PF11781;, GO:0005730;GO:0005654;GO:0005634;GO:0070860;GO:0005668;GO:0046872;GO:0001164;GO:0017025;GO:0042790;GO:0045815;GO:0001188;GO:0006363;GO:0006361;GO:0006351;, C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase I core factor complex; C:RNA polymerase transcription factor SL1 complex;, F:metal ion binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:TBP-class protein binding;, P:nucleolar large rRNA transcription by RNA polymerase I; P:positive regulation of gene expression, epigenetic; P:RNA polymerase I preinitiation complex assembly; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; P:transcription, DNA-templated;|Q53T94 B4DI42 F8WD72 Q15574 Q8WVC3,TATA box-binding protein-associated factor RNA polymerase I subunit B,RNA polymerase I-specific TBP-associated factor 63 kDa;TATA box-binding protein-associated factor 1B;Transcription initiation factor SL1/TIF-IB subunit B;, PF11781;, GO:0005730;GO:0005654;GO:0005634;GO:0070860;GO:0005668;GO:0046872;GO:0001164;GO:0017025;GO:0042790;GO:0045815;GO:0001188;GO:0006363;GO:0006361;GO:0006351;, C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase I core factor complex; C:RNA polymerase transcription factor SL1 complex;, F:metal ion binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:TBP-class protein binding;, P:nucleolar large rRNA transcription by RNA polymerase I; P:positive regulation of gene expression, epigenetic; P:RNA polymerase I preinitiation complex assembly; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; P:transcription, DNA-templated; scaffold12 indexed_genome mRNA 36926665 37070379 . - . ID=transcript_3250;P78536 O60226,Disintegrin and metalloproteinase domain-containing protein 17,Snake venom-like protease;TNF-alpha convertase;TNF-alpha-converting enzyme;, PF16698;PF00200;PF01562;, GO:0015629;GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005788;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004175;GO:0005178;GO:0005138;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005112;GO:0030165;GO:0008233;GO:0017124;GO:0042987;GO:0030183;GO:0007155;GO:0033627;GO:0048870;GO:0071403;GO:0050830;GO:0007173;GO:0002467;GO:0006509;GO:0031293;GO:0120163;GO:0002862;GO:0030512;GO:0002446;GO:0007220;GO:0007219;GO:0043536;GO:0030307;GO:0030335;GO:0008284;GO:0051272;GO:0032722;GO:0045737;GO:0045741;GO:1900087;GO:0002690;GO:0001934;GO:0010820;GO:0030511;GO:1903265;GO:1905564;GO:0016485;GO:0006508;GO:0035624;GO:0033025;GO:0042493;GO:0001666;GO:0032496;GO:0048536;GO:0033077;GO:0033209;GO:0035313;, C:actin cytoskeleton; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:interleukin-6 receptor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:Notch binding; F:PDZ domain binding; F:peptidase activity; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:B cell differentiation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell motility; P:cellular response to high density lipoprotein particle stimulus; P:defense response to Gram-positive bacterium; P:epidermal growth factor receptor signaling pathway; P:germinal center formation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neutrophil mediated immunity; P:Notch receptor processing; P:Notch signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of chemokine production; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of leukocyte chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of T cell chemotaxis; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of vascular endothelial cell proliferation; P:protein processing; P:proteolysis; P:receptor transactivation; P:regulation of mast cell apoptotic process; P:response to drug; P:response to hypoxia; P:response to lipopolysaccharide; P:spleen development; P:T cell differentiation in thymus; P:tumor necrosis factor-mediated signaling pathway; P:wound healing, spreading of epidermal cells;|P27348 D6W4Z5 Q567U5 Q5TZU8 Q9UP48,14-3-3 protein theta,14-3-3 protein T-cell;14-3-3 protein tau;Protein HS1;, PF00244;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005739;GO:0032991;GO:0045202;GO:0071889;GO:0042802;GO:0044325;GO:0008022;GO:0019904;GO:0047485;GO:0034766;GO:0045892;GO:1900740;GO:0006605;GO:0007264;GO:0021762;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:mitochondrion; C:protein-containing complex; C:synapse;, F:14-3-3 protein binding; F:identical protein binding; F:ion channel binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein N-terminus binding;, P:negative regulation of ion transmembrane transport; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein targeting; P:small GTPase mediated signal transduction; P:substantia nigra development;|P27348 D6W4Z5 Q567U5 Q5TZU8 Q9UP48,14-3-3 protein theta,14-3-3 protein T-cell;14-3-3 protein tau;Protein HS1;, PF00244;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005739;GO:0032991;GO:0045202;GO:0071889;GO:0042802;GO:0044325;GO:0008022;GO:0019904;GO:0047485;GO:0034766;GO:0045892;GO:1900740;GO:0006605;GO:0007264;GO:0021762;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:mitochondrion; C:protein-containing complex; C:synapse;, F:14-3-3 protein binding; F:identical protein binding; F:ion channel binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein N-terminus binding;, P:negative regulation of ion transmembrane transport; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein targeting; P:small GTPase mediated signal transduction; P:substantia nigra development;|P27348 D6W4Z5 Q567U5 Q5TZU8 Q9UP48,14-3-3 protein theta,14-3-3 protein T-cell;14-3-3 protein tau;Protein HS1;, PF00244;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005739;GO:0032991;GO:0045202;GO:0071889;GO:0042802;GO:0044325;GO:0008022;GO:0019904;GO:0047485;GO:0034766;GO:0045892;GO:1900740;GO:0006605;GO:0007264;GO:0021762;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:mitochondrion; C:protein-containing complex; C:synapse;, F:14-3-3 protein binding; F:identical protein binding; F:ion channel binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein N-terminus binding;, P:negative regulation of ion transmembrane transport; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein targeting; P:small GTPase mediated signal transduction; P:substantia nigra development;|P78536 O60226,Disintegrin and metalloproteinase domain-containing protein 17,Snake venom-like protease;TNF-alpha convertase;TNF-alpha-converting enzyme;, PF16698;PF00200;PF01562;, GO:0015629;GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005788;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004175;GO:0005178;GO:0005138;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005112;GO:0030165;GO:0008233;GO:0017124;GO:0042987;GO:0030183;GO:0007155;GO:0033627;GO:0048870;GO:0071403;GO:0050830;GO:0007173;GO:0002467;GO:0006509;GO:0031293;GO:0120163;GO:0002862;GO:0030512;GO:0002446;GO:0007220;GO:0007219;GO:0043536;GO:0030307;GO:0030335;GO:0008284;GO:0051272;GO:0032722;GO:0045737;GO:0045741;GO:1900087;GO:0002690;GO:0001934;GO:0010820;GO:0030511;GO:1903265;GO:1905564;GO:0016485;GO:0006508;GO:0035624;GO:0033025;GO:0042493;GO:0001666;GO:0032496;GO:0048536;GO:0033077;GO:0033209;GO:0035313;, C:actin cytoskeleton; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:interleukin-6 receptor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:Notch binding; F:PDZ domain binding; F:peptidase activity; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:B cell differentiation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell motility; P:cellular response to high density lipoprotein particle stimulus; P:defense response to Gram-positive bacterium; P:epidermal growth factor receptor signaling pathway; P:germinal center formation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neutrophil mediated immunity; P:Notch receptor processing; P:Notch signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of chemokine production; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of leukocyte chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of T cell chemotaxis; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of vascular endothelial cell proliferation; P:protein processing; P:proteolysis; P:receptor transactivation; P:regulation of mast cell apoptotic process; P:response to drug; P:response to hypoxia; P:response to lipopolysaccharide; P:spleen development; P:T cell differentiation in thymus; P:tumor necrosis factor-mediated signaling pathway; P:wound healing, spreading of epidermal cells;|P78536 O60226,Disintegrin and metalloproteinase domain-containing protein 17,Snake venom-like protease;TNF-alpha convertase;TNF-alpha-converting enzyme;, PF16698;PF00200;PF01562;, GO:0015629;GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005788;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004175;GO:0005178;GO:0005138;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005112;GO:0030165;GO:0008233;GO:0017124;GO:0042987;GO:0030183;GO:0007155;GO:0033627;GO:0048870;GO:0071403;GO:0050830;GO:0007173;GO:0002467;GO:0006509;GO:0031293;GO:0120163;GO:0002862;GO:0030512;GO:0002446;GO:0007220;GO:0007219;GO:0043536;GO:0030307;GO:0030335;GO:0008284;GO:0051272;GO:0032722;GO:0045737;GO:0045741;GO:1900087;GO:0002690;GO:0001934;GO:0010820;GO:0030511;GO:1903265;GO:1905564;GO:0016485;GO:0006508;GO:0035624;GO:0033025;GO:0042493;GO:0001666;GO:0032496;GO:0048536;GO:0033077;GO:0033209;GO:0035313;, C:actin cytoskeleton; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:interleukin-6 receptor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:Notch binding; F:PDZ domain binding; F:peptidase activity; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:B cell differentiation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell motility; P:cellular response to high density lipoprotein particle stimulus; P:defense response to Gram-positive bacterium; P:epidermal growth factor receptor signaling pathway; P:germinal center formation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neutrophil mediated immunity; P:Notch receptor processing; P:Notch signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of chemokine production; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of leukocyte chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of T cell chemotaxis; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of vascular endothelial cell proliferation; P:protein processing; P:proteolysis; P:receptor transactivation; P:regulation of mast cell apoptotic process; P:response to drug; P:response to hypoxia; P:response to lipopolysaccharide; P:spleen development; P:T cell differentiation in thymus; P:tumor necrosis factor-mediated signaling pathway; P:wound healing, spreading of epidermal cells;|P78536 O60226,Disintegrin and metalloproteinase domain-containing protein 17,Snake venom-like protease;TNF-alpha convertase;TNF-alpha-converting enzyme;, PF16698;PF00200;PF01562;, GO:0015629;GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005788;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004175;GO:0005178;GO:0005138;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005112;GO:0030165;GO:0008233;GO:0017124;GO:0042987;GO:0030183;GO:0007155;GO:0033627;GO:0048870;GO:0071403;GO:0050830;GO:0007173;GO:0002467;GO:0006509;GO:0031293;GO:0120163;GO:0002862;GO:0030512;GO:0002446;GO:0007220;GO:0007219;GO:0043536;GO:0030307;GO:0030335;GO:0008284;GO:0051272;GO:0032722;GO:0045737;GO:0045741;GO:1900087;GO:0002690;GO:0001934;GO:0010820;GO:0030511;GO:1903265;GO:1905564;GO:0016485;GO:0006508;GO:0035624;GO:0033025;GO:0042493;GO:0001666;GO:0032496;GO:0048536;GO:0033077;GO:0033209;GO:0035313;, C:actin cytoskeleton; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:interleukin-6 receptor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:Notch binding; F:PDZ domain binding; F:peptidase activity; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:B cell differentiation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell motility; P:cellular response to high density lipoprotein particle stimulus; P:defense response to Gram-positive bacterium; P:epidermal growth factor receptor signaling pathway; P:germinal center formation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neutrophil mediated immunity; P:Notch receptor processing; P:Notch signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of chemokine production; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of leukocyte chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of T cell chemotaxis; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of vascular endothelial cell proliferation; P:protein processing; P:proteolysis; P:receptor transactivation; P:regulation of mast cell apoptotic process; P:response to drug; P:response to hypoxia; P:response to lipopolysaccharide; P:spleen development; P:T cell differentiation in thymus; P:tumor necrosis factor-mediated signaling pathway; P:wound healing, spreading of epidermal cells;|P78536 O60226,Disintegrin and metalloproteinase domain-containing protein 17,Snake venom-like protease;TNF-alpha convertase;TNF-alpha-converting enzyme;, PF16698;PF00200;PF01562;, GO:0015629;GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005788;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004175;GO:0005178;GO:0005138;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005112;GO:0030165;GO:0008233;GO:0017124;GO:0042987;GO:0030183;GO:0007155;GO:0033627;GO:0048870;GO:0071403;GO:0050830;GO:0007173;GO:0002467;GO:0006509;GO:0031293;GO:0120163;GO:0002862;GO:0030512;GO:0002446;GO:0007220;GO:0007219;GO:0043536;GO:0030307;GO:0030335;GO:0008284;GO:0051272;GO:0032722;GO:0045737;GO:0045741;GO:1900087;GO:0002690;GO:0001934;GO:0010820;GO:0030511;GO:1903265;GO:1905564;GO:0016485;GO:0006508;GO:0035624;GO:0033025;GO:0042493;GO:0001666;GO:0032496;GO:0048536;GO:0033077;GO:0033209;GO:0035313;, C:actin cytoskeleton; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:interleukin-6 receptor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:Notch binding; F:PDZ domain binding; F:peptidase activity; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:B cell differentiation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell motility; P:cellular response to high density lipoprotein particle stimulus; P:defense response to Gram-positive bacterium; P:epidermal growth factor receptor signaling pathway; P:germinal center formation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neutrophil mediated immunity; P:Notch receptor processing; P:Notch signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of chemokine production; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of leukocyte chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of T cell chemotaxis; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of vascular endothelial cell proliferation; P:protein processing; P:proteolysis; P:receptor transactivation; P:regulation of mast cell apoptotic process; P:response to drug; P:response to hypoxia; P:response to lipopolysaccharide; P:spleen development; P:T cell differentiation in thymus; P:tumor necrosis factor-mediated signaling pathway; P:wound healing, spreading of epidermal cells;|P78536 O60226,Disintegrin and metalloproteinase domain-containing protein 17,Snake venom-like protease;TNF-alpha convertase;TNF-alpha-converting enzyme;, PF16698;PF00200;PF01562;, GO:0015629;GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005788;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004175;GO:0005178;GO:0005138;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005112;GO:0030165;GO:0008233;GO:0017124;GO:0042987;GO:0030183;GO:0007155;GO:0033627;GO:0048870;GO:0071403;GO:0050830;GO:0007173;GO:0002467;GO:0006509;GO:0031293;GO:0120163;GO:0002862;GO:0030512;GO:0002446;GO:0007220;GO:0007219;GO:0043536;GO:0030307;GO:0030335;GO:0008284;GO:0051272;GO:0032722;GO:0045737;GO:0045741;GO:1900087;GO:0002690;GO:0001934;GO:0010820;GO:0030511;GO:1903265;GO:1905564;GO:0016485;GO:0006508;GO:0035624;GO:0033025;GO:0042493;GO:0001666;GO:0032496;GO:0048536;GO:0033077;GO:0033209;GO:0035313;, C:actin cytoskeleton; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:interleukin-6 receptor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:Notch binding; F:PDZ domain binding; F:peptidase activity; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:B cell differentiation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell motility; P:cellular response to high density lipoprotein particle stimulus; P:defense response to Gram-positive bacterium; P:epidermal growth factor receptor signaling pathway; P:germinal center formation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neutrophil mediated immunity; P:Notch receptor processing; P:Notch signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of chemokine production; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of leukocyte chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of T cell chemotaxis; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of vascular endothelial cell proliferation; P:protein processing; P:proteolysis; P:receptor transactivation; P:regulation of mast cell apoptotic process; P:response to drug; P:response to hypoxia; P:response to lipopolysaccharide; P:spleen development; P:T cell differentiation in thymus; P:tumor necrosis factor-mediated signaling pathway; P:wound healing, spreading of epidermal cells;|P78536 O60226,Disintegrin and metalloproteinase domain-containing protein 17,Snake venom-like protease;TNF-alpha convertase;TNF-alpha-converting enzyme;, PF16698;PF00200;PF01562;, GO:0015629;GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005788;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004175;GO:0005178;GO:0005138;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005112;GO:0030165;GO:0008233;GO:0017124;GO:0042987;GO:0030183;GO:0007155;GO:0033627;GO:0048870;GO:0071403;GO:0050830;GO:0007173;GO:0002467;GO:0006509;GO:0031293;GO:0120163;GO:0002862;GO:0030512;GO:0002446;GO:0007220;GO:0007219;GO:0043536;GO:0030307;GO:0030335;GO:0008284;GO:0051272;GO:0032722;GO:0045737;GO:0045741;GO:1900087;GO:0002690;GO:0001934;GO:0010820;GO:0030511;GO:1903265;GO:1905564;GO:0016485;GO:0006508;GO:0035624;GO:0033025;GO:0042493;GO:0001666;GO:0032496;GO:0048536;GO:0033077;GO:0033209;GO:0035313;, C:actin cytoskeleton; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:interleukin-6 receptor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:Notch binding; F:PDZ domain binding; F:peptidase activity; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:B cell differentiation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell motility; P:cellular response to high density lipoprotein particle stimulus; P:defense response to Gram-positive bacterium; P:epidermal growth factor receptor signaling pathway; P:germinal center formation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neutrophil mediated immunity; P:Notch receptor processing; P:Notch signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of chemokine production; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of leukocyte chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of T cell chemotaxis; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of vascular endothelial cell proliferation; P:protein processing; P:proteolysis; P:receptor transactivation; P:regulation of mast cell apoptotic process; P:response to drug; P:response to hypoxia; P:response to lipopolysaccharide; P:spleen development; P:T cell differentiation in thymus; P:tumor necrosis factor-mediated signaling pathway; P:wound healing, spreading of epidermal cells;|P78536 O60226,Disintegrin and metalloproteinase domain-containing protein 17,Snake venom-like protease;TNF-alpha convertase;TNF-alpha-converting enzyme;, PF16698;PF00200;PF01562;, GO:0015629;GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005788;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004175;GO:0005178;GO:0005138;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005112;GO:0030165;GO:0008233;GO:0017124;GO:0042987;GO:0030183;GO:0007155;GO:0033627;GO:0048870;GO:0071403;GO:0050830;GO:0007173;GO:0002467;GO:0006509;GO:0031293;GO:0120163;GO:0002862;GO:0030512;GO:0002446;GO:0007220;GO:0007219;GO:0043536;GO:0030307;GO:0030335;GO:0008284;GO:0051272;GO:0032722;GO:0045737;GO:0045741;GO:1900087;GO:0002690;GO:0001934;GO:0010820;GO:0030511;GO:1903265;GO:1905564;GO:0016485;GO:0006508;GO:0035624;GO:0033025;GO:0042493;GO:0001666;GO:0032496;GO:0048536;GO:0033077;GO:0033209;GO:0035313;, C:actin cytoskeleton; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:interleukin-6 receptor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:Notch binding; F:PDZ domain binding; F:peptidase activity; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:B cell differentiation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell motility; P:cellular response to high density lipoprotein particle stimulus; P:defense response to Gram-positive bacterium; P:epidermal growth factor receptor signaling pathway; P:germinal center formation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neutrophil mediated immunity; P:Notch receptor processing; P:Notch signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of chemokine production; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of leukocyte chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of T cell chemotaxis; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of vascular endothelial cell proliferation; P:protein processing; P:proteolysis; P:receptor transactivation; P:regulation of mast cell apoptotic process; P:response to drug; P:response to hypoxia; P:response to lipopolysaccharide; P:spleen development; P:T cell differentiation in thymus; P:tumor necrosis factor-mediated signaling pathway; P:wound healing, spreading of epidermal cells;|P78536 O60226,Disintegrin and metalloproteinase domain-containing protein 17,Snake venom-like protease;TNF-alpha convertase;TNF-alpha-converting enzyme;, PF16698;PF00200;PF01562;, GO:0015629;GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005788;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004175;GO:0005178;GO:0005138;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005112;GO:0030165;GO:0008233;GO:0017124;GO:0042987;GO:0030183;GO:0007155;GO:0033627;GO:0048870;GO:0071403;GO:0050830;GO:0007173;GO:0002467;GO:0006509;GO:0031293;GO:0120163;GO:0002862;GO:0030512;GO:0002446;GO:0007220;GO:0007219;GO:0043536;GO:0030307;GO:0030335;GO:0008284;GO:0051272;GO:0032722;GO:0045737;GO:0045741;GO:1900087;GO:0002690;GO:0001934;GO:0010820;GO:0030511;GO:1903265;GO:1905564;GO:0016485;GO:0006508;GO:0035624;GO:0033025;GO:0042493;GO:0001666;GO:0032496;GO:0048536;GO:0033077;GO:0033209;GO:0035313;, C:actin cytoskeleton; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:interleukin-6 receptor binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:Notch binding; F:PDZ domain binding; F:peptidase activity; F:SH3 domain binding;, P:amyloid precursor protein catabolic process; P:B cell differentiation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell motility; P:cellular response to high density lipoprotein particle stimulus; P:defense response to Gram-positive bacterium; P:epidermal growth factor receptor signaling pathway; P:germinal center formation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neutrophil mediated immunity; P:Notch receptor processing; P:Notch signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of chemokine production; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of leukocyte chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of T cell chemotaxis; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of vascular endothelial cell proliferation; P:protein processing; P:proteolysis; P:receptor transactivation; P:regulation of mast cell apoptotic process; P:response to drug; P:response to hypoxia; P:response to lipopolysaccharide; P:spleen development; P:T cell differentiation in thymus; P:tumor necrosis factor-mediated signaling pathway; P:wound healing, spreading of epidermal cells;|Q2TAA2 B4DMV3,Isoamyl acetate-hydrolyzing esterase 1 homolog,, PF13472;, GO:0016787;GO:0042802;GO:0016042;, , F:hydrolase activity; F:identical protein binding;, P:lipid catabolic process;|Q2TAA2 B4DMV3,Isoamyl acetate-hydrolyzing esterase 1 homolog,, PF13472;, GO:0016787;GO:0042802;GO:0016042;, , F:hydrolase activity; F:identical protein binding;, P:lipid catabolic process;|Q2TAA2 B4DMV3,Isoamyl acetate-hydrolyzing esterase 1 homolog,, PF13472;, GO:0016787;GO:0042802;GO:0016042;, , F:hydrolase activity; F:identical protein binding;, P:lipid catabolic process;|Q2TAA2 B4DMV3,Isoamyl acetate-hydrolyzing esterase 1 homolog,, PF13472;, GO:0016787;GO:0042802;GO:0016042;, , F:hydrolase activity; F:identical protein binding;, P:lipid catabolic process; scaffold12 indexed_genome mRNA 37075928 37110737 . - . ID=transcript_3251;Q9UKF6 O14769 Q53RS2 Q96F36,Cleavage and polyadenylation specificity factor subunit 3,Cleavage and polyadenylation specificity factor 73 kDa subunit;mRNA 3'-end-processing endonuclease CPSF-73;, PF10996;PF11718;PF00753;PF07521;, GO:0005847;GO:0005654;GO:0008409;GO:0004521;GO:0046872;GO:0003723;GO:0031124;GO:0006398;GO:0006379;GO:0006406;GO:0006378;GO:0000398;GO:0006369;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:5'-3' exonuclease activity; F:endoribonuclease activity; F:metal ion binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA cleavage; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription;|Q9UKF6 O14769 Q53RS2 Q96F36,Cleavage and polyadenylation specificity factor subunit 3,Cleavage and polyadenylation specificity factor 73 kDa subunit;mRNA 3'-end-processing endonuclease CPSF-73;, PF10996;PF11718;PF00753;PF07521;, GO:0005847;GO:0005654;GO:0008409;GO:0004521;GO:0046872;GO:0003723;GO:0031124;GO:0006398;GO:0006379;GO:0006406;GO:0006378;GO:0000398;GO:0006369;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:5'-3' exonuclease activity; F:endoribonuclease activity; F:metal ion binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA cleavage; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription;|Q9UKF6 O14769 Q53RS2 Q96F36,Cleavage and polyadenylation specificity factor subunit 3,Cleavage and polyadenylation specificity factor 73 kDa subunit;mRNA 3'-end-processing endonuclease CPSF-73;, PF10996;PF11718;PF00753;PF07521;, GO:0005847;GO:0005654;GO:0008409;GO:0004521;GO:0046872;GO:0003723;GO:0031124;GO:0006398;GO:0006379;GO:0006406;GO:0006378;GO:0000398;GO:0006369;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:5'-3' exonuclease activity; F:endoribonuclease activity; F:metal ion binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA cleavage; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription;|Q9UKF6 O14769 Q53RS2 Q96F36,Cleavage and polyadenylation specificity factor subunit 3,Cleavage and polyadenylation specificity factor 73 kDa subunit;mRNA 3'-end-processing endonuclease CPSF-73;, PF10996;PF11718;PF00753;PF07521;, GO:0005847;GO:0005654;GO:0008409;GO:0004521;GO:0046872;GO:0003723;GO:0031124;GO:0006398;GO:0006379;GO:0006406;GO:0006378;GO:0000398;GO:0006369;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:5'-3' exonuclease activity; F:endoribonuclease activity; F:metal ion binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA cleavage; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription; scaffold12 indexed_genome mRNA 37110811 37137338 . + . ID=transcript_3252;O14713 D6W4Y9 O14714 Q53RS0,Integrin beta-1-binding protein 1,Integrin cytoplasmic domain-associated protein 1;, PF10480;, GO:0071944;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0030027;GO:0016020;GO:0016604;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0001726;GO:0005092;GO:0005178;GO:0032148;GO:0031214;GO:0097746;GO:0002043;GO:0030154;GO:0016477;GO:0007160;GO:0044344;GO:0035924;GO:0033622;GO:0007229;GO:0035556;GO:0051451;GO:0006933;GO:0090051;GO:0008285;GO:0070373;GO:0010764;GO:0051895;GO:0032091;GO:0006469;GO:0090315;GO:1900025;GO:0007219;GO:0051781;GO:0008284;GO:0010595;GO:0045747;GO:0051897;GO:0090314;GO:0051496;GO:0045944;GO:0072659;GO:0043113;GO:0033628;GO:0043087;GO:2001044;GO:0035148;, C:cell periphery; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol; C:lamellipodium; C:membrane; C:nuclear body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle;, F:GDP-dissociation inhibitor activity; F:integrin binding;, P:activation of protein kinase B activity; P:biomineral tissue development; P:blood vessel diameter maintenance; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:cell differentiation; P:cell migration; P:cell-matrix adhesion; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:integrin activation; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:myoblast migration; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast migration; P:negative regulation of focal adhesion assembly; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:negative regulation of protein targeting to membrane; P:negative regulation of substrate adhesion-dependent cell spreading; P:Notch signaling pathway; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell migration; P:positive regulation of Notch signaling pathway; P:positive regulation of protein kinase B signaling; P:positive regulation of protein targeting to membrane; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; P:protein localization to plasma membrane; P:receptor clustering; P:regulation of cell adhesion mediated by integrin; P:regulation of GTPase activity; P:regulation of integrin-mediated signaling pathway; P:tube formation;|O14713 D6W4Y9 O14714 Q53RS0,Integrin beta-1-binding protein 1,Integrin cytoplasmic domain-associated protein 1;, PF10480;, GO:0071944;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0030027;GO:0016020;GO:0016604;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0001726;GO:0005092;GO:0005178;GO:0032148;GO:0031214;GO:0097746;GO:0002043;GO:0030154;GO:0016477;GO:0007160;GO:0044344;GO:0035924;GO:0033622;GO:0007229;GO:0035556;GO:0051451;GO:0006933;GO:0090051;GO:0008285;GO:0070373;GO:0010764;GO:0051895;GO:0032091;GO:0006469;GO:0090315;GO:1900025;GO:0007219;GO:0051781;GO:0008284;GO:0010595;GO:0045747;GO:0051897;GO:0090314;GO:0051496;GO:0045944;GO:0072659;GO:0043113;GO:0033628;GO:0043087;GO:2001044;GO:0035148;, C:cell periphery; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol; C:lamellipodium; C:membrane; C:nuclear body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle;, F:GDP-dissociation inhibitor activity; F:integrin binding;, P:activation of protein kinase B activity; P:biomineral tissue development; P:blood vessel diameter maintenance; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:cell differentiation; P:cell migration; P:cell-matrix adhesion; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:integrin activation; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:myoblast migration; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast migration; P:negative regulation of focal adhesion assembly; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:negative regulation of protein targeting to membrane; P:negative regulation of substrate adhesion-dependent cell spreading; P:Notch signaling pathway; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell migration; P:positive regulation of Notch signaling pathway; P:positive regulation of protein kinase B signaling; P:positive regulation of protein targeting to membrane; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; P:protein localization to plasma membrane; P:receptor clustering; P:regulation of cell adhesion mediated by integrin; P:regulation of GTPase activity; P:regulation of integrin-mediated signaling pathway; P:tube formation;|O43150 D6W4Y8,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2,Development and differentiation-enhancing factor 2;Paxillin-associated protein with ARF GAP activity 3;Pyk2 C-terminus-associated protein;, PF12796;PF01412;PF00169;PF14604;, GO:0032580;GO:0005886;GO:0005096;GO:0046872;, C:Golgi cisterna membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;|O43150 D6W4Y8,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2,Development and differentiation-enhancing factor 2;Paxillin-associated protein with ARF GAP activity 3;Pyk2 C-terminus-associated protein;, PF12796;PF01412;PF00169;PF14604;, GO:0032580;GO:0005886;GO:0005096;GO:0046872;, C:Golgi cisterna membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding; scaffold12 indexed_genome mRNA 37453881 37507637 . + . ID=transcript_3253;Q6ZWT7 A9EDR2 Q8NCE7 Q96KY4,Lysophospholipid acyltransferase 2 {ECO:0000305},1-acylglycerophosphate O-acyltransferase MBOAT2 {ECO:0000305};1-acylglycerophosphocholine O-acyltransferase MBOAT2 {ECO:0000305};1-acylglycerophosphoethanolamine MBOAT2 O-acyltransferase {ECO:0000305};Lysophosphatidic acid acyltransferase;Lysophosphatidylcholine acyltransferase;Lysophosphatidylcholine acyltransferase 4;Lysophosphatidylethanolamine acyltransferase;Membrane-bound O-acyltransferase domain-containing protein 2;, PF03062;, GO:0005789;GO:0016021;GO:0016020;GO:0003841;GO:0047184;GO:0106262;GO:0106263;GO:0016746;GO:0030258;GO:0036151;GO:0036152;GO:0036150;GO:0008654;GO:0032330;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:lipid modification; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid biosynthetic process; P:regulation of chondrocyte differentiation;|Q6ZWT7 A9EDR2 Q8NCE7 Q96KY4,Lysophospholipid acyltransferase 2 {ECO:0000305},1-acylglycerophosphate O-acyltransferase MBOAT2 {ECO:0000305};1-acylglycerophosphocholine O-acyltransferase MBOAT2 {ECO:0000305};1-acylglycerophosphoethanolamine MBOAT2 O-acyltransferase {ECO:0000305};Lysophosphatidic acid acyltransferase;Lysophosphatidylcholine acyltransferase;Lysophosphatidylcholine acyltransferase 4;Lysophosphatidylethanolamine acyltransferase;Membrane-bound O-acyltransferase domain-containing protein 2;, PF03062;, GO:0005789;GO:0016021;GO:0016020;GO:0003841;GO:0047184;GO:0106262;GO:0106263;GO:0016746;GO:0030258;GO:0036151;GO:0036152;GO:0036150;GO:0008654;GO:0032330;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:lipid modification; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid biosynthetic process; P:regulation of chondrocyte differentiation; scaffold12 indexed_genome mRNA 37527298 37561017 . + . ID=transcript_3254;Q9ULH0 A1L4N4 Q4VC08 Q6MZU2 Q9H889 Q9H9E4 Q9NT37 Q9UF42,Kinase D-interacting substrate of 220 kDa,Ankyrin repeat-rich membrane-spanning protein;, PF12796;PF07693;, GO:0005829;GO:0016021;GO:0005770;GO:0016020;GO:0032991;GO:0030165;GO:0019887;GO:0000186;GO:1990090;GO:0048813;GO:0001701;GO:0038180;GO:0010976;, C:cytosol; C:integral component of membrane; C:late endosome; C:membrane; C:protein-containing complex;, F:PDZ domain binding; F:protein kinase regulator activity;, P:activation of MAPKK activity; P:cellular response to nerve growth factor stimulus; P:dendrite morphogenesis; P:in utero embryonic development; P:nerve growth factor signaling pathway; P:positive regulation of neuron projection development; scaffold12 indexed_genome mRNA 37562069 37620101 . + . ID=transcript_3255;Q9ULH0 A1L4N4 Q4VC08 Q6MZU2 Q9H889 Q9H9E4 Q9NT37 Q9UF42,Kinase D-interacting substrate of 220 kDa,Ankyrin repeat-rich membrane-spanning protein;, PF12796;PF07693;, GO:0005829;GO:0016021;GO:0005770;GO:0016020;GO:0032991;GO:0030165;GO:0019887;GO:0000186;GO:1990090;GO:0048813;GO:0001701;GO:0038180;GO:0010976;, C:cytosol; C:integral component of membrane; C:late endosome; C:membrane; C:protein-containing complex;, F:PDZ domain binding; F:protein kinase regulator activity;, P:activation of MAPKK activity; P:cellular response to nerve growth factor stimulus; P:dendrite morphogenesis; P:in utero embryonic development; P:nerve growth factor signaling pathway; P:positive regulation of neuron projection development;|Q9ULH0 A1L4N4 Q4VC08 Q6MZU2 Q9H889 Q9H9E4 Q9NT37 Q9UF42,Kinase D-interacting substrate of 220 kDa,Ankyrin repeat-rich membrane-spanning protein;, PF12796;PF07693;, GO:0005829;GO:0016021;GO:0005770;GO:0016020;GO:0032991;GO:0030165;GO:0019887;GO:0000186;GO:1990090;GO:0048813;GO:0001701;GO:0038180;GO:0010976;, C:cytosol; C:integral component of membrane; C:late endosome; C:membrane; C:protein-containing complex;, F:PDZ domain binding; F:protein kinase regulator activity;, P:activation of MAPKK activity; P:cellular response to nerve growth factor stimulus; P:dendrite morphogenesis; P:in utero embryonic development; P:nerve growth factor signaling pathway; P:positive regulation of neuron projection development;|Q9ULH0 A1L4N4 Q4VC08 Q6MZU2 Q9H889 Q9H9E4 Q9NT37 Q9UF42,Kinase D-interacting substrate of 220 kDa,Ankyrin repeat-rich membrane-spanning protein;, PF12796;PF07693;, GO:0005829;GO:0016021;GO:0005770;GO:0016020;GO:0032991;GO:0030165;GO:0019887;GO:0000186;GO:1990090;GO:0048813;GO:0001701;GO:0038180;GO:0010976;, C:cytosol; C:integral component of membrane; C:late endosome; C:membrane; C:protein-containing complex;, F:PDZ domain binding; F:protein kinase regulator activity;, P:activation of MAPKK activity; P:cellular response to nerve growth factor stimulus; P:dendrite morphogenesis; P:in utero embryonic development; P:nerve growth factor signaling pathway; P:positive regulation of neuron projection development;|Q9ULH0 A1L4N4 Q4VC08 Q6MZU2 Q9H889 Q9H9E4 Q9NT37 Q9UF42,Kinase D-interacting substrate of 220 kDa,Ankyrin repeat-rich membrane-spanning protein;, PF12796;PF07693;, GO:0005829;GO:0016021;GO:0005770;GO:0016020;GO:0032991;GO:0030165;GO:0019887;GO:0000186;GO:1990090;GO:0048813;GO:0001701;GO:0038180;GO:0010976;, C:cytosol; C:integral component of membrane; C:late endosome; C:membrane; C:protein-containing complex;, F:PDZ domain binding; F:protein kinase regulator activity;, P:activation of MAPKK activity; P:cellular response to nerve growth factor stimulus; P:dendrite morphogenesis; P:in utero embryonic development; P:nerve growth factor signaling pathway; P:positive regulation of neuron projection development;|Q9ULH0 A1L4N4 Q4VC08 Q6MZU2 Q9H889 Q9H9E4 Q9NT37 Q9UF42,Kinase D-interacting substrate of 220 kDa,Ankyrin repeat-rich membrane-spanning protein;, PF12796;PF07693;, GO:0005829;GO:0016021;GO:0005770;GO:0016020;GO:0032991;GO:0030165;GO:0019887;GO:0000186;GO:1990090;GO:0048813;GO:0001701;GO:0038180;GO:0010976;, C:cytosol; C:integral component of membrane; C:late endosome; C:membrane; C:protein-containing complex;, F:PDZ domain binding; F:protein kinase regulator activity;, P:activation of MAPKK activity; P:cellular response to nerve growth factor stimulus; P:dendrite morphogenesis; P:in utero embryonic development; P:nerve growth factor signaling pathway; P:positive regulation of neuron projection development;|Q9ULH0 A1L4N4 Q4VC08 Q6MZU2 Q9H889 Q9H9E4 Q9NT37 Q9UF42,Kinase D-interacting substrate of 220 kDa,Ankyrin repeat-rich membrane-spanning protein;, PF12796;PF07693;, GO:0005829;GO:0016021;GO:0005770;GO:0016020;GO:0032991;GO:0030165;GO:0019887;GO:0000186;GO:1990090;GO:0048813;GO:0001701;GO:0038180;GO:0010976;, C:cytosol; C:integral component of membrane; C:late endosome; C:membrane; C:protein-containing complex;, F:PDZ domain binding; F:protein kinase regulator activity;, P:activation of MAPKK activity; P:cellular response to nerve growth factor stimulus; P:dendrite morphogenesis; P:in utero embryonic development; P:nerve growth factor signaling pathway; P:positive regulation of neuron projection development; scaffold12 indexed_genome mRNA 37622342 37623279 . + . ID=transcript_3256;Q9B2Z0 Q9B2Z4 Q9T6H6 Q9T9Y0 Q9TEH4,Cytochrome b,Complex III subunit 3;Complex III subunit III;Cytochrome b-c1 complex subunit 3;Ubiquinol-cytochrome-c reductase complex cytochrome b subunit;, PF00032;PF00033;, GO:0031305;GO:0005743;GO:0005750;GO:0005739;GO:0046872;GO:0044877;GO:0008121;GO:0031100;GO:0015990;GO:0042538;GO:0006122;GO:0046686;GO:0051592;GO:0033590;GO:0046688;GO:0042493;GO:0045471;GO:0033762;GO:0009408;GO:0055093;GO:0001666;GO:0046689;GO:0009636;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:metal ion binding; F:protein-containing complex binding; F:ubiquinol-cytochrome-c reductase activity;, P:animal organ regeneration; P:electron transport coupled proton transport; P:hyperosmotic salinity response; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:response to cadmium ion; P:response to calcium ion; P:response to cobalamin; P:response to copper ion; P:response to drug; P:response to ethanol; P:response to glucagon; P:response to heat; P:response to hyperoxia; P:response to hypoxia; P:response to mercury ion; P:response to toxic substance; scaffold12 indexed_genome mRNA 37640235 37642202 . - . ID=transcript_3257;Q02363,DNA-binding protein inhibitor ID-2,Class B basic helix-loop-helix protein 26;Inhibitor of DNA binding 2;Inhibitor of differentiation 2;, PF00010;, GO:0005737;GO:0005829;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0044325;GO:0046983;GO:0001102;GO:0140416;GO:0030154;GO:0090398;GO:0032922;GO:0048557;GO:0061031;GO:0043153;GO:0061030;GO:0045475;GO:0060749;GO:0033598;GO:0043433;GO:0010629;GO:0051148;GO:0000122;GO:0045892;GO:0048663;GO:0045777;GO:0071158;GO:0010628;GO:0048661;GO:0071931;GO:0045893;GO:0042752;GO:2000045;GO:0019216;GO:2000177;GO:0045664;, C:cytoplasm; C:cytosol; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ion channel binding; F:protein dimerization activity; F:RNA polymerase II activating transcription factor binding; F:transcription regulator inhibitor activity;, P:cell differentiation; P:cellular senescence; P:circadian regulation of gene expression; P:embryonic digestive tract morphogenesis; P:endodermal digestive tract morphogenesis; P:entrainment of circadian clock by photoperiod; P:epithelial cell differentiation involved in mammary gland alveolus development; P:locomotor rhythm; P:mammary gland alveolus development; P:mammary gland epithelial cell proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron fate commitment; P:positive regulation of blood pressure; P:positive regulation of cell cycle arrest; P:positive regulation of gene expression; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of lipid metabolic process; P:regulation of neural precursor cell proliferation; P:regulation of neuron differentiation;|Q02363,DNA-binding protein inhibitor ID-2,Class B basic helix-loop-helix protein 26;Inhibitor of DNA binding 2;Inhibitor of differentiation 2;, PF00010;, GO:0005737;GO:0005829;GO:0000791;GO:0005654;GO:0005634;GO:0032991;GO:0044325;GO:0046983;GO:0001102;GO:0140416;GO:0030154;GO:0090398;GO:0032922;GO:0048557;GO:0061031;GO:0043153;GO:0061030;GO:0045475;GO:0060749;GO:0033598;GO:0043433;GO:0010629;GO:0051148;GO:0000122;GO:0045892;GO:0048663;GO:0045777;GO:0071158;GO:0010628;GO:0048661;GO:0071931;GO:0045893;GO:0042752;GO:2000045;GO:0019216;GO:2000177;GO:0045664;, C:cytoplasm; C:cytosol; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ion channel binding; F:protein dimerization activity; F:RNA polymerase II activating transcription factor binding; F:transcription regulator inhibitor activity;, P:cell differentiation; P:cellular senescence; P:circadian regulation of gene expression; P:embryonic digestive tract morphogenesis; P:endodermal digestive tract morphogenesis; P:entrainment of circadian clock by photoperiod; P:epithelial cell differentiation involved in mammary gland alveolus development; P:locomotor rhythm; P:mammary gland alveolus development; P:mammary gland epithelial cell proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron fate commitment; P:positive regulation of blood pressure; P:positive regulation of cell cycle arrest; P:positive regulation of gene expression; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of lipid metabolic process; P:regulation of neural precursor cell proliferation; P:regulation of neuron differentiation; scaffold12 indexed_genome mRNA 38881808 39007858 . - . ID=transcript_3258;P50876 D6W4Y6 Q585H5,E3 ubiquitin-protein ligase RNF144A,RING finger protein 144A;UbcM4-interacting protein 4;Ubiquitin-conjugating enzyme 7-interacting protein 4;, PF01485;, GO:0005737;GO:0030659;GO:0010008;GO:0005794;GO:0016021;GO:0043231;GO:0005886;GO:0000151;GO:0046872;GO:0031624;GO:0061630;GO:0032436;GO:0000209;GO:0016567;GO:0006511;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:endosome membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold12 indexed_genome mRNA 39063242 39063865 . - . ID=transcript_3259;Q5EBM0 A2RUB0 A5D8T2 B7ZM18 Q6ZRU2 Q96AL8,UMP-CMP kinase 2, mitochondrial,Nucleoside-diphosphate kinase;, PF02223;, GO:0005737;GO:0005739;GO:0005654;GO:0005524;GO:0036430;GO:0004127;GO:0036431;GO:0004550;GO:0004798;GO:0033862;GO:0009041;GO:0071222;GO:0006233;GO:0006235;GO:0006227;GO:0006165;GO:0009142;, C:cytoplasm; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:CMP kinase activity; F:cytidylate kinase activity; F:dCMP kinase activity; F:nucleoside diphosphate kinase activity; F:thymidylate kinase activity; F:UMP kinase activity; F:uridylate kinase activity;, P:cellular response to lipopolysaccharide; P:dTDP biosynthetic process; P:dTTP biosynthetic process; P:dUDP biosynthetic process; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; scaffold12 indexed_genome mRNA 39064745 39065473 . - . ID=transcript_3260;Q5EBM0 A2RUB0 A5D8T2 B7ZM18 Q6ZRU2 Q96AL8,UMP-CMP kinase 2, mitochondrial,Nucleoside-diphosphate kinase;, PF02223;, GO:0005737;GO:0005739;GO:0005654;GO:0005524;GO:0036430;GO:0004127;GO:0036431;GO:0004550;GO:0004798;GO:0033862;GO:0009041;GO:0071222;GO:0006233;GO:0006235;GO:0006227;GO:0006165;GO:0009142;, C:cytoplasm; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:CMP kinase activity; F:cytidylate kinase activity; F:dCMP kinase activity; F:nucleoside diphosphate kinase activity; F:thymidylate kinase activity; F:UMP kinase activity; F:uridylate kinase activity;, P:cellular response to lipopolysaccharide; P:dTDP biosynthetic process; P:dTTP biosynthetic process; P:dUDP biosynthetic process; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; scaffold12 indexed_genome mRNA 41170093 41192630 . - . ID=transcript_3261;Q7Z4J2,Putative glycosyltransferase 6 domain-containing protein 1,Galactosyltransferase family 6 domain-containing 1;, PF03414;, GO:0005794;GO:0016021;GO:0031982;GO:0016757;GO:0016758;GO:0005975;GO:0030259;, C:Golgi apparatus; C:integral component of membrane; C:vesicle;, F:transferase activity, transferring glycosyl groups; F:transferase activity, transferring hexosyl groups;, P:carbohydrate metabolic process; P:lipid glycosylation;|Q7Z4J2,Putative glycosyltransferase 6 domain-containing protein 1,Galactosyltransferase family 6 domain-containing 1;, PF03414;, GO:0005794;GO:0016021;GO:0031982;GO:0016757;GO:0016758;GO:0005975;GO:0030259;, C:Golgi apparatus; C:integral component of membrane; C:vesicle;, F:transferase activity, transferring glycosyl groups; F:transferase activity, transferring hexosyl groups;, P:carbohydrate metabolic process; P:lipid glycosylation; scaffold12 indexed_genome mRNA 41361553 41441505 . + . ID=transcript_3262;Q5VWQ8 A6H8V2 A6NHI9 B0QZB1 G3XA90 Q8TDL2 Q96SE1 Q9C0C0,Disabled homolog 2-interacting protein,ASK-interacting protein 1;DOC-2/DAB-2 interactive protein;, PF00168;PF12004;PF00616;, GO:1990597;GO:0030424;GO:0044300;GO:0044301;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0043025;GO:0032809;GO:1990032;GO:0005886;GO:0071889;GO:0045296;GO:0005123;GO:0005096;GO:0042802;GO:0019900;GO:0031434;GO:0031435;GO:0043548;GO:0036312;GO:0032266;GO:0070273;GO:0042803;GO:0019901;GO:0051721;GO:0044877;GO:0017124;GO:0035591;GO:0043184;GO:0007257;GO:0000185;GO:0001525;GO:0007049;GO:0021814;GO:0044257;GO:0071364;GO:0071347;GO:0071222;GO:0071356;GO:0034620;GO:0035924;GO:0072577;GO:0008625;GO:0007252;GO:0006954;GO:0045087;GO:0070059;GO:0021819;GO:0000165;GO:0016525;GO:0090090;GO:0008285;GO:1903363;GO:0010596;GO:0042059;GO:0010633;GO:0050680;GO:0010719;GO:0070373;GO:0048147;GO:0070317;GO:0034260;GO:0043124;GO:0043407;GO:0032088;GO:0043553;GO:0014067;GO:0001933;GO:0071901;GO:0046580;GO:0034144;GO:0000122;GO:0045892;GO:0030948;GO:1900747;GO:0048812;GO:0043065;GO:2001235;GO:0071158;GO:1900006;GO:1903896;GO:0046330;GO:0043507;GO:0043410;GO:2001224;GO:0010976;GO:1901800;GO:0045732;GO:0071902;GO:0031334;GO:0090129;GO:0045944;GO:0038026;GO:0040008;GO:0043087;GO:0043122;GO:1900744;GO:0043254;GO:0035148;GO:0036324;, C:AIP1-IRE1 complex; C:axon; C:cerebellar mossy fiber; C:climbing fiber; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:neuronal cell body; C:neuronal cell body membrane; C:parallel fiber; C:plasma membrane;, F:14-3-3 protein binding; F:cadherin binding; F:death receptor binding; F:GTPase activator activity; F:identical protein binding; F:kinase binding; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:SH3 domain binding; F:signaling adaptor activity; F:vascular endothelial growth factor receptor 2 binding;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:angiogenesis; P:cell cycle; P:cell motility involved in cerebral cortex radial glia guided migration; P:cellular protein catabolic process; P:cellular response to epidermal growth factor stimulus; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:cellular response to unfolded protein; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB phosphorylation; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:layer formation in cerebral cortex; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cellular protein catabolic process; P:negative regulation of endothelial cell migration; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of GTPase activity; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatidylinositol 3-kinase activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of Ras protein signal transduction; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of cell cycle arrest; P:positive regulation of dendrite development; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron migration; P:positive regulation of neuron projection development; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of synapse maturation; P:positive regulation of transcription by RNA polymerase II; P:reelin-mediated signaling pathway; P:regulation of growth; P:regulation of GTPase activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of p38MAPK cascade; P:regulation of protein-containing complex assembly; P:tube formation; P:vascular endothelial growth factor receptor-2 signaling pathway;|Q5VWQ8 A6H8V2 A6NHI9 B0QZB1 G3XA90 Q8TDL2 Q96SE1 Q9C0C0,Disabled homolog 2-interacting protein,ASK-interacting protein 1;DOC-2/DAB-2 interactive protein;, PF00168;PF12004;PF00616;, GO:1990597;GO:0030424;GO:0044300;GO:0044301;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0043025;GO:0032809;GO:1990032;GO:0005886;GO:0071889;GO:0045296;GO:0005123;GO:0005096;GO:0042802;GO:0019900;GO:0031434;GO:0031435;GO:0043548;GO:0036312;GO:0032266;GO:0070273;GO:0042803;GO:0019901;GO:0051721;GO:0044877;GO:0017124;GO:0035591;GO:0043184;GO:0007257;GO:0000185;GO:0001525;GO:0007049;GO:0021814;GO:0044257;GO:0071364;GO:0071347;GO:0071222;GO:0071356;GO:0034620;GO:0035924;GO:0072577;GO:0008625;GO:0007252;GO:0006954;GO:0045087;GO:0070059;GO:0021819;GO:0000165;GO:0016525;GO:0090090;GO:0008285;GO:1903363;GO:0010596;GO:0042059;GO:0010633;GO:0050680;GO:0010719;GO:0070373;GO:0048147;GO:0070317;GO:0034260;GO:0043124;GO:0043407;GO:0032088;GO:0043553;GO:0014067;GO:0001933;GO:0071901;GO:0046580;GO:0034144;GO:0000122;GO:0045892;GO:0030948;GO:1900747;GO:0048812;GO:0043065;GO:2001235;GO:0071158;GO:1900006;GO:1903896;GO:0046330;GO:0043507;GO:0043410;GO:2001224;GO:0010976;GO:1901800;GO:0045732;GO:0071902;GO:0031334;GO:0090129;GO:0045944;GO:0038026;GO:0040008;GO:0043087;GO:0043122;GO:1900744;GO:0043254;GO:0035148;GO:0036324;, C:AIP1-IRE1 complex; C:axon; C:cerebellar mossy fiber; C:climbing fiber; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:neuronal cell body; C:neuronal cell body membrane; C:parallel fiber; C:plasma membrane;, F:14-3-3 protein binding; F:cadherin binding; F:death receptor binding; F:GTPase activator activity; F:identical protein binding; F:kinase binding; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:SH3 domain binding; F:signaling adaptor activity; F:vascular endothelial growth factor receptor 2 binding;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:angiogenesis; P:cell cycle; P:cell motility involved in cerebral cortex radial glia guided migration; P:cellular protein catabolic process; P:cellular response to epidermal growth factor stimulus; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:cellular response to unfolded protein; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB phosphorylation; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:layer formation in cerebral cortex; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cellular protein catabolic process; P:negative regulation of endothelial cell migration; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of GTPase activity; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatidylinositol 3-kinase activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of Ras protein signal transduction; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of cell cycle arrest; P:positive regulation of dendrite development; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron migration; P:positive regulation of neuron projection development; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of synapse maturation; P:positive regulation of transcription by RNA polymerase II; P:reelin-mediated signaling pathway; P:regulation of growth; P:regulation of GTPase activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of p38MAPK cascade; P:regulation of protein-containing complex assembly; P:tube formation; P:vascular endothelial growth factor receptor-2 signaling pathway; scaffold12 indexed_genome mRNA 41525593 41554388 . - . ID=transcript_3263;Q5VWQ8 A6H8V2 A6NHI9 B0QZB1 G3XA90 Q8TDL2 Q96SE1 Q9C0C0,Disabled homolog 2-interacting protein,ASK-interacting protein 1;DOC-2/DAB-2 interactive protein;, PF00168;PF12004;PF00616;, GO:1990597;GO:0030424;GO:0044300;GO:0044301;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0043025;GO:0032809;GO:1990032;GO:0005886;GO:0071889;GO:0045296;GO:0005123;GO:0005096;GO:0042802;GO:0019900;GO:0031434;GO:0031435;GO:0043548;GO:0036312;GO:0032266;GO:0070273;GO:0042803;GO:0019901;GO:0051721;GO:0044877;GO:0017124;GO:0035591;GO:0043184;GO:0007257;GO:0000185;GO:0001525;GO:0007049;GO:0021814;GO:0044257;GO:0071364;GO:0071347;GO:0071222;GO:0071356;GO:0034620;GO:0035924;GO:0072577;GO:0008625;GO:0007252;GO:0006954;GO:0045087;GO:0070059;GO:0021819;GO:0000165;GO:0016525;GO:0090090;GO:0008285;GO:1903363;GO:0010596;GO:0042059;GO:0010633;GO:0050680;GO:0010719;GO:0070373;GO:0048147;GO:0070317;GO:0034260;GO:0043124;GO:0043407;GO:0032088;GO:0043553;GO:0014067;GO:0001933;GO:0071901;GO:0046580;GO:0034144;GO:0000122;GO:0045892;GO:0030948;GO:1900747;GO:0048812;GO:0043065;GO:2001235;GO:0071158;GO:1900006;GO:1903896;GO:0046330;GO:0043507;GO:0043410;GO:2001224;GO:0010976;GO:1901800;GO:0045732;GO:0071902;GO:0031334;GO:0090129;GO:0045944;GO:0038026;GO:0040008;GO:0043087;GO:0043122;GO:1900744;GO:0043254;GO:0035148;GO:0036324;, C:AIP1-IRE1 complex; C:axon; C:cerebellar mossy fiber; C:climbing fiber; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:neuronal cell body; C:neuronal cell body membrane; C:parallel fiber; C:plasma membrane;, F:14-3-3 protein binding; F:cadherin binding; F:death receptor binding; F:GTPase activator activity; F:identical protein binding; F:kinase binding; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:SH3 domain binding; F:signaling adaptor activity; F:vascular endothelial growth factor receptor 2 binding;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:angiogenesis; P:cell cycle; P:cell motility involved in cerebral cortex radial glia guided migration; P:cellular protein catabolic process; P:cellular response to epidermal growth factor stimulus; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:cellular response to unfolded protein; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB phosphorylation; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:layer formation in cerebral cortex; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cellular protein catabolic process; P:negative regulation of endothelial cell migration; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of GTPase activity; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatidylinositol 3-kinase activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of Ras protein signal transduction; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of cell cycle arrest; P:positive regulation of dendrite development; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron migration; P:positive regulation of neuron projection development; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of synapse maturation; P:positive regulation of transcription by RNA polymerase II; P:reelin-mediated signaling pathway; P:regulation of growth; P:regulation of GTPase activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of p38MAPK cascade; P:regulation of protein-containing complex assembly; P:tube formation; P:vascular endothelial growth factor receptor-2 signaling pathway;|Q5VWQ8 A6H8V2 A6NHI9 B0QZB1 G3XA90 Q8TDL2 Q96SE1 Q9C0C0,Disabled homolog 2-interacting protein,ASK-interacting protein 1;DOC-2/DAB-2 interactive protein;, PF00168;PF12004;PF00616;, GO:1990597;GO:0030424;GO:0044300;GO:0044301;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0043025;GO:0032809;GO:1990032;GO:0005886;GO:0071889;GO:0045296;GO:0005123;GO:0005096;GO:0042802;GO:0019900;GO:0031434;GO:0031435;GO:0043548;GO:0036312;GO:0032266;GO:0070273;GO:0042803;GO:0019901;GO:0051721;GO:0044877;GO:0017124;GO:0035591;GO:0043184;GO:0007257;GO:0000185;GO:0001525;GO:0007049;GO:0021814;GO:0044257;GO:0071364;GO:0071347;GO:0071222;GO:0071356;GO:0034620;GO:0035924;GO:0072577;GO:0008625;GO:0007252;GO:0006954;GO:0045087;GO:0070059;GO:0021819;GO:0000165;GO:0016525;GO:0090090;GO:0008285;GO:1903363;GO:0010596;GO:0042059;GO:0010633;GO:0050680;GO:0010719;GO:0070373;GO:0048147;GO:0070317;GO:0034260;GO:0043124;GO:0043407;GO:0032088;GO:0043553;GO:0014067;GO:0001933;GO:0071901;GO:0046580;GO:0034144;GO:0000122;GO:0045892;GO:0030948;GO:1900747;GO:0048812;GO:0043065;GO:2001235;GO:0071158;GO:1900006;GO:1903896;GO:0046330;GO:0043507;GO:0043410;GO:2001224;GO:0010976;GO:1901800;GO:0045732;GO:0071902;GO:0031334;GO:0090129;GO:0045944;GO:0038026;GO:0040008;GO:0043087;GO:0043122;GO:1900744;GO:0043254;GO:0035148;GO:0036324;, C:AIP1-IRE1 complex; C:axon; C:cerebellar mossy fiber; C:climbing fiber; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:neuronal cell body; C:neuronal cell body membrane; C:parallel fiber; C:plasma membrane;, F:14-3-3 protein binding; F:cadherin binding; F:death receptor binding; F:GTPase activator activity; F:identical protein binding; F:kinase binding; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:SH3 domain binding; F:signaling adaptor activity; F:vascular endothelial growth factor receptor 2 binding;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:angiogenesis; P:cell cycle; P:cell motility involved in cerebral cortex radial glia guided migration; P:cellular protein catabolic process; P:cellular response to epidermal growth factor stimulus; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:cellular response to unfolded protein; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB phosphorylation; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:layer formation in cerebral cortex; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cellular protein catabolic process; P:negative regulation of endothelial cell migration; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of GTPase activity; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatidylinositol 3-kinase activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of Ras protein signal transduction; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of cell cycle arrest; P:positive regulation of dendrite development; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron migration; P:positive regulation of neuron projection development; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of synapse maturation; P:positive regulation of transcription by RNA polymerase II; P:reelin-mediated signaling pathway; P:regulation of growth; P:regulation of GTPase activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of p38MAPK cascade; P:regulation of protein-containing complex assembly; P:tube formation; P:vascular endothelial growth factor receptor-2 signaling pathway;|Q5VWQ8 A6H8V2 A6NHI9 B0QZB1 G3XA90 Q8TDL2 Q96SE1 Q9C0C0,Disabled homolog 2-interacting protein,ASK-interacting protein 1;DOC-2/DAB-2 interactive protein;, PF00168;PF12004;PF00616;, GO:1990597;GO:0030424;GO:0044300;GO:0044301;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0043025;GO:0032809;GO:1990032;GO:0005886;GO:0071889;GO:0045296;GO:0005123;GO:0005096;GO:0042802;GO:0019900;GO:0031434;GO:0031435;GO:0043548;GO:0036312;GO:0032266;GO:0070273;GO:0042803;GO:0019901;GO:0051721;GO:0044877;GO:0017124;GO:0035591;GO:0043184;GO:0007257;GO:0000185;GO:0001525;GO:0007049;GO:0021814;GO:0044257;GO:0071364;GO:0071347;GO:0071222;GO:0071356;GO:0034620;GO:0035924;GO:0072577;GO:0008625;GO:0007252;GO:0006954;GO:0045087;GO:0070059;GO:0021819;GO:0000165;GO:0016525;GO:0090090;GO:0008285;GO:1903363;GO:0010596;GO:0042059;GO:0010633;GO:0050680;GO:0010719;GO:0070373;GO:0048147;GO:0070317;GO:0034260;GO:0043124;GO:0043407;GO:0032088;GO:0043553;GO:0014067;GO:0001933;GO:0071901;GO:0046580;GO:0034144;GO:0000122;GO:0045892;GO:0030948;GO:1900747;GO:0048812;GO:0043065;GO:2001235;GO:0071158;GO:1900006;GO:1903896;GO:0046330;GO:0043507;GO:0043410;GO:2001224;GO:0010976;GO:1901800;GO:0045732;GO:0071902;GO:0031334;GO:0090129;GO:0045944;GO:0038026;GO:0040008;GO:0043087;GO:0043122;GO:1900744;GO:0043254;GO:0035148;GO:0036324;, C:AIP1-IRE1 complex; C:axon; C:cerebellar mossy fiber; C:climbing fiber; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:neuronal cell body; C:neuronal cell body membrane; C:parallel fiber; C:plasma membrane;, F:14-3-3 protein binding; F:cadherin binding; F:death receptor binding; F:GTPase activator activity; F:identical protein binding; F:kinase binding; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:SH3 domain binding; F:signaling adaptor activity; F:vascular endothelial growth factor receptor 2 binding;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:angiogenesis; P:cell cycle; P:cell motility involved in cerebral cortex radial glia guided migration; P:cellular protein catabolic process; P:cellular response to epidermal growth factor stimulus; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:cellular response to unfolded protein; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB phosphorylation; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:layer formation in cerebral cortex; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cellular protein catabolic process; P:negative regulation of endothelial cell migration; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of GTPase activity; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatidylinositol 3-kinase activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of Ras protein signal transduction; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of cell cycle arrest; P:positive regulation of dendrite development; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron migration; P:positive regulation of neuron projection development; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of synapse maturation; P:positive regulation of transcription by RNA polymerase II; P:reelin-mediated signaling pathway; P:regulation of growth; P:regulation of GTPase activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of p38MAPK cascade; P:regulation of protein-containing complex assembly; P:tube formation; P:vascular endothelial growth factor receptor-2 signaling pathway;|Q5VWQ8 A6H8V2 A6NHI9 B0QZB1 G3XA90 Q8TDL2 Q96SE1 Q9C0C0,Disabled homolog 2-interacting protein,ASK-interacting protein 1;DOC-2/DAB-2 interactive protein;, PF00168;PF12004;PF00616;, GO:1990597;GO:0030424;GO:0044300;GO:0044301;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0043025;GO:0032809;GO:1990032;GO:0005886;GO:0071889;GO:0045296;GO:0005123;GO:0005096;GO:0042802;GO:0019900;GO:0031434;GO:0031435;GO:0043548;GO:0036312;GO:0032266;GO:0070273;GO:0042803;GO:0019901;GO:0051721;GO:0044877;GO:0017124;GO:0035591;GO:0043184;GO:0007257;GO:0000185;GO:0001525;GO:0007049;GO:0021814;GO:0044257;GO:0071364;GO:0071347;GO:0071222;GO:0071356;GO:0034620;GO:0035924;GO:0072577;GO:0008625;GO:0007252;GO:0006954;GO:0045087;GO:0070059;GO:0021819;GO:0000165;GO:0016525;GO:0090090;GO:0008285;GO:1903363;GO:0010596;GO:0042059;GO:0010633;GO:0050680;GO:0010719;GO:0070373;GO:0048147;GO:0070317;GO:0034260;GO:0043124;GO:0043407;GO:0032088;GO:0043553;GO:0014067;GO:0001933;GO:0071901;GO:0046580;GO:0034144;GO:0000122;GO:0045892;GO:0030948;GO:1900747;GO:0048812;GO:0043065;GO:2001235;GO:0071158;GO:1900006;GO:1903896;GO:0046330;GO:0043507;GO:0043410;GO:2001224;GO:0010976;GO:1901800;GO:0045732;GO:0071902;GO:0031334;GO:0090129;GO:0045944;GO:0038026;GO:0040008;GO:0043087;GO:0043122;GO:1900744;GO:0043254;GO:0035148;GO:0036324;, C:AIP1-IRE1 complex; C:axon; C:cerebellar mossy fiber; C:climbing fiber; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:neuronal cell body; C:neuronal cell body membrane; C:parallel fiber; C:plasma membrane;, F:14-3-3 protein binding; F:cadherin binding; F:death receptor binding; F:GTPase activator activity; F:identical protein binding; F:kinase binding; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:SH3 domain binding; F:signaling adaptor activity; F:vascular endothelial growth factor receptor 2 binding;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:angiogenesis; P:cell cycle; P:cell motility involved in cerebral cortex radial glia guided migration; P:cellular protein catabolic process; P:cellular response to epidermal growth factor stimulus; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:cellular response to unfolded protein; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB phosphorylation; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:layer formation in cerebral cortex; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cellular protein catabolic process; P:negative regulation of endothelial cell migration; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of GTPase activity; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatidylinositol 3-kinase activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of Ras protein signal transduction; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of cell cycle arrest; P:positive regulation of dendrite development; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron migration; P:positive regulation of neuron projection development; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of synapse maturation; P:positive regulation of transcription by RNA polymerase II; P:reelin-mediated signaling pathway; P:regulation of growth; P:regulation of GTPase activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of p38MAPK cascade; P:regulation of protein-containing complex assembly; P:tube formation; P:vascular endothelial growth factor receptor-2 signaling pathway; scaffold12 indexed_genome mRNA 41573207 41841557 . - . ID=transcript_3264;Q8NHH1 F8W6M1,Tubulin polyglutamylase TTLL11,Tubulin--tyrosine ligase-like protein 11;, PF03133;, GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0015631;GO:0070740;GO:0000226;GO:0051013;GO:0018095;, C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:microtubule severing; P:protein polyglutamylation;|Q8NHH1 F8W6M1,Tubulin polyglutamylase TTLL11,Tubulin--tyrosine ligase-like protein 11;, PF03133;, GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0015631;GO:0070740;GO:0000226;GO:0051013;GO:0018095;, C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:microtubule severing; P:protein polyglutamylation;|Q8NHH1 F8W6M1,Tubulin polyglutamylase TTLL11,Tubulin--tyrosine ligase-like protein 11;, PF03133;, GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0015631;GO:0070740;GO:0000226;GO:0051013;GO:0018095;, C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:microtubule severing; P:protein polyglutamylation; scaffold12 indexed_genome mRNA 41879200 41885846 . - . ID=transcript_3265;P51970 B1AM93 Q9Y6N0,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8,Complex I-19kD;Complex I-PGIV;NADH-ubiquinone oxidoreductase 19 kDa subunit;, PF06747;, GO:0005743;GO:0005758;GO:0005747;GO:0005739;GO:0008137;GO:0044877;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity; F:protein-containing complex binding;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold12 indexed_genome mRNA 41945091 41957858 . - . ID=transcript_3266;Q9UPM5,LIM/homeobox protein Lhx6,LIM/homeobox protein Lhx6.1;, PF00046;PF00412;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0048469;GO:0021853;GO:0021799;GO:0021800;GO:0021884;GO:0030182;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell maturation; P:cerebral cortex GABAergic interneuron migration; P:cerebral cortex radially oriented cell migration; P:cerebral cortex tangential migration; P:forebrain neuron development; P:neuron differentiation; P:regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 41969098 41990557 . - . ID=transcript_3267;Q96H35 B3KQ89,Probable RNA-binding protein 18,RNA-binding motif protein 18;, PF00076;, GO:0005829;GO:0045171;GO:0005654;GO:0003723;, C:cytosol; C:intercellular bridge; C:nucleoplasm;, F:RNA binding; scaffold12 indexed_genome mRNA 42081576 42105234 . + . ID=transcript_3268;Q5T7T8,Prostaglandin G/H synthase 1 {ECO:0000305},Cyclooxygenase-1 {ECO:0000303|PubMed:15308583};Prostaglandin H2 synthase 1;Prostaglandin-endoperoxide synthase 1;, PF03098;PF00008;, GO:0005737;GO:0005789;GO:0070062;GO:0005794;GO:0043231;GO:0001750;GO:0051213;GO:0020037;GO:0046872;GO:0004601;GO:0004666;GO:0019371;GO:0006954;GO:0001516;GO:0006692;GO:0008217;GO:0042127;GO:0006979;, C:cytoplasm; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:photoreceptor outer segment;, F:dioxygenase activity; F:heme binding; F:metal ion binding; F:peroxidase activity; F:prostaglandin-endoperoxide synthase activity;, P:cyclooxygenase pathway; P:inflammatory response; P:prostaglandin biosynthetic process; P:prostanoid metabolic process; P:regulation of blood pressure; P:regulation of cell population proliferation; P:response to oxidative stress; scaffold12 indexed_genome mRNA 42782702 42790966 . + . ID=transcript_3269;Q13371 Q4VXB6 Q96AF1 Q9UEW7 Q9UFL0 Q9UNX1 Q9UNX2,Phosducin-like protein,, PF02114;, GO:0005929;GO:0005737;GO:0005829;GO:0044877;GO:0030030;GO:1902605;GO:0061084;GO:0045880;GO:0006457;GO:0008277;GO:0007165;GO:0007601;, C:cilium; C:cytoplasm; C:cytosol;, F:protein-containing complex binding;, P:cell projection organization; P:heterotrimeric G-protein complex assembly; P:negative regulation of protein refolding; P:positive regulation of smoothened signaling pathway; P:protein folding; P:regulation of G protein-coupled receptor signaling pathway; P:signal transduction; P:visual perception;|Q13371 Q4VXB6 Q96AF1 Q9UEW7 Q9UFL0 Q9UNX1 Q9UNX2,Phosducin-like protein,, PF02114;, GO:0005929;GO:0005737;GO:0005829;GO:0044877;GO:0030030;GO:1902605;GO:0061084;GO:0045880;GO:0006457;GO:0008277;GO:0007165;GO:0007601;, C:cilium; C:cytoplasm; C:cytosol;, F:protein-containing complex binding;, P:cell projection organization; P:heterotrimeric G-protein complex assembly; P:negative regulation of protein refolding; P:positive regulation of smoothened signaling pathway; P:protein folding; P:regulation of G protein-coupled receptor signaling pathway; P:signal transduction; P:visual perception;|Q13371 Q4VXB6 Q96AF1 Q9UEW7 Q9UFL0 Q9UNX1 Q9UNX2,Phosducin-like protein,, PF02114;, GO:0005929;GO:0005737;GO:0005829;GO:0044877;GO:0030030;GO:1902605;GO:0061084;GO:0045880;GO:0006457;GO:0008277;GO:0007165;GO:0007601;, C:cilium; C:cytoplasm; C:cytosol;, F:protein-containing complex binding;, P:cell projection organization; P:heterotrimeric G-protein complex assembly; P:negative regulation of protein refolding; P:positive regulation of smoothened signaling pathway; P:protein folding; P:regulation of G protein-coupled receptor signaling pathway; P:signal transduction; P:visual perception; scaffold12 indexed_genome mRNA 42810093 42859945 . - . ID=transcript_3270;Q9NXE1,Roquin-2,Membrane-associated nucleic acid-binding protein;RING finger and CCCH-type zinc finger domain-containing protein 2;RING finger protein 164;RING-type E3 ubiquitin transferase Roquin-2 {ECO:0000305};, PF18386;PF00642;PF13445;, GO:0009986;GO:0010494;GO:0043231;GO:0016020;GO:0000932;GO:0003677;GO:0003725;GO:0046872;GO:0003729;GO:0003723;GO:0035613;GO:0061630;GO:0001782;GO:0060173;GO:0048286;GO:0048535;GO:0035264;GO:2000320;GO:0000288;GO:1901224;GO:0009791;GO:0000209;GO:2000628;GO:0043488;GO:0048536;GO:0043029;GO:0042098;GO:0050852;GO:0061470;GO:0006511;, C:cell surface; C:cytoplasmic stress granule; C:intracellular membrane-bounded organelle; C:membrane; C:P-body;, F:DNA binding; F:double-stranded RNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding; F:RNA stem-loop binding; F:ubiquitin protein ligase activity;, P:B cell homeostasis; P:limb development; P:lung alveolus development; P:lymph node development; P:multicellular organism growth; P:negative regulation of T-helper 17 cell differentiation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of NIK/NF-kappaB signaling; P:post-embryonic development; P:protein polyubiquitination; P:regulation of miRNA metabolic process; P:regulation of mRNA stability; P:spleen development; P:T cell homeostasis; P:T cell proliferation; P:T cell receptor signaling pathway; P:T follicular helper cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q9NXE1,Roquin-2,Membrane-associated nucleic acid-binding protein;RING finger and CCCH-type zinc finger domain-containing protein 2;RING finger protein 164;RING-type E3 ubiquitin transferase Roquin-2 {ECO:0000305};, PF18386;PF00642;PF13445;, GO:0009986;GO:0010494;GO:0043231;GO:0016020;GO:0000932;GO:0003677;GO:0003725;GO:0046872;GO:0003729;GO:0003723;GO:0035613;GO:0061630;GO:0001782;GO:0060173;GO:0048286;GO:0048535;GO:0035264;GO:2000320;GO:0000288;GO:1901224;GO:0009791;GO:0000209;GO:2000628;GO:0043488;GO:0048536;GO:0043029;GO:0042098;GO:0050852;GO:0061470;GO:0006511;, C:cell surface; C:cytoplasmic stress granule; C:intracellular membrane-bounded organelle; C:membrane; C:P-body;, F:DNA binding; F:double-stranded RNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding; F:RNA stem-loop binding; F:ubiquitin protein ligase activity;, P:B cell homeostasis; P:limb development; P:lung alveolus development; P:lymph node development; P:multicellular organism growth; P:negative regulation of T-helper 17 cell differentiation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of NIK/NF-kappaB signaling; P:post-embryonic development; P:protein polyubiquitination; P:regulation of miRNA metabolic process; P:regulation of mRNA stability; P:spleen development; P:T cell homeostasis; P:T cell proliferation; P:T cell receptor signaling pathway; P:T follicular helper cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q9NXE1,Roquin-2,Membrane-associated nucleic acid-binding protein;RING finger and CCCH-type zinc finger domain-containing protein 2;RING finger protein 164;RING-type E3 ubiquitin transferase Roquin-2 {ECO:0000305};, PF18386;PF00642;PF13445;, GO:0009986;GO:0010494;GO:0043231;GO:0016020;GO:0000932;GO:0003677;GO:0003725;GO:0046872;GO:0003729;GO:0003723;GO:0035613;GO:0061630;GO:0001782;GO:0060173;GO:0048286;GO:0048535;GO:0035264;GO:2000320;GO:0000288;GO:1901224;GO:0009791;GO:0000209;GO:2000628;GO:0043488;GO:0048536;GO:0043029;GO:0042098;GO:0050852;GO:0061470;GO:0006511;, C:cell surface; C:cytoplasmic stress granule; C:intracellular membrane-bounded organelle; C:membrane; C:P-body;, F:DNA binding; F:double-stranded RNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding; F:RNA stem-loop binding; F:ubiquitin protein ligase activity;, P:B cell homeostasis; P:limb development; P:lung alveolus development; P:lymph node development; P:multicellular organism growth; P:negative regulation of T-helper 17 cell differentiation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of NIK/NF-kappaB signaling; P:post-embryonic development; P:protein polyubiquitination; P:regulation of miRNA metabolic process; P:regulation of mRNA stability; P:spleen development; P:T cell homeostasis; P:T cell proliferation; P:T cell receptor signaling pathway; P:T follicular helper cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q9NXE1,Roquin-2,Membrane-associated nucleic acid-binding protein;RING finger and CCCH-type zinc finger domain-containing protein 2;RING finger protein 164;RING-type E3 ubiquitin transferase Roquin-2 {ECO:0000305};, PF18386;PF00642;PF13445;, GO:0009986;GO:0010494;GO:0043231;GO:0016020;GO:0000932;GO:0003677;GO:0003725;GO:0046872;GO:0003729;GO:0003723;GO:0035613;GO:0061630;GO:0001782;GO:0060173;GO:0048286;GO:0048535;GO:0035264;GO:2000320;GO:0000288;GO:1901224;GO:0009791;GO:0000209;GO:2000628;GO:0043488;GO:0048536;GO:0043029;GO:0042098;GO:0050852;GO:0061470;GO:0006511;, C:cell surface; C:cytoplasmic stress granule; C:intracellular membrane-bounded organelle; C:membrane; C:P-body;, F:DNA binding; F:double-stranded RNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding; F:RNA stem-loop binding; F:ubiquitin protein ligase activity;, P:B cell homeostasis; P:limb development; P:lung alveolus development; P:lymph node development; P:multicellular organism growth; P:negative regulation of T-helper 17 cell differentiation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of NIK/NF-kappaB signaling; P:post-embryonic development; P:protein polyubiquitination; P:regulation of miRNA metabolic process; P:regulation of mRNA stability; P:spleen development; P:T cell homeostasis; P:T cell proliferation; P:T cell receptor signaling pathway; P:T follicular helper cell differentiation; P:ubiquitin-dependent protein catabolic process; scaffold12 indexed_genome mRNA 42862240 42865050 . - . ID=transcript_3271;Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization; scaffold12 indexed_genome mRNA 42865213 42869019 . - . ID=transcript_3272;Q15916 A8K8N6,Zinc finger and BTB domain-containing protein 6,Zinc finger protein 482;Zinc finger protein with interaction domain;, PF00651;PF00096;, GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 42870452 42877395 . + . ID=transcript_3273;Q9HCK0 B3KQ53 Q8WTR1,Zinc finger and BTB domain-containing protein 26,Zinc finger protein 481;Zinc finger protein Bioref;, PF00651;PF00096;, GO:0005654;GO:0001227;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 42901012 43043679 . + . ID=transcript_3274;Q9Y3P9 B9A6L2 Q05CW2 Q6ZMY1 Q9HA28 Q9P0E2 Q9UG67,Rab GTPase-activating protein 1,GAP and centrosome-associated protein;Rab6 GTPase-activating protein GAPCenA;, PF12473;PF00640;PF00566;, GO:0005813;GO:0005829;GO:0005875;GO:0005096;GO:0031267;GO:0015631;GO:0090630;GO:0007049;GO:0006886;GO:0043087;, C:centrosome; C:cytosol; C:microtubule associated complex;, F:GTPase activator activity; F:small GTPase binding; F:tubulin binding;, P:activation of GTPase activity; P:cell cycle; P:intracellular protein transport; P:regulation of GTPase activity;|Q9Y3P9 B9A6L2 Q05CW2 Q6ZMY1 Q9HA28 Q9P0E2 Q9UG67,Rab GTPase-activating protein 1,GAP and centrosome-associated protein;Rab6 GTPase-activating protein GAPCenA;, PF12473;PF00640;PF00566;, GO:0005813;GO:0005829;GO:0005875;GO:0005096;GO:0031267;GO:0015631;GO:0090630;GO:0007049;GO:0006886;GO:0043087;, C:centrosome; C:cytosol; C:microtubule associated complex;, F:GTPase activator activity; F:small GTPase binding; F:tubulin binding;, P:activation of GTPase activity; P:cell cycle; P:intracellular protein transport; P:regulation of GTPase activity;|P61201 O88950 Q15647 Q6FGP4 Q9BY54 Q9R249 Q9UNI2 Q9UNQ5,COP9 signalosome complex subunit 2,Alien homolog;JAB1-containing signalosome subunit 2;Thyroid receptor-interacting protein 15;, PF01399;, GO:0008180;GO:0005737;GO:0005829;GO:0005654;GO:0003714;GO:0001833;GO:1903507;GO:0000122;GO:0045892;GO:0030182;GO:0000715;GO:0043687;GO:0000338;GO:0006468;GO:0007165;GO:0035914;GO:0006366;GO:0006283;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:transcription corepressor activity;, P:inner cell mass cell proliferation; P:negative regulation of nucleic acid-templated transcription; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:protein phosphorylation; P:signal transduction; P:skeletal muscle cell differentiation; P:transcription by RNA polymerase II; P:transcription-coupled nucleotide-excision repair;|Q9Y3P9 B9A6L2 Q05CW2 Q6ZMY1 Q9HA28 Q9P0E2 Q9UG67,Rab GTPase-activating protein 1,GAP and centrosome-associated protein;Rab6 GTPase-activating protein GAPCenA;, PF12473;PF00640;PF00566;, GO:0005813;GO:0005829;GO:0005875;GO:0005096;GO:0031267;GO:0015631;GO:0090630;GO:0007049;GO:0006886;GO:0043087;, C:centrosome; C:cytosol; C:microtubule associated complex;, F:GTPase activator activity; F:small GTPase binding; F:tubulin binding;, P:activation of GTPase activity; P:cell cycle; P:intracellular protein transport; P:regulation of GTPase activity;|Q9Y3P9 B9A6L2 Q05CW2 Q6ZMY1 Q9HA28 Q9P0E2 Q9UG67,Rab GTPase-activating protein 1,GAP and centrosome-associated protein;Rab6 GTPase-activating protein GAPCenA;, PF12473;PF00640;PF00566;, GO:0005813;GO:0005829;GO:0005875;GO:0005096;GO:0031267;GO:0015631;GO:0090630;GO:0007049;GO:0006886;GO:0043087;, C:centrosome; C:cytosol; C:microtubule associated complex;, F:GTPase activator activity; F:small GTPase binding; F:tubulin binding;, P:activation of GTPase activity; P:cell cycle; P:intracellular protein transport; P:regulation of GTPase activity;|Q9Y3P9 B9A6L2 Q05CW2 Q6ZMY1 Q9HA28 Q9P0E2 Q9UG67,Rab GTPase-activating protein 1,GAP and centrosome-associated protein;Rab6 GTPase-activating protein GAPCenA;, PF12473;PF00640;PF00566;, GO:0005813;GO:0005829;GO:0005875;GO:0005096;GO:0031267;GO:0015631;GO:0090630;GO:0007049;GO:0006886;GO:0043087;, C:centrosome; C:cytosol; C:microtubule associated complex;, F:GTPase activator activity; F:small GTPase binding; F:tubulin binding;, P:activation of GTPase activity; P:cell cycle; P:intracellular protein transport; P:regulation of GTPase activity;|Q9Y3P9 B9A6L2 Q05CW2 Q6ZMY1 Q9HA28 Q9P0E2 Q9UG67,Rab GTPase-activating protein 1,GAP and centrosome-associated protein;Rab6 GTPase-activating protein GAPCenA;, PF12473;PF00640;PF00566;, GO:0005813;GO:0005829;GO:0005875;GO:0005096;GO:0031267;GO:0015631;GO:0090630;GO:0007049;GO:0006886;GO:0043087;, C:centrosome; C:cytosol; C:microtubule associated complex;, F:GTPase activator activity; F:small GTPase binding; F:tubulin binding;, P:activation of GTPase activity; P:cell cycle; P:intracellular protein transport; P:regulation of GTPase activity; scaffold12 indexed_genome mRNA 43061576 43067573 . - . ID=transcript_3275;Q96SI9 Q32NB9 Q9BUE1 Q9BXG4 Q9H0B4 Q9H7V1 Q9NUK4,Spermatid perinuclear RNA-binding protein,, PF00035;PF07528;, GO:0005737;GO:0002177;GO:0005634;GO:0003677;GO:0003725;GO:0008017;GO:0003723;GO:0003727;GO:0007638;GO:0007275;GO:0007286;, C:cytoplasm; C:manchette; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:microtubule binding; F:RNA binding; F:single-stranded RNA binding;, P:mechanosensory behavior; P:multicellular organism development; P:spermatid development; scaffold12 indexed_genome mRNA 43067640 43124190 . - . ID=transcript_3276;Q96SI9 Q32NB9 Q9BUE1 Q9BXG4 Q9H0B4 Q9H7V1 Q9NUK4,Spermatid perinuclear RNA-binding protein,, PF00035;PF07528;, GO:0005737;GO:0002177;GO:0005634;GO:0003677;GO:0003725;GO:0008017;GO:0003723;GO:0003727;GO:0007638;GO:0007275;GO:0007286;, C:cytoplasm; C:manchette; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:microtubule binding; F:RNA binding; F:single-stranded RNA binding;, P:mechanosensory behavior; P:multicellular organism development; P:spermatid development;|Q96SI9 Q32NB9 Q9BUE1 Q9BXG4 Q9H0B4 Q9H7V1 Q9NUK4,Spermatid perinuclear RNA-binding protein,, PF00035;PF07528;, GO:0005737;GO:0002177;GO:0005634;GO:0003677;GO:0003725;GO:0008017;GO:0003723;GO:0003727;GO:0007638;GO:0007275;GO:0007286;, C:cytoplasm; C:manchette; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:microtubule binding; F:RNA binding; F:single-stranded RNA binding;, P:mechanosensory behavior; P:multicellular organism development; P:spermatid development; scaffold12 indexed_genome mRNA 43303518 43305531 . + . ID=transcript_3277;Q5IJ48 A2A3N4 Q0QD46 Q5JS41 Q5JS43 Q6ZTA9 Q6ZWI6,Protein crumbs homolog 2 {ECO:0000305},Crumbs-like protein 2;, PF00008;PF12661;PF02210;, GO:0016324;GO:0016327;GO:0030054;GO:0005737;GO:0070062;GO:0016021;GO:0005886;GO:0032991;GO:0019828;GO:0005509;GO:0044877;GO:0072359;GO:0030010;GO:0045197;GO:0007157;GO:0055111;GO:0045199;GO:0001707;GO:0010951;GO:0014028;GO:0045494;GO:0030513;GO:0010718;GO:0010470;GO:0050896;GO:0001895;GO:0046549;GO:0001756;GO:0007601;, C:apical plasma membrane; C:apicolateral plasma membrane; C:cell junction; C:cytoplasm; C:extracellular exosome; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:aspartic-type endopeptidase inhibitor activity; F:calcium ion binding; F:protein-containing complex binding;, P:circulatory system development; P:establishment of cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:ingression involved in gastrulation with mouth forming second; P:maintenance of epithelial cell apical/basal polarity; P:mesoderm formation; P:negative regulation of endopeptidase activity; P:notochord formation; P:photoreceptor cell maintenance; P:positive regulation of BMP signaling pathway; P:positive regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:response to stimulus; P:retina homeostasis; P:retinal cone cell development; P:somitogenesis; P:visual perception; scaffold12 indexed_genome mRNA 43314338 43316685 . + . ID=transcript_3278;Q5IJ48 A2A3N4 Q0QD46 Q5JS41 Q5JS43 Q6ZTA9 Q6ZWI6,Protein crumbs homolog 2 {ECO:0000305},Crumbs-like protein 2;, PF00008;PF12661;PF02210;, GO:0016324;GO:0016327;GO:0030054;GO:0005737;GO:0070062;GO:0016021;GO:0005886;GO:0032991;GO:0019828;GO:0005509;GO:0044877;GO:0072359;GO:0030010;GO:0045197;GO:0007157;GO:0055111;GO:0045199;GO:0001707;GO:0010951;GO:0014028;GO:0045494;GO:0030513;GO:0010718;GO:0010470;GO:0050896;GO:0001895;GO:0046549;GO:0001756;GO:0007601;, C:apical plasma membrane; C:apicolateral plasma membrane; C:cell junction; C:cytoplasm; C:extracellular exosome; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:aspartic-type endopeptidase inhibitor activity; F:calcium ion binding; F:protein-containing complex binding;, P:circulatory system development; P:establishment of cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:ingression involved in gastrulation with mouth forming second; P:maintenance of epithelial cell apical/basal polarity; P:mesoderm formation; P:negative regulation of endopeptidase activity; P:notochord formation; P:photoreceptor cell maintenance; P:positive regulation of BMP signaling pathway; P:positive regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:response to stimulus; P:retina homeostasis; P:retinal cone cell development; P:somitogenesis; P:visual perception; scaffold12 indexed_genome mRNA 43318122 43325676 . - . ID=transcript_3279;Q8IVD6 Q9H796,DENN domain-containing protein 1A {ECO:0000312|HGNC:HGNC:29324},Connecdenn 1 {ECO:0000303|PubMed:20154091};Protein FAM31A;, PF03455;PF02141;PF03456;, GO:0030136;GO:0030665;GO:0005829;GO:0030425;GO:0043231;GO:0043025;GO:0005654;GO:0042734;GO:0005085;GO:1901981;GO:0032266;GO:0017124;GO:0031267;GO:0032456;GO:0006897;GO:0043547;GO:0015031;GO:0032483;GO:0048488;, C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:nucleoplasm; C:presynaptic membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-3-phosphate binding; F:SH3 domain binding; F:small GTPase binding;, P:endocytic recycling; P:endocytosis; P:positive regulation of GTPase activity; P:protein transport; P:regulation of Rab protein signal transduction; P:synaptic vesicle endocytosis; scaffold12 indexed_genome mRNA 43340283 43708743 . - . ID=transcript_3280;Q8IVD6 Q9H796,DENN domain-containing protein 1A {ECO:0000312|HGNC:HGNC:29324},Connecdenn 1 {ECO:0000303|PubMed:20154091};Protein FAM31A;, PF03455;PF02141;PF03456;, GO:0030136;GO:0030665;GO:0005829;GO:0030425;GO:0043231;GO:0043025;GO:0005654;GO:0042734;GO:0005085;GO:1901981;GO:0032266;GO:0017124;GO:0031267;GO:0032456;GO:0006897;GO:0043547;GO:0015031;GO:0032483;GO:0048488;, C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:nucleoplasm; C:presynaptic membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-3-phosphate binding; F:SH3 domain binding; F:small GTPase binding;, P:endocytic recycling; P:endocytosis; P:positive regulation of GTPase activity; P:protein transport; P:regulation of Rab protein signal transduction; P:synaptic vesicle endocytosis; scaffold12 indexed_genome mRNA 43933389 43950691 . + . ID=transcript_3281;P50458 O95860 Q52M57 Q8N1Z3,LIM/homeobox protein Lhx2,, PF00046;PF00412;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0030182;GO:0045893;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:neuron differentiation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 44160840 44202806 . + . ID=transcript_3282;Q9HC98 B7Z2D9 Q5TBG3 Q5TBG9 Q6FG86 Q6IAR3 Q96E83 Q9ULX2,Serine/threonine-protein kinase Nek6,Never in mitosis A-related kinase 6;Protein kinase SID6-1512;, PF00069;, GO:0034451;GO:0005737;GO:0005829;GO:0005874;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0000922;GO:0033613;GO:0005524;GO:0019894;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0001222;GO:0031625;GO:0006915;GO:0051301;GO:0007059;GO:0007077;GO:0007052;GO:0018105;GO:0043123;GO:0046777;GO:0006468;GO:2000772;GO:0007346;GO:0030071;GO:0051225;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:microtubule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle pole;, F:activating transcription factor binding; F:ATP binding; F:kinesin binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transcription corepressor binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell division; P:chromosome segregation; P:mitotic nuclear envelope disassembly; P:mitotic spindle organization; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cellular senescence; P:regulation of mitotic cell cycle; P:regulation of mitotic metaphase/anaphase transition; P:spindle assembly;|Q9HC98 B7Z2D9 Q5TBG3 Q5TBG9 Q6FG86 Q6IAR3 Q96E83 Q9ULX2,Serine/threonine-protein kinase Nek6,Never in mitosis A-related kinase 6;Protein kinase SID6-1512;, PF00069;, GO:0034451;GO:0005737;GO:0005829;GO:0005874;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0000922;GO:0033613;GO:0005524;GO:0019894;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0001222;GO:0031625;GO:0006915;GO:0051301;GO:0007059;GO:0007077;GO:0007052;GO:0018105;GO:0043123;GO:0046777;GO:0006468;GO:2000772;GO:0007346;GO:0030071;GO:0051225;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:microtubule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle pole;, F:activating transcription factor binding; F:ATP binding; F:kinesin binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transcription corepressor binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell division; P:chromosome segregation; P:mitotic nuclear envelope disassembly; P:mitotic spindle organization; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cellular senescence; P:regulation of mitotic cell cycle; P:regulation of mitotic metaphase/anaphase transition; P:spindle assembly; scaffold12 indexed_genome mRNA 44206059 44206730 . + . ID=transcript_3283;Q99436 B4E0P1 Q5TBG6 Q96AG8 Q9BWA7,Proteasome subunit beta type-7,Macropain chain Z;Multicatalytic endopeptidase complex chain Z;Proteasome subunit Z;, PF12465;PF00227;, GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0016604;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0034774;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nuclear body; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:secretory granule lumen;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold12 indexed_genome mRNA 44232967 44234470 . - . ID=transcript_3284;Q99436 B4E0P1 Q5TBG6 Q96AG8 Q9BWA7,Proteasome subunit beta type-7,Macropain chain Z;Multicatalytic endopeptidase complex chain Z;Proteasome subunit Z;, PF12465;PF00227;, GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0016604;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0034774;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nuclear body; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:secretory granule lumen;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold12 indexed_genome mRNA 44284862 44310522 . + . ID=transcript_3285;Q7Z7M1 Q86SL4 Q8NH12,Adhesion G-protein coupled receptor D2 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 144;G-protein coupled receptor PGR24;, PF00002;PF01825;PF00354;, GO:0016021;GO:0005887;GO:0004930;GO:0007189;GO:0007166;GO:0007186;, C:integral component of membrane; C:integral component of plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway;|Q7Z7M1 Q86SL4 Q8NH12,Adhesion G-protein coupled receptor D2 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 144;G-protein coupled receptor PGR24;, PF00002;PF01825;PF00354;, GO:0016021;GO:0005887;GO:0004930;GO:0007189;GO:0007166;GO:0007186;, C:integral component of membrane; C:integral component of plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway;|Q7Z7M1 Q86SL4 Q8NH12,Adhesion G-protein coupled receptor D2 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 144;G-protein coupled receptor PGR24;, PF00002;PF01825;PF00354;, GO:0016021;GO:0005887;GO:0004930;GO:0007189;GO:0007166;GO:0007186;, C:integral component of membrane; C:integral component of plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold12 indexed_genome mRNA 44359971 44394890 . - . ID=transcript_3286;Q15406 O00551 O00603 Q5T6F4 Q8NHQ0 Q92898 Q99802,Nuclear receptor subfamily 6 group A member 1,Germ cell nuclear factor;Retinoid receptor-related testis-specific receptor;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0004879;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0008270;GO:0007276;GO:0000122;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:gamete generation; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold12 indexed_genome mRNA 44577452 44605940 . + . ID=transcript_3287;Q68BL7 Q5JTM5 Q5JTM6 Q6UXW1 Q7Z5V3,Olfactomedin-like protein 2A,Photomedin-1;, PF02191;, GO:0031012;GO:0005576;GO:0050840;GO:0042802;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:extracellular matrix binding; F:identical protein binding;, P:extracellular matrix organization;|Q68BL7 Q5JTM5 Q5JTM6 Q6UXW1 Q7Z5V3,Olfactomedin-like protein 2A,Photomedin-1;, PF02191;, GO:0031012;GO:0005576;GO:0050840;GO:0042802;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:extracellular matrix binding; F:identical protein binding;, P:extracellular matrix organization; scaffold12 indexed_genome mRNA 44642005 44648797 . - . ID=transcript_3288;Q5JTN6 A0PK24,WD repeat-containing protein 38,, PF00400;|Q5JTN6 A0PK24,WD repeat-containing protein 38,, PF00400;|P42766 A8K4V7 Q4VBY5 Q5JTN5 Q6IBC7 Q96QJ7 Q9BYF4,60S ribosomal protein L35,Large ribosomal subunit protein uL29 {ECO:0000303|PubMed:24524803};, PF00831;, GO:0005829;GO:0022625;GO:0016020;GO:0005730;GO:0003729;GO:0003723;GO:0003735;GO:0000463;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:membrane; C:nucleolus;, F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold12 indexed_genome mRNA 44655222 44662445 . + . ID=transcript_3289;Q9BPX5 Q7Z523,Actin-related protein 2/3 complex subunit 5-like protein,Arp2/3 complex 16 kDa subunit 2;, PF04699;, GO:0005885;GO:0005737;GO:0070062;GO:0005925;GO:0098978;GO:0051015;GO:0034314;GO:0016477;, C:Arp2/3 protein complex; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse;, F:actin filament binding;, P:Arp2/3 complex-mediated actin nucleation; P:cell migration;|Q9BPX5 Q7Z523,Actin-related protein 2/3 complex subunit 5-like protein,Arp2/3 complex 16 kDa subunit 2;, PF04699;, GO:0005885;GO:0005737;GO:0070062;GO:0005925;GO:0098978;GO:0051015;GO:0034314;GO:0016477;, C:Arp2/3 protein complex; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse;, F:actin filament binding;, P:Arp2/3 complex-mediated actin nucleation; P:cell migration;|Q9BPX5 Q7Z523,Actin-related protein 2/3 complex subunit 5-like protein,Arp2/3 complex 16 kDa subunit 2;, PF04699;, GO:0005885;GO:0005737;GO:0070062;GO:0005925;GO:0098978;GO:0051015;GO:0034314;GO:0016477;, C:Arp2/3 protein complex; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse;, F:actin filament binding;, P:Arp2/3 complex-mediated actin nucleation; P:cell migration; scaffold12 indexed_genome mRNA 44663426 44709691 . - . ID=transcript_3290;Q92805 Q5T164 Q8IYZ9,Golgin subfamily A member 1,Golgin-97;, PF01465;, GO:0001669;GO:0005829;GO:0005794;GO:0000139;GO:0048471;GO:0005802;, C:acrosomal vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:perinuclear region of cytoplasm; C:trans-Golgi network;|Q92805 Q5T164 Q8IYZ9,Golgin subfamily A member 1,Golgin-97;, PF01465;, GO:0001669;GO:0005829;GO:0005794;GO:0000139;GO:0048471;GO:0005802;, C:acrosomal vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:perinuclear region of cytoplasm; C:trans-Golgi network;|Q92805 Q5T164 Q8IYZ9,Golgin subfamily A member 1,Golgin-97;, PF01465;, GO:0001669;GO:0005829;GO:0005794;GO:0000139;GO:0048471;GO:0005802;, C:acrosomal vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:perinuclear region of cytoplasm; C:trans-Golgi network;|Q92805 Q5T164 Q8IYZ9,Golgin subfamily A member 1,Golgin-97;, PF01465;, GO:0001669;GO:0005829;GO:0005794;GO:0000139;GO:0048471;GO:0005802;, C:acrosomal vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:perinuclear region of cytoplasm; C:trans-Golgi network;|Q92805 Q5T164 Q8IYZ9,Golgin subfamily A member 1,Golgin-97;, PF01465;, GO:0001669;GO:0005829;GO:0005794;GO:0000139;GO:0048471;GO:0005802;, C:acrosomal vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:perinuclear region of cytoplasm; C:trans-Golgi network;|Q92805 Q5T164 Q8IYZ9,Golgin subfamily A member 1,Golgin-97;, PF01465;, GO:0001669;GO:0005829;GO:0005794;GO:0000139;GO:0048471;GO:0005802;, C:acrosomal vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:perinuclear region of cytoplasm; C:trans-Golgi network; scaffold12 indexed_genome mRNA 44718770 44746003 . - . ID=transcript_3291;Q8N9R8 Q3SXZ1 Q3SXZ2 Q5T163 Q8N1I4,Protein SCAI,Suppressor of cancer cell invasion protein;, PF12070;, GO:0005737;GO:0016021;GO:0031965;GO:0005654;GO:0005634;GO:0003714;GO:0030336;GO:0035024;GO:0006351;, C:cytoplasm; C:integral component of membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:transcription corepressor activity;, P:negative regulation of cell migration; P:negative regulation of Rho protein signal transduction; P:transcription, DNA-templated; scaffold12 indexed_genome mRNA 44747986 44833338 . - . ID=transcript_3292;Q8N9R8 Q3SXZ1 Q3SXZ2 Q5T163 Q8N1I4,Protein SCAI,Suppressor of cancer cell invasion protein;, PF12070;, GO:0005737;GO:0016021;GO:0031965;GO:0005654;GO:0005634;GO:0003714;GO:0030336;GO:0035024;GO:0006351;, C:cytoplasm; C:integral component of membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:transcription corepressor activity;, P:negative regulation of cell migration; P:negative regulation of Rho protein signal transduction; P:transcription, DNA-templated; scaffold12 indexed_genome mRNA 44837474 44873249 . - . ID=transcript_3293;O00743 B2R5V6 B7Z2W9 B7Z5K9 Q5U0A2 Q9UIC9,Serine/threonine-protein phosphatase 6 catalytic subunit,, PF00149;, GO:0005829;GO:0005739;GO:0005654;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0048208;GO:0000082;GO:0045087;GO:0006470;GO:0007004;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:COPII vesicle coating; P:G1/S transition of mitotic cell cycle; P:innate immune response; P:protein dephosphorylation; P:telomere maintenance via telomerase;|O00743 B2R5V6 B7Z2W9 B7Z5K9 Q5U0A2 Q9UIC9,Serine/threonine-protein phosphatase 6 catalytic subunit,, PF00149;, GO:0005829;GO:0005739;GO:0005654;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0048208;GO:0000082;GO:0045087;GO:0006470;GO:0007004;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:COPII vesicle coating; P:G1/S transition of mitotic cell cycle; P:innate immune response; P:protein dephosphorylation; P:telomere maintenance via telomerase;|O00743 B2R5V6 B7Z2W9 B7Z5K9 Q5U0A2 Q9UIC9,Serine/threonine-protein phosphatase 6 catalytic subunit,, PF00149;, GO:0005829;GO:0005739;GO:0005654;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0048208;GO:0000082;GO:0045087;GO:0006470;GO:0007004;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:COPII vesicle coating; P:G1/S transition of mitotic cell cycle; P:innate immune response; P:protein dephosphorylation; P:telomere maintenance via telomerase; scaffold12 indexed_genome mRNA 44879317 44898125 . + . ID=transcript_3294;Q7Z6M1 A8K403 O00568 Q69YR2 Q6FHA4 Q6IBG7 Q6P092 Q86Y76 Q9BWB1,Rab9 effector protein with kelch motifs {ECO:0000305},40 kDa Rab9 effector protein;p40;, PF01344;PF07646;, GO:0005829;GO:0005768;GO:0010008;GO:0032588;GO:0030133;GO:0006898;GO:0006904;, C:cytosol; C:endosome; C:endosome membrane; C:trans-Golgi network membrane; C:transport vesicle;, , P:receptor-mediated endocytosis; P:vesicle docking involved in exocytosis;|Q7Z6M1 A8K403 O00568 Q69YR2 Q6FHA4 Q6IBG7 Q6P092 Q86Y76 Q9BWB1,Rab9 effector protein with kelch motifs {ECO:0000305},40 kDa Rab9 effector protein;p40;, PF01344;PF07646;, GO:0005829;GO:0005768;GO:0010008;GO:0032588;GO:0030133;GO:0006898;GO:0006904;, C:cytosol; C:endosome; C:endosome membrane; C:trans-Golgi network membrane; C:transport vesicle;, , P:receptor-mediated endocytosis; P:vesicle docking involved in exocytosis;|Q7Z6M1 A8K403 O00568 Q69YR2 Q6FHA4 Q6IBG7 Q6P092 Q86Y76 Q9BWB1,Rab9 effector protein with kelch motifs {ECO:0000305},40 kDa Rab9 effector protein;p40;, PF01344;PF07646;, GO:0005829;GO:0005768;GO:0010008;GO:0032588;GO:0030133;GO:0006898;GO:0006904;, C:cytosol; C:endosome; C:endosome membrane; C:trans-Golgi network membrane; C:transport vesicle;, , P:receptor-mediated endocytosis; P:vesicle docking involved in exocytosis; scaffold12 indexed_genome mRNA 44898160 44899468 . - . ID=transcript_3295;Q7Z6M1 A8K403 O00568 Q69YR2 Q6FHA4 Q6IBG7 Q6P092 Q86Y76 Q9BWB1,Rab9 effector protein with kelch motifs {ECO:0000305},40 kDa Rab9 effector protein;p40;, PF01344;PF07646;, GO:0005829;GO:0005768;GO:0010008;GO:0032588;GO:0030133;GO:0006898;GO:0006904;, C:cytosol; C:endosome; C:endosome membrane; C:trans-Golgi network membrane; C:transport vesicle;, , P:receptor-mediated endocytosis; P:vesicle docking involved in exocytosis; scaffold12 indexed_genome mRNA 44901312 44905498 . + . ID=transcript_3296;P11021 B0QZ61 Q2EF78 Q9NPF1 Q9UK02,Endoplasmic reticulum chaperone BiP {ECO:0000305},78 kDa glucose-regulated protein {ECO:0000303|PubMed:2840249};Binding-immunoglobulin protein {ECO:0000303|Ref.4};Heat shock protein 70 family protein 5 {ECO:0000305};Heat shock protein family A member 5 {ECO:0000312|HGNC:HGNC:5238};Immunoglobulin heavy chain-binding protein {ECO:0000303|Ref.4};, PF00012;, GO:0009986;GO:0005737;GO:0005829;GO:0005783;GO:0034663;GO:0005788;GO:0005789;GO:0005793;GO:0070062;GO:0005925;GO:0030176;GO:0043231;GO:0042470;GO:0016020;GO:0030496;GO:0005739;GO:0005634;GO:0005886;GO:0032991;GO:0005790;GO:0005524;GO:0016887;GO:0045296;GO:0005509;GO:0051087;GO:0019899;GO:0031072;GO:0051787;GO:0019904;GO:0044183;GO:0043022;GO:0031625;GO:0051082;GO:0036500;GO:0071236;GO:0071277;GO:0071320;GO:0035690;GO:0071480;GO:0042149;GO:0071353;GO:0071287;GO:1990090;GO:0034620;GO:0021680;GO:0021589;GO:0051085;GO:0030968;GO:0006983;GO:0036498;GO:0001554;GO:0035437;GO:0043066;GO:1903895;GO:0031333;GO:0030512;GO:0051402;GO:0030182;GO:0036499;GO:0030335;GO:0010976;GO:0031398;GO:1990440;GO:0031204;GO:0034975;GO:0042026;GO:1903891;GO:1903894;GO:1903897;GO:0060904;GO:0042220;GO:1904313;GO:0097501;GO:0021762;GO:1901998;GO:0030433;, C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:focal adhesion; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:midbody; C:mitochondrion; C:nucleus; C:plasma membrane; C:protein-containing complex; C:smooth endoplasmic reticulum;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:chaperone binding; F:enzyme binding; F:heat shock protein binding; F:misfolded protein binding; F:protein domain specific binding; F:protein folding chaperone; F:ribosome binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:ATF6-mediated unfolded protein response; P:cellular response to antibiotic; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to drug; P:cellular response to gamma radiation; P:cellular response to glucose starvation; P:cellular response to interleukin-4; P:cellular response to manganese ion; P:cellular response to nerve growth factor stimulus; P:cellular response to unfolded protein; P:cerebellar Purkinje cell layer development; P:cerebellum structural organization; P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum unfolded protein response; P:ER overload response; P:IRE1-mediated unfolded protein response; P:luteolysis; P:maintenance of protein localization in endoplasmic reticulum; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:negative regulation of protein-containing complex assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron apoptotic process; P:neuron differentiation; P:PERK-mediated unfolded protein response; P:positive regulation of cell migration; P:positive regulation of neuron projection development; P:positive regulation of protein ubiquitination; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:posttranslational protein targeting to membrane, translocation; P:protein folding in endoplasmic reticulum; P:protein refolding; P:regulation of ATF6-mediated unfolded protein response; P:regulation of IRE1-mediated unfolded protein response; P:regulation of PERK-mediated unfolded protein response; P:regulation of protein folding in endoplasmic reticulum; P:response to cocaine; P:response to methamphetamine hydrochloride; P:stress response to metal ion; P:substantia nigra development; P:toxin transport; P:ubiquitin-dependent ERAD pathway;|P11021 B0QZ61 Q2EF78 Q9NPF1 Q9UK02,Endoplasmic reticulum chaperone BiP {ECO:0000305},78 kDa glucose-regulated protein {ECO:0000303|PubMed:2840249};Binding-immunoglobulin protein {ECO:0000303|Ref.4};Heat shock protein 70 family protein 5 {ECO:0000305};Heat shock protein family A member 5 {ECO:0000312|HGNC:HGNC:5238};Immunoglobulin heavy chain-binding protein {ECO:0000303|Ref.4};, PF00012;, GO:0009986;GO:0005737;GO:0005829;GO:0005783;GO:0034663;GO:0005788;GO:0005789;GO:0005793;GO:0070062;GO:0005925;GO:0030176;GO:0043231;GO:0042470;GO:0016020;GO:0030496;GO:0005739;GO:0005634;GO:0005886;GO:0032991;GO:0005790;GO:0005524;GO:0016887;GO:0045296;GO:0005509;GO:0051087;GO:0019899;GO:0031072;GO:0051787;GO:0019904;GO:0044183;GO:0043022;GO:0031625;GO:0051082;GO:0036500;GO:0071236;GO:0071277;GO:0071320;GO:0035690;GO:0071480;GO:0042149;GO:0071353;GO:0071287;GO:1990090;GO:0034620;GO:0021680;GO:0021589;GO:0051085;GO:0030968;GO:0006983;GO:0036498;GO:0001554;GO:0035437;GO:0043066;GO:1903895;GO:0031333;GO:0030512;GO:0051402;GO:0030182;GO:0036499;GO:0030335;GO:0010976;GO:0031398;GO:1990440;GO:0031204;GO:0034975;GO:0042026;GO:1903891;GO:1903894;GO:1903897;GO:0060904;GO:0042220;GO:1904313;GO:0097501;GO:0021762;GO:1901998;GO:0030433;, C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:focal adhesion; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:midbody; C:mitochondrion; C:nucleus; C:plasma membrane; C:protein-containing complex; C:smooth endoplasmic reticulum;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:chaperone binding; F:enzyme binding; F:heat shock protein binding; F:misfolded protein binding; F:protein domain specific binding; F:protein folding chaperone; F:ribosome binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:ATF6-mediated unfolded protein response; P:cellular response to antibiotic; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to drug; P:cellular response to gamma radiation; P:cellular response to glucose starvation; P:cellular response to interleukin-4; P:cellular response to manganese ion; P:cellular response to nerve growth factor stimulus; P:cellular response to unfolded protein; P:cerebellar Purkinje cell layer development; P:cerebellum structural organization; P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum unfolded protein response; P:ER overload response; P:IRE1-mediated unfolded protein response; P:luteolysis; P:maintenance of protein localization in endoplasmic reticulum; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:negative regulation of protein-containing complex assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron apoptotic process; P:neuron differentiation; P:PERK-mediated unfolded protein response; P:positive regulation of cell migration; P:positive regulation of neuron projection development; P:positive regulation of protein ubiquitination; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:posttranslational protein targeting to membrane, translocation; P:protein folding in endoplasmic reticulum; P:protein refolding; P:regulation of ATF6-mediated unfolded protein response; P:regulation of IRE1-mediated unfolded protein response; P:regulation of PERK-mediated unfolded protein response; P:regulation of protein folding in endoplasmic reticulum; P:response to cocaine; P:response to methamphetamine hydrochloride; P:stress response to metal ion; P:substantia nigra development; P:toxin transport; P:ubiquitin-dependent ERAD pathway;|P11021 B0QZ61 Q2EF78 Q9NPF1 Q9UK02,Endoplasmic reticulum chaperone BiP {ECO:0000305},78 kDa glucose-regulated protein {ECO:0000303|PubMed:2840249};Binding-immunoglobulin protein {ECO:0000303|Ref.4};Heat shock protein 70 family protein 5 {ECO:0000305};Heat shock protein family A member 5 {ECO:0000312|HGNC:HGNC:5238};Immunoglobulin heavy chain-binding protein {ECO:0000303|Ref.4};, PF00012;, GO:0009986;GO:0005737;GO:0005829;GO:0005783;GO:0034663;GO:0005788;GO:0005789;GO:0005793;GO:0070062;GO:0005925;GO:0030176;GO:0043231;GO:0042470;GO:0016020;GO:0030496;GO:0005739;GO:0005634;GO:0005886;GO:0032991;GO:0005790;GO:0005524;GO:0016887;GO:0045296;GO:0005509;GO:0051087;GO:0019899;GO:0031072;GO:0051787;GO:0019904;GO:0044183;GO:0043022;GO:0031625;GO:0051082;GO:0036500;GO:0071236;GO:0071277;GO:0071320;GO:0035690;GO:0071480;GO:0042149;GO:0071353;GO:0071287;GO:1990090;GO:0034620;GO:0021680;GO:0021589;GO:0051085;GO:0030968;GO:0006983;GO:0036498;GO:0001554;GO:0035437;GO:0043066;GO:1903895;GO:0031333;GO:0030512;GO:0051402;GO:0030182;GO:0036499;GO:0030335;GO:0010976;GO:0031398;GO:1990440;GO:0031204;GO:0034975;GO:0042026;GO:1903891;GO:1903894;GO:1903897;GO:0060904;GO:0042220;GO:1904313;GO:0097501;GO:0021762;GO:1901998;GO:0030433;, C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:focal adhesion; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:midbody; C:mitochondrion; C:nucleus; C:plasma membrane; C:protein-containing complex; C:smooth endoplasmic reticulum;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:chaperone binding; F:enzyme binding; F:heat shock protein binding; F:misfolded protein binding; F:protein domain specific binding; F:protein folding chaperone; F:ribosome binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:ATF6-mediated unfolded protein response; P:cellular response to antibiotic; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to drug; P:cellular response to gamma radiation; P:cellular response to glucose starvation; P:cellular response to interleukin-4; P:cellular response to manganese ion; P:cellular response to nerve growth factor stimulus; P:cellular response to unfolded protein; P:cerebellar Purkinje cell layer development; P:cerebellum structural organization; P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum unfolded protein response; P:ER overload response; P:IRE1-mediated unfolded protein response; P:luteolysis; P:maintenance of protein localization in endoplasmic reticulum; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:negative regulation of protein-containing complex assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron apoptotic process; P:neuron differentiation; P:PERK-mediated unfolded protein response; P:positive regulation of cell migration; P:positive regulation of neuron projection development; P:positive regulation of protein ubiquitination; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:posttranslational protein targeting to membrane, translocation; P:protein folding in endoplasmic reticulum; P:protein refolding; P:regulation of ATF6-mediated unfolded protein response; P:regulation of IRE1-mediated unfolded protein response; P:regulation of PERK-mediated unfolded protein response; P:regulation of protein folding in endoplasmic reticulum; P:response to cocaine; P:response to methamphetamine hydrochloride; P:stress response to metal ion; P:substantia nigra development; P:toxin transport; P:ubiquitin-dependent ERAD pathway;|P11021 B0QZ61 Q2EF78 Q9NPF1 Q9UK02,Endoplasmic reticulum chaperone BiP {ECO:0000305},78 kDa glucose-regulated protein {ECO:0000303|PubMed:2840249};Binding-immunoglobulin protein {ECO:0000303|Ref.4};Heat shock protein 70 family protein 5 {ECO:0000305};Heat shock protein family A member 5 {ECO:0000312|HGNC:HGNC:5238};Immunoglobulin heavy chain-binding protein {ECO:0000303|Ref.4};, PF00012;, GO:0009986;GO:0005737;GO:0005829;GO:0005783;GO:0034663;GO:0005788;GO:0005789;GO:0005793;GO:0070062;GO:0005925;GO:0030176;GO:0043231;GO:0042470;GO:0016020;GO:0030496;GO:0005739;GO:0005634;GO:0005886;GO:0032991;GO:0005790;GO:0005524;GO:0016887;GO:0045296;GO:0005509;GO:0051087;GO:0019899;GO:0031072;GO:0051787;GO:0019904;GO:0044183;GO:0043022;GO:0031625;GO:0051082;GO:0036500;GO:0071236;GO:0071277;GO:0071320;GO:0035690;GO:0071480;GO:0042149;GO:0071353;GO:0071287;GO:1990090;GO:0034620;GO:0021680;GO:0021589;GO:0051085;GO:0030968;GO:0006983;GO:0036498;GO:0001554;GO:0035437;GO:0043066;GO:1903895;GO:0031333;GO:0030512;GO:0051402;GO:0030182;GO:0036499;GO:0030335;GO:0010976;GO:0031398;GO:1990440;GO:0031204;GO:0034975;GO:0042026;GO:1903891;GO:1903894;GO:1903897;GO:0060904;GO:0042220;GO:1904313;GO:0097501;GO:0021762;GO:1901998;GO:0030433;, C:cell surface; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:focal adhesion; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:midbody; C:mitochondrion; C:nucleus; C:plasma membrane; C:protein-containing complex; C:smooth endoplasmic reticulum;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:chaperone binding; F:enzyme binding; F:heat shock protein binding; F:misfolded protein binding; F:protein domain specific binding; F:protein folding chaperone; F:ribosome binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:ATF6-mediated unfolded protein response; P:cellular response to antibiotic; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to drug; P:cellular response to gamma radiation; P:cellular response to glucose starvation; P:cellular response to interleukin-4; P:cellular response to manganese ion; P:cellular response to nerve growth factor stimulus; P:cellular response to unfolded protein; P:cerebellar Purkinje cell layer development; P:cerebellum structural organization; P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum unfolded protein response; P:ER overload response; P:IRE1-mediated unfolded protein response; P:luteolysis; P:maintenance of protein localization in endoplasmic reticulum; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:negative regulation of protein-containing complex assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron apoptotic process; P:neuron differentiation; P:PERK-mediated unfolded protein response; P:positive regulation of cell migration; P:positive regulation of neuron projection development; P:positive regulation of protein ubiquitination; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:posttranslational protein targeting to membrane, translocation; P:protein folding in endoplasmic reticulum; P:protein refolding; P:regulation of ATF6-mediated unfolded protein response; P:regulation of IRE1-mediated unfolded protein response; P:regulation of PERK-mediated unfolded protein response; P:regulation of protein folding in endoplasmic reticulum; P:response to cocaine; P:response to methamphetamine hydrochloride; P:stress response to metal ion; P:substantia nigra development; P:toxin transport; P:ubiquitin-dependent ERAD pathway; scaffold12 indexed_genome mRNA 44920343 44995057 . + . ID=transcript_3297;Q96CZ4 Q9NXQ1 Q9P207 Q9Y4N0,GTPase-activating protein and VPS9 domain-containing protein 1,GAPex-5;Rab5-activating protein 6;, PF18151;PF00616;PF02204;, GO:0005829;GO:0005768;GO:0005886;GO:0045296;GO:0032794;GO:0005096;GO:0005085;GO:0006897;GO:0061024;GO:0051223;GO:0007165;, C:cytosol; C:endosome; C:plasma membrane;, F:cadherin binding; F:GTPase activating protein binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:endocytosis; P:membrane organization; P:regulation of protein transport; P:signal transduction;|Q96CZ4 Q9NXQ1 Q9P207 Q9Y4N0,GTPase-activating protein and VPS9 domain-containing protein 1,GAPex-5;Rab5-activating protein 6;, PF18151;PF00616;PF02204;, GO:0005829;GO:0005768;GO:0005886;GO:0045296;GO:0032794;GO:0005096;GO:0005085;GO:0006897;GO:0061024;GO:0051223;GO:0007165;, C:cytosol; C:endosome; C:plasma membrane;, F:cadherin binding; F:GTPase activating protein binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:endocytosis; P:membrane organization; P:regulation of protein transport; P:signal transduction;|Q96CZ4 Q9NXQ1 Q9P207 Q9Y4N0,GTPase-activating protein and VPS9 domain-containing protein 1,GAPex-5;Rab5-activating protein 6;, PF18151;PF00616;PF02204;, GO:0005829;GO:0005768;GO:0005886;GO:0045296;GO:0032794;GO:0005096;GO:0005085;GO:0006897;GO:0061024;GO:0051223;GO:0007165;, C:cytosol; C:endosome; C:plasma membrane;, F:cadherin binding; F:GTPase activating protein binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:endocytosis; P:membrane organization; P:regulation of protein transport; P:signal transduction;|Q96CZ4 Q9NXQ1 Q9P207 Q9Y4N0,GTPase-activating protein and VPS9 domain-containing protein 1,GAPex-5;Rab5-activating protein 6;, PF18151;PF00616;PF02204;, GO:0005829;GO:0005768;GO:0005886;GO:0045296;GO:0032794;GO:0005096;GO:0005085;GO:0006897;GO:0061024;GO:0051223;GO:0007165;, C:cytosol; C:endosome; C:plasma membrane;, F:cadherin binding; F:GTPase activating protein binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:endocytosis; P:membrane organization; P:regulation of protein transport; P:signal transduction;|Q96CZ4 Q9NXQ1 Q9P207 Q9Y4N0,GTPase-activating protein and VPS9 domain-containing protein 1,GAPex-5;Rab5-activating protein 6;, PF18151;PF00616;PF02204;, GO:0005829;GO:0005768;GO:0005886;GO:0045296;GO:0032794;GO:0005096;GO:0005085;GO:0006897;GO:0061024;GO:0051223;GO:0007165;, C:cytosol; C:endosome; C:plasma membrane;, F:cadherin binding; F:GTPase activating protein binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:endocytosis; P:membrane organization; P:regulation of protein transport; P:signal transduction;|Q96CZ4 Q9NXQ1 Q9P207 Q9Y4N0,GTPase-activating protein and VPS9 domain-containing protein 1,GAPex-5;Rab5-activating protein 6;, PF18151;PF00616;PF02204;, GO:0005829;GO:0005768;GO:0005886;GO:0045296;GO:0032794;GO:0005096;GO:0005085;GO:0006897;GO:0061024;GO:0051223;GO:0007165;, C:cytosol; C:endosome; C:plasma membrane;, F:cadherin binding; F:GTPase activating protein binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:endocytosis; P:membrane organization; P:regulation of protein transport; P:signal transduction;|Q96CZ4 Q9NXQ1 Q9P207 Q9Y4N0,GTPase-activating protein and VPS9 domain-containing protein 1,GAPex-5;Rab5-activating protein 6;, PF18151;PF00616;PF02204;, GO:0005829;GO:0005768;GO:0005886;GO:0045296;GO:0032794;GO:0005096;GO:0005085;GO:0006897;GO:0061024;GO:0051223;GO:0007165;, C:cytosol; C:endosome; C:plasma membrane;, F:cadherin binding; F:GTPase activating protein binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:endocytosis; P:membrane organization; P:regulation of protein transport; P:signal transduction; scaffold12 indexed_genome mRNA 45059639 45285229 . - . ID=transcript_3298;Q699U1 Q699U2 Q699U3 Q699U4 Q6GVJ0 Q6GVJ1 Q6GVJ2,Target of rapamycin complex 2 subunit MAPKAP1,Mitogen-activated protein kinase 2-associated protein 1;Stress-activated map kinase-interacting protein 1;, PF16978;PF05422;PF16979;, GO:0005737;GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005886;GO:0031932;GO:0070300;GO:0005547;GO:0043325;GO:0080025;GO:0005546;GO:0019901;GO:0031267;GO:0032148;GO:0030950;GO:0046580;GO:0033138;GO:1900407;GO:1901796;GO:0021762;GO:0038203;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:plasma membrane; C:TORC2 complex;, F:phosphatidic acid binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase binding; F:small GTPase binding;, P:activation of protein kinase B activity; P:establishment or maintenance of actin cytoskeleton polarity; P:negative regulation of Ras protein signal transduction; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of cellular response to oxidative stress; P:regulation of signal transduction by p53 class mediator; P:substantia nigra development; P:TORC2 signaling;|Q699U1 Q699U2 Q699U3 Q699U4 Q6GVJ0 Q6GVJ1 Q6GVJ2,Target of rapamycin complex 2 subunit MAPKAP1,Mitogen-activated protein kinase 2-associated protein 1;Stress-activated map kinase-interacting protein 1;, PF16978;PF05422;PF16979;, GO:0005737;GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005886;GO:0031932;GO:0070300;GO:0005547;GO:0043325;GO:0080025;GO:0005546;GO:0019901;GO:0031267;GO:0032148;GO:0030950;GO:0046580;GO:0033138;GO:1900407;GO:1901796;GO:0021762;GO:0038203;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:plasma membrane; C:TORC2 complex;, F:phosphatidic acid binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase binding; F:small GTPase binding;, P:activation of protein kinase B activity; P:establishment or maintenance of actin cytoskeleton polarity; P:negative regulation of Ras protein signal transduction; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of cellular response to oxidative stress; P:regulation of signal transduction by p53 class mediator; P:substantia nigra development; P:TORC2 signaling; scaffold12 indexed_genome mRNA 45540552 45547390 . + . ID=transcript_3299;P40426 E9PB27 Q5JSA0 Q5JSA1 Q5VXL3 Q96PF9 Q96PG0,Pre-B-cell leukemia transcription factor 3,Homeobox protein PBX3;, PF00046;PF03792;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0009887;GO:0007387;GO:0007420;GO:0048568;GO:0001654;GO:0048666;GO:0007388;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:animal organ morphogenesis; P:anterior compartment pattern formation; P:brain development; P:embryonic organ development; P:eye development; P:neuron development; P:posterior compartment specification; P:regulation of transcription by RNA polymerase II;|P40426 E9PB27 Q5JSA0 Q5JSA1 Q5VXL3 Q96PF9 Q96PG0,Pre-B-cell leukemia transcription factor 3,Homeobox protein PBX3;, PF00046;PF03792;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0009887;GO:0007387;GO:0007420;GO:0048568;GO:0001654;GO:0048666;GO:0007388;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:animal organ morphogenesis; P:anterior compartment pattern formation; P:brain development; P:embryonic organ development; P:eye development; P:neuron development; P:posterior compartment specification; P:regulation of transcription by RNA polymerase II; scaffold12 indexed_genome mRNA 46050137 46055568 . + . ID=transcript_3300;Q9H7P6 Q8N6S7,Multivesicular body subunit 12B,ESCRT-I complex subunit MVB12B;Protein FAM125B;, PF10240;, GO:0005829;GO:0005769;GO:0010008;GO:0000813;GO:0070062;GO:0043657;GO:0005770;GO:0031902;GO:0005634;GO:0005886;GO:0031982;GO:0008289;GO:0016197;GO:0075733;GO:0015031;GO:0042058;GO:0043162;GO:0046755;GO:0019058;GO:0019075;, C:cytosol; C:early endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:host cell; C:late endosome; C:late endosome membrane; C:nucleus; C:plasma membrane; C:vesicle;, F:lipid binding;, P:endosomal transport; P:intracellular transport of virus; P:protein transport; P:regulation of epidermal growth factor receptor signaling pathway; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral life cycle; P:virus maturation;|Q9H7P6 Q8N6S7,Multivesicular body subunit 12B,ESCRT-I complex subunit MVB12B;Protein FAM125B;, PF10240;, GO:0005829;GO:0005769;GO:0010008;GO:0000813;GO:0070062;GO:0043657;GO:0005770;GO:0031902;GO:0005634;GO:0005886;GO:0031982;GO:0008289;GO:0016197;GO:0075733;GO:0015031;GO:0042058;GO:0043162;GO:0046755;GO:0019058;GO:0019075;, C:cytosol; C:early endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:host cell; C:late endosome; C:late endosome membrane; C:nucleus; C:plasma membrane; C:vesicle;, F:lipid binding;, P:endosomal transport; P:intracellular transport of virus; P:protein transport; P:regulation of epidermal growth factor receptor signaling pathway; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral life cycle; P:virus maturation; scaffold12 indexed_genome mRNA 46232760 48000086 . + . ID=transcript_3301;Q01105 A5A5H4 A6NGV1 B4DUE2 Q15541 Q5VXV1 Q5VXV2 Q6FHZ5,Protein SET,HLA-DR-associated protein II;Inhibitor of granzyme A-activated DNase;PHAPII;Phosphatase 2A inhibitor I2PP2A;Template-activating factor I;, PF00956;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005811;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0004864;GO:0019888;GO:0006260;GO:0007076;GO:0035067;GO:0043524;GO:0045892;GO:0006334;GO:0006337;GO:0043488;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:lipid droplet; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity;, P:DNA replication; P:mitotic chromosome condensation; P:negative regulation of histone acetylation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:nucleosome disassembly; P:regulation of mRNA stability; P:viral process;|O43298 Q5JU96,Zinc finger and BTB domain-containing protein 43,Zinc finger and BTB domain-containing protein 22B;Zinc finger protein 297B;ZnF-x;, PF00651;PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8NCN2 Q38IA7 Q5VYE9,Zinc finger and BTB domain-containing protein 34,, PF00651;PF00096;, GO:0000785;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8NCN2 Q38IA7 Q5VYE9,Zinc finger and BTB domain-containing protein 34,, PF00651;PF00096;, GO:0000785;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8WUV7 Q9NZ16,Ras-specific guanine nucleotide-releasing factor RalGPS1,Ral GEF with PH domain and SH3-binding motif 1;Ral guanine nucleotide exchange factor 2;RalA exchange factor RalGPS1;, PF00169;PF00617;, GO:0005737;GO:0005886;GO:0005085;GO:0035556;GO:0032485;GO:0007264;, C:cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:intracellular signal transduction; P:regulation of Ral protein signal transduction; P:small GTPase mediated signal transduction;|Q8WUV7 Q9NZ16,Ras-specific guanine nucleotide-releasing factor RalGPS1,Ral GEF with PH domain and SH3-binding motif 1;Ral guanine nucleotide exchange factor 2;RalA exchange factor RalGPS1;, PF00169;PF00617;, GO:0005737;GO:0005886;GO:0005085;GO:0035556;GO:0032485;GO:0007264;, C:cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:intracellular signal transduction; P:regulation of Ral protein signal transduction; P:small GTPase mediated signal transduction;|Q8WUV7 Q9NZ16,Ras-specific guanine nucleotide-releasing factor RalGPS1,Ral GEF with PH domain and SH3-binding motif 1;Ral guanine nucleotide exchange factor 2;RalA exchange factor RalGPS1;, PF00169;PF00617;, GO:0005737;GO:0005886;GO:0005085;GO:0035556;GO:0032485;GO:0007264;, C:cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:intracellular signal transduction; P:regulation of Ral protein signal transduction; P:small GTPase mediated signal transduction;|Q9UKU9 Q5JT58 Q8NCH7,Angiopoietin-related protein 2,Angiopoietin-like protein 2;, PF00147;, GO:0062023;GO:0070062;GO:0005615;GO:0005102;GO:0001525;GO:0007275;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space;, F:signaling receptor binding;, P:angiogenesis; P:multicellular organism development;|Q8WUV7 Q9NZ16,Ras-specific guanine nucleotide-releasing factor RalGPS1,Ral GEF with PH domain and SH3-binding motif 1;Ral guanine nucleotide exchange factor 2;RalA exchange factor RalGPS1;, PF00169;PF00617;, GO:0005737;GO:0005886;GO:0005085;GO:0035556;GO:0032485;GO:0007264;, C:cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:intracellular signal transduction; P:regulation of Ral protein signal transduction; P:small GTPase mediated signal transduction;|Q5VVW2 B4DEP7 B7Z3Q6 Q8IYU1 Q8N951 Q8ND89 Q9BQH6,GTPase-activating Rap/Ran-GAP domain-like protein 3,, PF00780;PF02145;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5VVW2 B4DEP7 B7Z3Q6 Q8IYU1 Q8N951 Q8ND89 Q9BQH6,GTPase-activating Rap/Ran-GAP domain-like protein 3,, PF00780;PF02145;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5VVW2 B4DEP7 B7Z3Q6 Q8IYU1 Q8N951 Q8ND89 Q9BQH6,GTPase-activating Rap/Ran-GAP domain-like protein 3,, PF00780;PF02145;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9C0B1 A2RUH1 B2RNS0 Q0P676 Q7Z785,Alpha-ketoglutarate-dependent dioxygenase FTO {ECO:0000305},Fat mass and obesity-associated protein {ECO:0000303|PubMed:17496892};U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO {ECO:0000305};U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO {ECO:0000305};mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO {ECO:0000305};mRNA N(6)-methyladenosine demethylase FTO {ECO:0000305};tRNA N1-methyl adenine demethylase FTO {ECO:0000305};, PF12934;PF12933;, GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0043734;GO:0008198;GO:0035516;GO:0035515;GO:1990931;GO:0016740;GO:1990984;GO:0006307;GO:0080111;GO:0061157;GO:0070989;GO:0035552;GO:0035553;GO:0090335;GO:0010883;GO:0040014;GO:0042245;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA-N1-methyladenine dioxygenase activity; F:ferrous iron binding; F:oxidative DNA demethylase activity; F:oxidative RNA demethylase activity; F:RNA N6-methyladenosine dioxygenase activity; F:transferase activity; F:tRNA demethylase activity;, P:DNA dealkylation involved in DNA repair; P:DNA demethylation; P:mRNA destabilization; P:oxidative demethylation; P:oxidative single-stranded DNA demethylation; P:oxidative single-stranded RNA demethylation; P:regulation of brown fat cell differentiation; P:regulation of lipid storage; P:regulation of multicellular organism growth; P:RNA repair;|Q5VVW2 B4DEP7 B7Z3Q6 Q8IYU1 Q8N951 Q8ND89 Q9BQH6,GTPase-activating Rap/Ran-GAP domain-like protein 3,, PF00780;PF02145;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5VVW2 B4DEP7 B7Z3Q6 Q8IYU1 Q8N951 Q8ND89 Q9BQH6,GTPase-activating Rap/Ran-GAP domain-like protein 3,, PF00780;PF02145;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5VVW2 B4DEP7 B7Z3Q6 Q8IYU1 Q8N951 Q8ND89 Q9BQH6,GTPase-activating Rap/Ran-GAP domain-like protein 3,, PF00780;PF02145;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5VVW2 B4DEP7 B7Z3Q6 Q8IYU1 Q8N951 Q8ND89 Q9BQH6,GTPase-activating Rap/Ran-GAP domain-like protein 3,, PF00780;PF02145;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5VVW2 B4DEP7 B7Z3Q6 Q8IYU1 Q8N951 Q8ND89 Q9BQH6,GTPase-activating Rap/Ran-GAP domain-like protein 3,, PF00780;PF02145;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5VVW2 B4DEP7 B7Z3Q6 Q8IYU1 Q8N951 Q8ND89 Q9BQH6,GTPase-activating Rap/Ran-GAP domain-like protein 3,, PF00780;PF02145;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5VVW2 B4DEP7 B7Z3Q6 Q8IYU1 Q8N951 Q8ND89 Q9BQH6,GTPase-activating Rap/Ran-GAP domain-like protein 3,, PF00780;PF02145;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9NY64 Q8WUZ9 Q9NSC4,Solute carrier family 2, facilitated glucose transporter member 8 {ECO:0000305},Glucose transporter type 8 {ECO:0000303|PubMed:10821868};Glucose transporter type X1 {ECO:0000303|PubMed:10671487};, PF00083;, GO:0030669;GO:0005887;GO:0005765;GO:0005886;GO:0008021;GO:0033300;GO:0005353;GO:0005536;GO:0005355;GO:0005975;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0008286;GO:0007141;GO:0061024;GO:0001666;, C:clathrin-coated endocytic vesicle membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane; C:synaptic vesicle;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose binding; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:insulin receptor signaling pathway; P:male meiosis I; P:membrane organization; P:response to hypoxia;|Q9NY64 Q8WUZ9 Q9NSC4,Solute carrier family 2, facilitated glucose transporter member 8 {ECO:0000305},Glucose transporter type 8 {ECO:0000303|PubMed:10821868};Glucose transporter type X1 {ECO:0000303|PubMed:10671487};, PF00083;, GO:0030669;GO:0005887;GO:0005765;GO:0005886;GO:0008021;GO:0033300;GO:0005353;GO:0005536;GO:0005355;GO:0005975;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0008286;GO:0007141;GO:0061024;GO:0001666;, C:clathrin-coated endocytic vesicle membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane; C:synaptic vesicle;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose binding; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:insulin receptor signaling pathway; P:male meiosis I; P:membrane organization; P:response to hypoxia;|Q9NY64 Q8WUZ9 Q9NSC4,Solute carrier family 2, facilitated glucose transporter member 8 {ECO:0000305},Glucose transporter type 8 {ECO:0000303|PubMed:10821868};Glucose transporter type X1 {ECO:0000303|PubMed:10671487};, PF00083;, GO:0030669;GO:0005887;GO:0005765;GO:0005886;GO:0008021;GO:0033300;GO:0005353;GO:0005536;GO:0005355;GO:0005975;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0008286;GO:0007141;GO:0061024;GO:0001666;, C:clathrin-coated endocytic vesicle membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane; C:synaptic vesicle;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose binding; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:insulin receptor signaling pathway; P:male meiosis I; P:membrane organization; P:response to hypoxia;|Q9NY64 Q8WUZ9 Q9NSC4,Solute carrier family 2, facilitated glucose transporter member 8 {ECO:0000305},Glucose transporter type 8 {ECO:0000303|PubMed:10821868};Glucose transporter type X1 {ECO:0000303|PubMed:10671487};, PF00083;, GO:0030669;GO:0005887;GO:0005765;GO:0005886;GO:0008021;GO:0033300;GO:0005353;GO:0005536;GO:0005355;GO:0005975;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0008286;GO:0007141;GO:0061024;GO:0001666;, C:clathrin-coated endocytic vesicle membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane; C:synaptic vesicle;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose binding; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:insulin receptor signaling pathway; P:male meiosis I; P:membrane organization; P:response to hypoxia;|Q9NY64 Q8WUZ9 Q9NSC4,Solute carrier family 2, facilitated glucose transporter member 8 {ECO:0000305},Glucose transporter type 8 {ECO:0000303|PubMed:10821868};Glucose transporter type X1 {ECO:0000303|PubMed:10671487};, PF00083;, GO:0030669;GO:0005887;GO:0005765;GO:0005886;GO:0008021;GO:0033300;GO:0005353;GO:0005536;GO:0005355;GO:0005975;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0008286;GO:0007141;GO:0061024;GO:0001666;, C:clathrin-coated endocytic vesicle membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane; C:synaptic vesicle;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose binding; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:insulin receptor signaling pathway; P:male meiosis I; P:membrane organization; P:response to hypoxia;|Q9NY64 Q8WUZ9 Q9NSC4,Solute carrier family 2, facilitated glucose transporter member 8 {ECO:0000305},Glucose transporter type 8 {ECO:0000303|PubMed:10821868};Glucose transporter type X1 {ECO:0000303|PubMed:10671487};, PF00083;, GO:0030669;GO:0005887;GO:0005765;GO:0005886;GO:0008021;GO:0033300;GO:0005353;GO:0005536;GO:0005355;GO:0005975;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0008286;GO:0007141;GO:0061024;GO:0001666;, C:clathrin-coated endocytic vesicle membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane; C:synaptic vesicle;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose binding; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:insulin receptor signaling pathway; P:male meiosis I; P:membrane organization; P:response to hypoxia;|Q15937 Q5VVW1 Q96NV1,Zinc finger protein 79,ZNFpT7;, PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q15937 Q5VVW1 Q96NV1,Zinc finger protein 79,ZNFpT7;, PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q15937 Q5VVW1 Q96NV1,Zinc finger protein 79,ZNFpT7;, PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P30050 Q5VVV2 Q6PB27,60S ribosomal protein L12,Large ribosomal subunit protein uL11 {ECO:0000303|PubMed:24524803};, PF00298;PF03946;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0015934;GO:0016020;GO:0014069;GO:0070180;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:large ribosomal subunit; C:membrane; C:postsynaptic density;, F:large ribosomal subunit rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P30050 Q5VVV2 Q6PB27,60S ribosomal protein L12,Large ribosomal subunit protein uL11 {ECO:0000303|PubMed:24524803};, PF00298;PF03946;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0015934;GO:0016020;GO:0014069;GO:0070180;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:large ribosomal subunit; C:membrane; C:postsynaptic density;, F:large ribosomal subunit rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P30050 Q5VVV2 Q6PB27,60S ribosomal protein L12,Large ribosomal subunit protein uL11 {ECO:0000303|PubMed:24524803};, PF00298;PF03946;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0015934;GO:0016020;GO:0014069;GO:0070180;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:large ribosomal subunit; C:membrane; C:postsynaptic density;, F:large ribosomal subunit rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q6UWE0 Q5VVV0 Q8NB40 Q96GT5 Q96MX5 Q96MZ7,E3 ubiquitin-protein ligase LRSAM1 {ECO:0000305},Leucine-rich repeat and sterile alpha motif-containing protein 1 {ECO:0000303|PubMed:20865121};RING-type E3 ubiquitin transferase LRSAM1 {ECO:0000305};Tsg101-associated ligase {ECO:0000303|PubMed:15256501};, PF13855;PF07647;, GO:0005737;GO:0005829;GO:0016020;GO:0046872;GO:0061630;GO:0004842;GO:0006914;GO:0045806;GO:2000786;GO:1904417;GO:0051865;GO:0030163;GO:0000209;GO:0070086;GO:0046755;, C:cytoplasm; C:cytosol; C:membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:autophagy; P:negative regulation of endocytosis; P:positive regulation of autophagosome assembly; P:positive regulation of xenophagy; P:protein autoubiquitination; P:protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent endocytosis; P:viral budding;|Q6UWE0 Q5VVV0 Q8NB40 Q96GT5 Q96MX5 Q96MZ7,E3 ubiquitin-protein ligase LRSAM1 {ECO:0000305},Leucine-rich repeat and sterile alpha motif-containing protein 1 {ECO:0000303|PubMed:20865121};RING-type E3 ubiquitin transferase LRSAM1 {ECO:0000305};Tsg101-associated ligase {ECO:0000303|PubMed:15256501};, PF13855;PF07647;, GO:0005737;GO:0005829;GO:0016020;GO:0046872;GO:0061630;GO:0004842;GO:0006914;GO:0045806;GO:2000786;GO:1904417;GO:0051865;GO:0030163;GO:0000209;GO:0070086;GO:0046755;, C:cytoplasm; C:cytosol; C:membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:autophagy; P:negative regulation of endocytosis; P:positive regulation of autophagosome assembly; P:positive regulation of xenophagy; P:protein autoubiquitination; P:protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent endocytosis; P:viral budding;|Q6UWE0 Q5VVV0 Q8NB40 Q96GT5 Q96MX5 Q96MZ7,E3 ubiquitin-protein ligase LRSAM1 {ECO:0000305},Leucine-rich repeat and sterile alpha motif-containing protein 1 {ECO:0000303|PubMed:20865121};RING-type E3 ubiquitin transferase LRSAM1 {ECO:0000305};Tsg101-associated ligase {ECO:0000303|PubMed:15256501};, PF13855;PF07647;, GO:0005737;GO:0005829;GO:0016020;GO:0046872;GO:0061630;GO:0004842;GO:0006914;GO:0045806;GO:2000786;GO:1904417;GO:0051865;GO:0030163;GO:0000209;GO:0070086;GO:0046755;, C:cytoplasm; C:cytosol; C:membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:autophagy; P:negative regulation of endocytosis; P:positive regulation of autophagosome assembly; P:positive regulation of xenophagy; P:protein autoubiquitination; P:protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent endocytosis; P:viral budding;|Q6UWE0 Q5VVV0 Q8NB40 Q96GT5 Q96MX5 Q96MZ7,E3 ubiquitin-protein ligase LRSAM1 {ECO:0000305},Leucine-rich repeat and sterile alpha motif-containing protein 1 {ECO:0000303|PubMed:20865121};RING-type E3 ubiquitin transferase LRSAM1 {ECO:0000305};Tsg101-associated ligase {ECO:0000303|PubMed:15256501};, PF13855;PF07647;, GO:0005737;GO:0005829;GO:0016020;GO:0046872;GO:0061630;GO:0004842;GO:0006914;GO:0045806;GO:2000786;GO:1904417;GO:0051865;GO:0030163;GO:0000209;GO:0070086;GO:0046755;, C:cytoplasm; C:cytosol; C:membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:autophagy; P:negative regulation of endocytosis; P:positive regulation of autophagosome assembly; P:positive regulation of xenophagy; P:protein autoubiquitination; P:protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent endocytosis; P:viral budding;|Q6UWE0 Q5VVV0 Q8NB40 Q96GT5 Q96MX5 Q96MZ7,E3 ubiquitin-protein ligase LRSAM1 {ECO:0000305},Leucine-rich repeat and sterile alpha motif-containing protein 1 {ECO:0000303|PubMed:20865121};RING-type E3 ubiquitin transferase LRSAM1 {ECO:0000305};Tsg101-associated ligase {ECO:0000303|PubMed:15256501};, PF13855;PF07647;, GO:0005737;GO:0005829;GO:0016020;GO:0046872;GO:0061630;GO:0004842;GO:0006914;GO:0045806;GO:2000786;GO:1904417;GO:0051865;GO:0030163;GO:0000209;GO:0070086;GO:0046755;, C:cytoplasm; C:cytosol; C:membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:autophagy; P:negative regulation of endocytosis; P:positive regulation of autophagosome assembly; P:positive regulation of xenophagy; P:protein autoubiquitination; P:protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent endocytosis; P:viral budding;|Q6UWE0 Q5VVV0 Q8NB40 Q96GT5 Q96MX5 Q96MZ7,E3 ubiquitin-protein ligase LRSAM1 {ECO:0000305},Leucine-rich repeat and sterile alpha motif-containing protein 1 {ECO:0000303|PubMed:20865121};RING-type E3 ubiquitin transferase LRSAM1 {ECO:0000305};Tsg101-associated ligase {ECO:0000303|PubMed:15256501};, PF13855;PF07647;, GO:0005737;GO:0005829;GO:0016020;GO:0046872;GO:0061630;GO:0004842;GO:0006914;GO:0045806;GO:2000786;GO:1904417;GO:0051865;GO:0030163;GO:0000209;GO:0070086;GO:0046755;, C:cytoplasm; C:cytosol; C:membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:autophagy; P:negative regulation of endocytosis; P:positive regulation of autophagosome assembly; P:positive regulation of xenophagy; P:protein autoubiquitination; P:protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent endocytosis; P:viral budding;|Q6UWE0 Q5VVV0 Q8NB40 Q96GT5 Q96MX5 Q96MZ7,E3 ubiquitin-protein ligase LRSAM1 {ECO:0000305},Leucine-rich repeat and sterile alpha motif-containing protein 1 {ECO:0000303|PubMed:20865121};RING-type E3 ubiquitin transferase LRSAM1 {ECO:0000305};Tsg101-associated ligase {ECO:0000303|PubMed:15256501};, PF13855;PF07647;, GO:0005737;GO:0005829;GO:0016020;GO:0046872;GO:0061630;GO:0004842;GO:0006914;GO:0045806;GO:2000786;GO:1904417;GO:0051865;GO:0030163;GO:0000209;GO:0070086;GO:0046755;, C:cytoplasm; C:cytosol; C:membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:autophagy; P:negative regulation of endocytosis; P:positive regulation of autophagosome assembly; P:positive regulation of xenophagy; P:protein autoubiquitination; P:protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent endocytosis; P:viral budding;|Q96TA1 Q4LE55 Q5VVW6 Q5VVW7 Q9BUS2 Q9NT35,Protein Niban 2 {ECO:0000305},Meg-3;Melanoma invasion by ERK {ECO:0000303|PubMed:21148485};Niban-like protein 1;Protein FAM129B;, , GO:0005912;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0003713;GO:0007411;GO:0030154;GO:0032274;GO:0044029;GO:0016525;GO:0043066;GO:0008285;GO:2000279;GO:0045746;GO:0045892;GO:0030948;GO:0040019;GO:0048743;GO:2000679;GO:0045893;, C:adherens junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:transcription coactivator activity;, P:axon guidance; P:cell differentiation; P:gonadotropin secretion; P:hypomethylation of CpG island; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of DNA biosynthetic process; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of embryonic development; P:positive regulation of skeletal muscle fiber development; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated;|Q96TA1 Q4LE55 Q5VVW6 Q5VVW7 Q9BUS2 Q9NT35,Protein Niban 2 {ECO:0000305},Meg-3;Melanoma invasion by ERK {ECO:0000303|PubMed:21148485};Niban-like protein 1;Protein FAM129B;, , GO:0005912;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0003713;GO:0007411;GO:0030154;GO:0032274;GO:0044029;GO:0016525;GO:0043066;GO:0008285;GO:2000279;GO:0045746;GO:0045892;GO:0030948;GO:0040019;GO:0048743;GO:2000679;GO:0045893;, C:adherens junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:transcription coactivator activity;, P:axon guidance; P:cell differentiation; P:gonadotropin secretion; P:hypomethylation of CpG island; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of DNA biosynthetic process; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of embryonic development; P:positive regulation of skeletal muscle fiber development; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated;|Q96TA1 Q4LE55 Q5VVW6 Q5VVW7 Q9BUS2 Q9NT35,Protein Niban 2 {ECO:0000305},Meg-3;Melanoma invasion by ERK {ECO:0000303|PubMed:21148485};Niban-like protein 1;Protein FAM129B;, , GO:0005912;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0003713;GO:0007411;GO:0030154;GO:0032274;GO:0044029;GO:0016525;GO:0043066;GO:0008285;GO:2000279;GO:0045746;GO:0045892;GO:0030948;GO:0040019;GO:0048743;GO:2000679;GO:0045893;, C:adherens junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:transcription coactivator activity;, P:axon guidance; P:cell differentiation; P:gonadotropin secretion; P:hypomethylation of CpG island; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of DNA biosynthetic process; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of embryonic development; P:positive regulation of skeletal muscle fiber development; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated;|Q96TA1 Q4LE55 Q5VVW6 Q5VVW7 Q9BUS2 Q9NT35,Protein Niban 2 {ECO:0000305},Meg-3;Melanoma invasion by ERK {ECO:0000303|PubMed:21148485};Niban-like protein 1;Protein FAM129B;, , GO:0005912;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0045296;GO:0003713;GO:0007411;GO:0030154;GO:0032274;GO:0044029;GO:0016525;GO:0043066;GO:0008285;GO:2000279;GO:0045746;GO:0045892;GO:0030948;GO:0040019;GO:0048743;GO:2000679;GO:0045893;, C:adherens junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cadherin binding; F:transcription coactivator activity;, P:axon guidance; P:cell differentiation; P:gonadotropin secretion; P:hypomethylation of CpG island; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of DNA biosynthetic process; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of embryonic development; P:positive regulation of skeletal muscle fiber development; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated;|P61764 B1AM97 Q28208 Q62759 Q64320 Q68CM6 Q96TG8,Syntaxin-binding protein 1,MUNC18-1;N-Sec1;Protein unc-18 homolog 1;Protein unc-18 homolog A;p67;, PF00995;, GO:0030424;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0098978;GO:0005739;GO:0005654;GO:0048471;GO:0045335;GO:0005886;GO:0031091;GO:0098794;GO:0048787;GO:0032991;GO:0030141;GO:0042802;GO:0043274;GO:0019904;GO:0019901;GO:0047485;GO:0003723;GO:0000149;GO:0019905;GO:0017075;GO:0007412;GO:0071346;GO:0003006;GO:0006886;GO:0060292;GO:0043524;GO:0031333;GO:0032229;GO:0007274;GO:0007269;GO:0006836;GO:0070527;GO:0002576;GO:0045956;GO:1903296;GO:0043306;GO:0106022;GO:0099525;GO:0072659;GO:0050821;GO:2000367;GO:0035542;GO:0031630;GO:0010807;GO:0032355;GO:0035493;GO:0016188;GO:0016082;GO:0006904;GO:0016192;, C:axon; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:mitochondrion; C:nucleoplasm; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule; C:postsynapse; C:presynaptic active zone membrane; C:protein-containing complex; C:secretory granule;, F:identical protein binding; F:phospholipase binding; F:protein domain specific binding; F:protein kinase binding; F:protein N-terminus binding; F:RNA binding; F:SNARE binding; F:syntaxin binding; F:syntaxin-1 binding;, P:axon target recognition; P:cellular response to interferon-gamma; P:developmental process involved in reproduction; P:intracellular protein transport; P:long-term synaptic depression; P:negative regulation of neuron apoptotic process; P:negative regulation of protein-containing complex assembly; P:negative regulation of synaptic transmission, GABAergic; P:neuromuscular synaptic transmission; P:neurotransmitter secretion; P:neurotransmitter transport; P:platelet aggregation; P:platelet degranulation; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of glutamate secretion, neurotransmission; P:positive regulation of mast cell degranulation; P:positive regulation of vesicle docking; P:presynaptic dense core vesicle exocytosis; P:protein localization to plasma membrane; P:protein stabilization; P:regulation of acrosomal vesicle exocytosis; P:regulation of SNARE complex assembly; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; P:regulation of synaptic vesicle priming; P:response to estradiol; P:SNARE complex assembly; P:synaptic vesicle maturation; P:synaptic vesicle priming; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|P61764 B1AM97 Q28208 Q62759 Q64320 Q68CM6 Q96TG8,Syntaxin-binding protein 1,MUNC18-1;N-Sec1;Protein unc-18 homolog 1;Protein unc-18 homolog A;p67;, PF00995;, GO:0030424;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0098978;GO:0005739;GO:0005654;GO:0048471;GO:0045335;GO:0005886;GO:0031091;GO:0098794;GO:0048787;GO:0032991;GO:0030141;GO:0042802;GO:0043274;GO:0019904;GO:0019901;GO:0047485;GO:0003723;GO:0000149;GO:0019905;GO:0017075;GO:0007412;GO:0071346;GO:0003006;GO:0006886;GO:0060292;GO:0043524;GO:0031333;GO:0032229;GO:0007274;GO:0007269;GO:0006836;GO:0070527;GO:0002576;GO:0045956;GO:1903296;GO:0043306;GO:0106022;GO:0099525;GO:0072659;GO:0050821;GO:2000367;GO:0035542;GO:0031630;GO:0010807;GO:0032355;GO:0035493;GO:0016188;GO:0016082;GO:0006904;GO:0016192;, C:axon; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:mitochondrion; C:nucleoplasm; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule; C:postsynapse; C:presynaptic active zone membrane; C:protein-containing complex; C:secretory granule;, F:identical protein binding; F:phospholipase binding; F:protein domain specific binding; F:protein kinase binding; F:protein N-terminus binding; F:RNA binding; F:SNARE binding; F:syntaxin binding; F:syntaxin-1 binding;, P:axon target recognition; P:cellular response to interferon-gamma; P:developmental process involved in reproduction; P:intracellular protein transport; P:long-term synaptic depression; P:negative regulation of neuron apoptotic process; P:negative regulation of protein-containing complex assembly; P:negative regulation of synaptic transmission, GABAergic; P:neuromuscular synaptic transmission; P:neurotransmitter secretion; P:neurotransmitter transport; P:platelet aggregation; P:platelet degranulation; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of glutamate secretion, neurotransmission; P:positive regulation of mast cell degranulation; P:positive regulation of vesicle docking; P:presynaptic dense core vesicle exocytosis; P:protein localization to plasma membrane; P:protein stabilization; P:regulation of acrosomal vesicle exocytosis; P:regulation of SNARE complex assembly; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; P:regulation of synaptic vesicle priming; P:response to estradiol; P:SNARE complex assembly; P:synaptic vesicle maturation; P:synaptic vesicle priming; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|P61764 B1AM97 Q28208 Q62759 Q64320 Q68CM6 Q96TG8,Syntaxin-binding protein 1,MUNC18-1;N-Sec1;Protein unc-18 homolog 1;Protein unc-18 homolog A;p67;, PF00995;, GO:0030424;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0098978;GO:0005739;GO:0005654;GO:0048471;GO:0045335;GO:0005886;GO:0031091;GO:0098794;GO:0048787;GO:0032991;GO:0030141;GO:0042802;GO:0043274;GO:0019904;GO:0019901;GO:0047485;GO:0003723;GO:0000149;GO:0019905;GO:0017075;GO:0007412;GO:0071346;GO:0003006;GO:0006886;GO:0060292;GO:0043524;GO:0031333;GO:0032229;GO:0007274;GO:0007269;GO:0006836;GO:0070527;GO:0002576;GO:0045956;GO:1903296;GO:0043306;GO:0106022;GO:0099525;GO:0072659;GO:0050821;GO:2000367;GO:0035542;GO:0031630;GO:0010807;GO:0032355;GO:0035493;GO:0016188;GO:0016082;GO:0006904;GO:0016192;, C:axon; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:mitochondrion; C:nucleoplasm; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule; C:postsynapse; C:presynaptic active zone membrane; C:protein-containing complex; C:secretory granule;, F:identical protein binding; F:phospholipase binding; F:protein domain specific binding; F:protein kinase binding; F:protein N-terminus binding; F:RNA binding; F:SNARE binding; F:syntaxin binding; F:syntaxin-1 binding;, P:axon target recognition; P:cellular response to interferon-gamma; P:developmental process involved in reproduction; P:intracellular protein transport; P:long-term synaptic depression; P:negative regulation of neuron apoptotic process; P:negative regulation of protein-containing complex assembly; P:negative regulation of synaptic transmission, GABAergic; P:neuromuscular synaptic transmission; P:neurotransmitter secretion; P:neurotransmitter transport; P:platelet aggregation; P:platelet degranulation; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of glutamate secretion, neurotransmission; P:positive regulation of mast cell degranulation; P:positive regulation of vesicle docking; P:presynaptic dense core vesicle exocytosis; P:protein localization to plasma membrane; P:protein stabilization; P:regulation of acrosomal vesicle exocytosis; P:regulation of SNARE complex assembly; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; P:regulation of synaptic vesicle priming; P:response to estradiol; P:SNARE complex assembly; P:synaptic vesicle maturation; P:synaptic vesicle priming; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|P61764 B1AM97 Q28208 Q62759 Q64320 Q68CM6 Q96TG8,Syntaxin-binding protein 1,MUNC18-1;N-Sec1;Protein unc-18 homolog 1;Protein unc-18 homolog A;p67;, PF00995;, GO:0030424;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0098978;GO:0005739;GO:0005654;GO:0048471;GO:0045335;GO:0005886;GO:0031091;GO:0098794;GO:0048787;GO:0032991;GO:0030141;GO:0042802;GO:0043274;GO:0019904;GO:0019901;GO:0047485;GO:0003723;GO:0000149;GO:0019905;GO:0017075;GO:0007412;GO:0071346;GO:0003006;GO:0006886;GO:0060292;GO:0043524;GO:0031333;GO:0032229;GO:0007274;GO:0007269;GO:0006836;GO:0070527;GO:0002576;GO:0045956;GO:1903296;GO:0043306;GO:0106022;GO:0099525;GO:0072659;GO:0050821;GO:2000367;GO:0035542;GO:0031630;GO:0010807;GO:0032355;GO:0035493;GO:0016188;GO:0016082;GO:0006904;GO:0016192;, C:axon; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:mitochondrion; C:nucleoplasm; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:platelet alpha granule; C:postsynapse; C:presynaptic active zone membrane; C:protein-containing complex; C:secretory granule;, F:identical protein binding; F:phospholipase binding; F:protein domain specific binding; F:protein kinase binding; F:protein N-terminus binding; F:RNA binding; F:SNARE binding; F:syntaxin binding; F:syntaxin-1 binding;, P:axon target recognition; P:cellular response to interferon-gamma; P:developmental process involved in reproduction; P:intracellular protein transport; P:long-term synaptic depression; P:negative regulation of neuron apoptotic process; P:negative regulation of protein-containing complex assembly; P:negative regulation of synaptic transmission, GABAergic; P:neuromuscular synaptic transmission; P:neurotransmitter secretion; P:neurotransmitter transport; P:platelet aggregation; P:platelet degranulation; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of glutamate secretion, neurotransmission; P:positive regulation of mast cell degranulation; P:positive regulation of vesicle docking; P:presynaptic dense core vesicle exocytosis; P:protein localization to plasma membrane; P:protein stabilization; P:regulation of acrosomal vesicle exocytosis; P:regulation of SNARE complex assembly; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; P:regulation of synaptic vesicle priming; P:response to estradiol; P:SNARE complex assembly; P:synaptic vesicle maturation; P:synaptic vesicle priming; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q5JU67 A5D8T9,Cilia- and flagella-associated protein 157 {ECO:0000305},, , GO:0036064;GO:0005829;GO:0043231;GO:0005886;GO:0008017;GO:0007288;, C:ciliary basal body; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:microtubule binding;, P:sperm axoneme assembly;|Q86Y79,Probable peptidyl-tRNA hydrolase,, PF01195;, GO:0004045;GO:0003723;, , F:aminoacyl-tRNA hydrolase activity; F:RNA binding;|Q86Y79,Probable peptidyl-tRNA hydrolase,, PF01195;, GO:0004045;GO:0003723;, , F:aminoacyl-tRNA hydrolase activity; F:RNA binding;|Q96SL7,Torsin-2A,Torsin family 2 member A;Torsin-related protein 1;, PF06309;, GO:0005788;GO:0005635;GO:0005524;GO:0016887;GO:0042802;GO:0051085;, C:endoplasmic reticulum lumen; C:nuclear envelope;, F:ATP binding; F:ATPase activity; F:identical protein binding;, P:chaperone cofactor-dependent protein refolding;|Q8N5H7 A8K5S8 E9PG48 Q5HYE5 Q5JU31 Q6UY42 Q8N6X3 Q9Y2X5,SH2 domain-containing protein 3C,Cas/HEF1-associated signal transducer {ECO:0000303|PubMed:17174122};Novel SH2-containing protein 3;SH2 domain-containing Eph receptor-binding protein 1;, PF00617;PF00017;, GO:0030424;GO:0005737;GO:0032587;GO:0005085;GO:0001784;GO:0007254;GO:0033138;GO:0007264;, C:axon; C:cytoplasm; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphotyrosine residue binding;, P:JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:small GTPase mediated signal transduction;|Q8N5H7 A8K5S8 E9PG48 Q5HYE5 Q5JU31 Q6UY42 Q8N6X3 Q9Y2X5,SH2 domain-containing protein 3C,Cas/HEF1-associated signal transducer {ECO:0000303|PubMed:17174122};Novel SH2-containing protein 3;SH2 domain-containing Eph receptor-binding protein 1;, PF00617;PF00017;, GO:0030424;GO:0005737;GO:0032587;GO:0005085;GO:0001784;GO:0007254;GO:0033138;GO:0007264;, C:axon; C:cytoplasm; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphotyrosine residue binding;, P:JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:small GTPase mediated signal transduction;|Q8N5H7 A8K5S8 E9PG48 Q5HYE5 Q5JU31 Q6UY42 Q8N6X3 Q9Y2X5,SH2 domain-containing protein 3C,Cas/HEF1-associated signal transducer {ECO:0000303|PubMed:17174122};Novel SH2-containing protein 3;SH2 domain-containing Eph receptor-binding protein 1;, PF00617;PF00017;, GO:0030424;GO:0005737;GO:0032587;GO:0005085;GO:0001784;GO:0007254;GO:0033138;GO:0007264;, C:axon; C:cytoplasm; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphotyrosine residue binding;, P:JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:small GTPase mediated signal transduction;|Q8N5H7 A8K5S8 E9PG48 Q5HYE5 Q5JU31 Q6UY42 Q8N6X3 Q9Y2X5,SH2 domain-containing protein 3C,Cas/HEF1-associated signal transducer {ECO:0000303|PubMed:17174122};Novel SH2-containing protein 3;SH2 domain-containing Eph receptor-binding protein 1;, PF00617;PF00017;, GO:0030424;GO:0005737;GO:0032587;GO:0005085;GO:0001784;GO:0007254;GO:0033138;GO:0007264;, C:axon; C:cytoplasm; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphotyrosine residue binding;, P:JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:small GTPase mediated signal transduction;|Q8N5H7 A8K5S8 E9PG48 Q5HYE5 Q5JU31 Q6UY42 Q8N6X3 Q9Y2X5,SH2 domain-containing protein 3C,Cas/HEF1-associated signal transducer {ECO:0000303|PubMed:17174122};Novel SH2-containing protein 3;SH2 domain-containing Eph receptor-binding protein 1;, PF00617;PF00017;, GO:0030424;GO:0005737;GO:0032587;GO:0005085;GO:0001784;GO:0007254;GO:0033138;GO:0007264;, C:axon; C:cytoplasm; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphotyrosine residue binding;, P:JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:small GTPase mediated signal transduction;|Q8N5H7 A8K5S8 E9PG48 Q5HYE5 Q5JU31 Q6UY42 Q8N6X3 Q9Y2X5,SH2 domain-containing protein 3C,Cas/HEF1-associated signal transducer {ECO:0000303|PubMed:17174122};Novel SH2-containing protein 3;SH2 domain-containing Eph receptor-binding protein 1;, PF00617;PF00017;, GO:0030424;GO:0005737;GO:0032587;GO:0005085;GO:0001784;GO:0007254;GO:0033138;GO:0007264;, C:axon; C:cytoplasm; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphotyrosine residue binding;, P:JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:small GTPase mediated signal transduction;|P50750 Q5JU24 Q5JU25 Q5U006 Q96TF1,Cyclin-dependent kinase 9,C-2K;Cell division cycle 2-like protein kinase 4;Cell division protein kinase 9;Serine/threonine-protein kinase PITALRE;Tat-associated kinase complex catalytic subunit;, PF00069;, GO:0008024;GO:0036464;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0070691;GO:0016605;GO:0008023;GO:0097322;GO:0005524;GO:0003682;GO:0004693;GO:0003677;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0000978;GO:0008353;GO:0001223;GO:0008283;GO:0071345;GO:0006281;GO:0071157;GO:1900364;GO:0070816;GO:0010613;GO:2001168;GO:0033129;GO:1903839;GO:0045944;GO:0050434;GO:0006468;GO:0006282;GO:0031056;GO:0051147;GO:0031297;GO:0042493;GO:0042795;GO:0006366;GO:0006368;GO:0006367;, C:cyclin/CDK positive transcription elongation factor complex; C:cytoplasmic ribonucleoprotein granule; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:P-TEFb complex; C:PML body; C:transcription elongation factor complex;, F:7SK snRNA binding; F:ATP binding; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:DNA binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription coactivator binding;, P:cell population proliferation; P:cellular response to cytokine stimulus; P:DNA repair; P:negative regulation of cell cycle arrest; P:negative regulation of mRNA polyadenylation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone phosphorylation; P:positive regulation of mRNA 3'-UTR binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:protein phosphorylation; P:regulation of DNA repair; P:regulation of histone modification; P:regulation of muscle cell differentiation; P:replication fork processing; P:response to drug; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter;|P50750 Q5JU24 Q5JU25 Q5U006 Q96TF1,Cyclin-dependent kinase 9,C-2K;Cell division cycle 2-like protein kinase 4;Cell division protein kinase 9;Serine/threonine-protein kinase PITALRE;Tat-associated kinase complex catalytic subunit;, PF00069;, GO:0008024;GO:0036464;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0070691;GO:0016605;GO:0008023;GO:0097322;GO:0005524;GO:0003682;GO:0004693;GO:0003677;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0000978;GO:0008353;GO:0001223;GO:0008283;GO:0071345;GO:0006281;GO:0071157;GO:1900364;GO:0070816;GO:0010613;GO:2001168;GO:0033129;GO:1903839;GO:0045944;GO:0050434;GO:0006468;GO:0006282;GO:0031056;GO:0051147;GO:0031297;GO:0042493;GO:0042795;GO:0006366;GO:0006368;GO:0006367;, C:cyclin/CDK positive transcription elongation factor complex; C:cytoplasmic ribonucleoprotein granule; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:P-TEFb complex; C:PML body; C:transcription elongation factor complex;, F:7SK snRNA binding; F:ATP binding; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:DNA binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription coactivator binding;, P:cell population proliferation; P:cellular response to cytokine stimulus; P:DNA repair; P:negative regulation of cell cycle arrest; P:negative regulation of mRNA polyadenylation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone phosphorylation; P:positive regulation of mRNA 3'-UTR binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:protein phosphorylation; P:regulation of DNA repair; P:regulation of histone modification; P:regulation of muscle cell differentiation; P:replication fork processing; P:response to drug; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter;|Q05932 B3KPW4 B7Z2Z3 F5H0K6 Q5JU19 Q5JU22 Q6P2P6,Folylpolyglutamate synthase, mitochondrial,Folylpoly-gamma-glutamate synthetase;Tetrahydrofolylpolyglutamate synthase;, , GO:0005737;GO:0005829;GO:0005743;GO:0005759;GO:0005739;GO:0005524;GO:0046872;GO:0004326;GO:0031100;GO:0007420;GO:0008283;GO:0046655;GO:0009396;GO:0006760;GO:0006536;GO:0001889;GO:0006139;GO:0006730;GO:0046901;, C:cytoplasm; C:cytosol; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:tetrahydrofolylpolyglutamate synthase activity;, P:animal organ regeneration; P:brain development; P:cell population proliferation; P:folic acid metabolic process; P:folic acid-containing compound biosynthetic process; P:folic acid-containing compound metabolic process; P:glutamate metabolic process; P:liver development; P:nucleobase-containing compound metabolic process; P:one-carbon metabolic process; P:tetrahydrofolylpolyglutamate biosynthetic process;|Q05932 B3KPW4 B7Z2Z3 F5H0K6 Q5JU19 Q5JU22 Q6P2P6,Folylpolyglutamate synthase, mitochondrial,Folylpoly-gamma-glutamate synthetase;Tetrahydrofolylpolyglutamate synthase;, , GO:0005737;GO:0005829;GO:0005743;GO:0005759;GO:0005739;GO:0005524;GO:0046872;GO:0004326;GO:0031100;GO:0007420;GO:0008283;GO:0046655;GO:0009396;GO:0006760;GO:0006536;GO:0001889;GO:0006139;GO:0006730;GO:0046901;, C:cytoplasm; C:cytosol; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:tetrahydrofolylpolyglutamate synthase activity;, P:animal organ regeneration; P:brain development; P:cell population proliferation; P:folic acid metabolic process; P:folic acid-containing compound biosynthetic process; P:folic acid-containing compound metabolic process; P:glutamate metabolic process; P:liver development; P:nucleobase-containing compound metabolic process; P:one-carbon metabolic process; P:tetrahydrofolylpolyglutamate biosynthetic process;|P17813 Q14248 Q14926 Q5T9C0,Endoglin,, PF00100;, GO:0009986;GO:0072563;GO:0009897;GO:0005615;GO:0005925;GO:0016021;GO:0016604;GO:0005886;GO:0043235;GO:0048185;GO:0015026;GO:0005534;GO:0005539;GO:0042802;GO:0042803;GO:0050431;GO:0005024;GO:0004888;GO:0034713;GO:0005114;GO:0001525;GO:0048844;GO:0055009;GO:1905222;GO:0030509;GO:0060348;GO:0001569;GO:0003209;GO:0003208;GO:0007155;GO:0060326;GO:0016477;GO:0003273;GO:0048870;GO:0071260;GO:0022009;GO:0070483;GO:0035912;GO:0003203;GO:0001837;GO:0003198;GO:0070278;GO:0022617;GO:0001947;GO:0030336;GO:0001937;GO:0010629;GO:0051001;GO:0060394;GO:0031953;GO:0000122;GO:0030512;GO:0003148;GO:0045766;GO:0030513;GO:0032967;GO:1905007;GO:0010862;GO:0051897;GO:0001934;GO:0003084;GO:0045944;GO:1905065;GO:0030155;GO:0042127;GO:0042325;GO:0006355;GO:0017015;GO:0031960;GO:0042493;GO:0001666;GO:0048745;GO:0007179;GO:0097084;GO:0001570;GO:0048845;GO:0003222;GO:0042060;, C:cell surface; C:endothelial microparticle; C:external side of plasma membrane; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:nuclear body; C:plasma membrane; C:receptor complex;, F:activin binding; F:coreceptor activity; F:galactose binding; F:glycosaminoglycan binding; F:identical protein binding; F:protein homodimerization activity; F:transforming growth factor beta binding; F:transforming growth factor beta-activated receptor activity; F:transmembrane signaling receptor activity; F:type I transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding;, P:angiogenesis; P:artery morphogenesis; P:atrial cardiac muscle tissue morphogenesis; P:atrioventricular canal morphogenesis; P:BMP signaling pathway; P:bone development; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell migration involved in endocardial cushion formation; P:cell motility; P:cellular response to mechanical stimulus; P:central nervous system vasculogenesis; P:detection of hypoxia; P:dorsal aorta morphogenesis; P:endocardial cushion morphogenesis; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:extracellular matrix constituent secretion; P:extracellular matrix disassembly; P:heart looping; P:negative regulation of cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of gene expression; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of protein autophosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:outflow tract septum morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of systemic arterial blood pressure; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell differentiation; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:regulation of phosphorylation; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to corticosteroid; P:response to drug; P:response to hypoxia; P:smooth muscle tissue development; P:transforming growth factor beta receptor signaling pathway; P:vascular associated smooth muscle cell development; P:vasculogenesis; P:venous blood vessel morphogenesis; P:ventricular trabecula myocardium morphogenesis; P:wound healing;|P17813 Q14248 Q14926 Q5T9C0,Endoglin,, PF00100;, GO:0009986;GO:0072563;GO:0009897;GO:0005615;GO:0005925;GO:0016021;GO:0016604;GO:0005886;GO:0043235;GO:0048185;GO:0015026;GO:0005534;GO:0005539;GO:0042802;GO:0042803;GO:0050431;GO:0005024;GO:0004888;GO:0034713;GO:0005114;GO:0001525;GO:0048844;GO:0055009;GO:1905222;GO:0030509;GO:0060348;GO:0001569;GO:0003209;GO:0003208;GO:0007155;GO:0060326;GO:0016477;GO:0003273;GO:0048870;GO:0071260;GO:0022009;GO:0070483;GO:0035912;GO:0003203;GO:0001837;GO:0003198;GO:0070278;GO:0022617;GO:0001947;GO:0030336;GO:0001937;GO:0010629;GO:0051001;GO:0060394;GO:0031953;GO:0000122;GO:0030512;GO:0003148;GO:0045766;GO:0030513;GO:0032967;GO:1905007;GO:0010862;GO:0051897;GO:0001934;GO:0003084;GO:0045944;GO:1905065;GO:0030155;GO:0042127;GO:0042325;GO:0006355;GO:0017015;GO:0031960;GO:0042493;GO:0001666;GO:0048745;GO:0007179;GO:0097084;GO:0001570;GO:0048845;GO:0003222;GO:0042060;, C:cell surface; C:endothelial microparticle; C:external side of plasma membrane; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:nuclear body; C:plasma membrane; C:receptor complex;, F:activin binding; F:coreceptor activity; F:galactose binding; F:glycosaminoglycan binding; F:identical protein binding; F:protein homodimerization activity; F:transforming growth factor beta binding; F:transforming growth factor beta-activated receptor activity; F:transmembrane signaling receptor activity; F:type I transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding;, P:angiogenesis; P:artery morphogenesis; P:atrial cardiac muscle tissue morphogenesis; P:atrioventricular canal morphogenesis; P:BMP signaling pathway; P:bone development; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell migration involved in endocardial cushion formation; P:cell motility; P:cellular response to mechanical stimulus; P:central nervous system vasculogenesis; P:detection of hypoxia; P:dorsal aorta morphogenesis; P:endocardial cushion morphogenesis; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:extracellular matrix constituent secretion; P:extracellular matrix disassembly; P:heart looping; P:negative regulation of cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of gene expression; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of protein autophosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:outflow tract septum morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of systemic arterial blood pressure; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell differentiation; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:regulation of phosphorylation; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to corticosteroid; P:response to drug; P:response to hypoxia; P:smooth muscle tissue development; P:transforming growth factor beta receptor signaling pathway; P:vascular associated smooth muscle cell development; P:vasculogenesis; P:venous blood vessel morphogenesis; P:ventricular trabecula myocardium morphogenesis; P:wound healing;|P17813 Q14248 Q14926 Q5T9C0,Endoglin,, PF00100;, GO:0009986;GO:0072563;GO:0009897;GO:0005615;GO:0005925;GO:0016021;GO:0016604;GO:0005886;GO:0043235;GO:0048185;GO:0015026;GO:0005534;GO:0005539;GO:0042802;GO:0042803;GO:0050431;GO:0005024;GO:0004888;GO:0034713;GO:0005114;GO:0001525;GO:0048844;GO:0055009;GO:1905222;GO:0030509;GO:0060348;GO:0001569;GO:0003209;GO:0003208;GO:0007155;GO:0060326;GO:0016477;GO:0003273;GO:0048870;GO:0071260;GO:0022009;GO:0070483;GO:0035912;GO:0003203;GO:0001837;GO:0003198;GO:0070278;GO:0022617;GO:0001947;GO:0030336;GO:0001937;GO:0010629;GO:0051001;GO:0060394;GO:0031953;GO:0000122;GO:0030512;GO:0003148;GO:0045766;GO:0030513;GO:0032967;GO:1905007;GO:0010862;GO:0051897;GO:0001934;GO:0003084;GO:0045944;GO:1905065;GO:0030155;GO:0042127;GO:0042325;GO:0006355;GO:0017015;GO:0031960;GO:0042493;GO:0001666;GO:0048745;GO:0007179;GO:0097084;GO:0001570;GO:0048845;GO:0003222;GO:0042060;, C:cell surface; C:endothelial microparticle; C:external side of plasma membrane; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:nuclear body; C:plasma membrane; C:receptor complex;, F:activin binding; F:coreceptor activity; F:galactose binding; F:glycosaminoglycan binding; F:identical protein binding; F:protein homodimerization activity; F:transforming growth factor beta binding; F:transforming growth factor beta-activated receptor activity; F:transmembrane signaling receptor activity; F:type I transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding;, P:angiogenesis; P:artery morphogenesis; P:atrial cardiac muscle tissue morphogenesis; P:atrioventricular canal morphogenesis; P:BMP signaling pathway; P:bone development; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell migration involved in endocardial cushion formation; P:cell motility; P:cellular response to mechanical stimulus; P:central nervous system vasculogenesis; P:detection of hypoxia; P:dorsal aorta morphogenesis; P:endocardial cushion morphogenesis; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:extracellular matrix constituent secretion; P:extracellular matrix disassembly; P:heart looping; P:negative regulation of cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of gene expression; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of protein autophosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:outflow tract septum morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of systemic arterial blood pressure; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell differentiation; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:regulation of phosphorylation; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to corticosteroid; P:response to drug; P:response to hypoxia; P:smooth muscle tissue development; P:transforming growth factor beta receptor signaling pathway; P:vascular associated smooth muscle cell development; P:vasculogenesis; P:venous blood vessel morphogenesis; P:ventricular trabecula myocardium morphogenesis; P:wound healing;|P17813 Q14248 Q14926 Q5T9C0,Endoglin,, PF00100;, GO:0009986;GO:0072563;GO:0009897;GO:0005615;GO:0005925;GO:0016021;GO:0016604;GO:0005886;GO:0043235;GO:0048185;GO:0015026;GO:0005534;GO:0005539;GO:0042802;GO:0042803;GO:0050431;GO:0005024;GO:0004888;GO:0034713;GO:0005114;GO:0001525;GO:0048844;GO:0055009;GO:1905222;GO:0030509;GO:0060348;GO:0001569;GO:0003209;GO:0003208;GO:0007155;GO:0060326;GO:0016477;GO:0003273;GO:0048870;GO:0071260;GO:0022009;GO:0070483;GO:0035912;GO:0003203;GO:0001837;GO:0003198;GO:0070278;GO:0022617;GO:0001947;GO:0030336;GO:0001937;GO:0010629;GO:0051001;GO:0060394;GO:0031953;GO:0000122;GO:0030512;GO:0003148;GO:0045766;GO:0030513;GO:0032967;GO:1905007;GO:0010862;GO:0051897;GO:0001934;GO:0003084;GO:0045944;GO:1905065;GO:0030155;GO:0042127;GO:0042325;GO:0006355;GO:0017015;GO:0031960;GO:0042493;GO:0001666;GO:0048745;GO:0007179;GO:0097084;GO:0001570;GO:0048845;GO:0003222;GO:0042060;, C:cell surface; C:endothelial microparticle; C:external side of plasma membrane; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:nuclear body; C:plasma membrane; C:receptor complex;, F:activin binding; F:coreceptor activity; F:galactose binding; F:glycosaminoglycan binding; F:identical protein binding; F:protein homodimerization activity; F:transforming growth factor beta binding; F:transforming growth factor beta-activated receptor activity; F:transmembrane signaling receptor activity; F:type I transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding;, P:angiogenesis; P:artery morphogenesis; P:atrial cardiac muscle tissue morphogenesis; P:atrioventricular canal morphogenesis; P:BMP signaling pathway; P:bone development; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell migration involved in endocardial cushion formation; P:cell motility; P:cellular response to mechanical stimulus; P:central nervous system vasculogenesis; P:detection of hypoxia; P:dorsal aorta morphogenesis; P:endocardial cushion morphogenesis; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:extracellular matrix constituent secretion; P:extracellular matrix disassembly; P:heart looping; P:negative regulation of cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of gene expression; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of protein autophosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:outflow tract septum morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of systemic arterial blood pressure; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell differentiation; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:regulation of phosphorylation; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to corticosteroid; P:response to drug; P:response to hypoxia; P:smooth muscle tissue development; P:transforming growth factor beta receptor signaling pathway; P:vascular associated smooth muscle cell development; P:vasculogenesis; P:venous blood vessel morphogenesis; P:ventricular trabecula myocardium morphogenesis; P:wound healing;|P17813 Q14248 Q14926 Q5T9C0,Endoglin,, PF00100;, GO:0009986;GO:0072563;GO:0009897;GO:0005615;GO:0005925;GO:0016021;GO:0016604;GO:0005886;GO:0043235;GO:0048185;GO:0015026;GO:0005534;GO:0005539;GO:0042802;GO:0042803;GO:0050431;GO:0005024;GO:0004888;GO:0034713;GO:0005114;GO:0001525;GO:0048844;GO:0055009;GO:1905222;GO:0030509;GO:0060348;GO:0001569;GO:0003209;GO:0003208;GO:0007155;GO:0060326;GO:0016477;GO:0003273;GO:0048870;GO:0071260;GO:0022009;GO:0070483;GO:0035912;GO:0003203;GO:0001837;GO:0003198;GO:0070278;GO:0022617;GO:0001947;GO:0030336;GO:0001937;GO:0010629;GO:0051001;GO:0060394;GO:0031953;GO:0000122;GO:0030512;GO:0003148;GO:0045766;GO:0030513;GO:0032967;GO:1905007;GO:0010862;GO:0051897;GO:0001934;GO:0003084;GO:0045944;GO:1905065;GO:0030155;GO:0042127;GO:0042325;GO:0006355;GO:0017015;GO:0031960;GO:0042493;GO:0001666;GO:0048745;GO:0007179;GO:0097084;GO:0001570;GO:0048845;GO:0003222;GO:0042060;, C:cell surface; C:endothelial microparticle; C:external side of plasma membrane; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:nuclear body; C:plasma membrane; C:receptor complex;, F:activin binding; F:coreceptor activity; F:galactose binding; F:glycosaminoglycan binding; F:identical protein binding; F:protein homodimerization activity; F:transforming growth factor beta binding; F:transforming growth factor beta-activated receptor activity; F:transmembrane signaling receptor activity; F:type I transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding;, P:angiogenesis; P:artery morphogenesis; P:atrial cardiac muscle tissue morphogenesis; P:atrioventricular canal morphogenesis; P:BMP signaling pathway; P:bone development; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell migration involved in endocardial cushion formation; P:cell motility; P:cellular response to mechanical stimulus; P:central nervous system vasculogenesis; P:detection of hypoxia; P:dorsal aorta morphogenesis; P:endocardial cushion morphogenesis; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:extracellular matrix constituent secretion; P:extracellular matrix disassembly; P:heart looping; P:negative regulation of cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of gene expression; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of protein autophosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:outflow tract septum morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of systemic arterial blood pressure; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell differentiation; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:regulation of phosphorylation; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to corticosteroid; P:response to drug; P:response to hypoxia; P:smooth muscle tissue development; P:transforming growth factor beta receptor signaling pathway; P:vascular associated smooth muscle cell development; P:vasculogenesis; P:venous blood vessel morphogenesis; P:ventricular trabecula myocardium morphogenesis; P:wound healing;|P00568 Q9BVK9 Q9UQC7,Adenylate kinase isoenzyme 1 {ECO:0000255|HAMAP-Rule:MF_03171},ATP-AMP transphosphorylase 1 {ECO:0000255|HAMAP-Rule:MF_03171};ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03171};Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03171};Myokinase {ECO:0000255|HAMAP-Rule:MF_03171};, , GO:0005737;GO:0005829;GO:0070062;GO:0004017;GO:0005524;GO:0004550;GO:0006172;GO:0046033;GO:0046034;GO:0015949;GO:0006165;GO:0009142;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:adenylate kinase activity; F:ATP binding; F:nucleoside diphosphate kinase activity;, P:ADP biosynthetic process; P:AMP metabolic process; P:ATP metabolic process; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process;|Q969X2 B3KQ01 Q5T9C4 Q5T9C5 Q9H8A2 Q9ULB8,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6,GalNAc alpha-2,6-sialyltransferase VI;ST6GalNAc VI {ECO:0000303|PubMed:12668675, ECO:0000303|PubMed:17123352};Sialyltransferase 7F;, PF00777;, GO:0005737;GO:0000139;GO:0016021;GO:0005886;GO:0001665;GO:0008373;GO:0009988;GO:0001574;GO:0009100;GO:0006687;GO:0006677;GO:0009312;GO:0009311;GO:0006486;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:cell-cell recognition; P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide metabolic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation;|Q969X2 B3KQ01 Q5T9C4 Q5T9C5 Q9H8A2 Q9ULB8,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6,GalNAc alpha-2,6-sialyltransferase VI;ST6GalNAc VI {ECO:0000303|PubMed:12668675, ECO:0000303|PubMed:17123352};Sialyltransferase 7F;, PF00777;, GO:0005737;GO:0000139;GO:0016021;GO:0005886;GO:0001665;GO:0008373;GO:0009988;GO:0001574;GO:0009100;GO:0006687;GO:0006677;GO:0009312;GO:0009311;GO:0006486;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:cell-cell recognition; P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide metabolic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation;|Q969X2 B3KQ01 Q5T9C4 Q5T9C5 Q9H8A2 Q9ULB8,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6,GalNAc alpha-2,6-sialyltransferase VI;ST6GalNAc VI {ECO:0000303|PubMed:12668675, ECO:0000303|PubMed:17123352};Sialyltransferase 7F;, PF00777;, GO:0005737;GO:0000139;GO:0016021;GO:0005886;GO:0001665;GO:0008373;GO:0009988;GO:0001574;GO:0009100;GO:0006687;GO:0006677;GO:0009312;GO:0009311;GO:0006486;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:cell-cell recognition; P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide metabolic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation;|Q969X2 B3KQ01 Q5T9C4 Q5T9C5 Q9H8A2 Q9ULB8,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6,GalNAc alpha-2,6-sialyltransferase VI;ST6GalNAc VI {ECO:0000303|PubMed:12668675, ECO:0000303|PubMed:17123352};Sialyltransferase 7F;, PF00777;, GO:0005737;GO:0000139;GO:0016021;GO:0005886;GO:0001665;GO:0008373;GO:0009988;GO:0001574;GO:0009100;GO:0006687;GO:0006677;GO:0009312;GO:0009311;GO:0006486;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:cell-cell recognition; P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide metabolic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation;|Q969X2 B3KQ01 Q5T9C4 Q5T9C5 Q9H8A2 Q9ULB8,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6,GalNAc alpha-2,6-sialyltransferase VI;ST6GalNAc VI {ECO:0000303|PubMed:12668675, ECO:0000303|PubMed:17123352};Sialyltransferase 7F;, PF00777;, GO:0005737;GO:0000139;GO:0016021;GO:0005886;GO:0001665;GO:0008373;GO:0009988;GO:0001574;GO:0009100;GO:0006687;GO:0006677;GO:0009312;GO:0009311;GO:0006486;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:cell-cell recognition; P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide metabolic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation;|Q969X2 B3KQ01 Q5T9C4 Q5T9C5 Q9H8A2 Q9ULB8,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6,GalNAc alpha-2,6-sialyltransferase VI;ST6GalNAc VI {ECO:0000303|PubMed:12668675, ECO:0000303|PubMed:17123352};Sialyltransferase 7F;, PF00777;, GO:0005737;GO:0000139;GO:0016021;GO:0005886;GO:0001665;GO:0008373;GO:0009988;GO:0001574;GO:0009100;GO:0006687;GO:0006677;GO:0009312;GO:0009311;GO:0006486;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:cell-cell recognition; P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide metabolic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation;|Q969X2 B3KQ01 Q5T9C4 Q5T9C5 Q9H8A2 Q9ULB8,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6,GalNAc alpha-2,6-sialyltransferase VI;ST6GalNAc VI {ECO:0000303|PubMed:12668675, ECO:0000303|PubMed:17123352};Sialyltransferase 7F;, PF00777;, GO:0005737;GO:0000139;GO:0016021;GO:0005886;GO:0001665;GO:0008373;GO:0009988;GO:0001574;GO:0009100;GO:0006687;GO:0006677;GO:0009312;GO:0009311;GO:0006486;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:cell-cell recognition; P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide metabolic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation;|Q9H4F1 Q5T9D0 Q9NWU6 Q9UKU1 Q9ULB9 Q9Y3G3 Q9Y3G4,Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase,NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc-alpha-2,6-sialyltransferase;ST6GalNAc IV;Sialyltransferase 3C;Sialyltransferase 7D;, PF00777;, GO:0000139;GO:0016021;GO:0047290;GO:0001665;GO:0008373;GO:0001574;GO:0006664;GO:0016266;GO:0009311;GO:0019082;, C:Golgi membrane; C:integral component of membrane;, F:(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity; F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; F:sialyltransferase activity;, P:ganglioside biosynthetic process; P:glycolipid metabolic process; P:O-glycan processing; P:oligosaccharide metabolic process; P:viral protein processing;|Q5T9C9 Q8IVS3,Phosphatidylinositol 4-phosphate 5-kinase-like protein 1,, PF01504;, GO:0042995;GO:0005829;GO:0016020;GO:0016308;GO:0005524;GO:0030336;GO:0010917;GO:0001933;GO:0043065;, C:cell projection; C:cytosol; C:membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:negative regulation of cell migration; P:negative regulation of mitochondrial membrane potential; P:negative regulation of protein phosphorylation; P:positive regulation of apoptotic process;|O94777 Q5XKK9 Q6FGH3,Dolichol phosphate-mannose biosynthesis regulatory protein {ECO:0000305},Dolichol-phosphate mannose synthase subunit 2;, PF07297;, GO:0033185;GO:0005789;GO:0000506;GO:0030176;GO:0008047;GO:0030234;GO:0019348;GO:0006506;GO:0016254;GO:0018279;GO:0035269;GO:0031647;, C:dolichol-phosphate-mannose synthase complex; C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of endoplasmic reticulum membrane;, F:enzyme activator activity; F:enzyme regulator activity;, P:dolichol metabolic process; P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; P:protein N-linked glycosylation via asparagine; P:protein O-linked mannosylation; P:regulation of protein stability;|Q5T9C2 A2A329 Q8TEL4,Protein FAM102A,Early estrogen-induced gene 1 protein;, PF10358;|Q5T9C2 A2A329 Q8TEL4,Protein FAM102A,Early estrogen-induced gene 1 protein;, PF10358;|Q5T9C2 A2A329 Q8TEL4,Protein FAM102A,Early estrogen-induced gene 1 protein;, PF10358;|Q5T9C2 A2A329 Q8TEL4,Protein FAM102A,Early estrogen-induced gene 1 protein;, PF10358;|Q69YI7 B3KV81 Q8WU12,Nuclear apoptosis-inducing factor 1,, PF13873;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0030308;GO:1902108;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane;, , P:negative regulation of cell growth; P:regulation of mitochondrial membrane permeability involved in apoptotic process;|Q69YI7 B3KV81 Q8WU12,Nuclear apoptosis-inducing factor 1,, PF13873;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0030308;GO:1902108;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane;, , P:negative regulation of cell growth; P:regulation of mitochondrial membrane permeability involved in apoptotic process;|Q6UX48 Q705K2 Q96PZ1 Q9BSA6,Calcium-binding mitochondrial carrier protein SCaMC-2,Mitochondrial ATP-Mg/Pi carrier protein 3;Mitochondrial Ca(2+)-dependent solute carrier protein 3;Small calcium-binding mitochondrial carrier protein 2;Solute carrier family 25 member 25;, PF13499;PF13833;PF00153;, GO:0016021;GO:0005743;GO:0005347;GO:0005509;GO:0060612;GO:0046034;GO:0070588;GO:0043010;GO:0045333;GO:0035264;GO:0014823;GO:0002021;GO:0032094;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:adipose tissue development; P:ATP metabolic process; P:calcium ion transmembrane transport; P:camera-type eye development; P:cellular respiration; P:multicellular organism growth; P:response to activity; P:response to dietary excess; P:response to food;|Q6UX48 Q705K2 Q96PZ1 Q9BSA6,Calcium-binding mitochondrial carrier protein SCaMC-2,Mitochondrial ATP-Mg/Pi carrier protein 3;Mitochondrial Ca(2+)-dependent solute carrier protein 3;Small calcium-binding mitochondrial carrier protein 2;Solute carrier family 25 member 25;, PF13499;PF13833;PF00153;, GO:0016021;GO:0005743;GO:0005347;GO:0005509;GO:0060612;GO:0046034;GO:0070588;GO:0043010;GO:0045333;GO:0035264;GO:0014823;GO:0002021;GO:0032094;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:adipose tissue development; P:ATP metabolic process; P:calcium ion transmembrane transport; P:camera-type eye development; P:cellular respiration; P:multicellular organism growth; P:response to activity; P:response to dietary excess; P:response to food;|Q6UX48 Q705K2 Q96PZ1 Q9BSA6,Calcium-binding mitochondrial carrier protein SCaMC-2,Mitochondrial ATP-Mg/Pi carrier protein 3;Mitochondrial Ca(2+)-dependent solute carrier protein 3;Small calcium-binding mitochondrial carrier protein 2;Solute carrier family 25 member 25;, PF13499;PF13833;PF00153;, GO:0016021;GO:0005743;GO:0005347;GO:0005509;GO:0060612;GO:0046034;GO:0070588;GO:0043010;GO:0045333;GO:0035264;GO:0014823;GO:0002021;GO:0032094;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:adipose tissue development; P:ATP metabolic process; P:calcium ion transmembrane transport; P:camera-type eye development; P:cellular respiration; P:multicellular organism growth; P:response to activity; P:response to dietary excess; P:response to food;|Q6UX48 Q705K2 Q96PZ1 Q9BSA6,Calcium-binding mitochondrial carrier protein SCaMC-2,Mitochondrial ATP-Mg/Pi carrier protein 3;Mitochondrial Ca(2+)-dependent solute carrier protein 3;Small calcium-binding mitochondrial carrier protein 2;Solute carrier family 25 member 25;, PF13499;PF13833;PF00153;, GO:0016021;GO:0005743;GO:0005347;GO:0005509;GO:0060612;GO:0046034;GO:0070588;GO:0043010;GO:0045333;GO:0035264;GO:0014823;GO:0002021;GO:0032094;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:adipose tissue development; P:ATP metabolic process; P:calcium ion transmembrane transport; P:camera-type eye development; P:cellular respiration; P:multicellular organism growth; P:response to activity; P:response to dietary excess; P:response to food;|Q6UX48 Q705K2 Q96PZ1 Q9BSA6,Calcium-binding mitochondrial carrier protein SCaMC-2,Mitochondrial ATP-Mg/Pi carrier protein 3;Mitochondrial Ca(2+)-dependent solute carrier protein 3;Small calcium-binding mitochondrial carrier protein 2;Solute carrier family 25 member 25;, PF13499;PF13833;PF00153;, GO:0016021;GO:0005743;GO:0005347;GO:0005509;GO:0060612;GO:0046034;GO:0070588;GO:0043010;GO:0045333;GO:0035264;GO:0014823;GO:0002021;GO:0032094;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:adipose tissue development; P:ATP metabolic process; P:calcium ion transmembrane transport; P:camera-type eye development; P:cellular respiration; P:multicellular organism growth; P:response to activity; P:response to dietary excess; P:response to food;|Q6UX48 Q705K2 Q96PZ1 Q9BSA6,Calcium-binding mitochondrial carrier protein SCaMC-2,Mitochondrial ATP-Mg/Pi carrier protein 3;Mitochondrial Ca(2+)-dependent solute carrier protein 3;Small calcium-binding mitochondrial carrier protein 2;Solute carrier family 25 member 25;, PF13499;PF13833;PF00153;, GO:0016021;GO:0005743;GO:0005347;GO:0005509;GO:0060612;GO:0046034;GO:0070588;GO:0043010;GO:0045333;GO:0035264;GO:0014823;GO:0002021;GO:0032094;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:adipose tissue development; P:ATP metabolic process; P:calcium ion transmembrane transport; P:camera-type eye development; P:cellular respiration; P:multicellular organism growth; P:response to activity; P:response to dietary excess; P:response to food;|Q9H7Z7 Q53EW9 Q5SYV6 Q96GI0 Q96GL2,Prostaglandin E synthase 2,Membrane-associated prostaglandin E synthase-2 {ECO:0000303|PubMed:12804604};Microsomal prostaglandin E synthase 2;Prostaglandin-H(2) E-isomerase;, PF13417;, GO:0035578;GO:0005829;GO:0005576;GO:0000139;GO:0016021;GO:0005739;GO:0005634;GO:0048471;GO:0036134;GO:0003677;GO:0043295;GO:0020037;GO:0016829;GO:0050220;GO:0015035;GO:0019371;GO:0006749;GO:0006629;GO:0043312;GO:0045893;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:12-hydroxyheptadecatrienoic acid synthase activity; F:DNA binding; F:glutathione binding; F:heme binding; F:lyase activity; F:prostaglandin-E synthase activity; F:protein disulfide oxidoreductase activity;, P:cyclooxygenase pathway; P:glutathione metabolic process; P:lipid metabolic process; P:neutrophil degranulation; P:positive regulation of transcription, DNA-templated;|Q9H7Z7 Q53EW9 Q5SYV6 Q96GI0 Q96GL2,Prostaglandin E synthase 2,Membrane-associated prostaglandin E synthase-2 {ECO:0000303|PubMed:12804604};Microsomal prostaglandin E synthase 2;Prostaglandin-H(2) E-isomerase;, PF13417;, GO:0035578;GO:0005829;GO:0005576;GO:0000139;GO:0016021;GO:0005739;GO:0005634;GO:0048471;GO:0036134;GO:0003677;GO:0043295;GO:0020037;GO:0016829;GO:0050220;GO:0015035;GO:0019371;GO:0006749;GO:0006629;GO:0043312;GO:0045893;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:12-hydroxyheptadecatrienoic acid synthase activity; F:DNA binding; F:glutathione binding; F:heme binding; F:lyase activity; F:prostaglandin-E synthase activity; F:protein disulfide oxidoreductase activity;, P:cyclooxygenase pathway; P:glutathione metabolic process; P:lipid metabolic process; P:neutrophil degranulation; P:positive regulation of transcription, DNA-templated;|Q9H7Z7 Q53EW9 Q5SYV6 Q96GI0 Q96GL2,Prostaglandin E synthase 2,Membrane-associated prostaglandin E synthase-2 {ECO:0000303|PubMed:12804604};Microsomal prostaglandin E synthase 2;Prostaglandin-H(2) E-isomerase;, PF13417;, GO:0035578;GO:0005829;GO:0005576;GO:0000139;GO:0016021;GO:0005739;GO:0005634;GO:0048471;GO:0036134;GO:0003677;GO:0043295;GO:0020037;GO:0016829;GO:0050220;GO:0015035;GO:0019371;GO:0006749;GO:0006629;GO:0043312;GO:0045893;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:12-hydroxyheptadecatrienoic acid synthase activity; F:DNA binding; F:glutathione binding; F:heme binding; F:lyase activity; F:prostaglandin-E synthase activity; F:protein disulfide oxidoreductase activity;, P:cyclooxygenase pathway; P:glutathione metabolic process; P:lipid metabolic process; P:neutrophil degranulation; P:positive regulation of transcription, DNA-templated;|Q9H7Z7 Q53EW9 Q5SYV6 Q96GI0 Q96GL2,Prostaglandin E synthase 2,Membrane-associated prostaglandin E synthase-2 {ECO:0000303|PubMed:12804604};Microsomal prostaglandin E synthase 2;Prostaglandin-H(2) E-isomerase;, PF13417;, GO:0035578;GO:0005829;GO:0005576;GO:0000139;GO:0016021;GO:0005739;GO:0005634;GO:0048471;GO:0036134;GO:0003677;GO:0043295;GO:0020037;GO:0016829;GO:0050220;GO:0015035;GO:0019371;GO:0006749;GO:0006629;GO:0043312;GO:0045893;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:12-hydroxyheptadecatrienoic acid synthase activity; F:DNA binding; F:glutathione binding; F:heme binding; F:lyase activity; F:prostaglandin-E synthase activity; F:protein disulfide oxidoreductase activity;, P:cyclooxygenase pathway; P:glutathione metabolic process; P:lipid metabolic process; P:neutrophil degranulation; P:positive regulation of transcription, DNA-templated;|Q9BUW7 Q5SYV8 Q9Y3F7,Bublin coiled-coil protein {ECO:0000312|HGNC:HGNC:17823},UPF0184 protein C9orf16;|Q9BUW7 Q5SYV8 Q9Y3F7,Bublin coiled-coil protein {ECO:0000312|HGNC:HGNC:17823},UPF0184 protein C9orf16;|Q9UHK4 Q9Y3F9 Q9Y3G0,Cip1-interacting zinc finger protein,CDKN1A-interacting zinc finger protein 1;Nuclear protein NP94;Zinc finger protein 356;, PF12171;, GO:0005654;GO:0005634;GO:0005886;GO:0003676;GO:0008270;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:nucleic acid binding; F:zinc ion binding;|Q9UHK4 Q9Y3F9 Q9Y3G0,Cip1-interacting zinc finger protein,CDKN1A-interacting zinc finger protein 1;Nuclear protein NP94;Zinc finger protein 356;, PF12171;, GO:0005654;GO:0005634;GO:0005886;GO:0003676;GO:0008270;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:nucleic acid binding; F:zinc ion binding;|Q9UHK4 Q9Y3F9 Q9Y3G0,Cip1-interacting zinc finger protein,CDKN1A-interacting zinc finger protein 1;Nuclear protein NP94;Zinc finger protein 356;, PF12171;, GO:0005654;GO:0005634;GO:0005886;GO:0003676;GO:0008270;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:nucleic acid binding; F:zinc ion binding;|Q9UHK4 Q9Y3F9 Q9Y3G0,Cip1-interacting zinc finger protein,CDKN1A-interacting zinc finger protein 1;Nuclear protein NP94;Zinc finger protein 356;, PF12171;, GO:0005654;GO:0005634;GO:0005886;GO:0003676;GO:0008270;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:nucleic acid binding; F:zinc ion binding;|Q9UHK4 Q9Y3F9 Q9Y3G0,Cip1-interacting zinc finger protein,CDKN1A-interacting zinc finger protein 1;Nuclear protein NP94;Zinc finger protein 356;, PF12171;, GO:0005654;GO:0005634;GO:0005886;GO:0003676;GO:0008270;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:nucleic acid binding; F:zinc ion binding;|Q9UHK4 Q9Y3F9 Q9Y3G0,Cip1-interacting zinc finger protein,CDKN1A-interacting zinc finger protein 1;Nuclear protein NP94;Zinc finger protein 356;, PF12171;, GO:0005654;GO:0005634;GO:0005886;GO:0003676;GO:0008270;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:nucleic acid binding; F:zinc ion binding;|Q05193 A6NLM6 Q5SYX0 Q5SYX2 Q6P3T6 Q86VD2,Dynamin-1,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005737;GO:0031410;GO:0044327;GO:0070062;GO:0016020;GO:0005874;GO:0015630;GO:0031966;GO:0005654;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0019901;GO:0003723;GO:0003374;GO:0006897;GO:0007032;GO:0048013;GO:0061025;GO:0000266;GO:0098884;GO:0031623;GO:0006898;GO:0050803;GO:0016185;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:dendritic spine head; C:extracellular exosome; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding; F:protein kinase binding; F:RNA binding;, P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:endosome organization; P:ephrin receptor signaling pathway; P:membrane fusion; P:mitochondrial fission; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of synapse structure or activity; P:synaptic vesicle budding from presynaptic endocytic zone membrane;|Q05193 A6NLM6 Q5SYX0 Q5SYX2 Q6P3T6 Q86VD2,Dynamin-1,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005737;GO:0031410;GO:0044327;GO:0070062;GO:0016020;GO:0005874;GO:0015630;GO:0031966;GO:0005654;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0019901;GO:0003723;GO:0003374;GO:0006897;GO:0007032;GO:0048013;GO:0061025;GO:0000266;GO:0098884;GO:0031623;GO:0006898;GO:0050803;GO:0016185;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:dendritic spine head; C:extracellular exosome; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding; F:protein kinase binding; F:RNA binding;, P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:endosome organization; P:ephrin receptor signaling pathway; P:membrane fusion; P:mitochondrial fission; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of synapse structure or activity; P:synaptic vesicle budding from presynaptic endocytic zone membrane;|Q05193 A6NLM6 Q5SYX0 Q5SYX2 Q6P3T6 Q86VD2,Dynamin-1,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005737;GO:0031410;GO:0044327;GO:0070062;GO:0016020;GO:0005874;GO:0015630;GO:0031966;GO:0005654;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0019901;GO:0003723;GO:0003374;GO:0006897;GO:0007032;GO:0048013;GO:0061025;GO:0000266;GO:0098884;GO:0031623;GO:0006898;GO:0050803;GO:0016185;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:dendritic spine head; C:extracellular exosome; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding; F:protein kinase binding; F:RNA binding;, P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:endosome organization; P:ephrin receptor signaling pathway; P:membrane fusion; P:mitochondrial fission; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of synapse structure or activity; P:synaptic vesicle budding from presynaptic endocytic zone membrane;|Q05193 A6NLM6 Q5SYX0 Q5SYX2 Q6P3T6 Q86VD2,Dynamin-1,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005737;GO:0031410;GO:0044327;GO:0070062;GO:0016020;GO:0005874;GO:0015630;GO:0031966;GO:0005654;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0019901;GO:0003723;GO:0003374;GO:0006897;GO:0007032;GO:0048013;GO:0061025;GO:0000266;GO:0098884;GO:0031623;GO:0006898;GO:0050803;GO:0016185;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:dendritic spine head; C:extracellular exosome; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding; F:protein kinase binding; F:RNA binding;, P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:endosome organization; P:ephrin receptor signaling pathway; P:membrane fusion; P:mitochondrial fission; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of synapse structure or activity; P:synaptic vesicle budding from presynaptic endocytic zone membrane;|Q05193 A6NLM6 Q5SYX0 Q5SYX2 Q6P3T6 Q86VD2,Dynamin-1,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005737;GO:0031410;GO:0044327;GO:0070062;GO:0016020;GO:0005874;GO:0015630;GO:0031966;GO:0005654;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0019901;GO:0003723;GO:0003374;GO:0006897;GO:0007032;GO:0048013;GO:0061025;GO:0000266;GO:0098884;GO:0031623;GO:0006898;GO:0050803;GO:0016185;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:dendritic spine head; C:extracellular exosome; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding; F:protein kinase binding; F:RNA binding;, P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:endosome organization; P:ephrin receptor signaling pathway; P:membrane fusion; P:mitochondrial fission; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of synapse structure or activity; P:synaptic vesicle budding from presynaptic endocytic zone membrane;|Q05193 A6NLM6 Q5SYX0 Q5SYX2 Q6P3T6 Q86VD2,Dynamin-1,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005737;GO:0031410;GO:0044327;GO:0070062;GO:0016020;GO:0005874;GO:0015630;GO:0031966;GO:0005654;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0019901;GO:0003723;GO:0003374;GO:0006897;GO:0007032;GO:0048013;GO:0061025;GO:0000266;GO:0098884;GO:0031623;GO:0006898;GO:0050803;GO:0016185;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:dendritic spine head; C:extracellular exosome; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding; F:protein kinase binding; F:RNA binding;, P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:endosome organization; P:ephrin receptor signaling pathway; P:membrane fusion; P:mitochondrial fission; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of synapse structure or activity; P:synaptic vesicle budding from presynaptic endocytic zone membrane;|Q08379 A0A0C4DGS5 Q6GRM9 Q9BRB0 Q9NYF9,Golgin subfamily A member 2,130 kDa cis-Golgi matrix protein {ECO:0000303|PubMed:8315394};GM130 autoantigen {ECO:0000303|PubMed:8315394};Golgin-95 {ECO:0000303|PubMed:8315394};, PF19046;PF15070;, GO:0005801;GO:0030134;GO:0033116;GO:0005794;GO:0000137;GO:0032580;GO:0000139;GO:0005874;GO:0072686;GO:0000922;GO:0045296;GO:0042802;GO:0061676;GO:0008017;GO:0019901;GO:0019905;GO:0008356;GO:0007098;GO:0048208;GO:0006888;GO:0090166;GO:0007030;GO:0090161;GO:0007020;GO:0090307;GO:0010507;GO:0032091;GO:0060050;GO:1904668;GO:0006486;GO:0051289;GO:0015031;GO:0051225;GO:0090306;, C:cis-Golgi network; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi cisterna membrane; C:Golgi membrane; C:microtubule; C:mitotic spindle; C:spindle pole;, F:cadherin binding; F:identical protein binding; F:importin-alpha family protein binding; F:microtubule binding; F:protein kinase binding; F:syntaxin binding;, P:asymmetric cell division; P:centrosome cycle; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi disassembly; P:Golgi organization; P:Golgi ribbon formation; P:microtubule nucleation; P:mitotic spindle assembly; P:negative regulation of autophagy; P:negative regulation of protein binding; P:positive regulation of protein glycosylation; P:positive regulation of ubiquitin protein ligase activity; P:protein glycosylation; P:protein homotetramerization; P:protein transport; P:spindle assembly; P:spindle assembly involved in meiosis;|Q08379 A0A0C4DGS5 Q6GRM9 Q9BRB0 Q9NYF9,Golgin subfamily A member 2,130 kDa cis-Golgi matrix protein {ECO:0000303|PubMed:8315394};GM130 autoantigen {ECO:0000303|PubMed:8315394};Golgin-95 {ECO:0000303|PubMed:8315394};, PF19046;PF15070;, GO:0005801;GO:0030134;GO:0033116;GO:0005794;GO:0000137;GO:0032580;GO:0000139;GO:0005874;GO:0072686;GO:0000922;GO:0045296;GO:0042802;GO:0061676;GO:0008017;GO:0019901;GO:0019905;GO:0008356;GO:0007098;GO:0048208;GO:0006888;GO:0090166;GO:0007030;GO:0090161;GO:0007020;GO:0090307;GO:0010507;GO:0032091;GO:0060050;GO:1904668;GO:0006486;GO:0051289;GO:0015031;GO:0051225;GO:0090306;, C:cis-Golgi network; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi cisterna membrane; C:Golgi membrane; C:microtubule; C:mitotic spindle; C:spindle pole;, F:cadherin binding; F:identical protein binding; F:importin-alpha family protein binding; F:microtubule binding; F:protein kinase binding; F:syntaxin binding;, P:asymmetric cell division; P:centrosome cycle; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi disassembly; P:Golgi organization; P:Golgi ribbon formation; P:microtubule nucleation; P:mitotic spindle assembly; P:negative regulation of autophagy; P:negative regulation of protein binding; P:positive regulation of protein glycosylation; P:positive regulation of ubiquitin protein ligase activity; P:protein glycosylation; P:protein homotetramerization; P:protein transport; P:spindle assembly; P:spindle assembly involved in meiosis;|Q08379 A0A0C4DGS5 Q6GRM9 Q9BRB0 Q9NYF9,Golgin subfamily A member 2,130 kDa cis-Golgi matrix protein {ECO:0000303|PubMed:8315394};GM130 autoantigen {ECO:0000303|PubMed:8315394};Golgin-95 {ECO:0000303|PubMed:8315394};, PF19046;PF15070;, GO:0005801;GO:0030134;GO:0033116;GO:0005794;GO:0000137;GO:0032580;GO:0000139;GO:0005874;GO:0072686;GO:0000922;GO:0045296;GO:0042802;GO:0061676;GO:0008017;GO:0019901;GO:0019905;GO:0008356;GO:0007098;GO:0048208;GO:0006888;GO:0090166;GO:0007030;GO:0090161;GO:0007020;GO:0090307;GO:0010507;GO:0032091;GO:0060050;GO:1904668;GO:0006486;GO:0051289;GO:0015031;GO:0051225;GO:0090306;, C:cis-Golgi network; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi cisterna membrane; C:Golgi membrane; C:microtubule; C:mitotic spindle; C:spindle pole;, F:cadherin binding; F:identical protein binding; F:importin-alpha family protein binding; F:microtubule binding; F:protein kinase binding; F:syntaxin binding;, P:asymmetric cell division; P:centrosome cycle; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi disassembly; P:Golgi organization; P:Golgi ribbon formation; P:microtubule nucleation; P:mitotic spindle assembly; P:negative regulation of autophagy; P:negative regulation of protein binding; P:positive regulation of protein glycosylation; P:positive regulation of ubiquitin protein ligase activity; P:protein glycosylation; P:protein homotetramerization; P:protein transport; P:spindle assembly; P:spindle assembly involved in meiosis;|Q08379 A0A0C4DGS5 Q6GRM9 Q9BRB0 Q9NYF9,Golgin subfamily A member 2,130 kDa cis-Golgi matrix protein {ECO:0000303|PubMed:8315394};GM130 autoantigen {ECO:0000303|PubMed:8315394};Golgin-95 {ECO:0000303|PubMed:8315394};, PF19046;PF15070;, GO:0005801;GO:0030134;GO:0033116;GO:0005794;GO:0000137;GO:0032580;GO:0000139;GO:0005874;GO:0072686;GO:0000922;GO:0045296;GO:0042802;GO:0061676;GO:0008017;GO:0019901;GO:0019905;GO:0008356;GO:0007098;GO:0048208;GO:0006888;GO:0090166;GO:0007030;GO:0090161;GO:0007020;GO:0090307;GO:0010507;GO:0032091;GO:0060050;GO:1904668;GO:0006486;GO:0051289;GO:0015031;GO:0051225;GO:0090306;, C:cis-Golgi network; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi cisterna membrane; C:Golgi membrane; C:microtubule; C:mitotic spindle; C:spindle pole;, F:cadherin binding; F:identical protein binding; F:importin-alpha family protein binding; F:microtubule binding; F:protein kinase binding; F:syntaxin binding;, P:asymmetric cell division; P:centrosome cycle; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi disassembly; P:Golgi organization; P:Golgi ribbon formation; P:microtubule nucleation; P:mitotic spindle assembly; P:negative regulation of autophagy; P:negative regulation of protein binding; P:positive regulation of protein glycosylation; P:positive regulation of ubiquitin protein ligase activity; P:protein glycosylation; P:protein homotetramerization; P:protein transport; P:spindle assembly; P:spindle assembly involved in meiosis;|Q08379 A0A0C4DGS5 Q6GRM9 Q9BRB0 Q9NYF9,Golgin subfamily A member 2,130 kDa cis-Golgi matrix protein {ECO:0000303|PubMed:8315394};GM130 autoantigen {ECO:0000303|PubMed:8315394};Golgin-95 {ECO:0000303|PubMed:8315394};, PF19046;PF15070;, GO:0005801;GO:0030134;GO:0033116;GO:0005794;GO:0000137;GO:0032580;GO:0000139;GO:0005874;GO:0072686;GO:0000922;GO:0045296;GO:0042802;GO:0061676;GO:0008017;GO:0019901;GO:0019905;GO:0008356;GO:0007098;GO:0048208;GO:0006888;GO:0090166;GO:0007030;GO:0090161;GO:0007020;GO:0090307;GO:0010507;GO:0032091;GO:0060050;GO:1904668;GO:0006486;GO:0051289;GO:0015031;GO:0051225;GO:0090306;, C:cis-Golgi network; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi cisterna membrane; C:Golgi membrane; C:microtubule; C:mitotic spindle; C:spindle pole;, F:cadherin binding; F:identical protein binding; F:importin-alpha family protein binding; F:microtubule binding; F:protein kinase binding; F:syntaxin binding;, P:asymmetric cell division; P:centrosome cycle; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi disassembly; P:Golgi organization; P:Golgi ribbon formation; P:microtubule nucleation; P:mitotic spindle assembly; P:negative regulation of autophagy; P:negative regulation of protein binding; P:positive regulation of protein glycosylation; P:positive regulation of ubiquitin protein ligase activity; P:protein glycosylation; P:protein homotetramerization; P:protein transport; P:spindle assembly; P:spindle assembly involved in meiosis;|Q08379 A0A0C4DGS5 Q6GRM9 Q9BRB0 Q9NYF9,Golgin subfamily A member 2,130 kDa cis-Golgi matrix protein {ECO:0000303|PubMed:8315394};GM130 autoantigen {ECO:0000303|PubMed:8315394};Golgin-95 {ECO:0000303|PubMed:8315394};, PF19046;PF15070;, GO:0005801;GO:0030134;GO:0033116;GO:0005794;GO:0000137;GO:0032580;GO:0000139;GO:0005874;GO:0072686;GO:0000922;GO:0045296;GO:0042802;GO:0061676;GO:0008017;GO:0019901;GO:0019905;GO:0008356;GO:0007098;GO:0048208;GO:0006888;GO:0090166;GO:0007030;GO:0090161;GO:0007020;GO:0090307;GO:0010507;GO:0032091;GO:0060050;GO:1904668;GO:0006486;GO:0051289;GO:0015031;GO:0051225;GO:0090306;, C:cis-Golgi network; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi cisterna membrane; C:Golgi membrane; C:microtubule; C:mitotic spindle; C:spindle pole;, F:cadherin binding; F:identical protein binding; F:importin-alpha family protein binding; F:microtubule binding; F:protein kinase binding; F:syntaxin binding;, P:asymmetric cell division; P:centrosome cycle; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi disassembly; P:Golgi organization; P:Golgi ribbon formation; P:microtubule nucleation; P:mitotic spindle assembly; P:negative regulation of autophagy; P:negative regulation of protein binding; P:positive regulation of protein glycosylation; P:positive regulation of ubiquitin protein ligase activity; P:protein glycosylation; P:protein homotetramerization; P:protein transport; P:spindle assembly; P:spindle assembly involved in meiosis;|Q1ZZU3 Q5SYX7 Q5SYX8 Q8N2W6,DNA repair protein SWI5 homolog,HBV DNAPTP1-transactivated protein A;Protein SAE3 homolog;, PF07061;, GO:0005634;GO:0032798;GO:0034974;GO:0071479;GO:0000724;, C:nucleus; C:Swi5-Sfr1 complex; C:Swi5-Swi2 complex;, , P:cellular response to ionizing radiation; P:double-strand break repair via homologous recombination;|O95900 B7Z7G5,Mitochondrial mRNA pseudouridine synthase TRUB2,, PF01509;, GO:0005759;GO:0005739;GO:0035770;GO:0009982;GO:0003723;GO:0006397;GO:1990481;GO:0070131;, C:mitochondrial matrix; C:mitochondrion; C:ribonucleoprotein granule;, F:pseudouridine synthase activity; F:RNA binding;, P:mRNA processing; P:mRNA pseudouridine synthesis; P:positive regulation of mitochondrial translation;|O95900 B7Z7G5,Mitochondrial mRNA pseudouridine synthase TRUB2,, PF01509;, GO:0005759;GO:0005739;GO:0035770;GO:0009982;GO:0003723;GO:0006397;GO:1990481;GO:0070131;, C:mitochondrial matrix; C:mitochondrion; C:ribonucleoprotein granule;, F:pseudouridine synthase activity; F:RNA binding;, P:mRNA processing; P:mRNA pseudouridine synthesis; P:positive regulation of mitochondrial translation;|O95900 B7Z7G5,Mitochondrial mRNA pseudouridine synthase TRUB2,, PF01509;, GO:0005759;GO:0005739;GO:0035770;GO:0009982;GO:0003723;GO:0006397;GO:1990481;GO:0070131;, C:mitochondrial matrix; C:mitochondrion; C:ribonucleoprotein granule;, F:pseudouridine synthase activity; F:RNA binding;, P:mRNA processing; P:mRNA pseudouridine synthesis; P:positive regulation of mitochondrial translation;|Q9Y3A0 A8WBK8 B2R958 Q5T4B8 Q96EW4,Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03111},Coenzyme Q biosynthesis protein 4 homolog {ECO:0000255|HAMAP-Rule:MF_03111};, PF05019;, GO:0031314;GO:0005739;GO:0032991;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrion; C:protein-containing complex;, , P:ubiquinone biosynthetic process;|Q9Y3A0 A8WBK8 B2R958 Q5T4B8 Q96EW4,Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03111},Coenzyme Q biosynthesis protein 4 homolog {ECO:0000255|HAMAP-Rule:MF_03111};, PF05019;, GO:0031314;GO:0005739;GO:0032991;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrion; C:protein-containing complex;, , P:ubiquinone biosynthetic process;|Q9Y3A0 A8WBK8 B2R958 Q5T4B8 Q96EW4,Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03111},Coenzyme Q biosynthesis protein 4 homolog {ECO:0000255|HAMAP-Rule:MF_03111};, PF05019;, GO:0031314;GO:0005739;GO:0032991;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrion; C:protein-containing complex;, , P:ubiquinone biosynthetic process;|Q6P1M0 A8K2F7 O95186 Q96G53,Long-chain fatty acid transport protein 4 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000250|UniProtKB:Q91VE0};Long-chain-fatty-acid--CoA ligase {ECO:0000250|UniProtKB:Q91VE0};Solute carrier family 27 member 4;Very long-chain acyl-CoA synthetase 4 {ECO:0000303|PubMed:24269233};, PF00501;PF13193;, GO:0031526;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005902;GO:0005886;GO:0047676;GO:0005324;GO:0004467;GO:0000166;GO:1901480;GO:0090434;GO:0090433;GO:0031957;GO:0090630;GO:0006631;GO:0015908;GO:0044381;GO:1990379;GO:0044539;GO:0001676;GO:0015909;GO:0001579;GO:0062003;GO:0046627;GO:0043065;GO:0007584;GO:0043588;GO:0150104;GO:0042760;, C:brush border membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:microvillus; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:nucleotide binding; F:oleate transmembrane transporter activity; F:oleoyl-CoA ligase activity; F:palmitoyl-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:activation of GTPase activity; P:fatty acid metabolic process; P:fatty acid transport; P:glucose import in response to insulin stimulus; P:lipid transport across blood-brain barrier; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty acid transport; P:medium-chain fatty acid transport; P:negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity; P:negative regulation of insulin receptor signaling pathway; P:positive regulation of apoptotic process; P:response to nutrient; P:skin development; P:transport across blood-brain barrier; P:very long-chain fatty acid catabolic process;|Q6P1M0 A8K2F7 O95186 Q96G53,Long-chain fatty acid transport protein 4 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000250|UniProtKB:Q91VE0};Long-chain-fatty-acid--CoA ligase {ECO:0000250|UniProtKB:Q91VE0};Solute carrier family 27 member 4;Very long-chain acyl-CoA synthetase 4 {ECO:0000303|PubMed:24269233};, PF00501;PF13193;, GO:0031526;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005902;GO:0005886;GO:0047676;GO:0005324;GO:0004467;GO:0000166;GO:1901480;GO:0090434;GO:0090433;GO:0031957;GO:0090630;GO:0006631;GO:0015908;GO:0044381;GO:1990379;GO:0044539;GO:0001676;GO:0015909;GO:0001579;GO:0062003;GO:0046627;GO:0043065;GO:0007584;GO:0043588;GO:0150104;GO:0042760;, C:brush border membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:microvillus; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:nucleotide binding; F:oleate transmembrane transporter activity; F:oleoyl-CoA ligase activity; F:palmitoyl-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:activation of GTPase activity; P:fatty acid metabolic process; P:fatty acid transport; P:glucose import in response to insulin stimulus; P:lipid transport across blood-brain barrier; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty acid transport; P:medium-chain fatty acid transport; P:negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity; P:negative regulation of insulin receptor signaling pathway; P:positive regulation of apoptotic process; P:response to nutrient; P:skin development; P:transport across blood-brain barrier; P:very long-chain fatty acid catabolic process;|Q9BTM9 B3KMH3 B4DV08 Q5T4B4,Ubiquitin-related modifier 1 {ECO:0000255|HAMAP-Rule:MF_03048},, PF09138;, GO:0005829;GO:0005634;GO:0031386;GO:0097163;GO:0032447;GO:0006400;GO:0034227;GO:0002098;, C:cytosol; C:nucleus;, F:protein tag; F:sulfur carrier activity;, P:protein urmylation; P:tRNA modification; P:tRNA thio-modification; P:tRNA wobble uridine modification;|Q9BTM9 B3KMH3 B4DV08 Q5T4B4,Ubiquitin-related modifier 1 {ECO:0000255|HAMAP-Rule:MF_03048},, PF09138;, GO:0005829;GO:0005634;GO:0031386;GO:0097163;GO:0032447;GO:0006400;GO:0034227;GO:0002098;, C:cytosol; C:nucleus;, F:protein tag; F:sulfur carrier activity;, P:protein urmylation; P:tRNA modification; P:tRNA thio-modification; P:tRNA wobble uridine modification;|Q9P226 Q9UMW5,Inactive glycosyltransferase 25 family member 3,Cerebral endothelial cell adhesion molecule;, PF01755;, GO:0005788;GO:0005886;GO:0042802;GO:0007155;GO:0007159;GO:0018215;, C:endoplasmic reticulum lumen; C:plasma membrane;, F:identical protein binding;, P:cell adhesion; P:leukocyte cell-cell adhesion; P:protein phosphopantetheinylation;|Q9P226 Q9UMW5,Inactive glycosyltransferase 25 family member 3,Cerebral endothelial cell adhesion molecule;, PF01755;, GO:0005788;GO:0005886;GO:0042802;GO:0007155;GO:0007159;GO:0018215;, C:endoplasmic reticulum lumen; C:plasma membrane;, F:identical protein binding;, P:cell adhesion; P:leukocyte cell-cell adhesion; P:protein phosphopantetheinylation;|Q9P226 Q9UMW5,Inactive glycosyltransferase 25 family member 3,Cerebral endothelial cell adhesion molecule;, PF01755;, GO:0005788;GO:0005886;GO:0042802;GO:0007155;GO:0007159;GO:0018215;, C:endoplasmic reticulum lumen; C:plasma membrane;, F:identical protein binding;, P:cell adhesion; P:leukocyte cell-cell adhesion; P:protein phosphopantetheinylation;|Q1W2J6 Q6UN26 Q7Z5I6 Q96FN2,Outer dense fiber protein 2,Cenexin;Outer dense fiber of sperm tails protein 2;, , GO:0120103;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005929;GO:0005829;GO:0005874;GO:0005634;GO:0001520;GO:0036126;GO:0000922;GO:0031267;GO:0005198;GO:0010457;GO:0097711;GO:0044782;GO:0000086;GO:0007275;GO:0008104;GO:1902017;GO:0010389;GO:0007286;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cilium; C:cytosol; C:microtubule; C:nucleus; C:outer dense fiber; C:sperm flagellum; C:spindle pole;, F:small GTPase binding; F:structural molecule activity;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:G2/M transition of mitotic cell cycle; P:multicellular organism development; P:protein localization; P:regulation of cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q1W2J6 Q6UN26 Q7Z5I6 Q96FN2,Outer dense fiber protein 2,Cenexin;Outer dense fiber of sperm tails protein 2;, , GO:0120103;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005929;GO:0005829;GO:0005874;GO:0005634;GO:0001520;GO:0036126;GO:0000922;GO:0031267;GO:0005198;GO:0010457;GO:0097711;GO:0044782;GO:0000086;GO:0007275;GO:0008104;GO:1902017;GO:0010389;GO:0007286;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cilium; C:cytosol; C:microtubule; C:nucleus; C:outer dense fiber; C:sperm flagellum; C:spindle pole;, F:small GTPase binding; F:structural molecule activity;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:G2/M transition of mitotic cell cycle; P:multicellular organism development; P:protein localization; P:regulation of cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q1W2J6 Q6UN26 Q7Z5I6 Q96FN2,Outer dense fiber protein 2,Cenexin;Outer dense fiber of sperm tails protein 2;, , GO:0120103;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005929;GO:0005829;GO:0005874;GO:0005634;GO:0001520;GO:0036126;GO:0000922;GO:0031267;GO:0005198;GO:0010457;GO:0097711;GO:0044782;GO:0000086;GO:0007275;GO:0008104;GO:1902017;GO:0010389;GO:0007286;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cilium; C:cytosol; C:microtubule; C:nucleus; C:outer dense fiber; C:sperm flagellum; C:spindle pole;, F:small GTPase binding; F:structural molecule activity;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:G2/M transition of mitotic cell cycle; P:multicellular organism development; P:protein localization; P:regulation of cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q1W2J6 Q6UN26 Q7Z5I6 Q96FN2,Outer dense fiber protein 2,Cenexin;Outer dense fiber of sperm tails protein 2;, , GO:0120103;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005929;GO:0005829;GO:0005874;GO:0005634;GO:0001520;GO:0036126;GO:0000922;GO:0031267;GO:0005198;GO:0010457;GO:0097711;GO:0044782;GO:0000086;GO:0007275;GO:0008104;GO:1902017;GO:0010389;GO:0007286;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cilium; C:cytosol; C:microtubule; C:nucleus; C:outer dense fiber; C:sperm flagellum; C:spindle pole;, F:small GTPase binding; F:structural molecule activity;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:G2/M transition of mitotic cell cycle; P:multicellular organism development; P:protein localization; P:regulation of cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q1W2J6 Q6UN26 Q7Z5I6 Q96FN2,Outer dense fiber protein 2,Cenexin;Outer dense fiber of sperm tails protein 2;, , GO:0120103;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005929;GO:0005829;GO:0005874;GO:0005634;GO:0001520;GO:0036126;GO:0000922;GO:0031267;GO:0005198;GO:0010457;GO:0097711;GO:0044782;GO:0000086;GO:0007275;GO:0008104;GO:1902017;GO:0010389;GO:0007286;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cilium; C:cytosol; C:microtubule; C:nucleus; C:outer dense fiber; C:sperm flagellum; C:spindle pole;, F:small GTPase binding; F:structural molecule activity;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:G2/M transition of mitotic cell cycle; P:multicellular organism development; P:protein localization; P:regulation of cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q1W2J6 Q6UN26 Q7Z5I6 Q96FN2,Outer dense fiber protein 2,Cenexin;Outer dense fiber of sperm tails protein 2;, , GO:0120103;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005929;GO:0005829;GO:0005874;GO:0005634;GO:0001520;GO:0036126;GO:0000922;GO:0031267;GO:0005198;GO:0010457;GO:0097711;GO:0044782;GO:0000086;GO:0007275;GO:0008104;GO:1902017;GO:0010389;GO:0007286;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cilium; C:cytosol; C:microtubule; C:nucleus; C:outer dense fiber; C:sperm flagellum; C:spindle pole;, F:small GTPase binding; F:structural molecule activity;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:G2/M transition of mitotic cell cycle; P:multicellular organism development; P:protein localization; P:regulation of cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q53GS7 O75458 Q53GT9 Q5VVU1 Q8NCP6 Q9UFL6,Nucleoporin GLE1,GLE1-like protein;, PF07817;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0005615;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005730;GO:0042802;GO:0000822;GO:0005543;GO:0031369;GO:0006406;GO:0016973;GO:0006446;GO:0006449;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extracellular space; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleolus;, F:identical protein binding; F:inositol hexakisphosphate binding; F:phospholipid binding; F:translation initiation factor binding;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:regulation of translational initiation; P:regulation of translational termination;|Q53GS7 O75458 Q53GT9 Q5VVU1 Q8NCP6 Q9UFL6,Nucleoporin GLE1,GLE1-like protein;, PF07817;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0005615;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005730;GO:0042802;GO:0000822;GO:0005543;GO:0031369;GO:0006406;GO:0016973;GO:0006446;GO:0006449;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extracellular space; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleolus;, F:identical protein binding; F:inositol hexakisphosphate binding; F:phospholipid binding; F:translation initiation factor binding;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:regulation of translational initiation; P:regulation of translational termination;|Q53GS7 O75458 Q53GT9 Q5VVU1 Q8NCP6 Q9UFL6,Nucleoporin GLE1,GLE1-like protein;, PF07817;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0005615;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005730;GO:0042802;GO:0000822;GO:0005543;GO:0031369;GO:0006406;GO:0016973;GO:0006446;GO:0006449;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extracellular space; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleolus;, F:identical protein binding; F:inositol hexakisphosphate binding; F:phospholipid binding; F:translation initiation factor binding;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:regulation of translational initiation; P:regulation of translational termination;|Q53GS7 O75458 Q53GT9 Q5VVU1 Q8NCP6 Q9UFL6,Nucleoporin GLE1,GLE1-like protein;, PF07817;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0005615;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005730;GO:0042802;GO:0000822;GO:0005543;GO:0031369;GO:0006406;GO:0016973;GO:0006446;GO:0006449;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extracellular space; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleolus;, F:identical protein binding; F:inositol hexakisphosphate binding; F:phospholipid binding; F:translation initiation factor binding;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:regulation of translational initiation; P:regulation of translational termination;|Q53GS7 O75458 Q53GT9 Q5VVU1 Q8NCP6 Q9UFL6,Nucleoporin GLE1,GLE1-like protein;, PF07817;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0005615;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005730;GO:0042802;GO:0000822;GO:0005543;GO:0031369;GO:0006406;GO:0016973;GO:0006446;GO:0006449;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extracellular space; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleolus;, F:identical protein binding; F:inositol hexakisphosphate binding; F:phospholipid binding; F:translation initiation factor binding;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:regulation of translational initiation; P:regulation of translational termination;|Q53GS7 O75458 Q53GT9 Q5VVU1 Q8NCP6 Q9UFL6,Nucleoporin GLE1,GLE1-like protein;, PF07817;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0005615;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005730;GO:0042802;GO:0000822;GO:0005543;GO:0031369;GO:0006406;GO:0016973;GO:0006446;GO:0006449;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extracellular space; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleolus;, F:identical protein binding; F:inositol hexakisphosphate binding; F:phospholipid binding; F:translation initiation factor binding;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:regulation of translational initiation; P:regulation of translational termination;|Q13813 Q13186 Q15324 Q16606 Q59EF1 Q5VXV5 Q5VXV6 Q7Z6M5 Q9P0V0,Spectrin alpha chain, non-erythrocytic 1,Alpha-II spectrin;Fodrin alpha chain;Spectrin, non-erythroid alpha subunit;, PF13499;PF08726;PF00018;PF00435;, GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0043231;GO:0016020;GO:0015630;GO:0035580;GO:0008091;GO:1904724;GO:0003779;GO:0045296;GO:0005509;GO:0005516;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;GO:0043312;, C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:specific granule lumen; C:spectrin; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:neutrophil degranulation;|Q13813 Q13186 Q15324 Q16606 Q59EF1 Q5VXV5 Q5VXV6 Q7Z6M5 Q9P0V0,Spectrin alpha chain, non-erythrocytic 1,Alpha-II spectrin;Fodrin alpha chain;Spectrin, non-erythroid alpha subunit;, PF13499;PF08726;PF00018;PF00435;, GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0043231;GO:0016020;GO:0015630;GO:0035580;GO:0008091;GO:1904724;GO:0003779;GO:0045296;GO:0005509;GO:0005516;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;GO:0043312;, C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:specific granule lumen; C:spectrin; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:neutrophil degranulation;|Q13813 Q13186 Q15324 Q16606 Q59EF1 Q5VXV5 Q5VXV6 Q7Z6M5 Q9P0V0,Spectrin alpha chain, non-erythrocytic 1,Alpha-II spectrin;Fodrin alpha chain;Spectrin, non-erythroid alpha subunit;, PF13499;PF08726;PF00018;PF00435;, GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0043231;GO:0016020;GO:0015630;GO:0035580;GO:0008091;GO:1904724;GO:0003779;GO:0045296;GO:0005509;GO:0005516;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;GO:0043312;, C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:specific granule lumen; C:spectrin; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:neutrophil degranulation;|Q13813 Q13186 Q15324 Q16606 Q59EF1 Q5VXV5 Q5VXV6 Q7Z6M5 Q9P0V0,Spectrin alpha chain, non-erythrocytic 1,Alpha-II spectrin;Fodrin alpha chain;Spectrin, non-erythroid alpha subunit;, PF13499;PF08726;PF00018;PF00435;, GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0043231;GO:0016020;GO:0015630;GO:0035580;GO:0008091;GO:1904724;GO:0003779;GO:0045296;GO:0005509;GO:0005516;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;GO:0043312;, C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:specific granule lumen; C:spectrin; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:neutrophil degranulation;|Q13813 Q13186 Q15324 Q16606 Q59EF1 Q5VXV5 Q5VXV6 Q7Z6M5 Q9P0V0,Spectrin alpha chain, non-erythrocytic 1,Alpha-II spectrin;Fodrin alpha chain;Spectrin, non-erythroid alpha subunit;, PF13499;PF08726;PF00018;PF00435;, GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0043231;GO:0016020;GO:0015630;GO:0035580;GO:0008091;GO:1904724;GO:0003779;GO:0045296;GO:0005509;GO:0005516;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;GO:0043312;, C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:specific granule lumen; C:spectrin; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:neutrophil degranulation;|Q13813 Q13186 Q15324 Q16606 Q59EF1 Q5VXV5 Q5VXV6 Q7Z6M5 Q9P0V0,Spectrin alpha chain, non-erythrocytic 1,Alpha-II spectrin;Fodrin alpha chain;Spectrin, non-erythroid alpha subunit;, PF13499;PF08726;PF00018;PF00435;, GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0043231;GO:0016020;GO:0015630;GO:0035580;GO:0008091;GO:1904724;GO:0003779;GO:0045296;GO:0005509;GO:0005516;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;GO:0043312;, C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:specific granule lumen; C:spectrin; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:neutrophil degranulation;|Q13813 Q13186 Q15324 Q16606 Q59EF1 Q5VXV5 Q5VXV6 Q7Z6M5 Q9P0V0,Spectrin alpha chain, non-erythrocytic 1,Alpha-II spectrin;Fodrin alpha chain;Spectrin, non-erythroid alpha subunit;, PF13499;PF08726;PF00018;PF00435;, GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0043231;GO:0016020;GO:0015630;GO:0035580;GO:0008091;GO:1904724;GO:0003779;GO:0045296;GO:0005509;GO:0005516;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;GO:0043312;, C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:specific granule lumen; C:spectrin; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:neutrophil degranulation;|Q13813 Q13186 Q15324 Q16606 Q59EF1 Q5VXV5 Q5VXV6 Q7Z6M5 Q9P0V0,Spectrin alpha chain, non-erythrocytic 1,Alpha-II spectrin;Fodrin alpha chain;Spectrin, non-erythroid alpha subunit;, PF13499;PF08726;PF00018;PF00435;, GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0043231;GO:0016020;GO:0015630;GO:0035580;GO:0008091;GO:1904724;GO:0003779;GO:0045296;GO:0005509;GO:0005516;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;GO:0043312;, C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:specific granule lumen; C:spectrin; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:neutrophil degranulation;|Q13813 Q13186 Q15324 Q16606 Q59EF1 Q5VXV5 Q5VXV6 Q7Z6M5 Q9P0V0,Spectrin alpha chain, non-erythrocytic 1,Alpha-II spectrin;Fodrin alpha chain;Spectrin, non-erythroid alpha subunit;, PF13499;PF08726;PF00018;PF00435;, GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0043231;GO:0016020;GO:0015630;GO:0035580;GO:0008091;GO:1904724;GO:0003779;GO:0045296;GO:0005509;GO:0005516;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;GO:0043312;, C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:specific granule lumen; C:spectrin; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:neutrophil degranulation;|Q13813 Q13186 Q15324 Q16606 Q59EF1 Q5VXV5 Q5VXV6 Q7Z6M5 Q9P0V0,Spectrin alpha chain, non-erythrocytic 1,Alpha-II spectrin;Fodrin alpha chain;Spectrin, non-erythroid alpha subunit;, PF13499;PF08726;PF00018;PF00435;, GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0043231;GO:0016020;GO:0015630;GO:0035580;GO:0008091;GO:1904724;GO:0003779;GO:0045296;GO:0005509;GO:0005516;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;GO:0043312;, C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:specific granule lumen; C:spectrin; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:neutrophil degranulation;|Q01105 A5A5H4 A6NGV1 B4DUE2 Q15541 Q5VXV1 Q5VXV2 Q6FHZ5,Protein SET,HLA-DR-associated protein II;Inhibitor of granzyme A-activated DNase;PHAPII;Phosphatase 2A inhibitor I2PP2A;Template-activating factor I;, PF00956;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005811;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0004864;GO:0019888;GO:0006260;GO:0007076;GO:0035067;GO:0043524;GO:0045892;GO:0006334;GO:0006337;GO:0043488;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:lipid droplet; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity;, P:DNA replication; P:mitotic chromosome condensation; P:negative regulation of histone acetylation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:nucleosome disassembly; P:regulation of mRNA stability; P:viral process; scaffold12 indexed_genome mRNA 48003523 48020330 . + . ID=transcript_3302;Q6P5Z2 Q9UM03,Serine/threonine-protein kinase N3,Protein kinase PKN-beta;Protein-kinase C-related kinase 3;, PF02185;PF00069;PF00433;, GO:0005794;GO:0005634;GO:0048471;GO:0005524;GO:0004698;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0010631;GO:0035556;GO:0018105;GO:0006468;GO:0007165;, C:Golgi apparatus; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:epithelial cell migration; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q6P5Z2 Q9UM03,Serine/threonine-protein kinase N3,Protein kinase PKN-beta;Protein-kinase C-related kinase 3;, PF02185;PF00069;PF00433;, GO:0005794;GO:0005634;GO:0048471;GO:0005524;GO:0004698;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0010631;GO:0035556;GO:0018105;GO:0006468;GO:0007165;, C:Golgi apparatus; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:epithelial cell migration; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q6P5Z2 Q9UM03,Serine/threonine-protein kinase N3,Protein kinase PKN-beta;Protein-kinase C-related kinase 3;, PF02185;PF00069;PF00433;, GO:0005794;GO:0005634;GO:0048471;GO:0005524;GO:0004698;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0010631;GO:0035556;GO:0018105;GO:0006468;GO:0007165;, C:Golgi apparatus; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:epithelial cell migration; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q6P5Z2 Q9UM03,Serine/threonine-protein kinase N3,Protein kinase PKN-beta;Protein-kinase C-related kinase 3;, PF02185;PF00069;PF00433;, GO:0005794;GO:0005634;GO:0048471;GO:0005524;GO:0004698;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0010631;GO:0035556;GO:0018105;GO:0006468;GO:0007165;, C:Golgi apparatus; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:epithelial cell migration; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q96GR4 A6NH95 B2RE03 Q5T265 Q5T267 Q5T268 Q86VT5 Q96T09,Palmitoyltransferase ZDHHC12 {ECO:0000305},DHHC domain-containing cysteine-rich protein 12 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 12 {ECO:0000312|HGNC:HGNC:19159};Zinc finger protein 400;, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0016409;GO:0019706;GO:0097116;GO:0018230;GO:0032230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:gephyrin clustering involved in postsynaptic density assembly; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of synaptic transmission, GABAergic; P:protein palmitoylation; P:protein targeting to membrane; scaffold12 indexed_genome mRNA 48027544 48043795 . - . ID=transcript_3303;Q7Z7L7 O00156 Q5T272 Q5T273,Protein zer-1 homolog {ECO:0000305},Hzyg;Zyg-11 homolog B-like protein;Zyg11b-like protein;, , GO:0031462;GO:0032436;GO:0006515;, C:Cul2-RING ubiquitin ligase complex;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein quality control for misfolded or incompletely synthesized proteins;|Q7Z7L7 O00156 Q5T272 Q5T273,Protein zer-1 homolog {ECO:0000305},Hzyg;Zyg-11 homolog B-like protein;Zyg11b-like protein;, , GO:0031462;GO:0032436;GO:0006515;, C:Cul2-RING ubiquitin ligase complex;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein quality control for misfolded or incompletely synthesized proteins;|Q7Z7L7 O00156 Q5T272 Q5T273,Protein zer-1 homolog {ECO:0000305},Hzyg;Zyg-11 homolog B-like protein;Zyg11b-like protein;, , GO:0031462;GO:0032436;GO:0006515;, C:Cul2-RING ubiquitin ligase complex;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein quality control for misfolded or incompletely synthesized proteins; scaffold12 indexed_genome mRNA 48068288 48075205 . + . ID=transcript_3304;Q9NVG8 A7E2E7 B3KW04 B9EGJ8 Q5T270 Q5T271,TBC1 domain family member 13,, PF00566;, GO:0005829;GO:0016020;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytosol; C:membrane;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; scaffold12 indexed_genome mRNA 48077048 48107537 . + . ID=transcript_3305;Q9NVG8 A7E2E7 B3KW04 B9EGJ8 Q5T270 Q5T271,TBC1 domain family member 13,, PF00566;, GO:0005829;GO:0016020;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytosol; C:membrane;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q9NVG8 A7E2E7 B3KW04 B9EGJ8 Q5T270 Q5T271,TBC1 domain family member 13,, PF00566;, GO:0005829;GO:0016020;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytosol; C:membrane;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q14249 Q5T281 Q9BSP2,Endonuclease G, mitochondrial,, PF01223;, GO:0005829;GO:0005743;GO:0005634;GO:0043204;GO:0004519;GO:0004521;GO:0046872;GO:0003676;GO:0000014;GO:0007568;GO:0006309;GO:0071277;GO:0071333;GO:0071456;GO:0006310;GO:0001701;GO:0036475;GO:1902512;GO:0043065;GO:1901300;GO:0046677;GO:0032355;GO:0009612;GO:0034612;, C:cytosol; C:mitochondrial inner membrane; C:nucleus; C:perikaryon;, F:endonuclease activity; F:endoribonuclease activity; F:metal ion binding; F:nucleic acid binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:aging; P:apoptotic DNA fragmentation; P:cellular response to calcium ion; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:DNA recombination; P:in utero embryonic development; P:neuron death in response to oxidative stress; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of apoptotic process; P:positive regulation of hydrogen peroxide-mediated programmed cell death; P:response to antibiotic; P:response to estradiol; P:response to mechanical stimulus; P:response to tumor necrosis factor;|Q14249 Q5T281 Q9BSP2,Endonuclease G, mitochondrial,, PF01223;, GO:0005829;GO:0005743;GO:0005634;GO:0043204;GO:0004519;GO:0004521;GO:0046872;GO:0003676;GO:0000014;GO:0007568;GO:0006309;GO:0071277;GO:0071333;GO:0071456;GO:0006310;GO:0001701;GO:0036475;GO:1902512;GO:0043065;GO:1901300;GO:0046677;GO:0032355;GO:0009612;GO:0034612;, C:cytosol; C:mitochondrial inner membrane; C:nucleus; C:perikaryon;, F:endonuclease activity; F:endoribonuclease activity; F:metal ion binding; F:nucleic acid binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:aging; P:apoptotic DNA fragmentation; P:cellular response to calcium ion; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:DNA recombination; P:in utero embryonic development; P:neuron death in response to oxidative stress; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of apoptotic process; P:positive regulation of hydrogen peroxide-mediated programmed cell death; P:response to antibiotic; P:response to estradiol; P:response to mechanical stimulus; P:response to tumor necrosis factor;|Q14249 Q5T281 Q9BSP2,Endonuclease G, mitochondrial,, PF01223;, GO:0005829;GO:0005743;GO:0005634;GO:0043204;GO:0004519;GO:0004521;GO:0046872;GO:0003676;GO:0000014;GO:0007568;GO:0006309;GO:0071277;GO:0071333;GO:0071456;GO:0006310;GO:0001701;GO:0036475;GO:1902512;GO:0043065;GO:1901300;GO:0046677;GO:0032355;GO:0009612;GO:0034612;, C:cytosol; C:mitochondrial inner membrane; C:nucleus; C:perikaryon;, F:endonuclease activity; F:endoribonuclease activity; F:metal ion binding; F:nucleic acid binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:aging; P:apoptotic DNA fragmentation; P:cellular response to calcium ion; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:DNA recombination; P:in utero embryonic development; P:neuron death in response to oxidative stress; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of apoptotic process; P:positive regulation of hydrogen peroxide-mediated programmed cell death; P:response to antibiotic; P:response to estradiol; P:response to mechanical stimulus; P:response to tumor necrosis factor;|Q14249 Q5T281 Q9BSP2,Endonuclease G, mitochondrial,, PF01223;, GO:0005829;GO:0005743;GO:0005634;GO:0043204;GO:0004519;GO:0004521;GO:0046872;GO:0003676;GO:0000014;GO:0007568;GO:0006309;GO:0071277;GO:0071333;GO:0071456;GO:0006310;GO:0001701;GO:0036475;GO:1902512;GO:0043065;GO:1901300;GO:0046677;GO:0032355;GO:0009612;GO:0034612;, C:cytosol; C:mitochondrial inner membrane; C:nucleus; C:perikaryon;, F:endonuclease activity; F:endoribonuclease activity; F:metal ion binding; F:nucleic acid binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:aging; P:apoptotic DNA fragmentation; P:cellular response to calcium ion; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:DNA recombination; P:in utero embryonic development; P:neuron death in response to oxidative stress; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of apoptotic process; P:positive regulation of hydrogen peroxide-mediated programmed cell death; P:response to antibiotic; P:response to estradiol; P:response to mechanical stimulus; P:response to tumor necrosis factor;|Q14249 Q5T281 Q9BSP2,Endonuclease G, mitochondrial,, PF01223;, GO:0005829;GO:0005743;GO:0005634;GO:0043204;GO:0004519;GO:0004521;GO:0046872;GO:0003676;GO:0000014;GO:0007568;GO:0006309;GO:0071277;GO:0071333;GO:0071456;GO:0006310;GO:0001701;GO:0036475;GO:1902512;GO:0043065;GO:1901300;GO:0046677;GO:0032355;GO:0009612;GO:0034612;, C:cytosol; C:mitochondrial inner membrane; C:nucleus; C:perikaryon;, F:endonuclease activity; F:endoribonuclease activity; F:metal ion binding; F:nucleic acid binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:aging; P:apoptotic DNA fragmentation; P:cellular response to calcium ion; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:DNA recombination; P:in utero embryonic development; P:neuron death in response to oxidative stress; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of apoptotic process; P:positive regulation of hydrogen peroxide-mediated programmed cell death; P:response to antibiotic; P:response to estradiol; P:response to mechanical stimulus; P:response to tumor necrosis factor;|Q5T280 Q0D2P6 Q6P469 Q6PGP9 Q6PIJ1 Q6PJV9,Putative methyltransferase C9orf114 {ECO:0000305},Centromere protein 32 {ECO:0000303|PubMed:25657325};Kinetochore-associated protein {ECO:0000303|PubMed:20813266};SPOUT domain-containing methyltransferase 1 {ECO:0000312|HGNC:HGNC:26933};, PF02598;, GO:0000777;GO:0005737;GO:0000776;GO:0072686;GO:0031616;GO:0008168;GO:0035198;GO:0003723;GO:0007049;GO:0051301;GO:0051661;GO:0032259;GO:0010608;GO:0035196;, C:condensed chromosome kinetochore; C:cytoplasm; C:kinetochore; C:mitotic spindle; C:spindle pole centrosome;, F:methyltransferase activity; F:miRNA binding; F:RNA binding;, P:cell cycle; P:cell division; P:maintenance of centrosome location; P:methylation; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA;|Q5T280 Q0D2P6 Q6P469 Q6PGP9 Q6PIJ1 Q6PJV9,Putative methyltransferase C9orf114 {ECO:0000305},Centromere protein 32 {ECO:0000303|PubMed:25657325};Kinetochore-associated protein {ECO:0000303|PubMed:20813266};SPOUT domain-containing methyltransferase 1 {ECO:0000312|HGNC:HGNC:26933};, PF02598;, GO:0000777;GO:0005737;GO:0000776;GO:0072686;GO:0031616;GO:0008168;GO:0035198;GO:0003723;GO:0007049;GO:0051301;GO:0051661;GO:0032259;GO:0010608;GO:0035196;, C:condensed chromosome kinetochore; C:cytoplasm; C:kinetochore; C:mitotic spindle; C:spindle pole centrosome;, F:methyltransferase activity; F:miRNA binding; F:RNA binding;, P:cell cycle; P:cell division; P:maintenance of centrosome location; P:methylation; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA;|Q5T280 Q0D2P6 Q6P469 Q6PGP9 Q6PIJ1 Q6PJV9,Putative methyltransferase C9orf114 {ECO:0000305},Centromere protein 32 {ECO:0000303|PubMed:25657325};Kinetochore-associated protein {ECO:0000303|PubMed:20813266};SPOUT domain-containing methyltransferase 1 {ECO:0000312|HGNC:HGNC:26933};, PF02598;, GO:0000777;GO:0005737;GO:0000776;GO:0072686;GO:0031616;GO:0008168;GO:0035198;GO:0003723;GO:0007049;GO:0051301;GO:0051661;GO:0032259;GO:0010608;GO:0035196;, C:condensed chromosome kinetochore; C:cytoplasm; C:kinetochore; C:mitotic spindle; C:spindle pole centrosome;, F:methyltransferase activity; F:miRNA binding; F:RNA binding;, P:cell cycle; P:cell division; P:maintenance of centrosome location; P:methylation; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; scaffold12 indexed_genome mRNA 48107599 48234953 . - . ID=transcript_3306;Q16773 Q5T275 Q8N191,Kynurenine--oxoglutarate transaminase 1 {ECO:0000305|PubMed:19338303},Cysteine-S-conjugate beta-lyase {ECO:0000305|PubMed:7883047};Glutamine transaminase K;Glutamine--phenylpyruvate transaminase {ECO:0000305|PubMed:7883047};Kynurenine aminotransferase 1 {ECO:0000312|HGNC:HGNC:1564};Kynurenine aminotransferase I;Kynurenine--oxoglutarate transaminase I;, PF00155;, GO:0005737;GO:0005829;GO:0005739;GO:0047804;GO:0047316;GO:0016212;GO:0042803;GO:0030170;GO:0009058;GO:0006575;GO:0009064;GO:0070189;GO:0097053;GO:0006558;GO:0006569;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:cysteine-S-conjugate beta-lyase activity; F:glutamine-phenylpyruvate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:biosynthetic process; P:cellular modified amino acid metabolic process; P:glutamine family amino acid metabolic process; P:kynurenine metabolic process; P:L-kynurenine catabolic process; P:L-phenylalanine metabolic process; P:tryptophan catabolic process;|Q16773 Q5T275 Q8N191,Kynurenine--oxoglutarate transaminase 1 {ECO:0000305|PubMed:19338303},Cysteine-S-conjugate beta-lyase {ECO:0000305|PubMed:7883047};Glutamine transaminase K;Glutamine--phenylpyruvate transaminase {ECO:0000305|PubMed:7883047};Kynurenine aminotransferase 1 {ECO:0000312|HGNC:HGNC:1564};Kynurenine aminotransferase I;Kynurenine--oxoglutarate transaminase I;, PF00155;, GO:0005737;GO:0005829;GO:0005739;GO:0047804;GO:0047316;GO:0016212;GO:0042803;GO:0030170;GO:0009058;GO:0006575;GO:0009064;GO:0070189;GO:0097053;GO:0006558;GO:0006569;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:cysteine-S-conjugate beta-lyase activity; F:glutamine-phenylpyruvate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:biosynthetic process; P:cellular modified amino acid metabolic process; P:glutamine family amino acid metabolic process; P:kynurenine metabolic process; P:L-kynurenine catabolic process; P:L-phenylalanine metabolic process; P:tryptophan catabolic process;|Q16773 Q5T275 Q8N191,Kynurenine--oxoglutarate transaminase 1 {ECO:0000305|PubMed:19338303},Cysteine-S-conjugate beta-lyase {ECO:0000305|PubMed:7883047};Glutamine transaminase K;Glutamine--phenylpyruvate transaminase {ECO:0000305|PubMed:7883047};Kynurenine aminotransferase 1 {ECO:0000312|HGNC:HGNC:1564};Kynurenine aminotransferase I;Kynurenine--oxoglutarate transaminase I;, PF00155;, GO:0005737;GO:0005829;GO:0005739;GO:0047804;GO:0047316;GO:0016212;GO:0042803;GO:0030170;GO:0009058;GO:0006575;GO:0009064;GO:0070189;GO:0097053;GO:0006558;GO:0006569;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:cysteine-S-conjugate beta-lyase activity; F:glutamine-phenylpyruvate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:biosynthetic process; P:cellular modified amino acid metabolic process; P:glutamine family amino acid metabolic process; P:kynurenine metabolic process; P:L-kynurenine catabolic process; P:L-phenylalanine metabolic process; P:tryptophan catabolic process;|Q16773 Q5T275 Q8N191,Kynurenine--oxoglutarate transaminase 1 {ECO:0000305|PubMed:19338303},Cysteine-S-conjugate beta-lyase {ECO:0000305|PubMed:7883047};Glutamine transaminase K;Glutamine--phenylpyruvate transaminase {ECO:0000305|PubMed:7883047};Kynurenine aminotransferase 1 {ECO:0000312|HGNC:HGNC:1564};Kynurenine aminotransferase I;Kynurenine--oxoglutarate transaminase I;, PF00155;, GO:0005737;GO:0005829;GO:0005739;GO:0047804;GO:0047316;GO:0016212;GO:0042803;GO:0030170;GO:0009058;GO:0006575;GO:0009064;GO:0070189;GO:0097053;GO:0006558;GO:0006569;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:cysteine-S-conjugate beta-lyase activity; F:glutamine-phenylpyruvate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:biosynthetic process; P:cellular modified amino acid metabolic process; P:glutamine family amino acid metabolic process; P:kynurenine metabolic process; P:L-kynurenine catabolic process; P:L-phenylalanine metabolic process; P:tryptophan catabolic process;|Q16773 Q5T275 Q8N191,Kynurenine--oxoglutarate transaminase 1 {ECO:0000305|PubMed:19338303},Cysteine-S-conjugate beta-lyase {ECO:0000305|PubMed:7883047};Glutamine transaminase K;Glutamine--phenylpyruvate transaminase {ECO:0000305|PubMed:7883047};Kynurenine aminotransferase 1 {ECO:0000312|HGNC:HGNC:1564};Kynurenine aminotransferase I;Kynurenine--oxoglutarate transaminase I;, PF00155;, GO:0005737;GO:0005829;GO:0005739;GO:0047804;GO:0047316;GO:0016212;GO:0042803;GO:0030170;GO:0009058;GO:0006575;GO:0009064;GO:0070189;GO:0097053;GO:0006558;GO:0006569;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:cysteine-S-conjugate beta-lyase activity; F:glutamine-phenylpyruvate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:biosynthetic process; P:cellular modified amino acid metabolic process; P:glutamine family amino acid metabolic process; P:kynurenine metabolic process; P:L-kynurenine catabolic process; P:L-phenylalanine metabolic process; P:tryptophan catabolic process;|Q8IWT6 Q6UXM2 Q8NCI0 Q9P2B1,Volume-regulated anion channel subunit LRRC8A {ECO:0000305},Leucine-rich repeat-containing protein 8A {ECO:0000303|PubMed:22532330};Swelling protein 1 {ECO:0000303|PubMed:24725410};, PF13855;PF12534;, GO:0009986;GO:1905103;GO:0016021;GO:0005887;GO:0034702;GO:0016020;GO:0005886;GO:0140360;GO:0042802;GO:0005225;GO:0098656;GO:0006820;GO:0015810;GO:0006884;GO:0001678;GO:1902476;GO:0140361;GO:0032024;GO:0045663;GO:0002329;GO:0034214;GO:0006970;GO:0007283;GO:0015734;GO:0055085;, C:cell surface; C:integral component of lysosomal membrane; C:integral component of membrane; C:integral component of plasma membrane; C:ion channel complex; C:membrane; C:plasma membrane;, F:cyclic-GMP-AMP transmembrane transporter activity; F:identical protein binding; F:volume-sensitive anion channel activity;, P:anion transmembrane transport; P:anion transport; P:aspartate transmembrane transport; P:cell volume homeostasis; P:cellular glucose homeostasis; P:chloride transmembrane transport; P:cyclic-GMP-AMP transmembrane import across plasma membrane; P:positive regulation of insulin secretion; P:positive regulation of myoblast differentiation; P:pre-B cell differentiation; P:protein hexamerization; P:response to osmotic stress; P:spermatogenesis; P:taurine transport; P:transmembrane transport;|Q8IWT6 Q6UXM2 Q8NCI0 Q9P2B1,Volume-regulated anion channel subunit LRRC8A {ECO:0000305},Leucine-rich repeat-containing protein 8A {ECO:0000303|PubMed:22532330};Swelling protein 1 {ECO:0000303|PubMed:24725410};, PF13855;PF12534;, GO:0009986;GO:1905103;GO:0016021;GO:0005887;GO:0034702;GO:0016020;GO:0005886;GO:0140360;GO:0042802;GO:0005225;GO:0098656;GO:0006820;GO:0015810;GO:0006884;GO:0001678;GO:1902476;GO:0140361;GO:0032024;GO:0045663;GO:0002329;GO:0034214;GO:0006970;GO:0007283;GO:0015734;GO:0055085;, C:cell surface; C:integral component of lysosomal membrane; C:integral component of membrane; C:integral component of plasma membrane; C:ion channel complex; C:membrane; C:plasma membrane;, F:cyclic-GMP-AMP transmembrane transporter activity; F:identical protein binding; F:volume-sensitive anion channel activity;, P:anion transmembrane transport; P:anion transport; P:aspartate transmembrane transport; P:cell volume homeostasis; P:cellular glucose homeostasis; P:chloride transmembrane transport; P:cyclic-GMP-AMP transmembrane import across plasma membrane; P:positive regulation of insulin secretion; P:positive regulation of myoblast differentiation; P:pre-B cell differentiation; P:protein hexamerization; P:response to osmotic stress; P:spermatogenesis; P:taurine transport; P:transmembrane transport;|Q96GM4,Phytanoyl-CoA dioxygenase domain-containing protein 1,, PF05721;, GO:0051213;GO:0046872;, , F:dioxygenase activity; F:metal ion binding;|Q96GM4,Phytanoyl-CoA dioxygenase domain-containing protein 1,, PF05721;, GO:0051213;GO:0046872;, , F:dioxygenase activity; F:metal ion binding;|Q96GM4,Phytanoyl-CoA dioxygenase domain-containing protein 1,, PF05721;, GO:0051213;GO:0046872;, , F:dioxygenase activity; F:metal ion binding;|Q96GM4,Phytanoyl-CoA dioxygenase domain-containing protein 1,, PF05721;, GO:0051213;GO:0046872;, , F:dioxygenase activity; F:metal ion binding;|Q96GM4,Phytanoyl-CoA dioxygenase domain-containing protein 1,, PF05721;, GO:0051213;GO:0046872;, , F:dioxygenase activity; F:metal ion binding;|Q96GM4,Phytanoyl-CoA dioxygenase domain-containing protein 1,, PF05721;, GO:0051213;GO:0046872;, , F:dioxygenase activity; F:metal ion binding;|Q5SRE5 Q14675 Q2TA87 Q7Z3K8 Q8IWF1,Nucleoporin NUP188 {ECO:0000305},, PF10487;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9UPQ8 Q5SRE6,Dolichol kinase,Transmembrane protein 15;, , GO:0005789;GO:0030176;GO:0004168;GO:0006489;GO:0043048;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:dolichol kinase activity;, P:dolichyl diphosphate biosynthetic process; P:dolichyl monophosphate biosynthetic process;|Q5SRE5 Q14675 Q2TA87 Q7Z3K8 Q8IWF1,Nucleoporin NUP188 {ECO:0000305},, PF10487;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q5SRE5 Q14675 Q2TA87 Q7Z3K8 Q8IWF1,Nucleoporin NUP188 {ECO:0000305},, PF10487;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q5SRE5 Q14675 Q2TA87 Q7Z3K8 Q8IWF1,Nucleoporin NUP188 {ECO:0000305},, PF10487;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q5SRE5 Q14675 Q2TA87 Q7Z3K8 Q8IWF1,Nucleoporin NUP188 {ECO:0000305},, PF10487;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q5SRE5 Q14675 Q2TA87 Q7Z3K8 Q8IWF1,Nucleoporin NUP188 {ECO:0000305},, PF10487;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q5SRE5 Q14675 Q2TA87 Q7Z3K8 Q8IWF1,Nucleoporin NUP188 {ECO:0000305},, PF10487;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q5SRE5 Q14675 Q2TA87 Q7Z3K8 Q8IWF1,Nucleoporin NUP188 {ECO:0000305},, PF10487;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q5SRE5 Q14675 Q2TA87 Q7Z3K8 Q8IWF1,Nucleoporin NUP188 {ECO:0000305},, PF10487;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q5SRE5 Q14675 Q2TA87 Q7Z3K8 Q8IWF1,Nucleoporin NUP188 {ECO:0000305},, PF10487;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0044611;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9NR46 A6NC47 A8MPS4 Q8WY61 Q96JH9,Endophilin-B2,SH3 domain-containing GRB2-like protein B2;, PF03114;PF14604;, GO:0005737;GO:0005829;GO:0005654;GO:0045296;GO:0042802;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cadherin binding; F:identical protein binding; scaffold12 indexed_genome mRNA 48236004 48240105 . - . ID=transcript_3307;Q9NR46 A6NC47 A8MPS4 Q8WY61 Q96JH9,Endophilin-B2,SH3 domain-containing GRB2-like protein B2;, PF03114;PF14604;, GO:0005737;GO:0005829;GO:0005654;GO:0045296;GO:0042802;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cadherin binding; F:identical protein binding;|Q9NR46 A6NC47 A8MPS4 Q8WY61 Q96JH9,Endophilin-B2,SH3 domain-containing GRB2-like protein B2;, PF03114;PF14604;, GO:0005737;GO:0005829;GO:0005654;GO:0045296;GO:0042802;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cadherin binding; F:identical protein binding; scaffold12 indexed_genome mRNA 48241612 48242280 . - . ID=transcript_3308;Q9NR46 A6NC47 A8MPS4 Q8WY61 Q96JH9,Endophilin-B2,SH3 domain-containing GRB2-like protein B2;, PF03114;PF14604;, GO:0005737;GO:0005829;GO:0005654;GO:0045296;GO:0042802;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cadherin binding; F:identical protein binding; scaffold12 indexed_genome mRNA 48245946 48246598 . - . ID=transcript_3309;Q9NR46 A6NC47 A8MPS4 Q8WY61 Q96JH9,Endophilin-B2,SH3 domain-containing GRB2-like protein B2;, PF03114;PF14604;, GO:0005737;GO:0005829;GO:0005654;GO:0045296;GO:0042802;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cadherin binding; F:identical protein binding; scaffold12 indexed_genome mRNA 48256041 48281845 . + . ID=transcript_3310;Q7L4E1 Q8NBM3 Q8TEJ6 Q969E6,Mitoguardin 2 {ECO:0000303|PubMed:26711011},Protein FAM73B {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0046982;GO:0042803;GO:0060348;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:bone development; P:mitochondrial fusion;|Q7L4E1 Q8NBM3 Q8TEJ6 Q969E6,Mitoguardin 2 {ECO:0000303|PubMed:26711011},Protein FAM73B {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0046982;GO:0042803;GO:0060348;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:bone development; P:mitochondrial fusion;|Q7L4E1 Q8NBM3 Q8TEJ6 Q969E6,Mitoguardin 2 {ECO:0000303|PubMed:26711011},Protein FAM73B {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0046982;GO:0042803;GO:0060348;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:bone development; P:mitochondrial fusion;|Q7L4E1 Q8NBM3 Q8TEJ6 Q969E6,Mitoguardin 2 {ECO:0000303|PubMed:26711011},Protein FAM73B {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0046982;GO:0042803;GO:0060348;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:bone development; P:mitochondrial fusion;|Q7L4E1 Q8NBM3 Q8TEJ6 Q969E6,Mitoguardin 2 {ECO:0000303|PubMed:26711011},Protein FAM73B {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0046982;GO:0042803;GO:0060348;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:bone development; P:mitochondrial fusion;|Q7L4E1 Q8NBM3 Q8TEJ6 Q969E6,Mitoguardin 2 {ECO:0000303|PubMed:26711011},Protein FAM73B {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0046982;GO:0042803;GO:0060348;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:bone development; P:mitochondrial fusion;|Q7L4E1 Q8NBM3 Q8TEJ6 Q969E6,Mitoguardin 2 {ECO:0000303|PubMed:26711011},Protein FAM73B {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0046982;GO:0042803;GO:0060348;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:bone development; P:mitochondrial fusion;|Q7L4E1 Q8NBM3 Q8TEJ6 Q969E6,Mitoguardin 2 {ECO:0000303|PubMed:26711011},Protein FAM73B {ECO:0000305};, PF10265;, GO:0005887;GO:0005741;GO:0046982;GO:0042803;GO:0060348;GO:0008053;, C:integral component of plasma membrane; C:mitochondrial outer membrane;, F:protein heterodimerization activity; F:protein homodimerization activity;, P:bone development; P:mitochondrial fusion; scaffold12 indexed_genome mRNA 48291695 48301703 . + . ID=transcript_3311;Q86YN1 A8K3U8 B0QZG4 Q96GF8 Q9Y3G1,Dolichyldiphosphatase 1,Dolichyl pyrophosphate phosphatase 1;, PF01569;, GO:0005789;GO:0030176;GO:0043231;GO:0047874;GO:0006489;GO:0008610;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:dolichyldiphosphatase activity;, P:dolichyl diphosphate biosynthetic process; P:lipid biosynthetic process; P:protein N-linked glycosylation;|Q86YN1 A8K3U8 B0QZG4 Q96GF8 Q9Y3G1,Dolichyldiphosphatase 1,Dolichyl pyrophosphate phosphatase 1;, PF01569;, GO:0005789;GO:0030176;GO:0043231;GO:0047874;GO:0006489;GO:0008610;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:dolichyldiphosphatase activity;, P:dolichyl diphosphate biosynthetic process; P:lipid biosynthetic process; P:protein N-linked glycosylation;|Q86YN1 A8K3U8 B0QZG4 Q96GF8 Q9Y3G1,Dolichyldiphosphatase 1,Dolichyl pyrophosphate phosphatase 1;, PF01569;, GO:0005789;GO:0030176;GO:0043231;GO:0047874;GO:0006489;GO:0008610;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:dolichyldiphosphatase activity;, P:dolichyl diphosphate biosynthetic process; P:lipid biosynthetic process; P:protein N-linked glycosylation;|Q86YN1 A8K3U8 B0QZG4 Q96GF8 Q9Y3G1,Dolichyldiphosphatase 1,Dolichyl pyrophosphate phosphatase 1;, PF01569;, GO:0005789;GO:0030176;GO:0043231;GO:0047874;GO:0006489;GO:0008610;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:dolichyldiphosphatase activity;, P:dolichyl diphosphate biosynthetic process; P:lipid biosynthetic process; P:protein N-linked glycosylation;|Q86YN1 A8K3U8 B0QZG4 Q96GF8 Q9Y3G1,Dolichyldiphosphatase 1,Dolichyl pyrophosphate phosphatase 1;, PF01569;, GO:0005789;GO:0030176;GO:0043231;GO:0047874;GO:0006489;GO:0008610;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:dolichyldiphosphatase activity;, P:dolichyl diphosphate biosynthetic process; P:lipid biosynthetic process; P:protein N-linked glycosylation; scaffold12 indexed_genome mRNA 48304745 48318984 . - . ID=transcript_3312;P43155 Q5T952 Q9BW16,Carnitine O-acetyltransferase {ECO:0000305},Carnitine acetyltransferase;, PF00755;, GO:0005829;GO:0005783;GO:0005743;GO:0005739;GO:0005782;GO:0005777;GO:0003997;GO:0004092;GO:0008458;GO:0019254;GO:0033540;GO:0051791;GO:0008104;GO:0046459;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA oxidase activity; F:carnitine O-acetyltransferase activity; F:carnitine O-octanoyltransferase activity;, P:carnitine metabolic process, CoA-linked; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:medium-chain fatty acid metabolic process; P:protein localization; P:short-chain fatty acid metabolic process;|P43155 Q5T952 Q9BW16,Carnitine O-acetyltransferase {ECO:0000305},Carnitine acetyltransferase;, PF00755;, GO:0005829;GO:0005783;GO:0005743;GO:0005739;GO:0005782;GO:0005777;GO:0003997;GO:0004092;GO:0008458;GO:0019254;GO:0033540;GO:0051791;GO:0008104;GO:0046459;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA oxidase activity; F:carnitine O-acetyltransferase activity; F:carnitine O-octanoyltransferase activity;, P:carnitine metabolic process, CoA-linked; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:medium-chain fatty acid metabolic process; P:protein localization; P:short-chain fatty acid metabolic process;|P43155 Q5T952 Q9BW16,Carnitine O-acetyltransferase {ECO:0000305},Carnitine acetyltransferase;, PF00755;, GO:0005829;GO:0005783;GO:0005743;GO:0005739;GO:0005782;GO:0005777;GO:0003997;GO:0004092;GO:0008458;GO:0019254;GO:0033540;GO:0051791;GO:0008104;GO:0046459;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA oxidase activity; F:carnitine O-acetyltransferase activity; F:carnitine O-octanoyltransferase activity;, P:carnitine metabolic process, CoA-linked; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:medium-chain fatty acid metabolic process; P:protein localization; P:short-chain fatty acid metabolic process;|P43155 Q5T952 Q9BW16,Carnitine O-acetyltransferase {ECO:0000305},Carnitine acetyltransferase;, PF00755;, GO:0005829;GO:0005783;GO:0005743;GO:0005739;GO:0005782;GO:0005777;GO:0003997;GO:0004092;GO:0008458;GO:0019254;GO:0033540;GO:0051791;GO:0008104;GO:0046459;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA oxidase activity; F:carnitine O-acetyltransferase activity; F:carnitine O-octanoyltransferase activity;, P:carnitine metabolic process, CoA-linked; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:medium-chain fatty acid metabolic process; P:protein localization; P:short-chain fatty acid metabolic process; scaffold12 indexed_genome mRNA 48323991 48355414 . + . ID=transcript_3313;Q9NNZ8 Q9NNZ9,Serine/threonine-protein phosphatase 2A activator,PP2A, subunit B', PR53 isoform;Phosphotyrosyl phosphatase activator;Serine/threonine-protein phosphatase 2A regulatory subunit 4;Serine/threonine-protein phosphatase 2A regulatory subunit B';, PF03095;, GO:0034704;GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0000159;GO:0005524;GO:0003755;GO:0042803;GO:0051721;GO:0019888;GO:0008160;GO:0005102;GO:0007052;GO:0032515;GO:0035308;GO:0043065;GO:0032516;GO:0035307;GO:0043666;, C:calcium channel complex; C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:ATP binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein homodimerization activity; F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein tyrosine phosphatase activator activity; F:signaling receptor binding;, P:mitotic spindle organization; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein dephosphorylation; P:regulation of phosphoprotein phosphatase activity;|Q9NNZ8 Q9NNZ9,Serine/threonine-protein phosphatase 2A activator,PP2A, subunit B', PR53 isoform;Phosphotyrosyl phosphatase activator;Serine/threonine-protein phosphatase 2A regulatory subunit 4;Serine/threonine-protein phosphatase 2A regulatory subunit B';, PF03095;, GO:0034704;GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0000159;GO:0005524;GO:0003755;GO:0042803;GO:0051721;GO:0019888;GO:0008160;GO:0005102;GO:0007052;GO:0032515;GO:0035308;GO:0043065;GO:0032516;GO:0035307;GO:0043666;, C:calcium channel complex; C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:ATP binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein homodimerization activity; F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein tyrosine phosphatase activator activity; F:signaling receptor binding;, P:mitotic spindle organization; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein dephosphorylation; P:regulation of phosphoprotein phosphatase activity;|Q9NNZ8 Q9NNZ9,Serine/threonine-protein phosphatase 2A activator,PP2A, subunit B', PR53 isoform;Phosphotyrosyl phosphatase activator;Serine/threonine-protein phosphatase 2A regulatory subunit 4;Serine/threonine-protein phosphatase 2A regulatory subunit B';, PF03095;, GO:0034704;GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0000159;GO:0005524;GO:0003755;GO:0042803;GO:0051721;GO:0019888;GO:0008160;GO:0005102;GO:0007052;GO:0032515;GO:0035308;GO:0043065;GO:0032516;GO:0035307;GO:0043666;, C:calcium channel complex; C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:ATP binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein homodimerization activity; F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein tyrosine phosphatase activator activity; F:signaling receptor binding;, P:mitotic spindle organization; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein dephosphorylation; P:regulation of phosphoprotein phosphatase activity;|Q9NNZ8 Q9NNZ9,Serine/threonine-protein phosphatase 2A activator,PP2A, subunit B', PR53 isoform;Phosphotyrosyl phosphatase activator;Serine/threonine-protein phosphatase 2A regulatory subunit 4;Serine/threonine-protein phosphatase 2A regulatory subunit B';, PF03095;, GO:0034704;GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0000159;GO:0005524;GO:0003755;GO:0042803;GO:0051721;GO:0019888;GO:0008160;GO:0005102;GO:0007052;GO:0032515;GO:0035308;GO:0043065;GO:0032516;GO:0035307;GO:0043666;, C:calcium channel complex; C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:ATP binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein homodimerization activity; F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein tyrosine phosphatase activator activity; F:signaling receptor binding;, P:mitotic spindle organization; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein dephosphorylation; P:regulation of phosphoprotein phosphatase activity;|Q9NNZ8 Q9NNZ9,Serine/threonine-protein phosphatase 2A activator,PP2A, subunit B', PR53 isoform;Phosphotyrosyl phosphatase activator;Serine/threonine-protein phosphatase 2A regulatory subunit 4;Serine/threonine-protein phosphatase 2A regulatory subunit B';, PF03095;, GO:0034704;GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0000159;GO:0005524;GO:0003755;GO:0042803;GO:0051721;GO:0019888;GO:0008160;GO:0005102;GO:0007052;GO:0032515;GO:0035308;GO:0043065;GO:0032516;GO:0035307;GO:0043666;, C:calcium channel complex; C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:ATP binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein homodimerization activity; F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein tyrosine phosphatase activator activity; F:signaling receptor binding;, P:mitotic spindle organization; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein dephosphorylation; P:regulation of phosphoprotein phosphatase activity;|Q9NNZ8 Q9NNZ9,Serine/threonine-protein phosphatase 2A activator,PP2A, subunit B', PR53 isoform;Phosphotyrosyl phosphatase activator;Serine/threonine-protein phosphatase 2A regulatory subunit 4;Serine/threonine-protein phosphatase 2A regulatory subunit B';, PF03095;, GO:0034704;GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0000159;GO:0005524;GO:0003755;GO:0042803;GO:0051721;GO:0019888;GO:0008160;GO:0005102;GO:0007052;GO:0032515;GO:0035308;GO:0043065;GO:0032516;GO:0035307;GO:0043666;, C:calcium channel complex; C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:ATP binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein homodimerization activity; F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein tyrosine phosphatase activator activity; F:signaling receptor binding;, P:mitotic spindle organization; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein dephosphorylation; P:regulation of phosphoprotein phosphatase activity;|Q9NNZ8 Q9NNZ9,Serine/threonine-protein phosphatase 2A activator,PP2A, subunit B', PR53 isoform;Phosphotyrosyl phosphatase activator;Serine/threonine-protein phosphatase 2A regulatory subunit 4;Serine/threonine-protein phosphatase 2A regulatory subunit B';, PF03095;, GO:0034704;GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0000159;GO:0005524;GO:0003755;GO:0042803;GO:0051721;GO:0019888;GO:0008160;GO:0005102;GO:0007052;GO:0032515;GO:0035308;GO:0043065;GO:0032516;GO:0035307;GO:0043666;, C:calcium channel complex; C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:ATP binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein homodimerization activity; F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein tyrosine phosphatase activator activity; F:signaling receptor binding;, P:mitotic spindle organization; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein dephosphorylation; P:regulation of phosphoprotein phosphatase activity;|Q9NNZ8 Q9NNZ9,Serine/threonine-protein phosphatase 2A activator,PP2A, subunit B', PR53 isoform;Phosphotyrosyl phosphatase activator;Serine/threonine-protein phosphatase 2A regulatory subunit 4;Serine/threonine-protein phosphatase 2A regulatory subunit B';, PF03095;, GO:0034704;GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0000159;GO:0005524;GO:0003755;GO:0042803;GO:0051721;GO:0019888;GO:0008160;GO:0005102;GO:0007052;GO:0032515;GO:0035308;GO:0043065;GO:0032516;GO:0035307;GO:0043666;, C:calcium channel complex; C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:ATP binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein homodimerization activity; F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein tyrosine phosphatase activator activity; F:signaling receptor binding;, P:mitotic spindle organization; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein dephosphorylation; P:regulation of phosphoprotein phosphatase activity;|Q9NNZ8 Q9NNZ9,Serine/threonine-protein phosphatase 2A activator,PP2A, subunit B', PR53 isoform;Phosphotyrosyl phosphatase activator;Serine/threonine-protein phosphatase 2A regulatory subunit 4;Serine/threonine-protein phosphatase 2A regulatory subunit B';, PF03095;, GO:0034704;GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0000159;GO:0005524;GO:0003755;GO:0042803;GO:0051721;GO:0019888;GO:0008160;GO:0005102;GO:0007052;GO:0032515;GO:0035308;GO:0043065;GO:0032516;GO:0035307;GO:0043666;, C:calcium channel complex; C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:ATP binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein homodimerization activity; F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein tyrosine phosphatase activator activity; F:signaling receptor binding;, P:mitotic spindle organization; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein dephosphorylation; P:regulation of phosphoprotein phosphatase activity;|Q9NNZ8 Q9NNZ9,Serine/threonine-protein phosphatase 2A activator,PP2A, subunit B', PR53 isoform;Phosphotyrosyl phosphatase activator;Serine/threonine-protein phosphatase 2A regulatory subunit 4;Serine/threonine-protein phosphatase 2A regulatory subunit B';, PF03095;, GO:0034704;GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0000159;GO:0005524;GO:0003755;GO:0042803;GO:0051721;GO:0019888;GO:0008160;GO:0005102;GO:0007052;GO:0032515;GO:0035308;GO:0043065;GO:0032516;GO:0035307;GO:0043666;, C:calcium channel complex; C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:ATP binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein homodimerization activity; F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein tyrosine phosphatase activator activity; F:signaling receptor binding;, P:mitotic spindle organization; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein dephosphorylation; P:regulation of phosphoprotein phosphatase activity; scaffold13 indexed_genome mRNA 32821 57282 . - . ID=transcript_3314;O76039 G9B9X4 Q14198 Q5H985 Q8IYC7 Q9UJL6,Cyclin-dependent kinase-like 5 {ECO:0000305},Serine/threonine-protein kinase 9;, PF00069;, GO:0005813;GO:0036064;GO:0097542;GO:0032839;GO:0044294;GO:0098978;GO:0005654;GO:0005634;GO:0048471;GO:0099092;GO:0032587;GO:0005524;GO:0004693;GO:0016301;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0001764;GO:0045773;GO:0050775;GO:0060999;GO:0043547;GO:0046777;GO:0006468;GO:1902017;GO:0050773;GO:0099175;, C:centrosome; C:ciliary basal body; C:ciliary tip; C:dendrite cytoplasm; C:dendritic growth cone; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density, intracellular component; C:ruffle membrane;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:neuron migration; P:positive regulation of axon extension; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine development; P:positive regulation of GTPase activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cilium assembly; P:regulation of dendrite development; P:regulation of postsynapse organization;|O76039 G9B9X4 Q14198 Q5H985 Q8IYC7 Q9UJL6,Cyclin-dependent kinase-like 5 {ECO:0000305},Serine/threonine-protein kinase 9;, PF00069;, GO:0005813;GO:0036064;GO:0097542;GO:0032839;GO:0044294;GO:0098978;GO:0005654;GO:0005634;GO:0048471;GO:0099092;GO:0032587;GO:0005524;GO:0004693;GO:0016301;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0001764;GO:0045773;GO:0050775;GO:0060999;GO:0043547;GO:0046777;GO:0006468;GO:1902017;GO:0050773;GO:0099175;, C:centrosome; C:ciliary basal body; C:ciliary tip; C:dendrite cytoplasm; C:dendritic growth cone; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density, intracellular component; C:ruffle membrane;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:neuron migration; P:positive regulation of axon extension; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine development; P:positive regulation of GTPase activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cilium assembly; P:regulation of dendrite development; P:regulation of postsynapse organization; scaffold13 indexed_genome mRNA 57392 206500 . - . ID=transcript_3315;O76039 G9B9X4 Q14198 Q5H985 Q8IYC7 Q9UJL6,Cyclin-dependent kinase-like 5 {ECO:0000305},Serine/threonine-protein kinase 9;, PF00069;, GO:0005813;GO:0036064;GO:0097542;GO:0032839;GO:0044294;GO:0098978;GO:0005654;GO:0005634;GO:0048471;GO:0099092;GO:0032587;GO:0005524;GO:0004693;GO:0016301;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0001764;GO:0045773;GO:0050775;GO:0060999;GO:0043547;GO:0046777;GO:0006468;GO:1902017;GO:0050773;GO:0099175;, C:centrosome; C:ciliary basal body; C:ciliary tip; C:dendrite cytoplasm; C:dendritic growth cone; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density, intracellular component; C:ruffle membrane;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:neuron migration; P:positive regulation of axon extension; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine development; P:positive regulation of GTPase activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cilium assembly; P:regulation of dendrite development; P:regulation of postsynapse organization; scaffold13 indexed_genome mRNA 414659 423303 . - . ID=transcript_3316;Q9NUJ7 A2BH51 A2BH52,PI-PLC X domain-containing protein 1,, PF00388;, GO:0005737;GO:0008081;GO:0006629;, C:cytoplasm;, F:phosphoric diester hydrolase activity;, P:lipid metabolic process; scaffold13 indexed_genome mRNA 768869 791586 . - . ID=transcript_3317;O15162 B2R8H8 B4DTE8,Phospholipid scramblase 1,Ca(2+)-dependent phospholipid scramblase 1;Erythrocyte phospholipid scramblase;Mg(2+)-dependent nuclease {ECO:0000303|PubMed:27206388};MmTRA1b;, PF03803;, GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005887;GO:0016020;GO:0045121;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0042609;GO:0003677;GO:0001228;GO:0019899;GO:0005154;GO:0032791;GO:0000287;GO:0045340;GO:0004518;GO:0017128;GO:0017124;GO:0001618;GO:0008270;GO:0006953;GO:0006915;GO:0051607;GO:0050765;GO:0045071;GO:0006659;GO:0070782;GO:0017121;GO:0030168;GO:1905820;GO:2000373;GO:0010628;GO:0045089;GO:0045944;GO:0060368;GO:0033003;GO:0035456;GO:0010288;, C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding; F:CD4 receptor binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:enzyme binding; F:epidermal growth factor receptor binding; F:lead ion binding; F:magnesium ion binding; F:mercury ion binding; F:nuclease activity; F:phospholipid scramblase activity; F:SH3 domain binding; F:virus receptor activity; F:zinc ion binding;, P:acute-phase response; P:apoptotic process; P:defense response to virus; P:negative regulation of phagocytosis; P:negative regulation of viral genome replication; P:phosphatidylserine biosynthetic process; P:phosphatidylserine exposure on apoptotic cell surface; P:plasma membrane phospholipid scrambling; P:platelet activation; P:positive regulation of chromosome separation; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of gene expression; P:positive regulation of innate immune response; P:positive regulation of transcription by RNA polymerase II; P:regulation of Fc receptor mediated stimulatory signaling pathway; P:regulation of mast cell activation; P:response to interferon-beta; P:response to lead ion; scaffold13 indexed_genome mRNA 1697955 1710871 . - . ID=transcript_3318;Q8N9L1 A0AVA2 B2RMQ8 B4DF89 B7Z2L2 C9J7D5 J3KQG1 Q4G157 Q9BZ94,Zinc finger protein ZIC 4,Zinc finger protein of the cerebellum 4;, PF00096;PF18366;, GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0007417;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:central nervous system development; P:regulation of transcription by RNA polymerase II;|Q8N9L1 A0AVA2 B2RMQ8 B4DF89 B7Z2L2 C9J7D5 J3KQG1 Q4G157 Q9BZ94,Zinc finger protein ZIC 4,Zinc finger protein of the cerebellum 4;, PF00096;PF18366;, GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0007417;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:central nervous system development; P:regulation of transcription by RNA polymerase II;|Q8N9L1 A0AVA2 B2RMQ8 B4DF89 B7Z2L2 C9J7D5 J3KQG1 Q4G157 Q9BZ94,Zinc finger protein ZIC 4,Zinc finger protein of the cerebellum 4;, PF00096;PF18366;, GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0007417;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:central nervous system development; P:regulation of transcription by RNA polymerase II; scaffold13 indexed_genome mRNA 1712823 1716646 . + . ID=transcript_3319;Q15915 Q2M3N1,Zinc finger protein ZIC 1,Zinc finger protein 201;Zinc finger protein of the cerebellum 1;, PF00096;PF18366;, GO:0005737;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0007420;GO:0030154;GO:0007417;GO:0042472;GO:0007389;GO:0042307;GO:0045893;GO:0008589;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:cell differentiation; P:central nervous system development; P:inner ear morphogenesis; P:pattern specification process; P:positive regulation of protein import into nucleus; P:positive regulation of transcription, DNA-templated; P:regulation of smoothened signaling pathway; P:regulation of transcription by RNA polymerase II; scaffold13 indexed_genome mRNA 1716682 1718520 . - . ID=transcript_3320;Q15915 Q2M3N1,Zinc finger protein ZIC 1,Zinc finger protein 201;Zinc finger protein of the cerebellum 1;, PF00096;PF18366;, GO:0005737;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0007420;GO:0030154;GO:0007417;GO:0042472;GO:0007389;GO:0042307;GO:0045893;GO:0008589;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:cell differentiation; P:central nervous system development; P:inner ear morphogenesis; P:pattern specification process; P:positive regulation of protein import into nucleus; P:positive regulation of transcription, DNA-templated; P:regulation of smoothened signaling pathway; P:regulation of transcription by RNA polymerase II; scaffold13 indexed_genome mRNA 2919784 2969312 . + . ID=transcript_3321;P30556 Q13725 Q8TBK4,Type-1 angiotensin II receptor,AT1AR;AT1BR;Angiotensin II type-1 receptor;, PF00001;, GO:0016021;GO:0005887;GO:0005886;GO:0001596;GO:0004945;GO:0031711;GO:0004930;GO:0046982;GO:0038166;GO:0097746;GO:0019722;GO:0060326;GO:0007186;GO:0006954;GO:0001822;GO:0034374;GO:0002034;GO:0086097;GO:0007200;GO:1903589;GO:0032270;GO:0010873;GO:0007204;GO:0051482;GO:0050729;GO:0010744;GO:0033864;GO:0032430;GO:2000379;GO:0001558;GO:0042127;GO:0050727;GO:0035813;GO:0003081;GO:0019229;GO:0002018;GO:0007266;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:angiotensin type I receptor activity; F:angiotensin type II receptor activity; F:bradykinin receptor binding; F:G protein-coupled receptor activity; F:protein heterodimerization activity;, P:angiotensin-activated signaling pathway; P:blood vessel diameter maintenance; P:calcium-mediated signaling; P:cell chemotaxis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:kidney development; P:low-density lipoprotein particle remodeling; P:maintenance of blood vessel diameter homeostasis by renin-angiotensin; P:phospholipase C-activating angiotensin-activated signaling pathway; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol esterification; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of inflammatory response; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of phospholipase A2 activity; P:positive regulation of reactive oxygen species metabolic process; P:regulation of cell growth; P:regulation of cell population proliferation; P:regulation of inflammatory response; P:regulation of renal sodium excretion; P:regulation of systemic arterial blood pressure by renin-angiotensin; P:regulation of vasoconstriction; P:renin-angiotensin regulation of aldosterone production; P:Rho protein signal transduction; scaffold13 indexed_genome mRNA 3084986 3117419 . + . ID=transcript_3322;P15088 Q96E94,Mast cell carboxypeptidase A,Carboxypeptidase A3;, PF00246;PF02244;, GO:0062023;GO:0005576;GO:0005615;GO:0030141;GO:0030133;GO:0004181;GO:0008270;GO:0002003;GO:0006508;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:secretory granule; C:transport vesicle;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:angiotensin maturation; P:proteolysis; scaffold13 indexed_genome mRNA 3221549 3258608 . + . ID=transcript_3323;P46976 D3DNH0 D3DNH1 D3DNH2 Q6FHZ1 Q9UNV0,Glycogenin-1,, PF01501;, GO:0005829;GO:0005576;GO:1904813;GO:0043202;GO:0016020;GO:0034774;GO:0008466;GO:0030145;GO:0042803;GO:0016757;GO:0102751;GO:0005978;GO:0043312;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:membrane; C:secretory granule lumen;, F:glycogenin glucosyltransferase activity; F:manganese ion binding; F:protein homodimerization activity; F:transferase activity, transferring glycosyl groups; F:UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity;, P:glycogen biosynthetic process; P:neutrophil degranulation;|P46976 D3DNH0 D3DNH1 D3DNH2 Q6FHZ1 Q9UNV0,Glycogenin-1,, PF01501;, GO:0005829;GO:0005576;GO:1904813;GO:0043202;GO:0016020;GO:0034774;GO:0008466;GO:0030145;GO:0042803;GO:0016757;GO:0102751;GO:0005978;GO:0043312;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:membrane; C:secretory granule lumen;, F:glycogenin glucosyltransferase activity; F:manganese ion binding; F:protein homodimerization activity; F:transferase activity, transferring glycosyl groups; F:UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity;, P:glycogen biosynthetic process; P:neutrophil degranulation;|P46976 D3DNH0 D3DNH1 D3DNH2 Q6FHZ1 Q9UNV0,Glycogenin-1,, PF01501;, GO:0005829;GO:0005576;GO:1904813;GO:0043202;GO:0016020;GO:0034774;GO:0008466;GO:0030145;GO:0042803;GO:0016757;GO:0102751;GO:0005978;GO:0043312;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:membrane; C:secretory granule lumen;, F:glycogenin glucosyltransferase activity; F:manganese ion binding; F:protein homodimerization activity; F:transferase activity, transferring glycosyl groups; F:UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity;, P:glycogen biosynthetic process; P:neutrophil degranulation; scaffold13 indexed_genome mRNA 3264607 3324397 . - . ID=transcript_3324;Q14527 D3DNH3 Q14536 Q16051 Q7KYJ6 Q86YA5 Q92652 Q96KM9,Helicase-like transcription factor,DNA-binding protein/plasminogen activator inhibitor 1 regulator;HIP116;RING finger protein 80;RING-type E3 ubiquitin transferase HLTF {ECO:0000305};SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3;Sucrose nonfermenting protein 2-like 3;, PF00271;PF08797;PF00176;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003723;GO:0061630;GO:0031625;GO:0008270;GO:0006325;GO:0045944;GO:0016567;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:chromatin organization; P:positive regulation of transcription by RNA polymerase II; P:protein ubiquitination;|Q14527 D3DNH3 Q14536 Q16051 Q7KYJ6 Q86YA5 Q92652 Q96KM9,Helicase-like transcription factor,DNA-binding protein/plasminogen activator inhibitor 1 regulator;HIP116;RING finger protein 80;RING-type E3 ubiquitin transferase HLTF {ECO:0000305};SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3;Sucrose nonfermenting protein 2-like 3;, PF00271;PF08797;PF00176;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003723;GO:0061630;GO:0031625;GO:0008270;GO:0006325;GO:0045944;GO:0016567;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:chromatin organization; P:positive regulation of transcription by RNA polymerase II; P:protein ubiquitination; scaffold13 indexed_genome mRNA 3351043 3382394 . + . ID=transcript_3325;Q969F9 A8K6G6 Q8WTV6 Q96AP1 Q96MR3 Q9H608,Hermansky-Pudlak syndrome 3 protein,, PF14763;PF14762;PF14761;, GO:0031084;GO:0005737;GO:0006996;GO:0043473;, C:BLOC-2 complex; C:cytoplasm;, , P:organelle organization; P:pigmentation;|Q969F9 A8K6G6 Q8WTV6 Q96AP1 Q96MR3 Q9H608,Hermansky-Pudlak syndrome 3 protein,, PF14763;PF14762;PF14761;, GO:0031084;GO:0005737;GO:0006996;GO:0043473;, C:BLOC-2 complex; C:cytoplasm;, , P:organelle organization; P:pigmentation;|Q969F9 A8K6G6 Q8WTV6 Q96AP1 Q96MR3 Q9H608,Hermansky-Pudlak syndrome 3 protein,, PF14763;PF14762;PF14761;, GO:0031084;GO:0005737;GO:0006996;GO:0043473;, C:BLOC-2 complex; C:cytoplasm;, , P:organelle organization; P:pigmentation; scaffold13 indexed_genome mRNA 3384994 3426539 . - . ID=transcript_3326;P00450 Q14063 Q2PP18 Q9UKS4,Ceruloplasmin,Ferroxidase;, PF00394;PF07731;PF07732;, GO:0072562;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005765;GO:0005886;GO:0051087;GO:0005507;GO:0004322;GO:0016491;GO:0006879;GO:0044267;GO:0006825;GO:0055072;GO:0006826;GO:0043687;, C:blood microparticle; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal membrane; C:plasma membrane;, F:chaperone binding; F:copper ion binding; F:ferroxidase activity; F:oxidoreductase activity;, P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:copper ion transport; P:iron ion homeostasis; P:iron ion transport; P:post-translational protein modification;|Q969F9 A8K6G6 Q8WTV6 Q96AP1 Q96MR3 Q9H608,Hermansky-Pudlak syndrome 3 protein,, PF14763;PF14762;PF14761;, GO:0031084;GO:0005737;GO:0006996;GO:0043473;, C:BLOC-2 complex; C:cytoplasm;, , P:organelle organization; P:pigmentation;|P00450 Q14063 Q2PP18 Q9UKS4,Ceruloplasmin,Ferroxidase;, PF00394;PF07731;PF07732;, GO:0072562;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005765;GO:0005886;GO:0051087;GO:0005507;GO:0004322;GO:0016491;GO:0006879;GO:0044267;GO:0006825;GO:0055072;GO:0006826;GO:0043687;, C:blood microparticle; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal membrane; C:plasma membrane;, F:chaperone binding; F:copper ion binding; F:ferroxidase activity; F:oxidoreductase activity;, P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:copper ion transport; P:iron ion homeostasis; P:iron ion transport; P:post-translational protein modification;|P00450 Q14063 Q2PP18 Q9UKS4,Ceruloplasmin,Ferroxidase;, PF00394;PF07731;PF07732;, GO:0072562;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005765;GO:0005886;GO:0051087;GO:0005507;GO:0004322;GO:0016491;GO:0006879;GO:0044267;GO:0006825;GO:0055072;GO:0006826;GO:0043687;, C:blood microparticle; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal membrane; C:plasma membrane;, F:chaperone binding; F:copper ion binding; F:ferroxidase activity; F:oxidoreductase activity;, P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:copper ion transport; P:iron ion homeostasis; P:iron ion transport; P:post-translational protein modification;|P00450 Q14063 Q2PP18 Q9UKS4,Ceruloplasmin,Ferroxidase;, PF00394;PF07731;PF07732;, GO:0072562;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005765;GO:0005886;GO:0051087;GO:0005507;GO:0004322;GO:0016491;GO:0006879;GO:0044267;GO:0006825;GO:0055072;GO:0006826;GO:0043687;, C:blood microparticle; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal membrane; C:plasma membrane;, F:chaperone binding; F:copper ion binding; F:ferroxidase activity; F:oxidoreductase activity;, P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:copper ion transport; P:iron ion homeostasis; P:iron ion transport; P:post-translational protein modification; scaffold13 indexed_genome mRNA 3516771 3543255 . - . ID=transcript_3327;Q96CE8 B2R8K0 D3DNH5,Transmembrane 4 L6 family member 18,, PF05805;, GO:0016021;, C:integral component of membrane; scaffold13 indexed_genome mRNA 3581407 3590923 . - . ID=transcript_3328;P30408 Q6IB51,Transmembrane 4 L6 family member 1,Membrane component chromosome 3 surface marker 1;Tumor-associated antigen L6;, PF05805;, GO:0016021;GO:0005887;, C:integral component of membrane; C:integral component of plasma membrane;|P30408 Q6IB51,Transmembrane 4 L6 family member 1,Membrane component chromosome 3 surface marker 1;Tumor-associated antigen L6;, PF05805;, GO:0016021;GO:0005887;, C:integral component of membrane; C:integral component of plasma membrane;|P30408 Q6IB51,Transmembrane 4 L6 family member 1,Membrane component chromosome 3 surface marker 1;Tumor-associated antigen L6;, PF05805;, GO:0016021;GO:0005887;, C:integral component of membrane; C:integral component of plasma membrane; scaffold13 indexed_genome mRNA 3699525 3722467 . + . ID=transcript_3329;P48230 B2RDA4,Transmembrane 4 L6 family member 4,Intestine and liver tetraspan membrane protein;, PF05805;, GO:0016021;GO:0042246;, C:integral component of membrane;, , P:tissue regeneration;|P48230 B2RDA4,Transmembrane 4 L6 family member 4,Intestine and liver tetraspan membrane protein;, PF05805;, GO:0016021;GO:0042246;, C:integral component of membrane;, , P:tissue regeneration; scaffold13 indexed_genome mRNA 3947834 3960953 . - . ID=transcript_3330;Q86X83 Q561V4 Q9H3L5 Q9Y5V1,COMM domain-containing protein 2,, PF07258;, GO:0005737;, C:cytoplasm;|Q86X83 Q561V4 Q9H3L5 Q9Y5V1,COMM domain-containing protein 2,, PF07258;, GO:0005737;, C:cytoplasm; scaffold13 indexed_genome mRNA 3972887 3973467 . + . ID=transcript_3331;A6NFN9 B4E2N8 E9PHT4,Protein ANKUB1,Ankyrin repeat and ubiquitin domain-containing 1;, PF00240; scaffold13 indexed_genome mRNA 4012610 4133466 . + . ID=transcript_3332;O43567 A6NC87 B3KR12 Q05D66 Q6IBJ9,E3 ubiquitin-protein ligase RNF13,RING finger protein 13;RING-type E3 ubiquitin transferase RNF13 {ECO:0000305};, PF02225;PF13639;, GO:0005829;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005637;GO:0005654;GO:0008432;GO:0046872;GO:0061630;GO:0004842;GO:0070304;GO:0051865;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nuclear inner membrane; C:nucleoplasm;, F:JUN kinase binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of stress-activated protein kinase signaling cascade; P:protein autoubiquitination; P:ubiquitin-dependent protein catabolic process;|O43567 A6NC87 B3KR12 Q05D66 Q6IBJ9,E3 ubiquitin-protein ligase RNF13,RING finger protein 13;RING-type E3 ubiquitin transferase RNF13 {ECO:0000305};, PF02225;PF13639;, GO:0005829;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005637;GO:0005654;GO:0008432;GO:0046872;GO:0061630;GO:0004842;GO:0070304;GO:0051865;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nuclear inner membrane; C:nucleoplasm;, F:JUN kinase binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of stress-activated protein kinase signaling cascade; P:protein autoubiquitination; P:ubiquitin-dependent protein catabolic process;|O43567 A6NC87 B3KR12 Q05D66 Q6IBJ9,E3 ubiquitin-protein ligase RNF13,RING finger protein 13;RING-type E3 ubiquitin transferase RNF13 {ECO:0000305};, PF02225;PF13639;, GO:0005829;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005637;GO:0005654;GO:0008432;GO:0046872;GO:0061630;GO:0004842;GO:0070304;GO:0051865;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nuclear inner membrane; C:nucleoplasm;, F:JUN kinase binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of stress-activated protein kinase signaling cascade; P:protein autoubiquitination; P:ubiquitin-dependent protein catabolic process;|O43567 A6NC87 B3KR12 Q05D66 Q6IBJ9,E3 ubiquitin-protein ligase RNF13,RING finger protein 13;RING-type E3 ubiquitin transferase RNF13 {ECO:0000305};, PF02225;PF13639;, GO:0005829;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005637;GO:0005654;GO:0008432;GO:0046872;GO:0061630;GO:0004842;GO:0070304;GO:0051865;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nuclear inner membrane; C:nucleoplasm;, F:JUN kinase binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of stress-activated protein kinase signaling cascade; P:protein autoubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold13 indexed_genome mRNA 4135496 4153009 . - . ID=transcript_3333;P35080 B2R4C8 D3DNI4 Q4VBQ4 Q8WVF9 Q9HBK2,Profilin-2,Profilin II;, PF00235;, GO:0005737;GO:0005856;GO:0070062;GO:0003779;GO:0003785;GO:0016887;GO:0005546;GO:0030036;GO:0030837;GO:0010633;GO:1900028;GO:0032233;GO:0030838;GO:0032781;GO:0033138;GO:0051496;GO:0050821;GO:0030833;, C:cytoplasm; C:cytoskeleton; C:extracellular exosome;, F:actin binding; F:actin monomer binding; F:ATPase activity; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization; P:negative regulation of epithelial cell migration; P:negative regulation of ruffle assembly; P:positive regulation of actin filament bundle assembly; P:positive regulation of actin filament polymerization; P:positive regulation of ATPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of stress fiber assembly; P:protein stabilization; P:regulation of actin filament polymerization;|P35080 B2R4C8 D3DNI4 Q4VBQ4 Q8WVF9 Q9HBK2,Profilin-2,Profilin II;, PF00235;, GO:0005737;GO:0005856;GO:0070062;GO:0003779;GO:0003785;GO:0016887;GO:0005546;GO:0030036;GO:0030837;GO:0010633;GO:1900028;GO:0032233;GO:0030838;GO:0032781;GO:0033138;GO:0051496;GO:0050821;GO:0030833;, C:cytoplasm; C:cytoskeleton; C:extracellular exosome;, F:actin binding; F:actin monomer binding; F:ATPase activity; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization; P:negative regulation of epithelial cell migration; P:negative regulation of ruffle assembly; P:positive regulation of actin filament bundle assembly; P:positive regulation of actin filament polymerization; P:positive regulation of ATPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of stress fiber assembly; P:protein stabilization; P:regulation of actin filament polymerization; scaffold13 indexed_genome mRNA 4647430 4656819 . + . ID=transcript_3334;O75157 D3DNI5 Q6PI50 Q9H2Z6 Q9H2Z7 Q9H2Z8,TSC22 domain family protein 2,TSC22-related-inducible leucine zipper protein 4;, PF01166;, GO:0006357;GO:0006970;, , , P:regulation of transcription by RNA polymerase II; P:response to osmotic stress;|O75157 D3DNI5 Q6PI50 Q9H2Z6 Q9H2Z7 Q9H2Z8,TSC22 domain family protein 2,TSC22-related-inducible leucine zipper protein 4;, PF01166;, GO:0006357;GO:0006970;, , , P:regulation of transcription by RNA polymerase II; P:response to osmotic stress; scaffold13 indexed_genome mRNA 4718741 4724116 . - . ID=transcript_3335;Q9Y6X1 D3DNI6,Stress-associated endoplasmic reticulum protein 1,Ribosome-attached membrane protein 4;, PF06624;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0005840;GO:0006464;GO:0030968;GO:0036498;GO:0007009;GO:0006486;GO:0045048;GO:0015031;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:ribosome;, , P:cellular protein modification process; P:endoplasmic reticulum unfolded protein response; P:IRE1-mediated unfolded protein response; P:plasma membrane organization; P:protein glycosylation; P:protein insertion into ER membrane; P:protein transport;|Q9Y6X1 D3DNI6,Stress-associated endoplasmic reticulum protein 1,Ribosome-attached membrane protein 4;, PF06624;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0005840;GO:0006464;GO:0030968;GO:0036498;GO:0007009;GO:0006486;GO:0045048;GO:0015031;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:ribosome;, , P:cellular protein modification process; P:endoplasmic reticulum unfolded protein response; P:IRE1-mediated unfolded protein response; P:plasma membrane organization; P:protein glycosylation; P:protein insertion into ER membrane; P:protein transport; scaffold13 indexed_genome mRNA 4724207 4761630 . + . ID=transcript_3336;Q96K81,Eukaryotic translation initiation factor 2A,65 kDa eukaryotic translation initiation factor 2A;, PF08662;, GO:0072562;GO:0005737;GO:0022627;GO:0005850;GO:0005615;GO:0045296;GO:0003729;GO:0043022;GO:0003743;GO:0000049;GO:0009967;GO:0006468;GO:0006417;GO:1990928;GO:0042255;GO:0032933;, C:blood microparticle; C:cytoplasm; C:cytosolic small ribosomal subunit; C:eukaryotic translation initiation factor 2 complex; C:extracellular space;, F:cadherin binding; F:mRNA binding; F:ribosome binding; F:translation initiation factor activity; F:tRNA binding;, P:positive regulation of signal transduction; P:protein phosphorylation; P:regulation of translation; P:response to amino acid starvation; P:ribosome assembly; P:SREBP signaling pathway;|Q96K81,Eukaryotic translation initiation factor 2A,65 kDa eukaryotic translation initiation factor 2A;, PF08662;, GO:0072562;GO:0005737;GO:0022627;GO:0005850;GO:0005615;GO:0045296;GO:0003729;GO:0043022;GO:0003743;GO:0000049;GO:0009967;GO:0006468;GO:0006417;GO:1990928;GO:0042255;GO:0032933;, C:blood microparticle; C:cytoplasm; C:cytosolic small ribosomal subunit; C:eukaryotic translation initiation factor 2 complex; C:extracellular space;, F:cadherin binding; F:mRNA binding; F:ribosome binding; F:translation initiation factor activity; F:tRNA binding;, P:positive regulation of signal transduction; P:protein phosphorylation; P:regulation of translation; P:response to amino acid starvation; P:ribosome assembly; P:SREBP signaling pathway; scaffold13 indexed_genome mRNA 4776504 4808748 . + . ID=transcript_3337;P62341 O95904 Q8IY80 Q9CZ45 Q9NZJ3,Thioredoxin reductase-like selenoprotein T {ECO:0000305},, PF10262;, GO:0005783;GO:0005789;GO:0016021;GO:0008430;GO:0004791;GO:0045454;GO:0098869;GO:0042593;GO:0035773;GO:0031016;GO:0007204;GO:0060124;GO:0009749;GO:0001514;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:selenium binding; F:thioredoxin-disulfide reductase activity;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:glucose homeostasis; P:insulin secretion involved in cellular response to glucose stimulus; P:pancreas development; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of growth hormone secretion; P:response to glucose; P:selenocysteine incorporation;|P62341 O95904 Q8IY80 Q9CZ45 Q9NZJ3,Thioredoxin reductase-like selenoprotein T {ECO:0000305},, PF10262;, GO:0005783;GO:0005789;GO:0016021;GO:0008430;GO:0004791;GO:0045454;GO:0098869;GO:0042593;GO:0035773;GO:0031016;GO:0007204;GO:0060124;GO:0009749;GO:0001514;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:selenium binding; F:thioredoxin-disulfide reductase activity;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:glucose homeostasis; P:insulin secretion involved in cellular response to glucose stimulus; P:pancreas development; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of growth hormone secretion; P:response to glucose; P:selenocysteine incorporation; scaffold13 indexed_genome mRNA 4829740 4840797 . - . ID=transcript_3338;Q7L0X2 Q8N9Y8 Q8NCQ6 Q8NCZ6,Glutamate-rich protein 6,Protein FAM194A;, PF14977; scaffold13 indexed_genome mRNA 4864925 4887717 . - . ID=transcript_3339;Q7L0X2 Q8N9Y8 Q8NCQ6 Q8NCZ6,Glutamate-rich protein 6,Protein FAM194A;, PF14977; scaffold13 indexed_genome mRNA 4927636 4929212 . + . ID=transcript_3340;O43255 O43270,E3 ubiquitin-protein ligase SIAH2,RING-type E3 ubiquitin transferase SIAH2 {ECO:0000305};Seven in absentia homolog 2;, PF03145;, GO:0005737;GO:0005829;GO:0005769;GO:0043231;GO:0043005;GO:0043025;GO:0005654;GO:0003714;GO:0031624;GO:0061630;GO:0004842;GO:0008270;GO:1990000;GO:0006915;GO:0007049;GO:0044257;GO:0007275;GO:0043066;GO:0090090;GO:0043154;GO:2001237;GO:1902842;GO:0043161;GO:0016579;GO:0000209;GO:0042752;GO:0031396;GO:0048511;GO:0007264;GO:0006511;, C:cytoplasm; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:neuron projection; C:neuronal cell body; C:nucleoplasm;, F:transcription corepressor activity; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:amyloid fibril formation; P:apoptotic process; P:cell cycle; P:cellular protein catabolic process; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of netrin-activated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of circadian rhythm; P:regulation of protein ubiquitination; P:rhythmic process; P:small GTPase mediated signal transduction; P:ubiquitin-dependent protein catabolic process; scaffold13 indexed_genome mRNA 5360035 5387138 . + . ID=transcript_3341;Q86YW9 Q96PC7 Q96PC8 Q9H9M5 Q9HCD7 Q9UI69,Mediator of RNA polymerase II transcription subunit 12-like protein,Mediator complex subunit 12-like protein;Thyroid hormone receptor-associated-like protein;Trinucleotide repeat-containing gene 11 protein-like;, PF09497;PF12145;PF12144;, GO:0016592;GO:0008013;GO:0003713;GO:0008134;GO:0006357;, C:mediator complex;, F:beta-catenin binding; F:transcription coactivator activity; F:transcription factor binding;, P:regulation of transcription by RNA polymerase II; scaffold13 indexed_genome mRNA 5393245 5395055 . - . ID=transcript_3342;O14626 D3DNJ4 Q8IV06,Probable G-protein coupled receptor 171,G-protein coupled receptor H963;, PF00001;, GO:0016021;GO:0005886;GO:0045028;GO:0004930;GO:0007186;GO:0045638;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled purinergic nucleotide receptor activity; F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of myeloid cell differentiation; scaffold13 indexed_genome mRNA 5408642 5418289 . - . ID=transcript_3343;Q15391 Q8IYT7,P2Y purinoceptor 14,G-protein coupled receptor 105;UDP-glucose receptor;, PF00001;, GO:0016021;GO:0005886;GO:0045028;GO:0045029;GO:0007186;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled purinergic nucleotide receptor activity; F:G protein-coupled UDP receptor activity;, P:G protein-coupled receptor signaling pathway; scaffold13 indexed_genome mRNA 5523828 5527137 . - . ID=transcript_3344;Q9BPV8 B2R827 Q05C50 Q6DKN4 Q8IUT5 Q8TDU7 Q9BY61,P2Y purinoceptor 13,G-protein coupled receptor 86;G-protein coupled receptor 94;, PF00001;, GO:0005783;GO:0016021;GO:0005886;GO:0045028;GO:0071407;GO:0007186;GO:0007194;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled purinergic nucleotide receptor activity;, P:cellular response to organic cyclic compound; P:G protein-coupled receptor signaling pathway; P:negative regulation of adenylate cyclase activity; scaffold13 indexed_genome mRNA 5534114 5537885 . - . ID=transcript_3345;Q9H244 D3DNJ5 Q546J7,P2Y purinoceptor 12,ADP-glucose receptor;P2T(AC);P2Y(AC);P2Y(cyc);P2Y12 platelet ADP receptor;SP1999;, PF00001;, GO:0009925;GO:0005901;GO:0044298;GO:0031253;GO:0009986;GO:0009897;GO:0016021;GO:0031224;GO:0005739;GO:0005886;GO:0001609;GO:0001621;GO:0045028;GO:0007202;GO:0007193;GO:0070588;GO:0019722;GO:0035585;GO:0030030;GO:0071318;GO:0021808;GO:0007186;GO:0007599;GO:0030032;GO:1904124;GO:0045596;GO:0010700;GO:0007200;GO:0030168;GO:0070527;GO:0033630;GO:0050921;GO:0033626;GO:0043270;GO:1904141;GO:0043552;GO:0051897;GO:1900029;GO:0071805;GO:0043491;GO:0051924;GO:0050920;GO:1904139;GO:0048678;GO:0006930;GO:0150063;, C:basal plasma membrane; C:caveola; C:cell body membrane; C:cell projection membrane; C:cell surface; C:external side of plasma membrane; C:integral component of membrane; C:intrinsic component of membrane; C:mitochondrion; C:plasma membrane;, F:G protein-coupled adenosine receptor activity; F:G protein-coupled ADP receptor activity; F:G protein-coupled purinergic nucleotide receptor activity;, P:activation of phospholipase C activity; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:calcium ion transmembrane transport; P:calcium-mediated signaling; P:calcium-mediated signaling using extracellular calcium source; P:cell projection organization; P:cellular response to ATP; P:cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration; P:G protein-coupled receptor signaling pathway; P:hemostasis; P:lamellipodium assembly; P:microglial cell migration; P:negative regulation of cell differentiation; P:negative regulation of norepinephrine secretion; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:platelet activation; P:platelet aggregation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of chemotaxis; P:positive regulation of integrin activation by cell surface receptor linked signal transduction; P:positive regulation of ion transport; P:positive regulation of microglial cell migration; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of ruffle assembly; P:potassium ion transmembrane transport; P:protein kinase B signaling; P:regulation of calcium ion transport; P:regulation of chemotaxis; P:regulation of microglial cell migration; P:response to axon injury; P:substrate-dependent cell migration, cell extension; P:visual system development; scaffold13 indexed_genome mRNA 5565289 5622806 . + . ID=transcript_3346;Q86YW9 Q96PC7 Q96PC8 Q9H9M5 Q9HCD7 Q9UI69,Mediator of RNA polymerase II transcription subunit 12-like protein,Mediator complex subunit 12-like protein;Thyroid hormone receptor-associated-like protein;Trinucleotide repeat-containing gene 11 protein-like;, PF09497;PF12145;PF12144;, GO:0016592;GO:0008013;GO:0003713;GO:0008134;GO:0006357;, C:mediator complex;, F:beta-catenin binding; F:transcription coactivator activity; F:transcription factor binding;, P:regulation of transcription by RNA polymerase II;|Q86YW9 Q96PC7 Q96PC8 Q9H9M5 Q9HCD7 Q9UI69,Mediator of RNA polymerase II transcription subunit 12-like protein,Mediator complex subunit 12-like protein;Thyroid hormone receptor-associated-like protein;Trinucleotide repeat-containing gene 11 protein-like;, PF09497;PF12145;PF12144;, GO:0016592;GO:0008013;GO:0003713;GO:0008134;GO:0006357;, C:mediator complex;, F:beta-catenin binding; F:transcription coactivator activity; F:transcription factor binding;, P:regulation of transcription by RNA polymerase II; scaffold13 indexed_genome mRNA 5622844 5634856 . - . ID=transcript_3347;Q6WRI0 Q86YJ9 Q8N772 Q8NA84,Immunoglobulin superfamily member 10,Calvaria mechanical force protein 608;, PF07679;PF13855;, GO:0005576;GO:0030154;GO:0007275;GO:0001503;GO:2001222;, C:extracellular region;, , P:cell differentiation; P:multicellular organism development; P:ossification; P:regulation of neuron migration; scaffold13 indexed_genome mRNA 5634865 5635413 . + . ID=transcript_3348;Q6WRI0 Q86YJ9 Q8N772 Q8NA84,Immunoglobulin superfamily member 10,Calvaria mechanical force protein 608;, PF07679;PF13855;, GO:0005576;GO:0030154;GO:0007275;GO:0001503;GO:2001222;, C:extracellular region;, , P:cell differentiation; P:multicellular organism development; P:ossification; P:regulation of neuron migration; scaffold13 indexed_genome mRNA 5635448 5636038 . - . ID=transcript_3349;Q6WRI0 Q86YJ9 Q8N772 Q8NA84,Immunoglobulin superfamily member 10,Calvaria mechanical force protein 608;, PF07679;PF13855;, GO:0005576;GO:0030154;GO:0007275;GO:0001503;GO:2001222;, C:extracellular region;, , P:cell differentiation; P:multicellular organism development; P:ossification; P:regulation of neuron migration; scaffold13 indexed_genome mRNA 5637642 5638649 . - . ID=transcript_3350;Q6WRI0 Q86YJ9 Q8N772 Q8NA84,Immunoglobulin superfamily member 10,Calvaria mechanical force protein 608;, PF07679;PF13855;, GO:0005576;GO:0030154;GO:0007275;GO:0001503;GO:2001222;, C:extracellular region;, , P:cell differentiation; P:multicellular organism development; P:ossification; P:regulation of neuron migration; scaffold13 indexed_genome mRNA 5641305 5645720 . + . ID=transcript_3351;Q6WRI0 Q86YJ9 Q8N772 Q8NA84,Immunoglobulin superfamily member 10,Calvaria mechanical force protein 608;, PF07679;PF13855;, GO:0005576;GO:0030154;GO:0007275;GO:0001503;GO:2001222;, C:extracellular region;, , P:cell differentiation; P:multicellular organism development; P:ossification; P:regulation of neuron migration; scaffold13 indexed_genome mRNA 5647062 5648505 . - . ID=transcript_3352;Q6WRI0 Q86YJ9 Q8N772 Q8NA84,Immunoglobulin superfamily member 10,Calvaria mechanical force protein 608;, PF07679;PF13855;, GO:0005576;GO:0030154;GO:0007275;GO:0001503;GO:2001222;, C:extracellular region;, , P:cell differentiation; P:multicellular organism development; P:ossification; P:regulation of neuron migration; scaffold13 indexed_genome mRNA 6098898 6099537 . + . ID=transcript_3353;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold13 indexed_genome mRNA 6152914 6172099 . + . ID=transcript_3354;P22760 A8K3L3 D3DNJ6 Q8N1A9,Arylacetamide deacetylase,, PF07859;, GO:0005789;GO:0016021;GO:0003824;GO:0019213;GO:0016787;GO:0016298;GO:0017171;GO:0004806;GO:0010898;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:catalytic activity; F:deacetylase activity; F:hydrolase activity; F:lipase activity; F:serine hydrolase activity; F:triglyceride lipase activity;, P:positive regulation of triglyceride catabolic process; P:xenobiotic metabolic process;|P22760 A8K3L3 D3DNJ6 Q8N1A9,Arylacetamide deacetylase,, PF07859;, GO:0005789;GO:0016021;GO:0003824;GO:0019213;GO:0016787;GO:0016298;GO:0017171;GO:0004806;GO:0010898;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:catalytic activity; F:deacetylase activity; F:hydrolase activity; F:lipase activity; F:serine hydrolase activity; F:triglyceride lipase activity;, P:positive regulation of triglyceride catabolic process; P:xenobiotic metabolic process; scaffold13 indexed_genome mRNA 6220357 6228032 . - . ID=transcript_3355;Q9BXA5 A8K305 Q8TDQ8,Succinate receptor 1,G-protein coupled receptor 91;P2Y purinoceptor 1-like;, PF00001;, GO:0070062;GO:0016021;GO:0005886;GO:0004930;GO:0007186;GO:0042593;GO:0002281;GO:0050921;GO:0050729;GO:0060177;GO:0002001;GO:0051592;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:macrophage activation involved in immune response; P:positive regulation of chemotaxis; P:positive regulation of inflammatory response; P:regulation of angiotensin metabolic process; P:renin secretion into blood stream; P:response to calcium ion; scaffold13 indexed_genome mRNA 6665372 6814707 . + . ID=transcript_3356;Q9NR56 E9PBW7 O43311 O43797 Q86UV8 Q86UV9 Q96P92 Q96RE3,Muscleblind-like protein 1,Triplet-expansion RNA-binding protein;, PF00642;, GO:0005737;GO:0010494;GO:0005829;GO:0005654;GO:0005634;GO:0003725;GO:0046872;GO:0003723;GO:0030326;GO:0001701;GO:0006397;GO:0045445;GO:0007399;GO:0000381;GO:0043484;GO:0008380;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:metal ion binding; F:RNA binding;, P:embryonic limb morphogenesis; P:in utero embryonic development; P:mRNA processing; P:myoblast differentiation; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing;|Q9NR56 E9PBW7 O43311 O43797 Q86UV8 Q86UV9 Q96P92 Q96RE3,Muscleblind-like protein 1,Triplet-expansion RNA-binding protein;, PF00642;, GO:0005737;GO:0010494;GO:0005829;GO:0005654;GO:0005634;GO:0003725;GO:0046872;GO:0003723;GO:0030326;GO:0001701;GO:0006397;GO:0045445;GO:0007399;GO:0000381;GO:0043484;GO:0008380;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:metal ion binding; F:RNA binding;, P:embryonic limb morphogenesis; P:in utero embryonic development; P:mRNA processing; P:myoblast differentiation; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing; scaffold13 indexed_genome mRNA 7149323 7154985 . + . ID=transcript_3357;P47900,P2Y purinoceptor 1,ADP receptor {ECO:0000303|PubMed:9038354};Purinergic receptor;, PF00001;, GO:0016324;GO:0016323;GO:0044297;GO:0009986;GO:0005929;GO:0030425;GO:0098978;GO:0005887;GO:0099059;GO:0005739;GO:0005886;GO:0014069;GO:0045211;GO:0031686;GO:0043531;GO:0005524;GO:0001621;GO:0045031;GO:0045028;GO:0046982;GO:0097110;GO:0038023;GO:0007193;GO:0007568;GO:0097746;GO:0007166;GO:0071318;GO:0071415;GO:0042755;GO:0001973;GO:0007186;GO:0008347;GO:0051100;GO:0010700;GO:0007200;GO:0030168;GO:0007204;GO:0070374;GO:0046887;GO:0032962;GO:0043270;GO:0060406;GO:0001934;GO:0045944;GO:0072659;GO:0008360;GO:0099509;GO:0010469;GO:2000300;GO:0090075;GO:0070848;GO:0009612;GO:0019233;GO:0023019;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell body; C:cell surface; C:cilium; C:dendrite; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:mitochondrion; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:A1 adenosine receptor binding; F:ADP binding; F:ATP binding; F:G protein-coupled ADP receptor activity; F:G protein-coupled ATP receptor activity; F:G protein-coupled purinergic nucleotide receptor activity; F:protein heterodimerization activity; F:scaffold protein binding; F:signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:aging; P:blood vessel diameter maintenance; P:cell surface receptor signaling pathway; P:cellular response to ATP; P:cellular response to purine-containing compound; P:eating behavior; P:G protein-coupled adenosine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glial cell migration; P:negative regulation of binding; P:negative regulation of norepinephrine secretion; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of hormone secretion; P:positive regulation of inositol trisphosphate biosynthetic process; P:positive regulation of ion transport; P:positive regulation of penile erection; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to plasma membrane; P:regulation of cell shape; P:regulation of presynaptic cytosolic calcium ion concentration; P:regulation of signaling receptor activity; P:regulation of synaptic vesicle exocytosis; P:relaxation of muscle; P:response to growth factor; P:response to mechanical stimulus; P:sensory perception of pain; P:signal transduction involved in regulation of gene expression;|P47900,P2Y purinoceptor 1,ADP receptor {ECO:0000303|PubMed:9038354};Purinergic receptor;, PF00001;, GO:0016324;GO:0016323;GO:0044297;GO:0009986;GO:0005929;GO:0030425;GO:0098978;GO:0005887;GO:0099059;GO:0005739;GO:0005886;GO:0014069;GO:0045211;GO:0031686;GO:0043531;GO:0005524;GO:0001621;GO:0045031;GO:0045028;GO:0046982;GO:0097110;GO:0038023;GO:0007193;GO:0007568;GO:0097746;GO:0007166;GO:0071318;GO:0071415;GO:0042755;GO:0001973;GO:0007186;GO:0008347;GO:0051100;GO:0010700;GO:0007200;GO:0030168;GO:0007204;GO:0070374;GO:0046887;GO:0032962;GO:0043270;GO:0060406;GO:0001934;GO:0045944;GO:0072659;GO:0008360;GO:0099509;GO:0010469;GO:2000300;GO:0090075;GO:0070848;GO:0009612;GO:0019233;GO:0023019;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell body; C:cell surface; C:cilium; C:dendrite; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:mitochondrion; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:A1 adenosine receptor binding; F:ADP binding; F:ATP binding; F:G protein-coupled ADP receptor activity; F:G protein-coupled ATP receptor activity; F:G protein-coupled purinergic nucleotide receptor activity; F:protein heterodimerization activity; F:scaffold protein binding; F:signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:aging; P:blood vessel diameter maintenance; P:cell surface receptor signaling pathway; P:cellular response to ATP; P:cellular response to purine-containing compound; P:eating behavior; P:G protein-coupled adenosine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glial cell migration; P:negative regulation of binding; P:negative regulation of norepinephrine secretion; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of hormone secretion; P:positive regulation of inositol trisphosphate biosynthetic process; P:positive regulation of ion transport; P:positive regulation of penile erection; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to plasma membrane; P:regulation of cell shape; P:regulation of presynaptic cytosolic calcium ion concentration; P:regulation of signaling receptor activity; P:regulation of synaptic vesicle exocytosis; P:relaxation of muscle; P:response to growth factor; P:response to mechanical stimulus; P:sensory perception of pain; P:signal transduction involved in regulation of gene expression; scaffold13 indexed_genome mRNA 8439845 8579541 . + . ID=transcript_3358;Q9H9R2 Q9UFW5,Rho guanine nucleotide exchange factor 26,SH3 domain-containing guanine exchange factor;, PF00621;PF00018;, GO:0005829;GO:0001726;GO:0005085;GO:0090630;GO:0001886;GO:0007186;GO:0043065;GO:0051056;GO:0097178;, C:cytosol; C:ruffle;, F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:endothelial cell morphogenesis; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:ruffle assembly;|Q9H9R2 Q9UFW5,Rho guanine nucleotide exchange factor 26,SH3 domain-containing guanine exchange factor;, PF00621;PF00018;, GO:0005829;GO:0001726;GO:0005085;GO:0090630;GO:0001886;GO:0007186;GO:0043065;GO:0051056;GO:0097178;, C:cytosol; C:ruffle;, F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:endothelial cell morphogenesis; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:ruffle assembly;|Q9H9R2 Q9UFW5,Rho guanine nucleotide exchange factor 26,SH3 domain-containing guanine exchange factor;, PF00621;PF00018;, GO:0005829;GO:0001726;GO:0005085;GO:0090630;GO:0001886;GO:0007186;GO:0043065;GO:0051056;GO:0097178;, C:cytosol; C:ruffle;, F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:endothelial cell morphogenesis; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:ruffle assembly;|Q9H9R2 Q9UFW5,Rho guanine nucleotide exchange factor 26,SH3 domain-containing guanine exchange factor;, PF00621;PF00018;, GO:0005829;GO:0001726;GO:0005085;GO:0090630;GO:0001886;GO:0007186;GO:0043065;GO:0051056;GO:0097178;, C:cytosol; C:ruffle;, F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:endothelial cell morphogenesis; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:ruffle assembly;|Q9H9R2 Q9UFW5,Rho guanine nucleotide exchange factor 26,SH3 domain-containing guanine exchange factor;, PF00621;PF00018;, GO:0005829;GO:0001726;GO:0005085;GO:0090630;GO:0001886;GO:0007186;GO:0043065;GO:0051056;GO:0097178;, C:cytosol; C:ruffle;, F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:endothelial cell morphogenesis; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:ruffle assembly; scaffold13 indexed_genome mRNA 8588021 8633033 . - . ID=transcript_3359;Q9H2U1 B2RB00 Q70JU3 Q8IYE5 Q9P240,ATP-dependent DNA/RNA helicase DHX36 {ECO:0000305},DEAD/H box polypeptide 36 {ECO:0000303|PubMed:12198572};DEAH-box protein 36 {ECO:0000305};G4-resolvase-1 {ECO:0000303|PubMed:16150737};MLE-like protein 1 {ECO:0000303|PubMed:14731398};RNA helicase associated with AU-rich element protein {ECO:0000303|PubMed:14731398};, PF00270;PF04408;PF00271;PF07717;, GO:0030424;GO:0000781;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0070062;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0043204;GO:0005524;GO:0003678;GO:0008094;GO:0003725;GO:0051880;GO:0002151;GO:0042826;GO:0000287;GO:0035925;GO:0003730;GO:0048027;GO:0070883;GO:0003723;GO:0003724;GO:0000978;GO:0003697;GO:0070034;GO:0000976;GO:0061158;GO:1903843;GO:0034605;GO:0034644;GO:0051607;GO:0044806;GO:0045087;GO:0017148;GO:0001503;GO:0051891;GO:2000767;GO:0061003;GO:0010628;GO:1901534;GO:0043123;GO:0032727;GO:1904582;GO:0031442;GO:0002735;GO:1900153;GO:0032206;GO:1904358;GO:0045944;GO:0060261;GO:0032481;GO:0045995;GO:0043488;GO:0006359;GO:1902064;GO:0043330;GO:0010501;GO:0007283;GO:0090669;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:extracellular exosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded RNA binding; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:histone deacetylase binding; F:magnesium ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:pre-miRNA binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:telomerase RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to arsenite ion; P:cellular response to heat; P:cellular response to UV; P:defense response to virus; P:G-quadruplex DNA unwinding; P:innate immune response; P:negative regulation of translation; P:ossification; P:positive regulation of cardioblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of gene expression; P:positive regulation of hematopoietic progenitor cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of intracellular mRNA localization; P:positive regulation of mRNA 3'-end processing; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of type I interferon production; P:regulation of embryonic development; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase III; P:regulation of transcription from RNA polymerase II promoter involved in spermatogenesis; P:response to exogenous dsRNA; P:RNA secondary structure unwinding; P:spermatogenesis; P:telomerase RNA stabilization;|Q9H2U1 B2RB00 Q70JU3 Q8IYE5 Q9P240,ATP-dependent DNA/RNA helicase DHX36 {ECO:0000305},DEAD/H box polypeptide 36 {ECO:0000303|PubMed:12198572};DEAH-box protein 36 {ECO:0000305};G4-resolvase-1 {ECO:0000303|PubMed:16150737};MLE-like protein 1 {ECO:0000303|PubMed:14731398};RNA helicase associated with AU-rich element protein {ECO:0000303|PubMed:14731398};, PF00270;PF04408;PF00271;PF07717;, GO:0030424;GO:0000781;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0070062;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0043204;GO:0005524;GO:0003678;GO:0008094;GO:0003725;GO:0051880;GO:0002151;GO:0042826;GO:0000287;GO:0035925;GO:0003730;GO:0048027;GO:0070883;GO:0003723;GO:0003724;GO:0000978;GO:0003697;GO:0070034;GO:0000976;GO:0061158;GO:1903843;GO:0034605;GO:0034644;GO:0051607;GO:0044806;GO:0045087;GO:0017148;GO:0001503;GO:0051891;GO:2000767;GO:0061003;GO:0010628;GO:1901534;GO:0043123;GO:0032727;GO:1904582;GO:0031442;GO:0002735;GO:1900153;GO:0032206;GO:1904358;GO:0045944;GO:0060261;GO:0032481;GO:0045995;GO:0043488;GO:0006359;GO:1902064;GO:0043330;GO:0010501;GO:0007283;GO:0090669;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:extracellular exosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded RNA binding; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:histone deacetylase binding; F:magnesium ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:pre-miRNA binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:telomerase RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to arsenite ion; P:cellular response to heat; P:cellular response to UV; P:defense response to virus; P:G-quadruplex DNA unwinding; P:innate immune response; P:negative regulation of translation; P:ossification; P:positive regulation of cardioblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of gene expression; P:positive regulation of hematopoietic progenitor cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of intracellular mRNA localization; P:positive regulation of mRNA 3'-end processing; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of type I interferon production; P:regulation of embryonic development; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase III; P:regulation of transcription from RNA polymerase II promoter involved in spermatogenesis; P:response to exogenous dsRNA; P:RNA secondary structure unwinding; P:spermatogenesis; P:telomerase RNA stabilization;|Q9H2U1 B2RB00 Q70JU3 Q8IYE5 Q9P240,ATP-dependent DNA/RNA helicase DHX36 {ECO:0000305},DEAD/H box polypeptide 36 {ECO:0000303|PubMed:12198572};DEAH-box protein 36 {ECO:0000305};G4-resolvase-1 {ECO:0000303|PubMed:16150737};MLE-like protein 1 {ECO:0000303|PubMed:14731398};RNA helicase associated with AU-rich element protein {ECO:0000303|PubMed:14731398};, PF00270;PF04408;PF00271;PF07717;, GO:0030424;GO:0000781;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0070062;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0043204;GO:0005524;GO:0003678;GO:0008094;GO:0003725;GO:0051880;GO:0002151;GO:0042826;GO:0000287;GO:0035925;GO:0003730;GO:0048027;GO:0070883;GO:0003723;GO:0003724;GO:0000978;GO:0003697;GO:0070034;GO:0000976;GO:0061158;GO:1903843;GO:0034605;GO:0034644;GO:0051607;GO:0044806;GO:0045087;GO:0017148;GO:0001503;GO:0051891;GO:2000767;GO:0061003;GO:0010628;GO:1901534;GO:0043123;GO:0032727;GO:1904582;GO:0031442;GO:0002735;GO:1900153;GO:0032206;GO:1904358;GO:0045944;GO:0060261;GO:0032481;GO:0045995;GO:0043488;GO:0006359;GO:1902064;GO:0043330;GO:0010501;GO:0007283;GO:0090669;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:extracellular exosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded RNA binding; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:histone deacetylase binding; F:magnesium ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:pre-miRNA binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:telomerase RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to arsenite ion; P:cellular response to heat; P:cellular response to UV; P:defense response to virus; P:G-quadruplex DNA unwinding; P:innate immune response; P:negative regulation of translation; P:ossification; P:positive regulation of cardioblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of gene expression; P:positive regulation of hematopoietic progenitor cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of intracellular mRNA localization; P:positive regulation of mRNA 3'-end processing; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of type I interferon production; P:regulation of embryonic development; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase III; P:regulation of transcription from RNA polymerase II promoter involved in spermatogenesis; P:response to exogenous dsRNA; P:RNA secondary structure unwinding; P:spermatogenesis; P:telomerase RNA stabilization;|Q9H2U1 B2RB00 Q70JU3 Q8IYE5 Q9P240,ATP-dependent DNA/RNA helicase DHX36 {ECO:0000305},DEAD/H box polypeptide 36 {ECO:0000303|PubMed:12198572};DEAH-box protein 36 {ECO:0000305};G4-resolvase-1 {ECO:0000303|PubMed:16150737};MLE-like protein 1 {ECO:0000303|PubMed:14731398};RNA helicase associated with AU-rich element protein {ECO:0000303|PubMed:14731398};, PF00270;PF04408;PF00271;PF07717;, GO:0030424;GO:0000781;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0070062;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0043204;GO:0005524;GO:0003678;GO:0008094;GO:0003725;GO:0051880;GO:0002151;GO:0042826;GO:0000287;GO:0035925;GO:0003730;GO:0048027;GO:0070883;GO:0003723;GO:0003724;GO:0000978;GO:0003697;GO:0070034;GO:0000976;GO:0061158;GO:1903843;GO:0034605;GO:0034644;GO:0051607;GO:0044806;GO:0045087;GO:0017148;GO:0001503;GO:0051891;GO:2000767;GO:0061003;GO:0010628;GO:1901534;GO:0043123;GO:0032727;GO:1904582;GO:0031442;GO:0002735;GO:1900153;GO:0032206;GO:1904358;GO:0045944;GO:0060261;GO:0032481;GO:0045995;GO:0043488;GO:0006359;GO:1902064;GO:0043330;GO:0010501;GO:0007283;GO:0090669;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:extracellular exosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded RNA binding; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:histone deacetylase binding; F:magnesium ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:pre-miRNA binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:telomerase RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to arsenite ion; P:cellular response to heat; P:cellular response to UV; P:defense response to virus; P:G-quadruplex DNA unwinding; P:innate immune response; P:negative regulation of translation; P:ossification; P:positive regulation of cardioblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of gene expression; P:positive regulation of hematopoietic progenitor cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of intracellular mRNA localization; P:positive regulation of mRNA 3'-end processing; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of type I interferon production; P:regulation of embryonic development; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase III; P:regulation of transcription from RNA polymerase II promoter involved in spermatogenesis; P:response to exogenous dsRNA; P:RNA secondary structure unwinding; P:spermatogenesis; P:telomerase RNA stabilization;|Q9H2U1 B2RB00 Q70JU3 Q8IYE5 Q9P240,ATP-dependent DNA/RNA helicase DHX36 {ECO:0000305},DEAD/H box polypeptide 36 {ECO:0000303|PubMed:12198572};DEAH-box protein 36 {ECO:0000305};G4-resolvase-1 {ECO:0000303|PubMed:16150737};MLE-like protein 1 {ECO:0000303|PubMed:14731398};RNA helicase associated with AU-rich element protein {ECO:0000303|PubMed:14731398};, PF00270;PF04408;PF00271;PF07717;, GO:0030424;GO:0000781;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0070062;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0043204;GO:0005524;GO:0003678;GO:0008094;GO:0003725;GO:0051880;GO:0002151;GO:0042826;GO:0000287;GO:0035925;GO:0003730;GO:0048027;GO:0070883;GO:0003723;GO:0003724;GO:0000978;GO:0003697;GO:0070034;GO:0000976;GO:0061158;GO:1903843;GO:0034605;GO:0034644;GO:0051607;GO:0044806;GO:0045087;GO:0017148;GO:0001503;GO:0051891;GO:2000767;GO:0061003;GO:0010628;GO:1901534;GO:0043123;GO:0032727;GO:1904582;GO:0031442;GO:0002735;GO:1900153;GO:0032206;GO:1904358;GO:0045944;GO:0060261;GO:0032481;GO:0045995;GO:0043488;GO:0006359;GO:1902064;GO:0043330;GO:0010501;GO:0007283;GO:0090669;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:extracellular exosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded RNA binding; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:histone deacetylase binding; F:magnesium ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:pre-miRNA binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:telomerase RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to arsenite ion; P:cellular response to heat; P:cellular response to UV; P:defense response to virus; P:G-quadruplex DNA unwinding; P:innate immune response; P:negative regulation of translation; P:ossification; P:positive regulation of cardioblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of gene expression; P:positive regulation of hematopoietic progenitor cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of intracellular mRNA localization; P:positive regulation of mRNA 3'-end processing; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of type I interferon production; P:regulation of embryonic development; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase III; P:regulation of transcription from RNA polymerase II promoter involved in spermatogenesis; P:response to exogenous dsRNA; P:RNA secondary structure unwinding; P:spermatogenesis; P:telomerase RNA stabilization;|Q9H2U1 B2RB00 Q70JU3 Q8IYE5 Q9P240,ATP-dependent DNA/RNA helicase DHX36 {ECO:0000305},DEAD/H box polypeptide 36 {ECO:0000303|PubMed:12198572};DEAH-box protein 36 {ECO:0000305};G4-resolvase-1 {ECO:0000303|PubMed:16150737};MLE-like protein 1 {ECO:0000303|PubMed:14731398};RNA helicase associated with AU-rich element protein {ECO:0000303|PubMed:14731398};, PF00270;PF04408;PF00271;PF07717;, GO:0030424;GO:0000781;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0070062;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0043204;GO:0005524;GO:0003678;GO:0008094;GO:0003725;GO:0051880;GO:0002151;GO:0042826;GO:0000287;GO:0035925;GO:0003730;GO:0048027;GO:0070883;GO:0003723;GO:0003724;GO:0000978;GO:0003697;GO:0070034;GO:0000976;GO:0061158;GO:1903843;GO:0034605;GO:0034644;GO:0051607;GO:0044806;GO:0045087;GO:0017148;GO:0001503;GO:0051891;GO:2000767;GO:0061003;GO:0010628;GO:1901534;GO:0043123;GO:0032727;GO:1904582;GO:0031442;GO:0002735;GO:1900153;GO:0032206;GO:1904358;GO:0045944;GO:0060261;GO:0032481;GO:0045995;GO:0043488;GO:0006359;GO:1902064;GO:0043330;GO:0010501;GO:0007283;GO:0090669;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:extracellular exosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded RNA binding; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:histone deacetylase binding; F:magnesium ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:pre-miRNA binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:telomerase RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to arsenite ion; P:cellular response to heat; P:cellular response to UV; P:defense response to virus; P:G-quadruplex DNA unwinding; P:innate immune response; P:negative regulation of translation; P:ossification; P:positive regulation of cardioblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of gene expression; P:positive regulation of hematopoietic progenitor cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of intracellular mRNA localization; P:positive regulation of mRNA 3'-end processing; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of type I interferon production; P:regulation of embryonic development; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase III; P:regulation of transcription from RNA polymerase II promoter involved in spermatogenesis; P:response to exogenous dsRNA; P:RNA secondary structure unwinding; P:spermatogenesis; P:telomerase RNA stabilization;|Q9H2U1 B2RB00 Q70JU3 Q8IYE5 Q9P240,ATP-dependent DNA/RNA helicase DHX36 {ECO:0000305},DEAD/H box polypeptide 36 {ECO:0000303|PubMed:12198572};DEAH-box protein 36 {ECO:0000305};G4-resolvase-1 {ECO:0000303|PubMed:16150737};MLE-like protein 1 {ECO:0000303|PubMed:14731398};RNA helicase associated with AU-rich element protein {ECO:0000303|PubMed:14731398};, PF00270;PF04408;PF00271;PF07717;, GO:0030424;GO:0000781;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0070062;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0043204;GO:0005524;GO:0003678;GO:0008094;GO:0003725;GO:0051880;GO:0002151;GO:0042826;GO:0000287;GO:0035925;GO:0003730;GO:0048027;GO:0070883;GO:0003723;GO:0003724;GO:0000978;GO:0003697;GO:0070034;GO:0000976;GO:0061158;GO:1903843;GO:0034605;GO:0034644;GO:0051607;GO:0044806;GO:0045087;GO:0017148;GO:0001503;GO:0051891;GO:2000767;GO:0061003;GO:0010628;GO:1901534;GO:0043123;GO:0032727;GO:1904582;GO:0031442;GO:0002735;GO:1900153;GO:0032206;GO:1904358;GO:0045944;GO:0060261;GO:0032481;GO:0045995;GO:0043488;GO:0006359;GO:1902064;GO:0043330;GO:0010501;GO:0007283;GO:0090669;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:extracellular exosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded RNA binding; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:histone deacetylase binding; F:magnesium ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:pre-miRNA binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:telomerase RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to arsenite ion; P:cellular response to heat; P:cellular response to UV; P:defense response to virus; P:G-quadruplex DNA unwinding; P:innate immune response; P:negative regulation of translation; P:ossification; P:positive regulation of cardioblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of gene expression; P:positive regulation of hematopoietic progenitor cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of intracellular mRNA localization; P:positive regulation of mRNA 3'-end processing; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of type I interferon production; P:regulation of embryonic development; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase III; P:regulation of transcription from RNA polymerase II promoter involved in spermatogenesis; P:response to exogenous dsRNA; P:RNA secondary structure unwinding; P:spermatogenesis; P:telomerase RNA stabilization;|Q9H2U1 B2RB00 Q70JU3 Q8IYE5 Q9P240,ATP-dependent DNA/RNA helicase DHX36 {ECO:0000305},DEAD/H box polypeptide 36 {ECO:0000303|PubMed:12198572};DEAH-box protein 36 {ECO:0000305};G4-resolvase-1 {ECO:0000303|PubMed:16150737};MLE-like protein 1 {ECO:0000303|PubMed:14731398};RNA helicase associated with AU-rich element protein {ECO:0000303|PubMed:14731398};, PF00270;PF04408;PF00271;PF07717;, GO:0030424;GO:0000781;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0070062;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0043204;GO:0005524;GO:0003678;GO:0008094;GO:0003725;GO:0051880;GO:0002151;GO:0042826;GO:0000287;GO:0035925;GO:0003730;GO:0048027;GO:0070883;GO:0003723;GO:0003724;GO:0000978;GO:0003697;GO:0070034;GO:0000976;GO:0061158;GO:1903843;GO:0034605;GO:0034644;GO:0051607;GO:0044806;GO:0045087;GO:0017148;GO:0001503;GO:0051891;GO:2000767;GO:0061003;GO:0010628;GO:1901534;GO:0043123;GO:0032727;GO:1904582;GO:0031442;GO:0002735;GO:1900153;GO:0032206;GO:1904358;GO:0045944;GO:0060261;GO:0032481;GO:0045995;GO:0043488;GO:0006359;GO:1902064;GO:0043330;GO:0010501;GO:0007283;GO:0090669;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:extracellular exosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded RNA binding; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:histone deacetylase binding; F:magnesium ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:pre-miRNA binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:telomerase RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to arsenite ion; P:cellular response to heat; P:cellular response to UV; P:defense response to virus; P:G-quadruplex DNA unwinding; P:innate immune response; P:negative regulation of translation; P:ossification; P:positive regulation of cardioblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of gene expression; P:positive regulation of hematopoietic progenitor cell differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of intracellular mRNA localization; P:positive regulation of mRNA 3'-end processing; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of type I interferon production; P:regulation of embryonic development; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase III; P:regulation of transcription from RNA polymerase II promoter involved in spermatogenesis; P:response to exogenous dsRNA; P:RNA secondary structure unwinding; P:spermatogenesis; P:telomerase RNA stabilization; scaffold13 indexed_genome mRNA 8638036 8640103 . - . ID=transcript_3360;Q86SP6,Probable G-protein coupled receptor 149,G-protein coupled receptor PGR10;, , GO:0005887;GO:0043005;GO:0004930;GO:0042923;GO:0042277;GO:0001547;GO:0060280;GO:0007218;GO:0001546;, C:integral component of plasma membrane; C:neuron projection;, F:G protein-coupled receptor activity; F:neuropeptide binding; F:peptide binding;, P:antral ovarian follicle growth; P:negative regulation of ovulation; P:neuropeptide signaling pathway; P:preantral ovarian follicle growth; scaffold13 indexed_genome mRNA 8709346 8716859 . - . ID=transcript_3361;Q86SP6,Probable G-protein coupled receptor 149,G-protein coupled receptor PGR10;, , GO:0005887;GO:0043005;GO:0004930;GO:0042923;GO:0042277;GO:0001547;GO:0060280;GO:0007218;GO:0001546;, C:integral component of plasma membrane; C:neuron projection;, F:G protein-coupled receptor activity; F:neuropeptide binding; F:peptide binding;, P:antral ovarian follicle growth; P:negative regulation of ovulation; P:neuropeptide signaling pathway; P:preantral ovarian follicle growth; scaffold13 indexed_genome mRNA 9333453 9440193 . + . ID=transcript_3362;P08473 A8K6U6 D3DNJ9 Q3MIX4,Neprilysin,Atriopeptidase;Common acute lymphocytic leukemia antigen;Enkephalinase;Neutral endopeptidase 24.11;Skin fibroblast elastase;, PF01431;PF05649;, GO:0030424;GO:0005903;GO:0009986;GO:0005737;GO:0031410;GO:0030425;GO:0005769;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0045121;GO:0044306;GO:0043025;GO:0005886;GO:0098793;GO:0030667;GO:0045202;GO:0008021;GO:0005802;GO:1901612;GO:0004175;GO:0008238;GO:0004222;GO:0008237;GO:0070012;GO:0042277;GO:0001786;GO:0042803;GO:0008270;GO:0007568;GO:0097242;GO:0150094;GO:0050435;GO:0002003;GO:0071345;GO:0071492;GO:0071493;GO:0046449;GO:0001822;GO:0007611;GO:0030324;GO:0061837;GO:0043312;GO:0006518;GO:0001890;GO:1900273;GO:0050769;GO:0016485;GO:0006508;GO:0090399;GO:0019233;, C:axon; C:brush border; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:early endosome; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:membrane raft; C:neuron projection terminus; C:neuronal cell body; C:plasma membrane; C:presynapse; C:secretory granule membrane; C:synapse; C:synaptic vesicle; C:trans-Golgi network;, F:cardiolipin binding; F:endopeptidase activity; F:exopeptidase activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:oligopeptidase activity; F:peptide binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:zinc ion binding;, P:aging; P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta metabolic process; P:angiotensin maturation; P:cellular response to cytokine stimulus; P:cellular response to UV-A; P:cellular response to UV-B; P:creatinine metabolic process; P:kidney development; P:learning or memory; P:lung development; P:neuropeptide processing; P:neutrophil degranulation; P:peptide metabolic process; P:placenta development; P:positive regulation of long-term synaptic potentiation; P:positive regulation of neurogenesis; P:protein processing; P:proteolysis; P:replicative senescence; P:sensory perception of pain; scaffold13 indexed_genome mRNA 9543803 9548630 . - . ID=transcript_3363;P0DN84 A0A1B0GTW0,Sarcoplasmic/endoplasmic reticulum calcium ATPase regulator DWORF {ECO:0000305},Dwarf open reading frame {ECO:0000303|PubMed:26816378};Small transmembrane regulator of ion transport 1 {ECO:0000312|HGNC:HGNC:52297};, , GO:0016021;GO:0033017;GO:0008047;GO:1902082;GO:1901894;GO:0031449;, C:integral component of membrane; C:sarcoplasmic reticulum membrane;, F:enzyme activator activity;, P:positive regulation of calcium ion import into sarcoplasmic reticulum; P:regulation of ATPase-coupled calcium transmembrane transporter activity; P:regulation of slow-twitch skeletal muscle fiber contraction; scaffold13 indexed_genome mRNA 9714854 9806351 . - . ID=transcript_3364;Q4KWH8 Q29RV9 Q4KWH9 Q68CN0 Q86XK4 Q9H9U2 Q9UPT3,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 {ECO:0000305},Phosphoinositide phospholipase C-eta-1;Phospholipase C-eta-1;Phospholipase C-like protein 3;, PF00168;PF09279;PF00388;PF00387;, GO:0005737;GO:0005829;GO:0043231;GO:0005886;GO:0005509;GO:0050429;GO:0004435;GO:0043647;GO:0016042;GO:0048015;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent phospholipase C activity; F:phosphatidylinositol phospholipase C activity;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol-mediated signaling;|Q4KWH8 Q29RV9 Q4KWH9 Q68CN0 Q86XK4 Q9H9U2 Q9UPT3,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 {ECO:0000305},Phosphoinositide phospholipase C-eta-1;Phospholipase C-eta-1;Phospholipase C-like protein 3;, PF00168;PF09279;PF00388;PF00387;, GO:0005737;GO:0005829;GO:0043231;GO:0005886;GO:0005509;GO:0050429;GO:0004435;GO:0043647;GO:0016042;GO:0048015;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent phospholipase C activity; F:phosphatidylinositol phospholipase C activity;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol-mediated signaling;|Q96PK6 B0LM41 B3KMN4 D6RGD8 O75932 Q2PYN1 Q53GV1 Q68DQ9 Q96PK5,RNA-binding protein 14,Paraspeckle protein 2;RNA-binding motif protein 14;RRM-containing coactivator activator/modulator;Synaptotagmin-interacting protein;, PF00076;, GO:0005737;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005667;GO:0003729;GO:0030374;GO:0003723;GO:0002218;GO:0098534;GO:0016575;GO:0045087;GO:0000398;GO:0046600;GO:0045944;GO:0009725;GO:0060395;, C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:transcription regulator complex;, F:mRNA binding; F:nuclear receptor coactivator activity; F:RNA binding;, P:activation of innate immune response; P:centriole assembly; P:histone deacetylation; P:innate immune response; P:mRNA splicing, via spliceosome; P:negative regulation of centriole replication; P:positive regulation of transcription by RNA polymerase II; P:response to hormone; P:SMAD protein signal transduction; scaffold13 indexed_genome mRNA 9963043 9981362 . - . ID=transcript_3365;Q6P1S2 A8K1H5 Q86YE6 Q8IXA7 Q96NB5,Protein C3orf33,Protein AC3-33;, , GO:0005615;GO:0016021;GO:0070373;GO:0051090;, C:extracellular space; C:integral component of membrane;, , P:negative regulation of ERK1 and ERK2 cascade; P:regulation of DNA-binding transcription factor activity; scaffold13 indexed_genome mRNA 10012830 10036558 . - . ID=transcript_3366;O00400 B2R5Q2 D3DNK4,Acetyl-coenzyme A transporter 1,Solute carrier family 33 member 1;, PF13000;, GO:0005789;GO:0000139;GO:0005887;GO:0016020;GO:0008521;GO:0015295;GO:0030509;GO:0060395;GO:0055085;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of plasma membrane; C:membrane;, F:acetyl-CoA transmembrane transporter activity; F:solute:proton symporter activity;, P:BMP signaling pathway; P:SMAD protein signal transduction; P:transmembrane transport;|O00400 B2R5Q2 D3DNK4,Acetyl-coenzyme A transporter 1,Solute carrier family 33 member 1;, PF13000;, GO:0005789;GO:0000139;GO:0005887;GO:0016020;GO:0008521;GO:0015295;GO:0030509;GO:0060395;GO:0055085;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of plasma membrane; C:membrane;, F:acetyl-CoA transmembrane transporter activity; F:solute:proton symporter activity;, P:BMP signaling pathway; P:SMAD protein signal transduction; P:transmembrane transport; scaffold13 indexed_genome mRNA 10091051 10091568 . - . ID=transcript_3367;P49915 A8K639 B4DXV7 F8W720,GMP synthase [glutamine-hydrolyzing],GMP synthetase;Glutamine amidotransferase;, PF00117;PF00958;PF02540;, GO:0005829;GO:0005524;GO:0003922;GO:0003921;GO:0016462;GO:0006541;GO:0006177;GO:0009113;GO:0009168;, C:cytosol;, F:ATP binding; F:GMP synthase (glutamine-hydrolyzing) activity; F:GMP synthase activity; F:pyrophosphatase activity;, P:glutamine metabolic process; P:GMP biosynthetic process; P:purine nucleobase biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; scaffold13 indexed_genome mRNA 10450170 10722556 . + . ID=transcript_3368;Q14722 A8K9H8 A8KAD4 B3KPZ4 Q13031 Q13302 Q16547 Q6PI60 Q99869,Voltage-gated potassium channel subunit beta-1,K(+) channel subunit beta-1;Kv-beta-1;, PF00248;, GO:0005829;GO:0032839;GO:0031234;GO:0044224;GO:0043204;GO:0005886;GO:0034705;GO:1990635;GO:0008076;GO:0004033;GO:0047834;GO:0044325;GO:0070402;GO:0015459;GO:0019904;GO:0005249;GO:0007420;GO:0060539;GO:0007507;GO:0045445;GO:1902260;GO:1903817;GO:0071805;GO:0006813;GO:1902259;GO:1901379;GO:0007519;, C:cytosol; C:dendrite cytoplasm; C:extrinsic component of cytoplasmic side of plasma membrane; C:juxtaparanode region of axon; C:perikaryon; C:plasma membrane; C:potassium channel complex; C:proximal dendrite; C:voltage-gated potassium channel complex;, F:aldo-keto reductase (NADP) activity; F:D-threo-aldose 1-dehydrogenase activity; F:ion channel binding; F:NADPH binding; F:potassium channel regulator activity; F:protein domain specific binding; F:voltage-gated potassium channel activity;, P:brain development; P:diaphragm development; P:heart development; P:myoblast differentiation; P:negative regulation of delayed rectifier potassium channel activity; P:negative regulation of voltage-gated potassium channel activity; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of delayed rectifier potassium channel activity; P:regulation of potassium ion transmembrane transport; P:skeletal muscle tissue development; scaffold13 indexed_genome mRNA 10724084 10735974 . - . ID=transcript_3369;Q9UNL2 B2R7D0 B4E2P2 D3DNK5 Q549M4,Translocon-associated protein subunit gamma,Signal sequence receptor subunit gamma;, PF07074;, GO:0005783;GO:0005789;GO:0016021;GO:0006614;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:SRP-dependent cotranslational protein targeting to membrane;|Q9UNL2 B2R7D0 B4E2P2 D3DNK5 Q549M4,Translocon-associated protein subunit gamma,Signal sequence receptor subunit gamma;, PF07074;, GO:0005783;GO:0005789;GO:0016021;GO:0006614;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:SRP-dependent cotranslational protein targeting to membrane;|Q9UNL2 B2R7D0 B4E2P2 D3DNK5 Q549M4,Translocon-associated protein subunit gamma,Signal sequence receptor subunit gamma;, PF07074;, GO:0005783;GO:0005789;GO:0016021;GO:0006614;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:SRP-dependent cotranslational protein targeting to membrane; scaffold13 indexed_genome mRNA 10862101 10885922 . + . ID=transcript_3370;Q7Z3E1 D3DNK6 Q68CY9 Q86VP4 Q9Y4P7,Protein mono-ADP-ribosyltransferase TIPARP {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 14 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 7 {ECO:0000303|PubMed:20106667};TCDD-inducible poly [ADP-ribose] polymerase {ECO:0000303|PubMed:12851707};, PF00644;, GO:0005634;GO:0000987;GO:0046872;GO:0003950;GO:1990404;GO:0008209;GO:0071407;GO:0008210;GO:0060325;GO:0008585;GO:0030097;GO:0001822;GO:0010629;GO:0048008;GO:0045732;GO:0009791;GO:0006471;GO:0070213;GO:0140289;GO:1904612;GO:0060021;GO:0048705;GO:0048745;GO:0001570;, C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:androgen metabolic process; P:cellular response to organic cyclic compound; P:estrogen metabolic process; P:face morphogenesis; P:female gonad development; P:hemopoiesis; P:kidney development; P:negative regulation of gene expression; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of protein catabolic process; P:post-embryonic development; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:roof of mouth development; P:skeletal system morphogenesis; P:smooth muscle tissue development; P:vasculogenesis;|Q7Z3E1 D3DNK6 Q68CY9 Q86VP4 Q9Y4P7,Protein mono-ADP-ribosyltransferase TIPARP {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 14 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 7 {ECO:0000303|PubMed:20106667};TCDD-inducible poly [ADP-ribose] polymerase {ECO:0000303|PubMed:12851707};, PF00644;, GO:0005634;GO:0000987;GO:0046872;GO:0003950;GO:1990404;GO:0008209;GO:0071407;GO:0008210;GO:0060325;GO:0008585;GO:0030097;GO:0001822;GO:0010629;GO:0048008;GO:0045732;GO:0009791;GO:0006471;GO:0070213;GO:0140289;GO:1904612;GO:0060021;GO:0048705;GO:0048745;GO:0001570;, C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:androgen metabolic process; P:cellular response to organic cyclic compound; P:estrogen metabolic process; P:face morphogenesis; P:female gonad development; P:hemopoiesis; P:kidney development; P:negative regulation of gene expression; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of protein catabolic process; P:post-embryonic development; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:roof of mouth development; P:skeletal system morphogenesis; P:smooth muscle tissue development; P:vasculogenesis;|Q7Z3E1 D3DNK6 Q68CY9 Q86VP4 Q9Y4P7,Protein mono-ADP-ribosyltransferase TIPARP {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 14 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 7 {ECO:0000303|PubMed:20106667};TCDD-inducible poly [ADP-ribose] polymerase {ECO:0000303|PubMed:12851707};, PF00644;, GO:0005634;GO:0000987;GO:0046872;GO:0003950;GO:1990404;GO:0008209;GO:0071407;GO:0008210;GO:0060325;GO:0008585;GO:0030097;GO:0001822;GO:0010629;GO:0048008;GO:0045732;GO:0009791;GO:0006471;GO:0070213;GO:0140289;GO:1904612;GO:0060021;GO:0048705;GO:0048745;GO:0001570;, C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:androgen metabolic process; P:cellular response to organic cyclic compound; P:estrogen metabolic process; P:face morphogenesis; P:female gonad development; P:hemopoiesis; P:kidney development; P:negative regulation of gene expression; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of protein catabolic process; P:post-embryonic development; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:roof of mouth development; P:skeletal system morphogenesis; P:smooth muscle tissue development; P:vasculogenesis; scaffold13 indexed_genome mRNA 10885941 10889415 . + . ID=transcript_3371;Q7Z3E1 D3DNK6 Q68CY9 Q86VP4 Q9Y4P7,Protein mono-ADP-ribosyltransferase TIPARP {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 14 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 7 {ECO:0000303|PubMed:20106667};TCDD-inducible poly [ADP-ribose] polymerase {ECO:0000303|PubMed:12851707};, PF00644;, GO:0005634;GO:0000987;GO:0046872;GO:0003950;GO:1990404;GO:0008209;GO:0071407;GO:0008210;GO:0060325;GO:0008585;GO:0030097;GO:0001822;GO:0010629;GO:0048008;GO:0045732;GO:0009791;GO:0006471;GO:0070213;GO:0140289;GO:1904612;GO:0060021;GO:0048705;GO:0048745;GO:0001570;, C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:androgen metabolic process; P:cellular response to organic cyclic compound; P:estrogen metabolic process; P:face morphogenesis; P:female gonad development; P:hemopoiesis; P:kidney development; P:negative regulation of gene expression; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of protein catabolic process; P:post-embryonic development; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:roof of mouth development; P:skeletal system morphogenesis; P:smooth muscle tissue development; P:vasculogenesis;|Q7Z3E1 D3DNK6 Q68CY9 Q86VP4 Q9Y4P7,Protein mono-ADP-ribosyltransferase TIPARP {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 14 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 7 {ECO:0000303|PubMed:20106667};TCDD-inducible poly [ADP-ribose] polymerase {ECO:0000303|PubMed:12851707};, PF00644;, GO:0005634;GO:0000987;GO:0046872;GO:0003950;GO:1990404;GO:0008209;GO:0071407;GO:0008210;GO:0060325;GO:0008585;GO:0030097;GO:0001822;GO:0010629;GO:0048008;GO:0045732;GO:0009791;GO:0006471;GO:0070213;GO:0140289;GO:1904612;GO:0060021;GO:0048705;GO:0048745;GO:0001570;, C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:androgen metabolic process; P:cellular response to organic cyclic compound; P:estrogen metabolic process; P:face morphogenesis; P:female gonad development; P:hemopoiesis; P:kidney development; P:negative regulation of gene expression; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of protein catabolic process; P:post-embryonic development; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:roof of mouth development; P:skeletal system morphogenesis; P:smooth muscle tissue development; P:vasculogenesis;|Q7Z3E1 D3DNK6 Q68CY9 Q86VP4 Q9Y4P7,Protein mono-ADP-ribosyltransferase TIPARP {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 14 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 7 {ECO:0000303|PubMed:20106667};TCDD-inducible poly [ADP-ribose] polymerase {ECO:0000303|PubMed:12851707};, PF00644;, GO:0005634;GO:0000987;GO:0046872;GO:0003950;GO:1990404;GO:0008209;GO:0071407;GO:0008210;GO:0060325;GO:0008585;GO:0030097;GO:0001822;GO:0010629;GO:0048008;GO:0045732;GO:0009791;GO:0006471;GO:0070213;GO:0140289;GO:1904612;GO:0060021;GO:0048705;GO:0048745;GO:0001570;, C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:androgen metabolic process; P:cellular response to organic cyclic compound; P:estrogen metabolic process; P:face morphogenesis; P:female gonad development; P:hemopoiesis; P:kidney development; P:negative regulation of gene expression; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of protein catabolic process; P:post-embryonic development; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:roof of mouth development; P:skeletal system morphogenesis; P:smooth muscle tissue development; P:vasculogenesis; scaffold13 indexed_genome mRNA 11116260 11237319 . + . ID=transcript_3372;Q6ZMV7,Leucine-, glutamate- and lysine-rich protein 1 scaffold13 indexed_genome mRNA 11296730 11309952 . - . ID=transcript_3373;Q9UK58 B3KMY3 C9JPL0 Q6NVY9 Q6UWS7 Q8NI48 Q96QT0 Q9NZF3,Cyclin-L1,, PF02984;PF00134;, GO:0016607;GO:0005634;GO:0016538;GO:0006357;GO:0006396;, C:nuclear speck; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II; P:RNA processing;|Q9UK58 B3KMY3 C9JPL0 Q6NVY9 Q6UWS7 Q8NI48 Q96QT0 Q9NZF3,Cyclin-L1,, PF02984;PF00134;, GO:0016607;GO:0005634;GO:0016538;GO:0006357;GO:0006396;, C:nuclear speck; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II; P:RNA processing;|Q9UK58 B3KMY3 C9JPL0 Q6NVY9 Q6UWS7 Q8NI48 Q96QT0 Q9NZF3,Cyclin-L1,, PF02984;PF00134;, GO:0016607;GO:0005634;GO:0016538;GO:0006357;GO:0006396;, C:nuclear speck; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II; P:RNA processing;|Q9UK58 B3KMY3 C9JPL0 Q6NVY9 Q6UWS7 Q8NI48 Q96QT0 Q9NZF3,Cyclin-L1,, PF02984;PF00134;, GO:0016607;GO:0005634;GO:0016538;GO:0006357;GO:0006396;, C:nuclear speck; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II; P:RNA processing; scaffold13 indexed_genome mRNA 11406411 11413175 . - . ID=transcript_3374;Q9C0H1 Q9H9Q7,Ventricular zone-expressed PH domain-containing protein homolog 1,Protein melted;, PF00169;, GO:0005886;GO:0010314;GO:0060392;GO:0030512;GO:0009966;, C:plasma membrane;, F:phosphatidylinositol-5-phosphate binding;, P:negative regulation of SMAD protein signal transduction; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of signal transduction;|Q9C0H1 Q9H9Q7,Ventricular zone-expressed PH domain-containing protein homolog 1,Protein melted;, PF00169;, GO:0005886;GO:0010314;GO:0060392;GO:0030512;GO:0009966;, C:plasma membrane;, F:phosphatidylinositol-5-phosphate binding;, P:negative regulation of SMAD protein signal transduction; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of signal transduction; scaffold13 indexed_genome mRNA 11457249 11566764 . - . ID=transcript_3375;Q9C0H1 Q9H9Q7,Ventricular zone-expressed PH domain-containing protein homolog 1,Protein melted;, PF00169;, GO:0005886;GO:0010314;GO:0060392;GO:0030512;GO:0009966;, C:plasma membrane;, F:phosphatidylinositol-5-phosphate binding;, P:negative regulation of SMAD protein signal transduction; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of signal transduction; scaffold13 indexed_genome mRNA 11574605 11580678 . + . ID=transcript_3376;P26022 B2R6T6 Q38M82,Pentraxin-related protein PTX3,Pentaxin-related protein PTX3;Tumor necrosis factor alpha-induced protein 5;Tumor necrosis factor-inducible gene 14 protein;, PF00354;, GO:0031012;GO:0005576;GO:0005615;GO:0035580;GO:1904724;GO:0001872;GO:0001849;GO:0042802;GO:0046790;GO:0030198;GO:0006954;GO:0045087;GO:0044869;GO:0044871;GO:0044793;GO:1903016;GO:1903019;GO:0046597;GO:0043312;GO:0008228;GO:0001550;GO:0045429;GO:0050766;GO:0001878;, C:extracellular matrix; C:extracellular region; C:extracellular space; C:specific granule lumen; C:tertiary granule lumen;, F:(1->3)-beta-D-glucan binding; F:complement component C1q complex binding; F:identical protein binding; F:virion binding;, P:extracellular matrix organization; P:inflammatory response; P:innate immune response; P:negative regulation by host of viral exo-alpha-sialidase activity; P:negative regulation by host of viral glycoprotein metabolic process; P:negative regulation by host of viral process; P:negative regulation of exo-alpha-sialidase activity; P:negative regulation of glycoprotein metabolic process; P:negative regulation of viral entry into host cell; P:neutrophil degranulation; P:opsonization; P:ovarian cumulus expansion; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of phagocytosis; P:response to yeast; scaffold13 indexed_genome mRNA 11594429 11656993 . - . ID=transcript_3377;Q9C0H1 Q9H9Q7,Ventricular zone-expressed PH domain-containing protein homolog 1,Protein melted;, PF00169;, GO:0005886;GO:0010314;GO:0060392;GO:0030512;GO:0009966;, C:plasma membrane;, F:phosphatidylinositol-5-phosphate binding;, P:negative regulation of SMAD protein signal transduction; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of signal transduction; scaffold13 indexed_genome mRNA 11958342 12680329 . - . ID=transcript_3378;P58340 E9PEU9 Q2TLE3 Q2TLE5 Q8N8F8 Q96MH1,Myeloid leukemia factor 1,Myelodysplasia-myeloid leukemia factor 1;, PF10248;, GO:0036064;GO:0005929;GO:0005737;GO:0005634;GO:0003677;GO:0019904;GO:0007050;GO:0002318;GO:0006355;GO:0006351;, C:ciliary basal body; C:cilium; C:cytoplasm; C:nucleus;, F:DNA binding; F:protein domain specific binding;, P:cell cycle arrest; P:myeloid progenitor cell differentiation; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q96IZ7 A8K2R9 Q96QK2 Q9NZE5,Serine/Arginine-related protein 53,Arginine/serine-rich coiled-coil protein 1;, , GO:0005737;GO:0016607;GO:0005634;GO:0000380;GO:0000398;GO:0006913;GO:0006468;GO:0046677;GO:0008380;, C:cytoplasm; C:nuclear speck; C:nucleus;, , P:alternative mRNA splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:nucleocytoplasmic transport; P:protein phosphorylation; P:response to antibiotic; P:RNA splicing;|Q96IZ7 A8K2R9 Q96QK2 Q9NZE5,Serine/Arginine-related protein 53,Arginine/serine-rich coiled-coil protein 1;, , GO:0005737;GO:0016607;GO:0005634;GO:0000380;GO:0000398;GO:0006913;GO:0006468;GO:0046677;GO:0008380;, C:cytoplasm; C:nuclear speck; C:nucleus;, , P:alternative mRNA splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:nucleocytoplasmic transport; P:protein phosphorylation; P:response to antibiotic; P:RNA splicing;|P58340 E9PEU9 Q2TLE3 Q2TLE5 Q8N8F8 Q96MH1,Myeloid leukemia factor 1,Myelodysplasia-myeloid leukemia factor 1;, PF10248;, GO:0036064;GO:0005929;GO:0005737;GO:0005634;GO:0003677;GO:0019904;GO:0007050;GO:0002318;GO:0006355;GO:0006351;, C:ciliary basal body; C:cilium; C:cytoplasm; C:nucleus;, F:DNA binding; F:protein domain specific binding;, P:cell cycle arrest; P:myeloid progenitor cell differentiation; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated;|P58340 E9PEU9 Q2TLE3 Q2TLE5 Q8N8F8 Q96MH1,Myeloid leukemia factor 1,Myelodysplasia-myeloid leukemia factor 1;, PF10248;, GO:0036064;GO:0005929;GO:0005737;GO:0005634;GO:0003677;GO:0019904;GO:0007050;GO:0002318;GO:0006355;GO:0006351;, C:ciliary basal body; C:cilium; C:cytoplasm; C:nucleus;, F:DNA binding; F:protein domain specific binding;, P:cell cycle arrest; P:myeloid progenitor cell differentiation; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated;|P58340 E9PEU9 Q2TLE3 Q2TLE5 Q8N8F8 Q96MH1,Myeloid leukemia factor 1,Myelodysplasia-myeloid leukemia factor 1;, PF10248;, GO:0036064;GO:0005929;GO:0005737;GO:0005634;GO:0003677;GO:0019904;GO:0007050;GO:0002318;GO:0006355;GO:0006351;, C:ciliary basal body; C:cilium; C:cytoplasm; C:nucleus;, F:DNA binding; F:protein domain specific binding;, P:cell cycle arrest; P:myeloid progenitor cell differentiation; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold13 indexed_genome mRNA 12683384 12732976 . + . ID=transcript_3379;Q96RP9 A6NCI9 B2RCB9 B3KRW1 Q6GTN2 Q96T39,Elongation factor G, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03061},Elongation factor G 1, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03061};Elongation factor G1 {ECO:0000255|HAMAP-Rule:MF_03061};, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0003723;GO:0003746;GO:0070125;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation elongation factor activity;, P:mitochondrial translational elongation;|Q96RP9 A6NCI9 B2RCB9 B3KRW1 Q6GTN2 Q96T39,Elongation factor G, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03061},Elongation factor G 1, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03061};Elongation factor G1 {ECO:0000255|HAMAP-Rule:MF_03061};, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0003723;GO:0003746;GO:0070125;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation elongation factor activity;, P:mitochondrial translational elongation;|Q96RP9 A6NCI9 B2RCB9 B3KRW1 Q6GTN2 Q96T39,Elongation factor G, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03061},Elongation factor G 1, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03061};Elongation factor G1 {ECO:0000255|HAMAP-Rule:MF_03061};, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0003723;GO:0003746;GO:0070125;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation elongation factor activity;, P:mitochondrial translational elongation;|Q9BS40 Q96PN2 Q9NQS6,Latexin,Endogenous carboxypeptidase inhibitor;Protein MUM;Tissue carboxypeptidase inhibitor;, PF06907;, GO:0005737;GO:0005615;GO:0008201;GO:0008191;GO:0050965;GO:0006954;, C:cytoplasm; C:extracellular space;, F:heparin binding; F:metalloendopeptidase inhibitor activity;, P:detection of temperature stimulus involved in sensory perception of pain; P:inflammatory response;|Q9BS40 Q96PN2 Q9NQS6,Latexin,Endogenous carboxypeptidase inhibitor;Protein MUM;Tissue carboxypeptidase inhibitor;, PF06907;, GO:0005737;GO:0005615;GO:0008201;GO:0008191;GO:0050965;GO:0006954;, C:cytoplasm; C:extracellular space;, F:heparin binding; F:metalloendopeptidase inhibitor activity;, P:detection of temperature stimulus involved in sensory perception of pain; P:inflammatory response; scaffold13 indexed_genome mRNA 12734448 12752745 . - . ID=transcript_3380;P49788 Q8N1D7,Retinoic acid receptor responder protein 1,Phorbol ester-induced gene 1 protein;RAR-responsive protein TIG1;Tazarotene-induced gene 1 protein;, PF06907;, GO:0070062;GO:0005615;GO:0016021;GO:0008191;GO:0008285;, C:extracellular exosome; C:extracellular space; C:integral component of membrane;, F:metalloendopeptidase inhibitor activity;, P:negative regulation of cell population proliferation;|P49788 Q8N1D7,Retinoic acid receptor responder protein 1,Phorbol ester-induced gene 1 protein;RAR-responsive protein TIG1;Tazarotene-induced gene 1 protein;, PF06907;, GO:0070062;GO:0005615;GO:0016021;GO:0008191;GO:0008285;, C:extracellular exosome; C:extracellular space; C:integral component of membrane;, F:metalloendopeptidase inhibitor activity;, P:negative regulation of cell population proliferation; scaffold13 indexed_genome mRNA 12837476 12862164 . + . ID=transcript_3381;Q8IVS1 Q8IXG4 Q9H7X1,Major facilitator superfamily domain-containing protein 1,Smooth muscle cell-associated protein 4;, PF07690;, GO:0016021;GO:0005764;GO:0042803;GO:0022857;GO:0061462;GO:0050821;, C:integral component of membrane; C:lysosome;, F:protein homodimerization activity; F:transmembrane transporter activity;, P:protein localization to lysosome; P:protein stabilization; scaffold13 indexed_genome mRNA 13940889 13957466 . + . ID=transcript_3382;Q9P0W5,Schwannomin-interacting protein 1 {ECO:0000312|HGNC:HGNC:15678},, PF10148;, GO:0030054;GO:0005737;GO:0005886;GO:0042802;GO:0035332;, C:cell junction; C:cytoplasm; C:plasma membrane;, F:identical protein binding;, P:positive regulation of hippo signaling;|Q9P0W5,Schwannomin-interacting protein 1 {ECO:0000312|HGNC:HGNC:15678},, PF10148;, GO:0030054;GO:0005737;GO:0005886;GO:0042802;GO:0035332;, C:cell junction; C:cytoplasm; C:plasma membrane;, F:identical protein binding;, P:positive regulation of hippo signaling; scaffold13 indexed_genome mRNA 13977380 13990160 . + . ID=transcript_3383;Q9P0W5,Schwannomin-interacting protein 1 {ECO:0000312|HGNC:HGNC:15678},, PF10148;, GO:0030054;GO:0005737;GO:0005886;GO:0042802;GO:0035332;, C:cell junction; C:cytoplasm; C:plasma membrane;, F:identical protein binding;, P:positive regulation of hippo signaling;|Q9P0W5,Schwannomin-interacting protein 1 {ECO:0000312|HGNC:HGNC:15678},, PF10148;, GO:0030054;GO:0005737;GO:0005886;GO:0042802;GO:0035332;, C:cell junction; C:cytoplasm; C:plasma membrane;, F:identical protein binding;, P:positive regulation of hippo signaling;|Q9P0W5,Schwannomin-interacting protein 1 {ECO:0000312|HGNC:HGNC:15678},, PF10148;, GO:0030054;GO:0005737;GO:0005886;GO:0042802;GO:0035332;, C:cell junction; C:cytoplasm; C:plasma membrane;, F:identical protein binding;, P:positive regulation of hippo signaling;|Q9P0W5,Schwannomin-interacting protein 1 {ECO:0000312|HGNC:HGNC:15678},, PF10148;, GO:0030054;GO:0005737;GO:0005886;GO:0042802;GO:0035332;, C:cell junction; C:cytoplasm; C:plasma membrane;, F:identical protein binding;, P:positive regulation of hippo signaling; scaffold13 indexed_genome mRNA 14107560 14108237 . - . ID=transcript_3384;P29459 Q96QZ1,Interleukin-12 subunit alpha,Cytotoxic lymphocyte maturation factor 35 kDa subunit;IL-12 subunit p35;NK cell stimulatory factor chain 1;, PF03039;, GO:0005788;GO:0005576;GO:0005615;GO:0043514;GO:0031906;GO:0005125;GO:0008083;GO:0042163;GO:0005143;GO:0045513;GO:0046982;GO:0007050;GO:0016477;GO:0098586;GO:0019221;GO:0050830;GO:0097191;GO:0006955;GO:0035722;GO:0070757;GO:1903588;GO:0032700;GO:0050709;GO:0048662;GO:1900747;GO:0045785;GO:2000510;GO:0032729;GO:0050671;GO:0032946;GO:0032816;GO:0045954;GO:0002860;GO:0051135;GO:0034393;GO:0001916;GO:0042531;GO:0032496;GO:0010224;GO:0009615;GO:0016032;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:interleukin-12 complex; C:late endosome lumen;, F:cytokine activity; F:growth factor activity; F:interleukin-12 beta subunit binding; F:interleukin-12 receptor binding; F:interleukin-27 binding; F:protein heterodimerization activity;, P:cell cycle arrest; P:cell migration; P:cellular response to virus; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:extrinsic apoptotic signaling pathway; P:immune response; P:interleukin-12-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of interleukin-17 production; P:negative regulation of protein secretion; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of vascular endothelial growth factor signaling pathway; P:positive regulation of cell adhesion; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of interferon-gamma production; P:positive regulation of lymphocyte proliferation; P:positive regulation of mononuclear cell proliferation; P:positive regulation of natural killer cell activation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:positive regulation of NK T cell activation; P:positive regulation of smooth muscle cell apoptotic process; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:response to lipopolysaccharide; P:response to UV-B; P:response to virus; P:viral process; scaffold13 indexed_genome mRNA 14117372 14142168 . - . ID=transcript_3385;Q9Y2E0,NACHT, LRR and PYD domains-containing protein 1 {ECO:0000305},Caspase recruitment domain-containing protein 7;Death effector filament-forming ced-4-like apoptosis protein;Nucleotide-binding domain and caspase recruitment domain;, PF00619;PF13553;PF13516;PF05729;PF17776;PF17779;PF02758;, GO:0005829;GO:0061702;GO:0072558;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0008656;GO:0003690;GO:0003725;GO:0019899;GO:0019904;GO:0006919;GO:0140374;GO:0006915;GO:0042742;GO:0051607;GO:0006954;GO:0051402;GO:1904784;GO:0032731;GO:0070269;GO:0042981;GO:0050727;GO:0032495;GO:0097264;GO:0016032;, C:cytosol; C:inflammasome complex; C:NLRP1 inflammasome complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:double-stranded DNA binding; F:double-stranded RNA binding; F:enzyme binding; F:protein domain specific binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:antiviral innate immune response; P:apoptotic process; P:defense response to bacterium; P:defense response to virus; P:inflammatory response; P:neuron apoptotic process; P:NLRP1 inflammasome complex assembly; P:positive regulation of interleukin-1 beta production; P:pyroptosis; P:regulation of apoptotic process; P:regulation of inflammatory response; P:response to muramyl dipeptide; P:self proteolysis; P:viral process; scaffold13 indexed_genome mRNA 14322671 14435089 . - . ID=transcript_3386;Q9P2H3 B4E0K1 C9J8I0 Q3MJC4 Q86YF4 Q9UIX1,Intraflagellar transport protein 80 homolog,WD repeat-containing protein 56;, , GO:0097731;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0030992;GO:0061975;GO:0035630;GO:0060271;GO:0001958;GO:0003418;GO:0035735;GO:0060173;GO:0050680;GO:2000051;GO:1905515;GO:0001649;GO:0033687;GO:0097500;GO:0007224;, C:9+0 non-motile cilium; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle B;, , P:articular cartilage development; P:bone mineralization involved in bone maturation; P:cilium assembly; P:endochondral ossification; P:growth plate cartilage chondrocyte differentiation; P:intraciliary transport involved in cilium assembly; P:limb development; P:negative regulation of epithelial cell proliferation; P:negative regulation of non-canonical Wnt signaling pathway; P:non-motile cilium assembly; P:osteoblast differentiation; P:osteoblast proliferation; P:receptor localization to non-motile cilium; P:smoothened signaling pathway; scaffold13 indexed_genome mRNA 14448453 14496452 . + . ID=transcript_3387;Q9NTJ3 A6NLT9 D3DNL8 O95752 Q8NDL4 Q9UNT9,Structural maintenance of chromosomes protein 4,Chromosome-associated polypeptide C;XCAP-C homolog;, PF06470;PF02463;, GO:0000775;GO:0000796;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0003697;GO:0051301;GO:0051383;GO:0010032;GO:0045132;GO:0007076;GO:0000070;, C:chromosome, centromeric region; C:condensin complex; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:single-stranded DNA binding;, P:cell division; P:kinetochore organization; P:meiotic chromosome condensation; P:meiotic chromosome segregation; P:mitotic chromosome condensation; P:mitotic sister chromatid segregation;|Q9NTJ3 A6NLT9 D3DNL8 O95752 Q8NDL4 Q9UNT9,Structural maintenance of chromosomes protein 4,Chromosome-associated polypeptide C;XCAP-C homolog;, PF06470;PF02463;, GO:0000775;GO:0000796;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0003697;GO:0051301;GO:0051383;GO:0010032;GO:0045132;GO:0007076;GO:0000070;, C:chromosome, centromeric region; C:condensin complex; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:single-stranded DNA binding;, P:cell division; P:kinetochore organization; P:meiotic chromosome condensation; P:meiotic chromosome segregation; P:mitotic chromosome condensation; P:mitotic sister chromatid segregation;|Q9NTJ3 A6NLT9 D3DNL8 O95752 Q8NDL4 Q9UNT9,Structural maintenance of chromosomes protein 4,Chromosome-associated polypeptide C;XCAP-C homolog;, PF06470;PF02463;, GO:0000775;GO:0000796;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0003697;GO:0051301;GO:0051383;GO:0010032;GO:0045132;GO:0007076;GO:0000070;, C:chromosome, centromeric region; C:condensin complex; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:single-stranded DNA binding;, P:cell division; P:kinetochore organization; P:meiotic chromosome condensation; P:meiotic chromosome segregation; P:mitotic chromosome condensation; P:mitotic sister chromatid segregation;|Q9NTJ3 A6NLT9 D3DNL8 O95752 Q8NDL4 Q9UNT9,Structural maintenance of chromosomes protein 4,Chromosome-associated polypeptide C;XCAP-C homolog;, PF06470;PF02463;, GO:0000775;GO:0000796;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0003697;GO:0051301;GO:0051383;GO:0010032;GO:0045132;GO:0007076;GO:0000070;, C:chromosome, centromeric region; C:condensin complex; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:single-stranded DNA binding;, P:cell division; P:kinetochore organization; P:meiotic chromosome condensation; P:meiotic chromosome segregation; P:mitotic chromosome condensation; P:mitotic sister chromatid segregation;|Q8IWR1 A8K5G9 D3DNL9,Tripartite motif-containing protein 59,RING finger protein 104;Tumor suppressor TSBF-1;, PF00643;PF13445;, GO:0005783;GO:0005789;GO:0016021;GO:0061630;GO:0008270;GO:0045087;GO:0043124;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; scaffold13 indexed_genome mRNA 14540062 14610179 . - . ID=transcript_3388;O00629 A8K4S6 D3DNM2 O00190,Importin subunit alpha-3,Importin alpha Q1;Karyopherin subunit alpha-4;, PF00514;PF16186;PF01749;, GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0019054;GO:0006607;, C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus;|O00629 A8K4S6 D3DNM2 O00190,Importin subunit alpha-3,Importin alpha Q1;Karyopherin subunit alpha-4;, PF00514;PF16186;PF01749;, GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0019054;GO:0006607;, C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus;|O00629 A8K4S6 D3DNM2 O00190,Importin subunit alpha-3,Importin alpha Q1;Karyopherin subunit alpha-4;, PF00514;PF16186;PF01749;, GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0019054;GO:0006607;, C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus;|O00629 A8K4S6 D3DNM2 O00190,Importin subunit alpha-3,Importin alpha Q1;Karyopherin subunit alpha-4;, PF00514;PF16186;PF01749;, GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0019054;GO:0006607;, C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus;|O00629 A8K4S6 D3DNM2 O00190,Importin subunit alpha-3,Importin alpha Q1;Karyopherin subunit alpha-4;, PF00514;PF16186;PF01749;, GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0019054;GO:0006607;, C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; scaffold13 indexed_genome mRNA 14770567 15091234 . + . ID=transcript_3389;Q5SGD2 Q2M3J2 Q96NM7,Protein phosphatase 1L,Protein phosphatase 1-like;Protein phosphatase 2C isoform epsilon;, PF00481;, GO:0005789;GO:0070062;GO:0016021;GO:0004724;GO:0046872;GO:0106306;GO:0106307;GO:0000165;GO:0006470;GO:0030148;GO:0007178;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:MAPK cascade; P:protein dephosphorylation; P:sphingolipid biosynthetic process; P:transmembrane receptor protein serine/threonine kinase signaling pathway; scaffold13 indexed_genome mRNA 15112457 15115292 . - . ID=transcript_3390;O75752 D3DNM4 Q3Y531 Q6IAI5 Q8NFM8 Q8NFM9 Q9HA06,UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 {ECO:0000305},Beta-1,3-galactosyltransferase 3;Beta-3-Gx-T3;Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase;Globoside synthase;UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase;, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0047273;GO:0008532;GO:0008499;GO:0006687;GO:0009312;GO:0030311;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity;, P:glycosphingolipid metabolic process; P:oligosaccharide biosynthetic process; P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation; scaffold13 indexed_genome mRNA 15265321 15299787 . + . ID=transcript_3391;Q96D46 D3DNM7 Q9Y2Z6,60S ribosomal export protein NMD3,, PF04981;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030674;GO:0043023;GO:0003723;GO:0032092;GO:1904751;GO:1902680;GO:0000055;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein-macromolecule adaptor activity; F:ribosomal large subunit binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of protein localization to nucleolus; P:positive regulation of RNA biosynthetic process; P:ribosomal large subunit export from nucleus;|Q96D46 D3DNM7 Q9Y2Z6,60S ribosomal export protein NMD3,, PF04981;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030674;GO:0043023;GO:0003723;GO:0032092;GO:1904751;GO:1902680;GO:0000055;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein-macromolecule adaptor activity; F:ribosomal large subunit binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of protein localization to nucleolus; P:positive regulation of RNA biosynthetic process; P:ribosomal large subunit export from nucleus;|Q96D46 D3DNM7 Q9Y2Z6,60S ribosomal export protein NMD3,, PF04981;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030674;GO:0043023;GO:0003723;GO:0032092;GO:1904751;GO:1902680;GO:0000055;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein-macromolecule adaptor activity; F:ribosomal large subunit binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of protein localization to nucleolus; P:positive regulation of RNA biosynthetic process; P:ribosomal large subunit export from nucleus;|Q96D46 D3DNM7 Q9Y2Z6,60S ribosomal export protein NMD3,, PF04981;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030674;GO:0043023;GO:0003723;GO:0032092;GO:1904751;GO:1902680;GO:0000055;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein-macromolecule adaptor activity; F:ribosomal large subunit binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of protein localization to nucleolus; P:positive regulation of RNA biosynthetic process; P:ribosomal large subunit export from nucleus;|Q96D46 D3DNM7 Q9Y2Z6,60S ribosomal export protein NMD3,, PF04981;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030674;GO:0043023;GO:0003723;GO:0032092;GO:1904751;GO:1902680;GO:0000055;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein-macromolecule adaptor activity; F:ribosomal large subunit binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of protein localization to nucleolus; P:positive regulation of RNA biosynthetic process; P:ribosomal large subunit export from nucleus;|Q96D46 D3DNM7 Q9Y2Z6,60S ribosomal export protein NMD3,, PF04981;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030674;GO:0043023;GO:0003723;GO:0032092;GO:1904751;GO:1902680;GO:0000055;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein-macromolecule adaptor activity; F:ribosomal large subunit binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of protein localization to nucleolus; P:positive regulation of RNA biosynthetic process; P:ribosomal large subunit export from nucleus; scaffold13 indexed_genome mRNA 15400104 15428897 . - . ID=transcript_3392;Q8NFR3 B2R5D3 D3DNM8 Q0P5S6,Serine palmitoyltransferase small subunit B,Protein ADMP;Small subunit of serine palmitoyltransferase B;, PF11779;, GO:0005789;GO:0016021;GO:0017059;GO:0046513;GO:0007029;GO:1904220;GO:0030148;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:serine C-palmitoyltransferase complex;, , P:ceramide biosynthetic process; P:endoplasmic reticulum organization; P:regulation of serine C-palmitoyltransferase activity; P:sphingolipid biosynthetic process; scaffold13 indexed_genome mRNA 18738578 18739392 . + . ID=transcript_3393;O94933 Q1RMY6,SLIT and NTRK-like protein 3,, PF13855;, GO:0098982;GO:0099061;GO:0099060;GO:0005886;GO:0007409;GO:0051965;GO:1905606;GO:0099560;, C:GABA-ergic synapse; C:integral component of postsynaptic density membrane; C:integral component of postsynaptic specialization membrane; C:plasma membrane;, , P:axonogenesis; P:positive regulation of synapse assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; scaffold13 indexed_genome mRNA 18739489 18746707 . + . ID=transcript_3394;O94933 Q1RMY6,SLIT and NTRK-like protein 3,, PF13855;, GO:0098982;GO:0099061;GO:0099060;GO:0005886;GO:0007409;GO:0051965;GO:1905606;GO:0099560;, C:GABA-ergic synapse; C:integral component of postsynaptic density membrane; C:integral component of postsynaptic specialization membrane; C:plasma membrane;, , P:axonogenesis; P:positive regulation of synapse assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion;|O94933 Q1RMY6,SLIT and NTRK-like protein 3,, PF13855;, GO:0098982;GO:0099061;GO:0099060;GO:0005886;GO:0007409;GO:0051965;GO:1905606;GO:0099560;, C:GABA-ergic synapse; C:integral component of postsynaptic density membrane; C:integral component of postsynaptic specialization membrane; C:plasma membrane;, , P:axonogenesis; P:positive regulation of synapse assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; scaffold13 indexed_genome mRNA 19248381 19314772 . - . ID=transcript_3395;P06276 A8K7P8,Cholinesterase,Acylcholine acylhydrolase;Butyrylcholine esterase;Choline esterase II;Pseudocholinesterase;, PF08674;PF00135;, GO:0072562;GO:0005788;GO:0005576;GO:0016020;GO:0005641;GO:0003990;GO:0001540;GO:0003824;GO:0033265;GO:0004104;GO:0019899;GO:0042802;GO:0019695;GO:0050783;GO:0007612;GO:0008285;GO:0050805;GO:0014016;GO:0043279;GO:0042493;GO:0051593;GO:0051384;, C:blood microparticle; C:endoplasmic reticulum lumen; C:extracellular region; C:membrane; C:nuclear envelope lumen;, F:acetylcholinesterase activity; F:amyloid-beta binding; F:catalytic activity; F:choline binding; F:cholinesterase activity; F:enzyme binding; F:identical protein binding;, P:choline metabolic process; P:cocaine metabolic process; P:learning; P:negative regulation of cell population proliferation; P:negative regulation of synaptic transmission; P:neuroblast differentiation; P:response to alkaloid; P:response to drug; P:response to folic acid; P:response to glucocorticoid;|P06276 A8K7P8,Cholinesterase,Acylcholine acylhydrolase;Butyrylcholine esterase;Choline esterase II;Pseudocholinesterase;, PF08674;PF00135;, GO:0072562;GO:0005788;GO:0005576;GO:0016020;GO:0005641;GO:0003990;GO:0001540;GO:0003824;GO:0033265;GO:0004104;GO:0019899;GO:0042802;GO:0019695;GO:0050783;GO:0007612;GO:0008285;GO:0050805;GO:0014016;GO:0043279;GO:0042493;GO:0051593;GO:0051384;, C:blood microparticle; C:endoplasmic reticulum lumen; C:extracellular region; C:membrane; C:nuclear envelope lumen;, F:acetylcholinesterase activity; F:amyloid-beta binding; F:catalytic activity; F:choline binding; F:cholinesterase activity; F:enzyme binding; F:identical protein binding;, P:choline metabolic process; P:cocaine metabolic process; P:learning; P:negative regulation of cell population proliferation; P:negative regulation of synaptic transmission; P:neuroblast differentiation; P:response to alkaloid; P:response to drug; P:response to folic acid; P:response to glucocorticoid; scaffold13 indexed_genome mRNA 20676762 20681562 . - . ID=transcript_3396;O75830,Serpin I2,Myoepithelium-derived serine protease inhibitor;Pancpin;Pancreas-specific protein TSA2004;Peptidase inhibitor 14;, PF00079;, GO:0070062;GO:0005615;GO:0004867;GO:0010951;GO:0030155;, C:extracellular exosome; C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity; P:regulation of cell adhesion; scaffold13 indexed_genome mRNA 20687847 20703332 . - . ID=transcript_3397;O75830,Serpin I2,Myoepithelium-derived serine protease inhibitor;Pancpin;Pancreas-specific protein TSA2004;Peptidase inhibitor 14;, PF00079;, GO:0070062;GO:0005615;GO:0004867;GO:0010951;GO:0030155;, C:extracellular exosome; C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity; P:regulation of cell adhesion; scaffold13 indexed_genome mRNA 20708950 20709454 . + . ID=transcript_3398;O75830,Serpin I2,Myoepithelium-derived serine protease inhibitor;Pancpin;Pancreas-specific protein TSA2004;Peptidase inhibitor 14;, PF00079;, GO:0070062;GO:0005615;GO:0004867;GO:0010951;GO:0030155;, C:extracellular exosome; C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity; P:regulation of cell adhesion; scaffold13 indexed_genome mRNA 20846528 20883669 . - . ID=transcript_3399;A8MWE9,EF-hand calcium-binding domain-containing protein 8,, , GO:0005509;, , F:calcium ion binding; scaffold13 indexed_genome mRNA 20912129 20944554 . - . ID=transcript_3400;Q9BUL8 A8K515 D3DNN5 O14811,Programmed cell death protein 10,Cerebral cavernous malformations 3 protein;TF-1 cell apoptosis-related protein 15;, , GO:0005737;GO:0005829;GO:0070062;GO:0090443;GO:0005794;GO:0000139;GO:0005886;GO:0042803;GO:0019901;GO:0047485;GO:0001525;GO:1990830;GO:0051683;GO:0090168;GO:0036481;GO:0043066;GO:1903588;GO:0090051;GO:0010629;GO:0030335;GO:0008284;GO:0010628;GO:0090316;GO:0043406;GO:0045747;GO:0033138;GO:0071902;GO:0032874;GO:0050821;GO:1903358;GO:0042542;GO:0044319;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:FAR/SIN/STRIPAK complex; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:protein homodimerization activity; F:protein kinase binding; F:protein N-terminus binding;, P:angiogenesis; P:cellular response to leukemia inhibitory factor; P:establishment of Golgi localization; P:Golgi reassembly; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of apoptotic process; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of gene expression; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of intracellular protein transport; P:positive regulation of MAP kinase activity; P:positive regulation of Notch signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of stress-activated MAPK cascade; P:protein stabilization; P:regulation of Golgi organization; P:response to hydrogen peroxide; P:wound healing, spreading of cells;|Q9BUL8 A8K515 D3DNN5 O14811,Programmed cell death protein 10,Cerebral cavernous malformations 3 protein;TF-1 cell apoptosis-related protein 15;, , GO:0005737;GO:0005829;GO:0070062;GO:0090443;GO:0005794;GO:0000139;GO:0005886;GO:0042803;GO:0019901;GO:0047485;GO:0001525;GO:1990830;GO:0051683;GO:0090168;GO:0036481;GO:0043066;GO:1903588;GO:0090051;GO:0010629;GO:0030335;GO:0008284;GO:0010628;GO:0090316;GO:0043406;GO:0045747;GO:0033138;GO:0071902;GO:0032874;GO:0050821;GO:1903358;GO:0042542;GO:0044319;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:FAR/SIN/STRIPAK complex; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:protein homodimerization activity; F:protein kinase binding; F:protein N-terminus binding;, P:angiogenesis; P:cellular response to leukemia inhibitory factor; P:establishment of Golgi localization; P:Golgi reassembly; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of apoptotic process; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of gene expression; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of intracellular protein transport; P:positive regulation of MAP kinase activity; P:positive regulation of Notch signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of stress-activated MAPK cascade; P:protein stabilization; P:regulation of Golgi organization; P:response to hydrogen peroxide; P:wound healing, spreading of cells; scaffold13 indexed_genome mRNA 20956641 21029908 . + . ID=transcript_3401;Q99574 A8K217 D3DNP1 Q6AHZ4,Neuroserpin,Peptidase inhibitor 12;Serpin I1;, PF00079;, GO:0060205;GO:0070062;GO:0005615;GO:0043025;GO:0043204;GO:0034774;GO:0004867;GO:0007417;GO:0010951;GO:0007422;GO:0010976;GO:0030155;, C:cytoplasmic vesicle lumen; C:extracellular exosome; C:extracellular space; C:neuronal cell body; C:perikaryon; C:secretory granule lumen;, F:serine-type endopeptidase inhibitor activity;, P:central nervous system development; P:negative regulation of endopeptidase activity; P:peripheral nervous system development; P:positive regulation of neuron projection development; P:regulation of cell adhesion; scaffold13 indexed_genome mRNA 21219834 21297517 . - . ID=transcript_3402;O00461,Golgi integral membrane protein 4,Golgi integral membrane protein, cis;Golgi phosphoprotein 4;Golgi-localized phosphoprotein of 130 kDa;, , GO:0005801;GO:0030139;GO:0010008;GO:0005794;GO:0032580;GO:0005796;GO:0000139;GO:0016021;GO:0016020;GO:0030133;, C:cis-Golgi network; C:endocytic vesicle; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi lumen; C:Golgi membrane; C:integral component of membrane; C:membrane; C:transport vesicle;|O00461,Golgi integral membrane protein 4,Golgi integral membrane protein, cis;Golgi phosphoprotein 4;Golgi-localized phosphoprotein of 130 kDa;, , GO:0005801;GO:0030139;GO:0010008;GO:0005794;GO:0032580;GO:0005796;GO:0000139;GO:0016021;GO:0016020;GO:0030133;, C:cis-Golgi network; C:endocytic vesicle; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi lumen; C:Golgi membrane; C:integral component of membrane; C:membrane; C:transport vesicle;|O00461,Golgi integral membrane protein 4,Golgi integral membrane protein, cis;Golgi phosphoprotein 4;Golgi-localized phosphoprotein of 130 kDa;, , GO:0005801;GO:0030139;GO:0010008;GO:0005794;GO:0032580;GO:0005796;GO:0000139;GO:0016021;GO:0016020;GO:0030133;, C:cis-Golgi network; C:endocytic vesicle; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi lumen; C:Golgi membrane; C:integral component of membrane; C:membrane; C:transport vesicle;|O00461,Golgi integral membrane protein 4,Golgi integral membrane protein, cis;Golgi phosphoprotein 4;Golgi-localized phosphoprotein of 130 kDa;, , GO:0005801;GO:0030139;GO:0010008;GO:0005794;GO:0032580;GO:0005796;GO:0000139;GO:0016021;GO:0016020;GO:0030133;, C:cis-Golgi network; C:endocytic vesicle; C:endosome membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi lumen; C:Golgi membrane; C:integral component of membrane; C:membrane; C:transport vesicle; scaffold13 indexed_genome mRNA 21967008 22059757 . + . ID=transcript_3403;O75095 Q4AC86 Q5VV39,Multiple epidermal growth factor-like domains protein 6,Epidermal growth factor-like protein 3;, PF07645;PF12661;PF00053;, GO:0005576;GO:0005509;, C:extracellular region;, F:calcium ion binding; scaffold13 indexed_genome mRNA 22234229 22283701 . - . ID=transcript_3404;Q13465 Q13466 Q16122 Q5HYI1 Q6FH90 Q6MZS6 Q8NEI5 Q99917,Histone-lysine N-methyltransferase MECOM {ECO:0000305},Ecotropic virus integration site 1 protein homolog;MDS1 and EVI1 complex locus protein {ECO:0000305};Myelodysplasia syndrome 1 protein;Myelodysplasia syndrome-associated protein 1;, PF00096;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0046974;GO:0046872;GO:0042803;GO:0000978;GO:0006915;GO:0030154;GO:0071425;GO:0070828;GO:0046329;GO:0043069;GO:0045892;GO:0045893;GO:0051726;GO:0006357;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cell differentiation; P:hematopoietic stem cell proliferation; P:heterochromatin organization; P:negative regulation of JNK cascade; P:negative regulation of programmed cell death; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; scaffold13 indexed_genome mRNA 22917046 22919023 . - . ID=transcript_3405;Q9BYD9 Q96IS0 Q96NJ0,Actin-related protein T3,Actin-related protein M1;, PF00022;, GO:0005737;GO:0005856;GO:0005634;, C:cytoplasm; C:cytoskeleton; C:nucleus; scaffold13 indexed_genome mRNA 22922444 22933649 . + . ID=transcript_3406;Q86Z11 Q86Z12 Q9NS01 Q9UIW8,Myoneurin,Zinc finger and BTB domain-containing protein 31;, PF00651;PF00096;, GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:1990830;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:regulation of transcription by RNA polymerase II;|Q86Z11 Q86Z12 Q9NS01 Q9UIW8,Myoneurin,Zinc finger and BTB domain-containing protein 31;, PF00651;PF00096;, GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:1990830;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:regulation of transcription by RNA polymerase II; scaffold13 indexed_genome mRNA 22933659 22939619 . + . ID=transcript_3407;Q86Z11 Q86Z12 Q9NS01 Q9UIW8,Myoneurin,Zinc finger and BTB domain-containing protein 31;, PF00651;PF00096;, GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:1990830;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:regulation of transcription by RNA polymerase II;|Q86Z11 Q86Z12 Q9NS01 Q9UIW8,Myoneurin,Zinc finger and BTB domain-containing protein 31;, PF00651;PF00096;, GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:1990830;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:regulation of transcription by RNA polymerase II; scaffold13 indexed_genome mRNA 22943447 22947664 . + . ID=transcript_3408;Q8IZ02 B4DEJ7 E9PBH2 G5E9T7,Leucine-rich repeat-containing protein 34,, PF13516;, GO:0005737;GO:0005730;GO:0030154;, C:cytoplasm; C:nucleolus;, , P:cell differentiation;|Q8IZ02 B4DEJ7 E9PBH2 G5E9T7,Leucine-rich repeat-containing protein 34,, PF13516;, GO:0005737;GO:0005730;GO:0030154;, C:cytoplasm; C:nucleolus;, , P:cell differentiation; scaffold13 indexed_genome mRNA 22948296 22963289 . - . ID=transcript_3409;Q8IZ02 B4DEJ7 E9PBH2 G5E9T7,Leucine-rich repeat-containing protein 34,, PF13516;, GO:0005737;GO:0005730;GO:0030154;, C:cytoplasm; C:nucleolus;, , P:cell differentiation;|Q8IZ02 B4DEJ7 E9PBH2 G5E9T7,Leucine-rich repeat-containing protein 34,, PF13516;, GO:0005737;GO:0005730;GO:0030154;, C:cytoplasm; C:nucleolus;, , P:cell differentiation; scaffold13 indexed_genome mRNA 22988892 23000786 . - . ID=transcript_3410;Q6UY01 B7ZL44 E5RJA9 Q17RA3 Q8N848 Q9H5N5 V9HW14,Leucine-rich repeat-containing protein 31,, PF13516; scaffold13 indexed_genome mRNA 23101341 23130721 . + . ID=transcript_3411;Q99442 D3DNQ0 O00682 O00729,Translocation protein SEC62,Translocation protein 1;, PF03839;, GO:0005783;GO:0030176;GO:0016021;GO:0016020;GO:0005791;GO:0038023;GO:0006613;GO:0006620;GO:0031204;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:rough endoplasmic reticulum;, F:signaling receptor activity;, P:cotranslational protein targeting to membrane; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation;|Q99442 D3DNQ0 O00682 O00729,Translocation protein SEC62,Translocation protein 1;, PF03839;, GO:0005783;GO:0030176;GO:0016021;GO:0016020;GO:0005791;GO:0038023;GO:0006613;GO:0006620;GO:0031204;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:rough endoplasmic reticulum;, F:signaling receptor activity;, P:cotranslational protein targeting to membrane; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; scaffold13 indexed_genome mRNA 23169510 23219171 . + . ID=transcript_3412;Q9UJ42 D3DNQ2,Probable G-protein coupled receptor 160,G-protein coupled receptor GPCR1;, , GO:0016021;GO:0005886;GO:0043235;GO:0004930;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:G protein-coupled receptor activity; scaffold13 indexed_genome mRNA 23227212 23298175 . - . ID=transcript_3413;Q8NDX5 A2RRP9 Q5HYF0 Q6NSG2 Q8NFT7 Q8NFZ1 Q8TBM2 Q9H971 Q9H9I4,Polyhomeotic-like protein 3,Early development regulatory protein 3;Homolog of polyhomeotic 3;, PF00536;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0008270;GO:0007275;GO:0070317;GO:0045892;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:zinc ion binding;, P:multicellular organism development; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated; scaffold13 indexed_genome mRNA 23332842 23403616 . + . ID=transcript_3414;P41743 D3DNQ4 Q8WW06,Protein kinase C iota type,Atypical protein kinase C-lambda/iota;nPKC-iota;, PF00130;PF00564;PF00069;PF00433;, GO:0016324;GO:0005923;GO:0031252;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0000139;GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0005886;GO:0098685;GO:0043220;GO:0005524;GO:0004698;GO:0046872;GO:0005543;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0007015;GO:0070830;GO:0016477;GO:0045216;GO:0032869;GO:0007010;GO:0035089;GO:0045197;GO:0042462;GO:0048194;GO:0035556;GO:0061024;GO:0043066;GO:0034351;GO:0043524;GO:0018105;GO:2000353;GO:0060252;GO:0046326;GO:0010976;GO:0051092;GO:0045747;GO:1903078;GO:0006468;GO:0006612;GO:0099072;GO:0070555;GO:0046903;GO:0016192;, C:apical plasma membrane; C:bicellular tight junction; C:cell leading edge; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:Golgi membrane; C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:plasma membrane; C:Schaffer collateral - CA1 synapse; C:Schmidt-Lanterman incisure;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:metal ion binding; F:phospholipid binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin filament organization; P:bicellular tight junction assembly; P:cell migration; P:cell-cell junction organization; P:cellular response to insulin stimulus; P:cytoskeleton organization; P:establishment of apical/basal cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:eye photoreceptor cell development; P:Golgi vesicle budding; P:intracellular signal transduction; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of glial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of glial cell proliferation; P:positive regulation of glucose import; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of Notch signaling pathway; P:positive regulation of protein localization to plasma membrane; P:protein phosphorylation; P:protein targeting to membrane; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:response to interleukin-1; P:secretion; P:vesicle-mediated transport;|P41743 D3DNQ4 Q8WW06,Protein kinase C iota type,Atypical protein kinase C-lambda/iota;nPKC-iota;, PF00130;PF00564;PF00069;PF00433;, GO:0016324;GO:0005923;GO:0031252;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0000139;GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0005886;GO:0098685;GO:0043220;GO:0005524;GO:0004698;GO:0046872;GO:0005543;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0007015;GO:0070830;GO:0016477;GO:0045216;GO:0032869;GO:0007010;GO:0035089;GO:0045197;GO:0042462;GO:0048194;GO:0035556;GO:0061024;GO:0043066;GO:0034351;GO:0043524;GO:0018105;GO:2000353;GO:0060252;GO:0046326;GO:0010976;GO:0051092;GO:0045747;GO:1903078;GO:0006468;GO:0006612;GO:0099072;GO:0070555;GO:0046903;GO:0016192;, C:apical plasma membrane; C:bicellular tight junction; C:cell leading edge; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:Golgi membrane; C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:plasma membrane; C:Schaffer collateral - CA1 synapse; C:Schmidt-Lanterman incisure;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:metal ion binding; F:phospholipid binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin filament organization; P:bicellular tight junction assembly; P:cell migration; P:cell-cell junction organization; P:cellular response to insulin stimulus; P:cytoskeleton organization; P:establishment of apical/basal cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:eye photoreceptor cell development; P:Golgi vesicle budding; P:intracellular signal transduction; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of glial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of glial cell proliferation; P:positive regulation of glucose import; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of Notch signaling pathway; P:positive regulation of protein localization to plasma membrane; P:protein phosphorylation; P:protein targeting to membrane; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:response to interleukin-1; P:secretion; P:vesicle-mediated transport;|P41743 D3DNQ4 Q8WW06,Protein kinase C iota type,Atypical protein kinase C-lambda/iota;nPKC-iota;, PF00130;PF00564;PF00069;PF00433;, GO:0016324;GO:0005923;GO:0031252;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0000139;GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0005886;GO:0098685;GO:0043220;GO:0005524;GO:0004698;GO:0046872;GO:0005543;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0007015;GO:0070830;GO:0016477;GO:0045216;GO:0032869;GO:0007010;GO:0035089;GO:0045197;GO:0042462;GO:0048194;GO:0035556;GO:0061024;GO:0043066;GO:0034351;GO:0043524;GO:0018105;GO:2000353;GO:0060252;GO:0046326;GO:0010976;GO:0051092;GO:0045747;GO:1903078;GO:0006468;GO:0006612;GO:0099072;GO:0070555;GO:0046903;GO:0016192;, C:apical plasma membrane; C:bicellular tight junction; C:cell leading edge; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:Golgi membrane; C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:plasma membrane; C:Schaffer collateral - CA1 synapse; C:Schmidt-Lanterman incisure;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:metal ion binding; F:phospholipid binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin filament organization; P:bicellular tight junction assembly; P:cell migration; P:cell-cell junction organization; P:cellular response to insulin stimulus; P:cytoskeleton organization; P:establishment of apical/basal cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:eye photoreceptor cell development; P:Golgi vesicle budding; P:intracellular signal transduction; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of glial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of glial cell proliferation; P:positive regulation of glucose import; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of Notch signaling pathway; P:positive regulation of protein localization to plasma membrane; P:protein phosphorylation; P:protein targeting to membrane; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:response to interleukin-1; P:secretion; P:vesicle-mediated transport;|P41743 D3DNQ4 Q8WW06,Protein kinase C iota type,Atypical protein kinase C-lambda/iota;nPKC-iota;, PF00130;PF00564;PF00069;PF00433;, GO:0016324;GO:0005923;GO:0031252;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0000139;GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0005886;GO:0098685;GO:0043220;GO:0005524;GO:0004698;GO:0046872;GO:0005543;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0007015;GO:0070830;GO:0016477;GO:0045216;GO:0032869;GO:0007010;GO:0035089;GO:0045197;GO:0042462;GO:0048194;GO:0035556;GO:0061024;GO:0043066;GO:0034351;GO:0043524;GO:0018105;GO:2000353;GO:0060252;GO:0046326;GO:0010976;GO:0051092;GO:0045747;GO:1903078;GO:0006468;GO:0006612;GO:0099072;GO:0070555;GO:0046903;GO:0016192;, C:apical plasma membrane; C:bicellular tight junction; C:cell leading edge; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:Golgi membrane; C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:plasma membrane; C:Schaffer collateral - CA1 synapse; C:Schmidt-Lanterman incisure;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:metal ion binding; F:phospholipid binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin filament organization; P:bicellular tight junction assembly; P:cell migration; P:cell-cell junction organization; P:cellular response to insulin stimulus; P:cytoskeleton organization; P:establishment of apical/basal cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:eye photoreceptor cell development; P:Golgi vesicle budding; P:intracellular signal transduction; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of glial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of glial cell proliferation; P:positive regulation of glucose import; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of Notch signaling pathway; P:positive regulation of protein localization to plasma membrane; P:protein phosphorylation; P:protein targeting to membrane; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:response to interleukin-1; P:secretion; P:vesicle-mediated transport; scaffold13 indexed_genome mRNA 23437489 23461976 . + . ID=transcript_3415;P12757 A6NGT1 B4DT50 O00464 P12756 Q07501,Ski-like protein,Ski-related oncogene;Ski-related protein;, PF08782;PF02437;, GO:0001669;GO:0005737;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0005667;GO:0003682;GO:0000981;GO:0001227;GO:0042802;GO:0019904;GO:0044877;GO:0000978;GO:0046332;GO:0001825;GO:0007050;GO:0070306;GO:0002260;GO:0030514;GO:0045596;GO:0000122;GO:0030512;GO:0050772;GO:1902043;GO:1902231;GO:0046677;GO:0034097;GO:0070848;GO:0007519;GO:0007283;GO:0007179;, C:acrosomal vesicle; C:cytoplasm; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex; C:transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein domain specific binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:SMAD binding;, P:blastocyst formation; P:cell cycle arrest; P:lens fiber cell differentiation; P:lymphocyte homeostasis; P:negative regulation of BMP signaling pathway; P:negative regulation of cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of axonogenesis; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:response to antibiotic; P:response to cytokine; P:response to growth factor; P:skeletal muscle tissue development; P:spermatogenesis; P:transforming growth factor beta receptor signaling pathway; scaffold13 indexed_genome mRNA 23479065 23493612 . + . ID=transcript_3416;O75508 B2R7C1 D3DNQ5 Q5U0P3,Claudin-11,Oligodendrocyte-specific protein;, PF00822;, GO:0030424;GO:0045178;GO:0005923;GO:0030054;GO:0016021;GO:0005811;GO:0005883;GO:0005886;GO:0070160;GO:0042802;GO:0005198;GO:0008366;GO:0070830;GO:0016338;GO:0007155;GO:0007283;GO:0120192;, C:axon; C:basal part of cell; C:bicellular tight junction; C:cell junction; C:integral component of membrane; C:lipid droplet; C:neurofilament; C:plasma membrane; C:tight junction;, F:identical protein binding; F:structural molecule activity;, P:axon ensheathment; P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:spermatogenesis; P:tight junction assembly; scaffold13 indexed_genome mRNA 23516918 23549168 . - . ID=transcript_3417;Q8TBB6 B3KV33 Q9HCF9,Probable cationic amino acid transporter,Solute carrier family 7 member 14;, PF13520;PF13906;, GO:0005829;GO:0016021;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0015171;GO:0006865;GO:0010923;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane;, F:amino acid transmembrane transporter activity;, P:amino acid transport; P:negative regulation of phosphatase activity; scaffold13 indexed_genome mRNA 23877011 23880441 . - . ID=transcript_3418;Q6P5R6 Q32Q77,60S ribosomal protein L22-like 1,Large ribosomal subunit protein eL22-like 1;, PF01776;, GO:0005840;GO:0003723;GO:0003735;GO:0002181;, C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation;|Q6P5R6 Q32Q77,60S ribosomal protein L22-like 1,Large ribosomal subunit protein eL22-like 1;, PF01776;, GO:0005840;GO:0003723;GO:0003735;GO:0002181;, C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; scaffold13 indexed_genome mRNA 23890716 23907895 . - . ID=transcript_3419;Q9GZV4 B2R4V5,Eukaryotic translation initiation factor 5A-2,Eukaryotic initiation factor 5A isoform 2;, PF01287;, GO:0005829;GO:0005789;GO:0043231;GO:0005643;GO:0043022;GO:0003746;GO:0051028;GO:0010509;GO:0008284;GO:0045901;GO:0045905;GO:0015031;GO:0007283;, C:cytosol; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:nuclear pore;, F:ribosome binding; F:translation elongation factor activity;, P:mRNA transport; P:polyamine homeostasis; P:positive regulation of cell population proliferation; P:positive regulation of translational elongation; P:positive regulation of translational termination; P:protein transport; P:spermatogenesis;|Q9GZV4 B2R4V5,Eukaryotic translation initiation factor 5A-2,Eukaryotic initiation factor 5A isoform 2;, PF01287;, GO:0005829;GO:0005789;GO:0043231;GO:0005643;GO:0043022;GO:0003746;GO:0051028;GO:0010509;GO:0008284;GO:0045901;GO:0045905;GO:0015031;GO:0007283;, C:cytosol; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:nuclear pore;, F:ribosome binding; F:translation elongation factor activity;, P:mRNA transport; P:polyamine homeostasis; P:positive regulation of cell population proliferation; P:positive regulation of translational elongation; P:positive regulation of translational termination; P:protein transport; P:spermatogenesis; scaffold13 indexed_genome mRNA 23952323 23988018 . - . ID=transcript_3420;P11168 A8K481 B2R936 B7Z547 F8W8V8 Q9UCW9,Solute carrier family 2, facilitated glucose transporter member 2 {ECO:0000305},Glucose transporter type 2, liver {ECO:0000303|PubMed:7593414};, PF00083;, GO:0016324;GO:0005903;GO:0005911;GO:0005737;GO:0005887;GO:0016020;GO:0005886;GO:0055056;GO:0033300;GO:0005353;GO:0005355;GO:0005975;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0106001;GO:0050796;, C:apical plasma membrane; C:brush border; C:cell-cell junction; C:cytoplasm; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:D-glucose transmembrane transporter activity; F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:intestinal hexose absorption; P:regulation of insulin secretion;|P11168 A8K481 B2R936 B7Z547 F8W8V8 Q9UCW9,Solute carrier family 2, facilitated glucose transporter member 2 {ECO:0000305},Glucose transporter type 2, liver {ECO:0000303|PubMed:7593414};, PF00083;, GO:0016324;GO:0005903;GO:0005911;GO:0005737;GO:0005887;GO:0016020;GO:0005886;GO:0055056;GO:0033300;GO:0005353;GO:0005355;GO:0005975;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0106001;GO:0050796;, C:apical plasma membrane; C:brush border; C:cell-cell junction; C:cytoplasm; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:D-glucose transmembrane transporter activity; F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:intestinal hexose absorption; P:regulation of insulin secretion; scaffold13 indexed_genome mRNA 24010871 24398868 . - . ID=transcript_3421;Q9UKE1 Q9UKE2 Q9UKE3 Q9UKE4,TRAF2 and NCK-interacting protein kinase,, PF00780;PF00069;, GO:0016324;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0098978;GO:0005654;GO:0005634;GO:0099092;GO:0098793;GO:0055037;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0007256;GO:0032147;GO:0007010;GO:0035556;GO:0000165;GO:0030033;GO:0048812;GO:0001934;GO:0046777;GO:0072659;GO:0006468;GO:0048814;GO:0031098;GO:0016055;, C:apical plasma membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynaptic density, intracellular component; C:presynapse; C:recycling endosome;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of JNKK activity; P:activation of protein kinase activity; P:cytoskeleton organization; P:intracellular signal transduction; P:MAPK cascade; P:microvillus assembly; P:neuron projection morphogenesis; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of dendrite morphogenesis; P:stress-activated protein kinase signaling cascade; P:Wnt signaling pathway;|Q9UKE1 Q9UKE2 Q9UKE3 Q9UKE4,TRAF2 and NCK-interacting protein kinase,, PF00780;PF00069;, GO:0016324;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0098978;GO:0005654;GO:0005634;GO:0099092;GO:0098793;GO:0055037;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0007256;GO:0032147;GO:0007010;GO:0035556;GO:0000165;GO:0030033;GO:0048812;GO:0001934;GO:0046777;GO:0072659;GO:0006468;GO:0048814;GO:0031098;GO:0016055;, C:apical plasma membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynaptic density, intracellular component; C:presynapse; C:recycling endosome;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of JNKK activity; P:activation of protein kinase activity; P:cytoskeleton organization; P:intracellular signal transduction; P:MAPK cascade; P:microvillus assembly; P:neuron projection morphogenesis; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of dendrite morphogenesis; P:stress-activated protein kinase signaling cascade; P:Wnt signaling pathway;|Q9UKE1 Q9UKE2 Q9UKE3 Q9UKE4,TRAF2 and NCK-interacting protein kinase,, PF00780;PF00069;, GO:0016324;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0098978;GO:0005654;GO:0005634;GO:0099092;GO:0098793;GO:0055037;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0007256;GO:0032147;GO:0007010;GO:0035556;GO:0000165;GO:0030033;GO:0048812;GO:0001934;GO:0046777;GO:0072659;GO:0006468;GO:0048814;GO:0031098;GO:0016055;, C:apical plasma membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynaptic density, intracellular component; C:presynapse; C:recycling endosome;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of JNKK activity; P:activation of protein kinase activity; P:cytoskeleton organization; P:intracellular signal transduction; P:MAPK cascade; P:microvillus assembly; P:neuron projection morphogenesis; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of dendrite morphogenesis; P:stress-activated protein kinase signaling cascade; P:Wnt signaling pathway;|Q9UKE1 Q9UKE2 Q9UKE3 Q9UKE4,TRAF2 and NCK-interacting protein kinase,, PF00780;PF00069;, GO:0016324;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0098978;GO:0005654;GO:0005634;GO:0099092;GO:0098793;GO:0055037;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0007256;GO:0032147;GO:0007010;GO:0035556;GO:0000165;GO:0030033;GO:0048812;GO:0001934;GO:0046777;GO:0072659;GO:0006468;GO:0048814;GO:0031098;GO:0016055;, C:apical plasma membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynaptic density, intracellular component; C:presynapse; C:recycling endosome;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of JNKK activity; P:activation of protein kinase activity; P:cytoskeleton organization; P:intracellular signal transduction; P:MAPK cascade; P:microvillus assembly; P:neuron projection morphogenesis; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of dendrite morphogenesis; P:stress-activated protein kinase signaling cascade; P:Wnt signaling pathway;|Q9UKE1 Q9UKE2 Q9UKE3 Q9UKE4,TRAF2 and NCK-interacting protein kinase,, PF00780;PF00069;, GO:0016324;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0098978;GO:0005654;GO:0005634;GO:0099092;GO:0098793;GO:0055037;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0007256;GO:0032147;GO:0007010;GO:0035556;GO:0000165;GO:0030033;GO:0048812;GO:0001934;GO:0046777;GO:0072659;GO:0006468;GO:0048814;GO:0031098;GO:0016055;, C:apical plasma membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynaptic density, intracellular component; C:presynapse; C:recycling endosome;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of JNKK activity; P:activation of protein kinase activity; P:cytoskeleton organization; P:intracellular signal transduction; P:MAPK cascade; P:microvillus assembly; P:neuron projection morphogenesis; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of dendrite morphogenesis; P:stress-activated protein kinase signaling cascade; P:Wnt signaling pathway; scaffold13 indexed_genome mRNA 24503751 24634671 . - . ID=transcript_3422;Q13393,Phospholipase D1 {ECO:0000305},Choline phosphatase 1;Phosphatidylcholine-hydrolyzing phospholipase D1;, PF00169;PF00614;PF13091;PF00787;, GO:0016324;GO:0098981;GO:0030139;GO:0005789;GO:0005768;GO:0005794;GO:0000139;GO:0031902;GO:0005765;GO:0016020;GO:0048471;GO:0005886;GO:0035579;GO:0070821;GO:0070290;GO:0035091;GO:0004630;GO:0048870;GO:0006935;GO:0048017;GO:0016042;GO:0043312;GO:0006654;GO:0045727;GO:0007265;GO:0032534;GO:0098693;GO:0007264;, C:apical plasma membrane; C:cholinergic synapse; C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:phosphatidylinositol binding; F:phospholipase D activity;, P:cell motility; P:chemotaxis; P:inositol lipid-mediated signaling; P:lipid catabolic process; P:neutrophil degranulation; P:phosphatidic acid biosynthetic process; P:positive regulation of translation; P:Ras protein signal transduction; P:regulation of microvillus assembly; P:regulation of synaptic vesicle cycle; P:small GTPase mediated signal transduction; scaffold13 indexed_genome mRNA 25107235 25267767 . + . ID=transcript_3423;Q8NBU7 Q96D78 Q9H5I7 Q9NSQ8,Fibronectin type III domain-containing protein 3B,Factor for adipocyte differentiation 104;HCV NS5A-binding protein 37;, PF00041;, GO:0016021;GO:0003723;, C:integral component of membrane;, F:RNA binding; scaffold13 indexed_genome mRNA 25348154 25348998 . - . ID=transcript_3424;Q92847 Q14D12 Q6ISR8 Q92848 Q96RJ7,Growth hormone secretagogue receptor type 1,GH-releasing peptide receptor;Ghrelin receptor;, PF00001;, GO:0009986;GO:0098978;GO:0099699;GO:0045121;GO:0043005;GO:0005886;GO:0098794;GO:0098685;GO:0004930;GO:0001616;GO:0016520;GO:0042802;GO:0017046;GO:0008154;GO:0008343;GO:0032869;GO:1990314;GO:0071222;GO:0097067;GO:0046697;GO:0007186;GO:0036321;GO:0030252;GO:0009755;GO:0007611;GO:0032099;GO:0050728;GO:0046676;GO:0032691;GO:0032715;GO:0090327;GO:2000110;GO:0010700;GO:0032720;GO:0032100;GO:1904000;GO:0045923;GO:0043568;GO:0040018;GO:0120058;GO:1904349;GO:1903672;GO:1905564;GO:0099170;GO:1905333;GO:0060123;GO:0043134;GO:0098696;GO:0099175;GO:0051963;GO:0051969;GO:0071548;GO:0032355;GO:0032354;GO:0032094;GO:0060416;GO:0009725;GO:1904008;GO:0007283;, C:cell surface; C:glutamatergic synapse; C:integral component of synaptic membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:postsynapse; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled receptor activity; F:growth hormone secretagogue receptor activity; F:growth hormone-releasing hormone receptor activity; F:identical protein binding; F:peptide hormone binding;, P:actin polymerization or depolymerization; P:adult feeding behavior; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to lipopolysaccharide; P:cellular response to thyroid hormone stimulus; P:decidualization; P:G protein-coupled receptor signaling pathway; P:ghrelin secretion; P:growth hormone secretion; P:hormone-mediated signaling pathway; P:learning or memory; P:negative regulation of appetite; P:negative regulation of inflammatory response; P:negative regulation of insulin secretion; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-6 production; P:negative regulation of locomotion involved in locomotory behavior; P:negative regulation of macrophage apoptotic process; P:negative regulation of norepinephrine secretion; P:negative regulation of tumor necrosis factor production; P:positive regulation of appetite; P:positive regulation of eating behavior; P:positive regulation of fatty acid metabolic process; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of multicellular organism growth; P:positive regulation of small intestinal transit; P:positive regulation of small intestine smooth muscle contraction; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial cell proliferation; P:postsynaptic modulation of chemical synaptic transmission; P:regulation of gastric motility; P:regulation of growth hormone secretion; P:regulation of hindgut contraction; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:regulation of postsynapse organization; P:regulation of synapse assembly; P:regulation of transmission of nerve impulse; P:response to dexamethasone; P:response to estradiol; P:response to follicle-stimulating hormone; P:response to food; P:response to growth hormone; P:response to hormone; P:response to monosodium glutamate; P:spermatogenesis; scaffold13 indexed_genome mRNA 25377298 25395614 . - . ID=transcript_3425;P50591 A1Y9B3,Tumor necrosis factor ligand superfamily member 10,Apo-2 ligand;TNF-related apoptosis-inducing ligand;, PF00229;, GO:0070062;GO:0005576;GO:0005887;GO:0005125;GO:0042802;GO:0005102;GO:0045569;GO:0005164;GO:0008270;GO:0006919;GO:0006915;GO:0007166;GO:0007267;GO:0006955;GO:0008584;GO:1902042;GO:0043065;GO:0043280;GO:2001238;GO:0043123;GO:0090200;GO:1902041;GO:0032868;GO:0007165;, C:extracellular exosome; C:extracellular region; C:integral component of plasma membrane;, F:cytokine activity; F:identical protein binding; F:signaling receptor binding; F:TRAIL binding; F:tumor necrosis factor receptor binding; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:immune response; P:male gonad development; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of release of cytochrome c from mitochondria; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:response to insulin; P:signal transduction;|P00414 Q14Y83,Cytochrome c oxidase subunit 3,Cytochrome c oxidase polypeptide III;, PF00510;, GO:0016021;GO:0005743;GO:0005739;GO:0045277;GO:0004129;GO:0009055;GO:0015453;GO:0009060;GO:0006123;GO:0008535;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:electron transfer activity; F:oxidoreduction-driven active transmembrane transporter activity;, P:aerobic respiration; P:mitochondrial electron transport, cytochrome c to oxygen; P:respiratory chain complex IV assembly; scaffold13 indexed_genome mRNA 25490865 25560210 . - . ID=transcript_3426;Q6PIU2 B7Z2K4 B7Z3A1 B7Z5U2 B7Z906 B7ZAW6 F5H7K4 Q86WZ1 Q9P2I4,Neutral cholesterol ester hydrolase 1,Arylacetamide deacetylase-like 1;, PF07859;, GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0052689;GO:0016787;GO:0046485;GO:0016042;GO:0034383;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:carboxylic ester hydrolase activity; F:hydrolase activity;, P:ether lipid metabolic process; P:lipid catabolic process; P:low-density lipoprotein particle clearance;|Q6PIU2 B7Z2K4 B7Z3A1 B7Z5U2 B7Z906 B7ZAW6 F5H7K4 Q86WZ1 Q9P2I4,Neutral cholesterol ester hydrolase 1,Arylacetamide deacetylase-like 1;, PF07859;, GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0052689;GO:0016787;GO:0046485;GO:0016042;GO:0034383;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:carboxylic ester hydrolase activity; F:hydrolase activity;, P:ether lipid metabolic process; P:lipid catabolic process; P:low-density lipoprotein particle clearance; scaffold13 indexed_genome mRNA 25608532 25658626 . + . ID=transcript_3427;Q9H8V3 Q0MT80 Q2M269 Q6U836 Q9NSV8 Q9NVW9,Protein ECT2,Epithelial cell-transforming sequence 2 oncogene;, PF00533;PF12738;PF00621;, GO:0005923;GO:0005938;GO:0005911;GO:0097149;GO:0032154;GO:0005737;GO:0005829;GO:0030496;GO:0072686;GO:0016604;GO:0005654;GO:0005634;GO:0005096;GO:0005085;GO:0042803;GO:0031267;GO:0090630;GO:0032147;GO:0070830;GO:0030154;GO:0000902;GO:0071277;GO:0070301;GO:0071479;GO:0007186;GO:0035556;GO:0000281;GO:0007399;GO:0043065;GO:0032467;GO:0043547;GO:0043123;GO:0045666;GO:0042307;GO:0051260;GO:0015031;GO:0051988;GO:2000431;GO:0045859;GO:0051056;, C:bicellular tight junction; C:cell cortex; C:cell-cell junction; C:centralspindlin complex; C:cleavage furrow; C:cytoplasm; C:cytosol; C:midbody; C:mitotic spindle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein homodimerization activity; F:small GTPase binding;, P:activation of GTPase activity; P:activation of protein kinase activity; P:bicellular tight junction assembly; P:cell differentiation; P:cell morphogenesis; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to ionizing radiation; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:mitotic cytokinesis; P:nervous system development; P:positive regulation of apoptotic process; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron differentiation; P:positive regulation of protein import into nucleus; P:protein homooligomerization; P:protein transport; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of cytokinesis, actomyosin contractile ring assembly; P:regulation of protein kinase activity; P:regulation of small GTPase mediated signal transduction; scaffold13 indexed_genome mRNA 25785632 25849249 . + . ID=transcript_3428;Q0R2V5 Q0R2V7 Q8NE67,Spermatogenesis-associated protein 16,Testis development protein NYD-SP12;, PF15015;, GO:0005794;GO:0030154;GO:0007275;GO:0007283;, C:Golgi apparatus;, , P:cell differentiation; P:multicellular organism development; P:spermatogenesis;|Q0R2V5 Q0R2V7 Q8NE67,Spermatogenesis-associated protein 16,Testis development protein NYD-SP12;, PF15015;, GO:0005794;GO:0030154;GO:0007275;GO:0007283;, C:Golgi apparatus;, , P:cell differentiation; P:multicellular organism development; P:spermatogenesis;|Q0R2V5 Q0R2V7 Q8NE67,Spermatogenesis-associated protein 16,Testis development protein NYD-SP12;, PF15015;, GO:0005794;GO:0030154;GO:0007275;GO:0007283;, C:Golgi apparatus;, , P:cell differentiation; P:multicellular organism development; P:spermatogenesis; scaffold13 indexed_genome mRNA 26389683 27104300 . + . ID=transcript_3429;Q8N2Q7 D2X2H5 Q9UPT2,Neuroligin-1,, PF00135;, GO:0098985;GO:0009986;GO:0030425;GO:0043198;GO:0043197;GO:0060076;GO:0009897;GO:0032433;GO:0005794;GO:0005887;GO:0099055;GO:0099060;GO:0017146;GO:0005886;GO:0098794;GO:0014069;GO:0098793;GO:0043235;GO:0089717;GO:0045202;GO:0043083;GO:0001540;GO:0050839;GO:0042802;GO:0042043;GO:0030165;GO:0044877;GO:0097110;GO:0038023;GO:0097113;GO:0016339;GO:0071277;GO:0007268;GO:0048789;GO:0045184;GO:1904861;GO:0007157;GO:0060291;GO:0050804;GO:0061002;GO:0007399;GO:0097115;GO:0007158;GO:0140058;GO:0031175;GO:0023041;GO:0097114;GO:0010841;GO:0060999;GO:2000463;GO:0051491;GO:1902533;GO:1905520;GO:1902474;GO:1900029;GO:0051965;GO:0032230;GO:0051968;GO:2000809;GO:1900244;GO:2000302;GO:0097119;GO:0097104;GO:0098698;GO:0099054;GO:0097105;GO:0035418;GO:0006605;GO:0097120;GO:2000311;GO:0045664;GO:2000310;GO:0002087;GO:0098942;GO:0048511;GO:0007416;GO:0099560;GO:0097091;GO:0048488;GO:0016080;GO:0048489;GO:0072553;, C:asymmetric, glutamatergic, excitatory synapse; C:cell surface; C:dendrite; C:dendritic shaft; C:dendritic spine; C:excitatory synapse; C:external side of plasma membrane; C:filopodium tip; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of postsynaptic specialization membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:presynapse; C:receptor complex; C:spanning component of membrane; C:synapse; C:synaptic cleft;, F:amyloid-beta binding; F:cell adhesion molecule binding; F:identical protein binding; F:neurexin family protein binding; F:PDZ domain binding; F:protein-containing complex binding; F:scaffold protein binding; F:signaling receptor activity;, P:AMPA glutamate receptor clustering; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular response to calcium ion; P:chemical synaptic transmission; P:cytoskeletal matrix organization at active zone; P:establishment of protein localization; P:excitatory synapse assembly; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:long-term synaptic potentiation; P:modulation of chemical synaptic transmission; P:negative regulation of dendritic spine morphogenesis; P:nervous system development; P:neurexin clustering involved in presynaptic membrane assembly; P:neuron cell-cell adhesion; P:neuron projection arborization; P:neuron projection development; P:neuronal signal transduction; P:NMDA glutamate receptor clustering; P:positive regulation of circadian sleep/wake cycle, wakefulness; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of filopodium assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of presynaptic active zone assembly; P:positive regulation of protein localization to synapse; P:positive regulation of ruffle assembly; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission, GABAergic; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of synaptic vesicle clustering; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:postsynaptic specialization assembly; P:presynapse assembly; P:presynaptic membrane assembly; P:protein localization to synapse; P:protein targeting; P:receptor localization to synapse; P:regulation of AMPA receptor activity; P:regulation of neuron differentiation; P:regulation of NMDA receptor activity; P:regulation of respiratory gaseous exchange by nervous system process; P:retrograde trans-synaptic signaling by trans-synaptic protein complex; P:rhythmic process; P:synapse assembly; P:synaptic membrane adhesion; P:synaptic vesicle clustering; P:synaptic vesicle endocytosis; P:synaptic vesicle targeting; P:synaptic vesicle transport; P:terminal button organization; scaffold13 indexed_genome mRNA 27946977 28326375 . + . ID=transcript_3430;Q58DX5 Q658X9 Q6H9J8 Q6H9J9 Q6PG38,Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2,, PF04389;, GO:0016021;GO:0005654;GO:0009617;, C:integral component of membrane; C:nucleoplasm;, , P:response to bacterium; scaffold13 indexed_genome mRNA 28673372 28738931 . + . ID=transcript_3431;Q58DX5 Q658X9 Q6H9J8 Q6H9J9 Q6PG38,Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2,, PF04389;, GO:0016021;GO:0005654;GO:0009617;, C:integral component of membrane; C:nucleoplasm;, , P:response to bacterium; scaffold13 indexed_genome mRNA 29871543 29911534 . - . ID=transcript_3432;Q9BZK7 D3DNQ9 Q14DC3 Q9H2I1 Q9H9A1,F-box-like/WD repeat-containing protein TBL1XR1,Nuclear receptor corepressor/HDAC3 complex subunit TBLR1;TBL1-related protein 1;Transducin beta-like 1X-related protein 1;, PF08513;PF00400;, GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0008013;GO:0042393;GO:0047485;GO:0003714;GO:0000976;GO:0016575;GO:0030522;GO:0000122;GO:0090263;GO:0045944;GO:0045893;GO:0043161;GO:0019216;GO:0006357;GO:0006367;, C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:beta-catenin binding; F:histone binding; F:protein N-terminus binding; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:histone deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q9BZK7 D3DNQ9 Q14DC3 Q9H2I1 Q9H9A1,F-box-like/WD repeat-containing protein TBL1XR1,Nuclear receptor corepressor/HDAC3 complex subunit TBLR1;TBL1-related protein 1;Transducin beta-like 1X-related protein 1;, PF08513;PF00400;, GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0008013;GO:0042393;GO:0047485;GO:0003714;GO:0000976;GO:0016575;GO:0030522;GO:0000122;GO:0090263;GO:0045944;GO:0045893;GO:0043161;GO:0019216;GO:0006357;GO:0006367;, C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:beta-catenin binding; F:histone binding; F:protein N-terminus binding; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:histone deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q9BZK7 D3DNQ9 Q14DC3 Q9H2I1 Q9H9A1,F-box-like/WD repeat-containing protein TBL1XR1,Nuclear receptor corepressor/HDAC3 complex subunit TBLR1;TBL1-related protein 1;Transducin beta-like 1X-related protein 1;, PF08513;PF00400;, GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0008013;GO:0042393;GO:0047485;GO:0003714;GO:0000976;GO:0016575;GO:0030522;GO:0000122;GO:0090263;GO:0045944;GO:0045893;GO:0043161;GO:0019216;GO:0006357;GO:0006367;, C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:beta-catenin binding; F:histone binding; F:protein N-terminus binding; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:histone deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q9BZK7 D3DNQ9 Q14DC3 Q9H2I1 Q9H9A1,F-box-like/WD repeat-containing protein TBL1XR1,Nuclear receptor corepressor/HDAC3 complex subunit TBLR1;TBL1-related protein 1;Transducin beta-like 1X-related protein 1;, PF08513;PF00400;, GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0008013;GO:0042393;GO:0047485;GO:0003714;GO:0000976;GO:0016575;GO:0030522;GO:0000122;GO:0090263;GO:0045944;GO:0045893;GO:0043161;GO:0019216;GO:0006357;GO:0006367;, C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:beta-catenin binding; F:histone binding; F:protein N-terminus binding; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:histone deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q9BZK7 D3DNQ9 Q14DC3 Q9H2I1 Q9H9A1,F-box-like/WD repeat-containing protein TBL1XR1,Nuclear receptor corepressor/HDAC3 complex subunit TBLR1;TBL1-related protein 1;Transducin beta-like 1X-related protein 1;, PF08513;PF00400;, GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0008013;GO:0042393;GO:0047485;GO:0003714;GO:0000976;GO:0016575;GO:0030522;GO:0000122;GO:0090263;GO:0045944;GO:0045893;GO:0043161;GO:0019216;GO:0006357;GO:0006367;, C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:beta-catenin binding; F:histone binding; F:protein N-terminus binding; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:histone deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold13 indexed_genome mRNA 31620158 31622035 . - . ID=transcript_3433;Q9Y691,Calcium-activated potassium channel subunit beta-2,BK channel subunit beta-2;Calcium-activated potassium channel, subfamily M subunit beta-2;Charybdotoxin receptor subunit beta-2;Hbeta3;K(VCA)beta-2;Maxi K channel subunit beta-2;Slo-beta-2;, PF03185;PF09303;, GO:0005887;GO:0005886;GO:0008076;GO:0015269;GO:0008200;GO:0015459;GO:0001508;GO:0005513;GO:0019228;GO:1901381;GO:0006813;GO:0019229;, C:integral component of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calcium-activated potassium channel activity; F:ion channel inhibitor activity; F:potassium channel regulator activity;, P:action potential; P:detection of calcium ion; P:neuronal action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transport; P:regulation of vasoconstriction; scaffold13 indexed_genome mRNA 31732775 31767104 . - . ID=transcript_3434;Q9HA38 B3KVA6 D3DNR1 Q96A21,Zinc finger matrin-type protein 3,Zinc finger protein WIG-1;p53-activated gene 608 protein;, PF12171;, GO:0005730;GO:0005654;GO:0005886;GO:0003723;GO:0008270;GO:0006915;GO:0006974;GO:0015031;GO:0040008;, C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:RNA binding; F:zinc ion binding;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:protein transport; P:regulation of growth; scaffold13 indexed_genome mRNA 31864279 31907273 . + . ID=transcript_3435;P42336 Q14CW1 Q99762,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha;Phosphoinositide 3-kinase alpha {ECO:0000303|PubMed:28676499};Phosphoinositide-3-kinase catalytic alpha polypeptide;Serine/threonine protein kinase PIK3CA;, PF00454;PF00792;PF02192;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0014704;GO:0030027;GO:0016020;GO:0048471;GO:0005942;GO:0005943;GO:0005944;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0043560;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0030295;GO:0106310;GO:0106311;GO:0030036;GO:0060612;GO:0001525;GO:0043276;GO:0007411;GO:0086003;GO:0060048;GO:0016477;GO:0071333;GO:0071464;GO:0019221;GO:0043542;GO:0097009;GO:0007173;GO:0038128;GO:0038095;GO:0038096;GO:0007186;GO:0006006;GO:0044029;GO:0038028;GO:0050900;GO:0001889;GO:0000165;GO:0030835;GO:2000811;GO:2000270;GO:0016242;GO:0043524;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0030168;GO:0010592;GO:0033138;GO:0014068;GO:0051897;GO:0032008;GO:0043491;GO:0110053;GO:0043457;GO:0010468;GO:2000653;GO:0040014;GO:0055119;GO:0035994;GO:0031295;GO:0050852;GO:0048010;GO:0038084;GO:0001944;, C:cytoplasm; C:cytosol; C:intercalated disc; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IA; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:insulin receptor substrate binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; F:protein kinase activator activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:adipose tissue development; P:angiogenesis; P:anoikis; P:axon guidance; P:cardiac muscle cell contraction; P:cardiac muscle contraction; P:cell migration; P:cellular response to glucose stimulus; P:cellular response to hydrostatic pressure; P:cytokine-mediated signaling pathway; P:endothelial cell migration; P:energy homeostasis; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:glucose metabolic process; P:hypomethylation of CpG island; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:leukocyte migration; P:liver development; P:MAPK cascade; P:negative regulation of actin filament depolymerization; P:negative regulation of anoikis; P:negative regulation of fibroblast apoptotic process; P:negative regulation of macroautophagy; P:negative regulation of neuron apoptotic process; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:platelet activation; P:positive regulation of lamellipodium assembly; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of TOR signaling; P:protein kinase B signaling; P:regulation of actin filament organization; P:regulation of cellular respiration; P:regulation of gene expression; P:regulation of genetic imprinting; P:regulation of multicellular organism growth; P:relaxation of cardiac muscle; P:response to muscle stretch; P:T cell costimulation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor signaling pathway; P:vasculature development;|P42336 Q14CW1 Q99762,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha;Phosphoinositide 3-kinase alpha {ECO:0000303|PubMed:28676499};Phosphoinositide-3-kinase catalytic alpha polypeptide;Serine/threonine protein kinase PIK3CA;, PF00454;PF00792;PF02192;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0014704;GO:0030027;GO:0016020;GO:0048471;GO:0005942;GO:0005943;GO:0005944;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0043560;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0030295;GO:0106310;GO:0106311;GO:0030036;GO:0060612;GO:0001525;GO:0043276;GO:0007411;GO:0086003;GO:0060048;GO:0016477;GO:0071333;GO:0071464;GO:0019221;GO:0043542;GO:0097009;GO:0007173;GO:0038128;GO:0038095;GO:0038096;GO:0007186;GO:0006006;GO:0044029;GO:0038028;GO:0050900;GO:0001889;GO:0000165;GO:0030835;GO:2000811;GO:2000270;GO:0016242;GO:0043524;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0030168;GO:0010592;GO:0033138;GO:0014068;GO:0051897;GO:0032008;GO:0043491;GO:0110053;GO:0043457;GO:0010468;GO:2000653;GO:0040014;GO:0055119;GO:0035994;GO:0031295;GO:0050852;GO:0048010;GO:0038084;GO:0001944;, C:cytoplasm; C:cytosol; C:intercalated disc; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IA; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:insulin receptor substrate binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; F:protein kinase activator activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:adipose tissue development; P:angiogenesis; P:anoikis; P:axon guidance; P:cardiac muscle cell contraction; P:cardiac muscle contraction; P:cell migration; P:cellular response to glucose stimulus; P:cellular response to hydrostatic pressure; P:cytokine-mediated signaling pathway; P:endothelial cell migration; P:energy homeostasis; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:glucose metabolic process; P:hypomethylation of CpG island; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:leukocyte migration; P:liver development; P:MAPK cascade; P:negative regulation of actin filament depolymerization; P:negative regulation of anoikis; P:negative regulation of fibroblast apoptotic process; P:negative regulation of macroautophagy; P:negative regulation of neuron apoptotic process; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:platelet activation; P:positive regulation of lamellipodium assembly; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of TOR signaling; P:protein kinase B signaling; P:regulation of actin filament organization; P:regulation of cellular respiration; P:regulation of gene expression; P:regulation of genetic imprinting; P:regulation of multicellular organism growth; P:relaxation of cardiac muscle; P:response to muscle stretch; P:T cell costimulation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor signaling pathway; P:vasculature development;|P42336 Q14CW1 Q99762,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha;Phosphoinositide 3-kinase alpha {ECO:0000303|PubMed:28676499};Phosphoinositide-3-kinase catalytic alpha polypeptide;Serine/threonine protein kinase PIK3CA;, PF00454;PF00792;PF02192;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0014704;GO:0030027;GO:0016020;GO:0048471;GO:0005942;GO:0005943;GO:0005944;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0043560;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0030295;GO:0106310;GO:0106311;GO:0030036;GO:0060612;GO:0001525;GO:0043276;GO:0007411;GO:0086003;GO:0060048;GO:0016477;GO:0071333;GO:0071464;GO:0019221;GO:0043542;GO:0097009;GO:0007173;GO:0038128;GO:0038095;GO:0038096;GO:0007186;GO:0006006;GO:0044029;GO:0038028;GO:0050900;GO:0001889;GO:0000165;GO:0030835;GO:2000811;GO:2000270;GO:0016242;GO:0043524;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0030168;GO:0010592;GO:0033138;GO:0014068;GO:0051897;GO:0032008;GO:0043491;GO:0110053;GO:0043457;GO:0010468;GO:2000653;GO:0040014;GO:0055119;GO:0035994;GO:0031295;GO:0050852;GO:0048010;GO:0038084;GO:0001944;, C:cytoplasm; C:cytosol; C:intercalated disc; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IA; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:insulin receptor substrate binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; F:protein kinase activator activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:adipose tissue development; P:angiogenesis; P:anoikis; P:axon guidance; P:cardiac muscle cell contraction; P:cardiac muscle contraction; P:cell migration; P:cellular response to glucose stimulus; P:cellular response to hydrostatic pressure; P:cytokine-mediated signaling pathway; P:endothelial cell migration; P:energy homeostasis; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:glucose metabolic process; P:hypomethylation of CpG island; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:leukocyte migration; P:liver development; P:MAPK cascade; P:negative regulation of actin filament depolymerization; P:negative regulation of anoikis; P:negative regulation of fibroblast apoptotic process; P:negative regulation of macroautophagy; P:negative regulation of neuron apoptotic process; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:platelet activation; P:positive regulation of lamellipodium assembly; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of TOR signaling; P:protein kinase B signaling; P:regulation of actin filament organization; P:regulation of cellular respiration; P:regulation of gene expression; P:regulation of genetic imprinting; P:regulation of multicellular organism growth; P:relaxation of cardiac muscle; P:response to muscle stretch; P:T cell costimulation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor signaling pathway; P:vasculature development;|Q9NPA1 B7Z9C9 D3DNR2 E9PER5 Q9NPG7 Q9NRM9 Q9UHN3,Calcium-activated potassium channel subunit beta-3,BK channel subunit beta-3;Calcium-activated potassium channel, subfamily M subunit beta-3;Charybdotoxin receptor subunit beta-3;K(VCA)beta-3;Maxi K channel subunit beta-3;Slo-beta-3;, PF03185;, GO:0005887;GO:0005886;GO:0008076;GO:0015269;GO:0015459;GO:0001508;GO:0005513;GO:0019228;GO:1901381;GO:0006813;, C:integral component of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calcium-activated potassium channel activity; F:potassium channel regulator activity;, P:action potential; P:detection of calcium ion; P:neuronal action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transport; scaffold13 indexed_genome mRNA 31976789 31985141 . + . ID=transcript_3436;Q9UID6 A9X3Z9 D3DNR3,Zinc finger protein 639,Zinc finger protein ANC_2H01;Zinc finger protein ZASC1;, , GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0046872;GO:0043621;GO:0000978;GO:0000976;GO:0043922;GO:0045892;GO:0043923;GO:0030307;GO:0045944;GO:0006357;GO:0046718;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:negative regulation by host of viral transcription; P:negative regulation of transcription, DNA-templated; P:positive regulation by host of viral transcription; P:positive regulation of cell growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:viral entry into host cell; scaffold13 indexed_genome mRNA 32001744 32050924 . - . ID=transcript_3437;Q8IWA4 A0A0C4DFN1 B2RAR1 D3DNR6 O15323 O60639 Q9BZB5 Q9NWQ2,Mitofusin-1,Fzo homolog {ECO:0000303|PubMed:11950885};Transmembrane GTPase MFN1;, PF00350;PF04799;, GO:0016021;GO:0031307;GO:0031306;GO:0005741;GO:0005739;GO:0098799;GO:0005525;GO:0003924;GO:0042802;GO:0046039;GO:0016236;GO:0008053;GO:1990613;GO:0051646;GO:0010918;, C:integral component of membrane; C:integral component of mitochondrial outer membrane; C:intrinsic component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:outer mitochondrial membrane protein complex;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:GTP metabolic process; P:macroautophagy; P:mitochondrial fusion; P:mitochondrial membrane fusion; P:mitochondrion localization; P:positive regulation of mitochondrial membrane potential;|Q8IWA4 A0A0C4DFN1 B2RAR1 D3DNR6 O15323 O60639 Q9BZB5 Q9NWQ2,Mitofusin-1,Fzo homolog {ECO:0000303|PubMed:11950885};Transmembrane GTPase MFN1;, PF00350;PF04799;, GO:0016021;GO:0031307;GO:0031306;GO:0005741;GO:0005739;GO:0098799;GO:0005525;GO:0003924;GO:0042802;GO:0046039;GO:0016236;GO:0008053;GO:1990613;GO:0051646;GO:0010918;, C:integral component of membrane; C:integral component of mitochondrial outer membrane; C:intrinsic component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:outer mitochondrial membrane protein complex;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:GTP metabolic process; P:macroautophagy; P:mitochondrial fusion; P:mitochondrial membrane fusion; P:mitochondrion localization; P:positive regulation of mitochondrial membrane potential;|Q8IWA4 A0A0C4DFN1 B2RAR1 D3DNR6 O15323 O60639 Q9BZB5 Q9NWQ2,Mitofusin-1,Fzo homolog {ECO:0000303|PubMed:11950885};Transmembrane GTPase MFN1;, PF00350;PF04799;, GO:0016021;GO:0031307;GO:0031306;GO:0005741;GO:0005739;GO:0098799;GO:0005525;GO:0003924;GO:0042802;GO:0046039;GO:0016236;GO:0008053;GO:1990613;GO:0051646;GO:0010918;, C:integral component of membrane; C:integral component of mitochondrial outer membrane; C:intrinsic component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:outer mitochondrial membrane protein complex;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:GTP metabolic process; P:macroautophagy; P:mitochondrial fusion; P:mitochondrial membrane fusion; P:mitochondrion localization; P:positive regulation of mitochondrial membrane potential;|Q8IWA4 A0A0C4DFN1 B2RAR1 D3DNR6 O15323 O60639 Q9BZB5 Q9NWQ2,Mitofusin-1,Fzo homolog {ECO:0000303|PubMed:11950885};Transmembrane GTPase MFN1;, PF00350;PF04799;, GO:0016021;GO:0031307;GO:0031306;GO:0005741;GO:0005739;GO:0098799;GO:0005525;GO:0003924;GO:0042802;GO:0046039;GO:0016236;GO:0008053;GO:1990613;GO:0051646;GO:0010918;, C:integral component of membrane; C:integral component of mitochondrial outer membrane; C:intrinsic component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:outer mitochondrial membrane protein complex;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:GTP metabolic process; P:macroautophagy; P:mitochondrial fusion; P:mitochondrial membrane fusion; P:mitochondrion localization; P:positive regulation of mitochondrial membrane potential;|Q9HAV0 B3KMH5 D3DNR8,Guanine nucleotide-binding protein subunit beta-4,Transducin beta chain 4;, PF00400;, GO:0005737;GO:0005829;GO:0070062;GO:0005834;GO:0005765;GO:0031682;GO:0044877;GO:0007186;GO:0006457;GO:0021762;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:heterotrimeric G-protein complex; C:lysosomal membrane;, F:G-protein gamma-subunit binding; F:protein-containing complex binding;, P:G protein-coupled receptor signaling pathway; P:protein folding; P:substantia nigra development; scaffold13 indexed_genome mRNA 32189996 32238652 . + . ID=transcript_3438;O96019 B3KMN1 D3DNR9 Q8TAE5 Q9BVS8 Q9H0W6,Actin-like protein 6A,53 kDa BRG1-associated factor A;Actin-related protein Baf53a;ArpNbeta;BRG1-associated factor 53A;INO80 complex subunit K;, PF00022;, GO:0000785;GO:0031011;GO:0071564;GO:0035267;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0016514;GO:0003682;GO:0003713;GO:0043044;GO:0001825;GO:0006338;GO:0006310;GO:0006281;GO:0043968;GO:0043967;GO:0007399;GO:0003407;GO:0016579;GO:0040008;GO:0006357;GO:0007165;GO:0021510;, C:chromatin; C:Ino80 complex; C:npBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:blastocyst formation; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone H2A acetylation; P:histone H4 acetylation; P:nervous system development; P:neural retina development; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:spinal cord development;|O96019 B3KMN1 D3DNR9 Q8TAE5 Q9BVS8 Q9H0W6,Actin-like protein 6A,53 kDa BRG1-associated factor A;Actin-related protein Baf53a;ArpNbeta;BRG1-associated factor 53A;INO80 complex subunit K;, PF00022;, GO:0000785;GO:0031011;GO:0071564;GO:0035267;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0016514;GO:0003682;GO:0003713;GO:0043044;GO:0001825;GO:0006338;GO:0006310;GO:0006281;GO:0043968;GO:0043967;GO:0007399;GO:0003407;GO:0016579;GO:0040008;GO:0006357;GO:0007165;GO:0021510;, C:chromatin; C:Ino80 complex; C:npBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:blastocyst formation; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone H2A acetylation; P:histone H4 acetylation; P:nervous system development; P:neural retina development; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:spinal cord development;|O94805 A4D2D0 O75421,Actin-like protein 6B {ECO:0000305},53 kDa BRG1-associated factor B;Actin-related protein Baf53b;ArpNalpha;BRG1-associated factor 53B;, PF00022;, GO:0071565;GO:0035267;GO:0005634;GO:0016514;GO:0003682;GO:0005200;GO:0003713;GO:0043044;GO:0006325;GO:0006338;GO:0016358;GO:0043967;GO:0007399;GO:0042551;GO:0006357;GO:0021510;, C:nBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:structural constituent of cytoskeleton; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin organization; P:chromatin remodeling; P:dendrite development; P:histone H4 acetylation; P:nervous system development; P:neuron maturation; P:regulation of transcription by RNA polymerase II; P:spinal cord development;|O96019 B3KMN1 D3DNR9 Q8TAE5 Q9BVS8 Q9H0W6,Actin-like protein 6A,53 kDa BRG1-associated factor A;Actin-related protein Baf53a;ArpNbeta;BRG1-associated factor 53A;INO80 complex subunit K;, PF00022;, GO:0000785;GO:0031011;GO:0071564;GO:0035267;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0016514;GO:0003682;GO:0003713;GO:0043044;GO:0001825;GO:0006338;GO:0006310;GO:0006281;GO:0043968;GO:0043967;GO:0007399;GO:0003407;GO:0016579;GO:0040008;GO:0006357;GO:0007165;GO:0021510;, C:chromatin; C:Ino80 complex; C:npBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:blastocyst formation; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone H2A acetylation; P:histone H4 acetylation; P:nervous system development; P:neural retina development; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:spinal cord development;|O96019 B3KMN1 D3DNR9 Q8TAE5 Q9BVS8 Q9H0W6,Actin-like protein 6A,53 kDa BRG1-associated factor A;Actin-related protein Baf53a;ArpNbeta;BRG1-associated factor 53A;INO80 complex subunit K;, PF00022;, GO:0000785;GO:0031011;GO:0071564;GO:0035267;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0016514;GO:0003682;GO:0003713;GO:0043044;GO:0001825;GO:0006338;GO:0006310;GO:0006281;GO:0043968;GO:0043967;GO:0007399;GO:0003407;GO:0016579;GO:0040008;GO:0006357;GO:0007165;GO:0021510;, C:chromatin; C:Ino80 complex; C:npBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:blastocyst formation; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone H2A acetylation; P:histone H4 acetylation; P:nervous system development; P:neural retina development; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:spinal cord development;|Q9HD33 Q6XRG1 Q8N5D1,39S ribosomal protein L47, mitochondrial,Mitochondrial large ribosomal subunit protein uL29m {ECO:0000303|PubMed:25278503};Nasopharyngeal carcinoma metastasis-related protein 1;, PF06984;, GO:0005743;GO:0005762;GO:0005739;GO:0003735;GO:0032543;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q9HD33 Q6XRG1 Q8N5D1,39S ribosomal protein L47, mitochondrial,Mitochondrial large ribosomal subunit protein uL29m {ECO:0000303|PubMed:25278503};Nasopharyngeal carcinoma metastasis-related protein 1;, PF06984;, GO:0005743;GO:0005762;GO:0005739;GO:0003735;GO:0032543;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q9HD33 Q6XRG1 Q8N5D1,39S ribosomal protein L47, mitochondrial,Mitochondrial large ribosomal subunit protein uL29m {ECO:0000303|PubMed:25278503};Nasopharyngeal carcinoma metastasis-related protein 1;, PF06984;, GO:0005743;GO:0005762;GO:0005739;GO:0003735;GO:0032543;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q9HD33 Q6XRG1 Q8N5D1,39S ribosomal protein L47, mitochondrial,Mitochondrial large ribosomal subunit protein uL29m {ECO:0000303|PubMed:25278503};Nasopharyngeal carcinoma metastasis-related protein 1;, PF06984;, GO:0005743;GO:0005762;GO:0005739;GO:0003735;GO:0032543;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold13 indexed_genome mRNA 32241551 32257803 . + . ID=transcript_3439;O43674 Q561V6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial,Complex I-SGDH;NADH-ubiquinone oxidoreductase SGDH subunit;, PF09781;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O43674 Q561V6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial,Complex I-SGDH;NADH-ubiquinone oxidoreductase SGDH subunit;, PF09781;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O43674 Q561V6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial,Complex I-SGDH;NADH-ubiquinone oxidoreductase SGDH subunit;, PF09781;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold13 indexed_genome mRNA 32307011 32410566 . + . ID=transcript_3440;Q92995 A8K2S3 B4DYF3 D3DNS2 Q96B25,Ubiquitin carboxyl-terminal hydrolase 13,Deubiquitinating enzyme 13;Isopeptidase T-3;Ubiquitin thioesterase 13;Ubiquitin-specific-processing protease 13;, PF00627;PF00443;PF02148;PF17807;, GO:0005829;GO:0005654;GO:0005634;GO:1904288;GO:0051087;GO:0004197;GO:1990380;GO:0070628;GO:0004843;GO:0043130;GO:0031625;GO:0044389;GO:0008270;GO:0006914;GO:0008283;GO:1904378;GO:0030318;GO:1904294;GO:0016579;GO:0035523;GO:0044313;GO:0070536;GO:0050821;GO:0010506;GO:0006355;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:BAT3 complex binding; F:chaperone binding; F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding; F:zinc ion binding;, P:autophagy; P:cell population proliferation; P:maintenance of unfolded protein involved in ERAD pathway; P:melanocyte differentiation; P:positive regulation of ERAD pathway; P:protein deubiquitination; P:protein K29-linked deubiquitination; P:protein K6-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process;|Q92995 A8K2S3 B4DYF3 D3DNS2 Q96B25,Ubiquitin carboxyl-terminal hydrolase 13,Deubiquitinating enzyme 13;Isopeptidase T-3;Ubiquitin thioesterase 13;Ubiquitin-specific-processing protease 13;, PF00627;PF00443;PF02148;PF17807;, GO:0005829;GO:0005654;GO:0005634;GO:1904288;GO:0051087;GO:0004197;GO:1990380;GO:0070628;GO:0004843;GO:0043130;GO:0031625;GO:0044389;GO:0008270;GO:0006914;GO:0008283;GO:1904378;GO:0030318;GO:1904294;GO:0016579;GO:0035523;GO:0044313;GO:0070536;GO:0050821;GO:0010506;GO:0006355;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:BAT3 complex binding; F:chaperone binding; F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:proteasome binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding; F:zinc ion binding;, P:autophagy; P:cell population proliferation; P:maintenance of unfolded protein involved in ERAD pathway; P:melanocyte differentiation; P:positive regulation of ERAD pathway; P:protein deubiquitination; P:protein K29-linked deubiquitination; P:protein K6-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:regulation of autophagy; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process; scaffold13 indexed_genome mRNA 32415323 32688948 . - . ID=transcript_3441;E9PH97 Q9NQD1 Q9P2U3 Q9P2U4,PEX5-related protein,PEX2-related protein;PEX5-like protein;Peroxin-5-related protein;Peroxisome biogenesis factor 5-like;Tetratricopeptide repeat-containing Rab8b-interacting protein;, PF13181;, GO:0005829;GO:0005778;GO:0043235;GO:0005052;GO:0000268;GO:0031267;GO:0016560;GO:0043949;, C:cytosol; C:peroxisomal membrane; C:receptor complex;, F:peroxisome matrix targeting signal-1 binding; F:peroxisome targeting sequence binding; F:small GTPase binding;, P:protein import into peroxisome matrix, docking; P:regulation of cAMP-mediated signaling;|E9PH97 Q9NQD1 Q9P2U3 Q9P2U4,PEX5-related protein,PEX2-related protein;PEX5-like protein;Peroxin-5-related protein;Peroxisome biogenesis factor 5-like;Tetratricopeptide repeat-containing Rab8b-interacting protein;, PF13181;, GO:0005829;GO:0005778;GO:0043235;GO:0005052;GO:0000268;GO:0031267;GO:0016560;GO:0043949;, C:cytosol; C:peroxisomal membrane; C:receptor complex;, F:peroxisome matrix targeting signal-1 binding; F:peroxisome targeting sequence binding; F:small GTPase binding;, P:protein import into peroxisome matrix, docking; P:regulation of cAMP-mediated signaling;|E9PH97 Q9NQD1 Q9P2U3 Q9P2U4,PEX5-related protein,PEX2-related protein;PEX5-like protein;Peroxin-5-related protein;Peroxisome biogenesis factor 5-like;Tetratricopeptide repeat-containing Rab8b-interacting protein;, PF13181;, GO:0005829;GO:0005778;GO:0043235;GO:0005052;GO:0000268;GO:0031267;GO:0016560;GO:0043949;, C:cytosol; C:peroxisomal membrane; C:receptor complex;, F:peroxisome matrix targeting signal-1 binding; F:peroxisome targeting sequence binding; F:small GTPase binding;, P:protein import into peroxisome matrix, docking; P:regulation of cAMP-mediated signaling; scaffold13 indexed_genome mRNA 33230178 33277079 . + . ID=transcript_3442;Q96N46 G5E9X0 Q6UWJ7 Q8TF22,Tetratricopeptide repeat protein 14,, , GO:0003676;, , F:nucleic acid binding;|Q96N46 G5E9X0 Q6UWJ7 Q8TF22,Tetratricopeptide repeat protein 14,, , GO:0003676;, , F:nucleic acid binding;|Q96N46 G5E9X0 Q6UWJ7 Q8TF22,Tetratricopeptide repeat protein 14,, , GO:0003676;, , F:nucleic acid binding;|Q9UFE4 B4E2H1,Coiled-coil domain-containing protein 39 {ECO:0000305},, , GO:0005930;GO:0005929;GO:0005829;GO:0005576;GO:0070286;GO:0007420;GO:0090660;GO:0003341;GO:0060285;GO:0071907;GO:0071910;GO:0035469;GO:0060287;GO:0061966;GO:0051649;GO:0030317;GO:0001947;GO:0036159;GO:0030324;GO:0044458;GO:0061512;GO:0003356;, C:axoneme; C:cilium; C:cytosol; C:extracellular region;, , P:axonemal dynein complex assembly; P:brain development; P:cerebrospinal fluid circulation; P:cilium movement; P:cilium-dependent cell motility; P:determination of digestive tract left/right asymmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:establishment of left/right asymmetry; P:establishment of localization in cell; P:flagellated sperm motility; P:heart looping; P:inner dynein arm assembly; P:lung development; P:motile cilium assembly; P:protein localization to cilium; P:regulation of cilium beat frequency;|Q9UFE4 B4E2H1,Coiled-coil domain-containing protein 39 {ECO:0000305},, , GO:0005930;GO:0005929;GO:0005829;GO:0005576;GO:0070286;GO:0007420;GO:0090660;GO:0003341;GO:0060285;GO:0071907;GO:0071910;GO:0035469;GO:0060287;GO:0061966;GO:0051649;GO:0030317;GO:0001947;GO:0036159;GO:0030324;GO:0044458;GO:0061512;GO:0003356;, C:axoneme; C:cilium; C:cytosol; C:extracellular region;, , P:axonemal dynein complex assembly; P:brain development; P:cerebrospinal fluid circulation; P:cilium movement; P:cilium-dependent cell motility; P:determination of digestive tract left/right asymmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:establishment of left/right asymmetry; P:establishment of localization in cell; P:flagellated sperm motility; P:heart looping; P:inner dynein arm assembly; P:lung development; P:motile cilium assembly; P:protein localization to cilium; P:regulation of cilium beat frequency;|Q9UFE4 B4E2H1,Coiled-coil domain-containing protein 39 {ECO:0000305},, , GO:0005930;GO:0005929;GO:0005829;GO:0005576;GO:0070286;GO:0007420;GO:0090660;GO:0003341;GO:0060285;GO:0071907;GO:0071910;GO:0035469;GO:0060287;GO:0061966;GO:0051649;GO:0030317;GO:0001947;GO:0036159;GO:0030324;GO:0044458;GO:0061512;GO:0003356;, C:axoneme; C:cilium; C:cytosol; C:extracellular region;, , P:axonemal dynein complex assembly; P:brain development; P:cerebrospinal fluid circulation; P:cilium movement; P:cilium-dependent cell motility; P:determination of digestive tract left/right asymmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:establishment of left/right asymmetry; P:establishment of localization in cell; P:flagellated sperm motility; P:heart looping; P:inner dynein arm assembly; P:lung development; P:motile cilium assembly; P:protein localization to cilium; P:regulation of cilium beat frequency; scaffold13 indexed_genome mRNA 33472856 33545934 . + . ID=transcript_3443;P51114 A8K9B8 Q7Z450 Q8N6R8,Fragile X mental retardation syndrome-related protein 1,, PF05641;PF12235;PF16096;PF16097;PF00013;PF17904;PF18336;, GO:0030424;GO:0043034;GO:0005737;GO:0036464;GO:0005829;GO:1902737;GO:0043197;GO:0044326;GO:0098978;GO:0030426;GO:0016020;GO:0043025;GO:0005730;GO:0005634;GO:0048471;GO:0005844;GO:0014069;GO:0098793;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0033592;GO:0045182;GO:0006915;GO:0030154;GO:0007517;GO:0017148;GO:2000637;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;GO:0060538;, C:axon; C:costamere; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuronal cell body; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:postsynaptic density; C:presynapse;, F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:RNA strand annealing activity; F:translation regulator activity;, P:apoptotic process; P:cell differentiation; P:muscle organ development; P:negative regulation of translation; P:positive regulation of gene silencing by miRNA; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability; P:skeletal muscle organ development;|P51114 A8K9B8 Q7Z450 Q8N6R8,Fragile X mental retardation syndrome-related protein 1,, PF05641;PF12235;PF16096;PF16097;PF00013;PF17904;PF18336;, GO:0030424;GO:0043034;GO:0005737;GO:0036464;GO:0005829;GO:1902737;GO:0043197;GO:0044326;GO:0098978;GO:0030426;GO:0016020;GO:0043025;GO:0005730;GO:0005634;GO:0048471;GO:0005844;GO:0014069;GO:0098793;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0033592;GO:0045182;GO:0006915;GO:0030154;GO:0007517;GO:0017148;GO:2000637;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;GO:0060538;, C:axon; C:costamere; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuronal cell body; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:postsynaptic density; C:presynapse;, F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:RNA strand annealing activity; F:translation regulator activity;, P:apoptotic process; P:cell differentiation; P:muscle organ development; P:negative regulation of translation; P:positive regulation of gene silencing by miRNA; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability; P:skeletal muscle organ development;|P51114 A8K9B8 Q7Z450 Q8N6R8,Fragile X mental retardation syndrome-related protein 1,, PF05641;PF12235;PF16096;PF16097;PF00013;PF17904;PF18336;, GO:0030424;GO:0043034;GO:0005737;GO:0036464;GO:0005829;GO:1902737;GO:0043197;GO:0044326;GO:0098978;GO:0030426;GO:0016020;GO:0043025;GO:0005730;GO:0005634;GO:0048471;GO:0005844;GO:0014069;GO:0098793;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0033592;GO:0045182;GO:0006915;GO:0030154;GO:0007517;GO:0017148;GO:2000637;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;GO:0060538;, C:axon; C:costamere; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuronal cell body; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:postsynaptic density; C:presynapse;, F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:RNA strand annealing activity; F:translation regulator activity;, P:apoptotic process; P:cell differentiation; P:muscle organ development; P:negative regulation of translation; P:positive regulation of gene silencing by miRNA; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability; P:skeletal muscle organ development;|P51114 A8K9B8 Q7Z450 Q8N6R8,Fragile X mental retardation syndrome-related protein 1,, PF05641;PF12235;PF16096;PF16097;PF00013;PF17904;PF18336;, GO:0030424;GO:0043034;GO:0005737;GO:0036464;GO:0005829;GO:1902737;GO:0043197;GO:0044326;GO:0098978;GO:0030426;GO:0016020;GO:0043025;GO:0005730;GO:0005634;GO:0048471;GO:0005844;GO:0014069;GO:0098793;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0033592;GO:0045182;GO:0006915;GO:0030154;GO:0007517;GO:0017148;GO:2000637;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;GO:0060538;, C:axon; C:costamere; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuronal cell body; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:postsynaptic density; C:presynapse;, F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:RNA strand annealing activity; F:translation regulator activity;, P:apoptotic process; P:cell differentiation; P:muscle organ development; P:negative regulation of translation; P:positive regulation of gene silencing by miRNA; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability; P:skeletal muscle organ development;|P51114 A8K9B8 Q7Z450 Q8N6R8,Fragile X mental retardation syndrome-related protein 1,, PF05641;PF12235;PF16096;PF16097;PF00013;PF17904;PF18336;, GO:0030424;GO:0043034;GO:0005737;GO:0036464;GO:0005829;GO:1902737;GO:0043197;GO:0044326;GO:0098978;GO:0030426;GO:0016020;GO:0043025;GO:0005730;GO:0005634;GO:0048471;GO:0005844;GO:0014069;GO:0098793;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0033592;GO:0045182;GO:0006915;GO:0030154;GO:0007517;GO:0017148;GO:2000637;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;GO:0060538;, C:axon; C:costamere; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuronal cell body; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:postsynaptic density; C:presynapse;, F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:RNA strand annealing activity; F:translation regulator activity;, P:apoptotic process; P:cell differentiation; P:muscle organ development; P:negative regulation of translation; P:positive regulation of gene silencing by miRNA; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability; P:skeletal muscle organ development;|P51114 A8K9B8 Q7Z450 Q8N6R8,Fragile X mental retardation syndrome-related protein 1,, PF05641;PF12235;PF16096;PF16097;PF00013;PF17904;PF18336;, GO:0030424;GO:0043034;GO:0005737;GO:0036464;GO:0005829;GO:1902737;GO:0043197;GO:0044326;GO:0098978;GO:0030426;GO:0016020;GO:0043025;GO:0005730;GO:0005634;GO:0048471;GO:0005844;GO:0014069;GO:0098793;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0033592;GO:0045182;GO:0006915;GO:0030154;GO:0007517;GO:0017148;GO:2000637;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;GO:0060538;, C:axon; C:costamere; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuronal cell body; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:postsynaptic density; C:presynapse;, F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:RNA strand annealing activity; F:translation regulator activity;, P:apoptotic process; P:cell differentiation; P:muscle organ development; P:negative regulation of translation; P:positive regulation of gene silencing by miRNA; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability; P:skeletal muscle organ development;|P51114 A8K9B8 Q7Z450 Q8N6R8,Fragile X mental retardation syndrome-related protein 1,, PF05641;PF12235;PF16096;PF16097;PF00013;PF17904;PF18336;, GO:0030424;GO:0043034;GO:0005737;GO:0036464;GO:0005829;GO:1902737;GO:0043197;GO:0044326;GO:0098978;GO:0030426;GO:0016020;GO:0043025;GO:0005730;GO:0005634;GO:0048471;GO:0005844;GO:0014069;GO:0098793;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0033592;GO:0045182;GO:0006915;GO:0030154;GO:0007517;GO:0017148;GO:2000637;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;GO:0060538;, C:axon; C:costamere; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuronal cell body; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:postsynaptic density; C:presynapse;, F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:RNA strand annealing activity; F:translation regulator activity;, P:apoptotic process; P:cell differentiation; P:muscle organ development; P:negative regulation of translation; P:positive regulation of gene silencing by miRNA; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability; P:skeletal muscle organ development;|P51114 A8K9B8 Q7Z450 Q8N6R8,Fragile X mental retardation syndrome-related protein 1,, PF05641;PF12235;PF16096;PF16097;PF00013;PF17904;PF18336;, GO:0030424;GO:0043034;GO:0005737;GO:0036464;GO:0005829;GO:1902737;GO:0043197;GO:0044326;GO:0098978;GO:0030426;GO:0016020;GO:0043025;GO:0005730;GO:0005634;GO:0048471;GO:0005844;GO:0014069;GO:0098793;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0033592;GO:0045182;GO:0006915;GO:0030154;GO:0007517;GO:0017148;GO:2000637;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;GO:0060538;, C:axon; C:costamere; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuronal cell body; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:postsynaptic density; C:presynapse;, F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:RNA strand annealing activity; F:translation regulator activity;, P:apoptotic process; P:cell differentiation; P:muscle organ development; P:negative regulation of translation; P:positive regulation of gene silencing by miRNA; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability; P:skeletal muscle organ development; scaffold13 indexed_genome mRNA 33549614 33557403 . - . ID=transcript_3444;Q96DA6 B2R4B1 C9JBV1,Mitochondrial import inner membrane translocase subunit TIM14,DnaJ homolog subfamily C member 19;, PF00226;, GO:0098800;GO:0016021;GO:0099617;GO:0005743;GO:0005739;GO:0001405;GO:0032991;GO:0001671;GO:0048806;GO:0006457;GO:0030150;GO:0006626;GO:1900208;GO:0007601;, C:inner mitochondrial membrane protein complex; C:integral component of membrane; C:matrix side of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:PAM complex, Tim23 associated import motor; C:protein-containing complex;, F:ATPase activator activity;, P:genitalia development; P:protein folding; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:regulation of cardiolipin metabolic process; P:visual perception;|Q96DA6 B2R4B1 C9JBV1,Mitochondrial import inner membrane translocase subunit TIM14,DnaJ homolog subfamily C member 19;, PF00226;, GO:0098800;GO:0016021;GO:0099617;GO:0005743;GO:0005739;GO:0001405;GO:0032991;GO:0001671;GO:0048806;GO:0006457;GO:0030150;GO:0006626;GO:1900208;GO:0007601;, C:inner mitochondrial membrane protein complex; C:integral component of membrane; C:matrix side of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:PAM complex, Tim23 associated import motor; C:protein-containing complex;, F:ATPase activator activity;, P:genitalia development; P:protein folding; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:regulation of cardiolipin metabolic process; P:visual perception;|Q96DA6 B2R4B1 C9JBV1,Mitochondrial import inner membrane translocase subunit TIM14,DnaJ homolog subfamily C member 19;, PF00226;, GO:0098800;GO:0016021;GO:0099617;GO:0005743;GO:0005739;GO:0001405;GO:0032991;GO:0001671;GO:0048806;GO:0006457;GO:0030150;GO:0006626;GO:1900208;GO:0007601;, C:inner mitochondrial membrane protein complex; C:integral component of membrane; C:matrix side of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:PAM complex, Tim23 associated import motor; C:protein-containing complex;, F:ATPase activator activity;, P:genitalia development; P:protein folding; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:regulation of cardiolipin metabolic process; P:visual perception; scaffold13 indexed_genome mRNA 35322172 35435359 . + . ID=transcript_3445;Q9Y2G3 Q96FN1 Q9UKK7,Phospholipid-transporting ATPase IF,ATPase IR;ATPase class VI type 11B;P4-ATPase flippase complex alpha subunit ATP11B;, PF16212;PF16209;, GO:0035577;GO:0005769;GO:0005783;GO:0016021;GO:0016020;GO:0005637;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0005524;GO:0140326;GO:0015075;GO:0000287;GO:0015917;GO:0034220;GO:0006811;GO:0043312;GO:0045332;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:ion transmembrane transporter activity; F:magnesium ion binding;, P:aminophospholipid transport; P:ion transmembrane transport; P:ion transport; P:neutrophil degranulation; P:phospholipid translocation;|Q9Y2G3 Q96FN1 Q9UKK7,Phospholipid-transporting ATPase IF,ATPase IR;ATPase class VI type 11B;P4-ATPase flippase complex alpha subunit ATP11B;, PF16212;PF16209;, GO:0035577;GO:0005769;GO:0005783;GO:0016021;GO:0016020;GO:0005637;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0005524;GO:0140326;GO:0015075;GO:0000287;GO:0015917;GO:0034220;GO:0006811;GO:0043312;GO:0045332;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:ion transmembrane transporter activity; F:magnesium ion binding;, P:aminophospholipid transport; P:ion transmembrane transport; P:ion transport; P:neutrophil degranulation; P:phospholipid translocation;|Q9Y2G3 Q96FN1 Q9UKK7,Phospholipid-transporting ATPase IF,ATPase IR;ATPase class VI type 11B;P4-ATPase flippase complex alpha subunit ATP11B;, PF16212;PF16209;, GO:0035577;GO:0005769;GO:0005783;GO:0016021;GO:0016020;GO:0005637;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0005524;GO:0140326;GO:0015075;GO:0000287;GO:0015917;GO:0034220;GO:0006811;GO:0043312;GO:0045332;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:ion transmembrane transporter activity; F:magnesium ion binding;, P:aminophospholipid transport; P:ion transmembrane transport; P:ion transport; P:neutrophil degranulation; P:phospholipid translocation; scaffold13 indexed_genome mRNA 35467228 35487616 . - . ID=transcript_3446;Q96GG9 B2RB37 Q7L3G9 Q8TEX7 Q9H6M1 Q9HCT3,DCN1-like protein 1 {ECO:0000305},DCUN1 domain-containing protein 1;Defective in cullin neddylation protein 1-like protein 1;Squamous cell carcinoma-related oncogene;, PF03556;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0043687;GO:0045116;GO:2000434;GO:0031396;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:protein neddylation; P:regulation of protein neddylation; P:regulation of protein ubiquitination; scaffold13 indexed_genome mRNA 35523912 35595460 . - . ID=transcript_3447;Q96RQ3 Q59ES4 Q9H959 Q9NS97,Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial,3-methylcrotonyl-CoA carboxylase 1;3-methylcrotonyl-CoA carboxylase biotin-containing subunit;3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha;, PF02785;PF00289;PF00364;PF02786;, GO:0002169;GO:0005829;GO:1905202;GO:0005759;GO:0005739;GO:0005524;GO:0009374;GO:0004075;GO:0016421;GO:0046872;GO:0004485;GO:0006768;GO:0009083;GO:0006552;, C:3-methylcrotonyl-CoA carboxylase complex, mitochondrial; C:cytosol; C:methylcrotonoyl-CoA carboxylase complex; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:biotin binding; F:biotin carboxylase activity; F:CoA carboxylase activity; F:metal ion binding; F:methylcrotonoyl-CoA carboxylase activity;, P:biotin metabolic process; P:branched-chain amino acid catabolic process; P:leucine catabolic process;|Q96RQ3 Q59ES4 Q9H959 Q9NS97,Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial,3-methylcrotonyl-CoA carboxylase 1;3-methylcrotonyl-CoA carboxylase biotin-containing subunit;3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha;, PF02785;PF00289;PF00364;PF02786;, GO:0002169;GO:0005829;GO:1905202;GO:0005759;GO:0005739;GO:0005524;GO:0009374;GO:0004075;GO:0016421;GO:0046872;GO:0004485;GO:0006768;GO:0009083;GO:0006552;, C:3-methylcrotonyl-CoA carboxylase complex, mitochondrial; C:cytosol; C:methylcrotonoyl-CoA carboxylase complex; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:biotin binding; F:biotin carboxylase activity; F:CoA carboxylase activity; F:metal ion binding; F:methylcrotonoyl-CoA carboxylase activity;, P:biotin metabolic process; P:branched-chain amino acid catabolic process; P:leucine catabolic process;|Q96RQ3 Q59ES4 Q9H959 Q9NS97,Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial,3-methylcrotonyl-CoA carboxylase 1;3-methylcrotonyl-CoA carboxylase biotin-containing subunit;3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha;, PF02785;PF00289;PF00364;PF02786;, GO:0002169;GO:0005829;GO:1905202;GO:0005759;GO:0005739;GO:0005524;GO:0009374;GO:0004075;GO:0016421;GO:0046872;GO:0004485;GO:0006768;GO:0009083;GO:0006552;, C:3-methylcrotonyl-CoA carboxylase complex, mitochondrial; C:cytosol; C:methylcrotonoyl-CoA carboxylase complex; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:biotin binding; F:biotin carboxylase activity; F:CoA carboxylase activity; F:metal ion binding; F:methylcrotonoyl-CoA carboxylase activity;, P:biotin metabolic process; P:branched-chain amino acid catabolic process; P:leucine catabolic process; scaffold13 indexed_genome mRNA 35616981 35639921 . - . ID=transcript_3448;Q9UQV4 D3DNS4 O94781 Q8NEC8,Lysosome-associated membrane glycoprotein 3,DC-lysosome-associated membrane glycoprotein;Protein TSC403;, PF01299;, GO:0097233;GO:0005769;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0048471;GO:0005886;GO:0031982;GO:0002250;GO:0072594;GO:0043154;GO:1901799;GO:0010628;GO:0010506;GO:1903900;GO:0035455;, C:alveolar lamellar body membrane; C:early endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, , P:adaptive immune response; P:establishment of protein localization to organelle; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of proteasomal protein catabolic process; P:positive regulation of gene expression; P:regulation of autophagy; P:regulation of viral life cycle; P:response to interferon-alpha;|Q9UQV4 D3DNS4 O94781 Q8NEC8,Lysosome-associated membrane glycoprotein 3,DC-lysosome-associated membrane glycoprotein;Protein TSC403;, PF01299;, GO:0097233;GO:0005769;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0048471;GO:0005886;GO:0031982;GO:0002250;GO:0072594;GO:0043154;GO:1901799;GO:0010628;GO:0010506;GO:1903900;GO:0035455;, C:alveolar lamellar body membrane; C:early endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, , P:adaptive immune response; P:establishment of protein localization to organelle; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of proteasomal protein catabolic process; P:positive regulation of gene expression; P:regulation of autophagy; P:regulation of viral life cycle; P:response to interferon-alpha; scaffold13 indexed_genome mRNA 35654231 35917033 . + . ID=transcript_3449;Q86YR7 O94942 Q6P2B8 Q6ZVJ5 Q8N318,Probable guanine nucleotide exchange factor MCF2L2,Dbs-related Rho family guanine nucleotide exchange factor;MCF2-transforming sequence-like protein 2;, PF13716;PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity;|Q86YR7 O94942 Q6P2B8 Q6ZVJ5 Q8N318,Probable guanine nucleotide exchange factor MCF2L2,Dbs-related Rho family guanine nucleotide exchange factor;MCF2-transforming sequence-like protein 2;, PF13716;PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity;|Q86YR7 O94942 Q6P2B8 Q6ZVJ5 Q8N318,Probable guanine nucleotide exchange factor MCF2L2,Dbs-related Rho family guanine nucleotide exchange factor;MCF2-transforming sequence-like protein 2;, PF13716;PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity;|Q86YR7 O94942 Q6P2B8 Q6ZVJ5 Q8N318,Probable guanine nucleotide exchange factor MCF2L2,Dbs-related Rho family guanine nucleotide exchange factor;MCF2-transforming sequence-like protein 2;, PF13716;PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity;|Q86YR7 O94942 Q6P2B8 Q6ZVJ5 Q8N318,Probable guanine nucleotide exchange factor MCF2L2,Dbs-related Rho family guanine nucleotide exchange factor;MCF2-transforming sequence-like protein 2;, PF13716;PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity;|Q9BYG0 D3DNS5 Q59FE3 Q7L9Z5 Q8WWP9,Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase {ECO:0000305},Lactotriaosylceramide synthase;UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5;, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0008457;GO:0047256;GO:0007420;GO:0007417;GO:0009247;GO:0016266;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity; F:lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity;, P:brain development; P:central nervous system development; P:glycolipid biosynthetic process; P:O-glycan processing; P:protein glycosylation; scaffold13 indexed_genome mRNA 35922424 35929768 . + . ID=transcript_3450;Q14240 D3DNU9 Q53XJ6 Q96B90 Q96EA8,Eukaryotic initiation factor 4A-II,ATP-dependent RNA helicase eIF4A-2;, PF00270;PF00271;, GO:0005829;GO:0016281;GO:0048471;GO:0005524;GO:0016887;GO:0004386;GO:0003723;GO:0003724;GO:0003743;GO:1990830;GO:0002183;GO:1900260;GO:0006446;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:translation initiation factor activity;, P:cellular response to leukemia inhibitory factor; P:cytoplasmic translational initiation; P:negative regulation of RNA-directed 5'-3' RNA polymerase activity; P:regulation of translational initiation; P:translational initiation; P:viral process;|Q14240 D3DNU9 Q53XJ6 Q96B90 Q96EA8,Eukaryotic initiation factor 4A-II,ATP-dependent RNA helicase eIF4A-2;, PF00270;PF00271;, GO:0005829;GO:0016281;GO:0048471;GO:0005524;GO:0016887;GO:0004386;GO:0003723;GO:0003724;GO:0003743;GO:1990830;GO:0002183;GO:1900260;GO:0006446;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:translation initiation factor activity;, P:cellular response to leukemia inhibitory factor; P:cytoplasmic translational initiation; P:negative regulation of RNA-directed 5'-3' RNA polymerase activity; P:regulation of translational initiation; P:translational initiation; P:viral process;|Q14240 D3DNU9 Q53XJ6 Q96B90 Q96EA8,Eukaryotic initiation factor 4A-II,ATP-dependent RNA helicase eIF4A-2;, PF00270;PF00271;, GO:0005829;GO:0016281;GO:0048471;GO:0005524;GO:0016887;GO:0004386;GO:0003723;GO:0003724;GO:0003743;GO:1990830;GO:0002183;GO:1900260;GO:0006446;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:translation initiation factor activity;, P:cellular response to leukemia inhibitory factor; P:cytoplasmic translational initiation; P:negative regulation of RNA-directed 5'-3' RNA polymerase activity; P:regulation of translational initiation; P:translational initiation; P:viral process; scaffold13 indexed_genome mRNA 35964353 35980357 . - . ID=transcript_3451;Q8WZ60 B2RB31 D3DNS8 Q8N5I1 Q8N892,Kelch-like protein 6,, PF07707;PF00651;PF01344;, GO:0050853;GO:0002467;, , , P:B cell receptor signaling pathway; P:germinal center formation; scaffold13 indexed_genome mRNA 36074290 36111812 . + . ID=transcript_3452;Q6TFL4 A5PLN8 Q9H620 Q9NXT9,Kelch-like protein 24,Kainate receptor-interacting protein for GluR6;Protein DRE1;, PF07707;PF00651;PF01344;, GO:0005912;GO:0030424;GO:0031463;GO:0005737;GO:0030057;GO:0043204;GO:0045109;GO:0051865;GO:0016567;GO:2000312;, C:adherens junction; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:desmosome; C:perikaryon;, , P:intermediate filament organization; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of kainate selective glutamate receptor activity;|Q6TFL4 A5PLN8 Q9H620 Q9NXT9,Kelch-like protein 24,Kainate receptor-interacting protein for GluR6;Protein DRE1;, PF07707;PF00651;PF01344;, GO:0005912;GO:0030424;GO:0031463;GO:0005737;GO:0030057;GO:0043204;GO:0045109;GO:0051865;GO:0016567;GO:2000312;, C:adherens junction; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:desmosome; C:perikaryon;, , P:intermediate filament organization; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of kainate selective glutamate receptor activity;|Q6TFL4 A5PLN8 Q9H620 Q9NXT9,Kelch-like protein 24,Kainate receptor-interacting protein for GluR6;Protein DRE1;, PF07707;PF00651;PF01344;, GO:0005912;GO:0030424;GO:0031463;GO:0005737;GO:0030057;GO:0043204;GO:0045109;GO:0051865;GO:0016567;GO:2000312;, C:adherens junction; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:desmosome; C:perikaryon;, , P:intermediate filament organization; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of kainate selective glutamate receptor activity;|Q6TFL4 A5PLN8 Q9H620 Q9NXT9,Kelch-like protein 24,Kainate receptor-interacting protein for GluR6;Protein DRE1;, PF07707;PF00651;PF01344;, GO:0005912;GO:0030424;GO:0031463;GO:0005737;GO:0030057;GO:0043204;GO:0045109;GO:0051865;GO:0016567;GO:2000312;, C:adherens junction; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:desmosome; C:perikaryon;, , P:intermediate filament organization; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of kainate selective glutamate receptor activity;|Q6TFL4 A5PLN8 Q9H620 Q9NXT9,Kelch-like protein 24,Kainate receptor-interacting protein for GluR6;Protein DRE1;, PF07707;PF00651;PF01344;, GO:0005912;GO:0030424;GO:0031463;GO:0005737;GO:0030057;GO:0043204;GO:0045109;GO:0051865;GO:0016567;GO:2000312;, C:adherens junction; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:desmosome; C:perikaryon;, , P:intermediate filament organization; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of kainate selective glutamate receptor activity;|Q6TFL4 A5PLN8 Q9H620 Q9NXT9,Kelch-like protein 24,Kainate receptor-interacting protein for GluR6;Protein DRE1;, PF07707;PF00651;PF01344;, GO:0005912;GO:0030424;GO:0031463;GO:0005737;GO:0030057;GO:0043204;GO:0045109;GO:0051865;GO:0016567;GO:2000312;, C:adherens junction; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:desmosome; C:perikaryon;, , P:intermediate filament organization; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of kainate selective glutamate receptor activity; scaffold13 indexed_genome mRNA 36136739 36557285 . + . ID=transcript_3453;Q92997 B4E3E5 D3DNT0 O14642 Q13531 Q8N5E9 Q92607,Segment polarity protein dishevelled homolog DVL-3,DSH homolog 3;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0000785;GO:0005829;GO:0008013;GO:0005109;GO:0002020;GO:0005102;GO:0031267;GO:1904886;GO:0060070;GO:0035556;GO:0090090;GO:0035567;GO:0038031;GO:0090179;GO:0043547;GO:0043507;GO:0150012;GO:0001934;GO:0045944;GO:0045893;GO:0050821;GO:1903827;GO:0042493;GO:0060071;, C:chromatin; C:cytosol;, F:beta-catenin binding; F:frizzled binding; F:protease binding; F:signaling receptor binding; F:small GTPase binding;, P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway via JNK cascade; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of GTPase activity; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection arborization; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of cellular protein localization; P:response to drug; P:Wnt signaling pathway, planar cell polarity pathway;|Q9ULM3 A7E2B9 D3DNS9 Q641P6 Q9NW96,YEATS domain-containing protein 2 {ECO:0000305},, PF03366;, GO:0005671;GO:0072686;GO:0042393;GO:0140030;GO:0017025;GO:0043966;GO:0000122;GO:0045892;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle;, F:histone binding; F:modification-dependent protein binding; F:TBP-class protein binding;, P:histone H3 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated;|Q9ULM3 A7E2B9 D3DNS9 Q641P6 Q9NW96,YEATS domain-containing protein 2 {ECO:0000305},, PF03366;, GO:0005671;GO:0072686;GO:0042393;GO:0140030;GO:0017025;GO:0043966;GO:0000122;GO:0045892;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle;, F:histone binding; F:modification-dependent protein binding; F:TBP-class protein binding;, P:histone H3 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated;|Q9ULM3 A7E2B9 D3DNS9 Q641P6 Q9NW96,YEATS domain-containing protein 2 {ECO:0000305},, PF03366;, GO:0005671;GO:0072686;GO:0042393;GO:0140030;GO:0017025;GO:0043966;GO:0000122;GO:0045892;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle;, F:histone binding; F:modification-dependent protein binding; F:TBP-class protein binding;, P:histone H3 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated;|Q9ULM3 A7E2B9 D3DNS9 Q641P6 Q9NW96,YEATS domain-containing protein 2 {ECO:0000305},, PF03366;, GO:0005671;GO:0072686;GO:0042393;GO:0140030;GO:0017025;GO:0043966;GO:0000122;GO:0045892;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle;, F:histone binding; F:modification-dependent protein binding; F:TBP-class protein binding;, P:histone H3 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated;|Q9ULM3 A7E2B9 D3DNS9 Q641P6 Q9NW96,YEATS domain-containing protein 2 {ECO:0000305},, PF03366;, GO:0005671;GO:0072686;GO:0042393;GO:0140030;GO:0017025;GO:0043966;GO:0000122;GO:0045892;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle;, F:histone binding; F:modification-dependent protein binding; F:TBP-class protein binding;, P:histone H3 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated;|Q9H9H5,MAP6 domain-containing protein 1,21 kDa STOP-like protein;, , GO:0005801;GO:0005798;GO:0005874;GO:0005516;GO:0008017;GO:0030705;GO:0000226;GO:0018009;GO:0007026;GO:0070507;, C:cis-Golgi network; C:Golgi-associated vesicle; C:microtubule;, F:calmodulin binding; F:microtubule binding;, P:cytoskeleton-dependent intracellular transport; P:microtubule cytoskeleton organization; P:N-terminal peptidyl-L-cysteine N-palmitoylation; P:negative regulation of microtubule depolymerization; P:regulation of microtubule cytoskeleton organization;|Q9H9H5,MAP6 domain-containing protein 1,21 kDa STOP-like protein;, , GO:0005801;GO:0005798;GO:0005874;GO:0005516;GO:0008017;GO:0030705;GO:0000226;GO:0018009;GO:0007026;GO:0070507;, C:cis-Golgi network; C:Golgi-associated vesicle; C:microtubule;, F:calmodulin binding; F:microtubule binding;, P:cytoskeleton-dependent intracellular transport; P:microtubule cytoskeleton organization; P:N-terminal peptidyl-L-cysteine N-palmitoylation; P:negative regulation of microtubule depolymerization; P:regulation of microtubule cytoskeleton organization;|Q9H300 Q96CQ4 Q9BTJ6 Q9P1E3,Presenilins-associated rhomboid-like protein, mitochondrial,Mitochondrial intramembrane cleaving protease PARL;, PF01694;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0004175;GO:0004252;GO:0033619;GO:0006851;GO:0006508;GO:0010821;GO:1903214;GO:0030162;GO:2000377;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:membrane protein proteolysis; P:mitochondrial calcium ion transmembrane transport; P:proteolysis; P:regulation of mitochondrion organization; P:regulation of protein targeting to mitochondrion; P:regulation of proteolysis; P:regulation of reactive oxygen species metabolic process;|Q9H300 Q96CQ4 Q9BTJ6 Q9P1E3,Presenilins-associated rhomboid-like protein, mitochondrial,Mitochondrial intramembrane cleaving protease PARL;, PF01694;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0004175;GO:0004252;GO:0033619;GO:0006851;GO:0006508;GO:0010821;GO:1903214;GO:0030162;GO:2000377;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:membrane protein proteolysis; P:mitochondrial calcium ion transmembrane transport; P:proteolysis; P:regulation of mitochondrion organization; P:regulation of protein targeting to mitochondrion; P:regulation of proteolysis; P:regulation of reactive oxygen species metabolic process;|Q9H300 Q96CQ4 Q9BTJ6 Q9P1E3,Presenilins-associated rhomboid-like protein, mitochondrial,Mitochondrial intramembrane cleaving protease PARL;, PF01694;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0004175;GO:0004252;GO:0033619;GO:0006851;GO:0006508;GO:0010821;GO:1903214;GO:0030162;GO:2000377;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:membrane protein proteolysis; P:mitochondrial calcium ion transmembrane transport; P:proteolysis; P:regulation of mitochondrion organization; P:regulation of protein targeting to mitochondrion; P:regulation of proteolysis; P:regulation of reactive oxygen species metabolic process;|Q9H300 Q96CQ4 Q9BTJ6 Q9P1E3,Presenilins-associated rhomboid-like protein, mitochondrial,Mitochondrial intramembrane cleaving protease PARL;, PF01694;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0004175;GO:0004252;GO:0033619;GO:0006851;GO:0006508;GO:0010821;GO:1903214;GO:0030162;GO:2000377;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:membrane protein proteolysis; P:mitochondrial calcium ion transmembrane transport; P:proteolysis; P:regulation of mitochondrion organization; P:regulation of protein targeting to mitochondrion; P:regulation of proteolysis; P:regulation of reactive oxygen species metabolic process;|Q9H300 Q96CQ4 Q9BTJ6 Q9P1E3,Presenilins-associated rhomboid-like protein, mitochondrial,Mitochondrial intramembrane cleaving protease PARL;, PF01694;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0004175;GO:0004252;GO:0033619;GO:0006851;GO:0006508;GO:0010821;GO:1903214;GO:0030162;GO:2000377;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:membrane protein proteolysis; P:mitochondrial calcium ion transmembrane transport; P:proteolysis; P:regulation of mitochondrion organization; P:regulation of protein targeting to mitochondrion; P:regulation of proteolysis; P:regulation of reactive oxygen species metabolic process;|Q9H300 Q96CQ4 Q9BTJ6 Q9P1E3,Presenilins-associated rhomboid-like protein, mitochondrial,Mitochondrial intramembrane cleaving protease PARL;, PF01694;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0004175;GO:0004252;GO:0033619;GO:0006851;GO:0006508;GO:0010821;GO:1903214;GO:0030162;GO:2000377;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:membrane protein proteolysis; P:mitochondrial calcium ion transmembrane transport; P:proteolysis; P:regulation of mitochondrion organization; P:regulation of protein targeting to mitochondrion; P:regulation of proteolysis; P:regulation of reactive oxygen species metabolic process;|Q9H300 Q96CQ4 Q9BTJ6 Q9P1E3,Presenilins-associated rhomboid-like protein, mitochondrial,Mitochondrial intramembrane cleaving protease PARL;, PF01694;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0004175;GO:0004252;GO:0033619;GO:0006851;GO:0006508;GO:0010821;GO:1903214;GO:0030162;GO:2000377;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:membrane protein proteolysis; P:mitochondrial calcium ion transmembrane transport; P:proteolysis; P:regulation of mitochondrion organization; P:regulation of protein targeting to mitochondrion; P:regulation of proteolysis; P:regulation of reactive oxygen species metabolic process;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q9UQC3,Multidrug resistance-associated protein 5,ATP-binding cassette sub-family C member 5;Multi-specific organic anion transporter C;SMRP;pABC11;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0010008;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0034634;GO:0015232;GO:0008514;GO:0015216;GO:0042910;GO:0070730;GO:0070731;GO:0140115;GO:0098838;GO:0034775;GO:0035351;GO:0030213;GO:0015865;GO:0055085;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:endosome membrane; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:heme transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cAMP transport; P:cGMP transport; P:export across plasma membrane; P:folate transmembrane transport; P:glutathione transmembrane transport; P:heme transmembrane transport; P:hyaluronan biosynthetic process; P:purine nucleotide transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q13144 Q541Z1 Q96D04,Translation initiation factor eIF-2B subunit epsilon,eIF-2B GDP-GTP exchange factor subunit epsilon;, PF00132;PF02020;, GO:0005737;GO:0005829;GO:0005851;GO:0005634;GO:0005085;GO:0003743;GO:0031369;GO:0014002;GO:0048708;GO:0042552;GO:0014003;GO:0001541;GO:0045948;GO:0034976;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:translation initiation factor activity; F:translation initiation factor binding;, P:astrocyte development; P:astrocyte differentiation; P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:positive regulation of translational initiation; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|Q13144 Q541Z1 Q96D04,Translation initiation factor eIF-2B subunit epsilon,eIF-2B GDP-GTP exchange factor subunit epsilon;, PF00132;PF02020;, GO:0005737;GO:0005829;GO:0005851;GO:0005634;GO:0005085;GO:0003743;GO:0031369;GO:0014002;GO:0048708;GO:0042552;GO:0014003;GO:0001541;GO:0045948;GO:0034976;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:translation initiation factor activity; F:translation initiation factor binding;, P:astrocyte development; P:astrocyte differentiation; P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:positive regulation of translational initiation; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|Q13144 Q541Z1 Q96D04,Translation initiation factor eIF-2B subunit epsilon,eIF-2B GDP-GTP exchange factor subunit epsilon;, PF00132;PF02020;, GO:0005737;GO:0005829;GO:0005851;GO:0005634;GO:0005085;GO:0003743;GO:0031369;GO:0014002;GO:0048708;GO:0042552;GO:0014003;GO:0001541;GO:0045948;GO:0034976;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:translation initiation factor activity; F:translation initiation factor binding;, P:astrocyte development; P:astrocyte differentiation; P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:positive regulation of translational initiation; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|Q13144 Q541Z1 Q96D04,Translation initiation factor eIF-2B subunit epsilon,eIF-2B GDP-GTP exchange factor subunit epsilon;, PF00132;PF02020;, GO:0005737;GO:0005829;GO:0005851;GO:0005634;GO:0005085;GO:0003743;GO:0031369;GO:0014002;GO:0048708;GO:0042552;GO:0014003;GO:0001541;GO:0045948;GO:0034976;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:translation initiation factor activity; F:translation initiation factor binding;, P:astrocyte development; P:astrocyte differentiation; P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:positive regulation of translational initiation; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|Q13144 Q541Z1 Q96D04,Translation initiation factor eIF-2B subunit epsilon,eIF-2B GDP-GTP exchange factor subunit epsilon;, PF00132;PF02020;, GO:0005737;GO:0005829;GO:0005851;GO:0005634;GO:0005085;GO:0003743;GO:0031369;GO:0014002;GO:0048708;GO:0042552;GO:0014003;GO:0001541;GO:0045948;GO:0034976;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:translation initiation factor activity; F:translation initiation factor binding;, P:astrocyte development; P:astrocyte differentiation; P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:positive regulation of translational initiation; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|Q92997 B4E3E5 D3DNT0 O14642 Q13531 Q8N5E9 Q92607,Segment polarity protein dishevelled homolog DVL-3,DSH homolog 3;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0000785;GO:0005829;GO:0008013;GO:0005109;GO:0002020;GO:0005102;GO:0031267;GO:1904886;GO:0060070;GO:0035556;GO:0090090;GO:0035567;GO:0038031;GO:0090179;GO:0043547;GO:0043507;GO:0150012;GO:0001934;GO:0045944;GO:0045893;GO:0050821;GO:1903827;GO:0042493;GO:0060071;, C:chromatin; C:cytosol;, F:beta-catenin binding; F:frizzled binding; F:protease binding; F:signaling receptor binding; F:small GTPase binding;, P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway via JNK cascade; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of GTPase activity; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection arborization; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of cellular protein localization; P:response to drug; P:Wnt signaling pathway, planar cell polarity pathway;|Q92997 B4E3E5 D3DNT0 O14642 Q13531 Q8N5E9 Q92607,Segment polarity protein dishevelled homolog DVL-3,DSH homolog 3;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0000785;GO:0005829;GO:0008013;GO:0005109;GO:0002020;GO:0005102;GO:0031267;GO:1904886;GO:0060070;GO:0035556;GO:0090090;GO:0035567;GO:0038031;GO:0090179;GO:0043547;GO:0043507;GO:0150012;GO:0001934;GO:0045944;GO:0045893;GO:0050821;GO:1903827;GO:0042493;GO:0060071;, C:chromatin; C:cytosol;, F:beta-catenin binding; F:frizzled binding; F:protease binding; F:signaling receptor binding; F:small GTPase binding;, P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway via JNK cascade; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of GTPase activity; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection arborization; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of cellular protein localization; P:response to drug; P:Wnt signaling pathway, planar cell polarity pathway;|Q92997 B4E3E5 D3DNT0 O14642 Q13531 Q8N5E9 Q92607,Segment polarity protein dishevelled homolog DVL-3,DSH homolog 3;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0000785;GO:0005829;GO:0008013;GO:0005109;GO:0002020;GO:0005102;GO:0031267;GO:1904886;GO:0060070;GO:0035556;GO:0090090;GO:0035567;GO:0038031;GO:0090179;GO:0043547;GO:0043507;GO:0150012;GO:0001934;GO:0045944;GO:0045893;GO:0050821;GO:1903827;GO:0042493;GO:0060071;, C:chromatin; C:cytosol;, F:beta-catenin binding; F:frizzled binding; F:protease binding; F:signaling receptor binding; F:small GTPase binding;, P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway via JNK cascade; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of GTPase activity; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection arborization; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of cellular protein localization; P:response to drug; P:Wnt signaling pathway, planar cell polarity pathway;|Q92997 B4E3E5 D3DNT0 O14642 Q13531 Q8N5E9 Q92607,Segment polarity protein dishevelled homolog DVL-3,DSH homolog 3;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0000785;GO:0005829;GO:0008013;GO:0005109;GO:0002020;GO:0005102;GO:0031267;GO:1904886;GO:0060070;GO:0035556;GO:0090090;GO:0035567;GO:0038031;GO:0090179;GO:0043547;GO:0043507;GO:0150012;GO:0001934;GO:0045944;GO:0045893;GO:0050821;GO:1903827;GO:0042493;GO:0060071;, C:chromatin; C:cytosol;, F:beta-catenin binding; F:frizzled binding; F:protease binding; F:signaling receptor binding; F:small GTPase binding;, P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway via JNK cascade; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of GTPase activity; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection arborization; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of cellular protein localization; P:response to drug; P:Wnt signaling pathway, planar cell polarity pathway; scaffold13 indexed_genome mRNA 36558355 36568924 . + . ID=transcript_3454;Q96CW1 A6NE12 D3DNT1 P20172 P53679,AP-2 complex subunit mu {ECO:0000305},AP-2 mu chain;Adaptin-mu2;Adaptor protein complex AP-2 subunit mu;Adaptor-related protein complex 2 subunit mu;Clathrin assembly protein complex 2 mu medium chain;Clathrin coat assembly protein AP50;Clathrin coat-associated protein AP50;HA2 50 kDa subunit;Plasma membrane adaptor AP-2 50 kDa protein;, PF00928;PF01217;, GO:0030122;GO:0045334;GO:0030669;GO:0005905;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0070062;GO:0043231;GO:0005765;GO:0005886;GO:0035615;GO:0044325;GO:0008289;GO:0050750;GO:0005048;GO:0019886;GO:0034622;GO:0072583;GO:0006897;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:1903077;GO:0031623;GO:0050690;GO:0097494;GO:0006900;GO:0016192;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane;, F:clathrin adaptor activity; F:ion channel binding; F:lipid binding; F:low-density lipoprotein particle receptor binding; F:signal sequence binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular protein-containing complex assembly; P:clathrin-dependent endocytosis; P:endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of protein localization to plasma membrane; P:receptor internalization; P:regulation of defense response to virus by virus; P:regulation of vesicle size; P:vesicle budding from membrane; P:vesicle-mediated transport; P:Wnt signaling pathway, planar cell polarity pathway;|Q96CW1 A6NE12 D3DNT1 P20172 P53679,AP-2 complex subunit mu {ECO:0000305},AP-2 mu chain;Adaptin-mu2;Adaptor protein complex AP-2 subunit mu;Adaptor-related protein complex 2 subunit mu;Clathrin assembly protein complex 2 mu medium chain;Clathrin coat assembly protein AP50;Clathrin coat-associated protein AP50;HA2 50 kDa subunit;Plasma membrane adaptor AP-2 50 kDa protein;, PF00928;PF01217;, GO:0030122;GO:0045334;GO:0030669;GO:0005905;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0070062;GO:0043231;GO:0005765;GO:0005886;GO:0035615;GO:0044325;GO:0008289;GO:0050750;GO:0005048;GO:0019886;GO:0034622;GO:0072583;GO:0006897;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:1903077;GO:0031623;GO:0050690;GO:0097494;GO:0006900;GO:0016192;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane;, F:clathrin adaptor activity; F:ion channel binding; F:lipid binding; F:low-density lipoprotein particle receptor binding; F:signal sequence binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular protein-containing complex assembly; P:clathrin-dependent endocytosis; P:endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of protein localization to plasma membrane; P:receptor internalization; P:regulation of defense response to virus by virus; P:regulation of vesicle size; P:vesicle budding from membrane; P:vesicle-mediated transport; P:Wnt signaling pathway, planar cell polarity pathway;|Q96CW1 A6NE12 D3DNT1 P20172 P53679,AP-2 complex subunit mu {ECO:0000305},AP-2 mu chain;Adaptin-mu2;Adaptor protein complex AP-2 subunit mu;Adaptor-related protein complex 2 subunit mu;Clathrin assembly protein complex 2 mu medium chain;Clathrin coat assembly protein AP50;Clathrin coat-associated protein AP50;HA2 50 kDa subunit;Plasma membrane adaptor AP-2 50 kDa protein;, PF00928;PF01217;, GO:0030122;GO:0045334;GO:0030669;GO:0005905;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0070062;GO:0043231;GO:0005765;GO:0005886;GO:0035615;GO:0044325;GO:0008289;GO:0050750;GO:0005048;GO:0019886;GO:0034622;GO:0072583;GO:0006897;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:1903077;GO:0031623;GO:0050690;GO:0097494;GO:0006900;GO:0016192;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane;, F:clathrin adaptor activity; F:ion channel binding; F:lipid binding; F:low-density lipoprotein particle receptor binding; F:signal sequence binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular protein-containing complex assembly; P:clathrin-dependent endocytosis; P:endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of protein localization to plasma membrane; P:receptor internalization; P:regulation of defense response to virus by virus; P:regulation of vesicle size; P:vesicle budding from membrane; P:vesicle-mediated transport; P:Wnt signaling pathway, planar cell polarity pathway; scaffold13 indexed_genome mRNA 36569691 36574100 . + . ID=transcript_3455;Q9NUQ8 A8K241 Q86UA2 Q8NAN1 Q96GS8 Q9H7A8,ATP-binding cassette sub-family F member 3,, PF00005;PF12848;, GO:0016020;GO:0005524;GO:0016887;GO:0045296;GO:0051607;, C:membrane;, F:ATP binding; F:ATPase activity; F:cadherin binding;, P:defense response to virus;|Q9NUQ8 A8K241 Q86UA2 Q8NAN1 Q96GS8 Q9H7A8,ATP-binding cassette sub-family F member 3,, PF00005;PF12848;, GO:0016020;GO:0005524;GO:0016887;GO:0045296;GO:0051607;, C:membrane;, F:ATP binding; F:ATPase activity; F:cadherin binding;, P:defense response to virus;|Q9NUQ8 A8K241 Q86UA2 Q8NAN1 Q96GS8 Q9H7A8,ATP-binding cassette sub-family F member 3,, PF00005;PF12848;, GO:0016020;GO:0005524;GO:0016887;GO:0045296;GO:0051607;, C:membrane;, F:ATP binding; F:ATPase activity; F:cadherin binding;, P:defense response to virus; scaffold13 indexed_genome mRNA 36574827 36578966 . + . ID=transcript_3456;Q9NUQ8 A8K241 Q86UA2 Q8NAN1 Q96GS8 Q9H7A8,ATP-binding cassette sub-family F member 3,, PF00005;PF12848;, GO:0016020;GO:0005524;GO:0016887;GO:0045296;GO:0051607;, C:membrane;, F:ATP binding; F:ATPase activity; F:cadherin binding;, P:defense response to virus;|Q9NUQ8 A8K241 Q86UA2 Q8NAN1 Q96GS8 Q9H7A8,ATP-binding cassette sub-family F member 3,, PF00005;PF12848;, GO:0016020;GO:0005524;GO:0016887;GO:0045296;GO:0051607;, C:membrane;, F:ATP binding; F:ATPase activity; F:cadherin binding;, P:defense response to virus; scaffold13 indexed_genome mRNA 36594108 36606613 . + . ID=transcript_3457;Q8N398 B9EGN7,von Willebrand factor A domain-containing protein 5B2,, PF13757;PF13768;|Q8N398 B9EGN7,von Willebrand factor A domain-containing protein 5B2,, PF13757;PF13768;|Q8N398 B9EGN7,von Willebrand factor A domain-containing protein 5B2,, PF13757;PF13768;|Q8N398 B9EGN7,von Willebrand factor A domain-containing protein 5B2,, PF13757;PF13768;|Q8N398 B9EGN7,von Willebrand factor A domain-containing protein 5B2,, PF13757;PF13768;|Q8N398 B9EGN7,von Willebrand factor A domain-containing protein 5B2,, PF13757;PF13768;|Q8N398 B9EGN7,von Willebrand factor A domain-containing protein 5B2,, PF13757;PF13768; scaffold13 indexed_genome mRNA 36606658 36611676 . - . ID=transcript_3458;Q92685 A8JZZ6 Q9BT71,Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase,Asparagine-linked glycosylation protein 3 homolog;Dol-P-Man-dependent alpha(1-3)-mannosyltransferase;Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase;Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase;Not56-like protein;, PF05208;, GO:0005783;GO:0005789;GO:0016021;GO:0000033;GO:0052925;GO:0006488;GO:0006486;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,3-mannosyltransferase activity; F:dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein glycosylation;|Q92685 A8JZZ6 Q9BT71,Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase,Asparagine-linked glycosylation protein 3 homolog;Dol-P-Man-dependent alpha(1-3)-mannosyltransferase;Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase;Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase;Not56-like protein;, PF05208;, GO:0005783;GO:0005789;GO:0016021;GO:0000033;GO:0052925;GO:0006488;GO:0006486;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,3-mannosyltransferase activity; F:dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein glycosylation;|Q92685 A8JZZ6 Q9BT71,Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase,Asparagine-linked glycosylation protein 3 homolog;Dol-P-Man-dependent alpha(1-3)-mannosyltransferase;Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase;Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase;Not56-like protein;, PF05208;, GO:0005783;GO:0005789;GO:0016021;GO:0000033;GO:0052925;GO:0006488;GO:0006486;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,3-mannosyltransferase activity; F:dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein glycosylation; scaffold13 indexed_genome mRNA 36612443 36617534 . + . ID=transcript_3459;P0DPD7 A5PLK8 O60344 Q6NTG7 Q6UW36 Q8NFD7 Q96NX3 Q96NX4 Q9BRZ8,EEF1A lysine methyltransferase 4 {ECO:0000305},, PF08241;, GO:0008168;GO:0016279;, , F:methyltransferase activity; F:protein-lysine N-methyltransferase activity; scaffold13 indexed_genome mRNA 36618228 36619037 . - . ID=transcript_3460;P0DPD7 A5PLK8 O60344 Q6NTG7 Q6UW36 Q8NFD7 Q96NX3 Q96NX4 Q9BRZ8,EEF1A lysine methyltransferase 4 {ECO:0000305},, PF08241;, GO:0008168;GO:0016279;, , F:methyltransferase activity; F:protein-lysine N-methyltransferase activity; scaffold13 indexed_genome mRNA 36629406 36646783 . + . ID=transcript_3461;P0DPD6 A5PLK8 O60344 Q6NTG7 Q6UW36 Q8NFD7 Q96NX3 Q96NX4 Q9BRZ8,Endothelin-converting enzyme 2 {ECO:0000303|PubMed:11718899},, PF01431;PF05649;, GO:0030659;GO:0000139;GO:0016021;GO:0005886;GO:0030658;GO:0046872;GO:0004222;GO:0008168;GO:0007267;GO:0007186;GO:0032259;GO:0016486;GO:0016485;, C:cytoplasmic vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:transport vesicle membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:methyltransferase activity;, P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:methylation; P:peptide hormone processing; P:protein processing;|P0DPD6 A5PLK8 O60344 Q6NTG7 Q6UW36 Q8NFD7 Q96NX3 Q96NX4 Q9BRZ8,Endothelin-converting enzyme 2 {ECO:0000303|PubMed:11718899},, PF01431;PF05649;, GO:0030659;GO:0000139;GO:0016021;GO:0005886;GO:0030658;GO:0046872;GO:0004222;GO:0008168;GO:0007267;GO:0007186;GO:0032259;GO:0016486;GO:0016485;, C:cytoplasmic vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:transport vesicle membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:methyltransferase activity;, P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:methylation; P:peptide hormone processing; P:protein processing;|P0DPD6 A5PLK8 O60344 Q6NTG7 Q6UW36 Q8NFD7 Q96NX3 Q96NX4 Q9BRZ8,Endothelin-converting enzyme 2 {ECO:0000303|PubMed:11718899},, PF01431;PF05649;, GO:0030659;GO:0000139;GO:0016021;GO:0005886;GO:0030658;GO:0046872;GO:0004222;GO:0008168;GO:0007267;GO:0007186;GO:0032259;GO:0016486;GO:0016485;, C:cytoplasmic vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:transport vesicle membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:methyltransferase activity;, P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:methylation; P:peptide hormone processing; P:protein processing;|P0DPD6 A5PLK8 O60344 Q6NTG7 Q6UW36 Q8NFD7 Q96NX3 Q96NX4 Q9BRZ8,Endothelin-converting enzyme 2 {ECO:0000303|PubMed:11718899},, PF01431;PF05649;, GO:0030659;GO:0000139;GO:0016021;GO:0005886;GO:0030658;GO:0046872;GO:0004222;GO:0008168;GO:0007267;GO:0007186;GO:0032259;GO:0016486;GO:0016485;, C:cytoplasmic vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:transport vesicle membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:methyltransferase activity;, P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:methylation; P:peptide hormone processing; P:protein processing;|P0DPD6 A5PLK8 O60344 Q6NTG7 Q6UW36 Q8NFD7 Q96NX3 Q96NX4 Q9BRZ8,Endothelin-converting enzyme 2 {ECO:0000303|PubMed:11718899},, PF01431;PF05649;, GO:0030659;GO:0000139;GO:0016021;GO:0005886;GO:0030658;GO:0046872;GO:0004222;GO:0008168;GO:0007267;GO:0007186;GO:0032259;GO:0016486;GO:0016485;, C:cytoplasmic vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:transport vesicle membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:methyltransferase activity;, P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:methylation; P:peptide hormone processing; P:protein processing;|P0DPD6 A5PLK8 O60344 Q6NTG7 Q6UW36 Q8NFD7 Q96NX3 Q96NX4 Q9BRZ8,Endothelin-converting enzyme 2 {ECO:0000303|PubMed:11718899},, PF01431;PF05649;, GO:0030659;GO:0000139;GO:0016021;GO:0005886;GO:0030658;GO:0046872;GO:0004222;GO:0008168;GO:0007267;GO:0007186;GO:0032259;GO:0016486;GO:0016485;, C:cytoplasmic vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:transport vesicle membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:methyltransferase activity;, P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:methylation; P:peptide hormone processing; P:protein processing;|P0DPD6 A5PLK8 O60344 Q6NTG7 Q6UW36 Q8NFD7 Q96NX3 Q96NX4 Q9BRZ8,Endothelin-converting enzyme 2 {ECO:0000303|PubMed:11718899},, PF01431;PF05649;, GO:0030659;GO:0000139;GO:0016021;GO:0005886;GO:0030658;GO:0046872;GO:0004222;GO:0008168;GO:0007267;GO:0007186;GO:0032259;GO:0016486;GO:0016485;, C:cytoplasmic vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:transport vesicle membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:methyltransferase activity;, P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:methylation; P:peptide hormone processing; P:protein processing; scaffold13 indexed_genome mRNA 36650943 36659918 . + . ID=transcript_3462;Q13200 B4DX07 B4DXY1 E7EW34 E9PCS3 Q12932 Q15321 Q53XQ4 Q96I12,26S proteasome non-ATPase regulatory subunit 2,26S proteasome regulatory subunit RPN1;26S proteasome regulatory subunit S2;26S proteasome subunit p97;Protein 55.11;Tumor necrosis factor type 1 receptor-associated protein 2;, PF01851;PF18051;PF17781;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008540;GO:0034515;GO:0034774;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, base subcomplex; C:proteasome storage granule; C:secretory granule lumen;, F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q13200 B4DX07 B4DXY1 E7EW34 E9PCS3 Q12932 Q15321 Q53XQ4 Q96I12,26S proteasome non-ATPase regulatory subunit 2,26S proteasome regulatory subunit RPN1;26S proteasome regulatory subunit S2;26S proteasome subunit p97;Protein 55.11;Tumor necrosis factor type 1 receptor-associated protein 2;, PF01851;PF18051;PF17781;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008540;GO:0034515;GO:0034774;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, base subcomplex; C:proteasome storage granule; C:secretory granule lumen;, F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q13200 B4DX07 B4DXY1 E7EW34 E9PCS3 Q12932 Q15321 Q53XQ4 Q96I12,26S proteasome non-ATPase regulatory subunit 2,26S proteasome regulatory subunit RPN1;26S proteasome regulatory subunit S2;26S proteasome subunit p97;Protein 55.11;Tumor necrosis factor type 1 receptor-associated protein 2;, PF01851;PF18051;PF17781;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008540;GO:0034515;GO:0034774;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, base subcomplex; C:proteasome storage granule; C:secretory granule lumen;, F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q13200 B4DX07 B4DXY1 E7EW34 E9PCS3 Q12932 Q15321 Q53XQ4 Q96I12,26S proteasome non-ATPase regulatory subunit 2,26S proteasome regulatory subunit RPN1;26S proteasome regulatory subunit S2;26S proteasome subunit p97;Protein 55.11;Tumor necrosis factor type 1 receptor-associated protein 2;, PF01851;PF18051;PF17781;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008540;GO:0034515;GO:0034774;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, base subcomplex; C:proteasome storage granule; C:secretory granule lumen;, F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q13200 B4DX07 B4DXY1 E7EW34 E9PCS3 Q12932 Q15321 Q53XQ4 Q96I12,26S proteasome non-ATPase regulatory subunit 2,26S proteasome regulatory subunit RPN1;26S proteasome regulatory subunit S2;26S proteasome subunit p97;Protein 55.11;Tumor necrosis factor type 1 receptor-associated protein 2;, PF01851;PF18051;PF17781;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008540;GO:0034515;GO:0034774;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, base subcomplex; C:proteasome storage granule; C:secretory granule lumen;, F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q13200 B4DX07 B4DXY1 E7EW34 E9PCS3 Q12932 Q15321 Q53XQ4 Q96I12,26S proteasome non-ATPase regulatory subunit 2,26S proteasome regulatory subunit RPN1;26S proteasome regulatory subunit S2;26S proteasome subunit p97;Protein 55.11;Tumor necrosis factor type 1 receptor-associated protein 2;, PF01851;PF18051;PF17781;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008540;GO:0034515;GO:0034774;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, base subcomplex; C:proteasome storage granule; C:secretory granule lumen;, F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold13 indexed_genome mRNA 36664367 36682245 . + . ID=transcript_3463;Q6ZN21 Q8N102,Eukaryotic translation initiation factor 4 gamma 1,p220;, PF02847;PF02854;PF02020;, GO:0005737;GO:0010494;GO:0005829;GO:0016281;GO:0016020;GO:0005634;GO:0005844;GO:0005524;GO:0008190;GO:0042802;GO:0060090;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001662;GO:0002191;GO:0034645;GO:0031669;GO:0032502;GO:0097009;GO:0010507;GO:1901215;GO:0010801;GO:0000184;GO:0010942;GO:0030307;GO:0032270;GO:1905537;GO:1900087;GO:1905618;GO:1905612;GO:0045666;GO:0033138;GO:0036493;GO:0080135;GO:0060964;GO:0043488;GO:1905696;GO:1905606;GO:0006446;GO:0006412;GO:0006413;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane; C:nucleus; C:polysome;, F:ATP binding; F:eukaryotic initiation factor 4E binding; F:identical protein binding; F:molecular adaptor activity; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:behavioral fear response; P:cap-dependent translational initiation; P:cellular macromolecule biosynthetic process; P:cellular response to nutrient levels; P:developmental process; P:energy homeostasis; P:negative regulation of autophagy; P:negative regulation of neuron death; P:negative regulation of peptidyl-threonine phosphorylation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell death; P:positive regulation of cell growth; P:positive regulation of cellular protein metabolic process; P:positive regulation of eukaryotic translation initiation factor 4F complex assembly; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of mRNA cap binding; P:positive regulation of neuron differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cellular response to stress; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of polysome binding; P:regulation of presynapse assembly; P:regulation of translational initiation; P:translation; P:translational initiation; P:viral process;|Q6ZN21 Q8N102,Eukaryotic translation initiation factor 4 gamma 1,p220;, PF02847;PF02854;PF02020;, GO:0005737;GO:0010494;GO:0005829;GO:0016281;GO:0016020;GO:0005634;GO:0005844;GO:0005524;GO:0008190;GO:0042802;GO:0060090;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001662;GO:0002191;GO:0034645;GO:0031669;GO:0032502;GO:0097009;GO:0010507;GO:1901215;GO:0010801;GO:0000184;GO:0010942;GO:0030307;GO:0032270;GO:1905537;GO:1900087;GO:1905618;GO:1905612;GO:0045666;GO:0033138;GO:0036493;GO:0080135;GO:0060964;GO:0043488;GO:1905696;GO:1905606;GO:0006446;GO:0006412;GO:0006413;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane; C:nucleus; C:polysome;, F:ATP binding; F:eukaryotic initiation factor 4E binding; F:identical protein binding; F:molecular adaptor activity; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:behavioral fear response; P:cap-dependent translational initiation; P:cellular macromolecule biosynthetic process; P:cellular response to nutrient levels; P:developmental process; P:energy homeostasis; P:negative regulation of autophagy; P:negative regulation of neuron death; P:negative regulation of peptidyl-threonine phosphorylation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell death; P:positive regulation of cell growth; P:positive regulation of cellular protein metabolic process; P:positive regulation of eukaryotic translation initiation factor 4F complex assembly; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of mRNA cap binding; P:positive regulation of neuron differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cellular response to stress; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of polysome binding; P:regulation of presynapse assembly; P:regulation of translational initiation; P:translation; P:translational initiation; P:viral process;|Q6ZN21 Q8N102,Eukaryotic translation initiation factor 4 gamma 1,p220;, PF02847;PF02854;PF02020;, GO:0005737;GO:0010494;GO:0005829;GO:0016281;GO:0016020;GO:0005634;GO:0005844;GO:0005524;GO:0008190;GO:0042802;GO:0060090;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001662;GO:0002191;GO:0034645;GO:0031669;GO:0032502;GO:0097009;GO:0010507;GO:1901215;GO:0010801;GO:0000184;GO:0010942;GO:0030307;GO:0032270;GO:1905537;GO:1900087;GO:1905618;GO:1905612;GO:0045666;GO:0033138;GO:0036493;GO:0080135;GO:0060964;GO:0043488;GO:1905696;GO:1905606;GO:0006446;GO:0006412;GO:0006413;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane; C:nucleus; C:polysome;, F:ATP binding; F:eukaryotic initiation factor 4E binding; F:identical protein binding; F:molecular adaptor activity; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:behavioral fear response; P:cap-dependent translational initiation; P:cellular macromolecule biosynthetic process; P:cellular response to nutrient levels; P:developmental process; P:energy homeostasis; P:negative regulation of autophagy; P:negative regulation of neuron death; P:negative regulation of peptidyl-threonine phosphorylation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell death; P:positive regulation of cell growth; P:positive regulation of cellular protein metabolic process; P:positive regulation of eukaryotic translation initiation factor 4F complex assembly; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of mRNA cap binding; P:positive regulation of neuron differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cellular response to stress; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of polysome binding; P:regulation of presynapse assembly; P:regulation of translational initiation; P:translation; P:translational initiation; P:viral process;|Q6ZN21 Q8N102,Eukaryotic translation initiation factor 4 gamma 1,p220;, PF02847;PF02854;PF02020;, GO:0005737;GO:0010494;GO:0005829;GO:0016281;GO:0016020;GO:0005634;GO:0005844;GO:0005524;GO:0008190;GO:0042802;GO:0060090;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001662;GO:0002191;GO:0034645;GO:0031669;GO:0032502;GO:0097009;GO:0010507;GO:1901215;GO:0010801;GO:0000184;GO:0010942;GO:0030307;GO:0032270;GO:1905537;GO:1900087;GO:1905618;GO:1905612;GO:0045666;GO:0033138;GO:0036493;GO:0080135;GO:0060964;GO:0043488;GO:1905696;GO:1905606;GO:0006446;GO:0006412;GO:0006413;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane; C:nucleus; C:polysome;, F:ATP binding; F:eukaryotic initiation factor 4E binding; F:identical protein binding; F:molecular adaptor activity; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:behavioral fear response; P:cap-dependent translational initiation; P:cellular macromolecule biosynthetic process; P:cellular response to nutrient levels; P:developmental process; P:energy homeostasis; P:negative regulation of autophagy; P:negative regulation of neuron death; P:negative regulation of peptidyl-threonine phosphorylation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell death; P:positive regulation of cell growth; P:positive regulation of cellular protein metabolic process; P:positive regulation of eukaryotic translation initiation factor 4F complex assembly; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of mRNA cap binding; P:positive regulation of neuron differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cellular response to stress; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of polysome binding; P:regulation of presynapse assembly; P:regulation of translational initiation; P:translation; P:translational initiation; P:viral process;|Q6ZN21 Q8N102,Eukaryotic translation initiation factor 4 gamma 1,p220;, PF02847;PF02854;PF02020;, GO:0005737;GO:0010494;GO:0005829;GO:0016281;GO:0016020;GO:0005634;GO:0005844;GO:0005524;GO:0008190;GO:0042802;GO:0060090;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001662;GO:0002191;GO:0034645;GO:0031669;GO:0032502;GO:0097009;GO:0010507;GO:1901215;GO:0010801;GO:0000184;GO:0010942;GO:0030307;GO:0032270;GO:1905537;GO:1900087;GO:1905618;GO:1905612;GO:0045666;GO:0033138;GO:0036493;GO:0080135;GO:0060964;GO:0043488;GO:1905696;GO:1905606;GO:0006446;GO:0006412;GO:0006413;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane; C:nucleus; C:polysome;, F:ATP binding; F:eukaryotic initiation factor 4E binding; F:identical protein binding; F:molecular adaptor activity; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:behavioral fear response; P:cap-dependent translational initiation; P:cellular macromolecule biosynthetic process; P:cellular response to nutrient levels; P:developmental process; P:energy homeostasis; P:negative regulation of autophagy; P:negative regulation of neuron death; P:negative regulation of peptidyl-threonine phosphorylation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell death; P:positive regulation of cell growth; P:positive regulation of cellular protein metabolic process; P:positive regulation of eukaryotic translation initiation factor 4F complex assembly; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of mRNA cap binding; P:positive regulation of neuron differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cellular response to stress; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of polysome binding; P:regulation of presynapse assembly; P:regulation of translational initiation; P:translation; P:translational initiation; P:viral process;|Q6ZN21 Q8N102,Eukaryotic translation initiation factor 4 gamma 1,p220;, PF02847;PF02854;PF02020;, GO:0005737;GO:0010494;GO:0005829;GO:0016281;GO:0016020;GO:0005634;GO:0005844;GO:0005524;GO:0008190;GO:0042802;GO:0060090;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001662;GO:0002191;GO:0034645;GO:0031669;GO:0032502;GO:0097009;GO:0010507;GO:1901215;GO:0010801;GO:0000184;GO:0010942;GO:0030307;GO:0032270;GO:1905537;GO:1900087;GO:1905618;GO:1905612;GO:0045666;GO:0033138;GO:0036493;GO:0080135;GO:0060964;GO:0043488;GO:1905696;GO:1905606;GO:0006446;GO:0006412;GO:0006413;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane; C:nucleus; C:polysome;, F:ATP binding; F:eukaryotic initiation factor 4E binding; F:identical protein binding; F:molecular adaptor activity; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:behavioral fear response; P:cap-dependent translational initiation; P:cellular macromolecule biosynthetic process; P:cellular response to nutrient levels; P:developmental process; P:energy homeostasis; P:negative regulation of autophagy; P:negative regulation of neuron death; P:negative regulation of peptidyl-threonine phosphorylation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell death; P:positive regulation of cell growth; P:positive regulation of cellular protein metabolic process; P:positive regulation of eukaryotic translation initiation factor 4F complex assembly; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of mRNA cap binding; P:positive regulation of neuron differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cellular response to stress; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of polysome binding; P:regulation of presynapse assembly; P:regulation of translational initiation; P:translation; P:translational initiation; P:viral process; scaffold13 indexed_genome mRNA 36683630 36685746 . + . ID=transcript_3464;Q6UXB0 D3DNT6 G5E9B1 Q8TA84,Protein FAM131A,, PF15010; scaffold13 indexed_genome mRNA 36685764 36701841 . - . ID=transcript_3465;P51788 B4DQT9 B4DZ58 E9PBD9 E9PCD2 O14864 Q6IPA9 Q8WU13,Chloride channel protein 2,, PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0005247;GO:0060689;GO:0006821;GO:0034220;GO:0032347;GO:0034765;GO:0060041;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:voltage-gated chloride channel activity;, P:cell differentiation involved in salivary gland development; P:chloride transport; P:ion transmembrane transport; P:regulation of aldosterone biosynthetic process; P:regulation of ion transmembrane transport; P:retina development in camera-type eye;|Q6UXB0 D3DNT6 G5E9B1 Q8TA84,Protein FAM131A,, PF15010;|P51788 B4DQT9 B4DZ58 E9PBD9 E9PCD2 O14864 Q6IPA9 Q8WU13,Chloride channel protein 2,, PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0005247;GO:0060689;GO:0006821;GO:0034220;GO:0032347;GO:0034765;GO:0060041;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:voltage-gated chloride channel activity;, P:cell differentiation involved in salivary gland development; P:chloride transport; P:ion transmembrane transport; P:regulation of aldosterone biosynthetic process; P:regulation of ion transmembrane transport; P:retina development in camera-type eye;|P51788 B4DQT9 B4DZ58 E9PBD9 E9PCD2 O14864 Q6IPA9 Q8WU13,Chloride channel protein 2,, PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0005247;GO:0060689;GO:0006821;GO:0034220;GO:0032347;GO:0034765;GO:0060041;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:voltage-gated chloride channel activity;, P:cell differentiation involved in salivary gland development; P:chloride transport; P:ion transmembrane transport; P:regulation of aldosterone biosynthetic process; P:regulation of ion transmembrane transport; P:retina development in camera-type eye; scaffold13 indexed_genome mRNA 36711081 36715039 . + . ID=transcript_3466;P52434 C9J413 C9JBJ6 C9JCU7 C9JUA8 P53802 Q969R0,DNA-directed RNA polymerases I, II, and III subunit RPABC3,DNA-directed RNA polymerase II subunit H;DNA-directed RNA polymerases I, II, and III 17.1 kDa polypeptide;RPB17;RPB8 homolog;, PF03870;, GO:0005829;GO:0005654;GO:0005634;GO:0032993;GO:0005736;GO:0005665;GO:0005666;GO:0003899;GO:0003697;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|P52434 C9J413 C9JBJ6 C9JCU7 C9JUA8 P53802 Q969R0,DNA-directed RNA polymerases I, II, and III subunit RPABC3,DNA-directed RNA polymerase II subunit H;DNA-directed RNA polymerases I, II, and III 17.1 kDa polypeptide;RPB17;RPB8 homolog;, PF03870;, GO:0005829;GO:0005654;GO:0005634;GO:0032993;GO:0005736;GO:0005665;GO:0005666;GO:0003899;GO:0003697;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|P52434 C9J413 C9JBJ6 C9JCU7 C9JUA8 P53802 Q969R0,DNA-directed RNA polymerases I, II, and III subunit RPABC3,DNA-directed RNA polymerase II subunit H;DNA-directed RNA polymerases I, II, and III 17.1 kDa polypeptide;RPB17;RPB8 homolog;, PF03870;, GO:0005829;GO:0005654;GO:0005634;GO:0032993;GO:0005736;GO:0005665;GO:0005666;GO:0003899;GO:0003697;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; scaffold13 indexed_genome mRNA 36718509 36727028 . - . ID=transcript_3467;P40225 A1L3Y0 B7ZLR8 B9EGA8 Q13020 Q15790 Q15791 Q15792,Thrombopoietin,C-mpl ligand;Megakaryocyte colony-stimulating factor;Megakaryocyte growth and development factor;Myeloproliferative leukemia virus oncogene ligand;, PF00758;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005179;GO:0005102;GO:0008283;GO:0035855;GO:0007275;GO:0008284;GO:0070374;GO:1902035;GO:0043410;GO:0045654;GO:0051897;GO:0001934;GO:0097696;GO:0038163;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:signaling receptor binding;, P:cell population proliferation; P:megakaryocyte development; P:multicellular organism development; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of hematopoietic stem cell proliferation; P:positive regulation of MAPK cascade; P:positive regulation of megakaryocyte differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:receptor signaling pathway via STAT; P:thrombopoietin-mediated signaling pathway;|P40225 A1L3Y0 B7ZLR8 B9EGA8 Q13020 Q15790 Q15791 Q15792,Thrombopoietin,C-mpl ligand;Megakaryocyte colony-stimulating factor;Megakaryocyte growth and development factor;Myeloproliferative leukemia virus oncogene ligand;, PF00758;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005179;GO:0005102;GO:0008283;GO:0035855;GO:0007275;GO:0008284;GO:0070374;GO:1902035;GO:0043410;GO:0045654;GO:0051897;GO:0001934;GO:0097696;GO:0038163;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:signaling receptor binding;, P:cell population proliferation; P:megakaryocyte development; P:multicellular organism development; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of hematopoietic stem cell proliferation; P:positive regulation of MAPK cascade; P:positive regulation of megakaryocyte differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:receptor signaling pathway via STAT; P:thrombopoietin-mediated signaling pathway;|P40225 A1L3Y0 B7ZLR8 B9EGA8 Q13020 Q15790 Q15791 Q15792,Thrombopoietin,C-mpl ligand;Megakaryocyte colony-stimulating factor;Megakaryocyte growth and development factor;Myeloproliferative leukemia virus oncogene ligand;, PF00758;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005179;GO:0005102;GO:0008283;GO:0035855;GO:0007275;GO:0008284;GO:0070374;GO:1902035;GO:0043410;GO:0045654;GO:0051897;GO:0001934;GO:0097696;GO:0038163;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:signaling receptor binding;, P:cell population proliferation; P:megakaryocyte development; P:multicellular organism development; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of hematopoietic stem cell proliferation; P:positive regulation of MAPK cascade; P:positive regulation of megakaryocyte differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:receptor signaling pathway via STAT; P:thrombopoietin-mediated signaling pathway;|P40225 A1L3Y0 B7ZLR8 B9EGA8 Q13020 Q15790 Q15791 Q15792,Thrombopoietin,C-mpl ligand;Megakaryocyte colony-stimulating factor;Megakaryocyte growth and development factor;Myeloproliferative leukemia virus oncogene ligand;, PF00758;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005179;GO:0005102;GO:0008283;GO:0035855;GO:0007275;GO:0008284;GO:0070374;GO:1902035;GO:0043410;GO:0045654;GO:0051897;GO:0001934;GO:0097696;GO:0038163;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:signaling receptor binding;, P:cell population proliferation; P:megakaryocyte development; P:multicellular organism development; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of hematopoietic stem cell proliferation; P:positive regulation of MAPK cascade; P:positive regulation of megakaryocyte differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:receptor signaling pathway via STAT; P:thrombopoietin-mediated signaling pathway; scaffold13 indexed_genome mRNA 36727671 36736437 . + . ID=transcript_3468;Q9P0Z4 Q9P0Z5,Chordin,, PF07452;PF00093;, GO:0005615;GO:0019955;GO:0021919;GO:0033504;GO:0030514;GO:0030336;GO:0045668;GO:0045785;GO:0002053;GO:0001501;, C:extracellular space;, F:cytokine binding;, P:BMP signaling pathway involved in spinal cord dorsal/ventral patterning; P:floor plate development; P:negative regulation of BMP signaling pathway; P:negative regulation of cell migration; P:negative regulation of osteoblast differentiation; P:positive regulation of cell adhesion; P:positive regulation of mesenchymal cell proliferation; P:skeletal system development; scaffold13 indexed_genome mRNA 36836939 36838747 . - . ID=transcript_3469;Q5T9Z0 Q8IVJ0,Transmembrane epididymal protein 1,Human epididymis-specific protein 9;, PF04819;, GO:0016021;, C:integral component of membrane;|Q5T9Z0 Q8IVJ0,Transmembrane epididymal protein 1,Human epididymis-specific protein 9;, PF04819;, GO:0016021;, C:integral component of membrane; scaffold13 indexed_genome mRNA 36897169 36917096 . + . ID=transcript_3470;P54753 Q7Z740,Ephrin type-B receptor 3,EPH-like tyrosine kinase 2;Embryonic kinase 2;Tyrosine-protein kinase TYRO6;, PF14575;PF01404;PF07699;PF00041;PF07714;PF00536;, GO:0005829;GO:0030425;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0008046;GO:0005003;GO:0004714;GO:0005005;GO:0001525;GO:0007411;GO:0007413;GO:0016477;GO:0021952;GO:0022038;GO:0060996;GO:0060997;GO:0048546;GO:0048013;GO:0007275;GO:0033674;GO:0051965;GO:0046777;GO:0050770;GO:0022407;GO:0043087;GO:0031290;GO:0060021;GO:0034446;GO:0048538;GO:0007169;GO:0001655;, C:cytosol; C:dendrite; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:axon guidance receptor activity; F:ephrin receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:angiogenesis; P:axon guidance; P:axonal fasciculation; P:cell migration; P:central nervous system projection neuron axonogenesis; P:corpus callosum development; P:dendritic spine development; P:dendritic spine morphogenesis; P:digestive tract morphogenesis; P:ephrin receptor signaling pathway; P:multicellular organism development; P:positive regulation of kinase activity; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of axonogenesis; P:regulation of cell-cell adhesion; P:regulation of GTPase activity; P:retinal ganglion cell axon guidance; P:roof of mouth development; P:substrate adhesion-dependent cell spreading; P:thymus development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:urogenital system development; scaffold13 indexed_genome mRNA 37026614 37028203 . - . ID=transcript_3471;Q9HAY2 Q9H215,Melanoma-associated antigen F1 {ECO:0000305},MAGE-F1 antigen;, PF01454;, GO:2000042;GO:2000060;GO:0097428;GO:0016567;, , , P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein maturation by iron-sulfur cluster transfer; P:protein ubiquitination; scaffold13 indexed_genome mRNA 37127875 37400227 . + . ID=transcript_3472;Q8N3P4 A8K8Q8 B9EIQ1 C9JB61 O94896 Q63HP2 Q9BVP9 Q9H9B0,Vacuolar protein sorting-associated protein 8 homolog,, PF12816;, GO:0033263;GO:0005769;GO:0046872;GO:0034058;GO:0015031;, C:CORVET complex; C:early endosome;, F:metal ion binding;, P:endosomal vesicle fusion; P:protein transport;|Q8N3P4 A8K8Q8 B9EIQ1 C9JB61 O94896 Q63HP2 Q9BVP9 Q9H9B0,Vacuolar protein sorting-associated protein 8 homolog,, PF12816;, GO:0033263;GO:0005769;GO:0046872;GO:0034058;GO:0015031;, C:CORVET complex; C:early endosome;, F:metal ion binding;, P:endosomal vesicle fusion; P:protein transport;|Q8N3P4 A8K8Q8 B9EIQ1 C9JB61 O94896 Q63HP2 Q9BVP9 Q9H9B0,Vacuolar protein sorting-associated protein 8 homolog,, PF12816;, GO:0033263;GO:0005769;GO:0046872;GO:0034058;GO:0015031;, C:CORVET complex; C:early endosome;, F:metal ion binding;, P:endosomal vesicle fusion; P:protein transport; scaffold13 indexed_genome mRNA 37405129 37410832 . + . ID=transcript_3473;A6NLC5 B2RNY2 B9EH83,UPF0524 protein C3orf70,, PF15823;, GO:0048512;GO:0007399;, , , P:circadian behavior; P:nervous system development; scaffold13 indexed_genome mRNA 37580391 37640308 . - . ID=transcript_3474;Q08426 A8K6Y3 B4DWG3 D3DNU0 Q58EZ5,Peroxisomal bifunctional enzyme {ECO:0000305},L-bifunctional protein {ECO:0000303|PubMed:15060085};Multifunctional enzyme 1;, PF00725;PF02737;PF00378;, GO:0005829;GO:0005782;GO:0005777;GO:0003857;GO:0004165;GO:0004300;GO:0019899;GO:0016863;GO:0016509;GO:0070403;GO:0006635;GO:0033540;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:3-hydroxyacyl-CoA dehydrogenase activity; F:dodecenoyl-CoA delta-isomerase activity; F:enoyl-CoA hydratase activity; F:enzyme binding; F:intramolecular oxidoreductase activity, transposing C=C bonds; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; F:NAD+ binding;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:protein localization; scaffold13 indexed_genome mRNA 37761586 37805583 . + . ID=transcript_3475;O43283 B2R6U2 B4DLE3 B4DMV2 B4DZJ4 D3DNU1 Q05BY6 Q15450 Q2NKN3,Mitogen-activated protein kinase kinase kinase 13,Leucine zipper-bearing kinase;Mixed lineage kinase;, PF07714;, GO:0005737;GO:0016020;GO:0005524;GO:0019899;GO:0042802;GO:0106137;GO:0004706;GO:0004709;GO:0046872;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0007256;GO:0007257;GO:0000186;GO:0007254;GO:0018105;GO:0045773;GO:1905492;GO:0014042;GO:0150012;GO:0051092;GO:0046777;GO:0006468;, C:cytoplasm; C:membrane;, F:ATP binding; F:enzyme binding; F:identical protein binding; F:IkappaB kinase complex binding; F:JUN kinase kinase kinase activity; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JNKK activity; P:activation of JUN kinase activity; P:activation of MAPKK activity; P:JNK cascade; P:peptidyl-serine phosphorylation; P:positive regulation of axon extension; P:positive regulation of branching morphogenesis of a nerve; P:positive regulation of neuron maturation; P:positive regulation of neuron projection arborization; P:positive regulation of NF-kappaB transcription factor activity; P:protein autophosphorylation; P:protein phosphorylation;|O43283 B2R6U2 B4DLE3 B4DMV2 B4DZJ4 D3DNU1 Q05BY6 Q15450 Q2NKN3,Mitogen-activated protein kinase kinase kinase 13,Leucine zipper-bearing kinase;Mixed lineage kinase;, PF07714;, GO:0005737;GO:0016020;GO:0005524;GO:0019899;GO:0042802;GO:0106137;GO:0004706;GO:0004709;GO:0046872;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0007256;GO:0007257;GO:0000186;GO:0007254;GO:0018105;GO:0045773;GO:1905492;GO:0014042;GO:0150012;GO:0051092;GO:0046777;GO:0006468;, C:cytoplasm; C:membrane;, F:ATP binding; F:enzyme binding; F:identical protein binding; F:IkappaB kinase complex binding; F:JUN kinase kinase kinase activity; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JNKK activity; P:activation of JUN kinase activity; P:activation of MAPKK activity; P:JNK cascade; P:peptidyl-serine phosphorylation; P:positive regulation of axon extension; P:positive regulation of branching morphogenesis of a nerve; P:positive regulation of neuron maturation; P:positive regulation of neuron projection arborization; P:positive regulation of NF-kappaB transcription factor activity; P:protein autophosphorylation; P:protein phosphorylation; scaffold13 indexed_genome mRNA 37811476 37813354 . + . ID=transcript_3476;Q96HV5 A8K4B3 D3DNU2 Q6ZMJ0,Transmembrane protein 41A,, PF09335;, GO:0016021;, C:integral component of membrane; scaffold13 indexed_genome mRNA 37816030 37821025 . - . ID=transcript_3477;Q96HV5 A8K4B3 D3DNU2 Q6ZMJ0,Transmembrane protein 41A,, PF09335;, GO:0016021;, C:integral component of membrane; scaffold13 indexed_genome mRNA 37890598 37927378 . + . ID=transcript_3478;Q9HC62 B4DQ42 Q8IW97 Q96SR2 Q9P2L5,Sentrin-specific protease 2,Axam2;SMT3-specific isopeptidase 2;Sentrin/SUMO-specific protease SENP2;, PF02902;, GO:0005829;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0016605;GO:0019904;GO:0070139;GO:0070140;GO:0009950;GO:0045444;GO:0007507;GO:0060711;GO:0051028;GO:0035562;GO:0032091;GO:0031397;GO:0001934;GO:0031398;GO:0045944;GO:0031648;GO:0016926;GO:0015031;GO:0032875;GO:2000045;GO:0030111;GO:0060712;GO:0060707;GO:0016055;, C:cytosol; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:PML body;, F:protein domain specific binding; F:SUMO-specific endopeptidase activity; F:SUMO-specific isopeptidase activity;, P:dorsal/ventral axis specification; P:fat cell differentiation; P:heart development; P:labyrinthine layer development; P:mRNA transport; P:negative regulation of chromatin binding; P:negative regulation of protein binding; P:negative regulation of protein ubiquitination; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein destabilization; P:protein desumoylation; P:protein transport; P:regulation of DNA endoreduplication; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of Wnt signaling pathway; P:spongiotrophoblast layer development; P:trophoblast giant cell differentiation; P:Wnt signaling pathway;|Q9HC62 B4DQ42 Q8IW97 Q96SR2 Q9P2L5,Sentrin-specific protease 2,Axam2;SMT3-specific isopeptidase 2;Sentrin/SUMO-specific protease SENP2;, PF02902;, GO:0005829;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0016605;GO:0019904;GO:0070139;GO:0070140;GO:0009950;GO:0045444;GO:0007507;GO:0060711;GO:0051028;GO:0035562;GO:0032091;GO:0031397;GO:0001934;GO:0031398;GO:0045944;GO:0031648;GO:0016926;GO:0015031;GO:0032875;GO:2000045;GO:0030111;GO:0060712;GO:0060707;GO:0016055;, C:cytosol; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:PML body;, F:protein domain specific binding; F:SUMO-specific endopeptidase activity; F:SUMO-specific isopeptidase activity;, P:dorsal/ventral axis specification; P:fat cell differentiation; P:heart development; P:labyrinthine layer development; P:mRNA transport; P:negative regulation of chromatin binding; P:negative regulation of protein binding; P:negative regulation of protein ubiquitination; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein destabilization; P:protein desumoylation; P:protein transport; P:regulation of DNA endoreduplication; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of Wnt signaling pathway; P:spongiotrophoblast layer development; P:trophoblast giant cell differentiation; P:Wnt signaling pathway;|Q9HC62 B4DQ42 Q8IW97 Q96SR2 Q9P2L5,Sentrin-specific protease 2,Axam2;SMT3-specific isopeptidase 2;Sentrin/SUMO-specific protease SENP2;, PF02902;, GO:0005829;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0016605;GO:0019904;GO:0070139;GO:0070140;GO:0009950;GO:0045444;GO:0007507;GO:0060711;GO:0051028;GO:0035562;GO:0032091;GO:0031397;GO:0001934;GO:0031398;GO:0045944;GO:0031648;GO:0016926;GO:0015031;GO:0032875;GO:2000045;GO:0030111;GO:0060712;GO:0060707;GO:0016055;, C:cytosol; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:PML body;, F:protein domain specific binding; F:SUMO-specific endopeptidase activity; F:SUMO-specific isopeptidase activity;, P:dorsal/ventral axis specification; P:fat cell differentiation; P:heart development; P:labyrinthine layer development; P:mRNA transport; P:negative regulation of chromatin binding; P:negative regulation of protein binding; P:negative regulation of protein ubiquitination; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein destabilization; P:protein desumoylation; P:protein transport; P:regulation of DNA endoreduplication; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of Wnt signaling pathway; P:spongiotrophoblast layer development; P:trophoblast giant cell differentiation; P:Wnt signaling pathway;|Q9HC62 B4DQ42 Q8IW97 Q96SR2 Q9P2L5,Sentrin-specific protease 2,Axam2;SMT3-specific isopeptidase 2;Sentrin/SUMO-specific protease SENP2;, PF02902;, GO:0005829;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0016605;GO:0019904;GO:0070139;GO:0070140;GO:0009950;GO:0045444;GO:0007507;GO:0060711;GO:0051028;GO:0035562;GO:0032091;GO:0031397;GO:0001934;GO:0031398;GO:0045944;GO:0031648;GO:0016926;GO:0015031;GO:0032875;GO:2000045;GO:0030111;GO:0060712;GO:0060707;GO:0016055;, C:cytosol; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:PML body;, F:protein domain specific binding; F:SUMO-specific endopeptidase activity; F:SUMO-specific isopeptidase activity;, P:dorsal/ventral axis specification; P:fat cell differentiation; P:heart development; P:labyrinthine layer development; P:mRNA transport; P:negative regulation of chromatin binding; P:negative regulation of protein binding; P:negative regulation of protein ubiquitination; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein destabilization; P:protein desumoylation; P:protein transport; P:regulation of DNA endoreduplication; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of Wnt signaling pathway; P:spongiotrophoblast layer development; P:trophoblast giant cell differentiation; P:Wnt signaling pathway;|Q9HC62 B4DQ42 Q8IW97 Q96SR2 Q9P2L5,Sentrin-specific protease 2,Axam2;SMT3-specific isopeptidase 2;Sentrin/SUMO-specific protease SENP2;, PF02902;, GO:0005829;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0016605;GO:0019904;GO:0070139;GO:0070140;GO:0009950;GO:0045444;GO:0007507;GO:0060711;GO:0051028;GO:0035562;GO:0032091;GO:0031397;GO:0001934;GO:0031398;GO:0045944;GO:0031648;GO:0016926;GO:0015031;GO:0032875;GO:2000045;GO:0030111;GO:0060712;GO:0060707;GO:0016055;, C:cytosol; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:PML body;, F:protein domain specific binding; F:SUMO-specific endopeptidase activity; F:SUMO-specific isopeptidase activity;, P:dorsal/ventral axis specification; P:fat cell differentiation; P:heart development; P:labyrinthine layer development; P:mRNA transport; P:negative regulation of chromatin binding; P:negative regulation of protein binding; P:negative regulation of protein ubiquitination; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein destabilization; P:protein desumoylation; P:protein transport; P:regulation of DNA endoreduplication; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of Wnt signaling pathway; P:spongiotrophoblast layer development; P:trophoblast giant cell differentiation; P:Wnt signaling pathway;|Q9HC62 B4DQ42 Q8IW97 Q96SR2 Q9P2L5,Sentrin-specific protease 2,Axam2;SMT3-specific isopeptidase 2;Sentrin/SUMO-specific protease SENP2;, PF02902;, GO:0005829;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0016605;GO:0019904;GO:0070139;GO:0070140;GO:0009950;GO:0045444;GO:0007507;GO:0060711;GO:0051028;GO:0035562;GO:0032091;GO:0031397;GO:0001934;GO:0031398;GO:0045944;GO:0031648;GO:0016926;GO:0015031;GO:0032875;GO:2000045;GO:0030111;GO:0060712;GO:0060707;GO:0016055;, C:cytosol; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:PML body;, F:protein domain specific binding; F:SUMO-specific endopeptidase activity; F:SUMO-specific isopeptidase activity;, P:dorsal/ventral axis specification; P:fat cell differentiation; P:heart development; P:labyrinthine layer development; P:mRNA transport; P:negative regulation of chromatin binding; P:negative regulation of protein binding; P:negative regulation of protein ubiquitination; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:protein destabilization; P:protein desumoylation; P:protein transport; P:regulation of DNA endoreduplication; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of Wnt signaling pathway; P:spongiotrophoblast layer development; P:trophoblast giant cell differentiation; P:Wnt signaling pathway; scaffold13 indexed_genome mRNA 37936835 37962310 . - . ID=transcript_3479;Q9Y6M1 A0A4Z0 B3FTN2 B3FTN3 B3FTN4,Insulin-like growth factor 2 mRNA-binding protein 2,Hepatocellular carcinoma autoantigen p62;IGF-II mRNA-binding protein 2;VICKZ family member 2;, PF00013;PF00076;, GO:0005737;GO:0005856;GO:0005829;GO:0005634;GO:0003730;GO:0048027;GO:0003729;GO:0003723;GO:0045182;GO:0009653;GO:0051028;GO:0017148;GO:0007399;GO:0001817;GO:0010468;GO:0043488;GO:0051252;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleus;, F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:mRNA binding; F:RNA binding; F:translation regulator activity;, P:anatomical structure morphogenesis; P:mRNA transport; P:negative regulation of translation; P:nervous system development; P:regulation of cytokine production; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of RNA metabolic process;|Q9Y6M1 A0A4Z0 B3FTN2 B3FTN3 B3FTN4,Insulin-like growth factor 2 mRNA-binding protein 2,Hepatocellular carcinoma autoantigen p62;IGF-II mRNA-binding protein 2;VICKZ family member 2;, PF00013;PF00076;, GO:0005737;GO:0005856;GO:0005829;GO:0005634;GO:0003730;GO:0048027;GO:0003729;GO:0003723;GO:0045182;GO:0009653;GO:0051028;GO:0017148;GO:0007399;GO:0001817;GO:0010468;GO:0043488;GO:0051252;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleus;, F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:mRNA binding; F:RNA binding; F:translation regulator activity;, P:anatomical structure morphogenesis; P:mRNA transport; P:negative regulation of translation; P:nervous system development; P:regulation of cytokine production; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of RNA metabolic process; scaffold13 indexed_genome mRNA 37964686 37971675 . - . ID=transcript_3480;Q9Y6M1 A0A4Z0 B3FTN2 B3FTN3 B3FTN4,Insulin-like growth factor 2 mRNA-binding protein 2,Hepatocellular carcinoma autoantigen p62;IGF-II mRNA-binding protein 2;VICKZ family member 2;, PF00013;PF00076;, GO:0005737;GO:0005856;GO:0005829;GO:0005634;GO:0003730;GO:0048027;GO:0003729;GO:0003723;GO:0045182;GO:0009653;GO:0051028;GO:0017148;GO:0007399;GO:0001817;GO:0010468;GO:0043488;GO:0051252;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleus;, F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:mRNA binding; F:RNA binding; F:translation regulator activity;, P:anatomical structure morphogenesis; P:mRNA transport; P:negative regulation of translation; P:nervous system development; P:regulation of cytokine production; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of RNA metabolic process; scaffold13 indexed_genome mRNA 38191616 38202252 . - . ID=transcript_3481;P62995 B4DVK2 D3DNU3 O15449 Q15815 Q64283,Transformer-2 protein homolog beta,Splicing factor, arginine/serine-rich 10;Transformer-2 protein homolog B;, PF00076;, GO:0005637;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0005681;GO:0042802;GO:0003729;GO:0036002;GO:0019904;GO:0003723;GO:0071333;GO:0021796;GO:1990403;GO:0000398;GO:0048026;GO:0000381;GO:0043484;GO:0000302;GO:0000375;, C:nuclear inner membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA binding; F:protein domain specific binding; F:RNA binding;, P:cellular response to glucose stimulus; P:cerebral cortex regionalization; P:embryonic brain development; P:mRNA splicing, via spliceosome; P:positive regulation of mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:response to reactive oxygen species; P:RNA splicing, via transesterification reactions; scaffold13 indexed_genome mRNA 38296470 38353421 . - . ID=transcript_3482;P41161 A6NH46 B7Z7D7 Q6IBN5,ETS translocation variant 5,Ets-related protein ERM;, PF00178;PF04621;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000977;GO:1990837;GO:0000976;GO:0030154;GO:0034599;GO:0048133;GO:0000122;GO:0060252;GO:0045666;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:cellular response to oxidative stress; P:male germ-line stem cell asymmetric division; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of glial cell proliferation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P41161 A6NH46 B7Z7D7 Q6IBN5,ETS translocation variant 5,Ets-related protein ERM;, PF00178;PF04621;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000977;GO:1990837;GO:0000976;GO:0030154;GO:0034599;GO:0048133;GO:0000122;GO:0060252;GO:0045666;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:cellular response to oxidative stress; P:male germ-line stem cell asymmetric division; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of glial cell proliferation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P41161 A6NH46 B7Z7D7 Q6IBN5,ETS translocation variant 5,Ets-related protein ERM;, PF00178;PF04621;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000977;GO:1990837;GO:0000976;GO:0030154;GO:0034599;GO:0048133;GO:0000122;GO:0060252;GO:0045666;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:cellular response to oxidative stress; P:male germ-line stem cell asymmetric division; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of glial cell proliferation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold13 indexed_genome mRNA 38387171 38401031 . - . ID=transcript_3483;P49619 B2RAH4 Q2M1H4 Q5FWG1,Diacylglycerol kinase gamma,Diglyceride kinase gamma;, PF00130;PF14513;PF00609;PF00781;, GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0008289;GO:0003951;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0090038;GO:0048666;GO:0006654;GO:0030168;GO:0007205;GO:0050773;, C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:lipid binding; F:NAD+ kinase activity;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of protein kinase C signaling; P:neuron development; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of dendrite development;|P49619 B2RAH4 Q2M1H4 Q5FWG1,Diacylglycerol kinase gamma,Diglyceride kinase gamma;, PF00130;PF14513;PF00609;PF00781;, GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0008289;GO:0003951;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0090038;GO:0048666;GO:0006654;GO:0030168;GO:0007205;GO:0050773;, C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:lipid binding; F:NAD+ kinase activity;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of protein kinase C signaling; P:neuron development; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of dendrite development; scaffold13 indexed_genome mRNA 38442319 38608312 . - . ID=transcript_3484;P49619 B2RAH4 Q2M1H4 Q5FWG1,Diacylglycerol kinase gamma,Diglyceride kinase gamma;, PF00130;PF14513;PF00609;PF00781;, GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0008289;GO:0003951;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0090038;GO:0048666;GO:0006654;GO:0030168;GO:0007205;GO:0050773;, C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:lipid binding; F:NAD+ kinase activity;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of protein kinase C signaling; P:neuron development; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of dendrite development;|P49619 B2RAH4 Q2M1H4 Q5FWG1,Diacylglycerol kinase gamma,Diglyceride kinase gamma;, PF00130;PF14513;PF00609;PF00781;, GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0008289;GO:0003951;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0090038;GO:0048666;GO:0006654;GO:0030168;GO:0007205;GO:0050773;, C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:lipid binding; F:NAD+ kinase activity;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of protein kinase C signaling; P:neuron development; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of dendrite development;|P49619 B2RAH4 Q2M1H4 Q5FWG1,Diacylglycerol kinase gamma,Diglyceride kinase gamma;, PF00130;PF14513;PF00609;PF00781;, GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0008289;GO:0003951;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0090038;GO:0048666;GO:0006654;GO:0030168;GO:0007205;GO:0050773;, C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:lipid binding; F:NAD+ kinase activity;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of protein kinase C signaling; P:neuron development; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of dendrite development; scaffold13 indexed_genome mRNA 38777696 38778840 . - . ID=transcript_3485;P22914 B2RAF8,Gamma-crystallin S,Beta-crystallin S;Gamma-S-crystallin;, PF00030;, GO:0005212;GO:0002088;GO:0002009;GO:0007601;, , F:structural constituent of eye lens;, P:lens development in camera-type eye; P:morphogenesis of an epithelium; P:visual perception; scaffold13 indexed_genome mRNA 38784858 38808987 . - . ID=transcript_3486;Q9NVR7 B3KW69 D3DNU6 G5E9J4,TBCC domain-containing protein 1,, PF07986;, GO:0005737;GO:0031616;GO:0000902;GO:0051661;GO:0051684;GO:0030334;GO:0008360;, C:cytoplasm; C:spindle pole centrosome;, , P:cell morphogenesis; P:maintenance of centrosome location; P:maintenance of Golgi location; P:regulation of cell migration; P:regulation of cell shape; scaffold13 indexed_genome mRNA 38812713 38828385 . + . ID=transcript_3487;Q9UBS4 Q542Y5 Q542Y9 Q6IAQ8 Q96JC6,DnaJ homolog subfamily B member 11,APOBEC1-binding protein 2;DnaJ protein homolog 9;ER-associated DNAJ;ER-associated Hsp40 co-chaperone;Endoplasmic reticulum DNA J domain-containing protein 3;HEDJ;Human DnaJ protein 9;PWP1-interacting protein 4;, PF00226;PF01556;, GO:0101031;GO:0005783;GO:0005788;GO:0016020;GO:0051787;GO:0051082;GO:0036498;GO:0032781;GO:0006457;GO:0051604;, C:chaperone complex; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:membrane;, F:misfolded protein binding; F:unfolded protein binding;, P:IRE1-mediated unfolded protein response; P:positive regulation of ATPase activity; P:protein folding; P:protein maturation;|Q9UBS4 Q542Y5 Q542Y9 Q6IAQ8 Q96JC6,DnaJ homolog subfamily B member 11,APOBEC1-binding protein 2;DnaJ protein homolog 9;ER-associated DNAJ;ER-associated Hsp40 co-chaperone;Endoplasmic reticulum DNA J domain-containing protein 3;HEDJ;Human DnaJ protein 9;PWP1-interacting protein 4;, PF00226;PF01556;, GO:0101031;GO:0005783;GO:0005788;GO:0016020;GO:0051787;GO:0051082;GO:0036498;GO:0032781;GO:0006457;GO:0051604;, C:chaperone complex; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:membrane;, F:misfolded protein binding; F:unfolded protein binding;, P:IRE1-mediated unfolded protein response; P:positive regulation of ATPase activity; P:protein folding; P:protein maturation; scaffold13 indexed_genome mRNA 38845184 38859128 . + . ID=transcript_3488;P02765 A8K9N6 B2R7G1 O14961 O14962 Q9P152,Alpha-2-HS-glycoprotein,Alpha-2-Z-globulin;Ba-alpha-2-glycoprotein;Fetuin-A;, PF00031;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005794;GO:0031093;GO:0034774;GO:0004869;GO:0004866;GO:0019210;GO:0006953;GO:0044267;GO:0030502;GO:0010951;GO:0046627;GO:0043312;GO:0006907;GO:0002576;GO:0050766;GO:0043687;GO:0030500;GO:0050727;GO:0001501;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:kinase inhibitor activity;, P:acute-phase response; P:cellular protein metabolic process; P:negative regulation of bone mineralization; P:negative regulation of endopeptidase activity; P:negative regulation of insulin receptor signaling pathway; P:neutrophil degranulation; P:pinocytosis; P:platelet degranulation; P:positive regulation of phagocytosis; P:post-translational protein modification; P:regulation of bone mineralization; P:regulation of inflammatory response; P:skeletal system development;|P02765 A8K9N6 B2R7G1 O14961 O14962 Q9P152,Alpha-2-HS-glycoprotein,Alpha-2-Z-globulin;Ba-alpha-2-glycoprotein;Fetuin-A;, PF00031;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005794;GO:0031093;GO:0034774;GO:0004869;GO:0004866;GO:0019210;GO:0006953;GO:0044267;GO:0030502;GO:0010951;GO:0046627;GO:0043312;GO:0006907;GO:0002576;GO:0050766;GO:0043687;GO:0030500;GO:0050727;GO:0001501;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:kinase inhibitor activity;, P:acute-phase response; P:cellular protein metabolic process; P:negative regulation of bone mineralization; P:negative regulation of endopeptidase activity; P:negative regulation of insulin receptor signaling pathway; P:neutrophil degranulation; P:pinocytosis; P:platelet degranulation; P:positive regulation of phagocytosis; P:post-translational protein modification; P:regulation of bone mineralization; P:regulation of inflammatory response; P:skeletal system development;|P02765 A8K9N6 B2R7G1 O14961 O14962 Q9P152,Alpha-2-HS-glycoprotein,Alpha-2-Z-globulin;Ba-alpha-2-glycoprotein;Fetuin-A;, PF00031;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005794;GO:0031093;GO:0034774;GO:0004869;GO:0004866;GO:0019210;GO:0006953;GO:0044267;GO:0030502;GO:0010951;GO:0046627;GO:0043312;GO:0006907;GO:0002576;GO:0050766;GO:0043687;GO:0030500;GO:0050727;GO:0001501;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:kinase inhibitor activity;, P:acute-phase response; P:cellular protein metabolic process; P:negative regulation of bone mineralization; P:negative regulation of endopeptidase activity; P:negative regulation of insulin receptor signaling pathway; P:neutrophil degranulation; P:pinocytosis; P:platelet degranulation; P:positive regulation of phagocytosis; P:post-translational protein modification; P:regulation of bone mineralization; P:regulation of inflammatory response; P:skeletal system development; scaffold13 indexed_genome mRNA 38886611 38900238 . + . ID=transcript_3489;Q9UGM5 B2RCW6 E9PG06 Q1RMZ0 Q5J876 Q6DK58 Q6GRB6 Q9Y6Z0,Fetuin-B,16G2;Fetuin-like protein IRL685;Gugu;, PF00031;, GO:0070062;GO:0005576;GO:0004869;GO:0004866;GO:0008191;GO:0007339;GO:0010951;GO:0007338;, C:extracellular exosome; C:extracellular region;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:metalloendopeptidase inhibitor activity;, P:binding of sperm to zona pellucida; P:negative regulation of endopeptidase activity; P:single fertilization;|Q9UGM5 B2RCW6 E9PG06 Q1RMZ0 Q5J876 Q6DK58 Q6GRB6 Q9Y6Z0,Fetuin-B,16G2;Fetuin-like protein IRL685;Gugu;, PF00031;, GO:0070062;GO:0005576;GO:0004869;GO:0004866;GO:0008191;GO:0007339;GO:0010951;GO:0007338;, C:extracellular exosome; C:extracellular region;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:metalloendopeptidase inhibitor activity;, P:binding of sperm to zona pellucida; P:negative regulation of endopeptidase activity; P:single fertilization; scaffold13 indexed_genome mRNA 38911050 38920736 . + . ID=transcript_3490;P04196 B9EK35 D3DNU7,Histidine-rich glycoprotein,Histidine-proline-rich glycoprotein;, PF00031;, GO:0072562;GO:0009986;GO:0062023;GO:0036019;GO:0070062;GO:0005576;GO:0005886;GO:0031093;GO:0004869;GO:0004866;GO:0020037;GO:0043395;GO:0008201;GO:0019865;GO:0046872;GO:0004867;GO:0005102;GO:0008270;GO:0001525;GO:0061844;GO:0006935;GO:0051838;GO:0050832;GO:0042730;GO:0015886;GO:0016525;GO:0043537;GO:0007162;GO:0033629;GO:0030308;GO:0008285;GO:0010951;GO:2001027;GO:0051918;GO:0010593;GO:1900747;GO:0030168;GO:0002576;GO:0043065;GO:2000504;GO:0051894;GO:0002839;GO:0032956;GO:0030193;GO:0010468;GO:0050730;GO:0010543;GO:0043254;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:endolysosome; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:platelet alpha granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:heme binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:immunoglobulin binding; F:metal ion binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding; F:zinc ion binding;, P:angiogenesis; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:chemotaxis; P:cytolysis by host of symbiont cells; P:defense response to fungus; P:fibrinolysis; P:heme transport; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell adhesion; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of endopeptidase activity; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of fibrinolysis; P:negative regulation of lamellipodium assembly; P:negative regulation of vascular endothelial growth factor signaling pathway; P:platelet activation; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel remodeling; P:positive regulation of focal adhesion assembly; P:positive regulation of immune response to tumor cell; P:regulation of actin cytoskeleton organization; P:regulation of blood coagulation; P:regulation of gene expression; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of platelet activation; P:regulation of protein-containing complex assembly;|P04196 B9EK35 D3DNU7,Histidine-rich glycoprotein,Histidine-proline-rich glycoprotein;, PF00031;, GO:0072562;GO:0009986;GO:0062023;GO:0036019;GO:0070062;GO:0005576;GO:0005886;GO:0031093;GO:0004869;GO:0004866;GO:0020037;GO:0043395;GO:0008201;GO:0019865;GO:0046872;GO:0004867;GO:0005102;GO:0008270;GO:0001525;GO:0061844;GO:0006935;GO:0051838;GO:0050832;GO:0042730;GO:0015886;GO:0016525;GO:0043537;GO:0007162;GO:0033629;GO:0030308;GO:0008285;GO:0010951;GO:2001027;GO:0051918;GO:0010593;GO:1900747;GO:0030168;GO:0002576;GO:0043065;GO:2000504;GO:0051894;GO:0002839;GO:0032956;GO:0030193;GO:0010468;GO:0050730;GO:0010543;GO:0043254;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:endolysosome; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:platelet alpha granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:heme binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:immunoglobulin binding; F:metal ion binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding; F:zinc ion binding;, P:angiogenesis; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:chemotaxis; P:cytolysis by host of symbiont cells; P:defense response to fungus; P:fibrinolysis; P:heme transport; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell adhesion; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of endopeptidase activity; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of fibrinolysis; P:negative regulation of lamellipodium assembly; P:negative regulation of vascular endothelial growth factor signaling pathway; P:platelet activation; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel remodeling; P:positive regulation of focal adhesion assembly; P:positive regulation of immune response to tumor cell; P:regulation of actin cytoskeleton organization; P:regulation of blood coagulation; P:regulation of gene expression; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of platelet activation; P:regulation of protein-containing complex assembly;|P04196 B9EK35 D3DNU7,Histidine-rich glycoprotein,Histidine-proline-rich glycoprotein;, PF00031;, GO:0072562;GO:0009986;GO:0062023;GO:0036019;GO:0070062;GO:0005576;GO:0005886;GO:0031093;GO:0004869;GO:0004866;GO:0020037;GO:0043395;GO:0008201;GO:0019865;GO:0046872;GO:0004867;GO:0005102;GO:0008270;GO:0001525;GO:0061844;GO:0006935;GO:0051838;GO:0050832;GO:0042730;GO:0015886;GO:0016525;GO:0043537;GO:0007162;GO:0033629;GO:0030308;GO:0008285;GO:0010951;GO:2001027;GO:0051918;GO:0010593;GO:1900747;GO:0030168;GO:0002576;GO:0043065;GO:2000504;GO:0051894;GO:0002839;GO:0032956;GO:0030193;GO:0010468;GO:0050730;GO:0010543;GO:0043254;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:endolysosome; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:platelet alpha granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:heme binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:immunoglobulin binding; F:metal ion binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding; F:zinc ion binding;, P:angiogenesis; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:chemotaxis; P:cytolysis by host of symbiont cells; P:defense response to fungus; P:fibrinolysis; P:heme transport; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell adhesion; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of endopeptidase activity; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of fibrinolysis; P:negative regulation of lamellipodium assembly; P:negative regulation of vascular endothelial growth factor signaling pathway; P:platelet activation; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel remodeling; P:positive regulation of focal adhesion assembly; P:positive regulation of immune response to tumor cell; P:regulation of actin cytoskeleton organization; P:regulation of blood coagulation; P:regulation of gene expression; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of platelet activation; P:regulation of protein-containing complex assembly;|P04196 B9EK35 D3DNU7,Histidine-rich glycoprotein,Histidine-proline-rich glycoprotein;, PF00031;, GO:0072562;GO:0009986;GO:0062023;GO:0036019;GO:0070062;GO:0005576;GO:0005886;GO:0031093;GO:0004869;GO:0004866;GO:0020037;GO:0043395;GO:0008201;GO:0019865;GO:0046872;GO:0004867;GO:0005102;GO:0008270;GO:0001525;GO:0061844;GO:0006935;GO:0051838;GO:0050832;GO:0042730;GO:0015886;GO:0016525;GO:0043537;GO:0007162;GO:0033629;GO:0030308;GO:0008285;GO:0010951;GO:2001027;GO:0051918;GO:0010593;GO:1900747;GO:0030168;GO:0002576;GO:0043065;GO:2000504;GO:0051894;GO:0002839;GO:0032956;GO:0030193;GO:0010468;GO:0050730;GO:0010543;GO:0043254;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:endolysosome; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:platelet alpha granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:heme binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:immunoglobulin binding; F:metal ion binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding; F:zinc ion binding;, P:angiogenesis; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:chemotaxis; P:cytolysis by host of symbiont cells; P:defense response to fungus; P:fibrinolysis; P:heme transport; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell adhesion; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of endopeptidase activity; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of fibrinolysis; P:negative regulation of lamellipodium assembly; P:negative regulation of vascular endothelial growth factor signaling pathway; P:platelet activation; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel remodeling; P:positive regulation of focal adhesion assembly; P:positive regulation of immune response to tumor cell; P:regulation of actin cytoskeleton organization; P:regulation of blood coagulation; P:regulation of gene expression; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of platelet activation; P:regulation of protein-containing complex assembly; scaffold13 indexed_genome mRNA 38925077 38948791 . + . ID=transcript_3491;P01042 A8K474 B2RCR2 C9JEX1 P01043 Q53EQ0 Q6PAU9 Q7M4P1,Kininogen-1,Alpha-2-thiol proteinase inhibitor;Fitzgerald factor;High molecular weight kininogen;Williams-Fitzgerald-Flaujeac factor;, PF00031;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0031093;GO:0004869;GO:0004866;GO:0008201;GO:0005102;GO:0008270;GO:0061844;GO:0007597;GO:0044267;GO:0007186;GO:0006954;GO:0031640;GO:0030195;GO:0007162;GO:0010951;GO:0045861;GO:0002576;GO:0043065;GO:0007204;GO:0043687;GO:0042311;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:platelet alpha granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:heparin binding; F:signaling receptor binding; F:zinc ion binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:blood coagulation, intrinsic pathway; P:cellular protein metabolic process; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:negative regulation of blood coagulation; P:negative regulation of cell adhesion; P:negative regulation of endopeptidase activity; P:negative regulation of proteolysis; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:post-translational protein modification; P:vasodilation;|P01042 A8K474 B2RCR2 C9JEX1 P01043 Q53EQ0 Q6PAU9 Q7M4P1,Kininogen-1,Alpha-2-thiol proteinase inhibitor;Fitzgerald factor;High molecular weight kininogen;Williams-Fitzgerald-Flaujeac factor;, PF00031;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0031093;GO:0004869;GO:0004866;GO:0008201;GO:0005102;GO:0008270;GO:0061844;GO:0007597;GO:0044267;GO:0007186;GO:0006954;GO:0031640;GO:0030195;GO:0007162;GO:0010951;GO:0045861;GO:0002576;GO:0043065;GO:0007204;GO:0043687;GO:0042311;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:platelet alpha granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:heparin binding; F:signaling receptor binding; F:zinc ion binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:blood coagulation, intrinsic pathway; P:cellular protein metabolic process; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:negative regulation of blood coagulation; P:negative regulation of cell adhesion; P:negative regulation of endopeptidase activity; P:negative regulation of proteolysis; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:post-translational protein modification; P:vasodilation; scaffold13 indexed_genome mRNA 38977906 38997880 . + . ID=transcript_3492;Q14240 D3DNU9 Q53XJ6 Q96B90 Q96EA8,Eukaryotic initiation factor 4A-II,ATP-dependent RNA helicase eIF4A-2;, PF00270;PF00271;, GO:0005829;GO:0016281;GO:0048471;GO:0005524;GO:0016887;GO:0004386;GO:0003723;GO:0003724;GO:0003743;GO:1990830;GO:0002183;GO:1900260;GO:0006446;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:translation initiation factor activity;, P:cellular response to leukemia inhibitory factor; P:cytoplasmic translational initiation; P:negative regulation of RNA-directed 5'-3' RNA polymerase activity; P:regulation of translational initiation; P:translational initiation; P:viral process;|Q14240 D3DNU9 Q53XJ6 Q96B90 Q96EA8,Eukaryotic initiation factor 4A-II,ATP-dependent RNA helicase eIF4A-2;, PF00270;PF00271;, GO:0005829;GO:0016281;GO:0048471;GO:0005524;GO:0016887;GO:0004386;GO:0003723;GO:0003724;GO:0003743;GO:1990830;GO:0002183;GO:1900260;GO:0006446;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:translation initiation factor activity;, P:cellular response to leukemia inhibitory factor; P:cytoplasmic translational initiation; P:negative regulation of RNA-directed 5'-3' RNA polymerase activity; P:regulation of translational initiation; P:translational initiation; P:viral process;|Q14240 D3DNU9 Q53XJ6 Q96B90 Q96EA8,Eukaryotic initiation factor 4A-II,ATP-dependent RNA helicase eIF4A-2;, PF00270;PF00271;, GO:0005829;GO:0016281;GO:0048471;GO:0005524;GO:0016887;GO:0004386;GO:0003723;GO:0003724;GO:0003743;GO:1990830;GO:0002183;GO:1900260;GO:0006446;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:translation initiation factor activity;, P:cellular response to leukemia inhibitory factor; P:cytoplasmic translational initiation; P:negative regulation of RNA-directed 5'-3' RNA polymerase activity; P:regulation of translational initiation; P:translational initiation; P:viral process;|P35249 B4DM41 D3DNV2 Q6FHX7,Replication factor C subunit 4,Activator 1 37 kDa subunit;Activator 1 subunit 4;Replication factor C 37 kDa subunit;, PF00004;PF08542;, GO:0031390;GO:0005663;GO:0031391;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003677;GO:0006287;GO:0042769;GO:0032508;GO:0006281;GO:0006260;GO:0006271;GO:0006261;GO:0070987;GO:0042276;GO:0006297;GO:0033683;GO:0006296;GO:1900264;GO:1901796;GO:0032201;GO:0006283;GO:0019985;, C:Ctf18 RFC-like complex; C:DNA replication factor C complex; C:Elg1 RFC-like complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:DNA binding;, P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA duplex unwinding; P:DNA repair; P:DNA replication; P:DNA strand elongation involved in DNA replication; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of DNA-directed DNA polymerase activity; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold13 indexed_genome mRNA 39019280 39032164 . + . ID=transcript_3493;Q15848 Q58EX9,Adiponectin,30 kDa adipocyte complement-related protein;Adipocyte complement-related 30 kDa protein;Adipocyte, C1q and collagen domain-containing protein;Adipose most abundant gene transcript 1 protein {ECO:0000303|PubMed:8619847};Gelatin-binding protein;, PF00386;PF01391;, GO:0009986;GO:0005581;GO:0062023;GO:0005783;GO:0005576;GO:0005615;GO:0005125;GO:0005179;GO:0042802;GO:0042803;GO:0033691;GO:0005102;GO:0050873;GO:0071320;GO:0035690;GO:0071872;GO:0032869;GO:0007623;GO:0070994;GO:0006635;GO:0019395;GO:0010467;GO:0006091;GO:0042593;GO:0006006;GO:0034383;GO:0045776;GO:0030336;GO:0120163;GO:2000279;GO:0070373;GO:0045599;GO:0045721;GO:0030853;GO:0034115;GO:0046888;GO:0043124;GO:0050728;GO:0090317;GO:1905598;GO:0010745;GO:0045650;GO:0043407;GO:2000590;GO:0050765;GO:0010642;GO:2000584;GO:0031953;GO:1900121;GO:0050805;GO:0045892;GO:0032720;GO:0010804;GO:1904753;GO:1904706;GO:2000481;GO:0010875;GO:0120162;GO:0045923;GO:0046326;GO:2000467;GO:0043123;GO:0032757;GO:0110113;GO:2000478;GO:0071639;GO:0033034;GO:0050731;GO:0010739;GO:0001934;GO:2000534;GO:0009967;GO:0072659;GO:0042304;GO:0010906;GO:0014823;GO:0009617;GO:0045471;GO:0051384;GO:0009749;GO:0001666;GO:0070543;GO:0007584;GO:0009744;GO:0034612;, C:cell surface; C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular region; C:extracellular space;, F:cytokine activity; F:hormone activity; F:identical protein binding; F:protein homodimerization activity; F:sialic acid binding; F:signaling receptor binding;, P:brown fat cell differentiation; P:cellular response to cAMP; P:cellular response to drug; P:cellular response to epinephrine stimulus; P:cellular response to insulin stimulus; P:circadian rhythm; P:detection of oxidative stress; P:fatty acid beta-oxidation; P:fatty acid oxidation; P:gene expression; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:glucose metabolic process; P:low-density lipoprotein particle clearance; P:negative regulation of blood pressure; P:negative regulation of cell migration; P:negative regulation of cold-induced thermogenesis; P:negative regulation of DNA biosynthetic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fat cell differentiation; P:negative regulation of gluconeogenesis; P:negative regulation of granulocyte differentiation; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of hormone secretion; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of intracellular protein transport; P:negative regulation of low-density lipoprotein receptor activity; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of macrophage differentiation; P:negative regulation of MAP kinase activity; P:negative regulation of metanephric mesenchymal cell migration; P:negative regulation of phagocytosis; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of platelet-derived growth factor receptor-alpha signaling pathway; P:negative regulation of protein autophosphorylation; P:negative regulation of receptor binding; P:negative regulation of synaptic transmission; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cholesterol efflux; P:positive regulation of cold-induced thermogenesis; P:positive regulation of fatty acid metabolic process; P:positive regulation of glucose import; P:positive regulation of glycogen (starch) synthase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-8 production; P:positive regulation of lipid transporter activity; P:positive regulation of metanephric glomerular visceral epithelial cell development; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of myeloid cell apoptotic process; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase A signaling; P:positive regulation of protein phosphorylation; P:positive regulation of renal albumin absorption; P:positive regulation of signal transduction; P:protein localization to plasma membrane; P:regulation of fatty acid biosynthetic process; P:regulation of glucose metabolic process; P:response to activity; P:response to bacterium; P:response to ethanol; P:response to glucocorticoid; P:response to glucose; P:response to hypoxia; P:response to linoleic acid; P:response to nutrient; P:response to sucrose; P:response to tumor necrosis factor; scaffold13 indexed_genome mRNA 39096317 39244785 . + . ID=transcript_3494;P15907 A8KA14 B2R513 D3DNV3,Beta-galactoside alpha-2,6-sialyltransferase 1,B-cell antigen CD75;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1;ST6Gal I;Sialyltransferase 1;, PF00777;, GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0003835;GO:0042803;GO:0008373;GO:0006959;GO:0006054;GO:0016266;GO:0018279;GO:0097503;GO:0019082;, C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:beta-galactoside alpha-2,6-sialyltransferase activity; F:protein homodimerization activity; F:sialyltransferase activity;, P:humoral immune response; P:N-acetylneuraminate metabolic process; P:O-glycan processing; P:protein N-linked glycosylation via asparagine; P:sialylation; P:viral protein processing;|P15907 A8KA14 B2R513 D3DNV3,Beta-galactoside alpha-2,6-sialyltransferase 1,B-cell antigen CD75;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1;ST6Gal I;Sialyltransferase 1;, PF00777;, GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0003835;GO:0042803;GO:0008373;GO:0006959;GO:0006054;GO:0016266;GO:0018279;GO:0097503;GO:0019082;, C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:beta-galactoside alpha-2,6-sialyltransferase activity; F:protein homodimerization activity; F:sialyltransferase activity;, P:humoral immune response; P:N-acetylneuraminate metabolic process; P:O-glycan processing; P:protein N-linked glycosylation via asparagine; P:sialylation; P:viral protein processing; scaffold13 indexed_genome mRNA 39351305 39376279 . - . ID=transcript_3495;P48740 A8K542 A8K6M1 B4E2L7 O95570 Q68D21 Q8IUV8 Q96RS4 Q9UF09,Mannan-binding lectin serine protease 1,Complement factor MASP-3;Complement-activating component of Ra-reactive factor;Mannose-binding lectin-associated serine protease 1;Mannose-binding protein-associated serine protease;Ra-reactive factor serine protease p100;Serine protease 5;, PF00431;PF00084;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005654;GO:0005509;GO:0048306;GO:0008233;GO:0042803;GO:0004252;GO:0006956;GO:0001867;GO:0045916;GO:0006898;, C:cytosol; C:extracellular region; C:extracellular space; C:nucleoplasm;, F:calcium ion binding; F:calcium-dependent protein binding; F:peptidase activity; F:protein homodimerization activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, lectin pathway; P:negative regulation of complement activation; P:receptor-mediated endocytosis;|P48740 A8K542 A8K6M1 B4E2L7 O95570 Q68D21 Q8IUV8 Q96RS4 Q9UF09,Mannan-binding lectin serine protease 1,Complement factor MASP-3;Complement-activating component of Ra-reactive factor;Mannose-binding lectin-associated serine protease 1;Mannose-binding protein-associated serine protease;Ra-reactive factor serine protease p100;Serine protease 5;, PF00431;PF00084;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005654;GO:0005509;GO:0048306;GO:0008233;GO:0042803;GO:0004252;GO:0006956;GO:0001867;GO:0045916;GO:0006898;, C:cytosol; C:extracellular region; C:extracellular space; C:nucleoplasm;, F:calcium ion binding; F:calcium-dependent protein binding; F:peptidase activity; F:protein homodimerization activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, lectin pathway; P:negative regulation of complement activation; P:receptor-mediated endocytosis;|P48740 A8K542 A8K6M1 B4E2L7 O95570 Q68D21 Q8IUV8 Q96RS4 Q9UF09,Mannan-binding lectin serine protease 1,Complement factor MASP-3;Complement-activating component of Ra-reactive factor;Mannose-binding lectin-associated serine protease 1;Mannose-binding protein-associated serine protease;Ra-reactive factor serine protease p100;Serine protease 5;, PF00431;PF00084;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005654;GO:0005509;GO:0048306;GO:0008233;GO:0042803;GO:0004252;GO:0006956;GO:0001867;GO:0045916;GO:0006898;, C:cytosol; C:extracellular region; C:extracellular space; C:nucleoplasm;, F:calcium ion binding; F:calcium-dependent protein binding; F:peptidase activity; F:protein homodimerization activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, lectin pathway; P:negative regulation of complement activation; P:receptor-mediated endocytosis;|P48740 A8K542 A8K6M1 B4E2L7 O95570 Q68D21 Q8IUV8 Q96RS4 Q9UF09,Mannan-binding lectin serine protease 1,Complement factor MASP-3;Complement-activating component of Ra-reactive factor;Mannose-binding lectin-associated serine protease 1;Mannose-binding protein-associated serine protease;Ra-reactive factor serine protease p100;Serine protease 5;, PF00431;PF00084;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005654;GO:0005509;GO:0048306;GO:0008233;GO:0042803;GO:0004252;GO:0006956;GO:0001867;GO:0045916;GO:0006898;, C:cytosol; C:extracellular region; C:extracellular space; C:nucleoplasm;, F:calcium ion binding; F:calcium-dependent protein binding; F:peptidase activity; F:protein homodimerization activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, lectin pathway; P:negative regulation of complement activation; P:receptor-mediated endocytosis;|P48740 A8K542 A8K6M1 B4E2L7 O95570 Q68D21 Q8IUV8 Q96RS4 Q9UF09,Mannan-binding lectin serine protease 1,Complement factor MASP-3;Complement-activating component of Ra-reactive factor;Mannose-binding lectin-associated serine protease 1;Mannose-binding protein-associated serine protease;Ra-reactive factor serine protease p100;Serine protease 5;, PF00431;PF00084;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005654;GO:0005509;GO:0048306;GO:0008233;GO:0042803;GO:0004252;GO:0006956;GO:0001867;GO:0045916;GO:0006898;, C:cytosol; C:extracellular region; C:extracellular space; C:nucleoplasm;, F:calcium ion binding; F:calcium-dependent protein binding; F:peptidase activity; F:protein homodimerization activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, lectin pathway; P:negative regulation of complement activation; P:receptor-mediated endocytosis; scaffold13 indexed_genome mRNA 39785882 39802619 . - . ID=transcript_3496;P41182 A7E241 B8PSA7 D3DNV5,B-cell lymphoma 6 protein,B-cell lymphoma 5 protein;Protein LAZ-3;Zinc finger and BTB domain-containing protein 27;Zinc finger protein 51;, PF00651;PF00096;, GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0031490;GO:0003700;GO:0001227;GO:0042802;GO:0001161;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0030036;GO:0030183;GO:0000902;GO:0006974;GO:0019221;GO:0048821;GO:0002467;GO:0006954;GO:0002903;GO:0030308;GO:0008285;GO:0001953;GO:2000773;GO:0048294;GO:0032764;GO:1903464;GO:0045746;GO:0035024;GO:0045629;GO:0000122;GO:0045892;GO:0043065;GO:0030890;GO:0051272;GO:0031065;GO:0045666;GO:0045591;GO:0008104;GO:0042981;GO:0045595;GO:0042127;GO:0001817;GO:0002634;GO:0043087;GO:0050776;GO:0002682;GO:0050727;GO:0043380;GO:0006357;GO:0007266;GO:0007283;GO:0042092;, C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:intronic transcription regulatory region sequence-specific DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:actin cytoskeleton organization; P:B cell differentiation; P:cell morphogenesis; P:cellular response to DNA damage stimulus; P:cytokine-mediated signaling pathway; P:erythrocyte development; P:germinal center formation; P:inflammatory response; P:negative regulation of B cell apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular senescence; P:negative regulation of isotype switching to IgE isotypes; P:negative regulation of mast cell cytokine production; P:negative regulation of mitotic cell cycle DNA replication; P:negative regulation of Notch signaling pathway; P:negative regulation of Rho protein signal transduction; P:negative regulation of T-helper 2 cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of cellular component movement; P:positive regulation of histone deacetylation; P:positive regulation of neuron differentiation; P:positive regulation of regulatory T cell differentiation; P:protein localization; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cytokine production; P:regulation of germinal center formation; P:regulation of GTPase activity; P:regulation of immune response; P:regulation of immune system process; P:regulation of inflammatory response; P:regulation of memory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:Rho protein signal transduction; P:spermatogenesis; P:type 2 immune response;|P41182 A7E241 B8PSA7 D3DNV5,B-cell lymphoma 6 protein,B-cell lymphoma 5 protein;Protein LAZ-3;Zinc finger and BTB domain-containing protein 27;Zinc finger protein 51;, PF00651;PF00096;, GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0031490;GO:0003700;GO:0001227;GO:0042802;GO:0001161;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0030036;GO:0030183;GO:0000902;GO:0006974;GO:0019221;GO:0048821;GO:0002467;GO:0006954;GO:0002903;GO:0030308;GO:0008285;GO:0001953;GO:2000773;GO:0048294;GO:0032764;GO:1903464;GO:0045746;GO:0035024;GO:0045629;GO:0000122;GO:0045892;GO:0043065;GO:0030890;GO:0051272;GO:0031065;GO:0045666;GO:0045591;GO:0008104;GO:0042981;GO:0045595;GO:0042127;GO:0001817;GO:0002634;GO:0043087;GO:0050776;GO:0002682;GO:0050727;GO:0043380;GO:0006357;GO:0007266;GO:0007283;GO:0042092;, C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:intronic transcription regulatory region sequence-specific DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:actin cytoskeleton organization; P:B cell differentiation; P:cell morphogenesis; P:cellular response to DNA damage stimulus; P:cytokine-mediated signaling pathway; P:erythrocyte development; P:germinal center formation; P:inflammatory response; P:negative regulation of B cell apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular senescence; P:negative regulation of isotype switching to IgE isotypes; P:negative regulation of mast cell cytokine production; P:negative regulation of mitotic cell cycle DNA replication; P:negative regulation of Notch signaling pathway; P:negative regulation of Rho protein signal transduction; P:negative regulation of T-helper 2 cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of cellular component movement; P:positive regulation of histone deacetylation; P:positive regulation of neuron differentiation; P:positive regulation of regulatory T cell differentiation; P:protein localization; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cytokine production; P:regulation of germinal center formation; P:regulation of GTPase activity; P:regulation of immune response; P:regulation of immune system process; P:regulation of inflammatory response; P:regulation of memory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:Rho protein signal transduction; P:spermatogenesis; P:type 2 immune response;|P41182 A7E241 B8PSA7 D3DNV5,B-cell lymphoma 6 protein,B-cell lymphoma 5 protein;Protein LAZ-3;Zinc finger and BTB domain-containing protein 27;Zinc finger protein 51;, PF00651;PF00096;, GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0031490;GO:0003700;GO:0001227;GO:0042802;GO:0001161;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0030036;GO:0030183;GO:0000902;GO:0006974;GO:0019221;GO:0048821;GO:0002467;GO:0006954;GO:0002903;GO:0030308;GO:0008285;GO:0001953;GO:2000773;GO:0048294;GO:0032764;GO:1903464;GO:0045746;GO:0035024;GO:0045629;GO:0000122;GO:0045892;GO:0043065;GO:0030890;GO:0051272;GO:0031065;GO:0045666;GO:0045591;GO:0008104;GO:0042981;GO:0045595;GO:0042127;GO:0001817;GO:0002634;GO:0043087;GO:0050776;GO:0002682;GO:0050727;GO:0043380;GO:0006357;GO:0007266;GO:0007283;GO:0042092;, C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:intronic transcription regulatory region sequence-specific DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:actin cytoskeleton organization; P:B cell differentiation; P:cell morphogenesis; P:cellular response to DNA damage stimulus; P:cytokine-mediated signaling pathway; P:erythrocyte development; P:germinal center formation; P:inflammatory response; P:negative regulation of B cell apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular senescence; P:negative regulation of isotype switching to IgE isotypes; P:negative regulation of mast cell cytokine production; P:negative regulation of mitotic cell cycle DNA replication; P:negative regulation of Notch signaling pathway; P:negative regulation of Rho protein signal transduction; P:negative regulation of T-helper 2 cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of cellular component movement; P:positive regulation of histone deacetylation; P:positive regulation of neuron differentiation; P:positive regulation of regulatory T cell differentiation; P:protein localization; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cytokine production; P:regulation of germinal center formation; P:regulation of GTPase activity; P:regulation of immune response; P:regulation of immune system process; P:regulation of inflammatory response; P:regulation of memory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:Rho protein signal transduction; P:spermatogenesis; P:type 2 immune response;|P41182 A7E241 B8PSA7 D3DNV5,B-cell lymphoma 6 protein,B-cell lymphoma 5 protein;Protein LAZ-3;Zinc finger and BTB domain-containing protein 27;Zinc finger protein 51;, PF00651;PF00096;, GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0031490;GO:0003700;GO:0001227;GO:0042802;GO:0001161;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0030036;GO:0030183;GO:0000902;GO:0006974;GO:0019221;GO:0048821;GO:0002467;GO:0006954;GO:0002903;GO:0030308;GO:0008285;GO:0001953;GO:2000773;GO:0048294;GO:0032764;GO:1903464;GO:0045746;GO:0035024;GO:0045629;GO:0000122;GO:0045892;GO:0043065;GO:0030890;GO:0051272;GO:0031065;GO:0045666;GO:0045591;GO:0008104;GO:0042981;GO:0045595;GO:0042127;GO:0001817;GO:0002634;GO:0043087;GO:0050776;GO:0002682;GO:0050727;GO:0043380;GO:0006357;GO:0007266;GO:0007283;GO:0042092;, C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:intronic transcription regulatory region sequence-specific DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:actin cytoskeleton organization; P:B cell differentiation; P:cell morphogenesis; P:cellular response to DNA damage stimulus; P:cytokine-mediated signaling pathway; P:erythrocyte development; P:germinal center formation; P:inflammatory response; P:negative regulation of B cell apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular senescence; P:negative regulation of isotype switching to IgE isotypes; P:negative regulation of mast cell cytokine production; P:negative regulation of mitotic cell cycle DNA replication; P:negative regulation of Notch signaling pathway; P:negative regulation of Rho protein signal transduction; P:negative regulation of T-helper 2 cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of cellular component movement; P:positive regulation of histone deacetylation; P:positive regulation of neuron differentiation; P:positive regulation of regulatory T cell differentiation; P:protein localization; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cytokine production; P:regulation of germinal center formation; P:regulation of GTPase activity; P:regulation of immune response; P:regulation of immune system process; P:regulation of inflammatory response; P:regulation of memory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:Rho protein signal transduction; P:spermatogenesis; P:type 2 immune response;|P41182 A7E241 B8PSA7 D3DNV5,B-cell lymphoma 6 protein,B-cell lymphoma 5 protein;Protein LAZ-3;Zinc finger and BTB domain-containing protein 27;Zinc finger protein 51;, PF00651;PF00096;, GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0031490;GO:0003700;GO:0001227;GO:0042802;GO:0001161;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0030036;GO:0030183;GO:0000902;GO:0006974;GO:0019221;GO:0048821;GO:0002467;GO:0006954;GO:0002903;GO:0030308;GO:0008285;GO:0001953;GO:2000773;GO:0048294;GO:0032764;GO:1903464;GO:0045746;GO:0035024;GO:0045629;GO:0000122;GO:0045892;GO:0043065;GO:0030890;GO:0051272;GO:0031065;GO:0045666;GO:0045591;GO:0008104;GO:0042981;GO:0045595;GO:0042127;GO:0001817;GO:0002634;GO:0043087;GO:0050776;GO:0002682;GO:0050727;GO:0043380;GO:0006357;GO:0007266;GO:0007283;GO:0042092;, C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:intronic transcription regulatory region sequence-specific DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:actin cytoskeleton organization; P:B cell differentiation; P:cell morphogenesis; P:cellular response to DNA damage stimulus; P:cytokine-mediated signaling pathway; P:erythrocyte development; P:germinal center formation; P:inflammatory response; P:negative regulation of B cell apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular senescence; P:negative regulation of isotype switching to IgE isotypes; P:negative regulation of mast cell cytokine production; P:negative regulation of mitotic cell cycle DNA replication; P:negative regulation of Notch signaling pathway; P:negative regulation of Rho protein signal transduction; P:negative regulation of T-helper 2 cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of cellular component movement; P:positive regulation of histone deacetylation; P:positive regulation of neuron differentiation; P:positive regulation of regulatory T cell differentiation; P:protein localization; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cytokine production; P:regulation of germinal center formation; P:regulation of GTPase activity; P:regulation of immune response; P:regulation of immune system process; P:regulation of inflammatory response; P:regulation of memory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:Rho protein signal transduction; P:spermatogenesis; P:type 2 immune response;|P41182 A7E241 B8PSA7 D3DNV5,B-cell lymphoma 6 protein,B-cell lymphoma 5 protein;Protein LAZ-3;Zinc finger and BTB domain-containing protein 27;Zinc finger protein 51;, PF00651;PF00096;, GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0031490;GO:0003700;GO:0001227;GO:0042802;GO:0001161;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0030036;GO:0030183;GO:0000902;GO:0006974;GO:0019221;GO:0048821;GO:0002467;GO:0006954;GO:0002903;GO:0030308;GO:0008285;GO:0001953;GO:2000773;GO:0048294;GO:0032764;GO:1903464;GO:0045746;GO:0035024;GO:0045629;GO:0000122;GO:0045892;GO:0043065;GO:0030890;GO:0051272;GO:0031065;GO:0045666;GO:0045591;GO:0008104;GO:0042981;GO:0045595;GO:0042127;GO:0001817;GO:0002634;GO:0043087;GO:0050776;GO:0002682;GO:0050727;GO:0043380;GO:0006357;GO:0007266;GO:0007283;GO:0042092;, C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:intronic transcription regulatory region sequence-specific DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:actin cytoskeleton organization; P:B cell differentiation; P:cell morphogenesis; P:cellular response to DNA damage stimulus; P:cytokine-mediated signaling pathway; P:erythrocyte development; P:germinal center formation; P:inflammatory response; P:negative regulation of B cell apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular senescence; P:negative regulation of isotype switching to IgE isotypes; P:negative regulation of mast cell cytokine production; P:negative regulation of mitotic cell cycle DNA replication; P:negative regulation of Notch signaling pathway; P:negative regulation of Rho protein signal transduction; P:negative regulation of T-helper 2 cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of cellular component movement; P:positive regulation of histone deacetylation; P:positive regulation of neuron differentiation; P:positive regulation of regulatory T cell differentiation; P:protein localization; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cytokine production; P:regulation of germinal center formation; P:regulation of GTPase activity; P:regulation of immune response; P:regulation of immune system process; P:regulation of inflammatory response; P:regulation of memory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:Rho protein signal transduction; P:spermatogenesis; P:type 2 immune response;|P41182 A7E241 B8PSA7 D3DNV5,B-cell lymphoma 6 protein,B-cell lymphoma 5 protein;Protein LAZ-3;Zinc finger and BTB domain-containing protein 27;Zinc finger protein 51;, PF00651;PF00096;, GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0031490;GO:0003700;GO:0001227;GO:0042802;GO:0001161;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0030036;GO:0030183;GO:0000902;GO:0006974;GO:0019221;GO:0048821;GO:0002467;GO:0006954;GO:0002903;GO:0030308;GO:0008285;GO:0001953;GO:2000773;GO:0048294;GO:0032764;GO:1903464;GO:0045746;GO:0035024;GO:0045629;GO:0000122;GO:0045892;GO:0043065;GO:0030890;GO:0051272;GO:0031065;GO:0045666;GO:0045591;GO:0008104;GO:0042981;GO:0045595;GO:0042127;GO:0001817;GO:0002634;GO:0043087;GO:0050776;GO:0002682;GO:0050727;GO:0043380;GO:0006357;GO:0007266;GO:0007283;GO:0042092;, C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:intronic transcription regulatory region sequence-specific DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:actin cytoskeleton organization; P:B cell differentiation; P:cell morphogenesis; P:cellular response to DNA damage stimulus; P:cytokine-mediated signaling pathway; P:erythrocyte development; P:germinal center formation; P:inflammatory response; P:negative regulation of B cell apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular senescence; P:negative regulation of isotype switching to IgE isotypes; P:negative regulation of mast cell cytokine production; P:negative regulation of mitotic cell cycle DNA replication; P:negative regulation of Notch signaling pathway; P:negative regulation of Rho protein signal transduction; P:negative regulation of T-helper 2 cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of cellular component movement; P:positive regulation of histone deacetylation; P:positive regulation of neuron differentiation; P:positive regulation of regulatory T cell differentiation; P:protein localization; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cytokine production; P:regulation of germinal center formation; P:regulation of GTPase activity; P:regulation of immune response; P:regulation of immune system process; P:regulation of inflammatory response; P:regulation of memory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:Rho protein signal transduction; P:spermatogenesis; P:type 2 immune response;|P41182 A7E241 B8PSA7 D3DNV5,B-cell lymphoma 6 protein,B-cell lymphoma 5 protein;Protein LAZ-3;Zinc finger and BTB domain-containing protein 27;Zinc finger protein 51;, PF00651;PF00096;, GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0031490;GO:0003700;GO:0001227;GO:0042802;GO:0001161;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0030036;GO:0030183;GO:0000902;GO:0006974;GO:0019221;GO:0048821;GO:0002467;GO:0006954;GO:0002903;GO:0030308;GO:0008285;GO:0001953;GO:2000773;GO:0048294;GO:0032764;GO:1903464;GO:0045746;GO:0035024;GO:0045629;GO:0000122;GO:0045892;GO:0043065;GO:0030890;GO:0051272;GO:0031065;GO:0045666;GO:0045591;GO:0008104;GO:0042981;GO:0045595;GO:0042127;GO:0001817;GO:0002634;GO:0043087;GO:0050776;GO:0002682;GO:0050727;GO:0043380;GO:0006357;GO:0007266;GO:0007283;GO:0042092;, C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:intronic transcription regulatory region sequence-specific DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:actin cytoskeleton organization; P:B cell differentiation; P:cell morphogenesis; P:cellular response to DNA damage stimulus; P:cytokine-mediated signaling pathway; P:erythrocyte development; P:germinal center formation; P:inflammatory response; P:negative regulation of B cell apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular senescence; P:negative regulation of isotype switching to IgE isotypes; P:negative regulation of mast cell cytokine production; P:negative regulation of mitotic cell cycle DNA replication; P:negative regulation of Notch signaling pathway; P:negative regulation of Rho protein signal transduction; P:negative regulation of T-helper 2 cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of cellular component movement; P:positive regulation of histone deacetylation; P:positive regulation of neuron differentiation; P:positive regulation of regulatory T cell differentiation; P:protein localization; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cytokine production; P:regulation of germinal center formation; P:regulation of GTPase activity; P:regulation of immune response; P:regulation of immune system process; P:regulation of inflammatory response; P:regulation of memory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:Rho protein signal transduction; P:spermatogenesis; P:type 2 immune response; scaffold13 indexed_genome mRNA 40551124 40819497 . + . ID=transcript_3497;Q93052 A1L4L6 D3DNV6 Q8NFX5,Lipoma-preferred partner,LIM domain-containing preferred translocation partner in lipoma;, PF00412;, GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0001725;GO:0046872;GO:0098609;, C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane; C:stress fiber;, F:metal ion binding;, P:cell-cell adhesion; scaffold13 indexed_genome mRNA 41850187 41874732 . - . ID=transcript_3498;Q8IVL5 B3KPK0 B3KWI9 D3DNV8 Q9NVI2,Prolyl 3-hydroxylase 2 {ECO:0000312|HGNC:HGNC:19317},Leprecan-like protein 1 {ECO:0000303|PubMed:15063763};Myxoid liposarcoma-associated protein 4 {ECO:0000303|PubMed:10449603};, PF13640;, GO:0005604;GO:0005829;GO:0005783;GO:0005788;GO:0005794;GO:0043231;GO:0005654;GO:0016529;GO:0005506;GO:0031418;GO:0019797;GO:0030199;GO:0032963;GO:0008285;GO:0019511;, C:basement membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:sarcoplasmic reticulum;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:collagen fibril organization; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:peptidyl-proline hydroxylation; scaffold13 indexed_genome mRNA 41875716 41894017 . - . ID=transcript_3499;Q8IVL5 B3KPK0 B3KWI9 D3DNV8 Q9NVI2,Prolyl 3-hydroxylase 2 {ECO:0000312|HGNC:HGNC:19317},Leprecan-like protein 1 {ECO:0000303|PubMed:15063763};Myxoid liposarcoma-associated protein 4 {ECO:0000303|PubMed:10449603};, PF13640;, GO:0005604;GO:0005829;GO:0005783;GO:0005788;GO:0005794;GO:0043231;GO:0005654;GO:0016529;GO:0005506;GO:0031418;GO:0019797;GO:0030199;GO:0032963;GO:0008285;GO:0019511;, C:basement membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:sarcoplasmic reticulum;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:collagen fibril organization; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:peptidyl-proline hydroxylation;|Q8IVL5 B3KPK0 B3KWI9 D3DNV8 Q9NVI2,Prolyl 3-hydroxylase 2 {ECO:0000312|HGNC:HGNC:19317},Leprecan-like protein 1 {ECO:0000303|PubMed:15063763};Myxoid liposarcoma-associated protein 4 {ECO:0000303|PubMed:10449603};, PF13640;, GO:0005604;GO:0005829;GO:0005783;GO:0005788;GO:0005794;GO:0043231;GO:0005654;GO:0016529;GO:0005506;GO:0031418;GO:0019797;GO:0030199;GO:0032963;GO:0008285;GO:0019511;, C:basement membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:sarcoplasmic reticulum;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:collagen fibril organization; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:peptidyl-proline hydroxylation;|Q8IVL5 B3KPK0 B3KWI9 D3DNV8 Q9NVI2,Prolyl 3-hydroxylase 2 {ECO:0000312|HGNC:HGNC:19317},Leprecan-like protein 1 {ECO:0000303|PubMed:15063763};Myxoid liposarcoma-associated protein 4 {ECO:0000303|PubMed:10449603};, PF13640;, GO:0005604;GO:0005829;GO:0005783;GO:0005788;GO:0005794;GO:0043231;GO:0005654;GO:0016529;GO:0005506;GO:0031418;GO:0019797;GO:0030199;GO:0032963;GO:0008285;GO:0019511;, C:basement membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:sarcoplasmic reticulum;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:collagen fibril organization; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:peptidyl-proline hydroxylation; scaffold13 indexed_genome mRNA 42156292 42172848 . - . ID=transcript_3500;O95832,Claudin-1,Senescence-associated epithelial membrane protein;, PF00822;, GO:0016324;GO:0016323;GO:0005923;GO:0005737;GO:0016021;GO:0005887;GO:0016328;GO:0005886;GO:0032991;GO:0070160;GO:0042802;GO:0005198;GO:0001618;GO:0007568;GO:0070830;GO:0016338;GO:0007155;GO:0034331;GO:0045216;GO:1903545;GO:0071346;GO:0071284;GO:0071560;GO:0071356;GO:0008065;GO:0090557;GO:0061436;GO:0042538;GO:0097421;GO:0035633;GO:1903348;GO:0030335;GO:0060054;GO:0090303;GO:0051259;GO:0071548;GO:0045471;GO:0070673;GO:0032496;GO:0009636;GO:0061772;, C:apical plasma membrane; C:basolateral plasma membrane; C:bicellular tight junction; C:cytoplasm; C:integral component of membrane; C:integral component of plasma membrane; C:lateral plasma membrane; C:plasma membrane; C:protein-containing complex; C:tight junction;, F:identical protein binding; F:structural molecule activity; F:virus receptor activity;, P:aging; P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:cell junction maintenance; P:cell-cell junction organization; P:cellular response to butyrate; P:cellular response to interferon-gamma; P:cellular response to lead ion; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:establishment of blood-nerve barrier; P:establishment of endothelial intestinal barrier; P:establishment of skin barrier; P:hyperosmotic salinity response; P:liver regeneration; P:maintenance of blood-brain barrier; P:positive regulation of bicellular tight junction assembly; P:positive regulation of cell migration; P:positive regulation of epithelial cell proliferation involved in wound healing; P:positive regulation of wound healing; P:protein complex oligomerization; P:response to dexamethasone; P:response to ethanol; P:response to interleukin-18; P:response to lipopolysaccharide; P:response to toxic substance; P:xenobiotic transport across blood-nerve barrier; scaffold13 indexed_genome mRNA 42490531 42538608 . + . ID=transcript_3501;Q9NPH3 B1NLD0 D3DNW0 O14915 Q86WJ7,Interleukin-1 receptor accessory protein,Interleukin-1 receptor 3;, PF18452;PF01582;, GO:0005576;GO:0098978;GO:0005887;GO:0016020;GO:0005886;GO:0004908;GO:0005149;GO:0002114;GO:0050135;GO:0061809;GO:0019221;GO:0006955;GO:0006954;GO:0045087;GO:0070498;GO:0038172;GO:0032736;GO:0032753;GO:0032754;GO:0032755;GO:0051092;GO:0051965;GO:0065003;GO:0099151;GO:1905606;GO:0099560;GO:0099545;, C:extracellular region; C:glutamatergic synapse; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:interleukin-1 receptor activity; F:interleukin-1 receptor binding; F:interleukin-33 receptor activity; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating;, P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:interleukin-33-mediated signaling pathway; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of synapse assembly; P:protein-containing complex assembly; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex;|Q9NPH3 B1NLD0 D3DNW0 O14915 Q86WJ7,Interleukin-1 receptor accessory protein,Interleukin-1 receptor 3;, PF18452;PF01582;, GO:0005576;GO:0098978;GO:0005887;GO:0016020;GO:0005886;GO:0004908;GO:0005149;GO:0002114;GO:0050135;GO:0061809;GO:0019221;GO:0006955;GO:0006954;GO:0045087;GO:0070498;GO:0038172;GO:0032736;GO:0032753;GO:0032754;GO:0032755;GO:0051092;GO:0051965;GO:0065003;GO:0099151;GO:1905606;GO:0099560;GO:0099545;, C:extracellular region; C:glutamatergic synapse; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:interleukin-1 receptor activity; F:interleukin-1 receptor binding; F:interleukin-33 receptor activity; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating;, P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:interleukin-33-mediated signaling pathway; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of synapse assembly; P:protein-containing complex assembly; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; P:trans-synaptic signaling by trans-synaptic complex; scaffold13 indexed_genome mRNA 43106629 43175580 . + . ID=transcript_3502;Q8IVM0 Q86VH7,Coiled-coil domain-containing protein 50,Protein Ymer;, PF15295;, GO:0005829;GO:0031625;GO:0007605;, C:cytosol;, F:ubiquitin protein ligase binding;, P:sensory perception of sound;|Q8IVM0 Q86VH7,Coiled-coil domain-containing protein 50,Protein Ymer;, PF15295;, GO:0005829;GO:0031625;GO:0007605;, C:cytosol;, F:ubiquitin protein ligase binding;, P:sensory perception of sound;|Q8IVM0 Q86VH7,Coiled-coil domain-containing protein 50,Protein Ymer;, PF15295;, GO:0005829;GO:0031625;GO:0007605;, C:cytosol;, F:ubiquitin protein ligase binding;, P:sensory perception of sound; scaffold13 indexed_genome mRNA 43761712 43785891 . - . ID=transcript_3503;P61328 B2R6B7 B2R976 O35339 P70376 Q8TBG5 Q92912 Q93001,Fibroblast growth factor 12,Fibroblast growth factor homologous factor 1;Myocyte-activating factor;, PF00167;, GO:0005737;GO:0005615;GO:0005634;GO:0045202;GO:0008083;GO:0008201;GO:0044325;GO:0017080;GO:0008344;GO:0086002;GO:0007267;GO:0007268;GO:0008543;GO:0007507;GO:0007254;GO:2001258;GO:0007399;GO:0050905;GO:0010765;GO:0003254;GO:0098908;GO:1902305;GO:2000649;GO:1905150;GO:0007165;, C:cytoplasm; C:extracellular space; C:nucleus; C:synapse;, F:growth factor activity; F:heparin binding; F:ion channel binding; F:sodium channel regulator activity;, P:adult locomotory behavior; P:cardiac muscle cell action potential involved in contraction; P:cell-cell signaling; P:chemical synaptic transmission; P:fibroblast growth factor receptor signaling pathway; P:heart development; P:JNK cascade; P:negative regulation of cation channel activity; P:nervous system development; P:neuromuscular process; P:positive regulation of sodium ion transport; P:regulation of membrane depolarization; P:regulation of neuronal action potential; P:regulation of sodium ion transmembrane transport; P:regulation of sodium ion transmembrane transporter activity; P:regulation of voltage-gated sodium channel activity; P:signal transduction; scaffold13 indexed_genome mRNA 44439522 44562570 . - . ID=transcript_3504;Q8IYB1 Q86VD8,Protein MB21D2,Mab-21 domain-containing protein 2;, PF03281;, GO:0045296;GO:0044877;, , F:cadherin binding; F:protein-containing complex binding; scaffold13 indexed_genome mRNA 44842420 44860035 . + . ID=transcript_3505;Q9HDD0 D2KX19 Q6X7C0 Q86WS9 X6R3D1,Phospholipase A and acyltransferase 1 {ECO:0000312|HGNC:HGNC:14922},HRAS-like suppressor 1;Phospholipid-metabolizing enzyme A-C1 {ECO:0000303|PubMed:21880860};, PF04970;, GO:0005737;GO:0016021;GO:0005641;GO:0005634;GO:0052740;GO:0016410;GO:0008374;GO:0052739;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0016042;GO:0070292;GO:0046470;, C:cytoplasm; C:integral component of membrane; C:nuclear envelope lumen; C:nucleus;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:N-acyltransferase activity; F:O-acyltransferase activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:lipid catabolic process; P:N-acylphosphatidylethanolamine metabolic process; P:phosphatidylcholine metabolic process;|Q9HDD0 D2KX19 Q6X7C0 Q86WS9 X6R3D1,Phospholipase A and acyltransferase 1 {ECO:0000312|HGNC:HGNC:14922},HRAS-like suppressor 1;Phospholipid-metabolizing enzyme A-C1 {ECO:0000303|PubMed:21880860};, PF04970;, GO:0005737;GO:0016021;GO:0005641;GO:0005634;GO:0052740;GO:0016410;GO:0008374;GO:0052739;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0016042;GO:0070292;GO:0046470;, C:cytoplasm; C:integral component of membrane; C:nuclear envelope lumen; C:nucleus;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:N-acyltransferase activity; F:O-acyltransferase activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:lipid catabolic process; P:N-acylphosphatidylethanolamine metabolic process; P:phosphatidylcholine metabolic process;|Q9HDD0 D2KX19 Q6X7C0 Q86WS9 X6R3D1,Phospholipase A and acyltransferase 1 {ECO:0000312|HGNC:HGNC:14922},HRAS-like suppressor 1;Phospholipid-metabolizing enzyme A-C1 {ECO:0000303|PubMed:21880860};, PF04970;, GO:0005737;GO:0016021;GO:0005641;GO:0005634;GO:0052740;GO:0016410;GO:0008374;GO:0052739;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0016042;GO:0070292;GO:0046470;, C:cytoplasm; C:integral component of membrane; C:nuclear envelope lumen; C:nucleus;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:N-acyltransferase activity; F:O-acyltransferase activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:lipid catabolic process; P:N-acylphosphatidylethanolamine metabolic process; P:phosphatidylcholine metabolic process; scaffold13 indexed_genome mRNA 44867516 44872395 . - . ID=transcript_3506;Q4VNC0 Q6UWS4 Q6ZWL0,Probable cation-transporting ATPase 13A5,P5-ATPase isoform 5;, PF00690;PF12409;, GO:0016021;GO:0005886;GO:0005524;GO:0016887;GO:0046872;GO:0006812;GO:0006874;GO:0034220;, C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cation transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; scaffold13 indexed_genome mRNA 45001591 45073948 . - . ID=transcript_3507;Q4VNC1 B7WPC7 Q6UY23 Q8N1Q9 Q9H043,Probable cation-transporting ATPase 13A4,P5-ATPase isoform 4;, PF00690;PF12409;, GO:0016021;GO:0005886;GO:0005524;GO:0016887;GO:0046872;GO:0006812;GO:0006874;GO:0034220;, C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cation transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; scaffold13 indexed_genome mRNA 45159227 45242636 . + . ID=transcript_3508;O60313 D3DNW4 E5KLJ5 E5KLJ6 E5KLJ7 E5KLK1 E5KLK2,Dynamin-like 120 kDa protein, mitochondrial,Optic atrophy protein 1;, PF00350;, GO:1904115;GO:0005737;GO:0005829;GO:0030425;GO:0031314;GO:0016021;GO:0016020;GO:0030061;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0005654;GO:1901612;GO:0005525;GO:0003924;GO:0019900;GO:0000287;GO:0008017;GO:0070300;GO:0044877;GO:0006915;GO:0019896;GO:0036444;GO:0071333;GO:0071456;GO:1905232;GO:0090398;GO:0090102;GO:0003374;GO:0046039;GO:0007007;GO:0048312;GO:0061025;GO:0097749;GO:0000266;GO:0008053;GO:0000002;GO:0070584;GO:0007005;GO:0043066;GO:1902236;GO:0090201;GO:0001843;GO:1900006;GO:0061003;GO:0046628;GO:0010636;GO:0014042;GO:0051259;GO:1904643;GO:0051602;GO:0014850;GO:0031667;GO:0060041;GO:0007601;, C:axon cytoplasm; C:cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:membrane; C:mitochondrial crista; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm;, F:cardiolipin binding; F:GTP binding; F:GTPase activity; F:kinase binding; F:magnesium ion binding; F:microtubule binding; F:phosphatidic acid binding; F:protein-containing complex binding;, P:apoptotic process; P:axonal transport of mitochondrion; P:calcium import into the mitochondrion; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:cellular response to L-glutamate; P:cellular senescence; P:cochlea development; P:dynamin family protein polymerization involved in mitochondrial fission; P:GTP metabolic process; P:inner mitochondrial membrane organization; P:intracellular distribution of mitochondria; P:membrane fusion; P:membrane tubulation; P:mitochondrial fission; P:mitochondrial fusion; P:mitochondrial genome maintenance; P:mitochondrion morphogenesis; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of release of cytochrome c from mitochondria; P:neural tube closure; P:positive regulation of dendrite development; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of mitochondrial fusion; P:positive regulation of neuron maturation; P:protein complex oligomerization; P:response to curcumin; P:response to electrical stimulus; P:response to muscle activity; P:response to nutrient levels; P:retina development in camera-type eye; P:visual perception;|O60313 D3DNW4 E5KLJ5 E5KLJ6 E5KLJ7 E5KLK1 E5KLK2,Dynamin-like 120 kDa protein, mitochondrial,Optic atrophy protein 1;, PF00350;, GO:1904115;GO:0005737;GO:0005829;GO:0030425;GO:0031314;GO:0016021;GO:0016020;GO:0030061;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0005654;GO:1901612;GO:0005525;GO:0003924;GO:0019900;GO:0000287;GO:0008017;GO:0070300;GO:0044877;GO:0006915;GO:0019896;GO:0036444;GO:0071333;GO:0071456;GO:1905232;GO:0090398;GO:0090102;GO:0003374;GO:0046039;GO:0007007;GO:0048312;GO:0061025;GO:0097749;GO:0000266;GO:0008053;GO:0000002;GO:0070584;GO:0007005;GO:0043066;GO:1902236;GO:0090201;GO:0001843;GO:1900006;GO:0061003;GO:0046628;GO:0010636;GO:0014042;GO:0051259;GO:1904643;GO:0051602;GO:0014850;GO:0031667;GO:0060041;GO:0007601;, C:axon cytoplasm; C:cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:membrane; C:mitochondrial crista; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm;, F:cardiolipin binding; F:GTP binding; F:GTPase activity; F:kinase binding; F:magnesium ion binding; F:microtubule binding; F:phosphatidic acid binding; F:protein-containing complex binding;, P:apoptotic process; P:axonal transport of mitochondrion; P:calcium import into the mitochondrion; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:cellular response to L-glutamate; P:cellular senescence; P:cochlea development; P:dynamin family protein polymerization involved in mitochondrial fission; P:GTP metabolic process; P:inner mitochondrial membrane organization; P:intracellular distribution of mitochondria; P:membrane fusion; P:membrane tubulation; P:mitochondrial fission; P:mitochondrial fusion; P:mitochondrial genome maintenance; P:mitochondrion morphogenesis; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of release of cytochrome c from mitochondria; P:neural tube closure; P:positive regulation of dendrite development; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of mitochondrial fusion; P:positive regulation of neuron maturation; P:protein complex oligomerization; P:response to curcumin; P:response to electrical stimulus; P:response to muscle activity; P:response to nutrient levels; P:retina development in camera-type eye; P:visual perception;|O60313 D3DNW4 E5KLJ5 E5KLJ6 E5KLJ7 E5KLK1 E5KLK2,Dynamin-like 120 kDa protein, mitochondrial,Optic atrophy protein 1;, PF00350;, GO:1904115;GO:0005737;GO:0005829;GO:0030425;GO:0031314;GO:0016021;GO:0016020;GO:0030061;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0005654;GO:1901612;GO:0005525;GO:0003924;GO:0019900;GO:0000287;GO:0008017;GO:0070300;GO:0044877;GO:0006915;GO:0019896;GO:0036444;GO:0071333;GO:0071456;GO:1905232;GO:0090398;GO:0090102;GO:0003374;GO:0046039;GO:0007007;GO:0048312;GO:0061025;GO:0097749;GO:0000266;GO:0008053;GO:0000002;GO:0070584;GO:0007005;GO:0043066;GO:1902236;GO:0090201;GO:0001843;GO:1900006;GO:0061003;GO:0046628;GO:0010636;GO:0014042;GO:0051259;GO:1904643;GO:0051602;GO:0014850;GO:0031667;GO:0060041;GO:0007601;, C:axon cytoplasm; C:cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:membrane; C:mitochondrial crista; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm;, F:cardiolipin binding; F:GTP binding; F:GTPase activity; F:kinase binding; F:magnesium ion binding; F:microtubule binding; F:phosphatidic acid binding; F:protein-containing complex binding;, P:apoptotic process; P:axonal transport of mitochondrion; P:calcium import into the mitochondrion; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:cellular response to L-glutamate; P:cellular senescence; P:cochlea development; P:dynamin family protein polymerization involved in mitochondrial fission; P:GTP metabolic process; P:inner mitochondrial membrane organization; P:intracellular distribution of mitochondria; P:membrane fusion; P:membrane tubulation; P:mitochondrial fission; P:mitochondrial fusion; P:mitochondrial genome maintenance; P:mitochondrion morphogenesis; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of release of cytochrome c from mitochondria; P:neural tube closure; P:positive regulation of dendrite development; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of mitochondrial fusion; P:positive regulation of neuron maturation; P:protein complex oligomerization; P:response to curcumin; P:response to electrical stimulus; P:response to muscle activity; P:response to nutrient levels; P:retina development in camera-type eye; P:visual perception;|O60313 D3DNW4 E5KLJ5 E5KLJ6 E5KLJ7 E5KLK1 E5KLK2,Dynamin-like 120 kDa protein, mitochondrial,Optic atrophy protein 1;, PF00350;, GO:1904115;GO:0005737;GO:0005829;GO:0030425;GO:0031314;GO:0016021;GO:0016020;GO:0030061;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0005654;GO:1901612;GO:0005525;GO:0003924;GO:0019900;GO:0000287;GO:0008017;GO:0070300;GO:0044877;GO:0006915;GO:0019896;GO:0036444;GO:0071333;GO:0071456;GO:1905232;GO:0090398;GO:0090102;GO:0003374;GO:0046039;GO:0007007;GO:0048312;GO:0061025;GO:0097749;GO:0000266;GO:0008053;GO:0000002;GO:0070584;GO:0007005;GO:0043066;GO:1902236;GO:0090201;GO:0001843;GO:1900006;GO:0061003;GO:0046628;GO:0010636;GO:0014042;GO:0051259;GO:1904643;GO:0051602;GO:0014850;GO:0031667;GO:0060041;GO:0007601;, C:axon cytoplasm; C:cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:membrane; C:mitochondrial crista; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm;, F:cardiolipin binding; F:GTP binding; F:GTPase activity; F:kinase binding; F:magnesium ion binding; F:microtubule binding; F:phosphatidic acid binding; F:protein-containing complex binding;, P:apoptotic process; P:axonal transport of mitochondrion; P:calcium import into the mitochondrion; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:cellular response to L-glutamate; P:cellular senescence; P:cochlea development; P:dynamin family protein polymerization involved in mitochondrial fission; P:GTP metabolic process; P:inner mitochondrial membrane organization; P:intracellular distribution of mitochondria; P:membrane fusion; P:membrane tubulation; P:mitochondrial fission; P:mitochondrial fusion; P:mitochondrial genome maintenance; P:mitochondrion morphogenesis; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of release of cytochrome c from mitochondria; P:neural tube closure; P:positive regulation of dendrite development; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of mitochondrial fusion; P:positive regulation of neuron maturation; P:protein complex oligomerization; P:response to curcumin; P:response to electrical stimulus; P:response to muscle activity; P:response to nutrient levels; P:retina development in camera-type eye; P:visual perception;|O60313 D3DNW4 E5KLJ5 E5KLJ6 E5KLJ7 E5KLK1 E5KLK2,Dynamin-like 120 kDa protein, mitochondrial,Optic atrophy protein 1;, PF00350;, GO:1904115;GO:0005737;GO:0005829;GO:0030425;GO:0031314;GO:0016021;GO:0016020;GO:0030061;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0005654;GO:1901612;GO:0005525;GO:0003924;GO:0019900;GO:0000287;GO:0008017;GO:0070300;GO:0044877;GO:0006915;GO:0019896;GO:0036444;GO:0071333;GO:0071456;GO:1905232;GO:0090398;GO:0090102;GO:0003374;GO:0046039;GO:0007007;GO:0048312;GO:0061025;GO:0097749;GO:0000266;GO:0008053;GO:0000002;GO:0070584;GO:0007005;GO:0043066;GO:1902236;GO:0090201;GO:0001843;GO:1900006;GO:0061003;GO:0046628;GO:0010636;GO:0014042;GO:0051259;GO:1904643;GO:0051602;GO:0014850;GO:0031667;GO:0060041;GO:0007601;, C:axon cytoplasm; C:cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:membrane; C:mitochondrial crista; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm;, F:cardiolipin binding; F:GTP binding; F:GTPase activity; F:kinase binding; F:magnesium ion binding; F:microtubule binding; F:phosphatidic acid binding; F:protein-containing complex binding;, P:apoptotic process; P:axonal transport of mitochondrion; P:calcium import into the mitochondrion; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:cellular response to L-glutamate; P:cellular senescence; P:cochlea development; P:dynamin family protein polymerization involved in mitochondrial fission; P:GTP metabolic process; P:inner mitochondrial membrane organization; P:intracellular distribution of mitochondria; P:membrane fusion; P:membrane tubulation; P:mitochondrial fission; P:mitochondrial fusion; P:mitochondrial genome maintenance; P:mitochondrion morphogenesis; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of release of cytochrome c from mitochondria; P:neural tube closure; P:positive regulation of dendrite development; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of mitochondrial fusion; P:positive regulation of neuron maturation; P:protein complex oligomerization; P:response to curcumin; P:response to electrical stimulus; P:response to muscle activity; P:response to nutrient levels; P:retina development in camera-type eye; P:visual perception; scaffold13 indexed_genome mRNA 45809431 45811847 . + . ID=transcript_3509;P22792 B2RPE7 Q86SU4 Q8N5V4,Carboxypeptidase N subunit 2,Carboxypeptidase N 83 kDa chain;Carboxypeptidase N large subunit;Carboxypeptidase N polypeptide 2;Carboxypeptidase N regulatory subunit;, PF13855;, GO:0072562;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0030234;GO:0050821;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:enzyme regulator activity;, P:protein stabilization; P:regulation of complement activation; scaffold13 indexed_genome mRNA 45871151 45955554 . - . ID=transcript_3510;Q9H7F0 Q8NC11 Q96KS1,Probable cation-transporting ATPase 13A3,ATPase family homolog up-regulated in senescence cells 1;, PF00689;PF00690;PF12409;, GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006812;GO:0006874;, C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cation transport; P:cellular calcium ion homeostasis; scaffold13 indexed_genome mRNA 46037686 46082697 . - . ID=transcript_3511;Q8N4G3,Transmembrane protein 44,, , GO:0016021;, C:integral component of membrane; scaffold13 indexed_genome mRNA 46082711 46083847 . - . ID=transcript_3512;Q8N4G3,Transmembrane protein 44,, , GO:0016021;, C:integral component of membrane; scaffold13 indexed_genome mRNA 46090313 46118035 . - . ID=transcript_3513;Q9H089 A0JLT4 A0PJK3 A6NI18 Q7L9H8 Q9NUK8,Large subunit GTPase 1 homolog,, PF01926;, GO:0015030;GO:0005829;GO:0005783;GO:0016020;GO:0016604;GO:0005654;GO:0005525;GO:0003924;GO:0051168;GO:0000054;, C:Cajal body; C:cytosol; C:endoplasmic reticulum; C:membrane; C:nuclear body; C:nucleoplasm;, F:GTP binding; F:GTPase activity;, P:nuclear export; P:ribosomal subunit export from nucleus;|Q9H089 A0JLT4 A0PJK3 A6NI18 Q7L9H8 Q9NUK8,Large subunit GTPase 1 homolog,, PF01926;, GO:0015030;GO:0005829;GO:0005783;GO:0016020;GO:0016604;GO:0005654;GO:0005525;GO:0003924;GO:0051168;GO:0000054;, C:Cajal body; C:cytosol; C:endoplasmic reticulum; C:membrane; C:nuclear body; C:nucleoplasm;, F:GTP binding; F:GTPase activity;, P:nuclear export; P:ribosomal subunit export from nucleus;|Q9H089 A0JLT4 A0PJK3 A6NI18 Q7L9H8 Q9NUK8,Large subunit GTPase 1 homolog,, PF01926;, GO:0015030;GO:0005829;GO:0005783;GO:0016020;GO:0016604;GO:0005654;GO:0005525;GO:0003924;GO:0051168;GO:0000054;, C:Cajal body; C:cytosol; C:endoplasmic reticulum; C:membrane; C:nuclear body; C:nucleoplasm;, F:GTP binding; F:GTPase activity;, P:nuclear export; P:ribosomal subunit export from nucleus;|Q9H089 A0JLT4 A0PJK3 A6NI18 Q7L9H8 Q9NUK8,Large subunit GTPase 1 homolog,, PF01926;, GO:0015030;GO:0005829;GO:0005783;GO:0016020;GO:0016604;GO:0005654;GO:0005525;GO:0003924;GO:0051168;GO:0000054;, C:Cajal body; C:cytosol; C:endoplasmic reticulum; C:membrane; C:nuclear body; C:nucleoplasm;, F:GTP binding; F:GTPase activity;, P:nuclear export; P:ribosomal subunit export from nucleus;|Q9H089 A0JLT4 A0PJK3 A6NI18 Q7L9H8 Q9NUK8,Large subunit GTPase 1 homolog,, PF01926;, GO:0015030;GO:0005829;GO:0005783;GO:0016020;GO:0016604;GO:0005654;GO:0005525;GO:0003924;GO:0051168;GO:0000054;, C:Cajal body; C:cytosol; C:endoplasmic reticulum; C:membrane; C:nuclear body; C:nucleoplasm;, F:GTP binding; F:GTPase activity;, P:nuclear export; P:ribosomal subunit export from nucleus;|Q9H089 A0JLT4 A0PJK3 A6NI18 Q7L9H8 Q9NUK8,Large subunit GTPase 1 homolog,, PF01926;, GO:0015030;GO:0005829;GO:0005783;GO:0016020;GO:0016604;GO:0005654;GO:0005525;GO:0003924;GO:0051168;GO:0000054;, C:Cajal body; C:cytosol; C:endoplasmic reticulum; C:membrane; C:nuclear body; C:nucleoplasm;, F:GTP binding; F:GTPase activity;, P:nuclear export; P:ribosomal subunit export from nucleus;|Q9H089 A0JLT4 A0PJK3 A6NI18 Q7L9H8 Q9NUK8,Large subunit GTPase 1 homolog,, PF01926;, GO:0015030;GO:0005829;GO:0005783;GO:0016020;GO:0016604;GO:0005654;GO:0005525;GO:0003924;GO:0051168;GO:0000054;, C:Cajal body; C:cytosol; C:endoplasmic reticulum; C:membrane; C:nuclear body; C:nucleoplasm;, F:GTP binding; F:GTPase activity;, P:nuclear export; P:ribosomal subunit export from nucleus; scaffold13 indexed_genome mRNA 46132462 46136543 . - . ID=transcript_3514;Q8N2R8 A3KME2 Q8IXP4 Q8WZ07,Protein FAM43A,, PF14719; scaffold13 indexed_genome mRNA 46485059 46661557 . - . ID=transcript_3515;Q8NBI6 D3DNW5 Q8NAL3 Q8WV03 Q96ME0,Xyloside xylosyltransferase 1 {ECO:0000303|PubMed:22117070},UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase;, PF01501;, GO:0030176;GO:0000287;GO:0030145;GO:0035252;GO:0140560;GO:0016266;, C:integral component of endoplasmic reticulum membrane;, F:magnesium ion binding; F:manganese ion binding; F:UDP-xylosyltransferase activity; F:xylosyl alpha-1,3-xylosyltransferase activity;, P:O-glycan processing; scaffold13 indexed_genome mRNA 46670915 46827153 . - . ID=transcript_3516;Q15057 A8K2V4 Q8N5Z8 Q9UQR3,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2,Centaurin-beta-2;, PF12796;PF01412;PF00169;, GO:0010008;GO:0016020;GO:0001726;GO:0005096;GO:0046872;GO:0030029;GO:1990090;GO:0032456;, C:endosome membrane; C:membrane; C:ruffle;, F:GTPase activator activity; F:metal ion binding;, P:actin filament-based process; P:cellular response to nerve growth factor stimulus; P:endocytic recycling; scaffold13 indexed_genome mRNA 46855162 46875138 . - . ID=transcript_3517;P41236,Protein phosphatase inhibitor 2,, PF04979;, GO:0004864;GO:0004865;GO:0006091;GO:0005977;GO:0043666;GO:0009966;, , F:protein phosphatase inhibitor activity; F:protein serine/threonine phosphatase inhibitor activity;, P:generation of precursor metabolites and energy; P:glycogen metabolic process; P:regulation of phosphoprotein phosphatase activity; P:regulation of signal transduction; scaffold13 indexed_genome mRNA 46897699 46911721 . - . ID=transcript_3518;P05090 B2R579 D3DNW6 Q6IBG6,Apolipoprotein D,, PF08212;, GO:0005737;GO:0022626;GO:0030425;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0043025;GO:0048471;GO:0015485;GO:0005319;GO:0007568;GO:0001525;GO:0007420;GO:0006006;GO:0030522;GO:0006629;GO:1900016;GO:0051895;GO:0060588;GO:0071638;GO:0010642;GO:0042308;GO:0048662;GO:2000098;GO:2000405;GO:0014012;GO:0048678;GO:0042493;GO:0000302;GO:0042246;, C:cytoplasm; C:cytosolic ribosome; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:neuronal cell body; C:perinuclear region of cytoplasm;, F:cholesterol binding; F:lipid transporter activity;, P:aging; P:angiogenesis; P:brain development; P:glucose metabolic process; P:intracellular receptor signaling pathway; P:lipid metabolic process; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of focal adhesion assembly; P:negative regulation of lipoprotein lipid oxidation; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of protein import into nucleus; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of smooth muscle cell-matrix adhesion; P:negative regulation of T cell migration; P:peripheral nervous system axon regeneration; P:response to axon injury; P:response to drug; P:response to reactive oxygen species; P:tissue regeneration;|P05090 B2R579 D3DNW6 Q6IBG6,Apolipoprotein D,, PF08212;, GO:0005737;GO:0022626;GO:0030425;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0043025;GO:0048471;GO:0015485;GO:0005319;GO:0007568;GO:0001525;GO:0007420;GO:0006006;GO:0030522;GO:0006629;GO:1900016;GO:0051895;GO:0060588;GO:0071638;GO:0010642;GO:0042308;GO:0048662;GO:2000098;GO:2000405;GO:0014012;GO:0048678;GO:0042493;GO:0000302;GO:0042246;, C:cytoplasm; C:cytosolic ribosome; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:neuronal cell body; C:perinuclear region of cytoplasm;, F:cholesterol binding; F:lipid transporter activity;, P:aging; P:angiogenesis; P:brain development; P:glucose metabolic process; P:intracellular receptor signaling pathway; P:lipid metabolic process; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of focal adhesion assembly; P:negative regulation of lipoprotein lipid oxidation; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of protein import into nucleus; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of smooth muscle cell-matrix adhesion; P:negative regulation of T cell migration; P:peripheral nervous system axon regeneration; P:response to axon injury; P:response to drug; P:response to reactive oxygen species; P:tissue regeneration;|P05090 B2R579 D3DNW6 Q6IBG6,Apolipoprotein D,, PF08212;, GO:0005737;GO:0022626;GO:0030425;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0043025;GO:0048471;GO:0015485;GO:0005319;GO:0007568;GO:0001525;GO:0007420;GO:0006006;GO:0030522;GO:0006629;GO:1900016;GO:0051895;GO:0060588;GO:0071638;GO:0010642;GO:0042308;GO:0048662;GO:2000098;GO:2000405;GO:0014012;GO:0048678;GO:0042493;GO:0000302;GO:0042246;, C:cytoplasm; C:cytosolic ribosome; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:neuronal cell body; C:perinuclear region of cytoplasm;, F:cholesterol binding; F:lipid transporter activity;, P:aging; P:angiogenesis; P:brain development; P:glucose metabolic process; P:intracellular receptor signaling pathway; P:lipid metabolic process; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of focal adhesion assembly; P:negative regulation of lipoprotein lipid oxidation; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of protein import into nucleus; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of smooth muscle cell-matrix adhesion; P:negative regulation of T cell migration; P:peripheral nervous system axon regeneration; P:response to axon injury; P:response to drug; P:response to reactive oxygen species; P:tissue regeneration; scaffold13 indexed_genome mRNA 46970600 47004475 . + . ID=transcript_3519;Q02338 D3DXC0 Q96ET1 Q9BRZ4,D-beta-hydroxybutyrate dehydrogenase, mitochondrial {ECO:0000305},3-hydroxybutyrate dehydrogenase {ECO:0000303|PubMed:1639787};Short chain dehydrogenase/reductase family 9C member 1;, PF00106;, GO:0099617;GO:0005759;GO:0005739;GO:0003858;GO:0046951;GO:0046952;, C:matrix side of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxybutyrate dehydrogenase activity;, P:ketone body biosynthetic process; P:ketone body catabolic process; scaffold13 indexed_genome mRNA 47185445 47768428 . + . ID=transcript_3520;E9PG21 Q12958,Disks large homolog 1 {ECO:0000305},Synapse-associated protein 97;hDlg;, PF00625;PF09058;PF10608;PF00595;PF10600;PF00018;, GO:0016324;GO:0005604;GO:0016323;GO:0005923;GO:0030054;GO:0031253;GO:0005911;GO:0005737;GO:0009898;GO:0005829;GO:0005783;GO:0005789;GO:0070062;GO:0098978;GO:0005794;GO:0001772;GO:0014704;GO:0043219;GO:0016328;GO:0045121;GO:0005874;GO:0097025;GO:0035748;GO:0031594;GO:0043005;GO:0033268;GO:0005634;GO:0048471;GO:0005886;GO:0098839;GO:0042383;GO:0097060;GO:0045296;GO:0008092;GO:0004385;GO:0044325;GO:0097016;GO:0031434;GO:0060090;GO:0019902;GO:0004721;GO:0015459;GO:0008022;GO:0019901;GO:0098919;GO:0007015;GO:0032147;GO:0042982;GO:0030953;GO:0070830;GO:0001658;GO:0098609;GO:0034629;GO:0007268;GO:0030866;GO:0043622;GO:0048704;GO:0001935;GO:0051660;GO:0007163;GO:0045197;GO:0060022;GO:0001771;GO:0002088;GO:0000165;GO:0031579;GO:0050680;GO:0070373;GO:2000134;GO:1903753;GO:0051898;GO:0042130;GO:0000122;GO:0099645;GO:0030432;GO:0030838;GO:0008284;GO:0043268;GO:1903078;GO:0072659;GO:0043113;GO:0097120;GO:0008360;GO:0042391;GO:0031641;GO:2000310;GO:1903764;GO:1903286;GO:1902473;GO:1902305;GO:0098911;GO:1903760;GO:0048608;GO:0048745;GO:0042110;GO:0016032;, C:apical plasma membrane; C:basement membrane; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection membrane; C:cell-cell junction; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:immunological synapse; C:intercalated disc; C:lateral loop; C:lateral plasma membrane; C:membrane raft; C:microtubule; C:MPP7-DLG1-LIN7 complex; C:myelin sheath abaxonal region; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density membrane; C:sarcolemma; C:synaptic membrane;, F:cadherin binding; F:cytoskeletal protein binding; F:guanylate kinase activity; F:ion channel binding; F:L27 domain binding; F:mitogen-activated protein kinase kinase binding; F:molecular adaptor activity; F:phosphatase binding; F:phosphoprotein phosphatase activity; F:potassium channel regulator activity; F:protein C-terminus binding; F:protein kinase binding; F:structural constituent of postsynaptic density;, P:actin filament organization; P:activation of protein kinase activity; P:amyloid precursor protein metabolic process; P:astral microtubule organization; P:bicellular tight junction assembly; P:branching involved in ureteric bud morphogenesis; P:cell-cell adhesion; P:cellular protein-containing complex localization; P:chemical synaptic transmission; P:cortical actin cytoskeleton organization; P:cortical microtubule organization; P:embryonic skeletal system morphogenesis; P:endothelial cell proliferation; P:establishment of centrosome localization; P:establishment or maintenance of cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:hard palate development; P:immunological synapse formation; P:lens development in camera-type eye; P:MAPK cascade; P:membrane raft organization; P:negative regulation of epithelial cell proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of p38MAPK cascade; P:negative regulation of protein kinase B signaling; P:negative regulation of T cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:peristalsis; P:positive regulation of actin filament polymerization; P:positive regulation of cell population proliferation; P:positive regulation of potassium ion transport; P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:receptor clustering; P:receptor localization to synapse; P:regulation of cell shape; P:regulation of membrane potential; P:regulation of myelination; P:regulation of NMDA receptor activity; P:regulation of potassium ion export across plasma membrane; P:regulation of potassium ion import; P:regulation of protein localization to synapse; P:regulation of sodium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell action potential; P:regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:reproductive structure development; P:smooth muscle tissue development; P:T cell activation; P:viral process;|Q96LK0 B2RA74 Q96I48,Centrosomal protein of 19 kDa,, PF14933;, GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005737;GO:0000922;GO:0060271;GO:0034454;GO:0097712;, C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytoplasm; C:spindle pole;, , P:cilium assembly; P:microtubule anchoring at centrosome; P:vesicle targeting, trans-Golgi to periciliary membrane compartment;|E9PG21 Q12958,Disks large homolog 1 {ECO:0000305},Synapse-associated protein 97;hDlg;, PF00625;PF09058;PF10608;PF00595;PF10600;PF00018;, GO:0016324;GO:0005604;GO:0016323;GO:0005923;GO:0030054;GO:0031253;GO:0005911;GO:0005737;GO:0009898;GO:0005829;GO:0005783;GO:0005789;GO:0070062;GO:0098978;GO:0005794;GO:0001772;GO:0014704;GO:0043219;GO:0016328;GO:0045121;GO:0005874;GO:0097025;GO:0035748;GO:0031594;GO:0043005;GO:0033268;GO:0005634;GO:0048471;GO:0005886;GO:0098839;GO:0042383;GO:0097060;GO:0045296;GO:0008092;GO:0004385;GO:0044325;GO:0097016;GO:0031434;GO:0060090;GO:0019902;GO:0004721;GO:0015459;GO:0008022;GO:0019901;GO:0098919;GO:0007015;GO:0032147;GO:0042982;GO:0030953;GO:0070830;GO:0001658;GO:0098609;GO:0034629;GO:0007268;GO:0030866;GO:0043622;GO:0048704;GO:0001935;GO:0051660;GO:0007163;GO:0045197;GO:0060022;GO:0001771;GO:0002088;GO:0000165;GO:0031579;GO:0050680;GO:0070373;GO:2000134;GO:1903753;GO:0051898;GO:0042130;GO:0000122;GO:0099645;GO:0030432;GO:0030838;GO:0008284;GO:0043268;GO:1903078;GO:0072659;GO:0043113;GO:0097120;GO:0008360;GO:0042391;GO:0031641;GO:2000310;GO:1903764;GO:1903286;GO:1902473;GO:1902305;GO:0098911;GO:1903760;GO:0048608;GO:0048745;GO:0042110;GO:0016032;, C:apical plasma membrane; C:basement membrane; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection membrane; C:cell-cell junction; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:immunological synapse; C:intercalated disc; C:lateral loop; C:lateral plasma membrane; C:membrane raft; C:microtubule; C:MPP7-DLG1-LIN7 complex; C:myelin sheath abaxonal region; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density membrane; C:sarcolemma; C:synaptic membrane;, F:cadherin binding; F:cytoskeletal protein binding; F:guanylate kinase activity; F:ion channel binding; F:L27 domain binding; F:mitogen-activated protein kinase kinase binding; F:molecular adaptor activity; F:phosphatase binding; F:phosphoprotein phosphatase activity; F:potassium channel regulator activity; F:protein C-terminus binding; F:protein kinase binding; F:structural constituent of postsynaptic density;, P:actin filament organization; P:activation of protein kinase activity; P:amyloid precursor protein metabolic process; P:astral microtubule organization; P:bicellular tight junction assembly; P:branching involved in ureteric bud morphogenesis; P:cell-cell adhesion; P:cellular protein-containing complex localization; P:chemical synaptic transmission; P:cortical actin cytoskeleton organization; P:cortical microtubule organization; P:embryonic skeletal system morphogenesis; P:endothelial cell proliferation; P:establishment of centrosome localization; P:establishment or maintenance of cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:hard palate development; P:immunological synapse formation; P:lens development in camera-type eye; P:MAPK cascade; P:membrane raft organization; P:negative regulation of epithelial cell proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of p38MAPK cascade; P:negative regulation of protein kinase B signaling; P:negative regulation of T cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:peristalsis; P:positive regulation of actin filament polymerization; P:positive regulation of cell population proliferation; P:positive regulation of potassium ion transport; P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:receptor clustering; P:receptor localization to synapse; P:regulation of cell shape; P:regulation of membrane potential; P:regulation of myelination; P:regulation of NMDA receptor activity; P:regulation of potassium ion export across plasma membrane; P:regulation of potassium ion import; P:regulation of protein localization to synapse; P:regulation of sodium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell action potential; P:regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:reproductive structure development; P:smooth muscle tissue development; P:T cell activation; P:viral process;|P08582 Q9BQE2,Melanotransferrin {ECO:0000312|HGNC:HGNC:7037},Melanoma-associated antigen p97;, PF00405;, GO:0046658;GO:0009986;GO:0005769;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0055037;GO:0005506;GO:0044267;GO:0055072;GO:0006826;GO:1900025;GO:0090091;GO:0010756;GO:0043687;, C:anchored component of plasma membrane; C:cell surface; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:recycling endosome;, F:iron ion binding;, P:cellular protein metabolic process; P:iron ion homeostasis; P:iron ion transport; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of extracellular matrix disassembly; P:positive regulation of plasminogen activation; P:post-translational protein modification;|P08582 Q9BQE2,Melanotransferrin {ECO:0000312|HGNC:HGNC:7037},Melanoma-associated antigen p97;, PF00405;, GO:0046658;GO:0009986;GO:0005769;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0055037;GO:0005506;GO:0044267;GO:0055072;GO:0006826;GO:1900025;GO:0090091;GO:0010756;GO:0043687;, C:anchored component of plasma membrane; C:cell surface; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:recycling endosome;, F:iron ion binding;, P:cellular protein metabolic process; P:iron ion homeostasis; P:iron ion transport; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of extracellular matrix disassembly; P:positive regulation of plasminogen activation; P:post-translational protein modification;|Q86VD9 Q9H9G6,GPI mannosyltransferase 4,GPI mannosyltransferase IV;Phosphatidylinositol-glycan biosynthesis class Z protein;SMP3 homolog;, PF03901;, GO:0005783;GO:0005789;GO:0016021;GO:0000026;GO:0000030;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,2-mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q86VD9 Q9H9G6,GPI mannosyltransferase 4,GPI mannosyltransferase IV;Phosphatidylinositol-glycan biosynthesis class Z protein;SMP3 homolog;, PF03901;, GO:0005783;GO:0005789;GO:0016021;GO:0000026;GO:0000030;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,2-mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|P52298 B2RE91 B4DMK7 E9PAR5 Q14924 Q2TS50,Nuclear cap-binding protein subunit 2,20 kDa nuclear cap-binding protein;Cell proliferation-inducing gene 55 protein;NCBP 20 kDa subunit;NCBP-interacting protein 1;, PF00076;, GO:0005737;GO:0005829;GO:0005845;GO:0005846;GO:0005654;GO:0005634;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0017069;GO:0006370;GO:0008543;GO:0031047;GO:0008334;GO:0031124;GO:0045292;GO:0006406;GO:0000398;GO:0051168;GO:0000184;GO:0031442;GO:0046833;GO:0098789;GO:0006446;GO:0006405;GO:0016070;GO:0008380;GO:0006408;GO:0042795;GO:0006369;GO:0006366;GO:0006368;, C:cytoplasm; C:cytosol; C:mRNA cap binding complex; C:nuclear cap binding complex; C:nucleoplasm; C:nucleus; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:snRNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:gene silencing by RNA; P:histone mRNA metabolic process; P:mRNA 3'-end processing; P:mRNA cis splicing, via spliceosome; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear export; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA 3'-end processing; P:positive regulation of RNA export from nucleus; P:pre-mRNA cleavage required for polyadenylation; P:regulation of translational initiation; P:RNA export from nucleus; P:RNA metabolic process; P:RNA splicing; P:snRNA export from nucleus; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P52298 B2RE91 B4DMK7 E9PAR5 Q14924 Q2TS50,Nuclear cap-binding protein subunit 2,20 kDa nuclear cap-binding protein;Cell proliferation-inducing gene 55 protein;NCBP 20 kDa subunit;NCBP-interacting protein 1;, PF00076;, GO:0005737;GO:0005829;GO:0005845;GO:0005846;GO:0005654;GO:0005634;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0017069;GO:0006370;GO:0008543;GO:0031047;GO:0008334;GO:0031124;GO:0045292;GO:0006406;GO:0000398;GO:0051168;GO:0000184;GO:0031442;GO:0046833;GO:0098789;GO:0006446;GO:0006405;GO:0016070;GO:0008380;GO:0006408;GO:0042795;GO:0006369;GO:0006366;GO:0006368;, C:cytoplasm; C:cytosol; C:mRNA cap binding complex; C:nuclear cap binding complex; C:nucleoplasm; C:nucleus; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:snRNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:gene silencing by RNA; P:histone mRNA metabolic process; P:mRNA 3'-end processing; P:mRNA cis splicing, via spliceosome; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear export; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA 3'-end processing; P:positive regulation of RNA export from nucleus; P:pre-mRNA cleavage required for polyadenylation; P:regulation of translational initiation; P:RNA export from nucleus; P:RNA metabolic process; P:RNA splicing; P:snRNA export from nucleus; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P52298 B2RE91 B4DMK7 E9PAR5 Q14924 Q2TS50,Nuclear cap-binding protein subunit 2,20 kDa nuclear cap-binding protein;Cell proliferation-inducing gene 55 protein;NCBP 20 kDa subunit;NCBP-interacting protein 1;, PF00076;, GO:0005737;GO:0005829;GO:0005845;GO:0005846;GO:0005654;GO:0005634;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0017069;GO:0006370;GO:0008543;GO:0031047;GO:0008334;GO:0031124;GO:0045292;GO:0006406;GO:0000398;GO:0051168;GO:0000184;GO:0031442;GO:0046833;GO:0098789;GO:0006446;GO:0006405;GO:0016070;GO:0008380;GO:0006408;GO:0042795;GO:0006369;GO:0006366;GO:0006368;, C:cytoplasm; C:cytosol; C:mRNA cap binding complex; C:nuclear cap binding complex; C:nucleoplasm; C:nucleus; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:snRNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:gene silencing by RNA; P:histone mRNA metabolic process; P:mRNA 3'-end processing; P:mRNA cis splicing, via spliceosome; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear export; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA 3'-end processing; P:positive regulation of RNA export from nucleus; P:pre-mRNA cleavage required for polyadenylation; P:regulation of translational initiation; P:RNA export from nucleus; P:RNA metabolic process; P:RNA splicing; P:snRNA export from nucleus; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P52298 B2RE91 B4DMK7 E9PAR5 Q14924 Q2TS50,Nuclear cap-binding protein subunit 2,20 kDa nuclear cap-binding protein;Cell proliferation-inducing gene 55 protein;NCBP 20 kDa subunit;NCBP-interacting protein 1;, PF00076;, GO:0005737;GO:0005829;GO:0005845;GO:0005846;GO:0005654;GO:0005634;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0017069;GO:0006370;GO:0008543;GO:0031047;GO:0008334;GO:0031124;GO:0045292;GO:0006406;GO:0000398;GO:0051168;GO:0000184;GO:0031442;GO:0046833;GO:0098789;GO:0006446;GO:0006405;GO:0016070;GO:0008380;GO:0006408;GO:0042795;GO:0006369;GO:0006366;GO:0006368;, C:cytoplasm; C:cytosol; C:mRNA cap binding complex; C:nuclear cap binding complex; C:nucleoplasm; C:nucleus; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:snRNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:gene silencing by RNA; P:histone mRNA metabolic process; P:mRNA 3'-end processing; P:mRNA cis splicing, via spliceosome; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear export; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA 3'-end processing; P:positive regulation of RNA export from nucleus; P:pre-mRNA cleavage required for polyadenylation; P:regulation of translational initiation; P:RNA export from nucleus; P:RNA metabolic process; P:RNA splicing; P:snRNA export from nucleus; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P52298 B2RE91 B4DMK7 E9PAR5 Q14924 Q2TS50,Nuclear cap-binding protein subunit 2,20 kDa nuclear cap-binding protein;Cell proliferation-inducing gene 55 protein;NCBP 20 kDa subunit;NCBP-interacting protein 1;, PF00076;, GO:0005737;GO:0005829;GO:0005845;GO:0005846;GO:0005654;GO:0005634;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0017069;GO:0006370;GO:0008543;GO:0031047;GO:0008334;GO:0031124;GO:0045292;GO:0006406;GO:0000398;GO:0051168;GO:0000184;GO:0031442;GO:0046833;GO:0098789;GO:0006446;GO:0006405;GO:0016070;GO:0008380;GO:0006408;GO:0042795;GO:0006369;GO:0006366;GO:0006368;, C:cytoplasm; C:cytosol; C:mRNA cap binding complex; C:nuclear cap binding complex; C:nucleoplasm; C:nucleus; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:snRNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:gene silencing by RNA; P:histone mRNA metabolic process; P:mRNA 3'-end processing; P:mRNA cis splicing, via spliceosome; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear export; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA 3'-end processing; P:positive regulation of RNA export from nucleus; P:pre-mRNA cleavage required for polyadenylation; P:regulation of translational initiation; P:RNA export from nucleus; P:RNA metabolic process; P:RNA splicing; P:snRNA export from nucleus; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q96HI0 B4DY82 Q96SA5,Sentrin-specific protease 5,Sentrin/SUMO-specific protease SENP5;, PF02902;, GO:0005813;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0019783;GO:0007049;GO:0051301;GO:0016926;, C:centrosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ubiquitin-like protein-specific protease activity;, P:cell cycle; P:cell division; P:protein desumoylation;|Q96HI0 B4DY82 Q96SA5,Sentrin-specific protease 5,Sentrin/SUMO-specific protease SENP5;, PF02902;, GO:0005813;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0019783;GO:0007049;GO:0051301;GO:0016926;, C:centrosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ubiquitin-like protein-specific protease activity;, P:cell cycle; P:cell division; P:protein desumoylation;|Q96HI0 B4DY82 Q96SA5,Sentrin-specific protease 5,Sentrin/SUMO-specific protease SENP5;, PF02902;, GO:0005813;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0019783;GO:0007049;GO:0051301;GO:0016926;, C:centrosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ubiquitin-like protein-specific protease activity;, P:cell cycle; P:cell division; P:protein desumoylation;|Q13177 Q13154 Q6ISC3,Serine/threonine-protein kinase PAK 2,Gamma-PAK;PAK65;S6/H4 kinase;p21-activated kinase 2;p58;, PF00786;PF00069;, GO:0005911;GO:0005737;GO:0005829;GO:0098978;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0005524;GO:0045296;GO:0042802;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0030296;GO:0031267;GO:0032147;GO:0034333;GO:0006915;GO:0070830;GO:0071407;GO:0060996;GO:0038095;GO:0035722;GO:0043066;GO:2001271;GO:0006469;GO:0051497;GO:0018105;GO:0016310;GO:2001238;GO:0050731;GO:0046777;GO:0150105;GO:0006468;GO:0050770;GO:0051493;GO:0050690;GO:0040008;GO:0007165;GO:0002223;GO:0031098;GO:0031295;GO:0050852;GO:0048010;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:ATP binding; F:cadherin binding; F:identical protein binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activator activity; F:small GTPase binding;, P:activation of protein kinase activity; P:adherens junction assembly; P:apoptotic process; P:bicellular tight junction assembly; P:cellular response to organic cyclic compound; P:dendritic spine development; P:Fc-epsilon receptor signaling pathway; P:interleukin-12-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; P:negative regulation of protein kinase activity; P:negative regulation of stress fiber assembly; P:peptidyl-serine phosphorylation; P:phosphorylation; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein autophosphorylation; P:protein localization to cell-cell junction; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cytoskeleton organization; P:regulation of defense response to virus by virus; P:regulation of growth; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated protein kinase signaling cascade; P:T cell costimulation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q8TBF5 Q9NWZ2,Phosphatidylinositol-glycan biosynthesis class X protein,, PF08320;, GO:0005789;GO:0016021;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:preassembly of GPI anchor in ER membrane;|Q8TBF5 Q9NWZ2,Phosphatidylinositol-glycan biosynthesis class X protein,, PF08320;, GO:0005789;GO:0016021;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:preassembly of GPI anchor in ER membrane; scaffold13 indexed_genome mRNA 47803611 47828397 . - . ID=transcript_3521;Q86YC3,Transforming growth factor beta activator LRRC33 {ECO:0000305},Leucine-rich repeat-containing protein 33 {ECO:0000305};Negative regulator of reactive oxygen species {ECO:0000250|UniProtKB:Q8BMT4};, PF13516;PF13855;, GO:0009986;GO:0005783;GO:0005789;GO:0005576;GO:0016021;GO:0005886;GO:0050431;GO:0006955;GO:0006954;GO:0014005;GO:0035583;GO:0006801;GO:0007179;GO:0036364;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:transforming growth factor beta binding;, P:immune response; P:inflammatory response; P:microglia development; P:sequestering of TGFbeta in extracellular matrix; P:superoxide metabolic process; P:transforming growth factor beta receptor signaling pathway; P:transforming growth factor beta1 activation;|Q86YC3,Transforming growth factor beta activator LRRC33 {ECO:0000305},Leucine-rich repeat-containing protein 33 {ECO:0000305};Negative regulator of reactive oxygen species {ECO:0000250|UniProtKB:Q8BMT4};, PF13516;PF13855;, GO:0009986;GO:0005783;GO:0005789;GO:0005576;GO:0016021;GO:0005886;GO:0050431;GO:0006955;GO:0006954;GO:0014005;GO:0035583;GO:0006801;GO:0007179;GO:0036364;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:transforming growth factor beta binding;, P:immune response; P:inflammatory response; P:microglia development; P:sequestering of TGFbeta in extracellular matrix; P:superoxide metabolic process; P:transforming growth factor beta receptor signaling pathway; P:transforming growth factor beta1 activation; scaffold13 indexed_genome mRNA 47874126 47883679 . - . ID=transcript_3522;P0C2W1 A6NF90 D3DXB5,F-box/SPRY domain-containing protein 1,F-box only protein 45;, PF12937;PF00622;, GO:0042995;GO:0098978;GO:0099524;GO:0014069;GO:0045211;GO:0099523;GO:0042734;GO:0019005;GO:0045202;GO:0021960;GO:0006974;GO:0021799;GO:0021800;GO:0021957;GO:0001764;GO:0043161;GO:0016567;GO:0060386;GO:0006511;, C:cell projection; C:glutamatergic synapse; C:postsynaptic cytosol; C:postsynaptic density; C:postsynaptic membrane; C:presynaptic cytosol; C:presynaptic membrane; C:SCF ubiquitin ligase complex; C:synapse;, , P:anterior commissure morphogenesis; P:cellular response to DNA damage stimulus; P:cerebral cortex radially oriented cell migration; P:cerebral cortex tangential migration; P:corticospinal tract morphogenesis; P:neuron migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:synapse assembly involved in innervation; P:ubiquitin-dependent protein catabolic process; scaffold13 indexed_genome mRNA 47889547 47900691 . + . ID=transcript_3523;Q7Z5U6 A0MNP1,WD repeat-containing protein 53,, PF12894;PF00400; scaffold13 indexed_genome mRNA 47906393 47907664 . + . ID=transcript_3524;Q9H442,Double zinc ribbon and ankyrin repeat-containing protein 1,, PF12773;PF13287;, GO:0046872;, , F:metal ion binding; scaffold13 indexed_genome mRNA 47928649 47932130 . + . ID=transcript_3525;Q147U7 B3KW20,Single-pass membrane and coiled-coil domain-containing protein 1,Single-pass membrane protein with coiled-coil domains 1;, PF15080;, GO:0016021;, C:integral component of membrane;|Q147U7 B3KW20,Single-pass membrane and coiled-coil domain-containing protein 1,Single-pass membrane protein with coiled-coil domains 1;, PF15080;, GO:0016021;, C:integral component of membrane;|Q147U7 B3KW20,Single-pass membrane and coiled-coil domain-containing protein 1,Single-pass membrane protein with coiled-coil domains 1;, PF15080;, GO:0016021;, C:integral component of membrane; scaffold13 indexed_genome mRNA 47933715 47957449 . + . ID=transcript_3526;Q8IYW5 Q8NA67 Q96NS4,E3 ubiquitin-protein ligase RNF168 {ECO:0000255|HAMAP-Rule:MF_03066},RING finger protein 168 {ECO:0000255|HAMAP-Rule:MF_03066};RING-type E3 ubiquitin transferase RNF168;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0035861;GO:0000151;GO:0003682;GO:0042393;GO:0070530;GO:0046872;GO:0031491;GO:0043130;GO:0004842;GO:0006974;GO:0006302;GO:0006303;GO:0070535;GO:0035518;GO:0036351;GO:0036352;GO:0036297;GO:0045190;GO:0034244;GO:0045739;GO:0070534;GO:0016567;GO:0010212;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:site of double-strand break; C:ubiquitin ligase complex;, F:chromatin binding; F:histone binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:nucleosome binding; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H2A K63-linked ubiquitination; P:histone H2A monoubiquitination; P:histone H2A-K13 ubiquitination; P:histone H2A-K15 ubiquitination; P:interstrand cross-link repair; P:isotype switching; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of DNA repair; P:protein K63-linked ubiquitination; P:protein ubiquitination; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process; scaffold13 indexed_genome mRNA 48029190 48035166 . + . ID=transcript_3527;O94888 D3DXB3 Q6ZP77 Q86X20 Q8N327,UBX domain-containing protein 7,, PF00789;, GO:0005829;GO:0016604;GO:0005654;GO:0034098;GO:0008134;GO:0043130;GO:0031625;GO:0043687;, C:cytosol; C:nuclear body; C:nucleoplasm; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:transcription factor binding; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:post-translational protein modification; scaffold13 indexed_genome mRNA 48047115 48052308 . + . ID=transcript_3528;Q96DZ7 B2RV20 E9PH22 Q336K7,Transmembrane 4 L6 family member 19,Osteoclast maturation-associated gene 4 protein;Tetraspan membrane protein OCTM4;, PF05805;, GO:0016021;, C:integral component of membrane; scaffold13 indexed_genome mRNA 48054042 48091194 . + . ID=transcript_3529;Q96DZ7 B2RV20 E9PH22 Q336K7,Transmembrane 4 L6 family member 19,Osteoclast maturation-associated gene 4 protein;Tetraspan membrane protein OCTM4;, PF05805;, GO:0016021;, C:integral component of membrane;|Q8WW35 A6NCN5,Dynein light chain Tctex-type protein 2B {ECO:0000305},Tctex1 domain-containing protein 2;, PF03645;, GO:0005929;GO:0005868;GO:0045505;GO:0060271;GO:0035721;GO:1902017;GO:1905799;, C:cilium; C:cytoplasmic dynein complex;, F:dynein intermediate chain binding;, P:cilium assembly; P:intraciliary retrograde transport; P:regulation of cilium assembly; P:regulation of intraciliary retrograde transport;|Q8WW35 A6NCN5,Dynein light chain Tctex-type protein 2B {ECO:0000305},Tctex1 domain-containing protein 2;, PF03645;, GO:0005929;GO:0005868;GO:0045505;GO:0060271;GO:0035721;GO:1902017;GO:1905799;, C:cilium; C:cytoplasmic dynein complex;, F:dynein intermediate chain binding;, P:cilium assembly; P:intraciliary retrograde transport; P:regulation of cilium assembly; P:regulation of intraciliary retrograde transport; scaffold13 indexed_genome mRNA 48093080 48133961 . + . ID=transcript_3530;P49585 A9LYK9 D3DXB1 Q86Y88,Choline-phosphate cytidylyltransferase A,CCT-alpha;CTP:phosphocholine cytidylyltransferase A;Phosphorylcholine transferase A;, PF01467;, GO:0005829;GO:0005783;GO:0005789;GO:0042587;GO:0005634;GO:0004105;GO:0042802;GO:0031210;GO:0006657;GO:0006656;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:glycogen granule; C:nucleus;, F:choline-phosphate cytidylyltransferase activity; F:identical protein binding; F:phosphatidylcholine binding;, P:CDP-choline pathway; P:phosphatidylcholine biosynthetic process; scaffold13 indexed_genome mRNA 48134035 48143070 . - . ID=transcript_3531;Q86UW1 Q6ZMC7,Organic solute transporter subunit alpha,Solute carrier family 51 subunit alpha;, PF03619;, GO:0016323;GO:0005789;GO:0016021;GO:0005886;GO:0032991;GO:0015125;GO:0046982;GO:0042803;GO:0015721;GO:0032782;, C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:bile acid transmembrane transporter activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:bile acid and bile salt transport; P:bile acid secretion; scaffold13 indexed_genome mRNA 48143076 48147771 . - . ID=transcript_3532;Q86UW1 Q6ZMC7,Organic solute transporter subunit alpha,Solute carrier family 51 subunit alpha;, PF03619;, GO:0016323;GO:0005789;GO:0016021;GO:0005886;GO:0032991;GO:0015125;GO:0046982;GO:0042803;GO:0015721;GO:0032782;, C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:bile acid transmembrane transporter activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:bile acid and bile salt transport; P:bile acid secretion; scaffold13 indexed_genome mRNA 48162963 48163650 . - . ID=transcript_3533;Q8WVZ1 A0A0B4J1W2 A8MSY6 B3KVI1,Palmitoyltransferase ZDHHC19,Zinc finger DHHC domain-containing protein 19;, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0048471;GO:0097356;GO:0019706;GO:0018230;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:perinucleolar compartment;, F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein targeting to membrane; scaffold13 indexed_genome mRNA 48165373 48174930 . + . ID=transcript_3534;Q8WVZ1 A0A0B4J1W2 A8MSY6 B3KVI1,Palmitoyltransferase ZDHHC19,Zinc finger DHHC domain-containing protein 19;, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0048471;GO:0097356;GO:0019706;GO:0018230;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:perinucleolar compartment;, F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein targeting to membrane; scaffold13 indexed_genome mRNA 48277070 48296760 . + . ID=transcript_3535;P02786 D3DXB0 Q1HE24 Q59G55 Q9UCN0 Q9UCU5 Q9UDF9 Q9UK21,Transferrin receptor protein 1,T9;p90;, PF02225;PF04389;PF04253;, GO:0016323;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0005768;GO:0010008;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:1990712;GO:0005887;GO:0043231;GO:0042470;GO:0016020;GO:0048471;GO:0005886;GO:0055037;GO:0003725;GO:0042802;GO:0042803;GO:0019901;GO:0044877;GO:0003723;GO:0004998;GO:0001618;GO:0006879;GO:0035690;GO:1990830;GO:0035556;GO:0006826;GO:0061024;GO:0043066;GO:0010637;GO:0030316;GO:0030890;GO:0045780;GO:0010628;GO:0043123;GO:0045830;GO:0051092;GO:0033138;GO:1900182;GO:0001934;GO:0031334;GO:0042102;GO:0031623;GO:0033572;GO:0150104;, C:basolateral plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endosome; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:HFE-transferrin receptor complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:double-stranded RNA binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA binding; F:transferrin receptor activity; F:virus receptor activity;, P:cellular iron ion homeostasis; P:cellular response to drug; P:cellular response to leukemia inhibitory factor; P:intracellular signal transduction; P:iron ion transport; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial fusion; P:osteoclast differentiation; P:positive regulation of B cell proliferation; P:positive regulation of bone resorption; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of isotype switching; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of T cell proliferation; P:receptor internalization; P:transferrin transport; P:transport across blood-brain barrier;|P02786 D3DXB0 Q1HE24 Q59G55 Q9UCN0 Q9UCU5 Q9UDF9 Q9UK21,Transferrin receptor protein 1,T9;p90;, PF02225;PF04389;PF04253;, GO:0016323;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0005768;GO:0010008;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:1990712;GO:0005887;GO:0043231;GO:0042470;GO:0016020;GO:0048471;GO:0005886;GO:0055037;GO:0003725;GO:0042802;GO:0042803;GO:0019901;GO:0044877;GO:0003723;GO:0004998;GO:0001618;GO:0006879;GO:0035690;GO:1990830;GO:0035556;GO:0006826;GO:0061024;GO:0043066;GO:0010637;GO:0030316;GO:0030890;GO:0045780;GO:0010628;GO:0043123;GO:0045830;GO:0051092;GO:0033138;GO:1900182;GO:0001934;GO:0031334;GO:0042102;GO:0031623;GO:0033572;GO:0150104;, C:basolateral plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endosome; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:HFE-transferrin receptor complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:double-stranded RNA binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA binding; F:transferrin receptor activity; F:virus receptor activity;, P:cellular iron ion homeostasis; P:cellular response to drug; P:cellular response to leukemia inhibitory factor; P:intracellular signal transduction; P:iron ion transport; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial fusion; P:osteoclast differentiation; P:positive regulation of B cell proliferation; P:positive regulation of bone resorption; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of isotype switching; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of T cell proliferation; P:receptor internalization; P:transferrin transport; P:transport across blood-brain barrier;|P02786 D3DXB0 Q1HE24 Q59G55 Q9UCN0 Q9UCU5 Q9UDF9 Q9UK21,Transferrin receptor protein 1,T9;p90;, PF02225;PF04389;PF04253;, GO:0016323;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0005768;GO:0010008;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:1990712;GO:0005887;GO:0043231;GO:0042470;GO:0016020;GO:0048471;GO:0005886;GO:0055037;GO:0003725;GO:0042802;GO:0042803;GO:0019901;GO:0044877;GO:0003723;GO:0004998;GO:0001618;GO:0006879;GO:0035690;GO:1990830;GO:0035556;GO:0006826;GO:0061024;GO:0043066;GO:0010637;GO:0030316;GO:0030890;GO:0045780;GO:0010628;GO:0043123;GO:0045830;GO:0051092;GO:0033138;GO:1900182;GO:0001934;GO:0031334;GO:0042102;GO:0031623;GO:0033572;GO:0150104;, C:basolateral plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endosome; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:HFE-transferrin receptor complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:double-stranded RNA binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA binding; F:transferrin receptor activity; F:virus receptor activity;, P:cellular iron ion homeostasis; P:cellular response to drug; P:cellular response to leukemia inhibitory factor; P:intracellular signal transduction; P:iron ion transport; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial fusion; P:osteoclast differentiation; P:positive regulation of B cell proliferation; P:positive regulation of bone resorption; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of isotype switching; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of T cell proliferation; P:receptor internalization; P:transferrin transport; P:transport across blood-brain barrier;|P02786 D3DXB0 Q1HE24 Q59G55 Q9UCN0 Q9UCU5 Q9UDF9 Q9UK21,Transferrin receptor protein 1,T9;p90;, PF02225;PF04389;PF04253;, GO:0016323;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0005768;GO:0010008;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:1990712;GO:0005887;GO:0043231;GO:0042470;GO:0016020;GO:0048471;GO:0005886;GO:0055037;GO:0003725;GO:0042802;GO:0042803;GO:0019901;GO:0044877;GO:0003723;GO:0004998;GO:0001618;GO:0006879;GO:0035690;GO:1990830;GO:0035556;GO:0006826;GO:0061024;GO:0043066;GO:0010637;GO:0030316;GO:0030890;GO:0045780;GO:0010628;GO:0043123;GO:0045830;GO:0051092;GO:0033138;GO:1900182;GO:0001934;GO:0031334;GO:0042102;GO:0031623;GO:0033572;GO:0150104;, C:basolateral plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endosome; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:HFE-transferrin receptor complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:double-stranded RNA binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA binding; F:transferrin receptor activity; F:virus receptor activity;, P:cellular iron ion homeostasis; P:cellular response to drug; P:cellular response to leukemia inhibitory factor; P:intracellular signal transduction; P:iron ion transport; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial fusion; P:osteoclast differentiation; P:positive regulation of B cell proliferation; P:positive regulation of bone resorption; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of isotype switching; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of T cell proliferation; P:receptor internalization; P:transferrin transport; P:transport across blood-brain barrier;|P02786 D3DXB0 Q1HE24 Q59G55 Q9UCN0 Q9UCU5 Q9UDF9 Q9UK21,Transferrin receptor protein 1,T9;p90;, PF02225;PF04389;PF04253;, GO:0016323;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0005768;GO:0010008;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:1990712;GO:0005887;GO:0043231;GO:0042470;GO:0016020;GO:0048471;GO:0005886;GO:0055037;GO:0003725;GO:0042802;GO:0042803;GO:0019901;GO:0044877;GO:0003723;GO:0004998;GO:0001618;GO:0006879;GO:0035690;GO:1990830;GO:0035556;GO:0006826;GO:0061024;GO:0043066;GO:0010637;GO:0030316;GO:0030890;GO:0045780;GO:0010628;GO:0043123;GO:0045830;GO:0051092;GO:0033138;GO:1900182;GO:0001934;GO:0031334;GO:0042102;GO:0031623;GO:0033572;GO:0150104;, C:basolateral plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endosome; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:HFE-transferrin receptor complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:double-stranded RNA binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA binding; F:transferrin receptor activity; F:virus receptor activity;, P:cellular iron ion homeostasis; P:cellular response to drug; P:cellular response to leukemia inhibitory factor; P:intracellular signal transduction; P:iron ion transport; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial fusion; P:osteoclast differentiation; P:positive regulation of B cell proliferation; P:positive regulation of bone resorption; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of isotype switching; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of T cell proliferation; P:receptor internalization; P:transferrin transport; P:transport across blood-brain barrier; scaffold13 indexed_genome mRNA 48308960 48348302 . + . ID=transcript_3536;Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q07912 Q6ZMQ0 Q8N6U7 Q96H59,Activated CDC42 kinase 1,Tyrosine kinase non-receptor protein 2;, PF09027;PF11555;PF07714;PF14604;, GO:0005912;GO:0005905;GO:0030136;GO:0097268;GO:0005737;GO:0030659;GO:0005829;GO:0005768;GO:0031234;GO:0070436;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0005154;GO:0005095;GO:0042802;GO:0046872;GO:0004715;GO:0106310;GO:0004712;GO:0106311;GO:0004713;GO:0005102;GO:0004714;GO:0031625;GO:0050699;GO:0030154;GO:0007166;GO:0006897;GO:0045087;GO:0016310;GO:0050731;GO:2000369;GO:0007264;GO:0007169;, C:adherens junction; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoophidium; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Grb2-EGFR complex; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:epidermal growth factor receptor binding; F:GTPase inhibitor activity; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding; F:WW domain binding;, P:cell differentiation; P:cell surface receptor signaling pathway; P:endocytosis; P:innate immune response; P:phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of clathrin-dependent endocytosis; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold14 indexed_genome mRNA 109653 124036 . - . ID=transcript_3537;Q9HAY1 Q9HCT1 Q9P2N8,Ral guanine nucleotide dissociation stimulator,Ral guanine nucleotide exchange factor;, PF00788;PF00617;PF00618;, GO:0005903;GO:0005829;GO:0005634;GO:0030695;GO:0005085;GO:0000165;GO:0007265;, C:brush border; C:cytosol; C:nucleus;, F:GTPase regulator activity; F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:Ras protein signal transduction; scaffold14 indexed_genome mRNA 358656 384117 . + . ID=transcript_3538;P17030 A9Z1X5 Q8IYE3 Q8NDD6 Q96MU2,Zinc finger protein 25,Zinc finger protein KOX19;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P17030 A9Z1X5 Q8IYE3 Q8NDD6 Q96MU2,Zinc finger protein 25,Zinc finger protein KOX19;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P17030 A9Z1X5 Q8IYE3 Q8NDD6 Q96MU2,Zinc finger protein 25,Zinc finger protein KOX19;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold14 indexed_genome mRNA 420850 421465 . + . ID=transcript_3539;Q07889 A8K2G3 B4DXG2,Son of sevenless homolog 1,, PF00125;PF00169;PF00617;PF00618;PF00621;, GO:0005737;GO:0005829;GO:0043025;GO:0005886;GO:0014069;GO:0003677;GO:0005096;GO:0005085;GO:0046982;GO:0017124;GO:0007411;GO:0001782;GO:0048514;GO:0003209;GO:0019221;GO:0007173;GO:0038128;GO:0061029;GO:0038095;GO:0007186;GO:0001942;GO:0061384;GO:0008286;GO:0050900;GO:0000165;GO:1904693;GO:0035264;GO:0048011;GO:0003344;GO:0043065;GO:0045742;GO:0051057;GO:0007265;GO:2000973;GO:0051056;GO:0033081;GO:0042129;GO:0060021;GO:0007165;GO:0007296;, C:cytoplasm; C:cytosol; C:neuronal cell body; C:plasma membrane; C:postsynaptic density;, F:DNA binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein heterodimerization activity; F:SH3 domain binding;, P:axon guidance; P:B cell homeostasis; P:blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:eyelid development in camera-type eye; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hair follicle development; P:heart trabecula morphogenesis; P:insulin receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:midbrain morphogenesis; P:multicellular organism growth; P:neurotrophin TRK receptor signaling pathway; P:pericardium morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of small GTPase mediated signal transduction; P:Ras protein signal transduction; P:regulation of pro-B cell differentiation; P:regulation of small GTPase mediated signal transduction; P:regulation of T cell differentiation in thymus; P:regulation of T cell proliferation; P:roof of mouth development; P:signal transduction; P:vitellogenesis; scaffold14 indexed_genome mRNA 422923 426559 . - . ID=transcript_3540;Q06732 Q06731 Q32MA2 Q86XY8 Q8NDW3,Zinc finger protein 33B,Zinc finger protein 11B;Zinc finger protein KOX2;, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold14 indexed_genome mRNA 471060 496318 . + . ID=transcript_3541;Q8NDW4 Q8NDV8 Q9UMP3,Zinc finger protein 248,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q8NDW4 Q8NDV8 Q9UMP3,Zinc finger protein 248,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q8NDW4 Q8NDV8 Q9UMP3,Zinc finger protein 248,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold14 indexed_genome mRNA 546066 582670 . + . ID=transcript_3542;Q14692 Q5QPT5 Q86XJ9,Ribosome biogenesis protein BMS1 homolog,Ribosome assembly protein BMS1 homolog;, PF08142;PF04950;, GO:0030686;GO:0005694;GO:0005730;GO:0005654;GO:0005524;GO:0005525;GO:0003924;GO:0003723;GO:0034511;GO:0000479;GO:0000462;GO:0006364;, C:90S preribosome; C:chromosome; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:GTP binding; F:GTPase activity; F:RNA binding; F:U3 snoRNA binding;, P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q14692 Q5QPT5 Q86XJ9,Ribosome biogenesis protein BMS1 homolog,Ribosome assembly protein BMS1 homolog;, PF08142;PF04950;, GO:0030686;GO:0005694;GO:0005730;GO:0005654;GO:0005524;GO:0005525;GO:0003924;GO:0003723;GO:0034511;GO:0000479;GO:0000462;GO:0006364;, C:90S preribosome; C:chromosome; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:GTP binding; F:GTPase activity; F:RNA binding; F:U3 snoRNA binding;, P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q14692 Q5QPT5 Q86XJ9,Ribosome biogenesis protein BMS1 homolog,Ribosome assembly protein BMS1 homolog;, PF08142;PF04950;, GO:0030686;GO:0005694;GO:0005730;GO:0005654;GO:0005524;GO:0005525;GO:0003924;GO:0003723;GO:0034511;GO:0000479;GO:0000462;GO:0006364;, C:90S preribosome; C:chromosome; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:GTP binding; F:GTPase activity; F:RNA binding; F:U3 snoRNA binding;, P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q14692 Q5QPT5 Q86XJ9,Ribosome biogenesis protein BMS1 homolog,Ribosome assembly protein BMS1 homolog;, PF08142;PF04950;, GO:0030686;GO:0005694;GO:0005730;GO:0005654;GO:0005524;GO:0005525;GO:0003924;GO:0003723;GO:0034511;GO:0000479;GO:0000462;GO:0006364;, C:90S preribosome; C:chromosome; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:GTP binding; F:GTPase activity; F:RNA binding; F:U3 snoRNA binding;, P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing; scaffold14 indexed_genome mRNA 852131 874827 . + . ID=transcript_3543;P07949 A8K6Z2 Q15250 Q9BTB0 Q9H4A2,Proto-oncogene tyrosine-protein kinase receptor Ret {ECO:0000305},Cadherin family member 12;Proto-oncogene c-Ret;, PF00028;PF07714;PF17756;PF17812;PF17813;, GO:0030424;GO:0030425;GO:0005769;GO:0010008;GO:0005887;GO:0045121;GO:0043025;GO:0005886;GO:0098797;GO:0043235;GO:0005524;GO:0005509;GO:0004713;GO:0038023;GO:0004714;GO:0006919;GO:0000187;GO:0007411;GO:0071300;GO:0001838;GO:0048484;GO:0035860;GO:0007156;GO:0060384;GO:0097021;GO:0000165;GO:0033619;GO:0007275;GO:0001755;GO:0007158;GO:0042551;GO:0061146;GO:0033630;GO:0030335;GO:0045793;GO:2001241;GO:0033674;GO:0043410;GO:0072300;GO:0014042;GO:0010976;GO:0033141;GO:0051897;GO:0045893;GO:0007497;GO:0006468;GO:0050770;GO:0030155;GO:0042493;GO:0048265;GO:0060041;GO:0007165;GO:0007169;GO:0035799;GO:0001657;, C:axon; C:dendrite; C:early endosome; C:endosome membrane; C:integral component of plasma membrane; C:membrane raft; C:neuronal cell body; C:plasma membrane; C:plasma membrane protein complex; C:receptor complex;, F:ATP binding; F:calcium ion binding; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of MAPK activity; P:axon guidance; P:cellular response to retinoic acid; P:embryonic epithelial tube formation; P:enteric nervous system development; P:glial cell-derived neurotrophic factor receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:innervation; P:lymphocyte migration into lymphoid organs; P:MAPK cascade; P:membrane protein proteolysis; P:multicellular organism development; P:neural crest cell migration; P:neuron cell-cell adhesion; P:neuron maturation; P:Peyer's patch morphogenesis; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell migration; P:positive regulation of cell size; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of metanephric glomerulus development; P:positive regulation of neuron maturation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription, DNA-templated; P:posterior midgut development; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cell adhesion; P:response to drug; P:response to pain; P:retina development in camera-type eye; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:ureter maturation; P:ureteric bud development;|P07949 A8K6Z2 Q15250 Q9BTB0 Q9H4A2,Proto-oncogene tyrosine-protein kinase receptor Ret {ECO:0000305},Cadherin family member 12;Proto-oncogene c-Ret;, PF00028;PF07714;PF17756;PF17812;PF17813;, GO:0030424;GO:0030425;GO:0005769;GO:0010008;GO:0005887;GO:0045121;GO:0043025;GO:0005886;GO:0098797;GO:0043235;GO:0005524;GO:0005509;GO:0004713;GO:0038023;GO:0004714;GO:0006919;GO:0000187;GO:0007411;GO:0071300;GO:0001838;GO:0048484;GO:0035860;GO:0007156;GO:0060384;GO:0097021;GO:0000165;GO:0033619;GO:0007275;GO:0001755;GO:0007158;GO:0042551;GO:0061146;GO:0033630;GO:0030335;GO:0045793;GO:2001241;GO:0033674;GO:0043410;GO:0072300;GO:0014042;GO:0010976;GO:0033141;GO:0051897;GO:0045893;GO:0007497;GO:0006468;GO:0050770;GO:0030155;GO:0042493;GO:0048265;GO:0060041;GO:0007165;GO:0007169;GO:0035799;GO:0001657;, C:axon; C:dendrite; C:early endosome; C:endosome membrane; C:integral component of plasma membrane; C:membrane raft; C:neuronal cell body; C:plasma membrane; C:plasma membrane protein complex; C:receptor complex;, F:ATP binding; F:calcium ion binding; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of MAPK activity; P:axon guidance; P:cellular response to retinoic acid; P:embryonic epithelial tube formation; P:enteric nervous system development; P:glial cell-derived neurotrophic factor receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:innervation; P:lymphocyte migration into lymphoid organs; P:MAPK cascade; P:membrane protein proteolysis; P:multicellular organism development; P:neural crest cell migration; P:neuron cell-cell adhesion; P:neuron maturation; P:Peyer's patch morphogenesis; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell migration; P:positive regulation of cell size; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of metanephric glomerulus development; P:positive regulation of neuron maturation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription, DNA-templated; P:posterior midgut development; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cell adhesion; P:response to drug; P:response to pain; P:retina development in camera-type eye; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:ureter maturation; P:ureteric bud development;|P07949 A8K6Z2 Q15250 Q9BTB0 Q9H4A2,Proto-oncogene tyrosine-protein kinase receptor Ret {ECO:0000305},Cadherin family member 12;Proto-oncogene c-Ret;, PF00028;PF07714;PF17756;PF17812;PF17813;, GO:0030424;GO:0030425;GO:0005769;GO:0010008;GO:0005887;GO:0045121;GO:0043025;GO:0005886;GO:0098797;GO:0043235;GO:0005524;GO:0005509;GO:0004713;GO:0038023;GO:0004714;GO:0006919;GO:0000187;GO:0007411;GO:0071300;GO:0001838;GO:0048484;GO:0035860;GO:0007156;GO:0060384;GO:0097021;GO:0000165;GO:0033619;GO:0007275;GO:0001755;GO:0007158;GO:0042551;GO:0061146;GO:0033630;GO:0030335;GO:0045793;GO:2001241;GO:0033674;GO:0043410;GO:0072300;GO:0014042;GO:0010976;GO:0033141;GO:0051897;GO:0045893;GO:0007497;GO:0006468;GO:0050770;GO:0030155;GO:0042493;GO:0048265;GO:0060041;GO:0007165;GO:0007169;GO:0035799;GO:0001657;, C:axon; C:dendrite; C:early endosome; C:endosome membrane; C:integral component of plasma membrane; C:membrane raft; C:neuronal cell body; C:plasma membrane; C:plasma membrane protein complex; C:receptor complex;, F:ATP binding; F:calcium ion binding; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of MAPK activity; P:axon guidance; P:cellular response to retinoic acid; P:embryonic epithelial tube formation; P:enteric nervous system development; P:glial cell-derived neurotrophic factor receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:innervation; P:lymphocyte migration into lymphoid organs; P:MAPK cascade; P:membrane protein proteolysis; P:multicellular organism development; P:neural crest cell migration; P:neuron cell-cell adhesion; P:neuron maturation; P:Peyer's patch morphogenesis; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell migration; P:positive regulation of cell size; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of metanephric glomerulus development; P:positive regulation of neuron maturation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription, DNA-templated; P:posterior midgut development; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cell adhesion; P:response to drug; P:response to pain; P:retina development in camera-type eye; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:ureter maturation; P:ureteric bud development;|P07949 A8K6Z2 Q15250 Q9BTB0 Q9H4A2,Proto-oncogene tyrosine-protein kinase receptor Ret {ECO:0000305},Cadherin family member 12;Proto-oncogene c-Ret;, PF00028;PF07714;PF17756;PF17812;PF17813;, GO:0030424;GO:0030425;GO:0005769;GO:0010008;GO:0005887;GO:0045121;GO:0043025;GO:0005886;GO:0098797;GO:0043235;GO:0005524;GO:0005509;GO:0004713;GO:0038023;GO:0004714;GO:0006919;GO:0000187;GO:0007411;GO:0071300;GO:0001838;GO:0048484;GO:0035860;GO:0007156;GO:0060384;GO:0097021;GO:0000165;GO:0033619;GO:0007275;GO:0001755;GO:0007158;GO:0042551;GO:0061146;GO:0033630;GO:0030335;GO:0045793;GO:2001241;GO:0033674;GO:0043410;GO:0072300;GO:0014042;GO:0010976;GO:0033141;GO:0051897;GO:0045893;GO:0007497;GO:0006468;GO:0050770;GO:0030155;GO:0042493;GO:0048265;GO:0060041;GO:0007165;GO:0007169;GO:0035799;GO:0001657;, C:axon; C:dendrite; C:early endosome; C:endosome membrane; C:integral component of plasma membrane; C:membrane raft; C:neuronal cell body; C:plasma membrane; C:plasma membrane protein complex; C:receptor complex;, F:ATP binding; F:calcium ion binding; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of MAPK activity; P:axon guidance; P:cellular response to retinoic acid; P:embryonic epithelial tube formation; P:enteric nervous system development; P:glial cell-derived neurotrophic factor receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:innervation; P:lymphocyte migration into lymphoid organs; P:MAPK cascade; P:membrane protein proteolysis; P:multicellular organism development; P:neural crest cell migration; P:neuron cell-cell adhesion; P:neuron maturation; P:Peyer's patch morphogenesis; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell migration; P:positive regulation of cell size; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of metanephric glomerulus development; P:positive regulation of neuron maturation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription, DNA-templated; P:posterior midgut development; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cell adhesion; P:response to drug; P:response to pain; P:retina development in camera-type eye; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:ureter maturation; P:ureteric bud development; scaffold14 indexed_genome mRNA 886222 887614 . - . ID=transcript_3544;P00414 Q14Y83,Cytochrome c oxidase subunit 3,Cytochrome c oxidase polypeptide III;, PF00510;, GO:0016021;GO:0005743;GO:0005739;GO:0045277;GO:0004129;GO:0009055;GO:0015453;GO:0009060;GO:0006123;GO:0008535;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:electron transfer activity; F:oxidoreduction-driven active transmembrane transporter activity;, P:aerobic respiration; P:mitochondrial electron transport, cytochrome c to oxygen; P:respiratory chain complex IV assembly; scaffold14 indexed_genome mRNA 941748 942281 . - . ID=transcript_3545;O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold14 indexed_genome mRNA 1000461 1017275 . + . ID=transcript_3546;O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold14 indexed_genome mRNA 1197073 1228526 . - . ID=transcript_3547;Q8N6G5 B3KWL7 Q6MZJ5 Q6MZP6 Q8TCH4 Q9P1I6,Chondroitin sulfate N-acetylgalactosaminyltransferase 2,Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2;, PF05679;, GO:0032580;GO:0000139;GO:0030173;GO:0016020;GO:0008376;GO:0047238;GO:0047237;GO:0046872;GO:0030206;GO:0050650;GO:0050653;GO:0050651;GO:0050652;GO:0030166;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:metal ion binding;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:dermatan sulfate proteoglycan biosynthetic process; P:dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:proteoglycan biosynthetic process;|Q8N6G5 B3KWL7 Q6MZJ5 Q6MZP6 Q8TCH4 Q9P1I6,Chondroitin sulfate N-acetylgalactosaminyltransferase 2,Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2;, PF05679;, GO:0032580;GO:0000139;GO:0030173;GO:0016020;GO:0008376;GO:0047238;GO:0047237;GO:0046872;GO:0030206;GO:0050650;GO:0050653;GO:0050651;GO:0050652;GO:0030166;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:metal ion binding;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:dermatan sulfate proteoglycan biosynthetic process; P:dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:proteoglycan biosynthetic process;|Q8N6G5 B3KWL7 Q6MZJ5 Q6MZP6 Q8TCH4 Q9P1I6,Chondroitin sulfate N-acetylgalactosaminyltransferase 2,Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2;, PF05679;, GO:0032580;GO:0000139;GO:0030173;GO:0016020;GO:0008376;GO:0047238;GO:0047237;GO:0046872;GO:0030206;GO:0050650;GO:0050653;GO:0050651;GO:0050652;GO:0030166;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:metal ion binding;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:dermatan sulfate proteoglycan biosynthetic process; P:dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:proteoglycan biosynthetic process; scaffold14 indexed_genome mRNA 1249482 1256902 . - . ID=transcript_3548;Q8N9B8 Q8TBF1,Ras-GEF domain-containing family member 1A,, PF00617;PF00618;, GO:0005829;GO:0005085;GO:0016477;GO:0000165;GO:0046579;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:cell migration; P:MAPK cascade; P:positive regulation of Ras protein signal transduction; P:small GTPase mediated signal transduction;|Q8N9B8 Q8TBF1,Ras-GEF domain-containing family member 1A,, PF00617;PF00618;, GO:0005829;GO:0005085;GO:0016477;GO:0000165;GO:0046579;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:cell migration; P:MAPK cascade; P:positive regulation of Ras protein signal transduction; P:small GTPase mediated signal transduction;|Q8N9B8 Q8TBF1,Ras-GEF domain-containing family member 1A,, PF00617;PF00618;, GO:0005829;GO:0005085;GO:0016477;GO:0000165;GO:0046579;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:cell migration; P:MAPK cascade; P:positive regulation of Ras protein signal transduction; P:small GTPase mediated signal transduction;|Q8N9B8 Q8TBF1,Ras-GEF domain-containing family member 1A,, PF00617;PF00618;, GO:0005829;GO:0005085;GO:0016477;GO:0000165;GO:0046579;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:cell migration; P:MAPK cascade; P:positive regulation of Ras protein signal transduction; P:small GTPase mediated signal transduction; scaffold14 indexed_genome mRNA 1468980 1477259 . - . ID=transcript_3549;P52597 B3KM84 Q5T0N2 Q96AU2,Heterogeneous nuclear ribonucleoprotein F,Nucleolin-like protein mcs94-1;, PF00076;PF08080;, GO:0071013;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:1990904;GO:0003723;GO:0003727;GO:0017025;GO:0008543;GO:0035722;GO:0000398;GO:0043484;GO:0016070;GO:0006396;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ribonucleoprotein complex;, F:RNA binding; F:single-stranded RNA binding; F:TBP-class protein binding;, P:fibroblast growth factor receptor signaling pathway; P:interleukin-12-mediated signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing;|P52597 B3KM84 Q5T0N2 Q96AU2,Heterogeneous nuclear ribonucleoprotein F,Nucleolin-like protein mcs94-1;, PF00076;PF08080;, GO:0071013;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:1990904;GO:0003723;GO:0003727;GO:0017025;GO:0008543;GO:0035722;GO:0000398;GO:0043484;GO:0016070;GO:0006396;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ribonucleoprotein complex;, F:RNA binding; F:single-stranded RNA binding; F:TBP-class protein binding;, P:fibroblast growth factor receptor signaling pathway; P:interleukin-12-mediated signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing; scaffold14 indexed_genome mRNA 1734720 1999699 . + . ID=transcript_3550;Q9H694,Protein bicaudal C homolog 1,, PF00013;PF00536;, GO:0005737;GO:0003723;GO:0007368;GO:0007507;GO:0001822;GO:0090090;, C:cytoplasm;, F:RNA binding;, P:determination of left/right symmetry; P:heart development; P:kidney development; P:negative regulation of canonical Wnt signaling pathway;|Q9H694,Protein bicaudal C homolog 1,, PF00013;PF00536;, GO:0005737;GO:0003723;GO:0007368;GO:0007507;GO:0001822;GO:0090090;, C:cytoplasm;, F:RNA binding;, P:determination of left/right symmetry; P:heart development; P:kidney development; P:negative regulation of canonical Wnt signaling pathway;|Q9H694,Protein bicaudal C homolog 1,, PF00013;PF00536;, GO:0005737;GO:0003723;GO:0007368;GO:0007507;GO:0001822;GO:0090090;, C:cytoplasm;, F:RNA binding;, P:determination of left/right symmetry; P:heart development; P:kidney development; P:negative regulation of canonical Wnt signaling pathway;|Q9H694,Protein bicaudal C homolog 1,, PF00013;PF00536;, GO:0005737;GO:0003723;GO:0007368;GO:0007507;GO:0001822;GO:0090090;, C:cytoplasm;, F:RNA binding;, P:determination of left/right symmetry; P:heart development; P:kidney development; P:negative regulation of canonical Wnt signaling pathway; scaffold14 indexed_genome mRNA 2447844 2712626 . - . ID=transcript_3551;Q96FC7 B7WP61 Q68DF3 Q6UXY3 Q8N3W3 Q96JM9 Q96NP7,Phytanoyl-CoA hydroxylase-interacting protein-like,, PF00041;, GO:0005737;, C:cytoplasm;|Q96FC7 B7WP61 Q68DF3 Q6UXY3 Q8N3W3 Q96JM9 Q96NP7,Phytanoyl-CoA hydroxylase-interacting protein-like,, PF00041;, GO:0005737;, C:cytoplasm;|Q8NE31 B7ZB77 Q5T631 Q6P2M3 Q99787,Protein FAM13C|Q8NE31 B7ZB77 Q5T631 Q6P2M3 Q99787,Protein FAM13C scaffold14 indexed_genome mRNA 3015998 3057175 . - . ID=transcript_3552;Q7RTY1 Q6ZMI2 Q9UFH8,Monocarboxylate transporter 9,Solute carrier family 16 member 9;, PF07690;, GO:0016021;GO:0005887;GO:0008028;GO:0015293;GO:0015718;GO:0046415;, C:integral component of membrane; C:integral component of plasma membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport; P:urate metabolic process; scaffold14 indexed_genome mRNA 3160689 3188394 . - . ID=transcript_3553;Q16204 Q15250 Q6GSG7,Coiled-coil domain-containing protein 6,Papillary thyroid carcinoma-encoded protein;Protein H4;, PF09755;, GO:0005856;GO:0005829;GO:0042802;GO:0017124;GO:0005200;, C:cytoskeleton; C:cytosol;, F:identical protein binding; F:SH3 domain binding; F:structural constituent of cytoskeleton; scaffold14 indexed_genome mRNA 3422155 3494470 . + . ID=transcript_3554;Q12955 B1AQT2 B4DIL1 E9PE32 Q13484 Q5CZH9 Q5VXD5 Q7Z3G4 Q9H0P5,Ankyrin-3 {ECO:0000303|PubMed:7836469},Ankyrin-G {ECO:0000303|PubMed:7836469};, PF00023;PF12796;PF13606;PF00531;PF17809;PF00791;, GO:0043194;GO:0009925;GO:0016323;GO:0009986;GO:0043034;GO:0005829;GO:0030425;GO:0005783;GO:0005794;GO:0014704;GO:0016328;GO:0005764;GO:0031594;GO:0043005;GO:0033268;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030315;GO:0030018;GO:0045296;GO:0008093;GO:0008092;GO:0044325;GO:0030674;GO:0030507;GO:0005200;GO:0007409;GO:0071286;GO:0006888;GO:0045184;GO:0043001;GO:0010960;GO:0072660;GO:0071709;GO:0000281;GO:1902260;GO:0007528;GO:0019228;GO:0007009;GO:2001259;GO:0010650;GO:0010628;GO:0034112;GO:1900827;GO:0045838;GO:0090314;GO:2000651;GO:0010765;GO:0099612;GO:0072659;GO:0043266;GO:0007165;, C:axon initial segment; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:costamere; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:intercalated disc; C:lateral plasma membrane; C:lysosome; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:T-tubule; C:Z disc;, F:cadherin binding; F:cytoskeletal anchor activity; F:cytoskeletal protein binding; F:ion channel binding; F:protein-macromolecule adaptor activity; F:spectrin binding; F:structural constituent of cytoskeleton;, P:axonogenesis; P:cellular response to magnesium ion; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization; P:Golgi to plasma membrane protein transport; P:magnesium ion homeostasis; P:maintenance of protein location in plasma membrane; P:membrane assembly; P:mitotic cytokinesis; P:negative regulation of delayed rectifier potassium channel activity; P:neuromuscular junction development; P:neuronal action potential; P:plasma membrane organization; P:positive regulation of cation channel activity; P:positive regulation of cell communication by electrical coupling; P:positive regulation of gene expression; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; P:positive regulation of membrane potential; P:positive regulation of protein targeting to membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein localization to axon; P:protein localization to plasma membrane; P:regulation of potassium ion transport; P:signal transduction;|Q12955 B1AQT2 B4DIL1 E9PE32 Q13484 Q5CZH9 Q5VXD5 Q7Z3G4 Q9H0P5,Ankyrin-3 {ECO:0000303|PubMed:7836469},Ankyrin-G {ECO:0000303|PubMed:7836469};, PF00023;PF12796;PF13606;PF00531;PF17809;PF00791;, GO:0043194;GO:0009925;GO:0016323;GO:0009986;GO:0043034;GO:0005829;GO:0030425;GO:0005783;GO:0005794;GO:0014704;GO:0016328;GO:0005764;GO:0031594;GO:0043005;GO:0033268;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030315;GO:0030018;GO:0045296;GO:0008093;GO:0008092;GO:0044325;GO:0030674;GO:0030507;GO:0005200;GO:0007409;GO:0071286;GO:0006888;GO:0045184;GO:0043001;GO:0010960;GO:0072660;GO:0071709;GO:0000281;GO:1902260;GO:0007528;GO:0019228;GO:0007009;GO:2001259;GO:0010650;GO:0010628;GO:0034112;GO:1900827;GO:0045838;GO:0090314;GO:2000651;GO:0010765;GO:0099612;GO:0072659;GO:0043266;GO:0007165;, C:axon initial segment; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:costamere; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:intercalated disc; C:lateral plasma membrane; C:lysosome; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:T-tubule; C:Z disc;, F:cadherin binding; F:cytoskeletal anchor activity; F:cytoskeletal protein binding; F:ion channel binding; F:protein-macromolecule adaptor activity; F:spectrin binding; F:structural constituent of cytoskeleton;, P:axonogenesis; P:cellular response to magnesium ion; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization; P:Golgi to plasma membrane protein transport; P:magnesium ion homeostasis; P:maintenance of protein location in plasma membrane; P:membrane assembly; P:mitotic cytokinesis; P:negative regulation of delayed rectifier potassium channel activity; P:neuromuscular junction development; P:neuronal action potential; P:plasma membrane organization; P:positive regulation of cation channel activity; P:positive regulation of cell communication by electrical coupling; P:positive regulation of gene expression; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; P:positive regulation of membrane potential; P:positive regulation of protein targeting to membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein localization to axon; P:protein localization to plasma membrane; P:regulation of potassium ion transport; P:signal transduction;|Q12955 B1AQT2 B4DIL1 E9PE32 Q13484 Q5CZH9 Q5VXD5 Q7Z3G4 Q9H0P5,Ankyrin-3 {ECO:0000303|PubMed:7836469},Ankyrin-G {ECO:0000303|PubMed:7836469};, PF00023;PF12796;PF13606;PF00531;PF17809;PF00791;, GO:0043194;GO:0009925;GO:0016323;GO:0009986;GO:0043034;GO:0005829;GO:0030425;GO:0005783;GO:0005794;GO:0014704;GO:0016328;GO:0005764;GO:0031594;GO:0043005;GO:0033268;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030315;GO:0030018;GO:0045296;GO:0008093;GO:0008092;GO:0044325;GO:0030674;GO:0030507;GO:0005200;GO:0007409;GO:0071286;GO:0006888;GO:0045184;GO:0043001;GO:0010960;GO:0072660;GO:0071709;GO:0000281;GO:1902260;GO:0007528;GO:0019228;GO:0007009;GO:2001259;GO:0010650;GO:0010628;GO:0034112;GO:1900827;GO:0045838;GO:0090314;GO:2000651;GO:0010765;GO:0099612;GO:0072659;GO:0043266;GO:0007165;, C:axon initial segment; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:costamere; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:intercalated disc; C:lateral plasma membrane; C:lysosome; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:T-tubule; C:Z disc;, F:cadherin binding; F:cytoskeletal anchor activity; F:cytoskeletal protein binding; F:ion channel binding; F:protein-macromolecule adaptor activity; F:spectrin binding; F:structural constituent of cytoskeleton;, P:axonogenesis; P:cellular response to magnesium ion; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization; P:Golgi to plasma membrane protein transport; P:magnesium ion homeostasis; P:maintenance of protein location in plasma membrane; P:membrane assembly; P:mitotic cytokinesis; P:negative regulation of delayed rectifier potassium channel activity; P:neuromuscular junction development; P:neuronal action potential; P:plasma membrane organization; P:positive regulation of cation channel activity; P:positive regulation of cell communication by electrical coupling; P:positive regulation of gene expression; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; P:positive regulation of membrane potential; P:positive regulation of protein targeting to membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein localization to axon; P:protein localization to plasma membrane; P:regulation of potassium ion transport; P:signal transduction;|Q12955 B1AQT2 B4DIL1 E9PE32 Q13484 Q5CZH9 Q5VXD5 Q7Z3G4 Q9H0P5,Ankyrin-3 {ECO:0000303|PubMed:7836469},Ankyrin-G {ECO:0000303|PubMed:7836469};, PF00023;PF12796;PF13606;PF00531;PF17809;PF00791;, GO:0043194;GO:0009925;GO:0016323;GO:0009986;GO:0043034;GO:0005829;GO:0030425;GO:0005783;GO:0005794;GO:0014704;GO:0016328;GO:0005764;GO:0031594;GO:0043005;GO:0033268;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030315;GO:0030018;GO:0045296;GO:0008093;GO:0008092;GO:0044325;GO:0030674;GO:0030507;GO:0005200;GO:0007409;GO:0071286;GO:0006888;GO:0045184;GO:0043001;GO:0010960;GO:0072660;GO:0071709;GO:0000281;GO:1902260;GO:0007528;GO:0019228;GO:0007009;GO:2001259;GO:0010650;GO:0010628;GO:0034112;GO:1900827;GO:0045838;GO:0090314;GO:2000651;GO:0010765;GO:0099612;GO:0072659;GO:0043266;GO:0007165;, C:axon initial segment; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:costamere; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:intercalated disc; C:lateral plasma membrane; C:lysosome; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:T-tubule; C:Z disc;, F:cadherin binding; F:cytoskeletal anchor activity; F:cytoskeletal protein binding; F:ion channel binding; F:protein-macromolecule adaptor activity; F:spectrin binding; F:structural constituent of cytoskeleton;, P:axonogenesis; P:cellular response to magnesium ion; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization; P:Golgi to plasma membrane protein transport; P:magnesium ion homeostasis; P:maintenance of protein location in plasma membrane; P:membrane assembly; P:mitotic cytokinesis; P:negative regulation of delayed rectifier potassium channel activity; P:neuromuscular junction development; P:neuronal action potential; P:plasma membrane organization; P:positive regulation of cation channel activity; P:positive regulation of cell communication by electrical coupling; P:positive regulation of gene expression; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; P:positive regulation of membrane potential; P:positive regulation of protein targeting to membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein localization to axon; P:protein localization to plasma membrane; P:regulation of potassium ion transport; P:signal transduction; scaffold14 indexed_genome mRNA 3511072 3585766 . - . ID=transcript_3555;Q12955 B1AQT2 B4DIL1 E9PE32 Q13484 Q5CZH9 Q5VXD5 Q7Z3G4 Q9H0P5,Ankyrin-3 {ECO:0000303|PubMed:7836469},Ankyrin-G {ECO:0000303|PubMed:7836469};, PF00023;PF12796;PF13606;PF00531;PF17809;PF00791;, GO:0043194;GO:0009925;GO:0016323;GO:0009986;GO:0043034;GO:0005829;GO:0030425;GO:0005783;GO:0005794;GO:0014704;GO:0016328;GO:0005764;GO:0031594;GO:0043005;GO:0033268;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030315;GO:0030018;GO:0045296;GO:0008093;GO:0008092;GO:0044325;GO:0030674;GO:0030507;GO:0005200;GO:0007409;GO:0071286;GO:0006888;GO:0045184;GO:0043001;GO:0010960;GO:0072660;GO:0071709;GO:0000281;GO:1902260;GO:0007528;GO:0019228;GO:0007009;GO:2001259;GO:0010650;GO:0010628;GO:0034112;GO:1900827;GO:0045838;GO:0090314;GO:2000651;GO:0010765;GO:0099612;GO:0072659;GO:0043266;GO:0007165;, C:axon initial segment; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:costamere; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:intercalated disc; C:lateral plasma membrane; C:lysosome; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:T-tubule; C:Z disc;, F:cadherin binding; F:cytoskeletal anchor activity; F:cytoskeletal protein binding; F:ion channel binding; F:protein-macromolecule adaptor activity; F:spectrin binding; F:structural constituent of cytoskeleton;, P:axonogenesis; P:cellular response to magnesium ion; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization; P:Golgi to plasma membrane protein transport; P:magnesium ion homeostasis; P:maintenance of protein location in plasma membrane; P:membrane assembly; P:mitotic cytokinesis; P:negative regulation of delayed rectifier potassium channel activity; P:neuromuscular junction development; P:neuronal action potential; P:plasma membrane organization; P:positive regulation of cation channel activity; P:positive regulation of cell communication by electrical coupling; P:positive regulation of gene expression; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; P:positive regulation of membrane potential; P:positive regulation of protein targeting to membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein localization to axon; P:protein localization to plasma membrane; P:regulation of potassium ion transport; P:signal transduction;|Q12955 B1AQT2 B4DIL1 E9PE32 Q13484 Q5CZH9 Q5VXD5 Q7Z3G4 Q9H0P5,Ankyrin-3 {ECO:0000303|PubMed:7836469},Ankyrin-G {ECO:0000303|PubMed:7836469};, PF00023;PF12796;PF13606;PF00531;PF17809;PF00791;, GO:0043194;GO:0009925;GO:0016323;GO:0009986;GO:0043034;GO:0005829;GO:0030425;GO:0005783;GO:0005794;GO:0014704;GO:0016328;GO:0005764;GO:0031594;GO:0043005;GO:0033268;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030315;GO:0030018;GO:0045296;GO:0008093;GO:0008092;GO:0044325;GO:0030674;GO:0030507;GO:0005200;GO:0007409;GO:0071286;GO:0006888;GO:0045184;GO:0043001;GO:0010960;GO:0072660;GO:0071709;GO:0000281;GO:1902260;GO:0007528;GO:0019228;GO:0007009;GO:2001259;GO:0010650;GO:0010628;GO:0034112;GO:1900827;GO:0045838;GO:0090314;GO:2000651;GO:0010765;GO:0099612;GO:0072659;GO:0043266;GO:0007165;, C:axon initial segment; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:costamere; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:intercalated disc; C:lateral plasma membrane; C:lysosome; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:T-tubule; C:Z disc;, F:cadherin binding; F:cytoskeletal anchor activity; F:cytoskeletal protein binding; F:ion channel binding; F:protein-macromolecule adaptor activity; F:spectrin binding; F:structural constituent of cytoskeleton;, P:axonogenesis; P:cellular response to magnesium ion; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization; P:Golgi to plasma membrane protein transport; P:magnesium ion homeostasis; P:maintenance of protein location in plasma membrane; P:membrane assembly; P:mitotic cytokinesis; P:negative regulation of delayed rectifier potassium channel activity; P:neuromuscular junction development; P:neuronal action potential; P:plasma membrane organization; P:positive regulation of cation channel activity; P:positive regulation of cell communication by electrical coupling; P:positive regulation of gene expression; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; P:positive regulation of membrane potential; P:positive regulation of protein targeting to membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein localization to axon; P:protein localization to plasma membrane; P:regulation of potassium ion transport; P:signal transduction;|Q15650 B2RAS0 Q96ED7 Q9UKH0,Activating signal cointegrator 1 {ECO:0000303|PubMed:10454579},Thyroid receptor-interacting protein 4 {ECO:0000303|PubMed:7776974};, PF04266;PF06221;, GO:0099053;GO:0005737;GO:0005829;GO:0005815;GO:0031594;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0030331;GO:0035035;GO:0016922;GO:0002020;GO:0019901;GO:0003713;GO:0044389;GO:0008270;GO:0030520;GO:0045893;GO:0045661;GO:0006355;GO:1901998;, C:activating signal cointegrator 1 complex; C:cytoplasm; C:cytosol; C:microtubule organizing center; C:neuromuscular junction; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:estrogen receptor binding; F:histone acetyltransferase binding; F:nuclear receptor binding; F:protease binding; F:protein kinase binding; F:transcription coactivator activity; F:ubiquitin-like protein ligase binding; F:zinc ion binding;, P:intracellular estrogen receptor signaling pathway; P:positive regulation of transcription, DNA-templated; P:regulation of myoblast differentiation; P:regulation of transcription, DNA-templated; P:toxin transport; scaffold14 indexed_genome mRNA 3598026 3776271 . - . ID=transcript_3556;Q12955 B1AQT2 B4DIL1 E9PE32 Q13484 Q5CZH9 Q5VXD5 Q7Z3G4 Q9H0P5,Ankyrin-3 {ECO:0000303|PubMed:7836469},Ankyrin-G {ECO:0000303|PubMed:7836469};, PF00023;PF12796;PF13606;PF00531;PF17809;PF00791;, GO:0043194;GO:0009925;GO:0016323;GO:0009986;GO:0043034;GO:0005829;GO:0030425;GO:0005783;GO:0005794;GO:0014704;GO:0016328;GO:0005764;GO:0031594;GO:0043005;GO:0033268;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030315;GO:0030018;GO:0045296;GO:0008093;GO:0008092;GO:0044325;GO:0030674;GO:0030507;GO:0005200;GO:0007409;GO:0071286;GO:0006888;GO:0045184;GO:0043001;GO:0010960;GO:0072660;GO:0071709;GO:0000281;GO:1902260;GO:0007528;GO:0019228;GO:0007009;GO:2001259;GO:0010650;GO:0010628;GO:0034112;GO:1900827;GO:0045838;GO:0090314;GO:2000651;GO:0010765;GO:0099612;GO:0072659;GO:0043266;GO:0007165;, C:axon initial segment; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:costamere; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:intercalated disc; C:lateral plasma membrane; C:lysosome; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:T-tubule; C:Z disc;, F:cadherin binding; F:cytoskeletal anchor activity; F:cytoskeletal protein binding; F:ion channel binding; F:protein-macromolecule adaptor activity; F:spectrin binding; F:structural constituent of cytoskeleton;, P:axonogenesis; P:cellular response to magnesium ion; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization; P:Golgi to plasma membrane protein transport; P:magnesium ion homeostasis; P:maintenance of protein location in plasma membrane; P:membrane assembly; P:mitotic cytokinesis; P:negative regulation of delayed rectifier potassium channel activity; P:neuromuscular junction development; P:neuronal action potential; P:plasma membrane organization; P:positive regulation of cation channel activity; P:positive regulation of cell communication by electrical coupling; P:positive regulation of gene expression; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; P:positive regulation of membrane potential; P:positive regulation of protein targeting to membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein localization to axon; P:protein localization to plasma membrane; P:regulation of potassium ion transport; P:signal transduction;|Q12955 B1AQT2 B4DIL1 E9PE32 Q13484 Q5CZH9 Q5VXD5 Q7Z3G4 Q9H0P5,Ankyrin-3 {ECO:0000303|PubMed:7836469},Ankyrin-G {ECO:0000303|PubMed:7836469};, PF00023;PF12796;PF13606;PF00531;PF17809;PF00791;, GO:0043194;GO:0009925;GO:0016323;GO:0009986;GO:0043034;GO:0005829;GO:0030425;GO:0005783;GO:0005794;GO:0014704;GO:0016328;GO:0005764;GO:0031594;GO:0043005;GO:0033268;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030315;GO:0030018;GO:0045296;GO:0008093;GO:0008092;GO:0044325;GO:0030674;GO:0030507;GO:0005200;GO:0007409;GO:0071286;GO:0006888;GO:0045184;GO:0043001;GO:0010960;GO:0072660;GO:0071709;GO:0000281;GO:1902260;GO:0007528;GO:0019228;GO:0007009;GO:2001259;GO:0010650;GO:0010628;GO:0034112;GO:1900827;GO:0045838;GO:0090314;GO:2000651;GO:0010765;GO:0099612;GO:0072659;GO:0043266;GO:0007165;, C:axon initial segment; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:costamere; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:intercalated disc; C:lateral plasma membrane; C:lysosome; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:T-tubule; C:Z disc;, F:cadherin binding; F:cytoskeletal anchor activity; F:cytoskeletal protein binding; F:ion channel binding; F:protein-macromolecule adaptor activity; F:spectrin binding; F:structural constituent of cytoskeleton;, P:axonogenesis; P:cellular response to magnesium ion; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization; P:Golgi to plasma membrane protein transport; P:magnesium ion homeostasis; P:maintenance of protein location in plasma membrane; P:membrane assembly; P:mitotic cytokinesis; P:negative regulation of delayed rectifier potassium channel activity; P:neuromuscular junction development; P:neuronal action potential; P:plasma membrane organization; P:positive regulation of cation channel activity; P:positive regulation of cell communication by electrical coupling; P:positive regulation of gene expression; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; P:positive regulation of membrane potential; P:positive regulation of protein targeting to membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein localization to axon; P:protein localization to plasma membrane; P:regulation of potassium ion transport; P:signal transduction;|Q12955 B1AQT2 B4DIL1 E9PE32 Q13484 Q5CZH9 Q5VXD5 Q7Z3G4 Q9H0P5,Ankyrin-3 {ECO:0000303|PubMed:7836469},Ankyrin-G {ECO:0000303|PubMed:7836469};, PF00023;PF12796;PF13606;PF00531;PF17809;PF00791;, GO:0043194;GO:0009925;GO:0016323;GO:0009986;GO:0043034;GO:0005829;GO:0030425;GO:0005783;GO:0005794;GO:0014704;GO:0016328;GO:0005764;GO:0031594;GO:0043005;GO:0033268;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030315;GO:0030018;GO:0045296;GO:0008093;GO:0008092;GO:0044325;GO:0030674;GO:0030507;GO:0005200;GO:0007409;GO:0071286;GO:0006888;GO:0045184;GO:0043001;GO:0010960;GO:0072660;GO:0071709;GO:0000281;GO:1902260;GO:0007528;GO:0019228;GO:0007009;GO:2001259;GO:0010650;GO:0010628;GO:0034112;GO:1900827;GO:0045838;GO:0090314;GO:2000651;GO:0010765;GO:0099612;GO:0072659;GO:0043266;GO:0007165;, C:axon initial segment; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:costamere; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:intercalated disc; C:lateral plasma membrane; C:lysosome; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:T-tubule; C:Z disc;, F:cadherin binding; F:cytoskeletal anchor activity; F:cytoskeletal protein binding; F:ion channel binding; F:protein-macromolecule adaptor activity; F:spectrin binding; F:structural constituent of cytoskeleton;, P:axonogenesis; P:cellular response to magnesium ion; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization; P:Golgi to plasma membrane protein transport; P:magnesium ion homeostasis; P:maintenance of protein location in plasma membrane; P:membrane assembly; P:mitotic cytokinesis; P:negative regulation of delayed rectifier potassium channel activity; P:neuromuscular junction development; P:neuronal action potential; P:plasma membrane organization; P:positive regulation of cation channel activity; P:positive regulation of cell communication by electrical coupling; P:positive regulation of gene expression; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; P:positive regulation of membrane potential; P:positive regulation of protein targeting to membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein localization to axon; P:protein localization to plasma membrane; P:regulation of potassium ion transport; P:signal transduction; scaffold14 indexed_genome mRNA 4150467 4164888 . + . ID=transcript_3557;P06493 A8K7C4 C9J497 O60764,Cyclin-dependent kinase 1,Cell division control protein 2 homolog;Cell division protein kinase 1;p34 protein kinase;, PF00069;, GO:0005813;GO:0000781;GO:0097125;GO:0000307;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0016020;GO:0030496;GO:0005739;GO:0072686;GO:0005654;GO:0005634;GO:0005876;GO:0005524;GO:0030332;GO:0097472;GO:0004693;GO:0035173;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0008353;GO:0001618;GO:0031145;GO:0006915;GO:0051301;GO:0016477;GO:0007098;GO:0097711;GO:0006977;GO:0006281;GO:0006260;GO:0030855;GO:0070371;GO:0000086;GO:0090166;GO:0000226;GO:0007076;GO:0007095;GO:0007077;GO:0007084;GO:0043066;GO:0018105;GO:0018107;GO:0010971;GO:1905448;GO:1900182;GO:0007344;GO:0016579;GO:0034501;GO:0006468;GO:0042752;GO:0045995;GO:0010389;GO:1901990;GO:0014038;GO:1901796;GO:0060260;GO:0048511;, C:centrosome; C:chromosome, telomeric region; C:cyclin B1-CDK1 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:midbody; C:mitochondrion; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle microtubule;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein kinase activity; F:cyclin-dependent protein serine/threonine kinase activity; F:histone kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:virus receptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:apoptotic process; P:cell division; P:cell migration; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA repair; P:DNA replication; P:epithelial cell differentiation; P:ERK1 and ERK2 cascade; P:G2/M transition of mitotic cell cycle; P:Golgi disassembly; P:microtubule cytoskeleton organization; P:mitotic chromosome condensation; P:mitotic G2 DNA damage checkpoint; P:mitotic nuclear envelope disassembly; P:mitotic nuclear envelope reassembly; P:negative regulation of apoptotic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of mitochondrial ATP synthesis coupled electron transport; P:positive regulation of protein localization to nucleus; P:pronuclear fusion; P:protein deubiquitination; P:protein localization to kinetochore; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of embryonic development; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic cell cycle phase transition; P:regulation of Schwann cell differentiation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription initiation from RNA polymerase II promoter; P:rhythmic process; scaffold14 indexed_genome mRNA 4244454 4325383 . - . ID=transcript_3558;O94844,Rho-related BTB domain-containing protein 1,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0010008;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0030865;GO:0043652;GO:0007163;GO:0032956;GO:0008360;GO:0007264;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:endosome membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:cortical cytoskeleton organization; P:engulfment of apoptotic cell; P:establishment or maintenance of cell polarity; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:small GTPase mediated signal transduction;|O94844,Rho-related BTB domain-containing protein 1,, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0010008;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0030865;GO:0043652;GO:0007163;GO:0032956;GO:0008360;GO:0007264;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:endosome membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:cortical cytoskeleton organization; P:engulfment of apoptotic cell; P:establishment or maintenance of cell polarity; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:small GTPase mediated signal transduction; scaffold14 indexed_genome mRNA 5196424 5329970 . + . ID=transcript_3559;Q8IVU9 Q5T1B8,Ciliary-associated calcium-binding coiled-coil protein 1 {ECO:0000312|HGNC:HGNC:28678},, PF14769;, GO:0005813;GO:0005737;GO:0036126;GO:0005509;, C:centrosome; C:cytoplasm; C:sperm flagellum;, F:calcium ion binding; scaffold14 indexed_genome mRNA 5624692 5666632 . + . ID=transcript_3560;Q14865 B4DLB3 Q05DG6 Q32Q59 Q5VST4 Q6NZ42 Q7Z3M4 Q8N421 Q9H786,AT-rich interactive domain-containing protein 5B,MRF1-like protein;Modulator recognition factor 2;, PF01388;, GO:0005654;GO:0005634;GO:0003677;GO:0003713;GO:0000976;GO:0060612;GO:0030325;GO:0048468;GO:1990830;GO:0060325;GO:0045444;GO:0060613;GO:0008585;GO:0010761;GO:0001822;GO:0001889;GO:0008584;GO:0035264;GO:0048644;GO:0000122;GO:0045892;GO:0006807;GO:0048008;GO:0051091;GO:0009791;GO:0006357;GO:0060021;GO:0048705;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:adipose tissue development; P:adrenal gland development; P:cell development; P:cellular response to leukemia inhibitory factor; P:face morphogenesis; P:fat cell differentiation; P:fat pad development; P:female gonad development; P:fibroblast migration; P:kidney development; P:liver development; P:male gonad development; P:multicellular organism growth; P:muscle organ morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nitrogen compound metabolic process; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of DNA-binding transcription factor activity; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; P:skeletal system morphogenesis; scaffold14 indexed_genome mRNA 5814789 5917283 . - . ID=transcript_3561;Q8IZC4 Q3ZCR1 Q68DZ6 Q8N8K1 Q8TAV2,Rhotekin-2,Pleckstrin homology domain-containing family K member 1;, PF08174;PF00169;, GO:0005737;GO:0005634;GO:0005886;GO:0030097;GO:2001243;GO:0008284;GO:0051092;GO:1901224;GO:0007165;, C:cytoplasm; C:nucleus; C:plasma membrane;, , P:hemopoiesis; P:negative regulation of intrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:signal transduction; scaffold14 indexed_genome mRNA 5988429 6006515 . + . ID=transcript_3562;Q70YC7,Protein ZNF365,DISC1-binding zinc-finger protein {ECO:0000303|PubMed:17389905};Protein su48;, , GO:0034451;GO:0005813;GO:0005737;GO:0043231;GO:0042802;GO:0046872;GO:0021687;GO:0140059;GO:0060997;GO:0010977;GO:0048714;GO:0110026;GO:0010569;GO:0000723;, C:centriolar satellite; C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:metal ion binding;, P:cerebellar molecular layer morphogenesis; P:dendrite arborization; P:dendritic spine morphogenesis; P:negative regulation of neuron projection development; P:positive regulation of oligodendrocyte differentiation; P:regulation of DNA strand resection involved in replication fork processing; P:regulation of double-strand break repair via homologous recombination; P:telomere maintenance; scaffold14 indexed_genome mRNA 6006753 6014898 . - . ID=transcript_3563;Q70YC7,Protein ZNF365,DISC1-binding zinc-finger protein {ECO:0000303|PubMed:17389905};Protein su48;, , GO:0034451;GO:0005813;GO:0005737;GO:0043231;GO:0042802;GO:0046872;GO:0021687;GO:0140059;GO:0060997;GO:0010977;GO:0048714;GO:0110026;GO:0010569;GO:0000723;, C:centriolar satellite; C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:metal ion binding;, P:cerebellar molecular layer morphogenesis; P:dendrite arborization; P:dendritic spine morphogenesis; P:negative regulation of neuron projection development; P:positive regulation of oligodendrocyte differentiation; P:regulation of DNA strand resection involved in replication fork processing; P:regulation of double-strand break repair via homologous recombination; P:telomere maintenance; scaffold14 indexed_genome mRNA 6421981 6427543 . - . ID=transcript_3564;Q96SZ5 B1AL29,2-aminoethanethiol dioxygenase,Cysteamine dioxygenase;, PF07847;, GO:0005829;GO:0047800;GO:0046872;GO:0000098;, C:cytosol;, F:cysteamine dioxygenase activity; F:metal ion binding;, P:sulfur amino acid catabolic process; scaffold14 indexed_genome mRNA 6428881 6432995 . + . ID=transcript_3565;P11161 B2R724 B3KRD7 Q68CZ5 Q8IV26 Q9UNA6,E3 SUMO-protein ligase EGR2,AT591;E3 SUMO-protein transferase ERG2 {ECO:0000305};Early growth response protein 2;Zinc finger protein Krox-20;, PF11928;PF00096;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0071837;GO:0046872;GO:0001102;GO:0000978;GO:0043565;GO:1990837;GO:0061665;GO:0000976;GO:0031625;GO:0007420;GO:0035284;GO:0071310;GO:0021612;GO:0045444;GO:0010467;GO:0007611;GO:0008045;GO:0042552;GO:0007399;GO:0007422;GO:0031643;GO:0014040;GO:0045944;GO:0045893;GO:0006611;GO:0016925;GO:0048168;GO:0030278;GO:0006357;GO:0032868;GO:0021660;GO:0021659;GO:0021666;GO:0021665;GO:0007622;GO:0014037;GO:0035914;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:HMG box domain binding; F:metal ion binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SUMO ligase activity; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:brain development; P:brain segmentation; P:cellular response to organic substance; P:facial nerve structural organization; P:fat cell differentiation; P:gene expression; P:learning or memory; P:motor neuron axon guidance; P:myelination; P:nervous system development; P:peripheral nervous system development; P:positive regulation of myelination; P:positive regulation of Schwann cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein export from nucleus; P:protein sumoylation; P:regulation of neuronal synaptic plasticity; P:regulation of ossification; P:regulation of transcription by RNA polymerase II; P:response to insulin; P:rhombomere 3 formation; P:rhombomere 3 structural organization; P:rhombomere 5 formation; P:rhombomere 5 structural organization; P:rhythmic behavior; P:Schwann cell differentiation; P:skeletal muscle cell differentiation;|P11161 B2R724 B3KRD7 Q68CZ5 Q8IV26 Q9UNA6,E3 SUMO-protein ligase EGR2,AT591;E3 SUMO-protein transferase ERG2 {ECO:0000305};Early growth response protein 2;Zinc finger protein Krox-20;, PF11928;PF00096;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0071837;GO:0046872;GO:0001102;GO:0000978;GO:0043565;GO:1990837;GO:0061665;GO:0000976;GO:0031625;GO:0007420;GO:0035284;GO:0071310;GO:0021612;GO:0045444;GO:0010467;GO:0007611;GO:0008045;GO:0042552;GO:0007399;GO:0007422;GO:0031643;GO:0014040;GO:0045944;GO:0045893;GO:0006611;GO:0016925;GO:0048168;GO:0030278;GO:0006357;GO:0032868;GO:0021660;GO:0021659;GO:0021666;GO:0021665;GO:0007622;GO:0014037;GO:0035914;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:HMG box domain binding; F:metal ion binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SUMO ligase activity; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:brain development; P:brain segmentation; P:cellular response to organic substance; P:facial nerve structural organization; P:fat cell differentiation; P:gene expression; P:learning or memory; P:motor neuron axon guidance; P:myelination; P:nervous system development; P:peripheral nervous system development; P:positive regulation of myelination; P:positive regulation of Schwann cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein export from nucleus; P:protein sumoylation; P:regulation of neuronal synaptic plasticity; P:regulation of ossification; P:regulation of transcription by RNA polymerase II; P:response to insulin; P:rhombomere 3 formation; P:rhombomere 3 structural organization; P:rhombomere 5 formation; P:rhombomere 5 structural organization; P:rhythmic behavior; P:Schwann cell differentiation; P:skeletal muscle cell differentiation; scaffold14 indexed_genome mRNA 6774496 6792740 . - . ID=transcript_3566;Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold14 indexed_genome mRNA 6794767 6823416 . - . ID=transcript_3567;Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold14 indexed_genome mRNA 6854999 6859508 . - . ID=transcript_3568;Q15652 A0T124 Q5SQZ8 Q5SQZ9 Q5SR00 Q7Z3E7 Q8N3U0 Q96KB9 Q9P2G7,Probable JmjC domain-containing histone demethylation protein 2C,Jumonji domain-containing protein 1C;Thyroid receptor-interacting protein 8;, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0051213;GO:0032454;GO:0046872;GO:0046966;GO:0003712;GO:0007596;GO:0033169;GO:0006357;GO:0006355;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:thyroid hormone receptor binding; F:transcription coregulator activity;, P:blood coagulation; P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold14 indexed_genome mRNA 7139376 7139912 . - . ID=transcript_3569;Q6NUK4 Q5JQR5 Q5QGT2 Q6PEW8 Q6PJY4,Receptor expression-enhancing protein 3,, PF03134;, GO:0005881;GO:0005789;GO:0071782;GO:0016021;GO:0016020;GO:0008017;GO:0051301;GO:0071786;GO:0007084;GO:0006998;, C:cytoplasmic microtubule; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of membrane; C:membrane;, F:microtubule binding;, P:cell division; P:endoplasmic reticulum tubular network organization; P:mitotic nuclear envelope reassembly; P:nuclear envelope organization; scaffold14 indexed_genome mRNA 7184892 7189189 . - . ID=transcript_3570;Q6NUK4 Q5JQR5 Q5QGT2 Q6PEW8 Q6PJY4,Receptor expression-enhancing protein 3,, PF03134;, GO:0005881;GO:0005789;GO:0071782;GO:0016021;GO:0016020;GO:0008017;GO:0051301;GO:0071786;GO:0007084;GO:0006998;, C:cytoplasmic microtubule; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of membrane; C:membrane;, F:microtubule binding;, P:cell division; P:endoplasmic reticulum tubular network organization; P:mitotic nuclear envelope reassembly; P:nuclear envelope organization;|Q6NUK4 Q5JQR5 Q5QGT2 Q6PEW8 Q6PJY4,Receptor expression-enhancing protein 3,, PF03134;, GO:0005881;GO:0005789;GO:0071782;GO:0016021;GO:0016020;GO:0008017;GO:0051301;GO:0071786;GO:0007084;GO:0006998;, C:cytoplasmic microtubule; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of membrane; C:membrane;, F:microtubule binding;, P:cell division; P:endoplasmic reticulum tubular network organization; P:mitotic nuclear envelope reassembly; P:nuclear envelope organization; scaffold14 indexed_genome mRNA 7864766 7865942 . - . ID=transcript_3571;Q6R2W3 Q2NKL9 Q5SRJ3 Q8TCN2 Q96MV9 Q96PW3,SCAN domain-containing protein 3,Transposon-derived Buster4 transposase-like protein;Zinc finger BED domain-containing protein 9;, PF02023;, GO:0005737;GO:0005634;GO:0003676;GO:0015074;GO:0045787;GO:0050679;, C:cytoplasm; C:nucleus;, F:nucleic acid binding;, P:DNA integration; P:positive regulation of cell cycle; P:positive regulation of epithelial cell proliferation; scaffold14 indexed_genome mRNA 9607921 10908197 . - . ID=transcript_3572;Q9UI47 Q5VSR2 Q6P056,Catenin alpha-3,Alpha T-catenin;Cadherin-associated protein;, PF01044;, GO:0005912;GO:0005856;GO:0005829;GO:0005916;GO:0030027;GO:0051015;GO:0008013;GO:0045296;GO:0007015;GO:0086073;GO:0098609;GO:0090136;GO:0086091;GO:0098911;, C:adherens junction; C:cytoskeleton; C:cytosol; C:fascia adherens; C:lamellipodium;, F:actin filament binding; F:beta-catenin binding; F:cadherin binding;, P:actin filament organization; P:bundle of His cell-Purkinje myocyte adhesion involved in cell communication; P:cell-cell adhesion; P:epithelial cell-cell adhesion; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell action potential;|Q86VH5 A8K2A3 Q2NKX7 Q6N0A3,Leucine-rich repeat transmembrane neuronal protein 3,, PF13855;, GO:0031012;GO:0005615;GO:0098978;GO:0099061;GO:1902004;GO:0051965;GO:0099054;, C:extracellular matrix; C:extracellular space; C:glutamatergic synapse; C:integral component of postsynaptic density membrane;, , P:positive regulation of amyloid-beta formation; P:positive regulation of synapse assembly; P:presynapse assembly;|Q86VH5 A8K2A3 Q2NKX7 Q6N0A3,Leucine-rich repeat transmembrane neuronal protein 3,, PF13855;, GO:0031012;GO:0005615;GO:0098978;GO:0099061;GO:1902004;GO:0051965;GO:0099054;, C:extracellular matrix; C:extracellular space; C:glutamatergic synapse; C:integral component of postsynaptic density membrane;, , P:positive regulation of amyloid-beta formation; P:positive regulation of synapse assembly; P:presynapse assembly; scaffold14 indexed_genome mRNA 11474365 11507108 . - . ID=transcript_3573;Q9UKB3 Q5JVQ1 Q9UKB2,DnaJ homolog subfamily C member 12,J domain-containing protein 1;, PF00226;, GO:0005737;, C:cytoplasm; scaffold14 indexed_genome mRNA 11611113 11615657 . + . ID=transcript_3574;Q96EB6 Q2XNF6 Q5JVQ0 Q9GZR9 Q9Y6F0,NAD-dependent protein deacetylase sirtuin-1 {ECO:0000305},NAD-dependent protein deacylase sirtuin-1;Regulatory protein SIR2 homolog 1;SIR2-like protein 1;, PF02146;, GO:0000785;GO:0005677;GO:0005737;GO:0005829;GO:0000791;GO:0001650;GO:0000792;GO:0005739;GO:0005635;GO:0005637;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0033553;GO:0043425;GO:0019213;GO:0019899;GO:0042393;GO:0004407;GO:0043398;GO:0042802;GO:1990254;GO:0046872;GO:0051019;GO:0070403;GO:0017136;GO:0046969;GO:0034979;GO:0035257;GO:0002039;GO:1990841;GO:0008022;GO:0033558;GO:0106231;GO:0000978;GO:0003713;GO:0003714;GO:0008134;GO:0001525;GO:0042595;GO:0007569;GO:0001678;GO:0006974;GO:0070301;GO:0071456;GO:0071479;GO:1990830;GO:0009267;GO:0071356;GO:0035356;GO:0042632;GO:0006325;GO:0032922;GO:0006346;GO:0000731;GO:0055089;GO:0031507;GO:0070829;GO:0016575;GO:0070932;GO:0042771;GO:0033210;GO:0030225;GO:0007517;GO:0060766;GO:0043066;GO:2000480;GO:0030308;GO:2000655;GO:2000773;GO:0043518;GO:0043433;GO:0045599;GO:0010629;GO:0051097;GO:0071441;GO:1900113;GO:2000619;GO:0043124;GO:1902166;GO:1901215;GO:0032088;GO:1902176;GO:2000757;GO:0042326;GO:0031393;GO:1901984;GO:0051898;GO:0032007;GO:0000122;GO:0045892;GO:0030512;GO:0001542;GO:0018394;GO:0034983;GO:0002821;GO:1904179;GO:0045766;GO:0043065;GO:0043536;GO:2000481;GO:0008284;GO:2000774;GO:0010875;GO:0043280;GO:0045739;GO:1902237;GO:0001938;GO:0045722;GO:0051574;GO:0046628;GO:0016239;GO:2000111;GO:0060907;GO:0045348;GO:0014068;GO:0001934;GO:0051152;GO:0045944;GO:0043161;GO:0006476;GO:0106230;GO:0031648;GO:0016567;GO:0000720;GO:0000183;GO:0042981;GO:0070857;GO:0090335;GO:0042127;GO:1900034;GO:0010824;GO:0032071;GO:0010906;GO:0010883;GO:0007346;GO:0035358;GO:0071900;GO:0034391;GO:0042542;GO:0032868;GO:0044321;GO:0006979;GO:0000012;GO:0007283;GO:0090400;GO:0007179;GO:0006642;GO:0070914;GO:0016032;GO:0050872;, C:chromatin; C:chromatin silencing complex; C:cytoplasm; C:cytosol; C:euchromatin; C:fibrillar center; C:heterochromatin; C:mitochondrion; C:nuclear envelope; C:nuclear inner membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:rDNA heterochromatin;, F:bHLH transcription factor binding; F:deacetylase activity; F:enzyme binding; F:histone binding; F:histone deacetylase activity; F:HLH domain binding; F:identical protein binding; F:keratin filament binding; F:metal ion binding; F:mitogen-activated protein kinase binding; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:NAD-dependent protein deacetylase activity; F:nuclear hormone receptor binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein deacetylase activity; F:protein-propionyllysine depropionylase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:angiogenesis; P:behavioral response to starvation; P:cell aging; P:cellular glucose homeostasis; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to starvation; P:cellular response to tumor necrosis factor; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:chromatin organization; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:DNA synthesis involved in DNA repair; P:fatty acid homeostasis; P:heterochromatin assembly; P:heterochromatin maintenance; P:histone deacetylation; P:histone H3 deacetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:leptin-mediated signaling pathway; P:macrophage differentiation; P:muscle organ development; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of cell growth; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of helicase activity; P:negative regulation of histone H3-K14 acetylation; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of neuron death; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of peptidyl-lysine acetylation; P:negative regulation of phosphorylation; P:negative regulation of prostaglandin biosynthetic process; P:negative regulation of protein acetylation; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:ovulation from ovarian follicle; P:peptidyl-lysine acetylation; P:peptidyl-lysine deacetylation; P:positive regulation of adaptive immune response; P:positive regulation of adipose tissue development; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cell population proliferation; P:positive regulation of cellular senescence; P:positive regulation of cholesterol efflux; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA repair; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endothelial cell proliferation; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K9 methylation; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of macroautophagy; P:positive regulation of macrophage apoptotic process; P:positive regulation of macrophage cytokine production; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deacetylation; P:protein depropionylation; P:protein destabilization; P:protein ubiquitination; P:pyrimidine dimer repair by nucleotide-excision repair; P:rDNA heterochromatin assembly; P:regulation of apoptotic process; P:regulation of bile acid biosynthetic process; P:regulation of brown fat cell differentiation; P:regulation of cell population proliferation; P:regulation of cellular response to heat; P:regulation of centrosome duplication; P:regulation of endodeoxyribonuclease activity; P:regulation of glucose metabolic process; P:regulation of lipid storage; P:regulation of mitotic cell cycle; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:regulation of protein serine/threonine kinase activity; P:regulation of smooth muscle cell apoptotic process; P:response to hydrogen peroxide; P:response to insulin; P:response to leptin; P:response to oxidative stress; P:single strand break repair; P:spermatogenesis; P:stress-induced premature senescence; P:transforming growth factor beta receptor signaling pathway; P:triglyceride mobilization; P:UV-damage excision repair; P:viral process; P:white fat cell differentiation; scaffold14 indexed_genome mRNA 11615687 11639784 . + . ID=transcript_3575;Q96EB6 Q2XNF6 Q5JVQ0 Q9GZR9 Q9Y6F0,NAD-dependent protein deacetylase sirtuin-1 {ECO:0000305},NAD-dependent protein deacylase sirtuin-1;Regulatory protein SIR2 homolog 1;SIR2-like protein 1;, PF02146;, GO:0000785;GO:0005677;GO:0005737;GO:0005829;GO:0000791;GO:0001650;GO:0000792;GO:0005739;GO:0005635;GO:0005637;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0033553;GO:0043425;GO:0019213;GO:0019899;GO:0042393;GO:0004407;GO:0043398;GO:0042802;GO:1990254;GO:0046872;GO:0051019;GO:0070403;GO:0017136;GO:0046969;GO:0034979;GO:0035257;GO:0002039;GO:1990841;GO:0008022;GO:0033558;GO:0106231;GO:0000978;GO:0003713;GO:0003714;GO:0008134;GO:0001525;GO:0042595;GO:0007569;GO:0001678;GO:0006974;GO:0070301;GO:0071456;GO:0071479;GO:1990830;GO:0009267;GO:0071356;GO:0035356;GO:0042632;GO:0006325;GO:0032922;GO:0006346;GO:0000731;GO:0055089;GO:0031507;GO:0070829;GO:0016575;GO:0070932;GO:0042771;GO:0033210;GO:0030225;GO:0007517;GO:0060766;GO:0043066;GO:2000480;GO:0030308;GO:2000655;GO:2000773;GO:0043518;GO:0043433;GO:0045599;GO:0010629;GO:0051097;GO:0071441;GO:1900113;GO:2000619;GO:0043124;GO:1902166;GO:1901215;GO:0032088;GO:1902176;GO:2000757;GO:0042326;GO:0031393;GO:1901984;GO:0051898;GO:0032007;GO:0000122;GO:0045892;GO:0030512;GO:0001542;GO:0018394;GO:0034983;GO:0002821;GO:1904179;GO:0045766;GO:0043065;GO:0043536;GO:2000481;GO:0008284;GO:2000774;GO:0010875;GO:0043280;GO:0045739;GO:1902237;GO:0001938;GO:0045722;GO:0051574;GO:0046628;GO:0016239;GO:2000111;GO:0060907;GO:0045348;GO:0014068;GO:0001934;GO:0051152;GO:0045944;GO:0043161;GO:0006476;GO:0106230;GO:0031648;GO:0016567;GO:0000720;GO:0000183;GO:0042981;GO:0070857;GO:0090335;GO:0042127;GO:1900034;GO:0010824;GO:0032071;GO:0010906;GO:0010883;GO:0007346;GO:0035358;GO:0071900;GO:0034391;GO:0042542;GO:0032868;GO:0044321;GO:0006979;GO:0000012;GO:0007283;GO:0090400;GO:0007179;GO:0006642;GO:0070914;GO:0016032;GO:0050872;, C:chromatin; C:chromatin silencing complex; C:cytoplasm; C:cytosol; C:euchromatin; C:fibrillar center; C:heterochromatin; C:mitochondrion; C:nuclear envelope; C:nuclear inner membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:rDNA heterochromatin;, F:bHLH transcription factor binding; F:deacetylase activity; F:enzyme binding; F:histone binding; F:histone deacetylase activity; F:HLH domain binding; F:identical protein binding; F:keratin filament binding; F:metal ion binding; F:mitogen-activated protein kinase binding; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:NAD-dependent protein deacetylase activity; F:nuclear hormone receptor binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein deacetylase activity; F:protein-propionyllysine depropionylase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:angiogenesis; P:behavioral response to starvation; P:cell aging; P:cellular glucose homeostasis; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to starvation; P:cellular response to tumor necrosis factor; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:chromatin organization; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:DNA synthesis involved in DNA repair; P:fatty acid homeostasis; P:heterochromatin assembly; P:heterochromatin maintenance; P:histone deacetylation; P:histone H3 deacetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:leptin-mediated signaling pathway; P:macrophage differentiation; P:muscle organ development; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of cell growth; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of helicase activity; P:negative regulation of histone H3-K14 acetylation; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of neuron death; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of peptidyl-lysine acetylation; P:negative regulation of phosphorylation; P:negative regulation of prostaglandin biosynthetic process; P:negative regulation of protein acetylation; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:ovulation from ovarian follicle; P:peptidyl-lysine acetylation; P:peptidyl-lysine deacetylation; P:positive regulation of adaptive immune response; P:positive regulation of adipose tissue development; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cell population proliferation; P:positive regulation of cellular senescence; P:positive regulation of cholesterol efflux; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA repair; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endothelial cell proliferation; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K9 methylation; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of macroautophagy; P:positive regulation of macrophage apoptotic process; P:positive regulation of macrophage cytokine production; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deacetylation; P:protein depropionylation; P:protein destabilization; P:protein ubiquitination; P:pyrimidine dimer repair by nucleotide-excision repair; P:rDNA heterochromatin assembly; P:regulation of apoptotic process; P:regulation of bile acid biosynthetic process; P:regulation of brown fat cell differentiation; P:regulation of cell population proliferation; P:regulation of cellular response to heat; P:regulation of centrosome duplication; P:regulation of endodeoxyribonuclease activity; P:regulation of glucose metabolic process; P:regulation of lipid storage; P:regulation of mitotic cell cycle; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:regulation of protein serine/threonine kinase activity; P:regulation of smooth muscle cell apoptotic process; P:response to hydrogen peroxide; P:response to insulin; P:response to leptin; P:response to oxidative stress; P:single strand break repair; P:spermatogenesis; P:stress-induced premature senescence; P:transforming growth factor beta receptor signaling pathway; P:triglyceride mobilization; P:UV-damage excision repair; P:viral process; P:white fat cell differentiation;|Q96EB6 Q2XNF6 Q5JVQ0 Q9GZR9 Q9Y6F0,NAD-dependent protein deacetylase sirtuin-1 {ECO:0000305},NAD-dependent protein deacylase sirtuin-1;Regulatory protein SIR2 homolog 1;SIR2-like protein 1;, PF02146;, GO:0000785;GO:0005677;GO:0005737;GO:0005829;GO:0000791;GO:0001650;GO:0000792;GO:0005739;GO:0005635;GO:0005637;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0033553;GO:0043425;GO:0019213;GO:0019899;GO:0042393;GO:0004407;GO:0043398;GO:0042802;GO:1990254;GO:0046872;GO:0051019;GO:0070403;GO:0017136;GO:0046969;GO:0034979;GO:0035257;GO:0002039;GO:1990841;GO:0008022;GO:0033558;GO:0106231;GO:0000978;GO:0003713;GO:0003714;GO:0008134;GO:0001525;GO:0042595;GO:0007569;GO:0001678;GO:0006974;GO:0070301;GO:0071456;GO:0071479;GO:1990830;GO:0009267;GO:0071356;GO:0035356;GO:0042632;GO:0006325;GO:0032922;GO:0006346;GO:0000731;GO:0055089;GO:0031507;GO:0070829;GO:0016575;GO:0070932;GO:0042771;GO:0033210;GO:0030225;GO:0007517;GO:0060766;GO:0043066;GO:2000480;GO:0030308;GO:2000655;GO:2000773;GO:0043518;GO:0043433;GO:0045599;GO:0010629;GO:0051097;GO:0071441;GO:1900113;GO:2000619;GO:0043124;GO:1902166;GO:1901215;GO:0032088;GO:1902176;GO:2000757;GO:0042326;GO:0031393;GO:1901984;GO:0051898;GO:0032007;GO:0000122;GO:0045892;GO:0030512;GO:0001542;GO:0018394;GO:0034983;GO:0002821;GO:1904179;GO:0045766;GO:0043065;GO:0043536;GO:2000481;GO:0008284;GO:2000774;GO:0010875;GO:0043280;GO:0045739;GO:1902237;GO:0001938;GO:0045722;GO:0051574;GO:0046628;GO:0016239;GO:2000111;GO:0060907;GO:0045348;GO:0014068;GO:0001934;GO:0051152;GO:0045944;GO:0043161;GO:0006476;GO:0106230;GO:0031648;GO:0016567;GO:0000720;GO:0000183;GO:0042981;GO:0070857;GO:0090335;GO:0042127;GO:1900034;GO:0010824;GO:0032071;GO:0010906;GO:0010883;GO:0007346;GO:0035358;GO:0071900;GO:0034391;GO:0042542;GO:0032868;GO:0044321;GO:0006979;GO:0000012;GO:0007283;GO:0090400;GO:0007179;GO:0006642;GO:0070914;GO:0016032;GO:0050872;, C:chromatin; C:chromatin silencing complex; C:cytoplasm; C:cytosol; C:euchromatin; C:fibrillar center; C:heterochromatin; C:mitochondrion; C:nuclear envelope; C:nuclear inner membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:rDNA heterochromatin;, F:bHLH transcription factor binding; F:deacetylase activity; F:enzyme binding; F:histone binding; F:histone deacetylase activity; F:HLH domain binding; F:identical protein binding; F:keratin filament binding; F:metal ion binding; F:mitogen-activated protein kinase binding; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:NAD-dependent protein deacetylase activity; F:nuclear hormone receptor binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein deacetylase activity; F:protein-propionyllysine depropionylase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:angiogenesis; P:behavioral response to starvation; P:cell aging; P:cellular glucose homeostasis; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to starvation; P:cellular response to tumor necrosis factor; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:chromatin organization; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:DNA synthesis involved in DNA repair; P:fatty acid homeostasis; P:heterochromatin assembly; P:heterochromatin maintenance; P:histone deacetylation; P:histone H3 deacetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:leptin-mediated signaling pathway; P:macrophage differentiation; P:muscle organ development; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of cell growth; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of helicase activity; P:negative regulation of histone H3-K14 acetylation; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of neuron death; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of peptidyl-lysine acetylation; P:negative regulation of phosphorylation; P:negative regulation of prostaglandin biosynthetic process; P:negative regulation of protein acetylation; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:ovulation from ovarian follicle; P:peptidyl-lysine acetylation; P:peptidyl-lysine deacetylation; P:positive regulation of adaptive immune response; P:positive regulation of adipose tissue development; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cell population proliferation; P:positive regulation of cellular senescence; P:positive regulation of cholesterol efflux; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA repair; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endothelial cell proliferation; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K9 methylation; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of macroautophagy; P:positive regulation of macrophage apoptotic process; P:positive regulation of macrophage cytokine production; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deacetylation; P:protein depropionylation; P:protein destabilization; P:protein ubiquitination; P:pyrimidine dimer repair by nucleotide-excision repair; P:rDNA heterochromatin assembly; P:regulation of apoptotic process; P:regulation of bile acid biosynthetic process; P:regulation of brown fat cell differentiation; P:regulation of cell population proliferation; P:regulation of cellular response to heat; P:regulation of centrosome duplication; P:regulation of endodeoxyribonuclease activity; P:regulation of glucose metabolic process; P:regulation of lipid storage; P:regulation of mitotic cell cycle; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:regulation of protein serine/threonine kinase activity; P:regulation of smooth muscle cell apoptotic process; P:response to hydrogen peroxide; P:response to insulin; P:response to leptin; P:response to oxidative stress; P:single strand break repair; P:spermatogenesis; P:stress-induced premature senescence; P:transforming growth factor beta receptor signaling pathway; P:triglyceride mobilization; P:UV-damage excision repair; P:viral process; P:white fat cell differentiation;|Q96EB6 Q2XNF6 Q5JVQ0 Q9GZR9 Q9Y6F0,NAD-dependent protein deacetylase sirtuin-1 {ECO:0000305},NAD-dependent protein deacylase sirtuin-1;Regulatory protein SIR2 homolog 1;SIR2-like protein 1;, PF02146;, GO:0000785;GO:0005677;GO:0005737;GO:0005829;GO:0000791;GO:0001650;GO:0000792;GO:0005739;GO:0005635;GO:0005637;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0033553;GO:0043425;GO:0019213;GO:0019899;GO:0042393;GO:0004407;GO:0043398;GO:0042802;GO:1990254;GO:0046872;GO:0051019;GO:0070403;GO:0017136;GO:0046969;GO:0034979;GO:0035257;GO:0002039;GO:1990841;GO:0008022;GO:0033558;GO:0106231;GO:0000978;GO:0003713;GO:0003714;GO:0008134;GO:0001525;GO:0042595;GO:0007569;GO:0001678;GO:0006974;GO:0070301;GO:0071456;GO:0071479;GO:1990830;GO:0009267;GO:0071356;GO:0035356;GO:0042632;GO:0006325;GO:0032922;GO:0006346;GO:0000731;GO:0055089;GO:0031507;GO:0070829;GO:0016575;GO:0070932;GO:0042771;GO:0033210;GO:0030225;GO:0007517;GO:0060766;GO:0043066;GO:2000480;GO:0030308;GO:2000655;GO:2000773;GO:0043518;GO:0043433;GO:0045599;GO:0010629;GO:0051097;GO:0071441;GO:1900113;GO:2000619;GO:0043124;GO:1902166;GO:1901215;GO:0032088;GO:1902176;GO:2000757;GO:0042326;GO:0031393;GO:1901984;GO:0051898;GO:0032007;GO:0000122;GO:0045892;GO:0030512;GO:0001542;GO:0018394;GO:0034983;GO:0002821;GO:1904179;GO:0045766;GO:0043065;GO:0043536;GO:2000481;GO:0008284;GO:2000774;GO:0010875;GO:0043280;GO:0045739;GO:1902237;GO:0001938;GO:0045722;GO:0051574;GO:0046628;GO:0016239;GO:2000111;GO:0060907;GO:0045348;GO:0014068;GO:0001934;GO:0051152;GO:0045944;GO:0043161;GO:0006476;GO:0106230;GO:0031648;GO:0016567;GO:0000720;GO:0000183;GO:0042981;GO:0070857;GO:0090335;GO:0042127;GO:1900034;GO:0010824;GO:0032071;GO:0010906;GO:0010883;GO:0007346;GO:0035358;GO:0071900;GO:0034391;GO:0042542;GO:0032868;GO:0044321;GO:0006979;GO:0000012;GO:0007283;GO:0090400;GO:0007179;GO:0006642;GO:0070914;GO:0016032;GO:0050872;, C:chromatin; C:chromatin silencing complex; C:cytoplasm; C:cytosol; C:euchromatin; C:fibrillar center; C:heterochromatin; C:mitochondrion; C:nuclear envelope; C:nuclear inner membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:rDNA heterochromatin;, F:bHLH transcription factor binding; F:deacetylase activity; F:enzyme binding; F:histone binding; F:histone deacetylase activity; F:HLH domain binding; F:identical protein binding; F:keratin filament binding; F:metal ion binding; F:mitogen-activated protein kinase binding; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:NAD-dependent protein deacetylase activity; F:nuclear hormone receptor binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein deacetylase activity; F:protein-propionyllysine depropionylase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:angiogenesis; P:behavioral response to starvation; P:cell aging; P:cellular glucose homeostasis; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to starvation; P:cellular response to tumor necrosis factor; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:chromatin organization; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:DNA synthesis involved in DNA repair; P:fatty acid homeostasis; P:heterochromatin assembly; P:heterochromatin maintenance; P:histone deacetylation; P:histone H3 deacetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:leptin-mediated signaling pathway; P:macrophage differentiation; P:muscle organ development; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of cell growth; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of helicase activity; P:negative regulation of histone H3-K14 acetylation; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of neuron death; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of peptidyl-lysine acetylation; P:negative regulation of phosphorylation; P:negative regulation of prostaglandin biosynthetic process; P:negative regulation of protein acetylation; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:ovulation from ovarian follicle; P:peptidyl-lysine acetylation; P:peptidyl-lysine deacetylation; P:positive regulation of adaptive immune response; P:positive regulation of adipose tissue development; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cell population proliferation; P:positive regulation of cellular senescence; P:positive regulation of cholesterol efflux; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA repair; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endothelial cell proliferation; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K9 methylation; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of macroautophagy; P:positive regulation of macrophage apoptotic process; P:positive regulation of macrophage cytokine production; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deacetylation; P:protein depropionylation; P:protein destabilization; P:protein ubiquitination; P:pyrimidine dimer repair by nucleotide-excision repair; P:rDNA heterochromatin assembly; P:regulation of apoptotic process; P:regulation of bile acid biosynthetic process; P:regulation of brown fat cell differentiation; P:regulation of cell population proliferation; P:regulation of cellular response to heat; P:regulation of centrosome duplication; P:regulation of endodeoxyribonuclease activity; P:regulation of glucose metabolic process; P:regulation of lipid storage; P:regulation of mitotic cell cycle; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:regulation of protein serine/threonine kinase activity; P:regulation of smooth muscle cell apoptotic process; P:response to hydrogen peroxide; P:response to insulin; P:response to leptin; P:response to oxidative stress; P:single strand break repair; P:spermatogenesis; P:stress-induced premature senescence; P:transforming growth factor beta receptor signaling pathway; P:triglyceride mobilization; P:UV-damage excision repair; P:viral process; P:white fat cell differentiation;|Q96EB6 Q2XNF6 Q5JVQ0 Q9GZR9 Q9Y6F0,NAD-dependent protein deacetylase sirtuin-1 {ECO:0000305},NAD-dependent protein deacylase sirtuin-1;Regulatory protein SIR2 homolog 1;SIR2-like protein 1;, PF02146;, GO:0000785;GO:0005677;GO:0005737;GO:0005829;GO:0000791;GO:0001650;GO:0000792;GO:0005739;GO:0005635;GO:0005637;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0033553;GO:0043425;GO:0019213;GO:0019899;GO:0042393;GO:0004407;GO:0043398;GO:0042802;GO:1990254;GO:0046872;GO:0051019;GO:0070403;GO:0017136;GO:0046969;GO:0034979;GO:0035257;GO:0002039;GO:1990841;GO:0008022;GO:0033558;GO:0106231;GO:0000978;GO:0003713;GO:0003714;GO:0008134;GO:0001525;GO:0042595;GO:0007569;GO:0001678;GO:0006974;GO:0070301;GO:0071456;GO:0071479;GO:1990830;GO:0009267;GO:0071356;GO:0035356;GO:0042632;GO:0006325;GO:0032922;GO:0006346;GO:0000731;GO:0055089;GO:0031507;GO:0070829;GO:0016575;GO:0070932;GO:0042771;GO:0033210;GO:0030225;GO:0007517;GO:0060766;GO:0043066;GO:2000480;GO:0030308;GO:2000655;GO:2000773;GO:0043518;GO:0043433;GO:0045599;GO:0010629;GO:0051097;GO:0071441;GO:1900113;GO:2000619;GO:0043124;GO:1902166;GO:1901215;GO:0032088;GO:1902176;GO:2000757;GO:0042326;GO:0031393;GO:1901984;GO:0051898;GO:0032007;GO:0000122;GO:0045892;GO:0030512;GO:0001542;GO:0018394;GO:0034983;GO:0002821;GO:1904179;GO:0045766;GO:0043065;GO:0043536;GO:2000481;GO:0008284;GO:2000774;GO:0010875;GO:0043280;GO:0045739;GO:1902237;GO:0001938;GO:0045722;GO:0051574;GO:0046628;GO:0016239;GO:2000111;GO:0060907;GO:0045348;GO:0014068;GO:0001934;GO:0051152;GO:0045944;GO:0043161;GO:0006476;GO:0106230;GO:0031648;GO:0016567;GO:0000720;GO:0000183;GO:0042981;GO:0070857;GO:0090335;GO:0042127;GO:1900034;GO:0010824;GO:0032071;GO:0010906;GO:0010883;GO:0007346;GO:0035358;GO:0071900;GO:0034391;GO:0042542;GO:0032868;GO:0044321;GO:0006979;GO:0000012;GO:0007283;GO:0090400;GO:0007179;GO:0006642;GO:0070914;GO:0016032;GO:0050872;, C:chromatin; C:chromatin silencing complex; C:cytoplasm; C:cytosol; C:euchromatin; C:fibrillar center; C:heterochromatin; C:mitochondrion; C:nuclear envelope; C:nuclear inner membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:rDNA heterochromatin;, F:bHLH transcription factor binding; F:deacetylase activity; F:enzyme binding; F:histone binding; F:histone deacetylase activity; F:HLH domain binding; F:identical protein binding; F:keratin filament binding; F:metal ion binding; F:mitogen-activated protein kinase binding; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:NAD-dependent protein deacetylase activity; F:nuclear hormone receptor binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein deacetylase activity; F:protein-propionyllysine depropionylase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:angiogenesis; P:behavioral response to starvation; P:cell aging; P:cellular glucose homeostasis; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to starvation; P:cellular response to tumor necrosis factor; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:chromatin organization; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:DNA synthesis involved in DNA repair; P:fatty acid homeostasis; P:heterochromatin assembly; P:heterochromatin maintenance; P:histone deacetylation; P:histone H3 deacetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:leptin-mediated signaling pathway; P:macrophage differentiation; P:muscle organ development; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of cell growth; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of helicase activity; P:negative regulation of histone H3-K14 acetylation; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of neuron death; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of peptidyl-lysine acetylation; P:negative regulation of phosphorylation; P:negative regulation of prostaglandin biosynthetic process; P:negative regulation of protein acetylation; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:ovulation from ovarian follicle; P:peptidyl-lysine acetylation; P:peptidyl-lysine deacetylation; P:positive regulation of adaptive immune response; P:positive regulation of adipose tissue development; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of cell population proliferation; P:positive regulation of cellular senescence; P:positive regulation of cholesterol efflux; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA repair; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endothelial cell proliferation; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K9 methylation; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of macroautophagy; P:positive regulation of macrophage apoptotic process; P:positive regulation of macrophage cytokine production; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deacetylation; P:protein depropionylation; P:protein destabilization; P:protein ubiquitination; P:pyrimidine dimer repair by nucleotide-excision repair; P:rDNA heterochromatin assembly; P:regulation of apoptotic process; P:regulation of bile acid biosynthetic process; P:regulation of brown fat cell differentiation; P:regulation of cell population proliferation; P:regulation of cellular response to heat; P:regulation of centrosome duplication; P:regulation of endodeoxyribonuclease activity; P:regulation of glucose metabolic process; P:regulation of lipid storage; P:regulation of mitotic cell cycle; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:regulation of protein serine/threonine kinase activity; P:regulation of smooth muscle cell apoptotic process; P:response to hydrogen peroxide; P:response to insulin; P:response to leptin; P:response to oxidative stress; P:single strand break repair; P:spermatogenesis; P:stress-induced premature senescence; P:transforming growth factor beta receptor signaling pathway; P:triglyceride mobilization; P:UV-damage excision repair; P:viral process; P:white fat cell differentiation; scaffold14 indexed_genome mRNA 11646289 11771864 . - . ID=transcript_3576;Q5GLZ8 Q5GC98 Q5GC99 Q5GCA0 Q8IXP9 Q9HCH9,Probable E3 ubiquitin-protein ligase HERC4,HECT domain and RCC1-like domain-containing protein 4;HECT-type E3 ubiquitin transferase HERC4;, PF00632;PF00415;, GO:0005829;GO:0001650;GO:0004842;GO:0030154;GO:0045879;GO:0007283;, C:cytosol; C:fibrillar center;, F:ubiquitin-protein transferase activity;, P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:spermatogenesis;|Q5GLZ8 Q5GC98 Q5GC99 Q5GCA0 Q8IXP9 Q9HCH9,Probable E3 ubiquitin-protein ligase HERC4,HECT domain and RCC1-like domain-containing protein 4;HECT-type E3 ubiquitin transferase HERC4;, PF00632;PF00415;, GO:0005829;GO:0001650;GO:0004842;GO:0030154;GO:0045879;GO:0007283;, C:cytosol; C:fibrillar center;, F:ubiquitin-protein transferase activity;, P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:spermatogenesis;|Q5GLZ8 Q5GC98 Q5GC99 Q5GCA0 Q8IXP9 Q9HCH9,Probable E3 ubiquitin-protein ligase HERC4,HECT domain and RCC1-like domain-containing protein 4;HECT-type E3 ubiquitin transferase HERC4;, PF00632;PF00415;, GO:0005829;GO:0001650;GO:0004842;GO:0030154;GO:0045879;GO:0007283;, C:cytosol; C:fibrillar center;, F:ubiquitin-protein transferase activity;, P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:spermatogenesis;|Q5GLZ8 Q5GC98 Q5GC99 Q5GCA0 Q8IXP9 Q9HCH9,Probable E3 ubiquitin-protein ligase HERC4,HECT domain and RCC1-like domain-containing protein 4;HECT-type E3 ubiquitin transferase HERC4;, PF00632;PF00415;, GO:0005829;GO:0001650;GO:0004842;GO:0030154;GO:0045879;GO:0007283;, C:cytosol; C:fibrillar center;, F:ubiquitin-protein transferase activity;, P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:spermatogenesis;|Q5GLZ8 Q5GC98 Q5GC99 Q5GCA0 Q8IXP9 Q9HCH9,Probable E3 ubiquitin-protein ligase HERC4,HECT domain and RCC1-like domain-containing protein 4;HECT-type E3 ubiquitin transferase HERC4;, PF00632;PF00415;, GO:0005829;GO:0001650;GO:0004842;GO:0030154;GO:0045879;GO:0007283;, C:cytosol; C:fibrillar center;, F:ubiquitin-protein transferase activity;, P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:spermatogenesis;|Q5GLZ8 Q5GC98 Q5GC99 Q5GCA0 Q8IXP9 Q9HCH9,Probable E3 ubiquitin-protein ligase HERC4,HECT domain and RCC1-like domain-containing protein 4;HECT-type E3 ubiquitin transferase HERC4;, PF00632;PF00415;, GO:0005829;GO:0001650;GO:0004842;GO:0030154;GO:0045879;GO:0007283;, C:cytosol; C:fibrillar center;, F:ubiquitin-protein transferase activity;, P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:spermatogenesis;|Q5GLZ8 Q5GC98 Q5GC99 Q5GCA0 Q8IXP9 Q9HCH9,Probable E3 ubiquitin-protein ligase HERC4,HECT domain and RCC1-like domain-containing protein 4;HECT-type E3 ubiquitin transferase HERC4;, PF00632;PF00415;, GO:0005829;GO:0001650;GO:0004842;GO:0030154;GO:0045879;GO:0007283;, C:cytosol; C:fibrillar center;, F:ubiquitin-protein transferase activity;, P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:spermatogenesis; scaffold14 indexed_genome mRNA 11780103 11879143 . + . ID=transcript_3577;Q86TC9 Q5VV35 Q5VV36 Q86T37 Q8N3L4 Q96K90 Q96KF5,Myopalladin,145 kDa sarcomeric protein;, PF07679;, GO:0030424;GO:0031674;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0098632;GO:0008092;GO:0051371;GO:0017124;GO:0007411;GO:0070593;GO:0007156;GO:0045214;, C:axon; C:I band; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cell-cell adhesion mediator activity; F:cytoskeletal protein binding; F:muscle alpha-actinin binding; F:SH3 domain binding;, P:axon guidance; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:sarcomere organization;|Q86TC9 Q5VV35 Q5VV36 Q86T37 Q8N3L4 Q96K90 Q96KF5,Myopalladin,145 kDa sarcomeric protein;, PF07679;, GO:0030424;GO:0031674;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0098632;GO:0008092;GO:0051371;GO:0017124;GO:0007411;GO:0070593;GO:0007156;GO:0045214;, C:axon; C:I band; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cell-cell adhesion mediator activity; F:cytoskeletal protein binding; F:muscle alpha-actinin binding; F:SH3 domain binding;, P:axon guidance; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:sarcomere organization; scaffold14 indexed_genome mRNA 11913246 11940919 . - . ID=transcript_3578;P30039 A8MZJ3 C9JIM0 Q9HCC2,Phenazine biosynthesis-like domain-containing protein,MAWD-binding protein;Unknown protein 32 from 2D-page of liver tissue;, PF02567;, GO:0005737;GO:0070062;GO:0042802;GO:0016853;GO:0009058;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0060392;GO:0030512;, C:cytoplasm; C:extracellular exosome;, F:identical protein binding; F:isomerase activity;, P:biosynthetic process; P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of SMAD protein signal transduction; P:negative regulation of transforming growth factor beta receptor signaling pathway;|P30039 A8MZJ3 C9JIM0 Q9HCC2,Phenazine biosynthesis-like domain-containing protein,MAWD-binding protein;Unknown protein 32 from 2D-page of liver tissue;, PF02567;, GO:0005737;GO:0070062;GO:0042802;GO:0016853;GO:0009058;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0060392;GO:0030512;, C:cytoplasm; C:extracellular exosome;, F:identical protein binding; F:isomerase activity;, P:biosynthetic process; P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of SMAD protein signal transduction; P:negative regulation of transforming growth factor beta receptor signaling pathway;|P30039 A8MZJ3 C9JIM0 Q9HCC2,Phenazine biosynthesis-like domain-containing protein,MAWD-binding protein;Unknown protein 32 from 2D-page of liver tissue;, PF02567;, GO:0005737;GO:0070062;GO:0042802;GO:0016853;GO:0009058;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0060392;GO:0030512;, C:cytoplasm; C:extracellular exosome;, F:identical protein binding; F:isomerase activity;, P:biosynthetic process; P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of SMAD protein signal transduction; P:negative regulation of transforming growth factor beta receptor signaling pathway;|P30039 A8MZJ3 C9JIM0 Q9HCC2,Phenazine biosynthesis-like domain-containing protein,MAWD-binding protein;Unknown protein 32 from 2D-page of liver tissue;, PF02567;, GO:0005737;GO:0070062;GO:0042802;GO:0016853;GO:0009058;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0060392;GO:0030512;, C:cytoplasm; C:extracellular exosome;, F:identical protein binding; F:isomerase activity;, P:biosynthetic process; P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of SMAD protein signal transduction; P:negative regulation of transforming growth factor beta receptor signaling pathway; scaffold14 indexed_genome mRNA 11948441 11959300 . + . ID=transcript_3579;Q9Y4J5,Heterogeneous nuclear ribonucleoprotein H3,Heterogeneous nuclear ribonucleoprotein 2H9;, PF00076;, GO:0005654;GO:0005634;GO:1990904;GO:0005681;GO:0003723;GO:0030855;GO:0000398;GO:0043484;GO:0006396;GO:0008380;, C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal complex;, F:RNA binding;, P:epithelial cell differentiation; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA processing; P:RNA splicing;|Q9Y4J5,Heterogeneous nuclear ribonucleoprotein H3,Heterogeneous nuclear ribonucleoprotein 2H9;, PF00076;, GO:0005654;GO:0005634;GO:1990904;GO:0005681;GO:0003723;GO:0030855;GO:0000398;GO:0043484;GO:0006396;GO:0008380;, C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal complex;, F:RNA binding;, P:epithelial cell differentiation; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA processing; P:RNA splicing;|Q9Y4J5,Heterogeneous nuclear ribonucleoprotein H3,Heterogeneous nuclear ribonucleoprotein 2H9;, PF00076;, GO:0005654;GO:0005634;GO:1990904;GO:0005681;GO:0003723;GO:0030855;GO:0000398;GO:0043484;GO:0006396;GO:0008380;, C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal complex;, F:RNA binding;, P:epithelial cell differentiation; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA processing; P:RNA splicing; scaffold14 indexed_genome mRNA 11959316 11982331 . - . ID=transcript_3580;Q8WXA3 B3KXB2 B4DFR0 Q5TC48 Q8IW33 Q96P51 Q9P1Z1,RUN and FYVE domain-containing protein 2,Rab4-interacting protein related;, PF01363;PF02759;, GO:0005737;GO:0005768;GO:0005634;GO:0046872;GO:0017124;GO:0030100;, C:cytoplasm; C:endosome; C:nucleus;, F:metal ion binding; F:SH3 domain binding;, P:regulation of endocytosis;|Q8WXA3 B3KXB2 B4DFR0 Q5TC48 Q8IW33 Q96P51 Q9P1Z1,RUN and FYVE domain-containing protein 2,Rab4-interacting protein related;, PF01363;PF02759;, GO:0005737;GO:0005768;GO:0005634;GO:0046872;GO:0017124;GO:0030100;, C:cytoplasm; C:endosome; C:nucleus;, F:metal ion binding; F:SH3 domain binding;, P:regulation of endocytosis;|Q8WXA3 B3KXB2 B4DFR0 Q5TC48 Q8IW33 Q96P51 Q9P1Z1,RUN and FYVE domain-containing protein 2,Rab4-interacting protein related;, PF01363;PF02759;, GO:0005737;GO:0005768;GO:0005634;GO:0046872;GO:0017124;GO:0030100;, C:cytoplasm; C:endosome; C:nucleus;, F:metal ion binding; F:SH3 domain binding;, P:regulation of endocytosis; scaffold14 indexed_genome mRNA 11982345 12000890 . - . ID=transcript_3581;Q8WXA3 B3KXB2 B4DFR0 Q5TC48 Q8IW33 Q96P51 Q9P1Z1,RUN and FYVE domain-containing protein 2,Rab4-interacting protein related;, PF01363;PF02759;, GO:0005737;GO:0005768;GO:0005634;GO:0046872;GO:0017124;GO:0030100;, C:cytoplasm; C:endosome; C:nucleus;, F:metal ion binding; F:SH3 domain binding;, P:regulation of endocytosis; scaffold14 indexed_genome mRNA 12011277 12048478 . - . ID=transcript_3582;P51530 Q2NKM1 Q5TC49 Q5TC50 Q6P455 Q6PI80 Q7Z6H9 Q8N346,DNA replication ATP-dependent helicase/nuclease DNA2,DNA replication ATP-dependent helicase-like homolog;, PF13086;PF13087;PF08696;, GO:0000781;GO:0005737;GO:0042645;GO:0005739;GO:0005654;GO:0005634;GO:0051539;GO:0043139;GO:0017108;GO:0005524;GO:0016887;GO:0003677;GO:0003678;GO:0004386;GO:0046872;GO:0004518;GO:0003723;GO:0017116;GO:0016890;GO:0006284;GO:0000729;GO:0006260;GO:0000076;GO:0033567;GO:0043137;GO:0044806;GO:0043504;GO:0006264;GO:1902990;GO:0090305;GO:0045740;GO:1901796;GO:0071932;GO:0090656;GO:0000723;GO:0032201;, C:chromosome, telomeric region; C:cytoplasm; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:5'-3' DNA helicase activity; F:5'-flap endonuclease activity; F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA helicase activity; F:helicase activity; F:metal ion binding; F:nuclease activity; F:RNA binding; F:single-stranded DNA helicase activity; F:site-specific endodeoxyribonuclease activity, specific for altered base;, P:base-excision repair; P:DNA double-strand break processing; P:DNA replication; P:DNA replication checkpoint; P:DNA replication, Okazaki fragment processing; P:DNA replication, removal of RNA primer; P:G-quadruplex DNA unwinding; P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:mitotic telomere maintenance via semi-conservative replication; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA replication; P:regulation of signal transduction by p53 class mediator; P:replication fork reversal; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication;|P51530 Q2NKM1 Q5TC49 Q5TC50 Q6P455 Q6PI80 Q7Z6H9 Q8N346,DNA replication ATP-dependent helicase/nuclease DNA2,DNA replication ATP-dependent helicase-like homolog;, PF13086;PF13087;PF08696;, GO:0000781;GO:0005737;GO:0042645;GO:0005739;GO:0005654;GO:0005634;GO:0051539;GO:0043139;GO:0017108;GO:0005524;GO:0016887;GO:0003677;GO:0003678;GO:0004386;GO:0046872;GO:0004518;GO:0003723;GO:0017116;GO:0016890;GO:0006284;GO:0000729;GO:0006260;GO:0000076;GO:0033567;GO:0043137;GO:0044806;GO:0043504;GO:0006264;GO:1902990;GO:0090305;GO:0045740;GO:1901796;GO:0071932;GO:0090656;GO:0000723;GO:0032201;, C:chromosome, telomeric region; C:cytoplasm; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:5'-3' DNA helicase activity; F:5'-flap endonuclease activity; F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA helicase activity; F:helicase activity; F:metal ion binding; F:nuclease activity; F:RNA binding; F:single-stranded DNA helicase activity; F:site-specific endodeoxyribonuclease activity, specific for altered base;, P:base-excision repair; P:DNA double-strand break processing; P:DNA replication; P:DNA replication checkpoint; P:DNA replication, Okazaki fragment processing; P:DNA replication, removal of RNA primer; P:G-quadruplex DNA unwinding; P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:mitotic telomere maintenance via semi-conservative replication; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA replication; P:regulation of signal transduction by p53 class mediator; P:replication fork reversal; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; scaffold14 indexed_genome mRNA 12055832 12084561 . - . ID=transcript_3583;P16260 Q8N2U1,Graves disease carrier protein,Graves disease autoantigen;Mitochondrial solute carrier protein homolog;Solute carrier family 25 member 16;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015297;GO:0015937;GO:0006839;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity;, P:coenzyme A biosynthetic process; P:mitochondrial transport;|P16260 Q8N2U1,Graves disease carrier protein,Graves disease autoantigen;Mitochondrial solute carrier protein homolog;Solute carrier family 25 member 16;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015297;GO:0015937;GO:0006839;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity;, P:coenzyme A biosynthetic process; P:mitochondrial transport;|P16260 Q8N2U1,Graves disease carrier protein,Graves disease autoantigen;Mitochondrial solute carrier protein homolog;Solute carrier family 25 member 16;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015297;GO:0015937;GO:0006839;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity;, P:coenzyme A biosynthetic process; P:mitochondrial transport;|P16260 Q8N2U1,Graves disease carrier protein,Graves disease autoantigen;Mitochondrial solute carrier protein homolog;Solute carrier family 25 member 16;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015297;GO:0015937;GO:0006839;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity;, P:coenzyme A biosynthetic process; P:mitochondrial transport; scaffold14 indexed_genome mRNA 12199843 12247447 . + . ID=transcript_3584;Q8NFU7 Q5VUP7 Q7Z6B6 Q8TCR1 Q9C0I7,Methylcytosine dioxygenase TET1,CXXC-type zinc finger protein 6;Leukemia-associated protein with a CXXC domain;Ten-eleven translocation 1 gene protein;, PF12851;PF02008;, GO:0005634;GO:0003677;GO:0005506;GO:0008327;GO:0070579;GO:0008270;GO:0006211;GO:0006325;GO:0080111;GO:0001826;GO:0090310;GO:0070989;GO:0008284;GO:0031062;GO:0045944;GO:0006493;GO:0019827;, C:nucleus;, F:DNA binding; F:iron ion binding; F:methyl-CpG binding; F:methylcytosine dioxygenase activity; F:zinc ion binding;, P:5-methylcytosine catabolic process; P:chromatin organization; P:DNA demethylation; P:inner cell mass cell differentiation; P:negative regulation of DNA methylation-dependent heterochromatin assembly; P:oxidative demethylation; P:positive regulation of cell population proliferation; P:positive regulation of histone methylation; P:positive regulation of transcription by RNA polymerase II; P:protein O-linked glycosylation; P:stem cell population maintenance; scaffold14 indexed_genome mRNA 12254168 12301023 . - . ID=transcript_3585;Q6PIZ0 Q6X935 Q9H8N4 Q9NVA7 Q9NVQ0 Q9NWM6,Cell division cycle and apoptosis regulator protein 1,Cell cycle and apoptosis regulatory protein 1;Death inducer with SAP domain;, PF14443;PF14444;PF02037;, GO:0005641;GO:0005654;GO:0005634;GO:0048471;GO:0030374;GO:0003723;GO:0000978;GO:0003713;GO:0003714;GO:0006915;GO:0007049;GO:0000398;GO:0043065;GO:0030335;GO:0008284;GO:0006355;, C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:apoptotic process; P:cell cycle; P:mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of transcription, DNA-templated;|Q6PIZ0 Q6X935 Q9H8N4 Q9NVA7 Q9NVQ0 Q9NWM6,Cell division cycle and apoptosis regulator protein 1,Cell cycle and apoptosis regulatory protein 1;Death inducer with SAP domain;, PF14443;PF14444;PF02037;, GO:0005641;GO:0005654;GO:0005634;GO:0048471;GO:0030374;GO:0003723;GO:0000978;GO:0003713;GO:0003714;GO:0006915;GO:0007049;GO:0000398;GO:0043065;GO:0030335;GO:0008284;GO:0006355;, C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:apoptotic process; P:cell cycle; P:mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of transcription, DNA-templated;|Q6PIZ0 Q6X935 Q9H8N4 Q9NVA7 Q9NVQ0 Q9NWM6,Cell division cycle and apoptosis regulator protein 1,Cell cycle and apoptosis regulatory protein 1;Death inducer with SAP domain;, PF14443;PF14444;PF02037;, GO:0005641;GO:0005654;GO:0005634;GO:0048471;GO:0030374;GO:0003723;GO:0000978;GO:0003713;GO:0003714;GO:0006915;GO:0007049;GO:0000398;GO:0043065;GO:0030335;GO:0008284;GO:0006355;, C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:apoptotic process; P:cell cycle; P:mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of transcription, DNA-templated;|Q6PIZ0 Q6X935 Q9H8N4 Q9NVA7 Q9NVQ0 Q9NWM6,Cell division cycle and apoptosis regulator protein 1,Cell cycle and apoptosis regulatory protein 1;Death inducer with SAP domain;, PF14443;PF14444;PF02037;, GO:0005641;GO:0005654;GO:0005634;GO:0048471;GO:0030374;GO:0003723;GO:0000978;GO:0003713;GO:0003714;GO:0006915;GO:0007049;GO:0000398;GO:0043065;GO:0030335;GO:0008284;GO:0006355;, C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:apoptotic process; P:cell cycle; P:mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of transcription, DNA-templated;|Q6PIZ0 Q6X935 Q9H8N4 Q9NVA7 Q9NVQ0 Q9NWM6,Cell division cycle and apoptosis regulator protein 1,Cell cycle and apoptosis regulatory protein 1;Death inducer with SAP domain;, PF14443;PF14444;PF02037;, GO:0005641;GO:0005654;GO:0005634;GO:0048471;GO:0030374;GO:0003723;GO:0000978;GO:0003713;GO:0003714;GO:0006915;GO:0007049;GO:0000398;GO:0043065;GO:0030335;GO:0008284;GO:0006355;, C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:apoptotic process; P:cell cycle; P:mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of transcription, DNA-templated;|Q6PIZ0 Q6X935 Q9H8N4 Q9NVA7 Q9NVQ0 Q9NWM6,Cell division cycle and apoptosis regulator protein 1,Cell cycle and apoptosis regulatory protein 1;Death inducer with SAP domain;, PF14443;PF14444;PF02037;, GO:0005641;GO:0005654;GO:0005634;GO:0048471;GO:0030374;GO:0003723;GO:0000978;GO:0003713;GO:0003714;GO:0006915;GO:0007049;GO:0000398;GO:0043065;GO:0030335;GO:0008284;GO:0006355;, C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:apoptotic process; P:cell cycle; P:mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of transcription, DNA-templated;|Q6PIZ0 Q6X935 Q9H8N4 Q9NVA7 Q9NVQ0 Q9NWM6,Cell division cycle and apoptosis regulator protein 1,Cell cycle and apoptosis regulatory protein 1;Death inducer with SAP domain;, PF14443;PF14444;PF02037;, GO:0005641;GO:0005654;GO:0005634;GO:0048471;GO:0030374;GO:0003723;GO:0000978;GO:0003713;GO:0003714;GO:0006915;GO:0007049;GO:0000398;GO:0043065;GO:0030335;GO:0008284;GO:0006355;, C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:apoptotic process; P:cell cycle; P:mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of transcription, DNA-templated; scaffold14 indexed_genome mRNA 12407762 12438021 . + . ID=transcript_3586;Q9BQ39 Q5VX37 Q8WV76 Q9BWI8,ATP-dependent RNA helicase DDX50,DEAD box protein 50;Gu-beta;Nucleolar protein Gu2;, PF00270;PF08152;PF00271;, GO:0016020;GO:0005730;GO:0005886;GO:0005524;GO:0003723;GO:0003724;, C:membrane; C:nucleolus; C:plasma membrane;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q9BQ39 Q5VX37 Q8WV76 Q9BWI8,ATP-dependent RNA helicase DDX50,DEAD box protein 50;Gu-beta;Nucleolar protein Gu2;, PF00270;PF08152;PF00271;, GO:0016020;GO:0005730;GO:0005886;GO:0005524;GO:0003723;GO:0003724;, C:membrane; C:nucleolus; C:plasma membrane;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q9BQ39 Q5VX37 Q8WV76 Q9BWI8,ATP-dependent RNA helicase DDX50,DEAD box protein 50;Gu-beta;Nucleolar protein Gu2;, PF00270;PF08152;PF00271;, GO:0016020;GO:0005730;GO:0005886;GO:0005524;GO:0003723;GO:0003724;, C:membrane; C:nucleolus; C:plasma membrane;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q9BQ39 Q5VX37 Q8WV76 Q9BWI8,ATP-dependent RNA helicase DDX50,DEAD box protein 50;Gu-beta;Nucleolar protein Gu2;, PF00270;PF08152;PF00271;, GO:0016020;GO:0005730;GO:0005886;GO:0005524;GO:0003723;GO:0003724;, C:membrane; C:nucleolus; C:plasma membrane;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q9BQ39 Q5VX37 Q8WV76 Q9BWI8,ATP-dependent RNA helicase DDX50,DEAD box protein 50;Gu-beta;Nucleolar protein Gu2;, PF00270;PF08152;PF00271;, GO:0016020;GO:0005730;GO:0005886;GO:0005524;GO:0003723;GO:0003724;, C:membrane; C:nucleolus; C:plasma membrane;, F:ATP binding; F:RNA binding; F:RNA helicase activity; scaffold14 indexed_genome mRNA 12444856 12468306 . + . ID=transcript_3587;Q9NR30 B2RDL0 Q13436 Q5VX41 Q68D35,Nucleolar RNA helicase 2 {ECO:0000305},DEAD box protein 21;Gu-alpha;Nucleolar RNA helicase Gu;Nucleolar RNA helicase II;RH II/Gu;, PF00270;PF08152;PF00271;, GO:0005694;GO:0005829;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0097322;GO:0005524;GO:0003725;GO:0042802;GO:0035198;GO:0003723;GO:0003724;GO:0019843;GO:0030515;GO:0051607;GO:0045087;GO:0001649;GO:0045815;GO:0043123;GO:0002735;GO:0062176;GO:0043330;GO:0006364;GO:0006366;, C:chromosome; C:cytosol; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:7SK snRNA binding; F:ATP binding; F:double-stranded RNA binding; F:identical protein binding; F:miRNA binding; F:RNA binding; F:RNA helicase activity; F:rRNA binding; F:snoRNA binding;, P:defense response to virus; P:innate immune response; P:osteoblast differentiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of myeloid dendritic cell cytokine production; P:R-loop disassembly; P:response to exogenous dsRNA; P:rRNA processing; P:transcription by RNA polymerase II; scaffold14 indexed_genome mRNA 12473729 12533760 . + . ID=transcript_3588;Q96EK5 A8K5M8 Q9BR89 Q9ULE1 Q9Y428,KIF-binding protein,KIF1-binding protein {ECO:0000305|PubMed:16225668};Kinesin family binding protein {ECO:0000312|HGNC:HGNC:23419};, PF12309;, GO:0005856;GO:0005739;GO:0019894;GO:0030154;GO:0006839;GO:0007399;, C:cytoskeleton; C:mitochondrion;, F:kinesin binding;, P:cell differentiation; P:mitochondrial transport; P:nervous system development;|Q96EK5 A8K5M8 Q9BR89 Q9ULE1 Q9Y428,KIF-binding protein,KIF1-binding protein {ECO:0000305|PubMed:16225668};Kinesin family binding protein {ECO:0000312|HGNC:HGNC:23419};, PF12309;, GO:0005856;GO:0005739;GO:0019894;GO:0030154;GO:0006839;GO:0007399;, C:cytoskeleton; C:mitochondrion;, F:kinesin binding;, P:cell differentiation; P:mitochondrial transport; P:nervous system development;|Q96EK5 A8K5M8 Q9BR89 Q9ULE1 Q9Y428,KIF-binding protein,KIF1-binding protein {ECO:0000305|PubMed:16225668};Kinesin family binding protein {ECO:0000312|HGNC:HGNC:23419};, PF12309;, GO:0005856;GO:0005739;GO:0019894;GO:0030154;GO:0006839;GO:0007399;, C:cytoskeleton; C:mitochondrion;, F:kinesin binding;, P:cell differentiation; P:mitochondrial transport; P:nervous system development;|Q96EK5 A8K5M8 Q9BR89 Q9ULE1 Q9Y428,KIF-binding protein,KIF1-binding protein {ECO:0000305|PubMed:16225668};Kinesin family binding protein {ECO:0000312|HGNC:HGNC:23419};, PF12309;, GO:0005856;GO:0005739;GO:0019894;GO:0030154;GO:0006839;GO:0007399;, C:cytoskeleton; C:mitochondrion;, F:kinesin binding;, P:cell differentiation; P:mitochondrial transport; P:nervous system development; scaffold14 indexed_genome mRNA 12549058 12561193 . - . ID=transcript_3589;B6SEH9,Endogenous retrovirus group V member 2 Env polyprotein,HERV-V_19q13.41 provirus ancestral Env polyprotein 2;, PF00429;, GO:0016021;, C:integral component of membrane; scaffold14 indexed_genome mRNA 12676999 12692226 . + . ID=transcript_3590;P10124 B2R4L7 Q5VW06,Serglycin,Hematopoietic proteoglycan core protein;Platelet proteoglycan core protein;Secretory granule proteoglycan core protein;, PF04360;, GO:0005576;GO:0005615;GO:0098978;GO:0005794;GO:0042629;GO:0031093;GO:0099091;GO:0098685;GO:0030141;GO:0006915;GO:0031214;GO:0140507;GO:0033382;GO:0033373;GO:0033364;GO:0050804;GO:0030502;GO:0001818;GO:0002576;GO:0016485;GO:0099175;GO:0033363;GO:0033371;, C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:Golgi apparatus; C:mast cell granule; C:platelet alpha granule lumen; C:postsynaptic specialization, intracellular component; C:Schaffer collateral - CA1 synapse; C:secretory granule;, , P:apoptotic process; P:biomineral tissue development; P:granzyme-mediated programmed cell death signaling pathway; P:maintenance of granzyme B location in T cell secretory granule; P:maintenance of protease location in mast cell secretory granule; P:mast cell secretory granule organization; P:modulation of chemical synaptic transmission; P:negative regulation of bone mineralization; P:negative regulation of cytokine production; P:platelet degranulation; P:protein processing; P:regulation of postsynapse organization; P:secretory granule organization; P:T cell secretory granule organization; scaffold14 indexed_genome mRNA 12711281 12746259 . + . ID=transcript_3591;O75436 A8MZ56 B2RDD3 Q8TBH4 Q9H982,Vacuolar protein sorting-associated protein 26A,Vesicle protein sorting 26A;, PF03643;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0005764;GO:0030904;GO:0030906;GO:0097422;GO:0031982;GO:0006886;GO:0016241;GO:0042147;GO:1990126;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:lysosome; C:retromer complex; C:retromer, cargo-selective complex; C:tubular endosome; C:vesicle;, , P:intracellular protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:Wnt signaling pathway;|O75436 A8MZ56 B2RDD3 Q8TBH4 Q9H982,Vacuolar protein sorting-associated protein 26A,Vesicle protein sorting 26A;, PF03643;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0005764;GO:0030904;GO:0030906;GO:0097422;GO:0031982;GO:0006886;GO:0016241;GO:0042147;GO:1990126;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:lysosome; C:retromer complex; C:retromer, cargo-selective complex; C:tubular endosome; C:vesicle;, , P:intracellular protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:Wnt signaling pathway;|O75436 A8MZ56 B2RDD3 Q8TBH4 Q9H982,Vacuolar protein sorting-associated protein 26A,Vesicle protein sorting 26A;, PF03643;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0005764;GO:0030904;GO:0030906;GO:0097422;GO:0031982;GO:0006886;GO:0016241;GO:0042147;GO:1990126;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:lysosome; C:retromer complex; C:retromer, cargo-selective complex; C:tubular endosome; C:vesicle;, , P:intracellular protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:Wnt signaling pathway;|O75436 A8MZ56 B2RDD3 Q8TBH4 Q9H982,Vacuolar protein sorting-associated protein 26A,Vesicle protein sorting 26A;, PF03643;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0005764;GO:0030904;GO:0030906;GO:0097422;GO:0031982;GO:0006886;GO:0016241;GO:0042147;GO:1990126;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:lysosome; C:retromer complex; C:retromer, cargo-selective complex; C:tubular endosome; C:vesicle;, , P:intracellular protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:Wnt signaling pathway; scaffold14 indexed_genome mRNA 12749592 12773129 . + . ID=transcript_3592;Q8IYB8 A8K301 O43630,ATP-dependent RNA helicase SUPV3L1, mitochondrial,Suppressor of var1 3-like protein 1;, PF00271;PF12513;PF18147;PF18114;, GO:0045025;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0034458;GO:0005524;GO:0003677;GO:0003678;GO:0003725;GO:0004386;GO:0042803;GO:0003723;GO:0003724;GO:0070827;GO:0032508;GO:0006310;GO:0000958;GO:0035946;GO:0035945;GO:0000965;GO:2000827;GO:0070584;GO:0043066;GO:0030307;GO:0000962;GO:0006401;, C:mitochondrial degradosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:3'-5' RNA helicase activity; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:double-stranded RNA binding; F:helicase activity; F:protein homodimerization activity; F:RNA binding; F:RNA helicase activity;, P:chromatin maintenance; P:DNA duplex unwinding; P:DNA recombination; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA surveillance; P:mitochondrial ncRNA surveillance; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA surveillance; P:mitochondrion morphogenesis; P:negative regulation of apoptotic process; P:positive regulation of cell growth; P:positive regulation of mitochondrial RNA catabolic process; P:RNA catabolic process;|Q8IYB8 A8K301 O43630,ATP-dependent RNA helicase SUPV3L1, mitochondrial,Suppressor of var1 3-like protein 1;, PF00271;PF12513;PF18147;PF18114;, GO:0045025;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0034458;GO:0005524;GO:0003677;GO:0003678;GO:0003725;GO:0004386;GO:0042803;GO:0003723;GO:0003724;GO:0070827;GO:0032508;GO:0006310;GO:0000958;GO:0035946;GO:0035945;GO:0000965;GO:2000827;GO:0070584;GO:0043066;GO:0030307;GO:0000962;GO:0006401;, C:mitochondrial degradosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:3'-5' RNA helicase activity; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:double-stranded RNA binding; F:helicase activity; F:protein homodimerization activity; F:RNA binding; F:RNA helicase activity;, P:chromatin maintenance; P:DNA duplex unwinding; P:DNA recombination; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA surveillance; P:mitochondrial ncRNA surveillance; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA surveillance; P:mitochondrion morphogenesis; P:negative regulation of apoptotic process; P:positive regulation of cell growth; P:positive regulation of mitochondrial RNA catabolic process; P:RNA catabolic process;|Q8IYB8 A8K301 O43630,ATP-dependent RNA helicase SUPV3L1, mitochondrial,Suppressor of var1 3-like protein 1;, PF00271;PF12513;PF18147;PF18114;, GO:0045025;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0034458;GO:0005524;GO:0003677;GO:0003678;GO:0003725;GO:0004386;GO:0042803;GO:0003723;GO:0003724;GO:0070827;GO:0032508;GO:0006310;GO:0000958;GO:0035946;GO:0035945;GO:0000965;GO:2000827;GO:0070584;GO:0043066;GO:0030307;GO:0000962;GO:0006401;, C:mitochondrial degradosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:3'-5' RNA helicase activity; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:double-stranded RNA binding; F:helicase activity; F:protein homodimerization activity; F:RNA binding; F:RNA helicase activity;, P:chromatin maintenance; P:DNA duplex unwinding; P:DNA recombination; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA surveillance; P:mitochondrial ncRNA surveillance; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA surveillance; P:mitochondrion morphogenesis; P:negative regulation of apoptotic process; P:positive regulation of cell growth; P:positive regulation of mitochondrial RNA catabolic process; P:RNA catabolic process;|Q8IYB8 A8K301 O43630,ATP-dependent RNA helicase SUPV3L1, mitochondrial,Suppressor of var1 3-like protein 1;, PF00271;PF12513;PF18147;PF18114;, GO:0045025;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0034458;GO:0005524;GO:0003677;GO:0003678;GO:0003725;GO:0004386;GO:0042803;GO:0003723;GO:0003724;GO:0070827;GO:0032508;GO:0006310;GO:0000958;GO:0035946;GO:0035945;GO:0000965;GO:2000827;GO:0070584;GO:0043066;GO:0030307;GO:0000962;GO:0006401;, C:mitochondrial degradosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:3'-5' RNA helicase activity; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:double-stranded RNA binding; F:helicase activity; F:protein homodimerization activity; F:RNA binding; F:RNA helicase activity;, P:chromatin maintenance; P:DNA duplex unwinding; P:DNA recombination; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA surveillance; P:mitochondrial ncRNA surveillance; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA surveillance; P:mitochondrion morphogenesis; P:negative regulation of apoptotic process; P:positive regulation of cell growth; P:positive regulation of mitochondrial RNA catabolic process; P:RNA catabolic process;|Q8IYB8 A8K301 O43630,ATP-dependent RNA helicase SUPV3L1, mitochondrial,Suppressor of var1 3-like protein 1;, PF00271;PF12513;PF18147;PF18114;, GO:0045025;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0034458;GO:0005524;GO:0003677;GO:0003678;GO:0003725;GO:0004386;GO:0042803;GO:0003723;GO:0003724;GO:0070827;GO:0032508;GO:0006310;GO:0000958;GO:0035946;GO:0035945;GO:0000965;GO:2000827;GO:0070584;GO:0043066;GO:0030307;GO:0000962;GO:0006401;, C:mitochondrial degradosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:3'-5' RNA helicase activity; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:double-stranded RNA binding; F:helicase activity; F:protein homodimerization activity; F:RNA binding; F:RNA helicase activity;, P:chromatin maintenance; P:DNA duplex unwinding; P:DNA recombination; P:mitochondrial mRNA catabolic process; P:mitochondrial mRNA surveillance; P:mitochondrial ncRNA surveillance; P:mitochondrial RNA 3'-end processing; P:mitochondrial RNA surveillance; P:mitochondrion morphogenesis; P:negative regulation of apoptotic process; P:positive regulation of cell growth; P:positive regulation of mitochondrial RNA catabolic process; P:RNA catabolic process; scaffold14 indexed_genome mRNA 12805192 12817747 . + . ID=transcript_3593;Q2TB90 B5MDN9 Q2TB91 Q5VTC7 Q7Z373 Q8WU37 Q96EH2 Q9H5Y9,Hexokinase HKDC1 {ECO:0000305},Hexokinase domain-containing protein 1 {ECO:0000305};, PF00349;PF03727;, GO:0005829;GO:0031966;GO:0005739;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0019158;GO:0001678;GO:0051156;GO:0006096;GO:0019318;, C:cytosol; C:mitochondrial membrane; C:mitochondrion;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:mannokinase activity;, P:cellular glucose homeostasis; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:hexose metabolic process; scaffold14 indexed_genome mRNA 12819281 12826951 . + . ID=transcript_3594;Q2TB90 B5MDN9 Q2TB91 Q5VTC7 Q7Z373 Q8WU37 Q96EH2 Q9H5Y9,Hexokinase HKDC1 {ECO:0000305},Hexokinase domain-containing protein 1 {ECO:0000305};, PF00349;PF03727;, GO:0005829;GO:0031966;GO:0005739;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0019158;GO:0001678;GO:0051156;GO:0006096;GO:0019318;, C:cytosol; C:mitochondrial membrane; C:mitochondrion;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:mannokinase activity;, P:cellular glucose homeostasis; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:hexose metabolic process;|Q2TB90 B5MDN9 Q2TB91 Q5VTC7 Q7Z373 Q8WU37 Q96EH2 Q9H5Y9,Hexokinase HKDC1 {ECO:0000305},Hexokinase domain-containing protein 1 {ECO:0000305};, PF00349;PF03727;, GO:0005829;GO:0031966;GO:0005739;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0019158;GO:0001678;GO:0051156;GO:0006096;GO:0019318;, C:cytosol; C:mitochondrial membrane; C:mitochondrion;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:mannokinase activity;, P:cellular glucose homeostasis; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:hexose metabolic process; scaffold14 indexed_genome mRNA 12891671 12959935 . + . ID=transcript_3595;P19367 E9PCK0 O43443 O43444 O75574 Q5VTC3 Q96HC8 Q9NNZ4 Q9NNZ5,Hexokinase-1 {ECO:0000305},Brain form hexokinase {ECO:0000303|PubMed:8706938};Hexokinase type I {ECO:0000303|PubMed:9531504};Hexokinase-A {ECO:0000250|UniProtKB:P05708};, PF00349;PF03727;, GO:0005829;GO:0045121;GO:0005741;GO:0005739;GO:0005524;GO:0008865;GO:0004340;GO:0047931;GO:0005536;GO:0004396;GO:0019158;GO:0042834;GO:0061621;GO:0046835;GO:0001678;GO:0072655;GO:0006002;GO:0051156;GO:0006096;GO:0006954;GO:0045087;GO:0072656;GO:0006013;GO:0002720;GO:0032731;, C:cytosol; C:membrane raft; C:mitochondrial outer membrane; C:mitochondrion;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucosamine kinase activity; F:glucose binding; F:hexokinase activity; F:mannokinase activity; F:peptidoglycan binding;, P:canonical glycolysis; P:carbohydrate phosphorylation; P:cellular glucose homeostasis; P:establishment of protein localization to mitochondrion; P:fructose 6-phosphate metabolic process; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:inflammatory response; P:innate immune response; P:maintenance of protein location in mitochondrion; P:mannose metabolic process; P:positive regulation of cytokine production involved in immune response; P:positive regulation of interleukin-1 beta production;|P19367 E9PCK0 O43443 O43444 O75574 Q5VTC3 Q96HC8 Q9NNZ4 Q9NNZ5,Hexokinase-1 {ECO:0000305},Brain form hexokinase {ECO:0000303|PubMed:8706938};Hexokinase type I {ECO:0000303|PubMed:9531504};Hexokinase-A {ECO:0000250|UniProtKB:P05708};, PF00349;PF03727;, GO:0005829;GO:0045121;GO:0005741;GO:0005739;GO:0005524;GO:0008865;GO:0004340;GO:0047931;GO:0005536;GO:0004396;GO:0019158;GO:0042834;GO:0061621;GO:0046835;GO:0001678;GO:0072655;GO:0006002;GO:0051156;GO:0006096;GO:0006954;GO:0045087;GO:0072656;GO:0006013;GO:0002720;GO:0032731;, C:cytosol; C:membrane raft; C:mitochondrial outer membrane; C:mitochondrion;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucosamine kinase activity; F:glucose binding; F:hexokinase activity; F:mannokinase activity; F:peptidoglycan binding;, P:canonical glycolysis; P:carbohydrate phosphorylation; P:cellular glucose homeostasis; P:establishment of protein localization to mitochondrion; P:fructose 6-phosphate metabolic process; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:inflammatory response; P:innate immune response; P:maintenance of protein location in mitochondrion; P:mannose metabolic process; P:positive regulation of cytokine production involved in immune response; P:positive regulation of interleukin-1 beta production;|P19367 E9PCK0 O43443 O43444 O75574 Q5VTC3 Q96HC8 Q9NNZ4 Q9NNZ5,Hexokinase-1 {ECO:0000305},Brain form hexokinase {ECO:0000303|PubMed:8706938};Hexokinase type I {ECO:0000303|PubMed:9531504};Hexokinase-A {ECO:0000250|UniProtKB:P05708};, PF00349;PF03727;, GO:0005829;GO:0045121;GO:0005741;GO:0005739;GO:0005524;GO:0008865;GO:0004340;GO:0047931;GO:0005536;GO:0004396;GO:0019158;GO:0042834;GO:0061621;GO:0046835;GO:0001678;GO:0072655;GO:0006002;GO:0051156;GO:0006096;GO:0006954;GO:0045087;GO:0072656;GO:0006013;GO:0002720;GO:0032731;, C:cytosol; C:membrane raft; C:mitochondrial outer membrane; C:mitochondrion;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucosamine kinase activity; F:glucose binding; F:hexokinase activity; F:mannokinase activity; F:peptidoglycan binding;, P:canonical glycolysis; P:carbohydrate phosphorylation; P:cellular glucose homeostasis; P:establishment of protein localization to mitochondrion; P:fructose 6-phosphate metabolic process; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:inflammatory response; P:innate immune response; P:maintenance of protein location in mitochondrion; P:mannose metabolic process; P:positive regulation of cytokine production involved in immune response; P:positive regulation of interleukin-1 beta production; scaffold14 indexed_genome mRNA 13009390 13061996 . + . ID=transcript_3596;O95858 Q6UW79,Tetraspanin-15,Tetraspan NET-7;Transmembrane 4 superfamily member 15;, PF00335;, GO:0030054;GO:0009986;GO:0005829;GO:0005788;GO:0005887;GO:0043231;GO:0031902;GO:0016604;GO:0005886;GO:0097197;GO:0019899;GO:1990000;GO:0045746;GO:0072659;GO:0051604;, C:cell junction; C:cell surface; C:cytosol; C:endoplasmic reticulum lumen; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:nuclear body; C:plasma membrane; C:tetraspanin-enriched microdomain;, F:enzyme binding;, P:amyloid fibril formation; P:negative regulation of Notch signaling pathway; P:protein localization to plasma membrane; P:protein maturation; scaffold14 indexed_genome mRNA 13146280 13149231 . + . ID=transcript_3597;Q96D05,Protein FAM241B {ECO:0000305},, PF15378;, GO:0016021;GO:0043231;, C:integral component of membrane; C:intracellular membrane-bounded organelle; scaffold14 indexed_genome mRNA 13298139 13448250 . + . ID=transcript_3598;Q5TAT4 Q5TAT5 Q7KZ33 Q7KZ49 Q99228 Q9NQ52,Collagen alpha-1(XIII) chain,COLXIIIA1;, PF01391;, GO:0005911;GO:0005581;GO:0005600;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005886;GO:0045211;GO:0005201;GO:0008201;GO:0030154;GO:0098609;GO:0007160;GO:0030574;GO:0030199;GO:0001958;GO:0030198;GO:0001763;GO:0030903;GO:0001501;, C:cell-cell junction; C:collagen trimer; C:collagen type XIII trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:plasma membrane; C:postsynaptic membrane;, F:extracellular matrix structural constituent; F:heparin binding;, P:cell differentiation; P:cell-cell adhesion; P:cell-matrix adhesion; P:collagen catabolic process; P:collagen fibril organization; P:endochondral ossification; P:extracellular matrix organization; P:morphogenesis of a branching structure; P:notochord development; P:skeletal system development; scaffold14 indexed_genome mRNA 13492410 13551715 . + . ID=transcript_3599;Q9P0M6 Q5SQT2,Core histone macro-H2A.2,, PF00125;PF16211;PF01661;, GO:0001740;GO:0000785;GO:0000781;GO:0070062;GO:0005654;GO:0000786;GO:0031490;GO:0003677;GO:0046982;GO:0000977;GO:0000976;GO:0007420;GO:0006342;GO:0007549;GO:0071169;GO:0045814;GO:0000122;GO:1901837;GO:0006334;GO:0045618;, C:Barr body; C:chromatin; C:chromosome, telomeric region; C:extracellular exosome; C:nucleoplasm; C:nucleosome;, F:chromatin DNA binding; F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:chromatin silencing; P:dosage compensation; P:establishment of protein localization to chromatin; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:nucleosome assembly; P:positive regulation of keratinocyte differentiation;|Q9P0M6 Q5SQT2,Core histone macro-H2A.2,, PF00125;PF16211;PF01661;, GO:0001740;GO:0000785;GO:0000781;GO:0070062;GO:0005654;GO:0000786;GO:0031490;GO:0003677;GO:0046982;GO:0000977;GO:0000976;GO:0007420;GO:0006342;GO:0007549;GO:0071169;GO:0045814;GO:0000122;GO:1901837;GO:0006334;GO:0045618;, C:Barr body; C:chromatin; C:chromosome, telomeric region; C:extracellular exosome; C:nucleoplasm; C:nucleosome;, F:chromatin DNA binding; F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:chromatin silencing; P:dosage compensation; P:establishment of protein localization to chromatin; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:nucleosome assembly; P:positive regulation of keratinocyte differentiation;|Q9P0M6 Q5SQT2,Core histone macro-H2A.2,, PF00125;PF16211;PF01661;, GO:0001740;GO:0000785;GO:0000781;GO:0070062;GO:0005654;GO:0000786;GO:0031490;GO:0003677;GO:0046982;GO:0000977;GO:0000976;GO:0007420;GO:0006342;GO:0007549;GO:0071169;GO:0045814;GO:0000122;GO:1901837;GO:0006334;GO:0045618;, C:Barr body; C:chromatin; C:chromosome, telomeric region; C:extracellular exosome; C:nucleoplasm; C:nucleosome;, F:chromatin DNA binding; F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:chromatin silencing; P:dosage compensation; P:establishment of protein localization to chromatin; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:nucleosome assembly; P:positive regulation of keratinocyte differentiation;|Q4G0J3 B2ZHN6 Q3B7A9 Q9P1S7 Q9Y3Z8,La-related protein 7 {ECO:0000303|PubMed:18483487},La ribonucleoprotein domain family member 7 {ECO:0000303|PubMed:18483487};P-TEFb-interaction protein for 7SK stability {ECO:0000303|PubMed:18249148};, PF05383;PF00076;PF08777;, GO:0120259;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0097322;GO:0003723;GO:0017070;GO:0000494;GO:0030154;GO:0006397;GO:0000122;GO:0034244;GO:0032897;GO:1904871;GO:1905382;GO:0048024;GO:0008380;GO:0007283;GO:1990438;, C:7SK snRNP; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:RNA binding; F:U6 snRNA binding;, P:box C/D RNA 3'-end processing; P:cell differentiation; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of viral transcription; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; P:U6 2'-O-snRNA methylation;|Q9P0M6 Q5SQT2,Core histone macro-H2A.2,, PF00125;PF16211;PF01661;, GO:0001740;GO:0000785;GO:0000781;GO:0070062;GO:0005654;GO:0000786;GO:0031490;GO:0003677;GO:0046982;GO:0000977;GO:0000976;GO:0007420;GO:0006342;GO:0007549;GO:0071169;GO:0045814;GO:0000122;GO:1901837;GO:0006334;GO:0045618;, C:Barr body; C:chromatin; C:chromosome, telomeric region; C:extracellular exosome; C:nucleoplasm; C:nucleosome;, F:chromatin DNA binding; F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:chromatin silencing; P:dosage compensation; P:establishment of protein localization to chromatin; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:nucleosome assembly; P:positive regulation of keratinocyte differentiation;|Q9P0M6 Q5SQT2,Core histone macro-H2A.2,, PF00125;PF16211;PF01661;, GO:0001740;GO:0000785;GO:0000781;GO:0070062;GO:0005654;GO:0000786;GO:0031490;GO:0003677;GO:0046982;GO:0000977;GO:0000976;GO:0007420;GO:0006342;GO:0007549;GO:0071169;GO:0045814;GO:0000122;GO:1901837;GO:0006334;GO:0045618;, C:Barr body; C:chromatin; C:chromosome, telomeric region; C:extracellular exosome; C:nucleoplasm; C:nucleosome;, F:chromatin DNA binding; F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:chromatin silencing; P:dosage compensation; P:establishment of protein localization to chromatin; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:nucleosome assembly; P:positive regulation of keratinocyte differentiation;|Q9BRQ8 B3KXI0 Q63Z39,Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900},Apoptosis-inducing factor homologous mitochondrion-associated inducer of death {ECO:0000303|PubMed:11980907};p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};, PF07992;, GO:0005737;GO:0005829;GO:0005615;GO:0016021;GO:0005811;GO:0005741;GO:0005739;GO:0005634;GO:0005886;GO:0003677;GO:0004174;GO:0050660;GO:0016655;GO:0008637;GO:0110076;GO:0043065;GO:0042981;GO:1900407;GO:0006743;, C:cytoplasm; C:cytosol; C:extracellular space; C:integral component of membrane; C:lipid droplet; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:plasma membrane;, F:DNA binding; F:electron-transferring-flavoprotein dehydrogenase activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;, P:apoptotic mitochondrial changes; P:negative regulation of ferroptosis; P:positive regulation of apoptotic process; P:regulation of apoptotic process; P:regulation of cellular response to oxidative stress; P:ubiquinone metabolic process;|Q9BRQ8 B3KXI0 Q63Z39,Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900},Apoptosis-inducing factor homologous mitochondrion-associated inducer of death {ECO:0000303|PubMed:11980907};p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};, PF07992;, GO:0005737;GO:0005829;GO:0005615;GO:0016021;GO:0005811;GO:0005741;GO:0005739;GO:0005634;GO:0005886;GO:0003677;GO:0004174;GO:0050660;GO:0016655;GO:0008637;GO:0110076;GO:0043065;GO:0042981;GO:1900407;GO:0006743;, C:cytoplasm; C:cytosol; C:extracellular space; C:integral component of membrane; C:lipid droplet; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:plasma membrane;, F:DNA binding; F:electron-transferring-flavoprotein dehydrogenase activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;, P:apoptotic mitochondrial changes; P:negative regulation of ferroptosis; P:positive regulation of apoptotic process; P:regulation of apoptotic process; P:regulation of cellular response to oxidative stress; P:ubiquinone metabolic process; scaffold14 indexed_genome mRNA 13554248 13556746 . - . ID=transcript_3600;Q9BRQ8 B3KXI0 Q63Z39,Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900},Apoptosis-inducing factor homologous mitochondrion-associated inducer of death {ECO:0000303|PubMed:11980907};p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};, PF07992;, GO:0005737;GO:0005829;GO:0005615;GO:0016021;GO:0005811;GO:0005741;GO:0005739;GO:0005634;GO:0005886;GO:0003677;GO:0004174;GO:0050660;GO:0016655;GO:0008637;GO:0110076;GO:0043065;GO:0042981;GO:1900407;GO:0006743;, C:cytoplasm; C:cytosol; C:extracellular space; C:integral component of membrane; C:lipid droplet; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:plasma membrane;, F:DNA binding; F:electron-transferring-flavoprotein dehydrogenase activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;, P:apoptotic mitochondrial changes; P:negative regulation of ferroptosis; P:positive regulation of apoptotic process; P:regulation of apoptotic process; P:regulation of cellular response to oxidative stress; P:ubiquinone metabolic process; scaffold14 indexed_genome mRNA 13568684 13604315 . - . ID=transcript_3601;Q9NR31 B4DQ19,GTP-binding protein SAR1a,COPII-associated small GTPase;, PF00025;, GO:0030127;GO:0070971;GO:0005794;GO:0005525;GO:0003924;GO:0090110;GO:0006888;GO:0006886;GO:0061024;GO:0070863;GO:0003400;GO:0016050;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:Golgi apparatus;, F:GTP binding; F:GTPase activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane organization; P:positive regulation of protein exit from endoplasmic reticulum; P:regulation of COPII vesicle coating; P:vesicle organization;|Q2T9J0 Q5SQT4 Q5SQU1 Q8N6H2 Q96AR5,Peroxisomal leader peptide-processing protease,Trypsin domain-containing protein 1;, , GO:0005829;GO:0016020;GO:0005782;GO:0005777;GO:0042802;GO:0002020;GO:0004252;GO:0008104;GO:0016485;GO:0006508;GO:0031998;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisome;, F:identical protein binding; F:protease binding; F:serine-type endopeptidase activity;, P:protein localization; P:protein processing; P:proteolysis; P:regulation of fatty acid beta-oxidation;|Q9NR31 B4DQ19,GTP-binding protein SAR1a,COPII-associated small GTPase;, PF00025;, GO:0030127;GO:0070971;GO:0005794;GO:0005525;GO:0003924;GO:0090110;GO:0006888;GO:0006886;GO:0061024;GO:0070863;GO:0003400;GO:0016050;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:Golgi apparatus;, F:GTP binding; F:GTPase activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane organization; P:positive regulation of protein exit from endoplasmic reticulum; P:regulation of COPII vesicle coating; P:vesicle organization; scaffold14 indexed_genome mRNA 13624910 13656837 . - . ID=transcript_3602;Q15181 Q2M348 Q5SQT7 Q6P7P4 Q9UQJ5 Q9Y5B1,Inorganic pyrophosphatase,Pyrophosphate phospho-hydrolase;, PF00719;, GO:0005737;GO:0005829;GO:0070062;GO:0004427;GO:0000287;GO:0071344;GO:0006796;GO:0006418;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:inorganic diphosphatase activity; F:magnesium ion binding;, P:diphosphate metabolic process; P:phosphate-containing compound metabolic process; P:tRNA aminoacylation for protein translation;|Q15181 Q2M348 Q5SQT7 Q6P7P4 Q9UQJ5 Q9Y5B1,Inorganic pyrophosphatase,Pyrophosphate phospho-hydrolase;, PF00719;, GO:0005737;GO:0005829;GO:0070062;GO:0004427;GO:0000287;GO:0071344;GO:0006796;GO:0006418;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:inorganic diphosphatase activity; F:magnesium ion binding;, P:diphosphate metabolic process; P:phosphate-containing compound metabolic process; P:tRNA aminoacylation for protein translation;|Q15181 Q2M348 Q5SQT7 Q6P7P4 Q9UQJ5 Q9Y5B1,Inorganic pyrophosphatase,Pyrophosphate phospho-hydrolase;, PF00719;, GO:0005737;GO:0005829;GO:0070062;GO:0004427;GO:0000287;GO:0071344;GO:0006796;GO:0006418;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:inorganic diphosphatase activity; F:magnesium ion binding;, P:diphosphate metabolic process; P:phosphate-containing compound metabolic process; P:tRNA aminoacylation for protein translation;|Q15181 Q2M348 Q5SQT7 Q6P7P4 Q9UQJ5 Q9Y5B1,Inorganic pyrophosphatase,Pyrophosphate phospho-hydrolase;, PF00719;, GO:0005737;GO:0005829;GO:0070062;GO:0004427;GO:0000287;GO:0071344;GO:0006796;GO:0006418;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:inorganic diphosphatase activity; F:magnesium ion binding;, P:diphosphate metabolic process; P:phosphate-containing compound metabolic process; P:tRNA aminoacylation for protein translation; scaffold14 indexed_genome mRNA 13708367 13785706 . - . ID=transcript_3603;Q8TCA0 Q5T6D4 Q5T6D6 Q9NVA6 Q9NVG3,Leucine-rich repeat-containing protein 20,, PF00560;PF13855; scaffold14 indexed_genome mRNA 13935410 13968693 . + . ID=transcript_3604;Q9ULE6 B2RMS1 B9EGC6 Q5JTK7 Q5JTK8,Paladin,, , GO:0005737;GO:0005829;GO:0004725;, C:cytoplasm; C:cytosol;, F:protein tyrosine phosphatase activity;|Q9ULE6 B2RMS1 B9EGC6 Q5JTK7 Q5JTK8,Paladin,, , GO:0005737;GO:0005829;GO:0004725;, C:cytoplasm; C:cytosol;, F:protein tyrosine phosphatase activity;|Q9ULE6 B2RMS1 B9EGC6 Q5JTK7 Q5JTK8,Paladin,, , GO:0005737;GO:0005829;GO:0004725;, C:cytoplasm; C:cytosol;, F:protein tyrosine phosphatase activity;|Q9ULE6 B2RMS1 B9EGC6 Q5JTK7 Q5JTK8,Paladin,, , GO:0005737;GO:0005829;GO:0004725;, C:cytoplasm; C:cytosol;, F:protein tyrosine phosphatase activity;|Q9ULE6 B2RMS1 B9EGC6 Q5JTK7 Q5JTK8,Paladin,, , GO:0005737;GO:0005829;GO:0004725;, C:cytoplasm; C:cytosol;, F:protein tyrosine phosphatase activity;|Q9ULE6 B2RMS1 B9EGC6 Q5JTK7 Q5JTK8,Paladin,, , GO:0005737;GO:0005829;GO:0004725;, C:cytoplasm; C:cytosol;, F:protein tyrosine phosphatase activity; scaffold14 indexed_genome mRNA 13992249 13993947 . - . ID=transcript_3605;P14222 B2R6X4 Q59F57 Q86WX7,Perforin-1,Cytolysin;Lymphocyte pore-forming protein;, PF00168;PF01823;, GO:0044194;GO:0005829;GO:0031904;GO:0005576;GO:0016021;GO:0016020;GO:0005886;GO:0005509;GO:0042802;GO:0022829;GO:0006915;GO:0006968;GO:0019835;GO:0002357;GO:0051607;GO:0002418;GO:0001771;GO:0051712;GO:0051260;GO:0001913;, C:cytolytic granule; C:cytosol; C:endosome lumen; C:extracellular region; C:integral component of membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:identical protein binding; F:wide pore channel activity;, P:apoptotic process; P:cellular defense response; P:cytolysis; P:defense response to tumor cell; P:defense response to virus; P:immune response to tumor cell; P:immunological synapse formation; P:positive regulation of killing of cells of other organism; P:protein homooligomerization; P:T cell mediated cytotoxicity; scaffold14 indexed_genome mRNA 14192776 14245830 . + . ID=transcript_3606;O95470 B2RBD4 Q7Z732 Q9ULG8 Q9UN89,Sphingosine-1-phosphate lyase 1 {ECO:0000305},Sphingosine-1-phosphate aldolase;, PF00282;, GO:0005783;GO:0005789;GO:0030176;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0008209;GO:0097190;GO:0006672;GO:0008210;GO:0060325;GO:0006631;GO:0010761;GO:0030097;GO:0001822;GO:0033327;GO:0001553;GO:0048008;GO:0009791;GO:0040014;GO:0060021;GO:0048705;GO:0007283;GO:0030148;GO:0030149;GO:0001570;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:androgen metabolic process; P:apoptotic signaling pathway; P:ceramide metabolic process; P:estrogen metabolic process; P:face morphogenesis; P:fatty acid metabolic process; P:fibroblast migration; P:hemopoiesis; P:kidney development; P:Leydig cell differentiation; P:luteinization; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:regulation of multicellular organism growth; P:roof of mouth development; P:skeletal system morphogenesis; P:spermatogenesis; P:sphingolipid biosynthetic process; P:sphingolipid catabolic process; P:vasculogenesis;|O95470 B2RBD4 Q7Z732 Q9ULG8 Q9UN89,Sphingosine-1-phosphate lyase 1 {ECO:0000305},Sphingosine-1-phosphate aldolase;, PF00282;, GO:0005783;GO:0005789;GO:0030176;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0008209;GO:0097190;GO:0006672;GO:0008210;GO:0060325;GO:0006631;GO:0010761;GO:0030097;GO:0001822;GO:0033327;GO:0001553;GO:0048008;GO:0009791;GO:0040014;GO:0060021;GO:0048705;GO:0007283;GO:0030148;GO:0030149;GO:0001570;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:androgen metabolic process; P:apoptotic signaling pathway; P:ceramide metabolic process; P:estrogen metabolic process; P:face morphogenesis; P:fatty acid metabolic process; P:fibroblast migration; P:hemopoiesis; P:kidney development; P:Leydig cell differentiation; P:luteinization; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:regulation of multicellular organism growth; P:roof of mouth development; P:skeletal system morphogenesis; P:spermatogenesis; P:sphingolipid biosynthetic process; P:sphingolipid catabolic process; P:vasculogenesis;|O95470 B2RBD4 Q7Z732 Q9ULG8 Q9UN89,Sphingosine-1-phosphate lyase 1 {ECO:0000305},Sphingosine-1-phosphate aldolase;, PF00282;, GO:0005783;GO:0005789;GO:0030176;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0008209;GO:0097190;GO:0006672;GO:0008210;GO:0060325;GO:0006631;GO:0010761;GO:0030097;GO:0001822;GO:0033327;GO:0001553;GO:0048008;GO:0009791;GO:0040014;GO:0060021;GO:0048705;GO:0007283;GO:0030148;GO:0030149;GO:0001570;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:androgen metabolic process; P:apoptotic signaling pathway; P:ceramide metabolic process; P:estrogen metabolic process; P:face morphogenesis; P:fatty acid metabolic process; P:fibroblast migration; P:hemopoiesis; P:kidney development; P:Leydig cell differentiation; P:luteinization; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:regulation of multicellular organism growth; P:roof of mouth development; P:skeletal system morphogenesis; P:spermatogenesis; P:sphingolipid biosynthetic process; P:sphingolipid catabolic process; P:vasculogenesis;|O95470 B2RBD4 Q7Z732 Q9ULG8 Q9UN89,Sphingosine-1-phosphate lyase 1 {ECO:0000305},Sphingosine-1-phosphate aldolase;, PF00282;, GO:0005783;GO:0005789;GO:0030176;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0008209;GO:0097190;GO:0006672;GO:0008210;GO:0060325;GO:0006631;GO:0010761;GO:0030097;GO:0001822;GO:0033327;GO:0001553;GO:0048008;GO:0009791;GO:0040014;GO:0060021;GO:0048705;GO:0007283;GO:0030148;GO:0030149;GO:0001570;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:androgen metabolic process; P:apoptotic signaling pathway; P:ceramide metabolic process; P:estrogen metabolic process; P:face morphogenesis; P:fatty acid metabolic process; P:fibroblast migration; P:hemopoiesis; P:kidney development; P:Leydig cell differentiation; P:luteinization; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:regulation of multicellular organism growth; P:roof of mouth development; P:skeletal system morphogenesis; P:spermatogenesis; P:sphingolipid biosynthetic process; P:sphingolipid catabolic process; P:vasculogenesis;|O95470 B2RBD4 Q7Z732 Q9ULG8 Q9UN89,Sphingosine-1-phosphate lyase 1 {ECO:0000305},Sphingosine-1-phosphate aldolase;, PF00282;, GO:0005783;GO:0005789;GO:0030176;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0008209;GO:0097190;GO:0006672;GO:0008210;GO:0060325;GO:0006631;GO:0010761;GO:0030097;GO:0001822;GO:0033327;GO:0001553;GO:0048008;GO:0009791;GO:0040014;GO:0060021;GO:0048705;GO:0007283;GO:0030148;GO:0030149;GO:0001570;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:androgen metabolic process; P:apoptotic signaling pathway; P:ceramide metabolic process; P:estrogen metabolic process; P:face morphogenesis; P:fatty acid metabolic process; P:fibroblast migration; P:hemopoiesis; P:kidney development; P:Leydig cell differentiation; P:luteinization; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:regulation of multicellular organism growth; P:roof of mouth development; P:skeletal system morphogenesis; P:spermatogenesis; P:sphingolipid biosynthetic process; P:sphingolipid catabolic process; P:vasculogenesis;|O95470 B2RBD4 Q7Z732 Q9ULG8 Q9UN89,Sphingosine-1-phosphate lyase 1 {ECO:0000305},Sphingosine-1-phosphate aldolase;, PF00282;, GO:0005783;GO:0005789;GO:0030176;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0008209;GO:0097190;GO:0006672;GO:0008210;GO:0060325;GO:0006631;GO:0010761;GO:0030097;GO:0001822;GO:0033327;GO:0001553;GO:0048008;GO:0009791;GO:0040014;GO:0060021;GO:0048705;GO:0007283;GO:0030148;GO:0030149;GO:0001570;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:androgen metabolic process; P:apoptotic signaling pathway; P:ceramide metabolic process; P:estrogen metabolic process; P:face morphogenesis; P:fatty acid metabolic process; P:fibroblast migration; P:hemopoiesis; P:kidney development; P:Leydig cell differentiation; P:luteinization; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:regulation of multicellular organism growth; P:roof of mouth development; P:skeletal system morphogenesis; P:spermatogenesis; P:sphingolipid biosynthetic process; P:sphingolipid catabolic process; P:vasculogenesis;|O95470 B2RBD4 Q7Z732 Q9ULG8 Q9UN89,Sphingosine-1-phosphate lyase 1 {ECO:0000305},Sphingosine-1-phosphate aldolase;, PF00282;, GO:0005783;GO:0005789;GO:0030176;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0008209;GO:0097190;GO:0006672;GO:0008210;GO:0060325;GO:0006631;GO:0010761;GO:0030097;GO:0001822;GO:0033327;GO:0001553;GO:0048008;GO:0009791;GO:0040014;GO:0060021;GO:0048705;GO:0007283;GO:0030148;GO:0030149;GO:0001570;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:androgen metabolic process; P:apoptotic signaling pathway; P:ceramide metabolic process; P:estrogen metabolic process; P:face morphogenesis; P:fatty acid metabolic process; P:fibroblast migration; P:hemopoiesis; P:kidney development; P:Leydig cell differentiation; P:luteinization; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:regulation of multicellular organism growth; P:roof of mouth development; P:skeletal system morphogenesis; P:spermatogenesis; P:sphingolipid biosynthetic process; P:sphingolipid catabolic process; P:vasculogenesis;|O95470 B2RBD4 Q7Z732 Q9ULG8 Q9UN89,Sphingosine-1-phosphate lyase 1 {ECO:0000305},Sphingosine-1-phosphate aldolase;, PF00282;, GO:0005783;GO:0005789;GO:0030176;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0008209;GO:0097190;GO:0006672;GO:0008210;GO:0060325;GO:0006631;GO:0010761;GO:0030097;GO:0001822;GO:0033327;GO:0001553;GO:0048008;GO:0009791;GO:0040014;GO:0060021;GO:0048705;GO:0007283;GO:0030148;GO:0030149;GO:0001570;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:androgen metabolic process; P:apoptotic signaling pathway; P:ceramide metabolic process; P:estrogen metabolic process; P:face morphogenesis; P:fatty acid metabolic process; P:fibroblast migration; P:hemopoiesis; P:kidney development; P:Leydig cell differentiation; P:luteinization; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:regulation of multicellular organism growth; P:roof of mouth development; P:skeletal system morphogenesis; P:spermatogenesis; P:sphingolipid biosynthetic process; P:sphingolipid catabolic process; P:vasculogenesis;|O95470 B2RBD4 Q7Z732 Q9ULG8 Q9UN89,Sphingosine-1-phosphate lyase 1 {ECO:0000305},Sphingosine-1-phosphate aldolase;, PF00282;, GO:0005783;GO:0005789;GO:0030176;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0008209;GO:0097190;GO:0006672;GO:0008210;GO:0060325;GO:0006631;GO:0010761;GO:0030097;GO:0001822;GO:0033327;GO:0001553;GO:0048008;GO:0009791;GO:0040014;GO:0060021;GO:0048705;GO:0007283;GO:0030148;GO:0030149;GO:0001570;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:androgen metabolic process; P:apoptotic signaling pathway; P:ceramide metabolic process; P:estrogen metabolic process; P:face morphogenesis; P:fatty acid metabolic process; P:fibroblast migration; P:hemopoiesis; P:kidney development; P:Leydig cell differentiation; P:luteinization; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:regulation of multicellular organism growth; P:roof of mouth development; P:skeletal system morphogenesis; P:spermatogenesis; P:sphingolipid biosynthetic process; P:sphingolipid catabolic process; P:vasculogenesis;|O95470 B2RBD4 Q7Z732 Q9ULG8 Q9UN89,Sphingosine-1-phosphate lyase 1 {ECO:0000305},Sphingosine-1-phosphate aldolase;, PF00282;, GO:0005783;GO:0005789;GO:0030176;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0008209;GO:0097190;GO:0006672;GO:0008210;GO:0060325;GO:0006631;GO:0010761;GO:0030097;GO:0001822;GO:0033327;GO:0001553;GO:0048008;GO:0009791;GO:0040014;GO:0060021;GO:0048705;GO:0007283;GO:0030148;GO:0030149;GO:0001570;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:androgen metabolic process; P:apoptotic signaling pathway; P:ceramide metabolic process; P:estrogen metabolic process; P:face morphogenesis; P:fatty acid metabolic process; P:fibroblast migration; P:hemopoiesis; P:kidney development; P:Leydig cell differentiation; P:luteinization; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:regulation of multicellular organism growth; P:roof of mouth development; P:skeletal system morphogenesis; P:spermatogenesis; P:sphingolipid biosynthetic process; P:sphingolipid catabolic process; P:vasculogenesis; scaffold14 indexed_genome mRNA 14302499 14307531 . - . ID=transcript_3607;P61457 P70519 P80095 Q9D930,Pterin-4-alpha-carbinolamine dehydratase,4-alpha-hydroxy-tetrahydropterin dehydratase;Dimerization cofactor of hepatocyte nuclear factor 1-alpha;Phenylalanine hydroxylase-stimulating protein;Pterin carbinolamine dehydratase;, PF01329;, GO:0005829;GO:0070062;GO:0005654;GO:0008124;GO:0042802;GO:0004505;GO:0003713;GO:0006558;GO:0043393;GO:0006729;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:4-alpha-hydroxytetrahydrobiopterin dehydratase activity; F:identical protein binding; F:phenylalanine 4-monooxygenase activity; F:transcription coactivator activity;, P:L-phenylalanine metabolic process; P:regulation of protein binding; P:tetrahydrobiopterin biosynthetic process;|P61457 P70519 P80095 Q9D930,Pterin-4-alpha-carbinolamine dehydratase,4-alpha-hydroxy-tetrahydropterin dehydratase;Dimerization cofactor of hepatocyte nuclear factor 1-alpha;Phenylalanine hydroxylase-stimulating protein;Pterin carbinolamine dehydratase;, PF01329;, GO:0005829;GO:0070062;GO:0005654;GO:0008124;GO:0042802;GO:0004505;GO:0003713;GO:0006558;GO:0043393;GO:0006729;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:4-alpha-hydroxytetrahydrobiopterin dehydratase activity; F:identical protein binding; F:phenylalanine 4-monooxygenase activity; F:transcription coactivator activity;, P:L-phenylalanine metabolic process; P:regulation of protein binding; P:tetrahydrobiopterin biosynthetic process; scaffold14 indexed_genome mRNA 14649031 14672764 . + . ID=transcript_3608;Q8IZJ1 Q5T3R9 Q5T3S0 Q86SN3 Q8N1Y2 Q9H9F3,Netrin receptor UNC5B,Protein unc-5 homolog 2;Protein unc-5 homolog B;p53-regulated receptor for death and life protein 1 {ECO:0000303|PubMed:12598906};, PF00531;PF07679;PF00090;PF17217;PF00791;, GO:0016021;GO:0045121;GO:0005886;GO:0005042;GO:0001525;GO:0033564;GO:0006915;GO:0007411;GO:2001240;GO:0043524;GO:0014068;, C:integral component of membrane; C:membrane raft; C:plasma membrane;, F:netrin receptor activity;, P:angiogenesis; P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of neuron apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; scaffold14 indexed_genome mRNA 14682891 14733333 . + . ID=transcript_3609;Q9NUS9,Equilibrative nucleoside transporter 3,Solute carrier family 29 member 3;, PF01733;, GO:0005794;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005886;GO:0005337;, C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:nucleoside transmembrane transporter activity; scaffold14 indexed_genome mRNA 14762715 14937230 . + . ID=transcript_3610;Q96JL3 Q9H4K9,Cadherin-23 {ECO:0000303|PubMed:11138009},Otocadherin {ECO:0000303|PubMed:15537665};, PF00028;, GO:0016342;GO:0016021;GO:0016020;GO:0032420;GO:0045296;GO:0005509;GO:0006816;GO:0016339;GO:0098742;GO:0050957;GO:0007156;GO:0060122;GO:0007626;GO:0045494;GO:0051480;GO:0050896;GO:0050953;GO:0007605;GO:0007601;, C:catenin complex; C:integral component of membrane; C:membrane; C:stereocilium;, F:cadherin binding; F:calcium ion binding;, P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:equilibrioception; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear receptor cell stereocilium organization; P:locomotory behavior; P:photoreceptor cell maintenance; P:regulation of cytosolic calcium ion concentration; P:response to stimulus; P:sensory perception of light stimulus; P:sensory perception of sound; P:visual perception; scaffold14 indexed_genome mRNA 15110976 15119489 . + . ID=transcript_3611;Q96JL3 Q9H4K9,Cadherin-23 {ECO:0000303|PubMed:11138009},Otocadherin {ECO:0000303|PubMed:15537665};, PF00028;, GO:0016342;GO:0016021;GO:0016020;GO:0032420;GO:0045296;GO:0005509;GO:0006816;GO:0016339;GO:0098742;GO:0050957;GO:0007156;GO:0060122;GO:0007626;GO:0045494;GO:0051480;GO:0050896;GO:0050953;GO:0007605;GO:0007601;, C:catenin complex; C:integral component of membrane; C:membrane; C:stereocilium;, F:cadherin binding; F:calcium ion binding;, P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:equilibrioception; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear receptor cell stereocilium organization; P:locomotory behavior; P:photoreceptor cell maintenance; P:regulation of cytosolic calcium ion concentration; P:response to stimulus; P:sensory perception of light stimulus; P:sensory perception of sound; P:visual perception; scaffold14 indexed_genome mRNA 15125992 15152165 . - . ID=transcript_3612;Q9H7M9 A1L0X9 A4ZYV1 A8MVH5 Q6UXF3 Q8WUG3 Q8WYZ8,V-type immunoglobulin domain-containing suppressor of T-cell activation {ECO:0000303|PubMed:24691993},Platelet receptor Gi24 {ECO:0000303|Ref.1};Stress-induced secreted protein-1 {ECO:0000303|Ref.2};V-set domain-containing immunoregulatory receptor {ECO:0000250|UniProtKB:Q9D659};V-set immunoregulatory receptor {ECO:0000312|HGNC:HGNC:30085};, PF07686;, GO:0016021;GO:0005886;GO:0061133;GO:0019899;GO:0042802;GO:2000562;GO:2000565;GO:0032689;GO:0032693;GO:0032700;GO:0032720;GO:0030335;GO:0120158;GO:0010950;GO:0010628;GO:0045591;GO:0050776;GO:0031638;, C:integral component of membrane; C:plasma membrane;, F:endopeptidase activator activity; F:enzyme binding; F:identical protein binding;, P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of CD8-positive, alpha-beta T cell proliferation; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-10 production; P:negative regulation of interleukin-17 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of cell migration; P:positive regulation of collagen catabolic process; P:positive regulation of endopeptidase activity; P:positive regulation of gene expression; P:positive regulation of regulatory T cell differentiation; P:regulation of immune response; P:zymogen activation;|Q9H7M9 A1L0X9 A4ZYV1 A8MVH5 Q6UXF3 Q8WUG3 Q8WYZ8,V-type immunoglobulin domain-containing suppressor of T-cell activation {ECO:0000303|PubMed:24691993},Platelet receptor Gi24 {ECO:0000303|Ref.1};Stress-induced secreted protein-1 {ECO:0000303|Ref.2};V-set domain-containing immunoregulatory receptor {ECO:0000250|UniProtKB:Q9D659};V-set immunoregulatory receptor {ECO:0000312|HGNC:HGNC:30085};, PF07686;, GO:0016021;GO:0005886;GO:0061133;GO:0019899;GO:0042802;GO:2000562;GO:2000565;GO:0032689;GO:0032693;GO:0032700;GO:0032720;GO:0030335;GO:0120158;GO:0010950;GO:0010628;GO:0045591;GO:0050776;GO:0031638;, C:integral component of membrane; C:plasma membrane;, F:endopeptidase activator activity; F:enzyme binding; F:identical protein binding;, P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of CD8-positive, alpha-beta T cell proliferation; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-10 production; P:negative regulation of interleukin-17 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of cell migration; P:positive regulation of collagen catabolic process; P:positive regulation of endopeptidase activity; P:positive regulation of gene expression; P:positive regulation of regulatory T cell differentiation; P:regulation of immune response; P:zymogen activation; scaffold14 indexed_genome mRNA 15168664 15176167 . + . ID=transcript_3613;Q96JL3 Q9H4K9,Cadherin-23 {ECO:0000303|PubMed:11138009},Otocadherin {ECO:0000303|PubMed:15537665};, PF00028;, GO:0016342;GO:0016021;GO:0016020;GO:0032420;GO:0045296;GO:0005509;GO:0006816;GO:0016339;GO:0098742;GO:0050957;GO:0007156;GO:0060122;GO:0007626;GO:0045494;GO:0051480;GO:0050896;GO:0050953;GO:0007605;GO:0007601;, C:catenin complex; C:integral component of membrane; C:membrane; C:stereocilium;, F:cadherin binding; F:calcium ion binding;, P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:equilibrioception; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear receptor cell stereocilium organization; P:locomotory behavior; P:photoreceptor cell maintenance; P:regulation of cytosolic calcium ion concentration; P:response to stimulus; P:sensory perception of light stimulus; P:sensory perception of sound; P:visual perception; scaffold14 indexed_genome mRNA 15179004 15195750 . + . ID=transcript_3614;Q96JL3 Q9H4K9,Cadherin-23 {ECO:0000303|PubMed:11138009},Otocadherin {ECO:0000303|PubMed:15537665};, PF00028;, GO:0016342;GO:0016021;GO:0016020;GO:0032420;GO:0045296;GO:0005509;GO:0006816;GO:0016339;GO:0098742;GO:0050957;GO:0007156;GO:0060122;GO:0007626;GO:0045494;GO:0051480;GO:0050896;GO:0050953;GO:0007605;GO:0007601;, C:catenin complex; C:integral component of membrane; C:membrane; C:stereocilium;, F:cadherin binding; F:calcium ion binding;, P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:equilibrioception; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear receptor cell stereocilium organization; P:locomotory behavior; P:photoreceptor cell maintenance; P:regulation of cytosolic calcium ion concentration; P:response to stimulus; P:sensory perception of light stimulus; P:sensory perception of sound; P:visual perception;|Q96JL3 Q9H4K9,Cadherin-23 {ECO:0000303|PubMed:11138009},Otocadherin {ECO:0000303|PubMed:15537665};, PF00028;, GO:0016342;GO:0016021;GO:0016020;GO:0032420;GO:0045296;GO:0005509;GO:0006816;GO:0016339;GO:0098742;GO:0050957;GO:0007156;GO:0060122;GO:0007626;GO:0045494;GO:0051480;GO:0050896;GO:0050953;GO:0007605;GO:0007601;, C:catenin complex; C:integral component of membrane; C:membrane; C:stereocilium;, F:cadherin binding; F:calcium ion binding;, P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:equilibrioception; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear receptor cell stereocilium organization; P:locomotory behavior; P:photoreceptor cell maintenance; P:regulation of cytosolic calcium ion concentration; P:response to stimulus; P:sensory perception of light stimulus; P:sensory perception of sound; P:visual perception;|Q96JL3 Q9H4K9,Cadherin-23 {ECO:0000303|PubMed:11138009},Otocadherin {ECO:0000303|PubMed:15537665};, PF00028;, GO:0016342;GO:0016021;GO:0016020;GO:0032420;GO:0045296;GO:0005509;GO:0006816;GO:0016339;GO:0098742;GO:0050957;GO:0007156;GO:0060122;GO:0007626;GO:0045494;GO:0051480;GO:0050896;GO:0050953;GO:0007605;GO:0007601;, C:catenin complex; C:integral component of membrane; C:membrane; C:stereocilium;, F:cadherin binding; F:calcium ion binding;, P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:equilibrioception; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear receptor cell stereocilium organization; P:locomotory behavior; P:photoreceptor cell maintenance; P:regulation of cytosolic calcium ion concentration; P:response to stimulus; P:sensory perception of light stimulus; P:sensory perception of sound; P:visual perception;|Q96JL3 Q9H4K9,Cadherin-23 {ECO:0000303|PubMed:11138009},Otocadherin {ECO:0000303|PubMed:15537665};, PF00028;, GO:0016342;GO:0016021;GO:0016020;GO:0032420;GO:0045296;GO:0005509;GO:0006816;GO:0016339;GO:0098742;GO:0050957;GO:0007156;GO:0060122;GO:0007626;GO:0045494;GO:0051480;GO:0050896;GO:0050953;GO:0007605;GO:0007601;, C:catenin complex; C:integral component of membrane; C:membrane; C:stereocilium;, F:cadherin binding; F:calcium ion binding;, P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:equilibrioception; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear receptor cell stereocilium organization; P:locomotory behavior; P:photoreceptor cell maintenance; P:regulation of cytosolic calcium ion concentration; P:response to stimulus; P:sensory perception of light stimulus; P:sensory perception of sound; P:visual perception; scaffold14 indexed_genome mRNA 15196200 15205761 . + . ID=transcript_3615;Q6IBQ6 Q92739 Q92740 Q92741 Q92742,Prosaposin,Proactivator polypeptide;, PF02199;PF05184;PF03489;, GO:0035577;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0005886;GO:0004565;GO:0008047;GO:1905573;GO:1905574;GO:1905575;GO:1905577;GO:1905576;GO:0042802;GO:0008289;GO:0005543;GO:0002020;GO:0042803;GO:0007193;GO:0060742;GO:0007186;GO:1905572;GO:0006687;GO:0006869;GO:0007041;GO:0043312;GO:0002576;GO:0060736;GO:0010506;GO:0019216;, C:azurophil granule membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:beta-galactosidase activity; F:enzyme activator activity; F:ganglioside GM1 binding; F:ganglioside GM2 binding; F:ganglioside GM3 binding; F:ganglioside GP1c binding; F:ganglioside GT1b binding; F:identical protein binding; F:lipid binding; F:phospholipid binding; F:protease binding; F:protein homodimerization activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:epithelial cell differentiation involved in prostate gland development; P:G protein-coupled receptor signaling pathway; P:ganglioside GM1 transport to membrane; P:glycosphingolipid metabolic process; P:lipid transport; P:lysosomal transport; P:neutrophil degranulation; P:platelet degranulation; P:prostate gland growth; P:regulation of autophagy; P:regulation of lipid metabolic process;|Q6IBQ6 Q92739 Q92740 Q92741 Q92742,Prosaposin,Proactivator polypeptide;, PF02199;PF05184;PF03489;, GO:0035577;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0005886;GO:0004565;GO:0008047;GO:1905573;GO:1905574;GO:1905575;GO:1905577;GO:1905576;GO:0042802;GO:0008289;GO:0005543;GO:0002020;GO:0042803;GO:0007193;GO:0060742;GO:0007186;GO:1905572;GO:0006687;GO:0006869;GO:0007041;GO:0043312;GO:0002576;GO:0060736;GO:0010506;GO:0019216;, C:azurophil granule membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:beta-galactosidase activity; F:enzyme activator activity; F:ganglioside GM1 binding; F:ganglioside GM2 binding; F:ganglioside GM3 binding; F:ganglioside GP1c binding; F:ganglioside GT1b binding; F:identical protein binding; F:lipid binding; F:phospholipid binding; F:protease binding; F:protein homodimerization activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:epithelial cell differentiation involved in prostate gland development; P:G protein-coupled receptor signaling pathway; P:ganglioside GM1 transport to membrane; P:glycosphingolipid metabolic process; P:lipid transport; P:lysosomal transport; P:neutrophil degranulation; P:platelet degranulation; P:prostate gland growth; P:regulation of autophagy; P:regulation of lipid metabolic process; scaffold14 indexed_genome mRNA 15326809 15328412 . + . ID=transcript_3616;Q7LGC8 O75099 Q52M30,Carbohydrate sulfotransferase 3,Chondroitin 6-O-sulfotransferase 1;Chondroitin 6-sulfotransferase;Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0;, PF00685;, GO:0000139;GO:0016021;GO:0005802;GO:0008459;GO:0001517;GO:0008146;GO:0005975;GO:0030206;GO:0006044;GO:0006790;, C:Golgi membrane; C:integral component of membrane; C:trans-Golgi network;, F:chondroitin 6-sulfotransferase activity; F:N-acetylglucosamine 6-O-sulfotransferase activity; F:sulfotransferase activity;, P:carbohydrate metabolic process; P:chondroitin sulfate biosynthetic process; P:N-acetylglucosamine metabolic process; P:sulfur compound metabolic process; scaffold14 indexed_genome mRNA 15375550 15398647 . - . ID=transcript_3617;Q92563 C9J767 Q6UW87,Testican-2,SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2;, PF07648;PF10591;PF00086;, GO:0031012;GO:0005576;GO:0005509;GO:0050840;GO:0005539;GO:0008191;GO:1990830;GO:0030198;GO:0010951;GO:0019800;GO:2000147;GO:0010811;GO:0045595;GO:0007416;, C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix binding; F:glycosaminoglycan binding; F:metalloendopeptidase inhibitor activity;, P:cellular response to leukemia inhibitory factor; P:extracellular matrix organization; P:negative regulation of endopeptidase activity; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; P:positive regulation of cell motility; P:positive regulation of cell-substrate adhesion; P:regulation of cell differentiation; P:synapse assembly;|Q92563 C9J767 Q6UW87,Testican-2,SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2;, PF07648;PF10591;PF00086;, GO:0031012;GO:0005576;GO:0005509;GO:0050840;GO:0005539;GO:0008191;GO:1990830;GO:0030198;GO:0010951;GO:0019800;GO:2000147;GO:0010811;GO:0045595;GO:0007416;, C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix binding; F:glycosaminoglycan binding; F:metalloendopeptidase inhibitor activity;, P:cellular response to leukemia inhibitory factor; P:extracellular matrix organization; P:negative regulation of endopeptidase activity; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; P:positive regulation of cell motility; P:positive regulation of cell-substrate adhesion; P:regulation of cell differentiation; P:synapse assembly;|Q92563 C9J767 Q6UW87,Testican-2,SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2;, PF07648;PF10591;PF00086;, GO:0031012;GO:0005576;GO:0005509;GO:0050840;GO:0005539;GO:0008191;GO:1990830;GO:0030198;GO:0010951;GO:0019800;GO:2000147;GO:0010811;GO:0045595;GO:0007416;, C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix binding; F:glycosaminoglycan binding; F:metalloendopeptidase inhibitor activity;, P:cellular response to leukemia inhibitory factor; P:extracellular matrix organization; P:negative regulation of endopeptidase activity; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; P:positive regulation of cell motility; P:positive regulation of cell-substrate adhesion; P:regulation of cell differentiation; P:synapse assembly; scaffold14 indexed_genome mRNA 15405657 15514908 . - . ID=transcript_3618;Q8N9N2 Q5SW06 Q5SW07 Q96EI8 Q9Y307,Activating signal cointegrator 1 complex subunit 1,ASC-1 complex subunit p50 {ECO:0000303|PubMed:12077347};Trip4 complex subunit p50 {ECO:0000303|PubMed:12077347};, PF10469;PF00013;, GO:0031594;GO:0016607;GO:0005654;GO:0005634;GO:0005667;GO:0003723;GO:0006307;GO:0006355;, C:neuromuscular junction; C:nuclear speck; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:RNA binding;, P:DNA dealkylation involved in DNA repair; P:regulation of transcription, DNA-templated;|Q96DE5,Anaphase-promoting complex subunit 16,Cyclosome subunit 16;, PF17256;, GO:0005680;GO:0000777;GO:0005829;GO:0000776;GO:0005654;GO:0031145;GO:0007049;GO:0051301;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q96DE5,Anaphase-promoting complex subunit 16,Cyclosome subunit 16;, PF17256;, GO:0005680;GO:0000777;GO:0005829;GO:0000776;GO:0005654;GO:0031145;GO:0007049;GO:0051301;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q96DE5,Anaphase-promoting complex subunit 16,Cyclosome subunit 16;, PF17256;, GO:0005680;GO:0000777;GO:0005829;GO:0000776;GO:0005654;GO:0031145;GO:0007049;GO:0051301;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q96DE5,Anaphase-promoting complex subunit 16,Cyclosome subunit 16;, PF17256;, GO:0005680;GO:0000777;GO:0005829;GO:0000776;GO:0005654;GO:0031145;GO:0007049;GO:0051301;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold14 indexed_genome mRNA 15545568 15548068 . - . ID=transcript_3619;Q9NX09 Q9H0S3,DNA damage-inducible transcript 4 protein,HIF-1 responsive protein RTP801;Protein regulated in development and DNA damage response 1;, PF07809;, GO:0005737;GO:0005829;GO:0005739;GO:0071889;GO:0006915;GO:0007420;GO:0071549;GO:0051607;GO:0042771;GO:0045820;GO:1902532;GO:0033137;GO:0010801;GO:0032007;GO:0030182;GO:0001764;GO:0048011;GO:1901216;GO:0032984;GO:0072593;GO:0032006;GO:0001666;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:14-3-3 protein binding;, P:apoptotic process; P:brain development; P:cellular response to dexamethasone stimulus; P:defense response to virus; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of glycolytic process; P:negative regulation of intracellular signal transduction; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of TOR signaling; P:neuron differentiation; P:neuron migration; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of neuron death; P:protein-containing complex disassembly; P:reactive oxygen species metabolic process; P:regulation of TOR signaling; P:response to hypoxia; scaffold14 indexed_genome mRNA 15586280 15605316 . - . ID=transcript_3620;Q9NXW2 B7Z7I3 Q9H6H0,DnaJ homolog subfamily B member 12 {ECO:0000312|HGNC:HGNC:14891},, PF00226;PF09320;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0031965;GO:0030544;GO:0034622;GO:0071218;GO:0051085;GO:0036503;GO:0030433;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear membrane;, F:Hsp70 protein binding;, P:cellular protein-containing complex assembly; P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ERAD pathway; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9NXW2 B7Z7I3 Q9H6H0,DnaJ homolog subfamily B member 12 {ECO:0000312|HGNC:HGNC:14891},, PF00226;PF09320;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0031965;GO:0030544;GO:0034622;GO:0071218;GO:0051085;GO:0036503;GO:0030433;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear membrane;, F:Hsp70 protein binding;, P:cellular protein-containing complex assembly; P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ERAD pathway; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9NXW2 B7Z7I3 Q9H6H0,DnaJ homolog subfamily B member 12 {ECO:0000312|HGNC:HGNC:14891},, PF00226;PF09320;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0031965;GO:0030544;GO:0034622;GO:0071218;GO:0051085;GO:0036503;GO:0030433;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear membrane;, F:Hsp70 protein binding;, P:cellular protein-containing complex assembly; P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ERAD pathway; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9NXW2 B7Z7I3 Q9H6H0,DnaJ homolog subfamily B member 12 {ECO:0000312|HGNC:HGNC:14891},, PF00226;PF09320;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0031965;GO:0030544;GO:0034622;GO:0071218;GO:0051085;GO:0036503;GO:0030433;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear membrane;, F:Hsp70 protein binding;, P:cellular protein-containing complex assembly; P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ERAD pathway; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9NXW2 B7Z7I3 Q9H6H0,DnaJ homolog subfamily B member 12 {ECO:0000312|HGNC:HGNC:14891},, PF00226;PF09320;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0031965;GO:0030544;GO:0034622;GO:0071218;GO:0051085;GO:0036503;GO:0030433;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear membrane;, F:Hsp70 protein binding;, P:cellular protein-containing complex assembly; P:cellular response to misfolded protein; P:chaperone cofactor-dependent protein refolding; P:ERAD pathway; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold14 indexed_genome mRNA 15619457 15757288 . - . ID=transcript_3621;Q9UFX0,Calcium uptake protein 1, mitochondrial,Atopy-related autoantigen CALC {ECO:0000303|PubMed:16002733};Calcium-binding atopy-related autoantigen 1 {ECO:0000303|PubMed:16002733};, PF13202;PF13833;, GO:0034704;GO:0032592;GO:0005622;GO:0005743;GO:0005758;GO:0005739;GO:1990246;GO:0005509;GO:0042802;GO:0046982;GO:0036444;GO:0070509;GO:0006952;GO:0051560;GO:0006851;GO:0051561;GO:0051260;GO:1900069;, C:calcium channel complex; C:integral component of mitochondrial membrane; C:intracellular anatomical structure; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:uniplex complex;, F:calcium ion binding; F:identical protein binding; F:protein heterodimerization activity;, P:calcium import into the mitochondrion; P:calcium ion import; P:defense response; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration; P:protein homooligomerization; P:regulation of cellular hyperosmotic salinity response;|Q9UFX0,Calcium uptake protein 1, mitochondrial,Atopy-related autoantigen CALC {ECO:0000303|PubMed:16002733};Calcium-binding atopy-related autoantigen 1 {ECO:0000303|PubMed:16002733};, PF13202;PF13833;, GO:0034704;GO:0032592;GO:0005622;GO:0005743;GO:0005758;GO:0005739;GO:1990246;GO:0005509;GO:0042802;GO:0046982;GO:0036444;GO:0070509;GO:0006952;GO:0051560;GO:0006851;GO:0051561;GO:0051260;GO:1900069;, C:calcium channel complex; C:integral component of mitochondrial membrane; C:intracellular anatomical structure; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:uniplex complex;, F:calcium ion binding; F:identical protein binding; F:protein heterodimerization activity;, P:calcium import into the mitochondrion; P:calcium ion import; P:defense response; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration; P:protein homooligomerization; P:regulation of cellular hyperosmotic salinity response; scaffold14 indexed_genome mRNA 15791900 15835050 . - . ID=transcript_3622;Q9UFX0,Calcium uptake protein 1, mitochondrial,Atopy-related autoantigen CALC {ECO:0000303|PubMed:16002733};Calcium-binding atopy-related autoantigen 1 {ECO:0000303|PubMed:16002733};, PF13202;PF13833;, GO:0034704;GO:0032592;GO:0005622;GO:0005743;GO:0005758;GO:0005739;GO:1990246;GO:0005509;GO:0042802;GO:0046982;GO:0036444;GO:0070509;GO:0006952;GO:0051560;GO:0006851;GO:0051561;GO:0051260;GO:1900069;, C:calcium channel complex; C:integral component of mitochondrial membrane; C:intracellular anatomical structure; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:uniplex complex;, F:calcium ion binding; F:identical protein binding; F:protein heterodimerization activity;, P:calcium import into the mitochondrion; P:calcium ion import; P:defense response; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration; P:protein homooligomerization; P:regulation of cellular hyperosmotic salinity response; scaffold14 indexed_genome mRNA 15927590 16138307 . + . ID=transcript_3623;Q8NE86 B2RDF3 B3KXV7 Q96FL3,Calcium uniporter protein, mitochondrial {ECO:0000303|PubMed:21685886},Coiled-coil domain-containing protein 109A {ECO:0000305};, PF04678;, GO:0034704;GO:0031305;GO:0005743;GO:0005739;GO:1990246;GO:0005262;GO:0042802;GO:0015292;GO:0090527;GO:0036444;GO:0019722;GO:0042593;GO:0051560;GO:0006851;GO:0032024;GO:0051561;GO:0090141;GO:0090023;GO:0051259;, C:calcium channel complex; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:uniplex complex;, F:calcium channel activity; F:identical protein binding; F:uniporter activity;, P:actin filament reorganization; P:calcium import into the mitochondrion; P:calcium-mediated signaling; P:glucose homeostasis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of insulin secretion; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:protein complex oligomerization;|Q8NE86 B2RDF3 B3KXV7 Q96FL3,Calcium uniporter protein, mitochondrial {ECO:0000303|PubMed:21685886},Coiled-coil domain-containing protein 109A {ECO:0000305};, PF04678;, GO:0034704;GO:0031305;GO:0005743;GO:0005739;GO:1990246;GO:0005262;GO:0042802;GO:0015292;GO:0090527;GO:0036444;GO:0019722;GO:0042593;GO:0051560;GO:0006851;GO:0032024;GO:0051561;GO:0090141;GO:0090023;GO:0051259;, C:calcium channel complex; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:uniplex complex;, F:calcium channel activity; F:identical protein binding; F:uniporter activity;, P:actin filament reorganization; P:calcium import into the mitochondrion; P:calcium-mediated signaling; P:glucose homeostasis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of insulin secretion; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:protein complex oligomerization;|Q8NE86 B2RDF3 B3KXV7 Q96FL3,Calcium uniporter protein, mitochondrial {ECO:0000303|PubMed:21685886},Coiled-coil domain-containing protein 109A {ECO:0000305};, PF04678;, GO:0034704;GO:0031305;GO:0005743;GO:0005739;GO:1990246;GO:0005262;GO:0042802;GO:0015292;GO:0090527;GO:0036444;GO:0019722;GO:0042593;GO:0051560;GO:0006851;GO:0032024;GO:0051561;GO:0090141;GO:0090023;GO:0051259;, C:calcium channel complex; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:uniplex complex;, F:calcium channel activity; F:identical protein binding; F:uniporter activity;, P:actin filament reorganization; P:calcium import into the mitochondrion; P:calcium-mediated signaling; P:glucose homeostasis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of insulin secretion; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:protein complex oligomerization;|Q8NE86 B2RDF3 B3KXV7 Q96FL3,Calcium uniporter protein, mitochondrial {ECO:0000303|PubMed:21685886},Coiled-coil domain-containing protein 109A {ECO:0000305};, PF04678;, GO:0034704;GO:0031305;GO:0005743;GO:0005739;GO:1990246;GO:0005262;GO:0042802;GO:0015292;GO:0090527;GO:0036444;GO:0019722;GO:0042593;GO:0051560;GO:0006851;GO:0032024;GO:0051561;GO:0090141;GO:0090023;GO:0051259;, C:calcium channel complex; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:uniplex complex;, F:calcium channel activity; F:identical protein binding; F:uniporter activity;, P:actin filament reorganization; P:calcium import into the mitochondrion; P:calcium-mediated signaling; P:glucose homeostasis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of insulin secretion; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:protein complex oligomerization;|Q8NE86 B2RDF3 B3KXV7 Q96FL3,Calcium uniporter protein, mitochondrial {ECO:0000303|PubMed:21685886},Coiled-coil domain-containing protein 109A {ECO:0000305};, PF04678;, GO:0034704;GO:0031305;GO:0005743;GO:0005739;GO:1990246;GO:0005262;GO:0042802;GO:0015292;GO:0090527;GO:0036444;GO:0019722;GO:0042593;GO:0051560;GO:0006851;GO:0032024;GO:0051561;GO:0090141;GO:0090023;GO:0051259;, C:calcium channel complex; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:uniplex complex;, F:calcium channel activity; F:identical protein binding; F:uniporter activity;, P:actin filament reorganization; P:calcium import into the mitochondrion; P:calcium-mediated signaling; P:glucose homeostasis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of insulin secretion; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:protein complex oligomerization;|Q8NE86 B2RDF3 B3KXV7 Q96FL3,Calcium uniporter protein, mitochondrial {ECO:0000303|PubMed:21685886},Coiled-coil domain-containing protein 109A {ECO:0000305};, PF04678;, GO:0034704;GO:0031305;GO:0005743;GO:0005739;GO:1990246;GO:0005262;GO:0042802;GO:0015292;GO:0090527;GO:0036444;GO:0019722;GO:0042593;GO:0051560;GO:0006851;GO:0032024;GO:0051561;GO:0090141;GO:0090023;GO:0051259;, C:calcium channel complex; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:uniplex complex;, F:calcium channel activity; F:identical protein binding; F:uniporter activity;, P:actin filament reorganization; P:calcium import into the mitochondrion; P:calcium-mediated signaling; P:glucose homeostasis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of insulin secretion; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:protein complex oligomerization; scaffold14 indexed_genome mRNA 16148602 16195099 . + . ID=transcript_3624;Q8WWZ8 A0AVP3 Q8N1M8,Oncoprotein-induced transcript 3 protein,Liver-specific zona pellucida domain-containing protein;, PF00100;, GO:0009986;GO:0005615;GO:0005635;GO:0005509;GO:0005201;GO:1903118;, C:cell surface; C:extracellular space; C:nuclear envelope;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:urate homeostasis;|Q8WWZ8 A0AVP3 Q8N1M8,Oncoprotein-induced transcript 3 protein,Liver-specific zona pellucida domain-containing protein;, PF00100;, GO:0009986;GO:0005615;GO:0005635;GO:0005509;GO:0005201;GO:1903118;, C:cell surface; C:extracellular space; C:nuclear envelope;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:urate homeostasis;|Q9BX93 B7ZL23 Q52LB2 Q96Q99,Group XIIB secretory phospholipase A2-like protein,Group XIII secretory phospholipase A2-like protein;sPLA2-GXIIB;, PF06951;, GO:0005576;GO:0005509;GO:0004623;GO:0050482;GO:0042632;GO:0016042;GO:0006644;GO:0070328;, C:extracellular region;, F:calcium ion binding; F:phospholipase A2 activity;, P:arachidonic acid secretion; P:cholesterol homeostasis; P:lipid catabolic process; P:phospholipid metabolic process; P:triglyceride homeostasis;|Q9BX93 B7ZL23 Q52LB2 Q96Q99,Group XIIB secretory phospholipase A2-like protein,Group XIII secretory phospholipase A2-like protein;sPLA2-GXIIB;, PF06951;, GO:0005576;GO:0005509;GO:0004623;GO:0050482;GO:0042632;GO:0016042;GO:0006644;GO:0070328;, C:extracellular region;, F:calcium ion binding; F:phospholipase A2 activity;, P:arachidonic acid secretion; P:cholesterol homeostasis; P:lipid catabolic process; P:phospholipid metabolic process; P:triglyceride homeostasis;|Q9BX93 B7ZL23 Q52LB2 Q96Q99,Group XIIB secretory phospholipase A2-like protein,Group XIII secretory phospholipase A2-like protein;sPLA2-GXIIB;, PF06951;, GO:0005576;GO:0005509;GO:0004623;GO:0050482;GO:0042632;GO:0016042;GO:0006644;GO:0070328;, C:extracellular region;, F:calcium ion binding; F:phospholipase A2 activity;, P:arachidonic acid secretion; P:cholesterol homeostasis; P:lipid catabolic process; P:phospholipid metabolic process; P:triglyceride homeostasis;|Q9BX93 B7ZL23 Q52LB2 Q96Q99,Group XIIB secretory phospholipase A2-like protein,Group XIII secretory phospholipase A2-like protein;sPLA2-GXIIB;, PF06951;, GO:0005576;GO:0005509;GO:0004623;GO:0050482;GO:0042632;GO:0016042;GO:0006644;GO:0070328;, C:extracellular region;, F:calcium ion binding; F:phospholipase A2 activity;, P:arachidonic acid secretion; P:cholesterol homeostasis; P:lipid catabolic process; P:phospholipid metabolic process; P:triglyceride homeostasis; scaffold14 indexed_genome mRNA 16287686 16289839 . + . ID=transcript_3625;P20290 A8K510 Q13893 Q76M56,Transcription factor BTF3,Nascent polypeptide-associated complex subunit beta;RNA polymerase B transcription factor 3;, PF01849;, GO:0005829;GO:0005854;GO:0005634;GO:0042788;GO:0003723;GO:0001701;GO:0015031;GO:0006366;, C:cytosol; C:nascent polypeptide-associated complex; C:nucleus; C:polysomal ribosome;, F:RNA binding;, P:in utero embryonic development; P:protein transport; P:transcription by RNA polymerase II; scaffold14 indexed_genome mRNA 16296748 16391173 . - . ID=transcript_3626;P13674 C9JL12 Q15082 Q15083 Q5VSQ5,Prolyl 4-hydroxylase subunit alpha-1,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1;, PF13640;PF08336;, GO:0005783;GO:0005788;GO:0043231;GO:0016020;GO:0005739;GO:0042802;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion;, F:identical protein binding; F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline;|P46778 Q16699,60S ribosomal protein L21,Large ribosomal subunit protein eL21 {ECO:0000303|PubMed:24524803};, PF01157;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P13674 C9JL12 Q15082 Q15083 Q5VSQ5,Prolyl 4-hydroxylase subunit alpha-1,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1;, PF13640;PF08336;, GO:0005783;GO:0005788;GO:0043231;GO:0016020;GO:0005739;GO:0042802;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion;, F:identical protein binding; F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; scaffold14 indexed_genome mRNA 16412257 16430799 . + . ID=transcript_3627;Q86X67 B4DV90 O95650 Q5SQM4 Q5SQM5 Q5SQM6 Q9Y3X2,NAD(P)H pyrophosphatase NUDT13, mitochondrial {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 13;Protein KiSS-16;, PF00293;PF09296;PF09297;, GO:0005759;GO:0005739;GO:0046872;GO:0000210;GO:0035529;GO:0006734;GO:0006742;GO:0015949;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:NAD+ diphosphatase activity; F:NADH pyrophosphatase activity;, P:NADH metabolic process; P:NADP catabolic process; P:nucleobase-containing small molecule interconversion;|Q86X67 B4DV90 O95650 Q5SQM4 Q5SQM5 Q5SQM6 Q9Y3X2,NAD(P)H pyrophosphatase NUDT13, mitochondrial {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 13;Protein KiSS-16;, PF00293;PF09296;PF09297;, GO:0005759;GO:0005739;GO:0046872;GO:0000210;GO:0035529;GO:0006734;GO:0006742;GO:0015949;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:NAD+ diphosphatase activity; F:NADH pyrophosphatase activity;, P:NADH metabolic process; P:NADP catabolic process; P:nucleobase-containing small molecule interconversion;|Q86X67 B4DV90 O95650 Q5SQM4 Q5SQM5 Q5SQM6 Q9Y3X2,NAD(P)H pyrophosphatase NUDT13, mitochondrial {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 13;Protein KiSS-16;, PF00293;PF09296;PF09297;, GO:0005759;GO:0005739;GO:0046872;GO:0000210;GO:0035529;GO:0006734;GO:0006742;GO:0015949;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:NAD+ diphosphatase activity; F:NADH pyrophosphatase activity;, P:NADH metabolic process; P:NADP catabolic process; P:nucleobase-containing small molecule interconversion;|Q86X67 B4DV90 O95650 Q5SQM4 Q5SQM5 Q5SQM6 Q9Y3X2,NAD(P)H pyrophosphatase NUDT13, mitochondrial {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 13;Protein KiSS-16;, PF00293;PF09296;PF09297;, GO:0005759;GO:0005739;GO:0046872;GO:0000210;GO:0035529;GO:0006734;GO:0006742;GO:0015949;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:NAD+ diphosphatase activity; F:NADH pyrophosphatase activity;, P:NADH metabolic process; P:NADP catabolic process; P:nucleobase-containing small molecule interconversion;|Q86X67 B4DV90 O95650 Q5SQM4 Q5SQM5 Q5SQM6 Q9Y3X2,NAD(P)H pyrophosphatase NUDT13, mitochondrial {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 13;Protein KiSS-16;, PF00293;PF09296;PF09297;, GO:0005759;GO:0005739;GO:0046872;GO:0000210;GO:0035529;GO:0006734;GO:0006742;GO:0015949;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:NAD+ diphosphatase activity; F:NADH pyrophosphatase activity;, P:NADH metabolic process; P:NADP catabolic process; P:nucleobase-containing small molecule interconversion;|Q86X67 B4DV90 O95650 Q5SQM4 Q5SQM5 Q5SQM6 Q9Y3X2,NAD(P)H pyrophosphatase NUDT13, mitochondrial {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 13;Protein KiSS-16;, PF00293;PF09296;PF09297;, GO:0005759;GO:0005739;GO:0046872;GO:0000210;GO:0035529;GO:0006734;GO:0006742;GO:0015949;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:NAD+ diphosphatase activity; F:NADH pyrophosphatase activity;, P:NADH metabolic process; P:NADP catabolic process; P:nucleobase-containing small molecule interconversion; scaffold14 indexed_genome mRNA 16430982 16458950 . - . ID=transcript_3628;O95905 C9JX46 E9PAW8,Protein ecdysoneless homolog {ECO:0000250|UniProtKB:Q9W032},Human suppressor of GCR two {ECO:0000303|PubMed:9928932};, PF07093;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035035;GO:0006397;GO:0045944;GO:0008380;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:mRNA processing; P:positive regulation of transcription by RNA polymerase II; P:RNA splicing;|Q7Z4G4 E1P570 Q5JY11 Q6PGQ5 Q9HC13,tRNA (guanine(10)-N2)-methyltransferase homolog,tRNA guanosine-2'-O-methyltransferase TRM11 homolog;, PF01170;, GO:0005737;GO:0008168;GO:0004809;GO:0000049;, C:cytoplasm;, F:methyltransferase activity; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;|O95905 C9JX46 E9PAW8,Protein ecdysoneless homolog {ECO:0000250|UniProtKB:Q9W032},Human suppressor of GCR two {ECO:0000303|PubMed:9928932};, PF07093;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035035;GO:0006397;GO:0045944;GO:0008380;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:mRNA processing; P:positive regulation of transcription by RNA polymerase II; P:RNA splicing;|O95905 C9JX46 E9PAW8,Protein ecdysoneless homolog {ECO:0000250|UniProtKB:Q9W032},Human suppressor of GCR two {ECO:0000303|PubMed:9928932};, PF07093;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035035;GO:0006397;GO:0045944;GO:0008380;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:mRNA processing; P:positive regulation of transcription by RNA polymerase II; P:RNA splicing; scaffold14 indexed_genome mRNA 16459008 16517521 . + . ID=transcript_3629;Q96BN6 Q9Y2I0,Primary cilium assembly protein FAM149B1 {ECO:0000305|PubMed:30905400},, PF12516;, GO:0005929;GO:0060271;GO:0061512;, C:cilium;, , P:cilium assembly; P:protein localization to cilium;|Q96BN6 Q9Y2I0,Primary cilium assembly protein FAM149B1 {ECO:0000305|PubMed:30905400},, PF12516;, GO:0005929;GO:0060271;GO:0061512;, C:cilium;, , P:cilium assembly; P:protein localization to cilium;|Q96BN6 Q9Y2I0,Primary cilium assembly protein FAM149B1 {ECO:0000305|PubMed:30905400},, PF12516;, GO:0005929;GO:0060271;GO:0061512;, C:cilium;, , P:cilium assembly; P:protein localization to cilium;|Q96BN6 Q9Y2I0,Primary cilium assembly protein FAM149B1 {ECO:0000305|PubMed:30905400},, PF12516;, GO:0005929;GO:0060271;GO:0061512;, C:cilium;, , P:cilium assembly; P:protein localization to cilium;|Q8WXX5 B2RMW6,DnaJ homolog subfamily C member 9,DnaJ protein SB73;, PF00226;, GO:0005737;GO:0005829;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0031072;GO:0032781;, C:cytoplasm; C:cytosol; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:heat shock protein binding;, P:positive regulation of ATPase activity;|Q8WXX5 B2RMW6,DnaJ homolog subfamily C member 9,DnaJ protein SB73;, PF00226;, GO:0005737;GO:0005829;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0031072;GO:0032781;, C:cytoplasm; C:cytosol; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:heat shock protein binding;, P:positive regulation of ATPase activity; scaffold14 indexed_genome mRNA 16520261 16523324 . - . ID=transcript_3630;Q9Y3D3 B4E032 Q96Q60,28S ribosomal protein S16, mitochondrial,Mitochondrial small ribosomal subunit protein bS16m {ECO:0000303|PubMed:25838379};, PF00886;, GO:0005829;GO:0005743;GO:0005763;GO:0005739;GO:0015935;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:small ribosomal subunit;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9Y3D3 B4E032 Q96Q60,28S ribosomal protein S16, mitochondrial,Mitochondrial small ribosomal subunit protein bS16m {ECO:0000303|PubMed:25838379};, PF00886;, GO:0005829;GO:0005743;GO:0005763;GO:0005739;GO:0015935;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:small ribosomal subunit;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold14 indexed_genome mRNA 16523428 16609067 . - . ID=transcript_3631;Q8NI31,Cilia- and flagella-associated protein 70 {ECO:0000312|HGNC:HGNC:30726},Tetratricopeptide repeat protein 18 {ECO:0000305};, PF13181;, GO:0005930;GO:0036064;GO:0070062;GO:0036157;GO:0036126;GO:0060271;GO:0003341;, C:axoneme; C:ciliary basal body; C:extracellular exosome; C:outer dynein arm; C:sperm flagellum;, , P:cilium assembly; P:cilium movement;|Q8NI31,Cilia- and flagella-associated protein 70 {ECO:0000312|HGNC:HGNC:30726},Tetratricopeptide repeat protein 18 {ECO:0000305};, PF13181;, GO:0005930;GO:0036064;GO:0070062;GO:0036157;GO:0036126;GO:0060271;GO:0003341;, C:axoneme; C:ciliary basal body; C:extracellular exosome; C:outer dynein arm; C:sperm flagellum;, , P:cilium assembly; P:cilium movement;|Q8NI31,Cilia- and flagella-associated protein 70 {ECO:0000312|HGNC:HGNC:30726},Tetratricopeptide repeat protein 18 {ECO:0000305};, PF13181;, GO:0005930;GO:0036064;GO:0070062;GO:0036157;GO:0036126;GO:0060271;GO:0003341;, C:axoneme; C:ciliary basal body; C:extracellular exosome; C:outer dynein arm; C:sperm flagellum;, , P:cilium assembly; P:cilium movement;|Q8NI31,Cilia- and flagella-associated protein 70 {ECO:0000312|HGNC:HGNC:30726},Tetratricopeptide repeat protein 18 {ECO:0000305};, PF13181;, GO:0005930;GO:0036064;GO:0070062;GO:0036157;GO:0036126;GO:0060271;GO:0003341;, C:axoneme; C:ciliary basal body; C:extracellular exosome; C:outer dynein arm; C:sperm flagellum;, , P:cilium assembly; P:cilium movement;|Q8NI31,Cilia- and flagella-associated protein 70 {ECO:0000312|HGNC:HGNC:30726},Tetratricopeptide repeat protein 18 {ECO:0000305};, PF13181;, GO:0005930;GO:0036064;GO:0070062;GO:0036157;GO:0036126;GO:0060271;GO:0003341;, C:axoneme; C:ciliary basal body; C:extracellular exosome; C:outer dynein arm; C:sperm flagellum;, , P:cilium assembly; P:cilium movement; scaffold14 indexed_genome mRNA 16611070 16634415 . - . ID=transcript_3632;P20073 Q5F2H3 Q5T0M6 Q5T0M7,Annexin A7,Annexin VII;Annexin-7;Synexin;, PF00191;, GO:0062023;GO:0005737;GO:0005789;GO:0070062;GO:0016020;GO:0005634;GO:0005509;GO:0005544;GO:0048306;GO:0005178;GO:0003723;GO:0006914;GO:0030855;GO:0061025;GO:0010629;GO:0051592;GO:0014070;, C:collagen-containing extracellular matrix; C:cytoplasm; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:nucleus;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:integrin binding; F:RNA binding;, P:autophagy; P:epithelial cell differentiation; P:membrane fusion; P:negative regulation of gene expression; P:response to calcium ion; P:response to organic cyclic compound;|P20073 Q5F2H3 Q5T0M6 Q5T0M7,Annexin A7,Annexin VII;Annexin-7;Synexin;, PF00191;, GO:0062023;GO:0005737;GO:0005789;GO:0070062;GO:0016020;GO:0005634;GO:0005509;GO:0005544;GO:0048306;GO:0005178;GO:0003723;GO:0006914;GO:0030855;GO:0061025;GO:0010629;GO:0051592;GO:0014070;, C:collagen-containing extracellular matrix; C:cytoplasm; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:nucleus;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:integrin binding; F:RNA binding;, P:autophagy; P:epithelial cell differentiation; P:membrane fusion; P:negative regulation of gene expression; P:response to calcium ion; P:response to organic cyclic compound;|P20073 Q5F2H3 Q5T0M6 Q5T0M7,Annexin A7,Annexin VII;Annexin-7;Synexin;, PF00191;, GO:0062023;GO:0005737;GO:0005789;GO:0070062;GO:0016020;GO:0005634;GO:0005509;GO:0005544;GO:0048306;GO:0005178;GO:0003723;GO:0006914;GO:0030855;GO:0061025;GO:0010629;GO:0051592;GO:0014070;, C:collagen-containing extracellular matrix; C:cytoplasm; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:nucleus;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:integrin binding; F:RNA binding;, P:autophagy; P:epithelial cell differentiation; P:membrane fusion; P:negative regulation of gene expression; P:response to calcium ion; P:response to organic cyclic compound; scaffold14 indexed_genome mRNA 16641907 16650586 . - . ID=transcript_3633;Q4VC12 A6NGH6 Q2VP95 Q5F2H5 Q7Z3M9 Q8N8G0,Putative protein MSS51 homolog, mitochondrial,Zinc finger MYND domain-containing protein 17;, PF01753;, GO:0046872;, , F:metal ion binding;|Q4VC12 A6NGH6 Q2VP95 Q5F2H5 Q7Z3M9 Q8N8G0,Putative protein MSS51 homolog, mitochondrial,Zinc finger MYND domain-containing protein 17;, PF01753;, GO:0046872;, , F:metal ion binding;|Q4VC12 A6NGH6 Q2VP95 Q5F2H5 Q7Z3M9 Q8N8G0,Putative protein MSS51 homolog, mitochondrial,Zinc finger MYND domain-containing protein 17;, PF01753;, GO:0046872;, , F:metal ion binding;|Q4VC12 A6NGH6 Q2VP95 Q5F2H5 Q7Z3M9 Q8N8G0,Putative protein MSS51 homolog, mitochondrial,Zinc finger MYND domain-containing protein 17;, PF01753;, GO:0046872;, , F:metal ion binding;|Q4VC12 A6NGH6 Q2VP95 Q5F2H5 Q7Z3M9 Q8N8G0,Putative protein MSS51 homolog, mitochondrial,Zinc finger MYND domain-containing protein 17;, PF01753;, GO:0046872;, , F:metal ion binding; scaffold14 indexed_genome mRNA 16650595 16658656 . - . ID=transcript_3634;P16298 P16299 Q5F2F9 Q8N1F0 Q8N3W4,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform,CAM-PRP catalytic subunit;Calmodulin-dependent calcineurin A subunit beta isoform;, PF00149;, GO:0005955;GO:0005737;GO:0005829;GO:0098978;GO:0005654;GO:0005886;GO:0030315;GO:0030018;GO:0005509;GO:0005516;GO:0033192;GO:0019899;GO:0046983;GO:0030346;GO:0106306;GO:0004722;GO:0106307;GO:0048675;GO:0097720;GO:0033173;GO:0017156;GO:0016311;GO:0038095;GO:0007507;GO:0007612;GO:0031987;GO:0001946;GO:0007613;GO:0001915;GO:0035774;GO:0045944;GO:0045893;GO:0006470;GO:0006468;GO:0050796;GO:0048167;GO:1900242;GO:0034097;GO:0007165;GO:0042110;GO:0030217;GO:0043029;GO:0042098;GO:0007223;, C:calcineurin complex; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:nucleoplasm; C:plasma membrane; C:T-tubule; C:Z disc;, F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein phosphatase activity; F:enzyme binding; F:protein dimerization activity; F:protein phosphatase 2B binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:axon extension; P:calcineurin-mediated signaling; P:calcineurin-NFAT signaling cascade; P:calcium-ion regulated exocytosis; P:dephosphorylation; P:Fc-epsilon receptor signaling pathway; P:heart development; P:learning; P:locomotion involved in locomotory behavior; P:lymphangiogenesis; P:memory; P:negative regulation of T cell mediated cytotoxicity; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of insulin secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle endocytosis; P:response to cytokine; P:signal transduction; P:T cell activation; P:T cell differentiation; P:T cell homeostasis; P:T cell proliferation; P:Wnt signaling pathway, calcium modulating pathway; scaffold14 indexed_genome mRNA 16658728 16706823 . - . ID=transcript_3635;P16298 P16299 Q5F2F9 Q8N1F0 Q8N3W4,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform,CAM-PRP catalytic subunit;Calmodulin-dependent calcineurin A subunit beta isoform;, PF00149;, GO:0005955;GO:0005737;GO:0005829;GO:0098978;GO:0005654;GO:0005886;GO:0030315;GO:0030018;GO:0005509;GO:0005516;GO:0033192;GO:0019899;GO:0046983;GO:0030346;GO:0106306;GO:0004722;GO:0106307;GO:0048675;GO:0097720;GO:0033173;GO:0017156;GO:0016311;GO:0038095;GO:0007507;GO:0007612;GO:0031987;GO:0001946;GO:0007613;GO:0001915;GO:0035774;GO:0045944;GO:0045893;GO:0006470;GO:0006468;GO:0050796;GO:0048167;GO:1900242;GO:0034097;GO:0007165;GO:0042110;GO:0030217;GO:0043029;GO:0042098;GO:0007223;, C:calcineurin complex; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:nucleoplasm; C:plasma membrane; C:T-tubule; C:Z disc;, F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein phosphatase activity; F:enzyme binding; F:protein dimerization activity; F:protein phosphatase 2B binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:axon extension; P:calcineurin-mediated signaling; P:calcineurin-NFAT signaling cascade; P:calcium-ion regulated exocytosis; P:dephosphorylation; P:Fc-epsilon receptor signaling pathway; P:heart development; P:learning; P:locomotion involved in locomotory behavior; P:lymphangiogenesis; P:memory; P:negative regulation of T cell mediated cytotoxicity; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of insulin secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle endocytosis; P:response to cytokine; P:signal transduction; P:T cell activation; P:T cell differentiation; P:T cell homeostasis; P:T cell proliferation; P:Wnt signaling pathway, calcium modulating pathway;|P16298 P16299 Q5F2F9 Q8N1F0 Q8N3W4,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform,CAM-PRP catalytic subunit;Calmodulin-dependent calcineurin A subunit beta isoform;, PF00149;, GO:0005955;GO:0005737;GO:0005829;GO:0098978;GO:0005654;GO:0005886;GO:0030315;GO:0030018;GO:0005509;GO:0005516;GO:0033192;GO:0019899;GO:0046983;GO:0030346;GO:0106306;GO:0004722;GO:0106307;GO:0048675;GO:0097720;GO:0033173;GO:0017156;GO:0016311;GO:0038095;GO:0007507;GO:0007612;GO:0031987;GO:0001946;GO:0007613;GO:0001915;GO:0035774;GO:0045944;GO:0045893;GO:0006470;GO:0006468;GO:0050796;GO:0048167;GO:1900242;GO:0034097;GO:0007165;GO:0042110;GO:0030217;GO:0043029;GO:0042098;GO:0007223;, C:calcineurin complex; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:nucleoplasm; C:plasma membrane; C:T-tubule; C:Z disc;, F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein phosphatase activity; F:enzyme binding; F:protein dimerization activity; F:protein phosphatase 2B binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:axon extension; P:calcineurin-mediated signaling; P:calcineurin-NFAT signaling cascade; P:calcium-ion regulated exocytosis; P:dephosphorylation; P:Fc-epsilon receptor signaling pathway; P:heart development; P:learning; P:locomotion involved in locomotory behavior; P:lymphangiogenesis; P:memory; P:negative regulation of T cell mediated cytotoxicity; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of insulin secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle endocytosis; P:response to cytokine; P:signal transduction; P:T cell activation; P:T cell differentiation; P:T cell homeostasis; P:T cell proliferation; P:Wnt signaling pathway, calcium modulating pathway;|P16298 P16299 Q5F2F9 Q8N1F0 Q8N3W4,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform,CAM-PRP catalytic subunit;Calmodulin-dependent calcineurin A subunit beta isoform;, PF00149;, GO:0005955;GO:0005737;GO:0005829;GO:0098978;GO:0005654;GO:0005886;GO:0030315;GO:0030018;GO:0005509;GO:0005516;GO:0033192;GO:0019899;GO:0046983;GO:0030346;GO:0106306;GO:0004722;GO:0106307;GO:0048675;GO:0097720;GO:0033173;GO:0017156;GO:0016311;GO:0038095;GO:0007507;GO:0007612;GO:0031987;GO:0001946;GO:0007613;GO:0001915;GO:0035774;GO:0045944;GO:0045893;GO:0006470;GO:0006468;GO:0050796;GO:0048167;GO:1900242;GO:0034097;GO:0007165;GO:0042110;GO:0030217;GO:0043029;GO:0042098;GO:0007223;, C:calcineurin complex; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:nucleoplasm; C:plasma membrane; C:T-tubule; C:Z disc;, F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein phosphatase activity; F:enzyme binding; F:protein dimerization activity; F:protein phosphatase 2B binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:axon extension; P:calcineurin-mediated signaling; P:calcineurin-NFAT signaling cascade; P:calcium-ion regulated exocytosis; P:dephosphorylation; P:Fc-epsilon receptor signaling pathway; P:heart development; P:learning; P:locomotion involved in locomotory behavior; P:lymphangiogenesis; P:memory; P:negative regulation of T cell mediated cytotoxicity; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of insulin secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle endocytosis; P:response to cytokine; P:signal transduction; P:T cell activation; P:T cell differentiation; P:T cell homeostasis; P:T cell proliferation; P:Wnt signaling pathway, calcium modulating pathway; scaffold14 indexed_genome mRNA 16708738 16827015 . - . ID=transcript_3636;A6PVS7 B3KVY1 B9ZVM1 Q5F2F4 Q6P1N6 Q6ZSP1 Q6ZSR1 Q6ZTM0 Q8N1X2,Inactive ubiquitin carboxyl-terminal hydrolase 54,Inactive ubiquitin-specific peptidase 54;, PF00443;, GO:0004843;GO:0016579;, , F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|A6PVS7 B3KVY1 B9ZVM1 Q5F2F4 Q6P1N6 Q6ZSP1 Q6ZSR1 Q6ZTM0 Q8N1X2,Inactive ubiquitin carboxyl-terminal hydrolase 54,Inactive ubiquitin-specific peptidase 54;, PF00443;, GO:0004843;GO:0016579;, , F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|A6PVS7 B3KVY1 B9ZVM1 Q5F2F4 Q6P1N6 Q6ZSP1 Q6ZSR1 Q6ZTM0 Q8N1X2,Inactive ubiquitin carboxyl-terminal hydrolase 54,Inactive ubiquitin-specific peptidase 54;, PF00443;, GO:0004843;GO:0016579;, , F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|A6PVS7 B3KVY1 B9ZVM1 Q5F2F4 Q6P1N6 Q6ZSP1 Q6ZSR1 Q6ZTM0 Q8N1X2,Inactive ubiquitin carboxyl-terminal hydrolase 54,Inactive ubiquitin-specific peptidase 54;, PF00443;, GO:0004843;GO:0016579;, , F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|A6PVS7 B3KVY1 B9ZVM1 Q5F2F4 Q6P1N6 Q6ZSP1 Q6ZSR1 Q6ZTM0 Q8N1X2,Inactive ubiquitin carboxyl-terminal hydrolase 54,Inactive ubiquitin-specific peptidase 54;, PF00443;, GO:0004843;GO:0016579;, , F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|A6PVS7 B3KVY1 B9ZVM1 Q5F2F4 Q6P1N6 Q6ZSP1 Q6ZSR1 Q6ZTM0 Q8N1X2,Inactive ubiquitin carboxyl-terminal hydrolase 54,Inactive ubiquitin-specific peptidase 54;, PF00443;, GO:0004843;GO:0016579;, , F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|A6PVS7 B3KVY1 B9ZVM1 Q5F2F4 Q6P1N6 Q6ZSP1 Q6ZSR1 Q6ZTM0 Q8N1X2,Inactive ubiquitin carboxyl-terminal hydrolase 54,Inactive ubiquitin-specific peptidase 54;, PF00443;, GO:0004843;GO:0016579;, , F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|A6PVS7 B3KVY1 B9ZVM1 Q5F2F4 Q6P1N6 Q6ZSP1 Q6ZSR1 Q6ZTM0 Q8N1X2,Inactive ubiquitin carboxyl-terminal hydrolase 54,Inactive ubiquitin-specific peptidase 54;, PF00443;, GO:0004843;GO:0016579;, , F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|A6PVS7 B3KVY1 B9ZVM1 Q5F2F4 Q6P1N6 Q6ZSP1 Q6ZSR1 Q6ZTM0 Q8N1X2,Inactive ubiquitin carboxyl-terminal hydrolase 54,Inactive ubiquitin-specific peptidase 54;, PF00443;, GO:0004843;GO:0016579;, , F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; scaffold14 indexed_genome mRNA 16830419 16841086 . - . ID=transcript_3637;Q9NP98 Q9H1I7,Myozenin-1,Calsarcin-2;Filamin-, actinin- and telethonin-binding protein;Protein FATZ;, PF05556;, GO:0015629;GO:0005634;GO:0031143;GO:0030018;GO:0003779;GO:0051373;GO:0004865;GO:0031433;GO:0030239;GO:0070885;GO:0043417;GO:0000122;GO:0045214;GO:0043503;GO:0007519;GO:0042060;, C:actin cytoskeleton; C:nucleus; C:pseudopodium; C:Z disc;, F:actin binding; F:FATZ binding; F:protein serine/threonine phosphatase inhibitor activity; F:telethonin binding;, P:myofibril assembly; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of skeletal muscle tissue regeneration; P:negative regulation of transcription by RNA polymerase II; P:sarcomere organization; P:skeletal muscle fiber adaptation; P:skeletal muscle tissue development; P:wound healing;|Q9NP98 Q9H1I7,Myozenin-1,Calsarcin-2;Filamin-, actinin- and telethonin-binding protein;Protein FATZ;, PF05556;, GO:0015629;GO:0005634;GO:0031143;GO:0030018;GO:0003779;GO:0051373;GO:0004865;GO:0031433;GO:0030239;GO:0070885;GO:0043417;GO:0000122;GO:0045214;GO:0043503;GO:0007519;GO:0042060;, C:actin cytoskeleton; C:nucleus; C:pseudopodium; C:Z disc;, F:actin binding; F:FATZ binding; F:protein serine/threonine phosphatase inhibitor activity; F:telethonin binding;, P:myofibril assembly; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of skeletal muscle tissue regeneration; P:negative regulation of transcription by RNA polymerase II; P:sarcomere organization; P:skeletal muscle fiber adaptation; P:skeletal muscle tissue development; P:wound healing; scaffold14 indexed_genome mRNA 16842955 16852450 . - . ID=transcript_3638;Q9H987 A5PKV9 Q68A20,Synaptopodin 2-like protein,, PF00595;, GO:0015629;GO:0030054;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0003007;GO:0032233;GO:0035025;GO:0051496;GO:0045214;, C:actin cytoskeleton; C:cell junction; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding;, P:heart morphogenesis; P:positive regulation of actin filament bundle assembly; P:positive regulation of Rho protein signal transduction; P:positive regulation of stress fiber assembly; P:sarcomere organization;|Q9H987 A5PKV9 Q68A20,Synaptopodin 2-like protein,, PF00595;, GO:0015629;GO:0030054;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0003007;GO:0032233;GO:0035025;GO:0051496;GO:0045214;, C:actin cytoskeleton; C:cell junction; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding;, P:heart morphogenesis; P:positive regulation of actin filament bundle assembly; P:positive regulation of Rho protein signal transduction; P:positive regulation of stress fiber assembly; P:sarcomere organization;|Q9H987 A5PKV9 Q68A20,Synaptopodin 2-like protein,, PF00595;, GO:0015629;GO:0030054;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0003007;GO:0032233;GO:0035025;GO:0051496;GO:0045214;, C:actin cytoskeleton; C:cell junction; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding;, P:heart morphogenesis; P:positive regulation of actin filament bundle assembly; P:positive regulation of Rho protein signal transduction; P:positive regulation of stress fiber assembly; P:sarcomere organization;|Q9H987 A5PKV9 Q68A20,Synaptopodin 2-like protein,, PF00595;, GO:0015629;GO:0030054;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0003007;GO:0032233;GO:0035025;GO:0051496;GO:0045214;, C:actin cytoskeleton; C:cell junction; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding;, P:heart morphogenesis; P:positive regulation of actin filament bundle assembly; P:positive regulation of Rho protein signal transduction; P:positive regulation of stress fiber assembly; P:sarcomere organization; scaffold14 indexed_genome mRNA 16866065 16901464 . - . ID=transcript_3639;P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|Q902F9,Endogenous retrovirus group K member 113 Env polyprotein,EnvK5 protein;Envelope polyprotein;HERV-K113 envelope protein;HERV-K_19p13.11 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity;|P63136,Endogenous retrovirus group K member 25 Pol protein,HERV-K_11q22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination;|P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|P53992 B4DZT4 Q8WV25,Protein transport protein Sec24C {ECO:0000305},SEC24-related protein C;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport;|Q495W5 Q495W7 Q8IYE4,Alpha-(1,3)-fucosyltransferase 11,Fucosyltransferase XI;Galactoside 3-L-fucosyltransferase 11;, PF17039;PF00852;, GO:0032580;GO:0016021;GO:0046920;GO:0036065;GO:0006486;, C:Golgi cisterna membrane; C:integral component of membrane;, F:alpha-(1->3)-fucosyltransferase activity;, P:fucosylation; P:protein glycosylation;|Q495W5 Q495W7 Q8IYE4,Alpha-(1,3)-fucosyltransferase 11,Fucosyltransferase XI;Galactoside 3-L-fucosyltransferase 11;, PF17039;PF00852;, GO:0032580;GO:0016021;GO:0046920;GO:0036065;GO:0006486;, C:Golgi cisterna membrane; C:integral component of membrane;, F:alpha-(1->3)-fucosyltransferase activity;, P:fucosylation; P:protein glycosylation; scaffold14 indexed_genome mRNA 16901785 16902545 . - . ID=transcript_3640;Q96BP2,Coiled-coil-helix-coiled-coil-helix domain-containing protein 1,28S ribosomal protein S37, mitochondrial;Mitochondrial small ribosomal subunit protein mS37 {ECO:0000303|PubMed:25838379};Nuclear protein C2360;, PF06747;, GO:0005829;GO:0001650;GO:0005743;GO:0005761;GO:0005739;GO:0005654;GO:0003723;GO:0070125;GO:0070126;, C:cytosol; C:fibrillar center; C:mitochondrial inner membrane; C:mitochondrial ribosome; C:mitochondrion; C:nucleoplasm;, F:RNA binding;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold14 indexed_genome mRNA 16904621 16918661 . + . ID=transcript_3641;A7E2V4 B2RP37 O94987 Q17RS8 Q2TAB8 Q6P439 Q8IW81 Q8NB34 Q9H8F3,Zinc finger SWIM domain-containing protein 8 {ECO:0000305},, , GO:0031462;GO:0031463;GO:0005829;GO:1990756;GO:0008270;GO:2000627;GO:0043161;GO:0016567;GO:1902667;, C:Cul2-RING ubiquitin ligase complex; C:Cul3-RING ubiquitin ligase complex; C:cytosol;, F:ubiquitin ligase-substrate adaptor activity; F:zinc ion binding;, P:positive regulation of miRNA catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of axon guidance;|A7E2V4 B2RP37 O94987 Q17RS8 Q2TAB8 Q6P439 Q8IW81 Q8NB34 Q9H8F3,Zinc finger SWIM domain-containing protein 8 {ECO:0000305},, , GO:0031462;GO:0031463;GO:0005829;GO:1990756;GO:0008270;GO:2000627;GO:0043161;GO:0016567;GO:1902667;, C:Cul2-RING ubiquitin ligase complex; C:Cul3-RING ubiquitin ligase complex; C:cytosol;, F:ubiquitin ligase-substrate adaptor activity; F:zinc ion binding;, P:positive regulation of miRNA catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of axon guidance; scaffold14 indexed_genome mRNA 16918757 16927064 . - . ID=transcript_3642;P52849 Q2TB32 Q59H89,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2,Glucosaminyl N-deacetylase/N-sulfotransferase 2;N-heparan sulfate sulfotransferase 2;, PF12062;PF00685;, GO:0005794;GO:0000139;GO:0016021;GO:0015016;GO:0019213;GO:0006024;GO:0015014;GO:0030210;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:[heparan sulfate]-glucosamine N-sulfotransferase activity; F:deacetylase activity;, P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process;|P52849 Q2TB32 Q59H89,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2,Glucosaminyl N-deacetylase/N-sulfotransferase 2;N-heparan sulfate sulfotransferase 2;, PF12062;PF00685;, GO:0005794;GO:0000139;GO:0016021;GO:0015016;GO:0019213;GO:0006024;GO:0015014;GO:0030210;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:[heparan sulfate]-glucosamine N-sulfotransferase activity; F:deacetylase activity;, P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; scaffold14 indexed_genome mRNA 16937828 16977661 . - . ID=transcript_3643;Q5SQZ3 Q5SQZ4 Q5SWX4 Q7KYX5 Q8N4I3 Q8NIA4,Calcium/calmodulin-dependent protein kinase type II subunit gamma,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0016020;GO:0043005;GO:0005654;GO:0033017;GO:0005524;GO:0004723;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0030154;GO:0030073;GO:0060333;GO:0007399;GO:0051924;GO:1900034;GO:0010975;GO:0014733;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:membrane; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:calcium-dependent protein serine/threonine phosphatase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:insulin secretion; P:interferon-gamma-mediated signaling pathway; P:nervous system development; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of neuron projection development; P:regulation of skeletal muscle adaptation;|Q5SQZ3 Q5SQZ4 Q5SWX4 Q7KYX5 Q8N4I3 Q8NIA4,Calcium/calmodulin-dependent protein kinase type II subunit gamma,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0016020;GO:0043005;GO:0005654;GO:0033017;GO:0005524;GO:0004723;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0030154;GO:0030073;GO:0060333;GO:0007399;GO:0051924;GO:1900034;GO:0010975;GO:0014733;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:membrane; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:calcium-dependent protein serine/threonine phosphatase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:insulin secretion; P:interferon-gamma-mediated signaling pathway; P:nervous system development; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of neuron projection development; P:regulation of skeletal muscle adaptation;|Q5SQZ3 Q5SQZ4 Q5SWX4 Q7KYX5 Q8N4I3 Q8NIA4,Calcium/calmodulin-dependent protein kinase type II subunit gamma,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0016020;GO:0043005;GO:0005654;GO:0033017;GO:0005524;GO:0004723;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0030154;GO:0030073;GO:0060333;GO:0007399;GO:0051924;GO:1900034;GO:0010975;GO:0014733;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:membrane; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:calcium-dependent protein serine/threonine phosphatase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:insulin secretion; P:interferon-gamma-mediated signaling pathway; P:nervous system development; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of neuron projection development; P:regulation of skeletal muscle adaptation;|Q5SQZ3 Q5SQZ4 Q5SWX4 Q7KYX5 Q8N4I3 Q8NIA4,Calcium/calmodulin-dependent protein kinase type II subunit gamma,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0016020;GO:0043005;GO:0005654;GO:0033017;GO:0005524;GO:0004723;GO:0005516;GO:0004683;GO:0042802;GO:0042803;GO:0106310;GO:0106311;GO:0030154;GO:0030073;GO:0060333;GO:0007399;GO:0051924;GO:1900034;GO:0010975;GO:0014733;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:membrane; C:neuron projection; C:nucleoplasm; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:calcium-dependent protein serine/threonine phosphatase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:insulin secretion; P:interferon-gamma-mediated signaling pathway; P:nervous system development; P:regulation of calcium ion transport; P:regulation of cellular response to heat; P:regulation of neuron projection development; P:regulation of skeletal muscle adaptation; scaffold14 indexed_genome mRNA 17030051 17032713 . + . ID=transcript_3644;P00749 B4DPZ2 Q15844 Q16618 Q53XS3 Q5SWW9 Q969W6,Urokinase-type plasminogen activator,, PF00051;PF00089;, GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005886;GO:0035579;GO:0070821;GO:0004252;GO:0007596;GO:0006935;GO:0042730;GO:0043312;GO:0031639;GO:0030335;GO:0006508;GO:0033628;GO:0042127;GO:0010469;GO:0014910;GO:2000097;GO:0061041;GO:0001666;GO:0007165;GO:0014909;, C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:serine-type endopeptidase activity;, P:blood coagulation; P:chemotaxis; P:fibrinolysis; P:neutrophil degranulation; P:plasminogen activation; P:positive regulation of cell migration; P:proteolysis; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of signaling receptor activity; P:regulation of smooth muscle cell migration; P:regulation of smooth muscle cell-matrix adhesion; P:regulation of wound healing; P:response to hypoxia; P:signal transduction; P:smooth muscle cell migration;|Q5SWW7 Q3KRG4 Q8NAK4,Uncharacterized protein C10orf55,, , GO:0042802;, , F:identical protein binding; scaffold14 indexed_genome mRNA 17033031 17036143 . + . ID=transcript_3645;P00749 B4DPZ2 Q15844 Q16618 Q53XS3 Q5SWW9 Q969W6,Urokinase-type plasminogen activator,, PF00051;PF00089;, GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005886;GO:0035579;GO:0070821;GO:0004252;GO:0007596;GO:0006935;GO:0042730;GO:0043312;GO:0031639;GO:0030335;GO:0006508;GO:0033628;GO:0042127;GO:0010469;GO:0014910;GO:2000097;GO:0061041;GO:0001666;GO:0007165;GO:0014909;, C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:serine-type endopeptidase activity;, P:blood coagulation; P:chemotaxis; P:fibrinolysis; P:neutrophil degranulation; P:plasminogen activation; P:positive regulation of cell migration; P:proteolysis; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of signaling receptor activity; P:regulation of smooth muscle cell migration; P:regulation of smooth muscle cell-matrix adhesion; P:regulation of wound healing; P:response to hypoxia; P:signal transduction; P:smooth muscle cell migration; scaffold14 indexed_genome mRNA 17111562 17211888 . + . ID=transcript_3646;P18206 Q16450 Q5SWX2 Q7Z3B8 Q8IXU7,Vinculin,Metavinculin;, PF01044;, GO:0005912;GO:0005903;GO:0044291;GO:0005911;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0005916;GO:1904813;GO:0005925;GO:0090637;GO:0045121;GO:0090636;GO:0005886;GO:0002102;GO:0032991;GO:0042383;GO:0034774;GO:0035580;GO:1990357;GO:0005915;GO:0003779;GO:0045294;GO:0008013;GO:0045296;GO:0002162;GO:0005198;GO:0031625;GO:0034333;GO:0043297;GO:0048675;GO:0007155;GO:0007160;GO:0090136;GO:0030032;GO:0035633;GO:0002009;GO:0006936;GO:0030336;GO:0043312;GO:0070527;GO:0002576;GO:0034394;GO:1903140;GO:0051893;GO:1904702;, C:adherens junction; C:brush border; C:cell-cell contact zone; C:cell-cell junction; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:inner dense plaque of desmosome; C:membrane raft; C:outer dense plaque of desmosome; C:plasma membrane; C:podosome; C:protein-containing complex; C:sarcolemma; C:secretory granule lumen; C:specific granule lumen; C:terminal web; C:zonula adherens;, F:actin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:dystroglycan binding; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:apical junction assembly; P:axon extension; P:cell adhesion; P:cell-matrix adhesion; P:epithelial cell-cell adhesion; P:lamellipodium assembly; P:maintenance of blood-brain barrier; P:morphogenesis of an epithelium; P:muscle contraction; P:negative regulation of cell migration; P:neutrophil degranulation; P:platelet aggregation; P:platelet degranulation; P:protein localization to cell surface; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of protein localization to adherens junction;|P18206 Q16450 Q5SWX2 Q7Z3B8 Q8IXU7,Vinculin,Metavinculin;, PF01044;, GO:0005912;GO:0005903;GO:0044291;GO:0005911;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0005916;GO:1904813;GO:0005925;GO:0090637;GO:0045121;GO:0090636;GO:0005886;GO:0002102;GO:0032991;GO:0042383;GO:0034774;GO:0035580;GO:1990357;GO:0005915;GO:0003779;GO:0045294;GO:0008013;GO:0045296;GO:0002162;GO:0005198;GO:0031625;GO:0034333;GO:0043297;GO:0048675;GO:0007155;GO:0007160;GO:0090136;GO:0030032;GO:0035633;GO:0002009;GO:0006936;GO:0030336;GO:0043312;GO:0070527;GO:0002576;GO:0034394;GO:1903140;GO:0051893;GO:1904702;, C:adherens junction; C:brush border; C:cell-cell contact zone; C:cell-cell junction; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:inner dense plaque of desmosome; C:membrane raft; C:outer dense plaque of desmosome; C:plasma membrane; C:podosome; C:protein-containing complex; C:sarcolemma; C:secretory granule lumen; C:specific granule lumen; C:terminal web; C:zonula adherens;, F:actin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:dystroglycan binding; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:apical junction assembly; P:axon extension; P:cell adhesion; P:cell-matrix adhesion; P:epithelial cell-cell adhesion; P:lamellipodium assembly; P:maintenance of blood-brain barrier; P:morphogenesis of an epithelium; P:muscle contraction; P:negative regulation of cell migration; P:neutrophil degranulation; P:platelet aggregation; P:platelet degranulation; P:protein localization to cell surface; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of protein localization to adherens junction;|P18206 Q16450 Q5SWX2 Q7Z3B8 Q8IXU7,Vinculin,Metavinculin;, PF01044;, GO:0005912;GO:0005903;GO:0044291;GO:0005911;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0005916;GO:1904813;GO:0005925;GO:0090637;GO:0045121;GO:0090636;GO:0005886;GO:0002102;GO:0032991;GO:0042383;GO:0034774;GO:0035580;GO:1990357;GO:0005915;GO:0003779;GO:0045294;GO:0008013;GO:0045296;GO:0002162;GO:0005198;GO:0031625;GO:0034333;GO:0043297;GO:0048675;GO:0007155;GO:0007160;GO:0090136;GO:0030032;GO:0035633;GO:0002009;GO:0006936;GO:0030336;GO:0043312;GO:0070527;GO:0002576;GO:0034394;GO:1903140;GO:0051893;GO:1904702;, C:adherens junction; C:brush border; C:cell-cell contact zone; C:cell-cell junction; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:inner dense plaque of desmosome; C:membrane raft; C:outer dense plaque of desmosome; C:plasma membrane; C:podosome; C:protein-containing complex; C:sarcolemma; C:secretory granule lumen; C:specific granule lumen; C:terminal web; C:zonula adherens;, F:actin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:dystroglycan binding; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:apical junction assembly; P:axon extension; P:cell adhesion; P:cell-matrix adhesion; P:epithelial cell-cell adhesion; P:lamellipodium assembly; P:maintenance of blood-brain barrier; P:morphogenesis of an epithelium; P:muscle contraction; P:negative regulation of cell migration; P:neutrophil degranulation; P:platelet aggregation; P:platelet degranulation; P:protein localization to cell surface; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of protein localization to adherens junction;|P18206 Q16450 Q5SWX2 Q7Z3B8 Q8IXU7,Vinculin,Metavinculin;, PF01044;, GO:0005912;GO:0005903;GO:0044291;GO:0005911;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0005916;GO:1904813;GO:0005925;GO:0090637;GO:0045121;GO:0090636;GO:0005886;GO:0002102;GO:0032991;GO:0042383;GO:0034774;GO:0035580;GO:1990357;GO:0005915;GO:0003779;GO:0045294;GO:0008013;GO:0045296;GO:0002162;GO:0005198;GO:0031625;GO:0034333;GO:0043297;GO:0048675;GO:0007155;GO:0007160;GO:0090136;GO:0030032;GO:0035633;GO:0002009;GO:0006936;GO:0030336;GO:0043312;GO:0070527;GO:0002576;GO:0034394;GO:1903140;GO:0051893;GO:1904702;, C:adherens junction; C:brush border; C:cell-cell contact zone; C:cell-cell junction; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:inner dense plaque of desmosome; C:membrane raft; C:outer dense plaque of desmosome; C:plasma membrane; C:podosome; C:protein-containing complex; C:sarcolemma; C:secretory granule lumen; C:specific granule lumen; C:terminal web; C:zonula adherens;, F:actin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:dystroglycan binding; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:apical junction assembly; P:axon extension; P:cell adhesion; P:cell-matrix adhesion; P:epithelial cell-cell adhesion; P:lamellipodium assembly; P:maintenance of blood-brain barrier; P:morphogenesis of an epithelium; P:muscle contraction; P:negative regulation of cell migration; P:neutrophil degranulation; P:platelet aggregation; P:platelet degranulation; P:protein localization to cell surface; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of protein localization to adherens junction;|P18206 Q16450 Q5SWX2 Q7Z3B8 Q8IXU7,Vinculin,Metavinculin;, PF01044;, GO:0005912;GO:0005903;GO:0044291;GO:0005911;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0005916;GO:1904813;GO:0005925;GO:0090637;GO:0045121;GO:0090636;GO:0005886;GO:0002102;GO:0032991;GO:0042383;GO:0034774;GO:0035580;GO:1990357;GO:0005915;GO:0003779;GO:0045294;GO:0008013;GO:0045296;GO:0002162;GO:0005198;GO:0031625;GO:0034333;GO:0043297;GO:0048675;GO:0007155;GO:0007160;GO:0090136;GO:0030032;GO:0035633;GO:0002009;GO:0006936;GO:0030336;GO:0043312;GO:0070527;GO:0002576;GO:0034394;GO:1903140;GO:0051893;GO:1904702;, C:adherens junction; C:brush border; C:cell-cell contact zone; C:cell-cell junction; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:inner dense plaque of desmosome; C:membrane raft; C:outer dense plaque of desmosome; C:plasma membrane; C:podosome; C:protein-containing complex; C:sarcolemma; C:secretory granule lumen; C:specific granule lumen; C:terminal web; C:zonula adherens;, F:actin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:dystroglycan binding; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:apical junction assembly; P:axon extension; P:cell adhesion; P:cell-matrix adhesion; P:epithelial cell-cell adhesion; P:lamellipodium assembly; P:maintenance of blood-brain barrier; P:morphogenesis of an epithelium; P:muscle contraction; P:negative regulation of cell migration; P:neutrophil degranulation; P:platelet aggregation; P:platelet degranulation; P:protein localization to cell surface; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of protein localization to adherens junction;|P18206 Q16450 Q5SWX2 Q7Z3B8 Q8IXU7,Vinculin,Metavinculin;, PF01044;, GO:0005912;GO:0005903;GO:0044291;GO:0005911;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0005916;GO:1904813;GO:0005925;GO:0090637;GO:0045121;GO:0090636;GO:0005886;GO:0002102;GO:0032991;GO:0042383;GO:0034774;GO:0035580;GO:1990357;GO:0005915;GO:0003779;GO:0045294;GO:0008013;GO:0045296;GO:0002162;GO:0005198;GO:0031625;GO:0034333;GO:0043297;GO:0048675;GO:0007155;GO:0007160;GO:0090136;GO:0030032;GO:0035633;GO:0002009;GO:0006936;GO:0030336;GO:0043312;GO:0070527;GO:0002576;GO:0034394;GO:1903140;GO:0051893;GO:1904702;, C:adherens junction; C:brush border; C:cell-cell contact zone; C:cell-cell junction; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:inner dense plaque of desmosome; C:membrane raft; C:outer dense plaque of desmosome; C:plasma membrane; C:podosome; C:protein-containing complex; C:sarcolemma; C:secretory granule lumen; C:specific granule lumen; C:terminal web; C:zonula adherens;, F:actin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:dystroglycan binding; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:apical junction assembly; P:axon extension; P:cell adhesion; P:cell-matrix adhesion; P:epithelial cell-cell adhesion; P:lamellipodium assembly; P:maintenance of blood-brain barrier; P:morphogenesis of an epithelium; P:muscle contraction; P:negative regulation of cell migration; P:neutrophil degranulation; P:platelet aggregation; P:platelet degranulation; P:protein localization to cell surface; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of protein localization to adherens junction;|P18206 Q16450 Q5SWX2 Q7Z3B8 Q8IXU7,Vinculin,Metavinculin;, PF01044;, GO:0005912;GO:0005903;GO:0044291;GO:0005911;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0005916;GO:1904813;GO:0005925;GO:0090637;GO:0045121;GO:0090636;GO:0005886;GO:0002102;GO:0032991;GO:0042383;GO:0034774;GO:0035580;GO:1990357;GO:0005915;GO:0003779;GO:0045294;GO:0008013;GO:0045296;GO:0002162;GO:0005198;GO:0031625;GO:0034333;GO:0043297;GO:0048675;GO:0007155;GO:0007160;GO:0090136;GO:0030032;GO:0035633;GO:0002009;GO:0006936;GO:0030336;GO:0043312;GO:0070527;GO:0002576;GO:0034394;GO:1903140;GO:0051893;GO:1904702;, C:adherens junction; C:brush border; C:cell-cell contact zone; C:cell-cell junction; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:inner dense plaque of desmosome; C:membrane raft; C:outer dense plaque of desmosome; C:plasma membrane; C:podosome; C:protein-containing complex; C:sarcolemma; C:secretory granule lumen; C:specific granule lumen; C:terminal web; C:zonula adherens;, F:actin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:dystroglycan binding; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:apical junction assembly; P:axon extension; P:cell adhesion; P:cell-matrix adhesion; P:epithelial cell-cell adhesion; P:lamellipodium assembly; P:maintenance of blood-brain barrier; P:morphogenesis of an epithelium; P:muscle contraction; P:negative regulation of cell migration; P:neutrophil degranulation; P:platelet aggregation; P:platelet degranulation; P:protein localization to cell surface; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of protein localization to adherens junction; scaffold14 indexed_genome mRNA 17211910 17220545 . + . ID=transcript_3647;P18206 Q16450 Q5SWX2 Q7Z3B8 Q8IXU7,Vinculin,Metavinculin;, PF01044;, GO:0005912;GO:0005903;GO:0044291;GO:0005911;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0005916;GO:1904813;GO:0005925;GO:0090637;GO:0045121;GO:0090636;GO:0005886;GO:0002102;GO:0032991;GO:0042383;GO:0034774;GO:0035580;GO:1990357;GO:0005915;GO:0003779;GO:0045294;GO:0008013;GO:0045296;GO:0002162;GO:0005198;GO:0031625;GO:0034333;GO:0043297;GO:0048675;GO:0007155;GO:0007160;GO:0090136;GO:0030032;GO:0035633;GO:0002009;GO:0006936;GO:0030336;GO:0043312;GO:0070527;GO:0002576;GO:0034394;GO:1903140;GO:0051893;GO:1904702;, C:adherens junction; C:brush border; C:cell-cell contact zone; C:cell-cell junction; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:inner dense plaque of desmosome; C:membrane raft; C:outer dense plaque of desmosome; C:plasma membrane; C:podosome; C:protein-containing complex; C:sarcolemma; C:secretory granule lumen; C:specific granule lumen; C:terminal web; C:zonula adherens;, F:actin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:dystroglycan binding; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:apical junction assembly; P:axon extension; P:cell adhesion; P:cell-matrix adhesion; P:epithelial cell-cell adhesion; P:lamellipodium assembly; P:maintenance of blood-brain barrier; P:morphogenesis of an epithelium; P:muscle contraction; P:negative regulation of cell migration; P:neutrophil degranulation; P:platelet aggregation; P:platelet degranulation; P:protein localization to cell surface; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of protein localization to adherens junction;|P18206 Q16450 Q5SWX2 Q7Z3B8 Q8IXU7,Vinculin,Metavinculin;, PF01044;, GO:0005912;GO:0005903;GO:0044291;GO:0005911;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0005916;GO:1904813;GO:0005925;GO:0090637;GO:0045121;GO:0090636;GO:0005886;GO:0002102;GO:0032991;GO:0042383;GO:0034774;GO:0035580;GO:1990357;GO:0005915;GO:0003779;GO:0045294;GO:0008013;GO:0045296;GO:0002162;GO:0005198;GO:0031625;GO:0034333;GO:0043297;GO:0048675;GO:0007155;GO:0007160;GO:0090136;GO:0030032;GO:0035633;GO:0002009;GO:0006936;GO:0030336;GO:0043312;GO:0070527;GO:0002576;GO:0034394;GO:1903140;GO:0051893;GO:1904702;, C:adherens junction; C:brush border; C:cell-cell contact zone; C:cell-cell junction; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:inner dense plaque of desmosome; C:membrane raft; C:outer dense plaque of desmosome; C:plasma membrane; C:podosome; C:protein-containing complex; C:sarcolemma; C:secretory granule lumen; C:specific granule lumen; C:terminal web; C:zonula adherens;, F:actin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:dystroglycan binding; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:apical junction assembly; P:axon extension; P:cell adhesion; P:cell-matrix adhesion; P:epithelial cell-cell adhesion; P:lamellipodium assembly; P:maintenance of blood-brain barrier; P:morphogenesis of an epithelium; P:muscle contraction; P:negative regulation of cell migration; P:neutrophil degranulation; P:platelet aggregation; P:platelet degranulation; P:protein localization to cell surface; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of protein localization to adherens junction;|P18206 Q16450 Q5SWX2 Q7Z3B8 Q8IXU7,Vinculin,Metavinculin;, PF01044;, GO:0005912;GO:0005903;GO:0044291;GO:0005911;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:0005916;GO:1904813;GO:0005925;GO:0090637;GO:0045121;GO:0090636;GO:0005886;GO:0002102;GO:0032991;GO:0042383;GO:0034774;GO:0035580;GO:1990357;GO:0005915;GO:0003779;GO:0045294;GO:0008013;GO:0045296;GO:0002162;GO:0005198;GO:0031625;GO:0034333;GO:0043297;GO:0048675;GO:0007155;GO:0007160;GO:0090136;GO:0030032;GO:0035633;GO:0002009;GO:0006936;GO:0030336;GO:0043312;GO:0070527;GO:0002576;GO:0034394;GO:1903140;GO:0051893;GO:1904702;, C:adherens junction; C:brush border; C:cell-cell contact zone; C:cell-cell junction; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:inner dense plaque of desmosome; C:membrane raft; C:outer dense plaque of desmosome; C:plasma membrane; C:podosome; C:protein-containing complex; C:sarcolemma; C:secretory granule lumen; C:specific granule lumen; C:terminal web; C:zonula adherens;, F:actin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:dystroglycan binding; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:adherens junction assembly; P:apical junction assembly; P:axon extension; P:cell adhesion; P:cell-matrix adhesion; P:epithelial cell-cell adhesion; P:lamellipodium assembly; P:maintenance of blood-brain barrier; P:morphogenesis of an epithelium; P:muscle contraction; P:negative regulation of cell migration; P:neutrophil degranulation; P:platelet aggregation; P:platelet degranulation; P:protein localization to cell surface; P:regulation of establishment of endothelial barrier; P:regulation of focal adhesion assembly; P:regulation of protein localization to adherens junction; scaffold14 indexed_genome mRNA 17221680 17242340 . - . ID=transcript_3648;Q9Y2T2 Q5JQ12 Q9H5L2,AP-3 complex subunit mu-1,AP-3 adaptor complex mu3A subunit;Adaptor-related protein complex 3 subunit mu-1;Mu-adaptin 3A;Mu3A-adaptin;, PF00928;PF01217;, GO:1904115;GO:0030131;GO:0031410;GO:0030659;GO:0005794;GO:0043231;GO:0005765;GO:0005764;GO:0031267;GO:0008089;GO:0048490;GO:0006897;GO:0006622;GO:0016192;GO:0016032;, C:axon cytoplasm; C:clathrin adaptor complex; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome;, F:small GTPase binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endocytosis; P:protein targeting to lysosome; P:vesicle-mediated transport; P:viral process;|Q9Y2T2 Q5JQ12 Q9H5L2,AP-3 complex subunit mu-1,AP-3 adaptor complex mu3A subunit;Adaptor-related protein complex 3 subunit mu-1;Mu-adaptin 3A;Mu3A-adaptin;, PF00928;PF01217;, GO:1904115;GO:0030131;GO:0031410;GO:0030659;GO:0005794;GO:0043231;GO:0005765;GO:0005764;GO:0031267;GO:0008089;GO:0048490;GO:0006897;GO:0006622;GO:0016192;GO:0016032;, C:axon cytoplasm; C:clathrin adaptor complex; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome;, F:small GTPase binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endocytosis; P:protein targeting to lysosome; P:vesicle-mediated transport; P:viral process;|Q9Y2T2 Q5JQ12 Q9H5L2,AP-3 complex subunit mu-1,AP-3 adaptor complex mu3A subunit;Adaptor-related protein complex 3 subunit mu-1;Mu-adaptin 3A;Mu3A-adaptin;, PF00928;PF01217;, GO:1904115;GO:0030131;GO:0031410;GO:0030659;GO:0005794;GO:0043231;GO:0005765;GO:0005764;GO:0031267;GO:0008089;GO:0048490;GO:0006897;GO:0006622;GO:0016192;GO:0016032;, C:axon cytoplasm; C:clathrin adaptor complex; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome;, F:small GTPase binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endocytosis; P:protein targeting to lysosome; P:vesicle-mediated transport; P:viral process;|Q9Y2T2 Q5JQ12 Q9H5L2,AP-3 complex subunit mu-1,AP-3 adaptor complex mu3A subunit;Adaptor-related protein complex 3 subunit mu-1;Mu-adaptin 3A;Mu3A-adaptin;, PF00928;PF01217;, GO:1904115;GO:0030131;GO:0031410;GO:0030659;GO:0005794;GO:0043231;GO:0005765;GO:0005764;GO:0031267;GO:0008089;GO:0048490;GO:0006897;GO:0006622;GO:0016192;GO:0016032;, C:axon cytoplasm; C:clathrin adaptor complex; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome;, F:small GTPase binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endocytosis; P:protein targeting to lysosome; P:vesicle-mediated transport; P:viral process;|Q9Y2T2 Q5JQ12 Q9H5L2,AP-3 complex subunit mu-1,AP-3 adaptor complex mu3A subunit;Adaptor-related protein complex 3 subunit mu-1;Mu-adaptin 3A;Mu3A-adaptin;, PF00928;PF01217;, GO:1904115;GO:0030131;GO:0031410;GO:0030659;GO:0005794;GO:0043231;GO:0005765;GO:0005764;GO:0031267;GO:0008089;GO:0048490;GO:0006897;GO:0006622;GO:0016192;GO:0016032;, C:axon cytoplasm; C:clathrin adaptor complex; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome;, F:small GTPase binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endocytosis; P:protein targeting to lysosome; P:vesicle-mediated transport; P:viral process;|Q9Y2T2 Q5JQ12 Q9H5L2,AP-3 complex subunit mu-1,AP-3 adaptor complex mu3A subunit;Adaptor-related protein complex 3 subunit mu-1;Mu-adaptin 3A;Mu3A-adaptin;, PF00928;PF01217;, GO:1904115;GO:0030131;GO:0031410;GO:0030659;GO:0005794;GO:0043231;GO:0005765;GO:0005764;GO:0031267;GO:0008089;GO:0048490;GO:0006897;GO:0006622;GO:0016192;GO:0016032;, C:axon cytoplasm; C:clathrin adaptor complex; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome;, F:small GTPase binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endocytosis; P:protein targeting to lysosome; P:vesicle-mediated transport; P:viral process; scaffold14 indexed_genome mRNA 17276348 17789153 . + . ID=transcript_3649;P55263 B7Z783 B7Z800 O00741 O00742 Q16710 Q5JQ10 Q5JQ11 Q9BTN2,Adenosine kinase,Adenosine 5'-phosphotransferase;, PF00294;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0004001;GO:0005524;GO:0046872;GO:0003723;GO:0044209;GO:0006175;GO:0006166;GO:0043101;GO:0009156;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:adenosine kinase activity; F:ATP binding; F:metal ion binding; F:RNA binding;, P:AMP salvage; P:dATP biosynthetic process; P:purine ribonucleoside salvage; P:purine-containing compound salvage; P:ribonucleoside monophosphate biosynthetic process; scaffold14 indexed_genome mRNA 17873383 18053226 . + . ID=transcript_3650;Q8WYB5 O15087 Q86Y05 Q8WU81 Q9UKW2 Q9UKW3 Q9UKX0,Histone acetyltransferase KAT6B,Histone acetyltransferase MOZ2;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4;Monocytic leukemia zinc finger protein-related factor;, PF01853;PF00628;PF17772;, GO:0070776;GO:0005654;GO:0000786;GO:0005634;GO:0016407;GO:0003677;GO:0004402;GO:0042393;GO:0046872;GO:0044877;GO:0003712;GO:0008134;GO:0016573;GO:0043966;GO:0045892;GO:0006334;GO:0045944;GO:0045893;GO:0006355;, C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleosome; C:nucleus;, F:acetyltransferase activity; F:DNA binding; F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:protein-containing complex binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H3 acetylation; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q8WYB5 O15087 Q86Y05 Q8WU81 Q9UKW2 Q9UKW3 Q9UKX0,Histone acetyltransferase KAT6B,Histone acetyltransferase MOZ2;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4;Monocytic leukemia zinc finger protein-related factor;, PF01853;PF00628;PF17772;, GO:0070776;GO:0005654;GO:0000786;GO:0005634;GO:0016407;GO:0003677;GO:0004402;GO:0042393;GO:0046872;GO:0044877;GO:0003712;GO:0008134;GO:0016573;GO:0043966;GO:0045892;GO:0006334;GO:0045944;GO:0045893;GO:0006355;, C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleosome; C:nucleus;, F:acetyltransferase activity; F:DNA binding; F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:protein-containing complex binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H3 acetylation; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q8WYB5 O15087 Q86Y05 Q8WU81 Q9UKW2 Q9UKW3 Q9UKX0,Histone acetyltransferase KAT6B,Histone acetyltransferase MOZ2;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4;Monocytic leukemia zinc finger protein-related factor;, PF01853;PF00628;PF17772;, GO:0070776;GO:0005654;GO:0000786;GO:0005634;GO:0016407;GO:0003677;GO:0004402;GO:0042393;GO:0046872;GO:0044877;GO:0003712;GO:0008134;GO:0016573;GO:0043966;GO:0045892;GO:0006334;GO:0045944;GO:0045893;GO:0006355;, C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleosome; C:nucleus;, F:acetyltransferase activity; F:DNA binding; F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:protein-containing complex binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H3 acetylation; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q8WYB5 O15087 Q86Y05 Q8WU81 Q9UKW2 Q9UKW3 Q9UKX0,Histone acetyltransferase KAT6B,Histone acetyltransferase MOZ2;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4;Monocytic leukemia zinc finger protein-related factor;, PF01853;PF00628;PF17772;, GO:0070776;GO:0005654;GO:0000786;GO:0005634;GO:0016407;GO:0003677;GO:0004402;GO:0042393;GO:0046872;GO:0044877;GO:0003712;GO:0008134;GO:0016573;GO:0043966;GO:0045892;GO:0006334;GO:0045944;GO:0045893;GO:0006355;, C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleosome; C:nucleus;, F:acetyltransferase activity; F:DNA binding; F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:protein-containing complex binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H3 acetylation; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q8WYB5 O15087 Q86Y05 Q8WU81 Q9UKW2 Q9UKW3 Q9UKX0,Histone acetyltransferase KAT6B,Histone acetyltransferase MOZ2;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4;Monocytic leukemia zinc finger protein-related factor;, PF01853;PF00628;PF17772;, GO:0070776;GO:0005654;GO:0000786;GO:0005634;GO:0016407;GO:0003677;GO:0004402;GO:0042393;GO:0046872;GO:0044877;GO:0003712;GO:0008134;GO:0016573;GO:0043966;GO:0045892;GO:0006334;GO:0045944;GO:0045893;GO:0006355;, C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleosome; C:nucleus;, F:acetyltransferase activity; F:DNA binding; F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:protein-containing complex binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H3 acetylation; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q8WYB5 O15087 Q86Y05 Q8WU81 Q9UKW2 Q9UKW3 Q9UKX0,Histone acetyltransferase KAT6B,Histone acetyltransferase MOZ2;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4;Monocytic leukemia zinc finger protein-related factor;, PF01853;PF00628;PF17772;, GO:0070776;GO:0005654;GO:0000786;GO:0005634;GO:0016407;GO:0003677;GO:0004402;GO:0042393;GO:0046872;GO:0044877;GO:0003712;GO:0008134;GO:0016573;GO:0043966;GO:0045892;GO:0006334;GO:0045944;GO:0045893;GO:0006355;, C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleosome; C:nucleus;, F:acetyltransferase activity; F:DNA binding; F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:protein-containing complex binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H3 acetylation; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q8WYB5 O15087 Q86Y05 Q8WU81 Q9UKW2 Q9UKW3 Q9UKX0,Histone acetyltransferase KAT6B,Histone acetyltransferase MOZ2;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4;Monocytic leukemia zinc finger protein-related factor;, PF01853;PF00628;PF17772;, GO:0070776;GO:0005654;GO:0000786;GO:0005634;GO:0016407;GO:0003677;GO:0004402;GO:0042393;GO:0046872;GO:0044877;GO:0003712;GO:0008134;GO:0016573;GO:0043966;GO:0045892;GO:0006334;GO:0045944;GO:0045893;GO:0006355;, C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleosome; C:nucleus;, F:acetyltransferase activity; F:DNA binding; F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:protein-containing complex binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H3 acetylation; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold14 indexed_genome mRNA 18059198 18094470 . - . ID=transcript_3651;Q68J44 B2RP93,Dual specificity phosphatase 29 {ECO:0000312|HGNC:HGNC:23481},Dual specificity phosphatase 27 {ECO:0000303|PubMed:17498703, ECO:0000303|PubMed:21543850};Dual specificity phosphatase DUPD1 {ECO:0000305};, , GO:0005737;GO:0005634;GO:0032991;GO:0033549;GO:0042803;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0042593;GO:0042692;GO:0070373;GO:0006470;, C:cytoplasm; C:nucleus; C:protein-containing complex;, F:MAP kinase phosphatase activity; F:protein homodimerization activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:glucose homeostasis; P:muscle cell differentiation; P:negative regulation of ERK1 and ERK2 cascade; P:protein dephosphorylation; scaffold14 indexed_genome mRNA 18112189 18125076 . - . ID=transcript_3652;Q96GC2,Dual specificity protein phosphatase 13 isoform B,Dual specificity phosphatase SKRP4;Testis- and skeletal-muscle-specific DSP;, , GO:0016791;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0016311;GO:0051321;GO:0006470;GO:0007283;, , F:phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dephosphorylation; P:meiotic cell cycle; P:protein dephosphorylation; P:spermatogenesis; scaffold14 indexed_genome mRNA 18126743 18177181 . + . ID=transcript_3653;Q96LT4 Q5JSC5 Q5JSC8 Q66K52,Sphingomyelin synthase-related protein 1 {ECO:0000305},Ceramide phosphoethanolamine synthase;Sterile alpha motif domain-containing protein 8;, PF14360;PF00536;, GO:0005829;GO:0005783;GO:0005789;GO:0030176;GO:0030173;GO:0016021;GO:0005887;GO:0047493;GO:0033188;GO:0046513;GO:2000303;GO:0030148;GO:0006686;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:ceramide cholinephosphotransferase activity; F:sphingomyelin synthase activity;, P:ceramide biosynthetic process; P:regulation of ceramide biosynthetic process; P:sphingolipid biosynthetic process; P:sphingomyelin biosynthetic process;|Q9H9S0 D3DUU4 Q2TTG0 Q6JZS5,Homeobox protein NANOG,Homeobox transcription factor Nanog;, PF00046;, GO:0000785;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0030154;GO:0019221;GO:0001714;GO:2000648;GO:0045944;GO:0045595;GO:0010468;GO:0006357;GO:0006355;GO:0035019;GO:0019827;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:cytokine-mediated signaling pathway; P:endodermal cell fate specification; P:positive regulation of stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell differentiation; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:somatic stem cell population maintenance; P:stem cell population maintenance; scaffold14 indexed_genome mRNA 18204842 18220290 . + . ID=transcript_3654;P45880 Q5VWK1 Q5VWK3 Q6IB40 Q7L3J5 Q9BWK8 Q9Y5I6,Voltage-dependent anion-selective channel protein 2,Outer mitochondrial membrane protein porin 2;, PF01459;, GO:0001669;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0000166;GO:0031210;GO:0015288;GO:0008308;GO:0006820;GO:0007339;GO:0097345;GO:2001243;GO:0032272;, C:acrosomal vesicle; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:nucleotide binding; F:phosphatidylcholine binding; F:porin activity; F:voltage-gated anion channel activity;, P:anion transport; P:binding of sperm to zona pellucida; P:mitochondrial outer membrane permeabilization; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein polymerization;|P45880 Q5VWK1 Q5VWK3 Q6IB40 Q7L3J5 Q9BWK8 Q9Y5I6,Voltage-dependent anion-selective channel protein 2,Outer mitochondrial membrane protein porin 2;, PF01459;, GO:0001669;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0000166;GO:0031210;GO:0015288;GO:0008308;GO:0006820;GO:0007339;GO:0097345;GO:2001243;GO:0032272;, C:acrosomal vesicle; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:nucleotide binding; F:phosphatidylcholine binding; F:porin activity; F:voltage-gated anion channel activity;, P:anion transport; P:binding of sperm to zona pellucida; P:mitochondrial outer membrane permeabilization; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein polymerization;|P45880 Q5VWK1 Q5VWK3 Q6IB40 Q7L3J5 Q9BWK8 Q9Y5I6,Voltage-dependent anion-selective channel protein 2,Outer mitochondrial membrane protein porin 2;, PF01459;, GO:0001669;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0000166;GO:0031210;GO:0015288;GO:0008308;GO:0006820;GO:0007339;GO:0097345;GO:2001243;GO:0032272;, C:acrosomal vesicle; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:nucleotide binding; F:phosphatidylcholine binding; F:porin activity; F:voltage-gated anion channel activity;, P:anion transport; P:binding of sperm to zona pellucida; P:mitochondrial outer membrane permeabilization; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein polymerization;|P45880 Q5VWK1 Q5VWK3 Q6IB40 Q7L3J5 Q9BWK8 Q9Y5I6,Voltage-dependent anion-selective channel protein 2,Outer mitochondrial membrane protein porin 2;, PF01459;, GO:0001669;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0000166;GO:0031210;GO:0015288;GO:0008308;GO:0006820;GO:0007339;GO:0097345;GO:2001243;GO:0032272;, C:acrosomal vesicle; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:nucleotide binding; F:phosphatidylcholine binding; F:porin activity; F:voltage-gated anion channel activity;, P:anion transport; P:binding of sperm to zona pellucida; P:mitochondrial outer membrane permeabilization; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein polymerization;|P45880 Q5VWK1 Q5VWK3 Q6IB40 Q7L3J5 Q9BWK8 Q9Y5I6,Voltage-dependent anion-selective channel protein 2,Outer mitochondrial membrane protein porin 2;, PF01459;, GO:0001669;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0000166;GO:0031210;GO:0015288;GO:0008308;GO:0006820;GO:0007339;GO:0097345;GO:2001243;GO:0032272;, C:acrosomal vesicle; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:nucleotide binding; F:phosphatidylcholine binding; F:porin activity; F:voltage-gated anion channel activity;, P:anion transport; P:binding of sperm to zona pellucida; P:mitochondrial outer membrane permeabilization; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein polymerization;|P45880 Q5VWK1 Q5VWK3 Q6IB40 Q7L3J5 Q9BWK8 Q9Y5I6,Voltage-dependent anion-selective channel protein 2,Outer mitochondrial membrane protein porin 2;, PF01459;, GO:0001669;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0000166;GO:0031210;GO:0015288;GO:0008308;GO:0006820;GO:0007339;GO:0097345;GO:2001243;GO:0032272;, C:acrosomal vesicle; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:nucleotide binding; F:phosphatidylcholine binding; F:porin activity; F:voltage-gated anion channel activity;, P:anion transport; P:binding of sperm to zona pellucida; P:mitochondrial outer membrane permeabilization; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein polymerization; scaffold14 indexed_genome mRNA 18221749 18223385 . - . ID=transcript_3655;Q86VU5 Q8TE79,Catechol O-methyltransferase domain-containing protein 1,, PF01596;, GO:0016021;GO:0008171;GO:0008757;GO:0032259;, C:integral component of membrane;, F:O-methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:methylation;|Q86VU5 Q8TE79,Catechol O-methyltransferase domain-containing protein 1,, PF01596;, GO:0016021;GO:0008171;GO:0008757;GO:0032259;, C:integral component of membrane;, F:O-methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:methylation; scaffold14 indexed_genome mRNA 18356385 18358325 . + . ID=transcript_3656;Q96F45 Q8NAC5 Q96E25 Q96IJ0,Zinc finger protein 503,, PF12402;, GO:0005634;GO:0046872;GO:0070491;GO:0070315;GO:0008285;GO:0010629;GO:0045892;GO:0061351;, C:nucleus;, F:metal ion binding; F:repressing transcription factor binding;, P:G1 to G0 transition involved in cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:neural precursor cell proliferation; scaffold14 indexed_genome mRNA 18358340 18360142 . - . ID=transcript_3657;Q96F45 Q8NAC5 Q96E25 Q96IJ0,Zinc finger protein 503,, PF12402;, GO:0005634;GO:0046872;GO:0070491;GO:0070315;GO:0008285;GO:0010629;GO:0045892;GO:0061351;, C:nucleus;, F:metal ion binding; F:repressing transcription factor binding;, P:G1 to G0 transition involved in cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:neural precursor cell proliferation; scaffold14 indexed_genome mRNA 18365501 18366078 . - . ID=transcript_3658;A6NEH8,Putative uncharacterized protein encoded by ZNF503-AS2,ZNF503 antisense RNA 2; scaffold14 indexed_genome mRNA 18391215 19535488 . + . ID=transcript_3659;Q9H2I8 B1AVW6,Leucine-rich melanocyte differentiation-associated protein {ECO:0000305},, , GO:0030318;, , , P:melanocyte differentiation; scaffold14 indexed_genome mRNA 19792533 19793206 . + . ID=transcript_3660;Q8N8A6 A8MPT9 Q5CZ71 Q8IXK5 Q96ED1,ATP-dependent RNA helicase DDX51,DEAD box protein 51;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0006364;, C:membrane; C:nucleolus; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:rRNA processing; scaffold14 indexed_genome mRNA 19796227 20534562 . - . ID=transcript_3661;Q96LG8 Q9UBB0 Q9UCX0 Q9UQK6,Calcium-activated potassium channel subunit alpha-1,BK channel;BKCA alpha;Calcium-activated potassium channel, subfamily M subunit alpha-1;K(VCA)alpha;KCa1.1;Maxi K channel;Slo-alpha;Slo1;Slowpoke homolog;, PF03493;PF00520;, GO:0016324;GO:0005901;GO:0016021;GO:0005886;GO:0045211;GO:0008076;GO:0003779;GO:0015269;GO:0042802;GO:0060072;GO:0046872;GO:0005249;GO:0030007;GO:0060073;GO:0045794;GO:0043065;GO:1901381;GO:0006813;GO:0042391;GO:0060087;GO:0051592;GO:0034465;GO:0001666;GO:0006970;GO:0060083;, C:apical plasma membrane; C:caveola; C:integral component of membrane; C:plasma membrane; C:postsynaptic membrane; C:voltage-gated potassium channel complex;, F:actin binding; F:calcium-activated potassium channel activity; F:identical protein binding; F:large conductance calcium-activated potassium channel activity; F:metal ion binding; F:voltage-gated potassium channel activity;, P:cellular potassium ion homeostasis; P:micturition; P:negative regulation of cell volume; P:positive regulation of apoptotic process; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transport; P:regulation of membrane potential; P:relaxation of vascular associated smooth muscle; P:response to calcium ion; P:response to carbon monoxide; P:response to hypoxia; P:response to osmotic stress; P:smooth muscle contraction involved in micturition;|Q96LG8 Q9UBB0 Q9UCX0 Q9UQK6,Calcium-activated potassium channel subunit alpha-1,BK channel;BKCA alpha;Calcium-activated potassium channel, subfamily M subunit alpha-1;K(VCA)alpha;KCa1.1;Maxi K channel;Slo-alpha;Slo1;Slowpoke homolog;, PF03493;PF00520;, GO:0016324;GO:0005901;GO:0016021;GO:0005886;GO:0045211;GO:0008076;GO:0003779;GO:0015269;GO:0042802;GO:0060072;GO:0046872;GO:0005249;GO:0030007;GO:0060073;GO:0045794;GO:0043065;GO:1901381;GO:0006813;GO:0042391;GO:0060087;GO:0051592;GO:0034465;GO:0001666;GO:0006970;GO:0060083;, C:apical plasma membrane; C:caveola; C:integral component of membrane; C:plasma membrane; C:postsynaptic membrane; C:voltage-gated potassium channel complex;, F:actin binding; F:calcium-activated potassium channel activity; F:identical protein binding; F:large conductance calcium-activated potassium channel activity; F:metal ion binding; F:voltage-gated potassium channel activity;, P:cellular potassium ion homeostasis; P:micturition; P:negative regulation of cell volume; P:positive regulation of apoptotic process; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transport; P:regulation of membrane potential; P:relaxation of vascular associated smooth muscle; P:response to calcium ion; P:response to carbon monoxide; P:response to hypoxia; P:response to osmotic stress; P:smooth muscle contraction involved in micturition;|Q96LG8 Q9UBB0 Q9UCX0 Q9UQK6,Calcium-activated potassium channel subunit alpha-1,BK channel;BKCA alpha;Calcium-activated potassium channel, subfamily M subunit alpha-1;K(VCA)alpha;KCa1.1;Maxi K channel;Slo-alpha;Slo1;Slowpoke homolog;, PF03493;PF00520;, GO:0016324;GO:0005901;GO:0016021;GO:0005886;GO:0045211;GO:0008076;GO:0003779;GO:0015269;GO:0042802;GO:0060072;GO:0046872;GO:0005249;GO:0030007;GO:0060073;GO:0045794;GO:0043065;GO:1901381;GO:0006813;GO:0042391;GO:0060087;GO:0051592;GO:0034465;GO:0001666;GO:0006970;GO:0060083;, C:apical plasma membrane; C:caveola; C:integral component of membrane; C:plasma membrane; C:postsynaptic membrane; C:voltage-gated potassium channel complex;, F:actin binding; F:calcium-activated potassium channel activity; F:identical protein binding; F:large conductance calcium-activated potassium channel activity; F:metal ion binding; F:voltage-gated potassium channel activity;, P:cellular potassium ion homeostasis; P:micturition; P:negative regulation of cell volume; P:positive regulation of apoptotic process; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transport; P:regulation of membrane potential; P:relaxation of vascular associated smooth muscle; P:response to calcium ion; P:response to carbon monoxide; P:response to hypoxia; P:response to osmotic stress; P:smooth muscle contraction involved in micturition; scaffold14 indexed_genome mRNA 20660960 20721859 . - . ID=transcript_3662;Q9Y4E3,Disks large homolog 5,Discs large protein P-dlg;Placenta and prostate DLG;, PF00625;PF00595;PF04822;, GO:0005912;GO:0030054;GO:0036064;GO:0005737;GO:0005886;GO:0014069;GO:0008013;GO:0008092;GO:0030159;GO:0045176;GO:0098609;GO:0001837;GO:0060441;GO:0045197;GO:0035556;GO:0030011;GO:0072205;GO:0030901;GO:0030336;GO:0008285;GO:0035331;GO:0042130;GO:0030859;GO:0060999;GO:0035332;GO:0045880;GO:0051965;GO:0071896;GO:0065003;GO:0042981;GO:0007165;GO:0045186;, C:adherens junction; C:cell junction; C:ciliary basal body; C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:beta-catenin binding; F:cytoskeletal protein binding; F:signaling receptor complex adaptor activity;, P:apical protein localization; P:cell-cell adhesion; P:epithelial to mesenchymal transition; P:epithelial tube branching involved in lung morphogenesis; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:maintenance of cell polarity; P:metanephric collecting duct development; P:midbrain development; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of hippo signaling; P:negative regulation of T cell proliferation; P:polarized epithelial cell differentiation; P:positive regulation of dendritic spine development; P:positive regulation of hippo signaling; P:positive regulation of smoothened signaling pathway; P:positive regulation of synapse assembly; P:protein localization to adherens junction; P:protein-containing complex assembly; P:regulation of apoptotic process; P:signal transduction; P:zonula adherens assembly;|Q9Y4E3,Disks large homolog 5,Discs large protein P-dlg;Placenta and prostate DLG;, PF00625;PF00595;PF04822;, GO:0005912;GO:0030054;GO:0036064;GO:0005737;GO:0005886;GO:0014069;GO:0008013;GO:0008092;GO:0030159;GO:0045176;GO:0098609;GO:0001837;GO:0060441;GO:0045197;GO:0035556;GO:0030011;GO:0072205;GO:0030901;GO:0030336;GO:0008285;GO:0035331;GO:0042130;GO:0030859;GO:0060999;GO:0035332;GO:0045880;GO:0051965;GO:0071896;GO:0065003;GO:0042981;GO:0007165;GO:0045186;, C:adherens junction; C:cell junction; C:ciliary basal body; C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:beta-catenin binding; F:cytoskeletal protein binding; F:signaling receptor complex adaptor activity;, P:apical protein localization; P:cell-cell adhesion; P:epithelial to mesenchymal transition; P:epithelial tube branching involved in lung morphogenesis; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:maintenance of cell polarity; P:metanephric collecting duct development; P:midbrain development; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of hippo signaling; P:negative regulation of T cell proliferation; P:polarized epithelial cell differentiation; P:positive regulation of dendritic spine development; P:positive regulation of hippo signaling; P:positive regulation of smoothened signaling pathway; P:positive regulation of synapse assembly; P:protein localization to adherens junction; P:protein-containing complex assembly; P:regulation of apoptotic process; P:signal transduction; P:zonula adherens assembly;|Q9Y4E3,Disks large homolog 5,Discs large protein P-dlg;Placenta and prostate DLG;, PF00625;PF00595;PF04822;, GO:0005912;GO:0030054;GO:0036064;GO:0005737;GO:0005886;GO:0014069;GO:0008013;GO:0008092;GO:0030159;GO:0045176;GO:0098609;GO:0001837;GO:0060441;GO:0045197;GO:0035556;GO:0030011;GO:0072205;GO:0030901;GO:0030336;GO:0008285;GO:0035331;GO:0042130;GO:0030859;GO:0060999;GO:0035332;GO:0045880;GO:0051965;GO:0071896;GO:0065003;GO:0042981;GO:0007165;GO:0045186;, C:adherens junction; C:cell junction; C:ciliary basal body; C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:beta-catenin binding; F:cytoskeletal protein binding; F:signaling receptor complex adaptor activity;, P:apical protein localization; P:cell-cell adhesion; P:epithelial to mesenchymal transition; P:epithelial tube branching involved in lung morphogenesis; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:maintenance of cell polarity; P:metanephric collecting duct development; P:midbrain development; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of hippo signaling; P:negative regulation of T cell proliferation; P:polarized epithelial cell differentiation; P:positive regulation of dendritic spine development; P:positive regulation of hippo signaling; P:positive regulation of smoothened signaling pathway; P:positive regulation of synapse assembly; P:protein localization to adherens junction; P:protein-containing complex assembly; P:regulation of apoptotic process; P:signal transduction; P:zonula adherens assembly;|Q9Y4E3,Disks large homolog 5,Discs large protein P-dlg;Placenta and prostate DLG;, PF00625;PF00595;PF04822;, GO:0005912;GO:0030054;GO:0036064;GO:0005737;GO:0005886;GO:0014069;GO:0008013;GO:0008092;GO:0030159;GO:0045176;GO:0098609;GO:0001837;GO:0060441;GO:0045197;GO:0035556;GO:0030011;GO:0072205;GO:0030901;GO:0030336;GO:0008285;GO:0035331;GO:0042130;GO:0030859;GO:0060999;GO:0035332;GO:0045880;GO:0051965;GO:0071896;GO:0065003;GO:0042981;GO:0007165;GO:0045186;, C:adherens junction; C:cell junction; C:ciliary basal body; C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:beta-catenin binding; F:cytoskeletal protein binding; F:signaling receptor complex adaptor activity;, P:apical protein localization; P:cell-cell adhesion; P:epithelial to mesenchymal transition; P:epithelial tube branching involved in lung morphogenesis; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:maintenance of cell polarity; P:metanephric collecting duct development; P:midbrain development; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of hippo signaling; P:negative regulation of T cell proliferation; P:polarized epithelial cell differentiation; P:positive regulation of dendritic spine development; P:positive regulation of hippo signaling; P:positive regulation of smoothened signaling pathway; P:positive regulation of synapse assembly; P:protein localization to adherens junction; P:protein-containing complex assembly; P:regulation of apoptotic process; P:signal transduction; P:zonula adherens assembly;|Q9Y4E3,Disks large homolog 5,Discs large protein P-dlg;Placenta and prostate DLG;, PF00625;PF00595;PF04822;, GO:0005912;GO:0030054;GO:0036064;GO:0005737;GO:0005886;GO:0014069;GO:0008013;GO:0008092;GO:0030159;GO:0045176;GO:0098609;GO:0001837;GO:0060441;GO:0045197;GO:0035556;GO:0030011;GO:0072205;GO:0030901;GO:0030336;GO:0008285;GO:0035331;GO:0042130;GO:0030859;GO:0060999;GO:0035332;GO:0045880;GO:0051965;GO:0071896;GO:0065003;GO:0042981;GO:0007165;GO:0045186;, C:adherens junction; C:cell junction; C:ciliary basal body; C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:beta-catenin binding; F:cytoskeletal protein binding; F:signaling receptor complex adaptor activity;, P:apical protein localization; P:cell-cell adhesion; P:epithelial to mesenchymal transition; P:epithelial tube branching involved in lung morphogenesis; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:maintenance of cell polarity; P:metanephric collecting duct development; P:midbrain development; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of hippo signaling; P:negative regulation of T cell proliferation; P:polarized epithelial cell differentiation; P:positive regulation of dendritic spine development; P:positive regulation of hippo signaling; P:positive regulation of smoothened signaling pathway; P:positive regulation of synapse assembly; P:protein localization to adherens junction; P:protein-containing complex assembly; P:regulation of apoptotic process; P:signal transduction; P:zonula adherens assembly;|Q9Y4E3,Disks large homolog 5,Discs large protein P-dlg;Placenta and prostate DLG;, PF00625;PF00595;PF04822;, GO:0005912;GO:0030054;GO:0036064;GO:0005737;GO:0005886;GO:0014069;GO:0008013;GO:0008092;GO:0030159;GO:0045176;GO:0098609;GO:0001837;GO:0060441;GO:0045197;GO:0035556;GO:0030011;GO:0072205;GO:0030901;GO:0030336;GO:0008285;GO:0035331;GO:0042130;GO:0030859;GO:0060999;GO:0035332;GO:0045880;GO:0051965;GO:0071896;GO:0065003;GO:0042981;GO:0007165;GO:0045186;, C:adherens junction; C:cell junction; C:ciliary basal body; C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:beta-catenin binding; F:cytoskeletal protein binding; F:signaling receptor complex adaptor activity;, P:apical protein localization; P:cell-cell adhesion; P:epithelial to mesenchymal transition; P:epithelial tube branching involved in lung morphogenesis; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:maintenance of cell polarity; P:metanephric collecting duct development; P:midbrain development; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of hippo signaling; P:negative regulation of T cell proliferation; P:polarized epithelial cell differentiation; P:positive regulation of dendritic spine development; P:positive regulation of hippo signaling; P:positive regulation of smoothened signaling pathway; P:positive regulation of synapse assembly; P:protein localization to adherens junction; P:protein-containing complex assembly; P:regulation of apoptotic process; P:signal transduction; P:zonula adherens assembly;|Q9Y4E3,Disks large homolog 5,Discs large protein P-dlg;Placenta and prostate DLG;, PF00625;PF00595;PF04822;, GO:0005912;GO:0030054;GO:0036064;GO:0005737;GO:0005886;GO:0014069;GO:0008013;GO:0008092;GO:0030159;GO:0045176;GO:0098609;GO:0001837;GO:0060441;GO:0045197;GO:0035556;GO:0030011;GO:0072205;GO:0030901;GO:0030336;GO:0008285;GO:0035331;GO:0042130;GO:0030859;GO:0060999;GO:0035332;GO:0045880;GO:0051965;GO:0071896;GO:0065003;GO:0042981;GO:0007165;GO:0045186;, C:adherens junction; C:cell junction; C:ciliary basal body; C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:beta-catenin binding; F:cytoskeletal protein binding; F:signaling receptor complex adaptor activity;, P:apical protein localization; P:cell-cell adhesion; P:epithelial to mesenchymal transition; P:epithelial tube branching involved in lung morphogenesis; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:maintenance of cell polarity; P:metanephric collecting duct development; P:midbrain development; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of hippo signaling; P:negative regulation of T cell proliferation; P:polarized epithelial cell differentiation; P:positive regulation of dendritic spine development; P:positive regulation of hippo signaling; P:positive regulation of smoothened signaling pathway; P:positive regulation of synapse assembly; P:protein localization to adherens junction; P:protein-containing complex assembly; P:regulation of apoptotic process; P:signal transduction; P:zonula adherens assembly;|Q9Y4E3,Disks large homolog 5,Discs large protein P-dlg;Placenta and prostate DLG;, PF00625;PF00595;PF04822;, GO:0005912;GO:0030054;GO:0036064;GO:0005737;GO:0005886;GO:0014069;GO:0008013;GO:0008092;GO:0030159;GO:0045176;GO:0098609;GO:0001837;GO:0060441;GO:0045197;GO:0035556;GO:0030011;GO:0072205;GO:0030901;GO:0030336;GO:0008285;GO:0035331;GO:0042130;GO:0030859;GO:0060999;GO:0035332;GO:0045880;GO:0051965;GO:0071896;GO:0065003;GO:0042981;GO:0007165;GO:0045186;, C:adherens junction; C:cell junction; C:ciliary basal body; C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:beta-catenin binding; F:cytoskeletal protein binding; F:signaling receptor complex adaptor activity;, P:apical protein localization; P:cell-cell adhesion; P:epithelial to mesenchymal transition; P:epithelial tube branching involved in lung morphogenesis; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:maintenance of cell polarity; P:metanephric collecting duct development; P:midbrain development; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of hippo signaling; P:negative regulation of T cell proliferation; P:polarized epithelial cell differentiation; P:positive regulation of dendritic spine development; P:positive regulation of hippo signaling; P:positive regulation of smoothened signaling pathway; P:positive regulation of synapse assembly; P:protein localization to adherens junction; P:protein-containing complex assembly; P:regulation of apoptotic process; P:signal transduction; P:zonula adherens assembly;|Q9Y4E3,Disks large homolog 5,Discs large protein P-dlg;Placenta and prostate DLG;, PF00625;PF00595;PF04822;, GO:0005912;GO:0030054;GO:0036064;GO:0005737;GO:0005886;GO:0014069;GO:0008013;GO:0008092;GO:0030159;GO:0045176;GO:0098609;GO:0001837;GO:0060441;GO:0045197;GO:0035556;GO:0030011;GO:0072205;GO:0030901;GO:0030336;GO:0008285;GO:0035331;GO:0042130;GO:0030859;GO:0060999;GO:0035332;GO:0045880;GO:0051965;GO:0071896;GO:0065003;GO:0042981;GO:0007165;GO:0045186;, C:adherens junction; C:cell junction; C:ciliary basal body; C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:beta-catenin binding; F:cytoskeletal protein binding; F:signaling receptor complex adaptor activity;, P:apical protein localization; P:cell-cell adhesion; P:epithelial to mesenchymal transition; P:epithelial tube branching involved in lung morphogenesis; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:maintenance of cell polarity; P:metanephric collecting duct development; P:midbrain development; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of hippo signaling; P:negative regulation of T cell proliferation; P:polarized epithelial cell differentiation; P:positive regulation of dendritic spine development; P:positive regulation of hippo signaling; P:positive regulation of smoothened signaling pathway; P:positive regulation of synapse assembly; P:protein localization to adherens junction; P:protein-containing complex assembly; P:regulation of apoptotic process; P:signal transduction; P:zonula adherens assembly; scaffold14 indexed_genome mRNA 20820587 20867146 . - . ID=transcript_3663;O14802 Q8IW34 Q8TCW5,DNA-directed RNA polymerase III subunit RPC1,DNA-directed RNA polymerase III largest subunit;DNA-directed RNA polymerase III subunit A;RNA polymerase III 155 kDa subunit;RNA polymerase III subunit C160;, PF04997;PF00623;PF04983;PF05000;PF04998;, GO:0005829;GO:0016020;GO:0005654;GO:0005666;GO:0003682;GO:0003677;GO:0003899;GO:0046872;GO:0051607;GO:0045087;GO:0032728;GO:0032481;GO:0006351;, C:cytosol; C:membrane; C:nucleoplasm; C:RNA polymerase III complex;, F:chromatin binding; F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding;, P:defense response to virus; P:innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:transcription, DNA-templated;|O14802 Q8IW34 Q8TCW5,DNA-directed RNA polymerase III subunit RPC1,DNA-directed RNA polymerase III largest subunit;DNA-directed RNA polymerase III subunit A;RNA polymerase III 155 kDa subunit;RNA polymerase III subunit C160;, PF04997;PF00623;PF04983;PF05000;PF04998;, GO:0005829;GO:0016020;GO:0005654;GO:0005666;GO:0003682;GO:0003677;GO:0003899;GO:0046872;GO:0051607;GO:0045087;GO:0032728;GO:0032481;GO:0006351;, C:cytosol; C:membrane; C:nucleoplasm; C:RNA polymerase III complex;, F:chromatin binding; F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding;, P:defense response to virus; P:innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:transcription, DNA-templated;|O14802 Q8IW34 Q8TCW5,DNA-directed RNA polymerase III subunit RPC1,DNA-directed RNA polymerase III largest subunit;DNA-directed RNA polymerase III subunit A;RNA polymerase III 155 kDa subunit;RNA polymerase III subunit C160;, PF04997;PF00623;PF04983;PF05000;PF04998;, GO:0005829;GO:0016020;GO:0005654;GO:0005666;GO:0003682;GO:0003677;GO:0003899;GO:0046872;GO:0051607;GO:0045087;GO:0032728;GO:0032481;GO:0006351;, C:cytosol; C:membrane; C:nucleoplasm; C:RNA polymerase III complex;, F:chromatin binding; F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding;, P:defense response to virus; P:innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:transcription, DNA-templated;|O14802 Q8IW34 Q8TCW5,DNA-directed RNA polymerase III subunit RPC1,DNA-directed RNA polymerase III largest subunit;DNA-directed RNA polymerase III subunit A;RNA polymerase III 155 kDa subunit;RNA polymerase III subunit C160;, PF04997;PF00623;PF04983;PF05000;PF04998;, GO:0005829;GO:0016020;GO:0005654;GO:0005666;GO:0003682;GO:0003677;GO:0003899;GO:0046872;GO:0051607;GO:0045087;GO:0032728;GO:0032481;GO:0006351;, C:cytosol; C:membrane; C:nucleoplasm; C:RNA polymerase III complex;, F:chromatin binding; F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding;, P:defense response to virus; P:innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:transcription, DNA-templated; scaffold14 indexed_genome mRNA 20868538 20871706 . + . ID=transcript_3664;P62847 E7EPK6 P16632 Q5T0P7 Q5T0P8 Q7Z3D1,40S ribosomal protein S24,Small ribosomal subunit protein eS24 {ECO:0000303|PubMed:24524803};, PF01282;, GO:0005829;GO:0022627;GO:0005783;GO:0016020;GO:0005654;GO:0005634;GO:0015935;GO:0003723;GO:0003735;GO:0031369;GO:0034101;GO:0000184;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:membrane; C:nucleoplasm; C:nucleus; C:small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome; F:translation initiation factor binding;, P:erythrocyte homeostasis; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold14 indexed_genome mRNA 21871448 21965179 . + . ID=transcript_3665;Q9ULJ6 Q5JSH9 Q7Z7E6,Zinc finger MIZ domain-containing protein 1,PIAS-like protein Zimp10;Retinoic acid-induced protein 17;, PF02891;PF18028;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0030374;GO:0046332;GO:0003713;GO:0008270;GO:0030521;GO:0048844;GO:0007569;GO:0048096;GO:0048589;GO:0003007;GO:0001701;GO:0048146;GO:0045747;GO:1903508;GO:0045582;GO:0045944;GO:0021852;GO:0033233;GO:0006357;GO:0060395;GO:0007179;GO:0001570;GO:0007296;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:SMAD binding; F:transcription coactivator activity; F:zinc ion binding;, P:androgen receptor signaling pathway; P:artery morphogenesis; P:cell aging; P:chromatin-mediated maintenance of transcription; P:developmental growth; P:heart morphogenesis; P:in utero embryonic development; P:positive regulation of fibroblast proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of nucleic acid-templated transcription; P:positive regulation of T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:pyramidal neuron migration; P:regulation of protein sumoylation; P:regulation of transcription by RNA polymerase II; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vasculogenesis; P:vitellogenesis; scaffold14 indexed_genome mRNA 21993656 22058428 . + . ID=transcript_3666;Q9ULJ6 Q5JSH9 Q7Z7E6,Zinc finger MIZ domain-containing protein 1,PIAS-like protein Zimp10;Retinoic acid-induced protein 17;, PF02891;PF18028;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0030374;GO:0046332;GO:0003713;GO:0008270;GO:0030521;GO:0048844;GO:0007569;GO:0048096;GO:0048589;GO:0003007;GO:0001701;GO:0048146;GO:0045747;GO:1903508;GO:0045582;GO:0045944;GO:0021852;GO:0033233;GO:0006357;GO:0060395;GO:0007179;GO:0001570;GO:0007296;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:SMAD binding; F:transcription coactivator activity; F:zinc ion binding;, P:androgen receptor signaling pathway; P:artery morphogenesis; P:cell aging; P:chromatin-mediated maintenance of transcription; P:developmental growth; P:heart morphogenesis; P:in utero embryonic development; P:positive regulation of fibroblast proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of nucleic acid-templated transcription; P:positive regulation of T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:pyramidal neuron migration; P:regulation of protein sumoylation; P:regulation of transcription by RNA polymerase II; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vasculogenesis; P:vitellogenesis;|Q9ULJ6 Q5JSH9 Q7Z7E6,Zinc finger MIZ domain-containing protein 1,PIAS-like protein Zimp10;Retinoic acid-induced protein 17;, PF02891;PF18028;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0030374;GO:0046332;GO:0003713;GO:0008270;GO:0030521;GO:0048844;GO:0007569;GO:0048096;GO:0048589;GO:0003007;GO:0001701;GO:0048146;GO:0045747;GO:1903508;GO:0045582;GO:0045944;GO:0021852;GO:0033233;GO:0006357;GO:0060395;GO:0007179;GO:0001570;GO:0007296;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:SMAD binding; F:transcription coactivator activity; F:zinc ion binding;, P:androgen receptor signaling pathway; P:artery morphogenesis; P:cell aging; P:chromatin-mediated maintenance of transcription; P:developmental growth; P:heart morphogenesis; P:in utero embryonic development; P:positive regulation of fibroblast proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of nucleic acid-templated transcription; P:positive regulation of T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:pyramidal neuron migration; P:regulation of protein sumoylation; P:regulation of transcription by RNA polymerase II; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vasculogenesis; P:vitellogenesis;|Q9ULJ6 Q5JSH9 Q7Z7E6,Zinc finger MIZ domain-containing protein 1,PIAS-like protein Zimp10;Retinoic acid-induced protein 17;, PF02891;PF18028;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0030374;GO:0046332;GO:0003713;GO:0008270;GO:0030521;GO:0048844;GO:0007569;GO:0048096;GO:0048589;GO:0003007;GO:0001701;GO:0048146;GO:0045747;GO:1903508;GO:0045582;GO:0045944;GO:0021852;GO:0033233;GO:0006357;GO:0060395;GO:0007179;GO:0001570;GO:0007296;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:SMAD binding; F:transcription coactivator activity; F:zinc ion binding;, P:androgen receptor signaling pathway; P:artery morphogenesis; P:cell aging; P:chromatin-mediated maintenance of transcription; P:developmental growth; P:heart morphogenesis; P:in utero embryonic development; P:positive regulation of fibroblast proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of nucleic acid-templated transcription; P:positive regulation of T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:pyramidal neuron migration; P:regulation of protein sumoylation; P:regulation of transcription by RNA polymerase II; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vasculogenesis; P:vitellogenesis; scaffold14 indexed_genome mRNA 22061710 22067301 . + . ID=transcript_3667;Q9ULJ6 Q5JSH9 Q7Z7E6,Zinc finger MIZ domain-containing protein 1,PIAS-like protein Zimp10;Retinoic acid-induced protein 17;, PF02891;PF18028;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0030374;GO:0046332;GO:0003713;GO:0008270;GO:0030521;GO:0048844;GO:0007569;GO:0048096;GO:0048589;GO:0003007;GO:0001701;GO:0048146;GO:0045747;GO:1903508;GO:0045582;GO:0045944;GO:0021852;GO:0033233;GO:0006357;GO:0060395;GO:0007179;GO:0001570;GO:0007296;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:SMAD binding; F:transcription coactivator activity; F:zinc ion binding;, P:androgen receptor signaling pathway; P:artery morphogenesis; P:cell aging; P:chromatin-mediated maintenance of transcription; P:developmental growth; P:heart morphogenesis; P:in utero embryonic development; P:positive regulation of fibroblast proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of nucleic acid-templated transcription; P:positive regulation of T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:pyramidal neuron migration; P:regulation of protein sumoylation; P:regulation of transcription by RNA polymerase II; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vasculogenesis; P:vitellogenesis; scaffold14 indexed_genome mRNA 22089190 22096234 . + . ID=transcript_3668;P30405 Q2YDB7 Q5W131,Peptidyl-prolyl cis-trans isomerase F, mitochondrial,Cyclophilin D;Cyclophilin F;Mitochondrial cyclophilin;Rotamase F;, PF00160;, GO:0005737;GO:0043231;GO:0016020;GO:0005743;GO:0005759;GO:0005757;GO:0005739;GO:0016018;GO:0003755;GO:0008637;GO:0071243;GO:0071277;GO:0070301;GO:1902686;GO:0070266;GO:0043066;GO:0032780;GO:2001243;GO:0090324;GO:2000276;GO:0090201;GO:0090200;GO:0006457;GO:0000413;GO:0046902;GO:1902445;GO:0010939;GO:0010849;GO:0002931;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:apoptotic mitochondrial changes; P:cellular response to arsenic-containing substance; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:necroptotic process; P:negative regulation of apoptotic process; P:negative regulation of ATPase activity; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of oxidative phosphorylation; P:negative regulation of oxidative phosphorylation uncoupler activity; P:negative regulation of release of cytochrome c from mitochondria; P:positive regulation of release of cytochrome c from mitochondria; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of mitochondrial membrane permeability; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; P:regulation of necrotic cell death; P:regulation of proton-transporting ATPase activity, rotational mechanism; P:response to ischemia;|P30405 Q2YDB7 Q5W131,Peptidyl-prolyl cis-trans isomerase F, mitochondrial,Cyclophilin D;Cyclophilin F;Mitochondrial cyclophilin;Rotamase F;, PF00160;, GO:0005737;GO:0043231;GO:0016020;GO:0005743;GO:0005759;GO:0005757;GO:0005739;GO:0016018;GO:0003755;GO:0008637;GO:0071243;GO:0071277;GO:0070301;GO:1902686;GO:0070266;GO:0043066;GO:0032780;GO:2001243;GO:0090324;GO:2000276;GO:0090201;GO:0090200;GO:0006457;GO:0000413;GO:0046902;GO:1902445;GO:0010939;GO:0010849;GO:0002931;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:apoptotic mitochondrial changes; P:cellular response to arsenic-containing substance; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:necroptotic process; P:negative regulation of apoptotic process; P:negative regulation of ATPase activity; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of oxidative phosphorylation; P:negative regulation of oxidative phosphorylation uncoupler activity; P:negative regulation of release of cytochrome c from mitochondria; P:positive regulation of release of cytochrome c from mitochondria; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of mitochondrial membrane permeability; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; P:regulation of necrotic cell death; P:regulation of proton-transporting ATPase activity, rotational mechanism; P:response to ischemia;|P30405 Q2YDB7 Q5W131,Peptidyl-prolyl cis-trans isomerase F, mitochondrial,Cyclophilin D;Cyclophilin F;Mitochondrial cyclophilin;Rotamase F;, PF00160;, GO:0005737;GO:0043231;GO:0016020;GO:0005743;GO:0005759;GO:0005757;GO:0005739;GO:0016018;GO:0003755;GO:0008637;GO:0071243;GO:0071277;GO:0070301;GO:1902686;GO:0070266;GO:0043066;GO:0032780;GO:2001243;GO:0090324;GO:2000276;GO:0090201;GO:0090200;GO:0006457;GO:0000413;GO:0046902;GO:1902445;GO:0010939;GO:0010849;GO:0002931;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:apoptotic mitochondrial changes; P:cellular response to arsenic-containing substance; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:necroptotic process; P:negative regulation of apoptotic process; P:negative regulation of ATPase activity; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of oxidative phosphorylation; P:negative regulation of oxidative phosphorylation uncoupler activity; P:negative regulation of release of cytochrome c from mitochondria; P:positive regulation of release of cytochrome c from mitochondria; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of mitochondrial membrane permeability; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; P:regulation of necrotic cell death; P:regulation of proton-transporting ATPase activity, rotational mechanism; P:response to ischemia; scaffold14 indexed_genome mRNA 22109768 22172125 . - . ID=transcript_3669;Q8N2G6 Q5U5T9 Q8TAG0,Zinc finger CCHC domain-containing protein 24,, PF17180;PF13696;, GO:0003723;GO:0008270;, , F:RNA binding; F:zinc ion binding; scaffold14 indexed_genome mRNA 22256563 22300215 . + . ID=transcript_3670;P50995 B4DVE7,Annexin A11,56 kDa autoantigen;Annexin XI;Annexin-11;Calcyclin-associated annexin 50;, PF00191;, GO:0042582;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0042470;GO:0016020;GO:0030496;GO:0005635;GO:0005654;GO:0045335;GO:0042581;GO:0005819;GO:0005509;GO:0005544;GO:0048306;GO:0023026;GO:0003723;GO:0044548;GO:0032506;GO:0006909;GO:0051592;, C:azurophil granule; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:melanosome; C:membrane; C:midbody; C:nuclear envelope; C:nucleoplasm; C:phagocytic vesicle; C:specific granule; C:spindle;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:MHC class II protein complex binding; F:RNA binding; F:S100 protein binding;, P:cytokinetic process; P:phagocytosis; P:response to calcium ion;|P50995 B4DVE7,Annexin A11,56 kDa autoantigen;Annexin XI;Annexin-11;Calcyclin-associated annexin 50;, PF00191;, GO:0042582;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0042470;GO:0016020;GO:0030496;GO:0005635;GO:0005654;GO:0045335;GO:0042581;GO:0005819;GO:0005509;GO:0005544;GO:0048306;GO:0023026;GO:0003723;GO:0044548;GO:0032506;GO:0006909;GO:0051592;, C:azurophil granule; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:melanosome; C:membrane; C:midbody; C:nuclear envelope; C:nucleoplasm; C:phagocytic vesicle; C:specific granule; C:spindle;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:MHC class II protein complex binding; F:RNA binding; F:S100 protein binding;, P:cytokinetic process; P:phagocytosis; P:response to calcium ion;|P50995 B4DVE7,Annexin A11,56 kDa autoantigen;Annexin XI;Annexin-11;Calcyclin-associated annexin 50;, PF00191;, GO:0042582;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0042470;GO:0016020;GO:0030496;GO:0005635;GO:0005654;GO:0045335;GO:0042581;GO:0005819;GO:0005509;GO:0005544;GO:0048306;GO:0023026;GO:0003723;GO:0044548;GO:0032506;GO:0006909;GO:0051592;, C:azurophil granule; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:melanosome; C:membrane; C:midbody; C:nuclear envelope; C:nucleoplasm; C:phagocytic vesicle; C:specific granule; C:spindle;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:MHC class II protein complex binding; F:RNA binding; F:S100 protein binding;, P:cytokinetic process; P:phagocytosis; P:response to calcium ion;|P50995 B4DVE7,Annexin A11,56 kDa autoantigen;Annexin XI;Annexin-11;Calcyclin-associated annexin 50;, PF00191;, GO:0042582;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0042470;GO:0016020;GO:0030496;GO:0005635;GO:0005654;GO:0045335;GO:0042581;GO:0005819;GO:0005509;GO:0005544;GO:0048306;GO:0023026;GO:0003723;GO:0044548;GO:0032506;GO:0006909;GO:0051592;, C:azurophil granule; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:melanosome; C:membrane; C:midbody; C:nuclear envelope; C:nucleoplasm; C:phagocytic vesicle; C:specific granule; C:spindle;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:MHC class II protein complex binding; F:RNA binding; F:S100 protein binding;, P:cytokinetic process; P:phagocytosis; P:response to calcium ion;|P50995 B4DVE7,Annexin A11,56 kDa autoantigen;Annexin XI;Annexin-11;Calcyclin-associated annexin 50;, PF00191;, GO:0042582;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0042470;GO:0016020;GO:0030496;GO:0005635;GO:0005654;GO:0045335;GO:0042581;GO:0005819;GO:0005509;GO:0005544;GO:0048306;GO:0023026;GO:0003723;GO:0044548;GO:0032506;GO:0006909;GO:0051592;, C:azurophil granule; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:melanosome; C:membrane; C:midbody; C:nuclear envelope; C:nucleoplasm; C:phagocytic vesicle; C:specific granule; C:spindle;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:MHC class II protein complex binding; F:RNA binding; F:S100 protein binding;, P:cytokinetic process; P:phagocytosis; P:response to calcium ion;|P50995 B4DVE7,Annexin A11,56 kDa autoantigen;Annexin XI;Annexin-11;Calcyclin-associated annexin 50;, PF00191;, GO:0042582;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0042470;GO:0016020;GO:0030496;GO:0005635;GO:0005654;GO:0045335;GO:0042581;GO:0005819;GO:0005509;GO:0005544;GO:0048306;GO:0023026;GO:0003723;GO:0044548;GO:0032506;GO:0006909;GO:0051592;, C:azurophil granule; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:melanosome; C:membrane; C:midbody; C:nuclear envelope; C:nucleoplasm; C:phagocytic vesicle; C:specific granule; C:spindle;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:MHC class II protein complex binding; F:RNA binding; F:S100 protein binding;, P:cytokinetic process; P:phagocytosis; P:response to calcium ion; scaffold14 indexed_genome mRNA 22302374 22315455 . - . ID=transcript_3671;Q5JTB6,Placenta-specific protein 9,, PF15205;, GO:0005576;, C:extracellular region; scaffold14 indexed_genome mRNA 22578521 22588707 . + . ID=transcript_3672;P35247 Q5T0M3 Q6FH08 Q86YK9 Q8TCD8 Q9UCJ2 Q9UCJ3,Pulmonary surfactant-associated protein D,Collectin-7;Lung surfactant protein D;, PF01391;PF00059;PF09006;, GO:0045334;GO:0005581;GO:0030139;GO:0005789;GO:0005576;GO:0005615;GO:0005764;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0042742;GO:0043152;GO:0045087;GO:0048286;GO:0048246;GO:0052405;GO:0032703;GO:0042130;GO:0050766;GO:0072593;GO:0006898;GO:1905226;GO:0001817;GO:0050776;GO:0007585;GO:0043129;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lysosome; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:defense response to bacterium; P:induction of bacterial agglutination; P:innate immune response; P:lung alveolus development; P:macrophage chemotaxis; P:negative regulation by host of symbiont molecular function; P:negative regulation of interleukin-2 production; P:negative regulation of T cell proliferation; P:positive regulation of phagocytosis; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:regulation of adhesion of symbiont to host epithelial cell; P:regulation of cytokine production; P:regulation of immune response; P:respiratory gaseous exchange by respiratory system; P:surfactant homeostasis; P:toll-like receptor signaling pathway;|P35247 Q5T0M3 Q6FH08 Q86YK9 Q8TCD8 Q9UCJ2 Q9UCJ3,Pulmonary surfactant-associated protein D,Collectin-7;Lung surfactant protein D;, PF01391;PF00059;PF09006;, GO:0045334;GO:0005581;GO:0030139;GO:0005789;GO:0005576;GO:0005615;GO:0005764;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0042742;GO:0043152;GO:0045087;GO:0048286;GO:0048246;GO:0052405;GO:0032703;GO:0042130;GO:0050766;GO:0072593;GO:0006898;GO:1905226;GO:0001817;GO:0050776;GO:0007585;GO:0043129;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lysosome; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:defense response to bacterium; P:induction of bacterial agglutination; P:innate immune response; P:lung alveolus development; P:macrophage chemotaxis; P:negative regulation by host of symbiont molecular function; P:negative regulation of interleukin-2 production; P:negative regulation of T cell proliferation; P:positive regulation of phagocytosis; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:regulation of adhesion of symbiont to host epithelial cell; P:regulation of cytokine production; P:regulation of immune response; P:respiratory gaseous exchange by respiratory system; P:surfactant homeostasis; P:toll-like receptor signaling pathway;|P35247 Q5T0M3 Q6FH08 Q86YK9 Q8TCD8 Q9UCJ2 Q9UCJ3,Pulmonary surfactant-associated protein D,Collectin-7;Lung surfactant protein D;, PF01391;PF00059;PF09006;, GO:0045334;GO:0005581;GO:0030139;GO:0005789;GO:0005576;GO:0005615;GO:0005764;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0042742;GO:0043152;GO:0045087;GO:0048286;GO:0048246;GO:0052405;GO:0032703;GO:0042130;GO:0050766;GO:0072593;GO:0006898;GO:1905226;GO:0001817;GO:0050776;GO:0007585;GO:0043129;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lysosome; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:defense response to bacterium; P:induction of bacterial agglutination; P:innate immune response; P:lung alveolus development; P:macrophage chemotaxis; P:negative regulation by host of symbiont molecular function; P:negative regulation of interleukin-2 production; P:negative regulation of T cell proliferation; P:positive regulation of phagocytosis; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:regulation of adhesion of symbiont to host epithelial cell; P:regulation of cytokine production; P:regulation of immune response; P:respiratory gaseous exchange by respiratory system; P:surfactant homeostasis; P:toll-like receptor signaling pathway;|P35247 Q5T0M3 Q6FH08 Q86YK9 Q8TCD8 Q9UCJ2 Q9UCJ3,Pulmonary surfactant-associated protein D,Collectin-7;Lung surfactant protein D;, PF01391;PF00059;PF09006;, GO:0045334;GO:0005581;GO:0030139;GO:0005789;GO:0005576;GO:0005615;GO:0005764;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0042742;GO:0043152;GO:0045087;GO:0048286;GO:0048246;GO:0052405;GO:0032703;GO:0042130;GO:0050766;GO:0072593;GO:0006898;GO:1905226;GO:0001817;GO:0050776;GO:0007585;GO:0043129;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lysosome; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:defense response to bacterium; P:induction of bacterial agglutination; P:innate immune response; P:lung alveolus development; P:macrophage chemotaxis; P:negative regulation by host of symbiont molecular function; P:negative regulation of interleukin-2 production; P:negative regulation of T cell proliferation; P:positive regulation of phagocytosis; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:regulation of adhesion of symbiont to host epithelial cell; P:regulation of cytokine production; P:regulation of immune response; P:respiratory gaseous exchange by respiratory system; P:surfactant homeostasis; P:toll-like receptor signaling pathway;|P35247 Q5T0M3 Q6FH08 Q86YK9 Q8TCD8 Q9UCJ2 Q9UCJ3,Pulmonary surfactant-associated protein D,Collectin-7;Lung surfactant protein D;, PF01391;PF00059;PF09006;, GO:0045334;GO:0005581;GO:0030139;GO:0005789;GO:0005576;GO:0005615;GO:0005764;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0042742;GO:0043152;GO:0045087;GO:0048286;GO:0048246;GO:0052405;GO:0032703;GO:0042130;GO:0050766;GO:0072593;GO:0006898;GO:1905226;GO:0001817;GO:0050776;GO:0007585;GO:0043129;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lysosome; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:defense response to bacterium; P:induction of bacterial agglutination; P:innate immune response; P:lung alveolus development; P:macrophage chemotaxis; P:negative regulation by host of symbiont molecular function; P:negative regulation of interleukin-2 production; P:negative regulation of T cell proliferation; P:positive regulation of phagocytosis; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:regulation of adhesion of symbiont to host epithelial cell; P:regulation of cytokine production; P:regulation of immune response; P:respiratory gaseous exchange by respiratory system; P:surfactant homeostasis; P:toll-like receptor signaling pathway;|P35247 Q5T0M3 Q6FH08 Q86YK9 Q8TCD8 Q9UCJ2 Q9UCJ3,Pulmonary surfactant-associated protein D,Collectin-7;Lung surfactant protein D;, PF01391;PF00059;PF09006;, GO:0045334;GO:0005581;GO:0030139;GO:0005789;GO:0005576;GO:0005615;GO:0005764;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0042742;GO:0043152;GO:0045087;GO:0048286;GO:0048246;GO:0052405;GO:0032703;GO:0042130;GO:0050766;GO:0072593;GO:0006898;GO:1905226;GO:0001817;GO:0050776;GO:0007585;GO:0043129;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lysosome; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:defense response to bacterium; P:induction of bacterial agglutination; P:innate immune response; P:lung alveolus development; P:macrophage chemotaxis; P:negative regulation by host of symbiont molecular function; P:negative regulation of interleukin-2 production; P:negative regulation of T cell proliferation; P:positive regulation of phagocytosis; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:regulation of adhesion of symbiont to host epithelial cell; P:regulation of cytokine production; P:regulation of immune response; P:respiratory gaseous exchange by respiratory system; P:surfactant homeostasis; P:toll-like receptor signaling pathway; scaffold14 indexed_genome mRNA 22704648 22706661 . - . ID=transcript_3673;P35247 Q5T0M3 Q6FH08 Q86YK9 Q8TCD8 Q9UCJ2 Q9UCJ3,Pulmonary surfactant-associated protein D,Collectin-7;Lung surfactant protein D;, PF01391;PF00059;PF09006;, GO:0045334;GO:0005581;GO:0030139;GO:0005789;GO:0005576;GO:0005615;GO:0005764;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0042742;GO:0043152;GO:0045087;GO:0048286;GO:0048246;GO:0052405;GO:0032703;GO:0042130;GO:0050766;GO:0072593;GO:0006898;GO:1905226;GO:0001817;GO:0050776;GO:0007585;GO:0043129;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lysosome; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:defense response to bacterium; P:induction of bacterial agglutination; P:innate immune response; P:lung alveolus development; P:macrophage chemotaxis; P:negative regulation by host of symbiont molecular function; P:negative regulation of interleukin-2 production; P:negative regulation of T cell proliferation; P:positive regulation of phagocytosis; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:regulation of adhesion of symbiont to host epithelial cell; P:regulation of cytokine production; P:regulation of immune response; P:respiratory gaseous exchange by respiratory system; P:surfactant homeostasis; P:toll-like receptor signaling pathway; scaffold14 indexed_genome mRNA 22919089 22919622 . - . ID=transcript_3674;P35247 Q5T0M3 Q6FH08 Q86YK9 Q8TCD8 Q9UCJ2 Q9UCJ3,Pulmonary surfactant-associated protein D,Collectin-7;Lung surfactant protein D;, PF01391;PF00059;PF09006;, GO:0045334;GO:0005581;GO:0030139;GO:0005789;GO:0005576;GO:0005615;GO:0005764;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0042742;GO:0043152;GO:0045087;GO:0048286;GO:0048246;GO:0052405;GO:0032703;GO:0042130;GO:0050766;GO:0072593;GO:0006898;GO:1905226;GO:0001817;GO:0050776;GO:0007585;GO:0043129;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lysosome; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:defense response to bacterium; P:induction of bacterial agglutination; P:innate immune response; P:lung alveolus development; P:macrophage chemotaxis; P:negative regulation by host of symbiont molecular function; P:negative regulation of interleukin-2 production; P:negative regulation of T cell proliferation; P:positive regulation of phagocytosis; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:regulation of adhesion of symbiont to host epithelial cell; P:regulation of cytokine production; P:regulation of immune response; P:respiratory gaseous exchange by respiratory system; P:surfactant homeostasis; P:toll-like receptor signaling pathway; scaffold14 indexed_genome mRNA 22935639 22939004 . - . ID=transcript_3675;Q96TF9,Mannose-binding protein C,Collectin-1;MBP1;Mannan-binding protein;Mannose-binding lectin;, PF01391;PF00059;, GO:0009986;GO:0005581;GO:0062023;GO:0005576;GO:0005615;GO:0048306;GO:0005537;GO:0005102;GO:0006953;GO:0006956;GO:0006958;GO:0001867;GO:0042742;GO:0050830;GO:0045087;GO:0048525;GO:0008228;GO:0006979;, C:cell surface; C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium-dependent protein binding; F:mannose binding; F:signaling receptor binding;, P:acute-phase response; P:complement activation; P:complement activation, classical pathway; P:complement activation, lectin pathway; P:defense response to bacterium; P:defense response to Gram-positive bacterium; P:innate immune response; P:negative regulation of viral process; P:opsonization; P:response to oxidative stress; scaffold14 indexed_genome mRNA 22943628 22949224 . - . ID=transcript_3676;P07714 Q14DV3 Q5RIR8 Q5RIR9,Pulmonary surfactant-associated protein A2,35 kDa pulmonary surfactant-associated protein;Alveolar proteinosis protein;Collectin-5;, PF00059;, GO:0045334;GO:0005581;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0007585;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:respiratory gaseous exchange by respiratory system; P:toll-like receptor signaling pathway;|P07714 Q14DV3 Q5RIR8 Q5RIR9,Pulmonary surfactant-associated protein A2,35 kDa pulmonary surfactant-associated protein;Alveolar proteinosis protein;Collectin-5;, PF00059;, GO:0045334;GO:0005581;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0007585;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:respiratory gaseous exchange by respiratory system; P:toll-like receptor signaling pathway; scaffold14 indexed_genome mRNA 22963854 22981084 . - . ID=transcript_3677;Q00266 D3DWD5 Q5QP09,S-adenosylmethionine synthase isoform type-1,Methionine adenosyltransferase 1;Methionine adenosyltransferase I/III;, PF02773;PF02772;PF00438;, GO:0005829;GO:0005524;GO:0042802;GO:0046872;GO:0004478;GO:0009087;GO:0032259;GO:0006730;GO:0051289;GO:0006556;GO:0001887;GO:0000096;, C:cytosol;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:methionine adenosyltransferase activity;, P:methionine catabolic process; P:methylation; P:one-carbon metabolic process; P:protein homotetramerization; P:S-adenosylmethionine biosynthetic process; P:selenium compound metabolic process; P:sulfur amino acid metabolic process;|Q00266 D3DWD5 Q5QP09,S-adenosylmethionine synthase isoform type-1,Methionine adenosyltransferase 1;Methionine adenosyltransferase I/III;, PF02773;PF02772;PF00438;, GO:0005829;GO:0005524;GO:0042802;GO:0046872;GO:0004478;GO:0009087;GO:0032259;GO:0006730;GO:0051289;GO:0006556;GO:0001887;GO:0000096;, C:cytosol;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:methionine adenosyltransferase activity;, P:methionine catabolic process; P:methylation; P:one-carbon metabolic process; P:protein homotetramerization; P:S-adenosylmethionine biosynthetic process; P:selenium compound metabolic process; P:sulfur amino acid metabolic process;|Q00266 D3DWD5 Q5QP09,S-adenosylmethionine synthase isoform type-1,Methionine adenosyltransferase 1;Methionine adenosyltransferase I/III;, PF02773;PF02772;PF00438;, GO:0005829;GO:0005524;GO:0042802;GO:0046872;GO:0004478;GO:0009087;GO:0032259;GO:0006730;GO:0051289;GO:0006556;GO:0001887;GO:0000096;, C:cytosol;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:methionine adenosyltransferase activity;, P:methionine catabolic process; P:methylation; P:one-carbon metabolic process; P:protein homotetramerization; P:S-adenosylmethionine biosynthetic process; P:selenium compound metabolic process; P:sulfur amino acid metabolic process;|Q00266 D3DWD5 Q5QP09,S-adenosylmethionine synthase isoform type-1,Methionine adenosyltransferase 1;Methionine adenosyltransferase I/III;, PF02773;PF02772;PF00438;, GO:0005829;GO:0005524;GO:0042802;GO:0046872;GO:0004478;GO:0009087;GO:0032259;GO:0006730;GO:0051289;GO:0006556;GO:0001887;GO:0000096;, C:cytosol;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:methionine adenosyltransferase activity;, P:methionine catabolic process; P:methylation; P:one-carbon metabolic process; P:protein homotetramerization; P:S-adenosylmethionine biosynthetic process; P:selenium compound metabolic process; P:sulfur amino acid metabolic process;|Q00266 D3DWD5 Q5QP09,S-adenosylmethionine synthase isoform type-1,Methionine adenosyltransferase 1;Methionine adenosyltransferase I/III;, PF02773;PF02772;PF00438;, GO:0005829;GO:0005524;GO:0042802;GO:0046872;GO:0004478;GO:0009087;GO:0032259;GO:0006730;GO:0051289;GO:0006556;GO:0001887;GO:0000096;, C:cytosol;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:methionine adenosyltransferase activity;, P:methionine catabolic process; P:methylation; P:one-carbon metabolic process; P:protein homotetramerization; P:S-adenosylmethionine biosynthetic process; P:selenium compound metabolic process; P:sulfur amino acid metabolic process; scaffold14 indexed_genome mRNA 23048223 23058559 . + . ID=transcript_3678;Q96IM9 D3DWD6 Q5QP07 Q5QP11,DPY30 domain-containing protein 2,, PF05186;, GO:0000781;GO:0044666;GO:0048188;GO:0006348;GO:0051568;, C:chromosome, telomeric region; C:MLL3/4 complex; C:Set1C/COMPASS complex;, , P:chromatin silencing at telomere; P:histone H3-K4 methylation; scaffold14 indexed_genome mRNA 23110929 23123026 . + . ID=transcript_3679;Q9BRX8 B2RD81 Q6UW08 Q8N2K3 Q8NBK9 Q96JR0,Peroxiredoxin-like 2A {ECO:0000305},Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes {ECO:0000303|PubMed:19951071, ECO:0000303|PubMed:26438880};Redox-regulatory protein FAM213A;, PF13911;, GO:0005737;GO:0005576;GO:0016209;GO:0045670;, C:cytoplasm; C:extracellular region;, F:antioxidant activity;, P:regulation of osteoclast differentiation;|Q9BRX8 B2RD81 Q6UW08 Q8N2K3 Q8NBK9 Q96JR0,Peroxiredoxin-like 2A {ECO:0000305},Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes {ECO:0000303|PubMed:19951071, ECO:0000303|PubMed:26438880};Redox-regulatory protein FAM213A;, PF13911;, GO:0005737;GO:0005576;GO:0016209;GO:0045670;, C:cytoplasm; C:extracellular region;, F:antioxidant activity;, P:regulation of osteoclast differentiation;|Q9BRX8 B2RD81 Q6UW08 Q8N2K3 Q8NBK9 Q96JR0,Peroxiredoxin-like 2A {ECO:0000305},Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes {ECO:0000303|PubMed:19951071, ECO:0000303|PubMed:26438880};Redox-regulatory protein FAM213A;, PF13911;, GO:0005737;GO:0005576;GO:0016209;GO:0045670;, C:cytoplasm; C:extracellular region;, F:antioxidant activity;, P:regulation of osteoclast differentiation;|Q9BRX8 B2RD81 Q6UW08 Q8N2K3 Q8NBK9 Q96JR0,Peroxiredoxin-like 2A {ECO:0000305},Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes {ECO:0000303|PubMed:19951071, ECO:0000303|PubMed:26438880};Redox-regulatory protein FAM213A;, PF13911;, GO:0005737;GO:0005576;GO:0016209;GO:0045670;, C:cytoplasm; C:extracellular region;, F:antioxidant activity;, P:regulation of osteoclast differentiation; scaffold14 indexed_genome mRNA 23200409 23206537 . + . ID=transcript_3680;Q8NG11 A6NHE1 B4DHY6 D3DWD7 D3DWD8 Q567U7 Q9BU34 Q9H0U1,Tetraspanin-14,DC-TM4F2;Transmembrane 4 superfamily member 14;, PF00335;, GO:0009986;GO:0005788;GO:0005887;GO:0005886;GO:0035579;GO:0070821;GO:0097197;GO:0019899;GO:1990000;GO:0043312;GO:0045747;GO:0072659;GO:0051604;, C:cell surface; C:endoplasmic reticulum lumen; C:integral component of plasma membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane; C:tetraspanin-enriched microdomain;, F:enzyme binding;, P:amyloid fibril formation; P:neutrophil degranulation; P:positive regulation of Notch signaling pathway; P:protein localization to plasma membrane; P:protein maturation; scaffold14 indexed_genome mRNA 24160462 25305235 . + . ID=transcript_3681;P56975 A4D7U1 Q0PEH2 Q5VYH3,Pro-neuregulin-3, membrane-bound isoform,, , GO:0005576;GO:0005615;GO:0098978;GO:0005887;GO:0045499;GO:0008083;GO:0030971;GO:0005102;GO:0030297;GO:0048513;GO:0021842;GO:0035556;GO:0060596;GO:0050804;GO:2001223;GO:0007389;GO:0001558;, C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:integral component of plasma membrane;, F:chemorepellent activity; F:growth factor activity; F:receptor tyrosine kinase binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activator activity;, P:animal organ development; P:chemorepulsion involved in interneuron migration from the subpallium to the cortex; P:intracellular signal transduction; P:mammary placode formation; P:modulation of chemical synaptic transmission; P:negative regulation of neuron migration; P:pattern specification process; P:regulation of cell growth; scaffold14 indexed_genome mRNA 26248583 26262201 . + . ID=transcript_3682;Q9H3K2 A8K9Z9 D3DWE0 O95894 Q5VT95 Q9H0P2,Growth hormone-inducible transmembrane protein,Dermal papilla-derived protein 2;Mitochondrial morphology and cristae structure 1;Transmembrane BAX inhibitor motif-containing protein 5;, PF01027;, GO:0070062;GO:0031305;GO:0005739;GO:0006915;GO:0007007;GO:0090201;GO:1905448;, C:extracellular exosome; C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:apoptotic process; P:inner mitochondrial membrane organization; P:negative regulation of release of cytochrome c from mitochondria; P:positive regulation of mitochondrial ATP synthesis coupled electron transport;|Q9H3K2 A8K9Z9 D3DWE0 O95894 Q5VT95 Q9H0P2,Growth hormone-inducible transmembrane protein,Dermal papilla-derived protein 2;Mitochondrial morphology and cristae structure 1;Transmembrane BAX inhibitor motif-containing protein 5;, PF01027;, GO:0070062;GO:0031305;GO:0005739;GO:0006915;GO:0007007;GO:0090201;GO:1905448;, C:extracellular exosome; C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:apoptotic process; P:inner mitochondrial membrane organization; P:negative regulation of release of cytochrome c from mitochondria; P:positive regulation of mitochondrial ATP synthesis coupled electron transport;|Q9H3K2 A8K9Z9 D3DWE0 O95894 Q5VT95 Q9H0P2,Growth hormone-inducible transmembrane protein,Dermal papilla-derived protein 2;Mitochondrial morphology and cristae structure 1;Transmembrane BAX inhibitor motif-containing protein 5;, PF01027;, GO:0070062;GO:0031305;GO:0005739;GO:0006915;GO:0007007;GO:0090201;GO:1905448;, C:extracellular exosome; C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:apoptotic process; P:inner mitochondrial membrane organization; P:negative regulation of release of cytochrome c from mitochondria; P:positive regulation of mitochondrial ATP synthesis coupled electron transport; scaffold14 indexed_genome mRNA 26288331 26309226 . + . ID=transcript_3683;Q96JP9 Q69YZ8 Q8IXY5,Cadherin-related family member 1 {ECO:0000305},Photoreceptor cadherin;Protocadherin-21;, PF00028;, GO:0005887;GO:0042622;GO:0005509;GO:0007155;GO:0007156;GO:0045494;GO:0008594;GO:0035845;, C:integral component of plasma membrane; C:photoreceptor outer segment membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:photoreceptor cell maintenance; P:photoreceptor cell morphogenesis; P:photoreceptor cell outer segment organization; scaffold14 indexed_genome mRNA 26309336 26311348 . + . ID=transcript_3684;Q96JP9 Q69YZ8 Q8IXY5,Cadherin-related family member 1 {ECO:0000305},Photoreceptor cadherin;Protocadherin-21;, PF00028;, GO:0005887;GO:0042622;GO:0005509;GO:0007155;GO:0007156;GO:0045494;GO:0008594;GO:0035845;, C:integral component of plasma membrane; C:photoreceptor outer segment membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:photoreceptor cell maintenance; P:photoreceptor cell morphogenesis; P:photoreceptor cell outer segment organization; scaffold14 indexed_genome mRNA 26393096 26541777 . + . ID=transcript_3685;Q9H7U1 B4DFY4 B4DQU9 B7WPE8 D3DWE2 Q8N6E9 Q9H2S0 Q9ULU1,Serine-rich coiled-coil domain-containing protein 2,Coiled-coil serine-rich protein 2;Protein GCAP14 homolog;, , GO:0005737;GO:0015630;GO:0008017;GO:0001578;, C:cytoplasm; C:microtubule cytoskeleton;, F:microtubule binding;, P:microtubule bundle formation; scaffold14 indexed_genome mRNA 26551851 26556911 . - . ID=transcript_3686;Q9H7U1 B4DFY4 B4DQU9 B7WPE8 D3DWE2 Q8N6E9 Q9H2S0 Q9ULU1,Serine-rich coiled-coil domain-containing protein 2,Coiled-coil serine-rich protein 2;Protein GCAP14 homolog;, , GO:0005737;GO:0015630;GO:0008017;GO:0001578;, C:cytoplasm; C:microtubule cytoskeleton;, F:microtubule binding;, P:microtubule bundle formation; scaffold14 indexed_genome mRNA 28209528 28258246 . - . ID=transcript_3687;Q7Z5K2 A7E2B5 Q5VSK5 Q8IX10 Q92549,Wings apart-like protein homolog,Friend of EBNA2 protein;WAPL cohesin release factor {ECO:0000312|HGNC:HGNC:23293};, PF07814;, GO:0005813;GO:0000785;GO:0005694;GO:0000775;GO:0005737;GO:0005829;GO:0005794;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0000795;GO:0051301;GO:0000278;GO:0035562;GO:0008156;GO:0045875;GO:0048146;GO:0071168;GO:0060623;GO:0051983;GO:0071922;GO:0009636;GO:0016032;, C:centrosome; C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, , P:cell division; P:mitotic cell cycle; P:negative regulation of chromatin binding; P:negative regulation of DNA replication; P:negative regulation of sister chromatid cohesion; P:positive regulation of fibroblast proliferation; P:protein localization to chromatin; P:regulation of chromosome condensation; P:regulation of chromosome segregation; P:regulation of cohesin loading; P:response to toxic substance; P:viral process;|Q7Z5K2 A7E2B5 Q5VSK5 Q8IX10 Q92549,Wings apart-like protein homolog,Friend of EBNA2 protein;WAPL cohesin release factor {ECO:0000312|HGNC:HGNC:23293};, PF07814;, GO:0005813;GO:0000785;GO:0005694;GO:0000775;GO:0005737;GO:0005829;GO:0005794;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0000795;GO:0051301;GO:0000278;GO:0035562;GO:0008156;GO:0045875;GO:0048146;GO:0071168;GO:0060623;GO:0051983;GO:0071922;GO:0009636;GO:0016032;, C:centrosome; C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, , P:cell division; P:mitotic cell cycle; P:negative regulation of chromatin binding; P:negative regulation of DNA replication; P:negative regulation of sister chromatid cohesion; P:positive regulation of fibroblast proliferation; P:protein localization to chromatin; P:regulation of chromosome condensation; P:regulation of chromosome segregation; P:regulation of cohesin loading; P:response to toxic substance; P:viral process;|Q7Z5K2 A7E2B5 Q5VSK5 Q8IX10 Q92549,Wings apart-like protein homolog,Friend of EBNA2 protein;WAPL cohesin release factor {ECO:0000312|HGNC:HGNC:23293};, PF07814;, GO:0005813;GO:0000785;GO:0005694;GO:0000775;GO:0005737;GO:0005829;GO:0005794;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0000795;GO:0051301;GO:0000278;GO:0035562;GO:0008156;GO:0045875;GO:0048146;GO:0071168;GO:0060623;GO:0051983;GO:0071922;GO:0009636;GO:0016032;, C:centrosome; C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, , P:cell division; P:mitotic cell cycle; P:negative regulation of chromatin binding; P:negative regulation of DNA replication; P:negative regulation of sister chromatid cohesion; P:positive regulation of fibroblast proliferation; P:protein localization to chromatin; P:regulation of chromosome condensation; P:regulation of chromosome segregation; P:regulation of cohesin loading; P:response to toxic substance; P:viral process; scaffold14 indexed_genome mRNA 28279659 28283004 . - . ID=transcript_3688;Q7Z5K2 A7E2B5 Q5VSK5 Q8IX10 Q92549,Wings apart-like protein homolog,Friend of EBNA2 protein;WAPL cohesin release factor {ECO:0000312|HGNC:HGNC:23293};, PF07814;, GO:0005813;GO:0000785;GO:0005694;GO:0000775;GO:0005737;GO:0005829;GO:0005794;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0000795;GO:0051301;GO:0000278;GO:0035562;GO:0008156;GO:0045875;GO:0048146;GO:0071168;GO:0060623;GO:0051983;GO:0071922;GO:0009636;GO:0016032;, C:centrosome; C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, , P:cell division; P:mitotic cell cycle; P:negative regulation of chromatin binding; P:negative regulation of DNA replication; P:negative regulation of sister chromatid cohesion; P:positive regulation of fibroblast proliferation; P:protein localization to chromatin; P:regulation of chromosome condensation; P:regulation of chromosome segregation; P:regulation of cohesin loading; P:response to toxic substance; P:viral process; scaffold14 indexed_genome mRNA 28370361 28391954 . + . ID=transcript_3689;Q9Y4Z4 Q9Y4Z5,LIM domain-binding protein 3,Protein cypher;Z-band alternatively spliced PDZ-motif protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005856;GO:0031941;GO:0048471;GO:0031143;GO:0001725;GO:0030018;GO:0003779;GO:0008092;GO:0046872;GO:0051371;GO:0005080;GO:0030036;GO:0007507;GO:0061061;GO:0045214;, C:adherens junction; C:cytoskeleton; C:filamentous actin; C:perinuclear region of cytoplasm; C:pseudopodium; C:stress fiber; C:Z disc;, F:actin binding; F:cytoskeletal protein binding; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development; P:sarcomere organization;|Q9Y4Z4 Q9Y4Z5,LIM domain-binding protein 3,Protein cypher;Z-band alternatively spliced PDZ-motif protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005856;GO:0031941;GO:0048471;GO:0031143;GO:0001725;GO:0030018;GO:0003779;GO:0008092;GO:0046872;GO:0051371;GO:0005080;GO:0030036;GO:0007507;GO:0061061;GO:0045214;, C:adherens junction; C:cytoskeleton; C:filamentous actin; C:perinuclear region of cytoplasm; C:pseudopodium; C:stress fiber; C:Z disc;, F:actin binding; F:cytoskeletal protein binding; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development; P:sarcomere organization;|Q9Y4Z4 Q9Y4Z5,LIM domain-binding protein 3,Protein cypher;Z-band alternatively spliced PDZ-motif protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005856;GO:0031941;GO:0048471;GO:0031143;GO:0001725;GO:0030018;GO:0003779;GO:0008092;GO:0046872;GO:0051371;GO:0005080;GO:0030036;GO:0007507;GO:0061061;GO:0045214;, C:adherens junction; C:cytoskeleton; C:filamentous actin; C:perinuclear region of cytoplasm; C:pseudopodium; C:stress fiber; C:Z disc;, F:actin binding; F:cytoskeletal protein binding; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development; P:sarcomere organization; scaffold14 indexed_genome mRNA 28392053 28429285 . + . ID=transcript_3690;Q9Y4Z4 Q9Y4Z5,LIM domain-binding protein 3,Protein cypher;Z-band alternatively spliced PDZ-motif protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005856;GO:0031941;GO:0048471;GO:0031143;GO:0001725;GO:0030018;GO:0003779;GO:0008092;GO:0046872;GO:0051371;GO:0005080;GO:0030036;GO:0007507;GO:0061061;GO:0045214;, C:adherens junction; C:cytoskeleton; C:filamentous actin; C:perinuclear region of cytoplasm; C:pseudopodium; C:stress fiber; C:Z disc;, F:actin binding; F:cytoskeletal protein binding; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development; P:sarcomere organization;|Q9Y4Z4 Q9Y4Z5,LIM domain-binding protein 3,Protein cypher;Z-band alternatively spliced PDZ-motif protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005856;GO:0031941;GO:0048471;GO:0031143;GO:0001725;GO:0030018;GO:0003779;GO:0008092;GO:0046872;GO:0051371;GO:0005080;GO:0030036;GO:0007507;GO:0061061;GO:0045214;, C:adherens junction; C:cytoskeleton; C:filamentous actin; C:perinuclear region of cytoplasm; C:pseudopodium; C:stress fiber; C:Z disc;, F:actin binding; F:cytoskeletal protein binding; F:metal ion binding; F:muscle alpha-actinin binding; F:protein kinase C binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development; P:sarcomere organization; scaffold14 indexed_genome mRNA 28555941 28589930 . + . ID=transcript_3691;P36894 A8K6U9 Q8NEN8,Bone morphogenetic protein receptor type-1A,Activin receptor-like kinase 3;Serine/threonine-protein kinase receptor R5;, PF01064;PF07714;PF08515;, GO:0030425;GO:0009897;GO:1990712;GO:0016021;GO:0043025;GO:0005886;GO:0043235;GO:0005524;GO:0098821;GO:0046872;GO:0042803;GO:0004674;GO:0046332;GO:0005025;GO:0060928;GO:0003171;GO:0030509;GO:0061312;GO:0003161;GO:0003215;GO:0071773;GO:0071363;GO:0002062;GO:0048589;GO:0035912;GO:0009950;GO:0009953;GO:0007398;GO:0042733;GO:0048568;GO:0003272;GO:0003203;GO:1905285;GO:0060914;GO:0035137;GO:0006955;GO:0001701;GO:0048368;GO:0030324;GO:0048382;GO:0001707;GO:0003183;GO:0001880;GO:0030514;GO:0010629;GO:0050768;GO:0014912;GO:0014032;GO:0021998;GO:0042475;GO:0003151;GO:0003148;GO:0048352;GO:0061626;GO:0021983;GO:0030513;GO:0030501;GO:0060045;GO:1904414;GO:0050679;GO:0002053;GO:0045669;GO:0010862;GO:1902895;GO:0060391;GO:0045944;GO:0032915;GO:1904707;GO:0006468;GO:0060043;GO:2000772;GO:0048378;GO:0060021;GO:0001756;GO:0019827;GO:0007179;GO:0003186;GO:0003223;GO:0060412;GO:0003222;, C:dendrite; C:external side of plasma membrane; C:HFE-transferrin receptor complex; C:integral component of membrane; C:neuronal cell body; C:plasma membrane; C:receptor complex;, F:ATP binding; F:BMP receptor activity; F:metal ion binding; F:protein homodimerization activity; F:protein serine/threonine kinase activity; F:SMAD binding; F:transforming growth factor beta receptor activity, type I;, P:atrioventricular node cell development; P:atrioventricular valve development; P:BMP signaling pathway; P:BMP signaling pathway involved in heart development; P:cardiac conduction system development; P:cardiac right ventricle morphogenesis; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:chondrocyte differentiation; P:developmental growth; P:dorsal aorta morphogenesis; P:dorsal/ventral axis specification; P:dorsal/ventral pattern formation; P:ectoderm development; P:embryonic digit morphogenesis; P:embryonic organ development; P:endocardial cushion formation; P:endocardial cushion morphogenesis; P:fibrous ring of heart morphogenesis; P:heart formation; P:hindlimb morphogenesis; P:immune response; P:in utero embryonic development; P:lateral mesoderm development; P:lung development; P:mesendoderm development; P:mesoderm formation; P:mitral valve morphogenesis; P:Mullerian duct regression; P:negative regulation of BMP signaling pathway; P:negative regulation of gene expression; P:negative regulation of neurogenesis; P:negative regulation of smooth muscle cell migration; P:neural crest cell development; P:neural plate mediolateral regionalization; P:odontogenesis of dentin-containing tooth; P:outflow tract morphogenesis; P:outflow tract septum morphogenesis; P:paraxial mesoderm structural organization; P:pharyngeal arch artery morphogenesis; P:pituitary gland development; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cardiac ventricle development; P:positive regulation of epithelial cell proliferation; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta2 production; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein phosphorylation; P:regulation of cardiac muscle cell proliferation; P:regulation of cellular senescence; P:regulation of lateral mesodermal cell fate specification; P:roof of mouth development; P:somitogenesis; P:stem cell population maintenance; P:transforming growth factor beta receptor signaling pathway; P:tricuspid valve morphogenesis; P:ventricular compact myocardium morphogenesis; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis;|P36894 A8K6U9 Q8NEN8,Bone morphogenetic protein receptor type-1A,Activin receptor-like kinase 3;Serine/threonine-protein kinase receptor R5;, PF01064;PF07714;PF08515;, GO:0030425;GO:0009897;GO:1990712;GO:0016021;GO:0043025;GO:0005886;GO:0043235;GO:0005524;GO:0098821;GO:0046872;GO:0042803;GO:0004674;GO:0046332;GO:0005025;GO:0060928;GO:0003171;GO:0030509;GO:0061312;GO:0003161;GO:0003215;GO:0071773;GO:0071363;GO:0002062;GO:0048589;GO:0035912;GO:0009950;GO:0009953;GO:0007398;GO:0042733;GO:0048568;GO:0003272;GO:0003203;GO:1905285;GO:0060914;GO:0035137;GO:0006955;GO:0001701;GO:0048368;GO:0030324;GO:0048382;GO:0001707;GO:0003183;GO:0001880;GO:0030514;GO:0010629;GO:0050768;GO:0014912;GO:0014032;GO:0021998;GO:0042475;GO:0003151;GO:0003148;GO:0048352;GO:0061626;GO:0021983;GO:0030513;GO:0030501;GO:0060045;GO:1904414;GO:0050679;GO:0002053;GO:0045669;GO:0010862;GO:1902895;GO:0060391;GO:0045944;GO:0032915;GO:1904707;GO:0006468;GO:0060043;GO:2000772;GO:0048378;GO:0060021;GO:0001756;GO:0019827;GO:0007179;GO:0003186;GO:0003223;GO:0060412;GO:0003222;, C:dendrite; C:external side of plasma membrane; C:HFE-transferrin receptor complex; C:integral component of membrane; C:neuronal cell body; C:plasma membrane; C:receptor complex;, F:ATP binding; F:BMP receptor activity; F:metal ion binding; F:protein homodimerization activity; F:protein serine/threonine kinase activity; F:SMAD binding; F:transforming growth factor beta receptor activity, type I;, P:atrioventricular node cell development; P:atrioventricular valve development; P:BMP signaling pathway; P:BMP signaling pathway involved in heart development; P:cardiac conduction system development; P:cardiac right ventricle morphogenesis; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:chondrocyte differentiation; P:developmental growth; P:dorsal aorta morphogenesis; P:dorsal/ventral axis specification; P:dorsal/ventral pattern formation; P:ectoderm development; P:embryonic digit morphogenesis; P:embryonic organ development; P:endocardial cushion formation; P:endocardial cushion morphogenesis; P:fibrous ring of heart morphogenesis; P:heart formation; P:hindlimb morphogenesis; P:immune response; P:in utero embryonic development; P:lateral mesoderm development; P:lung development; P:mesendoderm development; P:mesoderm formation; P:mitral valve morphogenesis; P:Mullerian duct regression; P:negative regulation of BMP signaling pathway; P:negative regulation of gene expression; P:negative regulation of neurogenesis; P:negative regulation of smooth muscle cell migration; P:neural crest cell development; P:neural plate mediolateral regionalization; P:odontogenesis of dentin-containing tooth; P:outflow tract morphogenesis; P:outflow tract septum morphogenesis; P:paraxial mesoderm structural organization; P:pharyngeal arch artery morphogenesis; P:pituitary gland development; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cardiac ventricle development; P:positive regulation of epithelial cell proliferation; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta2 production; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein phosphorylation; P:regulation of cardiac muscle cell proliferation; P:regulation of cellular senescence; P:regulation of lateral mesodermal cell fate specification; P:roof of mouth development; P:somitogenesis; P:stem cell population maintenance; P:transforming growth factor beta receptor signaling pathway; P:tricuspid valve morphogenesis; P:ventricular compact myocardium morphogenesis; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis; scaffold14 indexed_genome mRNA 28593657 28610566 . - . ID=transcript_3692;Q9H8L6 Q504V7 Q6P2N2,Multimerin-2,EMILIN-3;Elastin microfibril interface located protein 3;EndoGlyx-1 p125/p140 subunit;, PF00386;PF07546;, GO:0005604;GO:0062023;GO:0070062;GO:0005615;GO:0002042;GO:0090051;GO:0030948;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space;, , P:cell migration involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; scaffold14 indexed_genome mRNA 28611490 28616290 . + . ID=transcript_3693;O76070 O15104 Q96P61,Gamma-synuclein,Breast cancer-specific gene 1 protein;Persyn;Synoretin;, PF01387;, GO:0043679;GO:0005813;GO:0005737;GO:0070062;GO:0043025;GO:0048471;GO:0005819;GO:1903136;GO:0008344;GO:0007268;GO:0009306;GO:0014059;GO:1901214;GO:0046928;GO:0050808;GO:0048488;, C:axon terminus; C:centrosome; C:cytoplasm; C:extracellular exosome; C:neuronal cell body; C:perinuclear region of cytoplasm; C:spindle;, F:cuprous ion binding;, P:adult locomotory behavior; P:chemical synaptic transmission; P:protein secretion; P:regulation of dopamine secretion; P:regulation of neuron death; P:regulation of neurotransmitter secretion; P:synapse organization; P:synaptic vesicle endocytosis; scaffold14 indexed_genome mRNA 28629432 28634222 . + . ID=transcript_3694;A8MYX2,Protein FAM25E {ECO:0000305},, PF15825; scaffold14 indexed_genome mRNA 28648924 28650682 . + . ID=transcript_3695;P00367 B3KV55 B4DGN5 Q5TBU3,Glutamate dehydrogenase 1, mitochondrial,, PF00208;PF02812;, GO:0005737;GO:0005783;GO:0005759;GO:0005739;GO:0043531;GO:0005524;GO:0004352;GO:0004354;GO:0004353;GO:0005525;GO:0042802;GO:0070728;GO:0070403;GO:0006537;GO:0006538;GO:0009064;GO:0006541;GO:0032024;GO:0021762;GO:0072350;, C:cytoplasm; C:endoplasmic reticulum; C:mitochondrial matrix; C:mitochondrion;, F:ADP binding; F:ATP binding; F:glutamate dehydrogenase (NAD+) activity; F:glutamate dehydrogenase (NADP+) activity; F:glutamate dehydrogenase [NAD(P)+] activity; F:GTP binding; F:identical protein binding; F:leucine binding; F:NAD+ binding;, P:glutamate biosynthetic process; P:glutamate catabolic process; P:glutamine family amino acid metabolic process; P:glutamine metabolic process; P:positive regulation of insulin secretion; P:substantia nigra development; P:tricarboxylic acid metabolic process; scaffold14 indexed_genome mRNA 28657449 28657993 . - . ID=transcript_3696;P49448 B2R8G0 Q9UDQ4,Glutamate dehydrogenase 2, mitochondrial,, PF00208;PF02812;, GO:0005759;GO:0005739;GO:0043531;GO:0004352;GO:0004354;GO:0004353;GO:0005525;GO:0070728;GO:0006537;GO:0006538;GO:0006536;, C:mitochondrial matrix; C:mitochondrion;, F:ADP binding; F:glutamate dehydrogenase (NAD+) activity; F:glutamate dehydrogenase (NADP+) activity; F:glutamate dehydrogenase [NAD(P)+] activity; F:GTP binding; F:leucine binding;, P:glutamate biosynthetic process; P:glutamate catabolic process; P:glutamate metabolic process; scaffold14 indexed_genome mRNA 28659126 28659926 . - . ID=transcript_3697;P49448 B2R8G0 Q9UDQ4,Glutamate dehydrogenase 2, mitochondrial,, PF00208;PF02812;, GO:0005759;GO:0005739;GO:0043531;GO:0004352;GO:0004354;GO:0004353;GO:0005525;GO:0070728;GO:0006537;GO:0006538;GO:0006536;, C:mitochondrial matrix; C:mitochondrion;, F:ADP binding; F:glutamate dehydrogenase (NAD+) activity; F:glutamate dehydrogenase (NADP+) activity; F:glutamate dehydrogenase [NAD(P)+] activity; F:GTP binding; F:leucine binding;, P:glutamate biosynthetic process; P:glutamate catabolic process; P:glutamate metabolic process; scaffold14 indexed_genome mRNA 28696481 28812080 . + . ID=transcript_3698;Q86V20 O95885 Q9H991,Shieldin complex subunit 2 {ECO:0000312|HGNC:HGNC:28773},Protein FAM35A {ECO:0000305};RINN1-REV7-interacting novel NHEJ regulator 2 {ECO:0000303|PubMed:29656893};Shield complex subunit 2;, PF15793;, GO:0005694;GO:0005634;GO:0035861;GO:0006281;GO:2000042;GO:2001034;GO:0045830;GO:0010569;, C:chromosome; C:nucleus; C:site of double-strand break;, , P:DNA repair; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching; P:regulation of double-strand break repair via homologous recombination;|Q86V20 O95885 Q9H991,Shieldin complex subunit 2 {ECO:0000312|HGNC:HGNC:28773},Protein FAM35A {ECO:0000305};RINN1-REV7-interacting novel NHEJ regulator 2 {ECO:0000303|PubMed:29656893};Shield complex subunit 2;, PF15793;, GO:0005694;GO:0005634;GO:0035861;GO:0006281;GO:2000042;GO:2001034;GO:0045830;GO:0010569;, C:chromosome; C:nucleus; C:site of double-strand break;, , P:DNA repair; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching; P:regulation of double-strand break repair via homologous recombination; scaffold14 indexed_genome mRNA 28824028 28829422 . - . ID=transcript_3699;Q9BQS2 A5D6W8 Q5VY53 Q5VY55 Q7Z439 Q7Z440,Synaptotagmin-15,Chr10Syt;Synaptotagmin XV;, PF00168;, GO:0070382;GO:0016021;GO:0005886;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0000149;GO:0017156;GO:0071277;GO:0017158;GO:0014059;GO:0016192;, C:exocytic vesicle; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:SNARE binding;, P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:vesicle-mediated transport; scaffold14 indexed_genome mRNA 28856134 28860438 . + . ID=transcript_3700;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold14 indexed_genome mRNA 28951992 28954744 . + . ID=transcript_3701;P50391 Q13456 Q5ISU3 Q5T2X9 Q6FH06,Neuropeptide Y receptor type 4,Pancreatic polypeptide receptor 1;, PF00001;, GO:0005887;GO:0016020;GO:0005886;GO:0004930;GO:0001602;GO:0017046;GO:0007186;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:pancreatic polypeptide receptor activity; F:peptide hormone binding;, P:G protein-coupled receptor signaling pathway; scaffold14 indexed_genome mRNA 28989782 29006421 . - . ID=transcript_3702;P13928 A6NDE6 A6NLM1 B4DKI1 B4DTC9 Q5T2P8 Q5VTM4 Q6GMY3 Q9BT34,Annexin A8 {ECO:0000312|HGNC:HGNC:546},Annexin VIII {ECO:0000303|PubMed:1313714};Annexin-8 {ECO:0000303|PubMed:2530088};Vascular anticoagulant-beta {ECO:0000303|PubMed:2530088};, PF00191;, GO:0062023;GO:0005737;GO:0005829;GO:0031902;GO:0005886;GO:0051015;GO:0005509;GO:0005544;GO:0005547;GO:0043325;GO:0005546;GO:0007596;GO:0016197;GO:0007032;GO:1900138;GO:1900004;, C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:late endosome membrane; C:plasma membrane;, F:actin filament binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:blood coagulation; P:endosomal transport; P:endosome organization; P:negative regulation of phospholipase A2 activity; P:negative regulation of serine-type endopeptidase activity; scaffold14 indexed_genome mRNA 29232995 29235457 . - . ID=transcript_3703;A6NF34 H3BPS2,Anthrax toxin receptor-like,, PF05587;PF00092;, GO:0009986;GO:0016021;GO:0005886;GO:0046872;GO:0004888;GO:1901998;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:metal ion binding; F:transmembrane signaling receptor activity;, P:toxin transport; scaffold14 indexed_genome mRNA 29257761 29260054 . - . ID=transcript_3704;Q96MN9 Q05CE0,Zinc finger protein 488,, , GO:0005634;GO:0003677;GO:0046872;GO:0014003;GO:0006355;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:oligodendrocyte development; P:regulation of transcription, DNA-templated; scaffold14 indexed_genome mRNA 29283228 29286697 . + . ID=transcript_3705;Q9UK05 Q5VSQ9 Q9Y571,Growth/differentiation factor 2,Bone morphogenetic protein 9;, PF00019;PF00688;, GO:0070062;GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0032924;GO:0001525;GO:0048514;GO:0030509;GO:0001569;GO:0051216;GO:0006879;GO:0071773;GO:0016525;GO:0043537;GO:0030308;GO:2000279;GO:0008156;GO:0010596;GO:0001937;GO:0001503;GO:0001649;GO:0060389;GO:0045766;GO:0030513;GO:0061036;GO:0045603;GO:0001938;GO:0032757;GO:0010862;GO:0045944;GO:0045893;GO:0060395;GO:0001570;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity;, P:activin receptor signaling pathway; P:angiogenesis; P:blood vessel morphogenesis; P:BMP signaling pathway; P:branching involved in blood vessel morphogenesis; P:cartilage development; P:cellular iron ion homeostasis; P:cellular response to BMP stimulus; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell growth; P:negative regulation of DNA biosynthetic process; P:negative regulation of DNA replication; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:ossification; P:osteoblast differentiation; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cartilage development; P:positive regulation of endothelial cell differentiation; P:positive regulation of endothelial cell proliferation; P:positive regulation of interleukin-8 production; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:SMAD protein signal transduction; P:vasculogenesis; scaffold14 indexed_genome mRNA 29289202 29289879 . - . ID=transcript_3706;Q9UK05 Q5VSQ9 Q9Y571,Growth/differentiation factor 2,Bone morphogenetic protein 9;, PF00019;PF00688;, GO:0070062;GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0032924;GO:0001525;GO:0048514;GO:0030509;GO:0001569;GO:0051216;GO:0006879;GO:0071773;GO:0016525;GO:0043537;GO:0030308;GO:2000279;GO:0008156;GO:0010596;GO:0001937;GO:0001503;GO:0001649;GO:0060389;GO:0045766;GO:0030513;GO:0061036;GO:0045603;GO:0001938;GO:0032757;GO:0010862;GO:0045944;GO:0045893;GO:0060395;GO:0001570;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity;, P:activin receptor signaling pathway; P:angiogenesis; P:blood vessel morphogenesis; P:BMP signaling pathway; P:branching involved in blood vessel morphogenesis; P:cartilage development; P:cellular iron ion homeostasis; P:cellular response to BMP stimulus; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell growth; P:negative regulation of DNA biosynthetic process; P:negative regulation of DNA replication; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:ossification; P:osteoblast differentiation; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cartilage development; P:positive regulation of endothelial cell differentiation; P:positive regulation of endothelial cell proliferation; P:positive regulation of interleukin-8 production; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:SMAD protein signal transduction; P:vasculogenesis; scaffold14 indexed_genome mRNA 29297445 29310777 . - . ID=transcript_3707;P55107 Q5VSQ8 Q9UCX6,Growth/differentiation factor 10,Bone morphogenetic protein 3B;Bone-inducing protein;, PF00019;, GO:0062023;GO:0005615;GO:0005125;GO:0008083;GO:0045668;GO:0001649;GO:0010862;GO:0001501;GO:0060395;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular space;, F:cytokine activity; F:growth factor activity;, P:negative regulation of osteoblast differentiation; P:osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:skeletal system development; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway;|P55107 Q5VSQ8 Q9UCX6,Growth/differentiation factor 10,Bone morphogenetic protein 3B;Bone-inducing protein;, PF00019;, GO:0062023;GO:0005615;GO:0005125;GO:0008083;GO:0045668;GO:0001649;GO:0010862;GO:0001501;GO:0060395;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular space;, F:cytokine activity; F:growth factor activity;, P:negative regulation of osteoblast differentiation; P:osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:skeletal system development; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway;|P55107 Q5VSQ8 Q9UCX6,Growth/differentiation factor 10,Bone morphogenetic protein 3B;Bone-inducing protein;, PF00019;, GO:0062023;GO:0005615;GO:0005125;GO:0008083;GO:0045668;GO:0001649;GO:0010862;GO:0001501;GO:0060395;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular space;, F:cytokine activity; F:growth factor activity;, P:negative regulation of osteoblast differentiation; P:osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:skeletal system development; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; scaffold14 indexed_genome mRNA 29705865 29791269 . + . ID=transcript_3708;P45983 B5BTZ5 B7ZLV4 D3DX88 D3DX92 Q15709 Q15712 Q15713 Q308M2,Mitogen-activated protein kinase 8,JNK-46;Stress-activated protein kinase 1c;Stress-activated protein kinase JNK1;c-Jun N-terminal kinase 1;, PF00069;, GO:0030424;GO:0097441;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0045202;GO:0005524;GO:0019899;GO:0042826;GO:0035033;GO:0004705;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0034198;GO:0071276;GO:0071345;GO:0071222;GO:0071260;GO:0034614;GO:0006302;GO:0038095;GO:0035556;GO:0007254;GO:0007258;GO:0043066;GO:0032091;GO:0018105;GO:0018107;GO:0043065;GO:0031343;GO:0031281;GO:0090045;GO:0010628;GO:1900740;GO:0051247;GO:0006468;GO:0042752;GO:1902595;GO:0051090;GO:0010468;GO:0016241;GO:0032880;GO:0009612;GO:0006979;GO:0009411;GO:0048511;GO:0051403;, C:axon; C:basal dendrite; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:synapse;, F:ATP binding; F:enzyme binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to cytokine stimulus; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:double-strand break repair; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:JUN phosphorylation; P:negative regulation of apoptotic process; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of cell killing; P:positive regulation of cyclase activity; P:positive regulation of deacetylase activity; P:positive regulation of gene expression; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein metabolic process; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA replication origin binding; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of macroautophagy; P:regulation of protein localization; P:response to mechanical stimulus; P:response to oxidative stress; P:response to UV; P:rhythmic process; P:stress-activated MAPK cascade;|P45983 B5BTZ5 B7ZLV4 D3DX88 D3DX92 Q15709 Q15712 Q15713 Q308M2,Mitogen-activated protein kinase 8,JNK-46;Stress-activated protein kinase 1c;Stress-activated protein kinase JNK1;c-Jun N-terminal kinase 1;, PF00069;, GO:0030424;GO:0097441;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0045202;GO:0005524;GO:0019899;GO:0042826;GO:0035033;GO:0004705;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0034198;GO:0071276;GO:0071345;GO:0071222;GO:0071260;GO:0034614;GO:0006302;GO:0038095;GO:0035556;GO:0007254;GO:0007258;GO:0043066;GO:0032091;GO:0018105;GO:0018107;GO:0043065;GO:0031343;GO:0031281;GO:0090045;GO:0010628;GO:1900740;GO:0051247;GO:0006468;GO:0042752;GO:1902595;GO:0051090;GO:0010468;GO:0016241;GO:0032880;GO:0009612;GO:0006979;GO:0009411;GO:0048511;GO:0051403;, C:axon; C:basal dendrite; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:synapse;, F:ATP binding; F:enzyme binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to cytokine stimulus; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:double-strand break repair; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:JUN phosphorylation; P:negative regulation of apoptotic process; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of cell killing; P:positive regulation of cyclase activity; P:positive regulation of deacetylase activity; P:positive regulation of gene expression; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein metabolic process; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA replication origin binding; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of macroautophagy; P:regulation of protein localization; P:response to mechanical stimulus; P:response to oxidative stress; P:response to UV; P:rhythmic process; P:stress-activated MAPK cascade;|P45983 B5BTZ5 B7ZLV4 D3DX88 D3DX92 Q15709 Q15712 Q15713 Q308M2,Mitogen-activated protein kinase 8,JNK-46;Stress-activated protein kinase 1c;Stress-activated protein kinase JNK1;c-Jun N-terminal kinase 1;, PF00069;, GO:0030424;GO:0097441;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0045202;GO:0005524;GO:0019899;GO:0042826;GO:0035033;GO:0004705;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0034198;GO:0071276;GO:0071345;GO:0071222;GO:0071260;GO:0034614;GO:0006302;GO:0038095;GO:0035556;GO:0007254;GO:0007258;GO:0043066;GO:0032091;GO:0018105;GO:0018107;GO:0043065;GO:0031343;GO:0031281;GO:0090045;GO:0010628;GO:1900740;GO:0051247;GO:0006468;GO:0042752;GO:1902595;GO:0051090;GO:0010468;GO:0016241;GO:0032880;GO:0009612;GO:0006979;GO:0009411;GO:0048511;GO:0051403;, C:axon; C:basal dendrite; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:synapse;, F:ATP binding; F:enzyme binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to cytokine stimulus; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:double-strand break repair; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:JUN phosphorylation; P:negative regulation of apoptotic process; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of cell killing; P:positive regulation of cyclase activity; P:positive regulation of deacetylase activity; P:positive regulation of gene expression; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein metabolic process; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA replication origin binding; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of macroautophagy; P:regulation of protein localization; P:response to mechanical stimulus; P:response to oxidative stress; P:response to UV; P:rhythmic process; P:stress-activated MAPK cascade; scaffold14 indexed_genome mRNA 29791318 29803825 . - . ID=transcript_3709;P45983 B5BTZ5 B7ZLV4 D3DX88 D3DX92 Q15709 Q15712 Q15713 Q308M2,Mitogen-activated protein kinase 8,JNK-46;Stress-activated protein kinase 1c;Stress-activated protein kinase JNK1;c-Jun N-terminal kinase 1;, PF00069;, GO:0030424;GO:0097441;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0045202;GO:0005524;GO:0019899;GO:0042826;GO:0035033;GO:0004705;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0034198;GO:0071276;GO:0071345;GO:0071222;GO:0071260;GO:0034614;GO:0006302;GO:0038095;GO:0035556;GO:0007254;GO:0007258;GO:0043066;GO:0032091;GO:0018105;GO:0018107;GO:0043065;GO:0031343;GO:0031281;GO:0090045;GO:0010628;GO:1900740;GO:0051247;GO:0006468;GO:0042752;GO:1902595;GO:0051090;GO:0010468;GO:0016241;GO:0032880;GO:0009612;GO:0006979;GO:0009411;GO:0048511;GO:0051403;, C:axon; C:basal dendrite; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:synapse;, F:ATP binding; F:enzyme binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to cytokine stimulus; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:double-strand break repair; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:JUN phosphorylation; P:negative regulation of apoptotic process; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of cell killing; P:positive regulation of cyclase activity; P:positive regulation of deacetylase activity; P:positive regulation of gene expression; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein metabolic process; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA replication origin binding; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of macroautophagy; P:regulation of protein localization; P:response to mechanical stimulus; P:response to oxidative stress; P:response to UV; P:rhythmic process; P:stress-activated MAPK cascade;|P45983 B5BTZ5 B7ZLV4 D3DX88 D3DX92 Q15709 Q15712 Q15713 Q308M2,Mitogen-activated protein kinase 8,JNK-46;Stress-activated protein kinase 1c;Stress-activated protein kinase JNK1;c-Jun N-terminal kinase 1;, PF00069;, GO:0030424;GO:0097441;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0045202;GO:0005524;GO:0019899;GO:0042826;GO:0035033;GO:0004705;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0034198;GO:0071276;GO:0071345;GO:0071222;GO:0071260;GO:0034614;GO:0006302;GO:0038095;GO:0035556;GO:0007254;GO:0007258;GO:0043066;GO:0032091;GO:0018105;GO:0018107;GO:0043065;GO:0031343;GO:0031281;GO:0090045;GO:0010628;GO:1900740;GO:0051247;GO:0006468;GO:0042752;GO:1902595;GO:0051090;GO:0010468;GO:0016241;GO:0032880;GO:0009612;GO:0006979;GO:0009411;GO:0048511;GO:0051403;, C:axon; C:basal dendrite; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:synapse;, F:ATP binding; F:enzyme binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to cytokine stimulus; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:double-strand break repair; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:JUN phosphorylation; P:negative regulation of apoptotic process; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of cell killing; P:positive regulation of cyclase activity; P:positive regulation of deacetylase activity; P:positive regulation of gene expression; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein metabolic process; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA replication origin binding; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of macroautophagy; P:regulation of protein localization; P:response to mechanical stimulus; P:response to oxidative stress; P:response to UV; P:rhythmic process; P:stress-activated MAPK cascade;|P45983 B5BTZ5 B7ZLV4 D3DX88 D3DX92 Q15709 Q15712 Q15713 Q308M2,Mitogen-activated protein kinase 8,JNK-46;Stress-activated protein kinase 1c;Stress-activated protein kinase JNK1;c-Jun N-terminal kinase 1;, PF00069;, GO:0030424;GO:0097441;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0045202;GO:0005524;GO:0019899;GO:0042826;GO:0035033;GO:0004705;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0034198;GO:0071276;GO:0071345;GO:0071222;GO:0071260;GO:0034614;GO:0006302;GO:0038095;GO:0035556;GO:0007254;GO:0007258;GO:0043066;GO:0032091;GO:0018105;GO:0018107;GO:0043065;GO:0031343;GO:0031281;GO:0090045;GO:0010628;GO:1900740;GO:0051247;GO:0006468;GO:0042752;GO:1902595;GO:0051090;GO:0010468;GO:0016241;GO:0032880;GO:0009612;GO:0006979;GO:0009411;GO:0048511;GO:0051403;, C:axon; C:basal dendrite; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:synapse;, F:ATP binding; F:enzyme binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to cytokine stimulus; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:double-strand break repair; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:JUN phosphorylation; P:negative regulation of apoptotic process; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of cell killing; P:positive regulation of cyclase activity; P:positive regulation of deacetylase activity; P:positive regulation of gene expression; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein metabolic process; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA replication origin binding; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of macroautophagy; P:regulation of protein localization; P:response to mechanical stimulus; P:response to oxidative stress; P:response to UV; P:rhythmic process; P:stress-activated MAPK cascade;|P45983 B5BTZ5 B7ZLV4 D3DX88 D3DX92 Q15709 Q15712 Q15713 Q308M2,Mitogen-activated protein kinase 8,JNK-46;Stress-activated protein kinase 1c;Stress-activated protein kinase JNK1;c-Jun N-terminal kinase 1;, PF00069;, GO:0030424;GO:0097441;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0045202;GO:0005524;GO:0019899;GO:0042826;GO:0035033;GO:0004705;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0034198;GO:0071276;GO:0071345;GO:0071222;GO:0071260;GO:0034614;GO:0006302;GO:0038095;GO:0035556;GO:0007254;GO:0007258;GO:0043066;GO:0032091;GO:0018105;GO:0018107;GO:0043065;GO:0031343;GO:0031281;GO:0090045;GO:0010628;GO:1900740;GO:0051247;GO:0006468;GO:0042752;GO:1902595;GO:0051090;GO:0010468;GO:0016241;GO:0032880;GO:0009612;GO:0006979;GO:0009411;GO:0048511;GO:0051403;, C:axon; C:basal dendrite; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:synapse;, F:ATP binding; F:enzyme binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to cytokine stimulus; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:double-strand break repair; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:JUN phosphorylation; P:negative regulation of apoptotic process; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of cell killing; P:positive regulation of cyclase activity; P:positive regulation of deacetylase activity; P:positive regulation of gene expression; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein metabolic process; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA replication origin binding; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of macroautophagy; P:regulation of protein localization; P:response to mechanical stimulus; P:response to oxidative stress; P:response to UV; P:rhythmic process; P:stress-activated MAPK cascade; scaffold14 indexed_genome mRNA 29815652 29956599 . + . ID=transcript_3710;Q7Z5H3 A0AVP7 A5YM75 B4DED8 B9EGA0 C9JDM2 O00152 Q6ZSB0,Rho GTPase-activating protein 22,Rho-type GTPase-activating protein 22;, PF00169;PF00620;, GO:0005829;GO:0005925;GO:0098978;GO:0005634;GO:0005096;GO:0090630;GO:0001525;GO:0030154;GO:0099175;GO:0051056;GO:0007165;, C:cytosol; C:focal adhesion; C:glutamatergic synapse; C:nucleus;, F:GTPase activator activity;, P:activation of GTPase activity; P:angiogenesis; P:cell differentiation; P:regulation of postsynapse organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q7Z5H3 A0AVP7 A5YM75 B4DED8 B9EGA0 C9JDM2 O00152 Q6ZSB0,Rho GTPase-activating protein 22,Rho-type GTPase-activating protein 22;, PF00169;PF00620;, GO:0005829;GO:0005925;GO:0098978;GO:0005634;GO:0005096;GO:0090630;GO:0001525;GO:0030154;GO:0099175;GO:0051056;GO:0007165;, C:cytosol; C:focal adhesion; C:glutamatergic synapse; C:nucleus;, F:GTPase activator activity;, P:activation of GTPase activity; P:angiogenesis; P:cell differentiation; P:regulation of postsynapse organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q7Z5H3 A0AVP7 A5YM75 B4DED8 B9EGA0 C9JDM2 O00152 Q6ZSB0,Rho GTPase-activating protein 22,Rho-type GTPase-activating protein 22;, PF00169;PF00620;, GO:0005829;GO:0005925;GO:0098978;GO:0005634;GO:0005096;GO:0090630;GO:0001525;GO:0030154;GO:0099175;GO:0051056;GO:0007165;, C:cytosol; C:focal adhesion; C:glutamatergic synapse; C:nucleus;, F:GTPase activator activity;, P:activation of GTPase activity; P:angiogenesis; P:cell differentiation; P:regulation of postsynapse organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold14 indexed_genome mRNA 30108431 30117777 . + . ID=transcript_3711;Q6ZS81 B9ZVP2 Q86WZ4 Q8N4A3 Q8TEN7 Q96BE1 Q9H7H8 Q9HCG5,WD repeat- and FYVE domain-containing protein 4,, PF02138;PF14844;PF00400;, GO:0005769;GO:0005783;GO:0019882;GO:0006914;GO:0036037;GO:0098586;, C:early endosome; C:endoplasmic reticulum;, , P:antigen processing and presentation; P:autophagy; P:CD8-positive, alpha-beta T cell activation; P:cellular response to virus; scaffold14 indexed_genome mRNA 30131065 30258578 . + . ID=transcript_3712;Q6ZS81 B9ZVP2 Q86WZ4 Q8N4A3 Q8TEN7 Q96BE1 Q9H7H8 Q9HCG5,WD repeat- and FYVE domain-containing protein 4,, PF02138;PF14844;PF00400;, GO:0005769;GO:0005783;GO:0019882;GO:0006914;GO:0036037;GO:0098586;, C:early endosome; C:endoplasmic reticulum;, , P:antigen processing and presentation; P:autophagy; P:CD8-positive, alpha-beta T cell activation; P:cellular response to virus;|Q6ZS81 B9ZVP2 Q86WZ4 Q8N4A3 Q8TEN7 Q96BE1 Q9H7H8 Q9HCG5,WD repeat- and FYVE domain-containing protein 4,, PF02138;PF14844;PF00400;, GO:0005769;GO:0005783;GO:0019882;GO:0006914;GO:0036037;GO:0098586;, C:early endosome; C:endoplasmic reticulum;, , P:antigen processing and presentation; P:autophagy; P:CD8-positive, alpha-beta T cell activation; P:cellular response to virus;|Q6ZS81 B9ZVP2 Q86WZ4 Q8N4A3 Q8TEN7 Q96BE1 Q9H7H8 Q9HCG5,WD repeat- and FYVE domain-containing protein 4,, PF02138;PF14844;PF00400;, GO:0005769;GO:0005783;GO:0019882;GO:0006914;GO:0036037;GO:0098586;, C:early endosome; C:endoplasmic reticulum;, , P:antigen processing and presentation; P:autophagy; P:CD8-positive, alpha-beta T cell activation; P:cellular response to virus; scaffold14 indexed_genome mRNA 30278238 30346987 . - . ID=transcript_3713;Q8IW00 B4DNI6 Q96MX7,V-set and transmembrane domain-containing protein 4,, PF07686;, GO:0005576;GO:0016021;GO:0005886;, C:extracellular region; C:integral component of membrane; C:plasma membrane; scaffold14 indexed_genome mRNA 30393995 30404825 . - . ID=transcript_3714;Q5T292 A6XND2 Q5T289 Q5T291,Transmembrane protein 273 {ECO:0000305},, PF14986;, GO:0016021;, C:integral component of membrane; scaffold14 indexed_genome mRNA 30520359 30530094 . + . ID=transcript_3715;Q711Q0 A0AVL8,Cardiac-enriched FHL2-interacting protein {ECO:0000303|PubMed:28717008},, PF15232;, GO:0030018;GO:0070886;, C:Z disc;, , P:positive regulation of calcineurin-NFAT signaling cascade; scaffold14 indexed_genome mRNA 30619449 30625988 . + . ID=transcript_3716;Q03468 D3DX94 E7EV46 Q5W0L9,DNA excision repair protein ERCC-6,ATP-dependent helicase ERCC6;Cockayne syndrome protein CSB;, PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0090734;GO:0008023;GO:0005524;GO:0003682;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0008022;GO:0047485;GO:0030296;GO:0044877;GO:0070063;GO:0007256;GO:0007257;GO:0043044;GO:0006284;GO:0000077;GO:0032508;GO:0006281;GO:0097680;GO:0008630;GO:0035264;GO:2001033;GO:0022008;GO:0030182;GO:0031175;GO:0045494;GO:0045739;GO:0032786;GO:1905168;GO:0045815;GO:0060261;GO:0006290;GO:0032784;GO:0010332;GO:0006979;GO:0000303;GO:0009636;GO:0009411;GO:0010224;GO:0010165;GO:0000012;GO:0006366;GO:0006362;GO:0006283;, C:nucleolus; C:nucleoplasm; C:nucleus; C:site of DNA damage; C:transcription elongation factor complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:protein C-terminus binding; F:protein N-terminus binding; F:protein tyrosine kinase activator activity; F:protein-containing complex binding; F:RNA polymerase binding;, P:activation of JNKK activity; P:activation of JUN kinase activity; P:ATP-dependent chromatin remodeling; P:base-excision repair; P:DNA damage checkpoint; P:DNA duplex unwinding; P:DNA repair; P:double-strand break repair via classical nonhomologous end joining; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:multicellular organism growth; P:negative regulation of double-strand break repair via nonhomologous end joining; P:neurogenesis; P:neuron differentiation; P:neuron projection development; P:photoreceptor cell maintenance; P:positive regulation of DNA repair; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:pyrimidine dimer repair; P:regulation of DNA-templated transcription, elongation; P:response to gamma radiation; P:response to oxidative stress; P:response to superoxide; P:response to toxic substance; P:response to UV; P:response to UV-B; P:response to X-ray; P:single strand break repair; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase I promoter; P:transcription-coupled nucleotide-excision repair; scaffold14 indexed_genome mRNA 30626023 30679626 . - . ID=transcript_3717;Q03468 D3DX94 E7EV46 Q5W0L9,DNA excision repair protein ERCC-6,ATP-dependent helicase ERCC6;Cockayne syndrome protein CSB;, PF00271;PF00176;, GO:0005730;GO:0005654;GO:0005634;GO:0090734;GO:0008023;GO:0005524;GO:0003682;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0008022;GO:0047485;GO:0030296;GO:0044877;GO:0070063;GO:0007256;GO:0007257;GO:0043044;GO:0006284;GO:0000077;GO:0032508;GO:0006281;GO:0097680;GO:0008630;GO:0035264;GO:2001033;GO:0022008;GO:0030182;GO:0031175;GO:0045494;GO:0045739;GO:0032786;GO:1905168;GO:0045815;GO:0060261;GO:0006290;GO:0032784;GO:0010332;GO:0006979;GO:0000303;GO:0009636;GO:0009411;GO:0010224;GO:0010165;GO:0000012;GO:0006366;GO:0006362;GO:0006283;, C:nucleolus; C:nucleoplasm; C:nucleus; C:site of DNA damage; C:transcription elongation factor complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:protein C-terminus binding; F:protein N-terminus binding; F:protein tyrosine kinase activator activity; F:protein-containing complex binding; F:RNA polymerase binding;, P:activation of JNKK activity; P:activation of JUN kinase activity; P:ATP-dependent chromatin remodeling; P:base-excision repair; P:DNA damage checkpoint; P:DNA duplex unwinding; P:DNA repair; P:double-strand break repair via classical nonhomologous end joining; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:multicellular organism growth; P:negative regulation of double-strand break repair via nonhomologous end joining; P:neurogenesis; P:neuron differentiation; P:neuron projection development; P:photoreceptor cell maintenance; P:positive regulation of DNA repair; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:pyrimidine dimer repair; P:regulation of DNA-templated transcription, elongation; P:response to gamma radiation; P:response to oxidative stress; P:response to superoxide; P:response to toxic substance; P:response to UV; P:response to UV-B; P:response to X-ray; P:single strand break repair; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase I promoter; P:transcription-coupled nucleotide-excision repair; scaffold14 indexed_genome mRNA 30814352 30827084 . - . ID=transcript_3718;Q9ULD0 A8K2G1 B4DKG2 B4E193 Q8TAN9 Q9NVA0,2-oxoglutarate dehydrogenase-like, mitochondrial {ECO:0000250|UniProtKB:D3ZQD3},2-oxoglutarate dehydrogenase complex component E1-like {ECO:0000303|PubMed:23152800};Alpha-ketoglutarate dehydrogenase-like;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006096;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:glycolytic process; P:tricarboxylic acid cycle;|Q9ULD0 A8K2G1 B4DKG2 B4E193 Q8TAN9 Q9NVA0,2-oxoglutarate dehydrogenase-like, mitochondrial {ECO:0000250|UniProtKB:D3ZQD3},2-oxoglutarate dehydrogenase complex component E1-like {ECO:0000303|PubMed:23152800};Alpha-ketoglutarate dehydrogenase-like;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006096;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:glycolytic process; P:tricarboxylic acid cycle;|Q9ULD0 A8K2G1 B4DKG2 B4E193 Q8TAN9 Q9NVA0,2-oxoglutarate dehydrogenase-like, mitochondrial {ECO:0000250|UniProtKB:D3ZQD3},2-oxoglutarate dehydrogenase complex component E1-like {ECO:0000303|PubMed:23152800};Alpha-ketoglutarate dehydrogenase-like;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006096;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:glycolytic process; P:tricarboxylic acid cycle;|Q9ULD0 A8K2G1 B4DKG2 B4E193 Q8TAN9 Q9NVA0,2-oxoglutarate dehydrogenase-like, mitochondrial {ECO:0000250|UniProtKB:D3ZQD3},2-oxoglutarate dehydrogenase complex component E1-like {ECO:0000303|PubMed:23152800};Alpha-ketoglutarate dehydrogenase-like;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006096;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:glycolytic process; P:tricarboxylic acid cycle;|Q9ULD0 A8K2G1 B4DKG2 B4E193 Q8TAN9 Q9NVA0,2-oxoglutarate dehydrogenase-like, mitochondrial {ECO:0000250|UniProtKB:D3ZQD3},2-oxoglutarate dehydrogenase complex component E1-like {ECO:0000303|PubMed:23152800};Alpha-ketoglutarate dehydrogenase-like;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006096;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:glycolytic process; P:tricarboxylic acid cycle;|Q9ULD0 A8K2G1 B4DKG2 B4E193 Q8TAN9 Q9NVA0,2-oxoglutarate dehydrogenase-like, mitochondrial {ECO:0000250|UniProtKB:D3ZQD3},2-oxoglutarate dehydrogenase complex component E1-like {ECO:0000303|PubMed:23152800};Alpha-ketoglutarate dehydrogenase-like;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006096;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:glycolytic process; P:tricarboxylic acid cycle; scaffold14 indexed_genome mRNA 30830538 30838390 . - . ID=transcript_3719;Q9ULD0 A8K2G1 B4DKG2 B4E193 Q8TAN9 Q9NVA0,2-oxoglutarate dehydrogenase-like, mitochondrial {ECO:0000250|UniProtKB:D3ZQD3},2-oxoglutarate dehydrogenase complex component E1-like {ECO:0000303|PubMed:23152800};Alpha-ketoglutarate dehydrogenase-like;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006096;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:glycolytic process; P:tricarboxylic acid cycle;|Q9ULD0 A8K2G1 B4DKG2 B4E193 Q8TAN9 Q9NVA0,2-oxoglutarate dehydrogenase-like, mitochondrial {ECO:0000250|UniProtKB:D3ZQD3},2-oxoglutarate dehydrogenase complex component E1-like {ECO:0000303|PubMed:23152800};Alpha-ketoglutarate dehydrogenase-like;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006096;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:glycolytic process; P:tricarboxylic acid cycle;|Q9ULD0 A8K2G1 B4DKG2 B4E193 Q8TAN9 Q9NVA0,2-oxoglutarate dehydrogenase-like, mitochondrial {ECO:0000250|UniProtKB:D3ZQD3},2-oxoglutarate dehydrogenase complex component E1-like {ECO:0000303|PubMed:23152800};Alpha-ketoglutarate dehydrogenase-like;, PF16078;PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0045252;GO:0046872;GO:0004591;GO:0030976;GO:0006103;GO:0006096;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:oxoglutarate dehydrogenase complex;, F:metal ion binding; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:2-oxoglutarate metabolic process; P:glycolytic process; P:tricarboxylic acid cycle; scaffold14 indexed_genome mRNA 30869100 30884883 . - . ID=transcript_3720;Q9Y4W7,Poly(ADP-ribose) glycohydrolase {ECO:0000303|PubMed:14527731},, PF05028;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0005634;GO:0004649;GO:1990966;GO:0006287;GO:0005975;GO:0009225;GO:0006282;GO:0031056;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm; C:nucleus;, F:poly(ADP-ribose) glycohydrolase activity;, P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:carbohydrate metabolic process; P:nucleotide-sugar metabolic process; P:regulation of DNA repair; P:regulation of histone modification;|Q9Y4W7,Poly(ADP-ribose) glycohydrolase {ECO:0000303|PubMed:14527731},, PF05028;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0005634;GO:0004649;GO:1990966;GO:0006287;GO:0005975;GO:0009225;GO:0006282;GO:0031056;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm; C:nucleus;, F:poly(ADP-ribose) glycohydrolase activity;, P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:carbohydrate metabolic process; P:nucleotide-sugar metabolic process; P:regulation of DNA repair; P:regulation of histone modification;|Q9Y4W7,Poly(ADP-ribose) glycohydrolase {ECO:0000303|PubMed:14527731},, PF05028;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0005634;GO:0004649;GO:1990966;GO:0006287;GO:0005975;GO:0009225;GO:0006282;GO:0031056;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm; C:nucleus;, F:poly(ADP-ribose) glycohydrolase activity;, P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:carbohydrate metabolic process; P:nucleotide-sugar metabolic process; P:regulation of DNA repair; P:regulation of histone modification; scaffold14 indexed_genome mRNA 30893636 30992716 . - . ID=transcript_3721;Q9Y4W7,Poly(ADP-ribose) glycohydrolase {ECO:0000303|PubMed:14527731},, PF05028;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0005634;GO:0004649;GO:1990966;GO:0006287;GO:0005975;GO:0009225;GO:0006282;GO:0031056;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm; C:nucleus;, F:poly(ADP-ribose) glycohydrolase activity;, P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:carbohydrate metabolic process; P:nucleotide-sugar metabolic process; P:regulation of DNA repair; P:regulation of histone modification;|Q9Y4W7,Poly(ADP-ribose) glycohydrolase {ECO:0000303|PubMed:14527731},, PF05028;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0005634;GO:0004649;GO:1990966;GO:0006287;GO:0005975;GO:0009225;GO:0006282;GO:0031056;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm; C:nucleus;, F:poly(ADP-ribose) glycohydrolase activity;, P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:carbohydrate metabolic process; P:nucleotide-sugar metabolic process; P:regulation of DNA repair; P:regulation of histone modification; scaffold14 indexed_genome mRNA 30992771 31037141 . - . ID=transcript_3722;O14925 Q53FF8 Q5T1E6 Q6P5S5,Mitochondrial import inner membrane translocase subunit Tim23,, , GO:0031305;GO:0005743;GO:0005758;GO:0005739;GO:0005744;GO:0008320;GO:0030150;GO:0006626;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:TIM23 mitochondrial import inner membrane translocase complex;, F:protein transmembrane transporter activity;, P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion;|O14925 Q53FF8 Q5T1E6 Q6P5S5,Mitochondrial import inner membrane translocase subunit Tim23,, , GO:0031305;GO:0005743;GO:0005758;GO:0005739;GO:0005744;GO:0008320;GO:0030150;GO:0006626;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:TIM23 mitochondrial import inner membrane translocase complex;, F:protein transmembrane transporter activity;, P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion;|Q13772 A8K8W5 B4E260 E9PAV7 J3KQN8 Q14239,Nuclear receptor coactivator 4,Androgen receptor coactivator 70 kDa protein;Androgen receptor-associated protein of 70 kDa;Ret-activating protein ELE1;, PF12489;, GO:0044754;GO:0005634;GO:0003713;GO:0006879;GO:0071391;GO:0071394;GO:0030520;GO:0008584;GO:0006622;GO:0009725;, C:autolysosome; C:nucleus;, F:transcription coactivator activity;, P:cellular iron ion homeostasis; P:cellular response to estrogen stimulus; P:cellular response to testosterone stimulus; P:intracellular estrogen receptor signaling pathway; P:male gonad development; P:protein targeting to lysosome; P:response to hormone;|Q13772 A8K8W5 B4E260 E9PAV7 J3KQN8 Q14239,Nuclear receptor coactivator 4,Androgen receptor coactivator 70 kDa protein;Androgen receptor-associated protein of 70 kDa;Ret-activating protein ELE1;, PF12489;, GO:0044754;GO:0005634;GO:0003713;GO:0006879;GO:0071391;GO:0071394;GO:0030520;GO:0008584;GO:0006622;GO:0009725;, C:autolysosome; C:nucleus;, F:transcription coactivator activity;, P:cellular iron ion homeostasis; P:cellular response to estrogen stimulus; P:cellular response to testosterone stimulus; P:intracellular estrogen receptor signaling pathway; P:male gonad development; P:protein targeting to lysosome; P:response to hormone;|Q13772 A8K8W5 B4E260 E9PAV7 J3KQN8 Q14239,Nuclear receptor coactivator 4,Androgen receptor coactivator 70 kDa protein;Androgen receptor-associated protein of 70 kDa;Ret-activating protein ELE1;, PF12489;, GO:0044754;GO:0005634;GO:0003713;GO:0006879;GO:0071391;GO:0071394;GO:0030520;GO:0008584;GO:0006622;GO:0009725;, C:autolysosome; C:nucleus;, F:transcription coactivator activity;, P:cellular iron ion homeostasis; P:cellular response to estrogen stimulus; P:cellular response to testosterone stimulus; P:intracellular estrogen receptor signaling pathway; P:male gonad development; P:protein targeting to lysosome; P:response to hormone;|Q13772 A8K8W5 B4E260 E9PAV7 J3KQN8 Q14239,Nuclear receptor coactivator 4,Androgen receptor coactivator 70 kDa protein;Androgen receptor-associated protein of 70 kDa;Ret-activating protein ELE1;, PF12489;, GO:0044754;GO:0005634;GO:0003713;GO:0006879;GO:0071391;GO:0071394;GO:0030520;GO:0008584;GO:0006622;GO:0009725;, C:autolysosome; C:nucleus;, F:transcription coactivator activity;, P:cellular iron ion homeostasis; P:cellular response to estrogen stimulus; P:cellular response to testosterone stimulus; P:intracellular estrogen receptor signaling pathway; P:male gonad development; P:protein targeting to lysosome; P:response to hormone;|Q13772 A8K8W5 B4E260 E9PAV7 J3KQN8 Q14239,Nuclear receptor coactivator 4,Androgen receptor coactivator 70 kDa protein;Androgen receptor-associated protein of 70 kDa;Ret-activating protein ELE1;, PF12489;, GO:0044754;GO:0005634;GO:0003713;GO:0006879;GO:0071391;GO:0071394;GO:0030520;GO:0008584;GO:0006622;GO:0009725;, C:autolysosome; C:nucleus;, F:transcription coactivator activity;, P:cellular iron ion homeostasis; P:cellular response to estrogen stimulus; P:cellular response to testosterone stimulus; P:intracellular estrogen receptor signaling pathway; P:male gonad development; P:protein targeting to lysosome; P:response to hormone;|Q13772 A8K8W5 B4E260 E9PAV7 J3KQN8 Q14239,Nuclear receptor coactivator 4,Androgen receptor coactivator 70 kDa protein;Androgen receptor-associated protein of 70 kDa;Ret-activating protein ELE1;, PF12489;, GO:0044754;GO:0005634;GO:0003713;GO:0006879;GO:0071391;GO:0071394;GO:0030520;GO:0008584;GO:0006622;GO:0009725;, C:autolysosome; C:nucleus;, F:transcription coactivator activity;, P:cellular iron ion homeostasis; P:cellular response to estrogen stimulus; P:cellular response to testosterone stimulus; P:intracellular estrogen receptor signaling pathway; P:male gonad development; P:protein targeting to lysosome; P:response to hormone;|Q13772 A8K8W5 B4E260 E9PAV7 J3KQN8 Q14239,Nuclear receptor coactivator 4,Androgen receptor coactivator 70 kDa protein;Androgen receptor-associated protein of 70 kDa;Ret-activating protein ELE1;, PF12489;, GO:0044754;GO:0005634;GO:0003713;GO:0006879;GO:0071391;GO:0071394;GO:0030520;GO:0008584;GO:0006622;GO:0009725;, C:autolysosome; C:nucleus;, F:transcription coactivator activity;, P:cellular iron ion homeostasis; P:cellular response to estrogen stimulus; P:cellular response to testosterone stimulus; P:intracellular estrogen receptor signaling pathway; P:male gonad development; P:protein targeting to lysosome; P:response to hormone; scaffold14 indexed_genome mRNA 31039473 31050807 . - . ID=transcript_3723;P08118 B1API6 P11999 Q13125 Q6IAY9 Q9UC59,Beta-microseminoprotein,Immunoglobulin-binding factor;PN44;Prostate secreted seminal plasma protein;Prostate secretory protein of 94 amino acids;Seminal plasma beta-inhibin;, PF05825;, GO:0005615;GO:0005634;, C:extracellular space; C:nucleus; scaffold14 indexed_genome mRNA 31087354 31131404 . + . ID=transcript_3724;Q641Q2 A2A3S2 A2A3U6 Q5SNT6 Q6DHY0,WASH complex subunit 2A {ECO:0000312|HGNC:HGNC:23416},, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0008289;GO:0036010;GO:0015031;GO:0042147;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:lipid binding;, P:protein localization to endosome; P:protein transport; P:retrograde transport, endosome to Golgi;|Q641Q2 A2A3S2 A2A3U6 Q5SNT6 Q6DHY0,WASH complex subunit 2A {ECO:0000312|HGNC:HGNC:23416},, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0008289;GO:0036010;GO:0015031;GO:0042147;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:lipid binding;, P:protein localization to endosome; P:protein transport; P:retrograde transport, endosome to Golgi;|Q9Y4E1 B4DZQ6 B9EK53 F5H0J6 F5H871 Q5SQU4 Q5SQU5 Q7L521 Q9UG79,WASH complex subunit 2C {ECO:0000312|HGNC:HGNC:23414},Vaccinia virus penetration factor {ECO:0000303|PubMed:18550675};, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0005547;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1905394;GO:2000813;GO:0036010;GO:0015031;GO:1900024;GO:0042147;GO:1990126;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:retromer complex binding;, P:negative regulation of barbed-end actin filament capping; P:protein localization to endosome; P:protein transport; P:regulation of substrate adhesion-dependent cell spreading; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane;|Q9Y4E1 B4DZQ6 B9EK53 F5H0J6 F5H871 Q5SQU4 Q5SQU5 Q7L521 Q9UG79,WASH complex subunit 2C {ECO:0000312|HGNC:HGNC:23414},Vaccinia virus penetration factor {ECO:0000303|PubMed:18550675};, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0005547;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1905394;GO:2000813;GO:0036010;GO:0015031;GO:1900024;GO:0042147;GO:1990126;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:retromer complex binding;, P:negative regulation of barbed-end actin filament capping; P:protein localization to endosome; P:protein transport; P:regulation of substrate adhesion-dependent cell spreading; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane;|Q641Q2 A2A3S2 A2A3U6 Q5SNT6 Q6DHY0,WASH complex subunit 2A {ECO:0000312|HGNC:HGNC:23416},, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0008289;GO:0036010;GO:0015031;GO:0042147;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:lipid binding;, P:protein localization to endosome; P:protein transport; P:retrograde transport, endosome to Golgi;|Q9Y4E1 B4DZQ6 B9EK53 F5H0J6 F5H871 Q5SQU4 Q5SQU5 Q7L521 Q9UG79,WASH complex subunit 2C {ECO:0000312|HGNC:HGNC:23414},Vaccinia virus penetration factor {ECO:0000303|PubMed:18550675};, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0005547;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1905394;GO:2000813;GO:0036010;GO:0015031;GO:1900024;GO:0042147;GO:1990126;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:retromer complex binding;, P:negative regulation of barbed-end actin filament capping; P:protein localization to endosome; P:protein transport; P:regulation of substrate adhesion-dependent cell spreading; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane;|Q9Y4E1 B4DZQ6 B9EK53 F5H0J6 F5H871 Q5SQU4 Q5SQU5 Q7L521 Q9UG79,WASH complex subunit 2C {ECO:0000312|HGNC:HGNC:23414},Vaccinia virus penetration factor {ECO:0000303|PubMed:18550675};, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0005547;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1905394;GO:2000813;GO:0036010;GO:0015031;GO:1900024;GO:0042147;GO:1990126;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:retromer complex binding;, P:negative regulation of barbed-end actin filament capping; P:protein localization to endosome; P:protein transport; P:regulation of substrate adhesion-dependent cell spreading; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane;|Q9Y4E1 B4DZQ6 B9EK53 F5H0J6 F5H871 Q5SQU4 Q5SQU5 Q7L521 Q9UG79,WASH complex subunit 2C {ECO:0000312|HGNC:HGNC:23414},Vaccinia virus penetration factor {ECO:0000303|PubMed:18550675};, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0005547;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1905394;GO:2000813;GO:0036010;GO:0015031;GO:1900024;GO:0042147;GO:1990126;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:retromer complex binding;, P:negative regulation of barbed-end actin filament capping; P:protein localization to endosome; P:protein transport; P:regulation of substrate adhesion-dependent cell spreading; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane;|Q9Y4E1 B4DZQ6 B9EK53 F5H0J6 F5H871 Q5SQU4 Q5SQU5 Q7L521 Q9UG79,WASH complex subunit 2C {ECO:0000312|HGNC:HGNC:23414},Vaccinia virus penetration factor {ECO:0000303|PubMed:18550675};, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0005547;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1905394;GO:2000813;GO:0036010;GO:0015031;GO:1900024;GO:0042147;GO:1990126;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:retromer complex binding;, P:negative regulation of barbed-end actin filament capping; P:protein localization to endosome; P:protein transport; P:regulation of substrate adhesion-dependent cell spreading; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane;|Q641Q2 A2A3S2 A2A3U6 Q5SNT6 Q6DHY0,WASH complex subunit 2A {ECO:0000312|HGNC:HGNC:23416},, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0008289;GO:0036010;GO:0015031;GO:0042147;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:lipid binding;, P:protein localization to endosome; P:protein transport; P:retrograde transport, endosome to Golgi;|Q641Q2 A2A3S2 A2A3U6 Q5SNT6 Q6DHY0,WASH complex subunit 2A {ECO:0000312|HGNC:HGNC:23416},, PF15255;, GO:0005829;GO:0005769;GO:0031901;GO:0043231;GO:0005730;GO:0005886;GO:0071203;GO:0008289;GO:0036010;GO:0015031;GO:0042147;, C:cytosol; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:WASH complex;, F:lipid binding;, P:protein localization to endosome; P:protein transport; P:retrograde transport, endosome to Golgi; scaffold14 indexed_genome mRNA 31134748 31184367 . + . ID=transcript_3725;Q86XD8 A8K8V4 B2RAX2 Q5VVY5,AN1-type zinc finger protein 4,AN1-type zinc finger and ubiquitin domain-containing protein-like 1;, PF00240;PF01428;, GO:0008270;, , F:zinc ion binding;|Q86XD8 A8K8V4 B2RAX2 Q5VVY5,AN1-type zinc finger protein 4,AN1-type zinc finger and ubiquitin domain-containing protein-like 1;, PF00240;PF01428;, GO:0008270;, , F:zinc ion binding;|Q86XD8 A8K8V4 B2RAX2 Q5VVY5,AN1-type zinc finger protein 4,AN1-type zinc finger and ubiquitin domain-containing protein-like 1;, PF00240;PF01428;, GO:0008270;, , F:zinc ion binding; scaffold14 indexed_genome mRNA 31269853 31302822 . + . ID=transcript_3726;Q5T0T0 B2R8E7 H0Y7C6 Q5T0S8 Q8TC72,E3 ubiquitin-protein ligase MARCHF8,Cellular modulator of immune recognition;Membrane-associated RING finger protein 8;Membrane-associated RING-CH protein VIII;RING finger protein 178;RING-type E3 ubiquitin transferase MARCHF8 {ECO:0000305};, PF12906;, GO:0005737;GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0042287;GO:0061630;GO:0004842;GO:0008270;GO:0002250;GO:0002495;GO:0006955;GO:0000209;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:MHC protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:adaptive immune response; P:antigen processing and presentation of peptide antigen via MHC class II; P:immune response; P:protein polyubiquitination;|Q5T0T0 B2R8E7 H0Y7C6 Q5T0S8 Q8TC72,E3 ubiquitin-protein ligase MARCHF8,Cellular modulator of immune recognition;Membrane-associated RING finger protein 8;Membrane-associated RING-CH protein VIII;RING finger protein 178;RING-type E3 ubiquitin transferase MARCHF8 {ECO:0000305};, PF12906;, GO:0005737;GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0042287;GO:0061630;GO:0004842;GO:0008270;GO:0002250;GO:0002495;GO:0006955;GO:0000209;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:MHC protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:adaptive immune response; P:antigen processing and presentation of peptide antigen via MHC class II; P:immune response; P:protein polyubiquitination;|Q5T0T0 B2R8E7 H0Y7C6 Q5T0S8 Q8TC72,E3 ubiquitin-protein ligase MARCHF8,Cellular modulator of immune recognition;Membrane-associated RING finger protein 8;Membrane-associated RING-CH protein VIII;RING finger protein 178;RING-type E3 ubiquitin transferase MARCHF8 {ECO:0000305};, PF12906;, GO:0005737;GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0042287;GO:0061630;GO:0004842;GO:0008270;GO:0002250;GO:0002495;GO:0006955;GO:0000209;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:MHC protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:adaptive immune response; P:antigen processing and presentation of peptide antigen via MHC class II; P:immune response; P:protein polyubiquitination;|Q5T0T0 B2R8E7 H0Y7C6 Q5T0S8 Q8TC72,E3 ubiquitin-protein ligase MARCHF8,Cellular modulator of immune recognition;Membrane-associated RING finger protein 8;Membrane-associated RING-CH protein VIII;RING finger protein 178;RING-type E3 ubiquitin transferase MARCHF8 {ECO:0000305};, PF12906;, GO:0005737;GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0042287;GO:0061630;GO:0004842;GO:0008270;GO:0002250;GO:0002495;GO:0006955;GO:0000209;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:MHC protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:adaptive immune response; P:antigen processing and presentation of peptide antigen via MHC class II; P:immune response; P:protein polyubiquitination; scaffold14 indexed_genome mRNA 31308409 31346236 . + . ID=transcript_3727;P09917 B7ZLS0 E5FPY5 E5FPY7 E5FPY8 Q5JQ14,Polyunsaturated fatty acid 5-lipoxygenase {ECO:0000305},Arachidonate 5-lipoxygenase;, PF00305;PF01477;, GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005635;GO:0005641;GO:0016363;GO:0031965;GO:0005654;GO:0048471;GO:0034774;GO:0004052;GO:0004051;GO:0036403;GO:0016787;GO:0005506;GO:0016702;GO:0019369;GO:0019221;GO:0036336;GO:0042593;GO:0051122;GO:0006959;GO:0035655;GO:0002232;GO:0002523;GO:1901753;GO:0019370;GO:0006691;GO:0002540;GO:0043651;GO:0034440;GO:2001301;GO:0019372;GO:0042759;GO:0016525;GO:0001937;GO:0050728;GO:1903573;GO:1903671;GO:0061044;GO:0061045;GO:0043312;GO:0030501;GO:1904999;GO:1900407;GO:1900015;GO:0045598;GO:0050727;GO:0106014;GO:0050796;GO:1903426;, C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:nuclear envelope; C:nuclear envelope lumen; C:nuclear matrix; C:nuclear membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:secretory granule lumen;, F:arachidonate 12(S)-lipoxygenase activity; F:arachidonate 5-lipoxygenase activity; F:arachidonate 8(S)-lipoxygenase activity; F:hydrolase activity; F:iron ion binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;, P:arachidonic acid metabolic process; P:cytokine-mediated signaling pathway; P:dendritic cell migration; P:glucose homeostasis; P:hepoxilin biosynthetic process; P:humoral immune response; P:interleukin-18-mediated signaling pathway; P:leukocyte chemotaxis involved in inflammatory response; P:leukocyte migration involved in inflammatory response; P:leukotriene A4 biosynthetic process; P:leukotriene biosynthetic process; P:leukotriene metabolic process; P:leukotriene production involved in inflammatory response; P:linoleic acid metabolic process; P:lipid oxidation; P:lipoxin biosynthetic process; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell proliferation; P:negative regulation of inflammatory response; P:negative regulation of response to endoplasmic reticulum stress; P:negative regulation of sprouting angiogenesis; P:negative regulation of vascular wound healing; P:negative regulation of wound healing; P:neutrophil degranulation; P:positive regulation of bone mineralization; P:positive regulation of leukocyte adhesion to arterial endothelial cell; P:regulation of cellular response to oxidative stress; P:regulation of cytokine production involved in inflammatory response; P:regulation of fat cell differentiation; P:regulation of inflammatory response; P:regulation of inflammatory response to wounding; P:regulation of insulin secretion; P:regulation of reactive oxygen species biosynthetic process;|P09917 B7ZLS0 E5FPY5 E5FPY7 E5FPY8 Q5JQ14,Polyunsaturated fatty acid 5-lipoxygenase {ECO:0000305},Arachidonate 5-lipoxygenase;, PF00305;PF01477;, GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0005635;GO:0005641;GO:0016363;GO:0031965;GO:0005654;GO:0048471;GO:0034774;GO:0004052;GO:0004051;GO:0036403;GO:0016787;GO:0005506;GO:0016702;GO:0019369;GO:0019221;GO:0036336;GO:0042593;GO:0051122;GO:0006959;GO:0035655;GO:0002232;GO:0002523;GO:1901753;GO:0019370;GO:0006691;GO:0002540;GO:0043651;GO:0034440;GO:2001301;GO:0019372;GO:0042759;GO:0016525;GO:0001937;GO:0050728;GO:1903573;GO:1903671;GO:0061044;GO:0061045;GO:0043312;GO:0030501;GO:1904999;GO:1900407;GO:1900015;GO:0045598;GO:0050727;GO:0106014;GO:0050796;GO:1903426;, C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:nuclear envelope; C:nuclear envelope lumen; C:nuclear matrix; C:nuclear membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:secretory granule lumen;, F:arachidonate 12(S)-lipoxygenase activity; F:arachidonate 5-lipoxygenase activity; F:arachidonate 8(S)-lipoxygenase activity; F:hydrolase activity; F:iron ion binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;, P:arachidonic acid metabolic process; P:cytokine-mediated signaling pathway; P:dendritic cell migration; P:glucose homeostasis; P:hepoxilin biosynthetic process; P:humoral immune response; P:interleukin-18-mediated signaling pathway; P:leukocyte chemotaxis involved in inflammatory response; P:leukocyte migration involved in inflammatory response; P:leukotriene A4 biosynthetic process; P:leukotriene biosynthetic process; P:leukotriene metabolic process; P:leukotriene production involved in inflammatory response; P:linoleic acid metabolic process; P:lipid oxidation; P:lipoxin biosynthetic process; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell proliferation; P:negative regulation of inflammatory response; P:negative regulation of response to endoplasmic reticulum stress; P:negative regulation of sprouting angiogenesis; P:negative regulation of vascular wound healing; P:negative regulation of wound healing; P:neutrophil degranulation; P:positive regulation of bone mineralization; P:positive regulation of leukocyte adhesion to arterial endothelial cell; P:regulation of cellular response to oxidative stress; P:regulation of cytokine production involved in inflammatory response; P:regulation of fat cell differentiation; P:regulation of inflammatory response; P:regulation of inflammatory response to wounding; P:regulation of insulin secretion; P:regulation of reactive oxygen species biosynthetic process; scaffold14 indexed_genome mRNA 31537836 31570072 . - . ID=transcript_3728;Q9H2L5 Q86WH5 Q86WH6 Q86WH7 Q8N5A9 Q8TCK6,Ras association domain-containing protein 4,, PF16517;PF00788;, GO:0007049;GO:0007165;, , , P:cell cycle; P:signal transduction;|Q9H2L5 Q86WH5 Q86WH6 Q86WH7 Q8N5A9 Q8TCK6,Ras association domain-containing protein 4,, PF16517;PF00788;, GO:0007049;GO:0007165;, , , P:cell cycle; P:signal transduction;|Q9H2L5 Q86WH5 Q86WH6 Q86WH7 Q8N5A9 Q8TCK6,Ras association domain-containing protein 4,, PF16517;PF00788;, GO:0007049;GO:0007165;, , , P:cell cycle; P:signal transduction;|Q9NTK1 B2R6A1 O94997 Q5T735 Q76MX8,Protein DEPP1 {ECO:0000305},Decidual protein induced by progesterone {ECO:0000303|PubMed:16123073};Fasting-induced gene protein {ECO:0000303|Ref.2};, PF15343;, GO:0005737;GO:0043231;GO:0005739;GO:0005777;GO:0006914;GO:0010506;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:peroxisome;, , P:autophagy; P:regulation of autophagy; scaffold14 indexed_genome mRNA 31968385 31980510 . + . ID=transcript_3729;Q9H554,Stromal cell-derived factor 1,C-X-C motif chemokine 12;Intercrine reduced in hepatomas;Pre-B cell growth-stimulating factor;, PF00048;, GO:0062023;GO:0005737;GO:0009897;GO:0070062;GO:0005576;GO:0005634;GO:0008009;GO:0042379;GO:0045236;GO:0008083;GO:0005178;GO:0005102;GO:0008344;GO:0031100;GO:0061844;GO:0007411;GO:0008015;GO:0007155;GO:0060326;GO:0006874;GO:1990869;GO:0038146;GO:0070098;GO:0006935;GO:0006952;GO:0050966;GO:0050965;GO:0007186;GO:0006955;GO:0050930;GO:0033622;GO:0031640;GO:2000669;GO:1902230;GO:1903237;GO:0001764;GO:0048842;GO:0090280;GO:0045785;GO:0030335;GO:0033603;GO:0001938;GO:0090026;GO:0045666;GO:2000406;GO:0008064;GO:0009408;GO:0001666;GO:0043434;GO:0009314;GO:1990478;GO:0009615;GO:0007165;GO:0010818;GO:0022029;GO:0016032;, C:collagen-containing extracellular matrix; C:cytoplasm; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:nucleus;, F:chemokine activity; F:chemokine receptor binding; F:CXCR chemokine receptor binding; F:growth factor activity; F:integrin binding; F:signaling receptor binding;, P:adult locomotory behavior; P:animal organ regeneration; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:axon guidance; P:blood circulation; P:cell adhesion; P:cell chemotaxis; P:cellular calcium ion homeostasis; P:cellular response to chemokine; P:chemokine (C-X-C motif) ligand 12 signaling pathway; P:chemokine-mediated signaling pathway; P:chemotaxis; P:defense response; P:detection of mechanical stimulus involved in sensory perception of pain; P:detection of temperature stimulus involved in sensory perception of pain; P:G protein-coupled receptor signaling pathway; P:immune response; P:induction of positive chemotaxis; P:integrin activation; P:killing of cells of other organism; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of leukocyte tethering or rolling; P:neuron migration; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of calcium ion import; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of dopamine secretion; P:positive regulation of endothelial cell proliferation; P:positive regulation of monocyte chemotaxis; P:positive regulation of neuron differentiation; P:positive regulation of T cell migration; P:regulation of actin polymerization or depolymerization; P:response to heat; P:response to hypoxia; P:response to peptide hormone; P:response to radiation; P:response to ultrasound; P:response to virus; P:signal transduction; P:T cell chemotaxis; P:telencephalon cell migration; P:viral process;|Q9H554,Stromal cell-derived factor 1,C-X-C motif chemokine 12;Intercrine reduced in hepatomas;Pre-B cell growth-stimulating factor;, PF00048;, GO:0062023;GO:0005737;GO:0009897;GO:0070062;GO:0005576;GO:0005634;GO:0008009;GO:0042379;GO:0045236;GO:0008083;GO:0005178;GO:0005102;GO:0008344;GO:0031100;GO:0061844;GO:0007411;GO:0008015;GO:0007155;GO:0060326;GO:0006874;GO:1990869;GO:0038146;GO:0070098;GO:0006935;GO:0006952;GO:0050966;GO:0050965;GO:0007186;GO:0006955;GO:0050930;GO:0033622;GO:0031640;GO:2000669;GO:1902230;GO:1903237;GO:0001764;GO:0048842;GO:0090280;GO:0045785;GO:0030335;GO:0033603;GO:0001938;GO:0090026;GO:0045666;GO:2000406;GO:0008064;GO:0009408;GO:0001666;GO:0043434;GO:0009314;GO:1990478;GO:0009615;GO:0007165;GO:0010818;GO:0022029;GO:0016032;, C:collagen-containing extracellular matrix; C:cytoplasm; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:nucleus;, F:chemokine activity; F:chemokine receptor binding; F:CXCR chemokine receptor binding; F:growth factor activity; F:integrin binding; F:signaling receptor binding;, P:adult locomotory behavior; P:animal organ regeneration; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:axon guidance; P:blood circulation; P:cell adhesion; P:cell chemotaxis; P:cellular calcium ion homeostasis; P:cellular response to chemokine; P:chemokine (C-X-C motif) ligand 12 signaling pathway; P:chemokine-mediated signaling pathway; P:chemotaxis; P:defense response; P:detection of mechanical stimulus involved in sensory perception of pain; P:detection of temperature stimulus involved in sensory perception of pain; P:G protein-coupled receptor signaling pathway; P:immune response; P:induction of positive chemotaxis; P:integrin activation; P:killing of cells of other organism; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of leukocyte tethering or rolling; P:neuron migration; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of calcium ion import; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of dopamine secretion; P:positive regulation of endothelial cell proliferation; P:positive regulation of monocyte chemotaxis; P:positive regulation of neuron differentiation; P:positive regulation of T cell migration; P:regulation of actin polymerization or depolymerization; P:response to heat; P:response to hypoxia; P:response to peptide hormone; P:response to radiation; P:response to ultrasound; P:response to virus; P:signal transduction; P:T cell chemotaxis; P:telencephalon cell migration; P:viral process;|Q9H554,Stromal cell-derived factor 1,C-X-C motif chemokine 12;Intercrine reduced in hepatomas;Pre-B cell growth-stimulating factor;, PF00048;, GO:0062023;GO:0005737;GO:0009897;GO:0070062;GO:0005576;GO:0005634;GO:0008009;GO:0042379;GO:0045236;GO:0008083;GO:0005178;GO:0005102;GO:0008344;GO:0031100;GO:0061844;GO:0007411;GO:0008015;GO:0007155;GO:0060326;GO:0006874;GO:1990869;GO:0038146;GO:0070098;GO:0006935;GO:0006952;GO:0050966;GO:0050965;GO:0007186;GO:0006955;GO:0050930;GO:0033622;GO:0031640;GO:2000669;GO:1902230;GO:1903237;GO:0001764;GO:0048842;GO:0090280;GO:0045785;GO:0030335;GO:0033603;GO:0001938;GO:0090026;GO:0045666;GO:2000406;GO:0008064;GO:0009408;GO:0001666;GO:0043434;GO:0009314;GO:1990478;GO:0009615;GO:0007165;GO:0010818;GO:0022029;GO:0016032;, C:collagen-containing extracellular matrix; C:cytoplasm; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:nucleus;, F:chemokine activity; F:chemokine receptor binding; F:CXCR chemokine receptor binding; F:growth factor activity; F:integrin binding; F:signaling receptor binding;, P:adult locomotory behavior; P:animal organ regeneration; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:axon guidance; P:blood circulation; P:cell adhesion; P:cell chemotaxis; P:cellular calcium ion homeostasis; P:cellular response to chemokine; P:chemokine (C-X-C motif) ligand 12 signaling pathway; P:chemokine-mediated signaling pathway; P:chemotaxis; P:defense response; P:detection of mechanical stimulus involved in sensory perception of pain; P:detection of temperature stimulus involved in sensory perception of pain; P:G protein-coupled receptor signaling pathway; P:immune response; P:induction of positive chemotaxis; P:integrin activation; P:killing of cells of other organism; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of leukocyte tethering or rolling; P:neuron migration; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of calcium ion import; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of dopamine secretion; P:positive regulation of endothelial cell proliferation; P:positive regulation of monocyte chemotaxis; P:positive regulation of neuron differentiation; P:positive regulation of T cell migration; P:regulation of actin polymerization or depolymerization; P:response to heat; P:response to hypoxia; P:response to peptide hormone; P:response to radiation; P:response to ultrasound; P:response to virus; P:signal transduction; P:T cell chemotaxis; P:telencephalon cell migration; P:viral process; scaffold14 indexed_genome mRNA 32573087 32577780 . + . ID=transcript_3730;P17041 Q92951,Zinc finger protein 32,C2H2-546;Zinc finger protein KOX30;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|P17041 Q92951,Zinc finger protein 32,C2H2-546;Zinc finger protein KOX30;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|P17041 Q92951,Zinc finger protein 32,C2H2-546;Zinc finger protein KOX30;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold14 indexed_genome mRNA 32599996 32610391 . + . ID=transcript_3731;Q16600 Q5T1G9 Q8TAS5,Zinc finger protein 239,Zinc finger protein HOK-2;Zinc finger protein MOK-2;, PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0001227;GO:0046872;GO:0003723;GO:0000978;GO:0000122;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold14 indexed_genome mRNA 32614760 32630319 . - . ID=transcript_3732;Q00059 A8MRB2 A9QXC6 B5BU05 Q5U0C6,Transcription factor A, mitochondrial {ECO:0000305},Mitochondrial transcription factor 1;Transcription factor 6;Transcription factor 6-like 2;, PF00505;PF09011;, GO:0005829;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0032991;GO:0003682;GO:0008301;GO:0003700;GO:0031072;GO:0001018;GO:0034246;GO:0003723;GO:0043565;GO:0001223;GO:0000976;GO:0033108;GO:0006390;GO:0007005;GO:0045893;GO:0006391;, C:cytosol; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding, bending; F:DNA-binding transcription factor activity; F:heat shock protein binding; F:mitochondrial promoter sequence-specific DNA binding; F:mitochondrial transcription factor activity; F:RNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:transcription regulatory region sequence-specific DNA binding;, P:mitochondrial respiratory chain complex assembly; P:mitochondrial transcription; P:mitochondrion organization; P:positive regulation of transcription, DNA-templated; P:transcription initiation from mitochondrial promoter; scaffold14 indexed_genome mRNA 32644892 32682774 . - . ID=transcript_3733;P51668 A6NLF6 A8K786,Ubiquitin-conjugating enzyme E2 D1,(E3-independent) E2 ubiquitin-conjugating enzyme D1;E2 ubiquitin-conjugating enzyme D1;Stimulator of Fe transport;UBC4/5 homolog;UbcH5;Ubiquitin carrier protein D1;Ubiquitin-conjugating enzyme E2(17)KB 1;Ubiquitin-conjugating enzyme E2-17 kDa 1;Ubiquitin-protein ligase D1;, PF00179;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000151;GO:0005524;GO:0061631;GO:0061630;GO:0031625;GO:0004842;GO:0031145;GO:0002756;GO:0030514;GO:0000122;GO:1902916;GO:0031398;GO:0016579;GO:0070936;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:1901990;GO:0035666;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein polyubiquitination; P:positive regulation of protein ubiquitination; P:protein deubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:TRIF-dependent toll-like receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|P51668 A6NLF6 A8K786,Ubiquitin-conjugating enzyme E2 D1,(E3-independent) E2 ubiquitin-conjugating enzyme D1;E2 ubiquitin-conjugating enzyme D1;Stimulator of Fe transport;UBC4/5 homolog;UbcH5;Ubiquitin carrier protein D1;Ubiquitin-conjugating enzyme E2(17)KB 1;Ubiquitin-conjugating enzyme E2-17 kDa 1;Ubiquitin-protein ligase D1;, PF00179;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000151;GO:0005524;GO:0061631;GO:0061630;GO:0031625;GO:0004842;GO:0031145;GO:0002756;GO:0030514;GO:0000122;GO:1902916;GO:0031398;GO:0016579;GO:0070936;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:1901990;GO:0035666;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein polyubiquitination; P:positive regulation of protein ubiquitination; P:protein deubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:TRIF-dependent toll-like receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|P51668 A6NLF6 A8K786,Ubiquitin-conjugating enzyme E2 D1,(E3-independent) E2 ubiquitin-conjugating enzyme D1;E2 ubiquitin-conjugating enzyme D1;Stimulator of Fe transport;UBC4/5 homolog;UbcH5;Ubiquitin carrier protein D1;Ubiquitin-conjugating enzyme E2(17)KB 1;Ubiquitin-conjugating enzyme E2-17 kDa 1;Ubiquitin-protein ligase D1;, PF00179;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000151;GO:0005524;GO:0061631;GO:0061630;GO:0031625;GO:0004842;GO:0031145;GO:0002756;GO:0030514;GO:0000122;GO:1902916;GO:0031398;GO:0016579;GO:0070936;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:1901990;GO:0035666;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein polyubiquitination; P:positive regulation of protein ubiquitination; P:protein deubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:TRIF-dependent toll-like receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold14 indexed_genome mRNA 32713901 32718436 . - . ID=transcript_3734;Q9NZ45 Q1X902,CDGSH iron-sulfur domain-containing protein 1,MitoNEET;, PF10660;PF09360;, GO:0032473;GO:0016021;GO:0005741;GO:0005739;GO:0051537;GO:0042802;GO:0046872;GO:0043457;, C:cytoplasmic side of mitochondrial outer membrane; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:identical protein binding; F:metal ion binding;, P:regulation of cellular respiration; scaffold14 indexed_genome mRNA 32725247 32731258 . - . ID=transcript_3735;Q9NZ45 Q1X902,CDGSH iron-sulfur domain-containing protein 1,MitoNEET;, PF10660;PF09360;, GO:0032473;GO:0016021;GO:0005741;GO:0005739;GO:0051537;GO:0042802;GO:0046872;GO:0043457;, C:cytoplasmic side of mitochondrial outer membrane; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:identical protein binding; F:metal ion binding;, P:regulation of cellular respiration;|Q9NZ45 Q1X902,CDGSH iron-sulfur domain-containing protein 1,MitoNEET;, PF10660;PF09360;, GO:0032473;GO:0016021;GO:0005741;GO:0005739;GO:0051537;GO:0042802;GO:0046872;GO:0043457;, C:cytoplasmic side of mitochondrial outer membrane; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:identical protein binding; F:metal ion binding;, P:regulation of cellular respiration; scaffold14 indexed_genome mRNA 32744429 32799584 . + . ID=transcript_3736;Q8NFU5,Inositol polyphosphate multikinase,Inositol 1,3,4,6-tetrakisphosphate 5-kinase {ECO:0000303|PubMed:12223481};, PF03770;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0097243;GO:0047326;GO:0000825;GO:0051765;GO:0008440;GO:0000823;GO:0016301;GO:0046872;GO:0102732;GO:0052812;GO:0046934;GO:0032958;GO:0043647;GO:0032957;GO:0070266;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:flavonoid binding; F:inositol tetrakisphosphate 5-kinase activity; F:inositol tetrakisphosphate 6-kinase activity; F:inositol tetrakisphosphate kinase activity; F:inositol-1,4,5-trisphosphate 3-kinase activity; F:inositol-1,4,5-trisphosphate 6-kinase activity; F:kinase activity; F:metal ion binding; F:myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:inositol trisphosphate metabolic process; P:necroptotic process; scaffold14 indexed_genome mRNA 34486543 34490292 . + . ID=transcript_3737;O95229 A6NNV6 Q0D2I3 Q9BWD0,ZW10 interactor,ZW10-interacting protein 1;, PF15556;, GO:0000777;GO:0005737;GO:0005829;GO:0030425;GO:0000776;GO:0016604;GO:0005654;GO:0047485;GO:0051301;GO:0051649;GO:0000070;GO:0007094;GO:0007052;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:dendrite; C:kinetochore; C:nuclear body; C:nucleoplasm;, F:protein N-terminus binding;, P:cell division; P:establishment of localization in cell; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; scaffold14 indexed_genome mRNA 36447089 36546903 . + . ID=transcript_3738;Q96QT8,Protocadherin-15,, PF00028;PF18432;, GO:0005576;GO:0005615;GO:0005887;GO:0001750;GO:0032420;GO:0045202;GO:0005509;GO:0007155;GO:0050957;GO:0007156;GO:0048839;GO:0045494;GO:0050953;GO:0007605;, C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:photoreceptor outer segment; C:stereocilium; C:synapse;, F:calcium ion binding;, P:cell adhesion; P:equilibrioception; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear development; P:photoreceptor cell maintenance; P:sensory perception of light stimulus; P:sensory perception of sound; scaffold14 indexed_genome mRNA 36660445 36809674 . + . ID=transcript_3739;Q96QT8,Protocadherin-15,, PF00028;PF18432;, GO:0005576;GO:0005615;GO:0005887;GO:0001750;GO:0032420;GO:0045202;GO:0005509;GO:0007155;GO:0050957;GO:0007156;GO:0048839;GO:0045494;GO:0050953;GO:0007605;, C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:photoreceptor outer segment; C:stereocilium; C:synapse;, F:calcium ion binding;, P:cell adhesion; P:equilibrioception; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear development; P:photoreceptor cell maintenance; P:sensory perception of light stimulus; P:sensory perception of sound; scaffold14 indexed_genome mRNA 36836854 36846964 . + . ID=transcript_3740;Q96QT8,Protocadherin-15,, PF00028;PF18432;, GO:0005576;GO:0005615;GO:0005887;GO:0001750;GO:0032420;GO:0045202;GO:0005509;GO:0007155;GO:0050957;GO:0007156;GO:0048839;GO:0045494;GO:0050953;GO:0007605;, C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:photoreceptor outer segment; C:stereocilium; C:synapse;, F:calcium ion binding;, P:cell adhesion; P:equilibrioception; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inner ear development; P:photoreceptor cell maintenance; P:sensory perception of light stimulus; P:sensory perception of sound; scaffold14 indexed_genome mRNA 37541124 37548022 . + . ID=transcript_3741;Q96TF9,Mannose-binding protein C,Collectin-1;MBP1;Mannan-binding protein;Mannose-binding lectin;, PF01391;PF00059;, GO:0009986;GO:0005581;GO:0062023;GO:0005576;GO:0005615;GO:0048306;GO:0005537;GO:0005102;GO:0006953;GO:0006956;GO:0006958;GO:0001867;GO:0042742;GO:0050830;GO:0045087;GO:0048525;GO:0008228;GO:0006979;, C:cell surface; C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium-dependent protein binding; F:mannose binding; F:signaling receptor binding;, P:acute-phase response; P:complement activation; P:complement activation, classical pathway; P:complement activation, lectin pathway; P:defense response to bacterium; P:defense response to Gram-positive bacterium; P:innate immune response; P:negative regulation of viral process; P:opsonization; P:response to oxidative stress;|Q96TF9,Mannose-binding protein C,Collectin-1;MBP1;Mannan-binding protein;Mannose-binding lectin;, PF01391;PF00059;, GO:0009986;GO:0005581;GO:0062023;GO:0005576;GO:0005615;GO:0048306;GO:0005537;GO:0005102;GO:0006953;GO:0006956;GO:0006958;GO:0001867;GO:0042742;GO:0050830;GO:0045087;GO:0048525;GO:0008228;GO:0006979;, C:cell surface; C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium-dependent protein binding; F:mannose binding; F:signaling receptor binding;, P:acute-phase response; P:complement activation; P:complement activation, classical pathway; P:complement activation, lectin pathway; P:defense response to bacterium; P:defense response to Gram-positive bacterium; P:innate immune response; P:negative regulation of viral process; P:opsonization; P:response to oxidative stress; scaffold14 indexed_genome mRNA 37967249 37970327 . - . ID=transcript_3742;O94907 B2RC19,Dickkopf-related protein 1,SK;, PF04706;, GO:0031901;GO:0005576;GO:0005615;GO:0005886;GO:0039706;GO:0008083;GO:0050750;GO:0048019;GO:0007611;GO:0060173;GO:0090647;GO:0043066;GO:0090090;GO:1901296;GO:2000726;GO:0042662;GO:0030279;GO:0060394;GO:0033137;GO:0032091;GO:0000122;GO:0030178;GO:1904723;GO:0010942;GO:0010628;GO:0090082;GO:0043507;GO:1901216;GO:1902949;GO:0045813;GO:2000096;GO:1904338;GO:0042663;GO:0002090;GO:0098883;GO:0016055;, C:early endosome membrane; C:extracellular region; C:extracellular space; C:plasma membrane;, F:co-receptor binding; F:growth factor activity; F:low-density lipoprotein particle receptor binding; F:receptor antagonist activity;, P:learning or memory; P:limb development; P:modulation of age-related behavioral decline; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment; P:negative regulation of cardiac muscle cell differentiation; P:negative regulation of mesodermal cell fate specification; P:negative regulation of ossification; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of Wnt signaling pathway; P:negative regulation of Wnt-Frizzled-LRP5/6 complex assembly; P:positive regulation of cell death; P:positive regulation of gene expression; P:positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway; P:positive regulation of JUN kinase activity; P:positive regulation of neuron death; P:positive regulation of tau-protein kinase activity; P:positive regulation of Wnt signaling pathway, calcium modulating pathway; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:regulation of dopaminergic neuron differentiation; P:regulation of endodermal cell fate specification; P:regulation of receptor internalization; P:synapse pruning; P:Wnt signaling pathway; scaffold14 indexed_genome mRNA 38014240 38645314 . - . ID=transcript_3743;Q13976 A5YM56 B3KSF3 E2PU10 P14619 Q5JP05 Q5JSJ6 Q6P5T7,cGMP-dependent protein kinase 1,cGMP-dependent protein kinase I;, PF00027;PF16808;PF00069;, GO:0005737;GO:0005829;GO:0005794;GO:0005886;GO:0005524;GO:0005246;GO:0030553;GO:0004692;GO:0042802;GO:0004672;GO:0030036;GO:0002250;GO:0019934;GO:0016358;GO:0030900;GO:0090331;GO:1904753;GO:1904706;GO:0001764;GO:0006468;GO:0043087;GO:0060087;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:cGMP binding; F:cGMP-dependent protein kinase activity; F:identical protein binding; F:protein kinase activity;, P:actin cytoskeleton organization; P:adaptive immune response; P:cGMP-mediated signaling; P:dendrite development; P:forebrain development; P:negative regulation of platelet aggregation; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:neuron migration; P:protein phosphorylation; P:regulation of GTPase activity; P:relaxation of vascular associated smooth muscle; P:signal transduction;|Q13976 A5YM56 B3KSF3 E2PU10 P14619 Q5JP05 Q5JSJ6 Q6P5T7,cGMP-dependent protein kinase 1,cGMP-dependent protein kinase I;, PF00027;PF16808;PF00069;, GO:0005737;GO:0005829;GO:0005794;GO:0005886;GO:0005524;GO:0005246;GO:0030553;GO:0004692;GO:0042802;GO:0004672;GO:0030036;GO:0002250;GO:0019934;GO:0016358;GO:0030900;GO:0090331;GO:1904753;GO:1904706;GO:0001764;GO:0006468;GO:0043087;GO:0060087;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:cGMP binding; F:cGMP-dependent protein kinase activity; F:identical protein binding; F:protein kinase activity;, P:actin cytoskeleton organization; P:adaptive immune response; P:cGMP-mediated signaling; P:dendrite development; P:forebrain development; P:negative regulation of platelet aggregation; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:neuron migration; P:protein phosphorylation; P:regulation of GTPase activity; P:relaxation of vascular associated smooth muscle; P:signal transduction;|Q9H0L4 B2RAR9 O75174 Q53HK6 Q7LGE8 Q8N6T1,Cleavage stimulation factor subunit 2 tau variant,CF-1 64 kDa subunit tau variant;Cleavage stimulation factor 64 kDa subunit tau variant;TauCstF-64;, PF14327;PF14304;PF00076;, GO:0043231;GO:0005847;GO:0005654;GO:0003729;GO:0003723;GO:0031124;GO:0000398;GO:0098789;GO:0006369;, C:intracellular membrane-bounded organelle; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; scaffold14 indexed_genome mRNA 39005185 39176448 . - . ID=transcript_3744;Q13976 A5YM56 B3KSF3 E2PU10 P14619 Q5JP05 Q5JSJ6 Q6P5T7,cGMP-dependent protein kinase 1,cGMP-dependent protein kinase I;, PF00027;PF16808;PF00069;, GO:0005737;GO:0005829;GO:0005794;GO:0005886;GO:0005524;GO:0005246;GO:0030553;GO:0004692;GO:0042802;GO:0004672;GO:0030036;GO:0002250;GO:0019934;GO:0016358;GO:0030900;GO:0090331;GO:1904753;GO:1904706;GO:0001764;GO:0006468;GO:0043087;GO:0060087;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:cGMP binding; F:cGMP-dependent protein kinase activity; F:identical protein binding; F:protein kinase activity;, P:actin cytoskeleton organization; P:adaptive immune response; P:cGMP-mediated signaling; P:dendrite development; P:forebrain development; P:negative regulation of platelet aggregation; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:neuron migration; P:protein phosphorylation; P:regulation of GTPase activity; P:relaxation of vascular associated smooth muscle; P:signal transduction;|Q13976 A5YM56 B3KSF3 E2PU10 P14619 Q5JP05 Q5JSJ6 Q6P5T7,cGMP-dependent protein kinase 1,cGMP-dependent protein kinase I;, PF00027;PF16808;PF00069;, GO:0005737;GO:0005829;GO:0005794;GO:0005886;GO:0005524;GO:0005246;GO:0030553;GO:0004692;GO:0042802;GO:0004672;GO:0030036;GO:0002250;GO:0019934;GO:0016358;GO:0030900;GO:0090331;GO:1904753;GO:1904706;GO:0001764;GO:0006468;GO:0043087;GO:0060087;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:cGMP binding; F:cGMP-dependent protein kinase activity; F:identical protein binding; F:protein kinase activity;, P:actin cytoskeleton organization; P:adaptive immune response; P:cGMP-mediated signaling; P:dendrite development; P:forebrain development; P:negative regulation of platelet aggregation; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:neuron migration; P:protein phosphorylation; P:regulation of GTPase activity; P:relaxation of vascular associated smooth muscle; P:signal transduction; scaffold14 indexed_genome mRNA 39345408 39384240 . + . ID=transcript_3745;Q9NZD3,APOBEC1 complementation factor,APOBEC1-stimulating protein;, PF00076;, GO:0030895;GO:0005737;GO:0005783;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0003727;GO:0016554;GO:0016556;GO:0006397;GO:0050821;, C:apolipoprotein B mRNA editing enzyme complex; C:cytoplasm; C:endoplasmic reticulum; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded RNA binding;, P:cytidine to uridine editing; P:mRNA modification; P:mRNA processing; P:protein stabilization; scaffold14 indexed_genome mRNA 39431385 39443306 . - . ID=transcript_3746;Q9NR71 Q3KNU1 Q5SNT7 Q5SZP6 Q5SZP7 Q5T1D5 Q71ME6,Neutral ceramidase {ECO:0000305},Acylsphingosine deacylase 2;BCDase;LCDase;N-acylsphingosine amidohydrolase 2;Non-lysosomal ceramidase;, PF04734;PF17048;, GO:0005901;GO:0070062;GO:0005576;GO:0005794;GO:0000139;GO:0005887;GO:0005739;GO:0005886;GO:0005509;GO:0102121;GO:0071633;GO:0017040;GO:0070774;GO:0008270;GO:0006915;GO:0071345;GO:0046513;GO:0046514;GO:0006672;GO:0044241;GO:0042759;GO:2001234;GO:0007346;GO:0046512;GO:0006670;, C:caveola; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:mitochondrion; C:plasma membrane;, F:calcium ion binding; F:ceramidase activity; F:dihydroceramidase activity; F:N-acylsphingosine amidohydrolase activity; F:phytoceramidase activity; F:zinc ion binding;, P:apoptotic process; P:cellular response to cytokine stimulus; P:ceramide biosynthetic process; P:ceramide catabolic process; P:ceramide metabolic process; P:lipid digestion; P:long-chain fatty acid biosynthetic process; P:negative regulation of apoptotic signaling pathway; P:regulation of mitotic cell cycle; P:sphingosine biosynthetic process; P:sphingosine metabolic process; scaffold14 indexed_genome mRNA 39522318 39852563 . - . ID=transcript_3747;Q86VZ5 D3DWC4 Q68U43 Q6EKK0 Q75SP1,Phosphatidylcholine:ceramide cholinephosphotransferase 1,Medulla oblongata-derived protein;Sphingomyelin synthase 1;Transmembrane protein 23;, PF14360;, GO:0005783;GO:0000139;GO:0000138;GO:0030176;GO:0030173;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0047493;GO:0002950;GO:0016301;GO:0033188;GO:0006915;GO:0071222;GO:0071356;GO:0046513;GO:0006954;GO:0010628;GO:2001242;GO:0030148;GO:0006686;, C:endoplasmic reticulum; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane;, F:ceramide cholinephosphotransferase activity; F:ceramide phosphoethanolamine synthase activity; F:kinase activity; F:sphingomyelin synthase activity;, P:apoptotic process; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:inflammatory response; P:positive regulation of gene expression; P:regulation of intrinsic apoptotic signaling pathway; P:sphingolipid biosynthetic process; P:sphingomyelin biosynthetic process;|Q86VZ5 D3DWC4 Q68U43 Q6EKK0 Q75SP1,Phosphatidylcholine:ceramide cholinephosphotransferase 1,Medulla oblongata-derived protein;Sphingomyelin synthase 1;Transmembrane protein 23;, PF14360;, GO:0005783;GO:0000139;GO:0000138;GO:0030176;GO:0030173;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0047493;GO:0002950;GO:0016301;GO:0033188;GO:0006915;GO:0071222;GO:0071356;GO:0046513;GO:0006954;GO:0010628;GO:2001242;GO:0030148;GO:0006686;, C:endoplasmic reticulum; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane;, F:ceramide cholinephosphotransferase activity; F:ceramide phosphoethanolamine synthase activity; F:kinase activity; F:sphingomyelin synthase activity;, P:apoptotic process; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:inflammatory response; P:positive regulation of gene expression; P:regulation of intrinsic apoptotic signaling pathway; P:sphingolipid biosynthetic process; P:sphingomyelin biosynthetic process;|Q86VZ5 D3DWC4 Q68U43 Q6EKK0 Q75SP1,Phosphatidylcholine:ceramide cholinephosphotransferase 1,Medulla oblongata-derived protein;Sphingomyelin synthase 1;Transmembrane protein 23;, PF14360;, GO:0005783;GO:0000139;GO:0000138;GO:0030176;GO:0030173;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0047493;GO:0002950;GO:0016301;GO:0033188;GO:0006915;GO:0071222;GO:0071356;GO:0046513;GO:0006954;GO:0010628;GO:2001242;GO:0030148;GO:0006686;, C:endoplasmic reticulum; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane;, F:ceramide cholinephosphotransferase activity; F:ceramide phosphoethanolamine synthase activity; F:kinase activity; F:sphingomyelin synthase activity;, P:apoptotic process; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:inflammatory response; P:positive regulation of gene expression; P:regulation of intrinsic apoptotic signaling pathway; P:sphingolipid biosynthetic process; P:sphingomyelin biosynthetic process; scaffold14 indexed_genome mRNA 39950697 39982997 . + . ID=transcript_3748;Q9UNW1 F5H683 O95172 O95286 Q59EJ2 Q9UGA3,Multiple inositol polyphosphate phosphatase 1 {ECO:0000312|HGNC:HGNC:7102},2,3-bisphosphoglycerate 3-phosphatase {ECO:0000303|PubMed:18413611};Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase;, PF00328;, GO:0005783;GO:0005788;GO:0070062;GO:0003993;GO:0034417;GO:0052826;GO:0052745;GO:0101006;GO:0030282;GO:0043647;GO:0001503;GO:0006797;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome;, F:acid phosphatase activity; F:bisphosphoglycerate 3-phosphatase activity; F:inositol hexakisphosphate 2-phosphatase activity; F:inositol phosphate phosphatase activity; F:protein histidine phosphatase activity;, P:bone mineralization; P:inositol phosphate metabolic process; P:ossification; P:polyphosphate metabolic process; scaffold14 indexed_genome mRNA 40064919 40152546 . + . ID=transcript_3749;O95340 Q9BZL2 Q9P0G6 Q9UHM1 Q9UKD3 Q9UP30,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2,Sulfurylase kinase 2;, PF01747;PF14306;, GO:0005829;GO:0004020;GO:0005524;GO:0016779;GO:0004781;GO:0050428;GO:0001501;GO:0000103;, C:cytosol;, F:adenylylsulfate kinase activity; F:ATP binding; F:nucleotidyltransferase activity; F:sulfate adenylyltransferase (ATP) activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; P:skeletal system development; P:sulfate assimilation;|O95340 Q9BZL2 Q9P0G6 Q9UHM1 Q9UKD3 Q9UP30,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2,Sulfurylase kinase 2;, PF01747;PF14306;, GO:0005829;GO:0004020;GO:0005524;GO:0016779;GO:0004781;GO:0050428;GO:0001501;GO:0000103;, C:cytosol;, F:adenylylsulfate kinase activity; F:ATP binding; F:nucleotidyltransferase activity; F:sulfate adenylyltransferase (ATP) activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; P:skeletal system development; P:sulfate assimilation; scaffold14 indexed_genome mRNA 40158576 40198744 . - . ID=transcript_3750;Q8NBU5 D3DR26 Q6DKG1 Q6P4B9 Q8N3G1 Q8WYR9 Q969Y3,Outer mitochondrial transmembrane helix translocase {ECO:0000305},ATPase family AAA domain-containing protein 1 {ECO:0000305};Thorase {ECO:0000250|UniProtKB:Q9D5T0};, PF00004;PF17862;, GO:0005829;GO:0098978;GO:0016021;GO:0016020;GO:0005741;GO:0005778;GO:0045211;GO:0005524;GO:0016887;GO:0007612;GO:0007613;GO:0051967;GO:0002092;GO:0045046;GO:0099149;, C:cytosol; C:glutamatergic synapse; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:peroxisomal membrane; C:postsynaptic membrane;, F:ATP binding; F:ATPase activity;, P:learning; P:memory; P:negative regulation of synaptic transmission, glutamatergic; P:positive regulation of receptor internalization; P:protein import into peroxisome membrane; P:regulation of postsynaptic neurotransmitter receptor internalization;|Q8NBU5 D3DR26 Q6DKG1 Q6P4B9 Q8N3G1 Q8WYR9 Q969Y3,Outer mitochondrial transmembrane helix translocase {ECO:0000305},ATPase family AAA domain-containing protein 1 {ECO:0000305};Thorase {ECO:0000250|UniProtKB:Q9D5T0};, PF00004;PF17862;, GO:0005829;GO:0098978;GO:0016021;GO:0016020;GO:0005741;GO:0005778;GO:0045211;GO:0005524;GO:0016887;GO:0007612;GO:0007613;GO:0051967;GO:0002092;GO:0045046;GO:0099149;, C:cytosol; C:glutamatergic synapse; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:peroxisomal membrane; C:postsynaptic membrane;, F:ATP binding; F:ATPase activity;, P:learning; P:memory; P:negative regulation of synaptic transmission, glutamatergic; P:positive regulation of receptor internalization; P:protein import into peroxisome membrane; P:regulation of postsynaptic neurotransmitter receptor internalization;|Q8NBU5 D3DR26 Q6DKG1 Q6P4B9 Q8N3G1 Q8WYR9 Q969Y3,Outer mitochondrial transmembrane helix translocase {ECO:0000305},ATPase family AAA domain-containing protein 1 {ECO:0000305};Thorase {ECO:0000250|UniProtKB:Q9D5T0};, PF00004;PF17862;, GO:0005829;GO:0098978;GO:0016021;GO:0016020;GO:0005741;GO:0005778;GO:0045211;GO:0005524;GO:0016887;GO:0007612;GO:0007613;GO:0051967;GO:0002092;GO:0045046;GO:0099149;, C:cytosol; C:glutamatergic synapse; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:peroxisomal membrane; C:postsynaptic membrane;, F:ATP binding; F:ATPase activity;, P:learning; P:memory; P:negative regulation of synaptic transmission, glutamatergic; P:positive regulation of receptor internalization; P:protein import into peroxisome membrane; P:regulation of postsynaptic neurotransmitter receptor internalization;|Q8NBU5 D3DR26 Q6DKG1 Q6P4B9 Q8N3G1 Q8WYR9 Q969Y3,Outer mitochondrial transmembrane helix translocase {ECO:0000305},ATPase family AAA domain-containing protein 1 {ECO:0000305};Thorase {ECO:0000250|UniProtKB:Q9D5T0};, PF00004;PF17862;, GO:0005829;GO:0098978;GO:0016021;GO:0016020;GO:0005741;GO:0005778;GO:0045211;GO:0005524;GO:0016887;GO:0007612;GO:0007613;GO:0051967;GO:0002092;GO:0045046;GO:0099149;, C:cytosol; C:glutamatergic synapse; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:peroxisomal membrane; C:postsynaptic membrane;, F:ATP binding; F:ATPase activity;, P:learning; P:memory; P:negative regulation of synaptic transmission, glutamatergic; P:positive regulation of receptor internalization; P:protein import into peroxisome membrane; P:regulation of postsynaptic neurotransmitter receptor internalization; scaffold14 indexed_genome mRNA 40310329 40348171 . + . ID=transcript_3751;P60484 B2R904 F2YHV0 O00633 O02679 Q6ICT7,Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN,Mutated in multiple advanced cancers 1;Phosphatase and tensin homolog;, PF10409;, GO:0016324;GO:0042995;GO:0005737;GO:0009898;GO:0005829;GO:0043197;GO:0005576;GO:0005739;GO:0035749;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0099524;GO:0045211;GO:0043220;GO:0010997;GO:0019899;GO:0042802;GO:0051717;GO:0035255;GO:0008289;GO:0030165;GO:0016314;GO:0051800;GO:0004438;GO:0004721;GO:0005161;GO:0106306;GO:0004722;GO:0106307;GO:1990782;GO:0004725;GO:1990381;GO:0030534;GO:0007568;GO:0001525;GO:0006915;GO:0048854;GO:0060070;GO:0048738;GO:0016477;GO:0048870;GO:0071257;GO:0071361;GO:0071456;GO:0032869;GO:1990314;GO:0044320;GO:1990090;GO:0007417;GO:0032286;GO:0021955;GO:0060997;GO:0021542;GO:0016311;GO:0043542;GO:0048853;GO:0007507;GO:0046855;GO:0043647;GO:0007611;GO:0045475;GO:0007626;GO:0060292;GO:0060291;GO:0060179;GO:0042711;GO:0007613;GO:0033555;GO:0043066;GO:0048681;GO:0050771;GO:0060044;GO:0090344;GO:1902807;GO:0030336;GO:0008285;GO:0045792;GO:0045736;GO:0061002;GO:0050680;GO:0010719;GO:0070373;GO:0090394;GO:0051895;GO:2000134;GO:0051548;GO:0031642;GO:0010977;GO:0046621;GO:0033137;GO:0050765;GO:0014067;GO:1901017;GO:0051898;GO:0001933;GO:0090071;GO:2000272;GO:2000808;GO:1904706;GO:1903690;GO:0007270;GO:0014065;GO:0006661;GO:0046856;GO:0048008;GO:0010666;GO:0008284;GO:0051091;GO:0070374;GO:2000463;GO:0010628;GO:0045666;GO:1903984;GO:1904668;GO:2000060;GO:0097107;GO:0060134;GO:0097105;GO:0060736;GO:0006470;GO:0016579;GO:0043491;GO:0050821;GO:0002902;GO:0032535;GO:0033032;GO:0010975;GO:0051896;GO:0031647;GO:0032228;GO:0060260;GO:0014823;GO:0046685;GO:0033198;GO:0042493;GO:0032355;GO:0009749;GO:0007584;GO:0010043;GO:0060024;GO:0035176;GO:0007416;GO:0060074;, C:apical plasma membrane; C:cell projection; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:dendritic spine; C:extracellular region; C:mitochondrion; C:myelin sheath adaxonal region; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic cytosol; C:postsynaptic membrane; C:Schmidt-Lanterman incisure;, F:anaphase-promoting complex binding; F:enzyme binding; F:identical protein binding; F:inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity; F:ionotropic glutamate receptor binding; F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphoprotein phosphatase activity; F:platelet-derived growth factor receptor binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:ubiquitin-specific protease binding;, P:adult behavior; P:aging; P:angiogenesis; P:apoptotic process; P:brain morphogenesis; P:canonical Wnt signaling pathway; P:cardiac muscle tissue development; P:cell migration; P:cell motility; P:cellular response to electrical stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to nerve growth factor stimulus; P:central nervous system development; P:central nervous system myelin maintenance; P:central nervous system neuron axonogenesis; P:dendritic spine morphogenesis; P:dentate gyrus development; P:dephosphorylation; P:endothelial cell migration; P:forebrain morphogenesis; P:heart development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning or memory; P:locomotor rhythm; P:locomotory behavior; P:long-term synaptic depression; P:long-term synaptic potentiation; P:male mating behavior; P:maternal behavior; P:memory; P:multicellular organismal response to stress; P:negative regulation of apoptotic process; P:negative regulation of axon regeneration; P:negative regulation of axonogenesis; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell aging; P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell size; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of focal adhesion assembly; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of keratinocyte migration; P:negative regulation of myelination; P:negative regulation of neuron projection development; P:negative regulation of organ growth; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of phagocytosis; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of ribosome biogenesis; P:negative regulation of signaling receptor activity; P:negative regulation of synaptic vesicle clustering; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of wound healing, spreading of epidermal cells; P:neuron-neuron synaptic transmission; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:positive regulation of ubiquitin protein ligase activity; P:positive regulation of ubiquitin-dependent protein catabolic process; P:postsynaptic density assembly; P:prepulse inhibition; P:presynaptic membrane assembly; P:prostate gland growth; P:protein dephosphorylation; P:protein deubiquitination; P:protein kinase B signaling; P:protein stabilization; P:regulation of B cell apoptotic process; P:regulation of cellular component size; P:regulation of myeloid cell apoptotic process; P:regulation of neuron projection development; P:regulation of protein kinase B signaling; P:regulation of protein stability; P:regulation of synaptic transmission, GABAergic; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to activity; P:response to arsenic-containing substance; P:response to ATP; P:response to drug; P:response to estradiol; P:response to glucose; P:response to nutrient; P:response to zinc ion; P:rhythmic synaptic transmission; P:social behavior; P:synapse assembly; P:synapse maturation;|P60484 B2R904 F2YHV0 O00633 O02679 Q6ICT7,Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN,Mutated in multiple advanced cancers 1;Phosphatase and tensin homolog;, PF10409;, GO:0016324;GO:0042995;GO:0005737;GO:0009898;GO:0005829;GO:0043197;GO:0005576;GO:0005739;GO:0035749;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0099524;GO:0045211;GO:0043220;GO:0010997;GO:0019899;GO:0042802;GO:0051717;GO:0035255;GO:0008289;GO:0030165;GO:0016314;GO:0051800;GO:0004438;GO:0004721;GO:0005161;GO:0106306;GO:0004722;GO:0106307;GO:1990782;GO:0004725;GO:1990381;GO:0030534;GO:0007568;GO:0001525;GO:0006915;GO:0048854;GO:0060070;GO:0048738;GO:0016477;GO:0048870;GO:0071257;GO:0071361;GO:0071456;GO:0032869;GO:1990314;GO:0044320;GO:1990090;GO:0007417;GO:0032286;GO:0021955;GO:0060997;GO:0021542;GO:0016311;GO:0043542;GO:0048853;GO:0007507;GO:0046855;GO:0043647;GO:0007611;GO:0045475;GO:0007626;GO:0060292;GO:0060291;GO:0060179;GO:0042711;GO:0007613;GO:0033555;GO:0043066;GO:0048681;GO:0050771;GO:0060044;GO:0090344;GO:1902807;GO:0030336;GO:0008285;GO:0045792;GO:0045736;GO:0061002;GO:0050680;GO:0010719;GO:0070373;GO:0090394;GO:0051895;GO:2000134;GO:0051548;GO:0031642;GO:0010977;GO:0046621;GO:0033137;GO:0050765;GO:0014067;GO:1901017;GO:0051898;GO:0001933;GO:0090071;GO:2000272;GO:2000808;GO:1904706;GO:1903690;GO:0007270;GO:0014065;GO:0006661;GO:0046856;GO:0048008;GO:0010666;GO:0008284;GO:0051091;GO:0070374;GO:2000463;GO:0010628;GO:0045666;GO:1903984;GO:1904668;GO:2000060;GO:0097107;GO:0060134;GO:0097105;GO:0060736;GO:0006470;GO:0016579;GO:0043491;GO:0050821;GO:0002902;GO:0032535;GO:0033032;GO:0010975;GO:0051896;GO:0031647;GO:0032228;GO:0060260;GO:0014823;GO:0046685;GO:0033198;GO:0042493;GO:0032355;GO:0009749;GO:0007584;GO:0010043;GO:0060024;GO:0035176;GO:0007416;GO:0060074;, C:apical plasma membrane; C:cell projection; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:dendritic spine; C:extracellular region; C:mitochondrion; C:myelin sheath adaxonal region; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic cytosol; C:postsynaptic membrane; C:Schmidt-Lanterman incisure;, F:anaphase-promoting complex binding; F:enzyme binding; F:identical protein binding; F:inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity; F:ionotropic glutamate receptor binding; F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphoprotein phosphatase activity; F:platelet-derived growth factor receptor binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:ubiquitin-specific protease binding;, P:adult behavior; P:aging; P:angiogenesis; P:apoptotic process; P:brain morphogenesis; P:canonical Wnt signaling pathway; P:cardiac muscle tissue development; P:cell migration; P:cell motility; P:cellular response to electrical stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to nerve growth factor stimulus; P:central nervous system development; P:central nervous system myelin maintenance; P:central nervous system neuron axonogenesis; P:dendritic spine morphogenesis; P:dentate gyrus development; P:dephosphorylation; P:endothelial cell migration; P:forebrain morphogenesis; P:heart development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning or memory; P:locomotor rhythm; P:locomotory behavior; P:long-term synaptic depression; P:long-term synaptic potentiation; P:male mating behavior; P:maternal behavior; P:memory; P:multicellular organismal response to stress; P:negative regulation of apoptotic process; P:negative regulation of axon regeneration; P:negative regulation of axonogenesis; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell aging; P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell size; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of focal adhesion assembly; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of keratinocyte migration; P:negative regulation of myelination; P:negative regulation of neuron projection development; P:negative regulation of organ growth; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of phagocytosis; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of ribosome biogenesis; P:negative regulation of signaling receptor activity; P:negative regulation of synaptic vesicle clustering; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of wound healing, spreading of epidermal cells; P:neuron-neuron synaptic transmission; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:positive regulation of ubiquitin protein ligase activity; P:positive regulation of ubiquitin-dependent protein catabolic process; P:postsynaptic density assembly; P:prepulse inhibition; P:presynaptic membrane assembly; P:prostate gland growth; P:protein dephosphorylation; P:protein deubiquitination; P:protein kinase B signaling; P:protein stabilization; P:regulation of B cell apoptotic process; P:regulation of cellular component size; P:regulation of myeloid cell apoptotic process; P:regulation of neuron projection development; P:regulation of protein kinase B signaling; P:regulation of protein stability; P:regulation of synaptic transmission, GABAergic; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to activity; P:response to arsenic-containing substance; P:response to ATP; P:response to drug; P:response to estradiol; P:response to glucose; P:response to nutrient; P:response to zinc ion; P:rhythmic synaptic transmission; P:social behavior; P:synapse assembly; P:synapse maturation;|P60484 B2R904 F2YHV0 O00633 O02679 Q6ICT7,Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN,Mutated in multiple advanced cancers 1;Phosphatase and tensin homolog;, PF10409;, GO:0016324;GO:0042995;GO:0005737;GO:0009898;GO:0005829;GO:0043197;GO:0005576;GO:0005739;GO:0035749;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0099524;GO:0045211;GO:0043220;GO:0010997;GO:0019899;GO:0042802;GO:0051717;GO:0035255;GO:0008289;GO:0030165;GO:0016314;GO:0051800;GO:0004438;GO:0004721;GO:0005161;GO:0106306;GO:0004722;GO:0106307;GO:1990782;GO:0004725;GO:1990381;GO:0030534;GO:0007568;GO:0001525;GO:0006915;GO:0048854;GO:0060070;GO:0048738;GO:0016477;GO:0048870;GO:0071257;GO:0071361;GO:0071456;GO:0032869;GO:1990314;GO:0044320;GO:1990090;GO:0007417;GO:0032286;GO:0021955;GO:0060997;GO:0021542;GO:0016311;GO:0043542;GO:0048853;GO:0007507;GO:0046855;GO:0043647;GO:0007611;GO:0045475;GO:0007626;GO:0060292;GO:0060291;GO:0060179;GO:0042711;GO:0007613;GO:0033555;GO:0043066;GO:0048681;GO:0050771;GO:0060044;GO:0090344;GO:1902807;GO:0030336;GO:0008285;GO:0045792;GO:0045736;GO:0061002;GO:0050680;GO:0010719;GO:0070373;GO:0090394;GO:0051895;GO:2000134;GO:0051548;GO:0031642;GO:0010977;GO:0046621;GO:0033137;GO:0050765;GO:0014067;GO:1901017;GO:0051898;GO:0001933;GO:0090071;GO:2000272;GO:2000808;GO:1904706;GO:1903690;GO:0007270;GO:0014065;GO:0006661;GO:0046856;GO:0048008;GO:0010666;GO:0008284;GO:0051091;GO:0070374;GO:2000463;GO:0010628;GO:0045666;GO:1903984;GO:1904668;GO:2000060;GO:0097107;GO:0060134;GO:0097105;GO:0060736;GO:0006470;GO:0016579;GO:0043491;GO:0050821;GO:0002902;GO:0032535;GO:0033032;GO:0010975;GO:0051896;GO:0031647;GO:0032228;GO:0060260;GO:0014823;GO:0046685;GO:0033198;GO:0042493;GO:0032355;GO:0009749;GO:0007584;GO:0010043;GO:0060024;GO:0035176;GO:0007416;GO:0060074;, C:apical plasma membrane; C:cell projection; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:dendritic spine; C:extracellular region; C:mitochondrion; C:myelin sheath adaxonal region; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic cytosol; C:postsynaptic membrane; C:Schmidt-Lanterman incisure;, F:anaphase-promoting complex binding; F:enzyme binding; F:identical protein binding; F:inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity; F:ionotropic glutamate receptor binding; F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphoprotein phosphatase activity; F:platelet-derived growth factor receptor binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:ubiquitin-specific protease binding;, P:adult behavior; P:aging; P:angiogenesis; P:apoptotic process; P:brain morphogenesis; P:canonical Wnt signaling pathway; P:cardiac muscle tissue development; P:cell migration; P:cell motility; P:cellular response to electrical stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to nerve growth factor stimulus; P:central nervous system development; P:central nervous system myelin maintenance; P:central nervous system neuron axonogenesis; P:dendritic spine morphogenesis; P:dentate gyrus development; P:dephosphorylation; P:endothelial cell migration; P:forebrain morphogenesis; P:heart development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning or memory; P:locomotor rhythm; P:locomotory behavior; P:long-term synaptic depression; P:long-term synaptic potentiation; P:male mating behavior; P:maternal behavior; P:memory; P:multicellular organismal response to stress; P:negative regulation of apoptotic process; P:negative regulation of axon regeneration; P:negative regulation of axonogenesis; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell aging; P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell size; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of focal adhesion assembly; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of keratinocyte migration; P:negative regulation of myelination; P:negative regulation of neuron projection development; P:negative regulation of organ growth; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of phagocytosis; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of ribosome biogenesis; P:negative regulation of signaling receptor activity; P:negative regulation of synaptic vesicle clustering; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of wound healing, spreading of epidermal cells; P:neuron-neuron synaptic transmission; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:positive regulation of ubiquitin protein ligase activity; P:positive regulation of ubiquitin-dependent protein catabolic process; P:postsynaptic density assembly; P:prepulse inhibition; P:presynaptic membrane assembly; P:prostate gland growth; P:protein dephosphorylation; P:protein deubiquitination; P:protein kinase B signaling; P:protein stabilization; P:regulation of B cell apoptotic process; P:regulation of cellular component size; P:regulation of myeloid cell apoptotic process; P:regulation of neuron projection development; P:regulation of protein kinase B signaling; P:regulation of protein stability; P:regulation of synaptic transmission, GABAergic; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to activity; P:response to arsenic-containing substance; P:response to ATP; P:response to drug; P:response to estradiol; P:response to glucose; P:response to nutrient; P:response to zinc ion; P:rhythmic synaptic transmission; P:social behavior; P:synapse assembly; P:synapse maturation;|P60484 B2R904 F2YHV0 O00633 O02679 Q6ICT7,Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN,Mutated in multiple advanced cancers 1;Phosphatase and tensin homolog;, PF10409;, GO:0016324;GO:0042995;GO:0005737;GO:0009898;GO:0005829;GO:0043197;GO:0005576;GO:0005739;GO:0035749;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0099524;GO:0045211;GO:0043220;GO:0010997;GO:0019899;GO:0042802;GO:0051717;GO:0035255;GO:0008289;GO:0030165;GO:0016314;GO:0051800;GO:0004438;GO:0004721;GO:0005161;GO:0106306;GO:0004722;GO:0106307;GO:1990782;GO:0004725;GO:1990381;GO:0030534;GO:0007568;GO:0001525;GO:0006915;GO:0048854;GO:0060070;GO:0048738;GO:0016477;GO:0048870;GO:0071257;GO:0071361;GO:0071456;GO:0032869;GO:1990314;GO:0044320;GO:1990090;GO:0007417;GO:0032286;GO:0021955;GO:0060997;GO:0021542;GO:0016311;GO:0043542;GO:0048853;GO:0007507;GO:0046855;GO:0043647;GO:0007611;GO:0045475;GO:0007626;GO:0060292;GO:0060291;GO:0060179;GO:0042711;GO:0007613;GO:0033555;GO:0043066;GO:0048681;GO:0050771;GO:0060044;GO:0090344;GO:1902807;GO:0030336;GO:0008285;GO:0045792;GO:0045736;GO:0061002;GO:0050680;GO:0010719;GO:0070373;GO:0090394;GO:0051895;GO:2000134;GO:0051548;GO:0031642;GO:0010977;GO:0046621;GO:0033137;GO:0050765;GO:0014067;GO:1901017;GO:0051898;GO:0001933;GO:0090071;GO:2000272;GO:2000808;GO:1904706;GO:1903690;GO:0007270;GO:0014065;GO:0006661;GO:0046856;GO:0048008;GO:0010666;GO:0008284;GO:0051091;GO:0070374;GO:2000463;GO:0010628;GO:0045666;GO:1903984;GO:1904668;GO:2000060;GO:0097107;GO:0060134;GO:0097105;GO:0060736;GO:0006470;GO:0016579;GO:0043491;GO:0050821;GO:0002902;GO:0032535;GO:0033032;GO:0010975;GO:0051896;GO:0031647;GO:0032228;GO:0060260;GO:0014823;GO:0046685;GO:0033198;GO:0042493;GO:0032355;GO:0009749;GO:0007584;GO:0010043;GO:0060024;GO:0035176;GO:0007416;GO:0060074;, C:apical plasma membrane; C:cell projection; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:dendritic spine; C:extracellular region; C:mitochondrion; C:myelin sheath adaxonal region; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic cytosol; C:postsynaptic membrane; C:Schmidt-Lanterman incisure;, F:anaphase-promoting complex binding; F:enzyme binding; F:identical protein binding; F:inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity; F:ionotropic glutamate receptor binding; F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphoprotein phosphatase activity; F:platelet-derived growth factor receptor binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:ubiquitin-specific protease binding;, P:adult behavior; P:aging; P:angiogenesis; P:apoptotic process; P:brain morphogenesis; P:canonical Wnt signaling pathway; P:cardiac muscle tissue development; P:cell migration; P:cell motility; P:cellular response to electrical stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to nerve growth factor stimulus; P:central nervous system development; P:central nervous system myelin maintenance; P:central nervous system neuron axonogenesis; P:dendritic spine morphogenesis; P:dentate gyrus development; P:dephosphorylation; P:endothelial cell migration; P:forebrain morphogenesis; P:heart development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning or memory; P:locomotor rhythm; P:locomotory behavior; P:long-term synaptic depression; P:long-term synaptic potentiation; P:male mating behavior; P:maternal behavior; P:memory; P:multicellular organismal response to stress; P:negative regulation of apoptotic process; P:negative regulation of axon regeneration; P:negative regulation of axonogenesis; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell aging; P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell size; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of focal adhesion assembly; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of keratinocyte migration; P:negative regulation of myelination; P:negative regulation of neuron projection development; P:negative regulation of organ growth; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of phagocytosis; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of ribosome biogenesis; P:negative regulation of signaling receptor activity; P:negative regulation of synaptic vesicle clustering; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of wound healing, spreading of epidermal cells; P:neuron-neuron synaptic transmission; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:positive regulation of ubiquitin protein ligase activity; P:positive regulation of ubiquitin-dependent protein catabolic process; P:postsynaptic density assembly; P:prepulse inhibition; P:presynaptic membrane assembly; P:prostate gland growth; P:protein dephosphorylation; P:protein deubiquitination; P:protein kinase B signaling; P:protein stabilization; P:regulation of B cell apoptotic process; P:regulation of cellular component size; P:regulation of myeloid cell apoptotic process; P:regulation of neuron projection development; P:regulation of protein kinase B signaling; P:regulation of protein stability; P:regulation of synaptic transmission, GABAergic; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to activity; P:response to arsenic-containing substance; P:response to ATP; P:response to drug; P:response to estradiol; P:response to glucose; P:response to nutrient; P:response to zinc ion; P:rhythmic synaptic transmission; P:social behavior; P:synapse assembly; P:synapse maturation;|P60484 B2R904 F2YHV0 O00633 O02679 Q6ICT7,Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN,Mutated in multiple advanced cancers 1;Phosphatase and tensin homolog;, PF10409;, GO:0016324;GO:0042995;GO:0005737;GO:0009898;GO:0005829;GO:0043197;GO:0005576;GO:0005739;GO:0035749;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0099524;GO:0045211;GO:0043220;GO:0010997;GO:0019899;GO:0042802;GO:0051717;GO:0035255;GO:0008289;GO:0030165;GO:0016314;GO:0051800;GO:0004438;GO:0004721;GO:0005161;GO:0106306;GO:0004722;GO:0106307;GO:1990782;GO:0004725;GO:1990381;GO:0030534;GO:0007568;GO:0001525;GO:0006915;GO:0048854;GO:0060070;GO:0048738;GO:0016477;GO:0048870;GO:0071257;GO:0071361;GO:0071456;GO:0032869;GO:1990314;GO:0044320;GO:1990090;GO:0007417;GO:0032286;GO:0021955;GO:0060997;GO:0021542;GO:0016311;GO:0043542;GO:0048853;GO:0007507;GO:0046855;GO:0043647;GO:0007611;GO:0045475;GO:0007626;GO:0060292;GO:0060291;GO:0060179;GO:0042711;GO:0007613;GO:0033555;GO:0043066;GO:0048681;GO:0050771;GO:0060044;GO:0090344;GO:1902807;GO:0030336;GO:0008285;GO:0045792;GO:0045736;GO:0061002;GO:0050680;GO:0010719;GO:0070373;GO:0090394;GO:0051895;GO:2000134;GO:0051548;GO:0031642;GO:0010977;GO:0046621;GO:0033137;GO:0050765;GO:0014067;GO:1901017;GO:0051898;GO:0001933;GO:0090071;GO:2000272;GO:2000808;GO:1904706;GO:1903690;GO:0007270;GO:0014065;GO:0006661;GO:0046856;GO:0048008;GO:0010666;GO:0008284;GO:0051091;GO:0070374;GO:2000463;GO:0010628;GO:0045666;GO:1903984;GO:1904668;GO:2000060;GO:0097107;GO:0060134;GO:0097105;GO:0060736;GO:0006470;GO:0016579;GO:0043491;GO:0050821;GO:0002902;GO:0032535;GO:0033032;GO:0010975;GO:0051896;GO:0031647;GO:0032228;GO:0060260;GO:0014823;GO:0046685;GO:0033198;GO:0042493;GO:0032355;GO:0009749;GO:0007584;GO:0010043;GO:0060024;GO:0035176;GO:0007416;GO:0060074;, C:apical plasma membrane; C:cell projection; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:dendritic spine; C:extracellular region; C:mitochondrion; C:myelin sheath adaxonal region; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic cytosol; C:postsynaptic membrane; C:Schmidt-Lanterman incisure;, F:anaphase-promoting complex binding; F:enzyme binding; F:identical protein binding; F:inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity; F:ionotropic glutamate receptor binding; F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphoprotein phosphatase activity; F:platelet-derived growth factor receptor binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:ubiquitin-specific protease binding;, P:adult behavior; P:aging; P:angiogenesis; P:apoptotic process; P:brain morphogenesis; P:canonical Wnt signaling pathway; P:cardiac muscle tissue development; P:cell migration; P:cell motility; P:cellular response to electrical stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to nerve growth factor stimulus; P:central nervous system development; P:central nervous system myelin maintenance; P:central nervous system neuron axonogenesis; P:dendritic spine morphogenesis; P:dentate gyrus development; P:dephosphorylation; P:endothelial cell migration; P:forebrain morphogenesis; P:heart development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning or memory; P:locomotor rhythm; P:locomotory behavior; P:long-term synaptic depression; P:long-term synaptic potentiation; P:male mating behavior; P:maternal behavior; P:memory; P:multicellular organismal response to stress; P:negative regulation of apoptotic process; P:negative regulation of axon regeneration; P:negative regulation of axonogenesis; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell aging; P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell size; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of focal adhesion assembly; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of keratinocyte migration; P:negative regulation of myelination; P:negative regulation of neuron projection development; P:negative regulation of organ growth; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of phagocytosis; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of ribosome biogenesis; P:negative regulation of signaling receptor activity; P:negative regulation of synaptic vesicle clustering; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of wound healing, spreading of epidermal cells; P:neuron-neuron synaptic transmission; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:positive regulation of ubiquitin protein ligase activity; P:positive regulation of ubiquitin-dependent protein catabolic process; P:postsynaptic density assembly; P:prepulse inhibition; P:presynaptic membrane assembly; P:prostate gland growth; P:protein dephosphorylation; P:protein deubiquitination; P:protein kinase B signaling; P:protein stabilization; P:regulation of B cell apoptotic process; P:regulation of cellular component size; P:regulation of myeloid cell apoptotic process; P:regulation of neuron projection development; P:regulation of protein kinase B signaling; P:regulation of protein stability; P:regulation of synaptic transmission, GABAergic; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to activity; P:response to arsenic-containing substance; P:response to ATP; P:response to drug; P:response to estradiol; P:response to glucose; P:response to nutrient; P:response to zinc ion; P:rhythmic synaptic transmission; P:social behavior; P:synapse assembly; P:synapse maturation; scaffold14 indexed_genome mRNA 40657652 40923253 . - . ID=transcript_3752;Q5VYX0 Q9BS33 Q9NUP8,Renalase {ECO:0000303|PubMed:15841207},Monoamine oxidase-C;, PF01593;, GO:0005576;GO:0005615;GO:0051379;GO:0097621;GO:0070404;GO:0016651;GO:0034356;GO:0045776;GO:0010459;GO:0071871;GO:0002931;GO:1902074;, C:extracellular region; C:extracellular space;, F:epinephrine binding; F:monoamine oxidase activity; F:NADH binding; F:oxidoreductase activity, acting on NAD(P)H;, P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of blood pressure; P:negative regulation of heart rate; P:response to epinephrine; P:response to ischemia; P:response to salt; scaffold14 indexed_genome mRNA 41272933 41296074 . - . ID=transcript_3753;Q5VYY1 B2R9Y7 Q8WU06,Ankyrin repeat domain-containing protein 22,, PF12796; scaffold14 indexed_genome mRNA 41322179 41372565 . + . ID=transcript_3754;Q96FJ0 B3KPA7 Q5T9N4 Q5T9N9 Q7Z420 Q9P2H4,AMSH-like protease,STAM-binding protein-like 1;, PF01398;PF08969;, GO:0005829;GO:0005768;GO:0016020;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0004843;GO:0016579;GO:0070536;, C:cytosol; C:endosome; C:membrane;, F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:protein K63-linked deubiquitination;|Q96FJ0 B3KPA7 Q5T9N4 Q5T9N9 Q7Z420 Q9P2H4,AMSH-like protease,STAM-binding protein-like 1;, PF01398;PF08969;, GO:0005829;GO:0005768;GO:0016020;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0004843;GO:0016579;GO:0070536;, C:cytosol; C:endosome; C:membrane;, F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:protein K63-linked deubiquitination;|Q96FJ0 B3KPA7 Q5T9N4 Q5T9N9 Q7Z420 Q9P2H4,AMSH-like protease,STAM-binding protein-like 1;, PF01398;PF08969;, GO:0005829;GO:0005768;GO:0016020;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0004843;GO:0016579;GO:0070536;, C:cytosol; C:endosome; C:membrane;, F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:protein K63-linked deubiquitination;|Q96FJ0 B3KPA7 Q5T9N4 Q5T9N9 Q7Z420 Q9P2H4,AMSH-like protease,STAM-binding protein-like 1;, PF01398;PF08969;, GO:0005829;GO:0005768;GO:0016020;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0004843;GO:0016579;GO:0070536;, C:cytosol; C:endosome; C:membrane;, F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:protein K63-linked deubiquitination;|Q96FJ0 B3KPA7 Q5T9N4 Q5T9N9 Q7Z420 Q9P2H4,AMSH-like protease,STAM-binding protein-like 1;, PF01398;PF08969;, GO:0005829;GO:0005768;GO:0016020;GO:0070122;GO:0061578;GO:0046872;GO:0008237;GO:0004843;GO:0016579;GO:0070536;, C:cytosol; C:endosome; C:membrane;, F:isopeptidase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:protein K63-linked deubiquitination; scaffold14 indexed_genome mRNA 41382714 41393507 . - . ID=transcript_3755;P62736 B2R8A4 P03996 P04108 Q6FI19,Actin, aortic smooth muscle,Alpha-actin-2;Cell growth-inhibiting gene 46 protein;, PF00022;, GO:0044297;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0030027;GO:0032991;GO:0030485;GO:0005524;GO:0019901;GO:0072144;GO:0090131;GO:0006936;GO:0010628;GO:0045893;GO:0008217;GO:0009615;GO:0014829;, C:cell body; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:lamellipodium; C:protein-containing complex; C:smooth muscle contractile fiber;, F:ATP binding; F:protein kinase binding;, P:glomerular mesangial cell development; P:mesenchyme migration; P:muscle contraction; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:regulation of blood pressure; P:response to virus; P:vascular associated smooth muscle contraction;|P68032 P04270,Actin, alpha cardiac muscle 1,Alpha-cardiac actin;, PF00022;, GO:0005884;GO:0072562;GO:0044297;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0031674;GO:0030027;GO:0016020;GO:0030017;GO:0005524;GO:0016887;GO:0017022;GO:0007015;GO:0030048;GO:0033275;GO:0031032;GO:0060048;GO:0055008;GO:0055003;GO:0060047;GO:0090131;GO:0030049;GO:0010628;GO:0042493;GO:0045471;GO:0030240;, C:actin filament; C:blood microparticle; C:cell body; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:I band; C:lamellipodium; C:membrane; C:sarcomere;, F:ATP binding; F:ATPase activity; F:myosin binding;, P:actin filament organization; P:actin filament-based movement; P:actin-myosin filament sliding; P:actomyosin structure organization; P:cardiac muscle contraction; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:heart contraction; P:mesenchyme migration; P:muscle filament sliding; P:positive regulation of gene expression; P:response to drug; P:response to ethanol; P:skeletal muscle thin filament assembly;|P68032 P04270,Actin, alpha cardiac muscle 1,Alpha-cardiac actin;, PF00022;, GO:0005884;GO:0072562;GO:0044297;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0031674;GO:0030027;GO:0016020;GO:0030017;GO:0005524;GO:0016887;GO:0017022;GO:0007015;GO:0030048;GO:0033275;GO:0031032;GO:0060048;GO:0055008;GO:0055003;GO:0060047;GO:0090131;GO:0030049;GO:0010628;GO:0042493;GO:0045471;GO:0030240;, C:actin filament; C:blood microparticle; C:cell body; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:I band; C:lamellipodium; C:membrane; C:sarcomere;, F:ATP binding; F:ATPase activity; F:myosin binding;, P:actin filament organization; P:actin filament-based movement; P:actin-myosin filament sliding; P:actomyosin structure organization; P:cardiac muscle contraction; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:heart contraction; P:mesenchyme migration; P:muscle filament sliding; P:positive regulation of gene expression; P:response to drug; P:response to ethanol; P:skeletal muscle thin filament assembly; scaffold14 indexed_genome mRNA 41394332 41400040 . - . ID=transcript_3756;P62736 B2R8A4 P03996 P04108 Q6FI19,Actin, aortic smooth muscle,Alpha-actin-2;Cell growth-inhibiting gene 46 protein;, PF00022;, GO:0044297;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0030027;GO:0032991;GO:0030485;GO:0005524;GO:0019901;GO:0072144;GO:0090131;GO:0006936;GO:0010628;GO:0045893;GO:0008217;GO:0009615;GO:0014829;, C:cell body; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:lamellipodium; C:protein-containing complex; C:smooth muscle contractile fiber;, F:ATP binding; F:protein kinase binding;, P:glomerular mesangial cell development; P:mesenchyme migration; P:muscle contraction; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:regulation of blood pressure; P:response to virus; P:vascular associated smooth muscle contraction; scaffold14 indexed_genome mRNA 41438779 41470138 . + . ID=transcript_3757;Q5T9P2 Q5T9P3 Q6SSE9,Tumor necrosis factor receptor superfamily member 6,Apo-1 antigen;Apoptosis-mediating surface antigen FAS;FASLG receptor;, PF00531;PF00020;, GO:0031265;GO:0009986;GO:0005829;GO:0031264;GO:0009897;GO:0070062;GO:0016021;GO:0045121;GO:0016604;GO:0005886;GO:0005516;GO:0042802;GO:0019900;GO:0038023;GO:0005031;GO:0006919;GO:0006924;GO:0006915;GO:0097190;GO:0034198;GO:0071455;GO:0071260;GO:0097191;GO:0097192;GO:0036337;GO:0006955;GO:0097049;GO:0097527;GO:0043066;GO:1902042;GO:0043065;GO:2001235;GO:2001269;GO:0001934;GO:0065003;GO:0042981;GO:1902041;GO:0032872;GO:0007165;, C:CD95 death-inducing signaling complex; C:cell surface; C:cytosol; C:death-inducing signaling complex; C:external side of plasma membrane; C:extracellular exosome; C:integral component of membrane; C:membrane raft; C:nuclear body; C:plasma membrane;, F:calmodulin binding; F:identical protein binding; F:kinase binding; F:signaling receptor activity; F:tumor necrosis factor-activated receptor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation-induced cell death of T cells; P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to amino acid starvation; P:cellular response to hyperoxia; P:cellular response to mechanical stimulus; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:Fas signaling pathway; P:immune response; P:motor neuron apoptotic process; P:necroptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of protein phosphorylation; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of stress-activated MAPK cascade; P:signal transduction; scaffold14 indexed_genome mRNA 41664158 41666049 . - . ID=transcript_3758;O95992 B2RBY3,Cholesterol 25-hydroxylase,Cholesterol 25-monooxygenase;, PF04116;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0000254;GO:0001567;GO:0005506;GO:0016491;GO:0008395;GO:0035754;GO:0006699;GO:0008203;GO:0006629;GO:0016126;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:C-4 methylsterol oxidase activity; F:cholesterol 25-hydroxylase activity; F:iron ion binding; F:oxidoreductase activity; F:steroid hydroxylase activity;, P:B cell chemotaxis; P:bile acid biosynthetic process; P:cholesterol metabolic process; P:lipid metabolic process; P:sterol biosynthetic process; scaffold14 indexed_genome mRNA 41673366 41712000 . - . ID=transcript_3759;P38571 B2RBH5 D3DR29 Q16529 Q53H21 Q5T074 Q5T771 Q96EJ0,Lysosomal acid lipase/cholesteryl ester hydrolase,Cholesteryl esterase;Lipase A;Sterol esterase;, PF00561;, GO:0005829;GO:0001650;GO:0043231;GO:0043202;GO:0005764;GO:0005654;GO:0016298;GO:0004771;GO:0000902;GO:0008283;GO:0048873;GO:0006954;GO:0016042;GO:0034383;GO:0030324;GO:0016125;GO:0048771;, C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:nucleoplasm;, F:lipase activity; F:sterol esterase activity;, P:cell morphogenesis; P:cell population proliferation; P:homeostasis of number of cells within a tissue; P:inflammatory response; P:lipid catabolic process; P:low-density lipoprotein particle clearance; P:lung development; P:sterol metabolic process; P:tissue remodeling;|P38571 B2RBH5 D3DR29 Q16529 Q53H21 Q5T074 Q5T771 Q96EJ0,Lysosomal acid lipase/cholesteryl ester hydrolase,Cholesteryl esterase;Lipase A;Sterol esterase;, PF00561;, GO:0005829;GO:0001650;GO:0043231;GO:0043202;GO:0005764;GO:0005654;GO:0016298;GO:0004771;GO:0000902;GO:0008283;GO:0048873;GO:0006954;GO:0016042;GO:0034383;GO:0030324;GO:0016125;GO:0048771;, C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:nucleoplasm;, F:lipase activity; F:sterol esterase activity;, P:cell morphogenesis; P:cell population proliferation; P:homeostasis of number of cells within a tissue; P:inflammatory response; P:lipid catabolic process; P:low-density lipoprotein particle clearance; P:lung development; P:sterol metabolic process; P:tissue remodeling;|P38571 B2RBH5 D3DR29 Q16529 Q53H21 Q5T074 Q5T771 Q96EJ0,Lysosomal acid lipase/cholesteryl ester hydrolase,Cholesteryl esterase;Lipase A;Sterol esterase;, PF00561;, GO:0005829;GO:0001650;GO:0043231;GO:0043202;GO:0005764;GO:0005654;GO:0016298;GO:0004771;GO:0000902;GO:0008283;GO:0048873;GO:0006954;GO:0016042;GO:0034383;GO:0030324;GO:0016125;GO:0048771;, C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:nucleoplasm;, F:lipase activity; F:sterol esterase activity;, P:cell morphogenesis; P:cell population proliferation; P:homeostasis of number of cells within a tissue; P:inflammatory response; P:lipid catabolic process; P:low-density lipoprotein particle clearance; P:lung development; P:sterol metabolic process; P:tissue remodeling; scaffold14 indexed_genome mRNA 41749223 41750767 . + . ID=transcript_3760;P09913 Q5T767,Interferon-induced protein with tetratricopeptide repeats 2,ISG-54 K;Interferon-induced 54 kDa protein;, PF13181;, GO:0005737;GO:0005829;GO:0005783;GO:0003723;GO:0008637;GO:0035457;GO:0051607;GO:0032091;GO:0043065;GO:0009615;GO:0060337;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum;, F:RNA binding;, P:apoptotic mitochondrial changes; P:cellular response to interferon-alpha; P:defense response to virus; P:negative regulation of protein binding; P:positive regulation of apoptotic process; P:response to virus; P:type I interferon signaling pathway; scaffold14 indexed_genome mRNA 41791117 41801890 . + . ID=transcript_3761;P09914 B3KS50 D3DR31 Q5T7J1 Q96QM5,Interferon-induced protein with tetratricopeptide repeats 1,Interferon-induced 56 kDa protein;, PF13181;, GO:0005737;GO:0005829;GO:0043657;GO:0003723;GO:0071360;GO:0071357;GO:0051607;GO:0019060;GO:0051097;GO:0032091;GO:0045071;GO:0045070;GO:0050688;GO:0009615;GO:0060337;GO:0016032;, C:cytoplasm; C:cytosol; C:host cell;, F:RNA binding;, P:cellular response to exogenous dsRNA; P:cellular response to type I interferon; P:defense response to virus; P:intracellular transport of viral protein in host cell; P:negative regulation of helicase activity; P:negative regulation of protein binding; P:negative regulation of viral genome replication; P:positive regulation of viral genome replication; P:regulation of defense response to virus; P:response to virus; P:type I interferon signaling pathway; P:viral process; scaffold14 indexed_genome mRNA 41808400 41819539 . + . ID=transcript_3762;Q13325 B2R5X9 B4DDV1 Q5T7I9 Q6IAX3,Interferon-induced protein with tetratricopeptide repeats 5,Interferon-induced 58 kDa protein;Retinoic acid- and interferon-inducible 58 kDa protein;, PF07719;PF13181;, GO:0015629;GO:0045177;GO:0005829;GO:0005886;GO:0032587;GO:0003690;GO:0008266;GO:0003723;GO:0000339;GO:0003727;GO:0000049;GO:0051607;GO:0045071;GO:0043123;GO:0060337;, C:actin cytoskeleton; C:apical part of cell; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:double-stranded DNA binding; F:poly(U) RNA binding; F:RNA binding; F:RNA cap binding; F:single-stranded RNA binding; F:tRNA binding;, P:defense response to virus; P:negative regulation of viral genome replication; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:type I interferon signaling pathway; scaffold14 indexed_genome mRNA 41830863 41936318 . - . ID=transcript_3763;Q6ZSM3 E9PSF9 Q5M9M9 Q5T7J2 Q6ZV76,Monocarboxylate transporter 12 {ECO:0000305},Creatine transporter 2 {ECO:0000303|PubMed:23578822};Solute carrier family 16 member 12 {ECO:0000312|HGNC:HGNC:23094};, PF07690;, GO:0016323;GO:0016021;GO:0005887;GO:0005886;GO:0005308;GO:0008028;GO:0015293;GO:0015881;GO:0015718;GO:0150104;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:creatine transmembrane transporter activity; F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:creatine transmembrane transport; P:monocarboxylic acid transport; P:transport across blood-brain barrier; scaffold14 indexed_genome mRNA 41968053 42020987 . - . ID=transcript_3764;Q8TE04 A6NIP0 Q7RTX6 Q7Z495 Q8TBQ8,Pantothenate kinase 1,Pantothenic acid kinase 1;, PF03630;, GO:0030118;GO:0005829;GO:0005634;GO:0055037;GO:1905502;GO:0005524;GO:0004594;GO:0042803;GO:0015937;, C:clathrin coat; C:cytosol; C:nucleus; C:recycling endosome;, F:acetyl-CoA binding; F:ATP binding; F:pantothenate kinase activity; F:protein homodimerization activity;, P:coenzyme A biosynthetic process;|Q8TE04 A6NIP0 Q7RTX6 Q7Z495 Q8TBQ8,Pantothenate kinase 1,Pantothenic acid kinase 1;, PF03630;, GO:0030118;GO:0005829;GO:0005634;GO:0055037;GO:1905502;GO:0005524;GO:0004594;GO:0042803;GO:0015937;, C:clathrin coat; C:cytosol; C:nucleus; C:recycling endosome;, F:acetyl-CoA binding; F:ATP binding; F:pantothenate kinase activity; F:protein homodimerization activity;, P:coenzyme A biosynthetic process;|Q8TE04 A6NIP0 Q7RTX6 Q7Z495 Q8TBQ8,Pantothenate kinase 1,Pantothenic acid kinase 1;, PF03630;, GO:0030118;GO:0005829;GO:0005634;GO:0055037;GO:1905502;GO:0005524;GO:0004594;GO:0042803;GO:0015937;, C:clathrin coat; C:cytosol; C:nucleus; C:recycling endosome;, F:acetyl-CoA binding; F:ATP binding; F:pantothenate kinase activity; F:protein homodimerization activity;, P:coenzyme A biosynthetic process; scaffold14 indexed_genome mRNA 42076784 42149456 . + . ID=transcript_3765;Q9H6Q9 Q9H755 Q9NTC1 Q9UFR5,Kinesin-like protein KIF20B {ECO:0000305},Cancer/testis antigen 90;Kinesin family member 20B {ECO:0000312|HGNC:HGNC:7212};Kinesin-related motor interacting with PIN1 {ECO:0000303|PubMed:11470801};M-phase phosphoprotein 1 {ECO:0000303|PubMed:12740395};, PF00225;, GO:0005813;GO:0070938;GO:0005737;GO:0005829;GO:0030426;GO:0045171;GO:0005871;GO:0005874;GO:0030496;GO:1990023;GO:0097431;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0051233;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0042803;GO:0050699;GO:0007050;GO:0051301;GO:0007018;GO:0001843;GO:0048812;GO:0008284;GO:0032467;GO:0090316;GO:1903438;GO:2001224;GO:0035372;GO:2000114;GO:0007088;, C:centrosome; C:contractile ring; C:cytoplasm; C:cytosol; C:growth cone; C:intercellular bridge; C:kinesin complex; C:microtubule; C:midbody; C:mitotic spindle midzone; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein homodimerization activity; F:WW domain binding;, P:cell cycle arrest; P:cell division; P:microtubule-based movement; P:neural tube closure; P:neuron projection morphogenesis; P:positive regulation of cell population proliferation; P:positive regulation of cytokinesis; P:positive regulation of intracellular protein transport; P:positive regulation of mitotic cytokinetic process; P:positive regulation of neuron migration; P:protein localization to microtubule; P:regulation of establishment of cell polarity; P:regulation of mitotic nuclear division; scaffold14 indexed_genome mRNA 43012309 43012827 . - . ID=transcript_3766;P34969 B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03,5-hydroxytryptamine receptor 7,5-HT-X;Serotonin receptor 7;, PF00001;, GO:0030425;GO:0005887;GO:0005886;GO:0045202;GO:0032588;GO:0004993;GO:0030594;GO:0008015;GO:0007268;GO:0007623;GO:0007186;GO:0007187;GO:0002862;GO:0006939;GO:0042310;, C:dendrite; C:integral component of plasma membrane; C:plasma membrane; C:synapse; C:trans-Golgi network membrane;, F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity;, P:blood circulation; P:chemical synaptic transmission; P:circadian rhythm; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:negative regulation of inflammatory response to antigenic stimulus; P:smooth muscle contraction; P:vasoconstriction; scaffold14 indexed_genome mRNA 43108892 43136554 . + . ID=transcript_3767;P78346 B2R799 E9PB02,Ribonuclease P protein subunit p30,RNase P subunit 2;, PF01876;, GO:0030681;GO:0005655;GO:0005654;GO:0005634;GO:0000172;GO:0004526;GO:0033204;GO:0003723;GO:0090502;GO:0006364;GO:0001682;GO:0008033;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleoplasm; C:nucleus; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding; F:RNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:rRNA processing; P:tRNA 5'-leader removal; P:tRNA processing;|P78346 B2R799 E9PB02,Ribonuclease P protein subunit p30,RNase P subunit 2;, PF01876;, GO:0030681;GO:0005655;GO:0005654;GO:0005634;GO:0000172;GO:0004526;GO:0033204;GO:0003723;GO:0090502;GO:0006364;GO:0001682;GO:0008033;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleoplasm; C:nucleus; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding; F:RNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:rRNA processing; P:tRNA 5'-leader removal; P:tRNA processing;|P78346 B2R799 E9PB02,Ribonuclease P protein subunit p30,RNase P subunit 2;, PF01876;, GO:0030681;GO:0005655;GO:0005654;GO:0005634;GO:0000172;GO:0004526;GO:0033204;GO:0003723;GO:0090502;GO:0006364;GO:0001682;GO:0008033;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleoplasm; C:nucleus; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding; F:RNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:rRNA processing; P:tRNA 5'-leader removal; P:tRNA processing;|P78346 B2R799 E9PB02,Ribonuclease P protein subunit p30,RNase P subunit 2;, PF01876;, GO:0030681;GO:0005655;GO:0005654;GO:0005634;GO:0000172;GO:0004526;GO:0033204;GO:0003723;GO:0090502;GO:0006364;GO:0001682;GO:0008033;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleoplasm; C:nucleus; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding; F:RNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:rRNA processing; P:tRNA 5'-leader removal; P:tRNA processing;|P78346 B2R799 E9PB02,Ribonuclease P protein subunit p30,RNase P subunit 2;, PF01876;, GO:0030681;GO:0005655;GO:0005654;GO:0005634;GO:0000172;GO:0004526;GO:0033204;GO:0003723;GO:0090502;GO:0006364;GO:0001682;GO:0008033;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleoplasm; C:nucleus; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding; F:RNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:rRNA processing; P:tRNA 5'-leader removal; P:tRNA processing; scaffold14 indexed_genome mRNA 43150534 43159472 . - . ID=transcript_3768;Q15327 Q96LE7,Ankyrin repeat domain-containing protein 1,Cardiac ankyrin repeat protein;Cytokine-inducible gene C-193 protein;Cytokine-inducible nuclear protein;, PF12796;, GO:0005737;GO:0005829;GO:0001650;GO:0031674;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0042826;GO:0002039;GO:0070412;GO:0001085;GO:0061629;GO:0031432;GO:0003713;GO:0003714;GO:0055008;GO:0035690;GO:0071456;GO:0071347;GO:0071222;GO:0071260;GO:0071407;GO:0071560;GO:0071356;GO:2000279;GO:0000122;GO:0043065;GO:0043517;GO:0010976;GO:0050714;GO:0070528;GO:0019222;GO:0006357;GO:0035994;GO:0045214;GO:0035914;, C:cytoplasm; C:cytosol; C:fibrillar center; C:I band; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:histone deacetylase binding; F:p53 binding; F:R-SMAD binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:titin binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:cardiac muscle tissue morphogenesis; P:cellular response to drug; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to organic cyclic compound; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:negative regulation of DNA biosynthetic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of neuron projection development; P:positive regulation of protein secretion; P:protein kinase C signaling; P:regulation of metabolic process; P:regulation of transcription by RNA polymerase II; P:response to muscle stretch; P:sarcomere organization; P:skeletal muscle cell differentiation;|Q15327 Q96LE7,Ankyrin repeat domain-containing protein 1,Cardiac ankyrin repeat protein;Cytokine-inducible gene C-193 protein;Cytokine-inducible nuclear protein;, PF12796;, GO:0005737;GO:0005829;GO:0001650;GO:0031674;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0042826;GO:0002039;GO:0070412;GO:0001085;GO:0061629;GO:0031432;GO:0003713;GO:0003714;GO:0055008;GO:0035690;GO:0071456;GO:0071347;GO:0071222;GO:0071260;GO:0071407;GO:0071560;GO:0071356;GO:2000279;GO:0000122;GO:0043065;GO:0043517;GO:0010976;GO:0050714;GO:0070528;GO:0019222;GO:0006357;GO:0035994;GO:0045214;GO:0035914;, C:cytoplasm; C:cytosol; C:fibrillar center; C:I band; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:histone deacetylase binding; F:p53 binding; F:R-SMAD binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:titin binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:cardiac muscle tissue morphogenesis; P:cellular response to drug; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to organic cyclic compound; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:negative regulation of DNA biosynthetic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of neuron projection development; P:positive regulation of protein secretion; P:protein kinase C signaling; P:regulation of metabolic process; P:regulation of transcription by RNA polymerase II; P:response to muscle stretch; P:sarcomere organization; P:skeletal muscle cell differentiation; scaffold14 indexed_genome mRNA 43445432 43496554 . + . ID=transcript_3769;Q86SE9 B7Z892 D3DR33 Q6PK47 Q86TD0,Polycomb group RING finger protein 5,RING finger protein 159;, PF16207;, GO:0005813;GO:0005794;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0000805;GO:0046872;GO:0036353;GO:0060819;GO:0045944;GO:0006357;, C:centrosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:X chromosome;, F:metal ion binding;, P:histone H2A-K119 monoubiquitination; P:inactivation of X chromosome by genetic imprinting; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold14 indexed_genome mRNA 43645501 43699182 . + . ID=transcript_3770;Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination;|Q5U5R9 Q5VZ97 Q5VZ98 Q5VZ99 Q8N1X7 Q8TCP5,Probable E3 ubiquitin-protein ligase HECTD2,HECT domain-containing protein 2;HECT-type E3 ubiquitin transferase HECTD2;, PF00632;, GO:0005829;GO:0004842;GO:0000209;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:protein polyubiquitination; scaffold14 indexed_genome mRNA 43797193 43802200 . - . ID=transcript_3771;Q9UQK1 B2R7X0 O95686,Protein phosphatase 1 regulatory subunit 3C,Protein phosphatase 1 regulatory subunit 5;Protein targeting to glycogen;, PF03370;, GO:0005829;GO:0000164;GO:2001069;GO:0008157;GO:0019903;GO:0004722;GO:0005978;GO:0005977;GO:0005979;, C:cytosol; C:protein phosphatase type 1 complex;, F:glycogen binding; F:protein phosphatase 1 binding; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity;, P:glycogen biosynthetic process; P:glycogen metabolic process; P:regulation of glycogen biosynthetic process;|Q9UQK1 B2R7X0 O95686,Protein phosphatase 1 regulatory subunit 3C,Protein phosphatase 1 regulatory subunit 5;Protein targeting to glycogen;, PF03370;, GO:0005829;GO:0000164;GO:2001069;GO:0008157;GO:0019903;GO:0004722;GO:0005978;GO:0005977;GO:0005979;, C:cytosol; C:protein phosphatase type 1 complex;, F:glycogen binding; F:protein phosphatase 1 binding; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity;, P:glycogen biosynthetic process; P:glycogen metabolic process; P:regulation of glycogen biosynthetic process; scaffold14 indexed_genome mRNA 43957005 44000429 . + . ID=transcript_3772;Q9H2K2 B2RBD3 Q9H8F2 Q9HAS4,Poly [ADP-ribose] polymerase tankyrase-2 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 6 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 5B {ECO:0000303|PubMed:20106667};Protein poly-ADP-ribosyltransferase tankyrase-2 {ECO:0000305};TNKS-2;TRF1-interacting ankyrin-related ADP-ribose polymerase 2;Tankyrase II;Tankyrase-2;Tankyrase-like protein;Tankyrase-related protein;, PF00023;PF12796;PF00644;PF07647;, GO:0000781;GO:0005737;GO:0005829;GO:0000139;GO:0005635;GO:0005634;GO:0000242;GO:0048471;GO:0019899;GO:0046872;GO:0003950;GO:1990404;GO:0035264;GO:1904357;GO:0090263;GO:1904355;GO:0032212;GO:0006471;GO:0070213;GO:0070198;GO:0070212;GO:0000209;GO:0040014;GO:0016055;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:Golgi membrane; C:nuclear envelope; C:nucleus; C:pericentriolar material; C:perinuclear region of cytoplasm;, F:enzyme binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:multicellular organism growth; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to chromosome, telomeric region; P:protein poly-ADP-ribosylation; P:protein polyubiquitination; P:regulation of multicellular organism growth; P:Wnt signaling pathway;|Q9H2K2 B2RBD3 Q9H8F2 Q9HAS4,Poly [ADP-ribose] polymerase tankyrase-2 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 6 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 5B {ECO:0000303|PubMed:20106667};Protein poly-ADP-ribosyltransferase tankyrase-2 {ECO:0000305};TNKS-2;TRF1-interacting ankyrin-related ADP-ribose polymerase 2;Tankyrase II;Tankyrase-2;Tankyrase-like protein;Tankyrase-related protein;, PF00023;PF12796;PF00644;PF07647;, GO:0000781;GO:0005737;GO:0005829;GO:0000139;GO:0005635;GO:0005634;GO:0000242;GO:0048471;GO:0019899;GO:0046872;GO:0003950;GO:1990404;GO:0035264;GO:1904357;GO:0090263;GO:1904355;GO:0032212;GO:0006471;GO:0070213;GO:0070198;GO:0070212;GO:0000209;GO:0040014;GO:0016055;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:Golgi membrane; C:nuclear envelope; C:nucleus; C:pericentriolar material; C:perinuclear region of cytoplasm;, F:enzyme binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:multicellular organism growth; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to chromosome, telomeric region; P:protein poly-ADP-ribosylation; P:protein polyubiquitination; P:regulation of multicellular organism growth; P:Wnt signaling pathway;|Q9H2K2 B2RBD3 Q9H8F2 Q9HAS4,Poly [ADP-ribose] polymerase tankyrase-2 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 6 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 5B {ECO:0000303|PubMed:20106667};Protein poly-ADP-ribosyltransferase tankyrase-2 {ECO:0000305};TNKS-2;TRF1-interacting ankyrin-related ADP-ribose polymerase 2;Tankyrase II;Tankyrase-2;Tankyrase-like protein;Tankyrase-related protein;, PF00023;PF12796;PF00644;PF07647;, GO:0000781;GO:0005737;GO:0005829;GO:0000139;GO:0005635;GO:0005634;GO:0000242;GO:0048471;GO:0019899;GO:0046872;GO:0003950;GO:1990404;GO:0035264;GO:1904357;GO:0090263;GO:1904355;GO:0032212;GO:0006471;GO:0070213;GO:0070198;GO:0070212;GO:0000209;GO:0040014;GO:0016055;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:Golgi membrane; C:nuclear envelope; C:nucleus; C:pericentriolar material; C:perinuclear region of cytoplasm;, F:enzyme binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:multicellular organism growth; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to chromosome, telomeric region; P:protein poly-ADP-ribosylation; P:protein polyubiquitination; P:regulation of multicellular organism growth; P:Wnt signaling pathway;|Q9H2K2 B2RBD3 Q9H8F2 Q9HAS4,Poly [ADP-ribose] polymerase tankyrase-2 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 6 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 5B {ECO:0000303|PubMed:20106667};Protein poly-ADP-ribosyltransferase tankyrase-2 {ECO:0000305};TNKS-2;TRF1-interacting ankyrin-related ADP-ribose polymerase 2;Tankyrase II;Tankyrase-2;Tankyrase-like protein;Tankyrase-related protein;, PF00023;PF12796;PF00644;PF07647;, GO:0000781;GO:0005737;GO:0005829;GO:0000139;GO:0005635;GO:0005634;GO:0000242;GO:0048471;GO:0019899;GO:0046872;GO:0003950;GO:1990404;GO:0035264;GO:1904357;GO:0090263;GO:1904355;GO:0032212;GO:0006471;GO:0070213;GO:0070198;GO:0070212;GO:0000209;GO:0040014;GO:0016055;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:Golgi membrane; C:nuclear envelope; C:nucleus; C:pericentriolar material; C:perinuclear region of cytoplasm;, F:enzyme binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:multicellular organism growth; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to chromosome, telomeric region; P:protein poly-ADP-ribosylation; P:protein polyubiquitination; P:regulation of multicellular organism growth; P:Wnt signaling pathway;|Q9H2K2 B2RBD3 Q9H8F2 Q9HAS4,Poly [ADP-ribose] polymerase tankyrase-2 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 6 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 5B {ECO:0000303|PubMed:20106667};Protein poly-ADP-ribosyltransferase tankyrase-2 {ECO:0000305};TNKS-2;TRF1-interacting ankyrin-related ADP-ribose polymerase 2;Tankyrase II;Tankyrase-2;Tankyrase-like protein;Tankyrase-related protein;, PF00023;PF12796;PF00644;PF07647;, GO:0000781;GO:0005737;GO:0005829;GO:0000139;GO:0005635;GO:0005634;GO:0000242;GO:0048471;GO:0019899;GO:0046872;GO:0003950;GO:1990404;GO:0035264;GO:1904357;GO:0090263;GO:1904355;GO:0032212;GO:0006471;GO:0070213;GO:0070198;GO:0070212;GO:0000209;GO:0040014;GO:0016055;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:Golgi membrane; C:nuclear envelope; C:nucleus; C:pericentriolar material; C:perinuclear region of cytoplasm;, F:enzyme binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:multicellular organism growth; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to chromosome, telomeric region; P:protein poly-ADP-ribosylation; P:protein polyubiquitination; P:regulation of multicellular organism growth; P:Wnt signaling pathway;|Q9H2K2 B2RBD3 Q9H8F2 Q9HAS4,Poly [ADP-ribose] polymerase tankyrase-2 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 6 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 5B {ECO:0000303|PubMed:20106667};Protein poly-ADP-ribosyltransferase tankyrase-2 {ECO:0000305};TNKS-2;TRF1-interacting ankyrin-related ADP-ribose polymerase 2;Tankyrase II;Tankyrase-2;Tankyrase-like protein;Tankyrase-related protein;, PF00023;PF12796;PF00644;PF07647;, GO:0000781;GO:0005737;GO:0005829;GO:0000139;GO:0005635;GO:0005634;GO:0000242;GO:0048471;GO:0019899;GO:0046872;GO:0003950;GO:1990404;GO:0035264;GO:1904357;GO:0090263;GO:1904355;GO:0032212;GO:0006471;GO:0070213;GO:0070198;GO:0070212;GO:0000209;GO:0040014;GO:0016055;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:Golgi membrane; C:nuclear envelope; C:nucleus; C:pericentriolar material; C:perinuclear region of cytoplasm;, F:enzyme binding; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:multicellular organism growth; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to chromosome, telomeric region; P:protein poly-ADP-ribosylation; P:protein polyubiquitination; P:regulation of multicellular organism growth; P:Wnt signaling pathway; scaffold14 indexed_genome mRNA 44041740 44102070 . + . ID=transcript_3773;O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated; scaffold14 indexed_genome mRNA 44105315 44128661 . - . ID=transcript_3774;O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated;|O14981 B4E0W6 O43578,TATA-binding protein-associated factor 172,ATP-dependent helicase BTAF1;B-TFIID transcription factor-associated 170 kDa subunit;TAF(II)170;TBP-associated factor 172;, PF12054;PF00271;PF00176;, GO:0043231;GO:0005654;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0003712;GO:0035562;GO:0045892;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator activity;, P:negative regulation of chromatin binding; P:negative regulation of transcription, DNA-templated; scaffold14 indexed_genome mRNA 44170087 44326809 . + . ID=transcript_3775;Q8NE35 Q5T389 Q9NQJ7 Q9Y2E9,Cytoplasmic polyadenylation element-binding protein 3,, PF16366;PF16367;, GO:0097440;GO:0030014;GO:0005737;GO:0005829;GO:0030425;GO:1990124;GO:0030496;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045202;GO:0035925;GO:0003730;GO:0043022;GO:0003723;GO:0035613;GO:0008135;GO:0000900;GO:0061158;GO:0071230;GO:0007616;GO:2000766;GO:1900248;GO:0000122;GO:0017148;GO:0060999;GO:1900365;GO:1900153;GO:0060213;GO:0045727;GO:0060998;GO:0048167;, C:apical dendrite; C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:dendrite; C:messenger ribonucleoprotein complex; C:midbody; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:synapse;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA binding; F:RNA stem-loop binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to amino acid stimulus; P:long-term memory; P:negative regulation of cytoplasmic translation; P:negative regulation of cytoplasmic translational elongation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:positive regulation of dendritic spine development; P:positive regulation of mRNA polyadenylation; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of translation; P:regulation of dendritic spine development; P:regulation of synaptic plasticity;|Q8NE35 Q5T389 Q9NQJ7 Q9Y2E9,Cytoplasmic polyadenylation element-binding protein 3,, PF16366;PF16367;, GO:0097440;GO:0030014;GO:0005737;GO:0005829;GO:0030425;GO:1990124;GO:0030496;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045202;GO:0035925;GO:0003730;GO:0043022;GO:0003723;GO:0035613;GO:0008135;GO:0000900;GO:0061158;GO:0071230;GO:0007616;GO:2000766;GO:1900248;GO:0000122;GO:0017148;GO:0060999;GO:1900365;GO:1900153;GO:0060213;GO:0045727;GO:0060998;GO:0048167;, C:apical dendrite; C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:dendrite; C:messenger ribonucleoprotein complex; C:midbody; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:synapse;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA binding; F:RNA stem-loop binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to amino acid stimulus; P:long-term memory; P:negative regulation of cytoplasmic translation; P:negative regulation of cytoplasmic translational elongation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:positive regulation of dendritic spine development; P:positive regulation of mRNA polyadenylation; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of translation; P:regulation of dendritic spine development; P:regulation of synaptic plasticity;|Q8NE35 Q5T389 Q9NQJ7 Q9Y2E9,Cytoplasmic polyadenylation element-binding protein 3,, PF16366;PF16367;, GO:0097440;GO:0030014;GO:0005737;GO:0005829;GO:0030425;GO:1990124;GO:0030496;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045202;GO:0035925;GO:0003730;GO:0043022;GO:0003723;GO:0035613;GO:0008135;GO:0000900;GO:0061158;GO:0071230;GO:0007616;GO:2000766;GO:1900248;GO:0000122;GO:0017148;GO:0060999;GO:1900365;GO:1900153;GO:0060213;GO:0045727;GO:0060998;GO:0048167;, C:apical dendrite; C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:dendrite; C:messenger ribonucleoprotein complex; C:midbody; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:synapse;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA binding; F:RNA stem-loop binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to amino acid stimulus; P:long-term memory; P:negative regulation of cytoplasmic translation; P:negative regulation of cytoplasmic translational elongation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:positive regulation of dendritic spine development; P:positive regulation of mRNA polyadenylation; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of translation; P:regulation of dendritic spine development; P:regulation of synaptic plasticity;|Q17RY0 B7ZLQ7 Q7Z310 Q8N405 Q9C0J0,Cytoplasmic polyadenylation element-binding protein 4,, PF16366;PF16367;, GO:0005737;GO:0030425;GO:0043197;GO:0005783;GO:0030426;GO:1990124;GO:0043005;GO:0005634;GO:0048471;GO:0014069;GO:0045202;GO:0046872;GO:0003730;GO:0043022;GO:0003723;GO:0008135;GO:0000900;GO:0071230;GO:0036294;GO:0042149;GO:0035235;GO:2000766;GO:0043524;GO:0002931;, C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum; C:growth cone; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:ionotropic glutamate receptor signaling pathway; P:negative regulation of cytoplasmic translation; P:negative regulation of neuron apoptotic process; P:response to ischemia; scaffold14 indexed_genome mRNA 44372678 44424702 . + . ID=transcript_3776;Q9NX47,E3 ubiquitin-protein ligase MARCHF5,Membrane-associated RING finger protein 5;Membrane-associated RING-CH protein V;Mitochondrial ubiquitin ligase;RING finger protein 153;RING-type E3 ubiquitin transferase MARCHF5 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0051020;GO:0061630;GO:0008270;GO:0090344;GO:0090141;GO:0051865;GO:0070585;GO:0000209;GO:0090140;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of cell aging; P:positive regulation of mitochondrial fission; P:protein autoubiquitination; P:protein localization to mitochondrion; P:protein polyubiquitination; P:regulation of mitochondrial fission;|Q9NX47,E3 ubiquitin-protein ligase MARCHF5,Membrane-associated RING finger protein 5;Membrane-associated RING-CH protein V;Mitochondrial ubiquitin ligase;RING finger protein 153;RING-type E3 ubiquitin transferase MARCHF5 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0051020;GO:0061630;GO:0008270;GO:0090344;GO:0090141;GO:0051865;GO:0070585;GO:0000209;GO:0090140;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of cell aging; P:positive regulation of mitochondrial fission; P:protein autoubiquitination; P:protein localization to mitochondrion; P:protein polyubiquitination; P:regulation of mitochondrial fission;|Q9NX47,E3 ubiquitin-protein ligase MARCHF5,Membrane-associated RING finger protein 5;Membrane-associated RING-CH protein V;Mitochondrial ubiquitin ligase;RING finger protein 153;RING-type E3 ubiquitin transferase MARCHF5 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0051020;GO:0061630;GO:0008270;GO:0090344;GO:0090141;GO:0051865;GO:0070585;GO:0000209;GO:0090140;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTPase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of cell aging; P:positive regulation of mitochondrial fission; P:protein autoubiquitination; P:protein localization to mitochondrion; P:protein polyubiquitination; P:regulation of mitochondrial fission; scaffold14 indexed_genome mRNA 44485819 44489694 . - . ID=transcript_3777;P14735 B2R721 B7ZAU2 D3DR35 Q5T5N2,Insulin-degrading enzyme {ECO:0000303|PubMed:20364150},Abeta-degrading protease;Insulin protease {ECO:0000303|PubMed:20364150};Insulysin {ECO:0000303|PubMed:20364150};, PF00675;PF05193;PF16187;, GO:0016323;GO:0009986;GO:0005737;GO:0005829;GO:0031597;GO:0009897;GO:0070062;GO:0005615;GO:0005739;GO:0005634;GO:0005782;GO:0005777;GO:0001540;GO:0005524;GO:0016887;GO:0031626;GO:0004175;GO:0042802;GO:0043559;GO:0004222;GO:0042277;GO:0042803;GO:0044877;GO:0140036;GO:0001618;GO:0008270;GO:0097242;GO:0150094;GO:0050435;GO:0019885;GO:0010815;GO:0044257;GO:0008340;GO:0042447;GO:1901143;GO:1901142;GO:0008286;GO:0045861;GO:0043171;GO:0032092;GO:0045732;GO:0030163;GO:0008104;GO:0006508;GO:0051603;GO:1903715;GO:0010992;, C:basolateral plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:cytosolic proteasome complex; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:mitochondrion; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:amyloid-beta binding; F:ATP binding; F:ATPase activity; F:beta-endorphin binding; F:endopeptidase activity; F:identical protein binding; F:insulin binding; F:metalloendopeptidase activity; F:peptide binding; F:protein homodimerization activity; F:protein-containing complex binding; F:ubiquitin-dependent protein binding; F:virus receptor activity; F:zinc ion binding;, P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta metabolic process; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:bradykinin catabolic process; P:cellular protein catabolic process; P:determination of adult lifespan; P:hormone catabolic process; P:insulin catabolic process; P:insulin metabolic process; P:insulin receptor signaling pathway; P:negative regulation of proteolysis; P:peptide catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:protein catabolic process; P:protein localization; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of aerobic respiration; P:ubiquitin recycling;|P14735 B2R721 B7ZAU2 D3DR35 Q5T5N2,Insulin-degrading enzyme {ECO:0000303|PubMed:20364150},Abeta-degrading protease;Insulin protease {ECO:0000303|PubMed:20364150};Insulysin {ECO:0000303|PubMed:20364150};, PF00675;PF05193;PF16187;, GO:0016323;GO:0009986;GO:0005737;GO:0005829;GO:0031597;GO:0009897;GO:0070062;GO:0005615;GO:0005739;GO:0005634;GO:0005782;GO:0005777;GO:0001540;GO:0005524;GO:0016887;GO:0031626;GO:0004175;GO:0042802;GO:0043559;GO:0004222;GO:0042277;GO:0042803;GO:0044877;GO:0140036;GO:0001618;GO:0008270;GO:0097242;GO:0150094;GO:0050435;GO:0019885;GO:0010815;GO:0044257;GO:0008340;GO:0042447;GO:1901143;GO:1901142;GO:0008286;GO:0045861;GO:0043171;GO:0032092;GO:0045732;GO:0030163;GO:0008104;GO:0006508;GO:0051603;GO:1903715;GO:0010992;, C:basolateral plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:cytosolic proteasome complex; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:mitochondrion; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:amyloid-beta binding; F:ATP binding; F:ATPase activity; F:beta-endorphin binding; F:endopeptidase activity; F:identical protein binding; F:insulin binding; F:metalloendopeptidase activity; F:peptide binding; F:protein homodimerization activity; F:protein-containing complex binding; F:ubiquitin-dependent protein binding; F:virus receptor activity; F:zinc ion binding;, P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta metabolic process; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:bradykinin catabolic process; P:cellular protein catabolic process; P:determination of adult lifespan; P:hormone catabolic process; P:insulin catabolic process; P:insulin metabolic process; P:insulin receptor signaling pathway; P:negative regulation of proteolysis; P:peptide catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:protein catabolic process; P:protein localization; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of aerobic respiration; P:ubiquitin recycling; scaffold14 indexed_genome mRNA 44616019 44619204 . + . ID=transcript_3778;P52732 A0AV49 B2RMV3 Q15716 Q5VWX0,Kinesin-like protein KIF11,Kinesin-like protein 1;Kinesin-like spindle protein HKSP;Kinesin-related motor protein Eg5;Thyroid receptor-interacting protein 5;, PF00225;PF13931;, GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0072686;GO:0005634;GO:0032991;GO:0005819;GO:0000922;GO:0005524;GO:0008574;GO:0008017;GO:0003777;GO:0019901;GO:0019886;GO:0051301;GO:0007018;GO:0000278;GO:0007100;GO:0090307;GO:0007052;GO:0046602;GO:0006890;GO:0007051;, C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:mitotic spindle; C:nucleus; C:protein-containing complex; C:spindle; C:spindle pole;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:microtubule binding; F:microtubule motor activity; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic centrosome separation; P:mitotic spindle assembly; P:mitotic spindle organization; P:regulation of mitotic centrosome separation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:spindle organization; scaffold14 indexed_genome mRNA 44621098 44640313 . + . ID=transcript_3779;P52732 A0AV49 B2RMV3 Q15716 Q5VWX0,Kinesin-like protein KIF11,Kinesin-like protein 1;Kinesin-like spindle protein HKSP;Kinesin-related motor protein Eg5;Thyroid receptor-interacting protein 5;, PF00225;PF13931;, GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0072686;GO:0005634;GO:0032991;GO:0005819;GO:0000922;GO:0005524;GO:0008574;GO:0008017;GO:0003777;GO:0019901;GO:0019886;GO:0051301;GO:0007018;GO:0000278;GO:0007100;GO:0090307;GO:0007052;GO:0046602;GO:0006890;GO:0007051;, C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:mitotic spindle; C:nucleus; C:protein-containing complex; C:spindle; C:spindle pole;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:microtubule binding; F:microtubule motor activity; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic centrosome separation; P:mitotic spindle assembly; P:mitotic spindle organization; P:regulation of mitotic centrosome separation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:spindle organization; scaffold14 indexed_genome mRNA 44659599 44660691 . - . ID=transcript_3780;Q03014 B1AQ17 Q96CE9,Hematopoietically-expressed homeobox protein HHEX,Homeobox protein PRH;, PF00046;, GO:0000785;GO:0005737;GO:0005634;GO:0032993;GO:0008301;GO:0001228;GO:0000981;GO:0001227;GO:0008190;GO:0042803;GO:0070491;GO:0000978;GO:0043565;GO:0017025;GO:0008134;GO:0000976;GO:0009952;GO:0030183;GO:0030154;GO:0071103;GO:0006406;GO:0016525;GO:0045736;GO:0010944;GO:0000122;GO:0010621;GO:0045892;GO:0030948;GO:0016973;GO:0090263;GO:0045944;GO:0045893;GO:0030177;GO:0034504;GO:0070663;GO:0006357;GO:0043434;GO:0009611;GO:0016055;, C:chromatin; C:cytoplasm; C:nucleus; C:protein-DNA complex;, F:DNA binding, bending; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:eukaryotic initiation factor 4E binding; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:TBP-class protein binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anterior/posterior pattern specification; P:B cell differentiation; P:cell differentiation; P:DNA conformation change; P:mRNA export from nucleus; P:negative regulation of angiogenesis; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription by transcription factor localization; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:poly(A)+ mRNA export from nucleus; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:protein localization to nucleus; P:regulation of leukocyte proliferation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:response to wounding; P:Wnt signaling pathway; scaffold14 indexed_genome mRNA 44660756 44665347 . + . ID=transcript_3781;Q03014 B1AQ17 Q96CE9,Hematopoietically-expressed homeobox protein HHEX,Homeobox protein PRH;, PF00046;, GO:0000785;GO:0005737;GO:0005634;GO:0032993;GO:0008301;GO:0001228;GO:0000981;GO:0001227;GO:0008190;GO:0042803;GO:0070491;GO:0000978;GO:0043565;GO:0017025;GO:0008134;GO:0000976;GO:0009952;GO:0030183;GO:0030154;GO:0071103;GO:0006406;GO:0016525;GO:0045736;GO:0010944;GO:0000122;GO:0010621;GO:0045892;GO:0030948;GO:0016973;GO:0090263;GO:0045944;GO:0045893;GO:0030177;GO:0034504;GO:0070663;GO:0006357;GO:0043434;GO:0009611;GO:0016055;, C:chromatin; C:cytoplasm; C:nucleus; C:protein-DNA complex;, F:DNA binding, bending; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:eukaryotic initiation factor 4E binding; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:TBP-class protein binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anterior/posterior pattern specification; P:B cell differentiation; P:cell differentiation; P:DNA conformation change; P:mRNA export from nucleus; P:negative regulation of angiogenesis; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription by transcription factor localization; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:poly(A)+ mRNA export from nucleus; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:protein localization to nucleus; P:regulation of leukocyte proliferation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:response to wounding; P:Wnt signaling pathway; scaffold14 indexed_genome mRNA 44848613 44993012 . + . ID=transcript_3782;Q8TAG9 E9PHI3 Q5VXH8 Q9NZ24,Exocyst complex component 6,Exocyst complex component Sec15A;SEC15-like protein 1;, PF04091;, GO:0005829;GO:0000145;GO:0090543;GO:0030426;GO:0016020;GO:0048471;GO:0005886;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:0006904;, C:cytosol; C:exocyst; C:Flemming body; C:growth cone; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:vesicle docking involved in exocytosis;|Q8TAG9 E9PHI3 Q5VXH8 Q9NZ24,Exocyst complex component 6,Exocyst complex component Sec15A;SEC15-like protein 1;, PF04091;, GO:0005829;GO:0000145;GO:0090543;GO:0030426;GO:0016020;GO:0048471;GO:0005886;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:0006904;, C:cytosol; C:exocyst; C:Flemming body; C:growth cone; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:vesicle docking involved in exocytosis;|Q8TAG9 E9PHI3 Q5VXH8 Q9NZ24,Exocyst complex component 6,Exocyst complex component Sec15A;SEC15-like protein 1;, PF04091;, GO:0005829;GO:0000145;GO:0090543;GO:0030426;GO:0016020;GO:0048471;GO:0005886;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:0006904;, C:cytosol; C:exocyst; C:Flemming body; C:growth cone; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:vesicle docking involved in exocytosis;|Q8TAG9 E9PHI3 Q5VXH8 Q9NZ24,Exocyst complex component 6,Exocyst complex component Sec15A;SEC15-like protein 1;, PF04091;, GO:0005829;GO:0000145;GO:0090543;GO:0030426;GO:0016020;GO:0048471;GO:0005886;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:0006904;, C:cytosol; C:exocyst; C:Flemming body; C:growth cone; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:vesicle docking involved in exocytosis; scaffold14 indexed_genome mRNA 45003350 45003860 . + . ID=transcript_3783;Q6V0L0 Q5VXH6,Cytochrome P450 26C1,, PF00067;, GO:0005789;GO:0016021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0008401;GO:0001972;GO:0009952;GO:0007417;GO:0048387;GO:0014032;GO:0048284;GO:0034653;GO:0016125;GO:0006766;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:retinoic acid 4-hydroxylase activity; F:retinoic acid binding;, P:anterior/posterior pattern specification; P:central nervous system development; P:negative regulation of retinoic acid receptor signaling pathway; P:neural crest cell development; P:organelle fusion; P:retinoic acid catabolic process; P:sterol metabolic process; P:vitamin metabolic process; scaffold14 indexed_genome mRNA 45008026 45012257 . + . ID=transcript_3784;O43174 B3KNI4 Q5VXH9 Q5VXI0,Cytochrome P450 26A1,Cytochrome P450 retinoic acid-inactivating 1;Retinoic acid 4-hydroxylase {ECO:0000303|PubMed:9716180};Retinoic acid-metabolizing cytochrome;, PF00067;, GO:0005789;GO:0062183;GO:0062182;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0019825;GO:0008401;GO:0001972;GO:0001822;GO:0048387;GO:0032526;GO:0033189;GO:0034653;GO:0042573;GO:0016125;GO:0006766;GO:0006805;, C:endoplasmic reticulum membrane;, F:all-trans retinoic acid 18-hydroxylase activity; F:all-trans retinoic acid 4-hydrolase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:retinoic acid binding;, P:kidney development; P:negative regulation of retinoic acid receptor signaling pathway; P:response to retinoic acid; P:response to vitamin A; P:retinoic acid catabolic process; P:retinoic acid metabolic process; P:sterol metabolic process; P:vitamin metabolic process; P:xenobiotic metabolic process;|O43174 B3KNI4 Q5VXH9 Q5VXI0,Cytochrome P450 26A1,Cytochrome P450 retinoic acid-inactivating 1;Retinoic acid 4-hydroxylase {ECO:0000303|PubMed:9716180};Retinoic acid-metabolizing cytochrome;, PF00067;, GO:0005789;GO:0062183;GO:0062182;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0019825;GO:0008401;GO:0001972;GO:0001822;GO:0048387;GO:0032526;GO:0033189;GO:0034653;GO:0042573;GO:0016125;GO:0006766;GO:0006805;, C:endoplasmic reticulum membrane;, F:all-trans retinoic acid 18-hydroxylase activity; F:all-trans retinoic acid 4-hydrolase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:retinoic acid binding;, P:kidney development; P:negative regulation of retinoic acid receptor signaling pathway; P:response to retinoic acid; P:response to vitamin A; P:retinoic acid catabolic process; P:retinoic acid metabolic process; P:sterol metabolic process; P:vitamin metabolic process; P:xenobiotic metabolic process;|O43174 B3KNI4 Q5VXH9 Q5VXI0,Cytochrome P450 26A1,Cytochrome P450 retinoic acid-inactivating 1;Retinoic acid 4-hydroxylase {ECO:0000303|PubMed:9716180};Retinoic acid-metabolizing cytochrome;, PF00067;, GO:0005789;GO:0062183;GO:0062182;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0019825;GO:0008401;GO:0001972;GO:0001822;GO:0048387;GO:0032526;GO:0033189;GO:0034653;GO:0042573;GO:0016125;GO:0006766;GO:0006805;, C:endoplasmic reticulum membrane;, F:all-trans retinoic acid 18-hydroxylase activity; F:all-trans retinoic acid 4-hydrolase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:retinoic acid binding;, P:kidney development; P:negative regulation of retinoic acid receptor signaling pathway; P:response to retinoic acid; P:response to vitamin A; P:retinoic acid catabolic process; P:retinoic acid metabolic process; P:sterol metabolic process; P:vitamin metabolic process; P:xenobiotic metabolic process;|O43174 B3KNI4 Q5VXH9 Q5VXI0,Cytochrome P450 26A1,Cytochrome P450 retinoic acid-inactivating 1;Retinoic acid 4-hydroxylase {ECO:0000303|PubMed:9716180};Retinoic acid-metabolizing cytochrome;, PF00067;, GO:0005789;GO:0062183;GO:0062182;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0019825;GO:0008401;GO:0001972;GO:0001822;GO:0048387;GO:0032526;GO:0033189;GO:0034653;GO:0042573;GO:0016125;GO:0006766;GO:0006805;, C:endoplasmic reticulum membrane;, F:all-trans retinoic acid 18-hydroxylase activity; F:all-trans retinoic acid 4-hydrolase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:retinoic acid binding;, P:kidney development; P:negative regulation of retinoic acid receptor signaling pathway; P:response to retinoic acid; P:response to vitamin A; P:retinoic acid catabolic process; P:retinoic acid metabolic process; P:sterol metabolic process; P:vitamin metabolic process; P:xenobiotic metabolic process;|O43174 B3KNI4 Q5VXH9 Q5VXI0,Cytochrome P450 26A1,Cytochrome P450 retinoic acid-inactivating 1;Retinoic acid 4-hydroxylase {ECO:0000303|PubMed:9716180};Retinoic acid-metabolizing cytochrome;, PF00067;, GO:0005789;GO:0062183;GO:0062182;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0019825;GO:0008401;GO:0001972;GO:0001822;GO:0048387;GO:0032526;GO:0033189;GO:0034653;GO:0042573;GO:0016125;GO:0006766;GO:0006805;, C:endoplasmic reticulum membrane;, F:all-trans retinoic acid 18-hydroxylase activity; F:all-trans retinoic acid 4-hydrolase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:retinoic acid binding;, P:kidney development; P:negative regulation of retinoic acid receptor signaling pathway; P:response to retinoic acid; P:response to vitamin A; P:retinoic acid catabolic process; P:retinoic acid metabolic process; P:sterol metabolic process; P:vitamin metabolic process; P:xenobiotic metabolic process; scaffold14 indexed_genome mRNA 45217977 45361685 . - . ID=transcript_3785;Q9NZM0 Q9ULL3 Q9Y4U4,Myoferlin,Fer-1-like protein 3;, PF00168;PF08165;PF08150;PF08151;PF16165;, GO:0005901;GO:0031410;GO:0030659;GO:0070062;GO:0016021;GO:0043231;GO:0005635;GO:0031965;GO:0005886;GO:0046872;GO:0005543;GO:0008015;GO:0061025;GO:0006936;GO:0007520;GO:0007009;GO:0001778;GO:0033292;, C:caveola; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nuclear envelope; C:nuclear membrane; C:plasma membrane;, F:metal ion binding; F:phospholipid binding;, P:blood circulation; P:membrane fusion; P:muscle contraction; P:myoblast fusion; P:plasma membrane organization; P:plasma membrane repair; P:T-tubule organization;|Q9NZM0 Q9ULL3 Q9Y4U4,Myoferlin,Fer-1-like protein 3;, PF00168;PF08165;PF08150;PF08151;PF16165;, GO:0005901;GO:0031410;GO:0030659;GO:0070062;GO:0016021;GO:0043231;GO:0005635;GO:0031965;GO:0005886;GO:0046872;GO:0005543;GO:0008015;GO:0061025;GO:0006936;GO:0007520;GO:0007009;GO:0001778;GO:0033292;, C:caveola; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nuclear envelope; C:nuclear membrane; C:plasma membrane;, F:metal ion binding; F:phospholipid binding;, P:blood circulation; P:membrane fusion; P:muscle contraction; P:myoblast fusion; P:plasma membrane organization; P:plasma membrane repair; P:T-tubule organization;|Q9NZM0 Q9ULL3 Q9Y4U4,Myoferlin,Fer-1-like protein 3;, PF00168;PF08165;PF08150;PF08151;PF16165;, GO:0005901;GO:0031410;GO:0030659;GO:0070062;GO:0016021;GO:0043231;GO:0005635;GO:0031965;GO:0005886;GO:0046872;GO:0005543;GO:0008015;GO:0061025;GO:0006936;GO:0007520;GO:0007009;GO:0001778;GO:0033292;, C:caveola; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nuclear envelope; C:nuclear membrane; C:plasma membrane;, F:metal ion binding; F:phospholipid binding;, P:blood circulation; P:membrane fusion; P:muscle contraction; P:myoblast fusion; P:plasma membrane organization; P:plasma membrane repair; P:T-tubule organization; scaffold14 indexed_genome mRNA 45415198 45436484 . + . ID=transcript_3786;Q53EZ4 B2RDG8 D3DR37 Q32WF5 Q3MV20 Q5VY28 Q6N034 Q96H32 Q9NVS7,Centrosomal protein of 55 kDa {ECO:0000312|HGNC:HGNC:1161},Up-regulated in colon cancer 6;, PF12180;, GO:0034451;GO:0005814;GO:0005813;GO:0032154;GO:0005737;GO:0090543;GO:0045171;GO:0016020;GO:0030496;GO:0005886;GO:0042802;GO:1904888;GO:0045184;GO:0061952;GO:0000281;GO:0007275;GO:0014066;, C:centriolar satellite; C:centriole; C:centrosome; C:cleavage furrow; C:cytoplasm; C:Flemming body; C:intercellular bridge; C:membrane; C:midbody; C:plasma membrane;, F:identical protein binding;, P:cranial skeletal system development; P:establishment of protein localization; P:midbody abscission; P:mitotic cytokinesis; P:multicellular organism development; P:regulation of phosphatidylinositol 3-kinase signaling; scaffold14 indexed_genome mRNA 45455503 45477950 . + . ID=transcript_3787;Q5NUL3 Q495H1 Q5VY25 Q5VY26 Q7Z605 Q86SM7,Free fatty acid receptor 4,G-protein coupled receptor 120;G-protein coupled receptor 129;G-protein coupled receptor GT01;G-protein coupled receptor PGR4;Omega-3 fatty acid receptor 1;, PF00001;, GO:0060170;GO:0005929;GO:0030139;GO:0010008;GO:0005887;GO:0005765;GO:0005886;GO:1990763;GO:0005504;GO:0004930;GO:0008527;GO:0050873;GO:0007186;GO:0036321;GO:0046879;GO:0006954;GO:0043066;GO:0001818;GO:0050728;GO:0032691;GO:0090275;GO:0007200;GO:0090336;GO:0043950;GO:0120162;GO:0007204;GO:0070374;GO:0070094;GO:0045669;GO:0010827;GO:0050872;, C:ciliary membrane; C:cilium; C:endocytic vesicle; C:endosome membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane;, F:arrestin family protein binding; F:fatty acid binding; F:G protein-coupled receptor activity; F:taste receptor activity;, P:brown fat cell differentiation; P:G protein-coupled receptor signaling pathway; P:ghrelin secretion; P:hormone secretion; P:inflammatory response; P:negative regulation of apoptotic process; P:negative regulation of cytokine production; P:negative regulation of inflammatory response; P:negative regulation of interleukin-1 beta production; P:negative regulation of somatostatin secretion; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of brown fat cell differentiation; P:positive regulation of cAMP-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glucagon secretion; P:positive regulation of osteoblast differentiation; P:regulation of glucose transmembrane transport; P:white fat cell differentiation; scaffold14 indexed_genome mRNA 45478749 45490341 . - . ID=transcript_3788;P02753 D3DR38 O43478 O43479 Q5VY24 Q8WWA3 Q9P178,Retinol-binding protein 4,Plasma retinol-binding protein;, PF00061;, GO:0070062;GO:0005576;GO:0005615;GO:0032991;GO:0044877;GO:0016918;GO:0019841;GO:0034632;GO:0048738;GO:0048562;GO:0060059;GO:0048706;GO:0001654;GO:0048807;GO:0006094;GO:0042593;GO:0007507;GO:0060347;GO:0030324;GO:0030277;GO:0060044;GO:0002639;GO:0032024;GO:0045471;GO:0032526;GO:0001523;GO:0042572;GO:0034633;GO:0060157;GO:0060065;GO:0060068;GO:0007601;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:protein-containing complex;, F:protein-containing complex binding; F:retinal binding; F:retinol binding; F:retinol transmembrane transporter activity;, P:cardiac muscle tissue development; P:embryonic organ morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:embryonic skeletal system development; P:eye development; P:female genitalia morphogenesis; P:gluconeogenesis; P:glucose homeostasis; P:heart development; P:heart trabecula formation; P:lung development; P:maintenance of gastrointestinal epithelium; P:negative regulation of cardiac muscle cell proliferation; P:positive regulation of immunoglobulin production; P:positive regulation of insulin secretion; P:response to ethanol; P:response to retinoic acid; P:retinoid metabolic process; P:retinol metabolic process; P:retinol transport; P:urinary bladder development; P:uterus development; P:vagina development; P:visual perception;|P02753 D3DR38 O43478 O43479 Q5VY24 Q8WWA3 Q9P178,Retinol-binding protein 4,Plasma retinol-binding protein;, PF00061;, GO:0070062;GO:0005576;GO:0005615;GO:0032991;GO:0044877;GO:0016918;GO:0019841;GO:0034632;GO:0048738;GO:0048562;GO:0060059;GO:0048706;GO:0001654;GO:0048807;GO:0006094;GO:0042593;GO:0007507;GO:0060347;GO:0030324;GO:0030277;GO:0060044;GO:0002639;GO:0032024;GO:0045471;GO:0032526;GO:0001523;GO:0042572;GO:0034633;GO:0060157;GO:0060065;GO:0060068;GO:0007601;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:protein-containing complex;, F:protein-containing complex binding; F:retinal binding; F:retinol binding; F:retinol transmembrane transporter activity;, P:cardiac muscle tissue development; P:embryonic organ morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:embryonic skeletal system development; P:eye development; P:female genitalia morphogenesis; P:gluconeogenesis; P:glucose homeostasis; P:heart development; P:heart trabecula formation; P:lung development; P:maintenance of gastrointestinal epithelium; P:negative regulation of cardiac muscle cell proliferation; P:positive regulation of immunoglobulin production; P:positive regulation of insulin secretion; P:response to ethanol; P:response to retinoic acid; P:retinoid metabolic process; P:retinol metabolic process; P:retinol transport; P:urinary bladder development; P:uterus development; P:vagina development; P:visual perception;|P02753 D3DR38 O43478 O43479 Q5VY24 Q8WWA3 Q9P178,Retinol-binding protein 4,Plasma retinol-binding protein;, PF00061;, GO:0070062;GO:0005576;GO:0005615;GO:0032991;GO:0044877;GO:0016918;GO:0019841;GO:0034632;GO:0048738;GO:0048562;GO:0060059;GO:0048706;GO:0001654;GO:0048807;GO:0006094;GO:0042593;GO:0007507;GO:0060347;GO:0030324;GO:0030277;GO:0060044;GO:0002639;GO:0032024;GO:0045471;GO:0032526;GO:0001523;GO:0042572;GO:0034633;GO:0060157;GO:0060065;GO:0060068;GO:0007601;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:protein-containing complex;, F:protein-containing complex binding; F:retinal binding; F:retinol binding; F:retinol transmembrane transporter activity;, P:cardiac muscle tissue development; P:embryonic organ morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:embryonic skeletal system development; P:eye development; P:female genitalia morphogenesis; P:gluconeogenesis; P:glucose homeostasis; P:heart development; P:heart trabecula formation; P:lung development; P:maintenance of gastrointestinal epithelium; P:negative regulation of cardiac muscle cell proliferation; P:positive regulation of immunoglobulin production; P:positive regulation of insulin secretion; P:response to ethanol; P:response to retinoic acid; P:retinoid metabolic process; P:retinol metabolic process; P:retinol transport; P:urinary bladder development; P:uterus development; P:vagina development; P:visual perception; scaffold14 indexed_genome mRNA 45522378 45549803 . + . ID=transcript_3789;P51160 A6NCR6 Q5VY29,Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha',cGMP phosphodiesterase 6C;, PF01590;PF00233;, GO:0005886;GO:0047555;GO:0004114;GO:0030553;GO:0046872;GO:0007603;GO:0046549;GO:0007165;GO:0007601;, C:plasma membrane;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP binding; F:metal ion binding;, P:phototransduction, visible light; P:retinal cone cell development; P:signal transduction; P:visual perception;|P61927 B2R4H2 P02403 Q6IBB4 Q99883,60S ribosomal protein L37,G1.16;Large ribosomal subunit protein eL37 {ECO:0000303|PubMed:24524803};, PF01907;, GO:0005829;GO:0022625;GO:0045202;GO:0046872;GO:0003723;GO:0019843;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:synapse;, F:metal ion binding; F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P51160 A6NCR6 Q5VY29,Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha',cGMP phosphodiesterase 6C;, PF01590;PF00233;, GO:0005886;GO:0047555;GO:0004114;GO:0030553;GO:0046872;GO:0007603;GO:0046549;GO:0007165;GO:0007601;, C:plasma membrane;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP binding; F:metal ion binding;, P:phototransduction, visible light; P:retinal cone cell development; P:signal transduction; P:visual perception; scaffold14 indexed_genome mRNA 45549837 45570017 . - . ID=transcript_3790;Q8WVH5 Q96JQ8,Protein FRA10AC1,, PF09725;, GO:0005634;GO:0016791;GO:0016311;, C:nucleus;, F:phosphatase activity;, P:dephosphorylation; scaffold14 indexed_genome mRNA 45573519 45589522 . - . ID=transcript_3791;Q8WVH5 Q96JQ8,Protein FRA10AC1,, PF09725;, GO:0005634;GO:0016791;GO:0016311;, C:nucleus;, F:phosphatase activity;, P:dephosphorylation;|Q8WVH5 Q96JQ8,Protein FRA10AC1,, PF09725;, GO:0005634;GO:0016791;GO:0016311;, C:nucleus;, F:phosphatase activity;, P:dephosphorylation;|Q8WVH5 Q96JQ8,Protein FRA10AC1,, PF09725;, GO:0005634;GO:0016791;GO:0016311;, C:nucleus;, F:phosphatase activity;, P:dephosphorylation; scaffold14 indexed_genome mRNA 45625895 45627798 . + . ID=transcript_3792;O95970 A8K0Z1 B4E1S0 Q5W001 Q5W002 Q8NI23 Q96LF5,Leucine-rich glioma-inactivated protein 1,Epitempin-1;, PF03736;PF13855;, GO:0005576;GO:0005615;GO:0098978;GO:0043083;GO:0005102;GO:0007411;GO:0007399;GO:0031175;GO:0099645;GO:0030307;GO:0050806;, C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:synaptic cleft;, F:signaling receptor binding;, P:axon guidance; P:nervous system development; P:neuron projection development; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:positive regulation of cell growth; P:positive regulation of synaptic transmission;|O95970 A8K0Z1 B4E1S0 Q5W001 Q5W002 Q8NI23 Q96LF5,Leucine-rich glioma-inactivated protein 1,Epitempin-1;, PF03736;PF13855;, GO:0005576;GO:0005615;GO:0098978;GO:0043083;GO:0005102;GO:0007411;GO:0007399;GO:0031175;GO:0099645;GO:0030307;GO:0050806;, C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:synaptic cleft;, F:signaling receptor binding;, P:axon guidance; P:nervous system development; P:neuron projection development; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:positive regulation of cell growth; P:positive regulation of synaptic transmission; scaffold14 indexed_genome mRNA 45644102 45666372 . + . ID=transcript_3793;O95970 A8K0Z1 B4E1S0 Q5W001 Q5W002 Q8NI23 Q96LF5,Leucine-rich glioma-inactivated protein 1,Epitempin-1;, PF03736;PF13855;, GO:0005576;GO:0005615;GO:0098978;GO:0043083;GO:0005102;GO:0007411;GO:0007399;GO:0031175;GO:0099645;GO:0030307;GO:0050806;, C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:synaptic cleft;, F:signaling receptor binding;, P:axon guidance; P:nervous system development; P:neuron projection development; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:positive regulation of cell growth; P:positive regulation of synaptic transmission;|O95970 A8K0Z1 B4E1S0 Q5W001 Q5W002 Q8NI23 Q96LF5,Leucine-rich glioma-inactivated protein 1,Epitempin-1;, PF03736;PF13855;, GO:0005576;GO:0005615;GO:0098978;GO:0043083;GO:0005102;GO:0007411;GO:0007399;GO:0031175;GO:0099645;GO:0030307;GO:0050806;, C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:synaptic cleft;, F:signaling receptor binding;, P:axon guidance; P:nervous system development; P:neuron projection development; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:positive regulation of cell growth; P:positive regulation of synaptic transmission;|O95970 A8K0Z1 B4E1S0 Q5W001 Q5W002 Q8NI23 Q96LF5,Leucine-rich glioma-inactivated protein 1,Epitempin-1;, PF03736;PF13855;, GO:0005576;GO:0005615;GO:0098978;GO:0043083;GO:0005102;GO:0007411;GO:0007399;GO:0031175;GO:0099645;GO:0030307;GO:0050806;, C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:synaptic cleft;, F:signaling receptor binding;, P:axon guidance; P:nervous system development; P:neuron projection development; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:positive regulation of cell growth; P:positive regulation of synaptic transmission;|O95970 A8K0Z1 B4E1S0 Q5W001 Q5W002 Q8NI23 Q96LF5,Leucine-rich glioma-inactivated protein 1,Epitempin-1;, PF03736;PF13855;, GO:0005576;GO:0005615;GO:0098978;GO:0043083;GO:0005102;GO:0007411;GO:0007399;GO:0031175;GO:0099645;GO:0030307;GO:0050806;, C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:synaptic cleft;, F:signaling receptor binding;, P:axon guidance; P:nervous system development; P:neuron projection development; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:positive regulation of cell growth; P:positive regulation of synaptic transmission;|O95970 A8K0Z1 B4E1S0 Q5W001 Q5W002 Q8NI23 Q96LF5,Leucine-rich glioma-inactivated protein 1,Epitempin-1;, PF03736;PF13855;, GO:0005576;GO:0005615;GO:0098978;GO:0043083;GO:0005102;GO:0007411;GO:0007399;GO:0031175;GO:0099645;GO:0030307;GO:0050806;, C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:synaptic cleft;, F:signaling receptor binding;, P:axon guidance; P:nervous system development; P:neuron projection development; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:positive regulation of cell growth; P:positive regulation of synaptic transmission; scaffold14 indexed_genome mRNA 45755254 45778690 . + . ID=transcript_3794;Q2M3R5 Q86YG5 Q8NBA5,Solute carrier family 35 member G1,Partner of STIM1;Transmembrane protein 20;, PF00892;, GO:0005789;GO:0016021;GO:0005886;GO:1990034;GO:0051480;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, , P:calcium ion export across plasma membrane; P:regulation of cytosolic calcium ion concentration;|Q2M3R5 Q86YG5 Q8NBA5,Solute carrier family 35 member G1,Partner of STIM1;Transmembrane protein 20;, PF00892;, GO:0005789;GO:0016021;GO:0005886;GO:1990034;GO:0051480;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, , P:calcium ion export across plasma membrane; P:regulation of cytosolic calcium ion concentration; scaffold14 indexed_genome mRNA 46119300 46136375 . + . ID=transcript_3795;Q9H9X8 Q9HBX6 Q9HC53 Q9UHV3,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 {ECO:0000305},Pancreas-enriched phospholipase C;Phosphoinositide phospholipase C-epsilon-1;Phospholipase C-epsilon-1;, PF00168;PF09279;PF00388;PF00387;PF00788;PF00617;, GO:0005829;GO:0000139;GO:0030027;GO:0005886;GO:0019899;GO:0005085;GO:0046872;GO:0004435;GO:0004629;GO:0031267;GO:0000187;GO:0019722;GO:0007010;GO:0006651;GO:0007173;GO:0032835;GO:0007507;GO:0043647;GO:0048016;GO:0016042;GO:0048015;GO:0007200;GO:0007204;GO:0010592;GO:0007265;GO:0001558;GO:0008277;GO:0045859;GO:0046578;GO:0006940;, C:cytosol; C:Golgi membrane; C:lamellipodium; C:plasma membrane;, F:enzyme binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity; F:small GTPase binding;, P:activation of MAPK activity; P:calcium-mediated signaling; P:cytoskeleton organization; P:diacylglycerol biosynthetic process; P:epidermal growth factor receptor signaling pathway; P:glomerulus development; P:heart development; P:inositol phosphate metabolic process; P:inositol phosphate-mediated signaling; P:lipid catabolic process; P:phosphatidylinositol-mediated signaling; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of lamellipodium assembly; P:Ras protein signal transduction; P:regulation of cell growth; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of protein kinase activity; P:regulation of Ras protein signal transduction; P:regulation of smooth muscle contraction; scaffold14 indexed_genome mRNA 46136440 46193454 . + . ID=transcript_3796;Q9H9X8 Q9HBX6 Q9HC53 Q9UHV3,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 {ECO:0000305},Pancreas-enriched phospholipase C;Phosphoinositide phospholipase C-epsilon-1;Phospholipase C-epsilon-1;, PF00168;PF09279;PF00388;PF00387;PF00788;PF00617;, GO:0005829;GO:0000139;GO:0030027;GO:0005886;GO:0019899;GO:0005085;GO:0046872;GO:0004435;GO:0004629;GO:0031267;GO:0000187;GO:0019722;GO:0007010;GO:0006651;GO:0007173;GO:0032835;GO:0007507;GO:0043647;GO:0048016;GO:0016042;GO:0048015;GO:0007200;GO:0007204;GO:0010592;GO:0007265;GO:0001558;GO:0008277;GO:0045859;GO:0046578;GO:0006940;, C:cytosol; C:Golgi membrane; C:lamellipodium; C:plasma membrane;, F:enzyme binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity; F:small GTPase binding;, P:activation of MAPK activity; P:calcium-mediated signaling; P:cytoskeleton organization; P:diacylglycerol biosynthetic process; P:epidermal growth factor receptor signaling pathway; P:glomerulus development; P:heart development; P:inositol phosphate metabolic process; P:inositol phosphate-mediated signaling; P:lipid catabolic process; P:phosphatidylinositol-mediated signaling; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of lamellipodium assembly; P:Ras protein signal transduction; P:regulation of cell growth; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of protein kinase activity; P:regulation of Ras protein signal transduction; P:regulation of smooth muscle contraction;|Q9H9X8 Q9HBX6 Q9HC53 Q9UHV3,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 {ECO:0000305},Pancreas-enriched phospholipase C;Phosphoinositide phospholipase C-epsilon-1;Phospholipase C-epsilon-1;, PF00168;PF09279;PF00388;PF00387;PF00788;PF00617;, GO:0005829;GO:0000139;GO:0030027;GO:0005886;GO:0019899;GO:0005085;GO:0046872;GO:0004435;GO:0004629;GO:0031267;GO:0000187;GO:0019722;GO:0007010;GO:0006651;GO:0007173;GO:0032835;GO:0007507;GO:0043647;GO:0048016;GO:0016042;GO:0048015;GO:0007200;GO:0007204;GO:0010592;GO:0007265;GO:0001558;GO:0008277;GO:0045859;GO:0046578;GO:0006940;, C:cytosol; C:Golgi membrane; C:lamellipodium; C:plasma membrane;, F:enzyme binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity; F:small GTPase binding;, P:activation of MAPK activity; P:calcium-mediated signaling; P:cytoskeleton organization; P:diacylglycerol biosynthetic process; P:epidermal growth factor receptor signaling pathway; P:glomerulus development; P:heart development; P:inositol phosphate metabolic process; P:inositol phosphate-mediated signaling; P:lipid catabolic process; P:phosphatidylinositol-mediated signaling; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of lamellipodium assembly; P:Ras protein signal transduction; P:regulation of cell growth; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of protein kinase activity; P:regulation of Ras protein signal transduction; P:regulation of smooth muscle contraction; scaffold14 indexed_genome mRNA 46196994 46223876 . - . ID=transcript_3797;Q8WTT2 Q9H5M6 Q9H9D8,Nucleolar complex protein 3 homolog,Factor for adipocyte differentiation 24;NOC3-like protein;Nucleolar complex-associated protein 3-like protein;, PF03914;PF07540;, GO:0005739;GO:0016607;GO:0005730;GO:0005654;GO:0003682;GO:0003723;GO:0006270;GO:0045444;, C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:DNA replication initiation; P:fat cell differentiation;|Q8WTT2 Q9H5M6 Q9H9D8,Nucleolar complex protein 3 homolog,Factor for adipocyte differentiation 24;NOC3-like protein;Nucleolar complex-associated protein 3-like protein;, PF03914;PF07540;, GO:0005739;GO:0016607;GO:0005730;GO:0005654;GO:0003682;GO:0003723;GO:0006270;GO:0045444;, C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:DNA replication initiation; P:fat cell differentiation;|Q8WTT2 Q9H5M6 Q9H9D8,Nucleolar complex protein 3 homolog,Factor for adipocyte differentiation 24;NOC3-like protein;Nucleolar complex-associated protein 3-like protein;, PF03914;PF07540;, GO:0005739;GO:0016607;GO:0005730;GO:0005654;GO:0003682;GO:0003723;GO:0006270;GO:0045444;, C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:DNA replication initiation; P:fat cell differentiation; scaffold14 indexed_genome mRNA 46246677 46343268 . + . ID=transcript_3798;O60347 Q5VYA6 Q8WX26 Q8WX59 Q9UG83,TBC1 domain family member 12,, PF00566;, GO:0005776;GO:0055037;GO:0005096;GO:0090630;GO:0006886;GO:2000785;, C:autophagosome; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of autophagosome assembly;|O60347 Q5VYA6 Q8WX26 Q8WX59 Q9UG83,TBC1 domain family member 12,, PF00566;, GO:0005776;GO:0055037;GO:0005096;GO:0090630;GO:0006886;GO:2000785;, C:autophagosome; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of autophagosome assembly;|O60347 Q5VYA6 Q8WX26 Q8WX59 Q9UG83,TBC1 domain family member 12,, PF00566;, GO:0005776;GO:0055037;GO:0005096;GO:0090630;GO:0006886;GO:2000785;, C:autophagosome; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of autophagosome assembly;|O60347 Q5VYA6 Q8WX26 Q8WX59 Q9UG83,TBC1 domain family member 12,, PF00566;, GO:0005776;GO:0055037;GO:0005096;GO:0090630;GO:0006886;GO:2000785;, C:autophagosome; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of autophagosome assembly;|O60347 Q5VYA6 Q8WX26 Q8WX59 Q9UG83,TBC1 domain family member 12,, PF00566;, GO:0005776;GO:0055037;GO:0005096;GO:0090630;GO:0006886;GO:2000785;, C:autophagosome; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of autophagosome assembly;|O60347 Q5VYA6 Q8WX26 Q8WX59 Q9UG83,TBC1 domain family member 12,, PF00566;, GO:0005776;GO:0055037;GO:0005096;GO:0090630;GO:0006886;GO:2000785;, C:autophagosome; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of autophagosome assembly;|O60347 Q5VYA6 Q8WX26 Q8WX59 Q9UG83,TBC1 domain family member 12,, PF00566;, GO:0005776;GO:0055037;GO:0005096;GO:0090630;GO:0006886;GO:2000785;, C:autophagosome; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of autophagosome assembly;|O60347 Q5VYA6 Q8WX26 Q8WX59 Q9UG83,TBC1 domain family member 12,, PF00566;, GO:0005776;GO:0055037;GO:0005096;GO:0090630;GO:0006886;GO:2000785;, C:autophagosome; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of autophagosome assembly; scaffold14 indexed_genome mRNA 46356506 46389765 . + . ID=transcript_3799;Q76H81 Q7Z397 Q7Z5X2 Q8N6P4 Q9H4P5,Lymphoid-specific helicase,Proliferation-associated SNF2-like protein;SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6;, PF00271;PF00176;, GO:0000775;GO:0005634;GO:0005721;GO:0005524;GO:0003682;GO:0004386;GO:0070615;GO:0007049;GO:0051301;GO:0006306;GO:0006346;GO:0046651;GO:0010216;GO:0007275;GO:0031508;, C:chromosome, centromeric region; C:nucleus; C:pericentric heterochromatin;, F:ATP binding; F:chromatin binding; F:helicase activity; F:nucleosome-dependent ATPase activity;, P:cell cycle; P:cell division; P:DNA methylation; P:DNA methylation-dependent heterochromatin assembly; P:lymphocyte proliferation; P:maintenance of DNA methylation; P:multicellular organism development; P:pericentric heterochromatin assembly;|Q76H81 Q7Z397 Q7Z5X2 Q8N6P4 Q9H4P5,Lymphoid-specific helicase,Proliferation-associated SNF2-like protein;SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6;, PF00271;PF00176;, GO:0000775;GO:0005634;GO:0005721;GO:0005524;GO:0003682;GO:0004386;GO:0070615;GO:0007049;GO:0051301;GO:0006306;GO:0006346;GO:0046651;GO:0010216;GO:0007275;GO:0031508;, C:chromosome, centromeric region; C:nucleus; C:pericentric heterochromatin;, F:ATP binding; F:chromatin binding; F:helicase activity; F:nucleosome-dependent ATPase activity;, P:cell cycle; P:cell division; P:DNA methylation; P:DNA methylation-dependent heterochromatin assembly; P:lymphocyte proliferation; P:maintenance of DNA methylation; P:multicellular organism development; P:pericentric heterochromatin assembly; scaffold14 indexed_genome mRNA 46438256 46443785 . - . ID=transcript_3800;P33261 P33259 Q8WZB1 Q8WZB2 Q9UCD4,Cytochrome P450 2C19,(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC17;CYPIIC19;Cytochrome P450-11A;Cytochrome P450-254C;Fenbendazole monooxygenase (4'-hydroxylating) {ECO:0000305};Mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0019825;GO:0008395;GO:0017144;GO:0019373;GO:0042738;GO:0046483;GO:0016098;GO:0097267;GO:0006082;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P33260 B2R8K2 Q16703 Q16751 Q4VAT5 Q6GRG1,Cytochrome P450 2C18,CYPIIC18;Cytochrome P450-6b/29c;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008401;GO:0008395;GO:0019373;GO:0042738;GO:0006082;GO:0042573;GO:0042572;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:retinoic acid metabolic process; P:retinol metabolic process; P:xenobiotic metabolic process;|P33260 B2R8K2 Q16703 Q16751 Q4VAT5 Q6GRG1,Cytochrome P450 2C18,CYPIIC18;Cytochrome P450-6b/29c;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008401;GO:0008395;GO:0019373;GO:0042738;GO:0006082;GO:0042573;GO:0042572;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:retinoic acid metabolic process; P:retinol metabolic process; P:xenobiotic metabolic process; scaffold14 indexed_genome mRNA 46473776 46475151 . + . ID=transcript_3801;P33261 P33259 Q8WZB1 Q8WZB2 Q9UCD4,Cytochrome P450 2C19,(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC17;CYPIIC19;Cytochrome P450-11A;Cytochrome P450-254C;Fenbendazole monooxygenase (4'-hydroxylating) {ECO:0000305};Mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0019825;GO:0008395;GO:0017144;GO:0019373;GO:0042738;GO:0046483;GO:0016098;GO:0097267;GO:0006082;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P33261 P33259 Q8WZB1 Q8WZB2 Q9UCD4,Cytochrome P450 2C19,(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC17;CYPIIC19;Cytochrome P450-11A;Cytochrome P450-254C;Fenbendazole monooxygenase (4'-hydroxylating) {ECO:0000305};Mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0019825;GO:0008395;GO:0017144;GO:0019373;GO:0042738;GO:0046483;GO:0016098;GO:0097267;GO:0006082;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process; scaffold14 indexed_genome mRNA 46478649 46536650 . - . ID=transcript_3802;P33260 B2R8K2 Q16703 Q16751 Q4VAT5 Q6GRG1,Cytochrome P450 2C18,CYPIIC18;Cytochrome P450-6b/29c;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008401;GO:0008395;GO:0019373;GO:0042738;GO:0006082;GO:0042573;GO:0042572;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:retinoic acid metabolic process; P:retinol metabolic process; P:xenobiotic metabolic process;|P33261 P33259 Q8WZB1 Q8WZB2 Q9UCD4,Cytochrome P450 2C19,(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC17;CYPIIC19;Cytochrome P450-11A;Cytochrome P450-254C;Fenbendazole monooxygenase (4'-hydroxylating) {ECO:0000305};Mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0019825;GO:0008395;GO:0017144;GO:0019373;GO:0042738;GO:0046483;GO:0016098;GO:0097267;GO:0006082;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P11712 P11713 Q16756 Q16872 Q5VX92 Q6IRV8 Q8WW80,Cytochrome P450 2C9 {ECO:0000303|PubMed:8809086},(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC9;Cholesterol 25-hydroxylase {ECO:0000303|PubMed:3079764};Cytochrome P-450MP;Cytochrome P450 MP-4;Cytochrome P450 MP-8;Cytochrome P450 PB-1;S-mephenytoin 4-hydroxylase {ECO:0000303|PubMed:3079764};, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008405;GO:0008404;GO:0008392;GO:0070330;GO:0034875;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0008395;GO:0043603;GO:0008203;GO:0042737;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046456;GO:0042759;GO:0032787;GO:0016098;GO:0097267;GO:0006082;GO:0070989;GO:0008202;GO:0019627;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid 11,12-epoxygenase activity; F:arachidonic acid 14,15-epoxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:caffeine oxidase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:cellular amide metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:icosanoid biosynthetic process; P:long-chain fatty acid biosynthetic process; P:monocarboxylic acid metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:oxidative demethylation; P:steroid metabolic process; P:urea metabolic process; P:xenobiotic metabolic process;|P33260 B2R8K2 Q16703 Q16751 Q4VAT5 Q6GRG1,Cytochrome P450 2C18,CYPIIC18;Cytochrome P450-6b/29c;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008401;GO:0008395;GO:0019373;GO:0042738;GO:0006082;GO:0042573;GO:0042572;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:retinoic acid metabolic process; P:retinol metabolic process; P:xenobiotic metabolic process;|P11712 P11713 Q16756 Q16872 Q5VX92 Q6IRV8 Q8WW80,Cytochrome P450 2C9 {ECO:0000303|PubMed:8809086},(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC9;Cholesterol 25-hydroxylase {ECO:0000303|PubMed:3079764};Cytochrome P-450MP;Cytochrome P450 MP-4;Cytochrome P450 MP-8;Cytochrome P450 PB-1;S-mephenytoin 4-hydroxylase {ECO:0000303|PubMed:3079764};, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008405;GO:0008404;GO:0008392;GO:0070330;GO:0034875;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0008395;GO:0043603;GO:0008203;GO:0042737;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046456;GO:0042759;GO:0032787;GO:0016098;GO:0097267;GO:0006082;GO:0070989;GO:0008202;GO:0019627;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid 11,12-epoxygenase activity; F:arachidonic acid 14,15-epoxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:caffeine oxidase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:cellular amide metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:icosanoid biosynthetic process; P:long-chain fatty acid biosynthetic process; P:monocarboxylic acid metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:oxidative demethylation; P:steroid metabolic process; P:urea metabolic process; P:xenobiotic metabolic process; scaffold15 indexed_genome mRNA 97649 149259 . + . ID=transcript_3803;Q8NBW4 A0A0A8K8P2 B3KXV1 B7Z7D0 Q0P5S0 Q6MZJ8,Sodium-coupled neutral amino acid transporter 9 {ECO:0000305},Solute carrier family 38 member 9 {ECO:0000312|HGNC:HGNC:26907};Up-regulated in lung cancer 11 {ECO:0000303|Ref.2};, PF01490;, GO:1905103;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0015171;GO:0061459;GO:0015190;GO:0046872;GO:0003333;GO:0007050;GO:0034198;GO:0071230;GO:0032008;GO:0016241;, C:integral component of lysosomal membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:amino acid transmembrane transporter activity; F:L-arginine transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:metal ion binding;, P:amino acid transmembrane transport; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:positive regulation of TOR signaling; P:regulation of macroautophagy;|Q8NBW4 A0A0A8K8P2 B3KXV1 B7Z7D0 Q0P5S0 Q6MZJ8,Sodium-coupled neutral amino acid transporter 9 {ECO:0000305},Solute carrier family 38 member 9 {ECO:0000312|HGNC:HGNC:26907};Up-regulated in lung cancer 11 {ECO:0000303|Ref.2};, PF01490;, GO:1905103;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0015171;GO:0061459;GO:0015190;GO:0046872;GO:0003333;GO:0007050;GO:0034198;GO:0071230;GO:0032008;GO:0016241;, C:integral component of lysosomal membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:amino acid transmembrane transporter activity; F:L-arginine transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:metal ion binding;, P:amino acid transmembrane transport; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:positive regulation of TOR signaling; P:regulation of macroautophagy;|Q8NBW4 A0A0A8K8P2 B3KXV1 B7Z7D0 Q0P5S0 Q6MZJ8,Sodium-coupled neutral amino acid transporter 9 {ECO:0000305},Solute carrier family 38 member 9 {ECO:0000312|HGNC:HGNC:26907};Up-regulated in lung cancer 11 {ECO:0000303|Ref.2};, PF01490;, GO:1905103;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0015171;GO:0061459;GO:0015190;GO:0046872;GO:0003333;GO:0007050;GO:0034198;GO:0071230;GO:0032008;GO:0016241;, C:integral component of lysosomal membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:amino acid transmembrane transporter activity; F:L-arginine transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:metal ion binding;, P:amino acid transmembrane transport; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:positive regulation of TOR signaling; P:regulation of macroautophagy; scaffold15 indexed_genome mRNA 230098 230931 . + . ID=transcript_3804;O14494 B7ZKN8 G3XA95 O60457 O60463 Q17RZ4,Phospholipid phosphatase 1 {ECO:0000305},Lipid phosphate phosphohydrolase 1;PAP2-alpha;Phosphatidate phosphohydrolase type 2a;Phosphatidic acid phosphatase 2a;, PF01569;, GO:0016324;GO:0005901;GO:0070062;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0106235;GO:0000810;GO:0042577;GO:0008195;GO:0042392;GO:0030521;GO:0006672;GO:0030518;GO:0008285;GO:0046839;GO:0006644;GO:0007205;GO:0019216;GO:0007165;GO:0030148;GO:0006670;, C:apical plasma membrane; C:caveola; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:ceramide-1-phosphate phosphatase activity; F:diacylglycerol diphosphate phosphatase activity; F:lipid phosphatase activity; F:phosphatidate phosphatase activity; F:sphingosine-1-phosphate phosphatase activity;, P:androgen receptor signaling pathway; P:ceramide metabolic process; P:intracellular steroid hormone receptor signaling pathway; P:negative regulation of cell population proliferation; P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of lipid metabolic process; P:signal transduction; P:sphingolipid biosynthetic process; P:sphingosine metabolic process; scaffold15 indexed_genome mRNA 292319 293233 . + . ID=transcript_3805;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold15 indexed_genome mRNA 296898 477320 . + . ID=transcript_3806;O14494 B7ZKN8 G3XA95 O60457 O60463 Q17RZ4,Phospholipid phosphatase 1 {ECO:0000305},Lipid phosphate phosphohydrolase 1;PAP2-alpha;Phosphatidate phosphohydrolase type 2a;Phosphatidic acid phosphatase 2a;, PF01569;, GO:0016324;GO:0005901;GO:0070062;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0106235;GO:0000810;GO:0042577;GO:0008195;GO:0042392;GO:0030521;GO:0006672;GO:0030518;GO:0008285;GO:0046839;GO:0006644;GO:0007205;GO:0019216;GO:0007165;GO:0030148;GO:0006670;, C:apical plasma membrane; C:caveola; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:ceramide-1-phosphate phosphatase activity; F:diacylglycerol diphosphate phosphatase activity; F:lipid phosphatase activity; F:phosphatidate phosphatase activity; F:sphingosine-1-phosphate phosphatase activity;, P:androgen receptor signaling pathway; P:ceramide metabolic process; P:intracellular steroid hormone receptor signaling pathway; P:negative regulation of cell population proliferation; P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of lipid metabolic process; P:signal transduction; P:sphingolipid biosynthetic process; P:sphingosine metabolic process;|O14494 B7ZKN8 G3XA95 O60457 O60463 Q17RZ4,Phospholipid phosphatase 1 {ECO:0000305},Lipid phosphate phosphohydrolase 1;PAP2-alpha;Phosphatidate phosphohydrolase type 2a;Phosphatidic acid phosphatase 2a;, PF01569;, GO:0016324;GO:0005901;GO:0070062;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0106235;GO:0000810;GO:0042577;GO:0008195;GO:0042392;GO:0030521;GO:0006672;GO:0030518;GO:0008285;GO:0046839;GO:0006644;GO:0007205;GO:0019216;GO:0007165;GO:0030148;GO:0006670;, C:apical plasma membrane; C:caveola; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:ceramide-1-phosphate phosphatase activity; F:diacylglycerol diphosphate phosphatase activity; F:lipid phosphatase activity; F:phosphatidate phosphatase activity; F:sphingosine-1-phosphate phosphatase activity;, P:androgen receptor signaling pathway; P:ceramide metabolic process; P:intracellular steroid hormone receptor signaling pathway; P:negative regulation of cell population proliferation; P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of lipid metabolic process; P:signal transduction; P:sphingolipid biosynthetic process; P:sphingosine metabolic process;|P42285 Q2M386 Q6MZZ8 Q6P170 Q8N5R0 Q8TAG2,Exosome RNA helicase MTR4 {ECO:0000305},ATP-dependent RNA helicase DOB1 {ECO:0000303|PubMed:16782053};ATP-dependent RNA helicase SKIV2L2;Superkiller viralicidic activity 2-like 2;TRAMP-like complex helicase;, PF00270;PF08148;PF00271;PF13234;, GO:0071013;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0003723;GO:0003724;GO:0006974;GO:0000460;GO:0000398;GO:0006401;GO:0006364;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cellular response to DNA damage stimulus; P:maturation of 5.8S rRNA; P:mRNA splicing, via spliceosome; P:RNA catabolic process; P:rRNA processing; P:snRNA catabolic process;|P42285 Q2M386 Q6MZZ8 Q6P170 Q8N5R0 Q8TAG2,Exosome RNA helicase MTR4 {ECO:0000305},ATP-dependent RNA helicase DOB1 {ECO:0000303|PubMed:16782053};ATP-dependent RNA helicase SKIV2L2;Superkiller viralicidic activity 2-like 2;TRAMP-like complex helicase;, PF00270;PF08148;PF00271;PF13234;, GO:0071013;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0003723;GO:0003724;GO:0006974;GO:0000460;GO:0000398;GO:0006401;GO:0006364;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cellular response to DNA damage stimulus; P:maturation of 5.8S rRNA; P:mRNA splicing, via spliceosome; P:RNA catabolic process; P:rRNA processing; P:snRNA catabolic process;|P42285 Q2M386 Q6MZZ8 Q6P170 Q8N5R0 Q8TAG2,Exosome RNA helicase MTR4 {ECO:0000305},ATP-dependent RNA helicase DOB1 {ECO:0000303|PubMed:16782053};ATP-dependent RNA helicase SKIV2L2;Superkiller viralicidic activity 2-like 2;TRAMP-like complex helicase;, PF00270;PF08148;PF00271;PF13234;, GO:0071013;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0003723;GO:0003724;GO:0006974;GO:0000460;GO:0000398;GO:0006401;GO:0006364;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cellular response to DNA damage stimulus; P:maturation of 5.8S rRNA; P:mRNA splicing, via spliceosome; P:RNA catabolic process; P:rRNA processing; P:snRNA catabolic process;|P42285 Q2M386 Q6MZZ8 Q6P170 Q8N5R0 Q8TAG2,Exosome RNA helicase MTR4 {ECO:0000305},ATP-dependent RNA helicase DOB1 {ECO:0000303|PubMed:16782053};ATP-dependent RNA helicase SKIV2L2;Superkiller viralicidic activity 2-like 2;TRAMP-like complex helicase;, PF00270;PF08148;PF00271;PF13234;, GO:0071013;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0003723;GO:0003724;GO:0006974;GO:0000460;GO:0000398;GO:0006401;GO:0006364;GO:0016076;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cellular response to DNA damage stimulus; P:maturation of 5.8S rRNA; P:mRNA splicing, via spliceosome; P:RNA catabolic process; P:rRNA processing; P:snRNA catabolic process;|Q7Z478 O75549 Q63HN0 Q63HN3 Q8IWW2 Q8N3A1 Q9UMH2,ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068},DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};Nucleic acid helicase DDXx;, PF00270;PF04408;PF00271;PF07717;, GO:0022627;GO:0016282;GO:0005524;GO:0045296;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;, C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex;, F:ATP binding; F:cadherin binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;|Q7Z478 O75549 Q63HN0 Q63HN3 Q8IWW2 Q8N3A1 Q9UMH2,ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068},DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};Nucleic acid helicase DDXx;, PF00270;PF04408;PF00271;PF07717;, GO:0022627;GO:0016282;GO:0005524;GO:0045296;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;, C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex;, F:ATP binding; F:cadherin binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;|Q7Z478 O75549 Q63HN0 Q63HN3 Q8IWW2 Q8N3A1 Q9UMH2,ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068},DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};Nucleic acid helicase DDXx;, PF00270;PF04408;PF00271;PF07717;, GO:0022627;GO:0016282;GO:0005524;GO:0045296;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;, C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex;, F:ATP binding; F:cadherin binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;|Q7Z478 O75549 Q63HN0 Q63HN3 Q8IWW2 Q8N3A1 Q9UMH2,ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068},DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};Nucleic acid helicase DDXx;, PF00270;PF04408;PF00271;PF07717;, GO:0022627;GO:0016282;GO:0005524;GO:0045296;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;, C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex;, F:ATP binding; F:cadherin binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;|Q7Z478 O75549 Q63HN0 Q63HN3 Q8IWW2 Q8N3A1 Q9UMH2,ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068},DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};Nucleic acid helicase DDXx;, PF00270;PF04408;PF00271;PF07717;, GO:0022627;GO:0016282;GO:0005524;GO:0045296;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;, C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex;, F:ATP binding; F:cadherin binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;|Q7Z478 O75549 Q63HN0 Q63HN3 Q8IWW2 Q8N3A1 Q9UMH2,ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068},DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};Nucleic acid helicase DDXx;, PF00270;PF04408;PF00271;PF07717;, GO:0022627;GO:0016282;GO:0005524;GO:0045296;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;, C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex;, F:ATP binding; F:cadherin binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;|Q7Z478 O75549 Q63HN0 Q63HN3 Q8IWW2 Q8N3A1 Q9UMH2,ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068},DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};Nucleic acid helicase DDXx;, PF00270;PF04408;PF00271;PF07717;, GO:0022627;GO:0016282;GO:0005524;GO:0045296;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;, C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex;, F:ATP binding; F:cadherin binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;|Q7Z478 O75549 Q63HN0 Q63HN3 Q8IWW2 Q8N3A1 Q9UMH2,ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068},DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};Nucleic acid helicase DDXx;, PF00270;PF04408;PF00271;PF07717;, GO:0022627;GO:0016282;GO:0005524;GO:0045296;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;, C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex;, F:ATP binding; F:cadherin binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;|Q7Z478 O75549 Q63HN0 Q63HN3 Q8IWW2 Q8N3A1 Q9UMH2,ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068},DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};Nucleic acid helicase DDXx;, PF00270;PF04408;PF00271;PF07717;, GO:0022627;GO:0016282;GO:0005524;GO:0045296;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;, C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex;, F:ATP binding; F:cadherin binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;|P49207 Q6FG66 Q9BUZ2,60S ribosomal protein L34,Large ribosomal subunit protein eL34 {ECO:0000303|PubMed:24524803};, PF01199;, GO:0005829;GO:0022625;GO:0005783;GO:0070062;GO:0045296;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome;, F:cadherin binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold15 indexed_genome mRNA 537078 542380 . - . ID=transcript_3807;Q8TED1,Probable glutathione peroxidase 8,, PF00255;, GO:0005788;GO:0016021;GO:0004602;GO:0004601;GO:0034599;, C:endoplasmic reticulum lumen; C:integral component of membrane;, F:glutathione peroxidase activity; F:peroxidase activity;, P:cellular response to oxidative stress; scaffold15 indexed_genome mRNA 593137 596332 . - . ID=transcript_3808;P12544 A4PHN1 Q6IB36,Granzyme A {ECO:0000303|PubMed:3263427},CTL tryptase {ECO:0000303|PubMed:3047119};Cytotoxic T-lymphocyte proteinase 1 {ECO:0000303|PubMed:3047119};Fragmentin-1;Granzyme-1 {ECO:0000303|PubMed:3262682};Hanukkah factor {ECO:0000303|PubMed:3257574};, PF00089;, GO:0005576;GO:0001772;GO:0005634;GO:0042803;GO:0004252;GO:0006915;GO:0019835;GO:1902483;GO:0140507;GO:0006955;GO:0043392;GO:0032078;GO:0051354;GO:0043065;GO:0051603;GO:0070269;GO:0009617;, C:extracellular region; C:immunological synapse; C:nucleus;, F:protein homodimerization activity; F:serine-type endopeptidase activity;, P:apoptotic process; P:cytolysis; P:cytotoxic T cell pyroptotic process; P:granzyme-mediated programmed cell death signaling pathway; P:immune response; P:negative regulation of DNA binding; P:negative regulation of endodeoxyribonuclease activity; P:negative regulation of oxidoreductase activity; P:positive regulation of apoptotic process; P:proteolysis involved in cellular protein catabolic process; P:pyroptosis; P:response to bacterium; scaffold15 indexed_genome mRNA 608684 615806 . - . ID=transcript_3809;P12544 A4PHN1 Q6IB36,Granzyme A {ECO:0000303|PubMed:3263427},CTL tryptase {ECO:0000303|PubMed:3047119};Cytotoxic T-lymphocyte proteinase 1 {ECO:0000303|PubMed:3047119};Fragmentin-1;Granzyme-1 {ECO:0000303|PubMed:3262682};Hanukkah factor {ECO:0000303|PubMed:3257574};, PF00089;, GO:0005576;GO:0001772;GO:0005634;GO:0042803;GO:0004252;GO:0006915;GO:0019835;GO:1902483;GO:0140507;GO:0006955;GO:0043392;GO:0032078;GO:0051354;GO:0043065;GO:0051603;GO:0070269;GO:0009617;, C:extracellular region; C:immunological synapse; C:nucleus;, F:protein homodimerization activity; F:serine-type endopeptidase activity;, P:apoptotic process; P:cytolysis; P:cytotoxic T cell pyroptotic process; P:granzyme-mediated programmed cell death signaling pathway; P:immune response; P:negative regulation of DNA binding; P:negative regulation of endodeoxyribonuclease activity; P:negative regulation of oxidoreductase activity; P:positive regulation of apoptotic process; P:proteolysis involved in cellular protein catabolic process; P:pyroptosis; P:response to bacterium; scaffold15 indexed_genome mRNA 657491 667660 . - . ID=transcript_3810;P49863 B2R563,Granzyme K,Fragmentin-3;Granzyme-3;NK-tryptase-2;, PF00089;, GO:0005576;GO:0004252;GO:0008236;, C:extracellular region;, F:serine-type endopeptidase activity; F:serine-type peptidase activity; scaffold15 indexed_genome mRNA 699497 707540 . + . ID=transcript_3811;Q9NQ30 B2R4G3 Q15330 Q3V4E3 Q96ES3,Endothelial cell-specific molecule 1,, PF00219;, GO:0005576;GO:0005171;GO:0005520;GO:0005178;GO:0001525;GO:0008284;GO:1902204;GO:0002040;, C:extracellular region;, F:hepatocyte growth factor receptor binding; F:insulin-like growth factor binding; F:integrin binding;, P:angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of hepatocyte growth factor receptor signaling pathway; P:sprouting angiogenesis; scaffold15 indexed_genome mRNA 1109539 1140109 . - . ID=transcript_3812;Q96RF0 B4E2B3 H7BXX3 Q05BB3 Q0VG02,Sorting nexin-18,SH3 and PX domain-containing protein 3B;Sorting nexin-associated Golgi protein 1;, PF10456;PF00787;PF14604;, GO:0031410;GO:0030659;GO:0010008;GO:0070062;GO:0031234;GO:0005546;GO:0036089;GO:0006897;GO:0016197;GO:0000281;GO:0043547;GO:0015031;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:endosome membrane; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane;, F:phosphatidylinositol-4,5-bisphosphate binding;, P:cleavage furrow formation; P:endocytosis; P:endosomal transport; P:mitotic cytokinesis; P:positive regulation of GTPase activity; P:protein transport; scaffold15 indexed_genome mRNA 1182611 1192771 . - . ID=transcript_3813;Q12988,Heat shock protein beta-3,Heat shock 17 kDa protein;Protein 3;, PF00011;, GO:0005737;GO:0016607;GO:0005634;GO:0006986;, C:cytoplasm; C:nuclear speck; C:nucleus;, , P:response to unfolded protein;|Q12988,Heat shock protein beta-3,Heat shock 17 kDa protein;Protein 3;, PF00011;, GO:0005737;GO:0016607;GO:0005634;GO:0006986;, C:cytoplasm; C:nuclear speck; C:nucleus;, , P:response to unfolded protein;|Q12988,Heat shock protein beta-3,Heat shock 17 kDa protein;Protein 3;, PF00011;, GO:0005737;GO:0016607;GO:0005634;GO:0006986;, C:cytoplasm; C:nuclear speck; C:nucleus;, , P:response to unfolded protein; scaffold15 indexed_genome mRNA 1540102 1760289 . + . ID=transcript_3814;Q9NXU5 Q6IAD0,ADP-ribosylation factor-like protein 15,ADP-ribosylation factor-related protein 2;, PF00025;, GO:0070062;GO:0005525;, C:extracellular exosome;, F:GTP binding;|Q9NXU5 Q6IAD0,ADP-ribosylation factor-like protein 15,ADP-ribosylation factor-related protein 2;, PF00025;, GO:0070062;GO:0005525;, C:extracellular exosome;, F:GTP binding; scaffold15 indexed_genome mRNA 1905643 1910906 . + . ID=transcript_3815;O43181 Q9BS69,NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial,Complex I-18 kDa;Complex I-AQDQ;NADH-ubiquinone oxidoreductase 18 kDa subunit;, PF04800;, GO:0005743;GO:0005747;GO:0005739;GO:0008137;GO:0007420;GO:0045333;GO:0006120;GO:0032981;GO:0048146;GO:0072593;GO:0001932;GO:0051591;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:brain development; P:cellular respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:positive regulation of fibroblast proliferation; P:reactive oxygen species metabolic process; P:regulation of protein phosphorylation; P:response to cAMP;|O43181 Q9BS69,NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial,Complex I-18 kDa;Complex I-AQDQ;NADH-ubiquinone oxidoreductase 18 kDa subunit;, PF04800;, GO:0005743;GO:0005747;GO:0005739;GO:0008137;GO:0007420;GO:0045333;GO:0006120;GO:0032981;GO:0048146;GO:0072593;GO:0001932;GO:0051591;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:brain development; P:cellular respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:positive regulation of fibroblast proliferation; P:reactive oxygen species metabolic process; P:regulation of protein phosphorylation; P:response to cAMP; scaffold15 indexed_genome mRNA 2080692 2090495 . - . ID=transcript_3816;P19883 B5BU94 Q9BTH0,Follistatin {ECO:0000303|PubMed:3380788},Activin-binding protein {ECO:0000250|UniProtKB:P21674};, PF09289;PF07648;, GO:0005737;GO:0005576;GO:0005615;GO:0005634;GO:0048185;GO:0038102;GO:0043395;GO:0030509;GO:0030154;GO:0008585;GO:0007276;GO:0031069;GO:0002244;GO:0043616;GO:0007275;GO:0032926;GO:0045596;GO:0000122;GO:0042475;GO:0007389;GO:0051798;GO:0030510;GO:0001501;, C:cytoplasm; C:extracellular region; C:extracellular space; C:nucleus;, F:activin binding; F:activin receptor antagonist activity; F:heparan sulfate proteoglycan binding;, P:BMP signaling pathway; P:cell differentiation; P:female gonad development; P:gamete generation; P:hair follicle morphogenesis; P:hematopoietic progenitor cell differentiation; P:keratinocyte proliferation; P:multicellular organism development; P:negative regulation of activin receptor signaling pathway; P:negative regulation of cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis of dentin-containing tooth; P:pattern specification process; P:positive regulation of hair follicle development; P:regulation of BMP signaling pathway; P:skeletal system development;|P19883 B5BU94 Q9BTH0,Follistatin {ECO:0000303|PubMed:3380788},Activin-binding protein {ECO:0000250|UniProtKB:P21674};, PF09289;PF07648;, GO:0005737;GO:0005576;GO:0005615;GO:0005634;GO:0048185;GO:0038102;GO:0043395;GO:0030509;GO:0030154;GO:0008585;GO:0007276;GO:0031069;GO:0002244;GO:0043616;GO:0007275;GO:0032926;GO:0045596;GO:0000122;GO:0042475;GO:0007389;GO:0051798;GO:0030510;GO:0001501;, C:cytoplasm; C:extracellular region; C:extracellular space; C:nucleus;, F:activin binding; F:activin receptor antagonist activity; F:heparan sulfate proteoglycan binding;, P:BMP signaling pathway; P:cell differentiation; P:female gonad development; P:gamete generation; P:hair follicle morphogenesis; P:hematopoietic progenitor cell differentiation; P:keratinocyte proliferation; P:multicellular organism development; P:negative regulation of activin receptor signaling pathway; P:negative regulation of cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis of dentin-containing tooth; P:pattern specification process; P:positive regulation of hair follicle development; P:regulation of BMP signaling pathway; P:skeletal system development;|P19883 B5BU94 Q9BTH0,Follistatin {ECO:0000303|PubMed:3380788},Activin-binding protein {ECO:0000250|UniProtKB:P21674};, PF09289;PF07648;, GO:0005737;GO:0005576;GO:0005615;GO:0005634;GO:0048185;GO:0038102;GO:0043395;GO:0030509;GO:0030154;GO:0008585;GO:0007276;GO:0031069;GO:0002244;GO:0043616;GO:0007275;GO:0032926;GO:0045596;GO:0000122;GO:0042475;GO:0007389;GO:0051798;GO:0030510;GO:0001501;, C:cytoplasm; C:extracellular region; C:extracellular space; C:nucleus;, F:activin binding; F:activin receptor antagonist activity; F:heparan sulfate proteoglycan binding;, P:BMP signaling pathway; P:cell differentiation; P:female gonad development; P:gamete generation; P:hair follicle morphogenesis; P:hematopoietic progenitor cell differentiation; P:keratinocyte proliferation; P:multicellular organism development; P:negative regulation of activin receptor signaling pathway; P:negative regulation of cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis of dentin-containing tooth; P:pattern specification process; P:positive regulation of hair follicle development; P:regulation of BMP signaling pathway; P:skeletal system development;|P19883 B5BU94 Q9BTH0,Follistatin {ECO:0000303|PubMed:3380788},Activin-binding protein {ECO:0000250|UniProtKB:P21674};, PF09289;PF07648;, GO:0005737;GO:0005576;GO:0005615;GO:0005634;GO:0048185;GO:0038102;GO:0043395;GO:0030509;GO:0030154;GO:0008585;GO:0007276;GO:0031069;GO:0002244;GO:0043616;GO:0007275;GO:0032926;GO:0045596;GO:0000122;GO:0042475;GO:0007389;GO:0051798;GO:0030510;GO:0001501;, C:cytoplasm; C:extracellular region; C:extracellular space; C:nucleus;, F:activin binding; F:activin receptor antagonist activity; F:heparan sulfate proteoglycan binding;, P:BMP signaling pathway; P:cell differentiation; P:female gonad development; P:gamete generation; P:hair follicle morphogenesis; P:hematopoietic progenitor cell differentiation; P:keratinocyte proliferation; P:multicellular organism development; P:negative regulation of activin receptor signaling pathway; P:negative regulation of cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis of dentin-containing tooth; P:pattern specification process; P:positive regulation of hair follicle development; P:regulation of BMP signaling pathway; P:skeletal system development; scaffold15 indexed_genome mRNA 2469103 2470286 . - . ID=transcript_3817;O96007 Q6IAI3,Molybdopterin synthase catalytic subunit {ECO:0000255|HAMAP-Rule:MF_03052},MOCO1-B;Molybdenum cofactor synthesis protein 2 large subunit {ECO:0000255|HAMAP-Rule:MF_03052};Molybdenum cofactor synthesis protein 2B {ECO:0000255|HAMAP-Rule:MF_03052};Molybdopterin-synthase large subunit;, PF02391;, GO:0005829;GO:0019008;GO:0016607;GO:0005654;GO:0030366;GO:0006777;GO:0032324;, C:cytosol; C:molybdopterin synthase complex; C:nuclear speck; C:nucleoplasm;, F:molybdopterin synthase activity;, P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process; scaffold15 indexed_genome mRNA 2470802 2472322 . + . ID=transcript_3818;O96007 Q6IAI3,Molybdopterin synthase catalytic subunit {ECO:0000255|HAMAP-Rule:MF_03052},MOCO1-B;Molybdenum cofactor synthesis protein 2 large subunit {ECO:0000255|HAMAP-Rule:MF_03052};Molybdenum cofactor synthesis protein 2B {ECO:0000255|HAMAP-Rule:MF_03052};Molybdopterin-synthase large subunit;, PF02391;, GO:0005829;GO:0019008;GO:0016607;GO:0005654;GO:0030366;GO:0006777;GO:0032324;, C:cytosol; C:molybdopterin synthase complex; C:nuclear speck; C:nucleoplasm;, F:molybdopterin synthase activity;, P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process; scaffold15 indexed_genome mRNA 2485726 2508448 . - . ID=transcript_3819;P17301 Q14595,Integrin alpha-2,CD49 antigen-like family member B;Collagen receptor;Platelet membrane glycoprotein Ia;VLA-2 subunit alpha;, PF01839;PF08441;PF00092;, GO:0043679;GO:0045178;GO:0009986;GO:0009897;GO:0005925;GO:0034666;GO:0008305;GO:0005634;GO:0048471;GO:0005886;GO:0001540;GO:0005518;GO:0098639;GO:0038064;GO:0043395;GO:0005178;GO:0043236;GO:0046872;GO:0044877;GO:0001618;GO:0009887;GO:0007596;GO:0007155;GO:0033627;GO:0008283;GO:0007160;GO:0031589;GO:0071392;GO:0071260;GO:0038065;GO:0050966;GO:0045184;GO:0030198;GO:0007565;GO:0048041;GO:0070365;GO:0006971;GO:0007229;GO:0030879;GO:0048333;GO:0010694;GO:0045785;GO:0031346;GO:0033343;GO:0032967;GO:0043388;GO:0010634;GO:0050729;GO:0002687;GO:0060100;GO:0050927;GO:0014911;GO:0048661;GO:0045987;GO:0045727;GO:0051971;GO:0014075;GO:0042493;GO:0001666;GO:0033591;GO:0014850;GO:0071107;GO:0043589;GO:0006929;, C:axon terminus; C:basal part of cell; C:cell surface; C:external side of plasma membrane; C:focal adhesion; C:integrin alpha2-beta1 complex; C:integrin complex; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:amyloid-beta binding; F:collagen binding; F:collagen binding involved in cell-matrix adhesion; F:collagen receptor activity; F:heparan sulfate proteoglycan binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:protein-containing complex binding; F:virus receptor activity;, P:animal organ morphogenesis; P:blood coagulation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell population proliferation; P:cell-matrix adhesion; P:cell-substrate adhesion; P:cellular response to estradiol stimulus; P:cellular response to mechanical stimulus; P:collagen-activated signaling pathway; P:detection of mechanical stimulus involved in sensory perception of pain; P:establishment of protein localization; P:extracellular matrix organization; P:female pregnancy; P:focal adhesion assembly; P:hepatocyte differentiation; P:hypotonic response; P:integrin-mediated signaling pathway; P:mammary gland development; P:mesodermal cell differentiation; P:positive regulation of alkaline phosphatase activity; P:positive regulation of cell adhesion; P:positive regulation of cell projection organization; P:positive regulation of collagen binding; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA binding; P:positive regulation of epithelial cell migration; P:positive regulation of inflammatory response; P:positive regulation of leukocyte migration; P:positive regulation of phagocytosis, engulfment; P:positive regulation of positive chemotaxis; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of smooth muscle contraction; P:positive regulation of translation; P:positive regulation of transmission of nerve impulse; P:response to amine; P:response to drug; P:response to hypoxia; P:response to L-ascorbic acid; P:response to muscle activity; P:response to parathyroid hormone; P:skin morphogenesis; P:substrate-dependent cell migration; scaffold15 indexed_genome mRNA 2606249 2765844 . - . ID=transcript_3820;P56199 B2RNU0,Integrin alpha-1,CD49 antigen-like family member A;Laminin and collagen receptor;VLA-1;, PF01839;PF08441;PF00092;, GO:0001669;GO:0045178;GO:0009986;GO:0009897;GO:0070062;GO:0005925;GO:0034665;GO:0008305;GO:0016020;GO:0045121;GO:0043005;GO:0043204;GO:0005886;GO:0005518;GO:0098639;GO:0046872;GO:0019903;GO:0005102;GO:0000187;GO:0007160;GO:0045123;GO:0030198;GO:0007229;GO:0006936;GO:0008285;GO:0042059;GO:0048812;GO:0030593;GO:0043525;GO:0032516;GO:0042311;, C:acrosomal vesicle; C:basal part of cell; C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integrin alpha1-beta1 complex; C:integrin complex; C:membrane; C:membrane raft; C:neuron projection; C:perikaryon; C:plasma membrane;, F:collagen binding; F:collagen binding involved in cell-matrix adhesion; F:metal ion binding; F:protein phosphatase binding; F:signaling receptor binding;, P:activation of MAPK activity; P:cell-matrix adhesion; P:cellular extravasation; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:muscle contraction; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:neuron projection morphogenesis; P:neutrophil chemotaxis; P:positive regulation of neuron apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:vasodilation;|Q9BRX2 Q9GZS6 Q9Y306,Protein pelota homolog,, PF03463;PF03464;PF03465;, GO:0005737;GO:0005634;GO:0004519;GO:0046872;GO:0007049;GO:0051301;GO:0051276;GO:0007492;GO:0001833;GO:0060231;GO:0070651;GO:0070966;GO:0070481;GO:0030513;GO:0006417;GO:0032790;GO:0071025;GO:0019827;, C:cytoplasm; C:nucleus;, F:endonuclease activity; F:metal ion binding;, P:cell cycle; P:cell division; P:chromosome organization; P:endoderm development; P:inner cell mass cell proliferation; P:mesenchymal to epithelial transition; P:nonfunctional rRNA decay; P:nuclear-transcribed mRNA catabolic process, no-go decay; P:nuclear-transcribed mRNA catabolic process, non-stop decay; P:positive regulation of BMP signaling pathway; P:regulation of translation; P:ribosome disassembly; P:RNA surveillance; P:stem cell population maintenance; scaffold15 indexed_genome mRNA 4613205 4808763 . - . ID=transcript_3821;Q8N3A8 Q3KRB7 Q6DHZ1 Q9H754,Protein mono-ADP-ribosyltransferase PARP8 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 16 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 8 {ECO:0000303|PubMed:20106667};, PF00644;, GO:0003950;GO:1990404;GO:0006471;GO:0070213;GO:0140289;, , F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation;|Q8N3A8 Q3KRB7 Q6DHZ1 Q9H754,Protein mono-ADP-ribosyltransferase PARP8 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 16 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 8 {ECO:0000303|PubMed:20106667};, PF00644;, GO:0003950;GO:1990404;GO:0006471;GO:0070213;GO:0140289;, , F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; scaffold15 indexed_genome mRNA 4978643 5040663 . + . ID=transcript_3822;Q6PCB8 B7Z6S3 B7Z902,Embigin,, PF07679;PF00047;, GO:0030424;GO:0005887;GO:0005886;GO:0045202;GO:0098632;GO:0007411;GO:0070593;GO:0007156;GO:0035879;, C:axon; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:plasma membrane lactate transport; scaffold15 indexed_genome mRNA 5845485 5853760 . + . ID=transcript_3823;O60741,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Brain cyclic nucleotide-gated channel 1;, PF00027;PF00520;PF08412;, GO:0030424;GO:0030425;GO:0098855;GO:0005887;GO:0005886;GO:0030552;GO:0042802;GO:0005222;GO:0005267;GO:0022843;GO:0005249;GO:0005248;GO:0045176;GO:0071320;GO:0071805;GO:0051289;GO:0034765;GO:0042391;GO:0046549;GO:0035725;, C:axon; C:dendrite; C:HCN channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:cAMP binding; F:identical protein binding; F:intracellular cAMP-activated cation channel activity; F:potassium channel activity; F:voltage-gated cation channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:apical protein localization; P:cellular response to cAMP; P:potassium ion transmembrane transport; P:protein homotetramerization; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:retinal cone cell development; P:sodium ion transmembrane transport;|O60741,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Brain cyclic nucleotide-gated channel 1;, PF00027;PF00520;PF08412;, GO:0030424;GO:0030425;GO:0098855;GO:0005887;GO:0005886;GO:0030552;GO:0042802;GO:0005222;GO:0005267;GO:0022843;GO:0005249;GO:0005248;GO:0045176;GO:0071320;GO:0071805;GO:0051289;GO:0034765;GO:0042391;GO:0046549;GO:0035725;, C:axon; C:dendrite; C:HCN channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:cAMP binding; F:identical protein binding; F:intracellular cAMP-activated cation channel activity; F:potassium channel activity; F:voltage-gated cation channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:apical protein localization; P:cellular response to cAMP; P:potassium ion transmembrane transport; P:protein homotetramerization; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:retinal cone cell development; P:sodium ion transmembrane transport; scaffold15 indexed_genome mRNA 6288764 6294507 . - . ID=transcript_3824;Q9NP92 Q96I91 Q96Q19 Q9H0P8 Q9NSF9 Q9NZ76,39S ribosomal protein S30, mitochondrial,Mitochondrial large ribosomal subunit protein mL65 {ECO:0000303|PubMed:25278503};Mitochondrial large ribosomal subunit protein mS30 {ECO:0000303|PubMed:27023846};Programmed cell death protein 9;, PF07147;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0006915;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:apoptotic process; P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q6R2W3 Q2NKL9 Q5SRJ3 Q8TCN2 Q96MV9 Q96PW3,SCAN domain-containing protein 3,Transposon-derived Buster4 transposase-like protein;Zinc finger BED domain-containing protein 9;, PF02023;, GO:0005737;GO:0005634;GO:0003676;GO:0015074;GO:0045787;GO:0050679;, C:cytoplasm; C:nucleus;, F:nucleic acid binding;, P:DNA integration; P:positive regulation of cell cycle; P:positive regulation of epithelial cell proliferation; scaffold15 indexed_genome mRNA 6682764 6771173 . + . ID=transcript_3825;O15520 C7FDY0 Q6FHR3 Q6FHT6 Q96P59,Fibroblast growth factor 10,Keratinocyte growth factor 2;, PF00167;, GO:0009986;GO:0005737;GO:0005576;GO:0005615;GO:0005634;GO:0005886;GO:0042056;GO:0005104;GO:0008083;GO:0008201;GO:0005111;GO:0031532;GO:0000187;GO:0001525;GO:0009887;GO:0001974;GO:0060667;GO:0048754;GO:0060436;GO:0060449;GO:0060447;GO:0030154;GO:0007368;GO:0031076;GO:0048557;GO:0030538;GO:0009880;GO:0050673;GO:0060664;GO:0070371;GO:0000132;GO:0048807;GO:0008543;GO:0060595;GO:0031069;GO:0070384;GO:0050930;GO:0032808;GO:0060174;GO:0060173;GO:0060428;GO:0061115;GO:0060430;GO:0048808;GO:0060615;GO:0000165;GO:0060915;GO:0060496;GO:0001823;GO:0001656;GO:0003338;GO:0042693;GO:0071157;GO:0045596;GO:0008285;GO:2001240;GO:0042475;GO:0001759;GO:0030916;GO:0031016;GO:0021983;GO:0050918;GO:0032781;GO:0090263;GO:0008284;GO:0045739;GO:0010634;GO:0050679;GO:0060054;GO:0070374;GO:0048146;GO:1900087;GO:0010628;GO:0071338;GO:0051549;GO:0010838;GO:0050671;GO:0043410;GO:0045747;GO:0050731;GO:0051897;GO:0001934;GO:0046579;GO:0045944;GO:0050677;GO:0030949;GO:0070352;GO:0060513;GO:0034394;GO:0060019;GO:0032925;GO:0060665;GO:0030334;GO:0046877;GO:0008589;GO:0032355;GO:0032496;GO:0007431;GO:0061033;GO:0060879;GO:0051145;GO:0035019;GO:0048536;GO:0060661;GO:0070075;GO:0048538;GO:0030878;GO:0042246;GO:0060510;GO:0050674;GO:0050872;GO:0042060;, C:cell surface; C:cytoplasm; C:extracellular region; C:extracellular space; C:nucleus; C:plasma membrane;, F:chemoattractant activity; F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparin binding; F:type 2 fibroblast growth factor receptor binding;, P:actin cytoskeleton reorganization; P:activation of MAPK activity; P:angiogenesis; P:animal organ morphogenesis; P:blood vessel remodeling; P:branch elongation involved in salivary gland morphogenesis; P:branching morphogenesis of an epithelial tube; P:bronchiole morphogenesis; P:bud elongation involved in lung branching; P:bud outgrowth involved in lung branching; P:cell differentiation; P:determination of left/right symmetry; P:embryonic camera-type eye development; P:embryonic digestive tract morphogenesis; P:embryonic genitalia morphogenesis; P:embryonic pattern specification; P:epithelial cell proliferation; P:epithelial cell proliferation involved in salivary gland morphogenesis; P:ERK1 and ERK2 cascade; P:establishment of mitotic spindle orientation; P:female genitalia morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway involved in mammary gland specification; P:hair follicle morphogenesis; P:Harderian gland development; P:induction of positive chemotaxis; P:lacrimal gland development; P:limb bud formation; P:limb development; P:lung epithelium development; P:lung proximal/distal axis specification; P:lung saccule development; P:male genitalia morphogenesis; P:mammary gland bud formation; P:MAPK cascade; P:mesenchymal cell differentiation involved in lung development; P:mesenchymal-epithelial cell signaling involved in lung development; P:mesonephros development; P:metanephros development; P:metanephros morphogenesis; P:muscle cell fate commitment; P:negative regulation of cell cycle arrest; P:negative regulation of cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:odontogenesis of dentin-containing tooth; P:organ induction; P:otic vesicle formation; P:pancreas development; P:pituitary gland development; P:positive chemotaxis; P:positive regulation of ATPase activity; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of DNA repair; P:positive regulation of epithelial cell migration; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial cell proliferation involved in wound healing; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of hair follicle cell proliferation; P:positive regulation of keratinocyte migration; P:positive regulation of keratinocyte proliferation; P:positive regulation of lymphocyte proliferation; P:positive regulation of MAPK cascade; P:positive regulation of Notch signaling pathway; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of urothelial cell proliferation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of white fat cell proliferation; P:prostatic bud formation; P:protein localization to cell surface; P:radial glial cell differentiation; P:regulation of activin receptor signaling pathway; P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling; P:regulation of cell migration; P:regulation of saliva secretion; P:regulation of smoothened signaling pathway; P:response to estradiol; P:response to lipopolysaccharide; P:salivary gland development; P:secretion by lung epithelial cell involved in lung growth; P:semicircular canal fusion; P:smooth muscle cell differentiation; P:somatic stem cell population maintenance; P:spleen development; P:submandibular salivary gland formation; P:tear secretion; P:thymus development; P:thyroid gland development; P:tissue regeneration; P:type II pneumocyte differentiation; P:urothelial cell proliferation; P:white fat cell differentiation; P:wound healing; scaffold15 indexed_genome mRNA 7288309 7377222 . - . ID=transcript_3826;Q13423 Q16796 Q2TB60 Q8N3V4,NAD(P) transhydrogenase, mitochondrial,Nicotinamide nucleotide transhydrogenase;Pyridine nucleotide transhydrogenase;, PF01262;PF05222;PF02233;PF12769;, GO:0016021;GO:0016020;GO:0005743;GO:0005746;GO:0005739;GO:0051287;GO:0003957;GO:0008746;GO:0050661;GO:0045454;GO:0098869;GO:0006740;GO:0043066;GO:0001933;GO:0032364;GO:1903285;GO:0010918;GO:1902600;GO:0072593;GO:0033273;GO:0006099;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion;, F:NAD binding; F:NAD(P)+ transhydrogenase (B-specific) activity; F:NAD(P)+ transhydrogenase activity; F:NADP binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:NADPH regeneration; P:negative regulation of apoptotic process; P:negative regulation of protein phosphorylation; P:oxygen homeostasis; P:positive regulation of hydrogen peroxide catabolic process; P:positive regulation of mitochondrial membrane potential; P:proton transmembrane transport; P:reactive oxygen species metabolic process; P:response to vitamin; P:tricarboxylic acid cycle;|Q13423 Q16796 Q2TB60 Q8N3V4,NAD(P) transhydrogenase, mitochondrial,Nicotinamide nucleotide transhydrogenase;Pyridine nucleotide transhydrogenase;, PF01262;PF05222;PF02233;PF12769;, GO:0016021;GO:0016020;GO:0005743;GO:0005746;GO:0005739;GO:0051287;GO:0003957;GO:0008746;GO:0050661;GO:0045454;GO:0098869;GO:0006740;GO:0043066;GO:0001933;GO:0032364;GO:1903285;GO:0010918;GO:1902600;GO:0072593;GO:0033273;GO:0006099;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion;, F:NAD binding; F:NAD(P)+ transhydrogenase (B-specific) activity; F:NAD(P)+ transhydrogenase activity; F:NADP binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:NADPH regeneration; P:negative regulation of apoptotic process; P:negative regulation of protein phosphorylation; P:oxygen homeostasis; P:positive regulation of hydrogen peroxide catabolic process; P:positive regulation of mitochondrial membrane potential; P:proton transmembrane transport; P:reactive oxygen species metabolic process; P:response to vitamin; P:tricarboxylic acid cycle;|Q13423 Q16796 Q2TB60 Q8N3V4,NAD(P) transhydrogenase, mitochondrial,Nicotinamide nucleotide transhydrogenase;Pyridine nucleotide transhydrogenase;, PF01262;PF05222;PF02233;PF12769;, GO:0016021;GO:0016020;GO:0005743;GO:0005746;GO:0005739;GO:0051287;GO:0003957;GO:0008746;GO:0050661;GO:0045454;GO:0098869;GO:0006740;GO:0043066;GO:0001933;GO:0032364;GO:1903285;GO:0010918;GO:1902600;GO:0072593;GO:0033273;GO:0006099;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion;, F:NAD binding; F:NAD(P)+ transhydrogenase (B-specific) activity; F:NAD(P)+ transhydrogenase activity; F:NADP binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:NADPH regeneration; P:negative regulation of apoptotic process; P:negative regulation of protein phosphorylation; P:oxygen homeostasis; P:positive regulation of hydrogen peroxide catabolic process; P:positive regulation of mitochondrial membrane potential; P:proton transmembrane transport; P:reactive oxygen species metabolic process; P:response to vitamin; P:tricarboxylic acid cycle;|Q13423 Q16796 Q2TB60 Q8N3V4,NAD(P) transhydrogenase, mitochondrial,Nicotinamide nucleotide transhydrogenase;Pyridine nucleotide transhydrogenase;, PF01262;PF05222;PF02233;PF12769;, GO:0016021;GO:0016020;GO:0005743;GO:0005746;GO:0005739;GO:0051287;GO:0003957;GO:0008746;GO:0050661;GO:0045454;GO:0098869;GO:0006740;GO:0043066;GO:0001933;GO:0032364;GO:1903285;GO:0010918;GO:1902600;GO:0072593;GO:0033273;GO:0006099;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion;, F:NAD binding; F:NAD(P)+ transhydrogenase (B-specific) activity; F:NAD(P)+ transhydrogenase activity; F:NADP binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:NADPH regeneration; P:negative regulation of apoptotic process; P:negative regulation of protein phosphorylation; P:oxygen homeostasis; P:positive regulation of hydrogen peroxide catabolic process; P:positive regulation of mitochondrial membrane potential; P:proton transmembrane transport; P:reactive oxygen species metabolic process; P:response to vitamin; P:tricarboxylic acid cycle;|Q13423 Q16796 Q2TB60 Q8N3V4,NAD(P) transhydrogenase, mitochondrial,Nicotinamide nucleotide transhydrogenase;Pyridine nucleotide transhydrogenase;, PF01262;PF05222;PF02233;PF12769;, GO:0016021;GO:0016020;GO:0005743;GO:0005746;GO:0005739;GO:0051287;GO:0003957;GO:0008746;GO:0050661;GO:0045454;GO:0098869;GO:0006740;GO:0043066;GO:0001933;GO:0032364;GO:1903285;GO:0010918;GO:1902600;GO:0072593;GO:0033273;GO:0006099;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion;, F:NAD binding; F:NAD(P)+ transhydrogenase (B-specific) activity; F:NAD(P)+ transhydrogenase activity; F:NADP binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:NADPH regeneration; P:negative regulation of apoptotic process; P:negative regulation of protein phosphorylation; P:oxygen homeostasis; P:positive regulation of hydrogen peroxide catabolic process; P:positive regulation of mitochondrial membrane potential; P:proton transmembrane transport; P:reactive oxygen species metabolic process; P:response to vitamin; P:tricarboxylic acid cycle;|Q13423 Q16796 Q2TB60 Q8N3V4,NAD(P) transhydrogenase, mitochondrial,Nicotinamide nucleotide transhydrogenase;Pyridine nucleotide transhydrogenase;, PF01262;PF05222;PF02233;PF12769;, GO:0016021;GO:0016020;GO:0005743;GO:0005746;GO:0005739;GO:0051287;GO:0003957;GO:0008746;GO:0050661;GO:0045454;GO:0098869;GO:0006740;GO:0043066;GO:0001933;GO:0032364;GO:1903285;GO:0010918;GO:1902600;GO:0072593;GO:0033273;GO:0006099;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion;, F:NAD binding; F:NAD(P)+ transhydrogenase (B-specific) activity; F:NAD(P)+ transhydrogenase activity; F:NADP binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:NADPH regeneration; P:negative regulation of apoptotic process; P:negative regulation of protein phosphorylation; P:oxygen homeostasis; P:positive regulation of hydrogen peroxide catabolic process; P:positive regulation of mitochondrial membrane potential; P:proton transmembrane transport; P:reactive oxygen species metabolic process; P:response to vitamin; P:tricarboxylic acid cycle; scaffold15 indexed_genome mRNA 7408943 7415302 . + . ID=transcript_3827;Q9H074 A6NKV8 O60455 Q96B61 Q9BS63,Polyadenylate-binding protein-interacting protein 1,, PF02854;PF07145;, GO:0005737;GO:0005829;GO:0003723;GO:0008494;GO:0048255;GO:0006446;GO:0006413;, C:cytoplasm; C:cytosol;, F:RNA binding; F:translation activator activity;, P:mRNA stabilization; P:regulation of translational initiation; P:translational initiation;|Q9H074 A6NKV8 O60455 Q96B61 Q9BS63,Polyadenylate-binding protein-interacting protein 1,, PF02854;PF07145;, GO:0005737;GO:0005829;GO:0003723;GO:0008494;GO:0048255;GO:0006446;GO:0006413;, C:cytoplasm; C:cytosol;, F:RNA binding; F:translation activator activity;, P:mRNA stabilization; P:regulation of translational initiation; P:translational initiation; scaffold15 indexed_genome mRNA 7415355 7417021 . + . ID=transcript_3828;Q9H074 A6NKV8 O60455 Q96B61 Q9BS63,Polyadenylate-binding protein-interacting protein 1,, PF02854;PF07145;, GO:0005737;GO:0005829;GO:0003723;GO:0008494;GO:0048255;GO:0006446;GO:0006413;, C:cytoplasm; C:cytosol;, F:RNA binding; F:translation activator activity;, P:mRNA stabilization; P:regulation of translational initiation; P:translational initiation; scaffold15 indexed_genome mRNA 7417051 7418477 . + . ID=transcript_3829;P18669 Q9BWC0,Phosphoglycerate mutase 1,BPG-dependent PGAM 1;Phosphoglycerate mutase isozyme B;, PF00300;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0034774;GO:0004082;GO:0016787;GO:0004619;GO:0019901;GO:0061621;GO:0006094;GO:0006096;GO:0043312;GO:0006110;GO:0043456;GO:0045730;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:secretory granule lumen;, F:bisphosphoglycerate mutase activity; F:hydrolase activity; F:phosphoglycerate mutase activity; F:protein kinase binding;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:neutrophil degranulation; P:regulation of glycolytic process; P:regulation of pentose-phosphate shunt; P:respiratory burst; scaffold15 indexed_genome mRNA 7418479 7420247 . - . ID=transcript_3830;Q9H074 A6NKV8 O60455 Q96B61 Q9BS63,Polyadenylate-binding protein-interacting protein 1,, PF02854;PF07145;, GO:0005737;GO:0005829;GO:0003723;GO:0008494;GO:0048255;GO:0006446;GO:0006413;, C:cytoplasm; C:cytosol;, F:RNA binding; F:translation activator activity;, P:mRNA stabilization; P:regulation of translational initiation; P:translational initiation; scaffold15 indexed_genome mRNA 7421918 7425617 . + . ID=transcript_3831;Q9H074 A6NKV8 O60455 Q96B61 Q9BS63,Polyadenylate-binding protein-interacting protein 1,, PF02854;PF07145;, GO:0005737;GO:0005829;GO:0003723;GO:0008494;GO:0048255;GO:0006446;GO:0006413;, C:cytoplasm; C:cytosol;, F:RNA binding; F:translation activator activity;, P:mRNA stabilization; P:regulation of translational initiation; P:translational initiation; scaffold15 indexed_genome mRNA 7431882 7462495 . + . ID=transcript_3832;Q96MH7,Uncharacterized protein C5orf34,, PF15016;PF15025;|Q96MH7,Uncharacterized protein C5orf34,, PF15016;PF15025; scaffold15 indexed_genome mRNA 7465578 7482539 . + . ID=transcript_3833;Q0VDI3 B2RDA6 Q9H6Z2,Transmembrane protein 267 {ECO:0000312|HGNC:HGNC:26139},, , GO:0016021;, C:integral component of membrane;|Q0VDI3 B2RDA6 Q9H6Z2,Transmembrane protein 267 {ECO:0000312|HGNC:HGNC:26139},, , GO:0016021;, C:integral component of membrane; scaffold15 indexed_genome mRNA 7492341 7493521 . - . ID=transcript_3834;Q9WJR5 O15312,Endogenous retrovirus group K member 19 Pol protein,HERV-K(C19) Pol protein;HERV-K_19q11 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold15 indexed_genome mRNA 7503612 7520118 . + . ID=transcript_3835;Q9NRJ3 D7RIE7,C-C motif chemokine 28,Mucosae-associated epithelial chemokine;Protein CCK1;Small-inducible cytokine A28;, PF00048;, GO:0070062;GO:0005576;GO:0005615;GO:0008009;GO:0061844;GO:0060326;GO:0006935;GO:0051715;GO:0007186;GO:0006955;GO:0031640;GO:1903237;GO:0001954;GO:0007204;GO:0007584;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:chemokine activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell chemotaxis; P:chemotaxis; P:cytolysis in other organism; P:G protein-coupled receptor signaling pathway; P:immune response; P:killing of cells of other organism; P:negative regulation of leukocyte tethering or rolling; P:positive regulation of cell-matrix adhesion; P:positive regulation of cytosolic calcium ion concentration; P:response to nutrient; scaffold15 indexed_genome mRNA 7559709 7576051 . + . ID=transcript_3836;Q01581 B2RDL8,Hydroxymethylglutaryl-CoA synthase, cytoplasmic {ECO:0000305},3-hydroxy-3-methylglutaryl coenzyme A synthase;, PF08540;PF01154;, GO:0005737;GO:0005829;GO:0008144;GO:0004421;GO:0016853;GO:0043177;GO:0042803;GO:0006084;GO:0007420;GO:0071397;GO:0071372;GO:0071404;GO:0006695;GO:0010142;GO:0006629;GO:0001889;GO:0008584;GO:0019216;GO:0019222;GO:0042493;GO:0009645;GO:0014074;GO:0046690;GO:0033197;, C:cytoplasm; C:cytosol;, F:drug binding; F:hydroxymethylglutaryl-CoA synthase activity; F:isomerase activity; F:organic acid binding; F:protein homodimerization activity;, P:acetyl-CoA metabolic process; P:brain development; P:cellular response to cholesterol; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process, mevalonate pathway; P:lipid metabolic process; P:liver development; P:male gonad development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:response to drug; P:response to low light intensity stimulus; P:response to purine-containing compound; P:response to tellurium ion; P:response to vitamin E;|Q01581 B2RDL8,Hydroxymethylglutaryl-CoA synthase, cytoplasmic {ECO:0000305},3-hydroxy-3-methylglutaryl coenzyme A synthase;, PF08540;PF01154;, GO:0005737;GO:0005829;GO:0008144;GO:0004421;GO:0016853;GO:0043177;GO:0042803;GO:0006084;GO:0007420;GO:0071397;GO:0071372;GO:0071404;GO:0006695;GO:0010142;GO:0006629;GO:0001889;GO:0008584;GO:0019216;GO:0019222;GO:0042493;GO:0009645;GO:0014074;GO:0046690;GO:0033197;, C:cytoplasm; C:cytosol;, F:drug binding; F:hydroxymethylglutaryl-CoA synthase activity; F:isomerase activity; F:organic acid binding; F:protein homodimerization activity;, P:acetyl-CoA metabolic process; P:brain development; P:cellular response to cholesterol; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process, mevalonate pathway; P:lipid metabolic process; P:liver development; P:male gonad development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:response to drug; P:response to low light intensity stimulus; P:response to purine-containing compound; P:response to tellurium ion; P:response to vitamin E;|Q01581 B2RDL8,Hydroxymethylglutaryl-CoA synthase, cytoplasmic {ECO:0000305},3-hydroxy-3-methylglutaryl coenzyme A synthase;, PF08540;PF01154;, GO:0005737;GO:0005829;GO:0008144;GO:0004421;GO:0016853;GO:0043177;GO:0042803;GO:0006084;GO:0007420;GO:0071397;GO:0071372;GO:0071404;GO:0006695;GO:0010142;GO:0006629;GO:0001889;GO:0008584;GO:0019216;GO:0019222;GO:0042493;GO:0009645;GO:0014074;GO:0046690;GO:0033197;, C:cytoplasm; C:cytosol;, F:drug binding; F:hydroxymethylglutaryl-CoA synthase activity; F:isomerase activity; F:organic acid binding; F:protein homodimerization activity;, P:acetyl-CoA metabolic process; P:brain development; P:cellular response to cholesterol; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process, mevalonate pathway; P:lipid metabolic process; P:liver development; P:male gonad development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:response to drug; P:response to low light intensity stimulus; P:response to purine-containing compound; P:response to tellurium ion; P:response to vitamin E;|Q01581 B2RDL8,Hydroxymethylglutaryl-CoA synthase, cytoplasmic {ECO:0000305},3-hydroxy-3-methylglutaryl coenzyme A synthase;, PF08540;PF01154;, GO:0005737;GO:0005829;GO:0008144;GO:0004421;GO:0016853;GO:0043177;GO:0042803;GO:0006084;GO:0007420;GO:0071397;GO:0071372;GO:0071404;GO:0006695;GO:0010142;GO:0006629;GO:0001889;GO:0008584;GO:0019216;GO:0019222;GO:0042493;GO:0009645;GO:0014074;GO:0046690;GO:0033197;, C:cytoplasm; C:cytosol;, F:drug binding; F:hydroxymethylglutaryl-CoA synthase activity; F:isomerase activity; F:organic acid binding; F:protein homodimerization activity;, P:acetyl-CoA metabolic process; P:brain development; P:cellular response to cholesterol; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process, mevalonate pathway; P:lipid metabolic process; P:liver development; P:male gonad development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:response to drug; P:response to low light intensity stimulus; P:response to purine-containing compound; P:response to tellurium ion; P:response to vitamin E;|Q01581 B2RDL8,Hydroxymethylglutaryl-CoA synthase, cytoplasmic {ECO:0000305},3-hydroxy-3-methylglutaryl coenzyme A synthase;, PF08540;PF01154;, GO:0005737;GO:0005829;GO:0008144;GO:0004421;GO:0016853;GO:0043177;GO:0042803;GO:0006084;GO:0007420;GO:0071397;GO:0071372;GO:0071404;GO:0006695;GO:0010142;GO:0006629;GO:0001889;GO:0008584;GO:0019216;GO:0019222;GO:0042493;GO:0009645;GO:0014074;GO:0046690;GO:0033197;, C:cytoplasm; C:cytosol;, F:drug binding; F:hydroxymethylglutaryl-CoA synthase activity; F:isomerase activity; F:organic acid binding; F:protein homodimerization activity;, P:acetyl-CoA metabolic process; P:brain development; P:cellular response to cholesterol; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process, mevalonate pathway; P:lipid metabolic process; P:liver development; P:male gonad development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:response to drug; P:response to low light intensity stimulus; P:response to purine-containing compound; P:response to tellurium ion; P:response to vitamin E;|Q01581 B2RDL8,Hydroxymethylglutaryl-CoA synthase, cytoplasmic {ECO:0000305},3-hydroxy-3-methylglutaryl coenzyme A synthase;, PF08540;PF01154;, GO:0005737;GO:0005829;GO:0008144;GO:0004421;GO:0016853;GO:0043177;GO:0042803;GO:0006084;GO:0007420;GO:0071397;GO:0071372;GO:0071404;GO:0006695;GO:0010142;GO:0006629;GO:0001889;GO:0008584;GO:0019216;GO:0019222;GO:0042493;GO:0009645;GO:0014074;GO:0046690;GO:0033197;, C:cytoplasm; C:cytosol;, F:drug binding; F:hydroxymethylglutaryl-CoA synthase activity; F:isomerase activity; F:organic acid binding; F:protein homodimerization activity;, P:acetyl-CoA metabolic process; P:brain development; P:cellular response to cholesterol; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process, mevalonate pathway; P:lipid metabolic process; P:liver development; P:male gonad development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:response to drug; P:response to low light intensity stimulus; P:response to purine-containing compound; P:response to tellurium ion; P:response to vitamin E; scaffold15 indexed_genome mRNA 7584296 7694100 . - . ID=transcript_3837;Q8IY84 B3KVM1,Serine/threonine-protein kinase NIM1,NIM1 serine/threonine-protein kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0042149;GO:0035556;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to glucose starvation; P:intracellular signal transduction; P:protein phosphorylation;|P52739 B4DRL3 Q6PIF0,Zinc finger protein 131,, PF00651;, GO:0045111;GO:0005654;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:intermediate filament cytoskeleton; C:nucleoplasm;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P52739 B4DRL3 Q6PIF0,Zinc finger protein 131,, PF00651;, GO:0045111;GO:0005654;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:intermediate filament cytoskeleton; C:nucleoplasm;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P52739 B4DRL3 Q6PIF0,Zinc finger protein 131,, PF00651;, GO:0045111;GO:0005654;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:intermediate filament cytoskeleton; C:nucleoplasm;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold15 indexed_genome mRNA 7874054 7888709 . + . ID=transcript_3838;P49908 Q6PD59 Q6PI43 Q6PI87 Q6PJF9,Selenoprotein P {ECO:0000303|PubMed:27645994},, PF04593;PF04592;, GO:0070062;GO:0005576;GO:0031089;GO:0008430;GO:0002576;GO:0006979;GO:0001887;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:selenium binding;, P:platelet degranulation; P:response to oxidative stress; P:selenium compound metabolic process;|P49908 Q6PD59 Q6PI43 Q6PI87 Q6PJF9,Selenoprotein P {ECO:0000303|PubMed:27645994},, PF04593;PF04592;, GO:0070062;GO:0005576;GO:0031089;GO:0008430;GO:0002576;GO:0006979;GO:0001887;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:selenium binding;, P:platelet degranulation; P:response to oxidative stress; P:selenium compound metabolic process;|P49908 Q6PD59 Q6PI43 Q6PI87 Q6PJF9,Selenoprotein P {ECO:0000303|PubMed:27645994},, PF04593;PF04592;, GO:0070062;GO:0005576;GO:0031089;GO:0008430;GO:0002576;GO:0006979;GO:0001887;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:selenium binding;, P:platelet degranulation; P:response to oxidative stress; P:selenium compound metabolic process;|P49908 Q6PD59 Q6PI43 Q6PI87 Q6PJF9,Selenoprotein P {ECO:0000303|PubMed:27645994},, PF04593;PF04592;, GO:0070062;GO:0005576;GO:0031089;GO:0008430;GO:0002576;GO:0006979;GO:0001887;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:selenium binding;, P:platelet degranulation; P:response to oxidative stress; P:selenium compound metabolic process; scaffold15 indexed_genome mRNA 7961399 8146407 . - . ID=transcript_3839;P10912 Q9HCX2,Growth hormone receptor,Somatotropin receptor;, PF09067;PF00041;PF12772;, GO:0009986;GO:0036464;GO:0005829;GO:0009897;GO:0005576;GO:0005615;GO:0070195;GO:0016021;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0019838;GO:0004903;GO:0042802;GO:0017046;GO:0070064;GO:0042803;GO:0019901;GO:0042976;GO:0000187;GO:0032870;GO:0019221;GO:0006897;GO:0060396;GO:0060397;GO:0042445;GO:0048009;GO:0040018;GO:0050731;GO:0046427;GO:0042531;GO:0031623;GO:0007259;GO:0040014;GO:0046898;GO:0032355;GO:0019530;, C:cell surface; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:external side of plasma membrane; C:extracellular region; C:extracellular space; C:growth hormone receptor complex; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:growth hormone receptor activity; F:identical protein binding; F:peptide hormone binding; F:proline-rich region binding; F:protein homodimerization activity; F:protein kinase binding;, P:activation of Janus kinase activity; P:activation of MAPK activity; P:cellular response to hormone stimulus; P:cytokine-mediated signaling pathway; P:endocytosis; P:growth hormone receptor signaling pathway; P:growth hormone receptor signaling pathway via JAK-STAT; P:hormone metabolic process; P:insulin-like growth factor receptor signaling pathway; P:positive regulation of multicellular organism growth; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of tyrosine phosphorylation of STAT protein; P:receptor internalization; P:receptor signaling pathway via JAK-STAT; P:regulation of multicellular organism growth; P:response to cycloheximide; P:response to estradiol; P:taurine metabolic process; scaffold15 indexed_genome mRNA 8643024 8657796 . - . ID=transcript_3840;Q9UKT5 Q68CU8 Q86VT8 Q9UK98,F-box only protein 4,, PF00646;, GO:0005737;GO:0005829;GO:0019005;GO:0000151;GO:0042803;GO:0061630;GO:0004842;GO:0007568;GO:0019725;GO:0071479;GO:0035726;GO:0048147;GO:1900181;GO:1902916;GO:0031398;GO:0032212;GO:0043687;GO:0010608;GO:0031648;GO:0000209;GO:0016567;GO:2000001;GO:0031647;GO:0031146;GO:0000723;GO:0006511;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:protein homodimerization activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:aging; P:cellular homeostasis; P:cellular response to ionizing radiation; P:common myeloid progenitor cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of protein localization to nucleus; P:positive regulation of protein polyubiquitination; P:positive regulation of protein ubiquitination; P:positive regulation of telomere maintenance via telomerase; P:post-translational protein modification; P:posttranscriptional regulation of gene expression; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of protein stability; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:telomere maintenance; P:ubiquitin-dependent protein catabolic process;|Q9UKT5 Q68CU8 Q86VT8 Q9UK98,F-box only protein 4,, PF00646;, GO:0005737;GO:0005829;GO:0019005;GO:0000151;GO:0042803;GO:0061630;GO:0004842;GO:0007568;GO:0019725;GO:0071479;GO:0035726;GO:0048147;GO:1900181;GO:1902916;GO:0031398;GO:0032212;GO:0043687;GO:0010608;GO:0031648;GO:0000209;GO:0016567;GO:2000001;GO:0031647;GO:0031146;GO:0000723;GO:0006511;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:protein homodimerization activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:aging; P:cellular homeostasis; P:cellular response to ionizing radiation; P:common myeloid progenitor cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of protein localization to nucleus; P:positive regulation of protein polyubiquitination; P:positive regulation of protein ubiquitination; P:positive regulation of telomere maintenance via telomerase; P:post-translational protein modification; P:posttranscriptional regulation of gene expression; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of protein stability; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:telomere maintenance; P:ubiquitin-dependent protein catabolic process; scaffold15 indexed_genome mRNA 8665716 8687041 . + . ID=transcript_3841;Q96SE7 B3KU77 B9EG59 G5E9N4 Q8TCN1,Zinc finger protein 347,Zinc finger protein 1111;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|A6NDU8 A2RRM9,UPF0600 protein C5orf51,, PF17716;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold15 indexed_genome mRNA 8714169 8881238 . + . ID=transcript_3842;P55809 B2R5V2 B7Z528,Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial,3-oxoacid CoA-transferase 1;Somatic-type succinyl-CoA:3-oxoacid CoA-transferase;, PF01144;, GO:0005759;GO:0005739;GO:0008260;GO:0008410;GO:0042802;GO:0060612;GO:0007420;GO:0046950;GO:0007507;GO:0046952;GO:0042182;GO:0035774;GO:0014823;GO:0042493;GO:0045471;GO:0009725;GO:0007584;GO:0042594;, C:mitochondrial matrix; C:mitochondrion;, F:3-oxoacid CoA-transferase activity; F:CoA-transferase activity; F:identical protein binding;, P:adipose tissue development; P:brain development; P:cellular ketone body metabolic process; P:heart development; P:ketone body catabolic process; P:ketone catabolic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:response to activity; P:response to drug; P:response to ethanol; P:response to hormone; P:response to nutrient; P:response to starvation;|P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|P55809 B2R5V2 B7Z528,Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial,3-oxoacid CoA-transferase 1;Somatic-type succinyl-CoA:3-oxoacid CoA-transferase;, PF01144;, GO:0005759;GO:0005739;GO:0008260;GO:0008410;GO:0042802;GO:0060612;GO:0007420;GO:0046950;GO:0007507;GO:0046952;GO:0042182;GO:0035774;GO:0014823;GO:0042493;GO:0045471;GO:0009725;GO:0007584;GO:0042594;, C:mitochondrial matrix; C:mitochondrion;, F:3-oxoacid CoA-transferase activity; F:CoA-transferase activity; F:identical protein binding;, P:adipose tissue development; P:brain development; P:cellular ketone body metabolic process; P:heart development; P:ketone body catabolic process; P:ketone catabolic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:response to activity; P:response to drug; P:response to ethanol; P:response to hormone; P:response to nutrient; P:response to starvation; scaffold15 indexed_genome mRNA 9059917 9238794 . + . ID=transcript_3843;Q63HM9 A6NL04,PI-PLC X domain-containing protein 3,, , GO:0005737;GO:0008081;GO:0016042;GO:0007165;, C:cytoplasm;, F:phosphoric diester hydrolase activity;, P:lipid catabolic process; P:signal transduction; scaffold15 indexed_genome mRNA 9351396 9417328 . + . ID=transcript_3844;P13671,Complement component C6,, PF00057;PF01823;PF00084;PF00090;, GO:0070062;GO:0005576;GO:0005579;GO:0006956;GO:0006958;GO:0019835;GO:0001701;GO:0045087;GO:0030449;, C:extracellular exosome; C:extracellular region; C:membrane attack complex;, , P:complement activation; P:complement activation, classical pathway; P:cytolysis; P:in utero embryonic development; P:innate immune response; P:regulation of complement activation; scaffold15 indexed_genome mRNA 9554182 9610492 . - . ID=transcript_3845;P10643 A8K2T4 Q6P3T5 Q92489,Complement component C7,, PF18434;PF00057;PF01823;PF00084;PF00090;, GO:0070062;GO:0005576;GO:0005579;GO:0006883;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0030449;, C:extracellular exosome; C:extracellular region; C:membrane attack complex;, , P:cellular sodium ion homeostasis; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:regulation of complement activation;|P10643 A8K2T4 Q6P3T5 Q92489,Complement component C7,, PF18434;PF00057;PF01823;PF00084;PF00090;, GO:0070062;GO:0005576;GO:0005579;GO:0006883;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0030449;, C:extracellular exosome; C:extracellular region; C:membrane attack complex;, , P:cellular sodium ion homeostasis; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:regulation of complement activation; scaffold15 indexed_genome mRNA 9636182 9648901 . - . ID=transcript_3846;Q9BX69 Q52LR2,Caspase recruitment domain-containing protein 6,, PF00619;, GO:0006915;GO:0042981;, , , P:apoptotic process; P:regulation of apoptotic process;|Q9BX69 Q52LR2,Caspase recruitment domain-containing protein 6,, PF00619;, GO:0006915;GO:0042981;, , , P:apoptotic process; P:regulation of apoptotic process; scaffold15 indexed_genome mRNA 9695513 9715495 . - . ID=transcript_3847;Q13131 A8MTQ6 B2R7E1 O00286 Q5D0E1 Q86VS1 Q9UNQ4,5'-AMP-activated protein kinase catalytic subunit alpha-1,Acetyl-CoA carboxylase kinase;Hydroxymethylglutaryl-CoA reductase kinase;Tau-protein kinase PRKAA1;, PF16579;PF00069;, GO:0016324;GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0043025;GO:0016607;GO:0005654;GO:0031588;GO:0005634;GO:0050405;GO:0047322;GO:0004679;GO:0005524;GO:0004691;GO:0003682;GO:0035174;GO:0046872;GO:0008022;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0048156;GO:0050321;GO:0000187;GO:0015721;GO:0038183;GO:0061762;GO:0007050;GO:0071277;GO:0035690;GO:0071361;GO:0042149;GO:0071333;GO:0070301;GO:0071456;GO:0031669;GO:0071417;GO:0034599;GO:0071380;GO:0006695;GO:0009631;GO:0097009;GO:0006633;GO:0055089;GO:0019395;GO:0042593;GO:0006006;GO:0035556;GO:0008610;GO:0016236;GO:0061744;GO:0043066;GO:0010629;GO:0046318;GO:0046627;GO:0050995;GO:0032007;GO:1904428;GO:0070050;GO:0010508;GO:0008284;GO:1903829;GO:0045542;GO:0010628;GO:0045821;GO:1903109;GO:2000758;GO:1903955;GO:0048643;GO:0006468;GO:0120188;GO:0042752;GO:0016241;GO:0070507;GO:0033135;GO:1901796;GO:0062028;GO:0060627;GO:1904486;GO:0014823;GO:0031000;GO:1901563;GO:0010332;GO:0001666;GO:0009411;GO:0048511;GO:0007165;GO:0016055;, C:apical plasma membrane; C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:neuronal cell body; C:nuclear speck; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:[acetyl-CoA carboxylase] kinase activity; F:[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase activity; F:chromatin binding; F:histone serine kinase activity; F:metal ion binding; F:protein C-terminus binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of MAPK activity; P:bile acid and bile salt transport; P:bile acid signaling pathway; P:CAMKK-AMPK signaling cascade; P:cell cycle arrest; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to ethanol; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to nutrient levels; P:cellular response to organonitrogen compound; P:cellular response to oxidative stress; P:cellular response to prostaglandin E stimulus; P:cholesterol biosynthetic process; P:cold acclimation; P:energy homeostasis; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:fatty acid oxidation; P:glucose homeostasis; P:glucose metabolic process; P:intracellular signal transduction; P:lipid biosynthetic process; P:macroautophagy; P:motor behavior; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of glucosylceramide biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lipid catabolic process; P:negative regulation of TOR signaling; P:negative regulation of tubulin deacetylation; P:neuron cellular homeostasis; P:positive regulation of autophagy; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein localization; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of mitochondrial transcription; P:positive regulation of peptidyl-lysine acetylation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of skeletal muscle tissue development; P:protein phosphorylation; P:regulation of bile acid secretion; P:regulation of circadian rhythm; P:regulation of macroautophagy; P:regulation of microtubule cytoskeleton organization; P:regulation of peptidyl-serine phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of stress granule assembly; P:regulation of vesicle-mediated transport; P:response to 17alpha-ethynylestradiol; P:response to activity; P:response to caffeine; P:response to camptothecin; P:response to gamma radiation; P:response to hypoxia; P:response to UV; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway;|Q13131 A8MTQ6 B2R7E1 O00286 Q5D0E1 Q86VS1 Q9UNQ4,5'-AMP-activated protein kinase catalytic subunit alpha-1,Acetyl-CoA carboxylase kinase;Hydroxymethylglutaryl-CoA reductase kinase;Tau-protein kinase PRKAA1;, PF16579;PF00069;, GO:0016324;GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0043025;GO:0016607;GO:0005654;GO:0031588;GO:0005634;GO:0050405;GO:0047322;GO:0004679;GO:0005524;GO:0004691;GO:0003682;GO:0035174;GO:0046872;GO:0008022;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0048156;GO:0050321;GO:0000187;GO:0015721;GO:0038183;GO:0061762;GO:0007050;GO:0071277;GO:0035690;GO:0071361;GO:0042149;GO:0071333;GO:0070301;GO:0071456;GO:0031669;GO:0071417;GO:0034599;GO:0071380;GO:0006695;GO:0009631;GO:0097009;GO:0006633;GO:0055089;GO:0019395;GO:0042593;GO:0006006;GO:0035556;GO:0008610;GO:0016236;GO:0061744;GO:0043066;GO:0010629;GO:0046318;GO:0046627;GO:0050995;GO:0032007;GO:1904428;GO:0070050;GO:0010508;GO:0008284;GO:1903829;GO:0045542;GO:0010628;GO:0045821;GO:1903109;GO:2000758;GO:1903955;GO:0048643;GO:0006468;GO:0120188;GO:0042752;GO:0016241;GO:0070507;GO:0033135;GO:1901796;GO:0062028;GO:0060627;GO:1904486;GO:0014823;GO:0031000;GO:1901563;GO:0010332;GO:0001666;GO:0009411;GO:0048511;GO:0007165;GO:0016055;, C:apical plasma membrane; C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:neuronal cell body; C:nuclear speck; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:[acetyl-CoA carboxylase] kinase activity; F:[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase activity; F:chromatin binding; F:histone serine kinase activity; F:metal ion binding; F:protein C-terminus binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of MAPK activity; P:bile acid and bile salt transport; P:bile acid signaling pathway; P:CAMKK-AMPK signaling cascade; P:cell cycle arrest; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to ethanol; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to nutrient levels; P:cellular response to organonitrogen compound; P:cellular response to oxidative stress; P:cellular response to prostaglandin E stimulus; P:cholesterol biosynthetic process; P:cold acclimation; P:energy homeostasis; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:fatty acid oxidation; P:glucose homeostasis; P:glucose metabolic process; P:intracellular signal transduction; P:lipid biosynthetic process; P:macroautophagy; P:motor behavior; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of glucosylceramide biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lipid catabolic process; P:negative regulation of TOR signaling; P:negative regulation of tubulin deacetylation; P:neuron cellular homeostasis; P:positive regulation of autophagy; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein localization; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of mitochondrial transcription; P:positive regulation of peptidyl-lysine acetylation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of skeletal muscle tissue development; P:protein phosphorylation; P:regulation of bile acid secretion; P:regulation of circadian rhythm; P:regulation of macroautophagy; P:regulation of microtubule cytoskeleton organization; P:regulation of peptidyl-serine phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of stress granule assembly; P:regulation of vesicle-mediated transport; P:response to 17alpha-ethynylestradiol; P:response to activity; P:response to caffeine; P:response to camptothecin; P:response to gamma radiation; P:response to hypoxia; P:response to UV; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway;|Q13131 A8MTQ6 B2R7E1 O00286 Q5D0E1 Q86VS1 Q9UNQ4,5'-AMP-activated protein kinase catalytic subunit alpha-1,Acetyl-CoA carboxylase kinase;Hydroxymethylglutaryl-CoA reductase kinase;Tau-protein kinase PRKAA1;, PF16579;PF00069;, GO:0016324;GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0043025;GO:0016607;GO:0005654;GO:0031588;GO:0005634;GO:0050405;GO:0047322;GO:0004679;GO:0005524;GO:0004691;GO:0003682;GO:0035174;GO:0046872;GO:0008022;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0048156;GO:0050321;GO:0000187;GO:0015721;GO:0038183;GO:0061762;GO:0007050;GO:0071277;GO:0035690;GO:0071361;GO:0042149;GO:0071333;GO:0070301;GO:0071456;GO:0031669;GO:0071417;GO:0034599;GO:0071380;GO:0006695;GO:0009631;GO:0097009;GO:0006633;GO:0055089;GO:0019395;GO:0042593;GO:0006006;GO:0035556;GO:0008610;GO:0016236;GO:0061744;GO:0043066;GO:0010629;GO:0046318;GO:0046627;GO:0050995;GO:0032007;GO:1904428;GO:0070050;GO:0010508;GO:0008284;GO:1903829;GO:0045542;GO:0010628;GO:0045821;GO:1903109;GO:2000758;GO:1903955;GO:0048643;GO:0006468;GO:0120188;GO:0042752;GO:0016241;GO:0070507;GO:0033135;GO:1901796;GO:0062028;GO:0060627;GO:1904486;GO:0014823;GO:0031000;GO:1901563;GO:0010332;GO:0001666;GO:0009411;GO:0048511;GO:0007165;GO:0016055;, C:apical plasma membrane; C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:neuronal cell body; C:nuclear speck; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:[acetyl-CoA carboxylase] kinase activity; F:[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase activity; F:chromatin binding; F:histone serine kinase activity; F:metal ion binding; F:protein C-terminus binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of MAPK activity; P:bile acid and bile salt transport; P:bile acid signaling pathway; P:CAMKK-AMPK signaling cascade; P:cell cycle arrest; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to ethanol; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to nutrient levels; P:cellular response to organonitrogen compound; P:cellular response to oxidative stress; P:cellular response to prostaglandin E stimulus; P:cholesterol biosynthetic process; P:cold acclimation; P:energy homeostasis; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:fatty acid oxidation; P:glucose homeostasis; P:glucose metabolic process; P:intracellular signal transduction; P:lipid biosynthetic process; P:macroautophagy; P:motor behavior; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of glucosylceramide biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lipid catabolic process; P:negative regulation of TOR signaling; P:negative regulation of tubulin deacetylation; P:neuron cellular homeostasis; P:positive regulation of autophagy; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein localization; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of mitochondrial transcription; P:positive regulation of peptidyl-lysine acetylation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of skeletal muscle tissue development; P:protein phosphorylation; P:regulation of bile acid secretion; P:regulation of circadian rhythm; P:regulation of macroautophagy; P:regulation of microtubule cytoskeleton organization; P:regulation of peptidyl-serine phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of stress granule assembly; P:regulation of vesicle-mediated transport; P:response to 17alpha-ethynylestradiol; P:response to activity; P:response to caffeine; P:response to camptothecin; P:response to gamma radiation; P:response to hypoxia; P:response to UV; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway;|Q13131 A8MTQ6 B2R7E1 O00286 Q5D0E1 Q86VS1 Q9UNQ4,5'-AMP-activated protein kinase catalytic subunit alpha-1,Acetyl-CoA carboxylase kinase;Hydroxymethylglutaryl-CoA reductase kinase;Tau-protein kinase PRKAA1;, PF16579;PF00069;, GO:0016324;GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0043025;GO:0016607;GO:0005654;GO:0031588;GO:0005634;GO:0050405;GO:0047322;GO:0004679;GO:0005524;GO:0004691;GO:0003682;GO:0035174;GO:0046872;GO:0008022;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0048156;GO:0050321;GO:0000187;GO:0015721;GO:0038183;GO:0061762;GO:0007050;GO:0071277;GO:0035690;GO:0071361;GO:0042149;GO:0071333;GO:0070301;GO:0071456;GO:0031669;GO:0071417;GO:0034599;GO:0071380;GO:0006695;GO:0009631;GO:0097009;GO:0006633;GO:0055089;GO:0019395;GO:0042593;GO:0006006;GO:0035556;GO:0008610;GO:0016236;GO:0061744;GO:0043066;GO:0010629;GO:0046318;GO:0046627;GO:0050995;GO:0032007;GO:1904428;GO:0070050;GO:0010508;GO:0008284;GO:1903829;GO:0045542;GO:0010628;GO:0045821;GO:1903109;GO:2000758;GO:1903955;GO:0048643;GO:0006468;GO:0120188;GO:0042752;GO:0016241;GO:0070507;GO:0033135;GO:1901796;GO:0062028;GO:0060627;GO:1904486;GO:0014823;GO:0031000;GO:1901563;GO:0010332;GO:0001666;GO:0009411;GO:0048511;GO:0007165;GO:0016055;, C:apical plasma membrane; C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:neuronal cell body; C:nuclear speck; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:[acetyl-CoA carboxylase] kinase activity; F:[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase activity; F:chromatin binding; F:histone serine kinase activity; F:metal ion binding; F:protein C-terminus binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of MAPK activity; P:bile acid and bile salt transport; P:bile acid signaling pathway; P:CAMKK-AMPK signaling cascade; P:cell cycle arrest; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to ethanol; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to nutrient levels; P:cellular response to organonitrogen compound; P:cellular response to oxidative stress; P:cellular response to prostaglandin E stimulus; P:cholesterol biosynthetic process; P:cold acclimation; P:energy homeostasis; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:fatty acid oxidation; P:glucose homeostasis; P:glucose metabolic process; P:intracellular signal transduction; P:lipid biosynthetic process; P:macroautophagy; P:motor behavior; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of glucosylceramide biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lipid catabolic process; P:negative regulation of TOR signaling; P:negative regulation of tubulin deacetylation; P:neuron cellular homeostasis; P:positive regulation of autophagy; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein localization; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of mitochondrial transcription; P:positive regulation of peptidyl-lysine acetylation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of skeletal muscle tissue development; P:protein phosphorylation; P:regulation of bile acid secretion; P:regulation of circadian rhythm; P:regulation of macroautophagy; P:regulation of microtubule cytoskeleton organization; P:regulation of peptidyl-serine phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of stress granule assembly; P:regulation of vesicle-mediated transport; P:response to 17alpha-ethynylestradiol; P:response to activity; P:response to caffeine; P:response to camptothecin; P:response to gamma radiation; P:response to hypoxia; P:response to UV; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway;|Q13131 A8MTQ6 B2R7E1 O00286 Q5D0E1 Q86VS1 Q9UNQ4,5'-AMP-activated protein kinase catalytic subunit alpha-1,Acetyl-CoA carboxylase kinase;Hydroxymethylglutaryl-CoA reductase kinase;Tau-protein kinase PRKAA1;, PF16579;PF00069;, GO:0016324;GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0043025;GO:0016607;GO:0005654;GO:0031588;GO:0005634;GO:0050405;GO:0047322;GO:0004679;GO:0005524;GO:0004691;GO:0003682;GO:0035174;GO:0046872;GO:0008022;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0048156;GO:0050321;GO:0000187;GO:0015721;GO:0038183;GO:0061762;GO:0007050;GO:0071277;GO:0035690;GO:0071361;GO:0042149;GO:0071333;GO:0070301;GO:0071456;GO:0031669;GO:0071417;GO:0034599;GO:0071380;GO:0006695;GO:0009631;GO:0097009;GO:0006633;GO:0055089;GO:0019395;GO:0042593;GO:0006006;GO:0035556;GO:0008610;GO:0016236;GO:0061744;GO:0043066;GO:0010629;GO:0046318;GO:0046627;GO:0050995;GO:0032007;GO:1904428;GO:0070050;GO:0010508;GO:0008284;GO:1903829;GO:0045542;GO:0010628;GO:0045821;GO:1903109;GO:2000758;GO:1903955;GO:0048643;GO:0006468;GO:0120188;GO:0042752;GO:0016241;GO:0070507;GO:0033135;GO:1901796;GO:0062028;GO:0060627;GO:1904486;GO:0014823;GO:0031000;GO:1901563;GO:0010332;GO:0001666;GO:0009411;GO:0048511;GO:0007165;GO:0016055;, C:apical plasma membrane; C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:neuronal cell body; C:nuclear speck; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:[acetyl-CoA carboxylase] kinase activity; F:[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase activity; F:chromatin binding; F:histone serine kinase activity; F:metal ion binding; F:protein C-terminus binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of MAPK activity; P:bile acid and bile salt transport; P:bile acid signaling pathway; P:CAMKK-AMPK signaling cascade; P:cell cycle arrest; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to ethanol; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to nutrient levels; P:cellular response to organonitrogen compound; P:cellular response to oxidative stress; P:cellular response to prostaglandin E stimulus; P:cholesterol biosynthetic process; P:cold acclimation; P:energy homeostasis; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:fatty acid oxidation; P:glucose homeostasis; P:glucose metabolic process; P:intracellular signal transduction; P:lipid biosynthetic process; P:macroautophagy; P:motor behavior; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of glucosylceramide biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of lipid catabolic process; P:negative regulation of TOR signaling; P:negative regulation of tubulin deacetylation; P:neuron cellular homeostasis; P:positive regulation of autophagy; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein localization; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of mitochondrial transcription; P:positive regulation of peptidyl-lysine acetylation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of skeletal muscle tissue development; P:protein phosphorylation; P:regulation of bile acid secretion; P:regulation of circadian rhythm; P:regulation of macroautophagy; P:regulation of microtubule cytoskeleton organization; P:regulation of peptidyl-serine phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of stress granule assembly; P:regulation of vesicle-mediated transport; P:response to 17alpha-ethynylestradiol; P:response to activity; P:response to caffeine; P:response to camptothecin; P:response to gamma radiation; P:response to hypoxia; P:response to UV; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway; scaffold15 indexed_genome mRNA 9716970 9745812 . + . ID=transcript_3848;Q6PID6 B2R6G0 O95105,Tetratricopeptide repeat protein 33,Osmosis-responsive factor; scaffold15 indexed_genome mRNA 9756525 9769663 . - . ID=transcript_3849;P35408 Q3MJ87,Prostaglandin E2 receptor EP4 subtype,Prostanoid EP4 receptor;, PF00001;, GO:0016021;GO:0005886;GO:0004957;GO:0007189;GO:0007188;GO:0060348;GO:0071260;GO:0071380;GO:0070371;GO:0007186;GO:0006955;GO:0006954;GO:0007254;GO:0001818;GO:2000420;GO:0050728;GO:0002862;GO:0033624;GO:0001819;GO:0007204;GO:0050729;GO:0030278;GO:0051492;GO:0032496;GO:0009612;GO:0042093;, C:integral component of membrane; C:plasma membrane;, F:prostaglandin E receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:bone development; P:cellular response to mechanical stimulus; P:cellular response to prostaglandin E stimulus; P:ERK1 and ERK2 cascade; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:JNK cascade; P:negative regulation of cytokine production; P:negative regulation of eosinophil extravasation; P:negative regulation of inflammatory response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of integrin activation; P:positive regulation of cytokine production; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of inflammatory response; P:regulation of ossification; P:regulation of stress fiber assembly; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:T-helper cell differentiation; scaffold15 indexed_genome mRNA 10940585 10996433 . + . ID=transcript_3850;P98082 A6NES5 Q13598 Q9BTY0 Q9UK04,Disabled homolog 2,Adaptor molecule disabled-2;Differentially expressed in ovarian carcinoma 2;Differentially-expressed protein 2;, PF00640;, GO:0005905;GO:0030136;GO:0030665;GO:0005737;GO:0005829;GO:0001650;GO:0005925;GO:0043231;GO:0005765;GO:0005886;GO:0038024;GO:0035615;GO:0008022;GO:0046332;GO:0006915;GO:0035026;GO:0061024;GO:0007275;GO:0060766;GO:0043066;GO:0090090;GO:0032091;GO:1903077;GO:0000122;GO:0030335;GO:2000370;GO:2000643;GO:0045807;GO:0010718;GO:0010862;GO:0032436;GO:0001934;GO:0060391;GO:0045944;GO:0030511;GO:2000096;GO:0015031;GO:0006898;GO:0016055;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytosol; C:fibrillar center; C:focal adhesion; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane;, F:cargo receptor activity; F:clathrin adaptor activity; F:protein C-terminus binding; F:SMAD binding;, P:apoptotic process; P:leading edge cell differentiation; P:membrane organization; P:multicellular organism development; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein localization to plasma membrane; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell migration; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of early endosome to late endosome transport; P:positive regulation of endocytosis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:protein transport; P:receptor-mediated endocytosis; P:Wnt signaling pathway;|P98082 A6NES5 Q13598 Q9BTY0 Q9UK04,Disabled homolog 2,Adaptor molecule disabled-2;Differentially expressed in ovarian carcinoma 2;Differentially-expressed protein 2;, PF00640;, GO:0005905;GO:0030136;GO:0030665;GO:0005737;GO:0005829;GO:0001650;GO:0005925;GO:0043231;GO:0005765;GO:0005886;GO:0038024;GO:0035615;GO:0008022;GO:0046332;GO:0006915;GO:0035026;GO:0061024;GO:0007275;GO:0060766;GO:0043066;GO:0090090;GO:0032091;GO:1903077;GO:0000122;GO:0030335;GO:2000370;GO:2000643;GO:0045807;GO:0010718;GO:0010862;GO:0032436;GO:0001934;GO:0060391;GO:0045944;GO:0030511;GO:2000096;GO:0015031;GO:0006898;GO:0016055;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytosol; C:fibrillar center; C:focal adhesion; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane;, F:cargo receptor activity; F:clathrin adaptor activity; F:protein C-terminus binding; F:SMAD binding;, P:apoptotic process; P:leading edge cell differentiation; P:membrane organization; P:multicellular organism development; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein localization to plasma membrane; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell migration; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of early endosome to late endosome transport; P:positive regulation of endocytosis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:protein transport; P:receptor-mediated endocytosis; P:Wnt signaling pathway;|P98082 A6NES5 Q13598 Q9BTY0 Q9UK04,Disabled homolog 2,Adaptor molecule disabled-2;Differentially expressed in ovarian carcinoma 2;Differentially-expressed protein 2;, PF00640;, GO:0005905;GO:0030136;GO:0030665;GO:0005737;GO:0005829;GO:0001650;GO:0005925;GO:0043231;GO:0005765;GO:0005886;GO:0038024;GO:0035615;GO:0008022;GO:0046332;GO:0006915;GO:0035026;GO:0061024;GO:0007275;GO:0060766;GO:0043066;GO:0090090;GO:0032091;GO:1903077;GO:0000122;GO:0030335;GO:2000370;GO:2000643;GO:0045807;GO:0010718;GO:0010862;GO:0032436;GO:0001934;GO:0060391;GO:0045944;GO:0030511;GO:2000096;GO:0015031;GO:0006898;GO:0016055;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytosol; C:fibrillar center; C:focal adhesion; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane;, F:cargo receptor activity; F:clathrin adaptor activity; F:protein C-terminus binding; F:SMAD binding;, P:apoptotic process; P:leading edge cell differentiation; P:membrane organization; P:multicellular organism development; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein localization to plasma membrane; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell migration; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of early endosome to late endosome transport; P:positive regulation of endocytosis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:protein transport; P:receptor-mediated endocytosis; P:Wnt signaling pathway;|P98082 A6NES5 Q13598 Q9BTY0 Q9UK04,Disabled homolog 2,Adaptor molecule disabled-2;Differentially expressed in ovarian carcinoma 2;Differentially-expressed protein 2;, PF00640;, GO:0005905;GO:0030136;GO:0030665;GO:0005737;GO:0005829;GO:0001650;GO:0005925;GO:0043231;GO:0005765;GO:0005886;GO:0038024;GO:0035615;GO:0008022;GO:0046332;GO:0006915;GO:0035026;GO:0061024;GO:0007275;GO:0060766;GO:0043066;GO:0090090;GO:0032091;GO:1903077;GO:0000122;GO:0030335;GO:2000370;GO:2000643;GO:0045807;GO:0010718;GO:0010862;GO:0032436;GO:0001934;GO:0060391;GO:0045944;GO:0030511;GO:2000096;GO:0015031;GO:0006898;GO:0016055;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytosol; C:fibrillar center; C:focal adhesion; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane;, F:cargo receptor activity; F:clathrin adaptor activity; F:protein C-terminus binding; F:SMAD binding;, P:apoptotic process; P:leading edge cell differentiation; P:membrane organization; P:multicellular organism development; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein localization to plasma membrane; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell migration; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of early endosome to late endosome transport; P:positive regulation of endocytosis; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:protein transport; P:receptor-mediated endocytosis; P:Wnt signaling pathway; scaffold15 indexed_genome mRNA 11010372 11074032 . + . ID=transcript_3851;P02748,Complement component C9,, PF00057;PF01823;PF00090;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005579;GO:0044218;GO:0005886;GO:0001906;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0051260;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane attack complex; C:other organism cell membrane; C:plasma membrane;, , P:cell killing; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:protein homooligomerization; P:regulation of complement activation;|P02748,Complement component C9,, PF00057;PF01823;PF00090;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005579;GO:0044218;GO:0005886;GO:0001906;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0051260;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane attack complex; C:other organism cell membrane; C:plasma membrane;, , P:cell killing; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:protein homooligomerization; P:regulation of complement activation;|P02748,Complement component C9,, PF00057;PF01823;PF00090;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005579;GO:0044218;GO:0005886;GO:0001906;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0051260;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane attack complex; C:other organism cell membrane; C:plasma membrane;, , P:cell killing; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:protein homooligomerization; P:regulation of complement activation;|P02748,Complement component C9,, PF00057;PF01823;PF00090;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005579;GO:0044218;GO:0005886;GO:0001906;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0051260;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane attack complex; C:other organism cell membrane; C:plasma membrane;, , P:cell killing; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:protein homooligomerization; P:regulation of complement activation; scaffold15 indexed_genome mRNA 11162525 11253997 . + . ID=transcript_3852;O15117 A8K2Y8 B4DLN2 E9PBV9 O00359 Q9NZI9,FYN-binding protein 1 {ECO:0000312|HGNC:HGNC:4036},Adhesion and degranulation promoting adaptor protein;FYB-120/130;FYN-T-binding protein;SLAP-130;SLP-76-associated phosphoprotein;, PF14603;PF07653;, GO:0015629;GO:0030054;GO:0005829;GO:0005634;GO:0005886;GO:0032991;GO:0008289;GO:0044877;GO:0005102;GO:0006955;GO:0007229;GO:0072659;GO:0050852;, C:actin cytoskeleton; C:cell junction; C:cytosol; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:lipid binding; F:protein-containing complex binding; F:signaling receptor binding;, P:immune response; P:integrin-mediated signaling pathway; P:protein localization to plasma membrane; P:T cell receptor signaling pathway; scaffold15 indexed_genome mRNA 11283917 11376619 . + . ID=transcript_3853;Q6R327 B2RNX0 B7ZMF7 Q68DT5 Q86UB7 Q8N3A0 Q8NCM6,Rapamycin-insensitive companion of mTOR,AVO3 homolog;, PF14663;PF14666;PF14664;PF14665;PF14668;, GO:0005829;GO:0031932;GO:0019901;GO:0043539;GO:0043022;GO:0031532;GO:0032148;GO:0009792;GO:0018105;GO:0030838;GO:0001938;GO:0050731;GO:0051897;GO:0032008;GO:0032956;GO:2000114;GO:0010468;GO:0043087;GO:0050727;GO:0033135;GO:0051896;GO:1901796;GO:0038203;GO:0016032;, C:cytosol; C:TORC2 complex;, F:protein kinase binding; F:protein serine/threonine kinase activator activity; F:ribosome binding;, P:actin cytoskeleton reorganization; P:activation of protein kinase B activity; P:embryo development ending in birth or egg hatching; P:peptidyl-serine phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of endothelial cell proliferation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of TOR signaling; P:regulation of actin cytoskeleton organization; P:regulation of establishment of cell polarity; P:regulation of gene expression; P:regulation of GTPase activity; P:regulation of inflammatory response; P:regulation of peptidyl-serine phosphorylation; P:regulation of protein kinase B signaling; P:regulation of signal transduction by p53 class mediator; P:TORC2 signaling; P:viral process; scaffold15 indexed_genome mRNA 11376622 11404085 . + . ID=transcript_3854;Q6R327 B2RNX0 B7ZMF7 Q68DT5 Q86UB7 Q8N3A0 Q8NCM6,Rapamycin-insensitive companion of mTOR,AVO3 homolog;, PF14663;PF14666;PF14664;PF14665;PF14668;, GO:0005829;GO:0031932;GO:0019901;GO:0043539;GO:0043022;GO:0031532;GO:0032148;GO:0009792;GO:0018105;GO:0030838;GO:0001938;GO:0050731;GO:0051897;GO:0032008;GO:0032956;GO:2000114;GO:0010468;GO:0043087;GO:0050727;GO:0033135;GO:0051896;GO:1901796;GO:0038203;GO:0016032;, C:cytosol; C:TORC2 complex;, F:protein kinase binding; F:protein serine/threonine kinase activator activity; F:ribosome binding;, P:actin cytoskeleton reorganization; P:activation of protein kinase B activity; P:embryo development ending in birth or egg hatching; P:peptidyl-serine phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of endothelial cell proliferation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of TOR signaling; P:regulation of actin cytoskeleton organization; P:regulation of establishment of cell polarity; P:regulation of gene expression; P:regulation of GTPase activity; P:regulation of inflammatory response; P:regulation of peptidyl-serine phosphorylation; P:regulation of protein kinase B signaling; P:regulation of signal transduction by p53 class mediator; P:TORC2 signaling; P:viral process;|Q6R327 B2RNX0 B7ZMF7 Q68DT5 Q86UB7 Q8N3A0 Q8NCM6,Rapamycin-insensitive companion of mTOR,AVO3 homolog;, PF14663;PF14666;PF14664;PF14665;PF14668;, GO:0005829;GO:0031932;GO:0019901;GO:0043539;GO:0043022;GO:0031532;GO:0032148;GO:0009792;GO:0018105;GO:0030838;GO:0001938;GO:0050731;GO:0051897;GO:0032008;GO:0032956;GO:2000114;GO:0010468;GO:0043087;GO:0050727;GO:0033135;GO:0051896;GO:1901796;GO:0038203;GO:0016032;, C:cytosol; C:TORC2 complex;, F:protein kinase binding; F:protein serine/threonine kinase activator activity; F:ribosome binding;, P:actin cytoskeleton reorganization; P:activation of protein kinase B activity; P:embryo development ending in birth or egg hatching; P:peptidyl-serine phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of endothelial cell proliferation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of TOR signaling; P:regulation of actin cytoskeleton organization; P:regulation of establishment of cell polarity; P:regulation of gene expression; P:regulation of GTPase activity; P:regulation of inflammatory response; P:regulation of peptidyl-serine phosphorylation; P:regulation of protein kinase B signaling; P:regulation of signal transduction by p53 class mediator; P:TORC2 signaling; P:viral process; scaffold15 indexed_genome mRNA 11411896 11417004 . - . ID=transcript_3855;Q99650 Q6P4E8 Q96QJ6,Oncostatin-M-specific receptor subunit beta,Interleukin-31 receptor subunit beta;, PF00041;PF17971;, GO:0016324;GO:0009897;GO:0005900;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0004923;GO:0019221;GO:0038165;GO:0002675;GO:0008284;GO:0034097;, C:apical plasma membrane; C:external side of plasma membrane; C:oncostatin-M receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:leukemia inhibitory factor receptor activity;, P:cytokine-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of acute inflammatory response; P:positive regulation of cell population proliferation; P:response to cytokine;|Q99650 Q6P4E8 Q96QJ6,Oncostatin-M-specific receptor subunit beta,Interleukin-31 receptor subunit beta;, PF00041;PF17971;, GO:0016324;GO:0009897;GO:0005900;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0004923;GO:0019221;GO:0038165;GO:0002675;GO:0008284;GO:0034097;, C:apical plasma membrane; C:external side of plasma membrane; C:oncostatin-M receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:leukemia inhibitory factor receptor activity;, P:cytokine-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of acute inflammatory response; P:positive regulation of cell population proliferation; P:response to cytokine;|Q99650 Q6P4E8 Q96QJ6,Oncostatin-M-specific receptor subunit beta,Interleukin-31 receptor subunit beta;, PF00041;PF17971;, GO:0016324;GO:0009897;GO:0005900;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0004923;GO:0019221;GO:0038165;GO:0002675;GO:0008284;GO:0034097;, C:apical plasma membrane; C:external side of plasma membrane; C:oncostatin-M receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:leukemia inhibitory factor receptor activity;, P:cytokine-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of acute inflammatory response; P:positive regulation of cell population proliferation; P:response to cytokine;|Q99650 Q6P4E8 Q96QJ6,Oncostatin-M-specific receptor subunit beta,Interleukin-31 receptor subunit beta;, PF00041;PF17971;, GO:0016324;GO:0009897;GO:0005900;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0004923;GO:0019221;GO:0038165;GO:0002675;GO:0008284;GO:0034097;, C:apical plasma membrane; C:external side of plasma membrane; C:oncostatin-M receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:leukemia inhibitory factor receptor activity;, P:cytokine-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of acute inflammatory response; P:positive regulation of cell population proliferation; P:response to cytokine; scaffold15 indexed_genome mRNA 11419559 11456731 . - . ID=transcript_3856;Q99650 Q6P4E8 Q96QJ6,Oncostatin-M-specific receptor subunit beta,Interleukin-31 receptor subunit beta;, PF00041;PF17971;, GO:0016324;GO:0009897;GO:0005900;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0004923;GO:0019221;GO:0038165;GO:0002675;GO:0008284;GO:0034097;, C:apical plasma membrane; C:external side of plasma membrane; C:oncostatin-M receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:leukemia inhibitory factor receptor activity;, P:cytokine-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of acute inflammatory response; P:positive regulation of cell population proliferation; P:response to cytokine;|Q99650 Q6P4E8 Q96QJ6,Oncostatin-M-specific receptor subunit beta,Interleukin-31 receptor subunit beta;, PF00041;PF17971;, GO:0016324;GO:0009897;GO:0005900;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0004923;GO:0019221;GO:0038165;GO:0002675;GO:0008284;GO:0034097;, C:apical plasma membrane; C:external side of plasma membrane; C:oncostatin-M receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:leukemia inhibitory factor receptor activity;, P:cytokine-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of acute inflammatory response; P:positive regulation of cell population proliferation; P:response to cytokine; scaffold15 indexed_genome mRNA 11814957 11867813 . + . ID=transcript_3857;P42702 Q6LCD9,Leukemia inhibitory factor receptor,, PF00041;PF17971;PF18207;, GO:0009897;GO:0070062;GO:0005887;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0004923;GO:0007166;GO:0070120;GO:0019221;GO:0048861;GO:0038165;GO:0008284;GO:0001959;GO:0034097;, C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:leukemia inhibitory factor receptor activity;, P:cell surface receptor signaling pathway; P:ciliary neurotrophic factor-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:leukemia inhibitory factor signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of cell population proliferation; P:regulation of cytokine-mediated signaling pathway; P:response to cytokine;|P42702 Q6LCD9,Leukemia inhibitory factor receptor,, PF00041;PF17971;PF18207;, GO:0009897;GO:0070062;GO:0005887;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0004923;GO:0007166;GO:0070120;GO:0019221;GO:0048861;GO:0038165;GO:0008284;GO:0001959;GO:0034097;, C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:leukemia inhibitory factor receptor activity;, P:cell surface receptor signaling pathway; P:ciliary neurotrophic factor-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:leukemia inhibitory factor signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of cell population proliferation; P:regulation of cytokine-mediated signaling pathway; P:response to cytokine; scaffold15 indexed_genome mRNA 11878534 12072920 . - . ID=transcript_3858;Q63HQ2 A8K6D7 Q5U643 Q6P3V1 Q8N124 Q8N197 Q8N7Y0 Q8N8N5 Q8NAL2,Pikachurin,Agrin-like protein;EGF-like, fibronectin type-III and laminin G-like domain-containing protein;, PF00008;PF00041;PF00054;PF02210;, GO:0005604;GO:0042995;GO:0005614;GO:0048786;GO:0043083;GO:0005509;GO:0005539;GO:0009887;GO:0030198;GO:0019800;GO:0010811;GO:0009888;, C:basement membrane; C:cell projection; C:interstitial matrix; C:presynaptic active zone; C:synaptic cleft;, F:calcium ion binding; F:glycosaminoglycan binding;, P:animal organ morphogenesis; P:extracellular matrix organization; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; P:positive regulation of cell-substrate adhesion; P:tissue development; scaffold15 indexed_genome mRNA 12586747 12860500 . - . ID=transcript_3859;Q9NW82 Q9H053,WD repeat-containing protein 70,, PF00400;, GO:0005634;GO:0035861;GO:0019899;GO:1903775;GO:2001173;, C:nucleus; C:site of double-strand break;, F:enzyme binding;, P:regulation of DNA double-strand break processing; P:regulation of histone H2B conserved C-terminal lysine ubiquitination;|Q9NW82 Q9H053,WD repeat-containing protein 70,, PF00400;, GO:0005634;GO:0035861;GO:0019899;GO:1903775;GO:2001173;, C:nucleus; C:site of double-strand break;, F:enzyme binding;, P:regulation of DNA double-strand break processing; P:regulation of histone H2B conserved C-terminal lysine ubiquitination;|Q9NW82 Q9H053,WD repeat-containing protein 70,, PF00400;, GO:0005634;GO:0035861;GO:0019899;GO:1903775;GO:2001173;, C:nucleus; C:site of double-strand break;, F:enzyme binding;, P:regulation of DNA double-strand break processing; P:regulation of histone H2B conserved C-terminal lysine ubiquitination;|Q9NW82 Q9H053,WD repeat-containing protein 70,, PF00400;, GO:0005634;GO:0035861;GO:0019899;GO:1903775;GO:2001173;, C:nucleus; C:site of double-strand break;, F:enzyme binding;, P:regulation of DNA double-strand break processing; P:regulation of histone H2B conserved C-terminal lysine ubiquitination;|Q9NW82 Q9H053,WD repeat-containing protein 70,, PF00400;, GO:0005634;GO:0035861;GO:0019899;GO:1903775;GO:2001173;, C:nucleus; C:site of double-strand break;, F:enzyme binding;, P:regulation of DNA double-strand break processing; P:regulation of histone H2B conserved C-terminal lysine ubiquitination;|Q9NW82 Q9H053,WD repeat-containing protein 70,, PF00400;, GO:0005634;GO:0035861;GO:0019899;GO:1903775;GO:2001173;, C:nucleus; C:site of double-strand break;, F:enzyme binding;, P:regulation of DNA double-strand break processing; P:regulation of histone H2B conserved C-terminal lysine ubiquitination; scaffold15 indexed_genome mRNA 12864687 12917645 . + . ID=transcript_3860;O75694 Q9UBE9 Q9UFL5,Nuclear pore complex protein Nup155,155 kDa nucleoporin;Nucleoporin Nup155;, PF03177;PF08801;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0044611;GO:0017056;GO:0086014;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0006606;GO:0036228;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:atrial cardiac muscle cell action potential; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:protein import into nucleus; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|O75694 Q9UBE9 Q9UFL5,Nuclear pore complex protein Nup155,155 kDa nucleoporin;Nucleoporin Nup155;, PF03177;PF08801;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0044611;GO:0017056;GO:0086014;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0006606;GO:0036228;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:atrial cardiac muscle cell action potential; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:protein import into nucleus; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|O75694 Q9UBE9 Q9UFL5,Nuclear pore complex protein Nup155,155 kDa nucleoporin;Nucleoporin Nup155;, PF03177;PF08801;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0044611;GO:0017056;GO:0086014;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0006606;GO:0036228;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:atrial cardiac muscle cell action potential; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:protein import into nucleus; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|O75694 Q9UBE9 Q9UFL5,Nuclear pore complex protein Nup155,155 kDa nucleoporin;Nucleoporin Nup155;, PF03177;PF08801;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0044611;GO:0017056;GO:0086014;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0006606;GO:0036228;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:atrial cardiac muscle cell action potential; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:protein import into nucleus; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|O75694 Q9UBE9 Q9UFL5,Nuclear pore complex protein Nup155,155 kDa nucleoporin;Nucleoporin Nup155;, PF03177;PF08801;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0044611;GO:0017056;GO:0086014;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0006606;GO:0036228;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:atrial cardiac muscle cell action potential; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:protein import into nucleus; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|O75694 Q9UBE9 Q9UFL5,Nuclear pore complex protein Nup155,155 kDa nucleoporin;Nucleoporin Nup155;, PF03177;PF08801;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0044611;GO:0017056;GO:0086014;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0006606;GO:0036228;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:atrial cardiac muscle cell action potential; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:protein import into nucleus; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q32NC0 Q6GW03 Q9BXV6 Q9BXW2,UPF0711 protein C18orf21,HBV X-transactivated gene 13 protein;HBV XAg-transactivated protein 13;, PF15719;|O75694 Q9UBE9 Q9UFL5,Nuclear pore complex protein Nup155,155 kDa nucleoporin;Nucleoporin Nup155;, PF03177;PF08801;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0044611;GO:0017056;GO:0086014;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0006606;GO:0036228;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:atrial cardiac muscle cell action potential; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:protein import into nucleus; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|O75694 Q9UBE9 Q9UFL5,Nuclear pore complex protein Nup155,155 kDa nucleoporin;Nucleoporin Nup155;, PF03177;PF08801;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0044611;GO:0017056;GO:0086014;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0006606;GO:0036228;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:atrial cardiac muscle cell action potential; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:protein import into nucleus; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|O75694 Q9UBE9 Q9UFL5,Nuclear pore complex protein Nup155,155 kDa nucleoporin;Nucleoporin Nup155;, PF03177;PF08801;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0044611;GO:0017056;GO:0086014;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0006606;GO:0036228;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:atrial cardiac muscle cell action potential; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:protein import into nucleus; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold15 indexed_genome mRNA 12917706 12918754 . - . ID=transcript_3861;O75694 Q9UBE9 Q9UFL5,Nuclear pore complex protein Nup155,155 kDa nucleoporin;Nucleoporin Nup155;, PF03177;PF08801;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0044611;GO:0017056;GO:0086014;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0006606;GO:0036228;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore inner ring;, F:structural constituent of nuclear pore;, P:atrial cardiac muscle cell action potential; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:protein import into nucleus; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold15 indexed_genome mRNA 12934809 13039724 . + . ID=transcript_3862;Q9H799 A8MUB7 B7ZLV7 Q4G174 Q6DK46 Q8N8L4 Q9H5T1 Q9H8T9,Ciliogenesis and planar polarity effector 1 {ECO:0000305},Protein JBTS17;, PF15392;, GO:0035869;GO:0016021;GO:0060271;, C:ciliary transition zone; C:integral component of membrane;, , P:cilium assembly;|Q9H799 A8MUB7 B7ZLV7 Q4G174 Q6DK46 Q8N8L4 Q9H5T1 Q9H8T9,Ciliogenesis and planar polarity effector 1 {ECO:0000305},Protein JBTS17;, PF15392;, GO:0035869;GO:0016021;GO:0060271;, C:ciliary transition zone; C:integral component of membrane;, , P:cilium assembly;|Q9H799 A8MUB7 B7ZLV7 Q4G174 Q6DK46 Q8N8L4 Q9H5T1 Q9H8T9,Ciliogenesis and planar polarity effector 1 {ECO:0000305},Protein JBTS17;, PF15392;, GO:0035869;GO:0016021;GO:0060271;, C:ciliary transition zone; C:integral component of membrane;, , P:cilium assembly;|Q9H799 A8MUB7 B7ZLV7 Q4G174 Q6DK46 Q8N8L4 Q9H5T1 Q9H8T9,Ciliogenesis and planar polarity effector 1 {ECO:0000305},Protein JBTS17;, PF15392;, GO:0035869;GO:0016021;GO:0060271;, C:ciliary transition zone; C:integral component of membrane;, , P:cilium assembly;|Q9H799 A8MUB7 B7ZLV7 Q4G174 Q6DK46 Q8N8L4 Q9H5T1 Q9H8T9,Ciliogenesis and planar polarity effector 1 {ECO:0000305},Protein JBTS17;, PF15392;, GO:0035869;GO:0016021;GO:0060271;, C:ciliary transition zone; C:integral component of membrane;, , P:cilium assembly;|Q9H799 A8MUB7 B7ZLV7 Q4G174 Q6DK46 Q8N8L4 Q9H5T1 Q9H8T9,Ciliogenesis and planar polarity effector 1 {ECO:0000305},Protein JBTS17;, PF15392;, GO:0035869;GO:0016021;GO:0060271;, C:ciliary transition zone; C:integral component of membrane;, , P:cilium assembly;|Q9H799 A8MUB7 B7ZLV7 Q4G174 Q6DK46 Q8N8L4 Q9H5T1 Q9H8T9,Ciliogenesis and planar polarity effector 1 {ECO:0000305},Protein JBTS17;, PF15392;, GO:0035869;GO:0016021;GO:0060271;, C:ciliary transition zone; C:integral component of membrane;, , P:cilium assembly;|Q9H799 A8MUB7 B7ZLV7 Q4G174 Q6DK46 Q8N8L4 Q9H5T1 Q9H8T9,Ciliogenesis and planar polarity effector 1 {ECO:0000305},Protein JBTS17;, PF15392;, GO:0035869;GO:0016021;GO:0060271;, C:ciliary transition zone; C:integral component of membrane;, , P:cilium assembly;|Q9H799 A8MUB7 B7ZLV7 Q4G174 Q6DK46 Q8N8L4 Q9H5T1 Q9H8T9,Ciliogenesis and planar polarity effector 1 {ECO:0000305},Protein JBTS17;, PF15392;, GO:0035869;GO:0016021;GO:0060271;, C:ciliary transition zone; C:integral component of membrane;, , P:cilium assembly; scaffold15 indexed_genome mRNA 13052920 13120755 . - . ID=transcript_3863;Q6KC79 Q6KCD6 Q6N080 Q6ZT92 Q7Z2E6 Q8N4M5 Q9Y6Y3 Q9Y6Y4,Nipped-B-like protein,Delangin;SCC2 homolog;, PF12765;PF12830;, GO:0000785;GO:0005829;GO:0070062;GO:0032039;GO:0043231;GO:0005654;GO:0005634;GO:0090694;GO:0032116;GO:0003682;GO:0070087;GO:0042826;GO:0036033;GO:1990841;GO:0008022;GO:0047485;GO:0007420;GO:0034613;GO:0006974;GO:0071481;GO:0050890;GO:0071921;GO:0048589;GO:0048565;GO:0042471;GO:0048557;GO:0035115;GO:0048703;GO:0034087;GO:0071169;GO:0035261;GO:0048592;GO:0060325;GO:0045444;GO:0035136;GO:0061010;GO:0003007;GO:0034088;GO:0001656;GO:0007064;GO:0000122;GO:0045892;GO:0003151;GO:0031065;GO:1905406;GO:0040018;GO:2001224;GO:0045778;GO:0048638;GO:0045995;GO:0042634;GO:1990414;GO:0007605;GO:0019827;GO:0071733;GO:0061038;, C:chromatin; C:cytosol; C:extracellular exosome; C:integrator complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:Scc2-Scc4 cohesin loading complex; C:SMC loading complex;, F:chromatin binding; F:chromo shadow domain binding; F:histone deacetylase binding; F:mediator complex binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein N-terminus binding;, P:brain development; P:cellular protein localization; P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:cognition; P:cohesin loading; P:developmental growth; P:digestive tract development; P:ear morphogenesis; P:embryonic digestive tract morphogenesis; P:embryonic forelimb morphogenesis; P:embryonic viscerocranium morphogenesis; P:establishment of mitotic sister chromatid cohesion; P:establishment of protein localization to chromatin; P:external genitalia morphogenesis; P:eye morphogenesis; P:face morphogenesis; P:fat cell differentiation; P:forelimb morphogenesis; P:gall bladder development; P:heart morphogenesis; P:maintenance of mitotic sister chromatid cohesion; P:metanephros development; P:mitotic sister chromatid cohesion; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:outflow tract morphogenesis; P:positive regulation of histone deacetylation; P:positive regulation of mitotic cohesin loading; P:positive regulation of multicellular organism growth; P:positive regulation of neuron migration; P:positive regulation of ossification; P:regulation of developmental growth; P:regulation of embryonic development; P:regulation of hair cycle; P:replication-born double-strand break repair via sister chromatid exchange; P:sensory perception of sound; P:stem cell population maintenance; P:transcriptional activation by promoter-enhancer looping; P:uterus morphogenesis;|Q6KC79 Q6KCD6 Q6N080 Q6ZT92 Q7Z2E6 Q8N4M5 Q9Y6Y3 Q9Y6Y4,Nipped-B-like protein,Delangin;SCC2 homolog;, PF12765;PF12830;, GO:0000785;GO:0005829;GO:0070062;GO:0032039;GO:0043231;GO:0005654;GO:0005634;GO:0090694;GO:0032116;GO:0003682;GO:0070087;GO:0042826;GO:0036033;GO:1990841;GO:0008022;GO:0047485;GO:0007420;GO:0034613;GO:0006974;GO:0071481;GO:0050890;GO:0071921;GO:0048589;GO:0048565;GO:0042471;GO:0048557;GO:0035115;GO:0048703;GO:0034087;GO:0071169;GO:0035261;GO:0048592;GO:0060325;GO:0045444;GO:0035136;GO:0061010;GO:0003007;GO:0034088;GO:0001656;GO:0007064;GO:0000122;GO:0045892;GO:0003151;GO:0031065;GO:1905406;GO:0040018;GO:2001224;GO:0045778;GO:0048638;GO:0045995;GO:0042634;GO:1990414;GO:0007605;GO:0019827;GO:0071733;GO:0061038;, C:chromatin; C:cytosol; C:extracellular exosome; C:integrator complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:Scc2-Scc4 cohesin loading complex; C:SMC loading complex;, F:chromatin binding; F:chromo shadow domain binding; F:histone deacetylase binding; F:mediator complex binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein N-terminus binding;, P:brain development; P:cellular protein localization; P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:cognition; P:cohesin loading; P:developmental growth; P:digestive tract development; P:ear morphogenesis; P:embryonic digestive tract morphogenesis; P:embryonic forelimb morphogenesis; P:embryonic viscerocranium morphogenesis; P:establishment of mitotic sister chromatid cohesion; P:establishment of protein localization to chromatin; P:external genitalia morphogenesis; P:eye morphogenesis; P:face morphogenesis; P:fat cell differentiation; P:forelimb morphogenesis; P:gall bladder development; P:heart morphogenesis; P:maintenance of mitotic sister chromatid cohesion; P:metanephros development; P:mitotic sister chromatid cohesion; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:outflow tract morphogenesis; P:positive regulation of histone deacetylation; P:positive regulation of mitotic cohesin loading; P:positive regulation of multicellular organism growth; P:positive regulation of neuron migration; P:positive regulation of ossification; P:regulation of developmental growth; P:regulation of embryonic development; P:regulation of hair cycle; P:replication-born double-strand break repair via sister chromatid exchange; P:sensory perception of sound; P:stem cell population maintenance; P:transcriptional activation by promoter-enhancer looping; P:uterus morphogenesis;|Q6KC79 Q6KCD6 Q6N080 Q6ZT92 Q7Z2E6 Q8N4M5 Q9Y6Y3 Q9Y6Y4,Nipped-B-like protein,Delangin;SCC2 homolog;, PF12765;PF12830;, GO:0000785;GO:0005829;GO:0070062;GO:0032039;GO:0043231;GO:0005654;GO:0005634;GO:0090694;GO:0032116;GO:0003682;GO:0070087;GO:0042826;GO:0036033;GO:1990841;GO:0008022;GO:0047485;GO:0007420;GO:0034613;GO:0006974;GO:0071481;GO:0050890;GO:0071921;GO:0048589;GO:0048565;GO:0042471;GO:0048557;GO:0035115;GO:0048703;GO:0034087;GO:0071169;GO:0035261;GO:0048592;GO:0060325;GO:0045444;GO:0035136;GO:0061010;GO:0003007;GO:0034088;GO:0001656;GO:0007064;GO:0000122;GO:0045892;GO:0003151;GO:0031065;GO:1905406;GO:0040018;GO:2001224;GO:0045778;GO:0048638;GO:0045995;GO:0042634;GO:1990414;GO:0007605;GO:0019827;GO:0071733;GO:0061038;, C:chromatin; C:cytosol; C:extracellular exosome; C:integrator complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:Scc2-Scc4 cohesin loading complex; C:SMC loading complex;, F:chromatin binding; F:chromo shadow domain binding; F:histone deacetylase binding; F:mediator complex binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein N-terminus binding;, P:brain development; P:cellular protein localization; P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:cognition; P:cohesin loading; P:developmental growth; P:digestive tract development; P:ear morphogenesis; P:embryonic digestive tract morphogenesis; P:embryonic forelimb morphogenesis; P:embryonic viscerocranium morphogenesis; P:establishment of mitotic sister chromatid cohesion; P:establishment of protein localization to chromatin; P:external genitalia morphogenesis; P:eye morphogenesis; P:face morphogenesis; P:fat cell differentiation; P:forelimb morphogenesis; P:gall bladder development; P:heart morphogenesis; P:maintenance of mitotic sister chromatid cohesion; P:metanephros development; P:mitotic sister chromatid cohesion; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:outflow tract morphogenesis; P:positive regulation of histone deacetylation; P:positive regulation of mitotic cohesin loading; P:positive regulation of multicellular organism growth; P:positive regulation of neuron migration; P:positive regulation of ossification; P:regulation of developmental growth; P:regulation of embryonic development; P:regulation of hair cycle; P:replication-born double-strand break repair via sister chromatid exchange; P:sensory perception of sound; P:stem cell population maintenance; P:transcriptional activation by promoter-enhancer looping; P:uterus morphogenesis; scaffold15 indexed_genome mRNA 13141299 13168230 . - . ID=transcript_3864;Q6KC79 Q6KCD6 Q6N080 Q6ZT92 Q7Z2E6 Q8N4M5 Q9Y6Y3 Q9Y6Y4,Nipped-B-like protein,Delangin;SCC2 homolog;, PF12765;PF12830;, GO:0000785;GO:0005829;GO:0070062;GO:0032039;GO:0043231;GO:0005654;GO:0005634;GO:0090694;GO:0032116;GO:0003682;GO:0070087;GO:0042826;GO:0036033;GO:1990841;GO:0008022;GO:0047485;GO:0007420;GO:0034613;GO:0006974;GO:0071481;GO:0050890;GO:0071921;GO:0048589;GO:0048565;GO:0042471;GO:0048557;GO:0035115;GO:0048703;GO:0034087;GO:0071169;GO:0035261;GO:0048592;GO:0060325;GO:0045444;GO:0035136;GO:0061010;GO:0003007;GO:0034088;GO:0001656;GO:0007064;GO:0000122;GO:0045892;GO:0003151;GO:0031065;GO:1905406;GO:0040018;GO:2001224;GO:0045778;GO:0048638;GO:0045995;GO:0042634;GO:1990414;GO:0007605;GO:0019827;GO:0071733;GO:0061038;, C:chromatin; C:cytosol; C:extracellular exosome; C:integrator complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:Scc2-Scc4 cohesin loading complex; C:SMC loading complex;, F:chromatin binding; F:chromo shadow domain binding; F:histone deacetylase binding; F:mediator complex binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein N-terminus binding;, P:brain development; P:cellular protein localization; P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:cognition; P:cohesin loading; P:developmental growth; P:digestive tract development; P:ear morphogenesis; P:embryonic digestive tract morphogenesis; P:embryonic forelimb morphogenesis; P:embryonic viscerocranium morphogenesis; P:establishment of mitotic sister chromatid cohesion; P:establishment of protein localization to chromatin; P:external genitalia morphogenesis; P:eye morphogenesis; P:face morphogenesis; P:fat cell differentiation; P:forelimb morphogenesis; P:gall bladder development; P:heart morphogenesis; P:maintenance of mitotic sister chromatid cohesion; P:metanephros development; P:mitotic sister chromatid cohesion; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:outflow tract morphogenesis; P:positive regulation of histone deacetylation; P:positive regulation of mitotic cohesin loading; P:positive regulation of multicellular organism growth; P:positive regulation of neuron migration; P:positive regulation of ossification; P:regulation of developmental growth; P:regulation of embryonic development; P:regulation of hair cycle; P:replication-born double-strand break repair via sister chromatid exchange; P:sensory perception of sound; P:stem cell population maintenance; P:transcriptional activation by promoter-enhancer looping; P:uterus morphogenesis; scaffold15 indexed_genome mRNA 13451157 13530435 . - . ID=transcript_3865;P43003 B2R5T3 Q4JCQ8,Excitatory amino acid transporter 1 {ECO:0000303|PubMed:16042756, ECO:0000303|PubMed:8647279},Sodium-dependent glutamate/aspartate transporter 1 {ECO:0000303|PubMed:8647279};Solute carrier family 1 member 3;, PF00375;, GO:0009925;GO:0031410;GO:0005887;GO:0016020;GO:0098796;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0045202;GO:0015501;GO:0005314;GO:0005313;GO:0046872;GO:0007268;GO:1902476;GO:0070779;GO:0006811;GO:0140009;GO:0051938;GO:0098712;GO:0015813;GO:0006836;GO:0001504;GO:0071805;GO:0070633;GO:0150104;, C:basal plasma membrane; C:cytoplasmic vesicle; C:integral component of plasma membrane; C:membrane; C:membrane protein complex; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse;, F:glutamate:sodium symporter activity; F:high-affinity glutamate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:metal ion binding;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:D-aspartate import across plasma membrane; P:ion transport; P:L-aspartate import across plasma membrane; P:L-glutamate import; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:neurotransmitter uptake; P:potassium ion transmembrane transport; P:transepithelial transport; P:transport across blood-brain barrier;|P43003 B2R5T3 Q4JCQ8,Excitatory amino acid transporter 1 {ECO:0000303|PubMed:16042756, ECO:0000303|PubMed:8647279},Sodium-dependent glutamate/aspartate transporter 1 {ECO:0000303|PubMed:8647279};Solute carrier family 1 member 3;, PF00375;, GO:0009925;GO:0031410;GO:0005887;GO:0016020;GO:0098796;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0045202;GO:0015501;GO:0005314;GO:0005313;GO:0046872;GO:0007268;GO:1902476;GO:0070779;GO:0006811;GO:0140009;GO:0051938;GO:0098712;GO:0015813;GO:0006836;GO:0001504;GO:0071805;GO:0070633;GO:0150104;, C:basal plasma membrane; C:cytoplasmic vesicle; C:integral component of plasma membrane; C:membrane; C:membrane protein complex; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse;, F:glutamate:sodium symporter activity; F:high-affinity glutamate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:metal ion binding;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:D-aspartate import across plasma membrane; P:ion transport; P:L-aspartate import across plasma membrane; P:L-glutamate import; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:neurotransmitter uptake; P:potassium ion transmembrane transport; P:transepithelial transport; P:transport across blood-brain barrier;|P43003 B2R5T3 Q4JCQ8,Excitatory amino acid transporter 1 {ECO:0000303|PubMed:16042756, ECO:0000303|PubMed:8647279},Sodium-dependent glutamate/aspartate transporter 1 {ECO:0000303|PubMed:8647279};Solute carrier family 1 member 3;, PF00375;, GO:0009925;GO:0031410;GO:0005887;GO:0016020;GO:0098796;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0045202;GO:0015501;GO:0005314;GO:0005313;GO:0046872;GO:0007268;GO:1902476;GO:0070779;GO:0006811;GO:0140009;GO:0051938;GO:0098712;GO:0015813;GO:0006836;GO:0001504;GO:0071805;GO:0070633;GO:0150104;, C:basal plasma membrane; C:cytoplasmic vesicle; C:integral component of plasma membrane; C:membrane; C:membrane protein complex; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse;, F:glutamate:sodium symporter activity; F:high-affinity glutamate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:metal ion binding;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:D-aspartate import across plasma membrane; P:ion transport; P:L-aspartate import across plasma membrane; P:L-glutamate import; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:neurotransmitter uptake; P:potassium ion transmembrane transport; P:transepithelial transport; P:transport across blood-brain barrier;|P43003 B2R5T3 Q4JCQ8,Excitatory amino acid transporter 1 {ECO:0000303|PubMed:16042756, ECO:0000303|PubMed:8647279},Sodium-dependent glutamate/aspartate transporter 1 {ECO:0000303|PubMed:8647279};Solute carrier family 1 member 3;, PF00375;, GO:0009925;GO:0031410;GO:0005887;GO:0016020;GO:0098796;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0045202;GO:0015501;GO:0005314;GO:0005313;GO:0046872;GO:0007268;GO:1902476;GO:0070779;GO:0006811;GO:0140009;GO:0051938;GO:0098712;GO:0015813;GO:0006836;GO:0001504;GO:0071805;GO:0070633;GO:0150104;, C:basal plasma membrane; C:cytoplasmic vesicle; C:integral component of plasma membrane; C:membrane; C:membrane protein complex; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse;, F:glutamate:sodium symporter activity; F:high-affinity glutamate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:metal ion binding;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:D-aspartate import across plasma membrane; P:ion transport; P:L-aspartate import across plasma membrane; P:L-glutamate import; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:neurotransmitter uptake; P:potassium ion transmembrane transport; P:transepithelial transport; P:transport across blood-brain barrier;|P43003 B2R5T3 Q4JCQ8,Excitatory amino acid transporter 1 {ECO:0000303|PubMed:16042756, ECO:0000303|PubMed:8647279},Sodium-dependent glutamate/aspartate transporter 1 {ECO:0000303|PubMed:8647279};Solute carrier family 1 member 3;, PF00375;, GO:0009925;GO:0031410;GO:0005887;GO:0016020;GO:0098796;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0045202;GO:0015501;GO:0005314;GO:0005313;GO:0046872;GO:0007268;GO:1902476;GO:0070779;GO:0006811;GO:0140009;GO:0051938;GO:0098712;GO:0015813;GO:0006836;GO:0001504;GO:0071805;GO:0070633;GO:0150104;, C:basal plasma membrane; C:cytoplasmic vesicle; C:integral component of plasma membrane; C:membrane; C:membrane protein complex; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse;, F:glutamate:sodium symporter activity; F:high-affinity glutamate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:metal ion binding;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:D-aspartate import across plasma membrane; P:ion transport; P:L-aspartate import across plasma membrane; P:L-glutamate import; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:neurotransmitter uptake; P:potassium ion transmembrane transport; P:transepithelial transport; P:transport across blood-brain barrier; scaffold15 indexed_genome mRNA 13818310 13843571 . + . ID=transcript_3866;Q86VV4 B7Z866 E9PGP9 Q96LK2,Ran-binding protein 3-like,, PF00638;, GO:0005737;GO:0005643;GO:0046332;GO:1901706;GO:0045668;GO:0043547;GO:0045663;GO:0006611;, C:cytoplasm; C:nuclear pore;, F:SMAD binding;, P:mesenchymal cell differentiation involved in bone development; P:negative regulation of osteoblast differentiation; P:positive regulation of GTPase activity; P:positive regulation of myoblast differentiation; P:protein export from nucleus;|Q86VV4 B7Z866 E9PGP9 Q96LK2,Ran-binding protein 3-like,, PF00638;, GO:0005737;GO:0005643;GO:0046332;GO:1901706;GO:0045668;GO:0043547;GO:0045663;GO:0006611;, C:cytoplasm; C:nuclear pore;, F:SMAD binding;, P:mesenchymal cell differentiation involved in bone development; P:negative regulation of osteoblast differentiation; P:positive regulation of GTPase activity; P:positive regulation of myoblast differentiation; P:protein export from nucleus; scaffold15 indexed_genome mRNA 13861020 13907536 . + . ID=transcript_3867;Q4G0N4 B5MC93 Q6UTX5 Q96NM0,NAD kinase 2, mitochondrial,Mitochondrial NAD kinase;NAD kinase domain-containing protein 1, mitochondrial;, PF01513;, GO:0005759;GO:0005739;GO:0005524;GO:0003951;GO:0042803;GO:0019674;GO:0006741;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:NAD+ kinase activity; F:protein homodimerization activity;, P:NAD metabolic process; P:NADP biosynthetic process;|Q4G0N4 B5MC93 Q6UTX5 Q96NM0,NAD kinase 2, mitochondrial,Mitochondrial NAD kinase;NAD kinase domain-containing protein 1, mitochondrial;, PF01513;, GO:0005759;GO:0005739;GO:0005524;GO:0003951;GO:0042803;GO:0019674;GO:0006741;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:NAD+ kinase activity; F:protein homodimerization activity;, P:NAD metabolic process; P:NADP biosynthetic process;|Q4G0N4 B5MC93 Q6UTX5 Q96NM0,NAD kinase 2, mitochondrial,Mitochondrial NAD kinase;NAD kinase domain-containing protein 1, mitochondrial;, PF01513;, GO:0005759;GO:0005739;GO:0005524;GO:0003951;GO:0042803;GO:0019674;GO:0006741;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:NAD+ kinase activity; F:protein homodimerization activity;, P:NAD metabolic process; P:NADP biosynthetic process;|Q4G0N4 B5MC93 Q6UTX5 Q96NM0,NAD kinase 2, mitochondrial,Mitochondrial NAD kinase;NAD kinase domain-containing protein 1, mitochondrial;, PF01513;, GO:0005759;GO:0005739;GO:0005524;GO:0003951;GO:0042803;GO:0019674;GO:0006741;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:NAD+ kinase activity; F:protein homodimerization activity;, P:NAD metabolic process; P:NADP biosynthetic process; scaffold15 indexed_genome mRNA 13912253 13936702 . - . ID=transcript_3868;Q13309 A8K5E0 B4DJT4 Q8TDZ0 Q8TDZ1 Q9BV69,S-phase kinase-associated protein 2,Cyclin-A/CDK2-associated protein p45;F-box protein Skp2;F-box/LRR-repeat protein 1;p45skp2;, PF12937;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0019005;GO:0042802;GO:0031145;GO:0051607;GO:0000082;GO:0000086;GO:0045087;GO:0043687;GO:0043161;GO:0016579;GO:0070936;GO:0000209;GO:0042981;GO:0051726;GO:0031146;GO:0016032;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:identical protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:defense response to virus; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:innate immune response; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of apoptotic process; P:regulation of cell cycle; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q13309 A8K5E0 B4DJT4 Q8TDZ0 Q8TDZ1 Q9BV69,S-phase kinase-associated protein 2,Cyclin-A/CDK2-associated protein p45;F-box protein Skp2;F-box/LRR-repeat protein 1;p45skp2;, PF12937;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0019005;GO:0042802;GO:0031145;GO:0051607;GO:0000082;GO:0000086;GO:0045087;GO:0043687;GO:0043161;GO:0016579;GO:0070936;GO:0000209;GO:0042981;GO:0051726;GO:0031146;GO:0016032;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:identical protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:defense response to virus; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:innate immune response; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of apoptotic process; P:regulation of cell cycle; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process; scaffold15 indexed_genome mRNA 13937167 13949919 . - . ID=transcript_3869;Q13309 A8K5E0 B4DJT4 Q8TDZ0 Q8TDZ1 Q9BV69,S-phase kinase-associated protein 2,Cyclin-A/CDK2-associated protein p45;F-box protein Skp2;F-box/LRR-repeat protein 1;p45skp2;, PF12937;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0019005;GO:0042802;GO:0031145;GO:0051607;GO:0000082;GO:0000086;GO:0045087;GO:0043687;GO:0043161;GO:0016579;GO:0070936;GO:0000209;GO:0042981;GO:0051726;GO:0031146;GO:0016032;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:identical protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:defense response to virus; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:innate immune response; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:regulation of apoptotic process; P:regulation of cell cycle; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process; scaffold15 indexed_genome mRNA 13950127 13999567 . + . ID=transcript_3870;Q68DH5 B3KRB6 Q9NTC7,G-protein coupled receptor-associated protein LMBRD2 {ECO:0000305|PubMed:28388415},LMBR1 domain-containing protein 2 {ECO:0000312|HGNC:HGNC:25287};, PF04791;, GO:0016021;GO:0016020;GO:0005886;GO:0071875;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:adrenergic receptor signaling pathway;|Q68DH5 B3KRB6 Q9NTC7,G-protein coupled receptor-associated protein LMBRD2 {ECO:0000305|PubMed:28388415},LMBR1 domain-containing protein 2 {ECO:0000312|HGNC:HGNC:25287};, PF04791;, GO:0016021;GO:0016020;GO:0005886;GO:0071875;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:adrenergic receptor signaling pathway; scaffold15 indexed_genome mRNA 14027796 14031833 . + . ID=transcript_3871;Q6NUS8 G5E961 Q8IYS9 Q8NAW4 Q96DM6,UDP-glucuronosyltransferase 3A1,, PF00201;, GO:0016021;GO:0043231;GO:0043541;GO:0015020;GO:0008194;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:UDP-N-acetylglucosamine transferase complex;, F:glucuronosyltransferase activity; F:UDP-glycosyltransferase activity; scaffold15 indexed_genome mRNA 14059990 14063607 . + . ID=transcript_3872;Q3SY77 B4DUQ7 E9PFK7 Q6UXC4 Q8NBP2,UDP-glucuronosyltransferase 3A2,, PF00201;, GO:0016021;GO:0043231;GO:0015020;GO:0008194;GO:0071412;, C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:glucuronosyltransferase activity; F:UDP-glycosyltransferase activity;, P:cellular response to genistein;|Q6NUS8 G5E961 Q8IYS9 Q8NAW4 Q96DM6,UDP-glucuronosyltransferase 3A1,, PF00201;, GO:0016021;GO:0043231;GO:0043541;GO:0015020;GO:0008194;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:UDP-N-acetylglucosamine transferase complex;, F:glucuronosyltransferase activity; F:UDP-glycosyltransferase activity; scaffold15 indexed_genome mRNA 14083850 14101333 . + . ID=transcript_3873;Q8WWF8,Calcyphosin-like protein,, PF13499;, GO:0005737;GO:0005509;, C:cytoplasm;, F:calcium ion binding; scaffold15 indexed_genome mRNA 14183100 14183835 . - . ID=transcript_3874;Q9C093 Q2TAC9 Q96LL6 Q9H5C7 Q9H5Q7,Sperm flagellar protein 2,Protein KPL2;, PF06294;, GO:0005737;GO:0005576;GO:0005794;GO:0002177;GO:0036126;GO:0097225;GO:0048854;GO:0003351;GO:0060541;GO:0048705;GO:0007288;GO:0007283;, C:cytoplasm; C:extracellular region; C:Golgi apparatus; C:manchette; C:sperm flagellum; C:sperm midpiece;, , P:brain morphogenesis; P:epithelial cilium movement involved in extracellular fluid movement; P:respiratory system development; P:skeletal system morphogenesis; P:sperm axoneme assembly; P:spermatogenesis; scaffold15 indexed_genome mRNA 14186239 14209022 . - . ID=transcript_3875;Q9C093 Q2TAC9 Q96LL6 Q9H5C7 Q9H5Q7,Sperm flagellar protein 2,Protein KPL2;, PF06294;, GO:0005737;GO:0005576;GO:0005794;GO:0002177;GO:0036126;GO:0097225;GO:0048854;GO:0003351;GO:0060541;GO:0048705;GO:0007288;GO:0007283;, C:cytoplasm; C:extracellular region; C:Golgi apparatus; C:manchette; C:sperm flagellum; C:sperm midpiece;, , P:brain morphogenesis; P:epithelial cilium movement involved in extracellular fluid movement; P:respiratory system development; P:skeletal system morphogenesis; P:sperm axoneme assembly; P:spermatogenesis; scaffold15 indexed_genome mRNA 14214311 14234323 . - . ID=transcript_3876;Q9C093 Q2TAC9 Q96LL6 Q9H5C7 Q9H5Q7,Sperm flagellar protein 2,Protein KPL2;, PF06294;, GO:0005737;GO:0005576;GO:0005794;GO:0002177;GO:0036126;GO:0097225;GO:0048854;GO:0003351;GO:0060541;GO:0048705;GO:0007288;GO:0007283;, C:cytoplasm; C:extracellular region; C:Golgi apparatus; C:manchette; C:sperm flagellum; C:sperm midpiece;, , P:brain morphogenesis; P:epithelial cilium movement involved in extracellular fluid movement; P:respiratory system development; P:skeletal system morphogenesis; P:sperm axoneme assembly; P:spermatogenesis;|Q9C093 Q2TAC9 Q96LL6 Q9H5C7 Q9H5Q7,Sperm flagellar protein 2,Protein KPL2;, PF06294;, GO:0005737;GO:0005576;GO:0005794;GO:0002177;GO:0036126;GO:0097225;GO:0048854;GO:0003351;GO:0060541;GO:0048705;GO:0007288;GO:0007283;, C:cytoplasm; C:extracellular region; C:Golgi apparatus; C:manchette; C:sperm flagellum; C:sperm midpiece;, , P:brain morphogenesis; P:epithelial cilium movement involved in extracellular fluid movement; P:respiratory system development; P:skeletal system morphogenesis; P:sperm axoneme assembly; P:spermatogenesis; scaffold15 indexed_genome mRNA 14282183 14368276 . - . ID=transcript_3877;Q9C093 Q2TAC9 Q96LL6 Q9H5C7 Q9H5Q7,Sperm flagellar protein 2,Protein KPL2;, PF06294;, GO:0005737;GO:0005576;GO:0005794;GO:0002177;GO:0036126;GO:0097225;GO:0048854;GO:0003351;GO:0060541;GO:0048705;GO:0007288;GO:0007283;, C:cytoplasm; C:extracellular region; C:Golgi apparatus; C:manchette; C:sperm flagellum; C:sperm midpiece;, , P:brain morphogenesis; P:epithelial cilium movement involved in extracellular fluid movement; P:respiratory system development; P:skeletal system morphogenesis; P:sperm axoneme assembly; P:spermatogenesis;|Q9C093 Q2TAC9 Q96LL6 Q9H5C7 Q9H5Q7,Sperm flagellar protein 2,Protein KPL2;, PF06294;, GO:0005737;GO:0005576;GO:0005794;GO:0002177;GO:0036126;GO:0097225;GO:0048854;GO:0003351;GO:0060541;GO:0048705;GO:0007288;GO:0007283;, C:cytoplasm; C:extracellular region; C:Golgi apparatus; C:manchette; C:sperm flagellum; C:sperm midpiece;, , P:brain morphogenesis; P:epithelial cilium movement involved in extracellular fluid movement; P:respiratory system development; P:skeletal system morphogenesis; P:sperm axoneme assembly; P:spermatogenesis;|Q9C093 Q2TAC9 Q96LL6 Q9H5C7 Q9H5Q7,Sperm flagellar protein 2,Protein KPL2;, PF06294;, GO:0005737;GO:0005576;GO:0005794;GO:0002177;GO:0036126;GO:0097225;GO:0048854;GO:0003351;GO:0060541;GO:0048705;GO:0007288;GO:0007283;, C:cytoplasm; C:extracellular region; C:Golgi apparatus; C:manchette; C:sperm flagellum; C:sperm midpiece;, , P:brain morphogenesis; P:epithelial cilium movement involved in extracellular fluid movement; P:respiratory system development; P:skeletal system morphogenesis; P:sperm axoneme assembly; P:spermatogenesis;|Q9C093 Q2TAC9 Q96LL6 Q9H5C7 Q9H5Q7,Sperm flagellar protein 2,Protein KPL2;, PF06294;, GO:0005737;GO:0005576;GO:0005794;GO:0002177;GO:0036126;GO:0097225;GO:0048854;GO:0003351;GO:0060541;GO:0048705;GO:0007288;GO:0007283;, C:cytoplasm; C:extracellular region; C:Golgi apparatus; C:manchette; C:sperm flagellum; C:sperm midpiece;, , P:brain morphogenesis; P:epithelial cilium movement involved in extracellular fluid movement; P:respiratory system development; P:skeletal system morphogenesis; P:sperm axoneme assembly; P:spermatogenesis; scaffold15 indexed_genome mRNA 14729498 14871311 . + . ID=transcript_3878;Q9UHJ5,Prolactin receptor,, PF09067;, GO:0009986;GO:0031904;GO:0009897;GO:0005576;GO:0016021;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0004923;GO:0046872;GO:0017046;GO:0004925;GO:0042976;GO:0007171;GO:0019221;GO:0007566;GO:0060397;GO:0007595;GO:0043066;GO:0038165;GO:0008284;GO:0120162;GO:0006694;, C:cell surface; C:endosome lumen; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:leukemia inhibitory factor receptor activity; F:metal ion binding; F:peptide hormone binding; F:prolactin receptor activity;, P:activation of Janus kinase activity; P:activation of transmembrane receptor protein tyrosine kinase activity; P:cytokine-mediated signaling pathway; P:embryo implantation; P:growth hormone receptor signaling pathway via JAK-STAT; P:lactation; P:negative regulation of apoptotic process; P:oncostatin-M-mediated signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:steroid biosynthetic process;|Q9UHJ5,Prolactin receptor,, PF09067;, GO:0009986;GO:0031904;GO:0009897;GO:0005576;GO:0016021;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0004923;GO:0046872;GO:0017046;GO:0004925;GO:0042976;GO:0007171;GO:0019221;GO:0007566;GO:0060397;GO:0007595;GO:0043066;GO:0038165;GO:0008284;GO:0120162;GO:0006694;, C:cell surface; C:endosome lumen; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:leukemia inhibitory factor receptor activity; F:metal ion binding; F:peptide hormone binding; F:prolactin receptor activity;, P:activation of Janus kinase activity; P:activation of transmembrane receptor protein tyrosine kinase activity; P:cytokine-mediated signaling pathway; P:embryo implantation; P:growth hormone receptor signaling pathway via JAK-STAT; P:lactation; P:negative regulation of apoptotic process; P:oncostatin-M-mediated signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:steroid biosynthetic process;|Q9UHJ5,Prolactin receptor,, PF09067;, GO:0009986;GO:0031904;GO:0009897;GO:0005576;GO:0016021;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0004923;GO:0046872;GO:0017046;GO:0004925;GO:0042976;GO:0007171;GO:0019221;GO:0007566;GO:0060397;GO:0007595;GO:0043066;GO:0038165;GO:0008284;GO:0120162;GO:0006694;, C:cell surface; C:endosome lumen; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:leukemia inhibitory factor receptor activity; F:metal ion binding; F:peptide hormone binding; F:prolactin receptor activity;, P:activation of Janus kinase activity; P:activation of transmembrane receptor protein tyrosine kinase activity; P:cytokine-mediated signaling pathway; P:embryo implantation; P:growth hormone receptor signaling pathway via JAK-STAT; P:lactation; P:negative regulation of apoptotic process; P:oncostatin-M-mediated signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:steroid biosynthetic process;|Q9UHJ5,Prolactin receptor,, PF09067;, GO:0009986;GO:0031904;GO:0009897;GO:0005576;GO:0016021;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0004923;GO:0046872;GO:0017046;GO:0004925;GO:0042976;GO:0007171;GO:0019221;GO:0007566;GO:0060397;GO:0007595;GO:0043066;GO:0038165;GO:0008284;GO:0120162;GO:0006694;, C:cell surface; C:endosome lumen; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:leukemia inhibitory factor receptor activity; F:metal ion binding; F:peptide hormone binding; F:prolactin receptor activity;, P:activation of Janus kinase activity; P:activation of transmembrane receptor protein tyrosine kinase activity; P:cytokine-mediated signaling pathway; P:embryo implantation; P:growth hormone receptor signaling pathway via JAK-STAT; P:lactation; P:negative regulation of apoptotic process; P:oncostatin-M-mediated signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:steroid biosynthetic process;|Q9UHJ5,Prolactin receptor,, PF09067;, GO:0009986;GO:0031904;GO:0009897;GO:0005576;GO:0016021;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0004923;GO:0046872;GO:0017046;GO:0004925;GO:0042976;GO:0007171;GO:0019221;GO:0007566;GO:0060397;GO:0007595;GO:0043066;GO:0038165;GO:0008284;GO:0120162;GO:0006694;, C:cell surface; C:endosome lumen; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:leukemia inhibitory factor receptor activity; F:metal ion binding; F:peptide hormone binding; F:prolactin receptor activity;, P:activation of Janus kinase activity; P:activation of transmembrane receptor protein tyrosine kinase activity; P:cytokine-mediated signaling pathway; P:embryo implantation; P:growth hormone receptor signaling pathway via JAK-STAT; P:lactation; P:negative regulation of apoptotic process; P:oncostatin-M-mediated signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:steroid biosynthetic process; scaffold15 indexed_genome mRNA 14887404 14929349 . + . ID=transcript_3879;Q9BYV1 B7ZM47 E9PDL7 Q53FB4 Q53FY7 Q53G03 Q5W7Q1,Alanine--glyoxylate aminotransferase 2, mitochondrial,(R)-3-amino-2-methylpropionate--pyruvate transaminase;Beta-ALAAT II;Beta-alanine-pyruvate aminotransferase;D-AIBAT;, PF00202;, GO:0005759;GO:0005739;GO:0047305;GO:0008453;GO:0030170;GO:0019265;GO:0009436;GO:0046487;GO:0019481;GO:0045429;, C:mitochondrial matrix; C:mitochondrion;, F:(R)-3-amino-2-methylpropionate-pyruvate transaminase activity; F:alanine-glyoxylate transaminase activity; F:pyridoxal phosphate binding;, P:glycine biosynthetic process, by transamination of glyoxylate; P:glyoxylate catabolic process; P:glyoxylate metabolic process; P:L-alanine catabolic process, by transamination; P:positive regulation of nitric oxide biosynthetic process;|Q9BYV1 B7ZM47 E9PDL7 Q53FB4 Q53FY7 Q53G03 Q5W7Q1,Alanine--glyoxylate aminotransferase 2, mitochondrial,(R)-3-amino-2-methylpropionate--pyruvate transaminase;Beta-ALAAT II;Beta-alanine-pyruvate aminotransferase;D-AIBAT;, PF00202;, GO:0005759;GO:0005739;GO:0047305;GO:0008453;GO:0030170;GO:0019265;GO:0009436;GO:0046487;GO:0019481;GO:0045429;, C:mitochondrial matrix; C:mitochondrion;, F:(R)-3-amino-2-methylpropionate-pyruvate transaminase activity; F:alanine-glyoxylate transaminase activity; F:pyridoxal phosphate binding;, P:glycine biosynthetic process, by transamination of glyoxylate; P:glyoxylate catabolic process; P:glyoxylate metabolic process; P:L-alanine catabolic process, by transamination; P:positive regulation of nitric oxide biosynthetic process;|Q9BYV1 B7ZM47 E9PDL7 Q53FB4 Q53FY7 Q53G03 Q5W7Q1,Alanine--glyoxylate aminotransferase 2, mitochondrial,(R)-3-amino-2-methylpropionate--pyruvate transaminase;Beta-ALAAT II;Beta-alanine-pyruvate aminotransferase;D-AIBAT;, PF00202;, GO:0005759;GO:0005739;GO:0047305;GO:0008453;GO:0030170;GO:0019265;GO:0009436;GO:0046487;GO:0019481;GO:0045429;, C:mitochondrial matrix; C:mitochondrion;, F:(R)-3-amino-2-methylpropionate-pyruvate transaminase activity; F:alanine-glyoxylate transaminase activity; F:pyridoxal phosphate binding;, P:glycine biosynthetic process, by transamination of glyoxylate; P:glyoxylate catabolic process; P:glyoxylate metabolic process; P:L-alanine catabolic process, by transamination; P:positive regulation of nitric oxide biosynthetic process; scaffold15 indexed_genome mRNA 14954788 14983336 . - . ID=transcript_3880;Q5F1R6 Q3B7J9 Q6P086 Q6ZS43 Q86VC6,DnaJ homolog subfamily C member 21,DnaJ homolog subfamily A member 5;Protein GS3;, PF00226;PF12171;, GO:0005829;GO:0005730;GO:0005840;GO:0003723;GO:0008270;GO:0006457;, C:cytosol; C:nucleolus; C:ribosome;, F:RNA binding; F:zinc ion binding;, P:protein folding;|Q5F1R6 Q3B7J9 Q6P086 Q6ZS43 Q86VC6,DnaJ homolog subfamily C member 21,DnaJ homolog subfamily A member 5;Protein GS3;, PF00226;PF12171;, GO:0005829;GO:0005730;GO:0005840;GO:0003723;GO:0008270;GO:0006457;, C:cytosol; C:nucleolus; C:ribosome;, F:RNA binding; F:zinc ion binding;, P:protein folding;|Q5F1R6 Q3B7J9 Q6P086 Q6ZS43 Q86VC6,DnaJ homolog subfamily C member 21,DnaJ homolog subfamily A member 5;Protein GS3;, PF00226;PF12171;, GO:0005829;GO:0005730;GO:0005840;GO:0003723;GO:0008270;GO:0006457;, C:cytosol; C:nucleolus; C:ribosome;, F:RNA binding; F:zinc ion binding;, P:protein folding;|Q5F1R6 Q3B7J9 Q6P086 Q6ZS43 Q86VC6,DnaJ homolog subfamily C member 21,DnaJ homolog subfamily A member 5;Protein GS3;, PF00226;PF12171;, GO:0005829;GO:0005730;GO:0005840;GO:0003723;GO:0008270;GO:0006457;, C:cytosol; C:nucleolus; C:ribosome;, F:RNA binding; F:zinc ion binding;, P:protein folding;|Q5F1R6 Q3B7J9 Q6P086 Q6ZS43 Q86VC6,DnaJ homolog subfamily C member 21,DnaJ homolog subfamily A member 5;Protein GS3;, PF00226;PF12171;, GO:0005829;GO:0005730;GO:0005840;GO:0003723;GO:0008270;GO:0006457;, C:cytosol; C:nucleolus; C:ribosome;, F:RNA binding; F:zinc ion binding;, P:protein folding;|Q5F1R6 Q3B7J9 Q6P086 Q6ZS43 Q86VC6,DnaJ homolog subfamily C member 21,DnaJ homolog subfamily A member 5;Protein GS3;, PF00226;PF12171;, GO:0005829;GO:0005730;GO:0005840;GO:0003723;GO:0008270;GO:0006457;, C:cytosol; C:nucleolus; C:ribosome;, F:RNA binding; F:zinc ion binding;, P:protein folding; scaffold15 indexed_genome mRNA 14990948 14998792 . - . ID=transcript_3881;Q8TDN6 A8K0P5 Q3ZTT4 Q8N453 Q96DH1,Ribosome biogenesis protein BRX1 homolog,Brix domain-containing protein 2;, PF04427;, GO:0005694;GO:0005730;GO:0003723;GO:0019843;GO:0000027;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding; F:rRNA binding;, P:ribosomal large subunit assembly; P:rRNA processing;|Q8TDN6 A8K0P5 Q3ZTT4 Q8N453 Q96DH1,Ribosome biogenesis protein BRX1 homolog,Brix domain-containing protein 2;, PF04427;, GO:0005694;GO:0005730;GO:0003723;GO:0019843;GO:0000027;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding; F:rRNA binding;, P:ribosomal large subunit assembly; P:rRNA processing;|Q8TDN6 A8K0P5 Q3ZTT4 Q8N453 Q96DH1,Ribosome biogenesis protein BRX1 homolog,Brix domain-containing protein 2;, PF04427;, GO:0005694;GO:0005730;GO:0003723;GO:0019843;GO:0000027;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding; F:rRNA binding;, P:ribosomal large subunit assembly; P:rRNA processing; scaffold15 indexed_genome mRNA 15000423 15008431 . + . ID=transcript_3882;O60671 O75572 O95304 Q1W161 Q5KSM0 Q5KSM1 Q9UEP1,Cell cycle checkpoint protein RAD1,DNA repair exonuclease rad1 homolog;Rad1-like DNA damage checkpoint protein;, PF02144;, GO:0030896;GO:0005694;GO:0043231;GO:0005654;GO:0005634;GO:0008408;GO:0003684;GO:0008853;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0051598;GO:1901796;GO:0021762;, C:checkpoint clamp complex; C:chromosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:3'-5' exonuclease activity; F:damaged DNA binding; F:exodeoxyribonuclease III activity;, P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:meiotic recombination checkpoint; P:regulation of signal transduction by p53 class mediator; P:substantia nigra development;|O60671 O75572 O95304 Q1W161 Q5KSM0 Q5KSM1 Q9UEP1,Cell cycle checkpoint protein RAD1,DNA repair exonuclease rad1 homolog;Rad1-like DNA damage checkpoint protein;, PF02144;, GO:0030896;GO:0005694;GO:0043231;GO:0005654;GO:0005634;GO:0008408;GO:0003684;GO:0008853;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0051598;GO:1901796;GO:0021762;, C:checkpoint clamp complex; C:chromosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:3'-5' exonuclease activity; F:damaged DNA binding; F:exodeoxyribonuclease III activity;, P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:meiotic recombination checkpoint; P:regulation of signal transduction by p53 class mediator; P:substantia nigra development;|O60671 O75572 O95304 Q1W161 Q5KSM0 Q5KSM1 Q9UEP1,Cell cycle checkpoint protein RAD1,DNA repair exonuclease rad1 homolog;Rad1-like DNA damage checkpoint protein;, PF02144;, GO:0030896;GO:0005694;GO:0043231;GO:0005654;GO:0005634;GO:0008408;GO:0003684;GO:0008853;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0051598;GO:1901796;GO:0021762;, C:checkpoint clamp complex; C:chromosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:3'-5' exonuclease activity; F:damaged DNA binding; F:exodeoxyribonuclease III activity;, P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:meiotic recombination checkpoint; P:regulation of signal transduction by p53 class mediator; P:substantia nigra development;|O60671 O75572 O95304 Q1W161 Q5KSM0 Q5KSM1 Q9UEP1,Cell cycle checkpoint protein RAD1,DNA repair exonuclease rad1 homolog;Rad1-like DNA damage checkpoint protein;, PF02144;, GO:0030896;GO:0005694;GO:0043231;GO:0005654;GO:0005634;GO:0008408;GO:0003684;GO:0008853;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0051598;GO:1901796;GO:0021762;, C:checkpoint clamp complex; C:chromosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:3'-5' exonuclease activity; F:damaged DNA binding; F:exodeoxyribonuclease III activity;, P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:meiotic recombination checkpoint; P:regulation of signal transduction by p53 class mediator; P:substantia nigra development; scaffold15 indexed_genome mRNA 15067873 15085295 . - . ID=transcript_3883;Q9P0K7 E9PED3 Q6V1W9 Q7Z5I4 Q7Z733 Q9P2L2 Q9Y3T5,Ankycorbin,Ankyrin repeat and coiled-coil structure-containing protein;Novel retinal pigment epithelial cell protein;Retinoic acid-induced protein 14;, PF00023;PF12796;, GO:0005938;GO:0030054;GO:0005856;GO:0005829;GO:0001650;GO:0005654;GO:0003779;GO:0030154;GO:0007283;, C:cell cortex; C:cell junction; C:cytoskeleton; C:cytosol; C:fibrillar center; C:nucleoplasm;, F:actin binding;, P:cell differentiation; P:spermatogenesis;|Q9P0K7 E9PED3 Q6V1W9 Q7Z5I4 Q7Z733 Q9P2L2 Q9Y3T5,Ankycorbin,Ankyrin repeat and coiled-coil structure-containing protein;Novel retinal pigment epithelial cell protein;Retinoic acid-induced protein 14;, PF00023;PF12796;, GO:0005938;GO:0030054;GO:0005856;GO:0005829;GO:0001650;GO:0005654;GO:0003779;GO:0030154;GO:0007283;, C:cell cortex; C:cell junction; C:cytoskeleton; C:cytosol; C:fibrillar center; C:nucleoplasm;, F:actin binding;, P:cell differentiation; P:spermatogenesis;|Q9P0K7 E9PED3 Q6V1W9 Q7Z5I4 Q7Z733 Q9P2L2 Q9Y3T5,Ankycorbin,Ankyrin repeat and coiled-coil structure-containing protein;Novel retinal pigment epithelial cell protein;Retinoic acid-induced protein 14;, PF00023;PF12796;, GO:0005938;GO:0030054;GO:0005856;GO:0005829;GO:0001650;GO:0005654;GO:0003779;GO:0030154;GO:0007283;, C:cell cortex; C:cell junction; C:cytoskeleton; C:cytosol; C:fibrillar center; C:nucleoplasm;, F:actin binding;, P:cell differentiation; P:spermatogenesis;|Q9P0K7 E9PED3 Q6V1W9 Q7Z5I4 Q7Z733 Q9P2L2 Q9Y3T5,Ankycorbin,Ankyrin repeat and coiled-coil structure-containing protein;Novel retinal pigment epithelial cell protein;Retinoic acid-induced protein 14;, PF00023;PF12796;, GO:0005938;GO:0030054;GO:0005856;GO:0005829;GO:0001650;GO:0005654;GO:0003779;GO:0030154;GO:0007283;, C:cell cortex; C:cell junction; C:cytoskeleton; C:cytosol; C:fibrillar center; C:nucleoplasm;, F:actin binding;, P:cell differentiation; P:spermatogenesis; scaffold15 indexed_genome mRNA 15085323 15087411 . - . ID=transcript_3884;Q9P0K7 E9PED3 Q6V1W9 Q7Z5I4 Q7Z733 Q9P2L2 Q9Y3T5,Ankycorbin,Ankyrin repeat and coiled-coil structure-containing protein;Novel retinal pigment epithelial cell protein;Retinoic acid-induced protein 14;, PF00023;PF12796;, GO:0005938;GO:0030054;GO:0005856;GO:0005829;GO:0001650;GO:0005654;GO:0003779;GO:0030154;GO:0007283;, C:cell cortex; C:cell junction; C:cytoskeleton; C:cytosol; C:fibrillar center; C:nucleoplasm;, F:actin binding;, P:cell differentiation; P:spermatogenesis; scaffold15 indexed_genome mRNA 15461497 15488246 . + . ID=transcript_3885;Q9BXJ4 Q0VAN4 Q542Y2 Q6MZN1 Q96KY1,Complement C1q tumor necrosis factor-related protein 3,Collagenous repeat-containing sequence 26 kDa protein;Secretory protein CORS26;, PF00386;PF01391;, GO:0005581;GO:0070062;GO:0016020;GO:0042802;GO:0035356;GO:0045444;GO:0010629;GO:0045721;GO:0050728;GO:0032715;GO:0071638;GO:1901223;GO:0070165;GO:0001819;, C:collagen trimer; C:extracellular exosome; C:membrane;, F:identical protein binding;, P:cellular triglyceride homeostasis; P:fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of gluconeogenesis; P:negative regulation of inflammatory response; P:negative regulation of interleukin-6 production; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of adiponectin secretion; P:positive regulation of cytokine production; scaffold15 indexed_genome mRNA 15524087 15537553 . + . ID=transcript_3886;Q9UHK6 A5YM47 B8Y916 B8Y918 F8W9N1 O43673 Q3KT79 Q96GH1 Q9Y3Q1,Alpha-methylacyl-CoA racemase,2-methylacyl-CoA racemase {ECO:0000303|PubMed:11060344};, PF02515;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005782;GO:0005777;GO:0005886;GO:0008111;GO:0008410;GO:0005102;GO:0006699;GO:0008206;GO:0033540;GO:0008104;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:peroxisomal matrix; C:peroxisome; C:plasma membrane;, F:alpha-methylacyl-CoA racemase activity; F:CoA-transferase activity; F:signaling receptor binding;, P:bile acid biosynthetic process; P:bile acid metabolic process; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:protein localization;|Q9UHK6 A5YM47 B8Y916 B8Y918 F8W9N1 O43673 Q3KT79 Q96GH1 Q9Y3Q1,Alpha-methylacyl-CoA racemase,2-methylacyl-CoA racemase {ECO:0000303|PubMed:11060344};, PF02515;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005782;GO:0005777;GO:0005886;GO:0008111;GO:0008410;GO:0005102;GO:0006699;GO:0008206;GO:0033540;GO:0008104;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:peroxisomal matrix; C:peroxisome; C:plasma membrane;, F:alpha-methylacyl-CoA racemase activity; F:CoA-transferase activity; F:signaling receptor binding;, P:bile acid biosynthetic process; P:bile acid metabolic process; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:protein localization; scaffold15 indexed_genome mRNA 15563482 15576656 . + . ID=transcript_3887;Q9UMX9 Q6P2P0 Q9BTM3,Membrane-associated transporter protein,Melanoma antigen AIM1;Solute carrier family 45 member 2;, , GO:0016021;GO:0033162;GO:0016020;GO:0008506;GO:0048066;GO:0042438;GO:0050896;GO:0015770;GO:0007601;, C:integral component of membrane; C:melanosome membrane; C:membrane;, F:sucrose:proton symporter activity;, P:developmental pigmentation; P:melanin biosynthetic process; P:response to stimulus; P:sucrose transport; P:visual perception; scaffold15 indexed_genome mRNA 16025885 16038799 . - . ID=transcript_3888;P26639 A8K8I1 B4DEG8 Q96FP5 Q9BWA6,Threonine--tRNA ligase 1, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:11572};, PF03129;PF02824;PF00587;PF07973;, GO:0005829;GO:0070062;GO:0005524;GO:0042802;GO:0004829;GO:0000049;GO:0008270;GO:0006435;GO:0006418;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:identical protein binding; F:threonine-tRNA ligase activity; F:tRNA binding; F:zinc ion binding;, P:threonyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P26639 A8K8I1 B4DEG8 Q96FP5 Q9BWA6,Threonine--tRNA ligase 1, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:11572};, PF03129;PF02824;PF00587;PF07973;, GO:0005829;GO:0070062;GO:0005524;GO:0042802;GO:0004829;GO:0000049;GO:0008270;GO:0006435;GO:0006418;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:identical protein binding; F:threonine-tRNA ligase activity; F:tRNA binding; F:zinc ion binding;, P:threonyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P26639 A8K8I1 B4DEG8 Q96FP5 Q9BWA6,Threonine--tRNA ligase 1, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:11572};, PF03129;PF02824;PF00587;PF07973;, GO:0005829;GO:0070062;GO:0005524;GO:0042802;GO:0004829;GO:0000049;GO:0008270;GO:0006435;GO:0006418;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:identical protein binding; F:threonine-tRNA ligase activity; F:tRNA binding; F:zinc ion binding;, P:threonyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P26639 A8K8I1 B4DEG8 Q96FP5 Q9BWA6,Threonine--tRNA ligase 1, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:11572};, PF03129;PF02824;PF00587;PF07973;, GO:0005829;GO:0070062;GO:0005524;GO:0042802;GO:0004829;GO:0000049;GO:0008270;GO:0006435;GO:0006418;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:identical protein binding; F:threonine-tRNA ligase activity; F:tRNA binding; F:zinc ion binding;, P:threonyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P26639 A8K8I1 B4DEG8 Q96FP5 Q9BWA6,Threonine--tRNA ligase 1, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:11572};, PF03129;PF02824;PF00587;PF07973;, GO:0005829;GO:0070062;GO:0005524;GO:0042802;GO:0004829;GO:0000049;GO:0008270;GO:0006435;GO:0006418;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:identical protein binding; F:threonine-tRNA ligase activity; F:tRNA binding; F:zinc ion binding;, P:threonyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; scaffold15 indexed_genome mRNA 16041709 16048508 . - . ID=transcript_3889;P26639 A8K8I1 B4DEG8 Q96FP5 Q9BWA6,Threonine--tRNA ligase 1, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase 1 {ECO:0000312|HGNC:HGNC:11572};, PF03129;PF02824;PF00587;PF07973;, GO:0005829;GO:0070062;GO:0005524;GO:0042802;GO:0004829;GO:0000049;GO:0008270;GO:0006435;GO:0006418;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:identical protein binding; F:threonine-tRNA ligase activity; F:tRNA binding; F:zinc ion binding;, P:threonyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; scaffold15 indexed_genome mRNA 16626573 16700900 . - . ID=transcript_3890;P17342 A2RRD1 B4DT84 E7EPG9,Atrial natriuretic peptide receptor 3,Atrial natriuretic peptide clearance receptor;Atrial natriuretic peptide receptor type C;, PF01094;, GO:0070062;GO:0005887;GO:0032991;GO:0031404;GO:0008528;GO:0042562;GO:0016941;GO:0042277;GO:0017046;GO:0042803;GO:0007193;GO:0007194;GO:0120163;GO:0048662;GO:0002158;GO:0030157;GO:0048015;GO:0007200;GO:0051000;GO:0035810;GO:0008217;GO:0033688;GO:0001501;, C:extracellular exosome; C:integral component of plasma membrane; C:protein-containing complex;, F:chloride ion binding; F:G protein-coupled peptide receptor activity; F:hormone binding; F:natriuretic peptide receptor activity; F:peptide binding; F:peptide hormone binding; F:protein homodimerization activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:negative regulation of adenylate cyclase activity; P:negative regulation of cold-induced thermogenesis; P:negative regulation of smooth muscle cell proliferation; P:osteoclast proliferation; P:pancreatic juice secretion; P:phosphatidylinositol-mediated signaling; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of urine volume; P:regulation of blood pressure; P:regulation of osteoblast proliferation; P:skeletal system development; scaffold15 indexed_genome mRNA 16768236 16783643 . - . ID=transcript_3891;P53999 Q96L29,Activated RNA polymerase II transcriptional coactivator p15,Positive cofactor 4;SUB1 homolog;p14;, PF02229;, GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0042802;GO:0003723;GO:0000978;GO:0003697;GO:0003713;GO:0051053;GO:0060261;GO:0006357;GO:0060395;, C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:transcription coactivator activity;, P:negative regulation of DNA metabolic process; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription by RNA polymerase II; P:SMAD protein signal transduction;|P53999 Q96L29,Activated RNA polymerase II transcriptional coactivator p15,Positive cofactor 4;SUB1 homolog;p14;, PF02229;, GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0042802;GO:0003723;GO:0000978;GO:0003697;GO:0003713;GO:0051053;GO:0060261;GO:0006357;GO:0060395;, C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:transcription coactivator activity;, P:negative regulation of DNA metabolic process; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription by RNA polymerase II; P:SMAD protein signal transduction;|P53999 Q96L29,Activated RNA polymerase II transcriptional coactivator p15,Positive cofactor 4;SUB1 homolog;p14;, PF02229;, GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0042802;GO:0003723;GO:0000978;GO:0003697;GO:0003713;GO:0051053;GO:0060261;GO:0006357;GO:0060395;, C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:transcription coactivator activity;, P:negative regulation of DNA metabolic process; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription by RNA polymerase II; P:SMAD protein signal transduction; scaffold15 indexed_genome mRNA 16922279 16980102 . + . ID=transcript_3892;Q96KR1 B2RNR5 Q05C08 Q3B7X5 Q6P5A3 Q86UA0 Q9H6V4 Q9NTI1 Q9Y687,Zinc finger RNA-binding protein,M-phase phosphoprotein homolog;, PF07528;, GO:0005694;GO:0005737;GO:0005634;GO:0003677;GO:0003725;GO:0003723;GO:0003727;GO:0008270;GO:0007275;, C:chromosome; C:cytoplasm; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:RNA binding; F:single-stranded RNA binding; F:zinc ion binding;, P:multicellular organism development;|Q96KR1 B2RNR5 Q05C08 Q3B7X5 Q6P5A3 Q86UA0 Q9H6V4 Q9NTI1 Q9Y687,Zinc finger RNA-binding protein,M-phase phosphoprotein homolog;, PF07528;, GO:0005694;GO:0005737;GO:0005634;GO:0003677;GO:0003725;GO:0003723;GO:0003727;GO:0008270;GO:0007275;, C:chromosome; C:cytoplasm; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:RNA binding; F:single-stranded RNA binding; F:zinc ion binding;, P:multicellular organism development;|Q96KR1 B2RNR5 Q05C08 Q3B7X5 Q6P5A3 Q86UA0 Q9H6V4 Q9NTI1 Q9Y687,Zinc finger RNA-binding protein,M-phase phosphoprotein homolog;, PF07528;, GO:0005694;GO:0005737;GO:0005634;GO:0003677;GO:0003725;GO:0003723;GO:0003727;GO:0008270;GO:0007275;, C:chromosome; C:cytoplasm; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:RNA binding; F:single-stranded RNA binding; F:zinc ion binding;, P:multicellular organism development;|Q96KR1 B2RNR5 Q05C08 Q3B7X5 Q6P5A3 Q86UA0 Q9H6V4 Q9NTI1 Q9Y687,Zinc finger RNA-binding protein,M-phase phosphoprotein homolog;, PF07528;, GO:0005694;GO:0005737;GO:0005634;GO:0003677;GO:0003725;GO:0003723;GO:0003727;GO:0008270;GO:0007275;, C:chromosome; C:cytoplasm; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:RNA binding; F:single-stranded RNA binding; F:zinc ion binding;, P:multicellular organism development; scaffold15 indexed_genome mRNA 17031797 17059365 . + . ID=transcript_3893;Q9C0I1 Q69YJ4 Q6PFW3 Q96QU2 Q9NX27,Myotubularin-related protein 12,Inactive phosphatidylinositol 3-phosphatase 12 {ECO:0000305};Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit;, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0030017;GO:0016529;GO:0019208;GO:0004438;GO:0006661;GO:0046856;GO:1901998;, C:cytoplasm; C:cytosol; C:sarcomere; C:sarcoplasmic reticulum;, F:phosphatase regulator activity; F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:toxin transport;|Q9C0I1 Q69YJ4 Q6PFW3 Q96QU2 Q9NX27,Myotubularin-related protein 12,Inactive phosphatidylinositol 3-phosphatase 12 {ECO:0000305};Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit;, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0030017;GO:0016529;GO:0019208;GO:0004438;GO:0006661;GO:0046856;GO:1901998;, C:cytoplasm; C:cytosol; C:sarcomere; C:sarcoplasmic reticulum;, F:phosphatase regulator activity; F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:toxin transport;|Q9C0I1 Q69YJ4 Q6PFW3 Q96QU2 Q9NX27,Myotubularin-related protein 12,Inactive phosphatidylinositol 3-phosphatase 12 {ECO:0000305};Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit;, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0030017;GO:0016529;GO:0019208;GO:0004438;GO:0006661;GO:0046856;GO:1901998;, C:cytoplasm; C:cytosol; C:sarcomere; C:sarcoplasmic reticulum;, F:phosphatase regulator activity; F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:toxin transport;|Q9C0I1 Q69YJ4 Q6PFW3 Q96QU2 Q9NX27,Myotubularin-related protein 12,Inactive phosphatidylinositol 3-phosphatase 12 {ECO:0000305};Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit;, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0030017;GO:0016529;GO:0019208;GO:0004438;GO:0006661;GO:0046856;GO:1901998;, C:cytoplasm; C:cytosol; C:sarcomere; C:sarcoplasmic reticulum;, F:phosphatase regulator activity; F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:toxin transport;|Q9C0I1 Q69YJ4 Q6PFW3 Q96QU2 Q9NX27,Myotubularin-related protein 12,Inactive phosphatidylinositol 3-phosphatase 12 {ECO:0000305};Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit;, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0030017;GO:0016529;GO:0019208;GO:0004438;GO:0006661;GO:0046856;GO:1901998;, C:cytoplasm; C:cytosol; C:sarcomere; C:sarcoplasmic reticulum;, F:phosphatase regulator activity; F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:toxin transport; scaffold15 indexed_genome mRNA 17060046 17068274 . + . ID=transcript_3894;Q9C0I1 Q69YJ4 Q6PFW3 Q96QU2 Q9NX27,Myotubularin-related protein 12,Inactive phosphatidylinositol 3-phosphatase 12 {ECO:0000305};Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit;, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0030017;GO:0016529;GO:0019208;GO:0004438;GO:0006661;GO:0046856;GO:1901998;, C:cytoplasm; C:cytosol; C:sarcomere; C:sarcoplasmic reticulum;, F:phosphatase regulator activity; F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:toxin transport; scaffold15 indexed_genome mRNA 17106939 17161458 . + . ID=transcript_3895;Q9H4A6 Q9UIW5,Golgi phosphoprotein 3,Coat protein GPP34;Mitochondrial DNA absence factor;, PF05719;, GO:0005829;GO:0005768;GO:0005794;GO:0031985;GO:0032580;GO:0043231;GO:0005758;GO:0005739;GO:0005886;GO:0005802;GO:0019899;GO:0070273;GO:0090164;GO:0060352;GO:0016477;GO:0072752;GO:0010467;GO:0009101;GO:0007030;GO:0090161;GO:0043001;GO:0048194;GO:0030032;GO:0050901;GO:0043066;GO:0050714;GO:0032008;GO:0045053;GO:0009306;GO:0010821;GO:0006890;, C:cytosol; C:endosome; C:Golgi apparatus; C:Golgi cisterna; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:mitochondrial intermembrane space; C:mitochondrion; C:plasma membrane; C:trans-Golgi network;, F:enzyme binding; F:phosphatidylinositol-4-phosphate binding;, P:asymmetric Golgi ribbon formation; P:cell adhesion molecule production; P:cell migration; P:cellular response to rapamycin; P:gene expression; P:glycoprotein biosynthetic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi to plasma membrane protein transport; P:Golgi vesicle budding; P:lamellipodium assembly; P:leukocyte tethering or rolling; P:negative regulation of apoptotic process; P:positive regulation of protein secretion; P:positive regulation of TOR signaling; P:protein retention in Golgi apparatus; P:protein secretion; P:regulation of mitochondrion organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold15 indexed_genome mRNA 17176776 17258331 . - . ID=transcript_3896;O15018 Q9BXD4,PDZ domain-containing protein 2,Activated in prostate cancer protein;PDZ domain-containing protein 3;, PF00595;, GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0043231;GO:0005634;GO:0005886;GO:0007155;, C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, , P:cell adhesion;|O15018 Q9BXD4,PDZ domain-containing protein 2,Activated in prostate cancer protein;PDZ domain-containing protein 3;, PF00595;, GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0043231;GO:0005634;GO:0005886;GO:0007155;, C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, , P:cell adhesion;|O15018 Q9BXD4,PDZ domain-containing protein 2,Activated in prostate cancer protein;PDZ domain-containing protein 3;, PF00595;, GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0043231;GO:0005634;GO:0005886;GO:0007155;, C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, , P:cell adhesion;|O15018 Q9BXD4,PDZ domain-containing protein 2,Activated in prostate cancer protein;PDZ domain-containing protein 3;, PF00595;, GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0043231;GO:0005634;GO:0005886;GO:0007155;, C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, , P:cell adhesion;|O15018 Q9BXD4,PDZ domain-containing protein 2,Activated in prostate cancer protein;PDZ domain-containing protein 3;, PF00595;, GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0043231;GO:0005634;GO:0005886;GO:0007155;, C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, , P:cell adhesion;|O15018 Q9BXD4,PDZ domain-containing protein 2,Activated in prostate cancer protein;PDZ domain-containing protein 3;, PF00595;, GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0043231;GO:0005634;GO:0005886;GO:0007155;, C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, , P:cell adhesion;|O15018 Q9BXD4,PDZ domain-containing protein 2,Activated in prostate cancer protein;PDZ domain-containing protein 3;, PF00595;, GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0043231;GO:0005634;GO:0005886;GO:0007155;, C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, , P:cell adhesion;|O15018 Q9BXD4,PDZ domain-containing protein 2,Activated in prostate cancer protein;PDZ domain-containing protein 3;, PF00595;, GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0043231;GO:0005634;GO:0005886;GO:0007155;, C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, , P:cell adhesion;|O15018 Q9BXD4,PDZ domain-containing protein 2,Activated in prostate cancer protein;PDZ domain-containing protein 3;, PF00595;, GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0043231;GO:0005634;GO:0005886;GO:0007155;, C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, , P:cell adhesion;|O15018 Q9BXD4,PDZ domain-containing protein 2,Activated in prostate cancer protein;PDZ domain-containing protein 3;, PF00595;, GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0043231;GO:0005634;GO:0005886;GO:0007155;, C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, , P:cell adhesion; scaffold15 indexed_genome mRNA 17654073 17654858 . - . ID=transcript_3897;Q49AR2 Q8ND28 Q8WU61 Q9NUR1,UPF0489 protein C5orf22,, PF12640; scaffold15 indexed_genome mRNA 17656804 17667335 . - . ID=transcript_3898;Q49AR2 Q8ND28 Q8WU61 Q9NUR1,UPF0489 protein C5orf22,, PF12640;|Q49AR2 Q8ND28 Q8WU61 Q9NUR1,UPF0489 protein C5orf22,, PF12640;|Q49AR2 Q8ND28 Q8WU61 Q9NUR1,UPF0489 protein C5orf22,, PF12640; scaffold15 indexed_genome mRNA 17675961 17789251 . + . ID=transcript_3899;Q9NRR4 E7EMP9 Q7Z5V2 Q86YH0 Q9NW73 Q9Y2V9 Q9Y4Y0,Ribonuclease 3,Protein Drosha {ECO:0000303|PubMed:14508493};Ribonuclease III;p241;, PF00035;PF14622;PF00636;, GO:0005829;GO:0070877;GO:0005730;GO:0005654;GO:0005634;GO:0014069;GO:0017151;GO:0003725;GO:0001530;GO:0046872;GO:0070878;GO:0042803;GO:0070412;GO:0004525;GO:0003723;GO:0046332;GO:0050829;GO:0050830;GO:0010586;GO:0010628;GO:0031054;GO:0031053;GO:0030422;GO:0050727;GO:2000628;GO:0045589;GO:0042254;GO:0006396;GO:0016075;, C:cytosol; C:microprocessor complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:DEAD/H-box RNA helicase binding; F:double-stranded RNA binding; F:lipopolysaccharide binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:R-SMAD binding; F:ribonuclease III activity; F:RNA binding; F:SMAD binding;, P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:miRNA metabolic process; P:positive regulation of gene expression; P:pre-miRNA processing; P:primary miRNA processing; P:production of siRNA involved in RNA interference; P:regulation of inflammatory response; P:regulation of miRNA metabolic process; P:regulation of regulatory T cell differentiation; P:ribosome biogenesis; P:RNA processing; P:rRNA catabolic process;|Q9NRR4 E7EMP9 Q7Z5V2 Q86YH0 Q9NW73 Q9Y2V9 Q9Y4Y0,Ribonuclease 3,Protein Drosha {ECO:0000303|PubMed:14508493};Ribonuclease III;p241;, PF00035;PF14622;PF00636;, GO:0005829;GO:0070877;GO:0005730;GO:0005654;GO:0005634;GO:0014069;GO:0017151;GO:0003725;GO:0001530;GO:0046872;GO:0070878;GO:0042803;GO:0070412;GO:0004525;GO:0003723;GO:0046332;GO:0050829;GO:0050830;GO:0010586;GO:0010628;GO:0031054;GO:0031053;GO:0030422;GO:0050727;GO:2000628;GO:0045589;GO:0042254;GO:0006396;GO:0016075;, C:cytosol; C:microprocessor complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:DEAD/H-box RNA helicase binding; F:double-stranded RNA binding; F:lipopolysaccharide binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:R-SMAD binding; F:ribonuclease III activity; F:RNA binding; F:SMAD binding;, P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:miRNA metabolic process; P:positive regulation of gene expression; P:pre-miRNA processing; P:primary miRNA processing; P:production of siRNA involved in RNA interference; P:regulation of inflammatory response; P:regulation of miRNA metabolic process; P:regulation of regulatory T cell differentiation; P:ribosome biogenesis; P:RNA processing; P:rRNA catabolic process;|Q9NRR4 E7EMP9 Q7Z5V2 Q86YH0 Q9NW73 Q9Y2V9 Q9Y4Y0,Ribonuclease 3,Protein Drosha {ECO:0000303|PubMed:14508493};Ribonuclease III;p241;, PF00035;PF14622;PF00636;, GO:0005829;GO:0070877;GO:0005730;GO:0005654;GO:0005634;GO:0014069;GO:0017151;GO:0003725;GO:0001530;GO:0046872;GO:0070878;GO:0042803;GO:0070412;GO:0004525;GO:0003723;GO:0046332;GO:0050829;GO:0050830;GO:0010586;GO:0010628;GO:0031054;GO:0031053;GO:0030422;GO:0050727;GO:2000628;GO:0045589;GO:0042254;GO:0006396;GO:0016075;, C:cytosol; C:microprocessor complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:DEAD/H-box RNA helicase binding; F:double-stranded RNA binding; F:lipopolysaccharide binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:R-SMAD binding; F:ribonuclease III activity; F:RNA binding; F:SMAD binding;, P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:miRNA metabolic process; P:positive regulation of gene expression; P:pre-miRNA processing; P:primary miRNA processing; P:production of siRNA involved in RNA interference; P:regulation of inflammatory response; P:regulation of miRNA metabolic process; P:regulation of regulatory T cell differentiation; P:ribosome biogenesis; P:RNA processing; P:rRNA catabolic process;|Q9NRR4 E7EMP9 Q7Z5V2 Q86YH0 Q9NW73 Q9Y2V9 Q9Y4Y0,Ribonuclease 3,Protein Drosha {ECO:0000303|PubMed:14508493};Ribonuclease III;p241;, PF00035;PF14622;PF00636;, GO:0005829;GO:0070877;GO:0005730;GO:0005654;GO:0005634;GO:0014069;GO:0017151;GO:0003725;GO:0001530;GO:0046872;GO:0070878;GO:0042803;GO:0070412;GO:0004525;GO:0003723;GO:0046332;GO:0050829;GO:0050830;GO:0010586;GO:0010628;GO:0031054;GO:0031053;GO:0030422;GO:0050727;GO:2000628;GO:0045589;GO:0042254;GO:0006396;GO:0016075;, C:cytosol; C:microprocessor complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:DEAD/H-box RNA helicase binding; F:double-stranded RNA binding; F:lipopolysaccharide binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:R-SMAD binding; F:ribonuclease III activity; F:RNA binding; F:SMAD binding;, P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:miRNA metabolic process; P:positive regulation of gene expression; P:pre-miRNA processing; P:primary miRNA processing; P:production of siRNA involved in RNA interference; P:regulation of inflammatory response; P:regulation of miRNA metabolic process; P:regulation of regulatory T cell differentiation; P:ribosome biogenesis; P:RNA processing; P:rRNA catabolic process;|Q9NRR4 E7EMP9 Q7Z5V2 Q86YH0 Q9NW73 Q9Y2V9 Q9Y4Y0,Ribonuclease 3,Protein Drosha {ECO:0000303|PubMed:14508493};Ribonuclease III;p241;, PF00035;PF14622;PF00636;, GO:0005829;GO:0070877;GO:0005730;GO:0005654;GO:0005634;GO:0014069;GO:0017151;GO:0003725;GO:0001530;GO:0046872;GO:0070878;GO:0042803;GO:0070412;GO:0004525;GO:0003723;GO:0046332;GO:0050829;GO:0050830;GO:0010586;GO:0010628;GO:0031054;GO:0031053;GO:0030422;GO:0050727;GO:2000628;GO:0045589;GO:0042254;GO:0006396;GO:0016075;, C:cytosol; C:microprocessor complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:DEAD/H-box RNA helicase binding; F:double-stranded RNA binding; F:lipopolysaccharide binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:R-SMAD binding; F:ribonuclease III activity; F:RNA binding; F:SMAD binding;, P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:miRNA metabolic process; P:positive regulation of gene expression; P:pre-miRNA processing; P:primary miRNA processing; P:production of siRNA involved in RNA interference; P:regulation of inflammatory response; P:regulation of miRNA metabolic process; P:regulation of regulatory T cell differentiation; P:ribosome biogenesis; P:RNA processing; P:rRNA catabolic process; scaffold15 indexed_genome mRNA 21938213 21939023 . - . ID=transcript_3900;Q9ULB4 Q3B7I5,Cadherin-9,, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0099055;GO:0099056;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098609;GO:0098742;GO:0007043;GO:0007156;GO:0007275;GO:0007416;GO:0099560;, C:adherens junction; C:catenin complex; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; P:synapse assembly; P:synaptic membrane adhesion; scaffold15 indexed_genome mRNA 23877402 23988248 . + . ID=transcript_3901;Q9Y6N8 Q9ULB3,Cadherin-10,T2-cadherin;, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0098982;GO:0098978;GO:0099060;GO:0099059;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098609;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of postsynaptic specialization membrane; C:integral component of presynaptic active zone membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development;|Q9Y6N8 Q9ULB3,Cadherin-10,T2-cadherin;, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0098982;GO:0098978;GO:0099060;GO:0099059;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098609;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of postsynaptic specialization membrane; C:integral component of presynaptic active zone membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold15 indexed_genome mRNA 26303694 26308190 . + . ID=transcript_3902;P55289 B2RBT1 B7Z2U6 Q86UD2,Cadherin-12,Brain cadherin;Neural type cadherin 2;, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold15 indexed_genome mRNA 28125212 28509748 . + . ID=transcript_3903;Q13634 A8K0I2 B4DHG6 Q8N5Z2,Cadherin-18,Cadherin-14;, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold15 indexed_genome mRNA 30250620 30252302 . + . ID=transcript_3904;P80723 B4DJA8 D3DTD5 O43596 Q5U0S0 Q9BWA5,Brain acid soluble protein 1,22 kDa neuronal tissue-enriched acidic protein;Neuronal axonal membrane protein NAP-22;, PF05466;, GO:0030054;GO:0000785;GO:0005737;GO:0005856;GO:0070062;GO:0030426;GO:0016363;GO:0016607;GO:0005634;GO:0005886;GO:0016605;GO:0031982;GO:0019904;GO:0003714;GO:0000976;GO:0060539;GO:0072112;GO:0008406;GO:0060231;GO:0072075;GO:0045892;GO:0060421;GO:2001076;GO:0021762;GO:0007356;, C:cell junction; C:chromatin; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:growth cone; C:nuclear matrix; C:nuclear speck; C:nucleus; C:plasma membrane; C:PML body; C:vesicle;, F:protein domain specific binding; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:diaphragm development; P:glomerular visceral epithelial cell differentiation; P:gonad development; P:mesenchymal to epithelial transition; P:metanephric mesenchyme development; P:negative regulation of transcription, DNA-templated; P:positive regulation of heart growth; P:positive regulation of metanephric ureteric bud development; P:substantia nigra development; P:thorax and anterior abdomen determination; scaffold15 indexed_genome mRNA 30554247 30806461 . + . ID=transcript_3905;Q9HD67 A7E2D1 O94893 Q8IVX5 Q9NYM7 Q9P110 Q9P111 Q9UHF6,Unconventional myosin-X,Unconventional myosin-10;, PF00373;PF00612;PF16735;PF00063;PF00784;PF00169;PF00788;PF18597;, GO:0005938;GO:0005829;GO:0031527;GO:0032433;GO:0030027;GO:0016459;GO:0005730;GO:0005886;GO:0001726;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0005547;GO:0060002;GO:0030507;GO:0030705;GO:0038096;GO:0008360;GO:0051489;, C:cell cortex; C:cytosol; C:filopodium membrane; C:filopodium tip; C:lamellipodium; C:myosin complex; C:nucleolus; C:plasma membrane; C:ruffle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:plus-end directed microfilament motor activity; F:spectrin binding;, P:cytoskeleton-dependent intracellular transport; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:regulation of cell shape; P:regulation of filopodium assembly;|Q9HD67 A7E2D1 O94893 Q8IVX5 Q9NYM7 Q9P110 Q9P111 Q9UHF6,Unconventional myosin-X,Unconventional myosin-10;, PF00373;PF00612;PF16735;PF00063;PF00784;PF00169;PF00788;PF18597;, GO:0005938;GO:0005829;GO:0031527;GO:0032433;GO:0030027;GO:0016459;GO:0005730;GO:0005886;GO:0001726;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0005547;GO:0060002;GO:0030507;GO:0030705;GO:0038096;GO:0008360;GO:0051489;, C:cell cortex; C:cytosol; C:filopodium membrane; C:filopodium tip; C:lamellipodium; C:myosin complex; C:nucleolus; C:plasma membrane; C:ruffle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:plus-end directed microfilament motor activity; F:spectrin binding;, P:cytoskeleton-dependent intracellular transport; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:regulation of cell shape; P:regulation of filopodium assembly;|Q9HD67 A7E2D1 O94893 Q8IVX5 Q9NYM7 Q9P110 Q9P111 Q9UHF6,Unconventional myosin-X,Unconventional myosin-10;, PF00373;PF00612;PF16735;PF00063;PF00784;PF00169;PF00788;PF18597;, GO:0005938;GO:0005829;GO:0031527;GO:0032433;GO:0030027;GO:0016459;GO:0005730;GO:0005886;GO:0001726;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0005547;GO:0060002;GO:0030507;GO:0030705;GO:0038096;GO:0008360;GO:0051489;, C:cell cortex; C:cytosol; C:filopodium membrane; C:filopodium tip; C:lamellipodium; C:myosin complex; C:nucleolus; C:plasma membrane; C:ruffle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:plus-end directed microfilament motor activity; F:spectrin binding;, P:cytoskeleton-dependent intracellular transport; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:regulation of cell shape; P:regulation of filopodium assembly;|Q9HD67 A7E2D1 O94893 Q8IVX5 Q9NYM7 Q9P110 Q9P111 Q9UHF6,Unconventional myosin-X,Unconventional myosin-10;, PF00373;PF00612;PF16735;PF00063;PF00784;PF00169;PF00788;PF18597;, GO:0005938;GO:0005829;GO:0031527;GO:0032433;GO:0030027;GO:0016459;GO:0005730;GO:0005886;GO:0001726;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0005547;GO:0060002;GO:0030507;GO:0030705;GO:0038096;GO:0008360;GO:0051489;, C:cell cortex; C:cytosol; C:filopodium membrane; C:filopodium tip; C:lamellipodium; C:myosin complex; C:nucleolus; C:plasma membrane; C:ruffle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:plus-end directed microfilament motor activity; F:spectrin binding;, P:cytoskeleton-dependent intracellular transport; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:regulation of cell shape; P:regulation of filopodium assembly;|Q9HD67 A7E2D1 O94893 Q8IVX5 Q9NYM7 Q9P110 Q9P111 Q9UHF6,Unconventional myosin-X,Unconventional myosin-10;, PF00373;PF00612;PF16735;PF00063;PF00784;PF00169;PF00788;PF18597;, GO:0005938;GO:0005829;GO:0031527;GO:0032433;GO:0030027;GO:0016459;GO:0005730;GO:0005886;GO:0001726;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0005547;GO:0060002;GO:0030507;GO:0030705;GO:0038096;GO:0008360;GO:0051489;, C:cell cortex; C:cytosol; C:filopodium membrane; C:filopodium tip; C:lamellipodium; C:myosin complex; C:nucleolus; C:plasma membrane; C:ruffle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:plus-end directed microfilament motor activity; F:spectrin binding;, P:cytoskeleton-dependent intracellular transport; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:regulation of cell shape; P:regulation of filopodium assembly; scaffold15 indexed_genome mRNA 30873442 30994898 . - . ID=transcript_3906;Q9H6L5 Q69YN8 Q9H6K6 Q9H764 Q9NXM8,Reticulophagy regulator 1 {ECO:0000312|HGNC:HGNC:25964},Reticulophagy receptor 1 {ECO:0000305};, , GO:0005801;GO:0005783;GO:0030176;GO:0016604;GO:0005730;GO:0043524;GO:0061709;GO:0019233;, C:cis-Golgi network; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:nuclear body; C:nucleolus;, , P:negative regulation of neuron apoptotic process; P:reticulophagy; P:sensory perception of pain;|Q9H6L5 Q69YN8 Q9H6K6 Q9H764 Q9NXM8,Reticulophagy regulator 1 {ECO:0000312|HGNC:HGNC:25964},Reticulophagy receptor 1 {ECO:0000305};, , GO:0005801;GO:0005783;GO:0030176;GO:0016604;GO:0005730;GO:0043524;GO:0061709;GO:0019233;, C:cis-Golgi network; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:nuclear body; C:nucleolus;, , P:negative regulation of neuron apoptotic process; P:reticulophagy; P:sensory perception of pain;|Q9H6L5 Q69YN8 Q9H6K6 Q9H764 Q9NXM8,Reticulophagy regulator 1 {ECO:0000312|HGNC:HGNC:25964},Reticulophagy receptor 1 {ECO:0000305};, , GO:0005801;GO:0005783;GO:0030176;GO:0016604;GO:0005730;GO:0043524;GO:0061709;GO:0019233;, C:cis-Golgi network; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:nuclear body; C:nucleolus;, , P:negative regulation of neuron apoptotic process; P:reticulophagy; P:sensory perception of pain;|Q9H6L5 Q69YN8 Q9H6K6 Q9H764 Q9NXM8,Reticulophagy regulator 1 {ECO:0000312|HGNC:HGNC:25964},Reticulophagy receptor 1 {ECO:0000305};, , GO:0005801;GO:0005783;GO:0030176;GO:0016604;GO:0005730;GO:0043524;GO:0061709;GO:0019233;, C:cis-Golgi network; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:nuclear body; C:nucleolus;, , P:negative regulation of neuron apoptotic process; P:reticulophagy; P:sensory perception of pain;|Q9H6L5 Q69YN8 Q9H6K6 Q9H764 Q9NXM8,Reticulophagy regulator 1 {ECO:0000312|HGNC:HGNC:25964},Reticulophagy receptor 1 {ECO:0000305};, , GO:0005801;GO:0005783;GO:0030176;GO:0016604;GO:0005730;GO:0043524;GO:0061709;GO:0019233;, C:cis-Golgi network; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:nuclear body; C:nucleolus;, , P:negative regulation of neuron apoptotic process; P:reticulophagy; P:sensory perception of pain;|Q9H6L5 Q69YN8 Q9H6K6 Q9H764 Q9NXM8,Reticulophagy regulator 1 {ECO:0000312|HGNC:HGNC:25964},Reticulophagy receptor 1 {ECO:0000305};, , GO:0005801;GO:0005783;GO:0030176;GO:0016604;GO:0005730;GO:0043524;GO:0061709;GO:0019233;, C:cis-Golgi network; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:nuclear body; C:nucleolus;, , P:negative regulation of neuron apoptotic process; P:reticulophagy; P:sensory perception of pain; scaffold15 indexed_genome mRNA 31001185 31015957 . + . ID=transcript_3907;Q969S3,Zinc finger protein 622,Zinc finger-like protein 9;, PF12756;PF12171;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0030687;GO:0003723;GO:0008270;GO:0008631;GO:0043065;GO:0046330;GO:0033674;GO:0043410;GO:0042273;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:RNA binding; F:zinc ion binding;, P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:ribosomal large subunit biogenesis;|Q969S3,Zinc finger protein 622,Zinc finger-like protein 9;, PF12756;PF12171;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0030687;GO:0003723;GO:0008270;GO:0008631;GO:0043065;GO:0046330;GO:0033674;GO:0043410;GO:0042273;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:RNA binding; F:zinc ion binding;, P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:ribosomal large subunit biogenesis; scaffold15 indexed_genome mRNA 31511925 31522689 . - . ID=transcript_3908;Q9UJT9 B9EGF1 D6RDY7 O94926,F-box/LRR-repeat protein 7,F-box and leucine-rich repeat protein 7;F-box protein FBL6/FBL7;, PF12937;PF13516;, GO:0005813;GO:0005829;GO:0019005;GO:0000151;GO:0051301;GO:0000086;GO:0000278;GO:0010972;GO:0043687;GO:0000209;GO:0016567;GO:0010265;GO:0031146;GO:0006511;, C:centrosome; C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:cell division; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of G2/M transition of mitotic cell cycle; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process; scaffold15 indexed_genome mRNA 32480219 32641618 . + . ID=transcript_3909;Q9HCJ1 B2RCA7 B3KMG4 D3DTD4 Q9NQW2,Progressive ankylosis protein homolog,, PF07260;, GO:0016021;GO:0005887;GO:0019867;GO:0005886;GO:0030504;GO:0005315;GO:0015114;GO:0007626;GO:0030500;GO:0001501;GO:0055085;, C:integral component of membrane; C:integral component of plasma membrane; C:outer membrane; C:plasma membrane;, F:inorganic diphosphate transmembrane transporter activity; F:inorganic phosphate transmembrane transporter activity; F:phosphate ion transmembrane transporter activity;, P:locomotory behavior; P:regulation of bone mineralization; P:skeletal system development; P:transmembrane transport;|Q9HCJ1 B2RCA7 B3KMG4 D3DTD4 Q9NQW2,Progressive ankylosis protein homolog,, PF07260;, GO:0016021;GO:0005887;GO:0019867;GO:0005886;GO:0030504;GO:0005315;GO:0015114;GO:0007626;GO:0030500;GO:0001501;GO:0055085;, C:integral component of membrane; C:integral component of plasma membrane; C:outer membrane; C:plasma membrane;, F:inorganic diphosphate transmembrane transporter activity; F:inorganic phosphate transmembrane transporter activity; F:phosphate ion transmembrane transporter activity;, P:locomotory behavior; P:regulation of bone mineralization; P:skeletal system development; P:transmembrane transport; scaffold15 indexed_genome mRNA 32654943 32661132 . - . ID=transcript_3910;Q96BN8 D3DTD3 Q8NAS0 Q96IA3,Ubiquitin thioesterase otulin {ECO:0000305},Deubiquitinating enzyme otulin {ECO:0000303|PubMed:23806334};OTU domain-containing deubiquitinase with linear linkage specificity {ECO:0000303|PubMed:23806334};Ubiquitin thioesterase Gumby {ECO:0000250|UniProtKB:Q3UCV8};, PF16218;, GO:0005737;GO:0005829;GO:0071797;GO:0008234;GO:0004843;GO:0045087;GO:0050728;GO:0032088;GO:0070431;GO:1990108;GO:0016567;GO:0060828;GO:0010803;GO:0002040;GO:0016055;, C:cytoplasm; C:cytosol; C:LUBAC complex;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of inflammatory response; P:negative regulation of NF-kappaB transcription factor activity; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:protein linear deubiquitination; P:protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway; P:sprouting angiogenesis; P:Wnt signaling pathway;|Q96BN8 D3DTD3 Q8NAS0 Q96IA3,Ubiquitin thioesterase otulin {ECO:0000305},Deubiquitinating enzyme otulin {ECO:0000303|PubMed:23806334};OTU domain-containing deubiquitinase with linear linkage specificity {ECO:0000303|PubMed:23806334};Ubiquitin thioesterase Gumby {ECO:0000250|UniProtKB:Q3UCV8};, PF16218;, GO:0005737;GO:0005829;GO:0071797;GO:0008234;GO:0004843;GO:0045087;GO:0050728;GO:0032088;GO:0070431;GO:1990108;GO:0016567;GO:0060828;GO:0010803;GO:0002040;GO:0016055;, C:cytoplasm; C:cytosol; C:LUBAC complex;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:innate immune response; P:negative regulation of inflammatory response; P:negative regulation of NF-kappaB transcription factor activity; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:protein linear deubiquitination; P:protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway; P:sprouting angiogenesis; P:Wnt signaling pathway; scaffold15 indexed_genome mRNA 32719900 32720791 . + . ID=transcript_3911;Q9HB21 B3KQ55 D3DRE2 Q9BVK0,Pleckstrin homology domain-containing family A member 1,Tandem PH domain-containing protein 1;, PF00169;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0032587;GO:0008289;GO:0030165;GO:0043325;GO:0008209;GO:0050853;GO:0070301;GO:0045184;GO:0008210;GO:0060325;GO:0033327;GO:0001553;GO:0035264;GO:0051898;GO:0014065;GO:0006661;GO:0048008;GO:0009791;GO:0060021;GO:0031529;GO:0048705;GO:0007283;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane; C:ruffle membrane;, F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:androgen metabolic process; P:B cell receptor signaling pathway; P:cellular response to hydrogen peroxide; P:establishment of protein localization; P:estrogen metabolic process; P:face morphogenesis; P:Leydig cell differentiation; P:luteinization; P:multicellular organism growth; P:negative regulation of protein kinase B signaling; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:roof of mouth development; P:ruffle organization; P:skeletal system morphogenesis; P:spermatogenesis; scaffold15 indexed_genome mRNA 32727549 32734371 . - . ID=transcript_3912;Q9NUU6 Q53H50 Q9H037,Inactive ubiquitin thioesterase OTULINL,, PF16218;, GO:0005737;GO:0042406;GO:0005635;GO:0006508;, C:cytoplasm; C:extrinsic component of endoplasmic reticulum membrane; C:nuclear envelope;, , P:proteolysis;|Q9NUU6 Q53H50 Q9H037,Inactive ubiquitin thioesterase OTULINL,, PF16218;, GO:0005737;GO:0042406;GO:0005635;GO:0006508;, C:cytoplasm; C:extrinsic component of endoplasmic reticulum membrane; C:nuclear envelope;, , P:proteolysis;|Q9NUU6 Q53H50 Q9H037,Inactive ubiquitin thioesterase OTULINL,, PF16218;, GO:0005737;GO:0042406;GO:0005635;GO:0006508;, C:cytoplasm; C:extrinsic component of endoplasmic reticulum membrane; C:nuclear envelope;, , P:proteolysis;|Q9NUU6 Q53H50 Q9H037,Inactive ubiquitin thioesterase OTULINL,, PF16218;, GO:0005737;GO:0042406;GO:0005635;GO:0006508;, C:cytoplasm; C:extrinsic component of endoplasmic reticulum membrane; C:nuclear envelope;, , P:proteolysis;|Q9NUU6 Q53H50 Q9H037,Inactive ubiquitin thioesterase OTULINL,, PF16218;, GO:0005737;GO:0042406;GO:0005635;GO:0006508;, C:cytoplasm; C:extrinsic component of endoplasmic reticulum membrane; C:nuclear envelope;, , P:proteolysis; scaffold15 indexed_genome mRNA 32735024 32735714 . + . ID=transcript_3913;Q9NUU6 Q53H50 Q9H037,Inactive ubiquitin thioesterase OTULINL,, PF16218;, GO:0005737;GO:0042406;GO:0005635;GO:0006508;, C:cytoplasm; C:extrinsic component of endoplasmic reticulum membrane; C:nuclear envelope;, , P:proteolysis; scaffold15 indexed_genome mRNA 32807885 32822424 . - . ID=transcript_3914;O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; scaffold15 indexed_genome mRNA 32822450 32851474 . - . ID=transcript_3915;O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; scaffold15 indexed_genome mRNA 32851568 33028462 . - . ID=transcript_3916;O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; scaffold15 indexed_genome mRNA 33571018 33617091 . + . ID=transcript_3917;Q8TE73 Q92860 Q96L74 Q9H5S7 Q9HCG9,Dynein heavy chain 5, axonemal,Axonemal beta dynein heavy chain 5;Ciliary dynein heavy chain 5;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0097729;GO:0005930;GO:0005737;GO:0030286;GO:0005576;GO:0005874;GO:0031514;GO:0036157;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0060271;GO:0003341;GO:0007368;GO:0003351;GO:0051649;GO:0030317;GO:0007507;GO:0021670;GO:0007018;GO:0036158;, C:9+2 motile cilium; C:axoneme; C:cytoplasm; C:dynein complex; C:extracellular region; C:microtubule; C:motile cilium; C:outer dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium assembly; P:cilium movement; P:determination of left/right symmetry; P:epithelial cilium movement involved in extracellular fluid movement; P:establishment of localization in cell; P:flagellated sperm motility; P:heart development; P:lateral ventricle development; P:microtubule-based movement; P:outer dynein arm assembly; scaffold15 indexed_genome mRNA 35212934 36264076 . + . ID=transcript_3918;Q9UQB3 B0FTZ7 O00379 O15390 O43206 O43840 Q13589 Q9UM66 Q9UPM3,Catenin delta-2,Delta-catenin;GT24;Neural plakophilin-related ARM-repeat protein;Neurojungin;, PF00514;, GO:0005912;GO:0005737;GO:0030425;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0008013;GO:0045296;GO:0007155;GO:0098609;GO:0007043;GO:0060997;GO:0060828;GO:0007165;GO:0050808;GO:0016055;, C:adherens junction; C:cytoplasm; C:dendrite; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:beta-catenin binding; F:cadherin binding;, P:cell adhesion; P:cell-cell adhesion; P:cell-cell junction assembly; P:dendritic spine morphogenesis; P:regulation of canonical Wnt signaling pathway; P:signal transduction; P:synapse organization; P:Wnt signaling pathway; scaffold15 indexed_genome mRNA 36517197 36520846 . - . ID=transcript_3919;P51397 Q6FGC3 Q9BUC9,Death-associated protein 1,, PF15228;, GO:0070513;GO:0006919;GO:0006915;GO:0097190;GO:0006914;GO:0034198;GO:0010507;GO:0032088;GO:0045892;, , F:death domain binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:apoptotic signaling pathway; P:autophagy; P:cellular response to amino acid starvation; P:negative regulation of autophagy; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription, DNA-templated;|P51397 Q6FGC3 Q9BUC9,Death-associated protein 1,, PF15228;, GO:0070513;GO:0006919;GO:0006915;GO:0097190;GO:0006914;GO:0034198;GO:0010507;GO:0032088;GO:0045892;, , F:death domain binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:apoptotic signaling pathway; P:autophagy; P:cellular response to amino acid starvation; P:negative regulation of autophagy; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription, DNA-templated; scaffold15 indexed_genome mRNA 36729131 36748232 . - . ID=transcript_3920;Q96C74 D3DTC9 Q9BZX0,Ropporin-1-like protein,AKAP-associated sperm protein;, , GO:0005929;GO:0005737;GO:0005576;GO:0031514;GO:0042802;GO:0003351;GO:0030317;GO:0001932;GO:0048240;, C:cilium; C:cytoplasm; C:extracellular region; C:motile cilium;, F:identical protein binding;, P:epithelial cilium movement involved in extracellular fluid movement; P:flagellated sperm motility; P:regulation of protein phosphorylation; P:sperm capacitation; scaffold15 indexed_genome mRNA 36753218 36805684 . - . ID=transcript_3921;O60337 A5PKZ4 B4DKJ2 B4DT33 D3DTC8 O14670 Q86X77,E3 ubiquitin-protein ligase MARCHF6,Doa10 homolog;Membrane-associated RING finger protein 6;Membrane-associated RING-CH protein VI;Protein TEB-4 {ECO:0000303|PubMed:15673284, ECO:0000303|PubMed:16373356, ECO:0000303|PubMed:19651899};RING finger protein 176;RING-type E3 ubiquitin transferase MARCHF6 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0044322;GO:0000835;GO:0030176;GO:0016021;GO:0016020;GO:0019899;GO:0031624;GO:0061630;GO:0004842;GO:1990381;GO:0008270;GO:1904380;GO:0036503;GO:0010498;GO:0043161;GO:0070936;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:ER ubiquitin ligase complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:enzyme binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:zinc ion binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O60337 A5PKZ4 B4DKJ2 B4DT33 D3DTC8 O14670 Q86X77,E3 ubiquitin-protein ligase MARCHF6,Doa10 homolog;Membrane-associated RING finger protein 6;Membrane-associated RING-CH protein VI;Protein TEB-4 {ECO:0000303|PubMed:15673284, ECO:0000303|PubMed:16373356, ECO:0000303|PubMed:19651899};RING finger protein 176;RING-type E3 ubiquitin transferase MARCHF6 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0044322;GO:0000835;GO:0030176;GO:0016021;GO:0016020;GO:0019899;GO:0031624;GO:0061630;GO:0004842;GO:1990381;GO:0008270;GO:1904380;GO:0036503;GO:0010498;GO:0043161;GO:0070936;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:ER ubiquitin ligase complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:enzyme binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:zinc ion binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O60337 A5PKZ4 B4DKJ2 B4DT33 D3DTC8 O14670 Q86X77,E3 ubiquitin-protein ligase MARCHF6,Doa10 homolog;Membrane-associated RING finger protein 6;Membrane-associated RING-CH protein VI;Protein TEB-4 {ECO:0000303|PubMed:15673284, ECO:0000303|PubMed:16373356, ECO:0000303|PubMed:19651899};RING finger protein 176;RING-type E3 ubiquitin transferase MARCHF6 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0044322;GO:0000835;GO:0030176;GO:0016021;GO:0016020;GO:0019899;GO:0031624;GO:0061630;GO:0004842;GO:1990381;GO:0008270;GO:1904380;GO:0036503;GO:0010498;GO:0043161;GO:0070936;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:ER ubiquitin ligase complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:enzyme binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:zinc ion binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O60337 A5PKZ4 B4DKJ2 B4DT33 D3DTC8 O14670 Q86X77,E3 ubiquitin-protein ligase MARCHF6,Doa10 homolog;Membrane-associated RING finger protein 6;Membrane-associated RING-CH protein VI;Protein TEB-4 {ECO:0000303|PubMed:15673284, ECO:0000303|PubMed:16373356, ECO:0000303|PubMed:19651899};RING finger protein 176;RING-type E3 ubiquitin transferase MARCHF6 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0044322;GO:0000835;GO:0030176;GO:0016021;GO:0016020;GO:0019899;GO:0031624;GO:0061630;GO:0004842;GO:1990381;GO:0008270;GO:1904380;GO:0036503;GO:0010498;GO:0043161;GO:0070936;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:ER ubiquitin ligase complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:enzyme binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:zinc ion binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O60337 A5PKZ4 B4DKJ2 B4DT33 D3DTC8 O14670 Q86X77,E3 ubiquitin-protein ligase MARCHF6,Doa10 homolog;Membrane-associated RING finger protein 6;Membrane-associated RING-CH protein VI;Protein TEB-4 {ECO:0000303|PubMed:15673284, ECO:0000303|PubMed:16373356, ECO:0000303|PubMed:19651899};RING finger protein 176;RING-type E3 ubiquitin transferase MARCHF6 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0044322;GO:0000835;GO:0030176;GO:0016021;GO:0016020;GO:0019899;GO:0031624;GO:0061630;GO:0004842;GO:1990381;GO:0008270;GO:1904380;GO:0036503;GO:0010498;GO:0043161;GO:0070936;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:ER ubiquitin ligase complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:enzyme binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:zinc ion binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O60337 A5PKZ4 B4DKJ2 B4DT33 D3DTC8 O14670 Q86X77,E3 ubiquitin-protein ligase MARCHF6,Doa10 homolog;Membrane-associated RING finger protein 6;Membrane-associated RING-CH protein VI;Protein TEB-4 {ECO:0000303|PubMed:15673284, ECO:0000303|PubMed:16373356, ECO:0000303|PubMed:19651899};RING finger protein 176;RING-type E3 ubiquitin transferase MARCHF6 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0044322;GO:0000835;GO:0030176;GO:0016021;GO:0016020;GO:0019899;GO:0031624;GO:0061630;GO:0004842;GO:1990381;GO:0008270;GO:1904380;GO:0036503;GO:0010498;GO:0043161;GO:0070936;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:ER ubiquitin ligase complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:enzyme binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:zinc ion binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O60337 A5PKZ4 B4DKJ2 B4DT33 D3DTC8 O14670 Q86X77,E3 ubiquitin-protein ligase MARCHF6,Doa10 homolog;Membrane-associated RING finger protein 6;Membrane-associated RING-CH protein VI;Protein TEB-4 {ECO:0000303|PubMed:15673284, ECO:0000303|PubMed:16373356, ECO:0000303|PubMed:19651899};RING finger protein 176;RING-type E3 ubiquitin transferase MARCHF6 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0044322;GO:0000835;GO:0030176;GO:0016021;GO:0016020;GO:0019899;GO:0031624;GO:0061630;GO:0004842;GO:1990381;GO:0008270;GO:1904380;GO:0036503;GO:0010498;GO:0043161;GO:0070936;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:ER ubiquitin ligase complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:enzyme binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:zinc ion binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway;|O60337 A5PKZ4 B4DKJ2 B4DT33 D3DTC8 O14670 Q86X77,E3 ubiquitin-protein ligase MARCHF6,Doa10 homolog;Membrane-associated RING finger protein 6;Membrane-associated RING-CH protein VI;Protein TEB-4 {ECO:0000303|PubMed:15673284, ECO:0000303|PubMed:16373356, ECO:0000303|PubMed:19651899};RING finger protein 176;RING-type E3 ubiquitin transferase MARCHF6 {ECO:0000305};, PF12906;, GO:0005783;GO:0005789;GO:0044322;GO:0000835;GO:0030176;GO:0016021;GO:0016020;GO:0019899;GO:0031624;GO:0061630;GO:0004842;GO:1990381;GO:0008270;GO:1904380;GO:0036503;GO:0010498;GO:0043161;GO:0070936;GO:0016567;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:ER ubiquitin ligase complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:enzyme binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:zinc ion binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway; scaffold15 indexed_genome mRNA 36884390 36904027 . + . ID=transcript_3922;Q96DG6 D3DTC7 Q8TED6,Carboxymethylenebutenolidase homolog,, PF01738;, GO:0005829;GO:0070062;GO:0016787;GO:0006805;, C:cytosol; C:extracellular exosome;, F:hydrolase activity;, P:xenobiotic metabolic process;|Q96DG6 D3DTC7 Q8TED6,Carboxymethylenebutenolidase homolog,, PF01738;, GO:0005829;GO:0070062;GO:0016787;GO:0006805;, C:cytosol; C:extracellular exosome;, F:hydrolase activity;, P:xenobiotic metabolic process; scaffold15 indexed_genome mRNA 36910793 36919854 . - . ID=transcript_3923;P48643 A8JZY8 A8K2X8 B4DYD8,T-complex protein 1 subunit epsilon,CCT-epsilon;, PF00118;, GO:0044297;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0048487;GO:0031681;GO:0003730;GO:0048027;GO:0044183;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0009615;GO:1901998;, C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:G-protein beta-subunit binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:response to virus; P:toxin transport;|P48643 A8JZY8 A8K2X8 B4DYD8,T-complex protein 1 subunit epsilon,CCT-epsilon;, PF00118;, GO:0044297;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0048487;GO:0031681;GO:0003730;GO:0048027;GO:0044183;GO:0051082;GO:0007339;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0009615;GO:1901998;, C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:G-protein beta-subunit binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:protein folding chaperone; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:response to virus; P:toxin transport; scaffold15 indexed_genome mRNA 36929461 36940611 . + . ID=transcript_3924;Q6P4H8 B4DT41 B4DXK2 E9PBZ4,ATP synthase subunit C lysine N-methyltransferase {ECO:0000303|PubMed:30530489, ECO:0000305},Protein N-lysine methyltransferase FAM173B {ECO:0000305};, , GO:0016021;GO:0030061;GO:0005739;GO:0016279;GO:0018022;GO:0018023;GO:1905273;GO:1904058;GO:1905706;, C:integral component of membrane; C:mitochondrial crista; C:mitochondrion;, F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine methylation; P:peptidyl-lysine trimethylation; P:positive regulation of proton-transporting ATP synthase activity, rotational mechanism; P:positive regulation of sensory perception of pain; P:regulation of mitochondrial ATP synthesis coupled proton transport;|Q6P4H8 B4DT41 B4DXK2 E9PBZ4,ATP synthase subunit C lysine N-methyltransferase {ECO:0000303|PubMed:30530489, ECO:0000305},Protein N-lysine methyltransferase FAM173B {ECO:0000305};, , GO:0016021;GO:0030061;GO:0005739;GO:0016279;GO:0018022;GO:0018023;GO:1905273;GO:1904058;GO:1905706;, C:integral component of membrane; C:mitochondrial crista; C:mitochondrion;, F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine methylation; P:peptidyl-lysine trimethylation; P:positive regulation of proton-transporting ATP synthase activity, rotational mechanism; P:positive regulation of sensory perception of pain; P:regulation of mitochondrial ATP synthesis coupled proton transport; scaffold15 indexed_genome mRNA 39096988 39127849 . - . ID=transcript_3925;Q9UBK8 O60471 Q32MA9 Q7Z4M8,Methionine synthase reductase,Aquacobalamin reductase {ECO:0000303|PubMed:16769880};, PF00667;PF00258;PF00175;, GO:0005829;GO:0045111;GO:0005654;GO:0030586;GO:0050444;GO:0071949;GO:0050660;GO:0010181;GO:0050661;GO:0070402;GO:0003958;GO:0016491;GO:0016709;GO:0016723;GO:0009235;GO:0006306;GO:0046655;GO:0043418;GO:0050667;GO:0009086;GO:0006555;GO:0032259;GO:1904042;GO:0033353;GO:0000096;, C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm;, F:[methionine synthase] reductase activity; F:aquacobalamin reductase (NADPH) activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADP binding; F:NADPH binding; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor;, P:cobalamin metabolic process; P:DNA methylation; P:folic acid metabolic process; P:homocysteine catabolic process; P:homocysteine metabolic process; P:methionine biosynthetic process; P:methionine metabolic process; P:methylation; P:negative regulation of cystathionine beta-synthase activity; P:S-adenosylmethionine cycle; P:sulfur amino acid metabolic process;|Q9UBK8 O60471 Q32MA9 Q7Z4M8,Methionine synthase reductase,Aquacobalamin reductase {ECO:0000303|PubMed:16769880};, PF00667;PF00258;PF00175;, GO:0005829;GO:0045111;GO:0005654;GO:0030586;GO:0050444;GO:0071949;GO:0050660;GO:0010181;GO:0050661;GO:0070402;GO:0003958;GO:0016491;GO:0016709;GO:0016723;GO:0009235;GO:0006306;GO:0046655;GO:0043418;GO:0050667;GO:0009086;GO:0006555;GO:0032259;GO:1904042;GO:0033353;GO:0000096;, C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm;, F:[methionine synthase] reductase activity; F:aquacobalamin reductase (NADPH) activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADP binding; F:NADPH binding; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor;, P:cobalamin metabolic process; P:DNA methylation; P:folic acid metabolic process; P:homocysteine catabolic process; P:homocysteine metabolic process; P:methionine biosynthetic process; P:methionine metabolic process; P:methylation; P:negative regulation of cystathionine beta-synthase activity; P:S-adenosylmethionine cycle; P:sulfur amino acid metabolic process;|Q9UBK8 O60471 Q32MA9 Q7Z4M8,Methionine synthase reductase,Aquacobalamin reductase {ECO:0000303|PubMed:16769880};, PF00667;PF00258;PF00175;, GO:0005829;GO:0045111;GO:0005654;GO:0030586;GO:0050444;GO:0071949;GO:0050660;GO:0010181;GO:0050661;GO:0070402;GO:0003958;GO:0016491;GO:0016709;GO:0016723;GO:0009235;GO:0006306;GO:0046655;GO:0043418;GO:0050667;GO:0009086;GO:0006555;GO:0032259;GO:1904042;GO:0033353;GO:0000096;, C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm;, F:[methionine synthase] reductase activity; F:aquacobalamin reductase (NADPH) activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADP binding; F:NADPH binding; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor;, P:cobalamin metabolic process; P:DNA methylation; P:folic acid metabolic process; P:homocysteine catabolic process; P:homocysteine metabolic process; P:methionine biosynthetic process; P:methionine metabolic process; P:methylation; P:negative regulation of cystathionine beta-synthase activity; P:S-adenosylmethionine cycle; P:sulfur amino acid metabolic process;|Q9UBK8 O60471 Q32MA9 Q7Z4M8,Methionine synthase reductase,Aquacobalamin reductase {ECO:0000303|PubMed:16769880};, PF00667;PF00258;PF00175;, GO:0005829;GO:0045111;GO:0005654;GO:0030586;GO:0050444;GO:0071949;GO:0050660;GO:0010181;GO:0050661;GO:0070402;GO:0003958;GO:0016491;GO:0016709;GO:0016723;GO:0009235;GO:0006306;GO:0046655;GO:0043418;GO:0050667;GO:0009086;GO:0006555;GO:0032259;GO:1904042;GO:0033353;GO:0000096;, C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm;, F:[methionine synthase] reductase activity; F:aquacobalamin reductase (NADPH) activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADP binding; F:NADPH binding; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor;, P:cobalamin metabolic process; P:DNA methylation; P:folic acid metabolic process; P:homocysteine catabolic process; P:homocysteine metabolic process; P:methionine biosynthetic process; P:methionine metabolic process; P:methylation; P:negative regulation of cystathionine beta-synthase activity; P:S-adenosylmethionine cycle; P:sulfur amino acid metabolic process;|Q9UBK8 O60471 Q32MA9 Q7Z4M8,Methionine synthase reductase,Aquacobalamin reductase {ECO:0000303|PubMed:16769880};, PF00667;PF00258;PF00175;, GO:0005829;GO:0045111;GO:0005654;GO:0030586;GO:0050444;GO:0071949;GO:0050660;GO:0010181;GO:0050661;GO:0070402;GO:0003958;GO:0016491;GO:0016709;GO:0016723;GO:0009235;GO:0006306;GO:0046655;GO:0043418;GO:0050667;GO:0009086;GO:0006555;GO:0032259;GO:1904042;GO:0033353;GO:0000096;, C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm;, F:[methionine synthase] reductase activity; F:aquacobalamin reductase (NADPH) activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADP binding; F:NADPH binding; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor;, P:cobalamin metabolic process; P:DNA methylation; P:folic acid metabolic process; P:homocysteine catabolic process; P:homocysteine metabolic process; P:methionine biosynthetic process; P:methionine metabolic process; P:methylation; P:negative regulation of cystathionine beta-synthase activity; P:S-adenosylmethionine cycle; P:sulfur amino acid metabolic process;|Q9UBK8 O60471 Q32MA9 Q7Z4M8,Methionine synthase reductase,Aquacobalamin reductase {ECO:0000303|PubMed:16769880};, PF00667;PF00258;PF00175;, GO:0005829;GO:0045111;GO:0005654;GO:0030586;GO:0050444;GO:0071949;GO:0050660;GO:0010181;GO:0050661;GO:0070402;GO:0003958;GO:0016491;GO:0016709;GO:0016723;GO:0009235;GO:0006306;GO:0046655;GO:0043418;GO:0050667;GO:0009086;GO:0006555;GO:0032259;GO:1904042;GO:0033353;GO:0000096;, C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm;, F:[methionine synthase] reductase activity; F:aquacobalamin reductase (NADPH) activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADP binding; F:NADPH binding; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor;, P:cobalamin metabolic process; P:DNA methylation; P:folic acid metabolic process; P:homocysteine catabolic process; P:homocysteine metabolic process; P:methionine biosynthetic process; P:methionine metabolic process; P:methylation; P:negative regulation of cystathionine beta-synthase activity; P:S-adenosylmethionine cycle; P:sulfur amino acid metabolic process; scaffold15 indexed_genome mRNA 39128045 39137621 . + . ID=transcript_3926;Q14CZ7 Q9BVD3,FAST kinase domain-containing protein 3, mitochondrial,, PF06743;PF08368;PF08373;, GO:0005739;GO:0005654;GO:0003723;GO:0033617;GO:0070131;GO:0044528;, C:mitochondrion; C:nucleoplasm;, F:RNA binding;, P:mitochondrial cytochrome c oxidase assembly; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability;|Q14CZ7 Q9BVD3,FAST kinase domain-containing protein 3, mitochondrial,, PF06743;PF08368;PF08373;, GO:0005739;GO:0005654;GO:0003723;GO:0033617;GO:0070131;GO:0044528;, C:mitochondrion; C:nucleoplasm;, F:RNA binding;, P:mitochondrial cytochrome c oxidase assembly; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability; scaffold15 indexed_genome mRNA 39138318 39140002 . + . ID=transcript_3927;Q14CZ7 Q9BVD3,FAST kinase domain-containing protein 3, mitochondrial,, PF06743;PF08368;PF08373;, GO:0005739;GO:0005654;GO:0003723;GO:0033617;GO:0070131;GO:0044528;, C:mitochondrion; C:nucleoplasm;, F:RNA binding;, P:mitochondrial cytochrome c oxidase assembly; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability;|Q14CZ7 Q9BVD3,FAST kinase domain-containing protein 3, mitochondrial,, PF06743;PF08368;PF08373;, GO:0005739;GO:0005654;GO:0003723;GO:0033617;GO:0070131;GO:0044528;, C:mitochondrion; C:nucleoplasm;, F:RNA binding;, P:mitochondrial cytochrome c oxidase assembly; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability; scaffold15 indexed_genome mRNA 39164651 39165226 . - . ID=transcript_3928;A4QMS7,Uncharacterized protein C5orf49,, PF15074;, GO:0036064;, C:ciliary basal body; scaffold15 indexed_genome mRNA 39167065 39167823 . + . ID=transcript_3929;A4QMS7,Uncharacterized protein C5orf49,, PF15074;, GO:0036064;, C:ciliary basal body; scaffold15 indexed_genome mRNA 39176291 39182724 . - . ID=transcript_3930;Q08462 B7Z2C1 Q2NKL8 Q9UDB2 Q9UPU2,Adenylate cyclase type 2,ATP pyrophosphate-lyase 2;Adenylate cyclase type II;Adenylyl cyclase 2;, PF16214;PF06327;PF00211;, GO:0005737;GO:0030425;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004016;GO:0008179;GO:0005524;GO:0000287;GO:0030145;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007188;GO:0006171;GO:0019933;GO:1904322;GO:0071377;GO:0007186;GO:0002862;GO:0003091;, C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:adenylate cyclase activity; F:adenylate cyclase binding; F:ATP binding; F:magnesium ion binding; F:manganese ion binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cAMP-mediated signaling; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis; scaffold15 indexed_genome mRNA 39480961 39496610 . - . ID=transcript_3931;Q08462 B7Z2C1 Q2NKL8 Q9UDB2 Q9UPU2,Adenylate cyclase type 2,ATP pyrophosphate-lyase 2;Adenylate cyclase type II;Adenylyl cyclase 2;, PF16214;PF06327;PF00211;, GO:0005737;GO:0030425;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0004016;GO:0008179;GO:0005524;GO:0000287;GO:0030145;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007188;GO:0006171;GO:0019933;GO:1904322;GO:0071377;GO:0007186;GO:0002862;GO:0003091;, C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:adenylate cyclase activity; F:adenylate cyclase binding; F:ATP binding; F:magnesium ion binding; F:manganese ion binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cAMP-mediated signaling; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis; scaffold15 indexed_genome mRNA 40174381 40184547 . - . ID=transcript_3932;Q5XG87 A8K1E2 M1JCE6 O43289 Q17RZ1 Q9Y6C1,Terminal nucleotidyltransferase 4A {ECO:0000305},DNA polymerase sigma;LAK-1;Non-canonical poly(A) RNA polymerase PAPD7 {ECO:0000305};PAP-associated domain-containing protein 7;TRAMP-like complex polyadenylate polymerase;Terminal guanylyltransferase {ECO:0000305};Terminal uridylyltransferase 5;Topoisomerase-related function protein 4-1;, PF01909;PF03828;, GO:0005794;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0070568;GO:0046872;GO:0004652;GO:0043221;GO:0006302;GO:0007076;GO:0006397;GO:0060212;GO:1905870;GO:0042493;GO:0071076;GO:0031123;GO:0043631;GO:0007062;, C:Golgi apparatus; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:guanylyltransferase activity; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:SMC family protein binding;, P:double-strand break repair; P:mitotic chromosome condensation; P:mRNA processing; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:response to drug; P:RNA 3' uridylation; P:RNA 3'-end processing; P:RNA polyadenylation; P:sister chromatid cohesion;|Q5XG87 A8K1E2 M1JCE6 O43289 Q17RZ1 Q9Y6C1,Terminal nucleotidyltransferase 4A {ECO:0000305},DNA polymerase sigma;LAK-1;Non-canonical poly(A) RNA polymerase PAPD7 {ECO:0000305};PAP-associated domain-containing protein 7;TRAMP-like complex polyadenylate polymerase;Terminal guanylyltransferase {ECO:0000305};Terminal uridylyltransferase 5;Topoisomerase-related function protein 4-1;, PF01909;PF03828;, GO:0005794;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0070568;GO:0046872;GO:0004652;GO:0043221;GO:0006302;GO:0007076;GO:0006397;GO:0060212;GO:1905870;GO:0042493;GO:0071076;GO:0031123;GO:0043631;GO:0007062;, C:Golgi apparatus; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:guanylyltransferase activity; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:SMC family protein binding;, P:double-strand break repair; P:mitotic chromosome condensation; P:mRNA processing; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:response to drug; P:RNA 3' uridylation; P:RNA 3'-end processing; P:RNA polyadenylation; P:sister chromatid cohesion;|Q5XG87 A8K1E2 M1JCE6 O43289 Q17RZ1 Q9Y6C1,Terminal nucleotidyltransferase 4A {ECO:0000305},DNA polymerase sigma;LAK-1;Non-canonical poly(A) RNA polymerase PAPD7 {ECO:0000305};PAP-associated domain-containing protein 7;TRAMP-like complex polyadenylate polymerase;Terminal guanylyltransferase {ECO:0000305};Terminal uridylyltransferase 5;Topoisomerase-related function protein 4-1;, PF01909;PF03828;, GO:0005794;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0070568;GO:0046872;GO:0004652;GO:0043221;GO:0006302;GO:0007076;GO:0006397;GO:0060212;GO:1905870;GO:0042493;GO:0071076;GO:0031123;GO:0043631;GO:0007062;, C:Golgi apparatus; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:guanylyltransferase activity; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:SMC family protein binding;, P:double-strand break repair; P:mitotic chromosome condensation; P:mRNA processing; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:response to drug; P:RNA 3' uridylation; P:RNA 3'-end processing; P:RNA polyadenylation; P:sister chromatid cohesion;|Q5XG87 A8K1E2 M1JCE6 O43289 Q17RZ1 Q9Y6C1,Terminal nucleotidyltransferase 4A {ECO:0000305},DNA polymerase sigma;LAK-1;Non-canonical poly(A) RNA polymerase PAPD7 {ECO:0000305};PAP-associated domain-containing protein 7;TRAMP-like complex polyadenylate polymerase;Terminal guanylyltransferase {ECO:0000305};Terminal uridylyltransferase 5;Topoisomerase-related function protein 4-1;, PF01909;PF03828;, GO:0005794;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0070568;GO:0046872;GO:0004652;GO:0043221;GO:0006302;GO:0007076;GO:0006397;GO:0060212;GO:1905870;GO:0042493;GO:0071076;GO:0031123;GO:0043631;GO:0007062;, C:Golgi apparatus; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:guanylyltransferase activity; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:SMC family protein binding;, P:double-strand break repair; P:mitotic chromosome condensation; P:mRNA processing; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:response to drug; P:RNA 3' uridylation; P:RNA 3'-end processing; P:RNA polyadenylation; P:sister chromatid cohesion;|Q5XG87 A8K1E2 M1JCE6 O43289 Q17RZ1 Q9Y6C1,Terminal nucleotidyltransferase 4A {ECO:0000305},DNA polymerase sigma;LAK-1;Non-canonical poly(A) RNA polymerase PAPD7 {ECO:0000305};PAP-associated domain-containing protein 7;TRAMP-like complex polyadenylate polymerase;Terminal guanylyltransferase {ECO:0000305};Terminal uridylyltransferase 5;Topoisomerase-related function protein 4-1;, PF01909;PF03828;, GO:0005794;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0070568;GO:0046872;GO:0004652;GO:0043221;GO:0006302;GO:0007076;GO:0006397;GO:0060212;GO:1905870;GO:0042493;GO:0071076;GO:0031123;GO:0043631;GO:0007062;, C:Golgi apparatus; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:guanylyltransferase activity; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:SMC family protein binding;, P:double-strand break repair; P:mitotic chromosome condensation; P:mRNA processing; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:response to drug; P:RNA 3' uridylation; P:RNA 3'-end processing; P:RNA polyadenylation; P:sister chromatid cohesion; scaffold15 indexed_genome mRNA 40185474 40185995 . - . ID=transcript_3933;Q5XG87 A8K1E2 M1JCE6 O43289 Q17RZ1 Q9Y6C1,Terminal nucleotidyltransferase 4A {ECO:0000305},DNA polymerase sigma;LAK-1;Non-canonical poly(A) RNA polymerase PAPD7 {ECO:0000305};PAP-associated domain-containing protein 7;TRAMP-like complex polyadenylate polymerase;Terminal guanylyltransferase {ECO:0000305};Terminal uridylyltransferase 5;Topoisomerase-related function protein 4-1;, PF01909;PF03828;, GO:0005794;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0070568;GO:0046872;GO:0004652;GO:0043221;GO:0006302;GO:0007076;GO:0006397;GO:0060212;GO:1905870;GO:0042493;GO:0071076;GO:0031123;GO:0043631;GO:0007062;, C:Golgi apparatus; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:guanylyltransferase activity; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:SMC family protein binding;, P:double-strand break repair; P:mitotic chromosome condensation; P:mRNA processing; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:response to drug; P:RNA 3' uridylation; P:RNA 3'-end processing; P:RNA polyadenylation; P:sister chromatid cohesion; scaffold15 indexed_genome mRNA 40188160 40189659 . - . ID=transcript_3934;Q5XG87 A8K1E2 M1JCE6 O43289 Q17RZ1 Q9Y6C1,Terminal nucleotidyltransferase 4A {ECO:0000305},DNA polymerase sigma;LAK-1;Non-canonical poly(A) RNA polymerase PAPD7 {ECO:0000305};PAP-associated domain-containing protein 7;TRAMP-like complex polyadenylate polymerase;Terminal guanylyltransferase {ECO:0000305};Terminal uridylyltransferase 5;Topoisomerase-related function protein 4-1;, PF01909;PF03828;, GO:0005794;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0070568;GO:0046872;GO:0004652;GO:0043221;GO:0006302;GO:0007076;GO:0006397;GO:0060212;GO:1905870;GO:0042493;GO:0071076;GO:0031123;GO:0043631;GO:0007062;, C:Golgi apparatus; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;, F:ATP binding; F:guanylyltransferase activity; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:SMC family protein binding;, P:double-strand break repair; P:mitotic chromosome condensation; P:mRNA processing; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:response to drug; P:RNA 3' uridylation; P:RNA 3'-end processing; P:RNA polyadenylation; P:sister chromatid cohesion; scaffold15 indexed_genome mRNA 40268843 40283178 . - . ID=transcript_3935;P18405 B2R7Q1 Q9UHY4 Q9UP36 Q9UP37,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SR type 1;Steroid 5-alpha-reductase 1;, PF02544;, GO:0070852;GO:0005789;GO:0016021;GO:0043209;GO:0043025;GO:0048471;GO:0003865;GO:0033218;GO:0047751;GO:0009055;GO:0070402;GO:0016491;GO:0050213;GO:0006702;GO:0006710;GO:0060348;GO:0030154;GO:0071320;GO:0071549;GO:0071872;GO:0071392;GO:0071363;GO:0032869;GO:0009267;GO:0071394;GO:0021987;GO:0042747;GO:0016101;GO:0030540;GO:0021766;GO:0021854;GO:0001889;GO:0030539;GO:0008584;GO:0021983;GO:0042448;GO:0042493;GO:0043627;GO:0032354;GO:0060992;GO:0060416;GO:0014850;GO:0042428;GO:0007530;GO:0021510;GO:0006694;GO:0021794;GO:0001655;, C:cell body fiber; C:endoplasmic reticulum membrane; C:integral component of membrane; C:myelin sheath; C:neuronal cell body; C:perinuclear region of cytoplasm;, F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; F:amide binding; F:cholestenone 5-alpha-reductase activity; F:electron transfer activity; F:NADPH binding; F:oxidoreductase activity; F:progesterone 5-alpha-reductase activity;, P:androgen biosynthetic process; P:androgen catabolic process; P:bone development; P:cell differentiation; P:cellular response to cAMP; P:cellular response to dexamethasone stimulus; P:cellular response to epinephrine stimulus; P:cellular response to estradiol stimulus; P:cellular response to growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to starvation; P:cellular response to testosterone stimulus; P:cerebral cortex development; P:circadian sleep/wake cycle, REM sleep; P:diterpenoid metabolic process; P:female genitalia development; P:hippocampus development; P:hypothalamus development; P:liver development; P:male genitalia development; P:male gonad development; P:pituitary gland development; P:progesterone metabolic process; P:response to drug; P:response to estrogen; P:response to follicle-stimulating hormone; P:response to fungicide; P:response to growth hormone; P:response to muscle activity; P:serotonin metabolic process; P:sex determination; P:spinal cord development; P:steroid biosynthetic process; P:thalamus development; P:urogenital system development; scaffold15 indexed_genome mRNA 40320678 40348533 . + . ID=transcript_3936;Q08J23 A8K529 B2RNR4 B3KP09 B4DQW2 G3V1R4 Q9BVN4 Q9H858 Q9NXD9,RNA cytosine C(5)-methyltransferase NSUN2 {ECO:0000305},Myc-induced SUN domain-containing protein {ECO:0000303|PubMed:19596847};NOL1/NOP2/Sun domain family member 2 {ECO:0000303|PubMed:17215513};Substrate of AIM1/Aurora kinase B {ECO:0000303|PubMed:17215513};mRNA cytosine C(5)-methyltransferase;tRNA cytosine C(5)-methyltransferase;tRNA methyltransferase 4 homolog {ECO:0000303|PubMed:17071714};, PF01189;, GO:0033391;GO:0005737;GO:0070062;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:0008168;GO:0062152;GO:0003723;GO:0016428;GO:0000049;GO:0051301;GO:0048820;GO:0001701;GO:0033313;GO:0080009;GO:0010793;GO:2000736;GO:0001510;GO:0007286;GO:0030488;GO:0006400;GO:0036416;, C:chromatoid body; C:cytoplasm; C:extracellular exosome; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;, F:methyltransferase activity; F:mRNA (cytidine-5-)-methyltransferase activity; F:RNA binding; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA binding;, P:cell division; P:hair follicle maturation; P:in utero embryonic development; P:meiotic cell cycle checkpoint; P:mRNA methylation; P:regulation of mRNA export from nucleus; P:regulation of stem cell differentiation; P:RNA methylation; P:spermatid development; P:tRNA methylation; P:tRNA modification; P:tRNA stabilization;|Q08J23 A8K529 B2RNR4 B3KP09 B4DQW2 G3V1R4 Q9BVN4 Q9H858 Q9NXD9,RNA cytosine C(5)-methyltransferase NSUN2 {ECO:0000305},Myc-induced SUN domain-containing protein {ECO:0000303|PubMed:19596847};NOL1/NOP2/Sun domain family member 2 {ECO:0000303|PubMed:17215513};Substrate of AIM1/Aurora kinase B {ECO:0000303|PubMed:17215513};mRNA cytosine C(5)-methyltransferase;tRNA cytosine C(5)-methyltransferase;tRNA methyltransferase 4 homolog {ECO:0000303|PubMed:17071714};, PF01189;, GO:0033391;GO:0005737;GO:0070062;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:0008168;GO:0062152;GO:0003723;GO:0016428;GO:0000049;GO:0051301;GO:0048820;GO:0001701;GO:0033313;GO:0080009;GO:0010793;GO:2000736;GO:0001510;GO:0007286;GO:0030488;GO:0006400;GO:0036416;, C:chromatoid body; C:cytoplasm; C:extracellular exosome; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;, F:methyltransferase activity; F:mRNA (cytidine-5-)-methyltransferase activity; F:RNA binding; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA binding;, P:cell division; P:hair follicle maturation; P:in utero embryonic development; P:meiotic cell cycle checkpoint; P:mRNA methylation; P:regulation of mRNA export from nucleus; P:regulation of stem cell differentiation; P:RNA methylation; P:spermatid development; P:tRNA methylation; P:tRNA modification; P:tRNA stabilization;|Q08J23 A8K529 B2RNR4 B3KP09 B4DQW2 G3V1R4 Q9BVN4 Q9H858 Q9NXD9,RNA cytosine C(5)-methyltransferase NSUN2 {ECO:0000305},Myc-induced SUN domain-containing protein {ECO:0000303|PubMed:19596847};NOL1/NOP2/Sun domain family member 2 {ECO:0000303|PubMed:17215513};Substrate of AIM1/Aurora kinase B {ECO:0000303|PubMed:17215513};mRNA cytosine C(5)-methyltransferase;tRNA cytosine C(5)-methyltransferase;tRNA methyltransferase 4 homolog {ECO:0000303|PubMed:17071714};, PF01189;, GO:0033391;GO:0005737;GO:0070062;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:0008168;GO:0062152;GO:0003723;GO:0016428;GO:0000049;GO:0051301;GO:0048820;GO:0001701;GO:0033313;GO:0080009;GO:0010793;GO:2000736;GO:0001510;GO:0007286;GO:0030488;GO:0006400;GO:0036416;, C:chromatoid body; C:cytoplasm; C:extracellular exosome; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;, F:methyltransferase activity; F:mRNA (cytidine-5-)-methyltransferase activity; F:RNA binding; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA binding;, P:cell division; P:hair follicle maturation; P:in utero embryonic development; P:meiotic cell cycle checkpoint; P:mRNA methylation; P:regulation of mRNA export from nucleus; P:regulation of stem cell differentiation; P:RNA methylation; P:spermatid development; P:tRNA methylation; P:tRNA modification; P:tRNA stabilization;|Q08J23 A8K529 B2RNR4 B3KP09 B4DQW2 G3V1R4 Q9BVN4 Q9H858 Q9NXD9,RNA cytosine C(5)-methyltransferase NSUN2 {ECO:0000305},Myc-induced SUN domain-containing protein {ECO:0000303|PubMed:19596847};NOL1/NOP2/Sun domain family member 2 {ECO:0000303|PubMed:17215513};Substrate of AIM1/Aurora kinase B {ECO:0000303|PubMed:17215513};mRNA cytosine C(5)-methyltransferase;tRNA cytosine C(5)-methyltransferase;tRNA methyltransferase 4 homolog {ECO:0000303|PubMed:17071714};, PF01189;, GO:0033391;GO:0005737;GO:0070062;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:0008168;GO:0062152;GO:0003723;GO:0016428;GO:0000049;GO:0051301;GO:0048820;GO:0001701;GO:0033313;GO:0080009;GO:0010793;GO:2000736;GO:0001510;GO:0007286;GO:0030488;GO:0006400;GO:0036416;, C:chromatoid body; C:cytoplasm; C:extracellular exosome; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;, F:methyltransferase activity; F:mRNA (cytidine-5-)-methyltransferase activity; F:RNA binding; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA binding;, P:cell division; P:hair follicle maturation; P:in utero embryonic development; P:meiotic cell cycle checkpoint; P:mRNA methylation; P:regulation of mRNA export from nucleus; P:regulation of stem cell differentiation; P:RNA methylation; P:spermatid development; P:tRNA methylation; P:tRNA modification; P:tRNA stabilization; scaffold15 indexed_genome mRNA 40349262 40351045 . - . ID=transcript_3937;Q08J23 A8K529 B2RNR4 B3KP09 B4DQW2 G3V1R4 Q9BVN4 Q9H858 Q9NXD9,RNA cytosine C(5)-methyltransferase NSUN2 {ECO:0000305},Myc-induced SUN domain-containing protein {ECO:0000303|PubMed:19596847};NOL1/NOP2/Sun domain family member 2 {ECO:0000303|PubMed:17215513};Substrate of AIM1/Aurora kinase B {ECO:0000303|PubMed:17215513};mRNA cytosine C(5)-methyltransferase;tRNA cytosine C(5)-methyltransferase;tRNA methyltransferase 4 homolog {ECO:0000303|PubMed:17071714};, PF01189;, GO:0033391;GO:0005737;GO:0070062;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:0008168;GO:0062152;GO:0003723;GO:0016428;GO:0000049;GO:0051301;GO:0048820;GO:0001701;GO:0033313;GO:0080009;GO:0010793;GO:2000736;GO:0001510;GO:0007286;GO:0030488;GO:0006400;GO:0036416;, C:chromatoid body; C:cytoplasm; C:extracellular exosome; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;, F:methyltransferase activity; F:mRNA (cytidine-5-)-methyltransferase activity; F:RNA binding; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA binding;, P:cell division; P:hair follicle maturation; P:in utero embryonic development; P:meiotic cell cycle checkpoint; P:mRNA methylation; P:regulation of mRNA export from nucleus; P:regulation of stem cell differentiation; P:RNA methylation; P:spermatid development; P:tRNA methylation; P:tRNA modification; P:tRNA stabilization; scaffold15 indexed_genome mRNA 40412694 40414530 . + . ID=transcript_3938;A1L167,Ubiquitin-conjugating enzyme E2Q-like protein 1,E2Q-like ubiquitin-conjugating enzyme 1;, PF00179;, GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0061631;GO:0000209;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ubiquitin conjugating enzyme activity;, P:protein polyubiquitination;|A1L167,Ubiquitin-conjugating enzyme E2Q-like protein 1,E2Q-like ubiquitin-conjugating enzyme 1;, PF00179;, GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0061631;GO:0000209;, C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ubiquitin conjugating enzyme activity;, P:protein polyubiquitination; scaffold15 indexed_genome mRNA 40536097 40542365 . - . ID=transcript_3939;Q9BTT4 C6G491,Mediator of RNA polymerase II transcription subunit 10,Mediator complex subunit 10;Transformation-related gene 17 protein;Transformation-related gene 20 protein;, PF09748;, GO:0000785;GO:0016592;GO:0005654;GO:0000151;GO:0003712;GO:0061630;GO:0045944;GO:0060260;, C:chromatin; C:mediator complex; C:nucleoplasm; C:ubiquitin ligase complex;, F:transcription coregulator activity; F:ubiquitin protein ligase activity;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; scaffold15 indexed_genome mRNA 41323919 41373402 . - . ID=transcript_3940;Q9Y2F5 Q68DE1 Q6ZT40 Q7L587 Q7Z3A9 Q9NTH9,Little elongation complex subunit 1,Interactor of little elongator complex ELL subunit 1;, , GO:0015030;GO:0035363;GO:0016604;GO:0005654;GO:0008023;GO:0035327;GO:0030674;GO:0090316;GO:0031334;GO:0045945;GO:0042795;GO:0042796;, C:Cajal body; C:histone locus body; C:nuclear body; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:protein-macromolecule adaptor activity;, P:positive regulation of intracellular protein transport; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase III; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III;|Q9Y2F5 Q68DE1 Q6ZT40 Q7L587 Q7Z3A9 Q9NTH9,Little elongation complex subunit 1,Interactor of little elongator complex ELL subunit 1;, , GO:0015030;GO:0035363;GO:0016604;GO:0005654;GO:0008023;GO:0035327;GO:0030674;GO:0090316;GO:0031334;GO:0045945;GO:0042795;GO:0042796;, C:Cajal body; C:histone locus body; C:nuclear body; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:protein-macromolecule adaptor activity;, P:positive regulation of intracellular protein transport; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase III; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III;|Q9Y2F5 Q68DE1 Q6ZT40 Q7L587 Q7Z3A9 Q9NTH9,Little elongation complex subunit 1,Interactor of little elongator complex ELL subunit 1;, , GO:0015030;GO:0035363;GO:0016604;GO:0005654;GO:0008023;GO:0035327;GO:0030674;GO:0090316;GO:0031334;GO:0045945;GO:0042795;GO:0042796;, C:Cajal body; C:histone locus body; C:nuclear body; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:protein-macromolecule adaptor activity;, P:positive regulation of intracellular protein transport; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase III; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; scaffold15 indexed_genome mRNA 41480330 41526323 . - . ID=transcript_3941;Q8TE57 C6G490 Q8IVE2,A disintegrin and metalloproteinase with thrombospondin motifs 16,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0001658;GO:0030198;GO:0048232;GO:1902017;GO:0003073;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:branching involved in ureteric bud morphogenesis; P:extracellular matrix organization; P:male gamete generation; P:regulation of cilium assembly; P:regulation of systemic arterial blood pressure; scaffold15 indexed_genome mRNA 41552435 41580734 . - . ID=transcript_3942;Q8TE57 C6G490 Q8IVE2,A disintegrin and metalloproteinase with thrombospondin motifs 16,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0001658;GO:0030198;GO:0048232;GO:1902017;GO:0003073;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:branching involved in ureteric bud morphogenesis; P:extracellular matrix organization; P:male gamete generation; P:regulation of cilium assembly; P:regulation of systemic arterial blood pressure; scaffold15 indexed_genome mRNA 44418036 44418713 . + . ID=transcript_3943;P78413 B2RMW5 D3DTC5 H1AFL0 H1AFL1 Q2NL64 Q9UHR2,Iroquois-class homeodomain protein IRX-4,Homeodomain protein IRXA3;Iroquois homeobox protein 4;, PF05920;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0048468;GO:0048561;GO:0007507;GO:0030182;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell development; P:establishment of animal organ orientation; P:heart development; P:neuron differentiation; P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 170047 453466 . + . ID=transcript_3944;Q9C0A0 E9PFZ6 Q86YZ7,Contactin-associated protein-like 4,Cell recognition molecule Caspr4;, PF00754;PF02210;, GO:0042995;GO:0016021;GO:0042734;GO:0007155;GO:2000821;GO:0032225;GO:0032228;, C:cell projection; C:integral component of membrane; C:presynaptic membrane;, , P:cell adhesion; P:regulation of grooming behavior; P:regulation of synaptic transmission, dopaminergic; P:regulation of synaptic transmission, GABAergic;|Q9C0A0 E9PFZ6 Q86YZ7,Contactin-associated protein-like 4,Cell recognition molecule Caspr4;, PF00754;PF02210;, GO:0042995;GO:0016021;GO:0042734;GO:0007155;GO:2000821;GO:0032225;GO:0032228;, C:cell projection; C:integral component of membrane; C:presynaptic membrane;, , P:cell adhesion; P:regulation of grooming behavior; P:regulation of synaptic transmission, dopaminergic; P:regulation of synaptic transmission, GABAergic;|Q9C0A0 E9PFZ6 Q86YZ7,Contactin-associated protein-like 4,Cell recognition molecule Caspr4;, PF00754;PF02210;, GO:0042995;GO:0016021;GO:0042734;GO:0007155;GO:2000821;GO:0032225;GO:0032228;, C:cell projection; C:integral component of membrane; C:presynaptic membrane;, , P:cell adhesion; P:regulation of grooming behavior; P:regulation of synaptic transmission, dopaminergic; P:regulation of synaptic transmission, GABAergic;|Q9C0A0 E9PFZ6 Q86YZ7,Contactin-associated protein-like 4,Cell recognition molecule Caspr4;, PF00754;PF02210;, GO:0042995;GO:0016021;GO:0042734;GO:0007155;GO:2000821;GO:0032225;GO:0032228;, C:cell projection; C:integral component of membrane; C:presynaptic membrane;, , P:cell adhesion; P:regulation of grooming behavior; P:regulation of synaptic transmission, dopaminergic; P:regulation of synaptic transmission, GABAergic;|Q9C0A0 E9PFZ6 Q86YZ7,Contactin-associated protein-like 4,Cell recognition molecule Caspr4;, PF00754;PF02210;, GO:0042995;GO:0016021;GO:0042734;GO:0007155;GO:2000821;GO:0032225;GO:0032228;, C:cell projection; C:integral component of membrane; C:presynaptic membrane;, , P:cell adhesion; P:regulation of grooming behavior; P:regulation of synaptic transmission, dopaminergic; P:regulation of synaptic transmission, GABAergic;|Q9C0A0 E9PFZ6 Q86YZ7,Contactin-associated protein-like 4,Cell recognition molecule Caspr4;, PF00754;PF02210;, GO:0042995;GO:0016021;GO:0042734;GO:0007155;GO:2000821;GO:0032225;GO:0032228;, C:cell projection; C:integral component of membrane; C:presynaptic membrane;, , P:cell adhesion; P:regulation of grooming behavior; P:regulation of synaptic transmission, dopaminergic; P:regulation of synaptic transmission, GABAergic; scaffold16 indexed_genome mRNA 1199555 1212213 . - . ID=transcript_3945;Q8TE60 Q6P4R5 Q6ZWJ9,A disintegrin and metalloproteinase with thrombospondin motifs 18,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;GO:0001654;GO:0090331;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization; P:eye development; P:negative regulation of platelet aggregation;|Q8TE60 Q6P4R5 Q6ZWJ9,A disintegrin and metalloproteinase with thrombospondin motifs 18,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;GO:0001654;GO:0090331;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization; P:eye development; P:negative regulation of platelet aggregation; scaffold16 indexed_genome mRNA 1213486 1215132 . - . ID=transcript_3946;Q8TE60 Q6P4R5 Q6ZWJ9,A disintegrin and metalloproteinase with thrombospondin motifs 18,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;GO:0001654;GO:0090331;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization; P:eye development; P:negative regulation of platelet aggregation; scaffold16 indexed_genome mRNA 1620160 1628896 . + . ID=transcript_3947;P0C024 B4DLE5 H3BUB8,Peroxisomal coenzyme A diphosphatase NUDT7 {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 7;, PF00293;, GO:0005829;GO:0005782;GO:0005777;GO:0003986;GO:0010945;GO:0000287;GO:0030145;GO:0030515;GO:0046356;GO:0050873;GO:0044580;GO:0015938;GO:0036114;GO:0009132;GO:1902859;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:acetyl-CoA hydrolase activity; F:CoA pyrophosphatase activity; F:magnesium ion binding; F:manganese ion binding; F:snoRNA binding;, P:acetyl-CoA catabolic process; P:brown fat cell differentiation; P:butyryl-CoA catabolic process; P:coenzyme A catabolic process; P:medium-chain fatty-acyl-CoA catabolic process; P:nucleoside diphosphate metabolic process; P:propionyl-CoA catabolic process; P:protein localization;|P0C024 B4DLE5 H3BUB8,Peroxisomal coenzyme A diphosphatase NUDT7 {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 7;, PF00293;, GO:0005829;GO:0005782;GO:0005777;GO:0003986;GO:0010945;GO:0000287;GO:0030145;GO:0030515;GO:0046356;GO:0050873;GO:0044580;GO:0015938;GO:0036114;GO:0009132;GO:1902859;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:acetyl-CoA hydrolase activity; F:CoA pyrophosphatase activity; F:magnesium ion binding; F:manganese ion binding; F:snoRNA binding;, P:acetyl-CoA catabolic process; P:brown fat cell differentiation; P:butyryl-CoA catabolic process; P:coenzyme A catabolic process; P:medium-chain fatty-acyl-CoA catabolic process; P:nucleoside diphosphate metabolic process; P:propionyl-CoA catabolic process; P:protein localization;|P0C024 B4DLE5 H3BUB8,Peroxisomal coenzyme A diphosphatase NUDT7 {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 7;, PF00293;, GO:0005829;GO:0005782;GO:0005777;GO:0003986;GO:0010945;GO:0000287;GO:0030145;GO:0030515;GO:0046356;GO:0050873;GO:0044580;GO:0015938;GO:0036114;GO:0009132;GO:1902859;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:acetyl-CoA hydrolase activity; F:CoA pyrophosphatase activity; F:magnesium ion binding; F:manganese ion binding; F:snoRNA binding;, P:acetyl-CoA catabolic process; P:brown fat cell differentiation; P:butyryl-CoA catabolic process; P:coenzyme A catabolic process; P:medium-chain fatty-acyl-CoA catabolic process; P:nucleoside diphosphate metabolic process; P:propionyl-CoA catabolic process; P:protein localization;|P0C024 B4DLE5 H3BUB8,Peroxisomal coenzyme A diphosphatase NUDT7 {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 7;, PF00293;, GO:0005829;GO:0005782;GO:0005777;GO:0003986;GO:0010945;GO:0000287;GO:0030145;GO:0030515;GO:0046356;GO:0050873;GO:0044580;GO:0015938;GO:0036114;GO:0009132;GO:1902859;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:acetyl-CoA hydrolase activity; F:CoA pyrophosphatase activity; F:magnesium ion binding; F:manganese ion binding; F:snoRNA binding;, P:acetyl-CoA catabolic process; P:brown fat cell differentiation; P:butyryl-CoA catabolic process; P:coenzyme A catabolic process; P:medium-chain fatty-acyl-CoA catabolic process; P:nucleoside diphosphate metabolic process; P:propionyl-CoA catabolic process; P:protein localization; scaffold16 indexed_genome mRNA 1670593 1836374 . + . ID=transcript_3948;Q9HCJ6 Q8IYW8,Synaptic vesicle membrane protein VAT-1 homolog-like,, PF08240;, GO:0016491;GO:0008270;, , F:oxidoreductase activity; F:zinc ion binding;|Q6ZSS3 Q14DC7 Q8TE91,Zinc finger protein 621,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 1907412 2724588 . + . ID=transcript_3949;Q9NRF6 Q9NRK1 Q9NZC5,WW domain-containing oxidoreductase,Fragile site FRA16D oxidoreductase;Short chain dehydrogenase/reductase family 41C member 1;, PF00106;PF00397;, GO:0005737;GO:0005829;GO:0005794;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0019899;GO:0042802;GO:0016491;GO:0003713;GO:0071560;GO:0097191;GO:0072332;GO:0000122;GO:0030178;GO:0001649;GO:2001238;GO:2001241;GO:0045944;GO:0048705;GO:0016055;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:enzyme binding; F:identical protein binding; F:oxidoreductase activity; F:transcription coactivator activity;, P:cellular response to transforming growth factor beta stimulus; P:extrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of Wnt signaling pathway; P:osteoblast differentiation; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of transcription by RNA polymerase II; P:skeletal system morphogenesis; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 3836723 3847024 . + . ID=transcript_3950;Q8TF09,Dynein light chain roadblock-type 2,Dynein light chain 2B, cytoplasmic;Roadblock domain-containing protein 2;, PF03259;, GO:0005813;GO:0097542;GO:0005929;GO:0005737;GO:0005868;GO:0005874;GO:0045505;GO:0003777;GO:0035735;GO:0007018;, C:centrosome; C:ciliary tip; C:cilium; C:cytoplasm; C:cytoplasmic dynein complex; C:microtubule;, F:dynein intermediate chain binding; F:microtubule motor activity;, P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; scaffold16 indexed_genome mRNA 3891685 3896134 . - . ID=transcript_3951;Q8N8U2 Q7Z5I8,Chromodomain Y-like protein 2,, PF00385;PF00378;, GO:0005634;GO:0003824;GO:0003714;, C:nucleus;, F:catalytic activity; F:transcription corepressor activity; scaffold16 indexed_genome mRNA 3906727 4036982 . - . ID=transcript_3952;Q8N8U2 Q7Z5I8,Chromodomain Y-like protein 2,, PF00385;PF00378;, GO:0005634;GO:0003824;GO:0003714;, C:nucleus;, F:catalytic activity; F:transcription corepressor activity; scaffold16 indexed_genome mRNA 4179549 4180503 . + . ID=transcript_3953;Q9NRP2 D3DUK6,COX assembly mitochondrial protein 2 homolog,, PF08583;, GO:0005739;, C:mitochondrion; scaffold16 indexed_genome mRNA 4182298 4187582 . - . ID=transcript_3954;Q9NRP2 D3DUK6,COX assembly mitochondrial protein 2 homolog,, PF08583;, GO:0005739;, C:mitochondrion;|Q9NRP2 D3DUK6,COX assembly mitochondrial protein 2 homolog,, PF08583;, GO:0005739;, C:mitochondrion; scaffold16 indexed_genome mRNA 4199787 4211759 . + . ID=transcript_3955;Q9NZ83,Centromere protein N,Interphase centromere complex protein 32;, PF05238;, GO:0000777;GO:0005829;GO:0005654;GO:0034080;GO:0007059;GO:0051382;GO:0007052;, C:condensed chromosome kinetochore; C:cytosol; C:nucleoplasm;, , P:CENP-A containing nucleosome assembly; P:chromosome segregation; P:kinetochore assembly; P:mitotic spindle organization; scaffold16 indexed_genome mRNA 4228527 4234341 . + . ID=transcript_3956;O43313 A8K4H8 Q68DC9,ATM interactor,ATM/ATR-substrate CHK2-interacting zinc finger protein;Zinc finger protein 822;, , GO:0016604;GO:0005634;GO:0001228;GO:0000981;GO:0070840;GO:0046872;GO:0000976;GO:0006974;GO:0044458;GO:1902857;GO:0045944;GO:0045893;GO:0006357;, C:nuclear body; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:dynein complex binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to DNA damage stimulus; P:motile cilium assembly; P:positive regulation of non-motile cilium assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|O43313 A8K4H8 Q68DC9,ATM interactor,ATM/ATR-substrate CHK2-interacting zinc finger protein;Zinc finger protein 822;, , GO:0016604;GO:0005634;GO:0001228;GO:0000981;GO:0070840;GO:0046872;GO:0000976;GO:0006974;GO:0044458;GO:1902857;GO:0045944;GO:0045893;GO:0006357;, C:nuclear body; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:dynein complex binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to DNA damage stimulus; P:motile cilium assembly; P:positive regulation of non-motile cilium assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 4243469 4253071 . - . ID=transcript_3957;Q6P387 Q96MA7,Uncharacterized protein C16orf46,, PF15032;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold16 indexed_genome mRNA 4258283 4264424 . - . ID=transcript_3958;P23434 Q9H1E9,Glycine cleavage system H protein, mitochondrial {ECO:0000303|PubMed:1671321},Lipoic acid-containing protein;, PF01597;, GO:0005737;GO:0005960;GO:0005759;GO:0005739;GO:0004047;GO:0006546;GO:0019464;GO:0009249;, C:cytoplasm; C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion;, F:aminomethyltransferase activity;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein lipoylation;|P23434 Q9H1E9,Glycine cleavage system H protein, mitochondrial {ECO:0000303|PubMed:1671321},Lipoic acid-containing protein;, PF01597;, GO:0005737;GO:0005960;GO:0005759;GO:0005739;GO:0004047;GO:0006546;GO:0019464;GO:0009249;, C:cytoplasm; C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion;, F:aminomethyltransferase activity;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein lipoylation; scaffold16 indexed_genome mRNA 4287742 4293042 . - . ID=transcript_3959;Q7Z442 Q6UEE1 Q6ZN46 Q6ZSP2 Q8N1H9 Q96CL2 Q96Q08,Polycystic kidney disease protein 1-like 2,PC1-like 2 protein;Polycystin-1L2;, PF02140;PF01825;PF00059;PF08016;PF01477;PF02010;, GO:0016021;GO:0016020;GO:0005262;GO:0005509;GO:0030246;GO:0050982;, C:integral component of membrane; C:membrane;, F:calcium channel activity; F:calcium ion binding; F:carbohydrate binding;, P:detection of mechanical stimulus; scaffold16 indexed_genome mRNA 4397146 4426694 . + . ID=transcript_3960;Q9HAY6 A0AV48 A0AV50 Q9NVH5,Beta,beta-carotene 15,15'-dioxygenase,Beta-carotene dioxygenase 1;Beta-carotene oxygenase 1 {ECO:0000312|HGNC:HGNC:13815};, PF03055;, GO:0005829;GO:0003834;GO:0010436;GO:0046872;GO:1901810;GO:0016121;GO:0042574;GO:0001523;GO:0042572;GO:0035238;, C:cytosol;, F:beta-carotene 15,15'-monooxygenase activity; F:carotenoid dioxygenase activity; F:metal ion binding;, P:beta-carotene metabolic process; P:carotene catabolic process; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:vitamin A biosynthetic process; scaffold16 indexed_genome mRNA 4484227 4500838 . + . ID=transcript_3961;Q9H2C0,Gigaxonin,Kelch-like protein 16;, PF07707;PF00651;PF01344;, GO:0031463;GO:0005737;GO:0005856;GO:0005829;GO:0007010;GO:0043687;GO:0016567;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytoskeleton; C:cytosol;, , P:cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination;|Q9H2C0,Gigaxonin,Kelch-like protein 16;, PF07707;PF00651;PF01344;, GO:0031463;GO:0005737;GO:0005856;GO:0005829;GO:0007010;GO:0043687;GO:0016567;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytoskeleton; C:cytosol;, , P:cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; scaffold16 indexed_genome mRNA 4601402 4759480 . + . ID=transcript_3962;Q8IY22 Q9C0G9,C-Maf-inducing protein,Truncated c-Maf-inducing protein;, , GO:0005829;GO:0005654;GO:0001701;, C:cytosol; C:nucleoplasm;, , P:in utero embryonic development;|Q8IY22 Q9C0G9,C-Maf-inducing protein,Truncated c-Maf-inducing protein;, , GO:0005829;GO:0005654;GO:0001701;, C:cytosol; C:nucleoplasm;, , P:in utero embryonic development;|Q8IY22 Q9C0G9,C-Maf-inducing protein,Truncated c-Maf-inducing protein;, , GO:0005829;GO:0005654;GO:0001701;, C:cytosol; C:nucleoplasm;, , P:in utero embryonic development; scaffold16 indexed_genome mRNA 4882539 4911212 . + . ID=transcript_3963;P16885 D3DUL3 Q3ZTS2 Q59H45 Q969T5,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 {ECO:0000305},Phosphoinositide phospholipase C-gamma-2;Phospholipase C-IV;Phospholipase C-gamma-2;, PF00168;PF00388;PF00387;PF00017;PF00018;, GO:0005829;GO:0070062;GO:0005886;GO:0004435;GO:0140031;GO:0001784;GO:0032237;GO:0030183;GO:0050853;GO:0019722;GO:0038095;GO:0038096;GO:0002316;GO:0043647;GO:0032959;GO:0002862;GO:0043069;GO:0006661;GO:0009395;GO:0030168;GO:0010634;GO:0002092;GO:0032481;GO:0051209;GO:0032496;GO:0002223;GO:0050852;GO:0016055;, C:cytosol; C:extracellular exosome; C:plasma membrane;, F:phosphatidylinositol phospholipase C activity; F:phosphorylation-dependent protein binding; F:phosphotyrosine residue binding;, P:activation of store-operated calcium channel activity; P:B cell differentiation; P:B cell receptor signaling pathway; P:calcium-mediated signaling; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:follicular B cell differentiation; P:inositol phosphate metabolic process; P:inositol trisphosphate biosynthetic process; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of programmed cell death; P:phosphatidylinositol biosynthetic process; P:phospholipid catabolic process; P:platelet activation; P:positive regulation of epithelial cell migration; P:positive regulation of receptor internalization; P:positive regulation of type I interferon production; P:release of sequestered calcium ion into cytosol; P:response to lipopolysaccharide; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 4942208 4951539 . + . ID=transcript_3964;P16885 D3DUL3 Q3ZTS2 Q59H45 Q969T5,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 {ECO:0000305},Phosphoinositide phospholipase C-gamma-2;Phospholipase C-IV;Phospholipase C-gamma-2;, PF00168;PF00388;PF00387;PF00017;PF00018;, GO:0005829;GO:0070062;GO:0005886;GO:0004435;GO:0140031;GO:0001784;GO:0032237;GO:0030183;GO:0050853;GO:0019722;GO:0038095;GO:0038096;GO:0002316;GO:0043647;GO:0032959;GO:0002862;GO:0043069;GO:0006661;GO:0009395;GO:0030168;GO:0010634;GO:0002092;GO:0032481;GO:0051209;GO:0032496;GO:0002223;GO:0050852;GO:0016055;, C:cytosol; C:extracellular exosome; C:plasma membrane;, F:phosphatidylinositol phospholipase C activity; F:phosphorylation-dependent protein binding; F:phosphotyrosine residue binding;, P:activation of store-operated calcium channel activity; P:B cell differentiation; P:B cell receptor signaling pathway; P:calcium-mediated signaling; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:follicular B cell differentiation; P:inositol phosphate metabolic process; P:inositol trisphosphate biosynthetic process; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of programmed cell death; P:phosphatidylinositol biosynthetic process; P:phospholipid catabolic process; P:platelet activation; P:positive regulation of epithelial cell migration; P:positive regulation of receptor internalization; P:positive regulation of type I interferon production; P:release of sequestered calcium ion into cytosol; P:response to lipopolysaccharide; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 5011470 5015070 . - . ID=transcript_3965;Q8WUS8 B2RDS1 Q9P0D1,Short-chain dehydrogenase/reductase family 42E member 1 {ECO:0000303|PubMed:19027726},, PF01073;, GO:0016021;GO:0003854;GO:0016616;GO:0006694;, C:integral component of membrane;, F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:steroid biosynthetic process; scaffold16 indexed_genome mRNA 5060142 5142513 . + . ID=transcript_3966;P37059 B2R7T4,17-beta-hydroxysteroid dehydrogenase type 2 {ECO:0000305},20 alpha-hydroxysteroid dehydrogenase;E2DH;Estradiol 17-beta-dehydrogenase 2;Microsomal 17-beta-hydroxysteroid dehydrogenase;Short chain dehydrogenase/reductase family 9C member 2;Testosterone 17-beta-dehydrogenase;, PF00106;, GO:0005789;GO:0016021;GO:0047006;GO:0044594;GO:0072582;GO:0004303;GO:0047035;GO:0006703;GO:0001701;GO:0001890;GO:0032526;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:estradiol 17-beta-dehydrogenase activity; F:testosterone dehydrogenase (NAD+) activity;, P:estrogen biosynthetic process; P:in utero embryonic development; P:placenta development; P:response to retinoic acid;|P37059 B2R7T4,17-beta-hydroxysteroid dehydrogenase type 2 {ECO:0000305},20 alpha-hydroxysteroid dehydrogenase;E2DH;Estradiol 17-beta-dehydrogenase 2;Microsomal 17-beta-hydroxysteroid dehydrogenase;Short chain dehydrogenase/reductase family 9C member 2;Testosterone 17-beta-dehydrogenase;, PF00106;, GO:0005789;GO:0016021;GO:0047006;GO:0044594;GO:0072582;GO:0004303;GO:0047035;GO:0006703;GO:0001701;GO:0001890;GO:0032526;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:estradiol 17-beta-dehydrogenase activity; F:testosterone dehydrogenase (NAD+) activity;, P:estrogen biosynthetic process; P:in utero embryonic development; P:placenta development; P:response to retinoic acid; scaffold16 indexed_genome mRNA 5173450 5181982 . - . ID=transcript_3967;Q99547 B2RAF0,M-phase phosphoprotein 6 {ECO:0000305},, PF10175;, GO:0005829;GO:0000178;GO:0005730;GO:0005654;GO:0005634;GO:0003723;GO:0000460;GO:0006364;, C:cytosol; C:exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:maturation of 5.8S rRNA; P:rRNA processing; scaffold16 indexed_genome mRNA 6038597 6578672 . + . ID=transcript_3968;P55290 A8W476 A8W477 B7Z590 C9JRI6 J3KN62 Q6GTW4 Q8TBX3,Cadherin-13,Heart cadherin;P105;Truncated cadherin;, PF00028;PF08758;, GO:0031225;GO:0016342;GO:0005901;GO:0062023;GO:0005737;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0098982;GO:0043005;GO:0048471;GO:0005886;GO:0055100;GO:0045296;GO:0005509;GO:0071813;GO:0030169;GO:0042803;GO:0034332;GO:0016339;GO:0098742;GO:0043542;GO:0007156;GO:0043616;GO:0030032;GO:0051668;GO:0055096;GO:0000278;GO:0007162;GO:0008285;GO:0050850;GO:0030335;GO:0001954;GO:0001938;GO:0050927;GO:0048661;GO:0045944;GO:0016601;GO:0030100;GO:0042058;GO:0007266;GO:0002040;, C:anchored component of membrane; C:catenin complex; C:caveola; C:collagen-containing extracellular matrix; C:cytoplasm; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:GABA-ergic synapse; C:neuron projection; C:perinuclear region of cytoplasm; C:plasma membrane;, F:adiponectin binding; F:cadherin binding; F:calcium ion binding; F:lipoprotein particle binding; F:low-density lipoprotein particle binding; F:protein homodimerization activity;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:endothelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinocyte proliferation; P:lamellipodium assembly; P:localization within membrane; P:low-density lipoprotein particle mediated signaling; P:mitotic cell cycle; P:negative regulation of cell adhesion; P:negative regulation of cell population proliferation; P:positive regulation of calcium-mediated signaling; P:positive regulation of cell migration; P:positive regulation of cell-matrix adhesion; P:positive regulation of endothelial cell proliferation; P:positive regulation of positive chemotaxis; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:Rac protein signal transduction; P:regulation of endocytosis; P:regulation of epidermal growth factor receptor signaling pathway; P:Rho protein signal transduction; P:sprouting angiogenesis; scaffold16 indexed_genome mRNA 6586699 6591345 . + . ID=transcript_3969;O75506 Q53XA8 Q7Z5Z3,Heat shock factor-binding protein 1,Nasopharyngeal carcinoma-associated antigen 13;, PF06825;, GO:0005856;GO:0005829;GO:0005654;GO:0005634;GO:0042802;GO:0003714;GO:0070370;GO:0035987;GO:0006936;GO:0000122;GO:1900034;, C:cytoskeleton; C:cytosol; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:transcription corepressor activity;, P:cellular heat acclimation; P:endodermal cell differentiation; P:muscle contraction; P:negative regulation of transcription by RNA polymerase II; P:regulation of cellular response to heat; scaffold16 indexed_genome mRNA 6661307 6674398 . + . ID=transcript_3970;O95822 Q9UNU5 Q9Y3F2,Malonyl-CoA decarboxylase, mitochondrial {ECO:0000305},, PF05292;PF17408;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005782;GO:0005777;GO:0042802;GO:0050080;GO:0006085;GO:0006637;GO:0006633;GO:0019395;GO:2001294;GO:0046321;GO:0008104;GO:0031998;GO:0010906;GO:0002931;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:identical protein binding; F:malonyl-CoA decarboxylase activity;, P:acetyl-CoA biosynthetic process; P:acyl-CoA metabolic process; P:fatty acid biosynthetic process; P:fatty acid oxidation; P:malonyl-CoA catabolic process; P:positive regulation of fatty acid oxidation; P:protein localization; P:regulation of fatty acid beta-oxidation; P:regulation of glucose metabolic process; P:response to ischemia; scaffold16 indexed_genome mRNA 6709945 6760963 . - . ID=transcript_3971;Q9UJX0 Q52M33 Q86UQ1 Q96S88 Q9BZ70,Oxidative stress-induced growth inhibitor 1 {ECO:0000305},Bone marrow stromal cell-derived growth inhibitor {ECO:0000303|PubMed:15569677};Ovary, kidney and liver protein 38;Pregnancy-induced growth inhibitor OKL38 {ECO:0000305|PubMed:15569677};, , GO:0008083;GO:0030154;GO:0007275;GO:0030308;GO:0043065;GO:0042981;GO:0030334;GO:0042127;, , F:growth factor activity;, P:cell differentiation; P:multicellular organism development; P:negative regulation of cell growth; P:positive regulation of apoptotic process; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of cell population proliferation;|Q9UJX0 Q52M33 Q86UQ1 Q96S88 Q9BZ70,Oxidative stress-induced growth inhibitor 1 {ECO:0000305},Bone marrow stromal cell-derived growth inhibitor {ECO:0000303|PubMed:15569677};Ovary, kidney and liver protein 38;Pregnancy-induced growth inhibitor OKL38 {ECO:0000305|PubMed:15569677};, , GO:0008083;GO:0030154;GO:0007275;GO:0030308;GO:0043065;GO:0042981;GO:0030334;GO:0042127;, , F:growth factor activity;, P:cell differentiation; P:multicellular organism development; P:negative regulation of cell growth; P:positive regulation of apoptotic process; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of cell population proliferation;|Q7Z6G3 A2RRG3 H3BTW2 O75547 Q6ZSK0,N-terminal EF-hand calcium-binding protein 2,Neuronal calcium-binding protein 2;Synaptotagmin-interacting protein 2;, PF03992;PF13833;, GO:0030424;GO:0005737;GO:0030425;GO:0005886;GO:0031687;GO:0005509;GO:0042802;GO:0031802;GO:1904021;GO:0060168;GO:0070374;GO:1900451;GO:1905477;GO:0042984;, C:axon; C:cytoplasm; C:dendrite; C:plasma membrane;, F:A2A adenosine receptor binding; F:calcium ion binding; F:identical protein binding; F:type 5 metabotropic glutamate receptor binding;, P:negative regulation of G protein-coupled receptor internalization; P:positive regulation of adenosine receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glutamate receptor signaling pathway; P:positive regulation of protein localization to membrane; P:regulation of amyloid precursor protein biosynthetic process;|Q7Z6G3 A2RRG3 H3BTW2 O75547 Q6ZSK0,N-terminal EF-hand calcium-binding protein 2,Neuronal calcium-binding protein 2;Synaptotagmin-interacting protein 2;, PF03992;PF13833;, GO:0030424;GO:0005737;GO:0030425;GO:0005886;GO:0031687;GO:0005509;GO:0042802;GO:0031802;GO:1904021;GO:0060168;GO:0070374;GO:1900451;GO:1905477;GO:0042984;, C:axon; C:cytoplasm; C:dendrite; C:plasma membrane;, F:A2A adenosine receptor binding; F:calcium ion binding; F:identical protein binding; F:type 5 metabotropic glutamate receptor binding;, P:negative regulation of G protein-coupled receptor internalization; P:positive regulation of adenosine receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glutamate receptor signaling pathway; P:positive regulation of protein localization to membrane; P:regulation of amyloid precursor protein biosynthetic process;|Q7Z6G3 A2RRG3 H3BTW2 O75547 Q6ZSK0,N-terminal EF-hand calcium-binding protein 2,Neuronal calcium-binding protein 2;Synaptotagmin-interacting protein 2;, PF03992;PF13833;, GO:0030424;GO:0005737;GO:0030425;GO:0005886;GO:0031687;GO:0005509;GO:0042802;GO:0031802;GO:1904021;GO:0060168;GO:0070374;GO:1900451;GO:1905477;GO:0042984;, C:axon; C:cytoplasm; C:dendrite; C:plasma membrane;, F:A2A adenosine receptor binding; F:calcium ion binding; F:identical protein binding; F:type 5 metabotropic glutamate receptor binding;, P:negative regulation of G protein-coupled receptor internalization; P:positive regulation of adenosine receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glutamate receptor signaling pathway; P:positive regulation of protein localization to membrane; P:regulation of amyloid precursor protein biosynthetic process; scaffold16 indexed_genome mRNA 6812755 6857240 . - . ID=transcript_3972;Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress;|Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress;|Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress;|Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress;|Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress;|Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress;|Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress;|Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress;|Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress;|Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress;|Q14703 A8K6V8 Q24JQ2 Q9UF67,Membrane-bound transcription factor site-1 protease {ECO:0000305},Endopeptidase S1P {ECO:0000303|PubMed:10944850};Subtilisin/kexin-isozyme 1 {ECO:0000303|PubMed:10644685};, PF00082;, GO:0005788;GO:0005789;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0004252;GO:0036500;GO:0044267;GO:0008203;GO:0030968;GO:0007040;GO:0031293;GO:0043687;GO:0006606;GO:0006508;GO:0045540;GO:0060627;GO:0034976;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:serine-type endopeptidase activity;, P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:lysosome organization; P:membrane protein intracellular domain proteolysis; P:post-translational protein modification; P:protein import into nucleus; P:proteolysis; P:regulation of cholesterol biosynthetic process; P:regulation of vesicle-mediated transport; P:response to endoplasmic reticulum stress; scaffold16 indexed_genome mRNA 6862311 6868293 . - . ID=transcript_3973;Q3SXM5 B4DSL2 D3DUL4 Q3SXM4 Q8NC98 Q9BY22,Inactive hydroxysteroid dehydrogenase-like protein 1,Short chain dehydrogenase/reductase family 12C member 3;, PF00106;, GO:0045111;GO:0043231;GO:0005739;, C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:mitochondrion;|Q3SXM5 B4DSL2 D3DUL4 Q3SXM4 Q8NC98 Q9BY22,Inactive hydroxysteroid dehydrogenase-like protein 1,Short chain dehydrogenase/reductase family 12C member 3;, PF00106;, GO:0045111;GO:0043231;GO:0005739;, C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:mitochondrion; scaffold16 indexed_genome mRNA 6895236 6896702 . + . ID=transcript_3974;Q8NEP3 B4DJA3 Q69YI8 Q69YJ0 Q69YW5 Q96LP3 Q96MB6,Dynein assembly factor 1, axonemal,Leucine-rich repeat-containing protein 50;, , GO:0005930;GO:0005737;GO:0005829;GO:0005576;GO:0016607;GO:0005886;GO:0000922;GO:0070840;GO:0070286;GO:0060271;GO:0003341;GO:0071907;GO:0071910;GO:0035469;GO:0060287;GO:0001947;GO:0036159;GO:0060972;GO:0030324;GO:0044458;GO:0036158;GO:0003356;, C:axoneme; C:cytoplasm; C:cytosol; C:extracellular region; C:nuclear speck; C:plasma membrane; C:spindle pole;, F:dynein complex binding;, P:axonemal dynein complex assembly; P:cilium assembly; P:cilium movement; P:determination of digestive tract left/right asymmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:heart looping; P:inner dynein arm assembly; P:left/right pattern formation; P:lung development; P:motile cilium assembly; P:outer dynein arm assembly; P:regulation of cilium beat frequency; scaffold16 indexed_genome mRNA 6897576 6907399 . - . ID=transcript_3975;Q15572 B7Z5K5 B7Z5S4 B7Z908 B7Z9L7 Q59F67 Q8N6V3,TATA box-binding protein-associated factor RNA polymerase I subunit C,RNA polymerase I-specific TBP-associated factor 110 kDa;TATA box-binding protein-associated factor 1C;Transcription initiation factor SL1/TIF-IB subunit C;, , GO:0001650;GO:0005730;GO:0005654;GO:0001164;GO:0001181;GO:0045815;GO:0006363;GO:0006360;GO:0006366;GO:0006361;, C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA polymerase I core promoter sequence-specific DNA binding; F:RNA polymerase I general transcription initiation factor activity;, P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase I promoter;|Q15572 B7Z5K5 B7Z5S4 B7Z908 B7Z9L7 Q59F67 Q8N6V3,TATA box-binding protein-associated factor RNA polymerase I subunit C,RNA polymerase I-specific TBP-associated factor 110 kDa;TATA box-binding protein-associated factor 1C;Transcription initiation factor SL1/TIF-IB subunit C;, , GO:0001650;GO:0005730;GO:0005654;GO:0001164;GO:0001181;GO:0045815;GO:0006363;GO:0006360;GO:0006366;GO:0006361;, C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA polymerase I core promoter sequence-specific DNA binding; F:RNA polymerase I general transcription initiation factor activity;, P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase I promoter;|Q15572 B7Z5K5 B7Z5S4 B7Z908 B7Z9L7 Q59F67 Q8N6V3,TATA box-binding protein-associated factor RNA polymerase I subunit C,RNA polymerase I-specific TBP-associated factor 110 kDa;TATA box-binding protein-associated factor 1C;Transcription initiation factor SL1/TIF-IB subunit C;, , GO:0001650;GO:0005730;GO:0005654;GO:0001164;GO:0001181;GO:0045815;GO:0006363;GO:0006360;GO:0006366;GO:0006361;, C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA polymerase I core promoter sequence-specific DNA binding; F:RNA polymerase I general transcription initiation factor activity;, P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase I promoter; scaffold16 indexed_genome mRNA 6989200 7017120 . + . ID=transcript_3976;Q9HC57 D3DUL7 Q8NC27 Q9HAU1,WAP four-disulfide core domain protein 1,Prostate stromal protein ps20;ps20 growth inhibitor;, PF00095;, GO:0005615;GO:0004867;GO:0030308;GO:0050680;GO:0050728;GO:0061045;GO:0001558;GO:0042493;GO:0032355;, C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of cell growth; P:negative regulation of epithelial cell proliferation; P:negative regulation of inflammatory response; P:negative regulation of wound healing; P:regulation of cell growth; P:response to drug; P:response to estradiol; scaffold16 indexed_genome mRNA 7038389 7114179 . + . ID=transcript_3977;O75185 B4DU76 E7ES94 Q5HYC3 Q5S053 Q68CQ2,Calcium-transporting ATPase type 2C member 2 {ECO:0000305},Secretory pathway Ca(2+)-ATPase 2;, PF00689;PF00690;, GO:0009898;GO:0031410;GO:0005783;GO:0000139;GO:0016021;GO:0048471;GO:0005886;GO:0005524;GO:0016887;GO:0005388;GO:0015410;GO:0046872;GO:0008553;GO:0070588;GO:0006874;GO:0034220;GO:0061180;GO:0006828;GO:0090280;GO:0072659;, C:cytoplasmic side of plasma membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:manganese transmembrane transporter activity, phosphorylative mechanism; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:mammary gland epithelium development; P:manganese ion transport; P:positive regulation of calcium ion import; P:protein localization to plasma membrane;|O75185 B4DU76 E7ES94 Q5HYC3 Q5S053 Q68CQ2,Calcium-transporting ATPase type 2C member 2 {ECO:0000305},Secretory pathway Ca(2+)-ATPase 2;, PF00689;PF00690;, GO:0009898;GO:0031410;GO:0005783;GO:0000139;GO:0016021;GO:0048471;GO:0005886;GO:0005524;GO:0016887;GO:0005388;GO:0015410;GO:0046872;GO:0008553;GO:0070588;GO:0006874;GO:0034220;GO:0061180;GO:0006828;GO:0090280;GO:0072659;, C:cytoplasmic side of plasma membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:manganese transmembrane transporter activity, phosphorylative mechanism; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:mammary gland epithelium development; P:manganese ion transport; P:positive regulation of calcium ion import; P:protein localization to plasma membrane; scaffold16 indexed_genome mRNA 7117659 7138035 . - . ID=transcript_3978;Q6P9B6 Q8IZ64 Q9HCG3 Q9NTE8,MTOR-associated protein MEAK7 {ECO:0000305},MTOR associated protein, eak-7 homolog {ECO:0000312|HGNC:HGNC:29325};TBC/LysM-associated domain-containing protein 1;TLD domain-containing protein 1;, PF07534;, GO:0005737;GO:0005829;GO:0005765;GO:0016020;GO:0005730;GO:0005654;GO:1903204;GO:0150032;GO:0030334;GO:0042127;GO:0043200;GO:0032868;GO:0031667;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane; C:membrane; C:nucleolus; C:nucleoplasm;, , P:negative regulation of oxidative stress-induced neuron death; P:positive regulation of protein localization to lysosome; P:regulation of cell migration; P:regulation of cell population proliferation; P:response to amino acid; P:response to insulin; P:response to nutrient levels; P:TOR signaling;|Q6P9B6 Q8IZ64 Q9HCG3 Q9NTE8,MTOR-associated protein MEAK7 {ECO:0000305},MTOR associated protein, eak-7 homolog {ECO:0000312|HGNC:HGNC:29325};TBC/LysM-associated domain-containing protein 1;TLD domain-containing protein 1;, PF07534;, GO:0005737;GO:0005829;GO:0005765;GO:0016020;GO:0005730;GO:0005654;GO:1903204;GO:0150032;GO:0030334;GO:0042127;GO:0043200;GO:0032868;GO:0031667;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane; C:membrane; C:nucleolus; C:nucleoplasm;, , P:negative regulation of oxidative stress-induced neuron death; P:positive regulation of protein localization to lysosome; P:regulation of cell migration; P:regulation of cell population proliferation; P:response to amino acid; P:response to insulin; P:response to nutrient levels; P:TOR signaling;|Q6P9B6 Q8IZ64 Q9HCG3 Q9NTE8,MTOR-associated protein MEAK7 {ECO:0000305},MTOR associated protein, eak-7 homolog {ECO:0000312|HGNC:HGNC:29325};TBC/LysM-associated domain-containing protein 1;TLD domain-containing protein 1;, PF07534;, GO:0005737;GO:0005829;GO:0005765;GO:0016020;GO:0005730;GO:0005654;GO:1903204;GO:0150032;GO:0030334;GO:0042127;GO:0043200;GO:0032868;GO:0031667;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane; C:membrane; C:nucleolus; C:nucleoplasm;, , P:negative regulation of oxidative stress-induced neuron death; P:positive regulation of protein localization to lysosome; P:regulation of cell migration; P:regulation of cell population proliferation; P:response to amino acid; P:response to insulin; P:response to nutrient levels; P:TOR signaling; scaffold16 indexed_genome mRNA 7199203 7242411 . - . ID=transcript_3979;Q14019 B2RDU3 D3DUL9 Q86XM5,Coactosin-like protein,, PF00241;, GO:0030864;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0005886;GO:0034774;GO:0003779;GO:0051015;GO:0019899;GO:0050832;GO:0043312;GO:0030833;, C:cortical actin cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:plasma membrane; C:secretory granule lumen;, F:actin binding; F:actin filament binding; F:enzyme binding;, P:defense response to fungus; P:neutrophil degranulation; P:regulation of actin filament polymerization; scaffold16 indexed_genome mRNA 7269253 7272469 . + . ID=transcript_3980;Q8N4N3 Q8N5G6 Q9H9U6,Kelch-like protein 36,, PF07707;PF00651;PF01344;, GO:0097602;GO:0016567;, , F:cullin family protein binding;, P:protein ubiquitination;|Q8N4N3 Q8N5G6 Q9H9U6,Kelch-like protein 36,, PF07707;PF00651;PF01344;, GO:0097602;GO:0016567;, , F:cullin family protein binding;, P:protein ubiquitination; scaffold16 indexed_genome mRNA 7335629 7359265 . - . ID=transcript_3981;Q14694 B2RDJ8 B4DS84 Q9BWG7 Q9NSL7,Ubiquitin carboxyl-terminal hydrolase 10,Deubiquitinating enzyme 10;Ubiquitin thioesterase 10;Ubiquitin-specific-processing protease 10;, PF07145;PF00443;, GO:0005737;GO:0005829;GO:0005769;GO:0045111;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0044325;GO:0002039;GO:0003723;GO:0004843;GO:0006914;GO:0006974;GO:0071347;GO:0030330;GO:0043124;GO:0016579;GO:0010506;GO:0019985;GO:0006511;, C:cytoplasm; C:cytosol; C:early endosome; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:ion channel binding; F:p53 binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:protein deubiquitination; P:regulation of autophagy; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process;|Q14694 B2RDJ8 B4DS84 Q9BWG7 Q9NSL7,Ubiquitin carboxyl-terminal hydrolase 10,Deubiquitinating enzyme 10;Ubiquitin thioesterase 10;Ubiquitin-specific-processing protease 10;, PF07145;PF00443;, GO:0005737;GO:0005829;GO:0005769;GO:0045111;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0044325;GO:0002039;GO:0003723;GO:0004843;GO:0006914;GO:0006974;GO:0071347;GO:0030330;GO:0043124;GO:0016579;GO:0010506;GO:0019985;GO:0006511;, C:cytoplasm; C:cytosol; C:early endosome; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:ion channel binding; F:p53 binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:protein deubiquitination; P:regulation of autophagy; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process;|Q14694 B2RDJ8 B4DS84 Q9BWG7 Q9NSL7,Ubiquitin carboxyl-terminal hydrolase 10,Deubiquitinating enzyme 10;Ubiquitin thioesterase 10;Ubiquitin-specific-processing protease 10;, PF07145;PF00443;, GO:0005737;GO:0005829;GO:0005769;GO:0045111;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0044325;GO:0002039;GO:0003723;GO:0004843;GO:0006914;GO:0006974;GO:0071347;GO:0030330;GO:0043124;GO:0016579;GO:0010506;GO:0019985;GO:0006511;, C:cytoplasm; C:cytosol; C:early endosome; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:ion channel binding; F:p53 binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:protein deubiquitination; P:regulation of autophagy; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process;|Q14694 B2RDJ8 B4DS84 Q9BWG7 Q9NSL7,Ubiquitin carboxyl-terminal hydrolase 10,Deubiquitinating enzyme 10;Ubiquitin thioesterase 10;Ubiquitin-specific-processing protease 10;, PF07145;PF00443;, GO:0005737;GO:0005829;GO:0005769;GO:0045111;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0044325;GO:0002039;GO:0003723;GO:0004843;GO:0006914;GO:0006974;GO:0071347;GO:0030330;GO:0043124;GO:0016579;GO:0010506;GO:0019985;GO:0006511;, C:cytoplasm; C:cytosol; C:early endosome; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:ion channel binding; F:p53 binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:protein deubiquitination; P:regulation of autophagy; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process;|Q14694 B2RDJ8 B4DS84 Q9BWG7 Q9NSL7,Ubiquitin carboxyl-terminal hydrolase 10,Deubiquitinating enzyme 10;Ubiquitin thioesterase 10;Ubiquitin-specific-processing protease 10;, PF07145;PF00443;, GO:0005737;GO:0005829;GO:0005769;GO:0045111;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0044325;GO:0002039;GO:0003723;GO:0004843;GO:0006914;GO:0006974;GO:0071347;GO:0030330;GO:0043124;GO:0016579;GO:0010506;GO:0019985;GO:0006511;, C:cytoplasm; C:cytosol; C:early endosome; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:ion channel binding; F:p53 binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:protein deubiquitination; P:regulation of autophagy; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process;|Q14694 B2RDJ8 B4DS84 Q9BWG7 Q9NSL7,Ubiquitin carboxyl-terminal hydrolase 10,Deubiquitinating enzyme 10;Ubiquitin thioesterase 10;Ubiquitin-specific-processing protease 10;, PF07145;PF00443;, GO:0005737;GO:0005829;GO:0005769;GO:0045111;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0044325;GO:0002039;GO:0003723;GO:0004843;GO:0006914;GO:0006974;GO:0071347;GO:0030330;GO:0043124;GO:0016579;GO:0010506;GO:0019985;GO:0006511;, C:cytoplasm; C:cytosol; C:early endosome; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:ion channel binding; F:p53 binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:protein deubiquitination; P:regulation of autophagy; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process;|Q14694 B2RDJ8 B4DS84 Q9BWG7 Q9NSL7,Ubiquitin carboxyl-terminal hydrolase 10,Deubiquitinating enzyme 10;Ubiquitin thioesterase 10;Ubiquitin-specific-processing protease 10;, PF07145;PF00443;, GO:0005737;GO:0005829;GO:0005769;GO:0045111;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0044325;GO:0002039;GO:0003723;GO:0004843;GO:0006914;GO:0006974;GO:0071347;GO:0030330;GO:0043124;GO:0016579;GO:0010506;GO:0019985;GO:0006511;, C:cytoplasm; C:cytosol; C:early endosome; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:ion channel binding; F:p53 binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:protein deubiquitination; P:regulation of autophagy; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process;|Q14694 B2RDJ8 B4DS84 Q9BWG7 Q9NSL7,Ubiquitin carboxyl-terminal hydrolase 10,Deubiquitinating enzyme 10;Ubiquitin thioesterase 10;Ubiquitin-specific-processing protease 10;, PF07145;PF00443;, GO:0005737;GO:0005829;GO:0005769;GO:0045111;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0044325;GO:0002039;GO:0003723;GO:0004843;GO:0006914;GO:0006974;GO:0071347;GO:0030330;GO:0043124;GO:0016579;GO:0010506;GO:0019985;GO:0006511;, C:cytoplasm; C:cytosol; C:early endosome; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:ion channel binding; F:p53 binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:protein deubiquitination; P:regulation of autophagy; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process;|Q14694 B2RDJ8 B4DS84 Q9BWG7 Q9NSL7,Ubiquitin carboxyl-terminal hydrolase 10,Deubiquitinating enzyme 10;Ubiquitin thioesterase 10;Ubiquitin-specific-processing protease 10;, PF07145;PF00443;, GO:0005737;GO:0005829;GO:0005769;GO:0045111;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0044325;GO:0002039;GO:0003723;GO:0004843;GO:0006914;GO:0006974;GO:0071347;GO:0030330;GO:0043124;GO:0016579;GO:0010506;GO:0019985;GO:0006511;, C:cytoplasm; C:cytosol; C:early endosome; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:ion channel binding; F:p53 binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:DNA damage response, signal transduction by p53 class mediator; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:protein deubiquitination; P:regulation of autophagy; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process; scaffold16 indexed_genome mRNA 7408676 7443970 . + . ID=transcript_3982;Q9H0B8 D3DUM0 Q6P590 Q6UWH0 Q6UXC6 Q96IB1 Q96K61,Cysteine-rich secretory protein LCCL domain-containing 2,Cysteine-rich secretory protein 11;LCCL domain-containing cysteine-rich secretory protein 2;, PF00188;PF03815;, GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:1904813;GO:0034774;GO:0030133;GO:0005539;GO:0008201;GO:0030198;GO:0060325;GO:0030324;GO:0043312;, C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:secretory granule lumen; C:transport vesicle;, F:glycosaminoglycan binding; F:heparin binding;, P:extracellular matrix organization; P:face morphogenesis; P:lung development; P:neutrophil degranulation; scaffold16 indexed_genome mRNA 7520335 7522026 . - . ID=transcript_3983;Q9NXF8 D3DUM1 Q8WV42 Q9NVD8,Palmitoyltransferase ZDHHC7 {ECO:0000305},Acyltransferase ZDHHC7 {ECO:0000250|UniProtKB:Q91WU6};Zinc finger DHHC domain-containing protein 7 {ECO:0000312|HGNC:HGNC:18459};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0005654;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0044381;GO:0009895;GO:0018230;GO:0030859;GO:0018345;GO:0006612;GO:1902044;GO:0008277;GO:0150106;GO:1903076;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleoplasm;, F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity;, P:glucose import in response to insulin stimulus; P:negative regulation of catabolic process; P:peptidyl-L-cysteine S-palmitoylation; P:polarized epithelial cell differentiation; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of Fas signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of protein localization to cell-cell junction; P:regulation of protein localization to plasma membrane;|Q9NXF8 D3DUM1 Q8WV42 Q9NVD8,Palmitoyltransferase ZDHHC7 {ECO:0000305},Acyltransferase ZDHHC7 {ECO:0000250|UniProtKB:Q91WU6};Zinc finger DHHC domain-containing protein 7 {ECO:0000312|HGNC:HGNC:18459};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0005654;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0044381;GO:0009895;GO:0018230;GO:0030859;GO:0018345;GO:0006612;GO:1902044;GO:0008277;GO:0150106;GO:1903076;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleoplasm;, F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity;, P:glucose import in response to insulin stimulus; P:negative regulation of catabolic process; P:peptidyl-L-cysteine S-palmitoylation; P:polarized epithelial cell differentiation; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of Fas signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of protein localization to cell-cell junction; P:regulation of protein localization to plasma membrane; scaffold16 indexed_genome mRNA 7584435 7598737 . + . ID=transcript_3984;O60268 B4DSS5 D3DUM2 Q8N6G0,Uncharacterized protein KIAA0513,, , GO:0005737;, C:cytoplasm;|O60268 B4DSS5 D3DUM2 Q8N6G0,Uncharacterized protein KIAA0513,, , GO:0005737;, C:cytoplasm; scaffold16 indexed_genome mRNA 7598803 7600537 . - . ID=transcript_3985;O60268 B4DSS5 D3DUM2 Q8N6G0,Uncharacterized protein KIAA0513,, , GO:0005737;, C:cytoplasm; scaffold16 indexed_genome mRNA 8039587 8069805 . + . ID=transcript_3986;Q14687 D3DUM4 Q8IY61 Q96GA4 Q9BW09,Genetic suppressor element 1,, PF12540;|Q14687 D3DUM4 Q8IY61 Q96GA4 Q9BW09,Genetic suppressor element 1,, PF12540;|Q14687 D3DUM4 Q8IY61 Q96GA4 Q9BW09,Genetic suppressor element 1,, PF12540;|Q14687 D3DUM4 Q8IY61 Q96GA4 Q9BW09,Genetic suppressor element 1,, PF12540;|Q14687 D3DUM4 Q8IY61 Q96GA4 Q9BW09,Genetic suppressor element 1,, PF12540;|Q14687 D3DUM4 Q8IY61 Q96GA4 Q9BW09,Genetic suppressor element 1,, PF12540;|Q14687 D3DUM4 Q8IY61 Q96GA4 Q9BW09,Genetic suppressor element 1,, PF12540; scaffold16 indexed_genome mRNA 8171408 8182881 . - . ID=transcript_3987;O43402 C9JB21,ER membrane protein complex subunit 8,Neighbor of COX4;Protein FAM158B;, PF03665;, GO:0005737;GO:0005829;GO:0072546;GO:0016020;GO:0045050;GO:0071816;, C:cytoplasm; C:cytosol; C:EMC complex; C:membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|O43402 C9JB21,ER membrane protein complex subunit 8,Neighbor of COX4;Protein FAM158B;, PF03665;, GO:0005737;GO:0005829;GO:0072546;GO:0016020;GO:0045050;GO:0071816;, C:cytoplasm; C:cytosol; C:EMC complex; C:membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|O43402 C9JB21,ER membrane protein complex subunit 8,Neighbor of COX4;Protein FAM158B;, PF03665;, GO:0005737;GO:0005829;GO:0072546;GO:0016020;GO:0045050;GO:0071816;, C:cytoplasm; C:cytosol; C:EMC complex; C:membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane; scaffold16 indexed_genome mRNA 8187885 8195119 . + . ID=transcript_3988;P13073 B2R4J2 D3DUM7 Q6P666,Cytochrome c oxidase subunit 4 isoform 1, mitochondrial,Cytochrome c oxidase polypeptide IV;Cytochrome c oxidase subunit IV isoform 1;, PF02936;, GO:0005829;GO:0016021;GO:0016020;GO:0005743;GO:0005751;GO:0005739;GO:0005654;GO:0004129;GO:0006091;GO:0006123;GO:0007584;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen; P:response to nutrient;|P13073 B2R4J2 D3DUM7 Q6P666,Cytochrome c oxidase subunit 4 isoform 1, mitochondrial,Cytochrome c oxidase polypeptide IV;Cytochrome c oxidase subunit IV isoform 1;, PF02936;, GO:0005829;GO:0016021;GO:0016020;GO:0005743;GO:0005751;GO:0005739;GO:0005654;GO:0004129;GO:0006091;GO:0006123;GO:0007584;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen; P:response to nutrient;|P13073 B2R4J2 D3DUM7 Q6P666,Cytochrome c oxidase subunit 4 isoform 1, mitochondrial,Cytochrome c oxidase polypeptide IV;Cytochrome c oxidase subunit IV isoform 1;, PF02936;, GO:0005829;GO:0016021;GO:0016020;GO:0005743;GO:0005751;GO:0005739;GO:0005654;GO:0004129;GO:0006091;GO:0006123;GO:0007584;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen; P:response to nutrient; scaffold16 indexed_genome mRNA 8268549 8290092 . + . ID=transcript_3989;Q02556 A0AV82,Interferon regulatory factor 8 {ECO:0000305},Interferon consensus sequence-binding protein {ECO:0000303|PubMed:1460054};, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0006914;GO:0071346;GO:0071222;GO:0042742;GO:0042832;GO:0097028;GO:0002316;GO:0002314;GO:0006955;GO:0002376;GO:0060333;GO:0030099;GO:0000122;GO:0006909;GO:0002273;GO:0032729;GO:0032735;GO:0045944;GO:0006357;GO:0032479;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:autophagy; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:defense response to bacterium; P:defense response to protozoan; P:dendritic cell differentiation; P:follicular B cell differentiation; P:germinal center B cell differentiation; P:immune response; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:phagocytosis; P:plasmacytoid dendritic cell differentiation; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-12 production; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production; P:type I interferon signaling pathway;|Q02556 A0AV82,Interferon regulatory factor 8 {ECO:0000305},Interferon consensus sequence-binding protein {ECO:0000303|PubMed:1460054};, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0006914;GO:0071346;GO:0071222;GO:0042742;GO:0042832;GO:0097028;GO:0002316;GO:0002314;GO:0006955;GO:0002376;GO:0060333;GO:0030099;GO:0000122;GO:0006909;GO:0002273;GO:0032729;GO:0032735;GO:0045944;GO:0006357;GO:0032479;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:autophagy; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:defense response to bacterium; P:defense response to protozoan; P:dendritic cell differentiation; P:follicular B cell differentiation; P:germinal center B cell differentiation; P:immune response; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:phagocytosis; P:plasmacytoid dendritic cell differentiation; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-12 production; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production; P:type I interferon signaling pathway;|Q02556 A0AV82,Interferon regulatory factor 8 {ECO:0000305},Interferon consensus sequence-binding protein {ECO:0000303|PubMed:1460054};, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0006914;GO:0071346;GO:0071222;GO:0042742;GO:0042832;GO:0097028;GO:0002316;GO:0002314;GO:0006955;GO:0002376;GO:0060333;GO:0030099;GO:0000122;GO:0006909;GO:0002273;GO:0032729;GO:0032735;GO:0045944;GO:0006357;GO:0032479;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:autophagy; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:defense response to bacterium; P:defense response to protozoan; P:dendritic cell differentiation; P:follicular B cell differentiation; P:germinal center B cell differentiation; P:immune response; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:phagocytosis; P:plasmacytoid dendritic cell differentiation; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-12 production; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production; P:type I interferon signaling pathway; scaffold16 indexed_genome mRNA 8760028 8762636 . + . ID=transcript_3990;Q12946 B2RAF4 Q5FWE5,Forkhead box protein F1,Forkhead-related activator 1;Forkhead-related protein FKHL5;Forkhead-related transcription factor 1;, PF00250;, GO:0000785;GO:0005634;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0000977;GO:0043565;GO:0009887;GO:0001568;GO:0003214;GO:0098609;GO:0071345;GO:0071407;GO:0014822;GO:0007368;GO:0048565;GO:0097070;GO:0048557;GO:0048613;GO:0048617;GO:0003197;GO:0061030;GO:0060441;GO:0045198;GO:0030198;GO:0007507;GO:0001701;GO:0048371;GO:0048286;GO:0030324;GO:0060463;GO:0060426;GO:0090131;GO:0007494;GO:0001763;GO:0050728;GO:0043305;GO:0000122;GO:0031016;GO:0030335;GO:0010811;GO:0002053;GO:0045944;GO:0045893;GO:0006357;GO:0030323;GO:0060461;GO:0051145;GO:0007224;GO:0001756;GO:0060438;GO:0072189;GO:0001570;GO:0060841;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:animal organ morphogenesis; P:blood vessel development; P:cardiac left ventricle morphogenesis; P:cell-cell adhesion; P:cellular response to cytokine stimulus; P:cellular response to organic cyclic compound; P:detection of wounding; P:determination of left/right symmetry; P:digestive tract development; P:ductus arteriosus closure; P:embryonic digestive tract morphogenesis; P:embryonic ectodermal digestive tract morphogenesis; P:embryonic foregut morphogenesis; P:endocardial cushion development; P:epithelial cell differentiation involved in mammary gland alveolus development; P:epithelial tube branching involved in lung morphogenesis; P:establishment of epithelial cell apical/basal polarity; P:extracellular matrix organization; P:heart development; P:in utero embryonic development; P:lateral mesodermal cell differentiation; P:lung alveolus development; P:lung development; P:lung lobe morphogenesis; P:lung vasculature development; P:mesenchyme migration; P:midgut development; P:morphogenesis of a branching structure; P:negative regulation of inflammatory response; P:negative regulation of mast cell degranulation; P:negative regulation of transcription by RNA polymerase II; P:pancreas development; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:respiratory tube development; P:right lung morphogenesis; P:smooth muscle cell differentiation; P:smoothened signaling pathway; P:somitogenesis; P:trachea development; P:ureter development; P:vasculogenesis; P:venous blood vessel development; scaffold16 indexed_genome mRNA 8775340 8790859 . - . ID=transcript_3991;Q2M296 A8MQ77 B7ZLC0 B7ZLC2 D3DUM9 E9PAM1 Q9H878 Q9H954,Methenyltetrahydrofolate synthase domain-containing protein,, PF01812;PF00076;, GO:0005737;GO:0003723;, C:cytoplasm;, F:RNA binding;|Q2M296 A8MQ77 B7ZLC0 B7ZLC2 D3DUM9 E9PAM1 Q9H878 Q9H954,Methenyltetrahydrofolate synthase domain-containing protein,, PF01812;PF00076;, GO:0005737;GO:0003723;, C:cytoplasm;, F:RNA binding;|Q2M296 A8MQ77 B7ZLC0 B7ZLC2 D3DUM9 E9PAM1 Q9H878 Q9H954,Methenyltetrahydrofolate synthase domain-containing protein,, PF01812;PF00076;, GO:0005737;GO:0003723;, C:cytoplasm;, F:RNA binding;|Q2M296 A8MQ77 B7ZLC0 B7ZLC2 D3DUM9 E9PAM1 Q9H878 Q9H954,Methenyltetrahydrofolate synthase domain-containing protein,, PF01812;PF00076;, GO:0005737;GO:0003723;, C:cytoplasm;, F:RNA binding;|Q2M296 A8MQ77 B7ZLC0 B7ZLC2 D3DUM9 E9PAM1 Q9H878 Q9H954,Methenyltetrahydrofolate synthase domain-containing protein,, PF01812;PF00076;, GO:0005737;GO:0003723;, C:cytoplasm;, F:RNA binding; scaffold16 indexed_genome mRNA 9332797 9337345 . - . ID=transcript_3992;Q5XUX0 Q5K680 Q8WYV1 Q96D73 Q9UFV4,F-box only protein 31,, PF12937;, GO:0005813;GO:0005829;GO:0043025;GO:0019005;GO:0030332;GO:0031145;GO:0006974;GO:0031571;GO:0050775;GO:2001224;GO:0043687;GO:0000209;GO:0031146;, C:centrosome; C:cytosol; C:neuronal cell body; C:SCF ubiquitin ligase complex;, F:cyclin binding;, P:anaphase-promoting complex-dependent catabolic process; P:cellular response to DNA damage stimulus; P:mitotic G1 DNA damage checkpoint; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron migration; P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q5XUX0 Q5K680 Q8WYV1 Q96D73 Q9UFV4,F-box only protein 31,, PF12937;, GO:0005813;GO:0005829;GO:0043025;GO:0019005;GO:0030332;GO:0031145;GO:0006974;GO:0031571;GO:0050775;GO:2001224;GO:0043687;GO:0000209;GO:0031146;, C:centrosome; C:cytosol; C:neuronal cell body; C:SCF ubiquitin ligase complex;, F:cyclin binding;, P:anaphase-promoting complex-dependent catabolic process; P:cellular response to DNA damage stimulus; P:mitotic G1 DNA damage checkpoint; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron migration; P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold16 indexed_genome mRNA 9385152 9390505 . + . ID=transcript_3993;Q9GZQ8 Q6NW02,Microtubule-associated proteins 1A/1B light chain 3B {ECO:0000305},Autophagy-related protein LC3 B;Autophagy-related ubiquitin-like modifier LC3 B;MAP1 light chain 3-like protein 2;MAP1A/MAP1B light chain 3 B;Microtubule-associated protein 1 light chain 3 beta;, PF02991;, GO:0005776;GO:0000421;GO:0005930;GO:0031410;GO:0005829;GO:0012505;GO:0043231;GO:0005874;GO:0005739;GO:0031090;GO:0008017;GO:0031625;GO:0000045;GO:0097352;GO:0006914;GO:0000422;GO:0006995;GO:0009267;GO:0016236;GO:0000423;GO:0000425;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytoplasmic vesicle; C:cytosol; C:endomembrane system; C:intracellular membrane-bounded organelle; C:microtubule; C:mitochondrion; C:organelle membrane;, F:microtubule binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagosome maturation; P:autophagy; P:autophagy of mitochondrion; P:cellular response to nitrogen starvation; P:cellular response to starvation; P:macroautophagy; P:mitophagy; P:pexophagy;|Q9GZQ8 Q6NW02,Microtubule-associated proteins 1A/1B light chain 3B {ECO:0000305},Autophagy-related protein LC3 B;Autophagy-related ubiquitin-like modifier LC3 B;MAP1 light chain 3-like protein 2;MAP1A/MAP1B light chain 3 B;Microtubule-associated protein 1 light chain 3 beta;, PF02991;, GO:0005776;GO:0000421;GO:0005930;GO:0031410;GO:0005829;GO:0012505;GO:0043231;GO:0005874;GO:0005739;GO:0031090;GO:0008017;GO:0031625;GO:0000045;GO:0097352;GO:0006914;GO:0000422;GO:0006995;GO:0009267;GO:0016236;GO:0000423;GO:0000425;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytoplasmic vesicle; C:cytosol; C:endomembrane system; C:intracellular membrane-bounded organelle; C:microtubule; C:mitochondrion; C:organelle membrane;, F:microtubule binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagosome maturation; P:autophagy; P:autophagy of mitochondrion; P:cellular response to nitrogen starvation; P:cellular response to starvation; P:macroautophagy; P:mitophagy; P:pexophagy; scaffold16 indexed_genome mRNA 9390550 9403328 . - . ID=transcript_3994;Q8WYQ9 D3DUN1 O60324 Q3MJD8 Q9UFP0,Zinc finger CCHC domain-containing protein 14,BDG-29;, PF00098;, GO:0003676;GO:0035091;GO:0008270;, , F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding;|Q8WYQ9 D3DUN1 O60324 Q3MJD8 Q9UFP0,Zinc finger CCHC domain-containing protein 14,BDG-29;, PF00098;, GO:0003676;GO:0035091;GO:0008270;, , F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding;|Q8WYQ9 D3DUN1 O60324 Q3MJD8 Q9UFP0,Zinc finger CCHC domain-containing protein 14,BDG-29;, PF00098;, GO:0003676;GO:0035091;GO:0008270;, , F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding;|Q8WYQ9 D3DUN1 O60324 Q3MJD8 Q9UFP0,Zinc finger CCHC domain-containing protein 14,BDG-29;, PF00098;, GO:0003676;GO:0035091;GO:0008270;, , F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding;|Q8WYQ9 D3DUN1 O60324 Q3MJD8 Q9UFP0,Zinc finger CCHC domain-containing protein 14,BDG-29;, PF00098;, GO:0003676;GO:0035091;GO:0008270;, , F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding; scaffold16 indexed_genome mRNA 9403400 9441506 . - . ID=transcript_3995;Q8WYQ9 D3DUN1 O60324 Q3MJD8 Q9UFP0,Zinc finger CCHC domain-containing protein 14,BDG-29;, PF00098;, GO:0003676;GO:0035091;GO:0008270;, , F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding;|Q8WYQ9 D3DUN1 O60324 Q3MJD8 Q9UFP0,Zinc finger CCHC domain-containing protein 14,BDG-29;, PF00098;, GO:0003676;GO:0035091;GO:0008270;, , F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding; scaffold16 indexed_genome mRNA 9548101 9625187 . + . ID=transcript_3996;Q8WXH2 D3DUN2 Q8N471 Q9HDC3 Q9HDC4,Junctophilin-3,Junctophilin type 3;Trinucleotide repeat-containing gene 22 protein;, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0060402;GO:0035640;GO:0007612;GO:0040011;GO:0007613;GO:0050885;GO:0048168;GO:0060314;GO:0048167;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane;, , P:calcium ion transport into cytosol; P:exploration behavior; P:learning; P:locomotion; P:memory; P:neuromuscular process controlling balance; P:regulation of neuronal synaptic plasticity; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic plasticity;|Q8WXH2 D3DUN2 Q8N471 Q9HDC3 Q9HDC4,Junctophilin-3,Junctophilin type 3;Trinucleotide repeat-containing gene 22 protein;, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0060402;GO:0035640;GO:0007612;GO:0040011;GO:0007613;GO:0050885;GO:0048168;GO:0060314;GO:0048167;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane;, , P:calcium ion transport into cytosol; P:exploration behavior; P:learning; P:locomotion; P:memory; P:neuromuscular process controlling balance; P:regulation of neuronal synaptic plasticity; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic plasticity;|Q8WXH2 D3DUN2 Q8N471 Q9HDC3 Q9HDC4,Junctophilin-3,Junctophilin type 3;Trinucleotide repeat-containing gene 22 protein;, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0060402;GO:0035640;GO:0007612;GO:0040011;GO:0007613;GO:0050885;GO:0048168;GO:0060314;GO:0048167;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane;, , P:calcium ion transport into cytosol; P:exploration behavior; P:learning; P:locomotion; P:memory; P:neuromuscular process controlling balance; P:regulation of neuronal synaptic plasticity; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic plasticity;|Q8WXH2 D3DUN2 Q8N471 Q9HDC3 Q9HDC4,Junctophilin-3,Junctophilin type 3;Trinucleotide repeat-containing gene 22 protein;, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0060402;GO:0035640;GO:0007612;GO:0040011;GO:0007613;GO:0050885;GO:0048168;GO:0060314;GO:0048167;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane;, , P:calcium ion transport into cytosol; P:exploration behavior; P:learning; P:locomotion; P:memory; P:neuromuscular process controlling balance; P:regulation of neuronal synaptic plasticity; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic plasticity; scaffold16 indexed_genome mRNA 9628134 9659582 . - . ID=transcript_3997;Q8TBB5 D3DUN3 D3DUN4 D3DUN5 Q96F29 Q9BVN3,Kelch domain-containing protein 4,, PF07646;|Q8TBB5 D3DUN3 D3DUN4 D3DUN5 Q96F29 Q9BVN3,Kelch domain-containing protein 4,, PF07646;|Q8TBB5 D3DUN3 D3DUN4 D3DUN5 Q96F29 Q9BVN3,Kelch domain-containing protein 4,, PF07646; scaffold16 indexed_genome mRNA 9705483 9737215 . - . ID=transcript_3998;Q01650 Q8IV97 Q9UBN8 Q9UP15 Q9UQC0,Large neutral amino acids transporter small subunit 1,4F2 light chain;CD98 light chain;Integral membrane protein E16 {ECO:0000303|PubMed:9751058};L-type amino acid transporter 1 {ECO:0000303|PubMed:11557028};Solute carrier family 7 member 5;y+ system cationic amino acid transporter;, PF13520;, GO:1990184;GO:0016324;GO:0009925;GO:0016323;GO:0005829;GO:0098591;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0031528;GO:0005886;GO:0015171;GO:0015173;GO:0015179;GO:0015190;GO:0015196;GO:0015175;GO:0042605;GO:0015349;GO:0089718;GO:1902475;GO:1903801;GO:1904556;GO:0098713;GO:0050900;GO:0010629;GO:0015804;GO:0015823;GO:0002720;GO:0032729;GO:0032740;GO:0032753;GO:0070327;GO:0150104;GO:0042908;, C:amino acid transport complex; C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytosol; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:aromatic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:L-tryptophan transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity;, P:amino acid import across plasma membrane; P:L-alpha-amino acid transmembrane transport; P:L-leucine import across plasma membrane; P:L-tryptophan transmembrane transport; P:leucine import across plasma membrane; P:leukocyte migration; P:negative regulation of gene expression; P:neutral amino acid transport; P:phenylalanine transport; P:positive regulation of cytokine production involved in immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-4 production; P:thyroid hormone transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q01650 Q8IV97 Q9UBN8 Q9UP15 Q9UQC0,Large neutral amino acids transporter small subunit 1,4F2 light chain;CD98 light chain;Integral membrane protein E16 {ECO:0000303|PubMed:9751058};L-type amino acid transporter 1 {ECO:0000303|PubMed:11557028};Solute carrier family 7 member 5;y+ system cationic amino acid transporter;, PF13520;, GO:1990184;GO:0016324;GO:0009925;GO:0016323;GO:0005829;GO:0098591;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0031528;GO:0005886;GO:0015171;GO:0015173;GO:0015179;GO:0015190;GO:0015196;GO:0015175;GO:0042605;GO:0015349;GO:0089718;GO:1902475;GO:1903801;GO:1904556;GO:0098713;GO:0050900;GO:0010629;GO:0015804;GO:0015823;GO:0002720;GO:0032729;GO:0032740;GO:0032753;GO:0070327;GO:0150104;GO:0042908;, C:amino acid transport complex; C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytosol; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:aromatic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:L-tryptophan transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity;, P:amino acid import across plasma membrane; P:L-alpha-amino acid transmembrane transport; P:L-leucine import across plasma membrane; P:L-tryptophan transmembrane transport; P:leucine import across plasma membrane; P:leukocyte migration; P:negative regulation of gene expression; P:neutral amino acid transport; P:phenylalanine transport; P:positive regulation of cytokine production involved in immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-4 production; P:thyroid hormone transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q01650 Q8IV97 Q9UBN8 Q9UP15 Q9UQC0,Large neutral amino acids transporter small subunit 1,4F2 light chain;CD98 light chain;Integral membrane protein E16 {ECO:0000303|PubMed:9751058};L-type amino acid transporter 1 {ECO:0000303|PubMed:11557028};Solute carrier family 7 member 5;y+ system cationic amino acid transporter;, PF13520;, GO:1990184;GO:0016324;GO:0009925;GO:0016323;GO:0005829;GO:0098591;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0031528;GO:0005886;GO:0015171;GO:0015173;GO:0015179;GO:0015190;GO:0015196;GO:0015175;GO:0042605;GO:0015349;GO:0089718;GO:1902475;GO:1903801;GO:1904556;GO:0098713;GO:0050900;GO:0010629;GO:0015804;GO:0015823;GO:0002720;GO:0032729;GO:0032740;GO:0032753;GO:0070327;GO:0150104;GO:0042908;, C:amino acid transport complex; C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytosol; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:aromatic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:L-tryptophan transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity;, P:amino acid import across plasma membrane; P:L-alpha-amino acid transmembrane transport; P:L-leucine import across plasma membrane; P:L-tryptophan transmembrane transport; P:leucine import across plasma membrane; P:leukocyte migration; P:negative regulation of gene expression; P:neutral amino acid transport; P:phenylalanine transport; P:positive regulation of cytokine production involved in immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-4 production; P:thyroid hormone transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q01650 Q8IV97 Q9UBN8 Q9UP15 Q9UQC0,Large neutral amino acids transporter small subunit 1,4F2 light chain;CD98 light chain;Integral membrane protein E16 {ECO:0000303|PubMed:9751058};L-type amino acid transporter 1 {ECO:0000303|PubMed:11557028};Solute carrier family 7 member 5;y+ system cationic amino acid transporter;, PF13520;, GO:1990184;GO:0016324;GO:0009925;GO:0016323;GO:0005829;GO:0098591;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0031528;GO:0005886;GO:0015171;GO:0015173;GO:0015179;GO:0015190;GO:0015196;GO:0015175;GO:0042605;GO:0015349;GO:0089718;GO:1902475;GO:1903801;GO:1904556;GO:0098713;GO:0050900;GO:0010629;GO:0015804;GO:0015823;GO:0002720;GO:0032729;GO:0032740;GO:0032753;GO:0070327;GO:0150104;GO:0042908;, C:amino acid transport complex; C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytosol; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:aromatic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:L-tryptophan transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity;, P:amino acid import across plasma membrane; P:L-alpha-amino acid transmembrane transport; P:L-leucine import across plasma membrane; P:L-tryptophan transmembrane transport; P:leucine import across plasma membrane; P:leukocyte migration; P:negative regulation of gene expression; P:neutral amino acid transport; P:phenylalanine transport; P:positive regulation of cytokine production involved in immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-4 production; P:thyroid hormone transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q01650 Q8IV97 Q9UBN8 Q9UP15 Q9UQC0,Large neutral amino acids transporter small subunit 1,4F2 light chain;CD98 light chain;Integral membrane protein E16 {ECO:0000303|PubMed:9751058};L-type amino acid transporter 1 {ECO:0000303|PubMed:11557028};Solute carrier family 7 member 5;y+ system cationic amino acid transporter;, PF13520;, GO:1990184;GO:0016324;GO:0009925;GO:0016323;GO:0005829;GO:0098591;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0031528;GO:0005886;GO:0015171;GO:0015173;GO:0015179;GO:0015190;GO:0015196;GO:0015175;GO:0042605;GO:0015349;GO:0089718;GO:1902475;GO:1903801;GO:1904556;GO:0098713;GO:0050900;GO:0010629;GO:0015804;GO:0015823;GO:0002720;GO:0032729;GO:0032740;GO:0032753;GO:0070327;GO:0150104;GO:0042908;, C:amino acid transport complex; C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytosol; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:aromatic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:L-tryptophan transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity;, P:amino acid import across plasma membrane; P:L-alpha-amino acid transmembrane transport; P:L-leucine import across plasma membrane; P:L-tryptophan transmembrane transport; P:leucine import across plasma membrane; P:leukocyte migration; P:negative regulation of gene expression; P:neutral amino acid transport; P:phenylalanine transport; P:positive regulation of cytokine production involved in immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-4 production; P:thyroid hormone transport; P:transport across blood-brain barrier; P:xenobiotic transport; scaffold16 indexed_genome mRNA 9755209 9758004 . + . ID=transcript_3999;Q9Y2D0 A8K4T5,Carbonic anhydrase 5B, mitochondrial,Carbonate dehydratase VB;Carbonic anhydrase VB;, PF00194;, GO:0005737;GO:0005759;GO:0005739;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;GO:0009617;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process; P:response to bacterium;|P35218 B2RPF2,Carbonic anhydrase 5A, mitochondrial,Carbonate dehydratase VA;Carbonic anhydrase VA;, PF00194;, GO:0005737;GO:0005759;GO:0005739;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process; scaffold16 indexed_genome mRNA 9816212 9866777 . + . ID=transcript_4000;Q8N9N5 A8MU25 A8MX25 B2RCF7 B4DNJ9 F5GZM0 Q96GJ7 Q9NWY1,Protein BANP,BEN domain-containing protein 1;Btg3-associated nuclear protein;Scaffold/matrix-associated region-1-binding protein;, PF10523;, GO:0016604;GO:0005654;GO:0003677;GO:0042802;GO:0007049;GO:0006325;GO:0007275;GO:0042177;GO:0045893;GO:0034504;GO:1901796;, C:nuclear body; C:nucleoplasm;, F:DNA binding; F:identical protein binding;, P:cell cycle; P:chromatin organization; P:multicellular organism development; P:negative regulation of protein catabolic process; P:positive regulation of transcription, DNA-templated; P:protein localization to nucleus; P:regulation of signal transduction by p53 class mediator;|Q8N9N5 A8MU25 A8MX25 B2RCF7 B4DNJ9 F5GZM0 Q96GJ7 Q9NWY1,Protein BANP,BEN domain-containing protein 1;Btg3-associated nuclear protein;Scaffold/matrix-associated region-1-binding protein;, PF10523;, GO:0016604;GO:0005654;GO:0003677;GO:0042802;GO:0007049;GO:0006325;GO:0007275;GO:0042177;GO:0045893;GO:0034504;GO:1901796;, C:nuclear body; C:nucleoplasm;, F:DNA binding; F:identical protein binding;, P:cell cycle; P:chromatin organization; P:multicellular organism development; P:negative regulation of protein catabolic process; P:positive regulation of transcription, DNA-templated; P:protein localization to nucleus; P:regulation of signal transduction by p53 class mediator;|Q8N9N5 A8MU25 A8MX25 B2RCF7 B4DNJ9 F5GZM0 Q96GJ7 Q9NWY1,Protein BANP,BEN domain-containing protein 1;Btg3-associated nuclear protein;Scaffold/matrix-associated region-1-binding protein;, PF10523;, GO:0016604;GO:0005654;GO:0003677;GO:0042802;GO:0007049;GO:0006325;GO:0007275;GO:0042177;GO:0045893;GO:0034504;GO:1901796;, C:nuclear body; C:nucleoplasm;, F:DNA binding; F:identical protein binding;, P:cell cycle; P:chromatin organization; P:multicellular organism development; P:negative regulation of protein catabolic process; P:positive regulation of transcription, DNA-templated; P:protein localization to nucleus; P:regulation of signal transduction by p53 class mediator;|Q8N9N5 A8MU25 A8MX25 B2RCF7 B4DNJ9 F5GZM0 Q96GJ7 Q9NWY1,Protein BANP,BEN domain-containing protein 1;Btg3-associated nuclear protein;Scaffold/matrix-associated region-1-binding protein;, PF10523;, GO:0016604;GO:0005654;GO:0003677;GO:0042802;GO:0007049;GO:0006325;GO:0007275;GO:0042177;GO:0045893;GO:0034504;GO:1901796;, C:nuclear body; C:nucleoplasm;, F:DNA binding; F:identical protein binding;, P:cell cycle; P:chromatin organization; P:multicellular organism development; P:negative regulation of protein catabolic process; P:positive regulation of transcription, DNA-templated; P:protein localization to nucleus; P:regulation of signal transduction by p53 class mediator;|Q8N9N5 A8MU25 A8MX25 B2RCF7 B4DNJ9 F5GZM0 Q96GJ7 Q9NWY1,Protein BANP,BEN domain-containing protein 1;Btg3-associated nuclear protein;Scaffold/matrix-associated region-1-binding protein;, PF10523;, GO:0016604;GO:0005654;GO:0003677;GO:0042802;GO:0007049;GO:0006325;GO:0007275;GO:0042177;GO:0045893;GO:0034504;GO:1901796;, C:nuclear body; C:nucleoplasm;, F:DNA binding; F:identical protein binding;, P:cell cycle; P:chromatin organization; P:multicellular organism development; P:negative regulation of protein catabolic process; P:positive regulation of transcription, DNA-templated; P:protein localization to nucleus; P:regulation of signal transduction by p53 class mediator; scaffold16 indexed_genome mRNA 10195627 10196534 . + . ID=transcript_4001;Q8IX07,Zinc finger protein ZFPM1,Friend of GATA protein 1;Zinc finger protein 89A;Zinc finger protein multitype 1;, PF00096;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0017053;GO:0003677;GO:0046872;GO:0001102;GO:0001085;GO:0003714;GO:0008134;GO:0060413;GO:0003181;GO:0007596;GO:0055008;GO:0030154;GO:0060318;GO:0035162;GO:0030218;GO:0030851;GO:0007507;GO:0035855;GO:0030219;GO:0003192;GO:0045599;GO:0032713;GO:0060377;GO:0032091;GO:0000122;GO:0003151;GO:0030220;GO:0032729;GO:0045944;GO:0060319;GO:0032642;GO:0010724;GO:0045652;GO:0002295;GO:0071733;GO:0003195;GO:0060412;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex; C:transcription repressor complex;, F:DNA binding; F:metal ion binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:atrial septum morphogenesis; P:atrioventricular valve morphogenesis; P:blood coagulation; P:cardiac muscle tissue morphogenesis; P:cell differentiation; P:definitive erythrocyte differentiation; P:embryonic hemopoiesis; P:erythrocyte differentiation; P:granulocyte differentiation; P:heart development; P:megakaryocyte development; P:megakaryocyte differentiation; P:mitral valve formation; P:negative regulation of fat cell differentiation; P:negative regulation of interleukin-4 production; P:negative regulation of mast cell differentiation; P:negative regulation of protein binding; P:negative regulation of transcription by RNA polymerase II; P:outflow tract morphogenesis; P:platelet formation; P:positive regulation of interferon-gamma production; P:positive regulation of transcription by RNA polymerase II; P:primitive erythrocyte differentiation; P:regulation of chemokine production; P:regulation of definitive erythrocyte differentiation; P:regulation of megakaryocyte differentiation; P:T-helper cell lineage commitment; P:transcriptional activation by promoter-enhancer looping; P:tricuspid valve formation; P:ventricular septum morphogenesis; scaffold16 indexed_genome mRNA 10264909 10306565 . + . ID=transcript_4002;Q86VM9 Q96DG4 Q96MP7,Zinc finger CCCH domain-containing protein 18 {ECO:0000305},Nuclear protein NHN1;, PF18044;, GO:0016607;GO:0032991;GO:0046872;GO:0003723;, C:nuclear speck; C:protein-containing complex;, F:metal ion binding; F:RNA binding; scaffold16 indexed_genome mRNA 10315057 10322032 . - . ID=transcript_4003;P13498 Q14090 Q9BR72,Cytochrome b-245 light chain,Cytochrome b(558) alpha chain;Cytochrome b558 subunit alpha;Neutrophil cytochrome b 22 kDa polypeptide;Superoxide-generating NADPH oxidase light chain subunit;p22 phagocyte B-cytochrome;p22-phox;, PF05038;, GO:0005789;GO:0016020;GO:0043020;GO:0030670;GO:0005886;GO:0030141;GO:0035579;GO:0070821;GO:0009055;GO:0020037;GO:0046872;GO:0046982;GO:0017124;GO:0002479;GO:0045454;GO:0034599;GO:0017004;GO:0050665;GO:0006954;GO:0045087;GO:0043312;GO:0031343;GO:1900426;GO:0032755;GO:0050766;GO:1903428;GO:0034137;GO:0032760;GO:0045730;GO:0014895;GO:0042554;GO:0006801;GO:0048010;, C:endoplasmic reticulum membrane; C:membrane; C:NADPH oxidase complex; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule; C:specific granule membrane; C:tertiary granule membrane;, F:electron transfer activity; F:heme binding; F:metal ion binding; F:protein heterodimerization activity; F:SH3 domain binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell redox homeostasis; P:cellular response to oxidative stress; P:cytochrome complex assembly; P:hydrogen peroxide biosynthetic process; P:inflammatory response; P:innate immune response; P:neutrophil degranulation; P:positive regulation of cell killing; P:positive regulation of defense response to bacterium; P:positive regulation of interleukin-6 production; P:positive regulation of phagocytosis; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of toll-like receptor 2 signaling pathway; P:positive regulation of tumor necrosis factor production; P:respiratory burst; P:smooth muscle hypertrophy; P:superoxide anion generation; P:superoxide metabolic process; P:vascular endothelial growth factor receptor signaling pathway; scaffold16 indexed_genome mRNA 10322711 10329256 . - . ID=transcript_4004;P53602 Q53Y65,Diphosphomevalonate decarboxylase,Mevalonate (diphospho)decarboxylase;Mevalonate pyrophosphate decarboxylase;, PF00288;PF18376;, GO:0005829;GO:0005524;GO:0004163;GO:0030544;GO:0042803;GO:0006695;GO:0006489;GO:0019287;GO:0008299;GO:0008284;GO:0019216;, C:cytosol;, F:ATP binding; F:diphosphomevalonate decarboxylase activity; F:Hsp70 protein binding; F:protein homodimerization activity;, P:cholesterol biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:isoprenoid biosynthetic process; P:positive regulation of cell population proliferation; P:regulation of lipid metabolic process;|P53602 Q53Y65,Diphosphomevalonate decarboxylase,Mevalonate (diphospho)decarboxylase;Mevalonate pyrophosphate decarboxylase;, PF00288;PF18376;, GO:0005829;GO:0005524;GO:0004163;GO:0030544;GO:0042803;GO:0006695;GO:0006489;GO:0019287;GO:0008299;GO:0008284;GO:0019216;, C:cytosol;, F:ATP binding; F:diphosphomevalonate decarboxylase activity; F:Hsp70 protein binding; F:protein homodimerization activity;, P:cholesterol biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:isoprenoid biosynthetic process; P:positive regulation of cell population proliferation; P:regulation of lipid metabolic process; scaffold16 indexed_genome mRNA 10340260 10345111 . - . ID=transcript_4005;Q3KNW1 Q86SU5,Zinc finger protein SNAI3,Protein snail homolog 3;Zinc finger protein 293;, PF00096;, GO:0005634;GO:0005667;GO:0005507;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0006355;, C:nucleus; C:transcription regulator complex;, F:copper ion binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription, DNA-templated; scaffold16 indexed_genome mRNA 10357475 10400278 . - . ID=transcript_4006;Q96A37 B3KQ03 D3DX75 H3BTU8 Q96DM0,E3 ubiquitin-protein ligase RNF166 {ECO:0000303|PubMed:27880896},RING finger protein 166;RING-type E3 ubiquitin transferase RNF166 {ECO:0000305};, PF05605;PF18574;, GO:0005737;GO:0046872;GO:0061630;GO:0006914;GO:0045087;GO:0000209;GO:0006511;, C:cytoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:autophagy; P:innate immune response; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96A37 B3KQ03 D3DX75 H3BTU8 Q96DM0,E3 ubiquitin-protein ligase RNF166 {ECO:0000303|PubMed:27880896},RING finger protein 166;RING-type E3 ubiquitin transferase RNF166 {ECO:0000305};, PF05605;PF18574;, GO:0005737;GO:0046872;GO:0061630;GO:0006914;GO:0045087;GO:0000209;GO:0006511;, C:cytoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:autophagy; P:innate immune response; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96A37 B3KQ03 D3DX75 H3BTU8 Q96DM0,E3 ubiquitin-protein ligase RNF166 {ECO:0000303|PubMed:27880896},RING finger protein 166;RING-type E3 ubiquitin transferase RNF166 {ECO:0000305};, PF05605;PF18574;, GO:0005737;GO:0046872;GO:0061630;GO:0006914;GO:0045087;GO:0000209;GO:0006511;, C:cytoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:autophagy; P:innate immune response; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q2VPK5 B2RXK0 Q0P511 Q66K78 Q6P4C8 Q86SV4,Cytoplasmic tRNA 2-thiolation protein 2 {ECO:0000255|HAMAP-Rule:MF_03054},Cytosolic thiouridylase subunit 2;, PF10288;, GO:0005829;GO:0032991;GO:0016779;GO:0016783;GO:0000049;GO:0032447;GO:0006400;GO:0034227;GO:0002143;GO:0002098;, C:cytosol; C:protein-containing complex;, F:nucleotidyltransferase activity; F:sulfurtransferase activity; F:tRNA binding;, P:protein urmylation; P:tRNA modification; P:tRNA thio-modification; P:tRNA wobble position uridine thiolation; P:tRNA wobble uridine modification;|Q92508 A6NHT9 A7E2B7 Q0KKZ9,Piezo-type mechanosensitive ion channel component 1,Membrane protein induced by beta-amyloid treatment;Protein FAM38A;, PF15917;PF12166;, GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0031258;GO:0016020;GO:0005886;GO:0005261;GO:0008381;GO:0006812;GO:0071260;GO:0050982;GO:0033634;GO:0033625;GO:0010831;GO:0042391;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lamellipodium membrane; C:membrane; C:plasma membrane;, F:cation channel activity; F:mechanosensitive ion channel activity;, P:cation transport; P:cellular response to mechanical stimulus; P:detection of mechanical stimulus; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of integrin activation; P:positive regulation of myotube differentiation; P:regulation of membrane potential;|Q92508 A6NHT9 A7E2B7 Q0KKZ9,Piezo-type mechanosensitive ion channel component 1,Membrane protein induced by beta-amyloid treatment;Protein FAM38A;, PF15917;PF12166;, GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0031258;GO:0016020;GO:0005886;GO:0005261;GO:0008381;GO:0006812;GO:0071260;GO:0050982;GO:0033634;GO:0033625;GO:0010831;GO:0042391;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lamellipodium membrane; C:membrane; C:plasma membrane;, F:cation channel activity; F:mechanosensitive ion channel activity;, P:cation transport; P:cellular response to mechanical stimulus; P:detection of mechanical stimulus; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of integrin activation; P:positive regulation of myotube differentiation; P:regulation of membrane potential;|Q92508 A6NHT9 A7E2B7 Q0KKZ9,Piezo-type mechanosensitive ion channel component 1,Membrane protein induced by beta-amyloid treatment;Protein FAM38A;, PF15917;PF12166;, GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0031258;GO:0016020;GO:0005886;GO:0005261;GO:0008381;GO:0006812;GO:0071260;GO:0050982;GO:0033634;GO:0033625;GO:0010831;GO:0042391;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lamellipodium membrane; C:membrane; C:plasma membrane;, F:cation channel activity; F:mechanosensitive ion channel activity;, P:cation transport; P:cellular response to mechanical stimulus; P:detection of mechanical stimulus; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of integrin activation; P:positive regulation of myotube differentiation; P:regulation of membrane potential;|Q92508 A6NHT9 A7E2B7 Q0KKZ9,Piezo-type mechanosensitive ion channel component 1,Membrane protein induced by beta-amyloid treatment;Protein FAM38A;, PF15917;PF12166;, GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0031258;GO:0016020;GO:0005886;GO:0005261;GO:0008381;GO:0006812;GO:0071260;GO:0050982;GO:0033634;GO:0033625;GO:0010831;GO:0042391;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lamellipodium membrane; C:membrane; C:plasma membrane;, F:cation channel activity; F:mechanosensitive ion channel activity;, P:cation transport; P:cellular response to mechanical stimulus; P:detection of mechanical stimulus; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of integrin activation; P:positive regulation of myotube differentiation; P:regulation of membrane potential;|Q92508 A6NHT9 A7E2B7 Q0KKZ9,Piezo-type mechanosensitive ion channel component 1,Membrane protein induced by beta-amyloid treatment;Protein FAM38A;, PF15917;PF12166;, GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0031258;GO:0016020;GO:0005886;GO:0005261;GO:0008381;GO:0006812;GO:0071260;GO:0050982;GO:0033634;GO:0033625;GO:0010831;GO:0042391;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lamellipodium membrane; C:membrane; C:plasma membrane;, F:cation channel activity; F:mechanosensitive ion channel activity;, P:cation transport; P:cellular response to mechanical stimulus; P:detection of mechanical stimulus; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of integrin activation; P:positive regulation of myotube differentiation; P:regulation of membrane potential;|Q9H5I5 B7Z812 M4GPJ9 Q6ZS91 Q8N787 Q8NAR6 Q9H5R4,Piezo-type mechanosensitive ion channel component 2,Protein FAM38B;, PF15917;PF12166;, GO:0016021;GO:0016020;GO:0005886;GO:0005261;GO:0008381;GO:0006812;GO:0071260;GO:0050982;GO:0050974;GO:0042391;GO:0009612;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:cation channel activity; F:mechanosensitive ion channel activity;, P:cation transport; P:cellular response to mechanical stimulus; P:detection of mechanical stimulus; P:detection of mechanical stimulus involved in sensory perception; P:regulation of membrane potential; P:response to mechanical stimulus;|Q92508 A6NHT9 A7E2B7 Q0KKZ9,Piezo-type mechanosensitive ion channel component 1,Membrane protein induced by beta-amyloid treatment;Protein FAM38A;, PF15917;PF12166;, GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0031258;GO:0016020;GO:0005886;GO:0005261;GO:0008381;GO:0006812;GO:0071260;GO:0050982;GO:0033634;GO:0033625;GO:0010831;GO:0042391;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lamellipodium membrane; C:membrane; C:plasma membrane;, F:cation channel activity; F:mechanosensitive ion channel activity;, P:cation transport; P:cellular response to mechanical stimulus; P:detection of mechanical stimulus; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of integrin activation; P:positive regulation of myotube differentiation; P:regulation of membrane potential;|Q92508 A6NHT9 A7E2B7 Q0KKZ9,Piezo-type mechanosensitive ion channel component 1,Membrane protein induced by beta-amyloid treatment;Protein FAM38A;, PF15917;PF12166;, GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0031258;GO:0016020;GO:0005886;GO:0005261;GO:0008381;GO:0006812;GO:0071260;GO:0050982;GO:0033634;GO:0033625;GO:0010831;GO:0042391;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lamellipodium membrane; C:membrane; C:plasma membrane;, F:cation channel activity; F:mechanosensitive ion channel activity;, P:cation transport; P:cellular response to mechanical stimulus; P:detection of mechanical stimulus; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of integrin activation; P:positive regulation of myotube differentiation; P:regulation of membrane potential; scaffold16 indexed_genome mRNA 10442341 10444673 . + . ID=transcript_4007;Q9H211 Q86XX9 Q96CJ5 Q96GK5 Q96H67 Q96HE6 Q9BWM0,DNA replication factor Cdt1,Double parked homolog;, PF08839;PF16679;, GO:0000777;GO:0005829;GO:0000776;GO:0016604;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0070182;GO:0051315;GO:0051301;GO:0007059;GO:1902426;GO:0000076;GO:0006270;GO:0071163;GO:0051383;GO:0000278;GO:1905341;GO:0035563;GO:0045740;GO:2000105;GO:1905342;GO:0031334;GO:0036388;GO:0033044;GO:1902595;GO:0030174;GO:0033262;GO:0000083;GO:0072708;, C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:nuclear body; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA polymerase binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:deactivation of mitotic spindle assembly checkpoint; P:DNA replication checkpoint; P:DNA replication initiation; P:DNA replication preinitiation complex assembly; P:kinetochore organization; P:mitotic cell cycle; P:negative regulation of protein localization to kinetochore; P:positive regulation of chromatin binding; P:positive regulation of DNA replication; P:positive regulation of DNA-dependent DNA replication; P:positive regulation of protein localization to kinetochore; P:positive regulation of protein-containing complex assembly; P:pre-replicative complex assembly; P:regulation of chromosome organization; P:regulation of DNA replication origin binding; P:regulation of DNA-dependent DNA replication initiation; P:regulation of nuclear cell cycle DNA replication; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:response to sorbitol; scaffold16 indexed_genome mRNA 10445421 10447011 . - . ID=transcript_4008;P07741 G5E9J2 Q3KP55 Q68DF9,Adenine phosphoribosyltransferase,, PF00156;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0034774;GO:0002055;GO:0003999;GO:0016208;GO:0006168;GO:0044209;GO:0032869;GO:0007625;GO:0007595;GO:0043312;GO:0006166;GO:0043101;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:secretory granule lumen;, F:adenine binding; F:adenine phosphoribosyltransferase activity; F:AMP binding;, P:adenine salvage; P:AMP salvage; P:cellular response to insulin stimulus; P:grooming behavior; P:lactation; P:neutrophil degranulation; P:purine ribonucleoside salvage; P:purine-containing compound salvage; scaffold16 indexed_genome mRNA 10448616 10474696 . - . ID=transcript_4009;P34059 Q86VK3,N-acetylgalactosamine-6-sulfatase,Chondroitinsulfatase;Galactose-6-sulfate sulfatase;N-acetylgalactosamine-6-sulfate sulfatase;, PF00884;, GO:0035578;GO:0070062;GO:0005576;GO:0043202;GO:0004065;GO:0046872;GO:0003943;GO:0043890;GO:0008484;GO:0042340;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:lysosomal lumen;, F:arylsulfatase activity; F:metal ion binding; F:N-acetylgalactosamine-4-sulfatase activity; F:N-acetylgalactosamine-6-sulfatase activity; F:sulfuric ester hydrolase activity;, P:keratan sulfate catabolic process; P:neutrophil degranulation;|P34059 Q86VK3,N-acetylgalactosamine-6-sulfatase,Chondroitinsulfatase;Galactose-6-sulfate sulfatase;N-acetylgalactosamine-6-sulfate sulfatase;, PF00884;, GO:0035578;GO:0070062;GO:0005576;GO:0043202;GO:0004065;GO:0046872;GO:0003943;GO:0043890;GO:0008484;GO:0042340;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:lysosomal lumen;, F:arylsulfatase activity; F:metal ion binding; F:N-acetylgalactosamine-4-sulfatase activity; F:N-acetylgalactosamine-6-sulfatase activity; F:sulfuric ester hydrolase activity;, P:keratan sulfate catabolic process; P:neutrophil degranulation;|P34059 Q86VK3,N-acetylgalactosamine-6-sulfatase,Chondroitinsulfatase;Galactose-6-sulfate sulfatase;N-acetylgalactosamine-6-sulfate sulfatase;, PF00884;, GO:0035578;GO:0070062;GO:0005576;GO:0043202;GO:0004065;GO:0046872;GO:0003943;GO:0043890;GO:0008484;GO:0042340;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:lysosomal lumen;, F:arylsulfatase activity; F:metal ion binding; F:N-acetylgalactosamine-4-sulfatase activity; F:N-acetylgalactosamine-6-sulfatase activity; F:sulfuric ester hydrolase activity;, P:keratan sulfate catabolic process; P:neutrophil degranulation;|P34059 Q86VK3,N-acetylgalactosamine-6-sulfatase,Chondroitinsulfatase;Galactose-6-sulfate sulfatase;N-acetylgalactosamine-6-sulfate sulfatase;, PF00884;, GO:0035578;GO:0070062;GO:0005576;GO:0043202;GO:0004065;GO:0046872;GO:0003943;GO:0043890;GO:0008484;GO:0042340;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:lysosomal lumen;, F:arylsulfatase activity; F:metal ion binding; F:N-acetylgalactosamine-4-sulfatase activity; F:N-acetylgalactosamine-6-sulfatase activity; F:sulfuric ester hydrolase activity;, P:keratan sulfate catabolic process; P:neutrophil degranulation;|Q9UL33 B2R4M9 Q6ZTA7 Q9NZZ4,Trafficking protein particle complex subunit 2-like protein,, PF04628;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0043231;GO:0005634;GO:0048471;GO:0030008;GO:0048208;GO:0006888;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q9UL33 B2R4M9 Q6ZTA7 Q9NZZ4,Trafficking protein particle complex subunit 2-like protein,, PF04628;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0043231;GO:0005634;GO:0048471;GO:0030008;GO:0048208;GO:0006888;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q9UL33 B2R4M9 Q6ZTA7 Q9NZZ4,Trafficking protein particle complex subunit 2-like protein,, PF04628;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0043231;GO:0005634;GO:0048471;GO:0030008;GO:0048208;GO:0006888;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; scaffold16 indexed_genome mRNA 10479106 10493100 . - . ID=transcript_4010;Q6P5W6,Protein CBFA2T3,MTG8-related protein 2;Myeloid translocation gene on chromosome 16 protein;Zinc finger MYND domain-containing protein 4;, PF08788;PF07531;PF01753;, GO:0000139;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0003714;GO:0030851;GO:0008285;GO:0045820;GO:0045892;GO:0032436;GO:1903715;GO:0001666;GO:0006351;, C:Golgi membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:transcription corepressor activity;, P:granulocyte differentiation; P:negative regulation of cell population proliferation; P:negative regulation of glycolytic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of aerobic respiration; P:response to hypoxia; P:transcription, DNA-templated;|Q6P5W6,Protein CBFA2T3,MTG8-related protein 2;Myeloid translocation gene on chromosome 16 protein;Zinc finger MYND domain-containing protein 4;, PF08788;PF07531;PF01753;, GO:0000139;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0003714;GO:0030851;GO:0008285;GO:0045820;GO:0045892;GO:0032436;GO:1903715;GO:0001666;GO:0006351;, C:Golgi membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:transcription corepressor activity;, P:granulocyte differentiation; P:negative regulation of cell population proliferation; P:negative regulation of glycolytic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of aerobic respiration; P:response to hypoxia; P:transcription, DNA-templated; scaffold16 indexed_genome mRNA 10493288 10493941 . - . ID=transcript_4011;Q6P5W6,Protein CBFA2T3,MTG8-related protein 2;Myeloid translocation gene on chromosome 16 protein;Zinc finger MYND domain-containing protein 4;, PF08788;PF07531;PF01753;, GO:0000139;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0003714;GO:0030851;GO:0008285;GO:0045820;GO:0045892;GO:0032436;GO:1903715;GO:0001666;GO:0006351;, C:Golgi membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:transcription corepressor activity;, P:granulocyte differentiation; P:negative regulation of cell population proliferation; P:negative regulation of glycolytic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of aerobic respiration; P:response to hypoxia; P:transcription, DNA-templated; scaffold16 indexed_genome mRNA 10634665 10674944 . + . ID=transcript_4012;Q4G176 A8K4J8 C9JQL6 Q6INA0 Q8N2F7,Malonate--CoA ligase ACSF3, mitochondrial {ECO:0000305},Acyl-CoA synthetase family member 3;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0016878;GO:0005524;GO:0016405;GO:0090409;GO:0031957;GO:0006633;GO:0006631;GO:0035338;GO:0090410;, C:mitochondrial matrix; C:mitochondrion;, F:acid-thiol ligase activity; F:ATP binding; F:CoA-ligase activity; F:malonyl-CoA synthetase activity; F:very long-chain fatty acid-CoA ligase activity;, P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:malonate catabolic process;|Q4G176 A8K4J8 C9JQL6 Q6INA0 Q8N2F7,Malonate--CoA ligase ACSF3, mitochondrial {ECO:0000305},Acyl-CoA synthetase family member 3;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0016878;GO:0005524;GO:0016405;GO:0090409;GO:0031957;GO:0006633;GO:0006631;GO:0035338;GO:0090410;, C:mitochondrial matrix; C:mitochondrion;, F:acid-thiol ligase activity; F:ATP binding; F:CoA-ligase activity; F:malonyl-CoA synthetase activity; F:very long-chain fatty acid-CoA ligase activity;, P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:malonate catabolic process;|Q4G176 A8K4J8 C9JQL6 Q6INA0 Q8N2F7,Malonate--CoA ligase ACSF3, mitochondrial {ECO:0000305},Acyl-CoA synthetase family member 3;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0016878;GO:0005524;GO:0016405;GO:0090409;GO:0031957;GO:0006633;GO:0006631;GO:0035338;GO:0090410;, C:mitochondrial matrix; C:mitochondrion;, F:acid-thiol ligase activity; F:ATP binding; F:CoA-ligase activity; F:malonyl-CoA synthetase activity; F:very long-chain fatty acid-CoA ligase activity;, P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:malonate catabolic process;|Q4G176 A8K4J8 C9JQL6 Q6INA0 Q8N2F7,Malonate--CoA ligase ACSF3, mitochondrial {ECO:0000305},Acyl-CoA synthetase family member 3;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0016878;GO:0005524;GO:0016405;GO:0090409;GO:0031957;GO:0006633;GO:0006631;GO:0035338;GO:0090410;, C:mitochondrial matrix; C:mitochondrion;, F:acid-thiol ligase activity; F:ATP binding; F:CoA-ligase activity; F:malonyl-CoA synthetase activity; F:very long-chain fatty acid-CoA ligase activity;, P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:malonate catabolic process; scaffold16 indexed_genome mRNA 10684870 10704910 . + . ID=transcript_4013;P55291,Cadherin-15,Cadherin-14;Muscle cadherin;, PF00028;PF01049;, GO:0016342;GO:0005901;GO:0070062;GO:0005794;GO:0016021;GO:0031594;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0007155;GO:0098742;GO:0007156;GO:0051149;, C:catenin complex; C:caveola; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:neuromuscular junction; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of muscle cell differentiation;|P55291,Cadherin-15,Cadherin-14;Muscle cadherin;, PF00028;PF01049;, GO:0016342;GO:0005901;GO:0070062;GO:0005794;GO:0016021;GO:0031594;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0007155;GO:0098742;GO:0007156;GO:0051149;, C:catenin complex; C:caveola; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:neuromuscular junction; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of muscle cell differentiation;|P55291,Cadherin-15,Cadherin-14;Muscle cadherin;, PF00028;PF01049;, GO:0016342;GO:0005901;GO:0070062;GO:0005794;GO:0016021;GO:0031594;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0007155;GO:0098742;GO:0007156;GO:0051149;, C:catenin complex; C:caveola; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:neuromuscular junction; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of muscle cell differentiation; scaffold16 indexed_genome mRNA 10705428 10710147 . - . ID=transcript_4014;A6NKX4 S4R3Q8,Putative solute carrier family 22 member 31 {ECO:0000305},, PF00083;, GO:0016021;GO:0022857;GO:0006811;, C:integral component of membrane;, F:transmembrane transporter activity;, P:ion transport;|A6NKX4 S4R3Q8,Putative solute carrier family 22 member 31 {ECO:0000305},, PF00083;, GO:0016021;GO:0022857;GO:0006811;, C:integral component of membrane;, F:transmembrane transporter activity;, P:ion transport;|A6NKX4 S4R3Q8,Putative solute carrier family 22 member 31 {ECO:0000305},, PF00083;, GO:0016021;GO:0022857;GO:0006811;, C:integral component of membrane;, F:transmembrane transporter activity;, P:ion transport;|A6NKX4 S4R3Q8,Putative solute carrier family 22 member 31 {ECO:0000305},, PF00083;, GO:0016021;GO:0022857;GO:0006811;, C:integral component of membrane;, F:transmembrane transporter activity;, P:ion transport;|A6NKX4 S4R3Q8,Putative solute carrier family 22 member 31 {ECO:0000305},, PF00083;, GO:0016021;GO:0022857;GO:0006811;, C:integral component of membrane;, F:transmembrane transporter activity;, P:ion transport; scaffold16 indexed_genome mRNA 10750746 10778409 . - . ID=transcript_4015;Q6UB99 Q6NTG1 Q6QMF8,Ankyrin repeat domain-containing protein 11,Ankyrin repeat-containing cofactor 1;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0005634;GO:0009653;GO:0060325;GO:0042475;GO:0048705;, C:cytosol; C:nucleoplasm; C:nucleus;, , P:anatomical structure morphogenesis; P:face morphogenesis; P:odontogenesis of dentin-containing tooth; P:skeletal system morphogenesis;|Q6UB99 Q6NTG1 Q6QMF8,Ankyrin repeat domain-containing protein 11,Ankyrin repeat-containing cofactor 1;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0005634;GO:0009653;GO:0060325;GO:0042475;GO:0048705;, C:cytosol; C:nucleoplasm; C:nucleus;, , P:anatomical structure morphogenesis; P:face morphogenesis; P:odontogenesis of dentin-containing tooth; P:skeletal system morphogenesis;|Q6UB99 Q6NTG1 Q6QMF8,Ankyrin repeat domain-containing protein 11,Ankyrin repeat-containing cofactor 1;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0005634;GO:0009653;GO:0060325;GO:0042475;GO:0048705;, C:cytosol; C:nucleoplasm; C:nucleus;, , P:anatomical structure morphogenesis; P:face morphogenesis; P:odontogenesis of dentin-containing tooth; P:skeletal system morphogenesis;|Q6UB99 Q6NTG1 Q6QMF8,Ankyrin repeat domain-containing protein 11,Ankyrin repeat-containing cofactor 1;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0005634;GO:0009653;GO:0060325;GO:0042475;GO:0048705;, C:cytosol; C:nucleoplasm; C:nucleus;, , P:anatomical structure morphogenesis; P:face morphogenesis; P:odontogenesis of dentin-containing tooth; P:skeletal system morphogenesis;|Q6UB99 Q6NTG1 Q6QMF8,Ankyrin repeat domain-containing protein 11,Ankyrin repeat-containing cofactor 1;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0005634;GO:0009653;GO:0060325;GO:0042475;GO:0048705;, C:cytosol; C:nucleoplasm; C:nucleus;, , P:anatomical structure morphogenesis; P:face morphogenesis; P:odontogenesis of dentin-containing tooth; P:skeletal system morphogenesis;|Q6UB99 Q6NTG1 Q6QMF8,Ankyrin repeat domain-containing protein 11,Ankyrin repeat-containing cofactor 1;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0005634;GO:0009653;GO:0060325;GO:0042475;GO:0048705;, C:cytosol; C:nucleoplasm; C:nucleus;, , P:anatomical structure morphogenesis; P:face morphogenesis; P:odontogenesis of dentin-containing tooth; P:skeletal system morphogenesis;|Q6UB99 Q6NTG1 Q6QMF8,Ankyrin repeat domain-containing protein 11,Ankyrin repeat-containing cofactor 1;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0005634;GO:0009653;GO:0060325;GO:0042475;GO:0048705;, C:cytosol; C:nucleoplasm; C:nucleus;, , P:anatomical structure morphogenesis; P:face morphogenesis; P:odontogenesis of dentin-containing tooth; P:skeletal system morphogenesis;|Q6UB99 Q6NTG1 Q6QMF8,Ankyrin repeat domain-containing protein 11,Ankyrin repeat-containing cofactor 1;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0005634;GO:0009653;GO:0060325;GO:0042475;GO:0048705;, C:cytosol; C:nucleoplasm; C:nucleus;, , P:anatomical structure morphogenesis; P:face morphogenesis; P:odontogenesis of dentin-containing tooth; P:skeletal system morphogenesis; scaffold16 indexed_genome mRNA 10900469 10923829 . + . ID=transcript_4016;Q9UQ90 O75756 Q2TB70 Q58F00 Q96IB0,Paraplegin {ECO:0000250|UniProtKB:Q3ULF4},Cell matrix adhesion regulator {ECO:0000312|HGNC:HGNC:11237};Spastic paraplegia 7 protein {ECO:0000312|HGNC:HGNC:11237};, PF00004;PF17862;PF06480;PF01434;, GO:0005743;GO:0005757;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008233;GO:0051082;GO:0008270;GO:0042407;GO:0006851;GO:0008053;GO:1902686;GO:0034982;GO:0007399;GO:0065003;GO:0006508;GO:0046902;, C:mitochondrial inner membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:peptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:cristae formation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:mitochondrial protein processing; P:nervous system development; P:protein-containing complex assembly; P:proteolysis; P:regulation of mitochondrial membrane permeability;|Q9UQ90 O75756 Q2TB70 Q58F00 Q96IB0,Paraplegin {ECO:0000250|UniProtKB:Q3ULF4},Cell matrix adhesion regulator {ECO:0000312|HGNC:HGNC:11237};Spastic paraplegia 7 protein {ECO:0000312|HGNC:HGNC:11237};, PF00004;PF17862;PF06480;PF01434;, GO:0005743;GO:0005757;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008233;GO:0051082;GO:0008270;GO:0042407;GO:0006851;GO:0008053;GO:1902686;GO:0034982;GO:0007399;GO:0065003;GO:0006508;GO:0046902;, C:mitochondrial inner membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:peptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:cristae formation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:mitochondrial protein processing; P:nervous system development; P:protein-containing complex assembly; P:proteolysis; P:regulation of mitochondrial membrane permeability;|Q9UQ90 O75756 Q2TB70 Q58F00 Q96IB0,Paraplegin {ECO:0000250|UniProtKB:Q3ULF4},Cell matrix adhesion regulator {ECO:0000312|HGNC:HGNC:11237};Spastic paraplegia 7 protein {ECO:0000312|HGNC:HGNC:11237};, PF00004;PF17862;PF06480;PF01434;, GO:0005743;GO:0005757;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008233;GO:0051082;GO:0008270;GO:0042407;GO:0006851;GO:0008053;GO:1902686;GO:0034982;GO:0007399;GO:0065003;GO:0006508;GO:0046902;, C:mitochondrial inner membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:peptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:cristae formation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:mitochondrial protein processing; P:nervous system development; P:protein-containing complex assembly; P:proteolysis; P:regulation of mitochondrial membrane permeability;|Q9UQ90 O75756 Q2TB70 Q58F00 Q96IB0,Paraplegin {ECO:0000250|UniProtKB:Q3ULF4},Cell matrix adhesion regulator {ECO:0000312|HGNC:HGNC:11237};Spastic paraplegia 7 protein {ECO:0000312|HGNC:HGNC:11237};, PF00004;PF17862;PF06480;PF01434;, GO:0005743;GO:0005757;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008233;GO:0051082;GO:0008270;GO:0042407;GO:0006851;GO:0008053;GO:1902686;GO:0034982;GO:0007399;GO:0065003;GO:0006508;GO:0046902;, C:mitochondrial inner membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:peptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:cristae formation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:mitochondrial protein processing; P:nervous system development; P:protein-containing complex assembly; P:proteolysis; P:regulation of mitochondrial membrane permeability;|Q9UQ90 O75756 Q2TB70 Q58F00 Q96IB0,Paraplegin {ECO:0000250|UniProtKB:Q3ULF4},Cell matrix adhesion regulator {ECO:0000312|HGNC:HGNC:11237};Spastic paraplegia 7 protein {ECO:0000312|HGNC:HGNC:11237};, PF00004;PF17862;PF06480;PF01434;, GO:0005743;GO:0005757;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008233;GO:0051082;GO:0008270;GO:0042407;GO:0006851;GO:0008053;GO:1902686;GO:0034982;GO:0007399;GO:0065003;GO:0006508;GO:0046902;, C:mitochondrial inner membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:peptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:cristae formation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:mitochondrial protein processing; P:nervous system development; P:protein-containing complex assembly; P:proteolysis; P:regulation of mitochondrial membrane permeability;|Q9UQ90 O75756 Q2TB70 Q58F00 Q96IB0,Paraplegin {ECO:0000250|UniProtKB:Q3ULF4},Cell matrix adhesion regulator {ECO:0000312|HGNC:HGNC:11237};Spastic paraplegia 7 protein {ECO:0000312|HGNC:HGNC:11237};, PF00004;PF17862;PF06480;PF01434;, GO:0005743;GO:0005757;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008233;GO:0051082;GO:0008270;GO:0042407;GO:0006851;GO:0008053;GO:1902686;GO:0034982;GO:0007399;GO:0065003;GO:0006508;GO:0046902;, C:mitochondrial inner membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:peptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:cristae formation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:mitochondrial protein processing; P:nervous system development; P:protein-containing complex assembly; P:proteolysis; P:regulation of mitochondrial membrane permeability;|Q9UQ90 O75756 Q2TB70 Q58F00 Q96IB0,Paraplegin {ECO:0000250|UniProtKB:Q3ULF4},Cell matrix adhesion regulator {ECO:0000312|HGNC:HGNC:11237};Spastic paraplegia 7 protein {ECO:0000312|HGNC:HGNC:11237};, PF00004;PF17862;PF06480;PF01434;, GO:0005743;GO:0005757;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008233;GO:0051082;GO:0008270;GO:0042407;GO:0006851;GO:0008053;GO:1902686;GO:0034982;GO:0007399;GO:0065003;GO:0006508;GO:0046902;, C:mitochondrial inner membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:peptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:cristae formation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:mitochondrial protein processing; P:nervous system development; P:protein-containing complex assembly; P:proteolysis; P:regulation of mitochondrial membrane permeability;|Q9UQ90 O75756 Q2TB70 Q58F00 Q96IB0,Paraplegin {ECO:0000250|UniProtKB:Q3ULF4},Cell matrix adhesion regulator {ECO:0000312|HGNC:HGNC:11237};Spastic paraplegia 7 protein {ECO:0000312|HGNC:HGNC:11237};, PF00004;PF17862;PF06480;PF01434;, GO:0005743;GO:0005757;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008233;GO:0051082;GO:0008270;GO:0042407;GO:0006851;GO:0008053;GO:1902686;GO:0034982;GO:0007399;GO:0065003;GO:0006508;GO:0046902;, C:mitochondrial inner membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:peptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:cristae formation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:mitochondrial protein processing; P:nervous system development; P:protein-containing complex assembly; P:proteolysis; P:regulation of mitochondrial membrane permeability;|Q9UQ90 O75756 Q2TB70 Q58F00 Q96IB0,Paraplegin {ECO:0000250|UniProtKB:Q3ULF4},Cell matrix adhesion regulator {ECO:0000312|HGNC:HGNC:11237};Spastic paraplegia 7 protein {ECO:0000312|HGNC:HGNC:11237};, PF00004;PF17862;PF06480;PF01434;, GO:0005743;GO:0005757;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008233;GO:0051082;GO:0008270;GO:0042407;GO:0006851;GO:0008053;GO:1902686;GO:0034982;GO:0007399;GO:0065003;GO:0006508;GO:0046902;, C:mitochondrial inner membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:peptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:cristae formation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial outer membrane permeabilization involved in programmed cell death; P:mitochondrial protein processing; P:nervous system development; P:protein-containing complex assembly; P:proteolysis; P:regulation of mitochondrial membrane permeability; scaffold16 indexed_genome mRNA 10983832 10990896 . - . ID=transcript_4017;Q9HD42 A2RU09 Q14468 Q15779 Q96G31,Charged multivesicular body protein 1a,Chromatin-modifying protein 1a;Vacuolar protein sorting-associated protein 46-1;, PF03357;, GO:0000794;GO:0005829;GO:0005769;GO:0012505;GO:0000815;GO:0070062;GO:0005815;GO:0005771;GO:0016363;GO:0042802;GO:0008237;GO:0019904;GO:0042803;GO:0008270;GO:0051301;GO:0032509;GO:1904903;GO:0016458;GO:0045324;GO:0061952;GO:0007076;GO:0007080;GO:0036258;GO:0045786;GO:0045892;GO:0006997;GO:0015031;GO:0010824;GO:1901673;GO:0016192;GO:0039702;GO:0016032;, C:condensed nuclear chromosome; C:cytosol; C:early endosome; C:endomembrane system; C:ESCRT III complex; C:extracellular exosome; C:microtubule organizing center; C:multivesicular body; C:nuclear matrix;, F:identical protein binding; F:metallopeptidase activity; F:protein domain specific binding; F:protein homodimerization activity; F:zinc ion binding;, P:cell division; P:endosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:gene silencing; P:late endosome to vacuole transport; P:midbody abscission; P:mitotic chromosome condensation; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:negative regulation of cell cycle; P:negative regulation of transcription, DNA-templated; P:nucleus organization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:vesicle-mediated transport; P:viral budding via host ESCRT complex; P:viral process;|Q9HD42 A2RU09 Q14468 Q15779 Q96G31,Charged multivesicular body protein 1a,Chromatin-modifying protein 1a;Vacuolar protein sorting-associated protein 46-1;, PF03357;, GO:0000794;GO:0005829;GO:0005769;GO:0012505;GO:0000815;GO:0070062;GO:0005815;GO:0005771;GO:0016363;GO:0042802;GO:0008237;GO:0019904;GO:0042803;GO:0008270;GO:0051301;GO:0032509;GO:1904903;GO:0016458;GO:0045324;GO:0061952;GO:0007076;GO:0007080;GO:0036258;GO:0045786;GO:0045892;GO:0006997;GO:0015031;GO:0010824;GO:1901673;GO:0016192;GO:0039702;GO:0016032;, C:condensed nuclear chromosome; C:cytosol; C:early endosome; C:endomembrane system; C:ESCRT III complex; C:extracellular exosome; C:microtubule organizing center; C:multivesicular body; C:nuclear matrix;, F:identical protein binding; F:metallopeptidase activity; F:protein domain specific binding; F:protein homodimerization activity; F:zinc ion binding;, P:cell division; P:endosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:gene silencing; P:late endosome to vacuole transport; P:midbody abscission; P:mitotic chromosome condensation; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:negative regulation of cell cycle; P:negative regulation of transcription, DNA-templated; P:nucleus organization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:vesicle-mediated transport; P:viral budding via host ESCRT complex; P:viral process;|Q9HD42 A2RU09 Q14468 Q15779 Q96G31,Charged multivesicular body protein 1a,Chromatin-modifying protein 1a;Vacuolar protein sorting-associated protein 46-1;, PF03357;, GO:0000794;GO:0005829;GO:0005769;GO:0012505;GO:0000815;GO:0070062;GO:0005815;GO:0005771;GO:0016363;GO:0042802;GO:0008237;GO:0019904;GO:0042803;GO:0008270;GO:0051301;GO:0032509;GO:1904903;GO:0016458;GO:0045324;GO:0061952;GO:0007076;GO:0007080;GO:0036258;GO:0045786;GO:0045892;GO:0006997;GO:0015031;GO:0010824;GO:1901673;GO:0016192;GO:0039702;GO:0016032;, C:condensed nuclear chromosome; C:cytosol; C:early endosome; C:endomembrane system; C:ESCRT III complex; C:extracellular exosome; C:microtubule organizing center; C:multivesicular body; C:nuclear matrix;, F:identical protein binding; F:metallopeptidase activity; F:protein domain specific binding; F:protein homodimerization activity; F:zinc ion binding;, P:cell division; P:endosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:gene silencing; P:late endosome to vacuole transport; P:midbody abscission; P:mitotic chromosome condensation; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:negative regulation of cell cycle; P:negative regulation of transcription, DNA-templated; P:nucleus organization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:vesicle-mediated transport; P:viral budding via host ESCRT complex; P:viral process; scaffold16 indexed_genome mRNA 10992658 10999656 . + . ID=transcript_4018;Q96N06 A8WFL2 B4DZN8,Spermatogenesis-associated protein 33,, PF15382;, GO:0005737;GO:0005829;GO:0005634;, C:cytoplasm; C:cytosol; C:nucleus; scaffold16 indexed_genome mRNA 11001775 11014182 . + . ID=transcript_4019;Q15130 Q6PJC0,Cyclin-dependent kinase 10,Cell division protein kinase 10;Serine/threonine-protein kinase PISSLRE;, PF00069;, GO:0036064;GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0004674;GO:0106311;GO:0030030;GO:0008285;GO:1902018;GO:0018107;GO:0043410;GO:0006468;GO:0032956;GO:0007346;GO:0007089;, C:ciliary basal body; C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell projection organization; P:negative regulation of cell population proliferation; P:negative regulation of cilium assembly; P:peptidyl-threonine phosphorylation; P:positive regulation of MAPK cascade; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of mitotic cell cycle; P:traversing start control point of mitotic cell cycle;|Q15130 Q6PJC0,Cyclin-dependent kinase 10,Cell division protein kinase 10;Serine/threonine-protein kinase PISSLRE;, PF00069;, GO:0036064;GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0004674;GO:0106311;GO:0030030;GO:0008285;GO:1902018;GO:0018107;GO:0043410;GO:0006468;GO:0032956;GO:0007346;GO:0007089;, C:ciliary basal body; C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell projection organization; P:negative regulation of cell population proliferation; P:negative regulation of cilium assembly; P:peptidyl-threonine phosphorylation; P:positive regulation of MAPK cascade; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of mitotic cell cycle; P:traversing start control point of mitotic cell cycle;|Q15130 Q6PJC0,Cyclin-dependent kinase 10,Cell division protein kinase 10;Serine/threonine-protein kinase PISSLRE;, PF00069;, GO:0036064;GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0004674;GO:0106311;GO:0030030;GO:0008285;GO:1902018;GO:0018107;GO:0043410;GO:0006468;GO:0032956;GO:0007346;GO:0007089;, C:ciliary basal body; C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell projection organization; P:negative regulation of cell population proliferation; P:negative regulation of cilium assembly; P:peptidyl-threonine phosphorylation; P:positive regulation of MAPK cascade; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of mitotic cell cycle; P:traversing start control point of mitotic cell cycle;|Q15130 Q6PJC0,Cyclin-dependent kinase 10,Cell division protein kinase 10;Serine/threonine-protein kinase PISSLRE;, PF00069;, GO:0036064;GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0004674;GO:0106311;GO:0030030;GO:0008285;GO:1902018;GO:0018107;GO:0043410;GO:0006468;GO:0032956;GO:0007346;GO:0007089;, C:ciliary basal body; C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell projection organization; P:negative regulation of cell population proliferation; P:negative regulation of cilium assembly; P:peptidyl-threonine phosphorylation; P:positive regulation of MAPK cascade; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of mitotic cell cycle; P:traversing start control point of mitotic cell cycle;|Q8IUW3 D3DX85 Q8NHV3,Spermatogenesis-associated protein 2-like protein {ECO:0000305},, , GO:0005737;, C:cytoplasm; scaffold16 indexed_genome mRNA 11015911 11036474 . - . ID=transcript_4020;Q9Y2B5,VPS9 domain-containing protein 1,Protein ATP-BL;, PF02204;, GO:0005096;GO:0042802;GO:0005215;GO:0015986;, , F:GTPase activator activity; F:identical protein binding; F:transporter activity;, P:ATP synthesis coupled proton transport;|Q9Y2B5,VPS9 domain-containing protein 1,Protein ATP-BL;, PF02204;, GO:0005096;GO:0042802;GO:0005215;GO:0015986;, , F:GTPase activator activity; F:identical protein binding; F:transporter activity;, P:ATP synthesis coupled proton transport;|Q9Y2B5,VPS9 domain-containing protein 1,Protein ATP-BL;, PF02204;, GO:0005096;GO:0042802;GO:0005215;GO:0015986;, , F:GTPase activator activity; F:identical protein binding; F:transporter activity;, P:ATP synthesis coupled proton transport;|Q9Y2B5,VPS9 domain-containing protein 1,Protein ATP-BL;, PF02204;, GO:0005096;GO:0042802;GO:0005215;GO:0015986;, , F:GTPase activator activity; F:identical protein binding; F:transporter activity;, P:ATP synthesis coupled proton transport;|Q9Y2B5,VPS9 domain-containing protein 1,Protein ATP-BL;, PF02204;, GO:0005096;GO:0042802;GO:0005215;GO:0015986;, , F:GTPase activator activity; F:identical protein binding; F:transporter activity;, P:ATP synthesis coupled proton transport; scaffold16 indexed_genome mRNA 11036492 11046591 . - . ID=transcript_4021;Q8N554 Q0VGA1 Q2TBE8 Q3B7H7,Zinc finger protein 276,Zinc finger protein 477;, PF07776;PF00096;, GO:0005694;GO:0000777;GO:0000776;GO:0005634;GO:0043035;GO:1990837;GO:0008270;GO:0006357;, C:chromosome; C:condensed chromosome kinetochore; C:kinetochore; C:nucleus;, F:chromatin insulator sequence binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II;|Q8N554 Q0VGA1 Q2TBE8 Q3B7H7,Zinc finger protein 276,Zinc finger protein 477;, PF07776;PF00096;, GO:0005694;GO:0000777;GO:0000776;GO:0005634;GO:0043035;GO:1990837;GO:0008270;GO:0006357;, C:chromosome; C:condensed chromosome kinetochore; C:kinetochore; C:nucleus;, F:chromatin insulator sequence binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II;|Q8N554 Q0VGA1 Q2TBE8 Q3B7H7,Zinc finger protein 276,Zinc finger protein 477;, PF07776;PF00096;, GO:0005694;GO:0000777;GO:0000776;GO:0005634;GO:0043035;GO:1990837;GO:0008270;GO:0006357;, C:chromosome; C:condensed chromosome kinetochore; C:kinetochore; C:nucleus;, F:chromatin insulator sequence binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 11046747 11086865 . + . ID=transcript_4022;Q8N554 Q0VGA1 Q2TBE8 Q3B7H7,Zinc finger protein 276,Zinc finger protein 477;, PF07776;PF00096;, GO:0005694;GO:0000777;GO:0000776;GO:0005634;GO:0043035;GO:1990837;GO:0008270;GO:0006357;, C:chromosome; C:condensed chromosome kinetochore; C:kinetochore; C:nucleus;, F:chromatin insulator sequence binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II;|Q8N554 Q0VGA1 Q2TBE8 Q3B7H7,Zinc finger protein 276,Zinc finger protein 477;, PF07776;PF00096;, GO:0005694;GO:0000777;GO:0000776;GO:0005634;GO:0043035;GO:1990837;GO:0008270;GO:0006357;, C:chromosome; C:condensed chromosome kinetochore; C:kinetochore; C:nucleus;, F:chromatin insulator sequence binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II;|Q9UEL8 Q9UEL9 Q9UPK3 Q9Y6M2,Fanconi anemia group A protein,, PF03511;PF15865;, GO:0005737;GO:0043240;GO:0005654;GO:0005634;GO:0006281;GO:0008585;GO:0036297;GO:0008584;GO:0007140;GO:0065003;GO:2000348;GO:0042127;GO:0051090;GO:0050727;GO:0045589;, C:cytoplasm; C:Fanconi anaemia nuclear complex; C:nucleoplasm; C:nucleus;, , P:DNA repair; P:female gonad development; P:interstrand cross-link repair; P:male gonad development; P:male meiotic nuclear division; P:protein-containing complex assembly; P:regulation of CD40 signaling pathway; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of inflammatory response; P:regulation of regulatory T cell differentiation;|Q9UEL8 Q9UEL9 Q9UPK3 Q9Y6M2,Fanconi anemia group A protein,, PF03511;PF15865;, GO:0005737;GO:0043240;GO:0005654;GO:0005634;GO:0006281;GO:0008585;GO:0036297;GO:0008584;GO:0007140;GO:0065003;GO:2000348;GO:0042127;GO:0051090;GO:0050727;GO:0045589;, C:cytoplasm; C:Fanconi anaemia nuclear complex; C:nucleoplasm; C:nucleus;, , P:DNA repair; P:female gonad development; P:interstrand cross-link repair; P:male gonad development; P:male meiotic nuclear division; P:protein-containing complex assembly; P:regulation of CD40 signaling pathway; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of inflammatory response; P:regulation of regulatory T cell differentiation;|Q9UEL8 Q9UEL9 Q9UPK3 Q9Y6M2,Fanconi anemia group A protein,, PF03511;PF15865;, GO:0005737;GO:0043240;GO:0005654;GO:0005634;GO:0006281;GO:0008585;GO:0036297;GO:0008584;GO:0007140;GO:0065003;GO:2000348;GO:0042127;GO:0051090;GO:0050727;GO:0045589;, C:cytoplasm; C:Fanconi anaemia nuclear complex; C:nucleoplasm; C:nucleus;, , P:DNA repair; P:female gonad development; P:interstrand cross-link repair; P:male gonad development; P:male meiotic nuclear division; P:protein-containing complex assembly; P:regulation of CD40 signaling pathway; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of inflammatory response; P:regulation of regulatory T cell differentiation; scaffold16 indexed_genome mRNA 11101396 11121941 . + . ID=transcript_4023;Q8WWL2 A4QPB1 Q2TA98 Q6P433 Q8ND47 Q96JJ5,Protein spire homolog 2,, PF16474;, GO:0005938;GO:0032154;GO:0030659;GO:0005856;GO:0005829;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0015031;GO:0016192;, C:cell cortex; C:cleavage furrow; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:protein transport; P:vesicle-mediated transport;|Q8WWL2 A4QPB1 Q2TA98 Q6P433 Q8ND47 Q96JJ5,Protein spire homolog 2,, PF16474;, GO:0005938;GO:0032154;GO:0030659;GO:0005856;GO:0005829;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0015031;GO:0016192;, C:cell cortex; C:cleavage furrow; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:protein transport; P:vesicle-mediated transport;|Q8WWL2 A4QPB1 Q2TA98 Q6P433 Q8ND47 Q96JJ5,Protein spire homolog 2,, PF16474;, GO:0005938;GO:0032154;GO:0030659;GO:0005856;GO:0005829;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0015031;GO:0016192;, C:cell cortex; C:cleavage furrow; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:protein transport; P:vesicle-mediated transport;|Q8WWL2 A4QPB1 Q2TA98 Q6P433 Q8ND47 Q96JJ5,Protein spire homolog 2,, PF16474;, GO:0005938;GO:0032154;GO:0030659;GO:0005856;GO:0005829;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0015031;GO:0016192;, C:cell cortex; C:cleavage furrow; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:protein transport; P:vesicle-mediated transport;|Q8WWL2 A4QPB1 Q2TA98 Q6P433 Q8ND47 Q96JJ5,Protein spire homolog 2,, PF16474;, GO:0005938;GO:0032154;GO:0030659;GO:0005856;GO:0005829;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0015031;GO:0016192;, C:cell cortex; C:cleavage furrow; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:protein transport; P:vesicle-mediated transport;|Q8WWL2 A4QPB1 Q2TA98 Q6P433 Q8ND47 Q96JJ5,Protein spire homolog 2,, PF16474;, GO:0005938;GO:0032154;GO:0030659;GO:0005856;GO:0005829;GO:0003779;GO:0030036;GO:0051639;GO:0030041;GO:0045010;GO:0036089;GO:0051295;GO:0070649;GO:0048193;GO:0046907;GO:0040038;GO:2000781;GO:0015031;GO:0016192;, C:cell cortex; C:cleavage furrow; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol;, F:actin binding;, P:actin cytoskeleton organization; P:actin filament network formation; P:actin filament polymerization; P:actin nucleation; P:cleavage furrow formation; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:Golgi vesicle transport; P:intracellular transport; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:protein transport; P:vesicle-mediated transport; scaffold16 indexed_genome mRNA 11124359 11142413 . + . ID=transcript_4024;Q9BQ70 Q2MK75 Q9UPV3,Transcription factor 25,Nuclear localized protein 1;, PF04910;, GO:0005634;GO:1990112;GO:0003677;GO:0003714;GO:0007507;GO:0000122;, C:nucleus; C:RQC complex;, F:DNA binding; F:transcription corepressor activity;, P:heart development; P:negative regulation of transcription by RNA polymerase II;|Q9BQ70 Q2MK75 Q9UPV3,Transcription factor 25,Nuclear localized protein 1;, PF04910;, GO:0005634;GO:1990112;GO:0003677;GO:0003714;GO:0007507;GO:0000122;, C:nucleus; C:RQC complex;, F:DNA binding; F:transcription corepressor activity;, P:heart development; P:negative regulation of transcription by RNA polymerase II;|Q9BQ70 Q2MK75 Q9UPV3,Transcription factor 25,Nuclear localized protein 1;, PF04910;, GO:0005634;GO:1990112;GO:0003677;GO:0003714;GO:0007507;GO:0000122;, C:nucleus; C:RQC complex;, F:DNA binding; F:transcription corepressor activity;, P:heart development; P:negative regulation of transcription by RNA polymerase II;|Q9BQ70 Q2MK75 Q9UPV3,Transcription factor 25,Nuclear localized protein 1;, PF04910;, GO:0005634;GO:1990112;GO:0003677;GO:0003714;GO:0007507;GO:0000122;, C:nucleus; C:RQC complex;, F:DNA binding; F:transcription corepressor activity;, P:heart development; P:negative regulation of transcription by RNA polymerase II;|Q9BQ70 Q2MK75 Q9UPV3,Transcription factor 25,Nuclear localized protein 1;, PF04910;, GO:0005634;GO:1990112;GO:0003677;GO:0003714;GO:0007507;GO:0000122;, C:nucleus; C:RQC complex;, F:DNA binding; F:transcription corepressor activity;, P:heart development; P:negative regulation of transcription by RNA polymerase II;|Q9BQ70 Q2MK75 Q9UPV3,Transcription factor 25,Nuclear localized protein 1;, PF04910;, GO:0005634;GO:1990112;GO:0003677;GO:0003714;GO:0007507;GO:0000122;, C:nucleus; C:RQC complex;, F:DNA binding; F:transcription corepressor activity;, P:heart development; P:negative regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 11142465 11148209 . - . ID=transcript_4025;Q9BQ70 Q2MK75 Q9UPV3,Transcription factor 25,Nuclear localized protein 1;, PF04910;, GO:0005634;GO:1990112;GO:0003677;GO:0003714;GO:0007507;GO:0000122;, C:nucleus; C:RQC complex;, F:DNA binding; F:transcription corepressor activity;, P:heart development; P:negative regulation of transcription by RNA polymerase II;|Q9BQ70 Q2MK75 Q9UPV3,Transcription factor 25,Nuclear localized protein 1;, PF04910;, GO:0005634;GO:1990112;GO:0003677;GO:0003714;GO:0007507;GO:0000122;, C:nucleus; C:RQC complex;, F:DNA binding; F:transcription corepressor activity;, P:heart development; P:negative regulation of transcription by RNA polymerase II;|Q9BQ70 Q2MK75 Q9UPV3,Transcription factor 25,Nuclear localized protein 1;, PF04910;, GO:0005634;GO:1990112;GO:0003677;GO:0003714;GO:0007507;GO:0000122;, C:nucleus; C:RQC complex;, F:DNA binding; F:transcription corepressor activity;, P:heart development; P:negative regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 11150353 11151043 . - . ID=transcript_4026;Q9UN59 Q9UN60 Q9UN61 Q9UN62,Melanocyte-stimulating hormone receptor,Melanocortin receptor 1;, PF00001;, GO:0005737;GO:0005887;GO:0005886;GO:0008528;GO:0004930;GO:0004977;GO:0004980;GO:0031625;GO:0007189;GO:0007186;GO:0007187;GO:0035556;GO:0007275;GO:0002862;GO:0032720;GO:0043473;GO:0010739;GO:0051897;GO:0090037;GO:0045944;GO:0019222;GO:0009650;GO:0070914;, C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:melanocortin receptor activity; F:melanocyte-stimulating hormone receptor activity; F:ubiquitin protein ligase binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:intracellular signal transduction; P:multicellular organism development; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of tumor necrosis factor production; P:pigmentation; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein kinase C signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of metabolic process; P:UV protection; P:UV-damage excision repair; scaffold16 indexed_genome mRNA 11157717 11161615 . + . ID=transcript_4027;Q13509 A8K854 Q9BTZ0 Q9BW10,Tubulin beta-3 chain,Tubulin beta-4 chain;Tubulin beta-III;, PF00091;PF03953;, GO:0030424;GO:0005737;GO:0030425;GO:0070062;GO:0030175;GO:0030426;GO:0030027;GO:0005874;GO:0005634;GO:0005525;GO:0003924;GO:1990890;GO:0005200;GO:0007411;GO:1990791;GO:0000226;GO:0000278;, C:axon; C:cytoplasm; C:dendrite; C:extracellular exosome; C:filopodium; C:growth cone; C:lamellipodium; C:microtubule; C:nucleus;, F:GTP binding; F:GTPase activity; F:netrin receptor binding; F:structural constituent of cytoskeleton;, P:axon guidance; P:dorsal root ganglion development; P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q13509 A8K854 Q9BTZ0 Q9BW10,Tubulin beta-3 chain,Tubulin beta-4 chain;Tubulin beta-III;, PF00091;PF03953;, GO:0030424;GO:0005737;GO:0030425;GO:0070062;GO:0030175;GO:0030426;GO:0030027;GO:0005874;GO:0005634;GO:0005525;GO:0003924;GO:1990890;GO:0005200;GO:0007411;GO:1990791;GO:0000226;GO:0000278;, C:axon; C:cytoplasm; C:dendrite; C:extracellular exosome; C:filopodium; C:growth cone; C:lamellipodium; C:microtubule; C:nucleus;, F:GTP binding; F:GTPase activity; F:netrin receptor binding; F:structural constituent of cytoskeleton;, P:axon guidance; P:dorsal root ganglion development; P:microtubule cytoskeleton organization; P:mitotic cell cycle; scaffold16 indexed_genome mRNA 11170702 11183559 . - . ID=transcript_4028;Q6ZN54 B3KT65 B4DK62 B4E0S9 B7Z3H6 H3BUG7 Q8N8N3 Q9NXL0,Differentially expressed in FDCP 8 homolog,, PF00130;PF13901;, GO:0046872;GO:0035556;GO:0032418;GO:0045780;GO:1900029;, , F:metal ion binding;, P:intracellular signal transduction; P:lysosome localization; P:positive regulation of bone resorption; P:positive regulation of ruffle assembly;|Q6ZN54 B3KT65 B4DK62 B4E0S9 B7Z3H6 H3BUG7 Q8N8N3 Q9NXL0,Differentially expressed in FDCP 8 homolog,, PF00130;PF13901;, GO:0046872;GO:0035556;GO:0032418;GO:0045780;GO:1900029;, , F:metal ion binding;, P:intracellular signal transduction; P:lysosome localization; P:positive regulation of bone resorption; P:positive regulation of ruffle assembly;|Q6ZN54 B3KT65 B4DK62 B4E0S9 B7Z3H6 H3BUG7 Q8N8N3 Q9NXL0,Differentially expressed in FDCP 8 homolog,, PF00130;PF13901;, GO:0046872;GO:0035556;GO:0032418;GO:0045780;GO:1900029;, , F:metal ion binding;, P:intracellular signal transduction; P:lysosome localization; P:positive regulation of bone resorption; P:positive regulation of ruffle assembly;|Q6ZN54 B3KT65 B4DK62 B4E0S9 B7Z3H6 H3BUG7 Q8N8N3 Q9NXL0,Differentially expressed in FDCP 8 homolog,, PF00130;PF13901;, GO:0046872;GO:0035556;GO:0032418;GO:0045780;GO:1900029;, , F:metal ion binding;, P:intracellular signal transduction; P:lysosome localization; P:positive regulation of bone resorption; P:positive regulation of ruffle assembly; scaffold16 indexed_genome mRNA 11186154 11208383 . + . ID=transcript_4029;Q9Y4W6 Q6P1L0,AFG3-like protein 2 {ECO:0000305},Paraplegin-like protein;, PF00004;PF17862;PF06480;PF01434;, GO:0005745;GO:0005743;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008237;GO:0051082;GO:0008270;GO:0007409;GO:0036444;GO:0042407;GO:0033619;GO:0051560;GO:0006851;GO:0008053;GO:0034982;GO:0048747;GO:0042552;GO:0021675;GO:0007528;GO:0016540;GO:0016485;GO:0065003;GO:0006508;GO:0040014;GO:0060013;, C:m-AAA complex; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:axonogenesis; P:calcium import into the mitochondrion; P:cristae formation; P:membrane protein proteolysis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial protein processing; P:muscle fiber development; P:myelination; P:nerve development; P:neuromuscular junction development; P:protein autoprocessing; P:protein processing; P:protein-containing complex assembly; P:proteolysis; P:regulation of multicellular organism growth; P:righting reflex;|Q9Y4W6 Q6P1L0,AFG3-like protein 2 {ECO:0000305},Paraplegin-like protein;, PF00004;PF17862;PF06480;PF01434;, GO:0005745;GO:0005743;GO:0005739;GO:0005524;GO:0004176;GO:0004222;GO:0008237;GO:0051082;GO:0008270;GO:0007409;GO:0036444;GO:0042407;GO:0033619;GO:0051560;GO:0006851;GO:0008053;GO:0034982;GO:0048747;GO:0042552;GO:0021675;GO:0007528;GO:0016540;GO:0016485;GO:0065003;GO:0006508;GO:0040014;GO:0060013;, C:m-AAA complex; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:ATP-dependent peptidase activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:unfolded protein binding; F:zinc ion binding;, P:axonogenesis; P:calcium import into the mitochondrion; P:cristae formation; P:membrane protein proteolysis; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial fusion; P:mitochondrial protein processing; P:muscle fiber development; P:myelination; P:nerve development; P:neuromuscular junction development; P:protein autoprocessing; P:protein processing; P:protein-containing complex assembly; P:proteolysis; P:regulation of multicellular organism growth; P:righting reflex; scaffold16 indexed_genome mRNA 11225886 11238147 . + . ID=transcript_4030;O95995 B2RCT1 B7Z4U1 G3V1L5 Q2M234,Dynein regulatory complex subunit 4 {ECO:0000303|PubMed:27120127},Growth arrest-specific protein 11;Growth arrest-specific protein 8;, PF13851;, GO:0005930;GO:0036064;GO:0005929;GO:0005829;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0008017;GO:0031267;GO:0035082;GO:0034613;GO:0060294;GO:0030317;GO:0008285;GO:1903566;GO:0045880;GO:1904526;, C:axoneme; C:ciliary basal body; C:cilium; C:cytosol; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:microtubule binding; F:small GTPase binding;, P:axoneme assembly; P:cellular protein localization; P:cilium movement involved in cell motility; P:flagellated sperm motility; P:negative regulation of cell population proliferation; P:positive regulation of protein localization to cilium; P:positive regulation of smoothened signaling pathway; P:regulation of microtubule binding;|O95995 B2RCT1 B7Z4U1 G3V1L5 Q2M234,Dynein regulatory complex subunit 4 {ECO:0000303|PubMed:27120127},Growth arrest-specific protein 11;Growth arrest-specific protein 8;, PF13851;, GO:0005930;GO:0036064;GO:0005929;GO:0005829;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0008017;GO:0031267;GO:0035082;GO:0034613;GO:0060294;GO:0030317;GO:0008285;GO:1903566;GO:0045880;GO:1904526;, C:axoneme; C:ciliary basal body; C:cilium; C:cytosol; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:microtubule binding; F:small GTPase binding;, P:axoneme assembly; P:cellular protein localization; P:cilium movement involved in cell motility; P:flagellated sperm motility; P:negative regulation of cell population proliferation; P:positive regulation of protein localization to cilium; P:positive regulation of smoothened signaling pathway; P:regulation of microtubule binding; scaffold16 indexed_genome mRNA 11244324 11247092 . - . ID=transcript_4031;P02766 Q549C7 Q6IB96 Q9UBZ6 Q9UCM9,Transthyretin,ATTR;Prealbumin;TBPA;, PF00576;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:0032991;GO:0005179;GO:0042802;GO:0044877;GO:0070324;GO:1990000;GO:0030198;GO:0043312;GO:0006144;GO:0001523;GO:0042572;GO:0070327;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:protein-containing complex;, F:hormone activity; F:identical protein binding; F:protein-containing complex binding; F:thyroid hormone binding;, P:amyloid fibril formation; P:extracellular matrix organization; P:neutrophil degranulation; P:purine nucleobase metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:thyroid hormone transport; scaffold16 indexed_genome mRNA 11260437 11261017 . - . ID=transcript_4032;Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response; scaffold16 indexed_genome mRNA 11264480 11265018 . + . ID=transcript_4033;A6NKG5 E9PKS8,Retrotransposon-like protein 1,Mammalian retrotransposon derived protein 1;Paternally expressed gene 11 protein;Retrotransposon-derived protein PEG11;, PF16297;PF17919;, GO:0016021;GO:0007275;, C:integral component of membrane;, , P:multicellular organism development; scaffold16 indexed_genome mRNA 11436623 11463751 . - . ID=transcript_4034;Q9NZK2,Vacuolar protein sorting-associated protein 35,Maternal-embryonic 3;Vesicle protein sorting 35;, , GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0005770;GO:0005765;GO:0005764;GO:0099073;GO:0030904;GO:0030906;GO:0097422;GO:0031748;GO:0006886;GO:0043653;GO:0099074;GO:0060548;GO:0050728;GO:1902823;GO:1901215;GO:0099639;GO:1903364;GO:0060161;GO:0010628;GO:0090141;GO:0036010;GO:0032268;GO:1902950;GO:0016241;GO:0010821;GO:1905606;GO:0031647;GO:2000331;GO:0042147;GO:1990126;GO:0045056;GO:0016032;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:late endosome; C:lysosomal membrane; C:lysosome; C:mitochondrion-derived vesicle; C:retromer complex; C:retromer, cargo-selective complex; C:tubular endosome;, F:D1 dopamine receptor binding;, P:intracellular protein transport; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrion to lysosome transport; P:negative regulation of cell death; P:negative regulation of inflammatory response; P:negative regulation of late endosome to lysosome transport; P:negative regulation of neuron death; P:neurotransmitter receptor transport, endosome to plasma membrane; P:positive regulation of cellular protein catabolic process; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of mitochondrial fission; P:protein localization to endosome; P:regulation of cellular protein metabolic process; P:regulation of dendritic spine maintenance; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of presynapse assembly; P:regulation of protein stability; P:regulation of terminal button organization; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:transcytosis; P:viral process; P:Wnt signaling pathway;|Q9NZK2,Vacuolar protein sorting-associated protein 35,Maternal-embryonic 3;Vesicle protein sorting 35;, , GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0005770;GO:0005765;GO:0005764;GO:0099073;GO:0030904;GO:0030906;GO:0097422;GO:0031748;GO:0006886;GO:0043653;GO:0099074;GO:0060548;GO:0050728;GO:1902823;GO:1901215;GO:0099639;GO:1903364;GO:0060161;GO:0010628;GO:0090141;GO:0036010;GO:0032268;GO:1902950;GO:0016241;GO:0010821;GO:1905606;GO:0031647;GO:2000331;GO:0042147;GO:1990126;GO:0045056;GO:0016032;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:late endosome; C:lysosomal membrane; C:lysosome; C:mitochondrion-derived vesicle; C:retromer complex; C:retromer, cargo-selective complex; C:tubular endosome;, F:D1 dopamine receptor binding;, P:intracellular protein transport; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrion to lysosome transport; P:negative regulation of cell death; P:negative regulation of inflammatory response; P:negative regulation of late endosome to lysosome transport; P:negative regulation of neuron death; P:neurotransmitter receptor transport, endosome to plasma membrane; P:positive regulation of cellular protein catabolic process; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of mitochondrial fission; P:protein localization to endosome; P:regulation of cellular protein metabolic process; P:regulation of dendritic spine maintenance; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of presynapse assembly; P:regulation of protein stability; P:regulation of terminal button organization; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:transcytosis; P:viral process; P:Wnt signaling pathway;|Q9NZK2,Vacuolar protein sorting-associated protein 35,Maternal-embryonic 3;Vesicle protein sorting 35;, , GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0005770;GO:0005765;GO:0005764;GO:0099073;GO:0030904;GO:0030906;GO:0097422;GO:0031748;GO:0006886;GO:0043653;GO:0099074;GO:0060548;GO:0050728;GO:1902823;GO:1901215;GO:0099639;GO:1903364;GO:0060161;GO:0010628;GO:0090141;GO:0036010;GO:0032268;GO:1902950;GO:0016241;GO:0010821;GO:1905606;GO:0031647;GO:2000331;GO:0042147;GO:1990126;GO:0045056;GO:0016032;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:late endosome; C:lysosomal membrane; C:lysosome; C:mitochondrion-derived vesicle; C:retromer complex; C:retromer, cargo-selective complex; C:tubular endosome;, F:D1 dopamine receptor binding;, P:intracellular protein transport; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrion to lysosome transport; P:negative regulation of cell death; P:negative regulation of inflammatory response; P:negative regulation of late endosome to lysosome transport; P:negative regulation of neuron death; P:neurotransmitter receptor transport, endosome to plasma membrane; P:positive regulation of cellular protein catabolic process; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of mitochondrial fission; P:protein localization to endosome; P:regulation of cellular protein metabolic process; P:regulation of dendritic spine maintenance; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of presynapse assembly; P:regulation of protein stability; P:regulation of terminal button organization; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:transcytosis; P:viral process; P:Wnt signaling pathway;|Q9NZK2,Vacuolar protein sorting-associated protein 35,Maternal-embryonic 3;Vesicle protein sorting 35;, , GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0005770;GO:0005765;GO:0005764;GO:0099073;GO:0030904;GO:0030906;GO:0097422;GO:0031748;GO:0006886;GO:0043653;GO:0099074;GO:0060548;GO:0050728;GO:1902823;GO:1901215;GO:0099639;GO:1903364;GO:0060161;GO:0010628;GO:0090141;GO:0036010;GO:0032268;GO:1902950;GO:0016241;GO:0010821;GO:1905606;GO:0031647;GO:2000331;GO:0042147;GO:1990126;GO:0045056;GO:0016032;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:late endosome; C:lysosomal membrane; C:lysosome; C:mitochondrion-derived vesicle; C:retromer complex; C:retromer, cargo-selective complex; C:tubular endosome;, F:D1 dopamine receptor binding;, P:intracellular protein transport; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrion to lysosome transport; P:negative regulation of cell death; P:negative regulation of inflammatory response; P:negative regulation of late endosome to lysosome transport; P:negative regulation of neuron death; P:neurotransmitter receptor transport, endosome to plasma membrane; P:positive regulation of cellular protein catabolic process; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of mitochondrial fission; P:protein localization to endosome; P:regulation of cellular protein metabolic process; P:regulation of dendritic spine maintenance; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of presynapse assembly; P:regulation of protein stability; P:regulation of terminal button organization; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:transcytosis; P:viral process; P:Wnt signaling pathway;|Q9NZK2,Vacuolar protein sorting-associated protein 35,Maternal-embryonic 3;Vesicle protein sorting 35;, , GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0005770;GO:0005765;GO:0005764;GO:0099073;GO:0030904;GO:0030906;GO:0097422;GO:0031748;GO:0006886;GO:0043653;GO:0099074;GO:0060548;GO:0050728;GO:1902823;GO:1901215;GO:0099639;GO:1903364;GO:0060161;GO:0010628;GO:0090141;GO:0036010;GO:0032268;GO:1902950;GO:0016241;GO:0010821;GO:1905606;GO:0031647;GO:2000331;GO:0042147;GO:1990126;GO:0045056;GO:0016032;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:late endosome; C:lysosomal membrane; C:lysosome; C:mitochondrion-derived vesicle; C:retromer complex; C:retromer, cargo-selective complex; C:tubular endosome;, F:D1 dopamine receptor binding;, P:intracellular protein transport; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrion to lysosome transport; P:negative regulation of cell death; P:negative regulation of inflammatory response; P:negative regulation of late endosome to lysosome transport; P:negative regulation of neuron death; P:neurotransmitter receptor transport, endosome to plasma membrane; P:positive regulation of cellular protein catabolic process; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of mitochondrial fission; P:protein localization to endosome; P:regulation of cellular protein metabolic process; P:regulation of dendritic spine maintenance; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of presynapse assembly; P:regulation of protein stability; P:regulation of terminal button organization; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:transcytosis; P:viral process; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 11465509 11473036 . + . ID=transcript_4035;Q9Y5N6 B3KN89,Origin recognition complex subunit 6,, PF05460;, GO:0001650;GO:0016020;GO:0005664;GO:0005654;GO:0000808;GO:0003677;GO:0006260;GO:0006270;GO:0051782;GO:0036388;, C:fibrillar center; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:origin recognition complex;, F:DNA binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of cell division; P:pre-replicative complex assembly;|Q9Y5N6 B3KN89,Origin recognition complex subunit 6,, PF05460;, GO:0001650;GO:0016020;GO:0005664;GO:0005654;GO:0000808;GO:0003677;GO:0006260;GO:0006270;GO:0051782;GO:0036388;, C:fibrillar center; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:origin recognition complex;, F:DNA binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of cell division; P:pre-replicative complex assembly;|Q9Y5N6 B3KN89,Origin recognition complex subunit 6,, PF05460;, GO:0001650;GO:0016020;GO:0005664;GO:0005654;GO:0000808;GO:0003677;GO:0006260;GO:0006270;GO:0051782;GO:0036388;, C:fibrillar center; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:origin recognition complex;, F:DNA binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of cell division; P:pre-replicative complex assembly; scaffold16 indexed_genome mRNA 11484564 11531464 . - . ID=transcript_4036;Q32MK0 B5BUL9 B7Z5U8 Q32MK1 Q96DV1,Myosin light chain kinase 3,Cardiac-MyBP-C-associated Ca/CaM kinase;, PF00069;, GO:0015629;GO:0005737;GO:0005829;GO:0005524;GO:0004683;GO:0004687;GO:0055003;GO:0071347;GO:0060298;GO:0006468;GO:0002528;GO:0045214;GO:0048769;, C:actin cytoskeleton; C:cytoplasm; C:cytosol;, F:ATP binding; F:calmodulin-dependent protein kinase activity; F:myosin light chain kinase activity;, P:cardiac myofibril assembly; P:cellular response to interleukin-1; P:positive regulation of sarcomere organization; P:protein phosphorylation; P:regulation of vascular permeability involved in acute inflammatory response; P:sarcomere organization; P:sarcomerogenesis;|Q32MK0 B5BUL9 B7Z5U8 Q32MK1 Q96DV1,Myosin light chain kinase 3,Cardiac-MyBP-C-associated Ca/CaM kinase;, PF00069;, GO:0015629;GO:0005737;GO:0005829;GO:0005524;GO:0004683;GO:0004687;GO:0055003;GO:0071347;GO:0060298;GO:0006468;GO:0002528;GO:0045214;GO:0048769;, C:actin cytoskeleton; C:cytoplasm; C:cytosol;, F:ATP binding; F:calmodulin-dependent protein kinase activity; F:myosin light chain kinase activity;, P:cardiac myofibril assembly; P:cellular response to interleukin-1; P:positive regulation of sarcomere organization; P:protein phosphorylation; P:regulation of vascular permeability involved in acute inflammatory response; P:sarcomere organization; P:sarcomerogenesis; scaffold16 indexed_genome mRNA 11767985 11802509 . + . ID=transcript_4037;Q8TD30 Q8N9E2,Alanine aminotransferase 2,Glutamate pyruvate transaminase 2;Glutamic--alanine transaminase 2;Glutamic--pyruvic transaminase 2;, PF00155;, GO:0005759;GO:0004021;GO:0030170;GO:0006103;GO:0009058;GO:0042853;GO:0042851;GO:0009078;, C:mitochondrial matrix;, F:L-alanine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:L-alanine catabolic process; P:L-alanine metabolic process; P:pyruvate family amino acid metabolic process;|Q8TD30 Q8N9E2,Alanine aminotransferase 2,Glutamate pyruvate transaminase 2;Glutamic--alanine transaminase 2;Glutamic--pyruvic transaminase 2;, PF00155;, GO:0005759;GO:0004021;GO:0030170;GO:0006103;GO:0009058;GO:0042853;GO:0042851;GO:0009078;, C:mitochondrial matrix;, F:L-alanine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:L-alanine catabolic process; P:L-alanine metabolic process; P:pyruvate family amino acid metabolic process;|Q8TD30 Q8N9E2,Alanine aminotransferase 2,Glutamate pyruvate transaminase 2;Glutamic--alanine transaminase 2;Glutamic--pyruvic transaminase 2;, PF00155;, GO:0005759;GO:0004021;GO:0030170;GO:0006103;GO:0009058;GO:0042853;GO:0042851;GO:0009078;, C:mitochondrial matrix;, F:L-alanine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:L-alanine catabolic process; P:L-alanine metabolic process; P:pyruvate family amino acid metabolic process;|Q8TD30 Q8N9E2,Alanine aminotransferase 2,Glutamate pyruvate transaminase 2;Glutamic--alanine transaminase 2;Glutamic--pyruvic transaminase 2;, PF00155;, GO:0005759;GO:0004021;GO:0030170;GO:0006103;GO:0009058;GO:0042853;GO:0042851;GO:0009078;, C:mitochondrial matrix;, F:L-alanine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:L-alanine catabolic process; P:L-alanine metabolic process; P:pyruvate family amino acid metabolic process;|Q8TD30 Q8N9E2,Alanine aminotransferase 2,Glutamate pyruvate transaminase 2;Glutamic--alanine transaminase 2;Glutamic--pyruvic transaminase 2;, PF00155;, GO:0005759;GO:0004021;GO:0030170;GO:0006103;GO:0009058;GO:0042853;GO:0042851;GO:0009078;, C:mitochondrial matrix;, F:L-alanine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:L-alanine catabolic process; P:L-alanine metabolic process; P:pyruvate family amino acid metabolic process;|Q8TD30 Q8N9E2,Alanine aminotransferase 2,Glutamate pyruvate transaminase 2;Glutamic--alanine transaminase 2;Glutamic--pyruvic transaminase 2;, PF00155;, GO:0005759;GO:0004021;GO:0030170;GO:0006103;GO:0009058;GO:0042853;GO:0042851;GO:0009078;, C:mitochondrial matrix;, F:L-alanine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:L-alanine catabolic process; P:L-alanine metabolic process; P:pyruvate family amino acid metabolic process; scaffold16 indexed_genome mRNA 11827304 11832113 . - . ID=transcript_4038;O60884 B2R7L7 O14711,DnaJ homolog subfamily A member 2,Cell cycle progression restoration gene 3 protein;Dnj3;HIRA-interacting protein 4;Renal carcinoma antigen NY-REN-14;, PF00226;PF01556;PF00684;, GO:0005829;GO:0070062;GO:0016020;GO:0005524;GO:0001671;GO:0051087;GO:0031072;GO:0046872;GO:0051082;GO:0008284;GO:0042026;GO:0009408;, C:cytosol; C:extracellular exosome; C:membrane;, F:ATP binding; F:ATPase activator activity; F:chaperone binding; F:heat shock protein binding; F:metal ion binding; F:unfolded protein binding;, P:positive regulation of cell population proliferation; P:protein refolding; P:response to heat; scaffold16 indexed_genome mRNA 11833221 11836439 . - . ID=transcript_4039;O60884 B2R7L7 O14711,DnaJ homolog subfamily A member 2,Cell cycle progression restoration gene 3 protein;Dnj3;HIRA-interacting protein 4;Renal carcinoma antigen NY-REN-14;, PF00226;PF01556;PF00684;, GO:0005829;GO:0070062;GO:0016020;GO:0005524;GO:0001671;GO:0051087;GO:0031072;GO:0046872;GO:0051082;GO:0008284;GO:0042026;GO:0009408;, C:cytosol; C:extracellular exosome; C:membrane;, F:ATP binding; F:ATPase activator activity; F:chaperone binding; F:heat shock protein binding; F:metal ion binding; F:unfolded protein binding;, P:positive regulation of cell population proliferation; P:protein refolding; P:response to heat; scaffold16 indexed_genome mRNA 11838454 11840433 . + . ID=transcript_4040;O60884 B2R7L7 O14711,DnaJ homolog subfamily A member 2,Cell cycle progression restoration gene 3 protein;Dnj3;HIRA-interacting protein 4;Renal carcinoma antigen NY-REN-14;, PF00226;PF01556;PF00684;, GO:0005829;GO:0070062;GO:0016020;GO:0005524;GO:0001671;GO:0051087;GO:0031072;GO:0046872;GO:0051082;GO:0008284;GO:0042026;GO:0009408;, C:cytosol; C:extracellular exosome; C:membrane;, F:ATP binding; F:ATPase activator activity; F:chaperone binding; F:heat shock protein binding; F:metal ion binding; F:unfolded protein binding;, P:positive regulation of cell population proliferation; P:protein refolding; P:response to heat; scaffold16 indexed_genome mRNA 11927158 11938371 . - . ID=transcript_4041;Q8NC67 J3KNF1 Q7Z381 Q8ND51 Q96SP4 Q9NVY8,Neuropilin and tolloid-like protein 2,Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2;, PF00431;PF00057;, GO:0016021;GO:0014069;GO:0035255;GO:2000312;, C:integral component of membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding;, P:regulation of kainate selective glutamate receptor activity;|Q8NC67 J3KNF1 Q7Z381 Q8ND51 Q96SP4 Q9NVY8,Neuropilin and tolloid-like protein 2,Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2;, PF00431;PF00057;, GO:0016021;GO:0014069;GO:0035255;GO:2000312;, C:integral component of membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding;, P:regulation of kainate selective glutamate receptor activity; scaffold16 indexed_genome mRNA 11959141 11986033 . - . ID=transcript_4042;Q8NC67 J3KNF1 Q7Z381 Q8ND51 Q96SP4 Q9NVY8,Neuropilin and tolloid-like protein 2,Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2;, PF00431;PF00057;, GO:0016021;GO:0014069;GO:0035255;GO:2000312;, C:integral component of membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding;, P:regulation of kainate selective glutamate receptor activity;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q8NC67 J3KNF1 Q7Z381 Q8ND51 Q96SP4 Q9NVY8,Neuropilin and tolloid-like protein 2,Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2;, PF00431;PF00057;, GO:0016021;GO:0014069;GO:0035255;GO:2000312;, C:integral component of membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding;, P:regulation of kainate selective glutamate receptor activity;|Q8NC67 J3KNF1 Q7Z381 Q8ND51 Q96SP4 Q9NVY8,Neuropilin and tolloid-like protein 2,Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2;, PF00431;PF00057;, GO:0016021;GO:0014069;GO:0035255;GO:2000312;, C:integral component of membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding;, P:regulation of kainate selective glutamate receptor activity; scaffold16 indexed_genome mRNA 12012353 12298059 . + . ID=transcript_4043;Q8TB96 Q96SR4 Q9BRE2 Q9H2V9,T-cell immunomodulatory protein,Integrin-alpha FG-GAP repeat-containing protein 1;Linkin {ECO:0000303|PubMed:25437307};, PF13517;, GO:0070062;GO:0016021;GO:0005886;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;|Q8TB96 Q96SR4 Q9BRE2 Q9H2V9,T-cell immunomodulatory protein,Integrin-alpha FG-GAP repeat-containing protein 1;Linkin {ECO:0000303|PubMed:25437307};, PF13517;, GO:0070062;GO:0016021;GO:0005886;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;|Q8TB96 Q96SR4 Q9BRE2 Q9H2V9,T-cell immunomodulatory protein,Integrin-alpha FG-GAP repeat-containing protein 1;Linkin {ECO:0000303|PubMed:25437307};, PF13517;, GO:0070062;GO:0016021;GO:0005886;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;|Q8TB96 Q96SR4 Q9BRE2 Q9H2V9,T-cell immunomodulatory protein,Integrin-alpha FG-GAP repeat-containing protein 1;Linkin {ECO:0000303|PubMed:25437307};, PF13517;, GO:0070062;GO:0016021;GO:0005886;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane; scaffold16 indexed_genome mRNA 12298170 12519437 . + . ID=transcript_4044;Q93100 Q8N4T5,Phosphorylase b kinase regulatory subunit beta,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0006091;GO:0005980;GO:0005977;GO:0006468;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process; P:protein phosphorylation;|Q93100 Q8N4T5,Phosphorylase b kinase regulatory subunit beta,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0006091;GO:0005980;GO:0005977;GO:0006468;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process; P:protein phosphorylation;|Q93100 Q8N4T5,Phosphorylase b kinase regulatory subunit beta,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0006091;GO:0005980;GO:0005977;GO:0006468;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process; P:protein phosphorylation;|Q93100 Q8N4T5,Phosphorylase b kinase regulatory subunit beta,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0006091;GO:0005980;GO:0005977;GO:0006468;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process; P:protein phosphorylation;|Q93100 Q8N4T5,Phosphorylase b kinase regulatory subunit beta,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0006091;GO:0005980;GO:0005977;GO:0006468;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process; P:protein phosphorylation; scaffold16 indexed_genome mRNA 12997179 13006952 . - . ID=transcript_4045;Q96J66 Q8TDJ0 Q96JA6 Q9BX80,ATP-binding cassette sub-family C member 11 {ECO:0000303|PubMed:11483364},Multidrug resistance-associated protein 8 {ECO:0000303|PubMed:11591886};, PF00664;PF00005;, GO:0016324;GO:0030659;GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005774;GO:0015432;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0008514;GO:0015216;GO:0015721;GO:0071716;GO:0015711;GO:0015865;GO:0055085;GO:0042908;, C:apical plasma membrane; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vacuolar membrane;, F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity;, P:bile acid and bile salt transport; P:leukotriene transport; P:organic anion transport; P:purine nucleotide transport; P:transmembrane transport; P:xenobiotic transport; scaffold16 indexed_genome mRNA 13025159 13145100 . - . ID=transcript_4046;Q96J66 Q8TDJ0 Q96JA6 Q9BX80,ATP-binding cassette sub-family C member 11 {ECO:0000303|PubMed:11483364},Multidrug resistance-associated protein 8 {ECO:0000303|PubMed:11591886};, PF00664;PF00005;, GO:0016324;GO:0030659;GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005774;GO:0015432;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0008514;GO:0015216;GO:0015721;GO:0071716;GO:0015711;GO:0015865;GO:0055085;GO:0042908;, C:apical plasma membrane; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vacuolar membrane;, F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity;, P:bile acid and bile salt transport; P:leukotriene transport; P:organic anion transport; P:purine nucleotide transport; P:transmembrane transport; P:xenobiotic transport;|Q96J66 Q8TDJ0 Q96JA6 Q9BX80,ATP-binding cassette sub-family C member 11 {ECO:0000303|PubMed:11483364},Multidrug resistance-associated protein 8 {ECO:0000303|PubMed:11591886};, PF00664;PF00005;, GO:0016324;GO:0030659;GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005774;GO:0015432;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0008514;GO:0015216;GO:0015721;GO:0071716;GO:0015711;GO:0015865;GO:0055085;GO:0042908;, C:apical plasma membrane; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vacuolar membrane;, F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:purine nucleotide transmembrane transporter activity;, P:bile acid and bile salt transport; P:leukotriene transport; P:organic anion transport; P:purine nucleotide transport; P:transmembrane transport; P:xenobiotic transport;|Q86WA8 B7ZKL7 Q0D2H6 Q8N3B9 Q8NCE9 Q96K43,Lon protease homolog 2, peroxisomal {ECO:0000255|HAMAP-Rule:MF_03121},Lon protease-like protein 2 {ECO:0000255|HAMAP-Rule:MF_03121};Peroxisomal Lon protease {ECO:0000255|HAMAP-Rule:MF_03121};, PF00004;PF05362;PF02190;, GO:0005829;GO:0016020;GO:0005634;GO:0005782;GO:0005777;GO:0005524;GO:0004176;GO:0019899;GO:0008233;GO:0002020;GO:0004252;GO:0007031;GO:0016558;GO:0008104;GO:0016485;GO:0006515;GO:0006625;GO:0031998;GO:0014070;, C:cytosol; C:membrane; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:ATP binding; F:ATP-dependent peptidase activity; F:enzyme binding; F:peptidase activity; F:protease binding; F:serine-type endopeptidase activity;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization; P:protein processing; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein targeting to peroxisome; P:regulation of fatty acid beta-oxidation; P:response to organic cyclic compound;|Q86WA8 B7ZKL7 Q0D2H6 Q8N3B9 Q8NCE9 Q96K43,Lon protease homolog 2, peroxisomal {ECO:0000255|HAMAP-Rule:MF_03121},Lon protease-like protein 2 {ECO:0000255|HAMAP-Rule:MF_03121};Peroxisomal Lon protease {ECO:0000255|HAMAP-Rule:MF_03121};, PF00004;PF05362;PF02190;, GO:0005829;GO:0016020;GO:0005634;GO:0005782;GO:0005777;GO:0005524;GO:0004176;GO:0019899;GO:0008233;GO:0002020;GO:0004252;GO:0007031;GO:0016558;GO:0008104;GO:0016485;GO:0006515;GO:0006625;GO:0031998;GO:0014070;, C:cytosol; C:membrane; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:ATP binding; F:ATP-dependent peptidase activity; F:enzyme binding; F:peptidase activity; F:protease binding; F:serine-type endopeptidase activity;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization; P:protein processing; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein targeting to peroxisome; P:regulation of fatty acid beta-oxidation; P:response to organic cyclic compound;|Q86WA8 B7ZKL7 Q0D2H6 Q8N3B9 Q8NCE9 Q96K43,Lon protease homolog 2, peroxisomal {ECO:0000255|HAMAP-Rule:MF_03121},Lon protease-like protein 2 {ECO:0000255|HAMAP-Rule:MF_03121};Peroxisomal Lon protease {ECO:0000255|HAMAP-Rule:MF_03121};, PF00004;PF05362;PF02190;, GO:0005829;GO:0016020;GO:0005634;GO:0005782;GO:0005777;GO:0005524;GO:0004176;GO:0019899;GO:0008233;GO:0002020;GO:0004252;GO:0007031;GO:0016558;GO:0008104;GO:0016485;GO:0006515;GO:0006625;GO:0031998;GO:0014070;, C:cytosol; C:membrane; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:ATP binding; F:ATP-dependent peptidase activity; F:enzyme binding; F:peptidase activity; F:protease binding; F:serine-type endopeptidase activity;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization; P:protein processing; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein targeting to peroxisome; P:regulation of fatty acid beta-oxidation; P:response to organic cyclic compound;|Q86WA8 B7ZKL7 Q0D2H6 Q8N3B9 Q8NCE9 Q96K43,Lon protease homolog 2, peroxisomal {ECO:0000255|HAMAP-Rule:MF_03121},Lon protease-like protein 2 {ECO:0000255|HAMAP-Rule:MF_03121};Peroxisomal Lon protease {ECO:0000255|HAMAP-Rule:MF_03121};, PF00004;PF05362;PF02190;, GO:0005829;GO:0016020;GO:0005634;GO:0005782;GO:0005777;GO:0005524;GO:0004176;GO:0019899;GO:0008233;GO:0002020;GO:0004252;GO:0007031;GO:0016558;GO:0008104;GO:0016485;GO:0006515;GO:0006625;GO:0031998;GO:0014070;, C:cytosol; C:membrane; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:ATP binding; F:ATP-dependent peptidase activity; F:enzyme binding; F:peptidase activity; F:protease binding; F:serine-type endopeptidase activity;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization; P:protein processing; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein targeting to peroxisome; P:regulation of fatty acid beta-oxidation; P:response to organic cyclic compound;|Q86WA8 B7ZKL7 Q0D2H6 Q8N3B9 Q8NCE9 Q96K43,Lon protease homolog 2, peroxisomal {ECO:0000255|HAMAP-Rule:MF_03121},Lon protease-like protein 2 {ECO:0000255|HAMAP-Rule:MF_03121};Peroxisomal Lon protease {ECO:0000255|HAMAP-Rule:MF_03121};, PF00004;PF05362;PF02190;, GO:0005829;GO:0016020;GO:0005634;GO:0005782;GO:0005777;GO:0005524;GO:0004176;GO:0019899;GO:0008233;GO:0002020;GO:0004252;GO:0007031;GO:0016558;GO:0008104;GO:0016485;GO:0006515;GO:0006625;GO:0031998;GO:0014070;, C:cytosol; C:membrane; C:nucleus; C:peroxisomal matrix; C:peroxisome;, F:ATP binding; F:ATP-dependent peptidase activity; F:enzyme binding; F:peptidase activity; F:protease binding; F:serine-type endopeptidase activity;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization; P:protein processing; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein targeting to peroxisome; P:regulation of fatty acid beta-oxidation; P:response to organic cyclic compound; scaffold16 indexed_genome mRNA 13152901 13189178 . - . ID=transcript_4047;Q8IUQ4 A0FKF3 O43269 Q49A58 Q92880,E3 ubiquitin-protein ligase SIAH1,RING-type E3 ubiquitin transferase SIAH1 {ECO:0000305};Seven in absentia homolog 1;Siah-1a;, PF03145;, GO:0030877;GO:0005737;GO:0005829;GO:0005769;GO:0005634;GO:0005886;GO:0042802;GO:0008022;GO:0031624;GO:0061630;GO:0004842;GO:0008270;GO:1990000;GO:0009653;GO:0006915;GO:0007411;GO:0007049;GO:1902842;GO:0007399;GO:0051402;GO:0043065;GO:2001244;GO:0043161;GO:0030163;GO:0031648;GO:0000209;GO:0007283;GO:0006511;, C:beta-catenin destruction complex; C:cytoplasm; C:cytosol; C:early endosome; C:nucleus; C:plasma membrane;, F:identical protein binding; F:protein C-terminus binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:amyloid fibril formation; P:anatomical structure morphogenesis; P:apoptotic process; P:axon guidance; P:cell cycle; P:negative regulation of netrin-activated signaling pathway; P:nervous system development; P:neuron apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process;|Q8IUQ4 A0FKF3 O43269 Q49A58 Q92880,E3 ubiquitin-protein ligase SIAH1,RING-type E3 ubiquitin transferase SIAH1 {ECO:0000305};Seven in absentia homolog 1;Siah-1a;, PF03145;, GO:0030877;GO:0005737;GO:0005829;GO:0005769;GO:0005634;GO:0005886;GO:0042802;GO:0008022;GO:0031624;GO:0061630;GO:0004842;GO:0008270;GO:1990000;GO:0009653;GO:0006915;GO:0007411;GO:0007049;GO:1902842;GO:0007399;GO:0051402;GO:0043065;GO:2001244;GO:0043161;GO:0030163;GO:0031648;GO:0000209;GO:0007283;GO:0006511;, C:beta-catenin destruction complex; C:cytoplasm; C:cytosol; C:early endosome; C:nucleus; C:plasma membrane;, F:identical protein binding; F:protein C-terminus binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:amyloid fibril formation; P:anatomical structure morphogenesis; P:apoptotic process; P:axon guidance; P:cell cycle; P:negative regulation of netrin-activated signaling pathway; P:nervous system development; P:neuron apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process; scaffold16 indexed_genome mRNA 13338808 13359507 . - . ID=transcript_4048;O75113 A7MD49 Q2YDX1,NEDD4-binding protein 1 {ECO:0000250|UniProtKB:Q6A037},, PF11977;, GO:0005829;GO:0005730;GO:0005634;GO:0016605;GO:0003729;GO:0004540;GO:0043130;GO:0034644;GO:0045087;GO:0001818;GO:0032435;GO:0031397;GO:0045071;GO:0045088;, C:cytosol; C:nucleolus; C:nucleus; C:PML body;, F:mRNA binding; F:ribonuclease activity; F:ubiquitin binding;, P:cellular response to UV; P:innate immune response; P:negative regulation of cytokine production; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:negative regulation of viral genome replication; P:regulation of innate immune response;|O75113 A7MD49 Q2YDX1,NEDD4-binding protein 1 {ECO:0000250|UniProtKB:Q6A037},, PF11977;, GO:0005829;GO:0005730;GO:0005634;GO:0016605;GO:0003729;GO:0004540;GO:0043130;GO:0034644;GO:0045087;GO:0001818;GO:0032435;GO:0031397;GO:0045071;GO:0045088;, C:cytosol; C:nucleolus; C:nucleus; C:PML body;, F:mRNA binding; F:ribonuclease activity; F:ubiquitin binding;, P:cellular response to UV; P:innate immune response; P:negative regulation of cytokine production; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:negative regulation of viral genome replication; P:regulation of innate immune response;|O75113 A7MD49 Q2YDX1,NEDD4-binding protein 1 {ECO:0000250|UniProtKB:Q6A037},, PF11977;, GO:0005829;GO:0005730;GO:0005634;GO:0016605;GO:0003729;GO:0004540;GO:0043130;GO:0034644;GO:0045087;GO:0001818;GO:0032435;GO:0031397;GO:0045071;GO:0045088;, C:cytosol; C:nucleolus; C:nucleus; C:PML body;, F:mRNA binding; F:ribonuclease activity; F:ubiquitin binding;, P:cellular response to UV; P:innate immune response; P:negative regulation of cytokine production; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:negative regulation of viral genome replication; P:regulation of innate immune response; scaffold16 indexed_genome mRNA 14133936 14138232 . - . ID=transcript_4049;P23435 B2RAN9 P02682 Q52M09,Cerebellin-1,Precerebellin;, PF00386;, GO:0062023;GO:0005576;GO:0098978;GO:0098688;GO:0045211;GO:0043083;GO:0042802;GO:0021707;GO:0007268;GO:0007157;GO:0099558;GO:0090394;GO:1905703;GO:0007399;GO:1900454;GO:0051965;GO:0009306;GO:0099151;GO:1905606;GO:0050808;, C:collagen-containing extracellular matrix; C:extracellular region; C:glutamatergic synapse; C:parallel fiber to Purkinje cell synapse; C:postsynaptic membrane; C:synaptic cleft;, F:identical protein binding;, P:cerebellar granule cell differentiation; P:chemical synaptic transmission; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:maintenance of synapse structure; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of inhibitory synapse assembly; P:nervous system development; P:positive regulation of long-term synaptic depression; P:positive regulation of synapse assembly; P:protein secretion; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synapse organization; scaffold16 indexed_genome mRNA 14176222 14177459 . - . ID=transcript_4050;Q5THR3 A8K8P6 A8K8Y3 B0QYI4 B0QYI6 Q5U5T6 Q9BY88 Q9H5C4 Q9NSF5,EF-hand calcium-binding domain-containing protein 6,CAP-binding protein complex-interacting protein 1;DJ-1-binding protein;, PF08976;PF13499;PF13833;, GO:0005654;GO:0005509;, C:nucleoplasm;, F:calcium ion binding; scaffold16 indexed_genome mRNA 14350824 14497543 . - . ID=transcript_4051;Q2M1K9 O94860 Q76N04 Q9NZ13,Zinc finger protein 423,Olf1/EBF-associated zinc finger protein;Smad- and Olf-interacting zinc finger protein;, PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:0030154;GO:0021930;GO:0060271;GO:0120163;GO:0045892;GO:0007219;GO:0030513;GO:0045893;GO:0061512;GO:0006355;GO:0021938;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:cell differentiation; P:cerebellar granule cell precursor proliferation; P:cilium assembly; P:negative regulation of cold-induced thermogenesis; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:positive regulation of BMP signaling pathway; P:positive regulation of transcription, DNA-templated; P:protein localization to cilium; P:regulation of transcription, DNA-templated; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; scaffold16 indexed_genome mRNA 14800553 14903079 . - . ID=transcript_4052;Q7Z4Q2 A8K1N4 Q8N525 Q8WV56 Q96CC9 Q9NWN7,HEAT repeat-containing protein 3,, , GO:0051082;GO:0006606;GO:0042273;, , F:unfolded protein binding;, P:protein import into nucleus; P:ribosomal large subunit biogenesis;|Q8N9A8 Q4G1A9 Q5H9V0 Q8NE06,Nuclear envelope phosphatase-regulatory subunit 1,Transmembrane protein 188;, PF09771;, GO:0005737;GO:0005829;GO:0016021;GO:0071595;GO:0005635;GO:0031965;GO:0006629;GO:0007077;GO:0035307;GO:0010867;GO:0034504;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:Nem1-Spo7 phosphatase complex; C:nuclear envelope; C:nuclear membrane;, , P:lipid metabolic process; P:mitotic nuclear envelope disassembly; P:positive regulation of protein dephosphorylation; P:positive regulation of triglyceride biosynthetic process; P:protein localization to nucleus;|Q8N9A8 Q4G1A9 Q5H9V0 Q8NE06,Nuclear envelope phosphatase-regulatory subunit 1,Transmembrane protein 188;, PF09771;, GO:0005737;GO:0005829;GO:0016021;GO:0071595;GO:0005635;GO:0031965;GO:0006629;GO:0007077;GO:0035307;GO:0010867;GO:0034504;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:Nem1-Spo7 phosphatase complex; C:nuclear envelope; C:nuclear membrane;, , P:lipid metabolic process; P:mitotic nuclear envelope disassembly; P:positive regulation of protein dephosphorylation; P:positive regulation of triglyceride biosynthetic process; P:protein localization to nucleus;|Q7Z4Q2 A8K1N4 Q8N525 Q8WV56 Q96CC9 Q9NWN7,HEAT repeat-containing protein 3,, , GO:0051082;GO:0006606;GO:0042273;, , F:unfolded protein binding;, P:protein import into nucleus; P:ribosomal large subunit biogenesis;|Q7Z4Q2 A8K1N4 Q8N525 Q8WV56 Q96CC9 Q9NWN7,HEAT repeat-containing protein 3,, , GO:0051082;GO:0006606;GO:0042273;, , F:unfolded protein binding;, P:protein import into nucleus; P:ribosomal large subunit biogenesis;|Q7Z4Q2 A8K1N4 Q8N525 Q8WV56 Q96CC9 Q9NWN7,HEAT repeat-containing protein 3,, , GO:0051082;GO:0006606;GO:0042273;, , F:unfolded protein binding;, P:protein import into nucleus; P:ribosomal large subunit biogenesis;|Q7Z4Q2 A8K1N4 Q8N525 Q8WV56 Q96CC9 Q9NWN7,HEAT repeat-containing protein 3,, , GO:0051082;GO:0006606;GO:0042273;, , F:unfolded protein binding;, P:protein import into nucleus; P:ribosomal large subunit biogenesis;|Q7Z4Q2 A8K1N4 Q8N525 Q8WV56 Q96CC9 Q9NWN7,HEAT repeat-containing protein 3,, , GO:0051082;GO:0006606;GO:0042273;, , F:unfolded protein binding;, P:protein import into nucleus; P:ribosomal large subunit biogenesis;|Q7Z4Q2 A8K1N4 Q8N525 Q8WV56 Q96CC9 Q9NWN7,HEAT repeat-containing protein 3,, , GO:0051082;GO:0006606;GO:0042273;, , F:unfolded protein binding;, P:protein import into nucleus; P:ribosomal large subunit biogenesis; scaffold16 indexed_genome mRNA 15006698 15007747 . - . ID=transcript_4053;Q8NDF8 B4DV38 Q9NW67 Q9Y6C0,Terminal nucleotidyltransferase 4B {ECO:0000305},Non-canonical poly(A) RNA polymerase PAPD5 {ECO:0000305};PAP-associated domain-containing protein 5;Terminal guanylyltransferase {ECO:0000305};Terminal uridylyltransferase 3;Topoisomerase-related function protein 4-2;, PF01909;PF03828;, GO:0005737;GO:0005730;GO:0031499;GO:0003677;GO:0003887;GO:0070568;GO:0046872;GO:0004652;GO:0003723;GO:0070034;GO:0033500;GO:0007049;GO:0051301;GO:0071044;GO:0010587;GO:0006378;GO:0043629;GO:0043630;GO:0060212;GO:0032211;GO:1905870;GO:0071076;GO:0031123;GO:0006364;GO:0071050;, C:cytoplasm; C:nucleolus; C:TRAMP complex;, F:DNA binding; F:DNA-directed DNA polymerase activity; F:guanylyltransferase activity; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:telomerase RNA binding;, P:carbohydrate homeostasis; P:cell cycle; P:cell division; P:histone mRNA catabolic process; P:miRNA catabolic process; P:mRNA polyadenylation; P:ncRNA polyadenylation; P:ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:RNA 3' uridylation; P:RNA 3'-end processing; P:rRNA processing; P:sno(s)RNA polyadenylation; scaffold16 indexed_genome mRNA 15017013 15022783 . - . ID=transcript_4054;Q8NDF8 B4DV38 Q9NW67 Q9Y6C0,Terminal nucleotidyltransferase 4B {ECO:0000305},Non-canonical poly(A) RNA polymerase PAPD5 {ECO:0000305};PAP-associated domain-containing protein 5;Terminal guanylyltransferase {ECO:0000305};Terminal uridylyltransferase 3;Topoisomerase-related function protein 4-2;, PF01909;PF03828;, GO:0005737;GO:0005730;GO:0031499;GO:0003677;GO:0003887;GO:0070568;GO:0046872;GO:0004652;GO:0003723;GO:0070034;GO:0033500;GO:0007049;GO:0051301;GO:0071044;GO:0010587;GO:0006378;GO:0043629;GO:0043630;GO:0060212;GO:0032211;GO:1905870;GO:0071076;GO:0031123;GO:0006364;GO:0071050;, C:cytoplasm; C:nucleolus; C:TRAMP complex;, F:DNA binding; F:DNA-directed DNA polymerase activity; F:guanylyltransferase activity; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:telomerase RNA binding;, P:carbohydrate homeostasis; P:cell cycle; P:cell division; P:histone mRNA catabolic process; P:miRNA catabolic process; P:mRNA polyadenylation; P:ncRNA polyadenylation; P:ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:RNA 3' uridylation; P:RNA 3'-end processing; P:rRNA processing; P:sno(s)RNA polyadenylation;|Q8NDF8 B4DV38 Q9NW67 Q9Y6C0,Terminal nucleotidyltransferase 4B {ECO:0000305},Non-canonical poly(A) RNA polymerase PAPD5 {ECO:0000305};PAP-associated domain-containing protein 5;Terminal guanylyltransferase {ECO:0000305};Terminal uridylyltransferase 3;Topoisomerase-related function protein 4-2;, PF01909;PF03828;, GO:0005737;GO:0005730;GO:0031499;GO:0003677;GO:0003887;GO:0070568;GO:0046872;GO:0004652;GO:0003723;GO:0070034;GO:0033500;GO:0007049;GO:0051301;GO:0071044;GO:0010587;GO:0006378;GO:0043629;GO:0043630;GO:0060212;GO:0032211;GO:1905870;GO:0071076;GO:0031123;GO:0006364;GO:0071050;, C:cytoplasm; C:nucleolus; C:TRAMP complex;, F:DNA binding; F:DNA-directed DNA polymerase activity; F:guanylyltransferase activity; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:telomerase RNA binding;, P:carbohydrate homeostasis; P:cell cycle; P:cell division; P:histone mRNA catabolic process; P:miRNA catabolic process; P:mRNA polyadenylation; P:ncRNA polyadenylation; P:ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:RNA 3' uridylation; P:RNA 3'-end processing; P:rRNA processing; P:sno(s)RNA polyadenylation; scaffold16 indexed_genome mRNA 15075649 15104327 . + . ID=transcript_4055;P51828 A0AVA6,Adenylate cyclase type 7 {ECO:0000305},ATP pyrophosphate-lyase 7;Adenylate cyclase type VII;Adenylyl cyclase 7;, PF16214;PF06327;PF00211;, GO:0016021;GO:0005887;GO:0005886;GO:0004016;GO:0005524;GO:0046872;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:0071361;GO:0071377;GO:0071285;GO:0007186;GO:0060135;GO:1900016;GO:0002862;GO:0002819;GO:0003091;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to ethanol; P:cellular response to glucagon stimulus; P:cellular response to lithium ion; P:G protein-coupled receptor signaling pathway; P:maternal process involved in female pregnancy; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of inflammatory response to antigenic stimulus; P:regulation of adaptive immune response; P:renal water homeostasis; scaffold16 indexed_genome mRNA 15104329 15114061 . - . ID=transcript_4056;Q9NPI1 Q4VC09 Q8N2L9 Q96KA4 Q9BV48 Q9UH59,Bromodomain-containing protein 7,75 kDa bromodomain protein;Protein CELTIX-1;, PF00439;PF12024;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0042393;GO:0070577;GO:0002039;GO:0003713;GO:0003714;GO:0008134;GO:0000976;GO:0007049;GO:0008285;GO:2000134;GO:0045892;GO:0035066;GO:0045893;GO:1901796;GO:0006357;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone binding; F:lysine-acetylated histone binding; F:p53 binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|Q9NPI1 Q4VC09 Q8N2L9 Q96KA4 Q9BV48 Q9UH59,Bromodomain-containing protein 7,75 kDa bromodomain protein;Protein CELTIX-1;, PF00439;PF12024;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0042393;GO:0070577;GO:0002039;GO:0003713;GO:0003714;GO:0008134;GO:0000976;GO:0007049;GO:0008285;GO:2000134;GO:0045892;GO:0035066;GO:0045893;GO:1901796;GO:0006357;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone binding; F:lysine-acetylated histone binding; F:p53 binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|Q9NPI1 Q4VC09 Q8N2L9 Q96KA4 Q9BV48 Q9UH59,Bromodomain-containing protein 7,75 kDa bromodomain protein;Protein CELTIX-1;, PF00439;PF12024;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0042393;GO:0070577;GO:0002039;GO:0003713;GO:0003714;GO:0008134;GO:0000976;GO:0007049;GO:0008285;GO:2000134;GO:0045892;GO:0035066;GO:0045893;GO:1901796;GO:0006357;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone binding; F:lysine-acetylated histone binding; F:p53 binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|Q9NPI1 Q4VC09 Q8N2L9 Q96KA4 Q9BV48 Q9UH59,Bromodomain-containing protein 7,75 kDa bromodomain protein;Protein CELTIX-1;, PF00439;PF12024;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0042393;GO:0070577;GO:0002039;GO:0003713;GO:0003714;GO:0008134;GO:0000976;GO:0007049;GO:0008285;GO:2000134;GO:0045892;GO:0035066;GO:0045893;GO:1901796;GO:0006357;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone binding; F:lysine-acetylated histone binding; F:p53 binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway;|Q9NPI1 Q4VC09 Q8N2L9 Q96KA4 Q9BV48 Q9UH59,Bromodomain-containing protein 7,75 kDa bromodomain protein;Protein CELTIX-1;, PF00439;PF12024;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0042393;GO:0070577;GO:0002039;GO:0003713;GO:0003714;GO:0008134;GO:0000976;GO:0007049;GO:0008285;GO:2000134;GO:0045892;GO:0035066;GO:0045893;GO:1901796;GO:0006357;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone binding; F:lysine-acetylated histone binding; F:p53 binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 15126966 15130143 . - . ID=transcript_4057;Q9NPI1 Q4VC09 Q8N2L9 Q96KA4 Q9BV48 Q9UH59,Bromodomain-containing protein 7,75 kDa bromodomain protein;Protein CELTIX-1;, PF00439;PF12024;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0042393;GO:0070577;GO:0002039;GO:0003713;GO:0003714;GO:0008134;GO:0000976;GO:0007049;GO:0008285;GO:2000134;GO:0045892;GO:0035066;GO:0045893;GO:1901796;GO:0006357;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone binding; F:lysine-acetylated histone binding; F:p53 binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 15326369 15413679 . + . ID=transcript_4058;Q969G9 B2RC39 Q8WZ08,Protein naked cuticle homolog 1,, , GO:0005737;GO:0005886;GO:0000159;GO:0005509;GO:0030165;GO:0001754;GO:0090090;GO:1901233;GO:0030178;GO:1901231;GO:0045732;GO:2000096;GO:0090249;GO:0007525;GO:0016055;, C:cytoplasm; C:plasma membrane; C:protein phosphatase type 2A complex;, F:calcium ion binding; F:PDZ domain binding;, P:eye photoreceptor cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of convergent extension involved in axis elongation; P:negative regulation of Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway via JNK cascade; P:positive regulation of protein catabolic process; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:regulation of cell migration involved in somitogenic axis elongation; P:somatic muscle development; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 15446564 15454994 . - . ID=transcript_4059;Q7Z614 A8K9D5 Q08E98 Q6P4H2 Q8IV59,Sorting nexin-20,Selectin ligand-interactor cytoplasmic 1 {ECO:0000303|PubMed:18196517};, PF00787;, GO:0031901;GO:0005654;GO:0005886;GO:0032266;GO:0005546;GO:0015031;, C:early endosome membrane; C:nucleoplasm; C:plasma membrane;, F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:protein transport; scaffold16 indexed_genome mRNA 15469260 15503380 . + . ID=transcript_4060;Q9HC29 E2JEQ6 Q96RH5 Q96RH6 Q96RH8,Nucleotide-binding oligomerization domain-containing protein 2,Caspase recruitment domain-containing protein 15;Inflammatory bowel disease protein 1;, PF00619;PF13516;PF05729;PF17776;PF17779;, GO:0046658;GO:0016323;GO:0009986;GO:0005737;GO:0005856;GO:0005829;GO:0005794;GO:0005739;GO:0045335;GO:0005886;GO:0032991;GO:0031982;GO:0003779;GO:0005524;GO:0050700;GO:0019899;GO:0030544;GO:0051879;GO:0032500;GO:0038187;GO:0042834;GO:0019901;GO:0044877;GO:0002253;GO:0000187;GO:0071222;GO:0071225;GO:0071407;GO:0071224;GO:0006952;GO:0042742;GO:0050830;GO:0016045;GO:0009595;GO:0032498;GO:0045087;GO:0002227;GO:0070498;GO:0035556;GO:0007254;GO:0030277;GO:0002862;GO:0032689;GO:0032695;GO:0032701;GO:0032703;GO:2000110;GO:0032088;GO:0002710;GO:0034136;GO:0032720;GO:0070431;GO:0070423;GO:0002221;GO:0050871;GO:0006965;GO:0002720;GO:1900017;GO:0002606;GO:0002732;GO:0050679;GO:0070374;GO:0046645;GO:0002925;GO:0043123;GO:0045089;GO:0032731;GO:0032733;GO:0032735;GO:0032740;GO:0032755;GO:0032757;GO:0046330;GO:0043406;GO:0071639;GO:0051092;GO:1901224;GO:0051770;GO:0045747;GO:0051353;GO:0050731;GO:0050766;GO:0043552;GO:2000363;GO:0060585;GO:1902523;GO:0032874;GO:0045944;GO:0032760;GO:0002830;GO:1904417;GO:0050727;GO:0090022;GO:0043330;GO:0032495;GO:0007584;, C:anchored component of plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cytoplasm; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:mitochondrion; C:phagocytic vesicle; C:plasma membrane; C:protein-containing complex; C:vesicle;, F:actin binding; F:ATP binding; F:CARD domain binding; F:enzyme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:muramyl dipeptide binding; F:pattern recognition receptor activity; F:peptidoglycan binding; F:protein kinase binding; F:protein-containing complex binding;, P:activation of immune response; P:activation of MAPK activity; P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:cellular response to organic cyclic compound; P:cellular response to peptidoglycan; P:defense response; P:defense response to bacterium; P:defense response to Gram-positive bacterium; P:detection of bacterium; P:detection of biotic stimulus; P:detection of muramyl dipeptide; P:innate immune response; P:innate immune response in mucosa; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:maintenance of gastrointestinal epithelium; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of macrophage apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell mediated immunity; P:negative regulation of toll-like receptor 2 signaling pathway; P:negative regulation of tumor necrosis factor production; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:pattern recognition receptor signaling pathway; P:positive regulation of B cell activation; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:positive regulation of cytokine production involved in immune response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of dendritic cell cytokine production; P:positive regulation of epithelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gamma-delta T cell activation; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of innate immune response; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of MAP kinase activity; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of Notch signaling pathway; P:positive regulation of oxidoreductase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of prostaglandin-E synthase activity; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of stress-activated MAPK cascade; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type 2 immune response; P:positive regulation of xenophagy; P:regulation of inflammatory response; P:regulation of neutrophil chemotaxis; P:response to exogenous dsRNA; P:response to muramyl dipeptide; P:response to nutrient; scaffold16 indexed_genome mRNA 15520543 15584192 . + . ID=transcript_4061;Q9NQC7 O94934 Q7L3N6 Q96EH0 Q9NZX9,Ubiquitin carboxyl-terminal hydrolase CYLD,Deubiquitinating enzyme CYLD;Ubiquitin thioesterase CYLD;Ubiquitin-specific-processing protease CYLD;, PF01302;PF00443;, GO:0005813;GO:0036064;GO:0097542;GO:0005829;GO:0031234;GO:0005874;GO:0048471;GO:0005819;GO:0008234;GO:0061578;GO:0070064;GO:0019901;GO:0004843;GO:0008270;GO:0007049;GO:0045087;GO:0070266;GO:0090090;GO:0046329;GO:0032088;GO:1901223;GO:1903753;GO:0032480;GO:0070423;GO:2001238;GO:0016579;GO:0070536;GO:1990108;GO:1902017;GO:0050727;GO:2001242;GO:0070507;GO:0007346;GO:0060544;GO:0010803;GO:0006511;GO:0016055;, C:centrosome; C:ciliary basal body; C:ciliary tip; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:microtubule; C:perinuclear region of cytoplasm; C:spindle;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:proline-rich region binding; F:protein kinase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell cycle; P:innate immune response; P:necroptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of p38MAPK cascade; P:negative regulation of type I interferon production; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein linear deubiquitination; P:regulation of cilium assembly; P:regulation of inflammatory response; P:regulation of intrinsic apoptotic signaling pathway; P:regulation of microtubule cytoskeleton organization; P:regulation of mitotic cell cycle; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q9NQC7 O94934 Q7L3N6 Q96EH0 Q9NZX9,Ubiquitin carboxyl-terminal hydrolase CYLD,Deubiquitinating enzyme CYLD;Ubiquitin thioesterase CYLD;Ubiquitin-specific-processing protease CYLD;, PF01302;PF00443;, GO:0005813;GO:0036064;GO:0097542;GO:0005829;GO:0031234;GO:0005874;GO:0048471;GO:0005819;GO:0008234;GO:0061578;GO:0070064;GO:0019901;GO:0004843;GO:0008270;GO:0007049;GO:0045087;GO:0070266;GO:0090090;GO:0046329;GO:0032088;GO:1901223;GO:1903753;GO:0032480;GO:0070423;GO:2001238;GO:0016579;GO:0070536;GO:1990108;GO:1902017;GO:0050727;GO:2001242;GO:0070507;GO:0007346;GO:0060544;GO:0010803;GO:0006511;GO:0016055;, C:centrosome; C:ciliary basal body; C:ciliary tip; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:microtubule; C:perinuclear region of cytoplasm; C:spindle;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:proline-rich region binding; F:protein kinase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell cycle; P:innate immune response; P:necroptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of p38MAPK cascade; P:negative regulation of type I interferon production; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein linear deubiquitination; P:regulation of cilium assembly; P:regulation of inflammatory response; P:regulation of intrinsic apoptotic signaling pathway; P:regulation of microtubule cytoskeleton organization; P:regulation of mitotic cell cycle; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q9NQC7 O94934 Q7L3N6 Q96EH0 Q9NZX9,Ubiquitin carboxyl-terminal hydrolase CYLD,Deubiquitinating enzyme CYLD;Ubiquitin thioesterase CYLD;Ubiquitin-specific-processing protease CYLD;, PF01302;PF00443;, GO:0005813;GO:0036064;GO:0097542;GO:0005829;GO:0031234;GO:0005874;GO:0048471;GO:0005819;GO:0008234;GO:0061578;GO:0070064;GO:0019901;GO:0004843;GO:0008270;GO:0007049;GO:0045087;GO:0070266;GO:0090090;GO:0046329;GO:0032088;GO:1901223;GO:1903753;GO:0032480;GO:0070423;GO:2001238;GO:0016579;GO:0070536;GO:1990108;GO:1902017;GO:0050727;GO:2001242;GO:0070507;GO:0007346;GO:0060544;GO:0010803;GO:0006511;GO:0016055;, C:centrosome; C:ciliary basal body; C:ciliary tip; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:microtubule; C:perinuclear region of cytoplasm; C:spindle;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:proline-rich region binding; F:protein kinase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell cycle; P:innate immune response; P:necroptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of p38MAPK cascade; P:negative regulation of type I interferon production; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein linear deubiquitination; P:regulation of cilium assembly; P:regulation of inflammatory response; P:regulation of intrinsic apoptotic signaling pathway; P:regulation of microtubule cytoskeleton organization; P:regulation of mitotic cell cycle; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q9NQC7 O94934 Q7L3N6 Q96EH0 Q9NZX9,Ubiquitin carboxyl-terminal hydrolase CYLD,Deubiquitinating enzyme CYLD;Ubiquitin thioesterase CYLD;Ubiquitin-specific-processing protease CYLD;, PF01302;PF00443;, GO:0005813;GO:0036064;GO:0097542;GO:0005829;GO:0031234;GO:0005874;GO:0048471;GO:0005819;GO:0008234;GO:0061578;GO:0070064;GO:0019901;GO:0004843;GO:0008270;GO:0007049;GO:0045087;GO:0070266;GO:0090090;GO:0046329;GO:0032088;GO:1901223;GO:1903753;GO:0032480;GO:0070423;GO:2001238;GO:0016579;GO:0070536;GO:1990108;GO:1902017;GO:0050727;GO:2001242;GO:0070507;GO:0007346;GO:0060544;GO:0010803;GO:0006511;GO:0016055;, C:centrosome; C:ciliary basal body; C:ciliary tip; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:microtubule; C:perinuclear region of cytoplasm; C:spindle;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:proline-rich region binding; F:protein kinase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell cycle; P:innate immune response; P:necroptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of p38MAPK cascade; P:negative regulation of type I interferon production; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein linear deubiquitination; P:regulation of cilium assembly; P:regulation of inflammatory response; P:regulation of intrinsic apoptotic signaling pathway; P:regulation of microtubule cytoskeleton organization; P:regulation of mitotic cell cycle; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q9NQC7 O94934 Q7L3N6 Q96EH0 Q9NZX9,Ubiquitin carboxyl-terminal hydrolase CYLD,Deubiquitinating enzyme CYLD;Ubiquitin thioesterase CYLD;Ubiquitin-specific-processing protease CYLD;, PF01302;PF00443;, GO:0005813;GO:0036064;GO:0097542;GO:0005829;GO:0031234;GO:0005874;GO:0048471;GO:0005819;GO:0008234;GO:0061578;GO:0070064;GO:0019901;GO:0004843;GO:0008270;GO:0007049;GO:0045087;GO:0070266;GO:0090090;GO:0046329;GO:0032088;GO:1901223;GO:1903753;GO:0032480;GO:0070423;GO:2001238;GO:0016579;GO:0070536;GO:1990108;GO:1902017;GO:0050727;GO:2001242;GO:0070507;GO:0007346;GO:0060544;GO:0010803;GO:0006511;GO:0016055;, C:centrosome; C:ciliary basal body; C:ciliary tip; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:microtubule; C:perinuclear region of cytoplasm; C:spindle;, F:cysteine-type peptidase activity; F:Lys63-specific deubiquitinase activity; F:proline-rich region binding; F:protein kinase binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell cycle; P:innate immune response; P:necroptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of p38MAPK cascade; P:negative regulation of type I interferon production; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein linear deubiquitination; P:regulation of cilium assembly; P:regulation of inflammatory response; P:regulation of intrinsic apoptotic signaling pathway; P:regulation of microtubule cytoskeleton organization; P:regulation of mitotic cell cycle; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 15910664 15925484 . - . ID=transcript_4062;Q9NSC2 Q99881 Q9NSC3 Q9P1R0,Sal-like protein 1,Spalt-like transcription factor 1;Zinc finger protein 794;Zinc finger protein SALL1;Zinc finger protein Spalt-1;, PF00096;, GO:0010369;GO:0005737;GO:0000792;GO:0005654;GO:0005634;GO:0008013;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0030325;GO:0001658;GO:0048566;GO:0042733;GO:0008406;GO:0007507;GO:0031129;GO:0001822;GO:0072073;GO:0060173;GO:0003337;GO:0000122;GO:0045892;GO:0021889;GO:0061034;GO:0021553;GO:0021983;GO:0045944;GO:0045893;GO:0030177;GO:0006357;GO:0035019;GO:0001657;GO:0072092;GO:0003281;, C:chromocenter; C:cytoplasm; C:heterochromatin; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adrenal gland development; P:branching involved in ureteric bud morphogenesis; P:embryonic digestive tract development; P:embryonic digit morphogenesis; P:gonad development; P:heart development; P:inductive cell-cell signaling; P:kidney development; P:kidney epithelium development; P:limb development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:olfactory bulb interneuron differentiation; P:olfactory bulb mitral cell layer development; P:olfactory nerve development; P:pituitary gland development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription by RNA polymerase II; P:somatic stem cell population maintenance; P:ureteric bud development; P:ureteric bud invasion; P:ventricular septum development;|Q9NSC2 Q99881 Q9NSC3 Q9P1R0,Sal-like protein 1,Spalt-like transcription factor 1;Zinc finger protein 794;Zinc finger protein SALL1;Zinc finger protein Spalt-1;, PF00096;, GO:0010369;GO:0005737;GO:0000792;GO:0005654;GO:0005634;GO:0008013;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0030325;GO:0001658;GO:0048566;GO:0042733;GO:0008406;GO:0007507;GO:0031129;GO:0001822;GO:0072073;GO:0060173;GO:0003337;GO:0000122;GO:0045892;GO:0021889;GO:0061034;GO:0021553;GO:0021983;GO:0045944;GO:0045893;GO:0030177;GO:0006357;GO:0035019;GO:0001657;GO:0072092;GO:0003281;, C:chromocenter; C:cytoplasm; C:heterochromatin; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adrenal gland development; P:branching involved in ureteric bud morphogenesis; P:embryonic digestive tract development; P:embryonic digit morphogenesis; P:gonad development; P:heart development; P:inductive cell-cell signaling; P:kidney development; P:kidney epithelium development; P:limb development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:olfactory bulb interneuron differentiation; P:olfactory bulb mitral cell layer development; P:olfactory nerve development; P:pituitary gland development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription by RNA polymerase II; P:somatic stem cell population maintenance; P:ureteric bud development; P:ureteric bud invasion; P:ventricular septum development;|Q9NSC2 Q99881 Q9NSC3 Q9P1R0,Sal-like protein 1,Spalt-like transcription factor 1;Zinc finger protein 794;Zinc finger protein SALL1;Zinc finger protein Spalt-1;, PF00096;, GO:0010369;GO:0005737;GO:0000792;GO:0005654;GO:0005634;GO:0008013;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0030325;GO:0001658;GO:0048566;GO:0042733;GO:0008406;GO:0007507;GO:0031129;GO:0001822;GO:0072073;GO:0060173;GO:0003337;GO:0000122;GO:0045892;GO:0021889;GO:0061034;GO:0021553;GO:0021983;GO:0045944;GO:0045893;GO:0030177;GO:0006357;GO:0035019;GO:0001657;GO:0072092;GO:0003281;, C:chromocenter; C:cytoplasm; C:heterochromatin; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adrenal gland development; P:branching involved in ureteric bud morphogenesis; P:embryonic digestive tract development; P:embryonic digit morphogenesis; P:gonad development; P:heart development; P:inductive cell-cell signaling; P:kidney development; P:kidney epithelium development; P:limb development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:olfactory bulb interneuron differentiation; P:olfactory bulb mitral cell layer development; P:olfactory nerve development; P:pituitary gland development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription by RNA polymerase II; P:somatic stem cell population maintenance; P:ureteric bud development; P:ureteric bud invasion; P:ventricular septum development; scaffold16 indexed_genome mRNA 17190155 17196832 . - . ID=transcript_4063;O15405 B4DRD0 B5MCW4,TOX high mobility group box family member 3,CAG trinucleotide repeat-containing gene F9 protein;Trinucleotide repeat-containing gene 9 protein;, PF00505;, GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0031490;GO:0051219;GO:0042803;GO:0003713;GO:0006915;GO:0043524;GO:0045944;GO:0042981;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:chromatin DNA binding; F:phosphoprotein binding; F:protein homodimerization activity; F:transcription coactivator activity;, P:apoptotic process; P:negative regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of apoptotic process; P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 17740990 17742257 . - . ID=transcript_4064;P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold16 indexed_genome mRNA 17877017 17892773 . - . ID=transcript_4065;Q3L8U1 B2RTU2 B9ZVQ0 O15025 Q1WF12 Q6DTK9 Q9H9V7 Q9UHM2,Chromodomain-helicase-DNA-binding protein 9,ATP-dependent helicase CHD9;Chromatin-related mesenchymal modulator;Chromatin-remodeling factor CHROM1;Kismet homolog 2;PPAR-alpha-interacting complex protein 320 kDa;Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein;, PF07533;PF00385;PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005524;GO:0003677;GO:0003678;GO:0070615;GO:0006325;GO:0019216;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity;, P:chromatin organization; P:regulation of lipid metabolic process; scaffold16 indexed_genome mRNA 17927352 17929161 . + . ID=transcript_4066;Q3L8U1 B2RTU2 B9ZVQ0 O15025 Q1WF12 Q6DTK9 Q9H9V7 Q9UHM2,Chromodomain-helicase-DNA-binding protein 9,ATP-dependent helicase CHD9;Chromatin-related mesenchymal modulator;Chromatin-remodeling factor CHROM1;Kismet homolog 2;PPAR-alpha-interacting complex protein 320 kDa;Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein;, PF07533;PF00385;PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005524;GO:0003677;GO:0003678;GO:0070615;GO:0006325;GO:0019216;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity;, P:chromatin organization; P:regulation of lipid metabolic process; scaffold16 indexed_genome mRNA 17942391 18005740 . + . ID=transcript_4067;Q3L8U1 B2RTU2 B9ZVQ0 O15025 Q1WF12 Q6DTK9 Q9H9V7 Q9UHM2,Chromodomain-helicase-DNA-binding protein 9,ATP-dependent helicase CHD9;Chromatin-related mesenchymal modulator;Chromatin-remodeling factor CHROM1;Kismet homolog 2;PPAR-alpha-interacting complex protein 320 kDa;Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein;, PF07533;PF00385;PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005524;GO:0003677;GO:0003678;GO:0070615;GO:0006325;GO:0019216;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity;, P:chromatin organization; P:regulation of lipid metabolic process; scaffold16 indexed_genome mRNA 18006550 18007388 . + . ID=transcript_4068;Q3L8U1 B2RTU2 B9ZVQ0 O15025 Q1WF12 Q6DTK9 Q9H9V7 Q9UHM2,Chromodomain-helicase-DNA-binding protein 9,ATP-dependent helicase CHD9;Chromatin-related mesenchymal modulator;Chromatin-remodeling factor CHROM1;Kismet homolog 2;PPAR-alpha-interacting complex protein 320 kDa;Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein;, PF07533;PF00385;PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005524;GO:0003677;GO:0003678;GO:0070615;GO:0006325;GO:0019216;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity;, P:chromatin organization; P:regulation of lipid metabolic process; scaffold16 indexed_genome mRNA 18010530 18021299 . - . ID=transcript_4069;Q3L8U1 B2RTU2 B9ZVQ0 O15025 Q1WF12 Q6DTK9 Q9H9V7 Q9UHM2,Chromodomain-helicase-DNA-binding protein 9,ATP-dependent helicase CHD9;Chromatin-related mesenchymal modulator;Chromatin-remodeling factor CHROM1;Kismet homolog 2;PPAR-alpha-interacting complex protein 320 kDa;Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein;, PF07533;PF00385;PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005524;GO:0003677;GO:0003678;GO:0070615;GO:0006325;GO:0019216;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity;, P:chromatin organization; P:regulation of lipid metabolic process;|Q3L8U1 B2RTU2 B9ZVQ0 O15025 Q1WF12 Q6DTK9 Q9H9V7 Q9UHM2,Chromodomain-helicase-DNA-binding protein 9,ATP-dependent helicase CHD9;Chromatin-related mesenchymal modulator;Chromatin-remodeling factor CHROM1;Kismet homolog 2;PPAR-alpha-interacting complex protein 320 kDa;Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein;, PF07533;PF00385;PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005524;GO:0003677;GO:0003678;GO:0070615;GO:0006325;GO:0019216;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity;, P:chromatin organization; P:regulation of lipid metabolic process;|Q3L8U1 B2RTU2 B9ZVQ0 O15025 Q1WF12 Q6DTK9 Q9H9V7 Q9UHM2,Chromodomain-helicase-DNA-binding protein 9,ATP-dependent helicase CHD9;Chromatin-related mesenchymal modulator;Chromatin-remodeling factor CHROM1;Kismet homolog 2;PPAR-alpha-interacting complex protein 320 kDa;Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein;, PF07533;PF00385;PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005524;GO:0003677;GO:0003678;GO:0070615;GO:0006325;GO:0019216;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity;, P:chromatin organization; P:regulation of lipid metabolic process; scaffold16 indexed_genome mRNA 18041295 18079946 . + . ID=transcript_4070;Q08999 B7Z913 Q15073 Q16084 Q8NE70 Q92812,Retinoblastoma-like protein 2,130 kDa retinoblastoma-associated protein;Retinoblastoma-related protein 2;pRb2;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005694;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0030154;GO:0006325;GO:0006977;GO:2000134;GO:0010629;GO:0051302;GO:0043550;GO:0006357;, C:chromatin; C:chromosome; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:chromatin organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:regulation of cell division; P:regulation of lipid kinase activity; P:regulation of transcription by RNA polymerase II;|Q08999 B7Z913 Q15073 Q16084 Q8NE70 Q92812,Retinoblastoma-like protein 2,130 kDa retinoblastoma-associated protein;Retinoblastoma-related protein 2;pRb2;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005694;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0030154;GO:0006325;GO:0006977;GO:2000134;GO:0010629;GO:0051302;GO:0043550;GO:0006357;, C:chromatin; C:chromosome; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:chromatin organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:regulation of cell division; P:regulation of lipid kinase activity; P:regulation of transcription by RNA polymerase II;|Q08999 B7Z913 Q15073 Q16084 Q8NE70 Q92812,Retinoblastoma-like protein 2,130 kDa retinoblastoma-associated protein;Retinoblastoma-related protein 2;pRb2;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005694;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0030154;GO:0006325;GO:0006977;GO:2000134;GO:0010629;GO:0051302;GO:0043550;GO:0006357;, C:chromatin; C:chromosome; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:chromatin organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:regulation of cell division; P:regulation of lipid kinase activity; P:regulation of transcription by RNA polymerase II;|Q08999 B7Z913 Q15073 Q16084 Q8NE70 Q92812,Retinoblastoma-like protein 2,130 kDa retinoblastoma-associated protein;Retinoblastoma-related protein 2;pRb2;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005694;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0030154;GO:0006325;GO:0006977;GO:2000134;GO:0010629;GO:0051302;GO:0043550;GO:0006357;, C:chromatin; C:chromosome; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:chromatin organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:regulation of cell division; P:regulation of lipid kinase activity; P:regulation of transcription by RNA polymerase II;|Q08999 B7Z913 Q15073 Q16084 Q8NE70 Q92812,Retinoblastoma-like protein 2,130 kDa retinoblastoma-associated protein;Retinoblastoma-related protein 2;pRb2;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005694;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0030154;GO:0006325;GO:0006977;GO:2000134;GO:0010629;GO:0051302;GO:0043550;GO:0006357;, C:chromatin; C:chromosome; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:chromatin organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:regulation of cell division; P:regulation of lipid kinase activity; P:regulation of transcription by RNA polymerase II;|Q08999 B7Z913 Q15073 Q16084 Q8NE70 Q92812,Retinoblastoma-like protein 2,130 kDa retinoblastoma-associated protein;Retinoblastoma-related protein 2;pRb2;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005694;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0030154;GO:0006325;GO:0006977;GO:2000134;GO:0010629;GO:0051302;GO:0043550;GO:0006357;, C:chromatin; C:chromosome; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:chromatin organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:regulation of cell division; P:regulation of lipid kinase activity; P:regulation of transcription by RNA polymerase II;|Q08999 B7Z913 Q15073 Q16084 Q8NE70 Q92812,Retinoblastoma-like protein 2,130 kDa retinoblastoma-associated protein;Retinoblastoma-related protein 2;pRb2;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005694;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0030154;GO:0006325;GO:0006977;GO:2000134;GO:0010629;GO:0051302;GO:0043550;GO:0006357;, C:chromatin; C:chromosome; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:chromatin organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:regulation of cell division; P:regulation of lipid kinase activity; P:regulation of transcription by RNA polymerase II;|Q08999 B7Z913 Q15073 Q16084 Q8NE70 Q92812,Retinoblastoma-like protein 2,130 kDa retinoblastoma-associated protein;Retinoblastoma-related protein 2;pRb2;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005694;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0030154;GO:0006325;GO:0006977;GO:2000134;GO:0010629;GO:0051302;GO:0043550;GO:0006357;, C:chromatin; C:chromosome; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:chromatin organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:regulation of cell division; P:regulation of lipid kinase activity; P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 18084211 18090043 . - . ID=transcript_4071;Q9H8T0 Q503B1 Q53H38,AKT-interacting protein,Ft1;Fused toes protein homolog;, PF00179;, GO:0005829;GO:0070695;GO:0005634;GO:0005886;GO:0061631;GO:0006915;GO:0045022;GO:0007032;GO:0008333;GO:0007040;GO:0032092;GO:0001934;GO:0000209;GO:0015031;, C:cytosol; C:FHF complex; C:nucleus; C:plasma membrane;, F:ubiquitin conjugating enzyme activity;, P:apoptotic process; P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:lysosome organization; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:protein polyubiquitination; P:protein transport;|Q9H8T0 Q503B1 Q53H38,AKT-interacting protein,Ft1;Fused toes protein homolog;, PF00179;, GO:0005829;GO:0070695;GO:0005634;GO:0005886;GO:0061631;GO:0006915;GO:0045022;GO:0007032;GO:0008333;GO:0007040;GO:0032092;GO:0001934;GO:0000209;GO:0015031;, C:cytosol; C:FHF complex; C:nucleus; C:plasma membrane;, F:ubiquitin conjugating enzyme activity;, P:apoptotic process; P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:lysosome organization; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:protein polyubiquitination; P:protein transport;|Q9H8T0 Q503B1 Q53H38,AKT-interacting protein,Ft1;Fused toes protein homolog;, PF00179;, GO:0005829;GO:0070695;GO:0005634;GO:0005886;GO:0061631;GO:0006915;GO:0045022;GO:0007032;GO:0008333;GO:0007040;GO:0032092;GO:0001934;GO:0000209;GO:0015031;, C:cytosol; C:FHF complex; C:nucleus; C:plasma membrane;, F:ubiquitin conjugating enzyme activity;, P:apoptotic process; P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:lysosome organization; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:protein polyubiquitination; P:protein transport; scaffold16 indexed_genome mRNA 18173301 18268204 . + . ID=transcript_4072;Q68CZ1 A0PJ88 Q9Y2K8,Protein fantom,Nephrocystin-8;RPGR-interacting protein 1-like protein;, PF00168;PF11618;PF18111;, GO:0005879;GO:0005930;GO:0005923;GO:0005911;GO:0005813;GO:0036064;GO:0035253;GO:0035869;GO:0005929;GO:0005737;GO:0005829;GO:0005654;GO:0032391;GO:0005886;GO:0031870;GO:0021549;GO:0097711;GO:0090102;GO:0022038;GO:0007368;GO:0035115;GO:0035116;GO:0001736;GO:0007163;GO:0001701;GO:0001822;GO:0021670;GO:0001889;GO:0045744;GO:0021532;GO:1905515;GO:0043584;GO:0021772;GO:0060039;GO:0008589;GO:0046548;, C:axonemal microtubule; C:axoneme; C:bicellular tight junction; C:cell-cell junction; C:centrosome; C:ciliary basal body; C:ciliary rootlet; C:ciliary transition zone; C:cilium; C:cytoplasm; C:cytosol; C:nucleoplasm; C:photoreceptor connecting cilium; C:plasma membrane;, F:thromboxane A2 receptor binding;, P:cerebellum development; P:ciliary basal body-plasma membrane docking; P:cochlea development; P:corpus callosum development; P:determination of left/right symmetry; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:establishment of planar polarity; P:establishment or maintenance of cell polarity; P:in utero embryonic development; P:kidney development; P:lateral ventricle development; P:liver development; P:negative regulation of G protein-coupled receptor signaling pathway; P:neural tube patterning; P:non-motile cilium assembly; P:nose development; P:olfactory bulb development; P:pericardium development; P:regulation of smoothened signaling pathway; P:retinal rod cell development;|Q68CZ1 A0PJ88 Q9Y2K8,Protein fantom,Nephrocystin-8;RPGR-interacting protein 1-like protein;, PF00168;PF11618;PF18111;, GO:0005879;GO:0005930;GO:0005923;GO:0005911;GO:0005813;GO:0036064;GO:0035253;GO:0035869;GO:0005929;GO:0005737;GO:0005829;GO:0005654;GO:0032391;GO:0005886;GO:0031870;GO:0021549;GO:0097711;GO:0090102;GO:0022038;GO:0007368;GO:0035115;GO:0035116;GO:0001736;GO:0007163;GO:0001701;GO:0001822;GO:0021670;GO:0001889;GO:0045744;GO:0021532;GO:1905515;GO:0043584;GO:0021772;GO:0060039;GO:0008589;GO:0046548;, C:axonemal microtubule; C:axoneme; C:bicellular tight junction; C:cell-cell junction; C:centrosome; C:ciliary basal body; C:ciliary rootlet; C:ciliary transition zone; C:cilium; C:cytoplasm; C:cytosol; C:nucleoplasm; C:photoreceptor connecting cilium; C:plasma membrane;, F:thromboxane A2 receptor binding;, P:cerebellum development; P:ciliary basal body-plasma membrane docking; P:cochlea development; P:corpus callosum development; P:determination of left/right symmetry; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:establishment of planar polarity; P:establishment or maintenance of cell polarity; P:in utero embryonic development; P:kidney development; P:lateral ventricle development; P:liver development; P:negative regulation of G protein-coupled receptor signaling pathway; P:neural tube patterning; P:non-motile cilium assembly; P:nose development; P:olfactory bulb development; P:pericardium development; P:regulation of smoothened signaling pathway; P:retinal rod cell development;|Q68CZ1 A0PJ88 Q9Y2K8,Protein fantom,Nephrocystin-8;RPGR-interacting protein 1-like protein;, PF00168;PF11618;PF18111;, GO:0005879;GO:0005930;GO:0005923;GO:0005911;GO:0005813;GO:0036064;GO:0035253;GO:0035869;GO:0005929;GO:0005737;GO:0005829;GO:0005654;GO:0032391;GO:0005886;GO:0031870;GO:0021549;GO:0097711;GO:0090102;GO:0022038;GO:0007368;GO:0035115;GO:0035116;GO:0001736;GO:0007163;GO:0001701;GO:0001822;GO:0021670;GO:0001889;GO:0045744;GO:0021532;GO:1905515;GO:0043584;GO:0021772;GO:0060039;GO:0008589;GO:0046548;, C:axonemal microtubule; C:axoneme; C:bicellular tight junction; C:cell-cell junction; C:centrosome; C:ciliary basal body; C:ciliary rootlet; C:ciliary transition zone; C:cilium; C:cytoplasm; C:cytosol; C:nucleoplasm; C:photoreceptor connecting cilium; C:plasma membrane;, F:thromboxane A2 receptor binding;, P:cerebellum development; P:ciliary basal body-plasma membrane docking; P:cochlea development; P:corpus callosum development; P:determination of left/right symmetry; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:establishment of planar polarity; P:establishment or maintenance of cell polarity; P:in utero embryonic development; P:kidney development; P:lateral ventricle development; P:liver development; P:negative regulation of G protein-coupled receptor signaling pathway; P:neural tube patterning; P:non-motile cilium assembly; P:nose development; P:olfactory bulb development; P:pericardium development; P:regulation of smoothened signaling pathway; P:retinal rod cell development;|Q68CZ1 A0PJ88 Q9Y2K8,Protein fantom,Nephrocystin-8;RPGR-interacting protein 1-like protein;, PF00168;PF11618;PF18111;, GO:0005879;GO:0005930;GO:0005923;GO:0005911;GO:0005813;GO:0036064;GO:0035253;GO:0035869;GO:0005929;GO:0005737;GO:0005829;GO:0005654;GO:0032391;GO:0005886;GO:0031870;GO:0021549;GO:0097711;GO:0090102;GO:0022038;GO:0007368;GO:0035115;GO:0035116;GO:0001736;GO:0007163;GO:0001701;GO:0001822;GO:0021670;GO:0001889;GO:0045744;GO:0021532;GO:1905515;GO:0043584;GO:0021772;GO:0060039;GO:0008589;GO:0046548;, C:axonemal microtubule; C:axoneme; C:bicellular tight junction; C:cell-cell junction; C:centrosome; C:ciliary basal body; C:ciliary rootlet; C:ciliary transition zone; C:cilium; C:cytoplasm; C:cytosol; C:nucleoplasm; C:photoreceptor connecting cilium; C:plasma membrane;, F:thromboxane A2 receptor binding;, P:cerebellum development; P:ciliary basal body-plasma membrane docking; P:cochlea development; P:corpus callosum development; P:determination of left/right symmetry; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:establishment of planar polarity; P:establishment or maintenance of cell polarity; P:in utero embryonic development; P:kidney development; P:lateral ventricle development; P:liver development; P:negative regulation of G protein-coupled receptor signaling pathway; P:neural tube patterning; P:non-motile cilium assembly; P:nose development; P:olfactory bulb development; P:pericardium development; P:regulation of smoothened signaling pathway; P:retinal rod cell development;|Q68CZ1 A0PJ88 Q9Y2K8,Protein fantom,Nephrocystin-8;RPGR-interacting protein 1-like protein;, PF00168;PF11618;PF18111;, GO:0005879;GO:0005930;GO:0005923;GO:0005911;GO:0005813;GO:0036064;GO:0035253;GO:0035869;GO:0005929;GO:0005737;GO:0005829;GO:0005654;GO:0032391;GO:0005886;GO:0031870;GO:0021549;GO:0097711;GO:0090102;GO:0022038;GO:0007368;GO:0035115;GO:0035116;GO:0001736;GO:0007163;GO:0001701;GO:0001822;GO:0021670;GO:0001889;GO:0045744;GO:0021532;GO:1905515;GO:0043584;GO:0021772;GO:0060039;GO:0008589;GO:0046548;, C:axonemal microtubule; C:axoneme; C:bicellular tight junction; C:cell-cell junction; C:centrosome; C:ciliary basal body; C:ciliary rootlet; C:ciliary transition zone; C:cilium; C:cytoplasm; C:cytosol; C:nucleoplasm; C:photoreceptor connecting cilium; C:plasma membrane;, F:thromboxane A2 receptor binding;, P:cerebellum development; P:ciliary basal body-plasma membrane docking; P:cochlea development; P:corpus callosum development; P:determination of left/right symmetry; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:establishment of planar polarity; P:establishment or maintenance of cell polarity; P:in utero embryonic development; P:kidney development; P:lateral ventricle development; P:liver development; P:negative regulation of G protein-coupled receptor signaling pathway; P:neural tube patterning; P:non-motile cilium assembly; P:nose development; P:olfactory bulb development; P:pericardium development; P:regulation of smoothened signaling pathway; P:retinal rod cell development; scaffold16 indexed_genome mRNA 18679950 18683261 . - . ID=transcript_4073;Q9C0B1 A2RUH1 B2RNS0 Q0P676 Q7Z785,Alpha-ketoglutarate-dependent dioxygenase FTO {ECO:0000305},Fat mass and obesity-associated protein {ECO:0000303|PubMed:17496892};U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO {ECO:0000305};U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO {ECO:0000305};mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO {ECO:0000305};mRNA N(6)-methyladenosine demethylase FTO {ECO:0000305};tRNA N1-methyl adenine demethylase FTO {ECO:0000305};, PF12934;PF12933;, GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0043734;GO:0008198;GO:0035516;GO:0035515;GO:1990931;GO:0016740;GO:1990984;GO:0006307;GO:0080111;GO:0061157;GO:0070989;GO:0035552;GO:0035553;GO:0090335;GO:0010883;GO:0040014;GO:0042245;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA-N1-methyladenine dioxygenase activity; F:ferrous iron binding; F:oxidative DNA demethylase activity; F:oxidative RNA demethylase activity; F:RNA N6-methyladenosine dioxygenase activity; F:transferase activity; F:tRNA demethylase activity;, P:DNA dealkylation involved in DNA repair; P:DNA demethylation; P:mRNA destabilization; P:oxidative demethylation; P:oxidative single-stranded DNA demethylation; P:oxidative single-stranded RNA demethylation; P:regulation of brown fat cell differentiation; P:regulation of lipid storage; P:regulation of multicellular organism growth; P:RNA repair;|Q9C0B1 A2RUH1 B2RNS0 Q0P676 Q7Z785,Alpha-ketoglutarate-dependent dioxygenase FTO {ECO:0000305},Fat mass and obesity-associated protein {ECO:0000303|PubMed:17496892};U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO {ECO:0000305};U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO {ECO:0000305};mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO {ECO:0000305};mRNA N(6)-methyladenosine demethylase FTO {ECO:0000305};tRNA N1-methyl adenine demethylase FTO {ECO:0000305};, PF12934;PF12933;, GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0043734;GO:0008198;GO:0035516;GO:0035515;GO:1990931;GO:0016740;GO:1990984;GO:0006307;GO:0080111;GO:0061157;GO:0070989;GO:0035552;GO:0035553;GO:0090335;GO:0010883;GO:0040014;GO:0042245;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA-N1-methyladenine dioxygenase activity; F:ferrous iron binding; F:oxidative DNA demethylase activity; F:oxidative RNA demethylase activity; F:RNA N6-methyladenosine dioxygenase activity; F:transferase activity; F:tRNA demethylase activity;, P:DNA dealkylation involved in DNA repair; P:DNA demethylation; P:mRNA destabilization; P:oxidative demethylation; P:oxidative single-stranded DNA demethylation; P:oxidative single-stranded RNA demethylation; P:regulation of brown fat cell differentiation; P:regulation of lipid storage; P:regulation of multicellular organism growth; P:RNA repair; scaffold16 indexed_genome mRNA 18832821 18833474 . + . ID=transcript_4074;P78415 Q7Z4A4 Q7Z4A5 Q8IVC6,Iroquois-class homeodomain protein IRX-3,Homeodomain protein IRXB1;Iroquois homeobox protein 3;, PF05920;, GO:0030424;GO:0000785;GO:0005737;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0003167;GO:0048468;GO:0097009;GO:0060932;GO:0007498;GO:0001656;GO:0045665;GO:0030182;GO:1903598;GO:0045666;GO:0003165;GO:1901844;GO:0006357;GO:0072086;, C:axon; C:chromatin; C:cytoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:atrioventricular bundle cell differentiation; P:cell development; P:energy homeostasis; P:His-Purkinje system cell differentiation; P:mesoderm development; P:metanephros development; P:negative regulation of neuron differentiation; P:neuron differentiation; P:positive regulation of gap junction assembly; P:positive regulation of neuron differentiation; P:Purkinje myocyte development; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of transcription by RNA polymerase II; P:specification of loop of Henle identity; scaffold16 indexed_genome mRNA 19930371 19956599 . + . ID=transcript_4075;P08253 B2R6U1 B4DWH3 E9PE45 Q9UCJ8,72 kDa type IV collagenase {ECO:0000303|PubMed:2162831, ECO:0000303|PubMed:2834383},72 kDa gelatinase {ECO:0000303|PubMed:1655733};Gelatinase A;Matrix metalloproteinase-2;TBE-1;, PF00040;PF00045;PF00413;PF01471;, GO:0062023;GO:0005576;GO:0005615;GO:0005739;GO:0005634;GO:0005886;GO:0030017;GO:0004175;GO:0004222;GO:0008237;GO:0004252;GO:0008270;GO:0001525;GO:0001955;GO:0060346;GO:0044267;GO:0071230;GO:0034614;GO:0071492;GO:0030574;GO:0019221;GO:0007566;GO:0035987;GO:0048013;GO:0022617;GO:0030198;GO:0060325;GO:0001957;GO:1904707;GO:0006508;GO:1904645;GO:0001666;GO:0048771;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:mitochondrion; C:nucleus; C:plasma membrane; C:sarcomere;, F:endopeptidase activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:serine-type endopeptidase activity; F:zinc ion binding;, P:angiogenesis; P:blood vessel maturation; P:bone trabecula formation; P:cellular protein metabolic process; P:cellular response to amino acid stimulus; P:cellular response to reactive oxygen species; P:cellular response to UV-A; P:collagen catabolic process; P:cytokine-mediated signaling pathway; P:embryo implantation; P:endodermal cell differentiation; P:ephrin receptor signaling pathway; P:extracellular matrix disassembly; P:extracellular matrix organization; P:face morphogenesis; P:intramembranous ossification; P:positive regulation of vascular associated smooth muscle cell proliferation; P:proteolysis; P:response to amyloid-beta; P:response to hypoxia; P:tissue remodeling; scaffold16 indexed_genome mRNA 19963105 20010506 . + . ID=transcript_4076;Q7L5N7 A3KBM1 Q6MZJ6 Q9NX23,Lysophosphatidylcholine acyltransferase 2,1-acylglycerol-3-phosphate O-acyltransferase 11;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 1;Lysophosphatidic acid acyltransferase alpha;, PF01553;PF00036;PF13202;, GO:0005783;GO:0005789;GO:0000139;GO:0005795;GO:0016021;GO:0005811;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0005509;GO:0050200;GO:0061024;GO:0036151;GO:0006663;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:Golgi stack; C:integral component of membrane; C:lipid droplet; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:membrane organization; P:phosphatidylcholine acyl-chain remodeling; P:platelet activating factor biosynthetic process;|Q7L5N7 A3KBM1 Q6MZJ6 Q9NX23,Lysophosphatidylcholine acyltransferase 2,1-acylglycerol-3-phosphate O-acyltransferase 11;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 1;Lysophosphatidic acid acyltransferase alpha;, PF01553;PF00036;PF13202;, GO:0005783;GO:0005789;GO:0000139;GO:0005795;GO:0016021;GO:0005811;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0005509;GO:0050200;GO:0061024;GO:0036151;GO:0006663;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:Golgi stack; C:integral component of membrane; C:lipid droplet; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:membrane organization; P:phosphatidylcholine acyl-chain remodeling; P:platelet activating factor biosynthetic process;|Q7L5N7 A3KBM1 Q6MZJ6 Q9NX23,Lysophosphatidylcholine acyltransferase 2,1-acylglycerol-3-phosphate O-acyltransferase 11;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 1;Lysophosphatidic acid acyltransferase alpha;, PF01553;PF00036;PF13202;, GO:0005783;GO:0005789;GO:0000139;GO:0005795;GO:0016021;GO:0005811;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0005509;GO:0050200;GO:0061024;GO:0036151;GO:0006663;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:Golgi stack; C:integral component of membrane; C:lipid droplet; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:membrane organization; P:phosphatidylcholine acyl-chain remodeling; P:platelet activating factor biosynthetic process;|Q7L5N7 A3KBM1 Q6MZJ6 Q9NX23,Lysophosphatidylcholine acyltransferase 2,1-acylglycerol-3-phosphate O-acyltransferase 11;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 1;Lysophosphatidic acid acyltransferase alpha;, PF01553;PF00036;PF13202;, GO:0005783;GO:0005789;GO:0000139;GO:0005795;GO:0016021;GO:0005811;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0005509;GO:0050200;GO:0061024;GO:0036151;GO:0006663;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:Golgi stack; C:integral component of membrane; C:lipid droplet; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:membrane organization; P:phosphatidylcholine acyl-chain remodeling; P:platelet activating factor biosynthetic process; scaffold16 indexed_genome mRNA 20070808 20085214 . + . ID=transcript_4077;P23975 B2R707 B4DX48 Q96KH8,Sodium-dependent noradrenaline transporter,Norepinephrine transporter;Solute carrier family 6 member 2;, PF00209;, GO:0009986;GO:0005887;GO:0016020;GO:0045121;GO:0043005;GO:0032809;GO:0005886;GO:0042734;GO:0003779;GO:0043014;GO:0048487;GO:0005330;GO:0046872;GO:0008504;GO:0005326;GO:0005328;GO:0005334;GO:0007268;GO:0051583;GO:0015844;GO:0070050;GO:0006836;GO:0015874;GO:0051620;GO:0042493;GO:0048265;GO:0035725;, C:cell surface; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:neuron projection; C:neuronal cell body membrane; C:plasma membrane; C:presynaptic membrane;, F:actin binding; F:alpha-tubulin binding; F:beta-tubulin binding; F:dopamine:sodium symporter activity; F:metal ion binding; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:neurotransmitter:sodium symporter activity; F:norepinephrine:sodium symporter activity;, P:chemical synaptic transmission; P:dopamine uptake involved in synaptic transmission; P:monoamine transport; P:neuron cellular homeostasis; P:neurotransmitter transport; P:norepinephrine transport; P:norepinephrine uptake; P:response to drug; P:response to pain; P:sodium ion transmembrane transport; scaffold16 indexed_genome mRNA 20103934 20129784 . + . ID=transcript_4078;Q9ULY2,Liver carboxylesterase 1 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase;Brain carboxylesterase hBr1;Carboxylesterase 1;Cholesteryl ester hydrolase {ECO:0000303|PubMed:11015575};Cocaine carboxylesterase;Egasyn;HMSE;Methylumbelliferyl-acetate deacetylase 1;Monocyte/macrophage serine esterase;Retinyl ester hydrolase;Serine esterase 1;Triacylglycerol hydrolase;, PF00135;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005615;GO:0005811;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0002003;GO:0071397;GO:0071404;GO:0006695;GO:0090122;GO:0042632;GO:0008203;GO:0030855;GO:0016042;GO:0051791;GO:0010887;GO:0010875;GO:0090205;GO:0070857;GO:0120188;GO:0009636;GO:0043691;GO:0006805;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:lipid droplet;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:angiotensin maturation; P:cellular response to cholesterol; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:cholesterol ester hydrolysis involved in cholesterol transport; P:cholesterol homeostasis; P:cholesterol metabolic process; P:epithelial cell differentiation; P:lipid catabolic process; P:medium-chain fatty acid metabolic process; P:negative regulation of cholesterol storage; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol metabolic process; P:regulation of bile acid biosynthetic process; P:regulation of bile acid secretion; P:response to toxic substance; P:reverse cholesterol transport; P:xenobiotic metabolic process;|Q9ULY2,Liver carboxylesterase 1 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase;Brain carboxylesterase hBr1;Carboxylesterase 1;Cholesteryl ester hydrolase {ECO:0000303|PubMed:11015575};Cocaine carboxylesterase;Egasyn;HMSE;Methylumbelliferyl-acetate deacetylase 1;Monocyte/macrophage serine esterase;Retinyl ester hydrolase;Serine esterase 1;Triacylglycerol hydrolase;, PF00135;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005615;GO:0005811;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0002003;GO:0071397;GO:0071404;GO:0006695;GO:0090122;GO:0042632;GO:0008203;GO:0030855;GO:0016042;GO:0051791;GO:0010887;GO:0010875;GO:0090205;GO:0070857;GO:0120188;GO:0009636;GO:0043691;GO:0006805;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:lipid droplet;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:angiotensin maturation; P:cellular response to cholesterol; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:cholesterol ester hydrolysis involved in cholesterol transport; P:cholesterol homeostasis; P:cholesterol metabolic process; P:epithelial cell differentiation; P:lipid catabolic process; P:medium-chain fatty acid metabolic process; P:negative regulation of cholesterol storage; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol metabolic process; P:regulation of bile acid biosynthetic process; P:regulation of bile acid secretion; P:response to toxic substance; P:reverse cholesterol transport; P:xenobiotic metabolic process;|Q9ULY2,Liver carboxylesterase 1 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase;Brain carboxylesterase hBr1;Carboxylesterase 1;Cholesteryl ester hydrolase {ECO:0000303|PubMed:11015575};Cocaine carboxylesterase;Egasyn;HMSE;Methylumbelliferyl-acetate deacetylase 1;Monocyte/macrophage serine esterase;Retinyl ester hydrolase;Serine esterase 1;Triacylglycerol hydrolase;, PF00135;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005615;GO:0005811;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0002003;GO:0071397;GO:0071404;GO:0006695;GO:0090122;GO:0042632;GO:0008203;GO:0030855;GO:0016042;GO:0051791;GO:0010887;GO:0010875;GO:0090205;GO:0070857;GO:0120188;GO:0009636;GO:0043691;GO:0006805;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:lipid droplet;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:angiotensin maturation; P:cellular response to cholesterol; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:cholesterol ester hydrolysis involved in cholesterol transport; P:cholesterol homeostasis; P:cholesterol metabolic process; P:epithelial cell differentiation; P:lipid catabolic process; P:medium-chain fatty acid metabolic process; P:negative regulation of cholesterol storage; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol metabolic process; P:regulation of bile acid biosynthetic process; P:regulation of bile acid secretion; P:response to toxic substance; P:reverse cholesterol transport; P:xenobiotic metabolic process;|Q9ULY2,Liver carboxylesterase 1 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase;Brain carboxylesterase hBr1;Carboxylesterase 1;Cholesteryl ester hydrolase {ECO:0000303|PubMed:11015575};Cocaine carboxylesterase;Egasyn;HMSE;Methylumbelliferyl-acetate deacetylase 1;Monocyte/macrophage serine esterase;Retinyl ester hydrolase;Serine esterase 1;Triacylglycerol hydrolase;, PF00135;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005615;GO:0005811;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0002003;GO:0071397;GO:0071404;GO:0006695;GO:0090122;GO:0042632;GO:0008203;GO:0030855;GO:0016042;GO:0051791;GO:0010887;GO:0010875;GO:0090205;GO:0070857;GO:0120188;GO:0009636;GO:0043691;GO:0006805;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:lipid droplet;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:angiotensin maturation; P:cellular response to cholesterol; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:cholesterol ester hydrolysis involved in cholesterol transport; P:cholesterol homeostasis; P:cholesterol metabolic process; P:epithelial cell differentiation; P:lipid catabolic process; P:medium-chain fatty acid metabolic process; P:negative regulation of cholesterol storage; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol metabolic process; P:regulation of bile acid biosynthetic process; P:regulation of bile acid secretion; P:response to toxic substance; P:reverse cholesterol transport; P:xenobiotic metabolic process;|Q9ULY2,Liver carboxylesterase 1 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase;Brain carboxylesterase hBr1;Carboxylesterase 1;Cholesteryl ester hydrolase {ECO:0000303|PubMed:11015575};Cocaine carboxylesterase;Egasyn;HMSE;Methylumbelliferyl-acetate deacetylase 1;Monocyte/macrophage serine esterase;Retinyl ester hydrolase;Serine esterase 1;Triacylglycerol hydrolase;, PF00135;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005615;GO:0005811;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0002003;GO:0071397;GO:0071404;GO:0006695;GO:0090122;GO:0042632;GO:0008203;GO:0030855;GO:0016042;GO:0051791;GO:0010887;GO:0010875;GO:0090205;GO:0070857;GO:0120188;GO:0009636;GO:0043691;GO:0006805;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:lipid droplet;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:angiotensin maturation; P:cellular response to cholesterol; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:cholesterol ester hydrolysis involved in cholesterol transport; P:cholesterol homeostasis; P:cholesterol metabolic process; P:epithelial cell differentiation; P:lipid catabolic process; P:medium-chain fatty acid metabolic process; P:negative regulation of cholesterol storage; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol metabolic process; P:regulation of bile acid biosynthetic process; P:regulation of bile acid secretion; P:response to toxic substance; P:reverse cholesterol transport; P:xenobiotic metabolic process;|Q9ULY2,Liver carboxylesterase 1 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase;Brain carboxylesterase hBr1;Carboxylesterase 1;Cholesteryl ester hydrolase {ECO:0000303|PubMed:11015575};Cocaine carboxylesterase;Egasyn;HMSE;Methylumbelliferyl-acetate deacetylase 1;Monocyte/macrophage serine esterase;Retinyl ester hydrolase;Serine esterase 1;Triacylglycerol hydrolase;, PF00135;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005615;GO:0005811;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0002003;GO:0071397;GO:0071404;GO:0006695;GO:0090122;GO:0042632;GO:0008203;GO:0030855;GO:0016042;GO:0051791;GO:0010887;GO:0010875;GO:0090205;GO:0070857;GO:0120188;GO:0009636;GO:0043691;GO:0006805;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:lipid droplet;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:angiotensin maturation; P:cellular response to cholesterol; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:cholesterol ester hydrolysis involved in cholesterol transport; P:cholesterol homeostasis; P:cholesterol metabolic process; P:epithelial cell differentiation; P:lipid catabolic process; P:medium-chain fatty acid metabolic process; P:negative regulation of cholesterol storage; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol metabolic process; P:regulation of bile acid biosynthetic process; P:regulation of bile acid secretion; P:response to toxic substance; P:reverse cholesterol transport; P:xenobiotic metabolic process; scaffold16 indexed_genome mRNA 20177860 20179576 . + . ID=transcript_4079;P02795 Q14823 Q2HXR9 Q53XT9,Metallothionein-2,Metallothionein-2A;Metallothionein-II;, PF00131;, GO:0005737;GO:0005829;GO:0005634;GO:0046872;GO:0008270;GO:0006878;GO:0071276;GO:0071280;GO:0036018;GO:0036016;GO:0071294;GO:0006882;GO:0010273;GO:0060333;GO:0045926;GO:0010038;, C:cytoplasm; C:cytosol; C:nucleus;, F:metal ion binding; F:zinc ion binding;, P:cellular copper ion homeostasis; P:cellular response to cadmium ion; P:cellular response to copper ion; P:cellular response to erythropoietin; P:cellular response to interleukin-3; P:cellular response to zinc ion; P:cellular zinc ion homeostasis; P:detoxification of copper ion; P:interferon-gamma-mediated signaling pathway; P:negative regulation of growth; P:response to metal ion; scaffold16 indexed_genome mRNA 20264252 20286865 . + . ID=transcript_4080;Q9BXC9 Q96CM0 Q96SN9,Bardet-Biedl syndrome 2 protein,, PF14782;PF14783;PF14781;, GO:0034464;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0005902;GO:0031514;GO:0043005;GO:0032420;GO:0001103;GO:0030534;GO:0014824;GO:0048854;GO:0051216;GO:0021987;GO:0060271;GO:0045444;GO:0043001;GO:0021766;GO:0032402;GO:0038108;GO:0010629;GO:0040015;GO:1905515;GO:0045494;GO:0040018;GO:0008104;GO:0033365;GO:0060296;GO:0007288;GO:0021756;GO:0042311;GO:0007601;, C:BBSome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:microvillus; C:motile cilium; C:neuron projection; C:stereocilium;, F:RNA polymerase II repressing transcription factor binding;, P:adult behavior; P:artery smooth muscle contraction; P:brain morphogenesis; P:cartilage development; P:cerebral cortex development; P:cilium assembly; P:fat cell differentiation; P:Golgi to plasma membrane protein transport; P:hippocampus development; P:melanosome transport; P:negative regulation of appetite by leptin-mediated signaling pathway; P:negative regulation of gene expression; P:negative regulation of multicellular organism growth; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:positive regulation of multicellular organism growth; P:protein localization; P:protein localization to organelle; P:regulation of cilium beat frequency involved in ciliary motility; P:sperm axoneme assembly; P:striatum development; P:vasodilation; P:visual perception;|Q9BXC9 Q96CM0 Q96SN9,Bardet-Biedl syndrome 2 protein,, PF14782;PF14783;PF14781;, GO:0034464;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0005902;GO:0031514;GO:0043005;GO:0032420;GO:0001103;GO:0030534;GO:0014824;GO:0048854;GO:0051216;GO:0021987;GO:0060271;GO:0045444;GO:0043001;GO:0021766;GO:0032402;GO:0038108;GO:0010629;GO:0040015;GO:1905515;GO:0045494;GO:0040018;GO:0008104;GO:0033365;GO:0060296;GO:0007288;GO:0021756;GO:0042311;GO:0007601;, C:BBSome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:microvillus; C:motile cilium; C:neuron projection; C:stereocilium;, F:RNA polymerase II repressing transcription factor binding;, P:adult behavior; P:artery smooth muscle contraction; P:brain morphogenesis; P:cartilage development; P:cerebral cortex development; P:cilium assembly; P:fat cell differentiation; P:Golgi to plasma membrane protein transport; P:hippocampus development; P:melanosome transport; P:negative regulation of appetite by leptin-mediated signaling pathway; P:negative regulation of gene expression; P:negative regulation of multicellular organism growth; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:positive regulation of multicellular organism growth; P:protein localization; P:protein localization to organelle; P:regulation of cilium beat frequency involved in ciliary motility; P:sperm axoneme assembly; P:striatum development; P:vasodilation; P:visual perception;|Q9BXC9 Q96CM0 Q96SN9,Bardet-Biedl syndrome 2 protein,, PF14782;PF14783;PF14781;, GO:0034464;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0005902;GO:0031514;GO:0043005;GO:0032420;GO:0001103;GO:0030534;GO:0014824;GO:0048854;GO:0051216;GO:0021987;GO:0060271;GO:0045444;GO:0043001;GO:0021766;GO:0032402;GO:0038108;GO:0010629;GO:0040015;GO:1905515;GO:0045494;GO:0040018;GO:0008104;GO:0033365;GO:0060296;GO:0007288;GO:0021756;GO:0042311;GO:0007601;, C:BBSome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:microvillus; C:motile cilium; C:neuron projection; C:stereocilium;, F:RNA polymerase II repressing transcription factor binding;, P:adult behavior; P:artery smooth muscle contraction; P:brain morphogenesis; P:cartilage development; P:cerebral cortex development; P:cilium assembly; P:fat cell differentiation; P:Golgi to plasma membrane protein transport; P:hippocampus development; P:melanosome transport; P:negative regulation of appetite by leptin-mediated signaling pathway; P:negative regulation of gene expression; P:negative regulation of multicellular organism growth; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:positive regulation of multicellular organism growth; P:protein localization; P:protein localization to organelle; P:regulation of cilium beat frequency involved in ciliary motility; P:sperm axoneme assembly; P:striatum development; P:vasodilation; P:visual perception;|Q9BXC9 Q96CM0 Q96SN9,Bardet-Biedl syndrome 2 protein,, PF14782;PF14783;PF14781;, GO:0034464;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0005902;GO:0031514;GO:0043005;GO:0032420;GO:0001103;GO:0030534;GO:0014824;GO:0048854;GO:0051216;GO:0021987;GO:0060271;GO:0045444;GO:0043001;GO:0021766;GO:0032402;GO:0038108;GO:0010629;GO:0040015;GO:1905515;GO:0045494;GO:0040018;GO:0008104;GO:0033365;GO:0060296;GO:0007288;GO:0021756;GO:0042311;GO:0007601;, C:BBSome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:microvillus; C:motile cilium; C:neuron projection; C:stereocilium;, F:RNA polymerase II repressing transcription factor binding;, P:adult behavior; P:artery smooth muscle contraction; P:brain morphogenesis; P:cartilage development; P:cerebral cortex development; P:cilium assembly; P:fat cell differentiation; P:Golgi to plasma membrane protein transport; P:hippocampus development; P:melanosome transport; P:negative regulation of appetite by leptin-mediated signaling pathway; P:negative regulation of gene expression; P:negative regulation of multicellular organism growth; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:positive regulation of multicellular organism growth; P:protein localization; P:protein localization to organelle; P:regulation of cilium beat frequency involved in ciliary motility; P:sperm axoneme assembly; P:striatum development; P:vasodilation; P:visual perception; scaffold16 indexed_genome mRNA 20286907 20289752 . + . ID=transcript_4081;Q9BXC9 Q96CM0 Q96SN9,Bardet-Biedl syndrome 2 protein,, PF14782;PF14783;PF14781;, GO:0034464;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0005902;GO:0031514;GO:0043005;GO:0032420;GO:0001103;GO:0030534;GO:0014824;GO:0048854;GO:0051216;GO:0021987;GO:0060271;GO:0045444;GO:0043001;GO:0021766;GO:0032402;GO:0038108;GO:0010629;GO:0040015;GO:1905515;GO:0045494;GO:0040018;GO:0008104;GO:0033365;GO:0060296;GO:0007288;GO:0021756;GO:0042311;GO:0007601;, C:BBSome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:microvillus; C:motile cilium; C:neuron projection; C:stereocilium;, F:RNA polymerase II repressing transcription factor binding;, P:adult behavior; P:artery smooth muscle contraction; P:brain morphogenesis; P:cartilage development; P:cerebral cortex development; P:cilium assembly; P:fat cell differentiation; P:Golgi to plasma membrane protein transport; P:hippocampus development; P:melanosome transport; P:negative regulation of appetite by leptin-mediated signaling pathway; P:negative regulation of gene expression; P:negative regulation of multicellular organism growth; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:positive regulation of multicellular organism growth; P:protein localization; P:protein localization to organelle; P:regulation of cilium beat frequency involved in ciliary motility; P:sperm axoneme assembly; P:striatum development; P:vasodilation; P:visual perception; scaffold16 indexed_genome mRNA 20296130 20328527 . - . ID=transcript_4082;Q8N543 H3BUQ2 Q9H7U5 Q9H9J9 Q9HA87 Q9HCG0 Q9NVB6,Prolyl 3-hydroxylase OGFOD1,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1;Termination and polyadenylation 1 homolog;uS12 prolyl 3-hydroxylase {ECO:0000303|PubMed:25728928};, PF13661;PF10637;, GO:0005737;GO:0010494;GO:0005829;GO:0005654;GO:0005506;GO:0031418;GO:0031544;GO:0031543;GO:0008283;GO:0019511;GO:0018126;GO:0006449;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm;, F:iron ion binding; F:L-ascorbic acid binding; F:peptidyl-proline 3-dioxygenase activity; F:peptidyl-proline dioxygenase activity;, P:cell population proliferation; P:peptidyl-proline hydroxylation; P:protein hydroxylation; P:regulation of translational termination; P:stress granule assembly;|Q8N543 H3BUQ2 Q9H7U5 Q9H9J9 Q9HA87 Q9HCG0 Q9NVB6,Prolyl 3-hydroxylase OGFOD1,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1;Termination and polyadenylation 1 homolog;uS12 prolyl 3-hydroxylase {ECO:0000303|PubMed:25728928};, PF13661;PF10637;, GO:0005737;GO:0010494;GO:0005829;GO:0005654;GO:0005506;GO:0031418;GO:0031544;GO:0031543;GO:0008283;GO:0019511;GO:0018126;GO:0006449;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm;, F:iron ion binding; F:L-ascorbic acid binding; F:peptidyl-proline 3-dioxygenase activity; F:peptidyl-proline dioxygenase activity;, P:cell population proliferation; P:peptidyl-proline hydroxylation; P:protein hydroxylation; P:regulation of translational termination; P:stress granule assembly;|Q8N543 H3BUQ2 Q9H7U5 Q9H9J9 Q9HA87 Q9HCG0 Q9NVB6,Prolyl 3-hydroxylase OGFOD1,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1;Termination and polyadenylation 1 homolog;uS12 prolyl 3-hydroxylase {ECO:0000303|PubMed:25728928};, PF13661;PF10637;, GO:0005737;GO:0010494;GO:0005829;GO:0005654;GO:0005506;GO:0031418;GO:0031544;GO:0031543;GO:0008283;GO:0019511;GO:0018126;GO:0006449;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm;, F:iron ion binding; F:L-ascorbic acid binding; F:peptidyl-proline 3-dioxygenase activity; F:peptidyl-proline dioxygenase activity;, P:cell population proliferation; P:peptidyl-proline hydroxylation; P:protein hydroxylation; P:regulation of translational termination; P:stress granule assembly; scaffold16 indexed_genome mRNA 20328720 20345716 . + . ID=transcript_4083;O43809 Q6IB85 Q6NE84,Cleavage and polyadenylation specificity factor subunit 5 {ECO:0000303|PubMed:23187700},Cleavage and polyadenylation specificity factor 25 kDa subunit;Cleavage factor Im complex 25 kDa subunit {ECO:0000303|PubMed:9659921};Nucleoside diphosphate-linked moiety X motif 21;Nudix hydrolase 21 {ECO:0000305};Pre-mRNA cleavage factor Im 68 kDa subunit;, PF13869;, GO:0034451;GO:0005813;GO:0005737;GO:0005847;GO:0005849;GO:0016604;GO:0005654;GO:0005634;GO:0042382;GO:0003682;GO:0042826;GO:0016787;GO:0042802;GO:0035925;GO:0003729;GO:0042803;GO:0003723;GO:0030154;GO:1990120;GO:0031124;GO:0110104;GO:0006378;GO:0006397;GO:0000398;GO:0031439;GO:1900365;GO:2000975;GO:2000738;GO:0010608;GO:0098789;GO:0051290;GO:0051262;GO:0006369;, C:centriolar satellite; C:centrosome; C:cytoplasm; C:mRNA cleavage and polyadenylation specificity factor complex; C:mRNA cleavage factor complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:paraspeckles;, F:chromatin binding; F:histone deacetylase binding; F:hydrolase activity; F:identical protein binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA binding; F:protein homodimerization activity; F:RNA binding;, P:cell differentiation; P:messenger ribonucleoprotein complex assembly; P:mRNA 3'-end processing; P:mRNA alternative polyadenylation; P:mRNA polyadenylation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:positive regulation of mRNA cleavage; P:positive regulation of mRNA polyadenylation; P:positive regulation of pro-B cell differentiation; P:positive regulation of stem cell differentiation; P:posttranscriptional regulation of gene expression; P:pre-mRNA cleavage required for polyadenylation; P:protein heterotetramerization; P:protein tetramerization; P:termination of RNA polymerase II transcription;|O43809 Q6IB85 Q6NE84,Cleavage and polyadenylation specificity factor subunit 5 {ECO:0000303|PubMed:23187700},Cleavage and polyadenylation specificity factor 25 kDa subunit;Cleavage factor Im complex 25 kDa subunit {ECO:0000303|PubMed:9659921};Nucleoside diphosphate-linked moiety X motif 21;Nudix hydrolase 21 {ECO:0000305};Pre-mRNA cleavage factor Im 68 kDa subunit;, PF13869;, GO:0034451;GO:0005813;GO:0005737;GO:0005847;GO:0005849;GO:0016604;GO:0005654;GO:0005634;GO:0042382;GO:0003682;GO:0042826;GO:0016787;GO:0042802;GO:0035925;GO:0003729;GO:0042803;GO:0003723;GO:0030154;GO:1990120;GO:0031124;GO:0110104;GO:0006378;GO:0006397;GO:0000398;GO:0031439;GO:1900365;GO:2000975;GO:2000738;GO:0010608;GO:0098789;GO:0051290;GO:0051262;GO:0006369;, C:centriolar satellite; C:centrosome; C:cytoplasm; C:mRNA cleavage and polyadenylation specificity factor complex; C:mRNA cleavage factor complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:paraspeckles;, F:chromatin binding; F:histone deacetylase binding; F:hydrolase activity; F:identical protein binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA binding; F:protein homodimerization activity; F:RNA binding;, P:cell differentiation; P:messenger ribonucleoprotein complex assembly; P:mRNA 3'-end processing; P:mRNA alternative polyadenylation; P:mRNA polyadenylation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:positive regulation of mRNA cleavage; P:positive regulation of mRNA polyadenylation; P:positive regulation of pro-B cell differentiation; P:positive regulation of stem cell differentiation; P:posttranscriptional regulation of gene expression; P:pre-mRNA cleavage required for polyadenylation; P:protein heterotetramerization; P:protein tetramerization; P:termination of RNA polymerase II transcription; scaffold16 indexed_genome mRNA 20353683 20369976 . + . ID=transcript_4084;Q9UKV5 P26442 Q8IZ70,E3 ubiquitin-protein ligase AMFR,Autocrine motility factor receptor {ECO:0000303|PubMed:10456327};RING finger protein 45;gp78 {ECO:0000303|PubMed:11724934};, PF02845;PF18442;PF13639;, GO:0005829;GO:0030425;GO:0036513;GO:0005783;GO:0005789;GO:0044322;GO:0005794;GO:0030426;GO:0030176;GO:0016021;GO:0016020;GO:0043025;GO:0005634;GO:0048471;GO:0032991;GO:0000151;GO:1904288;GO:0051087;GO:0042802;GO:0046872;GO:0030674;GO:0038023;GO:0043130;GO:0061630;GO:0004842;GO:1990381;GO:0034450;GO:0007568;GO:1904380;GO:0030968;GO:0007611;GO:0090090;GO:0032092;GO:0051865;GO:0006457;GO:0070936;GO:0000209;GO:0016567;GO:2000638;GO:0007165;GO:0030433;GO:0006511;GO:0016055;, C:cytosol; C:dendrite; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Golgi apparatus; C:growth cone; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ubiquitin ligase complex;, F:BAT3 complex binding; F:chaperone binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:signaling receptor activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:ubiquitin-ubiquitin ligase activity;, P:aging; P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:learning or memory; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of protein binding; P:protein autoubiquitination; P:protein folding; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of SREBP signaling pathway; P:signal transduction; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 20370001 20394214 . + . ID=transcript_4085;Q9UKV5 P26442 Q8IZ70,E3 ubiquitin-protein ligase AMFR,Autocrine motility factor receptor {ECO:0000303|PubMed:10456327};RING finger protein 45;gp78 {ECO:0000303|PubMed:11724934};, PF02845;PF18442;PF13639;, GO:0005829;GO:0030425;GO:0036513;GO:0005783;GO:0005789;GO:0044322;GO:0005794;GO:0030426;GO:0030176;GO:0016021;GO:0016020;GO:0043025;GO:0005634;GO:0048471;GO:0032991;GO:0000151;GO:1904288;GO:0051087;GO:0042802;GO:0046872;GO:0030674;GO:0038023;GO:0043130;GO:0061630;GO:0004842;GO:1990381;GO:0034450;GO:0007568;GO:1904380;GO:0030968;GO:0007611;GO:0090090;GO:0032092;GO:0051865;GO:0006457;GO:0070936;GO:0000209;GO:0016567;GO:2000638;GO:0007165;GO:0030433;GO:0006511;GO:0016055;, C:cytosol; C:dendrite; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Golgi apparatus; C:growth cone; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ubiquitin ligase complex;, F:BAT3 complex binding; F:chaperone binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:signaling receptor activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:ubiquitin-ubiquitin ligase activity;, P:aging; P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:learning or memory; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of protein binding; P:protein autoubiquitination; P:protein folding; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of SREBP signaling pathway; P:signal transduction; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q9UKV5 P26442 Q8IZ70,E3 ubiquitin-protein ligase AMFR,Autocrine motility factor receptor {ECO:0000303|PubMed:10456327};RING finger protein 45;gp78 {ECO:0000303|PubMed:11724934};, PF02845;PF18442;PF13639;, GO:0005829;GO:0030425;GO:0036513;GO:0005783;GO:0005789;GO:0044322;GO:0005794;GO:0030426;GO:0030176;GO:0016021;GO:0016020;GO:0043025;GO:0005634;GO:0048471;GO:0032991;GO:0000151;GO:1904288;GO:0051087;GO:0042802;GO:0046872;GO:0030674;GO:0038023;GO:0043130;GO:0061630;GO:0004842;GO:1990381;GO:0034450;GO:0007568;GO:1904380;GO:0030968;GO:0007611;GO:0090090;GO:0032092;GO:0051865;GO:0006457;GO:0070936;GO:0000209;GO:0016567;GO:2000638;GO:0007165;GO:0030433;GO:0006511;GO:0016055;, C:cytosol; C:dendrite; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Golgi apparatus; C:growth cone; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ubiquitin ligase complex;, F:BAT3 complex binding; F:chaperone binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:signaling receptor activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:ubiquitin-ubiquitin ligase activity;, P:aging; P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:learning or memory; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of protein binding; P:protein autoubiquitination; P:protein folding; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of SREBP signaling pathway; P:signal transduction; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q9UKV5 P26442 Q8IZ70,E3 ubiquitin-protein ligase AMFR,Autocrine motility factor receptor {ECO:0000303|PubMed:10456327};RING finger protein 45;gp78 {ECO:0000303|PubMed:11724934};, PF02845;PF18442;PF13639;, GO:0005829;GO:0030425;GO:0036513;GO:0005783;GO:0005789;GO:0044322;GO:0005794;GO:0030426;GO:0030176;GO:0016021;GO:0016020;GO:0043025;GO:0005634;GO:0048471;GO:0032991;GO:0000151;GO:1904288;GO:0051087;GO:0042802;GO:0046872;GO:0030674;GO:0038023;GO:0043130;GO:0061630;GO:0004842;GO:1990381;GO:0034450;GO:0007568;GO:1904380;GO:0030968;GO:0007611;GO:0090090;GO:0032092;GO:0051865;GO:0006457;GO:0070936;GO:0000209;GO:0016567;GO:2000638;GO:0007165;GO:0030433;GO:0006511;GO:0016055;, C:cytosol; C:dendrite; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Golgi apparatus; C:growth cone; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ubiquitin ligase complex;, F:BAT3 complex binding; F:chaperone binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:signaling receptor activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:ubiquitin-ubiquitin ligase activity;, P:aging; P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:learning or memory; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of protein binding; P:protein autoubiquitination; P:protein folding; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of SREBP signaling pathway; P:signal transduction; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q9UKV5 P26442 Q8IZ70,E3 ubiquitin-protein ligase AMFR,Autocrine motility factor receptor {ECO:0000303|PubMed:10456327};RING finger protein 45;gp78 {ECO:0000303|PubMed:11724934};, PF02845;PF18442;PF13639;, GO:0005829;GO:0030425;GO:0036513;GO:0005783;GO:0005789;GO:0044322;GO:0005794;GO:0030426;GO:0030176;GO:0016021;GO:0016020;GO:0043025;GO:0005634;GO:0048471;GO:0032991;GO:0000151;GO:1904288;GO:0051087;GO:0042802;GO:0046872;GO:0030674;GO:0038023;GO:0043130;GO:0061630;GO:0004842;GO:1990381;GO:0034450;GO:0007568;GO:1904380;GO:0030968;GO:0007611;GO:0090090;GO:0032092;GO:0051865;GO:0006457;GO:0070936;GO:0000209;GO:0016567;GO:2000638;GO:0007165;GO:0030433;GO:0006511;GO:0016055;, C:cytosol; C:dendrite; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Golgi apparatus; C:growth cone; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ubiquitin ligase complex;, F:BAT3 complex binding; F:chaperone binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:signaling receptor activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-specific protease binding; F:ubiquitin-ubiquitin ligase activity;, P:aging; P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:learning or memory; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of protein binding; P:protein autoubiquitination; P:protein folding; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of SREBP signaling pathway; P:signal transduction; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 20396893 20399061 . + . ID=transcript_4086;P09471 P29777 Q8TD72 Q9UMV4,Guanine nucleotide-binding protein G(o) subunit alpha,, PF00503;, GO:0044297;GO:0030425;GO:0005834;GO:0043209;GO:0005886;GO:0051430;GO:0001664;GO:0031821;GO:0031683;GO:0005525;GO:0032794;GO:0003924;GO:0046872;GO:0031852;GO:0007188;GO:0007568;GO:0007212;GO:0030900;GO:0007626;GO:0006936;GO:0051926;GO:0031175;GO:0042475;GO:0043547;GO:0006457;GO:0008016;GO:0034097;GO:0042493;GO:0042542;GO:0043278;GO:0007223;, C:cell body; C:dendrite; C:heterotrimeric G-protein complex; C:myelin sheath; C:plasma membrane;, F:corticotropin-releasing hormone receptor 1 binding; F:G protein-coupled receptor binding; F:G protein-coupled serotonin receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activating protein binding; F:GTPase activity; F:metal ion binding; F:mu-type opioid receptor binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:dopamine receptor signaling pathway; P:forebrain development; P:locomotory behavior; P:muscle contraction; P:negative regulation of calcium ion transport; P:neuron projection development; P:odontogenesis of dentin-containing tooth; P:positive regulation of GTPase activity; P:protein folding; P:regulation of heart contraction; P:response to cytokine; P:response to drug; P:response to hydrogen peroxide; P:response to morphine; P:Wnt signaling pathway, calcium modulating pathway; scaffold16 indexed_genome mRNA 20399086 20427080 . - . ID=transcript_4087;P09471 P29777 Q8TD72 Q9UMV4,Guanine nucleotide-binding protein G(o) subunit alpha,, PF00503;, GO:0044297;GO:0030425;GO:0005834;GO:0043209;GO:0005886;GO:0051430;GO:0001664;GO:0031821;GO:0031683;GO:0005525;GO:0032794;GO:0003924;GO:0046872;GO:0031852;GO:0007188;GO:0007568;GO:0007212;GO:0030900;GO:0007626;GO:0006936;GO:0051926;GO:0031175;GO:0042475;GO:0043547;GO:0006457;GO:0008016;GO:0034097;GO:0042493;GO:0042542;GO:0043278;GO:0007223;, C:cell body; C:dendrite; C:heterotrimeric G-protein complex; C:myelin sheath; C:plasma membrane;, F:corticotropin-releasing hormone receptor 1 binding; F:G protein-coupled receptor binding; F:G protein-coupled serotonin receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activating protein binding; F:GTPase activity; F:metal ion binding; F:mu-type opioid receptor binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:dopamine receptor signaling pathway; P:forebrain development; P:locomotory behavior; P:muscle contraction; P:negative regulation of calcium ion transport; P:neuron projection development; P:odontogenesis of dentin-containing tooth; P:positive regulation of GTPase activity; P:protein folding; P:regulation of heart contraction; P:response to cytokine; P:response to drug; P:response to hydrogen peroxide; P:response to morphine; P:Wnt signaling pathway, calcium modulating pathway;|P09471 P29777 Q8TD72 Q9UMV4,Guanine nucleotide-binding protein G(o) subunit alpha,, PF00503;, GO:0044297;GO:0030425;GO:0005834;GO:0043209;GO:0005886;GO:0051430;GO:0001664;GO:0031821;GO:0031683;GO:0005525;GO:0032794;GO:0003924;GO:0046872;GO:0031852;GO:0007188;GO:0007568;GO:0007212;GO:0030900;GO:0007626;GO:0006936;GO:0051926;GO:0031175;GO:0042475;GO:0043547;GO:0006457;GO:0008016;GO:0034097;GO:0042493;GO:0042542;GO:0043278;GO:0007223;, C:cell body; C:dendrite; C:heterotrimeric G-protein complex; C:myelin sheath; C:plasma membrane;, F:corticotropin-releasing hormone receptor 1 binding; F:G protein-coupled receptor binding; F:G protein-coupled serotonin receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activating protein binding; F:GTPase activity; F:metal ion binding; F:mu-type opioid receptor binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:dopamine receptor signaling pathway; P:forebrain development; P:locomotory behavior; P:muscle contraction; P:negative regulation of calcium ion transport; P:neuron projection development; P:odontogenesis of dentin-containing tooth; P:positive regulation of GTPase activity; P:protein folding; P:regulation of heart contraction; P:response to cytokine; P:response to drug; P:response to hydrogen peroxide; P:response to morphine; P:Wnt signaling pathway, calcium modulating pathway;|P09471 P29777 Q8TD72 Q9UMV4,Guanine nucleotide-binding protein G(o) subunit alpha,, PF00503;, GO:0044297;GO:0030425;GO:0005834;GO:0043209;GO:0005886;GO:0051430;GO:0001664;GO:0031821;GO:0031683;GO:0005525;GO:0032794;GO:0003924;GO:0046872;GO:0031852;GO:0007188;GO:0007568;GO:0007212;GO:0030900;GO:0007626;GO:0006936;GO:0051926;GO:0031175;GO:0042475;GO:0043547;GO:0006457;GO:0008016;GO:0034097;GO:0042493;GO:0042542;GO:0043278;GO:0007223;, C:cell body; C:dendrite; C:heterotrimeric G-protein complex; C:myelin sheath; C:plasma membrane;, F:corticotropin-releasing hormone receptor 1 binding; F:G protein-coupled receptor binding; F:G protein-coupled serotonin receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activating protein binding; F:GTPase activity; F:metal ion binding; F:mu-type opioid receptor binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:dopamine receptor signaling pathway; P:forebrain development; P:locomotory behavior; P:muscle contraction; P:negative regulation of calcium ion transport; P:neuron projection development; P:odontogenesis of dentin-containing tooth; P:positive regulation of GTPase activity; P:protein folding; P:regulation of heart contraction; P:response to cytokine; P:response to drug; P:response to hydrogen peroxide; P:response to morphine; P:Wnt signaling pathway, calcium modulating pathway; scaffold16 indexed_genome mRNA 20887671 20895013 . - . ID=transcript_4088;Q9ULY2,Liver carboxylesterase 1 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase;Brain carboxylesterase hBr1;Carboxylesterase 1;Cholesteryl ester hydrolase {ECO:0000303|PubMed:11015575};Cocaine carboxylesterase;Egasyn;HMSE;Methylumbelliferyl-acetate deacetylase 1;Monocyte/macrophage serine esterase;Retinyl ester hydrolase;Serine esterase 1;Triacylglycerol hydrolase;, PF00135;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005615;GO:0005811;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0002003;GO:0071397;GO:0071404;GO:0006695;GO:0090122;GO:0042632;GO:0008203;GO:0030855;GO:0016042;GO:0051791;GO:0010887;GO:0010875;GO:0090205;GO:0070857;GO:0120188;GO:0009636;GO:0043691;GO:0006805;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:lipid droplet;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:angiotensin maturation; P:cellular response to cholesterol; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:cholesterol ester hydrolysis involved in cholesterol transport; P:cholesterol homeostasis; P:cholesterol metabolic process; P:epithelial cell differentiation; P:lipid catabolic process; P:medium-chain fatty acid metabolic process; P:negative regulation of cholesterol storage; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol metabolic process; P:regulation of bile acid biosynthetic process; P:regulation of bile acid secretion; P:response to toxic substance; P:reverse cholesterol transport; P:xenobiotic metabolic process;|Q9ULY2,Liver carboxylesterase 1 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase;Brain carboxylesterase hBr1;Carboxylesterase 1;Cholesteryl ester hydrolase {ECO:0000303|PubMed:11015575};Cocaine carboxylesterase;Egasyn;HMSE;Methylumbelliferyl-acetate deacetylase 1;Monocyte/macrophage serine esterase;Retinyl ester hydrolase;Serine esterase 1;Triacylglycerol hydrolase;, PF00135;, GO:0005737;GO:0005829;GO:0005783;GO:0005788;GO:0005615;GO:0005811;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0002003;GO:0071397;GO:0071404;GO:0006695;GO:0090122;GO:0042632;GO:0008203;GO:0030855;GO:0016042;GO:0051791;GO:0010887;GO:0010875;GO:0090205;GO:0070857;GO:0120188;GO:0009636;GO:0043691;GO:0006805;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:lipid droplet;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:angiotensin maturation; P:cellular response to cholesterol; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol biosynthetic process; P:cholesterol ester hydrolysis involved in cholesterol transport; P:cholesterol homeostasis; P:cholesterol metabolic process; P:epithelial cell differentiation; P:lipid catabolic process; P:medium-chain fatty acid metabolic process; P:negative regulation of cholesterol storage; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol metabolic process; P:regulation of bile acid biosynthetic process; P:regulation of bile acid secretion; P:response to toxic substance; P:reverse cholesterol transport; P:xenobiotic metabolic process; scaffold16 indexed_genome mRNA 20973276 21078834 . + . ID=transcript_4089;Q8N1F7 B3KPQ8 Q14705,Nuclear pore complex protein Nup93,93 kDa nucleoporin;Nucleoporin Nup93;, PF04097;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0051292;GO:0016973;GO:0060391;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060395;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:nuclear pore complex assembly; P:poly(A)+ mRNA export from nucleus; P:positive regulation of SMAD protein signal transduction; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:SMAD protein signal transduction; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8N1F7 B3KPQ8 Q14705,Nuclear pore complex protein Nup93,93 kDa nucleoporin;Nucleoporin Nup93;, PF04097;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0051292;GO:0016973;GO:0060391;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060395;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:nuclear pore complex assembly; P:poly(A)+ mRNA export from nucleus; P:positive regulation of SMAD protein signal transduction; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:SMAD protein signal transduction; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8N1F7 B3KPQ8 Q14705,Nuclear pore complex protein Nup93,93 kDa nucleoporin;Nucleoporin Nup93;, PF04097;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0051292;GO:0016973;GO:0060391;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060395;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:nuclear pore complex assembly; P:poly(A)+ mRNA export from nucleus; P:positive regulation of SMAD protein signal transduction; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:SMAD protein signal transduction; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8N1F7 B3KPQ8 Q14705,Nuclear pore complex protein Nup93,93 kDa nucleoporin;Nucleoporin Nup93;, PF04097;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0051292;GO:0016973;GO:0060391;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060395;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:nuclear pore complex assembly; P:poly(A)+ mRNA export from nucleus; P:positive regulation of SMAD protein signal transduction; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:SMAD protein signal transduction; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8N1F7 B3KPQ8 Q14705,Nuclear pore complex protein Nup93,93 kDa nucleoporin;Nucleoporin Nup93;, PF04097;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0051292;GO:0016973;GO:0060391;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060395;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:nuclear pore complex assembly; P:poly(A)+ mRNA export from nucleus; P:positive regulation of SMAD protein signal transduction; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:SMAD protein signal transduction; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8N1F7 B3KPQ8 Q14705,Nuclear pore complex protein Nup93,93 kDa nucleoporin;Nucleoporin Nup93;, PF04097;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0051292;GO:0016973;GO:0060391;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060395;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:nuclear pore complex assembly; P:poly(A)+ mRNA export from nucleus; P:positive regulation of SMAD protein signal transduction; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:SMAD protein signal transduction; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8N1F7 B3KPQ8 Q14705,Nuclear pore complex protein Nup93,93 kDa nucleoporin;Nucleoporin Nup93;, PF04097;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0051292;GO:0016973;GO:0060391;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060395;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:nuclear pore complex assembly; P:poly(A)+ mRNA export from nucleus; P:positive regulation of SMAD protein signal transduction; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:SMAD protein signal transduction; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8N1F7 B3KPQ8 Q14705,Nuclear pore complex protein Nup93,93 kDa nucleoporin;Nucleoporin Nup93;, PF04097;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0051292;GO:0016973;GO:0060391;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060395;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:nuclear pore complex assembly; P:poly(A)+ mRNA export from nucleus; P:positive regulation of SMAD protein signal transduction; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:SMAD protein signal transduction; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8N1F7 B3KPQ8 Q14705,Nuclear pore complex protein Nup93,93 kDa nucleoporin;Nucleoporin Nup93;, PF04097;, GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006998;GO:0051292;GO:0016973;GO:0060391;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060395;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:nuclear envelope organization; P:nuclear pore complex assembly; P:poly(A)+ mRNA export from nucleus; P:positive regulation of SMAD protein signal transduction; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:SMAD protein signal transduction; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold16 indexed_genome mRNA 21110839 21117260 . + . ID=transcript_4090;P55017 A8MSJ2 C9JNN9,Solute carrier family 12 member 3,Na-Cl cotransporter;Na-Cl symporter;Thiazide-sensitive sodium-chloride cotransporter;, PF00324;PF08403;PF03522;, GO:0016324;GO:0005829;GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0015379;GO:0015081;GO:0015378;GO:0008511;GO:0006884;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;GO:0055078;GO:0035725;GO:0006814;, C:apical plasma membrane; C:cytosol; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:potassium:chloride symporter activity; F:sodium ion transmembrane transporter activity; F:sodium:chloride symporter activity; F:sodium:potassium:chloride symporter activity;, P:cell volume homeostasis; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:sodium ion homeostasis; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold16 indexed_genome mRNA 21149131 21160705 . + . ID=transcript_4091;Q15011 E9PGD1 O60644 Q6IAN8 Q96D92,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein,Methyl methanesulfonate (MMF)-inducible fragment protein 1;, PF00240;, GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:1990037;GO:0016020;GO:0044325;GO:1990756;GO:0032469;GO:0030968;GO:0043154;GO:1902236;GO:2001243;GO:0036499;GO:1903071;GO:0045047;GO:1903069;GO:0031396;GO:0034976;GO:0006986;GO:0030970;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:Lewy body core; C:membrane;, F:ion channel binding; F:ubiquitin ligase-substrate adaptor activity;, P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum unfolded protein response; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway; P:PERK-mediated unfolded protein response; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein targeting to ER; P:regulation of ER-associated ubiquitin-dependent protein catabolic process; P:regulation of protein ubiquitination; P:response to endoplasmic reticulum stress; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q15011 E9PGD1 O60644 Q6IAN8 Q96D92,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein,Methyl methanesulfonate (MMF)-inducible fragment protein 1;, PF00240;, GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:1990037;GO:0016020;GO:0044325;GO:1990756;GO:0032469;GO:0030968;GO:0043154;GO:1902236;GO:2001243;GO:0036499;GO:1903071;GO:0045047;GO:1903069;GO:0031396;GO:0034976;GO:0006986;GO:0030970;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:Lewy body core; C:membrane;, F:ion channel binding; F:ubiquitin ligase-substrate adaptor activity;, P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum unfolded protein response; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway; P:PERK-mediated unfolded protein response; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein targeting to ER; P:regulation of ER-associated ubiquitin-dependent protein catabolic process; P:regulation of protein ubiquitination; P:response to endoplasmic reticulum stress; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q15011 E9PGD1 O60644 Q6IAN8 Q96D92,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein,Methyl methanesulfonate (MMF)-inducible fragment protein 1;, PF00240;, GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:1990037;GO:0016020;GO:0044325;GO:1990756;GO:0032469;GO:0030968;GO:0043154;GO:1902236;GO:2001243;GO:0036499;GO:1903071;GO:0045047;GO:1903069;GO:0031396;GO:0034976;GO:0006986;GO:0030970;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:Lewy body core; C:membrane;, F:ion channel binding; F:ubiquitin ligase-substrate adaptor activity;, P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum unfolded protein response; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway; P:PERK-mediated unfolded protein response; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein targeting to ER; P:regulation of ER-associated ubiquitin-dependent protein catabolic process; P:regulation of protein ubiquitination; P:response to endoplasmic reticulum stress; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q15011 E9PGD1 O60644 Q6IAN8 Q96D92,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein,Methyl methanesulfonate (MMF)-inducible fragment protein 1;, PF00240;, GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:1990037;GO:0016020;GO:0044325;GO:1990756;GO:0032469;GO:0030968;GO:0043154;GO:1902236;GO:2001243;GO:0036499;GO:1903071;GO:0045047;GO:1903069;GO:0031396;GO:0034976;GO:0006986;GO:0030970;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:Lewy body core; C:membrane;, F:ion channel binding; F:ubiquitin ligase-substrate adaptor activity;, P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum unfolded protein response; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway; P:PERK-mediated unfolded protein response; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:protein targeting to ER; P:regulation of ER-associated ubiquitin-dependent protein catabolic process; P:regulation of protein ubiquitination; P:response to endoplasmic reticulum stress; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold16 indexed_genome mRNA 21165964 21166632 . - . ID=transcript_4092;Q6ZN92,Putative inactive deoxyuridine 5'-triphosphate nucleotidohydrolase-like protein FLJ16323,, PF00692;, GO:0004170;GO:0000287;GO:0006226;GO:0046081;, , F:dUTP diphosphatase activity; F:magnesium ion binding;, P:dUMP biosynthetic process; P:dUTP catabolic process; scaffold16 indexed_genome mRNA 21192202 21280088 . + . ID=transcript_4093;Q86WI3 B5MEF1 C9JMD8 Q6P4A6 Q86VM7 Q8NF42 Q8TEE2 Q8TEJ1 Q969L7,Protein NLRC5,Caterpiller protein 16.1;Nucleotide-binding oligomerization domain protein 27;Nucleotide-binding oligomerization domain protein 4;, PF18461;PF13516;PF05729;PF17776;, GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0000978;GO:0051607;GO:0045087;GO:0035556;GO:0032088;GO:0032480;GO:0060339;GO:0060335;GO:0045345;GO:0045944;GO:0060340;GO:0043549;GO:0009617;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:defense response to virus; P:innate immune response; P:intracellular signal transduction; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon-mediated signaling pathway; P:regulation of kinase activity; P:response to bacterium;|Q86WI3 B5MEF1 C9JMD8 Q6P4A6 Q86VM7 Q8NF42 Q8TEE2 Q8TEJ1 Q969L7,Protein NLRC5,Caterpiller protein 16.1;Nucleotide-binding oligomerization domain protein 27;Nucleotide-binding oligomerization domain protein 4;, PF18461;PF13516;PF05729;PF17776;, GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0000978;GO:0051607;GO:0045087;GO:0035556;GO:0032088;GO:0032480;GO:0060339;GO:0060335;GO:0045345;GO:0045944;GO:0060340;GO:0043549;GO:0009617;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:defense response to virus; P:innate immune response; P:intracellular signal transduction; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon-mediated signaling pathway; P:regulation of kinase activity; P:response to bacterium;|Q86WI3 B5MEF1 C9JMD8 Q6P4A6 Q86VM7 Q8NF42 Q8TEE2 Q8TEJ1 Q969L7,Protein NLRC5,Caterpiller protein 16.1;Nucleotide-binding oligomerization domain protein 27;Nucleotide-binding oligomerization domain protein 4;, PF18461;PF13516;PF05729;PF17776;, GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0000978;GO:0051607;GO:0045087;GO:0035556;GO:0032088;GO:0032480;GO:0060339;GO:0060335;GO:0045345;GO:0045944;GO:0060340;GO:0043549;GO:0009617;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:defense response to virus; P:innate immune response; P:intracellular signal transduction; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon-mediated signaling pathway; P:regulation of kinase activity; P:response to bacterium;|Q86WI3 B5MEF1 C9JMD8 Q6P4A6 Q86VM7 Q8NF42 Q8TEE2 Q8TEJ1 Q969L7,Protein NLRC5,Caterpiller protein 16.1;Nucleotide-binding oligomerization domain protein 27;Nucleotide-binding oligomerization domain protein 4;, PF18461;PF13516;PF05729;PF17776;, GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0000978;GO:0051607;GO:0045087;GO:0035556;GO:0032088;GO:0032480;GO:0060339;GO:0060335;GO:0045345;GO:0045944;GO:0060340;GO:0043549;GO:0009617;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:defense response to virus; P:innate immune response; P:intracellular signal transduction; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon-mediated signaling pathway; P:regulation of kinase activity; P:response to bacterium;|Q86WI3 B5MEF1 C9JMD8 Q6P4A6 Q86VM7 Q8NF42 Q8TEE2 Q8TEJ1 Q969L7,Protein NLRC5,Caterpiller protein 16.1;Nucleotide-binding oligomerization domain protein 27;Nucleotide-binding oligomerization domain protein 4;, PF18461;PF13516;PF05729;PF17776;, GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0000978;GO:0051607;GO:0045087;GO:0035556;GO:0032088;GO:0032480;GO:0060339;GO:0060335;GO:0045345;GO:0045944;GO:0060340;GO:0043549;GO:0009617;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:defense response to virus; P:innate immune response; P:intracellular signal transduction; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon-mediated signaling pathway; P:regulation of kinase activity; P:response to bacterium;|Q86WI3 B5MEF1 C9JMD8 Q6P4A6 Q86VM7 Q8NF42 Q8TEE2 Q8TEJ1 Q969L7,Protein NLRC5,Caterpiller protein 16.1;Nucleotide-binding oligomerization domain protein 27;Nucleotide-binding oligomerization domain protein 4;, PF18461;PF13516;PF05729;PF17776;, GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0000978;GO:0051607;GO:0045087;GO:0035556;GO:0032088;GO:0032480;GO:0060339;GO:0060335;GO:0045345;GO:0045944;GO:0060340;GO:0043549;GO:0009617;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:defense response to virus; P:innate immune response; P:intracellular signal transduction; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon-mediated signaling pathway; P:regulation of kinase activity; P:response to bacterium;|Q86WI3 B5MEF1 C9JMD8 Q6P4A6 Q86VM7 Q8NF42 Q8TEE2 Q8TEJ1 Q969L7,Protein NLRC5,Caterpiller protein 16.1;Nucleotide-binding oligomerization domain protein 27;Nucleotide-binding oligomerization domain protein 4;, PF18461;PF13516;PF05729;PF17776;, GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0000978;GO:0051607;GO:0045087;GO:0035556;GO:0032088;GO:0032480;GO:0060339;GO:0060335;GO:0045345;GO:0045944;GO:0060340;GO:0043549;GO:0009617;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:defense response to virus; P:innate immune response; P:intracellular signal transduction; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon-mediated signaling pathway; P:regulation of kinase activity; P:response to bacterium; scaffold16 indexed_genome mRNA 21312415 21343601 . + . ID=transcript_4094;Q96FN4 Q68D19 Q719H8 Q86XP9,Copine-2 {ECO:0000305},Copine II {ECO:0000250|UniProtKB:Q99829, ECO:0000312|HGNC:HGNC:2315};, PF00168;PF07002;, GO:0005737;GO:0070062;GO:0005634;GO:0005886;GO:0005544;GO:0046872;GO:0071277;, C:cytoplasm; C:extracellular exosome; C:nucleus; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cellular response to calcium ion;|Q96FN4 Q68D19 Q719H8 Q86XP9,Copine-2 {ECO:0000305},Copine II {ECO:0000250|UniProtKB:Q99829, ECO:0000312|HGNC:HGNC:2315};, PF00168;PF07002;, GO:0005737;GO:0070062;GO:0005634;GO:0005886;GO:0005544;GO:0046872;GO:0071277;, C:cytoplasm; C:extracellular exosome; C:nucleus; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cellular response to calcium ion; scaffold16 indexed_genome mRNA 21348807 21384444 . - . ID=transcript_4095;Q9GZU8,PSME3-interacting protein {ECO:0000305},NEFA-interacting nuclear protein NIP30 {ECO:0000250|UniProtKB:Q91WE2};PA28G-interacting protein {ECO:0000303|PubMed:29934401};, PF10187;, GO:0005634;GO:1901799;GO:0032091;, C:nucleus;, , P:negative regulation of proteasomal protein catabolic process; P:negative regulation of protein binding; scaffold16 indexed_genome mRNA 21384706 21421101 . + . ID=transcript_4096;Q96DX4 Q6UX21 Q8ND53,RING finger and SPRY domain-containing protein 1,, PF00622;, GO:0005737;GO:0005576;GO:0046872;GO:0004842;GO:0051603;, C:cytoplasm; C:extracellular region;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:proteolysis involved in cellular protein catabolic process;|Q96DX4 Q6UX21 Q8ND53,RING finger and SPRY domain-containing protein 1,, PF00622;, GO:0005737;GO:0005576;GO:0046872;GO:0004842;GO:0051603;, C:cytoplasm; C:extracellular region;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:proteolysis involved in cellular protein catabolic process;|Q96DX4 Q6UX21 Q8ND53,RING finger and SPRY domain-containing protein 1,, PF00622;, GO:0005737;GO:0005576;GO:0046872;GO:0004842;GO:0051603;, C:cytoplasm; C:extracellular region;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:proteolysis involved in cellular protein catabolic process;|Q96DX4 Q6UX21 Q8ND53,RING finger and SPRY domain-containing protein 1,, PF00622;, GO:0005737;GO:0005576;GO:0046872;GO:0004842;GO:0051603;, C:cytoplasm; C:extracellular region;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:proteolysis involved in cellular protein catabolic process;|Q96DX4 Q6UX21 Q8ND53,RING finger and SPRY domain-containing protein 1,, PF00622;, GO:0005737;GO:0005576;GO:0046872;GO:0004842;GO:0051603;, C:cytoplasm; C:extracellular region;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:proteolysis involved in cellular protein catabolic process;|Q96DX4 Q6UX21 Q8ND53,RING finger and SPRY domain-containing protein 1,, PF00622;, GO:0005737;GO:0005576;GO:0046872;GO:0004842;GO:0051603;, C:cytoplasm; C:extracellular region;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:proteolysis involved in cellular protein catabolic process; scaffold16 indexed_genome mRNA 21421103 21428560 . + . ID=transcript_4097;Q9Y2Y0 B3KQJ5 Q504R0,ADP-ribosylation factor-like protein 2-binding protein,Binder of ARF2 protein 1;, PF11527;, GO:0005813;GO:0005929;GO:0005829;GO:0030496;GO:0005758;GO:0005759;GO:0005634;GO:0005819;GO:0030695;GO:0003713;GO:0051457;GO:0042531;GO:0007165;, C:centrosome; C:cilium; C:cytosol; C:midbody; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:nucleus; C:spindle;, F:GTPase regulator activity; F:transcription coactivator activity;, P:maintenance of protein location in nucleus; P:positive regulation of tyrosine phosphorylation of STAT protein; P:signal transduction;|Q9Y2Y0 B3KQJ5 Q504R0,ADP-ribosylation factor-like protein 2-binding protein,Binder of ARF2 protein 1;, PF11527;, GO:0005813;GO:0005929;GO:0005829;GO:0030496;GO:0005758;GO:0005759;GO:0005634;GO:0005819;GO:0030695;GO:0003713;GO:0051457;GO:0042531;GO:0007165;, C:centrosome; C:cilium; C:cytosol; C:midbody; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:nucleus; C:spindle;, F:GTPase regulator activity; F:transcription coactivator activity;, P:maintenance of protein location in nucleus; P:positive regulation of tyrosine phosphorylation of STAT protein; P:signal transduction; scaffold16 indexed_genome mRNA 21429647 21461581 . - . ID=transcript_4098;Q9Y342 B2R9T6,Plasmolipin,Plasma membrane proteolipid;, PF01284;, GO:0043218;GO:0016021;GO:0045121;GO:0019911;GO:0006811;GO:0042552;GO:0009611;, C:compact myelin; C:integral component of membrane; C:membrane raft;, F:structural constituent of myelin sheath;, P:ion transport; P:myelination; P:response to wounding;|Q9Y342 B2R9T6,Plasmolipin,Plasma membrane proteolipid;, PF01284;, GO:0043218;GO:0016021;GO:0045121;GO:0019911;GO:0006811;GO:0042552;GO:0009611;, C:compact myelin; C:integral component of membrane; C:membrane raft;, F:structural constituent of myelin sheath;, P:ion transport; P:myelination; P:response to wounding; scaffold16 indexed_genome mRNA 21533160 21539603 . + . ID=transcript_4099;O00626 A0N0Q6 B2R4W2,C-C motif chemokine 22,CC chemokine STCP-1;MDC(1-69);Macrophage-derived chemokine;Small-inducible cytokine A22;Stimulated T-cell chemotactic protein 1;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0008009;GO:0061844;GO:0007267;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0019221;GO:0007186;GO:0006955;GO:0006954;GO:0031640;GO:0048247;GO:0002548;GO:0030593;GO:0070374;GO:0043547;GO:0009615;GO:0007165;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:chemokine activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell-cell signaling; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:killing of cells of other organism; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:neutrophil chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:response to virus; P:signal transduction; scaffold16 indexed_genome mRNA 21550780 21563054 . + . ID=transcript_4100;P78423 O00672,Fractalkine,C-X3-C motif chemokine 1;CX3C membrane-anchored chemokine;Neurotactin;Small-inducible cytokine D1;, PF00048;, GO:0042995;GO:0009986;GO:0005576;GO:0005615;GO:0016021;GO:0016020;GO:0043025;GO:0048471;GO:0005886;GO:0048020;GO:0042056;GO:0008009;GO:0031737;GO:0045237;GO:0005178;GO:0005102;GO:0007568;GO:0035425;GO:0007155;GO:0060326;GO:0098609;GO:0007267;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0019221;GO:0006952;GO:0048245;GO:0007186;GO:0006955;GO:0006954;GO:0033622;GO:0050902;GO:0030595;GO:0002523;GO:0048247;GO:0001774;GO:0061518;GO:0002548;GO:0043066;GO:2001234;GO:0030336;GO:0010812;GO:1900450;GO:0110091;GO:0032690;GO:0032691;GO:0032715;GO:1903979;GO:2001223;GO:0032720;GO:0070050;GO:0016322;GO:0030593;GO:0050918;GO:0032233;GO:0051041;GO:0008284;GO:0001954;GO:0070374;GO:0043547;GO:0043123;GO:1903721;GO:0050729;GO:0043410;GO:1904141;GO:0002052;GO:0010976;GO:0051092;GO:0051897;GO:0051281;GO:0048661;GO:0045944;GO:0031664;GO:0050767;GO:0048167;GO:0002931;GO:0098883;, C:cell projection; C:cell surface; C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, F:CCR chemokine receptor binding; F:chemoattractant activity; F:chemokine activity; F:CX3C chemokine receptor binding; F:CXCR1 chemokine receptor binding; F:integrin binding; F:signaling receptor binding;, P:aging; P:autocrine signaling; P:cell adhesion; P:cell chemotaxis; P:cell-cell adhesion; P:cell-cell signaling; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:defense response; P:eosinophil chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:integrin activation; P:leukocyte adhesive activation; P:leukocyte chemotaxis; P:leukocyte migration involved in inflammatory response; P:lymphocyte chemotaxis; P:microglial cell activation; P:microglial cell proliferation; P:monocyte chemotaxis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell-substrate adhesion; P:negative regulation of glutamate receptor signaling pathway; P:negative regulation of hippocampal neuron apoptotic process; P:negative regulation of interleukin-1 alpha production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-6 production; P:negative regulation of microglial cell activation; P:negative regulation of neuron migration; P:negative regulation of tumor necrosis factor production; P:neuron cellular homeostasis; P:neuron remodeling; P:neutrophil chemotaxis; P:positive chemotaxis; P:positive regulation of actin filament bundle assembly; P:positive regulation of calcium-independent cell-cell adhesion; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of inflammatory response; P:positive regulation of MAPK cascade; P:positive regulation of microglial cell migration; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase B signaling; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of neurogenesis; P:regulation of synaptic plasticity; P:response to ischemia; P:synapse pruning;|P78423 O00672,Fractalkine,C-X3-C motif chemokine 1;CX3C membrane-anchored chemokine;Neurotactin;Small-inducible cytokine D1;, PF00048;, GO:0042995;GO:0009986;GO:0005576;GO:0005615;GO:0016021;GO:0016020;GO:0043025;GO:0048471;GO:0005886;GO:0048020;GO:0042056;GO:0008009;GO:0031737;GO:0045237;GO:0005178;GO:0005102;GO:0007568;GO:0035425;GO:0007155;GO:0060326;GO:0098609;GO:0007267;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0019221;GO:0006952;GO:0048245;GO:0007186;GO:0006955;GO:0006954;GO:0033622;GO:0050902;GO:0030595;GO:0002523;GO:0048247;GO:0001774;GO:0061518;GO:0002548;GO:0043066;GO:2001234;GO:0030336;GO:0010812;GO:1900450;GO:0110091;GO:0032690;GO:0032691;GO:0032715;GO:1903979;GO:2001223;GO:0032720;GO:0070050;GO:0016322;GO:0030593;GO:0050918;GO:0032233;GO:0051041;GO:0008284;GO:0001954;GO:0070374;GO:0043547;GO:0043123;GO:1903721;GO:0050729;GO:0043410;GO:1904141;GO:0002052;GO:0010976;GO:0051092;GO:0051897;GO:0051281;GO:0048661;GO:0045944;GO:0031664;GO:0050767;GO:0048167;GO:0002931;GO:0098883;, C:cell projection; C:cell surface; C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, F:CCR chemokine receptor binding; F:chemoattractant activity; F:chemokine activity; F:CX3C chemokine receptor binding; F:CXCR1 chemokine receptor binding; F:integrin binding; F:signaling receptor binding;, P:aging; P:autocrine signaling; P:cell adhesion; P:cell chemotaxis; P:cell-cell adhesion; P:cell-cell signaling; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:defense response; P:eosinophil chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:integrin activation; P:leukocyte adhesive activation; P:leukocyte chemotaxis; P:leukocyte migration involved in inflammatory response; P:lymphocyte chemotaxis; P:microglial cell activation; P:microglial cell proliferation; P:monocyte chemotaxis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell-substrate adhesion; P:negative regulation of glutamate receptor signaling pathway; P:negative regulation of hippocampal neuron apoptotic process; P:negative regulation of interleukin-1 alpha production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-6 production; P:negative regulation of microglial cell activation; P:negative regulation of neuron migration; P:negative regulation of tumor necrosis factor production; P:neuron cellular homeostasis; P:neuron remodeling; P:neutrophil chemotaxis; P:positive chemotaxis; P:positive regulation of actin filament bundle assembly; P:positive regulation of calcium-independent cell-cell adhesion; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of inflammatory response; P:positive regulation of MAPK cascade; P:positive regulation of microglial cell migration; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase B signaling; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of neurogenesis; P:regulation of synaptic plasticity; P:response to ischemia; P:synapse pruning;|P78423 O00672,Fractalkine,C-X3-C motif chemokine 1;CX3C membrane-anchored chemokine;Neurotactin;Small-inducible cytokine D1;, PF00048;, GO:0042995;GO:0009986;GO:0005576;GO:0005615;GO:0016021;GO:0016020;GO:0043025;GO:0048471;GO:0005886;GO:0048020;GO:0042056;GO:0008009;GO:0031737;GO:0045237;GO:0005178;GO:0005102;GO:0007568;GO:0035425;GO:0007155;GO:0060326;GO:0098609;GO:0007267;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0019221;GO:0006952;GO:0048245;GO:0007186;GO:0006955;GO:0006954;GO:0033622;GO:0050902;GO:0030595;GO:0002523;GO:0048247;GO:0001774;GO:0061518;GO:0002548;GO:0043066;GO:2001234;GO:0030336;GO:0010812;GO:1900450;GO:0110091;GO:0032690;GO:0032691;GO:0032715;GO:1903979;GO:2001223;GO:0032720;GO:0070050;GO:0016322;GO:0030593;GO:0050918;GO:0032233;GO:0051041;GO:0008284;GO:0001954;GO:0070374;GO:0043547;GO:0043123;GO:1903721;GO:0050729;GO:0043410;GO:1904141;GO:0002052;GO:0010976;GO:0051092;GO:0051897;GO:0051281;GO:0048661;GO:0045944;GO:0031664;GO:0050767;GO:0048167;GO:0002931;GO:0098883;, C:cell projection; C:cell surface; C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, F:CCR chemokine receptor binding; F:chemoattractant activity; F:chemokine activity; F:CX3C chemokine receptor binding; F:CXCR1 chemokine receptor binding; F:integrin binding; F:signaling receptor binding;, P:aging; P:autocrine signaling; P:cell adhesion; P:cell chemotaxis; P:cell-cell adhesion; P:cell-cell signaling; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:defense response; P:eosinophil chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:integrin activation; P:leukocyte adhesive activation; P:leukocyte chemotaxis; P:leukocyte migration involved in inflammatory response; P:lymphocyte chemotaxis; P:microglial cell activation; P:microglial cell proliferation; P:monocyte chemotaxis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell-substrate adhesion; P:negative regulation of glutamate receptor signaling pathway; P:negative regulation of hippocampal neuron apoptotic process; P:negative regulation of interleukin-1 alpha production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-6 production; P:negative regulation of microglial cell activation; P:negative regulation of neuron migration; P:negative regulation of tumor necrosis factor production; P:neuron cellular homeostasis; P:neuron remodeling; P:neutrophil chemotaxis; P:positive chemotaxis; P:positive regulation of actin filament bundle assembly; P:positive regulation of calcium-independent cell-cell adhesion; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of inflammatory response; P:positive regulation of MAPK cascade; P:positive regulation of microglial cell migration; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase B signaling; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of neurogenesis; P:regulation of synaptic plasticity; P:response to ischemia; P:synapse pruning; scaffold16 indexed_genome mRNA 21600151 21613654 . - . ID=transcript_4101;Q6FI81 A8K8B6 O75206 O75207 Q9H0W1 Q9P1L7,Anamorsin {ECO:0000255|HAMAP-Rule:MF_03115},Cytokine-induced apoptosis inhibitor 1 {ECO:0000255|HAMAP-Rule:MF_03115};Fe-S cluster assembly protein DRE2 homolog {ECO:0000255|HAMAP-Rule:MF_03115};, PF05093;PF08241;, GO:0005737;GO:0005758;GO:0005739;GO:0005730;GO:0005654;GO:0051537;GO:0051539;GO:0009055;GO:0046872;GO:0008168;GO:0006915;GO:0030097;GO:0016226;GO:0043066;, C:cytoplasm; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:methyltransferase activity;, P:apoptotic process; P:hemopoiesis; P:iron-sulfur cluster assembly; P:negative regulation of apoptotic process;|Q6FI81 A8K8B6 O75206 O75207 Q9H0W1 Q9P1L7,Anamorsin {ECO:0000255|HAMAP-Rule:MF_03115},Cytokine-induced apoptosis inhibitor 1 {ECO:0000255|HAMAP-Rule:MF_03115};Fe-S cluster assembly protein DRE2 homolog {ECO:0000255|HAMAP-Rule:MF_03115};, PF05093;PF08241;, GO:0005737;GO:0005758;GO:0005739;GO:0005730;GO:0005654;GO:0051537;GO:0051539;GO:0009055;GO:0046872;GO:0008168;GO:0006915;GO:0030097;GO:0016226;GO:0043066;, C:cytoplasm; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:methyltransferase activity;, P:apoptotic process; P:hemopoiesis; P:iron-sulfur cluster assembly; P:negative regulation of apoptotic process;|Q6FI81 A8K8B6 O75206 O75207 Q9H0W1 Q9P1L7,Anamorsin {ECO:0000255|HAMAP-Rule:MF_03115},Cytokine-induced apoptosis inhibitor 1 {ECO:0000255|HAMAP-Rule:MF_03115};Fe-S cluster assembly protein DRE2 homolog {ECO:0000255|HAMAP-Rule:MF_03115};, PF05093;PF08241;, GO:0005737;GO:0005758;GO:0005739;GO:0005730;GO:0005654;GO:0051537;GO:0051539;GO:0009055;GO:0046872;GO:0008168;GO:0006915;GO:0030097;GO:0016226;GO:0043066;, C:cytoplasm; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:methyltransferase activity;, P:apoptotic process; P:hemopoiesis; P:iron-sulfur cluster assembly; P:negative regulation of apoptotic process;|Q6FI81 A8K8B6 O75206 O75207 Q9H0W1 Q9P1L7,Anamorsin {ECO:0000255|HAMAP-Rule:MF_03115},Cytokine-induced apoptosis inhibitor 1 {ECO:0000255|HAMAP-Rule:MF_03115};Fe-S cluster assembly protein DRE2 homolog {ECO:0000255|HAMAP-Rule:MF_03115};, PF05093;PF08241;, GO:0005737;GO:0005758;GO:0005739;GO:0005730;GO:0005654;GO:0051537;GO:0051539;GO:0009055;GO:0046872;GO:0008168;GO:0006915;GO:0030097;GO:0016226;GO:0043066;, C:cytoplasm; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:methyltransferase activity;, P:apoptotic process; P:hemopoiesis; P:iron-sulfur cluster assembly; P:negative regulation of apoptotic process; scaffold16 indexed_genome mRNA 21613720 21627264 . + . ID=transcript_4102;O75208 A8K3L2 Q7L5V7 Q7Z5T6 Q8NBL4 Q9NTJ2 Q9P056,Ubiquinone biosynthesis protein COQ9, mitochondrial,, PF08511;, GO:0005743;GO:0005739;GO:0008289;GO:0042803;GO:0006120;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:lipid binding; F:protein homodimerization activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:ubiquinone biosynthetic process;|P35268 B2R495 Q6IBD1,60S ribosomal protein L22,EBER-associated protein;Epstein-Barr virus small RNA-associated protein;Heparin-binding protein HBp15;Large ribosomal subunit protein eL22 {ECO:0000303|PubMed:24524803};, PF01776;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0098978;GO:0005634;GO:0098793;GO:1990904;GO:0008201;GO:0042802;GO:0003723;GO:0003735;GO:0045182;GO:0046632;GO:0002181;GO:0000184;GO:0099577;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:presynapse; C:ribonucleoprotein complex;, F:heparin binding; F:identical protein binding; F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:alpha-beta T cell differentiation; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation at presynapse, modulating synaptic transmission; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|O75208 A8K3L2 Q7L5V7 Q7Z5T6 Q8NBL4 Q9NTJ2 Q9P056,Ubiquinone biosynthesis protein COQ9, mitochondrial,, PF08511;, GO:0005743;GO:0005739;GO:0008289;GO:0042803;GO:0006120;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:lipid binding; F:protein homodimerization activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:ubiquinone biosynthetic process;|O75208 A8K3L2 Q7L5V7 Q7Z5T6 Q8NBL4 Q9NTJ2 Q9P056,Ubiquinone biosynthesis protein COQ9, mitochondrial,, PF08511;, GO:0005743;GO:0005739;GO:0008289;GO:0042803;GO:0006120;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:lipid binding; F:protein homodimerization activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:ubiquinone biosynthetic process; scaffold16 indexed_genome mRNA 21627287 21643572 . + . ID=transcript_4103;P19387 O15161,DNA-directed RNA polymerase II subunit RPB3 {ECO:0000305},DNA-directed RNA polymerase II 33 kDa polypeptide;DNA-directed RNA polymerase II subunit C;RPB31 {ECO:0000250|UniProtKB:P97760};, PF01000;PF01193;, GO:0005829;GO:0005654;GO:0005634;GO:0005665;GO:0003677;GO:0003899;GO:0046983;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:protein dimerization activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|P19387 O15161,DNA-directed RNA polymerase II subunit RPB3 {ECO:0000305},DNA-directed RNA polymerase II 33 kDa polypeptide;DNA-directed RNA polymerase II subunit C;RPB31 {ECO:0000250|UniProtKB:P97760};, PF01000;PF01193;, GO:0005829;GO:0005654;GO:0005634;GO:0005665;GO:0003677;GO:0003899;GO:0046983;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:protein dimerization activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|P19387 O15161,DNA-directed RNA polymerase II subunit RPB3 {ECO:0000305},DNA-directed RNA polymerase II 33 kDa polypeptide;DNA-directed RNA polymerase II subunit C;RPB31 {ECO:0000250|UniProtKB:P97760};, PF01000;PF01193;, GO:0005829;GO:0005654;GO:0005634;GO:0005665;GO:0003677;GO:0003899;GO:0046983;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:protein dimerization activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|Q8TEW6 O75209 Q9BTP2 Q9NVV3,Docking protein 4,Downstream of tyrosine kinase 4;Insulin receptor substrate 5;, PF02174;, GO:0005829;GO:0007411;, C:cytosol;, , P:axon guidance;|Q8TEW6 O75209 Q9BTP2 Q9NVV3,Docking protein 4,Downstream of tyrosine kinase 4;Insulin receptor substrate 5;, PF02174;, GO:0005829;GO:0007411;, C:cytosol;, , P:axon guidance;|Q8TEW6 O75209 Q9BTP2 Q9NVV3,Docking protein 4,Downstream of tyrosine kinase 4;Insulin receptor substrate 5;, PF02174;, GO:0005829;GO:0007411;, C:cytosol;, , P:axon guidance;|Q8TEW6 O75209 Q9BTP2 Q9NVV3,Docking protein 4,Downstream of tyrosine kinase 4;Insulin receptor substrate 5;, PF02174;, GO:0005829;GO:0007411;, C:cytosol;, , P:axon guidance; scaffold16 indexed_genome mRNA 21668923 21692674 . - . ID=transcript_4104;Q96A19 Q9BT74,Coiled-coil domain-containing protein 102A,, PF01576;, GO:0016459;, C:myosin complex; scaffold16 indexed_genome mRNA 21713364 21716628 . + . ID=transcript_4105;Q8IZF4 A0A024R6S3 A8K9R8 B3KXZ5 Q6ZMH7 Q6ZML4 Q86SL8 Q8IZ14,Adhesion G-protein coupled receptor G5,G-protein coupled receptor 114;G-protein coupled receptor PGR27;, PF00002;PF01825;, GO:0016021;GO:0005887;GO:0004930;GO:0007189;GO:0007166;GO:0007186;, C:integral component of membrane; C:integral component of plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold16 indexed_genome mRNA 21718680 21725680 . + . ID=transcript_4106;Q8IZF4 A0A024R6S3 A8K9R8 B3KXZ5 Q6ZMH7 Q6ZML4 Q86SL8 Q8IZ14,Adhesion G-protein coupled receptor G5,G-protein coupled receptor 114;G-protein coupled receptor PGR27;, PF00002;PF01825;, GO:0016021;GO:0005887;GO:0004930;GO:0007189;GO:0007166;GO:0007186;, C:integral component of membrane; C:integral component of plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold16 indexed_genome mRNA 21774430 21810980 . + . ID=transcript_4107;Q9Y653 A6NIT7 A6NJV9 B0M0K4 B4DR54 O95966 Q6ZMP1 Q8NGB3 Q96HB4,Adhesion G-protein coupled receptor G1,G-protein coupled receptor 56;Protein TM7XN1;, PF00002;PF18619;PF01825;PF18587;, GO:0070062;GO:0097451;GO:0016021;GO:0005887;GO:0045121;GO:0005518;GO:0050840;GO:0004930;GO:0008201;GO:0007189;GO:0001525;GO:0007420;GO:0007155;GO:0016477;GO:0007166;GO:0007267;GO:0021801;GO:0021796;GO:0007186;GO:0061484;GO:0021819;GO:0008285;GO:2001223;GO:0045785;GO:2000179;GO:0035025;GO:0070528;GO:0007266;GO:0072520;GO:0010573;, C:extracellular exosome; C:glial limiting end-foot; C:integral component of membrane; C:integral component of plasma membrane; C:membrane raft;, F:collagen binding; F:extracellular matrix binding; F:G protein-coupled receptor activity; F:heparin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:angiogenesis; P:brain development; P:cell adhesion; P:cell migration; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cerebral cortex radial glia guided migration; P:cerebral cortex regionalization; P:G protein-coupled receptor signaling pathway; P:hematopoietic stem cell homeostasis; P:layer formation in cerebral cortex; P:negative regulation of cell population proliferation; P:negative regulation of neuron migration; P:positive regulation of cell adhesion; P:positive regulation of neural precursor cell proliferation; P:positive regulation of Rho protein signal transduction; P:protein kinase C signaling; P:Rho protein signal transduction; P:seminiferous tubule development; P:vascular endothelial growth factor production;|Q9Y653 A6NIT7 A6NJV9 B0M0K4 B4DR54 O95966 Q6ZMP1 Q8NGB3 Q96HB4,Adhesion G-protein coupled receptor G1,G-protein coupled receptor 56;Protein TM7XN1;, PF00002;PF18619;PF01825;PF18587;, GO:0070062;GO:0097451;GO:0016021;GO:0005887;GO:0045121;GO:0005518;GO:0050840;GO:0004930;GO:0008201;GO:0007189;GO:0001525;GO:0007420;GO:0007155;GO:0016477;GO:0007166;GO:0007267;GO:0021801;GO:0021796;GO:0007186;GO:0061484;GO:0021819;GO:0008285;GO:2001223;GO:0045785;GO:2000179;GO:0035025;GO:0070528;GO:0007266;GO:0072520;GO:0010573;, C:extracellular exosome; C:glial limiting end-foot; C:integral component of membrane; C:integral component of plasma membrane; C:membrane raft;, F:collagen binding; F:extracellular matrix binding; F:G protein-coupled receptor activity; F:heparin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:angiogenesis; P:brain development; P:cell adhesion; P:cell migration; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cerebral cortex radial glia guided migration; P:cerebral cortex regionalization; P:G protein-coupled receptor signaling pathway; P:hematopoietic stem cell homeostasis; P:layer formation in cerebral cortex; P:negative regulation of cell population proliferation; P:negative regulation of neuron migration; P:positive regulation of cell adhesion; P:positive regulation of neural precursor cell proliferation; P:positive regulation of Rho protein signal transduction; P:protein kinase C signaling; P:Rho protein signal transduction; P:seminiferous tubule development; P:vascular endothelial growth factor production;|Q9Y653 A6NIT7 A6NJV9 B0M0K4 B4DR54 O95966 Q6ZMP1 Q8NGB3 Q96HB4,Adhesion G-protein coupled receptor G1,G-protein coupled receptor 56;Protein TM7XN1;, PF00002;PF18619;PF01825;PF18587;, GO:0070062;GO:0097451;GO:0016021;GO:0005887;GO:0045121;GO:0005518;GO:0050840;GO:0004930;GO:0008201;GO:0007189;GO:0001525;GO:0007420;GO:0007155;GO:0016477;GO:0007166;GO:0007267;GO:0021801;GO:0021796;GO:0007186;GO:0061484;GO:0021819;GO:0008285;GO:2001223;GO:0045785;GO:2000179;GO:0035025;GO:0070528;GO:0007266;GO:0072520;GO:0010573;, C:extracellular exosome; C:glial limiting end-foot; C:integral component of membrane; C:integral component of plasma membrane; C:membrane raft;, F:collagen binding; F:extracellular matrix binding; F:G protein-coupled receptor activity; F:heparin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:angiogenesis; P:brain development; P:cell adhesion; P:cell migration; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cerebral cortex radial glia guided migration; P:cerebral cortex regionalization; P:G protein-coupled receptor signaling pathway; P:hematopoietic stem cell homeostasis; P:layer formation in cerebral cortex; P:negative regulation of cell population proliferation; P:negative regulation of neuron migration; P:positive regulation of cell adhesion; P:positive regulation of neural precursor cell proliferation; P:positive regulation of Rho protein signal transduction; P:protein kinase C signaling; P:Rho protein signal transduction; P:seminiferous tubule development; P:vascular endothelial growth factor production; scaffold16 indexed_genome mRNA 21868492 21880902 . + . ID=transcript_4108;Q9BVA0 A6NCG6 O60620,Katanin p80 WD40 repeat-containing subunit B1 {ECO:0000255|HAMAP-Rule:MF_03022},p80 katanin {ECO:0000255|HAMAP-Rule:MF_03022};, PF13925;PF00400;, GO:0005813;GO:0005737;GO:0005829;GO:0030426;GO:0008352;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0043025;GO:0005634;GO:0005886;GO:0005819;GO:0000922;GO:0060590;GO:0070840;GO:0008017;GO:0046982;GO:0051301;GO:0007019;GO:0051013;GO:0007079;GO:0007026;GO:0010942;GO:0031117;GO:0010976;GO:0006605;, C:centrosome; C:cytoplasm; C:cytosol; C:growth cone; C:katanin complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:neuronal cell body; C:nucleus; C:plasma membrane; C:spindle; C:spindle pole;, F:ATPase regulator activity; F:dynein complex binding; F:microtubule binding; F:protein heterodimerization activity;, P:cell division; P:microtubule depolymerization; P:microtubule severing; P:mitotic chromosome movement towards spindle pole; P:negative regulation of microtubule depolymerization; P:positive regulation of cell death; P:positive regulation of microtubule depolymerization; P:positive regulation of neuron projection development; P:protein targeting;|Q9BVA0 A6NCG6 O60620,Katanin p80 WD40 repeat-containing subunit B1 {ECO:0000255|HAMAP-Rule:MF_03022},p80 katanin {ECO:0000255|HAMAP-Rule:MF_03022};, PF13925;PF00400;, GO:0005813;GO:0005737;GO:0005829;GO:0030426;GO:0008352;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0043025;GO:0005634;GO:0005886;GO:0005819;GO:0000922;GO:0060590;GO:0070840;GO:0008017;GO:0046982;GO:0051301;GO:0007019;GO:0051013;GO:0007079;GO:0007026;GO:0010942;GO:0031117;GO:0010976;GO:0006605;, C:centrosome; C:cytoplasm; C:cytosol; C:growth cone; C:katanin complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:neuronal cell body; C:nucleus; C:plasma membrane; C:spindle; C:spindle pole;, F:ATPase regulator activity; F:dynein complex binding; F:microtubule binding; F:protein heterodimerization activity;, P:cell division; P:microtubule depolymerization; P:microtubule severing; P:mitotic chromosome movement towards spindle pole; P:negative regulation of microtubule depolymerization; P:positive regulation of cell death; P:positive regulation of microtubule depolymerization; P:positive regulation of neuron projection development; P:protein targeting;|Q9BVA0 A6NCG6 O60620,Katanin p80 WD40 repeat-containing subunit B1 {ECO:0000255|HAMAP-Rule:MF_03022},p80 katanin {ECO:0000255|HAMAP-Rule:MF_03022};, PF13925;PF00400;, GO:0005813;GO:0005737;GO:0005829;GO:0030426;GO:0008352;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0043025;GO:0005634;GO:0005886;GO:0005819;GO:0000922;GO:0060590;GO:0070840;GO:0008017;GO:0046982;GO:0051301;GO:0007019;GO:0051013;GO:0007079;GO:0007026;GO:0010942;GO:0031117;GO:0010976;GO:0006605;, C:centrosome; C:cytoplasm; C:cytosol; C:growth cone; C:katanin complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:neuronal cell body; C:nucleus; C:plasma membrane; C:spindle; C:spindle pole;, F:ATPase regulator activity; F:dynein complex binding; F:microtubule binding; F:protein heterodimerization activity;, P:cell division; P:microtubule depolymerization; P:microtubule severing; P:mitotic chromosome movement towards spindle pole; P:negative regulation of microtubule depolymerization; P:positive regulation of cell death; P:positive regulation of microtubule depolymerization; P:positive regulation of neuron projection development; P:protein targeting; scaffold16 indexed_genome mRNA 21881524 21886502 . + . ID=transcript_4109;Q9BVA0 A6NCG6 O60620,Katanin p80 WD40 repeat-containing subunit B1 {ECO:0000255|HAMAP-Rule:MF_03022},p80 katanin {ECO:0000255|HAMAP-Rule:MF_03022};, PF13925;PF00400;, GO:0005813;GO:0005737;GO:0005829;GO:0030426;GO:0008352;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0043025;GO:0005634;GO:0005886;GO:0005819;GO:0000922;GO:0060590;GO:0070840;GO:0008017;GO:0046982;GO:0051301;GO:0007019;GO:0051013;GO:0007079;GO:0007026;GO:0010942;GO:0031117;GO:0010976;GO:0006605;, C:centrosome; C:cytoplasm; C:cytosol; C:growth cone; C:katanin complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:neuronal cell body; C:nucleus; C:plasma membrane; C:spindle; C:spindle pole;, F:ATPase regulator activity; F:dynein complex binding; F:microtubule binding; F:protein heterodimerization activity;, P:cell division; P:microtubule depolymerization; P:microtubule severing; P:mitotic chromosome movement towards spindle pole; P:negative regulation of microtubule depolymerization; P:positive regulation of cell death; P:positive regulation of microtubule depolymerization; P:positive regulation of neuron projection development; P:protein targeting;|Q9BVA0 A6NCG6 O60620,Katanin p80 WD40 repeat-containing subunit B1 {ECO:0000255|HAMAP-Rule:MF_03022},p80 katanin {ECO:0000255|HAMAP-Rule:MF_03022};, PF13925;PF00400;, GO:0005813;GO:0005737;GO:0005829;GO:0030426;GO:0008352;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0043025;GO:0005634;GO:0005886;GO:0005819;GO:0000922;GO:0060590;GO:0070840;GO:0008017;GO:0046982;GO:0051301;GO:0007019;GO:0051013;GO:0007079;GO:0007026;GO:0010942;GO:0031117;GO:0010976;GO:0006605;, C:centrosome; C:cytoplasm; C:cytosol; C:growth cone; C:katanin complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:neuronal cell body; C:nucleus; C:plasma membrane; C:spindle; C:spindle pole;, F:ATPase regulator activity; F:dynein complex binding; F:microtubule binding; F:protein heterodimerization activity;, P:cell division; P:microtubule depolymerization; P:microtubule severing; P:mitotic chromosome movement towards spindle pole; P:negative regulation of microtubule depolymerization; P:positive regulation of cell death; P:positive regulation of microtubule depolymerization; P:positive regulation of neuron projection development; P:protein targeting; scaffold16 indexed_genome mRNA 21886908 21892441 . - . ID=transcript_4110;Q9BVG8 A8K6S2 B7Z484 O75299 Q49A29 Q49AQ0 Q59G19 Q8IUT3 Q96HW6,Kinesin-like protein KIFC3,, PF00225;, GO:0005813;GO:0030659;GO:0070062;GO:0005794;GO:0005871;GO:0005874;GO:0005915;GO:0005524;GO:0008569;GO:0042802;GO:0008017;GO:0003777;GO:0090136;GO:0007030;GO:0007018;GO:0007601;GO:0045218;, C:centrosome; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:Golgi apparatus; C:kinesin complex; C:microtubule; C:zonula adherens;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:epithelial cell-cell adhesion; P:Golgi organization; P:microtubule-based movement; P:visual perception; P:zonula adherens maintenance;|Q9BVG8 A8K6S2 B7Z484 O75299 Q49A29 Q49AQ0 Q59G19 Q8IUT3 Q96HW6,Kinesin-like protein KIFC3,, PF00225;, GO:0005813;GO:0030659;GO:0070062;GO:0005794;GO:0005871;GO:0005874;GO:0005915;GO:0005524;GO:0008569;GO:0042802;GO:0008017;GO:0003777;GO:0090136;GO:0007030;GO:0007018;GO:0007601;GO:0045218;, C:centrosome; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:Golgi apparatus; C:kinesin complex; C:microtubule; C:zonula adherens;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:epithelial cell-cell adhesion; P:Golgi organization; P:microtubule-based movement; P:visual perception; P:zonula adherens maintenance; scaffold16 indexed_genome mRNA 21894423 21922546 . - . ID=transcript_4111;Q9BVG8 A8K6S2 B7Z484 O75299 Q49A29 Q49AQ0 Q59G19 Q8IUT3 Q96HW6,Kinesin-like protein KIFC3,, PF00225;, GO:0005813;GO:0030659;GO:0070062;GO:0005794;GO:0005871;GO:0005874;GO:0005915;GO:0005524;GO:0008569;GO:0042802;GO:0008017;GO:0003777;GO:0090136;GO:0007030;GO:0007018;GO:0007601;GO:0045218;, C:centrosome; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:Golgi apparatus; C:kinesin complex; C:microtubule; C:zonula adherens;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:epithelial cell-cell adhesion; P:Golgi organization; P:microtubule-based movement; P:visual perception; P:zonula adherens maintenance;|Q9BVG8 A8K6S2 B7Z484 O75299 Q49A29 Q49AQ0 Q59G19 Q8IUT3 Q96HW6,Kinesin-like protein KIFC3,, PF00225;, GO:0005813;GO:0030659;GO:0070062;GO:0005794;GO:0005871;GO:0005874;GO:0005915;GO:0005524;GO:0008569;GO:0042802;GO:0008017;GO:0003777;GO:0090136;GO:0007030;GO:0007018;GO:0007601;GO:0045218;, C:centrosome; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:Golgi apparatus; C:kinesin complex; C:microtubule; C:zonula adherens;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:epithelial cell-cell adhesion; P:Golgi organization; P:microtubule-based movement; P:visual perception; P:zonula adherens maintenance; scaffold16 indexed_genome mRNA 22068616 22073284 . - . ID=transcript_4112;Q9P2F9 Q52LH8,Zinc finger protein 319,, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 22076832 22090555 . + . ID=transcript_4113;Q9BQ65 B4DWE3 B4DZW5 Q96FZ9 Q9H8X8,U6 snRNA phosphodiesterase {ECO:0000255|HAMAP-Rule:MF_03040},, PF09749;, GO:0045171;GO:0005654;GO:0005634;GO:0000175;GO:1990838;GO:0008380;GO:0034477;, C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends;, P:RNA splicing; P:U6 snRNA 3'-end processing;|Q9BQ65 B4DWE3 B4DZW5 Q96FZ9 Q9H8X8,U6 snRNA phosphodiesterase {ECO:0000255|HAMAP-Rule:MF_03040},, PF09749;, GO:0045171;GO:0005654;GO:0005634;GO:0000175;GO:1990838;GO:0008380;GO:0034477;, C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends;, P:RNA splicing; P:U6 snRNA 3'-end processing; scaffold16 indexed_genome mRNA 22104585 22124427 . + . ID=transcript_4114;P51511 A0A2U6 Q14111,Matrix metalloproteinase-15,Membrane-type matrix metalloproteinase 2;Membrane-type-2 matrix metalloproteinase;SMCP-2;, PF11857;PF00045;PF00413;PF01471;, GO:0031012;GO:0005887;GO:0005886;GO:0008047;GO:0070006;GO:0004222;GO:0008270;GO:0006464;GO:0030574;GO:0035987;GO:0022617;GO:0030198;GO:0006508;GO:0032355;, C:extracellular matrix; C:integral component of plasma membrane; C:plasma membrane;, F:enzyme activator activity; F:metalloaminopeptidase activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:cellular protein modification process; P:collagen catabolic process; P:endodermal cell differentiation; P:extracellular matrix disassembly; P:extracellular matrix organization; P:proteolysis; P:response to estradiol; scaffold16 indexed_genome mRNA 22160153 22162288 . - . ID=transcript_4115;Q9Y6A4,Cilia- and flagella-associated protein 20,Basal body up-regulated protein 22;Transcription factor IIB;, PF05018;, GO:0005814;GO:0036064;GO:0005929;GO:0005737;GO:0070062;GO:0005874;GO:0031514;GO:0005654;GO:0003723;GO:0060271;GO:0007275;GO:2000147;GO:2000253;GO:0018095;GO:0060296;, C:centriole; C:ciliary basal body; C:cilium; C:cytoplasm; C:extracellular exosome; C:microtubule; C:motile cilium; C:nucleoplasm;, F:RNA binding;, P:cilium assembly; P:multicellular organism development; P:positive regulation of cell motility; P:positive regulation of feeding behavior; P:protein polyglutamylation; P:regulation of cilium beat frequency involved in ciliary motility;|Q9Y6A4,Cilia- and flagella-associated protein 20,Basal body up-regulated protein 22;Transcription factor IIB;, PF05018;, GO:0005814;GO:0036064;GO:0005929;GO:0005737;GO:0070062;GO:0005874;GO:0031514;GO:0005654;GO:0003723;GO:0060271;GO:0007275;GO:2000147;GO:2000253;GO:0018095;GO:0060296;, C:centriole; C:ciliary basal body; C:cilium; C:cytoplasm; C:extracellular exosome; C:microtubule; C:motile cilium; C:nucleoplasm;, F:RNA binding;, P:cilium assembly; P:multicellular organism development; P:positive regulation of cell motility; P:positive regulation of feeding behavior; P:protein polyglutamylation; P:regulation of cilium beat frequency involved in ciliary motility; scaffold16 indexed_genome mRNA 22180964 22215694 . - . ID=transcript_4116;P68400 B4DYS6 D3DVV8 P19138 P20426 Q14013 Q5U065,Casein kinase II subunit alpha,, PF00069;, GO:0005829;GO:0005654;GO:0005634;GO:0016581;GO:0005886;GO:0005956;GO:0016580;GO:0005524;GO:0051879;GO:0042802;GO:0016301;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0061077;GO:0016236;GO:0007076;GO:2001234;GO:0043154;GO:2000059;GO:0018105;GO:0018107;GO:0006656;GO:0030307;GO:0008284;GO:0045732;GO:0030177;GO:0006457;GO:0006468;GO:0051726;GO:1905818;GO:1901796;GO:0048511;GO:0007165;GO:0016055;, C:cytosol; C:nucleoplasm; C:nucleus; C:NuRD complex; C:plasma membrane; C:protein kinase CK2 complex; C:Sin3 complex;, F:ATP binding; F:Hsp90 protein binding; F:identical protein binding; F:kinase activity; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:chaperone-mediated protein folding; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of protein catabolic process; P:positive regulation of Wnt signaling pathway; P:protein folding; P:protein phosphorylation; P:regulation of cell cycle; P:regulation of chromosome separation; P:regulation of signal transduction by p53 class mediator; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway;|P19784,Casein kinase II subunit alpha',, PF00069;, GO:0001669;GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005956;GO:0005524;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0021987;GO:0097421;GO:0016236;GO:0007076;GO:2001234;GO:2000059;GO:0018105;GO:0018107;GO:0006656;GO:1903955;GO:0006457;GO:1903146;GO:0051726;GO:1905818;GO:1901796;GO:0007283;GO:0016055;, C:acrosomal vesicle; C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein kinase CK2 complex;, F:ATP binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cerebral cortex development; P:liver regeneration; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of protein targeting to mitochondrion; P:protein folding; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle; P:regulation of chromosome separation; P:regulation of signal transduction by p53 class mediator; P:spermatogenesis; P:Wnt signaling pathway;|P19784,Casein kinase II subunit alpha',, PF00069;, GO:0001669;GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005956;GO:0005524;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0021987;GO:0097421;GO:0016236;GO:0007076;GO:2001234;GO:2000059;GO:0018105;GO:0018107;GO:0006656;GO:1903955;GO:0006457;GO:1903146;GO:0051726;GO:1905818;GO:1901796;GO:0007283;GO:0016055;, C:acrosomal vesicle; C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein kinase CK2 complex;, F:ATP binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cerebral cortex development; P:liver regeneration; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of protein targeting to mitochondrion; P:protein folding; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle; P:regulation of chromosome separation; P:regulation of signal transduction by p53 class mediator; P:spermatogenesis; P:Wnt signaling pathway;|P19784,Casein kinase II subunit alpha',, PF00069;, GO:0001669;GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005956;GO:0005524;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0021987;GO:0097421;GO:0016236;GO:0007076;GO:2001234;GO:2000059;GO:0018105;GO:0018107;GO:0006656;GO:1903955;GO:0006457;GO:1903146;GO:0051726;GO:1905818;GO:1901796;GO:0007283;GO:0016055;, C:acrosomal vesicle; C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein kinase CK2 complex;, F:ATP binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cerebral cortex development; P:liver regeneration; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of protein targeting to mitochondrion; P:protein folding; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle; P:regulation of chromosome separation; P:regulation of signal transduction by p53 class mediator; P:spermatogenesis; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 22251721 22281386 . + . ID=transcript_4117;Q9H0I3 B2RAQ7 B4DR20 Q9NZX2,Coiled-coil domain-containing protein 113,, PF13870;, GO:0005930;GO:0034451;GO:0036064;GO:0032991;GO:0060271;, C:axoneme; C:centriolar satellite; C:ciliary basal body; C:protein-containing complex;, , P:cilium assembly; scaffold16 indexed_genome mRNA 22365748 22367958 . + . ID=transcript_4118;Q9BRX5 B2RDP3 E9PB21 Q9H870,DNA replication complex GINS protein PSF3,GINS complex subunit 3;, PF05916;, GO:0071162;GO:0000811;GO:0005654;GO:0006271;GO:1902975;, C:CMG complex; C:GINS complex; C:nucleoplasm;, , P:DNA strand elongation involved in DNA replication; P:mitotic DNA replication initiation; scaffold16 indexed_genome mRNA 22446531 22458202 . + . ID=transcript_4119;Q9GZN3 Q9GZX0,Protein NDRG4,Brain development-related molecule 1;N-myc downstream-regulated gene 4 protein;Vascular smooth muscle cell-associated protein 8;, PF03096;, GO:0016323;GO:0031253;GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0007420;GO:0060038;GO:0030154;GO:0060973;GO:0035050;GO:0001947;GO:0010642;GO:0014912;GO:0048662;GO:0070374;GO:0010976;GO:2001135;GO:0007165;GO:0048278;GO:0008542;, C:basolateral plasma membrane; C:cell projection membrane; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion;, , P:brain development; P:cardiac muscle cell proliferation; P:cell differentiation; P:cell migration involved in heart development; P:embryonic heart tube development; P:heart looping; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of neuron projection development; P:regulation of endocytic recycling; P:signal transduction; P:vesicle docking; P:visual learning;|Q9GZN3 Q9GZX0,Protein NDRG4,Brain development-related molecule 1;N-myc downstream-regulated gene 4 protein;Vascular smooth muscle cell-associated protein 8;, PF03096;, GO:0016323;GO:0031253;GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0007420;GO:0060038;GO:0030154;GO:0060973;GO:0035050;GO:0001947;GO:0010642;GO:0014912;GO:0048662;GO:0070374;GO:0010976;GO:2001135;GO:0007165;GO:0048278;GO:0008542;, C:basolateral plasma membrane; C:cell projection membrane; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion;, , P:brain development; P:cardiac muscle cell proliferation; P:cell differentiation; P:cell migration involved in heart development; P:embryonic heart tube development; P:heart looping; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of neuron projection development; P:regulation of endocytic recycling; P:signal transduction; P:vesicle docking; P:visual learning;|Q9GZN3 Q9GZX0,Protein NDRG4,Brain development-related molecule 1;N-myc downstream-regulated gene 4 protein;Vascular smooth muscle cell-associated protein 8;, PF03096;, GO:0016323;GO:0031253;GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0007420;GO:0060038;GO:0030154;GO:0060973;GO:0035050;GO:0001947;GO:0010642;GO:0014912;GO:0048662;GO:0070374;GO:0010976;GO:2001135;GO:0007165;GO:0048278;GO:0008542;, C:basolateral plasma membrane; C:cell projection membrane; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion;, , P:brain development; P:cardiac muscle cell proliferation; P:cell differentiation; P:cell migration involved in heart development; P:embryonic heart tube development; P:heart looping; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of neuron projection development; P:regulation of endocytic recycling; P:signal transduction; P:vesicle docking; P:visual learning;|Q9GZN3 Q9GZX0,Protein NDRG4,Brain development-related molecule 1;N-myc downstream-regulated gene 4 protein;Vascular smooth muscle cell-associated protein 8;, PF03096;, GO:0016323;GO:0031253;GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0007420;GO:0060038;GO:0030154;GO:0060973;GO:0035050;GO:0001947;GO:0010642;GO:0014912;GO:0048662;GO:0070374;GO:0010976;GO:2001135;GO:0007165;GO:0048278;GO:0008542;, C:basolateral plasma membrane; C:cell projection membrane; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion;, , P:brain development; P:cardiac muscle cell proliferation; P:cell differentiation; P:cell migration involved in heart development; P:embryonic heart tube development; P:heart looping; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of neuron projection development; P:regulation of endocytic recycling; P:signal transduction; P:vesicle docking; P:visual learning;|Q9GZN3 Q9GZX0,Protein NDRG4,Brain development-related molecule 1;N-myc downstream-regulated gene 4 protein;Vascular smooth muscle cell-associated protein 8;, PF03096;, GO:0016323;GO:0031253;GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0007420;GO:0060038;GO:0030154;GO:0060973;GO:0035050;GO:0001947;GO:0010642;GO:0014912;GO:0048662;GO:0070374;GO:0010976;GO:2001135;GO:0007165;GO:0048278;GO:0008542;, C:basolateral plasma membrane; C:cell projection membrane; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion;, , P:brain development; P:cardiac muscle cell proliferation; P:cell differentiation; P:cell migration involved in heart development; P:embryonic heart tube development; P:heart looping; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of neuron projection development; P:regulation of endocytic recycling; P:signal transduction; P:vesicle docking; P:visual learning; scaffold16 indexed_genome mRNA 22459515 22461455 . + . ID=transcript_4120;Q8TBK2 A8K380 B5ME38 Q9H787,N-lysine methyltransferase SETD6,SET domain-containing protein 6;, PF09273;PF00856;, GO:0005829;GO:0005654;GO:0005634;GO:0051059;GO:0016279;GO:0034968;GO:0032088;GO:0018026;GO:0050727;GO:0048863;GO:0019827;, C:cytosol; C:nucleoplasm; C:nucleus;, F:NF-kappaB binding; F:protein-lysine N-methyltransferase activity;, P:histone lysine methylation; P:negative regulation of NF-kappaB transcription factor activity; P:peptidyl-lysine monomethylation; P:regulation of inflammatory response; P:stem cell differentiation; P:stem cell population maintenance;|Q8TBK2 A8K380 B5ME38 Q9H787,N-lysine methyltransferase SETD6,SET domain-containing protein 6;, PF09273;PF00856;, GO:0005829;GO:0005654;GO:0005634;GO:0051059;GO:0016279;GO:0034968;GO:0032088;GO:0018026;GO:0050727;GO:0048863;GO:0019827;, C:cytosol; C:nucleoplasm; C:nucleus;, F:NF-kappaB binding; F:protein-lysine N-methyltransferase activity;, P:histone lysine methylation; P:negative regulation of NF-kappaB transcription factor activity; P:peptidyl-lysine monomethylation; P:regulation of inflammatory response; P:stem cell differentiation; P:stem cell population maintenance; scaffold16 indexed_genome mRNA 22461462 22549020 . + . ID=transcript_4121;Q8TBK2 A8K380 B5ME38 Q9H787,N-lysine methyltransferase SETD6,SET domain-containing protein 6;, PF09273;PF00856;, GO:0005829;GO:0005654;GO:0005634;GO:0051059;GO:0016279;GO:0034968;GO:0032088;GO:0018026;GO:0050727;GO:0048863;GO:0019827;, C:cytosol; C:nucleoplasm; C:nucleus;, F:NF-kappaB binding; F:protein-lysine N-methyltransferase activity;, P:histone lysine methylation; P:negative regulation of NF-kappaB transcription factor activity; P:peptidyl-lysine monomethylation; P:regulation of inflammatory response; P:stem cell differentiation; P:stem cell population maintenance;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|A5YKK6 Q68DX7 Q7Z3K2 Q8IWB8 Q8TB53 Q9BVZ6 Q9UFR8 Q9UI27 Q9Y2L0,CCR4-NOT transcription complex subunit 1,CCR4-associated factor 1;Negative regulator of transcription subunit 1 homolog;, PF16415;PF16418;PF16417;PF12842;PF04054;, GO:0030014;GO:0030015;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0000932;GO:0005778;GO:0070016;GO:0030331;GO:0060090;GO:0019904;GO:0042974;GO:0003723;GO:0006977;GO:0035195;GO:0033147;GO:0048387;GO:0000122;GO:0017148;GO:0000288;GO:0000289;GO:0010606;GO:0061014;GO:1900153;GO:0060213;GO:2000036;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:extracellular space; C:membrane; C:nucleus; C:P-body; C:peroxisomal membrane;, F:armadillo repeat domain binding; F:estrogen receptor binding; F:molecular adaptor activity; F:protein domain specific binding; F:retinoic acid receptor binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by miRNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of stem cell population maintenance; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation; scaffold16 indexed_genome mRNA 22585287 22597696 . - . ID=transcript_4122;Q9NVC3 Q53GJ9 Q9H9I5,Putative sodium-coupled neutral amino acid transporter 7,Solute carrier family 38 member 7;, PF01490;, GO:0030424;GO:0016021;GO:0043025;GO:0015171;GO:0015180;GO:0015179;GO:0015182;GO:0015183;GO:0005313;GO:0015186;GO:0005290;GO:0015190;GO:0015191;GO:0015194;GO:0003333;GO:0006814;, C:axon; C:integral component of membrane; C:neuronal cell body;, F:amino acid transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-asparagine transmembrane transporter activity; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:L-methionine transmembrane transporter activity; F:L-serine transmembrane transporter activity;, P:amino acid transmembrane transport; P:sodium ion transport;|Q9NVC3 Q53GJ9 Q9H9I5,Putative sodium-coupled neutral amino acid transporter 7,Solute carrier family 38 member 7;, PF01490;, GO:0030424;GO:0016021;GO:0043025;GO:0015171;GO:0015180;GO:0015179;GO:0015182;GO:0015183;GO:0005313;GO:0015186;GO:0005290;GO:0015190;GO:0015191;GO:0015194;GO:0003333;GO:0006814;, C:axon; C:integral component of membrane; C:neuronal cell body;, F:amino acid transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-asparagine transmembrane transporter activity; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:L-methionine transmembrane transporter activity; F:L-serine transmembrane transporter activity;, P:amino acid transmembrane transport; P:sodium ion transport;|Q9NVC3 Q53GJ9 Q9H9I5,Putative sodium-coupled neutral amino acid transporter 7,Solute carrier family 38 member 7;, PF01490;, GO:0030424;GO:0016021;GO:0043025;GO:0015171;GO:0015180;GO:0015179;GO:0015182;GO:0015183;GO:0005313;GO:0015186;GO:0005290;GO:0015190;GO:0015191;GO:0015194;GO:0003333;GO:0006814;, C:axon; C:integral component of membrane; C:neuronal cell body;, F:amino acid transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-asparagine transmembrane transporter activity; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:L-methionine transmembrane transporter activity; F:L-serine transmembrane transporter activity;, P:amino acid transmembrane transport; P:sodium ion transport; scaffold16 indexed_genome mRNA 22603898 22635079 . - . ID=transcript_4123;P00505 B4DJA6 E7ERW2 Q53FL3 Q9BWA3,Aspartate aminotransferase, mitochondrial,Fatty acid-binding protein;Glutamate oxaloacetate transaminase 2;Kynurenine aminotransferase 4;Kynurenine aminotransferase IV;Kynurenine--oxoglutarate transaminase 4;Kynurenine--oxoglutarate transaminase IV;Plasma membrane-associated fatty acid-binding protein;Transaminase A;, PF00155;, GO:0009986;GO:0070062;GO:0005743;GO:0005759;GO:0005739;GO:0043204;GO:0005886;GO:0032991;GO:0030315;GO:0016597;GO:0019899;GO:0042802;GO:0016212;GO:0004069;GO:0005543;GO:0030170;GO:0003723;GO:0006103;GO:0019470;GO:0006532;GO:0006533;GO:0009066;GO:0006531;GO:0015908;GO:0007565;GO:0006094;GO:0019551;GO:0019550;GO:0006536;GO:0009064;GO:0046487;GO:0007595;GO:0006107;GO:0045471;GO:0032868;GO:0043278;GO:0014850;, C:cell surface; C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:T-tubule;, F:amino acid binding; F:enzyme binding; F:identical protein binding; F:kynurenine-oxoglutarate transaminase activity; F:L-aspartate:2-oxoglutarate aminotransferase activity; F:phospholipid binding; F:pyridoxal phosphate binding; F:RNA binding;, P:2-oxoglutarate metabolic process; P:4-hydroxyproline catabolic process; P:aspartate biosynthetic process; P:aspartate catabolic process; P:aspartate family amino acid metabolic process; P:aspartate metabolic process; P:fatty acid transport; P:female pregnancy; P:gluconeogenesis; P:glutamate catabolic process to 2-oxoglutarate; P:glutamate catabolic process to aspartate; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:glyoxylate metabolic process; P:lactation; P:oxaloacetate metabolic process; P:response to ethanol; P:response to insulin; P:response to morphine; P:response to muscle activity;|P00505 B4DJA6 E7ERW2 Q53FL3 Q9BWA3,Aspartate aminotransferase, mitochondrial,Fatty acid-binding protein;Glutamate oxaloacetate transaminase 2;Kynurenine aminotransferase 4;Kynurenine aminotransferase IV;Kynurenine--oxoglutarate transaminase 4;Kynurenine--oxoglutarate transaminase IV;Plasma membrane-associated fatty acid-binding protein;Transaminase A;, PF00155;, GO:0009986;GO:0070062;GO:0005743;GO:0005759;GO:0005739;GO:0043204;GO:0005886;GO:0032991;GO:0030315;GO:0016597;GO:0019899;GO:0042802;GO:0016212;GO:0004069;GO:0005543;GO:0030170;GO:0003723;GO:0006103;GO:0019470;GO:0006532;GO:0006533;GO:0009066;GO:0006531;GO:0015908;GO:0007565;GO:0006094;GO:0019551;GO:0019550;GO:0006536;GO:0009064;GO:0046487;GO:0007595;GO:0006107;GO:0045471;GO:0032868;GO:0043278;GO:0014850;, C:cell surface; C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:T-tubule;, F:amino acid binding; F:enzyme binding; F:identical protein binding; F:kynurenine-oxoglutarate transaminase activity; F:L-aspartate:2-oxoglutarate aminotransferase activity; F:phospholipid binding; F:pyridoxal phosphate binding; F:RNA binding;, P:2-oxoglutarate metabolic process; P:4-hydroxyproline catabolic process; P:aspartate biosynthetic process; P:aspartate catabolic process; P:aspartate family amino acid metabolic process; P:aspartate metabolic process; P:fatty acid transport; P:female pregnancy; P:gluconeogenesis; P:glutamate catabolic process to 2-oxoglutarate; P:glutamate catabolic process to aspartate; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:glyoxylate metabolic process; P:lactation; P:oxaloacetate metabolic process; P:response to ethanol; P:response to insulin; P:response to morphine; P:response to muscle activity;|P00505 B4DJA6 E7ERW2 Q53FL3 Q9BWA3,Aspartate aminotransferase, mitochondrial,Fatty acid-binding protein;Glutamate oxaloacetate transaminase 2;Kynurenine aminotransferase 4;Kynurenine aminotransferase IV;Kynurenine--oxoglutarate transaminase 4;Kynurenine--oxoglutarate transaminase IV;Plasma membrane-associated fatty acid-binding protein;Transaminase A;, PF00155;, GO:0009986;GO:0070062;GO:0005743;GO:0005759;GO:0005739;GO:0043204;GO:0005886;GO:0032991;GO:0030315;GO:0016597;GO:0019899;GO:0042802;GO:0016212;GO:0004069;GO:0005543;GO:0030170;GO:0003723;GO:0006103;GO:0019470;GO:0006532;GO:0006533;GO:0009066;GO:0006531;GO:0015908;GO:0007565;GO:0006094;GO:0019551;GO:0019550;GO:0006536;GO:0009064;GO:0046487;GO:0007595;GO:0006107;GO:0045471;GO:0032868;GO:0043278;GO:0014850;, C:cell surface; C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:T-tubule;, F:amino acid binding; F:enzyme binding; F:identical protein binding; F:kynurenine-oxoglutarate transaminase activity; F:L-aspartate:2-oxoglutarate aminotransferase activity; F:phospholipid binding; F:pyridoxal phosphate binding; F:RNA binding;, P:2-oxoglutarate metabolic process; P:4-hydroxyproline catabolic process; P:aspartate biosynthetic process; P:aspartate catabolic process; P:aspartate family amino acid metabolic process; P:aspartate metabolic process; P:fatty acid transport; P:female pregnancy; P:gluconeogenesis; P:glutamate catabolic process to 2-oxoglutarate; P:glutamate catabolic process to aspartate; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:glyoxylate metabolic process; P:lactation; P:oxaloacetate metabolic process; P:response to ethanol; P:response to insulin; P:response to morphine; P:response to muscle activity;|P00505 B4DJA6 E7ERW2 Q53FL3 Q9BWA3,Aspartate aminotransferase, mitochondrial,Fatty acid-binding protein;Glutamate oxaloacetate transaminase 2;Kynurenine aminotransferase 4;Kynurenine aminotransferase IV;Kynurenine--oxoglutarate transaminase 4;Kynurenine--oxoglutarate transaminase IV;Plasma membrane-associated fatty acid-binding protein;Transaminase A;, PF00155;, GO:0009986;GO:0070062;GO:0005743;GO:0005759;GO:0005739;GO:0043204;GO:0005886;GO:0032991;GO:0030315;GO:0016597;GO:0019899;GO:0042802;GO:0016212;GO:0004069;GO:0005543;GO:0030170;GO:0003723;GO:0006103;GO:0019470;GO:0006532;GO:0006533;GO:0009066;GO:0006531;GO:0015908;GO:0007565;GO:0006094;GO:0019551;GO:0019550;GO:0006536;GO:0009064;GO:0046487;GO:0007595;GO:0006107;GO:0045471;GO:0032868;GO:0043278;GO:0014850;, C:cell surface; C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:T-tubule;, F:amino acid binding; F:enzyme binding; F:identical protein binding; F:kynurenine-oxoglutarate transaminase activity; F:L-aspartate:2-oxoglutarate aminotransferase activity; F:phospholipid binding; F:pyridoxal phosphate binding; F:RNA binding;, P:2-oxoglutarate metabolic process; P:4-hydroxyproline catabolic process; P:aspartate biosynthetic process; P:aspartate catabolic process; P:aspartate family amino acid metabolic process; P:aspartate metabolic process; P:fatty acid transport; P:female pregnancy; P:gluconeogenesis; P:glutamate catabolic process to 2-oxoglutarate; P:glutamate catabolic process to aspartate; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:glyoxylate metabolic process; P:lactation; P:oxaloacetate metabolic process; P:response to ethanol; P:response to insulin; P:response to morphine; P:response to muscle activity;|P00505 B4DJA6 E7ERW2 Q53FL3 Q9BWA3,Aspartate aminotransferase, mitochondrial,Fatty acid-binding protein;Glutamate oxaloacetate transaminase 2;Kynurenine aminotransferase 4;Kynurenine aminotransferase IV;Kynurenine--oxoglutarate transaminase 4;Kynurenine--oxoglutarate transaminase IV;Plasma membrane-associated fatty acid-binding protein;Transaminase A;, PF00155;, GO:0009986;GO:0070062;GO:0005743;GO:0005759;GO:0005739;GO:0043204;GO:0005886;GO:0032991;GO:0030315;GO:0016597;GO:0019899;GO:0042802;GO:0016212;GO:0004069;GO:0005543;GO:0030170;GO:0003723;GO:0006103;GO:0019470;GO:0006532;GO:0006533;GO:0009066;GO:0006531;GO:0015908;GO:0007565;GO:0006094;GO:0019551;GO:0019550;GO:0006536;GO:0009064;GO:0046487;GO:0007595;GO:0006107;GO:0045471;GO:0032868;GO:0043278;GO:0014850;, C:cell surface; C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:T-tubule;, F:amino acid binding; F:enzyme binding; F:identical protein binding; F:kynurenine-oxoglutarate transaminase activity; F:L-aspartate:2-oxoglutarate aminotransferase activity; F:phospholipid binding; F:pyridoxal phosphate binding; F:RNA binding;, P:2-oxoglutarate metabolic process; P:4-hydroxyproline catabolic process; P:aspartate biosynthetic process; P:aspartate catabolic process; P:aspartate family amino acid metabolic process; P:aspartate metabolic process; P:fatty acid transport; P:female pregnancy; P:gluconeogenesis; P:glutamate catabolic process to 2-oxoglutarate; P:glutamate catabolic process to aspartate; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:glyoxylate metabolic process; P:lactation; P:oxaloacetate metabolic process; P:response to ethanol; P:response to insulin; P:response to morphine; P:response to muscle activity;|P00505 B4DJA6 E7ERW2 Q53FL3 Q9BWA3,Aspartate aminotransferase, mitochondrial,Fatty acid-binding protein;Glutamate oxaloacetate transaminase 2;Kynurenine aminotransferase 4;Kynurenine aminotransferase IV;Kynurenine--oxoglutarate transaminase 4;Kynurenine--oxoglutarate transaminase IV;Plasma membrane-associated fatty acid-binding protein;Transaminase A;, PF00155;, GO:0009986;GO:0070062;GO:0005743;GO:0005759;GO:0005739;GO:0043204;GO:0005886;GO:0032991;GO:0030315;GO:0016597;GO:0019899;GO:0042802;GO:0016212;GO:0004069;GO:0005543;GO:0030170;GO:0003723;GO:0006103;GO:0019470;GO:0006532;GO:0006533;GO:0009066;GO:0006531;GO:0015908;GO:0007565;GO:0006094;GO:0019551;GO:0019550;GO:0006536;GO:0009064;GO:0046487;GO:0007595;GO:0006107;GO:0045471;GO:0032868;GO:0043278;GO:0014850;, C:cell surface; C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:T-tubule;, F:amino acid binding; F:enzyme binding; F:identical protein binding; F:kynurenine-oxoglutarate transaminase activity; F:L-aspartate:2-oxoglutarate aminotransferase activity; F:phospholipid binding; F:pyridoxal phosphate binding; F:RNA binding;, P:2-oxoglutarate metabolic process; P:4-hydroxyproline catabolic process; P:aspartate biosynthetic process; P:aspartate catabolic process; P:aspartate family amino acid metabolic process; P:aspartate metabolic process; P:fatty acid transport; P:female pregnancy; P:gluconeogenesis; P:glutamate catabolic process to 2-oxoglutarate; P:glutamate catabolic process to aspartate; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:glyoxylate metabolic process; P:lactation; P:oxaloacetate metabolic process; P:response to ethanol; P:response to insulin; P:response to morphine; P:response to muscle activity; scaffold16 indexed_genome mRNA 25301161 25304623 . - . ID=transcript_4124;P55286 B3KWC1 Q14DC6 Q9ULB2,Cadherin-8,, PF00028;PF01049;, GO:0005912;GO:0043679;GO:0016342;GO:0098978;GO:0016021;GO:0005886;GO:0043083;GO:0097060;GO:0045296;GO:0005509;GO:0042802;GO:0034332;GO:0016339;GO:0007155;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;GO:0050807;GO:0009409;GO:0035249;, C:adherens junction; C:axon terminus; C:catenin complex; C:glutamatergic synapse; C:integral component of membrane; C:plasma membrane; C:synaptic cleft; C:synaptic membrane;, F:cadherin binding; F:calcium ion binding; F:identical protein binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; P:regulation of synapse organization; P:response to cold; P:synaptic transmission, glutamatergic; scaffold16 indexed_genome mRNA 25374123 25454115 . - . ID=transcript_4125;P55286 B3KWC1 Q14DC6 Q9ULB2,Cadherin-8,, PF00028;PF01049;, GO:0005912;GO:0043679;GO:0016342;GO:0098978;GO:0016021;GO:0005886;GO:0043083;GO:0097060;GO:0045296;GO:0005509;GO:0042802;GO:0034332;GO:0016339;GO:0007155;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;GO:0050807;GO:0009409;GO:0035249;, C:adherens junction; C:axon terminus; C:catenin complex; C:glutamatergic synapse; C:integral component of membrane; C:plasma membrane; C:synaptic cleft; C:synaptic membrane;, F:cadherin binding; F:calcium ion binding; F:identical protein binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; P:regulation of synapse organization; P:response to cold; P:synaptic transmission, glutamatergic; scaffold16 indexed_genome mRNA 25457624 25674755 . - . ID=transcript_4126;P55286 B3KWC1 Q14DC6 Q9ULB2,Cadherin-8,, PF00028;PF01049;, GO:0005912;GO:0043679;GO:0016342;GO:0098978;GO:0016021;GO:0005886;GO:0043083;GO:0097060;GO:0045296;GO:0005509;GO:0042802;GO:0034332;GO:0016339;GO:0007155;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;GO:0050807;GO:0009409;GO:0035249;, C:adherens junction; C:axon terminus; C:catenin complex; C:glutamatergic synapse; C:integral component of membrane; C:plasma membrane; C:synaptic cleft; C:synaptic membrane;, F:cadherin binding; F:calcium ion binding; F:identical protein binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; P:regulation of synapse organization; P:response to cold; P:synaptic transmission, glutamatergic; scaffold16 indexed_genome mRNA 28373000 28522735 . - . ID=transcript_4127;P55287 A8K5D6 A8MZC8 B7WP28 Q15065 Q15066 Q9UQ93 Q9UQ94,Cadherin-11,OSF-4;Osteoblast cadherin;, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0005737;GO:0070062;GO:0098978;GO:0016021;GO:0005886;GO:0098685;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0007155;GO:0000902;GO:0098742;GO:0007043;GO:0021957;GO:0007156;GO:0050804;GO:0007275;GO:0001503;GO:0001501;, C:adherens junction; C:catenin complex; C:cytoplasm; C:extracellular exosome; C:glutamatergic synapse; C:integral component of membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:corticospinal tract morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:modulation of chemical synaptic transmission; P:multicellular organism development; P:ossification; P:skeletal system development;|P55287 A8K5D6 A8MZC8 B7WP28 Q15065 Q15066 Q9UQ93 Q9UQ94,Cadherin-11,OSF-4;Osteoblast cadherin;, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0005737;GO:0070062;GO:0098978;GO:0016021;GO:0005886;GO:0098685;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0007155;GO:0000902;GO:0098742;GO:0007043;GO:0021957;GO:0007156;GO:0050804;GO:0007275;GO:0001503;GO:0001501;, C:adherens junction; C:catenin complex; C:cytoplasm; C:extracellular exosome; C:glutamatergic synapse; C:integral component of membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:corticospinal tract morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:modulation of chemical synaptic transmission; P:multicellular organism development; P:ossification; P:skeletal system development; scaffold16 indexed_genome mRNA 29791410 31274343 . + . ID=transcript_4128;P33151 Q4VAI5 Q4VAI6,Cadherin-5,7B4 antigen;Vascular endothelial cadherin;, PF00028;PF01049;, GO:0005912;GO:0005923;GO:0016342;GO:0030054;GO:0009986;GO:0005911;GO:0009897;GO:0016021;GO:0016020;GO:0031965;GO:0005654;GO:0005886;GO:0008013;GO:0070700;GO:0045296;GO:0005509;GO:0070051;GO:0044325;GO:0019903;GO:1990782;GO:0005102;GO:0043184;GO:0034332;GO:0070830;GO:0043534;GO:0001955;GO:0016339;GO:0000902;GO:0098609;GO:0044331;GO:0098742;GO:0007043;GO:0006874;GO:0007156;GO:0035633;GO:0007275;GO:0008285;GO:2000352;GO:0050728;GO:0031115;GO:0045766;GO:0030513;GO:0030335;GO:1903142;GO:0010628;GO:0035307;GO:0031334;GO:1902396;GO:2000114;GO:0001932;GO:0043114;GO:0007179;GO:0001944;, C:adherens junction; C:bicellular tight junction; C:catenin complex; C:cell junction; C:cell surface; C:cell-cell junction; C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:beta-catenin binding; F:BMP receptor binding; F:cadherin binding; F:calcium ion binding; F:fibrinogen binding; F:ion channel binding; F:protein phosphatase binding; F:protein tyrosine kinase binding; F:signaling receptor binding; F:vascular endothelial growth factor receptor 2 binding;, P:adherens junction organization; P:bicellular tight junction assembly; P:blood vessel endothelial cell migration; P:blood vessel maturation; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:cellular calcium ion homeostasis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:maintenance of blood-brain barrier; P:multicellular organism development; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of microtubule polymerization; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cell migration; P:positive regulation of establishment of endothelial barrier; P:positive regulation of gene expression; P:positive regulation of protein dephosphorylation; P:positive regulation of protein-containing complex assembly; P:protein localization to bicellular tight junction; P:regulation of establishment of cell polarity; P:regulation of protein phosphorylation; P:regulation of vascular permeability; P:transforming growth factor beta receptor signaling pathway; P:vasculature development;|P33151 Q4VAI5 Q4VAI6,Cadherin-5,7B4 antigen;Vascular endothelial cadherin;, PF00028;PF01049;, GO:0005912;GO:0005923;GO:0016342;GO:0030054;GO:0009986;GO:0005911;GO:0009897;GO:0016021;GO:0016020;GO:0031965;GO:0005654;GO:0005886;GO:0008013;GO:0070700;GO:0045296;GO:0005509;GO:0070051;GO:0044325;GO:0019903;GO:1990782;GO:0005102;GO:0043184;GO:0034332;GO:0070830;GO:0043534;GO:0001955;GO:0016339;GO:0000902;GO:0098609;GO:0044331;GO:0098742;GO:0007043;GO:0006874;GO:0007156;GO:0035633;GO:0007275;GO:0008285;GO:2000352;GO:0050728;GO:0031115;GO:0045766;GO:0030513;GO:0030335;GO:1903142;GO:0010628;GO:0035307;GO:0031334;GO:1902396;GO:2000114;GO:0001932;GO:0043114;GO:0007179;GO:0001944;, C:adherens junction; C:bicellular tight junction; C:catenin complex; C:cell junction; C:cell surface; C:cell-cell junction; C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:beta-catenin binding; F:BMP receptor binding; F:cadherin binding; F:calcium ion binding; F:fibrinogen binding; F:ion channel binding; F:protein phosphatase binding; F:protein tyrosine kinase binding; F:signaling receptor binding; F:vascular endothelial growth factor receptor 2 binding;, P:adherens junction organization; P:bicellular tight junction assembly; P:blood vessel endothelial cell migration; P:blood vessel maturation; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:cellular calcium ion homeostasis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:maintenance of blood-brain barrier; P:multicellular organism development; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of microtubule polymerization; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cell migration; P:positive regulation of establishment of endothelial barrier; P:positive regulation of gene expression; P:positive regulation of protein dephosphorylation; P:positive regulation of protein-containing complex assembly; P:protein localization to bicellular tight junction; P:regulation of establishment of cell polarity; P:regulation of protein phosphorylation; P:regulation of vascular permeability; P:transforming growth factor beta receptor signaling pathway; P:vasculature development;|P33151 Q4VAI5 Q4VAI6,Cadherin-5,7B4 antigen;Vascular endothelial cadherin;, PF00028;PF01049;, GO:0005912;GO:0005923;GO:0016342;GO:0030054;GO:0009986;GO:0005911;GO:0009897;GO:0016021;GO:0016020;GO:0031965;GO:0005654;GO:0005886;GO:0008013;GO:0070700;GO:0045296;GO:0005509;GO:0070051;GO:0044325;GO:0019903;GO:1990782;GO:0005102;GO:0043184;GO:0034332;GO:0070830;GO:0043534;GO:0001955;GO:0016339;GO:0000902;GO:0098609;GO:0044331;GO:0098742;GO:0007043;GO:0006874;GO:0007156;GO:0035633;GO:0007275;GO:0008285;GO:2000352;GO:0050728;GO:0031115;GO:0045766;GO:0030513;GO:0030335;GO:1903142;GO:0010628;GO:0035307;GO:0031334;GO:1902396;GO:2000114;GO:0001932;GO:0043114;GO:0007179;GO:0001944;, C:adherens junction; C:bicellular tight junction; C:catenin complex; C:cell junction; C:cell surface; C:cell-cell junction; C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:beta-catenin binding; F:BMP receptor binding; F:cadherin binding; F:calcium ion binding; F:fibrinogen binding; F:ion channel binding; F:protein phosphatase binding; F:protein tyrosine kinase binding; F:signaling receptor binding; F:vascular endothelial growth factor receptor 2 binding;, P:adherens junction organization; P:bicellular tight junction assembly; P:blood vessel endothelial cell migration; P:blood vessel maturation; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:cellular calcium ion homeostasis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:maintenance of blood-brain barrier; P:multicellular organism development; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of microtubule polymerization; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cell migration; P:positive regulation of establishment of endothelial barrier; P:positive regulation of gene expression; P:positive regulation of protein dephosphorylation; P:positive regulation of protein-containing complex assembly; P:protein localization to bicellular tight junction; P:regulation of establishment of cell polarity; P:regulation of protein phosphorylation; P:regulation of vascular permeability; P:transforming growth factor beta receptor signaling pathway; P:vasculature development;|P33151 Q4VAI5 Q4VAI6,Cadherin-5,7B4 antigen;Vascular endothelial cadherin;, PF00028;PF01049;, GO:0005912;GO:0005923;GO:0016342;GO:0030054;GO:0009986;GO:0005911;GO:0009897;GO:0016021;GO:0016020;GO:0031965;GO:0005654;GO:0005886;GO:0008013;GO:0070700;GO:0045296;GO:0005509;GO:0070051;GO:0044325;GO:0019903;GO:1990782;GO:0005102;GO:0043184;GO:0034332;GO:0070830;GO:0043534;GO:0001955;GO:0016339;GO:0000902;GO:0098609;GO:0044331;GO:0098742;GO:0007043;GO:0006874;GO:0007156;GO:0035633;GO:0007275;GO:0008285;GO:2000352;GO:0050728;GO:0031115;GO:0045766;GO:0030513;GO:0030335;GO:1903142;GO:0010628;GO:0035307;GO:0031334;GO:1902396;GO:2000114;GO:0001932;GO:0043114;GO:0007179;GO:0001944;, C:adherens junction; C:bicellular tight junction; C:catenin complex; C:cell junction; C:cell surface; C:cell-cell junction; C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:beta-catenin binding; F:BMP receptor binding; F:cadherin binding; F:calcium ion binding; F:fibrinogen binding; F:ion channel binding; F:protein phosphatase binding; F:protein tyrosine kinase binding; F:signaling receptor binding; F:vascular endothelial growth factor receptor 2 binding;, P:adherens junction organization; P:bicellular tight junction assembly; P:blood vessel endothelial cell migration; P:blood vessel maturation; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:cellular calcium ion homeostasis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:maintenance of blood-brain barrier; P:multicellular organism development; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of microtubule polymerization; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cell migration; P:positive regulation of establishment of endothelial barrier; P:positive regulation of gene expression; P:positive regulation of protein dephosphorylation; P:positive regulation of protein-containing complex assembly; P:protein localization to bicellular tight junction; P:regulation of establishment of cell polarity; P:regulation of protein phosphorylation; P:regulation of vascular permeability; P:transforming growth factor beta receptor signaling pathway; P:vasculature development;|P33151 Q4VAI5 Q4VAI6,Cadherin-5,7B4 antigen;Vascular endothelial cadherin;, PF00028;PF01049;, GO:0005912;GO:0005923;GO:0016342;GO:0030054;GO:0009986;GO:0005911;GO:0009897;GO:0016021;GO:0016020;GO:0031965;GO:0005654;GO:0005886;GO:0008013;GO:0070700;GO:0045296;GO:0005509;GO:0070051;GO:0044325;GO:0019903;GO:1990782;GO:0005102;GO:0043184;GO:0034332;GO:0070830;GO:0043534;GO:0001955;GO:0016339;GO:0000902;GO:0098609;GO:0044331;GO:0098742;GO:0007043;GO:0006874;GO:0007156;GO:0035633;GO:0007275;GO:0008285;GO:2000352;GO:0050728;GO:0031115;GO:0045766;GO:0030513;GO:0030335;GO:1903142;GO:0010628;GO:0035307;GO:0031334;GO:1902396;GO:2000114;GO:0001932;GO:0043114;GO:0007179;GO:0001944;, C:adherens junction; C:bicellular tight junction; C:catenin complex; C:cell junction; C:cell surface; C:cell-cell junction; C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:beta-catenin binding; F:BMP receptor binding; F:cadherin binding; F:calcium ion binding; F:fibrinogen binding; F:ion channel binding; F:protein phosphatase binding; F:protein tyrosine kinase binding; F:signaling receptor binding; F:vascular endothelial growth factor receptor 2 binding;, P:adherens junction organization; P:bicellular tight junction assembly; P:blood vessel endothelial cell migration; P:blood vessel maturation; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:cellular calcium ion homeostasis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:maintenance of blood-brain barrier; P:multicellular organism development; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of microtubule polymerization; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cell migration; P:positive regulation of establishment of endothelial barrier; P:positive regulation of gene expression; P:positive regulation of protein dephosphorylation; P:positive regulation of protein-containing complex assembly; P:protein localization to bicellular tight junction; P:regulation of establishment of cell polarity; P:regulation of protein phosphorylation; P:regulation of vascular permeability; P:transforming growth factor beta receptor signaling pathway; P:vasculature development;|Q8N9A8 Q4G1A9 Q5H9V0 Q8NE06,Nuclear envelope phosphatase-regulatory subunit 1,Transmembrane protein 188;, PF09771;, GO:0005737;GO:0005829;GO:0016021;GO:0071595;GO:0005635;GO:0031965;GO:0006629;GO:0007077;GO:0035307;GO:0010867;GO:0034504;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:Nem1-Spo7 phosphatase complex; C:nuclear envelope; C:nuclear membrane;, , P:lipid metabolic process; P:mitotic nuclear envelope disassembly; P:positive regulation of protein dephosphorylation; P:positive regulation of triglyceride biosynthetic process; P:protein localization to nucleus;|O00142 B4DGJ7 B4DZK7 B7ZAB1 E5KNQ5 E9PH08 O15238,Thymidine kinase 2, mitochondrial,Mt-TK;, PF01712;, GO:0005737;GO:0005759;GO:0005524;GO:0019136;GO:0004797;GO:0071897;GO:0006139;GO:0043097;, C:cytoplasm; C:mitochondrial matrix;, F:ATP binding; F:deoxynucleoside kinase activity; F:thymidine kinase activity;, P:DNA biosynthetic process; P:nucleobase-containing compound metabolic process; P:pyrimidine nucleoside salvage;|O00142 B4DGJ7 B4DZK7 B7ZAB1 E5KNQ5 E9PH08 O15238,Thymidine kinase 2, mitochondrial,Mt-TK;, PF01712;, GO:0005737;GO:0005759;GO:0005524;GO:0019136;GO:0004797;GO:0071897;GO:0006139;GO:0043097;, C:cytoplasm; C:mitochondrial matrix;, F:ATP binding; F:deoxynucleoside kinase activity; F:thymidine kinase activity;, P:DNA biosynthetic process; P:nucleobase-containing compound metabolic process; P:pyrimidine nucleoside salvage;|O00142 B4DGJ7 B4DZK7 B7ZAB1 E5KNQ5 E9PH08 O15238,Thymidine kinase 2, mitochondrial,Mt-TK;, PF01712;, GO:0005737;GO:0005759;GO:0005524;GO:0019136;GO:0004797;GO:0071897;GO:0006139;GO:0043097;, C:cytoplasm; C:mitochondrial matrix;, F:ATP binding; F:deoxynucleoside kinase activity; F:thymidine kinase activity;, P:DNA biosynthetic process; P:nucleobase-containing compound metabolic process; P:pyrimidine nucleoside salvage;|O00142 B4DGJ7 B4DZK7 B7ZAB1 E5KNQ5 E9PH08 O15238,Thymidine kinase 2, mitochondrial,Mt-TK;, PF01712;, GO:0005737;GO:0005759;GO:0005524;GO:0019136;GO:0004797;GO:0071897;GO:0006139;GO:0043097;, C:cytoplasm; C:mitochondrial matrix;, F:ATP binding; F:deoxynucleoside kinase activity; F:thymidine kinase activity;, P:DNA biosynthetic process; P:nucleobase-containing compound metabolic process; P:pyrimidine nucleoside salvage;|Q96MX0 A6NCL9 Q8IUU8 Q8IWQ6 Q8IYE2 Q8IZ39 Q8IZ59,CKLF-like MARVEL transmembrane domain-containing protein 3,Chemokine-like factor superfamily member 3;, PF01284;, GO:0031410;GO:0005829;GO:0005615;GO:0016021;GO:0005125;GO:0006935;, C:cytoplasmic vesicle; C:cytosol; C:extracellular space; C:integral component of membrane;, F:cytokine activity;, P:chemotaxis;|Q8IZR5 Q52M40 Q8IZR4 Q8IZV1,CKLF-like MARVEL transmembrane domain-containing protein 4,Chemokine-like factor superfamily member 4;, PF01284;, GO:0016021;, C:integral component of membrane;|O43237 A8K6V1 B4DZP4 Q8TAT3,Cytoplasmic dynein 1 light intermediate chain 2,Dynein light intermediate chain 2, cytosolic;LIC53/55;, PF05783;, GO:0005813;GO:0005868;GO:0005829;GO:0000776;GO:0005770;GO:0005764;GO:0016020;GO:0005874;GO:0005524;GO:0045504;GO:0042802;GO:0035973;GO:0019886;GO:1990090;GO:0051642;GO:0006888;GO:0000226;GO:0007018;GO:0007052;GO:0019058;, C:centrosome; C:cytoplasmic dynein complex; C:cytosol; C:kinetochore; C:late endosome; C:lysosome; C:membrane; C:microtubule;, F:ATP binding; F:dynein heavy chain binding; F:identical protein binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular response to nerve growth factor stimulus; P:centrosome localization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule cytoskeleton organization; P:microtubule-based movement; P:mitotic spindle organization; P:viral life cycle;|O43237 A8K6V1 B4DZP4 Q8TAT3,Cytoplasmic dynein 1 light intermediate chain 2,Dynein light intermediate chain 2, cytosolic;LIC53/55;, PF05783;, GO:0005813;GO:0005868;GO:0005829;GO:0000776;GO:0005770;GO:0005764;GO:0016020;GO:0005874;GO:0005524;GO:0045504;GO:0042802;GO:0035973;GO:0019886;GO:1990090;GO:0051642;GO:0006888;GO:0000226;GO:0007018;GO:0007052;GO:0019058;, C:centrosome; C:cytoplasmic dynein complex; C:cytosol; C:kinetochore; C:late endosome; C:lysosome; C:membrane; C:microtubule;, F:ATP binding; F:dynein heavy chain binding; F:identical protein binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular response to nerve growth factor stimulus; P:centrosome localization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule cytoskeleton organization; P:microtubule-based movement; P:mitotic spindle organization; P:viral life cycle;|O43237 A8K6V1 B4DZP4 Q8TAT3,Cytoplasmic dynein 1 light intermediate chain 2,Dynein light intermediate chain 2, cytosolic;LIC53/55;, PF05783;, GO:0005813;GO:0005868;GO:0005829;GO:0000776;GO:0005770;GO:0005764;GO:0016020;GO:0005874;GO:0005524;GO:0045504;GO:0042802;GO:0035973;GO:0019886;GO:1990090;GO:0051642;GO:0006888;GO:0000226;GO:0007018;GO:0007052;GO:0019058;, C:centrosome; C:cytoplasmic dynein complex; C:cytosol; C:kinetochore; C:late endosome; C:lysosome; C:membrane; C:microtubule;, F:ATP binding; F:dynein heavy chain binding; F:identical protein binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular response to nerve growth factor stimulus; P:centrosome localization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule cytoskeleton organization; P:microtubule-based movement; P:mitotic spindle organization; P:viral life cycle;|O43237 A8K6V1 B4DZP4 Q8TAT3,Cytoplasmic dynein 1 light intermediate chain 2,Dynein light intermediate chain 2, cytosolic;LIC53/55;, PF05783;, GO:0005813;GO:0005868;GO:0005829;GO:0000776;GO:0005770;GO:0005764;GO:0016020;GO:0005874;GO:0005524;GO:0045504;GO:0042802;GO:0035973;GO:0019886;GO:1990090;GO:0051642;GO:0006888;GO:0000226;GO:0007018;GO:0007052;GO:0019058;, C:centrosome; C:cytoplasmic dynein complex; C:cytosol; C:kinetochore; C:late endosome; C:lysosome; C:membrane; C:microtubule;, F:ATP binding; F:dynein heavy chain binding; F:identical protein binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular response to nerve growth factor stimulus; P:centrosome localization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule cytoskeleton organization; P:microtubule-based movement; P:mitotic spindle organization; P:viral life cycle;|Q8NA31 A0AUW1,Telomere repeats-binding bouquet formation protein 1 {ECO:0000250|UniProtKB:Q8C0V1},Coiled-coil domain-containing protein 79 {ECO:0000312|HGNC:HGNC:26675};, PF00249;, GO:0000781;GO:0005637;GO:0070187;GO:0007129;GO:0070197;GO:0045141;, C:chromosome, telomeric region; C:nuclear inner membrane; C:shelterin complex;, , P:homologous chromosome pairing at meiosis; P:meiotic attachment of telomere to nuclear envelope; P:meiotic telomere clustering;|Q8NA31 A0AUW1,Telomere repeats-binding bouquet formation protein 1 {ECO:0000250|UniProtKB:Q8C0V1},Coiled-coil domain-containing protein 79 {ECO:0000312|HGNC:HGNC:26675};, PF00249;, GO:0000781;GO:0005637;GO:0070187;GO:0007129;GO:0070197;GO:0045141;, C:chromosome, telomeric region; C:nuclear inner membrane; C:shelterin complex;, , P:homologous chromosome pairing at meiosis; P:meiotic attachment of telomere to nuclear envelope; P:meiotic telomere clustering;|Q13564 A6NCK0 A6NFN4 A8MU28 B2R700 B3KUP9,NEDD8-activating enzyme E1 regulatory subunit,Amyloid beta precursor protein-binding protein 1, 59 kDa;Amyloid protein-binding protein 1;Proto-oncogene protein 1;, PF00899;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0019781;GO:0046982;GO:0031625;GO:0033314;GO:0051402;GO:0043687;GO:0032446;GO:0045116;GO:0042981;GO:0043523;GO:0007165;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:NEDD8 activating enzyme activity; F:protein heterodimerization activity; F:ubiquitin protein ligase binding;, P:mitotic DNA replication checkpoint; P:neuron apoptotic process; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:regulation of apoptotic process; P:regulation of neuron apoptotic process; P:signal transduction;|Q13564 A6NCK0 A6NFN4 A8MU28 B2R700 B3KUP9,NEDD8-activating enzyme E1 regulatory subunit,Amyloid beta precursor protein-binding protein 1, 59 kDa;Amyloid protein-binding protein 1;Proto-oncogene protein 1;, PF00899;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0019781;GO:0046982;GO:0031625;GO:0033314;GO:0051402;GO:0043687;GO:0032446;GO:0045116;GO:0042981;GO:0043523;GO:0007165;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:NEDD8 activating enzyme activity; F:protein heterodimerization activity; F:ubiquitin protein ligase binding;, P:mitotic DNA replication checkpoint; P:neuron apoptotic process; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:regulation of apoptotic process; P:regulation of neuron apoptotic process; P:signal transduction;|Q13564 A6NCK0 A6NFN4 A8MU28 B2R700 B3KUP9,NEDD8-activating enzyme E1 regulatory subunit,Amyloid beta precursor protein-binding protein 1, 59 kDa;Amyloid protein-binding protein 1;Proto-oncogene protein 1;, PF00899;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0019781;GO:0046982;GO:0031625;GO:0033314;GO:0051402;GO:0043687;GO:0032446;GO:0045116;GO:0042981;GO:0043523;GO:0007165;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:NEDD8 activating enzyme activity; F:protein heterodimerization activity; F:ubiquitin protein ligase binding;, P:mitotic DNA replication checkpoint; P:neuron apoptotic process; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:regulation of apoptotic process; P:regulation of neuron apoptotic process; P:signal transduction;|Q13564 A6NCK0 A6NFN4 A8MU28 B2R700 B3KUP9,NEDD8-activating enzyme E1 regulatory subunit,Amyloid beta precursor protein-binding protein 1, 59 kDa;Amyloid protein-binding protein 1;Proto-oncogene protein 1;, PF00899;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0019781;GO:0046982;GO:0031625;GO:0033314;GO:0051402;GO:0043687;GO:0032446;GO:0045116;GO:0042981;GO:0043523;GO:0007165;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:NEDD8 activating enzyme activity; F:protein heterodimerization activity; F:ubiquitin protein ligase binding;, P:mitotic DNA replication checkpoint; P:neuron apoptotic process; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:regulation of apoptotic process; P:regulation of neuron apoptotic process; P:signal transduction;|Q13564 A6NCK0 A6NFN4 A8MU28 B2R700 B3KUP9,NEDD8-activating enzyme E1 regulatory subunit,Amyloid beta precursor protein-binding protein 1, 59 kDa;Amyloid protein-binding protein 1;Proto-oncogene protein 1;, PF00899;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0019781;GO:0046982;GO:0031625;GO:0033314;GO:0051402;GO:0043687;GO:0032446;GO:0045116;GO:0042981;GO:0043523;GO:0007165;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:NEDD8 activating enzyme activity; F:protein heterodimerization activity; F:ubiquitin protein ligase binding;, P:mitotic DNA replication checkpoint; P:neuron apoptotic process; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:regulation of apoptotic process; P:regulation of neuron apoptotic process; P:signal transduction;|Q13564 A6NCK0 A6NFN4 A8MU28 B2R700 B3KUP9,NEDD8-activating enzyme E1 regulatory subunit,Amyloid beta precursor protein-binding protein 1, 59 kDa;Amyloid protein-binding protein 1;Proto-oncogene protein 1;, PF00899;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0019781;GO:0046982;GO:0031625;GO:0033314;GO:0051402;GO:0043687;GO:0032446;GO:0045116;GO:0042981;GO:0043523;GO:0007165;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:NEDD8 activating enzyme activity; F:protein heterodimerization activity; F:ubiquitin protein ligase binding;, P:mitotic DNA replication checkpoint; P:neuron apoptotic process; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:regulation of apoptotic process; P:regulation of neuron apoptotic process; P:signal transduction;|Q13564 A6NCK0 A6NFN4 A8MU28 B2R700 B3KUP9,NEDD8-activating enzyme E1 regulatory subunit,Amyloid beta precursor protein-binding protein 1, 59 kDa;Amyloid protein-binding protein 1;Proto-oncogene protein 1;, PF00899;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0019781;GO:0046982;GO:0031625;GO:0033314;GO:0051402;GO:0043687;GO:0032446;GO:0045116;GO:0042981;GO:0043523;GO:0007165;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:NEDD8 activating enzyme activity; F:protein heterodimerization activity; F:ubiquitin protein ligase binding;, P:mitotic DNA replication checkpoint; P:neuron apoptotic process; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:regulation of apoptotic process; P:regulation of neuron apoptotic process; P:signal transduction;|Q13564 A6NCK0 A6NFN4 A8MU28 B2R700 B3KUP9,NEDD8-activating enzyme E1 regulatory subunit,Amyloid beta precursor protein-binding protein 1, 59 kDa;Amyloid protein-binding protein 1;Proto-oncogene protein 1;, PF00899;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0019781;GO:0046982;GO:0031625;GO:0033314;GO:0051402;GO:0043687;GO:0032446;GO:0045116;GO:0042981;GO:0043523;GO:0007165;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:NEDD8 activating enzyme activity; F:protein heterodimerization activity; F:ubiquitin protein ligase binding;, P:mitotic DNA replication checkpoint; P:neuron apoptotic process; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:regulation of apoptotic process; P:regulation of neuron apoptotic process; P:signal transduction;|P43166 Q541F0 Q86YU0,Carbonic anhydrase 7,Carbonate dehydratase VII;Carbonic anhydrase VII;, PF00194;, GO:0005829;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;GO:0032849;GO:0032230;GO:2001225;GO:0051453;, C:cytosol;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process; P:positive regulation of cellular pH reduction; P:positive regulation of synaptic transmission, GABAergic; P:regulation of chloride transport; P:regulation of intracellular pH;|Q9P2J9 A8K924,[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial,Pyruvate dehydrogenase phosphatase catalytic subunit 2;, PF00481;, GO:0005759;GO:0005739;GO:0004741;GO:0004724;GO:0046872;GO:1904184;GO:0006470;GO:0010510;, C:mitochondrial matrix; C:mitochondrion;, F:[pyruvate dehydrogenase (lipoamide)] phosphatase activity; F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding;, P:positive regulation of pyruvate dehydrogenase activity; P:protein dephosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate;|O75309 B4DPA8 H3BPD3 Q6UW93,Cadherin-16,Kidney-specific cadherin;, PF00028;, GO:0016323;GO:0070062;GO:0005887;GO:0005509;GO:0016339;GO:0007155;GO:0007156;, C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|O75309 B4DPA8 H3BPD3 Q6UW93,Cadherin-16,Kidney-specific cadherin;, PF00028;, GO:0016323;GO:0070062;GO:0005887;GO:0005509;GO:0016339;GO:0007155;GO:0007156;, C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|P55042 Q96F39,GTP-binding protein RAD,RAD1;Ras associated with diabetes;, PF00071;, GO:0005829;GO:0005886;GO:0005246;GO:0005516;GO:0005525;GO:0003924;GO:1901842;GO:0007264;, C:cytosol; C:plasma membrane;, F:calcium channel regulator activity; F:calmodulin binding; F:GTP binding; F:GTPase activity;, P:negative regulation of high voltage-gated calcium channel activity; P:small GTPase mediated signal transduction;|Q9Y3D0,Cytosolic iron-sulfur assembly component 2B {ECO:0000305},MSS19-interacting protein of 18 kDa;Mitotic spindle-associated MMXD complex subunit MIP18;Protein FAM96B;, PF01883;, GO:0097361;GO:0005737;GO:0005829;GO:0030496;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0007059;GO:0016226;GO:0106035;GO:0097428;, C:CIA complex; C:cytoplasm; C:cytosol; C:midbody; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle;, , P:chromosome segregation; P:iron-sulfur cluster assembly; P:protein maturation by [4Fe-4S] cluster transfer; P:protein maturation by iron-sulfur cluster transfer;|Q9Y3D0,Cytosolic iron-sulfur assembly component 2B {ECO:0000305},MSS19-interacting protein of 18 kDa;Mitotic spindle-associated MMXD complex subunit MIP18;Protein FAM96B;, PF01883;, GO:0097361;GO:0005737;GO:0005829;GO:0030496;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0007059;GO:0016226;GO:0106035;GO:0097428;, C:CIA complex; C:cytoplasm; C:cytosol; C:midbody; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle;, , P:chromosome segregation; P:iron-sulfur cluster assembly; P:protein maturation by [4Fe-4S] cluster transfer; P:protein maturation by iron-sulfur cluster transfer;|Q9Y3D0,Cytosolic iron-sulfur assembly component 2B {ECO:0000305},MSS19-interacting protein of 18 kDa;Mitotic spindle-associated MMXD complex subunit MIP18;Protein FAM96B;, PF01883;, GO:0097361;GO:0005737;GO:0005829;GO:0030496;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0007059;GO:0016226;GO:0106035;GO:0097428;, C:CIA complex; C:cytoplasm; C:cytosol; C:midbody; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle;, , P:chromosome segregation; P:iron-sulfur cluster assembly; P:protein maturation by [4Fe-4S] cluster transfer; P:protein maturation by iron-sulfur cluster transfer;|O00748 A0A024R6X1 A8K367 Q16859 Q5MAB8 Q7Z366 Q8IUP4 Q8TCP8,Cocaine esterase {ECO:0000305},Carboxylesterase 2;Methylumbelliferyl-acetate deacetylase 2;, PF00135;, GO:0005783;GO:0005788;GO:0005615;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0009056;GO:0016042;GO:0006693;GO:0006805;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:catabolic process; P:lipid catabolic process; P:prostaglandin metabolic process; P:xenobiotic metabolic process;|O00748 A0A024R6X1 A8K367 Q16859 Q5MAB8 Q7Z366 Q8IUP4 Q8TCP8,Cocaine esterase {ECO:0000305},Carboxylesterase 2;Methylumbelliferyl-acetate deacetylase 2;, PF00135;, GO:0005783;GO:0005788;GO:0005615;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0009056;GO:0016042;GO:0006693;GO:0006805;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:catabolic process; P:lipid catabolic process; P:prostaglandin metabolic process; P:xenobiotic metabolic process;|O00748 A0A024R6X1 A8K367 Q16859 Q5MAB8 Q7Z366 Q8IUP4 Q8TCP8,Cocaine esterase {ECO:0000305},Carboxylesterase 2;Methylumbelliferyl-acetate deacetylase 2;, PF00135;, GO:0005783;GO:0005788;GO:0005615;GO:0052689;GO:0080030;GO:0047374;GO:0004771;GO:0004806;GO:0009056;GO:0016042;GO:0006693;GO:0006805;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:methylumbelliferyl-acetate deacetylase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:catabolic process; P:lipid catabolic process; P:prostaglandin metabolic process; P:xenobiotic metabolic process;|Q6UWW8 B2Z3W9 F5H242 Q7Z6J1 Q9H6X7,Carboxylesterase 3,Liver carboxylesterase 31 homolog;, PF00135;, GO:0005829;GO:0005788;GO:0070062;GO:0005615;GO:0052689;GO:0080030;GO:0004771;GO:0004806;GO:0016042;GO:0034383;GO:0006805;, C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:lipid catabolic process; P:low-density lipoprotein particle clearance; P:xenobiotic metabolic process;|Q6UWW8 B2Z3W9 F5H242 Q7Z6J1 Q9H6X7,Carboxylesterase 3,Liver carboxylesterase 31 homolog;, PF00135;, GO:0005829;GO:0005788;GO:0070062;GO:0005615;GO:0052689;GO:0080030;GO:0004771;GO:0004806;GO:0016042;GO:0034383;GO:0006805;, C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:lipid catabolic process; P:low-density lipoprotein particle clearance; P:xenobiotic metabolic process;|Q6NT32 B7Z252 B7ZLB6 Q8NBC8 Q96DN9,Carboxylesterase 5A,Carboxylesterase-like urinary excreted protein homolog;, PF00135;, GO:0005615;GO:0052689;GO:0080030;GO:0004771;GO:0004806;GO:0016042;, C:extracellular space;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:lipid catabolic process;|Q6UWW8 B2Z3W9 F5H242 Q7Z6J1 Q9H6X7,Carboxylesterase 3,Liver carboxylesterase 31 homolog;, PF00135;, GO:0005829;GO:0005788;GO:0070062;GO:0005615;GO:0052689;GO:0080030;GO:0004771;GO:0004806;GO:0016042;GO:0034383;GO:0006805;, C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space;, F:carboxylic ester hydrolase activity; F:methyl indole-3-acetate esterase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:lipid catabolic process; P:low-density lipoprotein particle clearance; P:xenobiotic metabolic process;|Q9BSU1 Q9HA86,UPF0183 protein C16orf70,, PF03676;, GO:0030425;GO:0030672;GO:0005802;GO:0043001;, C:dendrite; C:synaptic vesicle membrane; C:trans-Golgi network;, , P:Golgi to plasma membrane protein transport;|Q9BSU1 Q9HA86,UPF0183 protein C16orf70,, PF03676;, GO:0030425;GO:0030672;GO:0005802;GO:0043001;, C:dendrite; C:synaptic vesicle membrane; C:trans-Golgi network;, , P:Golgi to plasma membrane protein transport;|Q9BSU1 Q9HA86,UPF0183 protein C16orf70,, PF03676;, GO:0030425;GO:0030672;GO:0005802;GO:0043001;, C:dendrite; C:synaptic vesicle membrane; C:trans-Golgi network;, , P:Golgi to plasma membrane protein transport;|Q9BSU1 Q9HA86,UPF0183 protein C16orf70,, PF03676;, GO:0030425;GO:0030672;GO:0005802;GO:0043001;, C:dendrite; C:synaptic vesicle membrane; C:trans-Golgi network;, , P:Golgi to plasma membrane protein transport;|Q9BSU1 Q9HA86,UPF0183 protein C16orf70,, PF03676;, GO:0030425;GO:0030672;GO:0005802;GO:0043001;, C:dendrite; C:synaptic vesicle membrane; C:trans-Golgi network;, , P:Golgi to plasma membrane protein transport;|Q9BSU1 Q9HA86,UPF0183 protein C16orf70,, PF03676;, GO:0030425;GO:0030672;GO:0005802;GO:0043001;, C:dendrite; C:synaptic vesicle membrane; C:trans-Golgi network;, , P:Golgi to plasma membrane protein transport;|Q6UX72 Q96EK0,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 {ECO:0000312|HGNC:HGNC:28714},, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0008532;GO:0030311;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity;, P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation;|Q9BSU1 Q9HA86,UPF0183 protein C16orf70,, PF03676;, GO:0030425;GO:0030672;GO:0005802;GO:0043001;, C:dendrite; C:synaptic vesicle membrane; C:trans-Golgi network;, , P:Golgi to plasma membrane protein transport;|Q9BSU1 Q9HA86,UPF0183 protein C16orf70,, PF03676;, GO:0030425;GO:0030672;GO:0005802;GO:0043001;, C:dendrite; C:synaptic vesicle membrane; C:trans-Golgi network;, , P:Golgi to plasma membrane protein transport;|Q15628 B2RDS3 B3KQZ9 Q52NZ1,Tumor necrosis factor receptor type 1-associated DEATH domain protein,TNFRSF1A-associated via death domain;, PF00531;PF09034;, GO:0005737;GO:0005856;GO:0005829;GO:0031264;GO:0045121;GO:0005634;GO:0005886;GO:0043235;GO:0002947;GO:0070513;GO:0042802;GO:0019900;GO:0044877;GO:0005068;GO:0005164;GO:0006919;GO:0006915;GO:0071356;GO:0071550;GO:0097191;GO:0008625;GO:0007249;GO:1902042;GO:0043065;GO:0030335;GO:0051798;GO:0043123;GO:0050729;GO:0051092;GO:1901224;GO:1902041;GO:0010803;GO:0007165;GO:0033209;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:nucleus; C:plasma membrane; C:receptor complex; C:tumor necrosis factor receptor superfamily complex;, F:death domain binding; F:identical protein binding; F:kinase binding; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine kinase adaptor activity; F:tumor necrosis factor receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of hair follicle development; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of tumor necrosis factor-mediated signaling pathway; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway;|Q15628 B2RDS3 B3KQZ9 Q52NZ1,Tumor necrosis factor receptor type 1-associated DEATH domain protein,TNFRSF1A-associated via death domain;, PF00531;PF09034;, GO:0005737;GO:0005856;GO:0005829;GO:0031264;GO:0045121;GO:0005634;GO:0005886;GO:0043235;GO:0002947;GO:0070513;GO:0042802;GO:0019900;GO:0044877;GO:0005068;GO:0005164;GO:0006919;GO:0006915;GO:0071356;GO:0071550;GO:0097191;GO:0008625;GO:0007249;GO:1902042;GO:0043065;GO:0030335;GO:0051798;GO:0043123;GO:0050729;GO:0051092;GO:1901224;GO:1902041;GO:0010803;GO:0007165;GO:0033209;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:nucleus; C:plasma membrane; C:receptor complex; C:tumor necrosis factor receptor superfamily complex;, F:death domain binding; F:identical protein binding; F:kinase binding; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine kinase adaptor activity; F:tumor necrosis factor receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of hair follicle development; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of tumor necrosis factor-mediated signaling pathway; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway;|Q96CD0 Q9NUM0,F-box/LRR-repeat protein 8,F-box and leucine-rich repeat protein 8;F-box protein FBL8;, PF12937;, GO:0005829;GO:0005634;GO:0019005;GO:0043153;GO:0000086;GO:0043687;GO:0000209;GO:0051726;GO:0031146;, C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:post-translational protein modification; P:protein polyubiquitination; P:regulation of cell cycle; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9ULV5 Q99472 Q9ULV6,Heat shock factor protein 4,Heat shock transcription factor 4;, PF00447;, GO:0000785;GO:0016607;GO:0005634;GO:0003700;GO:0000981;GO:0042802;GO:0019903;GO:0000978;GO:1990837;GO:0043010;GO:0048468;GO:0033169;GO:0000122;GO:0045597;GO:0008284;GO:0045944;GO:0006357;GO:0007601;, C:chromatin; C:nuclear speck; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:camera-type eye development; P:cell development; P:histone H3-K9 demethylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:visual perception;|Q9ULV5 Q99472 Q9ULV6,Heat shock factor protein 4,Heat shock transcription factor 4;, PF00447;, GO:0000785;GO:0016607;GO:0005634;GO:0003700;GO:0000981;GO:0042802;GO:0019903;GO:0000978;GO:1990837;GO:0043010;GO:0048468;GO:0033169;GO:0000122;GO:0045597;GO:0008284;GO:0045944;GO:0006357;GO:0007601;, C:chromatin; C:nuclear speck; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:camera-type eye development; P:cell development; P:histone H3-K9 demethylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:visual perception;|Q9ULV5 Q99472 Q9ULV6,Heat shock factor protein 4,Heat shock transcription factor 4;, PF00447;, GO:0000785;GO:0016607;GO:0005634;GO:0003700;GO:0000981;GO:0042802;GO:0019903;GO:0000978;GO:1990837;GO:0043010;GO:0048468;GO:0033169;GO:0000122;GO:0045597;GO:0008284;GO:0045944;GO:0006357;GO:0007601;, C:chromatin; C:nuclear speck; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:camera-type eye development; P:cell development; P:histone H3-K9 demethylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:visual perception;|Q9ULV5 Q99472 Q9ULV6,Heat shock factor protein 4,Heat shock transcription factor 4;, PF00447;, GO:0000785;GO:0016607;GO:0005634;GO:0003700;GO:0000981;GO:0042802;GO:0019903;GO:0000978;GO:1990837;GO:0043010;GO:0048468;GO:0033169;GO:0000122;GO:0045597;GO:0008284;GO:0045944;GO:0006357;GO:0007601;, C:chromatin; C:nuclear speck; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:camera-type eye development; P:cell development; P:histone H3-K9 demethylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:visual perception;|Q68EN5 A2VCS8 Q8N3H9 Q8NAQ5 Q96IE5,Uncharacterized protein KIAA0895-like,, PF08014;|Q68EN5 A2VCS8 Q8N3H9 Q8NAQ5 Q96IE5,Uncharacterized protein KIAA0895-like,, PF08014;|Q68EN5 A2VCS8 Q8N3H9 Q8NAQ5 Q96IE5,Uncharacterized protein KIAA0895-like,, PF08014;|Q86VI1 A8K7I9 Q8NAD2 Q8TEN2,Exocyst complex component 3-like protein,Protein Jiangli;, PF06046;, GO:0000145;GO:0030141;GO:0030133;GO:0000149;GO:0051601;GO:0006887;GO:0030072;, C:exocyst; C:secretory granule; C:transport vesicle;, F:SNARE binding;, P:exocyst localization; P:exocytosis; P:peptide hormone secretion;|Q86VI1 A8K7I9 Q8NAD2 Q8TEN2,Exocyst complex component 3-like protein,Protein Jiangli;, PF06046;, GO:0000145;GO:0030141;GO:0030133;GO:0000149;GO:0051601;GO:0006887;GO:0030072;, C:exocyst; C:secretory granule; C:transport vesicle;, F:SNARE binding;, P:exocyst localization; P:exocytosis; P:peptide hormone secretion;|Q86VI1 A8K7I9 Q8NAD2 Q8TEN2,Exocyst complex component 3-like protein,Protein Jiangli;, PF06046;, GO:0000145;GO:0030141;GO:0030133;GO:0000149;GO:0051601;GO:0006887;GO:0030072;, C:exocyst; C:secretory granule; C:transport vesicle;, F:SNARE binding;, P:exocyst localization; P:exocytosis; P:peptide hormone secretion;|Q96BJ8 B4DV86 Q9H8A5,Engulfment and cell motility protein 3,, PF11841;PF04727;PF16457;, GO:0005737;GO:0017124;GO:0007015;GO:0006915;GO:0016477;GO:0048870;GO:0006909;, C:cytoplasm;, F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell migration; P:cell motility; P:phagocytosis;|Q16254 A6NGR8 B5BU56 Q12991 Q15328,Transcription factor E2F4,, PF16421;PF02319;, GO:0000785;GO:0005737;GO:0005654;GO:0090575;GO:0003677;GO:0001216;GO:0001228;GO:0003700;GO:0000981;GO:1990841;GO:0046983;GO:0019904;GO:0000978;GO:1990837;GO:0008134;GO:0009887;GO:0008015;GO:0006884;GO:0098534;GO:0006977;GO:0002064;GO:0044458;GO:1903251;GO:0045944;GO:0042127;GO:0006357;GO:0000083;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:promoter-specific chromatin binding; F:protein dimerization activity; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:animal organ morphogenesis; P:blood circulation; P:cell volume homeostasis; P:centriole assembly; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epithelial cell development; P:motile cilium assembly; P:multi-ciliated epithelial cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q96BJ8 B4DV86 Q9H8A5,Engulfment and cell motility protein 3,, PF11841;PF04727;PF16457;, GO:0005737;GO:0017124;GO:0007015;GO:0006915;GO:0016477;GO:0048870;GO:0006909;, C:cytoplasm;, F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell migration; P:cell motility; P:phagocytosis;|Q96BJ8 B4DV86 Q9H8A5,Engulfment and cell motility protein 3,, PF11841;PF04727;PF16457;, GO:0005737;GO:0017124;GO:0007015;GO:0006915;GO:0016477;GO:0048870;GO:0006909;, C:cytoplasm;, F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell migration; P:cell motility; P:phagocytosis;|Q8WV35 B2RE92 Q9UKA0,Leucine-rich repeat-containing protein 29,F-box and leucine-rich repeat protein 9;F-box protein FBL9;F-box/LRR-repeat protein 9;, PF00560;PF13516;|Q96IG2 A8K729 Q38J52,F-box/LRR-repeat protein 20,F-box and leucine-rich repeat protein 20;F-box/LRR-repeat protein 2-like;, PF12937;PF13516;, GO:0005829;GO:0019005;GO:0043687;GO:0000209;GO:0031146;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9BTX3 Q05CT0 Q96D25 Q9NZZ7,Transmembrane protein 208,, PF05620;, GO:0005789;GO:0016021;GO:0043231;GO:0005773;GO:0006914;GO:0006624;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:vacuole;, , P:autophagy; P:vacuolar protein processing;|Q9Y613 Q59F76 Q6Y1F2 Q76MS8 Q8N521,FH1/FH2 domain-containing protein 1,Formin homolog overexpressed in spleen 1;Formin homology 2 domain-containing protein 1;, PF02181;PF18382;, GO:0032059;GO:0005737;GO:0005856;GO:0005829;GO:0014704;GO:0016020;GO:0005654;GO:0005634;GO:0051015;GO:0042802;GO:0019904;GO:0043621;GO:0051639;GO:0030866;GO:0051660;GO:0007097;GO:0051496;GO:0045944;GO:0051492;, C:bleb; C:cytoplasm; C:cytoskeleton; C:cytosol; C:intercalated disc; C:membrane; C:nucleoplasm; C:nucleus;, F:actin filament binding; F:identical protein binding; F:protein domain specific binding; F:protein self-association;, P:actin filament network formation; P:cortical actin cytoskeleton organization; P:establishment of centrosome localization; P:nuclear migration; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of stress fiber assembly;|Q9Y613 Q59F76 Q6Y1F2 Q76MS8 Q8N521,FH1/FH2 domain-containing protein 1,Formin homolog overexpressed in spleen 1;Formin homology 2 domain-containing protein 1;, PF02181;PF18382;, GO:0032059;GO:0005737;GO:0005856;GO:0005829;GO:0014704;GO:0016020;GO:0005654;GO:0005634;GO:0051015;GO:0042802;GO:0019904;GO:0043621;GO:0051639;GO:0030866;GO:0051660;GO:0007097;GO:0051496;GO:0045944;GO:0051492;, C:bleb; C:cytoplasm; C:cytoskeleton; C:cytosol; C:intercalated disc; C:membrane; C:nucleoplasm; C:nucleus;, F:actin filament binding; F:identical protein binding; F:protein domain specific binding; F:protein self-association;, P:actin filament network formation; P:cortical actin cytoskeleton organization; P:establishment of centrosome localization; P:nuclear migration; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of stress fiber assembly;|Q9Y613 Q59F76 Q6Y1F2 Q76MS8 Q8N521,FH1/FH2 domain-containing protein 1,Formin homolog overexpressed in spleen 1;Formin homology 2 domain-containing protein 1;, PF02181;PF18382;, GO:0032059;GO:0005737;GO:0005856;GO:0005829;GO:0014704;GO:0016020;GO:0005654;GO:0005634;GO:0051015;GO:0042802;GO:0019904;GO:0043621;GO:0051639;GO:0030866;GO:0051660;GO:0007097;GO:0051496;GO:0045944;GO:0051492;, C:bleb; C:cytoplasm; C:cytoskeleton; C:cytosol; C:intercalated disc; C:membrane; C:nucleoplasm; C:nucleus;, F:actin filament binding; F:identical protein binding; F:protein domain specific binding; F:protein self-association;, P:actin filament network formation; P:cortical actin cytoskeleton organization; P:establishment of centrosome localization; P:nuclear migration; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of stress fiber assembly;|Q9Y613 Q59F76 Q6Y1F2 Q76MS8 Q8N521,FH1/FH2 domain-containing protein 1,Formin homolog overexpressed in spleen 1;Formin homology 2 domain-containing protein 1;, PF02181;PF18382;, GO:0032059;GO:0005737;GO:0005856;GO:0005829;GO:0014704;GO:0016020;GO:0005654;GO:0005634;GO:0051015;GO:0042802;GO:0019904;GO:0043621;GO:0051639;GO:0030866;GO:0051660;GO:0007097;GO:0051496;GO:0045944;GO:0051492;, C:bleb; C:cytoplasm; C:cytoskeleton; C:cytosol; C:intercalated disc; C:membrane; C:nucleoplasm; C:nucleus;, F:actin filament binding; F:identical protein binding; F:protein domain specific binding; F:protein self-association;, P:actin filament network formation; P:cortical actin cytoskeleton organization; P:establishment of centrosome localization; P:nuclear migration; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of stress fiber assembly;|Q9Y613 Q59F76 Q6Y1F2 Q76MS8 Q8N521,FH1/FH2 domain-containing protein 1,Formin homolog overexpressed in spleen 1;Formin homology 2 domain-containing protein 1;, PF02181;PF18382;, GO:0032059;GO:0005737;GO:0005856;GO:0005829;GO:0014704;GO:0016020;GO:0005654;GO:0005634;GO:0051015;GO:0042802;GO:0019904;GO:0043621;GO:0051639;GO:0030866;GO:0051660;GO:0007097;GO:0051496;GO:0045944;GO:0051492;, C:bleb; C:cytoplasm; C:cytoskeleton; C:cytosol; C:intercalated disc; C:membrane; C:nucleoplasm; C:nucleus;, F:actin filament binding; F:identical protein binding; F:protein domain specific binding; F:protein self-association;, P:actin filament network formation; P:cortical actin cytoskeleton organization; P:establishment of centrosome localization; P:nuclear migration; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of stress fiber assembly;|Q14940 A5PKY7 Q9Y626,Sodium/hydrogen exchanger 5,Na(+)/H(+) exchanger 5;Solute carrier family 9 member 5;, PF00999;, GO:0016021;GO:0005886;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:plasma membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q14940 A5PKY7 Q9Y626,Sodium/hydrogen exchanger 5,Na(+)/H(+) exchanger 5;Solute carrier family 9 member 5;, PF00999;, GO:0016021;GO:0005886;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:plasma membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q14940 A5PKY7 Q9Y626,Sodium/hydrogen exchanger 5,Na(+)/H(+) exchanger 5;Solute carrier family 9 member 5;, PF00999;, GO:0016021;GO:0005886;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:plasma membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q14940 A5PKY7 Q9Y626,Sodium/hydrogen exchanger 5,Na(+)/H(+) exchanger 5;Solute carrier family 9 member 5;, PF00999;, GO:0016021;GO:0005886;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:plasma membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q14940 A5PKY7 Q9Y626,Sodium/hydrogen exchanger 5,Na(+)/H(+) exchanger 5;Solute carrier family 9 member 5;, PF00999;, GO:0016021;GO:0005886;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:plasma membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q14940 A5PKY7 Q9Y626,Sodium/hydrogen exchanger 5,Na(+)/H(+) exchanger 5;Solute carrier family 9 member 5;, PF00999;, GO:0016021;GO:0005886;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:plasma membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q14940 A5PKY7 Q9Y626,Sodium/hydrogen exchanger 5,Na(+)/H(+) exchanger 5;Solute carrier family 9 member 5;, PF00999;, GO:0016021;GO:0005886;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:plasma membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q14940 A5PKY7 Q9Y626,Sodium/hydrogen exchanger 5,Na(+)/H(+) exchanger 5;Solute carrier family 9 member 5;, PF00999;, GO:0016021;GO:0005886;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:plasma membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q1X8D7 A4FTV6 A6NDE9 A8K8E6 B7Z7B3 Q7Z5K5,Leucine-rich repeat-containing protein 36,ROR gamma-binding protein 70;|Q9BW30 Q49AH9 Q9Y326 Q9Y6H0,Tubulin polymerization-promoting protein family member 3 {ECO:0000303|PubMed:19633818},TPPP/p20 {ECO:0000303|PubMed:17105200};, PF05517;, GO:0005737;GO:0005874;GO:0015631;GO:0046697;GO:0007566;GO:0001578;GO:0046785;GO:0032273;, C:cytoplasm; C:microtubule;, F:tubulin binding;, P:decidualization; P:embryo implantation; P:microtubule bundle formation; P:microtubule polymerization; P:positive regulation of protein polymerization;|Q9BW30 Q49AH9 Q9Y326 Q9Y6H0,Tubulin polymerization-promoting protein family member 3 {ECO:0000303|PubMed:19633818},TPPP/p20 {ECO:0000303|PubMed:17105200};, PF05517;, GO:0005737;GO:0005874;GO:0015631;GO:0046697;GO:0007566;GO:0001578;GO:0046785;GO:0032273;, C:cytoplasm; C:microtubule;, F:tubulin binding;, P:decidualization; P:embryo implantation; P:microtubule bundle formation; P:microtubule polymerization; P:positive regulation of protein polymerization;|Q8WTX9 O15461,Palmitoyltransferase ZDHHC1 {ECO:0000305},DHHC domain-containing cysteine-rich protein 1 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 1 {ECO:0000312|HGNC:HGNC:17916};Zinc finger protein 377;, PF01529;, GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0003677;GO:0016409;GO:0019706;GO:0140374;GO:0018230;GO:0002230;GO:1905668;GO:0032461;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane;, F:DNA binding; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:antiviral innate immune response; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of defense response to virus by host; P:positive regulation of protein localization to endosome; P:positive regulation of protein oligomerization; P:protein palmitoylation; P:protein targeting to membrane;|Q8WTX9 O15461,Palmitoyltransferase ZDHHC1 {ECO:0000305},DHHC domain-containing cysteine-rich protein 1 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 1 {ECO:0000312|HGNC:HGNC:17916};Zinc finger protein 377;, PF01529;, GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0003677;GO:0016409;GO:0019706;GO:0140374;GO:0018230;GO:0002230;GO:1905668;GO:0032461;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane;, F:DNA binding; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:antiviral innate immune response; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of defense response to virus by host; P:positive regulation of protein localization to endosome; P:positive regulation of protein oligomerization; P:protein palmitoylation; P:protein targeting to membrane;|Q8WTX9 O15461,Palmitoyltransferase ZDHHC1 {ECO:0000305},DHHC domain-containing cysteine-rich protein 1 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 1 {ECO:0000312|HGNC:HGNC:17916};Zinc finger protein 377;, PF01529;, GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0003677;GO:0016409;GO:0019706;GO:0140374;GO:0018230;GO:0002230;GO:1905668;GO:0032461;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane;, F:DNA binding; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:antiviral innate immune response; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of defense response to virus by host; P:positive regulation of protein localization to endosome; P:positive regulation of protein oligomerization; P:protein palmitoylation; P:protein targeting to membrane;|Q8WTX9 O15461,Palmitoyltransferase ZDHHC1 {ECO:0000305},DHHC domain-containing cysteine-rich protein 1 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 1 {ECO:0000312|HGNC:HGNC:17916};Zinc finger protein 377;, PF01529;, GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0003677;GO:0016409;GO:0019706;GO:0140374;GO:0018230;GO:0002230;GO:1905668;GO:0032461;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane;, F:DNA binding; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:antiviral innate immune response; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of defense response to virus by host; P:positive regulation of protein localization to endosome; P:positive regulation of protein oligomerization; P:protein palmitoylation; P:protein targeting to membrane;|Q8WTX9 O15461,Palmitoyltransferase ZDHHC1 {ECO:0000305},DHHC domain-containing cysteine-rich protein 1 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 1 {ECO:0000312|HGNC:HGNC:17916};Zinc finger protein 377;, PF01529;, GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0003677;GO:0016409;GO:0019706;GO:0140374;GO:0018230;GO:0002230;GO:1905668;GO:0032461;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane;, F:DNA binding; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:antiviral innate immune response; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of defense response to virus by host; P:positive regulation of protein localization to endosome; P:positive regulation of protein oligomerization; P:protein palmitoylation; P:protein targeting to membrane;|Q8WTX9 O15461,Palmitoyltransferase ZDHHC1 {ECO:0000305},DHHC domain-containing cysteine-rich protein 1 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 1 {ECO:0000312|HGNC:HGNC:17916};Zinc finger protein 377;, PF01529;, GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0003677;GO:0016409;GO:0019706;GO:0140374;GO:0018230;GO:0002230;GO:1905668;GO:0032461;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane;, F:DNA binding; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:antiviral innate immune response; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of defense response to virus by host; P:positive regulation of protein localization to endosome; P:positive regulation of protein oligomerization; P:protein palmitoylation; P:protein targeting to membrane;|Q8WTX9 O15461,Palmitoyltransferase ZDHHC1 {ECO:0000305},DHHC domain-containing cysteine-rich protein 1 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 1 {ECO:0000312|HGNC:HGNC:17916};Zinc finger protein 377;, PF01529;, GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0003677;GO:0016409;GO:0019706;GO:0140374;GO:0018230;GO:0002230;GO:1905668;GO:0032461;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane;, F:DNA binding; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:antiviral innate immune response; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of defense response to virus by host; P:positive regulation of protein localization to endosome; P:positive regulation of protein oligomerization; P:protein palmitoylation; P:protein targeting to membrane;|Q8WTX9 O15461,Palmitoyltransferase ZDHHC1 {ECO:0000305},DHHC domain-containing cysteine-rich protein 1 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 1 {ECO:0000312|HGNC:HGNC:17916};Zinc finger protein 377;, PF01529;, GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0003677;GO:0016409;GO:0019706;GO:0140374;GO:0018230;GO:0002230;GO:1905668;GO:0032461;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane;, F:DNA binding; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:antiviral innate immune response; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of defense response to virus by host; P:positive regulation of protein localization to endosome; P:positive regulation of protein oligomerization; P:protein palmitoylation; P:protein targeting to membrane;|Q8WTX9 O15461,Palmitoyltransferase ZDHHC1 {ECO:0000305},DHHC domain-containing cysteine-rich protein 1 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 1 {ECO:0000312|HGNC:HGNC:17916};Zinc finger protein 377;, PF01529;, GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0003677;GO:0016409;GO:0019706;GO:0140374;GO:0018230;GO:0002230;GO:1905668;GO:0032461;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane;, F:DNA binding; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:antiviral innate immune response; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of defense response to virus by host; P:positive regulation of protein localization to endosome; P:positive regulation of protein oligomerization; P:protein palmitoylation; P:protein targeting to membrane;|P61421 P12953 Q02547,V-type proton ATPase subunit d 1,32 kDa accessory protein;V-ATPase 40 kDa accessory protein;V-ATPase AC39 subunit;Vacuolar proton pump subunit d 1;, PF01992;, GO:0005769;GO:0010008;GO:0070062;GO:0005765;GO:0016020;GO:0030670;GO:0033181;GO:0033179;GO:0016471;GO:0046961;GO:0006879;GO:0034198;GO:0036295;GO:0060271;GO:0008286;GO:0034220;GO:0036498;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0007035;GO:0007034;, C:early endosome; C:endosome membrane; C:extracellular exosome; C:lysosomal membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane proton-transporting V-type ATPase complex; C:proton-transporting V-type ATPase, V0 domain; C:vacuolar proton-transporting V-type ATPase complex;, F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to amino acid starvation; P:cellular response to increased oxygen levels; P:cilium assembly; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:IRE1-mediated unfolded protein response; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification; P:vacuolar transport;|P61421 P12953 Q02547,V-type proton ATPase subunit d 1,32 kDa accessory protein;V-ATPase 40 kDa accessory protein;V-ATPase AC39 subunit;Vacuolar proton pump subunit d 1;, PF01992;, GO:0005769;GO:0010008;GO:0070062;GO:0005765;GO:0016020;GO:0030670;GO:0033181;GO:0033179;GO:0016471;GO:0046961;GO:0006879;GO:0034198;GO:0036295;GO:0060271;GO:0008286;GO:0034220;GO:0036498;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0007035;GO:0007034;, C:early endosome; C:endosome membrane; C:extracellular exosome; C:lysosomal membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane proton-transporting V-type ATPase complex; C:proton-transporting V-type ATPase, V0 domain; C:vacuolar proton-transporting V-type ATPase complex;, F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to amino acid starvation; P:cellular response to increased oxygen levels; P:cilium assembly; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:IRE1-mediated unfolded protein response; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification; P:vacuolar transport;|P61421 P12953 Q02547,V-type proton ATPase subunit d 1,32 kDa accessory protein;V-ATPase 40 kDa accessory protein;V-ATPase AC39 subunit;Vacuolar proton pump subunit d 1;, PF01992;, GO:0005769;GO:0010008;GO:0070062;GO:0005765;GO:0016020;GO:0030670;GO:0033181;GO:0033179;GO:0016471;GO:0046961;GO:0006879;GO:0034198;GO:0036295;GO:0060271;GO:0008286;GO:0034220;GO:0036498;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0007035;GO:0007034;, C:early endosome; C:endosome membrane; C:extracellular exosome; C:lysosomal membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane proton-transporting V-type ATPase complex; C:proton-transporting V-type ATPase, V0 domain; C:vacuolar proton-transporting V-type ATPase complex;, F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to amino acid starvation; P:cellular response to increased oxygen levels; P:cilium assembly; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:IRE1-mediated unfolded protein response; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification; P:vacuolar transport;|P61421 P12953 Q02547,V-type proton ATPase subunit d 1,32 kDa accessory protein;V-ATPase 40 kDa accessory protein;V-ATPase AC39 subunit;Vacuolar proton pump subunit d 1;, PF01992;, GO:0005769;GO:0010008;GO:0070062;GO:0005765;GO:0016020;GO:0030670;GO:0033181;GO:0033179;GO:0016471;GO:0046961;GO:0006879;GO:0034198;GO:0036295;GO:0060271;GO:0008286;GO:0034220;GO:0036498;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0007035;GO:0007034;, C:early endosome; C:endosome membrane; C:extracellular exosome; C:lysosomal membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane proton-transporting V-type ATPase complex; C:proton-transporting V-type ATPase, V0 domain; C:vacuolar proton-transporting V-type ATPase complex;, F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to amino acid starvation; P:cellular response to increased oxygen levels; P:cilium assembly; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:IRE1-mediated unfolded protein response; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification; P:vacuolar transport;|P61421 P12953 Q02547,V-type proton ATPase subunit d 1,32 kDa accessory protein;V-ATPase 40 kDa accessory protein;V-ATPase AC39 subunit;Vacuolar proton pump subunit d 1;, PF01992;, GO:0005769;GO:0010008;GO:0070062;GO:0005765;GO:0016020;GO:0030670;GO:0033181;GO:0033179;GO:0016471;GO:0046961;GO:0006879;GO:0034198;GO:0036295;GO:0060271;GO:0008286;GO:0034220;GO:0036498;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0007035;GO:0007034;, C:early endosome; C:endosome membrane; C:extracellular exosome; C:lysosomal membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane proton-transporting V-type ATPase complex; C:proton-transporting V-type ATPase, V0 domain; C:vacuolar proton-transporting V-type ATPase complex;, F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to amino acid starvation; P:cellular response to increased oxygen levels; P:cilium assembly; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:IRE1-mediated unfolded protein response; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:vacuolar acidification; P:vacuolar transport;|Q9H8D9,Rho family-interacting cell polarization regulator 1,, PF15903;, GO:0031252;GO:0005737;GO:0070062;GO:0005794;GO:0016020;GO:0012506;GO:0071889;GO:1990869;GO:0009267;GO:0051683;GO:2001107;GO:0035024;GO:0030335;GO:0090316;GO:0034067;GO:0009611;GO:0007266;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:vesicle membrane;, F:14-3-3 protein binding;, P:cellular response to chemokine; P:cellular response to starvation; P:establishment of Golgi localization; P:negative regulation of Rho guanyl-nucleotide exchange factor activity; P:negative regulation of Rho protein signal transduction; P:positive regulation of cell migration; P:positive regulation of intracellular protein transport; P:protein localization to Golgi apparatus; P:response to wounding; P:Rho protein signal transduction;|Q9H8D9,Rho family-interacting cell polarization regulator 1,, PF15903;, GO:0031252;GO:0005737;GO:0070062;GO:0005794;GO:0016020;GO:0012506;GO:0071889;GO:1990869;GO:0009267;GO:0051683;GO:2001107;GO:0035024;GO:0030335;GO:0090316;GO:0034067;GO:0009611;GO:0007266;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:vesicle membrane;, F:14-3-3 protein binding;, P:cellular response to chemokine; P:cellular response to starvation; P:establishment of Golgi localization; P:negative regulation of Rho guanyl-nucleotide exchange factor activity; P:negative regulation of Rho protein signal transduction; P:positive regulation of cell migration; P:positive regulation of intracellular protein transport; P:protein localization to Golgi apparatus; P:response to wounding; P:Rho protein signal transduction;|Q9H8D9,Rho family-interacting cell polarization regulator 1,, PF15903;, GO:0031252;GO:0005737;GO:0070062;GO:0005794;GO:0016020;GO:0012506;GO:0071889;GO:1990869;GO:0009267;GO:0051683;GO:2001107;GO:0035024;GO:0030335;GO:0090316;GO:0034067;GO:0009611;GO:0007266;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:vesicle membrane;, F:14-3-3 protein binding;, P:cellular response to chemokine; P:cellular response to starvation; P:establishment of Golgi localization; P:negative regulation of Rho guanyl-nucleotide exchange factor activity; P:negative regulation of Rho protein signal transduction; P:positive regulation of cell migration; P:positive regulation of intracellular protein transport; P:protein localization to Golgi apparatus; P:response to wounding; P:Rho protein signal transduction;|Q9H8D9,Rho family-interacting cell polarization regulator 1,, PF15903;, GO:0031252;GO:0005737;GO:0070062;GO:0005794;GO:0016020;GO:0012506;GO:0071889;GO:1990869;GO:0009267;GO:0051683;GO:2001107;GO:0035024;GO:0030335;GO:0090316;GO:0034067;GO:0009611;GO:0007266;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:vesicle membrane;, F:14-3-3 protein binding;, P:cellular response to chemokine; P:cellular response to starvation; P:establishment of Golgi localization; P:negative regulation of Rho guanyl-nucleotide exchange factor activity; P:negative regulation of Rho protein signal transduction; P:positive regulation of cell migration; P:positive regulation of intracellular protein transport; P:protein localization to Golgi apparatus; P:response to wounding; P:Rho protein signal transduction;|Q9H8D9,Rho family-interacting cell polarization regulator 1,, PF15903;, GO:0031252;GO:0005737;GO:0070062;GO:0005794;GO:0016020;GO:0012506;GO:0071889;GO:1990869;GO:0009267;GO:0051683;GO:2001107;GO:0035024;GO:0030335;GO:0090316;GO:0034067;GO:0009611;GO:0007266;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:vesicle membrane;, F:14-3-3 protein binding;, P:cellular response to chemokine; P:cellular response to starvation; P:establishment of Golgi localization; P:negative regulation of Rho guanyl-nucleotide exchange factor activity; P:negative regulation of Rho protein signal transduction; P:positive regulation of cell migration; P:positive regulation of intracellular protein transport; P:protein localization to Golgi apparatus; P:response to wounding; P:Rho protein signal transduction;|Q9H8D9,Rho family-interacting cell polarization regulator 1,, PF15903;, GO:0031252;GO:0005737;GO:0070062;GO:0005794;GO:0016020;GO:0012506;GO:0071889;GO:1990869;GO:0009267;GO:0051683;GO:2001107;GO:0035024;GO:0030335;GO:0090316;GO:0034067;GO:0009611;GO:0007266;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:vesicle membrane;, F:14-3-3 protein binding;, P:cellular response to chemokine; P:cellular response to starvation; P:establishment of Golgi localization; P:negative regulation of Rho guanyl-nucleotide exchange factor activity; P:negative regulation of Rho protein signal transduction; P:positive regulation of cell migration; P:positive regulation of intracellular protein transport; P:protein localization to Golgi apparatus; P:response to wounding; P:Rho protein signal transduction;|P49711 B5MC38 Q53XI7 Q59EL8,Transcriptional repressor CTCF,11-zinc finger protein;CCCTC-binding factor;CTCFL paralog;, PF00096;, GO:0000775;GO:0000793;GO:0005730;GO:0005654;GO:0005634;GO:0043035;GO:0003700;GO:0001227;GO:0000978;GO:0043565;GO:0000976;GO:0008270;GO:0007059;GO:0006306;GO:0071514;GO:0010216;GO:0008285;GO:0000122;GO:0045892;GO:0016584;GO:0010628;GO:0045893;GO:0071459;GO:0070602;GO:0006349;GO:0040029;GO:0035065;GO:0031060;GO:0040030;GO:0006357;, C:chromosome, centromeric region; C:condensed chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin insulator sequence binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:chromosome segregation; P:DNA methylation; P:genetic imprinting; P:maintenance of DNA methylation; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nucleosome positioning; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein localization to chromosome, centromeric region; P:regulation of centromeric sister chromatid cohesion; P:regulation of gene expression by genetic imprinting; P:regulation of gene expression, epigenetic; P:regulation of histone acetylation; P:regulation of histone methylation; P:regulation of molecular function, epigenetic; P:regulation of transcription by RNA polymerase II;|P49711 B5MC38 Q53XI7 Q59EL8,Transcriptional repressor CTCF,11-zinc finger protein;CCCTC-binding factor;CTCFL paralog;, PF00096;, GO:0000775;GO:0000793;GO:0005730;GO:0005654;GO:0005634;GO:0043035;GO:0003700;GO:0001227;GO:0000978;GO:0043565;GO:0000976;GO:0008270;GO:0007059;GO:0006306;GO:0071514;GO:0010216;GO:0008285;GO:0000122;GO:0045892;GO:0016584;GO:0010628;GO:0045893;GO:0071459;GO:0070602;GO:0006349;GO:0040029;GO:0035065;GO:0031060;GO:0040030;GO:0006357;, C:chromosome, centromeric region; C:condensed chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin insulator sequence binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:chromosome segregation; P:DNA methylation; P:genetic imprinting; P:maintenance of DNA methylation; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nucleosome positioning; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein localization to chromosome, centromeric region; P:regulation of centromeric sister chromatid cohesion; P:regulation of gene expression by genetic imprinting; P:regulation of gene expression, epigenetic; P:regulation of histone acetylation; P:regulation of histone methylation; P:regulation of molecular function, epigenetic; P:regulation of transcription by RNA polymerase II;|P49711 B5MC38 Q53XI7 Q59EL8,Transcriptional repressor CTCF,11-zinc finger protein;CCCTC-binding factor;CTCFL paralog;, PF00096;, GO:0000775;GO:0000793;GO:0005730;GO:0005654;GO:0005634;GO:0043035;GO:0003700;GO:0001227;GO:0000978;GO:0043565;GO:0000976;GO:0008270;GO:0007059;GO:0006306;GO:0071514;GO:0010216;GO:0008285;GO:0000122;GO:0045892;GO:0016584;GO:0010628;GO:0045893;GO:0071459;GO:0070602;GO:0006349;GO:0040029;GO:0035065;GO:0031060;GO:0040030;GO:0006357;, C:chromosome, centromeric region; C:condensed chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin insulator sequence binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:chromosome segregation; P:DNA methylation; P:genetic imprinting; P:maintenance of DNA methylation; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nucleosome positioning; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein localization to chromosome, centromeric region; P:regulation of centromeric sister chromatid cohesion; P:regulation of gene expression by genetic imprinting; P:regulation of gene expression, epigenetic; P:regulation of histone acetylation; P:regulation of histone methylation; P:regulation of molecular function, epigenetic; P:regulation of transcription by RNA polymerase II;|P49711 B5MC38 Q53XI7 Q59EL8,Transcriptional repressor CTCF,11-zinc finger protein;CCCTC-binding factor;CTCFL paralog;, PF00096;, GO:0000775;GO:0000793;GO:0005730;GO:0005654;GO:0005634;GO:0043035;GO:0003700;GO:0001227;GO:0000978;GO:0043565;GO:0000976;GO:0008270;GO:0007059;GO:0006306;GO:0071514;GO:0010216;GO:0008285;GO:0000122;GO:0045892;GO:0016584;GO:0010628;GO:0045893;GO:0071459;GO:0070602;GO:0006349;GO:0040029;GO:0035065;GO:0031060;GO:0040030;GO:0006357;, C:chromosome, centromeric region; C:condensed chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin insulator sequence binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:chromosome segregation; P:DNA methylation; P:genetic imprinting; P:maintenance of DNA methylation; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nucleosome positioning; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein localization to chromosome, centromeric region; P:regulation of centromeric sister chromatid cohesion; P:regulation of gene expression by genetic imprinting; P:regulation of gene expression, epigenetic; P:regulation of histone acetylation; P:regulation of histone methylation; P:regulation of molecular function, epigenetic; P:regulation of transcription by RNA polymerase II;|P49711 B5MC38 Q53XI7 Q59EL8,Transcriptional repressor CTCF,11-zinc finger protein;CCCTC-binding factor;CTCFL paralog;, PF00096;, GO:0000775;GO:0000793;GO:0005730;GO:0005654;GO:0005634;GO:0043035;GO:0003700;GO:0001227;GO:0000978;GO:0043565;GO:0000976;GO:0008270;GO:0007059;GO:0006306;GO:0071514;GO:0010216;GO:0008285;GO:0000122;GO:0045892;GO:0016584;GO:0010628;GO:0045893;GO:0071459;GO:0070602;GO:0006349;GO:0040029;GO:0035065;GO:0031060;GO:0040030;GO:0006357;, C:chromosome, centromeric region; C:condensed chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin insulator sequence binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:chromosome segregation; P:DNA methylation; P:genetic imprinting; P:maintenance of DNA methylation; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nucleosome positioning; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein localization to chromosome, centromeric region; P:regulation of centromeric sister chromatid cohesion; P:regulation of gene expression by genetic imprinting; P:regulation of gene expression, epigenetic; P:regulation of histone acetylation; P:regulation of histone methylation; P:regulation of molecular function, epigenetic; P:regulation of transcription by RNA polymerase II;|Q6F5E8 B8X2Z3,Capping protein, Arp2/3 and myosin-I linker protein 2 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker 2 {ECO:0000312|HGNC:HGNC:27089};F-actin-uncapping protein RLTPR {ECO:0000305};Leucine-rich repeat-containing protein 16C;RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein {ECO:0000303|PubMed:15588584};, PF17888;PF16000;PF13516;, GO:0015629;GO:0031252;GO:0005737;GO:0031234;GO:0045111;GO:0030027;GO:0044354;GO:0016020;GO:0005886;GO:0001726;GO:0005543;GO:0044877;GO:0051639;GO:0007163;GO:0061339;GO:0030011;GO:2000813;GO:0030335;GO:0090091;GO:0010592;GO:1902745;GO:1900029;GO:0044319;, C:actin cytoskeleton; C:cell leading edge; C:cytoplasm; C:extrinsic component of cytoplasmic side of plasma membrane; C:intermediate filament cytoskeleton; C:lamellipodium; C:macropinosome; C:membrane; C:plasma membrane; C:ruffle;, F:phospholipid binding; F:protein-containing complex binding;, P:actin filament network formation; P:establishment or maintenance of cell polarity; P:establishment or maintenance of monopolar cell polarity; P:maintenance of cell polarity; P:negative regulation of barbed-end actin filament capping; P:positive regulation of cell migration; P:positive regulation of extracellular matrix disassembly; P:positive regulation of lamellipodium assembly; P:positive regulation of lamellipodium organization; P:positive regulation of ruffle assembly; P:wound healing, spreading of cells;|Q6F5E8 B8X2Z3,Capping protein, Arp2/3 and myosin-I linker protein 2 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker 2 {ECO:0000312|HGNC:HGNC:27089};F-actin-uncapping protein RLTPR {ECO:0000305};Leucine-rich repeat-containing protein 16C;RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein {ECO:0000303|PubMed:15588584};, PF17888;PF16000;PF13516;, GO:0015629;GO:0031252;GO:0005737;GO:0031234;GO:0045111;GO:0030027;GO:0044354;GO:0016020;GO:0005886;GO:0001726;GO:0005543;GO:0044877;GO:0051639;GO:0007163;GO:0061339;GO:0030011;GO:2000813;GO:0030335;GO:0090091;GO:0010592;GO:1902745;GO:1900029;GO:0044319;, C:actin cytoskeleton; C:cell leading edge; C:cytoplasm; C:extrinsic component of cytoplasmic side of plasma membrane; C:intermediate filament cytoskeleton; C:lamellipodium; C:macropinosome; C:membrane; C:plasma membrane; C:ruffle;, F:phospholipid binding; F:protein-containing complex binding;, P:actin filament network formation; P:establishment or maintenance of cell polarity; P:establishment or maintenance of monopolar cell polarity; P:maintenance of cell polarity; P:negative regulation of barbed-end actin filament capping; P:positive regulation of cell migration; P:positive regulation of extracellular matrix disassembly; P:positive regulation of lamellipodium assembly; P:positive regulation of lamellipodium organization; P:positive regulation of ruffle assembly; P:wound healing, spreading of cells;|Q6F5E8 B8X2Z3,Capping protein, Arp2/3 and myosin-I linker protein 2 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker 2 {ECO:0000312|HGNC:HGNC:27089};F-actin-uncapping protein RLTPR {ECO:0000305};Leucine-rich repeat-containing protein 16C;RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein {ECO:0000303|PubMed:15588584};, PF17888;PF16000;PF13516;, GO:0015629;GO:0031252;GO:0005737;GO:0031234;GO:0045111;GO:0030027;GO:0044354;GO:0016020;GO:0005886;GO:0001726;GO:0005543;GO:0044877;GO:0051639;GO:0007163;GO:0061339;GO:0030011;GO:2000813;GO:0030335;GO:0090091;GO:0010592;GO:1902745;GO:1900029;GO:0044319;, C:actin cytoskeleton; C:cell leading edge; C:cytoplasm; C:extrinsic component of cytoplasmic side of plasma membrane; C:intermediate filament cytoskeleton; C:lamellipodium; C:macropinosome; C:membrane; C:plasma membrane; C:ruffle;, F:phospholipid binding; F:protein-containing complex binding;, P:actin filament network formation; P:establishment or maintenance of cell polarity; P:establishment or maintenance of monopolar cell polarity; P:maintenance of cell polarity; P:negative regulation of barbed-end actin filament capping; P:positive regulation of cell migration; P:positive regulation of extracellular matrix disassembly; P:positive regulation of lamellipodium assembly; P:positive regulation of lamellipodium organization; P:positive regulation of ruffle assembly; P:wound healing, spreading of cells;|Q96AP0 A0A0C4DGT6 Q562H5 Q9H8F9,Adrenocortical dysplasia protein homolog {ECO:0000305},POT1 and TIN2-interacting protein;, PF10341;, GO:0000781;GO:0016604;GO:0000783;GO:0005654;GO:0070187;GO:0005697;GO:0070182;GO:0044877;GO:0042162;GO:0045007;GO:0070200;GO:0006886;GO:0048239;GO:0032211;GO:1900051;GO:0060381;GO:0051973;GO:0032212;GO:0031848;GO:0070198;GO:0032202;GO:0016233;GO:0000723;GO:0032201;GO:0007004;, C:chromosome, telomeric region; C:nuclear body; C:nuclear telomere cap complex; C:nucleoplasm; C:shelterin complex; C:telomerase holoenzyme complex;, F:DNA polymerase binding; F:protein-containing complex binding; F:telomeric DNA binding;, P:depurination; P:establishment of protein localization to telomere; P:intracellular protein transport; P:negative regulation of DNA recombination at telomere; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of histone exchange; P:positive regulation of single-stranded telomeric DNA binding; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:protection from non-homologous end joining at telomere; P:protein localization to chromosome, telomeric region; P:telomere assembly; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase;|Q96AP0 A0A0C4DGT6 Q562H5 Q9H8F9,Adrenocortical dysplasia protein homolog {ECO:0000305},POT1 and TIN2-interacting protein;, PF10341;, GO:0000781;GO:0016604;GO:0000783;GO:0005654;GO:0070187;GO:0005697;GO:0070182;GO:0044877;GO:0042162;GO:0045007;GO:0070200;GO:0006886;GO:0048239;GO:0032211;GO:1900051;GO:0060381;GO:0051973;GO:0032212;GO:0031848;GO:0070198;GO:0032202;GO:0016233;GO:0000723;GO:0032201;GO:0007004;, C:chromosome, telomeric region; C:nuclear body; C:nuclear telomere cap complex; C:nucleoplasm; C:shelterin complex; C:telomerase holoenzyme complex;, F:DNA polymerase binding; F:protein-containing complex binding; F:telomeric DNA binding;, P:depurination; P:establishment of protein localization to telomere; P:intracellular protein transport; P:negative regulation of DNA recombination at telomere; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of histone exchange; P:positive regulation of single-stranded telomeric DNA binding; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:protection from non-homologous end joining at telomere; P:protein localization to chromosome, telomeric region; P:telomere assembly; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase;|Q9NPB6 O14911 Q9NPJ7,Partitioning defective 6 homolog alpha,PAR6C;Tax interaction protein 40;, PF00564;PF00595;, GO:0016324;GO:0005923;GO:0005938;GO:0034451;GO:0005813;GO:0005829;GO:0005634;GO:0005886;GO:0001726;GO:0030742;GO:0005080;GO:0031267;GO:0008134;GO:0070830;GO:0051301;GO:0045217;GO:0007098;GO:0007163;GO:0001933;GO:1904781;GO:0050714;GO:0060341;GO:0007179;GO:0016032;GO:0060071;, C:apical plasma membrane; C:bicellular tight junction; C:cell cortex; C:centriolar satellite; C:centrosome; C:cytosol; C:nucleus; C:plasma membrane; C:ruffle;, F:GTP-dependent protein binding; F:protein kinase C binding; F:small GTPase binding; F:transcription factor binding;, P:bicellular tight junction assembly; P:cell division; P:cell-cell junction maintenance; P:centrosome cycle; P:establishment or maintenance of cell polarity; P:negative regulation of protein phosphorylation; P:positive regulation of protein localization to centrosome; P:positive regulation of protein secretion; P:regulation of cellular localization; P:transforming growth factor beta receptor signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9NPB6 O14911 Q9NPJ7,Partitioning defective 6 homolog alpha,PAR6C;Tax interaction protein 40;, PF00564;PF00595;, GO:0016324;GO:0005923;GO:0005938;GO:0034451;GO:0005813;GO:0005829;GO:0005634;GO:0005886;GO:0001726;GO:0030742;GO:0005080;GO:0031267;GO:0008134;GO:0070830;GO:0051301;GO:0045217;GO:0007098;GO:0007163;GO:0001933;GO:1904781;GO:0050714;GO:0060341;GO:0007179;GO:0016032;GO:0060071;, C:apical plasma membrane; C:bicellular tight junction; C:cell cortex; C:centriolar satellite; C:centrosome; C:cytosol; C:nucleus; C:plasma membrane; C:ruffle;, F:GTP-dependent protein binding; F:protein kinase C binding; F:small GTPase binding; F:transcription factor binding;, P:bicellular tight junction assembly; P:cell division; P:cell-cell junction maintenance; P:centrosome cycle; P:establishment or maintenance of cell polarity; P:negative regulation of protein phosphorylation; P:positive regulation of protein localization to centrosome; P:positive regulation of protein secretion; P:regulation of cellular localization; P:transforming growth factor beta receptor signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9H0I2 Q6UWD7,Enkurin domain-containing protein 1,, PF13864;, GO:0097546;GO:0005881;GO:0015630;, C:ciliary base; C:cytoplasmic microtubule; C:microtubule cytoskeleton;|Q9H0I2 Q6UWD7,Enkurin domain-containing protein 1,, PF13864;, GO:0097546;GO:0005881;GO:0015630;, C:ciliary base; C:cytoplasmic microtubule; C:microtubule cytoskeleton;|Q3B7J2 Q69YL9 Q6UXX6 Q7L648 Q8TE86 Q9BQ07 R4GNG5,Glucose-fructose oxidoreductase domain-containing protein 2,, PF01408;PF02894;, GO:0031012;GO:0005576;GO:0016491;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:oxidoreductase activity;, P:extracellular matrix organization;|Q6VN20 A4FTY2 B4DID0 B4DQH9 E7EW27 Q9P264,Ran-binding protein 10,, PF10607;PF08513;PF00622;, GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0007166;GO:0007010;, C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, , P:cell surface receptor signaling pathway; P:cytoskeleton organization;|Q6VN20 A4FTY2 B4DID0 B4DQH9 E7EW27 Q9P264,Ran-binding protein 10,, PF10607;PF08513;PF00622;, GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0007166;GO:0007010;, C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, , P:cell surface receptor signaling pathway; P:cytoskeleton organization;|Q6VN20 A4FTY2 B4DID0 B4DQH9 E7EW27 Q9P264,Ran-binding protein 10,, PF10607;PF08513;PF00622;, GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0007166;GO:0007010;, C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, , P:cell surface receptor signaling pathway; P:cytoskeleton organization;|Q2TAA8 Q9P105,Translin-associated factor X-interacting protein 1,, PF15739;, GO:0005737;GO:0048471;GO:0030154;GO:0007275;GO:0007283;, C:cytoplasm; C:perinuclear region of cytoplasm;, , P:cell differentiation; P:multicellular organism development; P:spermatogenesis;|Q2TAA8 Q9P105,Translin-associated factor X-interacting protein 1,, PF15739;, GO:0005737;GO:0048471;GO:0030154;GO:0007275;GO:0007283;, C:cytoplasm; C:perinuclear region of cytoplasm;, , P:cell differentiation; P:multicellular organism development; P:spermatogenesis;|Q96BT3 Q96I29 Q96IC6 Q96NK9 Q9H901,Centromere protein T,Interphase centromere complex protein 22;, PF15511;PF16171;, GO:0000775;GO:0000778;GO:0005829;GO:0000776;GO:0016604;GO:0005654;GO:0003677;GO:0046982;GO:0051301;GO:0034080;GO:0051276;GO:0007059;GO:0051382;GO:0000278;GO:0007052;GO:1903394;, C:chromosome, centromeric region; C:condensed nuclear chromosome kinetochore; C:cytosol; C:kinetochore; C:nuclear body; C:nucleoplasm;, F:DNA binding; F:protein heterodimerization activity;, P:cell division; P:CENP-A containing nucleosome assembly; P:chromosome organization; P:chromosome segregation; P:kinetochore assembly; P:mitotic cell cycle; P:mitotic spindle organization; P:protein localization to kinetochore involved in kinetochore assembly;|Q96EK4 A4UCT5 A8K002 O94795,THAP domain-containing protein 11,, PF05485;, GO:0000785;GO:0005829;GO:0005654;GO:0003677;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P61970 B2R4G7 P13662 Q6IB67,Nuclear transport factor 2 {ECO:0000303|PubMed:7744965},Placental protein 15 {ECO:0000303|PubMed:3380696};, PF02136;, GO:0005829;GO:0070062;GO:0005637;GO:0031965;GO:0005640;GO:0044613;GO:0005654;GO:0042802;GO:0061608;GO:0031267;GO:0017056;GO:0051028;GO:1904046;GO:0006913;GO:0042307;GO:0006611;GO:0006606;GO:0090204;, C:cytosol; C:extracellular exosome; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nuclear pore central transport channel; C:nucleoplasm;, F:identical protein binding; F:nuclear import signal receptor activity; F:small GTPase binding; F:structural constituent of nuclear pore;, P:mRNA transport; P:negative regulation of vascular endothelial growth factor production; P:nucleocytoplasmic transport; P:positive regulation of protein import into nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein localization to nuclear pore;|P61970 B2R4G7 P13662 Q6IB67,Nuclear transport factor 2 {ECO:0000303|PubMed:7744965},Placental protein 15 {ECO:0000303|PubMed:3380696};, PF02136;, GO:0005829;GO:0070062;GO:0005637;GO:0031965;GO:0005640;GO:0044613;GO:0005654;GO:0042802;GO:0061608;GO:0031267;GO:0017056;GO:0051028;GO:1904046;GO:0006913;GO:0042307;GO:0006611;GO:0006606;GO:0090204;, C:cytosol; C:extracellular exosome; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nuclear pore central transport channel; C:nucleoplasm;, F:identical protein binding; F:nuclear import signal receptor activity; F:small GTPase binding; F:structural constituent of nuclear pore;, P:mRNA transport; P:negative regulation of vascular endothelial growth factor production; P:nucleocytoplasmic transport; P:positive regulation of protein import into nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein localization to nuclear pore;|P61970 B2R4G7 P13662 Q6IB67,Nuclear transport factor 2 {ECO:0000303|PubMed:7744965},Placental protein 15 {ECO:0000303|PubMed:3380696};, PF02136;, GO:0005829;GO:0070062;GO:0005637;GO:0031965;GO:0005640;GO:0044613;GO:0005654;GO:0042802;GO:0061608;GO:0031267;GO:0017056;GO:0051028;GO:1904046;GO:0006913;GO:0042307;GO:0006611;GO:0006606;GO:0090204;, C:cytosol; C:extracellular exosome; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nuclear pore central transport channel; C:nucleoplasm;, F:identical protein binding; F:nuclear import signal receptor activity; F:small GTPase binding; F:structural constituent of nuclear pore;, P:mRNA transport; P:negative regulation of vascular endothelial growth factor production; P:nucleocytoplasmic transport; P:positive regulation of protein import into nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein localization to nuclear pore;|P61970 B2R4G7 P13662 Q6IB67,Nuclear transport factor 2 {ECO:0000303|PubMed:7744965},Placental protein 15 {ECO:0000303|PubMed:3380696};, PF02136;, GO:0005829;GO:0070062;GO:0005637;GO:0031965;GO:0005640;GO:0044613;GO:0005654;GO:0042802;GO:0061608;GO:0031267;GO:0017056;GO:0051028;GO:1904046;GO:0006913;GO:0042307;GO:0006611;GO:0006606;GO:0090204;, C:cytosol; C:extracellular exosome; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nuclear pore central transport channel; C:nucleoplasm;, F:identical protein binding; F:nuclear import signal receptor activity; F:small GTPase binding; F:structural constituent of nuclear pore;, P:mRNA transport; P:negative regulation of vascular endothelial growth factor production; P:nucleocytoplasmic transport; P:positive regulation of protein import into nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein localization to nuclear pore;|P61970 B2R4G7 P13662 Q6IB67,Nuclear transport factor 2 {ECO:0000303|PubMed:7744965},Placental protein 15 {ECO:0000303|PubMed:3380696};, PF02136;, GO:0005829;GO:0070062;GO:0005637;GO:0031965;GO:0005640;GO:0044613;GO:0005654;GO:0042802;GO:0061608;GO:0031267;GO:0017056;GO:0051028;GO:1904046;GO:0006913;GO:0042307;GO:0006611;GO:0006606;GO:0090204;, C:cytosol; C:extracellular exosome; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nuclear pore central transport channel; C:nucleoplasm;, F:identical protein binding; F:nuclear import signal receptor activity; F:small GTPase binding; F:structural constituent of nuclear pore;, P:mRNA transport; P:negative regulation of vascular endothelial growth factor production; P:nucleocytoplasmic transport; P:positive regulation of protein import into nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein localization to nuclear pore;|Q6P2E9 A6NGM1 A8K4T4 Q13025 Q13826 Q6ZR12 Q7Z6H7,Enhancer of mRNA-decapping protein 4,Autoantigen Ge-1;Autoantigen RCD-8;Human enhancer of decapping large subunit;, PF16529;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0031087;GO:0043928;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body;, , P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA;|Q6P2E9 A6NGM1 A8K4T4 Q13025 Q13826 Q6ZR12 Q7Z6H7,Enhancer of mRNA-decapping protein 4,Autoantigen Ge-1;Autoantigen RCD-8;Human enhancer of decapping large subunit;, PF16529;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0031087;GO:0043928;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body;, , P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA;|Q6P2E9 A6NGM1 A8K4T4 Q13025 Q13826 Q6ZR12 Q7Z6H7,Enhancer of mRNA-decapping protein 4,Autoantigen Ge-1;Autoantigen RCD-8;Human enhancer of decapping large subunit;, PF16529;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0031087;GO:0043928;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body;, , P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA;|Q6P2E9 A6NGM1 A8K4T4 Q13025 Q13826 Q6ZR12 Q7Z6H7,Enhancer of mRNA-decapping protein 4,Autoantigen Ge-1;Autoantigen RCD-8;Human enhancer of decapping large subunit;, PF16529;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0031087;GO:0043928;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body;, , P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA;|P11801 Q9NY19,Serine/threonine-protein kinase H1,Protein serine kinase H1;, PF00069;, GO:0005829;GO:0005789;GO:0005794;GO:0005815;GO:0016607;GO:0005886;GO:0005524;GO:0106310;GO:0106311;GO:0007368;GO:0007507;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:microtubule organizing center; C:nuclear speck; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:determination of left/right symmetry; P:heart development;|P40306 B2R5J4 Q5U098,Proteasome subunit beta type-10,Low molecular mass protein 10;Macropain subunit MECl-1;Multicatalytic endopeptidase complex subunit MECl-1;Proteasome MECl-1;Proteasome subunit beta-2i;, PF12465;PF00227;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:1990111;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0000902;GO:0038095;GO:0006959;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0042098;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:spermatoproteasome complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell morphogenesis; P:Fc-epsilon receptor signaling pathway; P:humoral immune response; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell proliferation; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P04180 Q53XQ3,Phosphatidylcholine-sterol acyltransferase,1-alkyl-2-acetylglycerophosphocholine esterase;Lecithin-cholesterol acyltransferase;Phospholipid-cholesterol acyltransferase;Platelet-activating factor acetylhydrolase {ECO:0000303|PubMed:8016111};, PF02450;, GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0003847;GO:0034186;GO:0004607;GO:0047179;GO:0004806;GO:0034435;GO:0042632;GO:0008203;GO:0030301;GO:0034375;GO:0006629;GO:0042158;GO:0006656;GO:0046470;GO:0006644;GO:0090107;GO:0043691;GO:0034372;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:apolipoprotein A-I binding; F:phosphatidylcholine-sterol O-acyltransferase activity; F:platelet-activating factor acetyltransferase activity; F:triglyceride lipase activity;, P:cholesterol esterification; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:high-density lipoprotein particle remodeling; P:lipid metabolic process; P:lipoprotein biosynthetic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylcholine metabolic process; P:phospholipid metabolic process; P:regulation of high-density lipoprotein particle assembly; P:reverse cholesterol transport; P:very-low-density lipoprotein particle remodeling;|P04180 Q53XQ3,Phosphatidylcholine-sterol acyltransferase,1-alkyl-2-acetylglycerophosphocholine esterase;Lecithin-cholesterol acyltransferase;Phospholipid-cholesterol acyltransferase;Platelet-activating factor acetylhydrolase {ECO:0000303|PubMed:8016111};, PF02450;, GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0003847;GO:0034186;GO:0004607;GO:0047179;GO:0004806;GO:0034435;GO:0042632;GO:0008203;GO:0030301;GO:0034375;GO:0006629;GO:0042158;GO:0006656;GO:0046470;GO:0006644;GO:0090107;GO:0043691;GO:0034372;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:apolipoprotein A-I binding; F:phosphatidylcholine-sterol O-acyltransferase activity; F:platelet-activating factor acetyltransferase activity; F:triglyceride lipase activity;, P:cholesterol esterification; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:high-density lipoprotein particle remodeling; P:lipid metabolic process; P:lipoprotein biosynthetic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylcholine metabolic process; P:phospholipid metabolic process; P:regulation of high-density lipoprotein particle assembly; P:reverse cholesterol transport; P:very-low-density lipoprotein particle remodeling;|O75893 Q13953 Q96LD5,Solute carrier family 12 member 4,Electroneutral potassium-chloride cotransporter 1;Erythroid K-Cl cotransporter 1;, PF00324;PF03522;, GO:0005887;GO:0005765;GO:0016020;GO:0005886;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|O75893 Q13953 Q96LD5,Solute carrier family 12 member 4,Electroneutral potassium-chloride cotransporter 1;Erythroid K-Cl cotransporter 1;, PF00324;PF03522;, GO:0005887;GO:0005765;GO:0016020;GO:0005886;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|O75893 Q13953 Q96LD5,Solute carrier family 12 member 4,Electroneutral potassium-chloride cotransporter 1;Erythroid K-Cl cotransporter 1;, PF00324;PF03522;, GO:0005887;GO:0005765;GO:0016020;GO:0005886;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|Q9UHW9 A0AV76 Q2VI00 Q7Z2E7 Q7Z4G5 Q8TDD4 Q9UFR2 Q9Y642 Q9Y665,Solute carrier family 12 member 6,Electroneutral potassium-chloride cotransporter 3;K-Cl cotransporter 3;, PF00324;PF03522;, GO:0016323;GO:0016021;GO:0005887;GO:0005886;GO:0045202;GO:0008519;GO:0015079;GO:0015379;GO:0019901;GO:0140157;GO:0001525;GO:0006884;GO:0071476;GO:0071477;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:angiogenesis; P:cell volume homeostasis; P:cellular hypotonic response; P:cellular hypotonic salinity response; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|O75893 Q13953 Q96LD5,Solute carrier family 12 member 4,Electroneutral potassium-chloride cotransporter 1;Erythroid K-Cl cotransporter 1;, PF00324;PF03522;, GO:0005887;GO:0005765;GO:0016020;GO:0005886;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|O75893 Q13953 Q96LD5,Solute carrier family 12 member 4,Electroneutral potassium-chloride cotransporter 1;Erythroid K-Cl cotransporter 1;, PF00324;PF03522;, GO:0005887;GO:0005765;GO:0016020;GO:0005886;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|O75893 Q13953 Q96LD5,Solute carrier family 12 member 4,Electroneutral potassium-chloride cotransporter 1;Erythroid K-Cl cotransporter 1;, PF00324;PF03522;, GO:0005887;GO:0005765;GO:0016020;GO:0005886;GO:0045202;GO:0008519;GO:0015379;GO:0019901;GO:0140157;GO:0006884;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:cell volume homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|A0A0U1RQF7,DPEP2 neighbor protein|Q9NUL7,Probable ATP-dependent RNA helicase DDX28,Mitochondrial DEAD box protein 28;, PF00270;PF00271;, GO:0005829;GO:0042645;GO:0005739;GO:0005730;GO:0005654;GO:0035770;GO:0005524;GO:0003723;GO:0003724;GO:0019843;GO:1902775;, C:cytosol; C:mitochondrial nucleoid; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:ribonucleoprotein granule;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:rRNA binding;, P:mitochondrial large ribosomal subunit assembly;|Q9NX74 A8K3G3 Q4H4D9,tRNA-dihydrouridine(20) synthase [NAD(P)+]-like,Dihydrouridine synthase 2;Up-regulated in lung cancer protein 8;tRNA-dihydrouridine synthase 2-like;, PF00035;PF01207;, GO:0005737;GO:0005829;GO:0005783;GO:0003725;GO:0050660;GO:0010181;GO:0070402;GO:0004860;GO:0000049;GO:0017150;GO:0102264;GO:0060548;GO:0002943;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum;, F:double-stranded RNA binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADPH binding; F:protein kinase inhibitor activity; F:tRNA binding; F:tRNA dihydrouridine synthase activity; F:tRNA-dihydrouridine20 synthase activity;, P:negative regulation of cell death; P:tRNA dihydrouridine synthesis;|Q9NX74 A8K3G3 Q4H4D9,tRNA-dihydrouridine(20) synthase [NAD(P)+]-like,Dihydrouridine synthase 2;Up-regulated in lung cancer protein 8;tRNA-dihydrouridine synthase 2-like;, PF00035;PF01207;, GO:0005737;GO:0005829;GO:0005783;GO:0003725;GO:0050660;GO:0010181;GO:0070402;GO:0004860;GO:0000049;GO:0017150;GO:0102264;GO:0060548;GO:0002943;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum;, F:double-stranded RNA binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADPH binding; F:protein kinase inhibitor activity; F:tRNA binding; F:tRNA dihydrouridine synthase activity; F:tRNA-dihydrouridine20 synthase activity;, P:negative regulation of cell death; P:tRNA dihydrouridine synthesis;|Q12968 O75211 Q14516 Q99840 Q99841 Q99842,Nuclear factor of activated T-cells, cytoplasmic 3,NFATx;T-cell transcription factor NFAT4 {ECO:0000303|PubMed:7749981};, PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0008134;GO:0033173;GO:0038095;GO:0006954;GO:0007275;GO:1902894;GO:1905064;GO:0045944;GO:0006357;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:calcineurin-NFAT signaling cascade; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:multicellular organism development; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 31293320 31323884 . + . ID=transcript_4129;Q12968 O75211 Q14516 Q99840 Q99841 Q99842,Nuclear factor of activated T-cells, cytoplasmic 3,NFATx;T-cell transcription factor NFAT4 {ECO:0000303|PubMed:7749981};, PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0008134;GO:0033173;GO:0038095;GO:0006954;GO:0007275;GO:1902894;GO:1905064;GO:0045944;GO:0006357;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:calcineurin-NFAT signaling cascade; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:multicellular organism development; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9H6T0 Q8N6H8 Q8WZ15 Q9H6I4,Epithelial splicing regulatory protein 2,RNA-binding motif protein 35B;RNA-binding protein 35B;, , GO:0005654;GO:0005634;GO:1990904;GO:0003729;GO:0003723;GO:0000380;GO:0060445;GO:0060441;GO:0008543;GO:0050679;GO:0043484;, C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:branching involved in salivary gland morphogenesis; P:epithelial tube branching involved in lung morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:positive regulation of epithelial cell proliferation; P:regulation of RNA splicing;|Q8NCC3 B3KMF3 B4DUD1 Q53GZ1 Q9NPQ6 Q9UG04 Q9Y2B3,Phospholipase A2 group XV,1-O-acylceramide synthase {ECO:0000303|PubMed:11790796};LCAT-like lysophospholipase {ECO:0000303|PubMed:10092508};Lysophospholipase 3;Lysosomal phospholipase A and acyltransferase;Lysosomal phospholipase A2 {ECO:0000303|PubMed:11790796, ECO:0000303|PubMed:23958596};, PF02450;, GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005764;GO:0016020;GO:0005654;GO:0052740;GO:0016411;GO:0047499;GO:0004622;GO:0008374;GO:0102545;GO:0052739;GO:0008970;GO:0102567;GO:0102568;GO:0005543;GO:0004806;GO:0008270;GO:0006672;GO:0006651;GO:0009062;GO:0006650;GO:0006629;GO:0034638;GO:0046470;GO:0046338;GO:0046471;GO:0006658;GO:0006644;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:nucleoplasm;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:acylglycerol O-acyltransferase activity; F:calcium-independent phospholipase A2 activity; F:lysophospholipase activity; F:O-acyltransferase activity; F:phosphatidyl phospholipase B activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:phospholipid binding; F:triglyceride lipase activity; F:zinc ion binding;, P:ceramide metabolic process; P:diacylglycerol biosynthetic process; P:fatty acid catabolic process; P:glycerophospholipid metabolic process; P:lipid metabolic process; P:phosphatidylcholine catabolic process; P:phosphatidylcholine metabolic process; P:phosphatidylethanolamine catabolic process; P:phosphatidylglycerol metabolic process; P:phosphatidylserine metabolic process; P:phospholipid metabolic process;|Q8NCC3 B3KMF3 B4DUD1 Q53GZ1 Q9NPQ6 Q9UG04 Q9Y2B3,Phospholipase A2 group XV,1-O-acylceramide synthase {ECO:0000303|PubMed:11790796};LCAT-like lysophospholipase {ECO:0000303|PubMed:10092508};Lysophospholipase 3;Lysosomal phospholipase A and acyltransferase;Lysosomal phospholipase A2 {ECO:0000303|PubMed:11790796, ECO:0000303|PubMed:23958596};, PF02450;, GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005764;GO:0016020;GO:0005654;GO:0052740;GO:0016411;GO:0047499;GO:0004622;GO:0008374;GO:0102545;GO:0052739;GO:0008970;GO:0102567;GO:0102568;GO:0005543;GO:0004806;GO:0008270;GO:0006672;GO:0006651;GO:0009062;GO:0006650;GO:0006629;GO:0034638;GO:0046470;GO:0046338;GO:0046471;GO:0006658;GO:0006644;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:nucleoplasm;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:acylglycerol O-acyltransferase activity; F:calcium-independent phospholipase A2 activity; F:lysophospholipase activity; F:O-acyltransferase activity; F:phosphatidyl phospholipase B activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:phospholipid binding; F:triglyceride lipase activity; F:zinc ion binding;, P:ceramide metabolic process; P:diacylglycerol biosynthetic process; P:fatty acid catabolic process; P:glycerophospholipid metabolic process; P:lipid metabolic process; P:phosphatidylcholine catabolic process; P:phosphatidylcholine metabolic process; P:phosphatidylethanolamine catabolic process; P:phosphatidylglycerol metabolic process; P:phosphatidylserine metabolic process; P:phospholipid metabolic process; scaffold16 indexed_genome mRNA 31324672 31345755 . + . ID=transcript_4130;Q92536 Q68DS4 Q7L1N3,Y+L amino acid transporter 2,Cationic amino acid transporter, y+ system;Solute carrier family 7 member 6;y(+)L-type amino acid transporter 2;, PF13520;, GO:0016323;GO:0005887;GO:0043231;GO:0005886;GO:0015171;GO:0015297;GO:0015174;GO:0015179;GO:0003333;GO:0006865;GO:1990822;GO:0050900;GO:0015822;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:antiporter activity; F:basic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:basic amino acid transmembrane transport; P:leukocyte migration; P:ornithine transport; scaffold16 indexed_genome mRNA 31346522 31362421 . + . ID=transcript_4131;Q92536 Q68DS4 Q7L1N3,Y+L amino acid transporter 2,Cationic amino acid transporter, y+ system;Solute carrier family 7 member 6;y(+)L-type amino acid transporter 2;, PF13520;, GO:0016323;GO:0005887;GO:0043231;GO:0005886;GO:0015171;GO:0015297;GO:0015174;GO:0015179;GO:0003333;GO:0006865;GO:1990822;GO:0050900;GO:0015822;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:antiporter activity; F:basic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:basic amino acid transmembrane transport; P:leukocyte migration; P:ornithine transport;|Q92536 Q68DS4 Q7L1N3,Y+L amino acid transporter 2,Cationic amino acid transporter, y+ system;Solute carrier family 7 member 6;y(+)L-type amino acid transporter 2;, PF13520;, GO:0016323;GO:0005887;GO:0043231;GO:0005886;GO:0015171;GO:0015297;GO:0015174;GO:0015179;GO:0003333;GO:0006865;GO:1990822;GO:0050900;GO:0015822;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:antiporter activity; F:basic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:basic amino acid transmembrane transport; P:leukocyte migration; P:ornithine transport;|Q96CW6 Q8TCZ3 Q9H8R8,Probable RNA polymerase II nuclear localization protein SLC7A6OS,ADAMS proteinase-related protein;Solute carrier family 7 member 6 opposite strand transcript;, PF08574;, GO:0005737;GO:0005634;GO:0032502;GO:0002244;GO:0015031;, C:cytoplasm; C:nucleus;, , P:developmental process; P:hematopoietic progenitor cell differentiation; P:protein transport;|Q96CW6 Q8TCZ3 Q9H8R8,Probable RNA polymerase II nuclear localization protein SLC7A6OS,ADAMS proteinase-related protein;Solute carrier family 7 member 6 opposite strand transcript;, PF08574;, GO:0005737;GO:0005634;GO:0032502;GO:0002244;GO:0015031;, C:cytoplasm; C:nucleus;, , P:developmental process; P:hematopoietic progenitor cell differentiation; P:protein transport;|Q96CW6 Q8TCZ3 Q9H8R8,Probable RNA polymerase II nuclear localization protein SLC7A6OS,ADAMS proteinase-related protein;Solute carrier family 7 member 6 opposite strand transcript;, PF08574;, GO:0005737;GO:0005634;GO:0032502;GO:0002244;GO:0015031;, C:cytoplasm; C:nucleus;, , P:developmental process; P:hematopoietic progenitor cell differentiation; P:protein transport;|Q96CW6 Q8TCZ3 Q9H8R8,Probable RNA polymerase II nuclear localization protein SLC7A6OS,ADAMS proteinase-related protein;Solute carrier family 7 member 6 opposite strand transcript;, PF08574;, GO:0005737;GO:0005634;GO:0032502;GO:0002244;GO:0015031;, C:cytoplasm; C:nucleus;, , P:developmental process; P:hematopoietic progenitor cell differentiation; P:protein transport; scaffold16 indexed_genome mRNA 31362508 31403134 . + . ID=transcript_4132;Q9NVM4 B3KPR0 B3KUG9 B4E379 Q96PV5 Q9H9L0,Protein arginine N-methyltransferase 7,Histone-arginine N-methyltransferase PRMT7;[Myelin basic protein]-arginine N-methyltransferase PRMT7;, , GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0016277;GO:0042393;GO:0044020;GO:0008469;GO:0035241;GO:0035243;GO:0043021;GO:0008757;GO:0030154;GO:0043046;GO:0034969;GO:0016571;GO:0018216;GO:0006349;GO:0043393;GO:0000387;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:[myelin basic protein]-arginine N-methyltransferase activity; F:histone binding; F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity; F:ribonucleoprotein complex binding; F:S-adenosylmethionine-dependent methyltransferase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:histone arginine methylation; P:histone methylation; P:peptidyl-arginine methylation; P:regulation of gene expression by genetic imprinting; P:regulation of protein binding; P:spliceosomal snRNP assembly;|Q9NVM4 B3KPR0 B3KUG9 B4E379 Q96PV5 Q9H9L0,Protein arginine N-methyltransferase 7,Histone-arginine N-methyltransferase PRMT7;[Myelin basic protein]-arginine N-methyltransferase PRMT7;, , GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0016277;GO:0042393;GO:0044020;GO:0008469;GO:0035241;GO:0035243;GO:0043021;GO:0008757;GO:0030154;GO:0043046;GO:0034969;GO:0016571;GO:0018216;GO:0006349;GO:0043393;GO:0000387;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:[myelin basic protein]-arginine N-methyltransferase activity; F:histone binding; F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity; F:ribonucleoprotein complex binding; F:S-adenosylmethionine-dependent methyltransferase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:histone arginine methylation; P:histone methylation; P:peptidyl-arginine methylation; P:regulation of gene expression by genetic imprinting; P:regulation of protein binding; P:spliceosomal snRNP assembly;|Q9NVM4 B3KPR0 B3KUG9 B4E379 Q96PV5 Q9H9L0,Protein arginine N-methyltransferase 7,Histone-arginine N-methyltransferase PRMT7;[Myelin basic protein]-arginine N-methyltransferase PRMT7;, , GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0016277;GO:0042393;GO:0044020;GO:0008469;GO:0035241;GO:0035243;GO:0043021;GO:0008757;GO:0030154;GO:0043046;GO:0034969;GO:0016571;GO:0018216;GO:0006349;GO:0043393;GO:0000387;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:[myelin basic protein]-arginine N-methyltransferase activity; F:histone binding; F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity; F:ribonucleoprotein complex binding; F:S-adenosylmethionine-dependent methyltransferase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:histone arginine methylation; P:histone methylation; P:peptidyl-arginine methylation; P:regulation of gene expression by genetic imprinting; P:regulation of protein binding; P:spliceosomal snRNP assembly;|Q9NVM4 B3KPR0 B3KUG9 B4E379 Q96PV5 Q9H9L0,Protein arginine N-methyltransferase 7,Histone-arginine N-methyltransferase PRMT7;[Myelin basic protein]-arginine N-methyltransferase PRMT7;, , GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0016277;GO:0042393;GO:0044020;GO:0008469;GO:0035241;GO:0035243;GO:0043021;GO:0008757;GO:0030154;GO:0043046;GO:0034969;GO:0016571;GO:0018216;GO:0006349;GO:0043393;GO:0000387;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:[myelin basic protein]-arginine N-methyltransferase activity; F:histone binding; F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity; F:ribonucleoprotein complex binding; F:S-adenosylmethionine-dependent methyltransferase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:histone arginine methylation; P:histone methylation; P:peptidyl-arginine methylation; P:regulation of gene expression by genetic imprinting; P:regulation of protein binding; P:spliceosomal snRNP assembly; scaffold16 indexed_genome mRNA 31405183 31415059 . - . ID=transcript_4133;Q9NY59 B7ZL82 Q2M1S8,Sphingomyelin phosphodiesterase 3 {ECO:0000305},Neutral sphingomyelinase 2;Neutral sphingomyelinase II;, PF03372;, GO:0005737;GO:0005576;GO:0000137;GO:0000139;GO:0005886;GO:0042802;GO:0046872;GO:0061751;GO:0070300;GO:0001786;GO:0004620;GO:0004767;GO:0030509;GO:0098868;GO:0030282;GO:0070301;GO:0071286;GO:0140052;GO:1901653;GO:0071461;GO:0071356;GO:0006672;GO:0003433;GO:0032963;GO:0097187;GO:0071897;GO:0001958;GO:0085029;GO:0070314;GO:0006687;GO:0002244;GO:0048286;GO:0140014;GO:0035264;GO:1900126;GO:0030072;GO:0048008;GO:0015774;GO:2000304;GO:1903543;GO:0045840;GO:0048661;GO:0043491;GO:0061035;GO:0002685;GO:0001932;GO:0090520;GO:0006685;GO:0006684;, C:cytoplasm; C:extracellular region; C:Golgi cis cisterna; C:Golgi membrane; C:plasma membrane;, F:identical protein binding; F:metal ion binding; F:neutral sphingomyelin phosphodiesterase activity; F:phosphatidic acid binding; F:phosphatidylserine binding; F:phospholipase activity; F:sphingomyelin phosphodiesterase activity;, P:BMP signaling pathway; P:bone growth; P:bone mineralization; P:cellular response to hydrogen peroxide; P:cellular response to magnesium ion; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cellular response to peptide; P:cellular response to redox state; P:cellular response to tumor necrosis factor; P:ceramide metabolic process; P:chondrocyte development involved in endochondral bone morphogenesis; P:collagen metabolic process; P:dentinogenesis; P:DNA biosynthetic process; P:endochondral ossification; P:extracellular matrix assembly; P:G1 to G0 transition; P:glycosphingolipid metabolic process; P:hematopoietic progenitor cell differentiation; P:lung alveolus development; P:mitotic nuclear division; P:multicellular organism growth; P:negative regulation of hyaluronan biosynthetic process; P:peptide hormone secretion; P:platelet-derived growth factor receptor signaling pathway; P:polysaccharide transport; P:positive regulation of ceramide biosynthetic process; P:positive regulation of exosomal secretion; P:positive regulation of mitotic nuclear division; P:positive regulation of smooth muscle cell proliferation; P:protein kinase B signaling; P:regulation of cartilage development; P:regulation of leukocyte migration; P:regulation of protein phosphorylation; P:sphingolipid mediated signaling pathway; P:sphingomyelin catabolic process; P:sphingomyelin metabolic process;|Q9NY59 B7ZL82 Q2M1S8,Sphingomyelin phosphodiesterase 3 {ECO:0000305},Neutral sphingomyelinase 2;Neutral sphingomyelinase II;, PF03372;, GO:0005737;GO:0005576;GO:0000137;GO:0000139;GO:0005886;GO:0042802;GO:0046872;GO:0061751;GO:0070300;GO:0001786;GO:0004620;GO:0004767;GO:0030509;GO:0098868;GO:0030282;GO:0070301;GO:0071286;GO:0140052;GO:1901653;GO:0071461;GO:0071356;GO:0006672;GO:0003433;GO:0032963;GO:0097187;GO:0071897;GO:0001958;GO:0085029;GO:0070314;GO:0006687;GO:0002244;GO:0048286;GO:0140014;GO:0035264;GO:1900126;GO:0030072;GO:0048008;GO:0015774;GO:2000304;GO:1903543;GO:0045840;GO:0048661;GO:0043491;GO:0061035;GO:0002685;GO:0001932;GO:0090520;GO:0006685;GO:0006684;, C:cytoplasm; C:extracellular region; C:Golgi cis cisterna; C:Golgi membrane; C:plasma membrane;, F:identical protein binding; F:metal ion binding; F:neutral sphingomyelin phosphodiesterase activity; F:phosphatidic acid binding; F:phosphatidylserine binding; F:phospholipase activity; F:sphingomyelin phosphodiesterase activity;, P:BMP signaling pathway; P:bone growth; P:bone mineralization; P:cellular response to hydrogen peroxide; P:cellular response to magnesium ion; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cellular response to peptide; P:cellular response to redox state; P:cellular response to tumor necrosis factor; P:ceramide metabolic process; P:chondrocyte development involved in endochondral bone morphogenesis; P:collagen metabolic process; P:dentinogenesis; P:DNA biosynthetic process; P:endochondral ossification; P:extracellular matrix assembly; P:G1 to G0 transition; P:glycosphingolipid metabolic process; P:hematopoietic progenitor cell differentiation; P:lung alveolus development; P:mitotic nuclear division; P:multicellular organism growth; P:negative regulation of hyaluronan biosynthetic process; P:peptide hormone secretion; P:platelet-derived growth factor receptor signaling pathway; P:polysaccharide transport; P:positive regulation of ceramide biosynthetic process; P:positive regulation of exosomal secretion; P:positive regulation of mitotic nuclear division; P:positive regulation of smooth muscle cell proliferation; P:protein kinase B signaling; P:regulation of cartilage development; P:regulation of leukocyte migration; P:regulation of protein phosphorylation; P:sphingolipid mediated signaling pathway; P:sphingomyelin catabolic process; P:sphingomyelin metabolic process;|Q9NY59 B7ZL82 Q2M1S8,Sphingomyelin phosphodiesterase 3 {ECO:0000305},Neutral sphingomyelinase 2;Neutral sphingomyelinase II;, PF03372;, GO:0005737;GO:0005576;GO:0000137;GO:0000139;GO:0005886;GO:0042802;GO:0046872;GO:0061751;GO:0070300;GO:0001786;GO:0004620;GO:0004767;GO:0030509;GO:0098868;GO:0030282;GO:0070301;GO:0071286;GO:0140052;GO:1901653;GO:0071461;GO:0071356;GO:0006672;GO:0003433;GO:0032963;GO:0097187;GO:0071897;GO:0001958;GO:0085029;GO:0070314;GO:0006687;GO:0002244;GO:0048286;GO:0140014;GO:0035264;GO:1900126;GO:0030072;GO:0048008;GO:0015774;GO:2000304;GO:1903543;GO:0045840;GO:0048661;GO:0043491;GO:0061035;GO:0002685;GO:0001932;GO:0090520;GO:0006685;GO:0006684;, C:cytoplasm; C:extracellular region; C:Golgi cis cisterna; C:Golgi membrane; C:plasma membrane;, F:identical protein binding; F:metal ion binding; F:neutral sphingomyelin phosphodiesterase activity; F:phosphatidic acid binding; F:phosphatidylserine binding; F:phospholipase activity; F:sphingomyelin phosphodiesterase activity;, P:BMP signaling pathway; P:bone growth; P:bone mineralization; P:cellular response to hydrogen peroxide; P:cellular response to magnesium ion; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cellular response to peptide; P:cellular response to redox state; P:cellular response to tumor necrosis factor; P:ceramide metabolic process; P:chondrocyte development involved in endochondral bone morphogenesis; P:collagen metabolic process; P:dentinogenesis; P:DNA biosynthetic process; P:endochondral ossification; P:extracellular matrix assembly; P:G1 to G0 transition; P:glycosphingolipid metabolic process; P:hematopoietic progenitor cell differentiation; P:lung alveolus development; P:mitotic nuclear division; P:multicellular organism growth; P:negative regulation of hyaluronan biosynthetic process; P:peptide hormone secretion; P:platelet-derived growth factor receptor signaling pathway; P:polysaccharide transport; P:positive regulation of ceramide biosynthetic process; P:positive regulation of exosomal secretion; P:positive regulation of mitotic nuclear division; P:positive regulation of smooth muscle cell proliferation; P:protein kinase B signaling; P:regulation of cartilage development; P:regulation of leukocyte migration; P:regulation of protein phosphorylation; P:sphingolipid mediated signaling pathway; P:sphingomyelin catabolic process; P:sphingomyelin metabolic process; scaffold16 indexed_genome mRNA 31562825 31584522 . + . ID=transcript_4134;Q8TF47 B2RU00 B3KVE7 L7S2P3 Q49AD1 Q96MQ6,Zinc finger protein 90 homolog,Zinc finger protein 756;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0043392;GO:0000122;GO:0045893;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of DNA binding; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 31593843 31596115 . + . ID=transcript_4135;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold16 indexed_genome mRNA 31648348 31677835 . + . ID=transcript_4136;P22223 B2R6F4 Q05DI6,Cadherin-3,Placental cadherin;, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0030054;GO:0005737;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0007155;GO:0098742;GO:0022405;GO:0007156;GO:0031424;GO:0051796;GO:0032912;GO:0090263;GO:0010628;GO:0043568;GO:0010838;GO:0048023;GO:1902910;GO:0032773;GO:0060901;GO:0042493;GO:0001895;GO:0007601;GO:0042060;, C:adherens junction; C:catenin complex; C:cell junction; C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:hair cycle process; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinization; P:negative regulation of timing of catagen; P:negative regulation of transforming growth factor beta2 production; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of keratinocyte proliferation; P:positive regulation of melanin biosynthetic process; P:positive regulation of melanosome transport; P:positive regulation of monophenol monooxygenase activity; P:regulation of hair cycle by canonical Wnt signaling pathway; P:response to drug; P:retina homeostasis; P:visual perception; P:wound healing; scaffold16 indexed_genome mRNA 31679543 31690724 . + . ID=transcript_4137;P22223 B2R6F4 Q05DI6,Cadherin-3,Placental cadherin;, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0030054;GO:0005737;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0007155;GO:0098742;GO:0022405;GO:0007156;GO:0031424;GO:0051796;GO:0032912;GO:0090263;GO:0010628;GO:0043568;GO:0010838;GO:0048023;GO:1902910;GO:0032773;GO:0060901;GO:0042493;GO:0001895;GO:0007601;GO:0042060;, C:adherens junction; C:catenin complex; C:cell junction; C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:hair cycle process; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinization; P:negative regulation of timing of catagen; P:negative regulation of transforming growth factor beta2 production; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of keratinocyte proliferation; P:positive regulation of melanin biosynthetic process; P:positive regulation of melanosome transport; P:positive regulation of monophenol monooxygenase activity; P:regulation of hair cycle by canonical Wnt signaling pathway; P:response to drug; P:retina homeostasis; P:visual perception; P:wound healing; scaffold16 indexed_genome mRNA 31690729 31691521 . - . ID=transcript_4138;P22223 B2R6F4 Q05DI6,Cadherin-3,Placental cadherin;, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0030054;GO:0005737;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0007155;GO:0098742;GO:0022405;GO:0007156;GO:0031424;GO:0051796;GO:0032912;GO:0090263;GO:0010628;GO:0043568;GO:0010838;GO:0048023;GO:1902910;GO:0032773;GO:0060901;GO:0042493;GO:0001895;GO:0007601;GO:0042060;, C:adherens junction; C:catenin complex; C:cell junction; C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:hair cycle process; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinization; P:negative regulation of timing of catagen; P:negative regulation of transforming growth factor beta2 production; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of keratinocyte proliferation; P:positive regulation of melanin biosynthetic process; P:positive regulation of melanosome transport; P:positive regulation of monophenol monooxygenase activity; P:regulation of hair cycle by canonical Wnt signaling pathway; P:response to drug; P:retina homeostasis; P:visual perception; P:wound healing; scaffold16 indexed_genome mRNA 31722669 31794998 . + . ID=transcript_4139;P12830 A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8,Cadherin-1,CAM 120/80;Epithelial cadherin;Uvomorulin;, PF00028;PF01049;PF08758;, GO:0015629;GO:0005912;GO:0043296;GO:0016342;GO:0030054;GO:0005737;GO:0009898;GO:0005768;GO:0070062;GO:0005576;GO:0016600;GO:0098978;GO:0016021;GO:0030027;GO:0016328;GO:0048471;GO:0005886;GO:0098794;GO:0005802;GO:0030506;GO:0008013;GO:0045296;GO:0005509;GO:0050839;GO:0045295;GO:0032794;GO:0042802;GO:0034332;GO:0098609;GO:0098742;GO:0071681;GO:0071285;GO:0035635;GO:0030198;GO:0007156;GO:0030336;GO:0022408;GO:0031175;GO:0021983;GO:0042307;GO:0045893;GO:0072659;GO:0010468;GO:0099576;GO:0042493;GO:0009636;GO:0007416;, C:actin cytoskeleton; C:adherens junction; C:apical junction complex; C:catenin complex; C:cell junction; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:endosome; C:extracellular exosome; C:extracellular region; C:flotillin complex; C:glutamatergic synapse; C:integral component of membrane; C:lamellipodium; C:lateral plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:trans-Golgi network;, F:ankyrin binding; F:beta-catenin binding; F:cadherin binding; F:calcium ion binding; F:cell adhesion molecule binding; F:gamma-catenin binding; F:GTPase activating protein binding; F:identical protein binding;, P:adherens junction organization; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cellular response to indole-3-methanol; P:cellular response to lithium ion; P:entry of bacterium into host cell; P:extracellular matrix organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:neuron projection development; P:pituitary gland development; P:positive regulation of protein import into nucleus; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:regulation of gene expression; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:response to drug; P:response to toxic substance; P:synapse assembly; scaffold16 indexed_genome mRNA 31808731 31977673 . + . ID=transcript_4140;Q9C0B7 Q569F9 Q9H9K1,Transport and Golgi organization protein 6 homolog,Transmembrane and coiled-coil domain-containing protein 7;, PF10363;PF10304;, GO:0016021;GO:0009306;, C:integral component of membrane;, , P:protein secretion; scaffold16 indexed_genome mRNA 31994338 31999121 . + . ID=transcript_4141;O00219 A8K5T5 Q8WTZ0 Q9NYP0,Hyaluronan synthase 3,Hyaluronate synthase 3;Hyaluronic acid synthase 3;, , GO:0005737;GO:0036117;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0050501;GO:0042802;GO:0005975;GO:0085029;GO:0045226;GO:0030213;GO:1900106;GO:0045893;, C:cytoplasm; C:hyaluranon cable; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane;, F:hyaluronan synthase activity; F:identical protein binding;, P:carbohydrate metabolic process; P:extracellular matrix assembly; P:extracellular polysaccharide biosynthetic process; P:hyaluronan biosynthetic process; P:positive regulation of hyaluranon cable assembly; P:positive regulation of transcription, DNA-templated; scaffold16 indexed_genome mRNA 31999230 31999861 . + . ID=transcript_4142;O00219 A8K5T5 Q8WTZ0 Q9NYP0,Hyaluronan synthase 3,Hyaluronate synthase 3;Hyaluronic acid synthase 3;, , GO:0005737;GO:0036117;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0050501;GO:0042802;GO:0005975;GO:0085029;GO:0045226;GO:0030213;GO:1900106;GO:0045893;, C:cytoplasm; C:hyaluranon cable; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane;, F:hyaluronan synthase activity; F:identical protein binding;, P:carbohydrate metabolic process; P:extracellular matrix assembly; P:extracellular polysaccharide biosynthetic process; P:hyaluronan biosynthetic process; P:positive regulation of hyaluranon cable assembly; P:positive regulation of transcription, DNA-templated; scaffold16 indexed_genome mRNA 32002440 32013149 . - . ID=transcript_4143;P0CG12 A8MYX8 Q71E72 Q8NDH8 Q8WV66 Q9NX73,Decreased expression in renal and prostate cancer protein {ECO:0000305},, , GO:0070062;GO:0005654;, C:extracellular exosome; C:nucleoplasm;|P0CG13 A8MYX8 Q71E72 Q8NDH8 Q8WV66 Q9NX73,Chromosome transmission fidelity protein 8 homolog {ECO:0000305},, PF09696;, GO:0031390;GO:0005654;GO:0003677;GO:0032508;GO:0007064;GO:1900264;GO:0032201;, C:Ctf18 RFC-like complex; C:nucleoplasm;, F:DNA binding;, P:DNA duplex unwinding; P:mitotic sister chromatid cohesion; P:positive regulation of DNA-directed DNA polymerase activity; P:telomere maintenance via semi-conservative replication;|P0CG13 A8MYX8 Q71E72 Q8NDH8 Q8WV66 Q9NX73,Chromosome transmission fidelity protein 8 homolog {ECO:0000305},, PF09696;, GO:0031390;GO:0005654;GO:0003677;GO:0032508;GO:0007064;GO:1900264;GO:0032201;, C:Ctf18 RFC-like complex; C:nucleoplasm;, F:DNA binding;, P:DNA duplex unwinding; P:mitotic sister chromatid cohesion; P:positive regulation of DNA-directed DNA polymerase activity; P:telomere maintenance via semi-conservative replication; scaffold16 indexed_genome mRNA 32013198 32040377 . + . ID=transcript_4144;Q969X6 Q8NCD9 Q8TF14 Q96SP0 Q96SR9 Q96SZ9 Q96T13 Q9BWK6,U3 small nucleolar RNA-associated protein 4 homolog,Cirhin;UTP4 small subunit processome component;, PF00400;, GO:0030686;GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030490;GO:0000462;GO:0006355;GO:0006364;, C:90S preribosome; C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of transcription, DNA-templated; P:rRNA processing;|Q969X6 Q8NCD9 Q8TF14 Q96SP0 Q96SR9 Q96SZ9 Q96T13 Q9BWK6,U3 small nucleolar RNA-associated protein 4 homolog,Cirhin;UTP4 small subunit processome component;, PF00400;, GO:0030686;GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030490;GO:0000462;GO:0006355;GO:0006364;, C:90S preribosome; C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of transcription, DNA-templated; P:rRNA processing;|Q969X6 Q8NCD9 Q8TF14 Q96SP0 Q96SR9 Q96SZ9 Q96T13 Q9BWK6,U3 small nucleolar RNA-associated protein 4 homolog,Cirhin;UTP4 small subunit processome component;, PF00400;, GO:0030686;GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030490;GO:0000462;GO:0006355;GO:0006364;, C:90S preribosome; C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of transcription, DNA-templated; P:rRNA processing;|Q969X6 Q8NCD9 Q8TF14 Q96SP0 Q96SR9 Q96SZ9 Q96T13 Q9BWK6,U3 small nucleolar RNA-associated protein 4 homolog,Cirhin;UTP4 small subunit processome component;, PF00400;, GO:0030686;GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030490;GO:0000462;GO:0006355;GO:0006364;, C:90S preribosome; C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of transcription, DNA-templated; P:rRNA processing; scaffold16 indexed_genome mRNA 32134326 32144025 . - . ID=transcript_4145;Q9UN37 B2RCB7 Q8TF07 Q9UI03 Q9Y582,Vacuolar protein sorting-associated protein 4A {ECO:0000305},Protein SKD2;VPS4-1;, PF00004;PF17862;PF04212;PF09336;, GO:0005813;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0090543;GO:0005770;GO:0031902;GO:0005764;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0000922;GO:0005774;GO:0005524;GO:0016887;GO:0008022;GO:0019904;GO:0044877;GO:0009838;GO:0000916;GO:0051301;GO:0061640;GO:0016197;GO:0034058;GO:1904896;GO:1904903;GO:0032367;GO:0061738;GO:0016236;GO:0061952;GO:0044878;GO:0007080;GO:0007084;GO:0036258;GO:0032466;GO:0006998;GO:0031468;GO:0006997;GO:1903543;GO:1903774;GO:1903902;GO:1902188;GO:0006622;GO:0032880;GO:1903076;GO:0043162;GO:0090611;GO:0007033;GO:0006900;GO:0072319;GO:0016192;GO:0039702;GO:0019058;GO:0016032;GO:0019076;, C:centrosome; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:Flemming body; C:late endosome; C:late endosome membrane; C:lysosome; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle pole; C:vacuolar membrane;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding;, P:abscission; P:actomyosin contractile ring contraction; P:cell division; P:cytoskeleton-dependent cytokinesis; P:endosomal transport; P:endosomal vesicle fusion; P:ESCRT complex disassembly; P:ESCRT III complex disassembly; P:intracellular cholesterol transport; P:late endosomal microautophagy; P:macroautophagy; P:midbody abscission; P:mitotic cytokinesis checkpoint; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of cytokinesis; P:nuclear envelope organization; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of exosomal secretion; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral life cycle; P:positive regulation of viral release from host cell; P:protein targeting to lysosome; P:regulation of protein localization; P:regulation of protein localization to plasma membrane; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:vacuole organization; P:vesicle budding from membrane; P:vesicle uncoating; P:vesicle-mediated transport; P:viral budding via host ESCRT complex; P:viral life cycle; P:viral process; P:viral release from host cell;|Q9UN37 B2RCB7 Q8TF07 Q9UI03 Q9Y582,Vacuolar protein sorting-associated protein 4A {ECO:0000305},Protein SKD2;VPS4-1;, PF00004;PF17862;PF04212;PF09336;, GO:0005813;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0090543;GO:0005770;GO:0031902;GO:0005764;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0000922;GO:0005774;GO:0005524;GO:0016887;GO:0008022;GO:0019904;GO:0044877;GO:0009838;GO:0000916;GO:0051301;GO:0061640;GO:0016197;GO:0034058;GO:1904896;GO:1904903;GO:0032367;GO:0061738;GO:0016236;GO:0061952;GO:0044878;GO:0007080;GO:0007084;GO:0036258;GO:0032466;GO:0006998;GO:0031468;GO:0006997;GO:1903543;GO:1903774;GO:1903902;GO:1902188;GO:0006622;GO:0032880;GO:1903076;GO:0043162;GO:0090611;GO:0007033;GO:0006900;GO:0072319;GO:0016192;GO:0039702;GO:0019058;GO:0016032;GO:0019076;, C:centrosome; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:Flemming body; C:late endosome; C:late endosome membrane; C:lysosome; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle pole; C:vacuolar membrane;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding;, P:abscission; P:actomyosin contractile ring contraction; P:cell division; P:cytoskeleton-dependent cytokinesis; P:endosomal transport; P:endosomal vesicle fusion; P:ESCRT complex disassembly; P:ESCRT III complex disassembly; P:intracellular cholesterol transport; P:late endosomal microautophagy; P:macroautophagy; P:midbody abscission; P:mitotic cytokinesis checkpoint; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of cytokinesis; P:nuclear envelope organization; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of exosomal secretion; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral life cycle; P:positive regulation of viral release from host cell; P:protein targeting to lysosome; P:regulation of protein localization; P:regulation of protein localization to plasma membrane; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:vacuole organization; P:vesicle budding from membrane; P:vesicle uncoating; P:vesicle-mediated transport; P:viral budding via host ESCRT complex; P:viral life cycle; P:viral process; P:viral release from host cell;|Q9UN37 B2RCB7 Q8TF07 Q9UI03 Q9Y582,Vacuolar protein sorting-associated protein 4A {ECO:0000305},Protein SKD2;VPS4-1;, PF00004;PF17862;PF04212;PF09336;, GO:0005813;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0090543;GO:0005770;GO:0031902;GO:0005764;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0000922;GO:0005774;GO:0005524;GO:0016887;GO:0008022;GO:0019904;GO:0044877;GO:0009838;GO:0000916;GO:0051301;GO:0061640;GO:0016197;GO:0034058;GO:1904896;GO:1904903;GO:0032367;GO:0061738;GO:0016236;GO:0061952;GO:0044878;GO:0007080;GO:0007084;GO:0036258;GO:0032466;GO:0006998;GO:0031468;GO:0006997;GO:1903543;GO:1903774;GO:1903902;GO:1902188;GO:0006622;GO:0032880;GO:1903076;GO:0043162;GO:0090611;GO:0007033;GO:0006900;GO:0072319;GO:0016192;GO:0039702;GO:0019058;GO:0016032;GO:0019076;, C:centrosome; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:Flemming body; C:late endosome; C:late endosome membrane; C:lysosome; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle pole; C:vacuolar membrane;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding;, P:abscission; P:actomyosin contractile ring contraction; P:cell division; P:cytoskeleton-dependent cytokinesis; P:endosomal transport; P:endosomal vesicle fusion; P:ESCRT complex disassembly; P:ESCRT III complex disassembly; P:intracellular cholesterol transport; P:late endosomal microautophagy; P:macroautophagy; P:midbody abscission; P:mitotic cytokinesis checkpoint; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of cytokinesis; P:nuclear envelope organization; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of exosomal secretion; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral life cycle; P:positive regulation of viral release from host cell; P:protein targeting to lysosome; P:regulation of protein localization; P:regulation of protein localization to plasma membrane; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:vacuole organization; P:vesicle budding from membrane; P:vesicle uncoating; P:vesicle-mediated transport; P:viral budding via host ESCRT complex; P:viral life cycle; P:viral process; P:viral release from host cell;|Q9UN37 B2RCB7 Q8TF07 Q9UI03 Q9Y582,Vacuolar protein sorting-associated protein 4A {ECO:0000305},Protein SKD2;VPS4-1;, PF00004;PF17862;PF04212;PF09336;, GO:0005813;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0090543;GO:0005770;GO:0031902;GO:0005764;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0000922;GO:0005774;GO:0005524;GO:0016887;GO:0008022;GO:0019904;GO:0044877;GO:0009838;GO:0000916;GO:0051301;GO:0061640;GO:0016197;GO:0034058;GO:1904896;GO:1904903;GO:0032367;GO:0061738;GO:0016236;GO:0061952;GO:0044878;GO:0007080;GO:0007084;GO:0036258;GO:0032466;GO:0006998;GO:0031468;GO:0006997;GO:1903543;GO:1903774;GO:1903902;GO:1902188;GO:0006622;GO:0032880;GO:1903076;GO:0043162;GO:0090611;GO:0007033;GO:0006900;GO:0072319;GO:0016192;GO:0039702;GO:0019058;GO:0016032;GO:0019076;, C:centrosome; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:Flemming body; C:late endosome; C:late endosome membrane; C:lysosome; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle pole; C:vacuolar membrane;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding;, P:abscission; P:actomyosin contractile ring contraction; P:cell division; P:cytoskeleton-dependent cytokinesis; P:endosomal transport; P:endosomal vesicle fusion; P:ESCRT complex disassembly; P:ESCRT III complex disassembly; P:intracellular cholesterol transport; P:late endosomal microautophagy; P:macroautophagy; P:midbody abscission; P:mitotic cytokinesis checkpoint; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of cytokinesis; P:nuclear envelope organization; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of exosomal secretion; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral life cycle; P:positive regulation of viral release from host cell; P:protein targeting to lysosome; P:regulation of protein localization; P:regulation of protein localization to plasma membrane; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:vacuole organization; P:vesicle budding from membrane; P:vesicle uncoating; P:vesicle-mediated transport; P:viral budding via host ESCRT complex; P:viral life cycle; P:viral process; P:viral release from host cell;|Q9UN37 B2RCB7 Q8TF07 Q9UI03 Q9Y582,Vacuolar protein sorting-associated protein 4A {ECO:0000305},Protein SKD2;VPS4-1;, PF00004;PF17862;PF04212;PF09336;, GO:0005813;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0090543;GO:0005770;GO:0031902;GO:0005764;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0000922;GO:0005774;GO:0005524;GO:0016887;GO:0008022;GO:0019904;GO:0044877;GO:0009838;GO:0000916;GO:0051301;GO:0061640;GO:0016197;GO:0034058;GO:1904896;GO:1904903;GO:0032367;GO:0061738;GO:0016236;GO:0061952;GO:0044878;GO:0007080;GO:0007084;GO:0036258;GO:0032466;GO:0006998;GO:0031468;GO:0006997;GO:1903543;GO:1903774;GO:1903902;GO:1902188;GO:0006622;GO:0032880;GO:1903076;GO:0043162;GO:0090611;GO:0007033;GO:0006900;GO:0072319;GO:0016192;GO:0039702;GO:0019058;GO:0016032;GO:0019076;, C:centrosome; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:Flemming body; C:late endosome; C:late endosome membrane; C:lysosome; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle pole; C:vacuolar membrane;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding;, P:abscission; P:actomyosin contractile ring contraction; P:cell division; P:cytoskeleton-dependent cytokinesis; P:endosomal transport; P:endosomal vesicle fusion; P:ESCRT complex disassembly; P:ESCRT III complex disassembly; P:intracellular cholesterol transport; P:late endosomal microautophagy; P:macroautophagy; P:midbody abscission; P:mitotic cytokinesis checkpoint; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of cytokinesis; P:nuclear envelope organization; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of exosomal secretion; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral life cycle; P:positive regulation of viral release from host cell; P:protein targeting to lysosome; P:regulation of protein localization; P:regulation of protein localization to plasma membrane; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:vacuole organization; P:vesicle budding from membrane; P:vesicle uncoating; P:vesicle-mediated transport; P:viral budding via host ESCRT complex; P:viral life cycle; P:viral process; P:viral release from host cell; scaffold16 indexed_genome mRNA 32144040 32187837 . - . ID=transcript_4146;Q9HBH1 Q8WUN6,Peptide deformylase, mitochondrial,Polypeptide deformylase;, PF01327;, GO:0005739;GO:0046872;GO:0042586;GO:0043686;GO:0031365;GO:0018206;GO:0008284;GO:0006412;, C:mitochondrion;, F:metal ion binding; F:peptide deformylase activity;, P:co-translational protein modification; P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:positive regulation of cell population proliferation; P:translation;|Q9HBH1 Q8WUN6,Peptide deformylase, mitochondrial,Polypeptide deformylase;, PF01327;, GO:0005739;GO:0046872;GO:0042586;GO:0043686;GO:0031365;GO:0018206;GO:0008284;GO:0006412;, C:mitochondrion;, F:metal ion binding; F:peptide deformylase activity;, P:co-translational protein modification; P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:positive regulation of cell population proliferation; P:translation;|Q96MW5 Q0VAK2 Q8WVV6 Q9H6F8,Conserved oligomeric Golgi complex subunit 8,Component of oligomeric Golgi complex 8;, PF04124;, GO:0005794;GO:0000139;GO:0017119;GO:0016020;GO:0032588;GO:0006888;GO:0006891;GO:0015031;, C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q96MW5 Q0VAK2 Q8WVV6 Q9H6F8,Conserved oligomeric Golgi complex subunit 8,Component of oligomeric Golgi complex 8;, PF04124;, GO:0005794;GO:0000139;GO:0017119;GO:0016020;GO:0032588;GO:0006888;GO:0006891;GO:0015031;, C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q96MW5 Q0VAK2 Q8WVV6 Q9H6F8,Conserved oligomeric Golgi complex subunit 8,Component of oligomeric Golgi complex 8;, PF04124;, GO:0005794;GO:0000139;GO:0017119;GO:0016020;GO:0032588;GO:0006888;GO:0006891;GO:0015031;, C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q96MW5 Q0VAK2 Q8WVV6 Q9H6F8,Conserved oligomeric Golgi complex subunit 8,Component of oligomeric Golgi complex 8;, PF04124;, GO:0005794;GO:0000139;GO:0017119;GO:0016020;GO:0032588;GO:0006888;GO:0006891;GO:0015031;, C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q9Y221 B2RD04 Q9NZZ0,60S ribosome subunit biogenesis protein NIP7 homolog,KD93;, PF03657;PF17833;, GO:0005829;GO:0005730;GO:0005654;GO:0030687;GO:0003723;GO:0042273;GO:0042255;, C:cytosol; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:RNA binding;, P:ribosomal large subunit biogenesis; P:ribosome assembly;|Q9Y221 B2RD04 Q9NZZ0,60S ribosome subunit biogenesis protein NIP7 homolog,KD93;, PF03657;PF17833;, GO:0005829;GO:0005730;GO:0005654;GO:0030687;GO:0003723;GO:0042273;GO:0042255;, C:cytosol; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:RNA binding;, P:ribosomal large subunit biogenesis; P:ribosome assembly;|Q8WW62 Q6UXN5,Transmembrane emp24 domain-containing protein 6,p24 family protein gamma-5;, PF01105;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0016021;GO:0006888;GO:0007030;GO:0006886;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport;|Q8WW62 Q6UXN5,Transmembrane emp24 domain-containing protein 6,p24 family protein gamma-5;, PF01105;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0016021;GO:0006888;GO:0007030;GO:0006886;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport;|Q15554,Telomeric repeat-binding factor 2,TTAGGG repeat-binding factor 2;Telomeric DNA-binding protein;, PF00249;PF16772;PF08558;, GO:1904115;GO:0000781;GO:0001673;GO:0016604;GO:0000783;GO:0005654;GO:0005634;GO:0070187;GO:0003691;GO:0019899;GO:0098505;GO:0008022;GO:0042803;GO:0044877;GO:0042162;GO:0099087;GO:0090398;GO:0045007;GO:0001701;GO:1903770;GO:2000773;GO:0048239;GO:1905778;GO:0010629;GO:1904430;GO:1904354;GO:0032205;GO:0032208;GO:0032214;GO:0032211;GO:1904357;GO:1903824;GO:1905839;GO:0010628;GO:1900051;GO:0051000;GO:0032206;GO:0031848;GO:0070198;GO:0032204;GO:0032210;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0061820;GO:0031627;, C:axon cytoplasm; C:chromosome, telomeric region; C:male germ cell nucleus; C:nuclear body; C:nuclear telomere cap complex; C:nucleoplasm; C:nucleus; C:shelterin complex;, F:double-stranded telomeric DNA binding; F:enzyme binding; F:G-rich strand telomeric DNA binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric DNA binding;, P:anterograde axonal transport of messenger ribonucleoprotein complex; P:cellular senescence; P:depurination; P:in utero embryonic development; P:negative regulation of beta-galactosidase activity; P:negative regulation of cellular senescence; P:negative regulation of DNA recombination at telomere; P:negative regulation of exonuclease activity; P:negative regulation of gene expression; P:negative regulation of t-circle formation; P:negative regulation of telomere capping; P:negative regulation of telomere maintenance; P:negative regulation of telomere maintenance via recombination; P:negative regulation of telomere maintenance via semi-conservative replication; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of telomere single strand break repair; P:negative regulation of telomeric D-loop disassembly; P:positive regulation of gene expression; P:positive regulation of histone exchange; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of telomere maintenance; P:protection from non-homologous end joining at telomere; P:protein localization to chromosome, telomeric region; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomeric D-loop disassembly; P:telomeric loop formation;|Q15554,Telomeric repeat-binding factor 2,TTAGGG repeat-binding factor 2;Telomeric DNA-binding protein;, PF00249;PF16772;PF08558;, GO:1904115;GO:0000781;GO:0001673;GO:0016604;GO:0000783;GO:0005654;GO:0005634;GO:0070187;GO:0003691;GO:0019899;GO:0098505;GO:0008022;GO:0042803;GO:0044877;GO:0042162;GO:0099087;GO:0090398;GO:0045007;GO:0001701;GO:1903770;GO:2000773;GO:0048239;GO:1905778;GO:0010629;GO:1904430;GO:1904354;GO:0032205;GO:0032208;GO:0032214;GO:0032211;GO:1904357;GO:1903824;GO:1905839;GO:0010628;GO:1900051;GO:0051000;GO:0032206;GO:0031848;GO:0070198;GO:0032204;GO:0032210;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0061820;GO:0031627;, C:axon cytoplasm; C:chromosome, telomeric region; C:male germ cell nucleus; C:nuclear body; C:nuclear telomere cap complex; C:nucleoplasm; C:nucleus; C:shelterin complex;, F:double-stranded telomeric DNA binding; F:enzyme binding; F:G-rich strand telomeric DNA binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric DNA binding;, P:anterograde axonal transport of messenger ribonucleoprotein complex; P:cellular senescence; P:depurination; P:in utero embryonic development; P:negative regulation of beta-galactosidase activity; P:negative regulation of cellular senescence; P:negative regulation of DNA recombination at telomere; P:negative regulation of exonuclease activity; P:negative regulation of gene expression; P:negative regulation of t-circle formation; P:negative regulation of telomere capping; P:negative regulation of telomere maintenance; P:negative regulation of telomere maintenance via recombination; P:negative regulation of telomere maintenance via semi-conservative replication; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of telomere single strand break repair; P:negative regulation of telomeric D-loop disassembly; P:positive regulation of gene expression; P:positive regulation of histone exchange; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of telomere maintenance; P:protection from non-homologous end joining at telomere; P:protein localization to chromosome, telomeric region; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomeric D-loop disassembly; P:telomeric loop formation;|Q15554,Telomeric repeat-binding factor 2,TTAGGG repeat-binding factor 2;Telomeric DNA-binding protein;, PF00249;PF16772;PF08558;, GO:1904115;GO:0000781;GO:0001673;GO:0016604;GO:0000783;GO:0005654;GO:0005634;GO:0070187;GO:0003691;GO:0019899;GO:0098505;GO:0008022;GO:0042803;GO:0044877;GO:0042162;GO:0099087;GO:0090398;GO:0045007;GO:0001701;GO:1903770;GO:2000773;GO:0048239;GO:1905778;GO:0010629;GO:1904430;GO:1904354;GO:0032205;GO:0032208;GO:0032214;GO:0032211;GO:1904357;GO:1903824;GO:1905839;GO:0010628;GO:1900051;GO:0051000;GO:0032206;GO:0031848;GO:0070198;GO:0032204;GO:0032210;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0061820;GO:0031627;, C:axon cytoplasm; C:chromosome, telomeric region; C:male germ cell nucleus; C:nuclear body; C:nuclear telomere cap complex; C:nucleoplasm; C:nucleus; C:shelterin complex;, F:double-stranded telomeric DNA binding; F:enzyme binding; F:G-rich strand telomeric DNA binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric DNA binding;, P:anterograde axonal transport of messenger ribonucleoprotein complex; P:cellular senescence; P:depurination; P:in utero embryonic development; P:negative regulation of beta-galactosidase activity; P:negative regulation of cellular senescence; P:negative regulation of DNA recombination at telomere; P:negative regulation of exonuclease activity; P:negative regulation of gene expression; P:negative regulation of t-circle formation; P:negative regulation of telomere capping; P:negative regulation of telomere maintenance; P:negative regulation of telomere maintenance via recombination; P:negative regulation of telomere maintenance via semi-conservative replication; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of telomere single strand break repair; P:negative regulation of telomeric D-loop disassembly; P:positive regulation of gene expression; P:positive regulation of histone exchange; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of telomere maintenance; P:protection from non-homologous end joining at telomere; P:protein localization to chromosome, telomeric region; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomeric D-loop disassembly; P:telomeric loop formation;|Q15554,Telomeric repeat-binding factor 2,TTAGGG repeat-binding factor 2;Telomeric DNA-binding protein;, PF00249;PF16772;PF08558;, GO:1904115;GO:0000781;GO:0001673;GO:0016604;GO:0000783;GO:0005654;GO:0005634;GO:0070187;GO:0003691;GO:0019899;GO:0098505;GO:0008022;GO:0042803;GO:0044877;GO:0042162;GO:0099087;GO:0090398;GO:0045007;GO:0001701;GO:1903770;GO:2000773;GO:0048239;GO:1905778;GO:0010629;GO:1904430;GO:1904354;GO:0032205;GO:0032208;GO:0032214;GO:0032211;GO:1904357;GO:1903824;GO:1905839;GO:0010628;GO:1900051;GO:0051000;GO:0032206;GO:0031848;GO:0070198;GO:0032204;GO:0032210;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0061820;GO:0031627;, C:axon cytoplasm; C:chromosome, telomeric region; C:male germ cell nucleus; C:nuclear body; C:nuclear telomere cap complex; C:nucleoplasm; C:nucleus; C:shelterin complex;, F:double-stranded telomeric DNA binding; F:enzyme binding; F:G-rich strand telomeric DNA binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric DNA binding;, P:anterograde axonal transport of messenger ribonucleoprotein complex; P:cellular senescence; P:depurination; P:in utero embryonic development; P:negative regulation of beta-galactosidase activity; P:negative regulation of cellular senescence; P:negative regulation of DNA recombination at telomere; P:negative regulation of exonuclease activity; P:negative regulation of gene expression; P:negative regulation of t-circle formation; P:negative regulation of telomere capping; P:negative regulation of telomere maintenance; P:negative regulation of telomere maintenance via recombination; P:negative regulation of telomere maintenance via semi-conservative replication; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of telomere single strand break repair; P:negative regulation of telomeric D-loop disassembly; P:positive regulation of gene expression; P:positive regulation of histone exchange; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of telomere maintenance; P:protection from non-homologous end joining at telomere; P:protein localization to chromosome, telomeric region; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomeric D-loop disassembly; P:telomeric loop formation;|Q15554,Telomeric repeat-binding factor 2,TTAGGG repeat-binding factor 2;Telomeric DNA-binding protein;, PF00249;PF16772;PF08558;, GO:1904115;GO:0000781;GO:0001673;GO:0016604;GO:0000783;GO:0005654;GO:0005634;GO:0070187;GO:0003691;GO:0019899;GO:0098505;GO:0008022;GO:0042803;GO:0044877;GO:0042162;GO:0099087;GO:0090398;GO:0045007;GO:0001701;GO:1903770;GO:2000773;GO:0048239;GO:1905778;GO:0010629;GO:1904430;GO:1904354;GO:0032205;GO:0032208;GO:0032214;GO:0032211;GO:1904357;GO:1903824;GO:1905839;GO:0010628;GO:1900051;GO:0051000;GO:0032206;GO:0031848;GO:0070198;GO:0032204;GO:0032210;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0061820;GO:0031627;, C:axon cytoplasm; C:chromosome, telomeric region; C:male germ cell nucleus; C:nuclear body; C:nuclear telomere cap complex; C:nucleoplasm; C:nucleus; C:shelterin complex;, F:double-stranded telomeric DNA binding; F:enzyme binding; F:G-rich strand telomeric DNA binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric DNA binding;, P:anterograde axonal transport of messenger ribonucleoprotein complex; P:cellular senescence; P:depurination; P:in utero embryonic development; P:negative regulation of beta-galactosidase activity; P:negative regulation of cellular senescence; P:negative regulation of DNA recombination at telomere; P:negative regulation of exonuclease activity; P:negative regulation of gene expression; P:negative regulation of t-circle formation; P:negative regulation of telomere capping; P:negative regulation of telomere maintenance; P:negative regulation of telomere maintenance via recombination; P:negative regulation of telomere maintenance via semi-conservative replication; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of telomere single strand break repair; P:negative regulation of telomeric D-loop disassembly; P:positive regulation of gene expression; P:positive regulation of histone exchange; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of telomere maintenance; P:protection from non-homologous end joining at telomere; P:protein localization to chromosome, telomeric region; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomeric D-loop disassembly; P:telomeric loop formation; scaffold16 indexed_genome mRNA 32230986 32255292 . + . ID=transcript_4147;O43169 A8K6B1 J3KNF8 Q96CC3 Q9BT35,Cytochrome b5 type B,Cytochrome b5 outer mitochondrial membrane isoform;, PF00173;, GO:0016021;GO:0043231;GO:0016020;GO:0005741;GO:1903958;GO:0009055;GO:0008047;GO:0020037;GO:0046872;GO:0006809;GO:0006979;GO:0006805;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane; C:nitric-oxide synthase complex;, F:electron transfer activity; F:enzyme activator activity; F:heme binding; F:metal ion binding;, P:nitric oxide biosynthetic process; P:response to oxidative stress; P:xenobiotic metabolic process;|O43169 A8K6B1 J3KNF8 Q96CC3 Q9BT35,Cytochrome b5 type B,Cytochrome b5 outer mitochondrial membrane isoform;, PF00173;, GO:0016021;GO:0043231;GO:0016020;GO:0005741;GO:1903958;GO:0009055;GO:0008047;GO:0020037;GO:0046872;GO:0006809;GO:0006979;GO:0006805;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane; C:nitric-oxide synthase complex;, F:electron transfer activity; F:enzyme activator activity; F:heme binding; F:metal ion binding;, P:nitric oxide biosynthetic process; P:response to oxidative stress; P:xenobiotic metabolic process;|O43169 A8K6B1 J3KNF8 Q96CC3 Q9BT35,Cytochrome b5 type B,Cytochrome b5 outer mitochondrial membrane isoform;, PF00173;, GO:0016021;GO:0043231;GO:0016020;GO:0005741;GO:1903958;GO:0009055;GO:0008047;GO:0020037;GO:0046872;GO:0006809;GO:0006979;GO:0006805;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane; C:nitric-oxide synthase complex;, F:electron transfer activity; F:enzyme activator activity; F:heme binding; F:metal ion binding;, P:nitric oxide biosynthetic process; P:response to oxidative stress; P:xenobiotic metabolic process; scaffold16 indexed_genome mRNA 32392611 32448017 . + . ID=transcript_4148;O94916 A2RRB4 A6H8V5 E9PHR7 O95693 Q7LA65 Q969Q8 Q96QH3 Q9UN18,Nuclear factor of activated T-cells 5,T-cell transcription factor NFAT5;Tonicity-responsive enhancer-binding protein {ECO:0000303|PubMed:10051678};, PF16179;PF00554;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0033173;GO:0071345;GO:0007588;GO:1904996;GO:1901224;GO:0045944;GO:0070884;GO:0006357;GO:0006970;GO:0007165;GO:0006366;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:calcineurin-NFAT signaling cascade; P:cellular response to cytokine stimulus; P:excretion; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of calcineurin-NFAT signaling cascade; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress; P:signal transduction; P:transcription by RNA polymerase II;|O94916 A2RRB4 A6H8V5 E9PHR7 O95693 Q7LA65 Q969Q8 Q96QH3 Q9UN18,Nuclear factor of activated T-cells 5,T-cell transcription factor NFAT5;Tonicity-responsive enhancer-binding protein {ECO:0000303|PubMed:10051678};, PF16179;PF00554;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0033173;GO:0071345;GO:0007588;GO:1904996;GO:1901224;GO:0045944;GO:0070884;GO:0006357;GO:0006970;GO:0007165;GO:0006366;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:calcineurin-NFAT signaling cascade; P:cellular response to cytokine stimulus; P:excretion; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of calcineurin-NFAT signaling cascade; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress; P:signal transduction; P:transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 32454327 32468008 . - . ID=transcript_4149;P15559 B2R5Y9 B4DNM7 B7ZAD1 Q86UK1,NAD(P)H dehydrogenase [quinone] 1,Azoreductase;DT-diaphorase;Menadione reductase;NAD(P)H:quinone oxidoreductase 1;Phylloquinone reductase;Quinone reductase 1;, PF02525;, GO:0005737;GO:0005829;GO:0030425;GO:0043025;GO:0045202;GO:0004128;GO:0042802;GO:0003955;GO:0050136;GO:0008753;GO:0003723;GO:0004784;GO:0007568;GO:0045454;GO:0070301;GO:0071248;GO:0006116;GO:0070995;GO:0043066;GO:0043086;GO:0006809;GO:0043525;GO:0006521;GO:0043279;GO:0014075;GO:0009743;GO:0042493;GO:0051602;GO:0032355;GO:0045471;GO:1905395;GO:0009725;GO:1904880;GO:0002931;GO:1904844;GO:0007584;GO:0006979;GO:0033574;GO:1904772;GO:0009636;GO:0007271;GO:0006805;, C:cytoplasm; C:cytosol; C:dendrite; C:neuronal cell body; C:synapse;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:identical protein binding; F:NAD(P)H dehydrogenase (quinone) activity; F:NADH dehydrogenase (quinone) activity; F:NADPH dehydrogenase (quinone) activity; F:RNA binding; F:superoxide dismutase activity;, P:aging; P:cell redox homeostasis; P:cellular response to hydrogen peroxide; P:cellular response to metal ion; P:NADH oxidation; P:NADPH oxidation; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:nitric oxide biosynthetic process; P:positive regulation of neuron apoptotic process; P:regulation of cellular amino acid metabolic process; P:response to alkaloid; P:response to amine; P:response to carbohydrate; P:response to drug; P:response to electrical stimulus; P:response to estradiol; P:response to ethanol; P:response to flavonoid; P:response to hormone; P:response to hydrogen sulfide; P:response to ischemia; P:response to L-glutamine; P:response to nutrient; P:response to oxidative stress; P:response to testosterone; P:response to tetrachloromethane; P:response to toxic substance; P:synaptic transmission, cholinergic; P:xenobiotic metabolic process;|P15559 B2R5Y9 B4DNM7 B7ZAD1 Q86UK1,NAD(P)H dehydrogenase [quinone] 1,Azoreductase;DT-diaphorase;Menadione reductase;NAD(P)H:quinone oxidoreductase 1;Phylloquinone reductase;Quinone reductase 1;, PF02525;, GO:0005737;GO:0005829;GO:0030425;GO:0043025;GO:0045202;GO:0004128;GO:0042802;GO:0003955;GO:0050136;GO:0008753;GO:0003723;GO:0004784;GO:0007568;GO:0045454;GO:0070301;GO:0071248;GO:0006116;GO:0070995;GO:0043066;GO:0043086;GO:0006809;GO:0043525;GO:0006521;GO:0043279;GO:0014075;GO:0009743;GO:0042493;GO:0051602;GO:0032355;GO:0045471;GO:1905395;GO:0009725;GO:1904880;GO:0002931;GO:1904844;GO:0007584;GO:0006979;GO:0033574;GO:1904772;GO:0009636;GO:0007271;GO:0006805;, C:cytoplasm; C:cytosol; C:dendrite; C:neuronal cell body; C:synapse;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:identical protein binding; F:NAD(P)H dehydrogenase (quinone) activity; F:NADH dehydrogenase (quinone) activity; F:NADPH dehydrogenase (quinone) activity; F:RNA binding; F:superoxide dismutase activity;, P:aging; P:cell redox homeostasis; P:cellular response to hydrogen peroxide; P:cellular response to metal ion; P:NADH oxidation; P:NADPH oxidation; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:nitric oxide biosynthetic process; P:positive regulation of neuron apoptotic process; P:regulation of cellular amino acid metabolic process; P:response to alkaloid; P:response to amine; P:response to carbohydrate; P:response to drug; P:response to electrical stimulus; P:response to estradiol; P:response to ethanol; P:response to flavonoid; P:response to hormone; P:response to hydrogen sulfide; P:response to ischemia; P:response to L-glutamine; P:response to nutrient; P:response to oxidative stress; P:response to testosterone; P:response to tetrachloromethane; P:response to toxic substance; P:synaptic transmission, cholinergic; P:xenobiotic metabolic process; scaffold16 indexed_genome mRNA 32482088 32489700 . - . ID=transcript_4150;Q9ULX3 Q7L6B7 Q7M4M4 Q7Z4B5 Q9NWB0,RNA-binding protein NOB1,Phosphorylation regulatory protein HP-10;Protein ART-4;, PF08772;PF17146;PF15017;, GO:0005829;GO:0005654;GO:0030688;GO:0004521;GO:0046872;GO:0000469;GO:0030490;GO:0006364;GO:0007601;, C:cytosol; C:nucleoplasm; C:preribosome, small subunit precursor;, F:endoribonuclease activity; F:metal ion binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA; P:rRNA processing; P:visual perception;|Q9ULX3 Q7L6B7 Q7M4M4 Q7Z4B5 Q9NWB0,RNA-binding protein NOB1,Phosphorylation regulatory protein HP-10;Protein ART-4;, PF08772;PF17146;PF15017;, GO:0005829;GO:0005654;GO:0030688;GO:0004521;GO:0046872;GO:0000469;GO:0030490;GO:0006364;GO:0007601;, C:cytosol; C:nucleoplasm; C:preribosome, small subunit precursor;, F:endoribonuclease activity; F:metal ion binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA; P:rRNA processing; P:visual perception;|Q9ULX3 Q7L6B7 Q7M4M4 Q7Z4B5 Q9NWB0,RNA-binding protein NOB1,Phosphorylation regulatory protein HP-10;Protein ART-4;, PF08772;PF17146;PF15017;, GO:0005829;GO:0005654;GO:0030688;GO:0004521;GO:0046872;GO:0000469;GO:0030490;GO:0006364;GO:0007601;, C:cytosol; C:nucleoplasm; C:preribosome, small subunit precursor;, F:endoribonuclease activity; F:metal ion binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA; P:rRNA processing; P:visual perception;|Q9ULX3 Q7L6B7 Q7M4M4 Q7Z4B5 Q9NWB0,RNA-binding protein NOB1,Phosphorylation regulatory protein HP-10;Protein ART-4;, PF08772;PF17146;PF15017;, GO:0005829;GO:0005654;GO:0030688;GO:0004521;GO:0046872;GO:0000469;GO:0030490;GO:0006364;GO:0007601;, C:cytosol; C:nucleoplasm; C:preribosome, small subunit precursor;, F:endoribonuclease activity; F:metal ion binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA; P:rRNA processing; P:visual perception;|Q9ULX3 Q7L6B7 Q7M4M4 Q7Z4B5 Q9NWB0,RNA-binding protein NOB1,Phosphorylation regulatory protein HP-10;Protein ART-4;, PF08772;PF17146;PF15017;, GO:0005829;GO:0005654;GO:0030688;GO:0004521;GO:0046872;GO:0000469;GO:0030490;GO:0006364;GO:0007601;, C:cytosol; C:nucleoplasm; C:preribosome, small subunit precursor;, F:endoribonuclease activity; F:metal ion binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA; P:rRNA processing; P:visual perception;|Q9ULX3 Q7L6B7 Q7M4M4 Q7Z4B5 Q9NWB0,RNA-binding protein NOB1,Phosphorylation regulatory protein HP-10;Protein ART-4;, PF08772;PF17146;PF15017;, GO:0005829;GO:0005654;GO:0030688;GO:0004521;GO:0046872;GO:0000469;GO:0030490;GO:0006364;GO:0007601;, C:cytosol; C:nucleoplasm; C:preribosome, small subunit precursor;, F:endoribonuclease activity; F:metal ion binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA; P:rRNA processing; P:visual perception;|Q9ULX3 Q7L6B7 Q7M4M4 Q7Z4B5 Q9NWB0,RNA-binding protein NOB1,Phosphorylation regulatory protein HP-10;Protein ART-4;, PF08772;PF17146;PF15017;, GO:0005829;GO:0005654;GO:0030688;GO:0004521;GO:0046872;GO:0000469;GO:0030490;GO:0006364;GO:0007601;, C:cytosol; C:nucleoplasm; C:preribosome, small subunit precursor;, F:endoribonuclease activity; F:metal ion binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA; P:rRNA processing; P:visual perception; scaffold16 indexed_genome mRNA 32490354 32491618 . - . ID=transcript_4151;Q9ULX3 Q7L6B7 Q7M4M4 Q7Z4B5 Q9NWB0,RNA-binding protein NOB1,Phosphorylation regulatory protein HP-10;Protein ART-4;, PF08772;PF17146;PF15017;, GO:0005829;GO:0005654;GO:0030688;GO:0004521;GO:0046872;GO:0000469;GO:0030490;GO:0006364;GO:0007601;, C:cytosol; C:nucleoplasm; C:preribosome, small subunit precursor;, F:endoribonuclease activity; F:metal ion binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA; P:rRNA processing; P:visual perception; scaffold16 indexed_genome mRNA 32517181 32645419 . + . ID=transcript_4152;Q9BWN6,NEDD4-like E3 ubiquitin-protein ligase WWP2,Atrophin-1-interacting protein 2;HECT-type E3 ubiquitin transferase WWP2;WW domain-containing protein 2;, PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0000151;GO:0001085;GO:0008134;GO:0061630;GO:0004842;GO:0006464;GO:0006858;GO:0043433;GO:0010629;GO:0045746;GO:0051224;GO:0000122;GO:0045892;GO:0032410;GO:0045732;GO:0043161;GO:0051865;GO:0070534;GO:0000209;GO:0016567;GO:0034765;GO:0042391;GO:1901016;GO:0046718;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus; C:ubiquitin ligase complex;, F:RNA polymerase II transcription factor binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:extracellular transport; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of protein transport; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:regulation of potassium ion transmembrane transporter activity; P:viral entry into host cell;|Q9BWN6,NEDD4-like E3 ubiquitin-protein ligase WWP2,Atrophin-1-interacting protein 2;HECT-type E3 ubiquitin transferase WWP2;WW domain-containing protein 2;, PF00632;PF00397;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0000151;GO:0001085;GO:0008134;GO:0061630;GO:0004842;GO:0006464;GO:0006858;GO:0043433;GO:0010629;GO:0045746;GO:0051224;GO:0000122;GO:0045892;GO:0032410;GO:0045732;GO:0043161;GO:0051865;GO:0070534;GO:0000209;GO:0016567;GO:0034765;GO:0042391;GO:1901016;GO:0046718;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus; C:ubiquitin ligase complex;, F:RNA polymerase II transcription factor binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:extracellular transport; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of protein transport; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:regulation of potassium ion transmembrane transporter activity; P:viral entry into host cell; scaffold16 indexed_genome mRNA 32654649 32663779 . - . ID=transcript_4153;P51665 D3DWS9 Q6PKI2 Q96E97,26S proteasome non-ATPase regulatory subunit 7,26S proteasome regulatory subunit RPN8;26S proteasome regulatory subunit S12;Mov34 protein homolog;Proteasome subunit p40;, PF01398;PF13012;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000502;GO:0005838;GO:0034774;GO:0070122;GO:0042803;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome regulatory particle; C:secretory granule lumen;, F:isopeptidase activity; F:protein homodimerization activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P51665 D3DWS9 Q6PKI2 Q96E97,26S proteasome non-ATPase regulatory subunit 7,26S proteasome regulatory subunit RPN8;26S proteasome regulatory subunit S12;Mov34 protein homolog;Proteasome subunit p40;, PF01398;PF13012;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000502;GO:0005838;GO:0034774;GO:0070122;GO:0042803;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome regulatory particle; C:secretory granule lumen;, F:isopeptidase activity; F:protein homodimerization activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P51665 D3DWS9 Q6PKI2 Q96E97,26S proteasome non-ATPase regulatory subunit 7,26S proteasome regulatory subunit RPN8;26S proteasome regulatory subunit S12;Mov34 protein homolog;Proteasome subunit p40;, PF01398;PF13012;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000502;GO:0005838;GO:0034774;GO:0070122;GO:0042803;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome regulatory particle; C:secretory granule lumen;, F:isopeptidase activity; F:protein homodimerization activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold16 indexed_genome mRNA 33822324 33823689 . + . ID=transcript_4154;Q15911 D3DWS8 O15101 Q13719 Q6ZP98,Zinc finger homeobox protein 3,AT motif-binding factor 1;AT-binding transcription factor 1;Alpha-fetoprotein enhancer-binding protein;Zinc finger homeodomain protein 3;, PF00046;PF00096;, GO:0000785;GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0000978;GO:0000976;GO:0008270;GO:0007420;GO:0007050;GO:0032922;GO:0007517;GO:0045662;GO:0000122;GO:0045785;GO:0045663;GO:0045944;GO:0045893;GO:1904059;GO:0045664;GO:0006357;GO:0006355;GO:0071559;, C:chromatin; C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:brain development; P:cell cycle arrest; P:circadian regulation of gene expression; P:muscle organ development; P:negative regulation of myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell adhesion; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of locomotor rhythm; P:regulation of neuron differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to transforming growth factor beta; scaffold16 indexed_genome mRNA 33823698 33824724 . + . ID=transcript_4155;Q15911 D3DWS8 O15101 Q13719 Q6ZP98,Zinc finger homeobox protein 3,AT motif-binding factor 1;AT-binding transcription factor 1;Alpha-fetoprotein enhancer-binding protein;Zinc finger homeodomain protein 3;, PF00046;PF00096;, GO:0000785;GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0000978;GO:0000976;GO:0008270;GO:0007420;GO:0007050;GO:0032922;GO:0007517;GO:0045662;GO:0000122;GO:0045785;GO:0045663;GO:0045944;GO:0045893;GO:1904059;GO:0045664;GO:0006357;GO:0006355;GO:0071559;, C:chromatin; C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:brain development; P:cell cycle arrest; P:circadian regulation of gene expression; P:muscle organ development; P:negative regulation of myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell adhesion; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of locomotor rhythm; P:regulation of neuron differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to transforming growth factor beta; scaffold16 indexed_genome mRNA 33824793 33970142 . + . ID=transcript_4156;Q15911 D3DWS8 O15101 Q13719 Q6ZP98,Zinc finger homeobox protein 3,AT motif-binding factor 1;AT-binding transcription factor 1;Alpha-fetoprotein enhancer-binding protein;Zinc finger homeodomain protein 3;, PF00046;PF00096;, GO:0000785;GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0000978;GO:0000976;GO:0008270;GO:0007420;GO:0007050;GO:0032922;GO:0007517;GO:0045662;GO:0000122;GO:0045785;GO:0045663;GO:0045944;GO:0045893;GO:1904059;GO:0045664;GO:0006357;GO:0006355;GO:0071559;, C:chromatin; C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:brain development; P:cell cycle arrest; P:circadian regulation of gene expression; P:muscle organ development; P:negative regulation of myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell adhesion; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of locomotor rhythm; P:regulation of neuron differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to transforming growth factor beta;|Q15911 D3DWS8 O15101 Q13719 Q6ZP98,Zinc finger homeobox protein 3,AT motif-binding factor 1;AT-binding transcription factor 1;Alpha-fetoprotein enhancer-binding protein;Zinc finger homeodomain protein 3;, PF00046;PF00096;, GO:0000785;GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0000978;GO:0000976;GO:0008270;GO:0007420;GO:0007050;GO:0032922;GO:0007517;GO:0045662;GO:0000122;GO:0045785;GO:0045663;GO:0045944;GO:0045893;GO:1904059;GO:0045664;GO:0006357;GO:0006355;GO:0071559;, C:chromatin; C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:brain development; P:cell cycle arrest; P:circadian regulation of gene expression; P:muscle organ development; P:negative regulation of myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell adhesion; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of locomotor rhythm; P:regulation of neuron differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to transforming growth factor beta; scaffold16 indexed_genome mRNA 33970158 33980076 . + . ID=transcript_4157;Q15911 D3DWS8 O15101 Q13719 Q6ZP98,Zinc finger homeobox protein 3,AT motif-binding factor 1;AT-binding transcription factor 1;Alpha-fetoprotein enhancer-binding protein;Zinc finger homeodomain protein 3;, PF00046;PF00096;, GO:0000785;GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0000978;GO:0000976;GO:0008270;GO:0007420;GO:0007050;GO:0032922;GO:0007517;GO:0045662;GO:0000122;GO:0045785;GO:0045663;GO:0045944;GO:0045893;GO:1904059;GO:0045664;GO:0006357;GO:0006355;GO:0071559;, C:chromatin; C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:brain development; P:cell cycle arrest; P:circadian regulation of gene expression; P:muscle organ development; P:negative regulation of myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell adhesion; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of locomotor rhythm; P:regulation of neuron differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to transforming growth factor beta; scaffold16 indexed_genome mRNA 34560896 34564981 . + . ID=transcript_4158;Q8TBY8 B3KVI9 G3V1Q7 H7BY07 Q8NA09 Q9BY16 Q9H0H4,Polyamine-modulated factor 1-binding protein 1,, , GO:0005737;GO:0097224;GO:0007283;, C:cytoplasm; C:sperm connecting piece;, , P:spermatogenesis; scaffold16 indexed_genome mRNA 34568961 34570382 . + . ID=transcript_4159;Q8TBY8 B3KVI9 G3V1Q7 H7BY07 Q8NA09 Q9BY16 Q9H0H4,Polyamine-modulated factor 1-binding protein 1,, , GO:0005737;GO:0097224;GO:0007283;, C:cytoplasm; C:sperm connecting piece;, , P:spermatogenesis; scaffold16 indexed_genome mRNA 34572883 34623062 . - . ID=transcript_4160;Q92620 B4DVG8 D3DWS7 O75212 Q96HN7,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16,ATP-dependent RNA helicase DHX38;DEAH box protein 38;, PF00270;PF04408;PF00271;PF07717;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0005524;GO:0003723;GO:0003724;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus;|Q92620 B4DVG8 D3DWS7 O75212 Q96HN7,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16,ATP-dependent RNA helicase DHX38;DEAH box protein 38;, PF00270;PF04408;PF00271;PF07717;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0005681;GO:0005524;GO:0003723;GO:0003724;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus;|Q9NX01 D3DWS6,Thioredoxin-like protein 4B,Dim1-like protein;, PF02966;, GO:0005829;GO:0005654;GO:0005681;GO:0046540;GO:0005682;GO:0007049;GO:0000398;, C:cytosol; C:nucleoplasm; C:spliceosomal complex; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, , P:cell cycle; P:mRNA splicing, via spliceosome;|Q9NX01 D3DWS6,Thioredoxin-like protein 4B,Dim1-like protein;, PF02966;, GO:0005829;GO:0005654;GO:0005681;GO:0046540;GO:0005682;GO:0007049;GO:0000398;, C:cytosol; C:nucleoplasm; C:spliceosomal complex; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, , P:cell cycle; P:mRNA splicing, via spliceosome;|P00738 B0AZL5 P00737 Q0VAC4 Q0VAC5 Q2PP15 Q3B7J0 Q6LBY9 Q9UC67,Haptoglobin,Zonulin;, PF00089;, GO:0072562;GO:0071682;GO:0070062;GO:0005576;GO:0005615;GO:0031838;GO:0035580;GO:1904724;GO:0016209;GO:0030492;GO:0004252;GO:0002526;GO:0006953;GO:0006952;GO:0042742;GO:2000296;GO:0051354;GO:0043312;GO:0010942;GO:0006898;GO:0042542;GO:0031638;, C:blood microparticle; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:haptoglobin-hemoglobin complex; C:specific granule lumen; C:tertiary granule lumen;, F:antioxidant activity; F:hemoglobin binding; F:serine-type endopeptidase activity;, P:acute inflammatory response; P:acute-phase response; P:defense response; P:defense response to bacterium; P:negative regulation of hydrogen peroxide catabolic process; P:negative regulation of oxidoreductase activity; P:neutrophil degranulation; P:positive regulation of cell death; P:receptor-mediated endocytosis; P:response to hydrogen peroxide; P:zymogen activation; scaffold16 indexed_genome mRNA 34637962 34647565 . - . ID=transcript_4161;Q02127 A8K8C8 Q6P176,Dihydroorotate dehydrogenase (quinone), mitochondrial,Dihydroorotate oxidase;, PF01180;, GO:0005829;GO:0016021;GO:0005743;GO:0005739;GO:0043025;GO:0005654;GO:0004152;GO:0008144;GO:0010181;GO:0048039;GO:0006207;GO:0044205;GO:0007565;GO:0007595;GO:0043065;GO:0046134;GO:0009220;GO:0090140;GO:0031000;GO:0042493;GO:1903576;GO:0042594;, C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:neuronal cell body; C:nucleoplasm;, F:dihydroorotate dehydrogenase activity; F:drug binding; F:FMN binding; F:ubiquinone binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:female pregnancy; P:lactation; P:positive regulation of apoptotic process; P:pyrimidine nucleoside biosynthetic process; P:pyrimidine ribonucleotide biosynthetic process; P:regulation of mitochondrial fission; P:response to caffeine; P:response to drug; P:response to L-arginine; P:response to starvation;|Q02127 A8K8C8 Q6P176,Dihydroorotate dehydrogenase (quinone), mitochondrial,Dihydroorotate oxidase;, PF01180;, GO:0005829;GO:0016021;GO:0005743;GO:0005739;GO:0043025;GO:0005654;GO:0004152;GO:0008144;GO:0010181;GO:0048039;GO:0006207;GO:0044205;GO:0007565;GO:0007595;GO:0043065;GO:0046134;GO:0009220;GO:0090140;GO:0031000;GO:0042493;GO:1903576;GO:0042594;, C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:neuronal cell body; C:nucleoplasm;, F:dihydroorotate dehydrogenase activity; F:drug binding; F:FMN binding; F:ubiquinone binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:female pregnancy; P:lactation; P:positive regulation of apoptotic process; P:pyrimidine nucleoside biosynthetic process; P:pyrimidine ribonucleotide biosynthetic process; P:regulation of mitochondrial fission; P:response to caffeine; P:response to drug; P:response to L-arginine; P:response to starvation; scaffold16 indexed_genome mRNA 34690615 34691522 . + . ID=transcript_4162;Q7Z443,Polycystic kidney disease protein 1-like 3,PC1-like 3 protein;Polycystin-1L3;, PF01825;PF00059;PF08016;PF01477;, GO:0034703;GO:0070062;GO:0016020;GO:0005886;GO:0043235;GO:0005262;GO:0030246;GO:0006812;GO:0071468;GO:0001581;GO:0050982;GO:0001822;GO:0050915;, C:cation channel complex; C:extracellular exosome; C:membrane; C:plasma membrane; C:receptor complex;, F:calcium channel activity; F:carbohydrate binding;, P:cation transport; P:cellular response to acidic pH; P:detection of chemical stimulus involved in sensory perception of sour taste; P:detection of mechanical stimulus; P:kidney development; P:sensory perception of sour taste; scaffold16 indexed_genome mRNA 34701200 34712794 . + . ID=transcript_4163;Q7Z442 Q6UEE1 Q6ZN46 Q6ZSP2 Q8N1H9 Q96CL2 Q96Q08,Polycystic kidney disease protein 1-like 2,PC1-like 2 protein;Polycystin-1L2;, PF02140;PF01825;PF00059;PF08016;PF01477;PF02010;, GO:0016021;GO:0016020;GO:0005262;GO:0005509;GO:0030246;GO:0050982;, C:integral component of membrane; C:membrane;, F:calcium channel activity; F:calcium ion binding; F:carbohydrate binding;, P:detection of mechanical stimulus; scaffold16 indexed_genome mRNA 34715914 34721268 . + . ID=transcript_4164;Q7Z443,Polycystic kidney disease protein 1-like 3,PC1-like 3 protein;Polycystin-1L3;, PF01825;PF00059;PF08016;PF01477;, GO:0034703;GO:0070062;GO:0016020;GO:0005886;GO:0043235;GO:0005262;GO:0030246;GO:0006812;GO:0071468;GO:0001581;GO:0050982;GO:0001822;GO:0050915;, C:cation channel complex; C:extracellular exosome; C:membrane; C:plasma membrane; C:receptor complex;, F:calcium channel activity; F:carbohydrate binding;, P:cation transport; P:cellular response to acidic pH; P:detection of chemical stimulus involved in sensory perception of sour taste; P:detection of mechanical stimulus; P:kidney development; P:sensory perception of sour taste; scaffold16 indexed_genome mRNA 34771993 34783659 . + . ID=transcript_4165;O75541 A6NK48 B4DKK4 D3DWS3,Zinc finger protein 821,, , GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|O75541 A6NK48 B4DKK4 D3DWS3,Zinc finger protein 821,, , GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|O75541 A6NK48 B4DKK4 D3DWS3,Zinc finger protein 821,, , GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 34784747 34790009 . - . ID=transcript_4166;O75541 A6NK48 B4DKK4 D3DWS3,Zinc finger protein 821,, , GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|O75541 A6NK48 B4DKK4 D3DWS3,Zinc finger protein 821,, , GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 34796742 34802513 . - . ID=transcript_4167;P0C7T5,Ataxin-1-like,Brother of ataxin-1;, PF08517;, GO:0030425;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0048856;GO:0007420;GO:0030198;GO:0007612;GO:0048286;GO:0007613;GO:0000122;GO:1902035;GO:0006355;GO:0035176;, C:dendrite; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding;, P:anatomical structure development; P:brain development; P:extracellular matrix organization; P:learning; P:lung alveolus development; P:memory; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hematopoietic stem cell proliferation; P:regulation of transcription, DNA-templated; P:social behavior; scaffold16 indexed_genome mRNA 34822055 34899285 . + . ID=transcript_4168;O43747 O75709 O75842 Q9UG09 Q9Y3U4,AP-1 complex subunit gamma-1,Adaptor protein complex AP-1 subunit gamma-1;Adaptor-related protein complex 1 subunit gamma-1;Clathrin assembly protein complex 1 gamma-1 large chain;Gamma1-adaptin;Golgi adaptor HA1/AP1 adaptin subunit gamma-1;, PF01602;PF02883;, GO:0030121;GO:0030136;GO:0030665;GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0055037;GO:0032588;GO:0140312;GO:0035615;GO:0030742;GO:0019894;GO:0031267;GO:0019886;GO:0035646;GO:0090160;GO:0006896;GO:0006886;GO:0032438;GO:0043323;GO:0045954;GO:0006892;GO:0006898;GO:0050690;, C:AP-1 adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:recycling endosome; C:trans-Golgi network membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:GTP-dependent protein binding; F:kinesin binding; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endosome to melanosome transport; P:Golgi to lysosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:positive regulation of natural killer cell degranulation; P:positive regulation of natural killer cell mediated cytotoxicity; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus;|O43747 O75709 O75842 Q9UG09 Q9Y3U4,AP-1 complex subunit gamma-1,Adaptor protein complex AP-1 subunit gamma-1;Adaptor-related protein complex 1 subunit gamma-1;Clathrin assembly protein complex 1 gamma-1 large chain;Gamma1-adaptin;Golgi adaptor HA1/AP1 adaptin subunit gamma-1;, PF01602;PF02883;, GO:0030121;GO:0030136;GO:0030665;GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0055037;GO:0032588;GO:0140312;GO:0035615;GO:0030742;GO:0019894;GO:0031267;GO:0019886;GO:0035646;GO:0090160;GO:0006896;GO:0006886;GO:0032438;GO:0043323;GO:0045954;GO:0006892;GO:0006898;GO:0050690;, C:AP-1 adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:recycling endosome; C:trans-Golgi network membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:GTP-dependent protein binding; F:kinesin binding; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endosome to melanosome transport; P:Golgi to lysosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:positive regulation of natural killer cell degranulation; P:positive regulation of natural killer cell mediated cytotoxicity; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus;|O43747 O75709 O75842 Q9UG09 Q9Y3U4,AP-1 complex subunit gamma-1,Adaptor protein complex AP-1 subunit gamma-1;Adaptor-related protein complex 1 subunit gamma-1;Clathrin assembly protein complex 1 gamma-1 large chain;Gamma1-adaptin;Golgi adaptor HA1/AP1 adaptin subunit gamma-1;, PF01602;PF02883;, GO:0030121;GO:0030136;GO:0030665;GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0055037;GO:0032588;GO:0140312;GO:0035615;GO:0030742;GO:0019894;GO:0031267;GO:0019886;GO:0035646;GO:0090160;GO:0006896;GO:0006886;GO:0032438;GO:0043323;GO:0045954;GO:0006892;GO:0006898;GO:0050690;, C:AP-1 adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:recycling endosome; C:trans-Golgi network membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:GTP-dependent protein binding; F:kinesin binding; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endosome to melanosome transport; P:Golgi to lysosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:positive regulation of natural killer cell degranulation; P:positive regulation of natural killer cell mediated cytotoxicity; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus;|O43747 O75709 O75842 Q9UG09 Q9Y3U4,AP-1 complex subunit gamma-1,Adaptor protein complex AP-1 subunit gamma-1;Adaptor-related protein complex 1 subunit gamma-1;Clathrin assembly protein complex 1 gamma-1 large chain;Gamma1-adaptin;Golgi adaptor HA1/AP1 adaptin subunit gamma-1;, PF01602;PF02883;, GO:0030121;GO:0030136;GO:0030665;GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0055037;GO:0032588;GO:0140312;GO:0035615;GO:0030742;GO:0019894;GO:0031267;GO:0019886;GO:0035646;GO:0090160;GO:0006896;GO:0006886;GO:0032438;GO:0043323;GO:0045954;GO:0006892;GO:0006898;GO:0050690;, C:AP-1 adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:recycling endosome; C:trans-Golgi network membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:GTP-dependent protein binding; F:kinesin binding; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endosome to melanosome transport; P:Golgi to lysosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:positive regulation of natural killer cell degranulation; P:positive regulation of natural killer cell mediated cytotoxicity; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus;|O43747 O75709 O75842 Q9UG09 Q9Y3U4,AP-1 complex subunit gamma-1,Adaptor protein complex AP-1 subunit gamma-1;Adaptor-related protein complex 1 subunit gamma-1;Clathrin assembly protein complex 1 gamma-1 large chain;Gamma1-adaptin;Golgi adaptor HA1/AP1 adaptin subunit gamma-1;, PF01602;PF02883;, GO:0030121;GO:0030136;GO:0030665;GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0055037;GO:0032588;GO:0140312;GO:0035615;GO:0030742;GO:0019894;GO:0031267;GO:0019886;GO:0035646;GO:0090160;GO:0006896;GO:0006886;GO:0032438;GO:0043323;GO:0045954;GO:0006892;GO:0006898;GO:0050690;, C:AP-1 adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:recycling endosome; C:trans-Golgi network membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:GTP-dependent protein binding; F:kinesin binding; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endosome to melanosome transport; P:Golgi to lysosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:positive regulation of natural killer cell degranulation; P:positive regulation of natural killer cell mediated cytotoxicity; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; scaffold16 indexed_genome mRNA 34914156 34948828 . + . ID=transcript_4169;Q6ZVD8 A1L374 Q9NV17 Q9Y2E3,PH domain leucine-rich repeat-containing protein phosphatase 2,PH domain leucine-rich repeat-containing protein phosphatase-like;, PF13855;PF00481;, GO:0005737;GO:0005829;GO:0045171;GO:0043231;GO:0016020;GO:0072686;GO:0005654;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0051898;GO:0007165;, C:cytoplasm; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:membrane; C:mitotic spindle; C:nucleoplasm;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:negative regulation of protein kinase B signaling; P:signal transduction;|Q6ZVD8 A1L374 Q9NV17 Q9Y2E3,PH domain leucine-rich repeat-containing protein phosphatase 2,PH domain leucine-rich repeat-containing protein phosphatase-like;, PF13855;PF00481;, GO:0005737;GO:0005829;GO:0045171;GO:0043231;GO:0016020;GO:0072686;GO:0005654;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0051898;GO:0007165;, C:cytoplasm; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:membrane; C:mitotic spindle; C:nucleoplasm;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:negative regulation of protein kinase B signaling; P:signal transduction;|Q6ZVD8 A1L374 Q9NV17 Q9Y2E3,PH domain leucine-rich repeat-containing protein phosphatase 2,PH domain leucine-rich repeat-containing protein phosphatase-like;, PF13855;PF00481;, GO:0005737;GO:0005829;GO:0045171;GO:0043231;GO:0016020;GO:0072686;GO:0005654;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0051898;GO:0007165;, C:cytoplasm; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:membrane; C:mitotic spindle; C:nucleoplasm;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:negative regulation of protein kinase B signaling; P:signal transduction; scaffold16 indexed_genome mRNA 34949116 34964580 . + . ID=transcript_4170;Q6ZVD8 A1L374 Q9NV17 Q9Y2E3,PH domain leucine-rich repeat-containing protein phosphatase 2,PH domain leucine-rich repeat-containing protein phosphatase-like;, PF13855;PF00481;, GO:0005737;GO:0005829;GO:0045171;GO:0043231;GO:0016020;GO:0072686;GO:0005654;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0051898;GO:0007165;, C:cytoplasm; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:membrane; C:mitotic spindle; C:nucleoplasm;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:negative regulation of protein kinase B signaling; P:signal transduction;|Q6ZVD8 A1L374 Q9NV17 Q9Y2E3,PH domain leucine-rich repeat-containing protein phosphatase 2,PH domain leucine-rich repeat-containing protein phosphatase-like;, PF13855;PF00481;, GO:0005737;GO:0005829;GO:0045171;GO:0043231;GO:0016020;GO:0072686;GO:0005654;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0051898;GO:0007165;, C:cytoplasm; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:membrane; C:mitotic spindle; C:nucleoplasm;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:negative regulation of protein kinase B signaling; P:signal transduction; scaffold16 indexed_genome mRNA 34973490 34974246 . - . ID=transcript_4171;Q96A59 A8K820 H3BQM5 Q96MJ4,MARVEL domain-containing protein 3,, , GO:0005923;GO:0005737;GO:0031410;GO:0016021;GO:0031435;GO:0070830;GO:0045216;GO:0010633;GO:0050680;GO:0046329;GO:1902414;GO:0006970;, C:bicellular tight junction; C:cytoplasm; C:cytoplasmic vesicle; C:integral component of membrane;, F:mitogen-activated protein kinase kinase kinase binding;, P:bicellular tight junction assembly; P:cell-cell junction organization; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of JNK cascade; P:protein localization to cell junction; P:response to osmotic stress; scaffold16 indexed_genome mRNA 35021492 35030600 . + . ID=transcript_4172;P17735 B2R8I1 D3DWS2,Tyrosine aminotransferase,L-tyrosine:2-oxoglutarate aminotransferase;, PF00155;PF07706;, GO:0005829;GO:0005739;GO:0016597;GO:0042802;GO:0004838;GO:0030170;GO:0006103;GO:0009058;GO:0006536;GO:0006559;GO:0051384;GO:0046689;GO:0006979;GO:0006572;, C:cytosol; C:mitochondrion;, F:amino acid binding; F:identical protein binding; F:L-tyrosine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:L-phenylalanine catabolic process; P:response to glucocorticoid; P:response to mercury ion; P:response to oxidative stress; P:tyrosine catabolic process;|P17735 B2R8I1 D3DWS2,Tyrosine aminotransferase,L-tyrosine:2-oxoglutarate aminotransferase;, PF00155;PF07706;, GO:0005829;GO:0005739;GO:0016597;GO:0042802;GO:0004838;GO:0030170;GO:0006103;GO:0009058;GO:0006536;GO:0006559;GO:0051384;GO:0046689;GO:0006979;GO:0006572;, C:cytosol; C:mitochondrion;, F:amino acid binding; F:identical protein binding; F:L-tyrosine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:L-phenylalanine catabolic process; P:response to glucocorticoid; P:response to mercury ion; P:response to oxidative stress; P:tyrosine catabolic process;|P17735 B2R8I1 D3DWS2,Tyrosine aminotransferase,L-tyrosine:2-oxoglutarate aminotransferase;, PF00155;PF07706;, GO:0005829;GO:0005739;GO:0016597;GO:0042802;GO:0004838;GO:0030170;GO:0006103;GO:0009058;GO:0006536;GO:0006559;GO:0051384;GO:0046689;GO:0006979;GO:0006572;, C:cytosol; C:mitochondrion;, F:amino acid binding; F:identical protein binding; F:L-tyrosine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:L-phenylalanine catabolic process; P:response to glucocorticoid; P:response to mercury ion; P:response to oxidative stress; P:tyrosine catabolic process;|P17735 B2R8I1 D3DWS2,Tyrosine aminotransferase,L-tyrosine:2-oxoglutarate aminotransferase;, PF00155;PF07706;, GO:0005829;GO:0005739;GO:0016597;GO:0042802;GO:0004838;GO:0030170;GO:0006103;GO:0009058;GO:0006536;GO:0006559;GO:0051384;GO:0046689;GO:0006979;GO:0006572;, C:cytosol; C:mitochondrion;, F:amino acid binding; F:identical protein binding; F:L-tyrosine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:L-phenylalanine catabolic process; P:response to glucocorticoid; P:response to mercury ion; P:response to oxidative stress; P:tyrosine catabolic process;|P17735 B2R8I1 D3DWS2,Tyrosine aminotransferase,L-tyrosine:2-oxoglutarate aminotransferase;, PF00155;PF07706;, GO:0005829;GO:0005739;GO:0016597;GO:0042802;GO:0004838;GO:0030170;GO:0006103;GO:0009058;GO:0006536;GO:0006559;GO:0051384;GO:0046689;GO:0006979;GO:0006572;, C:cytosol; C:mitochondrion;, F:amino acid binding; F:identical protein binding; F:L-tyrosine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:L-phenylalanine catabolic process; P:response to glucocorticoid; P:response to mercury ion; P:response to oxidative stress; P:tyrosine catabolic process;|P17735 B2R8I1 D3DWS2,Tyrosine aminotransferase,L-tyrosine:2-oxoglutarate aminotransferase;, PF00155;PF07706;, GO:0005829;GO:0005739;GO:0016597;GO:0042802;GO:0004838;GO:0030170;GO:0006103;GO:0009058;GO:0006536;GO:0006559;GO:0051384;GO:0046689;GO:0006979;GO:0006572;, C:cytosol; C:mitochondrion;, F:amino acid binding; F:identical protein binding; F:L-tyrosine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:L-phenylalanine catabolic process; P:response to glucocorticoid; P:response to mercury ion; P:response to oxidative stress; P:tyrosine catabolic process; scaffold16 indexed_genome mRNA 35124793 35135388 . + . ID=transcript_4173;P17023 A8K895 Q86Y66 Q8NDE2 Q96M79 Q96NE5,Zinc finger protein 19,Zinc finger protein KOX12;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 35149098 35163781 . + . ID=transcript_4174;Q6ZNG0 Q8N223,Zinc finger protein 620,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P17027 Q8NDP5 Q96IT3 Q9UG42,Zinc finger protein 23,Zinc finger protein 359;Zinc finger protein 612;Zinc finger protein KOX16;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 35163854 35177412 . + . ID=transcript_4175;A0A1W2PR48,Transducin-like enhancer protein 7 {ECO:0000305},, PF00400;, GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0090090;, C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:negative regulation of canonical Wnt signaling pathway;|A0A1W2PR48,Transducin-like enhancer protein 7 {ECO:0000305},, PF00400;, GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0090090;, C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:negative regulation of canonical Wnt signaling pathway;|A0A1W2PR48,Transducin-like enhancer protein 7 {ECO:0000305},, PF00400;, GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0090090;, C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:negative regulation of canonical Wnt signaling pathway; scaffold16 indexed_genome mRNA 35205490 35233849 . - . ID=transcript_4176;P22676 A8K4Y1 Q53HD2 Q96BK4,Calretinin,29 kDa calbindin;, PF13405;PF13499;, GO:0032437;GO:0005829;GO:0030425;GO:0005921;GO:0043005;GO:0005634;GO:0098688;GO:0032420;GO:0045202;GO:0097060;GO:0043195;GO:0005509;GO:0099534;GO:0051480;GO:1900271;GO:0099509;, C:cuticular plate; C:cytosol; C:dendrite; C:gap junction; C:neuron projection; C:nucleus; C:parallel fiber to Purkinje cell synapse; C:stereocilium; C:synapse; C:synaptic membrane; C:terminal bouton;, F:calcium ion binding; F:calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration;, P:regulation of cytosolic calcium ion concentration; P:regulation of long-term synaptic potentiation; P:regulation of presynaptic cytosolic calcium ion concentration; scaffold16 indexed_genome mRNA 35301917 35309369 . + . ID=transcript_4177;Q8IYT2 B2RCD5 D3DWS1 Q8NE77 Q8NFR5 Q9H8Z4 Q9NUS3 Q9NXF5,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2,Cap methyltransferase 2;Cap2 2'O-ribose methyltransferase 2;FtsJ methyltransferase domain-containing protein 1;Protein adrift homolog;, PF01728;, GO:0005737;GO:0005634;GO:0004483;GO:0006370;GO:0097309;GO:0097310;, C:cytoplasm; C:nucleus;, F:mRNA (nucleoside-2'-O-)-methyltransferase activity;, P:7-methylguanosine mRNA capping; P:cap1 mRNA methylation; P:cap2 mRNA methylation; scaffold16 indexed_genome mRNA 35635304 35640432 . + . ID=transcript_4178;Q96JG3 Q96SS4 Q9H5U3 Q9H9B8 Q9NTI0 Q9UBE5,Hydrocephalus-inducing protein homolog,, PF15780;PF17213;, GO:1990716;GO:1990718;GO:1904158;GO:0003341;GO:0002064;GO:0060438;GO:0021591;, C:axonemal central apparatus; C:axonemal central pair projection;, , P:axonemal central apparatus assembly; P:cilium movement; P:epithelial cell development; P:trachea development; P:ventricular system development; scaffold16 indexed_genome mRNA 35679417 35685355 . + . ID=transcript_4179;Q96JG3 Q96SS4 Q9H5U3 Q9H9B8 Q9NTI0 Q9UBE5,Hydrocephalus-inducing protein homolog,, PF15780;PF17213;, GO:1990716;GO:1990718;GO:1904158;GO:0003341;GO:0002064;GO:0060438;GO:0021591;, C:axonemal central apparatus; C:axonemal central pair projection;, , P:axonemal central apparatus assembly; P:cilium movement; P:epithelial cell development; P:trachea development; P:ventricular system development; scaffold16 indexed_genome mRNA 35689454 35694258 . + . ID=transcript_4180;Q96JG3 Q96SS4 Q9H5U3 Q9H9B8 Q9NTI0 Q9UBE5,Hydrocephalus-inducing protein homolog,, PF15780;PF17213;, GO:1990716;GO:1990718;GO:1904158;GO:0003341;GO:0002064;GO:0060438;GO:0021591;, C:axonemal central apparatus; C:axonemal central pair projection;, , P:axonemal central apparatus assembly; P:cilium movement; P:epithelial cell development; P:trachea development; P:ventricular system development; scaffold16 indexed_genome mRNA 35736041 35746089 . + . ID=transcript_4181;O95707 Q5XKL7 Q6FHW9 Q9UQQ3,Ribonuclease P protein subunit p29,, PF01868;, GO:0030681;GO:0005730;GO:0005654;GO:0000172;GO:0030677;GO:0004526;GO:0033204;GO:0006364;GO:0001682;, C:multimeric ribonuclease P complex; C:nucleolus; C:nucleoplasm; C:ribonuclease MRP complex; C:ribonuclease P complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding;, P:rRNA processing; P:tRNA 5'-leader removal;|O95707 Q5XKL7 Q6FHW9 Q9UQQ3,Ribonuclease P protein subunit p29,, PF01868;, GO:0030681;GO:0005730;GO:0005654;GO:0000172;GO:0030677;GO:0004526;GO:0033204;GO:0006364;GO:0001682;, C:multimeric ribonuclease P complex; C:nucleolus; C:nucleoplasm; C:ribonuclease MRP complex; C:ribonuclease P complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding;, P:rRNA processing; P:tRNA 5'-leader removal; scaffold16 indexed_genome mRNA 35781300 35790907 . + . ID=transcript_4182;Q96S99 Q96K11 Q9BUB9,Pleckstrin homology domain-containing family F member 1,Lysosome-associated apoptosis-inducing protein containing PH and FYVE domains;PH and FYVE domain-containing protein 1;Phafin-1;Zinc finger FYVE domain-containing protein 15;, PF01363;PF00169;, GO:0010008;GO:0005765;GO:0005764;GO:0005634;GO:0048471;GO:0046872;GO:0035091;GO:0032266;GO:0070273;GO:0010314;GO:0006915;GO:0007032;GO:0010508;GO:2001244;GO:0072659;GO:0016050;, C:endosome membrane; C:lysosomal membrane; C:lysosome; C:nucleus; C:perinuclear region of cytoplasm;, F:metal ion binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:apoptotic process; P:endosome organization; P:positive regulation of autophagy; P:positive regulation of intrinsic apoptotic signaling pathway; P:protein localization to plasma membrane; P:vesicle organization; scaffold16 indexed_genome mRNA 35801940 35820414 . - . ID=transcript_4183;Q9NSK7 B3KQ16 Q0D2Q0 Q6P4C5 Q9BSL7,Protein C19orf12,, , GO:0005829;GO:0005783;GO:0016021;GO:0031966;GO:0005739;GO:0006915;GO:0006914;GO:0051560;GO:0006979;, C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;, , P:apoptotic process; P:autophagy; P:mitochondrial calcium ion homeostasis; P:response to oxidative stress; scaffold16 indexed_genome mRNA 35932723 35936860 . + . ID=transcript_4184;P24864 A8K684 Q14091 Q8NFG1 Q92501 Q9UD21,G1/S-specific cyclin-E1,, PF02984;PF00134;, GO:0005813;GO:0097134;GO:0000307;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016538;GO:0016301;GO:0019901;GO:0051301;GO:0006270;GO:0000082;GO:0007129;GO:0044772;GO:0000122;GO:1902462;GO:0006468;GO:1903827;GO:0000079;GO:0000083;GO:0000723;GO:0016055;, C:centrosome; C:cyclin E1-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:kinase activity; F:protein kinase binding;, P:cell division; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:homologous chromosome pairing at meiosis; P:mitotic cell cycle phase transition; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of mesenchymal stem cell proliferation; P:protein phosphorylation; P:regulation of cellular protein localization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:telomere maintenance; P:Wnt signaling pathway;|P24864 A8K684 Q14091 Q8NFG1 Q92501 Q9UD21,G1/S-specific cyclin-E1,, PF02984;PF00134;, GO:0005813;GO:0097134;GO:0000307;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016538;GO:0016301;GO:0019901;GO:0051301;GO:0006270;GO:0000082;GO:0007129;GO:0044772;GO:0000122;GO:1902462;GO:0006468;GO:1903827;GO:0000079;GO:0000083;GO:0000723;GO:0016055;, C:centrosome; C:cyclin E1-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:kinase activity; F:protein kinase binding;, P:cell division; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:homologous chromosome pairing at meiosis; P:mitotic cell cycle phase transition; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of mesenchymal stem cell proliferation; P:protein phosphorylation; P:regulation of cellular protein localization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:telomere maintenance; P:Wnt signaling pathway; scaffold16 indexed_genome mRNA 36076801 36107454 . + . ID=transcript_4185;O94763 A8K805 H7BY42 Q8TC23 Q9UNU3,Unconventional prefoldin RPB5 interactor 1,Protein NNX3;Protein phosphatase 1 regulatory subunit 19;RNA polymerase II subunit 5-mediating protein;, PF02996;, GO:0005737;GO:0005829;GO:0030425;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0019212;GO:0051219;GO:0004864;GO:0000993;GO:0003714;GO:0071363;GO:0071383;GO:2001243;GO:0010923;GO:0000122;GO:0001558;GO:0006357;GO:0009615;, C:cytoplasm; C:cytosol; C:dendrite; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:phosphatase inhibitor activity; F:phosphoprotein binding; F:protein phosphatase inhibitor activity; F:RNA polymerase II complex binding; F:transcription corepressor activity;, P:cellular response to growth factor stimulus; P:cellular response to steroid hormone stimulus; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of phosphatase activity; P:negative regulation of transcription by RNA polymerase II; P:regulation of cell growth; P:regulation of transcription by RNA polymerase II; P:response to virus;|O94763 A8K805 H7BY42 Q8TC23 Q9UNU3,Unconventional prefoldin RPB5 interactor 1,Protein NNX3;Protein phosphatase 1 regulatory subunit 19;RNA polymerase II subunit 5-mediating protein;, PF02996;, GO:0005737;GO:0005829;GO:0030425;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0019212;GO:0051219;GO:0004864;GO:0000993;GO:0003714;GO:0071363;GO:0071383;GO:2001243;GO:0010923;GO:0000122;GO:0001558;GO:0006357;GO:0009615;, C:cytoplasm; C:cytosol; C:dendrite; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:phosphatase inhibitor activity; F:phosphoprotein binding; F:protein phosphatase inhibitor activity; F:RNA polymerase II complex binding; F:transcription corepressor activity;, P:cellular response to growth factor stimulus; P:cellular response to steroid hormone stimulus; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of phosphatase activity; P:negative regulation of transcription by RNA polymerase II; P:regulation of cell growth; P:regulation of transcription by RNA polymerase II; P:response to virus;|O94763 A8K805 H7BY42 Q8TC23 Q9UNU3,Unconventional prefoldin RPB5 interactor 1,Protein NNX3;Protein phosphatase 1 regulatory subunit 19;RNA polymerase II subunit 5-mediating protein;, PF02996;, GO:0005737;GO:0005829;GO:0030425;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0019212;GO:0051219;GO:0004864;GO:0000993;GO:0003714;GO:0071363;GO:0071383;GO:2001243;GO:0010923;GO:0000122;GO:0001558;GO:0006357;GO:0009615;, C:cytoplasm; C:cytosol; C:dendrite; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:phosphatase inhibitor activity; F:phosphoprotein binding; F:protein phosphatase inhibitor activity; F:RNA polymerase II complex binding; F:transcription corepressor activity;, P:cellular response to growth factor stimulus; P:cellular response to steroid hormone stimulus; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of phosphatase activity; P:negative regulation of transcription by RNA polymerase II; P:regulation of cell growth; P:regulation of transcription by RNA polymerase II; P:response to virus;|O94763 A8K805 H7BY42 Q8TC23 Q9UNU3,Unconventional prefoldin RPB5 interactor 1,Protein NNX3;Protein phosphatase 1 regulatory subunit 19;RNA polymerase II subunit 5-mediating protein;, PF02996;, GO:0005737;GO:0005829;GO:0030425;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0019212;GO:0051219;GO:0004864;GO:0000993;GO:0003714;GO:0071363;GO:0071383;GO:2001243;GO:0010923;GO:0000122;GO:0001558;GO:0006357;GO:0009615;, C:cytoplasm; C:cytosol; C:dendrite; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:phosphatase inhibitor activity; F:phosphoprotein binding; F:protein phosphatase inhibitor activity; F:RNA polymerase II complex binding; F:transcription corepressor activity;, P:cellular response to growth factor stimulus; P:cellular response to steroid hormone stimulus; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of phosphatase activity; P:negative regulation of transcription by RNA polymerase II; P:regulation of cell growth; P:regulation of transcription by RNA polymerase II; P:response to virus; scaffold16 indexed_genome mRNA 36565746 36717514 . + . ID=transcript_4186;O15090 A2RU18,Zinc finger protein 536,, PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0044323;GO:0000978;GO:0045665;GO:0048387;GO:0000122;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of neuron differentiation; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold16 indexed_genome mRNA 37311578 37313057 . - . ID=transcript_4187;Q63HK5 A1L0U7 Q9H0G6 Q9P254,Teashirt homolog 3,Zinc finger protein 537;, , GO:0000785;GO:0030426;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0003677;GO:0000981;GO:0046872;GO:0060291;GO:0007275;GO:0045892;GO:0051968;GO:0002087;GO:0006357;, C:chromatin; C:growth cone; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:long-term synaptic potentiation; P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:positive regulation of synaptic transmission, glutamatergic; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 37313061 37313642 . - . ID=transcript_4188;Q63HK5 A1L0U7 Q9H0G6 Q9P254,Teashirt homolog 3,Zinc finger protein 537;, , GO:0000785;GO:0030426;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0003677;GO:0000981;GO:0046872;GO:0060291;GO:0007275;GO:0045892;GO:0051968;GO:0002087;GO:0006357;, C:chromatin; C:growth cone; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:long-term synaptic potentiation; P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:positive regulation of synaptic transmission, glutamatergic; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription by RNA polymerase II; scaffold16 indexed_genome mRNA 37314217 37315319 . + . ID=transcript_4189;Q63HK5 A1L0U7 Q9H0G6 Q9P254,Teashirt homolog 3,Zinc finger protein 537;, , GO:0000785;GO:0030426;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0003677;GO:0000981;GO:0046872;GO:0060291;GO:0007275;GO:0045892;GO:0051968;GO:0002087;GO:0006357;, C:chromatin; C:growth cone; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:long-term synaptic potentiation; P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:positive regulation of synaptic transmission, glutamatergic; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription by RNA polymerase II; scaffold17 indexed_genome mRNA 139420 155469 . + . ID=transcript_4190;P09417 A8K158 B3KW71 Q53F52 Q9H3M5,Dihydropteridine reductase,HDHPR;Quinoid dihydropteridine reductase;Short chain dehydrogenase/reductase family 33C member 1;, PF00106;, GO:0005737;GO:0005829;GO:0070062;GO:0043005;GO:0004155;GO:0009055;GO:0042802;GO:0070404;GO:0070402;GO:0006520;GO:0035690;GO:0051066;GO:0006559;GO:0006558;GO:0001889;GO:0010044;GO:0033762;GO:0010288;GO:0006729;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuron projection;, F:6,7-dihydropteridine reductase activity; F:electron transfer activity; F:identical protein binding; F:NADH binding; F:NADPH binding;, P:cellular amino acid metabolic process; P:cellular response to drug; P:dihydrobiopterin metabolic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:liver development; P:response to aluminum ion; P:response to glucagon; P:response to lead ion; P:tetrahydrobiopterin biosynthetic process;|P09417 A8K158 B3KW71 Q53F52 Q9H3M5,Dihydropteridine reductase,HDHPR;Quinoid dihydropteridine reductase;Short chain dehydrogenase/reductase family 33C member 1;, PF00106;, GO:0005737;GO:0005829;GO:0070062;GO:0043005;GO:0004155;GO:0009055;GO:0042802;GO:0070404;GO:0070402;GO:0006520;GO:0035690;GO:0051066;GO:0006559;GO:0006558;GO:0001889;GO:0010044;GO:0033762;GO:0010288;GO:0006729;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuron projection;, F:6,7-dihydropteridine reductase activity; F:electron transfer activity; F:identical protein binding; F:NADH binding; F:NADPH binding;, P:cellular amino acid metabolic process; P:cellular response to drug; P:dihydrobiopterin metabolic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:liver development; P:response to aluminum ion; P:response to glucagon; P:response to lead ion; P:tetrahydrobiopterin biosynthetic process;|P09417 A8K158 B3KW71 Q53F52 Q9H3M5,Dihydropteridine reductase,HDHPR;Quinoid dihydropteridine reductase;Short chain dehydrogenase/reductase family 33C member 1;, PF00106;, GO:0005737;GO:0005829;GO:0070062;GO:0043005;GO:0004155;GO:0009055;GO:0042802;GO:0070404;GO:0070402;GO:0006520;GO:0035690;GO:0051066;GO:0006559;GO:0006558;GO:0001889;GO:0010044;GO:0033762;GO:0010288;GO:0006729;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuron projection;, F:6,7-dihydropteridine reductase activity; F:electron transfer activity; F:identical protein binding; F:NADH binding; F:NADPH binding;, P:cellular amino acid metabolic process; P:cellular response to drug; P:dihydrobiopterin metabolic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:liver development; P:response to aluminum ion; P:response to glucagon; P:response to lead ion; P:tetrahydrobiopterin biosynthetic process;|P09417 A8K158 B3KW71 Q53F52 Q9H3M5,Dihydropteridine reductase,HDHPR;Quinoid dihydropteridine reductase;Short chain dehydrogenase/reductase family 33C member 1;, PF00106;, GO:0005737;GO:0005829;GO:0070062;GO:0043005;GO:0004155;GO:0009055;GO:0042802;GO:0070404;GO:0070402;GO:0006520;GO:0035690;GO:0051066;GO:0006559;GO:0006558;GO:0001889;GO:0010044;GO:0033762;GO:0010288;GO:0006729;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuron projection;, F:6,7-dihydropteridine reductase activity; F:electron transfer activity; F:identical protein binding; F:NADH binding; F:NADPH binding;, P:cellular amino acid metabolic process; P:cellular response to drug; P:dihydrobiopterin metabolic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:liver development; P:response to aluminum ion; P:response to glucagon; P:response to lead ion; P:tetrahydrobiopterin biosynthetic process;|P09417 A8K158 B3KW71 Q53F52 Q9H3M5,Dihydropteridine reductase,HDHPR;Quinoid dihydropteridine reductase;Short chain dehydrogenase/reductase family 33C member 1;, PF00106;, GO:0005737;GO:0005829;GO:0070062;GO:0043005;GO:0004155;GO:0009055;GO:0042802;GO:0070404;GO:0070402;GO:0006520;GO:0035690;GO:0051066;GO:0006559;GO:0006558;GO:0001889;GO:0010044;GO:0033762;GO:0010288;GO:0006729;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuron projection;, F:6,7-dihydropteridine reductase activity; F:electron transfer activity; F:identical protein binding; F:NADH binding; F:NADPH binding;, P:cellular amino acid metabolic process; P:cellular response to drug; P:dihydrobiopterin metabolic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:liver development; P:response to aluminum ion; P:response to glucagon; P:response to lead ion; P:tetrahydrobiopterin biosynthetic process; scaffold17 indexed_genome mRNA 156063 157164 . + . ID=transcript_4191;P09417 A8K158 B3KW71 Q53F52 Q9H3M5,Dihydropteridine reductase,HDHPR;Quinoid dihydropteridine reductase;Short chain dehydrogenase/reductase family 33C member 1;, PF00106;, GO:0005737;GO:0005829;GO:0070062;GO:0043005;GO:0004155;GO:0009055;GO:0042802;GO:0070404;GO:0070402;GO:0006520;GO:0035690;GO:0051066;GO:0006559;GO:0006558;GO:0001889;GO:0010044;GO:0033762;GO:0010288;GO:0006729;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuron projection;, F:6,7-dihydropteridine reductase activity; F:electron transfer activity; F:identical protein binding; F:NADH binding; F:NADPH binding;, P:cellular amino acid metabolic process; P:cellular response to drug; P:dihydrobiopterin metabolic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:liver development; P:response to aluminum ion; P:response to glucagon; P:response to lead ion; P:tetrahydrobiopterin biosynthetic process; scaffold17 indexed_genome mRNA 715055 1149269 . + . ID=transcript_4192;O43679 O60619 O75480,LIM domain-binding protein 2,Carboxyl-terminal LIM domain-binding protein 1;LIM domain-binding factor CLIM1;, PF17916;PF01803;, GO:0031252;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005667;GO:0019899;GO:0030274;GO:0001102;GO:0003712;GO:0010669;GO:0001942;GO:0000122;GO:0007399;GO:0044089;GO:0045944;GO:0030334;GO:0043549;GO:0035019;, C:cell leading edge; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:transcription regulator complex;, F:enzyme binding; F:LIM domain binding; F:RNA polymerase II activating transcription factor binding; F:transcription coregulator activity;, P:epithelial structure maintenance; P:hair follicle development; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of cellular component biogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell migration; P:regulation of kinase activity; P:somatic stem cell population maintenance; scaffold17 indexed_genome mRNA 1455435 1466176 . - . ID=transcript_4193;Q6NXT6 Q8N2S3 Q9NZK9,Transmembrane anterior posterior transformation protein 1 homolog,Cytomegalovirus partial fusion receptor;, PF05346;, GO:0005813;GO:0036064;GO:0030176;GO:0016021;GO:0016520;GO:0051216;GO:0030030;GO:0048706;GO:0035437;GO:0014032;GO:0001503;GO:1903012;GO:0061036;GO:0045724;GO:0016032;, C:centrosome; C:ciliary basal body; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:growth hormone-releasing hormone receptor activity;, P:cartilage development; P:cell projection organization; P:embryonic skeletal system development; P:maintenance of protein localization in endoplasmic reticulum; P:neural crest cell development; P:ossification; P:positive regulation of bone development; P:positive regulation of cartilage development; P:positive regulation of cilium assembly; P:viral process;|Q6NXT6 Q8N2S3 Q9NZK9,Transmembrane anterior posterior transformation protein 1 homolog,Cytomegalovirus partial fusion receptor;, PF05346;, GO:0005813;GO:0036064;GO:0030176;GO:0016021;GO:0016520;GO:0051216;GO:0030030;GO:0048706;GO:0035437;GO:0014032;GO:0001503;GO:1903012;GO:0061036;GO:0045724;GO:0016032;, C:centrosome; C:ciliary basal body; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:growth hormone-releasing hormone receptor activity;, P:cartilage development; P:cell projection organization; P:embryonic skeletal system development; P:maintenance of protein localization in endoplasmic reticulum; P:neural crest cell development; P:ossification; P:positive regulation of bone development; P:positive regulation of cartilage development; P:positive regulation of cilium assembly; P:viral process;|Q6NXT6 Q8N2S3 Q9NZK9,Transmembrane anterior posterior transformation protein 1 homolog,Cytomegalovirus partial fusion receptor;, PF05346;, GO:0005813;GO:0036064;GO:0030176;GO:0016021;GO:0016520;GO:0051216;GO:0030030;GO:0048706;GO:0035437;GO:0014032;GO:0001503;GO:1903012;GO:0061036;GO:0045724;GO:0016032;, C:centrosome; C:ciliary basal body; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:growth hormone-releasing hormone receptor activity;, P:cartilage development; P:cell projection organization; P:embryonic skeletal system development; P:maintenance of protein localization in endoplasmic reticulum; P:neural crest cell development; P:ossification; P:positive regulation of bone development; P:positive regulation of cartilage development; P:positive regulation of cilium assembly; P:viral process; scaffold17 indexed_genome mRNA 1467561 1470529 . + . ID=transcript_4194;Q6NXT6 Q8N2S3 Q9NZK9,Transmembrane anterior posterior transformation protein 1 homolog,Cytomegalovirus partial fusion receptor;, PF05346;, GO:0005813;GO:0036064;GO:0030176;GO:0016021;GO:0016520;GO:0051216;GO:0030030;GO:0048706;GO:0035437;GO:0014032;GO:0001503;GO:1903012;GO:0061036;GO:0045724;GO:0016032;, C:centrosome; C:ciliary basal body; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:growth hormone-releasing hormone receptor activity;, P:cartilage development; P:cell projection organization; P:embryonic skeletal system development; P:maintenance of protein localization in endoplasmic reticulum; P:neural crest cell development; P:ossification; P:positive regulation of bone development; P:positive regulation of cartilage development; P:positive regulation of cilium assembly; P:viral process; scaffold17 indexed_genome mRNA 1764381 1818001 . - . ID=transcript_4195;P28907 O00121 O00122 Q96HY4,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2'-phospho-ADP-ribosyl cyclase;2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase;2'-phospho-cyclic-ADP-ribose transferase;ADP-ribosyl cyclase 1;Cyclic ADP-ribose hydrolase 1;T10;, PF02267;, GO:0016323;GO:0009986;GO:0070062;GO:0016021;GO:0016020;GO:0005634;GO:0005886;GO:0030667;GO:0042802;GO:0050135;GO:0003953;GO:0061809;GO:0016849;GO:0016740;GO:0097190;GO:0014824;GO:0050853;GO:0007565;GO:0060292;GO:0019674;GO:0043066;GO:0045779;GO:0010977;GO:0045892;GO:0030890;GO:0030307;GO:0007204;GO:0032024;GO:0045893;GO:0045907;GO:0042493;GO:0032355;GO:0033194;GO:0001666;GO:0070555;GO:0032570;GO:0032526;GO:0007165;, C:basolateral plasma membrane; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleus; C:plasma membrane; C:secretory granule membrane;, F:identical protein binding; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:phosphorus-oxygen lyase activity; F:transferase activity;, P:apoptotic signaling pathway; P:artery smooth muscle contraction; P:B cell receptor signaling pathway; P:female pregnancy; P:long-term synaptic depression; P:NAD metabolic process; P:negative regulation of apoptotic process; P:negative regulation of bone resorption; P:negative regulation of neuron projection development; P:negative regulation of transcription, DNA-templated; P:positive regulation of B cell proliferation; P:positive regulation of cell growth; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of insulin secretion; P:positive regulation of transcription, DNA-templated; P:positive regulation of vasoconstriction; P:response to drug; P:response to estradiol; P:response to hydroperoxide; P:response to hypoxia; P:response to interleukin-1; P:response to progesterone; P:response to retinoic acid; P:signal transduction;|P28907 O00121 O00122 Q96HY4,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2'-phospho-ADP-ribosyl cyclase;2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase;2'-phospho-cyclic-ADP-ribose transferase;ADP-ribosyl cyclase 1;Cyclic ADP-ribose hydrolase 1;T10;, PF02267;, GO:0016323;GO:0009986;GO:0070062;GO:0016021;GO:0016020;GO:0005634;GO:0005886;GO:0030667;GO:0042802;GO:0050135;GO:0003953;GO:0061809;GO:0016849;GO:0016740;GO:0097190;GO:0014824;GO:0050853;GO:0007565;GO:0060292;GO:0019674;GO:0043066;GO:0045779;GO:0010977;GO:0045892;GO:0030890;GO:0030307;GO:0007204;GO:0032024;GO:0045893;GO:0045907;GO:0042493;GO:0032355;GO:0033194;GO:0001666;GO:0070555;GO:0032570;GO:0032526;GO:0007165;, C:basolateral plasma membrane; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleus; C:plasma membrane; C:secretory granule membrane;, F:identical protein binding; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:phosphorus-oxygen lyase activity; F:transferase activity;, P:apoptotic signaling pathway; P:artery smooth muscle contraction; P:B cell receptor signaling pathway; P:female pregnancy; P:long-term synaptic depression; P:NAD metabolic process; P:negative regulation of apoptotic process; P:negative regulation of bone resorption; P:negative regulation of neuron projection development; P:negative regulation of transcription, DNA-templated; P:positive regulation of B cell proliferation; P:positive regulation of cell growth; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of insulin secretion; P:positive regulation of transcription, DNA-templated; P:positive regulation of vasoconstriction; P:response to drug; P:response to estradiol; P:response to hydroperoxide; P:response to hypoxia; P:response to interleukin-1; P:response to progesterone; P:response to retinoic acid; P:signal transduction; scaffold17 indexed_genome mRNA 1883515 1914530 . - . ID=transcript_4196;Q10588 B2R6A2 Q1XII0 Q5U0K0 Q96EN3,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,ADP-ribosyl cyclase 2;Bone marrow stromal antigen 1;Cyclic ADP-ribose hydrolase 2;, PF02267;, GO:0031225;GO:0070062;GO:0005576;GO:0019898;GO:0005886;GO:0035579;GO:0001931;GO:0061811;GO:0061812;GO:0050135;GO:0003953;GO:0061809;GO:0016849;GO:0016740;GO:0006959;GO:0019674;GO:0043312;GO:0030890;GO:0008284;GO:0032956;GO:0050848;GO:0001952;GO:0002691;GO:0050727;GO:2001044;GO:0090022;GO:0050730;GO:0090322;GO:0007165;, C:anchored component of membrane; C:extracellular exosome; C:extracellular region; C:extrinsic component of membrane; C:plasma membrane; C:specific granule membrane; C:uropod;, F:ADP-ribosyl cyclase activity; F:cyclic ADP-ribose hydrolase; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:phosphorus-oxygen lyase activity; F:transferase activity;, P:humoral immune response; P:NAD metabolic process; P:neutrophil degranulation; P:positive regulation of B cell proliferation; P:positive regulation of cell population proliferation; P:regulation of actin cytoskeleton organization; P:regulation of calcium-mediated signaling; P:regulation of cell-matrix adhesion; P:regulation of cellular extravasation; P:regulation of inflammatory response; P:regulation of integrin-mediated signaling pathway; P:regulation of neutrophil chemotaxis; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of superoxide metabolic process; P:signal transduction;|Q10588 B2R6A2 Q1XII0 Q5U0K0 Q96EN3,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,ADP-ribosyl cyclase 2;Bone marrow stromal antigen 1;Cyclic ADP-ribose hydrolase 2;, PF02267;, GO:0031225;GO:0070062;GO:0005576;GO:0019898;GO:0005886;GO:0035579;GO:0001931;GO:0061811;GO:0061812;GO:0050135;GO:0003953;GO:0061809;GO:0016849;GO:0016740;GO:0006959;GO:0019674;GO:0043312;GO:0030890;GO:0008284;GO:0032956;GO:0050848;GO:0001952;GO:0002691;GO:0050727;GO:2001044;GO:0090022;GO:0050730;GO:0090322;GO:0007165;, C:anchored component of membrane; C:extracellular exosome; C:extracellular region; C:extrinsic component of membrane; C:plasma membrane; C:specific granule membrane; C:uropod;, F:ADP-ribosyl cyclase activity; F:cyclic ADP-ribose hydrolase; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:phosphorus-oxygen lyase activity; F:transferase activity;, P:humoral immune response; P:NAD metabolic process; P:neutrophil degranulation; P:positive regulation of B cell proliferation; P:positive regulation of cell population proliferation; P:regulation of actin cytoskeleton organization; P:regulation of calcium-mediated signaling; P:regulation of cell-matrix adhesion; P:regulation of cellular extravasation; P:regulation of inflammatory response; P:regulation of integrin-mediated signaling pathway; P:regulation of neutrophil chemotaxis; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of superoxide metabolic process; P:signal transduction; scaffold17 indexed_genome mRNA 1928200 1931208 . - . ID=transcript_4197;P0CF97,Protein FAM200B {ECO:0000305} scaffold17 indexed_genome mRNA 1985870 2023585 . + . ID=transcript_4198;Q9UKC8,F-box/LRR-repeat protein 5,F-box and leucine-rich repeat protein 5;F-box protein FBL4/FBL5;p45SKP2-like protein;, PF12937;PF01814;PF13516;, GO:0005829;GO:0048471;GO:0019005;GO:0000151;GO:0005506;GO:0004842;GO:0006879;GO:0055072;GO:1903364;GO:0043687;GO:0000209;GO:0016567;GO:0031146;, C:cytosol; C:perinuclear region of cytoplasm; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:iron ion binding; F:ubiquitin-protein transferase activity;, P:cellular iron ion homeostasis; P:iron ion homeostasis; P:positive regulation of cellular protein catabolic process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold17 indexed_genome mRNA 2028648 2060001 . - . ID=transcript_4199;Q9P2K1 A6ND97 B3FW08 D6RB72 E7EP21 E9PEV5 Q3SYP3 Q9H8A7,Coiled-coil and C2 domain-containing protein 2A,, PF00168;PF15625;PF17661;, GO:0035869;GO:0005856;GO:0005829;GO:0036038;GO:0097711;GO:0060271;GO:0007224;, C:ciliary transition zone; C:cytoskeleton; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:smoothened signaling pathway;|Q9P2K1 A6ND97 B3FW08 D6RB72 E7EP21 E9PEV5 Q3SYP3 Q9H8A7,Coiled-coil and C2 domain-containing protein 2A,, PF00168;PF15625;PF17661;, GO:0035869;GO:0005856;GO:0005829;GO:0036038;GO:0097711;GO:0060271;GO:0007224;, C:ciliary transition zone; C:cytoskeleton; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:smoothened signaling pathway;|Q9P2K1 A6ND97 B3FW08 D6RB72 E7EP21 E9PEV5 Q3SYP3 Q9H8A7,Coiled-coil and C2 domain-containing protein 2A,, PF00168;PF15625;PF17661;, GO:0035869;GO:0005856;GO:0005829;GO:0036038;GO:0097711;GO:0060271;GO:0007224;, C:ciliary transition zone; C:cytoskeleton; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:smoothened signaling pathway;|Q9P2K1 A6ND97 B3FW08 D6RB72 E7EP21 E9PEV5 Q3SYP3 Q9H8A7,Coiled-coil and C2 domain-containing protein 2A,, PF00168;PF15625;PF17661;, GO:0035869;GO:0005856;GO:0005829;GO:0036038;GO:0097711;GO:0060271;GO:0007224;, C:ciliary transition zone; C:cytoskeleton; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:smoothened signaling pathway;|Q9P2K1 A6ND97 B3FW08 D6RB72 E7EP21 E9PEV5 Q3SYP3 Q9H8A7,Coiled-coil and C2 domain-containing protein 2A,, PF00168;PF15625;PF17661;, GO:0035869;GO:0005856;GO:0005829;GO:0036038;GO:0097711;GO:0060271;GO:0007224;, C:ciliary transition zone; C:cytoskeleton; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:smoothened signaling pathway; scaffold17 indexed_genome mRNA 2062278 2149267 . - . ID=transcript_4200;Q9P2K1 A6ND97 B3FW08 D6RB72 E7EP21 E9PEV5 Q3SYP3 Q9H8A7,Coiled-coil and C2 domain-containing protein 2A,, PF00168;PF15625;PF17661;, GO:0035869;GO:0005856;GO:0005829;GO:0036038;GO:0097711;GO:0060271;GO:0007224;, C:ciliary transition zone; C:cytoskeleton; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:smoothened signaling pathway; scaffold17 indexed_genome mRNA 2176657 2299725 . - . ID=transcript_4201;Q9BXJ2 B2RBT3 J3KPW3,Complement C1q tumor necrosis factor-related protein 7,, PF00386;PF01391;, GO:0005581;GO:0005576;, C:collagen trimer; C:extracellular region;|Q9BXJ2 B2RBT3 J3KPW3,Complement C1q tumor necrosis factor-related protein 7,, PF00386;PF01391;, GO:0005581;GO:0005576;, C:collagen trimer; C:extracellular region; scaffold17 indexed_genome mRNA 2510313 2576763 . - . ID=transcript_4202;Q7Z5Q1 E7EPM3 F5H160 Q3B8N6 Q3MI89 Q3MI90 Q3MI92 Q7Z5Q0,Cytoplasmic polyadenylation element-binding protein 2,, PF16366;PF16367;, GO:0005737;GO:1990124;GO:0043005;GO:0005634;GO:0045202;GO:0005095;GO:0035925;GO:0003730;GO:0043023;GO:0043024;GO:0043022;GO:0003723;GO:0008135;GO:0000900;GO:0071243;GO:0071456;GO:0032869;GO:0034599;GO:2000766;GO:1900248;GO:0034260;, C:cytoplasm; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleus; C:synapse;, F:GTPase inhibitor activity; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosomal large subunit binding; F:ribosomal small subunit binding; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to arsenic-containing substance; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to oxidative stress; P:negative regulation of cytoplasmic translation; P:negative regulation of cytoplasmic translational elongation; P:negative regulation of GTPase activity;|Q7Z5Q1 E7EPM3 F5H160 Q3B8N6 Q3MI89 Q3MI90 Q3MI92 Q7Z5Q0,Cytoplasmic polyadenylation element-binding protein 2,, PF16366;PF16367;, GO:0005737;GO:1990124;GO:0043005;GO:0005634;GO:0045202;GO:0005095;GO:0035925;GO:0003730;GO:0043023;GO:0043024;GO:0043022;GO:0003723;GO:0008135;GO:0000900;GO:0071243;GO:0071456;GO:0032869;GO:0034599;GO:2000766;GO:1900248;GO:0034260;, C:cytoplasm; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleus; C:synapse;, F:GTPase inhibitor activity; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosomal large subunit binding; F:ribosomal small subunit binding; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to arsenic-containing substance; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to oxidative stress; P:negative regulation of cytoplasmic translation; P:negative regulation of cytoplasmic translational elongation; P:negative regulation of GTPase activity;|Q17RY0 B7ZLQ7 Q7Z310 Q8N405 Q9C0J0,Cytoplasmic polyadenylation element-binding protein 4,, PF16366;PF16367;, GO:0005737;GO:0030425;GO:0043197;GO:0005783;GO:0030426;GO:1990124;GO:0043005;GO:0005634;GO:0048471;GO:0014069;GO:0045202;GO:0046872;GO:0003730;GO:0043022;GO:0003723;GO:0008135;GO:0000900;GO:0071230;GO:0036294;GO:0042149;GO:0035235;GO:2000766;GO:0043524;GO:0002931;, C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum; C:growth cone; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:ionotropic glutamate receptor signaling pathway; P:negative regulation of cytoplasmic translation; P:negative regulation of neuron apoptotic process; P:response to ischemia;|Q7Z5Q1 E7EPM3 F5H160 Q3B8N6 Q3MI89 Q3MI90 Q3MI92 Q7Z5Q0,Cytoplasmic polyadenylation element-binding protein 2,, PF16366;PF16367;, GO:0005737;GO:1990124;GO:0043005;GO:0005634;GO:0045202;GO:0005095;GO:0035925;GO:0003730;GO:0043023;GO:0043024;GO:0043022;GO:0003723;GO:0008135;GO:0000900;GO:0071243;GO:0071456;GO:0032869;GO:0034599;GO:2000766;GO:1900248;GO:0034260;, C:cytoplasm; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleus; C:synapse;, F:GTPase inhibitor activity; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosomal large subunit binding; F:ribosomal small subunit binding; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to arsenic-containing substance; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to oxidative stress; P:negative regulation of cytoplasmic translation; P:negative regulation of cytoplasmic translational elongation; P:negative regulation of GTPase activity; scaffold17 indexed_genome mRNA 3801346 3821667 . + . ID=transcript_4203;Q8NFC6 Q6P0M8 Q96AL1 Q9H6G0 Q9NTD6 Q9P2L9,Biorientation of chromosomes in cell division protein 1-like 1 {ECO:0000305},, , GO:0005813;GO:0000940;GO:0005654;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0006974;GO:0006281;GO:0032515;GO:0031297;, C:centrosome; C:condensed chromosome outer kinetochore; C:nucleoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of phosphoprotein phosphatase activity; P:replication fork processing;|Q8NFC6 Q6P0M8 Q96AL1 Q9H6G0 Q9NTD6 Q9P2L9,Biorientation of chromosomes in cell division protein 1-like 1 {ECO:0000305},, , GO:0005813;GO:0000940;GO:0005654;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0006974;GO:0006281;GO:0032515;GO:0031297;, C:centrosome; C:condensed chromosome outer kinetochore; C:nucleoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of phosphoprotein phosphatase activity; P:replication fork processing; scaffold17 indexed_genome mRNA 3821713 3840919 . + . ID=transcript_4204;Q8NFC6 Q6P0M8 Q96AL1 Q9H6G0 Q9NTD6 Q9P2L9,Biorientation of chromosomes in cell division protein 1-like 1 {ECO:0000305},, , GO:0005813;GO:0000940;GO:0005654;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0006974;GO:0006281;GO:0032515;GO:0031297;, C:centrosome; C:condensed chromosome outer kinetochore; C:nucleoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of phosphoprotein phosphatase activity; P:replication fork processing;|Q8NFC6 Q6P0M8 Q96AL1 Q9H6G0 Q9NTD6 Q9P2L9,Biorientation of chromosomes in cell division protein 1-like 1 {ECO:0000305},, , GO:0005813;GO:0000940;GO:0005654;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0006974;GO:0006281;GO:0032515;GO:0031297;, C:centrosome; C:condensed chromosome outer kinetochore; C:nucleoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of phosphoprotein phosphatase activity; P:replication fork processing;|Q8NFC6 Q6P0M8 Q96AL1 Q9H6G0 Q9NTD6 Q9P2L9,Biorientation of chromosomes in cell division protein 1-like 1 {ECO:0000305},, , GO:0005813;GO:0000940;GO:0005654;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0006974;GO:0006281;GO:0032515;GO:0031297;, C:centrosome; C:condensed chromosome outer kinetochore; C:nucleoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of phosphoprotein phosphatase activity; P:replication fork processing;|Q8NFC6 Q6P0M8 Q96AL1 Q9H6G0 Q9NTD6 Q9P2L9,Biorientation of chromosomes in cell division protein 1-like 1 {ECO:0000305},, , GO:0005813;GO:0000940;GO:0005654;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0006974;GO:0006281;GO:0032515;GO:0031297;, C:centrosome; C:condensed chromosome outer kinetochore; C:nucleoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of phosphoprotein phosphatase activity; P:replication fork processing;|Q8NFC6 Q6P0M8 Q96AL1 Q9H6G0 Q9NTD6 Q9P2L9,Biorientation of chromosomes in cell division protein 1-like 1 {ECO:0000305},, , GO:0005813;GO:0000940;GO:0005654;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0006974;GO:0006281;GO:0032515;GO:0031297;, C:centrosome; C:condensed chromosome outer kinetochore; C:nucleoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of phosphoprotein phosphatase activity; P:replication fork processing;|Q8NFC6 Q6P0M8 Q96AL1 Q9H6G0 Q9NTD6 Q9P2L9,Biorientation of chromosomes in cell division protein 1-like 1 {ECO:0000305},, , GO:0005813;GO:0000940;GO:0005654;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0006974;GO:0006281;GO:0032515;GO:0031297;, C:centrosome; C:condensed chromosome outer kinetochore; C:nucleoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of phosphoprotein phosphatase activity; P:replication fork processing; scaffold17 indexed_genome mRNA 3842075 3845144 . + . ID=transcript_4205;Q8NFC6 Q6P0M8 Q96AL1 Q9H6G0 Q9NTD6 Q9P2L9,Biorientation of chromosomes in cell division protein 1-like 1 {ECO:0000305},, , GO:0005813;GO:0000940;GO:0005654;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0006974;GO:0006281;GO:0032515;GO:0031297;, C:centrosome; C:condensed chromosome outer kinetochore; C:nucleoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of phosphoprotein phosphatase activity; P:replication fork processing;|Q8NFC6 Q6P0M8 Q96AL1 Q9H6G0 Q9NTD6 Q9P2L9,Biorientation of chromosomes in cell division protein 1-like 1 {ECO:0000305},, , GO:0005813;GO:0000940;GO:0005654;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0006974;GO:0006281;GO:0032515;GO:0031297;, C:centrosome; C:condensed chromosome outer kinetochore; C:nucleoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of phosphoprotein phosphatase activity; P:replication fork processing; scaffold17 indexed_genome mRNA 3928871 4018767 . + . ID=transcript_4206;P51157 G8JLC5 Q8IYR8 Q8NI05,Ras-related protein Rab-28,, PF00071;, GO:0036064;GO:0035253;GO:0005737;GO:0012505;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0006886;GO:1901998;, C:ciliary basal body; C:ciliary rootlet; C:cytoplasm; C:endomembrane system; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:toxin transport;|P51157 G8JLC5 Q8IYR8 Q8NI05,Ras-related protein Rab-28,, PF00071;, GO:0036064;GO:0035253;GO:0005737;GO:0012505;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0006886;GO:1901998;, C:ciliary basal body; C:ciliary rootlet; C:cytoplasm; C:endomembrane system; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:toxin transport;|P51157 G8JLC5 Q8IYR8 Q8NI05,Ras-related protein Rab-28,, PF00071;, GO:0036064;GO:0035253;GO:0005737;GO:0012505;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0006886;GO:1901998;, C:ciliary basal body; C:ciliary rootlet; C:cytoplasm; C:endomembrane system; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:toxin transport; scaffold17 indexed_genome mRNA 5864496 5898603 . + . ID=transcript_4207;O14792 B3KUA6 Q6PEY8,Heparan sulfate glucosamine 3-O-sulfotransferase 1,Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1;, PF00685;, GO:0005796;GO:0008467;GO:0008146;GO:0006024;, C:Golgi lumen;, F:[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity; F:sulfotransferase activity;, P:glycosaminoglycan biosynthetic process; scaffold17 indexed_genome mRNA 6834337 6838200 . - . ID=transcript_4208;Q9C0D4 Q96LN8,Zinc finger protein 518B,, , GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold17 indexed_genome mRNA 7002160 7041171 . + . ID=transcript_4209;O75083 A8K6E9 A8MPU4 O75313 Q8N6E5 Q9UG05 Q9UG78 Q9UQE0,WD repeat-containing protein 1,Actin-interacting protein 1;NORI-1;, PF00400;, GO:0030054;GO:0042995;GO:0005911;GO:0030864;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0002102;GO:0051015;GO:0030042;GO:0030043;GO:0043297;GO:0030865;GO:0042247;GO:0040011;GO:0045199;GO:0002446;GO:1990266;GO:0002576;GO:0030220;GO:0030836;GO:0030834;GO:0008360;GO:0048713;GO:0060307;GO:0045214;GO:0007605;, C:cell junction; C:cell projection; C:cell-cell junction; C:cortical actin cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:podosome;, F:actin filament binding;, P:actin filament depolymerization; P:actin filament fragmentation; P:apical junction assembly; P:cortical cytoskeleton organization; P:establishment of planar polarity of follicular epithelium; P:locomotion; P:maintenance of epithelial cell apical/basal polarity; P:neutrophil mediated immunity; P:neutrophil migration; P:platelet degranulation; P:platelet formation; P:positive regulation of actin filament depolymerization; P:regulation of actin filament depolymerization; P:regulation of cell shape; P:regulation of oligodendrocyte differentiation; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:sarcomere organization; P:sensory perception of sound;|O75083 A8K6E9 A8MPU4 O75313 Q8N6E5 Q9UG05 Q9UG78 Q9UQE0,WD repeat-containing protein 1,Actin-interacting protein 1;NORI-1;, PF00400;, GO:0030054;GO:0042995;GO:0005911;GO:0030864;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0002102;GO:0051015;GO:0030042;GO:0030043;GO:0043297;GO:0030865;GO:0042247;GO:0040011;GO:0045199;GO:0002446;GO:1990266;GO:0002576;GO:0030220;GO:0030836;GO:0030834;GO:0008360;GO:0048713;GO:0060307;GO:0045214;GO:0007605;, C:cell junction; C:cell projection; C:cell-cell junction; C:cortical actin cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:podosome;, F:actin filament binding;, P:actin filament depolymerization; P:actin filament fragmentation; P:apical junction assembly; P:cortical cytoskeleton organization; P:establishment of planar polarity of follicular epithelium; P:locomotion; P:maintenance of epithelial cell apical/basal polarity; P:neutrophil mediated immunity; P:neutrophil migration; P:platelet degranulation; P:platelet formation; P:positive regulation of actin filament depolymerization; P:regulation of actin filament depolymerization; P:regulation of cell shape; P:regulation of oligodendrocyte differentiation; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:sarcomere organization; P:sensory perception of sound;|O75083 A8K6E9 A8MPU4 O75313 Q8N6E5 Q9UG05 Q9UG78 Q9UQE0,WD repeat-containing protein 1,Actin-interacting protein 1;NORI-1;, PF00400;, GO:0030054;GO:0042995;GO:0005911;GO:0030864;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0002102;GO:0051015;GO:0030042;GO:0030043;GO:0043297;GO:0030865;GO:0042247;GO:0040011;GO:0045199;GO:0002446;GO:1990266;GO:0002576;GO:0030220;GO:0030836;GO:0030834;GO:0008360;GO:0048713;GO:0060307;GO:0045214;GO:0007605;, C:cell junction; C:cell projection; C:cell-cell junction; C:cortical actin cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:podosome;, F:actin filament binding;, P:actin filament depolymerization; P:actin filament fragmentation; P:apical junction assembly; P:cortical cytoskeleton organization; P:establishment of planar polarity of follicular epithelium; P:locomotion; P:maintenance of epithelial cell apical/basal polarity; P:neutrophil mediated immunity; P:neutrophil migration; P:platelet degranulation; P:platelet formation; P:positive regulation of actin filament depolymerization; P:regulation of actin filament depolymerization; P:regulation of cell shape; P:regulation of oligodendrocyte differentiation; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:sarcomere organization; P:sensory perception of sound;|O75083 A8K6E9 A8MPU4 O75313 Q8N6E5 Q9UG05 Q9UG78 Q9UQE0,WD repeat-containing protein 1,Actin-interacting protein 1;NORI-1;, PF00400;, GO:0030054;GO:0042995;GO:0005911;GO:0030864;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0002102;GO:0051015;GO:0030042;GO:0030043;GO:0043297;GO:0030865;GO:0042247;GO:0040011;GO:0045199;GO:0002446;GO:1990266;GO:0002576;GO:0030220;GO:0030836;GO:0030834;GO:0008360;GO:0048713;GO:0060307;GO:0045214;GO:0007605;, C:cell junction; C:cell projection; C:cell-cell junction; C:cortical actin cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:podosome;, F:actin filament binding;, P:actin filament depolymerization; P:actin filament fragmentation; P:apical junction assembly; P:cortical cytoskeleton organization; P:establishment of planar polarity of follicular epithelium; P:locomotion; P:maintenance of epithelial cell apical/basal polarity; P:neutrophil mediated immunity; P:neutrophil migration; P:platelet degranulation; P:platelet formation; P:positive regulation of actin filament depolymerization; P:regulation of actin filament depolymerization; P:regulation of cell shape; P:regulation of oligodendrocyte differentiation; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:sarcomere organization; P:sensory perception of sound; scaffold17 indexed_genome mRNA 7435007 7445380 . - . ID=transcript_4210;Q5BJH2 B4DHS7 D3DVS1 D3DVS3 Q5H9U6 Q96I94,Transmembrane protein 128,, , GO:0016021;, C:integral component of membrane;|Q5BJH2 B4DHS7 D3DVS1 D3DVS3 Q5H9U6 Q96I94,Transmembrane protein 128,, , GO:0016021;, C:integral component of membrane;|Q5BJH2 B4DHS7 D3DVS1 D3DVS3 Q5H9U6 Q96I94,Transmembrane protein 128,, , GO:0016021;, C:integral component of membrane;|Q5BJH2 B4DHS7 D3DVS1 D3DVS3 Q5H9U6 Q96I94,Transmembrane protein 128,, , GO:0016021;, C:integral component of membrane;|Q5BJH2 B4DHS7 D3DVS1 D3DVS3 Q5H9U6 Q96I94,Transmembrane protein 128,, , GO:0016021;, C:integral component of membrane; scaffold17 indexed_genome mRNA 7460115 7495162 . - . ID=transcript_4211;Q9NX58 D3DVS4 Q6FI78 Q9NYS1,Cell growth-regulating nucleolar protein,, PF17848;PF08790;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0001750;GO:0033613;GO:0003677;GO:0042802;GO:0046872;GO:0003723;GO:0140416;GO:0048821;GO:0045087;GO:0045824;GO:0000122;GO:0050766;GO:0045943;GO:0006364;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:photoreceptor outer segment;, F:activating transcription factor binding; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription regulator inhibitor activity;, P:erythrocyte development; P:innate immune response; P:negative regulation of innate immune response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of phagocytosis; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q9NX58 D3DVS4 Q6FI78 Q9NYS1,Cell growth-regulating nucleolar protein,, PF17848;PF08790;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0001750;GO:0033613;GO:0003677;GO:0042802;GO:0046872;GO:0003723;GO:0140416;GO:0048821;GO:0045087;GO:0045824;GO:0000122;GO:0050766;GO:0045943;GO:0006364;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:photoreceptor outer segment;, F:activating transcription factor binding; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription regulator inhibitor activity;, P:erythrocyte development; P:innate immune response; P:negative regulation of innate immune response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of phagocytosis; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q9NX58 D3DVS4 Q6FI78 Q9NYS1,Cell growth-regulating nucleolar protein,, PF17848;PF08790;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0001750;GO:0033613;GO:0003677;GO:0042802;GO:0046872;GO:0003723;GO:0140416;GO:0048821;GO:0045087;GO:0045824;GO:0000122;GO:0050766;GO:0045943;GO:0006364;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:photoreceptor outer segment;, F:activating transcription factor binding; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription regulator inhibitor activity;, P:erythrocyte development; P:innate immune response; P:negative regulation of innate immune response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of phagocytosis; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q9NX58 D3DVS4 Q6FI78 Q9NYS1,Cell growth-regulating nucleolar protein,, PF17848;PF08790;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0001750;GO:0033613;GO:0003677;GO:0042802;GO:0046872;GO:0003723;GO:0140416;GO:0048821;GO:0045087;GO:0045824;GO:0000122;GO:0050766;GO:0045943;GO:0006364;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:photoreceptor outer segment;, F:activating transcription factor binding; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription regulator inhibitor activity;, P:erythrocyte development; P:innate immune response; P:negative regulation of innate immune response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of phagocytosis; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q6ZSB9 A8K936 Q32ML0 Q59FJ4 Q5EBN0 Q8TB80,Zinc finger and BTB domain-containing protein 49,Zinc finger protein 509;, PF00651;PF00096;, GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001223;GO:0008134;GO:0007050;GO:0008285;GO:0045944;GO:0006357;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:transcription factor binding;, P:cell cycle arrest; P:negative regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q6ZSB9 A8K936 Q32ML0 Q59FJ4 Q5EBN0 Q8TB80,Zinc finger and BTB domain-containing protein 49,Zinc finger protein 509;, PF00651;PF00096;, GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001223;GO:0008134;GO:0007050;GO:0008285;GO:0045944;GO:0006357;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:transcription factor binding;, P:cell cycle arrest; P:negative regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold17 indexed_genome mRNA 7502246 7511636 . - . ID=transcript_4212;Q6ZSB9 A8K936 Q32ML0 Q59FJ4 Q5EBN0 Q8TB80,Zinc finger and BTB domain-containing protein 49,Zinc finger protein 509;, PF00651;PF00096;, GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001223;GO:0008134;GO:0007050;GO:0008285;GO:0045944;GO:0006357;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:transcription factor binding;, P:cell cycle arrest; P:negative regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q6ZSB9 A8K936 Q32ML0 Q59FJ4 Q5EBN0 Q8TB80,Zinc finger and BTB domain-containing protein 49,Zinc finger protein 509;, PF00651;PF00096;, GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001223;GO:0008134;GO:0007050;GO:0008285;GO:0045944;GO:0006357;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:transcription factor binding;, P:cell cycle arrest; P:negative regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q6ZSB9 A8K936 Q32ML0 Q59FJ4 Q5EBN0 Q8TB80,Zinc finger and BTB domain-containing protein 49,Zinc finger protein 509;, PF00651;PF00096;, GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001223;GO:0008134;GO:0007050;GO:0008285;GO:0045944;GO:0006357;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:transcription factor binding;, P:cell cycle arrest; P:negative regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q6ZSB9 A8K936 Q32ML0 Q59FJ4 Q5EBN0 Q8TB80,Zinc finger and BTB domain-containing protein 49,Zinc finger protein 509;, PF00651;PF00096;, GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001223;GO:0008134;GO:0007050;GO:0008285;GO:0045944;GO:0006357;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:transcription factor binding;, P:cell cycle arrest; P:negative regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q6ZSB9 A8K936 Q32ML0 Q59FJ4 Q5EBN0 Q8TB80,Zinc finger and BTB domain-containing protein 49,Zinc finger protein 509;, PF00651;PF00096;, GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001223;GO:0008134;GO:0007050;GO:0008285;GO:0045944;GO:0006357;, C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:transcription factor binding;, P:cell cycle arrest; P:negative regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold17 indexed_genome mRNA 7558067 7632797 . + . ID=transcript_4213;Q9P2W9 Q596L3 Q5TZP5,Syntaxin-18,Cell growth-inhibiting gene 9 protein;, PF10496;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0031201;GO:0019904;GO:0005484;GO:0090158;GO:0006886;GO:1902953;GO:1902117;GO:1903358;GO:0006890;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:SNARE complex;, F:protein domain specific binding; F:SNAP receptor activity;, P:endoplasmic reticulum membrane organization; P:intracellular protein transport; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of organelle assembly; P:regulation of Golgi organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P42857 B4DXC5 Q49AQ1,Neuronal vesicle trafficking-associated protein 1 {ECO:0000305},Neuron-enriched endosomal protein of 21 kDa {ECO:0000303|PubMed:20878061};Neuron-specific protein family member 1 {ECO:0000312|HGNC:HGNC:18790};, PF06387;, GO:0005737;GO:0030659;GO:0030425;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0098978;GO:0032580;GO:0016021;GO:0005770;GO:0016328;GO:0043202;GO:0032585;GO:0005634;GO:0098845;GO:0045211;GO:0055038;GO:0036477;GO:0032588;GO:0032051;GO:0005102;GO:0042982;GO:0006915;GO:0048268;GO:0007212;GO:0016197;GO:0099627;GO:0098887;GO:0001921;GO:0099630;GO:0001881;GO:1900271;GO:0098814;GO:0099003;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:dendrite; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:glutamatergic synapse; C:Golgi cisterna membrane; C:integral component of membrane; C:late endosome; C:lateral plasma membrane; C:lysosomal lumen; C:multivesicular body membrane; C:nucleus; C:postsynaptic endosome; C:postsynaptic membrane; C:recycling endosome membrane; C:somatodendritic compartment; C:trans-Golgi network membrane;, F:clathrin light chain binding; F:signaling receptor binding;, P:amyloid precursor protein metabolic process; P:apoptotic process; P:clathrin coat assembly; P:dopamine receptor signaling pathway; P:endosomal transport; P:neurotransmitter receptor cycle; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:positive regulation of receptor recycling; P:postsynaptic neurotransmitter receptor cycle; P:receptor recycling; P:regulation of long-term synaptic potentiation; P:spontaneous synaptic transmission; P:vesicle-mediated transport in synapse;|Q9P2W9 Q596L3 Q5TZP5,Syntaxin-18,Cell growth-inhibiting gene 9 protein;, PF10496;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0031201;GO:0019904;GO:0005484;GO:0090158;GO:0006886;GO:1902953;GO:1902117;GO:1903358;GO:0006890;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:SNARE complex;, F:protein domain specific binding; F:SNAP receptor activity;, P:endoplasmic reticulum membrane organization; P:intracellular protein transport; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of organelle assembly; P:regulation of Golgi organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9P2W9 Q596L3 Q5TZP5,Syntaxin-18,Cell growth-inhibiting gene 9 protein;, PF10496;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0031201;GO:0019904;GO:0005484;GO:0090158;GO:0006886;GO:1902953;GO:1902117;GO:1903358;GO:0006890;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:SNARE complex;, F:protein domain specific binding; F:SNAP receptor activity;, P:endoplasmic reticulum membrane organization; P:intracellular protein transport; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of organelle assembly; P:regulation of Golgi organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold17 indexed_genome mRNA 8120462 8125201 . - . ID=transcript_4214;Q9NRR1,Cytokine-like protein 1,Protein C17;, PF15153;, GO:0005615;GO:0005102;GO:1990079;GO:0002062;GO:0050650;GO:0048839;GO:0051091;GO:0045944;GO:0007165;, C:extracellular space;, F:signaling receptor binding;, P:cartilage homeostasis; P:chondrocyte differentiation; P:chondroitin sulfate proteoglycan biosynthetic process; P:inner ear development; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:signal transduction; scaffold17 indexed_genome mRNA 8505663 8538260 . + . ID=transcript_4215;Q9NY57 Q6UXH3 Q8IY14,Serine/threonine-protein kinase 32B,Yet another novel kinase 2;, PF00069;, GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;, , F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; scaffold17 indexed_genome mRNA 8579361 8605116 . - . ID=transcript_4216;Q86UK5 Q86YT3 Q86YT4 Q8NG49,Limbin,Ellis-van Creveld syndrome protein 2;, PF12297;, GO:0060170;GO:0005929;GO:0005737;GO:0005856;GO:0016021;GO:0005634;GO:0098797;GO:0007224;, C:ciliary membrane; C:cilium; C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:nucleus; C:plasma membrane protein complex;, , P:smoothened signaling pathway; scaffold17 indexed_genome mRNA 8622736 8633192 . - . ID=transcript_4217;Q86UK5 Q86YT3 Q86YT4 Q8NG49,Limbin,Ellis-van Creveld syndrome protein 2;, PF12297;, GO:0060170;GO:0005929;GO:0005737;GO:0005856;GO:0016021;GO:0005634;GO:0098797;GO:0007224;, C:ciliary membrane; C:cilium; C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:nucleus; C:plasma membrane protein complex;, , P:smoothened signaling pathway; scaffold17 indexed_genome mRNA 8658722 8711742 . - . ID=transcript_4218;Q86UK5 Q86YT3 Q86YT4 Q8NG49,Limbin,Ellis-van Creveld syndrome protein 2;, PF12297;, GO:0060170;GO:0005929;GO:0005737;GO:0005856;GO:0016021;GO:0005634;GO:0098797;GO:0007224;, C:ciliary membrane; C:cilium; C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:nucleus; C:plasma membrane protein complex;, , P:smoothened signaling pathway; scaffold17 indexed_genome mRNA 8711753 8733104 . - . ID=transcript_4219;Q86UK5 Q86YT3 Q86YT4 Q8NG49,Limbin,Ellis-van Creveld syndrome protein 2;, PF12297;, GO:0060170;GO:0005929;GO:0005737;GO:0005856;GO:0016021;GO:0005634;GO:0098797;GO:0007224;, C:ciliary membrane; C:cilium; C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:nucleus; C:plasma membrane protein complex;, , P:smoothened signaling pathway; scaffold17 indexed_genome mRNA 8736782 8829717 . + . ID=transcript_4220;P57679,Ellis-van Creveld syndrome protein,DWF-1;, , GO:0036064;GO:0060170;GO:0005929;GO:0005737;GO:0016021;GO:0098797;GO:0051216;GO:0003416;GO:0007517;GO:0045880;GO:0001501;GO:0007224;, C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytoplasm; C:integral component of membrane; C:plasma membrane protein complex;, , P:cartilage development; P:endochondral bone growth; P:muscle organ development; P:positive regulation of smoothened signaling pathway; P:skeletal system development; P:smoothened signaling pathway; scaffold17 indexed_genome mRNA 8837385 8838518 . - . ID=transcript_4221;Q14194 A0EJG6 Q13024 Q4W5F1 Q96TC8,Dihydropyrimidinase-related protein 1,Collapsin response mediator protein 1;Inactive dihydropyrimidinase {ECO:0000305};Unc-33-like phosphoprotein 3;, PF01979;, GO:0005813;GO:0005829;GO:0030426;GO:0030496;GO:0005634;GO:0043204;GO:0005819;GO:0031005;GO:0016810;GO:0042802;GO:0007411;GO:0000226;GO:1904530;GO:0010977;GO:0007399;GO:0006139;, C:centrosome; C:cytosol; C:growth cone; C:midbody; C:nucleus; C:perikaryon; C:spindle;, F:filamin binding; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:identical protein binding;, P:axon guidance; P:microtubule cytoskeleton organization; P:negative regulation of actin filament binding; P:negative regulation of neuron projection development; P:nervous system development; P:nucleobase-containing compound metabolic process; scaffold17 indexed_genome mRNA 8846617 8857267 . - . ID=transcript_4222;Q14194 A0EJG6 Q13024 Q4W5F1 Q96TC8,Dihydropyrimidinase-related protein 1,Collapsin response mediator protein 1;Inactive dihydropyrimidinase {ECO:0000305};Unc-33-like phosphoprotein 3;, PF01979;, GO:0005813;GO:0005829;GO:0030426;GO:0030496;GO:0005634;GO:0043204;GO:0005819;GO:0031005;GO:0016810;GO:0042802;GO:0007411;GO:0000226;GO:1904530;GO:0010977;GO:0007399;GO:0006139;, C:centrosome; C:cytosol; C:growth cone; C:midbody; C:nucleus; C:perikaryon; C:spindle;, F:filamin binding; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:identical protein binding;, P:axon guidance; P:microtubule cytoskeleton organization; P:negative regulation of actin filament binding; P:negative regulation of neuron projection development; P:nervous system development; P:nucleobase-containing compound metabolic process; scaffold17 indexed_genome mRNA 9068550 9115158 . - . ID=transcript_4223;Q86Y69 Q8N7G3,Janus kinase and microtubule-interacting protein 1,GABA-B receptor-binding protein;Multiple alpha-helices and RNA-linker protein 1;, PF16034;, GO:0005737;GO:0019898;GO:0005874;GO:1990904;GO:0050811;GO:0019900;GO:0008017;GO:0003723;GO:0050890;GO:0015031;, C:cytoplasm; C:extrinsic component of membrane; C:microtubule; C:ribonucleoprotein complex;, F:GABA receptor binding; F:kinase binding; F:microtubule binding; F:RNA binding;, P:cognition; P:protein transport; scaffold17 indexed_genome mRNA 9231720 9262135 . + . ID=transcript_4224;Q9NP66 A6NHY3 D3DW78 Q53G31 Q9NSF6,High mobility group protein 20A,HMG box-containing protein 20A;HMG domain-containing protein 1;HMG domain-containing protein HMGX1;, PF00505;, GO:0005634;GO:0003677;GO:0042802;GO:0006325;GO:0045665;GO:0033234;GO:0000122;GO:0010468;GO:0006355;, C:nucleus;, F:DNA binding; F:identical protein binding;, P:chromatin organization; P:negative regulation of neuron differentiation; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription, DNA-templated; scaffold17 indexed_genome mRNA 9288160 9321153 . + . ID=transcript_4225;O76024 B2R797 D3DVT1 Q8N6I3 Q9UNW6,Wolframin,, , GO:0030425;GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0051117;GO:0031625;GO:0055074;GO:0044267;GO:0032469;GO:0030968;GO:0006983;GO:0042593;GO:0036498;GO:0001822;GO:1903892;GO:0043433;GO:0043524;GO:0043069;GO:0000122;GO:2000675;GO:0050877;GO:0051928;GO:0045927;GO:0051247;GO:0031398;GO:0043687;GO:0022417;GO:0050821;GO:0003091;GO:0034976;GO:0007605;GO:0030433;GO:0007601;, C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:ATPase binding; F:ubiquitin protein ligase binding;, P:calcium ion homeostasis; P:cellular protein metabolic process; P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum unfolded protein response; P:ER overload response; P:glucose homeostasis; P:IRE1-mediated unfolded protein response; P:kidney development; P:negative regulation of ATF6-mediated unfolded protein response; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron apoptotic process; P:negative regulation of programmed cell death; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of type B pancreatic cell apoptotic process; P:nervous system process; P:positive regulation of calcium ion transport; P:positive regulation of growth; P:positive regulation of protein metabolic process; P:positive regulation of protein ubiquitination; P:post-translational protein modification; P:protein maturation by protein folding; P:protein stabilization; P:renal water homeostasis; P:response to endoplasmic reticulum stress; P:sensory perception of sound; P:ubiquitin-dependent ERAD pathway; P:visual perception;|O76024 B2R797 D3DVT1 Q8N6I3 Q9UNW6,Wolframin,, , GO:0030425;GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0051117;GO:0031625;GO:0055074;GO:0044267;GO:0032469;GO:0030968;GO:0006983;GO:0042593;GO:0036498;GO:0001822;GO:1903892;GO:0043433;GO:0043524;GO:0043069;GO:0000122;GO:2000675;GO:0050877;GO:0051928;GO:0045927;GO:0051247;GO:0031398;GO:0043687;GO:0022417;GO:0050821;GO:0003091;GO:0034976;GO:0007605;GO:0030433;GO:0007601;, C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:ATPase binding; F:ubiquitin protein ligase binding;, P:calcium ion homeostasis; P:cellular protein metabolic process; P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum unfolded protein response; P:ER overload response; P:glucose homeostasis; P:IRE1-mediated unfolded protein response; P:kidney development; P:negative regulation of ATF6-mediated unfolded protein response; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron apoptotic process; P:negative regulation of programmed cell death; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of type B pancreatic cell apoptotic process; P:nervous system process; P:positive regulation of calcium ion transport; P:positive regulation of growth; P:positive regulation of protein metabolic process; P:positive regulation of protein ubiquitination; P:post-translational protein modification; P:protein maturation by protein folding; P:protein stabilization; P:renal water homeostasis; P:response to endoplasmic reticulum stress; P:sensory perception of sound; P:ubiquitin-dependent ERAD pathway; P:visual perception;|O76024 B2R797 D3DVT1 Q8N6I3 Q9UNW6,Wolframin,, , GO:0030425;GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0051117;GO:0031625;GO:0055074;GO:0044267;GO:0032469;GO:0030968;GO:0006983;GO:0042593;GO:0036498;GO:0001822;GO:1903892;GO:0043433;GO:0043524;GO:0043069;GO:0000122;GO:2000675;GO:0050877;GO:0051928;GO:0045927;GO:0051247;GO:0031398;GO:0043687;GO:0022417;GO:0050821;GO:0003091;GO:0034976;GO:0007605;GO:0030433;GO:0007601;, C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:ATPase binding; F:ubiquitin protein ligase binding;, P:calcium ion homeostasis; P:cellular protein metabolic process; P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum unfolded protein response; P:ER overload response; P:glucose homeostasis; P:IRE1-mediated unfolded protein response; P:kidney development; P:negative regulation of ATF6-mediated unfolded protein response; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron apoptotic process; P:negative regulation of programmed cell death; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of type B pancreatic cell apoptotic process; P:nervous system process; P:positive regulation of calcium ion transport; P:positive regulation of growth; P:positive regulation of protein metabolic process; P:positive regulation of protein ubiquitination; P:post-translational protein modification; P:protein maturation by protein folding; P:protein stabilization; P:renal water homeostasis; P:response to endoplasmic reticulum stress; P:sensory perception of sound; P:ubiquitin-dependent ERAD pathway; P:visual perception; scaffold17 indexed_genome mRNA 9335918 9489745 . - . ID=transcript_4226;Q9Y2T4 A8MSY7 B7Z3Y1 Q7Z4V7 Q8NEC4 Q9H3G7,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform,IMYPNO1;PP2A subunit B isoform B55-gamma;PP2A subunit B isoform PR55-gamma;PP2A subunit B isoform R2-gamma;PP2A subunit B isoform gamma;, , GO:0005829;GO:0000159;GO:0019888;GO:0070262;, C:cytosol; C:protein phosphatase type 2A complex;, F:protein phosphatase regulator activity;, P:peptidyl-serine dephosphorylation; scaffold17 indexed_genome mRNA 9677395 9693576 . - . ID=transcript_4227;Q13316 A1L4L3 O43265,Dentin matrix acidic phosphoprotein 1,, PF07263;, GO:0005788;GO:0031012;GO:0005576;GO:0005634;GO:0005509;GO:0050840;GO:0005178;GO:0031214;GO:0044267;GO:0030198;GO:0001503;GO:0010811;GO:0043687;GO:0070173;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:nucleus;, F:calcium ion binding; F:extracellular matrix binding; F:integrin binding;, P:biomineral tissue development; P:cellular protein metabolic process; P:extracellular matrix organization; P:ossification; P:positive regulation of cell-substrate adhesion; P:post-translational protein modification; P:regulation of enamel mineralization; scaffold17 indexed_genome mRNA 9785330 9832877 . + . ID=transcript_4228;Q14515 B4E2Z0 E7ESU2 Q14800,SPARC-like protein 1,High endothelial venule protein;MAST 9;, PF09289;PF00050;PF10591;, GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0098978;GO:0005509;GO:0005518;GO:0050840;GO:0048856;GO:0044267;GO:0043687;GO:0007165;GO:0099560;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:glutamatergic synapse;, F:calcium ion binding; F:collagen binding; F:extracellular matrix binding;, P:anatomical structure development; P:cellular protein metabolic process; P:post-translational protein modification; P:signal transduction; P:synaptic membrane adhesion;|Q14515 B4E2Z0 E7ESU2 Q14800,SPARC-like protein 1,High endothelial venule protein;MAST 9;, PF09289;PF00050;PF10591;, GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0098978;GO:0005509;GO:0005518;GO:0050840;GO:0048856;GO:0044267;GO:0043687;GO:0007165;GO:0099560;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:glutamatergic synapse;, F:calcium ion binding; F:collagen binding; F:extracellular matrix binding;, P:anatomical structure development; P:cellular protein metabolic process; P:post-translational protein modification; P:signal transduction; P:synaptic membrane adhesion; scaffold17 indexed_genome mRNA 9846237 9880749 . - . ID=transcript_4229;Q9BW91 Q8NBN1 Q8NCB9 Q8NG25,ADP-ribose pyrophosphatase, mitochondrial,ADP-ribose diphosphatase;ADP-ribose phosphohydrolase;Adenosine diphosphoribose pyrophosphatase;Nucleoside diphosphate-linked moiety X motif 9;, PF00293;, GO:0030054;GO:0070062;GO:0005759;GO:0005739;GO:0016604;GO:0031965;GO:0047631;GO:0019144;GO:0046032;GO:0046709;GO:0034656;, C:cell junction; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nuclear body; C:nuclear membrane;, F:ADP-ribose diphosphatase activity; F:ADP-sugar diphosphatase activity;, P:ADP catabolic process; P:IDP catabolic process; P:nucleobase-containing small molecule catabolic process;|Q9BW91 Q8NBN1 Q8NCB9 Q8NG25,ADP-ribose pyrophosphatase, mitochondrial,ADP-ribose diphosphatase;ADP-ribose phosphohydrolase;Adenosine diphosphoribose pyrophosphatase;Nucleoside diphosphate-linked moiety X motif 9;, PF00293;, GO:0030054;GO:0070062;GO:0005759;GO:0005739;GO:0016604;GO:0031965;GO:0047631;GO:0019144;GO:0046032;GO:0046709;GO:0034656;, C:cell junction; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nuclear body; C:nuclear membrane;, F:ADP-ribose diphosphatase activity; F:ADP-sugar diphosphatase activity;, P:ADP catabolic process; P:IDP catabolic process; P:nucleobase-containing small molecule catabolic process; scaffold17 indexed_genome mRNA 9923019 9959523 . + . ID=transcript_4230;Q8NBQ5 Q96HF6 Q9UKU4,Estradiol 17-beta-dehydrogenase 11,17-beta-hydroxysteroid dehydrogenase 11;17-beta-hydroxysteroid dehydrogenase XI;Cutaneous T-cell lymphoma-associated antigen HD-CL-03;Dehydrogenase/reductase SDR family member 8;Retinal short-chain dehydrogenase/reductase 2;Short chain dehydrogenase/reductase family 16C member 2;, PF00106;, GO:0005737;GO:0005829;GO:0005783;GO:0005811;GO:0044594;GO:0072582;GO:0016616;GO:0016229;GO:0006710;GO:0006703;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:steroid dehydrogenase activity;, P:androgen catabolic process; P:estrogen biosynthetic process;|Q8NBQ5 Q96HF6 Q9UKU4,Estradiol 17-beta-dehydrogenase 11,17-beta-hydroxysteroid dehydrogenase 11;17-beta-hydroxysteroid dehydrogenase XI;Cutaneous T-cell lymphoma-associated antigen HD-CL-03;Dehydrogenase/reductase SDR family member 8;Retinal short-chain dehydrogenase/reductase 2;Short chain dehydrogenase/reductase family 16C member 2;, PF00106;, GO:0005737;GO:0005829;GO:0005783;GO:0005811;GO:0044594;GO:0072582;GO:0016616;GO:0016229;GO:0006710;GO:0006703;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:steroid dehydrogenase activity;, P:androgen catabolic process; P:estrogen biosynthetic process; scaffold17 indexed_genome mRNA 9961243 9963276 . + . ID=transcript_4231;Q9Y2D8 A8K8W0 B4DFE3 D3DT13 J3KR02 Q6P2P8 Q6ULS1 Q7L168 Q9UIX0,Afadin- and alpha-actinin-binding protein,Afadin DIL domain-interacting protein;SSX2-interacting protein;, PF11559;, GO:0005912;GO:0031252;GO:0034451;GO:0036064;GO:0005737;GO:0005634;GO:0032991;GO:0019904;GO:0007155;GO:0007098;GO:0060271;GO:0035735;GO:2000145;GO:0035020;, C:adherens junction; C:cell leading edge; C:centriolar satellite; C:ciliary basal body; C:cytoplasm; C:nucleus; C:protein-containing complex;, F:protein domain specific binding;, P:cell adhesion; P:centrosome cycle; P:cilium assembly; P:intraciliary transport involved in cilium assembly; P:regulation of cell motility; P:regulation of Rac protein signal transduction; scaffold17 indexed_genome mRNA 9975499 10002778 . + . ID=transcript_4232;Q7Z5P4 A8K9R9 Q2M1L5 Q86W22 Q86W23,17-beta-hydroxysteroid dehydrogenase 13,Short chain dehydrogenase/reductase family 16C member 3;Short-chain dehydrogenase/reductase 9;, PF00106;, GO:0005829;GO:0005783;GO:0005811;GO:0016616;GO:0016229;GO:0034389;GO:0046889;, C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:steroid dehydrogenase activity;, P:lipid droplet organization; P:positive regulation of lipid biosynthetic process;|Q7Z5P4 A8K9R9 Q2M1L5 Q86W22 Q86W23,17-beta-hydroxysteroid dehydrogenase 13,Short chain dehydrogenase/reductase family 16C member 3;Short-chain dehydrogenase/reductase 9;, PF00106;, GO:0005829;GO:0005783;GO:0005811;GO:0016616;GO:0016229;GO:0034389;GO:0046889;, C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:steroid dehydrogenase activity;, P:lipid droplet organization; P:positive regulation of lipid biosynthetic process;|Q7Z5P4 A8K9R9 Q2M1L5 Q86W22 Q86W23,17-beta-hydroxysteroid dehydrogenase 13,Short chain dehydrogenase/reductase family 16C member 3;Short-chain dehydrogenase/reductase 9;, PF00106;, GO:0005829;GO:0005783;GO:0005811;GO:0016616;GO:0016229;GO:0034389;GO:0046889;, C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:steroid dehydrogenase activity;, P:lipid droplet organization; P:positive regulation of lipid biosynthetic process; scaffold17 indexed_genome mRNA 10072532 10090576 . + . ID=transcript_4233;Q9P2G9 Q53XA3 Q6N018,Kelch-like protein 8,, PF07707;PF00651;PF01344;, GO:0031463;GO:0005654;GO:0016567;GO:0006511;, C:Cul3-RING ubiquitin ligase complex; C:nucleoplasm;, , P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold17 indexed_genome mRNA 10110315 10203863 . - . ID=transcript_4234;P51825 B4DTU1 E9PBM3,AF4/FMR2 family member 1,ALL1-fused gene from chromosome 4 protein;Protein FEL;Proto-oncogene AF4;, PF18876;PF18875;, GO:0032783;GO:0008023;GO:0010468;, C:super elongation complex; C:transcription elongation factor complex;, , P:regulation of gene expression;|P51825 B4DTU1 E9PBM3,AF4/FMR2 family member 1,ALL1-fused gene from chromosome 4 protein;Protein FEL;Proto-oncogene AF4;, PF18876;PF18875;, GO:0032783;GO:0008023;GO:0010468;, C:super elongation complex; C:transcription elongation factor complex;, , P:regulation of gene expression; scaffold17 indexed_genome mRNA 10432289 10649785 . - . ID=transcript_4235;Q9NYN9 Q9UDA8,Tyrosine-protein phosphatase non-receptor type 13,Fas-associated protein-tyrosine phosphatase 1;PTP-BAS;Protein-tyrosine phosphatase 1E;Protein-tyrosine phosphatase PTPL1;, PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0044297;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0001650;GO:0030027;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0036312;GO:0004725;GO:0071345;GO:0001933;GO:0035335;GO:0006661;GO:0006470;GO:0014066;, C:cell body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:fibrillar center; C:lamellipodium; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:negative regulation of protein phosphorylation; P:peptidyl-tyrosine dephosphorylation; P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling;|Q9NYN9 Q9UDA8,Tyrosine-protein phosphatase non-receptor type 13,Fas-associated protein-tyrosine phosphatase 1;PTP-BAS;Protein-tyrosine phosphatase 1E;Protein-tyrosine phosphatase PTPL1;, PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0044297;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0001650;GO:0030027;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0036312;GO:0004725;GO:0071345;GO:0001933;GO:0035335;GO:0006661;GO:0006470;GO:0014066;, C:cell body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:fibrillar center; C:lamellipodium; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:negative regulation of protein phosphorylation; P:peptidyl-tyrosine dephosphorylation; P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling;|Q9NYN9 Q9UDA8,Tyrosine-protein phosphatase non-receptor type 13,Fas-associated protein-tyrosine phosphatase 1;PTP-BAS;Protein-tyrosine phosphatase 1E;Protein-tyrosine phosphatase PTPL1;, PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0044297;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0001650;GO:0030027;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0036312;GO:0004725;GO:0071345;GO:0001933;GO:0035335;GO:0006661;GO:0006470;GO:0014066;, C:cell body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:fibrillar center; C:lamellipodium; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:negative regulation of protein phosphorylation; P:peptidyl-tyrosine dephosphorylation; P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling;|Q9NYN9 Q9UDA8,Tyrosine-protein phosphatase non-receptor type 13,Fas-associated protein-tyrosine phosphatase 1;PTP-BAS;Protein-tyrosine phosphatase 1E;Protein-tyrosine phosphatase PTPL1;, PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0044297;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0001650;GO:0030027;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0036312;GO:0004725;GO:0071345;GO:0001933;GO:0035335;GO:0006661;GO:0006470;GO:0014066;, C:cell body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:fibrillar center; C:lamellipodium; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:negative regulation of protein phosphorylation; P:peptidyl-tyrosine dephosphorylation; P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; scaffold17 indexed_genome mRNA 10890397 11248547 . + . ID=transcript_4236;P53779 A6NFS3 A6NG28 B3KQ94 Q15707 Q49AP1,Mitogen-activated protein kinase 10,MAP kinase p49 3F12;Stress-activated protein kinase 1b;Stress-activated protein kinase JNK3;c-Jun N-terminal kinase 3;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0004705;GO:0004707;GO:0004708;GO:0106310;GO:0106311;GO:0038095;GO:0035556;GO:0007254;GO:0006468;GO:0042752;GO:0051090;GO:0010468;GO:0009416;GO:0048511;GO:0007165;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:MAP kinase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:response to light stimulus; P:rhythmic process; P:signal transduction;|Q8N5C5,Mitogen-activated protein kinase 9,JNK-55;Stress-activated protein kinase 1a;Stress-activated protein kinase JNK2;c-Jun N-terminal kinase 2;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0004705;GO:0004707;GO:0106310;GO:0004712;GO:0106311;GO:0008134;GO:0071276;GO:0034614;GO:0038095;GO:0035556;GO:0007254;GO:0018105;GO:2001235;GO:0010628;GO:0010744;GO:0071803;GO:0031398;GO:1901485;GO:0061833;GO:0006468;GO:0042752;GO:0051090;GO:0010468;GO:0048511;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transcription factor binding;, P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of podosome assembly; P:positive regulation of protein ubiquitination; P:positive regulation of transcription factor catabolic process; P:protein localization to tricellular tight junction; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:rhythmic process;|P53779 A6NFS3 A6NG28 B3KQ94 Q15707 Q49AP1,Mitogen-activated protein kinase 10,MAP kinase p49 3F12;Stress-activated protein kinase 1b;Stress-activated protein kinase JNK3;c-Jun N-terminal kinase 3;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0004705;GO:0004707;GO:0004708;GO:0106310;GO:0106311;GO:0038095;GO:0035556;GO:0007254;GO:0006468;GO:0042752;GO:0051090;GO:0010468;GO:0009416;GO:0048511;GO:0007165;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:MAP kinase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:response to light stimulus; P:rhythmic process; P:signal transduction;|P53779 A6NFS3 A6NG28 B3KQ94 Q15707 Q49AP1,Mitogen-activated protein kinase 10,MAP kinase p49 3F12;Stress-activated protein kinase 1b;Stress-activated protein kinase JNK3;c-Jun N-terminal kinase 3;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0004705;GO:0004707;GO:0004708;GO:0106310;GO:0106311;GO:0038095;GO:0035556;GO:0007254;GO:0006468;GO:0042752;GO:0051090;GO:0010468;GO:0009416;GO:0048511;GO:0007165;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:MAP kinase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:response to light stimulus; P:rhythmic process; P:signal transduction;|P53779 A6NFS3 A6NG28 B3KQ94 Q15707 Q49AP1,Mitogen-activated protein kinase 10,MAP kinase p49 3F12;Stress-activated protein kinase 1b;Stress-activated protein kinase JNK3;c-Jun N-terminal kinase 3;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0004705;GO:0004707;GO:0004708;GO:0106310;GO:0106311;GO:0038095;GO:0035556;GO:0007254;GO:0006468;GO:0042752;GO:0051090;GO:0010468;GO:0009416;GO:0048511;GO:0007165;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:MAP kinase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:response to light stimulus; P:rhythmic process; P:signal transduction; scaffold17 indexed_genome mRNA 11259599 11449496 . + . ID=transcript_4237;Q8N264 Q4KMG1 Q6ZNV3 Q86TI5 Q86WE4 Q9H0T6,Rho GTPase-activating protein 24,Filamin-A-associated RhoGAP;RAC1- and CDC42-specific GTPase-activating protein of 72 kDa;Rho-type GTPase-activating protein 24;RhoGAP of 73 kDa;Sarcoma antigen NY-SAR-88;p73RhoGAP;, PF00169;PF00620;, GO:0005912;GO:0042995;GO:0005856;GO:0005829;GO:0005925;GO:0005096;GO:0090630;GO:0001525;GO:0030154;GO:0035021;GO:1900028;GO:0051056;GO:0007165;GO:0035313;, C:adherens junction; C:cell projection; C:cytoskeleton; C:cytosol; C:focal adhesion;, F:GTPase activator activity;, P:activation of GTPase activity; P:angiogenesis; P:cell differentiation; P:negative regulation of Rac protein signal transduction; P:negative regulation of ruffle assembly; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:wound healing, spreading of epidermal cells;|Q8N264 Q4KMG1 Q6ZNV3 Q86TI5 Q86WE4 Q9H0T6,Rho GTPase-activating protein 24,Filamin-A-associated RhoGAP;RAC1- and CDC42-specific GTPase-activating protein of 72 kDa;Rho-type GTPase-activating protein 24;RhoGAP of 73 kDa;Sarcoma antigen NY-SAR-88;p73RhoGAP;, PF00169;PF00620;, GO:0005912;GO:0042995;GO:0005856;GO:0005829;GO:0005925;GO:0005096;GO:0090630;GO:0001525;GO:0030154;GO:0035021;GO:1900028;GO:0051056;GO:0007165;GO:0035313;, C:adherens junction; C:cell projection; C:cytoskeleton; C:cytosol; C:focal adhesion;, F:GTPase activator activity;, P:activation of GTPase activity; P:angiogenesis; P:cell differentiation; P:negative regulation of Rac protein signal transduction; P:negative regulation of ruffle assembly; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:wound healing, spreading of epidermal cells; scaffold17 indexed_genome mRNA 12262977 12540553 . + . ID=transcript_4238;Q8IZQ1 Q4W5K5 Q6P0Q5 Q8N1T2 Q8NAV6 Q96BS7 Q96D33 Q96N85 Q9Y2J7,WD repeat and FYVE domain-containing protein 3,Autophagy-linked FYVE protein;, PF02138;PF01363;PF14844;, GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0097635;GO:0019898;GO:0016234;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0043204;GO:0005886;GO:0016605;GO:0005545;GO:0046872;GO:0035973;GO:0007275;, C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:extrinsic component of autophagosome membrane; C:extrinsic component of membrane; C:inclusion body; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:perikaryon; C:plasma membrane; C:PML body;, F:1-phosphatidylinositol binding; F:metal ion binding;, P:aggrephagy; P:multicellular organism development;|Q8IZQ1 Q4W5K5 Q6P0Q5 Q8N1T2 Q8NAV6 Q96BS7 Q96D33 Q96N85 Q9Y2J7,WD repeat and FYVE domain-containing protein 3,Autophagy-linked FYVE protein;, PF02138;PF01363;PF14844;, GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0097635;GO:0019898;GO:0016234;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0043204;GO:0005886;GO:0016605;GO:0005545;GO:0046872;GO:0035973;GO:0007275;, C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:extrinsic component of autophagosome membrane; C:extrinsic component of membrane; C:inclusion body; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:perikaryon; C:plasma membrane; C:PML body;, F:1-phosphatidylinositol binding; F:metal ion binding;, P:aggrephagy; P:multicellular organism development;|Q8IZQ1 Q4W5K5 Q6P0Q5 Q8N1T2 Q8NAV6 Q96BS7 Q96D33 Q96N85 Q9Y2J7,WD repeat and FYVE domain-containing protein 3,Autophagy-linked FYVE protein;, PF02138;PF01363;PF14844;, GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0097635;GO:0019898;GO:0016234;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0043204;GO:0005886;GO:0016605;GO:0005545;GO:0046872;GO:0035973;GO:0007275;, C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:extrinsic component of autophagosome membrane; C:extrinsic component of membrane; C:inclusion body; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:perikaryon; C:plasma membrane; C:PML body;, F:1-phosphatidylinositol binding; F:metal ion binding;, P:aggrephagy; P:multicellular organism development;|Q8IZQ1 Q4W5K5 Q6P0Q5 Q8N1T2 Q8NAV6 Q96BS7 Q96D33 Q96N85 Q9Y2J7,WD repeat and FYVE domain-containing protein 3,Autophagy-linked FYVE protein;, PF02138;PF01363;PF14844;, GO:0005776;GO:0030424;GO:0005737;GO:0005829;GO:0097635;GO:0019898;GO:0016234;GO:0005635;GO:0031965;GO:0005730;GO:0005654;GO:0043204;GO:0005886;GO:0016605;GO:0005545;GO:0046872;GO:0035973;GO:0007275;, C:autophagosome; C:axon; C:cytoplasm; C:cytosol; C:extrinsic component of autophagosome membrane; C:extrinsic component of membrane; C:inclusion body; C:nuclear envelope; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:perikaryon; C:plasma membrane; C:PML body;, F:1-phosphatidylinositol binding; F:metal ion binding;, P:aggrephagy; P:multicellular organism development; scaffold17 indexed_genome mRNA 12552468 12597059 . - . ID=transcript_4239;Q92903 B2RAL5 O00163,Phosphatidate cytidylyltransferase 1 {ECO:0000305},CDP-DAG synthase 1;CDP-DG synthase 1;CDP-diacylglycerol synthase 1;CDP-diglyceride pyrophosphorylase 1;CDP-diglyceride synthase 1;CTP:phosphatidate cytidylyltransferase 1;, , GO:0005783;GO:0005789;GO:0016021;GO:0004142;GO:0004605;GO:0016024;GO:0140042;GO:0006661;GO:0007602;GO:0045600;GO:0007165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:diacylglycerol cholinephosphotransferase activity; F:phosphatidate cytidylyltransferase activity;, P:CDP-diacylglycerol biosynthetic process; P:lipid droplet formation; P:phosphatidylinositol biosynthetic process; P:phototransduction; P:positive regulation of fat cell differentiation; P:signal transduction;|Q92903 B2RAL5 O00163,Phosphatidate cytidylyltransferase 1 {ECO:0000305},CDP-DAG synthase 1;CDP-DG synthase 1;CDP-diacylglycerol synthase 1;CDP-diglyceride pyrophosphorylase 1;CDP-diglyceride synthase 1;CTP:phosphatidate cytidylyltransferase 1;, , GO:0005783;GO:0005789;GO:0016021;GO:0004142;GO:0004605;GO:0016024;GO:0140042;GO:0006661;GO:0007602;GO:0045600;GO:0007165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:diacylglycerol cholinephosphotransferase activity; F:phosphatidate cytidylyltransferase activity;, P:CDP-diacylglycerol biosynthetic process; P:lipid droplet formation; P:phosphatidylinositol biosynthetic process; P:phototransduction; P:positive regulation of fat cell differentiation; P:signal transduction;|Q92903 B2RAL5 O00163,Phosphatidate cytidylyltransferase 1 {ECO:0000305},CDP-DAG synthase 1;CDP-DG synthase 1;CDP-diacylglycerol synthase 1;CDP-diglyceride pyrophosphorylase 1;CDP-diglyceride synthase 1;CTP:phosphatidate cytidylyltransferase 1;, , GO:0005783;GO:0005789;GO:0016021;GO:0004142;GO:0004605;GO:0016024;GO:0140042;GO:0006661;GO:0007602;GO:0045600;GO:0007165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:diacylglycerol cholinephosphotransferase activity; F:phosphatidate cytidylyltransferase activity;, P:CDP-diacylglycerol biosynthetic process; P:lipid droplet formation; P:phosphatidylinositol biosynthetic process; P:phototransduction; P:positive regulation of fat cell differentiation; P:signal transduction; scaffold17 indexed_genome mRNA 13474834 14489764 . + . ID=transcript_4240;Q86SK9 B2RPG0 Q4W5Q5 Q8NDS0 Q9H7D1,Stearoyl-CoA desaturase 5 {ECO:0000303|PubMed:22745828},Acyl-CoA-desaturase 4 {ECO:0000303|PubMed:12727354};HSCD5 {ECO:0000303|PubMed:15907797};Stearoyl-CoA 9-desaturase {ECO:0000303|PubMed:15907797};Stearoyl-CoA desaturase 2 {ECO:0000303|PubMed:15610069};, PF00487;, GO:0005789;GO:0016021;GO:0005506;GO:0016491;GO:0004768;GO:0046949;GO:1903966;GO:0007399;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:iron ion binding; F:oxidoreductase activity; F:stearoyl-CoA 9-desaturase activity;, P:fatty-acyl-CoA biosynthetic process; P:monounsaturated fatty acid biosynthetic process; P:nervous system development; P:unsaturated fatty acid biosynthetic process;|Q6UWZ7 A5JJ07 Q9H8I1 Q9H9N4,BRCA1-A complex subunit Abraxas 1 {ECO:0000312|HGNC:HGNC:25829},Coiled-coil domain-containing protein 98;Protein FAM175A;, , GO:0070531;GO:0016604;GO:0005654;GO:0005634;GO:0008017;GO:0031593;GO:0008608;GO:0006325;GO:0006302;GO:0006303;GO:0090307;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:mitotic spindle assembly; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q53EU6 Q68CJ4 Q6GPI6 Q96NA3,Glycerol-3-phosphate acyltransferase 3 {ECO:0000312|HGNC:HGNC:28157},1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10 {ECO:0000303|PubMed:19318427};1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9;Acyl-CoA:glycerol-3-phosphate acyltransferase 3 {ECO:0000303|PubMed:19318427};Lung cancer metastasis-associated protein 1;Lysophosphatidic acid acyltransferase theta;MAG-1;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0003841;GO:0004366;GO:0102420;GO:0016024;GO:0006072;GO:0006654;GO:0032006;GO:0019432;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:CDP-diacylglycerol biosynthetic process; P:glycerol-3-phosphate metabolic process; P:phosphatidic acid biosynthetic process; P:regulation of TOR signaling; P:triglyceride biosynthetic process;|Q53EU6 Q68CJ4 Q6GPI6 Q96NA3,Glycerol-3-phosphate acyltransferase 3 {ECO:0000312|HGNC:HGNC:28157},1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10 {ECO:0000303|PubMed:19318427};1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9;Acyl-CoA:glycerol-3-phosphate acyltransferase 3 {ECO:0000303|PubMed:19318427};Lung cancer metastasis-associated protein 1;Lysophosphatidic acid acyltransferase theta;MAG-1;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0003841;GO:0004366;GO:0102420;GO:0016024;GO:0006072;GO:0006654;GO:0032006;GO:0019432;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:CDP-diacylglycerol biosynthetic process; P:glycerol-3-phosphate metabolic process; P:phosphatidic acid biosynthetic process; P:regulation of TOR signaling; P:triglyceride biosynthetic process;|Q53EU6 Q68CJ4 Q6GPI6 Q96NA3,Glycerol-3-phosphate acyltransferase 3 {ECO:0000312|HGNC:HGNC:28157},1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10 {ECO:0000303|PubMed:19318427};1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9;Acyl-CoA:glycerol-3-phosphate acyltransferase 3 {ECO:0000303|PubMed:19318427};Lung cancer metastasis-associated protein 1;Lysophosphatidic acid acyltransferase theta;MAG-1;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0003841;GO:0004366;GO:0102420;GO:0016024;GO:0006072;GO:0006654;GO:0032006;GO:0019432;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:CDP-diacylglycerol biosynthetic process; P:glycerol-3-phosphate metabolic process; P:phosphatidic acid biosynthetic process; P:regulation of TOR signaling; P:triglyceride biosynthetic process;|Q6UWZ7 A5JJ07 Q9H8I1 Q9H9N4,BRCA1-A complex subunit Abraxas 1 {ECO:0000312|HGNC:HGNC:25829},Coiled-coil domain-containing protein 98;Protein FAM175A;, , GO:0070531;GO:0016604;GO:0005654;GO:0005634;GO:0008017;GO:0031593;GO:0008608;GO:0006325;GO:0006302;GO:0006303;GO:0090307;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:mitotic spindle assembly; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q6UWZ7 A5JJ07 Q9H8I1 Q9H9N4,BRCA1-A complex subunit Abraxas 1 {ECO:0000312|HGNC:HGNC:25829},Coiled-coil domain-containing protein 98;Protein FAM175A;, , GO:0070531;GO:0016604;GO:0005654;GO:0005634;GO:0008017;GO:0031593;GO:0008608;GO:0006325;GO:0006302;GO:0006303;GO:0090307;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:mitotic spindle assembly; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q6UWZ7 A5JJ07 Q9H8I1 Q9H9N4,BRCA1-A complex subunit Abraxas 1 {ECO:0000312|HGNC:HGNC:25829},Coiled-coil domain-containing protein 98;Protein FAM175A;, , GO:0070531;GO:0016604;GO:0005654;GO:0005634;GO:0008017;GO:0031593;GO:0008608;GO:0006325;GO:0006302;GO:0006303;GO:0090307;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:mitotic spindle assembly; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q6UWZ7 A5JJ07 Q9H8I1 Q9H9N4,BRCA1-A complex subunit Abraxas 1 {ECO:0000312|HGNC:HGNC:25829},Coiled-coil domain-containing protein 98;Protein FAM175A;, , GO:0070531;GO:0016604;GO:0005654;GO:0005634;GO:0008017;GO:0031593;GO:0008608;GO:0006325;GO:0006302;GO:0006303;GO:0090307;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:mitotic spindle assembly; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q6UWZ7 A5JJ07 Q9H8I1 Q9H9N4,BRCA1-A complex subunit Abraxas 1 {ECO:0000312|HGNC:HGNC:25829},Coiled-coil domain-containing protein 98;Protein FAM175A;, , GO:0070531;GO:0016604;GO:0005654;GO:0005634;GO:0008017;GO:0031593;GO:0008608;GO:0006325;GO:0006302;GO:0006303;GO:0090307;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:mitotic spindle assembly; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q6UWZ7 A5JJ07 Q9H8I1 Q9H9N4,BRCA1-A complex subunit Abraxas 1 {ECO:0000312|HGNC:HGNC:25829},Coiled-coil domain-containing protein 98;Protein FAM175A;, , GO:0070531;GO:0016604;GO:0005654;GO:0005634;GO:0008017;GO:0031593;GO:0008608;GO:0006325;GO:0006302;GO:0006303;GO:0090307;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:mitotic spindle assembly; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q8TDG4 Q05DF9 Q502W9 Q659B8 Q6ZQX4 Q6ZTS4 Q96EX7,Helicase POLQ-like,Mus308-like helicase;POLQ-like helicase;, PF00270;PF00271;, GO:0005634;GO:0005524;GO:0003677;GO:1990518;GO:0000724;GO:0006364;, C:nucleus;, F:ATP binding; F:DNA binding; F:single-stranded 3'-5' DNA helicase activity;, P:double-strand break repair via homologous recombination; P:rRNA processing;|Q8TDG4 Q05DF9 Q502W9 Q659B8 Q6ZQX4 Q6ZTS4 Q96EX7,Helicase POLQ-like,Mus308-like helicase;POLQ-like helicase;, PF00270;PF00271;, GO:0005634;GO:0005524;GO:0003677;GO:1990518;GO:0000724;GO:0006364;, C:nucleus;, F:ATP binding; F:DNA binding; F:single-stranded 3'-5' DNA helicase activity;, P:double-strand break repair via homologous recombination; P:rRNA processing;|Q8TDG4 Q05DF9 Q502W9 Q659B8 Q6ZQX4 Q6ZTS4 Q96EX7,Helicase POLQ-like,Mus308-like helicase;POLQ-like helicase;, PF00270;PF00271;, GO:0005634;GO:0005524;GO:0003677;GO:1990518;GO:0000724;GO:0006364;, C:nucleus;, F:ATP binding; F:DNA binding; F:single-stranded 3'-5' DNA helicase activity;, P:double-strand break repair via homologous recombination; P:rRNA processing;|Q8TDG4 Q05DF9 Q502W9 Q659B8 Q6ZQX4 Q6ZTS4 Q96EX7,Helicase POLQ-like,Mus308-like helicase;POLQ-like helicase;, PF00270;PF00271;, GO:0005634;GO:0005524;GO:0003677;GO:1990518;GO:0000724;GO:0006364;, C:nucleus;, F:ATP binding; F:DNA binding; F:single-stranded 3'-5' DNA helicase activity;, P:double-strand break repair via homologous recombination; P:rRNA processing;|Q9Y251 A9JIG7 C7F7I3 C7F7I4 E9PCA9 E9PGR1 Q53GE5 Q9UL39,Heparanase,Endo-glucoronidase;Heparanase-1;, PF03662;, GO:0031012;GO:0005576;GO:1904974;GO:0043231;GO:0043202;GO:0005765;GO:0005764;GO:0045121;GO:0005654;GO:0005634;GO:0035580;GO:0004566;GO:0030305;GO:0045545;GO:0060055;GO:0007160;GO:0006027;GO:0030200;GO:0043312;GO:0030194;GO:0051798;GO:0033690;GO:0051897;GO:0010575;GO:0006029;GO:0051797;GO:0061042;, C:extracellular matrix; C:extracellular region; C:heparanase complex; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane raft; C:nucleoplasm; C:nucleus; C:specific granule lumen;, F:beta-glucuronidase activity; F:heparanase activity; F:syndecan binding;, P:angiogenesis involved in wound healing; P:cell-matrix adhesion; P:glycosaminoglycan catabolic process; P:heparan sulfate proteoglycan catabolic process; P:neutrophil degranulation; P:positive regulation of blood coagulation; P:positive regulation of hair follicle development; P:positive regulation of osteoblast proliferation; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular endothelial growth factor production; P:proteoglycan metabolic process; P:regulation of hair follicle development; P:vascular wound healing;|Q96H96 O95331 Q1JQ78 Q684R2,4-hydroxybenzoate polyprenyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03189},4-hydroxybenzoate decaprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};COQ2 homolog;Para-hydroxybenzoate--polyprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};, PF01040;, GO:0031305;GO:0005743;GO:0002083;GO:0047293;GO:0004659;GO:0016765;GO:0006071;GO:0008299;GO:0006744;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane;, F:4-hydroxybenzoate decaprenyltransferase activity; F:4-hydroxybenzoate nonaprenyltransferase activity; F:prenyltransferase activity; F:transferase activity, transferring alkyl or aryl (other than methyl) groups;, P:glycerol metabolic process; P:isoprenoid biosynthetic process; P:ubiquinone biosynthetic process;|Q96H96 O95331 Q1JQ78 Q684R2,4-hydroxybenzoate polyprenyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03189},4-hydroxybenzoate decaprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};COQ2 homolog;Para-hydroxybenzoate--polyprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};, PF01040;, GO:0031305;GO:0005743;GO:0002083;GO:0047293;GO:0004659;GO:0016765;GO:0006071;GO:0008299;GO:0006744;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane;, F:4-hydroxybenzoate decaprenyltransferase activity; F:4-hydroxybenzoate nonaprenyltransferase activity; F:prenyltransferase activity; F:transferase activity, transferring alkyl or aryl (other than methyl) groups;, P:glycerol metabolic process; P:isoprenoid biosynthetic process; P:ubiquinone biosynthetic process;|Q96H96 O95331 Q1JQ78 Q684R2,4-hydroxybenzoate polyprenyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03189},4-hydroxybenzoate decaprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};COQ2 homolog;Para-hydroxybenzoate--polyprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};, PF01040;, GO:0031305;GO:0005743;GO:0002083;GO:0047293;GO:0004659;GO:0016765;GO:0006071;GO:0008299;GO:0006744;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane;, F:4-hydroxybenzoate decaprenyltransferase activity; F:4-hydroxybenzoate nonaprenyltransferase activity; F:prenyltransferase activity; F:transferase activity, transferring alkyl or aryl (other than methyl) groups;, P:glycerol metabolic process; P:isoprenoid biosynthetic process; P:ubiquinone biosynthetic process;|Q96H96 O95331 Q1JQ78 Q684R2,4-hydroxybenzoate polyprenyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03189},4-hydroxybenzoate decaprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};COQ2 homolog;Para-hydroxybenzoate--polyprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};, PF01040;, GO:0031305;GO:0005743;GO:0002083;GO:0047293;GO:0004659;GO:0016765;GO:0006071;GO:0008299;GO:0006744;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane;, F:4-hydroxybenzoate decaprenyltransferase activity; F:4-hydroxybenzoate nonaprenyltransferase activity; F:prenyltransferase activity; F:transferase activity, transferring alkyl or aryl (other than methyl) groups;, P:glycerol metabolic process; P:isoprenoid biosynthetic process; P:ubiquinone biosynthetic process;|Q9NZF1 C1K3N2,Placenta-specific gene 8 protein,Protein C15;, PF04749;, GO:0035578;GO:0005576;GO:0003682;GO:0050873;GO:0042742;GO:0043066;GO:0040015;GO:0043312;GO:0008284;GO:0120162;GO:0045944;GO:0009409;, C:azurophil granule lumen; C:extracellular region;, F:chromatin binding;, P:brown fat cell differentiation; P:defense response to bacterium; P:negative regulation of apoptotic process; P:negative regulation of multicellular organism growth; P:neutrophil degranulation; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:response to cold;|Q9BT78 B3KN88 B3KST5 Q561W7 Q9NW31 Q9Y677,COP9 signalosome complex subunit 4,JAB1-containing signalosome subunit 4;, PF18420;PF01399;, GO:0030054;GO:0008180;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0008021;GO:0000715;GO:0043687;GO:0000338;GO:0006283;, C:cell junction; C:COP9 signalosome; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:synaptic vesicle;, , P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair;|Q9BT78 B3KN88 B3KST5 Q561W7 Q9NW31 Q9Y677,COP9 signalosome complex subunit 4,JAB1-containing signalosome subunit 4;, PF18420;PF01399;, GO:0030054;GO:0008180;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0008021;GO:0000715;GO:0043687;GO:0000338;GO:0006283;, C:cell junction; C:COP9 signalosome; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:synaptic vesicle;, , P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair;|Q9BT78 B3KN88 B3KST5 Q561W7 Q9NW31 Q9Y677,COP9 signalosome complex subunit 4,JAB1-containing signalosome subunit 4;, PF18420;PF01399;, GO:0030054;GO:0008180;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0008021;GO:0000715;GO:0043687;GO:0000338;GO:0006283;, C:cell junction; C:COP9 signalosome; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:synaptic vesicle;, , P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair;|Q9BT78 B3KN88 B3KST5 Q561W7 Q9NW31 Q9Y677,COP9 signalosome complex subunit 4,JAB1-containing signalosome subunit 4;, PF18420;PF01399;, GO:0030054;GO:0008180;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0008021;GO:0000715;GO:0043687;GO:0000338;GO:0006283;, C:cell junction; C:COP9 signalosome; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:synaptic vesicle;, , P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair;|Q9BT78 B3KN88 B3KST5 Q561W7 Q9NW31 Q9Y677,COP9 signalosome complex subunit 4,JAB1-containing signalosome subunit 4;, PF18420;PF01399;, GO:0030054;GO:0008180;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0008021;GO:0000715;GO:0043687;GO:0000338;GO:0006283;, C:cell junction; C:COP9 signalosome; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:synaptic vesicle;, , P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair;|Q9BT78 B3KN88 B3KST5 Q561W7 Q9NW31 Q9Y677,COP9 signalosome complex subunit 4,JAB1-containing signalosome subunit 4;, PF18420;PF01399;, GO:0030054;GO:0008180;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0008021;GO:0000715;GO:0043687;GO:0000338;GO:0006283;, C:cell junction; C:COP9 signalosome; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:synaptic vesicle;, , P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair;|Q6MZP7 Q32M68 Q32M69 Q6N071 Q76B60,Protein lin-54 homolog,CXC domain-containing protein 1;, PF03638;, GO:0005654;GO:0005634;GO:0046872;GO:0003680;GO:0001067;GO:0007049;GO:0016584;GO:0051726;GO:0006355;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:minor groove of adenine-thymine-rich DNA binding; F:regulatory region nucleic acid binding;, P:cell cycle; P:nucleosome positioning; P:regulation of cell cycle; P:regulation of transcription, DNA-templated;|Q6MZP7 Q32M68 Q32M69 Q6N071 Q76B60,Protein lin-54 homolog,CXC domain-containing protein 1;, PF03638;, GO:0005654;GO:0005634;GO:0046872;GO:0003680;GO:0001067;GO:0007049;GO:0016584;GO:0051726;GO:0006355;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:minor groove of adenine-thymine-rich DNA binding; F:regulatory region nucleic acid binding;, P:cell cycle; P:nucleosome positioning; P:regulation of cell cycle; P:regulation of transcription, DNA-templated;|Q6MZP7 Q32M68 Q32M69 Q6N071 Q76B60,Protein lin-54 homolog,CXC domain-containing protein 1;, PF03638;, GO:0005654;GO:0005634;GO:0046872;GO:0003680;GO:0001067;GO:0007049;GO:0016584;GO:0051726;GO:0006355;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:minor groove of adenine-thymine-rich DNA binding; F:regulatory region nucleic acid binding;, P:cell cycle; P:nucleosome positioning; P:regulation of cell cycle; P:regulation of transcription, DNA-templated;|Q6MZP7 Q32M68 Q32M69 Q6N071 Q76B60,Protein lin-54 homolog,CXC domain-containing protein 1;, PF03638;, GO:0005654;GO:0005634;GO:0046872;GO:0003680;GO:0001067;GO:0007049;GO:0016584;GO:0051726;GO:0006355;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:minor groove of adenine-thymine-rich DNA binding; F:regulatory region nucleic acid binding;, P:cell cycle; P:nucleosome positioning; P:regulation of cell cycle; P:regulation of transcription, DNA-templated;|Q6MZP7 Q32M68 Q32M69 Q6N071 Q76B60,Protein lin-54 homolog,CXC domain-containing protein 1;, PF03638;, GO:0005654;GO:0005634;GO:0046872;GO:0003680;GO:0001067;GO:0007049;GO:0016584;GO:0051726;GO:0006355;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:minor groove of adenine-thymine-rich DNA binding; F:regulatory region nucleic acid binding;, P:cell cycle; P:nucleosome positioning; P:regulation of cell cycle; P:regulation of transcription, DNA-templated;|Q6MZP7 Q32M68 Q32M69 Q6N071 Q76B60,Protein lin-54 homolog,CXC domain-containing protein 1;, PF03638;, GO:0005654;GO:0005634;GO:0046872;GO:0003680;GO:0001067;GO:0007049;GO:0016584;GO:0051726;GO:0006355;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:minor groove of adenine-thymine-rich DNA binding; F:regulatory region nucleic acid binding;, P:cell cycle; P:nucleosome positioning; P:regulation of cell cycle; P:regulation of transcription, DNA-templated;|Q9H5L6 B3KRE2 Q59AC9,DNA transposase THAP9,THAP domain-containing protein 9;, PF05485;PF12017;, GO:0003677;GO:0046872;GO:0043565;GO:0016740;GO:0004803;GO:0015074;GO:0006310;GO:0006313;, , F:DNA binding; F:metal ion binding; F:sequence-specific DNA binding; F:transferase activity; F:transposase activity;, P:DNA integration; P:DNA recombination; P:transposition, DNA-mediated;|Q9H5L6 B3KRE2 Q59AC9,DNA transposase THAP9,THAP domain-containing protein 9;, PF05485;PF12017;, GO:0003677;GO:0046872;GO:0043565;GO:0016740;GO:0004803;GO:0015074;GO:0006310;GO:0006313;, , F:DNA binding; F:metal ion binding; F:sequence-specific DNA binding; F:transferase activity; F:transposase activity;, P:DNA integration; P:DNA recombination; P:transposition, DNA-mediated;|Q9H5L6 B3KRE2 Q59AC9,DNA transposase THAP9,THAP domain-containing protein 9;, PF05485;PF12017;, GO:0003677;GO:0046872;GO:0043565;GO:0016740;GO:0004803;GO:0015074;GO:0006310;GO:0006313;, , F:DNA binding; F:metal ion binding; F:sequence-specific DNA binding; F:transferase activity; F:transposase activity;, P:DNA integration; P:DNA recombination; P:transposition, DNA-mediated;|Q6ZU90 Q7LCX9 Q86TJ0 Q8IZH4 Q9P048 Q9P0A6 Q9UM05 Q9UM06,Protein transport protein Sec31A,ABP125;ABP130;SEC31-like protein 1;SEC31-related protein A;Web1-like protein;, PF12931;, GO:0030127;GO:0030134;GO:0005737;GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0043231;GO:0048471;GO:0030120;GO:0048306;GO:0005198;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0007029;GO:0006888;GO:0006886;GO:0036498;GO:0051592;, C:COPII vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:vesicle coat;, F:calcium-dependent protein binding; F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:IRE1-mediated unfolded protein response; P:response to calcium ion;|Q6ZU90 Q7LCX9 Q86TJ0 Q8IZH4 Q9P048 Q9P0A6 Q9UM05 Q9UM06,Protein transport protein Sec31A,ABP125;ABP130;SEC31-like protein 1;SEC31-related protein A;Web1-like protein;, PF12931;, GO:0030127;GO:0030134;GO:0005737;GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0043231;GO:0048471;GO:0030120;GO:0048306;GO:0005198;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0007029;GO:0006888;GO:0006886;GO:0036498;GO:0051592;, C:COPII vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:vesicle coat;, F:calcium-dependent protein binding; F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:IRE1-mediated unfolded protein response; P:response to calcium ion;|Q6ZU90 Q7LCX9 Q86TJ0 Q8IZH4 Q9P048 Q9P0A6 Q9UM05 Q9UM06,Protein transport protein Sec31A,ABP125;ABP130;SEC31-like protein 1;SEC31-related protein A;Web1-like protein;, PF12931;, GO:0030127;GO:0030134;GO:0005737;GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0043231;GO:0048471;GO:0030120;GO:0048306;GO:0005198;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0007029;GO:0006888;GO:0006886;GO:0036498;GO:0051592;, C:COPII vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:vesicle coat;, F:calcium-dependent protein binding; F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:IRE1-mediated unfolded protein response; P:response to calcium ion;|Q6ZU90 Q7LCX9 Q86TJ0 Q8IZH4 Q9P048 Q9P0A6 Q9UM05 Q9UM06,Protein transport protein Sec31A,ABP125;ABP130;SEC31-like protein 1;SEC31-related protein A;Web1-like protein;, PF12931;, GO:0030127;GO:0030134;GO:0005737;GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0043231;GO:0048471;GO:0030120;GO:0048306;GO:0005198;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0007029;GO:0006888;GO:0006886;GO:0036498;GO:0051592;, C:COPII vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:vesicle coat;, F:calcium-dependent protein binding; F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:IRE1-mediated unfolded protein response; P:response to calcium ion;|Q6ZU90 Q7LCX9 Q86TJ0 Q8IZH4 Q9P048 Q9P0A6 Q9UM05 Q9UM06,Protein transport protein Sec31A,ABP125;ABP130;SEC31-like protein 1;SEC31-related protein A;Web1-like protein;, PF12931;, GO:0030127;GO:0030134;GO:0005737;GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0043231;GO:0048471;GO:0030120;GO:0048306;GO:0005198;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0007029;GO:0006888;GO:0006886;GO:0036498;GO:0051592;, C:COPII vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:vesicle coat;, F:calcium-dependent protein binding; F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:IRE1-mediated unfolded protein response; P:response to calcium ion;|Q86SK9 B2RPG0 Q4W5Q5 Q8NDS0 Q9H7D1,Stearoyl-CoA desaturase 5 {ECO:0000303|PubMed:22745828},Acyl-CoA-desaturase 4 {ECO:0000303|PubMed:12727354};HSCD5 {ECO:0000303|PubMed:15907797};Stearoyl-CoA 9-desaturase {ECO:0000303|PubMed:15907797};Stearoyl-CoA desaturase 2 {ECO:0000303|PubMed:15610069};, PF00487;, GO:0005789;GO:0016021;GO:0005506;GO:0016491;GO:0004768;GO:0046949;GO:1903966;GO:0007399;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:iron ion binding; F:oxidoreductase activity; F:stearoyl-CoA 9-desaturase activity;, P:fatty-acyl-CoA biosynthetic process; P:monounsaturated fatty acid biosynthetic process; P:nervous system development; P:unsaturated fatty acid biosynthetic process; scaffold17 indexed_genome mRNA 14560722 14671164 . + . ID=transcript_4241;B9EJG8 B7Z4J5 B7Z4L3 B7Z692 B7Z6X6,Transmembrane protein 150C,, PF10277;, GO:0005887;GO:0005765;GO:0005764;GO:0008381;GO:0071260;GO:0019230;GO:0010506;, C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome;, F:mechanosensitive ion channel activity;, P:cellular response to mechanical stimulus; P:proprioception; P:regulation of autophagy; scaffold17 indexed_genome mRNA 14692088 14727490 . - . ID=transcript_4242;Q9UHY7 Q7Z4C5 Q9BVC2,Enolase-phosphatase E1 {ECO:0000255|HAMAP-Rule:MF_03117},2,3-diketo-5-methylthio-1-phosphopentane phosphatase {ECO:0000255|HAMAP-Rule:MF_03117};MASA homolog {ECO:0000255|HAMAP-Rule:MF_03117};, , GO:0005829;GO:0005634;GO:0043715;GO:0043716;GO:0043874;GO:0000287;GO:0019509;GO:0019284;, C:cytosol; C:nucleus;, F:2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity; F:2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity; F:acireductone synthase activity; F:magnesium ion binding;, P:L-methionine salvage from methylthioadenosine; P:L-methionine salvage from S-adenosylmethionine;|Q9UHY7 Q7Z4C5 Q9BVC2,Enolase-phosphatase E1 {ECO:0000255|HAMAP-Rule:MF_03117},2,3-diketo-5-methylthio-1-phosphopentane phosphatase {ECO:0000255|HAMAP-Rule:MF_03117};MASA homolog {ECO:0000255|HAMAP-Rule:MF_03117};, , GO:0005829;GO:0005634;GO:0043715;GO:0043716;GO:0043874;GO:0000287;GO:0019509;GO:0019284;, C:cytosol; C:nucleus;, F:2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity; F:2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity; F:acireductone synthase activity; F:magnesium ion binding;, P:L-methionine salvage from methylthioadenosine; P:L-methionine salvage from S-adenosylmethionine; scaffold17 indexed_genome mRNA 14739364 14747478 . + . ID=transcript_4243;O14979 Q6SPF2 Q7KZ74 Q7KZ75 Q96IM0 Q96S43,Heterogeneous nuclear ribonucleoprotein D-like,AU-rich element RNA-binding factor;JKT41-binding protein;Protein laAUF1;, PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0003690;GO:0008143;GO:0034046;GO:0003723;GO:0003697;GO:0035722;GO:0010468;GO:0006396;, C:cytosol; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:double-stranded DNA binding; F:poly(A) binding; F:poly(G) binding; F:RNA binding; F:single-stranded DNA binding;, P:interleukin-12-mediated signaling pathway; P:regulation of gene expression; P:RNA processing;|O14979 Q6SPF2 Q7KZ74 Q7KZ75 Q96IM0 Q96S43,Heterogeneous nuclear ribonucleoprotein D-like,AU-rich element RNA-binding factor;JKT41-binding protein;Protein laAUF1;, PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0003690;GO:0008143;GO:0034046;GO:0003723;GO:0003697;GO:0035722;GO:0010468;GO:0006396;, C:cytosol; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:double-stranded DNA binding; F:poly(A) binding; F:poly(G) binding; F:RNA binding; F:single-stranded DNA binding;, P:interleukin-12-mediated signaling pathway; P:regulation of gene expression; P:RNA processing; scaffold17 indexed_genome mRNA 14787837 14793085 . + . ID=transcript_4244;Q9UCE9,Heterogeneous nuclear ribonucleoprotein D0,AU-rich element RNA-binding protein 1;, PF08143;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0045202;GO:0003682;GO:0042826;GO:0003680;GO:0035925;GO:0003723;GO:0042162;GO:0008134;GO:0061158;GO:0071230;GO:0071392;GO:0071732;GO:1904586;GO:0021549;GO:0097167;GO:1990828;GO:0001889;GO:0000398;GO:0048255;GO:0042789;GO:1905663;GO:1904355;GO:0045944;GO:0045893;GO:0045727;GO:0042752;GO:0010468;GO:0043488;GO:0032204;GO:0006355;GO:0051592;GO:0051602;GO:1901355;GO:1904383;GO:0006401;GO:0016070;GO:0006396;, C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:synapse;, F:chromatin binding; F:histone deacetylase binding; F:minor groove of adenine-thymine-rich DNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:telomeric DNA binding; F:transcription factor binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to amino acid stimulus; P:cellular response to estradiol stimulus; P:cellular response to nitric oxide; P:cellular response to putrescine; P:cerebellum development; P:circadian regulation of translation; P:hepatocyte dedifferentiation; P:liver development; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:mRNA transcription by RNA polymerase II; P:positive regulation of telomerase RNA reverse transcriptase activity; P:positive regulation of telomere capping; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of telomere maintenance; P:regulation of transcription, DNA-templated; P:response to calcium ion; P:response to electrical stimulus; P:response to rapamycin; P:response to sodium phosphate; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing; scaffold17 indexed_genome mRNA 14793110 14804732 . + . ID=transcript_4245;Q9UCE9,Heterogeneous nuclear ribonucleoprotein D0,AU-rich element RNA-binding protein 1;, PF08143;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0045202;GO:0003682;GO:0042826;GO:0003680;GO:0035925;GO:0003723;GO:0042162;GO:0008134;GO:0061158;GO:0071230;GO:0071392;GO:0071732;GO:1904586;GO:0021549;GO:0097167;GO:1990828;GO:0001889;GO:0000398;GO:0048255;GO:0042789;GO:1905663;GO:1904355;GO:0045944;GO:0045893;GO:0045727;GO:0042752;GO:0010468;GO:0043488;GO:0032204;GO:0006355;GO:0051592;GO:0051602;GO:1901355;GO:1904383;GO:0006401;GO:0016070;GO:0006396;, C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:synapse;, F:chromatin binding; F:histone deacetylase binding; F:minor groove of adenine-thymine-rich DNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:telomeric DNA binding; F:transcription factor binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to amino acid stimulus; P:cellular response to estradiol stimulus; P:cellular response to nitric oxide; P:cellular response to putrescine; P:cerebellum development; P:circadian regulation of translation; P:hepatocyte dedifferentiation; P:liver development; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:mRNA transcription by RNA polymerase II; P:positive regulation of telomerase RNA reverse transcriptase activity; P:positive regulation of telomere capping; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of telomere maintenance; P:regulation of transcription, DNA-templated; P:response to calcium ion; P:response to electrical stimulus; P:response to rapamycin; P:response to sodium phosphate; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing;|Q9UCE9,Heterogeneous nuclear ribonucleoprotein D0,AU-rich element RNA-binding protein 1;, PF08143;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0045202;GO:0003682;GO:0042826;GO:0003680;GO:0035925;GO:0003723;GO:0042162;GO:0008134;GO:0061158;GO:0071230;GO:0071392;GO:0071732;GO:1904586;GO:0021549;GO:0097167;GO:1990828;GO:0001889;GO:0000398;GO:0048255;GO:0042789;GO:1905663;GO:1904355;GO:0045944;GO:0045893;GO:0045727;GO:0042752;GO:0010468;GO:0043488;GO:0032204;GO:0006355;GO:0051592;GO:0051602;GO:1901355;GO:1904383;GO:0006401;GO:0016070;GO:0006396;, C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:synapse;, F:chromatin binding; F:histone deacetylase binding; F:minor groove of adenine-thymine-rich DNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:telomeric DNA binding; F:transcription factor binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to amino acid stimulus; P:cellular response to estradiol stimulus; P:cellular response to nitric oxide; P:cellular response to putrescine; P:cerebellum development; P:circadian regulation of translation; P:hepatocyte dedifferentiation; P:liver development; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:mRNA transcription by RNA polymerase II; P:positive regulation of telomerase RNA reverse transcriptase activity; P:positive regulation of telomere capping; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of telomere maintenance; P:regulation of transcription, DNA-templated; P:response to calcium ion; P:response to electrical stimulus; P:response to rapamycin; P:response to sodium phosphate; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing;|Q9UCE9,Heterogeneous nuclear ribonucleoprotein D0,AU-rich element RNA-binding protein 1;, PF08143;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0045202;GO:0003682;GO:0042826;GO:0003680;GO:0035925;GO:0003723;GO:0042162;GO:0008134;GO:0061158;GO:0071230;GO:0071392;GO:0071732;GO:1904586;GO:0021549;GO:0097167;GO:1990828;GO:0001889;GO:0000398;GO:0048255;GO:0042789;GO:1905663;GO:1904355;GO:0045944;GO:0045893;GO:0045727;GO:0042752;GO:0010468;GO:0043488;GO:0032204;GO:0006355;GO:0051592;GO:0051602;GO:1901355;GO:1904383;GO:0006401;GO:0016070;GO:0006396;, C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:synapse;, F:chromatin binding; F:histone deacetylase binding; F:minor groove of adenine-thymine-rich DNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:telomeric DNA binding; F:transcription factor binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to amino acid stimulus; P:cellular response to estradiol stimulus; P:cellular response to nitric oxide; P:cellular response to putrescine; P:cerebellum development; P:circadian regulation of translation; P:hepatocyte dedifferentiation; P:liver development; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:mRNA transcription by RNA polymerase II; P:positive regulation of telomerase RNA reverse transcriptase activity; P:positive regulation of telomere capping; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of telomere maintenance; P:regulation of transcription, DNA-templated; P:response to calcium ion; P:response to electrical stimulus; P:response to rapamycin; P:response to sodium phosphate; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing;|Q9UCE9,Heterogeneous nuclear ribonucleoprotein D0,AU-rich element RNA-binding protein 1;, PF08143;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0045202;GO:0003682;GO:0042826;GO:0003680;GO:0035925;GO:0003723;GO:0042162;GO:0008134;GO:0061158;GO:0071230;GO:0071392;GO:0071732;GO:1904586;GO:0021549;GO:0097167;GO:1990828;GO:0001889;GO:0000398;GO:0048255;GO:0042789;GO:1905663;GO:1904355;GO:0045944;GO:0045893;GO:0045727;GO:0042752;GO:0010468;GO:0043488;GO:0032204;GO:0006355;GO:0051592;GO:0051602;GO:1901355;GO:1904383;GO:0006401;GO:0016070;GO:0006396;, C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:synapse;, F:chromatin binding; F:histone deacetylase binding; F:minor groove of adenine-thymine-rich DNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:telomeric DNA binding; F:transcription factor binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to amino acid stimulus; P:cellular response to estradiol stimulus; P:cellular response to nitric oxide; P:cellular response to putrescine; P:cerebellum development; P:circadian regulation of translation; P:hepatocyte dedifferentiation; P:liver development; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:mRNA transcription by RNA polymerase II; P:positive regulation of telomerase RNA reverse transcriptase activity; P:positive regulation of telomere capping; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of telomere maintenance; P:regulation of transcription, DNA-templated; P:response to calcium ion; P:response to electrical stimulus; P:response to rapamycin; P:response to sodium phosphate; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing; scaffold17 indexed_genome mRNA 15470997 15634803 . + . ID=transcript_4246;Q0VAM2 Q0VAM1 Q4W5L7 Q4W5M3 Q96MY8,Ras-GEF domain-containing family member 1B,GPI gamma-4;, PF00617;PF00618;, GO:0005769;GO:0005770;GO:0030496;GO:0005085;GO:0007264;, C:early endosome; C:late endosome; C:midbody;, F:guanyl-nucleotide exchange factor activity;, P:small GTPase mediated signal transduction;|Q0VAM2 Q0VAM1 Q4W5L7 Q4W5M3 Q96MY8,Ras-GEF domain-containing family member 1B,GPI gamma-4;, PF00617;PF00618;, GO:0005769;GO:0005770;GO:0030496;GO:0005085;GO:0007264;, C:early endosome; C:late endosome; C:midbody;, F:guanyl-nucleotide exchange factor activity;, P:small GTPase mediated signal transduction;|Q0VAM2 Q0VAM1 Q4W5L7 Q4W5M3 Q96MY8,Ras-GEF domain-containing family member 1B,GPI gamma-4;, PF00617;PF00618;, GO:0005769;GO:0005770;GO:0030496;GO:0005085;GO:0007264;, C:early endosome; C:late endosome; C:midbody;, F:guanyl-nucleotide exchange factor activity;, P:small GTPase mediated signal transduction;|Q0VAM2 Q0VAM1 Q4W5L7 Q4W5M3 Q96MY8,Ras-GEF domain-containing family member 1B,GPI gamma-4;, PF00617;PF00618;, GO:0005769;GO:0005770;GO:0030496;GO:0005085;GO:0007264;, C:early endosome; C:late endosome; C:midbody;, F:guanyl-nucleotide exchange factor activity;, P:small GTPase mediated signal transduction; scaffold17 indexed_genome mRNA 15872258 15897819 . + . ID=transcript_4247;Q13237 B4DMX3 E7EPE6 O00125 O60916,cGMP-dependent protein kinase 2,cGMP-dependent protein kinase II;, PF00027;PF00069;, GO:0016324;GO:0005829;GO:0031965;GO:0005524;GO:0030553;GO:0004692;GO:0042802;GO:0004672;GO:0106310;GO:0106311;GO:0000165;GO:2001226;GO:0036289;GO:0072659;GO:0006468;GO:0007165;GO:0046146;, C:apical plasma membrane; C:cytosol; C:nuclear membrane;, F:ATP binding; F:cGMP binding; F:cGMP-dependent protein kinase activity; F:identical protein binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:MAPK cascade; P:negative regulation of chloride transport; P:peptidyl-serine autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:signal transduction; P:tetrahydrobiopterin metabolic process; scaffold17 indexed_genome mRNA 15925915 15943164 . + . ID=transcript_4248;Q13237 B4DMX3 E7EPE6 O00125 O60916,cGMP-dependent protein kinase 2,cGMP-dependent protein kinase II;, PF00027;PF00069;, GO:0016324;GO:0005829;GO:0031965;GO:0005524;GO:0030553;GO:0004692;GO:0042802;GO:0004672;GO:0106310;GO:0106311;GO:0000165;GO:2001226;GO:0036289;GO:0072659;GO:0006468;GO:0007165;GO:0046146;, C:apical plasma membrane; C:cytosol; C:nuclear membrane;, F:ATP binding; F:cGMP binding; F:cGMP-dependent protein kinase activity; F:identical protein binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:MAPK cascade; P:negative regulation of chloride transport; P:peptidyl-serine autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:signal transduction; P:tetrahydrobiopterin metabolic process; scaffold17 indexed_genome mRNA 15984940 15993499 . - . ID=transcript_4249;P12645 Q4VAS5,Bone morphogenetic protein 3,Bone morphogenetic protein 3A;Osteogenin;, PF00019;, GO:0070062;GO:0005615;GO:0070700;GO:0005125;GO:0008083;GO:0005102;GO:0051216;GO:0007267;GO:0001649;GO:0010862;GO:0001501;GO:0060395;, C:extracellular exosome; C:extracellular space;, F:BMP receptor binding; F:cytokine activity; F:growth factor activity; F:signaling receptor binding;, P:cartilage development; P:cell-cell signaling; P:osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:skeletal system development; P:SMAD protein signal transduction; scaffold17 indexed_genome mRNA 16085817 16476119 . - . ID=transcript_4250;Q6V702 E7EQ13 Q6ZQY4 Q8N4G9,Cilia- and flagella-associated protein 299 {ECO:0000305},, PF14713;, GO:0005737;GO:0005634;, C:cytoplasm; C:nucleus; scaffold17 indexed_genome mRNA 16774059 16787152 . - . ID=transcript_4251;P12034 B2R554 O75846 Q3Y8M3 Q8NF90,Fibroblast growth factor 5,Heparin-binding growth factor 5;Smag-82;, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0009887;GO:0030154;GO:0007267;GO:0008543;GO:0010001;GO:0000165;GO:0007399;GO:0051781;GO:0008284;GO:0010628;GO:0051897;GO:0001934;GO:0030334;GO:0023019;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:fibroblast growth factor receptor signaling pathway; P:glial cell differentiation; P:MAPK cascade; P:nervous system development; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:regulation of cell migration; P:signal transduction involved in regulation of gene expression; scaffold17 indexed_genome mRNA 16860445 16864959 . - . ID=transcript_4252;Q9NQV8 A8K7X2 Q6IQ36,PR domain zinc finger protein 8,PR domain-containing protein 8;, PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0008168;GO:0032259;GO:0014003;GO:0006355;, C:nucleus;, F:DNA binding; F:metal ion binding; F:methyltransferase activity;, P:methylation; P:oligodendrocyte development; P:regulation of transcription, DNA-templated; scaffold17 indexed_genome mRNA 16977503 17149383 . + . ID=transcript_4253;P58335 Q4W5H6 Q59E98 Q5JPE9 Q86UI1 Q8N4J8 Q8NB13 Q96NC7,Anthrax toxin receptor 2,Capillary morphogenesis gene 2 protein;, PF05586;PF05587;PF00092;, GO:0009986;GO:0005789;GO:0010008;GO:0005576;GO:0016021;GO:0005886;GO:0046872;GO:0004888;GO:1901998;, C:cell surface; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:metal ion binding; F:transmembrane signaling receptor activity;, P:toxin transport; scaffold17 indexed_genome mRNA 17987503 18013453 . + . ID=transcript_4254;Q6TCH7 A8K5B7 B3KP59 Q6PIQ1 Q86X05 Q8NCP9,Progestin and adipoQ receptor family member 3 {ECO:0000303|PubMed:16044242},Progestin and adipoQ receptor family member III;Raf kinase trapping to Golgi {ECO:0000303|PubMed:18547165};, PF03006;, GO:0005794;GO:0000139;GO:0016021;GO:0038023;GO:0000165;GO:0043407;GO:0010977;GO:0033137;GO:0001933;GO:0034067;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:signaling receptor activity;, P:MAPK cascade; P:negative regulation of MAP kinase activity; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein phosphorylation; P:protein localization to Golgi apparatus;|Q6TCH7 A8K5B7 B3KP59 Q6PIQ1 Q86X05 Q8NCP9,Progestin and adipoQ receptor family member 3 {ECO:0000303|PubMed:16044242},Progestin and adipoQ receptor family member III;Raf kinase trapping to Golgi {ECO:0000303|PubMed:18547165};, PF03006;, GO:0005794;GO:0000139;GO:0016021;GO:0038023;GO:0000165;GO:0043407;GO:0010977;GO:0033137;GO:0001933;GO:0034067;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:signaling receptor activity;, P:MAPK cascade; P:negative regulation of MAP kinase activity; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein phosphorylation; P:protein localization to Golgi apparatus; scaffold17 indexed_genome mRNA 18015289 18020812 . - . ID=transcript_4255;Q9NSY1 O94791 Q4W5H2 Q8IYF2 Q8N2G7 Q8NHG9 Q9NTG8,BMP-2-inducible protein kinase {ECO:0000250|UniProtKB:Q91Z96},, PF15282;PF00069;, GO:0005737;GO:0016607;GO:0005634;GO:0035612;GO:0005524;GO:0019208;GO:0106310;GO:0004674;GO:0106311;GO:0045747;GO:0006468;GO:0030500;GO:2000369;, C:cytoplasm; C:nuclear speck; C:nucleus;, F:AP-2 adaptor complex binding; F:ATP binding; F:phosphatase regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:positive regulation of Notch signaling pathway; P:protein phosphorylation; P:regulation of bone mineralization; P:regulation of clathrin-dependent endocytosis; scaffold17 indexed_genome mRNA 18040409 18041255 . + . ID=transcript_4256;Q9NSY1 O94791 Q4W5H2 Q8IYF2 Q8N2G7 Q8NHG9 Q9NTG8,BMP-2-inducible protein kinase {ECO:0000250|UniProtKB:Q91Z96},, PF15282;PF00069;, GO:0005737;GO:0016607;GO:0005634;GO:0035612;GO:0005524;GO:0019208;GO:0106310;GO:0004674;GO:0106311;GO:0045747;GO:0006468;GO:0030500;GO:2000369;, C:cytoplasm; C:nuclear speck; C:nucleus;, F:AP-2 adaptor complex binding; F:ATP binding; F:phosphatase regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:positive regulation of Notch signaling pathway; P:protein phosphorylation; P:regulation of bone mineralization; P:regulation of clathrin-dependent endocytosis; scaffold17 indexed_genome mRNA 18293621 18361506 . - . ID=transcript_4257;P12429 B2R9W6 Q6LET2,Annexin A3,35-alpha calcimedin;Annexin III;Annexin-3;Inositol 1,2-cyclic phosphate 2-phosphohydrolase;Lipocortin III;Placental anticoagulant protein III;, PF00191;, GO:0030424;GO:0005737;GO:0030425;GO:0070062;GO:0016020;GO:0043025;GO:0030670;GO:0005886;GO:0042581;GO:0005509;GO:0005544;GO:0048306;GO:0019834;GO:0031100;GO:0042742;GO:0021766;GO:0043312;GO:0006909;GO:0045766;GO:0051054;GO:0051091;GO:0010595;GO:0051384;GO:0070848;, C:axon; C:cytoplasm; C:dendrite; C:extracellular exosome; C:membrane; C:neuronal cell body; C:phagocytic vesicle membrane; C:plasma membrane; C:specific granule;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:phospholipase A2 inhibitor activity;, P:animal organ regeneration; P:defense response to bacterium; P:hippocampus development; P:neutrophil degranulation; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of DNA metabolic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell migration; P:response to glucocorticoid; P:response to growth factor;|P12429 B2R9W6 Q6LET2,Annexin A3,35-alpha calcimedin;Annexin III;Annexin-3;Inositol 1,2-cyclic phosphate 2-phosphohydrolase;Lipocortin III;Placental anticoagulant protein III;, PF00191;, GO:0030424;GO:0005737;GO:0030425;GO:0070062;GO:0016020;GO:0043025;GO:0030670;GO:0005886;GO:0042581;GO:0005509;GO:0005544;GO:0048306;GO:0019834;GO:0031100;GO:0042742;GO:0021766;GO:0043312;GO:0006909;GO:0045766;GO:0051054;GO:0051091;GO:0010595;GO:0051384;GO:0070848;, C:axon; C:cytoplasm; C:dendrite; C:extracellular exosome; C:membrane; C:neuronal cell body; C:phagocytic vesicle membrane; C:plasma membrane; C:specific granule;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:phospholipase A2 inhibitor activity;, P:animal organ regeneration; P:defense response to bacterium; P:hippocampus development; P:neutrophil degranulation; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of DNA metabolic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell migration; P:response to glucocorticoid; P:response to growth factor;|P12429 B2R9W6 Q6LET2,Annexin A3,35-alpha calcimedin;Annexin III;Annexin-3;Inositol 1,2-cyclic phosphate 2-phosphohydrolase;Lipocortin III;Placental anticoagulant protein III;, PF00191;, GO:0030424;GO:0005737;GO:0030425;GO:0070062;GO:0016020;GO:0043025;GO:0030670;GO:0005886;GO:0042581;GO:0005509;GO:0005544;GO:0048306;GO:0019834;GO:0031100;GO:0042742;GO:0021766;GO:0043312;GO:0006909;GO:0045766;GO:0051054;GO:0051091;GO:0010595;GO:0051384;GO:0070848;, C:axon; C:cytoplasm; C:dendrite; C:extracellular exosome; C:membrane; C:neuronal cell body; C:phagocytic vesicle membrane; C:plasma membrane; C:specific granule;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:phospholipase A2 inhibitor activity;, P:animal organ regeneration; P:defense response to bacterium; P:hippocampus development; P:neutrophil degranulation; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of DNA metabolic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell migration; P:response to glucocorticoid; P:response to growth factor;|P12429 B2R9W6 Q6LET2,Annexin A3,35-alpha calcimedin;Annexin III;Annexin-3;Inositol 1,2-cyclic phosphate 2-phosphohydrolase;Lipocortin III;Placental anticoagulant protein III;, PF00191;, GO:0030424;GO:0005737;GO:0030425;GO:0070062;GO:0016020;GO:0043025;GO:0030670;GO:0005886;GO:0042581;GO:0005509;GO:0005544;GO:0048306;GO:0019834;GO:0031100;GO:0042742;GO:0021766;GO:0043312;GO:0006909;GO:0045766;GO:0051054;GO:0051091;GO:0010595;GO:0051384;GO:0070848;, C:axon; C:cytoplasm; C:dendrite; C:extracellular exosome; C:membrane; C:neuronal cell body; C:phagocytic vesicle membrane; C:plasma membrane; C:specific granule;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:phospholipase A2 inhibitor activity;, P:animal organ regeneration; P:defense response to bacterium; P:hippocampus development; P:neutrophil degranulation; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of DNA metabolic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell migration; P:response to glucocorticoid; P:response to growth factor; scaffold17 indexed_genome mRNA 18370449 18394136 . - . ID=transcript_4258;Q86XX4 A2RRR8 Q86UZ4 Q8N3U9 Q8NAU7 Q96JW7 Q9H6N9 Q9P228,Extracellular matrix organizing protein FRAS1 {ECO:0000250|UniProtKB:Q80T14},Fraser syndrome 1 protein {ECO:0000303|PubMed:12766769};, PF03160;PF00093;, GO:0005604;GO:0016021;GO:0005886;GO:0005201;GO:0046872;GO:0007154;GO:0030326;GO:0003338;GO:0002009;GO:0015031;GO:0060021;GO:0043588;, C:basement membrane; C:integral component of membrane; C:plasma membrane;, F:extracellular matrix structural constituent; F:metal ion binding;, P:cell communication; P:embryonic limb morphogenesis; P:metanephros morphogenesis; P:morphogenesis of an epithelium; P:protein transport; P:roof of mouth development; P:skin development; scaffold17 indexed_genome mRNA 18394148 18406046 . - . ID=transcript_4259;Q86XX4 A2RRR8 Q86UZ4 Q8N3U9 Q8NAU7 Q96JW7 Q9H6N9 Q9P228,Extracellular matrix organizing protein FRAS1 {ECO:0000250|UniProtKB:Q80T14},Fraser syndrome 1 protein {ECO:0000303|PubMed:12766769};, PF03160;PF00093;, GO:0005604;GO:0016021;GO:0005886;GO:0005201;GO:0046872;GO:0007154;GO:0030326;GO:0003338;GO:0002009;GO:0015031;GO:0060021;GO:0043588;, C:basement membrane; C:integral component of membrane; C:plasma membrane;, F:extracellular matrix structural constituent; F:metal ion binding;, P:cell communication; P:embryonic limb morphogenesis; P:metanephros morphogenesis; P:morphogenesis of an epithelium; P:protein transport; P:roof of mouth development; P:skin development; scaffold17 indexed_genome mRNA 18406063 18412393 . - . ID=transcript_4260;Q86XX4 A2RRR8 Q86UZ4 Q8N3U9 Q8NAU7 Q96JW7 Q9H6N9 Q9P228,Extracellular matrix organizing protein FRAS1 {ECO:0000250|UniProtKB:Q80T14},Fraser syndrome 1 protein {ECO:0000303|PubMed:12766769};, PF03160;PF00093;, GO:0005604;GO:0016021;GO:0005886;GO:0005201;GO:0046872;GO:0007154;GO:0030326;GO:0003338;GO:0002009;GO:0015031;GO:0060021;GO:0043588;, C:basement membrane; C:integral component of membrane; C:plasma membrane;, F:extracellular matrix structural constituent; F:metal ion binding;, P:cell communication; P:embryonic limb morphogenesis; P:metanephros morphogenesis; P:morphogenesis of an epithelium; P:protein transport; P:roof of mouth development; P:skin development; scaffold17 indexed_genome mRNA 18417172 18428851 . - . ID=transcript_4261;Q86XX4 A2RRR8 Q86UZ4 Q8N3U9 Q8NAU7 Q96JW7 Q9H6N9 Q9P228,Extracellular matrix organizing protein FRAS1 {ECO:0000250|UniProtKB:Q80T14},Fraser syndrome 1 protein {ECO:0000303|PubMed:12766769};, PF03160;PF00093;, GO:0005604;GO:0016021;GO:0005886;GO:0005201;GO:0046872;GO:0007154;GO:0030326;GO:0003338;GO:0002009;GO:0015031;GO:0060021;GO:0043588;, C:basement membrane; C:integral component of membrane; C:plasma membrane;, F:extracellular matrix structural constituent; F:metal ion binding;, P:cell communication; P:embryonic limb morphogenesis; P:metanephros morphogenesis; P:morphogenesis of an epithelium; P:protein transport; P:roof of mouth development; P:skin development; scaffold17 indexed_genome mRNA 18428885 18438241 . - . ID=transcript_4262;Q86XX4 A2RRR8 Q86UZ4 Q8N3U9 Q8NAU7 Q96JW7 Q9H6N9 Q9P228,Extracellular matrix organizing protein FRAS1 {ECO:0000250|UniProtKB:Q80T14},Fraser syndrome 1 protein {ECO:0000303|PubMed:12766769};, PF03160;PF00093;, GO:0005604;GO:0016021;GO:0005886;GO:0005201;GO:0046872;GO:0007154;GO:0030326;GO:0003338;GO:0002009;GO:0015031;GO:0060021;GO:0043588;, C:basement membrane; C:integral component of membrane; C:plasma membrane;, F:extracellular matrix structural constituent; F:metal ion binding;, P:cell communication; P:embryonic limb morphogenesis; P:metanephros morphogenesis; P:morphogenesis of an epithelium; P:protein transport; P:roof of mouth development; P:skin development; scaffold17 indexed_genome mRNA 18975363 19040471 . - . ID=transcript_4263;Q9BYD6 A6NG03 Q4W5B8 Q6IAG4 Q96BW3 Q9H793 Q9NRL5,39S ribosomal protein L1, mitochondrial,Mitochondrial large ribosomal subunit protein uL1m {ECO:0000303|PubMed:25278503};, PF00687;, GO:0022625;GO:0005743;GO:0003723;GO:0003735;GO:0000470;GO:0070125;GO:0070126;, C:cytosolic large ribosomal subunit; C:mitochondrial inner membrane;, F:RNA binding; F:structural constituent of ribosome;, P:maturation of LSU-rRNA; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold17 indexed_genome mRNA 19086415 19190044 . + . ID=transcript_4264;Q96LI5 Q9UF92,CCR4-NOT transcription complex subunit 6-like,Carbon catabolite repressor protein 4 homolog B;, PF03372;PF13855;, GO:0030014;GO:0005737;GO:0005829;GO:0005634;GO:0000175;GO:0046872;GO:0004535;GO:0006977;GO:0031047;GO:0061157;GO:0006397;GO:0000289;GO:0008284;GO:0010606;, C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:nucleus;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:mRNA destabilization; P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cell population proliferation; P:positive regulation of cytoplasmic mRNA processing body assembly; scaffold17 indexed_genome mRNA 19200745 19217343 . + . ID=transcript_4265;Q96LI5 Q9UF92,CCR4-NOT transcription complex subunit 6-like,Carbon catabolite repressor protein 4 homolog B;, PF03372;PF13855;, GO:0030014;GO:0005737;GO:0005829;GO:0005634;GO:0000175;GO:0046872;GO:0004535;GO:0006977;GO:0031047;GO:0061157;GO:0006397;GO:0000289;GO:0008284;GO:0010606;, C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:nucleus;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:mRNA destabilization; P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cell population proliferation; P:positive regulation of cytoplasmic mRNA processing body assembly; scaffold17 indexed_genome mRNA 19567782 19577299 . - . ID=transcript_4266;Q16589 B4DF25 Q6FGA7 Q6FGC6,Cyclin-G2,, PF00134;, GO:0000307;GO:0005737;GO:0005634;GO:0016538;GO:0051301;GO:0044772;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q16589 B4DF25 Q6FGA7 Q6FGC6,Cyclin-G2,, PF00134;, GO:0000307;GO:0005737;GO:0005634;GO:0016538;GO:0051301;GO:0044772;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q16589 B4DF25 Q6FGA7 Q6FGC6,Cyclin-G2,, PF00134;, GO:0000307;GO:0005737;GO:0005634;GO:0016538;GO:0051301;GO:0044772;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q16589 B4DF25 Q6FGA7 Q6FGC6,Cyclin-G2,, PF00134;, GO:0000307;GO:0005737;GO:0005634;GO:0016538;GO:0051301;GO:0044772;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold17 indexed_genome mRNA 19653785 19682148 . + . ID=transcript_4267;Q14094 B2R6M0 B7Z6X4,Cyclin-I {ECO:0000305},, PF00134;, GO:0000307;GO:0005737;GO:0031965;GO:0005634;GO:0016538;GO:0044772;GO:0000079;GO:0007283;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis;|Q14094 B2R6M0 B7Z6X4,Cyclin-I {ECO:0000305},, PF00134;, GO:0000307;GO:0005737;GO:0031965;GO:0005634;GO:0016538;GO:0044772;GO:0000079;GO:0007283;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis;|Q14094 B2R6M0 B7Z6X4,Cyclin-I {ECO:0000305},, PF00134;, GO:0000307;GO:0005737;GO:0031965;GO:0005634;GO:0016538;GO:0044772;GO:0000079;GO:0007283;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis;|Q14094 B2R6M0 B7Z6X4,Cyclin-I {ECO:0000305},, PF00134;, GO:0000307;GO:0005737;GO:0031965;GO:0005634;GO:0016538;GO:0044772;GO:0000079;GO:0007283;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis;|Q14094 B2R6M0 B7Z6X4,Cyclin-I {ECO:0000305},, PF00134;, GO:0000307;GO:0005737;GO:0031965;GO:0005634;GO:0016538;GO:0044772;GO:0000079;GO:0007283;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis; scaffold17 indexed_genome mRNA 19687996 19691217 . + . ID=transcript_4268;Q14094 B2R6M0 B7Z6X4,Cyclin-I {ECO:0000305},, PF00134;, GO:0000307;GO:0005737;GO:0031965;GO:0005634;GO:0016538;GO:0044772;GO:0000079;GO:0007283;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis; scaffold17 indexed_genome mRNA 19696446 19790113 . - . ID=transcript_4269;Q9NVA2 B7Z7Z6 E9KL32 Q4W5G1 Q7L4N1 Q96SP1 Q9UFY9,Septin-11,, PF00735;, GO:0030424;GO:0032153;GO:0043197;GO:0098982;GO:0098978;GO:0015630;GO:0099629;GO:0031105;GO:0005940;GO:0001725;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:0050807;, C:axon; C:cell division site; C:dendritic spine; C:GABA-ergic synapse; C:glutamatergic synapse; C:microtubule cytoskeleton; C:postsynaptic specialization of symmetric synapse; C:septin complex; C:septin ring; C:stress fiber;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:regulation of synapse organization; scaffold17 indexed_genome mRNA 19919944 19950864 . - . ID=transcript_4270;Q8TF72 Q5QTQ3 Q6ZRW3 Q96IR9 Q9P247,Protein Shroom3,Shroom-related protein;, PF08688;PF08687;PF00595;, GO:0005912;GO:0043296;GO:0016324;GO:0030864;GO:0005856;GO:0005874;GO:0051015;GO:0007015;GO:0045176;GO:0000902;GO:0043482;GO:0002064;GO:0001843;GO:0007389;GO:0008360;, C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:cortical actin cytoskeleton; C:cytoskeleton; C:microtubule;, F:actin filament binding;, P:actin filament organization; P:apical protein localization; P:cell morphogenesis; P:cellular pigment accumulation; P:epithelial cell development; P:neural tube closure; P:pattern specification process; P:regulation of cell shape; scaffold17 indexed_genome mRNA 19951631 20235955 . - . ID=transcript_4271;Q8TF72 Q5QTQ3 Q6ZRW3 Q96IR9 Q9P247,Protein Shroom3,Shroom-related protein;, PF08688;PF08687;PF00595;, GO:0005912;GO:0043296;GO:0016324;GO:0030864;GO:0005856;GO:0005874;GO:0051015;GO:0007015;GO:0045176;GO:0000902;GO:0043482;GO:0002064;GO:0001843;GO:0007389;GO:0008360;, C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:cortical actin cytoskeleton; C:cytoskeleton; C:microtubule;, F:actin filament binding;, P:actin filament organization; P:apical protein localization; P:cell morphogenesis; P:cellular pigment accumulation; P:epithelial cell development; P:neural tube closure; P:pattern specification process; P:regulation of cell shape; scaffold17 indexed_genome mRNA 20244033 20305256 . + . ID=transcript_4272;Q5M9N0 Q8IYQ1 Q8N7D4 Q8N7E3,Coiled-coil domain-containing protein 158,, PF15921; scaffold17 indexed_genome mRNA 20305300 20320179 . + . ID=transcript_4273;Q5M9N0 Q8IYQ1 Q8N7D4 Q8N7E3,Coiled-coil domain-containing protein 158,, PF15921;|Q5M9N0 Q8IYQ1 Q8N7D4 Q8N7E3,Coiled-coil domain-containing protein 158,, PF15921; scaffold17 indexed_genome mRNA 20321410 20328058 . - . ID=transcript_4274;O95210 B3KVZ9,Starch-binding domain-containing protein 1 {ECO:0000303|PubMed:20810658},Genethonin-1 {ECO:0000303|PubMed:20810658};Glycophagy cargo receptor STBD1 {ECO:0000305};, PF00686;, GO:0005783;GO:0005789;GO:0101003;GO:0005887;GO:0016020;GO:0048471;GO:0034045;GO:0005886;GO:0030315;GO:0070821;GO:0019899;GO:2001069;GO:0030247;GO:2001070;GO:0005980;GO:0061723;GO:0046907;GO:0043312;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:membrane; C:perinuclear region of cytoplasm; C:phagophore assembly site membrane; C:plasma membrane; C:T-tubule; C:tertiary granule membrane;, F:enzyme binding; F:glycogen binding; F:polysaccharide binding; F:starch binding;, P:glycogen catabolic process; P:glycophagy; P:intracellular transport; P:neutrophil degranulation; scaffold17 indexed_genome mRNA 20346081 20359270 . - . ID=transcript_4275;Q6ZV65 D6R8Y4,Protein FAM47E,, PF14642;, GO:0000785;GO:0005737;GO:0005634;GO:0008047;GO:0034401;GO:0034968;GO:0071168;, C:chromatin; C:cytoplasm; C:nucleus;, F:enzyme activator activity;, P:chromatin organization involved in regulation of transcription; P:histone lysine methylation; P:protein localization to chromatin; scaffold17 indexed_genome mRNA 20359307 20370004 . - . ID=transcript_4276;Q6ZV65 D6R8Y4,Protein FAM47E,, PF14642;, GO:0000785;GO:0005737;GO:0005634;GO:0008047;GO:0034401;GO:0034968;GO:0071168;, C:chromatin; C:cytoplasm; C:nucleus;, F:enzyme activator activity;, P:chromatin organization involved in regulation of transcription; P:histone lysine methylation; P:protein localization to chromatin; scaffold17 indexed_genome mRNA 20419032 20492403 . + . ID=transcript_4277;Q14108 B4DKD8 E7EM68 Q53Y63,Lysosome membrane protein 2,85 kDa lysosomal membrane sialoglycoprotein;CD36 antigen-like 2;Lysosome membrane protein II;Scavenger receptor class B member 2;, PF01130;, GO:0030669;GO:0005737;GO:0030666;GO:0005789;GO:0010008;GO:0070062;GO:0005925;GO:0000139;GO:0016021;GO:0031902;GO:0043202;GO:0005765;GO:0016020;GO:0005886;GO:0038024;GO:0015485;GO:0019899;GO:0031210;GO:0001786;GO:0042803;GO:0005044;GO:0004888;GO:0001618;GO:0015917;GO:0061024;GO:0010976;GO:0006622;GO:0006898;GO:0043471;GO:1904978;GO:1905123;GO:1905671;, C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:integral component of membrane; C:late endosome membrane; C:lysosomal lumen; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:cargo receptor activity; F:cholesterol binding; F:enzyme binding; F:phosphatidylcholine binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:scavenger receptor activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:aminophospholipid transport; P:membrane organization; P:positive regulation of neuron projection development; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of cellular carbohydrate catabolic process; P:regulation of endosome organization; P:regulation of glucosylceramidase activity; P:regulation of lysosome organization;|Q14108 B4DKD8 E7EM68 Q53Y63,Lysosome membrane protein 2,85 kDa lysosomal membrane sialoglycoprotein;CD36 antigen-like 2;Lysosome membrane protein II;Scavenger receptor class B member 2;, PF01130;, GO:0030669;GO:0005737;GO:0030666;GO:0005789;GO:0010008;GO:0070062;GO:0005925;GO:0000139;GO:0016021;GO:0031902;GO:0043202;GO:0005765;GO:0016020;GO:0005886;GO:0038024;GO:0015485;GO:0019899;GO:0031210;GO:0001786;GO:0042803;GO:0005044;GO:0004888;GO:0001618;GO:0015917;GO:0061024;GO:0010976;GO:0006622;GO:0006898;GO:0043471;GO:1904978;GO:1905123;GO:1905671;, C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:integral component of membrane; C:late endosome membrane; C:lysosomal lumen; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:cargo receptor activity; F:cholesterol binding; F:enzyme binding; F:phosphatidylcholine binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:scavenger receptor activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:aminophospholipid transport; P:membrane organization; P:positive regulation of neuron projection development; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of cellular carbohydrate catabolic process; P:regulation of endosome organization; P:regulation of glucosylceramidase activity; P:regulation of lysosome organization;|Q14108 B4DKD8 E7EM68 Q53Y63,Lysosome membrane protein 2,85 kDa lysosomal membrane sialoglycoprotein;CD36 antigen-like 2;Lysosome membrane protein II;Scavenger receptor class B member 2;, PF01130;, GO:0030669;GO:0005737;GO:0030666;GO:0005789;GO:0010008;GO:0070062;GO:0005925;GO:0000139;GO:0016021;GO:0031902;GO:0043202;GO:0005765;GO:0016020;GO:0005886;GO:0038024;GO:0015485;GO:0019899;GO:0031210;GO:0001786;GO:0042803;GO:0005044;GO:0004888;GO:0001618;GO:0015917;GO:0061024;GO:0010976;GO:0006622;GO:0006898;GO:0043471;GO:1904978;GO:1905123;GO:1905671;, C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:integral component of membrane; C:late endosome membrane; C:lysosomal lumen; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:cargo receptor activity; F:cholesterol binding; F:enzyme binding; F:phosphatidylcholine binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:scavenger receptor activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:aminophospholipid transport; P:membrane organization; P:positive regulation of neuron projection development; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of cellular carbohydrate catabolic process; P:regulation of endosome organization; P:regulation of glucosylceramidase activity; P:regulation of lysosome organization; scaffold17 indexed_genome mRNA 20499144 20568175 . + . ID=transcript_4278;Q7Z3B4 B2RCK7 B4DT35 Q96EA7 Q9NVL5 Q9P0I1,Nucleoporin p54,54 kDa nucleoporin;, PF13874;PF18437;, GO:0043657;GO:0005635;GO:0031965;GO:0044613;GO:0042802;GO:0044877;GO:0017056;GO:0075733;GO:0006406;GO:0006607;GO:0006999;GO:0036228;GO:0016925;GO:0006605;GO:1900034;GO:0060964;GO:0006110;GO:0042306;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear envelope; C:nuclear membrane; C:nuclear pore central transport channel;, F:identical protein binding; F:protein-containing complex binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:protein targeting; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of protein import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q7Z3B4 B2RCK7 B4DT35 Q96EA7 Q9NVL5 Q9P0I1,Nucleoporin p54,54 kDa nucleoporin;, PF13874;PF18437;, GO:0043657;GO:0005635;GO:0031965;GO:0044613;GO:0042802;GO:0044877;GO:0017056;GO:0075733;GO:0006406;GO:0006607;GO:0006999;GO:0036228;GO:0016925;GO:0006605;GO:1900034;GO:0060964;GO:0006110;GO:0042306;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear envelope; C:nuclear membrane; C:nuclear pore central transport channel;, F:identical protein binding; F:protein-containing complex binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:protein targeting; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of protein import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q7Z3B4 B2RCK7 B4DT35 Q96EA7 Q9NVL5 Q9P0I1,Nucleoporin p54,54 kDa nucleoporin;, PF13874;PF18437;, GO:0043657;GO:0005635;GO:0031965;GO:0044613;GO:0042802;GO:0044877;GO:0017056;GO:0075733;GO:0006406;GO:0006607;GO:0006999;GO:0036228;GO:0016925;GO:0006605;GO:1900034;GO:0060964;GO:0006110;GO:0042306;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear envelope; C:nuclear membrane; C:nuclear pore central transport channel;, F:identical protein binding; F:protein-containing complex binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:protein targeting; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of protein import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q7Z3B4 B2RCK7 B4DT35 Q96EA7 Q9NVL5 Q9P0I1,Nucleoporin p54,54 kDa nucleoporin;, PF13874;PF18437;, GO:0043657;GO:0005635;GO:0031965;GO:0044613;GO:0042802;GO:0044877;GO:0017056;GO:0075733;GO:0006406;GO:0006607;GO:0006999;GO:0036228;GO:0016925;GO:0006605;GO:1900034;GO:0060964;GO:0006110;GO:0042306;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear envelope; C:nuclear membrane; C:nuclear pore central transport channel;, F:identical protein binding; F:protein-containing complex binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:protein targeting; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of protein import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q7Z3B4 B2RCK7 B4DT35 Q96EA7 Q9NVL5 Q9P0I1,Nucleoporin p54,54 kDa nucleoporin;, PF13874;PF18437;, GO:0043657;GO:0005635;GO:0031965;GO:0044613;GO:0042802;GO:0044877;GO:0017056;GO:0075733;GO:0006406;GO:0006607;GO:0006999;GO:0036228;GO:0016925;GO:0006605;GO:1900034;GO:0060964;GO:0006110;GO:0042306;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear envelope; C:nuclear membrane; C:nuclear pore central transport channel;, F:identical protein binding; F:protein-containing complex binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:protein localization to nuclear inner membrane; P:protein sumoylation; P:protein targeting; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of protein import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q13508 Q53XW3 Q6FHT7 Q8WVJ7 Q93069 Q96HL1,Ecto-ADP-ribosyltransferase 3,ADP-ribosyltransferase C2 and C3 toxin-like 3;Mono(ADP-ribosyl)transferase 3;NAD(P)(+)--arginine ADP-ribosyltransferase 3;, PF01129;, GO:0031225;GO:0070062;GO:0005576;GO:0031226;GO:0005886;GO:0003950;GO:0106274;GO:0106275;GO:0018120;GO:0006471;, C:anchored component of membrane; C:extracellular exosome; C:extracellular region; C:intrinsic component of plasma membrane; C:plasma membrane;, F:NAD+ ADP-ribosyltransferase activity; F:NAD+-protein-arginine ADP-ribosyltransferase activity; F:NADP+-protein-arginine ADP-ribosyltransferase activity;, P:peptidyl-arginine ADP-ribosylation; P:protein ADP-ribosylation;|Q13508 Q53XW3 Q6FHT7 Q8WVJ7 Q93069 Q96HL1,Ecto-ADP-ribosyltransferase 3,ADP-ribosyltransferase C2 and C3 toxin-like 3;Mono(ADP-ribosyl)transferase 3;NAD(P)(+)--arginine ADP-ribosyltransferase 3;, PF01129;, GO:0031225;GO:0070062;GO:0005576;GO:0031226;GO:0005886;GO:0003950;GO:0106274;GO:0106275;GO:0018120;GO:0006471;, C:anchored component of membrane; C:extracellular exosome; C:extracellular region; C:intrinsic component of plasma membrane; C:plasma membrane;, F:NAD+ ADP-ribosyltransferase activity; F:NAD+-protein-arginine ADP-ribosyltransferase activity; F:NADP+-protein-arginine ADP-ribosyltransferase activity;, P:peptidyl-arginine ADP-ribosylation; P:protein ADP-ribosylation; scaffold17 indexed_genome mRNA 20616246 20618282 . + . ID=transcript_4279;O14625 Q53YA3 Q92840,C-X-C motif chemokine 11,Beta-R1;H174;Interferon gamma-inducible protein 9;Interferon-inducible T-cell alpha chemoattractant;Small-inducible cytokine B11;, PF00048;, GO:0005576;GO:0005615;GO:0008009;GO:0045236;GO:0048248;GO:0008201;GO:0007189;GO:0061844;GO:0007267;GO:0071222;GO:0070098;GO:0006935;GO:0007186;GO:0006954;GO:0031640;GO:0030593;GO:0051281;GO:0042127;GO:0007165;GO:0010818;, C:extracellular region; C:extracellular space;, F:chemokine activity; F:CXCR chemokine receptor binding; F:CXCR3 chemokine receptor binding; F:heparin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell-cell signaling; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:neutrophil chemotaxis; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of cell population proliferation; P:signal transduction; P:T cell chemotaxis; scaffold17 indexed_genome mRNA 20633190 20635533 . + . ID=transcript_4280;P02778 Q96QJ5,C-X-C motif chemokine 10,10 kDa interferon gamma-induced protein;Small-inducible cytokine B10;, PF00048;, GO:0009897;GO:0005576;GO:0005615;GO:0008603;GO:0042056;GO:0008009;GO:0045236;GO:0048248;GO:0008201;GO:0005102;GO:0007189;GO:0061844;GO:0008015;GO:0007166;GO:0007267;GO:0034605;GO:0071222;GO:0070098;GO:0006935;GO:0019221;GO:0051607;GO:0042118;GO:0007186;GO:0006954;GO:0031640;GO:0007517;GO:0016525;GO:0045662;GO:1901740;GO:0030593;GO:0008284;GO:0090026;GO:0051281;GO:2000406;GO:0045944;GO:0042981;GO:0042127;GO:1901509;GO:0010819;GO:0010996;GO:0009409;GO:0010332;GO:0033280;GO:0007165;GO:0010818;, C:external side of plasma membrane; C:extracellular region; C:extracellular space;, F:cAMP-dependent protein kinase regulator activity; F:chemoattractant activity; F:chemokine activity; F:CXCR chemokine receptor binding; F:CXCR3 chemokine receptor binding; F:heparin binding; F:signaling receptor binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:blood circulation; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cellular response to heat; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:defense response to virus; P:endothelial cell activation; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:muscle organ development; P:negative regulation of angiogenesis; P:negative regulation of myoblast differentiation; P:negative regulation of myoblast fusion; P:neutrophil chemotaxis; P:positive regulation of cell population proliferation; P:positive regulation of monocyte chemotaxis; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of T cell migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of endothelial tube morphogenesis; P:regulation of T cell chemotaxis; P:response to auditory stimulus; P:response to cold; P:response to gamma radiation; P:response to vitamin D; P:signal transduction; P:T cell chemotaxis; scaffold17 indexed_genome mRNA 20652989 20657974 . + . ID=transcript_4281;Q07325 Q503B4,C-X-C motif chemokine 9,Gamma-interferon-induced monokine;Monokine induced by interferon-gamma;Small-inducible cytokine B9;, PF00048;, GO:0009897;GO:0005576;GO:0005615;GO:0008009;GO:0045236;GO:0048248;GO:0005125;GO:0007189;GO:0061844;GO:0007267;GO:0006968;GO:0071222;GO:0070098;GO:0006935;GO:0006952;GO:0051607;GO:0007186;GO:0006954;GO:0031640;GO:0030593;GO:0045663;GO:1901741;GO:0051281;GO:0042127;GO:0007165;, C:external side of plasma membrane; C:extracellular region; C:extracellular space;, F:chemokine activity; F:CXCR chemokine receptor binding; F:CXCR3 chemokine receptor binding; F:cytokine activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell-cell signaling; P:cellular defense response; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:chemotaxis; P:defense response; P:defense response to virus; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:neutrophil chemotaxis; P:positive regulation of myoblast differentiation; P:positive regulation of myoblast fusion; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of cell population proliferation; P:signal transduction; scaffold17 indexed_genome mRNA 20671924 20699401 . + . ID=transcript_4282;Q9NVU7 Q32Q11 Q68D52 Q7Z5U4 Q9H831 Q9H9P6,Protein SDA1 homolog,Nucleolar protein 130;SDA1 domain-containing protein 1;, PF08158;PF05285;, GO:0005730;GO:0005654;GO:0030036;GO:0042273;GO:0000055;, C:nucleolus; C:nucleoplasm;, , P:actin cytoskeleton organization; P:ribosomal large subunit biogenesis; P:ribosomal large subunit export from nucleus;|Q9NVU7 Q32Q11 Q68D52 Q7Z5U4 Q9H831 Q9H9P6,Protein SDA1 homolog,Nucleolar protein 130;SDA1 domain-containing protein 1;, PF08158;PF05285;, GO:0005730;GO:0005654;GO:0030036;GO:0042273;GO:0000055;, C:nucleolus; C:nucleoplasm;, , P:actin cytoskeleton organization; P:ribosomal large subunit biogenesis; P:ribosomal large subunit export from nucleus;|Q9NVU7 Q32Q11 Q68D52 Q7Z5U4 Q9H831 Q9H9P6,Protein SDA1 homolog,Nucleolar protein 130;SDA1 domain-containing protein 1;, PF08158;PF05285;, GO:0005730;GO:0005654;GO:0030036;GO:0042273;GO:0000055;, C:nucleolus; C:nucleoplasm;, , P:actin cytoskeleton organization; P:ribosomal large subunit biogenesis; P:ribosomal large subunit export from nucleus; scaffold17 indexed_genome mRNA 20719008 20746044 . + . ID=transcript_4283;Q02083 Q5KTF2 Q96EY2 Q9BRA8,N-acylethanolamine-hydrolyzing acid amidase {ECO:0000305},Acid ceramidase-like protein;Acylsphingosine deacylase NAAA {ECO:0000305};N-acylsphingosine amidohydrolase-like;, PF02275;PF15508;, GO:0005737;GO:0070062;GO:0019898;GO:0043202;GO:0005764;GO:0098793;GO:0102121;GO:0017064;GO:0016810;GO:0047412;GO:0017040;GO:0008134;GO:0006631;GO:0016042;GO:0070291;GO:0070292;GO:0007269;GO:0006670;, C:cytoplasm; C:extracellular exosome; C:extrinsic component of membrane; C:lysosomal lumen; C:lysosome; C:presynapse;, F:ceramidase activity; F:fatty acid amide hydrolase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:N-(long-chain-acyl)ethanolamine deacylase activity; F:N-acylsphingosine amidohydrolase activity; F:transcription factor binding;, P:fatty acid metabolic process; P:lipid catabolic process; P:N-acylethanolamine metabolic process; P:N-acylphosphatidylethanolamine metabolic process; P:neurotransmitter secretion; P:sphingosine metabolic process; scaffold17 indexed_genome mRNA 20773258 20792150 . + . ID=transcript_4284;O14830 O14831,Serine/threonine-protein phosphatase with EF-hands 2,, PF13499;PF00149;PF08321;, GO:0005829;GO:0005634;GO:0001917;GO:0001750;GO:0005509;GO:0030544;GO:0051879;GO:0005506;GO:0030145;GO:0031435;GO:0106306;GO:0004722;GO:0106307;GO:0050906;GO:0043409;GO:0010801;GO:0006470;GO:0043506;GO:0043405;GO:0007601;, C:cytosol; C:nucleus; C:photoreceptor inner segment; C:photoreceptor outer segment;, F:calcium ion binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron ion binding; F:manganese ion binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:detection of stimulus involved in sensory perception; P:negative regulation of MAPK cascade; P:negative regulation of peptidyl-threonine phosphorylation; P:protein dephosphorylation; P:regulation of JUN kinase activity; P:regulation of MAP kinase activity; P:visual perception; scaffold17 indexed_genome mRNA 20864472 20924763 . - . ID=transcript_4285;O60763 B2RAQ0 Q6PK63 Q86TB8 Q8N592,General vesicular transport factor p115,Protein USO1 homolog;Transcytosis-associated protein;Vesicle-docking protein;, PF18770;PF04871;PF04869;, GO:0005829;GO:0005783;GO:0012507;GO:0001650;GO:0005794;GO:0000139;GO:0005795;GO:0016020;GO:0005815;GO:0048471;GO:0030133;GO:0045296;GO:0003723;GO:0048208;GO:0006888;GO:0007030;GO:0048211;GO:0006886;GO:0061025;GO:1900076;GO:0032252;GO:0007264;GO:0045056;GO:0048280;, C:cytosol; C:endoplasmic reticulum; C:ER to Golgi transport vesicle membrane; C:fibrillar center; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:membrane; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:transport vesicle;, F:cadherin binding; F:RNA binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi vesicle docking; P:intracellular protein transport; P:membrane fusion; P:regulation of cellular response to insulin stimulus; P:secretory granule localization; P:small GTPase mediated signal transduction; P:transcytosis; P:vesicle fusion with Golgi apparatus;|O60763 B2RAQ0 Q6PK63 Q86TB8 Q8N592,General vesicular transport factor p115,Protein USO1 homolog;Transcytosis-associated protein;Vesicle-docking protein;, PF18770;PF04871;PF04869;, GO:0005829;GO:0005783;GO:0012507;GO:0001650;GO:0005794;GO:0000139;GO:0005795;GO:0016020;GO:0005815;GO:0048471;GO:0030133;GO:0045296;GO:0003723;GO:0048208;GO:0006888;GO:0007030;GO:0048211;GO:0006886;GO:0061025;GO:1900076;GO:0032252;GO:0007264;GO:0045056;GO:0048280;, C:cytosol; C:endoplasmic reticulum; C:ER to Golgi transport vesicle membrane; C:fibrillar center; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:membrane; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:transport vesicle;, F:cadherin binding; F:RNA binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi vesicle docking; P:intracellular protein transport; P:membrane fusion; P:regulation of cellular response to insulin stimulus; P:secretory granule localization; P:small GTPase mediated signal transduction; P:transcytosis; P:vesicle fusion with Golgi apparatus;|O60763 B2RAQ0 Q6PK63 Q86TB8 Q8N592,General vesicular transport factor p115,Protein USO1 homolog;Transcytosis-associated protein;Vesicle-docking protein;, PF18770;PF04871;PF04869;, GO:0005829;GO:0005783;GO:0012507;GO:0001650;GO:0005794;GO:0000139;GO:0005795;GO:0016020;GO:0005815;GO:0048471;GO:0030133;GO:0045296;GO:0003723;GO:0048208;GO:0006888;GO:0007030;GO:0048211;GO:0006886;GO:0061025;GO:1900076;GO:0032252;GO:0007264;GO:0045056;GO:0048280;, C:cytosol; C:endoplasmic reticulum; C:ER to Golgi transport vesicle membrane; C:fibrillar center; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:membrane; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:transport vesicle;, F:cadherin binding; F:RNA binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi vesicle docking; P:intracellular protein transport; P:membrane fusion; P:regulation of cellular response to insulin stimulus; P:secretory granule localization; P:small GTPase mediated signal transduction; P:transcytosis; P:vesicle fusion with Golgi apparatus; scaffold17 indexed_genome mRNA 20994682 21012920 . + . ID=transcript_4286;Q9UN86 A8K6X1 O60606 O75149 Q9UPA1,Ras GTPase-activating protein-binding protein 2,GAP SH3 domain-binding protein 2;, PF02136;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:1990904;GO:0003729;GO:0003723;GO:0030159;GO:0007253;GO:0045087;GO:0051028;GO:0062029;GO:0051260;GO:0007265;GO:0034063;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding; F:signaling receptor complex adaptor activity;, P:cytoplasmic sequestering of NF-kappaB; P:innate immune response; P:mRNA transport; P:positive regulation of stress granule assembly; P:protein homooligomerization; P:Ras protein signal transduction; P:stress granule assembly; P:viral process;|Q9UN86 A8K6X1 O60606 O75149 Q9UPA1,Ras GTPase-activating protein-binding protein 2,GAP SH3 domain-binding protein 2;, PF02136;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:1990904;GO:0003729;GO:0003723;GO:0030159;GO:0007253;GO:0045087;GO:0051028;GO:0062029;GO:0051260;GO:0007265;GO:0034063;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding; F:signaling receptor complex adaptor activity;, P:cytoplasmic sequestering of NF-kappaB; P:innate immune response; P:mRNA transport; P:positive regulation of stress granule assembly; P:protein homooligomerization; P:Ras protein signal transduction; P:stress granule assembly; P:viral process;|Q9UN86 A8K6X1 O60606 O75149 Q9UPA1,Ras GTPase-activating protein-binding protein 2,GAP SH3 domain-binding protein 2;, PF02136;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:1990904;GO:0003729;GO:0003723;GO:0030159;GO:0007253;GO:0045087;GO:0051028;GO:0062029;GO:0051260;GO:0007265;GO:0034063;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding; F:signaling receptor complex adaptor activity;, P:cytoplasmic sequestering of NF-kappaB; P:innate immune response; P:mRNA transport; P:positive regulation of stress granule assembly; P:protein homooligomerization; P:Ras protein signal transduction; P:stress granule assembly; P:viral process; scaffold17 indexed_genome mRNA 21021428 21076784 . + . ID=transcript_4287;Q92772 B2R695,Cyclin-dependent kinase-like 2 {ECO:0000305},Protein kinase p56 KKIAMRE {ECO:0000303|PubMed:9000130};Serine/threonine-protein kinase KKIAMRE;, PF00069;, GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0106311;GO:0006468;GO:0007548;GO:0007165;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:sex differentiation; P:signal transduction; scaffold17 indexed_genome mRNA 21116540 21149493 . - . ID=transcript_4288;Q2KN33 Q59GN7 Q86X26 Q96PR5,RING finger and CHY zinc finger domain-containing protein 1,Androgen receptor N-terminal-interacting protein;CH-rich-interacting match with PLAG1;E3 ubiquitin-protein ligase Pirh2;RING finger protein 199;RING-type E3 ubiquitin transferase RCHY1;Zinc finger protein 363;p53-induced RING-H2 protein;, PF05495;PF13639;PF14599;, GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0000151;GO:0002039;GO:0042803;GO:0061630;GO:0008270;GO:0070987;GO:0032436;GO:0031398;GO:0051865;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:p53 binding; F:protein homodimerization activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:error-free translesion synthesis; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein autoubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8TBB0 B4E146 Q5HYJ7 Q5JPC6,THAP domain-containing protein 6,, PF05485;, GO:0015630;GO:0003677;GO:0046872;, C:microtubule cytoskeleton;, F:DNA binding; F:metal ion binding;|Q8TBB0 B4E146 Q5HYJ7 Q5JPC6,THAP domain-containing protein 6,, PF05485;, GO:0015630;GO:0003677;GO:0046872;, C:microtubule cytoskeleton;, F:DNA binding; F:metal ion binding;|Q2KN33 Q59GN7 Q86X26 Q96PR5,RING finger and CHY zinc finger domain-containing protein 1,Androgen receptor N-terminal-interacting protein;CH-rich-interacting match with PLAG1;E3 ubiquitin-protein ligase Pirh2;RING finger protein 199;RING-type E3 ubiquitin transferase RCHY1;Zinc finger protein 363;p53-induced RING-H2 protein;, PF05495;PF13639;PF14599;, GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0000151;GO:0002039;GO:0042803;GO:0061630;GO:0008270;GO:0070987;GO:0032436;GO:0031398;GO:0051865;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:p53 binding; F:protein homodimerization activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:error-free translesion synthesis; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein autoubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q2KN33 Q59GN7 Q86X26 Q96PR5,RING finger and CHY zinc finger domain-containing protein 1,Androgen receptor N-terminal-interacting protein;CH-rich-interacting match with PLAG1;E3 ubiquitin-protein ligase Pirh2;RING finger protein 199;RING-type E3 ubiquitin transferase RCHY1;Zinc finger protein 363;p53-induced RING-H2 protein;, PF05495;PF13639;PF14599;, GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0000151;GO:0002039;GO:0042803;GO:0061630;GO:0008270;GO:0070987;GO:0032436;GO:0031398;GO:0051865;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:p53 binding; F:protein homodimerization activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:error-free translesion synthesis; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein autoubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q2KN33 Q59GN7 Q86X26 Q96PR5,RING finger and CHY zinc finger domain-containing protein 1,Androgen receptor N-terminal-interacting protein;CH-rich-interacting match with PLAG1;E3 ubiquitin-protein ligase Pirh2;RING finger protein 199;RING-type E3 ubiquitin transferase RCHY1;Zinc finger protein 363;p53-induced RING-H2 protein;, PF05495;PF13639;PF14599;, GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0000151;GO:0002039;GO:0042803;GO:0061630;GO:0008270;GO:0070987;GO:0032436;GO:0031398;GO:0051865;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:p53 binding; F:protein homodimerization activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:error-free translesion synthesis; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein autoubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q2KN33 Q59GN7 Q86X26 Q96PR5,RING finger and CHY zinc finger domain-containing protein 1,Androgen receptor N-terminal-interacting protein;CH-rich-interacting match with PLAG1;E3 ubiquitin-protein ligase Pirh2;RING finger protein 199;RING-type E3 ubiquitin transferase RCHY1;Zinc finger protein 363;p53-induced RING-H2 protein;, PF05495;PF13639;PF14599;, GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0000151;GO:0002039;GO:0042803;GO:0061630;GO:0008270;GO:0070987;GO:0032436;GO:0031398;GO:0051865;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:p53 binding; F:protein homodimerization activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:error-free translesion synthesis; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein autoubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold17 indexed_genome mRNA 21473005 21600212 . - . ID=transcript_4289;Q6UWI2 B3KMQ9 Q96DV8 Q9Y4S1,Prostate androgen-regulated mucin-like protein 1,, PF17061;, GO:0005829;GO:0005769;GO:0010008;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0005654;GO:0005886;GO:0051973;, C:cytosol; C:early endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:nucleoplasm; C:plasma membrane;, , P:positive regulation of telomerase activity;|Q6UWI2 B3KMQ9 Q96DV8 Q9Y4S1,Prostate androgen-regulated mucin-like protein 1,, PF17061;, GO:0005829;GO:0005769;GO:0010008;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0005654;GO:0005886;GO:0051973;, C:cytosol; C:early endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:nucleoplasm; C:plasma membrane;, , P:positive regulation of telomerase activity; scaffold17 indexed_genome mRNA 21710707 21758857 . + . ID=transcript_4290;P35070 Q96F48,Probetacellulin,, , GO:0030669;GO:0005576;GO:0005615;GO:0016021;GO:0005886;GO:0005154;GO:0008083;GO:0007173;GO:0038128;GO:0000165;GO:0061024;GO:0043066;GO:0042059;GO:0045597;GO:0051781;GO:0008284;GO:0045741;GO:0048146;GO:0045840;GO:0051897;GO:0035810;GO:2000145;GO:0007165;, C:clathrin-coated endocytic vesicle membrane; C:extracellular region; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:epidermal growth factor receptor binding; F:growth factor activity;, P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:MAPK cascade; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of cell differentiation; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of fibroblast proliferation; P:positive regulation of mitotic nuclear division; P:positive regulation of protein kinase B signaling; P:positive regulation of urine volume; P:regulation of cell motility; P:signal transduction; scaffold17 indexed_genome mRNA 22045045 22054783 . - . ID=transcript_4291;P15514 Q5U026,Amphiregulin {ECO:0000303|PubMed:2325643},Colorectum cell-derived growth factor {ECO:0000303|PubMed:1333777};, , GO:0009986;GO:0030669;GO:0005789;GO:0033116;GO:0012507;GO:0005576;GO:0005615;GO:0016021;GO:0005125;GO:0005154;GO:0008083;GO:0007267;GO:0048208;GO:0006888;GO:0007173;GO:0007186;GO:0000165;GO:0061024;GO:0042059;GO:0008284;GO:0045741;GO:0010838;GO:0051897;GO:0007165;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:extracellular region; C:extracellular space; C:integral component of membrane;, F:cytokine activity; F:epidermal growth factor receptor binding; F:growth factor activity;, P:cell-cell signaling; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:epidermal growth factor receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:MAPK cascade; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of keratinocyte proliferation; P:positive regulation of protein kinase B signaling; P:signal transduction; scaffold17 indexed_genome mRNA 22106874 22124249 . - . ID=transcript_4292;O14944 B2RC66 Q6FH69,Proepiregulin,, , GO:0030669;GO:0005576;GO:0005615;GO:0005887;GO:0005154;GO:0008083;GO:0009653;GO:0001525;GO:0009887;GO:0007267;GO:0019221;GO:0007173;GO:0038128;GO:0007143;GO:0030216;GO:0043616;GO:0042700;GO:0000165;GO:0061024;GO:0009299;GO:0008285;GO:0042059;GO:0050680;GO:0051151;GO:0045892;GO:0001556;GO:0001550;GO:0030728;GO:0051781;GO:0008284;GO:0001819;GO:0045740;GO:0045741;GO:0048146;GO:0045089;GO:0032755;GO:0045840;GO:0042327;GO:0045860;GO:0051897;GO:0048661;GO:0048160;GO:2000145;GO:0043434;GO:0007165;GO:0042060;, C:clathrin-coated endocytic vesicle membrane; C:extracellular region; C:extracellular space; C:integral component of plasma membrane;, F:epidermal growth factor receptor binding; F:growth factor activity;, P:anatomical structure morphogenesis; P:angiogenesis; P:animal organ morphogenesis; P:cell-cell signaling; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:female meiotic nuclear division; P:keratinocyte differentiation; P:keratinocyte proliferation; P:luteinizing hormone signaling pathway; P:MAPK cascade; P:membrane organization; P:mRNA transcription; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epithelial cell proliferation; P:negative regulation of smooth muscle cell differentiation; P:negative regulation of transcription, DNA-templated; P:oocyte maturation; P:ovarian cumulus expansion; P:ovulation; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of cytokine production; P:positive regulation of DNA replication; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of fibroblast proliferation; P:positive regulation of innate immune response; P:positive regulation of interleukin-6 production; P:positive regulation of mitotic nuclear division; P:positive regulation of phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:primary follicle stage; P:regulation of cell motility; P:response to peptide hormone; P:signal transduction; P:wound healing; scaffold17 indexed_genome mRNA 22347894 22349747 . - . ID=transcript_4293;P19875 Q6FGD6 Q9UPB8,C-X-C motif chemokine 2,Growth-regulated protein beta;Macrophage inflammatory protein 2-alpha;, PF00048;, GO:0005576;GO:0005615;GO:0008009;GO:0045236;GO:0061844;GO:0071222;GO:0070098;GO:0006935;GO:0019221;GO:0007186;GO:0006954;GO:0031640;GO:0030593;GO:0002237;, C:extracellular region; C:extracellular space;, F:chemokine activity; F:CXCR chemokine receptor binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:neutrophil chemotaxis; P:response to molecule of bacterial origin; scaffold17 indexed_genome mRNA 22361847 22363847 . - . ID=transcript_4294;P19875 Q6FGD6 Q9UPB8,C-X-C motif chemokine 2,Growth-regulated protein beta;Macrophage inflammatory protein 2-alpha;, PF00048;, GO:0005576;GO:0005615;GO:0008009;GO:0045236;GO:0061844;GO:0071222;GO:0070098;GO:0006935;GO:0019221;GO:0007186;GO:0006954;GO:0031640;GO:0030593;GO:0002237;, C:extracellular region; C:extracellular space;, F:chemokine activity; F:CXCR chemokine receptor binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:neutrophil chemotaxis; P:response to molecule of bacterial origin;|P19875 Q6FGD6 Q9UPB8,C-X-C motif chemokine 2,Growth-regulated protein beta;Macrophage inflammatory protein 2-alpha;, PF00048;, GO:0005576;GO:0005615;GO:0008009;GO:0045236;GO:0061844;GO:0071222;GO:0070098;GO:0006935;GO:0019221;GO:0007186;GO:0006954;GO:0031640;GO:0030593;GO:0002237;, C:extracellular region; C:extracellular space;, F:chemokine activity; F:CXCR chemokine receptor binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:neutrophil chemotaxis; P:response to molecule of bacterial origin; scaffold17 indexed_genome mRNA 22446813 22451557 . - . ID=transcript_4295;P80162 B2R4X3 Q4W5D4,C-X-C motif chemokine 6,Chemokine alpha 3;Granulocyte chemotactic protein 2;Small-inducible cytokine B6;, PF00048;, GO:0005576;GO:0005615;GO:0008009;GO:0045236;GO:0008201;GO:0061844;GO:0007267;GO:0071222;GO:0070098;GO:0006935;GO:0042742;GO:0007186;GO:0006954;GO:0001776;GO:0042119;GO:0030593;GO:0032642;GO:0070951;GO:0007165;, C:extracellular region; C:extracellular space;, F:chemokine activity; F:CXCR chemokine receptor binding; F:heparin binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell-cell signaling; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:chemotaxis; P:defense response to bacterium; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:leukocyte homeostasis; P:neutrophil activation; P:neutrophil chemotaxis; P:regulation of chemokine production; P:regulation of neutrophil mediated killing of gram-negative bacterium; P:signal transduction; scaffold17 indexed_genome mRNA 22458411 22460080 . + . ID=transcript_4296;P19875 Q6FGD6 Q9UPB8,C-X-C motif chemokine 2,Growth-regulated protein beta;Macrophage inflammatory protein 2-alpha;, PF00048;, GO:0005576;GO:0005615;GO:0008009;GO:0045236;GO:0061844;GO:0071222;GO:0070098;GO:0006935;GO:0019221;GO:0007186;GO:0006954;GO:0031640;GO:0030593;GO:0002237;, C:extracellular region; C:extracellular space;, F:chemokine activity; F:CXCR chemokine receptor binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:neutrophil chemotaxis; P:response to molecule of bacterial origin; scaffold17 indexed_genome mRNA 22488017 22489236 . - . ID=transcript_4297;P02776 Q53X61 Q9UC64 Q9UC65,Platelet factor 4,C-X-C motif chemokine 4;Iroplact;Oncostatin-A;, PF00048;, GO:0062023;GO:0005737;GO:0005576;GO:0005615;GO:0031093;GO:0020005;GO:0008009;GO:0045236;GO:0048248;GO:0008201;GO:0007189;GO:0061844;GO:0071222;GO:0070098;GO:0019221;GO:0042832;GO:0007186;GO:0006954;GO:0051873;GO:0031640;GO:0030595;GO:0016525;GO:2001240;GO:0045653;GO:0045347;GO:0030593;GO:0030168;GO:0002576;GO:0010628;GO:0010744;GO:0045651;GO:0045944;GO:0032760;GO:0042127;GO:0045652;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen; C:symbiont-containing vacuole membrane;, F:chemokine activity; F:CXCR chemokine receptor binding; F:CXCR3 chemokine receptor binding; F:heparin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to protozoan; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing by host of symbiont cells; P:killing of cells of other organism; P:leukocyte chemotaxis; P:negative regulation of angiogenesis; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of megakaryocyte differentiation; P:negative regulation of MHC class II biosynthetic process; P:neutrophil chemotaxis; P:platelet activation; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of macrophage differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of cell population proliferation; P:regulation of megakaryocyte differentiation; scaffold17 indexed_genome mRNA 22496147 22497817 . - . ID=transcript_4298;P02775 B2R5F3 Q6IBJ8,Platelet basic protein,C-X-C motif chemokine 7;Leukocyte-derived growth factor;Macrophage-derived growth factor;Small-inducible cytokine B7;, PF00048;, GO:0005576;GO:0005615;GO:0031091;GO:0031093;GO:1904724;GO:0008009;GO:0045236;GO:0005355;GO:0008083;GO:0061844;GO:0071222;GO:0070098;GO:0042742;GO:0007186;GO:1904659;GO:0006954;GO:0031640;GO:0030593;GO:0043312;GO:0002576;GO:0051781;, C:extracellular region; C:extracellular space; C:platelet alpha granule; C:platelet alpha granule lumen; C:tertiary granule lumen;, F:chemokine activity; F:CXCR chemokine receptor binding; F:glucose transmembrane transporter activity; F:growth factor activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:defense response to bacterium; P:G protein-coupled receptor signaling pathway; P:glucose transmembrane transport; P:inflammatory response; P:killing of cells of other organism; P:neutrophil chemotaxis; P:neutrophil degranulation; P:platelet degranulation; P:positive regulation of cell division; scaffold17 indexed_genome mRNA 22511561 22513636 . - . ID=transcript_4299;P42830 Q96QE1,C-X-C motif chemokine 5,ENA-78(1-78);Epithelial-derived neutrophil-activating protein 78;Neutrophil-activating peptide ENA-78;Small-inducible cytokine B5;, PF00048;, GO:0005576;GO:0005615;GO:0008009;GO:0045236;GO:0042802;GO:0061844;GO:0007267;GO:0071222;GO:0070098;GO:0006935;GO:0007186;GO:0006954;GO:0030593;GO:0008284;GO:0007165;, C:extracellular region; C:extracellular space;, F:chemokine activity; F:CXCR chemokine receptor binding; F:identical protein binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell-cell signaling; P:cellular response to lipopolysaccharide; P:chemokine-mediated signaling pathway; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:neutrophil chemotaxis; P:positive regulation of cell population proliferation; P:signal transduction; scaffold17 indexed_genome mRNA 22585671 22588329 . - . ID=transcript_4300;Q9UCS0,Interleukin-8,C-X-C motif chemokine 8;Chemokine (C-X-C motif) ligand 8;Emoctakin;Granulocyte chemotactic protein 1;Monocyte-derived neutrophil chemotactic factor;Monocyte-derived neutrophil-activating peptide;Neutrophil-activating protein 1;Protein 3-10C;T-cell chemotactic factor;, PF00048;, GO:0005576;GO:0005615;GO:0008009;GO:0045236;GO:0005153;GO:0001525;GO:0061844;GO:0019722;GO:0007050;GO:0044344;GO:0071347;GO:0071222;GO:0071356;GO:0070098;GO:0006935;GO:0019221;GO:0048566;GO:0007186;GO:0050930;GO:0006954;GO:0035556;GO:0031640;GO:0060354;GO:0008285;GO:0045744;GO:0010629;GO:0042119;GO:0030593;GO:0036499;GO:0045766;GO:0031328;GO:0010628;GO:0090023;GO:0031623;GO:0030155;GO:2000535;GO:0045091;GO:0034976;GO:0002237;GO:0007165;, C:extracellular region; C:extracellular space;, F:chemokine activity; F:CXCR chemokine receptor binding; F:interleukin-8 receptor binding;, P:angiogenesis; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:calcium-mediated signaling; P:cell cycle arrest; P:cellular response to fibroblast growth factor stimulus; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:embryonic digestive tract development; P:G protein-coupled receptor signaling pathway; P:induction of positive chemotaxis; P:inflammatory response; P:intracellular signal transduction; P:killing of cells of other organism; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell population proliferation; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of gene expression; P:neutrophil activation; P:neutrophil chemotaxis; P:PERK-mediated unfolded protein response; P:positive regulation of angiogenesis; P:positive regulation of cellular biosynthetic process; P:positive regulation of gene expression; P:positive regulation of neutrophil chemotaxis; P:receptor internalization; P:regulation of cell adhesion; P:regulation of entry of bacterium into host cell; P:regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:response to endoplasmic reticulum stress; P:response to molecule of bacterial origin; P:signal transduction; scaffold17 indexed_genome mRNA 22752874 22755521 . + . ID=transcript_4301;Q6ZTQ3 Q68DT2 Q6PDA6 Q86WG9 Q86WH0,Ras association domain-containing protein 6,, PF16517;PF00788;, GO:0006915;GO:0042981;GO:0007165;, , , P:apoptotic process; P:regulation of apoptotic process; P:signal transduction; scaffold17 indexed_genome mRNA 22771102 22793720 . - . ID=transcript_4302;P02771 B2RBU3,Alpha-fetoprotein,Alpha-1-fetoprotein;Alpha-fetoglobulin;, PF00273;, GO:0005737;GO:0005788;GO:0005615;GO:0005504;GO:0008270;GO:0044267;GO:0043687;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular space;, F:fatty acid binding; F:zinc ion binding;, P:cellular protein metabolic process; P:post-translational protein modification;|P02771 B2RBU3,Alpha-fetoprotein,Alpha-1-fetoprotein;Alpha-fetoglobulin;, PF00273;, GO:0005737;GO:0005788;GO:0005615;GO:0005504;GO:0008270;GO:0044267;GO:0043687;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular space;, F:fatty acid binding; F:zinc ion binding;, P:cellular protein metabolic process; P:post-translational protein modification;|P02771 B2RBU3,Alpha-fetoprotein,Alpha-1-fetoprotein;Alpha-fetoglobulin;, PF00273;, GO:0005737;GO:0005788;GO:0005615;GO:0005504;GO:0008270;GO:0044267;GO:0043687;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular space;, F:fatty acid binding; F:zinc ion binding;, P:cellular protein metabolic process; P:post-translational protein modification;|P02771 B2RBU3,Alpha-fetoprotein,Alpha-1-fetoprotein;Alpha-fetoglobulin;, PF00273;, GO:0005737;GO:0005788;GO:0005615;GO:0005504;GO:0008270;GO:0044267;GO:0043687;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular space;, F:fatty acid binding; F:zinc ion binding;, P:cellular protein metabolic process; P:post-translational protein modification;|P02771 B2RBU3,Alpha-fetoprotein,Alpha-1-fetoprotein;Alpha-fetoglobulin;, PF00273;, GO:0005737;GO:0005788;GO:0005615;GO:0005504;GO:0008270;GO:0044267;GO:0043687;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular space;, F:fatty acid binding; F:zinc ion binding;, P:cellular protein metabolic process; P:post-translational protein modification; scaffold17 indexed_genome mRNA 22799944 22814552 . - . ID=transcript_4303;P02771 B2RBU3,Alpha-fetoprotein,Alpha-1-fetoprotein;Alpha-fetoglobulin;, PF00273;, GO:0005737;GO:0005788;GO:0005615;GO:0005504;GO:0008270;GO:0044267;GO:0043687;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular space;, F:fatty acid binding; F:zinc ion binding;, P:cellular protein metabolic process; P:post-translational protein modification;|P02771 B2RBU3,Alpha-fetoprotein,Alpha-1-fetoprotein;Alpha-fetoglobulin;, PF00273;, GO:0005737;GO:0005788;GO:0005615;GO:0005504;GO:0008270;GO:0044267;GO:0043687;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular space;, F:fatty acid binding; F:zinc ion binding;, P:cellular protein metabolic process; P:post-translational protein modification; scaffold17 indexed_genome mRNA 22816915 22838251 . - . ID=transcript_4304;P43652 A8K3E1 Q32MR3 Q4W5C5,Afamin,Alpha-albumin {ECO:0000303|PubMed:8755513};, PF00273;, GO:0072562;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005504;GO:0008431;GO:0008270;GO:0050821;GO:0071693;GO:0051180;, C:blood microparticle; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:fatty acid binding; F:vitamin E binding; F:zinc ion binding;, P:protein stabilization; P:protein transport within extracellular region; P:vitamin transport;|P43652 A8K3E1 Q32MR3 Q4W5C5,Afamin,Alpha-albumin {ECO:0000303|PubMed:8755513};, PF00273;, GO:0072562;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005504;GO:0008431;GO:0008270;GO:0050821;GO:0071693;GO:0051180;, C:blood microparticle; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:fatty acid binding; F:vitamin E binding; F:zinc ion binding;, P:protein stabilization; P:protein transport within extracellular region; P:vitamin transport;|P43652 A8K3E1 Q32MR3 Q4W5C5,Afamin,Alpha-albumin {ECO:0000303|PubMed:8755513};, PF00273;, GO:0072562;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005504;GO:0008431;GO:0008270;GO:0050821;GO:0071693;GO:0051180;, C:blood microparticle; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:fatty acid binding; F:vitamin E binding; F:zinc ion binding;, P:protein stabilization; P:protein transport within extracellular region; P:vitamin transport;|P43652 A8K3E1 Q32MR3 Q4W5C5,Afamin,Alpha-albumin {ECO:0000303|PubMed:8755513};, PF00273;, GO:0072562;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005504;GO:0008431;GO:0008270;GO:0050821;GO:0071693;GO:0051180;, C:blood microparticle; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:fatty acid binding; F:vitamin E binding; F:zinc ion binding;, P:protein stabilization; P:protein transport within extracellular region; P:vitamin transport;|P43652 A8K3E1 Q32MR3 Q4W5C5,Afamin,Alpha-albumin {ECO:0000303|PubMed:8755513};, PF00273;, GO:0072562;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005504;GO:0008431;GO:0008270;GO:0050821;GO:0071693;GO:0051180;, C:blood microparticle; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:fatty acid binding; F:vitamin E binding; F:zinc ion binding;, P:protein stabilization; P:protein transport within extracellular region; P:vitamin transport;|P43652 A8K3E1 Q32MR3 Q4W5C5,Afamin,Alpha-albumin {ECO:0000303|PubMed:8755513};, PF00273;, GO:0072562;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005504;GO:0008431;GO:0008270;GO:0050821;GO:0071693;GO:0051180;, C:blood microparticle; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:fatty acid binding; F:vitamin E binding; F:zinc ion binding;, P:protein stabilization; P:protein transport within extracellular region; P:vitamin transport;|P43652 A8K3E1 Q32MR3 Q4W5C5,Afamin,Alpha-albumin {ECO:0000303|PubMed:8755513};, PF00273;, GO:0072562;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005504;GO:0008431;GO:0008270;GO:0050821;GO:0071693;GO:0051180;, C:blood microparticle; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:fatty acid binding; F:vitamin E binding; F:zinc ion binding;, P:protein stabilization; P:protein transport within extracellular region; P:vitamin transport;|P43652 A8K3E1 Q32MR3 Q4W5C5,Afamin,Alpha-albumin {ECO:0000303|PubMed:8755513};, PF00273;, GO:0072562;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005504;GO:0008431;GO:0008270;GO:0050821;GO:0071693;GO:0051180;, C:blood microparticle; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:fatty acid binding; F:vitamin E binding; F:zinc ion binding;, P:protein stabilization; P:protein transport within extracellular region; P:vitamin transport; scaffold17 indexed_genome mRNA 22876366 22890438 . - . ID=transcript_4305;Q8IUK7 Q9P157 Q9P1I7 Q9UHS3 Q9UJZ0,Albumin,, PF00273;, GO:0072562;GO:0005737;GO:0005783;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0005634;GO:0031093;GO:0032991;GO:0016209;GO:0051087;GO:0005507;GO:0003677;GO:1903981;GO:0140272;GO:0005504;GO:0042802;GO:0030170;GO:0015643;GO:0008270;GO:0044267;GO:0009267;GO:0006783;GO:0042167;GO:0034375;GO:0051659;GO:0043066;GO:0043069;GO:0002576;GO:0043687;GO:0006898;GO:0001895;, C:blood microparticle; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:nucleus; C:platelet alpha granule lumen; C:protein-containing complex;, F:antioxidant activity; F:chaperone binding; F:copper ion binding; F:DNA binding; F:enterobactin binding; F:exogenous protein binding; F:fatty acid binding; F:identical protein binding; F:pyridoxal phosphate binding; F:toxic substance binding; F:zinc ion binding;, P:cellular protein metabolic process; P:cellular response to starvation; P:heme biosynthetic process; P:heme catabolic process; P:high-density lipoprotein particle remodeling; P:maintenance of mitochondrion location; P:negative regulation of apoptotic process; P:negative regulation of programmed cell death; P:platelet degranulation; P:post-translational protein modification; P:receptor-mediated endocytosis; P:retina homeostasis;|Q8IUK7 Q9P157 Q9P1I7 Q9UHS3 Q9UJZ0,Albumin,, PF00273;, GO:0072562;GO:0005737;GO:0005783;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0005634;GO:0031093;GO:0032991;GO:0016209;GO:0051087;GO:0005507;GO:0003677;GO:1903981;GO:0140272;GO:0005504;GO:0042802;GO:0030170;GO:0015643;GO:0008270;GO:0044267;GO:0009267;GO:0006783;GO:0042167;GO:0034375;GO:0051659;GO:0043066;GO:0043069;GO:0002576;GO:0043687;GO:0006898;GO:0001895;, C:blood microparticle; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:nucleus; C:platelet alpha granule lumen; C:protein-containing complex;, F:antioxidant activity; F:chaperone binding; F:copper ion binding; F:DNA binding; F:enterobactin binding; F:exogenous protein binding; F:fatty acid binding; F:identical protein binding; F:pyridoxal phosphate binding; F:toxic substance binding; F:zinc ion binding;, P:cellular protein metabolic process; P:cellular response to starvation; P:heme biosynthetic process; P:heme catabolic process; P:high-density lipoprotein particle remodeling; P:maintenance of mitochondrion location; P:negative regulation of apoptotic process; P:negative regulation of programmed cell death; P:platelet degranulation; P:post-translational protein modification; P:receptor-mediated endocytosis; P:retina homeostasis;|Q8IUK7 Q9P157 Q9P1I7 Q9UHS3 Q9UJZ0,Albumin,, PF00273;, GO:0072562;GO:0005737;GO:0005783;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0005634;GO:0031093;GO:0032991;GO:0016209;GO:0051087;GO:0005507;GO:0003677;GO:1903981;GO:0140272;GO:0005504;GO:0042802;GO:0030170;GO:0015643;GO:0008270;GO:0044267;GO:0009267;GO:0006783;GO:0042167;GO:0034375;GO:0051659;GO:0043066;GO:0043069;GO:0002576;GO:0043687;GO:0006898;GO:0001895;, C:blood microparticle; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:nucleus; C:platelet alpha granule lumen; C:protein-containing complex;, F:antioxidant activity; F:chaperone binding; F:copper ion binding; F:DNA binding; F:enterobactin binding; F:exogenous protein binding; F:fatty acid binding; F:identical protein binding; F:pyridoxal phosphate binding; F:toxic substance binding; F:zinc ion binding;, P:cellular protein metabolic process; P:cellular response to starvation; P:heme biosynthetic process; P:heme catabolic process; P:high-density lipoprotein particle remodeling; P:maintenance of mitochondrion location; P:negative regulation of apoptotic process; P:negative regulation of programmed cell death; P:platelet degranulation; P:post-translational protein modification; P:receptor-mediated endocytosis; P:retina homeostasis; scaffold17 indexed_genome mRNA 22891180 22895797 . - . ID=transcript_4306;Q8IUK7 Q9P157 Q9P1I7 Q9UHS3 Q9UJZ0,Albumin,, PF00273;, GO:0072562;GO:0005737;GO:0005783;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0005634;GO:0031093;GO:0032991;GO:0016209;GO:0051087;GO:0005507;GO:0003677;GO:1903981;GO:0140272;GO:0005504;GO:0042802;GO:0030170;GO:0015643;GO:0008270;GO:0044267;GO:0009267;GO:0006783;GO:0042167;GO:0034375;GO:0051659;GO:0043066;GO:0043069;GO:0002576;GO:0043687;GO:0006898;GO:0001895;, C:blood microparticle; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:nucleus; C:platelet alpha granule lumen; C:protein-containing complex;, F:antioxidant activity; F:chaperone binding; F:copper ion binding; F:DNA binding; F:enterobactin binding; F:exogenous protein binding; F:fatty acid binding; F:identical protein binding; F:pyridoxal phosphate binding; F:toxic substance binding; F:zinc ion binding;, P:cellular protein metabolic process; P:cellular response to starvation; P:heme biosynthetic process; P:heme catabolic process; P:high-density lipoprotein particle remodeling; P:maintenance of mitochondrion location; P:negative regulation of apoptotic process; P:negative regulation of programmed cell death; P:platelet degranulation; P:post-translational protein modification; P:receptor-mediated endocytosis; P:retina homeostasis; scaffold17 indexed_genome mRNA 22936588 22941151 . - . ID=transcript_4307;P02792 B2R4B9 Q6IBT7 Q7Z2W1 Q86WI9 Q8WU07 Q96AU9 Q96CU0 Q9BTZ8,Ferritin light chain,, PF00210;, GO:0044754;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0008043;GO:0016020;GO:0008199;GO:0008198;GO:0042802;GO:0005506;GO:0006879;GO:0006880;GO:0055072;GO:0006826;GO:0043312;GO:0006892;, C:autolysosome; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular ferritin complex; C:membrane;, F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:iron ion binding;, P:cellular iron ion homeostasis; P:intracellular sequestering of iron ion; P:iron ion homeostasis; P:iron ion transport; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; scaffold17 indexed_genome mRNA 23098039 23180057 . + . ID=transcript_4308;Q9H288 Q9H6J9,Ankyrin repeat domain-containing protein 17,Gene trap ankyrin repeat protein;Serologically defined breast cancer antigen NY-BR-16;, PF00023;PF12796;PF00013;, GO:0000785;GO:0005737;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0003682;GO:0003723;GO:0001955;GO:0042742;GO:0045087;GO:0051151;GO:0045787;GO:1900087;GO:0043123;GO:1900245;GO:1900246;GO:0006275;GO:0016032;, C:chromatin; C:cytoplasm; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA binding;, P:blood vessel maturation; P:defense response to bacterium; P:innate immune response; P:negative regulation of smooth muscle cell differentiation; P:positive regulation of cell cycle; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MDA-5 signaling pathway; P:positive regulation of RIG-I signaling pathway; P:regulation of DNA replication; P:viral process;|Q9H288 Q9H6J9,Ankyrin repeat domain-containing protein 17,Gene trap ankyrin repeat protein;Serologically defined breast cancer antigen NY-BR-16;, PF00023;PF12796;PF00013;, GO:0000785;GO:0005737;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0003682;GO:0003723;GO:0001955;GO:0042742;GO:0045087;GO:0051151;GO:0045787;GO:1900087;GO:0043123;GO:1900245;GO:1900246;GO:0006275;GO:0016032;, C:chromatin; C:cytoplasm; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA binding;, P:blood vessel maturation; P:defense response to bacterium; P:innate immune response; P:negative regulation of smooth muscle cell differentiation; P:positive regulation of cell cycle; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MDA-5 signaling pathway; P:positive regulation of RIG-I signaling pathway; P:regulation of DNA replication; P:viral process;|Q9H288 Q9H6J9,Ankyrin repeat domain-containing protein 17,Gene trap ankyrin repeat protein;Serologically defined breast cancer antigen NY-BR-16;, PF00023;PF12796;PF00013;, GO:0000785;GO:0005737;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0003682;GO:0003723;GO:0001955;GO:0042742;GO:0045087;GO:0051151;GO:0045787;GO:1900087;GO:0043123;GO:1900245;GO:1900246;GO:0006275;GO:0016032;, C:chromatin; C:cytoplasm; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA binding;, P:blood vessel maturation; P:defense response to bacterium; P:innate immune response; P:negative regulation of smooth muscle cell differentiation; P:positive regulation of cell cycle; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MDA-5 signaling pathway; P:positive regulation of RIG-I signaling pathway; P:regulation of DNA replication; P:viral process;|Q9H288 Q9H6J9,Ankyrin repeat domain-containing protein 17,Gene trap ankyrin repeat protein;Serologically defined breast cancer antigen NY-BR-16;, PF00023;PF12796;PF00013;, GO:0000785;GO:0005737;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0003682;GO:0003723;GO:0001955;GO:0042742;GO:0045087;GO:0051151;GO:0045787;GO:1900087;GO:0043123;GO:1900245;GO:1900246;GO:0006275;GO:0016032;, C:chromatin; C:cytoplasm; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA binding;, P:blood vessel maturation; P:defense response to bacterium; P:innate immune response; P:negative regulation of smooth muscle cell differentiation; P:positive regulation of cell cycle; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MDA-5 signaling pathway; P:positive regulation of RIG-I signaling pathway; P:regulation of DNA replication; P:viral process;|Q9H288 Q9H6J9,Ankyrin repeat domain-containing protein 17,Gene trap ankyrin repeat protein;Serologically defined breast cancer antigen NY-BR-16;, PF00023;PF12796;PF00013;, GO:0000785;GO:0005737;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0003682;GO:0003723;GO:0001955;GO:0042742;GO:0045087;GO:0051151;GO:0045787;GO:1900087;GO:0043123;GO:1900245;GO:1900246;GO:0006275;GO:0016032;, C:chromatin; C:cytoplasm; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA binding;, P:blood vessel maturation; P:defense response to bacterium; P:innate immune response; P:negative regulation of smooth muscle cell differentiation; P:positive regulation of cell cycle; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MDA-5 signaling pathway; P:positive regulation of RIG-I signaling pathway; P:regulation of DNA replication; P:viral process;|Q9H288 Q9H6J9,Ankyrin repeat domain-containing protein 17,Gene trap ankyrin repeat protein;Serologically defined breast cancer antigen NY-BR-16;, PF00023;PF12796;PF00013;, GO:0000785;GO:0005737;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0003682;GO:0003723;GO:0001955;GO:0042742;GO:0045087;GO:0051151;GO:0045787;GO:1900087;GO:0043123;GO:1900245;GO:1900246;GO:0006275;GO:0016032;, C:chromatin; C:cytoplasm; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA binding;, P:blood vessel maturation; P:defense response to bacterium; P:innate immune response; P:negative regulation of smooth muscle cell differentiation; P:positive regulation of cell cycle; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MDA-5 signaling pathway; P:positive regulation of RIG-I signaling pathway; P:regulation of DNA replication; P:viral process;|Q9H288 Q9H6J9,Ankyrin repeat domain-containing protein 17,Gene trap ankyrin repeat protein;Serologically defined breast cancer antigen NY-BR-16;, PF00023;PF12796;PF00013;, GO:0000785;GO:0005737;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0003682;GO:0003723;GO:0001955;GO:0042742;GO:0045087;GO:0051151;GO:0045787;GO:1900087;GO:0043123;GO:1900245;GO:1900246;GO:0006275;GO:0016032;, C:chromatin; C:cytoplasm; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA binding;, P:blood vessel maturation; P:defense response to bacterium; P:innate immune response; P:negative regulation of smooth muscle cell differentiation; P:positive regulation of cell cycle; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MDA-5 signaling pathway; P:positive regulation of RIG-I signaling pathway; P:regulation of DNA replication; P:viral process;|Q9H288 Q9H6J9,Ankyrin repeat domain-containing protein 17,Gene trap ankyrin repeat protein;Serologically defined breast cancer antigen NY-BR-16;, PF00023;PF12796;PF00013;, GO:0000785;GO:0005737;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0003682;GO:0003723;GO:0001955;GO:0042742;GO:0045087;GO:0051151;GO:0045787;GO:1900087;GO:0043123;GO:1900245;GO:1900246;GO:0006275;GO:0016032;, C:chromatin; C:cytoplasm; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA binding;, P:blood vessel maturation; P:defense response to bacterium; P:innate immune response; P:negative regulation of smooth muscle cell differentiation; P:positive regulation of cell cycle; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MDA-5 signaling pathway; P:positive regulation of RIG-I signaling pathway; P:regulation of DNA replication; P:viral process; scaffold17 indexed_genome mRNA 23183625 23195383 . + . ID=transcript_4309;Q8N8Q8 Q2PB66 Q2PB67 Q2PB68 Q49B97 Q6IPP9,Cytochrome c oxidase assembly protein COX18, mitochondrial,Cytochrome c oxidase assembly protein 18;, PF02096;, GO:0031305;GO:0032977;GO:0033617;GO:0051205;GO:0032979;GO:0051204;GO:0008535;, C:integral component of mitochondrial inner membrane;, F:membrane insertase activity;, P:mitochondrial cytochrome c oxidase assembly; P:protein insertion into membrane; P:protein insertion into mitochondrial inner membrane from matrix; P:protein insertion into mitochondrial membrane; P:respiratory chain complex IV assembly;|Q8N8Q8 Q2PB66 Q2PB67 Q2PB68 Q49B97 Q6IPP9,Cytochrome c oxidase assembly protein COX18, mitochondrial,Cytochrome c oxidase assembly protein 18;, PF02096;, GO:0031305;GO:0032977;GO:0033617;GO:0051205;GO:0032979;GO:0051204;GO:0008535;, C:integral component of mitochondrial inner membrane;, F:membrane insertase activity;, P:mitochondrial cytochrome c oxidase assembly; P:protein insertion into membrane; P:protein insertion into mitochondrial inner membrane from matrix; P:protein insertion into mitochondrial membrane; P:respiratory chain complex IV assembly;|Q8N8Q8 Q2PB66 Q2PB67 Q2PB68 Q49B97 Q6IPP9,Cytochrome c oxidase assembly protein COX18, mitochondrial,Cytochrome c oxidase assembly protein 18;, PF02096;, GO:0031305;GO:0032977;GO:0033617;GO:0051205;GO:0032979;GO:0051204;GO:0008535;, C:integral component of mitochondrial inner membrane;, F:membrane insertase activity;, P:mitochondrial cytochrome c oxidase assembly; P:protein insertion into membrane; P:protein insertion into mitochondrial inner membrane from matrix; P:protein insertion into mitochondrial membrane; P:respiratory chain complex IV assembly;|Q8N8Q8 Q2PB66 Q2PB67 Q2PB68 Q49B97 Q6IPP9,Cytochrome c oxidase assembly protein COX18, mitochondrial,Cytochrome c oxidase assembly protein 18;, PF02096;, GO:0031305;GO:0032977;GO:0033617;GO:0051205;GO:0032979;GO:0051204;GO:0008535;, C:integral component of mitochondrial inner membrane;, F:membrane insertase activity;, P:mitochondrial cytochrome c oxidase assembly; P:protein insertion into membrane; P:protein insertion into mitochondrial inner membrane from matrix; P:protein insertion into mitochondrial membrane; P:respiratory chain complex IV assembly; scaffold17 indexed_genome mRNA 24214441 24246845 . + . ID=transcript_4310;P02774 B4DPP2 D6RAK8 Q16309 Q16310 Q53F31 Q6GTG1,Vitamin D-binding protein,Gc protein-derived macrophage activating factor {ECO:0000303|PubMed:16302727};Gc-globulin;Group-specific component;Vitamin D-binding protein-macrophage activating factor;, PF00273;PF09164;, GO:0072562;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0043202;GO:0003779;GO:1902118;GO:0005499;GO:0090482;GO:0042359;GO:0051180;, C:blood microparticle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal lumen;, F:actin binding; F:calcidiol binding; F:vitamin D binding; F:vitamin transmembrane transporter activity;, P:vitamin D metabolic process; P:vitamin transport;|P02774 B4DPP2 D6RAK8 Q16309 Q16310 Q53F31 Q6GTG1,Vitamin D-binding protein,Gc protein-derived macrophage activating factor {ECO:0000303|PubMed:16302727};Gc-globulin;Group-specific component;Vitamin D-binding protein-macrophage activating factor;, PF00273;PF09164;, GO:0072562;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0043202;GO:0003779;GO:1902118;GO:0005499;GO:0090482;GO:0042359;GO:0051180;, C:blood microparticle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal lumen;, F:actin binding; F:calcidiol binding; F:vitamin D binding; F:vitamin transmembrane transporter activity;, P:vitamin D metabolic process; P:vitamin transport;|P02774 B4DPP2 D6RAK8 Q16309 Q16310 Q53F31 Q6GTG1,Vitamin D-binding protein,Gc protein-derived macrophage activating factor {ECO:0000303|PubMed:16302727};Gc-globulin;Group-specific component;Vitamin D-binding protein-macrophage activating factor;, PF00273;PF09164;, GO:0072562;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0043202;GO:0003779;GO:1902118;GO:0005499;GO:0090482;GO:0042359;GO:0051180;, C:blood microparticle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal lumen;, F:actin binding; F:calcidiol binding; F:vitamin D binding; F:vitamin transmembrane transporter activity;, P:vitamin D metabolic process; P:vitamin transport; scaffold17 indexed_genome mRNA 24246882 24263096 . + . ID=transcript_4311;P02774 B4DPP2 D6RAK8 Q16309 Q16310 Q53F31 Q6GTG1,Vitamin D-binding protein,Gc protein-derived macrophage activating factor {ECO:0000303|PubMed:16302727};Gc-globulin;Group-specific component;Vitamin D-binding protein-macrophage activating factor;, PF00273;PF09164;, GO:0072562;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0043202;GO:0003779;GO:1902118;GO:0005499;GO:0090482;GO:0042359;GO:0051180;, C:blood microparticle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal lumen;, F:actin binding; F:calcidiol binding; F:vitamin D binding; F:vitamin transmembrane transporter activity;, P:vitamin D metabolic process; P:vitamin transport; scaffold17 indexed_genome mRNA 24407440 24603340 . - . ID=transcript_4312;Q9Y6R1 C4B714 O15153 Q8NEJ2 Q9H262 Q9NRZ1 Q9UIC0 Q9UIC1 Q9UP50,Electrogenic sodium bicarbonate cotransporter 1,Na(+)/HCO3(-) cotransporter;Solute carrier family 4 member 4;kNBC1;, PF07565;PF00955;, GO:0016323;GO:0009986;GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0042802;GO:0005452;GO:0008510;GO:0015293;GO:0022857;GO:0015701;GO:0050801;GO:0045821;GO:0051453;GO:0042391;GO:0036376;GO:0035725;GO:0006814;GO:0055085;GO:0150104;, C:basolateral plasma membrane; C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:identical protein binding; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:ion homeostasis; P:positive regulation of glycolytic process; P:regulation of intracellular pH; P:regulation of membrane potential; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y6R1 C4B714 O15153 Q8NEJ2 Q9H262 Q9NRZ1 Q9UIC0 Q9UIC1 Q9UP50,Electrogenic sodium bicarbonate cotransporter 1,Na(+)/HCO3(-) cotransporter;Solute carrier family 4 member 4;kNBC1;, PF07565;PF00955;, GO:0016323;GO:0009986;GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0042802;GO:0005452;GO:0008510;GO:0015293;GO:0022857;GO:0015701;GO:0050801;GO:0045821;GO:0051453;GO:0042391;GO:0036376;GO:0035725;GO:0006814;GO:0055085;GO:0150104;, C:basolateral plasma membrane; C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:identical protein binding; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:ion homeostasis; P:positive regulation of glycolytic process; P:regulation of intracellular pH; P:regulation of membrane potential; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transmembrane transport; P:transport across blood-brain barrier; scaffold17 indexed_genome mRNA 24867615 24893581 . - . ID=transcript_4313;P27707 B2R8V6 Q5TZY7 Q6FI11,Deoxycytidine kinase,Deoxyadenosine kinase;Deoxyguanosine kinase;, PF01712;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005524;GO:0004136;GO:0004137;GO:0004138;GO:0019136;GO:0008144;GO:0042803;GO:0043101;GO:0043097;GO:0006220;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:deoxyadenosine kinase activity; F:deoxycytidine kinase activity; F:deoxyguanosine kinase activity; F:deoxynucleoside kinase activity; F:drug binding; F:protein homodimerization activity;, P:purine-containing compound salvage; P:pyrimidine nucleoside salvage; P:pyrimidine nucleotide metabolic process; scaffold17 indexed_genome mRNA 24899398 24969567 . - . ID=transcript_4314;Q7L9L4 B2R8U6 B4DRY3 Q8IY23,MOB kinase activator 1B,Mob1 homolog 1A;Mob1B;Mps one binder kinase activator-like 1A;, PF03637;, GO:0005737;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0019209;GO:0019900;GO:0046872;GO:0035329;GO:0031952;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:kinase activator activity; F:kinase binding; F:metal ion binding;, P:hippo signaling; P:regulation of protein autophosphorylation;|Q7L9L4 B2R8U6 B4DRY3 Q8IY23,MOB kinase activator 1B,Mob1 homolog 1A;Mob1B;Mps one binder kinase activator-like 1A;, PF03637;, GO:0005737;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0019209;GO:0019900;GO:0046872;GO:0035329;GO:0031952;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:kinase activator activity; F:kinase binding; F:metal ion binding;, P:hippo signaling; P:regulation of protein autophosphorylation;|Q7L9L4 B2R8U6 B4DRY3 Q8IY23,MOB kinase activator 1B,Mob1 homolog 1A;Mob1B;Mps one binder kinase activator-like 1A;, PF03637;, GO:0005737;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0019209;GO:0019900;GO:0046872;GO:0035329;GO:0031952;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:kinase activator activity; F:kinase binding; F:metal ion binding;, P:hippo signaling; P:regulation of protein autophosphorylation; scaffold17 indexed_genome mRNA 24983557 25006703 . + . ID=transcript_4315;Q12849 B3KPW0 Q4W5S5 Q6ZST3 Q8IWD6 Q8NBD2,G-rich sequence factor 1,, PF00076;, GO:0005737;GO:0042645;GO:0005739;GO:0005654;GO:1990904;GO:0035770;GO:0003729;GO:0003723;GO:0009952;GO:0016331;GO:0006378;GO:0000962;GO:0043484;GO:0008033;, C:cytoplasm; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:RNA binding;, P:anterior/posterior pattern specification; P:morphogenesis of embryonic epithelium; P:mRNA polyadenylation; P:positive regulation of mitochondrial RNA catabolic process; P:regulation of RNA splicing; P:tRNA processing;|Q12849 B3KPW0 Q4W5S5 Q6ZST3 Q8IWD6 Q8NBD2,G-rich sequence factor 1,, PF00076;, GO:0005737;GO:0042645;GO:0005739;GO:0005654;GO:1990904;GO:0035770;GO:0003729;GO:0003723;GO:0009952;GO:0016331;GO:0006378;GO:0000962;GO:0043484;GO:0008033;, C:cytoplasm; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:RNA binding;, P:anterior/posterior pattern specification; P:morphogenesis of embryonic epithelium; P:mRNA polyadenylation; P:positive regulation of mitochondrial RNA catabolic process; P:regulation of RNA splicing; P:tRNA processing;|Q12849 B3KPW0 Q4W5S5 Q6ZST3 Q8IWD6 Q8NBD2,G-rich sequence factor 1,, PF00076;, GO:0005737;GO:0042645;GO:0005739;GO:0005654;GO:1990904;GO:0035770;GO:0003729;GO:0003723;GO:0009952;GO:0016331;GO:0006378;GO:0000962;GO:0043484;GO:0008033;, C:cytoplasm; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:RNA binding;, P:anterior/posterior pattern specification; P:morphogenesis of embryonic epithelium; P:mRNA polyadenylation; P:positive regulation of mitochondrial RNA catabolic process; P:regulation of RNA splicing; P:tRNA processing;|Q12849 B3KPW0 Q4W5S5 Q6ZST3 Q8IWD6 Q8NBD2,G-rich sequence factor 1,, PF00076;, GO:0005737;GO:0042645;GO:0005739;GO:0005654;GO:1990904;GO:0035770;GO:0003729;GO:0003723;GO:0009952;GO:0016331;GO:0006378;GO:0000962;GO:0043484;GO:0008033;, C:cytoplasm; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:RNA binding;, P:anterior/posterior pattern specification; P:morphogenesis of embryonic epithelium; P:mRNA polyadenylation; P:positive regulation of mitochondrial RNA catabolic process; P:regulation of RNA splicing; P:tRNA processing;|Q12849 B3KPW0 Q4W5S5 Q6ZST3 Q8IWD6 Q8NBD2,G-rich sequence factor 1,, PF00076;, GO:0005737;GO:0042645;GO:0005739;GO:0005654;GO:1990904;GO:0035770;GO:0003729;GO:0003723;GO:0009952;GO:0016331;GO:0006378;GO:0000962;GO:0043484;GO:0008033;, C:cytoplasm; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:RNA binding;, P:anterior/posterior pattern specification; P:morphogenesis of embryonic epithelium; P:mRNA polyadenylation; P:positive regulation of mitochondrial RNA catabolic process; P:regulation of RNA splicing; P:tRNA processing; scaffold17 indexed_genome mRNA 25028260 25116616 . - . ID=transcript_4316;Q7L099 B3KM25 B4DYW7 D9N163 O94948 Q9UI00,Protein RUFY3 {ECO:0000305},RUN and FYVE domain-containing protein 3 {ECO:0000312|HGNC:HGNC:30285};Rap2-interacting protein x {ECO:0000250|UniProtKB:Q9D394};Single axon-regulated protein {ECO:0000250|UniProtKB:Q5FVJ0};, PF02759;, GO:0030424;GO:0030054;GO:0005737;GO:0005829;GO:0030425;GO:0012505;GO:0030175;GO:0030426;GO:0030027;GO:0016020;GO:0043025;GO:0043204;GO:0007015;GO:0050771;GO:0045773;GO:0030335;GO:0090316;GO:0050770;GO:2000114;, C:axon; C:cell junction; C:cytoplasm; C:cytosol; C:dendrite; C:endomembrane system; C:filopodium; C:growth cone; C:lamellipodium; C:membrane; C:neuronal cell body; C:perikaryon;, , P:actin filament organization; P:negative regulation of axonogenesis; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of intracellular protein transport; P:regulation of axonogenesis; P:regulation of establishment of cell polarity;|Q7L099 B3KM25 B4DYW7 D9N163 O94948 Q9UI00,Protein RUFY3 {ECO:0000305},RUN and FYVE domain-containing protein 3 {ECO:0000312|HGNC:HGNC:30285};Rap2-interacting protein x {ECO:0000250|UniProtKB:Q9D394};Single axon-regulated protein {ECO:0000250|UniProtKB:Q5FVJ0};, PF02759;, GO:0030424;GO:0030054;GO:0005737;GO:0005829;GO:0030425;GO:0012505;GO:0030175;GO:0030426;GO:0030027;GO:0016020;GO:0043025;GO:0043204;GO:0007015;GO:0050771;GO:0045773;GO:0030335;GO:0090316;GO:0050770;GO:2000114;, C:axon; C:cell junction; C:cytoplasm; C:cytosol; C:dendrite; C:endomembrane system; C:filopodium; C:growth cone; C:lamellipodium; C:membrane; C:neuronal cell body; C:perikaryon;, , P:actin filament organization; P:negative regulation of axonogenesis; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of intracellular protein transport; P:regulation of axonogenesis; P:regulation of establishment of cell polarity; scaffold17 indexed_genome mRNA 25127304 25131514 . + . ID=transcript_4317;Q9NQZ2 Q6FI82,Something about silencing protein 10,Charged amino acid-rich leucine zipper 1;Disrupter of silencing SAS10;UTP3 homolog;, PF09368;PF04000;, GO:0005730;GO:0005654;GO:0005634;GO:0032040;GO:0003723;GO:0007420;GO:0006325;GO:0000462;GO:0006364;, C:nucleolus; C:nucleoplasm; C:nucleus; C:small-subunit processome;, F:RNA binding;, P:brain development; P:chromatin organization; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing; scaffold17 indexed_genome mRNA 25159304 25169275 . + . ID=transcript_4318;P01591,Immunoglobulin J chain,Joining chain of multimeric IgA and IgM {ECO:0000312|HGNC:HGNC:5713};, PF15097;, GO:0072562;GO:0071750;GO:0070062;GO:0005576;GO:0005615;GO:0071748;GO:0071756;GO:0071752;GO:0071751;GO:0003823;GO:0019862;GO:0034987;GO:0042803;GO:0030674;GO:0002250;GO:0019731;GO:0003094;GO:0006959;GO:0006955;GO:0045087;GO:0050900;GO:0060267;GO:0065003;GO:0006898;GO:0001895;, C:blood microparticle; C:dimeric IgA immunoglobulin complex; C:extracellular exosome; C:extracellular region; C:extracellular space; C:monomeric IgA immunoglobulin complex; C:pentameric IgM immunoglobulin complex; C:secretory dimeric IgA immunoglobulin complex; C:secretory IgA immunoglobulin complex;, F:antigen binding; F:IgA binding; F:immunoglobulin receptor binding; F:protein homodimerization activity; F:protein-macromolecule adaptor activity;, P:adaptive immune response; P:antibacterial humoral response; P:glomerular filtration; P:humoral immune response; P:immune response; P:innate immune response; P:leukocyte migration; P:positive regulation of respiratory burst; P:protein-containing complex assembly; P:receptor-mediated endocytosis; P:retina homeostasis; scaffold17 indexed_genome mRNA 25586548 25587272 . + . ID=transcript_4319;Q8IWE4 B3KVY4,DCN1-like protein 3,DCUN1 domain-containing protein 3;Defective in cullin neddylation protein 1-like protein 3;Squamous cell carcinoma-related oncogene 3 {ECO:0000303|PubMed:25349211};, PF03556;, GO:0005737;GO:0005634;GO:0048471;GO:0005886;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:0030308;GO:2000134;GO:2000435;GO:0043065;GO:2000436;GO:0051443;GO:0043687;GO:0045116;GO:0010564;GO:2000434;GO:0010332;GO:0010225;, C:cytoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein neddylation; P:positive regulation of apoptotic process; P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:protein neddylation; P:regulation of cell cycle process; P:regulation of protein neddylation; P:response to gamma radiation; P:response to UV-C; scaffold17 indexed_genome mRNA 25993852 26045721 . + . ID=transcript_4320;P0DTE4 B4E2F4 D3GER1 D3GER2 E9PDM7 J3KNA3 Q9Y4X1,UDP-glucuronosyltransferase 2A1 {ECO:0000303|PubMed:18719240},, PF00201;, GO:0005789;GO:0016021;GO:0015020;GO:0008206;GO:0052695;GO:0050896;GO:0007608;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:glucuronosyltransferase activity;, P:bile acid metabolic process; P:cellular glucuronidation; P:response to stimulus; P:sensory perception of smell;|Q6UWM9 Q9H6S4,UDP-glucuronosyltransferase 2A3,, PF00201;, GO:0016021;GO:0043231;GO:0015020;GO:0052695;, C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:glucuronosyltransferase activity;, P:cellular glucuronidation; scaffold17 indexed_genome mRNA 26121020 26149660 . + . ID=transcript_4321;P0DTE5 B4E2F4 D3GER1 D3GER2 E9PDM7 J3KNA3 Q9Y4X1,UDP-glucuronosyltransferase 2A2 {ECO:0000303|PubMed:19858781},, PF00201;, GO:0005789;GO:0016021;GO:0015020;GO:0008206;GO:0052695;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:glucuronosyltransferase activity;, P:bile acid metabolic process; P:cellular glucuronidation; scaffold17 indexed_genome mRNA 26153250 26154047 . + . ID=transcript_4322;P0DTE5 B4E2F4 D3GER1 D3GER2 E9PDM7 J3KNA3 Q9Y4X1,UDP-glucuronosyltransferase 2A2 {ECO:0000303|PubMed:19858781},, PF00201;, GO:0005789;GO:0016021;GO:0015020;GO:0008206;GO:0052695;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:glucuronosyltransferase activity;, P:bile acid metabolic process; P:cellular glucuronidation; scaffold17 indexed_genome mRNA 26188726 26203962 . + . ID=transcript_4323;P16662 B2R810 Q6GTW0,UDP-glucuronosyltransferase 2B7 {ECO:0000303|PubMed:18719240},3,4-catechol estrogen-specific UDPGT;UDP-glucuronosyltransferase 2B9;UDPGTh-2;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0015020;GO:0008209;GO:0052695;GO:0008210;GO:0006629;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:glucuronosyltransferase activity;, P:androgen metabolic process; P:cellular glucuronidation; P:estrogen metabolic process; P:lipid metabolic process; scaffold17 indexed_genome mRNA 26327807 26365706 . + . ID=transcript_4324;O75795,UDP-glucuronosyltransferase 2B17 {ECO:0000303|PubMed:18719240},C19-steroid-specific UDP-glucuronosyltransferase;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0015020;GO:0052695;GO:0008210;GO:0008202;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:glucuronosyltransferase activity;, P:cellular glucuronidation; P:estrogen metabolic process; P:steroid metabolic process; scaffold17 indexed_genome mRNA 26476943 26498424 . + . ID=transcript_4325;Q6QQX7,UDP-glucuronosyltransferase 2B4 {ECO:0000303|PubMed:18719240},HLUG25;Hyodeoxycholic acid-specific UDPGT;UDPGTh-1;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0015020;GO:0052695;GO:0008210;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:glucuronosyltransferase activity;, P:cellular glucuronidation; P:estrogen metabolic process; scaffold17 indexed_genome mRNA 26511369 26531749 . + . ID=transcript_4326;P16662 B2R810 Q6GTW0,UDP-glucuronosyltransferase 2B7 {ECO:0000303|PubMed:18719240},3,4-catechol estrogen-specific UDPGT;UDP-glucuronosyltransferase 2B9;UDPGTh-2;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0015020;GO:0008209;GO:0052695;GO:0008210;GO:0006629;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:glucuronosyltransferase activity;, P:androgen metabolic process; P:cellular glucuronidation; P:estrogen metabolic process; P:lipid metabolic process;|O75795,UDP-glucuronosyltransferase 2B17 {ECO:0000303|PubMed:18719240},C19-steroid-specific UDP-glucuronosyltransferase;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0015020;GO:0052695;GO:0008210;GO:0008202;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:glucuronosyltransferase activity;, P:cellular glucuronidation; P:estrogen metabolic process; P:steroid metabolic process; scaffold17 indexed_genome mRNA 26575132 26591907 . + . ID=transcript_4327;Q6QQX7,UDP-glucuronosyltransferase 2B4 {ECO:0000303|PubMed:18719240},HLUG25;Hyodeoxycholic acid-specific UDPGT;UDPGTh-1;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0015020;GO:0052695;GO:0008210;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:glucuronosyltransferase activity;, P:cellular glucuronidation; P:estrogen metabolic process;|P16662 B2R810 Q6GTW0,UDP-glucuronosyltransferase 2B7 {ECO:0000303|PubMed:18719240},3,4-catechol estrogen-specific UDPGT;UDP-glucuronosyltransferase 2B9;UDPGTh-2;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0015020;GO:0008209;GO:0052695;GO:0008210;GO:0006629;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:glucuronosyltransferase activity;, P:androgen metabolic process; P:cellular glucuronidation; P:estrogen metabolic process; P:lipid metabolic process;|P16662 B2R810 Q6GTW0,UDP-glucuronosyltransferase 2B7 {ECO:0000303|PubMed:18719240},3,4-catechol estrogen-specific UDPGT;UDP-glucuronosyltransferase 2B9;UDPGTh-2;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0015020;GO:0008209;GO:0052695;GO:0008210;GO:0006629;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:glucuronosyltransferase activity;, P:androgen metabolic process; P:cellular glucuronidation; P:estrogen metabolic process; P:lipid metabolic process; scaffold17 indexed_genome mRNA 26640474 26657506 . + . ID=transcript_4328;Q6QQX7,UDP-glucuronosyltransferase 2B4 {ECO:0000303|PubMed:18719240},HLUG25;Hyodeoxycholic acid-specific UDPGT;UDPGTh-1;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0015020;GO:0052695;GO:0008210;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:glucuronosyltransferase activity;, P:cellular glucuronidation; P:estrogen metabolic process;|P36537 A8K9M3 B4DPP1 Q14CR8,UDP-glucuronosyltransferase 2B10,, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0008194;GO:0006629;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:UDP-glycosyltransferase activity;, P:lipid metabolic process;|P16662 B2R810 Q6GTW0,UDP-glucuronosyltransferase 2B7 {ECO:0000303|PubMed:18719240},3,4-catechol estrogen-specific UDPGT;UDP-glucuronosyltransferase 2B9;UDPGTh-2;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0015020;GO:0008209;GO:0052695;GO:0008210;GO:0006629;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:glucuronosyltransferase activity;, P:androgen metabolic process; P:cellular glucuronidation; P:estrogen metabolic process; P:lipid metabolic process; scaffold17 indexed_genome mRNA 26720433 26725845 . + . ID=transcript_4329;P16662 B2R810 Q6GTW0,UDP-glucuronosyltransferase 2B7 {ECO:0000303|PubMed:18719240},3,4-catechol estrogen-specific UDPGT;UDP-glucuronosyltransferase 2B9;UDPGTh-2;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0015020;GO:0008209;GO:0052695;GO:0008210;GO:0006629;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:glucuronosyltransferase activity;, P:androgen metabolic process; P:cellular glucuronidation; P:estrogen metabolic process; P:lipid metabolic process;|P36537 A8K9M3 B4DPP1 Q14CR8,UDP-glucuronosyltransferase 2B10,, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0008194;GO:0006629;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:UDP-glycosyltransferase activity;, P:lipid metabolic process; scaffold17 indexed_genome mRNA 26775218 26795570 . + . ID=transcript_4330;Q6QQX7,UDP-glucuronosyltransferase 2B4 {ECO:0000303|PubMed:18719240},HLUG25;Hyodeoxycholic acid-specific UDPGT;UDPGTh-1;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0015020;GO:0052695;GO:0008210;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:glucuronosyltransferase activity;, P:cellular glucuronidation; P:estrogen metabolic process; scaffold17 indexed_genome mRNA 26804414 26824390 . + . ID=transcript_4331;Q6QQX7,UDP-glucuronosyltransferase 2B4 {ECO:0000303|PubMed:18719240},HLUG25;Hyodeoxycholic acid-specific UDPGT;UDPGTh-1;, PF00201;, GO:0005789;GO:0016021;GO:0043231;GO:0015020;GO:0052695;GO:0008210;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:glucuronosyltransferase activity;, P:cellular glucuronidation; P:estrogen metabolic process;|Q6UWM9 Q9H6S4,UDP-glucuronosyltransferase 2A3,, PF00201;, GO:0016021;GO:0043231;GO:0015020;GO:0052695;, C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:glucuronosyltransferase activity;, P:cellular glucuronidation; scaffold17 indexed_genome mRNA 26862259 26902022 . - . ID=transcript_4332;Q96MU7 Q4W5Q3 Q7Z622 Q8TF35,YTH domain-containing protein 1 {ECO:0000305},Splicing factor YT521 {ECO:0000303|PubMed:12755701};, PF04146;, GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0003729;GO:1990247;GO:0003723;GO:0009048;GO:0006406;GO:0006376;GO:0000398;GO:0010608;GO:0000381;GO:0048024;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding;, P:dosage compensation by inactivation of X chromosome; P:mRNA export from nucleus; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:posttranscriptional regulation of gene expression; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome;|Q96MU7 Q4W5Q3 Q7Z622 Q8TF35,YTH domain-containing protein 1 {ECO:0000305},Splicing factor YT521 {ECO:0000303|PubMed:12755701};, PF04146;, GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0003729;GO:1990247;GO:0003723;GO:0009048;GO:0006406;GO:0006376;GO:0000398;GO:0010608;GO:0000381;GO:0048024;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding;, P:dosage compensation by inactivation of X chromosome; P:mRNA export from nucleus; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:posttranscriptional regulation of gene expression; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome;|Q96MU7 Q4W5Q3 Q7Z622 Q8TF35,YTH domain-containing protein 1 {ECO:0000305},Splicing factor YT521 {ECO:0000303|PubMed:12755701};, PF04146;, GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0003729;GO:1990247;GO:0003723;GO:0009048;GO:0006406;GO:0006376;GO:0000398;GO:0010608;GO:0000381;GO:0048024;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding;, P:dosage compensation by inactivation of X chromosome; P:mRNA export from nucleus; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:posttranscriptional regulation of gene expression; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome;|Q96MU7 Q4W5Q3 Q7Z622 Q8TF35,YTH domain-containing protein 1 {ECO:0000305},Splicing factor YT521 {ECO:0000303|PubMed:12755701};, PF04146;, GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0003729;GO:1990247;GO:0003723;GO:0009048;GO:0006406;GO:0006376;GO:0000398;GO:0010608;GO:0000381;GO:0048024;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding;, P:dosage compensation by inactivation of X chromosome; P:mRNA export from nucleus; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:posttranscriptional regulation of gene expression; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome;|Q96MU7 Q4W5Q3 Q7Z622 Q8TF35,YTH domain-containing protein 1 {ECO:0000305},Splicing factor YT521 {ECO:0000303|PubMed:12755701};, PF04146;, GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0003729;GO:1990247;GO:0003723;GO:0009048;GO:0006406;GO:0006376;GO:0000398;GO:0010608;GO:0000381;GO:0048024;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding;, P:dosage compensation by inactivation of X chromosome; P:mRNA export from nucleus; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:posttranscriptional regulation of gene expression; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome;|Q96MU7 Q4W5Q3 Q7Z622 Q8TF35,YTH domain-containing protein 1 {ECO:0000305},Splicing factor YT521 {ECO:0000303|PubMed:12755701};, PF04146;, GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0003729;GO:1990247;GO:0003723;GO:0009048;GO:0006406;GO:0006376;GO:0000398;GO:0010608;GO:0000381;GO:0048024;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding;, P:dosage compensation by inactivation of X chromosome; P:mRNA export from nucleus; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:posttranscriptional regulation of gene expression; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; scaffold17 indexed_genome mRNA 27519076 27607766 . + . ID=transcript_4333;Q9H3T7 Q9NVC9,Ubiquitin-like modifier-activating enzyme 6,Monocyte protein 4;Ubiquitin-activating enzyme E1-like protein 2;, PF16191;PF16190;PF09358;PF00899;PF10585;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0019780;GO:0004839;GO:0021764;GO:0006974;GO:0060996;GO:0021766;GO:0007612;GO:0007626;GO:0032446;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:FAT10 activating enzyme activity; F:ubiquitin activating enzyme activity;, P:amygdala development; P:cellular response to DNA damage stimulus; P:dendritic spine development; P:hippocampus development; P:learning; P:locomotory behavior; P:protein modification by small protein conjugation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H3T7 Q9NVC9,Ubiquitin-like modifier-activating enzyme 6,Monocyte protein 4;Ubiquitin-activating enzyme E1-like protein 2;, PF16191;PF16190;PF09358;PF00899;PF10585;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0019780;GO:0004839;GO:0021764;GO:0006974;GO:0060996;GO:0021766;GO:0007612;GO:0007626;GO:0032446;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:FAT10 activating enzyme activity; F:ubiquitin activating enzyme activity;, P:amygdala development; P:cellular response to DNA damage stimulus; P:dendritic spine development; P:hippocampus development; P:learning; P:locomotory behavior; P:protein modification by small protein conjugation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold17 indexed_genome mRNA 27623587 27626827 . - . ID=transcript_4334;Q9ULZ2 B2R980,Signal-transducing adaptor protein 1,BCR downstream-signaling protein 1;Docking protein BRDG1;Stem cell adaptor protein 1;, PF00169;PF00017;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0005157;GO:0005543;GO:0001784;GO:0019901;GO:0035591;GO:0005068;GO:0071222;GO:0010760;GO:1902227;GO:1904140;GO:0042326;GO:1900028;GO:2000251;GO:0050861;GO:0010628;GO:1903980;GO:1904151;GO:1903997;GO:0060100;GO:0007169;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:macrophage colony-stimulating factor receptor binding; F:phospholipid binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:signaling adaptor activity; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:cellular response to lipopolysaccharide; P:negative regulation of macrophage chemotaxis; P:negative regulation of macrophage colony-stimulating factor signaling pathway; P:negative regulation of microglial cell migration; P:negative regulation of phosphorylation; P:negative regulation of ruffle assembly; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of microglial cell activation; P:positive regulation of microglial cell mediated cytotoxicity; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of phagocytosis, engulfment; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold17 indexed_genome mRNA 27628531 27629251 . - . ID=transcript_4335;Q9ULZ2 B2R980,Signal-transducing adaptor protein 1,BCR downstream-signaling protein 1;Docking protein BRDG1;Stem cell adaptor protein 1;, PF00169;PF00017;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0005157;GO:0005543;GO:0001784;GO:0019901;GO:0035591;GO:0005068;GO:0071222;GO:0010760;GO:1902227;GO:1904140;GO:0042326;GO:1900028;GO:2000251;GO:0050861;GO:0010628;GO:1903980;GO:1904151;GO:1903997;GO:0060100;GO:0007169;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:macrophage colony-stimulating factor receptor binding; F:phospholipid binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:signaling adaptor activity; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:cellular response to lipopolysaccharide; P:negative regulation of macrophage chemotaxis; P:negative regulation of macrophage colony-stimulating factor signaling pathway; P:negative regulation of microglial cell migration; P:negative regulation of phosphorylation; P:negative regulation of ruffle assembly; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of microglial cell activation; P:positive regulation of microglial cell mediated cytotoxicity; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of phagocytosis, engulfment; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold17 indexed_genome mRNA 27636084 27636635 . + . ID=transcript_4336;Q9ULZ2 B2R980,Signal-transducing adaptor protein 1,BCR downstream-signaling protein 1;Docking protein BRDG1;Stem cell adaptor protein 1;, PF00169;PF00017;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0005157;GO:0005543;GO:0001784;GO:0019901;GO:0035591;GO:0005068;GO:0071222;GO:0010760;GO:1902227;GO:1904140;GO:0042326;GO:1900028;GO:2000251;GO:0050861;GO:0010628;GO:1903980;GO:1904151;GO:1903997;GO:0060100;GO:0007169;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:macrophage colony-stimulating factor receptor binding; F:phospholipid binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:signaling adaptor activity; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:cellular response to lipopolysaccharide; P:negative regulation of macrophage chemotaxis; P:negative regulation of macrophage colony-stimulating factor signaling pathway; P:negative regulation of microglial cell migration; P:negative regulation of phosphorylation; P:negative regulation of ruffle assembly; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of microglial cell activation; P:positive regulation of microglial cell mediated cytotoxicity; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of phagocytosis, engulfment; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold17 indexed_genome mRNA 27658849 27739842 . + . ID=transcript_4337;Q03188 Q6PIR0 Q8IW27 Q9P0M5,Centromere protein C,Centromere autoantigen C;Centromere protein C 1;Interphase centromere complex protein 7;, PF11699;PF15620;PF15622;, GO:0000779;GO:0000778;GO:0005829;GO:0000776;GO:0030496;GO:0016604;GO:0005654;GO:0005721;GO:0019237;GO:0003677;GO:0042802;GO:0051315;GO:0051301;GO:0034080;GO:0007059;GO:0051382;GO:0000278;GO:0007052;GO:0051455;, C:condensed chromosome, centromeric region; C:condensed nuclear chromosome kinetochore; C:cytosol; C:kinetochore; C:midbody; C:nuclear body; C:nucleoplasm; C:pericentric heterochromatin;, F:centromeric DNA binding; F:DNA binding; F:identical protein binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:CENP-A containing nucleosome assembly; P:chromosome segregation; P:kinetochore assembly; P:mitotic cell cycle; P:mitotic spindle organization; P:monopolar spindle attachment to meiosis I kinetochore;|Q03188 Q6PIR0 Q8IW27 Q9P0M5,Centromere protein C,Centromere autoantigen C;Centromere protein C 1;Interphase centromere complex protein 7;, PF11699;PF15620;PF15622;, GO:0000779;GO:0000778;GO:0005829;GO:0000776;GO:0030496;GO:0016604;GO:0005654;GO:0005721;GO:0019237;GO:0003677;GO:0042802;GO:0051315;GO:0051301;GO:0034080;GO:0007059;GO:0051382;GO:0000278;GO:0007052;GO:0051455;, C:condensed chromosome, centromeric region; C:condensed nuclear chromosome kinetochore; C:cytosol; C:kinetochore; C:midbody; C:nuclear body; C:nucleoplasm; C:pericentric heterochromatin;, F:centromeric DNA binding; F:DNA binding; F:identical protein binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:CENP-A containing nucleosome assembly; P:chromosome segregation; P:kinetochore assembly; P:mitotic cell cycle; P:mitotic spindle organization; P:monopolar spindle attachment to meiosis I kinetochore;|Q03188 Q6PIR0 Q8IW27 Q9P0M5,Centromere protein C,Centromere autoantigen C;Centromere protein C 1;Interphase centromere complex protein 7;, PF11699;PF15620;PF15622;, GO:0000779;GO:0000778;GO:0005829;GO:0000776;GO:0030496;GO:0016604;GO:0005654;GO:0005721;GO:0019237;GO:0003677;GO:0042802;GO:0051315;GO:0051301;GO:0034080;GO:0007059;GO:0051382;GO:0000278;GO:0007052;GO:0051455;, C:condensed chromosome, centromeric region; C:condensed nuclear chromosome kinetochore; C:cytosol; C:kinetochore; C:midbody; C:nuclear body; C:nucleoplasm; C:pericentric heterochromatin;, F:centromeric DNA binding; F:DNA binding; F:identical protein binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:CENP-A containing nucleosome assembly; P:chromosome segregation; P:kinetochore assembly; P:mitotic cell cycle; P:mitotic spindle organization; P:monopolar spindle attachment to meiosis I kinetochore; scaffold17 indexed_genome mRNA 27740247 27740752 . + . ID=transcript_4338;P62906 B2R801 P52859 P53025 Q5TZT6 Q8J013,60S ribosomal protein L10a,CSA-19;Large ribosomal subunit protein uL1 {ECO:0000303|PubMed:24524803};Neural precursor cell expressed developmentally down-regulated protein 6;, PF00687;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000470;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:maturation of LSU-rRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold17 indexed_genome mRNA 29545692 29727633 . + . ID=transcript_4339;P54756 Q7Z3F2,Ephrin type-A receptor 5,Brain-specific kinase;EPH homology kinase 1;EPH-like kinase 7;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0030424;GO:0030425;GO:0009897;GO:0005887;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0043235;GO:0005791;GO:0005524;GO:0005003;GO:0005004;GO:0004714;GO:0005005;GO:0007411;GO:0019933;GO:0048013;GO:0021766;GO:0007275;GO:0048666;GO:0032793;GO:0033674;GO:0032956;GO:0043087;GO:0061178;GO:0007169;, C:axon; C:dendrite; C:external side of plasma membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:rough endoplasmic reticulum;, F:ATP binding; F:ephrin receptor activity; F:GPI-linked ephrin receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:cAMP-mediated signaling; P:ephrin receptor signaling pathway; P:hippocampus development; P:multicellular organism development; P:neuron development; P:positive regulation of CREB transcription factor activity; P:positive regulation of kinase activity; P:regulation of actin cytoskeleton organization; P:regulation of GTPase activity; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold17 indexed_genome mRNA 29796578 29912808 . + . ID=transcript_4340;P54756 Q7Z3F2,Ephrin type-A receptor 5,Brain-specific kinase;EPH homology kinase 1;EPH-like kinase 7;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0030424;GO:0030425;GO:0009897;GO:0005887;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0043235;GO:0005791;GO:0005524;GO:0005003;GO:0005004;GO:0004714;GO:0005005;GO:0007411;GO:0019933;GO:0048013;GO:0021766;GO:0007275;GO:0048666;GO:0032793;GO:0033674;GO:0032956;GO:0043087;GO:0061178;GO:0007169;, C:axon; C:dendrite; C:external side of plasma membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:rough endoplasmic reticulum;, F:ATP binding; F:ephrin receptor activity; F:GPI-linked ephrin receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:cAMP-mediated signaling; P:ephrin receptor signaling pathway; P:hippocampus development; P:multicellular organism development; P:neuron development; P:positive regulation of CREB transcription factor activity; P:positive regulation of kinase activity; P:regulation of actin cytoskeleton organization; P:regulation of GTPase activity; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P54756 Q7Z3F2,Ephrin type-A receptor 5,Brain-specific kinase;EPH homology kinase 1;EPH-like kinase 7;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0030424;GO:0030425;GO:0009897;GO:0005887;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0043235;GO:0005791;GO:0005524;GO:0005003;GO:0005004;GO:0004714;GO:0005005;GO:0007411;GO:0019933;GO:0048013;GO:0021766;GO:0007275;GO:0048666;GO:0032793;GO:0033674;GO:0032956;GO:0043087;GO:0061178;GO:0007169;, C:axon; C:dendrite; C:external side of plasma membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:rough endoplasmic reticulum;, F:ATP binding; F:ephrin receptor activity; F:GPI-linked ephrin receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:cAMP-mediated signaling; P:ephrin receptor signaling pathway; P:hippocampus development; P:multicellular organism development; P:neuron development; P:positive regulation of CREB transcription factor activity; P:positive regulation of kinase activity; P:regulation of actin cytoskeleton organization; P:regulation of GTPase activity; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold17 indexed_genome mRNA 30710615 30796597 . + . ID=transcript_4341;Q5HYJ1,Trans-2,3-enoyl-CoA reductase-like,Steroid 5-alpha-reductase 2-like 2 protein;, PF02544;, GO:0005783;GO:0016021;GO:0016491;GO:0016627;GO:0042761;, C:endoplasmic reticulum; C:integral component of membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:very long-chain fatty acid biosynthetic process;|Q5HYJ1,Trans-2,3-enoyl-CoA reductase-like,Steroid 5-alpha-reductase 2-like 2 protein;, PF02544;, GO:0005783;GO:0016021;GO:0016491;GO:0016627;GO:0042761;, C:endoplasmic reticulum; C:integral component of membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:very long-chain fatty acid biosynthetic process;|Q5HYJ1,Trans-2,3-enoyl-CoA reductase-like,Steroid 5-alpha-reductase 2-like 2 protein;, PF02544;, GO:0005783;GO:0016021;GO:0016491;GO:0016627;GO:0042761;, C:endoplasmic reticulum; C:integral component of membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:very long-chain fatty acid biosynthetic process; scaffold17 indexed_genome mRNA 30804018 30850098 . + . ID=transcript_4342;Q5HYJ1,Trans-2,3-enoyl-CoA reductase-like,Steroid 5-alpha-reductase 2-like 2 protein;, PF02544;, GO:0005783;GO:0016021;GO:0016491;GO:0016627;GO:0042761;, C:endoplasmic reticulum; C:integral component of membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:very long-chain fatty acid biosynthetic process;|Q5HYJ1,Trans-2,3-enoyl-CoA reductase-like,Steroid 5-alpha-reductase 2-like 2 protein;, PF02544;, GO:0005783;GO:0016021;GO:0016491;GO:0016627;GO:0042761;, C:endoplasmic reticulum; C:integral component of membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:very long-chain fatty acid biosynthetic process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q5HYJ1,Trans-2,3-enoyl-CoA reductase-like,Steroid 5-alpha-reductase 2-like 2 protein;, PF02544;, GO:0005783;GO:0016021;GO:0016491;GO:0016627;GO:0042761;, C:endoplasmic reticulum; C:integral component of membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:very long-chain fatty acid biosynthetic process; scaffold17 indexed_genome mRNA 32800511 33103968 . - . ID=transcript_4343;Q9HAR2 E9PE04 O94867 Q9NWK5,Adhesion G protein-coupled receptor L3 {ECO:0000312|HGNC:HGNC:20974},Calcium-independent alpha-latrotoxin receptor 3 {ECO:0000250|UniProtKB:Q9Z173};Latrophilin-3 {ECO:0000312|HGNC:HGNC:20974};Lectomedin-3;, PF00002;PF16489;PF02140;PF01825;PF02354;PF02191;, GO:0030424;GO:0005911;GO:0098978;GO:0016021;GO:0005887;GO:0005509;GO:0030246;GO:0004930;GO:0007189;GO:0007420;GO:0007166;GO:0098742;GO:0007186;GO:0001764;GO:0007416;, C:axon; C:cell-cell junction; C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane;, F:calcium ion binding; F:carbohydrate binding; F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:brain development; P:cell surface receptor signaling pathway; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:G protein-coupled receptor signaling pathway; P:neuron migration; P:synapse assembly; scaffold17 indexed_genome mRNA 37573503 37629283 . - . ID=transcript_4344;P30876 A8K1A8 Q8IZ61,DNA-directed RNA polymerase II subunit RPB2,DNA-directed RNA polymerase II 140 kDa polypeptide;DNA-directed RNA polymerase II subunit B;RNA polymerase II subunit 2;RNA polymerase II subunit B2;, PF04563;PF04561;PF04565;PF04566;PF04567;PF00562;PF04560;, GO:0016020;GO:0005654;GO:0005634;GO:0005665;GO:0003682;GO:0003677;GO:0003899;GO:0046872;GO:0032549;GO:0003723;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:membrane; C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:chromatin binding; F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding; F:ribonucleoside binding; F:RNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|P30876 A8K1A8 Q8IZ61,DNA-directed RNA polymerase II subunit RPB2,DNA-directed RNA polymerase II 140 kDa polypeptide;DNA-directed RNA polymerase II subunit B;RNA polymerase II subunit 2;RNA polymerase II subunit B2;, PF04563;PF04561;PF04565;PF04566;PF04567;PF00562;PF04560;, GO:0016020;GO:0005654;GO:0005634;GO:0005665;GO:0003682;GO:0003677;GO:0003899;GO:0046872;GO:0032549;GO:0003723;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:membrane; C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:chromatin binding; F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding; F:ribonucleoside binding; F:RNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|P30876 A8K1A8 Q8IZ61,DNA-directed RNA polymerase II subunit RPB2,DNA-directed RNA polymerase II 140 kDa polypeptide;DNA-directed RNA polymerase II subunit B;RNA polymerase II subunit 2;RNA polymerase II subunit B2;, PF04563;PF04561;PF04565;PF04566;PF04567;PF00562;PF04560;, GO:0016020;GO:0005654;GO:0005634;GO:0005665;GO:0003682;GO:0003677;GO:0003899;GO:0046872;GO:0032549;GO:0003723;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:membrane; C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:chromatin binding; F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding; F:ribonucleoside binding; F:RNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|P30876 A8K1A8 Q8IZ61,DNA-directed RNA polymerase II subunit RPB2,DNA-directed RNA polymerase II 140 kDa polypeptide;DNA-directed RNA polymerase II subunit B;RNA polymerase II subunit 2;RNA polymerase II subunit B2;, PF04563;PF04561;PF04565;PF04566;PF04567;PF00562;PF04560;, GO:0016020;GO:0005654;GO:0005634;GO:0005665;GO:0003682;GO:0003677;GO:0003899;GO:0046872;GO:0032549;GO:0003723;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:membrane; C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:chromatin binding; F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:metal ion binding; F:ribonucleoside binding; F:RNA binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; scaffold17 indexed_genome mRNA 37630062 37641021 . + . ID=transcript_4345;Q8NC60 Q8N7L6 Q9BSQ9,Nitric oxide-associated protein 1,, PF01926;, GO:0005743;GO:0005739;GO:0005525;GO:0003723;GO:0006915;GO:0032543;GO:0010941;GO:0043457;, C:mitochondrial inner membrane; C:mitochondrion;, F:GTP binding; F:RNA binding;, P:apoptotic process; P:mitochondrial translation; P:regulation of cell death; P:regulation of cellular respiration;|Q8NC60 Q8N7L6 Q9BSQ9,Nitric oxide-associated protein 1,, PF01926;, GO:0005743;GO:0005739;GO:0005525;GO:0003723;GO:0006915;GO:0032543;GO:0010941;GO:0043457;, C:mitochondrial inner membrane; C:mitochondrion;, F:GTP binding; F:RNA binding;, P:apoptotic process; P:mitochondrial translation; P:regulation of cell death; P:regulation of cellular respiration;|Q8NC60 Q8N7L6 Q9BSQ9,Nitric oxide-associated protein 1,, PF01926;, GO:0005743;GO:0005739;GO:0005525;GO:0003723;GO:0006915;GO:0032543;GO:0010941;GO:0043457;, C:mitochondrial inner membrane; C:mitochondrion;, F:GTP binding; F:RNA binding;, P:apoptotic process; P:mitochondrial translation; P:regulation of cell death; P:regulation of cellular respiration; scaffold18 indexed_genome mRNA 493 1574 . - . ID=transcript_4346;P33261 P33259 Q8WZB1 Q8WZB2 Q9UCD4,Cytochrome P450 2C19,(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC17;CYPIIC19;Cytochrome P450-11A;Cytochrome P450-254C;Fenbendazole monooxygenase (4'-hydroxylating) {ECO:0000305};Mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0019825;GO:0008395;GO:0017144;GO:0019373;GO:0042738;GO:0046483;GO:0016098;GO:0097267;GO:0006082;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process; scaffold18 indexed_genome mRNA 190609 192883 . + . ID=transcript_4347;P33260 B2R8K2 Q16703 Q16751 Q4VAT5 Q6GRG1,Cytochrome P450 2C18,CYPIIC18;Cytochrome P450-6b/29c;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008401;GO:0008395;GO:0019373;GO:0042738;GO:0006082;GO:0042573;GO:0042572;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:retinoic acid metabolic process; P:retinol metabolic process; P:xenobiotic metabolic process; scaffold18 indexed_genome mRNA 193467 205305 . - . ID=transcript_4348;P10632 A8K9N8 B0AZN2 B7Z1F6 Q5VX93 Q8WWB1 Q9UCZ9,Cytochrome P450 2C8 {ECO:0000303|PubMed:26427316},CYPIIC8;Cytochrome P450 IIC2;Cytochrome P450 MP-12;Cytochrome P450 MP-20;Cytochrome P450 form 1;S-mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0034875;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0008401;GO:0008395;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046456;GO:0002933;GO:0042759;GO:0097267;GO:0006082;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:caffeine oxidase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:icosanoid biosynthetic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P10632 A8K9N8 B0AZN2 B7Z1F6 Q5VX93 Q8WWB1 Q9UCZ9,Cytochrome P450 2C8 {ECO:0000303|PubMed:26427316},CYPIIC8;Cytochrome P450 IIC2;Cytochrome P450 MP-12;Cytochrome P450 MP-20;Cytochrome P450 form 1;S-mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0034875;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0008401;GO:0008395;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046456;GO:0002933;GO:0042759;GO:0097267;GO:0006082;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:caffeine oxidase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:icosanoid biosynthetic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process; scaffold18 indexed_genome mRNA 324171 326677 . + . ID=transcript_4349;P10632 A8K9N8 B0AZN2 B7Z1F6 Q5VX93 Q8WWB1 Q9UCZ9,Cytochrome P450 2C8 {ECO:0000303|PubMed:26427316},CYPIIC8;Cytochrome P450 IIC2;Cytochrome P450 MP-12;Cytochrome P450 MP-20;Cytochrome P450 form 1;S-mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0034875;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0008401;GO:0008395;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046456;GO:0002933;GO:0042759;GO:0097267;GO:0006082;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:caffeine oxidase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:icosanoid biosynthetic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process; scaffold18 indexed_genome mRNA 361595 377844 . - . ID=transcript_4350;P33260 B2R8K2 Q16703 Q16751 Q4VAT5 Q6GRG1,Cytochrome P450 2C18,CYPIIC18;Cytochrome P450-6b/29c;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008401;GO:0008395;GO:0019373;GO:0042738;GO:0006082;GO:0042573;GO:0042572;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:retinoic acid metabolic process; P:retinol metabolic process; P:xenobiotic metabolic process; scaffold18 indexed_genome mRNA 495959 516154 . + . ID=transcript_4351;P11712 P11713 Q16756 Q16872 Q5VX92 Q6IRV8 Q8WW80,Cytochrome P450 2C9 {ECO:0000303|PubMed:8809086},(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC9;Cholesterol 25-hydroxylase {ECO:0000303|PubMed:3079764};Cytochrome P-450MP;Cytochrome P450 MP-4;Cytochrome P450 MP-8;Cytochrome P450 PB-1;S-mephenytoin 4-hydroxylase {ECO:0000303|PubMed:3079764};, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008405;GO:0008404;GO:0008392;GO:0070330;GO:0034875;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0008395;GO:0043603;GO:0008203;GO:0042737;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046456;GO:0042759;GO:0032787;GO:0016098;GO:0097267;GO:0006082;GO:0070989;GO:0008202;GO:0019627;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid 11,12-epoxygenase activity; F:arachidonic acid 14,15-epoxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:caffeine oxidase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:cellular amide metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:icosanoid biosynthetic process; P:long-chain fatty acid biosynthetic process; P:monocarboxylic acid metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:oxidative demethylation; P:steroid metabolic process; P:urea metabolic process; P:xenobiotic metabolic process; scaffold18 indexed_genome mRNA 532300 533160 . + . ID=transcript_4352;P33260 B2R8K2 Q16703 Q16751 Q4VAT5 Q6GRG1,Cytochrome P450 2C18,CYPIIC18;Cytochrome P450-6b/29c;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008401;GO:0008395;GO:0019373;GO:0042738;GO:0006082;GO:0042573;GO:0042572;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:retinoic acid metabolic process; P:retinol metabolic process; P:xenobiotic metabolic process; scaffold18 indexed_genome mRNA 577964 607565 . + . ID=transcript_4353;P11712 P11713 Q16756 Q16872 Q5VX92 Q6IRV8 Q8WW80,Cytochrome P450 2C9 {ECO:0000303|PubMed:8809086},(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC9;Cholesterol 25-hydroxylase {ECO:0000303|PubMed:3079764};Cytochrome P-450MP;Cytochrome P450 MP-4;Cytochrome P450 MP-8;Cytochrome P450 PB-1;S-mephenytoin 4-hydroxylase {ECO:0000303|PubMed:3079764};, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008405;GO:0008404;GO:0008392;GO:0070330;GO:0034875;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0008395;GO:0043603;GO:0008203;GO:0042737;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046456;GO:0042759;GO:0032787;GO:0016098;GO:0097267;GO:0006082;GO:0070989;GO:0008202;GO:0019627;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid 11,12-epoxygenase activity; F:arachidonic acid 14,15-epoxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:caffeine oxidase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:cellular amide metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:icosanoid biosynthetic process; P:long-chain fatty acid biosynthetic process; P:monocarboxylic acid metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:oxidative demethylation; P:steroid metabolic process; P:urea metabolic process; P:xenobiotic metabolic process;|P11712 P11713 Q16756 Q16872 Q5VX92 Q6IRV8 Q8WW80,Cytochrome P450 2C9 {ECO:0000303|PubMed:8809086},(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC9;Cholesterol 25-hydroxylase {ECO:0000303|PubMed:3079764};Cytochrome P-450MP;Cytochrome P450 MP-4;Cytochrome P450 MP-8;Cytochrome P450 PB-1;S-mephenytoin 4-hydroxylase {ECO:0000303|PubMed:3079764};, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008405;GO:0008404;GO:0008392;GO:0070330;GO:0034875;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0008395;GO:0043603;GO:0008203;GO:0042737;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046456;GO:0042759;GO:0032787;GO:0016098;GO:0097267;GO:0006082;GO:0070989;GO:0008202;GO:0019627;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid 11,12-epoxygenase activity; F:arachidonic acid 14,15-epoxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:caffeine oxidase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:cellular amide metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:icosanoid biosynthetic process; P:long-chain fatty acid biosynthetic process; P:monocarboxylic acid metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:oxidative demethylation; P:steroid metabolic process; P:urea metabolic process; P:xenobiotic metabolic process;|P33260 B2R8K2 Q16703 Q16751 Q4VAT5 Q6GRG1,Cytochrome P450 2C18,CYPIIC18;Cytochrome P450-6b/29c;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008401;GO:0008395;GO:0019373;GO:0042738;GO:0006082;GO:0042573;GO:0042572;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:retinoic acid metabolic process; P:retinol metabolic process; P:xenobiotic metabolic process; scaffold18 indexed_genome mRNA 798708 837541 . - . ID=transcript_4354;O00151 B2RBS6 Q5VZH5 Q9BPZ9,PDZ and LIM domain protein 1,C-terminal LIM domain protein 1;Elfin;LIM domain protein CLP-36;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005737;GO:0005856;GO:0031941;GO:0005925;GO:0001725;GO:0005667;GO:0030018;GO:0003779;GO:0098641;GO:0046872;GO:0051371;GO:0003713;GO:0030036;GO:0030950;GO:0010761;GO:0007507;GO:0030011;GO:0061061;GO:0006357;GO:0001666;GO:0006979;GO:0043149;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:filamentous actin; C:focal adhesion; C:stress fiber; C:transcription regulator complex; C:Z disc;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:transcription coactivator activity;, P:actin cytoskeleton organization; P:establishment or maintenance of actin cytoskeleton polarity; P:fibroblast migration; P:heart development; P:maintenance of cell polarity; P:muscle structure development; P:regulation of transcription by RNA polymerase II; P:response to hypoxia; P:response to oxidative stress; P:stress fiber assembly;|O00151 B2RBS6 Q5VZH5 Q9BPZ9,PDZ and LIM domain protein 1,C-terminal LIM domain protein 1;Elfin;LIM domain protein CLP-36;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005737;GO:0005856;GO:0031941;GO:0005925;GO:0001725;GO:0005667;GO:0030018;GO:0003779;GO:0098641;GO:0046872;GO:0051371;GO:0003713;GO:0030036;GO:0030950;GO:0010761;GO:0007507;GO:0030011;GO:0061061;GO:0006357;GO:0001666;GO:0006979;GO:0043149;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:filamentous actin; C:focal adhesion; C:stress fiber; C:transcription regulator complex; C:Z disc;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:transcription coactivator activity;, P:actin cytoskeleton organization; P:establishment or maintenance of actin cytoskeleton polarity; P:fibroblast migration; P:heart development; P:maintenance of cell polarity; P:muscle structure development; P:regulation of transcription by RNA polymerase II; P:response to hypoxia; P:response to oxidative stress; P:stress fiber assembly;|O00151 B2RBS6 Q5VZH5 Q9BPZ9,PDZ and LIM domain protein 1,C-terminal LIM domain protein 1;Elfin;LIM domain protein CLP-36;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005737;GO:0005856;GO:0031941;GO:0005925;GO:0001725;GO:0005667;GO:0030018;GO:0003779;GO:0098641;GO:0046872;GO:0051371;GO:0003713;GO:0030036;GO:0030950;GO:0010761;GO:0007507;GO:0030011;GO:0061061;GO:0006357;GO:0001666;GO:0006979;GO:0043149;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:filamentous actin; C:focal adhesion; C:stress fiber; C:transcription regulator complex; C:Z disc;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:muscle alpha-actinin binding; F:transcription coactivator activity;, P:actin cytoskeleton organization; P:establishment or maintenance of actin cytoskeleton polarity; P:fibroblast migration; P:heart development; P:maintenance of cell polarity; P:muscle structure development; P:regulation of transcription by RNA polymerase II; P:response to hypoxia; P:response to oxidative stress; P:stress fiber assembly; scaffold18 indexed_genome mRNA 869552 961144 . - . ID=transcript_4355;Q8IVQ4 Q96KF3 Q96KF4 Q9BX64 Q9BX65 Q9P2Q0 Q9UFT2 Q9UHN7 Q9Y338,Sorbin and SH3 domain-containing protein 1,Ponsin;SH3 domain protein 5;SH3P12;c-Cbl-associated protein;, PF00018;PF07653;PF14604;PF02208;, GO:0005912;GO:0030055;GO:0005813;GO:0005829;GO:0005925;GO:0045121;GO:0016363;GO:0005634;GO:0005886;GO:0001725;GO:0005915;GO:0003779;GO:0008092;GO:0005158;GO:0030159;GO:0007160;GO:0032869;GO:0048041;GO:0008286;GO:0006936;GO:0046326;GO:0045725;GO:0046628;GO:0046889;GO:1903078;GO:0043149;, C:adherens junction; C:cell-substrate junction; C:centrosome; C:cytosol; C:focal adhesion; C:membrane raft; C:nuclear matrix; C:nucleus; C:plasma membrane; C:stress fiber; C:zonula adherens;, F:actin binding; F:cytoskeletal protein binding; F:insulin receptor binding; F:signaling receptor complex adaptor activity;, P:cell-matrix adhesion; P:cellular response to insulin stimulus; P:focal adhesion assembly; P:insulin receptor signaling pathway; P:muscle contraction; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of lipid biosynthetic process; P:positive regulation of protein localization to plasma membrane; P:stress fiber assembly;|Q8IVQ4 Q96KF3 Q96KF4 Q9BX64 Q9BX65 Q9P2Q0 Q9UFT2 Q9UHN7 Q9Y338,Sorbin and SH3 domain-containing protein 1,Ponsin;SH3 domain protein 5;SH3P12;c-Cbl-associated protein;, PF00018;PF07653;PF14604;PF02208;, GO:0005912;GO:0030055;GO:0005813;GO:0005829;GO:0005925;GO:0045121;GO:0016363;GO:0005634;GO:0005886;GO:0001725;GO:0005915;GO:0003779;GO:0008092;GO:0005158;GO:0030159;GO:0007160;GO:0032869;GO:0048041;GO:0008286;GO:0006936;GO:0046326;GO:0045725;GO:0046628;GO:0046889;GO:1903078;GO:0043149;, C:adherens junction; C:cell-substrate junction; C:centrosome; C:cytosol; C:focal adhesion; C:membrane raft; C:nuclear matrix; C:nucleus; C:plasma membrane; C:stress fiber; C:zonula adherens;, F:actin binding; F:cytoskeletal protein binding; F:insulin receptor binding; F:signaling receptor complex adaptor activity;, P:cell-matrix adhesion; P:cellular response to insulin stimulus; P:focal adhesion assembly; P:insulin receptor signaling pathway; P:muscle contraction; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of lipid biosynthetic process; P:positive regulation of protein localization to plasma membrane; P:stress fiber assembly;|Q8IVQ4 Q96KF3 Q96KF4 Q9BX64 Q9BX65 Q9P2Q0 Q9UFT2 Q9UHN7 Q9Y338,Sorbin and SH3 domain-containing protein 1,Ponsin;SH3 domain protein 5;SH3P12;c-Cbl-associated protein;, PF00018;PF07653;PF14604;PF02208;, GO:0005912;GO:0030055;GO:0005813;GO:0005829;GO:0005925;GO:0045121;GO:0016363;GO:0005634;GO:0005886;GO:0001725;GO:0005915;GO:0003779;GO:0008092;GO:0005158;GO:0030159;GO:0007160;GO:0032869;GO:0048041;GO:0008286;GO:0006936;GO:0046326;GO:0045725;GO:0046628;GO:0046889;GO:1903078;GO:0043149;, C:adherens junction; C:cell-substrate junction; C:centrosome; C:cytosol; C:focal adhesion; C:membrane raft; C:nuclear matrix; C:nucleus; C:plasma membrane; C:stress fiber; C:zonula adherens;, F:actin binding; F:cytoskeletal protein binding; F:insulin receptor binding; F:signaling receptor complex adaptor activity;, P:cell-matrix adhesion; P:cellular response to insulin stimulus; P:focal adhesion assembly; P:insulin receptor signaling pathway; P:muscle contraction; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of lipid biosynthetic process; P:positive regulation of protein localization to plasma membrane; P:stress fiber assembly;|Q8IVQ4 Q96KF3 Q96KF4 Q9BX64 Q9BX65 Q9P2Q0 Q9UFT2 Q9UHN7 Q9Y338,Sorbin and SH3 domain-containing protein 1,Ponsin;SH3 domain protein 5;SH3P12;c-Cbl-associated protein;, PF00018;PF07653;PF14604;PF02208;, GO:0005912;GO:0030055;GO:0005813;GO:0005829;GO:0005925;GO:0045121;GO:0016363;GO:0005634;GO:0005886;GO:0001725;GO:0005915;GO:0003779;GO:0008092;GO:0005158;GO:0030159;GO:0007160;GO:0032869;GO:0048041;GO:0008286;GO:0006936;GO:0046326;GO:0045725;GO:0046628;GO:0046889;GO:1903078;GO:0043149;, C:adherens junction; C:cell-substrate junction; C:centrosome; C:cytosol; C:focal adhesion; C:membrane raft; C:nuclear matrix; C:nucleus; C:plasma membrane; C:stress fiber; C:zonula adherens;, F:actin binding; F:cytoskeletal protein binding; F:insulin receptor binding; F:signaling receptor complex adaptor activity;, P:cell-matrix adhesion; P:cellular response to insulin stimulus; P:focal adhesion assembly; P:insulin receptor signaling pathway; P:muscle contraction; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of lipid biosynthetic process; P:positive regulation of protein localization to plasma membrane; P:stress fiber assembly;|Q8IVQ4 Q96KF3 Q96KF4 Q9BX64 Q9BX65 Q9P2Q0 Q9UFT2 Q9UHN7 Q9Y338,Sorbin and SH3 domain-containing protein 1,Ponsin;SH3 domain protein 5;SH3P12;c-Cbl-associated protein;, PF00018;PF07653;PF14604;PF02208;, GO:0005912;GO:0030055;GO:0005813;GO:0005829;GO:0005925;GO:0045121;GO:0016363;GO:0005634;GO:0005886;GO:0001725;GO:0005915;GO:0003779;GO:0008092;GO:0005158;GO:0030159;GO:0007160;GO:0032869;GO:0048041;GO:0008286;GO:0006936;GO:0046326;GO:0045725;GO:0046628;GO:0046889;GO:1903078;GO:0043149;, C:adherens junction; C:cell-substrate junction; C:centrosome; C:cytosol; C:focal adhesion; C:membrane raft; C:nuclear matrix; C:nucleus; C:plasma membrane; C:stress fiber; C:zonula adherens;, F:actin binding; F:cytoskeletal protein binding; F:insulin receptor binding; F:signaling receptor complex adaptor activity;, P:cell-matrix adhesion; P:cellular response to insulin stimulus; P:focal adhesion assembly; P:insulin receptor signaling pathway; P:muscle contraction; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of lipid biosynthetic process; P:positive regulation of protein localization to plasma membrane; P:stress fiber assembly;|Q8IVQ4 Q96KF3 Q96KF4 Q9BX64 Q9BX65 Q9P2Q0 Q9UFT2 Q9UHN7 Q9Y338,Sorbin and SH3 domain-containing protein 1,Ponsin;SH3 domain protein 5;SH3P12;c-Cbl-associated protein;, PF00018;PF07653;PF14604;PF02208;, GO:0005912;GO:0030055;GO:0005813;GO:0005829;GO:0005925;GO:0045121;GO:0016363;GO:0005634;GO:0005886;GO:0001725;GO:0005915;GO:0003779;GO:0008092;GO:0005158;GO:0030159;GO:0007160;GO:0032869;GO:0048041;GO:0008286;GO:0006936;GO:0046326;GO:0045725;GO:0046628;GO:0046889;GO:1903078;GO:0043149;, C:adherens junction; C:cell-substrate junction; C:centrosome; C:cytosol; C:focal adhesion; C:membrane raft; C:nuclear matrix; C:nucleus; C:plasma membrane; C:stress fiber; C:zonula adherens;, F:actin binding; F:cytoskeletal protein binding; F:insulin receptor binding; F:signaling receptor complex adaptor activity;, P:cell-matrix adhesion; P:cellular response to insulin stimulus; P:focal adhesion assembly; P:insulin receptor signaling pathway; P:muscle contraction; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of lipid biosynthetic process; P:positive regulation of protein localization to plasma membrane; P:stress fiber assembly;|Q8IVQ4 Q96KF3 Q96KF4 Q9BX64 Q9BX65 Q9P2Q0 Q9UFT2 Q9UHN7 Q9Y338,Sorbin and SH3 domain-containing protein 1,Ponsin;SH3 domain protein 5;SH3P12;c-Cbl-associated protein;, PF00018;PF07653;PF14604;PF02208;, GO:0005912;GO:0030055;GO:0005813;GO:0005829;GO:0005925;GO:0045121;GO:0016363;GO:0005634;GO:0005886;GO:0001725;GO:0005915;GO:0003779;GO:0008092;GO:0005158;GO:0030159;GO:0007160;GO:0032869;GO:0048041;GO:0008286;GO:0006936;GO:0046326;GO:0045725;GO:0046628;GO:0046889;GO:1903078;GO:0043149;, C:adherens junction; C:cell-substrate junction; C:centrosome; C:cytosol; C:focal adhesion; C:membrane raft; C:nuclear matrix; C:nucleus; C:plasma membrane; C:stress fiber; C:zonula adherens;, F:actin binding; F:cytoskeletal protein binding; F:insulin receptor binding; F:signaling receptor complex adaptor activity;, P:cell-matrix adhesion; P:cellular response to insulin stimulus; P:focal adhesion assembly; P:insulin receptor signaling pathway; P:muscle contraction; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of lipid biosynthetic process; P:positive regulation of protein localization to plasma membrane; P:stress fiber assembly;|Q8IVQ4 Q96KF3 Q96KF4 Q9BX64 Q9BX65 Q9P2Q0 Q9UFT2 Q9UHN7 Q9Y338,Sorbin and SH3 domain-containing protein 1,Ponsin;SH3 domain protein 5;SH3P12;c-Cbl-associated protein;, PF00018;PF07653;PF14604;PF02208;, GO:0005912;GO:0030055;GO:0005813;GO:0005829;GO:0005925;GO:0045121;GO:0016363;GO:0005634;GO:0005886;GO:0001725;GO:0005915;GO:0003779;GO:0008092;GO:0005158;GO:0030159;GO:0007160;GO:0032869;GO:0048041;GO:0008286;GO:0006936;GO:0046326;GO:0045725;GO:0046628;GO:0046889;GO:1903078;GO:0043149;, C:adherens junction; C:cell-substrate junction; C:centrosome; C:cytosol; C:focal adhesion; C:membrane raft; C:nuclear matrix; C:nucleus; C:plasma membrane; C:stress fiber; C:zonula adherens;, F:actin binding; F:cytoskeletal protein binding; F:insulin receptor binding; F:signaling receptor complex adaptor activity;, P:cell-matrix adhesion; P:cellular response to insulin stimulus; P:focal adhesion assembly; P:insulin receptor signaling pathway; P:muscle contraction; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of lipid biosynthetic process; P:positive regulation of protein localization to plasma membrane; P:stress fiber assembly;|Q8IVQ4 Q96KF3 Q96KF4 Q9BX64 Q9BX65 Q9P2Q0 Q9UFT2 Q9UHN7 Q9Y338,Sorbin and SH3 domain-containing protein 1,Ponsin;SH3 domain protein 5;SH3P12;c-Cbl-associated protein;, PF00018;PF07653;PF14604;PF02208;, GO:0005912;GO:0030055;GO:0005813;GO:0005829;GO:0005925;GO:0045121;GO:0016363;GO:0005634;GO:0005886;GO:0001725;GO:0005915;GO:0003779;GO:0008092;GO:0005158;GO:0030159;GO:0007160;GO:0032869;GO:0048041;GO:0008286;GO:0006936;GO:0046326;GO:0045725;GO:0046628;GO:0046889;GO:1903078;GO:0043149;, C:adherens junction; C:cell-substrate junction; C:centrosome; C:cytosol; C:focal adhesion; C:membrane raft; C:nuclear matrix; C:nucleus; C:plasma membrane; C:stress fiber; C:zonula adherens;, F:actin binding; F:cytoskeletal protein binding; F:insulin receptor binding; F:signaling receptor complex adaptor activity;, P:cell-matrix adhesion; P:cellular response to insulin stimulus; P:focal adhesion assembly; P:insulin receptor signaling pathway; P:muscle contraction; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of lipid biosynthetic process; P:positive regulation of protein localization to plasma membrane; P:stress fiber assembly; scaffold18 indexed_genome mRNA 965323 989609 . - . ID=transcript_4356;Q8IVQ4 Q96KF3 Q96KF4 Q9BX64 Q9BX65 Q9P2Q0 Q9UFT2 Q9UHN7 Q9Y338,Sorbin and SH3 domain-containing protein 1,Ponsin;SH3 domain protein 5;SH3P12;c-Cbl-associated protein;, PF00018;PF07653;PF14604;PF02208;, GO:0005912;GO:0030055;GO:0005813;GO:0005829;GO:0005925;GO:0045121;GO:0016363;GO:0005634;GO:0005886;GO:0001725;GO:0005915;GO:0003779;GO:0008092;GO:0005158;GO:0030159;GO:0007160;GO:0032869;GO:0048041;GO:0008286;GO:0006936;GO:0046326;GO:0045725;GO:0046628;GO:0046889;GO:1903078;GO:0043149;, C:adherens junction; C:cell-substrate junction; C:centrosome; C:cytosol; C:focal adhesion; C:membrane raft; C:nuclear matrix; C:nucleus; C:plasma membrane; C:stress fiber; C:zonula adherens;, F:actin binding; F:cytoskeletal protein binding; F:insulin receptor binding; F:signaling receptor complex adaptor activity;, P:cell-matrix adhesion; P:cellular response to insulin stimulus; P:focal adhesion assembly; P:insulin receptor signaling pathway; P:muscle contraction; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of lipid biosynthetic process; P:positive regulation of protein localization to plasma membrane; P:stress fiber assembly; scaffold18 indexed_genome mRNA 1142631 1189980 . - . ID=transcript_4357;Q5T567 Q9UM72,Delta-1-pyrroline-5-carboxylate synthase,Aldehyde dehydrogenase family 18 member A1;, PF00696;PF00171;, GO:0005743;GO:0005739;GO:0005524;GO:0004349;GO:0004350;GO:0042802;GO:0003723;GO:0019240;GO:0006536;GO:0009064;GO:0055129;GO:0006592;GO:0006561;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:glutamate 5-kinase activity; F:glutamate-5-semialdehyde dehydrogenase activity; F:identical protein binding; F:RNA binding;, P:citrulline biosynthetic process; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:ornithine biosynthetic process; P:proline biosynthetic process;|Q5T567 Q9UM72,Delta-1-pyrroline-5-carboxylate synthase,Aldehyde dehydrogenase family 18 member A1;, PF00696;PF00171;, GO:0005743;GO:0005739;GO:0005524;GO:0004349;GO:0004350;GO:0042802;GO:0003723;GO:0019240;GO:0006536;GO:0009064;GO:0055129;GO:0006592;GO:0006561;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:glutamate 5-kinase activity; F:glutamate-5-semialdehyde dehydrogenase activity; F:identical protein binding; F:RNA binding;, P:citrulline biosynthetic process; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:ornithine biosynthetic process; P:proline biosynthetic process;|Q5T567 Q9UM72,Delta-1-pyrroline-5-carboxylate synthase,Aldehyde dehydrogenase family 18 member A1;, PF00696;PF00171;, GO:0005743;GO:0005739;GO:0005524;GO:0004349;GO:0004350;GO:0042802;GO:0003723;GO:0019240;GO:0006536;GO:0009064;GO:0055129;GO:0006592;GO:0006561;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:glutamate 5-kinase activity; F:glutamate-5-semialdehyde dehydrogenase activity; F:identical protein binding; F:RNA binding;, P:citrulline biosynthetic process; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:ornithine biosynthetic process; P:proline biosynthetic process;|Q5T567 Q9UM72,Delta-1-pyrroline-5-carboxylate synthase,Aldehyde dehydrogenase family 18 member A1;, PF00696;PF00171;, GO:0005743;GO:0005739;GO:0005524;GO:0004349;GO:0004350;GO:0042802;GO:0003723;GO:0019240;GO:0006536;GO:0009064;GO:0055129;GO:0006592;GO:0006561;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:glutamate 5-kinase activity; F:glutamate-5-semialdehyde dehydrogenase activity; F:identical protein binding; F:RNA binding;, P:citrulline biosynthetic process; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:ornithine biosynthetic process; P:proline biosynthetic process;|Q5T567 Q9UM72,Delta-1-pyrroline-5-carboxylate synthase,Aldehyde dehydrogenase family 18 member A1;, PF00696;PF00171;, GO:0005743;GO:0005739;GO:0005524;GO:0004349;GO:0004350;GO:0042802;GO:0003723;GO:0019240;GO:0006536;GO:0009064;GO:0055129;GO:0006592;GO:0006561;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:glutamate 5-kinase activity; F:glutamate-5-semialdehyde dehydrogenase activity; F:identical protein binding; F:RNA binding;, P:citrulline biosynthetic process; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:ornithine biosynthetic process; P:proline biosynthetic process;|Q5T567 Q9UM72,Delta-1-pyrroline-5-carboxylate synthase,Aldehyde dehydrogenase family 18 member A1;, PF00696;PF00171;, GO:0005743;GO:0005739;GO:0005524;GO:0004349;GO:0004350;GO:0042802;GO:0003723;GO:0019240;GO:0006536;GO:0009064;GO:0055129;GO:0006592;GO:0006561;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:glutamate 5-kinase activity; F:glutamate-5-semialdehyde dehydrogenase activity; F:identical protein binding; F:RNA binding;, P:citrulline biosynthetic process; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:ornithine biosynthetic process; P:proline biosynthetic process;|Q5T567 Q9UM72,Delta-1-pyrroline-5-carboxylate synthase,Aldehyde dehydrogenase family 18 member A1;, PF00696;PF00171;, GO:0005743;GO:0005739;GO:0005524;GO:0004349;GO:0004350;GO:0042802;GO:0003723;GO:0019240;GO:0006536;GO:0009064;GO:0055129;GO:0006592;GO:0006561;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:glutamate 5-kinase activity; F:glutamate-5-semialdehyde dehydrogenase activity; F:identical protein binding; F:RNA binding;, P:citrulline biosynthetic process; P:glutamate metabolic process; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:ornithine biosynthetic process; P:proline biosynthetic process; scaffold18 indexed_genome mRNA 1193943 1215413 . - . ID=transcript_4358;Q96GF7 Q9Y3U1,Tectonic-3,, PF07773;, GO:0060170;GO:0016021;GO:0005634;GO:0006915;GO:0097711;GO:0060271;GO:0043065;GO:0007224;, C:ciliary membrane; C:integral component of membrane; C:nucleus;, , P:apoptotic process; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:positive regulation of apoptotic process; P:smoothened signaling pathway;|Q96GF7 Q9Y3U1,Tectonic-3,, PF07773;, GO:0060170;GO:0016021;GO:0005634;GO:0006915;GO:0097711;GO:0060271;GO:0043065;GO:0007224;, C:ciliary membrane; C:integral component of membrane; C:nucleus;, , P:apoptotic process; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:positive regulation of apoptotic process; P:smoothened signaling pathway;|Q96GF7 Q9Y3U1,Tectonic-3,, PF07773;, GO:0060170;GO:0016021;GO:0005634;GO:0006915;GO:0097711;GO:0060271;GO:0043065;GO:0007224;, C:ciliary membrane; C:integral component of membrane; C:nucleus;, , P:apoptotic process; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:positive regulation of apoptotic process; P:smoothened signaling pathway;|Q96GF7 Q9Y3U1,Tectonic-3,, PF07773;, GO:0060170;GO:0016021;GO:0005634;GO:0006915;GO:0097711;GO:0060271;GO:0043065;GO:0007224;, C:ciliary membrane; C:integral component of membrane; C:nucleus;, , P:apoptotic process; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:positive regulation of apoptotic process; P:smoothened signaling pathway; scaffold18 indexed_genome mRNA 1314838 1335977 . + . ID=transcript_4359;Q9UQQ9 Q9Y3Q9,Ectonucleoside triphosphate diphosphohydrolase 1,Ecto-ATP diphosphohydrolase 1;Ecto-apyrase;Lymphoid cell activation antigen;, PF01150;, GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0102490;GO:0005524;GO:0102485;GO:0102486;GO:0102491;GO:0102488;GO:0102487;GO:0102489;GO:0004382;GO:0017110;GO:0045134;GO:0007596;GO:0007155;GO:0034656;GO:0009134;GO:0035590;, C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:8-oxo-dGTP phosphohydrolase activity; F:ATP binding; F:dATP phosphohydrolase activity; F:dCTP phosphohydrolase activity; F:dGTP phosphohydrolase activity; F:dTTP phosphohydrolase activity; F:dUTP phosphohydrolase activity; F:GTP phosphohydrolase activity; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:uridine-diphosphatase activity;, P:blood coagulation; P:cell adhesion; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:purinergic nucleotide receptor signaling pathway; scaffold18 indexed_genome mRNA 1467739 1484867 . + . ID=transcript_4360;Q5T5M9 B7Z4E7 Q86XL1 Q9NV69,Cyclin-J,, PF02984;PF00134;, GO:0005813;GO:0000307;GO:0005737;GO:0005634;GO:0016538;GO:0044772;GO:0000079;, C:centrosome; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold18 indexed_genome mRNA 1556345 1566465 . + . ID=transcript_4361;Q6AHZ1 A0PJI5 O15044 Q32MP4,Zinc finger protein 518A,, , GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold18 indexed_genome mRNA 1575736 1655303 . - . ID=transcript_4362;Q8WV28 O75498 O75499 Q2MD49,B-cell linker protein,B-cell adapter containing a SH2 domain protein;B-cell adapter containing a Src homology 2 domain protein;Cytoplasmic adapter protein;Src homology 2 domain-containing leukocyte protein of 65 kDa;, PF00017;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005886;GO:0019899;GO:1990782;GO:0042169;GO:0035591;GO:0005068;GO:0030183;GO:0050853;GO:0006959;GO:0006954;GO:0035556;GO:0010628;GO:0007169;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:plasma membrane;, F:enzyme binding; F:protein tyrosine kinase binding; F:SH2 domain binding; F:signaling adaptor activity; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:B cell differentiation; P:B cell receptor signaling pathway; P:humoral immune response; P:inflammatory response; P:intracellular signal transduction; P:positive regulation of gene expression; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold18 indexed_genome mRNA 1726279 1732478 . - . ID=transcript_4363;Q96PE5 A8MX69 A8MYG4 B4DK96 B4DKH0 Q5W102,Opalin,Oligodendrocytic myelin paranodal and inner loop protein;Transmembrane protein 10;, , GO:0044291;GO:0005794;GO:0016021;GO:0005886;GO:0048713;, C:cell-cell contact zone; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:regulation of oligodendrocyte differentiation;|Q96PE5 A8MX69 A8MYG4 B4DK96 B4DKH0 Q5W102,Opalin,Oligodendrocytic myelin paranodal and inner loop protein;Transmembrane protein 10;, , GO:0044291;GO:0005794;GO:0016021;GO:0005886;GO:0048713;, C:cell-cell contact zone; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:regulation of oligodendrocyte differentiation;|Q96PE5 A8MX69 A8MYG4 B4DK96 B4DKH0 Q5W102,Opalin,Oligodendrocytic myelin paranodal and inner loop protein;Transmembrane protein 10;, , GO:0044291;GO:0005794;GO:0016021;GO:0005886;GO:0048713;, C:cell-cell contact zone; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:regulation of oligodendrocyte differentiation; scaffold18 indexed_genome mRNA 1898197 1947094 . - . ID=transcript_4364;Q9HD45 Q5TB57 Q6UWE7 Q9NWL8 Q9P0G9 Q9UHW8,Transmembrane 9 superfamily member 3,EP70-P-iso;SM-11044-binding protein;, PF02990;, GO:0016021;GO:0016020;GO:0072657;, C:integral component of membrane; C:membrane;, , P:protein localization to membrane;|Q9HD45 Q5TB57 Q6UWE7 Q9NWL8 Q9P0G9 Q9UHW8,Transmembrane 9 superfamily member 3,EP70-P-iso;SM-11044-binding protein;, PF02990;, GO:0016021;GO:0016020;GO:0072657;, C:integral component of membrane; C:membrane;, , P:protein localization to membrane; scaffold18 indexed_genome mRNA 1967198 2083040 . - . ID=transcript_4365;Q6ZUJ8 Q5TB56 Q5VXJ9 Q8N6J6 Q8NAC8,Phosphoinositide 3-kinase adapter protein 1,B-cell adapter for phosphoinositide 3-kinase;B-cell phosphoinositide 3-kinase adapter protein 1;, PF14545;PF18567;, GO:0005829;GO:0016020;GO:0005886;GO:0042802;GO:0036312;GO:0005102;GO:0014068;GO:0051897;GO:0050727;GO:0034134;GO:0034142;GO:0034154;GO:0034162;, C:cytosol; C:membrane; C:plasma membrane;, F:identical protein binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:signaling receptor binding;, P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:regulation of inflammatory response; P:toll-like receptor 2 signaling pathway; P:toll-like receptor 4 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; scaffold18 indexed_genome mRNA 2236639 2274065 . + . ID=transcript_4366;Q9Y457,Ligand-dependent corepressor,Mblk1-related protein 2;, PF05225;, GO:0005654;GO:0005634;GO:0003677;GO:0030331;GO:0042826;GO:1990226;GO:0001226;GO:0003714;GO:1990381;GO:0071392;GO:0000122;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:estrogen receptor binding; F:histone deacetylase binding; F:histone methyltransferase binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:ubiquitin-specific protease binding;, P:cellular response to estradiol stimulus; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold18 indexed_genome mRNA 2297163 2299401 . + . ID=transcript_4367;A8MVM7,Putative uncharacterized protein ENSP00000382790,, PF15090; scaffold18 indexed_genome mRNA 2314670 2370575 . - . ID=transcript_4368;O75093 Q5T0V1 Q8WWZ2 Q9UIL7,Slit homolog 1 protein,Multiple epidermal growth factor-like domains protein 4;, PF00008;PF12661;PF02210;PF13855;PF01463;PF01462;, GO:0005615;GO:0005509;GO:0008201;GO:0048495;GO:0048846;GO:0007411;GO:0033563;GO:0048853;GO:0008045;GO:0050919;GO:0051964;GO:0007097;GO:0031290;GO:0022028;, C:extracellular space;, F:calcium ion binding; F:heparin binding; F:Roundabout binding;, P:axon extension involved in axon guidance; P:axon guidance; P:dorsal/ventral axon guidance; P:forebrain morphogenesis; P:motor neuron axon guidance; P:negative chemotaxis; P:negative regulation of synapse assembly; P:nuclear migration; P:retinal ganglion cell axon guidance; P:tangential migration from the subventricular zone to the olfactory bulb;|O75093 Q5T0V1 Q8WWZ2 Q9UIL7,Slit homolog 1 protein,Multiple epidermal growth factor-like domains protein 4;, PF00008;PF12661;PF02210;PF13855;PF01463;PF01462;, GO:0005615;GO:0005509;GO:0008201;GO:0048495;GO:0048846;GO:0007411;GO:0033563;GO:0048853;GO:0008045;GO:0050919;GO:0051964;GO:0007097;GO:0031290;GO:0022028;, C:extracellular space;, F:calcium ion binding; F:heparin binding; F:Roundabout binding;, P:axon extension involved in axon guidance; P:axon guidance; P:dorsal/ventral axon guidance; P:forebrain morphogenesis; P:motor neuron axon guidance; P:negative chemotaxis; P:negative regulation of synapse assembly; P:nuclear migration; P:retinal ganglion cell axon guidance; P:tangential migration from the subventricular zone to the olfactory bulb; scaffold18 indexed_genome mRNA 2515911 2547156 . - . ID=transcript_4369;Q8NF34 Q8TEK1,Rho GTPase-activating protein 19,Rho-type GTPase-activating protein 19;, PF00620;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005096;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold18 indexed_genome mRNA 2590847 2591871 . + . ID=transcript_4370;Q92837 Q5JTI1 Q8NE74 Q8TDW9,Proto-oncogene FRAT1,Frequently rearranged in advanced T-cell lymphomas 1;, PF05350;, GO:0005737;GO:0005829;GO:0043231;GO:1904886;GO:0060070;GO:0090263;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle;, , P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; scaffold18 indexed_genome mRNA 2602810 2604389 . + . ID=transcript_4371;O75474 Q5JTI0 Q8WUL9 Q9BYG2,GSK-3-binding protein FRAT2,Frequently rearranged in advanced T-cell lymphomas 2;, PF05350;, GO:0005737;GO:0005829;GO:1904886;, C:cytoplasm; C:cytosol;, , P:beta-catenin destruction complex disassembly; scaffold18 indexed_genome mRNA 2632734 2660854 . - . ID=transcript_4372;Q5JTH9 B4DK00 E9PCK7 Q5JTH8 Q69YK4 Q96E87 Q9BUH3 Q9Y4C7,RRP12-like protein,, PF08161;, GO:0005829;GO:0016021;GO:0043231;GO:0031965;GO:0005730;GO:0005886;GO:0003723;GO:0006364;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nuclear membrane; C:nucleolus; C:plasma membrane;, F:RNA binding;, P:rRNA processing;|Q5JTH9 B4DK00 E9PCK7 Q5JTH8 Q69YK4 Q96E87 Q9BUH3 Q9Y4C7,RRP12-like protein,, PF08161;, GO:0005829;GO:0016021;GO:0043231;GO:0031965;GO:0005730;GO:0005886;GO:0003723;GO:0006364;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nuclear membrane; C:nucleolus; C:plasma membrane;, F:RNA binding;, P:rRNA processing;|Q5JTH9 B4DK00 E9PCK7 Q5JTH8 Q69YK4 Q96E87 Q9BUH3 Q9Y4C7,RRP12-like protein,, PF08161;, GO:0005829;GO:0016021;GO:0043231;GO:0031965;GO:0005730;GO:0005886;GO:0003723;GO:0006364;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nuclear membrane; C:nucleolus; C:plasma membrane;, F:RNA binding;, P:rRNA processing; scaffold18 indexed_genome mRNA 2676676 2683893 . - . ID=transcript_4373;P18669 Q9BWC0,Phosphoglycerate mutase 1,BPG-dependent PGAM 1;Phosphoglycerate mutase isozyme B;, PF00300;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0034774;GO:0004082;GO:0016787;GO:0004619;GO:0019901;GO:0061621;GO:0006094;GO:0006096;GO:0043312;GO:0006110;GO:0043456;GO:0045730;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:secretory granule lumen;, F:bisphosphoglycerate mutase activity; F:hydrolase activity; F:phosphoglycerate mutase activity; F:protein kinase binding;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:neutrophil degranulation; P:regulation of glycolytic process; P:regulation of pentose-phosphate shunt; P:respiratory burst;|P18669 Q9BWC0,Phosphoglycerate mutase 1,BPG-dependent PGAM 1;Phosphoglycerate mutase isozyme B;, PF00300;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0034774;GO:0004082;GO:0016787;GO:0004619;GO:0019901;GO:0061621;GO:0006094;GO:0006096;GO:0043312;GO:0006110;GO:0043456;GO:0045730;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:secretory granule lumen;, F:bisphosphoglycerate mutase activity; F:hydrolase activity; F:phosphoglycerate mutase activity; F:protein kinase binding;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:neutrophil degranulation; P:regulation of glycolytic process; P:regulation of pentose-phosphate shunt; P:respiratory burst;|P18669 Q9BWC0,Phosphoglycerate mutase 1,BPG-dependent PGAM 1;Phosphoglycerate mutase isozyme B;, PF00300;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0034774;GO:0004082;GO:0016787;GO:0004619;GO:0019901;GO:0061621;GO:0006094;GO:0006096;GO:0043312;GO:0006110;GO:0043456;GO:0045730;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:secretory granule lumen;, F:bisphosphoglycerate mutase activity; F:hydrolase activity; F:phosphoglycerate mutase activity; F:protein kinase binding;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:neutrophil degranulation; P:regulation of glycolytic process; P:regulation of pentose-phosphate shunt; P:respiratory burst;|P18669 Q9BWC0,Phosphoglycerate mutase 1,BPG-dependent PGAM 1;Phosphoglycerate mutase isozyme B;, PF00300;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0034774;GO:0004082;GO:0016787;GO:0004619;GO:0019901;GO:0061621;GO:0006094;GO:0006096;GO:0043312;GO:0006110;GO:0043456;GO:0045730;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:secretory granule lumen;, F:bisphosphoglycerate mutase activity; F:hydrolase activity; F:phosphoglycerate mutase activity; F:protein kinase binding;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:neutrophil degranulation; P:regulation of glycolytic process; P:regulation of pentose-phosphate shunt; P:respiratory burst; scaffold18 indexed_genome mRNA 2684642 2688448 . - . ID=transcript_4374;Q9Y3B2 B2R9B3 Q5JTH3,Exosome complex component CSL4,Exosome component 1;, PF14382;PF10447;, GO:0005737;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0003723;GO:0043928;GO:0043488;GO:0090503;GO:0006364;, C:cytoplasm; C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:regulation of mRNA stability; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:rRNA processing;|Q9Y3B2 B2R9B3 Q5JTH3,Exosome complex component CSL4,Exosome component 1;, PF14382;PF10447;, GO:0005737;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0003723;GO:0043928;GO:0043488;GO:0090503;GO:0006364;, C:cytoplasm; C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:regulation of mRNA stability; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:rRNA processing; scaffold18 indexed_genome mRNA 2691418 2738245 . + . ID=transcript_4375;Q969W1 D3DR52 D3DR53 D3DR54 Q5JTG7 Q5JTH0 Q8N4Z6 Q8WY84 Q9BSV3,Palmitoyltransferase ZDHHC16 {ECO:0000305},Abl-philin 2 {ECO:0000303|PubMed:17123647};Zinc finger DHHC domain-containing protein 16;, PF01529;, GO:0005789;GO:0005794;GO:0016021;GO:0016409;GO:0019706;GO:0006915;GO:0006974;GO:0001654;GO:0007507;GO:0018345;GO:0021537;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:eye development; P:heart development; P:protein palmitoylation; P:telencephalon development;|Q969W1 D3DR52 D3DR53 D3DR54 Q5JTG7 Q5JTH0 Q8N4Z6 Q8WY84 Q9BSV3,Palmitoyltransferase ZDHHC16 {ECO:0000305},Abl-philin 2 {ECO:0000303|PubMed:17123647};Zinc finger DHHC domain-containing protein 16;, PF01529;, GO:0005789;GO:0005794;GO:0016021;GO:0016409;GO:0019706;GO:0006915;GO:0006974;GO:0001654;GO:0007507;GO:0018345;GO:0021537;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:eye development; P:heart development; P:protein palmitoylation; P:telencephalon development;|Q969W1 D3DR52 D3DR53 D3DR54 Q5JTG7 Q5JTH0 Q8N4Z6 Q8WY84 Q9BSV3,Palmitoyltransferase ZDHHC16 {ECO:0000305},Abl-philin 2 {ECO:0000303|PubMed:17123647};Zinc finger DHHC domain-containing protein 16;, PF01529;, GO:0005789;GO:0005794;GO:0016021;GO:0016409;GO:0019706;GO:0006915;GO:0006974;GO:0001654;GO:0007507;GO:0018345;GO:0021537;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:eye development; P:heart development; P:protein palmitoylation; P:telencephalon development;|Q969W1 D3DR52 D3DR53 D3DR54 Q5JTG7 Q5JTH0 Q8N4Z6 Q8WY84 Q9BSV3,Palmitoyltransferase ZDHHC16 {ECO:0000305},Abl-philin 2 {ECO:0000303|PubMed:17123647};Zinc finger DHHC domain-containing protein 16;, PF01529;, GO:0005789;GO:0005794;GO:0016021;GO:0016409;GO:0019706;GO:0006915;GO:0006974;GO:0001654;GO:0007507;GO:0018345;GO:0021537;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:eye development; P:heart development; P:protein palmitoylation; P:telencephalon development;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated;|Q66K82 Q7L4W8 Q969Z1 Q96DF1 Q96MR1 Q96RK5 Q96SK1 Q9BUE2 Q9BYS9,MMS19 nucleotide excision repair protein homolog,MET18 homolog;MMS19-like protein;, PF12460;PF14500;, GO:0097361;GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005675;GO:0019899;GO:0030331;GO:0030674;GO:0030159;GO:0003713;GO:0006974;GO:0007059;GO:0006259;GO:0006281;GO:0016226;GO:0006289;GO:0000160;GO:1905168;GO:0045893;GO:0097428;GO:0009725;GO:0006351;, C:CIA complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIIH holo complex;, F:enzyme binding; F:estrogen receptor binding; F:protein-macromolecule adaptor activity; F:signaling receptor complex adaptor activity; F:transcription coactivator activity;, P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA metabolic process; P:DNA repair; P:iron-sulfur cluster assembly; P:nucleotide-excision repair; P:phosphorelay signal transduction system; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; P:protein maturation by iron-sulfur cluster transfer; P:response to hormone; P:transcription, DNA-templated; scaffold18 indexed_genome mRNA 2738491 2789029 . + . ID=transcript_4376;Q9HAC8 D3DR57 Q53HI3,Ubiquitin domain-containing protein 1,, PF16455;PF00240; scaffold18 indexed_genome mRNA 2790745 2798404 . + . ID=transcript_4377;Q9GZV1 Q3B778 Q5T456 Q70EZ9 Q8WUD7 Q96MG0 Q9NQC9,Ankyrin repeat domain-containing protein 2,Skeletal muscle ankyrin repeat protein;, PF12796;, GO:0005829;GO:0000791;GO:0031674;GO:0043231;GO:0005634;GO:0016605;GO:0043422;GO:0061629;GO:0008307;GO:0006936;GO:0007517;GO:0045662;GO:0000122;GO:0006357;GO:0043619;, C:cytosol; C:euchromatin; C:I band; C:intracellular membrane-bounded organelle; C:nucleus; C:PML body;, F:protein kinase B binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:structural constituent of muscle;, P:muscle contraction; P:muscle organ development; P:negative regulation of myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress;|Q9GZV1 Q3B778 Q5T456 Q70EZ9 Q8WUD7 Q96MG0 Q9NQC9,Ankyrin repeat domain-containing protein 2,Skeletal muscle ankyrin repeat protein;, PF12796;, GO:0005829;GO:0000791;GO:0031674;GO:0043231;GO:0005634;GO:0016605;GO:0043422;GO:0061629;GO:0008307;GO:0006936;GO:0007517;GO:0045662;GO:0000122;GO:0006357;GO:0043619;, C:cytosol; C:euchromatin; C:I band; C:intracellular membrane-bounded organelle; C:nucleus; C:PML body;, F:protein kinase B binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:structural constituent of muscle;, P:muscle contraction; P:muscle organ development; P:negative regulation of myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; scaffold18 indexed_genome mRNA 2800191 2822753 . + . ID=transcript_4378;Q86XE5 A8K075 Q5T680 Q5T684 Q711P0 Q8N9F2 Q96EV5,4-hydroxy-2-oxoglutarate aldolase, mitochondrial,Dihydrodipicolinate synthase-like;Probable 2-keto-4-hydroxyglutarate aldolase;Protein 569272;, PF00701;, GO:0005759;GO:0005739;GO:0008700;GO:0042803;GO:0019470;GO:0009436;GO:0046487;GO:0033609;GO:0042866;, C:mitochondrial matrix; C:mitochondrion;, F:4-hydroxy-2-oxoglutarate aldolase activity; F:protein homodimerization activity;, P:4-hydroxyproline catabolic process; P:glyoxylate catabolic process; P:glyoxylate metabolic process; P:oxalate metabolic process; P:pyruvate biosynthetic process;|Q86XE5 A8K075 Q5T680 Q5T684 Q711P0 Q8N9F2 Q96EV5,4-hydroxy-2-oxoglutarate aldolase, mitochondrial,Dihydrodipicolinate synthase-like;Probable 2-keto-4-hydroxyglutarate aldolase;Protein 569272;, PF00701;, GO:0005759;GO:0005739;GO:0008700;GO:0042803;GO:0019470;GO:0009436;GO:0046487;GO:0033609;GO:0042866;, C:mitochondrial matrix; C:mitochondrion;, F:4-hydroxy-2-oxoglutarate aldolase activity; F:protein homodimerization activity;, P:4-hydroxyproline catabolic process; P:glyoxylate catabolic process; P:glyoxylate metabolic process; P:oxalate metabolic process; P:pyruvate biosynthetic process; scaffold18 indexed_genome mRNA 2825026 2828685 . - . ID=transcript_4379;Q8NDC4 Q86Y54,MORN repeat-containing protein 4,Protein 44050;Retinophilin {ECO:0000303|PubMed:17285308};, PF02493;, GO:0005737;GO:0032433;GO:0032426;GO:0048678;, C:cytoplasm; C:filopodium tip; C:stereocilium tip;, , P:response to axon injury;|Q8NDC4 Q86Y54,MORN repeat-containing protein 4,Protein 44050;Retinophilin {ECO:0000303|PubMed:17285308};, PF02493;, GO:0005737;GO:0032433;GO:0032426;GO:0048678;, C:cytoplasm; C:filopodium tip; C:stereocilium tip;, , P:response to axon injury; scaffold18 indexed_genome mRNA 2828871 2838106 . - . ID=transcript_4380;Q8NDC4 Q86Y54,MORN repeat-containing protein 4,Protein 44050;Retinophilin {ECO:0000303|PubMed:17285308};, PF02493;, GO:0005737;GO:0032433;GO:0032426;GO:0048678;, C:cytoplasm; C:filopodium tip; C:stereocilium tip;, , P:response to axon injury; scaffold18 indexed_genome mRNA 2868874 2888136 . + . ID=transcript_4381;Q9BTU6 D3DR59 Q9NSG8,Phosphatidylinositol 4-kinase type 2-alpha,Phosphatidylinositol 4-kinase type II-alpha;, PF00454;, GO:0031410;GO:0005829;GO:0030425;GO:0005768;GO:0035838;GO:0005887;GO:0031224;GO:0005765;GO:0016020;GO:0045121;GO:0005739;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0042734;GO:0005802;GO:0004430;GO:0035651;GO:0005524;GO:0000287;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endosome; C:growing cell tip; C:integral component of plasma membrane; C:intrinsic component of membrane; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrion; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:presynaptic membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:AP-3 adaptor complex binding; F:ATP binding; F:magnesium ion binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation;|Q9BTU6 D3DR59 Q9NSG8,Phosphatidylinositol 4-kinase type 2-alpha,Phosphatidylinositol 4-kinase type II-alpha;, PF00454;, GO:0031410;GO:0005829;GO:0030425;GO:0005768;GO:0035838;GO:0005887;GO:0031224;GO:0005765;GO:0016020;GO:0045121;GO:0005739;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0042734;GO:0005802;GO:0004430;GO:0035651;GO:0005524;GO:0000287;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endosome; C:growing cell tip; C:integral component of plasma membrane; C:intrinsic component of membrane; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrion; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:presynaptic membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:AP-3 adaptor complex binding; F:ATP binding; F:magnesium ion binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation;|Q9BTU6 D3DR59 Q9NSG8,Phosphatidylinositol 4-kinase type 2-alpha,Phosphatidylinositol 4-kinase type II-alpha;, PF00454;, GO:0031410;GO:0005829;GO:0030425;GO:0005768;GO:0035838;GO:0005887;GO:0031224;GO:0005765;GO:0016020;GO:0045121;GO:0005739;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0042734;GO:0005802;GO:0004430;GO:0035651;GO:0005524;GO:0000287;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endosome; C:growing cell tip; C:integral component of plasma membrane; C:intrinsic component of membrane; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrion; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:presynaptic membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:AP-3 adaptor complex binding; F:ATP binding; F:magnesium ion binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation;|Q9BTU6 D3DR59 Q9NSG8,Phosphatidylinositol 4-kinase type 2-alpha,Phosphatidylinositol 4-kinase type II-alpha;, PF00454;, GO:0031410;GO:0005829;GO:0030425;GO:0005768;GO:0035838;GO:0005887;GO:0031224;GO:0005765;GO:0016020;GO:0045121;GO:0005739;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0042734;GO:0005802;GO:0004430;GO:0035651;GO:0005524;GO:0000287;GO:0007032;GO:0007030;GO:0006661;GO:0046854;, C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endosome; C:growing cell tip; C:integral component of plasma membrane; C:intrinsic component of membrane; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrion; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:presynaptic membrane; C:trans-Golgi network;, F:1-phosphatidylinositol 4-kinase activity; F:AP-3 adaptor complex binding; F:ATP binding; F:magnesium ion binding;, P:endosome organization; P:Golgi organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; scaffold18 indexed_genome mRNA 2902184 2906686 . + . ID=transcript_4382;Q9BSK0,MARVEL domain-containing protein 1,, PF01284;, GO:0005737;GO:0005856;GO:0016021;GO:0005634;GO:0005886;GO:0019911;GO:0007049;GO:0042552;, C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:nucleus; C:plasma membrane;, F:structural constituent of myelin sheath;, P:cell cycle; P:myelination; scaffold18 indexed_genome mRNA 2919234 2942062 . + . ID=transcript_4383;Q5T4F3 Q8N1K0 Q8N6D6 Q8NCA0 Q8NDE4 Q96M08,Protrudin,Spastic paraplegia 33 protein {ECO:0000303|PubMed:24668814};Zinc finger FYVE domain-containing protein 27;, PF01363;, GO:0030424;GO:0005829;GO:0030425;GO:0005783;GO:0071782;GO:0032584;GO:0030176;GO:0043231;GO:0005654;GO:0055038;GO:0042802;GO:0046872;GO:0043621;GO:0071787;GO:0031175;GO:0048011;GO:0045773;GO:0072659;GO:0016192;, C:axon; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum tubular network; C:growth cone membrane; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:recycling endosome membrane;, F:identical protein binding; F:metal ion binding; F:protein self-association;, P:endoplasmic reticulum tubular network formation; P:neuron projection development; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of axon extension; P:protein localization to plasma membrane; P:vesicle-mediated transport;|Q5T4F3 Q8N1K0 Q8N6D6 Q8NCA0 Q8NDE4 Q96M08,Protrudin,Spastic paraplegia 33 protein {ECO:0000303|PubMed:24668814};Zinc finger FYVE domain-containing protein 27;, PF01363;, GO:0030424;GO:0005829;GO:0030425;GO:0005783;GO:0071782;GO:0032584;GO:0030176;GO:0043231;GO:0005654;GO:0055038;GO:0042802;GO:0046872;GO:0043621;GO:0071787;GO:0031175;GO:0048011;GO:0045773;GO:0072659;GO:0016192;, C:axon; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum tubular network; C:growth cone membrane; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:recycling endosome membrane;, F:identical protein binding; F:metal ion binding; F:protein self-association;, P:endoplasmic reticulum tubular network formation; P:neuron projection development; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of axon extension; P:protein localization to plasma membrane; P:vesicle-mediated transport;|Q5T4F3 Q8N1K0 Q8N6D6 Q8NCA0 Q8NDE4 Q96M08,Protrudin,Spastic paraplegia 33 protein {ECO:0000303|PubMed:24668814};Zinc finger FYVE domain-containing protein 27;, PF01363;, GO:0030424;GO:0005829;GO:0030425;GO:0005783;GO:0071782;GO:0032584;GO:0030176;GO:0043231;GO:0005654;GO:0055038;GO:0042802;GO:0046872;GO:0043621;GO:0071787;GO:0031175;GO:0048011;GO:0045773;GO:0072659;GO:0016192;, C:axon; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum tubular network; C:growth cone membrane; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:recycling endosome membrane;, F:identical protein binding; F:metal ion binding; F:protein self-association;, P:endoplasmic reticulum tubular network formation; P:neuron projection development; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of axon extension; P:protein localization to plasma membrane; P:vesicle-mediated transport; scaffold18 indexed_genome mRNA 3021409 3035039 . + . ID=transcript_4384;Q2TAP0 Q5T4F5,Golgin subfamily A member 7B,, PF10256;, GO:0000139;GO:0002178;GO:0019899;GO:0018230;GO:0018215;GO:0006612;, C:Golgi membrane; C:palmitoyltransferase complex;, F:enzyme binding;, P:peptidyl-L-cysteine S-palmitoylation; P:protein phosphopantetheinylation; P:protein targeting to membrane; scaffold18 indexed_genome mRNA 3047796 3199002 . - . ID=transcript_4385;Q9NQ79 B1ALN4 Q5T4F8 Q8N4H6 Q8TE52 Q9NQ78 Q9NQ80 Q9NW46,Cartilage acidic protein 1,68 kDa chondrocyte-expressed protein;ASPIC;, PF07645;PF07593;PF13517;, GO:0070062;GO:0005509;, C:extracellular exosome;, F:calcium ion binding; scaffold18 indexed_genome mRNA 3353916 3360369 . - . ID=transcript_4386;Q96JB6 Q5W0B3 Q96DY1 Q96PC0 Q9H6T5,Lysyl oxidase homolog 4,Lysyl oxidase-like protein 4;Lysyl oxidase-related protein C;, PF01186;PF00530;, GO:0070062;GO:0005615;GO:0016020;GO:0043235;GO:0005507;GO:0004720;GO:0005044;GO:0030199;GO:0018057;, C:extracellular exosome; C:extracellular space; C:membrane; C:receptor complex;, F:copper ion binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:collagen fibril organization; P:peptidyl-lysine oxidation; scaffold18 indexed_genome mRNA 3360406 3368616 . - . ID=transcript_4387;Q96JB6 Q5W0B3 Q96DY1 Q96PC0 Q9H6T5,Lysyl oxidase homolog 4,Lysyl oxidase-like protein 4;Lysyl oxidase-related protein C;, PF01186;PF00530;, GO:0070062;GO:0005615;GO:0016020;GO:0043235;GO:0005507;GO:0004720;GO:0005044;GO:0030199;GO:0018057;, C:extracellular exosome; C:extracellular space; C:membrane; C:receptor complex;, F:copper ion binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:collagen fibril organization; P:peptidyl-lysine oxidation; scaffold18 indexed_genome mRNA 3495057 3544180 . - . ID=transcript_4388;Q8N2H3 D3DR61 Q5TAA9 Q9BRQ1,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 {ECO:0000305},, PF01593;, GO:0005759;GO:0016491;GO:0007005;, C:mitochondrial matrix;, F:oxidoreductase activity;, P:mitochondrion organization;|Q8N2H3 D3DR61 Q5TAA9 Q9BRQ1,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 {ECO:0000305},, PF01593;, GO:0005759;GO:0016491;GO:0007005;, C:mitochondrial matrix;, F:oxidoreductase activity;, P:mitochondrion organization;|Q8N2H3 D3DR61 Q5TAA9 Q9BRQ1,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 {ECO:0000305},, PF01593;, GO:0005759;GO:0016491;GO:0007005;, C:mitochondrial matrix;, F:oxidoreductase activity;, P:mitochondrion organization;|Q8N2H3 D3DR61 Q5TAA9 Q9BRQ1,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 {ECO:0000305},, PF01593;, GO:0005759;GO:0016491;GO:0007005;, C:mitochondrial matrix;, F:oxidoreductase activity;, P:mitochondrion organization;|Q8N2H3 D3DR61 Q5TAA9 Q9BRQ1,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 {ECO:0000305},, PF01593;, GO:0005759;GO:0016491;GO:0007005;, C:mitochondrial matrix;, F:oxidoreductase activity;, P:mitochondrion organization;|Q92902 A8MRT2 O15402 O15502 Q5TAA3 Q8WXE5,Hermansky-Pudlak syndrome 1 protein,, PF19036;PF19037;PF19038;, GO:0031085;GO:0005737;GO:0031410;GO:0005829;GO:0005764;GO:0005085;GO:0046983;GO:0007040;GO:1903232;GO:0050896;GO:0016192;GO:0007601;, C:BLOC-3 complex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosome;, F:guanyl-nucleotide exchange factor activity; F:protein dimerization activity;, P:lysosome organization; P:melanosome assembly; P:response to stimulus; P:vesicle-mediated transport; P:visual perception; scaffold18 indexed_genome mRNA 4272127 4273973 . + . ID=transcript_4389;Q9NRU3 Q4QQG7 Q4QQH8 Q4QQP9 Q9NT45,Metal transporter CNNM1,Ancient conserved domain-containing protein 1;Cyclin-M1;, PF00571;PF01595;, GO:0016021;GO:0043231;GO:0005886;GO:0022857;GO:0006811;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:transmembrane transporter activity;, P:ion transport; scaffold18 indexed_genome mRNA 4306110 4337813 . - . ID=transcript_4390;Q9NRU3 Q4QQG7 Q4QQH8 Q4QQP9 Q9NT45,Metal transporter CNNM1,Ancient conserved domain-containing protein 1;Cyclin-M1;, PF00571;PF01595;, GO:0016021;GO:0043231;GO:0005886;GO:0022857;GO:0006811;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:transmembrane transporter activity;, P:ion transport;|Q9NRU3 Q4QQG7 Q4QQH8 Q4QQP9 Q9NT45,Metal transporter CNNM1,Ancient conserved domain-containing protein 1;Cyclin-M1;, PF00571;PF01595;, GO:0016021;GO:0043231;GO:0005886;GO:0022857;GO:0006811;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:transmembrane transporter activity;, P:ion transport; scaffold18 indexed_genome mRNA 4343219 4365111 . - . ID=transcript_4391;P17174 B2R6R7 B7Z7E9 Q5VW80,Aspartate aminotransferase, cytoplasmic,Cysteine aminotransferase, cytoplasmic;Cysteine transaminase, cytoplasmic;Glutamate oxaloacetate transaminase 1;Transaminase A;, PF00155;, GO:0043679;GO:0005737;GO:0005829;GO:0070062;GO:0005764;GO:0005654;GO:0005634;GO:0031406;GO:0004069;GO:0047801;GO:0004609;GO:0030170;GO:0006103;GO:0006532;GO:0006533;GO:0009066;GO:0006531;GO:0032869;GO:0071260;GO:0055089;GO:0006094;GO:0019551;GO:0019550;GO:0006536;GO:0006114;GO:0032966;GO:0051481;GO:0051902;GO:0007219;GO:0006107;GO:0030511;GO:0046686;GO:0009743;GO:0051384;GO:0035902;GO:1990267;GO:0060290;, C:axon terminus; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosome; C:nucleoplasm; C:nucleus;, F:carboxylic acid binding; F:L-aspartate:2-oxoglutarate aminotransferase activity; F:L-cysteine:2-oxoglutarate aminotransferase activity; F:phosphatidylserine decarboxylase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:aspartate biosynthetic process; P:aspartate catabolic process; P:aspartate family amino acid metabolic process; P:aspartate metabolic process; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:fatty acid homeostasis; P:gluconeogenesis; P:glutamate catabolic process to 2-oxoglutarate; P:glutamate catabolic process to aspartate; P:glutamate metabolic process; P:glycerol biosynthetic process; P:negative regulation of collagen biosynthetic process; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of mitochondrial depolarization; P:Notch signaling pathway; P:oxaloacetate metabolic process; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:response to cadmium ion; P:response to carbohydrate; P:response to glucocorticoid; P:response to immobilization stress; P:response to transition metal nanoparticle; P:transdifferentiation;|P17174 B2R6R7 B7Z7E9 Q5VW80,Aspartate aminotransferase, cytoplasmic,Cysteine aminotransferase, cytoplasmic;Cysteine transaminase, cytoplasmic;Glutamate oxaloacetate transaminase 1;Transaminase A;, PF00155;, GO:0043679;GO:0005737;GO:0005829;GO:0070062;GO:0005764;GO:0005654;GO:0005634;GO:0031406;GO:0004069;GO:0047801;GO:0004609;GO:0030170;GO:0006103;GO:0006532;GO:0006533;GO:0009066;GO:0006531;GO:0032869;GO:0071260;GO:0055089;GO:0006094;GO:0019551;GO:0019550;GO:0006536;GO:0006114;GO:0032966;GO:0051481;GO:0051902;GO:0007219;GO:0006107;GO:0030511;GO:0046686;GO:0009743;GO:0051384;GO:0035902;GO:1990267;GO:0060290;, C:axon terminus; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosome; C:nucleoplasm; C:nucleus;, F:carboxylic acid binding; F:L-aspartate:2-oxoglutarate aminotransferase activity; F:L-cysteine:2-oxoglutarate aminotransferase activity; F:phosphatidylserine decarboxylase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:aspartate biosynthetic process; P:aspartate catabolic process; P:aspartate family amino acid metabolic process; P:aspartate metabolic process; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:fatty acid homeostasis; P:gluconeogenesis; P:glutamate catabolic process to 2-oxoglutarate; P:glutamate catabolic process to aspartate; P:glutamate metabolic process; P:glycerol biosynthetic process; P:negative regulation of collagen biosynthetic process; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of mitochondrial depolarization; P:Notch signaling pathway; P:oxaloacetate metabolic process; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:response to cadmium ion; P:response to carbohydrate; P:response to glucocorticoid; P:response to immobilization stress; P:response to transition metal nanoparticle; P:transdifferentiation;|P17174 B2R6R7 B7Z7E9 Q5VW80,Aspartate aminotransferase, cytoplasmic,Cysteine aminotransferase, cytoplasmic;Cysteine transaminase, cytoplasmic;Glutamate oxaloacetate transaminase 1;Transaminase A;, PF00155;, GO:0043679;GO:0005737;GO:0005829;GO:0070062;GO:0005764;GO:0005654;GO:0005634;GO:0031406;GO:0004069;GO:0047801;GO:0004609;GO:0030170;GO:0006103;GO:0006532;GO:0006533;GO:0009066;GO:0006531;GO:0032869;GO:0071260;GO:0055089;GO:0006094;GO:0019551;GO:0019550;GO:0006536;GO:0006114;GO:0032966;GO:0051481;GO:0051902;GO:0007219;GO:0006107;GO:0030511;GO:0046686;GO:0009743;GO:0051384;GO:0035902;GO:1990267;GO:0060290;, C:axon terminus; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosome; C:nucleoplasm; C:nucleus;, F:carboxylic acid binding; F:L-aspartate:2-oxoglutarate aminotransferase activity; F:L-cysteine:2-oxoglutarate aminotransferase activity; F:phosphatidylserine decarboxylase activity; F:pyridoxal phosphate binding;, P:2-oxoglutarate metabolic process; P:aspartate biosynthetic process; P:aspartate catabolic process; P:aspartate family amino acid metabolic process; P:aspartate metabolic process; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:fatty acid homeostasis; P:gluconeogenesis; P:glutamate catabolic process to 2-oxoglutarate; P:glutamate catabolic process to aspartate; P:glutamate metabolic process; P:glycerol biosynthetic process; P:negative regulation of collagen biosynthetic process; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of mitochondrial depolarization; P:Notch signaling pathway; P:oxaloacetate metabolic process; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:response to cadmium ion; P:response to carbohydrate; P:response to glucocorticoid; P:response to immobilization stress; P:response to transition metal nanoparticle; P:transdifferentiation; scaffold18 indexed_genome mRNA 4513434 4523490 . - . ID=transcript_4392;Q96A46 Q4VBZ0 Q5T777 Q86VX5 Q969G8 Q9H2J3,Mitoferrin-2,Mitochondrial RNA-splicing protein 3/4 homolog;Mitochondrial iron transporter 2;Solute carrier family 25 member 28;, PF00153;, GO:0016021;GO:0005743;GO:0005381;GO:0048250;GO:0055072;, C:integral component of membrane; C:mitochondrial inner membrane;, F:iron ion transmembrane transporter activity;, P:iron import into the mitochondrion; P:iron ion homeostasis; scaffold18 indexed_genome mRNA 4572798 4602464 . + . ID=transcript_4393;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q7KZN9 A8K6I9 O60556 O75878 Q5TD00 Q5TD01 Q7Z3Q3 Q9NTN0,Cytochrome c oxidase assembly protein COX15 homolog,, PF02628;, GO:0070069;GO:0016021;GO:0005743;GO:0005746;GO:0005739;GO:0005654;GO:0004129;GO:0020037;GO:0060090;GO:0016653;GO:0016627;GO:0045333;GO:0006784;GO:0006783;GO:0006123;GO:1902600;GO:0008535;GO:0007585;, C:cytochrome complex; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion; C:nucleoplasm;, F:cytochrome-c oxidase activity; F:heme binding; F:molecular adaptor activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:cellular respiration; P:heme A biosynthetic process; P:heme biosynthetic process; P:mitochondrial electron transport, cytochrome c to oxygen; P:proton transmembrane transport; P:respiratory chain complex IV assembly; P:respiratory gaseous exchange by respiratory system;|Q7KZN9 A8K6I9 O60556 O75878 Q5TD00 Q5TD01 Q7Z3Q3 Q9NTN0,Cytochrome c oxidase assembly protein COX15 homolog,, PF02628;, GO:0070069;GO:0016021;GO:0005743;GO:0005746;GO:0005739;GO:0005654;GO:0004129;GO:0020037;GO:0060090;GO:0016653;GO:0016627;GO:0045333;GO:0006784;GO:0006783;GO:0006123;GO:1902600;GO:0008535;GO:0007585;, C:cytochrome complex; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion; C:nucleoplasm;, F:cytochrome-c oxidase activity; F:heme binding; F:molecular adaptor activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:cellular respiration; P:heme A biosynthetic process; P:heme biosynthetic process; P:mitochondrial electron transport, cytochrome c to oxygen; P:proton transmembrane transport; P:respiratory chain complex IV assembly; P:respiratory gaseous exchange by respiratory system;|Q7KZN9 A8K6I9 O60556 O75878 Q5TD00 Q5TD01 Q7Z3Q3 Q9NTN0,Cytochrome c oxidase assembly protein COX15 homolog,, PF02628;, GO:0070069;GO:0016021;GO:0005743;GO:0005746;GO:0005739;GO:0005654;GO:0004129;GO:0020037;GO:0060090;GO:0016653;GO:0016627;GO:0045333;GO:0006784;GO:0006783;GO:0006123;GO:1902600;GO:0008535;GO:0007585;, C:cytochrome complex; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion; C:nucleoplasm;, F:cytochrome-c oxidase activity; F:heme binding; F:molecular adaptor activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:cellular respiration; P:heme A biosynthetic process; P:heme biosynthetic process; P:mitochondrial electron transport, cytochrome c to oxygen; P:proton transmembrane transport; P:respiratory chain complex IV assembly; P:respiratory gaseous exchange by respiratory system;|Q7KZN9 A8K6I9 O60556 O75878 Q5TD00 Q5TD01 Q7Z3Q3 Q9NTN0,Cytochrome c oxidase assembly protein COX15 homolog,, PF02628;, GO:0070069;GO:0016021;GO:0005743;GO:0005746;GO:0005739;GO:0005654;GO:0004129;GO:0020037;GO:0060090;GO:0016653;GO:0016627;GO:0045333;GO:0006784;GO:0006783;GO:0006123;GO:1902600;GO:0008535;GO:0007585;, C:cytochrome complex; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion; C:nucleoplasm;, F:cytochrome-c oxidase activity; F:heme binding; F:molecular adaptor activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:cellular respiration; P:heme A biosynthetic process; P:heme biosynthetic process; P:mitochondrial electron transport, cytochrome c to oxygen; P:proton transmembrane transport; P:respiratory chain complex IV assembly; P:respiratory gaseous exchange by respiratory system;|Q7KZN9 A8K6I9 O60556 O75878 Q5TD00 Q5TD01 Q7Z3Q3 Q9NTN0,Cytochrome c oxidase assembly protein COX15 homolog,, PF02628;, GO:0070069;GO:0016021;GO:0005743;GO:0005746;GO:0005739;GO:0005654;GO:0004129;GO:0020037;GO:0060090;GO:0016653;GO:0016627;GO:0045333;GO:0006784;GO:0006783;GO:0006123;GO:1902600;GO:0008535;GO:0007585;, C:cytochrome complex; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrion; C:nucleoplasm;, F:cytochrome-c oxidase activity; F:heme binding; F:molecular adaptor activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:cellular respiration; P:heme A biosynthetic process; P:heme biosynthetic process; P:mitochondrial electron transport, cytochrome c to oxygen; P:proton transmembrane transport; P:respiratory chain complex IV assembly; P:respiratory gaseous exchange by respiratory system; scaffold18 indexed_genome mRNA 4602574 4635539 . + . ID=transcript_4394;Q9NTM9 Q5TCZ8 Q9Y321,Copper homeostasis protein cutC homolog,, PF03932;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005507;GO:0055070;GO:0006825;GO:0051262;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:copper ion binding;, P:copper ion homeostasis; P:copper ion transport; P:protein tetramerization;|Q9NTM9 Q5TCZ8 Q9Y321,Copper homeostasis protein cutC homolog,, PF03932;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005507;GO:0055070;GO:0006825;GO:0051262;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:copper ion binding;, P:copper ion homeostasis; P:copper ion transport; P:protein tetramerization; scaffold18 indexed_genome mRNA 4663113 4736152 . + . ID=transcript_4395;Q92887 B2RMT8 Q14022 Q5T2B1 Q92500 Q92798 Q99663 Q9UMS2,ATP-binding cassette sub-family C member 2,Canalicular multidrug resistance protein;Canalicular multispecific organic anion transporter 1 {ECO:0000305};Multidrug resistance-associated protein 2;, PF00664;PF00005;, GO:0016324;GO:0031526;GO:0009986;GO:0005887;GO:0046581;GO:0046691;GO:0016020;GO:0005886;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015127;GO:0008514;GO:0019904;GO:0042910;GO:1901086;GO:0015721;GO:0038183;GO:0015723;GO:0015722;GO:0030644;GO:0071549;GO:0035690;GO:0071347;GO:0071354;GO:0071222;GO:0071356;GO:0046618;GO:0006855;GO:0007565;GO:0042167;GO:0006954;GO:0071716;GO:0015694;GO:0010629;GO:0015732;GO:0120188;GO:1904486;GO:0097327;GO:0046685;GO:0032355;GO:0043627;GO:0033762;GO:0009408;GO:0031427;GO:0006979;GO:0070327;GO:0070633;GO:0055085;GO:0150104;GO:0042178;GO:1990961;GO:1990962;, C:apical plasma membrane; C:brush border membrane; C:cell surface; C:integral component of plasma membrane; C:intercellular canaliculus; C:intracellular canaliculus; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bilirubin transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:protein domain specific binding; F:xenobiotic transmembrane transporter activity;, P:benzylpenicillin metabolic process; P:bile acid and bile salt transport; P:bile acid signaling pathway; P:bilirubin transport; P:canalicular bile acid transport; P:cellular chloride ion homeostasis; P:cellular response to dexamethasone stimulus; P:cellular response to drug; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:drug export; P:drug transmembrane transport; P:female pregnancy; P:heme catabolic process; P:inflammatory response; P:leukotriene transport; P:mercury ion transport; P:negative regulation of gene expression; P:prostaglandin transport; P:regulation of bile acid secretion; P:response to 17alpha-ethynylestradiol; P:response to antineoplastic agent; P:response to arsenic-containing substance; P:response to estradiol; P:response to estrogen; P:response to glucagon; P:response to heat; P:response to methotrexate; P:response to oxidative stress; P:thyroid hormone transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic catabolic process; P:xenobiotic detoxification by transmembrane export across the plasma membrane; P:xenobiotic transport across blood-brain barrier;|Q92887 B2RMT8 Q14022 Q5T2B1 Q92500 Q92798 Q99663 Q9UMS2,ATP-binding cassette sub-family C member 2,Canalicular multidrug resistance protein;Canalicular multispecific organic anion transporter 1 {ECO:0000305};Multidrug resistance-associated protein 2;, PF00664;PF00005;, GO:0016324;GO:0031526;GO:0009986;GO:0005887;GO:0046581;GO:0046691;GO:0016020;GO:0005886;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015127;GO:0008514;GO:0019904;GO:0042910;GO:1901086;GO:0015721;GO:0038183;GO:0015723;GO:0015722;GO:0030644;GO:0071549;GO:0035690;GO:0071347;GO:0071354;GO:0071222;GO:0071356;GO:0046618;GO:0006855;GO:0007565;GO:0042167;GO:0006954;GO:0071716;GO:0015694;GO:0010629;GO:0015732;GO:0120188;GO:1904486;GO:0097327;GO:0046685;GO:0032355;GO:0043627;GO:0033762;GO:0009408;GO:0031427;GO:0006979;GO:0070327;GO:0070633;GO:0055085;GO:0150104;GO:0042178;GO:1990961;GO:1990962;, C:apical plasma membrane; C:brush border membrane; C:cell surface; C:integral component of plasma membrane; C:intercellular canaliculus; C:intracellular canaliculus; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:bilirubin transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:protein domain specific binding; F:xenobiotic transmembrane transporter activity;, P:benzylpenicillin metabolic process; P:bile acid and bile salt transport; P:bile acid signaling pathway; P:bilirubin transport; P:canalicular bile acid transport; P:cellular chloride ion homeostasis; P:cellular response to dexamethasone stimulus; P:cellular response to drug; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:drug export; P:drug transmembrane transport; P:female pregnancy; P:heme catabolic process; P:inflammatory response; P:leukotriene transport; P:mercury ion transport; P:negative regulation of gene expression; P:prostaglandin transport; P:regulation of bile acid secretion; P:response to 17alpha-ethynylestradiol; P:response to antineoplastic agent; P:response to arsenic-containing substance; P:response to estradiol; P:response to estrogen; P:response to glucagon; P:response to heat; P:response to methotrexate; P:response to oxidative stress; P:thyroid hormone transport; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic catabolic process; P:xenobiotic detoxification by transmembrane export across the plasma membrane; P:xenobiotic transport across blood-brain barrier; scaffold18 indexed_genome mRNA 4738569 4739646 . + . ID=transcript_4396;Q15417 B4DFK6 B4DP09 F8WA86 Q6FHA7,Calponin-3,Calponin, acidic isoform;, PF00402;PF00307;, GO:0015629;GO:0005912;GO:0005829;GO:0043197;GO:0005925;GO:0043025;GO:0014069;GO:0003779;GO:0098641;GO:0005516;GO:0008017;GO:0031032;GO:0030855;GO:0032780;, C:actin cytoskeleton; C:adherens junction; C:cytosol; C:dendritic spine; C:focal adhesion; C:neuronal cell body; C:postsynaptic density;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:calmodulin binding; F:microtubule binding;, P:actomyosin structure organization; P:epithelial cell differentiation; P:negative regulation of ATPase activity; scaffold18 indexed_genome mRNA 4741943 4744310 . + . ID=transcript_4397;Q6IPT4 B7ZBS4 Q8NF25,NADH-cytochrome b5 reductase-like,, PF00970;PF00175;PF09791;, GO:0005789;GO:0005654;GO:0004128;GO:0015701;, C:endoplasmic reticulum membrane; C:nucleoplasm;, F:cytochrome-b5 reductase activity, acting on NAD(P)H;, P:bicarbonate transport; scaffold18 indexed_genome mRNA 4746956 5295307 . - . ID=transcript_4398;Q6XZF7 Q8IVY3 Q9Y2L3,Dynamin-binding protein {ECO:0000312|HGNC:HGNC:30373},Scaffold protein Tuba {ECO:0000305|PubMed:14506234};, PF03114;PF00621;PF00018;PF07653;PF14604;, GO:0005911;GO:0005856;GO:0005794;GO:0005795;GO:0098793;GO:0045202;GO:0005085;GO:0007568;GO:0035556;GO:0008360;, C:cell-cell junction; C:cytoskeleton; C:Golgi apparatus; C:Golgi stack; C:presynapse; C:synapse;, F:guanyl-nucleotide exchange factor activity;, P:aging; P:intracellular signal transduction; P:regulation of cell shape;|Q6XZF7 Q8IVY3 Q9Y2L3,Dynamin-binding protein {ECO:0000312|HGNC:HGNC:30373},Scaffold protein Tuba {ECO:0000305|PubMed:14506234};, PF03114;PF00621;PF00018;PF07653;PF14604;, GO:0005911;GO:0005856;GO:0005794;GO:0005795;GO:0098793;GO:0045202;GO:0005085;GO:0007568;GO:0035556;GO:0008360;, C:cell-cell junction; C:cytoskeleton; C:Golgi apparatus; C:Golgi stack; C:presynapse; C:synapse;, F:guanyl-nucleotide exchange factor activity;, P:aging; P:intracellular signal transduction; P:regulation of cell shape;|Q6XZF7 Q8IVY3 Q9Y2L3,Dynamin-binding protein {ECO:0000312|HGNC:HGNC:30373},Scaffold protein Tuba {ECO:0000305|PubMed:14506234};, PF03114;PF00621;PF00018;PF07653;PF14604;, GO:0005911;GO:0005856;GO:0005794;GO:0005795;GO:0098793;GO:0045202;GO:0005085;GO:0007568;GO:0035556;GO:0008360;, C:cell-cell junction; C:cytoskeleton; C:Golgi apparatus; C:Golgi stack; C:presynapse; C:synapse;, F:guanyl-nucleotide exchange factor activity;, P:aging; P:intracellular signal transduction; P:regulation of cell shape;|O95169 A8K0L4 Q5W143 Q5W144 Q5W145 Q9UG53 Q9UJR4 Q9UQF3,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial,Complex I-ASHI;NADH-ubiquinone oxidoreductase ASHI subunit;, PF05821;, GO:0005783;GO:0016021;GO:0005743;GO:0005759;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:endoplasmic reticulum; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|Q6XZF7 Q8IVY3 Q9Y2L3,Dynamin-binding protein {ECO:0000312|HGNC:HGNC:30373},Scaffold protein Tuba {ECO:0000305|PubMed:14506234};, PF03114;PF00621;PF00018;PF07653;PF14604;, GO:0005911;GO:0005856;GO:0005794;GO:0005795;GO:0098793;GO:0045202;GO:0005085;GO:0007568;GO:0035556;GO:0008360;, C:cell-cell junction; C:cytoskeleton; C:Golgi apparatus; C:Golgi stack; C:presynapse; C:synapse;, F:guanyl-nucleotide exchange factor activity;, P:aging; P:intracellular signal transduction; P:regulation of cell shape;|P15169 B1AP59,Carboxypeptidase N catalytic chain,Anaphylatoxin inactivator;Arginine carboxypeptidase;Carboxypeptidase N polypeptide 1;Carboxypeptidase N small subunit;Kininase-1;Lysine carboxypeptidase;Plasma carboxypeptidase B;Serum carboxypeptidase N;, PF00246;, GO:0005576;GO:0005615;GO:0004181;GO:0008270;GO:0010815;GO:0006518;GO:0016485;GO:0030449;GO:0051384;, C:extracellular region; C:extracellular space;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:bradykinin catabolic process; P:peptide metabolic process; P:protein processing; P:regulation of complement activation; P:response to glucocorticoid;|P33261 P33259 Q8WZB1 Q8WZB2 Q9UCD4,Cytochrome P450 2C19,(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC17;CYPIIC19;Cytochrome P450-11A;Cytochrome P450-254C;Fenbendazole monooxygenase (4'-hydroxylating) {ECO:0000305};Mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0019825;GO:0008395;GO:0017144;GO:0019373;GO:0042738;GO:0046483;GO:0016098;GO:0097267;GO:0006082;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P33261 P33259 Q8WZB1 Q8WZB2 Q9UCD4,Cytochrome P450 2C19,(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC17;CYPIIC19;Cytochrome P450-11A;Cytochrome P450-254C;Fenbendazole monooxygenase (4'-hydroxylating) {ECO:0000305};Mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0019825;GO:0008395;GO:0017144;GO:0019373;GO:0042738;GO:0046483;GO:0016098;GO:0097267;GO:0006082;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P10632 A8K9N8 B0AZN2 B7Z1F6 Q5VX93 Q8WWB1 Q9UCZ9,Cytochrome P450 2C8 {ECO:0000303|PubMed:26427316},CYPIIC8;Cytochrome P450 IIC2;Cytochrome P450 MP-12;Cytochrome P450 MP-20;Cytochrome P450 form 1;S-mephenytoin 4-hydroxylase;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0034875;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0008401;GO:0008395;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046456;GO:0002933;GO:0042759;GO:0097267;GO:0006082;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:caffeine oxidase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity;, P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:icosanoid biosynthetic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|O75477 B0QZ42 D3DR65 Q53HV0,Erlin-1 {ECO:0000303|PubMed:16835267},Endoplasmic reticulum lipid raft-associated protein 1;Protein KE04 {ECO:0000305|PubMed:11118313};Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1;, PF01145;, GO:0005783;GO:0005789;GO:0016021;GO:0032991;GO:0015485;GO:0031625;GO:0008203;GO:0045541;GO:0045717;GO:0032933;GO:0055085;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, F:cholesterol binding; F:ubiquitin protein ligase binding;, P:cholesterol metabolic process; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of fatty acid biosynthetic process; P:SREBP signaling pathway; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|O75477 B0QZ42 D3DR65 Q53HV0,Erlin-1 {ECO:0000303|PubMed:16835267},Endoplasmic reticulum lipid raft-associated protein 1;Protein KE04 {ECO:0000305|PubMed:11118313};Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1;, PF01145;, GO:0005783;GO:0005789;GO:0016021;GO:0032991;GO:0015485;GO:0031625;GO:0008203;GO:0045541;GO:0045717;GO:0032933;GO:0055085;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, F:cholesterol binding; F:ubiquitin protein ligase binding;, P:cholesterol metabolic process; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of fatty acid biosynthetic process; P:SREBP signaling pathway; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|O75477 B0QZ42 D3DR65 Q53HV0,Erlin-1 {ECO:0000303|PubMed:16835267},Endoplasmic reticulum lipid raft-associated protein 1;Protein KE04 {ECO:0000305|PubMed:11118313};Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1;, PF01145;, GO:0005783;GO:0005789;GO:0016021;GO:0032991;GO:0015485;GO:0031625;GO:0008203;GO:0045541;GO:0045717;GO:0032933;GO:0055085;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, F:cholesterol binding; F:ubiquitin protein ligase binding;, P:cholesterol metabolic process; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of fatty acid biosynthetic process; P:SREBP signaling pathway; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|O75477 B0QZ42 D3DR65 Q53HV0,Erlin-1 {ECO:0000303|PubMed:16835267},Endoplasmic reticulum lipid raft-associated protein 1;Protein KE04 {ECO:0000305|PubMed:11118313};Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1;, PF01145;, GO:0005783;GO:0005789;GO:0016021;GO:0032991;GO:0015485;GO:0031625;GO:0008203;GO:0045541;GO:0045717;GO:0032933;GO:0055085;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, F:cholesterol binding; F:ubiquitin protein ligase binding;, P:cholesterol metabolic process; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of fatty acid biosynthetic process; P:SREBP signaling pathway; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|O75477 B0QZ42 D3DR65 Q53HV0,Erlin-1 {ECO:0000303|PubMed:16835267},Endoplasmic reticulum lipid raft-associated protein 1;Protein KE04 {ECO:0000305|PubMed:11118313};Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1;, PF01145;, GO:0005783;GO:0005789;GO:0016021;GO:0032991;GO:0015485;GO:0031625;GO:0008203;GO:0045541;GO:0045717;GO:0032933;GO:0055085;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, F:cholesterol binding; F:ubiquitin protein ligase binding;, P:cholesterol metabolic process; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of fatty acid biosynthetic process; P:SREBP signaling pathway; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|O15111 O14666 Q13132 Q5W0I4 Q92467,Inhibitor of nuclear factor kappa-B kinase subunit alpha,Conserved helix-loop-helix ubiquitous kinase;I-kappa-B kinase 1;Nuclear factor NF-kappa-B inhibitor kinase alpha;Transcription factor 16;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0005654;GO:0005524;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0004674;GO:0044877;GO:0097110;GO:1990459;GO:0009653;GO:0002479;GO:0071276;GO:0034614;GO:0071356;GO:0098586;GO:0038095;GO:0007249;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0032088;GO:0038061;GO:0018105;GO:0043123;GO:0032727;GO:0051092;GO:0045944;GO:0045893;GO:0006468;GO:0010803;GO:0010034;GO:0043200;GO:0061847;GO:0042493;GO:0033194;GO:0032496;GO:0009636;GO:0009615;GO:0007266;GO:0003009;GO:0002223;GO:0051403;GO:0051146;GO:0050852;GO:0035666;GO:0033209;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:nucleoplasm;, F:ATP binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine/threonine kinase activity; F:protein-containing complex binding; F:scaffold protein binding; F:transferrin receptor binding;, P:anatomical structure morphogenesis; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:cellular response to virus; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:NIK/NF-kappaB signaling; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to acetate; P:response to amino acid; P:response to cholecystokinin; P:response to drug; P:response to hydroperoxide; P:response to lipopolysaccharide; P:response to toxic substance; P:response to virus; P:Rho protein signal transduction; P:skeletal muscle contraction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:striated muscle cell differentiation; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|O15111 O14666 Q13132 Q5W0I4 Q92467,Inhibitor of nuclear factor kappa-B kinase subunit alpha,Conserved helix-loop-helix ubiquitous kinase;I-kappa-B kinase 1;Nuclear factor NF-kappa-B inhibitor kinase alpha;Transcription factor 16;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0005654;GO:0005524;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0004674;GO:0044877;GO:0097110;GO:1990459;GO:0009653;GO:0002479;GO:0071276;GO:0034614;GO:0071356;GO:0098586;GO:0038095;GO:0007249;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0032088;GO:0038061;GO:0018105;GO:0043123;GO:0032727;GO:0051092;GO:0045944;GO:0045893;GO:0006468;GO:0010803;GO:0010034;GO:0043200;GO:0061847;GO:0042493;GO:0033194;GO:0032496;GO:0009636;GO:0009615;GO:0007266;GO:0003009;GO:0002223;GO:0051403;GO:0051146;GO:0050852;GO:0035666;GO:0033209;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:nucleoplasm;, F:ATP binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine/threonine kinase activity; F:protein-containing complex binding; F:scaffold protein binding; F:transferrin receptor binding;, P:anatomical structure morphogenesis; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:cellular response to virus; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:NIK/NF-kappaB signaling; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to acetate; P:response to amino acid; P:response to cholecystokinin; P:response to drug; P:response to hydroperoxide; P:response to lipopolysaccharide; P:response to toxic substance; P:response to virus; P:Rho protein signal transduction; P:skeletal muscle contraction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:striated muscle cell differentiation; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|O15111 O14666 Q13132 Q5W0I4 Q92467,Inhibitor of nuclear factor kappa-B kinase subunit alpha,Conserved helix-loop-helix ubiquitous kinase;I-kappa-B kinase 1;Nuclear factor NF-kappa-B inhibitor kinase alpha;Transcription factor 16;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0005654;GO:0005524;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0004674;GO:0044877;GO:0097110;GO:1990459;GO:0009653;GO:0002479;GO:0071276;GO:0034614;GO:0071356;GO:0098586;GO:0038095;GO:0007249;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0032088;GO:0038061;GO:0018105;GO:0043123;GO:0032727;GO:0051092;GO:0045944;GO:0045893;GO:0006468;GO:0010803;GO:0010034;GO:0043200;GO:0061847;GO:0042493;GO:0033194;GO:0032496;GO:0009636;GO:0009615;GO:0007266;GO:0003009;GO:0002223;GO:0051403;GO:0051146;GO:0050852;GO:0035666;GO:0033209;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:nucleoplasm;, F:ATP binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine/threonine kinase activity; F:protein-containing complex binding; F:scaffold protein binding; F:transferrin receptor binding;, P:anatomical structure morphogenesis; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:cellular response to virus; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:NIK/NF-kappaB signaling; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to acetate; P:response to amino acid; P:response to cholecystokinin; P:response to drug; P:response to hydroperoxide; P:response to lipopolysaccharide; P:response to toxic substance; P:response to virus; P:Rho protein signal transduction; P:skeletal muscle contraction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:striated muscle cell differentiation; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|O15111 O14666 Q13132 Q5W0I4 Q92467,Inhibitor of nuclear factor kappa-B kinase subunit alpha,Conserved helix-loop-helix ubiquitous kinase;I-kappa-B kinase 1;Nuclear factor NF-kappa-B inhibitor kinase alpha;Transcription factor 16;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0005654;GO:0005524;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0004674;GO:0044877;GO:0097110;GO:1990459;GO:0009653;GO:0002479;GO:0071276;GO:0034614;GO:0071356;GO:0098586;GO:0038095;GO:0007249;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0032088;GO:0038061;GO:0018105;GO:0043123;GO:0032727;GO:0051092;GO:0045944;GO:0045893;GO:0006468;GO:0010803;GO:0010034;GO:0043200;GO:0061847;GO:0042493;GO:0033194;GO:0032496;GO:0009636;GO:0009615;GO:0007266;GO:0003009;GO:0002223;GO:0051403;GO:0051146;GO:0050852;GO:0035666;GO:0033209;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:nucleoplasm;, F:ATP binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine/threonine kinase activity; F:protein-containing complex binding; F:scaffold protein binding; F:transferrin receptor binding;, P:anatomical structure morphogenesis; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:cellular response to virus; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:NIK/NF-kappaB signaling; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to acetate; P:response to amino acid; P:response to cholecystokinin; P:response to drug; P:response to hydroperoxide; P:response to lipopolysaccharide; P:response to toxic substance; P:response to virus; P:Rho protein signal transduction; P:skeletal muscle contraction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:striated muscle cell differentiation; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|O15111 O14666 Q13132 Q5W0I4 Q92467,Inhibitor of nuclear factor kappa-B kinase subunit alpha,Conserved helix-loop-helix ubiquitous kinase;I-kappa-B kinase 1;Nuclear factor NF-kappa-B inhibitor kinase alpha;Transcription factor 16;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0005654;GO:0005524;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0004674;GO:0044877;GO:0097110;GO:1990459;GO:0009653;GO:0002479;GO:0071276;GO:0034614;GO:0071356;GO:0098586;GO:0038095;GO:0007249;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0032088;GO:0038061;GO:0018105;GO:0043123;GO:0032727;GO:0051092;GO:0045944;GO:0045893;GO:0006468;GO:0010803;GO:0010034;GO:0043200;GO:0061847;GO:0042493;GO:0033194;GO:0032496;GO:0009636;GO:0009615;GO:0007266;GO:0003009;GO:0002223;GO:0051403;GO:0051146;GO:0050852;GO:0035666;GO:0033209;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:nucleoplasm;, F:ATP binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine/threonine kinase activity; F:protein-containing complex binding; F:scaffold protein binding; F:transferrin receptor binding;, P:anatomical structure morphogenesis; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:cellular response to virus; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:NIK/NF-kappaB signaling; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to acetate; P:response to amino acid; P:response to cholecystokinin; P:response to drug; P:response to hydroperoxide; P:response to lipopolysaccharide; P:response to toxic substance; P:response to virus; P:Rho protein signal transduction; P:skeletal muscle contraction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:striated muscle cell differentiation; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q69YN2 B4DHX1 D3DR66 Q5W0I3 Q96HC3 Q9H865 Q9NV13,CWF19-like protein 1,, PF04677;PF04676;, GO:0071014;GO:0061632;GO:0000398;, C:post-mRNA release spliceosomal complex;, F:RNA lariat debranching enzyme activator activity;, P:mRNA splicing, via spliceosome;|Q69YN2 B4DHX1 D3DR66 Q5W0I3 Q96HC3 Q9H865 Q9NV13,CWF19-like protein 1,, PF04677;PF04676;, GO:0071014;GO:0061632;GO:0000398;, C:post-mRNA release spliceosomal complex;, F:RNA lariat debranching enzyme activator activity;, P:mRNA splicing, via spliceosome;|Q69YN2 B4DHX1 D3DR66 Q5W0I3 Q96HC3 Q9H865 Q9NV13,CWF19-like protein 1,, PF04677;PF04676;, GO:0071014;GO:0061632;GO:0000398;, C:post-mRNA release spliceosomal complex;, F:RNA lariat debranching enzyme activator activity;, P:mRNA splicing, via spliceosome;|Q69YN2 B4DHX1 D3DR66 Q5W0I3 Q96HC3 Q9H865 Q9NV13,CWF19-like protein 1,, PF04677;PF04676;, GO:0071014;GO:0061632;GO:0000398;, C:post-mRNA release spliceosomal complex;, F:RNA lariat debranching enzyme activator activity;, P:mRNA splicing, via spliceosome;|Q69YN2 B4DHX1 D3DR66 Q5W0I3 Q96HC3 Q9H865 Q9NV13,CWF19-like protein 1,, PF04677;PF04676;, GO:0071014;GO:0061632;GO:0000398;, C:post-mRNA release spliceosomal complex;, F:RNA lariat debranching enzyme activator activity;, P:mRNA splicing, via spliceosome;|Q69YN2 B4DHX1 D3DR66 Q5W0I3 Q96HC3 Q9H865 Q9NV13,CWF19-like protein 1,, PF04677;PF04676;, GO:0071014;GO:0061632;GO:0000398;, C:post-mRNA release spliceosomal complex;, F:RNA lariat debranching enzyme activator activity;, P:mRNA splicing, via spliceosome;|Q69YN2 B4DHX1 D3DR66 Q5W0I3 Q96HC3 Q9H865 Q9NV13,CWF19-like protein 1,, PF04677;PF04676;, GO:0071014;GO:0061632;GO:0000398;, C:post-mRNA release spliceosomal complex;, F:RNA lariat debranching enzyme activator activity;, P:mRNA splicing, via spliceosome;|Q6QNY1 B4DQV2 Q5W040 Q8WUI8,Biogenesis of lysosome-related organelles complex 1 subunit 2,Centrosome-associated protein;, PF10046;, GO:1904115;GO:0031083;GO:0099078;GO:0005813;GO:0000930;GO:0005765;GO:0005739;GO:0005634;GO:0043015;GO:0008022;GO:0008089;GO:0048490;GO:0016197;GO:0008625;GO:0032418;GO:0032438;GO:0007020;GO:0097345;GO:0031175;GO:0060155;GO:0008284;GO:0045893;, C:axon cytoplasm; C:BLOC-1 complex; C:BORC complex; C:centrosome; C:gamma-tubulin complex; C:lysosomal membrane; C:mitochondrion; C:nucleus;, F:gamma-tubulin binding; F:protein C-terminus binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endosomal transport; P:extrinsic apoptotic signaling pathway via death domain receptors; P:lysosome localization; P:melanosome organization; P:microtubule nucleation; P:mitochondrial outer membrane permeabilization; P:neuron projection development; P:platelet dense granule organization; P:positive regulation of cell population proliferation; P:positive regulation of transcription, DNA-templated;|Q9P0L9 O75972 Q5W039 Q9UP35 Q9UPA2,Polycystic kidney disease 2-like 1 protein,Polycystin-2 homolog;Polycystin-2L1;Polycystin-L {ECO:0000303|PubMed:10517637, ECO:0000303|PubMed:9748274};Polycystin-L1;, PF08016;, GO:0034704;GO:0009986;GO:0060170;GO:0031410;GO:0005783;GO:0016021;GO:0005887;GO:0043231;GO:0016020;GO:0097730;GO:0005886;GO:0043235;GO:0051393;GO:0005227;GO:0005262;GO:0005509;GO:0015269;GO:0005261;GO:0008092;GO:0042802;GO:0051371;GO:0005272;GO:0033040;GO:0006812;GO:0071468;GO:0001581;GO:0050912;GO:0050982;GO:0098662;GO:0071805;GO:0051289;GO:0009415;GO:0050915;GO:0007224;GO:0035725;, C:calcium channel complex; C:cell surface; C:ciliary membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:non-motile cilium; C:plasma membrane; C:receptor complex;, F:alpha-actinin binding; F:calcium activated cation channel activity; F:calcium channel activity; F:calcium ion binding; F:calcium-activated potassium channel activity; F:cation channel activity; F:cytoskeletal protein binding; F:identical protein binding; F:muscle alpha-actinin binding; F:sodium channel activity; F:sour taste receptor activity;, P:cation transport; P:cellular response to acidic pH; P:detection of chemical stimulus involved in sensory perception of sour taste; P:detection of chemical stimulus involved in sensory perception of taste; P:detection of mechanical stimulus; P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:protein homotetramerization; P:response to water; P:sensory perception of sour taste; P:smoothened signaling pathway; P:sodium ion transmembrane transport;|Q9P0L9 O75972 Q5W039 Q9UP35 Q9UPA2,Polycystic kidney disease 2-like 1 protein,Polycystin-2 homolog;Polycystin-2L1;Polycystin-L {ECO:0000303|PubMed:10517637, ECO:0000303|PubMed:9748274};Polycystin-L1;, PF08016;, GO:0034704;GO:0009986;GO:0060170;GO:0031410;GO:0005783;GO:0016021;GO:0005887;GO:0043231;GO:0016020;GO:0097730;GO:0005886;GO:0043235;GO:0051393;GO:0005227;GO:0005262;GO:0005509;GO:0015269;GO:0005261;GO:0008092;GO:0042802;GO:0051371;GO:0005272;GO:0033040;GO:0006812;GO:0071468;GO:0001581;GO:0050912;GO:0050982;GO:0098662;GO:0071805;GO:0051289;GO:0009415;GO:0050915;GO:0007224;GO:0035725;, C:calcium channel complex; C:cell surface; C:ciliary membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:non-motile cilium; C:plasma membrane; C:receptor complex;, F:alpha-actinin binding; F:calcium activated cation channel activity; F:calcium channel activity; F:calcium ion binding; F:calcium-activated potassium channel activity; F:cation channel activity; F:cytoskeletal protein binding; F:identical protein binding; F:muscle alpha-actinin binding; F:sodium channel activity; F:sour taste receptor activity;, P:cation transport; P:cellular response to acidic pH; P:detection of chemical stimulus involved in sensory perception of sour taste; P:detection of chemical stimulus involved in sensory perception of taste; P:detection of mechanical stimulus; P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:protein homotetramerization; P:response to water; P:sensory perception of sour taste; P:smoothened signaling pathway; P:sodium ion transmembrane transport;|Q9BS07 Q9Y695,Stearoyl-CoA desaturase {ECO:0000303|PubMed:18765284},Acyl-CoA desaturase;Delta(9)-desaturase;Fatty acid desaturase;, , GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0005730;GO:0005506;GO:0016491;GO:0032896;GO:0004768;GO:0046949;GO:0030522;GO:1903966;GO:0120162;GO:0019216;GO:0070542;GO:0006636;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleolus;, F:iron ion binding; F:oxidoreductase activity; F:palmitoyl-CoA 9-desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:fatty-acyl-CoA biosynthetic process; P:intracellular receptor signaling pathway; P:monounsaturated fatty acid biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:regulation of lipid metabolic process; P:response to fatty acid; P:unsaturated fatty acid biosynthetic process;|Q9BS07 Q9Y695,Stearoyl-CoA desaturase {ECO:0000303|PubMed:18765284},Acyl-CoA desaturase;Delta(9)-desaturase;Fatty acid desaturase;, , GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0005730;GO:0005506;GO:0016491;GO:0032896;GO:0004768;GO:0046949;GO:0030522;GO:1903966;GO:0120162;GO:0019216;GO:0070542;GO:0006636;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleolus;, F:iron ion binding; F:oxidoreductase activity; F:palmitoyl-CoA 9-desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:fatty-acyl-CoA biosynthetic process; P:intracellular receptor signaling pathway; P:monounsaturated fatty acid biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:regulation of lipid metabolic process; P:response to fatty acid; P:unsaturated fatty acid biosynthetic process;|Q9BS07 Q9Y695,Stearoyl-CoA desaturase {ECO:0000303|PubMed:18765284},Acyl-CoA desaturase;Delta(9)-desaturase;Fatty acid desaturase;, , GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0005730;GO:0005506;GO:0016491;GO:0032896;GO:0004768;GO:0046949;GO:0030522;GO:1903966;GO:0120162;GO:0019216;GO:0070542;GO:0006636;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleolus;, F:iron ion binding; F:oxidoreductase activity; F:palmitoyl-CoA 9-desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:fatty-acyl-CoA biosynthetic process; P:intracellular receptor signaling pathway; P:monounsaturated fatty acid biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:regulation of lipid metabolic process; P:response to fatty acid; P:unsaturated fatty acid biosynthetic process;|Q9BS07 Q9Y695,Stearoyl-CoA desaturase {ECO:0000303|PubMed:18765284},Acyl-CoA desaturase;Delta(9)-desaturase;Fatty acid desaturase;, , GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0005730;GO:0005506;GO:0016491;GO:0032896;GO:0004768;GO:0046949;GO:0030522;GO:1903966;GO:0120162;GO:0019216;GO:0070542;GO:0006636;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleolus;, F:iron ion binding; F:oxidoreductase activity; F:palmitoyl-CoA 9-desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:fatty-acyl-CoA biosynthetic process; P:intracellular receptor signaling pathway; P:monounsaturated fatty acid biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:regulation of lipid metabolic process; P:response to fatty acid; P:unsaturated fatty acid biosynthetic process;|Q9BS07 Q9Y695,Stearoyl-CoA desaturase {ECO:0000303|PubMed:18765284},Acyl-CoA desaturase;Delta(9)-desaturase;Fatty acid desaturase;, , GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0005730;GO:0005506;GO:0016491;GO:0032896;GO:0004768;GO:0046949;GO:0030522;GO:1903966;GO:0120162;GO:0019216;GO:0070542;GO:0006636;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleolus;, F:iron ion binding; F:oxidoreductase activity; F:palmitoyl-CoA 9-desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:fatty-acyl-CoA biosynthetic process; P:intracellular receptor signaling pathway; P:monounsaturated fatty acid biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:regulation of lipid metabolic process; P:response to fatty acid; P:unsaturated fatty acid biosynthetic process;|Q93098 O00771 Q5VX55 Q8WYK9,Protein Wnt-8b,, PF00110;, GO:0005576;GO:0005615;GO:0005125;GO:0005109;GO:0048018;GO:1904886;GO:0060070;GO:0045165;GO:0071300;GO:0048263;GO:0007369;GO:0007399;GO:0030182;GO:0032355;GO:0032526;GO:0007165;GO:0016055;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:frizzled binding; F:receptor ligand activity;, P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:cell fate commitment; P:cellular response to retinoic acid; P:determination of dorsal identity; P:gastrulation; P:nervous system development; P:neuron differentiation; P:response to estradiol; P:response to retinoic acid; P:signal transduction; P:Wnt signaling pathway;|Q93098 O00771 Q5VX55 Q8WYK9,Protein Wnt-8b,, PF00110;, GO:0005576;GO:0005615;GO:0005125;GO:0005109;GO:0048018;GO:1904886;GO:0060070;GO:0045165;GO:0071300;GO:0048263;GO:0007369;GO:0007399;GO:0030182;GO:0032355;GO:0032526;GO:0007165;GO:0016055;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:frizzled binding; F:receptor ligand activity;, P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:cell fate commitment; P:cellular response to retinoic acid; P:determination of dorsal identity; P:gastrulation; P:nervous system development; P:neuron differentiation; P:response to estradiol; P:response to retinoic acid; P:signal transduction; P:Wnt signaling pathway;|Q9H1J5 Q96S51,Protein Wnt-8a,Protein Wnt-8d;, PF00110;, GO:0062023;GO:0005576;GO:0005615;GO:0005125;GO:0005109;GO:0048018;GO:0009948;GO:1904886;GO:0060070;GO:0061317;GO:0044335;GO:0045165;GO:0014034;GO:0030182;GO:0045944;GO:0032526;GO:0062009;GO:0016055;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:cytokine activity; F:frizzled binding; F:receptor ligand activity;, P:anterior/posterior axis specification; P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment; P:canonical Wnt signaling pathway involved in neural crest cell differentiation; P:cell fate commitment; P:neural crest cell fate commitment; P:neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:secondary palate development; P:Wnt signaling pathway;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|Q9NQW1 B7ZM75 Q6MZS3 Q86UF0 Q9Y4Q8,Protein transport protein Sec31B,SEC31-like protein 2;SEC31-related protein B;SEC31B-1;, , GO:0030127;GO:0070971;GO:0005789;GO:0030120;GO:0005198;GO:0090110;GO:0007029;GO:0006886;, C:COPII vesicle coat; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:vesicle coat;, F:structural molecule activity;, P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:intracellular protein transport;|O95169 A8K0L4 Q5W143 Q5W144 Q5W145 Q9UG53 Q9UJR4 Q9UQF3,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial,Complex I-ASHI;NADH-ubiquinone oxidoreductase ASHI subunit;, PF05821;, GO:0005783;GO:0016021;GO:0005743;GO:0005759;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:endoplasmic reticulum; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O95169 A8K0L4 Q5W143 Q5W144 Q5W145 Q9UG53 Q9UJR4 Q9UQF3,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial,Complex I-ASHI;NADH-ubiquinone oxidoreductase ASHI subunit;, PF05821;, GO:0005783;GO:0016021;GO:0005743;GO:0005759;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:endoplasmic reticulum; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O95169 A8K0L4 Q5W143 Q5W144 Q5W145 Q9UG53 Q9UJR4 Q9UQF3,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial,Complex I-ASHI;NADH-ubiquinone oxidoreductase ASHI subunit;, PF05821;, GO:0005783;GO:0016021;GO:0005743;GO:0005759;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:endoplasmic reticulum; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold18 indexed_genome mRNA 5297277 5307573 . + . ID=transcript_4399;Q9NWT6 D3DR69 Q5W147 Q969Q7 Q9NPV5,Hypoxia-inducible factor 1-alpha inhibitor,Factor inhibiting HIF-1;Hypoxia-inducible factor asparagine hydroxylase;, PF13621;, GO:0005737;GO:0005829;GO:0005654;GO:0048471;GO:0016706;GO:0071532;GO:0031406;GO:0008198;GO:0102113;GO:0051059;GO:0005112;GO:0019826;GO:0036140;GO:0036139;GO:0042803;GO:0008270;GO:0045746;GO:0061428;GO:0042265;GO:0042264;GO:0036138;GO:0045663;GO:2001214;GO:0061418;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:2-oxoglutarate-dependent dioxygenase activity; F:ankyrin repeat binding; F:carboxylic acid binding; F:ferrous iron binding; F:hypoxia-inducible factor-asparagine oxygenase activity; F:NF-kappaB binding; F:Notch binding; F:oxygen sensor activity; F:peptidyl-asparagine 3-dioxygenase activity; F:peptidyl-histidine dioxygenase activity; F:protein homodimerization activity; F:zinc ion binding;, P:negative regulation of Notch signaling pathway; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:peptidyl-asparagine hydroxylation; P:peptidyl-aspartic acid hydroxylation; P:peptidyl-histidine hydroxylation; P:positive regulation of myoblast differentiation; P:positive regulation of vasculogenesis; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia;|Q9NWT6 D3DR69 Q5W147 Q969Q7 Q9NPV5,Hypoxia-inducible factor 1-alpha inhibitor,Factor inhibiting HIF-1;Hypoxia-inducible factor asparagine hydroxylase;, PF13621;, GO:0005737;GO:0005829;GO:0005654;GO:0048471;GO:0016706;GO:0071532;GO:0031406;GO:0008198;GO:0102113;GO:0051059;GO:0005112;GO:0019826;GO:0036140;GO:0036139;GO:0042803;GO:0008270;GO:0045746;GO:0061428;GO:0042265;GO:0042264;GO:0036138;GO:0045663;GO:2001214;GO:0061418;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:2-oxoglutarate-dependent dioxygenase activity; F:ankyrin repeat binding; F:carboxylic acid binding; F:ferrous iron binding; F:hypoxia-inducible factor-asparagine oxygenase activity; F:NF-kappaB binding; F:Notch binding; F:oxygen sensor activity; F:peptidyl-asparagine 3-dioxygenase activity; F:peptidyl-histidine dioxygenase activity; F:protein homodimerization activity; F:zinc ion binding;, P:negative regulation of Notch signaling pathway; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:peptidyl-asparagine hydroxylation; P:peptidyl-aspartic acid hydroxylation; P:peptidyl-histidine hydroxylation; P:positive regulation of myoblast differentiation; P:positive regulation of vasculogenesis; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; scaffold18 indexed_genome mRNA 5484531 5558875 . + . ID=transcript_4400;Q02962 Q15105 Q15110 Q15837 Q5SZP2 Q5SZP3,Paired box protein Pax-2,, PF00292;PF12403;, GO:0034451;GO:0000785;GO:0005764;GO:0005815;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0000987;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0000976;GO:0007568;GO:0048856;GO:0007409;GO:0048854;GO:0001658;GO:0043010;GO:0001709;GO:0071364;GO:0071333;GO:0070301;GO:0071300;GO:0090102;GO:0090103;GO:0010001;GO:0042472;GO:0060231;GO:0003337;GO:0007501;GO:0001823;GO:0072205;GO:0072221;GO:0072207;GO:0072162;GO:0072075;GO:0072289;GO:0043066;GO:1900215;GO:1900218;GO:0043154;GO:0072305;GO:1900212;GO:0043069;GO:2000378;GO:0045892;GO:0072179;GO:0001843;GO:0061360;GO:0002072;GO:0021554;GO:0021631;GO:0021633;GO:0090190;GO:0050679;GO:0072108;GO:2000594;GO:0072300;GO:2000597;GO:0045944;GO:0045893;GO:0039003;GO:0048793;GO:0043491;GO:0072593;GO:0072307;GO:0035566;GO:0006357;GO:0031667;GO:0003406;GO:0048863;GO:0072189;GO:0035799;GO:0001655;GO:0021650;GO:0007601;, C:centriolar satellite; C:chromatin; C:lysosome; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:anatomical structure development; P:axonogenesis; P:brain morphogenesis; P:branching involved in ureteric bud morphogenesis; P:camera-type eye development; P:cell fate determination; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucose stimulus; P:cellular response to hydrogen peroxide; P:cellular response to retinoic acid; P:cochlea development; P:cochlea morphogenesis; P:glial cell differentiation; P:inner ear morphogenesis; P:mesenchymal to epithelial transition; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; P:mesodermal cell fate specification; P:mesonephros development; P:metanephric collecting duct development; P:metanephric distal convoluted tubule development; P:metanephric epithelium development; P:metanephric mesenchymal cell differentiation; P:metanephric mesenchyme development; P:metanephric nephron tubule formation; P:negative regulation of apoptotic process; P:negative regulation of apoptotic process involved in metanephric collecting duct development; P:negative regulation of apoptotic process involved in metanephric nephron tubule development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis; P:negative regulation of mesenchymal cell apoptotic process involved in metanephros development; P:negative regulation of programmed cell death; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of transcription, DNA-templated; P:nephric duct formation; P:neural tube closure; P:optic chiasma development; P:optic cup morphogenesis involved in camera-type eye development; P:optic nerve development; P:optic nerve morphogenesis; P:optic nerve structural organization; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of epithelial cell proliferation; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; P:positive regulation of metanephric DCT cell differentiation; P:positive regulation of metanephric glomerulus development; P:positive regulation of optic nerve formation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:pronephric field specification; P:pronephros development; P:protein kinase B signaling; P:reactive oxygen species metabolic process; P:regulation of metanephric nephron tubule epithelial cell differentiation; P:regulation of metanephros size; P:regulation of transcription by RNA polymerase II; P:response to nutrient levels; P:retinal pigment epithelium development; P:stem cell differentiation; P:ureter development; P:ureter maturation; P:urogenital system development; P:vestibulocochlear nerve formation; P:visual perception; scaffold18 indexed_genome mRNA 5639962 5670660 . - . ID=transcript_4401;Q8IX21 A8K950 B1AL17 Q5W0L8 Q6GMU6 Q9NPE8,SMC5-SMC6 complex localization factor protein 2 {ECO:0000312|HGNC:HGNC:17814},Smc5/6 localization factor 1 {ECO:0000303|PubMed:25931565};, PF14816;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0035861;GO:0044877;GO:0031625;GO:0006974;GO:0006281;GO:2000781;GO:0034184;GO:0031334;GO:1990166;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:positive regulation of double-strand break repair; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of protein-containing complex assembly; P:protein localization to site of double-strand break;|Q8IX21 A8K950 B1AL17 Q5W0L8 Q6GMU6 Q9NPE8,SMC5-SMC6 complex localization factor protein 2 {ECO:0000312|HGNC:HGNC:17814},Smc5/6 localization factor 1 {ECO:0000303|PubMed:25931565};, PF14816;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0035861;GO:0044877;GO:0031625;GO:0006974;GO:0006281;GO:2000781;GO:0034184;GO:0031334;GO:1990166;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:positive regulation of double-strand break repair; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of protein-containing complex assembly; P:protein localization to site of double-strand break; scaffold18 indexed_genome mRNA 5677151 5694700 . + . ID=transcript_4402;Q9NTN9 A1A5C6 A6NJY8 Q58EY1 Q9HCF3,Semaphorin-4G,, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9NTN9 A1A5C6 A6NJY8 Q58EY1 Q9HCF3,Semaphorin-4G,, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q96RR1 B2CQL2 Q6MZX2 Q6PJP5 Q96RR0,Twinkle protein, mitochondrial {ECO:0000305},Progressive external ophthalmoplegia 1 protein;T7 gp4-like protein with intramitochondrial nucleoid localization;T7-like mitochondrial DNA helicase;Twinkle mtDNA helicase {ECO:0000312|HGNC:HGNC:1160};, , GO:0005759;GO:0042645;GO:0005739;GO:0043139;GO:0005524;GO:0003678;GO:0042802;GO:0002020;GO:0003697;GO:0071333;GO:0006268;GO:0006264;GO:0006390;GO:0007005;GO:0034214;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:5'-3' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:identical protein binding; F:protease binding; F:single-stranded DNA binding;, P:cellular response to glucose stimulus; P:DNA unwinding involved in DNA replication; P:mitochondrial DNA replication; P:mitochondrial transcription; P:mitochondrion organization; P:protein hexamerization; scaffold18 indexed_genome mRNA 5694986 5699042 . + . ID=transcript_4403;Q96RR1 B2CQL2 Q6MZX2 Q6PJP5 Q96RR0,Twinkle protein, mitochondrial {ECO:0000305},Progressive external ophthalmoplegia 1 protein;T7 gp4-like protein with intramitochondrial nucleoid localization;T7-like mitochondrial DNA helicase;Twinkle mtDNA helicase {ECO:0000312|HGNC:HGNC:1160};, , GO:0005759;GO:0042645;GO:0005739;GO:0043139;GO:0005524;GO:0003678;GO:0042802;GO:0002020;GO:0003697;GO:0071333;GO:0006268;GO:0006264;GO:0006390;GO:0007005;GO:0034214;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:5'-3' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:identical protein binding; F:protease binding; F:single-stranded DNA binding;, P:cellular response to glucose stimulus; P:DNA unwinding involved in DNA replication; P:mitochondrial DNA replication; P:mitochondrial transcription; P:mitochondrion organization; P:protein hexamerization;|Q96RR1 B2CQL2 Q6MZX2 Q6PJP5 Q96RR0,Twinkle protein, mitochondrial {ECO:0000305},Progressive external ophthalmoplegia 1 protein;T7 gp4-like protein with intramitochondrial nucleoid localization;T7-like mitochondrial DNA helicase;Twinkle mtDNA helicase {ECO:0000312|HGNC:HGNC:1160};, , GO:0005759;GO:0042645;GO:0005739;GO:0043139;GO:0005524;GO:0003678;GO:0042802;GO:0002020;GO:0003697;GO:0071333;GO:0006268;GO:0006264;GO:0006390;GO:0007005;GO:0034214;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:5'-3' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:identical protein binding; F:protease binding; F:single-stranded DNA binding;, P:cellular response to glucose stimulus; P:DNA unwinding involved in DNA replication; P:mitochondrial DNA replication; P:mitochondrial transcription; P:mitochondrion organization; P:protein hexamerization;|Q96RR1 B2CQL2 Q6MZX2 Q6PJP5 Q96RR0,Twinkle protein, mitochondrial {ECO:0000305},Progressive external ophthalmoplegia 1 protein;T7 gp4-like protein with intramitochondrial nucleoid localization;T7-like mitochondrial DNA helicase;Twinkle mtDNA helicase {ECO:0000312|HGNC:HGNC:1160};, , GO:0005759;GO:0042645;GO:0005739;GO:0043139;GO:0005524;GO:0003678;GO:0042802;GO:0002020;GO:0003697;GO:0071333;GO:0006268;GO:0006264;GO:0006390;GO:0007005;GO:0034214;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:5'-3' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:identical protein binding; F:protease binding; F:single-stranded DNA binding;, P:cellular response to glucose stimulus; P:DNA unwinding involved in DNA replication; P:mitochondrial DNA replication; P:mitochondrial transcription; P:mitochondrion organization; P:protein hexamerization;|Q96RR1 B2CQL2 Q6MZX2 Q6PJP5 Q96RR0,Twinkle protein, mitochondrial {ECO:0000305},Progressive external ophthalmoplegia 1 protein;T7 gp4-like protein with intramitochondrial nucleoid localization;T7-like mitochondrial DNA helicase;Twinkle mtDNA helicase {ECO:0000312|HGNC:HGNC:1160};, , GO:0005759;GO:0042645;GO:0005739;GO:0043139;GO:0005524;GO:0003678;GO:0042802;GO:0002020;GO:0003697;GO:0071333;GO:0006268;GO:0006264;GO:0006390;GO:0007005;GO:0034214;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:5'-3' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:identical protein binding; F:protease binding; F:single-stranded DNA binding;, P:cellular response to glucose stimulus; P:DNA unwinding involved in DNA replication; P:mitochondrial DNA replication; P:mitochondrial transcription; P:mitochondrion organization; P:protein hexamerization; scaffold18 indexed_genome mRNA 5707041 5721750 . + . ID=transcript_4404;Q9BRK4 B1AL14 D3DR72 Q8N3I0 Q96J79 Q96JL2,Leucine zipper putative tumor suppressor 2 {ECO:0000255|HAMAP-Rule:MF_03026},Protein LAPSER1 {ECO:0000255|HAMAP-Rule:MF_03026};, , GO:0005813;GO:0005829;GO:0005874;GO:0030496;GO:0005886;GO:0031982;GO:0051013;GO:0000281;GO:0090090;GO:0008285;GO:1900181;GO:0051168;GO:0060682;GO:0051255;GO:0072197;GO:0016055;, C:centrosome; C:cytosol; C:microtubule; C:midbody; C:plasma membrane; C:vesicle;, , P:microtubule severing; P:mitotic cytokinesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of protein localization to nucleus; P:nuclear export; P:primary ureteric bud growth; P:spindle midzone assembly; P:ureter morphogenesis; P:Wnt signaling pathway;|Q9BRK4 B1AL14 D3DR72 Q8N3I0 Q96J79 Q96JL2,Leucine zipper putative tumor suppressor 2 {ECO:0000255|HAMAP-Rule:MF_03026},Protein LAPSER1 {ECO:0000255|HAMAP-Rule:MF_03026};, , GO:0005813;GO:0005829;GO:0005874;GO:0030496;GO:0005886;GO:0031982;GO:0051013;GO:0000281;GO:0090090;GO:0008285;GO:1900181;GO:0051168;GO:0060682;GO:0051255;GO:0072197;GO:0016055;, C:centrosome; C:cytosol; C:microtubule; C:midbody; C:plasma membrane; C:vesicle;, , P:microtubule severing; P:mitotic cytokinesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of protein localization to nucleus; P:nuclear export; P:primary ureteric bud growth; P:spindle midzone assembly; P:ureter morphogenesis; P:Wnt signaling pathway;|Q9Y250 D3DSQ6 Q9Y5V7 Q9Y5V8 Q9Y5V9 Q9Y5W0 Q9Y5W1 Q9Y5W2,Leucine zipper putative tumor suppressor 1,F37/esophageal cancer-related gene-coding leucine-zipper motif;Fez1;, , GO:0016324;GO:0044297;GO:0005737;GO:0043198;GO:0043197;GO:0014069;GO:0045211;GO:0008017;GO:0044772;GO:0016242;GO:0048814;GO:0048167;, C:apical plasma membrane; C:cell body; C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:postsynaptic density; C:postsynaptic membrane;, F:microtubule binding;, P:mitotic cell cycle phase transition; P:negative regulation of macroautophagy; P:regulation of dendrite morphogenesis; P:regulation of synaptic plasticity;|Q9H5P4 D5FJ77 Q8N321,PDZ domain-containing protein 7 {ECO:0000305},, PF00595;, GO:0005929;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:1990696;GO:0042802;GO:0060117;GO:0060088;GO:0050910;GO:0045184;GO:0007605;, C:cilium; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell development; P:auditory receptor cell stereocilium organization; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:sensory perception of sound;|Q9H5P4 D5FJ77 Q8N321,PDZ domain-containing protein 7 {ECO:0000305},, PF00595;, GO:0005929;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:1990696;GO:0042802;GO:0060117;GO:0060088;GO:0050910;GO:0045184;GO:0007605;, C:cilium; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell development; P:auditory receptor cell stereocilium organization; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:sensory perception of sound;|Q9H5P4 D5FJ77 Q8N321,PDZ domain-containing protein 7 {ECO:0000305},, PF00595;, GO:0005929;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:1990696;GO:0042802;GO:0060117;GO:0060088;GO:0050910;GO:0045184;GO:0007605;, C:cilium; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell development; P:auditory receptor cell stereocilium organization; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:sensory perception of sound;|Q9H5P4 D5FJ77 Q8N321,PDZ domain-containing protein 7 {ECO:0000305},, PF00595;, GO:0005929;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:1990696;GO:0042802;GO:0060117;GO:0060088;GO:0050910;GO:0045184;GO:0007605;, C:cilium; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell development; P:auditory receptor cell stereocilium organization; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:sensory perception of sound;|Q9H5P4 D5FJ77 Q8N321,PDZ domain-containing protein 7 {ECO:0000305},, PF00595;, GO:0005929;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:1990696;GO:0042802;GO:0060117;GO:0060088;GO:0050910;GO:0045184;GO:0007605;, C:cilium; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell development; P:auditory receptor cell stereocilium organization; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:sensory perception of sound;|Q9H5P4 D5FJ77 Q8N321,PDZ domain-containing protein 7 {ECO:0000305},, PF00595;, GO:0005929;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:1990696;GO:0042802;GO:0060117;GO:0060088;GO:0050910;GO:0045184;GO:0007605;, C:cilium; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell development; P:auditory receptor cell stereocilium organization; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:sensory perception of sound; scaffold18 indexed_genome mRNA 5721891 5731337 . - . ID=transcript_4405;Q9H5P4 D5FJ77 Q8N321,PDZ domain-containing protein 7 {ECO:0000305},, PF00595;, GO:0005929;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:1990696;GO:0042802;GO:0060117;GO:0060088;GO:0050910;GO:0045184;GO:0007605;, C:cilium; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell development; P:auditory receptor cell stereocilium organization; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:sensory perception of sound;|Q9H5P4 D5FJ77 Q8N321,PDZ domain-containing protein 7 {ECO:0000305},, PF00595;, GO:0005929;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:1990696;GO:0042802;GO:0060117;GO:0060088;GO:0050910;GO:0045184;GO:0007605;, C:cilium; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell development; P:auditory receptor cell stereocilium organization; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:sensory perception of sound; scaffold18 indexed_genome mRNA 5732744 5751572 . - . ID=transcript_4406;Q9BWM7 Q8NCJ0 Q9NTP4,Sideroflexin-3 {ECO:0000303|PubMed:30442778},, PF03820;, GO:0031305;GO:0005739;GO:0022889;GO:0022857;GO:1990542;GO:0006730;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:mitochondrial transmembrane transport; P:one-carbon metabolic process; P:serine import into mitochondrion;|Q9BWM7 Q8NCJ0 Q9NTP4,Sideroflexin-3 {ECO:0000303|PubMed:30442778},, PF03820;, GO:0031305;GO:0005739;GO:0022889;GO:0022857;GO:1990542;GO:0006730;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:mitochondrial transmembrane transport; P:one-carbon metabolic process; P:serine import into mitochondrion;|Q9BWM7 Q8NCJ0 Q9NTP4,Sideroflexin-3 {ECO:0000303|PubMed:30442778},, PF03820;, GO:0031305;GO:0005739;GO:0022889;GO:0022857;GO:1990542;GO:0006730;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:mitochondrial transmembrane transport; P:one-carbon metabolic process; P:serine import into mitochondrion;|Q9BWM7 Q8NCJ0 Q9NTP4,Sideroflexin-3 {ECO:0000303|PubMed:30442778},, PF03820;, GO:0031305;GO:0005739;GO:0022889;GO:0022857;GO:1990542;GO:0006730;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:mitochondrial transmembrane transport; P:one-carbon metabolic process; P:serine import into mitochondrion; scaffold18 indexed_genome mRNA 5762795 5763895 . + . ID=transcript_4407;Q96I82 D3DR74 Q6ZMB1 Q9BQ73,Kazal-type serine protease inhibitor domain-containing protein 1,, PF07679;PF00219;PF07648;, GO:0005576;GO:0005614;GO:0005520;GO:0030154;GO:0030198;GO:0007275;GO:0001503;GO:0001558;GO:0009966;, C:extracellular region; C:interstitial matrix;, F:insulin-like growth factor binding;, P:cell differentiation; P:extracellular matrix organization; P:multicellular organism development; P:ossification; P:regulation of cell growth; P:regulation of signal transduction; scaffold18 indexed_genome mRNA 5763942 5765848 . + . ID=transcript_4408;Q96I82 D3DR74 Q6ZMB1 Q9BQ73,Kazal-type serine protease inhibitor domain-containing protein 1,, PF07679;PF00219;PF07648;, GO:0005576;GO:0005614;GO:0005520;GO:0030154;GO:0030198;GO:0007275;GO:0001503;GO:0001558;GO:0009966;, C:extracellular region; C:interstitial matrix;, F:insulin-like growth factor binding;, P:cell differentiation; P:extracellular matrix organization; P:multicellular organism development; P:ossification; P:regulation of cell growth; P:regulation of signal transduction; scaffold18 indexed_genome mRNA 6012918 6187867 . + . ID=transcript_4409;Q9Y297 B5MD49 Q5W141 Q5W142 Q9Y213,F-box/WD repeat-containing protein 1A,E3RSIkappaB;Epididymis tissue protein Li 2a;F-box and WD repeats protein beta-TrCP;pIkappaBalpha-E3 receptor subunit;, PF12125;PF12937;PF00400;, GO:0005829;GO:0005654;GO:0019005;GO:0008013;GO:0016874;GO:0046983;GO:0045309;GO:1990757;GO:1990756;GO:0061630;GO:0060444;GO:0071407;GO:0038095;GO:0000086;GO:0070498;GO:0033598;GO:0043433;GO:0045879;GO:0045892;GO:0038061;GO:0042753;GO:0045862;GO:0045893;GO:1904668;GO:0043687;GO:0043161;GO:0006470;GO:0031648;GO:0070936;GO:0000209;GO:0016567;GO:0060828;GO:0042752;GO:0043122;GO:1901990;GO:0061136;GO:0048511;GO:0031146;GO:0007165;GO:0002223;GO:0051403;GO:0050852;GO:0006511;GO:0016032;GO:0016055;, C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:ligase activity; F:protein dimerization activity; F:protein phosphorylated amino acid binding; F:ubiquitin ligase activator activity; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase activity;, P:branching involved in mammary gland duct morphogenesis; P:cellular response to organic cyclic compound; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:mammary gland epithelial cell proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of circadian rhythm; P:positive regulation of proteolysis; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:protein destabilization; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:regulation of circadian rhythm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitotic cell cycle phase transition; P:regulation of proteasomal protein catabolic process; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process; P:Wnt signaling pathway;|Q9Y297 B5MD49 Q5W141 Q5W142 Q9Y213,F-box/WD repeat-containing protein 1A,E3RSIkappaB;Epididymis tissue protein Li 2a;F-box and WD repeats protein beta-TrCP;pIkappaBalpha-E3 receptor subunit;, PF12125;PF12937;PF00400;, GO:0005829;GO:0005654;GO:0019005;GO:0008013;GO:0016874;GO:0046983;GO:0045309;GO:1990757;GO:1990756;GO:0061630;GO:0060444;GO:0071407;GO:0038095;GO:0000086;GO:0070498;GO:0033598;GO:0043433;GO:0045879;GO:0045892;GO:0038061;GO:0042753;GO:0045862;GO:0045893;GO:1904668;GO:0043687;GO:0043161;GO:0006470;GO:0031648;GO:0070936;GO:0000209;GO:0016567;GO:0060828;GO:0042752;GO:0043122;GO:1901990;GO:0061136;GO:0048511;GO:0031146;GO:0007165;GO:0002223;GO:0051403;GO:0050852;GO:0006511;GO:0016032;GO:0016055;, C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:ligase activity; F:protein dimerization activity; F:protein phosphorylated amino acid binding; F:ubiquitin ligase activator activity; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase activity;, P:branching involved in mammary gland duct morphogenesis; P:cellular response to organic cyclic compound; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:mammary gland epithelial cell proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of circadian rhythm; P:positive regulation of proteolysis; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:protein destabilization; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:regulation of circadian rhythm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitotic cell cycle phase transition; P:regulation of proteasomal protein catabolic process; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process; P:Wnt signaling pathway;|Q9Y297 B5MD49 Q5W141 Q5W142 Q9Y213,F-box/WD repeat-containing protein 1A,E3RSIkappaB;Epididymis tissue protein Li 2a;F-box and WD repeats protein beta-TrCP;pIkappaBalpha-E3 receptor subunit;, PF12125;PF12937;PF00400;, GO:0005829;GO:0005654;GO:0019005;GO:0008013;GO:0016874;GO:0046983;GO:0045309;GO:1990757;GO:1990756;GO:0061630;GO:0060444;GO:0071407;GO:0038095;GO:0000086;GO:0070498;GO:0033598;GO:0043433;GO:0045879;GO:0045892;GO:0038061;GO:0042753;GO:0045862;GO:0045893;GO:1904668;GO:0043687;GO:0043161;GO:0006470;GO:0031648;GO:0070936;GO:0000209;GO:0016567;GO:0060828;GO:0042752;GO:0043122;GO:1901990;GO:0061136;GO:0048511;GO:0031146;GO:0007165;GO:0002223;GO:0051403;GO:0050852;GO:0006511;GO:0016032;GO:0016055;, C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:ligase activity; F:protein dimerization activity; F:protein phosphorylated amino acid binding; F:ubiquitin ligase activator activity; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase activity;, P:branching involved in mammary gland duct morphogenesis; P:cellular response to organic cyclic compound; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:mammary gland epithelial cell proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of circadian rhythm; P:positive regulation of proteolysis; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:protein destabilization; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:regulation of circadian rhythm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitotic cell cycle phase transition; P:regulation of proteasomal protein catabolic process; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process; P:Wnt signaling pathway;|Q9Y297 B5MD49 Q5W141 Q5W142 Q9Y213,F-box/WD repeat-containing protein 1A,E3RSIkappaB;Epididymis tissue protein Li 2a;F-box and WD repeats protein beta-TrCP;pIkappaBalpha-E3 receptor subunit;, PF12125;PF12937;PF00400;, GO:0005829;GO:0005654;GO:0019005;GO:0008013;GO:0016874;GO:0046983;GO:0045309;GO:1990757;GO:1990756;GO:0061630;GO:0060444;GO:0071407;GO:0038095;GO:0000086;GO:0070498;GO:0033598;GO:0043433;GO:0045879;GO:0045892;GO:0038061;GO:0042753;GO:0045862;GO:0045893;GO:1904668;GO:0043687;GO:0043161;GO:0006470;GO:0031648;GO:0070936;GO:0000209;GO:0016567;GO:0060828;GO:0042752;GO:0043122;GO:1901990;GO:0061136;GO:0048511;GO:0031146;GO:0007165;GO:0002223;GO:0051403;GO:0050852;GO:0006511;GO:0016032;GO:0016055;, C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:ligase activity; F:protein dimerization activity; F:protein phosphorylated amino acid binding; F:ubiquitin ligase activator activity; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase activity;, P:branching involved in mammary gland duct morphogenesis; P:cellular response to organic cyclic compound; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:mammary gland epithelial cell proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of circadian rhythm; P:positive regulation of proteolysis; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:protein destabilization; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:regulation of circadian rhythm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitotic cell cycle phase transition; P:regulation of proteasomal protein catabolic process; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process; P:Wnt signaling pathway;|Q9Y297 B5MD49 Q5W141 Q5W142 Q9Y213,F-box/WD repeat-containing protein 1A,E3RSIkappaB;Epididymis tissue protein Li 2a;F-box and WD repeats protein beta-TrCP;pIkappaBalpha-E3 receptor subunit;, PF12125;PF12937;PF00400;, GO:0005829;GO:0005654;GO:0019005;GO:0008013;GO:0016874;GO:0046983;GO:0045309;GO:1990757;GO:1990756;GO:0061630;GO:0060444;GO:0071407;GO:0038095;GO:0000086;GO:0070498;GO:0033598;GO:0043433;GO:0045879;GO:0045892;GO:0038061;GO:0042753;GO:0045862;GO:0045893;GO:1904668;GO:0043687;GO:0043161;GO:0006470;GO:0031648;GO:0070936;GO:0000209;GO:0016567;GO:0060828;GO:0042752;GO:0043122;GO:1901990;GO:0061136;GO:0048511;GO:0031146;GO:0007165;GO:0002223;GO:0051403;GO:0050852;GO:0006511;GO:0016032;GO:0016055;, C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:ligase activity; F:protein dimerization activity; F:protein phosphorylated amino acid binding; F:ubiquitin ligase activator activity; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase activity;, P:branching involved in mammary gland duct morphogenesis; P:cellular response to organic cyclic compound; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:mammary gland epithelial cell proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of circadian rhythm; P:positive regulation of proteolysis; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:protein destabilization; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:regulation of circadian rhythm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitotic cell cycle phase transition; P:regulation of proteasomal protein catabolic process; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process; P:Wnt signaling pathway;|Q9Y297 B5MD49 Q5W141 Q5W142 Q9Y213,F-box/WD repeat-containing protein 1A,E3RSIkappaB;Epididymis tissue protein Li 2a;F-box and WD repeats protein beta-TrCP;pIkappaBalpha-E3 receptor subunit;, PF12125;PF12937;PF00400;, GO:0005829;GO:0005654;GO:0019005;GO:0008013;GO:0016874;GO:0046983;GO:0045309;GO:1990757;GO:1990756;GO:0061630;GO:0060444;GO:0071407;GO:0038095;GO:0000086;GO:0070498;GO:0033598;GO:0043433;GO:0045879;GO:0045892;GO:0038061;GO:0042753;GO:0045862;GO:0045893;GO:1904668;GO:0043687;GO:0043161;GO:0006470;GO:0031648;GO:0070936;GO:0000209;GO:0016567;GO:0060828;GO:0042752;GO:0043122;GO:1901990;GO:0061136;GO:0048511;GO:0031146;GO:0007165;GO:0002223;GO:0051403;GO:0050852;GO:0006511;GO:0016032;GO:0016055;, C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:ligase activity; F:protein dimerization activity; F:protein phosphorylated amino acid binding; F:ubiquitin ligase activator activity; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase activity;, P:branching involved in mammary gland duct morphogenesis; P:cellular response to organic cyclic compound; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:interleukin-1-mediated signaling pathway; P:mammary gland epithelial cell proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of circadian rhythm; P:positive regulation of proteolysis; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:protein destabilization; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:regulation of circadian rhythm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitotic cell cycle phase transition; P:regulation of proteasomal protein catabolic process; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process; P:Wnt signaling pathway; scaffold18 indexed_genome mRNA 6208222 6321508 . - . ID=transcript_4410;Q9UGP5 D3DR76 Q5JQP5 Q6NUM2 Q9BTN8 Q9HA10 Q9HB35,DNA polymerase lambda {ECO:0000305},DNA polymerase beta-2 {ECO:0000303|PubMed:10887191};DNA polymerase kappa {ECO:0000303|Ref.1};, PF14792;PF14791;PF10391;PF14716;, GO:0005654;GO:0005634;GO:0051575;GO:0003677;GO:0003887;GO:0046872;GO:0006287;GO:0071897;GO:0006260;GO:0000724;GO:0006303;GO:0006289;GO:0016446;, C:nucleoplasm; C:nucleus;, F:5'-deoxyribose-5-phosphate lyase activity; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA replication; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:nucleotide-excision repair; P:somatic hypermutation of immunoglobulin genes;|Q9UGP5 D3DR76 Q5JQP5 Q6NUM2 Q9BTN8 Q9HA10 Q9HB35,DNA polymerase lambda {ECO:0000305},DNA polymerase beta-2 {ECO:0000303|PubMed:10887191};DNA polymerase kappa {ECO:0000303|Ref.1};, PF14792;PF14791;PF10391;PF14716;, GO:0005654;GO:0005634;GO:0051575;GO:0003677;GO:0003887;GO:0046872;GO:0006287;GO:0071897;GO:0006260;GO:0000724;GO:0006303;GO:0006289;GO:0016446;, C:nucleoplasm; C:nucleus;, F:5'-deoxyribose-5-phosphate lyase activity; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA replication; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:nucleotide-excision repair; P:somatic hypermutation of immunoglobulin genes;|Q9UGP5 D3DR76 Q5JQP5 Q6NUM2 Q9BTN8 Q9HA10 Q9HB35,DNA polymerase lambda {ECO:0000305},DNA polymerase beta-2 {ECO:0000303|PubMed:10887191};DNA polymerase kappa {ECO:0000303|Ref.1};, PF14792;PF14791;PF10391;PF14716;, GO:0005654;GO:0005634;GO:0051575;GO:0003677;GO:0003887;GO:0046872;GO:0006287;GO:0071897;GO:0006260;GO:0000724;GO:0006303;GO:0006289;GO:0016446;, C:nucleoplasm; C:nucleus;, F:5'-deoxyribose-5-phosphate lyase activity; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA replication; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:nucleotide-excision repair; P:somatic hypermutation of immunoglobulin genes;|Q9UGP5 D3DR76 Q5JQP5 Q6NUM2 Q9BTN8 Q9HA10 Q9HB35,DNA polymerase lambda {ECO:0000305},DNA polymerase beta-2 {ECO:0000303|PubMed:10887191};DNA polymerase kappa {ECO:0000303|Ref.1};, PF14792;PF14791;PF10391;PF14716;, GO:0005654;GO:0005634;GO:0051575;GO:0003677;GO:0003887;GO:0046872;GO:0006287;GO:0071897;GO:0006260;GO:0000724;GO:0006303;GO:0006289;GO:0016446;, C:nucleoplasm; C:nucleus;, F:5'-deoxyribose-5-phosphate lyase activity; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA replication; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:nucleotide-excision repair; P:somatic hypermutation of immunoglobulin genes;|Q9UGP5 D3DR76 Q5JQP5 Q6NUM2 Q9BTN8 Q9HA10 Q9HB35,DNA polymerase lambda {ECO:0000305},DNA polymerase beta-2 {ECO:0000303|PubMed:10887191};DNA polymerase kappa {ECO:0000303|Ref.1};, PF14792;PF14791;PF10391;PF14716;, GO:0005654;GO:0005634;GO:0051575;GO:0003677;GO:0003887;GO:0046872;GO:0006287;GO:0071897;GO:0006260;GO:0000724;GO:0006303;GO:0006289;GO:0016446;, C:nucleoplasm; C:nucleus;, F:5'-deoxyribose-5-phosphate lyase activity; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA replication; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:nucleotide-excision repair; P:somatic hypermutation of immunoglobulin genes;|Q9BVM2 A8K289 Q6QNL3 Q8N5R1 Q9UFY6,Protein DPCD,, PF14913;, GO:0005576;GO:0005634;GO:0007368;GO:0003351;GO:0030317;GO:0021670;GO:0060972;GO:0007283;GO:0021678;, C:extracellular region; C:nucleus;, , P:determination of left/right symmetry; P:epithelial cilium movement involved in extracellular fluid movement; P:flagellated sperm motility; P:lateral ventricle development; P:left/right pattern formation; P:spermatogenesis; P:third ventricle development;|Q9UGP5 D3DR76 Q5JQP5 Q6NUM2 Q9BTN8 Q9HA10 Q9HB35,DNA polymerase lambda {ECO:0000305},DNA polymerase beta-2 {ECO:0000303|PubMed:10887191};DNA polymerase kappa {ECO:0000303|Ref.1};, PF14792;PF14791;PF10391;PF14716;, GO:0005654;GO:0005634;GO:0051575;GO:0003677;GO:0003887;GO:0046872;GO:0006287;GO:0071897;GO:0006260;GO:0000724;GO:0006303;GO:0006289;GO:0016446;, C:nucleoplasm; C:nucleus;, F:5'-deoxyribose-5-phosphate lyase activity; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA replication; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:nucleotide-excision repair; P:somatic hypermutation of immunoglobulin genes;|Q9BVM2 A8K289 Q6QNL3 Q8N5R1 Q9UFY6,Protein DPCD,, PF14913;, GO:0005576;GO:0005634;GO:0007368;GO:0003351;GO:0030317;GO:0021670;GO:0060972;GO:0007283;GO:0021678;, C:extracellular region; C:nucleus;, , P:determination of left/right symmetry; P:epithelial cilium movement involved in extracellular fluid movement; P:flagellated sperm motility; P:lateral ventricle development; P:left/right pattern formation; P:spermatogenesis; P:third ventricle development;|Q9BVM2 A8K289 Q6QNL3 Q8N5R1 Q9UFY6,Protein DPCD,, PF14913;, GO:0005576;GO:0005634;GO:0007368;GO:0003351;GO:0030317;GO:0021670;GO:0060972;GO:0007283;GO:0021678;, C:extracellular region; C:nucleus;, , P:determination of left/right symmetry; P:epithelial cilium movement involved in extracellular fluid movement; P:flagellated sperm motility; P:lateral ventricle development; P:left/right pattern formation; P:spermatogenesis; P:third ventricle development;|P57775 Q5SVS1 Q96IM6,F-box/WD repeat-containing protein 4,Dactylin;F-box and WD-40 domain-containing protein 4;, PF12937;PF00400;, GO:0005829;GO:0019005;GO:0000151;GO:0030326;GO:0043687;GO:0000209;GO:0031146;GO:0006511;GO:0016055;, C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:embryonic limb morphogenesis; P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|P57775 Q5SVS1 Q96IM6,F-box/WD repeat-containing protein 4,Dactylin;F-box and WD-40 domain-containing protein 4;, PF12937;PF00400;, GO:0005829;GO:0019005;GO:0000151;GO:0030326;GO:0043687;GO:0000209;GO:0031146;GO:0006511;GO:0016055;, C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:embryonic limb morphogenesis; P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway; scaffold18 indexed_genome mRNA 6401167 6403547 . - . ID=transcript_4411;O75607 Q9UNY6,Nucleoplasmin-3,, PF03066;, GO:0015629;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0003682;GO:0042393;GO:0003723;GO:0006338;GO:0006364;GO:0009303;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm;, F:chromatin binding; F:histone binding; F:RNA binding;, P:chromatin remodeling; P:rRNA processing; P:rRNA transcription; scaffold18 indexed_genome mRNA 6403873 6431132 . - . ID=transcript_4412;O60502 B7WPB9 D3DR79 E9PGF9 O75166 Q86WV0 Q8IV98 Q9BVA5 Q9HAR0,Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305},Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};Beta-N-acetylhexosaminidase;Beta-hexosaminidase;Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-glucosaminidase;Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;, PF07555;, GO:0005829;GO:0016020;GO:0005634;GO:0102167;GO:0102571;GO:0102166;GO:0016231;GO:0004415;GO:0006516;GO:0009100;GO:0006044;GO:0006517;GO:0006493;GO:0016032;, C:cytosol; C:membrane; C:nucleus;, F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:beta-N-acetylglucosaminidase activity; F:hyalurononglucosaminidase activity;, P:glycoprotein catabolic process; P:glycoprotein metabolic process; P:N-acetylglucosamine metabolic process; P:protein deglycosylation; P:protein O-linked glycosylation; P:viral process;|O60502 B7WPB9 D3DR79 E9PGF9 O75166 Q86WV0 Q8IV98 Q9BVA5 Q9HAR0,Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305},Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};Beta-N-acetylhexosaminidase;Beta-hexosaminidase;Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-glucosaminidase;Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;, PF07555;, GO:0005829;GO:0016020;GO:0005634;GO:0102167;GO:0102571;GO:0102166;GO:0016231;GO:0004415;GO:0006516;GO:0009100;GO:0006044;GO:0006517;GO:0006493;GO:0016032;, C:cytosol; C:membrane; C:nucleus;, F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:beta-N-acetylglucosaminidase activity; F:hyalurononglucosaminidase activity;, P:glycoprotein catabolic process; P:glycoprotein metabolic process; P:N-acetylglucosamine metabolic process; P:protein deglycosylation; P:protein O-linked glycosylation; P:viral process;|O60502 B7WPB9 D3DR79 E9PGF9 O75166 Q86WV0 Q8IV98 Q9BVA5 Q9HAR0,Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305},Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};Beta-N-acetylhexosaminidase;Beta-hexosaminidase;Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-glucosaminidase;Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;, PF07555;, GO:0005829;GO:0016020;GO:0005634;GO:0102167;GO:0102571;GO:0102166;GO:0016231;GO:0004415;GO:0006516;GO:0009100;GO:0006044;GO:0006517;GO:0006493;GO:0016032;, C:cytosol; C:membrane; C:nucleus;, F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:beta-N-acetylglucosaminidase activity; F:hyalurononglucosaminidase activity;, P:glycoprotein catabolic process; P:glycoprotein metabolic process; P:N-acetylglucosamine metabolic process; P:protein deglycosylation; P:protein O-linked glycosylation; P:viral process;|O60502 B7WPB9 D3DR79 E9PGF9 O75166 Q86WV0 Q8IV98 Q9BVA5 Q9HAR0,Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305},Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};Beta-N-acetylhexosaminidase;Beta-hexosaminidase;Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-glucosaminidase;Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;, PF07555;, GO:0005829;GO:0016020;GO:0005634;GO:0102167;GO:0102571;GO:0102166;GO:0016231;GO:0004415;GO:0006516;GO:0009100;GO:0006044;GO:0006517;GO:0006493;GO:0016032;, C:cytosol; C:membrane; C:nucleus;, F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:beta-N-acetylglucosaminidase activity; F:hyalurononglucosaminidase activity;, P:glycoprotein catabolic process; P:glycoprotein metabolic process; P:N-acetylglucosamine metabolic process; P:protein deglycosylation; P:protein O-linked glycosylation; P:viral process;|O60502 B7WPB9 D3DR79 E9PGF9 O75166 Q86WV0 Q8IV98 Q9BVA5 Q9HAR0,Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305},Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};Beta-N-acetylhexosaminidase;Beta-hexosaminidase;Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-glucosaminidase;Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;, PF07555;, GO:0005829;GO:0016020;GO:0005634;GO:0102167;GO:0102571;GO:0102166;GO:0016231;GO:0004415;GO:0006516;GO:0009100;GO:0006044;GO:0006517;GO:0006493;GO:0016032;, C:cytosol; C:membrane; C:nucleus;, F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:beta-N-acetylglucosaminidase activity; F:hyalurononglucosaminidase activity;, P:glycoprotein catabolic process; P:glycoprotein metabolic process; P:N-acetylglucosamine metabolic process; P:protein deglycosylation; P:protein O-linked glycosylation; P:viral process;|O60502 B7WPB9 D3DR79 E9PGF9 O75166 Q86WV0 Q8IV98 Q9BVA5 Q9HAR0,Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305},Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};Beta-N-acetylhexosaminidase;Beta-hexosaminidase;Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-glucosaminidase;Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;, PF07555;, GO:0005829;GO:0016020;GO:0005634;GO:0102167;GO:0102571;GO:0102166;GO:0016231;GO:0004415;GO:0006516;GO:0009100;GO:0006044;GO:0006517;GO:0006493;GO:0016032;, C:cytosol; C:membrane; C:nucleus;, F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:beta-N-acetylglucosaminidase activity; F:hyalurononglucosaminidase activity;, P:glycoprotein catabolic process; P:glycoprotein metabolic process; P:N-acetylglucosamine metabolic process; P:protein deglycosylation; P:protein O-linked glycosylation; P:viral process;|O60502 B7WPB9 D3DR79 E9PGF9 O75166 Q86WV0 Q8IV98 Q9BVA5 Q9HAR0,Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305},Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};Beta-N-acetylhexosaminidase;Beta-hexosaminidase;Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-glucosaminidase;Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;, PF07555;, GO:0005829;GO:0016020;GO:0005634;GO:0102167;GO:0102571;GO:0102166;GO:0016231;GO:0004415;GO:0006516;GO:0009100;GO:0006044;GO:0006517;GO:0006493;GO:0016032;, C:cytosol; C:membrane; C:nucleus;, F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:beta-N-acetylglucosaminidase activity; F:hyalurononglucosaminidase activity;, P:glycoprotein catabolic process; P:glycoprotein metabolic process; P:N-acetylglucosamine metabolic process; P:protein deglycosylation; P:protein O-linked glycosylation; P:viral process;|O60502 B7WPB9 D3DR79 E9PGF9 O75166 Q86WV0 Q8IV98 Q9BVA5 Q9HAR0,Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305},Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};Beta-N-acetylhexosaminidase;Beta-hexosaminidase;Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-glucosaminidase;Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;, PF07555;, GO:0005829;GO:0016020;GO:0005634;GO:0102167;GO:0102571;GO:0102166;GO:0016231;GO:0004415;GO:0006516;GO:0009100;GO:0006044;GO:0006517;GO:0006493;GO:0016032;, C:cytosol; C:membrane; C:nucleus;, F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:beta-N-acetylglucosaminidase activity; F:hyalurononglucosaminidase activity;, P:glycoprotein catabolic process; P:glycoprotein metabolic process; P:N-acetylglucosamine metabolic process; P:protein deglycosylation; P:protein O-linked glycosylation; P:viral process;|O60502 B7WPB9 D3DR79 E9PGF9 O75166 Q86WV0 Q8IV98 Q9BVA5 Q9HAR0,Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305},Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};Beta-N-acetylhexosaminidase;Beta-hexosaminidase;Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-glucosaminidase;Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;, PF07555;, GO:0005829;GO:0016020;GO:0005634;GO:0102167;GO:0102571;GO:0102166;GO:0016231;GO:0004415;GO:0006516;GO:0009100;GO:0006044;GO:0006517;GO:0006493;GO:0016032;, C:cytosol; C:membrane; C:nucleus;, F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:beta-N-acetylglucosaminidase activity; F:hyalurononglucosaminidase activity;, P:glycoprotein catabolic process; P:glycoprotein metabolic process; P:N-acetylglucosamine metabolic process; P:protein deglycosylation; P:protein O-linked glycosylation; P:viral process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|O60502 B7WPB9 D3DR79 E9PGF9 O75166 Q86WV0 Q8IV98 Q9BVA5 Q9HAR0,Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305},Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};Beta-N-acetylhexosaminidase;Beta-hexosaminidase;Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};N-acetyl-beta-D-glucosaminidase;N-acetyl-beta-glucosaminidase;Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;, PF07555;, GO:0005829;GO:0016020;GO:0005634;GO:0102167;GO:0102571;GO:0102166;GO:0016231;GO:0004415;GO:0006516;GO:0009100;GO:0006044;GO:0006517;GO:0006493;GO:0016032;, C:cytosol; C:membrane; C:nucleus;, F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; F:beta-N-acetylglucosaminidase activity; F:hyalurononglucosaminidase activity;, P:glycoprotein catabolic process; P:glycoprotein metabolic process; P:N-acetylglucosamine metabolic process; P:protein deglycosylation; P:protein O-linked glycosylation; P:viral process; scaffold18 indexed_genome mRNA 6437731 6442223 . - . ID=transcript_4413;Q96T42 Q96T43 Q96T44 Q9H0N4 Q9HD10 Q9HD11 Q9NS60 Q9NY10 Q9NZI1,Kv channel-interacting protein 2,A-type potassium channel modulatory protein 2;Cardiac voltage-gated potassium channel modulatory subunit;Potassium channel-interacting protein 2;, PF13499;PF13833;, GO:0005737;GO:0005886;GO:0034705;GO:0045202;GO:0008076;GO:0005509;GO:0046923;GO:0042802;GO:0044325;GO:0005267;GO:0015459;GO:0047485;GO:0005244;GO:0061337;GO:0007268;GO:0045163;GO:0005513;GO:0086009;GO:0086013;GO:0006936;GO:1903766;GO:1903818;GO:0097623;GO:0006813;GO:0008016;GO:1901379;GO:0007165;, C:cytoplasm; C:plasma membrane; C:potassium channel complex; C:synapse; C:voltage-gated potassium channel complex;, F:calcium ion binding; F:ER retention sequence binding; F:identical protein binding; F:ion channel binding; F:potassium channel activity; F:potassium channel regulator activity; F:protein N-terminus binding; F:voltage-gated ion channel activity;, P:cardiac conduction; P:chemical synaptic transmission; P:clustering of voltage-gated potassium channels; P:detection of calcium ion; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:muscle contraction; P:positive regulation of potassium ion export across plasma membrane; P:positive regulation of voltage-gated potassium channel activity; P:potassium ion export across plasma membrane; P:potassium ion transport; P:regulation of heart contraction; P:regulation of potassium ion transmembrane transport; P:signal transduction;|Q96T42 Q96T43 Q96T44 Q9H0N4 Q9HD10 Q9HD11 Q9NS60 Q9NY10 Q9NZI1,Kv channel-interacting protein 2,A-type potassium channel modulatory protein 2;Cardiac voltage-gated potassium channel modulatory subunit;Potassium channel-interacting protein 2;, PF13499;PF13833;, GO:0005737;GO:0005886;GO:0034705;GO:0045202;GO:0008076;GO:0005509;GO:0046923;GO:0042802;GO:0044325;GO:0005267;GO:0015459;GO:0047485;GO:0005244;GO:0061337;GO:0007268;GO:0045163;GO:0005513;GO:0086009;GO:0086013;GO:0006936;GO:1903766;GO:1903818;GO:0097623;GO:0006813;GO:0008016;GO:1901379;GO:0007165;, C:cytoplasm; C:plasma membrane; C:potassium channel complex; C:synapse; C:voltage-gated potassium channel complex;, F:calcium ion binding; F:ER retention sequence binding; F:identical protein binding; F:ion channel binding; F:potassium channel activity; F:potassium channel regulator activity; F:protein N-terminus binding; F:voltage-gated ion channel activity;, P:cardiac conduction; P:chemical synaptic transmission; P:clustering of voltage-gated potassium channels; P:detection of calcium ion; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:muscle contraction; P:positive regulation of potassium ion export across plasma membrane; P:positive regulation of voltage-gated potassium channel activity; P:potassium ion export across plasma membrane; P:potassium ion transport; P:regulation of heart contraction; P:regulation of potassium ion transmembrane transport; P:signal transduction;|Q96T42 Q96T43 Q96T44 Q9H0N4 Q9HD10 Q9HD11 Q9NS60 Q9NY10 Q9NZI1,Kv channel-interacting protein 2,A-type potassium channel modulatory protein 2;Cardiac voltage-gated potassium channel modulatory subunit;Potassium channel-interacting protein 2;, PF13499;PF13833;, GO:0005737;GO:0005886;GO:0034705;GO:0045202;GO:0008076;GO:0005509;GO:0046923;GO:0042802;GO:0044325;GO:0005267;GO:0015459;GO:0047485;GO:0005244;GO:0061337;GO:0007268;GO:0045163;GO:0005513;GO:0086009;GO:0086013;GO:0006936;GO:1903766;GO:1903818;GO:0097623;GO:0006813;GO:0008016;GO:1901379;GO:0007165;, C:cytoplasm; C:plasma membrane; C:potassium channel complex; C:synapse; C:voltage-gated potassium channel complex;, F:calcium ion binding; F:ER retention sequence binding; F:identical protein binding; F:ion channel binding; F:potassium channel activity; F:potassium channel regulator activity; F:protein N-terminus binding; F:voltage-gated ion channel activity;, P:cardiac conduction; P:chemical synaptic transmission; P:clustering of voltage-gated potassium channels; P:detection of calcium ion; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:muscle contraction; P:positive regulation of potassium ion export across plasma membrane; P:positive regulation of voltage-gated potassium channel activity; P:potassium ion export across plasma membrane; P:potassium ion transport; P:regulation of heart contraction; P:regulation of potassium ion transmembrane transport; P:signal transduction; scaffold18 indexed_genome mRNA 6442245 6445462 . + . ID=transcript_4414;Q96T42 Q96T43 Q96T44 Q9H0N4 Q9HD10 Q9HD11 Q9NS60 Q9NY10 Q9NZI1,Kv channel-interacting protein 2,A-type potassium channel modulatory protein 2;Cardiac voltage-gated potassium channel modulatory subunit;Potassium channel-interacting protein 2;, PF13499;PF13833;, GO:0005737;GO:0005886;GO:0034705;GO:0045202;GO:0008076;GO:0005509;GO:0046923;GO:0042802;GO:0044325;GO:0005267;GO:0015459;GO:0047485;GO:0005244;GO:0061337;GO:0007268;GO:0045163;GO:0005513;GO:0086009;GO:0086013;GO:0006936;GO:1903766;GO:1903818;GO:0097623;GO:0006813;GO:0008016;GO:1901379;GO:0007165;, C:cytoplasm; C:plasma membrane; C:potassium channel complex; C:synapse; C:voltage-gated potassium channel complex;, F:calcium ion binding; F:ER retention sequence binding; F:identical protein binding; F:ion channel binding; F:potassium channel activity; F:potassium channel regulator activity; F:protein N-terminus binding; F:voltage-gated ion channel activity;, P:cardiac conduction; P:chemical synaptic transmission; P:clustering of voltage-gated potassium channels; P:detection of calcium ion; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:muscle contraction; P:positive regulation of potassium ion export across plasma membrane; P:positive regulation of voltage-gated potassium channel activity; P:potassium ion export across plasma membrane; P:potassium ion transport; P:regulation of heart contraction; P:regulation of potassium ion transmembrane transport; P:signal transduction; scaffold18 indexed_genome mRNA 6458421 6636163 . - . ID=transcript_4415;Q5T2E6 Q2TB87 Q9H8Z9,Armadillo-like helical domain-containing protein 3 {ECO:0000305},, PF08427;, GO:0005829;GO:0000139;GO:0016021;GO:1903358;, C:cytosol; C:Golgi membrane; C:integral component of membrane;, , P:regulation of Golgi organization;|Q5T2E6 Q2TB87 Q9H8Z9,Armadillo-like helical domain-containing protein 3 {ECO:0000305},, PF08427;, GO:0005829;GO:0000139;GO:0016021;GO:1903358;, C:cytosol; C:Golgi membrane; C:integral component of membrane;, , P:regulation of Golgi organization;|Q5T2E6 Q2TB87 Q9H8Z9,Armadillo-like helical domain-containing protein 3 {ECO:0000305},, PF08427;, GO:0005829;GO:0000139;GO:0016021;GO:1903358;, C:cytosol; C:Golgi membrane; C:integral component of membrane;, , P:regulation of Golgi organization; scaffold18 indexed_genome mRNA 6638136 6641427 . - . ID=transcript_4416;Q86YV9 Q5VV69 Q9H685,Hermansky-Pudlak syndrome 6 protein,Ruby-eye protein homolog;, PF15702;, GO:0031084;GO:0031901;GO:0005783;GO:0005765;GO:0016020;GO:0030742;GO:0031267;GO:0007596;GO:0032418;GO:0030318;GO:0006996;GO:0072657;, C:BLOC-2 complex; C:early endosome membrane; C:endoplasmic reticulum; C:lysosomal membrane; C:membrane;, F:GTP-dependent protein binding; F:small GTPase binding;, P:blood coagulation; P:lysosome localization; P:melanocyte differentiation; P:organelle organization; P:protein localization to membrane; scaffold18 indexed_genome mRNA 6664153 6667230 . - . ID=transcript_4417;Q86U70 B4DUC4 O75479 O96010 Q1EQX1 Q9UGM4,LIM domain-binding protein 1,Carboxyl-terminal LIM domain-binding protein 2;LIM domain-binding factor CLIM2;Nuclear LIM interactor;, PF17916;PF01803;, GO:1990907;GO:0031252;GO:0000785;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0003682;GO:0003677;GO:0140297;GO:0019899;GO:0030274;GO:0042803;GO:0043621;GO:0001102;GO:0003712;GO:0009948;GO:0022607;GO:0021702;GO:0010669;GO:0001702;GO:0001942;GO:0043973;GO:0048382;GO:0007275;GO:0045647;GO:0000122;GO:0045892;GO:0007399;GO:0030182;GO:0045785;GO:0046985;GO:0045944;GO:0030334;GO:0051893;GO:1902036;GO:0043549;GO:0034243;GO:0006355;GO:0035019;GO:0006366;GO:0000972;GO:0016055;, C:beta-catenin-TCF complex; C:cell leading edge; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor binding; F:enzyme binding; F:LIM domain binding; F:protein homodimerization activity; F:protein self-association; F:RNA polymerase II activating transcription factor binding; F:transcription coregulator activity;, P:anterior/posterior axis specification; P:cellular component assembly; P:cerebellar Purkinje cell differentiation; P:epithelial structure maintenance; P:gastrulation with mouth forming second; P:hair follicle development; P:histone H3-K4 acetylation; P:mesendoderm development; P:multicellular organism development; P:negative regulation of erythrocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neuron differentiation; P:positive regulation of cell adhesion; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell migration; P:regulation of focal adhesion assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of kinase activity; P:regulation of transcription elongation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:somatic stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:Wnt signaling pathway; scaffold18 indexed_genome mRNA 6668155 6668751 . + . ID=transcript_4418;Q86U70 B4DUC4 O75479 O96010 Q1EQX1 Q9UGM4,LIM domain-binding protein 1,Carboxyl-terminal LIM domain-binding protein 2;LIM domain-binding factor CLIM2;Nuclear LIM interactor;, PF17916;PF01803;, GO:1990907;GO:0031252;GO:0000785;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0003682;GO:0003677;GO:0140297;GO:0019899;GO:0030274;GO:0042803;GO:0043621;GO:0001102;GO:0003712;GO:0009948;GO:0022607;GO:0021702;GO:0010669;GO:0001702;GO:0001942;GO:0043973;GO:0048382;GO:0007275;GO:0045647;GO:0000122;GO:0045892;GO:0007399;GO:0030182;GO:0045785;GO:0046985;GO:0045944;GO:0030334;GO:0051893;GO:1902036;GO:0043549;GO:0034243;GO:0006355;GO:0035019;GO:0006366;GO:0000972;GO:0016055;, C:beta-catenin-TCF complex; C:cell leading edge; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor binding; F:enzyme binding; F:LIM domain binding; F:protein homodimerization activity; F:protein self-association; F:RNA polymerase II activating transcription factor binding; F:transcription coregulator activity;, P:anterior/posterior axis specification; P:cellular component assembly; P:cerebellar Purkinje cell differentiation; P:epithelial structure maintenance; P:gastrulation with mouth forming second; P:hair follicle development; P:histone H3-K4 acetylation; P:mesendoderm development; P:multicellular organism development; P:negative regulation of erythrocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neuron differentiation; P:positive regulation of cell adhesion; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell migration; P:regulation of focal adhesion assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of kinase activity; P:regulation of transcription elongation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:somatic stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:Wnt signaling pathway; scaffold18 indexed_genome mRNA 6668821 6674519 . - . ID=transcript_4419;Q86U70 B4DUC4 O75479 O96010 Q1EQX1 Q9UGM4,LIM domain-binding protein 1,Carboxyl-terminal LIM domain-binding protein 2;LIM domain-binding factor CLIM2;Nuclear LIM interactor;, PF17916;PF01803;, GO:1990907;GO:0031252;GO:0000785;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0003682;GO:0003677;GO:0140297;GO:0019899;GO:0030274;GO:0042803;GO:0043621;GO:0001102;GO:0003712;GO:0009948;GO:0022607;GO:0021702;GO:0010669;GO:0001702;GO:0001942;GO:0043973;GO:0048382;GO:0007275;GO:0045647;GO:0000122;GO:0045892;GO:0007399;GO:0030182;GO:0045785;GO:0046985;GO:0045944;GO:0030334;GO:0051893;GO:1902036;GO:0043549;GO:0034243;GO:0006355;GO:0035019;GO:0006366;GO:0000972;GO:0016055;, C:beta-catenin-TCF complex; C:cell leading edge; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor binding; F:enzyme binding; F:LIM domain binding; F:protein homodimerization activity; F:protein self-association; F:RNA polymerase II activating transcription factor binding; F:transcription coregulator activity;, P:anterior/posterior axis specification; P:cellular component assembly; P:cerebellar Purkinje cell differentiation; P:epithelial structure maintenance; P:gastrulation with mouth forming second; P:hair follicle development; P:histone H3-K4 acetylation; P:mesendoderm development; P:multicellular organism development; P:negative regulation of erythrocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neuron differentiation; P:positive regulation of cell adhesion; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell migration; P:regulation of focal adhesion assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of kinase activity; P:regulation of transcription elongation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:somatic stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:Wnt signaling pathway; scaffold18 indexed_genome mRNA 6686423 6695835 . + . ID=transcript_4420;Q5VV67 Q5VV66 Q6P3U5 Q6P3W1 Q76N31 Q9BUJ3 Q9BZE5 Q9Y4E0,Peroxisome proliferator-activated receptor gamma coactivator-related protein 1,PGC-1-related coactivator;, PF00076;, GO:0005654;GO:0005634;GO:0030374;GO:0003723;GO:0008134;GO:0007005;GO:0051091;GO:0045944;, C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:RNA binding; F:transcription factor binding;, P:mitochondrion organization; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II;|Q5VV67 Q5VV66 Q6P3U5 Q6P3W1 Q76N31 Q9BUJ3 Q9BZE5 Q9Y4E0,Peroxisome proliferator-activated receptor gamma coactivator-related protein 1,PGC-1-related coactivator;, PF00076;, GO:0005654;GO:0005634;GO:0030374;GO:0003723;GO:0008134;GO:0007005;GO:0051091;GO:0045944;, C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:RNA binding; F:transcription factor binding;, P:mitochondrion organization; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; scaffold18 indexed_genome mRNA 6695879 6700674 . + . ID=transcript_4421;Q5VV67 Q5VV66 Q6P3U5 Q6P3W1 Q76N31 Q9BUJ3 Q9BZE5 Q9Y4E0,Peroxisome proliferator-activated receptor gamma coactivator-related protein 1,PGC-1-related coactivator;, PF00076;, GO:0005654;GO:0005634;GO:0030374;GO:0003723;GO:0008134;GO:0007005;GO:0051091;GO:0045944;, C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:RNA binding; F:transcription factor binding;, P:mitochondrion organization; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II;|Q5VV67 Q5VV66 Q6P3U5 Q6P3W1 Q76N31 Q9BUJ3 Q9BZE5 Q9Y4E0,Peroxisome proliferator-activated receptor gamma coactivator-related protein 1,PGC-1-related coactivator;, PF00076;, GO:0005654;GO:0005634;GO:0030374;GO:0003723;GO:0008134;GO:0007005;GO:0051091;GO:0045944;, C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:RNA binding; F:transcription factor binding;, P:mitochondrion organization; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II;|Q5VV67 Q5VV66 Q6P3U5 Q6P3W1 Q76N31 Q9BUJ3 Q9BZE5 Q9Y4E0,Peroxisome proliferator-activated receptor gamma coactivator-related protein 1,PGC-1-related coactivator;, PF00076;, GO:0005654;GO:0005634;GO:0030374;GO:0003723;GO:0008134;GO:0007005;GO:0051091;GO:0045944;, C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:RNA binding; F:transcription factor binding;, P:mitochondrion organization; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II;|Q5VV67 Q5VV66 Q6P3U5 Q6P3W1 Q76N31 Q9BUJ3 Q9BZE5 Q9Y4E0,Peroxisome proliferator-activated receptor gamma coactivator-related protein 1,PGC-1-related coactivator;, PF00076;, GO:0005654;GO:0005634;GO:0030374;GO:0003723;GO:0008134;GO:0007005;GO:0051091;GO:0045944;, C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:RNA binding; F:transcription factor binding;, P:mitochondrion organization; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II;|Q5VV67 Q5VV66 Q6P3U5 Q6P3W1 Q76N31 Q9BUJ3 Q9BZE5 Q9Y4E0,Peroxisome proliferator-activated receptor gamma coactivator-related protein 1,PGC-1-related coactivator;, PF00076;, GO:0005654;GO:0005634;GO:0030374;GO:0003723;GO:0008134;GO:0007005;GO:0051091;GO:0045944;, C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:RNA binding; F:transcription factor binding;, P:mitochondrion organization; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II;|Q5VV67 Q5VV66 Q6P3U5 Q6P3W1 Q76N31 Q9BUJ3 Q9BZE5 Q9Y4E0,Peroxisome proliferator-activated receptor gamma coactivator-related protein 1,PGC-1-related coactivator;, PF00076;, GO:0005654;GO:0005634;GO:0030374;GO:0003723;GO:0008134;GO:0007005;GO:0051091;GO:0045944;, C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:RNA binding; F:transcription factor binding;, P:mitochondrion organization; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; scaffold18 indexed_genome mRNA 6702104 6712638 . + . ID=transcript_4422;Q14978 Q15030 Q5VV70 Q9BUV3,Nucleolar and coiled-body phosphoprotein 1 {ECO:0000305},140 kDa nucleolar phosphoprotein {ECO:0000303|PubMed:10567578};Hepatitis C virus NS5A-transactivated protein 13;Nucleolar 130 kDa protein {ECO:0000303|PubMed:7657714};Nucleolar phosphoprotein p130 {ECO:0000303|PubMed:7657714};, PF05022;, GO:0031428;GO:0031429;GO:0015030;GO:0005737;GO:0001650;GO:0005730;GO:0005654;GO:0005524;GO:0034512;GO:0062064;GO:0034513;GO:0062065;GO:0003677;GO:0003700;GO:0005525;GO:0008139;GO:0019904;GO:0046982;GO:0030674;GO:0003723;GO:0008134;GO:0033979;GO:0000278;GO:0014032;GO:0014029;GO:0007000;GO:0008284;GO:0045893;GO:0042306;GO:0006417;GO:0006970;GO:0006364;, C:box C/D RNP complex; C:box H/ACA snoRNP complex; C:Cajal body; C:cytoplasm; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:box C/D RNA binding; F:box C/D snoRNP complex binding; F:box H/ACA snoRNA binding; F:box H/ACA snoRNP complex binding; F:DNA binding; F:DNA-binding transcription factor activity; F:GTP binding; F:nuclear localization sequence binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein-macromolecule adaptor activity; F:RNA binding; F:transcription factor binding;, P:box H/ACA RNA metabolic process; P:mitotic cell cycle; P:neural crest cell development; P:neural crest formation; P:nucleolus organization; P:positive regulation of cell population proliferation; P:positive regulation of transcription, DNA-templated; P:regulation of protein import into nucleus; P:regulation of translation; P:response to osmotic stress; P:rRNA processing;|Q14978 Q15030 Q5VV70 Q9BUV3,Nucleolar and coiled-body phosphoprotein 1 {ECO:0000305},140 kDa nucleolar phosphoprotein {ECO:0000303|PubMed:10567578};Hepatitis C virus NS5A-transactivated protein 13;Nucleolar 130 kDa protein {ECO:0000303|PubMed:7657714};Nucleolar phosphoprotein p130 {ECO:0000303|PubMed:7657714};, PF05022;, GO:0031428;GO:0031429;GO:0015030;GO:0005737;GO:0001650;GO:0005730;GO:0005654;GO:0005524;GO:0034512;GO:0062064;GO:0034513;GO:0062065;GO:0003677;GO:0003700;GO:0005525;GO:0008139;GO:0019904;GO:0046982;GO:0030674;GO:0003723;GO:0008134;GO:0033979;GO:0000278;GO:0014032;GO:0014029;GO:0007000;GO:0008284;GO:0045893;GO:0042306;GO:0006417;GO:0006970;GO:0006364;, C:box C/D RNP complex; C:box H/ACA snoRNP complex; C:Cajal body; C:cytoplasm; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:box C/D RNA binding; F:box C/D snoRNP complex binding; F:box H/ACA snoRNA binding; F:box H/ACA snoRNP complex binding; F:DNA binding; F:DNA-binding transcription factor activity; F:GTP binding; F:nuclear localization sequence binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein-macromolecule adaptor activity; F:RNA binding; F:transcription factor binding;, P:box H/ACA RNA metabolic process; P:mitotic cell cycle; P:neural crest cell development; P:neural crest formation; P:nucleolus organization; P:positive regulation of cell population proliferation; P:positive regulation of transcription, DNA-templated; P:regulation of protein import into nucleus; P:regulation of translation; P:response to osmotic stress; P:rRNA processing; scaffold18 indexed_genome mRNA 6792607 6896392 . + . ID=transcript_4423;Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process; scaffold18 indexed_genome mRNA 6899006 6920148 . + . ID=transcript_4424;Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|Q92538 Q149P0 Q149P1 Q5VXX3 Q96CK6 Q96HZ3 Q9H473,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,, PF01369;PF12783;, GO:0031252;GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005811;GO:0016020;GO:0005802;GO:0005085;GO:0005547;GO:0080025;GO:0002263;GO:0098586;GO:0060271;GO:0048205;GO:0006888;GO:0097111;GO:0061162;GO:0090166;GO:0007030;GO:0006895;GO:0030593;GO:0006892;GO:0070973;GO:1903420;GO:0034067;GO:0015031;GO:1903409;GO:0032012;GO:0007346;GO:2000008;GO:0042147;GO:0006890;GO:0016032;, C:cell leading edge; C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:lipid droplet; C:membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:cell activation involved in immune response; P:cellular response to virus; P:cilium assembly; P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:establishment of monopolar cell polarity; P:Golgi disassembly; P:Golgi organization; P:Golgi to endosome transport; P:neutrophil chemotaxis; P:post-Golgi vesicle-mediated transport; P:protein localization to endoplasmic reticulum exit site; P:protein localization to endoplasmic reticulum tubular network; P:protein localization to Golgi apparatus; P:protein transport; P:reactive oxygen species biosynthetic process; P:regulation of ARF protein signal transduction; P:regulation of mitotic cell cycle; P:regulation of protein localization to cell surface; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process; scaffold18 indexed_genome mRNA 6925249 6932982 . + . ID=transcript_4425;Q00653 A8K9D9 D3DR83 Q04860 Q9BU75 Q9H471 Q9H472,Nuclear factor NF-kappa-B p100 subunit,DNA-binding factor KBF2;H2TF1;Lymphocyte translocation chromosome 10 protein;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2;Oncogene Lyt-10;, PF12796;PF00531;PF16179;PF00554;, GO:0033257;GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0007568;GO:0030198;GO:0002268;GO:0002467;GO:0038061;GO:0051092;GO:0045944;GO:0032481;GO:0006357;GO:0006355;GO:0034097;GO:0032496;GO:0048511;GO:0048536;, C:Bcl3/NF-kappaB2 complex; C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:aging; P:extracellular matrix organization; P:follicular dendritic cell differentiation; P:germinal center formation; P:NIK/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to cytokine; P:response to lipopolysaccharide; P:rhythmic process; P:spleen development;|Q00653 A8K9D9 D3DR83 Q04860 Q9BU75 Q9H471 Q9H472,Nuclear factor NF-kappa-B p100 subunit,DNA-binding factor KBF2;H2TF1;Lymphocyte translocation chromosome 10 protein;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2;Oncogene Lyt-10;, PF12796;PF00531;PF16179;PF00554;, GO:0033257;GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0007568;GO:0030198;GO:0002268;GO:0002467;GO:0038061;GO:0051092;GO:0045944;GO:0032481;GO:0006357;GO:0006355;GO:0034097;GO:0032496;GO:0048511;GO:0048536;, C:Bcl3/NF-kappaB2 complex; C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:aging; P:extracellular matrix organization; P:follicular dendritic cell differentiation; P:germinal center formation; P:NIK/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to cytokine; P:response to lipopolysaccharide; P:rhythmic process; P:spleen development;|Q00653 A8K9D9 D3DR83 Q04860 Q9BU75 Q9H471 Q9H472,Nuclear factor NF-kappa-B p100 subunit,DNA-binding factor KBF2;H2TF1;Lymphocyte translocation chromosome 10 protein;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2;Oncogene Lyt-10;, PF12796;PF00531;PF16179;PF00554;, GO:0033257;GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0007568;GO:0030198;GO:0002268;GO:0002467;GO:0038061;GO:0051092;GO:0045944;GO:0032481;GO:0006357;GO:0006355;GO:0034097;GO:0032496;GO:0048511;GO:0048536;, C:Bcl3/NF-kappaB2 complex; C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:aging; P:extracellular matrix organization; P:follicular dendritic cell differentiation; P:germinal center formation; P:NIK/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to cytokine; P:response to lipopolysaccharide; P:rhythmic process; P:spleen development; scaffold18 indexed_genome mRNA 6933333 6951191 . - . ID=transcript_4426;A5PKW4 B1AKX7 D3DR87 Q15673 Q8IVG0,PH and SEC7 domain-containing protein 1,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6;Exchange factor for ARF6 A;Pleckstrin homology and SEC7 domain-containing protein 1;, PF15410;PF01369;, GO:0032154;GO:0043197;GO:0098999;GO:0099092;GO:0032587;GO:0005085;GO:0005543;GO:0031175;GO:0032012;GO:0007165;, C:cleavage furrow; C:dendritic spine; C:extrinsic component of postsynaptic endosome membrane; C:postsynaptic density, intracellular component; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:neuron projection development; P:regulation of ARF protein signal transduction; P:signal transduction;|A5PKW4 B1AKX7 D3DR87 Q15673 Q8IVG0,PH and SEC7 domain-containing protein 1,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6;Exchange factor for ARF6 A;Pleckstrin homology and SEC7 domain-containing protein 1;, PF15410;PF01369;, GO:0032154;GO:0043197;GO:0098999;GO:0099092;GO:0032587;GO:0005085;GO:0005543;GO:0031175;GO:0032012;GO:0007165;, C:cleavage furrow; C:dendritic spine; C:extrinsic component of postsynaptic endosome membrane; C:postsynaptic density, intracellular component; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:neuron projection development; P:regulation of ARF protein signal transduction; P:signal transduction;|A5PKW4 B1AKX7 D3DR87 Q15673 Q8IVG0,PH and SEC7 domain-containing protein 1,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6;Exchange factor for ARF6 A;Pleckstrin homology and SEC7 domain-containing protein 1;, PF15410;PF01369;, GO:0032154;GO:0043197;GO:0098999;GO:0099092;GO:0032587;GO:0005085;GO:0005543;GO:0031175;GO:0032012;GO:0007165;, C:cleavage furrow; C:dendritic spine; C:extrinsic component of postsynaptic endosome membrane; C:postsynaptic density, intracellular component; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:neuron projection development; P:regulation of ARF protein signal transduction; P:signal transduction;|A5PKW4 B1AKX7 D3DR87 Q15673 Q8IVG0,PH and SEC7 domain-containing protein 1,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6;Exchange factor for ARF6 A;Pleckstrin homology and SEC7 domain-containing protein 1;, PF15410;PF01369;, GO:0032154;GO:0043197;GO:0098999;GO:0099092;GO:0032587;GO:0005085;GO:0005543;GO:0031175;GO:0032012;GO:0007165;, C:cleavage furrow; C:dendritic spine; C:extrinsic component of postsynaptic endosome membrane; C:postsynaptic density, intracellular component; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:neuron projection development; P:regulation of ARF protein signal transduction; P:signal transduction;|A5PKW4 B1AKX7 D3DR87 Q15673 Q8IVG0,PH and SEC7 domain-containing protein 1,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6;Exchange factor for ARF6 A;Pleckstrin homology and SEC7 domain-containing protein 1;, PF15410;PF01369;, GO:0032154;GO:0043197;GO:0098999;GO:0099092;GO:0032587;GO:0005085;GO:0005543;GO:0031175;GO:0032012;GO:0007165;, C:cleavage furrow; C:dendritic spine; C:extrinsic component of postsynaptic endosome membrane; C:postsynaptic density, intracellular component; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:neuron projection development; P:regulation of ARF protein signal transduction; P:signal transduction;|A5PKW4 B1AKX7 D3DR87 Q15673 Q8IVG0,PH and SEC7 domain-containing protein 1,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6;Exchange factor for ARF6 A;Pleckstrin homology and SEC7 domain-containing protein 1;, PF15410;PF01369;, GO:0032154;GO:0043197;GO:0098999;GO:0099092;GO:0032587;GO:0005085;GO:0005543;GO:0031175;GO:0032012;GO:0007165;, C:cleavage furrow; C:dendritic spine; C:extrinsic component of postsynaptic endosome membrane; C:postsynaptic density, intracellular component; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:neuron projection development; P:regulation of ARF protein signal transduction; P:signal transduction;|A5PKW4 B1AKX7 D3DR87 Q15673 Q8IVG0,PH and SEC7 domain-containing protein 1,Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6;Exchange factor for ARF6 A;Pleckstrin homology and SEC7 domain-containing protein 1;, PF15410;PF01369;, GO:0032154;GO:0043197;GO:0098999;GO:0099092;GO:0032587;GO:0005085;GO:0005543;GO:0031175;GO:0032012;GO:0007165;, C:cleavage furrow; C:dendritic spine; C:extrinsic component of postsynaptic endosome membrane; C:postsynaptic density, intracellular component; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:neuron projection development; P:regulation of ARF protein signal transduction; P:signal transduction; scaffold18 indexed_genome mRNA 6952909 6955286 . + . ID=transcript_4427;Q5JWA5,F-box/LRR-repeat protein 15,F-box only protein 37;, PF00646;PF13516;, GO:0005737;GO:0005829;GO:0019005;GO:0030282;GO:0009953;GO:0000086;GO:0030513;GO:0043687;GO:0000209;GO:0016567;GO:0031146;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex;, , P:bone mineralization; P:dorsal/ventral pattern formation; P:G2/M transition of mitotic cell cycle; P:positive regulation of BMP signaling pathway; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold18 indexed_genome mRNA 6955475 6963085 . - . ID=transcript_4428;Q9H467 D3DR88 Q9BWG8,CUE domain-containing protein 2,, , GO:0005829;GO:0031965;GO:0005654;GO:0043130;GO:1900016;GO:0010936;, C:cytosol; C:nuclear membrane; C:nucleoplasm;, F:ubiquitin binding;, P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of macrophage cytokine production;|Q9H467 D3DR88 Q9BWG8,CUE domain-containing protein 2,, , GO:0005829;GO:0031965;GO:0005654;GO:0043130;GO:1900016;GO:0010936;, C:cytosol; C:nuclear membrane; C:nucleoplasm;, F:ubiquitin binding;, P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of macrophage cytokine production; scaffold18 indexed_genome mRNA 6991092 6998299 . + . ID=transcript_4429;Q14CX5 Q6NWM8 Q6NWM9 Q6PEZ7 Q9H679,Transmembrane protein 180 {ECO:0000312|HGNC:HGNC:26196},Major facilitator superfamily domain-containing 13A {ECO:0000312|HGNC:HGNC:26196};, , GO:0016021;, C:integral component of membrane;|Q14CX5 Q6NWM8 Q6NWM9 Q6PEZ7 Q9H679,Transmembrane protein 180 {ECO:0000312|HGNC:HGNC:26196},Major facilitator superfamily domain-containing 13A {ECO:0000312|HGNC:HGNC:26196};, , GO:0016021;, C:integral component of membrane;|Q14CX5 Q6NWM8 Q6NWM9 Q6PEZ7 Q9H679,Transmembrane protein 180 {ECO:0000312|HGNC:HGNC:26196},Major facilitator superfamily domain-containing 13A {ECO:0000312|HGNC:HGNC:26196};, , GO:0016021;, C:integral component of membrane; scaffold18 indexed_genome mRNA 6998356 7007863 . - . ID=transcript_4430;P61163 B2R6B0 P42024,Alpha-centractin,ARP1;Actin-RPV;Centrosome-associated actin homolog;, PF00022;, GO:0099738;GO:0005814;GO:0005813;GO:0030137;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0002177;GO:0005875;GO:0015630;GO:0005524;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0010389;GO:0007283;GO:0016192;, C:cell cortex region; C:centriole; C:centrosome; C:COPI-coated vesicle; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:manchette; C:microtubule associated complex; C:microtubule cytoskeleton;, F:ATP binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spermatogenesis; P:vesicle-mediated transport;|P61163 B2R6B0 P42024,Alpha-centractin,ARP1;Actin-RPV;Centrosome-associated actin homolog;, PF00022;, GO:0099738;GO:0005814;GO:0005813;GO:0030137;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0002177;GO:0005875;GO:0015630;GO:0005524;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0010389;GO:0007283;GO:0016192;, C:cell cortex region; C:centriole; C:centrosome; C:COPI-coated vesicle; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:manchette; C:microtubule associated complex; C:microtubule cytoskeleton;, F:ATP binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spermatogenesis; P:vesicle-mediated transport;|P61163 B2R6B0 P42024,Alpha-centractin,ARP1;Actin-RPV;Centrosome-associated actin homolog;, PF00022;, GO:0099738;GO:0005814;GO:0005813;GO:0030137;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0002177;GO:0005875;GO:0015630;GO:0005524;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0010389;GO:0007283;GO:0016192;, C:cell cortex region; C:centriole; C:centrosome; C:COPI-coated vesicle; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:manchette; C:microtubule associated complex; C:microtubule cytoskeleton;, F:ATP binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spermatogenesis; P:vesicle-mediated transport; scaffold18 indexed_genome mRNA 7017067 7122399 . + . ID=transcript_4431;Q9UMX1 Q7LCP7 Q9NT90 Q9NZ07 Q9UHK2 Q9UHM8 Q9UMY0,Suppressor of fused homolog {ECO:0000303|PubMed:10559945, ECO:0000303|PubMed:10564661},, PF05076;PF12470;, GO:0097546;GO:0097542;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0019901;GO:0003714;GO:0008134;GO:0035904;GO:0060976;GO:0042994;GO:0001947;GO:0007275;GO:0043433;GO:0045668;GO:0042308;GO:0045879;GO:1901621;GO:0000122;GO:2000059;GO:0001843;GO:0006508;GO:0006355;GO:0007165;GO:0001501;GO:0043588;GO:0021776;GO:0021775;GO:0003281;, C:ciliary base; C:ciliary tip; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:protein kinase binding; F:transcription corepressor activity; F:transcription factor binding;, P:aorta development; P:coronary vasculature development; P:cytoplasmic sequestering of transcription factor; P:heart looping; P:multicellular organism development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of osteoblast differentiation; P:negative regulation of protein import into nucleus; P:negative regulation of smoothened signaling pathway; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:neural tube closure; P:proteolysis; P:regulation of transcription, DNA-templated; P:signal transduction; P:skeletal system development; P:skin development; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; P:ventricular septum development;|Q9UMX1 Q7LCP7 Q9NT90 Q9NZ07 Q9UHK2 Q9UHM8 Q9UMY0,Suppressor of fused homolog {ECO:0000303|PubMed:10559945, ECO:0000303|PubMed:10564661},, PF05076;PF12470;, GO:0097546;GO:0097542;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0019901;GO:0003714;GO:0008134;GO:0035904;GO:0060976;GO:0042994;GO:0001947;GO:0007275;GO:0043433;GO:0045668;GO:0042308;GO:0045879;GO:1901621;GO:0000122;GO:2000059;GO:0001843;GO:0006508;GO:0006355;GO:0007165;GO:0001501;GO:0043588;GO:0021776;GO:0021775;GO:0003281;, C:ciliary base; C:ciliary tip; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:protein kinase binding; F:transcription corepressor activity; F:transcription factor binding;, P:aorta development; P:coronary vasculature development; P:cytoplasmic sequestering of transcription factor; P:heart looping; P:multicellular organism development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of osteoblast differentiation; P:negative regulation of protein import into nucleus; P:negative regulation of smoothened signaling pathway; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:neural tube closure; P:proteolysis; P:regulation of transcription, DNA-templated; P:signal transduction; P:skeletal system development; P:skin development; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; P:ventricular septum development;|Q9UMX1 Q7LCP7 Q9NT90 Q9NZ07 Q9UHK2 Q9UHM8 Q9UMY0,Suppressor of fused homolog {ECO:0000303|PubMed:10559945, ECO:0000303|PubMed:10564661},, PF05076;PF12470;, GO:0097546;GO:0097542;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0019901;GO:0003714;GO:0008134;GO:0035904;GO:0060976;GO:0042994;GO:0001947;GO:0007275;GO:0043433;GO:0045668;GO:0042308;GO:0045879;GO:1901621;GO:0000122;GO:2000059;GO:0001843;GO:0006508;GO:0006355;GO:0007165;GO:0001501;GO:0043588;GO:0021776;GO:0021775;GO:0003281;, C:ciliary base; C:ciliary tip; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:protein kinase binding; F:transcription corepressor activity; F:transcription factor binding;, P:aorta development; P:coronary vasculature development; P:cytoplasmic sequestering of transcription factor; P:heart looping; P:multicellular organism development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of osteoblast differentiation; P:negative regulation of protein import into nucleus; P:negative regulation of smoothened signaling pathway; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:neural tube closure; P:proteolysis; P:regulation of transcription, DNA-templated; P:signal transduction; P:skeletal system development; P:skin development; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; P:ventricular septum development;|Q9UMX1 Q7LCP7 Q9NT90 Q9NZ07 Q9UHK2 Q9UHM8 Q9UMY0,Suppressor of fused homolog {ECO:0000303|PubMed:10559945, ECO:0000303|PubMed:10564661},, PF05076;PF12470;, GO:0097546;GO:0097542;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0019901;GO:0003714;GO:0008134;GO:0035904;GO:0060976;GO:0042994;GO:0001947;GO:0007275;GO:0043433;GO:0045668;GO:0042308;GO:0045879;GO:1901621;GO:0000122;GO:2000059;GO:0001843;GO:0006508;GO:0006355;GO:0007165;GO:0001501;GO:0043588;GO:0021776;GO:0021775;GO:0003281;, C:ciliary base; C:ciliary tip; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:protein kinase binding; F:transcription corepressor activity; F:transcription factor binding;, P:aorta development; P:coronary vasculature development; P:cytoplasmic sequestering of transcription factor; P:heart looping; P:multicellular organism development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of osteoblast differentiation; P:negative regulation of protein import into nucleus; P:negative regulation of smoothened signaling pathway; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:neural tube closure; P:proteolysis; P:regulation of transcription, DNA-templated; P:signal transduction; P:skeletal system development; P:skin development; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; P:ventricular septum development; scaffold18 indexed_genome mRNA 7131467 7144729 . + . ID=transcript_4432;Q9BZR9 A6NI31 Q9C028,E3 ubiquitin-protein ligase TRIM8,Glioblastoma-expressed RING finger protein;RING finger protein 27;RING-type E3 ubiquitin transferase TRIM8 {ECO:0000305};Tripartite motif-containing protein 8;, , GO:0005829;GO:0016605;GO:0042802;GO:0042803;GO:0003713;GO:0016740;GO:0008270;GO:0045087;GO:0060333;GO:0046597;GO:1902187;GO:0032897;GO:0010508;GO:0051091;GO:0043123;GO:0051092;GO:1900182;GO:0016567;GO:0019827;, C:cytosol; C:PML body;, F:identical protein binding; F:protein homodimerization activity; F:transcription coactivator activity; F:transferase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:negative regulation of viral transcription; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein localization to nucleus; P:protein ubiquitination; P:stem cell population maintenance; scaffold18 indexed_genome mRNA 7158880 7189484 . - . ID=transcript_4433;P36405 B2R6C7 Q53X83 Q5JSM2,ADP-ribosylation factor-like protein 3,, PF00025;, GO:0005813;GO:0005929;GO:0005737;GO:0005881;GO:0070062;GO:0005794;GO:0000139;GO:0015630;GO:0030496;GO:0005654;GO:0005634;GO:0032391;GO:0005876;GO:0019003;GO:0005525;GO:0032794;GO:0003924;GO:0000287;GO:0008017;GO:0060271;GO:0006893;GO:0042073;GO:0001822;GO:0000281;GO:0042461;GO:0006892;GO:1903441;GO:0061512;GO:0007264;GO:0007224;, C:centrosome; C:cilium; C:cytoplasm; C:cytoplasmic microtubule; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:microtubule cytoskeleton; C:midbody; C:nucleoplasm; C:nucleus; C:photoreceptor connecting cilium; C:spindle microtubule;, F:GDP binding; F:GTP binding; F:GTPase activating protein binding; F:GTPase activity; F:magnesium ion binding; F:microtubule binding;, P:cilium assembly; P:Golgi to plasma membrane transport; P:intraciliary transport; P:kidney development; P:mitotic cytokinesis; P:photoreceptor cell development; P:post-Golgi vesicle-mediated transport; P:protein localization to ciliary membrane; P:protein localization to cilium; P:small GTPase mediated signal transduction; P:smoothened signaling pathway; scaffold18 indexed_genome mRNA 7189789 7207777 . + . ID=transcript_4434;Q96NB2 Q5JSM6,Sideroflexin-2 {ECO:0000303|Ref.2},, PF03820;, GO:0031305;GO:0005739;GO:0022889;GO:0022857;GO:1990542;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:mitochondrial transmembrane transport; P:serine import into mitochondrion;|Q96NB2 Q5JSM6,Sideroflexin-2 {ECO:0000303|Ref.2},, PF03820;, GO:0031305;GO:0005739;GO:0022889;GO:0022857;GO:1990542;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:mitochondrial transmembrane transport; P:serine import into mitochondrion;|Q96NB2 Q5JSM6,Sideroflexin-2 {ECO:0000303|Ref.2},, PF03820;, GO:0031305;GO:0005739;GO:0022889;GO:0022857;GO:1990542;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:mitochondrial transmembrane transport; P:serine import into mitochondrion;|Q96NB2 Q5JSM6,Sideroflexin-2 {ECO:0000303|Ref.2},, PF03820;, GO:0031305;GO:0005739;GO:0022889;GO:0022857;GO:1990542;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:mitochondrial transmembrane transport; P:serine import into mitochondrion; scaffold18 indexed_genome mRNA 7289548 7300074 . - . ID=transcript_4435;Q9HBK9 A6NP79 Q0VDK3 Q0VDK4 Q5PZ02,Arsenite methyltransferase,Methylarsonite methyltransferase;S-adenosyl-L-methionine:arsenic(III) methyltransferase;, PF13847;, GO:0005829;GO:0030791;GO:0030792;GO:0008168;GO:0018872;GO:0032259;GO:0009404;, C:cytosol;, F:arsenite methyltransferase activity; F:methylarsonite methyltransferase activity; F:methyltransferase activity;, P:arsonoacetate metabolic process; P:methylation; P:toxin metabolic process;|Q9HBK9 A6NP79 Q0VDK3 Q0VDK4 Q5PZ02,Arsenite methyltransferase,Methylarsonite methyltransferase;S-adenosyl-L-methionine:arsenic(III) methyltransferase;, PF13847;, GO:0005829;GO:0030791;GO:0030792;GO:0008168;GO:0018872;GO:0032259;GO:0009404;, C:cytosol;, F:arsenite methyltransferase activity; F:methylarsonite methyltransferase activity; F:methyltransferase activity;, P:arsonoacetate metabolic process; P:methylation; P:toxin metabolic process; scaffold18 indexed_genome mRNA 7300078 7301123 . + . ID=transcript_4436;Q9HBK9 A6NP79 Q0VDK3 Q0VDK4 Q5PZ02,Arsenite methyltransferase,Methylarsonite methyltransferase;S-adenosyl-L-methionine:arsenic(III) methyltransferase;, PF13847;, GO:0005829;GO:0030791;GO:0030792;GO:0008168;GO:0018872;GO:0032259;GO:0009404;, C:cytosol;, F:arsenite methyltransferase activity; F:methylarsonite methyltransferase activity; F:methyltransferase activity;, P:arsonoacetate metabolic process; P:methylation; P:toxin metabolic process; scaffold18 indexed_genome mRNA 7303454 7304097 . + . ID=transcript_4437;Q9HBK9 A6NP79 Q0VDK3 Q0VDK4 Q5PZ02,Arsenite methyltransferase,Methylarsonite methyltransferase;S-adenosyl-L-methionine:arsenic(III) methyltransferase;, PF13847;, GO:0005829;GO:0030791;GO:0030792;GO:0008168;GO:0018872;GO:0032259;GO:0009404;, C:cytosol;, F:arsenite methyltransferase activity; F:methylarsonite methyltransferase activity; F:methyltransferase activity;, P:arsonoacetate metabolic process; P:methylation; P:toxin metabolic process; scaffold18 indexed_genome mRNA 7334985 7498945 . + . ID=transcript_4438;Q9H8M5 Q5T569 Q5T570 Q8WU59 Q9H952 Q9NRK5 Q9NXT4,Metal transporter CNNM2,Ancient conserved domain-containing protein 2;Cyclin-M2;, PF00571;PF01595;, GO:0016323;GO:0016021;GO:0043231;GO:0005886;GO:0005524;GO:0015095;GO:0022857;GO:0010960;, C:basolateral plasma membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ATP binding; F:magnesium ion transmembrane transporter activity; F:transmembrane transporter activity;, P:magnesium ion homeostasis;|Q9H8M5 Q5T569 Q5T570 Q8WU59 Q9H952 Q9NRK5 Q9NXT4,Metal transporter CNNM2,Ancient conserved domain-containing protein 2;Cyclin-M2;, PF00571;PF01595;, GO:0016323;GO:0016021;GO:0043231;GO:0005886;GO:0005524;GO:0015095;GO:0022857;GO:0010960;, C:basolateral plasma membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ATP binding; F:magnesium ion transmembrane transporter activity; F:transmembrane transporter activity;, P:magnesium ion homeostasis;|Q9H8M5 Q5T569 Q5T570 Q8WU59 Q9H952 Q9NRK5 Q9NXT4,Metal transporter CNNM2,Ancient conserved domain-containing protein 2;Cyclin-M2;, PF00571;PF01595;, GO:0016323;GO:0016021;GO:0043231;GO:0005886;GO:0005524;GO:0015095;GO:0022857;GO:0010960;, C:basolateral plasma membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ATP binding; F:magnesium ion transmembrane transporter activity; F:transmembrane transporter activity;, P:magnesium ion homeostasis;|Q9H8M5 Q5T569 Q5T570 Q8WU59 Q9H952 Q9NRK5 Q9NXT4,Metal transporter CNNM2,Ancient conserved domain-containing protein 2;Cyclin-M2;, PF00571;PF01595;, GO:0016323;GO:0016021;GO:0043231;GO:0005886;GO:0005524;GO:0015095;GO:0022857;GO:0010960;, C:basolateral plasma membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ATP binding; F:magnesium ion transmembrane transporter activity; F:transmembrane transporter activity;, P:magnesium ion homeostasis; scaffold18 indexed_genome mRNA 7508681 7524420 . - . ID=transcript_4439;P49902 B7Z382 D3DR91 Q5JUV5,Cytosolic purine 5'-nucleotidase,Cytosolic 5'-nucleotidase II;, PF05761;, GO:0005829;GO:0008253;GO:0050484;GO:0046872;GO:0000166;GO:0046085;GO:0017144;GO:0046040;GO:0006195;, C:cytosol;, F:5'-nucleotidase activity; F:GMP 5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine metabolic process; P:drug metabolic process; P:IMP metabolic process; P:purine nucleotide catabolic process;|P49902 B7Z382 D3DR91 Q5JUV5,Cytosolic purine 5'-nucleotidase,Cytosolic 5'-nucleotidase II;, PF05761;, GO:0005829;GO:0008253;GO:0050484;GO:0046872;GO:0000166;GO:0046085;GO:0017144;GO:0046040;GO:0006195;, C:cytosol;, F:5'-nucleotidase activity; F:GMP 5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine metabolic process; P:drug metabolic process; P:IMP metabolic process; P:purine nucleotide catabolic process;|P49902 B7Z382 D3DR91 Q5JUV5,Cytosolic purine 5'-nucleotidase,Cytosolic 5'-nucleotidase II;, PF05761;, GO:0005829;GO:0008253;GO:0050484;GO:0046872;GO:0000166;GO:0046085;GO:0017144;GO:0046040;GO:0006195;, C:cytosol;, F:5'-nucleotidase activity; F:GMP 5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine metabolic process; P:drug metabolic process; P:IMP metabolic process; P:purine nucleotide catabolic process;|P49902 B7Z382 D3DR91 Q5JUV5,Cytosolic purine 5'-nucleotidase,Cytosolic 5'-nucleotidase II;, PF05761;, GO:0005829;GO:0008253;GO:0050484;GO:0046872;GO:0000166;GO:0046085;GO:0017144;GO:0046040;GO:0006195;, C:cytosol;, F:5'-nucleotidase activity; F:GMP 5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine metabolic process; P:drug metabolic process; P:IMP metabolic process; P:purine nucleotide catabolic process;|P49902 B7Z382 D3DR91 Q5JUV5,Cytosolic purine 5'-nucleotidase,Cytosolic 5'-nucleotidase II;, PF05761;, GO:0005829;GO:0008253;GO:0050484;GO:0046872;GO:0000166;GO:0046085;GO:0017144;GO:0046040;GO:0006195;, C:cytosol;, F:5'-nucleotidase activity; F:GMP 5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine metabolic process; P:drug metabolic process; P:IMP metabolic process; P:purine nucleotide catabolic process; scaffold18 indexed_genome mRNA 7524431 7672899 . - . ID=transcript_4440;P49902 B7Z382 D3DR91 Q5JUV5,Cytosolic purine 5'-nucleotidase,Cytosolic 5'-nucleotidase II;, PF05761;, GO:0005829;GO:0008253;GO:0050484;GO:0046872;GO:0000166;GO:0046085;GO:0017144;GO:0046040;GO:0006195;, C:cytosol;, F:5'-nucleotidase activity; F:GMP 5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine metabolic process; P:drug metabolic process; P:IMP metabolic process; P:purine nucleotide catabolic process;|P49902 B7Z382 D3DR91 Q5JUV5,Cytosolic purine 5'-nucleotidase,Cytosolic 5'-nucleotidase II;, PF05761;, GO:0005829;GO:0008253;GO:0050484;GO:0046872;GO:0000166;GO:0046085;GO:0017144;GO:0046040;GO:0006195;, C:cytosol;, F:5'-nucleotidase activity; F:GMP 5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine metabolic process; P:drug metabolic process; P:IMP metabolic process; P:purine nucleotide catabolic process;|Q16352 B1AQK0 Q9BRC5,Alpha-internexin,66 kDa neurofilament protein;Neurofilament 5;, PF00038;PF04732;, GO:0036464;GO:0005615;GO:0005883;GO:0098794;GO:0098685;GO:0005200;GO:0098973;GO:0099184;GO:0030154;GO:1990830;GO:0060052;GO:0021762;, C:cytoplasmic ribonucleoprotein granule; C:extracellular space; C:neurofilament; C:postsynapse; C:Schaffer collateral - CA1 synapse;, F:structural constituent of cytoskeleton; F:structural constituent of postsynaptic actin cytoskeleton; F:structural constituent of postsynaptic intermediate filament cytoskeleton;, P:cell differentiation; P:cellular response to leukemia inhibitory factor; P:neurofilament cytoskeleton organization; P:substantia nigra development;|Q16352 B1AQK0 Q9BRC5,Alpha-internexin,66 kDa neurofilament protein;Neurofilament 5;, PF00038;PF04732;, GO:0036464;GO:0005615;GO:0005883;GO:0098794;GO:0098685;GO:0005200;GO:0098973;GO:0099184;GO:0030154;GO:1990830;GO:0060052;GO:0021762;, C:cytoplasmic ribonucleoprotein granule; C:extracellular space; C:neurofilament; C:postsynapse; C:Schaffer collateral - CA1 synapse;, F:structural constituent of cytoskeleton; F:structural constituent of postsynaptic actin cytoskeleton; F:structural constituent of postsynaptic intermediate filament cytoskeleton;, P:cell differentiation; P:cellular response to leukemia inhibitory factor; P:neurofilament cytoskeleton organization; P:substantia nigra development;|Q16352 B1AQK0 Q9BRC5,Alpha-internexin,66 kDa neurofilament protein;Neurofilament 5;, PF00038;PF04732;, GO:0036464;GO:0005615;GO:0005883;GO:0098794;GO:0098685;GO:0005200;GO:0098973;GO:0099184;GO:0030154;GO:1990830;GO:0060052;GO:0021762;, C:cytoplasmic ribonucleoprotein granule; C:extracellular space; C:neurofilament; C:postsynapse; C:Schaffer collateral - CA1 synapse;, F:structural constituent of cytoskeleton; F:structural constituent of postsynaptic actin cytoskeleton; F:structural constituent of postsynaptic intermediate filament cytoskeleton;, P:cell differentiation; P:cellular response to leukemia inhibitory factor; P:neurofilament cytoskeleton organization; P:substantia nigra development; scaffold18 indexed_genome mRNA 7681983 7711848 . - . ID=transcript_4441;Q9BYE7 A8K3R4 Q5SYD1 Q5SYD6 Q96ID9 Q96SJ1,Polycomb group RING finger protein 6,Mel18 and Bmi1-like RING finger;RING finger protein 134;, , GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0046872;GO:0036353;GO:0070317;GO:0000122;GO:0045892;GO:0006357;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:metal ion binding;, P:histone H2A-K119 monoubiquitination; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9BYE7 A8K3R4 Q5SYD1 Q5SYD6 Q96ID9 Q96SJ1,Polycomb group RING finger protein 6,Mel18 and Bmi1-like RING finger;RING finger protein 134;, , GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0046872;GO:0036353;GO:0070317;GO:0000122;GO:0045892;GO:0006357;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:metal ion binding;, P:histone H2A-K119 monoubiquitination; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9BYE7 A8K3R4 Q5SYD1 Q5SYD6 Q96ID9 Q96SJ1,Polycomb group RING finger protein 6,Mel18 and Bmi1-like RING finger;RING finger protein 134;, , GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0046872;GO:0036353;GO:0070317;GO:0000122;GO:0045892;GO:0006357;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:metal ion binding;, P:histone H2A-K119 monoubiquitination; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold18 indexed_genome mRNA 7741439 7761016 . + . ID=transcript_4442;Q15542 A8K5B4 B2RMR0 B7ZKJ6 Q53EM4 Q5SYD5 Q86UZ7 Q9Y4K5,Transcription initiation factor TFIID subunit 5,Transcription initiation factor TFIID 100 kDa subunit;, PF04494;PF00400;, GO:0015629;GO:0000785;GO:0005654;GO:0005634;GO:0005669;GO:0033276;GO:0042802;GO:0016251;GO:0006352;GO:0043966;GO:1901796;GO:0006355;GO:0042795;GO:0006366;GO:0006367;GO:0016032;, C:actin cytoskeleton; C:chromatin; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:identical protein binding; F:RNA polymerase II general transcription initiation factor activity;, P:DNA-templated transcription, initiation; P:histone H3 acetylation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q15542 A8K5B4 B2RMR0 B7ZKJ6 Q53EM4 Q5SYD5 Q86UZ7 Q9Y4K5,Transcription initiation factor TFIID subunit 5,Transcription initiation factor TFIID 100 kDa subunit;, PF04494;PF00400;, GO:0015629;GO:0000785;GO:0005654;GO:0005634;GO:0005669;GO:0033276;GO:0042802;GO:0016251;GO:0006352;GO:0043966;GO:1901796;GO:0006355;GO:0042795;GO:0006366;GO:0006367;GO:0016032;, C:actin cytoskeleton; C:chromatin; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:identical protein binding; F:RNA polymerase II general transcription initiation factor activity;, P:DNA-templated transcription, initiation; P:histone H3 acetylation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q15542 A8K5B4 B2RMR0 B7ZKJ6 Q53EM4 Q5SYD5 Q86UZ7 Q9Y4K5,Transcription initiation factor TFIID subunit 5,Transcription initiation factor TFIID 100 kDa subunit;, PF04494;PF00400;, GO:0015629;GO:0000785;GO:0005654;GO:0005634;GO:0005669;GO:0033276;GO:0042802;GO:0016251;GO:0006352;GO:0043966;GO:1901796;GO:0006355;GO:0042795;GO:0006366;GO:0006367;GO:0016032;, C:actin cytoskeleton; C:chromatin; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:identical protein binding; F:RNA polymerase II general transcription initiation factor activity;, P:DNA-templated transcription, initiation; P:histone H3 acetylation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q15542 A8K5B4 B2RMR0 B7ZKJ6 Q53EM4 Q5SYD5 Q86UZ7 Q9Y4K5,Transcription initiation factor TFIID subunit 5,Transcription initiation factor TFIID 100 kDa subunit;, PF04494;PF00400;, GO:0015629;GO:0000785;GO:0005654;GO:0005634;GO:0005669;GO:0033276;GO:0042802;GO:0016251;GO:0006352;GO:0043966;GO:1901796;GO:0006355;GO:0042795;GO:0006366;GO:0006367;GO:0016032;, C:actin cytoskeleton; C:chromatin; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:identical protein binding; F:RNA polymerase II general transcription initiation factor activity;, P:DNA-templated transcription, initiation; P:histone H3 acetylation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q96IX5 B2R4N2 D3DR92,ATP synthase membrane subunit K, mitochondrial {ECO:0000305},ATP synthase membrane subunit DAPIT, mitochondrial {ECO:0000305};Diabetes-associated protein in insulin-sensitive tissues;HCV F-transactivated protein 2;Up-regulated during skeletal muscle growth protein 5 {ECO:0000305};, PF14960;, GO:0016021;GO:0005753;GO:0005739;, C:integral component of membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrion; scaffold18 indexed_genome mRNA 7762994 7806415 . + . ID=transcript_4443;Q14690 Q2TA92 Q5W093 Q6P2J3 Q86VQ8 Q9H4P1,Protein RRP5 homolog,NF-kappa-B-binding protein;Programmed cell death protein 11;, PF00575;PF05843;, GO:0005730;GO:0005654;GO:0005634;GO:0032040;GO:0003723;GO:0008134;GO:0006397;GO:0006364;, C:nucleolus; C:nucleoplasm; C:nucleus; C:small-subunit processome;, F:RNA binding; F:transcription factor binding;, P:mRNA processing; P:rRNA processing;|Q14690 Q2TA92 Q5W093 Q6P2J3 Q86VQ8 Q9H4P1,Protein RRP5 homolog,NF-kappa-B-binding protein;Programmed cell death protein 11;, PF00575;PF05843;, GO:0005730;GO:0005654;GO:0005634;GO:0032040;GO:0003723;GO:0008134;GO:0006397;GO:0006364;, C:nucleolus; C:nucleoplasm; C:nucleus; C:small-subunit processome;, F:RNA binding; F:transcription factor binding;, P:mRNA processing; P:rRNA processing;|Q14690 Q2TA92 Q5W093 Q6P2J3 Q86VQ8 Q9H4P1,Protein RRP5 homolog,NF-kappa-B-binding protein;Programmed cell death protein 11;, PF00575;PF05843;, GO:0005730;GO:0005654;GO:0005634;GO:0032040;GO:0003723;GO:0008134;GO:0006397;GO:0006364;, C:nucleolus; C:nucleoplasm; C:nucleus; C:small-subunit processome;, F:RNA binding; F:transcription factor binding;, P:mRNA processing; P:rRNA processing;|Q14690 Q2TA92 Q5W093 Q6P2J3 Q86VQ8 Q9H4P1,Protein RRP5 homolog,NF-kappa-B-binding protein;Programmed cell death protein 11;, PF00575;PF05843;, GO:0005730;GO:0005654;GO:0005634;GO:0032040;GO:0003723;GO:0008134;GO:0006397;GO:0006364;, C:nucleolus; C:nucleoplasm; C:nucleus; C:small-subunit processome;, F:RNA binding; F:transcription factor binding;, P:mRNA processing; P:rRNA processing; scaffold18 indexed_genome mRNA 7808504 7813329 . - . ID=transcript_4444;Q9HA72 D3DR94 O95893 Q6ZUV9,Calcium homeostasis modulator protein 2,Protein FAM26B;, PF14798;, GO:0005887;GO:0005261;GO:0043065;, C:integral component of plasma membrane;, F:cation channel activity;, P:positive regulation of apoptotic process; scaffold18 indexed_genome mRNA 7901889 7934425 . + . ID=transcript_4445;O76050 Q5TDR2 Q5TDR3 Q8TAN0 Q9H463,E3 ubiquitin-protein ligase NEURL1,Neuralized-like protein 1A;RING finger protein 67;RING-type E3 ubiquitin transferase NEURL1 {ECO:0000305};, PF07177;, GO:0097440;GO:0043197;GO:0043204;GO:0048471;GO:0005886;GO:0014069;GO:0046872;GO:0045183;GO:0061630;GO:0004842;GO:0007420;GO:0071230;GO:0007595;GO:0008285;GO:0045746;GO:0007399;GO:0007219;GO:0043065;GO:0060999;GO:0045741;GO:0051491;GO:0048170;GO:0090129;GO:0006513;GO:0007519;GO:0007288;, C:apical dendrite; C:dendritic spine; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:metal ion binding; F:translation factor activity, non-nucleic acid binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:brain development; P:cellular response to amino acid stimulus; P:lactation; P:negative regulation of cell population proliferation; P:negative regulation of Notch signaling pathway; P:nervous system development; P:Notch signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine development; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of filopodium assembly; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of synapse maturation; P:protein monoubiquitination; P:skeletal muscle tissue development; P:sperm axoneme assembly; scaffold18 indexed_genome mRNA 7942815 8000118 . - . ID=transcript_4446;Q5TCZ1 D3DR98 O43302 Q5TCZ2 Q5TDQ8,SH3 and PX domain-containing protein 2A,Adapter protein TKS5;Five SH3 domain-containing protein;SH3 multiple domains protein 1;Tyrosine kinase substrate with five SH3 domains;, PF00787;PF00018;, GO:0030054;GO:0042995;GO:0005737;GO:0005829;GO:0002102;GO:0060090;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0002020;GO:0016176;GO:0030198;GO:0001701;GO:0072675;GO:0006801;, C:cell junction; C:cell projection; C:cytoplasm; C:cytosol; C:podosome;, F:molecular adaptor activity; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protease binding; F:superoxide-generating NADPH oxidase activator activity;, P:extracellular matrix organization; P:in utero embryonic development; P:osteoclast fusion; P:superoxide metabolic process;|Q5TCZ1 D3DR98 O43302 Q5TCZ2 Q5TDQ8,SH3 and PX domain-containing protein 2A,Adapter protein TKS5;Five SH3 domain-containing protein;SH3 multiple domains protein 1;Tyrosine kinase substrate with five SH3 domains;, PF00787;PF00018;, GO:0030054;GO:0042995;GO:0005737;GO:0005829;GO:0002102;GO:0060090;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0002020;GO:0016176;GO:0030198;GO:0001701;GO:0072675;GO:0006801;, C:cell junction; C:cell projection; C:cytoplasm; C:cytosol; C:podosome;, F:molecular adaptor activity; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protease binding; F:superoxide-generating NADPH oxidase activator activity;, P:extracellular matrix organization; P:in utero embryonic development; P:osteoclast fusion; P:superoxide metabolic process; scaffold18 indexed_genome mRNA 8218280 8236245 . - . ID=transcript_4447;Q9H668 D3DR99 Q5TCZ0,CST complex subunit STN1,Oligonucleotide/oligosaccharide-binding fold-containing protein 1;Suppressor of cdc thirteen homolog;, PF09170;PF01336;, GO:0000781;GO:1990879;GO:0001650;GO:0045111;GO:0043231;GO:0005654;GO:0005634;GO:0003697;GO:0043047;GO:0042162;GO:0032211;GO:0045740;GO:0016233;GO:0000723;GO:0032201;GO:0010833;, C:chromosome, telomeric region; C:CST complex; C:fibrillar center; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:single-stranded DNA binding; F:single-stranded telomeric DNA binding; F:telomeric DNA binding;, P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA replication; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomere lengthening;|Q9H668 D3DR99 Q5TCZ0,CST complex subunit STN1,Oligonucleotide/oligosaccharide-binding fold-containing protein 1;Suppressor of cdc thirteen homolog;, PF09170;PF01336;, GO:0000781;GO:1990879;GO:0001650;GO:0045111;GO:0043231;GO:0005654;GO:0005634;GO:0003697;GO:0043047;GO:0042162;GO:0032211;GO:0045740;GO:0016233;GO:0000723;GO:0032201;GO:0010833;, C:chromosome, telomeric region; C:CST complex; C:fibrillar center; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:single-stranded DNA binding; F:single-stranded telomeric DNA binding; F:telomeric DNA binding;, P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA replication; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomere lengthening;|Q9H668 D3DR99 Q5TCZ0,CST complex subunit STN1,Oligonucleotide/oligosaccharide-binding fold-containing protein 1;Suppressor of cdc thirteen homolog;, PF09170;PF01336;, GO:0000781;GO:1990879;GO:0001650;GO:0045111;GO:0043231;GO:0005654;GO:0005634;GO:0003697;GO:0043047;GO:0042162;GO:0032211;GO:0045740;GO:0016233;GO:0000723;GO:0032201;GO:0010833;, C:chromosome, telomeric region; C:CST complex; C:fibrillar center; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:single-stranded DNA binding; F:single-stranded telomeric DNA binding; F:telomeric DNA binding;, P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA replication; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomere lengthening; scaffold18 indexed_genome mRNA 8236269 8255361 . - . ID=transcript_4448;Q9H668 D3DR99 Q5TCZ0,CST complex subunit STN1,Oligonucleotide/oligosaccharide-binding fold-containing protein 1;Suppressor of cdc thirteen homolog;, PF09170;PF01336;, GO:0000781;GO:1990879;GO:0001650;GO:0045111;GO:0043231;GO:0005654;GO:0005634;GO:0003697;GO:0043047;GO:0042162;GO:0032211;GO:0045740;GO:0016233;GO:0000723;GO:0032201;GO:0010833;, C:chromosome, telomeric region; C:CST complex; C:fibrillar center; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:single-stranded DNA binding; F:single-stranded telomeric DNA binding; F:telomeric DNA binding;, P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA replication; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomere lengthening; scaffold18 indexed_genome mRNA 8309387 8351202 . + . ID=transcript_4449;Q9NQL1,STE20-like serine/threonine-protein kinase,CTCL tumor antigen se20-9;STE20-related serine/threonine-protein kinase;Serine/threonine-protein kinase 2;, PF00069;PF12474;, GO:0031252;GO:0005737;GO:0070062;GO:0048471;GO:0005524;GO:0045296;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0031122;GO:0046777;GO:0042981;GO:0030334;GO:0051893;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:perinuclear region of cytoplasm;, F:ATP binding; F:cadherin binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cytoplasmic microtubule organization; P:protein autophosphorylation; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of focal adhesion assembly; scaffold18 indexed_genome mRNA 8351396 8367239 . + . ID=transcript_4450;Q9NQL1,STE20-like serine/threonine-protein kinase,CTCL tumor antigen se20-9;STE20-related serine/threonine-protein kinase;Serine/threonine-protein kinase 2;, PF00069;PF12474;, GO:0031252;GO:0005737;GO:0070062;GO:0048471;GO:0005524;GO:0045296;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0031122;GO:0046777;GO:0042981;GO:0030334;GO:0051893;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:perinuclear region of cytoplasm;, F:ATP binding; F:cadherin binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cytoplasmic microtubule organization; P:protein autophosphorylation; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of focal adhesion assembly;|Q9NQL1,STE20-like serine/threonine-protein kinase,CTCL tumor antigen se20-9;STE20-related serine/threonine-protein kinase;Serine/threonine-protein kinase 2;, PF00069;PF12474;, GO:0031252;GO:0005737;GO:0070062;GO:0048471;GO:0005524;GO:0045296;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0031122;GO:0046777;GO:0042981;GO:0030334;GO:0051893;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:perinuclear region of cytoplasm;, F:ATP binding; F:cadherin binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cytoplasmic microtubule organization; P:protein autophosphorylation; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of focal adhesion assembly;|Q9NQL1,STE20-like serine/threonine-protein kinase,CTCL tumor antigen se20-9;STE20-related serine/threonine-protein kinase;Serine/threonine-protein kinase 2;, PF00069;PF12474;, GO:0031252;GO:0005737;GO:0070062;GO:0048471;GO:0005524;GO:0045296;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0031122;GO:0046777;GO:0042981;GO:0030334;GO:0051893;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:perinuclear region of cytoplasm;, F:ATP binding; F:cadherin binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cytoplasmic microtubule organization; P:protein autophosphorylation; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of focal adhesion assembly;|Q9NQL1,STE20-like serine/threonine-protein kinase,CTCL tumor antigen se20-9;STE20-related serine/threonine-protein kinase;Serine/threonine-protein kinase 2;, PF00069;PF12474;, GO:0031252;GO:0005737;GO:0070062;GO:0048471;GO:0005524;GO:0045296;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0031122;GO:0046777;GO:0042981;GO:0030334;GO:0051893;, C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:perinuclear region of cytoplasm;, F:ATP binding; F:cadherin binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cytoplasmic microtubule organization; P:protein autophosphorylation; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of focal adhesion assembly; scaffold18 indexed_genome mRNA 8368198 8370686 . - . ID=transcript_4451;Q9UMD9 Q02802 Q5JV36 Q99018 Q9NQK9 Q9UC14,Collagen alpha-1(XVII) chain,180 kDa bullous pemphigoid antigen 2;Bullous pemphigoid antigen 2;, PF01391;, GO:0005604;GO:0005911;GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0030056;GO:0005887;GO:0005886;GO:0005201;GO:0030020;GO:0007160;GO:0030199;GO:0008544;GO:0030198;GO:0031581;GO:0050776;, C:basement membrane; C:cell-cell junction; C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:hemidesmosome; C:integral component of plasma membrane; C:plasma membrane;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:cell-matrix adhesion; P:collagen fibril organization; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:regulation of immune response; scaffold18 indexed_genome mRNA 8401297 8415449 . - . ID=transcript_4452;Q9UMD9 Q02802 Q5JV36 Q99018 Q9NQK9 Q9UC14,Collagen alpha-1(XVII) chain,180 kDa bullous pemphigoid antigen 2;Bullous pemphigoid antigen 2;, PF01391;, GO:0005604;GO:0005911;GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0030056;GO:0005887;GO:0005886;GO:0005201;GO:0030020;GO:0007160;GO:0030199;GO:0008544;GO:0030198;GO:0031581;GO:0050776;, C:basement membrane; C:cell-cell junction; C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:hemidesmosome; C:integral component of plasma membrane; C:plasma membrane;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:cell-matrix adhesion; P:collagen fibril organization; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:regulation of immune response; scaffold18 indexed_genome mRNA 8464422 8468887 . + . ID=transcript_4453;Q86XK3 A8K569 B2RTV8 Q5JT39 Q5JT40 Q8WW47,Swi5-dependent recombination DNA repair protein 1 homolog,Meiosis protein 5 homolog;, PF10376;, GO:0005634;GO:0032798;GO:0030374;GO:0071391;GO:0000724;GO:0045893;, C:nucleus; C:Swi5-Sfr1 complex;, F:nuclear receptor coactivator activity;, P:cellular response to estrogen stimulus; P:double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated;|Q86XK3 A8K569 B2RTV8 Q5JT39 Q5JT40 Q8WW47,Swi5-dependent recombination DNA repair protein 1 homolog,Meiosis protein 5 homolog;, PF10376;, GO:0005634;GO:0032798;GO:0030374;GO:0071391;GO:0000724;GO:0045893;, C:nucleus; C:Swi5-Sfr1 complex;, F:nuclear receptor coactivator activity;, P:cellular response to estrogen stimulus; P:double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated;|Q86XK3 A8K569 B2RTV8 Q5JT39 Q5JT40 Q8WW47,Swi5-dependent recombination DNA repair protein 1 homolog,Meiosis protein 5 homolog;, PF10376;, GO:0005634;GO:0032798;GO:0030374;GO:0071391;GO:0000724;GO:0045893;, C:nucleus; C:Swi5-Sfr1 complex;, F:nuclear receptor coactivator activity;, P:cellular response to estrogen stimulus; P:double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated; scaffold18 indexed_genome mRNA 8471715 8490310 . - . ID=transcript_4454;Q8NDM7 Q8N9Z8 Q8NE17 Q9H085 Q9H5W3,Cilia- and flagella-associated protein 43 {ECO:0000312|HGNC:HGNC:26684},WD repeat-containing protein 96 {ECO:0000312|HGNC:HGNC:26684};, , GO:0097729;GO:0005930;GO:0005576;GO:0007420;GO:0090660;GO:0060271;GO:0044458;GO:0120197;GO:0003356;GO:0007288;, C:9+2 motile cilium; C:axoneme; C:extracellular region;, , P:brain development; P:cerebrospinal fluid circulation; P:cilium assembly; P:motile cilium assembly; P:mucociliary clearance; P:regulation of cilium beat frequency; P:sperm axoneme assembly; scaffold18 indexed_genome mRNA 8567174 8574860 . + . ID=transcript_4455;P78417 D3DRA3 F5H7H0 Q5TA03 Q7Z3T2,Glutathione S-transferase omega-1,Glutathione S-transferase omega 1-1;Glutathione-dependent dehydroascorbate reductase;Monomethylarsonic acid reductase;S-(Phenacyl)glutathione reductase;, PF14497;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0045174;GO:0004364;GO:0050610;GO:0016491;GO:0071243;GO:1901687;GO:0006749;GO:0035722;GO:0019852;GO:0032259;GO:0060315;GO:0060316;GO:0014810;GO:0010881;GO:0010880;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:glutathione dehydrogenase (ascorbate) activity; F:glutathione transferase activity; F:methylarsonate reductase activity; F:oxidoreductase activity;, P:cellular response to arsenic-containing substance; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:interleukin-12-mediated signaling pathway; P:L-ascorbic acid metabolic process; P:methylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:xenobiotic catabolic process; scaffold18 indexed_genome mRNA 8574924 8582560 . + . ID=transcript_4456;P78417 D3DRA3 F5H7H0 Q5TA03 Q7Z3T2,Glutathione S-transferase omega-1,Glutathione S-transferase omega 1-1;Glutathione-dependent dehydroascorbate reductase;Monomethylarsonic acid reductase;S-(Phenacyl)glutathione reductase;, PF14497;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0045174;GO:0004364;GO:0050610;GO:0016491;GO:0071243;GO:1901687;GO:0006749;GO:0035722;GO:0019852;GO:0032259;GO:0060315;GO:0060316;GO:0014810;GO:0010881;GO:0010880;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:glutathione dehydrogenase (ascorbate) activity; F:glutathione transferase activity; F:methylarsonate reductase activity; F:oxidoreductase activity;, P:cellular response to arsenic-containing substance; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:interleukin-12-mediated signaling pathway; P:L-ascorbic acid metabolic process; P:methylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:xenobiotic catabolic process;|P78417 D3DRA3 F5H7H0 Q5TA03 Q7Z3T2,Glutathione S-transferase omega-1,Glutathione S-transferase omega 1-1;Glutathione-dependent dehydroascorbate reductase;Monomethylarsonic acid reductase;S-(Phenacyl)glutathione reductase;, PF14497;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0045174;GO:0004364;GO:0050610;GO:0016491;GO:0071243;GO:1901687;GO:0006749;GO:0035722;GO:0019852;GO:0032259;GO:0060315;GO:0060316;GO:0014810;GO:0010881;GO:0010880;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:glutathione dehydrogenase (ascorbate) activity; F:glutathione transferase activity; F:methylarsonate reductase activity; F:oxidoreductase activity;, P:cellular response to arsenic-containing substance; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:interleukin-12-mediated signaling pathway; P:L-ascorbic acid metabolic process; P:methylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:xenobiotic catabolic process; scaffold18 indexed_genome mRNA 8593733 8602779 . + . ID=transcript_4457;P78417 D3DRA3 F5H7H0 Q5TA03 Q7Z3T2,Glutathione S-transferase omega-1,Glutathione S-transferase omega 1-1;Glutathione-dependent dehydroascorbate reductase;Monomethylarsonic acid reductase;S-(Phenacyl)glutathione reductase;, PF14497;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0045174;GO:0004364;GO:0050610;GO:0016491;GO:0071243;GO:1901687;GO:0006749;GO:0035722;GO:0019852;GO:0032259;GO:0060315;GO:0060316;GO:0014810;GO:0010881;GO:0010880;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:glutathione dehydrogenase (ascorbate) activity; F:glutathione transferase activity; F:methylarsonate reductase activity; F:oxidoreductase activity;, P:cellular response to arsenic-containing substance; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:interleukin-12-mediated signaling pathway; P:L-ascorbic acid metabolic process; P:methylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:xenobiotic catabolic process;|P78417 D3DRA3 F5H7H0 Q5TA03 Q7Z3T2,Glutathione S-transferase omega-1,Glutathione S-transferase omega 1-1;Glutathione-dependent dehydroascorbate reductase;Monomethylarsonic acid reductase;S-(Phenacyl)glutathione reductase;, PF14497;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0045174;GO:0004364;GO:0050610;GO:0016491;GO:0071243;GO:1901687;GO:0006749;GO:0035722;GO:0019852;GO:0032259;GO:0060315;GO:0060316;GO:0014810;GO:0010881;GO:0010880;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:glutathione dehydrogenase (ascorbate) activity; F:glutathione transferase activity; F:methylarsonate reductase activity; F:oxidoreductase activity;, P:cellular response to arsenic-containing substance; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:interleukin-12-mediated signaling pathway; P:L-ascorbic acid metabolic process; P:methylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:xenobiotic catabolic process;|P78417 D3DRA3 F5H7H0 Q5TA03 Q7Z3T2,Glutathione S-transferase omega-1,Glutathione S-transferase omega 1-1;Glutathione-dependent dehydroascorbate reductase;Monomethylarsonic acid reductase;S-(Phenacyl)glutathione reductase;, PF14497;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0045174;GO:0004364;GO:0050610;GO:0016491;GO:0071243;GO:1901687;GO:0006749;GO:0035722;GO:0019852;GO:0032259;GO:0060315;GO:0060316;GO:0014810;GO:0010881;GO:0010880;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:glutathione dehydrogenase (ascorbate) activity; F:glutathione transferase activity; F:methylarsonate reductase activity; F:oxidoreductase activity;, P:cellular response to arsenic-containing substance; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:interleukin-12-mediated signaling pathway; P:L-ascorbic acid metabolic process; P:methylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:xenobiotic catabolic process;|P78417 D3DRA3 F5H7H0 Q5TA03 Q7Z3T2,Glutathione S-transferase omega-1,Glutathione S-transferase omega 1-1;Glutathione-dependent dehydroascorbate reductase;Monomethylarsonic acid reductase;S-(Phenacyl)glutathione reductase;, PF14497;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0045174;GO:0004364;GO:0050610;GO:0016491;GO:0071243;GO:1901687;GO:0006749;GO:0035722;GO:0019852;GO:0032259;GO:0060315;GO:0060316;GO:0014810;GO:0010881;GO:0010880;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:glutathione dehydrogenase (ascorbate) activity; F:glutathione transferase activity; F:methylarsonate reductase activity; F:oxidoreductase activity;, P:cellular response to arsenic-containing substance; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:interleukin-12-mediated signaling pathway; P:L-ascorbic acid metabolic process; P:methylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:xenobiotic catabolic process;|P78417 D3DRA3 F5H7H0 Q5TA03 Q7Z3T2,Glutathione S-transferase omega-1,Glutathione S-transferase omega 1-1;Glutathione-dependent dehydroascorbate reductase;Monomethylarsonic acid reductase;S-(Phenacyl)glutathione reductase;, PF14497;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0045174;GO:0004364;GO:0050610;GO:0016491;GO:0071243;GO:1901687;GO:0006749;GO:0035722;GO:0019852;GO:0032259;GO:0060315;GO:0060316;GO:0014810;GO:0010881;GO:0010880;GO:0042178;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:glutathione dehydrogenase (ascorbate) activity; F:glutathione transferase activity; F:methylarsonate reductase activity; F:oxidoreductase activity;, P:cellular response to arsenic-containing substance; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:interleukin-12-mediated signaling pathway; P:L-ascorbic acid metabolic process; P:methylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:xenobiotic catabolic process; scaffold18 indexed_genome mRNA 8637501 8641216 . - . ID=transcript_4458;Q8IWB1 D3DRA5 Q5JU17 Q96MS8 Q9C0A9,Inositol 1,4,5-trisphosphate receptor-interacting protein,Protein DANGER;, PF03281;, GO:0016021;GO:0016020;GO:0005640;GO:0005886;GO:0004860;GO:1902042;, C:integral component of membrane; C:membrane; C:nuclear outer membrane; C:plasma membrane;, F:protein kinase inhibitor activity;, P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; scaffold18 indexed_genome mRNA 9567166 9598046 . + . ID=transcript_4459;Q9UPU3 Q5VXF9 Q9NQJ2,VPS10 domain-containing receptor SorCS3,, PF00801;PF15902;PF15901;, GO:0098978;GO:0016021;GO:0099061;GO:0016020;GO:0008188;GO:0007612;GO:0007613;GO:0007218;GO:1900452;, C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:membrane;, F:neuropeptide receptor activity;, P:learning; P:memory; P:neuropeptide signaling pathway; P:regulation of long-term synaptic depression;|Q9UPU3 Q5VXF9 Q9NQJ2,VPS10 domain-containing receptor SorCS3,, PF00801;PF15902;PF15901;, GO:0098978;GO:0016021;GO:0099061;GO:0016020;GO:0008188;GO:0007612;GO:0007613;GO:0007218;GO:1900452;, C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:membrane;, F:neuropeptide receptor activity;, P:learning; P:memory; P:neuropeptide signaling pathway; P:regulation of long-term synaptic depression; scaffold18 indexed_genome mRNA 10897943 10935372 . - . ID=transcript_4460;Q9H1Y2,VPS10 domain-containing receptor SorCS1,, PF00801;PF15902;PF15901;, GO:0005794;GO:0016021;GO:0016020;GO:0008188;GO:0007218;GO:0006892;, C:Golgi apparatus; C:integral component of membrane; C:membrane;, F:neuropeptide receptor activity;, P:neuropeptide signaling pathway; P:post-Golgi vesicle-mediated transport; scaffold18 indexed_genome mRNA 10953607 11002279 . - . ID=transcript_4461;Q9H1Y2,VPS10 domain-containing receptor SorCS1,, PF00801;PF15902;PF15901;, GO:0005794;GO:0016021;GO:0016020;GO:0008188;GO:0007218;GO:0006892;, C:Golgi apparatus; C:integral component of membrane; C:membrane;, F:neuropeptide receptor activity;, P:neuropeptide signaling pathway; P:post-Golgi vesicle-mediated transport; scaffold18 indexed_genome mRNA 13629957 13684511 . - . ID=transcript_4462;Q9NQW7 A8K071 G5E9Y2 G8JLB2 O15250 Q53EX6 Q8N3Q0 Q96D23,Xaa-Pro aminopeptidase 1,Aminoacylproline aminopeptidase;Cytosolic aminopeptidase P;Soluble aminopeptidase P;X-Pro aminopeptidase 1;X-prolyl aminopeptidase 1, soluble;, PF01321;PF00557;PF16188;, GO:0005737;GO:0005829;GO:0070062;GO:0004177;GO:0030145;GO:0070006;GO:0042803;GO:0010815;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aminopeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:protein homodimerization activity;, P:bradykinin catabolic process; P:proteolysis;|Q9NQW7 A8K071 G5E9Y2 G8JLB2 O15250 Q53EX6 Q8N3Q0 Q96D23,Xaa-Pro aminopeptidase 1,Aminoacylproline aminopeptidase;Cytosolic aminopeptidase P;Soluble aminopeptidase P;X-Pro aminopeptidase 1;X-prolyl aminopeptidase 1, soluble;, PF01321;PF00557;PF16188;, GO:0005737;GO:0005829;GO:0070062;GO:0004177;GO:0030145;GO:0070006;GO:0042803;GO:0010815;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aminopeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:protein homodimerization activity;, P:bradykinin catabolic process; P:proteolysis;|Q9NQW7 A8K071 G5E9Y2 G8JLB2 O15250 Q53EX6 Q8N3Q0 Q96D23,Xaa-Pro aminopeptidase 1,Aminoacylproline aminopeptidase;Cytosolic aminopeptidase P;Soluble aminopeptidase P;X-Pro aminopeptidase 1;X-prolyl aminopeptidase 1, soluble;, PF01321;PF00557;PF16188;, GO:0005737;GO:0005829;GO:0070062;GO:0004177;GO:0030145;GO:0070006;GO:0042803;GO:0010815;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aminopeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:protein homodimerization activity;, P:bradykinin catabolic process; P:proteolysis;|Q9NQW7 A8K071 G5E9Y2 G8JLB2 O15250 Q53EX6 Q8N3Q0 Q96D23,Xaa-Pro aminopeptidase 1,Aminoacylproline aminopeptidase;Cytosolic aminopeptidase P;Soluble aminopeptidase P;X-Pro aminopeptidase 1;X-prolyl aminopeptidase 1, soluble;, PF01321;PF00557;PF16188;, GO:0005737;GO:0005829;GO:0070062;GO:0004177;GO:0030145;GO:0070006;GO:0042803;GO:0010815;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aminopeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:protein homodimerization activity;, P:bradykinin catabolic process; P:proteolysis;|Q9NQW7 A8K071 G5E9Y2 G8JLB2 O15250 Q53EX6 Q8N3Q0 Q96D23,Xaa-Pro aminopeptidase 1,Aminoacylproline aminopeptidase;Cytosolic aminopeptidase P;Soluble aminopeptidase P;X-Pro aminopeptidase 1;X-prolyl aminopeptidase 1, soluble;, PF01321;PF00557;PF16188;, GO:0005737;GO:0005829;GO:0070062;GO:0004177;GO:0030145;GO:0070006;GO:0042803;GO:0010815;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aminopeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:protein homodimerization activity;, P:bradykinin catabolic process; P:proteolysis; scaffold18 indexed_genome mRNA 13777086 13908648 . + . ID=transcript_4463;Q9UEY8 D3DRA8 O43243 Q5VU09 Q92773 Q9UEY7,Gamma-adducin,Adducin-like protein 70;, PF00596;, GO:0005903;GO:0005938;GO:0005911;GO:0000794;GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0014069;GO:0051015;GO:0005516;GO:0005200;GO:0051016;GO:0055085;, C:brush border; C:cell cortex; C:cell-cell junction; C:condensed nuclear chromosome; C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane; C:postsynaptic density;, F:actin filament binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:barbed-end actin filament capping; P:transmembrane transport;|Q9UEY8 D3DRA8 O43243 Q5VU09 Q92773 Q9UEY7,Gamma-adducin,Adducin-like protein 70;, PF00596;, GO:0005903;GO:0005938;GO:0005911;GO:0000794;GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0014069;GO:0051015;GO:0005516;GO:0005200;GO:0051016;GO:0055085;, C:brush border; C:cell cortex; C:cell-cell junction; C:condensed nuclear chromosome; C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane; C:postsynaptic density;, F:actin filament binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:barbed-end actin filament capping; P:transmembrane transport;|Q9UEY8 D3DRA8 O43243 Q5VU09 Q92773 Q9UEY7,Gamma-adducin,Adducin-like protein 70;, PF00596;, GO:0005903;GO:0005938;GO:0005911;GO:0000794;GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0014069;GO:0051015;GO:0005516;GO:0005200;GO:0051016;GO:0055085;, C:brush border; C:cell cortex; C:cell-cell junction; C:condensed nuclear chromosome; C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane; C:postsynaptic density;, F:actin filament binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:barbed-end actin filament capping; P:transmembrane transport;|Q9UEY8 D3DRA8 O43243 Q5VU09 Q92773 Q9UEY7,Gamma-adducin,Adducin-like protein 70;, PF00596;, GO:0005903;GO:0005938;GO:0005911;GO:0000794;GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0014069;GO:0051015;GO:0005516;GO:0005200;GO:0051016;GO:0055085;, C:brush border; C:cell cortex; C:cell-cell junction; C:condensed nuclear chromosome; C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane; C:postsynaptic density;, F:actin filament binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:barbed-end actin filament capping; P:transmembrane transport;|Q9UEY8 D3DRA8 O43243 Q5VU09 Q92773 Q9UEY7,Gamma-adducin,Adducin-like protein 70;, PF00596;, GO:0005903;GO:0005938;GO:0005911;GO:0000794;GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0014069;GO:0051015;GO:0005516;GO:0005200;GO:0051016;GO:0055085;, C:brush border; C:cell cortex; C:cell-cell junction; C:condensed nuclear chromosome; C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane; C:postsynaptic density;, F:actin filament binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:barbed-end actin filament capping; P:transmembrane transport;|Q9UEY8 D3DRA8 O43243 Q5VU09 Q92773 Q9UEY7,Gamma-adducin,Adducin-like protein 70;, PF00596;, GO:0005903;GO:0005938;GO:0005911;GO:0000794;GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0014069;GO:0051015;GO:0005516;GO:0005200;GO:0051016;GO:0055085;, C:brush border; C:cell cortex; C:cell-cell junction; C:condensed nuclear chromosome; C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane; C:postsynaptic density;, F:actin filament binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:barbed-end actin filament capping; P:transmembrane transport;|Q9UEY8 D3DRA8 O43243 Q5VU09 Q92773 Q9UEY7,Gamma-adducin,Adducin-like protein 70;, PF00596;, GO:0005903;GO:0005938;GO:0005911;GO:0000794;GO:0005856;GO:0005829;GO:0016020;GO:0005886;GO:0014069;GO:0051015;GO:0005516;GO:0005200;GO:0051016;GO:0055085;, C:brush border; C:cell cortex; C:cell-cell junction; C:condensed nuclear chromosome; C:cytoskeleton; C:cytosol; C:membrane; C:plasma membrane; C:postsynaptic density;, F:actin filament binding; F:calmodulin binding; F:structural constituent of cytoskeleton;, P:barbed-end actin filament capping; P:transmembrane transport; scaffold18 indexed_genome mRNA 13973865 14066886 . + . ID=transcript_4464;P50539 B1ANN7 D3DR25 D3DRA9 Q15887 Q6FHW2 Q96E53,Max-interacting protein 1,Class C basic helix-loop-helix protein 11;, PF00010;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0090575;GO:0000981;GO:0046983;GO:0000978;GO:0000122;GO:0006357;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P50539 B1ANN7 D3DR25 D3DRA9 Q15887 Q6FHW2 Q96E53,Max-interacting protein 1,Class C basic helix-loop-helix protein 11;, PF00010;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0090575;GO:0000981;GO:0046983;GO:0000978;GO:0000122;GO:0006357;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|P50539 B1ANN7 D3DR25 D3DRA9 Q15887 Q6FHW2 Q96E53,Max-interacting protein 1,Class C basic helix-loop-helix protein 11;, PF00010;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0090575;GO:0000981;GO:0046983;GO:0000978;GO:0000122;GO:0006357;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold18 indexed_genome mRNA 14067073 14079897 . - . ID=transcript_4465;O75940 B2RA27 D3DRB1 Q5T3K6,Survival of motor neuron-related-splicing factor 30,30 kDa splicing factor SMNrp;SMN-related protein;Survival motor neuron domain-containing protein 1;, PF06003;, GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0006915;GO:0000398;GO:0000375;, C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions;|O75940 B2RA27 D3DRB1 Q5T3K6,Survival of motor neuron-related-splicing factor 30,30 kDa splicing factor SMNrp;SMN-related protein;Survival motor neuron domain-containing protein 1;, PF06003;, GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0006915;GO:0000398;GO:0000375;, C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions;|O75940 B2RA27 D3DRB1 Q5T3K6,Survival of motor neuron-related-splicing factor 30,30 kDa splicing factor SMNrp;SMN-related protein;Survival motor neuron domain-containing protein 1;, PF06003;, GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0006915;GO:0000398;GO:0000375;, C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions;|O75940 B2RA27 D3DRB1 Q5T3K6,Survival of motor neuron-related-splicing factor 30,30 kDa splicing factor SMNrp;SMN-related protein;Survival motor neuron domain-containing protein 1;, PF06003;, GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0006915;GO:0000398;GO:0000375;, C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; scaffold18 indexed_genome mRNA 14267565 14273674 . + . ID=transcript_4466;Q16690 Q12997 Q5T603,Dual specificity protein phosphatase 5,Dual specificity protein phosphatase hVH3;, PF00581;, GO:0005737;GO:0005654;GO:0005634;GO:0017017;GO:0051019;GO:0016791;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0008330;GO:0000187;GO:0016311;GO:0001706;GO:0000188;GO:0000165;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:activation of MAPK activity; P:dephosphorylation; P:endoderm formation; P:inactivation of MAPK activity; P:MAPK cascade; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation;|Q16690 Q12997 Q5T603,Dual specificity protein phosphatase 5,Dual specificity protein phosphatase hVH3;, PF00581;, GO:0005737;GO:0005654;GO:0005634;GO:0017017;GO:0051019;GO:0016791;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0008330;GO:0000187;GO:0016311;GO:0001706;GO:0000188;GO:0000165;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:activation of MAPK activity; P:dephosphorylation; P:endoderm formation; P:inactivation of MAPK activity; P:MAPK cascade; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation;|Q16690 Q12997 Q5T603,Dual specificity protein phosphatase 5,Dual specificity protein phosphatase hVH3;, PF00581;, GO:0005737;GO:0005654;GO:0005634;GO:0017017;GO:0051019;GO:0016791;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0008330;GO:0000187;GO:0016311;GO:0001706;GO:0000188;GO:0000165;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:activation of MAPK activity; P:dephosphorylation; P:endoderm formation; P:inactivation of MAPK activity; P:MAPK cascade; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; scaffold18 indexed_genome mRNA 14316239 14325605 . + . ID=transcript_4467;Q9UQE7 A8K156 O60464 Q5T482,Structural maintenance of chromosomes protein 3,Basement membrane-associated chondroitin proteoglycan;Chondroitin sulfate proteoglycan 6;Chromosome-associated polypeptide;, PF06470;PF02463;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0000800;GO:0030893;GO:0097431;GO:0016363;GO:0034991;GO:0005654;GO:0005524;GO:0016887;GO:0048487;GO:0003682;GO:0070840;GO:0036033;GO:0003777;GO:0046982;GO:0051301;GO:0006281;GO:0051321;GO:0000278;GO:0090307;GO:0006275;GO:0007062;GO:0019827;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:lateral element; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:chromatin binding; F:dynein complex binding; F:mediator complex binding; F:microtubule motor activity; F:protein heterodimerization activity;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic cell cycle; P:mitotic spindle assembly; P:regulation of DNA replication; P:sister chromatid cohesion; P:stem cell population maintenance;|Q9UQE7 A8K156 O60464 Q5T482,Structural maintenance of chromosomes protein 3,Basement membrane-associated chondroitin proteoglycan;Chondroitin sulfate proteoglycan 6;Chromosome-associated polypeptide;, PF06470;PF02463;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0000800;GO:0030893;GO:0097431;GO:0016363;GO:0034991;GO:0005654;GO:0005524;GO:0016887;GO:0048487;GO:0003682;GO:0070840;GO:0036033;GO:0003777;GO:0046982;GO:0051301;GO:0006281;GO:0051321;GO:0000278;GO:0090307;GO:0006275;GO:0007062;GO:0019827;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:lateral element; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:chromatin binding; F:dynein complex binding; F:mediator complex binding; F:microtubule motor activity; F:protein heterodimerization activity;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic cell cycle; P:mitotic spindle assembly; P:regulation of DNA replication; P:sister chromatid cohesion; P:stem cell population maintenance; scaffold18 indexed_genome mRNA 14329050 14354777 . + . ID=transcript_4468;Q9UQE7 A8K156 O60464 Q5T482,Structural maintenance of chromosomes protein 3,Basement membrane-associated chondroitin proteoglycan;Chondroitin sulfate proteoglycan 6;Chromosome-associated polypeptide;, PF06470;PF02463;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0000800;GO:0030893;GO:0097431;GO:0016363;GO:0034991;GO:0005654;GO:0005524;GO:0016887;GO:0048487;GO:0003682;GO:0070840;GO:0036033;GO:0003777;GO:0046982;GO:0051301;GO:0006281;GO:0051321;GO:0000278;GO:0090307;GO:0006275;GO:0007062;GO:0019827;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:lateral element; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:chromatin binding; F:dynein complex binding; F:mediator complex binding; F:microtubule motor activity; F:protein heterodimerization activity;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic cell cycle; P:mitotic spindle assembly; P:regulation of DNA replication; P:sister chromatid cohesion; P:stem cell population maintenance;|Q9UQE7 A8K156 O60464 Q5T482,Structural maintenance of chromosomes protein 3,Basement membrane-associated chondroitin proteoglycan;Chondroitin sulfate proteoglycan 6;Chromosome-associated polypeptide;, PF06470;PF02463;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0000800;GO:0030893;GO:0097431;GO:0016363;GO:0034991;GO:0005654;GO:0005524;GO:0016887;GO:0048487;GO:0003682;GO:0070840;GO:0036033;GO:0003777;GO:0046982;GO:0051301;GO:0006281;GO:0051321;GO:0000278;GO:0090307;GO:0006275;GO:0007062;GO:0019827;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:lateral element; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:chromatin binding; F:dynein complex binding; F:mediator complex binding; F:microtubule motor activity; F:protein heterodimerization activity;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic cell cycle; P:mitotic spindle assembly; P:regulation of DNA replication; P:sister chromatid cohesion; P:stem cell population maintenance;|Q9UQE7 A8K156 O60464 Q5T482,Structural maintenance of chromosomes protein 3,Basement membrane-associated chondroitin proteoglycan;Chondroitin sulfate proteoglycan 6;Chromosome-associated polypeptide;, PF06470;PF02463;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0000800;GO:0030893;GO:0097431;GO:0016363;GO:0034991;GO:0005654;GO:0005524;GO:0016887;GO:0048487;GO:0003682;GO:0070840;GO:0036033;GO:0003777;GO:0046982;GO:0051301;GO:0006281;GO:0051321;GO:0000278;GO:0090307;GO:0006275;GO:0007062;GO:0019827;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:lateral element; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:chromatin binding; F:dynein complex binding; F:mediator complex binding; F:microtubule motor activity; F:protein heterodimerization activity;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic cell cycle; P:mitotic spindle assembly; P:regulation of DNA replication; P:sister chromatid cohesion; P:stem cell population maintenance;|Q9UQE7 A8K156 O60464 Q5T482,Structural maintenance of chromosomes protein 3,Basement membrane-associated chondroitin proteoglycan;Chondroitin sulfate proteoglycan 6;Chromosome-associated polypeptide;, PF06470;PF02463;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0000800;GO:0030893;GO:0097431;GO:0016363;GO:0034991;GO:0005654;GO:0005524;GO:0016887;GO:0048487;GO:0003682;GO:0070840;GO:0036033;GO:0003777;GO:0046982;GO:0051301;GO:0006281;GO:0051321;GO:0000278;GO:0090307;GO:0006275;GO:0007062;GO:0019827;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:lateral element; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:chromatin binding; F:dynein complex binding; F:mediator complex binding; F:microtubule motor activity; F:protein heterodimerization activity;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic cell cycle; P:mitotic spindle assembly; P:regulation of DNA replication; P:sister chromatid cohesion; P:stem cell population maintenance;|Q9UQE7 A8K156 O60464 Q5T482,Structural maintenance of chromosomes protein 3,Basement membrane-associated chondroitin proteoglycan;Chondroitin sulfate proteoglycan 6;Chromosome-associated polypeptide;, PF06470;PF02463;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0000800;GO:0030893;GO:0097431;GO:0016363;GO:0034991;GO:0005654;GO:0005524;GO:0016887;GO:0048487;GO:0003682;GO:0070840;GO:0036033;GO:0003777;GO:0046982;GO:0051301;GO:0006281;GO:0051321;GO:0000278;GO:0090307;GO:0006275;GO:0007062;GO:0019827;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:lateral element; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:chromatin binding; F:dynein complex binding; F:mediator complex binding; F:microtubule motor activity; F:protein heterodimerization activity;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic cell cycle; P:mitotic spindle assembly; P:regulation of DNA replication; P:sister chromatid cohesion; P:stem cell population maintenance;|Q9UQE7 A8K156 O60464 Q5T482,Structural maintenance of chromosomes protein 3,Basement membrane-associated chondroitin proteoglycan;Chondroitin sulfate proteoglycan 6;Chromosome-associated polypeptide;, PF06470;PF02463;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0000800;GO:0030893;GO:0097431;GO:0016363;GO:0034991;GO:0005654;GO:0005524;GO:0016887;GO:0048487;GO:0003682;GO:0070840;GO:0036033;GO:0003777;GO:0046982;GO:0051301;GO:0006281;GO:0051321;GO:0000278;GO:0090307;GO:0006275;GO:0007062;GO:0019827;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:lateral element; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:chromatin binding; F:dynein complex binding; F:mediator complex binding; F:microtubule motor activity; F:protein heterodimerization activity;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic cell cycle; P:mitotic spindle assembly; P:regulation of DNA replication; P:sister chromatid cohesion; P:stem cell population maintenance;|Q9UQE7 A8K156 O60464 Q5T482,Structural maintenance of chromosomes protein 3,Basement membrane-associated chondroitin proteoglycan;Chondroitin sulfate proteoglycan 6;Chromosome-associated polypeptide;, PF06470;PF02463;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0000800;GO:0030893;GO:0097431;GO:0016363;GO:0034991;GO:0005654;GO:0005524;GO:0016887;GO:0048487;GO:0003682;GO:0070840;GO:0036033;GO:0003777;GO:0046982;GO:0051301;GO:0006281;GO:0051321;GO:0000278;GO:0090307;GO:0006275;GO:0007062;GO:0019827;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:lateral element; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:chromatin binding; F:dynein complex binding; F:mediator complex binding; F:microtubule motor activity; F:protein heterodimerization activity;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic cell cycle; P:mitotic spindle assembly; P:regulation of DNA replication; P:sister chromatid cohesion; P:stem cell population maintenance;|Q9UQE7 A8K156 O60464 Q5T482,Structural maintenance of chromosomes protein 3,Basement membrane-associated chondroitin proteoglycan;Chondroitin sulfate proteoglycan 6;Chromosome-associated polypeptide;, PF06470;PF02463;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0000800;GO:0030893;GO:0097431;GO:0016363;GO:0034991;GO:0005654;GO:0005524;GO:0016887;GO:0048487;GO:0003682;GO:0070840;GO:0036033;GO:0003777;GO:0046982;GO:0051301;GO:0006281;GO:0051321;GO:0000278;GO:0090307;GO:0006275;GO:0007062;GO:0019827;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:lateral element; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nuclear meiotic cohesin complex; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:beta-tubulin binding; F:chromatin binding; F:dynein complex binding; F:mediator complex binding; F:microtubule motor activity; F:protein heterodimerization activity;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic cell cycle; P:mitotic spindle assembly; P:regulation of DNA replication; P:sister chromatid cohesion; P:stem cell population maintenance; scaffold18 indexed_genome mRNA 14532791 14589409 . + . ID=transcript_4469;Q5T481 A6NIP5 B5A868 Q5JVI1,RNA-binding protein 20,RNA-binding motif protein 20;, , GO:0005634;GO:0003729;GO:0003723;GO:0008270;GO:0007507;GO:0006397;GO:0033120;GO:0043484;GO:0008380;, C:nucleus;, F:mRNA binding; F:RNA binding; F:zinc ion binding;, P:heart development; P:mRNA processing; P:positive regulation of RNA splicing; P:regulation of RNA splicing; P:RNA splicing;|Q5T481 A6NIP5 B5A868 Q5JVI1,RNA-binding protein 20,RNA-binding motif protein 20;, , GO:0005634;GO:0003729;GO:0003723;GO:0008270;GO:0007507;GO:0006397;GO:0033120;GO:0043484;GO:0008380;, C:nucleus;, F:mRNA binding; F:RNA binding; F:zinc ion binding;, P:heart development; P:mRNA processing; P:positive regulation of RNA splicing; P:regulation of RNA splicing; P:RNA splicing;|Q5T481 A6NIP5 B5A868 Q5JVI1,RNA-binding protein 20,RNA-binding motif protein 20;, , GO:0005634;GO:0003729;GO:0003723;GO:0008270;GO:0007507;GO:0006397;GO:0033120;GO:0043484;GO:0008380;, C:nucleus;, F:mRNA binding; F:RNA binding; F:zinc ion binding;, P:heart development; P:mRNA processing; P:positive regulation of RNA splicing; P:regulation of RNA splicing; P:RNA splicing;|Q5T481 A6NIP5 B5A868 Q5JVI1,RNA-binding protein 20,RNA-binding motif protein 20;, , GO:0005634;GO:0003729;GO:0003723;GO:0008270;GO:0007507;GO:0006397;GO:0033120;GO:0043484;GO:0008380;, C:nucleus;, F:mRNA binding; F:RNA binding; F:zinc ion binding;, P:heart development; P:mRNA processing; P:positive regulation of RNA splicing; P:regulation of RNA splicing; P:RNA splicing; scaffold18 indexed_genome mRNA 14625480 14656769 . + . ID=transcript_4470;Q53EL6 B2RCV4 B5ME91 O15501 Q5VZS6 Q6PJI5 Q8TAR5 Q99834,Programmed cell death protein 4,Neoplastic transformation inhibitor protein;Nuclear antigen H731-like;Protein 197/15a;, PF02847;, GO:0005737;GO:0005829;GO:0005634;GO:0003723;GO:0006915;GO:0030509;GO:0007569;GO:0071222;GO:0060940;GO:0035722;GO:0043066;GO:0045786;GO:1900016;GO:0043508;GO:1904761;GO:0045892;GO:1905064;GO:1904706;GO:2000353;GO:0050729;GO:1901224;GO:1905461;, C:cytoplasm; C:cytosol; C:nucleus;, F:RNA binding;, P:apoptotic process; P:BMP signaling pathway; P:cell aging; P:cellular response to lipopolysaccharide; P:epithelial to mesenchymal transition involved in cardiac fibroblast development; P:interleukin-12-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell cycle; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of JUN kinase activity; P:negative regulation of myofibroblast differentiation; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular associated smooth muscle cell differentiation; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of vascular associated smooth muscle cell apoptotic process;|Q53EL6 B2RCV4 B5ME91 O15501 Q5VZS6 Q6PJI5 Q8TAR5 Q99834,Programmed cell death protein 4,Neoplastic transformation inhibitor protein;Nuclear antigen H731-like;Protein 197/15a;, PF02847;, GO:0005737;GO:0005829;GO:0005634;GO:0003723;GO:0006915;GO:0030509;GO:0007569;GO:0071222;GO:0060940;GO:0035722;GO:0043066;GO:0045786;GO:1900016;GO:0043508;GO:1904761;GO:0045892;GO:1905064;GO:1904706;GO:2000353;GO:0050729;GO:1901224;GO:1905461;, C:cytoplasm; C:cytosol; C:nucleus;, F:RNA binding;, P:apoptotic process; P:BMP signaling pathway; P:cell aging; P:cellular response to lipopolysaccharide; P:epithelial to mesenchymal transition involved in cardiac fibroblast development; P:interleukin-12-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell cycle; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of JUN kinase activity; P:negative regulation of myofibroblast differentiation; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular associated smooth muscle cell differentiation; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of vascular associated smooth muscle cell apoptotic process;|Q53EL6 B2RCV4 B5ME91 O15501 Q5VZS6 Q6PJI5 Q8TAR5 Q99834,Programmed cell death protein 4,Neoplastic transformation inhibitor protein;Nuclear antigen H731-like;Protein 197/15a;, PF02847;, GO:0005737;GO:0005829;GO:0005634;GO:0003723;GO:0006915;GO:0030509;GO:0007569;GO:0071222;GO:0060940;GO:0035722;GO:0043066;GO:0045786;GO:1900016;GO:0043508;GO:1904761;GO:0045892;GO:1905064;GO:1904706;GO:2000353;GO:0050729;GO:1901224;GO:1905461;, C:cytoplasm; C:cytosol; C:nucleus;, F:RNA binding;, P:apoptotic process; P:BMP signaling pathway; P:cell aging; P:cellular response to lipopolysaccharide; P:epithelial to mesenchymal transition involved in cardiac fibroblast development; P:interleukin-12-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell cycle; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of JUN kinase activity; P:negative regulation of myofibroblast differentiation; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular associated smooth muscle cell differentiation; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of vascular associated smooth muscle cell apoptotic process;|Q53EL6 B2RCV4 B5ME91 O15501 Q5VZS6 Q6PJI5 Q8TAR5 Q99834,Programmed cell death protein 4,Neoplastic transformation inhibitor protein;Nuclear antigen H731-like;Protein 197/15a;, PF02847;, GO:0005737;GO:0005829;GO:0005634;GO:0003723;GO:0006915;GO:0030509;GO:0007569;GO:0071222;GO:0060940;GO:0035722;GO:0043066;GO:0045786;GO:1900016;GO:0043508;GO:1904761;GO:0045892;GO:1905064;GO:1904706;GO:2000353;GO:0050729;GO:1901224;GO:1905461;, C:cytoplasm; C:cytosol; C:nucleus;, F:RNA binding;, P:apoptotic process; P:BMP signaling pathway; P:cell aging; P:cellular response to lipopolysaccharide; P:epithelial to mesenchymal transition involved in cardiac fibroblast development; P:interleukin-12-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell cycle; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of JUN kinase activity; P:negative regulation of myofibroblast differentiation; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular associated smooth muscle cell differentiation; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of vascular associated smooth muscle cell apoptotic process;|Q53EL6 B2RCV4 B5ME91 O15501 Q5VZS6 Q6PJI5 Q8TAR5 Q99834,Programmed cell death protein 4,Neoplastic transformation inhibitor protein;Nuclear antigen H731-like;Protein 197/15a;, PF02847;, GO:0005737;GO:0005829;GO:0005634;GO:0003723;GO:0006915;GO:0030509;GO:0007569;GO:0071222;GO:0060940;GO:0035722;GO:0043066;GO:0045786;GO:1900016;GO:0043508;GO:1904761;GO:0045892;GO:1905064;GO:1904706;GO:2000353;GO:0050729;GO:1901224;GO:1905461;, C:cytoplasm; C:cytosol; C:nucleus;, F:RNA binding;, P:apoptotic process; P:BMP signaling pathway; P:cell aging; P:cellular response to lipopolysaccharide; P:epithelial to mesenchymal transition involved in cardiac fibroblast development; P:interleukin-12-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell cycle; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of JUN kinase activity; P:negative regulation of myofibroblast differentiation; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular associated smooth muscle cell differentiation; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of vascular associated smooth muscle cell apoptotic process; scaffold18 indexed_genome mRNA 14656772 14766267 . + . ID=transcript_4471;A8MTZ0 E9PIY9 E9PM41 E9PRI7,BBSome-interacting protein 1,BBSome-interacting protein of 10 kDa;, PF14777;, GO:0034464;GO:0005737;GO:0005829;GO:0060271;GO:0015031;GO:0097500;, C:BBSome; C:cytoplasm; C:cytosol;, , P:cilium assembly; P:protein transport; P:receptor localization to non-motile cilium;|A8MTZ0 E9PIY9 E9PM41 E9PRI7,BBSome-interacting protein 1,BBSome-interacting protein of 10 kDa;, PF14777;, GO:0034464;GO:0005737;GO:0005829;GO:0060271;GO:0015031;GO:0097500;, C:BBSome; C:cytoplasm; C:cytosol;, , P:cilium assembly; P:protein transport; P:receptor localization to non-motile cilium;|Q9UQ13 A8K9W8 B3KR23 O76063 Q5VZS8 Q5VZS9,Leucine-rich repeat protein SHOC-2,Protein soc-2 homolog;Protein sur-8 homolog;, PF13855;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000164;GO:0008157;GO:0019903;GO:0019888;GO:0008543;GO:0000165;GO:0046579;GO:0007265;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:protein phosphatase type 1 complex;, F:protein phosphatase 1 binding; F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:positive regulation of Ras protein signal transduction; P:Ras protein signal transduction; P:signal transduction;|A8MTZ0 E9PIY9 E9PM41 E9PRI7,BBSome-interacting protein 1,BBSome-interacting protein of 10 kDa;, PF14777;, GO:0034464;GO:0005737;GO:0005829;GO:0060271;GO:0015031;GO:0097500;, C:BBSome; C:cytoplasm; C:cytosol;, , P:cilium assembly; P:protein transport; P:receptor localization to non-motile cilium; scaffold18 indexed_genome mRNA 15821478 15877513 . + . ID=transcript_4472;Q9HCL2 Q5VW51 Q86TA3,Glycerol-3-phosphate acyltransferase 1, mitochondrial {ECO:0000305},, PF01553;, GO:0016021;GO:0031966;GO:0005741;GO:0005886;GO:0004366;GO:0102420;GO:0006637;GO:0016024;GO:0051607;GO:0006651;GO:0055089;GO:0006631;GO:0006072;GO:0070236;GO:0006654;GO:0006655;GO:0008654;GO:0055091;GO:0042104;GO:0040018;GO:0001817;GO:0033146;GO:0019216;GO:0009749;GO:0019432;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:plasma membrane;, F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:acyl-CoA metabolic process; P:CDP-diacylglycerol biosynthetic process; P:defense response to virus; P:diacylglycerol biosynthetic process; P:fatty acid homeostasis; P:fatty acid metabolic process; P:glycerol-3-phosphate metabolic process; P:negative regulation of activation-induced cell death of T cells; P:phosphatidic acid biosynthetic process; P:phosphatidylglycerol biosynthetic process; P:phospholipid biosynthetic process; P:phospholipid homeostasis; P:positive regulation of activated T cell proliferation; P:positive regulation of multicellular organism growth; P:regulation of cytokine production; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:response to glucose; P:triglyceride biosynthetic process;|Q9HCL2 Q5VW51 Q86TA3,Glycerol-3-phosphate acyltransferase 1, mitochondrial {ECO:0000305},, PF01553;, GO:0016021;GO:0031966;GO:0005741;GO:0005886;GO:0004366;GO:0102420;GO:0006637;GO:0016024;GO:0051607;GO:0006651;GO:0055089;GO:0006631;GO:0006072;GO:0070236;GO:0006654;GO:0006655;GO:0008654;GO:0055091;GO:0042104;GO:0040018;GO:0001817;GO:0033146;GO:0019216;GO:0009749;GO:0019432;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:plasma membrane;, F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:acyl-CoA metabolic process; P:CDP-diacylglycerol biosynthetic process; P:defense response to virus; P:diacylglycerol biosynthetic process; P:fatty acid homeostasis; P:fatty acid metabolic process; P:glycerol-3-phosphate metabolic process; P:negative regulation of activation-induced cell death of T cells; P:phosphatidic acid biosynthetic process; P:phosphatidylglycerol biosynthetic process; P:phospholipid biosynthetic process; P:phospholipid homeostasis; P:positive regulation of activated T cell proliferation; P:positive regulation of multicellular organism growth; P:regulation of cytokine production; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:response to glucose; P:triglyceride biosynthetic process;|Q9HCL2 Q5VW51 Q86TA3,Glycerol-3-phosphate acyltransferase 1, mitochondrial {ECO:0000305},, PF01553;, GO:0016021;GO:0031966;GO:0005741;GO:0005886;GO:0004366;GO:0102420;GO:0006637;GO:0016024;GO:0051607;GO:0006651;GO:0055089;GO:0006631;GO:0006072;GO:0070236;GO:0006654;GO:0006655;GO:0008654;GO:0055091;GO:0042104;GO:0040018;GO:0001817;GO:0033146;GO:0019216;GO:0009749;GO:0019432;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:plasma membrane;, F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:acyl-CoA metabolic process; P:CDP-diacylglycerol biosynthetic process; P:defense response to virus; P:diacylglycerol biosynthetic process; P:fatty acid homeostasis; P:fatty acid metabolic process; P:glycerol-3-phosphate metabolic process; P:negative regulation of activation-induced cell death of T cells; P:phosphatidic acid biosynthetic process; P:phosphatidylglycerol biosynthetic process; P:phospholipid biosynthetic process; P:phospholipid homeostasis; P:positive regulation of activated T cell proliferation; P:positive regulation of multicellular organism growth; P:regulation of cytokine production; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:response to glucose; P:triglyceride biosynthetic process;|Q9HCL2 Q5VW51 Q86TA3,Glycerol-3-phosphate acyltransferase 1, mitochondrial {ECO:0000305},, PF01553;, GO:0016021;GO:0031966;GO:0005741;GO:0005886;GO:0004366;GO:0102420;GO:0006637;GO:0016024;GO:0051607;GO:0006651;GO:0055089;GO:0006631;GO:0006072;GO:0070236;GO:0006654;GO:0006655;GO:0008654;GO:0055091;GO:0042104;GO:0040018;GO:0001817;GO:0033146;GO:0019216;GO:0009749;GO:0019432;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:plasma membrane;, F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:acyl-CoA metabolic process; P:CDP-diacylglycerol biosynthetic process; P:defense response to virus; P:diacylglycerol biosynthetic process; P:fatty acid homeostasis; P:fatty acid metabolic process; P:glycerol-3-phosphate metabolic process; P:negative regulation of activation-induced cell death of T cells; P:phosphatidic acid biosynthetic process; P:phosphatidylglycerol biosynthetic process; P:phospholipid biosynthetic process; P:phospholipid homeostasis; P:positive regulation of activated T cell proliferation; P:positive regulation of multicellular organism growth; P:regulation of cytokine production; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:response to glucose; P:triglyceride biosynthetic process; scaffold18 indexed_genome mRNA 16024311 16072974 . + . ID=transcript_4473;Q9ULC5 A6GV77 D3DRB3 Q6UX44 Q9UIU4,Long-chain-fatty-acid--CoA ligase 5 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000305};Long-chain acyl-CoA synthetase 5;, PF00501;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005730;GO:0005654;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0008610;GO:0001676;GO:0035338;GO:0010747;GO:2001236;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity;, P:lipid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of long-chain fatty acid import across plasma membrane; P:regulation of extrinsic apoptotic signaling pathway;|Q9ULC5 A6GV77 D3DRB3 Q6UX44 Q9UIU4,Long-chain-fatty-acid--CoA ligase 5 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000305};Long-chain acyl-CoA synthetase 5;, PF00501;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005730;GO:0005654;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0008610;GO:0001676;GO:0035338;GO:0010747;GO:2001236;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity;, P:lipid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of long-chain fatty acid import across plasma membrane; P:regulation of extrinsic apoptotic signaling pathway;|Q9ULC5 A6GV77 D3DRB3 Q6UX44 Q9UIU4,Long-chain-fatty-acid--CoA ligase 5 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000305};Long-chain acyl-CoA synthetase 5;, PF00501;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005730;GO:0005654;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0008610;GO:0001676;GO:0035338;GO:0010747;GO:2001236;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity;, P:lipid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of long-chain fatty acid import across plasma membrane; P:regulation of extrinsic apoptotic signaling pathway;|P33121 B7Z452 D3DP57 P41215 Q8N8V7 Q8TA99,Long-chain-fatty-acid--CoA ligase 1 {ECO:0000305},Acyl-CoA synthetase 1;Arachidonate--CoA ligase;Long-chain acyl-CoA synthetase 1;Long-chain acyl-CoA synthetase 2;Long-chain fatty acid-CoA ligase 2;Palmitoyl-CoA ligase 1;Palmitoyl-CoA ligase 2;Phytanate--CoA ligase;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0090434;GO:0050197;GO:0070251;GO:0033211;GO:0036109;GO:0015908;GO:0043651;GO:0008610;GO:0044539;GO:0001676;GO:0035338;GO:0120162;GO:0010747;GO:0071902;GO:0019222;GO:0042493;GO:0007584;GO:0034201;GO:0014070;GO:0019432;GO:0000038;GO:0042178;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:oleoyl-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:alpha-linolenic acid metabolic process; P:fatty acid transport; P:linoleic acid metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of long-chain fatty acid import across plasma membrane; P:positive regulation of protein serine/threonine kinase activity; P:regulation of metabolic process; P:response to drug; P:response to nutrient; P:response to oleic acid; P:response to organic cyclic compound; P:triglyceride biosynthetic process; P:very long-chain fatty acid metabolic process; P:xenobiotic catabolic process; scaffold18 indexed_genome mRNA 16076823 16091207 . - . ID=transcript_4474;Q9H6R6 D3DRB6 Q53G45 Q96IV7 Q9H605,Palmitoyltransferase ZDHHC6 {ECO:0000305},Stearoyltransferase ZDHHC6 {ECO:0000305};Transmembrane protein H4 {ECO:0000303|Ref.1};Zinc finger DHHC domain-containing protein 6 {ECO:0000303|PubMed:22314232};Zinc finger protein 376;, PF01529;PF07653;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0016409;GO:0019706;GO:0140439;GO:0016747;GO:0018230;GO:0010636;GO:0043543;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:transferase activity, transferring acyl groups other than amino-acyl groups;, P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of mitochondrial fusion; P:protein acylation; P:protein palmitoylation; P:protein targeting to membrane;|Q9H6R6 D3DRB6 Q53G45 Q96IV7 Q9H605,Palmitoyltransferase ZDHHC6 {ECO:0000305},Stearoyltransferase ZDHHC6 {ECO:0000305};Transmembrane protein H4 {ECO:0000303|Ref.1};Zinc finger DHHC domain-containing protein 6 {ECO:0000303|PubMed:22314232};Zinc finger protein 376;, PF01529;PF07653;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0016409;GO:0019706;GO:0140439;GO:0016747;GO:0018230;GO:0010636;GO:0043543;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:transferase activity, transferring acyl groups other than amino-acyl groups;, P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of mitochondrial fusion; P:protein acylation; P:protein palmitoylation; P:protein targeting to membrane;|Q9H6R6 D3DRB6 Q53G45 Q96IV7 Q9H605,Palmitoyltransferase ZDHHC6 {ECO:0000305},Stearoyltransferase ZDHHC6 {ECO:0000305};Transmembrane protein H4 {ECO:0000303|Ref.1};Zinc finger DHHC domain-containing protein 6 {ECO:0000303|PubMed:22314232};Zinc finger protein 376;, PF01529;PF07653;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0016409;GO:0019706;GO:0140439;GO:0016747;GO:0018230;GO:0010636;GO:0043543;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:transferase activity, transferring acyl groups other than amino-acyl groups;, P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of mitochondrial fusion; P:protein acylation; P:protein palmitoylation; P:protein targeting to membrane;|Q9H6R6 D3DRB6 Q53G45 Q96IV7 Q9H605,Palmitoyltransferase ZDHHC6 {ECO:0000305},Stearoyltransferase ZDHHC6 {ECO:0000305};Transmembrane protein H4 {ECO:0000303|Ref.1};Zinc finger DHHC domain-containing protein 6 {ECO:0000303|PubMed:22314232};Zinc finger protein 376;, PF01529;PF07653;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0016409;GO:0019706;GO:0140439;GO:0016747;GO:0018230;GO:0010636;GO:0043543;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:transferase activity, transferring acyl groups other than amino-acyl groups;, P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of mitochondrial fusion; P:protein acylation; P:protein palmitoylation; P:protein targeting to membrane; scaffold18 indexed_genome mRNA 16092140 16094038 . + . ID=transcript_4475;Q96AJ9 A2A307 B4E137 Q5W0D7,Vesicle transport through interaction with t-SNAREs homolog 1A,Vesicle transport v-SNARE protein Vti1-like 2;Vti1-rp2;, PF05008;, GO:0005776;GO:0030136;GO:0005829;GO:0005789;GO:0005768;GO:0012507;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0031902;GO:0044306;GO:0043025;GO:0048471;GO:0031201;GO:0008021;GO:0032588;GO:0005484;GO:0000149;GO:0006914;GO:0006888;GO:0090161;GO:0006896;GO:0006891;GO:0006623;GO:0042147;GO:0048280;GO:0050882;, C:autophagosome; C:clathrin-coated vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:endosome; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:neuron projection terminus; C:neuronal cell body; C:perinuclear region of cytoplasm; C:SNARE complex; C:synaptic vesicle; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding;, P:autophagy; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi ribbon formation; P:Golgi to vacuole transport; P:intra-Golgi vesicle-mediated transport; P:protein targeting to vacuole; P:retrograde transport, endosome to Golgi; P:vesicle fusion with Golgi apparatus; P:voluntary musculoskeletal movement; scaffold18 indexed_genome mRNA 16175887 16453290 . + . ID=transcript_4476;Q96AJ9 A2A307 B4E137 Q5W0D7,Vesicle transport through interaction with t-SNAREs homolog 1A,Vesicle transport v-SNARE protein Vti1-like 2;Vti1-rp2;, PF05008;, GO:0005776;GO:0030136;GO:0005829;GO:0005789;GO:0005768;GO:0012507;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0031902;GO:0044306;GO:0043025;GO:0048471;GO:0031201;GO:0008021;GO:0032588;GO:0005484;GO:0000149;GO:0006914;GO:0006888;GO:0090161;GO:0006896;GO:0006891;GO:0006623;GO:0042147;GO:0048280;GO:0050882;, C:autophagosome; C:clathrin-coated vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:endosome; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:neuron projection terminus; C:neuronal cell body; C:perinuclear region of cytoplasm; C:SNARE complex; C:synaptic vesicle; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding;, P:autophagy; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi ribbon formation; P:Golgi to vacuole transport; P:intra-Golgi vesicle-mediated transport; P:protein targeting to vacuole; P:retrograde transport, endosome to Golgi; P:vesicle fusion with Golgi apparatus; P:voluntary musculoskeletal movement; scaffold18 indexed_genome mRNA 16577071 16778795 . + . ID=transcript_4477;Q9NQB5 Q9NQB6 Q9NQB7 Q9ULC2,Transcription factor 7-like 2,HMG box transcription factor 4;T-cell-specific transcription factor 4;, PF08347;PF00505;, GO:1990907;GO:0070369;GO:0071664;GO:0000785;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0070016;GO:0008013;GO:0003700;GO:0000981;GO:0045295;GO:0035257;GO:0019901;GO:0000978;GO:0001103;GO:0043565;GO:0008134;GO:0000976;GO:1904837;GO:0001568;GO:0060070;GO:0044334;GO:0007050;GO:0045444;GO:0042593;GO:0043570;GO:0048625;GO:0090090;GO:0043433;GO:2001237;GO:0000122;GO:0045892;GO:2000675;GO:0031016;GO:0050679;GO:0010909;GO:0032024;GO:0032092;GO:0046827;GO:0051897;GO:0045944;GO:0032350;GO:0048660;GO:0006357;GO:0060260;GO:0009749;GO:0007223;, C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:catenin-TCF7L2 complex; C:chromatin; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex;, F:armadillo repeat domain binding; F:beta-catenin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:gamma-catenin binding; F:nuclear hormone receptor binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:blood vessel development; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; P:cell cycle arrest; P:fat cell differentiation; P:glucose homeostasis; P:maintenance of DNA repeat elements; P:myoblast fate commitment; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of type B pancreatic cell apoptotic process; P:pancreas development; P:positive regulation of epithelial cell proliferation; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; P:positive regulation of insulin secretion; P:positive regulation of protein binding; P:positive regulation of protein export from nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of hormone metabolic process; P:regulation of smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to glucose; P:Wnt signaling pathway, calcium modulating pathway;|Q9NQB5 Q9NQB6 Q9NQB7 Q9ULC2,Transcription factor 7-like 2,HMG box transcription factor 4;T-cell-specific transcription factor 4;, PF08347;PF00505;, GO:1990907;GO:0070369;GO:0071664;GO:0000785;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0070016;GO:0008013;GO:0003700;GO:0000981;GO:0045295;GO:0035257;GO:0019901;GO:0000978;GO:0001103;GO:0043565;GO:0008134;GO:0000976;GO:1904837;GO:0001568;GO:0060070;GO:0044334;GO:0007050;GO:0045444;GO:0042593;GO:0043570;GO:0048625;GO:0090090;GO:0043433;GO:2001237;GO:0000122;GO:0045892;GO:2000675;GO:0031016;GO:0050679;GO:0010909;GO:0032024;GO:0032092;GO:0046827;GO:0051897;GO:0045944;GO:0032350;GO:0048660;GO:0006357;GO:0060260;GO:0009749;GO:0007223;, C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:catenin-TCF7L2 complex; C:chromatin; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex;, F:armadillo repeat domain binding; F:beta-catenin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:gamma-catenin binding; F:nuclear hormone receptor binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:blood vessel development; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; P:cell cycle arrest; P:fat cell differentiation; P:glucose homeostasis; P:maintenance of DNA repeat elements; P:myoblast fate commitment; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of type B pancreatic cell apoptotic process; P:pancreas development; P:positive regulation of epithelial cell proliferation; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; P:positive regulation of insulin secretion; P:positive regulation of protein binding; P:positive regulation of protein export from nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of hormone metabolic process; P:regulation of smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to glucose; P:Wnt signaling pathway, calcium modulating pathway; scaffold18 indexed_genome mRNA 17127158 17236577 . + . ID=transcript_4478;Q14520 A8K467 B7Z8U5 F5H5M6 O00663,Hyaluronan-binding protein 2,Factor VII-activating protease;Factor seven-activating protease;Hepatocyte growth factor activator-like protein;Plasma hyaluronan-binding protein;, PF00008;PF00051;PF00089;, GO:0005576;GO:0005615;GO:0005509;GO:0005539;GO:0008233;GO:0004252;GO:0007155;GO:0006508;, C:extracellular region; C:extracellular space;, F:calcium ion binding; F:glycosaminoglycan binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:cell adhesion; P:proteolysis;|Q14520 A8K467 B7Z8U5 F5H5M6 O00663,Hyaluronan-binding protein 2,Factor VII-activating protease;Factor seven-activating protease;Hepatocyte growth factor activator-like protein;Plasma hyaluronan-binding protein;, PF00008;PF00051;PF00089;, GO:0005576;GO:0005615;GO:0005509;GO:0005539;GO:0008233;GO:0004252;GO:0007155;GO:0006508;, C:extracellular region; C:extracellular space;, F:calcium ion binding; F:glycosaminoglycan binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:cell adhesion; P:proteolysis;|Q14520 A8K467 B7Z8U5 F5H5M6 O00663,Hyaluronan-binding protein 2,Factor VII-activating protease;Factor seven-activating protease;Hepatocyte growth factor activator-like protein;Plasma hyaluronan-binding protein;, PF00008;PF00051;PF00089;, GO:0005576;GO:0005615;GO:0005509;GO:0005539;GO:0008233;GO:0004252;GO:0007155;GO:0006508;, C:extracellular region; C:extracellular space;, F:calcium ion binding; F:glycosaminoglycan binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:cell adhesion; P:proteolysis;|Q14520 A8K467 B7Z8U5 F5H5M6 O00663,Hyaluronan-binding protein 2,Factor VII-activating protease;Factor seven-activating protease;Hepatocyte growth factor activator-like protein;Plasma hyaluronan-binding protein;, PF00008;PF00051;PF00089;, GO:0005576;GO:0005615;GO:0005509;GO:0005539;GO:0008233;GO:0004252;GO:0007155;GO:0006508;, C:extracellular region; C:extracellular space;, F:calcium ion binding; F:glycosaminoglycan binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:cell adhesion; P:proteolysis;|Q719H6 Q86TC5 Q86TD6 Q86TE6 Q86VF6 Q8N3R6 Q8N8F9 Q8TCH0 Q96MG4,Nebulin-related-anchoring protein,, PF00412;PF00880;, GO:0005916;GO:0005927;GO:0030018;GO:0003779;GO:0051015;GO:0046872;GO:0051371;GO:0071691;GO:0048747;, C:fascia adherens; C:muscle tendon junction; C:Z disc;, F:actin binding; F:actin filament binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development;|Q719H6 Q86TC5 Q86TD6 Q86TE6 Q86VF6 Q8N3R6 Q8N8F9 Q8TCH0 Q96MG4,Nebulin-related-anchoring protein,, PF00412;PF00880;, GO:0005916;GO:0005927;GO:0030018;GO:0003779;GO:0051015;GO:0046872;GO:0051371;GO:0071691;GO:0048747;, C:fascia adherens; C:muscle tendon junction; C:Z disc;, F:actin binding; F:actin filament binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development; scaffold18 indexed_genome mRNA 17246143 17286581 . + . ID=transcript_4479;P55210 B4DQU7 B5BU45 D3DRB8 Q13364 Q53YD5 Q5SVL0 Q5SVL3 Q96BA0,Caspase-7,Apoptotic protease Mch-3;CMH-1;ICE-like apoptotic protease 3;, , GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0097153;GO:0097200;GO:0008234;GO:0008233;GO:0006915;GO:0072734;GO:0097194;GO:0006508;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:cysteine-type peptidase activity; F:peptidase activity;, P:apoptotic process; P:cellular response to staurosporine; P:execution phase of apoptosis; P:proteolysis; scaffold18 indexed_genome mRNA 17384063 17465289 . - . ID=transcript_4480;Q6PJP8 D3DRC1 Q14701 Q6P5Y3 Q6PKL4,DNA cross-link repair 1A protein,SNM1 homolog A;, PF07522;, GO:0001650;GO:0005654;GO:0035312;GO:0003684;GO:0046872;GO:0007049;GO:0051301;GO:0006303;GO:0036297;GO:0031848;, C:fibrillar center; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:damaged DNA binding; F:metal ion binding;, P:cell cycle; P:cell division; P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:protection from non-homologous end joining at telomere;|Q8NBF2 Q8N1H1 Q8N5A6,NHL repeat-containing protein 2,, PF01436;PF13905;, GO:0005829;GO:0005576;GO:0031093;GO:0002576;, C:cytosol; C:extracellular region; C:platelet alpha granule lumen;, , P:platelet degranulation; scaffold18 indexed_genome mRNA 17688080 17728252 . - . ID=transcript_4481;Q7Z3E2 Q2M2V6 Q3ZB81 Q6NS91 Q7RTP1 Q8N117 Q8N3G3 Q8N6C2 Q9NWA3,Coiled-coil domain-containing protein 186,CTCL tumor antigen HD-CL-01/L14-2;, , GO:0005794;GO:0035773;GO:0009617;GO:0099518;, C:Golgi apparatus;, , P:insulin secretion involved in cellular response to glucose stimulus; P:response to bacterium; P:vesicle cytoskeletal trafficking;|Q7Z3E2 Q2M2V6 Q3ZB81 Q6NS91 Q7RTP1 Q8N117 Q8N3G3 Q8N6C2 Q9NWA3,Coiled-coil domain-containing protein 186,CTCL tumor antigen HD-CL-01/L14-2;, , GO:0005794;GO:0035773;GO:0009617;GO:0099518;, C:Golgi apparatus;, , P:insulin secretion involved in cellular response to glucose stimulus; P:response to bacterium; P:vesicle cytoskeletal trafficking;|Q7Z3E2 Q2M2V6 Q3ZB81 Q6NS91 Q7RTP1 Q8N117 Q8N3G3 Q8N6C2 Q9NWA3,Coiled-coil domain-containing protein 186,CTCL tumor antigen HD-CL-01/L14-2;, , GO:0005794;GO:0035773;GO:0009617;GO:0099518;, C:Golgi apparatus;, , P:insulin secretion involved in cellular response to glucose stimulus; P:response to bacterium; P:vesicle cytoskeletal trafficking;|Q7Z3E2 Q2M2V6 Q3ZB81 Q6NS91 Q7RTP1 Q8N117 Q8N3G3 Q8N6C2 Q9NWA3,Coiled-coil domain-containing protein 186,CTCL tumor antigen HD-CL-01/L14-2;, , GO:0005794;GO:0035773;GO:0009617;GO:0099518;, C:Golgi apparatus;, , P:insulin secretion involved in cellular response to glucose stimulus; P:response to bacterium; P:vesicle cytoskeletal trafficking;|Q7Z3E2 Q2M2V6 Q3ZB81 Q6NS91 Q7RTP1 Q8N117 Q8N3G3 Q8N6C2 Q9NWA3,Coiled-coil domain-containing protein 186,CTCL tumor antigen HD-CL-01/L14-2;, , GO:0005794;GO:0035773;GO:0009617;GO:0099518;, C:Golgi apparatus;, , P:insulin secretion involved in cellular response to glucose stimulus; P:response to bacterium; P:vesicle cytoskeletal trafficking; scaffold18 indexed_genome mRNA 17794184 17814511 . + . ID=transcript_4482;Q5GFL6 A1A5D4 B5MDJ8 Q6ZS39 Q6ZWJ7 Q708C5 Q70UZ8,von Willebrand factor A domain-containing protein 2,A domain-containing protein similar to matrilin and collagen;Colon cancer secreted protein 2;, PF00008;PF00092;, GO:0005604;GO:0062023;GO:0070062;GO:0005615;GO:0005509;GO:0042802;GO:0007161;GO:0046626;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space;, F:calcium ion binding; F:identical protein binding;, P:calcium-independent cell-matrix adhesion; P:regulation of insulin receptor signaling pathway; scaffold18 indexed_genome mRNA 17823478 17844550 . + . ID=transcript_4483;Q5GFL6 A1A5D4 B5MDJ8 Q6ZS39 Q6ZWJ7 Q708C5 Q70UZ8,von Willebrand factor A domain-containing protein 2,A domain-containing protein similar to matrilin and collagen;Colon cancer secreted protein 2;, PF00008;PF00092;, GO:0005604;GO:0062023;GO:0070062;GO:0005615;GO:0005509;GO:0042802;GO:0007161;GO:0046626;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space;, F:calcium ion binding; F:identical protein binding;, P:calcium-independent cell-matrix adhesion; P:regulation of insulin receptor signaling pathway;|Q5GFL6 A1A5D4 B5MDJ8 Q6ZS39 Q6ZWJ7 Q708C5 Q70UZ8,von Willebrand factor A domain-containing protein 2,A domain-containing protein similar to matrilin and collagen;Colon cancer secreted protein 2;, PF00008;PF00092;, GO:0005604;GO:0062023;GO:0070062;GO:0005615;GO:0005509;GO:0042802;GO:0007161;GO:0046626;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space;, F:calcium ion binding; F:identical protein binding;, P:calcium-independent cell-matrix adhesion; P:regulation of insulin receptor signaling pathway;|Q5GFL6 A1A5D4 B5MDJ8 Q6ZS39 Q6ZWJ7 Q708C5 Q70UZ8,von Willebrand factor A domain-containing protein 2,A domain-containing protein similar to matrilin and collagen;Colon cancer secreted protein 2;, PF00008;PF00092;, GO:0005604;GO:0062023;GO:0070062;GO:0005615;GO:0005509;GO:0042802;GO:0007161;GO:0046626;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space;, F:calcium ion binding; F:identical protein binding;, P:calcium-independent cell-matrix adhesion; P:regulation of insulin receptor signaling pathway;|Q5GFL6 A1A5D4 B5MDJ8 Q6ZS39 Q6ZWJ7 Q708C5 Q70UZ8,von Willebrand factor A domain-containing protein 2,A domain-containing protein similar to matrilin and collagen;Colon cancer secreted protein 2;, PF00008;PF00092;, GO:0005604;GO:0062023;GO:0070062;GO:0005615;GO:0005509;GO:0042802;GO:0007161;GO:0046626;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space;, F:calcium ion binding; F:identical protein binding;, P:calcium-independent cell-matrix adhesion; P:regulation of insulin receptor signaling pathway; scaffold18 indexed_genome mRNA 17844705 17846289 . + . ID=transcript_4484;P40938 C9JU95 O15252 Q5W0E8,Replication factor C subunit 3,Activator 1 38 kDa subunit;Activator 1 subunit 3;Replication factor C 38 kDa subunit;, , GO:0031390;GO:0005663;GO:0005654;GO:0005634;GO:0003689;GO:0006287;GO:0042769;GO:0032508;GO:0006281;GO:0006260;GO:0006271;GO:0000731;GO:0006261;GO:0070987;GO:0042276;GO:0006297;GO:0033683;GO:0006296;GO:1900264;GO:1901796;GO:0046683;GO:0032201;GO:0006283;GO:0019985;, C:Ctf18 RFC-like complex; C:DNA replication factor C complex; C:nucleoplasm; C:nucleus;, F:DNA clamp loader activity;, P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA duplex unwinding; P:DNA repair; P:DNA replication; P:DNA strand elongation involved in DNA replication; P:DNA synthesis involved in DNA repair; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of DNA-directed DNA polymerase activity; P:regulation of signal transduction by p53 class mediator; P:response to organophosphorus; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold18 indexed_genome mRNA 17847338 17865423 . - . ID=transcript_4485;Q8N4X5 A8K6P7 B3KVQ8 Q2UZW3 Q8TB54 Q96PX4 Q96SY5,Actin filament-associated protein 1-like 2,, PF00169;, GO:0005737;GO:0005829;GO:0005886;GO:0030296;GO:0042169;GO:0017124;GO:0035591;GO:0006954;GO:0045742;GO:0032757;GO:0045893;GO:0032675;GO:0007346;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:protein tyrosine kinase activator activity; F:SH2 domain binding; F:SH3 domain binding; F:signaling adaptor activity;, P:inflammatory response; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of transcription, DNA-templated; P:regulation of interleukin-6 production; P:regulation of mitotic cell cycle;|Q8N4X5 A8K6P7 B3KVQ8 Q2UZW3 Q8TB54 Q96PX4 Q96SY5,Actin filament-associated protein 1-like 2,, PF00169;, GO:0005737;GO:0005829;GO:0005886;GO:0030296;GO:0042169;GO:0017124;GO:0035591;GO:0006954;GO:0045742;GO:0032757;GO:0045893;GO:0032675;GO:0007346;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:protein tyrosine kinase activator activity; F:SH2 domain binding; F:SH3 domain binding; F:signaling adaptor activity;, P:inflammatory response; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of transcription, DNA-templated; P:regulation of interleukin-6 production; P:regulation of mitotic cell cycle;|Q8N4X5 A8K6P7 B3KVQ8 Q2UZW3 Q8TB54 Q96PX4 Q96SY5,Actin filament-associated protein 1-like 2,, PF00169;, GO:0005737;GO:0005829;GO:0005886;GO:0030296;GO:0042169;GO:0017124;GO:0035591;GO:0006954;GO:0045742;GO:0032757;GO:0045893;GO:0032675;GO:0007346;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:protein tyrosine kinase activator activity; F:SH2 domain binding; F:SH3 domain binding; F:signaling adaptor activity;, P:inflammatory response; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of transcription, DNA-templated; P:regulation of interleukin-6 production; P:regulation of mitotic cell cycle;|Q8N4X5 A8K6P7 B3KVQ8 Q2UZW3 Q8TB54 Q96PX4 Q96SY5,Actin filament-associated protein 1-like 2,, PF00169;, GO:0005737;GO:0005829;GO:0005886;GO:0030296;GO:0042169;GO:0017124;GO:0035591;GO:0006954;GO:0045742;GO:0032757;GO:0045893;GO:0032675;GO:0007346;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:protein tyrosine kinase activator activity; F:SH2 domain binding; F:SH3 domain binding; F:signaling adaptor activity;, P:inflammatory response; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of transcription, DNA-templated; P:regulation of interleukin-6 production; P:regulation of mitotic cell cycle;|Q8N4X5 A8K6P7 B3KVQ8 Q2UZW3 Q8TB54 Q96PX4 Q96SY5,Actin filament-associated protein 1-like 2,, PF00169;, GO:0005737;GO:0005829;GO:0005886;GO:0030296;GO:0042169;GO:0017124;GO:0035591;GO:0006954;GO:0045742;GO:0032757;GO:0045893;GO:0032675;GO:0007346;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:protein tyrosine kinase activator activity; F:SH2 domain binding; F:SH3 domain binding; F:signaling adaptor activity;, P:inflammatory response; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of transcription, DNA-templated; P:regulation of interleukin-6 production; P:regulation of mitotic cell cycle; scaffold18 indexed_genome mRNA 17991807 18025394 . - . ID=transcript_4486;Q5T6N3 Q5T6N5 Q68CQ9 Q9BUP1,Actin-binding LIM protein 1,Actin-binding LIM protein family member 1;Actin-binding double zinc finger protein;LIMAB1;Limatin;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0030027;GO:0001725;GO:0003779;GO:0051015;GO:0046872;GO:0009887;GO:0060271;GO:0007010;GO:0030032;GO:0007601;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:stress fiber;, F:actin binding; F:actin filament binding; F:metal ion binding;, P:animal organ morphogenesis; P:cilium assembly; P:cytoskeleton organization; P:lamellipodium assembly; P:visual perception;|Q5T6N3 Q5T6N5 Q68CQ9 Q9BUP1,Actin-binding LIM protein 1,Actin-binding LIM protein family member 1;Actin-binding double zinc finger protein;LIMAB1;Limatin;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0030027;GO:0001725;GO:0003779;GO:0051015;GO:0046872;GO:0009887;GO:0060271;GO:0007010;GO:0030032;GO:0007601;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:stress fiber;, F:actin binding; F:actin filament binding; F:metal ion binding;, P:animal organ morphogenesis; P:cilium assembly; P:cytoskeleton organization; P:lamellipodium assembly; P:visual perception;|Q5T6N3 Q5T6N5 Q68CQ9 Q9BUP1,Actin-binding LIM protein 1,Actin-binding LIM protein family member 1;Actin-binding double zinc finger protein;LIMAB1;Limatin;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0030027;GO:0001725;GO:0003779;GO:0051015;GO:0046872;GO:0009887;GO:0060271;GO:0007010;GO:0030032;GO:0007601;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:stress fiber;, F:actin binding; F:actin filament binding; F:metal ion binding;, P:animal organ morphogenesis; P:cilium assembly; P:cytoskeleton organization; P:lamellipodium assembly; P:visual perception;|Q5T6N3 Q5T6N5 Q68CQ9 Q9BUP1,Actin-binding LIM protein 1,Actin-binding LIM protein family member 1;Actin-binding double zinc finger protein;LIMAB1;Limatin;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0030027;GO:0001725;GO:0003779;GO:0051015;GO:0046872;GO:0009887;GO:0060271;GO:0007010;GO:0030032;GO:0007601;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:stress fiber;, F:actin binding; F:actin filament binding; F:metal ion binding;, P:animal organ morphogenesis; P:cilium assembly; P:cytoskeleton organization; P:lamellipodium assembly; P:visual perception;|Q5T6N3 Q5T6N5 Q68CQ9 Q9BUP1,Actin-binding LIM protein 1,Actin-binding LIM protein family member 1;Actin-binding double zinc finger protein;LIMAB1;Limatin;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0030027;GO:0001725;GO:0003779;GO:0051015;GO:0046872;GO:0009887;GO:0060271;GO:0007010;GO:0030032;GO:0007601;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:stress fiber;, F:actin binding; F:actin filament binding; F:metal ion binding;, P:animal organ morphogenesis; P:cilium assembly; P:cytoskeleton organization; P:lamellipodium assembly; P:visual perception;|Q5T6N3 Q5T6N5 Q68CQ9 Q9BUP1,Actin-binding LIM protein 1,Actin-binding LIM protein family member 1;Actin-binding double zinc finger protein;LIMAB1;Limatin;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0030027;GO:0001725;GO:0003779;GO:0051015;GO:0046872;GO:0009887;GO:0060271;GO:0007010;GO:0030032;GO:0007601;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:stress fiber;, F:actin binding; F:actin filament binding; F:metal ion binding;, P:animal organ morphogenesis; P:cilium assembly; P:cytoskeleton organization; P:lamellipodium assembly; P:visual perception; scaffold18 indexed_genome mRNA 18041907 18173825 . - . ID=transcript_4487;Q5T6N3 Q5T6N5 Q68CQ9 Q9BUP1,Actin-binding LIM protein 1,Actin-binding LIM protein family member 1;Actin-binding double zinc finger protein;LIMAB1;Limatin;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0030027;GO:0001725;GO:0003779;GO:0051015;GO:0046872;GO:0009887;GO:0060271;GO:0007010;GO:0030032;GO:0007601;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:stress fiber;, F:actin binding; F:actin filament binding; F:metal ion binding;, P:animal organ morphogenesis; P:cilium assembly; P:cytoskeleton organization; P:lamellipodium assembly; P:visual perception; scaffold18 indexed_genome mRNA 18356704 18399020 . + . ID=transcript_4488;Q5W0V3 Q5H9P7 Q5W0V2 Q8IY76 Q9HCH2,Protein FAM160B1,, PF10257;|Q5W0V3 Q5H9P7 Q5W0V2 Q8IY76 Q9HCH2,Protein FAM160B1,, PF10257;|Q5W0V3 Q5H9P7 Q5W0V2 Q8IY76 Q9HCH2,Protein FAM160B1,, PF10257;|Q5W0V3 Q5H9P7 Q5W0V2 Q8IY76 Q9HCH2,Protein FAM160B1,, PF10257;|Q5W0V3 Q5H9P7 Q5W0V2 Q8IY76 Q9HCH2,Protein FAM160B1,, PF10257;|Q5W0V3 Q5H9P7 Q5W0V2 Q8IY76 Q9HCH2,Protein FAM160B1,, PF10257; scaffold18 indexed_genome mRNA 18474515 18505690 . + . ID=transcript_4489;Q8WWH5 B2R716 Q53ES2,Probable tRNA pseudouridine synthase 1 {ECO:0000305},, PF01509;, GO:0005829;GO:0005739;GO:0005634;GO:0009982;GO:0003723;GO:1990481;GO:0006400;, C:cytosol; C:mitochondrion; C:nucleus;, F:pseudouridine synthase activity; F:RNA binding;, P:mRNA pseudouridine synthesis; P:tRNA modification; scaffold18 indexed_genome mRNA 18612992 18774533 . + . ID=transcript_4490;Q5VV63 O60283 Q5JSE8 Q5T5Y9 Q6T256 Q6ZSN4 Q86WX2,Attractin-like protein 1,, PF00431;PF07974;PF00059;PF01437;, GO:0005604;GO:0016021;GO:0030246;GO:0009887;GO:0016477;GO:0007186;GO:0034446;GO:0009888;, C:basement membrane; C:integral component of membrane;, F:carbohydrate binding;, P:animal organ morphogenesis; P:cell migration; P:G protein-coupled receptor signaling pathway; P:substrate adhesion-dependent cell spreading; P:tissue development; scaffold18 indexed_genome mRNA 18838729 19343515 . + . ID=transcript_4491;Q5VV63 O60283 Q5JSE8 Q5T5Y9 Q6T256 Q6ZSN4 Q86WX2,Attractin-like protein 1,, PF00431;PF07974;PF00059;PF01437;, GO:0005604;GO:0016021;GO:0030246;GO:0009887;GO:0016477;GO:0007186;GO:0034446;GO:0009888;, C:basement membrane; C:integral component of membrane;, F:carbohydrate binding;, P:animal organ morphogenesis; P:cell migration; P:G protein-coupled receptor signaling pathway; P:substrate adhesion-dependent cell spreading; P:tissue development; scaffold18 indexed_genome mRNA 20018669 20050413 . - . ID=transcript_4492;O43301,Heat shock 70 kDa protein 12A,, , GO:0005737;GO:0070062;GO:0005634;GO:0005524;, C:cytoplasm; C:extracellular exosome; C:nucleus;, F:ATP binding;|O43301,Heat shock 70 kDa protein 12A,, , GO:0005737;GO:0070062;GO:0005634;GO:0005524;, C:cytoplasm; C:extracellular exosome; C:nucleus;, F:ATP binding;|O43301,Heat shock 70 kDa protein 12A,, , GO:0005737;GO:0070062;GO:0005634;GO:0005524;, C:cytoplasm; C:extracellular exosome; C:nucleus;, F:ATP binding; scaffold18 indexed_genome mRNA 20188525 20325275 . + . ID=transcript_4493;A6NNW6 A0A087WZY6 A6NI74 B8ZZN9 J3KNX1,Enolase 4 {ECO:0000305},2-phospho-D-glycerate hydro-lyase;, PF00113;, GO:0000015;GO:0000287;GO:0004634;GO:0006096;GO:0032889;, C:phosphopyruvate hydratase complex;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:glycolytic process; P:regulation of vacuole fusion, non-autophagic;|A6NNW6 A0A087WZY6 A6NI74 B8ZZN9 J3KNX1,Enolase 4 {ECO:0000305},2-phospho-D-glycerate hydro-lyase;, PF00113;, GO:0000015;GO:0000287;GO:0004634;GO:0006096;GO:0032889;, C:phosphopyruvate hydratase complex;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:glycolytic process; P:regulation of vacuole fusion, non-autophagic;|A6NNW6 A0A087WZY6 A6NI74 B8ZZN9 J3KNX1,Enolase 4 {ECO:0000305},2-phospho-D-glycerate hydro-lyase;, PF00113;, GO:0000015;GO:0000287;GO:0004634;GO:0006096;GO:0032889;, C:phosphopyruvate hydratase complex;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:glycolytic process; P:regulation of vacuole fusion, non-autophagic;|A6NNW6 A0A087WZY6 A6NI74 B8ZZN9 J3KNX1,Enolase 4 {ECO:0000305},2-phospho-D-glycerate hydro-lyase;, PF00113;, GO:0000015;GO:0000287;GO:0004634;GO:0006096;GO:0032889;, C:phosphopyruvate hydratase complex;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:glycolytic process; P:regulation of vacuole fusion, non-autophagic;|Q68DG1 Q6PIM5 Q9HCH4 Q9NUV0,Shootin-1 {ECO:0000312|HGNC:HGNC:29319},Shootin1 {ECO:0000250|UniProtKB:A0MZ67};, , GO:0030424;GO:0044295;GO:0031252;GO:0005737;GO:0030175;GO:0030426;GO:0030027;GO:0005874;GO:0005875;GO:0015630;GO:0043204;GO:0048471;GO:0051015;GO:0045296;GO:0042802;GO:0019894;GO:0061573;GO:0007409;GO:0032488;GO:0060327;GO:0061163;GO:0038007;GO:0048812;GO:0045773;GO:2001224;GO:0007265;GO:2000114;GO:0006930;, C:axon; C:axonal growth cone; C:cell leading edge; C:cytoplasm; C:filopodium; C:growth cone; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perikaryon; C:perinuclear region of cytoplasm;, F:actin filament binding; F:cadherin binding; F:identical protein binding; F:kinesin binding;, P:actin filament bundle retrograde transport; P:axonogenesis; P:Cdc42 protein signal transduction; P:cytoplasmic actin-based contraction involved in cell motility; P:endoplasmic reticulum polarization; P:netrin-activated signaling pathway; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of neuron migration; P:Ras protein signal transduction; P:regulation of establishment of cell polarity; P:substrate-dependent cell migration, cell extension;|A6NNW6 A0A087WZY6 A6NI74 B8ZZN9 J3KNX1,Enolase 4 {ECO:0000305},2-phospho-D-glycerate hydro-lyase;, PF00113;, GO:0000015;GO:0000287;GO:0004634;GO:0006096;GO:0032889;, C:phosphopyruvate hydratase complex;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:glycolytic process; P:regulation of vacuole fusion, non-autophagic;|Q68DG1 Q6PIM5 Q9HCH4 Q9NUV0,Shootin-1 {ECO:0000312|HGNC:HGNC:29319},Shootin1 {ECO:0000250|UniProtKB:A0MZ67};, , GO:0030424;GO:0044295;GO:0031252;GO:0005737;GO:0030175;GO:0030426;GO:0030027;GO:0005874;GO:0005875;GO:0015630;GO:0043204;GO:0048471;GO:0051015;GO:0045296;GO:0042802;GO:0019894;GO:0061573;GO:0007409;GO:0032488;GO:0060327;GO:0061163;GO:0038007;GO:0048812;GO:0045773;GO:2001224;GO:0007265;GO:2000114;GO:0006930;, C:axon; C:axonal growth cone; C:cell leading edge; C:cytoplasm; C:filopodium; C:growth cone; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perikaryon; C:perinuclear region of cytoplasm;, F:actin filament binding; F:cadherin binding; F:identical protein binding; F:kinesin binding;, P:actin filament bundle retrograde transport; P:axonogenesis; P:Cdc42 protein signal transduction; P:cytoplasmic actin-based contraction involved in cell motility; P:endoplasmic reticulum polarization; P:netrin-activated signaling pathway; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of neuron migration; P:Ras protein signal transduction; P:regulation of establishment of cell polarity; P:substrate-dependent cell migration, cell extension;|Q68DG1 Q6PIM5 Q9HCH4 Q9NUV0,Shootin-1 {ECO:0000312|HGNC:HGNC:29319},Shootin1 {ECO:0000250|UniProtKB:A0MZ67};, , GO:0030424;GO:0044295;GO:0031252;GO:0005737;GO:0030175;GO:0030426;GO:0030027;GO:0005874;GO:0005875;GO:0015630;GO:0043204;GO:0048471;GO:0051015;GO:0045296;GO:0042802;GO:0019894;GO:0061573;GO:0007409;GO:0032488;GO:0060327;GO:0061163;GO:0038007;GO:0048812;GO:0045773;GO:2001224;GO:0007265;GO:2000114;GO:0006930;, C:axon; C:axonal growth cone; C:cell leading edge; C:cytoplasm; C:filopodium; C:growth cone; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perikaryon; C:perinuclear region of cytoplasm;, F:actin filament binding; F:cadherin binding; F:identical protein binding; F:kinesin binding;, P:actin filament bundle retrograde transport; P:axonogenesis; P:Cdc42 protein signal transduction; P:cytoplasmic actin-based contraction involved in cell motility; P:endoplasmic reticulum polarization; P:netrin-activated signaling pathway; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of neuron migration; P:Ras protein signal transduction; P:regulation of establishment of cell polarity; P:substrate-dependent cell migration, cell extension;|Q68DG1 Q6PIM5 Q9HCH4 Q9NUV0,Shootin-1 {ECO:0000312|HGNC:HGNC:29319},Shootin1 {ECO:0000250|UniProtKB:A0MZ67};, , GO:0030424;GO:0044295;GO:0031252;GO:0005737;GO:0030175;GO:0030426;GO:0030027;GO:0005874;GO:0005875;GO:0015630;GO:0043204;GO:0048471;GO:0051015;GO:0045296;GO:0042802;GO:0019894;GO:0061573;GO:0007409;GO:0032488;GO:0060327;GO:0061163;GO:0038007;GO:0048812;GO:0045773;GO:2001224;GO:0007265;GO:2000114;GO:0006930;, C:axon; C:axonal growth cone; C:cell leading edge; C:cytoplasm; C:filopodium; C:growth cone; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perikaryon; C:perinuclear region of cytoplasm;, F:actin filament binding; F:cadherin binding; F:identical protein binding; F:kinesin binding;, P:actin filament bundle retrograde transport; P:axonogenesis; P:Cdc42 protein signal transduction; P:cytoplasmic actin-based contraction involved in cell motility; P:endoplasmic reticulum polarization; P:netrin-activated signaling pathway; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of neuron migration; P:Ras protein signal transduction; P:regulation of establishment of cell polarity; P:substrate-dependent cell migration, cell extension;|Q68DG1 Q6PIM5 Q9HCH4 Q9NUV0,Shootin-1 {ECO:0000312|HGNC:HGNC:29319},Shootin1 {ECO:0000250|UniProtKB:A0MZ67};, , GO:0030424;GO:0044295;GO:0031252;GO:0005737;GO:0030175;GO:0030426;GO:0030027;GO:0005874;GO:0005875;GO:0015630;GO:0043204;GO:0048471;GO:0051015;GO:0045296;GO:0042802;GO:0019894;GO:0061573;GO:0007409;GO:0032488;GO:0060327;GO:0061163;GO:0038007;GO:0048812;GO:0045773;GO:2001224;GO:0007265;GO:2000114;GO:0006930;, C:axon; C:axonal growth cone; C:cell leading edge; C:cytoplasm; C:filopodium; C:growth cone; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perikaryon; C:perinuclear region of cytoplasm;, F:actin filament binding; F:cadherin binding; F:identical protein binding; F:kinesin binding;, P:actin filament bundle retrograde transport; P:axonogenesis; P:Cdc42 protein signal transduction; P:cytoplasmic actin-based contraction involved in cell motility; P:endoplasmic reticulum polarization; P:netrin-activated signaling pathway; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of neuron migration; P:Ras protein signal transduction; P:regulation of establishment of cell polarity; P:substrate-dependent cell migration, cell extension;|Q68DG1 Q6PIM5 Q9HCH4 Q9NUV0,Shootin-1 {ECO:0000312|HGNC:HGNC:29319},Shootin1 {ECO:0000250|UniProtKB:A0MZ67};, , GO:0030424;GO:0044295;GO:0031252;GO:0005737;GO:0030175;GO:0030426;GO:0030027;GO:0005874;GO:0005875;GO:0015630;GO:0043204;GO:0048471;GO:0051015;GO:0045296;GO:0042802;GO:0019894;GO:0061573;GO:0007409;GO:0032488;GO:0060327;GO:0061163;GO:0038007;GO:0048812;GO:0045773;GO:2001224;GO:0007265;GO:2000114;GO:0006930;, C:axon; C:axonal growth cone; C:cell leading edge; C:cytoplasm; C:filopodium; C:growth cone; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perikaryon; C:perinuclear region of cytoplasm;, F:actin filament binding; F:cadherin binding; F:identical protein binding; F:kinesin binding;, P:actin filament bundle retrograde transport; P:axonogenesis; P:Cdc42 protein signal transduction; P:cytoplasmic actin-based contraction involved in cell motility; P:endoplasmic reticulum polarization; P:netrin-activated signaling pathway; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of neuron migration; P:Ras protein signal transduction; P:regulation of establishment of cell polarity; P:substrate-dependent cell migration, cell extension;|Q68DG1 Q6PIM5 Q9HCH4 Q9NUV0,Shootin-1 {ECO:0000312|HGNC:HGNC:29319},Shootin1 {ECO:0000250|UniProtKB:A0MZ67};, , GO:0030424;GO:0044295;GO:0031252;GO:0005737;GO:0030175;GO:0030426;GO:0030027;GO:0005874;GO:0005875;GO:0015630;GO:0043204;GO:0048471;GO:0051015;GO:0045296;GO:0042802;GO:0019894;GO:0061573;GO:0007409;GO:0032488;GO:0060327;GO:0061163;GO:0038007;GO:0048812;GO:0045773;GO:2001224;GO:0007265;GO:2000114;GO:0006930;, C:axon; C:axonal growth cone; C:cell leading edge; C:cytoplasm; C:filopodium; C:growth cone; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perikaryon; C:perinuclear region of cytoplasm;, F:actin filament binding; F:cadherin binding; F:identical protein binding; F:kinesin binding;, P:actin filament bundle retrograde transport; P:axonogenesis; P:Cdc42 protein signal transduction; P:cytoplasmic actin-based contraction involved in cell motility; P:endoplasmic reticulum polarization; P:netrin-activated signaling pathway; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of neuron migration; P:Ras protein signal transduction; P:regulation of establishment of cell polarity; P:substrate-dependent cell migration, cell extension; scaffold18 indexed_genome mRNA 20531806 20532358 . - . ID=transcript_4494;Q05940 B2RC96 D3DRC4 Q15876 Q4G147 Q5VW49 Q9H3P6,Synaptic vesicular amine transporter,Monoamine transporter;Solute carrier family 18 member 2;Vesicular amine transporter 2;, PF07690;, GO:0005813;GO:0070083;GO:0098691;GO:0005887;GO:0043231;GO:0016020;GO:0005886;GO:0008021;GO:0030672;GO:0043195;GO:0008504;GO:0005335;GO:0022857;GO:0015842;GO:0007268;GO:0015872;GO:0007626;GO:0015844;GO:1903427;GO:0098700;GO:0006836;GO:0009791;GO:0001975;GO:0009636;GO:0042137;, C:centrosome; C:clathrin-sculpted monoamine transport vesicle membrane; C:dopaminergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:synaptic vesicle; C:synaptic vesicle membrane; C:terminal bouton;, F:monoamine transmembrane transporter activity; F:serotonin:sodium symporter activity; F:transmembrane transporter activity;, P:aminergic neurotransmitter loading into synaptic vesicle; P:chemical synaptic transmission; P:dopamine transport; P:locomotory behavior; P:monoamine transport; P:negative regulation of reactive oxygen species biosynthetic process; P:neurotransmitter loading into synaptic vesicle; P:neurotransmitter transport; P:post-embryonic development; P:response to amphetamine; P:response to toxic substance; P:sequestering of neurotransmitter; scaffold18 indexed_genome mRNA 20537244 20613206 . - . ID=transcript_4495;Q8NEN9 Q86WE0 Q86WE5 Q9UFF1,PDZ domain-containing protein 8 {ECO:0000305},Sarcoma antigen NY-SAR-84/NY-SAR-104 {ECO:0000303|PubMed:12601173};, PF00130;PF17820;, GO:0005789;GO:0016021;GO:0016020;GO:0044233;GO:0005739;GO:0008289;GO:0046872;GO:0007010;GO:0035556;GO:0006869;GO:0051560;GO:1990456;GO:0022604;GO:0016032;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion;, F:lipid binding; F:metal ion binding;, P:cytoskeleton organization; P:intracellular signal transduction; P:lipid transport; P:mitochondrial calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:regulation of cell morphogenesis; P:viral process; scaffold18 indexed_genome mRNA 21184718 21216265 . - . ID=transcript_4496;Q7L804 A6NEI4 Q3I768 Q9Y2F0,Rab11 family-interacting protein 2,NRip11;, PF00168;PF09457;, GO:0042995;GO:0030659;GO:0005768;GO:0043231;GO:0005654;GO:0001891;GO:0055038;GO:0042802;GO:0042803;GO:0019901;GO:0031267;GO:0030010;GO:0035773;GO:0006909;GO:0043547;GO:1903078;GO:0045055;GO:0003091;GO:0035669;, C:cell projection; C:cytoplasmic vesicle membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:phagocytic cup; C:recycling endosome membrane;, F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:small GTPase binding;, P:establishment of cell polarity; P:insulin secretion involved in cellular response to glucose stimulus; P:phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of protein localization to plasma membrane; P:regulated exocytosis; P:renal water homeostasis; P:TRAM-dependent toll-like receptor 4 signaling pathway; scaffold18 indexed_genome mRNA 21216312 21222517 . - . ID=transcript_4497;Q7L804 A6NEI4 Q3I768 Q9Y2F0,Rab11 family-interacting protein 2,NRip11;, PF00168;PF09457;, GO:0042995;GO:0030659;GO:0005768;GO:0043231;GO:0005654;GO:0001891;GO:0055038;GO:0042802;GO:0042803;GO:0019901;GO:0031267;GO:0030010;GO:0035773;GO:0006909;GO:0043547;GO:1903078;GO:0045055;GO:0003091;GO:0035669;, C:cell projection; C:cytoplasmic vesicle membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:phagocytic cup; C:recycling endosome membrane;, F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:small GTPase binding;, P:establishment of cell polarity; P:insulin secretion involved in cellular response to glucose stimulus; P:phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of protein localization to plasma membrane; P:regulated exocytosis; P:renal water homeostasis; P:TRAM-dependent toll-like receptor 4 signaling pathway;|Q7L804 A6NEI4 Q3I768 Q9Y2F0,Rab11 family-interacting protein 2,NRip11;, PF00168;PF09457;, GO:0042995;GO:0030659;GO:0005768;GO:0043231;GO:0005654;GO:0001891;GO:0055038;GO:0042802;GO:0042803;GO:0019901;GO:0031267;GO:0030010;GO:0035773;GO:0006909;GO:0043547;GO:1903078;GO:0045055;GO:0003091;GO:0035669;, C:cell projection; C:cytoplasmic vesicle membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:phagocytic cup; C:recycling endosome membrane;, F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:small GTPase binding;, P:establishment of cell polarity; P:insulin secretion involved in cellular response to glucose stimulus; P:phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of protein localization to plasma membrane; P:regulated exocytosis; P:renal water homeostasis; P:TRAM-dependent toll-like receptor 4 signaling pathway; scaffold18 indexed_genome mRNA 21487755 21517477 . - . ID=transcript_4498;Q9H8W3 D3DRC6 Q5T373 Q9H5V5,Protein FAM204A|Q9H8W3 D3DRC6 Q5T373 Q9H5V5,Protein FAM204A|Q9H8W3 D3DRC6 Q5T373 Q9H5V5,Protein FAM204A|Q9H8W3 D3DRC6 Q5T373 Q9H5V5,Protein FAM204A scaffold18 indexed_genome mRNA 21843722 21911236 . - . ID=transcript_4499;Q86Y37 Q5XPL7 Q8IY11 Q8N7S4,CDK2-associated and cullin domain-containing protein 1,Cdk-associated cullin 1;, PF00888;, GO:0019901;GO:0031625;GO:0000082;GO:0008284;GO:0045860;GO:0006511;, , F:protein kinase binding; F:ubiquitin protein ligase binding;, P:G1/S transition of mitotic cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of protein kinase activity; P:ubiquitin-dependent protein catabolic process; scaffold18 indexed_genome mRNA 22117189 22121771 . - . ID=transcript_4500;Q14152 B1AMV5 B4DYS1 F5H335 O00653 Q15778,Eukaryotic translation initiation factor 3 subunit A {ECO:0000255|HAMAP-Rule:MF_03000},Eukaryotic translation initiation factor 3 subunit 10 {ECO:0000255|HAMAP-Rule:MF_03000};eIF-3-theta {ECO:0000255|HAMAP-Rule:MF_03000};eIF3 p167;eIF3 p180;eIF3 p185;, PF01399;, GO:0005737;GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071540;GO:0071541;GO:0016020;GO:0005874;GO:0043614;GO:0005730;GO:0005654;GO:0014069;GO:0003729;GO:0030971;GO:0003723;GO:0005198;GO:0003743;GO:0001732;GO:0075522;GO:0070373;GO:0002188;GO:0006413;GO:0075525;, C:cytoplasm; C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane; C:microtubule; C:multi-eIF complex; C:nucleolus; C:nucleoplasm; C:postsynaptic density;, F:mRNA binding; F:receptor tyrosine kinase binding; F:RNA binding; F:structural molecule activity; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:negative regulation of ERK1 and ERK2 cascade; P:translation reinitiation; P:translational initiation; P:viral translational termination-reinitiation; scaffold18 indexed_genome mRNA 22122499 22148612 . - . ID=transcript_4501;Q14152 B1AMV5 B4DYS1 F5H335 O00653 Q15778,Eukaryotic translation initiation factor 3 subunit A {ECO:0000255|HAMAP-Rule:MF_03000},Eukaryotic translation initiation factor 3 subunit 10 {ECO:0000255|HAMAP-Rule:MF_03000};eIF-3-theta {ECO:0000255|HAMAP-Rule:MF_03000};eIF3 p167;eIF3 p180;eIF3 p185;, PF01399;, GO:0005737;GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071540;GO:0071541;GO:0016020;GO:0005874;GO:0043614;GO:0005730;GO:0005654;GO:0014069;GO:0003729;GO:0030971;GO:0003723;GO:0005198;GO:0003743;GO:0001732;GO:0075522;GO:0070373;GO:0002188;GO:0006413;GO:0075525;, C:cytoplasm; C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane; C:microtubule; C:multi-eIF complex; C:nucleolus; C:nucleoplasm; C:postsynaptic density;, F:mRNA binding; F:receptor tyrosine kinase binding; F:RNA binding; F:structural molecule activity; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:negative regulation of ERK1 and ERK2 cascade; P:translation reinitiation; P:translational initiation; P:viral translational termination-reinitiation;|Q14152 B1AMV5 B4DYS1 F5H335 O00653 Q15778,Eukaryotic translation initiation factor 3 subunit A {ECO:0000255|HAMAP-Rule:MF_03000},Eukaryotic translation initiation factor 3 subunit 10 {ECO:0000255|HAMAP-Rule:MF_03000};eIF-3-theta {ECO:0000255|HAMAP-Rule:MF_03000};eIF3 p167;eIF3 p180;eIF3 p185;, PF01399;, GO:0005737;GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071540;GO:0071541;GO:0016020;GO:0005874;GO:0043614;GO:0005730;GO:0005654;GO:0014069;GO:0003729;GO:0030971;GO:0003723;GO:0005198;GO:0003743;GO:0001732;GO:0075522;GO:0070373;GO:0002188;GO:0006413;GO:0075525;, C:cytoplasm; C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane; C:microtubule; C:multi-eIF complex; C:nucleolus; C:nucleoplasm; C:postsynaptic density;, F:mRNA binding; F:receptor tyrosine kinase binding; F:RNA binding; F:structural molecule activity; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:negative regulation of ERK1 and ERK2 cascade; P:translation reinitiation; P:translational initiation; P:viral translational termination-reinitiation;|Q14152 B1AMV5 B4DYS1 F5H335 O00653 Q15778,Eukaryotic translation initiation factor 3 subunit A {ECO:0000255|HAMAP-Rule:MF_03000},Eukaryotic translation initiation factor 3 subunit 10 {ECO:0000255|HAMAP-Rule:MF_03000};eIF-3-theta {ECO:0000255|HAMAP-Rule:MF_03000};eIF3 p167;eIF3 p180;eIF3 p185;, PF01399;, GO:0005737;GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071540;GO:0071541;GO:0016020;GO:0005874;GO:0043614;GO:0005730;GO:0005654;GO:0014069;GO:0003729;GO:0030971;GO:0003723;GO:0005198;GO:0003743;GO:0001732;GO:0075522;GO:0070373;GO:0002188;GO:0006413;GO:0075525;, C:cytoplasm; C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane; C:microtubule; C:multi-eIF complex; C:nucleolus; C:nucleoplasm; C:postsynaptic density;, F:mRNA binding; F:receptor tyrosine kinase binding; F:RNA binding; F:structural molecule activity; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:negative regulation of ERK1 and ERK2 cascade; P:translation reinitiation; P:translational initiation; P:viral translational termination-reinitiation;|Q14152 B1AMV5 B4DYS1 F5H335 O00653 Q15778,Eukaryotic translation initiation factor 3 subunit A {ECO:0000255|HAMAP-Rule:MF_03000},Eukaryotic translation initiation factor 3 subunit 10 {ECO:0000255|HAMAP-Rule:MF_03000};eIF-3-theta {ECO:0000255|HAMAP-Rule:MF_03000};eIF3 p167;eIF3 p180;eIF3 p185;, PF01399;, GO:0005737;GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071540;GO:0071541;GO:0016020;GO:0005874;GO:0043614;GO:0005730;GO:0005654;GO:0014069;GO:0003729;GO:0030971;GO:0003723;GO:0005198;GO:0003743;GO:0001732;GO:0075522;GO:0070373;GO:0002188;GO:0006413;GO:0075525;, C:cytoplasm; C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane; C:microtubule; C:multi-eIF complex; C:nucleolus; C:nucleoplasm; C:postsynaptic density;, F:mRNA binding; F:receptor tyrosine kinase binding; F:RNA binding; F:structural molecule activity; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:negative regulation of ERK1 and ERK2 cascade; P:translation reinitiation; P:translational initiation; P:viral translational termination-reinitiation;|Q14152 B1AMV5 B4DYS1 F5H335 O00653 Q15778,Eukaryotic translation initiation factor 3 subunit A {ECO:0000255|HAMAP-Rule:MF_03000},Eukaryotic translation initiation factor 3 subunit 10 {ECO:0000255|HAMAP-Rule:MF_03000};eIF-3-theta {ECO:0000255|HAMAP-Rule:MF_03000};eIF3 p167;eIF3 p180;eIF3 p185;, PF01399;, GO:0005737;GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071540;GO:0071541;GO:0016020;GO:0005874;GO:0043614;GO:0005730;GO:0005654;GO:0014069;GO:0003729;GO:0030971;GO:0003723;GO:0005198;GO:0003743;GO:0001732;GO:0075522;GO:0070373;GO:0002188;GO:0006413;GO:0075525;, C:cytoplasm; C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane; C:microtubule; C:multi-eIF complex; C:nucleolus; C:nucleoplasm; C:postsynaptic density;, F:mRNA binding; F:receptor tyrosine kinase binding; F:RNA binding; F:structural molecule activity; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:negative regulation of ERK1 and ERK2 cascade; P:translation reinitiation; P:translational initiation; P:viral translational termination-reinitiation; scaffold18 indexed_genome mRNA 22170305 22172495 . + . ID=transcript_4502;Q8TCE6 B1AMV6 B4DDC3 D3DRC8 Q9NXW4,DENN domain-containing protein 10 {ECO:0000305},Protein FAM45A;, , GO:0005770;GO:0005085;GO:0031267;GO:0032509;GO:0015031;GO:2000641;, C:late endosome;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:endosome transport via multivesicular body sorting pathway; P:protein transport; P:regulation of early endosome to late endosome transport;|Q8TCE6 B1AMV6 B4DDC3 D3DRC8 Q9NXW4,DENN domain-containing protein 10 {ECO:0000305},Protein FAM45A;, , GO:0005770;GO:0005085;GO:0031267;GO:0032509;GO:0015031;GO:2000641;, C:late endosome;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:endosome transport via multivesicular body sorting pathway; P:protein transport; P:regulation of early endosome to late endosome transport; scaffold18 indexed_genome mRNA 22173419 22203212 . - . ID=transcript_4503;Q8TCE6 B1AMV6 B4DDC3 D3DRC8 Q9NXW4,DENN domain-containing protein 10 {ECO:0000305},Protein FAM45A;, , GO:0005770;GO:0005085;GO:0031267;GO:0032509;GO:0015031;GO:2000641;, C:late endosome;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:endosome transport via multivesicular body sorting pathway; P:protein transport; P:regulation of early endosome to late endosome transport;|Q8TCE6 B1AMV6 B4DDC3 D3DRC8 Q9NXW4,DENN domain-containing protein 10 {ECO:0000305},Protein FAM45A;, , GO:0005770;GO:0005085;GO:0031267;GO:0032509;GO:0015031;GO:2000641;, C:late endosome;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:endosome transport via multivesicular body sorting pathway; P:protein transport; P:regulation of early endosome to late endosome transport;|Q6NSW5 Q5H9G7 Q9NZ36,Putative DENN domain-containing protein 10 B {ECO:0000305},DENND10 pseudogene 1 {ECO:0000312|HGNC:HGNC:30886};Putative protein FAM45B;, , GO:0005770;GO:0005085;GO:0031267;GO:0015031;GO:2000641;, C:late endosome;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:protein transport; P:regulation of early endosome to late endosome transport;|Q8TCE6 B1AMV6 B4DDC3 D3DRC8 Q9NXW4,DENN domain-containing protein 10 {ECO:0000305},Protein FAM45A;, , GO:0005770;GO:0005085;GO:0031267;GO:0032509;GO:0015031;GO:2000641;, C:late endosome;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:endosome transport via multivesicular body sorting pathway; P:protein transport; P:regulation of early endosome to late endosome transport;|Q6NSW5 Q5H9G7 Q9NZ36,Putative DENN domain-containing protein 10 B {ECO:0000305},DENND10 pseudogene 1 {ECO:0000312|HGNC:HGNC:30886};Putative protein FAM45B;, , GO:0005770;GO:0005085;GO:0031267;GO:0015031;GO:2000641;, C:late endosome;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:protein transport; P:regulation of early endosome to late endosome transport;|Q8TCE6 B1AMV6 B4DDC3 D3DRC8 Q9NXW4,DENN domain-containing protein 10 {ECO:0000305},Protein FAM45A;, , GO:0005770;GO:0005085;GO:0031267;GO:0032509;GO:0015031;GO:2000641;, C:late endosome;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:endosome transport via multivesicular body sorting pathway; P:protein transport; P:regulation of early endosome to late endosome transport;|Q6P4A7 Q6WSU4 Q86TD9,Sideroflexin-4 {ECO:0000303|PubMed:15489334},Breast cancer resistance marker 1 {ECO:0000303|Ref.1};, PF03820;, GO:0031305;GO:0005739;GO:0015075;GO:0022857;GO:0006865;GO:1990542;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:ion transmembrane transporter activity; F:transmembrane transporter activity;, P:amino acid transport; P:mitochondrial transmembrane transport; scaffold18 indexed_genome mRNA 22203263 22213124 . - . ID=transcript_4504;P30048 B2R7Z0 D3DRC9 E9PH29 P35690 Q0D2H1 Q13776 Q5T5V2 Q96HK4,Thioredoxin-dependent peroxide reductase, mitochondrial,Antioxidant protein 1;HBC189;Peroxiredoxin III;Peroxiredoxin-3;Protein MER5 homolog;Thioredoxin-dependent peroxiredoxin 3 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0005769;GO:0005759;GO:0005739;GO:0032991;GO:0008785;GO:0043027;GO:0042802;GO:0019900;GO:0008022;GO:0019901;GO:0008379;GO:0045454;GO:0034599;GO:0034614;GO:0042744;GO:0001893;GO:0007005;GO:0030099;GO:0043066;GO:0033673;GO:0018171;GO:0008284;GO:0051092;GO:0051881;GO:0042542;GO:0032496;GO:0006979;, C:cytoplasm; C:cytosol; C:early endosome; C:mitochondrial matrix; C:mitochondrion; C:protein-containing complex;, F:alkyl hydroperoxide reductase activity; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:kinase binding; F:protein C-terminus binding; F:protein kinase binding; F:thioredoxin peroxidase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:cellular response to reactive oxygen species; P:hydrogen peroxide catabolic process; P:maternal placenta development; P:mitochondrion organization; P:myeloid cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of kinase activity; P:peptidyl-cysteine oxidation; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of mitochondrial membrane potential; P:response to hydrogen peroxide; P:response to lipopolysaccharide; P:response to oxidative stress;|P30048 B2R7Z0 D3DRC9 E9PH29 P35690 Q0D2H1 Q13776 Q5T5V2 Q96HK4,Thioredoxin-dependent peroxide reductase, mitochondrial,Antioxidant protein 1;HBC189;Peroxiredoxin III;Peroxiredoxin-3;Protein MER5 homolog;Thioredoxin-dependent peroxiredoxin 3 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0005769;GO:0005759;GO:0005739;GO:0032991;GO:0008785;GO:0043027;GO:0042802;GO:0019900;GO:0008022;GO:0019901;GO:0008379;GO:0045454;GO:0034599;GO:0034614;GO:0042744;GO:0001893;GO:0007005;GO:0030099;GO:0043066;GO:0033673;GO:0018171;GO:0008284;GO:0051092;GO:0051881;GO:0042542;GO:0032496;GO:0006979;, C:cytoplasm; C:cytosol; C:early endosome; C:mitochondrial matrix; C:mitochondrion; C:protein-containing complex;, F:alkyl hydroperoxide reductase activity; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:kinase binding; F:protein C-terminus binding; F:protein kinase binding; F:thioredoxin peroxidase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:cellular response to reactive oxygen species; P:hydrogen peroxide catabolic process; P:maternal placenta development; P:mitochondrion organization; P:myeloid cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of kinase activity; P:peptidyl-cysteine oxidation; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of mitochondrial membrane potential; P:response to hydrogen peroxide; P:response to lipopolysaccharide; P:response to oxidative stress;|P30048 B2R7Z0 D3DRC9 E9PH29 P35690 Q0D2H1 Q13776 Q5T5V2 Q96HK4,Thioredoxin-dependent peroxide reductase, mitochondrial,Antioxidant protein 1;HBC189;Peroxiredoxin III;Peroxiredoxin-3;Protein MER5 homolog;Thioredoxin-dependent peroxiredoxin 3 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0005769;GO:0005759;GO:0005739;GO:0032991;GO:0008785;GO:0043027;GO:0042802;GO:0019900;GO:0008022;GO:0019901;GO:0008379;GO:0045454;GO:0034599;GO:0034614;GO:0042744;GO:0001893;GO:0007005;GO:0030099;GO:0043066;GO:0033673;GO:0018171;GO:0008284;GO:0051092;GO:0051881;GO:0042542;GO:0032496;GO:0006979;, C:cytoplasm; C:cytosol; C:early endosome; C:mitochondrial matrix; C:mitochondrion; C:protein-containing complex;, F:alkyl hydroperoxide reductase activity; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:kinase binding; F:protein C-terminus binding; F:protein kinase binding; F:thioredoxin peroxidase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:cellular response to reactive oxygen species; P:hydrogen peroxide catabolic process; P:maternal placenta development; P:mitochondrion organization; P:myeloid cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of kinase activity; P:peptidyl-cysteine oxidation; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of mitochondrial membrane potential; P:response to hydrogen peroxide; P:response to lipopolysaccharide; P:response to oxidative stress;|P30048 B2R7Z0 D3DRC9 E9PH29 P35690 Q0D2H1 Q13776 Q5T5V2 Q96HK4,Thioredoxin-dependent peroxide reductase, mitochondrial,Antioxidant protein 1;HBC189;Peroxiredoxin III;Peroxiredoxin-3;Protein MER5 homolog;Thioredoxin-dependent peroxiredoxin 3 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0005769;GO:0005759;GO:0005739;GO:0032991;GO:0008785;GO:0043027;GO:0042802;GO:0019900;GO:0008022;GO:0019901;GO:0008379;GO:0045454;GO:0034599;GO:0034614;GO:0042744;GO:0001893;GO:0007005;GO:0030099;GO:0043066;GO:0033673;GO:0018171;GO:0008284;GO:0051092;GO:0051881;GO:0042542;GO:0032496;GO:0006979;, C:cytoplasm; C:cytosol; C:early endosome; C:mitochondrial matrix; C:mitochondrion; C:protein-containing complex;, F:alkyl hydroperoxide reductase activity; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:kinase binding; F:protein C-terminus binding; F:protein kinase binding; F:thioredoxin peroxidase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:cellular response to reactive oxygen species; P:hydrogen peroxide catabolic process; P:maternal placenta development; P:mitochondrion organization; P:myeloid cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of kinase activity; P:peptidyl-cysteine oxidation; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of mitochondrial membrane potential; P:response to hydrogen peroxide; P:response to lipopolysaccharide; P:response to oxidative stress;|P30048 B2R7Z0 D3DRC9 E9PH29 P35690 Q0D2H1 Q13776 Q5T5V2 Q96HK4,Thioredoxin-dependent peroxide reductase, mitochondrial,Antioxidant protein 1;HBC189;Peroxiredoxin III;Peroxiredoxin-3;Protein MER5 homolog;Thioredoxin-dependent peroxiredoxin 3 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0005769;GO:0005759;GO:0005739;GO:0032991;GO:0008785;GO:0043027;GO:0042802;GO:0019900;GO:0008022;GO:0019901;GO:0008379;GO:0045454;GO:0034599;GO:0034614;GO:0042744;GO:0001893;GO:0007005;GO:0030099;GO:0043066;GO:0033673;GO:0018171;GO:0008284;GO:0051092;GO:0051881;GO:0042542;GO:0032496;GO:0006979;, C:cytoplasm; C:cytosol; C:early endosome; C:mitochondrial matrix; C:mitochondrion; C:protein-containing complex;, F:alkyl hydroperoxide reductase activity; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:kinase binding; F:protein C-terminus binding; F:protein kinase binding; F:thioredoxin peroxidase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:cellular response to reactive oxygen species; P:hydrogen peroxide catabolic process; P:maternal placenta development; P:mitochondrion organization; P:myeloid cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of kinase activity; P:peptidyl-cysteine oxidation; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of mitochondrial membrane potential; P:response to hydrogen peroxide; P:response to lipopolysaccharide; P:response to oxidative stress; scaffold18 indexed_genome mRNA 22233668 22457866 . + . ID=transcript_4505;P34947 D3DRD0 Q5T059,G protein-coupled receptor kinase 5,G protein-coupled receptor kinase GRK5;, PF00069;PF00615;, GO:0005737;GO:0005829;GO:0031965;GO:0016607;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0005543;GO:0005080;GO:0004674;GO:0007188;GO:0006915;GO:0007186;GO:0043066;GO:0008284;GO:0046777;GO:0051726;GO:0008277;GO:0007217;GO:0016055;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear speck; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:phospholipid binding; F:protein kinase C binding; F:protein serine/threonine kinase activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation; P:protein autophosphorylation; P:regulation of cell cycle; P:regulation of G protein-coupled receptor signaling pathway; P:tachykinin receptor signaling pathway; P:Wnt signaling pathway;|P34947 D3DRD0 Q5T059,G protein-coupled receptor kinase 5,G protein-coupled receptor kinase GRK5;, PF00069;PF00615;, GO:0005737;GO:0005829;GO:0031965;GO:0016607;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0005543;GO:0005080;GO:0004674;GO:0007188;GO:0006915;GO:0007186;GO:0043066;GO:0008284;GO:0046777;GO:0051726;GO:0008277;GO:0007217;GO:0016055;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear speck; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:phospholipid binding; F:protein kinase C binding; F:protein serine/threonine kinase activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation; P:protein autophosphorylation; P:regulation of cell cycle; P:regulation of G protein-coupled receptor signaling pathway; P:tachykinin receptor signaling pathway; P:Wnt signaling pathway;|P34947 D3DRD0 Q5T059,G protein-coupled receptor kinase 5,G protein-coupled receptor kinase GRK5;, PF00069;PF00615;, GO:0005737;GO:0005829;GO:0031965;GO:0016607;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0005543;GO:0005080;GO:0004674;GO:0007188;GO:0006915;GO:0007186;GO:0043066;GO:0008284;GO:0046777;GO:0051726;GO:0008277;GO:0007217;GO:0016055;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear speck; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:phospholipid binding; F:protein kinase C binding; F:protein serine/threonine kinase activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation; P:protein autophosphorylation; P:regulation of cell cycle; P:regulation of G protein-coupled receptor signaling pathway; P:tachykinin receptor signaling pathway; P:Wnt signaling pathway;|P34947 D3DRD0 Q5T059,G protein-coupled receptor kinase 5,G protein-coupled receptor kinase GRK5;, PF00069;PF00615;, GO:0005737;GO:0005829;GO:0031965;GO:0016607;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0005543;GO:0005080;GO:0004674;GO:0007188;GO:0006915;GO:0007186;GO:0043066;GO:0008284;GO:0046777;GO:0051726;GO:0008277;GO:0007217;GO:0016055;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear speck; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:phospholipid binding; F:protein kinase C binding; F:protein serine/threonine kinase activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation; P:protein autophosphorylation; P:regulation of cell cycle; P:regulation of G protein-coupled receptor signaling pathway; P:tachykinin receptor signaling pathway; P:Wnt signaling pathway;|P34947 D3DRD0 Q5T059,G protein-coupled receptor kinase 5,G protein-coupled receptor kinase GRK5;, PF00069;PF00615;, GO:0005737;GO:0005829;GO:0031965;GO:0016607;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0005543;GO:0005080;GO:0004674;GO:0007188;GO:0006915;GO:0007186;GO:0043066;GO:0008284;GO:0046777;GO:0051726;GO:0008277;GO:0007217;GO:0016055;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear speck; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:phospholipid binding; F:protein kinase C binding; F:protein serine/threonine kinase activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation; P:protein autophosphorylation; P:regulation of cell cycle; P:regulation of G protein-coupled receptor signaling pathway; P:tachykinin receptor signaling pathway; P:Wnt signaling pathway;|P34947 D3DRD0 Q5T059,G protein-coupled receptor kinase 5,G protein-coupled receptor kinase GRK5;, PF00069;PF00615;, GO:0005737;GO:0005829;GO:0031965;GO:0016607;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0005543;GO:0005080;GO:0004674;GO:0007188;GO:0006915;GO:0007186;GO:0043066;GO:0008284;GO:0046777;GO:0051726;GO:0008277;GO:0007217;GO:0016055;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear speck; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:phospholipid binding; F:protein kinase C binding; F:protein serine/threonine kinase activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation; P:protein autophosphorylation; P:regulation of cell cycle; P:regulation of G protein-coupled receptor signaling pathway; P:tachykinin receptor signaling pathway; P:Wnt signaling pathway;|P34947 D3DRD0 Q5T059,G protein-coupled receptor kinase 5,G protein-coupled receptor kinase GRK5;, PF00069;PF00615;, GO:0005737;GO:0005829;GO:0031965;GO:0016607;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0005543;GO:0005080;GO:0004674;GO:0007188;GO:0006915;GO:0007186;GO:0043066;GO:0008284;GO:0046777;GO:0051726;GO:0008277;GO:0007217;GO:0016055;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear speck; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:phospholipid binding; F:protein kinase C binding; F:protein serine/threonine kinase activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation; P:protein autophosphorylation; P:regulation of cell cycle; P:regulation of G protein-coupled receptor signaling pathway; P:tachykinin receptor signaling pathway; P:Wnt signaling pathway; scaffold18 indexed_genome mRNA 22499375 22541585 . - . ID=transcript_4506;O43665 A8K408 B1AMR8 Q6IAZ6 Q96GN0,Regulator of G-protein signaling 10,, PF00615;, GO:0043679;GO:0005829;GO:0043197;GO:0043025;GO:0005634;GO:0005886;GO:0001965;GO:0005096;GO:0007213;GO:0007186;GO:0009968;GO:0043547;GO:0008277;GO:0001975;, C:axon terminus; C:cytosol; C:dendritic spine; C:neuronal cell body; C:nucleus; C:plasma membrane;, F:G-protein alpha-subunit binding; F:GTPase activator activity;, P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of G protein-coupled receptor signaling pathway; P:response to amphetamine; scaffold18 indexed_genome mRNA 22566391 22588612 . - . ID=transcript_4507;Q01085 A8K3T0 A8K4L9,Nucleolysin TIAR,TIA-1-related protein;, PF00076;, GO:0005737;GO:0010494;GO:0005764;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003723;GO:0006915;GO:0006952;GO:0008543;GO:0006357;, C:cytoplasm; C:cytoplasmic stress granule; C:lysosome; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:defense response; P:fibroblast growth factor receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q01085 A8K3T0 A8K4L9,Nucleolysin TIAR,TIA-1-related protein;, PF00076;, GO:0005737;GO:0010494;GO:0005764;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003723;GO:0006915;GO:0006952;GO:0008543;GO:0006357;, C:cytoplasm; C:cytoplasmic stress granule; C:lysosome; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:defense response; P:fibroblast growth factor receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q01085 A8K3T0 A8K4L9,Nucleolysin TIAR,TIA-1-related protein;, PF00076;, GO:0005737;GO:0010494;GO:0005764;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003723;GO:0006915;GO:0006952;GO:0008543;GO:0006357;, C:cytoplasm; C:cytoplasmic stress granule; C:lysosome; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:defense response; P:fibroblast growth factor receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q01085 A8K3T0 A8K4L9,Nucleolysin TIAR,TIA-1-related protein;, PF00076;, GO:0005737;GO:0010494;GO:0005764;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003723;GO:0006915;GO:0006952;GO:0008543;GO:0006357;, C:cytoplasm; C:cytoplasmic stress granule; C:lysosome; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:defense response; P:fibroblast growth factor receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q01085 A8K3T0 A8K4L9,Nucleolysin TIAR,TIA-1-related protein;, PF00076;, GO:0005737;GO:0010494;GO:0005764;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003723;GO:0006915;GO:0006952;GO:0008543;GO:0006357;, C:cytoplasm; C:cytoplasmic stress granule; C:lysosome; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:defense response; P:fibroblast growth factor receptor signaling pathway; P:regulation of transcription by RNA polymerase II; scaffold18 indexed_genome mRNA 22630646 22657246 . + . ID=transcript_4508;O95817 A8K5L8 Q3B763 Q9NT20 Q9P120,BAG family molecular chaperone regulator 3,Bcl-2-associated athanogene 3;Bcl-2-binding protein Bis;Docking protein CAIR-1;, PF02179;PF00397;, GO:0016235;GO:0101031;GO:0005737;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0005886;GO:0001725;GO:0030018;GO:0000774;GO:0045296;GO:0051087;GO:0045505;GO:0031072;GO:0044877;GO:0070842;GO:0000045;GO:0007420;GO:0034605;GO:0071260;GO:0034620;GO:0061684;GO:0072321;GO:0097192;GO:0008625;GO:0046716;GO:0043066;GO:1903215;GO:0010664;GO:0097201;GO:1905337;GO:0046827;GO:0042307;GO:0006457;GO:0050821;GO:0098840;GO:1900034;GO:0021510;, C:aggresome; C:chaperone complex; C:cytoplasm; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:plasma membrane; C:stress fiber; C:Z disc;, F:adenyl-nucleotide exchange factor activity; F:cadherin binding; F:chaperone binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:protein-containing complex binding;, P:aggresome assembly; P:autophagosome assembly; P:brain development; P:cellular response to heat; P:cellular response to mechanical stimulus; P:cellular response to unfolded protein; P:chaperone-mediated autophagy; P:chaperone-mediated protein transport; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:muscle cell cellular homeostasis; P:negative regulation of apoptotic process; P:negative regulation of protein targeting to mitochondrion; P:negative regulation of striated muscle cell apoptotic process; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of aggrephagy; P:positive regulation of protein export from nucleus; P:positive regulation of protein import into nucleus; P:protein folding; P:protein stabilization; P:protein transport along microtubule; P:regulation of cellular response to heat; P:spinal cord development; scaffold18 indexed_genome mRNA 22657282 22659406 . + . ID=transcript_4509;O95817 A8K5L8 Q3B763 Q9NT20 Q9P120,BAG family molecular chaperone regulator 3,Bcl-2-associated athanogene 3;Bcl-2-binding protein Bis;Docking protein CAIR-1;, PF02179;PF00397;, GO:0016235;GO:0101031;GO:0005737;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0005886;GO:0001725;GO:0030018;GO:0000774;GO:0045296;GO:0051087;GO:0045505;GO:0031072;GO:0044877;GO:0070842;GO:0000045;GO:0007420;GO:0034605;GO:0071260;GO:0034620;GO:0061684;GO:0072321;GO:0097192;GO:0008625;GO:0046716;GO:0043066;GO:1903215;GO:0010664;GO:0097201;GO:1905337;GO:0046827;GO:0042307;GO:0006457;GO:0050821;GO:0098840;GO:1900034;GO:0021510;, C:aggresome; C:chaperone complex; C:cytoplasm; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:plasma membrane; C:stress fiber; C:Z disc;, F:adenyl-nucleotide exchange factor activity; F:cadherin binding; F:chaperone binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:protein-containing complex binding;, P:aggresome assembly; P:autophagosome assembly; P:brain development; P:cellular response to heat; P:cellular response to mechanical stimulus; P:cellular response to unfolded protein; P:chaperone-mediated autophagy; P:chaperone-mediated protein transport; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:muscle cell cellular homeostasis; P:negative regulation of apoptotic process; P:negative regulation of protein targeting to mitochondrion; P:negative regulation of striated muscle cell apoptotic process; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of aggrephagy; P:positive regulation of protein export from nucleus; P:positive regulation of protein import into nucleus; P:protein folding; P:protein stabilization; P:protein transport along microtubule; P:regulation of cellular response to heat; P:spinal cord development; scaffold18 indexed_genome mRNA 22751515 22818444 . + . ID=transcript_4510;Q9NT51,Phosphatidylinositide phosphatase SAC2 {ECO:0000305},Inositol polyphosphate 5-phosphatase F {ECO:0000312|HGNC:HGNC:17054};Sac domain-containing inositol phosphatase 2;Sac domain-containing phosphoinositide 4-phosphatase 2 {ECO:0000305|PubMed:25869668, ECO:0000305|PubMed:25869669};, PF12456;PF02383;, GO:0030424;GO:0045334;GO:0005905;GO:0030425;GO:0005769;GO:0031901;GO:0043231;GO:0043025;GO:0055037;GO:0008934;GO:0052832;GO:0052833;GO:0034596;GO:0034595;GO:0043812;GO:0042803;GO:0008344;GO:0014898;GO:0072583;GO:0048681;GO:0033137;GO:0042532;GO:0006661;GO:0031161;GO:0046856;GO:0048015;GO:0001921;GO:2000145;GO:2001135;GO:0051896;, C:axon; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:dendrite; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:recycling endosome;, F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:protein homodimerization activity;, P:adult locomotory behavior; P:cardiac muscle hypertrophy in response to stress; P:clathrin-dependent endocytosis; P:negative regulation of axon regeneration; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of tyrosine phosphorylation of STAT protein; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol catabolic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor recycling; P:regulation of cell motility; P:regulation of endocytic recycling; P:regulation of protein kinase B signaling;|Q9NT51,Phosphatidylinositide phosphatase SAC2 {ECO:0000305},Inositol polyphosphate 5-phosphatase F {ECO:0000312|HGNC:HGNC:17054};Sac domain-containing inositol phosphatase 2;Sac domain-containing phosphoinositide 4-phosphatase 2 {ECO:0000305|PubMed:25869668, ECO:0000305|PubMed:25869669};, PF12456;PF02383;, GO:0030424;GO:0045334;GO:0005905;GO:0030425;GO:0005769;GO:0031901;GO:0043231;GO:0043025;GO:0055037;GO:0008934;GO:0052832;GO:0052833;GO:0034596;GO:0034595;GO:0043812;GO:0042803;GO:0008344;GO:0014898;GO:0072583;GO:0048681;GO:0033137;GO:0042532;GO:0006661;GO:0031161;GO:0046856;GO:0048015;GO:0001921;GO:2000145;GO:2001135;GO:0051896;, C:axon; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:dendrite; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:recycling endosome;, F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:protein homodimerization activity;, P:adult locomotory behavior; P:cardiac muscle hypertrophy in response to stress; P:clathrin-dependent endocytosis; P:negative regulation of axon regeneration; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of tyrosine phosphorylation of STAT protein; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol catabolic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor recycling; P:regulation of cell motility; P:regulation of endocytic recycling; P:regulation of protein kinase B signaling;|Q9NT51,Phosphatidylinositide phosphatase SAC2 {ECO:0000305},Inositol polyphosphate 5-phosphatase F {ECO:0000312|HGNC:HGNC:17054};Sac domain-containing inositol phosphatase 2;Sac domain-containing phosphoinositide 4-phosphatase 2 {ECO:0000305|PubMed:25869668, ECO:0000305|PubMed:25869669};, PF12456;PF02383;, GO:0030424;GO:0045334;GO:0005905;GO:0030425;GO:0005769;GO:0031901;GO:0043231;GO:0043025;GO:0055037;GO:0008934;GO:0052832;GO:0052833;GO:0034596;GO:0034595;GO:0043812;GO:0042803;GO:0008344;GO:0014898;GO:0072583;GO:0048681;GO:0033137;GO:0042532;GO:0006661;GO:0031161;GO:0046856;GO:0048015;GO:0001921;GO:2000145;GO:2001135;GO:0051896;, C:axon; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:dendrite; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:recycling endosome;, F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:protein homodimerization activity;, P:adult locomotory behavior; P:cardiac muscle hypertrophy in response to stress; P:clathrin-dependent endocytosis; P:negative regulation of axon regeneration; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of tyrosine phosphorylation of STAT protein; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol catabolic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor recycling; P:regulation of cell motility; P:regulation of endocytic recycling; P:regulation of protein kinase B signaling;|Q9NT51,Phosphatidylinositide phosphatase SAC2 {ECO:0000305},Inositol polyphosphate 5-phosphatase F {ECO:0000312|HGNC:HGNC:17054};Sac domain-containing inositol phosphatase 2;Sac domain-containing phosphoinositide 4-phosphatase 2 {ECO:0000305|PubMed:25869668, ECO:0000305|PubMed:25869669};, PF12456;PF02383;, GO:0030424;GO:0045334;GO:0005905;GO:0030425;GO:0005769;GO:0031901;GO:0043231;GO:0043025;GO:0055037;GO:0008934;GO:0052832;GO:0052833;GO:0034596;GO:0034595;GO:0043812;GO:0042803;GO:0008344;GO:0014898;GO:0072583;GO:0048681;GO:0033137;GO:0042532;GO:0006661;GO:0031161;GO:0046856;GO:0048015;GO:0001921;GO:2000145;GO:2001135;GO:0051896;, C:axon; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:dendrite; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:recycling endosome;, F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:protein homodimerization activity;, P:adult locomotory behavior; P:cardiac muscle hypertrophy in response to stress; P:clathrin-dependent endocytosis; P:negative regulation of axon regeneration; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of tyrosine phosphorylation of STAT protein; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol catabolic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor recycling; P:regulation of cell motility; P:regulation of endocytic recycling; P:regulation of protein kinase B signaling;|Q9NT51,Phosphatidylinositide phosphatase SAC2 {ECO:0000305},Inositol polyphosphate 5-phosphatase F {ECO:0000312|HGNC:HGNC:17054};Sac domain-containing inositol phosphatase 2;Sac domain-containing phosphoinositide 4-phosphatase 2 {ECO:0000305|PubMed:25869668, ECO:0000305|PubMed:25869669};, PF12456;PF02383;, GO:0030424;GO:0045334;GO:0005905;GO:0030425;GO:0005769;GO:0031901;GO:0043231;GO:0043025;GO:0055037;GO:0008934;GO:0052832;GO:0052833;GO:0034596;GO:0034595;GO:0043812;GO:0042803;GO:0008344;GO:0014898;GO:0072583;GO:0048681;GO:0033137;GO:0042532;GO:0006661;GO:0031161;GO:0046856;GO:0048015;GO:0001921;GO:2000145;GO:2001135;GO:0051896;, C:axon; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:dendrite; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:recycling endosome;, F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:protein homodimerization activity;, P:adult locomotory behavior; P:cardiac muscle hypertrophy in response to stress; P:clathrin-dependent endocytosis; P:negative regulation of axon regeneration; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of tyrosine phosphorylation of STAT protein; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol catabolic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor recycling; P:regulation of cell motility; P:regulation of endocytic recycling; P:regulation of protein kinase B signaling;|Q9NT51,Phosphatidylinositide phosphatase SAC2 {ECO:0000305},Inositol polyphosphate 5-phosphatase F {ECO:0000312|HGNC:HGNC:17054};Sac domain-containing inositol phosphatase 2;Sac domain-containing phosphoinositide 4-phosphatase 2 {ECO:0000305|PubMed:25869668, ECO:0000305|PubMed:25869669};, PF12456;PF02383;, GO:0030424;GO:0045334;GO:0005905;GO:0030425;GO:0005769;GO:0031901;GO:0043231;GO:0043025;GO:0055037;GO:0008934;GO:0052832;GO:0052833;GO:0034596;GO:0034595;GO:0043812;GO:0042803;GO:0008344;GO:0014898;GO:0072583;GO:0048681;GO:0033137;GO:0042532;GO:0006661;GO:0031161;GO:0046856;GO:0048015;GO:0001921;GO:2000145;GO:2001135;GO:0051896;, C:axon; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:dendrite; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:recycling endosome;, F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:protein homodimerization activity;, P:adult locomotory behavior; P:cardiac muscle hypertrophy in response to stress; P:clathrin-dependent endocytosis; P:negative regulation of axon regeneration; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of tyrosine phosphorylation of STAT protein; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol catabolic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor recycling; P:regulation of cell motility; P:regulation of endocytic recycling; P:regulation of protein kinase B signaling;|Q3ZAQ7 A6NKV7 B3KUA9,Vacuolar ATPase assembly integral membrane protein VMA21 {ECO:0000255|HAMAP-Rule:MF_03058},Myopathy with excessive autophagy protein;, PF09446;, GO:0005789;GO:0033116;GO:0012507;GO:0016021;GO:0005764;GO:0005773;GO:0043462;GO:0070072;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:integral component of membrane; C:lysosome; C:vacuole;, , P:regulation of ATPase activity; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q9NT51,Phosphatidylinositide phosphatase SAC2 {ECO:0000305},Inositol polyphosphate 5-phosphatase F {ECO:0000312|HGNC:HGNC:17054};Sac domain-containing inositol phosphatase 2;Sac domain-containing phosphoinositide 4-phosphatase 2 {ECO:0000305|PubMed:25869668, ECO:0000305|PubMed:25869669};, PF12456;PF02383;, GO:0030424;GO:0045334;GO:0005905;GO:0030425;GO:0005769;GO:0031901;GO:0043231;GO:0043025;GO:0055037;GO:0008934;GO:0052832;GO:0052833;GO:0034596;GO:0034595;GO:0043812;GO:0042803;GO:0008344;GO:0014898;GO:0072583;GO:0048681;GO:0033137;GO:0042532;GO:0006661;GO:0031161;GO:0046856;GO:0048015;GO:0001921;GO:2000145;GO:2001135;GO:0051896;, C:axon; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:dendrite; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:recycling endosome;, F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:protein homodimerization activity;, P:adult locomotory behavior; P:cardiac muscle hypertrophy in response to stress; P:clathrin-dependent endocytosis; P:negative regulation of axon regeneration; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of tyrosine phosphorylation of STAT protein; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol catabolic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor recycling; P:regulation of cell motility; P:regulation of endocytic recycling; P:regulation of protein kinase B signaling;|Q9NT51,Phosphatidylinositide phosphatase SAC2 {ECO:0000305},Inositol polyphosphate 5-phosphatase F {ECO:0000312|HGNC:HGNC:17054};Sac domain-containing inositol phosphatase 2;Sac domain-containing phosphoinositide 4-phosphatase 2 {ECO:0000305|PubMed:25869668, ECO:0000305|PubMed:25869669};, PF12456;PF02383;, GO:0030424;GO:0045334;GO:0005905;GO:0030425;GO:0005769;GO:0031901;GO:0043231;GO:0043025;GO:0055037;GO:0008934;GO:0052832;GO:0052833;GO:0034596;GO:0034595;GO:0043812;GO:0042803;GO:0008344;GO:0014898;GO:0072583;GO:0048681;GO:0033137;GO:0042532;GO:0006661;GO:0031161;GO:0046856;GO:0048015;GO:0001921;GO:2000145;GO:2001135;GO:0051896;, C:axon; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:dendrite; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:recycling endosome;, F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:protein homodimerization activity;, P:adult locomotory behavior; P:cardiac muscle hypertrophy in response to stress; P:clathrin-dependent endocytosis; P:negative regulation of axon regeneration; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of tyrosine phosphorylation of STAT protein; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol catabolic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor recycling; P:regulation of cell motility; P:regulation of endocytic recycling; P:regulation of protein kinase B signaling;|Q9NT51,Phosphatidylinositide phosphatase SAC2 {ECO:0000305},Inositol polyphosphate 5-phosphatase F {ECO:0000312|HGNC:HGNC:17054};Sac domain-containing inositol phosphatase 2;Sac domain-containing phosphoinositide 4-phosphatase 2 {ECO:0000305|PubMed:25869668, ECO:0000305|PubMed:25869669};, PF12456;PF02383;, GO:0030424;GO:0045334;GO:0005905;GO:0030425;GO:0005769;GO:0031901;GO:0043231;GO:0043025;GO:0055037;GO:0008934;GO:0052832;GO:0052833;GO:0034596;GO:0034595;GO:0043812;GO:0042803;GO:0008344;GO:0014898;GO:0072583;GO:0048681;GO:0033137;GO:0042532;GO:0006661;GO:0031161;GO:0046856;GO:0048015;GO:0001921;GO:2000145;GO:2001135;GO:0051896;, C:axon; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:dendrite; C:early endosome; C:early endosome membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:recycling endosome;, F:inositol monophosphate 1-phosphatase activity; F:inositol monophosphate 3-phosphatase activity; F:inositol monophosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 4-phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:protein homodimerization activity;, P:adult locomotory behavior; P:cardiac muscle hypertrophy in response to stress; P:clathrin-dependent endocytosis; P:negative regulation of axon regeneration; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of tyrosine phosphorylation of STAT protein; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol catabolic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor recycling; P:regulation of cell motility; P:regulation of endocytic recycling; P:regulation of protein kinase B signaling; scaffold18 indexed_genome mRNA 22819210 22831713 . - . ID=transcript_4511;Q9BTE3 B3KSP7 Q6IA56 Q9BVT9 Q9H916,Mini-chromosome maintenance complex-binding protein,, PF09739;, GO:0030054;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0006261;GO:0007062;, C:cell junction; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:DNA-dependent DNA replication; P:sister chromatid cohesion;|Q9BTE3 B3KSP7 Q6IA56 Q9BVT9 Q9H916,Mini-chromosome maintenance complex-binding protein,, PF09739;, GO:0030054;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0006261;GO:0007062;, C:cell junction; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:DNA-dependent DNA replication; P:sister chromatid cohesion;|Q9BTE3 B3KSP7 Q6IA56 Q9BVT9 Q9H916,Mini-chromosome maintenance complex-binding protein,, PF09739;, GO:0030054;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0006261;GO:0007062;, C:cell junction; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:DNA-dependent DNA replication; P:sister chromatid cohesion;|Q9BTE3 B3KSP7 Q6IA56 Q9BVT9 Q9H916,Mini-chromosome maintenance complex-binding protein,, PF09739;, GO:0030054;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0006261;GO:0007062;, C:cell junction; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:DNA-dependent DNA replication; P:sister chromatid cohesion;|Q9BTE3 B3KSP7 Q6IA56 Q9BVT9 Q9H916,Mini-chromosome maintenance complex-binding protein,, PF09739;, GO:0030054;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0006261;GO:0007062;, C:cell junction; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:DNA-dependent DNA replication; P:sister chromatid cohesion;|Q9BTE3 B3KSP7 Q6IA56 Q9BVT9 Q9H916,Mini-chromosome maintenance complex-binding protein,, PF09739;, GO:0030054;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0006261;GO:0007062;, C:cell junction; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:DNA-dependent DNA replication; P:sister chromatid cohesion; scaffold18 indexed_genome mRNA 22831858 22833495 . + . ID=transcript_4512;Q9BTE3 B3KSP7 Q6IA56 Q9BVT9 Q9H916,Mini-chromosome maintenance complex-binding protein,, PF09739;, GO:0030054;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0006261;GO:0007062;, C:cell junction; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:DNA-dependent DNA replication; P:sister chromatid cohesion; scaffold18 indexed_genome mRNA 22872311 22910457 . + . ID=transcript_4513;Q9Y6Y8 D3DRD2 Q8IXH5 Q9BUK5,SEC23-interacting protein,p125;, PF02862;PF00536;, GO:0030134;GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0012507;GO:0005794;GO:0043231;GO:0046872;GO:0004620;GO:0003723;GO:0048208;GO:0007030;GO:0006886;, C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle;, F:metal ion binding; F:phospholipase activity; F:RNA binding;, P:COPII vesicle coating; P:Golgi organization; P:intracellular protein transport;|Q9Y6Y8 D3DRD2 Q8IXH5 Q9BUK5,SEC23-interacting protein,p125;, PF02862;PF00536;, GO:0030134;GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0012507;GO:0005794;GO:0043231;GO:0046872;GO:0004620;GO:0003723;GO:0048208;GO:0007030;GO:0006886;, C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle;, F:metal ion binding; F:phospholipase activity; F:RNA binding;, P:COPII vesicle coating; P:Golgi organization; P:intracellular protein transport;|Q9Y6Y8 D3DRD2 Q8IXH5 Q9BUK5,SEC23-interacting protein,p125;, PF02862;PF00536;, GO:0030134;GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0012507;GO:0005794;GO:0043231;GO:0046872;GO:0004620;GO:0003723;GO:0048208;GO:0007030;GO:0006886;, C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle;, F:metal ion binding; F:phospholipase activity; F:RNA binding;, P:COPII vesicle coating; P:Golgi organization; P:intracellular protein transport;|Q9Y6Y8 D3DRD2 Q8IXH5 Q9BUK5,SEC23-interacting protein,p125;, PF02862;PF00536;, GO:0030134;GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0012507;GO:0005794;GO:0043231;GO:0046872;GO:0004620;GO:0003723;GO:0048208;GO:0007030;GO:0006886;, C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle;, F:metal ion binding; F:phospholipase activity; F:RNA binding;, P:COPII vesicle coating; P:Golgi organization; P:intracellular protein transport; scaffold18 indexed_genome mRNA 23663091 23720144 . + . ID=transcript_4514;Q9BZH6 Q5VWA1 Q9P2J6,WD repeat-containing protein 11,Bromodomain and WD repeat-containing protein 2;WD repeat-containing protein 15;, , GO:0005930;GO:0036064;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0016020;GO:0015630;GO:0005634;GO:0005802;GO:0060271;GO:0060322;GO:0007507;GO:0006886;GO:0035264;GO:0008589;GO:0099041;, C:axoneme; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:membrane; C:microtubule cytoskeleton; C:nucleus; C:trans-Golgi network;, , P:cilium assembly; P:head development; P:heart development; P:intracellular protein transport; P:multicellular organism growth; P:regulation of smoothened signaling pathway; P:vesicle tethering to Golgi;|Q9BZH6 Q5VWA1 Q9P2J6,WD repeat-containing protein 11,Bromodomain and WD repeat-containing protein 2;WD repeat-containing protein 15;, , GO:0005930;GO:0036064;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0016020;GO:0015630;GO:0005634;GO:0005802;GO:0060271;GO:0060322;GO:0007507;GO:0006886;GO:0035264;GO:0008589;GO:0099041;, C:axoneme; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:membrane; C:microtubule cytoskeleton; C:nucleus; C:trans-Golgi network;, , P:cilium assembly; P:head development; P:heart development; P:intracellular protein transport; P:multicellular organism growth; P:regulation of smoothened signaling pathway; P:vesicle tethering to Golgi;|Q9BZH6 Q5VWA1 Q9P2J6,WD repeat-containing protein 11,Bromodomain and WD repeat-containing protein 2;WD repeat-containing protein 15;, , GO:0005930;GO:0036064;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0016020;GO:0015630;GO:0005634;GO:0005802;GO:0060271;GO:0060322;GO:0007507;GO:0006886;GO:0035264;GO:0008589;GO:0099041;, C:axoneme; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:membrane; C:microtubule cytoskeleton; C:nucleus; C:trans-Golgi network;, , P:cilium assembly; P:head development; P:heart development; P:intracellular protein transport; P:multicellular organism growth; P:regulation of smoothened signaling pathway; P:vesicle tethering to Golgi;|Q9BZH6 Q5VWA1 Q9P2J6,WD repeat-containing protein 11,Bromodomain and WD repeat-containing protein 2;WD repeat-containing protein 15;, , GO:0005930;GO:0036064;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0016020;GO:0015630;GO:0005634;GO:0005802;GO:0060271;GO:0060322;GO:0007507;GO:0006886;GO:0035264;GO:0008589;GO:0099041;, C:axoneme; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:membrane; C:microtubule cytoskeleton; C:nucleus; C:trans-Golgi network;, , P:cilium assembly; P:head development; P:heart development; P:intracellular protein transport; P:multicellular organism growth; P:regulation of smoothened signaling pathway; P:vesicle tethering to Golgi;|Q9BZH6 Q5VWA1 Q9P2J6,WD repeat-containing protein 11,Bromodomain and WD repeat-containing protein 2;WD repeat-containing protein 15;, , GO:0005930;GO:0036064;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0016020;GO:0015630;GO:0005634;GO:0005802;GO:0060271;GO:0060322;GO:0007507;GO:0006886;GO:0035264;GO:0008589;GO:0099041;, C:axoneme; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:membrane; C:microtubule cytoskeleton; C:nucleus; C:trans-Golgi network;, , P:cilium assembly; P:head development; P:heart development; P:intracellular protein transport; P:multicellular organism growth; P:regulation of smoothened signaling pathway; P:vesicle tethering to Golgi;|Q9BZH6 Q5VWA1 Q9P2J6,WD repeat-containing protein 11,Bromodomain and WD repeat-containing protein 2;WD repeat-containing protein 15;, , GO:0005930;GO:0036064;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0016020;GO:0015630;GO:0005634;GO:0005802;GO:0060271;GO:0060322;GO:0007507;GO:0006886;GO:0035264;GO:0008589;GO:0099041;, C:axoneme; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:membrane; C:microtubule cytoskeleton; C:nucleus; C:trans-Golgi network;, , P:cilium assembly; P:head development; P:heart development; P:intracellular protein transport; P:multicellular organism growth; P:regulation of smoothened signaling pathway; P:vesicle tethering to Golgi;|Q9BZH6 Q5VWA1 Q9P2J6,WD repeat-containing protein 11,Bromodomain and WD repeat-containing protein 2;WD repeat-containing protein 15;, , GO:0005930;GO:0036064;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0016020;GO:0015630;GO:0005634;GO:0005802;GO:0060271;GO:0060322;GO:0007507;GO:0006886;GO:0035264;GO:0008589;GO:0099041;, C:axoneme; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:membrane; C:microtubule cytoskeleton; C:nucleus; C:trans-Golgi network;, , P:cilium assembly; P:head development; P:heart development; P:intracellular protein transport; P:multicellular organism growth; P:regulation of smoothened signaling pathway; P:vesicle tethering to Golgi;|Q9BZH6 Q5VWA1 Q9P2J6,WD repeat-containing protein 11,Bromodomain and WD repeat-containing protein 2;WD repeat-containing protein 15;, , GO:0005930;GO:0036064;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0016020;GO:0015630;GO:0005634;GO:0005802;GO:0060271;GO:0060322;GO:0007507;GO:0006886;GO:0035264;GO:0008589;GO:0099041;, C:axoneme; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:membrane; C:microtubule cytoskeleton; C:nucleus; C:trans-Golgi network;, , P:cilium assembly; P:head development; P:heart development; P:intracellular protein transport; P:multicellular organism growth; P:regulation of smoothened signaling pathway; P:vesicle tethering to Golgi; scaffold18 indexed_genome mRNA 24265648 24297288 . - . ID=transcript_4515;Q9UQH7 Q9UQH8 Q9UQH9 Q9UQI0,Fibroblast growth factor receptor 2,K-sam;Keratinocyte growth factor receptor;, PF18123;PF07679;PF07714;, GO:0005938;GO:0009986;GO:0005737;GO:0031410;GO:0060076;GO:0005576;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0004714;GO:0001525;GO:0009887;GO:0006915;GO:0007409;GO:0060348;GO:0030282;GO:0060349;GO:0060667;GO:0060670;GO:0060442;GO:0060445;GO:0048755;GO:0060449;GO:0045165;GO:0007267;GO:0071300;GO:0071560;GO:0048565;GO:0048701;GO:0048557;GO:0048568;GO:0048562;GO:0009880;GO:0003416;GO:0048730;GO:0030855;GO:0060664;GO:0001837;GO:0008543;GO:0035603;GO:0060595;GO:0035602;GO:0035607;GO:0035604;GO:0022612;GO:0031069;GO:0001701;GO:0042472;GO:0032808;GO:0060601;GO:0060174;GO:0048286;GO:0030324;GO:0060463;GO:0060484;GO:0060615;GO:0000165;GO:0003149;GO:0048762;GO:0060915;GO:0060916;GO:0048333;GO:0030901;GO:0016331;GO:0007275;GO:0010839;GO:0000122;GO:0042476;GO:0021769;GO:0035265;GO:0030916;GO:0003148;GO:0018108;GO:0090263;GO:0060045;GO:0045787;GO:0051781;GO:0008284;GO:0050679;GO:0060501;GO:0070374;GO:0033674;GO:0043410;GO:0002053;GO:0010518;GO:0051897;GO:0048661;GO:0045944;GO:0030177;GO:0009791;GO:0060527;GO:0060523;GO:0060512;GO:0046777;GO:0021860;GO:0070372;GO:0060688;GO:0045667;GO:0033688;GO:0051150;GO:0008589;GO:0048608;GO:0045471;GO:0032496;GO:0048705;GO:0060529;GO:0007169;GO:0001657;GO:0055010;GO:0021847;GO:0042060;, C:cell cortex; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:excitatory synapse; C:extracellular region; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:animal organ morphogenesis; P:apoptotic process; P:axonogenesis; P:bone development; P:bone mineralization; P:bone morphogenesis; P:branch elongation involved in salivary gland morphogenesis; P:branching involved in labyrinthine layer morphogenesis; P:branching involved in prostate gland morphogenesis; P:branching involved in salivary gland morphogenesis; P:branching morphogenesis of a nerve; P:bud elongation involved in lung branching; P:cell fate commitment; P:cell-cell signaling; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:digestive tract development; P:embryonic cranial skeleton morphogenesis; P:embryonic digestive tract morphogenesis; P:embryonic organ development; P:embryonic organ morphogenesis; P:embryonic pattern specification; P:endochondral bone growth; P:epidermis morphogenesis; P:epithelial cell differentiation; P:epithelial cell proliferation involved in salivary gland morphogenesis; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway involved in hemopoiesis; P:fibroblast growth factor receptor signaling pathway involved in mammary gland specification; P:fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell; P:fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development; P:fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow; P:gland morphogenesis; P:hair follicle morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:lacrimal gland development; P:lateral sprouting from an epithelium; P:limb bud formation; P:lung alveolus development; P:lung development; P:lung lobe morphogenesis; P:lung-associated mesenchyme development; P:mammary gland bud formation; P:MAPK cascade; P:membranous septum morphogenesis; P:mesenchymal cell differentiation; P:mesenchymal cell differentiation involved in lung development; P:mesenchymal cell proliferation involved in lung development; P:mesodermal cell differentiation; P:midbrain development; P:morphogenesis of embryonic epithelium; P:multicellular organism development; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis; P:orbitofrontal cortex development; P:organ growth; P:otic vesicle formation; P:outflow tract septum morphogenesis; P:peptidyl-tyrosine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell cycle; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway; P:post-embryonic development; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; P:prostate epithelial cord elongation; P:prostate gland morphogenesis; P:protein autophosphorylation; P:pyramidal neuron development; P:regulation of ERK1 and ERK2 cascade; P:regulation of morphogenesis of a branching structure; P:regulation of osteoblast differentiation; P:regulation of osteoblast proliferation; P:regulation of smooth muscle cell differentiation; P:regulation of smoothened signaling pathway; P:reproductive structure development; P:response to ethanol; P:response to lipopolysaccharide; P:skeletal system morphogenesis; P:squamous basal epithelial stem cell differentiation involved in prostate gland acinus development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:ureteric bud development; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular zone neuroblast division; P:wound healing;|Q9UQH7 Q9UQH8 Q9UQH9 Q9UQI0,Fibroblast growth factor receptor 2,K-sam;Keratinocyte growth factor receptor;, PF18123;PF07679;PF07714;, GO:0005938;GO:0009986;GO:0005737;GO:0031410;GO:0060076;GO:0005576;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0004714;GO:0001525;GO:0009887;GO:0006915;GO:0007409;GO:0060348;GO:0030282;GO:0060349;GO:0060667;GO:0060670;GO:0060442;GO:0060445;GO:0048755;GO:0060449;GO:0045165;GO:0007267;GO:0071300;GO:0071560;GO:0048565;GO:0048701;GO:0048557;GO:0048568;GO:0048562;GO:0009880;GO:0003416;GO:0048730;GO:0030855;GO:0060664;GO:0001837;GO:0008543;GO:0035603;GO:0060595;GO:0035602;GO:0035607;GO:0035604;GO:0022612;GO:0031069;GO:0001701;GO:0042472;GO:0032808;GO:0060601;GO:0060174;GO:0048286;GO:0030324;GO:0060463;GO:0060484;GO:0060615;GO:0000165;GO:0003149;GO:0048762;GO:0060915;GO:0060916;GO:0048333;GO:0030901;GO:0016331;GO:0007275;GO:0010839;GO:0000122;GO:0042476;GO:0021769;GO:0035265;GO:0030916;GO:0003148;GO:0018108;GO:0090263;GO:0060045;GO:0045787;GO:0051781;GO:0008284;GO:0050679;GO:0060501;GO:0070374;GO:0033674;GO:0043410;GO:0002053;GO:0010518;GO:0051897;GO:0048661;GO:0045944;GO:0030177;GO:0009791;GO:0060527;GO:0060523;GO:0060512;GO:0046777;GO:0021860;GO:0070372;GO:0060688;GO:0045667;GO:0033688;GO:0051150;GO:0008589;GO:0048608;GO:0045471;GO:0032496;GO:0048705;GO:0060529;GO:0007169;GO:0001657;GO:0055010;GO:0021847;GO:0042060;, C:cell cortex; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:excitatory synapse; C:extracellular region; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:animal organ morphogenesis; P:apoptotic process; P:axonogenesis; P:bone development; P:bone mineralization; P:bone morphogenesis; P:branch elongation involved in salivary gland morphogenesis; P:branching involved in labyrinthine layer morphogenesis; P:branching involved in prostate gland morphogenesis; P:branching involved in salivary gland morphogenesis; P:branching morphogenesis of a nerve; P:bud elongation involved in lung branching; P:cell fate commitment; P:cell-cell signaling; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:digestive tract development; P:embryonic cranial skeleton morphogenesis; P:embryonic digestive tract morphogenesis; P:embryonic organ development; P:embryonic organ morphogenesis; P:embryonic pattern specification; P:endochondral bone growth; P:epidermis morphogenesis; P:epithelial cell differentiation; P:epithelial cell proliferation involved in salivary gland morphogenesis; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway involved in hemopoiesis; P:fibroblast growth factor receptor signaling pathway involved in mammary gland specification; P:fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell; P:fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development; P:fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow; P:gland morphogenesis; P:hair follicle morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:lacrimal gland development; P:lateral sprouting from an epithelium; P:limb bud formation; P:lung alveolus development; P:lung development; P:lung lobe morphogenesis; P:lung-associated mesenchyme development; P:mammary gland bud formation; P:MAPK cascade; P:membranous septum morphogenesis; P:mesenchymal cell differentiation; P:mesenchymal cell differentiation involved in lung development; P:mesenchymal cell proliferation involved in lung development; P:mesodermal cell differentiation; P:midbrain development; P:morphogenesis of embryonic epithelium; P:multicellular organism development; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis; P:orbitofrontal cortex development; P:organ growth; P:otic vesicle formation; P:outflow tract septum morphogenesis; P:peptidyl-tyrosine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell cycle; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway; P:post-embryonic development; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; P:prostate epithelial cord elongation; P:prostate gland morphogenesis; P:protein autophosphorylation; P:pyramidal neuron development; P:regulation of ERK1 and ERK2 cascade; P:regulation of morphogenesis of a branching structure; P:regulation of osteoblast differentiation; P:regulation of osteoblast proliferation; P:regulation of smooth muscle cell differentiation; P:regulation of smoothened signaling pathway; P:reproductive structure development; P:response to ethanol; P:response to lipopolysaccharide; P:skeletal system morphogenesis; P:squamous basal epithelial stem cell differentiation involved in prostate gland acinus development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:ureteric bud development; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular zone neuroblast division; P:wound healing;|Q9UQH7 Q9UQH8 Q9UQH9 Q9UQI0,Fibroblast growth factor receptor 2,K-sam;Keratinocyte growth factor receptor;, PF18123;PF07679;PF07714;, GO:0005938;GO:0009986;GO:0005737;GO:0031410;GO:0060076;GO:0005576;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0004714;GO:0001525;GO:0009887;GO:0006915;GO:0007409;GO:0060348;GO:0030282;GO:0060349;GO:0060667;GO:0060670;GO:0060442;GO:0060445;GO:0048755;GO:0060449;GO:0045165;GO:0007267;GO:0071300;GO:0071560;GO:0048565;GO:0048701;GO:0048557;GO:0048568;GO:0048562;GO:0009880;GO:0003416;GO:0048730;GO:0030855;GO:0060664;GO:0001837;GO:0008543;GO:0035603;GO:0060595;GO:0035602;GO:0035607;GO:0035604;GO:0022612;GO:0031069;GO:0001701;GO:0042472;GO:0032808;GO:0060601;GO:0060174;GO:0048286;GO:0030324;GO:0060463;GO:0060484;GO:0060615;GO:0000165;GO:0003149;GO:0048762;GO:0060915;GO:0060916;GO:0048333;GO:0030901;GO:0016331;GO:0007275;GO:0010839;GO:0000122;GO:0042476;GO:0021769;GO:0035265;GO:0030916;GO:0003148;GO:0018108;GO:0090263;GO:0060045;GO:0045787;GO:0051781;GO:0008284;GO:0050679;GO:0060501;GO:0070374;GO:0033674;GO:0043410;GO:0002053;GO:0010518;GO:0051897;GO:0048661;GO:0045944;GO:0030177;GO:0009791;GO:0060527;GO:0060523;GO:0060512;GO:0046777;GO:0021860;GO:0070372;GO:0060688;GO:0045667;GO:0033688;GO:0051150;GO:0008589;GO:0048608;GO:0045471;GO:0032496;GO:0048705;GO:0060529;GO:0007169;GO:0001657;GO:0055010;GO:0021847;GO:0042060;, C:cell cortex; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:excitatory synapse; C:extracellular region; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:animal organ morphogenesis; P:apoptotic process; P:axonogenesis; P:bone development; P:bone mineralization; P:bone morphogenesis; P:branch elongation involved in salivary gland morphogenesis; P:branching involved in labyrinthine layer morphogenesis; P:branching involved in prostate gland morphogenesis; P:branching involved in salivary gland morphogenesis; P:branching morphogenesis of a nerve; P:bud elongation involved in lung branching; P:cell fate commitment; P:cell-cell signaling; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:digestive tract development; P:embryonic cranial skeleton morphogenesis; P:embryonic digestive tract morphogenesis; P:embryonic organ development; P:embryonic organ morphogenesis; P:embryonic pattern specification; P:endochondral bone growth; P:epidermis morphogenesis; P:epithelial cell differentiation; P:epithelial cell proliferation involved in salivary gland morphogenesis; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway involved in hemopoiesis; P:fibroblast growth factor receptor signaling pathway involved in mammary gland specification; P:fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell; P:fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development; P:fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow; P:gland morphogenesis; P:hair follicle morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:lacrimal gland development; P:lateral sprouting from an epithelium; P:limb bud formation; P:lung alveolus development; P:lung development; P:lung lobe morphogenesis; P:lung-associated mesenchyme development; P:mammary gland bud formation; P:MAPK cascade; P:membranous septum morphogenesis; P:mesenchymal cell differentiation; P:mesenchymal cell differentiation involved in lung development; P:mesenchymal cell proliferation involved in lung development; P:mesodermal cell differentiation; P:midbrain development; P:morphogenesis of embryonic epithelium; P:multicellular organism development; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis; P:orbitofrontal cortex development; P:organ growth; P:otic vesicle formation; P:outflow tract septum morphogenesis; P:peptidyl-tyrosine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell cycle; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway; P:post-embryonic development; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; P:prostate epithelial cord elongation; P:prostate gland morphogenesis; P:protein autophosphorylation; P:pyramidal neuron development; P:regulation of ERK1 and ERK2 cascade; P:regulation of morphogenesis of a branching structure; P:regulation of osteoblast differentiation; P:regulation of osteoblast proliferation; P:regulation of smooth muscle cell differentiation; P:regulation of smoothened signaling pathway; P:reproductive structure development; P:response to ethanol; P:response to lipopolysaccharide; P:skeletal system morphogenesis; P:squamous basal epithelial stem cell differentiation involved in prostate gland acinus development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:ureteric bud development; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular zone neuroblast division; P:wound healing; scaffold18 indexed_genome mRNA 24302157 24367093 . - . ID=transcript_4516;Q9UQH7 Q9UQH8 Q9UQH9 Q9UQI0,Fibroblast growth factor receptor 2,K-sam;Keratinocyte growth factor receptor;, PF18123;PF07679;PF07714;, GO:0005938;GO:0009986;GO:0005737;GO:0031410;GO:0060076;GO:0005576;GO:0005794;GO:0016021;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0004714;GO:0001525;GO:0009887;GO:0006915;GO:0007409;GO:0060348;GO:0030282;GO:0060349;GO:0060667;GO:0060670;GO:0060442;GO:0060445;GO:0048755;GO:0060449;GO:0045165;GO:0007267;GO:0071300;GO:0071560;GO:0048565;GO:0048701;GO:0048557;GO:0048568;GO:0048562;GO:0009880;GO:0003416;GO:0048730;GO:0030855;GO:0060664;GO:0001837;GO:0008543;GO:0035603;GO:0060595;GO:0035602;GO:0035607;GO:0035604;GO:0022612;GO:0031069;GO:0001701;GO:0042472;GO:0032808;GO:0060601;GO:0060174;GO:0048286;GO:0030324;GO:0060463;GO:0060484;GO:0060615;GO:0000165;GO:0003149;GO:0048762;GO:0060915;GO:0060916;GO:0048333;GO:0030901;GO:0016331;GO:0007275;GO:0010839;GO:0000122;GO:0042476;GO:0021769;GO:0035265;GO:0030916;GO:0003148;GO:0018108;GO:0090263;GO:0060045;GO:0045787;GO:0051781;GO:0008284;GO:0050679;GO:0060501;GO:0070374;GO:0033674;GO:0043410;GO:0002053;GO:0010518;GO:0051897;GO:0048661;GO:0045944;GO:0030177;GO:0009791;GO:0060527;GO:0060523;GO:0060512;GO:0046777;GO:0021860;GO:0070372;GO:0060688;GO:0045667;GO:0033688;GO:0051150;GO:0008589;GO:0048608;GO:0045471;GO:0032496;GO:0048705;GO:0060529;GO:0007169;GO:0001657;GO:0055010;GO:0021847;GO:0042060;, C:cell cortex; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:excitatory synapse; C:extracellular region; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:animal organ morphogenesis; P:apoptotic process; P:axonogenesis; P:bone development; P:bone mineralization; P:bone morphogenesis; P:branch elongation involved in salivary gland morphogenesis; P:branching involved in labyrinthine layer morphogenesis; P:branching involved in prostate gland morphogenesis; P:branching involved in salivary gland morphogenesis; P:branching morphogenesis of a nerve; P:bud elongation involved in lung branching; P:cell fate commitment; P:cell-cell signaling; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:digestive tract development; P:embryonic cranial skeleton morphogenesis; P:embryonic digestive tract morphogenesis; P:embryonic organ development; P:embryonic organ morphogenesis; P:embryonic pattern specification; P:endochondral bone growth; P:epidermis morphogenesis; P:epithelial cell differentiation; P:epithelial cell proliferation involved in salivary gland morphogenesis; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway involved in hemopoiesis; P:fibroblast growth factor receptor signaling pathway involved in mammary gland specification; P:fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell; P:fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development; P:fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow; P:gland morphogenesis; P:hair follicle morphogenesis; P:in utero embryonic development; P:inner ear morphogenesis; P:lacrimal gland development; P:lateral sprouting from an epithelium; P:limb bud formation; P:lung alveolus development; P:lung development; P:lung lobe morphogenesis; P:lung-associated mesenchyme development; P:mammary gland bud formation; P:MAPK cascade; P:membranous septum morphogenesis; P:mesenchymal cell differentiation; P:mesenchymal cell differentiation involved in lung development; P:mesenchymal cell proliferation involved in lung development; P:mesodermal cell differentiation; P:midbrain development; P:morphogenesis of embryonic epithelium; P:multicellular organism development; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis; P:orbitofrontal cortex development; P:organ growth; P:otic vesicle formation; P:outflow tract septum morphogenesis; P:peptidyl-tyrosine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell cycle; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway; P:post-embryonic development; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; P:prostate epithelial cord elongation; P:prostate gland morphogenesis; P:protein autophosphorylation; P:pyramidal neuron development; P:regulation of ERK1 and ERK2 cascade; P:regulation of morphogenesis of a branching structure; P:regulation of osteoblast differentiation; P:regulation of osteoblast proliferation; P:regulation of smooth muscle cell differentiation; P:regulation of smoothened signaling pathway; P:reproductive structure development; P:response to ethanol; P:response to lipopolysaccharide; P:skeletal system morphogenesis; P:squamous basal epithelial stem cell differentiation involved in prostate gland acinus development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:ureteric bud development; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular zone neuroblast division; P:wound healing; scaffold18 indexed_genome mRNA 24491830 24573038 . - . ID=transcript_4517;O95260 O95261 Q5SQQ3 Q8WW04,Arginyl-tRNA--protein transferase 1,Arginine-tRNA--protein transferase 1;, PF04377;PF04376;, GO:0005737;GO:0005634;GO:0004057;GO:0010498;GO:0016598;, C:cytoplasm; C:nucleus;, F:arginyltransferase activity;, P:proteasomal protein catabolic process; P:protein arginylation;|O95260 O95261 Q5SQQ3 Q8WW04,Arginyl-tRNA--protein transferase 1,Arginine-tRNA--protein transferase 1;, PF04377;PF04376;, GO:0005737;GO:0005634;GO:0004057;GO:0010498;GO:0016598;, C:cytoplasm; C:nucleus;, F:arginyltransferase activity;, P:proteasomal protein catabolic process; P:protein arginylation;|O95260 O95261 Q5SQQ3 Q8WW04,Arginyl-tRNA--protein transferase 1,Arginine-tRNA--protein transferase 1;, PF04377;PF04376;, GO:0005737;GO:0005634;GO:0004057;GO:0010498;GO:0016598;, C:cytoplasm; C:nucleus;, F:arginyltransferase activity;, P:proteasomal protein catabolic process; P:protein arginylation;|O95260 O95261 Q5SQQ3 Q8WW04,Arginyl-tRNA--protein transferase 1,Arginine-tRNA--protein transferase 1;, PF04377;PF04376;, GO:0005737;GO:0005634;GO:0004057;GO:0010498;GO:0016598;, C:cytoplasm; C:nucleus;, F:arginyltransferase activity;, P:proteasomal protein catabolic process; P:protein arginylation; scaffold18 indexed_genome mRNA 24578894 24615491 . - . ID=transcript_4518;O95260 O95261 Q5SQQ3 Q8WW04,Arginyl-tRNA--protein transferase 1,Arginine-tRNA--protein transferase 1;, PF04377;PF04376;, GO:0005737;GO:0005634;GO:0004057;GO:0010498;GO:0016598;, C:cytoplasm; C:nucleus;, F:arginyltransferase activity;, P:proteasomal protein catabolic process; P:protein arginylation; scaffold18 indexed_genome mRNA 24628910 24654283 . - . ID=transcript_4519;O95260 O95261 Q5SQQ3 Q8WW04,Arginyl-tRNA--protein transferase 1,Arginine-tRNA--protein transferase 1;, PF04377;PF04376;, GO:0005737;GO:0005634;GO:0004057;GO:0010498;GO:0016598;, C:cytoplasm; C:nucleus;, F:arginyltransferase activity;, P:proteasomal protein catabolic process; P:protein arginylation; scaffold18 indexed_genome mRNA 24667126 24680589 . - . ID=transcript_4520;Q9NXX6 Q5SQQ5 Q6P673 Q8WY66 Q9BS90,Non-structural maintenance of chromosomes element 4 homolog A,, PF15412;PF08743;, GO:0000781;GO:0016604;GO:0005654;GO:0005634;GO:0030915;GO:0006310;GO:0006281;GO:2001022;, C:chromosome, telomeric region; C:nuclear body; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, , P:DNA recombination; P:DNA repair; P:positive regulation of response to DNA damage stimulus;|Q9NXX6 Q5SQQ5 Q6P673 Q8WY66 Q9BS90,Non-structural maintenance of chromosomes element 4 homolog A,, PF15412;PF08743;, GO:0000781;GO:0016604;GO:0005654;GO:0005634;GO:0030915;GO:0006310;GO:0006281;GO:2001022;, C:chromosome, telomeric region; C:nuclear body; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, , P:DNA recombination; P:DNA repair; P:positive regulation of response to DNA damage stimulus;|Q9NXX6 Q5SQQ5 Q6P673 Q8WY66 Q9BS90,Non-structural maintenance of chromosomes element 4 homolog A,, PF15412;PF08743;, GO:0000781;GO:0016604;GO:0005654;GO:0005634;GO:0030915;GO:0006310;GO:0006281;GO:2001022;, C:chromosome, telomeric region; C:nuclear body; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, , P:DNA recombination; P:DNA repair; P:positive regulation of response to DNA damage stimulus;|Q9NXX6 Q5SQQ5 Q6P673 Q8WY66 Q9BS90,Non-structural maintenance of chromosomes element 4 homolog A,, PF15412;PF08743;, GO:0000781;GO:0016604;GO:0005654;GO:0005634;GO:0030915;GO:0006310;GO:0006281;GO:2001022;, C:chromosome, telomeric region; C:nuclear body; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, , P:DNA recombination; P:DNA repair; P:positive regulation of response to DNA damage stimulus;|Q9NXX6 Q5SQQ5 Q6P673 Q8WY66 Q9BS90,Non-structural maintenance of chromosomes element 4 homolog A,, PF15412;PF08743;, GO:0000781;GO:0016604;GO:0005654;GO:0005634;GO:0030915;GO:0006310;GO:0006281;GO:2001022;, C:chromosome, telomeric region; C:nuclear body; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, , P:DNA recombination; P:DNA repair; P:positive regulation of response to DNA damage stimulus;|Q9NXX6 Q5SQQ5 Q6P673 Q8WY66 Q9BS90,Non-structural maintenance of chromosomes element 4 homolog A,, PF15412;PF08743;, GO:0000781;GO:0016604;GO:0005654;GO:0005634;GO:0030915;GO:0006310;GO:0006281;GO:2001022;, C:chromosome, telomeric region; C:nuclear body; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, , P:DNA recombination; P:DNA repair; P:positive regulation of response to DNA damage stimulus;|Q9NXX6 Q5SQQ5 Q6P673 Q8WY66 Q9BS90,Non-structural maintenance of chromosomes element 4 homolog A,, PF15412;PF08743;, GO:0000781;GO:0016604;GO:0005654;GO:0005634;GO:0030915;GO:0006310;GO:0006281;GO:2001022;, C:chromosome, telomeric region; C:nuclear body; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, , P:DNA recombination; P:DNA repair; P:positive regulation of response to DNA damage stimulus; scaffold18 indexed_genome mRNA 24721684 24770887 . + . ID=transcript_4521;Q9BVQ1 Q9NZ41 Q9NZR5,Transforming acidic coiled-coil-containing protein 2,Anti-Zuai-1;, PF05010;, GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0035257;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, F:nuclear hormone receptor binding;, P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization; scaffold18 indexed_genome mRNA 24882551 24929967 . + . ID=transcript_4522;Q9BVQ1 Q9NZ41 Q9NZR5,Transforming acidic coiled-coil-containing protein 2,Anti-Zuai-1;, PF05010;, GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0035257;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, F:nuclear hormone receptor binding;, P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q9BVQ1 Q9NZ41 Q9NZR5,Transforming acidic coiled-coil-containing protein 2,Anti-Zuai-1;, PF05010;, GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0035257;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, F:nuclear hormone receptor binding;, P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q9BVQ1 Q9NZ41 Q9NZR5,Transforming acidic coiled-coil-containing protein 2,Anti-Zuai-1;, PF05010;, GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0035257;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, F:nuclear hormone receptor binding;, P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q9BVQ1 Q9NZ41 Q9NZR5,Transforming acidic coiled-coil-containing protein 2,Anti-Zuai-1;, PF05010;, GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0035257;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, F:nuclear hormone receptor binding;, P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q9BVQ1 Q9NZ41 Q9NZR5,Transforming acidic coiled-coil-containing protein 2,Anti-Zuai-1;, PF05010;, GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0035257;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, F:nuclear hormone receptor binding;, P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q9BVQ1 Q9NZ41 Q9NZR5,Transforming acidic coiled-coil-containing protein 2,Anti-Zuai-1;, PF05010;, GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0035257;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, F:nuclear hormone receptor binding;, P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q9BVQ1 Q9NZ41 Q9NZR5,Transforming acidic coiled-coil-containing protein 2,Anti-Zuai-1;, PF05010;, GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0035257;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane;, F:nuclear hormone receptor binding;, P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization; scaffold18 indexed_genome mRNA 25065462 25080308 . + . ID=transcript_4523;Q9HB21 B3KQ55 D3DRE2 Q9BVK0,Pleckstrin homology domain-containing family A member 1,Tandem PH domain-containing protein 1;, PF00169;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0032587;GO:0008289;GO:0030165;GO:0043325;GO:0008209;GO:0050853;GO:0070301;GO:0045184;GO:0008210;GO:0060325;GO:0033327;GO:0001553;GO:0035264;GO:0051898;GO:0014065;GO:0006661;GO:0048008;GO:0009791;GO:0060021;GO:0031529;GO:0048705;GO:0007283;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane; C:ruffle membrane;, F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:androgen metabolic process; P:B cell receptor signaling pathway; P:cellular response to hydrogen peroxide; P:establishment of protein localization; P:estrogen metabolic process; P:face morphogenesis; P:Leydig cell differentiation; P:luteinization; P:multicellular organism growth; P:negative regulation of protein kinase B signaling; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:roof of mouth development; P:ruffle organization; P:skeletal system morphogenesis; P:spermatogenesis;|Q9HB21 B3KQ55 D3DRE2 Q9BVK0,Pleckstrin homology domain-containing family A member 1,Tandem PH domain-containing protein 1;, PF00169;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0032587;GO:0008289;GO:0030165;GO:0043325;GO:0008209;GO:0050853;GO:0070301;GO:0045184;GO:0008210;GO:0060325;GO:0033327;GO:0001553;GO:0035264;GO:0051898;GO:0014065;GO:0006661;GO:0048008;GO:0009791;GO:0060021;GO:0031529;GO:0048705;GO:0007283;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane; C:ruffle membrane;, F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:androgen metabolic process; P:B cell receptor signaling pathway; P:cellular response to hydrogen peroxide; P:establishment of protein localization; P:estrogen metabolic process; P:face morphogenesis; P:Leydig cell differentiation; P:luteinization; P:multicellular organism growth; P:negative regulation of protein kinase B signaling; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:roof of mouth development; P:ruffle organization; P:skeletal system morphogenesis; P:spermatogenesis; scaffold18 indexed_genome mRNA 25154768 25159837 . + . ID=transcript_4524;Q92743 D3DRE4 Q9UNS5,Serine protease HTRA1,High-temperature requirement A serine peptidase 1;L56;Serine protease 11;, PF00219;PF07648;PF17820;, GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0042802;GO:0005520;GO:0004252;GO:0008236;GO:0060718;GO:0097187;GO:0022617;GO:0030514;GO:0050687;GO:0030512;GO:0001890;GO:0050679;GO:0006508;, C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:identical protein binding; F:insulin-like growth factor binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:chorionic trophoblast cell differentiation; P:dentinogenesis; P:extracellular matrix disassembly; P:negative regulation of BMP signaling pathway; P:negative regulation of defense response to virus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:placenta development; P:positive regulation of epithelial cell proliferation; P:proteolysis;|Q92743 D3DRE4 Q9UNS5,Serine protease HTRA1,High-temperature requirement A serine peptidase 1;L56;Serine protease 11;, PF00219;PF07648;PF17820;, GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0042802;GO:0005520;GO:0004252;GO:0008236;GO:0060718;GO:0097187;GO:0022617;GO:0030514;GO:0050687;GO:0030512;GO:0001890;GO:0050679;GO:0006508;, C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:identical protein binding; F:insulin-like growth factor binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:chorionic trophoblast cell differentiation; P:dentinogenesis; P:extracellular matrix disassembly; P:negative regulation of BMP signaling pathway; P:negative regulation of defense response to virus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:placenta development; P:positive regulation of epithelial cell proliferation; P:proteolysis; scaffold18 indexed_genome mRNA 25162804 25164319 . + . ID=transcript_4525;Q92743 D3DRE4 Q9UNS5,Serine protease HTRA1,High-temperature requirement A serine peptidase 1;L56;Serine protease 11;, PF00219;PF07648;PF17820;, GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0042802;GO:0005520;GO:0004252;GO:0008236;GO:0060718;GO:0097187;GO:0022617;GO:0030514;GO:0050687;GO:0030512;GO:0001890;GO:0050679;GO:0006508;, C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:identical protein binding; F:insulin-like growth factor binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:chorionic trophoblast cell differentiation; P:dentinogenesis; P:extracellular matrix disassembly; P:negative regulation of BMP signaling pathway; P:negative regulation of defense response to virus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:placenta development; P:positive regulation of epithelial cell proliferation; P:proteolysis; scaffold18 indexed_genome mRNA 25232661 25261708 . + . ID=transcript_4526;Q9Y4V9,Deleted in malignant brain tumors 1 protein,Glycoprotein 340;Hensin;Salivary agglutinin;Surfactant pulmonary-associated D-binding protein;, PF00431;PF00530;PF00100;, GO:0005737;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0019898;GO:0030670;GO:0042589;GO:0048306;GO:0003677;GO:0050840;GO:1904399;GO:0001530;GO:0070891;GO:0038187;GO:0005044;GO:0035375;GO:0061844;GO:0044267;GO:0006952;GO:0050829;GO:0050830;GO:0051607;GO:0042494;GO:0030855;GO:0043152;GO:0045087;GO:0007275;GO:0015031;GO:0006898;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:extrinsic component of membrane; C:phagocytic vesicle membrane; C:zymogen granule membrane;, F:calcium-dependent protein binding; F:DNA binding; F:extracellular matrix binding; F:heparan sulfate binding; F:lipopolysaccharide binding; F:lipoteichoic acid binding; F:pattern recognition receptor activity; F:scavenger receptor activity; F:zymogen binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular protein metabolic process; P:defense response; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:defense response to virus; P:detection of bacterial lipoprotein; P:epithelial cell differentiation; P:induction of bacterial agglutination; P:innate immune response; P:multicellular organism development; P:protein transport; P:receptor-mediated endocytosis; P:viral process;|Q9Y4V9,Deleted in malignant brain tumors 1 protein,Glycoprotein 340;Hensin;Salivary agglutinin;Surfactant pulmonary-associated D-binding protein;, PF00431;PF00530;PF00100;, GO:0005737;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0019898;GO:0030670;GO:0042589;GO:0048306;GO:0003677;GO:0050840;GO:1904399;GO:0001530;GO:0070891;GO:0038187;GO:0005044;GO:0035375;GO:0061844;GO:0044267;GO:0006952;GO:0050829;GO:0050830;GO:0051607;GO:0042494;GO:0030855;GO:0043152;GO:0045087;GO:0007275;GO:0015031;GO:0006898;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:extrinsic component of membrane; C:phagocytic vesicle membrane; C:zymogen granule membrane;, F:calcium-dependent protein binding; F:DNA binding; F:extracellular matrix binding; F:heparan sulfate binding; F:lipopolysaccharide binding; F:lipoteichoic acid binding; F:pattern recognition receptor activity; F:scavenger receptor activity; F:zymogen binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular protein metabolic process; P:defense response; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:defense response to virus; P:detection of bacterial lipoprotein; P:epithelial cell differentiation; P:induction of bacterial agglutination; P:innate immune response; P:multicellular organism development; P:protein transport; P:receptor-mediated endocytosis; P:viral process;|Q9Y4V9,Deleted in malignant brain tumors 1 protein,Glycoprotein 340;Hensin;Salivary agglutinin;Surfactant pulmonary-associated D-binding protein;, PF00431;PF00530;PF00100;, GO:0005737;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0019898;GO:0030670;GO:0042589;GO:0048306;GO:0003677;GO:0050840;GO:1904399;GO:0001530;GO:0070891;GO:0038187;GO:0005044;GO:0035375;GO:0061844;GO:0044267;GO:0006952;GO:0050829;GO:0050830;GO:0051607;GO:0042494;GO:0030855;GO:0043152;GO:0045087;GO:0007275;GO:0015031;GO:0006898;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:extrinsic component of membrane; C:phagocytic vesicle membrane; C:zymogen granule membrane;, F:calcium-dependent protein binding; F:DNA binding; F:extracellular matrix binding; F:heparan sulfate binding; F:lipopolysaccharide binding; F:lipoteichoic acid binding; F:pattern recognition receptor activity; F:scavenger receptor activity; F:zymogen binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular protein metabolic process; P:defense response; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:defense response to virus; P:detection of bacterial lipoprotein; P:epithelial cell differentiation; P:induction of bacterial agglutination; P:innate immune response; P:multicellular organism development; P:protein transport; P:receptor-mediated endocytosis; P:viral process;|Q9Y4V9,Deleted in malignant brain tumors 1 protein,Glycoprotein 340;Hensin;Salivary agglutinin;Surfactant pulmonary-associated D-binding protein;, PF00431;PF00530;PF00100;, GO:0005737;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0019898;GO:0030670;GO:0042589;GO:0048306;GO:0003677;GO:0050840;GO:1904399;GO:0001530;GO:0070891;GO:0038187;GO:0005044;GO:0035375;GO:0061844;GO:0044267;GO:0006952;GO:0050829;GO:0050830;GO:0051607;GO:0042494;GO:0030855;GO:0043152;GO:0045087;GO:0007275;GO:0015031;GO:0006898;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:extrinsic component of membrane; C:phagocytic vesicle membrane; C:zymogen granule membrane;, F:calcium-dependent protein binding; F:DNA binding; F:extracellular matrix binding; F:heparan sulfate binding; F:lipopolysaccharide binding; F:lipoteichoic acid binding; F:pattern recognition receptor activity; F:scavenger receptor activity; F:zymogen binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular protein metabolic process; P:defense response; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:defense response to virus; P:detection of bacterial lipoprotein; P:epithelial cell differentiation; P:induction of bacterial agglutination; P:innate immune response; P:multicellular organism development; P:protein transport; P:receptor-mediated endocytosis; P:viral process; scaffold18 indexed_genome mRNA 25442890 25444795 . + . ID=transcript_4527;A6NFZ4,Protein FAM24A,, PF15193;, GO:0005576;, C:extracellular region; scaffold18 indexed_genome mRNA 25469519 25470505 . - . ID=transcript_4528;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold18 indexed_genome mRNA 25470603 25471522 . + . ID=transcript_4529;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold18 indexed_genome mRNA 25472064 25473684 . + . ID=transcript_4530;Q9H8K7 Q0P6C6 Q8N597,ATPase PAAT {ECO:0000305},Protein associated with ABC transporters {ECO:0000303|PubMed:25063848};, PF14958;, GO:0005737;GO:0005739;GO:0016887;GO:0042802;, C:cytoplasm; C:mitochondrion;, F:ATPase activity; F:identical protein binding; scaffold18 indexed_genome mRNA 25493241 25494102 . + . ID=transcript_4531;Q86UP6 A8K080 B2RN93 D3DRE5 Q7Z660 Q7Z661 Q86SG1 Q86UP5 Q9HAR7,CUB and zona pellucida-like domain-containing protein 1,Transmembrane protein UO-44;, PF00431;PF00100;, GO:0016021;GO:0016020;GO:0030658;GO:0042589;GO:0007155;GO:0007049;GO:0051301;GO:0032023;, C:integral component of membrane; C:membrane; C:transport vesicle membrane; C:zymogen granule membrane;, , P:cell adhesion; P:cell cycle; P:cell division; P:trypsinogen activation; scaffold18 indexed_genome mRNA 25497725 25498706 . - . ID=transcript_4532;Q9H8K7 Q0P6C6 Q8N597,ATPase PAAT {ECO:0000305},Protein associated with ABC transporters {ECO:0000303|PubMed:25063848};, PF14958;, GO:0005737;GO:0005739;GO:0016887;GO:0042802;, C:cytoplasm; C:mitochondrion;, F:ATPase activity; F:identical protein binding; scaffold18 indexed_genome mRNA 25508411 25512326 . - . ID=transcript_4533;Q9H8K7 Q0P6C6 Q8N597,ATPase PAAT {ECO:0000305},Protein associated with ABC transporters {ECO:0000303|PubMed:25063848};, PF14958;, GO:0005737;GO:0005739;GO:0016887;GO:0042802;, C:cytoplasm; C:mitochondrion;, F:ATPase activity; F:identical protein binding; scaffold18 indexed_genome mRNA 25522426 25535304 . + . ID=transcript_4534;Q8IV42 Q6ZSS9,L-seryl-tRNA(Sec) kinase,O-phosphoseryl-tRNA(Sec) kinase;, PF08433;, GO:0005524;GO:0016301;GO:0043915;GO:0000049;GO:0097056;GO:0006412;, , F:ATP binding; F:kinase activity; F:L-seryl-tRNA(Sec) kinase activity; F:tRNA binding;, P:selenocysteinyl-tRNA(Sec) biosynthetic process; P:translation; scaffold18 indexed_genome mRNA 25538987 25546040 . - . ID=transcript_4535;Q9H5V7 B3KVH7 D3DRE7 Q9H2T0,Zinc finger protein Pegasus,Ikaros family zinc finger protein 5;, , GO:0005634;GO:0032991;GO:0003700;GO:0001227;GO:0019904;GO:0000978;GO:0000977;GO:0008270;GO:0000122;GO:0006357;, C:nucleus; C:protein-containing complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9H5V7 B3KVH7 D3DRE7 Q9H2T0,Zinc finger protein Pegasus,Ikaros family zinc finger protein 5;, , GO:0005634;GO:0032991;GO:0003700;GO:0001227;GO:0019904;GO:0000978;GO:0000977;GO:0008270;GO:0000122;GO:0006357;, C:nucleus; C:protein-containing complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold18 indexed_genome mRNA 25557074 25583997 . + . ID=transcript_4536;P45954 B4DQ51 Q5SQN6 Q96CX7,Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:7698750},2-methyl branched chain acyl-CoA dehydrogenase;2-methylbutyryl-coenzyme A dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005759;GO:0005739;GO:0003853;GO:0050660;GO:0042802;GO:0102035;GO:0016937;GO:0009083;GO:0006631;GO:0006550;, C:mitochondrial matrix; C:mitochondrion;, F:2-methylacyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:isobutyryl-CoA:FAD oxidoreductase activity; F:short-branched-chain-acyl-CoA dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:fatty acid metabolic process; P:isoleucine catabolic process; scaffold18 indexed_genome mRNA 25584685 25595288 . + . ID=transcript_4537;P45954 B4DQ51 Q5SQN6 Q96CX7,Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:7698750},2-methyl branched chain acyl-CoA dehydrogenase;2-methylbutyryl-coenzyme A dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005759;GO:0005739;GO:0003853;GO:0050660;GO:0042802;GO:0102035;GO:0016937;GO:0009083;GO:0006631;GO:0006550;, C:mitochondrial matrix; C:mitochondrion;, F:2-methylacyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:isobutyryl-CoA:FAD oxidoreductase activity; F:short-branched-chain-acyl-CoA dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:fatty acid metabolic process; P:isoleucine catabolic process;|P45954 B4DQ51 Q5SQN6 Q96CX7,Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:7698750},2-methyl branched chain acyl-CoA dehydrogenase;2-methylbutyryl-coenzyme A dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005759;GO:0005739;GO:0003853;GO:0050660;GO:0042802;GO:0102035;GO:0016937;GO:0009083;GO:0006631;GO:0006550;, C:mitochondrial matrix; C:mitochondrion;, F:2-methylacyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:isobutyryl-CoA:FAD oxidoreductase activity; F:short-branched-chain-acyl-CoA dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:fatty acid metabolic process; P:isoleucine catabolic process; scaffold18 indexed_genome mRNA 25694870 25706286 . + . ID=transcript_4538;O43684 A6NJ42 B2R6E7 D3DRE9 O43685,Mitotic checkpoint protein BUB3,, PF00400;, GO:1990298;GO:0000777;GO:0005829;GO:0000776;GO:0033597;GO:0005654;GO:0043130;GO:0031145;GO:0008608;GO:0051301;GO:0051321;GO:0000070;GO:0007094;GO:0007052;GO:0034501;GO:0007096;GO:1901990;GO:0006511;, C:bub1-bub3 complex; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:mitotic checkpoint complex; C:nucleoplasm;, F:ubiquitin binding;, P:anaphase-promoting complex-dependent catabolic process; P:attachment of spindle microtubules to kinetochore; P:cell division; P:meiotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to kinetochore; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|O43684 A6NJ42 B2R6E7 D3DRE9 O43685,Mitotic checkpoint protein BUB3,, PF00400;, GO:1990298;GO:0000777;GO:0005829;GO:0000776;GO:0033597;GO:0005654;GO:0043130;GO:0031145;GO:0008608;GO:0051301;GO:0051321;GO:0000070;GO:0007094;GO:0007052;GO:0034501;GO:0007096;GO:1901990;GO:0006511;, C:bub1-bub3 complex; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:mitotic checkpoint complex; C:nucleoplasm;, F:ubiquitin binding;, P:anaphase-promoting complex-dependent catabolic process; P:attachment of spindle microtubules to kinetochore; P:cell division; P:meiotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to kinetochore; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|O43684 A6NJ42 B2R6E7 D3DRE9 O43685,Mitotic checkpoint protein BUB3,, PF00400;, GO:1990298;GO:0000777;GO:0005829;GO:0000776;GO:0033597;GO:0005654;GO:0043130;GO:0031145;GO:0008608;GO:0051301;GO:0051321;GO:0000070;GO:0007094;GO:0007052;GO:0034501;GO:0007096;GO:1901990;GO:0006511;, C:bub1-bub3 complex; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:mitotic checkpoint complex; C:nucleoplasm;, F:ubiquitin binding;, P:anaphase-promoting complex-dependent catabolic process; P:attachment of spindle microtubules to kinetochore; P:cell division; P:meiotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to kinetochore; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|O43684 A6NJ42 B2R6E7 D3DRE9 O43685,Mitotic checkpoint protein BUB3,, PF00400;, GO:1990298;GO:0000777;GO:0005829;GO:0000776;GO:0033597;GO:0005654;GO:0043130;GO:0031145;GO:0008608;GO:0051301;GO:0051321;GO:0000070;GO:0007094;GO:0007052;GO:0034501;GO:0007096;GO:1901990;GO:0006511;, C:bub1-bub3 complex; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:mitotic checkpoint complex; C:nucleoplasm;, F:ubiquitin binding;, P:anaphase-promoting complex-dependent catabolic process; P:attachment of spindle microtubules to kinetochore; P:cell division; P:meiotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to kinetochore; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold18 indexed_genome mRNA 26230479 26231737 . + . ID=transcript_4539;Q8N436 B4E3Q2,Inactive carboxypeptidase-like protein X2,, PF00754;PF00246;, GO:0005615;GO:0004181;GO:0008270;GO:0006518;GO:0016485;, C:extracellular space;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing; scaffold18 indexed_genome mRNA 26231754 26253362 . - . ID=transcript_4540;Q8N436 B4E3Q2,Inactive carboxypeptidase-like protein X2,, PF00754;PF00246;, GO:0005615;GO:0004181;GO:0008270;GO:0006518;GO:0016485;, C:extracellular space;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing; scaffold18 indexed_genome mRNA 26446164 26480339 . - . ID=transcript_4541;Q7LFX5 O60338 O60474 Q86VM4,Carbohydrate sulfotransferase 15,B-cell RAG-associated gene protein;N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase;, , GO:0000139;GO:0016021;GO:0050656;GO:0050659;GO:0030206;GO:0019319;, C:Golgi membrane; C:integral component of membrane;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity;, P:chondroitin sulfate biosynthetic process; P:hexose biosynthetic process; scaffold18 indexed_genome mRNA 26771005 26788184 . - . ID=transcript_4542;P04181 D3DRF0 Q16068 Q16069 Q68CS0 Q6IAV9 Q9UD03,Ornithine aminotransferase, mitochondrial,Ornithine delta-aminotransferase;Ornithine--oxo-acid aminotransferase;, PF00202;, GO:0005737;GO:0005759;GO:0005739;GO:0005654;GO:0042802;GO:0050155;GO:0004587;GO:0030170;GO:0019544;GO:0010121;GO:0009064;GO:0055129;GO:0007601;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:identical protein binding; F:ornithine(lysine) transaminase activity; F:ornithine-oxo-acid transaminase activity; F:pyridoxal phosphate binding;, P:arginine catabolic process to glutamate; P:arginine catabolic process to proline via ornithine; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:visual perception;|P04181 D3DRF0 Q16068 Q16069 Q68CS0 Q6IAV9 Q9UD03,Ornithine aminotransferase, mitochondrial,Ornithine delta-aminotransferase;Ornithine--oxo-acid aminotransferase;, PF00202;, GO:0005737;GO:0005759;GO:0005739;GO:0005654;GO:0042802;GO:0050155;GO:0004587;GO:0030170;GO:0019544;GO:0010121;GO:0009064;GO:0055129;GO:0007601;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:identical protein binding; F:ornithine(lysine) transaminase activity; F:ornithine-oxo-acid transaminase activity; F:pyridoxal phosphate binding;, P:arginine catabolic process to glutamate; P:arginine catabolic process to proline via ornithine; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:visual perception;|P04181 D3DRF0 Q16068 Q16069 Q68CS0 Q6IAV9 Q9UD03,Ornithine aminotransferase, mitochondrial,Ornithine delta-aminotransferase;Ornithine--oxo-acid aminotransferase;, PF00202;, GO:0005737;GO:0005759;GO:0005739;GO:0005654;GO:0042802;GO:0050155;GO:0004587;GO:0030170;GO:0019544;GO:0010121;GO:0009064;GO:0055129;GO:0007601;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:identical protein binding; F:ornithine(lysine) transaminase activity; F:ornithine-oxo-acid transaminase activity; F:pyridoxal phosphate binding;, P:arginine catabolic process to glutamate; P:arginine catabolic process to proline via ornithine; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:visual perception;|P04181 D3DRF0 Q16068 Q16069 Q68CS0 Q6IAV9 Q9UD03,Ornithine aminotransferase, mitochondrial,Ornithine delta-aminotransferase;Ornithine--oxo-acid aminotransferase;, PF00202;, GO:0005737;GO:0005759;GO:0005739;GO:0005654;GO:0042802;GO:0050155;GO:0004587;GO:0030170;GO:0019544;GO:0010121;GO:0009064;GO:0055129;GO:0007601;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:identical protein binding; F:ornithine(lysine) transaminase activity; F:ornithine-oxo-acid transaminase activity; F:pyridoxal phosphate binding;, P:arginine catabolic process to glutamate; P:arginine catabolic process to proline via ornithine; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:visual perception; scaffold18 indexed_genome mRNA 26959256 26960640 . - . ID=transcript_4543;Q9H008 B3KP20 Q2TBE9 Q5VUV9 Q5VUW0,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,, PF13344;, GO:0005829;GO:0016607;GO:0005634;GO:0004427;GO:0000287;GO:0016791;GO:0101006;GO:0042803;GO:0016311;GO:0006796;GO:0006470;GO:0009168;, C:cytosol; C:nuclear speck; C:nucleus;, F:inorganic diphosphatase activity; F:magnesium ion binding; F:phosphatase activity; F:protein histidine phosphatase activity; F:protein homodimerization activity;, P:dephosphorylation; P:phosphate-containing compound metabolic process; P:protein dephosphorylation; P:purine ribonucleoside monophosphate biosynthetic process; scaffold18 indexed_genome mRNA 26962924 27041824 . - . ID=transcript_4544;Q14153 D3DRF1 Q5VUW1 Q5VUW2 Q8N5S6,Protein FAM53B {ECO:0000305},Protein simplet {ECO:0000303|PubMed:25183871};, PF15242;, GO:0005634;GO:0090263;GO:0006606;GO:0060828;GO:0016055;, C:nucleus;, , P:positive regulation of canonical Wnt signaling pathway; P:protein import into nucleus; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q14153 D3DRF1 Q5VUW1 Q5VUW2 Q8N5S6,Protein FAM53B {ECO:0000305},Protein simplet {ECO:0000303|PubMed:25183871};, PF15242;, GO:0005634;GO:0090263;GO:0006606;GO:0060828;GO:0016055;, C:nucleus;, , P:positive regulation of canonical Wnt signaling pathway; P:protein import into nucleus; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold18 indexed_genome mRNA 27087496 27099298 . - . ID=transcript_4545;Q5JPI9 A8MPY7,EEF1A lysine methyltransferase 2 {ECO:0000255|HAMAP-Rule:MF_03188, ECO:0000312|HGNC:HGNC:33787},Methyltransferase-like protein 10 {ECO:0000255|HAMAP-Rule:MF_03188};Protein-lysine N-methyltransferase METTL10 {ECO:0000255|HAMAP-Rule:MF_03188};, PF13847;, GO:0005737;GO:0005829;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0008168;GO:0016279;GO:0018027;GO:0018022;GO:0018026;GO:0006479;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:methyltransferase activity; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine dimethylation; P:peptidyl-lysine methylation; P:peptidyl-lysine monomethylation; P:protein methylation;|Q5JPI9 A8MPY7,EEF1A lysine methyltransferase 2 {ECO:0000255|HAMAP-Rule:MF_03188, ECO:0000312|HGNC:HGNC:33787},Methyltransferase-like protein 10 {ECO:0000255|HAMAP-Rule:MF_03188};Protein-lysine N-methyltransferase METTL10 {ECO:0000255|HAMAP-Rule:MF_03188};, PF13847;, GO:0005737;GO:0005829;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0008168;GO:0016279;GO:0018027;GO:0018022;GO:0018026;GO:0006479;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:methyltransferase activity; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine dimethylation; P:peptidyl-lysine methylation; P:peptidyl-lysine monomethylation; P:protein methylation;|Q5JPI9 A8MPY7,EEF1A lysine methyltransferase 2 {ECO:0000255|HAMAP-Rule:MF_03188, ECO:0000312|HGNC:HGNC:33787},Methyltransferase-like protein 10 {ECO:0000255|HAMAP-Rule:MF_03188};Protein-lysine N-methyltransferase METTL10 {ECO:0000255|HAMAP-Rule:MF_03188};, PF13847;, GO:0005737;GO:0005829;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0008168;GO:0016279;GO:0018027;GO:0018022;GO:0018026;GO:0006479;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:methyltransferase activity; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine dimethylation; P:peptidyl-lysine methylation; P:peptidyl-lysine monomethylation; P:protein methylation; scaffold18 indexed_genome mRNA 27102726 27106238 . - . ID=transcript_4546;Q5JPI9 A8MPY7,EEF1A lysine methyltransferase 2 {ECO:0000255|HAMAP-Rule:MF_03188, ECO:0000312|HGNC:HGNC:33787},Methyltransferase-like protein 10 {ECO:0000255|HAMAP-Rule:MF_03188};Protein-lysine N-methyltransferase METTL10 {ECO:0000255|HAMAP-Rule:MF_03188};, PF13847;, GO:0005737;GO:0005829;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0008168;GO:0016279;GO:0018027;GO:0018022;GO:0018026;GO:0006479;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:methyltransferase activity; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine dimethylation; P:peptidyl-lysine methylation; P:peptidyl-lysine monomethylation; P:protein methylation;|Q5JPI9 A8MPY7,EEF1A lysine methyltransferase 2 {ECO:0000255|HAMAP-Rule:MF_03188, ECO:0000312|HGNC:HGNC:33787},Methyltransferase-like protein 10 {ECO:0000255|HAMAP-Rule:MF_03188};Protein-lysine N-methyltransferase METTL10 {ECO:0000255|HAMAP-Rule:MF_03188};, PF13847;, GO:0005737;GO:0005829;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0008168;GO:0016279;GO:0018027;GO:0018022;GO:0018026;GO:0006479;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:methyltransferase activity; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine dimethylation; P:peptidyl-lysine methylation; P:peptidyl-lysine monomethylation; P:protein methylation; scaffold18 indexed_genome mRNA 27112086 27140132 . + . ID=transcript_4547;Q15018 B4DKR2 Q96H11,BRISC complex subunit Abraxas 2 {ECO:0000312|HGNC:HGNC:28975},Abraxas brother protein 1 {ECO:0000303|PubMed:22974638};Protein FAM175B;, , GO:0070552;GO:0005737;GO:0005829;GO:0005874;GO:0005634;GO:0000922;GO:0008017;GO:0031593;GO:0008608;GO:0051301;GO:0007059;GO:0000278;GO:0090307;GO:0016579;GO:0070536;GO:0002931;, C:BRISC complex; C:cytoplasm; C:cytosol; C:microtubule; C:nucleus; C:spindle pole;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:mitotic spindle assembly; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ischemia;|Q15018 B4DKR2 Q96H11,BRISC complex subunit Abraxas 2 {ECO:0000312|HGNC:HGNC:28975},Abraxas brother protein 1 {ECO:0000303|PubMed:22974638};Protein FAM175B;, , GO:0070552;GO:0005737;GO:0005829;GO:0005874;GO:0005634;GO:0000922;GO:0008017;GO:0031593;GO:0008608;GO:0051301;GO:0007059;GO:0000278;GO:0090307;GO:0016579;GO:0070536;GO:0002931;, C:BRISC complex; C:cytoplasm; C:cytosol; C:microtubule; C:nucleus; C:spindle pole;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:mitotic spindle assembly; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ischemia;|Q15018 B4DKR2 Q96H11,BRISC complex subunit Abraxas 2 {ECO:0000312|HGNC:HGNC:28975},Abraxas brother protein 1 {ECO:0000303|PubMed:22974638};Protein FAM175B;, , GO:0070552;GO:0005737;GO:0005829;GO:0005874;GO:0005634;GO:0000922;GO:0008017;GO:0031593;GO:0008608;GO:0051301;GO:0007059;GO:0000278;GO:0090307;GO:0016579;GO:0070536;GO:0002931;, C:BRISC complex; C:cytoplasm; C:cytosol; C:microtubule; C:nucleus; C:spindle pole;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:mitotic spindle assembly; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ischemia;|Q15018 B4DKR2 Q96H11,BRISC complex subunit Abraxas 2 {ECO:0000312|HGNC:HGNC:28975},Abraxas brother protein 1 {ECO:0000303|PubMed:22974638};Protein FAM175B;, , GO:0070552;GO:0005737;GO:0005829;GO:0005874;GO:0005634;GO:0000922;GO:0008017;GO:0031593;GO:0008608;GO:0051301;GO:0007059;GO:0000278;GO:0090307;GO:0016579;GO:0070536;GO:0002931;, C:BRISC complex; C:cytoplasm; C:cytosol; C:microtubule; C:nucleus; C:spindle pole;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:mitotic spindle assembly; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ischemia;|Q15018 B4DKR2 Q96H11,BRISC complex subunit Abraxas 2 {ECO:0000312|HGNC:HGNC:28975},Abraxas brother protein 1 {ECO:0000303|PubMed:22974638};Protein FAM175B;, , GO:0070552;GO:0005737;GO:0005829;GO:0005874;GO:0005634;GO:0000922;GO:0008017;GO:0031593;GO:0008608;GO:0051301;GO:0007059;GO:0000278;GO:0090307;GO:0016579;GO:0070536;GO:0002931;, C:BRISC complex; C:cytoplasm; C:cytosol; C:microtubule; C:nucleus; C:spindle pole;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:mitotic spindle assembly; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ischemia;|Q15018 B4DKR2 Q96H11,BRISC complex subunit Abraxas 2 {ECO:0000312|HGNC:HGNC:28975},Abraxas brother protein 1 {ECO:0000303|PubMed:22974638};Protein FAM175B;, , GO:0070552;GO:0005737;GO:0005829;GO:0005874;GO:0005634;GO:0000922;GO:0008017;GO:0031593;GO:0008608;GO:0051301;GO:0007059;GO:0000278;GO:0090307;GO:0016579;GO:0070536;GO:0002931;, C:BRISC complex; C:cytoplasm; C:cytosol; C:microtubule; C:nucleus; C:spindle pole;, F:microtubule binding; F:polyubiquitin modification-dependent protein binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:mitotic spindle assembly; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ischemia; scaffold18 indexed_genome mRNA 27200216 27276961 . + . ID=transcript_4548;Q9UGI0 B4DZ98 D3DRF4 Q5SQP6 Q69YK3,Ubiquitin thioesterase ZRANB1,TRAF-binding domain-containing protein;Zinc finger Ran-binding domain-containing protein 1;, PF18418;PF02338;PF00641;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0008234;GO:0070530;GO:0046872;GO:0004843;GO:0016477;GO:0007010;GO:0030177;GO:0016579;GO:0071947;GO:0035523;GO:1990168;GO:0070536;GO:0022604;GO:0016055;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cell migration; P:cytoskeleton organization; P:positive regulation of Wnt signaling pathway; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein K29-linked deubiquitination; P:protein K33-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of cell morphogenesis; P:Wnt signaling pathway;|Q9UGI0 B4DZ98 D3DRF4 Q5SQP6 Q69YK3,Ubiquitin thioesterase ZRANB1,TRAF-binding domain-containing protein;Zinc finger Ran-binding domain-containing protein 1;, PF18418;PF02338;PF00641;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0008234;GO:0070530;GO:0046872;GO:0004843;GO:0016477;GO:0007010;GO:0030177;GO:0016579;GO:0071947;GO:0035523;GO:1990168;GO:0070536;GO:0022604;GO:0016055;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cell migration; P:cytoskeleton organization; P:positive regulation of Wnt signaling pathway; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein K29-linked deubiquitination; P:protein K33-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of cell morphogenesis; P:Wnt signaling pathway; scaffold18 indexed_genome mRNA 27276981 27293830 . - . ID=transcript_4549;P56545 A8K2X5 D3DRF5 O43449 Q5SQP7 Q69YI3 Q86SV0 Q8IY44 Q9H2T8,C-terminal-binding protein 2,, PF00389;PF02826;, GO:0098982;GO:0098978;GO:0005634;GO:0098684;GO:0098831;GO:0099523;GO:0017053;GO:0003682;GO:0042802;GO:0051287;GO:0016616;GO:0019901;GO:0044877;GO:0042974;GO:0001226;GO:0098882;GO:0003713;GO:0003714;GO:1990830;GO:0008285;GO:0000122;GO:0045892;GO:0035563;GO:0048386;GO:0045944;GO:0016081;GO:0019079;GO:0050872;, C:GABA-ergic synapse; C:glutamatergic synapse; C:nucleus; C:photoreceptor ribbon synapse; C:presynaptic active zone cytoplasmic component; C:presynaptic cytosol; C:transcription repressor complex;, F:chromatin binding; F:identical protein binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein kinase binding; F:protein-containing complex binding; F:retinoic acid receptor binding; F:RNA polymerase II transcription corepressor binding; F:structural constituent of presynaptic active zone; F:transcription coactivator activity; F:transcription corepressor activity;, P:cellular response to leukemia inhibitory factor; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin binding; P:positive regulation of retinoic acid receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:synaptic vesicle docking; P:viral genome replication; P:white fat cell differentiation;|P56545 A8K2X5 D3DRF5 O43449 Q5SQP7 Q69YI3 Q86SV0 Q8IY44 Q9H2T8,C-terminal-binding protein 2,, PF00389;PF02826;, GO:0098982;GO:0098978;GO:0005634;GO:0098684;GO:0098831;GO:0099523;GO:0017053;GO:0003682;GO:0042802;GO:0051287;GO:0016616;GO:0019901;GO:0044877;GO:0042974;GO:0001226;GO:0098882;GO:0003713;GO:0003714;GO:1990830;GO:0008285;GO:0000122;GO:0045892;GO:0035563;GO:0048386;GO:0045944;GO:0016081;GO:0019079;GO:0050872;, C:GABA-ergic synapse; C:glutamatergic synapse; C:nucleus; C:photoreceptor ribbon synapse; C:presynaptic active zone cytoplasmic component; C:presynaptic cytosol; C:transcription repressor complex;, F:chromatin binding; F:identical protein binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein kinase binding; F:protein-containing complex binding; F:retinoic acid receptor binding; F:RNA polymerase II transcription corepressor binding; F:structural constituent of presynaptic active zone; F:transcription coactivator activity; F:transcription corepressor activity;, P:cellular response to leukemia inhibitory factor; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin binding; P:positive regulation of retinoic acid receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:synaptic vesicle docking; P:viral genome replication; P:white fat cell differentiation; scaffold18 indexed_genome mRNA 27994989 28019883 . + . ID=transcript_4550;Q3B7T1 B2RC65 Q3KR40 Q4G190 Q5VZQ4 Q8IZ74 Q9Y3W4,Erythroid differentiation-related factor 1,, , GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated;|Q3B7T1 B2RC65 Q3KR40 Q4G190 Q5VZQ4 Q8IZ74 Q9Y3W4,Erythroid differentiation-related factor 1,, , GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated;|Q3B7T1 B2RC65 Q3KR40 Q4G190 Q5VZQ4 Q8IZ74 Q9Y3W4,Erythroid differentiation-related factor 1,, , GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated;|Q3B7T1 B2RC65 Q3KR40 Q4G190 Q5VZQ4 Q8IZ74 Q9Y3W4,Erythroid differentiation-related factor 1,, , GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated;|Q3B7T1 B2RC65 Q3KR40 Q4G190 Q5VZQ4 Q8IZ74 Q9Y3W4,Erythroid differentiation-related factor 1,, , GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated; scaffold18 indexed_genome mRNA 28020485 28023745 . + . ID=transcript_4551;Q3B7T1 B2RC65 Q3KR40 Q4G190 Q5VZQ4 Q8IZ74 Q9Y3W4,Erythroid differentiation-related factor 1,, , GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated;|Q3B7T1 B2RC65 Q3KR40 Q4G190 Q5VZQ4 Q8IZ74 Q9Y3W4,Erythroid differentiation-related factor 1,, , GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated; scaffold18 indexed_genome mRNA 28023778 28025988 . - . ID=transcript_4552;Q3B7T1 B2RC65 Q3KR40 Q4G190 Q5VZQ4 Q8IZ74 Q9Y3W4,Erythroid differentiation-related factor 1,, , GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated;|Q3B7T1 B2RC65 Q3KR40 Q4G190 Q5VZQ4 Q8IZ74 Q9Y3W4,Erythroid differentiation-related factor 1,, , GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated; scaffold18 indexed_genome mRNA 28038797 28040112 . - . ID=transcript_4553;P10746 B2RC13 D3DRF7 Q9H2T1,Uroporphyrinogen-III synthase,Hydroxymethylbilane hydrolyase [cyclizing];Uroporphyrinogen-III cosynthase;, PF02602;, GO:0005829;GO:0005739;GO:0004852;GO:0006783;GO:0006782;GO:0006780;, C:cytosol; C:mitochondrion;, F:uroporphyrinogen-III synthase activity;, P:heme biosynthetic process; P:protoporphyrinogen IX biosynthetic process; P:uroporphyrinogen III biosynthetic process; scaffold18 indexed_genome mRNA 28041726 28059506 . - . ID=transcript_4554;P10746 B2RC13 D3DRF7 Q9H2T1,Uroporphyrinogen-III synthase,Hydroxymethylbilane hydrolyase [cyclizing];Uroporphyrinogen-III cosynthase;, PF02602;, GO:0005829;GO:0005739;GO:0004852;GO:0006783;GO:0006782;GO:0006780;, C:cytosol; C:mitochondrion;, F:uroporphyrinogen-III synthase activity;, P:heme biosynthetic process; P:protoporphyrinogen IX biosynthetic process; P:uroporphyrinogen III biosynthetic process;|P10746 B2RC13 D3DRF7 Q9H2T1,Uroporphyrinogen-III synthase,Hydroxymethylbilane hydrolyase [cyclizing];Uroporphyrinogen-III cosynthase;, PF02602;, GO:0005829;GO:0005739;GO:0004852;GO:0006783;GO:0006782;GO:0006780;, C:cytosol; C:mitochondrion;, F:uroporphyrinogen-III synthase activity;, P:heme biosynthetic process; P:protoporphyrinogen IX biosynthetic process; P:uroporphyrinogen III biosynthetic process;|P10746 B2RC13 D3DRF7 Q9H2T1,Uroporphyrinogen-III synthase,Hydroxymethylbilane hydrolyase [cyclizing];Uroporphyrinogen-III cosynthase;, PF02602;, GO:0005829;GO:0005739;GO:0004852;GO:0006783;GO:0006782;GO:0006780;, C:cytosol; C:mitochondrion;, F:uroporphyrinogen-III synthase activity;, P:heme biosynthetic process; P:protoporphyrinogen IX biosynthetic process; P:uroporphyrinogen III biosynthetic process;|P10746 B2RC13 D3DRF7 Q9H2T1,Uroporphyrinogen-III synthase,Hydroxymethylbilane hydrolyase [cyclizing];Uroporphyrinogen-III cosynthase;, PF02602;, GO:0005829;GO:0005739;GO:0004852;GO:0006783;GO:0006782;GO:0006780;, C:cytosol; C:mitochondrion;, F:uroporphyrinogen-III synthase activity;, P:heme biosynthetic process; P:protoporphyrinogen IX biosynthetic process; P:uroporphyrinogen III biosynthetic process; scaffold18 indexed_genome mRNA 28068354 28069058 . - . ID=transcript_4555;Q9P287 B3KP45 Q8ND15 Q96GC4 Q9P288,BRCA2 and CDKN1A-interacting protein,P21- and CDK-associated protein 1;Protein TOK-1;, PF13862;, GO:0005814;GO:0005813;GO:0005829;GO:0097431;GO:0019908;GO:0005654;GO:0005634;GO:0019207;GO:0003723;GO:0015631;GO:0006281;GO:0000132;GO:0034453;GO:0000226;GO:0090307;GO:0007052;GO:0061101;GO:0000079;, C:centriole; C:centrosome; C:cytosol; C:mitotic spindle pole; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nucleoplasm; C:nucleus;, F:kinase regulator activity; F:RNA binding; F:tubulin binding;, P:DNA repair; P:establishment of mitotic spindle orientation; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:neuroendocrine cell differentiation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold18 indexed_genome mRNA 28072338 28109371 . + . ID=transcript_4556;Q9P287 B3KP45 Q8ND15 Q96GC4 Q9P288,BRCA2 and CDKN1A-interacting protein,P21- and CDK-associated protein 1;Protein TOK-1;, PF13862;, GO:0005814;GO:0005813;GO:0005829;GO:0097431;GO:0019908;GO:0005654;GO:0005634;GO:0019207;GO:0003723;GO:0015631;GO:0006281;GO:0000132;GO:0034453;GO:0000226;GO:0090307;GO:0007052;GO:0061101;GO:0000079;, C:centriole; C:centrosome; C:cytosol; C:mitotic spindle pole; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nucleoplasm; C:nucleus;, F:kinase regulator activity; F:RNA binding; F:tubulin binding;, P:DNA repair; P:establishment of mitotic spindle orientation; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:neuroendocrine cell differentiation; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9P287 B3KP45 Q8ND15 Q96GC4 Q9P288,BRCA2 and CDKN1A-interacting protein,P21- and CDK-associated protein 1;Protein TOK-1;, PF13862;, GO:0005814;GO:0005813;GO:0005829;GO:0097431;GO:0019908;GO:0005654;GO:0005634;GO:0019207;GO:0003723;GO:0015631;GO:0006281;GO:0000132;GO:0034453;GO:0000226;GO:0090307;GO:0007052;GO:0061101;GO:0000079;, C:centriole; C:centrosome; C:cytosol; C:mitotic spindle pole; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nucleoplasm; C:nucleus;, F:kinase regulator activity; F:RNA binding; F:tubulin binding;, P:DNA repair; P:establishment of mitotic spindle orientation; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:neuroendocrine cell differentiation; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9NSL5 Q9NV74 Q9NVJ7,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32,DEAD/H box 32;DEAD/H helicase-like protein 1;DEAH box protein 32;HuDDX32;, PF04408;PF07717;, GO:0005739;GO:0005681;GO:0005524;GO:0003723;GO:0003724;, C:mitochondrion; C:spliceosomal complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q9P287 B3KP45 Q8ND15 Q96GC4 Q9P288,BRCA2 and CDKN1A-interacting protein,P21- and CDK-associated protein 1;Protein TOK-1;, PF13862;, GO:0005814;GO:0005813;GO:0005829;GO:0097431;GO:0019908;GO:0005654;GO:0005634;GO:0019207;GO:0003723;GO:0015631;GO:0006281;GO:0000132;GO:0034453;GO:0000226;GO:0090307;GO:0007052;GO:0061101;GO:0000079;, C:centriole; C:centrosome; C:cytosol; C:mitotic spindle pole; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nucleoplasm; C:nucleus;, F:kinase regulator activity; F:RNA binding; F:tubulin binding;, P:DNA repair; P:establishment of mitotic spindle orientation; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:neuroendocrine cell differentiation; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9P287 B3KP45 Q8ND15 Q96GC4 Q9P288,BRCA2 and CDKN1A-interacting protein,P21- and CDK-associated protein 1;Protein TOK-1;, PF13862;, GO:0005814;GO:0005813;GO:0005829;GO:0097431;GO:0019908;GO:0005654;GO:0005634;GO:0019207;GO:0003723;GO:0015631;GO:0006281;GO:0000132;GO:0034453;GO:0000226;GO:0090307;GO:0007052;GO:0061101;GO:0000079;, C:centriole; C:centrosome; C:cytosol; C:mitotic spindle pole; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nucleoplasm; C:nucleus;, F:kinase regulator activity; F:RNA binding; F:tubulin binding;, P:DNA repair; P:establishment of mitotic spindle orientation; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:neuroendocrine cell differentiation; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9NSL5 Q9NV74 Q9NVJ7,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32,DEAD/H box 32;DEAD/H helicase-like protein 1;DEAH box protein 32;HuDDX32;, PF04408;PF07717;, GO:0005739;GO:0005681;GO:0005524;GO:0003723;GO:0003724;, C:mitochondrion; C:spliceosomal complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q9NSL5 Q9NV74 Q9NVJ7,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32,DEAD/H box 32;DEAD/H helicase-like protein 1;DEAH box protein 32;HuDDX32;, PF04408;PF07717;, GO:0005739;GO:0005681;GO:0005524;GO:0003723;GO:0003724;, C:mitochondrion; C:spliceosomal complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q9NSL5 Q9NV74 Q9NVJ7,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32,DEAD/H box 32;DEAD/H helicase-like protein 1;DEAH box protein 32;HuDDX32;, PF04408;PF07717;, GO:0005739;GO:0005681;GO:0005524;GO:0003723;GO:0003724;, C:mitochondrion; C:spliceosomal complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;|Q9NSL5 Q9NV74 Q9NVJ7,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32,DEAD/H box 32;DEAD/H helicase-like protein 1;DEAH box protein 32;HuDDX32;, PF04408;PF07717;, GO:0005739;GO:0005681;GO:0005524;GO:0003723;GO:0003724;, C:mitochondrion; C:spliceosomal complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity; scaffold18 indexed_genome mRNA 28217781 28227168 . + . ID=transcript_4557;Q8TC84 Q6UXY9 Q6X7T6,Fibronectin type 3 and ankyrin repeat domains protein 1 {ECO:0000305},, PF12796;, GO:0036064;GO:0097546;GO:0005929;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0043066;GO:0043065;GO:0051091;GO:0045893;GO:0042981;, C:ciliary basal body; C:ciliary base; C:cilium; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, , P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription, DNA-templated; P:regulation of apoptotic process; scaffold18 indexed_genome mRNA 28273423 28325919 . - . ID=transcript_4558;O43184 O60470 Q5JRP0 Q5JRP1 Q6P9E3 Q6UWB0,Disintegrin and metalloproteinase domain-containing protein 12,Meltrin-alpha;, PF08516;PF00200;PF01562;PF01421;, GO:0005576;GO:0016021;GO:0005654;GO:0005886;GO:0046872;GO:0004222;GO:0008237;GO:0017124;GO:0007155;GO:0030198;GO:0007520;GO:0045766;, C:extracellular region; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:SH3 domain binding;, P:cell adhesion; P:extracellular matrix organization; P:myoblast fusion; P:positive regulation of angiogenesis; scaffold18 indexed_genome mRNA 29155381 29647619 . + . ID=transcript_4559;Q14185 A9Z1Z5,Dedicator of cytokinesis protein 1,180 kDa protein downstream of CRK;, PF06920;PF14429;PF16172;PF00018;, GO:0005737;GO:0005829;GO:0032045;GO:0016020;GO:0016607;GO:0005654;GO:0005096;GO:0005085;GO:0017124;GO:0006915;GO:0007596;GO:0038096;GO:0007229;GO:0006911;GO:0010634;GO:1900026;GO:0007165;GO:0007264;GO:0048010;, C:cytoplasm; C:cytosol; C:guanyl-nucleotide exchange factor complex; C:membrane; C:nuclear speck; C:nucleoplasm;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:apoptotic process; P:blood coagulation; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:integrin-mediated signaling pathway; P:phagocytosis, engulfment; P:positive regulation of epithelial cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:signal transduction; P:small GTPase mediated signal transduction; P:vascular endothelial growth factor receptor signaling pathway;|Q6ZSG2 B2RNT4 B7ZME7,Inhibitory synaptic factor 2A {ECO:0000305},, PF15265;, GO:0014069;GO:0060080;, C:postsynaptic density;, , P:inhibitory postsynaptic potential; scaffold18 indexed_genome mRNA 30144738 30188686 . + . ID=transcript_4560;P23469 Q13345 Q5VWH3 Q5VWH4 Q96KQ6,Receptor-type tyrosine-protein phosphatase epsilon,, PF00102;, GO:0005737;GO:0016021;GO:0005634;GO:0005886;GO:0004725;GO:0005001;GO:0046627;GO:0006470;, C:cytoplasm; C:integral component of membrane; C:nucleus; C:plasma membrane;, F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:negative regulation of insulin receptor signaling pathway; P:protein dephosphorylation;|P23469 Q13345 Q5VWH3 Q5VWH4 Q96KQ6,Receptor-type tyrosine-protein phosphatase epsilon,, PF00102;, GO:0005737;GO:0016021;GO:0005634;GO:0005886;GO:0004725;GO:0005001;GO:0046627;GO:0006470;, C:cytoplasm; C:integral component of membrane; C:nucleus; C:plasma membrane;, F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:negative regulation of insulin receptor signaling pathway; P:protein dephosphorylation;|P23469 Q13345 Q5VWH3 Q5VWH4 Q96KQ6,Receptor-type tyrosine-protein phosphatase epsilon,, PF00102;, GO:0005737;GO:0016021;GO:0005634;GO:0005886;GO:0004725;GO:0005001;GO:0046627;GO:0006470;, C:cytoplasm; C:integral component of membrane; C:nucleus; C:plasma membrane;, F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:negative regulation of insulin receptor signaling pathway; P:protein dephosphorylation; scaffold18 indexed_genome mRNA 30194881 30197939 . - . ID=transcript_4561;P46013 Q5VWH2,Proliferation marker protein Ki-67 {ECO:0000305},Antigen identified by monoclonal antibody Ki-67 {ECO:0000303|PubMed:8227122};, PF00498;PF08065;PF15276;, GO:0005694;GO:0016020;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0008022;GO:0003723;GO:0007049;GO:0008283;GO:1902275;GO:0051983;GO:0007088;, C:chromosome; C:membrane; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:protein C-terminus binding; F:RNA binding;, P:cell cycle; P:cell population proliferation; P:regulation of chromatin organization; P:regulation of chromosome segregation; P:regulation of mitotic nuclear division; scaffold18 indexed_genome mRNA 30198026 30199365 . - . ID=transcript_4562;P46013 Q5VWH2,Proliferation marker protein Ki-67 {ECO:0000305},Antigen identified by monoclonal antibody Ki-67 {ECO:0000303|PubMed:8227122};, PF00498;PF08065;PF15276;, GO:0005694;GO:0016020;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0008022;GO:0003723;GO:0007049;GO:0008283;GO:1902275;GO:0051983;GO:0007088;, C:chromosome; C:membrane; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:protein C-terminus binding; F:RNA binding;, P:cell cycle; P:cell population proliferation; P:regulation of chromatin organization; P:regulation of chromosome segregation; P:regulation of mitotic nuclear division; scaffold18 indexed_genome mRNA 30199805 30200503 . + . ID=transcript_4563;P46013 Q5VWH2,Proliferation marker protein Ki-67 {ECO:0000305},Antigen identified by monoclonal antibody Ki-67 {ECO:0000303|PubMed:8227122};, PF00498;PF08065;PF15276;, GO:0005694;GO:0016020;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0008022;GO:0003723;GO:0007049;GO:0008283;GO:1902275;GO:0051983;GO:0007088;, C:chromosome; C:membrane; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:protein C-terminus binding; F:RNA binding;, P:cell cycle; P:cell population proliferation; P:regulation of chromatin organization; P:regulation of chromosome segregation; P:regulation of mitotic nuclear division; scaffold18 indexed_genome mRNA 31573598 31796492 . + . ID=transcript_4564;P16455 Q5VY78,Methylated-DNA--protein-cysteine methyltransferase,6-O-methylguanine-DNA methyltransferase;O-6-methylguanine-DNA-alkyltransferase;, PF01035;PF02870;, GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0009008;GO:0046872;GO:0003908;GO:0008168;GO:0006307;GO:0006266;GO:0006281;GO:0043066;GO:2000781;, C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-methyltransferase activity; F:metal ion binding; F:methylated-DNA-[protein]-cysteine S-methyltransferase activity; F:methyltransferase activity;, P:DNA dealkylation involved in DNA repair; P:DNA ligation; P:DNA repair; P:negative regulation of apoptotic process; P:positive regulation of double-strand break repair; scaffold18 indexed_genome mRNA 31855770 31883916 . - . ID=transcript_4565;Q9H4W6 A0AUY1 Q5T6H9 Q9H4W5,Transcription factor COE3,Early B-cell factor 3;Olf-1/EBF-like 2;, PF16422;PF16423;PF01833;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0046983;GO:0000978;GO:0007275;GO:0045893;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold18 indexed_genome mRNA 32047183 32075306 . - . ID=transcript_4566;A0A1B0GUT2,Uncharacterized protein C10orf143 {ECO:0000305} scaffold18 indexed_genome mRNA 32106637 32112892 . + . ID=transcript_4567;O76003 B3KMP7 B3KMQ5 D3DRG2 Q5JV01 Q96CE0 Q9P1B0 Q9P1B1,Glutaredoxin-3,PKC-interacting cousin of thioredoxin {ECO:0000303|PubMed:10636891};PKC-theta-interacting protein;Thioredoxin-like protein 2;, PF00462;PF00085;, GO:0005938;GO:0005829;GO:0030425;GO:0005634;GO:0030018;GO:0042802;GO:0051536;GO:0046872;GO:0015035;GO:0005080;GO:0003723;GO:0044571;GO:0006879;GO:0010614;GO:0097428;GO:0002026;, C:cell cortex; C:cytosol; C:dendrite; C:nucleus; C:Z disc;, F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:protein disulfide oxidoreductase activity; F:protein kinase C binding; F:RNA binding;, P:[2Fe-2S] cluster assembly; P:cellular iron ion homeostasis; P:negative regulation of cardiac muscle hypertrophy; P:protein maturation by iron-sulfur cluster transfer; P:regulation of the force of heart contraction;|O76003 B3KMP7 B3KMQ5 D3DRG2 Q5JV01 Q96CE0 Q9P1B0 Q9P1B1,Glutaredoxin-3,PKC-interacting cousin of thioredoxin {ECO:0000303|PubMed:10636891};PKC-theta-interacting protein;Thioredoxin-like protein 2;, PF00462;PF00085;, GO:0005938;GO:0005829;GO:0030425;GO:0005634;GO:0030018;GO:0042802;GO:0051536;GO:0046872;GO:0015035;GO:0005080;GO:0003723;GO:0044571;GO:0006879;GO:0010614;GO:0097428;GO:0002026;, C:cell cortex; C:cytosol; C:dendrite; C:nucleus; C:Z disc;, F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:protein disulfide oxidoreductase activity; F:protein kinase C binding; F:RNA binding;, P:[2Fe-2S] cluster assembly; P:cellular iron ion homeostasis; P:negative regulation of cardiac muscle hypertrophy; P:protein maturation by iron-sulfur cluster transfer; P:regulation of the force of heart contraction; scaffold18 indexed_genome mRNA 32117362 32129090 . + . ID=transcript_4568;O76003 B3KMP7 B3KMQ5 D3DRG2 Q5JV01 Q96CE0 Q9P1B0 Q9P1B1,Glutaredoxin-3,PKC-interacting cousin of thioredoxin {ECO:0000303|PubMed:10636891};PKC-theta-interacting protein;Thioredoxin-like protein 2;, PF00462;PF00085;, GO:0005938;GO:0005829;GO:0030425;GO:0005634;GO:0030018;GO:0042802;GO:0051536;GO:0046872;GO:0015035;GO:0005080;GO:0003723;GO:0044571;GO:0006879;GO:0010614;GO:0097428;GO:0002026;, C:cell cortex; C:cytosol; C:dendrite; C:nucleus; C:Z disc;, F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:protein disulfide oxidoreductase activity; F:protein kinase C binding; F:RNA binding;, P:[2Fe-2S] cluster assembly; P:cellular iron ion homeostasis; P:negative regulation of cardiac muscle hypertrophy; P:protein maturation by iron-sulfur cluster transfer; P:regulation of the force of heart contraction;|O76003 B3KMP7 B3KMQ5 D3DRG2 Q5JV01 Q96CE0 Q9P1B0 Q9P1B1,Glutaredoxin-3,PKC-interacting cousin of thioredoxin {ECO:0000303|PubMed:10636891};PKC-theta-interacting protein;Thioredoxin-like protein 2;, PF00462;PF00085;, GO:0005938;GO:0005829;GO:0030425;GO:0005634;GO:0030018;GO:0042802;GO:0051536;GO:0046872;GO:0015035;GO:0005080;GO:0003723;GO:0044571;GO:0006879;GO:0010614;GO:0097428;GO:0002026;, C:cell cortex; C:cytosol; C:dendrite; C:nucleus; C:Z disc;, F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:protein disulfide oxidoreductase activity; F:protein kinase C binding; F:RNA binding;, P:[2Fe-2S] cluster assembly; P:cellular iron ion homeostasis; P:negative regulation of cardiac muscle hypertrophy; P:protein maturation by iron-sulfur cluster transfer; P:regulation of the force of heart contraction; scaffold18 indexed_genome mRNA 32789940 32805188 . - . ID=transcript_4569;Q5VWI1 Q5VWI2 Q86XM8,Transcription elongation regulator 1-like protein,, PF01846;, GO:0005634;GO:0070063;GO:0003712;, C:nucleus;, F:RNA polymerase binding; F:transcription coregulator activity; scaffold18 indexed_genome mRNA 32975258 33527953 . + . ID=transcript_4570;Q5VZ66 A6PW00 Q69YM6 Q6ZT29,Janus kinase and microtubule-interacting protein 3,Neuroendocrine long coiled-coil protein 2;, PF16034;, GO:0005794;GO:0019900;GO:0008017;, C:Golgi apparatus;, F:kinase binding; F:microtubule binding;|Q66LE6 A8KAK0 Q5SQJ2 Q9P1Y7,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform,PP2A subunit B isoform B55-delta;PP2A subunit B isoform PR55-delta;PP2A subunit B isoform R2-delta;PP2A subunit B isoform delta;, , GO:0005829;GO:0000159;GO:0019888;GO:0051301;GO:0010458;GO:0000278;GO:0070262;, C:cytosol; C:protein phosphatase type 2A complex;, F:protein phosphatase regulator activity;, P:cell division; P:exit from mitosis; P:mitotic cell cycle; P:peptidyl-serine dephosphorylation;|Q00005 A6NEJ2 A8K102 B3KPD0 B7Z2F2 B7Z304 D3DQF7 D3DQF8 G3V149,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform,PP2A subunit B isoform B55-beta;PP2A subunit B isoform PR55-beta;PP2A subunit B isoform R2-beta;PP2A subunit B isoform beta;, , GO:0005856;GO:0005829;GO:0005741;GO:0005739;GO:0000159;GO:0019888;GO:0006915;GO:0070262;, C:cytoskeleton; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:protein phosphatase type 2A complex;, F:protein phosphatase regulator activity;, P:apoptotic process; P:peptidyl-serine dephosphorylation;|Q12983 O14620 Q96GP0,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,, PF06553;, GO:0005737;GO:0030425;GO:0005783;GO:0031307;GO:0031966;GO:0005741;GO:0005739;GO:0005635;GO:0005654;GO:0005634;GO:0014069;GO:0051020;GO:0042802;GO:0042803;GO:0006915;GO:0048102;GO:0000422;GO:0050873;GO:0010659;GO:0008219;GO:0071279;GO:0070301;GO:0071456;GO:0071260;GO:0021987;GO:0051607;GO:0140507;GO:1990144;GO:0043653;GO:0097345;GO:0035694;GO:0043066;GO:0060548;GO:0045837;GO:0010637;GO:1902109;GO:0010917;GO:2000378;GO:0051402;GO:0048709;GO:0043065;GO:0010508;GO:1903599;GO:0010666;GO:0016239;GO:0051561;GO:0090141;GO:0010940;GO:0043068;GO:0043243;GO:0090200;GO:0072593;GO:1903715;GO:0046902;GO:0043067;GO:0048678;GO:0009617;GO:0055093;GO:0001666;GO:0090649;GO:1901998;GO:0016032;, C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:integral component of mitochondrial outer membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:GTPase binding; F:identical protein binding; F:protein homodimerization activity;, P:apoptotic process; P:autophagic cell death; P:autophagy of mitochondrion; P:brown fat cell differentiation; P:cardiac muscle cell apoptotic process; P:cell death; P:cellular response to cobalt ion; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to mechanical stimulus; P:cerebral cortex development; P:defense response to virus; P:granzyme-mediated programmed cell death signaling pathway; P:intrinsic apoptotic signaling pathway in response to hypoxia; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial outer membrane permeabilization; P:mitochondrial protein catabolic process; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of membrane potential; P:negative regulation of mitochondrial fusion; P:negative regulation of mitochondrial membrane permeability involved in apoptotic process; P:negative regulation of mitochondrial membrane potential; P:negative regulation of reactive oxygen species metabolic process; P:neuron apoptotic process; P:oligodendrocyte differentiation; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial fission; P:positive regulation of necrotic cell death; P:positive regulation of programmed cell death; P:positive regulation of protein-containing complex disassembly; P:positive regulation of release of cytochrome c from mitochondria; P:reactive oxygen species metabolic process; P:regulation of aerobic respiration; P:regulation of mitochondrial membrane permeability; P:regulation of programmed cell death; P:response to axon injury; P:response to bacterium; P:response to hyperoxia; P:response to hypoxia; P:response to oxygen-glucose deprivation; P:toxin transport; P:viral process;|Q12983 O14620 Q96GP0,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,, PF06553;, GO:0005737;GO:0030425;GO:0005783;GO:0031307;GO:0031966;GO:0005741;GO:0005739;GO:0005635;GO:0005654;GO:0005634;GO:0014069;GO:0051020;GO:0042802;GO:0042803;GO:0006915;GO:0048102;GO:0000422;GO:0050873;GO:0010659;GO:0008219;GO:0071279;GO:0070301;GO:0071456;GO:0071260;GO:0021987;GO:0051607;GO:0140507;GO:1990144;GO:0043653;GO:0097345;GO:0035694;GO:0043066;GO:0060548;GO:0045837;GO:0010637;GO:1902109;GO:0010917;GO:2000378;GO:0051402;GO:0048709;GO:0043065;GO:0010508;GO:1903599;GO:0010666;GO:0016239;GO:0051561;GO:0090141;GO:0010940;GO:0043068;GO:0043243;GO:0090200;GO:0072593;GO:1903715;GO:0046902;GO:0043067;GO:0048678;GO:0009617;GO:0055093;GO:0001666;GO:0090649;GO:1901998;GO:0016032;, C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:integral component of mitochondrial outer membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:GTPase binding; F:identical protein binding; F:protein homodimerization activity;, P:apoptotic process; P:autophagic cell death; P:autophagy of mitochondrion; P:brown fat cell differentiation; P:cardiac muscle cell apoptotic process; P:cell death; P:cellular response to cobalt ion; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to mechanical stimulus; P:cerebral cortex development; P:defense response to virus; P:granzyme-mediated programmed cell death signaling pathway; P:intrinsic apoptotic signaling pathway in response to hypoxia; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial outer membrane permeabilization; P:mitochondrial protein catabolic process; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of membrane potential; P:negative regulation of mitochondrial fusion; P:negative regulation of mitochondrial membrane permeability involved in apoptotic process; P:negative regulation of mitochondrial membrane potential; P:negative regulation of reactive oxygen species metabolic process; P:neuron apoptotic process; P:oligodendrocyte differentiation; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial fission; P:positive regulation of necrotic cell death; P:positive regulation of programmed cell death; P:positive regulation of protein-containing complex disassembly; P:positive regulation of release of cytochrome c from mitochondria; P:reactive oxygen species metabolic process; P:regulation of aerobic respiration; P:regulation of mitochondrial membrane permeability; P:regulation of programmed cell death; P:response to axon injury; P:response to bacterium; P:response to hyperoxia; P:response to hypoxia; P:response to oxygen-glucose deprivation; P:toxin transport; P:viral process;|Q5VZ66 A6PW00 Q69YM6 Q6ZT29,Janus kinase and microtubule-interacting protein 3,Neuroendocrine long coiled-coil protein 2;, PF16034;, GO:0005794;GO:0019900;GO:0008017;, C:Golgi apparatus;, F:kinase binding; F:microtubule binding;|Q5VZ66 A6PW00 Q69YM6 Q6ZT29,Janus kinase and microtubule-interacting protein 3,Neuroendocrine long coiled-coil protein 2;, PF16034;, GO:0005794;GO:0019900;GO:0008017;, C:Golgi apparatus;, F:kinase binding; F:microtubule binding;|Q5VZ66 A6PW00 Q69YM6 Q6ZT29,Janus kinase and microtubule-interacting protein 3,Neuroendocrine long coiled-coil protein 2;, PF16034;, GO:0005794;GO:0019900;GO:0008017;, C:Golgi apparatus;, F:kinase binding; F:microtubule binding; scaffold18 indexed_genome mRNA 33528671 33559660 . + . ID=transcript_4571;O14531 B2RMQ1 D3DRG5 O00240 Q5T0Q7,Dihydropyrimidinase-related protein 4,Collapsin response mediator protein 3;UNC33-like phosphoprotein 4;, PF01979;, GO:0005829;GO:0031005;GO:0016810;GO:0007399;GO:0070997;GO:0097485;, C:cytosol;, F:filamin binding; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds;, P:nervous system development; P:neuron death; P:neuron projection guidance; scaffold18 indexed_genome mRNA 33570446 33571069 . - . ID=transcript_4572;Q86UX6 Q5T0Q5 Q86UE1,Serine/threonine-protein kinase 32C,PKE;Yet another novel kinase 3;, PF00069;, GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;, , F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; scaffold18 indexed_genome mRNA 33571241 33571840 . - . ID=transcript_4573;Q86UX6 Q5T0Q5 Q86UE1,Serine/threonine-protein kinase 32C,PKE;Yet another novel kinase 3;, PF00069;, GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;, , F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; scaffold18 indexed_genome mRNA 33583753 33585873 . + . ID=transcript_4574;Q8N7C8 Q8NA21,Leucine-rich repeat-containing protein 27,, PF13855; scaffold18 indexed_genome mRNA 33585883 33608105 . + . ID=transcript_4575;Q8N7C8 Q8NA21,Leucine-rich repeat-containing protein 27,, PF13855;|Q8N7C8 Q8NA21,Leucine-rich repeat-containing protein 27,, PF13855;|Q8N7C8 Q8NA21,Leucine-rich repeat-containing protein 27,, PF13855;|Q8N7C8 Q8NA21,Leucine-rich repeat-containing protein 27,, PF13855; scaffold18 indexed_genome mRNA 33626294 33629651 . - . ID=transcript_4576;Q6NUJ5 A6NM90 B5MDQ1 H9KV61 Q5SZI0 Q6ZQX5 Q96F43,PWWP domain-containing protein 2B,, PF00855;, GO:0005654;, C:nucleoplasm; scaffold18 indexed_genome mRNA 33886877 33892517 . - . ID=transcript_4577;Q14642 D3DXI3 Q14640 Q5JSF1,Inositol polyphosphate-5-phosphatase A,43 kDa inositol polyphosphate 5-phosphatase {ECO:0000303|PubMed:8006039};Type I inositol 1,4,5-trisphosphate 5-phosphatase {ECO:0000303|PubMed:8013665};, PF03372;, GO:0030425;GO:0016020;GO:0005886;GO:0052659;GO:0052658;GO:0004445;GO:0042731;GO:0046855;GO:0043647;GO:0048016;GO:1901215;GO:0046856;, C:dendrite; C:membrane; C:plasma membrane;, F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:PH domain binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:inositol phosphate-mediated signaling; P:negative regulation of neuron death; P:phosphatidylinositol dephosphorylation; scaffold18 indexed_genome mRNA 33894016 33899758 . + . ID=transcript_4578;Q14642 D3DXI3 Q14640 Q5JSF1,Inositol polyphosphate-5-phosphatase A,43 kDa inositol polyphosphate 5-phosphatase {ECO:0000303|PubMed:8006039};Type I inositol 1,4,5-trisphosphate 5-phosphatase {ECO:0000303|PubMed:8013665};, PF03372;, GO:0030425;GO:0016020;GO:0005886;GO:0052659;GO:0052658;GO:0004445;GO:0042731;GO:0046855;GO:0043647;GO:0048016;GO:1901215;GO:0046856;, C:dendrite; C:membrane; C:plasma membrane;, F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:PH domain binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:inositol phosphate-mediated signaling; P:negative regulation of neuron death; P:phosphatidylinositol dephosphorylation;|Q14642 D3DXI3 Q14640 Q5JSF1,Inositol polyphosphate-5-phosphatase A,43 kDa inositol polyphosphate 5-phosphatase {ECO:0000303|PubMed:8006039};Type I inositol 1,4,5-trisphosphate 5-phosphatase {ECO:0000303|PubMed:8013665};, PF03372;, GO:0030425;GO:0016020;GO:0005886;GO:0052659;GO:0052658;GO:0004445;GO:0042731;GO:0046855;GO:0043647;GO:0048016;GO:1901215;GO:0046856;, C:dendrite; C:membrane; C:plasma membrane;, F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:PH domain binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:inositol phosphate-mediated signaling; P:negative regulation of neuron death; P:phosphatidylinositol dephosphorylation; scaffold18 indexed_genome mRNA 33922930 33941789 . - . ID=transcript_4579;Q8IYW2 B1AP44 B7WPK8 Q5JSF7 Q5SR76 Q5SR77 Q86ST2 Q8N777 Q9NTQ5,Cilia- and flagella-associated protein 46 {ECO:0000305},Tetratricopeptide repeat protein 40 {ECO:0000312|HGNC:HGNC:25247};, , GO:0005930;GO:0035082;GO:0060294;, C:axoneme;, , P:axoneme assembly; P:cilium movement involved in cell motility;|Q8IYW2 B1AP44 B7WPK8 Q5JSF7 Q5SR76 Q5SR77 Q86ST2 Q8N777 Q9NTQ5,Cilia- and flagella-associated protein 46 {ECO:0000305},Tetratricopeptide repeat protein 40 {ECO:0000312|HGNC:HGNC:25247};, , GO:0005930;GO:0035082;GO:0060294;, C:axoneme;, , P:axoneme assembly; P:cilium movement involved in cell motility;|Q8IYW2 B1AP44 B7WPK8 Q5JSF7 Q5SR76 Q5SR77 Q86ST2 Q8N777 Q9NTQ5,Cilia- and flagella-associated protein 46 {ECO:0000305},Tetratricopeptide repeat protein 40 {ECO:0000312|HGNC:HGNC:25247};, , GO:0005930;GO:0035082;GO:0060294;, C:axoneme;, , P:axoneme assembly; P:cilium movement involved in cell motility; scaffold19 indexed_genome mRNA 1023323 1071403 . - . ID=transcript_4580;Q12913 Q15255 Q6P4H4 Q8NHM2 Q9UDA9,Receptor-type tyrosine-protein phosphatase eta,Density-enhanced phosphatase 1;HPTP eta;Protein-tyrosine phosphatase receptor type J;, PF00041;PF18861;PF00102;, GO:0009986;GO:0005911;GO:0070062;GO:0001772;GO:0005887;GO:0005886;GO:0032587;GO:0035579;GO:0008013;GO:0045296;GO:0070097;GO:0045295;GO:0051019;GO:0016791;GO:0005161;GO:0019901;GO:0004725;GO:0030183;GO:0035584;GO:0060242;GO:0019221;GO:0030308;GO:0030336;GO:0008285;GO:0042059;GO:0043407;GO:0010642;GO:0051898;GO:0050860;GO:0043116;GO:0043312;GO:0035335;GO:0048008;GO:0050918;GO:0045785;GO:1905451;GO:0051894;GO:0043410;GO:0050731;GO:0051897;GO:0032760;GO:0006470;GO:0030155;GO:0050852;, C:cell surface; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:integral component of plasma membrane; C:plasma membrane; C:ruffle membrane; C:specific granule membrane;, F:beta-catenin binding; F:cadherin binding; F:delta-catenin binding; F:gamma-catenin binding; F:mitogen-activated protein kinase binding; F:phosphatase activity; F:platelet-derived growth factor receptor binding; F:protein kinase binding; F:protein tyrosine phosphatase activity;, P:B cell differentiation; P:calcium-mediated signaling using intracellular calcium source; P:contact inhibition; P:cytokine-mediated signaling pathway; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of protein kinase B signaling; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of vascular permeability; P:neutrophil degranulation; P:peptidyl-tyrosine dephosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive chemotaxis; P:positive regulation of cell adhesion; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of focal adhesion assembly; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor production; P:protein dephosphorylation; P:regulation of cell adhesion; P:T cell receptor signaling pathway; scaffold19 indexed_genome mRNA 1304696 1347985 . + . ID=transcript_4581;Q12769 B4DYE8 B4E2J9 Q08AD3 Q7Z5X6 Q96GB3 Q9H660,Nuclear pore complex protein Nup160,160 kDa nucleoporin;Nucleoporin Nup160;, , GO:0005829;GO:0043657;GO:0005635;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q12769 B4DYE8 B4E2J9 Q08AD3 Q7Z5X6 Q96GB3 Q9H660,Nuclear pore complex protein Nup160,160 kDa nucleoporin;Nucleoporin Nup160;, , GO:0005829;GO:0043657;GO:0005635;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q12769 B4DYE8 B4E2J9 Q08AD3 Q7Z5X6 Q96GB3 Q9H660,Nuclear pore complex protein Nup160,160 kDa nucleoporin;Nucleoporin Nup160;, , GO:0005829;GO:0043657;GO:0005635;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q12769 B4DYE8 B4E2J9 Q08AD3 Q7Z5X6 Q96GB3 Q9H660,Nuclear pore complex protein Nup160,160 kDa nucleoporin;Nucleoporin Nup160;, , GO:0005829;GO:0043657;GO:0005635;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q12769 B4DYE8 B4E2J9 Q08AD3 Q7Z5X6 Q96GB3 Q9H660,Nuclear pore complex protein Nup160,160 kDa nucleoporin;Nucleoporin Nup160;, , GO:0005829;GO:0043657;GO:0005635;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q12769 B4DYE8 B4E2J9 Q08AD3 Q7Z5X6 Q96GB3 Q9H660,Nuclear pore complex protein Nup160,160 kDa nucleoporin;Nucleoporin Nup160;, , GO:0005829;GO:0043657;GO:0005635;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q12769 B4DYE8 B4E2J9 Q08AD3 Q7Z5X6 Q96GB3 Q9H660,Nuclear pore complex protein Nup160,160 kDa nucleoporin;Nucleoporin Nup160;, , GO:0005829;GO:0043657;GO:0005635;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q12769 B4DYE8 B4E2J9 Q08AD3 Q7Z5X6 Q96GB3 Q9H660,Nuclear pore complex protein Nup160,160 kDa nucleoporin;Nucleoporin Nup160;, , GO:0005829;GO:0043657;GO:0005635;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q12769 B4DYE8 B4E2J9 Q08AD3 Q7Z5X6 Q96GB3 Q9H660,Nuclear pore complex protein Nup160,160 kDa nucleoporin;Nucleoporin Nup160;, , GO:0005829;GO:0043657;GO:0005635;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q12769 B4DYE8 B4E2J9 Q08AD3 Q7Z5X6 Q96GB3 Q9H660,Nuclear pore complex protein Nup160,160 kDa nucleoporin;Nucleoporin Nup160;, , GO:0005829;GO:0043657;GO:0005635;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold19 indexed_genome mRNA 1358791 1389974 . + . ID=transcript_4582;Q8N3X1 Q9H985 Q9NT81 Q9Y2L7,Formin-binding protein 4,Formin-binding protein 30;, PF00397;, GO:0016607;, C:nuclear speck;|Q8N3X1 Q9H985 Q9NT81 Q9Y2L7,Formin-binding protein 4,Formin-binding protein 30;, PF00397;, GO:0016607;, C:nuclear speck;|Q8N3X1 Q9H985 Q9NT81 Q9Y2L7,Formin-binding protein 4,Formin-binding protein 30;, PF00397;, GO:0016607;, C:nuclear speck;|Q8N3X1 Q9H985 Q9NT81 Q9Y2L7,Formin-binding protein 4,Formin-binding protein 30;, PF00397;, GO:0016607;, C:nuclear speck; scaffold19 indexed_genome mRNA 1391281 1393194 . + . ID=transcript_4583;Q5U5Z8 A8MPX2 Q53FV5 Q8IV57 Q9H5C0,Cytosolic carboxypeptidase 2,ATP/GTP-binding protein-like 2;, PF18027;PF00246;, GO:0005814;GO:0036064;GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:centriole; C:ciliary basal body; C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation; scaffold19 indexed_genome mRNA 1393682 1421280 . + . ID=transcript_4584;Q5U5Z8 A8MPX2 Q53FV5 Q8IV57 Q9H5C0,Cytosolic carboxypeptidase 2,ATP/GTP-binding protein-like 2;, PF18027;PF00246;, GO:0005814;GO:0036064;GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:centriole; C:ciliary basal body; C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation;|Q5U5Z8 A8MPX2 Q53FV5 Q8IV57 Q9H5C0,Cytosolic carboxypeptidase 2,ATP/GTP-binding protein-like 2;, PF18027;PF00246;, GO:0005814;GO:0036064;GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:centriole; C:ciliary basal body; C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation;|Q5U5Z8 A8MPX2 Q53FV5 Q8IV57 Q9H5C0,Cytosolic carboxypeptidase 2,ATP/GTP-binding protein-like 2;, PF18027;PF00246;, GO:0005814;GO:0036064;GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:centriole; C:ciliary basal body; C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation;|Q5U5Z8 A8MPX2 Q53FV5 Q8IV57 Q9H5C0,Cytosolic carboxypeptidase 2,ATP/GTP-binding protein-like 2;, PF18027;PF00246;, GO:0005814;GO:0036064;GO:0005829;GO:0004181;GO:0008270;GO:0035610;, C:centriole; C:ciliary basal body; C:cytosol;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:protein side chain deglutamylation; scaffold19 indexed_genome mRNA 1450980 1463370 . + . ID=transcript_4585;Q9Y6C9 B2R7L8,Mitochondrial carrier homolog 2,Met-induced mitochondrial protein;, PF00153;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0005634;GO:0043065;GO:0070585;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, , P:positive regulation of apoptotic process; P:protein localization to mitochondrion;|Q9Y6C9 B2R7L8,Mitochondrial carrier homolog 2,Met-induced mitochondrial protein;, PF00153;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0005634;GO:0043065;GO:0070585;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, , P:positive regulation of apoptotic process; P:protein localization to mitochondrion;|Q9Y6C9 B2R7L8,Mitochondrial carrier homolog 2,Met-induced mitochondrial protein;, PF00153;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0005634;GO:0043065;GO:0070585;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, , P:positive regulation of apoptotic process; P:protein localization to mitochondrion;|Q9Y6C9 B2R7L8,Mitochondrial carrier homolog 2,Met-induced mitochondrial protein;, PF00153;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0005634;GO:0043065;GO:0070585;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, , P:positive regulation of apoptotic process; P:protein localization to mitochondrion; scaffold19 indexed_genome mRNA 1483099 1485975 . + . ID=transcript_4586;Q9BXJ3 Q8IV25,Complement C1q tumor necrosis factor-related protein 4,C1q/TNF-related protein 4 {ECO:0000303|PubMed:24366864};, PF00386;, GO:0005615;GO:0005125;GO:0032755;GO:0070105;GO:1901224;GO:0032760;, C:extracellular space;, F:cytokine activity;, P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of tumor necrosis factor production; scaffold19 indexed_genome mRNA 1491428 1505550 . - . ID=transcript_4587;O75489 B2R9J1 B4DFM8 Q9UNQ8,NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial,Complex I-30kD;NADH-ubiquinone oxidoreductase 30 kDa subunit;, PF00329;, GO:0005743;GO:0005759;GO:0031966;GO:0005747;GO:0005739;GO:0016604;GO:0009055;GO:0008137;GO:0003954;GO:0006120;GO:0032981;GO:0030308;GO:2001243;GO:0072593;GO:0021762;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nuclear body;, F:electron transfer activity; F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway; P:reactive oxygen species metabolic process; P:substantia nigra development;|O75489 B2R9J1 B4DFM8 Q9UNQ8,NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial,Complex I-30kD;NADH-ubiquinone oxidoreductase 30 kDa subunit;, PF00329;, GO:0005743;GO:0005759;GO:0031966;GO:0005747;GO:0005739;GO:0016604;GO:0009055;GO:0008137;GO:0003954;GO:0006120;GO:0032981;GO:0030308;GO:2001243;GO:0072593;GO:0021762;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nuclear body;, F:electron transfer activity; F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway; P:reactive oxygen species metabolic process; P:substantia nigra development;|O75489 B2R9J1 B4DFM8 Q9UNQ8,NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial,Complex I-30kD;NADH-ubiquinone oxidoreductase 30 kDa subunit;, PF00329;, GO:0005743;GO:0005759;GO:0031966;GO:0005747;GO:0005739;GO:0016604;GO:0009055;GO:0008137;GO:0003954;GO:0006120;GO:0032981;GO:0030308;GO:2001243;GO:0072593;GO:0021762;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nuclear body;, F:electron transfer activity; F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway; P:reactive oxygen species metabolic process; P:substantia nigra development;|O75489 B2R9J1 B4DFM8 Q9UNQ8,NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial,Complex I-30kD;NADH-ubiquinone oxidoreductase 30 kDa subunit;, PF00329;, GO:0005743;GO:0005759;GO:0031966;GO:0005747;GO:0005739;GO:0016604;GO:0009055;GO:0008137;GO:0003954;GO:0006120;GO:0032981;GO:0030308;GO:2001243;GO:0072593;GO:0021762;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nuclear body;, F:electron transfer activity; F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway; P:reactive oxygen species metabolic process; P:substantia nigra development;|O75489 B2R9J1 B4DFM8 Q9UNQ8,NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial,Complex I-30kD;NADH-ubiquinone oxidoreductase 30 kDa subunit;, PF00329;, GO:0005743;GO:0005759;GO:0031966;GO:0005747;GO:0005739;GO:0016604;GO:0009055;GO:0008137;GO:0003954;GO:0006120;GO:0032981;GO:0030308;GO:2001243;GO:0072593;GO:0021762;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nuclear body;, F:electron transfer activity; F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway; P:reactive oxygen species metabolic process; P:substantia nigra development;|Q9NVX7 D3DQS1 D3DQS2 Q6IA85 Q9BUC3 Q9NV76,Kelch repeat and BTB domain-containing protein 4,BTB and kelch domain-containing protein 4;, PF07707;PF00651;|Q9NVX7 D3DQS1 D3DQS2 Q6IA85 Q9BUC3 Q9NV76,Kelch repeat and BTB domain-containing protein 4,BTB and kelch domain-containing protein 4;, PF07707;PF00651; scaffold19 indexed_genome mRNA 1505955 1507903 . - . ID=transcript_4588;Q8WUK0 E9PAT8 Q7Z557 Q96CR2 Q9BXV8,Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 {ECO:0000305},PTEN-like phosphatase;Phosphoinositide lipid phosphatase;Protein-tyrosine phosphatase mitochondrial 1;, , GO:0005743;GO:0005739;GO:0005634;GO:0008962;GO:0004439;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0032049;GO:2001242;, C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:phosphatidylglycerophosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cardiolipin biosynthetic process; P:regulation of intrinsic apoptotic signaling pathway; scaffold19 indexed_genome mRNA 1586340 1599948 . + . ID=transcript_4589;Q92879 B4E2U5 D3DQS0 F8W940 Q4LE52 Q9NP83 Q9NR06,CUGBP Elav-like family member 1,50 kDa nuclear polyadenylated RNA-binding protein;Bruno-like protein 2;CUG triplet repeat RNA-binding protein 1;CUG-BP- and ETR-3-like factor 1;Deadenylation factor CUG-BP;Embryo deadenylation element-binding protein homolog;RNA-binding protein BRUNOL-2;, PF00076;, GO:0005737;GO:0010494;GO:0016020;GO:0005654;GO:0005634;GO:0097356;GO:1990904;GO:0042835;GO:0003730;GO:0003729;GO:0036002;GO:0003723;GO:0000900;GO:0009792;GO:0007281;GO:0061157;GO:0006397;GO:0006376;GO:0008285;GO:0010629;GO:0010942;GO:0010628;GO:0016441;GO:0000381;GO:0050727;GO:0043484;GO:0016246;, C:cytoplasm; C:cytoplasmic stress granule; C:membrane; C:nucleoplasm; C:nucleus; C:perinucleolar compartment; C:ribonucleoprotein complex;, F:BRE binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA binding; F:RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:embryo development ending in birth or egg hatching; P:germ cell development; P:mRNA destabilization; P:mRNA processing; P:mRNA splice site selection; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:positive regulation of cell death; P:positive regulation of gene expression; P:posttranscriptional gene silencing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of inflammatory response; P:regulation of RNA splicing; P:RNA interference;|Q92879 B4E2U5 D3DQS0 F8W940 Q4LE52 Q9NP83 Q9NR06,CUGBP Elav-like family member 1,50 kDa nuclear polyadenylated RNA-binding protein;Bruno-like protein 2;CUG triplet repeat RNA-binding protein 1;CUG-BP- and ETR-3-like factor 1;Deadenylation factor CUG-BP;Embryo deadenylation element-binding protein homolog;RNA-binding protein BRUNOL-2;, PF00076;, GO:0005737;GO:0010494;GO:0016020;GO:0005654;GO:0005634;GO:0097356;GO:1990904;GO:0042835;GO:0003730;GO:0003729;GO:0036002;GO:0003723;GO:0000900;GO:0009792;GO:0007281;GO:0061157;GO:0006397;GO:0006376;GO:0008285;GO:0010629;GO:0010942;GO:0010628;GO:0016441;GO:0000381;GO:0050727;GO:0043484;GO:0016246;, C:cytoplasm; C:cytoplasmic stress granule; C:membrane; C:nucleoplasm; C:nucleus; C:perinucleolar compartment; C:ribonucleoprotein complex;, F:BRE binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA binding; F:RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:embryo development ending in birth or egg hatching; P:germ cell development; P:mRNA destabilization; P:mRNA processing; P:mRNA splice site selection; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:positive regulation of cell death; P:positive regulation of gene expression; P:posttranscriptional gene silencing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of inflammatory response; P:regulation of RNA splicing; P:RNA interference;|Q92879 B4E2U5 D3DQS0 F8W940 Q4LE52 Q9NP83 Q9NR06,CUGBP Elav-like family member 1,50 kDa nuclear polyadenylated RNA-binding protein;Bruno-like protein 2;CUG triplet repeat RNA-binding protein 1;CUG-BP- and ETR-3-like factor 1;Deadenylation factor CUG-BP;Embryo deadenylation element-binding protein homolog;RNA-binding protein BRUNOL-2;, PF00076;, GO:0005737;GO:0010494;GO:0016020;GO:0005654;GO:0005634;GO:0097356;GO:1990904;GO:0042835;GO:0003730;GO:0003729;GO:0036002;GO:0003723;GO:0000900;GO:0009792;GO:0007281;GO:0061157;GO:0006397;GO:0006376;GO:0008285;GO:0010629;GO:0010942;GO:0010628;GO:0016441;GO:0000381;GO:0050727;GO:0043484;GO:0016246;, C:cytoplasm; C:cytoplasmic stress granule; C:membrane; C:nucleoplasm; C:nucleus; C:perinucleolar compartment; C:ribonucleoprotein complex;, F:BRE binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA binding; F:RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:embryo development ending in birth or egg hatching; P:germ cell development; P:mRNA destabilization; P:mRNA processing; P:mRNA splice site selection; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:positive regulation of cell death; P:positive regulation of gene expression; P:posttranscriptional gene silencing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of inflammatory response; P:regulation of RNA splicing; P:RNA interference;|Q92879 B4E2U5 D3DQS0 F8W940 Q4LE52 Q9NP83 Q9NR06,CUGBP Elav-like family member 1,50 kDa nuclear polyadenylated RNA-binding protein;Bruno-like protein 2;CUG triplet repeat RNA-binding protein 1;CUG-BP- and ETR-3-like factor 1;Deadenylation factor CUG-BP;Embryo deadenylation element-binding protein homolog;RNA-binding protein BRUNOL-2;, PF00076;, GO:0005737;GO:0010494;GO:0016020;GO:0005654;GO:0005634;GO:0097356;GO:1990904;GO:0042835;GO:0003730;GO:0003729;GO:0036002;GO:0003723;GO:0000900;GO:0009792;GO:0007281;GO:0061157;GO:0006397;GO:0006376;GO:0008285;GO:0010629;GO:0010942;GO:0010628;GO:0016441;GO:0000381;GO:0050727;GO:0043484;GO:0016246;, C:cytoplasm; C:cytoplasmic stress granule; C:membrane; C:nucleoplasm; C:nucleus; C:perinucleolar compartment; C:ribonucleoprotein complex;, F:BRE binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA binding; F:RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:embryo development ending in birth or egg hatching; P:germ cell development; P:mRNA destabilization; P:mRNA processing; P:mRNA splice site selection; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:positive regulation of cell death; P:positive regulation of gene expression; P:posttranscriptional gene silencing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of inflammatory response; P:regulation of RNA splicing; P:RNA interference;|Q92879 B4E2U5 D3DQS0 F8W940 Q4LE52 Q9NP83 Q9NR06,CUGBP Elav-like family member 1,50 kDa nuclear polyadenylated RNA-binding protein;Bruno-like protein 2;CUG triplet repeat RNA-binding protein 1;CUG-BP- and ETR-3-like factor 1;Deadenylation factor CUG-BP;Embryo deadenylation element-binding protein homolog;RNA-binding protein BRUNOL-2;, PF00076;, GO:0005737;GO:0010494;GO:0016020;GO:0005654;GO:0005634;GO:0097356;GO:1990904;GO:0042835;GO:0003730;GO:0003729;GO:0036002;GO:0003723;GO:0000900;GO:0009792;GO:0007281;GO:0061157;GO:0006397;GO:0006376;GO:0008285;GO:0010629;GO:0010942;GO:0010628;GO:0016441;GO:0000381;GO:0050727;GO:0043484;GO:0016246;, C:cytoplasm; C:cytoplasmic stress granule; C:membrane; C:nucleoplasm; C:nucleus; C:perinucleolar compartment; C:ribonucleoprotein complex;, F:BRE binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA binding; F:RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:embryo development ending in birth or egg hatching; P:germ cell development; P:mRNA destabilization; P:mRNA processing; P:mRNA splice site selection; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:positive regulation of cell death; P:positive regulation of gene expression; P:posttranscriptional gene silencing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of inflammatory response; P:regulation of RNA splicing; P:RNA interference; scaffold19 indexed_genome mRNA 1613807 1627713 . - . ID=transcript_4590;Q13702 Q8TDF3 Q9BTD9,43 kDa receptor-associated protein of the synapse,43 kDa postsynaptic protein;Acetylcholine receptor-associated 43 kDa protein;RING finger protein 205;, PF10579;PF17874;PF13639;, GO:0005813;GO:0005829;GO:0005794;GO:0031594;GO:0005886;GO:0099634;GO:0033130;GO:0035255;GO:0046872;GO:0043495;GO:0007268;GO:1903540;GO:1900075;GO:0043525;GO:1901626;GO:0007271;, C:centrosome; C:cytosol; C:Golgi apparatus; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization membrane;, F:acetylcholine receptor binding; F:ionotropic glutamate receptor binding; F:metal ion binding; F:protein-membrane adaptor activity;, P:chemical synaptic transmission; P:establishment of protein localization to postsynaptic membrane; P:positive regulation of neuromuscular synaptic transmission; P:positive regulation of neuron apoptotic process; P:regulation of postsynaptic membrane organization; P:synaptic transmission, cholinergic;|Q13702 Q8TDF3 Q9BTD9,43 kDa receptor-associated protein of the synapse,43 kDa postsynaptic protein;Acetylcholine receptor-associated 43 kDa protein;RING finger protein 205;, PF10579;PF17874;PF13639;, GO:0005813;GO:0005829;GO:0005794;GO:0031594;GO:0005886;GO:0099634;GO:0033130;GO:0035255;GO:0046872;GO:0043495;GO:0007268;GO:1903540;GO:1900075;GO:0043525;GO:1901626;GO:0007271;, C:centrosome; C:cytosol; C:Golgi apparatus; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization membrane;, F:acetylcholine receptor binding; F:ionotropic glutamate receptor binding; F:metal ion binding; F:protein-membrane adaptor activity;, P:chemical synaptic transmission; P:establishment of protein localization to postsynaptic membrane; P:positive regulation of neuromuscular synaptic transmission; P:positive regulation of neuron apoptotic process; P:regulation of postsynaptic membrane organization; P:synaptic transmission, cholinergic;|Q13702 Q8TDF3 Q9BTD9,43 kDa receptor-associated protein of the synapse,43 kDa postsynaptic protein;Acetylcholine receptor-associated 43 kDa protein;RING finger protein 205;, PF10579;PF17874;PF13639;, GO:0005813;GO:0005829;GO:0005794;GO:0031594;GO:0005886;GO:0099634;GO:0033130;GO:0035255;GO:0046872;GO:0043495;GO:0007268;GO:1903540;GO:1900075;GO:0043525;GO:1901626;GO:0007271;, C:centrosome; C:cytosol; C:Golgi apparatus; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization membrane;, F:acetylcholine receptor binding; F:ionotropic glutamate receptor binding; F:metal ion binding; F:protein-membrane adaptor activity;, P:chemical synaptic transmission; P:establishment of protein localization to postsynaptic membrane; P:positive regulation of neuromuscular synaptic transmission; P:positive regulation of neuron apoptotic process; P:regulation of postsynaptic membrane organization; P:synaptic transmission, cholinergic;|Q13702 Q8TDF3 Q9BTD9,43 kDa receptor-associated protein of the synapse,43 kDa postsynaptic protein;Acetylcholine receptor-associated 43 kDa protein;RING finger protein 205;, PF10579;PF17874;PF13639;, GO:0005813;GO:0005829;GO:0005794;GO:0031594;GO:0005886;GO:0099634;GO:0033130;GO:0035255;GO:0046872;GO:0043495;GO:0007268;GO:1903540;GO:1900075;GO:0043525;GO:1901626;GO:0007271;, C:centrosome; C:cytosol; C:Golgi apparatus; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization membrane;, F:acetylcholine receptor binding; F:ionotropic glutamate receptor binding; F:metal ion binding; F:protein-membrane adaptor activity;, P:chemical synaptic transmission; P:establishment of protein localization to postsynaptic membrane; P:positive regulation of neuromuscular synaptic transmission; P:positive regulation of neuron apoptotic process; P:regulation of postsynaptic membrane organization; P:synaptic transmission, cholinergic; scaffold19 indexed_genome mRNA 1632016 1639246 . + . ID=transcript_4591;P17980 B2R8V1 Q3B757 Q3B865 Q53HU5 Q6GPG8 Q6IBS1 Q96HD3,26S proteasome regulatory subunit 6A,26S proteasome AAA-ATPase subunit RPT5;Proteasome 26S subunit ATPase 3;Proteasome subunit P50;Tat-binding protein 1;, PF00004;PF17862;PF16450;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0022624;GO:0000502;GO:0008540;GO:0034774;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0043921;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0045899;GO:0045944;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:modulation by host of viral transcription; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P17980 B2R8V1 Q3B757 Q3B865 Q53HU5 Q6GPG8 Q6IBS1 Q96HD3,26S proteasome regulatory subunit 6A,26S proteasome AAA-ATPase subunit RPT5;Proteasome 26S subunit ATPase 3;Proteasome subunit P50;Tat-binding protein 1;, PF00004;PF17862;PF16450;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0022624;GO:0000502;GO:0008540;GO:0034774;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0043921;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0045899;GO:0045944;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:modulation by host of viral transcription; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P17980 B2R8V1 Q3B757 Q3B865 Q53HU5 Q6GPG8 Q6IBS1 Q96HD3,26S proteasome regulatory subunit 6A,26S proteasome AAA-ATPase subunit RPT5;Proteasome 26S subunit ATPase 3;Proteasome subunit P50;Tat-binding protein 1;, PF00004;PF17862;PF16450;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0022624;GO:0000502;GO:0008540;GO:0034774;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0043921;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0045899;GO:0045944;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:modulation by host of viral transcription; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold19 indexed_genome mRNA 1639355 1646151 . - . ID=transcript_4592;Q96H72 D3DQR6 D3DQR7 E9PLY1 E9PQV3 Q659D9 Q8N7C9 Q8WV10,Zinc transporter ZIP13,LIV-1 subfamily of ZIP zinc transporter 9;Solute carrier family 39 member 13;Zrt- and Irt-like protein 13;, PF02535;, GO:0005783;GO:0005794;GO:0030173;GO:0016021;GO:0048471;GO:0042803;GO:0005385;GO:0006882;GO:0061448;GO:0010043;GO:0071577;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:connective tissue development; P:response to zinc ion; P:zinc ion transmembrane transport;|Q96H72 D3DQR6 D3DQR7 E9PLY1 E9PQV3 Q659D9 Q8N7C9 Q8WV10,Zinc transporter ZIP13,LIV-1 subfamily of ZIP zinc transporter 9;Solute carrier family 39 member 13;Zrt- and Irt-like protein 13;, PF02535;, GO:0005783;GO:0005794;GO:0030173;GO:0016021;GO:0048471;GO:0042803;GO:0005385;GO:0006882;GO:0061448;GO:0010043;GO:0071577;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:connective tissue development; P:response to zinc ion; P:zinc ion transmembrane transport;|Q96H72 D3DQR6 D3DQR7 E9PLY1 E9PQV3 Q659D9 Q8N7C9 Q8WV10,Zinc transporter ZIP13,LIV-1 subfamily of ZIP zinc transporter 9;Solute carrier family 39 member 13;Zrt- and Irt-like protein 13;, PF02535;, GO:0005783;GO:0005794;GO:0030173;GO:0016021;GO:0048471;GO:0042803;GO:0005385;GO:0006882;GO:0061448;GO:0010043;GO:0071577;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:connective tissue development; P:response to zinc ion; P:zinc ion transmembrane transport;|Q96H72 D3DQR6 D3DQR7 E9PLY1 E9PQV3 Q659D9 Q8N7C9 Q8WV10,Zinc transporter ZIP13,LIV-1 subfamily of ZIP zinc transporter 9;Solute carrier family 39 member 13;Zrt- and Irt-like protein 13;, PF02535;, GO:0005783;GO:0005794;GO:0030173;GO:0016021;GO:0048471;GO:0042803;GO:0005385;GO:0006882;GO:0061448;GO:0010043;GO:0071577;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:connective tissue development; P:response to zinc ion; P:zinc ion transmembrane transport; scaffold19 indexed_genome mRNA 1684447 1688063 . + . ID=transcript_4593;P17947,Transcription factor PU.1,31 kDa-transforming protein;, PF00178;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0000987;GO:0001216;GO:0001228;GO:0003700;GO:0000981;GO:0140297;GO:0001217;GO:0001227;GO:0042826;GO:0051525;GO:0140311;GO:0003723;GO:0000978;GO:0001085;GO:0008134;GO:0000976;GO:0060033;GO:1902262;GO:0030154;GO:0071361;GO:0034401;GO:0002357;GO:0098508;GO:0030218;GO:0002316;GO:0002314;GO:0030851;GO:0043966;GO:0044027;GO:0002327;GO:0070102;GO:0031663;GO:0030225;GO:0043011;GO:0002573;GO:1904178;GO:0010629;GO:0045814;GO:0090241;GO:0045347;GO:0043314;GO:0032088;GO:1901223;GO:0120186;GO:0000122;GO:0045892;GO:0090402;GO:1904238;GO:1905036;GO:1904151;GO:2000529;GO:1900745;GO:1902895;GO:0045944;GO:0045893;GO:0002572;GO:0051090;GO:0045646;GO:1901674;GO:1905453;GO:0006357;GO:0006355;GO:0035019;GO:0036462;GO:0007179;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:NFAT protein binding; F:protein sequestering activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure regression; P:apoptotic process involved in blood vessel morphogenesis; P:cell differentiation; P:cellular response to ethanol; P:chromatin organization involved in regulation of transcription; P:defense response to tumor cell; P:endothelial to hematopoietic transition; P:erythrocyte differentiation; P:follicular B cell differentiation; P:germinal center B cell differentiation; P:granulocyte differentiation; P:histone H3 acetylation; P:hypermethylation of CpG island; P:immature B cell differentiation; P:interleukin-6-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:macrophage differentiation; P:myeloid dendritic cell differentiation; P:myeloid leukocyte differentiation; P:negative regulation of adipose tissue development; P:negative regulation of gene expression; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H4 acetylation; P:negative regulation of MHC class II biosynthetic process; P:negative regulation of neutrophil degranulation; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of protein localization to chromatin; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:oncogene-induced cell senescence; P:pericyte cell differentiation; P:positive regulation of antifungal innate immune response; P:positive regulation of microglial cell mediated cytotoxicity; P:positive regulation of myeloid dendritic cell chemotaxis; P:positive regulation of p38MAPK cascade; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:pro-T cell differentiation; P:regulation of DNA-binding transcription factor activity; P:regulation of erythrocyte differentiation; P:regulation of histone H3-K27 acetylation; P:regulation of myeloid progenitor cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:somatic stem cell population maintenance; P:TRAIL-activated apoptotic signaling pathway; P:transforming growth factor beta receptor signaling pathway;|P17947,Transcription factor PU.1,31 kDa-transforming protein;, PF00178;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0000987;GO:0001216;GO:0001228;GO:0003700;GO:0000981;GO:0140297;GO:0001217;GO:0001227;GO:0042826;GO:0051525;GO:0140311;GO:0003723;GO:0000978;GO:0001085;GO:0008134;GO:0000976;GO:0060033;GO:1902262;GO:0030154;GO:0071361;GO:0034401;GO:0002357;GO:0098508;GO:0030218;GO:0002316;GO:0002314;GO:0030851;GO:0043966;GO:0044027;GO:0002327;GO:0070102;GO:0031663;GO:0030225;GO:0043011;GO:0002573;GO:1904178;GO:0010629;GO:0045814;GO:0090241;GO:0045347;GO:0043314;GO:0032088;GO:1901223;GO:0120186;GO:0000122;GO:0045892;GO:0090402;GO:1904238;GO:1905036;GO:1904151;GO:2000529;GO:1900745;GO:1902895;GO:0045944;GO:0045893;GO:0002572;GO:0051090;GO:0045646;GO:1901674;GO:1905453;GO:0006357;GO:0006355;GO:0035019;GO:0036462;GO:0007179;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:NFAT protein binding; F:protein sequestering activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure regression; P:apoptotic process involved in blood vessel morphogenesis; P:cell differentiation; P:cellular response to ethanol; P:chromatin organization involved in regulation of transcription; P:defense response to tumor cell; P:endothelial to hematopoietic transition; P:erythrocyte differentiation; P:follicular B cell differentiation; P:germinal center B cell differentiation; P:granulocyte differentiation; P:histone H3 acetylation; P:hypermethylation of CpG island; P:immature B cell differentiation; P:interleukin-6-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:macrophage differentiation; P:myeloid dendritic cell differentiation; P:myeloid leukocyte differentiation; P:negative regulation of adipose tissue development; P:negative regulation of gene expression; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H4 acetylation; P:negative regulation of MHC class II biosynthetic process; P:negative regulation of neutrophil degranulation; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of protein localization to chromatin; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:oncogene-induced cell senescence; P:pericyte cell differentiation; P:positive regulation of antifungal innate immune response; P:positive regulation of microglial cell mediated cytotoxicity; P:positive regulation of myeloid dendritic cell chemotaxis; P:positive regulation of p38MAPK cascade; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:pro-T cell differentiation; P:regulation of DNA-binding transcription factor activity; P:regulation of erythrocyte differentiation; P:regulation of histone H3-K27 acetylation; P:regulation of myeloid progenitor cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:somatic stem cell population maintenance; P:TRAIL-activated apoptotic signaling pathway; P:transforming growth factor beta receptor signaling pathway; scaffold19 indexed_genome mRNA 1693326 1707883 . - . ID=transcript_4594;Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis;|Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis;|Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis;|Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis;|Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis;|Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis;|Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis;|Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis;|Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis;|Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis;|Q14896 A5PL00 Q16410 Q6R2F7 Q9UE27 Q9UM53,Myosin-binding protein C, cardiac-type,C-protein, cardiac muscle isoform;, PF00041;PF07679;PF18362;, GO:0031672;GO:0014705;GO:0097512;GO:0005829;GO:0030017;GO:0005863;GO:0003779;GO:0001671;GO:0042802;GO:0046872;GO:0017022;GO:0032036;GO:0008307;GO:0031432;GO:0060048;GO:0007155;GO:0003007;GO:0030049;GO:0032781;GO:0032971;GO:0006942;GO:0055010;, C:A band; C:C zone; C:cardiac myofibril; C:cytosol; C:sarcomere; C:striated muscle myosin thick filament;, F:actin binding; F:ATPase activator activity; F:identical protein binding; F:metal ion binding; F:myosin binding; F:myosin heavy chain binding; F:structural constituent of muscle; F:titin binding;, P:cardiac muscle contraction; P:cell adhesion; P:heart morphogenesis; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of muscle filament sliding; P:regulation of striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; scaffold19 indexed_genome mRNA 1707910 1721289 . - . ID=transcript_4595;Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway; scaffold19 indexed_genome mRNA 1721549 1749457 . - . ID=transcript_4596;Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8WXG3 Q8WXG4 Q8WXG5 Q8WZ63,MAP kinase-activating death domain protein,Differentially expressed in normal and neoplastic cells;Insulinoma glucagonoma clone 20;Rab3 GDP/GTP exchange factor;, PF02141;PF03456;, GO:0005737;GO:0005829;GO:0016021;GO:0005886;GO:0045202;GO:0005123;GO:0005085;GO:0030295;GO:0000187;GO:0007166;GO:0097194;GO:0042981;GO:0051726;GO:2001236;GO:1902041;GO:0032483;GO:0010803;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:plasma membrane; C:synapse;, F:death receptor binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase activator activity;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:execution phase of apoptosis; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Rab protein signal transduction; P:regulation of tumor necrosis factor-mediated signaling pathway; scaffold19 indexed_genome mRNA 1754087 1761341 . - . ID=transcript_4597;Q13133 A8K3J9 D3DQR1 Q8IW13 Q96H87,Oxysterols receptor LXR-alpha,Liver X receptor alpha;Nuclear receptor subfamily 1 group H member 3;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0043235;GO:0090575;GO:0015485;GO:0003677;GO:0000981;GO:0004879;GO:0000978;GO:0032810;GO:0000976;GO:0008270;GO:0043277;GO:0030154;GO:0071222;GO:0042632;GO:0030522;GO:0055088;GO:0010887;GO:0120163;GO:0050728;GO:0060336;GO:0032369;GO:0043031;GO:0010745;GO:0090188;GO:0048550;GO:1903573;GO:0090341;GO:0000122;GO:0036151;GO:0032270;GO:0010875;GO:0032376;GO:0045723;GO:0051006;GO:0034145;GO:0045944;GO:0045893;GO:0010867;GO:0042752;GO:0032570;GO:0055092;GO:0006367;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:cholesterol binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sterol response element binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:apoptotic cell clearance; P:cell differentiation; P:cellular response to lipopolysaccharide; P:cholesterol homeostasis; P:intracellular receptor signaling pathway; P:lipid homeostasis; P:negative regulation of cholesterol storage; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of lipid transport; P:negative regulation of macrophage activation; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of pancreatic juice secretion; P:negative regulation of pinocytosis; P:negative regulation of response to endoplasmic reticulum stress; P:negative regulation of secretion of lysosomal enzymes; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylcholine acyl-chain remodeling; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol transport; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of lipoprotein lipase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of triglyceride biosynthetic process; P:regulation of circadian rhythm; P:response to progesterone; P:sterol homeostasis; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis;|Q13133 A8K3J9 D3DQR1 Q8IW13 Q96H87,Oxysterols receptor LXR-alpha,Liver X receptor alpha;Nuclear receptor subfamily 1 group H member 3;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0043235;GO:0090575;GO:0015485;GO:0003677;GO:0000981;GO:0004879;GO:0000978;GO:0032810;GO:0000976;GO:0008270;GO:0043277;GO:0030154;GO:0071222;GO:0042632;GO:0030522;GO:0055088;GO:0010887;GO:0120163;GO:0050728;GO:0060336;GO:0032369;GO:0043031;GO:0010745;GO:0090188;GO:0048550;GO:1903573;GO:0090341;GO:0000122;GO:0036151;GO:0032270;GO:0010875;GO:0032376;GO:0045723;GO:0051006;GO:0034145;GO:0045944;GO:0045893;GO:0010867;GO:0042752;GO:0032570;GO:0055092;GO:0006367;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:cholesterol binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sterol response element binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:apoptotic cell clearance; P:cell differentiation; P:cellular response to lipopolysaccharide; P:cholesterol homeostasis; P:intracellular receptor signaling pathway; P:lipid homeostasis; P:negative regulation of cholesterol storage; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of lipid transport; P:negative regulation of macrophage activation; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of pancreatic juice secretion; P:negative regulation of pinocytosis; P:negative regulation of response to endoplasmic reticulum stress; P:negative regulation of secretion of lysosomal enzymes; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylcholine acyl-chain remodeling; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol transport; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of lipoprotein lipase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of triglyceride biosynthetic process; P:regulation of circadian rhythm; P:response to progesterone; P:sterol homeostasis; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis;|Q13133 A8K3J9 D3DQR1 Q8IW13 Q96H87,Oxysterols receptor LXR-alpha,Liver X receptor alpha;Nuclear receptor subfamily 1 group H member 3;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0043235;GO:0090575;GO:0015485;GO:0003677;GO:0000981;GO:0004879;GO:0000978;GO:0032810;GO:0000976;GO:0008270;GO:0043277;GO:0030154;GO:0071222;GO:0042632;GO:0030522;GO:0055088;GO:0010887;GO:0120163;GO:0050728;GO:0060336;GO:0032369;GO:0043031;GO:0010745;GO:0090188;GO:0048550;GO:1903573;GO:0090341;GO:0000122;GO:0036151;GO:0032270;GO:0010875;GO:0032376;GO:0045723;GO:0051006;GO:0034145;GO:0045944;GO:0045893;GO:0010867;GO:0042752;GO:0032570;GO:0055092;GO:0006367;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:cholesterol binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sterol response element binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:apoptotic cell clearance; P:cell differentiation; P:cellular response to lipopolysaccharide; P:cholesterol homeostasis; P:intracellular receptor signaling pathway; P:lipid homeostasis; P:negative regulation of cholesterol storage; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of lipid transport; P:negative regulation of macrophage activation; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of pancreatic juice secretion; P:negative regulation of pinocytosis; P:negative regulation of response to endoplasmic reticulum stress; P:negative regulation of secretion of lysosomal enzymes; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylcholine acyl-chain remodeling; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol transport; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of lipoprotein lipase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of triglyceride biosynthetic process; P:regulation of circadian rhythm; P:response to progesterone; P:sterol homeostasis; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis;|Q13133 A8K3J9 D3DQR1 Q8IW13 Q96H87,Oxysterols receptor LXR-alpha,Liver X receptor alpha;Nuclear receptor subfamily 1 group H member 3;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0043235;GO:0090575;GO:0015485;GO:0003677;GO:0000981;GO:0004879;GO:0000978;GO:0032810;GO:0000976;GO:0008270;GO:0043277;GO:0030154;GO:0071222;GO:0042632;GO:0030522;GO:0055088;GO:0010887;GO:0120163;GO:0050728;GO:0060336;GO:0032369;GO:0043031;GO:0010745;GO:0090188;GO:0048550;GO:1903573;GO:0090341;GO:0000122;GO:0036151;GO:0032270;GO:0010875;GO:0032376;GO:0045723;GO:0051006;GO:0034145;GO:0045944;GO:0045893;GO:0010867;GO:0042752;GO:0032570;GO:0055092;GO:0006367;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:cholesterol binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sterol response element binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:apoptotic cell clearance; P:cell differentiation; P:cellular response to lipopolysaccharide; P:cholesterol homeostasis; P:intracellular receptor signaling pathway; P:lipid homeostasis; P:negative regulation of cholesterol storage; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of lipid transport; P:negative regulation of macrophage activation; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of pancreatic juice secretion; P:negative regulation of pinocytosis; P:negative regulation of response to endoplasmic reticulum stress; P:negative regulation of secretion of lysosomal enzymes; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylcholine acyl-chain remodeling; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol transport; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of lipoprotein lipase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of triglyceride biosynthetic process; P:regulation of circadian rhythm; P:response to progesterone; P:sterol homeostasis; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis;|Q13133 A8K3J9 D3DQR1 Q8IW13 Q96H87,Oxysterols receptor LXR-alpha,Liver X receptor alpha;Nuclear receptor subfamily 1 group H member 3;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0043235;GO:0090575;GO:0015485;GO:0003677;GO:0000981;GO:0004879;GO:0000978;GO:0032810;GO:0000976;GO:0008270;GO:0043277;GO:0030154;GO:0071222;GO:0042632;GO:0030522;GO:0055088;GO:0010887;GO:0120163;GO:0050728;GO:0060336;GO:0032369;GO:0043031;GO:0010745;GO:0090188;GO:0048550;GO:1903573;GO:0090341;GO:0000122;GO:0036151;GO:0032270;GO:0010875;GO:0032376;GO:0045723;GO:0051006;GO:0034145;GO:0045944;GO:0045893;GO:0010867;GO:0042752;GO:0032570;GO:0055092;GO:0006367;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:cholesterol binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sterol response element binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:apoptotic cell clearance; P:cell differentiation; P:cellular response to lipopolysaccharide; P:cholesterol homeostasis; P:intracellular receptor signaling pathway; P:lipid homeostasis; P:negative regulation of cholesterol storage; P:negative regulation of cold-induced thermogenesis; P:negative regulation of inflammatory response; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of lipid transport; P:negative regulation of macrophage activation; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of pancreatic juice secretion; P:negative regulation of pinocytosis; P:negative regulation of response to endoplasmic reticulum stress; P:negative regulation of secretion of lysosomal enzymes; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylcholine acyl-chain remodeling; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol transport; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of lipoprotein lipase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of triglyceride biosynthetic process; P:regulation of circadian rhythm; P:response to progesterone; P:sterol homeostasis; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis; scaffold19 indexed_genome mRNA 1769615 1798591 . + . ID=transcript_4598;P11117 E9PCI1 Q561W5 Q9BTU7,Lysosomal acid phosphatase,, PF00328;, GO:0070062;GO:0016021;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0003993;GO:0016791;GO:0016311;GO:0007040;, C:extracellular exosome; C:integral component of membrane; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane;, F:acid phosphatase activity; F:phosphatase activity;, P:dephosphorylation; P:lysosome organization;|P11117 E9PCI1 Q561W5 Q9BTU7,Lysosomal acid phosphatase,, PF00328;, GO:0070062;GO:0016021;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0003993;GO:0016791;GO:0016311;GO:0007040;, C:extracellular exosome; C:integral component of membrane; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane;, F:acid phosphatase activity; F:phosphatase activity;, P:dephosphorylation; P:lysosome organization;|P11117 E9PCI1 Q561W5 Q9BTU7,Lysosomal acid phosphatase,, PF00328;, GO:0070062;GO:0016021;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0003993;GO:0016791;GO:0016311;GO:0007040;, C:extracellular exosome; C:integral component of membrane; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane;, F:acid phosphatase activity; F:phosphatase activity;, P:dephosphorylation; P:lysosome organization;|P11117 E9PCI1 Q561W5 Q9BTU7,Lysosomal acid phosphatase,, PF00328;, GO:0070062;GO:0016021;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0003993;GO:0016791;GO:0016311;GO:0007040;, C:extracellular exosome; C:integral component of membrane; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane;, F:acid phosphatase activity; F:phosphatase activity;, P:dephosphorylation; P:lysosome organization;|Q92466 B2R875 Q76E54 Q76E55 Q76E56 Q76E57,DNA damage-binding protein 2,DDB p48 subunit;Damage-specific DNA-binding protein 2;UV-damaged DNA-binding protein 2;, PF00400;, GO:0030054;GO:0080008;GO:0031465;GO:0005654;GO:0005634;GO:0032991;GO:0003684;GO:0003677;GO:0044877;GO:0006281;GO:0070911;GO:0035518;GO:0006289;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043687;GO:0051865;GO:0016579;GO:0000209;GO:0006290;GO:0009411;GO:0070914;, C:cell junction; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:damaged DNA binding; F:DNA binding; F:protein-containing complex binding;, P:DNA repair; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:post-translational protein modification; P:protein autoubiquitination; P:protein deubiquitination; P:protein polyubiquitination; P:pyrimidine dimer repair; P:response to UV; P:UV-damage excision repair; scaffold19 indexed_genome mRNA 1817319 1818541 . - . ID=transcript_4599;Q9UKS6 A6NH84 Q9H331 Q9NWV9,Protein kinase C and casein kinase substrate in neurons protein 3,SH3 domain-containing protein 6511;, PF00611;PF14604;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0070062;GO:0005886;GO:0019855;GO:0008092;GO:0042802;GO:0008289;GO:0005543;GO:0007010;GO:0006897;GO:0051926;GO:0045806;GO:0097320;GO:0051044;GO:0030100;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:extracellular exosome; C:plasma membrane;, F:calcium channel inhibitor activity; F:cytoskeletal protein binding; F:identical protein binding; F:lipid binding; F:phospholipid binding;, P:cytoskeleton organization; P:endocytosis; P:negative regulation of calcium ion transport; P:negative regulation of endocytosis; P:plasma membrane tubulation; P:positive regulation of membrane protein ectodomain proteolysis; P:regulation of endocytosis; scaffold19 indexed_genome mRNA 1820427 1821244 . + . ID=transcript_4600;Q9UKS6 A6NH84 Q9H331 Q9NWV9,Protein kinase C and casein kinase substrate in neurons protein 3,SH3 domain-containing protein 6511;, PF00611;PF14604;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0070062;GO:0005886;GO:0019855;GO:0008092;GO:0042802;GO:0008289;GO:0005543;GO:0007010;GO:0006897;GO:0051926;GO:0045806;GO:0097320;GO:0051044;GO:0030100;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:extracellular exosome; C:plasma membrane;, F:calcium channel inhibitor activity; F:cytoskeletal protein binding; F:identical protein binding; F:lipid binding; F:phospholipid binding;, P:cytoskeleton organization; P:endocytosis; P:negative regulation of calcium ion transport; P:negative regulation of endocytosis; P:plasma membrane tubulation; P:positive regulation of membrane protein ectodomain proteolysis; P:regulation of endocytosis; scaffold19 indexed_genome mRNA 1823087 1833520 . + . ID=transcript_4601;Q8N6H7 B4DX29 B7Z9M7 D3DQQ9 Q3LIF2 Q8N3I1 Q96SX7,ADP-ribosylation factor GTPase-activating protein 2,GTPase-activating protein ZNF289;Zinc finger protein 289;, PF01412;, GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0046872;GO:0048205;GO:0006888;GO:0015031;GO:0006890;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q8N6H7 B4DX29 B7Z9M7 D3DQQ9 Q3LIF2 Q8N3I1 Q96SX7,ADP-ribosylation factor GTPase-activating protein 2,GTPase-activating protein ZNF289;Zinc finger protein 289;, PF01412;, GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0046872;GO:0048205;GO:0006888;GO:0015031;GO:0006890;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q8N6H7 B4DX29 B7Z9M7 D3DQQ9 Q3LIF2 Q8N3I1 Q96SX7,ADP-ribosylation factor GTPase-activating protein 2,GTPase-activating protein ZNF289;Zinc finger protein 289;, PF01412;, GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0046872;GO:0048205;GO:0006888;GO:0015031;GO:0006890;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q8N6H7 B4DX29 B7Z9M7 D3DQQ9 Q3LIF2 Q8N3I1 Q96SX7,ADP-ribosylation factor GTPase-activating protein 2,GTPase-activating protein ZNF289;Zinc finger protein 289;, PF01412;, GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0046872;GO:0048205;GO:0006888;GO:0015031;GO:0006890;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q8N6H7 B4DX29 B7Z9M7 D3DQQ9 Q3LIF2 Q8N3I1 Q96SX7,ADP-ribosylation factor GTPase-activating protein 2,GTPase-activating protein ZNF289;Zinc finger protein 289;, PF01412;, GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0046872;GO:0048205;GO:0006888;GO:0015031;GO:0006890;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold19 indexed_genome mRNA 1834867 2041493 . - . ID=transcript_4602;Q9H6J7 D3DQQ8 E9PAX7 Q7L077 Q96CS8 Q9BQH4 Q9BUW5,UPF0705 protein C11orf49 scaffold19 indexed_genome mRNA 2070640 2112291 . + . ID=transcript_4603;O75096 B2RN39 Q4AC85 Q5KTZ5,Low-density lipoprotein receptor-related protein 4,Multiple epidermal growth factor-like domains 7;, PF12662;PF00057;PF00058;, GO:0009986;GO:0030425;GO:0016021;GO:0031594;GO:0043025;GO:0005886;GO:0044853;GO:0014069;GO:0097060;GO:0034185;GO:0005509;GO:0042803;GO:0030971;GO:0097110;GO:0150094;GO:0048813;GO:0009953;GO:0042733;GO:0006897;GO:0001942;GO:0001822;GO:0060173;GO:0050771;GO:0090090;GO:0030279;GO:0042475;GO:0050731;GO:1901631;GO:1904395;GO:0097104;GO:0097105;GO:0009954;GO:0071340;GO:0050808;GO:0051124;GO:0016055;, C:cell surface; C:dendrite; C:integral component of membrane; C:neuromuscular junction; C:neuronal cell body; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:synaptic membrane;, F:apolipoprotein binding; F:calcium ion binding; F:protein homodimerization activity; F:receptor tyrosine kinase binding; F:scaffold protein binding;, P:amyloid-beta clearance by cellular catabolic process; P:dendrite morphogenesis; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:endocytosis; P:hair follicle development; P:kidney development; P:limb development; P:negative regulation of axonogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ossification; P:odontogenesis of dentin-containing tooth; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of presynaptic membrane organization; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; P:postsynaptic membrane assembly; P:presynaptic membrane assembly; P:proximal/distal pattern formation; P:skeletal muscle acetylcholine-gated channel clustering; P:synapse organization; P:synaptic growth at neuromuscular junction; P:Wnt signaling pathway;|O75096 B2RN39 Q4AC85 Q5KTZ5,Low-density lipoprotein receptor-related protein 4,Multiple epidermal growth factor-like domains 7;, PF12662;PF00057;PF00058;, GO:0009986;GO:0030425;GO:0016021;GO:0031594;GO:0043025;GO:0005886;GO:0044853;GO:0014069;GO:0097060;GO:0034185;GO:0005509;GO:0042803;GO:0030971;GO:0097110;GO:0150094;GO:0048813;GO:0009953;GO:0042733;GO:0006897;GO:0001942;GO:0001822;GO:0060173;GO:0050771;GO:0090090;GO:0030279;GO:0042475;GO:0050731;GO:1901631;GO:1904395;GO:0097104;GO:0097105;GO:0009954;GO:0071340;GO:0050808;GO:0051124;GO:0016055;, C:cell surface; C:dendrite; C:integral component of membrane; C:neuromuscular junction; C:neuronal cell body; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:synaptic membrane;, F:apolipoprotein binding; F:calcium ion binding; F:protein homodimerization activity; F:receptor tyrosine kinase binding; F:scaffold protein binding;, P:amyloid-beta clearance by cellular catabolic process; P:dendrite morphogenesis; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:endocytosis; P:hair follicle development; P:kidney development; P:limb development; P:negative regulation of axonogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ossification; P:odontogenesis of dentin-containing tooth; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of presynaptic membrane organization; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; P:postsynaptic membrane assembly; P:presynaptic membrane assembly; P:proximal/distal pattern formation; P:skeletal muscle acetylcholine-gated channel clustering; P:synapse organization; P:synaptic growth at neuromuscular junction; P:Wnt signaling pathway;|O75096 B2RN39 Q4AC85 Q5KTZ5,Low-density lipoprotein receptor-related protein 4,Multiple epidermal growth factor-like domains 7;, PF12662;PF00057;PF00058;, GO:0009986;GO:0030425;GO:0016021;GO:0031594;GO:0043025;GO:0005886;GO:0044853;GO:0014069;GO:0097060;GO:0034185;GO:0005509;GO:0042803;GO:0030971;GO:0097110;GO:0150094;GO:0048813;GO:0009953;GO:0042733;GO:0006897;GO:0001942;GO:0001822;GO:0060173;GO:0050771;GO:0090090;GO:0030279;GO:0042475;GO:0050731;GO:1901631;GO:1904395;GO:0097104;GO:0097105;GO:0009954;GO:0071340;GO:0050808;GO:0051124;GO:0016055;, C:cell surface; C:dendrite; C:integral component of membrane; C:neuromuscular junction; C:neuronal cell body; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:synaptic membrane;, F:apolipoprotein binding; F:calcium ion binding; F:protein homodimerization activity; F:receptor tyrosine kinase binding; F:scaffold protein binding;, P:amyloid-beta clearance by cellular catabolic process; P:dendrite morphogenesis; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:endocytosis; P:hair follicle development; P:kidney development; P:limb development; P:negative regulation of axonogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ossification; P:odontogenesis of dentin-containing tooth; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of presynaptic membrane organization; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; P:postsynaptic membrane assembly; P:presynaptic membrane assembly; P:proximal/distal pattern formation; P:skeletal muscle acetylcholine-gated channel clustering; P:synapse organization; P:synaptic growth at neuromuscular junction; P:Wnt signaling pathway; scaffold19 indexed_genome mRNA 2123597 2222935 . + . ID=transcript_4604;Q14008 Q05D70 Q0VAX7 Q0VAX8 Q14668 Q2TA89 Q6NSH4,Cytoskeleton-associated protein 5,Colonic and hepatic tumor overexpressed gene protein;, PF12348;, GO:0005813;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0016020;GO:0005730;GO:0005886;GO:0032991;GO:0000922;GO:0045296;GO:0008017;GO:0061863;GO:0043021;GO:0051301;GO:0007098;GO:0051298;GO:0097711;GO:0030951;GO:0000086;GO:0007019;GO:0046785;GO:0007052;GO:0090063;GO:0010389;GO:0050658;GO:0007051;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:membrane; C:nucleolus; C:plasma membrane; C:protein-containing complex; C:spindle pole;, F:cadherin binding; F:microtubule binding; F:microtubule plus end polymerase; F:ribonucleoprotein complex binding;, P:cell division; P:centrosome cycle; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:establishment or maintenance of microtubule cytoskeleton polarity; P:G2/M transition of mitotic cell cycle; P:microtubule depolymerization; P:microtubule polymerization; P:mitotic spindle organization; P:positive regulation of microtubule nucleation; P:regulation of G2/M transition of mitotic cell cycle; P:RNA transport; P:spindle organization;|Q14008 Q05D70 Q0VAX7 Q0VAX8 Q14668 Q2TA89 Q6NSH4,Cytoskeleton-associated protein 5,Colonic and hepatic tumor overexpressed gene protein;, PF12348;, GO:0005813;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0016020;GO:0005730;GO:0005886;GO:0032991;GO:0000922;GO:0045296;GO:0008017;GO:0061863;GO:0043021;GO:0051301;GO:0007098;GO:0051298;GO:0097711;GO:0030951;GO:0000086;GO:0007019;GO:0046785;GO:0007052;GO:0090063;GO:0010389;GO:0050658;GO:0007051;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:membrane; C:nucleolus; C:plasma membrane; C:protein-containing complex; C:spindle pole;, F:cadherin binding; F:microtubule binding; F:microtubule plus end polymerase; F:ribonucleoprotein complex binding;, P:cell division; P:centrosome cycle; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:establishment or maintenance of microtubule cytoskeleton polarity; P:G2/M transition of mitotic cell cycle; P:microtubule depolymerization; P:microtubule polymerization; P:mitotic spindle organization; P:positive regulation of microtubule nucleation; P:regulation of G2/M transition of mitotic cell cycle; P:RNA transport; P:spindle organization;|Q14008 Q05D70 Q0VAX7 Q0VAX8 Q14668 Q2TA89 Q6NSH4,Cytoskeleton-associated protein 5,Colonic and hepatic tumor overexpressed gene protein;, PF12348;, GO:0005813;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0016020;GO:0005730;GO:0005886;GO:0032991;GO:0000922;GO:0045296;GO:0008017;GO:0061863;GO:0043021;GO:0051301;GO:0007098;GO:0051298;GO:0097711;GO:0030951;GO:0000086;GO:0007019;GO:0046785;GO:0007052;GO:0090063;GO:0010389;GO:0050658;GO:0007051;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:membrane; C:nucleolus; C:plasma membrane; C:protein-containing complex; C:spindle pole;, F:cadherin binding; F:microtubule binding; F:microtubule plus end polymerase; F:ribonucleoprotein complex binding;, P:cell division; P:centrosome cycle; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:establishment or maintenance of microtubule cytoskeleton polarity; P:G2/M transition of mitotic cell cycle; P:microtubule depolymerization; P:microtubule polymerization; P:mitotic spindle organization; P:positive regulation of microtubule nucleation; P:regulation of G2/M transition of mitotic cell cycle; P:RNA transport; P:spindle organization;|Q14008 Q05D70 Q0VAX7 Q0VAX8 Q14668 Q2TA89 Q6NSH4,Cytoskeleton-associated protein 5,Colonic and hepatic tumor overexpressed gene protein;, PF12348;, GO:0005813;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0016020;GO:0005730;GO:0005886;GO:0032991;GO:0000922;GO:0045296;GO:0008017;GO:0061863;GO:0043021;GO:0051301;GO:0007098;GO:0051298;GO:0097711;GO:0030951;GO:0000086;GO:0007019;GO:0046785;GO:0007052;GO:0090063;GO:0010389;GO:0050658;GO:0007051;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:membrane; C:nucleolus; C:plasma membrane; C:protein-containing complex; C:spindle pole;, F:cadherin binding; F:microtubule binding; F:microtubule plus end polymerase; F:ribonucleoprotein complex binding;, P:cell division; P:centrosome cycle; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:establishment or maintenance of microtubule cytoskeleton polarity; P:G2/M transition of mitotic cell cycle; P:microtubule depolymerization; P:microtubule polymerization; P:mitotic spindle organization; P:positive regulation of microtubule nucleation; P:regulation of G2/M transition of mitotic cell cycle; P:RNA transport; P:spindle organization;|Q14008 Q05D70 Q0VAX7 Q0VAX8 Q14668 Q2TA89 Q6NSH4,Cytoskeleton-associated protein 5,Colonic and hepatic tumor overexpressed gene protein;, PF12348;, GO:0005813;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0016020;GO:0005730;GO:0005886;GO:0032991;GO:0000922;GO:0045296;GO:0008017;GO:0061863;GO:0043021;GO:0051301;GO:0007098;GO:0051298;GO:0097711;GO:0030951;GO:0000086;GO:0007019;GO:0046785;GO:0007052;GO:0090063;GO:0010389;GO:0050658;GO:0007051;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:membrane; C:nucleolus; C:plasma membrane; C:protein-containing complex; C:spindle pole;, F:cadherin binding; F:microtubule binding; F:microtubule plus end polymerase; F:ribonucleoprotein complex binding;, P:cell division; P:centrosome cycle; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:establishment or maintenance of microtubule cytoskeleton polarity; P:G2/M transition of mitotic cell cycle; P:microtubule depolymerization; P:microtubule polymerization; P:mitotic spindle organization; P:positive regulation of microtubule nucleation; P:regulation of G2/M transition of mitotic cell cycle; P:RNA transport; P:spindle organization;|Q14008 Q05D70 Q0VAX7 Q0VAX8 Q14668 Q2TA89 Q6NSH4,Cytoskeleton-associated protein 5,Colonic and hepatic tumor overexpressed gene protein;, PF12348;, GO:0005813;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0016020;GO:0005730;GO:0005886;GO:0032991;GO:0000922;GO:0045296;GO:0008017;GO:0061863;GO:0043021;GO:0051301;GO:0007098;GO:0051298;GO:0097711;GO:0030951;GO:0000086;GO:0007019;GO:0046785;GO:0007052;GO:0090063;GO:0010389;GO:0050658;GO:0007051;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:membrane; C:nucleolus; C:plasma membrane; C:protein-containing complex; C:spindle pole;, F:cadherin binding; F:microtubule binding; F:microtubule plus end polymerase; F:ribonucleoprotein complex binding;, P:cell division; P:centrosome cycle; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:establishment or maintenance of microtubule cytoskeleton polarity; P:G2/M transition of mitotic cell cycle; P:microtubule depolymerization; P:microtubule polymerization; P:mitotic spindle organization; P:positive regulation of microtubule nucleation; P:regulation of G2/M transition of mitotic cell cycle; P:RNA transport; P:spindle organization;|Q14008 Q05D70 Q0VAX7 Q0VAX8 Q14668 Q2TA89 Q6NSH4,Cytoskeleton-associated protein 5,Colonic and hepatic tumor overexpressed gene protein;, PF12348;, GO:0005813;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0016020;GO:0005730;GO:0005886;GO:0032991;GO:0000922;GO:0045296;GO:0008017;GO:0061863;GO:0043021;GO:0051301;GO:0007098;GO:0051298;GO:0097711;GO:0030951;GO:0000086;GO:0007019;GO:0046785;GO:0007052;GO:0090063;GO:0010389;GO:0050658;GO:0007051;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:membrane; C:nucleolus; C:plasma membrane; C:protein-containing complex; C:spindle pole;, F:cadherin binding; F:microtubule binding; F:microtubule plus end polymerase; F:ribonucleoprotein complex binding;, P:cell division; P:centrosome cycle; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:establishment or maintenance of microtubule cytoskeleton polarity; P:G2/M transition of mitotic cell cycle; P:microtubule depolymerization; P:microtubule polymerization; P:mitotic spindle organization; P:positive regulation of microtubule nucleation; P:regulation of G2/M transition of mitotic cell cycle; P:RNA transport; P:spindle organization;|Q14008 Q05D70 Q0VAX7 Q0VAX8 Q14668 Q2TA89 Q6NSH4,Cytoskeleton-associated protein 5,Colonic and hepatic tumor overexpressed gene protein;, PF12348;, GO:0005813;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0016020;GO:0005730;GO:0005886;GO:0032991;GO:0000922;GO:0045296;GO:0008017;GO:0061863;GO:0043021;GO:0051301;GO:0007098;GO:0051298;GO:0097711;GO:0030951;GO:0000086;GO:0007019;GO:0046785;GO:0007052;GO:0090063;GO:0010389;GO:0050658;GO:0007051;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:membrane; C:nucleolus; C:plasma membrane; C:protein-containing complex; C:spindle pole;, F:cadherin binding; F:microtubule binding; F:microtubule plus end polymerase; F:ribonucleoprotein complex binding;, P:cell division; P:centrosome cycle; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:establishment or maintenance of microtubule cytoskeleton polarity; P:G2/M transition of mitotic cell cycle; P:microtubule depolymerization; P:microtubule polymerization; P:mitotic spindle organization; P:positive regulation of microtubule nucleation; P:regulation of G2/M transition of mitotic cell cycle; P:RNA transport; P:spindle organization; scaffold19 indexed_genome mRNA 2226198 2240262 . - . ID=transcript_4605;P00734 B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1,Prothrombin,Coagulation factor II;, PF00594;PF00051;PF09396;PF00089;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0005509;GO:0008047;GO:0008083;GO:0008201;GO:0001530;GO:0004252;GO:0005102;GO:0070053;GO:0006953;GO:0061844;GO:0007596;GO:0007597;GO:0007166;GO:0044267;GO:0051838;GO:0006888;GO:0042730;GO:0007186;GO:0050900;GO:0007275;GO:0048712;GO:1900016;GO:0051918;GO:0010544;GO:0045861;GO:0070945;GO:0030168;GO:0030194;GO:0030307;GO:0008284;GO:0032967;GO:0090218;GO:0014068;GO:1900738;GO:1900182;GO:0001934;GO:2000379;GO:0046427;GO:0051281;GO:0006508;GO:0030193;GO:0008360;GO:0030449;GO:0051480;GO:0009611;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane;, F:calcium ion binding; F:enzyme activator activity; F:growth factor activity; F:heparin binding; F:lipopolysaccharide binding; F:serine-type endopeptidase activity; F:signaling receptor binding; F:thrombospondin receptor activity;, P:acute-phase response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell surface receptor signaling pathway; P:cellular protein metabolic process; P:cytolysis by host of symbiont cells; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fibrinolysis; P:G protein-coupled receptor signaling pathway; P:leukocyte migration; P:multicellular organism development; P:negative regulation of astrocyte differentiation; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fibrinolysis; P:negative regulation of platelet activation; P:negative regulation of proteolysis; P:neutrophil-mediated killing of gram-negative bacterium; P:platelet activation; P:positive regulation of blood coagulation; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of lipid kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of release of sequestered calcium ion into cytosol; P:proteolysis; P:regulation of blood coagulation; P:regulation of cell shape; P:regulation of complement activation; P:regulation of cytosolic calcium ion concentration; P:response to wounding;|P00734 B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1,Prothrombin,Coagulation factor II;, PF00594;PF00051;PF09396;PF00089;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0005509;GO:0008047;GO:0008083;GO:0008201;GO:0001530;GO:0004252;GO:0005102;GO:0070053;GO:0006953;GO:0061844;GO:0007596;GO:0007597;GO:0007166;GO:0044267;GO:0051838;GO:0006888;GO:0042730;GO:0007186;GO:0050900;GO:0007275;GO:0048712;GO:1900016;GO:0051918;GO:0010544;GO:0045861;GO:0070945;GO:0030168;GO:0030194;GO:0030307;GO:0008284;GO:0032967;GO:0090218;GO:0014068;GO:1900738;GO:1900182;GO:0001934;GO:2000379;GO:0046427;GO:0051281;GO:0006508;GO:0030193;GO:0008360;GO:0030449;GO:0051480;GO:0009611;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane;, F:calcium ion binding; F:enzyme activator activity; F:growth factor activity; F:heparin binding; F:lipopolysaccharide binding; F:serine-type endopeptidase activity; F:signaling receptor binding; F:thrombospondin receptor activity;, P:acute-phase response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell surface receptor signaling pathway; P:cellular protein metabolic process; P:cytolysis by host of symbiont cells; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fibrinolysis; P:G protein-coupled receptor signaling pathway; P:leukocyte migration; P:multicellular organism development; P:negative regulation of astrocyte differentiation; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fibrinolysis; P:negative regulation of platelet activation; P:negative regulation of proteolysis; P:neutrophil-mediated killing of gram-negative bacterium; P:platelet activation; P:positive regulation of blood coagulation; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of lipid kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of release of sequestered calcium ion into cytosol; P:proteolysis; P:regulation of blood coagulation; P:regulation of cell shape; P:regulation of complement activation; P:regulation of cytosolic calcium ion concentration; P:response to wounding;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|P00734 B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1,Prothrombin,Coagulation factor II;, PF00594;PF00051;PF09396;PF00089;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0005509;GO:0008047;GO:0008083;GO:0008201;GO:0001530;GO:0004252;GO:0005102;GO:0070053;GO:0006953;GO:0061844;GO:0007596;GO:0007597;GO:0007166;GO:0044267;GO:0051838;GO:0006888;GO:0042730;GO:0007186;GO:0050900;GO:0007275;GO:0048712;GO:1900016;GO:0051918;GO:0010544;GO:0045861;GO:0070945;GO:0030168;GO:0030194;GO:0030307;GO:0008284;GO:0032967;GO:0090218;GO:0014068;GO:1900738;GO:1900182;GO:0001934;GO:2000379;GO:0046427;GO:0051281;GO:0006508;GO:0030193;GO:0008360;GO:0030449;GO:0051480;GO:0009611;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane;, F:calcium ion binding; F:enzyme activator activity; F:growth factor activity; F:heparin binding; F:lipopolysaccharide binding; F:serine-type endopeptidase activity; F:signaling receptor binding; F:thrombospondin receptor activity;, P:acute-phase response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell surface receptor signaling pathway; P:cellular protein metabolic process; P:cytolysis by host of symbiont cells; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fibrinolysis; P:G protein-coupled receptor signaling pathway; P:leukocyte migration; P:multicellular organism development; P:negative regulation of astrocyte differentiation; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fibrinolysis; P:negative regulation of platelet activation; P:negative regulation of proteolysis; P:neutrophil-mediated killing of gram-negative bacterium; P:platelet activation; P:positive regulation of blood coagulation; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of lipid kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of release of sequestered calcium ion into cytosol; P:proteolysis; P:regulation of blood coagulation; P:regulation of cell shape; P:regulation of complement activation; P:regulation of cytosolic calcium ion concentration; P:response to wounding;|P00734 B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1,Prothrombin,Coagulation factor II;, PF00594;PF00051;PF09396;PF00089;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0005509;GO:0008047;GO:0008083;GO:0008201;GO:0001530;GO:0004252;GO:0005102;GO:0070053;GO:0006953;GO:0061844;GO:0007596;GO:0007597;GO:0007166;GO:0044267;GO:0051838;GO:0006888;GO:0042730;GO:0007186;GO:0050900;GO:0007275;GO:0048712;GO:1900016;GO:0051918;GO:0010544;GO:0045861;GO:0070945;GO:0030168;GO:0030194;GO:0030307;GO:0008284;GO:0032967;GO:0090218;GO:0014068;GO:1900738;GO:1900182;GO:0001934;GO:2000379;GO:0046427;GO:0051281;GO:0006508;GO:0030193;GO:0008360;GO:0030449;GO:0051480;GO:0009611;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane;, F:calcium ion binding; F:enzyme activator activity; F:growth factor activity; F:heparin binding; F:lipopolysaccharide binding; F:serine-type endopeptidase activity; F:signaling receptor binding; F:thrombospondin receptor activity;, P:acute-phase response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell surface receptor signaling pathway; P:cellular protein metabolic process; P:cytolysis by host of symbiont cells; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fibrinolysis; P:G protein-coupled receptor signaling pathway; P:leukocyte migration; P:multicellular organism development; P:negative regulation of astrocyte differentiation; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fibrinolysis; P:negative regulation of platelet activation; P:negative regulation of proteolysis; P:neutrophil-mediated killing of gram-negative bacterium; P:platelet activation; P:positive regulation of blood coagulation; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of lipid kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of release of sequestered calcium ion into cytosol; P:proteolysis; P:regulation of blood coagulation; P:regulation of cell shape; P:regulation of complement activation; P:regulation of cytosolic calcium ion concentration; P:response to wounding;|P00734 B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1,Prothrombin,Coagulation factor II;, PF00594;PF00051;PF09396;PF00089;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0005509;GO:0008047;GO:0008083;GO:0008201;GO:0001530;GO:0004252;GO:0005102;GO:0070053;GO:0006953;GO:0061844;GO:0007596;GO:0007597;GO:0007166;GO:0044267;GO:0051838;GO:0006888;GO:0042730;GO:0007186;GO:0050900;GO:0007275;GO:0048712;GO:1900016;GO:0051918;GO:0010544;GO:0045861;GO:0070945;GO:0030168;GO:0030194;GO:0030307;GO:0008284;GO:0032967;GO:0090218;GO:0014068;GO:1900738;GO:1900182;GO:0001934;GO:2000379;GO:0046427;GO:0051281;GO:0006508;GO:0030193;GO:0008360;GO:0030449;GO:0051480;GO:0009611;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane;, F:calcium ion binding; F:enzyme activator activity; F:growth factor activity; F:heparin binding; F:lipopolysaccharide binding; F:serine-type endopeptidase activity; F:signaling receptor binding; F:thrombospondin receptor activity;, P:acute-phase response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell surface receptor signaling pathway; P:cellular protein metabolic process; P:cytolysis by host of symbiont cells; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fibrinolysis; P:G protein-coupled receptor signaling pathway; P:leukocyte migration; P:multicellular organism development; P:negative regulation of astrocyte differentiation; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of fibrinolysis; P:negative regulation of platelet activation; P:negative regulation of proteolysis; P:neutrophil-mediated killing of gram-negative bacterium; P:platelet activation; P:positive regulation of blood coagulation; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of lipid kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of release of sequestered calcium ion into cytosol; P:proteolysis; P:regulation of blood coagulation; P:regulation of cell shape; P:regulation of complement activation; P:regulation of cytosolic calcium ion concentration; P:response to wounding; scaffold19 indexed_genome mRNA 2242587 2243248 . + . ID=transcript_4606;Q9UC61,Peptidyl-prolyl cis-trans isomerase A,Cyclophilin A;Cyclosporin A-binding protein;Rotamase A;, PF00160;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0043231;GO:0016020;GO:0005634;GO:0032991;GO:0034774;GO:0031982;GO:0016018;GO:1904399;GO:0005178;GO:0003755;GO:0003723;GO:0051082;GO:0046790;GO:0000187;GO:0032148;GO:0006915;GO:0060352;GO:0034599;GO:0042118;GO:0044409;GO:0075713;GO:0019064;GO:0035722;GO:0030595;GO:0050900;GO:0034389;GO:1902176;GO:0061944;GO:0006469;GO:0001933;GO:0032873;GO:1903901;GO:0030593;GO:0043312;GO:0030168;GO:0070527;GO:0051092;GO:0035307;GO:0001934;GO:0050714;GO:0045070;GO:0006457;GO:0000413;GO:2001233;GO:0045069;GO:0006278;GO:0019061;GO:0019058;GO:0019076;GO:0019068;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:protein-containing complex; C:secretory granule lumen; C:vesicle;, F:cyclosporin A binding; F:heparan sulfate binding; F:integrin binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding; F:unfolded protein binding; F:virion binding;, P:activation of MAPK activity; P:activation of protein kinase B activity; P:apoptotic process; P:cell adhesion molecule production; P:cellular response to oxidative stress; P:endothelial cell activation; P:entry into host; P:establishment of integrated proviral latency; P:fusion of virus membrane with host plasma membrane; P:interleukin-12-mediated signaling pathway; P:leukocyte chemotaxis; P:leukocyte migration; P:lipid droplet organization; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein K48-linked ubiquitination; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of viral life cycle; P:neutrophil chemotaxis; P:neutrophil degranulation; P:platelet activation; P:platelet aggregation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein dephosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein secretion; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of apoptotic signaling pathway; P:regulation of viral genome replication; P:RNA-dependent DNA biosynthetic process; P:uncoating of virus; P:viral life cycle; P:viral release from host cell; P:virion assembly; scaffold19 indexed_genome mRNA 2256131 2258753 . - . ID=transcript_4607;Q9H9D4,Zinc finger protein 408,PR domain zinc finger protein 17;, PF00096;, GO:0005634;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold19 indexed_genome mRNA 2259830 2279081 . + . ID=transcript_4608;Q07960 D3DQQ6,Rho GTPase-activating protein 1,CDC42 GTPase-activating protein;GTPase-activating protein rhoGAP;Rho-related small GTPase protein activator;Rho-type GTPase-activating protein 1;p50-RhoGAP;, PF13716;PF00620;, GO:0005737;GO:0005829;GO:0010008;GO:0070062;GO:0048471;GO:0045296;GO:0005096;GO:0017124;GO:0031267;GO:0016197;GO:2001136;GO:0051056;GO:0007266;GO:0007264;GO:0033572;, C:cytoplasm; C:cytosol; C:endosome membrane; C:extracellular exosome; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:SH3 domain binding; F:small GTPase binding;, P:endosomal transport; P:negative regulation of endocytic recycling; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:small GTPase mediated signal transduction; P:transferrin transport;|Q07960 D3DQQ6,Rho GTPase-activating protein 1,CDC42 GTPase-activating protein;GTPase-activating protein rhoGAP;Rho-related small GTPase protein activator;Rho-type GTPase-activating protein 1;p50-RhoGAP;, PF13716;PF00620;, GO:0005737;GO:0005829;GO:0010008;GO:0070062;GO:0048471;GO:0045296;GO:0005096;GO:0017124;GO:0031267;GO:0016197;GO:2001136;GO:0051056;GO:0007266;GO:0007264;GO:0033572;, C:cytoplasm; C:cytosol; C:endosome membrane; C:extracellular exosome; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:SH3 domain binding; F:small GTPase binding;, P:endosomal transport; P:negative regulation of endocytic recycling; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:small GTPase mediated signal transduction; P:transferrin transport;|Q07960 D3DQQ6,Rho GTPase-activating protein 1,CDC42 GTPase-activating protein;GTPase-activating protein rhoGAP;Rho-related small GTPase protein activator;Rho-type GTPase-activating protein 1;p50-RhoGAP;, PF13716;PF00620;, GO:0005737;GO:0005829;GO:0010008;GO:0070062;GO:0048471;GO:0045296;GO:0005096;GO:0017124;GO:0031267;GO:0016197;GO:2001136;GO:0051056;GO:0007266;GO:0007264;GO:0033572;, C:cytoplasm; C:cytosol; C:endosome membrane; C:extracellular exosome; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:SH3 domain binding; F:small GTPase binding;, P:endosomal transport; P:negative regulation of endocytic recycling; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:small GTPase mediated signal transduction; P:transferrin transport;|Q07960 D3DQQ6,Rho GTPase-activating protein 1,CDC42 GTPase-activating protein;GTPase-activating protein rhoGAP;Rho-related small GTPase protein activator;Rho-type GTPase-activating protein 1;p50-RhoGAP;, PF13716;PF00620;, GO:0005737;GO:0005829;GO:0010008;GO:0070062;GO:0048471;GO:0045296;GO:0005096;GO:0017124;GO:0031267;GO:0016197;GO:2001136;GO:0051056;GO:0007266;GO:0007264;GO:0033572;, C:cytoplasm; C:cytosol; C:endosome membrane; C:extracellular exosome; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:SH3 domain binding; F:small GTPase binding;, P:endosomal transport; P:negative regulation of endocytic recycling; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:small GTPase mediated signal transduction; P:transferrin transport; scaffold19 indexed_genome mRNA 2281943 2328862 . - . ID=transcript_4609;O75143 B4DFI4 D3DQQ1 D3DQQ2 E9PQZ8 Q53EN6 Q9BRL3 Q9H8B0,Autophagy-related protein 13,, PF10033;, GO:1990316;GO:0005829;GO:0005789;GO:0019898;GO:0005739;GO:0000407;GO:0019901;GO:0000045;GO:0016236;GO:0000423;GO:0034727;GO:1903955;GO:0034497;GO:0016241;GO:0098780;, C:Atg1/ULK1 kinase complex; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:mitochondrion; C:phagophore assembly site;, F:protein kinase binding;, P:autophagosome assembly; P:macroautophagy; P:mitophagy; P:piecemeal microautophagy of the nucleus; P:positive regulation of protein targeting to mitochondrion; P:protein localization to phagophore assembly site; P:regulation of macroautophagy; P:response to mitochondrial depolarisation;|O75143 B4DFI4 D3DQQ1 D3DQQ2 E9PQZ8 Q53EN6 Q9BRL3 Q9H8B0,Autophagy-related protein 13,, PF10033;, GO:1990316;GO:0005829;GO:0005789;GO:0019898;GO:0005739;GO:0000407;GO:0019901;GO:0000045;GO:0016236;GO:0000423;GO:0034727;GO:1903955;GO:0034497;GO:0016241;GO:0098780;, C:Atg1/ULK1 kinase complex; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:mitochondrion; C:phagophore assembly site;, F:protein kinase binding;, P:autophagosome assembly; P:macroautophagy; P:mitophagy; P:piecemeal microautophagy of the nucleus; P:positive regulation of protein targeting to mitochondrion; P:protein localization to phagophore assembly site; P:regulation of macroautophagy; P:response to mitochondrial depolarisation;|O75143 B4DFI4 D3DQQ1 D3DQQ2 E9PQZ8 Q53EN6 Q9BRL3 Q9H8B0,Autophagy-related protein 13,, PF10033;, GO:1990316;GO:0005829;GO:0005789;GO:0019898;GO:0005739;GO:0000407;GO:0019901;GO:0000045;GO:0016236;GO:0000423;GO:0034727;GO:1903955;GO:0034497;GO:0016241;GO:0098780;, C:Atg1/ULK1 kinase complex; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:mitochondrion; C:phagophore assembly site;, F:protein kinase binding;, P:autophagosome assembly; P:macroautophagy; P:mitophagy; P:piecemeal microautophagy of the nucleus; P:positive regulation of protein targeting to mitochondrion; P:protein localization to phagophore assembly site; P:regulation of macroautophagy; P:response to mitochondrial depolarisation;|O75143 B4DFI4 D3DQQ1 D3DQQ2 E9PQZ8 Q53EN6 Q9BRL3 Q9H8B0,Autophagy-related protein 13,, PF10033;, GO:1990316;GO:0005829;GO:0005789;GO:0019898;GO:0005739;GO:0000407;GO:0019901;GO:0000045;GO:0016236;GO:0000423;GO:0034727;GO:1903955;GO:0034497;GO:0016241;GO:0098780;, C:Atg1/ULK1 kinase complex; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:mitochondrion; C:phagophore assembly site;, F:protein kinase binding;, P:autophagosome assembly; P:macroautophagy; P:mitophagy; P:piecemeal microautophagy of the nucleus; P:positive regulation of protein targeting to mitochondrion; P:protein localization to phagophore assembly site; P:regulation of macroautophagy; P:response to mitochondrial depolarisation;|O75143 B4DFI4 D3DQQ1 D3DQQ2 E9PQZ8 Q53EN6 Q9BRL3 Q9H8B0,Autophagy-related protein 13,, PF10033;, GO:1990316;GO:0005829;GO:0005789;GO:0019898;GO:0005739;GO:0000407;GO:0019901;GO:0000045;GO:0016236;GO:0000423;GO:0034727;GO:1903955;GO:0034497;GO:0016241;GO:0098780;, C:Atg1/ULK1 kinase complex; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:mitochondrion; C:phagophore assembly site;, F:protein kinase binding;, P:autophagosome assembly; P:macroautophagy; P:mitophagy; P:piecemeal microautophagy of the nucleus; P:positive regulation of protein targeting to mitochondrion; P:protein localization to phagophore assembly site; P:regulation of macroautophagy; P:response to mitochondrial depolarisation; scaffold19 indexed_genome mRNA 2329187 2338989 . + . ID=transcript_4610;Q96MB7 D3DQP9,Putative nuclease HARBI1,Harbinger transposase-derived nuclease;, PF13359;, GO:0034451;GO:0005829;GO:0005634;GO:0005886;GO:0046872;GO:0004518;, C:centriolar satellite; C:cytosol; C:nucleus; C:plasma membrane;, F:metal ion binding; F:nuclease activity; scaffold19 indexed_genome mRNA 2372862 2507970 . + . ID=transcript_4611;Q9C0C7 A6XN33 D3DQP8 G3V193 Q86XD6 Q9H8Z0 Q9NXE7,Activating molecule in BECN1-regulated autophagy protein 1,, , GO:0005776;GO:0005930;GO:0005737;GO:0005829;GO:0043231;GO:0005741;GO:0005739;GO:0048471;GO:0045335;GO:0051020;GO:0031625;GO:0000045;GO:0006914;GO:0000422;GO:0030154;GO:0009267;GO:0016236;GO:0000423;GO:0010667;GO:0008285;GO:0043524;GO:0021915;GO:0010508;GO:0043552;GO:0098780;, C:autophagosome; C:axoneme; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:phagocytic vesicle;, F:GTPase binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:cell differentiation; P:cellular response to starvation; P:macroautophagy; P:mitophagy; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of neuron apoptotic process; P:neural tube development; P:positive regulation of autophagy; P:positive regulation of phosphatidylinositol 3-kinase activity; P:response to mitochondrial depolarisation;|Q9C0C7 A6XN33 D3DQP8 G3V193 Q86XD6 Q9H8Z0 Q9NXE7,Activating molecule in BECN1-regulated autophagy protein 1,, , GO:0005776;GO:0005930;GO:0005737;GO:0005829;GO:0043231;GO:0005741;GO:0005739;GO:0048471;GO:0045335;GO:0051020;GO:0031625;GO:0000045;GO:0006914;GO:0000422;GO:0030154;GO:0009267;GO:0016236;GO:0000423;GO:0010667;GO:0008285;GO:0043524;GO:0021915;GO:0010508;GO:0043552;GO:0098780;, C:autophagosome; C:axoneme; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:phagocytic vesicle;, F:GTPase binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:cell differentiation; P:cellular response to starvation; P:macroautophagy; P:mitophagy; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of neuron apoptotic process; P:neural tube development; P:positive regulation of autophagy; P:positive regulation of phosphatidylinositol 3-kinase activity; P:response to mitochondrial depolarisation; scaffold19 indexed_genome mRNA 2519824 2536494 . - . ID=transcript_4612;Q8IVW9,Diacylglycerol kinase zeta {ECO:0000303|PubMed:8626588},Diglyceride kinase zeta;, PF12796;PF00130;PF00609;PF00781;, GO:0005737;GO:0005829;GO:0098978;GO:0030027;GO:0016607;GO:0005634;GO:0005886;GO:0014069;GO:0005524;GO:0004143;GO:0016301;GO:0001727;GO:0046872;GO:0003951;GO:0008022;GO:0016477;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0031571;GO:0045930;GO:0050860;GO:0006654;GO:0030168;GO:0090216;GO:0007205;GO:0051966;, C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:lamellipodium; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:ATP binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid kinase activity; F:metal ion binding; F:NAD+ kinase activity; F:protein C-terminus binding;, P:cell migration; P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:mitotic G1 DNA damage checkpoint; P:negative regulation of mitotic cell cycle; P:negative regulation of T cell receptor signaling pathway; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, glutamatergic;|Q8IVW9,Diacylglycerol kinase zeta {ECO:0000303|PubMed:8626588},Diglyceride kinase zeta;, PF12796;PF00130;PF00609;PF00781;, GO:0005737;GO:0005829;GO:0098978;GO:0030027;GO:0016607;GO:0005634;GO:0005886;GO:0014069;GO:0005524;GO:0004143;GO:0016301;GO:0001727;GO:0046872;GO:0003951;GO:0008022;GO:0016477;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0031571;GO:0045930;GO:0050860;GO:0006654;GO:0030168;GO:0090216;GO:0007205;GO:0051966;, C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:lamellipodium; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:ATP binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid kinase activity; F:metal ion binding; F:NAD+ kinase activity; F:protein C-terminus binding;, P:cell migration; P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:mitotic G1 DNA damage checkpoint; P:negative regulation of mitotic cell cycle; P:negative regulation of T cell receptor signaling pathway; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, glutamatergic;|Q8IVW9,Diacylglycerol kinase zeta {ECO:0000303|PubMed:8626588},Diglyceride kinase zeta;, PF12796;PF00130;PF00609;PF00781;, GO:0005737;GO:0005829;GO:0098978;GO:0030027;GO:0016607;GO:0005634;GO:0005886;GO:0014069;GO:0005524;GO:0004143;GO:0016301;GO:0001727;GO:0046872;GO:0003951;GO:0008022;GO:0016477;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0031571;GO:0045930;GO:0050860;GO:0006654;GO:0030168;GO:0090216;GO:0007205;GO:0051966;, C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:lamellipodium; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:ATP binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid kinase activity; F:metal ion binding; F:NAD+ kinase activity; F:protein C-terminus binding;, P:cell migration; P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:mitotic G1 DNA damage checkpoint; P:negative regulation of mitotic cell cycle; P:negative regulation of T cell receptor signaling pathway; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, glutamatergic;|Q8IVW9,Diacylglycerol kinase zeta {ECO:0000303|PubMed:8626588},Diglyceride kinase zeta;, PF12796;PF00130;PF00609;PF00781;, GO:0005737;GO:0005829;GO:0098978;GO:0030027;GO:0016607;GO:0005634;GO:0005886;GO:0014069;GO:0005524;GO:0004143;GO:0016301;GO:0001727;GO:0046872;GO:0003951;GO:0008022;GO:0016477;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0031571;GO:0045930;GO:0050860;GO:0006654;GO:0030168;GO:0090216;GO:0007205;GO:0051966;, C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:lamellipodium; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:ATP binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid kinase activity; F:metal ion binding; F:NAD+ kinase activity; F:protein C-terminus binding;, P:cell migration; P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:mitotic G1 DNA damage checkpoint; P:negative regulation of mitotic cell cycle; P:negative regulation of T cell receptor signaling pathway; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, glutamatergic;|Q8IVW9,Diacylglycerol kinase zeta {ECO:0000303|PubMed:8626588},Diglyceride kinase zeta;, PF12796;PF00130;PF00609;PF00781;, GO:0005737;GO:0005829;GO:0098978;GO:0030027;GO:0016607;GO:0005634;GO:0005886;GO:0014069;GO:0005524;GO:0004143;GO:0016301;GO:0001727;GO:0046872;GO:0003951;GO:0008022;GO:0016477;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0031571;GO:0045930;GO:0050860;GO:0006654;GO:0030168;GO:0090216;GO:0007205;GO:0051966;, C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:lamellipodium; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:ATP binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid kinase activity; F:metal ion binding; F:NAD+ kinase activity; F:protein C-terminus binding;, P:cell migration; P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:mitotic G1 DNA damage checkpoint; P:negative regulation of mitotic cell cycle; P:negative regulation of T cell receptor signaling pathway; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, glutamatergic; scaffold19 indexed_genome mRNA 2595004 2596009 . - . ID=transcript_4613;Q96BA8 Q8N2D5 Q96CP0,Cyclic AMP-responsive element-binding protein 3-like protein 1,Old astrocyte specifically-induced substance;, PF00170;, GO:0000785;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005634;GO:0035497;GO:0003682;GO:0001228;GO:0000981;GO:0001227;GO:1990837;GO:0046332;GO:0000976;GO:0030968;GO:0070278;GO:0007275;GO:1902236;GO:0040037;GO:0010629;GO:1903671;GO:0045892;GO:0001649;GO:0032967;GO:1990440;GO:0006357;GO:0016032;, C:chromatin; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleus;, F:cAMP response element binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding; F:SMAD binding; F:transcription regulatory region sequence-specific DNA binding;, P:endoplasmic reticulum unfolded protein response; P:extracellular matrix constituent secretion; P:multicellular organism development; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of gene expression; P:negative regulation of sprouting angiogenesis; P:negative regulation of transcription, DNA-templated; P:osteoblast differentiation; P:positive regulation of collagen biosynthetic process; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II; P:viral process; scaffold19 indexed_genome mRNA 2784684 2953618 . + . ID=transcript_4614;Q96BD5 D3DQP5 Q6AWA2 Q9C0G7 Q9H8V9 Q9HAK6 Q9NZE9,PHD finger protein 21A,BHC80a;BRAF35-HDAC complex protein BHC80;, PF00628;, GO:1990391;GO:0000118;GO:0005654;GO:0003682;GO:0003677;GO:0046872;GO:0007596;GO:0006325;GO:0000122;, C:DNA repair complex; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin binding; F:DNA binding; F:metal ion binding;, P:blood coagulation; P:chromatin organization; P:negative regulation of transcription by RNA polymerase II;|Q96BD5 D3DQP5 Q6AWA2 Q9C0G7 Q9H8V9 Q9HAK6 Q9NZE9,PHD finger protein 21A,BHC80a;BRAF35-HDAC complex protein BHC80;, PF00628;, GO:1990391;GO:0000118;GO:0005654;GO:0003682;GO:0003677;GO:0046872;GO:0007596;GO:0006325;GO:0000122;, C:DNA repair complex; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin binding; F:DNA binding; F:metal ion binding;, P:blood coagulation; P:chromatin organization; P:negative regulation of transcription by RNA polymerase II;|Q96BD5 D3DQP5 Q6AWA2 Q9C0G7 Q9H8V9 Q9HAK6 Q9NZE9,PHD finger protein 21A,BHC80a;BRAF35-HDAC complex protein BHC80;, PF00628;, GO:1990391;GO:0000118;GO:0005654;GO:0003682;GO:0003677;GO:0046872;GO:0007596;GO:0006325;GO:0000122;, C:DNA repair complex; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin binding; F:DNA binding; F:metal ion binding;, P:blood coagulation; P:chromatin organization; P:negative regulation of transcription by RNA polymerase II; scaffold19 indexed_genome mRNA 2953623 2963964 . + . ID=transcript_4615;Q96BD5 D3DQP5 Q6AWA2 Q9C0G7 Q9H8V9 Q9HAK6 Q9NZE9,PHD finger protein 21A,BHC80a;BRAF35-HDAC complex protein BHC80;, PF00628;, GO:1990391;GO:0000118;GO:0005654;GO:0003682;GO:0003677;GO:0046872;GO:0007596;GO:0006325;GO:0000122;, C:DNA repair complex; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin binding; F:DNA binding; F:metal ion binding;, P:blood coagulation; P:chromatin organization; P:negative regulation of transcription by RNA polymerase II;|Q96BD5 D3DQP5 Q6AWA2 Q9C0G7 Q9H8V9 Q9HAK6 Q9NZE9,PHD finger protein 21A,BHC80a;BRAF35-HDAC complex protein BHC80;, PF00628;, GO:1990391;GO:0000118;GO:0005654;GO:0003682;GO:0003677;GO:0046872;GO:0007596;GO:0006325;GO:0000122;, C:DNA repair complex; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin binding; F:DNA binding; F:metal ion binding;, P:blood coagulation; P:chromatin organization; P:negative regulation of transcription by RNA polymerase II; scaffold19 indexed_genome mRNA 2963987 2972119 . - . ID=transcript_4616;Q8N3Y3 A6NN75 Q8N8Y6 Q8NAK3 Q8WY62,LARGE xylosyl- and glucuronyltransferase 2 {ECO:0000312|HGNC:HGNC:16522},Glycosyltransferase-like 1B;, PF01501;, GO:0005794;GO:0000139;GO:0016021;GO:0015020;GO:0030145;GO:0042285;GO:0046716;GO:0006493;GO:0035269;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:glucuronosyltransferase activity; F:manganese ion binding; F:xylosyltransferase activity;, P:muscle cell cellular homeostasis; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q8N3Y3 A6NN75 Q8N8Y6 Q8NAK3 Q8WY62,LARGE xylosyl- and glucuronyltransferase 2 {ECO:0000312|HGNC:HGNC:16522},Glycosyltransferase-like 1B;, PF01501;, GO:0005794;GO:0000139;GO:0016021;GO:0015020;GO:0030145;GO:0042285;GO:0046716;GO:0006493;GO:0035269;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:glucuronosyltransferase activity; F:manganese ion binding; F:xylosyltransferase activity;, P:muscle cell cellular homeostasis; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q8N3Y3 A6NN75 Q8N8Y6 Q8NAK3 Q8WY62,LARGE xylosyl- and glucuronyltransferase 2 {ECO:0000312|HGNC:HGNC:16522},Glycosyltransferase-like 1B;, PF01501;, GO:0005794;GO:0000139;GO:0016021;GO:0015020;GO:0030145;GO:0042285;GO:0046716;GO:0006493;GO:0035269;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:glucuronosyltransferase activity; F:manganese ion binding; F:xylosyltransferase activity;, P:muscle cell cellular homeostasis; P:protein O-linked glycosylation; P:protein O-linked mannosylation; scaffold19 indexed_genome mRNA 2977236 2984276 . + . ID=transcript_4617;Q9Y5Y5 Q9BWB9,Peroxisomal membrane protein PEX16,Peroxin-16;Peroxisomal biogenesis factor 16;, PF08610;, GO:0005829;GO:0005783;GO:0005789;GO:0005779;GO:0016020;GO:0005778;GO:0005777;GO:0008022;GO:0106101;GO:0032581;GO:0016557;GO:0007031;GO:0016558;GO:0045046;GO:0006625;GO:0022615;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of peroxisomal membrane; C:membrane; C:peroxisomal membrane; C:peroxisome;, F:protein C-terminus binding;, P:ER-dependent peroxisome localization; P:ER-dependent peroxisome organization; P:peroxisome membrane biogenesis; P:peroxisome organization; P:protein import into peroxisome matrix; P:protein import into peroxisome membrane; P:protein targeting to peroxisome; P:protein to membrane docking;|Q9Y5Y5 Q9BWB9,Peroxisomal membrane protein PEX16,Peroxin-16;Peroxisomal biogenesis factor 16;, PF08610;, GO:0005829;GO:0005783;GO:0005789;GO:0005779;GO:0016020;GO:0005778;GO:0005777;GO:0008022;GO:0106101;GO:0032581;GO:0016557;GO:0007031;GO:0016558;GO:0045046;GO:0006625;GO:0022615;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of peroxisomal membrane; C:membrane; C:peroxisomal membrane; C:peroxisome;, F:protein C-terminus binding;, P:ER-dependent peroxisome localization; P:ER-dependent peroxisome organization; P:peroxisome membrane biogenesis; P:peroxisome organization; P:protein import into peroxisome matrix; P:protein import into peroxisome membrane; P:protein targeting to peroxisome; P:protein to membrane docking;|Q9Y5Y5 Q9BWB9,Peroxisomal membrane protein PEX16,Peroxin-16;Peroxisomal biogenesis factor 16;, PF08610;, GO:0005829;GO:0005783;GO:0005789;GO:0005779;GO:0016020;GO:0005778;GO:0005777;GO:0008022;GO:0106101;GO:0032581;GO:0016557;GO:0007031;GO:0016558;GO:0045046;GO:0006625;GO:0022615;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of peroxisomal membrane; C:membrane; C:peroxisomal membrane; C:peroxisome;, F:protein C-terminus binding;, P:ER-dependent peroxisome localization; P:ER-dependent peroxisome organization; P:peroxisome membrane biogenesis; P:peroxisome organization; P:protein import into peroxisome matrix; P:protein import into peroxisome membrane; P:protein targeting to peroxisome; P:protein to membrane docking;|Q9Y5Y5 Q9BWB9,Peroxisomal membrane protein PEX16,Peroxin-16;Peroxisomal biogenesis factor 16;, PF08610;, GO:0005829;GO:0005783;GO:0005789;GO:0005779;GO:0016020;GO:0005778;GO:0005777;GO:0008022;GO:0106101;GO:0032581;GO:0016557;GO:0007031;GO:0016558;GO:0045046;GO:0006625;GO:0022615;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of peroxisomal membrane; C:membrane; C:peroxisomal membrane; C:peroxisome;, F:protein C-terminus binding;, P:ER-dependent peroxisome localization; P:ER-dependent peroxisome organization; P:peroxisome membrane biogenesis; P:peroxisome organization; P:protein import into peroxisome matrix; P:protein import into peroxisome membrane; P:protein targeting to peroxisome; P:protein to membrane docking; scaffold19 indexed_genome mRNA 2987790 2993213 . - . ID=transcript_4618;Q9UQF2 D3DQP4 O43407,C-Jun-amino-terminal kinase-interacting protein 1,Islet-brain 1;JNK MAP kinase scaffold protein 1;Mitogen-activated protein kinase 8-interacting protein 1;, PF00640;PF14604;, GO:0044295;GO:0044297;GO:0005737;GO:0005829;GO:0044294;GO:0044302;GO:0005789;GO:0031966;GO:0005634;GO:0048471;GO:0005886;GO:0045202;GO:0008432;GO:0019894;GO:0005078;GO:0031434;GO:0031435;GO:0004860;GO:0007258;GO:2001243;GO:0043508;GO:0046330;GO:2000564;GO:0046328;GO:0006355;GO:0016192;, C:axonal growth cone; C:cell body; C:cytoplasm; C:cytosol; C:dendritic growth cone; C:dentate gyrus mossy fiber; C:endoplasmic reticulum membrane; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse;, F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase inhibitor activity;, P:JUN phosphorylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of JUN kinase activity; P:positive regulation of JNK cascade; P:regulation of CD8-positive, alpha-beta T cell proliferation; P:regulation of JNK cascade; P:regulation of transcription, DNA-templated; P:vesicle-mediated transport;|Q9UQF2 D3DQP4 O43407,C-Jun-amino-terminal kinase-interacting protein 1,Islet-brain 1;JNK MAP kinase scaffold protein 1;Mitogen-activated protein kinase 8-interacting protein 1;, PF00640;PF14604;, GO:0044295;GO:0044297;GO:0005737;GO:0005829;GO:0044294;GO:0044302;GO:0005789;GO:0031966;GO:0005634;GO:0048471;GO:0005886;GO:0045202;GO:0008432;GO:0019894;GO:0005078;GO:0031434;GO:0031435;GO:0004860;GO:0007258;GO:2001243;GO:0043508;GO:0046330;GO:2000564;GO:0046328;GO:0006355;GO:0016192;, C:axonal growth cone; C:cell body; C:cytoplasm; C:cytosol; C:dendritic growth cone; C:dentate gyrus mossy fiber; C:endoplasmic reticulum membrane; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse;, F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase inhibitor activity;, P:JUN phosphorylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of JUN kinase activity; P:positive regulation of JNK cascade; P:regulation of CD8-positive, alpha-beta T cell proliferation; P:regulation of JNK cascade; P:regulation of transcription, DNA-templated; P:vesicle-mediated transport;|Q9UQF2 D3DQP4 O43407,C-Jun-amino-terminal kinase-interacting protein 1,Islet-brain 1;JNK MAP kinase scaffold protein 1;Mitogen-activated protein kinase 8-interacting protein 1;, PF00640;PF14604;, GO:0044295;GO:0044297;GO:0005737;GO:0005829;GO:0044294;GO:0044302;GO:0005789;GO:0031966;GO:0005634;GO:0048471;GO:0005886;GO:0045202;GO:0008432;GO:0019894;GO:0005078;GO:0031434;GO:0031435;GO:0004860;GO:0007258;GO:2001243;GO:0043508;GO:0046330;GO:2000564;GO:0046328;GO:0006355;GO:0016192;, C:axonal growth cone; C:cell body; C:cytoplasm; C:cytosol; C:dendritic growth cone; C:dentate gyrus mossy fiber; C:endoplasmic reticulum membrane; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse;, F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase inhibitor activity;, P:JUN phosphorylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of JUN kinase activity; P:positive regulation of JNK cascade; P:regulation of CD8-positive, alpha-beta T cell proliferation; P:regulation of JNK cascade; P:regulation of transcription, DNA-templated; P:vesicle-mediated transport; scaffold19 indexed_genome mRNA 3013381 3046641 . - . ID=transcript_4619;Q49AN0 B4DH32 B4DZD6 O75148 Q8IV71,Cryptochrome-2,, PF00875;PF03441;, GO:0005737;GO:0005829;GO:0005576;GO:0016607;GO:0005634;GO:0009882;GO:0003684;GO:0003677;GO:0071949;GO:0019902;GO:0003697;GO:0000976;GO:0009785;GO:0032922;GO:0007623;GO:0043153;GO:0042593;GO:0042754;GO:2000323;GO:0032515;GO:0000122;GO:0045892;GO:0018298;GO:0042752;GO:2000118;GO:0014823;GO:0009416;, C:cytoplasm; C:cytosol; C:extracellular region; C:nuclear speck; C:nucleus;, F:blue light photoreceptor activity; F:damaged DNA binding; F:DNA binding; F:FAD binding; F:phosphatase binding; F:single-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:blue light signaling pathway; P:circadian regulation of gene expression; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:glucose homeostasis; P:negative regulation of circadian rhythm; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein-chromophore linkage; P:regulation of circadian rhythm; P:regulation of sodium-dependent phosphate transport; P:response to activity; P:response to light stimulus;|Q49AN0 B4DH32 B4DZD6 O75148 Q8IV71,Cryptochrome-2,, PF00875;PF03441;, GO:0005737;GO:0005829;GO:0005576;GO:0016607;GO:0005634;GO:0009882;GO:0003684;GO:0003677;GO:0071949;GO:0019902;GO:0003697;GO:0000976;GO:0009785;GO:0032922;GO:0007623;GO:0043153;GO:0042593;GO:0042754;GO:2000323;GO:0032515;GO:0000122;GO:0045892;GO:0018298;GO:0042752;GO:2000118;GO:0014823;GO:0009416;, C:cytoplasm; C:cytosol; C:extracellular region; C:nuclear speck; C:nucleus;, F:blue light photoreceptor activity; F:damaged DNA binding; F:DNA binding; F:FAD binding; F:phosphatase binding; F:single-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:blue light signaling pathway; P:circadian regulation of gene expression; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:glucose homeostasis; P:negative regulation of circadian rhythm; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein-chromophore linkage; P:regulation of circadian rhythm; P:regulation of sodium-dependent phosphate transport; P:response to activity; P:response to light stimulus;|Q49AN0 B4DH32 B4DZD6 O75148 Q8IV71,Cryptochrome-2,, PF00875;PF03441;, GO:0005737;GO:0005829;GO:0005576;GO:0016607;GO:0005634;GO:0009882;GO:0003684;GO:0003677;GO:0071949;GO:0019902;GO:0003697;GO:0000976;GO:0009785;GO:0032922;GO:0007623;GO:0043153;GO:0042593;GO:0042754;GO:2000323;GO:0032515;GO:0000122;GO:0045892;GO:0018298;GO:0042752;GO:2000118;GO:0014823;GO:0009416;, C:cytoplasm; C:cytosol; C:extracellular region; C:nuclear speck; C:nucleus;, F:blue light photoreceptor activity; F:damaged DNA binding; F:DNA binding; F:FAD binding; F:phosphatase binding; F:single-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:blue light signaling pathway; P:circadian regulation of gene expression; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:glucose homeostasis; P:negative regulation of circadian rhythm; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein-chromophore linkage; P:regulation of circadian rhythm; P:regulation of sodium-dependent phosphate transport; P:response to activity; P:response to light stimulus;|Q49AN0 B4DH32 B4DZD6 O75148 Q8IV71,Cryptochrome-2,, PF00875;PF03441;, GO:0005737;GO:0005829;GO:0005576;GO:0016607;GO:0005634;GO:0009882;GO:0003684;GO:0003677;GO:0071949;GO:0019902;GO:0003697;GO:0000976;GO:0009785;GO:0032922;GO:0007623;GO:0043153;GO:0042593;GO:0042754;GO:2000323;GO:0032515;GO:0000122;GO:0045892;GO:0018298;GO:0042752;GO:2000118;GO:0014823;GO:0009416;, C:cytoplasm; C:cytosol; C:extracellular region; C:nuclear speck; C:nucleus;, F:blue light photoreceptor activity; F:damaged DNA binding; F:DNA binding; F:FAD binding; F:phosphatase binding; F:single-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:blue light signaling pathway; P:circadian regulation of gene expression; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:glucose homeostasis; P:negative regulation of circadian rhythm; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein-chromophore linkage; P:regulation of circadian rhythm; P:regulation of sodium-dependent phosphate transport; P:response to activity; P:response to light stimulus;|Q49AN0 B4DH32 B4DZD6 O75148 Q8IV71,Cryptochrome-2,, PF00875;PF03441;, GO:0005737;GO:0005829;GO:0005576;GO:0016607;GO:0005634;GO:0009882;GO:0003684;GO:0003677;GO:0071949;GO:0019902;GO:0003697;GO:0000976;GO:0009785;GO:0032922;GO:0007623;GO:0043153;GO:0042593;GO:0042754;GO:2000323;GO:0032515;GO:0000122;GO:0045892;GO:0018298;GO:0042752;GO:2000118;GO:0014823;GO:0009416;, C:cytoplasm; C:cytosol; C:extracellular region; C:nuclear speck; C:nucleus;, F:blue light photoreceptor activity; F:damaged DNA binding; F:DNA binding; F:FAD binding; F:phosphatase binding; F:single-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:blue light signaling pathway; P:circadian regulation of gene expression; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:glucose homeostasis; P:negative regulation of circadian rhythm; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein-chromophore linkage; P:regulation of circadian rhythm; P:regulation of sodium-dependent phosphate transport; P:response to activity; P:response to light stimulus;|Q49AN0 B4DH32 B4DZD6 O75148 Q8IV71,Cryptochrome-2,, PF00875;PF03441;, GO:0005737;GO:0005829;GO:0005576;GO:0016607;GO:0005634;GO:0009882;GO:0003684;GO:0003677;GO:0071949;GO:0019902;GO:0003697;GO:0000976;GO:0009785;GO:0032922;GO:0007623;GO:0043153;GO:0042593;GO:0042754;GO:2000323;GO:0032515;GO:0000122;GO:0045892;GO:0018298;GO:0042752;GO:2000118;GO:0014823;GO:0009416;, C:cytoplasm; C:cytosol; C:extracellular region; C:nuclear speck; C:nucleus;, F:blue light photoreceptor activity; F:damaged DNA binding; F:DNA binding; F:FAD binding; F:phosphatase binding; F:single-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:blue light signaling pathway; P:circadian regulation of gene expression; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:glucose homeostasis; P:negative regulation of circadian rhythm; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein-chromophore linkage; P:regulation of circadian rhythm; P:regulation of sodium-dependent phosphate transport; P:response to activity; P:response to light stimulus; scaffold19 indexed_genome mRNA 3073075 3079768 . - . ID=transcript_4620;Q96A29 B2RDB2 Q9BV76 Q9NUJ8,GDP-fucose transporter 1,Solute carrier family 35 member C1;, PF03151;, GO:0005794;GO:0000139;GO:0016021;GO:0015297;GO:0005457;GO:0008643;GO:0036085;GO:0030259;GO:0045746;GO:0036066;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:antiporter activity; F:GDP-fucose transmembrane transporter activity;, P:carbohydrate transport; P:GDP-fucose import into Golgi lumen; P:lipid glycosylation; P:negative regulation of Notch signaling pathway; P:protein O-linked fucosylation; scaffold19 indexed_genome mRNA 3222224 3225789 . - . ID=transcript_4621;O43916 D3DQP2,Carbohydrate sulfotransferase 1,Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1;Keratan sulfate Gal-6 sulfotransferase;, PF00685;, GO:0000139;GO:0016021;GO:0005802;GO:0045130;GO:0001517;GO:0008146;GO:0006012;GO:0006954;GO:0018146;GO:0042339;GO:0006044;GO:0005976;GO:0006790;, C:Golgi membrane; C:integral component of membrane; C:trans-Golgi network;, F:keratan sulfotransferase activity; F:N-acetylglucosamine 6-O-sulfotransferase activity; F:sulfotransferase activity;, P:galactose metabolic process; P:inflammatory response; P:keratan sulfate biosynthetic process; P:keratan sulfate metabolic process; P:N-acetylglucosamine metabolic process; P:polysaccharide metabolic process; P:sulfur compound metabolic process; scaffold19 indexed_genome mRNA 3564308 3606774 . + . ID=transcript_4622;Q7L8C5 A8K4P4 D3DQP1 Q9BQS3 Q9H041 Q9P2C0,Synaptotagmin-13,Synaptotagmin XIII;, PF00168;, GO:0030424;GO:0070382;GO:0005887;GO:0043231;GO:0005886;GO:0045202;GO:0030133;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0000149;GO:0017156;GO:0071277;GO:0017158;GO:0014059;GO:0006906;GO:0016192;, C:axon; C:exocytic vesicle; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:synapse; C:transport vesicle;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:SNARE binding;, P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:vesicle fusion; P:vesicle-mediated transport;|Q7L8C5 A8K4P4 D3DQP1 Q9BQS3 Q9H041 Q9P2C0,Synaptotagmin-13,Synaptotagmin XIII;, PF00168;, GO:0030424;GO:0070382;GO:0005887;GO:0043231;GO:0005886;GO:0045202;GO:0030133;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0000149;GO:0017156;GO:0071277;GO:0017158;GO:0014059;GO:0006906;GO:0016192;, C:axon; C:exocytic vesicle; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:synapse; C:transport vesicle;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:SNARE binding;, P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:vesicle fusion; P:vesicle-mediated transport; scaffold19 indexed_genome mRNA 3619475 3620600 . - . ID=transcript_4623;O60290 A0AUL8,Zinc finger protein 862,, PF05699;PF14291;PF01352;, GO:0005634;GO:0046872;GO:0046983;GO:0006355;, C:nucleus;, F:metal ion binding; F:protein dimerization activity;, P:regulation of transcription, DNA-templated; scaffold19 indexed_genome mRNA 3635109 3641882 . - . ID=transcript_4624;Q86VE0,Myb-related transcription factor, partner of profilin,Myb-related protein p42POP;Partner of profilin;, PF13873;, GO:0005634;GO:0000981;GO:0001227;GO:0042802;GO:0000978;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold19 indexed_genome mRNA 3641921 3670000 . - . ID=transcript_4625;Q9NQV5 Q8N9F1,PR domain-containing protein 11,, , GO:0005829;GO:0005634;GO:0003682;GO:0008168;GO:0032259;GO:0030308;GO:0045892;GO:2000271;GO:0045893;GO:0051726;GO:0010468;GO:0043408;, C:cytosol; C:nucleus;, F:chromatin binding; F:methyltransferase activity;, P:methylation; P:negative regulation of cell growth; P:negative regulation of transcription, DNA-templated; P:positive regulation of fibroblast apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell cycle; P:regulation of gene expression; P:regulation of MAPK cascade; scaffold19 indexed_genome mRNA 3906765 4108226 . - . ID=transcript_4626;O14683 Q3ZCS0,Tumor protein p53-inducible protein 11,p53-induced gene 11 protein;, PF14936;, GO:0016021;GO:0008285;, C:integral component of membrane;, , P:negative regulation of cell population proliferation;|O14683 Q3ZCS0,Tumor protein p53-inducible protein 11,p53-induced gene 11 protein;, PF14936;, GO:0016021;GO:0008285;, C:integral component of membrane;, , P:negative regulation of cell population proliferation;|Q96SJ8 Q6UY44 Q8NBI9,Tetraspanin-18,, PF00335;, GO:0005887;, C:integral component of plasma membrane;|Q96SJ8 Q6UY44 Q8NBI9,Tetraspanin-18,, PF00335;, GO:0005887;, C:integral component of plasma membrane;|Q96SJ8 Q6UY44 Q8NBI9,Tetraspanin-18,, PF00335;, GO:0005887;, C:integral component of plasma membrane; scaffold19 indexed_genome mRNA 4195985 4254628 . - . ID=transcript_4627;P27701 D3DQN6 E9PC70 Q7Z2D4 Q7Z5N2,CD82 antigen,C33 antigen;IA4;Inducible membrane protein R2;Metastasis suppressor Kangai-1;Suppressor of tumorigenicity 6 protein;Tetraspanin-27;, PF00335;, GO:0070062;GO:0005887;GO:0005886;, C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; scaffold19 indexed_genome mRNA 4531456 4677502 . - . ID=transcript_4628;Q93063 B2R5Z6 C9JU51 J3KPT2 O15288,Exostosin-2,Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Multiple exostoses protein 2;Putative tumor suppressor protein EXT2;, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0043541;GO:0050508;GO:0015020;GO:0042328;GO:0046872;GO:0050509;GO:0046982;GO:0016757;GO:0030154;GO:0033692;GO:0044344;GO:0060350;GO:0042044;GO:0010467;GO:0006024;GO:0060047;GO:0015012;GO:0015014;GO:0030210;GO:0001707;GO:0050891;GO:0001503;GO:0006487;GO:0008217;GO:0007165;GO:0055078;GO:0051923;GO:0042311;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:UDP-N-acetylglucosamine transferase complex;, F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronosyltransferase activity; F:heparan sulfate N-acetylglucosaminyltransferase activity; F:metal ion binding; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; F:protein heterodimerization activity; F:transferase activity, transferring glycosyl groups;, P:cell differentiation; P:cellular polysaccharide biosynthetic process; P:cellular response to fibroblast growth factor stimulus; P:endochondral bone morphogenesis; P:fluid transport; P:gene expression; P:glycosaminoglycan biosynthetic process; P:heart contraction; P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:mesoderm formation; P:multicellular organismal water homeostasis; P:ossification; P:protein N-linked glycosylation; P:regulation of blood pressure; P:signal transduction; P:sodium ion homeostasis; P:sulfation; P:vasodilation;|Q93063 B2R5Z6 C9JU51 J3KPT2 O15288,Exostosin-2,Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Multiple exostoses protein 2;Putative tumor suppressor protein EXT2;, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0043541;GO:0050508;GO:0015020;GO:0042328;GO:0046872;GO:0050509;GO:0046982;GO:0016757;GO:0030154;GO:0033692;GO:0044344;GO:0060350;GO:0042044;GO:0010467;GO:0006024;GO:0060047;GO:0015012;GO:0015014;GO:0030210;GO:0001707;GO:0050891;GO:0001503;GO:0006487;GO:0008217;GO:0007165;GO:0055078;GO:0051923;GO:0042311;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:UDP-N-acetylglucosamine transferase complex;, F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronosyltransferase activity; F:heparan sulfate N-acetylglucosaminyltransferase activity; F:metal ion binding; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; F:protein heterodimerization activity; F:transferase activity, transferring glycosyl groups;, P:cell differentiation; P:cellular polysaccharide biosynthetic process; P:cellular response to fibroblast growth factor stimulus; P:endochondral bone morphogenesis; P:fluid transport; P:gene expression; P:glycosaminoglycan biosynthetic process; P:heart contraction; P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:mesoderm formation; P:multicellular organismal water homeostasis; P:ossification; P:protein N-linked glycosylation; P:regulation of blood pressure; P:signal transduction; P:sodium ion homeostasis; P:sulfation; P:vasodilation;|Q93063 B2R5Z6 C9JU51 J3KPT2 O15288,Exostosin-2,Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Multiple exostoses protein 2;Putative tumor suppressor protein EXT2;, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0043541;GO:0050508;GO:0015020;GO:0042328;GO:0046872;GO:0050509;GO:0046982;GO:0016757;GO:0030154;GO:0033692;GO:0044344;GO:0060350;GO:0042044;GO:0010467;GO:0006024;GO:0060047;GO:0015012;GO:0015014;GO:0030210;GO:0001707;GO:0050891;GO:0001503;GO:0006487;GO:0008217;GO:0007165;GO:0055078;GO:0051923;GO:0042311;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:UDP-N-acetylglucosamine transferase complex;, F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronosyltransferase activity; F:heparan sulfate N-acetylglucosaminyltransferase activity; F:metal ion binding; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; F:protein heterodimerization activity; F:transferase activity, transferring glycosyl groups;, P:cell differentiation; P:cellular polysaccharide biosynthetic process; P:cellular response to fibroblast growth factor stimulus; P:endochondral bone morphogenesis; P:fluid transport; P:gene expression; P:glycosaminoglycan biosynthetic process; P:heart contraction; P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:mesoderm formation; P:multicellular organismal water homeostasis; P:ossification; P:protein N-linked glycosylation; P:regulation of blood pressure; P:signal transduction; P:sodium ion homeostasis; P:sulfation; P:vasodilation; scaffold19 indexed_genome mRNA 4685491 4703308 . - . ID=transcript_4629;Q96QU6 B4E219 Q8WUL4 Q96LX5,1-aminocyclopropane-1-carboxylate synthase-like protein 1,, PF00155;, GO:0003824;GO:0042802;GO:0030170;GO:0042218;, , F:catalytic activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:1-aminocyclopropane-1-carboxylate biosynthetic process;|Q96QU6 B4E219 Q8WUL4 Q96LX5,1-aminocyclopropane-1-carboxylate synthase-like protein 1,, PF00155;, GO:0003824;GO:0042802;GO:0030170;GO:0042218;, , F:catalytic activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:1-aminocyclopropane-1-carboxylate biosynthetic process;|Q96QU6 B4E219 Q8WUL4 Q96LX5,1-aminocyclopropane-1-carboxylate synthase-like protein 1,, PF00155;, GO:0003824;GO:0042802;GO:0030170;GO:0042218;, , F:catalytic activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:1-aminocyclopropane-1-carboxylate biosynthetic process; scaffold19 indexed_genome mRNA 4860672 4900491 . - . ID=transcript_4630;Q96Q83 A6NDJ1 Q3SYI0 Q6NX57 Q96BU8,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 {ECO:0000305},Alkylated DNA repair protein alkB homolog 3 {ECO:0000303|PubMed:12594517};DEPC-1 {ECO:0000303|Ref.1};Prostate cancer antigen 1 {ECO:0000303|Ref.1};, PF13532;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043734;GO:0008198;GO:0031418;GO:1990930;GO:0008283;GO:0006307;GO:0006281;GO:0035552;GO:0035553;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-N1-methyladenine dioxygenase activity; F:ferrous iron binding; F:L-ascorbic acid binding; F:RNA N1-methyladenosine dioxygenase activity;, P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA repair; P:oxidative single-stranded DNA demethylation; P:oxidative single-stranded RNA demethylation;|Q96Q83 A6NDJ1 Q3SYI0 Q6NX57 Q96BU8,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 {ECO:0000305},Alkylated DNA repair protein alkB homolog 3 {ECO:0000303|PubMed:12594517};DEPC-1 {ECO:0000303|Ref.1};Prostate cancer antigen 1 {ECO:0000303|Ref.1};, PF13532;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043734;GO:0008198;GO:0031418;GO:1990930;GO:0008283;GO:0006307;GO:0006281;GO:0035552;GO:0035553;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-N1-methyladenine dioxygenase activity; F:ferrous iron binding; F:L-ascorbic acid binding; F:RNA N1-methyladenosine dioxygenase activity;, P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA repair; P:oxidative single-stranded DNA demethylation; P:oxidative single-stranded RNA demethylation;|Q96Q83 A6NDJ1 Q3SYI0 Q6NX57 Q96BU8,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 {ECO:0000305},Alkylated DNA repair protein alkB homolog 3 {ECO:0000303|PubMed:12594517};DEPC-1 {ECO:0000303|Ref.1};Prostate cancer antigen 1 {ECO:0000303|Ref.1};, PF13532;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043734;GO:0008198;GO:0031418;GO:1990930;GO:0008283;GO:0006307;GO:0006281;GO:0035552;GO:0035553;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-N1-methyladenine dioxygenase activity; F:ferrous iron binding; F:L-ascorbic acid binding; F:RNA N1-methyladenosine dioxygenase activity;, P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA repair; P:oxidative single-stranded DNA demethylation; P:oxidative single-stranded RNA demethylation;|Q96Q83 A6NDJ1 Q3SYI0 Q6NX57 Q96BU8,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 {ECO:0000305},Alkylated DNA repair protein alkB homolog 3 {ECO:0000303|PubMed:12594517};DEPC-1 {ECO:0000303|Ref.1};Prostate cancer antigen 1 {ECO:0000303|Ref.1};, PF13532;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043734;GO:0008198;GO:0031418;GO:1990930;GO:0008283;GO:0006307;GO:0006281;GO:0035552;GO:0035553;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-N1-methyladenine dioxygenase activity; F:ferrous iron binding; F:L-ascorbic acid binding; F:RNA N1-methyladenosine dioxygenase activity;, P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA repair; P:oxidative single-stranded DNA demethylation; P:oxidative single-stranded RNA demethylation;|Q96Q83 A6NDJ1 Q3SYI0 Q6NX57 Q96BU8,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 {ECO:0000305},Alkylated DNA repair protein alkB homolog 3 {ECO:0000303|PubMed:12594517};DEPC-1 {ECO:0000303|Ref.1};Prostate cancer antigen 1 {ECO:0000303|Ref.1};, PF13532;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043734;GO:0008198;GO:0031418;GO:1990930;GO:0008283;GO:0006307;GO:0006281;GO:0035552;GO:0035553;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-N1-methyladenine dioxygenase activity; F:ferrous iron binding; F:L-ascorbic acid binding; F:RNA N1-methyladenosine dioxygenase activity;, P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA repair; P:oxidative single-stranded DNA demethylation; P:oxidative single-stranded RNA demethylation;|Q96Q83 A6NDJ1 Q3SYI0 Q6NX57 Q96BU8,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 {ECO:0000305},Alkylated DNA repair protein alkB homolog 3 {ECO:0000303|PubMed:12594517};DEPC-1 {ECO:0000303|Ref.1};Prostate cancer antigen 1 {ECO:0000303|Ref.1};, PF13532;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043734;GO:0008198;GO:0031418;GO:1990930;GO:0008283;GO:0006307;GO:0006281;GO:0035552;GO:0035553;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-N1-methyladenine dioxygenase activity; F:ferrous iron binding; F:L-ascorbic acid binding; F:RNA N1-methyladenosine dioxygenase activity;, P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA repair; P:oxidative single-stranded DNA demethylation; P:oxidative single-stranded RNA demethylation; scaffold19 indexed_genome mRNA 4918353 5081982 . - . ID=transcript_4631;Q53GQ0 A8K9B0 D3DR23 Q96EA9 Q96JU2 Q9Y6G8,Very-long-chain 3-oxoacyl-CoA reductase {ECO:0000305},17-beta-hydroxysteroid dehydrogenase 12 {ECO:0000303|PubMed:16166196};3-ketoacyl-CoA reductase {ECO:0000303|PubMed:12482854};Estradiol 17-beta-dehydrogenase 12 {ECO:0000303|PubMed:16166196};Short chain dehydrogenase/reductase family 12C member 1;, PF00106;, GO:0005789;GO:0031012;GO:0009923;GO:0016021;GO:0044594;GO:0072582;GO:0102339;GO:0102340;GO:0102342;GO:0102341;GO:0005518;GO:0001968;GO:0008201;GO:0050062;GO:0006703;GO:0030198;GO:0006633;GO:0035338;GO:0010811;, C:endoplasmic reticulum membrane; C:extracellular matrix; C:fatty acid elongase complex; C:integral component of membrane;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3-oxo-arachidoyl-CoA reductase activity; F:3-oxo-behenoyl-CoA reductase activity; F:3-oxo-cerotoyl-CoA reductase activity; F:3-oxo-lignoceroyl-CoA reductase activity; F:collagen binding; F:fibronectin binding; F:heparin binding; F:long-chain-fatty-acyl-CoA reductase activity;, P:estrogen biosynthetic process; P:extracellular matrix organization; P:fatty acid biosynthetic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cell-substrate adhesion;|Q53GQ0 A8K9B0 D3DR23 Q96EA9 Q96JU2 Q9Y6G8,Very-long-chain 3-oxoacyl-CoA reductase {ECO:0000305},17-beta-hydroxysteroid dehydrogenase 12 {ECO:0000303|PubMed:16166196};3-ketoacyl-CoA reductase {ECO:0000303|PubMed:12482854};Estradiol 17-beta-dehydrogenase 12 {ECO:0000303|PubMed:16166196};Short chain dehydrogenase/reductase family 12C member 1;, PF00106;, GO:0005789;GO:0031012;GO:0009923;GO:0016021;GO:0044594;GO:0072582;GO:0102339;GO:0102340;GO:0102342;GO:0102341;GO:0005518;GO:0001968;GO:0008201;GO:0050062;GO:0006703;GO:0030198;GO:0006633;GO:0035338;GO:0010811;, C:endoplasmic reticulum membrane; C:extracellular matrix; C:fatty acid elongase complex; C:integral component of membrane;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3-oxo-arachidoyl-CoA reductase activity; F:3-oxo-behenoyl-CoA reductase activity; F:3-oxo-cerotoyl-CoA reductase activity; F:3-oxo-lignoceroyl-CoA reductase activity; F:collagen binding; F:fibronectin binding; F:heparin binding; F:long-chain-fatty-acyl-CoA reductase activity;, P:estrogen biosynthetic process; P:extracellular matrix organization; P:fatty acid biosynthetic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cell-substrate adhesion; scaffold19 indexed_genome mRNA 5275296 5280570 . - . ID=transcript_4632;Q96AE7 G3XAB3 Q8NEC0,Tetratricopeptide repeat protein 17,, PF13181;, GO:0015629;GO:0005737;GO:0005829;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization;|Q96AE7 G3XAB3 Q8NEC0,Tetratricopeptide repeat protein 17,, PF13181;, GO:0015629;GO:0005737;GO:0005829;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization;|Q96AE7 G3XAB3 Q8NEC0,Tetratricopeptide repeat protein 17,, PF13181;, GO:0015629;GO:0005737;GO:0005829;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization;|Q96AE7 G3XAB3 Q8NEC0,Tetratricopeptide repeat protein 17,, PF13181;, GO:0015629;GO:0005737;GO:0005829;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization; scaffold19 indexed_genome mRNA 5300276 5393767 . - . ID=transcript_4633;Q96AE7 G3XAB3 Q8NEC0,Tetratricopeptide repeat protein 17,, PF13181;, GO:0015629;GO:0005737;GO:0005829;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization;|Q96AE7 G3XAB3 Q8NEC0,Tetratricopeptide repeat protein 17,, PF13181;, GO:0015629;GO:0005737;GO:0005829;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization;|Q96AE7 G3XAB3 Q8NEC0,Tetratricopeptide repeat protein 17,, PF13181;, GO:0015629;GO:0005737;GO:0005829;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization;|Q96AE7 G3XAB3 Q8NEC0,Tetratricopeptide repeat protein 17,, PF13181;, GO:0015629;GO:0005737;GO:0005829;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization;|Q96AE7 G3XAB3 Q8NEC0,Tetratricopeptide repeat protein 17,, PF13181;, GO:0015629;GO:0005737;GO:0005829;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization; scaffold19 indexed_genome mRNA 5400269 5429608 . - . ID=transcript_4634;Q9BZZ5 B4DGR0 B4DRJ2 B4E283 D3DR21 O15441 Q9Y4J7,Apoptosis inhibitor 5,Antiapoptosis clone 11 protein;Cell migration-inducing gene 8 protein;Fibroblast growth factor 2-interacting factor;Protein XAGL;, PF05918;, GO:0005737;GO:0016020;GO:0016607;GO:0005634;GO:0005681;GO:0017134;GO:0003723;GO:0006915;GO:0043066;GO:2000270;, C:cytoplasm; C:membrane; C:nuclear speck; C:nucleus; C:spliceosomal complex;, F:fibroblast growth factor binding; F:RNA binding;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of fibroblast apoptotic process;|Q9BZZ5 B4DGR0 B4DRJ2 B4E283 D3DR21 O15441 Q9Y4J7,Apoptosis inhibitor 5,Antiapoptosis clone 11 protein;Cell migration-inducing gene 8 protein;Fibroblast growth factor 2-interacting factor;Protein XAGL;, PF05918;, GO:0005737;GO:0016020;GO:0016607;GO:0005634;GO:0005681;GO:0017134;GO:0003723;GO:0006915;GO:0043066;GO:2000270;, C:cytoplasm; C:membrane; C:nuclear speck; C:nucleus; C:spliceosomal complex;, F:fibroblast growth factor binding; F:RNA binding;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of fibroblast apoptotic process;|Q9BZZ5 B4DGR0 B4DRJ2 B4E283 D3DR21 O15441 Q9Y4J7,Apoptosis inhibitor 5,Antiapoptosis clone 11 protein;Cell migration-inducing gene 8 protein;Fibroblast growth factor 2-interacting factor;Protein XAGL;, PF05918;, GO:0005737;GO:0016020;GO:0016607;GO:0005634;GO:0005681;GO:0017134;GO:0003723;GO:0006915;GO:0043066;GO:2000270;, C:cytoplasm; C:membrane; C:nuclear speck; C:nucleus; C:spliceosomal complex;, F:fibroblast growth factor binding; F:RNA binding;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of fibroblast apoptotic process;|Q9BZZ5 B4DGR0 B4DRJ2 B4E283 D3DR21 O15441 Q9Y4J7,Apoptosis inhibitor 5,Antiapoptosis clone 11 protein;Cell migration-inducing gene 8 protein;Fibroblast growth factor 2-interacting factor;Protein XAGL;, PF05918;, GO:0005737;GO:0016020;GO:0016607;GO:0005634;GO:0005681;GO:0017134;GO:0003723;GO:0006915;GO:0043066;GO:2000270;, C:cytoplasm; C:membrane; C:nuclear speck; C:nucleus; C:spliceosomal complex;, F:fibroblast growth factor binding; F:RNA binding;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of fibroblast apoptotic process;|Q9BZZ5 B4DGR0 B4DRJ2 B4E283 D3DR21 O15441 Q9Y4J7,Apoptosis inhibitor 5,Antiapoptosis clone 11 protein;Cell migration-inducing gene 8 protein;Fibroblast growth factor 2-interacting factor;Protein XAGL;, PF05918;, GO:0005737;GO:0016020;GO:0016607;GO:0005634;GO:0005681;GO:0017134;GO:0003723;GO:0006915;GO:0043066;GO:2000270;, C:cytoplasm; C:membrane; C:nuclear speck; C:nucleus; C:spliceosomal complex;, F:fibroblast growth factor binding; F:RNA binding;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of fibroblast apoptotic process;|Q9BZZ5 B4DGR0 B4DRJ2 B4E283 D3DR21 O15441 Q9Y4J7,Apoptosis inhibitor 5,Antiapoptosis clone 11 protein;Cell migration-inducing gene 8 protein;Fibroblast growth factor 2-interacting factor;Protein XAGL;, PF05918;, GO:0005737;GO:0016020;GO:0016607;GO:0005634;GO:0005681;GO:0017134;GO:0003723;GO:0006915;GO:0043066;GO:2000270;, C:cytoplasm; C:membrane; C:nuclear speck; C:nucleus; C:spliceosomal complex;, F:fibroblast growth factor binding; F:RNA binding;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of fibroblast apoptotic process; scaffold19 indexed_genome mRNA 8095362 8276479 . + . ID=transcript_4635;Q9HCJ2 A8K0T1 Q7L0N3,Leucine-rich repeat-containing protein 4C,Netrin-G1 ligand;, PF07679;PF13306;PF13855;, GO:0005615;GO:0098978;GO:0016021;GO:0099061;GO:0016020;GO:0098685;GO:0050839;GO:0098632;GO:0050804;GO:0050770;GO:0099560;, C:extracellular space; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:cell-cell adhesion mediator activity;, P:modulation of chemical synaptic transmission; P:regulation of axonogenesis; P:synaptic membrane adhesion; scaffold19 indexed_genome mRNA 11319739 11320457 . + . ID=transcript_4636;Q86VG3 D3DR18 Q96DD6,Intraflagellar transport-associated protein,Protein HEPIS;, PF17722;, GO:0097731;GO:0005829;GO:0120160;GO:0007340;GO:0007283;, C:9+0 non-motile cilium; C:cytosol;, F:intraciliary transport particle A binding;, P:acrosome reaction; P:spermatogenesis; scaffold19 indexed_genome mRNA 11439907 11460237 . + . ID=transcript_4637;Q9Y4K3 A6NKI7 A8KAB3 D3DR16 Q8NEH5,TNF receptor-associated factor 6,E3 ubiquitin-protein ligase TRAF6;Interleukin-1 signal transducer;RING finger protein 85;RING-type E3 ubiquitin transferase TRAF6 {ECO:0000305};, PF18048;PF02176;, GO:0035631;GO:0005938;GO:0005737;GO:0009898;GO:0005829;GO:0010008;GO:0005811;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0042826;GO:0042802;GO:0031435;GO:0043422;GO:0019901;GO:0047485;GO:0031996;GO:0005164;GO:0031624;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:0000187;GO:0007250;GO:0032147;GO:0019886;GO:0045453;GO:0048468;GO:0071345;GO:0006974;GO:0071222;GO:0002753;GO:0038095;GO:0007249;GO:0001701;GO:0070498;GO:0007254;GO:0031293;GO:0002755;GO:0043011;GO:0043066;GO:0000122;GO:0045892;GO:0001843;GO:0070423;GO:0042475;GO:0001503;GO:0030316;GO:0043065;GO:0051091;GO:0043123;GO:0032735;GO:0032743;GO:0032755;GO:0046330;GO:0043507;GO:1904996;GO:0031666;GO:0051092;GO:1901224;GO:0045672;GO:0031398;GO:0048661;GO:0002726;GO:0042102;GO:0045944;GO:2000679;GO:0051865;GO:0016579;GO:0070534;GO:0000209;GO:0043122;GO:0002637;GO:0070555;GO:0002223;GO:0050852;GO:0042088;GO:0034162;GO:0002224;GO:0033209;, C:CD40 receptor complex; C:cell cortex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endosome membrane; C:lipid droplet; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:histone deacetylase binding; F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase B binding; F:protein kinase binding; F:protein N-terminus binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of MAPK activity; P:activation of NF-kappaB-inducing kinase activity; P:activation of protein kinase activity; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:bone resorption; P:cell development; P:cellular response to cytokine stimulus; P:cellular response to DNA damage stimulus; P:cellular response to lipopolysaccharide; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:in utero embryonic development; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:membrane protein intracellular domain proteolysis; P:MyD88-dependent toll-like receptor signaling pathway; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:nucleotide-binding oligomerization domain containing signaling pathway; P:odontogenesis of dentin-containing tooth; P:ossification; P:osteoclast differentiation; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of lipopolysaccharide-mediated signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of osteoclast differentiation; P:positive regulation of protein ubiquitination; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T cell cytokine production; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein autoubiquitination; P:protein deubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of immunoglobulin production; P:response to interleukin-1; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:T-helper 1 type immune response; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q9Y4K3 A6NKI7 A8KAB3 D3DR16 Q8NEH5,TNF receptor-associated factor 6,E3 ubiquitin-protein ligase TRAF6;Interleukin-1 signal transducer;RING finger protein 85;RING-type E3 ubiquitin transferase TRAF6 {ECO:0000305};, PF18048;PF02176;, GO:0035631;GO:0005938;GO:0005737;GO:0009898;GO:0005829;GO:0010008;GO:0005811;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0042826;GO:0042802;GO:0031435;GO:0043422;GO:0019901;GO:0047485;GO:0031996;GO:0005164;GO:0031624;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:0000187;GO:0007250;GO:0032147;GO:0019886;GO:0045453;GO:0048468;GO:0071345;GO:0006974;GO:0071222;GO:0002753;GO:0038095;GO:0007249;GO:0001701;GO:0070498;GO:0007254;GO:0031293;GO:0002755;GO:0043011;GO:0043066;GO:0000122;GO:0045892;GO:0001843;GO:0070423;GO:0042475;GO:0001503;GO:0030316;GO:0043065;GO:0051091;GO:0043123;GO:0032735;GO:0032743;GO:0032755;GO:0046330;GO:0043507;GO:1904996;GO:0031666;GO:0051092;GO:1901224;GO:0045672;GO:0031398;GO:0048661;GO:0002726;GO:0042102;GO:0045944;GO:2000679;GO:0051865;GO:0016579;GO:0070534;GO:0000209;GO:0043122;GO:0002637;GO:0070555;GO:0002223;GO:0050852;GO:0042088;GO:0034162;GO:0002224;GO:0033209;, C:CD40 receptor complex; C:cell cortex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endosome membrane; C:lipid droplet; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:histone deacetylase binding; F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase B binding; F:protein kinase binding; F:protein N-terminus binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of MAPK activity; P:activation of NF-kappaB-inducing kinase activity; P:activation of protein kinase activity; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:bone resorption; P:cell development; P:cellular response to cytokine stimulus; P:cellular response to DNA damage stimulus; P:cellular response to lipopolysaccharide; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:in utero embryonic development; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:membrane protein intracellular domain proteolysis; P:MyD88-dependent toll-like receptor signaling pathway; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:nucleotide-binding oligomerization domain containing signaling pathway; P:odontogenesis of dentin-containing tooth; P:ossification; P:osteoclast differentiation; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of lipopolysaccharide-mediated signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of osteoclast differentiation; P:positive regulation of protein ubiquitination; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T cell cytokine production; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein autoubiquitination; P:protein deubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of immunoglobulin production; P:response to interleukin-1; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:T-helper 1 type immune response; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q9Y4K3 A6NKI7 A8KAB3 D3DR16 Q8NEH5,TNF receptor-associated factor 6,E3 ubiquitin-protein ligase TRAF6;Interleukin-1 signal transducer;RING finger protein 85;RING-type E3 ubiquitin transferase TRAF6 {ECO:0000305};, PF18048;PF02176;, GO:0035631;GO:0005938;GO:0005737;GO:0009898;GO:0005829;GO:0010008;GO:0005811;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0042826;GO:0042802;GO:0031435;GO:0043422;GO:0019901;GO:0047485;GO:0031996;GO:0005164;GO:0031624;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:0000187;GO:0007250;GO:0032147;GO:0019886;GO:0045453;GO:0048468;GO:0071345;GO:0006974;GO:0071222;GO:0002753;GO:0038095;GO:0007249;GO:0001701;GO:0070498;GO:0007254;GO:0031293;GO:0002755;GO:0043011;GO:0043066;GO:0000122;GO:0045892;GO:0001843;GO:0070423;GO:0042475;GO:0001503;GO:0030316;GO:0043065;GO:0051091;GO:0043123;GO:0032735;GO:0032743;GO:0032755;GO:0046330;GO:0043507;GO:1904996;GO:0031666;GO:0051092;GO:1901224;GO:0045672;GO:0031398;GO:0048661;GO:0002726;GO:0042102;GO:0045944;GO:2000679;GO:0051865;GO:0016579;GO:0070534;GO:0000209;GO:0043122;GO:0002637;GO:0070555;GO:0002223;GO:0050852;GO:0042088;GO:0034162;GO:0002224;GO:0033209;, C:CD40 receptor complex; C:cell cortex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endosome membrane; C:lipid droplet; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:histone deacetylase binding; F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase B binding; F:protein kinase binding; F:protein N-terminus binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of MAPK activity; P:activation of NF-kappaB-inducing kinase activity; P:activation of protein kinase activity; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:bone resorption; P:cell development; P:cellular response to cytokine stimulus; P:cellular response to DNA damage stimulus; P:cellular response to lipopolysaccharide; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:in utero embryonic development; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:membrane protein intracellular domain proteolysis; P:MyD88-dependent toll-like receptor signaling pathway; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:nucleotide-binding oligomerization domain containing signaling pathway; P:odontogenesis of dentin-containing tooth; P:ossification; P:osteoclast differentiation; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of lipopolysaccharide-mediated signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of osteoclast differentiation; P:positive regulation of protein ubiquitination; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T cell cytokine production; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein autoubiquitination; P:protein deubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of immunoglobulin production; P:response to interleukin-1; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:T-helper 1 type immune response; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q9Y4K3 A6NKI7 A8KAB3 D3DR16 Q8NEH5,TNF receptor-associated factor 6,E3 ubiquitin-protein ligase TRAF6;Interleukin-1 signal transducer;RING finger protein 85;RING-type E3 ubiquitin transferase TRAF6 {ECO:0000305};, PF18048;PF02176;, GO:0035631;GO:0005938;GO:0005737;GO:0009898;GO:0005829;GO:0010008;GO:0005811;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0042826;GO:0042802;GO:0031435;GO:0043422;GO:0019901;GO:0047485;GO:0031996;GO:0005164;GO:0031624;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:0000187;GO:0007250;GO:0032147;GO:0019886;GO:0045453;GO:0048468;GO:0071345;GO:0006974;GO:0071222;GO:0002753;GO:0038095;GO:0007249;GO:0001701;GO:0070498;GO:0007254;GO:0031293;GO:0002755;GO:0043011;GO:0043066;GO:0000122;GO:0045892;GO:0001843;GO:0070423;GO:0042475;GO:0001503;GO:0030316;GO:0043065;GO:0051091;GO:0043123;GO:0032735;GO:0032743;GO:0032755;GO:0046330;GO:0043507;GO:1904996;GO:0031666;GO:0051092;GO:1901224;GO:0045672;GO:0031398;GO:0048661;GO:0002726;GO:0042102;GO:0045944;GO:2000679;GO:0051865;GO:0016579;GO:0070534;GO:0000209;GO:0043122;GO:0002637;GO:0070555;GO:0002223;GO:0050852;GO:0042088;GO:0034162;GO:0002224;GO:0033209;, C:CD40 receptor complex; C:cell cortex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endosome membrane; C:lipid droplet; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:histone deacetylase binding; F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase B binding; F:protein kinase binding; F:protein N-terminus binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of MAPK activity; P:activation of NF-kappaB-inducing kinase activity; P:activation of protein kinase activity; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:bone resorption; P:cell development; P:cellular response to cytokine stimulus; P:cellular response to DNA damage stimulus; P:cellular response to lipopolysaccharide; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:in utero embryonic development; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:membrane protein intracellular domain proteolysis; P:MyD88-dependent toll-like receptor signaling pathway; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:nucleotide-binding oligomerization domain containing signaling pathway; P:odontogenesis of dentin-containing tooth; P:ossification; P:osteoclast differentiation; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of lipopolysaccharide-mediated signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of osteoclast differentiation; P:positive regulation of protein ubiquitination; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T cell cytokine production; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein autoubiquitination; P:protein deubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of immunoglobulin production; P:response to interleukin-1; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:T-helper 1 type immune response; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; scaffold19 indexed_genome mRNA 11649194 11655267 . - . ID=transcript_4638;Q9P000 E9PAN2 Q96FI2 Q9H0R0,COMM domain-containing protein 9,, PF07258;, GO:0005829;GO:0005576;GO:1904813;GO:0005794;GO:0005654;GO:0034774;GO:0042632;GO:0043312;GO:0006814;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nucleoplasm; C:secretory granule lumen;, , P:cholesterol homeostasis; P:neutrophil degranulation; P:sodium ion transport;|Q9P000 E9PAN2 Q96FI2 Q9H0R0,COMM domain-containing protein 9,, PF07258;, GO:0005829;GO:0005576;GO:1904813;GO:0005794;GO:0005654;GO:0034774;GO:0042632;GO:0043312;GO:0006814;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:nucleoplasm; C:secretory granule lumen;, , P:cholesterol homeostasis; P:neutrophil degranulation; P:sodium ion transport; scaffold19 indexed_genome mRNA 11687231 11807413 . - . ID=transcript_4639;Q86YD5 B7Z1U3 B9EG81 Q8NBJ0,Low-density lipoprotein receptor class A domain-containing protein 3,, PF00057;, GO:0016021;GO:0005886;GO:0001540;GO:0006898;GO:0070613;, C:integral component of membrane; C:plasma membrane;, F:amyloid-beta binding;, P:receptor-mediated endocytosis; P:regulation of protein processing; scaffold19 indexed_genome mRNA 12090989 12195620 . - . ID=transcript_4640;Q96DX7 D3DR14 Q96QY2 Q9UGK0,Tripartite motif-containing protein 44,Protein DIPB;, PF00643;, GO:0005737;GO:0061630;GO:0008270;GO:0061944;GO:0001961;GO:0002230;GO:1901224;GO:0045893;GO:0050821;GO:0016567;GO:0010468;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of protein K48-linked ubiquitination; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of defense response to virus by host; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:protein ubiquitination; P:regulation of gene expression;|Q96DX7 D3DR14 Q96QY2 Q9UGK0,Tripartite motif-containing protein 44,Protein DIPB;, PF00643;, GO:0005737;GO:0061630;GO:0008270;GO:0061944;GO:0001961;GO:0002230;GO:1901224;GO:0045893;GO:0050821;GO:0016567;GO:0010468;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of protein K48-linked ubiquitination; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of defense response to virus by host; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:protein ubiquitination; P:regulation of gene expression;|Q96DX7 D3DR14 Q96QY2 Q9UGK0,Tripartite motif-containing protein 44,Protein DIPB;, PF00643;, GO:0005737;GO:0061630;GO:0008270;GO:0061944;GO:0001961;GO:0002230;GO:1901224;GO:0045893;GO:0050821;GO:0016567;GO:0010468;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of protein K48-linked ubiquitination; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of defense response to virus by host; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:protein ubiquitination; P:regulation of gene expression; scaffold19 indexed_genome mRNA 12257752 12260482 . + . ID=transcript_4641;Q6UXH9 A8MQ58 B7ZA73 Q5EBL7 Q5JPI4 Q6N062 Q71RE9 Q96JW2 Q9Y432,Inactive serine protease PAMR1,Peptidase domain-containing protein associated with muscle regeneration 1;Regeneration-associated muscle protease homolog;, PF00431;PF00008;PF00084;PF00089;, GO:0005576;GO:0005509;, C:extracellular region;, F:calcium ion binding; scaffold19 indexed_genome mRNA 12358893 12421572 . + . ID=transcript_4642;Q6UXH9 A8MQ58 B7ZA73 Q5EBL7 Q5JPI4 Q6N062 Q71RE9 Q96JW2 Q9Y432,Inactive serine protease PAMR1,Peptidase domain-containing protein associated with muscle regeneration 1;Regeneration-associated muscle protease homolog;, PF00431;PF00008;PF00084;PF00089;, GO:0005576;GO:0005509;, C:extracellular region;, F:calcium ion binding; scaffold19 indexed_genome mRNA 12435992 12562737 . + . ID=transcript_4643;P43004 B4DQE9 Q14417 Q541G6 U3KQQ4,Excitatory amino acid transporter 2,Glutamate/aspartate transporter II;Sodium-dependent glutamate/aspartate transporter 2;Solute carrier family 1 member 2;, PF00375;, GO:0097449;GO:0044297;GO:0009986;GO:0005887;GO:0099056;GO:0016020;GO:0098796;GO:0045121;GO:0005886;GO:0015501;GO:0005314;GO:0005313;GO:0046872;GO:0007268;GO:0070779;GO:0006811;GO:0070778;GO:0098712;GO:0015813;GO:0006836;GO:0070207;GO:0070633;GO:0150104;, C:astrocyte projection; C:cell body; C:cell surface; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:membrane; C:membrane protein complex; C:membrane raft; C:plasma membrane;, F:glutamate:sodium symporter activity; F:high-affinity glutamate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:metal ion binding;, P:chemical synaptic transmission; P:D-aspartate import across plasma membrane; P:ion transport; P:L-aspartate transmembrane transport; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:protein homotrimerization; P:transepithelial transport; P:transport across blood-brain barrier; scaffold19 indexed_genome mRNA 12624429 12713528 . - . ID=transcript_4644;Q96J24 Q9H5A5 Q9UC28 Q9UC29 Q9UC30 Q9UCB0 Q9UJ36,CD44 antigen,CDw44;Epican;Extracellular matrix receptor III;GP90 lymphocyte homing/adhesion receptor;HUTCH-I;Heparan sulfate proteoglycan;Hermes antigen;Hyaluronate receptor;Phagocytic glycoprotein 1;Phagocytic glycoprotein I;, PF00193;, GO:0016324;GO:0016323;GO:0042995;GO:0009986;GO:0005829;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0031258;GO:0035692;GO:0005902;GO:0005886;GO:0030667;GO:0005518;GO:0005540;GO:0004888;GO:0051216;GO:0007155;GO:0016477;GO:0098609;GO:0007160;GO:0044344;GO:0022617;GO:0030198;GO:0030214;GO:0006954;GO:0060333;GO:0050900;GO:0070487;GO:0043066;GO:0043154;GO:0043518;GO:1902166;GO:0043312;GO:0070374;GO:0034116;GO:1900625;GO:0033138;GO:0050731;GO:2000392;GO:0042110;GO:0044319;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell projection; C:cell surface; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:lamellipodium membrane; C:macrophage migration inhibitory factor receptor complex; C:microvillus; C:plasma membrane; C:secretory granule membrane;, F:collagen binding; F:hyaluronic acid binding; F:transmembrane signaling receptor activity;, P:cartilage development; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-matrix adhesion; P:cellular response to fibroblast growth factor stimulus; P:extracellular matrix disassembly; P:extracellular matrix organization; P:hyaluronan catabolic process; P:inflammatory response; P:interferon-gamma-mediated signaling pathway; P:leukocyte migration; P:monocyte aggregation; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:neutrophil degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of monocyte aggregation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of lamellipodium morphogenesis; P:T cell activation; P:wound healing, spreading of cells;|Q96J24 Q9H5A5 Q9UC28 Q9UC29 Q9UC30 Q9UCB0 Q9UJ36,CD44 antigen,CDw44;Epican;Extracellular matrix receptor III;GP90 lymphocyte homing/adhesion receptor;HUTCH-I;Heparan sulfate proteoglycan;Hermes antigen;Hyaluronate receptor;Phagocytic glycoprotein 1;Phagocytic glycoprotein I;, PF00193;, GO:0016324;GO:0016323;GO:0042995;GO:0009986;GO:0005829;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0031258;GO:0035692;GO:0005902;GO:0005886;GO:0030667;GO:0005518;GO:0005540;GO:0004888;GO:0051216;GO:0007155;GO:0016477;GO:0098609;GO:0007160;GO:0044344;GO:0022617;GO:0030198;GO:0030214;GO:0006954;GO:0060333;GO:0050900;GO:0070487;GO:0043066;GO:0043154;GO:0043518;GO:1902166;GO:0043312;GO:0070374;GO:0034116;GO:1900625;GO:0033138;GO:0050731;GO:2000392;GO:0042110;GO:0044319;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell projection; C:cell surface; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:lamellipodium membrane; C:macrophage migration inhibitory factor receptor complex; C:microvillus; C:plasma membrane; C:secretory granule membrane;, F:collagen binding; F:hyaluronic acid binding; F:transmembrane signaling receptor activity;, P:cartilage development; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-matrix adhesion; P:cellular response to fibroblast growth factor stimulus; P:extracellular matrix disassembly; P:extracellular matrix organization; P:hyaluronan catabolic process; P:inflammatory response; P:interferon-gamma-mediated signaling pathway; P:leukocyte migration; P:monocyte aggregation; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:neutrophil degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of monocyte aggregation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of lamellipodium morphogenesis; P:T cell activation; P:wound healing, spreading of cells;|Q96J24 Q9H5A5 Q9UC28 Q9UC29 Q9UC30 Q9UCB0 Q9UJ36,CD44 antigen,CDw44;Epican;Extracellular matrix receptor III;GP90 lymphocyte homing/adhesion receptor;HUTCH-I;Heparan sulfate proteoglycan;Hermes antigen;Hyaluronate receptor;Phagocytic glycoprotein 1;Phagocytic glycoprotein I;, PF00193;, GO:0016324;GO:0016323;GO:0042995;GO:0009986;GO:0005829;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0031258;GO:0035692;GO:0005902;GO:0005886;GO:0030667;GO:0005518;GO:0005540;GO:0004888;GO:0051216;GO:0007155;GO:0016477;GO:0098609;GO:0007160;GO:0044344;GO:0022617;GO:0030198;GO:0030214;GO:0006954;GO:0060333;GO:0050900;GO:0070487;GO:0043066;GO:0043154;GO:0043518;GO:1902166;GO:0043312;GO:0070374;GO:0034116;GO:1900625;GO:0033138;GO:0050731;GO:2000392;GO:0042110;GO:0044319;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell projection; C:cell surface; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:lamellipodium membrane; C:macrophage migration inhibitory factor receptor complex; C:microvillus; C:plasma membrane; C:secretory granule membrane;, F:collagen binding; F:hyaluronic acid binding; F:transmembrane signaling receptor activity;, P:cartilage development; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-matrix adhesion; P:cellular response to fibroblast growth factor stimulus; P:extracellular matrix disassembly; P:extracellular matrix organization; P:hyaluronan catabolic process; P:inflammatory response; P:interferon-gamma-mediated signaling pathway; P:leukocyte migration; P:monocyte aggregation; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:neutrophil degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of monocyte aggregation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of lamellipodium morphogenesis; P:T cell activation; P:wound healing, spreading of cells;|Q96J24 Q9H5A5 Q9UC28 Q9UC29 Q9UC30 Q9UCB0 Q9UJ36,CD44 antigen,CDw44;Epican;Extracellular matrix receptor III;GP90 lymphocyte homing/adhesion receptor;HUTCH-I;Heparan sulfate proteoglycan;Hermes antigen;Hyaluronate receptor;Phagocytic glycoprotein 1;Phagocytic glycoprotein I;, PF00193;, GO:0016324;GO:0016323;GO:0042995;GO:0009986;GO:0005829;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0031258;GO:0035692;GO:0005902;GO:0005886;GO:0030667;GO:0005518;GO:0005540;GO:0004888;GO:0051216;GO:0007155;GO:0016477;GO:0098609;GO:0007160;GO:0044344;GO:0022617;GO:0030198;GO:0030214;GO:0006954;GO:0060333;GO:0050900;GO:0070487;GO:0043066;GO:0043154;GO:0043518;GO:1902166;GO:0043312;GO:0070374;GO:0034116;GO:1900625;GO:0033138;GO:0050731;GO:2000392;GO:0042110;GO:0044319;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell projection; C:cell surface; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:lamellipodium membrane; C:macrophage migration inhibitory factor receptor complex; C:microvillus; C:plasma membrane; C:secretory granule membrane;, F:collagen binding; F:hyaluronic acid binding; F:transmembrane signaling receptor activity;, P:cartilage development; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-matrix adhesion; P:cellular response to fibroblast growth factor stimulus; P:extracellular matrix disassembly; P:extracellular matrix organization; P:hyaluronan catabolic process; P:inflammatory response; P:interferon-gamma-mediated signaling pathway; P:leukocyte migration; P:monocyte aggregation; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:neutrophil degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of monocyte aggregation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of lamellipodium morphogenesis; P:T cell activation; P:wound healing, spreading of cells;|Q96J24 Q9H5A5 Q9UC28 Q9UC29 Q9UC30 Q9UCB0 Q9UJ36,CD44 antigen,CDw44;Epican;Extracellular matrix receptor III;GP90 lymphocyte homing/adhesion receptor;HUTCH-I;Heparan sulfate proteoglycan;Hermes antigen;Hyaluronate receptor;Phagocytic glycoprotein 1;Phagocytic glycoprotein I;, PF00193;, GO:0016324;GO:0016323;GO:0042995;GO:0009986;GO:0005829;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0031258;GO:0035692;GO:0005902;GO:0005886;GO:0030667;GO:0005518;GO:0005540;GO:0004888;GO:0051216;GO:0007155;GO:0016477;GO:0098609;GO:0007160;GO:0044344;GO:0022617;GO:0030198;GO:0030214;GO:0006954;GO:0060333;GO:0050900;GO:0070487;GO:0043066;GO:0043154;GO:0043518;GO:1902166;GO:0043312;GO:0070374;GO:0034116;GO:1900625;GO:0033138;GO:0050731;GO:2000392;GO:0042110;GO:0044319;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell projection; C:cell surface; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:lamellipodium membrane; C:macrophage migration inhibitory factor receptor complex; C:microvillus; C:plasma membrane; C:secretory granule membrane;, F:collagen binding; F:hyaluronic acid binding; F:transmembrane signaling receptor activity;, P:cartilage development; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-matrix adhesion; P:cellular response to fibroblast growth factor stimulus; P:extracellular matrix disassembly; P:extracellular matrix organization; P:hyaluronan catabolic process; P:inflammatory response; P:interferon-gamma-mediated signaling pathway; P:leukocyte migration; P:monocyte aggregation; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:neutrophil degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of monocyte aggregation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of lamellipodium morphogenesis; P:T cell activation; P:wound healing, spreading of cells;|Q96J24 Q9H5A5 Q9UC28 Q9UC29 Q9UC30 Q9UCB0 Q9UJ36,CD44 antigen,CDw44;Epican;Extracellular matrix receptor III;GP90 lymphocyte homing/adhesion receptor;HUTCH-I;Heparan sulfate proteoglycan;Hermes antigen;Hyaluronate receptor;Phagocytic glycoprotein 1;Phagocytic glycoprotein I;, PF00193;, GO:0016324;GO:0016323;GO:0042995;GO:0009986;GO:0005829;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0031258;GO:0035692;GO:0005902;GO:0005886;GO:0030667;GO:0005518;GO:0005540;GO:0004888;GO:0051216;GO:0007155;GO:0016477;GO:0098609;GO:0007160;GO:0044344;GO:0022617;GO:0030198;GO:0030214;GO:0006954;GO:0060333;GO:0050900;GO:0070487;GO:0043066;GO:0043154;GO:0043518;GO:1902166;GO:0043312;GO:0070374;GO:0034116;GO:1900625;GO:0033138;GO:0050731;GO:2000392;GO:0042110;GO:0044319;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell projection; C:cell surface; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:lamellipodium membrane; C:macrophage migration inhibitory factor receptor complex; C:microvillus; C:plasma membrane; C:secretory granule membrane;, F:collagen binding; F:hyaluronic acid binding; F:transmembrane signaling receptor activity;, P:cartilage development; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-matrix adhesion; P:cellular response to fibroblast growth factor stimulus; P:extracellular matrix disassembly; P:extracellular matrix organization; P:hyaluronan catabolic process; P:inflammatory response; P:interferon-gamma-mediated signaling pathway; P:leukocyte migration; P:monocyte aggregation; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:neutrophil degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of monocyte aggregation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of lamellipodium morphogenesis; P:T cell activation; P:wound healing, spreading of cells; scaffold19 indexed_genome mRNA 12850315 12922184 . - . ID=transcript_4645;O00330 B4DW62 D3DR11 E9PB14 E9PBP7 O60221 Q96FV8 Q99783,Pyruvate dehydrogenase protein X component, mitochondrial,Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex;E3-binding protein;Lipoyl-containing pyruvate dehydrogenase complex component X;proX;, PF00198;PF00364;PF02817;, GO:0005759;GO:0005739;GO:0045254;GO:0016746;GO:0061732;GO:0006090;, C:mitochondrial matrix; C:mitochondrion; C:pyruvate dehydrogenase complex;, F:transferase activity, transferring acyl groups;, P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:pyruvate metabolic process;|O00330 B4DW62 D3DR11 E9PB14 E9PBP7 O60221 Q96FV8 Q99783,Pyruvate dehydrogenase protein X component, mitochondrial,Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex;E3-binding protein;Lipoyl-containing pyruvate dehydrogenase complex component X;proX;, PF00198;PF00364;PF02817;, GO:0005759;GO:0005739;GO:0045254;GO:0016746;GO:0061732;GO:0006090;, C:mitochondrial matrix; C:mitochondrion; C:pyruvate dehydrogenase complex;, F:transferase activity, transferring acyl groups;, P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:pyruvate metabolic process;|O00330 B4DW62 D3DR11 E9PB14 E9PBP7 O60221 Q96FV8 Q99783,Pyruvate dehydrogenase protein X component, mitochondrial,Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex;E3-binding protein;Lipoyl-containing pyruvate dehydrogenase complex component X;proX;, PF00198;PF00364;PF02817;, GO:0005759;GO:0005739;GO:0045254;GO:0016746;GO:0061732;GO:0006090;, C:mitochondrial matrix; C:mitochondrion; C:pyruvate dehydrogenase complex;, F:transferase activity, transferring acyl groups;, P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:pyruvate metabolic process; scaffold19 indexed_genome mRNA 12922280 12949697 . + . ID=transcript_4646;Q96GX9 A8K9D3 Q6PJX6 Q8WVU2 Q96HK2 Q9Y318,Methylthioribulose-1-phosphate dehydratase {ECO:0000255|HAMAP-Rule:MF_03116},APAF1-interacting protein {ECO:0000255|HAMAP-Rule:MF_03116};, PF00596;, GO:0005737;GO:0005829;GO:0042802;GO:0046570;GO:0008270;GO:0006915;GO:0019509;GO:0019284;GO:0043066;GO:0051289;GO:0070269;GO:0070372;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:methylthioribulose 1-phosphate dehydratase activity; F:zinc ion binding;, P:apoptotic process; P:L-methionine salvage from methylthioadenosine; P:L-methionine salvage from S-adenosylmethionine; P:negative regulation of apoptotic process; P:protein homotetramerization; P:pyroptosis; P:regulation of ERK1 and ERK2 cascade;|Q96GX9 A8K9D3 Q6PJX6 Q8WVU2 Q96HK2 Q9Y318,Methylthioribulose-1-phosphate dehydratase {ECO:0000255|HAMAP-Rule:MF_03116},APAF1-interacting protein {ECO:0000255|HAMAP-Rule:MF_03116};, PF00596;, GO:0005737;GO:0005829;GO:0042802;GO:0046570;GO:0008270;GO:0006915;GO:0019509;GO:0019284;GO:0043066;GO:0051289;GO:0070269;GO:0070372;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:methylthioribulose 1-phosphate dehydratase activity; F:zinc ion binding;, P:apoptotic process; P:L-methionine salvage from methylthioadenosine; P:L-methionine salvage from S-adenosylmethionine; P:negative regulation of apoptotic process; P:protein homotetramerization; P:pyroptosis; P:regulation of ERK1 and ERK2 cascade;|Q96GX9 A8K9D3 Q6PJX6 Q8WVU2 Q96HK2 Q9Y318,Methylthioribulose-1-phosphate dehydratase {ECO:0000255|HAMAP-Rule:MF_03116},APAF1-interacting protein {ECO:0000255|HAMAP-Rule:MF_03116};, PF00596;, GO:0005737;GO:0005829;GO:0042802;GO:0046570;GO:0008270;GO:0006915;GO:0019509;GO:0019284;GO:0043066;GO:0051289;GO:0070269;GO:0070372;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:methylthioribulose 1-phosphate dehydratase activity; F:zinc ion binding;, P:apoptotic process; P:L-methionine salvage from methylthioadenosine; P:L-methionine salvage from S-adenosylmethionine; P:negative regulation of apoptotic process; P:protein homotetramerization; P:pyroptosis; P:regulation of ERK1 and ERK2 cascade;|Q96GX9 A8K9D3 Q6PJX6 Q8WVU2 Q96HK2 Q9Y318,Methylthioribulose-1-phosphate dehydratase {ECO:0000255|HAMAP-Rule:MF_03116},APAF1-interacting protein {ECO:0000255|HAMAP-Rule:MF_03116};, PF00596;, GO:0005737;GO:0005829;GO:0042802;GO:0046570;GO:0008270;GO:0006915;GO:0019509;GO:0019284;GO:0043066;GO:0051289;GO:0070269;GO:0070372;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:methylthioribulose 1-phosphate dehydratase activity; F:zinc ion binding;, P:apoptotic process; P:L-methionine salvage from methylthioadenosine; P:L-methionine salvage from S-adenosylmethionine; P:negative regulation of apoptotic process; P:protein homotetramerization; P:pyroptosis; P:regulation of ERK1 and ERK2 cascade; scaffold19 indexed_genome mRNA 13112738 13143439 . - . ID=transcript_4647;Q9NZC4 D3DR08 D3DR10 E9PSB2 Q9H509 Q9UKF9 Q9Y5V4 Q9Y5V5,ETS homologous factor,ETS domain-containing transcription factor;Epithelium-specific Ets transcription factor 3;, PF00178;PF02198;, GO:0000785;GO:0005794;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0030154;GO:0030855;GO:0050673;GO:0007275;GO:0045944;GO:0045893;GO:0006357;GO:0006366;, C:chromatin; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell differentiation; P:epithelial cell differentiation; P:epithelial cell proliferation; P:multicellular organism development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold19 indexed_genome mRNA 13318085 13318783 . + . ID=transcript_4648;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold19 indexed_genome mRNA 13321205 13357414 . - . ID=transcript_4649;P04040 A8K6C0 B2RCZ9 D3DR07 Q2M1U4 Q4VXX5 Q9BWT9 Q9UC85,Catalase,, PF00199;PF06628;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005794;GO:0043231;GO:0005764;GO:0016020;GO:0005758;GO:0005739;GO:0005782;GO:0005778;GO:0005777;GO:0005886;GO:0032991;GO:0034774;GO:0004046;GO:0016209;GO:0004096;GO:0019899;GO:0020037;GO:0042802;GO:0046872;GO:0050661;GO:0016684;GO:0000268;GO:0042803;GO:0009060;GO:0007568;GO:0071363;GO:0034599;GO:0008203;GO:0020027;GO:0042744;GO:0043066;GO:0032088;GO:0043312;GO:0001649;GO:0051781;GO:0051092;GO:0014068;GO:0008104;GO:0014823;GO:0046686;GO:0042493;GO:0032355;GO:0045471;GO:0070542;GO:0042542;GO:0055093;GO:0001666;GO:0014854;GO:0032868;GO:0033591;GO:0010288;GO:0009642;GO:0010193;GO:0080184;GO:0000302;GO:0033189;GO:0033197;GO:0006641;GO:0001657;GO:0009650;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:aminoacylase activity; F:antioxidant activity; F:catalase activity; F:enzyme binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:NADP binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxisome targeting sequence binding; F:protein homodimerization activity;, P:aerobic respiration; P:aging; P:cellular response to growth factor stimulus; P:cellular response to oxidative stress; P:cholesterol metabolic process; P:hemoglobin metabolic process; P:hydrogen peroxide catabolic process; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:neutrophil degranulation; P:osteoblast differentiation; P:positive regulation of cell division; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein localization; P:response to activity; P:response to cadmium ion; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to fatty acid; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to hypoxia; P:response to inactivity; P:response to insulin; P:response to L-ascorbic acid; P:response to lead ion; P:response to light intensity; P:response to ozone; P:response to phenylpropanoid; P:response to reactive oxygen species; P:response to vitamin A; P:response to vitamin E; P:triglyceride metabolic process; P:ureteric bud development; P:UV protection;|P04040 A8K6C0 B2RCZ9 D3DR07 Q2M1U4 Q4VXX5 Q9BWT9 Q9UC85,Catalase,, PF00199;PF06628;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005794;GO:0043231;GO:0005764;GO:0016020;GO:0005758;GO:0005739;GO:0005782;GO:0005778;GO:0005777;GO:0005886;GO:0032991;GO:0034774;GO:0004046;GO:0016209;GO:0004096;GO:0019899;GO:0020037;GO:0042802;GO:0046872;GO:0050661;GO:0016684;GO:0000268;GO:0042803;GO:0009060;GO:0007568;GO:0071363;GO:0034599;GO:0008203;GO:0020027;GO:0042744;GO:0043066;GO:0032088;GO:0043312;GO:0001649;GO:0051781;GO:0051092;GO:0014068;GO:0008104;GO:0014823;GO:0046686;GO:0042493;GO:0032355;GO:0045471;GO:0070542;GO:0042542;GO:0055093;GO:0001666;GO:0014854;GO:0032868;GO:0033591;GO:0010288;GO:0009642;GO:0010193;GO:0080184;GO:0000302;GO:0033189;GO:0033197;GO:0006641;GO:0001657;GO:0009650;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:aminoacylase activity; F:antioxidant activity; F:catalase activity; F:enzyme binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:NADP binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxisome targeting sequence binding; F:protein homodimerization activity;, P:aerobic respiration; P:aging; P:cellular response to growth factor stimulus; P:cellular response to oxidative stress; P:cholesterol metabolic process; P:hemoglobin metabolic process; P:hydrogen peroxide catabolic process; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:neutrophil degranulation; P:osteoblast differentiation; P:positive regulation of cell division; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein localization; P:response to activity; P:response to cadmium ion; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to fatty acid; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to hypoxia; P:response to inactivity; P:response to insulin; P:response to L-ascorbic acid; P:response to lead ion; P:response to light intensity; P:response to ozone; P:response to phenylpropanoid; P:response to reactive oxygen species; P:response to vitamin A; P:response to vitamin E; P:triglyceride metabolic process; P:ureteric bud development; P:UV protection;|P04040 A8K6C0 B2RCZ9 D3DR07 Q2M1U4 Q4VXX5 Q9BWT9 Q9UC85,Catalase,, PF00199;PF06628;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005794;GO:0043231;GO:0005764;GO:0016020;GO:0005758;GO:0005739;GO:0005782;GO:0005778;GO:0005777;GO:0005886;GO:0032991;GO:0034774;GO:0004046;GO:0016209;GO:0004096;GO:0019899;GO:0020037;GO:0042802;GO:0046872;GO:0050661;GO:0016684;GO:0000268;GO:0042803;GO:0009060;GO:0007568;GO:0071363;GO:0034599;GO:0008203;GO:0020027;GO:0042744;GO:0043066;GO:0032088;GO:0043312;GO:0001649;GO:0051781;GO:0051092;GO:0014068;GO:0008104;GO:0014823;GO:0046686;GO:0042493;GO:0032355;GO:0045471;GO:0070542;GO:0042542;GO:0055093;GO:0001666;GO:0014854;GO:0032868;GO:0033591;GO:0010288;GO:0009642;GO:0010193;GO:0080184;GO:0000302;GO:0033189;GO:0033197;GO:0006641;GO:0001657;GO:0009650;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:aminoacylase activity; F:antioxidant activity; F:catalase activity; F:enzyme binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:NADP binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxisome targeting sequence binding; F:protein homodimerization activity;, P:aerobic respiration; P:aging; P:cellular response to growth factor stimulus; P:cellular response to oxidative stress; P:cholesterol metabolic process; P:hemoglobin metabolic process; P:hydrogen peroxide catabolic process; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:neutrophil degranulation; P:osteoblast differentiation; P:positive regulation of cell division; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein localization; P:response to activity; P:response to cadmium ion; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to fatty acid; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to hypoxia; P:response to inactivity; P:response to insulin; P:response to L-ascorbic acid; P:response to lead ion; P:response to light intensity; P:response to ozone; P:response to phenylpropanoid; P:response to reactive oxygen species; P:response to vitamin A; P:response to vitamin E; P:triglyceride metabolic process; P:ureteric bud development; P:UV protection;|P04040 A8K6C0 B2RCZ9 D3DR07 Q2M1U4 Q4VXX5 Q9BWT9 Q9UC85,Catalase,, PF00199;PF06628;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005794;GO:0043231;GO:0005764;GO:0016020;GO:0005758;GO:0005739;GO:0005782;GO:0005778;GO:0005777;GO:0005886;GO:0032991;GO:0034774;GO:0004046;GO:0016209;GO:0004096;GO:0019899;GO:0020037;GO:0042802;GO:0046872;GO:0050661;GO:0016684;GO:0000268;GO:0042803;GO:0009060;GO:0007568;GO:0071363;GO:0034599;GO:0008203;GO:0020027;GO:0042744;GO:0043066;GO:0032088;GO:0043312;GO:0001649;GO:0051781;GO:0051092;GO:0014068;GO:0008104;GO:0014823;GO:0046686;GO:0042493;GO:0032355;GO:0045471;GO:0070542;GO:0042542;GO:0055093;GO:0001666;GO:0014854;GO:0032868;GO:0033591;GO:0010288;GO:0009642;GO:0010193;GO:0080184;GO:0000302;GO:0033189;GO:0033197;GO:0006641;GO:0001657;GO:0009650;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:aminoacylase activity; F:antioxidant activity; F:catalase activity; F:enzyme binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:NADP binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxisome targeting sequence binding; F:protein homodimerization activity;, P:aerobic respiration; P:aging; P:cellular response to growth factor stimulus; P:cellular response to oxidative stress; P:cholesterol metabolic process; P:hemoglobin metabolic process; P:hydrogen peroxide catabolic process; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:neutrophil degranulation; P:osteoblast differentiation; P:positive regulation of cell division; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein localization; P:response to activity; P:response to cadmium ion; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to fatty acid; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to hypoxia; P:response to inactivity; P:response to insulin; P:response to L-ascorbic acid; P:response to lead ion; P:response to light intensity; P:response to ozone; P:response to phenylpropanoid; P:response to reactive oxygen species; P:response to vitamin A; P:response to vitamin E; P:triglyceride metabolic process; P:ureteric bud development; P:UV protection;|P04040 A8K6C0 B2RCZ9 D3DR07 Q2M1U4 Q4VXX5 Q9BWT9 Q9UC85,Catalase,, PF00199;PF06628;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005794;GO:0043231;GO:0005764;GO:0016020;GO:0005758;GO:0005739;GO:0005782;GO:0005778;GO:0005777;GO:0005886;GO:0032991;GO:0034774;GO:0004046;GO:0016209;GO:0004096;GO:0019899;GO:0020037;GO:0042802;GO:0046872;GO:0050661;GO:0016684;GO:0000268;GO:0042803;GO:0009060;GO:0007568;GO:0071363;GO:0034599;GO:0008203;GO:0020027;GO:0042744;GO:0043066;GO:0032088;GO:0043312;GO:0001649;GO:0051781;GO:0051092;GO:0014068;GO:0008104;GO:0014823;GO:0046686;GO:0042493;GO:0032355;GO:0045471;GO:0070542;GO:0042542;GO:0055093;GO:0001666;GO:0014854;GO:0032868;GO:0033591;GO:0010288;GO:0009642;GO:0010193;GO:0080184;GO:0000302;GO:0033189;GO:0033197;GO:0006641;GO:0001657;GO:0009650;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:aminoacylase activity; F:antioxidant activity; F:catalase activity; F:enzyme binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:NADP binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxisome targeting sequence binding; F:protein homodimerization activity;, P:aerobic respiration; P:aging; P:cellular response to growth factor stimulus; P:cellular response to oxidative stress; P:cholesterol metabolic process; P:hemoglobin metabolic process; P:hydrogen peroxide catabolic process; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:neutrophil degranulation; P:osteoblast differentiation; P:positive regulation of cell division; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein localization; P:response to activity; P:response to cadmium ion; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to fatty acid; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to hypoxia; P:response to inactivity; P:response to insulin; P:response to L-ascorbic acid; P:response to lead ion; P:response to light intensity; P:response to ozone; P:response to phenylpropanoid; P:response to reactive oxygen species; P:response to vitamin A; P:response to vitamin E; P:triglyceride metabolic process; P:ureteric bud development; P:UV protection;|P04040 A8K6C0 B2RCZ9 D3DR07 Q2M1U4 Q4VXX5 Q9BWT9 Q9UC85,Catalase,, PF00199;PF06628;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005794;GO:0043231;GO:0005764;GO:0016020;GO:0005758;GO:0005739;GO:0005782;GO:0005778;GO:0005777;GO:0005886;GO:0032991;GO:0034774;GO:0004046;GO:0016209;GO:0004096;GO:0019899;GO:0020037;GO:0042802;GO:0046872;GO:0050661;GO:0016684;GO:0000268;GO:0042803;GO:0009060;GO:0007568;GO:0071363;GO:0034599;GO:0008203;GO:0020027;GO:0042744;GO:0043066;GO:0032088;GO:0043312;GO:0001649;GO:0051781;GO:0051092;GO:0014068;GO:0008104;GO:0014823;GO:0046686;GO:0042493;GO:0032355;GO:0045471;GO:0070542;GO:0042542;GO:0055093;GO:0001666;GO:0014854;GO:0032868;GO:0033591;GO:0010288;GO:0009642;GO:0010193;GO:0080184;GO:0000302;GO:0033189;GO:0033197;GO:0006641;GO:0001657;GO:0009650;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:aminoacylase activity; F:antioxidant activity; F:catalase activity; F:enzyme binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:NADP binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxisome targeting sequence binding; F:protein homodimerization activity;, P:aerobic respiration; P:aging; P:cellular response to growth factor stimulus; P:cellular response to oxidative stress; P:cholesterol metabolic process; P:hemoglobin metabolic process; P:hydrogen peroxide catabolic process; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:neutrophil degranulation; P:osteoblast differentiation; P:positive regulation of cell division; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein localization; P:response to activity; P:response to cadmium ion; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to fatty acid; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to hypoxia; P:response to inactivity; P:response to insulin; P:response to L-ascorbic acid; P:response to lead ion; P:response to light intensity; P:response to ozone; P:response to phenylpropanoid; P:response to reactive oxygen species; P:response to vitamin A; P:response to vitamin E; P:triglyceride metabolic process; P:ureteric bud development; P:UV protection; scaffold19 indexed_genome mRNA 13398388 13580855 . + . ID=transcript_4650;Q8N961 A8K6S9 E9PRW7 Q52LD6 Q6MZW4 Q8NB44,Ankyrin repeat and BTB/POZ domain-containing protein 2,, PF00023;PF12796;PF00651;, GO:0046982;GO:0097237;, , F:protein heterodimerization activity;, P:cellular response to toxic substance;|Q8N961 A8K6S9 E9PRW7 Q52LD6 Q6MZW4 Q8NB44,Ankyrin repeat and BTB/POZ domain-containing protein 2,, PF00023;PF12796;PF00651;, GO:0046982;GO:0097237;, , F:protein heterodimerization activity;, P:cellular response to toxic substance;|Q8N961 A8K6S9 E9PRW7 Q52LD6 Q6MZW4 Q8NB44,Ankyrin repeat and BTB/POZ domain-containing protein 2,, PF00023;PF12796;PF00651;, GO:0046982;GO:0097237;, , F:protein heterodimerization activity;, P:cellular response to toxic substance;|Q8N961 A8K6S9 E9PRW7 Q52LD6 Q6MZW4 Q8NB44,Ankyrin repeat and BTB/POZ domain-containing protein 2,, PF00023;PF12796;PF00651;, GO:0046982;GO:0097237;, , F:protein heterodimerization activity;, P:cellular response to toxic substance; scaffold19 indexed_genome mRNA 13586090 13592410 . - . ID=transcript_4651;Q9H0A0 B4DFD5 E7ESU4 E9PMN9 Q86WK5 Q9C0F4 Q9HA61 Q9NVF2,RNA cytidine acetyltransferase {ECO:0000255|HAMAP-Rule:MF_03211, ECO:0000303|PubMed:25411247},18S rRNA cytosine acetyltransferase {ECO:0000255|HAMAP-Rule:MF_03211, ECO:0000303|PubMed:25653167};N-acetyltransferase 10 {ECO:0000255|HAMAP-Rule:MF_03211};N-acetyltransferase-like protein {ECO:0000303|PubMed:14592445};, PF08351;PF13718;PF05127;PF13725;, GO:0000781;GO:0016020;GO:0030496;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0005524;GO:0070182;GO:0106162;GO:0008080;GO:0003723;GO:1990883;GO:0000049;GO:0032211;GO:0045727;GO:0006473;GO:0010824;GO:1904812;GO:0000154;GO:0051391;, C:chromosome, telomeric region; C:membrane; C:midbody; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:ATP binding; F:DNA polymerase binding; F:mRNA N-acetyltransferase activity; F:N-acetyltransferase activity; F:RNA binding; F:rRNA cytidine N-acetyltransferase activity; F:tRNA binding;, P:negative regulation of telomere maintenance via telomerase; P:positive regulation of translation; P:protein acetylation; P:regulation of centrosome duplication; P:rRNA acetylation involved in maturation of SSU-rRNA; P:rRNA modification; P:tRNA acetylation; scaffold19 indexed_genome mRNA 13597487 13626799 . - . ID=transcript_4652;Q9H0A0 B4DFD5 E7ESU4 E9PMN9 Q86WK5 Q9C0F4 Q9HA61 Q9NVF2,RNA cytidine acetyltransferase {ECO:0000255|HAMAP-Rule:MF_03211, ECO:0000303|PubMed:25411247},18S rRNA cytosine acetyltransferase {ECO:0000255|HAMAP-Rule:MF_03211, ECO:0000303|PubMed:25653167};N-acetyltransferase 10 {ECO:0000255|HAMAP-Rule:MF_03211};N-acetyltransferase-like protein {ECO:0000303|PubMed:14592445};, PF08351;PF13718;PF05127;PF13725;, GO:0000781;GO:0016020;GO:0030496;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0005524;GO:0070182;GO:0106162;GO:0008080;GO:0003723;GO:1990883;GO:0000049;GO:0032211;GO:0045727;GO:0006473;GO:0010824;GO:1904812;GO:0000154;GO:0051391;, C:chromosome, telomeric region; C:membrane; C:midbody; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:ATP binding; F:DNA polymerase binding; F:mRNA N-acetyltransferase activity; F:N-acetyltransferase activity; F:RNA binding; F:rRNA cytidine N-acetyltransferase activity; F:tRNA binding;, P:negative regulation of telomere maintenance via telomerase; P:positive regulation of translation; P:protein acetylation; P:regulation of centrosome duplication; P:rRNA acetylation involved in maturation of SSU-rRNA; P:rRNA modification; P:tRNA acetylation;|Q9H0A0 B4DFD5 E7ESU4 E9PMN9 Q86WK5 Q9C0F4 Q9HA61 Q9NVF2,RNA cytidine acetyltransferase {ECO:0000255|HAMAP-Rule:MF_03211, ECO:0000303|PubMed:25411247},18S rRNA cytosine acetyltransferase {ECO:0000255|HAMAP-Rule:MF_03211, ECO:0000303|PubMed:25653167};N-acetyltransferase 10 {ECO:0000255|HAMAP-Rule:MF_03211};N-acetyltransferase-like protein {ECO:0000303|PubMed:14592445};, PF08351;PF13718;PF05127;PF13725;, GO:0000781;GO:0016020;GO:0030496;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0005524;GO:0070182;GO:0106162;GO:0008080;GO:0003723;GO:1990883;GO:0000049;GO:0032211;GO:0045727;GO:0006473;GO:0010824;GO:1904812;GO:0000154;GO:0051391;, C:chromosome, telomeric region; C:membrane; C:midbody; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:ATP binding; F:DNA polymerase binding; F:mRNA N-acetyltransferase activity; F:N-acetyltransferase activity; F:RNA binding; F:rRNA cytidine N-acetyltransferase activity; F:tRNA binding;, P:negative regulation of telomere maintenance via telomerase; P:positive regulation of translation; P:protein acetylation; P:regulation of centrosome duplication; P:rRNA acetylation involved in maturation of SSU-rRNA; P:rRNA modification; P:tRNA acetylation; scaffold19 indexed_genome mRNA 13629566 13665092 . - . ID=transcript_4653;Q14444 A6NMY7 D3DR06 Q15074 Q6IMN4 Q6IMN7 Q9BV09,Caprin-1,Cell cycle-associated protein 1;Cytoplasmic activation- and proliferation-associated protein 1;GPI-anchored membrane protein 1;GPI-anchored protein p137;Membrane component chromosome 11 surface marker 1;RNA granule protein 105;, PF12287;PF18293;, GO:0031252;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0030027;GO:0016020;GO:0000932;GO:0045202;GO:0003723;GO:0017148;GO:0050775;GO:0061003;, C:cell leading edge; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:lamellipodium; C:membrane; C:P-body; C:synapse;, F:RNA binding;, P:negative regulation of translation; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine morphogenesis;|Q14444 A6NMY7 D3DR06 Q15074 Q6IMN4 Q6IMN7 Q9BV09,Caprin-1,Cell cycle-associated protein 1;Cytoplasmic activation- and proliferation-associated protein 1;GPI-anchored membrane protein 1;GPI-anchored protein p137;Membrane component chromosome 11 surface marker 1;RNA granule protein 105;, PF12287;PF18293;, GO:0031252;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0030027;GO:0016020;GO:0000932;GO:0045202;GO:0003723;GO:0017148;GO:0050775;GO:0061003;, C:cell leading edge; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:lamellipodium; C:membrane; C:P-body; C:synapse;, F:RNA binding;, P:negative regulation of translation; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine morphogenesis; scaffold19 indexed_genome mRNA 13846013 13854215 . + . ID=transcript_4654;P25791 Q9HD58,Rhombotin-2,Cysteine-rich protein TTG-2;LIM domain only protein 2;T-cell translocation protein 2;, PF00412;, GO:0005654;GO:0005667;GO:0043425;GO:0042802;GO:0046872;GO:0001102;GO:0003713;GO:0001221;GO:0097067;GO:0007275;GO:0045944;GO:1902036;, C:nucleoplasm; C:transcription regulator complex;, F:bHLH transcription factor binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity; F:transcription coregulator binding;, P:cellular response to thyroid hormone stimulus; P:multicellular organism development; P:positive regulation of transcription by RNA polymerase II; P:regulation of hematopoietic stem cell differentiation;|P25791 Q9HD58,Rhombotin-2,Cysteine-rich protein TTG-2;LIM domain only protein 2;T-cell translocation protein 2;, PF00412;, GO:0005654;GO:0005667;GO:0043425;GO:0042802;GO:0046872;GO:0001102;GO:0003713;GO:0001221;GO:0097067;GO:0007275;GO:0045944;GO:1902036;, C:nucleoplasm; C:transcription regulator complex;, F:bHLH transcription factor binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity; F:transcription coregulator binding;, P:cellular response to thyroid hormone stimulus; P:multicellular organism development; P:positive regulation of transcription by RNA polymerase II; P:regulation of hematopoietic stem cell differentiation; scaffold19 indexed_genome mRNA 13914086 13917219 . + . ID=transcript_4655;Q9UK99 B3KY16 D3DR05 Q86X90 Q9H0V2 Q9NUX2,F-box only protein 3,, PF04379;PF12937;PF09346;, GO:0005829;GO:0005654;GO:0004842;GO:0006508;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:proteolysis; scaffold19 indexed_genome mRNA 13917256 13933557 . + . ID=transcript_4656;Q9UK99 B3KY16 D3DR05 Q86X90 Q9H0V2 Q9NUX2,F-box only protein 3,, PF04379;PF12937;PF09346;, GO:0005829;GO:0005654;GO:0004842;GO:0006508;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:proteolysis;|Q9UK99 B3KY16 D3DR05 Q86X90 Q9H0V2 Q9NUX2,F-box only protein 3,, PF04379;PF12937;PF09346;, GO:0005829;GO:0005654;GO:0004842;GO:0006508;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:proteolysis;|Q9UK99 B3KY16 D3DR05 Q86X90 Q9H0V2 Q9NUX2,F-box only protein 3,, PF04379;PF12937;PF09346;, GO:0005829;GO:0005654;GO:0004842;GO:0006508;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:proteolysis; scaffold19 indexed_genome mRNA 13933582 13947365 . + . ID=transcript_4657;Q9UK99 B3KY16 D3DR05 Q86X90 Q9H0V2 Q9NUX2,F-box only protein 3,, PF04379;PF12937;PF09346;, GO:0005829;GO:0005654;GO:0004842;GO:0006508;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:proteolysis;|Q9UK99 B3KY16 D3DR05 Q86X90 Q9H0V2 Q9NUX2,F-box only protein 3,, PF04379;PF12937;PF09346;, GO:0005829;GO:0005654;GO:0004842;GO:0006508;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:proteolysis;|Q9UK99 B3KY16 D3DR05 Q86X90 Q9H0V2 Q9NUX2,F-box only protein 3,, PF04379;PF12937;PF09346;, GO:0005829;GO:0005654;GO:0004842;GO:0006508;, C:cytosol; C:nucleoplasm;, F:ubiquitin-protein transferase activity;, P:proteolysis; scaffold19 indexed_genome mRNA 13971367 13980798 . + . ID=transcript_4658;P13987 E9PR17,CD59 glycoprotein,1F5 antigen;20 kDa homologous restriction factor;MAC-inhibitory protein;MEM43 antigen;Membrane attack complex inhibition factor;Membrane inhibitor of reactive lysis;Protectin;, PF00021;, GO:0031362;GO:0009986;GO:0005789;GO:0033116;GO:0012507;GO:0070062;GO:0005615;GO:0005925;GO:0000139;GO:0016020;GO:0005886;GO:0035579;GO:0070821;GO:0030133;GO:0031982;GO:0001848;GO:0007596;GO:0007166;GO:0048208;GO:0006888;GO:0001971;GO:0043312;GO:0030449;GO:1903659;, C:anchored component of external side of plasma membrane; C:cell surface; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:Golgi membrane; C:membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane; C:transport vesicle; C:vesicle;, F:complement binding;, P:blood coagulation; P:cell surface receptor signaling pathway; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of activation of membrane attack complex; P:neutrophil degranulation; P:regulation of complement activation; P:regulation of complement-dependent cytotoxicity; scaffold19 indexed_genome mRNA 14015837 14032205 . - . ID=transcript_4659;Q6ZVL6 B0QYU0,UPF0606 protein KIAA1549L,, PF12877;, GO:0016021;, C:integral component of membrane;|Q6ZVL6 B0QYU0,UPF0606 protein KIAA1549L,, PF12877;, GO:0016021;, C:integral component of membrane; scaffold19 indexed_genome mRNA 14041649 14141751 . - . ID=transcript_4660;Q6ZVL6 B0QYU0,UPF0606 protein KIAA1549L,, PF12877;, GO:0016021;, C:integral component of membrane;|Q6ZVL6 B0QYU0,UPF0606 protein KIAA1549L,, PF12877;, GO:0016021;, C:integral component of membrane; scaffold19 indexed_genome mRNA 14344404 14401650 . - . ID=transcript_4661;Q9H422 O14632 Q2PBG4 Q2PBG5 Q92632 Q9HAS2,Homeodomain-interacting protein kinase 3,Androgen receptor-interacting nuclear protein kinase;Fas-interacting serine/threonine-protein kinase;Homolog of protein kinase YAK1;, PF00069;, GO:0005737;GO:0005829;GO:0016604;GO:0005634;GO:0005886;GO:0016605;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0006915;GO:0009299;GO:0043066;GO:0043508;GO:0018105;GO:0018107;GO:0006468;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleus; C:plasma membrane; C:PML body;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:apoptotic process; P:mRNA transcription; P:negative regulation of apoptotic process; P:negative regulation of JUN kinase activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; scaffold19 indexed_genome mRNA 14531034 14587662 . + . ID=transcript_4662;Q12996 A8K471 D3DR04 E9PB40 Q32P22 Q96FQ8 Q96QD6 Q96QK4,Cleavage stimulation factor subunit 3,CF-1 77 kDa subunit;Cleavage stimulation factor 77 kDa subunit;, PF05843;, GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0031123;GO:0006369;, C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA 3'-end processing; P:termination of RNA polymerase II transcription;|Q12996 A8K471 D3DR04 E9PB40 Q32P22 Q96FQ8 Q96QD6 Q96QK4,Cleavage stimulation factor subunit 3,CF-1 77 kDa subunit;Cleavage stimulation factor 77 kDa subunit;, PF05843;, GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0031123;GO:0006369;, C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA 3'-end processing; P:termination of RNA polymerase II transcription;|Q12996 A8K471 D3DR04 E9PB40 Q32P22 Q96FQ8 Q96QD6 Q96QK4,Cleavage stimulation factor subunit 3,CF-1 77 kDa subunit;Cleavage stimulation factor 77 kDa subunit;, PF05843;, GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0031123;GO:0006369;, C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA 3'-end processing; P:termination of RNA polymerase II transcription;|Q12996 A8K471 D3DR04 E9PB40 Q32P22 Q96FQ8 Q96QD6 Q96QK4,Cleavage stimulation factor subunit 3,CF-1 77 kDa subunit;Cleavage stimulation factor 77 kDa subunit;, PF05843;, GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0031123;GO:0006369;, C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA 3'-end processing; P:termination of RNA polymerase II transcription;|Q12996 A8K471 D3DR04 E9PB40 Q32P22 Q96FQ8 Q96QD6 Q96QK4,Cleavage stimulation factor subunit 3,CF-1 77 kDa subunit;Cleavage stimulation factor 77 kDa subunit;, PF05843;, GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0031123;GO:0006369;, C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA 3'-end processing; P:termination of RNA polymerase II transcription;|Q12996 A8K471 D3DR04 E9PB40 Q32P22 Q96FQ8 Q96QD6 Q96QK4,Cleavage stimulation factor subunit 3,CF-1 77 kDa subunit;Cleavage stimulation factor 77 kDa subunit;, PF05843;, GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0031123;GO:0006369;, C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA 3'-end processing; P:termination of RNA polymerase II transcription; scaffold19 indexed_genome mRNA 14587749 14595297 . - . ID=transcript_4663;Q12996 A8K471 D3DR04 E9PB40 Q32P22 Q96FQ8 Q96QD6 Q96QK4,Cleavage stimulation factor subunit 3,CF-1 77 kDa subunit;Cleavage stimulation factor 77 kDa subunit;, PF05843;, GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0031123;GO:0006369;, C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA 3'-end processing; P:termination of RNA polymerase II transcription;|Q12996 A8K471 D3DR04 E9PB40 Q32P22 Q96FQ8 Q96QD6 Q96QK4,Cleavage stimulation factor subunit 3,CF-1 77 kDa subunit;Cleavage stimulation factor 77 kDa subunit;, PF05843;, GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0031123;GO:0006369;, C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA 3'-end processing; P:termination of RNA polymerase II transcription;|Q12996 A8K471 D3DR04 E9PB40 Q32P22 Q96FQ8 Q96QD6 Q96QK4,Cleavage stimulation factor subunit 3,CF-1 77 kDa subunit;Cleavage stimulation factor 77 kDa subunit;, PF05843;, GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0031123;GO:0006369;, C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA 3'-end processing; P:termination of RNA polymerase II transcription;|Q12996 A8K471 D3DR04 E9PB40 Q32P22 Q96FQ8 Q96QD6 Q96QK4,Cleavage stimulation factor subunit 3,CF-1 77 kDa subunit;Cleavage stimulation factor 77 kDa subunit;, PF05843;, GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0031123;GO:0006369;, C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA 3'-end processing; P:termination of RNA polymerase II transcription; scaffold19 indexed_genome mRNA 14597641 14634785 . - . ID=transcript_4664;Q9NUJ3 D3DR01 Q8IVX4,T-complex protein 11-like protein 1,, PF05794;, GO:0005874;GO:0007165;, C:microtubule;, , P:signal transduction;|Q9NUJ3 D3DR01 Q8IVX4,T-complex protein 11-like protein 1,, PF05794;, GO:0005874;GO:0007165;, C:microtubule;, , P:signal transduction;|Q9NUJ3 D3DR01 Q8IVX4,T-complex protein 11-like protein 1,, PF05794;, GO:0005874;GO:0007165;, C:microtubule;, , P:signal transduction;|Q9NUJ3 D3DR01 Q8IVX4,T-complex protein 11-like protein 1,, PF05794;, GO:0005874;GO:0007165;, C:microtubule;, , P:signal transduction; scaffold19 indexed_genome mRNA 14637763 14666221 . - . ID=transcript_4665;Q96QD5 G5E941 Q8N602 Q8NCU9 Q9UGK5,DEP domain-containing protein 7,Protein TR2/D15;, PF00610;, GO:0005829;GO:0035556;GO:0051056;, C:cytosol;, , P:intracellular signal transduction; P:regulation of small GTPase mediated signal transduction;|Q96QD5 G5E941 Q8N602 Q8NCU9 Q9UGK5,DEP domain-containing protein 7,Protein TR2/D15;, PF00610;, GO:0005829;GO:0035556;GO:0051056;, C:cytosol;, , P:intracellular signal transduction; P:regulation of small GTPase mediated signal transduction; scaffold19 indexed_genome mRNA 14687114 14709416 . - . ID=transcript_4666;Q2KHR3 Q6ZU30 Q6ZUR5,Glutamine and serine-rich protein 1,, PF13926; scaffold19 indexed_genome mRNA 14724761 14732046 . - . ID=transcript_4667;Q2KHR3 Q6ZU30 Q6ZUR5,Glutamine and serine-rich protein 1,, PF13926; scaffold19 indexed_genome mRNA 15000310 15017701 . - . ID=transcript_4668;Q7L2H7 A8K7X4 B4E2Q4 O60735 Q2F836 Q53HL6 Q9BXW1,Eukaryotic translation initiation factor 3 subunit M {ECO:0000255|HAMAP-Rule:MF_03012},Fetal lung protein B5;PCI domain-containing protein 1;, PF18005;PF01399;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0003743;GO:0031369;GO:0002183;GO:0001732;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m;, F:translation initiation factor activity; F:translation initiation factor binding;, P:cytoplasmic translational initiation; P:formation of cytoplasmic translation initiation complex; P:translational initiation; P:viral process;|Q7L2H7 A8K7X4 B4E2Q4 O60735 Q2F836 Q53HL6 Q9BXW1,Eukaryotic translation initiation factor 3 subunit M {ECO:0000255|HAMAP-Rule:MF_03012},Fetal lung protein B5;PCI domain-containing protein 1;, PF18005;PF01399;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0003743;GO:0031369;GO:0002183;GO:0001732;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m;, F:translation initiation factor activity; F:translation initiation factor binding;, P:cytoplasmic translational initiation; P:formation of cytoplasmic translation initiation complex; P:translational initiation; P:viral process;|Q7L2H7 A8K7X4 B4E2Q4 O60735 Q2F836 Q53HL6 Q9BXW1,Eukaryotic translation initiation factor 3 subunit M {ECO:0000255|HAMAP-Rule:MF_03012},Fetal lung protein B5;PCI domain-containing protein 1;, PF18005;PF01399;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0003743;GO:0031369;GO:0002183;GO:0001732;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m;, F:translation initiation factor activity; F:translation initiation factor binding;, P:cytoplasmic translational initiation; P:formation of cytoplasmic translation initiation complex; P:translational initiation; P:viral process;|Q7L2H7 A8K7X4 B4E2Q4 O60735 Q2F836 Q53HL6 Q9BXW1,Eukaryotic translation initiation factor 3 subunit M {ECO:0000255|HAMAP-Rule:MF_03012},Fetal lung protein B5;PCI domain-containing protein 1;, PF18005;PF01399;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0003743;GO:0031369;GO:0002183;GO:0001732;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m;, F:translation initiation factor activity; F:translation initiation factor binding;, P:cytoplasmic translational initiation; P:formation of cytoplasmic translation initiation complex; P:translational initiation; P:viral process; scaffold19 indexed_genome mRNA 15155598 15186256 . + . ID=transcript_4669;Q8IYZ5,Wilms tumor protein,WT33;, PF02165;PF00096;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0070742;GO:0001228;GO:0003700;GO:0000981;GO:0010385;GO:0044729;GO:0003723;GO:0000978;GO:0043565;GO:0000976;GO:0008270;GO:0035802;GO:0030325;GO:0001658;GO:0043010;GO:0060923;GO:0071320;GO:0071371;GO:0060539;GO:0030855;GO:0007281;GO:0032836;GO:0072112;GO:0032835;GO:0008406;GO:0007507;GO:0001822;GO:0030539;GO:0008584;GO:0060231;GO:0072207;GO:0072075;GO:0072284;GO:0043066;GO:0030308;GO:0008285;GO:2000195;GO:0072302;GO:0000122;GO:0045892;GO:0017148;GO:0043065;GO:1905643;GO:0010628;GO:0060421;GO:2000020;GO:2001076;GO:1902895;GO:0045944;GO:0045893;GO:0072166;GO:0003156;GO:0006357;GO:0006355;GO:0008380;GO:0007530;GO:0007356;GO:0009888;GO:0001657;GO:0001570;GO:0061032;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded methylated DNA binding; F:hemi-methylated DNA-binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:adrenal cortex formation; P:adrenal gland development; P:branching involved in ureteric bud morphogenesis; P:camera-type eye development; P:cardiac muscle cell fate commitment; P:cellular response to cAMP; P:cellular response to gonadotropin stimulus; P:diaphragm development; P:epithelial cell differentiation; P:germ cell development; P:glomerular basement membrane development; P:glomerular visceral epithelial cell differentiation; P:glomerulus development; P:gonad development; P:heart development; P:kidney development; P:male genitalia development; P:male gonad development; P:mesenchymal to epithelial transition; P:metanephric epithelium development; P:metanephric mesenchyme development; P:metanephric S-shaped body morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of female gonad development; P:negative regulation of metanephric glomerular mesangial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:positive regulation of apoptotic process; P:positive regulation of DNA methylation; P:positive regulation of gene expression; P:positive regulation of heart growth; P:positive regulation of male gonad development; P:positive regulation of metanephric ureteric bud development; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:posterior mesonephric tubule development; P:regulation of animal organ formation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:RNA splicing; P:sex determination; P:thorax and anterior abdomen determination; P:tissue development; P:ureteric bud development; P:vasculogenesis; P:visceral serous pericardium development;|Q8IYZ5,Wilms tumor protein,WT33;, PF02165;PF00096;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0070742;GO:0001228;GO:0003700;GO:0000981;GO:0010385;GO:0044729;GO:0003723;GO:0000978;GO:0043565;GO:0000976;GO:0008270;GO:0035802;GO:0030325;GO:0001658;GO:0043010;GO:0060923;GO:0071320;GO:0071371;GO:0060539;GO:0030855;GO:0007281;GO:0032836;GO:0072112;GO:0032835;GO:0008406;GO:0007507;GO:0001822;GO:0030539;GO:0008584;GO:0060231;GO:0072207;GO:0072075;GO:0072284;GO:0043066;GO:0030308;GO:0008285;GO:2000195;GO:0072302;GO:0000122;GO:0045892;GO:0017148;GO:0043065;GO:1905643;GO:0010628;GO:0060421;GO:2000020;GO:2001076;GO:1902895;GO:0045944;GO:0045893;GO:0072166;GO:0003156;GO:0006357;GO:0006355;GO:0008380;GO:0007530;GO:0007356;GO:0009888;GO:0001657;GO:0001570;GO:0061032;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded methylated DNA binding; F:hemi-methylated DNA-binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:adrenal cortex formation; P:adrenal gland development; P:branching involved in ureteric bud morphogenesis; P:camera-type eye development; P:cardiac muscle cell fate commitment; P:cellular response to cAMP; P:cellular response to gonadotropin stimulus; P:diaphragm development; P:epithelial cell differentiation; P:germ cell development; P:glomerular basement membrane development; P:glomerular visceral epithelial cell differentiation; P:glomerulus development; P:gonad development; P:heart development; P:kidney development; P:male genitalia development; P:male gonad development; P:mesenchymal to epithelial transition; P:metanephric epithelium development; P:metanephric mesenchyme development; P:metanephric S-shaped body morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of female gonad development; P:negative regulation of metanephric glomerular mesangial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:positive regulation of apoptotic process; P:positive regulation of DNA methylation; P:positive regulation of gene expression; P:positive regulation of heart growth; P:positive regulation of male gonad development; P:positive regulation of metanephric ureteric bud development; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:posterior mesonephric tubule development; P:regulation of animal organ formation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:RNA splicing; P:sex determination; P:thorax and anterior abdomen determination; P:tissue development; P:ureteric bud development; P:vasculogenesis; P:visceral serous pericardium development; scaffold19 indexed_genome mRNA 15435010 15452567 . - . ID=transcript_4670;Q15293 B7Z1M1 D3DR00,Reticulocalbin-1,, PF13202;PF13499;, GO:0005783;GO:0005788;GO:0005509;GO:0043010;GO:0044267;GO:0001701;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:calcium ion binding;, P:camera-type eye development; P:cellular protein metabolic process; P:in utero embryonic development; P:post-translational protein modification;|Q15293 B7Z1M1 D3DR00,Reticulocalbin-1,, PF13202;PF13499;, GO:0005783;GO:0005788;GO:0005509;GO:0043010;GO:0044267;GO:0001701;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:calcium ion binding;, P:camera-type eye development; P:cellular protein metabolic process; P:in utero embryonic development; P:post-translational protein modification; scaffold19 indexed_genome mRNA 15655514 15668929 . + . ID=transcript_4671;P26367 Q6N006 Q99413,Paired box protein Pax-6,Aniridia type II protein;Oculorhombin;, PF00046;PF00292;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0035035;GO:0019901;GO:0070412;GO:0000978;GO:1990837;GO:0008134;GO:0000976;GO:0048856;GO:0009887;GO:0001568;GO:0007417;GO:0061303;GO:0001654;GO:0042593;GO:0061072;GO:0050768;GO:0000122;GO:0048663;GO:0003322;GO:1904798;GO:0010628;GO:0045944;GO:0045893;GO:0006357;GO:0009611;GO:0021517;GO:0007601;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein kinase binding; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure development; P:animal organ morphogenesis; P:blood vessel development; P:central nervous system development; P:cornea development in camera-type eye; P:eye development; P:glucose homeostasis; P:iris morphogenesis; P:negative regulation of neurogenesis; P:negative regulation of transcription by RNA polymerase II; P:neuron fate commitment; P:pancreatic A cell development; P:positive regulation of core promoter binding; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to wounding; P:ventral spinal cord development; P:visual perception;|P26367 Q6N006 Q99413,Paired box protein Pax-6,Aniridia type II protein;Oculorhombin;, PF00046;PF00292;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0035035;GO:0019901;GO:0070412;GO:0000978;GO:1990837;GO:0008134;GO:0000976;GO:0048856;GO:0009887;GO:0001568;GO:0007417;GO:0061303;GO:0001654;GO:0042593;GO:0061072;GO:0050768;GO:0000122;GO:0048663;GO:0003322;GO:1904798;GO:0010628;GO:0045944;GO:0045893;GO:0006357;GO:0009611;GO:0021517;GO:0007601;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein kinase binding; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure development; P:animal organ morphogenesis; P:blood vessel development; P:central nervous system development; P:cornea development in camera-type eye; P:eye development; P:glucose homeostasis; P:iris morphogenesis; P:negative regulation of neurogenesis; P:negative regulation of transcription by RNA polymerase II; P:neuron fate commitment; P:pancreatic A cell development; P:positive regulation of core promoter binding; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to wounding; P:ventral spinal cord development; P:visual perception;|P26367 Q6N006 Q99413,Paired box protein Pax-6,Aniridia type II protein;Oculorhombin;, PF00046;PF00292;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0035035;GO:0019901;GO:0070412;GO:0000978;GO:1990837;GO:0008134;GO:0000976;GO:0048856;GO:0009887;GO:0001568;GO:0007417;GO:0061303;GO:0001654;GO:0042593;GO:0061072;GO:0050768;GO:0000122;GO:0048663;GO:0003322;GO:1904798;GO:0010628;GO:0045944;GO:0045893;GO:0006357;GO:0009611;GO:0021517;GO:0007601;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein kinase binding; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure development; P:animal organ morphogenesis; P:blood vessel development; P:central nervous system development; P:cornea development in camera-type eye; P:eye development; P:glucose homeostasis; P:iris morphogenesis; P:negative regulation of neurogenesis; P:negative regulation of transcription by RNA polymerase II; P:neuron fate commitment; P:pancreatic A cell development; P:positive regulation of core promoter binding; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to wounding; P:ventral spinal cord development; P:visual perception;|P26367 Q6N006 Q99413,Paired box protein Pax-6,Aniridia type II protein;Oculorhombin;, PF00046;PF00292;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0035035;GO:0019901;GO:0070412;GO:0000978;GO:1990837;GO:0008134;GO:0000976;GO:0048856;GO:0009887;GO:0001568;GO:0007417;GO:0061303;GO:0001654;GO:0042593;GO:0061072;GO:0050768;GO:0000122;GO:0048663;GO:0003322;GO:1904798;GO:0010628;GO:0045944;GO:0045893;GO:0006357;GO:0009611;GO:0021517;GO:0007601;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein kinase binding; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure development; P:animal organ morphogenesis; P:blood vessel development; P:central nervous system development; P:cornea development in camera-type eye; P:eye development; P:glucose homeostasis; P:iris morphogenesis; P:negative regulation of neurogenesis; P:negative regulation of transcription by RNA polymerase II; P:neuron fate commitment; P:pancreatic A cell development; P:positive regulation of core promoter binding; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to wounding; P:ventral spinal cord development; P:visual perception; scaffold19 indexed_genome mRNA 15668986 15910619 . + . ID=transcript_4672;P26367 Q6N006 Q99413,Paired box protein Pax-6,Aniridia type II protein;Oculorhombin;, PF00046;PF00292;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0035035;GO:0019901;GO:0070412;GO:0000978;GO:1990837;GO:0008134;GO:0000976;GO:0048856;GO:0009887;GO:0001568;GO:0007417;GO:0061303;GO:0001654;GO:0042593;GO:0061072;GO:0050768;GO:0000122;GO:0048663;GO:0003322;GO:1904798;GO:0010628;GO:0045944;GO:0045893;GO:0006357;GO:0009611;GO:0021517;GO:0007601;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein kinase binding; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure development; P:animal organ morphogenesis; P:blood vessel development; P:central nervous system development; P:cornea development in camera-type eye; P:eye development; P:glucose homeostasis; P:iris morphogenesis; P:negative regulation of neurogenesis; P:negative regulation of transcription by RNA polymerase II; P:neuron fate commitment; P:pancreatic A cell development; P:positive regulation of core promoter binding; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to wounding; P:ventral spinal cord development; P:visual perception;|P26367 Q6N006 Q99413,Paired box protein Pax-6,Aniridia type II protein;Oculorhombin;, PF00046;PF00292;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0035035;GO:0019901;GO:0070412;GO:0000978;GO:1990837;GO:0008134;GO:0000976;GO:0048856;GO:0009887;GO:0001568;GO:0007417;GO:0061303;GO:0001654;GO:0042593;GO:0061072;GO:0050768;GO:0000122;GO:0048663;GO:0003322;GO:1904798;GO:0010628;GO:0045944;GO:0045893;GO:0006357;GO:0009611;GO:0021517;GO:0007601;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:protein kinase binding; F:R-SMAD binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure development; P:animal organ morphogenesis; P:blood vessel development; P:central nervous system development; P:cornea development in camera-type eye; P:eye development; P:glucose homeostasis; P:iris morphogenesis; P:negative regulation of neurogenesis; P:negative regulation of transcription by RNA polymerase II; P:neuron fate commitment; P:pancreatic A cell development; P:positive regulation of core promoter binding; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to wounding; P:ventral spinal cord development; P:visual perception;|Q96EB1 B4E3W0 E7EPZ6 Q9H4E8 Q9NX11,Elongator complex protein 4,PAX6 neighbor gene protein;, PF05625;, GO:0005737;GO:0033588;GO:0005654;GO:0008023;GO:0008607;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:phosphorylase kinase regulator activity;, P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96EB1 B4E3W0 E7EPZ6 Q9H4E8 Q9NX11,Elongator complex protein 4,PAX6 neighbor gene protein;, PF05625;, GO:0005737;GO:0033588;GO:0005654;GO:0008023;GO:0008607;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:phosphorylase kinase regulator activity;, P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96EB1 B4E3W0 E7EPZ6 Q9H4E8 Q9NX11,Elongator complex protein 4,PAX6 neighbor gene protein;, PF05625;, GO:0005737;GO:0033588;GO:0005654;GO:0008023;GO:0008607;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:phosphorylase kinase regulator activity;, P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96EB1 B4E3W0 E7EPZ6 Q9H4E8 Q9NX11,Elongator complex protein 4,PAX6 neighbor gene protein;, PF05625;, GO:0005737;GO:0033588;GO:0005654;GO:0008023;GO:0008607;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:phosphorylase kinase regulator activity;, P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96EB1 B4E3W0 E7EPZ6 Q9H4E8 Q9NX11,Elongator complex protein 4,PAX6 neighbor gene protein;, PF05625;, GO:0005737;GO:0033588;GO:0005654;GO:0008023;GO:0008607;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:phosphorylase kinase regulator activity;, P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification;|Q96EB1 B4E3W0 E7EPZ6 Q9H4E8 Q9NX11,Elongator complex protein 4,PAX6 neighbor gene protein;, PF05625;, GO:0005737;GO:0033588;GO:0005654;GO:0008023;GO:0008607;GO:0006357;GO:0006368;GO:0002098;, C:cytoplasm; C:elongator holoenzyme complex; C:nucleoplasm; C:transcription elongation factor complex;, F:phosphorylase kinase regulator activity;, P:regulation of transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:tRNA wobble uridine modification; scaffold19 indexed_genome mRNA 15910776 16055834 . + . ID=transcript_4673;Q96LU5 D3DQZ7 Q96SH9,Mitochondrial inner membrane protease subunit 1,IMP1-like protein;, PF10502;, GO:0042720;GO:0005739;GO:0008236;GO:0006627;, C:mitochondrial inner membrane peptidase complex; C:mitochondrion;, F:serine-type peptidase activity;, P:protein processing involved in protein targeting to mitochondrion;|Q9UHD4 D3DS73 Q546V8 Q9NNW9,Cell death activator CIDE-B,Cell death-inducing DFFA-like effector B;, PF02017;, GO:0005829;GO:0048471;GO:0042802;GO:0097202;GO:0006915;GO:0038183;GO:0097194;GO:0008630;GO:0010942;GO:0090200;GO:0042981;GO:0031667;GO:0016032;, C:cytosol; C:perinuclear region of cytoplasm;, F:identical protein binding;, P:activation of cysteine-type endopeptidase activity; P:apoptotic process; P:bile acid signaling pathway; P:execution phase of apoptosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of cell death; P:positive regulation of release of cytochrome c from mitochondria; P:regulation of apoptotic process; P:response to nutrient levels; P:viral process;|Q6P3W2 A8K0V0 B1ALC1 I6L9B4,DnaJ homolog subfamily C member 24 {ECO:0000305},CSL-type zinc finger-containing protein 3;Diphthamide biosynthesis protein 4;, PF00226;PF05207;, GO:0005737;GO:0005856;GO:0001671;GO:0008198;GO:0008270;GO:0061077;GO:0017183;GO:0032781;, C:cytoplasm; C:cytoskeleton;, F:ATPase activator activity; F:ferrous iron binding; F:zinc ion binding;, P:chaperone-mediated protein folding; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; P:positive regulation of ATPase activity;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold19 indexed_genome mRNA 16331956 16421994 . + . ID=transcript_4674;M0R2J8 A6PVL6 B1AL47 B7WNX6 P59894 Q6ZRR9 Q6ZU04,Doublecortin domain-containing protein 1 {ECO:0000305},Doublecortin domain-containing 5 protein {ECO:0000303|PubMed:22159412};, , GO:0005737;GO:0090543;GO:0005874;GO:0030496;GO:0072686;GO:0030246;GO:0008017;GO:0007049;GO:0051301;GO:0035556;GO:1902412;, C:cytoplasm; C:Flemming body; C:microtubule; C:midbody; C:mitotic spindle;, F:carbohydrate binding; F:microtubule binding;, P:cell cycle; P:cell division; P:intracellular signal transduction; P:regulation of mitotic cytokinesis; scaffold19 indexed_genome mRNA 16428125 16445655 . + . ID=transcript_4675;M0R2J8 A6PVL6 B1AL47 B7WNX6 P59894 Q6ZRR9 Q6ZU04,Doublecortin domain-containing protein 1 {ECO:0000305},Doublecortin domain-containing 5 protein {ECO:0000303|PubMed:22159412};, , GO:0005737;GO:0090543;GO:0005874;GO:0030496;GO:0072686;GO:0030246;GO:0008017;GO:0007049;GO:0051301;GO:0035556;GO:1902412;, C:cytoplasm; C:Flemming body; C:microtubule; C:midbody; C:mitotic spindle;, F:carbohydrate binding; F:microtubule binding;, P:cell cycle; P:cell division; P:intracellular signal transduction; P:regulation of mitotic cytokinesis; scaffold19 indexed_genome mRNA 16454537 16464395 . + . ID=transcript_4676;M0R2J8 A6PVL6 B1AL47 B7WNX6 P59894 Q6ZRR9 Q6ZU04,Doublecortin domain-containing protein 1 {ECO:0000305},Doublecortin domain-containing 5 protein {ECO:0000303|PubMed:22159412};, , GO:0005737;GO:0090543;GO:0005874;GO:0030496;GO:0072686;GO:0030246;GO:0008017;GO:0007049;GO:0051301;GO:0035556;GO:1902412;, C:cytoplasm; C:Flemming body; C:microtubule; C:midbody; C:mitotic spindle;, F:carbohydrate binding; F:microtubule binding;, P:cell cycle; P:cell division; P:intracellular signal transduction; P:regulation of mitotic cytokinesis; scaffold19 indexed_genome mRNA 16477203 16502336 . + . ID=transcript_4677;M0R2J8 A6PVL6 B1AL47 B7WNX6 P59894 Q6ZRR9 Q6ZU04,Doublecortin domain-containing protein 1 {ECO:0000305},Doublecortin domain-containing 5 protein {ECO:0000303|PubMed:22159412};, , GO:0005737;GO:0090543;GO:0005874;GO:0030496;GO:0072686;GO:0030246;GO:0008017;GO:0007049;GO:0051301;GO:0035556;GO:1902412;, C:cytoplasm; C:Flemming body; C:microtubule; C:midbody; C:mitotic spindle;, F:carbohydrate binding; F:microtubule binding;, P:cell cycle; P:cell division; P:intracellular signal transduction; P:regulation of mitotic cytokinesis; scaffold19 indexed_genome mRNA 16807631 17004155 . + . ID=transcript_4678;Q15777 D3DQZ5 E9PB10 Q59GE6,Metallophosphoesterase MPPED2,Fetal brain protein 239;Metallophosphoesterase domain-containing protein 2;, PF00149;, GO:0016208;GO:0019002;GO:0030145;GO:0008081;, , F:AMP binding; F:GMP binding; F:manganese ion binding; F:phosphoric diester hydrolase activity; scaffold19 indexed_genome mRNA 17095801 17098567 . - . ID=transcript_4679;Q8N8R7 Q5HYH9,ARL14 effector protein,ARF7 effector protein;, PF14949;, GO:0005829;GO:0005925;GO:0043231;GO:0005730;GO:0005654;GO:0005886;, C:cytosol; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:plasma membrane; scaffold19 indexed_genome mRNA 18826002 18827019 . + . ID=transcript_4680;A6NJ78 A8MRS5 B7WNU2 Q3MHD3 Q8N601 Q8NBA7,12S rRNA N4-methylcytidine (m4C) methyltransferase,Methyltransferase 5 domain-containing protein 1;Methyltransferase-like protein 15;, PF01795;, GO:0005759;GO:0071424;GO:0070475;, C:mitochondrial matrix;, F:rRNA (cytosine-N4-)-methyltransferase activity;, P:rRNA base methylation; scaffold19 indexed_genome mRNA 18973134 19175876 . - . ID=transcript_4681;A6NJ78 A8MRS5 B7WNU2 Q3MHD3 Q8N601 Q8NBA7,12S rRNA N4-methylcytidine (m4C) methyltransferase,Methyltransferase 5 domain-containing protein 1;Methyltransferase-like protein 15;, PF01795;, GO:0005759;GO:0071424;GO:0070475;, C:mitochondrial matrix;, F:rRNA (cytosine-N4-)-methyltransferase activity;, P:rRNA base methylation; scaffold19 indexed_genome mRNA 19541372 19601834 . + . ID=transcript_4682;Q9UC24,Brain-derived neurotrophic factor,Abrineurin;, PF00243;, GO:0030424;GO:0005737;GO:0030425;GO:0005576;GO:0005615;GO:0005739;GO:0016607;GO:0048471;GO:0008021;GO:0008083;GO:0005163;GO:0007202;GO:0007411;GO:0031547;GO:0048668;GO:0007613;GO:0050804;GO:2001234;GO:0010832;GO:0043524;GO:0021675;GO:0038180;GO:0007399;GO:0048812;GO:0048011;GO:0007422;GO:0031550;GO:0048672;GO:0010976;GO:1903997;GO:0033138;GO:1900122;GO:0051965;GO:0045664;GO:2000008;GO:0007416;GO:0007169;, C:axon; C:cytoplasm; C:dendrite; C:extracellular region; C:extracellular space; C:mitochondrion; C:nuclear speck; C:perinuclear region of cytoplasm; C:synaptic vesicle;, F:growth factor activity; F:nerve growth factor receptor binding;, P:activation of phospholipase C activity; P:axon guidance; P:brain-derived neurotrophic factor receptor signaling pathway; P:collateral sprouting; P:memory; P:modulation of chemical synaptic transmission; P:negative regulation of apoptotic signaling pathway; P:negative regulation of myotube differentiation; P:negative regulation of neuron apoptotic process; P:nerve development; P:nerve growth factor signaling pathway; P:nervous system development; P:neuron projection morphogenesis; P:neurotrophin TRK receptor signaling pathway; P:peripheral nervous system development; P:positive regulation of brain-derived neurotrophic factor receptor signaling pathway; P:positive regulation of collateral sprouting; P:positive regulation of neuron projection development; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of receptor binding; P:positive regulation of synapse assembly; P:regulation of neuron differentiation; P:regulation of protein localization to cell surface; P:synapse assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold19 indexed_genome mRNA 19759414 19761552 . + . ID=transcript_4683;Q9NUP9,Protein lin-7 homolog C,Mammalian lin-seven protein 3;Vertebrate lin-7 homolog 3;, PF02828;PF00595;, GO:0016323;GO:0005923;GO:0005911;GO:0005737;GO:0098978;GO:0097025;GO:0005886;GO:0098839;GO:0098793;GO:0045202;GO:0008092;GO:0097016;GO:0030165;GO:0019904;GO:0006887;GO:0045199;GO:0002011;GO:0007269;GO:0006836;GO:1903361;GO:0015031;, C:basolateral plasma membrane; C:bicellular tight junction; C:cell-cell junction; C:cytoplasm; C:glutamatergic synapse; C:MPP7-DLG1-LIN7 complex; C:plasma membrane; C:postsynaptic density membrane; C:presynapse; C:synapse;, F:cytoskeletal protein binding; F:L27 domain binding; F:PDZ domain binding; F:protein domain specific binding;, P:exocytosis; P:maintenance of epithelial cell apical/basal polarity; P:morphogenesis of an epithelial sheet; P:neurotransmitter secretion; P:neurotransmitter transport; P:protein localization to basolateral plasma membrane; P:protein transport; scaffold19 indexed_genome mRNA 19786318 19886475 . + . ID=transcript_4684;Q9BXB1 A6NCH3 G5E9B3 Q8N537 Q9NYD1,Leucine-rich repeat-containing G-protein coupled receptor 4,G-protein coupled receptor 48;, PF00001;PF13855;PF01462;, GO:0005887;GO:0005886;GO:0008528;GO:0004930;GO:0016500;GO:0004888;GO:0007190;GO:0007189;GO:0030282;GO:0046849;GO:0061290;GO:0072202;GO:0032922;GO:0048565;GO:2001013;GO:0001942;GO:0009755;GO:0045087;GO:0036335;GO:0030539;GO:0072224;GO:0072282;GO:0120163;GO:0001818;GO:0034122;GO:0045892;GO:0001649;GO:0090190;GO:0090263;GO:0045893;GO:0007283;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:protein-hormone receptor activity; F:transmembrane signaling receptor activity;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:bone mineralization; P:bone remodeling; P:canonical Wnt signaling pathway involved in metanephric kidney development; P:cell differentiation involved in metanephros development; P:circadian regulation of gene expression; P:digestive tract development; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:hair follicle development; P:hormone-mediated signaling pathway; P:innate immune response; P:intestinal stem cell homeostasis; P:male genitalia development; P:metanephric glomerulus development; P:metanephric nephron tubule morphogenesis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of cytokine production; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transcription, DNA-templated; P:osteoblast differentiation; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription, DNA-templated; P:spermatogenesis;|Q9BXB1 A6NCH3 G5E9B3 Q8N537 Q9NYD1,Leucine-rich repeat-containing G-protein coupled receptor 4,G-protein coupled receptor 48;, PF00001;PF13855;PF01462;, GO:0005887;GO:0005886;GO:0008528;GO:0004930;GO:0016500;GO:0004888;GO:0007190;GO:0007189;GO:0030282;GO:0046849;GO:0061290;GO:0072202;GO:0032922;GO:0048565;GO:2001013;GO:0001942;GO:0009755;GO:0045087;GO:0036335;GO:0030539;GO:0072224;GO:0072282;GO:0120163;GO:0001818;GO:0034122;GO:0045892;GO:0001649;GO:0090190;GO:0090263;GO:0045893;GO:0007283;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:protein-hormone receptor activity; F:transmembrane signaling receptor activity;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:bone mineralization; P:bone remodeling; P:canonical Wnt signaling pathway involved in metanephric kidney development; P:cell differentiation involved in metanephros development; P:circadian regulation of gene expression; P:digestive tract development; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:hair follicle development; P:hormone-mediated signaling pathway; P:innate immune response; P:intestinal stem cell homeostasis; P:male genitalia development; P:metanephric glomerulus development; P:metanephric nephron tubule morphogenesis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of cytokine production; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transcription, DNA-templated; P:osteoblast differentiation; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription, DNA-templated; P:spermatogenesis;|Q9BXB1 A6NCH3 G5E9B3 Q8N537 Q9NYD1,Leucine-rich repeat-containing G-protein coupled receptor 4,G-protein coupled receptor 48;, PF00001;PF13855;PF01462;, GO:0005887;GO:0005886;GO:0008528;GO:0004930;GO:0016500;GO:0004888;GO:0007190;GO:0007189;GO:0030282;GO:0046849;GO:0061290;GO:0072202;GO:0032922;GO:0048565;GO:2001013;GO:0001942;GO:0009755;GO:0045087;GO:0036335;GO:0030539;GO:0072224;GO:0072282;GO:0120163;GO:0001818;GO:0034122;GO:0045892;GO:0001649;GO:0090190;GO:0090263;GO:0045893;GO:0007283;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:protein-hormone receptor activity; F:transmembrane signaling receptor activity;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:bone mineralization; P:bone remodeling; P:canonical Wnt signaling pathway involved in metanephric kidney development; P:cell differentiation involved in metanephros development; P:circadian regulation of gene expression; P:digestive tract development; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:hair follicle development; P:hormone-mediated signaling pathway; P:innate immune response; P:intestinal stem cell homeostasis; P:male genitalia development; P:metanephric glomerulus development; P:metanephric nephron tubule morphogenesis; P:negative regulation of cold-induced thermogenesis; P:negative regulation of cytokine production; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transcription, DNA-templated; P:osteoblast differentiation; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription, DNA-templated; P:spermatogenesis; scaffold19 indexed_genome mRNA 19891727 19935828 . + . ID=transcript_4685;Q96HJ3 B2R8G2 Q8IX69 Q9H2A6 Q9Y599,Coiled-coil domain-containing protein 34,Renal carcinoma antigen NY-REN-41;, PF13904; scaffold19 indexed_genome mRNA 20133406 20200139 . - . ID=transcript_4686;O75936 B2R8L7 D3DQZ1 Q6IBJ2,Gamma-butyrobetaine dioxygenase,Gamma-butyrobetaine hydroxylase;Gamma-butyrobetaine,2-oxoglutarate dioxygenase;, PF06155;PF02668;, GO:0005829;GO:0070062;GO:0005739;GO:0008336;GO:0042802;GO:0005506;GO:0008270;GO:0045329;, C:cytosol; C:extracellular exosome; C:mitochondrion;, F:gamma-butyrobetaine dioxygenase activity; F:identical protein binding; F:iron ion binding; F:zinc ion binding;, P:carnitine biosynthetic process;|O75936 B2R8L7 D3DQZ1 Q6IBJ2,Gamma-butyrobetaine dioxygenase,Gamma-butyrobetaine hydroxylase;Gamma-butyrobetaine,2-oxoglutarate dioxygenase;, PF06155;PF02668;, GO:0005829;GO:0070062;GO:0005739;GO:0008336;GO:0042802;GO:0005506;GO:0008270;GO:0045329;, C:cytosol; C:extracellular exosome; C:mitochondrion;, F:gamma-butyrobetaine dioxygenase activity; F:identical protein binding; F:iron ion binding; F:zinc ion binding;, P:carnitine biosynthetic process; scaffold19 indexed_genome mRNA 20247770 20249474 . + . ID=transcript_4687;Q8TAL6,Fin bud initiation factor homolog,, PF15819;, GO:0005783;GO:0005576;GO:0005794;GO:0042803;GO:0070528;GO:0071548;GO:0010042;, C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus;, F:protein homodimerization activity;, P:protein kinase C signaling; P:response to dexamethasone; P:response to manganese ion; scaffold19 indexed_genome mRNA 20574372 20623735 . - . ID=transcript_4688;Q9BYT9 B7Z3F5,Anoctamin-3,Transmembrane protein 16C;, PF16178;PF04547;, GO:0016021;GO:0005886;GO:0005254;GO:0046983;GO:0061588;GO:1902476;GO:0034220;GO:0055085;, C:integral component of membrane; C:plasma membrane;, F:chloride channel activity; F:protein dimerization activity;, P:calcium activated phospholipid scrambling; P:chloride transmembrane transport; P:ion transmembrane transport; P:transmembrane transport; scaffold19 indexed_genome mRNA 20637770 20650890 . + . ID=transcript_4689;Q8N387 B3KY00 E9PII6 F8W945 Q6UWS3 Q8IXI8 Q8WW41,Mucin-15,, PF15672;, GO:0005576;GO:0005796;GO:0016021;GO:0005886;GO:0016266;GO:0002223;, C:extracellular region; C:Golgi lumen; C:integral component of membrane; C:plasma membrane;, , P:O-glycan processing; P:stimulatory C-type lectin receptor signaling pathway; scaffold19 indexed_genome mRNA 21237281 21241843 . - . ID=transcript_4690;Q13402 B9A011 F8VUN5 P78427 Q13321 Q14785 Q92821 Q92822,Unconventional myosin-VIIa,, PF00373;PF00612;PF00063;PF00784;, GO:0015629;GO:0016324;GO:0005938;GO:0005737;GO:0005829;GO:0005765;GO:0042470;GO:0005902;GO:0031477;GO:0032391;GO:0001917;GO:0001750;GO:0032420;GO:0120044;GO:0045202;GO:1990435;GO:0031982;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0005516;GO:0042802;GO:0000146;GO:0019904;GO:0047485;GO:0030507;GO:0007015;GO:0030048;GO:0060088;GO:0034613;GO:0050957;GO:0042462;GO:0006886;GO:0007040;GO:0042490;GO:0001845;GO:0051904;GO:0048563;GO:0007423;GO:0050953;GO:0007605;GO:0030050;GO:0007601;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:melanosome; C:microvillus; C:myosin VII complex; C:photoreceptor connecting cilium; C:photoreceptor inner segment; C:photoreceptor outer segment; C:stereocilium; C:stereocilium base; C:synapse; C:upper tip-link density; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:calmodulin binding; F:identical protein binding; F:microfilament motor activity; F:protein domain specific binding; F:protein N-terminus binding; F:spectrin binding;, P:actin filament organization; P:actin filament-based movement; P:auditory receptor cell stereocilium organization; P:cellular protein localization; P:equilibrioception; P:eye photoreceptor cell development; P:intracellular protein transport; P:lysosome organization; P:mechanoreceptor differentiation; P:phagolysosome assembly; P:pigment granule transport; P:post-embryonic animal organ morphogenesis; P:sensory organ development; P:sensory perception of light stimulus; P:sensory perception of sound; P:vesicle transport along actin filament; P:visual perception; scaffold19 indexed_genome mRNA 21258756 21271588 . - . ID=transcript_4691;Q13402 B9A011 F8VUN5 P78427 Q13321 Q14785 Q92821 Q92822,Unconventional myosin-VIIa,, PF00373;PF00612;PF00063;PF00784;, GO:0015629;GO:0016324;GO:0005938;GO:0005737;GO:0005829;GO:0005765;GO:0042470;GO:0005902;GO:0031477;GO:0032391;GO:0001917;GO:0001750;GO:0032420;GO:0120044;GO:0045202;GO:1990435;GO:0031982;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0005516;GO:0042802;GO:0000146;GO:0019904;GO:0047485;GO:0030507;GO:0007015;GO:0030048;GO:0060088;GO:0034613;GO:0050957;GO:0042462;GO:0006886;GO:0007040;GO:0042490;GO:0001845;GO:0051904;GO:0048563;GO:0007423;GO:0050953;GO:0007605;GO:0030050;GO:0007601;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:melanosome; C:microvillus; C:myosin VII complex; C:photoreceptor connecting cilium; C:photoreceptor inner segment; C:photoreceptor outer segment; C:stereocilium; C:stereocilium base; C:synapse; C:upper tip-link density; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:calmodulin binding; F:identical protein binding; F:microfilament motor activity; F:protein domain specific binding; F:protein N-terminus binding; F:spectrin binding;, P:actin filament organization; P:actin filament-based movement; P:auditory receptor cell stereocilium organization; P:cellular protein localization; P:equilibrioception; P:eye photoreceptor cell development; P:intracellular protein transport; P:lysosome organization; P:mechanoreceptor differentiation; P:phagolysosome assembly; P:pigment granule transport; P:post-embryonic animal organ morphogenesis; P:sensory organ development; P:sensory perception of light stimulus; P:sensory perception of sound; P:vesicle transport along actin filament; P:visual perception; scaffold19 indexed_genome mRNA 21327973 21343002 . - . ID=transcript_4692;O15484 O00263,Calpain-5,Calpain htra-3;New calpain 3;, PF00168;PF01067;PF00648;, GO:0009986;GO:0005737;GO:0070062;GO:0005925;GO:0004198;GO:0006508;GO:0007165;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:focal adhesion;, F:calcium-dependent cysteine-type endopeptidase activity;, P:proteolysis; P:signal transduction; scaffold19 indexed_genome mRNA 21360181 21384350 . - . ID=transcript_4693;O15484 O00263,Calpain-5,Calpain htra-3;New calpain 3;, PF00168;PF01067;PF00648;, GO:0009986;GO:0005737;GO:0070062;GO:0005925;GO:0004198;GO:0006508;GO:0007165;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:focal adhesion;, F:calcium-dependent cysteine-type endopeptidase activity;, P:proteolysis; P:signal transduction; scaffold19 indexed_genome mRNA 21444213 21537962 . - . ID=transcript_4694;Q9NUN7 B2RC99,Alkaline ceramidase 3,Alkaline dihydroceramidase SB89;Alkaline phytoceramidase;, PF05875;, GO:0005789;GO:0030176;GO:0030173;GO:0016021;GO:0005509;GO:0102121;GO:0071633;GO:0017040;GO:0070774;GO:0008270;GO:0046514;GO:0042552;GO:0071602;GO:0008284;GO:0043067;GO:0030148;GO:0046512;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:ceramidase activity; F:dihydroceramidase activity; F:N-acylsphingosine amidohydrolase activity; F:phytoceramidase activity; F:zinc ion binding;, P:ceramide catabolic process; P:myelination; P:phytosphingosine biosynthetic process; P:positive regulation of cell population proliferation; P:regulation of programmed cell death; P:sphingolipid biosynthetic process; P:sphingosine biosynthetic process; scaffold19 indexed_genome mRNA 21654556 21658819 . - . ID=transcript_4695;Q8WUA8 B3KQT7 Q6UXK1 Q9UG10 Q9UJX9,Tsukushi {ECO:0000303|PubMed:30232710},E2-induced gene 4 protein;Leucine-rich repeat-containing protein 54;, PF13855;, GO:0005615;GO:0050431;GO:0021960;GO:0098868;GO:0043010;GO:0033344;GO:0042632;GO:0008203;GO:0061073;GO:0021540;GO:0097009;GO:0003431;GO:0021766;GO:0060122;GO:0021670;GO:1904761;GO:0010977;GO:0032911;GO:0030178;GO:0042635;GO:0010468;GO:0042060;, C:extracellular space;, F:transforming growth factor beta binding;, P:anterior commissure morphogenesis; P:bone growth; P:camera-type eye development; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:ciliary body morphogenesis; P:corpus callosum morphogenesis; P:energy homeostasis; P:growth plate cartilage chondrocyte development; P:hippocampus development; P:inner ear receptor cell stereocilium organization; P:lateral ventricle development; P:negative regulation of myofibroblast differentiation; P:negative regulation of neuron projection development; P:negative regulation of transforming growth factor beta1 production; P:negative regulation of Wnt signaling pathway; P:positive regulation of hair cycle; P:regulation of gene expression; P:wound healing; scaffold19 indexed_genome mRNA 21805493 21809467 . + . ID=transcript_4696;Q14392 Q86V06,Transforming growth factor beta activator LRRC32 {ECO:0000305},Garpin {ECO:0000303|PubMed:8180135};Glycoprotein A repetitions predominant {ECO:0000303|PubMed:19750484, ECO:0000303|PubMed:8180135};Leucine-rich repeat-containing protein 32 {ECO:0000303|PubMed:19651619};, PF13855;PF01462;, GO:0009986;GO:0031012;GO:0005615;GO:0005887;GO:0005654;GO:0050431;GO:0046007;GO:0001818;GO:0010628;GO:1901388;GO:1901398;GO:0062009;GO:0007179;, C:cell surface; C:extracellular matrix; C:extracellular space; C:integral component of plasma membrane; C:nucleoplasm;, F:transforming growth factor beta binding;, P:negative regulation of activated T cell proliferation; P:negative regulation of cytokine production; P:positive regulation of gene expression; P:regulation of transforming growth factor beta activation; P:regulation of transforming growth factor beta3 activation; P:secondary palate development; P:transforming growth factor beta receptor signaling pathway; scaffold19 indexed_genome mRNA 21906697 21920167 . - . ID=transcript_4697;Q9NRH0,BRCA2-interacting transcriptional repressor EMSY {ECO:0000312|HGNC:HGNC:18071},, PF03735;, GO:0005654;GO:0042802;GO:0006325;GO:0006281;GO:0006355;, C:nucleoplasm;, F:identical protein binding;, P:chromatin organization; P:DNA repair; P:regulation of transcription, DNA-templated;|Q9NRH0,BRCA2-interacting transcriptional repressor EMSY {ECO:0000312|HGNC:HGNC:18071},, PF03735;, GO:0005654;GO:0042802;GO:0006325;GO:0006281;GO:0006355;, C:nucleoplasm;, F:identical protein binding;, P:chromatin organization; P:DNA repair; P:regulation of transcription, DNA-templated;|Q9NRH0,BRCA2-interacting transcriptional repressor EMSY {ECO:0000312|HGNC:HGNC:18071},, PF03735;, GO:0005654;GO:0042802;GO:0006325;GO:0006281;GO:0006355;, C:nucleoplasm;, F:identical protein binding;, P:chromatin organization; P:DNA repair; P:regulation of transcription, DNA-templated;|Q9NRH0,BRCA2-interacting transcriptional repressor EMSY {ECO:0000312|HGNC:HGNC:18071},, PF03735;, GO:0005654;GO:0042802;GO:0006325;GO:0006281;GO:0006355;, C:nucleoplasm;, F:identical protein binding;, P:chromatin organization; P:DNA repair; P:regulation of transcription, DNA-templated;|Q9NRH0,BRCA2-interacting transcriptional repressor EMSY {ECO:0000312|HGNC:HGNC:18071},, PF03735;, GO:0005654;GO:0042802;GO:0006325;GO:0006281;GO:0006355;, C:nucleoplasm;, F:identical protein binding;, P:chromatin organization; P:DNA repair; P:regulation of transcription, DNA-templated; scaffold19 indexed_genome mRNA 21921027 21988007 . - . ID=transcript_4698;Q9NRH0,BRCA2-interacting transcriptional repressor EMSY {ECO:0000312|HGNC:HGNC:18071},, PF03735;, GO:0005654;GO:0042802;GO:0006325;GO:0006281;GO:0006355;, C:nucleoplasm;, F:identical protein binding;, P:chromatin organization; P:DNA repair; P:regulation of transcription, DNA-templated; scaffold19 indexed_genome mRNA 22039639 22040613 . + . ID=transcript_4699;Q3ZCU0 Q8N9C3,Protein GVQW3 {ECO:0000305},GVQW motif-containing protein 3 {ECO:0000305};, PF17906; scaffold19 indexed_genome mRNA 22040835 22076372 . + . ID=transcript_4700;O43422 A8K728 Q17RY9 Q8WTW1 Q9Y3Z4,52 kDa repressor of the inhibitor of the protein kinase,58 kDa interferon-induced protein kinase-interacting protein;Death-associated protein 4;THAP domain-containing protein 0;THAP domain-containing protein 12 {ECO:0000312|HGNC:HGNC:9440};, PF05699;PF14291;PF05485;, GO:0005634;GO:0003677;GO:0046872;GO:0046983;GO:0008285;GO:0007165;, C:nucleus;, F:DNA binding; F:metal ion binding; F:protein dimerization activity;, P:negative regulation of cell population proliferation; P:signal transduction; scaffold19 indexed_genome mRNA 22211785 22233805 . + . ID=transcript_4701;O96014 B2R8Z6 Q14DE8 Q8WZ98,Protein Wnt-11,, PF00110;, GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0005125;GO:0005109;GO:0005096;GO:0030295;GO:0030325;GO:0048844;GO:0003283;GO:0070830;GO:0030282;GO:0060070;GO:0045165;GO:0071260;GO:0071300;GO:0060197;GO:0060028;GO:0048706;GO:0001837;GO:0060484;GO:0045199;GO:0072177;GO:0043066;GO:0090090;GO:0061037;GO:0060548;GO:0030308;GO:0030336;GO:0090272;GO:0072201;GO:0045892;GO:0061101;GO:0030182;GO:0048570;GO:0001649;GO:0003151;GO:0048341;GO:0003402;GO:0060775;GO:0043065;GO:0030335;GO:0010628;GO:0043547;GO:0090082;GO:0090037;GO:0051496;GO:0045893;GO:0032915;GO:0003138;GO:0034394;GO:0006468;GO:0031667;GO:0003139;GO:0062009;GO:0061053;GO:0060675;GO:0060412;GO:0016055;GO:0007223;GO:0060071;, C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:cytokine activity; F:frizzled binding; F:GTPase activator activity; F:protein kinase activator activity;, P:adrenal gland development; P:artery morphogenesis; P:atrial septum development; P:bicellular tight junction assembly; P:bone mineralization; P:canonical Wnt signaling pathway; P:cell fate commitment; P:cellular response to mechanical stimulus; P:cellular response to retinoic acid; P:cloacal septation; P:convergent extension involved in axis elongation; P:embryonic skeletal system development; P:epithelial to mesenchymal transition; P:lung-associated mesenchyme development; P:maintenance of epithelial cell apical/basal polarity; P:mesonephric duct development; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cartilage development; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of fibroblast growth factor production; P:negative regulation of mesenchymal cell proliferation; P:negative regulation of transcription, DNA-templated; P:neuroendocrine cell differentiation; P:neuron differentiation; P:notochord morphogenesis; P:osteoblast differentiation; P:outflow tract morphogenesis; P:paraxial mesoderm formation; P:planar cell polarity pathway involved in axis elongation; P:planar cell polarity pathway involved in gastrula mediolateral intercalation; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway; P:positive regulation of protein kinase C signaling; P:positive regulation of stress fiber assembly; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta2 production; P:primary heart field specification; P:protein localization to cell surface; P:protein phosphorylation; P:response to nutrient levels; P:secondary heart field specification; P:secondary palate development; P:somite development; P:ureteric bud morphogenesis; P:ventricular septum morphogenesis; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway;|O96014 B2R8Z6 Q14DE8 Q8WZ98,Protein Wnt-11,, PF00110;, GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0005125;GO:0005109;GO:0005096;GO:0030295;GO:0030325;GO:0048844;GO:0003283;GO:0070830;GO:0030282;GO:0060070;GO:0045165;GO:0071260;GO:0071300;GO:0060197;GO:0060028;GO:0048706;GO:0001837;GO:0060484;GO:0045199;GO:0072177;GO:0043066;GO:0090090;GO:0061037;GO:0060548;GO:0030308;GO:0030336;GO:0090272;GO:0072201;GO:0045892;GO:0061101;GO:0030182;GO:0048570;GO:0001649;GO:0003151;GO:0048341;GO:0003402;GO:0060775;GO:0043065;GO:0030335;GO:0010628;GO:0043547;GO:0090082;GO:0090037;GO:0051496;GO:0045893;GO:0032915;GO:0003138;GO:0034394;GO:0006468;GO:0031667;GO:0003139;GO:0062009;GO:0061053;GO:0060675;GO:0060412;GO:0016055;GO:0007223;GO:0060071;, C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:cytokine activity; F:frizzled binding; F:GTPase activator activity; F:protein kinase activator activity;, P:adrenal gland development; P:artery morphogenesis; P:atrial septum development; P:bicellular tight junction assembly; P:bone mineralization; P:canonical Wnt signaling pathway; P:cell fate commitment; P:cellular response to mechanical stimulus; P:cellular response to retinoic acid; P:cloacal septation; P:convergent extension involved in axis elongation; P:embryonic skeletal system development; P:epithelial to mesenchymal transition; P:lung-associated mesenchyme development; P:maintenance of epithelial cell apical/basal polarity; P:mesonephric duct development; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cartilage development; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of fibroblast growth factor production; P:negative regulation of mesenchymal cell proliferation; P:negative regulation of transcription, DNA-templated; P:neuroendocrine cell differentiation; P:neuron differentiation; P:notochord morphogenesis; P:osteoblast differentiation; P:outflow tract morphogenesis; P:paraxial mesoderm formation; P:planar cell polarity pathway involved in axis elongation; P:planar cell polarity pathway involved in gastrula mediolateral intercalation; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway; P:positive regulation of protein kinase C signaling; P:positive regulation of stress fiber assembly; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta2 production; P:primary heart field specification; P:protein localization to cell surface; P:protein phosphorylation; P:response to nutrient levels; P:secondary heart field specification; P:secondary palate development; P:somite development; P:ureteric bud morphogenesis; P:ventricular septum morphogenesis; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway;|O96014 B2R8Z6 Q14DE8 Q8WZ98,Protein Wnt-11,, PF00110;, GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0005125;GO:0005109;GO:0005096;GO:0030295;GO:0030325;GO:0048844;GO:0003283;GO:0070830;GO:0030282;GO:0060070;GO:0045165;GO:0071260;GO:0071300;GO:0060197;GO:0060028;GO:0048706;GO:0001837;GO:0060484;GO:0045199;GO:0072177;GO:0043066;GO:0090090;GO:0061037;GO:0060548;GO:0030308;GO:0030336;GO:0090272;GO:0072201;GO:0045892;GO:0061101;GO:0030182;GO:0048570;GO:0001649;GO:0003151;GO:0048341;GO:0003402;GO:0060775;GO:0043065;GO:0030335;GO:0010628;GO:0043547;GO:0090082;GO:0090037;GO:0051496;GO:0045893;GO:0032915;GO:0003138;GO:0034394;GO:0006468;GO:0031667;GO:0003139;GO:0062009;GO:0061053;GO:0060675;GO:0060412;GO:0016055;GO:0007223;GO:0060071;, C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:cytokine activity; F:frizzled binding; F:GTPase activator activity; F:protein kinase activator activity;, P:adrenal gland development; P:artery morphogenesis; P:atrial septum development; P:bicellular tight junction assembly; P:bone mineralization; P:canonical Wnt signaling pathway; P:cell fate commitment; P:cellular response to mechanical stimulus; P:cellular response to retinoic acid; P:cloacal septation; P:convergent extension involved in axis elongation; P:embryonic skeletal system development; P:epithelial to mesenchymal transition; P:lung-associated mesenchyme development; P:maintenance of epithelial cell apical/basal polarity; P:mesonephric duct development; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cartilage development; P:negative regulation of cell death; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of fibroblast growth factor production; P:negative regulation of mesenchymal cell proliferation; P:negative regulation of transcription, DNA-templated; P:neuroendocrine cell differentiation; P:neuron differentiation; P:notochord morphogenesis; P:osteoblast differentiation; P:outflow tract morphogenesis; P:paraxial mesoderm formation; P:planar cell polarity pathway involved in axis elongation; P:planar cell polarity pathway involved in gastrula mediolateral intercalation; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway; P:positive regulation of protein kinase C signaling; P:positive regulation of stress fiber assembly; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta2 production; P:primary heart field specification; P:protein localization to cell surface; P:protein phosphorylation; P:response to nutrient levels; P:secondary heart field specification; P:secondary palate development; P:somite development; P:ureteric bud morphogenesis; P:ventricular septum morphogenesis; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold19 indexed_genome mRNA 22293170 22598634 . + . ID=transcript_4702;Q9P2Y5 B3KTC1 O00392,UV radiation resistance-associated gene protein,p63;, PF10186;, GO:0000421;GO:0005813;GO:0000775;GO:0005737;GO:0005769;GO:0005783;GO:0005768;GO:0005770;GO:0005764;GO:0000323;GO:0030496;GO:0045335;GO:0032991;GO:0017124;GO:0000149;GO:0097352;GO:0006914;GO:0007098;GO:0007059;GO:0006281;GO:0097680;GO:0051684;GO:0071985;GO:1901098;GO:0032801;GO:0032465;GO:0071900;GO:0006890;GO:0035493;GO:0007051;GO:0046718;, C:autophagosome membrane; C:centrosome; C:chromosome, centromeric region; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:endosome; C:late endosome; C:lysosome; C:lytic vacuole; C:midbody; C:phagocytic vesicle; C:protein-containing complex;, F:SH3 domain binding; F:SNARE binding;, P:autophagosome maturation; P:autophagy; P:centrosome cycle; P:chromosome segregation; P:DNA repair; P:double-strand break repair via classical nonhomologous end joining; P:maintenance of Golgi location; P:multivesicular body sorting pathway; P:positive regulation of autophagosome maturation; P:receptor catabolic process; P:regulation of cytokinesis; P:regulation of protein serine/threonine kinase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:SNARE complex assembly; P:spindle organization; P:viral entry into host cell;|Q9P2Y5 B3KTC1 O00392,UV radiation resistance-associated gene protein,p63;, PF10186;, GO:0000421;GO:0005813;GO:0000775;GO:0005737;GO:0005769;GO:0005783;GO:0005768;GO:0005770;GO:0005764;GO:0000323;GO:0030496;GO:0045335;GO:0032991;GO:0017124;GO:0000149;GO:0097352;GO:0006914;GO:0007098;GO:0007059;GO:0006281;GO:0097680;GO:0051684;GO:0071985;GO:1901098;GO:0032801;GO:0032465;GO:0071900;GO:0006890;GO:0035493;GO:0007051;GO:0046718;, C:autophagosome membrane; C:centrosome; C:chromosome, centromeric region; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:endosome; C:late endosome; C:lysosome; C:lytic vacuole; C:midbody; C:phagocytic vesicle; C:protein-containing complex;, F:SH3 domain binding; F:SNARE binding;, P:autophagosome maturation; P:autophagy; P:centrosome cycle; P:chromosome segregation; P:DNA repair; P:double-strand break repair via classical nonhomologous end joining; P:maintenance of Golgi location; P:multivesicular body sorting pathway; P:positive regulation of autophagosome maturation; P:receptor catabolic process; P:regulation of cytokinesis; P:regulation of protein serine/threonine kinase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:SNARE complex assembly; P:spindle organization; P:viral entry into host cell;|Q9P2Y5 B3KTC1 O00392,UV radiation resistance-associated gene protein,p63;, PF10186;, GO:0000421;GO:0005813;GO:0000775;GO:0005737;GO:0005769;GO:0005783;GO:0005768;GO:0005770;GO:0005764;GO:0000323;GO:0030496;GO:0045335;GO:0032991;GO:0017124;GO:0000149;GO:0097352;GO:0006914;GO:0007098;GO:0007059;GO:0006281;GO:0097680;GO:0051684;GO:0071985;GO:1901098;GO:0032801;GO:0032465;GO:0071900;GO:0006890;GO:0035493;GO:0007051;GO:0046718;, C:autophagosome membrane; C:centrosome; C:chromosome, centromeric region; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:endosome; C:late endosome; C:lysosome; C:lytic vacuole; C:midbody; C:phagocytic vesicle; C:protein-containing complex;, F:SH3 domain binding; F:SNARE binding;, P:autophagosome maturation; P:autophagy; P:centrosome cycle; P:chromosome segregation; P:DNA repair; P:double-strand break repair via classical nonhomologous end joining; P:maintenance of Golgi location; P:multivesicular body sorting pathway; P:positive regulation of autophagosome maturation; P:receptor catabolic process; P:regulation of cytokinesis; P:regulation of protein serine/threonine kinase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:SNARE complex assembly; P:spindle organization; P:viral entry into host cell; scaffold19 indexed_genome mRNA 22613427 22649482 . - . ID=transcript_4703;Q96PD7 A6ND76 Q5U810 Q68CL3 Q68DJ0 Q8NDB7 Q96BS0 Q9BYE5,Diacylglycerol O-acyltransferase 2 {ECO:0000305},Acyl-CoA retinol O-fatty-acyltransferase;Diglyceride acyltransferase 2;, PF03982;, GO:0005829;GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0043231;GO:0005811;GO:0005739;GO:1990578;GO:0048471;GO:0003846;GO:0004144;GO:0008374;GO:0042803;GO:0050252;GO:0036155;GO:0038183;GO:0071400;GO:0035356;GO:0042632;GO:0006651;GO:0046339;GO:0060613;GO:0055089;GO:0006071;GO:0006629;GO:0019915;GO:0035336;GO:0034383;GO:0006640;GO:0046322;GO:0045722;GO:0010867;GO:0090181;GO:0050746;GO:0097006;GO:0019432;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion; C:perinuclear endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:O-acyltransferase activity; F:protein homodimerization activity; F:retinol O-fatty-acyltransferase activity;, P:acylglycerol acyl-chain remodeling; P:bile acid signaling pathway; P:cellular response to oleic acid; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:diacylglycerol biosynthetic process; P:diacylglycerol metabolic process; P:fat pad development; P:fatty acid homeostasis; P:glycerol metabolic process; P:lipid metabolic process; P:lipid storage; P:long-chain fatty-acyl-CoA metabolic process; P:low-density lipoprotein particle clearance; P:monoacylglycerol biosynthetic process; P:negative regulation of fatty acid oxidation; P:positive regulation of gluconeogenesis; P:positive regulation of triglyceride biosynthetic process; P:regulation of cholesterol metabolic process; P:regulation of lipoprotein metabolic process; P:regulation of plasma lipoprotein particle levels; P:triglyceride biosynthetic process; scaffold19 indexed_genome mRNA 22994102 22995724 . - . ID=transcript_4704;Q96JE9 A7E2A1 Q6P3T0 Q6ZWB8,Microtubule-associated protein 6,Stable tubule-only polypeptide;, , GO:0030424;GO:0005801;GO:0030425;GO:0005798;GO:0005874;GO:0048471;GO:0030658;GO:0005516;GO:0008017;GO:0030705;GO:0048813;GO:0032418;GO:0000226;GO:0050772;GO:0070507;, C:axon; C:cis-Golgi network; C:dendrite; C:Golgi-associated vesicle; C:microtubule; C:perinuclear region of cytoplasm; C:transport vesicle membrane;, F:calmodulin binding; F:microtubule binding;, P:cytoskeleton-dependent intracellular transport; P:dendrite morphogenesis; P:lysosome localization; P:microtubule cytoskeleton organization; P:positive regulation of axonogenesis; P:regulation of microtubule cytoskeleton organization; scaffold19 indexed_genome mRNA 23079883 23081456 . + . ID=transcript_4705;Q96JE9 A7E2A1 Q6P3T0 Q6ZWB8,Microtubule-associated protein 6,Stable tubule-only polypeptide;, , GO:0030424;GO:0005801;GO:0030425;GO:0005798;GO:0005874;GO:0048471;GO:0030658;GO:0005516;GO:0008017;GO:0030705;GO:0048813;GO:0032418;GO:0000226;GO:0050772;GO:0070507;, C:axon; C:cis-Golgi network; C:dendrite; C:Golgi-associated vesicle; C:microtubule; C:perinuclear region of cytoplasm; C:transport vesicle membrane;, F:calmodulin binding; F:microtubule binding;, P:cytoskeleton-dependent intracellular transport; P:dendrite morphogenesis; P:lysosome localization; P:microtubule cytoskeleton organization; P:positive regulation of axonogenesis; P:regulation of microtubule cytoskeleton organization; scaffold19 indexed_genome mRNA 23096648 23106317 . - . ID=transcript_4706;P50454 B3KVJ3 P29043 Q5XPB4 Q6NSJ6 Q8IY96 Q9NP88,Serpin H1,47 kDa heat shock protein;Arsenic-transactivated protein 3;Cell proliferation-inducing gene 14 protein;Collagen-binding protein;Rheumatoid arthritis-related antigen RA-A47;, PF00079;, GO:0062023;GO:0005783;GO:0005788;GO:0005793;GO:0005615;GO:0045121;GO:0005518;GO:0003723;GO:0004867;GO:0051082;GO:0003433;GO:0032964;GO:0030199;GO:0010951;GO:0051604;GO:0006986;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular space; C:membrane raft;, F:collagen binding; F:RNA binding; F:serine-type endopeptidase inhibitor activity; F:unfolded protein binding;, P:chondrocyte development involved in endochondral bone morphogenesis; P:collagen biosynthetic process; P:collagen fibril organization; P:negative regulation of endopeptidase activity; P:protein maturation; P:response to unfolded protein;|P50454 B3KVJ3 P29043 Q5XPB4 Q6NSJ6 Q8IY96 Q9NP88,Serpin H1,47 kDa heat shock protein;Arsenic-transactivated protein 3;Cell proliferation-inducing gene 14 protein;Collagen-binding protein;Rheumatoid arthritis-related antigen RA-A47;, PF00079;, GO:0062023;GO:0005783;GO:0005788;GO:0005793;GO:0005615;GO:0045121;GO:0005518;GO:0003723;GO:0004867;GO:0051082;GO:0003433;GO:0032964;GO:0030199;GO:0010951;GO:0051604;GO:0006986;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular space; C:membrane raft;, F:collagen binding; F:RNA binding; F:serine-type endopeptidase inhibitor activity; F:unfolded protein binding;, P:chondrocyte development involved in endochondral bone morphogenesis; P:collagen biosynthetic process; P:collagen fibril organization; P:negative regulation of endopeptidase activity; P:protein maturation; P:response to unfolded protein;|P50454 B3KVJ3 P29043 Q5XPB4 Q6NSJ6 Q8IY96 Q9NP88,Serpin H1,47 kDa heat shock protein;Arsenic-transactivated protein 3;Cell proliferation-inducing gene 14 protein;Collagen-binding protein;Rheumatoid arthritis-related antigen RA-A47;, PF00079;, GO:0062023;GO:0005783;GO:0005788;GO:0005793;GO:0005615;GO:0045121;GO:0005518;GO:0003723;GO:0004867;GO:0051082;GO:0003433;GO:0032964;GO:0030199;GO:0010951;GO:0051604;GO:0006986;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular space; C:membrane raft;, F:collagen binding; F:RNA binding; F:serine-type endopeptidase inhibitor activity; F:unfolded protein binding;, P:chondrocyte development involved in endochondral bone morphogenesis; P:collagen biosynthetic process; P:collagen fibril organization; P:negative regulation of endopeptidase activity; P:protein maturation; P:response to unfolded protein; scaffold19 indexed_genome mRNA 23145365 23147005 . - . ID=transcript_4707;Q8WTR4 Q49AQ5 Q6UX76 Q7Z4S0 Q8N781 Q8NCB7 Q8TB77,Glycerophosphodiester phosphodiesterase domain-containing protein 5 {ECO:0000305},Glycerophosphocholine phosphodiesterase GDPD5 {ECO:0000250|UniProtKB:Q640M6};Glycerophosphodiester phosphodiesterase 2;Phosphoinositide phospholipase C GDPD5 {ECO:0000305};, PF03009;, GO:0012505;GO:0030426;GO:0016021;GO:0048471;GO:0047389;GO:0004435;GO:0006629;GO:0007399;, C:endomembrane system; C:growth cone; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:glycerophosphocholine phosphodiesterase activity; F:phosphatidylinositol phospholipase C activity;, P:lipid metabolic process; P:nervous system development; scaffold19 indexed_genome mRNA 23151580 23155430 . + . ID=transcript_4708;Q6PF15 A2RU06 F5H412 Q86XM7 Q8NBB1,Kelch-like protein 35,, PF07707;PF00651;PF01344;|Q6PF15 A2RU06 F5H412 Q86XM7 Q8NBB1,Kelch-like protein 35,, PF07707;PF00651;PF01344; scaffold19 indexed_genome mRNA 23155435 23159488 . + . ID=transcript_4709;Q6PF15 A2RU06 F5H412 Q86XM7 Q8NBB1,Kelch-like protein 35,, PF07707;PF00651;PF01344; scaffold19 indexed_genome mRNA 23161556 23168553 . - . ID=transcript_4710;P23396 B2R7N5 J3KN86 Q498B5 Q8NI95,40S ribosomal protein S3,Small ribosomal subunit protein uS3 {ECO:0000303|PubMed:24524803};, PF07650;PF00189;, GO:0005737;GO:0005829;GO:0022627;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005743;GO:0005759;GO:0072686;GO:0071159;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005844;GO:0014069;GO:1990904;GO:0005840;GO:0032587;GO:0140078;GO:0003684;GO:0003677;GO:0003906;GO:0004520;GO:0019899;GO:0030544;GO:0051879;GO:0051536;GO:0019900;GO:0008017;GO:0003729;GO:0032357;GO:0032358;GO:0051018;GO:0019901;GO:0044877;GO:0003723;GO:0070181;GO:0003735;GO:0097100;GO:0008134;GO:0015631;GO:0044390;GO:0006915;GO:0051301;GO:0006974;GO:0070301;GO:0034614;GO:0071356;GO:0007059;GO:0042769;GO:0006281;GO:0045738;GO:0031397;GO:0017148;GO:0000184;GO:0042104;GO:2001235;GO:1905053;GO:2001272;GO:1902546;GO:0045739;GO:0032079;GO:0010628;GO:0032743;GO:1902231;GO:0043507;GO:0031116;GO:0051092;GO:1901224;GO:0031334;GO:0050862;GO:0042981;GO:0061481;GO:0051225;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitotic spindle; C:NF-kappaB complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:polysome; C:postsynaptic density; C:ribonucleoprotein complex; C:ribosome; C:ruffle membrane;, F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA binding; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:endodeoxyribonuclease activity; F:enzyme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron-sulfur cluster binding; F:kinase binding; F:microtubule binding; F:mRNA binding; F:oxidized purine DNA binding; F:oxidized pyrimidine DNA binding; F:protein kinase A binding; F:protein kinase binding; F:protein-containing complex binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome; F:supercoiled DNA binding; F:transcription factor binding; F:tubulin binding; F:ubiquitin-like protein conjugating enzyme binding;, P:apoptotic process; P:cell division; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:chromosome segregation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:negative regulation of DNA repair; P:negative regulation of protein ubiquitination; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of activated T cell proliferation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of base-excision repair; P:positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; P:positive regulation of DNA N-glycosylase activity; P:positive regulation of DNA repair; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of gene expression; P:positive regulation of interleukin-2 production; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of JUN kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein-containing complex assembly; P:positive regulation of T cell receptor signaling pathway; P:regulation of apoptotic process; P:response to TNF agonist; P:spindle assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P23396 B2R7N5 J3KN86 Q498B5 Q8NI95,40S ribosomal protein S3,Small ribosomal subunit protein uS3 {ECO:0000303|PubMed:24524803};, PF07650;PF00189;, GO:0005737;GO:0005829;GO:0022627;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005743;GO:0005759;GO:0072686;GO:0071159;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005844;GO:0014069;GO:1990904;GO:0005840;GO:0032587;GO:0140078;GO:0003684;GO:0003677;GO:0003906;GO:0004520;GO:0019899;GO:0030544;GO:0051879;GO:0051536;GO:0019900;GO:0008017;GO:0003729;GO:0032357;GO:0032358;GO:0051018;GO:0019901;GO:0044877;GO:0003723;GO:0070181;GO:0003735;GO:0097100;GO:0008134;GO:0015631;GO:0044390;GO:0006915;GO:0051301;GO:0006974;GO:0070301;GO:0034614;GO:0071356;GO:0007059;GO:0042769;GO:0006281;GO:0045738;GO:0031397;GO:0017148;GO:0000184;GO:0042104;GO:2001235;GO:1905053;GO:2001272;GO:1902546;GO:0045739;GO:0032079;GO:0010628;GO:0032743;GO:1902231;GO:0043507;GO:0031116;GO:0051092;GO:1901224;GO:0031334;GO:0050862;GO:0042981;GO:0061481;GO:0051225;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitotic spindle; C:NF-kappaB complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:polysome; C:postsynaptic density; C:ribonucleoprotein complex; C:ribosome; C:ruffle membrane;, F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA binding; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:endodeoxyribonuclease activity; F:enzyme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron-sulfur cluster binding; F:kinase binding; F:microtubule binding; F:mRNA binding; F:oxidized purine DNA binding; F:oxidized pyrimidine DNA binding; F:protein kinase A binding; F:protein kinase binding; F:protein-containing complex binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome; F:supercoiled DNA binding; F:transcription factor binding; F:tubulin binding; F:ubiquitin-like protein conjugating enzyme binding;, P:apoptotic process; P:cell division; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:chromosome segregation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:negative regulation of DNA repair; P:negative regulation of protein ubiquitination; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of activated T cell proliferation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of base-excision repair; P:positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; P:positive regulation of DNA N-glycosylase activity; P:positive regulation of DNA repair; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of gene expression; P:positive regulation of interleukin-2 production; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of JUN kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein-containing complex assembly; P:positive regulation of T cell receptor signaling pathway; P:regulation of apoptotic process; P:response to TNF agonist; P:spindle assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P23396 B2R7N5 J3KN86 Q498B5 Q8NI95,40S ribosomal protein S3,Small ribosomal subunit protein uS3 {ECO:0000303|PubMed:24524803};, PF07650;PF00189;, GO:0005737;GO:0005829;GO:0022627;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005743;GO:0005759;GO:0072686;GO:0071159;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005844;GO:0014069;GO:1990904;GO:0005840;GO:0032587;GO:0140078;GO:0003684;GO:0003677;GO:0003906;GO:0004520;GO:0019899;GO:0030544;GO:0051879;GO:0051536;GO:0019900;GO:0008017;GO:0003729;GO:0032357;GO:0032358;GO:0051018;GO:0019901;GO:0044877;GO:0003723;GO:0070181;GO:0003735;GO:0097100;GO:0008134;GO:0015631;GO:0044390;GO:0006915;GO:0051301;GO:0006974;GO:0070301;GO:0034614;GO:0071356;GO:0007059;GO:0042769;GO:0006281;GO:0045738;GO:0031397;GO:0017148;GO:0000184;GO:0042104;GO:2001235;GO:1905053;GO:2001272;GO:1902546;GO:0045739;GO:0032079;GO:0010628;GO:0032743;GO:1902231;GO:0043507;GO:0031116;GO:0051092;GO:1901224;GO:0031334;GO:0050862;GO:0042981;GO:0061481;GO:0051225;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitotic spindle; C:NF-kappaB complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:polysome; C:postsynaptic density; C:ribonucleoprotein complex; C:ribosome; C:ruffle membrane;, F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA binding; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:endodeoxyribonuclease activity; F:enzyme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron-sulfur cluster binding; F:kinase binding; F:microtubule binding; F:mRNA binding; F:oxidized purine DNA binding; F:oxidized pyrimidine DNA binding; F:protein kinase A binding; F:protein kinase binding; F:protein-containing complex binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome; F:supercoiled DNA binding; F:transcription factor binding; F:tubulin binding; F:ubiquitin-like protein conjugating enzyme binding;, P:apoptotic process; P:cell division; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:chromosome segregation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:negative regulation of DNA repair; P:negative regulation of protein ubiquitination; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of activated T cell proliferation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of base-excision repair; P:positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; P:positive regulation of DNA N-glycosylase activity; P:positive regulation of DNA repair; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of gene expression; P:positive regulation of interleukin-2 production; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of JUN kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein-containing complex assembly; P:positive regulation of T cell receptor signaling pathway; P:regulation of apoptotic process; P:response to TNF agonist; P:spindle assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P23396 B2R7N5 J3KN86 Q498B5 Q8NI95,40S ribosomal protein S3,Small ribosomal subunit protein uS3 {ECO:0000303|PubMed:24524803};, PF07650;PF00189;, GO:0005737;GO:0005829;GO:0022627;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005743;GO:0005759;GO:0072686;GO:0071159;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005844;GO:0014069;GO:1990904;GO:0005840;GO:0032587;GO:0140078;GO:0003684;GO:0003677;GO:0003906;GO:0004520;GO:0019899;GO:0030544;GO:0051879;GO:0051536;GO:0019900;GO:0008017;GO:0003729;GO:0032357;GO:0032358;GO:0051018;GO:0019901;GO:0044877;GO:0003723;GO:0070181;GO:0003735;GO:0097100;GO:0008134;GO:0015631;GO:0044390;GO:0006915;GO:0051301;GO:0006974;GO:0070301;GO:0034614;GO:0071356;GO:0007059;GO:0042769;GO:0006281;GO:0045738;GO:0031397;GO:0017148;GO:0000184;GO:0042104;GO:2001235;GO:1905053;GO:2001272;GO:1902546;GO:0045739;GO:0032079;GO:0010628;GO:0032743;GO:1902231;GO:0043507;GO:0031116;GO:0051092;GO:1901224;GO:0031334;GO:0050862;GO:0042981;GO:0061481;GO:0051225;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitotic spindle; C:NF-kappaB complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:polysome; C:postsynaptic density; C:ribonucleoprotein complex; C:ribosome; C:ruffle membrane;, F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA binding; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:endodeoxyribonuclease activity; F:enzyme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron-sulfur cluster binding; F:kinase binding; F:microtubule binding; F:mRNA binding; F:oxidized purine DNA binding; F:oxidized pyrimidine DNA binding; F:protein kinase A binding; F:protein kinase binding; F:protein-containing complex binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome; F:supercoiled DNA binding; F:transcription factor binding; F:tubulin binding; F:ubiquitin-like protein conjugating enzyme binding;, P:apoptotic process; P:cell division; P:cellular response to DNA damage stimulus; P:cellular response to hydrogen peroxide; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:chromosome segregation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:negative regulation of DNA repair; P:negative regulation of protein ubiquitination; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of activated T cell proliferation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of base-excision repair; P:positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; P:positive regulation of DNA N-glycosylase activity; P:positive regulation of DNA repair; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of gene expression; P:positive regulation of interleukin-2 production; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of JUN kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein-containing complex assembly; P:positive regulation of T cell receptor signaling pathway; P:regulation of apoptotic process; P:response to TNF agonist; P:spindle assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold19 indexed_genome mRNA 23207130 23294504 . + . ID=transcript_4711;P49407 B6V9G8 O75625 O75630 Q2PP20 Q9BTK8,Beta-arrestin-1,Arrestin beta-1;Non-visual arrestin-2 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0000785;GO:0005905;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0043197;GO:0005768;GO:0000139;GO:0005765;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0031143;GO:0031691;GO:0031692;GO:0031701;GO:0035612;GO:1990763;GO:0035615;GO:0004857;GO:0030331;GO:0031762;GO:0001664;GO:0005096;GO:0005159;GO:0044325;GO:0045309;GO:0003713;GO:0008134;GO:0031625;GO:0031896;GO:0000187;GO:0042699;GO:0002031;GO:0007186;GO:0016573;GO:0061024;GO:0070373;GO:0034260;GO:0032715;GO:0032717;GO:0043524;GO:0032088;GO:0045746;GO:0001933;GO:0031397;GO:0030168;GO:0008284;GO:0043280;GO:0070374;GO:0035066;GO:0090240;GO:0001934;GO:0031398;GO:0002092;GO:0035025;GO:0034393;GO:0045944;GO:0006892;GO:0043161;GO:0015031;GO:0016567;GO:0006357;GO:0042493;GO:0043149;GO:0006511;, C:basolateral plasma membrane; C:chromatin; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic spine; C:endosome; C:Golgi membrane; C:lysosomal membrane; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:pseudopodium;, F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:AP-2 adaptor complex binding; F:arrestin family protein binding; F:clathrin adaptor activity; F:enzyme inhibitor activity; F:estrogen receptor binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:GTPase activator activity; F:insulin-like growth factor receptor binding; F:ion channel binding; F:protein phosphorylated amino acid binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:V2 vasopressin receptor binding;, P:activation of MAPK activity; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:histone acetylation; P:membrane organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of GTPase activity; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of Notch signaling pathway; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:platelet activation; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of histone acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of receptor internalization; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:post-Golgi vesicle-mediated transport; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein transport; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:response to drug; P:stress fiber assembly; P:ubiquitin-dependent protein catabolic process;|P49407 B6V9G8 O75625 O75630 Q2PP20 Q9BTK8,Beta-arrestin-1,Arrestin beta-1;Non-visual arrestin-2 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0000785;GO:0005905;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0043197;GO:0005768;GO:0000139;GO:0005765;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0031143;GO:0031691;GO:0031692;GO:0031701;GO:0035612;GO:1990763;GO:0035615;GO:0004857;GO:0030331;GO:0031762;GO:0001664;GO:0005096;GO:0005159;GO:0044325;GO:0045309;GO:0003713;GO:0008134;GO:0031625;GO:0031896;GO:0000187;GO:0042699;GO:0002031;GO:0007186;GO:0016573;GO:0061024;GO:0070373;GO:0034260;GO:0032715;GO:0032717;GO:0043524;GO:0032088;GO:0045746;GO:0001933;GO:0031397;GO:0030168;GO:0008284;GO:0043280;GO:0070374;GO:0035066;GO:0090240;GO:0001934;GO:0031398;GO:0002092;GO:0035025;GO:0034393;GO:0045944;GO:0006892;GO:0043161;GO:0015031;GO:0016567;GO:0006357;GO:0042493;GO:0043149;GO:0006511;, C:basolateral plasma membrane; C:chromatin; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic spine; C:endosome; C:Golgi membrane; C:lysosomal membrane; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:pseudopodium;, F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:AP-2 adaptor complex binding; F:arrestin family protein binding; F:clathrin adaptor activity; F:enzyme inhibitor activity; F:estrogen receptor binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:GTPase activator activity; F:insulin-like growth factor receptor binding; F:ion channel binding; F:protein phosphorylated amino acid binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:V2 vasopressin receptor binding;, P:activation of MAPK activity; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:histone acetylation; P:membrane organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of GTPase activity; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of Notch signaling pathway; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:platelet activation; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of histone acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of receptor internalization; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:post-Golgi vesicle-mediated transport; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein transport; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:response to drug; P:stress fiber assembly; P:ubiquitin-dependent protein catabolic process;|P49407 B6V9G8 O75625 O75630 Q2PP20 Q9BTK8,Beta-arrestin-1,Arrestin beta-1;Non-visual arrestin-2 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0000785;GO:0005905;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0043197;GO:0005768;GO:0000139;GO:0005765;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0031143;GO:0031691;GO:0031692;GO:0031701;GO:0035612;GO:1990763;GO:0035615;GO:0004857;GO:0030331;GO:0031762;GO:0001664;GO:0005096;GO:0005159;GO:0044325;GO:0045309;GO:0003713;GO:0008134;GO:0031625;GO:0031896;GO:0000187;GO:0042699;GO:0002031;GO:0007186;GO:0016573;GO:0061024;GO:0070373;GO:0034260;GO:0032715;GO:0032717;GO:0043524;GO:0032088;GO:0045746;GO:0001933;GO:0031397;GO:0030168;GO:0008284;GO:0043280;GO:0070374;GO:0035066;GO:0090240;GO:0001934;GO:0031398;GO:0002092;GO:0035025;GO:0034393;GO:0045944;GO:0006892;GO:0043161;GO:0015031;GO:0016567;GO:0006357;GO:0042493;GO:0043149;GO:0006511;, C:basolateral plasma membrane; C:chromatin; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic spine; C:endosome; C:Golgi membrane; C:lysosomal membrane; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:pseudopodium;, F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:AP-2 adaptor complex binding; F:arrestin family protein binding; F:clathrin adaptor activity; F:enzyme inhibitor activity; F:estrogen receptor binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:GTPase activator activity; F:insulin-like growth factor receptor binding; F:ion channel binding; F:protein phosphorylated amino acid binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:V2 vasopressin receptor binding;, P:activation of MAPK activity; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:histone acetylation; P:membrane organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of GTPase activity; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of Notch signaling pathway; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:platelet activation; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of histone acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of receptor internalization; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:post-Golgi vesicle-mediated transport; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein transport; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:response to drug; P:stress fiber assembly; P:ubiquitin-dependent protein catabolic process;|P49407 B6V9G8 O75625 O75630 Q2PP20 Q9BTK8,Beta-arrestin-1,Arrestin beta-1;Non-visual arrestin-2 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0000785;GO:0005905;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0043197;GO:0005768;GO:0000139;GO:0005765;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0031143;GO:0031691;GO:0031692;GO:0031701;GO:0035612;GO:1990763;GO:0035615;GO:0004857;GO:0030331;GO:0031762;GO:0001664;GO:0005096;GO:0005159;GO:0044325;GO:0045309;GO:0003713;GO:0008134;GO:0031625;GO:0031896;GO:0000187;GO:0042699;GO:0002031;GO:0007186;GO:0016573;GO:0061024;GO:0070373;GO:0034260;GO:0032715;GO:0032717;GO:0043524;GO:0032088;GO:0045746;GO:0001933;GO:0031397;GO:0030168;GO:0008284;GO:0043280;GO:0070374;GO:0035066;GO:0090240;GO:0001934;GO:0031398;GO:0002092;GO:0035025;GO:0034393;GO:0045944;GO:0006892;GO:0043161;GO:0015031;GO:0016567;GO:0006357;GO:0042493;GO:0043149;GO:0006511;, C:basolateral plasma membrane; C:chromatin; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic spine; C:endosome; C:Golgi membrane; C:lysosomal membrane; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:pseudopodium;, F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:AP-2 adaptor complex binding; F:arrestin family protein binding; F:clathrin adaptor activity; F:enzyme inhibitor activity; F:estrogen receptor binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:GTPase activator activity; F:insulin-like growth factor receptor binding; F:ion channel binding; F:protein phosphorylated amino acid binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:V2 vasopressin receptor binding;, P:activation of MAPK activity; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:histone acetylation; P:membrane organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of GTPase activity; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of Notch signaling pathway; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:platelet activation; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of histone acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of receptor internalization; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:post-Golgi vesicle-mediated transport; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein transport; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:response to drug; P:stress fiber assembly; P:ubiquitin-dependent protein catabolic process;|P49407 B6V9G8 O75625 O75630 Q2PP20 Q9BTK8,Beta-arrestin-1,Arrestin beta-1;Non-visual arrestin-2 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0000785;GO:0005905;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0043197;GO:0005768;GO:0000139;GO:0005765;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0031143;GO:0031691;GO:0031692;GO:0031701;GO:0035612;GO:1990763;GO:0035615;GO:0004857;GO:0030331;GO:0031762;GO:0001664;GO:0005096;GO:0005159;GO:0044325;GO:0045309;GO:0003713;GO:0008134;GO:0031625;GO:0031896;GO:0000187;GO:0042699;GO:0002031;GO:0007186;GO:0016573;GO:0061024;GO:0070373;GO:0034260;GO:0032715;GO:0032717;GO:0043524;GO:0032088;GO:0045746;GO:0001933;GO:0031397;GO:0030168;GO:0008284;GO:0043280;GO:0070374;GO:0035066;GO:0090240;GO:0001934;GO:0031398;GO:0002092;GO:0035025;GO:0034393;GO:0045944;GO:0006892;GO:0043161;GO:0015031;GO:0016567;GO:0006357;GO:0042493;GO:0043149;GO:0006511;, C:basolateral plasma membrane; C:chromatin; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic spine; C:endosome; C:Golgi membrane; C:lysosomal membrane; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:pseudopodium;, F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:AP-2 adaptor complex binding; F:arrestin family protein binding; F:clathrin adaptor activity; F:enzyme inhibitor activity; F:estrogen receptor binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:GTPase activator activity; F:insulin-like growth factor receptor binding; F:ion channel binding; F:protein phosphorylated amino acid binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:V2 vasopressin receptor binding;, P:activation of MAPK activity; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:histone acetylation; P:membrane organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of GTPase activity; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of Notch signaling pathway; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:platelet activation; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of histone acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of receptor internalization; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:post-Golgi vesicle-mediated transport; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein transport; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:response to drug; P:stress fiber assembly; P:ubiquitin-dependent protein catabolic process;|P49407 B6V9G8 O75625 O75630 Q2PP20 Q9BTK8,Beta-arrestin-1,Arrestin beta-1;Non-visual arrestin-2 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0000785;GO:0005905;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0043197;GO:0005768;GO:0000139;GO:0005765;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0031143;GO:0031691;GO:0031692;GO:0031701;GO:0035612;GO:1990763;GO:0035615;GO:0004857;GO:0030331;GO:0031762;GO:0001664;GO:0005096;GO:0005159;GO:0044325;GO:0045309;GO:0003713;GO:0008134;GO:0031625;GO:0031896;GO:0000187;GO:0042699;GO:0002031;GO:0007186;GO:0016573;GO:0061024;GO:0070373;GO:0034260;GO:0032715;GO:0032717;GO:0043524;GO:0032088;GO:0045746;GO:0001933;GO:0031397;GO:0030168;GO:0008284;GO:0043280;GO:0070374;GO:0035066;GO:0090240;GO:0001934;GO:0031398;GO:0002092;GO:0035025;GO:0034393;GO:0045944;GO:0006892;GO:0043161;GO:0015031;GO:0016567;GO:0006357;GO:0042493;GO:0043149;GO:0006511;, C:basolateral plasma membrane; C:chromatin; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic spine; C:endosome; C:Golgi membrane; C:lysosomal membrane; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:pseudopodium;, F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:AP-2 adaptor complex binding; F:arrestin family protein binding; F:clathrin adaptor activity; F:enzyme inhibitor activity; F:estrogen receptor binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:GTPase activator activity; F:insulin-like growth factor receptor binding; F:ion channel binding; F:protein phosphorylated amino acid binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:V2 vasopressin receptor binding;, P:activation of MAPK activity; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:histone acetylation; P:membrane organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of GTPase activity; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of Notch signaling pathway; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:platelet activation; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of histone acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of receptor internalization; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:post-Golgi vesicle-mediated transport; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein transport; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:response to drug; P:stress fiber assembly; P:ubiquitin-dependent protein catabolic process;|P49407 B6V9G8 O75625 O75630 Q2PP20 Q9BTK8,Beta-arrestin-1,Arrestin beta-1;Non-visual arrestin-2 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0000785;GO:0005905;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0043197;GO:0005768;GO:0000139;GO:0005765;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0031143;GO:0031691;GO:0031692;GO:0031701;GO:0035612;GO:1990763;GO:0035615;GO:0004857;GO:0030331;GO:0031762;GO:0001664;GO:0005096;GO:0005159;GO:0044325;GO:0045309;GO:0003713;GO:0008134;GO:0031625;GO:0031896;GO:0000187;GO:0042699;GO:0002031;GO:0007186;GO:0016573;GO:0061024;GO:0070373;GO:0034260;GO:0032715;GO:0032717;GO:0043524;GO:0032088;GO:0045746;GO:0001933;GO:0031397;GO:0030168;GO:0008284;GO:0043280;GO:0070374;GO:0035066;GO:0090240;GO:0001934;GO:0031398;GO:0002092;GO:0035025;GO:0034393;GO:0045944;GO:0006892;GO:0043161;GO:0015031;GO:0016567;GO:0006357;GO:0042493;GO:0043149;GO:0006511;, C:basolateral plasma membrane; C:chromatin; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic spine; C:endosome; C:Golgi membrane; C:lysosomal membrane; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:pseudopodium;, F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:AP-2 adaptor complex binding; F:arrestin family protein binding; F:clathrin adaptor activity; F:enzyme inhibitor activity; F:estrogen receptor binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:GTPase activator activity; F:insulin-like growth factor receptor binding; F:ion channel binding; F:protein phosphorylated amino acid binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:V2 vasopressin receptor binding;, P:activation of MAPK activity; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:histone acetylation; P:membrane organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of GTPase activity; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of Notch signaling pathway; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:platelet activation; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of histone acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of receptor internalization; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:post-Golgi vesicle-mediated transport; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein transport; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:response to drug; P:stress fiber assembly; P:ubiquitin-dependent protein catabolic process; scaffold19 indexed_genome mRNA 23341429 23393276 . + . ID=transcript_4712;O94956 A8K2G9 B4DGA9 B4DTB0 E7ERN5 E9PPU8 Q9H2Z0 Q9UFU1,Solute carrier organic anion transporter family member 2B1,Organic anion transporter B;Organic anion transporter polypeptide-related protein 2;Solute carrier family 21 member 9;, PF03137;, GO:0016324;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;GO:0055085;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport; P:transmembrane transport; P:transport across blood-brain barrier;|O94956 A8K2G9 B4DGA9 B4DTB0 E7ERN5 E9PPU8 Q9H2Z0 Q9UFU1,Solute carrier organic anion transporter family member 2B1,Organic anion transporter B;Organic anion transporter polypeptide-related protein 2;Solute carrier family 21 member 9;, PF03137;, GO:0016324;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;GO:0055085;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport; P:transmembrane transport; P:transport across blood-brain barrier;|O94956 A8K2G9 B4DGA9 B4DTB0 E7ERN5 E9PPU8 Q9H2Z0 Q9UFU1,Solute carrier organic anion transporter family member 2B1,Organic anion transporter B;Organic anion transporter polypeptide-related protein 2;Solute carrier family 21 member 9;, PF03137;, GO:0016324;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;GO:0055085;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport; P:transmembrane transport; P:transport across blood-brain barrier;|O94956 A8K2G9 B4DGA9 B4DTB0 E7ERN5 E9PPU8 Q9H2Z0 Q9UFU1,Solute carrier organic anion transporter family member 2B1,Organic anion transporter B;Organic anion transporter polypeptide-related protein 2;Solute carrier family 21 member 9;, PF03137;, GO:0016324;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;GO:0055085;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport; P:transmembrane transport; P:transport across blood-brain barrier;|O94956 A8K2G9 B4DGA9 B4DTB0 E7ERN5 E9PPU8 Q9H2Z0 Q9UFU1,Solute carrier organic anion transporter family member 2B1,Organic anion transporter B;Organic anion transporter polypeptide-related protein 2;Solute carrier family 21 member 9;, PF03137;, GO:0016324;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;GO:0055085;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport; P:transmembrane transport; P:transport across blood-brain barrier;|O94956 A8K2G9 B4DGA9 B4DTB0 E7ERN5 E9PPU8 Q9H2Z0 Q9UFU1,Solute carrier organic anion transporter family member 2B1,Organic anion transporter B;Organic anion transporter polypeptide-related protein 2;Solute carrier family 21 member 9;, PF03137;, GO:0016324;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;GO:0055085;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport; P:transmembrane transport; P:transport across blood-brain barrier;|O94956 A8K2G9 B4DGA9 B4DTB0 E7ERN5 E9PPU8 Q9H2Z0 Q9UFU1,Solute carrier organic anion transporter family member 2B1,Organic anion transporter B;Organic anion transporter polypeptide-related protein 2;Solute carrier family 21 member 9;, PF03137;, GO:0016324;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;GO:0055085;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport; P:transmembrane transport; P:transport across blood-brain barrier; scaffold19 indexed_genome mRNA 23481143 23499350 . - . ID=transcript_4713;Q9UQ49 A8K327 Q9NQE1,Sialidase-3,Ganglioside sialidasedis;Membrane sialidase;N-acetyl-alpha-neuraminidase 3;, PF13088;, GO:0005901;GO:0005737;GO:0031901;GO:0009897;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0055038;GO:0016997;GO:0052794;GO:0052795;GO:0052796;GO:0004308;GO:0005975;GO:0006689;GO:0006687;GO:1900186;GO:0009313;GO:0045742;, C:caveola; C:cytoplasm; C:early endosome membrane; C:external side of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:recycling endosome membrane;, F:alpha-sialidase activity; F:exo-alpha-(2->3)-sialidase activity; F:exo-alpha-(2->6)-sialidase activity; F:exo-alpha-(2->8)-sialidase activity; F:exo-alpha-sialidase activity;, P:carbohydrate metabolic process; P:ganglioside catabolic process; P:glycosphingolipid metabolic process; P:negative regulation of clathrin-dependent endocytosis; P:oligosaccharide catabolic process; P:positive regulation of epidermal growth factor receptor signaling pathway; scaffold19 indexed_genome mRNA 23510418 23687198 . - . ID=transcript_4714;Q8NCN4 Q6N015,E3 ubiquitin-protein ligase RNF169,RING finger protein 169;RING-type E3 ubiquitin transferase RNF169 {ECO:0000305};, , GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0070530;GO:0046872;GO:0031491;GO:0016740;GO:0006974;GO:2000780;GO:0016567;, C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:nucleosome binding; F:transferase activity;, P:cellular response to DNA damage stimulus; P:negative regulation of double-strand break repair; P:protein ubiquitination;|Q15005 Q15507 Q3KQT0 Q641R4 Q6FG65 Q6IRX0 Q6P1P4 Q96HU9,Signal peptidase complex subunit 2,Microsomal signal peptidase 25 kDa subunit;, PF06703;, GO:0005789;GO:0016021;GO:0005787;GO:0008233;GO:0045047;GO:0006465;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:signal peptidase complex;, F:peptidase activity;, P:protein targeting to ER; P:signal peptide processing;|Q6P2D8 B5MD90 J3KNJ1 Q7RTT7 Q7Z463 Q7Z4U0,X-ray radiation resistance-associated protein 1,, , GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0010165;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:response to X-ray;|Q6P2D8 B5MD90 J3KNJ1 Q7RTT7 Q7Z463 Q7Z4U0,X-ray radiation resistance-associated protein 1,, , GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0010165;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:response to X-ray;|Q6P2D8 B5MD90 J3KNJ1 Q7RTT7 Q7Z463 Q7Z4U0,X-ray radiation resistance-associated protein 1,, , GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0010165;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:response to X-ray;|Q8NCN4 Q6N015,E3 ubiquitin-protein ligase RNF169,RING finger protein 169;RING-type E3 ubiquitin transferase RNF169 {ECO:0000305};, , GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0070530;GO:0046872;GO:0031491;GO:0016740;GO:0006974;GO:2000780;GO:0016567;, C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:nucleosome binding; F:transferase activity;, P:cellular response to DNA damage stimulus; P:negative regulation of double-strand break repair; P:protein ubiquitination;|Q8NCN4 Q6N015,E3 ubiquitin-protein ligase RNF169,RING finger protein 169;RING-type E3 ubiquitin transferase RNF169 {ECO:0000305};, , GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0070530;GO:0046872;GO:0031491;GO:0016740;GO:0006974;GO:2000780;GO:0016567;, C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:nucleosome binding; F:transferase activity;, P:cellular response to DNA damage stimulus; P:negative regulation of double-strand break repair; P:protein ubiquitination; scaffold19 indexed_genome mRNA 23714159 23746248 . + . ID=transcript_4715;Q6WN34 A5PKU9 Q6WN30 Q6WN31 Q6WN32 Q7Z5J3,Chordin-like protein 2,Breast tumor novel factor 1;Chordin-related protein 2;, PF00093;, GO:0005737;GO:0005615;GO:0051216;GO:0030154;GO:0001503;, C:cytoplasm; C:extracellular space;, , P:cartilage development; P:cell differentiation; P:ossification; scaffold19 indexed_genome mRNA 23803613 23851269 . - . ID=transcript_4716;Q15054 B7ZAI6 Q32MZ9 Q32N00,DNA polymerase delta subunit 3,DNA polymerase delta subunit C {ECO:0000303|PubMed:11595739};DNA polymerase delta subunit p66;DNA polymerase delta subunit p68 {ECO:0000303|PubMed:22148433, ECO:0000303|PubMed:22801543};, PF09507;, GO:0005737;GO:0043625;GO:0005654;GO:0016035;GO:0030674;GO:0006287;GO:0071897;GO:0042769;GO:0006271;GO:0000731;GO:1904161;GO:0006298;GO:0006297;GO:0033683;GO:0006296;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:cytoplasm; C:delta DNA polymerase complex; C:nucleoplasm; C:zeta DNA polymerase complex;, F:protein-macromolecule adaptor activity;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA damage response, detection of DNA damage; P:DNA strand elongation involved in DNA replication; P:DNA synthesis involved in DNA repair; P:DNA synthesis involved in UV-damage excision repair; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|Q15054 B7ZAI6 Q32MZ9 Q32N00,DNA polymerase delta subunit 3,DNA polymerase delta subunit C {ECO:0000303|PubMed:11595739};DNA polymerase delta subunit p66;DNA polymerase delta subunit p68 {ECO:0000303|PubMed:22148433, ECO:0000303|PubMed:22801543};, PF09507;, GO:0005737;GO:0043625;GO:0005654;GO:0016035;GO:0030674;GO:0006287;GO:0071897;GO:0042769;GO:0006271;GO:0000731;GO:1904161;GO:0006298;GO:0006297;GO:0033683;GO:0006296;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:cytoplasm; C:delta DNA polymerase complex; C:nucleoplasm; C:zeta DNA polymerase complex;, F:protein-macromolecule adaptor activity;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA damage response, detection of DNA damage; P:DNA strand elongation involved in DNA replication; P:DNA synthesis involved in DNA repair; P:DNA synthesis involved in UV-damage excision repair; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|Q15054 B7ZAI6 Q32MZ9 Q32N00,DNA polymerase delta subunit 3,DNA polymerase delta subunit C {ECO:0000303|PubMed:11595739};DNA polymerase delta subunit p66;DNA polymerase delta subunit p68 {ECO:0000303|PubMed:22148433, ECO:0000303|PubMed:22801543};, PF09507;, GO:0005737;GO:0043625;GO:0005654;GO:0016035;GO:0030674;GO:0006287;GO:0071897;GO:0042769;GO:0006271;GO:0000731;GO:1904161;GO:0006298;GO:0006297;GO:0033683;GO:0006296;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:cytoplasm; C:delta DNA polymerase complex; C:nucleoplasm; C:zeta DNA polymerase complex;, F:protein-macromolecule adaptor activity;, P:base-excision repair, gap-filling; P:DNA biosynthetic process; P:DNA damage response, detection of DNA damage; P:DNA strand elongation involved in DNA replication; P:DNA synthesis involved in DNA repair; P:DNA synthesis involved in UV-damage excision repair; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold19 indexed_genome mRNA 23936476 23947527 . + . ID=transcript_4717;Q9Y6H6,Potassium voltage-gated channel subfamily E member 3,MinK-related peptide 2;Minimum potassium ion channel-related peptide 2;Potassium channel subunit beta MiRP2;, PF02060;, GO:0005737;GO:0030425;GO:0045121;GO:0032809;GO:0043204;GO:0031982;GO:0008076;GO:0044325;GO:0015459;GO:0005249;GO:0086011;GO:0098915;GO:1902260;GO:1905025;GO:1903765;GO:1903817;GO:1901387;GO:0097623;GO:0086091;GO:0060307;GO:0086005;, C:cytoplasm; C:dendrite; C:membrane raft; C:neuronal cell body membrane; C:perikaryon; C:vesicle; C:voltage-gated potassium channel complex;, F:ion channel binding; F:potassium channel regulator activity; F:voltage-gated potassium channel activity;, P:membrane repolarization during action potential; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:negative regulation of delayed rectifier potassium channel activity; P:negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential; P:negative regulation of potassium ion export across plasma membrane; P:negative regulation of voltage-gated potassium channel activity; P:positive regulation of voltage-gated calcium channel activity; P:potassium ion export across plasma membrane; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:ventricular cardiac muscle cell action potential; scaffold19 indexed_genome mRNA 23996382 24056457 . + . ID=transcript_4718;Q6PCE3 Q96MQ7 Q9UIK3,Glucose 1,6-bisphosphate synthase,PMMLP;Phosphoglucomutase-2-like 1;, PF02878;PF02879;PF02880;PF00408;, GO:0005829;GO:0047933;GO:0016868;GO:0046872;GO:0019388;GO:0051156;GO:0006006;GO:0005978;GO:0005980;, C:cytosol;, F:glucose-1,6-bisphosphate synthase activity; F:intramolecular transferase activity, phosphotransferases; F:metal ion binding;, P:galactose catabolic process; P:glucose 6-phosphate metabolic process; P:glucose metabolic process; P:glycogen biosynthetic process; P:glycogen catabolic process; scaffold19 indexed_genome mRNA 24074312 24112867 . + . ID=transcript_4719;Q7Z4N8 A0AV13 B4DUD3 Q5EBL3 Q5JPA9,Prolyl 4-hydroxylase subunit alpha-3,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3;, PF13640;PF08336;, GO:0005783;GO:0005788;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline;|Q7Z4N8 A0AV13 B4DUD3 Q5EBL3 Q5JPA9,Prolyl 4-hydroxylase subunit alpha-3,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3;, PF13640;PF08336;, GO:0005783;GO:0005788;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; scaffold19 indexed_genome mRNA 24113928 24114504 . + . ID=transcript_4720;Q7Z4N8 A0AV13 B4DUD3 Q5EBL3 Q5JPA9,Prolyl 4-hydroxylase subunit alpha-3,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3;, PF13640;PF08336;, GO:0005783;GO:0005788;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; scaffold19 indexed_genome mRNA 24116316 24122495 . + . ID=transcript_4721;Q7Z4N8 A0AV13 B4DUD3 Q5EBL3 Q5JPA9,Prolyl 4-hydroxylase subunit alpha-3,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3;, PF13640;PF08336;, GO:0005783;GO:0005788;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline;|Q7Z4N8 A0AV13 B4DUD3 Q5EBL3 Q5JPA9,Prolyl 4-hydroxylase subunit alpha-3,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3;, PF13640;PF08336;, GO:0005783;GO:0005788;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline;|Q7Z4N8 A0AV13 B4DUD3 Q5EBL3 Q5JPA9,Prolyl 4-hydroxylase subunit alpha-3,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3;, PF13640;PF08336;, GO:0005783;GO:0005788;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; scaffold19 indexed_genome mRNA 24126612 24181421 . - . ID=transcript_4722;Q9Y570 B3KMU6 B5MEE7 J3QT22 Q8WYG8 Q9NVT5 Q9UI18,Protein phosphatase methylesterase 1,, PF12697;, GO:0005654;GO:0045296;GO:0051722;GO:0019901;GO:0051723;GO:0051721;GO:0019903;GO:0004864;GO:0019888;GO:0000086;GO:0006482;, C:nucleoplasm;, F:cadherin binding; F:protein C-terminal methylesterase activity; F:protein kinase binding; F:protein methylesterase activity; F:protein phosphatase 2A binding; F:protein phosphatase binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity;, P:G2/M transition of mitotic cell cycle; P:protein demethylation;|Q9Y570 B3KMU6 B5MEE7 J3QT22 Q8WYG8 Q9NVT5 Q9UI18,Protein phosphatase methylesterase 1,, PF12697;, GO:0005654;GO:0045296;GO:0051722;GO:0019901;GO:0051723;GO:0051721;GO:0019903;GO:0004864;GO:0019888;GO:0000086;GO:0006482;, C:nucleoplasm;, F:cadherin binding; F:protein C-terminal methylesterase activity; F:protein kinase binding; F:protein methylesterase activity; F:protein phosphatase 2A binding; F:protein phosphatase binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity;, P:G2/M transition of mitotic cell cycle; P:protein demethylation;|Q9Y570 B3KMU6 B5MEE7 J3QT22 Q8WYG8 Q9NVT5 Q9UI18,Protein phosphatase methylesterase 1,, PF12697;, GO:0005654;GO:0045296;GO:0051722;GO:0019901;GO:0051723;GO:0051721;GO:0019903;GO:0004864;GO:0019888;GO:0000086;GO:0006482;, C:nucleoplasm;, F:cadherin binding; F:protein C-terminal methylesterase activity; F:protein kinase binding; F:protein methylesterase activity; F:protein phosphatase 2A binding; F:protein phosphatase binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity;, P:G2/M transition of mitotic cell cycle; P:protein demethylation;|Q9Y570 B3KMU6 B5MEE7 J3QT22 Q8WYG8 Q9NVT5 Q9UI18,Protein phosphatase methylesterase 1,, PF12697;, GO:0005654;GO:0045296;GO:0051722;GO:0019901;GO:0051723;GO:0051721;GO:0019903;GO:0004864;GO:0019888;GO:0000086;GO:0006482;, C:nucleoplasm;, F:cadherin binding; F:protein C-terminal methylesterase activity; F:protein kinase binding; F:protein methylesterase activity; F:protein phosphatase 2A binding; F:protein phosphatase binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity;, P:G2/M transition of mitotic cell cycle; P:protein demethylation; scaffold19 indexed_genome mRNA 24185104 24216027 . + . ID=transcript_4723;Q9Y4M2,C2 domain-containing protein 3,, PF00168;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0007420;GO:0061511;GO:0097711;GO:0042733;GO:0001947;GO:0001701;GO:0021997;GO:0021915;GO:1905515;GO:0071539;GO:0016485;GO:0030162;GO:0008589;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol;, , P:brain development; P:centriole elongation; P:ciliary basal body-plasma membrane docking; P:embryonic digit morphogenesis; P:heart looping; P:in utero embryonic development; P:neural plate axis specification; P:neural tube development; P:non-motile cilium assembly; P:protein localization to centrosome; P:protein processing; P:regulation of proteolysis; P:regulation of smoothened signaling pathway; scaffold19 indexed_genome mRNA 24220376 24285581 . + . ID=transcript_4724;Q9Y4M2,C2 domain-containing protein 3,, PF00168;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0007420;GO:0061511;GO:0097711;GO:0042733;GO:0001947;GO:0001701;GO:0021997;GO:0021915;GO:1905515;GO:0071539;GO:0016485;GO:0030162;GO:0008589;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol;, , P:brain development; P:centriole elongation; P:ciliary basal body-plasma membrane docking; P:embryonic digit morphogenesis; P:heart looping; P:in utero embryonic development; P:neural plate axis specification; P:neural tube development; P:non-motile cilium assembly; P:protein localization to centrosome; P:protein processing; P:regulation of proteolysis; P:regulation of smoothened signaling pathway; scaffold19 indexed_genome mRNA 24299402 24300993 . + . ID=transcript_4725;Q9Y4M2,C2 domain-containing protein 3,, PF00168;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0007420;GO:0061511;GO:0097711;GO:0042733;GO:0001947;GO:0001701;GO:0021997;GO:0021915;GO:1905515;GO:0071539;GO:0016485;GO:0030162;GO:0008589;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol;, , P:brain development; P:centriole elongation; P:ciliary basal body-plasma membrane docking; P:embryonic digit morphogenesis; P:heart looping; P:in utero embryonic development; P:neural plate axis specification; P:neural tube development; P:non-motile cilium assembly; P:protein localization to centrosome; P:protein processing; P:regulation of proteolysis; P:regulation of smoothened signaling pathway;|Q9Y4M2,C2 domain-containing protein 3,, PF00168;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0007420;GO:0061511;GO:0097711;GO:0042733;GO:0001947;GO:0001701;GO:0021997;GO:0021915;GO:1905515;GO:0071539;GO:0016485;GO:0030162;GO:0008589;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol;, , P:brain development; P:centriole elongation; P:ciliary basal body-plasma membrane docking; P:embryonic digit morphogenesis; P:heart looping; P:in utero embryonic development; P:neural plate axis specification; P:neural tube development; P:non-motile cilium assembly; P:protein localization to centrosome; P:protein processing; P:regulation of proteolysis; P:regulation of smoothened signaling pathway; scaffold19 indexed_genome mRNA 24303984 24315508 . + . ID=transcript_4726;P55916 O60475 Q96HL3,Mitochondrial uncoupling protein 3,Solute carrier family 25 member 9;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0017077;GO:0005215;GO:1990845;GO:0007568;GO:0032870;GO:0006631;GO:0006629;GO:1990542;GO:1902600;GO:0007585;GO:0014823;GO:0009409;GO:0051384;GO:0001666;GO:0032868;GO:0007584;GO:0000303;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:oxidative phosphorylation uncoupler activity; F:transporter activity;, P:adaptive thermogenesis; P:aging; P:cellular response to hormone stimulus; P:fatty acid metabolic process; P:lipid metabolic process; P:mitochondrial transmembrane transport; P:proton transmembrane transport; P:respiratory gaseous exchange by respiratory system; P:response to activity; P:response to cold; P:response to glucocorticoid; P:response to hypoxia; P:response to insulin; P:response to nutrient; P:response to superoxide; scaffold19 indexed_genome mRNA 24336528 24343265 . + . ID=transcript_4727;P55851 Q4PJH8 Q53HM3,Mitochondrial uncoupling protein 2,Solute carrier family 25 member 8;UCPH;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0017077;GO:1990845;GO:0007568;GO:0034198;GO:0071333;GO:0032869;GO:0007565;GO:0097421;GO:1990542;GO:0043066;GO:0061179;GO:0010942;GO:0120162;GO:1902600;GO:0051881;GO:0009409;GO:0070542;GO:0001666;GO:0000303;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:oxidative phosphorylation uncoupler activity;, P:adaptive thermogenesis; P:aging; P:cellular response to amino acid starvation; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:female pregnancy; P:liver regeneration; P:mitochondrial transmembrane transport; P:negative regulation of apoptotic process; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of cell death; P:positive regulation of cold-induced thermogenesis; P:proton transmembrane transport; P:regulation of mitochondrial membrane potential; P:response to cold; P:response to fatty acid; P:response to hypoxia; P:response to superoxide;|P55851 Q4PJH8 Q53HM3,Mitochondrial uncoupling protein 2,Solute carrier family 25 member 8;UCPH;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0017077;GO:1990845;GO:0007568;GO:0034198;GO:0071333;GO:0032869;GO:0007565;GO:0097421;GO:1990542;GO:0043066;GO:0061179;GO:0010942;GO:0120162;GO:1902600;GO:0051881;GO:0009409;GO:0070542;GO:0001666;GO:0000303;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:oxidative phosphorylation uncoupler activity;, P:adaptive thermogenesis; P:aging; P:cellular response to amino acid starvation; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:female pregnancy; P:liver regeneration; P:mitochondrial transmembrane transport; P:negative regulation of apoptotic process; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of cell death; P:positive regulation of cold-induced thermogenesis; P:proton transmembrane transport; P:regulation of mitochondrial membrane potential; P:response to cold; P:response to fatty acid; P:response to hypoxia; P:response to superoxide; scaffold19 indexed_genome mRNA 24346376 24359378 . - . ID=transcript_4728;P59910 B3LEP4 Q8IZW5,DnaJ homolog subfamily B member 13,Testis and spermatogenesis cell-related protein 6;Testis spermatocyte apoptosis-related gene 6 protein;Testis spermatogenesis apoptosis-related gene 3 protein;Testis spermatogenesis apoptosis-related gene 6 protein;, PF00226;PF01556;, GO:0005930;GO:0005829;GO:0031514;GO:0097224;GO:0036126;GO:0051087;GO:0051082;GO:1904158;GO:0051085;, C:axoneme; C:cytosol; C:motile cilium; C:sperm connecting piece; C:sperm flagellum;, F:chaperone binding; F:unfolded protein binding;, P:axonemal central apparatus assembly; P:chaperone cofactor-dependent protein refolding; scaffold19 indexed_genome mRNA 24366374 24410938 . - . ID=transcript_4729;Q9BRP4 A6NDR5 B4DPB0 B7ZAS9 Q4G165 Q53HS9 Q7Z500 Q8TBU6 Q9HAB6,Proteasomal ATPase-associated factor 1,Protein G-16;WD repeat-containing protein 71;, PF00400;, GO:0000502;GO:0016032;, C:proteasome complex;, , P:viral process;|Q9BRP4 A6NDR5 B4DPB0 B7ZAS9 Q4G165 Q53HS9 Q7Z500 Q8TBU6 Q9HAB6,Proteasomal ATPase-associated factor 1,Protein G-16;WD repeat-containing protein 71;, PF00400;, GO:0000502;GO:0016032;, C:proteasome complex;, , P:viral process;|Q9BRP4 A6NDR5 B4DPB0 B7ZAS9 Q4G165 Q53HS9 Q7Z500 Q8TBU6 Q9HAB6,Proteasomal ATPase-associated factor 1,Protein G-16;WD repeat-containing protein 71;, PF00400;, GO:0000502;GO:0016032;, C:proteasome complex;, , P:viral process;|Q9BRP4 A6NDR5 B4DPB0 B7ZAS9 Q4G165 Q53HS9 Q7Z500 Q8TBU6 Q9HAB6,Proteasomal ATPase-associated factor 1,Protein G-16;WD repeat-containing protein 71;, PF00400;, GO:0000502;GO:0016032;, C:proteasome complex;, , P:viral process;|Q9BRP4 A6NDR5 B4DPB0 B7ZAS9 Q4G165 Q53HS9 Q7Z500 Q8TBU6 Q9HAB6,Proteasomal ATPase-associated factor 1,Protein G-16;WD repeat-containing protein 71;, PF00400;, GO:0000502;GO:0016032;, C:proteasome complex;, , P:viral process;|Q9BRP4 A6NDR5 B4DPB0 B7ZAS9 Q4G165 Q53HS9 Q7Z500 Q8TBU6 Q9HAB6,Proteasomal ATPase-associated factor 1,Protein G-16;WD repeat-containing protein 71;, PF00400;, GO:0000502;GO:0016032;, C:proteasome complex;, , P:viral process;|Q9NYJ1 B2RAA0 Q69YU4,Cytochrome c oxidase assembly factor 4 homolog, mitochondrial,Coiled-coil-helix-coiled-coil-helix domain-containing protein 8;E2-induced gene 2 protein;, , GO:0005758;GO:0005739;GO:0033617;, C:mitochondrial intermembrane space; C:mitochondrion;, , P:mitochondrial cytochrome c oxidase assembly; scaffold19 indexed_genome mRNA 24418040 24421885 . + . ID=transcript_4730;Q96GC5 B4DN34 Q49AK7 Q4U2Q4 Q9P091 Q9Y5J0,39S ribosomal protein L48, mitochondrial,Mitochondrial large ribosomal subunit protein mL48 {ECO:0000303|PubMed:25278503};, PF00338;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q96GC5 B4DN34 Q49AK7 Q4U2Q4 Q9P091 Q9Y5J0,39S ribosomal protein L48, mitochondrial,Mitochondrial large ribosomal subunit protein mL48 {ECO:0000303|PubMed:25278503};, PF00338;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q96GC5 B4DN34 Q49AK7 Q4U2Q4 Q9P091 Q9Y5J0,39S ribosomal protein L48, mitochondrial,Mitochondrial large ribosomal subunit protein mL48 {ECO:0000303|PubMed:25278503};, PF00338;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold19 indexed_genome mRNA 24540910 24554199 . - . ID=transcript_4731;Q9NRW1 B2R5Z9 B7Z337 D3DND3 Q92929,Ras-related protein Rab-6B,, PF00071;, GO:0031410;GO:0005829;GO:0012505;GO:0005793;GO:0005794;GO:0000139;GO:0098793;GO:0005525;GO:0003924;GO:0031489;GO:0006891;GO:0006886;GO:0042147;GO:0006890;, C:cytoplasmic vesicle; C:cytosol; C:endomembrane system; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:myosin V binding;, P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold19 indexed_genome mRNA 24579140 24582802 . + . ID=transcript_4732;P20340 A8K133 B7Z772 F5H668 Q1W5D8 Q5U0A8 Q9UBE4,Ras-related protein Rab-6A,, PF00071;, GO:0031410;GO:0005829;GO:0012505;GO:0005789;GO:0070381;GO:0070062;GO:0005794;GO:0000139;GO:0016020;GO:0005886;GO:0030667;GO:0005802;GO:0032588;GO:0005525;GO:0003924;GO:0031489;GO:0019904;GO:0019882;GO:0034498;GO:0006891;GO:0006886;GO:0072385;GO:0043312;GO:0018125;GO:0034067;GO:0042147;GO:0006890;GO:0016032;, C:cytoplasmic vesicle; C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endosome to plasma membrane transport vesicle; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:GTP binding; F:GTPase activity; F:myosin V binding; F:protein domain specific binding;, P:antigen processing and presentation; P:early endosome to Golgi transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:minus-end-directed organelle transport along microtubule; P:neutrophil degranulation; P:peptidyl-cysteine methylation; P:protein localization to Golgi apparatus; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process; scaffold19 indexed_genome mRNA 24598046 24611390 . - . ID=transcript_4733;Q9UF11 A8K0Q5 B2RBP1 B7Z716 Q9UBF5 Q9UI37 Q9UI44,Pleckstrin homology domain-containing family B member 1,Evectin-1;PH domain-containing protein in retina 1;Pleckstrin homology domain retinal protein 1;, PF00169;, GO:0005737;GO:0016021;GO:0007275;GO:0007602;GO:0045595;, C:cytoplasm; C:integral component of membrane;, , P:multicellular organism development; P:phototransduction; P:regulation of cell differentiation;|Q9UF11 A8K0Q5 B2RBP1 B7Z716 Q9UBF5 Q9UI37 Q9UI44,Pleckstrin homology domain-containing family B member 1,Evectin-1;PH domain-containing protein in retina 1;Pleckstrin homology domain retinal protein 1;, PF00169;, GO:0005737;GO:0016021;GO:0007275;GO:0007602;GO:0045595;, C:cytoplasm; C:integral component of membrane;, , P:multicellular organism development; P:phototransduction; P:regulation of cell differentiation;|Q9UF11 A8K0Q5 B2RBP1 B7Z716 Q9UBF5 Q9UI37 Q9UI44,Pleckstrin homology domain-containing family B member 1,Evectin-1;PH domain-containing protein in retina 1;Pleckstrin homology domain retinal protein 1;, PF00169;, GO:0005737;GO:0016021;GO:0007275;GO:0007602;GO:0045595;, C:cytoplasm; C:integral component of membrane;, , P:multicellular organism development; P:phototransduction; P:regulation of cell differentiation; scaffold19 indexed_genome mRNA 24645527 24847561 . + . ID=transcript_4734;Q92567 A2ICY2 A2ID81 Q86UG2,Protein FAM168A,Tongue cancer chemotherapy resistance-associated protein 1;, PF14944;, GO:1905053;, , , P:positive regulation of base-excision repair; scaffold19 indexed_genome mRNA 24855771 24863205 . - . ID=transcript_4735;Q969Z4 Q86V34 Q96JU1 Q9BUX7,Tumor necrosis factor receptor superfamily member 19L,Receptor expressed in lymphoid tissues;, PF12606;, GO:0016021;GO:0005654;GO:0048471;GO:0005886;GO:0097186;GO:0006915;, C:integral component of membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:amelogenesis; P:apoptotic process; scaffold19 indexed_genome mRNA 24884909 24899321 . - . ID=transcript_4736;Q96PE2 B2RP20 Q86XU2 Q8N2S0 Q9Y4G3,Rho guanine nucleotide exchange factor 17,164 kDa Rho-specific guanine-nucleotide exchange factor;Tumor endothelial marker 4;, PF00621;, GO:0005829;GO:0005085;GO:0030036;GO:0007186;GO:0043065;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q96PE2 B2RP20 Q86XU2 Q8N2S0 Q9Y4G3,Rho guanine nucleotide exchange factor 17,164 kDa Rho-specific guanine-nucleotide exchange factor;Tumor endothelial marker 4;, PF00621;, GO:0005829;GO:0005085;GO:0030036;GO:0007186;GO:0043065;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q96PE2 B2RP20 Q86XU2 Q8N2S0 Q9Y4G3,Rho guanine nucleotide exchange factor 17,164 kDa Rho-specific guanine-nucleotide exchange factor;Tumor endothelial marker 4;, PF00621;, GO:0005829;GO:0005085;GO:0030036;GO:0007186;GO:0043065;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q96PE2 B2RP20 Q86XU2 Q8N2S0 Q9Y4G3,Rho guanine nucleotide exchange factor 17,164 kDa Rho-specific guanine-nucleotide exchange factor;Tumor endothelial marker 4;, PF00621;, GO:0005829;GO:0005085;GO:0030036;GO:0007186;GO:0043065;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q96PE2 B2RP20 Q86XU2 Q8N2S0 Q9Y4G3,Rho guanine nucleotide exchange factor 17,164 kDa Rho-specific guanine-nucleotide exchange factor;Tumor endothelial marker 4;, PF00621;, GO:0005829;GO:0005085;GO:0030036;GO:0007186;GO:0043065;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q96PE2 B2RP20 Q86XU2 Q8N2S0 Q9Y4G3,Rho guanine nucleotide exchange factor 17,164 kDa Rho-specific guanine-nucleotide exchange factor;Tumor endothelial marker 4;, PF00621;, GO:0005829;GO:0005085;GO:0030036;GO:0007186;GO:0043065;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q96PE2 B2RP20 Q86XU2 Q8N2S0 Q9Y4G3,Rho guanine nucleotide exchange factor 17,164 kDa Rho-specific guanine-nucleotide exchange factor;Tumor endothelial marker 4;, PF00621;, GO:0005829;GO:0005085;GO:0030036;GO:0007186;GO:0043065;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q96PE2 B2RP20 Q86XU2 Q8N2S0 Q9Y4G3,Rho guanine nucleotide exchange factor 17,164 kDa Rho-specific guanine-nucleotide exchange factor;Tumor endothelial marker 4;, PF00621;, GO:0005829;GO:0005085;GO:0030036;GO:0007186;GO:0043065;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q96PE2 B2RP20 Q86XU2 Q8N2S0 Q9Y4G3,Rho guanine nucleotide exchange factor 17,164 kDa Rho-specific guanine-nucleotide exchange factor;Tumor endothelial marker 4;, PF00621;, GO:0005829;GO:0005085;GO:0030036;GO:0007186;GO:0043065;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; scaffold19 indexed_genome mRNA 24899405 24942791 . - . ID=transcript_4737;Q96PE2 B2RP20 Q86XU2 Q8N2S0 Q9Y4G3,Rho guanine nucleotide exchange factor 17,164 kDa Rho-specific guanine-nucleotide exchange factor;Tumor endothelial marker 4;, PF00621;, GO:0005829;GO:0005085;GO:0030036;GO:0007186;GO:0043065;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; scaffold19 indexed_genome mRNA 24949359 24957003 . - . ID=transcript_4738;P41231 B2R9W3 Q96EM8,P2Y purinoceptor 2,ATP receptor;P2U purinoceptor 1;P2U receptor 1;Purinergic receptor;, PF00001;, GO:0005887;GO:0005886;GO:0045028;GO:0038023;GO:0097746;GO:0006873;GO:0071318;GO:0007186;GO:0007200;GO:0070257;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled purinergic nucleotide receptor activity; F:signaling receptor activity;, P:blood vessel diameter maintenance; P:cellular ion homeostasis; P:cellular response to ATP; P:G protein-coupled receptor signaling pathway; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of mucus secretion; scaffold19 indexed_genome mRNA 25061325 25269348 . + . ID=transcript_4739;O94868 B4DNI3 Q7L8J9 Q8WVM2 Q96FV7 Q9UF77,F-BAR and double SH3 domains protein 2,Carom {ECO:0000303|PubMed:14627983};Protein nervous wreck 1 {ECO:0000250|UniProtKB:Q3USJ8};SH3 multiple domains protein 3;, PF00611;PF00018;PF14604;, GO:0005905;GO:0031594;GO:0005886;GO:0055037;GO:0120043;GO:0005547;GO:0043325;GO:0072583;GO:0007274;GO:0030838;GO:2000601;GO:0015031;GO:0030833;, C:clathrin-coated pit; C:neuromuscular junction; C:plasma membrane; C:recycling endosome; C:stereocilium shaft;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:clathrin-dependent endocytosis; P:neuromuscular synaptic transmission; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:protein transport; P:regulation of actin filament polymerization;|O94868 B4DNI3 Q7L8J9 Q8WVM2 Q96FV7 Q9UF77,F-BAR and double SH3 domains protein 2,Carom {ECO:0000303|PubMed:14627983};Protein nervous wreck 1 {ECO:0000250|UniProtKB:Q3USJ8};SH3 multiple domains protein 3;, PF00611;PF00018;PF14604;, GO:0005905;GO:0031594;GO:0005886;GO:0055037;GO:0120043;GO:0005547;GO:0043325;GO:0072583;GO:0007274;GO:0030838;GO:2000601;GO:0015031;GO:0030833;, C:clathrin-coated pit; C:neuromuscular junction; C:plasma membrane; C:recycling endosome; C:stereocilium shaft;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:clathrin-dependent endocytosis; P:neuromuscular synaptic transmission; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:protein transport; P:regulation of actin filament polymerization;|O94868 B4DNI3 Q7L8J9 Q8WVM2 Q96FV7 Q9UF77,F-BAR and double SH3 domains protein 2,Carom {ECO:0000303|PubMed:14627983};Protein nervous wreck 1 {ECO:0000250|UniProtKB:Q3USJ8};SH3 multiple domains protein 3;, PF00611;PF00018;PF14604;, GO:0005905;GO:0031594;GO:0005886;GO:0055037;GO:0120043;GO:0005547;GO:0043325;GO:0072583;GO:0007274;GO:0030838;GO:2000601;GO:0015031;GO:0030833;, C:clathrin-coated pit; C:neuromuscular junction; C:plasma membrane; C:recycling endosome; C:stereocilium shaft;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:clathrin-dependent endocytosis; P:neuromuscular synaptic transmission; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:protein transport; P:regulation of actin filament polymerization;|O94868 B4DNI3 Q7L8J9 Q8WVM2 Q96FV7 Q9UF77,F-BAR and double SH3 domains protein 2,Carom {ECO:0000303|PubMed:14627983};Protein nervous wreck 1 {ECO:0000250|UniProtKB:Q3USJ8};SH3 multiple domains protein 3;, PF00611;PF00018;PF14604;, GO:0005905;GO:0031594;GO:0005886;GO:0055037;GO:0120043;GO:0005547;GO:0043325;GO:0072583;GO:0007274;GO:0030838;GO:2000601;GO:0015031;GO:0030833;, C:clathrin-coated pit; C:neuromuscular junction; C:plasma membrane; C:recycling endosome; C:stereocilium shaft;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:clathrin-dependent endocytosis; P:neuromuscular synaptic transmission; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:protein transport; P:regulation of actin filament polymerization; scaffold19 indexed_genome mRNA 25279170 25295245 . + . ID=transcript_4740;Q8NAA4 A5PL30 B2RPK5 Q658V4 Q6PID3 Q8NBG0,Protein Atg16l2 {ECO:0000305},APG16-like 2;Autophagy-related protein 16-2;WD repeat-containing protein 80;, PF08614;PF00400;, GO:0000421;GO:0005829;GO:0005654;GO:0000045;GO:0039689;GO:0015031;, C:autophagosome membrane; C:cytosol; C:nucleoplasm;, , P:autophagosome assembly; P:negative stranded viral RNA replication; P:protein transport;|Q8NAA4 A5PL30 B2RPK5 Q658V4 Q6PID3 Q8NBG0,Protein Atg16l2 {ECO:0000305},APG16-like 2;Autophagy-related protein 16-2;WD repeat-containing protein 80;, PF08614;PF00400;, GO:0000421;GO:0005829;GO:0005654;GO:0000045;GO:0039689;GO:0015031;, C:autophagosome membrane; C:cytosol; C:nucleoplasm;, , P:autophagosome assembly; P:negative stranded viral RNA replication; P:protein transport;|Q8NAA4 A5PL30 B2RPK5 Q658V4 Q6PID3 Q8NBG0,Protein Atg16l2 {ECO:0000305},APG16-like 2;Autophagy-related protein 16-2;WD repeat-containing protein 80;, PF08614;PF00400;, GO:0000421;GO:0005829;GO:0005654;GO:0000045;GO:0039689;GO:0015031;, C:autophagosome membrane; C:cytosol; C:nucleoplasm;, , P:autophagosome assembly; P:negative stranded viral RNA replication; P:protein transport;|Q8NAA4 A5PL30 B2RPK5 Q658V4 Q6PID3 Q8NBG0,Protein Atg16l2 {ECO:0000305},APG16-like 2;Autophagy-related protein 16-2;WD repeat-containing protein 80;, PF08614;PF00400;, GO:0000421;GO:0005829;GO:0005654;GO:0000045;GO:0039689;GO:0015031;, C:autophagosome membrane; C:cytosol; C:nucleoplasm;, , P:autophagosome assembly; P:negative stranded viral RNA replication; P:protein transport;|Q8NAA4 A5PL30 B2RPK5 Q658V4 Q6PID3 Q8NBG0,Protein Atg16l2 {ECO:0000305},APG16-like 2;Autophagy-related protein 16-2;WD repeat-containing protein 80;, PF08614;PF00400;, GO:0000421;GO:0005829;GO:0005654;GO:0000045;GO:0039689;GO:0015031;, C:autophagosome membrane; C:cytosol; C:nucleoplasm;, , P:autophagosome assembly; P:negative stranded viral RNA replication; P:protein transport;|Q8NAA4 A5PL30 B2RPK5 Q658V4 Q6PID3 Q8NBG0,Protein Atg16l2 {ECO:0000305},APG16-like 2;Autophagy-related protein 16-2;WD repeat-containing protein 80;, PF08614;PF00400;, GO:0000421;GO:0005829;GO:0005654;GO:0000045;GO:0039689;GO:0015031;, C:autophagosome membrane; C:cytosol; C:nucleoplasm;, , P:autophagosome assembly; P:negative stranded viral RNA replication; P:protein transport;|Q8NAA4 A5PL30 B2RPK5 Q658V4 Q6PID3 Q8NBG0,Protein Atg16l2 {ECO:0000305},APG16-like 2;Autophagy-related protein 16-2;WD repeat-containing protein 80;, PF08614;PF00400;, GO:0000421;GO:0005829;GO:0005654;GO:0000045;GO:0039689;GO:0015031;, C:autophagosome membrane; C:cytosol; C:nucleoplasm;, , P:autophagosome assembly; P:negative stranded viral RNA replication; P:protein transport;|Q8NAA4 A5PL30 B2RPK5 Q658V4 Q6PID3 Q8NBG0,Protein Atg16l2 {ECO:0000305},APG16-like 2;Autophagy-related protein 16-2;WD repeat-containing protein 80;, PF08614;PF00400;, GO:0000421;GO:0005829;GO:0005654;GO:0000045;GO:0039689;GO:0015031;, C:autophagosome membrane; C:cytosol; C:nucleoplasm;, , P:autophagosome assembly; P:negative stranded viral RNA replication; P:protein transport;|Q8NAA4 A5PL30 B2RPK5 Q658V4 Q6PID3 Q8NBG0,Protein Atg16l2 {ECO:0000305},APG16-like 2;Autophagy-related protein 16-2;WD repeat-containing protein 80;, PF08614;PF00400;, GO:0000421;GO:0005829;GO:0005654;GO:0000045;GO:0039689;GO:0015031;, C:autophagosome membrane; C:cytosol; C:nucleoplasm;, , P:autophagosome assembly; P:negative stranded viral RNA replication; P:protein transport;|Q8NAA4 A5PL30 B2RPK5 Q658V4 Q6PID3 Q8NBG0,Protein Atg16l2 {ECO:0000305},APG16-like 2;Autophagy-related protein 16-2;WD repeat-containing protein 80;, PF08614;PF00400;, GO:0000421;GO:0005829;GO:0005654;GO:0000045;GO:0039689;GO:0015031;, C:autophagosome membrane; C:cytosol; C:nucleoplasm;, , P:autophagosome assembly; P:negative stranded viral RNA replication; P:protein transport; scaffold19 indexed_genome mRNA 25318343 25342203 . + . ID=transcript_4741;Q9Y365 O60532,START domain-containing protein 10,Antigen NY-CO-28;PCTP-like protein;Serologically defined colon cancer antigen 28;StAR-related lipid transfer protein 10;, PF01852;, GO:0005829;GO:0046581;GO:0016020;GO:0005902;GO:0031514;GO:0008289;GO:0006869;GO:0006656;, C:cytosol; C:intercellular canaliculus; C:membrane; C:microvillus; C:motile cilium;, F:lipid binding;, P:lipid transport; P:phosphatidylcholine biosynthetic process;|Q9Y365 O60532,START domain-containing protein 10,Antigen NY-CO-28;PCTP-like protein;Serologically defined colon cancer antigen 28;StAR-related lipid transfer protein 10;, PF01852;, GO:0005829;GO:0046581;GO:0016020;GO:0005902;GO:0031514;GO:0008289;GO:0006869;GO:0006656;, C:cytosol; C:intercellular canaliculus; C:membrane; C:microvillus; C:motile cilium;, F:lipid binding;, P:lipid transport; P:phosphatidylcholine biosynthetic process;|Q9Y365 O60532,START domain-containing protein 10,Antigen NY-CO-28;PCTP-like protein;Serologically defined colon cancer antigen 28;StAR-related lipid transfer protein 10;, PF01852;, GO:0005829;GO:0046581;GO:0016020;GO:0005902;GO:0031514;GO:0008289;GO:0006869;GO:0006656;, C:cytosol; C:intercellular canaliculus; C:membrane; C:microvillus; C:motile cilium;, F:lipid binding;, P:lipid transport; P:phosphatidylcholine biosynthetic process; scaffold19 indexed_genome mRNA 25342874 25377467 . + . ID=transcript_4742;Q96L71,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1,Centaurin-delta-2;, PF01412;PF00169;PF00788;PF00620;PF00536;, GO:0031410;GO:0005829;GO:0005794;GO:0032580;GO:0043231;GO:0005654;GO:0005886;GO:0005802;GO:0005096;GO:0046872;GO:0005547;GO:0031702;GO:0030037;GO:0051497;GO:0045742;GO:0051491;GO:0043547;GO:0001921;GO:0008360;GO:0051270;GO:0051056;GO:0007165;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:type 1 angiotensin receptor binding;, P:actin filament reorganization involved in cell cycle; P:negative regulation of stress fiber assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:positive regulation of receptor recycling; P:regulation of cell shape; P:regulation of cellular component movement; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold19 indexed_genome mRNA 25378459 25401864 . + . ID=transcript_4743;Q96L71,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1,Centaurin-delta-2;, PF01412;PF00169;PF00788;PF00620;PF00536;, GO:0031410;GO:0005829;GO:0005794;GO:0032580;GO:0043231;GO:0005654;GO:0005886;GO:0005802;GO:0005096;GO:0046872;GO:0005547;GO:0031702;GO:0030037;GO:0051497;GO:0045742;GO:0051491;GO:0043547;GO:0001921;GO:0008360;GO:0051270;GO:0051056;GO:0007165;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:type 1 angiotensin receptor binding;, P:actin filament reorganization involved in cell cycle; P:negative regulation of stress fiber assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:positive regulation of receptor recycling; P:regulation of cell shape; P:regulation of cellular component movement; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q96L71,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1,Centaurin-delta-2;, PF01412;PF00169;PF00788;PF00620;PF00536;, GO:0031410;GO:0005829;GO:0005794;GO:0032580;GO:0043231;GO:0005654;GO:0005886;GO:0005802;GO:0005096;GO:0046872;GO:0005547;GO:0031702;GO:0030037;GO:0051497;GO:0045742;GO:0051491;GO:0043547;GO:0001921;GO:0008360;GO:0051270;GO:0051056;GO:0007165;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:type 1 angiotensin receptor binding;, P:actin filament reorganization involved in cell cycle; P:negative regulation of stress fiber assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:positive regulation of receptor recycling; P:regulation of cell shape; P:regulation of cellular component movement; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q96L71,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1,Centaurin-delta-2;, PF01412;PF00169;PF00788;PF00620;PF00536;, GO:0031410;GO:0005829;GO:0005794;GO:0032580;GO:0043231;GO:0005654;GO:0005886;GO:0005802;GO:0005096;GO:0046872;GO:0005547;GO:0031702;GO:0030037;GO:0051497;GO:0045742;GO:0051491;GO:0043547;GO:0001921;GO:0008360;GO:0051270;GO:0051056;GO:0007165;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:type 1 angiotensin receptor binding;, P:actin filament reorganization involved in cell cycle; P:negative regulation of stress fiber assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:positive regulation of receptor recycling; P:regulation of cell shape; P:regulation of cellular component movement; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q96L71,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1,Centaurin-delta-2;, PF01412;PF00169;PF00788;PF00620;PF00536;, GO:0031410;GO:0005829;GO:0005794;GO:0032580;GO:0043231;GO:0005654;GO:0005886;GO:0005802;GO:0005096;GO:0046872;GO:0005547;GO:0031702;GO:0030037;GO:0051497;GO:0045742;GO:0051491;GO:0043547;GO:0001921;GO:0008360;GO:0051270;GO:0051056;GO:0007165;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:type 1 angiotensin receptor binding;, P:actin filament reorganization involved in cell cycle; P:negative regulation of stress fiber assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:positive regulation of receptor recycling; P:regulation of cell shape; P:regulation of cellular component movement; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q96L71,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1,Centaurin-delta-2;, PF01412;PF00169;PF00788;PF00620;PF00536;, GO:0031410;GO:0005829;GO:0005794;GO:0032580;GO:0043231;GO:0005654;GO:0005886;GO:0005802;GO:0005096;GO:0046872;GO:0005547;GO:0031702;GO:0030037;GO:0051497;GO:0045742;GO:0051491;GO:0043547;GO:0001921;GO:0008360;GO:0051270;GO:0051056;GO:0007165;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:type 1 angiotensin receptor binding;, P:actin filament reorganization involved in cell cycle; P:negative regulation of stress fiber assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:positive regulation of receptor recycling; P:regulation of cell shape; P:regulation of cellular component movement; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold19 indexed_genome mRNA 25401912 25402724 . - . ID=transcript_4744;Q96L71,Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1,Centaurin-delta-2;, PF01412;PF00169;PF00788;PF00620;PF00536;, GO:0031410;GO:0005829;GO:0005794;GO:0032580;GO:0043231;GO:0005654;GO:0005886;GO:0005802;GO:0005096;GO:0046872;GO:0005547;GO:0031702;GO:0030037;GO:0051497;GO:0045742;GO:0051491;GO:0043547;GO:0001921;GO:0008360;GO:0051270;GO:0051056;GO:0007165;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:type 1 angiotensin receptor binding;, P:actin filament reorganization involved in cell cycle; P:negative regulation of stress fiber assembly; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:positive regulation of receptor recycling; P:regulation of cell shape; P:regulation of cellular component movement; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold19 indexed_genome mRNA 25473541 25507296 . + . ID=transcript_4745;O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1,cGMP-dependent 3',5'-cyclic phosphodiesterase,Cyclic GMP-stimulated phosphodiesterase;, PF01590;PF13185;PF00233;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005743;GO:0005759;GO:0005741;GO:0005634;GO:0048471;GO:0005886;GO:0042734;GO:0097060;GO:0004115;GO:0047555;GO:0004114;GO:0030552;GO:0030553;GO:0004118;GO:0042802;GO:0000287;GO:0042301;GO:0042803;GO:0030911;GO:0008270;GO:0007193;GO:0035904;GO:0019933;GO:1904613;GO:0071320;GO:0071321;GO:0035690;GO:0097011;GO:0036006;GO:0071260;GO:0071560;GO:0046069;GO:0019934;GO:0061028;GO:0007186;GO:0003170;GO:0030224;GO:0043951;GO:0010754;GO:0000122;GO:0043116;GO:0010628;GO:0050729;GO:0043117;GO:0043949;GO:0010752;GO:0010821;GO:0007165;GO:0003281;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial outer membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynaptic membrane; C:synaptic membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:cGMP binding; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:magnesium ion binding; F:phosphate ion binding; F:protein homodimerization activity; F:TPR domain binding; F:zinc ion binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:aorta development; P:cAMP-mediated signaling; P:cellular response to 2,3,7,8-tetrachlorodibenzodioxine; P:cellular response to cAMP; P:cellular response to cGMP; P:cellular response to drug; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cellular response to mechanical stimulus; P:cellular response to transforming growth factor beta stimulus; P:cGMP catabolic process; P:cGMP-mediated signaling; P:establishment of endothelial barrier; P:G protein-coupled receptor signaling pathway; P:heart valve development; P:monocyte differentiation; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cGMP-mediated signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular permeability; P:positive regulation of gene expression; P:positive regulation of inflammatory response; P:positive regulation of vascular permeability; P:regulation of cAMP-mediated signaling; P:regulation of cGMP-mediated signaling; P:regulation of mitochondrion organization; P:signal transduction; P:ventricular septum development;|O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1,cGMP-dependent 3',5'-cyclic phosphodiesterase,Cyclic GMP-stimulated phosphodiesterase;, PF01590;PF13185;PF00233;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005743;GO:0005759;GO:0005741;GO:0005634;GO:0048471;GO:0005886;GO:0042734;GO:0097060;GO:0004115;GO:0047555;GO:0004114;GO:0030552;GO:0030553;GO:0004118;GO:0042802;GO:0000287;GO:0042301;GO:0042803;GO:0030911;GO:0008270;GO:0007193;GO:0035904;GO:0019933;GO:1904613;GO:0071320;GO:0071321;GO:0035690;GO:0097011;GO:0036006;GO:0071260;GO:0071560;GO:0046069;GO:0019934;GO:0061028;GO:0007186;GO:0003170;GO:0030224;GO:0043951;GO:0010754;GO:0000122;GO:0043116;GO:0010628;GO:0050729;GO:0043117;GO:0043949;GO:0010752;GO:0010821;GO:0007165;GO:0003281;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial outer membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynaptic membrane; C:synaptic membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:cGMP binding; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:magnesium ion binding; F:phosphate ion binding; F:protein homodimerization activity; F:TPR domain binding; F:zinc ion binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:aorta development; P:cAMP-mediated signaling; P:cellular response to 2,3,7,8-tetrachlorodibenzodioxine; P:cellular response to cAMP; P:cellular response to cGMP; P:cellular response to drug; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cellular response to mechanical stimulus; P:cellular response to transforming growth factor beta stimulus; P:cGMP catabolic process; P:cGMP-mediated signaling; P:establishment of endothelial barrier; P:G protein-coupled receptor signaling pathway; P:heart valve development; P:monocyte differentiation; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cGMP-mediated signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular permeability; P:positive regulation of gene expression; P:positive regulation of inflammatory response; P:positive regulation of vascular permeability; P:regulation of cAMP-mediated signaling; P:regulation of cGMP-mediated signaling; P:regulation of mitochondrion organization; P:signal transduction; P:ventricular septum development;|O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1,cGMP-dependent 3',5'-cyclic phosphodiesterase,Cyclic GMP-stimulated phosphodiesterase;, PF01590;PF13185;PF00233;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005743;GO:0005759;GO:0005741;GO:0005634;GO:0048471;GO:0005886;GO:0042734;GO:0097060;GO:0004115;GO:0047555;GO:0004114;GO:0030552;GO:0030553;GO:0004118;GO:0042802;GO:0000287;GO:0042301;GO:0042803;GO:0030911;GO:0008270;GO:0007193;GO:0035904;GO:0019933;GO:1904613;GO:0071320;GO:0071321;GO:0035690;GO:0097011;GO:0036006;GO:0071260;GO:0071560;GO:0046069;GO:0019934;GO:0061028;GO:0007186;GO:0003170;GO:0030224;GO:0043951;GO:0010754;GO:0000122;GO:0043116;GO:0010628;GO:0050729;GO:0043117;GO:0043949;GO:0010752;GO:0010821;GO:0007165;GO:0003281;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial outer membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynaptic membrane; C:synaptic membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:cGMP binding; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:magnesium ion binding; F:phosphate ion binding; F:protein homodimerization activity; F:TPR domain binding; F:zinc ion binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:aorta development; P:cAMP-mediated signaling; P:cellular response to 2,3,7,8-tetrachlorodibenzodioxine; P:cellular response to cAMP; P:cellular response to cGMP; P:cellular response to drug; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cellular response to mechanical stimulus; P:cellular response to transforming growth factor beta stimulus; P:cGMP catabolic process; P:cGMP-mediated signaling; P:establishment of endothelial barrier; P:G protein-coupled receptor signaling pathway; P:heart valve development; P:monocyte differentiation; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cGMP-mediated signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular permeability; P:positive regulation of gene expression; P:positive regulation of inflammatory response; P:positive regulation of vascular permeability; P:regulation of cAMP-mediated signaling; P:regulation of cGMP-mediated signaling; P:regulation of mitochondrion organization; P:signal transduction; P:ventricular septum development;|O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1,cGMP-dependent 3',5'-cyclic phosphodiesterase,Cyclic GMP-stimulated phosphodiesterase;, PF01590;PF13185;PF00233;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005743;GO:0005759;GO:0005741;GO:0005634;GO:0048471;GO:0005886;GO:0042734;GO:0097060;GO:0004115;GO:0047555;GO:0004114;GO:0030552;GO:0030553;GO:0004118;GO:0042802;GO:0000287;GO:0042301;GO:0042803;GO:0030911;GO:0008270;GO:0007193;GO:0035904;GO:0019933;GO:1904613;GO:0071320;GO:0071321;GO:0035690;GO:0097011;GO:0036006;GO:0071260;GO:0071560;GO:0046069;GO:0019934;GO:0061028;GO:0007186;GO:0003170;GO:0030224;GO:0043951;GO:0010754;GO:0000122;GO:0043116;GO:0010628;GO:0050729;GO:0043117;GO:0043949;GO:0010752;GO:0010821;GO:0007165;GO:0003281;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial outer membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynaptic membrane; C:synaptic membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:cGMP binding; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:magnesium ion binding; F:phosphate ion binding; F:protein homodimerization activity; F:TPR domain binding; F:zinc ion binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:aorta development; P:cAMP-mediated signaling; P:cellular response to 2,3,7,8-tetrachlorodibenzodioxine; P:cellular response to cAMP; P:cellular response to cGMP; P:cellular response to drug; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cellular response to mechanical stimulus; P:cellular response to transforming growth factor beta stimulus; P:cGMP catabolic process; P:cGMP-mediated signaling; P:establishment of endothelial barrier; P:G protein-coupled receptor signaling pathway; P:heart valve development; P:monocyte differentiation; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cGMP-mediated signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular permeability; P:positive regulation of gene expression; P:positive regulation of inflammatory response; P:positive regulation of vascular permeability; P:regulation of cAMP-mediated signaling; P:regulation of cGMP-mediated signaling; P:regulation of mitochondrion organization; P:signal transduction; P:ventricular septum development; scaffold19 indexed_genome mRNA 25607934 25748995 . + . ID=transcript_4746;Q9H078 B4DXJ7 B4DXP7 B4DXW4 E7EWN6 F8W7P6 Q8ND11 Q9H8Y0,Caseinolytic peptidase B protein homolog,Suppressor of potassium transport defect 3;, PF07724;PF12796;PF10431;, GO:0005737;GO:0005758;GO:0005739;GO:0005524;GO:0016887;GO:0140374;GO:0034605;GO:0039529;, C:cytoplasm; C:mitochondrial intermembrane space; C:mitochondrion;, F:ATP binding; F:ATPase activity;, P:antiviral innate immune response; P:cellular response to heat; P:RIG-I signaling pathway; scaffold19 indexed_genome mRNA 25783292 25793629 . - . ID=transcript_4747;O15357 B2RTX5 Q13577 Q13578,Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 {ECO:0000305},Inositol polyphosphate phosphatase-like protein 1;Protein 51C;SH2 domain-containing inositol 5'-phosphatase 2;, PF03372;PF00536;PF00017;, GO:0005856;GO:0005829;GO:0030175;GO:0005794;GO:0030027;GO:0016607;GO:0005634;GO:0005886;GO:0003779;GO:0034485;GO:0042169;GO:0017124;GO:0007015;GO:0007155;GO:0019221;GO:0001958;GO:0006897;GO:0006006;GO:0002376;GO:0043647;GO:0008285;GO:0010629;GO:0006661;GO:0046856;GO:0009791;GO:0032868;GO:0097178;, C:cytoskeleton; C:cytosol; C:filopodium; C:Golgi apparatus; C:lamellipodium; C:nuclear speck; C:nucleus; C:plasma membrane;, F:actin binding; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:SH2 domain binding; F:SH3 domain binding;, P:actin filament organization; P:cell adhesion; P:cytokine-mediated signaling pathway; P:endochondral ossification; P:endocytosis; P:glucose metabolic process; P:immune system process; P:inositol phosphate metabolic process; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:post-embryonic development; P:response to insulin; P:ruffle assembly;|O15357 B2RTX5 Q13577 Q13578,Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 {ECO:0000305},Inositol polyphosphate phosphatase-like protein 1;Protein 51C;SH2 domain-containing inositol 5'-phosphatase 2;, PF03372;PF00536;PF00017;, GO:0005856;GO:0005829;GO:0030175;GO:0005794;GO:0030027;GO:0016607;GO:0005634;GO:0005886;GO:0003779;GO:0034485;GO:0042169;GO:0017124;GO:0007015;GO:0007155;GO:0019221;GO:0001958;GO:0006897;GO:0006006;GO:0002376;GO:0043647;GO:0008285;GO:0010629;GO:0006661;GO:0046856;GO:0009791;GO:0032868;GO:0097178;, C:cytoskeleton; C:cytosol; C:filopodium; C:Golgi apparatus; C:lamellipodium; C:nuclear speck; C:nucleus; C:plasma membrane;, F:actin binding; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:SH2 domain binding; F:SH3 domain binding;, P:actin filament organization; P:cell adhesion; P:cytokine-mediated signaling pathway; P:endochondral ossification; P:endocytosis; P:glucose metabolic process; P:immune system process; P:inositol phosphate metabolic process; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:post-embryonic development; P:response to insulin; P:ruffle assembly;|O15357 B2RTX5 Q13577 Q13578,Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 {ECO:0000305},Inositol polyphosphate phosphatase-like protein 1;Protein 51C;SH2 domain-containing inositol 5'-phosphatase 2;, PF03372;PF00536;PF00017;, GO:0005856;GO:0005829;GO:0030175;GO:0005794;GO:0030027;GO:0016607;GO:0005634;GO:0005886;GO:0003779;GO:0034485;GO:0042169;GO:0017124;GO:0007015;GO:0007155;GO:0019221;GO:0001958;GO:0006897;GO:0006006;GO:0002376;GO:0043647;GO:0008285;GO:0010629;GO:0006661;GO:0046856;GO:0009791;GO:0032868;GO:0097178;, C:cytoskeleton; C:cytosol; C:filopodium; C:Golgi apparatus; C:lamellipodium; C:nuclear speck; C:nucleus; C:plasma membrane;, F:actin binding; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:SH2 domain binding; F:SH3 domain binding;, P:actin filament organization; P:cell adhesion; P:cytokine-mediated signaling pathway; P:endochondral ossification; P:endocytosis; P:glucose metabolic process; P:immune system process; P:inositol phosphate metabolic process; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:post-embryonic development; P:response to insulin; P:ruffle assembly;|O15357 B2RTX5 Q13577 Q13578,Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 {ECO:0000305},Inositol polyphosphate phosphatase-like protein 1;Protein 51C;SH2 domain-containing inositol 5'-phosphatase 2;, PF03372;PF00536;PF00017;, GO:0005856;GO:0005829;GO:0030175;GO:0005794;GO:0030027;GO:0016607;GO:0005634;GO:0005886;GO:0003779;GO:0034485;GO:0042169;GO:0017124;GO:0007015;GO:0007155;GO:0019221;GO:0001958;GO:0006897;GO:0006006;GO:0002376;GO:0043647;GO:0008285;GO:0010629;GO:0006661;GO:0046856;GO:0009791;GO:0032868;GO:0097178;, C:cytoskeleton; C:cytosol; C:filopodium; C:Golgi apparatus; C:lamellipodium; C:nuclear speck; C:nucleus; C:plasma membrane;, F:actin binding; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:SH2 domain binding; F:SH3 domain binding;, P:actin filament organization; P:cell adhesion; P:cytokine-mediated signaling pathway; P:endochondral ossification; P:endocytosis; P:glucose metabolic process; P:immune system process; P:inositol phosphate metabolic process; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:post-embryonic development; P:response to insulin; P:ruffle assembly; scaffold19 indexed_genome mRNA 25808688 25812410 . - . ID=transcript_4748;P14207 Q05CA5 Q6GTE8,Folate receptor beta,Folate receptor 2;Folate receptor, fetal/placental;Placental folate-binding protein;, PF03024;, GO:0031362;GO:0009986;GO:0005576;GO:0005886;GO:0005542;GO:0061714;GO:0051870;GO:0038023;GO:0007155;GO:1904447;GO:0046655;GO:0015884;GO:0007342;GO:0006954;GO:0008284;GO:0035036;, C:anchored component of external side of plasma membrane; C:cell surface; C:extracellular region; C:plasma membrane;, F:folic acid binding; F:folic acid receptor activity; F:methotrexate binding; F:signaling receptor activity;, P:cell adhesion; P:folate import across plasma membrane; P:folic acid metabolic process; P:folic acid transport; P:fusion of sperm to egg plasma membrane involved in single fertilization; P:inflammatory response; P:positive regulation of cell population proliferation; P:sperm-egg recognition; scaffold19 indexed_genome mRNA 25830470 25903275 . - . ID=transcript_4749;P15328 Q53EW2 Q6FGT8 Q6LC90 Q9UCT2,Folate receptor alpha,Adult folate-binding protein;Folate receptor 1;Folate receptor, adult;KB cells FBP;Ovarian tumor-associated antigen MOv18;, PF03024;, GO:0031362;GO:0016324;GO:0016323;GO:0031526;GO:0009986;GO:0030136;GO:0005789;GO:0033116;GO:0005768;GO:0012507;GO:0070062;GO:0000139;GO:0016020;GO:0005634;GO:0005886;GO:0030133;GO:0005542;GO:0061714;GO:0051870;GO:0038023;GO:0061713;GO:0031103;GO:0003253;GO:0007155;GO:0071231;GO:0048208;GO:0006888;GO:1904447;GO:0046655;GO:0015884;GO:0007342;GO:0001947;GO:0003147;GO:0061626;GO:0006898;GO:0060828;GO:0017015;GO:0035036;, C:anchored component of external side of plasma membrane; C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:cell surface; C:clathrin-coated vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:endosome; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:Golgi membrane; C:membrane; C:nucleus; C:plasma membrane; C:transport vesicle;, F:folic acid binding; F:folic acid receptor activity; F:methotrexate binding; F:signaling receptor activity;, P:anterior neural tube closure; P:axon regeneration; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; P:cell adhesion; P:cellular response to folic acid; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:folate import across plasma membrane; P:folic acid metabolic process; P:folic acid transport; P:fusion of sperm to egg plasma membrane involved in single fertilization; P:heart looping; P:neural crest cell migration involved in heart formation; P:pharyngeal arch artery morphogenesis; P:receptor-mediated endocytosis; P:regulation of canonical Wnt signaling pathway; P:regulation of transforming growth factor beta receptor signaling pathway; P:sperm-egg recognition;|P15328 Q53EW2 Q6FGT8 Q6LC90 Q9UCT2,Folate receptor alpha,Adult folate-binding protein;Folate receptor 1;Folate receptor, adult;KB cells FBP;Ovarian tumor-associated antigen MOv18;, PF03024;, GO:0031362;GO:0016324;GO:0016323;GO:0031526;GO:0009986;GO:0030136;GO:0005789;GO:0033116;GO:0005768;GO:0012507;GO:0070062;GO:0000139;GO:0016020;GO:0005634;GO:0005886;GO:0030133;GO:0005542;GO:0061714;GO:0051870;GO:0038023;GO:0061713;GO:0031103;GO:0003253;GO:0007155;GO:0071231;GO:0048208;GO:0006888;GO:1904447;GO:0046655;GO:0015884;GO:0007342;GO:0001947;GO:0003147;GO:0061626;GO:0006898;GO:0060828;GO:0017015;GO:0035036;, C:anchored component of external side of plasma membrane; C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:cell surface; C:clathrin-coated vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:endosome; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:Golgi membrane; C:membrane; C:nucleus; C:plasma membrane; C:transport vesicle;, F:folic acid binding; F:folic acid receptor activity; F:methotrexate binding; F:signaling receptor activity;, P:anterior neural tube closure; P:axon regeneration; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; P:cell adhesion; P:cellular response to folic acid; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:folate import across plasma membrane; P:folic acid metabolic process; P:folic acid transport; P:fusion of sperm to egg plasma membrane involved in single fertilization; P:heart looping; P:neural crest cell migration involved in heart formation; P:pharyngeal arch artery morphogenesis; P:receptor-mediated endocytosis; P:regulation of canonical Wnt signaling pathway; P:regulation of transforming growth factor beta receptor signaling pathway; P:sperm-egg recognition;|P60006 G3V1Q3 Q9CXK2 Q9Y269,Anaphase-promoting complex subunit 15,, PF15243;, GO:0005680;GO:0005829;GO:0005654;GO:0031145;GO:0007049;GO:0051301;GO:0007096;GO:1901990;GO:0090266;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic cell cycle spindle assembly checkpoint; P:ubiquitin-dependent protein catabolic process;|P60006 G3V1Q3 Q9CXK2 Q9Y269,Anaphase-promoting complex subunit 15,, PF15243;, GO:0005680;GO:0005829;GO:0005654;GO:0031145;GO:0007049;GO:0051301;GO:0007096;GO:1901990;GO:0090266;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic cell cycle spindle assembly checkpoint; P:ubiquitin-dependent protein catabolic process; scaffold19 indexed_genome mRNA 25905635 25907275 . - . ID=transcript_4750;Q8WZ04 B7Z816,Transmembrane O-methyltransferase {ECO:0000250|UniProtKB:A1Y9I9},Catechol O-methyltransferase 2 {ECO:0000303|PubMed:18794526};Protein LRTOMT2;, PF01596;, GO:0005783;GO:0016021;GO:0005886;GO:0016206;GO:0102084;GO:0008171;GO:0102938;GO:0060117;GO:0042424;GO:0032502;GO:0042417;GO:0032259;GO:0042135;GO:0007605;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, F:catechol O-methyltransferase activity; F:L-dopa O-methyltransferase activity; F:O-methyltransferase activity; F:orcinol O-methyltransferase activity;, P:auditory receptor cell development; P:catecholamine catabolic process; P:developmental process; P:dopamine metabolic process; P:methylation; P:neurotransmitter catabolic process; P:sensory perception of sound; scaffold19 indexed_genome mRNA 25908219 25917939 . + . ID=transcript_4751;Q6IAA8 Q8WZ09 Q9NWT0,Ragulator complex protein LAMTOR1,Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1;Lipid raft adaptor protein p18;Protein associated with DRMs and endosomes;p27Kip1-releasing factor from RhoA;, PF15454;, GO:0035577;GO:0070062;GO:0101003;GO:0031902;GO:0005765;GO:0005764;GO:0045121;GO:0005886;GO:0071986;GO:0035579;GO:0051020;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:0042632;GO:0016197;GO:0007032;GO:0032418;GO:0007040;GO:0043312;GO:0043410;GO:0032008;GO:0050790;GO:0001558;GO:0010874;GO:0010872;GO:0060620;GO:0016241;GO:0001919;, C:azurophil granule membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane raft; C:plasma membrane; C:Ragulator complex; C:specific granule membrane;, F:GTPase binding;, P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cholesterol homeostasis; P:endosomal transport; P:endosome organization; P:lysosome localization; P:lysosome organization; P:neutrophil degranulation; P:positive regulation of MAPK cascade; P:positive regulation of TOR signaling; P:regulation of catalytic activity; P:regulation of cell growth; P:regulation of cholesterol efflux; P:regulation of cholesterol esterification; P:regulation of cholesterol import; P:regulation of macroautophagy; P:regulation of receptor recycling;|Q96E66 B2R7X1 B6CZ35 B6CZ36 B6CZ37 B6CZ38 B6CZ39 B7Z5I4,Leucine-rich repeat-containing protein 51,Protein LRTOMT1;, , GO:0005737;, C:cytoplasm;|Q96E66 B2R7X1 B6CZ35 B6CZ36 B6CZ37 B6CZ38 B6CZ39 B7Z5I4,Leucine-rich repeat-containing protein 51,Protein LRTOMT1;, , GO:0005737;, C:cytoplasm; scaffold19 indexed_genome mRNA 25919528 25928912 . - . ID=transcript_4752;Q96E66 B2R7X1 B6CZ35 B6CZ36 B6CZ37 B6CZ38 B6CZ39 B7Z5I4,Leucine-rich repeat-containing protein 51,Protein LRTOMT1;, , GO:0005737;, C:cytoplasm; scaffold19 indexed_genome mRNA 25962926 26000194 . + . ID=transcript_4753;Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization;|Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization;|Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization;|Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization;|Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization;|Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization;|Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization;|Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization;|Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization;|Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization;|Q14980 H0YH75 Q14981 Q9BTE9,Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059},Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};SP-H antigen {ECO:0000303|PubMed:8408288};, , GO:0005938;GO:0099738;GO:0005813;GO:0005694;GO:0055028;GO:1905720;GO:0005829;GO:0030425;GO:0070062;GO:0019897;GO:0000139;GO:0097575;GO:0016328;GO:0097427;GO:0036449;GO:0035371;GO:0072686;GO:0061673;GO:1990023;GO:0097431;GO:0043025;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0005876;GO:0000922;GO:0031616;GO:0097718;GO:0070840;GO:0008017;GO:0051011;GO:0051010;GO:0035091;GO:0008022;GO:0019904;GO:0044877;GO:0005198;GO:0015631;GO:0055048;GO:0030953;GO:0051301;GO:0007059;GO:0000132;GO:0051321;GO:0001578;GO:0006997;GO:0030513;GO:0051984;GO:1905820;GO:0051798;GO:0032388;GO:0045618;GO:0031116;GO:1902846;GO:1904778;GO:1902365;GO:1905832;GO:0090235;GO:0060236;, C:cell cortex; C:cell cortex region; C:centrosome; C:chromosome; C:cortical microtubule; C:cytoplasmic microtubule bundle; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of plasma membrane; C:Golgi membrane; C:lateral cell cortex; C:lateral plasma membrane; C:microtubule bundle; C:microtubule minus-end; C:microtubule plus-end; C:mitotic spindle; C:mitotic spindle astral microtubule; C:mitotic spindle midzone; C:mitotic spindle pole; C:neuronal cell body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle microtubule; C:spindle pole; C:spindle pole centrosome;, F:disordered domain specific binding; F:dynein complex binding; F:microtubule binding; F:microtubule minus-end binding; F:microtubule plus-end binding; F:phosphatidylinositol binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:structural molecule activity; F:tubulin binding;, P:anastral spindle assembly; P:astral microtubule organization; P:cell division; P:chromosome segregation; P:establishment of mitotic spindle orientation; P:meiotic cell cycle; P:microtubule bundle formation; P:nucleus organization; P:positive regulation of BMP signaling pathway; P:positive regulation of chromosome segregation; P:positive regulation of chromosome separation; P:positive regulation of hair follicle development; P:positive regulation of intracellular transport; P:positive regulation of keratinocyte differentiation; P:positive regulation of microtubule polymerization; P:positive regulation of mitotic spindle elongation; P:positive regulation of protein localization to cell cortex; P:positive regulation of protein localization to spindle pole body; P:positive regulation of spindle assembly; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization; scaffold19 indexed_genome mRNA 26000377 26050385 . - . ID=transcript_4754;Q9H920 B3KSW8 Q6IA57 Q6P449 Q96DB4,RING finger protein 121,, , GO:0005789;GO:0000139;GO:0016021;GO:0046872;GO:0061630;GO:0030968;GO:0030433;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:endoplasmic reticulum unfolded protein response; P:ubiquitin-dependent ERAD pathway;|Q9H920 B3KSW8 Q6IA57 Q6P449 Q96DB4,RING finger protein 121,, , GO:0005789;GO:0000139;GO:0016021;GO:0046872;GO:0061630;GO:0030968;GO:0030433;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:endoplasmic reticulum unfolded protein response; P:ubiquitin-dependent ERAD pathway;|Q9H920 B3KSW8 Q6IA57 Q6P449 Q96DB4,RING finger protein 121,, , GO:0005789;GO:0000139;GO:0016021;GO:0046872;GO:0061630;GO:0030968;GO:0030433;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:endoplasmic reticulum unfolded protein response; P:ubiquitin-dependent ERAD pathway; scaffold19 indexed_genome mRNA 26084118 26098450 . + . ID=transcript_4755;Q6ZNB5,Putative short transient receptor potential channel 2-like protein,, PF01834;, GO:0005694;GO:0005730;GO:0003684;GO:0000012;, C:chromosome; C:nucleolus;, F:damaged DNA binding;, P:single strand break repair; scaffold19 indexed_genome mRNA 26106257 26121452 . + . ID=transcript_4756;Q9Y210 Q52M59 Q9HCW3 Q9NQA8 Q9NQA9,Short transient receptor potential channel 6,Transient receptor protein 6;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005737;GO:0005887;GO:0016020;GO:0005886;GO:0036057;GO:0003779;GO:0042805;GO:0051117;GO:0005261;GO:0030276;GO:0070679;GO:0042803;GO:0015279;GO:0007568;GO:0070588;GO:0006812;GO:0070301;GO:0071456;GO:0006828;GO:0050774;GO:0030182;GO:0030168;GO:0051928;GO:0007204;GO:0032414;GO:0045666;GO:0010800;GO:0051480;GO:0007338;, C:cation channel complex; C:cytoplasm; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:slit diaphragm;, F:actin binding; F:actinin binding; F:ATPase binding; F:cation channel activity; F:clathrin binding; F:inositol 1,4,5 trisphosphate binding; F:protein homodimerization activity; F:store-operated calcium channel activity;, P:aging; P:calcium ion transmembrane transport; P:cation transport; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:manganese ion transport; P:negative regulation of dendrite morphogenesis; P:neuron differentiation; P:platelet activation; P:positive regulation of calcium ion transport; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ion transmembrane transporter activity; P:positive regulation of neuron differentiation; P:positive regulation of peptidyl-threonine phosphorylation; P:regulation of cytosolic calcium ion concentration; P:single fertilization;|Q13507 A7VJS1 E9PCJ9 O00593 Q15660 Q52M35 Q5G1L5,Short transient receptor potential channel 3,Transient receptor protein 3;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0005262;GO:0070679;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0007602;GO:0030168;GO:0010524;GO:1903244;GO:0051480;GO:0033198;GO:0051592;GO:0007338;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:calcium channel activity; F:inositol 1,4,5 trisphosphate binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:phototransduction; P:platelet activation; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cardiac muscle hypertrophy in response to stress; P:regulation of cytosolic calcium ion concentration; P:response to ATP; P:response to calcium ion; P:single fertilization;|Q9HCX4 A1A4Z4 F5H5U9 Q70T26 Q8IWP7,Short transient receptor potential channel 7,Transient receptor protein 7;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005801;GO:0005887;GO:0005635;GO:0048471;GO:0005886;GO:0070679;GO:0015279;GO:0070588;GO:0006828;GO:0030168;GO:0051480;GO:0007338;, C:cation channel complex; C:cis-Golgi network; C:integral component of plasma membrane; C:nuclear envelope; C:perinuclear region of cytoplasm; C:plasma membrane;, F:inositol 1,4,5 trisphosphate binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:manganese ion transport; P:platelet activation; P:regulation of cytosolic calcium ion concentration; P:single fertilization;|Q9HCX4 A1A4Z4 F5H5U9 Q70T26 Q8IWP7,Short transient receptor potential channel 7,Transient receptor protein 7;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005801;GO:0005887;GO:0005635;GO:0048471;GO:0005886;GO:0070679;GO:0015279;GO:0070588;GO:0006828;GO:0030168;GO:0051480;GO:0007338;, C:cation channel complex; C:cis-Golgi network; C:integral component of plasma membrane; C:nuclear envelope; C:perinuclear region of cytoplasm; C:plasma membrane;, F:inositol 1,4,5 trisphosphate binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:manganese ion transport; P:platelet activation; P:regulation of cytosolic calcium ion concentration; P:single fertilization; scaffold19 indexed_genome mRNA 26162963 26167037 . - . ID=transcript_4757;Q96L15 C9IYG7 Q6UX84 Q86W02,Ecto-ADP-ribosyltransferase 5,ADP-ribosyltransferase C2 and C3 toxin-like 5;Mono(ADP-ribosyl)transferase 5;NAD(P)(+)--arginine ADP-ribosyltransferase 5;, PF01129;, GO:0005576;GO:0003950;GO:0106274;GO:0106275;GO:0018120;, C:extracellular region;, F:NAD+ ADP-ribosyltransferase activity; F:NAD+-protein-arginine ADP-ribosyltransferase activity; F:NADP+-protein-arginine ADP-ribosyltransferase activity;, P:peptidyl-arginine ADP-ribosylation;|Q96L15 C9IYG7 Q6UX84 Q86W02,Ecto-ADP-ribosyltransferase 5,ADP-ribosyltransferase C2 and C3 toxin-like 5;Mono(ADP-ribosyl)transferase 5;NAD(P)(+)--arginine ADP-ribosyltransferase 5;, PF01129;, GO:0005576;GO:0003950;GO:0106274;GO:0106275;GO:0018120;, C:extracellular region;, F:NAD+ ADP-ribosyltransferase activity; F:NAD+-protein-arginine ADP-ribosyltransferase activity; F:NADP+-protein-arginine ADP-ribosyltransferase activity;, P:peptidyl-arginine ADP-ribosylation; scaffold19 indexed_genome mRNA 26178156 26193595 . + . ID=transcript_4758;P52961 Q6NTD2 Q96KT9,GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1,ADP-ribosyltransferase C2 and C3 toxin-like 1;Mono(ADP-ribosyl)transferase 1;, PF01129;, GO:0031225;GO:0005886;GO:0033017;GO:0003950;GO:0106274;GO:0106275;GO:0018120;GO:0006471;, C:anchored component of membrane; C:plasma membrane; C:sarcoplasmic reticulum membrane;, F:NAD+ ADP-ribosyltransferase activity; F:NAD+-protein-arginine ADP-ribosyltransferase activity; F:NADP+-protein-arginine ADP-ribosyltransferase activity;, P:peptidyl-arginine ADP-ribosylation; P:protein ADP-ribosylation;|Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,Nicotinic acetylcholine receptor subunit alpha-10;, PF02931;PF02932;, GO:0030424;GO:0098981;GO:0005887;GO:0099060;GO:0016020;GO:0043005;GO:0043204;GO:0045202;GO:0022848;GO:0005262;GO:0030594;GO:0005102;GO:0004888;GO:0007268;GO:0050910;GO:0042472;GO:0034220;GO:0070373;GO:0050877;GO:0007204;GO:0042127;GO:0042391;GO:0007165;GO:0007271;, C:axon; C:cholinergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:membrane; C:neuron projection; C:perikaryon; C:synapse;, F:acetylcholine-gated cation-selective channel activity; F:calcium channel activity; F:neurotransmitter receptor activity; F:signaling receptor binding; F:transmembrane signaling receptor activity;, P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception of sound; P:inner ear morphogenesis; P:ion transmembrane transport; P:negative regulation of ERK1 and ERK2 cascade; P:nervous system process; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cell population proliferation; P:regulation of membrane potential; P:signal transduction; P:synaptic transmission, cholinergic; scaffold19 indexed_genome mRNA 26193638 26197962 . + . ID=transcript_4759;Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,Nicotinic acetylcholine receptor subunit alpha-10;, PF02931;PF02932;, GO:0030424;GO:0098981;GO:0005887;GO:0099060;GO:0016020;GO:0043005;GO:0043204;GO:0045202;GO:0022848;GO:0005262;GO:0030594;GO:0005102;GO:0004888;GO:0007268;GO:0050910;GO:0042472;GO:0034220;GO:0070373;GO:0050877;GO:0007204;GO:0042127;GO:0042391;GO:0007165;GO:0007271;, C:axon; C:cholinergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:membrane; C:neuron projection; C:perikaryon; C:synapse;, F:acetylcholine-gated cation-selective channel activity; F:calcium channel activity; F:neurotransmitter receptor activity; F:signaling receptor binding; F:transmembrane signaling receptor activity;, P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception of sound; P:inner ear morphogenesis; P:ion transmembrane transport; P:negative regulation of ERK1 and ERK2 cascade; P:nervous system process; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cell population proliferation; P:regulation of membrane potential; P:signal transduction; P:synaptic transmission, cholinergic; scaffold19 indexed_genome mRNA 26202555 26206893 . - . ID=transcript_4760;Q9Y6J5,Nuclear pore complex protein Nup98-Nup96,, PF04096;PF12110;, GO:0005829;GO:0043657;GO:0043231;GO:0016604;GO:0005635;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0031080;GO:0005654;GO:1990904;GO:0003729;GO:0008139;GO:1990841;GO:0008236;GO:0017056;GO:0003713;GO:0005215;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0051292;GO:0006999;GO:0006913;GO:0048026;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nuclear pore outer ring; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA binding; F:nuclear localization sequence binding; F:promoter-specific chromatin binding; F:serine-type peptidase activity; F:structural constituent of nuclear pore; F:transcription coactivator activity; F:transporter activity;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nuclear pore complex assembly; P:nuclear pore organization; P:nucleocytoplasmic transport; P:positive regulation of mRNA splicing, via spliceosome; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9Y6J5,Nuclear pore complex protein Nup98-Nup96,, PF04096;PF12110;, GO:0005829;GO:0043657;GO:0043231;GO:0016604;GO:0005635;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0031080;GO:0005654;GO:1990904;GO:0003729;GO:0008139;GO:1990841;GO:0008236;GO:0017056;GO:0003713;GO:0005215;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0051292;GO:0006999;GO:0006913;GO:0048026;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nuclear pore outer ring; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA binding; F:nuclear localization sequence binding; F:promoter-specific chromatin binding; F:serine-type peptidase activity; F:structural constituent of nuclear pore; F:transcription coactivator activity; F:transporter activity;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nuclear pore complex assembly; P:nuclear pore organization; P:nucleocytoplasmic transport; P:positive regulation of mRNA splicing, via spliceosome; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold19 indexed_genome mRNA 26206951 26220706 . - . ID=transcript_4761;Q9Y6J5,Nuclear pore complex protein Nup98-Nup96,, PF04096;PF12110;, GO:0005829;GO:0043657;GO:0043231;GO:0016604;GO:0005635;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0031080;GO:0005654;GO:1990904;GO:0003729;GO:0008139;GO:1990841;GO:0008236;GO:0017056;GO:0003713;GO:0005215;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0051292;GO:0006999;GO:0006913;GO:0048026;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nuclear pore outer ring; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA binding; F:nuclear localization sequence binding; F:promoter-specific chromatin binding; F:serine-type peptidase activity; F:structural constituent of nuclear pore; F:transcription coactivator activity; F:transporter activity;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nuclear pore complex assembly; P:nuclear pore organization; P:nucleocytoplasmic transport; P:positive regulation of mRNA splicing, via spliceosome; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9Y6J5,Nuclear pore complex protein Nup98-Nup96,, PF04096;PF12110;, GO:0005829;GO:0043657;GO:0043231;GO:0016604;GO:0005635;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0031080;GO:0005654;GO:1990904;GO:0003729;GO:0008139;GO:1990841;GO:0008236;GO:0017056;GO:0003713;GO:0005215;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0051292;GO:0006999;GO:0006913;GO:0048026;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nuclear pore outer ring; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA binding; F:nuclear localization sequence binding; F:promoter-specific chromatin binding; F:serine-type peptidase activity; F:structural constituent of nuclear pore; F:transcription coactivator activity; F:transporter activity;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nuclear pore complex assembly; P:nuclear pore organization; P:nucleocytoplasmic transport; P:positive regulation of mRNA splicing, via spliceosome; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold19 indexed_genome mRNA 26225789 26260787 . - . ID=transcript_4762;Q9Y6J5,Nuclear pore complex protein Nup98-Nup96,, PF04096;PF12110;, GO:0005829;GO:0043657;GO:0043231;GO:0016604;GO:0005635;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0031080;GO:0005654;GO:1990904;GO:0003729;GO:0008139;GO:1990841;GO:0008236;GO:0017056;GO:0003713;GO:0005215;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0051292;GO:0006999;GO:0006913;GO:0048026;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nuclear pore outer ring; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA binding; F:nuclear localization sequence binding; F:promoter-specific chromatin binding; F:serine-type peptidase activity; F:structural constituent of nuclear pore; F:transcription coactivator activity; F:transporter activity;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nuclear pore complex assembly; P:nuclear pore organization; P:nucleocytoplasmic transport; P:positive regulation of mRNA splicing, via spliceosome; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9Y6J5,Nuclear pore complex protein Nup98-Nup96,, PF04096;PF12110;, GO:0005829;GO:0043657;GO:0043231;GO:0016604;GO:0005635;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0031080;GO:0005654;GO:1990904;GO:0003729;GO:0008139;GO:1990841;GO:0008236;GO:0017056;GO:0003713;GO:0005215;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0051292;GO:0006999;GO:0006913;GO:0048026;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nuclear pore outer ring; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA binding; F:nuclear localization sequence binding; F:promoter-specific chromatin binding; F:serine-type peptidase activity; F:structural constituent of nuclear pore; F:transcription coactivator activity; F:transporter activity;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nuclear pore complex assembly; P:nuclear pore organization; P:nucleocytoplasmic transport; P:positive regulation of mRNA splicing, via spliceosome; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold19 indexed_genome mRNA 26265220 26288498 . - . ID=transcript_4763;Q9Y6J5,Nuclear pore complex protein Nup98-Nup96,, PF04096;PF12110;, GO:0005829;GO:0043657;GO:0043231;GO:0016604;GO:0005635;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0031080;GO:0005654;GO:1990904;GO:0003729;GO:0008139;GO:1990841;GO:0008236;GO:0017056;GO:0003713;GO:0005215;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0051292;GO:0006999;GO:0006913;GO:0048026;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nuclear pore outer ring; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA binding; F:nuclear localization sequence binding; F:promoter-specific chromatin binding; F:serine-type peptidase activity; F:structural constituent of nuclear pore; F:transcription coactivator activity; F:transporter activity;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nuclear pore complex assembly; P:nuclear pore organization; P:nucleocytoplasmic transport; P:positive regulation of mRNA splicing, via spliceosome; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold19 indexed_genome mRNA 26295833 26309426 . + . ID=transcript_4764;Q9UHJ9 E9PJG5 H7BXL9 Q6UC77 Q96G66 Q9UF01 Q9Y4N1,Post-GPI attachment to proteins factor 2 {ECO:0000305},FGF receptor-activating protein 1;, PF10277;, GO:0005789;GO:0000139;GO:0016021;GO:0006506;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, , P:GPI anchor biosynthetic process;|Q9UHJ9 E9PJG5 H7BXL9 Q6UC77 Q96G66 Q9UF01 Q9Y4N1,Post-GPI attachment to proteins factor 2 {ECO:0000305},FGF receptor-activating protein 1;, PF10277;, GO:0005789;GO:0000139;GO:0016021;GO:0006506;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, , P:GPI anchor biosynthetic process;|Q9UHJ9 E9PJG5 H7BXL9 Q6UC77 Q96G66 Q9UF01 Q9Y4N1,Post-GPI attachment to proteins factor 2 {ECO:0000305},FGF receptor-activating protein 1;, PF10277;, GO:0005789;GO:0000139;GO:0016021;GO:0006506;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, , P:GPI anchor biosynthetic process;|Q9UHJ9 E9PJG5 H7BXL9 Q6UC77 Q96G66 Q9UF01 Q9Y4N1,Post-GPI attachment to proteins factor 2 {ECO:0000305},FGF receptor-activating protein 1;, PF10277;, GO:0005789;GO:0000139;GO:0016021;GO:0006506;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, , P:GPI anchor biosynthetic process;|Q9UHJ9 E9PJG5 H7BXL9 Q6UC77 Q96G66 Q9UF01 Q9Y4N1,Post-GPI attachment to proteins factor 2 {ECO:0000305},FGF receptor-activating protein 1;, PF10277;, GO:0005789;GO:0000139;GO:0016021;GO:0006506;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, , P:GPI anchor biosynthetic process;|Q9UHJ9 E9PJG5 H7BXL9 Q6UC77 Q96G66 Q9UF01 Q9Y4N1,Post-GPI attachment to proteins factor 2 {ECO:0000305},FGF receptor-activating protein 1;, PF10277;, GO:0005789;GO:0000139;GO:0016021;GO:0006506;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, , P:GPI anchor biosynthetic process; scaffold19 indexed_genome mRNA 26310093 26311306 . + . ID=transcript_4765;P84095 P35238 Q8NI04,Rho-related GTP-binding protein RhoG,, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0005789;GO:0070062;GO:0005925;GO:0043231;GO:0005886;GO:0030667;GO:0005525;GO:0003924;GO:0019901;GO:0030036;GO:0007015;GO:0090630;GO:0060326;GO:0030031;GO:0030865;GO:0043652;GO:0007163;GO:0008045;GO:0043312;GO:0008284;GO:0051897;GO:1903078;GO:0045893;GO:0016601;GO:0032956;GO:0008360;GO:1902622;GO:1900027;GO:0051056;GO:0007266;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:focal adhesion; C:intracellular membrane-bounded organelle; C:plasma membrane; C:secretory granule membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:activation of GTPase activity; P:cell chemotaxis; P:cell projection assembly; P:cortical cytoskeleton organization; P:engulfment of apoptotic cell; P:establishment or maintenance of cell polarity; P:motor neuron axon guidance; P:neutrophil degranulation; P:positive regulation of cell population proliferation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of transcription, DNA-templated; P:Rac protein signal transduction; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of neutrophil migration; P:regulation of ruffle assembly; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold19 indexed_genome mRNA 26332442 26527418 . + . ID=transcript_4766;Q13586 E9PQJ4 Q8N382,Stromal interaction molecule 1,, PF07647;PF16533;, GO:0032541;GO:0005783;GO:0005789;GO:0030176;GO:0005887;GO:0005874;GO:0005886;GO:0044853;GO:0033017;GO:0005246;GO:0005509;GO:0042802;GO:0051010;GO:0002020;GO:0032237;GO:0006874;GO:0005513;GO:0070166;GO:0045762;GO:0045766;GO:0051924;GO:1903779;GO:2001256;GO:0002115;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:microtubule; C:plasma membrane; C:plasma membrane raft; C:sarcoplasmic reticulum membrane;, F:calcium channel regulator activity; F:calcium ion binding; F:identical protein binding; F:microtubule plus-end binding; F:protease binding;, P:activation of store-operated calcium channel activity; P:cellular calcium ion homeostasis; P:detection of calcium ion; P:enamel mineralization; P:positive regulation of adenylate cyclase activity; P:positive regulation of angiogenesis; P:regulation of calcium ion transport; P:regulation of cardiac conduction; P:regulation of store-operated calcium entry; P:store-operated calcium entry;|Q13586 E9PQJ4 Q8N382,Stromal interaction molecule 1,, PF07647;PF16533;, GO:0032541;GO:0005783;GO:0005789;GO:0030176;GO:0005887;GO:0005874;GO:0005886;GO:0044853;GO:0033017;GO:0005246;GO:0005509;GO:0042802;GO:0051010;GO:0002020;GO:0032237;GO:0006874;GO:0005513;GO:0070166;GO:0045762;GO:0045766;GO:0051924;GO:1903779;GO:2001256;GO:0002115;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:microtubule; C:plasma membrane; C:plasma membrane raft; C:sarcoplasmic reticulum membrane;, F:calcium channel regulator activity; F:calcium ion binding; F:identical protein binding; F:microtubule plus-end binding; F:protease binding;, P:activation of store-operated calcium channel activity; P:cellular calcium ion homeostasis; P:detection of calcium ion; P:enamel mineralization; P:positive regulation of adenylate cyclase activity; P:positive regulation of angiogenesis; P:regulation of calcium ion transport; P:regulation of cardiac conduction; P:regulation of store-operated calcium entry; P:store-operated calcium entry;|Q13586 E9PQJ4 Q8N382,Stromal interaction molecule 1,, PF07647;PF16533;, GO:0032541;GO:0005783;GO:0005789;GO:0030176;GO:0005887;GO:0005874;GO:0005886;GO:0044853;GO:0033017;GO:0005246;GO:0005509;GO:0042802;GO:0051010;GO:0002020;GO:0032237;GO:0006874;GO:0005513;GO:0070166;GO:0045762;GO:0045766;GO:0051924;GO:1903779;GO:2001256;GO:0002115;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:microtubule; C:plasma membrane; C:plasma membrane raft; C:sarcoplasmic reticulum membrane;, F:calcium channel regulator activity; F:calcium ion binding; F:identical protein binding; F:microtubule plus-end binding; F:protease binding;, P:activation of store-operated calcium channel activity; P:cellular calcium ion homeostasis; P:detection of calcium ion; P:enamel mineralization; P:positive regulation of adenylate cyclase activity; P:positive regulation of angiogenesis; P:regulation of calcium ion transport; P:regulation of cardiac conduction; P:regulation of store-operated calcium entry; P:store-operated calcium entry;|Q13586 E9PQJ4 Q8N382,Stromal interaction molecule 1,, PF07647;PF16533;, GO:0032541;GO:0005783;GO:0005789;GO:0030176;GO:0005887;GO:0005874;GO:0005886;GO:0044853;GO:0033017;GO:0005246;GO:0005509;GO:0042802;GO:0051010;GO:0002020;GO:0032237;GO:0006874;GO:0005513;GO:0070166;GO:0045762;GO:0045766;GO:0051924;GO:1903779;GO:2001256;GO:0002115;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:microtubule; C:plasma membrane; C:plasma membrane raft; C:sarcoplasmic reticulum membrane;, F:calcium channel regulator activity; F:calcium ion binding; F:identical protein binding; F:microtubule plus-end binding; F:protease binding;, P:activation of store-operated calcium channel activity; P:cellular calcium ion homeostasis; P:detection of calcium ion; P:enamel mineralization; P:positive regulation of adenylate cyclase activity; P:positive regulation of angiogenesis; P:regulation of calcium ion transport; P:regulation of cardiac conduction; P:regulation of store-operated calcium entry; P:store-operated calcium entry; scaffold19 indexed_genome mRNA 26529359 26562164 . + . ID=transcript_4767;P23921 Q9UNN2,Ribonucleoside-diphosphate reductase large subunit,Ribonucleoside-diphosphate reductase subunit M1;Ribonucleotide reductase large subunit;, PF03477;PF02867;PF00317;, GO:0042995;GO:0005829;GO:0043025;GO:0005635;GO:0005971;GO:0005524;GO:0097718;GO:0042802;GO:0061731;GO:0004748;GO:0021846;GO:0009263;GO:0006260;GO:0008584;GO:0000278;GO:0015949;GO:0051290;GO:0006206;GO:0010212;GO:0060041;, C:cell projection; C:cytosol; C:neuronal cell body; C:nuclear envelope; C:ribonucleoside-diphosphate reductase complex;, F:ATP binding; F:disordered domain specific binding; F:identical protein binding; F:ribonucleoside-diphosphate reductase activity; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor;, P:cell proliferation in forebrain; P:deoxyribonucleotide biosynthetic process; P:DNA replication; P:male gonad development; P:mitotic cell cycle; P:nucleobase-containing small molecule interconversion; P:protein heterotetramerization; P:pyrimidine nucleobase metabolic process; P:response to ionizing radiation; P:retina development in camera-type eye;|P23921 Q9UNN2,Ribonucleoside-diphosphate reductase large subunit,Ribonucleoside-diphosphate reductase subunit M1;Ribonucleotide reductase large subunit;, PF03477;PF02867;PF00317;, GO:0042995;GO:0005829;GO:0043025;GO:0005635;GO:0005971;GO:0005524;GO:0097718;GO:0042802;GO:0061731;GO:0004748;GO:0021846;GO:0009263;GO:0006260;GO:0008584;GO:0000278;GO:0015949;GO:0051290;GO:0006206;GO:0010212;GO:0060041;, C:cell projection; C:cytosol; C:neuronal cell body; C:nuclear envelope; C:ribonucleoside-diphosphate reductase complex;, F:ATP binding; F:disordered domain specific binding; F:identical protein binding; F:ribonucleoside-diphosphate reductase activity; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor;, P:cell proliferation in forebrain; P:deoxyribonucleotide biosynthetic process; P:DNA replication; P:male gonad development; P:mitotic cell cycle; P:nucleobase-containing small molecule interconversion; P:protein heterotetramerization; P:pyrimidine nucleobase metabolic process; P:response to ionizing radiation; P:retina development in camera-type eye; scaffold19 indexed_genome mRNA 26562172 26568565 . + . ID=transcript_4768;P23921 Q9UNN2,Ribonucleoside-diphosphate reductase large subunit,Ribonucleoside-diphosphate reductase subunit M1;Ribonucleotide reductase large subunit;, PF03477;PF02867;PF00317;, GO:0042995;GO:0005829;GO:0043025;GO:0005635;GO:0005971;GO:0005524;GO:0097718;GO:0042802;GO:0061731;GO:0004748;GO:0021846;GO:0009263;GO:0006260;GO:0008584;GO:0000278;GO:0015949;GO:0051290;GO:0006206;GO:0010212;GO:0060041;, C:cell projection; C:cytosol; C:neuronal cell body; C:nuclear envelope; C:ribonucleoside-diphosphate reductase complex;, F:ATP binding; F:disordered domain specific binding; F:identical protein binding; F:ribonucleoside-diphosphate reductase activity; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor;, P:cell proliferation in forebrain; P:deoxyribonucleotide biosynthetic process; P:DNA replication; P:male gonad development; P:mitotic cell cycle; P:nucleobase-containing small molecule interconversion; P:protein heterotetramerization; P:pyrimidine nucleobase metabolic process; P:response to ionizing radiation; P:retina development in camera-type eye; scaffold19 indexed_genome mRNA 26836415 26848867 . - . ID=transcript_4769;P19474 Q5XPV5 Q96RF8,E3 ubiquitin-protein ligase TRIM21,52 kDa Ro protein;52 kDa ribonucleoprotein autoantigen Ro/SS-A;RING finger protein 81;RING-type E3 ubiquitin transferase TRIM21 {ECO:0000305};Ro(SS-A);Sjoegren syndrome type A antigen;Tripartite motif-containing protein 21;, PF13765;PF00622;PF00643;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005654;GO:0005634;GO:0000932;GO:1990904;GO:0003677;GO:0042802;GO:0042803;GO:0019901;GO:0003723;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0007049;GO:0045087;GO:0060333;GO:0045824;GO:0032088;GO:0090086;GO:1902187;GO:0032897;GO:0010508;GO:0045787;GO:0051091;GO:0043123;GO:0051092;GO:0032092;GO:0046598;GO:0051865;GO:0031648;GO:0070534;GO:0006513;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0032479;GO:0046596;GO:0034341;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleoplasm; C:nucleus; C:P-body; C:ribonucleoprotein complex;, F:DNA binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:RNA binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cell cycle; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of innate immune response; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein deubiquitination; P:negative regulation of viral release from host cell; P:negative regulation of viral transcription; P:positive regulation of autophagy; P:positive regulation of cell cycle; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein binding; P:positive regulation of viral entry into host cell; P:protein autoubiquitination; P:protein destabilization; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of type I interferon production; P:regulation of viral entry into host cell; P:response to interferon-gamma; scaffold19 indexed_genome mRNA 27058399 27073974 . - . ID=transcript_4770;Q9NW18,E3 ubiquitin-protein ligase TRIM68,RING finger protein 137;RING-type E3 ubiquitin transferase TRIM68 {ECO:0000305};SSA protein SS-56;Tripartite motif-containing protein 68;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0050681;GO:0035035;GO:0042802;GO:0042803;GO:0019901;GO:0061630;GO:0004842;GO:0008270;GO:0045087;GO:0060333;GO:0010508;GO:0043123;GO:0051092;GO:0051865;GO:0000209;GO:0016567;GO:0060765;GO:0010468;GO:0032880;GO:0046596;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:androgen receptor binding; F:histone acetyltransferase binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of autophagy; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of androgen receptor signaling pathway; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell;|Q9NW18,E3 ubiquitin-protein ligase TRIM68,RING finger protein 137;RING-type E3 ubiquitin transferase TRIM68 {ECO:0000305};SSA protein SS-56;Tripartite motif-containing protein 68;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0050681;GO:0035035;GO:0042802;GO:0042803;GO:0019901;GO:0061630;GO:0004842;GO:0008270;GO:0045087;GO:0060333;GO:0010508;GO:0043123;GO:0051092;GO:0051865;GO:0000209;GO:0016567;GO:0060765;GO:0010468;GO:0032880;GO:0046596;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:androgen receptor binding; F:histone acetyltransferase binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of autophagy; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of androgen receptor signaling pathway; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell;|Q9NW18,E3 ubiquitin-protein ligase TRIM68,RING finger protein 137;RING-type E3 ubiquitin transferase TRIM68 {ECO:0000305};SSA protein SS-56;Tripartite motif-containing protein 68;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0050681;GO:0035035;GO:0042802;GO:0042803;GO:0019901;GO:0061630;GO:0004842;GO:0008270;GO:0045087;GO:0060333;GO:0010508;GO:0043123;GO:0051092;GO:0051865;GO:0000209;GO:0016567;GO:0060765;GO:0010468;GO:0032880;GO:0046596;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:androgen receptor binding; F:histone acetyltransferase binding; F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of autophagy; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of androgen receptor signaling pathway; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell; scaffold19 indexed_genome mRNA 28287242 28288858 . - . ID=transcript_4771;Q6FI08 Q6R7N2 Q8IZI1 Q9BX96 Q9UCD6 Q9UCP8 Q9UCP9,Hemoglobin subunit beta,Beta-globin;Hemoglobin beta chain;, PF00042;, GO:0072562;GO:0005829;GO:0071682;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0031838;GO:0005833;GO:1904724;GO:0020037;GO:0031721;GO:0030492;GO:0046872;GO:0043177;GO:0019825;GO:0005344;GO:0015701;GO:0007596;GO:0098869;GO:0042744;GO:0043312;GO:0030185;GO:0015671;GO:0070527;GO:0010942;GO:0045429;GO:0006898;GO:0008217;GO:0070293;GO:0042542;, C:blood microparticle; C:cytosol; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:haptoglobin-hemoglobin complex; C:hemoglobin complex; C:tertiary granule lumen;, F:heme binding; F:hemoglobin alpha binding; F:hemoglobin binding; F:metal ion binding; F:organic acid binding; F:oxygen binding; F:oxygen carrier activity;, P:bicarbonate transport; P:blood coagulation; P:cellular oxidant detoxification; P:hydrogen peroxide catabolic process; P:neutrophil degranulation; P:nitric oxide transport; P:oxygen transport; P:platelet aggregation; P:positive regulation of cell death; P:positive regulation of nitric oxide biosynthetic process; P:receptor-mediated endocytosis; P:regulation of blood pressure; P:renal absorption; P:response to hydrogen peroxide; scaffold19 indexed_genome mRNA 28766639 28785583 . + . ID=transcript_4772;Q9C030 A8K2A7 B4DDQ5 Q86WZ8 Q9HCR1,Tripartite motif-containing protein 6,RING finger protein 89;RING-type E3 ubiquitin transferase TRIM6 {ECO:0000305};, PF00622;PF00643;PF13445;, GO:0005737;GO:0005829;GO:0005654;GO:0042802;GO:0042803;GO:0019901;GO:1990782;GO:0030674;GO:0008134;GO:0061630;GO:0008270;GO:0035458;GO:0098586;GO:0010994;GO:0045087;GO:0010629;GO:2000737;GO:0045892;GO:0045071;GO:0010508;GO:0002720;GO:0002230;GO:0043123;GO:0051092;GO:0033138;GO:0010800;GO:2000679;GO:0060340;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;GO:0032496;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:protein tyrosine kinase binding; F:protein-macromolecule adaptor activity; F:transcription factor binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to interferon-beta; P:cellular response to virus; P:free ubiquitin chain polymerization; P:innate immune response; P:negative regulation of gene expression; P:negative regulation of stem cell differentiation; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral genome replication; P:positive regulation of autophagy; P:positive regulation of cytokine production involved in immune response; P:positive regulation of defense response to virus by host; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of type I interferon-mediated signaling pathway; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell; P:response to lipopolysaccharide; P:viral process;|Q9C030 A8K2A7 B4DDQ5 Q86WZ8 Q9HCR1,Tripartite motif-containing protein 6,RING finger protein 89;RING-type E3 ubiquitin transferase TRIM6 {ECO:0000305};, PF00622;PF00643;PF13445;, GO:0005737;GO:0005829;GO:0005654;GO:0042802;GO:0042803;GO:0019901;GO:1990782;GO:0030674;GO:0008134;GO:0061630;GO:0008270;GO:0035458;GO:0098586;GO:0010994;GO:0045087;GO:0010629;GO:2000737;GO:0045892;GO:0045071;GO:0010508;GO:0002720;GO:0002230;GO:0043123;GO:0051092;GO:0033138;GO:0010800;GO:2000679;GO:0060340;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;GO:0032496;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:protein tyrosine kinase binding; F:protein-macromolecule adaptor activity; F:transcription factor binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to interferon-beta; P:cellular response to virus; P:free ubiquitin chain polymerization; P:innate immune response; P:negative regulation of gene expression; P:negative regulation of stem cell differentiation; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral genome replication; P:positive regulation of autophagy; P:positive regulation of cytokine production involved in immune response; P:positive regulation of defense response to virus by host; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of type I interferon-mediated signaling pathway; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell; P:response to lipopolysaccharide; P:viral process; scaffold19 indexed_genome mRNA 28797028 28811374 . + . ID=transcript_4773;Q9BYJ4 D3DQS7 Q9C016 Q9HCR0 Q9HCR1 Q9HCR2,Tripartite motif-containing protein 34,Interferon-responsive finger protein 1;RING finger protein 21;, PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005654;GO:0042802;GO:0042803;GO:0019901;GO:0061630;GO:0008270;GO:0051607;GO:0045087;GO:0060333;GO:0010508;GO:0051091;GO:0043123;GO:0051092;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell;|Q8IYM9 Q05CQ0 Q15521,E3 ubiquitin-protein ligase TRIM22,50 kDa-stimulated trans-acting factor;RING finger protein 94;RING-type E3 ubiquitin transferase TRIM22 {ECO:0000305};Staf-50;Tripartite motif-containing protein 22;, PF00622;PF00643;, GO:0015030;GO:0005737;GO:0005829;GO:0005794;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0042803;GO:0019901;GO:0030674;GO:0003713;GO:0003714;GO:0061630;GO:0008270;GO:0051607;GO:0006955;GO:0045087;GO:0060333;GO:0010508;GO:0051091;GO:0043123;GO:0051092;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0006355;GO:0046596;GO:0009615;GO:0016032;, C:Cajal body; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:transcription coactivator activity; F:transcription corepressor activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:defense response to virus; P:immune response; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of transcription, DNA-templated; P:regulation of viral entry into host cell; P:response to virus; P:viral process;|Q9BYJ4 D3DQS7 Q9C016 Q9HCR0 Q9HCR1 Q9HCR2,Tripartite motif-containing protein 34,Interferon-responsive finger protein 1;RING finger protein 21;, PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005654;GO:0042802;GO:0042803;GO:0019901;GO:0061630;GO:0008270;GO:0051607;GO:0045087;GO:0060333;GO:0010508;GO:0051091;GO:0043123;GO:0051092;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell; scaffold19 indexed_genome mRNA 28863608 28865039 . - . ID=transcript_4774;Q9BYJ4 D3DQS7 Q9C016 Q9HCR0 Q9HCR1 Q9HCR2,Tripartite motif-containing protein 34,Interferon-responsive finger protein 1;RING finger protein 21;, PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005654;GO:0042802;GO:0042803;GO:0019901;GO:0061630;GO:0008270;GO:0051607;GO:0045087;GO:0060333;GO:0010508;GO:0051091;GO:0043123;GO:0051092;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:identical protein binding; F:protein homodimerization activity; F:protein kinase binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell;|Q9C034,Tripartite motif-containing protein 5,RING finger protein 88;RING-type E3 ubiquitin transferase TRIM5 {ECO:0000305};, PF00622;PF00643;PF13445;, GO:0005737;GO:0005829;GO:0005654;GO:0000932;GO:0042802;GO:0038187;GO:0042803;GO:0019901;GO:0030674;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0002218;GO:0006914;GO:0051607;GO:0045087;GO:0060333;GO:0046597;GO:1902187;GO:0010508;GO:0051091;GO:0043123;GO:0043410;GO:0051092;GO:0070534;GO:0000209;GO:0016567;GO:0010468;GO:0031664;GO:0032880;GO:0046596;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:P-body;, F:identical protein binding; F:pattern recognition receptor activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of innate immune response; P:autophagy; P:defense response to virus; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAPK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of protein localization; P:regulation of viral entry into host cell; P:viral process; scaffold19 indexed_genome mRNA 28882274 28899116 . + . ID=transcript_4775;Q9C034,Tripartite motif-containing protein 5,RING finger protein 88;RING-type E3 ubiquitin transferase TRIM5 {ECO:0000305};, PF00622;PF00643;PF13445;, GO:0005737;GO:0005829;GO:0005654;GO:0000932;GO:0042802;GO:0038187;GO:0042803;GO:0019901;GO:0030674;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0002218;GO:0006914;GO:0051607;GO:0045087;GO:0060333;GO:0046597;GO:1902187;GO:0010508;GO:0051091;GO:0043123;GO:0043410;GO:0051092;GO:0070534;GO:0000209;GO:0016567;GO:0010468;GO:0031664;GO:0032880;GO:0046596;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:P-body;, F:identical protein binding; F:pattern recognition receptor activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of innate immune response; P:autophagy; P:defense response to virus; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAPK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of protein localization; P:regulation of viral entry into host cell; P:viral process;|Q9C034,Tripartite motif-containing protein 5,RING finger protein 88;RING-type E3 ubiquitin transferase TRIM5 {ECO:0000305};, PF00622;PF00643;PF13445;, GO:0005737;GO:0005829;GO:0005654;GO:0000932;GO:0042802;GO:0038187;GO:0042803;GO:0019901;GO:0030674;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0002218;GO:0006914;GO:0051607;GO:0045087;GO:0060333;GO:0046597;GO:1902187;GO:0010508;GO:0051091;GO:0043123;GO:0043410;GO:0051092;GO:0070534;GO:0000209;GO:0016567;GO:0010468;GO:0031664;GO:0032880;GO:0046596;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:P-body;, F:identical protein binding; F:pattern recognition receptor activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of innate immune response; P:autophagy; P:defense response to virus; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAPK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of protein localization; P:regulation of viral entry into host cell; P:viral process; scaffold19 indexed_genome mRNA 28911970 28918325 . + . ID=transcript_4776;Q9C034,Tripartite motif-containing protein 5,RING finger protein 88;RING-type E3 ubiquitin transferase TRIM5 {ECO:0000305};, PF00622;PF00643;PF13445;, GO:0005737;GO:0005829;GO:0005654;GO:0000932;GO:0042802;GO:0038187;GO:0042803;GO:0019901;GO:0030674;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0002218;GO:0006914;GO:0051607;GO:0045087;GO:0060333;GO:0046597;GO:1902187;GO:0010508;GO:0051091;GO:0043123;GO:0043410;GO:0051092;GO:0070534;GO:0000209;GO:0016567;GO:0010468;GO:0031664;GO:0032880;GO:0046596;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:P-body;, F:identical protein binding; F:pattern recognition receptor activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of innate immune response; P:autophagy; P:defense response to virus; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAPK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of protein localization; P:regulation of viral entry into host cell; P:viral process;|Q9C034,Tripartite motif-containing protein 5,RING finger protein 88;RING-type E3 ubiquitin transferase TRIM5 {ECO:0000305};, PF00622;PF00643;PF13445;, GO:0005737;GO:0005829;GO:0005654;GO:0000932;GO:0042802;GO:0038187;GO:0042803;GO:0019901;GO:0030674;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0002218;GO:0006914;GO:0051607;GO:0045087;GO:0060333;GO:0046597;GO:1902187;GO:0010508;GO:0051091;GO:0043123;GO:0043410;GO:0051092;GO:0070534;GO:0000209;GO:0016567;GO:0010468;GO:0031664;GO:0032880;GO:0046596;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:P-body;, F:identical protein binding; F:pattern recognition receptor activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of innate immune response; P:autophagy; P:defense response to virus; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAPK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of lipopolysaccharide-mediated signaling pathway; P:regulation of protein localization; P:regulation of viral entry into host cell; P:viral process; scaffold19 indexed_genome mRNA 29600976 29637103 . - . ID=transcript_4777;Q8N5U0,Uncharacterized protein C11orf42,, PF15668;|Q8N612 Q9C0A4 Q9H0N3 Q9H624,FTS and Hook-interacting protein,Protein FAM160A2;, PF10257;, GO:0005829;GO:0070695;GO:0045022;GO:0007032;GO:0008333;GO:0007040;GO:0015031;, C:cytosol; C:FHF complex;, , P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:lysosome organization; P:protein transport;|Q8N612 Q9C0A4 Q9H0N3 Q9H624,FTS and Hook-interacting protein,Protein FAM160A2;, PF10257;, GO:0005829;GO:0070695;GO:0045022;GO:0007032;GO:0008333;GO:0007040;GO:0015031;, C:cytosol; C:FHF complex;, , P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:lysosome organization; P:protein transport; scaffold19 indexed_genome mRNA 29661646 29672564 . + . ID=transcript_4778;P32239 A8K7P9 O75824 Q16144 Q92492 Q96LC6 Q9NYK7 Q9UBV1,Gastrin/cholecystokinin type B receptor {ECO:0000303|PubMed:8415658},Cholecystokinin-2 receptor {ECO:0000303|PubMed:11926817};, PF00001;, GO:0016021;GO:0005886;GO:0046935;GO:0004951;GO:0015054;GO:0017046;GO:0031741;GO:0007166;GO:0038188;GO:0048565;GO:0007186;GO:0001696;GO:0048732;GO:0045851;GO:0007200;GO:0008284;GO:0007204;, C:integral component of membrane; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:cholecystokinin receptor activity; F:gastrin receptor activity; F:peptide hormone binding; F:type B gastrin/cholecystokinin receptor binding;, P:cell surface receptor signaling pathway; P:cholecystokinin signaling pathway; P:digestive tract development; P:G protein-coupled receptor signaling pathway; P:gastric acid secretion; P:gland development; P:pH reduction; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; scaffold19 indexed_genome mRNA 29718681 29720594 . - . ID=transcript_4779;Q969G5,Caveolae-associated protein 3 {ECO:0000312|HGNC:HGNC:9400},Cavin-3;Protein kinase C delta-binding protein;Serum deprivation response factor-related gene product that binds to C-kinase;, PF15237;, GO:0005901;GO:0005737;GO:0005829;GO:0032991;GO:0005080;GO:0032922;, C:caveola; C:cytoplasm; C:cytosol; C:protein-containing complex;, F:protein kinase C binding;, P:circadian regulation of gene expression; scaffold19 indexed_genome mRNA 29776984 29781543 . + . ID=transcript_4780;P17405 A8K8M3 E9PKS3 P17406 Q13811 Q16837 Q16841,Sphingomyelin phosphodiesterase {ECO:0000305},Acid sphingomyelinase {ECO:0000303|PubMed:27349982, ECO:0000303|PubMed:33163980};, PF00149;, GO:0036019;GO:0005768;GO:0070062;GO:0005615;GO:0042599;GO:0005811;GO:0043202;GO:0005764;GO:0005886;GO:0061750;GO:0016798;GO:0008081;GO:0004767;GO:0008270;GO:0071277;GO:0034644;GO:0046513;GO:0008203;GO:0006687;GO:0043407;GO:0007399;GO:0001778;GO:0043065;GO:0045807;GO:0035307;GO:0042220;GO:0042493;GO:0070555;GO:0010212;GO:0034612;GO:0034340;GO:0009615;GO:0007165;GO:0006685;GO:0006684;GO:0023021;GO:0046718;GO:0042060;, C:endolysosome; C:endosome; C:extracellular exosome; C:extracellular space; C:lamellar body; C:lipid droplet; C:lysosomal lumen; C:lysosome; C:plasma membrane;, F:acid sphingomyelin phosphodiesterase activity; F:hydrolase activity, acting on glycosyl bonds; F:phosphoric diester hydrolase activity; F:sphingomyelin phosphodiesterase activity; F:zinc ion binding;, P:cellular response to calcium ion; P:cellular response to UV; P:ceramide biosynthetic process; P:cholesterol metabolic process; P:glycosphingolipid metabolic process; P:negative regulation of MAP kinase activity; P:nervous system development; P:plasma membrane repair; P:positive regulation of apoptotic process; P:positive regulation of endocytosis; P:positive regulation of protein dephosphorylation; P:response to cocaine; P:response to drug; P:response to interleukin-1; P:response to ionizing radiation; P:response to tumor necrosis factor; P:response to type I interferon; P:response to virus; P:signal transduction; P:sphingomyelin catabolic process; P:sphingomyelin metabolic process; P:termination of signal transduction; P:viral entry into host cell; P:wound healing;|P17405 A8K8M3 E9PKS3 P17406 Q13811 Q16837 Q16841,Sphingomyelin phosphodiesterase {ECO:0000305},Acid sphingomyelinase {ECO:0000303|PubMed:27349982, ECO:0000303|PubMed:33163980};, PF00149;, GO:0036019;GO:0005768;GO:0070062;GO:0005615;GO:0042599;GO:0005811;GO:0043202;GO:0005764;GO:0005886;GO:0061750;GO:0016798;GO:0008081;GO:0004767;GO:0008270;GO:0071277;GO:0034644;GO:0046513;GO:0008203;GO:0006687;GO:0043407;GO:0007399;GO:0001778;GO:0043065;GO:0045807;GO:0035307;GO:0042220;GO:0042493;GO:0070555;GO:0010212;GO:0034612;GO:0034340;GO:0009615;GO:0007165;GO:0006685;GO:0006684;GO:0023021;GO:0046718;GO:0042060;, C:endolysosome; C:endosome; C:extracellular exosome; C:extracellular space; C:lamellar body; C:lipid droplet; C:lysosomal lumen; C:lysosome; C:plasma membrane;, F:acid sphingomyelin phosphodiesterase activity; F:hydrolase activity, acting on glycosyl bonds; F:phosphoric diester hydrolase activity; F:sphingomyelin phosphodiesterase activity; F:zinc ion binding;, P:cellular response to calcium ion; P:cellular response to UV; P:ceramide biosynthetic process; P:cholesterol metabolic process; P:glycosphingolipid metabolic process; P:negative regulation of MAP kinase activity; P:nervous system development; P:plasma membrane repair; P:positive regulation of apoptotic process; P:positive regulation of endocytosis; P:positive regulation of protein dephosphorylation; P:response to cocaine; P:response to drug; P:response to interleukin-1; P:response to ionizing radiation; P:response to tumor necrosis factor; P:response to type I interferon; P:response to virus; P:signal transduction; P:sphingomyelin catabolic process; P:sphingomyelin metabolic process; P:termination of signal transduction; P:viral entry into host cell; P:wound healing;|P17405 A8K8M3 E9PKS3 P17406 Q13811 Q16837 Q16841,Sphingomyelin phosphodiesterase {ECO:0000305},Acid sphingomyelinase {ECO:0000303|PubMed:27349982, ECO:0000303|PubMed:33163980};, PF00149;, GO:0036019;GO:0005768;GO:0070062;GO:0005615;GO:0042599;GO:0005811;GO:0043202;GO:0005764;GO:0005886;GO:0061750;GO:0016798;GO:0008081;GO:0004767;GO:0008270;GO:0071277;GO:0034644;GO:0046513;GO:0008203;GO:0006687;GO:0043407;GO:0007399;GO:0001778;GO:0043065;GO:0045807;GO:0035307;GO:0042220;GO:0042493;GO:0070555;GO:0010212;GO:0034612;GO:0034340;GO:0009615;GO:0007165;GO:0006685;GO:0006684;GO:0023021;GO:0046718;GO:0042060;, C:endolysosome; C:endosome; C:extracellular exosome; C:extracellular space; C:lamellar body; C:lipid droplet; C:lysosomal lumen; C:lysosome; C:plasma membrane;, F:acid sphingomyelin phosphodiesterase activity; F:hydrolase activity, acting on glycosyl bonds; F:phosphoric diester hydrolase activity; F:sphingomyelin phosphodiesterase activity; F:zinc ion binding;, P:cellular response to calcium ion; P:cellular response to UV; P:ceramide biosynthetic process; P:cholesterol metabolic process; P:glycosphingolipid metabolic process; P:negative regulation of MAP kinase activity; P:nervous system development; P:plasma membrane repair; P:positive regulation of apoptotic process; P:positive regulation of endocytosis; P:positive regulation of protein dephosphorylation; P:response to cocaine; P:response to drug; P:response to interleukin-1; P:response to ionizing radiation; P:response to tumor necrosis factor; P:response to type I interferon; P:response to virus; P:signal transduction; P:sphingomyelin catabolic process; P:sphingomyelin metabolic process; P:termination of signal transduction; P:viral entry into host cell; P:wound healing; scaffold19 indexed_genome mRNA 29781683 29782253 . + . ID=transcript_4781;Q96A93 V9GYK0 V9GYT4,Amyloid-beta A4 precursor protein-binding family B member 1,Protein Fe65;, PF00640;PF00397;, GO:0005737;GO:0005783;GO:0030426;GO:0030027;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0001540;GO:0003682;GO:0042393;GO:0050750;GO:0070064;GO:0003713;GO:0008134;GO:0031625;GO:0006915;GO:0007409;GO:0007050;GO:0006974;GO:0006302;GO:0043967;GO:0030308;GO:0000122;GO:0043065;GO:0050714;GO:0045944;GO:0045893;GO:0006355;GO:0007165;, C:cytoplasm; C:endoplasmic reticulum; C:growth cone; C:lamellipodium; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:amyloid-beta binding; F:chromatin binding; F:histone binding; F:low-density lipoprotein particle receptor binding; F:proline-rich region binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:axonogenesis; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:double-strand break repair; P:histone H4 acetylation; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of protein secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:signal transduction; scaffold19 indexed_genome mRNA 29782368 29804944 . + . ID=transcript_4782;Q96A93 V9GYK0 V9GYT4,Amyloid-beta A4 precursor protein-binding family B member 1,Protein Fe65;, PF00640;PF00397;, GO:0005737;GO:0005783;GO:0030426;GO:0030027;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0001540;GO:0003682;GO:0042393;GO:0050750;GO:0070064;GO:0003713;GO:0008134;GO:0031625;GO:0006915;GO:0007409;GO:0007050;GO:0006974;GO:0006302;GO:0043967;GO:0030308;GO:0000122;GO:0043065;GO:0050714;GO:0045944;GO:0045893;GO:0006355;GO:0007165;, C:cytoplasm; C:endoplasmic reticulum; C:growth cone; C:lamellipodium; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:amyloid-beta binding; F:chromatin binding; F:histone binding; F:low-density lipoprotein particle receptor binding; F:proline-rich region binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:axonogenesis; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:double-strand break repair; P:histone H4 acetylation; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of protein secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:signal transduction;|Q96A93 V9GYK0 V9GYT4,Amyloid-beta A4 precursor protein-binding family B member 1,Protein Fe65;, PF00640;PF00397;, GO:0005737;GO:0005783;GO:0030426;GO:0030027;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0001540;GO:0003682;GO:0042393;GO:0050750;GO:0070064;GO:0003713;GO:0008134;GO:0031625;GO:0006915;GO:0007409;GO:0007050;GO:0006974;GO:0006302;GO:0043967;GO:0030308;GO:0000122;GO:0043065;GO:0050714;GO:0045944;GO:0045893;GO:0006355;GO:0007165;, C:cytoplasm; C:endoplasmic reticulum; C:growth cone; C:lamellipodium; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:amyloid-beta binding; F:chromatin binding; F:histone binding; F:low-density lipoprotein particle receptor binding; F:proline-rich region binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:axonogenesis; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:double-strand break repair; P:histone H4 acetylation; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of protein secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:signal transduction;|Q96A93 V9GYK0 V9GYT4,Amyloid-beta A4 precursor protein-binding family B member 1,Protein Fe65;, PF00640;PF00397;, GO:0005737;GO:0005783;GO:0030426;GO:0030027;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0001540;GO:0003682;GO:0042393;GO:0050750;GO:0070064;GO:0003713;GO:0008134;GO:0031625;GO:0006915;GO:0007409;GO:0007050;GO:0006974;GO:0006302;GO:0043967;GO:0030308;GO:0000122;GO:0043065;GO:0050714;GO:0045944;GO:0045893;GO:0006355;GO:0007165;, C:cytoplasm; C:endoplasmic reticulum; C:growth cone; C:lamellipodium; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:amyloid-beta binding; F:chromatin binding; F:histone binding; F:low-density lipoprotein particle receptor binding; F:proline-rich region binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:axonogenesis; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:double-strand break repair; P:histone H4 acetylation; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of protein secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:signal transduction;|Q96A93 V9GYK0 V9GYT4,Amyloid-beta A4 precursor protein-binding family B member 1,Protein Fe65;, PF00640;PF00397;, GO:0005737;GO:0005783;GO:0030426;GO:0030027;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0001540;GO:0003682;GO:0042393;GO:0050750;GO:0070064;GO:0003713;GO:0008134;GO:0031625;GO:0006915;GO:0007409;GO:0007050;GO:0006974;GO:0006302;GO:0043967;GO:0030308;GO:0000122;GO:0043065;GO:0050714;GO:0045944;GO:0045893;GO:0006355;GO:0007165;, C:cytoplasm; C:endoplasmic reticulum; C:growth cone; C:lamellipodium; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:amyloid-beta binding; F:chromatin binding; F:histone binding; F:low-density lipoprotein particle receptor binding; F:proline-rich region binding; F:transcription coactivator activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:axonogenesis; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:double-strand break repair; P:histone H4 acetylation; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of protein secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:signal transduction; scaffold19 indexed_genome mRNA 29810259 29823939 . - . ID=transcript_4783;P02790 B2R957,Hemopexin,Beta-1B-glycoprotein;, PF00045;, GO:0072562;GO:0062023;GO:0071682;GO:0070062;GO:0005576;GO:0005615;GO:0015232;GO:0046872;GO:0006879;GO:0042168;GO:0015886;GO:0020027;GO:0002925;GO:0002639;GO:0060335;GO:0042531;GO:0006898;GO:0016032;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:heme transmembrane transporter activity; F:metal ion binding;, P:cellular iron ion homeostasis; P:heme metabolic process; P:heme transport; P:hemoglobin metabolic process; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of immunoglobulin production; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of tyrosine phosphorylation of STAT protein; P:receptor-mediated endocytosis; P:viral process;|P02790 B2R957,Hemopexin,Beta-1B-glycoprotein;, PF00045;, GO:0072562;GO:0062023;GO:0071682;GO:0070062;GO:0005576;GO:0005615;GO:0015232;GO:0046872;GO:0006879;GO:0042168;GO:0015886;GO:0020027;GO:0002925;GO:0002639;GO:0060335;GO:0042531;GO:0006898;GO:0016032;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:heme transmembrane transporter activity; F:metal ion binding;, P:cellular iron ion homeostasis; P:heme metabolic process; P:heme transport; P:hemoglobin metabolic process; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of immunoglobulin production; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of tyrosine phosphorylation of STAT protein; P:receptor-mediated endocytosis; P:viral process;|P02790 B2R957,Hemopexin,Beta-1B-glycoprotein;, PF00045;, GO:0072562;GO:0062023;GO:0071682;GO:0070062;GO:0005576;GO:0005615;GO:0015232;GO:0046872;GO:0006879;GO:0042168;GO:0015886;GO:0020027;GO:0002925;GO:0002639;GO:0060335;GO:0042531;GO:0006898;GO:0016032;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:heme transmembrane transporter activity; F:metal ion binding;, P:cellular iron ion homeostasis; P:heme metabolic process; P:heme transport; P:hemoglobin metabolic process; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of immunoglobulin production; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of tyrosine phosphorylation of STAT protein; P:receptor-mediated endocytosis; P:viral process; scaffold19 indexed_genome mRNA 29830736 29856100 . - . ID=transcript_4784;O75382 B7Z5E6 F5H2Q8 Q4V9L4 Q9C038 Q9C039,Tripartite motif-containing protein 3,Brain-expressed RING finger protein;RING finger protein 22;RING finger protein 97;, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0030425;GO:0005769;GO:0005794;GO:0042802;GO:0008022;GO:0061630;GO:0008270;GO:0007399;GO:0043161;GO:0000209;GO:0015031;, C:cytoplasm; C:dendrite; C:early endosome; C:Golgi apparatus;, F:identical protein binding; F:protein C-terminus binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:nervous system development; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein transport;|O75382 B7Z5E6 F5H2Q8 Q4V9L4 Q9C038 Q9C039,Tripartite motif-containing protein 3,Brain-expressed RING finger protein;RING finger protein 22;RING finger protein 97;, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0030425;GO:0005769;GO:0005794;GO:0042802;GO:0008022;GO:0061630;GO:0008270;GO:0007399;GO:0043161;GO:0000209;GO:0015031;, C:cytoplasm; C:dendrite; C:early endosome; C:Golgi apparatus;, F:identical protein binding; F:protein C-terminus binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:nervous system development; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein transport;|O75382 B7Z5E6 F5H2Q8 Q4V9L4 Q9C038 Q9C039,Tripartite motif-containing protein 3,Brain-expressed RING finger protein;RING finger protein 22;RING finger protein 97;, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0030425;GO:0005769;GO:0005794;GO:0042802;GO:0008022;GO:0061630;GO:0008270;GO:0007399;GO:0043161;GO:0000209;GO:0015031;, C:cytoplasm; C:dendrite; C:early endosome; C:Golgi apparatus;, F:identical protein binding; F:protein C-terminus binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:nervous system development; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein transport;|O75382 B7Z5E6 F5H2Q8 Q4V9L4 Q9C038 Q9C039,Tripartite motif-containing protein 3,Brain-expressed RING finger protein;RING finger protein 22;RING finger protein 97;, PF00630;PF01436;PF00643;PF13445;, GO:0005737;GO:0030425;GO:0005769;GO:0005794;GO:0042802;GO:0008022;GO:0061630;GO:0008270;GO:0007399;GO:0043161;GO:0000209;GO:0015031;, C:cytoplasm; C:dendrite; C:early endosome; C:Golgi apparatus;, F:identical protein binding; F:protein C-terminus binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:nervous system development; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein transport; scaffold19 indexed_genome mRNA 29858273 29862678 . - . ID=transcript_4785;P53365 B4DX86 B4E306 D3DQT5,Arfaptin-2,ADP-ribosylation factor-interacting protein 2;Partner of RAC1;, PF06456;, GO:0005938;GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0032588;GO:0045296;GO:0005525;GO:0030742;GO:0042802;GO:0140090;GO:0070273;GO:0005543;GO:0019904;GO:0031267;GO:0030036;GO:0006914;GO:0006886;GO:0030032;GO:0034315;GO:0031529;GO:0007264;, C:cell cortex; C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle; C:trans-Golgi network membrane;, F:cadherin binding; F:GTP binding; F:GTP-dependent protein binding; F:identical protein binding; F:membrane curvature sensor activity; F:phosphatidylinositol-4-phosphate binding; F:phospholipid binding; F:protein domain specific binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:autophagy; P:intracellular protein transport; P:lamellipodium assembly; P:regulation of Arp2/3 complex-mediated actin nucleation; P:ruffle organization; P:small GTPase mediated signal transduction;|P53365 B4DX86 B4E306 D3DQT5,Arfaptin-2,ADP-ribosylation factor-interacting protein 2;Partner of RAC1;, PF06456;, GO:0005938;GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0032588;GO:0045296;GO:0005525;GO:0030742;GO:0042802;GO:0140090;GO:0070273;GO:0005543;GO:0019904;GO:0031267;GO:0030036;GO:0006914;GO:0006886;GO:0030032;GO:0034315;GO:0031529;GO:0007264;, C:cell cortex; C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle; C:trans-Golgi network membrane;, F:cadherin binding; F:GTP binding; F:GTP-dependent protein binding; F:identical protein binding; F:membrane curvature sensor activity; F:phosphatidylinositol-4-phosphate binding; F:phospholipid binding; F:protein domain specific binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:autophagy; P:intracellular protein transport; P:lamellipodium assembly; P:regulation of Arp2/3 complex-mediated actin nucleation; P:ruffle organization; P:small GTPase mediated signal transduction;|P53365 B4DX86 B4E306 D3DQT5,Arfaptin-2,ADP-ribosylation factor-interacting protein 2;Partner of RAC1;, PF06456;, GO:0005938;GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0032588;GO:0045296;GO:0005525;GO:0030742;GO:0042802;GO:0140090;GO:0070273;GO:0005543;GO:0019904;GO:0031267;GO:0030036;GO:0006914;GO:0006886;GO:0030032;GO:0034315;GO:0031529;GO:0007264;, C:cell cortex; C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle; C:trans-Golgi network membrane;, F:cadherin binding; F:GTP binding; F:GTP-dependent protein binding; F:identical protein binding; F:membrane curvature sensor activity; F:phosphatidylinositol-4-phosphate binding; F:phospholipid binding; F:protein domain specific binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:autophagy; P:intracellular protein transport; P:lamellipodium assembly; P:regulation of Arp2/3 complex-mediated actin nucleation; P:ruffle organization; P:small GTPase mediated signal transduction; scaffold19 indexed_genome mRNA 29863495 29866049 . + . ID=transcript_4786;Q9Y5J6 Q96FF3,Mitochondrial import inner membrane translocase subunit Tim10 B,Fracture callus protein 1;FxC1;Mitochondrial import inner membrane translocase subunit Tim9 B;TIMM10B;, PF02953;, GO:0005743;GO:0005758;GO:0042719;GO:0042721;GO:0046872;GO:0140318;GO:0007160;GO:0045039;GO:0006626;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial intermembrane space protein transporter complex; C:TIM22 mitochondrial import inner membrane insertion complex;, F:metal ion binding; F:protein transporter activity;, P:cell-matrix adhesion; P:protein insertion into mitochondrial inner membrane; P:protein targeting to mitochondrion; scaffold19 indexed_genome mRNA 29918366 29924376 . - . ID=transcript_4787;Q96M86 Q2NKK8 Q6UWI9 Q8NAA2 Q8TEE6 Q9NSZ9,Dynein heavy chain domain-containing protein 1,Dynein heavy chain domain 1-like protein;Protein CCDC35;, PF12774;PF12780;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0030286;GO:0070062;GO:0036156;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003341;GO:0007018;, C:dynein complex; C:extracellular exosome; C:inner dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium movement; P:microtubule-based movement; scaffold19 indexed_genome mRNA 29927518 29929082 . + . ID=transcript_4788;Q96M86 Q2NKK8 Q6UWI9 Q8NAA2 Q8TEE6 Q9NSZ9,Dynein heavy chain domain-containing protein 1,Dynein heavy chain domain 1-like protein;Protein CCDC35;, PF12774;PF12780;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0030286;GO:0070062;GO:0036156;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003341;GO:0007018;, C:dynein complex; C:extracellular exosome; C:inner dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium movement; P:microtubule-based movement; scaffold19 indexed_genome mRNA 29929086 29933606 . + . ID=transcript_4789;Q96M86 Q2NKK8 Q6UWI9 Q8NAA2 Q8TEE6 Q9NSZ9,Dynein heavy chain domain-containing protein 1,Dynein heavy chain domain 1-like protein;Protein CCDC35;, PF12774;PF12780;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0030286;GO:0070062;GO:0036156;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003341;GO:0007018;, C:dynein complex; C:extracellular exosome; C:inner dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium movement; P:microtubule-based movement;|Q9Y4Z0,U6 snRNA-associated Sm-like protein LSm4,Glycine-rich protein;, PF01423;, GO:0005829;GO:0120115;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0032991;GO:0097526;GO:0071005;GO:0046540;GO:0005688;GO:0042731;GO:0003723;GO:0017070;GO:0043928;GO:0000398;GO:0033962;GO:0008380;GO:0000387;, C:cytosol; C:Lsm2-8 complex; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:protein-containing complex; C:spliceosomal tri-snRNP complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:PH domain binding; F:RNA binding; F:U6 snRNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA splicing, via spliceosome; P:P-body assembly; P:RNA splicing; P:spliceosomal snRNP assembly; scaffold19 indexed_genome mRNA 29934158 29935370 . - . ID=transcript_4790;Q96M86 Q2NKK8 Q6UWI9 Q8NAA2 Q8TEE6 Q9NSZ9,Dynein heavy chain domain-containing protein 1,Dynein heavy chain domain 1-like protein;Protein CCDC35;, PF12774;PF12780;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0030286;GO:0070062;GO:0036156;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003341;GO:0007018;, C:dynein complex; C:extracellular exosome; C:inner dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium movement; P:microtubule-based movement; scaffold19 indexed_genome mRNA 29935709 29936210 . - . ID=transcript_4791;Q96M86 Q2NKK8 Q6UWI9 Q8NAA2 Q8TEE6 Q9NSZ9,Dynein heavy chain domain-containing protein 1,Dynein heavy chain domain 1-like protein;Protein CCDC35;, PF12774;PF12780;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0030286;GO:0070062;GO:0036156;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003341;GO:0007018;, C:dynein complex; C:extracellular exosome; C:inner dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium movement; P:microtubule-based movement; scaffold19 indexed_genome mRNA 29936332 29937389 . + . ID=transcript_4792;Q96M86 Q2NKK8 Q6UWI9 Q8NAA2 Q8TEE6 Q9NSZ9,Dynein heavy chain domain-containing protein 1,Dynein heavy chain domain 1-like protein;Protein CCDC35;, PF12774;PF12780;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0030286;GO:0070062;GO:0036156;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003341;GO:0007018;, C:dynein complex; C:extracellular exosome; C:inner dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium movement; P:microtubule-based movement; scaffold19 indexed_genome mRNA 29941448 29941949 . + . ID=transcript_4793;Q96M86 Q2NKK8 Q6UWI9 Q8NAA2 Q8TEE6 Q9NSZ9,Dynein heavy chain domain-containing protein 1,Dynein heavy chain domain 1-like protein;Protein CCDC35;, PF12774;PF12780;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0030286;GO:0070062;GO:0036156;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003341;GO:0007018;, C:dynein complex; C:extracellular exosome; C:inner dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium movement; P:microtubule-based movement; scaffold19 indexed_genome mRNA 29953754 29978198 . - . ID=transcript_4794;O43159 Q7KZ78 Q9BVM6,Ribosomal RNA-processing protein 8,Cerebral protein 1;Nucleomethylin;, PF05148;, GO:0005677;GO:0005829;GO:0005730;GO:0005654;GO:0005886;GO:0033553;GO:0035064;GO:0003723;GO:0008757;GO:0042149;GO:0072332;GO:0032259;GO:0071158;GO:0000183;GO:0046015;GO:0006364;, C:chromatin silencing complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:rDNA heterochromatin;, F:methylated histone binding; F:RNA binding; F:S-adenosylmethionine-dependent methyltransferase activity;, P:cellular response to glucose starvation; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:methylation; P:positive regulation of cell cycle arrest; P:rDNA heterochromatin assembly; P:regulation of transcription by glucose; P:rRNA processing;|Q13418 B7Z1I0 B7Z418 D3DQU0 P57043 Q68DZ3,Integrin-linked protein kinase {ECO:0000303|PubMed:8538749},59 kDa serine/threonine-protein kinase {ECO:0000303|PubMed:8538749};Beta-integrin-linked kinase {ECO:0000250|UniProtKB:P57044};ILK-1 {ECO:0000303|PubMed:10871859};ILK-2 {ECO:0000303|PubMed:10871859};p59ILK {ECO:0000303|PubMed:8538749};, PF12796;PF07714;, GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0005654;GO:0005886;GO:0030017;GO:0005524;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0034329;GO:0000902;GO:0007160;GO:0007229;GO:0070527;GO:0090263;GO:1901224;GO:0042327;GO:0001934;GO:0009967;GO:1900026;GO:0045893;GO:0006468;GO:0034446;GO:0033209;, C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleoplasm; C:plasma membrane; C:sarcomere;, F:ATP binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell junction assembly; P:cell morphogenesis; P:cell-matrix adhesion; P:integrin-mediated signaling pathway; P:platelet aggregation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:substrate adhesion-dependent cell spreading; P:tumor necrosis factor-mediated signaling pathway;|Q13418 B7Z1I0 B7Z418 D3DQU0 P57043 Q68DZ3,Integrin-linked protein kinase {ECO:0000303|PubMed:8538749},59 kDa serine/threonine-protein kinase {ECO:0000303|PubMed:8538749};Beta-integrin-linked kinase {ECO:0000250|UniProtKB:P57044};ILK-1 {ECO:0000303|PubMed:10871859};ILK-2 {ECO:0000303|PubMed:10871859};p59ILK {ECO:0000303|PubMed:8538749};, PF12796;PF07714;, GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0005654;GO:0005886;GO:0030017;GO:0005524;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0034329;GO:0000902;GO:0007160;GO:0007229;GO:0070527;GO:0090263;GO:1901224;GO:0042327;GO:0001934;GO:0009967;GO:1900026;GO:0045893;GO:0006468;GO:0034446;GO:0033209;, C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleoplasm; C:plasma membrane; C:sarcomere;, F:ATP binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell junction assembly; P:cell morphogenesis; P:cell-matrix adhesion; P:integrin-mediated signaling pathway; P:platelet aggregation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:substrate adhesion-dependent cell spreading; P:tumor necrosis factor-mediated signaling pathway;|Q13418 B7Z1I0 B7Z418 D3DQU0 P57043 Q68DZ3,Integrin-linked protein kinase {ECO:0000303|PubMed:8538749},59 kDa serine/threonine-protein kinase {ECO:0000303|PubMed:8538749};Beta-integrin-linked kinase {ECO:0000250|UniProtKB:P57044};ILK-1 {ECO:0000303|PubMed:10871859};ILK-2 {ECO:0000303|PubMed:10871859};p59ILK {ECO:0000303|PubMed:8538749};, PF12796;PF07714;, GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0005654;GO:0005886;GO:0030017;GO:0005524;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0034329;GO:0000902;GO:0007160;GO:0007229;GO:0070527;GO:0090263;GO:1901224;GO:0042327;GO:0001934;GO:0009967;GO:1900026;GO:0045893;GO:0006468;GO:0034446;GO:0033209;, C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleoplasm; C:plasma membrane; C:sarcomere;, F:ATP binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell junction assembly; P:cell morphogenesis; P:cell-matrix adhesion; P:integrin-mediated signaling pathway; P:platelet aggregation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:substrate adhesion-dependent cell spreading; P:tumor necrosis factor-mediated signaling pathway;|Q13418 B7Z1I0 B7Z418 D3DQU0 P57043 Q68DZ3,Integrin-linked protein kinase {ECO:0000303|PubMed:8538749},59 kDa serine/threonine-protein kinase {ECO:0000303|PubMed:8538749};Beta-integrin-linked kinase {ECO:0000250|UniProtKB:P57044};ILK-1 {ECO:0000303|PubMed:10871859};ILK-2 {ECO:0000303|PubMed:10871859};p59ILK {ECO:0000303|PubMed:8538749};, PF12796;PF07714;, GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0005654;GO:0005886;GO:0030017;GO:0005524;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0034329;GO:0000902;GO:0007160;GO:0007229;GO:0070527;GO:0090263;GO:1901224;GO:0042327;GO:0001934;GO:0009967;GO:1900026;GO:0045893;GO:0006468;GO:0034446;GO:0033209;, C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleoplasm; C:plasma membrane; C:sarcomere;, F:ATP binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell junction assembly; P:cell morphogenesis; P:cell-matrix adhesion; P:integrin-mediated signaling pathway; P:platelet aggregation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:substrate adhesion-dependent cell spreading; P:tumor necrosis factor-mediated signaling pathway;|Q13418 B7Z1I0 B7Z418 D3DQU0 P57043 Q68DZ3,Integrin-linked protein kinase {ECO:0000303|PubMed:8538749},59 kDa serine/threonine-protein kinase {ECO:0000303|PubMed:8538749};Beta-integrin-linked kinase {ECO:0000250|UniProtKB:P57044};ILK-1 {ECO:0000303|PubMed:10871859};ILK-2 {ECO:0000303|PubMed:10871859};p59ILK {ECO:0000303|PubMed:8538749};, PF12796;PF07714;, GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0005654;GO:0005886;GO:0030017;GO:0005524;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0034329;GO:0000902;GO:0007160;GO:0007229;GO:0070527;GO:0090263;GO:1901224;GO:0042327;GO:0001934;GO:0009967;GO:1900026;GO:0045893;GO:0006468;GO:0034446;GO:0033209;, C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleoplasm; C:plasma membrane; C:sarcomere;, F:ATP binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell junction assembly; P:cell morphogenesis; P:cell-matrix adhesion; P:integrin-mediated signaling pathway; P:platelet aggregation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:substrate adhesion-dependent cell spreading; P:tumor necrosis factor-mediated signaling pathway;|Q13418 B7Z1I0 B7Z418 D3DQU0 P57043 Q68DZ3,Integrin-linked protein kinase {ECO:0000303|PubMed:8538749},59 kDa serine/threonine-protein kinase {ECO:0000303|PubMed:8538749};Beta-integrin-linked kinase {ECO:0000250|UniProtKB:P57044};ILK-1 {ECO:0000303|PubMed:10871859};ILK-2 {ECO:0000303|PubMed:10871859};p59ILK {ECO:0000303|PubMed:8538749};, PF12796;PF07714;, GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0005654;GO:0005886;GO:0030017;GO:0005524;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0034329;GO:0000902;GO:0007160;GO:0007229;GO:0070527;GO:0090263;GO:1901224;GO:0042327;GO:0001934;GO:0009967;GO:1900026;GO:0045893;GO:0006468;GO:0034446;GO:0033209;, C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleoplasm; C:plasma membrane; C:sarcomere;, F:ATP binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell junction assembly; P:cell morphogenesis; P:cell-matrix adhesion; P:integrin-mediated signaling pathway; P:platelet aggregation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:substrate adhesion-dependent cell spreading; P:tumor necrosis factor-mediated signaling pathway;|Q13418 B7Z1I0 B7Z418 D3DQU0 P57043 Q68DZ3,Integrin-linked protein kinase {ECO:0000303|PubMed:8538749},59 kDa serine/threonine-protein kinase {ECO:0000303|PubMed:8538749};Beta-integrin-linked kinase {ECO:0000250|UniProtKB:P57044};ILK-1 {ECO:0000303|PubMed:10871859};ILK-2 {ECO:0000303|PubMed:10871859};p59ILK {ECO:0000303|PubMed:8538749};, PF12796;PF07714;, GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0005654;GO:0005886;GO:0030017;GO:0005524;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0034329;GO:0000902;GO:0007160;GO:0007229;GO:0070527;GO:0090263;GO:1901224;GO:0042327;GO:0001934;GO:0009967;GO:1900026;GO:0045893;GO:0006468;GO:0034446;GO:0033209;, C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleoplasm; C:plasma membrane; C:sarcomere;, F:ATP binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell junction assembly; P:cell morphogenesis; P:cell-matrix adhesion; P:integrin-mediated signaling pathway; P:platelet aggregation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:substrate adhesion-dependent cell spreading; P:tumor necrosis factor-mediated signaling pathway;|Q12962 O00703 Q13175 Q6FH13,Transcription initiation factor TFIID subunit 10,STAF28;Transcription initiation factor TFIID 30 kDa subunit;, PF03540;, GO:0005737;GO:0005654;GO:0005634;GO:0000125;GO:0048471;GO:0030914;GO:0005669;GO:0033276;GO:0003677;GO:0019899;GO:0030331;GO:0042802;GO:1990841;GO:0070063;GO:0016251;GO:0006915;GO:0034622;GO:0006352;GO:0000082;GO:0070365;GO:0016578;GO:0043966;GO:0035264;GO:0016579;GO:0051101;GO:0010468;GO:1901796;GO:0006366;GO:0006367;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:PCAF complex; C:perinuclear region of cytoplasm; C:STAGA complex; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:DNA binding; F:enzyme binding; F:estrogen receptor binding; F:identical protein binding; F:promoter-specific chromatin binding; F:RNA polymerase binding; F:RNA polymerase II general transcription initiation factor activity;, P:apoptotic process; P:cellular protein-containing complex assembly; P:DNA-templated transcription, initiation; P:G1/S transition of mitotic cell cycle; P:hepatocyte differentiation; P:histone deubiquitination; P:histone H3 acetylation; P:multicellular organism growth; P:protein deubiquitination; P:regulation of DNA binding; P:regulation of gene expression; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold19 indexed_genome mRNA 29988973 29996868 . - . ID=transcript_4795;O14773 Q53HT1 Q5JAK6 Q6UX56 Q71JP6 Q96C37,Tripeptidyl-peptidase 1,Cell growth-inhibiting gene 1 protein;Lysosomal pepstatin-insensitive protease;Tripeptidyl aminopeptidase;Tripeptidyl-peptidase I;, PF00082;PF09286;, GO:0070062;GO:0005794;GO:0043202;GO:0005764;GO:0042470;GO:0045121;GO:0055037;GO:0004175;GO:0035727;GO:0046872;GO:0008233;GO:0042277;GO:0004252;GO:0008236;GO:0120146;GO:0008240;GO:0045453;GO:0007417;GO:0030855;GO:0036498;GO:0006629;GO:1905146;GO:0007040;GO:0007399;GO:0050885;GO:0043171;GO:0030163;GO:0070198;GO:0006508;, C:extracellular exosome; C:Golgi apparatus; C:lysosomal lumen; C:lysosome; C:melanosome; C:membrane raft; C:recycling endosome;, F:endopeptidase activity; F:lysophosphatidic acid binding; F:metal ion binding; F:peptidase activity; F:peptide binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:sulfatide binding; F:tripeptidyl-peptidase activity;, P:bone resorption; P:central nervous system development; P:epithelial cell differentiation; P:IRE1-mediated unfolded protein response; P:lipid metabolic process; P:lysosomal protein catabolic process; P:lysosome organization; P:nervous system development; P:neuromuscular process controlling balance; P:peptide catabolic process; P:protein catabolic process; P:protein localization to chromosome, telomeric region; P:proteolysis;|O14773 Q53HT1 Q5JAK6 Q6UX56 Q71JP6 Q96C37,Tripeptidyl-peptidase 1,Cell growth-inhibiting gene 1 protein;Lysosomal pepstatin-insensitive protease;Tripeptidyl aminopeptidase;Tripeptidyl-peptidase I;, PF00082;PF09286;, GO:0070062;GO:0005794;GO:0043202;GO:0005764;GO:0042470;GO:0045121;GO:0055037;GO:0004175;GO:0035727;GO:0046872;GO:0008233;GO:0042277;GO:0004252;GO:0008236;GO:0120146;GO:0008240;GO:0045453;GO:0007417;GO:0030855;GO:0036498;GO:0006629;GO:1905146;GO:0007040;GO:0007399;GO:0050885;GO:0043171;GO:0030163;GO:0070198;GO:0006508;, C:extracellular exosome; C:Golgi apparatus; C:lysosomal lumen; C:lysosome; C:melanosome; C:membrane raft; C:recycling endosome;, F:endopeptidase activity; F:lysophosphatidic acid binding; F:metal ion binding; F:peptidase activity; F:peptide binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:sulfatide binding; F:tripeptidyl-peptidase activity;, P:bone resorption; P:central nervous system development; P:epithelial cell differentiation; P:IRE1-mediated unfolded protein response; P:lipid metabolic process; P:lysosomal protein catabolic process; P:lysosome organization; P:nervous system development; P:neuromuscular process controlling balance; P:peptide catabolic process; P:protein catabolic process; P:protein localization to chromosome, telomeric region; P:proteolysis;|O14773 Q53HT1 Q5JAK6 Q6UX56 Q71JP6 Q96C37,Tripeptidyl-peptidase 1,Cell growth-inhibiting gene 1 protein;Lysosomal pepstatin-insensitive protease;Tripeptidyl aminopeptidase;Tripeptidyl-peptidase I;, PF00082;PF09286;, GO:0070062;GO:0005794;GO:0043202;GO:0005764;GO:0042470;GO:0045121;GO:0055037;GO:0004175;GO:0035727;GO:0046872;GO:0008233;GO:0042277;GO:0004252;GO:0008236;GO:0120146;GO:0008240;GO:0045453;GO:0007417;GO:0030855;GO:0036498;GO:0006629;GO:1905146;GO:0007040;GO:0007399;GO:0050885;GO:0043171;GO:0030163;GO:0070198;GO:0006508;, C:extracellular exosome; C:Golgi apparatus; C:lysosomal lumen; C:lysosome; C:melanosome; C:membrane raft; C:recycling endosome;, F:endopeptidase activity; F:lysophosphatidic acid binding; F:metal ion binding; F:peptidase activity; F:peptide binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:sulfatide binding; F:tripeptidyl-peptidase activity;, P:bone resorption; P:central nervous system development; P:epithelial cell differentiation; P:IRE1-mediated unfolded protein response; P:lipid metabolic process; P:lysosomal protein catabolic process; P:lysosome organization; P:nervous system development; P:neuromuscular process controlling balance; P:peptide catabolic process; P:protein catabolic process; P:protein localization to chromosome, telomeric region; P:proteolysis; scaffold19 indexed_genome mRNA 29997620 30003656 . - . ID=transcript_4796;Q96JQ0 O15098,Protocadherin-16,Cadherin-19;Cadherin-25;Fibroblast cadherin-1;Protein dachsous homolog 1;, PF00028;, GO:0005912;GO:0045177;GO:0016342;GO:0016021;GO:0016020;GO:0045296;GO:0005509;GO:0034332;GO:0001658;GO:0016339;GO:0003273;GO:0000902;GO:0098742;GO:0007043;GO:0090102;GO:0072137;GO:0048565;GO:0007157;GO:0035329;GO:0007156;GO:0003192;GO:0007275;GO:0021915;GO:0022008;GO:0043931;GO:0007389;GO:0036342;GO:0072659;, C:adherens junction; C:apical part of cell; C:catenin complex; C:integral component of membrane; C:membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:branching involved in ureteric bud morphogenesis; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell migration involved in endocardial cushion formation; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:cochlea development; P:condensed mesenchymal cell proliferation; P:digestive tract development; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:hippo signaling; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:mitral valve formation; P:multicellular organism development; P:neural tube development; P:neurogenesis; P:ossification involved in bone maturation; P:pattern specification process; P:post-anal tail morphogenesis; P:protein localization to plasma membrane; scaffold19 indexed_genome mRNA 30003662 30019800 . - . ID=transcript_4797;Q96JQ0 O15098,Protocadherin-16,Cadherin-19;Cadherin-25;Fibroblast cadherin-1;Protein dachsous homolog 1;, PF00028;, GO:0005912;GO:0045177;GO:0016342;GO:0016021;GO:0016020;GO:0045296;GO:0005509;GO:0034332;GO:0001658;GO:0016339;GO:0003273;GO:0000902;GO:0098742;GO:0007043;GO:0090102;GO:0072137;GO:0048565;GO:0007157;GO:0035329;GO:0007156;GO:0003192;GO:0007275;GO:0021915;GO:0022008;GO:0043931;GO:0007389;GO:0036342;GO:0072659;, C:adherens junction; C:apical part of cell; C:catenin complex; C:integral component of membrane; C:membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:branching involved in ureteric bud morphogenesis; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell migration involved in endocardial cushion formation; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:cochlea development; P:condensed mesenchymal cell proliferation; P:digestive tract development; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:hippo signaling; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:mitral valve formation; P:multicellular organism development; P:neural tube development; P:neurogenesis; P:ossification involved in bone maturation; P:pattern specification process; P:post-anal tail morphogenesis; P:protein localization to plasma membrane; scaffold19 indexed_genome mRNA 30052273 30062715 . - . ID=transcript_4798;Q9NRX2 D3DQU3 Q6IAH8 Q96Q53 Q9C066,39S ribosomal protein L17, mitochondrial,LYST-interacting protein 2;Mitochondrial large ribosomal subunit protein bL17m {ECO:0000303|PubMed:25278503};, PF01196;, GO:0015934;GO:0005743;GO:0005762;GO:0005739;GO:0019904;GO:0003735;GO:0070125;GO:0070126;, C:large ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:protein domain specific binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold19 indexed_genome mRNA 30085964 30089379 . + . ID=transcript_4799;Q7Z2Y8 A6NFL2 Q9H8N5,Interferon-induced very large GTPase 1,Interferon-induced very large GTPase pseudogene 1;, , GO:0005829;GO:0005634;GO:0005525;, C:cytosol; C:nucleus;, F:GTP binding; scaffold19 indexed_genome mRNA 30156876 30157431 . - . ID=transcript_4800;Q7Z2Y8 A6NFL2 Q9H8N5,Interferon-induced very large GTPase 1,Interferon-induced very large GTPase pseudogene 1;, , GO:0005829;GO:0005634;GO:0005525;, C:cytosol; C:nucleus;, F:GTP binding; scaffold19 indexed_genome mRNA 30157442 30158226 . - . ID=transcript_4801;Q7Z2Y8 A6NFL2 Q9H8N5,Interferon-induced very large GTPase 1,Interferon-induced very large GTPase pseudogene 1;, , GO:0005829;GO:0005634;GO:0005525;, C:cytosol; C:nucleus;, F:GTP binding; scaffold19 indexed_genome mRNA 30565612 30583900 . + . ID=transcript_4802;Q9UL58 Q96C84,Zinc finger protein 215,BWSCR2-associated zinc finger protein 2;Zinc finger protein with KRAB and SCAN domains 11;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold19 indexed_genome mRNA 30585796 30587920 . + . ID=transcript_4803;Q9UL58 Q96C84,Zinc finger protein 215,BWSCR2-associated zinc finger protein 2;Zinc finger protein with KRAB and SCAN domains 11;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold19 indexed_genome mRNA 30602453 30604298 . + . ID=transcript_4804;Q9UL59 B2R8Q1,Zinc finger protein 214,BWSCR2-associated zinc finger protein 1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold19 indexed_genome mRNA 30605292 30621084 . - . ID=transcript_4805;Q9UL59 B2R8Q1,Zinc finger protein 214,BWSCR2-associated zinc finger protein 1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold19 indexed_genome mRNA 30850602 31053946 . + . ID=transcript_4806;Q86SS6,Synaptotagmin-9,Synaptotagmin IX;, PF00168;, GO:0030669;GO:0031045;GO:0070382;GO:0098686;GO:0030285;GO:0005886;GO:0030667;GO:0005509;GO:0005544;GO:0030276;GO:0042802;GO:0005546;GO:0001786;GO:0000149;GO:0019905;GO:0099502;GO:0017156;GO:0071277;GO:0061024;GO:0045956;GO:0017158;GO:0014059;GO:0050796;GO:0016192;, C:clathrin-coated endocytic vesicle membrane; C:dense core granule; C:exocytic vesicle; C:hippocampal mossy fiber to CA3 synapse; C:integral component of synaptic vesicle membrane; C:plasma membrane; C:secretory granule membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:identical protein binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium-dependent activation of synaptic vesicle fusion; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:membrane organization; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of insulin secretion; P:vesicle-mediated transport;|Q86SS6,Synaptotagmin-9,Synaptotagmin IX;, PF00168;, GO:0030669;GO:0031045;GO:0070382;GO:0098686;GO:0030285;GO:0005886;GO:0030667;GO:0005509;GO:0005544;GO:0030276;GO:0042802;GO:0005546;GO:0001786;GO:0000149;GO:0019905;GO:0099502;GO:0017156;GO:0071277;GO:0061024;GO:0045956;GO:0017158;GO:0014059;GO:0050796;GO:0016192;, C:clathrin-coated endocytic vesicle membrane; C:dense core granule; C:exocytic vesicle; C:hippocampal mossy fiber to CA3 synapse; C:integral component of synaptic vesicle membrane; C:plasma membrane; C:secretory granule membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:identical protein binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium-dependent activation of synaptic vesicle fusion; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:membrane organization; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of insulin secretion; P:vesicle-mediated transport; scaffold19 indexed_genome mRNA 31076569 31105748 . + . ID=transcript_4807;Q6UWY5 B4DP03 Q569G4,Olfactomedin-like protein 1,, PF02191;, GO:0005576;, C:extracellular region; scaffold19 indexed_genome mRNA 31125260 31201692 . + . ID=transcript_4808;Q8ND30 B7Z433 E9PK77 O75337 Q8WW26,Liprin-beta-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2;, PF00536;PF07647;, GO:0005829;GO:0005615;GO:0048786;GO:0042802;GO:0007528;GO:0050808;, C:cytosol; C:extracellular space; C:presynaptic active zone;, F:identical protein binding;, P:neuromuscular junction development; P:synapse organization; scaffold19 indexed_genome mRNA 31209354 31264065 . + . ID=transcript_4809;Q8ND30 B7Z433 E9PK77 O75337 Q8WW26,Liprin-beta-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2;, PF00536;PF07647;, GO:0005829;GO:0005615;GO:0048786;GO:0042802;GO:0007528;GO:0050808;, C:cytosol; C:extracellular space; C:presynaptic active zone;, F:identical protein binding;, P:neuromuscular junction development; P:synapse organization;|Q8ND30 B7Z433 E9PK77 O75337 Q8WW26,Liprin-beta-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2;, PF00536;PF07647;, GO:0005829;GO:0005615;GO:0048786;GO:0042802;GO:0007528;GO:0050808;, C:cytosol; C:extracellular space; C:presynaptic active zone;, F:identical protein binding;, P:neuromuscular junction development; P:synapse organization;|Q8ND30 B7Z433 E9PK77 O75337 Q8WW26,Liprin-beta-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2;, PF00536;PF07647;, GO:0005829;GO:0005615;GO:0048786;GO:0042802;GO:0007528;GO:0050808;, C:cytosol; C:extracellular space; C:presynaptic active zone;, F:identical protein binding;, P:neuromuscular junction development; P:synapse organization;|Q8ND30 B7Z433 E9PK77 O75337 Q8WW26,Liprin-beta-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2;, PF00536;PF07647;, GO:0005829;GO:0005615;GO:0048786;GO:0042802;GO:0007528;GO:0050808;, C:cytosol; C:extracellular space; C:presynaptic active zone;, F:identical protein binding;, P:neuromuscular junction development; P:synapse organization;|Q8ND30 B7Z433 E9PK77 O75337 Q8WW26,Liprin-beta-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2;, PF00536;PF07647;, GO:0005829;GO:0005615;GO:0048786;GO:0042802;GO:0007528;GO:0050808;, C:cytosol; C:extracellular space; C:presynaptic active zone;, F:identical protein binding;, P:neuromuscular junction development; P:synapse organization; scaffold19 indexed_genome mRNA 31277738 31278324 . + . ID=transcript_4810;Q6BCY4 Q9BVA3 Q9UF68 Q9UHJ0,NADH-cytochrome b5 reductase 2,, PF00970;PF00175;, GO:0005789;GO:0016020;GO:0005634;GO:0004128;GO:0071949;GO:0015701;GO:0016126;, C:endoplasmic reticulum membrane; C:membrane; C:nucleus;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:FAD binding;, P:bicarbonate transport; P:sterol biosynthetic process; scaffold19 indexed_genome mRNA 31712083 31755571 . + . ID=transcript_4811;P50607 D3DQU4 O00293 Q6B007,Tubby protein homolog,, PF01167;PF16322;, GO:0005929;GO:0005737;GO:0005829;GO:0005576;GO:0005634;GO:0005886;GO:0001664;GO:0120160;GO:0044877;GO:0042073;GO:0006910;GO:0045494;GO:0050766;GO:0061512;GO:1903546;GO:0097500;GO:0008277;GO:0009725;GO:0060041;GO:0007605;, C:cilium; C:cytoplasm; C:cytosol; C:extracellular region; C:nucleus; C:plasma membrane;, F:G protein-coupled receptor binding; F:intraciliary transport particle A binding; F:protein-containing complex binding;, P:intraciliary transport; P:phagocytosis, recognition; P:photoreceptor cell maintenance; P:positive regulation of phagocytosis; P:protein localization to cilium; P:protein localization to photoreceptor outer segment; P:receptor localization to non-motile cilium; P:regulation of G protein-coupled receptor signaling pathway; P:response to hormone; P:retina development in camera-type eye; P:sensory perception of sound;|P50607 D3DQU4 O00293 Q6B007,Tubby protein homolog,, PF01167;PF16322;, GO:0005929;GO:0005737;GO:0005829;GO:0005576;GO:0005634;GO:0005886;GO:0001664;GO:0120160;GO:0044877;GO:0042073;GO:0006910;GO:0045494;GO:0050766;GO:0061512;GO:1903546;GO:0097500;GO:0008277;GO:0009725;GO:0060041;GO:0007605;, C:cilium; C:cytoplasm; C:cytosol; C:extracellular region; C:nucleus; C:plasma membrane;, F:G protein-coupled receptor binding; F:intraciliary transport particle A binding; F:protein-containing complex binding;, P:intraciliary transport; P:phagocytosis, recognition; P:photoreceptor cell maintenance; P:positive regulation of phagocytosis; P:protein localization to cilium; P:protein localization to photoreceptor outer segment; P:receptor localization to non-motile cilium; P:regulation of G protein-coupled receptor signaling pathway; P:response to hormone; P:retina development in camera-type eye; P:sensory perception of sound;|P50607 D3DQU4 O00293 Q6B007,Tubby protein homolog,, PF01167;PF16322;, GO:0005929;GO:0005737;GO:0005829;GO:0005576;GO:0005634;GO:0005886;GO:0001664;GO:0120160;GO:0044877;GO:0042073;GO:0006910;GO:0045494;GO:0050766;GO:0061512;GO:1903546;GO:0097500;GO:0008277;GO:0009725;GO:0060041;GO:0007605;, C:cilium; C:cytoplasm; C:cytosol; C:extracellular region; C:nucleus; C:plasma membrane;, F:G protein-coupled receptor binding; F:intraciliary transport particle A binding; F:protein-containing complex binding;, P:intraciliary transport; P:phagocytosis, recognition; P:photoreceptor cell maintenance; P:positive regulation of phagocytosis; P:protein localization to cilium; P:protein localization to photoreceptor outer segment; P:receptor localization to non-motile cilium; P:regulation of G protein-coupled receptor signaling pathway; P:response to hormone; P:retina development in camera-type eye; P:sensory perception of sound;|Q7Z5B4 B0B1U0 B2RD25 D3DQU5 Q6UX78 Q7Z5B3 Q86T94 Q8TBJ9 Q9HAH8,Protein RIC-3,Resistant to inhibitor of cholinesterase 3;, PF15361;, GO:0005789;GO:0000139;GO:0016021;GO:0043231;GO:0043005;GO:0043025;GO:0045202;GO:0033130;GO:0044183;GO:0034622;GO:0007204;GO:0034394;GO:0007271;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:neuron projection; C:neuronal cell body; C:synapse;, F:acetylcholine receptor binding; F:protein folding chaperone;, P:cellular protein-containing complex assembly; P:positive regulation of cytosolic calcium ion concentration; P:protein localization to cell surface; P:synaptic transmission, cholinergic;|Q7Z5B4 B0B1U0 B2RD25 D3DQU5 Q6UX78 Q7Z5B3 Q86T94 Q8TBJ9 Q9HAH8,Protein RIC-3,Resistant to inhibitor of cholinesterase 3;, PF15361;, GO:0005789;GO:0000139;GO:0016021;GO:0043231;GO:0043005;GO:0043025;GO:0045202;GO:0033130;GO:0044183;GO:0034622;GO:0007204;GO:0034394;GO:0007271;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:neuron projection; C:neuronal cell body; C:synapse;, F:acetylcholine receptor binding; F:protein folding chaperone;, P:cellular protein-containing complex assembly; P:positive regulation of cytosolic calcium ion concentration; P:protein localization to cell surface; P:synaptic transmission, cholinergic; scaffold19 indexed_genome mRNA 32006447 32089056 . - . ID=transcript_4812;Q9BYT3 Q658S6 Q8NEF5,Serine/threonine-protein kinase 33,, PF00069;, GO:0005737;GO:0005634;GO:0048471;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0044773;GO:0046777;GO:0042770;, C:cytoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:mitotic DNA damage checkpoint; P:protein autophosphorylation; P:signal transduction in response to DNA damage; scaffold19 indexed_genome mRNA 32207770 32230565 . - . ID=transcript_4813;O15016 Q9BQQ4,Tripartite motif-containing protein 66,, PF00439;PF00628;PF00643;, GO:0016235;GO:0005654;GO:0008270;, C:aggresome; C:nucleoplasm;, F:zinc ion binding;|O15016 Q9BQQ4,Tripartite motif-containing protein 66,, PF00439;PF00628;PF00643;, GO:0016235;GO:0005654;GO:0008270;, C:aggresome; C:nucleoplasm;, F:zinc ion binding; scaffold19 indexed_genome mRNA 32230580 32247063 . - . ID=transcript_4814;O15016 Q9BQQ4,Tripartite motif-containing protein 66,, PF00439;PF00628;PF00643;, GO:0016235;GO:0005654;GO:0008270;, C:aggresome; C:nucleoplasm;, F:zinc ion binding; scaffold19 indexed_genome mRNA 32269651 32272410 . + . ID=transcript_4815;P46776 B2R4B3,60S ribosomal protein L27a,Large ribosomal subunit protein uL15 {ECO:0000303|PubMed:24524803};, PF00828;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P46776 B2R4B3,60S ribosomal protein L27a,Large ribosomal subunit protein uL15 {ECO:0000303|PubMed:24524803};, PF00828;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P46776 B2R4B3,60S ribosomal protein L27a,Large ribosomal subunit protein uL15 {ECO:0000303|PubMed:24524803};, PF00828;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold19 indexed_genome mRNA 32279778 32320288 . - . ID=transcript_4816;P78524 B2R6X7 B3KXQ6 P78523 Q16492 Q7KYY2 Q7KZ12 Q8NE12 Q9BQQ6,DENN domain-containing protein 2B,HeLa tumor suppression 1;Suppression of tumorigenicity 5 protein;, PF03455;PF02141;PF03456;, GO:0005938;GO:0005886;GO:0055037;GO:0005085;GO:0070374;, C:cell cortex; C:plasma membrane; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of ERK1 and ERK2 cascade;|P78524 B2R6X7 B3KXQ6 P78523 Q16492 Q7KYY2 Q7KZ12 Q8NE12 Q9BQQ6,DENN domain-containing protein 2B,HeLa tumor suppression 1;Suppression of tumorigenicity 5 protein;, PF03455;PF02141;PF03456;, GO:0005938;GO:0005886;GO:0055037;GO:0005085;GO:0070374;, C:cell cortex; C:plasma membrane; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of ERK1 and ERK2 cascade;|P78524 B2R6X7 B3KXQ6 P78523 Q16492 Q7KYY2 Q7KZ12 Q8NE12 Q9BQQ6,DENN domain-containing protein 2B,HeLa tumor suppression 1;Suppression of tumorigenicity 5 protein;, PF03455;PF02141;PF03456;, GO:0005938;GO:0005886;GO:0055037;GO:0005085;GO:0070374;, C:cell cortex; C:plasma membrane; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of ERK1 and ERK2 cascade;|P78524 B2R6X7 B3KXQ6 P78523 Q16492 Q7KYY2 Q7KZ12 Q8NE12 Q9BQQ6,DENN domain-containing protein 2B,HeLa tumor suppression 1;Suppression of tumorigenicity 5 protein;, PF03455;PF02141;PF03456;, GO:0005938;GO:0005886;GO:0055037;GO:0005085;GO:0070374;, C:cell cortex; C:plasma membrane; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of ERK1 and ERK2 cascade;|P78524 B2R6X7 B3KXQ6 P78523 Q16492 Q7KYY2 Q7KZ12 Q8NE12 Q9BQQ6,DENN domain-containing protein 2B,HeLa tumor suppression 1;Suppression of tumorigenicity 5 protein;, PF03455;PF02141;PF03456;, GO:0005938;GO:0005886;GO:0055037;GO:0005085;GO:0070374;, C:cell cortex; C:plasma membrane; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of ERK1 and ERK2 cascade;|P78524 B2R6X7 B3KXQ6 P78523 Q16492 Q7KYY2 Q7KZ12 Q8NE12 Q9BQQ6,DENN domain-containing protein 2B,HeLa tumor suppression 1;Suppression of tumorigenicity 5 protein;, PF03455;PF02141;PF03456;, GO:0005938;GO:0005886;GO:0055037;GO:0005085;GO:0070374;, C:cell cortex; C:plasma membrane; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of ERK1 and ERK2 cascade;|P78524 B2R6X7 B3KXQ6 P78523 Q16492 Q7KYY2 Q7KZ12 Q8NE12 Q9BQQ6,DENN domain-containing protein 2B,HeLa tumor suppression 1;Suppression of tumorigenicity 5 protein;, PF03455;PF02141;PF03456;, GO:0005938;GO:0005886;GO:0055037;GO:0005085;GO:0070374;, C:cell cortex; C:plasma membrane; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of ERK1 and ERK2 cascade; scaffold19 indexed_genome mRNA 32470368 32477885 . + . ID=transcript_4817;Q9NQ31 Q8NBS2 Q8TAC6 Q8TAD3 Q8TAE0,A-kinase-interacting protein 1,Breast cancer-associated gene 3 protein;PKA-interacting protein;Proline-rich protein BCA3;, , GO:0005654;GO:1901222;GO:0034446;, C:nucleoplasm;, , P:regulation of NIK/NF-kappaB signaling; P:substrate adhesion-dependent cell spreading;|Q9NQ31 Q8NBS2 Q8TAC6 Q8TAD3 Q8TAE0,A-kinase-interacting protein 1,Breast cancer-associated gene 3 protein;PKA-interacting protein;Proline-rich protein BCA3;, , GO:0005654;GO:1901222;GO:0034446;, C:nucleoplasm;, , P:regulation of NIK/NF-kappaB signaling; P:substrate adhesion-dependent cell spreading;|Q9NQ31 Q8NBS2 Q8TAC6 Q8TAD3 Q8TAE0,A-kinase-interacting protein 1,Breast cancer-associated gene 3 protein;PKA-interacting protein;Proline-rich protein BCA3;, , GO:0005654;GO:1901222;GO:0034446;, C:nucleoplasm;, , P:regulation of NIK/NF-kappaB signaling; P:substrate adhesion-dependent cell spreading;|Q9NQ31 Q8NBS2 Q8TAC6 Q8TAD3 Q8TAE0,A-kinase-interacting protein 1,Breast cancer-associated gene 3 protein;PKA-interacting protein;Proline-rich protein BCA3;, , GO:0005654;GO:1901222;GO:0034446;, C:nucleoplasm;, , P:regulation of NIK/NF-kappaB signaling; P:substrate adhesion-dependent cell spreading; scaffold19 indexed_genome mRNA 32477907 32486391 . - . ID=transcript_4818;Q9NQ32 Q53FB2 Q8N6Y9,Uncharacterized protein C11orf16,, PF15057;|Q9NQ32 Q53FB2 Q8N6Y9,Uncharacterized protein C11orf16,, PF15057; scaffold19 indexed_genome mRNA 32500022 32516756 . - . ID=transcript_4819;Q9NQ34 Q7Z649,Transmembrane protein 9B,, PF05434;, GO:0031901;GO:0016021;GO:0005765;GO:0043123;, C:early endosome membrane; C:integral component of membrane; C:lysosomal membrane;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold19 indexed_genome mRNA 32527467 32555493 . - . ID=transcript_4820;Q9NQ35 Q86WD9,Nuclear receptor-interacting protein 3,Sarcoma antigen NY-SAR-105;, PF09668;, GO:0004190;, , F:aspartic-type endopeptidase activity;|Q9NQ35 Q86WD9,Nuclear receptor-interacting protein 3,Sarcoma antigen NY-SAR-105;, PF09668;, GO:0004190;, , F:aspartic-type endopeptidase activity; scaffold19 indexed_genome mRNA 32568044 32637218 . - . ID=transcript_4821;Q9NQ36 Q2NKQ8 Q6ZWI1,Signal peptide, CUB and EGF-like domain-containing protein 2 {ECO:0000303|PubMed:19480626},Protein CEGP1 {ECO:0000250|UniProtKB:Q9JJS0};Scube/You {ECO:0000250|UniProtKB:Q9JJS0};, PF12662;PF00431;PF12947;PF07645;PF07699;, GO:0009986;GO:0005576;GO:0005615;GO:0005509;GO:0008289;GO:0007275;GO:0007165;, C:cell surface; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:lipid binding;, P:multicellular organism development; P:signal transduction; scaffold19 indexed_genome mRNA 32667635 32760888 . - . ID=transcript_4822;Q6IQ26 B4DJ15 E9PS91 Q96GN3 Q9H6U7 Q9UFV0 Q9UPR1,DENN domain-containing protein 5A,Rab6-interacting protein 1;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0000139;GO:0005802;GO:0005085;GO:0010977;GO:0042147;, C:cytosol; C:Golgi membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity;, P:negative regulation of neuron projection development; P:retrograde transport, endosome to Golgi;|Q6IQ26 B4DJ15 E9PS91 Q96GN3 Q9H6U7 Q9UFV0 Q9UPR1,DENN domain-containing protein 5A,Rab6-interacting protein 1;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0000139;GO:0005802;GO:0005085;GO:0010977;GO:0042147;, C:cytosol; C:Golgi membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity;, P:negative regulation of neuron projection development; P:retrograde transport, endosome to Golgi;|Q6IQ26 B4DJ15 E9PS91 Q96GN3 Q9H6U7 Q9UFV0 Q9UPR1,DENN domain-containing protein 5A,Rab6-interacting protein 1;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0000139;GO:0005802;GO:0005085;GO:0010977;GO:0042147;, C:cytosol; C:Golgi membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity;, P:negative regulation of neuron projection development; P:retrograde transport, endosome to Golgi;|Q6IQ26 B4DJ15 E9PS91 Q96GN3 Q9H6U7 Q9UFV0 Q9UPR1,DENN domain-containing protein 5A,Rab6-interacting protein 1;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0000139;GO:0005802;GO:0005085;GO:0010977;GO:0042147;, C:cytosol; C:Golgi membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity;, P:negative regulation of neuron projection development; P:retrograde transport, endosome to Golgi;|Q6IQ26 B4DJ15 E9PS91 Q96GN3 Q9H6U7 Q9UFV0 Q9UPR1,DENN domain-containing protein 5A,Rab6-interacting protein 1;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0000139;GO:0005802;GO:0005085;GO:0010977;GO:0042147;, C:cytosol; C:Golgi membrane; C:trans-Golgi network;, F:guanyl-nucleotide exchange factor activity;, P:negative regulation of neuron projection development; P:retrograde transport, endosome to Golgi; scaffold19 indexed_genome mRNA 32799191 32825199 . - . ID=transcript_4823;Q5BJD5 D3DQU9 E9PP29 Q15055 Q4G0P0,Transmembrane protein 41B {ECO:0000305},Protein stasimon {ECO:0000303|PubMed:30352685};, PF09335;, GO:0005789;GO:0016021;GO:0044233;GO:0000045;GO:0007399;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane;, , P:autophagosome assembly; P:nervous system development;|Q5BJD5 D3DQU9 E9PP29 Q15055 Q4G0P0,Transmembrane protein 41B {ECO:0000305},Protein stasimon {ECO:0000303|PubMed:30352685};, PF09335;, GO:0005789;GO:0016021;GO:0044233;GO:0000045;GO:0007399;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane;, , P:autophagosome assembly; P:nervous system development;|Q5BJD5 D3DQU9 E9PP29 Q15055 Q4G0P0,Transmembrane protein 41B {ECO:0000305},Protein stasimon {ECO:0000303|PubMed:30352685};, PF09335;, GO:0005789;GO:0016021;GO:0044233;GO:0000045;GO:0007399;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane;, , P:autophagosome assembly; P:nervous system development;|Q5BJD5 D3DQU9 E9PP29 Q15055 Q4G0P0,Transmembrane protein 41B {ECO:0000305},Protein stasimon {ECO:0000303|PubMed:30352685};, PF09335;, GO:0005789;GO:0016021;GO:0044233;GO:0000045;GO:0007399;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane;, , P:autophagosome assembly; P:nervous system development; scaffold19 indexed_genome mRNA 32892888 32940164 . + . ID=transcript_4824;O95373 A6NNM5 B2R786 Q1RMF7 Q9H177 Q9NTE3,Importin-7,Ran-binding protein 7;, PF08506;PF03810;, GO:0005829;GO:0016020;GO:0005635;GO:0005643;GO:0005654;GO:0030695;GO:0042393;GO:0046332;GO:0031267;GO:0005215;GO:0045087;GO:0045736;GO:0006606;GO:0007165;GO:0016032;, C:cytosol; C:membrane; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:GTPase regulator activity; F:histone binding; F:SMAD binding; F:small GTPase binding; F:transporter activity;, P:innate immune response; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:protein import into nucleus; P:signal transduction; P:viral process;|O95373 A6NNM5 B2R786 Q1RMF7 Q9H177 Q9NTE3,Importin-7,Ran-binding protein 7;, PF08506;PF03810;, GO:0005829;GO:0016020;GO:0005635;GO:0005643;GO:0005654;GO:0030695;GO:0042393;GO:0046332;GO:0031267;GO:0005215;GO:0045087;GO:0045736;GO:0006606;GO:0007165;GO:0016032;, C:cytosol; C:membrane; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:GTPase regulator activity; F:histone binding; F:SMAD binding; F:small GTPase binding; F:transporter activity;, P:innate immune response; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:protein import into nucleus; P:signal transduction; P:viral process;|O95373 A6NNM5 B2R786 Q1RMF7 Q9H177 Q9NTE3,Importin-7,Ran-binding protein 7;, PF08506;PF03810;, GO:0005829;GO:0016020;GO:0005635;GO:0005643;GO:0005654;GO:0030695;GO:0042393;GO:0046332;GO:0031267;GO:0005215;GO:0045087;GO:0045736;GO:0006606;GO:0007165;GO:0016032;, C:cytosol; C:membrane; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:GTPase regulator activity; F:histone binding; F:SMAD binding; F:small GTPase binding; F:transporter activity;, P:innate immune response; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:protein import into nucleus; P:signal transduction; P:viral process;|O95373 A6NNM5 B2R786 Q1RMF7 Q9H177 Q9NTE3,Importin-7,Ran-binding protein 7;, PF08506;PF03810;, GO:0005829;GO:0016020;GO:0005635;GO:0005643;GO:0005654;GO:0030695;GO:0042393;GO:0046332;GO:0031267;GO:0005215;GO:0045087;GO:0045736;GO:0006606;GO:0007165;GO:0016032;, C:cytosol; C:membrane; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:GTPase regulator activity; F:histone binding; F:SMAD binding; F:small GTPase binding; F:transporter activity;, P:innate immune response; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:protein import into nucleus; P:signal transduction; P:viral process;|O95373 A6NNM5 B2R786 Q1RMF7 Q9H177 Q9NTE3,Importin-7,Ran-binding protein 7;, PF08506;PF03810;, GO:0005829;GO:0016020;GO:0005635;GO:0005643;GO:0005654;GO:0030695;GO:0042393;GO:0046332;GO:0031267;GO:0005215;GO:0045087;GO:0045736;GO:0006606;GO:0007165;GO:0016032;, C:cytosol; C:membrane; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:GTPase regulator activity; F:histone binding; F:SMAD binding; F:small GTPase binding; F:transporter activity;, P:innate immune response; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:protein import into nucleus; P:signal transduction; P:viral process;|O95373 A6NNM5 B2R786 Q1RMF7 Q9H177 Q9NTE3,Importin-7,Ran-binding protein 7;, PF08506;PF03810;, GO:0005829;GO:0016020;GO:0005635;GO:0005643;GO:0005654;GO:0030695;GO:0042393;GO:0046332;GO:0031267;GO:0005215;GO:0045087;GO:0045736;GO:0006606;GO:0007165;GO:0016032;, C:cytosol; C:membrane; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:GTPase regulator activity; F:histone binding; F:SMAD binding; F:small GTPase binding; F:transporter activity;, P:innate immune response; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:protein import into nucleus; P:signal transduction; P:viral process; scaffold19 indexed_genome mRNA 32971797 33016907 . + . ID=transcript_4825;P52747 A8K518 B4DLY5 E7ER34 O75559 Q8WUK9,Zinc finger protein 143,SPH-binding factor;Selenocysteine tRNA gene transcription-activating factor;, PF00096;, GO:0005654;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:1905382;GO:0045944;GO:0045945;GO:0006357;GO:0006359;GO:0006355;GO:0042795;, C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of snRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III; P:regulation of transcription, DNA-templated; P:snRNA transcription by RNA polymerase II;|P52747 A8K518 B4DLY5 E7ER34 O75559 Q8WUK9,Zinc finger protein 143,SPH-binding factor;Selenocysteine tRNA gene transcription-activating factor;, PF00096;, GO:0005654;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:1905382;GO:0045944;GO:0045945;GO:0006357;GO:0006359;GO:0006355;GO:0042795;, C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of snRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III; P:regulation of transcription, DNA-templated; P:snRNA transcription by RNA polymerase II; scaffold19 indexed_genome mRNA 33154887 33179503 . + . ID=transcript_4826;Q9UH65 D3DQV1 O75135 Q7LCY6 Q9P061 Q9P0Z8,Switch-associated protein 70,, PF00169;, GO:0015629;GO:0005737;GO:0030027;GO:0005634;GO:0005886;GO:0005524;GO:0045296;GO:0005509;GO:0003677;GO:0051017;GO:0045190;GO:0030835;GO:0033633;GO:1902309;GO:0032233;GO:0007204;GO:0060754;GO:0032880;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:nucleus; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:calcium ion binding; F:DNA binding;, P:actin filament bundle assembly; P:isotype switching; P:negative regulation of actin filament depolymerization; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of peptidyl-serine dephosphorylation; P:positive regulation of actin filament bundle assembly; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of mast cell chemotaxis; P:regulation of protein localization;|Q9UH65 D3DQV1 O75135 Q7LCY6 Q9P061 Q9P0Z8,Switch-associated protein 70,, PF00169;, GO:0015629;GO:0005737;GO:0030027;GO:0005634;GO:0005886;GO:0005524;GO:0045296;GO:0005509;GO:0003677;GO:0051017;GO:0045190;GO:0030835;GO:0033633;GO:1902309;GO:0032233;GO:0007204;GO:0060754;GO:0032880;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:nucleus; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:calcium ion binding; F:DNA binding;, P:actin filament bundle assembly; P:isotype switching; P:negative regulation of actin filament depolymerization; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of peptidyl-serine dephosphorylation; P:positive regulation of actin filament bundle assembly; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of mast cell chemotaxis; P:regulation of protein localization;|Q9UH65 D3DQV1 O75135 Q7LCY6 Q9P061 Q9P0Z8,Switch-associated protein 70,, PF00169;, GO:0015629;GO:0005737;GO:0030027;GO:0005634;GO:0005886;GO:0005524;GO:0045296;GO:0005509;GO:0003677;GO:0051017;GO:0045190;GO:0030835;GO:0033633;GO:1902309;GO:0032233;GO:0007204;GO:0060754;GO:0032880;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:nucleus; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:calcium ion binding; F:DNA binding;, P:actin filament bundle assembly; P:isotype switching; P:negative regulation of actin filament depolymerization; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of peptidyl-serine dephosphorylation; P:positive regulation of actin filament bundle assembly; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of mast cell chemotaxis; P:regulation of protein localization;|Q9UH65 D3DQV1 O75135 Q7LCY6 Q9P061 Q9P0Z8,Switch-associated protein 70,, PF00169;, GO:0015629;GO:0005737;GO:0030027;GO:0005634;GO:0005886;GO:0005524;GO:0045296;GO:0005509;GO:0003677;GO:0051017;GO:0045190;GO:0030835;GO:0033633;GO:1902309;GO:0032233;GO:0007204;GO:0060754;GO:0032880;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:nucleus; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:calcium ion binding; F:DNA binding;, P:actin filament bundle assembly; P:isotype switching; P:negative regulation of actin filament depolymerization; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of peptidyl-serine dephosphorylation; P:positive regulation of actin filament bundle assembly; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of mast cell chemotaxis; P:regulation of protein localization;|Q9UH65 D3DQV1 O75135 Q7LCY6 Q9P061 Q9P0Z8,Switch-associated protein 70,, PF00169;, GO:0015629;GO:0005737;GO:0030027;GO:0005634;GO:0005886;GO:0005524;GO:0045296;GO:0005509;GO:0003677;GO:0051017;GO:0045190;GO:0030835;GO:0033633;GO:1902309;GO:0032233;GO:0007204;GO:0060754;GO:0032880;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:nucleus; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:calcium ion binding; F:DNA binding;, P:actin filament bundle assembly; P:isotype switching; P:negative regulation of actin filament depolymerization; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of peptidyl-serine dephosphorylation; P:positive regulation of actin filament bundle assembly; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of mast cell chemotaxis; P:regulation of protein localization;|Q9UH65 D3DQV1 O75135 Q7LCY6 Q9P061 Q9P0Z8,Switch-associated protein 70,, PF00169;, GO:0015629;GO:0005737;GO:0030027;GO:0005634;GO:0005886;GO:0005524;GO:0045296;GO:0005509;GO:0003677;GO:0051017;GO:0045190;GO:0030835;GO:0033633;GO:1902309;GO:0032233;GO:0007204;GO:0060754;GO:0032880;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:nucleus; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:calcium ion binding; F:DNA binding;, P:actin filament bundle assembly; P:isotype switching; P:negative regulation of actin filament depolymerization; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of peptidyl-serine dephosphorylation; P:positive regulation of actin filament bundle assembly; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of mast cell chemotaxis; P:regulation of protein localization;|Q9UH65 D3DQV1 O75135 Q7LCY6 Q9P061 Q9P0Z8,Switch-associated protein 70,, PF00169;, GO:0015629;GO:0005737;GO:0030027;GO:0005634;GO:0005886;GO:0005524;GO:0045296;GO:0005509;GO:0003677;GO:0051017;GO:0045190;GO:0030835;GO:0033633;GO:1902309;GO:0032233;GO:0007204;GO:0060754;GO:0032880;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium; C:nucleus; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:calcium ion binding; F:DNA binding;, P:actin filament bundle assembly; P:isotype switching; P:negative regulation of actin filament depolymerization; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of peptidyl-serine dephosphorylation; P:positive regulation of actin filament bundle assembly; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of mast cell chemotaxis; P:regulation of protein localization; scaffold19 indexed_genome mRNA 33203555 33254243 . - . ID=transcript_4827;Q9C097,Myotubularin-related protein 13 {ECO:0000305},Inactive phosphatidylinositol 3-phosphatase 13 {ECO:0000305};SET-binding factor 2 {ECO:0000303|PubMed:12554688};, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0030424;GO:0005829;GO:0010008;GO:0016020;GO:0048471;GO:0005085;GO:0019208;GO:0006914;GO:0042552;GO:0043087;, C:axon; C:cytosol; C:endosome membrane; C:membrane; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity;, P:autophagy; P:myelination; P:regulation of GTPase activity;|Q9C097,Myotubularin-related protein 13 {ECO:0000305},Inactive phosphatidylinositol 3-phosphatase 13 {ECO:0000305};SET-binding factor 2 {ECO:0000303|PubMed:12554688};, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0030424;GO:0005829;GO:0010008;GO:0016020;GO:0048471;GO:0005085;GO:0019208;GO:0006914;GO:0042552;GO:0043087;, C:axon; C:cytosol; C:endosome membrane; C:membrane; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity;, P:autophagy; P:myelination; P:regulation of GTPase activity;|Q9C097,Myotubularin-related protein 13 {ECO:0000305},Inactive phosphatidylinositol 3-phosphatase 13 {ECO:0000305};SET-binding factor 2 {ECO:0000303|PubMed:12554688};, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0030424;GO:0005829;GO:0010008;GO:0016020;GO:0048471;GO:0005085;GO:0019208;GO:0006914;GO:0042552;GO:0043087;, C:axon; C:cytosol; C:endosome membrane; C:membrane; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity;, P:autophagy; P:myelination; P:regulation of GTPase activity;|Q9C097,Myotubularin-related protein 13 {ECO:0000305},Inactive phosphatidylinositol 3-phosphatase 13 {ECO:0000305};SET-binding factor 2 {ECO:0000303|PubMed:12554688};, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0030424;GO:0005829;GO:0010008;GO:0016020;GO:0048471;GO:0005085;GO:0019208;GO:0006914;GO:0042552;GO:0043087;, C:axon; C:cytosol; C:endosome membrane; C:membrane; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity;, P:autophagy; P:myelination; P:regulation of GTPase activity;|Q9C097,Myotubularin-related protein 13 {ECO:0000305},Inactive phosphatidylinositol 3-phosphatase 13 {ECO:0000305};SET-binding factor 2 {ECO:0000303|PubMed:12554688};, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0030424;GO:0005829;GO:0010008;GO:0016020;GO:0048471;GO:0005085;GO:0019208;GO:0006914;GO:0042552;GO:0043087;, C:axon; C:cytosol; C:endosome membrane; C:membrane; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity;, P:autophagy; P:myelination; P:regulation of GTPase activity; scaffold19 indexed_genome mRNA 33258374 33458681 . - . ID=transcript_4828;Q9C097,Myotubularin-related protein 13 {ECO:0000305},Inactive phosphatidylinositol 3-phosphatase 13 {ECO:0000305};SET-binding factor 2 {ECO:0000303|PubMed:12554688};, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0030424;GO:0005829;GO:0010008;GO:0016020;GO:0048471;GO:0005085;GO:0019208;GO:0006914;GO:0042552;GO:0043087;, C:axon; C:cytosol; C:endosome membrane; C:membrane; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity;, P:autophagy; P:myelination; P:regulation of GTPase activity; scaffold20 indexed_genome mRNA 530824 573914 . + . ID=transcript_4829;Q9NRQ2 A8K2E9 Q2TTR3 Q658L3 Q6ZR73 Q7Z505,Phospholipid scramblase 4,Ca(2+)-dependent phospholipid scramblase 4;Cell growth-inhibiting gene 43 protein;TRA1;, PF03803;, GO:0016021;GO:0005886;GO:0005509;GO:0042609;GO:0019899;GO:0017128;GO:0017124;GO:0071222;GO:0017121;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:CD4 receptor binding; F:enzyme binding; F:phospholipid scramblase activity; F:SH3 domain binding;, P:cellular response to lipopolysaccharide; P:plasma membrane phospholipid scrambling;|Q9NRQ2 A8K2E9 Q2TTR3 Q658L3 Q6ZR73 Q7Z505,Phospholipid scramblase 4,Ca(2+)-dependent phospholipid scramblase 4;Cell growth-inhibiting gene 43 protein;TRA1;, PF03803;, GO:0016021;GO:0005886;GO:0005509;GO:0042609;GO:0019899;GO:0017128;GO:0017124;GO:0071222;GO:0017121;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:CD4 receptor binding; F:enzyme binding; F:phospholipid scramblase activity; F:SH3 domain binding;, P:cellular response to lipopolysaccharide; P:plasma membrane phospholipid scrambling;|Q9NRQ2 A8K2E9 Q2TTR3 Q658L3 Q6ZR73 Q7Z505,Phospholipid scramblase 4,Ca(2+)-dependent phospholipid scramblase 4;Cell growth-inhibiting gene 43 protein;TRA1;, PF03803;, GO:0016021;GO:0005886;GO:0005509;GO:0042609;GO:0019899;GO:0017128;GO:0017124;GO:0071222;GO:0017121;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:CD4 receptor binding; F:enzyme binding; F:phospholipid scramblase activity; F:SH3 domain binding;, P:cellular response to lipopolysaccharide; P:plasma membrane phospholipid scrambling; scaffold20 indexed_genome mRNA 615377 744675 . + . ID=transcript_4830;O00469 B3KWS3 Q59ED2 Q8N170,Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 {ECO:0000305},Lysyl hydroxylase 2;, PF03171;, GO:0005783;GO:0005789;GO:0070062;GO:0030867;GO:0005506;GO:0031418;GO:0008475;GO:0006464;GO:0030199;GO:0046947;GO:0017185;GO:0001666;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:rough endoplasmic reticulum membrane;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-lysine 5-dioxygenase activity;, P:cellular protein modification process; P:collagen fibril organization; P:hydroxylysine biosynthetic process; P:peptidyl-lysine hydroxylation; P:response to hypoxia; scaffold20 indexed_genome mRNA 3038181 3039715 . - . ID=transcript_4831;Q8NDZ4 B2RCF2 B7Z1W3,Divergent protein kinase domain 2A {ECO:0000305},Deleted in autism protein 1 {ECO:0000303|PubMed:18621663};Golgi Protein of 49 kDa {ECO:0000303|PubMed:18651652};Hypoxia and AKT-induced stem cell factor;, PF12260;, GO:0030126;GO:0005615;GO:0000139;GO:0060038;GO:0034392;GO:1900020;GO:0014066;, C:COPI vesicle coat; C:extracellular space; C:Golgi membrane;, , P:cardiac muscle cell proliferation; P:negative regulation of smooth muscle cell apoptotic process; P:positive regulation of protein kinase C activity; P:regulation of phosphatidylinositol 3-kinase signaling; scaffold20 indexed_genome mRNA 3041144 3044304 . - . ID=transcript_4832;Q8NDZ4 B2RCF2 B7Z1W3,Divergent protein kinase domain 2A {ECO:0000305},Deleted in autism protein 1 {ECO:0000303|PubMed:18621663};Golgi Protein of 49 kDa {ECO:0000303|PubMed:18651652};Hypoxia and AKT-induced stem cell factor;, PF12260;, GO:0030126;GO:0005615;GO:0000139;GO:0060038;GO:0034392;GO:1900020;GO:0014066;, C:COPI vesicle coat; C:extracellular space; C:Golgi membrane;, , P:cardiac muscle cell proliferation; P:negative regulation of smooth muscle cell apoptotic process; P:positive regulation of protein kinase C activity; P:regulation of phosphatidylinositol 3-kinase signaling; scaffold20 indexed_genome mRNA 3278420 3883226 . + . ID=transcript_4833;Q8IVB4 A6NMQ9 Q3LIC2 Q5JPI6 Q5WA58 Q8NAB9,Sodium/hydrogen exchanger 9,Na(+)/H(+) exchanger 9;Solute carrier family 9 member 9;, PF00999;, GO:0016021;GO:0031902;GO:0005886;GO:0055037;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:late endosome membrane; C:plasma membrane; C:recycling endosome;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q8IVB4 A6NMQ9 Q3LIC2 Q5JPI6 Q5WA58 Q8NAB9,Sodium/hydrogen exchanger 9,Na(+)/H(+) exchanger 9;Solute carrier family 9 member 9;, PF00999;, GO:0016021;GO:0031902;GO:0005886;GO:0055037;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:late endosome membrane; C:plasma membrane; C:recycling endosome;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane; scaffold20 indexed_genome mRNA 4038501 4043456 . - . ID=transcript_4834;Q9Y4C5 D3DNG5 Q2M370 Q9GZN5 Q9UED5 Q9Y6F2,Carbohydrate sulfotransferase 2,Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 2;N-acetylglucosamine 6-O-sulfotransferase 1;, PF00685;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0031228;GO:0005654;GO:0005802;GO:0001517;GO:0008146;GO:0005975;GO:0006954;GO:0018146;GO:0007275;GO:0006044;GO:0006790;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intrinsic component of Golgi membrane; C:nucleoplasm; C:trans-Golgi network;, F:N-acetylglucosamine 6-O-sulfotransferase activity; F:sulfotransferase activity;, P:carbohydrate metabolic process; P:inflammatory response; P:keratan sulfate biosynthetic process; P:multicellular organism development; P:N-acetylglucosamine metabolic process; P:sulfur compound metabolic process; scaffold20 indexed_genome mRNA 4109745 4156456 . - . ID=transcript_4835;O15042 A0PJ60 Q0D2M1 Q2NKQ7 Q9BR70,U2 snRNP-associated SURP motif-containing protein,140 kDa Ser/Arg-rich domain protein;U2-associated protein SR140;, PF04818;PF08312;PF00076;PF01805;, GO:0005654;GO:0005634;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splicing, via spliceosome;|O15042 A0PJ60 Q0D2M1 Q2NKQ7 Q9BR70,U2 snRNP-associated SURP motif-containing protein,140 kDa Ser/Arg-rich domain protein;U2-associated protein SR140;, PF04818;PF08312;PF00076;PF01805;, GO:0005654;GO:0005634;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splicing, via spliceosome;|O15042 A0PJ60 Q0D2M1 Q2NKQ7 Q9BR70,U2 snRNP-associated SURP motif-containing protein,140 kDa Ser/Arg-rich domain protein;U2-associated protein SR140;, PF04818;PF08312;PF00076;PF01805;, GO:0005654;GO:0005634;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splicing, via spliceosome;|O15042 A0PJ60 Q0D2M1 Q2NKQ7 Q9BR70,U2 snRNP-associated SURP motif-containing protein,140 kDa Ser/Arg-rich domain protein;U2-associated protein SR140;, PF04818;PF08312;PF00076;PF01805;, GO:0005654;GO:0005634;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splicing, via spliceosome;|O15042 A0PJ60 Q0D2M1 Q2NKQ7 Q9BR70,U2 snRNP-associated SURP motif-containing protein,140 kDa Ser/Arg-rich domain protein;U2-associated protein SR140;, PF04818;PF08312;PF00076;PF01805;, GO:0005654;GO:0005634;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splicing, via spliceosome;|O15042 A0PJ60 Q0D2M1 Q2NKQ7 Q9BR70,U2 snRNP-associated SURP motif-containing protein,140 kDa Ser/Arg-rich domain protein;U2-associated protein SR140;, PF04818;PF08312;PF00076;PF01805;, GO:0005654;GO:0005634;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splicing, via spliceosome; scaffold20 indexed_genome mRNA 4203199 4205303 . + . ID=transcript_4836;Q6ZVX9 Q147T6,Membrane progestin receptor epsilon {ECO:0000303|PubMed:23763432},Membrane progesterone P4 receptor epsilon {ECO:0000303|PubMed:23763432};Membrane progesterone receptor epsilon {ECO:0000303|PubMed:23763432};Progesterone and adipoQ receptor family member 9;Progestin and adipoQ receptor family member 9;Progestin and adipoQ receptor family member IX;, PF03006;, GO:0016021;GO:0005886;GO:0038023;GO:0005496;, C:integral component of membrane; C:plasma membrane;, F:signaling receptor activity; F:steroid binding; scaffold20 indexed_genome mRNA 4287992 4372105 . + . ID=transcript_4837;Q9UKZ9 B2RCH9 D3DNG4 Q9BRH3,Procollagen C-endopeptidase enhancer 2,Procollagen COOH-terminal proteinase enhancer 2;, PF00431;PF01759;, GO:0005576;GO:0005518;GO:0008201;GO:0016504;GO:1990830;, C:extracellular region;, F:collagen binding; F:heparin binding; F:peptidase activator activity;, P:cellular response to leukemia inhibitory factor; scaffold20 indexed_genome mRNA 4402189 4408232 . - . ID=transcript_4838;P48995 Q14CE4,Short transient receptor potential channel 1,Transient receptor protein 1;, PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0043235;GO:0051117;GO:0005262;GO:0005261;GO:0070679;GO:0044325;GO:0005102;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0042438;GO:0051281;GO:1903779;GO:0051480;GO:0051592;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATPase binding; F:calcium channel activity; F:cation channel activity; F:inositol 1,4,5 trisphosphate binding; F:ion channel binding; F:signaling receptor binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:melanin biosynthetic process; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:response to calcium ion;|P48995 Q14CE4,Short transient receptor potential channel 1,Transient receptor protein 1;, PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0043235;GO:0051117;GO:0005262;GO:0005261;GO:0070679;GO:0044325;GO:0005102;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0042438;GO:0051281;GO:1903779;GO:0051480;GO:0051592;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATPase binding; F:calcium channel activity; F:cation channel activity; F:inositol 1,4,5 trisphosphate binding; F:ion channel binding; F:signaling receptor binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:melanin biosynthetic process; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:response to calcium ion;|P48995 Q14CE4,Short transient receptor potential channel 1,Transient receptor protein 1;, PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0043235;GO:0051117;GO:0005262;GO:0005261;GO:0070679;GO:0044325;GO:0005102;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0042438;GO:0051281;GO:1903779;GO:0051480;GO:0051592;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATPase binding; F:calcium channel activity; F:cation channel activity; F:inositol 1,4,5 trisphosphate binding; F:ion channel binding; F:signaling receptor binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:melanin biosynthetic process; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:response to calcium ion; scaffold20 indexed_genome mRNA 4408976 4457865 . - . ID=transcript_4839;P48995 Q14CE4,Short transient receptor potential channel 1,Transient receptor protein 1;, PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0043235;GO:0051117;GO:0005262;GO:0005261;GO:0070679;GO:0044325;GO:0005102;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0042438;GO:0051281;GO:1903779;GO:0051480;GO:0051592;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATPase binding; F:calcium channel activity; F:cation channel activity; F:inositol 1,4,5 trisphosphate binding; F:ion channel binding; F:signaling receptor binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:melanin biosynthetic process; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:response to calcium ion;|P48995 Q14CE4,Short transient receptor potential channel 1,Transient receptor protein 1;, PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0043235;GO:0051117;GO:0005262;GO:0005261;GO:0070679;GO:0044325;GO:0005102;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0042438;GO:0051281;GO:1903779;GO:0051480;GO:0051592;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATPase binding; F:calcium channel activity; F:cation channel activity; F:inositol 1,4,5 trisphosphate binding; F:ion channel binding; F:signaling receptor binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:melanin biosynthetic process; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:response to calcium ion;|P48995 Q14CE4,Short transient receptor potential channel 1,Transient receptor protein 1;, PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0043235;GO:0051117;GO:0005262;GO:0005261;GO:0070679;GO:0044325;GO:0005102;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0042438;GO:0051281;GO:1903779;GO:0051480;GO:0051592;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATPase binding; F:calcium channel activity; F:cation channel activity; F:inositol 1,4,5 trisphosphate binding; F:ion channel binding; F:signaling receptor binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:melanin biosynthetic process; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:response to calcium ion;|P48995 Q14CE4,Short transient receptor potential channel 1,Transient receptor protein 1;, PF00520;PF08344;, GO:0034703;GO:0005887;GO:0005886;GO:0043235;GO:0051117;GO:0005262;GO:0005261;GO:0070679;GO:0044325;GO:0005102;GO:0015279;GO:0070588;GO:0006816;GO:0006828;GO:0042438;GO:0051281;GO:1903779;GO:0051480;GO:0051592;, C:cation channel complex; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATPase binding; F:calcium channel activity; F:cation channel activity; F:inositol 1,4,5 trisphosphate binding; F:ion channel binding; F:signaling receptor binding; F:store-operated calcium channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:manganese ion transport; P:melanin biosynthetic process; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:response to calcium ion; scaffold20 indexed_genome mRNA 4476630 4611125 . - . ID=transcript_4840;Q14651 A8K2Q1 D3DNG3 Q8NEG6,Plastin-1,Intestine-specific plastin;, PF00307;PF13499;, GO:0005884;GO:0032432;GO:0005903;GO:0005737;GO:0070062;GO:0032420;GO:1990357;GO:0051015;GO:0005509;GO:0005200;GO:0051017;GO:0051639;GO:0060088;GO:0001951;GO:0040018;GO:1903078;GO:0032532;GO:1902896;GO:0060121;, C:actin filament; C:actin filament bundle; C:brush border; C:cytoplasm; C:extracellular exosome; C:stereocilium; C:terminal web;, F:actin filament binding; F:calcium ion binding; F:structural constituent of cytoskeleton;, P:actin filament bundle assembly; P:actin filament network formation; P:auditory receptor cell stereocilium organization; P:intestinal D-glucose absorption; P:positive regulation of multicellular organism growth; P:positive regulation of protein localization to plasma membrane; P:regulation of microvillus length; P:terminal web assembly; P:vestibular receptor cell stereocilium organization;|P63208 D3DQ97 D3DQ98 P34991 Q8TAY2,S-phase kinase-associated protein 1,Cyclin-A/CDK2-associated protein p19;Organ of Corti protein 2;Organ of Corti protein II;RNA polymerase II elongation factor-like protein;SIII;Transcription elongation factor B polypeptide 1-like;p19skp1;, PF01466;PF03931;, GO:0005813;GO:0031467;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0008013;GO:0097602;GO:1990444;GO:0019904;GO:1990756;GO:0006879;GO:0038095;GO:0000086;GO:0035518;GO:0070498;GO:0051457;GO:0010972;GO:0038061;GO:1904668;GO:0043687;GO:0070936;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:cullin family protein binding; F:F-box domain binding; F:protein domain specific binding; F:ubiquitin ligase-substrate adaptor activity;, P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:histone H2A monoubiquitination; P:interleukin-1-mediated signaling pathway; P:maintenance of protein location in nucleus; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway;|Q14651 A8K2Q1 D3DNG3 Q8NEG6,Plastin-1,Intestine-specific plastin;, PF00307;PF13499;, GO:0005884;GO:0032432;GO:0005903;GO:0005737;GO:0070062;GO:0032420;GO:1990357;GO:0051015;GO:0005509;GO:0005200;GO:0051017;GO:0051639;GO:0060088;GO:0001951;GO:0040018;GO:1903078;GO:0032532;GO:1902896;GO:0060121;, C:actin filament; C:actin filament bundle; C:brush border; C:cytoplasm; C:extracellular exosome; C:stereocilium; C:terminal web;, F:actin filament binding; F:calcium ion binding; F:structural constituent of cytoskeleton;, P:actin filament bundle assembly; P:actin filament network formation; P:auditory receptor cell stereocilium organization; P:intestinal D-glucose absorption; P:positive regulation of multicellular organism growth; P:positive regulation of protein localization to plasma membrane; P:regulation of microvillus length; P:terminal web assembly; P:vestibular receptor cell stereocilium organization;|Q14651 A8K2Q1 D3DNG3 Q8NEG6,Plastin-1,Intestine-specific plastin;, PF00307;PF13499;, GO:0005884;GO:0032432;GO:0005903;GO:0005737;GO:0070062;GO:0032420;GO:1990357;GO:0051015;GO:0005509;GO:0005200;GO:0051017;GO:0051639;GO:0060088;GO:0001951;GO:0040018;GO:1903078;GO:0032532;GO:1902896;GO:0060121;, C:actin filament; C:actin filament bundle; C:brush border; C:cytoplasm; C:extracellular exosome; C:stereocilium; C:terminal web;, F:actin filament binding; F:calcium ion binding; F:structural constituent of cytoskeleton;, P:actin filament bundle assembly; P:actin filament network formation; P:auditory receptor cell stereocilium organization; P:intestinal D-glucose absorption; P:positive regulation of multicellular organism growth; P:positive regulation of protein localization to plasma membrane; P:regulation of microvillus length; P:terminal web assembly; P:vestibular receptor cell stereocilium organization;|Q14651 A8K2Q1 D3DNG3 Q8NEG6,Plastin-1,Intestine-specific plastin;, PF00307;PF13499;, GO:0005884;GO:0032432;GO:0005903;GO:0005737;GO:0070062;GO:0032420;GO:1990357;GO:0051015;GO:0005509;GO:0005200;GO:0051017;GO:0051639;GO:0060088;GO:0001951;GO:0040018;GO:1903078;GO:0032532;GO:1902896;GO:0060121;, C:actin filament; C:actin filament bundle; C:brush border; C:cytoplasm; C:extracellular exosome; C:stereocilium; C:terminal web;, F:actin filament binding; F:calcium ion binding; F:structural constituent of cytoskeleton;, P:actin filament bundle assembly; P:actin filament network formation; P:auditory receptor cell stereocilium organization; P:intestinal D-glucose absorption; P:positive regulation of multicellular organism growth; P:positive regulation of protein localization to plasma membrane; P:regulation of microvillus length; P:terminal web assembly; P:vestibular receptor cell stereocilium organization;|Q14651 A8K2Q1 D3DNG3 Q8NEG6,Plastin-1,Intestine-specific plastin;, PF00307;PF13499;, GO:0005884;GO:0032432;GO:0005903;GO:0005737;GO:0070062;GO:0032420;GO:1990357;GO:0051015;GO:0005509;GO:0005200;GO:0051017;GO:0051639;GO:0060088;GO:0001951;GO:0040018;GO:1903078;GO:0032532;GO:1902896;GO:0060121;, C:actin filament; C:actin filament bundle; C:brush border; C:cytoplasm; C:extracellular exosome; C:stereocilium; C:terminal web;, F:actin filament binding; F:calcium ion binding; F:structural constituent of cytoskeleton;, P:actin filament bundle assembly; P:actin filament network formation; P:auditory receptor cell stereocilium organization; P:intestinal D-glucose absorption; P:positive regulation of multicellular organism growth; P:positive regulation of protein localization to plasma membrane; P:regulation of microvillus length; P:terminal web assembly; P:vestibular receptor cell stereocilium organization; scaffold20 indexed_genome mRNA 4631448 4744425 . + . ID=transcript_4841;Q13535 Q59HB2 Q7KYL3 Q93051 Q9BXK4,Serine/threonine-protein kinase ATR,Ataxia telangiectasia and Rad3-related protein;FRAP-related protein 1;, PF02259;PF02260;PF00454;PF08064;, GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0003677;GO:0032405;GO:0032407;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006974;GO:0071480;GO:0034644;GO:0000077;GO:0006281;GO:0006260;GO:0097695;GO:0097694;GO:0036297;GO:0007275;GO:0008156;GO:0018105;GO:0043517;GO:1904884;GO:0032212;GO:0046777;GO:0070198;GO:1900034;GO:1901796;GO:0031297;GO:0090399;GO:0042493;GO:0000723;, C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:DNA binding; F:MutLalpha complex binding; F:MutSalpha complex binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:interstrand cross-link repair; P:multicellular organism development; P:negative regulation of DNA replication; P:peptidyl-serine phosphorylation; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to chromosome, telomeric region; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to drug; P:telomere maintenance;|Q13535 Q59HB2 Q7KYL3 Q93051 Q9BXK4,Serine/threonine-protein kinase ATR,Ataxia telangiectasia and Rad3-related protein;FRAP-related protein 1;, PF02259;PF02260;PF00454;PF08064;, GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0003677;GO:0032405;GO:0032407;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006974;GO:0071480;GO:0034644;GO:0000077;GO:0006281;GO:0006260;GO:0097695;GO:0097694;GO:0036297;GO:0007275;GO:0008156;GO:0018105;GO:0043517;GO:1904884;GO:0032212;GO:0046777;GO:0070198;GO:1900034;GO:1901796;GO:0031297;GO:0090399;GO:0042493;GO:0000723;, C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:DNA binding; F:MutLalpha complex binding; F:MutSalpha complex binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:interstrand cross-link repair; P:multicellular organism development; P:negative regulation of DNA replication; P:peptidyl-serine phosphorylation; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to chromosome, telomeric region; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to drug; P:telomere maintenance;|Q13535 Q59HB2 Q7KYL3 Q93051 Q9BXK4,Serine/threonine-protein kinase ATR,Ataxia telangiectasia and Rad3-related protein;FRAP-related protein 1;, PF02259;PF02260;PF00454;PF08064;, GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0003677;GO:0032405;GO:0032407;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006974;GO:0071480;GO:0034644;GO:0000077;GO:0006281;GO:0006260;GO:0097695;GO:0097694;GO:0036297;GO:0007275;GO:0008156;GO:0018105;GO:0043517;GO:1904884;GO:0032212;GO:0046777;GO:0070198;GO:1900034;GO:1901796;GO:0031297;GO:0090399;GO:0042493;GO:0000723;, C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:DNA binding; F:MutLalpha complex binding; F:MutSalpha complex binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:interstrand cross-link repair; P:multicellular organism development; P:negative regulation of DNA replication; P:peptidyl-serine phosphorylation; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to chromosome, telomeric region; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to drug; P:telomere maintenance;|Q13535 Q59HB2 Q7KYL3 Q93051 Q9BXK4,Serine/threonine-protein kinase ATR,Ataxia telangiectasia and Rad3-related protein;FRAP-related protein 1;, PF02259;PF02260;PF00454;PF08064;, GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0003677;GO:0032405;GO:0032407;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006974;GO:0071480;GO:0034644;GO:0000077;GO:0006281;GO:0006260;GO:0097695;GO:0097694;GO:0036297;GO:0007275;GO:0008156;GO:0018105;GO:0043517;GO:1904884;GO:0032212;GO:0046777;GO:0070198;GO:1900034;GO:1901796;GO:0031297;GO:0090399;GO:0042493;GO:0000723;, C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:DNA binding; F:MutLalpha complex binding; F:MutSalpha complex binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:interstrand cross-link repair; P:multicellular organism development; P:negative regulation of DNA replication; P:peptidyl-serine phosphorylation; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to chromosome, telomeric region; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to drug; P:telomere maintenance;|Q13535 Q59HB2 Q7KYL3 Q93051 Q9BXK4,Serine/threonine-protein kinase ATR,Ataxia telangiectasia and Rad3-related protein;FRAP-related protein 1;, PF02259;PF02260;PF00454;PF08064;, GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0003677;GO:0032405;GO:0032407;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006974;GO:0071480;GO:0034644;GO:0000077;GO:0006281;GO:0006260;GO:0097695;GO:0097694;GO:0036297;GO:0007275;GO:0008156;GO:0018105;GO:0043517;GO:1904884;GO:0032212;GO:0046777;GO:0070198;GO:1900034;GO:1901796;GO:0031297;GO:0090399;GO:0042493;GO:0000723;, C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:DNA binding; F:MutLalpha complex binding; F:MutSalpha complex binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:interstrand cross-link repair; P:multicellular organism development; P:negative regulation of DNA replication; P:peptidyl-serine phosphorylation; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to chromosome, telomeric region; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to drug; P:telomere maintenance;|Q13535 Q59HB2 Q7KYL3 Q93051 Q9BXK4,Serine/threonine-protein kinase ATR,Ataxia telangiectasia and Rad3-related protein;FRAP-related protein 1;, PF02259;PF02260;PF00454;PF08064;, GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0003677;GO:0032405;GO:0032407;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006974;GO:0071480;GO:0034644;GO:0000077;GO:0006281;GO:0006260;GO:0097695;GO:0097694;GO:0036297;GO:0007275;GO:0008156;GO:0018105;GO:0043517;GO:1904884;GO:0032212;GO:0046777;GO:0070198;GO:1900034;GO:1901796;GO:0031297;GO:0090399;GO:0042493;GO:0000723;, C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:DNA binding; F:MutLalpha complex binding; F:MutSalpha complex binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:interstrand cross-link repair; P:multicellular organism development; P:negative regulation of DNA replication; P:peptidyl-serine phosphorylation; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to chromosome, telomeric region; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to drug; P:telomere maintenance;|Q13535 Q59HB2 Q7KYL3 Q93051 Q9BXK4,Serine/threonine-protein kinase ATR,Ataxia telangiectasia and Rad3-related protein;FRAP-related protein 1;, PF02259;PF02260;PF00454;PF08064;, GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0003677;GO:0032405;GO:0032407;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006974;GO:0071480;GO:0034644;GO:0000077;GO:0006281;GO:0006260;GO:0097695;GO:0097694;GO:0036297;GO:0007275;GO:0008156;GO:0018105;GO:0043517;GO:1904884;GO:0032212;GO:0046777;GO:0070198;GO:1900034;GO:1901796;GO:0031297;GO:0090399;GO:0042493;GO:0000723;, C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:DNA binding; F:MutLalpha complex binding; F:MutSalpha complex binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:interstrand cross-link repair; P:multicellular organism development; P:negative regulation of DNA replication; P:peptidyl-serine phosphorylation; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to chromosome, telomeric region; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to drug; P:telomere maintenance;|Q13535 Q59HB2 Q7KYL3 Q93051 Q9BXK4,Serine/threonine-protein kinase ATR,Ataxia telangiectasia and Rad3-related protein;FRAP-related protein 1;, PF02259;PF02260;PF00454;PF08064;, GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0003677;GO:0032405;GO:0032407;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006974;GO:0071480;GO:0034644;GO:0000077;GO:0006281;GO:0006260;GO:0097695;GO:0097694;GO:0036297;GO:0007275;GO:0008156;GO:0018105;GO:0043517;GO:1904884;GO:0032212;GO:0046777;GO:0070198;GO:1900034;GO:1901796;GO:0031297;GO:0090399;GO:0042493;GO:0000723;, C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:DNA binding; F:MutLalpha complex binding; F:MutSalpha complex binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:interstrand cross-link repair; P:multicellular organism development; P:negative regulation of DNA replication; P:peptidyl-serine phosphorylation; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to chromosome, telomeric region; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to drug; P:telomere maintenance; scaffold20 indexed_genome mRNA 4745177 4854132 . + . ID=transcript_4842;Q8IZH2 Q4G0S3 Q68D88 Q6AI24 Q6MZS8 Q86WS7 Q8N8U4 Q9UF39,5'-3' exoribonuclease 1,Strand-exchange protein 1 homolog;, PF18129;PF18332;PF18334;PF17846;PF03159;, GO:0005829;GO:0030425;GO:0016020;GO:0043025;GO:0005634;GO:0000932;GO:0005886;GO:0045202;GO:0004534;GO:0051880;GO:0002151;GO:0003723;GO:0070034;GO:0071409;GO:1905795;GO:0071044;GO:0032211;GO:0017148;GO:0071028;GO:0000956;GO:0043488;GO:0033574;GO:0090503;GO:0016075;, C:cytosol; C:dendrite; C:membrane; C:neuronal cell body; C:nucleus; C:P-body; C:plasma membrane; C:synapse;, F:5'-3' exoribonuclease activity; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:RNA binding; F:telomerase RNA binding;, P:cellular response to cycloheximide; P:cellular response to puromycin; P:histone mRNA catabolic process; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of translation; P:nuclear mRNA surveillance; P:nuclear-transcribed mRNA catabolic process; P:regulation of mRNA stability; P:response to testosterone; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:rRNA catabolic process;|Q8IZH2 Q4G0S3 Q68D88 Q6AI24 Q6MZS8 Q86WS7 Q8N8U4 Q9UF39,5'-3' exoribonuclease 1,Strand-exchange protein 1 homolog;, PF18129;PF18332;PF18334;PF17846;PF03159;, GO:0005829;GO:0030425;GO:0016020;GO:0043025;GO:0005634;GO:0000932;GO:0005886;GO:0045202;GO:0004534;GO:0051880;GO:0002151;GO:0003723;GO:0070034;GO:0071409;GO:1905795;GO:0071044;GO:0032211;GO:0017148;GO:0071028;GO:0000956;GO:0043488;GO:0033574;GO:0090503;GO:0016075;, C:cytosol; C:dendrite; C:membrane; C:neuronal cell body; C:nucleus; C:P-body; C:plasma membrane; C:synapse;, F:5'-3' exoribonuclease activity; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:RNA binding; F:telomerase RNA binding;, P:cellular response to cycloheximide; P:cellular response to puromycin; P:histone mRNA catabolic process; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of translation; P:nuclear mRNA surveillance; P:nuclear-transcribed mRNA catabolic process; P:regulation of mRNA stability; P:response to testosterone; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:rRNA catabolic process;|Q8IZH2 Q4G0S3 Q68D88 Q6AI24 Q6MZS8 Q86WS7 Q8N8U4 Q9UF39,5'-3' exoribonuclease 1,Strand-exchange protein 1 homolog;, PF18129;PF18332;PF18334;PF17846;PF03159;, GO:0005829;GO:0030425;GO:0016020;GO:0043025;GO:0005634;GO:0000932;GO:0005886;GO:0045202;GO:0004534;GO:0051880;GO:0002151;GO:0003723;GO:0070034;GO:0071409;GO:1905795;GO:0071044;GO:0032211;GO:0017148;GO:0071028;GO:0000956;GO:0043488;GO:0033574;GO:0090503;GO:0016075;, C:cytosol; C:dendrite; C:membrane; C:neuronal cell body; C:nucleus; C:P-body; C:plasma membrane; C:synapse;, F:5'-3' exoribonuclease activity; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:RNA binding; F:telomerase RNA binding;, P:cellular response to cycloheximide; P:cellular response to puromycin; P:histone mRNA catabolic process; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of translation; P:nuclear mRNA surveillance; P:nuclear-transcribed mRNA catabolic process; P:regulation of mRNA stability; P:response to testosterone; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:rRNA catabolic process;|Q8IZH2 Q4G0S3 Q68D88 Q6AI24 Q6MZS8 Q86WS7 Q8N8U4 Q9UF39,5'-3' exoribonuclease 1,Strand-exchange protein 1 homolog;, PF18129;PF18332;PF18334;PF17846;PF03159;, GO:0005829;GO:0030425;GO:0016020;GO:0043025;GO:0005634;GO:0000932;GO:0005886;GO:0045202;GO:0004534;GO:0051880;GO:0002151;GO:0003723;GO:0070034;GO:0071409;GO:1905795;GO:0071044;GO:0032211;GO:0017148;GO:0071028;GO:0000956;GO:0043488;GO:0033574;GO:0090503;GO:0016075;, C:cytosol; C:dendrite; C:membrane; C:neuronal cell body; C:nucleus; C:P-body; C:plasma membrane; C:synapse;, F:5'-3' exoribonuclease activity; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:RNA binding; F:telomerase RNA binding;, P:cellular response to cycloheximide; P:cellular response to puromycin; P:histone mRNA catabolic process; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of translation; P:nuclear mRNA surveillance; P:nuclear-transcribed mRNA catabolic process; P:regulation of mRNA stability; P:response to testosterone; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:rRNA catabolic process; scaffold20 indexed_genome mRNA 4889049 4972207 . + . ID=transcript_4843;Q6ZS86 B2R9I2 D3DNG2 Q8N2A7 Q8N5E6,Putative glycerol kinase 5,ATP:glycerol 3-phosphotransferase 5;, PF02782;PF00370;, GO:0005739;GO:0005524;GO:0004370;GO:0016773;GO:0019563;GO:0006071;GO:0046167;GO:0016310;GO:0006641;, C:mitochondrion;, F:ATP binding; F:glycerol kinase activity; F:phosphotransferase activity, alcohol group as acceptor;, P:glycerol catabolic process; P:glycerol metabolic process; P:glycerol-3-phosphate biosynthetic process; P:phosphorylation; P:triglyceride metabolic process;|Q6ZS86 B2R9I2 D3DNG2 Q8N2A7 Q8N5E6,Putative glycerol kinase 5,ATP:glycerol 3-phosphotransferase 5;, PF02782;PF00370;, GO:0005739;GO:0005524;GO:0004370;GO:0016773;GO:0019563;GO:0006071;GO:0046167;GO:0016310;GO:0006641;, C:mitochondrion;, F:ATP binding; F:glycerol kinase activity; F:phosphotransferase activity, alcohol group as acceptor;, P:glycerol catabolic process; P:glycerol metabolic process; P:glycerol-3-phosphate biosynthetic process; P:phosphorylation; P:triglyceride metabolic process; scaffold20 indexed_genome mRNA 4985153 5197117 . + . ID=transcript_4844;Q8WU88 Q9UG28,Transcription factor Dp-2,E2F dimerization partner 2;, PF08781;PF02319;, GO:0000785;GO:0005739;GO:0072686;GO:0005654;GO:0005634;GO:0090575;GO:0003677;GO:0000981;GO:0019904;GO:0008134;GO:0006977;GO:0007507;GO:0070317;GO:0045892;GO:1900740;GO:0045944;GO:0006357;GO:0000083;, C:chromatin; C:mitochondrion; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:heart development; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q8WU88 Q9UG28,Transcription factor Dp-2,E2F dimerization partner 2;, PF08781;PF02319;, GO:0000785;GO:0005739;GO:0072686;GO:0005654;GO:0005634;GO:0090575;GO:0003677;GO:0000981;GO:0019904;GO:0008134;GO:0006977;GO:0007507;GO:0070317;GO:0045892;GO:1900740;GO:0045944;GO:0006357;GO:0000083;, C:chromatin; C:mitochondrion; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:heart development; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; scaffold20 indexed_genome mRNA 5218562 5241904 . - . ID=transcript_4845;P54709 B7Z1N7,Sodium/potassium-transporting ATPase subunit beta-3,Sodium/potassium-dependent ATPase subunit beta-3;, PF00287;, GO:0005901;GO:0070062;GO:0042470;GO:0005886;GO:0005890;GO:0036126;GO:0001671;GO:0051117;GO:0005391;GO:0030674;GO:0030007;GO:0006883;GO:0034220;GO:0050900;GO:0086009;GO:0032781;GO:1903288;GO:1901018;GO:1903278;GO:1990573;GO:0071805;GO:0072659;GO:0050821;GO:1903779;GO:0036376;GO:0035725;, C:caveola; C:extracellular exosome; C:melanosome; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum;, F:ATPase activator activity; F:ATPase binding; F:P-type sodium:potassium-exchanging ATPase activity; F:protein-macromolecule adaptor activity;, P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:leukocyte migration; P:membrane repolarization; P:positive regulation of ATPase activity; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of sodium ion export across plasma membrane; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:protein localization to plasma membrane; P:protein stabilization; P:regulation of cardiac conduction; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport;|P54709 B7Z1N7,Sodium/potassium-transporting ATPase subunit beta-3,Sodium/potassium-dependent ATPase subunit beta-3;, PF00287;, GO:0005901;GO:0070062;GO:0042470;GO:0005886;GO:0005890;GO:0036126;GO:0001671;GO:0051117;GO:0005391;GO:0030674;GO:0030007;GO:0006883;GO:0034220;GO:0050900;GO:0086009;GO:0032781;GO:1903288;GO:1901018;GO:1903278;GO:1990573;GO:0071805;GO:0072659;GO:0050821;GO:1903779;GO:0036376;GO:0035725;, C:caveola; C:extracellular exosome; C:melanosome; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum;, F:ATPase activator activity; F:ATPase binding; F:P-type sodium:potassium-exchanging ATPase activity; F:protein-macromolecule adaptor activity;, P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:leukocyte migration; P:membrane repolarization; P:positive regulation of ATPase activity; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of sodium ion export across plasma membrane; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:protein localization to plasma membrane; P:protein stabilization; P:regulation of cardiac conduction; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport;|P54709 B7Z1N7,Sodium/potassium-transporting ATPase subunit beta-3,Sodium/potassium-dependent ATPase subunit beta-3;, PF00287;, GO:0005901;GO:0070062;GO:0042470;GO:0005886;GO:0005890;GO:0036126;GO:0001671;GO:0051117;GO:0005391;GO:0030674;GO:0030007;GO:0006883;GO:0034220;GO:0050900;GO:0086009;GO:0032781;GO:1903288;GO:1901018;GO:1903278;GO:1990573;GO:0071805;GO:0072659;GO:0050821;GO:1903779;GO:0036376;GO:0035725;, C:caveola; C:extracellular exosome; C:melanosome; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum;, F:ATPase activator activity; F:ATPase binding; F:P-type sodium:potassium-exchanging ATPase activity; F:protein-macromolecule adaptor activity;, P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:leukocyte migration; P:membrane repolarization; P:positive regulation of ATPase activity; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of sodium ion export across plasma membrane; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:protein localization to plasma membrane; P:protein stabilization; P:regulation of cardiac conduction; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; scaffold20 indexed_genome mRNA 5320589 5399793 . - . ID=transcript_4846;Q8WTQ7,Rhodopsin kinase GRK7,G protein-coupled receptor kinase 7;G protein-coupled receptor kinase GRK7;, PF00069;PF00615;, GO:0097381;GO:0005524;GO:0004703;GO:0050254;GO:0046777;GO:0022400;GO:0007165;GO:0007601;, C:photoreceptor disc membrane;, F:ATP binding; F:G protein-coupled receptor kinase activity; F:rhodopsin kinase activity;, P:protein autophosphorylation; P:regulation of rhodopsin mediated signaling pathway; P:signal transduction; P:visual perception;|Q9UBF6 A8K1H9 A8MTB5 C9JYL3 D3DNF7 D3DNF8 Q9BXN8 Q9Y5M7,RING-box protein 2,CKII beta-binding protein 1;RING finger protein 7;Regulator of cullins 2;Sensitive to apoptosis gene protein;, PF12678;, GO:0031466;GO:0031461;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005507;GO:0097602;GO:0061663;GO:0061630;GO:0008270;GO:0043687;GO:0045116;GO:0016567;GO:0051775;GO:0006511;, C:Cul5-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:copper ion binding; F:cullin family protein binding; F:NEDD8 ligase activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:post-translational protein modification; P:protein neddylation; P:protein ubiquitination; P:response to redox state; P:ubiquitin-dependent protein catabolic process;|Q9UBF6 A8K1H9 A8MTB5 C9JYL3 D3DNF7 D3DNF8 Q9BXN8 Q9Y5M7,RING-box protein 2,CKII beta-binding protein 1;RING finger protein 7;Regulator of cullins 2;Sensitive to apoptosis gene protein;, PF12678;, GO:0031466;GO:0031461;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005507;GO:0097602;GO:0061663;GO:0061630;GO:0008270;GO:0043687;GO:0045116;GO:0016567;GO:0051775;GO:0006511;, C:Cul5-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:copper ion binding; F:cullin family protein binding; F:NEDD8 ligase activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:post-translational protein modification; P:protein neddylation; P:protein ubiquitination; P:response to redox state; P:ubiquitin-dependent protein catabolic process; scaffold20 indexed_genome mRNA 5509965 5607961 . - . ID=transcript_4847;Q15283 A8K7K1 G3V0F9 O00695 Q15284 Q92594 Q99577 Q9UEQ2,Ras GTPase-activating protein 2,GTPase-activating protein 1m;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0048471;GO:0005096;GO:0046872;GO:0005543;GO:0000165;GO:0046580;GO:0007165;, C:cytosol; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:signal transduction;|Q15283 A8K7K1 G3V0F9 O00695 Q15284 Q92594 Q99577 Q9UEQ2,Ras GTPase-activating protein 2,GTPase-activating protein 1m;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0048471;GO:0005096;GO:0046872;GO:0005543;GO:0000165;GO:0046580;GO:0007165;, C:cytosol; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:signal transduction;|Q15283 A8K7K1 G3V0F9 O00695 Q15284 Q92594 Q99577 Q9UEQ2,Ras GTPase-activating protein 2,GTPase-activating protein 1m;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0048471;GO:0005096;GO:0046872;GO:0005543;GO:0000165;GO:0046580;GO:0007165;, C:cytosol; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:signal transduction;|Q15283 A8K7K1 G3V0F9 O00695 Q15284 Q92594 Q99577 Q9UEQ2,Ras GTPase-activating protein 2,GTPase-activating protein 1m;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0048471;GO:0005096;GO:0046872;GO:0005543;GO:0000165;GO:0046580;GO:0007165;, C:cytosol; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:signal transduction; scaffold20 indexed_genome mRNA 5700605 5745235 . - . ID=transcript_4848;Q8NAP3 D3DNF6,Zinc finger and BTB domain-containing protein 38,, PF00651;PF00096;, GO:0072562;GO:0005694;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0008327;GO:0042803;GO:0000978;GO:0006974;GO:0045892;GO:0045944;GO:0006275;GO:0006355;, C:blood microparticle; C:chromosome; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:methyl-CpG binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to DNA damage stimulus; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA replication; P:regulation of transcription, DNA-templated; scaffold20 indexed_genome mRNA 5855072 5930205 . - . ID=transcript_4849;Q8TE99 D3DNF5 Q49AJ2 W0TR04,2-phosphoxylose phosphatase 1 {ECO:0000303|PubMed:24425863},Acid phosphatase-like protein 2;Xylosyl phosphatase {ECO:0000303|PubMed:24425863, ECO:0000312|EMBL:BAO45795.1};epididymis luminal protein 124 {ECO:0000303|Ref.2, ECO:0000312|EMBL:ACJ13731.1};, PF00328;, GO:0005794;GO:0000139;GO:0016021;GO:0016791;GO:0050650;GO:0016311;GO:0006024;GO:0010909;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:phosphatase activity;, P:chondroitin sulfate proteoglycan biosynthetic process; P:dephosphorylation; P:glycosaminoglycan biosynthetic process; P:positive regulation of heparan sulfate proteoglycan biosynthetic process;|Q8TE99 D3DNF5 Q49AJ2 W0TR04,2-phosphoxylose phosphatase 1 {ECO:0000303|PubMed:24425863},Acid phosphatase-like protein 2;Xylosyl phosphatase {ECO:0000303|PubMed:24425863, ECO:0000312|EMBL:BAO45795.1};epididymis luminal protein 124 {ECO:0000303|Ref.2, ECO:0000312|EMBL:ACJ13731.1};, PF00328;, GO:0005794;GO:0000139;GO:0016021;GO:0016791;GO:0050650;GO:0016311;GO:0006024;GO:0010909;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:phosphatase activity;, P:chondroitin sulfate proteoglycan biosynthetic process; P:dephosphorylation; P:glycosaminoglycan biosynthetic process; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; scaffold20 indexed_genome mRNA 6153837 6194478 . - . ID=transcript_4850;Q96CQ1 A8MYF7 Q05CY1 Q9H0G8 Q9NVN5,Solute carrier family 25 member 36,, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015218;GO:0000002;GO:0007005;GO:1990519;GO:0006864;GO:0051881;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:pyrimidine nucleotide transmembrane transporter activity;, P:mitochondrial genome maintenance; P:mitochondrion organization; P:pyrimidine nucleotide import into mitochondrion; P:pyrimidine nucleotide transport; P:regulation of mitochondrial membrane potential;|Q96CQ1 A8MYF7 Q05CY1 Q9H0G8 Q9NVN5,Solute carrier family 25 member 36,, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015218;GO:0000002;GO:0007005;GO:1990519;GO:0006864;GO:0051881;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:pyrimidine nucleotide transmembrane transporter activity;, P:mitochondrial genome maintenance; P:mitochondrion organization; P:pyrimidine nucleotide import into mitochondrion; P:pyrimidine nucleotide transport; P:regulation of mitochondrial membrane potential;|Q96CQ1 A8MYF7 Q05CY1 Q9H0G8 Q9NVN5,Solute carrier family 25 member 36,, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015218;GO:0000002;GO:0007005;GO:1990519;GO:0006864;GO:0051881;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:pyrimidine nucleotide transmembrane transporter activity;, P:mitochondrial genome maintenance; P:mitochondrion organization; P:pyrimidine nucleotide import into mitochondrion; P:pyrimidine nucleotide transport; P:regulation of mitochondrial membrane potential;|Q96CQ1 A8MYF7 Q05CY1 Q9H0G8 Q9NVN5,Solute carrier family 25 member 36,, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015218;GO:0000002;GO:0007005;GO:1990519;GO:0006864;GO:0051881;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:pyrimidine nucleotide transmembrane transporter activity;, P:mitochondrial genome maintenance; P:mitochondrion organization; P:pyrimidine nucleotide import into mitochondrion; P:pyrimidine nucleotide transport; P:regulation of mitochondrial membrane potential;|Q96CQ1 A8MYF7 Q05CY1 Q9H0G8 Q9NVN5,Solute carrier family 25 member 36,, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015218;GO:0000002;GO:0007005;GO:1990519;GO:0006864;GO:0051881;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:pyrimidine nucleotide transmembrane transporter activity;, P:mitochondrial genome maintenance; P:mitochondrion organization; P:pyrimidine nucleotide import into mitochondrion; P:pyrimidine nucleotide transport; P:regulation of mitochondrial membrane potential; scaffold20 indexed_genome mRNA 7488745 7621486 . + . ID=transcript_4851;Q96T66 B3KVR6 D3DNF2 D3DNF3 Q8N4G1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 {ECO:0000305},Nicotinamide-nucleotide adenylyltransferase 3;Nicotinate-nucleotide adenylyltransferase 3;Pyridine nucleotide adenylyltransferase 3;, PF01467;, GO:0005759;GO:0005739;GO:0005634;GO:0005524;GO:0000309;GO:0004515;GO:0009435;GO:0019674;GO:0009165;, C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:ATP binding; F:nicotinamide-nucleotide adenylyltransferase activity; F:nicotinate-nucleotide adenylyltransferase activity;, P:NAD biosynthetic process; P:NAD metabolic process; P:nucleotide biosynthetic process; scaffold20 indexed_genome mRNA 7653766 7680407 . + . ID=transcript_4852;P09455 A8K2Q0 B7Z7A0 E7EWV0 F2Z2F2 Q6FGX8,Retinol-binding protein 1,Cellular retinol-binding protein;Cellular retinol-binding protein I;, PF00061;, GO:0005829;GO:0005811;GO:0005654;GO:1904768;GO:0016918;GO:0005501;GO:0055088;GO:0002138;GO:0001523;GO:0006776;, C:cytosol; C:lipid droplet; C:nucleoplasm;, F:all-trans-retinol binding; F:retinal binding; F:retinoid binding;, P:lipid homeostasis; P:retinoic acid biosynthetic process; P:retinoid metabolic process; P:vitamin A metabolic process; scaffold20 indexed_genome mRNA 7825396 7868538 . - . ID=transcript_4853;P35606 B4DZI8,Coatomer subunit beta',Beta'-coat protein;p102;, PF04053;PF00400;, GO:0030126;GO:0005829;GO:0005789;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0006890;GO:1901998;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:toxin transport;|P35606 B4DZI8,Coatomer subunit beta',Beta'-coat protein;p102;, PF04053;PF00400;, GO:0030126;GO:0005829;GO:0005789;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0006890;GO:1901998;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:toxin transport;|P35606 B4DZI8,Coatomer subunit beta',Beta'-coat protein;p102;, PF04053;PF00400;, GO:0030126;GO:0005829;GO:0005789;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0006890;GO:1901998;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:toxin transport;|P35606 B4DZI8,Coatomer subunit beta',Beta'-coat protein;p102;, PF04053;PF00400;, GO:0030126;GO:0005829;GO:0005789;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0006890;GO:1901998;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:toxin transport;|P35606 B4DZI8,Coatomer subunit beta',Beta'-coat protein;p102;, PF04053;PF00400;, GO:0030126;GO:0005829;GO:0005789;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0006890;GO:1901998;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:toxin transport;|P82650 Q9H3I1,28S ribosomal protein S22, mitochondrial,Mitochondrial small ribosomal subunit protein mS22 {ECO:0000303|PubMed:25838379};, PF10245;, GO:0005743;GO:0005761;GO:0005763;GO:0005739;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial ribosome; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|P82650 Q9H3I1,28S ribosomal protein S22, mitochondrial,Mitochondrial small ribosomal subunit protein mS22 {ECO:0000303|PubMed:25838379};, PF10245;, GO:0005743;GO:0005761;GO:0005763;GO:0005739;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial ribosome; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|P82650 Q9H3I1,28S ribosomal protein S22, mitochondrial,Mitochondrial small ribosomal subunit protein mS22 {ECO:0000303|PubMed:25838379};, PF10245;, GO:0005743;GO:0005761;GO:0005763;GO:0005739;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial ribosome; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|P82650 Q9H3I1,28S ribosomal protein S22, mitochondrial,Mitochondrial small ribosomal subunit protein mS22 {ECO:0000303|PubMed:25838379};, PF10245;, GO:0005743;GO:0005761;GO:0005763;GO:0005739;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial ribosome; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold20 indexed_genome mRNA 8499122 8521352 . - . ID=transcript_4854;Q8NHQ1 B7Z5I8 B7Z7E8 D3DNE9 F5GZX8 Q96B31 Q9H2C3 Q9H2Z1 Q9H940,Centrosomal protein of 70 kDa,p10-binding protein;, , GO:0005813;GO:0005829;GO:0043015;GO:0042802;GO:0097711;GO:0000086;GO:0010389;GO:0070507;, C:centrosome; C:cytosol;, F:gamma-tubulin binding; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule cytoskeleton organization; scaffold20 indexed_genome mRNA 8539798 8563272 . + . ID=transcript_4855;Q9NVQ4 Q6IAN2,Fas apoptotic inhibitory molecule 1,, PF06905;, GO:0005737;GO:0006915;GO:0007249;GO:1902042;GO:0050769;, C:cytoplasm;, , P:apoptotic process; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of neurogenesis; scaffold20 indexed_genome mRNA 8575748 8577347 . - . ID=transcript_4856;P42338 D3DNF0 Q24JU2,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta;, PF00454;PF00792;PF02192;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0030496;GO:0005730;GO:0005654;GO:0005634;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0000187;GO:0006914;GO:0007411;GO:0016477;GO:0006935;GO:0019221;GO:0006897;GO:0038095;GO:0038096;GO:0007186;GO:0050900;GO:0000165;GO:0043407;GO:0051898;GO:1903671;GO:1900747;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0030168;GO:0070527;GO:0010508;GO:0010595;GO:0010628;GO:0033031;GO:0051000;GO:0014068;GO:0051897;GO:0035022;GO:0001952;GO:2000369;GO:0002931;GO:0007165;GO:0003376;GO:0050852;GO:0007169;GO:0048010;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:midbody; C:nucleolus; C:nucleoplasm; C:nucleus; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:activation of MAPK activity; P:autophagy; P:axon guidance; P:cell migration; P:chemotaxis; P:cytokine-mediated signaling pathway; P:endocytosis; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:negative regulation of MAP kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of sprouting angiogenesis; P:negative regulation of vascular endothelial growth factor signaling pathway; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:platelet activation; P:platelet aggregation; P:positive regulation of autophagy; P:positive regulation of endothelial cell migration; P:positive regulation of gene expression; P:positive regulation of neutrophil apoptotic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of Rac protein signal transduction; P:regulation of cell-matrix adhesion; P:regulation of clathrin-dependent endocytosis; P:response to ischemia; P:signal transduction; P:sphingosine-1-phosphate receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold20 indexed_genome mRNA 8714708 8814208 . + . ID=transcript_4857;P42338 D3DNF0 Q24JU2,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta;, PF00454;PF00792;PF02192;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0030496;GO:0005730;GO:0005654;GO:0005634;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0000187;GO:0006914;GO:0007411;GO:0016477;GO:0006935;GO:0019221;GO:0006897;GO:0038095;GO:0038096;GO:0007186;GO:0050900;GO:0000165;GO:0043407;GO:0051898;GO:1903671;GO:1900747;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0030168;GO:0070527;GO:0010508;GO:0010595;GO:0010628;GO:0033031;GO:0051000;GO:0014068;GO:0051897;GO:0035022;GO:0001952;GO:2000369;GO:0002931;GO:0007165;GO:0003376;GO:0050852;GO:0007169;GO:0048010;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:midbody; C:nucleolus; C:nucleoplasm; C:nucleus; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:activation of MAPK activity; P:autophagy; P:axon guidance; P:cell migration; P:chemotaxis; P:cytokine-mediated signaling pathway; P:endocytosis; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:negative regulation of MAP kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of sprouting angiogenesis; P:negative regulation of vascular endothelial growth factor signaling pathway; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:platelet activation; P:platelet aggregation; P:positive regulation of autophagy; P:positive regulation of endothelial cell migration; P:positive regulation of gene expression; P:positive regulation of neutrophil apoptotic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of Rac protein signal transduction; P:regulation of cell-matrix adhesion; P:regulation of clathrin-dependent endocytosis; P:response to ischemia; P:signal transduction; P:sphingosine-1-phosphate receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold20 indexed_genome mRNA 8827864 8842486 . - . ID=transcript_4858;Q9NVQ4 Q6IAN2,Fas apoptotic inhibitory molecule 1,, PF06905;, GO:0005737;GO:0006915;GO:0007249;GO:1902042;GO:0050769;, C:cytoplasm;, , P:apoptotic process; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of neurogenesis;|Q9NVQ4 Q6IAN2,Fas apoptotic inhibitory molecule 1,, PF06905;, GO:0005737;GO:0006915;GO:0007249;GO:1902042;GO:0050769;, C:cytoplasm;, , P:apoptotic process; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of neurogenesis; scaffold20 indexed_genome mRNA 8904436 8942638 . + . ID=transcript_4859;Q8NHQ1 B7Z5I8 B7Z7E8 D3DNE9 F5GZX8 Q96B31 Q9H2C3 Q9H2Z1 Q9H940,Centrosomal protein of 70 kDa,p10-binding protein;, , GO:0005813;GO:0005829;GO:0043015;GO:0042802;GO:0097711;GO:0000086;GO:0010389;GO:0070507;, C:centrosome; C:cytosol;, F:gamma-tubulin binding; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule cytoskeleton organization;|Q8NHQ1 B7Z5I8 B7Z7E8 D3DNE9 F5GZX8 Q96B31 Q9H2C3 Q9H2Z1 Q9H940,Centrosomal protein of 70 kDa,p10-binding protein;, , GO:0005813;GO:0005829;GO:0043015;GO:0042802;GO:0097711;GO:0000086;GO:0010389;GO:0070507;, C:centrosome; C:cytosol;, F:gamma-tubulin binding; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule cytoskeleton organization;|Q8NHQ1 B7Z5I8 B7Z7E8 D3DNE9 F5GZX8 Q96B31 Q9H2C3 Q9H2Z1 Q9H940,Centrosomal protein of 70 kDa,p10-binding protein;, , GO:0005813;GO:0005829;GO:0043015;GO:0042802;GO:0097711;GO:0000086;GO:0010389;GO:0070507;, C:centrosome; C:cytosol;, F:gamma-tubulin binding; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule cytoskeleton organization;|Q8NHQ1 B7Z5I8 B7Z7E8 D3DNE9 F5GZX8 Q96B31 Q9H2C3 Q9H2Z1 Q9H940,Centrosomal protein of 70 kDa,p10-binding protein;, , GO:0005813;GO:0005829;GO:0043015;GO:0042802;GO:0097711;GO:0000086;GO:0010389;GO:0070507;, C:centrosome; C:cytosol;, F:gamma-tubulin binding; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule cytoskeleton organization; scaffold20 indexed_genome mRNA 8954183 8964020 . - . ID=transcript_4860;A0FGR9 A8K0G5 Q6ZV21 Q8NDZ5 Q9BQR9,Extended synaptotagmin-3 {ECO:0000305},Chr3Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0044232;GO:0005509;GO:0005544;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR9 A8K0G5 Q6ZV21 Q8NDZ5 Q9BQR9,Extended synaptotagmin-3 {ECO:0000305},Chr3Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0044232;GO:0005509;GO:0005544;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR9 A8K0G5 Q6ZV21 Q8NDZ5 Q9BQR9,Extended synaptotagmin-3 {ECO:0000305},Chr3Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0044232;GO:0005509;GO:0005544;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport; scaffold20 indexed_genome mRNA 8965892 9007467 . - . ID=transcript_4861;A0FGR9 A8K0G5 Q6ZV21 Q8NDZ5 Q9BQR9,Extended synaptotagmin-3 {ECO:0000305},Chr3Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0044232;GO:0005509;GO:0005544;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport; scaffold20 indexed_genome mRNA 9066386 9068857 . - . ID=transcript_4862;O14807 B4DIK0 Q86WX8,Ras-related protein M-Ras,Ras-related protein R-Ras3;, PF00071;, GO:0005886;GO:0019003;GO:0005525;GO:0030742;GO:0003924;GO:0030036;GO:1990830;GO:0000165;GO:0007275;GO:0007517;GO:0007265;, C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity;, P:actin cytoskeleton organization; P:cellular response to leukemia inhibitory factor; P:MAPK cascade; P:multicellular organism development; P:muscle organ development; P:Ras protein signal transduction; scaffold20 indexed_genome mRNA 9153045 9175688 . + . ID=transcript_4863;Q86XW9 Q7Z4A8 Q8N1V7,Thioredoxin domain-containing protein 6 {ECO:0000305},Thioredoxin-like protein 2;, PF00334;PF00085;, GO:0005737;GO:0005856;GO:0004550;GO:0006241;GO:0006183;GO:0006228;, C:cytoplasm; C:cytoskeleton;, F:nucleoside diphosphate kinase activity;, P:CTP biosynthetic process; P:GTP biosynthetic process; P:UTP biosynthetic process;|Q86XW9 Q7Z4A8 Q8N1V7,Thioredoxin domain-containing protein 6 {ECO:0000305},Thioredoxin-like protein 2;, PF00334;PF00085;, GO:0005737;GO:0005856;GO:0004550;GO:0006241;GO:0006183;GO:0006228;, C:cytoplasm; C:cytoskeleton;, F:nucleoside diphosphate kinase activity;, P:CTP biosynthetic process; P:GTP biosynthetic process; P:UTP biosynthetic process; scaffold20 indexed_genome mRNA 9177540 9284186 . - . ID=transcript_4864;Q9NV02 Q9NV94 Q9Y4R9,Armadillo repeat-containing protein 8,, PF00514;, GO:0005737;GO:0005829;GO:0005576;GO:0034657;GO:0043231;GO:0005654;GO:0005634;GO:0035580;GO:1904724;GO:0000151;GO:0043312;GO:0043161;, C:cytoplasm; C:cytosol; C:extracellular region; C:GID complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:ubiquitin ligase complex;, , P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q9NV02 Q9NV94 Q9Y4R9,Armadillo repeat-containing protein 8,, PF00514;, GO:0005737;GO:0005829;GO:0005576;GO:0034657;GO:0043231;GO:0005654;GO:0005634;GO:0035580;GO:1904724;GO:0000151;GO:0043312;GO:0043161;, C:cytoplasm; C:cytosol; C:extracellular region; C:GID complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:ubiquitin ligase complex;, , P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q9NV02 Q9NV94 Q9Y4R9,Armadillo repeat-containing protein 8,, PF00514;, GO:0005737;GO:0005829;GO:0005576;GO:0034657;GO:0043231;GO:0005654;GO:0005634;GO:0035580;GO:1904724;GO:0000151;GO:0043312;GO:0043161;, C:cytoplasm; C:cytosol; C:extracellular region; C:GID complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:ubiquitin ligase complex;, , P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q9NV02 Q9NV94 Q9Y4R9,Armadillo repeat-containing protein 8,, PF00514;, GO:0005737;GO:0005829;GO:0005576;GO:0034657;GO:0043231;GO:0005654;GO:0005634;GO:0035580;GO:1904724;GO:0000151;GO:0043312;GO:0043161;, C:cytoplasm; C:cytosol; C:extracellular region; C:GID complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:ubiquitin ligase complex;, , P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q9NV02 Q9NV94 Q9Y4R9,Armadillo repeat-containing protein 8,, PF00514;, GO:0005737;GO:0005829;GO:0005576;GO:0034657;GO:0043231;GO:0005654;GO:0005634;GO:0035580;GO:1904724;GO:0000151;GO:0043312;GO:0043161;, C:cytoplasm; C:cytosol; C:extracellular region; C:GID complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:ubiquitin ligase complex;, , P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q9NV02 Q9NV94 Q9Y4R9,Armadillo repeat-containing protein 8,, PF00514;, GO:0005737;GO:0005829;GO:0005576;GO:0034657;GO:0043231;GO:0005654;GO:0005634;GO:0035580;GO:1904724;GO:0000151;GO:0043312;GO:0043161;, C:cytoplasm; C:cytosol; C:extracellular region; C:GID complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:ubiquitin ligase complex;, , P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q9NV02 Q9NV94 Q9Y4R9,Armadillo repeat-containing protein 8,, PF00514;, GO:0005737;GO:0005829;GO:0005576;GO:0034657;GO:0043231;GO:0005654;GO:0005634;GO:0035580;GO:1904724;GO:0000151;GO:0043312;GO:0043161;, C:cytoplasm; C:cytosol; C:extracellular region; C:GID complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:ubiquitin ligase complex;, , P:neutrophil degranulation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; scaffold20 indexed_genome mRNA 9296369 9298660 . + . ID=transcript_4865;Q9UK59 Q96GH0 Q9NXQ6,Lariat debranching enzyme,, PF05011;PF00149;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0008419;GO:0000398;GO:0000375;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:RNA lariat debranching enzyme activity;, P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions;|Q9UK59 Q96GH0 Q9NXQ6,Lariat debranching enzyme,, PF05011;PF00149;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0008419;GO:0000398;GO:0000375;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:RNA lariat debranching enzyme activity;, P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; scaffold20 indexed_genome mRNA 9298669 9299459 . - . ID=transcript_4866;Q9UK59 Q96GH0 Q9NXQ6,Lariat debranching enzyme,, PF05011;PF00149;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0008419;GO:0000398;GO:0000375;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:RNA lariat debranching enzyme activity;, P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; scaffold20 indexed_genome mRNA 9299512 9302581 . - . ID=transcript_4867;Q9UK59 Q96GH0 Q9NXQ6,Lariat debranching enzyme,, PF05011;PF00149;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0008419;GO:0000398;GO:0000375;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:RNA lariat debranching enzyme activity;, P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; scaffold20 indexed_genome mRNA 9302595 9303533 . + . ID=transcript_4868;Q9UK59 Q96GH0 Q9NXQ6,Lariat debranching enzyme,, PF05011;PF00149;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0008419;GO:0000398;GO:0000375;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:RNA lariat debranching enzyme activity;, P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; scaffold20 indexed_genome mRNA 9306084 9307868 . - . ID=transcript_4869;Q9UK59 Q96GH0 Q9NXQ6,Lariat debranching enzyme,, PF05011;PF00149;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0008419;GO:0000398;GO:0000375;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:RNA lariat debranching enzyme activity;, P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions;|Q9UK59 Q96GH0 Q9NXQ6,Lariat debranching enzyme,, PF05011;PF00149;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0008419;GO:0000398;GO:0000375;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:RNA lariat debranching enzyme activity;, P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; scaffold20 indexed_genome mRNA 9367842 9413736 . + . ID=transcript_4870;Q8IYY4 C9JUG5 Q96M38,Zinc finger protein DZIP1L {ECO:0000305},DAZ-interacting protein 1-like protein;, PF13815;, GO:0005930;GO:0005814;GO:0036064;GO:0005737;GO:0046872;GO:1905349;GO:0060271;GO:0033504;GO:0021532;GO:0061512;GO:0032880;GO:0007224;, C:axoneme; C:centriole; C:ciliary basal body; C:cytoplasm;, F:metal ion binding;, P:ciliary transition zone assembly; P:cilium assembly; P:floor plate development; P:neural tube patterning; P:protein localization to cilium; P:regulation of protein localization; P:smoothened signaling pathway;|Q8IYY4 C9JUG5 Q96M38,Zinc finger protein DZIP1L {ECO:0000305},DAZ-interacting protein 1-like protein;, PF13815;, GO:0005930;GO:0005814;GO:0036064;GO:0005737;GO:0046872;GO:1905349;GO:0060271;GO:0033504;GO:0021532;GO:0061512;GO:0032880;GO:0007224;, C:axoneme; C:centriole; C:ciliary basal body; C:cytoplasm;, F:metal ion binding;, P:ciliary transition zone assembly; P:cilium assembly; P:floor plate development; P:neural tube patterning; P:protein localization to cilium; P:regulation of protein localization; P:smoothened signaling pathway; scaffold20 indexed_genome mRNA 9415190 9424857 . + . ID=transcript_4871;Q8IYY4 C9JUG5 Q96M38,Zinc finger protein DZIP1L {ECO:0000305},DAZ-interacting protein 1-like protein;, PF13815;, GO:0005930;GO:0005814;GO:0036064;GO:0005737;GO:0046872;GO:1905349;GO:0060271;GO:0033504;GO:0021532;GO:0061512;GO:0032880;GO:0007224;, C:axoneme; C:centriole; C:ciliary basal body; C:cytoplasm;, F:metal ion binding;, P:ciliary transition zone assembly; P:cilium assembly; P:floor plate development; P:neural tube patterning; P:protein localization to cilium; P:regulation of protein localization; P:smoothened signaling pathway;|Q8IYY4 C9JUG5 Q96M38,Zinc finger protein DZIP1L {ECO:0000305},DAZ-interacting protein 1-like protein;, PF13815;, GO:0005930;GO:0005814;GO:0036064;GO:0005737;GO:0046872;GO:1905349;GO:0060271;GO:0033504;GO:0021532;GO:0061512;GO:0032880;GO:0007224;, C:axoneme; C:centriole; C:ciliary basal body; C:cytoplasm;, F:metal ion binding;, P:ciliary transition zone assembly; P:cilium assembly; P:floor plate development; P:neural tube patterning; P:protein localization to cilium; P:regulation of protein localization; P:smoothened signaling pathway; scaffold20 indexed_genome mRNA 9466459 9484548 . - . ID=transcript_4872;P56856 A5PL21 Q96PH4,Claudin-18,, PF00822;, GO:0005923;GO:0016021;GO:0005886;GO:0042802;GO:0005198;GO:0070830;GO:0016338;GO:0007155;GO:0048565;GO:0045779;GO:2001205;GO:1900181;GO:0045471;GO:0071847;, C:bicellular tight junction; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:structural molecule activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:digestive tract development; P:negative regulation of bone resorption; P:negative regulation of osteoclast development; P:negative regulation of protein localization to nucleus; P:response to ethanol; P:TNFSF11-mediated signaling pathway; scaffold20 indexed_genome mRNA 10490622 10491222 . + . ID=transcript_4873;P16333 B7Z751 D3DNE3,Cytoplasmic protein NCK1,NCK adaptor protein 1;SH2/SH3 adaptor protein NCK-alpha;, PF00017;PF00018;PF14604;, GO:0005911;GO:0005737;GO:0005829;GO:0005783;GO:0005634;GO:0005886;GO:0000164;GO:0005840;GO:0012506;GO:0045296;GO:0008093;GO:0046875;GO:0071074;GO:0019904;GO:0004860;GO:0030674;GO:0030971;GO:0035591;GO:0005102;GO:0030159;GO:0007015;GO:0048013;GO:0038096;GO:0030032;GO:0060548;GO:1903912;GO:0046627;GO:0033137;GO:1903898;GO:1990441;GO:0070262;GO:0030838;GO:1903676;GO:1903679;GO:1902237;GO:0010976;GO:0042102;GO:0045944;GO:0036493;GO:0030334;GO:0051707;GO:0007172;GO:0006930;GO:0042110;GO:0050852;GO:0048010;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleus; C:plasma membrane; C:protein phosphatase type 1 complex; C:ribosome; C:vesicle membrane;, F:cadherin binding; F:cytoskeletal anchor activity; F:ephrin receptor binding; F:eukaryotic initiation factor eIF2 binding; F:protein domain specific binding; F:protein kinase inhibitor activity; F:protein-macromolecule adaptor activity; F:receptor tyrosine kinase binding; F:signaling adaptor activity; F:signaling receptor binding; F:signaling receptor complex adaptor activity;, P:actin filament organization; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium assembly; P:negative regulation of cell death; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:peptidyl-serine dephosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cap-dependent translational initiation; P:positive regulation of cap-independent translational initiation; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of neuron projection development; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cell migration; P:response to other organism; P:signal complex assembly; P:substrate-dependent cell migration, cell extension; P:T cell activation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold20 indexed_genome mRNA 10493259 10504063 . - . ID=transcript_4874;P16333 B7Z751 D3DNE3,Cytoplasmic protein NCK1,NCK adaptor protein 1;SH2/SH3 adaptor protein NCK-alpha;, PF00017;PF00018;PF14604;, GO:0005911;GO:0005737;GO:0005829;GO:0005783;GO:0005634;GO:0005886;GO:0000164;GO:0005840;GO:0012506;GO:0045296;GO:0008093;GO:0046875;GO:0071074;GO:0019904;GO:0004860;GO:0030674;GO:0030971;GO:0035591;GO:0005102;GO:0030159;GO:0007015;GO:0048013;GO:0038096;GO:0030032;GO:0060548;GO:1903912;GO:0046627;GO:0033137;GO:1903898;GO:1990441;GO:0070262;GO:0030838;GO:1903676;GO:1903679;GO:1902237;GO:0010976;GO:0042102;GO:0045944;GO:0036493;GO:0030334;GO:0051707;GO:0007172;GO:0006930;GO:0042110;GO:0050852;GO:0048010;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleus; C:plasma membrane; C:protein phosphatase type 1 complex; C:ribosome; C:vesicle membrane;, F:cadherin binding; F:cytoskeletal anchor activity; F:ephrin receptor binding; F:eukaryotic initiation factor eIF2 binding; F:protein domain specific binding; F:protein kinase inhibitor activity; F:protein-macromolecule adaptor activity; F:receptor tyrosine kinase binding; F:signaling adaptor activity; F:signaling receptor binding; F:signaling receptor complex adaptor activity;, P:actin filament organization; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium assembly; P:negative regulation of cell death; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:peptidyl-serine dephosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cap-dependent translational initiation; P:positive regulation of cap-independent translational initiation; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of neuron projection development; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cell migration; P:response to other organism; P:signal complex assembly; P:substrate-dependent cell migration, cell extension; P:T cell activation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold20 indexed_genome mRNA 10551761 10593057 . - . ID=transcript_4875;Q8TBE7 B2RA80 D3DNE1 Q9BWN4 Q9H0S6,Solute carrier family 35 member G2 {ECO:0000312|HGNC:HGNC:28480},Transmembrane protein 22 {ECO:0000303|PubMed:19148500};, PF00892;, GO:0005794;GO:0016021;GO:0005887;GO:0005886;, C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;|Q8TBE7 B2RA80 D3DNE1 Q9BWN4 Q9H0S6,Solute carrier family 35 member G2 {ECO:0000312|HGNC:HGNC:28480},Transmembrane protein 22 {ECO:0000303|PubMed:19148500};, PF00892;, GO:0005794;GO:0016021;GO:0005887;GO:0005886;, C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; scaffold20 indexed_genome mRNA 10814589 11165442 . + . ID=transcript_4876;Q8WVM7 O00539 Q6P275,Cohesin subunit SA-1,SCC3 homolog 1;Stromal antigen 1;, PF08514;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0097431;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0090307;GO:0007062;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:mitotic spindle pole; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:mitotic spindle assembly; P:sister chromatid cohesion;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q8WVM7 O00539 Q6P275,Cohesin subunit SA-1,SCC3 homolog 1;Stromal antigen 1;, PF08514;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0097431;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0090307;GO:0007062;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:mitotic spindle pole; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:mitotic spindle assembly; P:sister chromatid cohesion;|Q8WVM7 O00539 Q6P275,Cohesin subunit SA-1,SCC3 homolog 1;Stromal antigen 1;, PF08514;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0097431;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0090307;GO:0007062;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:mitotic spindle pole; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:mitotic spindle assembly; P:sister chromatid cohesion;|Q8WVM7 O00539 Q6P275,Cohesin subunit SA-1,SCC3 homolog 1;Stromal antigen 1;, PF08514;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0097431;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0090307;GO:0007062;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:mitotic spindle pole; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:mitotic spindle assembly; P:sister chromatid cohesion; scaffold20 indexed_genome mRNA 11165776 11167328 . - . ID=transcript_4877;Q8WVM7 O00539 Q6P275,Cohesin subunit SA-1,SCC3 homolog 1;Stromal antigen 1;, PF08514;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0097431;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0090307;GO:0007062;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:mitotic spindle pole; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:mitotic spindle assembly; P:sister chromatid cohesion; scaffold20 indexed_genome mRNA 11173060 11177967 . + . ID=transcript_4878;Q8WVM7 O00539 Q6P275,Cohesin subunit SA-1,SCC3 homolog 1;Stromal antigen 1;, PF08514;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0097431;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0090307;GO:0007062;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:mitotic spindle pole; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:mitotic spindle assembly; P:sister chromatid cohesion;|Q8WVM7 O00539 Q6P275,Cohesin subunit SA-1,SCC3 homolog 1;Stromal antigen 1;, PF08514;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0097431;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0090307;GO:0007062;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:mitotic spindle pole; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:mitotic spindle assembly; P:sister chromatid cohesion;|Q8WVM7 O00539 Q6P275,Cohesin subunit SA-1,SCC3 homolog 1;Stromal antigen 1;, PF08514;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0097431;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0090307;GO:0007062;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:mitotic spindle pole; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:mitotic spindle assembly; P:sister chromatid cohesion;|Q8WVM7 O00539 Q6P275,Cohesin subunit SA-1,SCC3 homolog 1;Stromal antigen 1;, PF08514;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0097431;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0090307;GO:0007062;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:mitotic spindle pole; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:mitotic spindle assembly; P:sister chromatid cohesion; scaffold20 indexed_genome mRNA 11184881 11186032 . + . ID=transcript_4879;P05166 B7Z2Z4 Q16813 Q96CX0,Propionyl-CoA carboxylase beta chain, mitochondrial {ECO:0000305|PubMed:8188292},Propanoyl-CoA:carbon dioxide ligase subunit beta;, PF01039;, GO:0005829;GO:0005759;GO:0005739;GO:0005524;GO:0004658;GO:0006768;GO:0019626;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:propionyl-CoA carboxylase activity;, P:biotin metabolic process; P:short-chain fatty acid catabolic process; scaffold20 indexed_genome mRNA 11330377 11361663 . + . ID=transcript_4880;Q9HCI7 B4DYL4 G5E9I1 Q0D2P1 Q8NDB4 Q9NVS4,E3 ubiquitin-protein ligase MSL2,E3 ubiquitin-protein transferase MSL2 {ECO:0000305};Male-specific lethal 2-like 1;Male-specific lethal-2 homolog;Male-specific lethal-2 homolog 1;RING finger protein 184;, PF16682;PF16685;, GO:0072487;GO:0005654;GO:0046872;GO:0061630;GO:0043984;GO:0016567;, C:MSL complex; C:nucleoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:histone H4-K16 acetylation; P:protein ubiquitination; scaffold20 indexed_genome mRNA 11362995 11500094 . - . ID=transcript_4881;Q06190 A8KAE7 B4DNU1 B7ZAE3 Q06189 Q9NPQ5,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha,PP2A subunit B isoform PR72/PR130;PP2A subunit B isoform R3 isoform;PP2A subunit B isoforms B''-PR72/PR130;PP2A subunit B isoforms B72/B130;Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B;, PF17958;PF13499;, GO:0000159;GO:0005509;GO:0019888;GO:0030674;GO:0001754;GO:0090090;GO:0090263;GO:0045732;GO:0006470;GO:0090249;GO:0007525;GO:0061053;GO:0090244;, C:protein phosphatase type 2A complex;, F:calcium ion binding; F:protein phosphatase regulator activity; F:protein-macromolecule adaptor activity;, P:eye photoreceptor cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:protein dephosphorylation; P:regulation of cell migration involved in somitogenic axis elongation; P:somatic muscle development; P:somite development; P:Wnt signaling pathway involved in somitogenesis; scaffold20 indexed_genome mRNA 11538733 11539630 . - . ID=transcript_4882;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold20 indexed_genome mRNA 12273520 12732928 . - . ID=transcript_4883;P54762 A8K593 B3KTB2 B5A969 O43569 O95142 O95143 Q0VG87,Ephrin type-B receptor 1,ELK;EPH tyrosine kinase 2;EPH-like kinase 6;Neuronally-expressed EPH-related tyrosine kinase;Tyrosine-protein kinase receptor EPH-2;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0005829;GO:0030425;GO:0031901;GO:0005783;GO:0070062;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0004714;GO:0005005;GO:0001525;GO:0007411;GO:0060326;GO:0031589;GO:0021952;GO:0060996;GO:0060997;GO:0050965;GO:0048013;GO:0030010;GO:0007275;GO:1902725;GO:1902723;GO:0061351;GO:0022008;GO:0033674;GO:0051965;GO:0046777;GO:0070372;GO:0046328;GO:1901214;GO:0031290;GO:0014719;GO:0007169;, C:cytosol; C:dendrite; C:early endosome membrane; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:angiogenesis; P:axon guidance; P:cell chemotaxis; P:cell-substrate adhesion; P:central nervous system projection neuron axonogenesis; P:dendritic spine development; P:dendritic spine morphogenesis; P:detection of temperature stimulus involved in sensory perception of pain; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:multicellular organism development; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:neural precursor cell proliferation; P:neurogenesis; P:positive regulation of kinase activity; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of JNK cascade; P:regulation of neuron death; P:retinal ganglion cell axon guidance; P:skeletal muscle satellite cell activation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P54762 A8K593 B3KTB2 B5A969 O43569 O95142 O95143 Q0VG87,Ephrin type-B receptor 1,ELK;EPH tyrosine kinase 2;EPH-like kinase 6;Neuronally-expressed EPH-related tyrosine kinase;Tyrosine-protein kinase receptor EPH-2;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0005829;GO:0030425;GO:0031901;GO:0005783;GO:0070062;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0004714;GO:0005005;GO:0001525;GO:0007411;GO:0060326;GO:0031589;GO:0021952;GO:0060996;GO:0060997;GO:0050965;GO:0048013;GO:0030010;GO:0007275;GO:1902725;GO:1902723;GO:0061351;GO:0022008;GO:0033674;GO:0051965;GO:0046777;GO:0070372;GO:0046328;GO:1901214;GO:0031290;GO:0014719;GO:0007169;, C:cytosol; C:dendrite; C:early endosome membrane; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:angiogenesis; P:axon guidance; P:cell chemotaxis; P:cell-substrate adhesion; P:central nervous system projection neuron axonogenesis; P:dendritic spine development; P:dendritic spine morphogenesis; P:detection of temperature stimulus involved in sensory perception of pain; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:multicellular organism development; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:neural precursor cell proliferation; P:neurogenesis; P:positive regulation of kinase activity; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of JNK cascade; P:regulation of neuron death; P:retinal ganglion cell axon guidance; P:skeletal muscle satellite cell activation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P54762 A8K593 B3KTB2 B5A969 O43569 O95142 O95143 Q0VG87,Ephrin type-B receptor 1,ELK;EPH tyrosine kinase 2;EPH-like kinase 6;Neuronally-expressed EPH-related tyrosine kinase;Tyrosine-protein kinase receptor EPH-2;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0005829;GO:0030425;GO:0031901;GO:0005783;GO:0070062;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0004714;GO:0005005;GO:0001525;GO:0007411;GO:0060326;GO:0031589;GO:0021952;GO:0060996;GO:0060997;GO:0050965;GO:0048013;GO:0030010;GO:0007275;GO:1902725;GO:1902723;GO:0061351;GO:0022008;GO:0033674;GO:0051965;GO:0046777;GO:0070372;GO:0046328;GO:1901214;GO:0031290;GO:0014719;GO:0007169;, C:cytosol; C:dendrite; C:early endosome membrane; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:angiogenesis; P:axon guidance; P:cell chemotaxis; P:cell-substrate adhesion; P:central nervous system projection neuron axonogenesis; P:dendritic spine development; P:dendritic spine morphogenesis; P:detection of temperature stimulus involved in sensory perception of pain; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:multicellular organism development; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:neural precursor cell proliferation; P:neurogenesis; P:positive regulation of kinase activity; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of JNK cascade; P:regulation of neuron death; P:retinal ganglion cell axon guidance; P:skeletal muscle satellite cell activation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P54762 A8K593 B3KTB2 B5A969 O43569 O95142 O95143 Q0VG87,Ephrin type-B receptor 1,ELK;EPH tyrosine kinase 2;EPH-like kinase 6;Neuronally-expressed EPH-related tyrosine kinase;Tyrosine-protein kinase receptor EPH-2;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0005829;GO:0030425;GO:0031901;GO:0005783;GO:0070062;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0004714;GO:0005005;GO:0001525;GO:0007411;GO:0060326;GO:0031589;GO:0021952;GO:0060996;GO:0060997;GO:0050965;GO:0048013;GO:0030010;GO:0007275;GO:1902725;GO:1902723;GO:0061351;GO:0022008;GO:0033674;GO:0051965;GO:0046777;GO:0070372;GO:0046328;GO:1901214;GO:0031290;GO:0014719;GO:0007169;, C:cytosol; C:dendrite; C:early endosome membrane; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:angiogenesis; P:axon guidance; P:cell chemotaxis; P:cell-substrate adhesion; P:central nervous system projection neuron axonogenesis; P:dendritic spine development; P:dendritic spine morphogenesis; P:detection of temperature stimulus involved in sensory perception of pain; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:multicellular organism development; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:neural precursor cell proliferation; P:neurogenesis; P:positive regulation of kinase activity; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of JNK cascade; P:regulation of neuron death; P:retinal ganglion cell axon guidance; P:skeletal muscle satellite cell activation; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold20 indexed_genome mRNA 12882731 12931688 . + . ID=transcript_4884;Q8NBH2 B7Z1S4 Q6ZT15,Kyphoscoliosis peptidase {ECO:0000305},, PF01841;, GO:0005856;GO:0030018;GO:0008233;, C:cytoskeleton; C:Z disc;, F:peptidase activity;|Q8NBH2 B7Z1S4 Q6ZT15,Kyphoscoliosis peptidase {ECO:0000305},, PF01841;, GO:0005856;GO:0030018;GO:0008233;, C:cytoskeleton; C:Z disc;, F:peptidase activity;|Q8NBH2 B7Z1S4 Q6ZT15,Kyphoscoliosis peptidase {ECO:0000305},, PF01841;, GO:0005856;GO:0030018;GO:0008233;, C:cytoskeleton; C:Z disc;, F:peptidase activity; scaffold20 indexed_genome mRNA 12954433 12975557 . - . ID=transcript_4885;Q96MT8 D3DND8 D3DND9 D3DNE0 Q96CR0 Q9H8F5 Q9H8N0,Centrosomal protein of 63 kDa {ECO:0000305},, PF17045;, GO:0005814;GO:0005813;GO:0005829;GO:0000922;GO:0051301;GO:0007099;GO:0097711;GO:0098535;GO:0000077;GO:0000086;GO:0010389;GO:0042770;GO:0051225;, C:centriole; C:centrosome; C:cytosol; C:spindle pole;, , P:cell division; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:DNA damage checkpoint; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction in response to DNA damage; P:spindle assembly;|Q96MT8 D3DND8 D3DND9 D3DNE0 Q96CR0 Q9H8F5 Q9H8N0,Centrosomal protein of 63 kDa {ECO:0000305},, PF17045;, GO:0005814;GO:0005813;GO:0005829;GO:0000922;GO:0051301;GO:0007099;GO:0097711;GO:0098535;GO:0000077;GO:0000086;GO:0010389;GO:0042770;GO:0051225;, C:centriole; C:centrosome; C:cytosol; C:spindle pole;, , P:cell division; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:DNA damage checkpoint; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction in response to DNA damage; P:spindle assembly;|Q96MT8 D3DND8 D3DND9 D3DNE0 Q96CR0 Q9H8F5 Q9H8N0,Centrosomal protein of 63 kDa {ECO:0000305},, PF17045;, GO:0005814;GO:0005813;GO:0005829;GO:0000922;GO:0051301;GO:0007099;GO:0097711;GO:0098535;GO:0000077;GO:0000086;GO:0010389;GO:0042770;GO:0051225;, C:centriole; C:centrosome; C:cytosol; C:spindle pole;, , P:cell division; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:DNA damage checkpoint; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction in response to DNA damage; P:spindle assembly;|Q96MT8 D3DND8 D3DND9 D3DNE0 Q96CR0 Q9H8F5 Q9H8N0,Centrosomal protein of 63 kDa {ECO:0000305},, PF17045;, GO:0005814;GO:0005813;GO:0005829;GO:0000922;GO:0051301;GO:0007099;GO:0097711;GO:0098535;GO:0000077;GO:0000086;GO:0010389;GO:0042770;GO:0051225;, C:centriole; C:centrosome; C:cytosol; C:spindle pole;, , P:cell division; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:DNA damage checkpoint; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction in response to DNA damage; P:spindle assembly; scaffold20 indexed_genome mRNA 12998326 13032098 . - . ID=transcript_4886;Q96MT8 D3DND8 D3DND9 D3DNE0 Q96CR0 Q9H8F5 Q9H8N0,Centrosomal protein of 63 kDa {ECO:0000305},, PF17045;, GO:0005814;GO:0005813;GO:0005829;GO:0000922;GO:0051301;GO:0007099;GO:0097711;GO:0098535;GO:0000077;GO:0000086;GO:0010389;GO:0042770;GO:0051225;, C:centriole; C:centrosome; C:cytosol; C:spindle pole;, , P:cell division; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:DNA damage checkpoint; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction in response to DNA damage; P:spindle assembly;|Q96MT8 D3DND8 D3DND9 D3DNE0 Q96CR0 Q9H8F5 Q9H8N0,Centrosomal protein of 63 kDa {ECO:0000305},, PF17045;, GO:0005814;GO:0005813;GO:0005829;GO:0000922;GO:0051301;GO:0007099;GO:0097711;GO:0098535;GO:0000077;GO:0000086;GO:0010389;GO:0042770;GO:0051225;, C:centriole; C:centrosome; C:cytosol; C:spindle pole;, , P:cell division; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:DNA damage checkpoint; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction in response to DNA damage; P:spindle assembly;|Q96MT8 D3DND8 D3DND9 D3DNE0 Q96CR0 Q9H8F5 Q9H8N0,Centrosomal protein of 63 kDa {ECO:0000305},, PF17045;, GO:0005814;GO:0005813;GO:0005829;GO:0000922;GO:0051301;GO:0007099;GO:0097711;GO:0098535;GO:0000077;GO:0000086;GO:0010389;GO:0042770;GO:0051225;, C:centriole; C:centrosome; C:cytosol; C:spindle pole;, , P:cell division; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:DNA damage checkpoint; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction in response to DNA damage; P:spindle assembly; scaffold20 indexed_genome mRNA 13036801 13037784 . + . ID=transcript_4887;Q9BS18 Q9Y3V0,Anaphase-promoting complex subunit 13,Cyclosome subunit 13;, PF05839;, GO:0005680;GO:0007049;GO:0051301;GO:0070979;, C:anaphase-promoting complex;, , P:cell cycle; P:cell division; P:protein K11-linked ubiquitination; scaffold20 indexed_genome mRNA 13139856 13157736 . + . ID=transcript_4888;Q9Y2J4 A8K6F1 B7Z5Q1 E9PHW3 Q53EP1 Q96F99 Q9UKB4,Angiomotin-like protein 2,Leman coiled-coil protein;, PF12240;, GO:0005923;GO:0031410;GO:0005829;GO:0005886;GO:0055037;GO:0030036;GO:0001525;GO:0003365;GO:0035329;GO:0030334;GO:0016055;, C:bicellular tight junction; C:cytoplasmic vesicle; C:cytosol; C:plasma membrane; C:recycling endosome;, , P:actin cytoskeleton organization; P:angiogenesis; P:establishment of cell polarity involved in ameboidal cell migration; P:hippo signaling; P:regulation of cell migration; P:Wnt signaling pathway;|Q9Y2J4 A8K6F1 B7Z5Q1 E9PHW3 Q53EP1 Q96F99 Q9UKB4,Angiomotin-like protein 2,Leman coiled-coil protein;, PF12240;, GO:0005923;GO:0031410;GO:0005829;GO:0005886;GO:0055037;GO:0030036;GO:0001525;GO:0003365;GO:0035329;GO:0030334;GO:0016055;, C:bicellular tight junction; C:cytoplasmic vesicle; C:cytosol; C:plasma membrane; C:recycling endosome;, , P:actin cytoskeleton organization; P:angiogenesis; P:establishment of cell polarity involved in ameboidal cell migration; P:hippo signaling; P:regulation of cell migration; P:Wnt signaling pathway; scaffold20 indexed_genome mRNA 13308828 13309461 . + . ID=transcript_4889;P34925 A0A087WUK1 A0A096LNL3 Q04696,Tyrosine-protein kinase RYK {ECO:0000305},, PF07714;PF02019;, GO:0005737;GO:0016021;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:1904929;GO:0005109;GO:0016301;GO:0004888;GO:0042813;GO:0017147;GO:0007411;GO:0007409;GO:0060070;GO:0033278;GO:0036518;GO:0071679;GO:0022038;GO:1904948;GO:0007275;GO:0048843;GO:0022008;GO:0030182;GO:0031175;GO:0035567;GO:0018108;GO:1904938;GO:0033674;GO:0043410;GO:0007165;GO:0048705;GO:0007416;GO:0007169;GO:0016055;GO:1904953;, C:cytoplasm; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:frizzled binding; F:kinase activity; F:transmembrane signaling receptor activity; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:axon guidance; P:axonogenesis; P:canonical Wnt signaling pathway; P:cell proliferation in midbrain; P:chemorepulsion of dopaminergic neuron axon; P:commissural neuron axon guidance; P:corpus callosum development; P:midbrain dopaminergic neuron differentiation; P:multicellular organism development; P:negative regulation of axon extension involved in axon guidance; P:neurogenesis; P:neuron differentiation; P:neuron projection development; P:non-canonical Wnt signaling pathway; P:peptidyl-tyrosine phosphorylation; P:planar cell polarity pathway involved in axon guidance; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:signal transduction; P:skeletal system morphogenesis; P:synapse assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:Wnt signaling pathway; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; scaffold20 indexed_genome mRNA 13319762 13328396 . + . ID=transcript_4890;P34925 A0A087WUK1 A0A096LNL3 Q04696,Tyrosine-protein kinase RYK {ECO:0000305},, PF07714;PF02019;, GO:0005737;GO:0016021;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:1904929;GO:0005109;GO:0016301;GO:0004888;GO:0042813;GO:0017147;GO:0007411;GO:0007409;GO:0060070;GO:0033278;GO:0036518;GO:0071679;GO:0022038;GO:1904948;GO:0007275;GO:0048843;GO:0022008;GO:0030182;GO:0031175;GO:0035567;GO:0018108;GO:1904938;GO:0033674;GO:0043410;GO:0007165;GO:0048705;GO:0007416;GO:0007169;GO:0016055;GO:1904953;, C:cytoplasm; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:frizzled binding; F:kinase activity; F:transmembrane signaling receptor activity; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:axon guidance; P:axonogenesis; P:canonical Wnt signaling pathway; P:cell proliferation in midbrain; P:chemorepulsion of dopaminergic neuron axon; P:commissural neuron axon guidance; P:corpus callosum development; P:midbrain dopaminergic neuron differentiation; P:multicellular organism development; P:negative regulation of axon extension involved in axon guidance; P:neurogenesis; P:neuron differentiation; P:neuron projection development; P:non-canonical Wnt signaling pathway; P:peptidyl-tyrosine phosphorylation; P:planar cell polarity pathway involved in axon guidance; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:signal transduction; P:skeletal system morphogenesis; P:synapse assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:Wnt signaling pathway; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; scaffold20 indexed_genome mRNA 13335545 13336974 . - . ID=transcript_4891;P34925 A0A087WUK1 A0A096LNL3 Q04696,Tyrosine-protein kinase RYK {ECO:0000305},, PF07714;PF02019;, GO:0005737;GO:0016021;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:1904929;GO:0005109;GO:0016301;GO:0004888;GO:0042813;GO:0017147;GO:0007411;GO:0007409;GO:0060070;GO:0033278;GO:0036518;GO:0071679;GO:0022038;GO:1904948;GO:0007275;GO:0048843;GO:0022008;GO:0030182;GO:0031175;GO:0035567;GO:0018108;GO:1904938;GO:0033674;GO:0043410;GO:0007165;GO:0048705;GO:0007416;GO:0007169;GO:0016055;GO:1904953;, C:cytoplasm; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:frizzled binding; F:kinase activity; F:transmembrane signaling receptor activity; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:axon guidance; P:axonogenesis; P:canonical Wnt signaling pathway; P:cell proliferation in midbrain; P:chemorepulsion of dopaminergic neuron axon; P:commissural neuron axon guidance; P:corpus callosum development; P:midbrain dopaminergic neuron differentiation; P:multicellular organism development; P:negative regulation of axon extension involved in axon guidance; P:neurogenesis; P:neuron differentiation; P:neuron projection development; P:non-canonical Wnt signaling pathway; P:peptidyl-tyrosine phosphorylation; P:planar cell polarity pathway involved in axon guidance; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:signal transduction; P:skeletal system morphogenesis; P:synapse assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:Wnt signaling pathway; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; scaffold20 indexed_genome mRNA 13367309 13368185 . + . ID=transcript_4892;P34925 A0A087WUK1 A0A096LNL3 Q04696,Tyrosine-protein kinase RYK {ECO:0000305},, PF07714;PF02019;, GO:0005737;GO:0016021;GO:0005887;GO:0016020;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:1904929;GO:0005109;GO:0016301;GO:0004888;GO:0042813;GO:0017147;GO:0007411;GO:0007409;GO:0060070;GO:0033278;GO:0036518;GO:0071679;GO:0022038;GO:1904948;GO:0007275;GO:0048843;GO:0022008;GO:0030182;GO:0031175;GO:0035567;GO:0018108;GO:1904938;GO:0033674;GO:0043410;GO:0007165;GO:0048705;GO:0007416;GO:0007169;GO:0016055;GO:1904953;, C:cytoplasm; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:frizzled binding; F:kinase activity; F:transmembrane signaling receptor activity; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:axon guidance; P:axonogenesis; P:canonical Wnt signaling pathway; P:cell proliferation in midbrain; P:chemorepulsion of dopaminergic neuron axon; P:commissural neuron axon guidance; P:corpus callosum development; P:midbrain dopaminergic neuron differentiation; P:multicellular organism development; P:negative regulation of axon extension involved in axon guidance; P:neurogenesis; P:neuron differentiation; P:neuron projection development; P:non-canonical Wnt signaling pathway; P:peptidyl-tyrosine phosphorylation; P:planar cell polarity pathway involved in axon guidance; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:signal transduction; P:skeletal system morphogenesis; P:synapse assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:Wnt signaling pathway; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; scaffold20 indexed_genome mRNA 13504076 13588860 . + . ID=transcript_4893;Q92959 Q86V98 Q8IUN2,Solute carrier organic anion transporter family member 2A1 {ECO:0000305},Prostaglandin transporter;Solute carrier family 21 member 2;, PF07648;PF03137;, GO:0005887;GO:0016020;GO:0005886;GO:0005319;GO:0015132;GO:0015347;GO:0006869;GO:0015732;GO:0043252;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:lipid transporter activity; F:prostaglandin transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:lipid transport; P:prostaglandin transport; P:sodium-independent organic anion transport; scaffold20 indexed_genome mRNA 13621470 13680191 . + . ID=transcript_4894;Q9NRW1 B2R5Z9 B7Z337 D3DND3 Q92929,Ras-related protein Rab-6B,, PF00071;, GO:0031410;GO:0005829;GO:0012505;GO:0005793;GO:0005794;GO:0000139;GO:0098793;GO:0005525;GO:0003924;GO:0031489;GO:0006891;GO:0006886;GO:0042147;GO:0006890;, C:cytoplasmic vesicle; C:cytosol; C:endomembrane system; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:myosin V binding;, P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NRW1 B2R5Z9 B7Z337 D3DND3 Q92929,Ras-related protein Rab-6B,, PF00071;, GO:0031410;GO:0005829;GO:0012505;GO:0005793;GO:0005794;GO:0000139;GO:0098793;GO:0005525;GO:0003924;GO:0031489;GO:0006891;GO:0006886;GO:0042147;GO:0006890;, C:cytoplasmic vesicle; C:cytosol; C:endomembrane system; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:myosin V binding;, P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NRW1 B2R5Z9 B7Z337 D3DND3 Q92929,Ras-related protein Rab-6B,, PF00071;, GO:0031410;GO:0005829;GO:0012505;GO:0005793;GO:0005794;GO:0000139;GO:0098793;GO:0005525;GO:0003924;GO:0031489;GO:0006891;GO:0006886;GO:0042147;GO:0006890;, C:cytoplasmic vesicle; C:cytosol; C:endomembrane system; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:myosin V binding;, P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold20 indexed_genome mRNA 13724202 13734218 . - . ID=transcript_4895;P02787 O43890 Q1HBA5 Q9NQB8 Q9UHV0,Serotransferrin,Beta-1 metal-binding globulin;Siderophilin;, PF00405;, GO:0016324;GO:0045178;GO:0009925;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0030139;GO:0005788;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:1990712;GO:0005770;GO:0048471;GO:0005886;GO:0055037;GO:0034774;GO:0031982;GO:0008199;GO:0008198;GO:0034986;GO:1990459;GO:0007015;GO:0007257;GO:0019731;GO:0006879;GO:0044267;GO:0071281;GO:0070371;GO:0055072;GO:0006826;GO:0061024;GO:0030316;GO:0002576;GO:0045780;GO:2000147;GO:0048260;GO:0045893;GO:0043687;GO:0034756;GO:0031647;GO:0001895;GO:0060395;GO:0033572;, C:apical plasma membrane; C:basal part of cell; C:basal plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum lumen; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:HFE-transferrin receptor complex; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule lumen; C:vesicle;, F:ferric iron binding; F:ferrous iron binding; F:iron chaperone activity; F:transferrin receptor binding;, P:actin filament organization; P:activation of JUN kinase activity; P:antibacterial humoral response; P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:cellular response to iron ion; P:ERK1 and ERK2 cascade; P:iron ion homeostasis; P:iron ion transport; P:membrane organization; P:osteoclast differentiation; P:platelet degranulation; P:positive regulation of bone resorption; P:positive regulation of cell motility; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:regulation of iron ion transport; P:regulation of protein stability; P:retina homeostasis; P:SMAD protein signal transduction; P:transferrin transport;|P02787 O43890 Q1HBA5 Q9NQB8 Q9UHV0,Serotransferrin,Beta-1 metal-binding globulin;Siderophilin;, PF00405;, GO:0016324;GO:0045178;GO:0009925;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0030139;GO:0005788;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:1990712;GO:0005770;GO:0048471;GO:0005886;GO:0055037;GO:0034774;GO:0031982;GO:0008199;GO:0008198;GO:0034986;GO:1990459;GO:0007015;GO:0007257;GO:0019731;GO:0006879;GO:0044267;GO:0071281;GO:0070371;GO:0055072;GO:0006826;GO:0061024;GO:0030316;GO:0002576;GO:0045780;GO:2000147;GO:0048260;GO:0045893;GO:0043687;GO:0034756;GO:0031647;GO:0001895;GO:0060395;GO:0033572;, C:apical plasma membrane; C:basal part of cell; C:basal plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum lumen; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:HFE-transferrin receptor complex; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule lumen; C:vesicle;, F:ferric iron binding; F:ferrous iron binding; F:iron chaperone activity; F:transferrin receptor binding;, P:actin filament organization; P:activation of JUN kinase activity; P:antibacterial humoral response; P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:cellular response to iron ion; P:ERK1 and ERK2 cascade; P:iron ion homeostasis; P:iron ion transport; P:membrane organization; P:osteoclast differentiation; P:platelet degranulation; P:positive regulation of bone resorption; P:positive regulation of cell motility; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:regulation of iron ion transport; P:regulation of protein stability; P:retina homeostasis; P:SMAD protein signal transduction; P:transferrin transport; scaffold20 indexed_genome mRNA 13734249 13768387 . - . ID=transcript_4896;Q16789 Q5DSM0 Q8IU92 Q8IZH6 Q8TCD2 Q96KZ4 Q96KZ5 Q9H1Z3 Q9UCY5,Lactotransferrin,Growth-inhibiting protein 12;Talalactoferrin;, PF00405;, GO:0009986;GO:0005737;GO:0005769;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0097013;GO:0005886;GO:0032991;GO:0055037;GO:0030141;GO:0042581;GO:0035580;GO:1904724;GO:0004869;GO:0003677;GO:0008201;GO:0005506;GO:0001530;GO:0043539;GO:0004252;GO:1990000;GO:0019731;GO:0019732;GO:0061844;GO:0019730;GO:0060349;GO:0050829;GO:0050830;GO:0006959;GO:0045087;GO:0002227;GO:0006826;GO:0031640;GO:0051673;GO:0044793;GO:0043066;GO:0032780;GO:2000117;GO:0031665;GO:0045837;GO:2001205;GO:1900229;GO:2000308;GO:0045071;GO:0048525;GO:0043312;GO:0001503;GO:1900159;GO:1902732;GO:0043123;GO:0051092;GO:0045669;GO:0033690;GO:0071902;GO:0034145;GO:0001817;GO:0032680;GO:0001895;GO:0033214;, C:cell surface; C:cytoplasm; C:early endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:phagocytic vesicle lumen; C:plasma membrane; C:protein-containing complex; C:recycling endosome; C:secretory granule; C:specific granule; C:specific granule lumen; C:tertiary granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:DNA binding; F:heparin binding; F:iron ion binding; F:lipopolysaccharide binding; F:protein serine/threonine kinase activator activity; F:serine-type endopeptidase activity;, P:amyloid fibril formation; P:antibacterial humoral response; P:antifungal humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:antimicrobial humoral response; P:bone morphogenesis; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:humoral immune response; P:innate immune response; P:innate immune response in mucosa; P:iron ion transport; P:killing of cells of other organism; P:membrane disruption in other organism; P:negative regulation by host of viral process; P:negative regulation of apoptotic process; P:negative regulation of ATPase activity; P:negative regulation of cysteine-type endopeptidase activity; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of membrane potential; P:negative regulation of osteoclast development; P:negative regulation of single-species biofilm formation in or on host organism; P:negative regulation of tumor necrosis factor (ligand) superfamily member 11 production; P:negative regulation of viral genome replication; P:negative regulation of viral process; P:neutrophil degranulation; P:ossification; P:positive regulation of bone mineralization involved in bone maturation; P:positive regulation of chondrocyte proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:regulation of cytokine production; P:regulation of tumor necrosis factor production; P:retina homeostasis; P:siderophore-dependent iron import into cell;|P02787 O43890 Q1HBA5 Q9NQB8 Q9UHV0,Serotransferrin,Beta-1 metal-binding globulin;Siderophilin;, PF00405;, GO:0016324;GO:0045178;GO:0009925;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0030139;GO:0005788;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:1990712;GO:0005770;GO:0048471;GO:0005886;GO:0055037;GO:0034774;GO:0031982;GO:0008199;GO:0008198;GO:0034986;GO:1990459;GO:0007015;GO:0007257;GO:0019731;GO:0006879;GO:0044267;GO:0071281;GO:0070371;GO:0055072;GO:0006826;GO:0061024;GO:0030316;GO:0002576;GO:0045780;GO:2000147;GO:0048260;GO:0045893;GO:0043687;GO:0034756;GO:0031647;GO:0001895;GO:0060395;GO:0033572;, C:apical plasma membrane; C:basal part of cell; C:basal plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum lumen; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:HFE-transferrin receptor complex; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule lumen; C:vesicle;, F:ferric iron binding; F:ferrous iron binding; F:iron chaperone activity; F:transferrin receptor binding;, P:actin filament organization; P:activation of JUN kinase activity; P:antibacterial humoral response; P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:cellular response to iron ion; P:ERK1 and ERK2 cascade; P:iron ion homeostasis; P:iron ion transport; P:membrane organization; P:osteoclast differentiation; P:platelet degranulation; P:positive regulation of bone resorption; P:positive regulation of cell motility; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:regulation of iron ion transport; P:regulation of protein stability; P:retina homeostasis; P:SMAD protein signal transduction; P:transferrin transport;|P02787 O43890 Q1HBA5 Q9NQB8 Q9UHV0,Serotransferrin,Beta-1 metal-binding globulin;Siderophilin;, PF00405;, GO:0016324;GO:0045178;GO:0009925;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0030139;GO:0005788;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:1990712;GO:0005770;GO:0048471;GO:0005886;GO:0055037;GO:0034774;GO:0031982;GO:0008199;GO:0008198;GO:0034986;GO:1990459;GO:0007015;GO:0007257;GO:0019731;GO:0006879;GO:0044267;GO:0071281;GO:0070371;GO:0055072;GO:0006826;GO:0061024;GO:0030316;GO:0002576;GO:0045780;GO:2000147;GO:0048260;GO:0045893;GO:0043687;GO:0034756;GO:0031647;GO:0001895;GO:0060395;GO:0033572;, C:apical plasma membrane; C:basal part of cell; C:basal plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum lumen; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:HFE-transferrin receptor complex; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule lumen; C:vesicle;, F:ferric iron binding; F:ferrous iron binding; F:iron chaperone activity; F:transferrin receptor binding;, P:actin filament organization; P:activation of JUN kinase activity; P:antibacterial humoral response; P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:cellular response to iron ion; P:ERK1 and ERK2 cascade; P:iron ion homeostasis; P:iron ion transport; P:membrane organization; P:osteoclast differentiation; P:platelet degranulation; P:positive regulation of bone resorption; P:positive regulation of cell motility; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:regulation of iron ion transport; P:regulation of protein stability; P:retina homeostasis; P:SMAD protein signal transduction; P:transferrin transport;|P02787 O43890 Q1HBA5 Q9NQB8 Q9UHV0,Serotransferrin,Beta-1 metal-binding globulin;Siderophilin;, PF00405;, GO:0016324;GO:0045178;GO:0009925;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0030139;GO:0005788;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:1990712;GO:0005770;GO:0048471;GO:0005886;GO:0055037;GO:0034774;GO:0031982;GO:0008199;GO:0008198;GO:0034986;GO:1990459;GO:0007015;GO:0007257;GO:0019731;GO:0006879;GO:0044267;GO:0071281;GO:0070371;GO:0055072;GO:0006826;GO:0061024;GO:0030316;GO:0002576;GO:0045780;GO:2000147;GO:0048260;GO:0045893;GO:0043687;GO:0034756;GO:0031647;GO:0001895;GO:0060395;GO:0033572;, C:apical plasma membrane; C:basal part of cell; C:basal plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum lumen; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:HFE-transferrin receptor complex; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule lumen; C:vesicle;, F:ferric iron binding; F:ferrous iron binding; F:iron chaperone activity; F:transferrin receptor binding;, P:actin filament organization; P:activation of JUN kinase activity; P:antibacterial humoral response; P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:cellular response to iron ion; P:ERK1 and ERK2 cascade; P:iron ion homeostasis; P:iron ion transport; P:membrane organization; P:osteoclast differentiation; P:platelet degranulation; P:positive regulation of bone resorption; P:positive regulation of cell motility; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:regulation of iron ion transport; P:regulation of protein stability; P:retina homeostasis; P:SMAD protein signal transduction; P:transferrin transport;|P02787 O43890 Q1HBA5 Q9NQB8 Q9UHV0,Serotransferrin,Beta-1 metal-binding globulin;Siderophilin;, PF00405;, GO:0016324;GO:0045178;GO:0009925;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0030139;GO:0005788;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:1990712;GO:0005770;GO:0048471;GO:0005886;GO:0055037;GO:0034774;GO:0031982;GO:0008199;GO:0008198;GO:0034986;GO:1990459;GO:0007015;GO:0007257;GO:0019731;GO:0006879;GO:0044267;GO:0071281;GO:0070371;GO:0055072;GO:0006826;GO:0061024;GO:0030316;GO:0002576;GO:0045780;GO:2000147;GO:0048260;GO:0045893;GO:0043687;GO:0034756;GO:0031647;GO:0001895;GO:0060395;GO:0033572;, C:apical plasma membrane; C:basal part of cell; C:basal plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum lumen; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:HFE-transferrin receptor complex; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule lumen; C:vesicle;, F:ferric iron binding; F:ferrous iron binding; F:iron chaperone activity; F:transferrin receptor binding;, P:actin filament organization; P:activation of JUN kinase activity; P:antibacterial humoral response; P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:cellular response to iron ion; P:ERK1 and ERK2 cascade; P:iron ion homeostasis; P:iron ion transport; P:membrane organization; P:osteoclast differentiation; P:platelet degranulation; P:positive regulation of bone resorption; P:positive regulation of cell motility; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:regulation of iron ion transport; P:regulation of protein stability; P:retina homeostasis; P:SMAD protein signal transduction; P:transferrin transport;|Q16789 Q5DSM0 Q8IU92 Q8IZH6 Q8TCD2 Q96KZ4 Q96KZ5 Q9H1Z3 Q9UCY5,Lactotransferrin,Growth-inhibiting protein 12;Talalactoferrin;, PF00405;, GO:0009986;GO:0005737;GO:0005769;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0097013;GO:0005886;GO:0032991;GO:0055037;GO:0030141;GO:0042581;GO:0035580;GO:1904724;GO:0004869;GO:0003677;GO:0008201;GO:0005506;GO:0001530;GO:0043539;GO:0004252;GO:1990000;GO:0019731;GO:0019732;GO:0061844;GO:0019730;GO:0060349;GO:0050829;GO:0050830;GO:0006959;GO:0045087;GO:0002227;GO:0006826;GO:0031640;GO:0051673;GO:0044793;GO:0043066;GO:0032780;GO:2000117;GO:0031665;GO:0045837;GO:2001205;GO:1900229;GO:2000308;GO:0045071;GO:0048525;GO:0043312;GO:0001503;GO:1900159;GO:1902732;GO:0043123;GO:0051092;GO:0045669;GO:0033690;GO:0071902;GO:0034145;GO:0001817;GO:0032680;GO:0001895;GO:0033214;, C:cell surface; C:cytoplasm; C:early endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:phagocytic vesicle lumen; C:plasma membrane; C:protein-containing complex; C:recycling endosome; C:secretory granule; C:specific granule; C:specific granule lumen; C:tertiary granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:DNA binding; F:heparin binding; F:iron ion binding; F:lipopolysaccharide binding; F:protein serine/threonine kinase activator activity; F:serine-type endopeptidase activity;, P:amyloid fibril formation; P:antibacterial humoral response; P:antifungal humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:antimicrobial humoral response; P:bone morphogenesis; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:humoral immune response; P:innate immune response; P:innate immune response in mucosa; P:iron ion transport; P:killing of cells of other organism; P:membrane disruption in other organism; P:negative regulation by host of viral process; P:negative regulation of apoptotic process; P:negative regulation of ATPase activity; P:negative regulation of cysteine-type endopeptidase activity; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of membrane potential; P:negative regulation of osteoclast development; P:negative regulation of single-species biofilm formation in or on host organism; P:negative regulation of tumor necrosis factor (ligand) superfamily member 11 production; P:negative regulation of viral genome replication; P:negative regulation of viral process; P:neutrophil degranulation; P:ossification; P:positive regulation of bone mineralization involved in bone maturation; P:positive regulation of chondrocyte proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:regulation of cytokine production; P:regulation of tumor necrosis factor production; P:retina homeostasis; P:siderophore-dependent iron import into cell; scaffold20 indexed_genome mRNA 13791812 13837614 . - . ID=transcript_4897;P02787 O43890 Q1HBA5 Q9NQB8 Q9UHV0,Serotransferrin,Beta-1 metal-binding globulin;Siderophilin;, PF00405;, GO:0016324;GO:0045178;GO:0009925;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0030139;GO:0005788;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:1990712;GO:0005770;GO:0048471;GO:0005886;GO:0055037;GO:0034774;GO:0031982;GO:0008199;GO:0008198;GO:0034986;GO:1990459;GO:0007015;GO:0007257;GO:0019731;GO:0006879;GO:0044267;GO:0071281;GO:0070371;GO:0055072;GO:0006826;GO:0061024;GO:0030316;GO:0002576;GO:0045780;GO:2000147;GO:0048260;GO:0045893;GO:0043687;GO:0034756;GO:0031647;GO:0001895;GO:0060395;GO:0033572;, C:apical plasma membrane; C:basal part of cell; C:basal plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum lumen; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:HFE-transferrin receptor complex; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule lumen; C:vesicle;, F:ferric iron binding; F:ferrous iron binding; F:iron chaperone activity; F:transferrin receptor binding;, P:actin filament organization; P:activation of JUN kinase activity; P:antibacterial humoral response; P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:cellular response to iron ion; P:ERK1 and ERK2 cascade; P:iron ion homeostasis; P:iron ion transport; P:membrane organization; P:osteoclast differentiation; P:platelet degranulation; P:positive regulation of bone resorption; P:positive regulation of cell motility; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:regulation of iron ion transport; P:regulation of protein stability; P:retina homeostasis; P:SMAD protein signal transduction; P:transferrin transport;|P02787 O43890 Q1HBA5 Q9NQB8 Q9UHV0,Serotransferrin,Beta-1 metal-binding globulin;Siderophilin;, PF00405;, GO:0016324;GO:0045178;GO:0009925;GO:0072562;GO:0009986;GO:0030669;GO:0005905;GO:0031410;GO:0005769;GO:0030139;GO:0005788;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:1990712;GO:0005770;GO:0048471;GO:0005886;GO:0055037;GO:0034774;GO:0031982;GO:0008199;GO:0008198;GO:0034986;GO:1990459;GO:0007015;GO:0007257;GO:0019731;GO:0006879;GO:0044267;GO:0071281;GO:0070371;GO:0055072;GO:0006826;GO:0061024;GO:0030316;GO:0002576;GO:0045780;GO:2000147;GO:0048260;GO:0045893;GO:0043687;GO:0034756;GO:0031647;GO:0001895;GO:0060395;GO:0033572;, C:apical plasma membrane; C:basal part of cell; C:basal plasma membrane; C:blood microparticle; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum lumen; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:HFE-transferrin receptor complex; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule lumen; C:vesicle;, F:ferric iron binding; F:ferrous iron binding; F:iron chaperone activity; F:transferrin receptor binding;, P:actin filament organization; P:activation of JUN kinase activity; P:antibacterial humoral response; P:cellular iron ion homeostasis; P:cellular protein metabolic process; P:cellular response to iron ion; P:ERK1 and ERK2 cascade; P:iron ion homeostasis; P:iron ion transport; P:membrane organization; P:osteoclast differentiation; P:platelet degranulation; P:positive regulation of bone resorption; P:positive regulation of cell motility; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:regulation of iron ion transport; P:regulation of protein stability; P:retina homeostasis; P:SMAD protein signal transduction; P:transferrin transport; scaffold20 indexed_genome mRNA 13869209 13944566 . + . ID=transcript_4898;Q92547 B7Z7W8 Q7LGC1 Q9UEB9,DNA topoisomerase 2-binding protein 1,DNA topoisomerase II-beta-binding protein 1;DNA topoisomerase II-binding protein 1;, PF00533;PF12738;, GO:0015629;GO:0005694;GO:0000794;GO:0005737;GO:0043231;GO:0001673;GO:0005815;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0000922;GO:0003677;GO:0042802;GO:0008022;GO:0006974;GO:0006259;GO:0006281;GO:0006260;GO:0006270;GO:0033314;GO:0007095;GO:1901796;GO:0010212;, C:actin cytoskeleton; C:chromosome; C:condensed nuclear chromosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:male germ cell nucleus; C:microtubule organizing center; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:spindle pole;, F:DNA binding; F:identical protein binding; F:protein C-terminus binding;, P:cellular response to DNA damage stimulus; P:DNA metabolic process; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:mitotic DNA replication checkpoint; P:mitotic G2 DNA damage checkpoint; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation;|Q92547 B7Z7W8 Q7LGC1 Q9UEB9,DNA topoisomerase 2-binding protein 1,DNA topoisomerase II-beta-binding protein 1;DNA topoisomerase II-binding protein 1;, PF00533;PF12738;, GO:0015629;GO:0005694;GO:0000794;GO:0005737;GO:0043231;GO:0001673;GO:0005815;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0000922;GO:0003677;GO:0042802;GO:0008022;GO:0006974;GO:0006259;GO:0006281;GO:0006260;GO:0006270;GO:0033314;GO:0007095;GO:1901796;GO:0010212;, C:actin cytoskeleton; C:chromosome; C:condensed nuclear chromosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:male germ cell nucleus; C:microtubule organizing center; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:spindle pole;, F:DNA binding; F:identical protein binding; F:protein C-terminus binding;, P:cellular response to DNA damage stimulus; P:DNA metabolic process; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:mitotic DNA replication checkpoint; P:mitotic G2 DNA damage checkpoint; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation;|Q92547 B7Z7W8 Q7LGC1 Q9UEB9,DNA topoisomerase 2-binding protein 1,DNA topoisomerase II-beta-binding protein 1;DNA topoisomerase II-binding protein 1;, PF00533;PF12738;, GO:0015629;GO:0005694;GO:0000794;GO:0005737;GO:0043231;GO:0001673;GO:0005815;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0000922;GO:0003677;GO:0042802;GO:0008022;GO:0006974;GO:0006259;GO:0006281;GO:0006260;GO:0006270;GO:0033314;GO:0007095;GO:1901796;GO:0010212;, C:actin cytoskeleton; C:chromosome; C:condensed nuclear chromosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:male germ cell nucleus; C:microtubule organizing center; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:spindle pole;, F:DNA binding; F:identical protein binding; F:protein C-terminus binding;, P:cellular response to DNA damage stimulus; P:DNA metabolic process; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:mitotic DNA replication checkpoint; P:mitotic G2 DNA damage checkpoint; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; scaffold20 indexed_genome mRNA 13988505 13990292 . + . ID=transcript_4899;Q9UKY7 B3KUC2 Q96IP9,Protein CDV3 homolog,, PF15359;, GO:0005737;GO:0005829;GO:0005886;, C:cytoplasm; C:cytosol; C:plasma membrane; scaffold20 indexed_genome mRNA 14079689 14155376 . - . ID=transcript_4900;Q13515 Q14D32 Q9HBW5,Phakinin {ECO:0000303|PubMed:28935373},49 kDa cytoskeletal protein;Beaded filament structural protein 2 {ECO:0000303|PubMed:10729115};Lens fiber cell beaded filament protein CP 47 {ECO:0000303|PubMed:28935373};Lens fiber cell beaded filament protein CP 49 {ECO:0000303|PubMed:8636093};Lens intermediate filament-like light {ECO:0000303|PubMed:10729115};, PF00038;, GO:0005938;GO:0005882;GO:0005886;GO:0005200;GO:0005212;GO:0048469;GO:0045109;GO:0070307;GO:0050896;GO:0007601;, C:cell cortex; C:intermediate filament; C:plasma membrane;, F:structural constituent of cytoskeleton; F:structural constituent of eye lens;, P:cell maturation; P:intermediate filament organization; P:lens fiber cell development; P:response to stimulus; P:visual perception; scaffold20 indexed_genome mRNA 14158107 14159345 . - . ID=transcript_4901;Q6UXF1 D3DNC9 Q9BQH1 Q9BW81 Q9C0H3,Transmembrane protein 108 {ECO:0000312|HGNC:HGNC:28451},Retrolinkin {ECO:0000305};, PF15759;, GO:0030424;GO:1904115;GO:0030425;GO:0005769;GO:0010008;GO:0016021;GO:0014069;GO:0036477;GO:1990416;GO:0097484;GO:0021542;GO:0098815;GO:0031175;GO:0051388;GO:0097106;GO:0006898;GO:0008090;, C:axon; C:axon cytoplasm; C:dendrite; C:early endosome; C:endosome membrane; C:integral component of membrane; C:postsynaptic density; C:somatodendritic compartment;, , P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dentate gyrus development; P:modulation of excitatory postsynaptic potential; P:neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:postsynaptic density organization; P:receptor-mediated endocytosis; P:retrograde axonal transport; scaffold20 indexed_genome mRNA 14173823 14601486 . - . ID=transcript_4902;Q6UXF1 D3DNC9 Q9BQH1 Q9BW81 Q9C0H3,Transmembrane protein 108 {ECO:0000312|HGNC:HGNC:28451},Retrolinkin {ECO:0000305};, PF15759;, GO:0030424;GO:1904115;GO:0030425;GO:0005769;GO:0010008;GO:0016021;GO:0014069;GO:0036477;GO:1990416;GO:0097484;GO:0021542;GO:0098815;GO:0031175;GO:0051388;GO:0097106;GO:0006898;GO:0008090;, C:axon; C:axon cytoplasm; C:dendrite; C:early endosome; C:endosome membrane; C:integral component of membrane; C:postsynaptic density; C:somatodendritic compartment;, , P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dentate gyrus development; P:modulation of excitatory postsynaptic potential; P:neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:postsynaptic density organization; P:receptor-mediated endocytosis; P:retrograde axonal transport; scaffold20 indexed_genome mRNA 14986126 15044028 . + . ID=transcript_4903;Q96N70 Q96NK2,Nephrocystin-3,, PF13176;, GO:0005929;GO:0005829;GO:0005576;GO:0003283;GO:0060271;GO:0060027;GO:0071908;GO:0007368;GO:0071910;GO:0035469;GO:0071909;GO:0060287;GO:0001947;GO:0001822;GO:0060993;GO:0030324;GO:0048496;GO:0090090;GO:0045494;GO:2000167;GO:2000095;GO:0072189;GO:0016055;, C:cilium; C:cytosol; C:extracellular region;, , P:atrial septum development; P:cilium assembly; P:convergent extension involved in gastrulation; P:determination of intestine left/right asymmetry; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:determination of stomach left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:heart looping; P:kidney development; P:kidney morphogenesis; P:lung development; P:maintenance of animal organ identity; P:negative regulation of canonical Wnt signaling pathway; P:photoreceptor cell maintenance; P:regulation of planar cell polarity pathway involved in neural tube closure; P:regulation of Wnt signaling pathway, planar cell polarity pathway; P:ureter development; P:Wnt signaling pathway;|Q96N70 Q96NK2,Nephrocystin-3,, PF13176;, GO:0005929;GO:0005829;GO:0005576;GO:0003283;GO:0060271;GO:0060027;GO:0071908;GO:0007368;GO:0071910;GO:0035469;GO:0071909;GO:0060287;GO:0001947;GO:0001822;GO:0060993;GO:0030324;GO:0048496;GO:0090090;GO:0045494;GO:2000167;GO:2000095;GO:0072189;GO:0016055;, C:cilium; C:cytosol; C:extracellular region;, , P:atrial septum development; P:cilium assembly; P:convergent extension involved in gastrulation; P:determination of intestine left/right asymmetry; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:determination of stomach left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:heart looping; P:kidney development; P:kidney morphogenesis; P:lung development; P:maintenance of animal organ identity; P:negative regulation of canonical Wnt signaling pathway; P:photoreceptor cell maintenance; P:regulation of planar cell polarity pathway involved in neural tube closure; P:regulation of Wnt signaling pathway, planar cell polarity pathway; P:ureter development; P:Wnt signaling pathway;|Q96N70 Q96NK2,Nephrocystin-3,, PF13176;, GO:0005929;GO:0005829;GO:0005576;GO:0003283;GO:0060271;GO:0060027;GO:0071908;GO:0007368;GO:0071910;GO:0035469;GO:0071909;GO:0060287;GO:0001947;GO:0001822;GO:0060993;GO:0030324;GO:0048496;GO:0090090;GO:0045494;GO:2000167;GO:2000095;GO:0072189;GO:0016055;, C:cilium; C:cytosol; C:extracellular region;, , P:atrial septum development; P:cilium assembly; P:convergent extension involved in gastrulation; P:determination of intestine left/right asymmetry; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:determination of stomach left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:heart looping; P:kidney development; P:kidney morphogenesis; P:lung development; P:maintenance of animal organ identity; P:negative regulation of canonical Wnt signaling pathway; P:photoreceptor cell maintenance; P:regulation of planar cell polarity pathway involved in neural tube closure; P:regulation of Wnt signaling pathway, planar cell polarity pathway; P:ureter development; P:Wnt signaling pathway;|Q96N70 Q96NK2,Nephrocystin-3,, PF13176;, GO:0005929;GO:0005829;GO:0005576;GO:0003283;GO:0060271;GO:0060027;GO:0071908;GO:0007368;GO:0071910;GO:0035469;GO:0071909;GO:0060287;GO:0001947;GO:0001822;GO:0060993;GO:0030324;GO:0048496;GO:0090090;GO:0045494;GO:2000167;GO:2000095;GO:0072189;GO:0016055;, C:cilium; C:cytosol; C:extracellular region;, , P:atrial septum development; P:cilium assembly; P:convergent extension involved in gastrulation; P:determination of intestine left/right asymmetry; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:determination of stomach left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:heart looping; P:kidney development; P:kidney morphogenesis; P:lung development; P:maintenance of animal organ identity; P:negative regulation of canonical Wnt signaling pathway; P:photoreceptor cell maintenance; P:regulation of planar cell polarity pathway involved in neural tube closure; P:regulation of Wnt signaling pathway, planar cell polarity pathway; P:ureter development; P:Wnt signaling pathway;|Q96N70 Q96NK2,Nephrocystin-3,, PF13176;, GO:0005929;GO:0005829;GO:0005576;GO:0003283;GO:0060271;GO:0060027;GO:0071908;GO:0007368;GO:0071910;GO:0035469;GO:0071909;GO:0060287;GO:0001947;GO:0001822;GO:0060993;GO:0030324;GO:0048496;GO:0090090;GO:0045494;GO:2000167;GO:2000095;GO:0072189;GO:0016055;, C:cilium; C:cytosol; C:extracellular region;, , P:atrial septum development; P:cilium assembly; P:convergent extension involved in gastrulation; P:determination of intestine left/right asymmetry; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:determination of stomach left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:heart looping; P:kidney development; P:kidney morphogenesis; P:lung development; P:maintenance of animal organ identity; P:negative regulation of canonical Wnt signaling pathway; P:photoreceptor cell maintenance; P:regulation of planar cell polarity pathway involved in neural tube closure; P:regulation of Wnt signaling pathway, planar cell polarity pathway; P:ureter development; P:Wnt signaling pathway;|Q96N70 Q96NK2,Nephrocystin-3,, PF13176;, GO:0005929;GO:0005829;GO:0005576;GO:0003283;GO:0060271;GO:0060027;GO:0071908;GO:0007368;GO:0071910;GO:0035469;GO:0071909;GO:0060287;GO:0001947;GO:0001822;GO:0060993;GO:0030324;GO:0048496;GO:0090090;GO:0045494;GO:2000167;GO:2000095;GO:0072189;GO:0016055;, C:cilium; C:cytosol; C:extracellular region;, , P:atrial septum development; P:cilium assembly; P:convergent extension involved in gastrulation; P:determination of intestine left/right asymmetry; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:determination of stomach left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:heart looping; P:kidney development; P:kidney morphogenesis; P:lung development; P:maintenance of animal organ identity; P:negative regulation of canonical Wnt signaling pathway; P:photoreceptor cell maintenance; P:regulation of planar cell polarity pathway involved in neural tube closure; P:regulation of Wnt signaling pathway, planar cell polarity pathway; P:ureter development; P:Wnt signaling pathway; scaffold20 indexed_genome mRNA 15045499 15076626 . - . ID=transcript_4904;Q9GZZ9 A6NJL3 D3DNC8 Q96ST1,Ubiquitin-like modifier-activating enzyme 5 {ECO:0000305},ThiFP1 {ECO:0000303|PubMed:16328888};UFM1-activating enzyme {ECO:0000303|PubMed:15071506};Ubiquitin-activating enzyme E1 domain-containing protein 1 {ECO:0000303|PubMed:16328888};, PF00899;, GO:0005737;GO:0005829;GO:0005789;GO:0005794;GO:0043231;GO:0005634;GO:0005524;GO:0042803;GO:0071566;GO:0008270;GO:0030218;GO:0030219;GO:0050905;GO:1990592;GO:0032446;GO:0071569;GO:0033146;GO:0034976;GO:0061709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleus;, F:ATP binding; F:protein homodimerization activity; F:UFM1 activating enzyme activity; F:zinc ion binding;, P:erythrocyte differentiation; P:megakaryocyte differentiation; P:neuromuscular process; P:protein K69-linked ufmylation; P:protein modification by small protein conjugation; P:protein ufmylation; P:regulation of intracellular estrogen receptor signaling pathway; P:response to endoplasmic reticulum stress; P:reticulophagy;|Q9GZZ9 A6NJL3 D3DNC8 Q96ST1,Ubiquitin-like modifier-activating enzyme 5 {ECO:0000305},ThiFP1 {ECO:0000303|PubMed:16328888};UFM1-activating enzyme {ECO:0000303|PubMed:15071506};Ubiquitin-activating enzyme E1 domain-containing protein 1 {ECO:0000303|PubMed:16328888};, PF00899;, GO:0005737;GO:0005829;GO:0005789;GO:0005794;GO:0043231;GO:0005634;GO:0005524;GO:0042803;GO:0071566;GO:0008270;GO:0030218;GO:0030219;GO:0050905;GO:1990592;GO:0032446;GO:0071569;GO:0033146;GO:0034976;GO:0061709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleus;, F:ATP binding; F:protein homodimerization activity; F:UFM1 activating enzyme activity; F:zinc ion binding;, P:erythrocyte differentiation; P:megakaryocyte differentiation; P:neuromuscular process; P:protein K69-linked ufmylation; P:protein modification by small protein conjugation; P:protein ufmylation; P:regulation of intracellular estrogen receptor signaling pathway; P:response to endoplasmic reticulum stress; P:reticulophagy; scaffold20 indexed_genome mRNA 15076658 15174987 . + . ID=transcript_4905;Q709F0 Q08AF0 Q658N9 Q658Y2 Q6ZND2 Q8WUT6 Q9H9R3,Acyl-CoA dehydrogenase family member 11,, PF00441;PF02770;PF02771;PF01636;, GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0005777;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0006635;GO:0033539;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:peroxisome;, F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase;|Q709F0 Q08AF0 Q658N9 Q658Y2 Q6ZND2 Q8WUT6 Q9H9R3,Acyl-CoA dehydrogenase family member 11,, PF00441;PF02770;PF02771;PF01636;, GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0005777;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0006635;GO:0033539;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:peroxisome;, F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase;|Q9NPB9 B2R9U7,Atypical chemokine receptor 4,C-C chemokine receptor type 11;CC chemokine receptor-like 1;CCX CKR;, PF00001;, GO:0005769;GO:0009897;GO:0005887;GO:0005886;GO:0055037;GO:0019957;GO:0016493;GO:0004950;GO:0005044;GO:0019722;GO:0060326;GO:0006935;GO:0007186;GO:0006955;GO:0007204;, C:early endosome; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane; C:recycling endosome;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:chemokine receptor activity; F:scavenger receptor activity;, P:calcium-mediated signaling; P:cell chemotaxis; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:positive regulation of cytosolic calcium ion concentration;|Q709F0 Q08AF0 Q658N9 Q658Y2 Q6ZND2 Q8WUT6 Q9H9R3,Acyl-CoA dehydrogenase family member 11,, PF00441;PF02770;PF02771;PF01636;, GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0005777;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0006635;GO:0033539;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:peroxisome;, F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase;|Q709F0 Q08AF0 Q658N9 Q658Y2 Q6ZND2 Q8WUT6 Q9H9R3,Acyl-CoA dehydrogenase family member 11,, PF00441;PF02770;PF02771;PF01636;, GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0005777;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0006635;GO:0033539;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus; C:peroxisome;, F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; scaffold20 indexed_genome mRNA 15200061 15307854 . + . ID=transcript_4906;O75165 Q3L0T1 Q6PI82 Q6UJ77 Q6ZSW1 Q6ZUT5 Q86XG3 Q96DC1 Q9BWK9,DnaJ homolog subfamily C member 13,Required for receptor-mediated endocytosis 8;, PF00226;PF14237;, GO:0035577;GO:0005829;GO:0031901;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0030667;GO:0007032;GO:0043312;GO:0001649;GO:0015031;GO:0006898;GO:2000641;GO:1902954;, C:azurophil granule membrane; C:cytosol; C:early endosome membrane; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, , P:endosome organization; P:neutrophil degranulation; P:osteoblast differentiation; P:protein transport; P:receptor-mediated endocytosis; P:regulation of early endosome to late endosome transport; P:regulation of early endosome to recycling endosome transport;|O75165 Q3L0T1 Q6PI82 Q6UJ77 Q6ZSW1 Q6ZUT5 Q86XG3 Q96DC1 Q9BWK9,DnaJ homolog subfamily C member 13,Required for receptor-mediated endocytosis 8;, PF00226;PF14237;, GO:0035577;GO:0005829;GO:0031901;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0030667;GO:0007032;GO:0043312;GO:0001649;GO:0015031;GO:0006898;GO:2000641;GO:1902954;, C:azurophil granule membrane; C:cytosol; C:early endosome membrane; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, , P:endosome organization; P:neutrophil degranulation; P:osteoblast differentiation; P:protein transport; P:receptor-mediated endocytosis; P:regulation of early endosome to late endosome transport; P:regulation of early endosome to recycling endosome transport;|O75165 Q3L0T1 Q6PI82 Q6UJ77 Q6ZSW1 Q6ZUT5 Q86XG3 Q96DC1 Q9BWK9,DnaJ homolog subfamily C member 13,Required for receptor-mediated endocytosis 8;, PF00226;PF14237;, GO:0035577;GO:0005829;GO:0031901;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0030667;GO:0007032;GO:0043312;GO:0001649;GO:0015031;GO:0006898;GO:2000641;GO:1902954;, C:azurophil granule membrane; C:cytosol; C:early endosome membrane; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, , P:endosome organization; P:neutrophil degranulation; P:osteoblast differentiation; P:protein transport; P:receptor-mediated endocytosis; P:regulation of early endosome to late endosome transport; P:regulation of early endosome to recycling endosome transport;|O75165 Q3L0T1 Q6PI82 Q6UJ77 Q6ZSW1 Q6ZUT5 Q86XG3 Q96DC1 Q9BWK9,DnaJ homolog subfamily C member 13,Required for receptor-mediated endocytosis 8;, PF00226;PF14237;, GO:0035577;GO:0005829;GO:0031901;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0030667;GO:0007032;GO:0043312;GO:0001649;GO:0015031;GO:0006898;GO:2000641;GO:1902954;, C:azurophil granule membrane; C:cytosol; C:early endosome membrane; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, , P:endosome organization; P:neutrophil degranulation; P:osteoblast differentiation; P:protein transport; P:receptor-mediated endocytosis; P:regulation of early endosome to late endosome transport; P:regulation of early endosome to recycling endosome transport;|O75165 Q3L0T1 Q6PI82 Q6UJ77 Q6ZSW1 Q6ZUT5 Q86XG3 Q96DC1 Q9BWK9,DnaJ homolog subfamily C member 13,Required for receptor-mediated endocytosis 8;, PF00226;PF14237;, GO:0035577;GO:0005829;GO:0031901;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0030667;GO:0007032;GO:0043312;GO:0001649;GO:0015031;GO:0006898;GO:2000641;GO:1902954;, C:azurophil granule membrane; C:cytosol; C:early endosome membrane; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, , P:endosome organization; P:neutrophil degranulation; P:osteoblast differentiation; P:protein transport; P:receptor-mediated endocytosis; P:regulation of early endosome to late endosome transport; P:regulation of early endosome to recycling endosome transport;|O75165 Q3L0T1 Q6PI82 Q6UJ77 Q6ZSW1 Q6ZUT5 Q86XG3 Q96DC1 Q9BWK9,DnaJ homolog subfamily C member 13,Required for receptor-mediated endocytosis 8;, PF00226;PF14237;, GO:0035577;GO:0005829;GO:0031901;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0030667;GO:0007032;GO:0043312;GO:0001649;GO:0015031;GO:0006898;GO:2000641;GO:1902954;, C:azurophil granule membrane; C:cytosol; C:early endosome membrane; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, , P:endosome organization; P:neutrophil degranulation; P:osteoblast differentiation; P:protein transport; P:receptor-mediated endocytosis; P:regulation of early endosome to late endosome transport; P:regulation of early endosome to recycling endosome transport;|O75165 Q3L0T1 Q6PI82 Q6UJ77 Q6ZSW1 Q6ZUT5 Q86XG3 Q96DC1 Q9BWK9,DnaJ homolog subfamily C member 13,Required for receptor-mediated endocytosis 8;, PF00226;PF14237;, GO:0035577;GO:0005829;GO:0031901;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0030667;GO:0007032;GO:0043312;GO:0001649;GO:0015031;GO:0006898;GO:2000641;GO:1902954;, C:azurophil granule membrane; C:cytosol; C:early endosome membrane; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, , P:endosome organization; P:neutrophil degranulation; P:osteoblast differentiation; P:protein transport; P:receptor-mediated endocytosis; P:regulation of early endosome to late endosome transport; P:regulation of early endosome to recycling endosome transport; scaffold20 indexed_genome mRNA 16534235 16587752 . + . ID=transcript_4907;P09001 Q6IBT2,39S ribosomal protein L3, mitochondrial,Mitochondrial large ribosomal subunit protein uL3m {ECO:0000303|PubMed:25278503};, PF00297;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|P09001 Q6IBT2,39S ribosomal protein L3, mitochondrial,Mitochondrial large ribosomal subunit protein uL3m {ECO:0000303|PubMed:25278503};, PF00297;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|P09001 Q6IBT2,39S ribosomal protein L3, mitochondrial,Mitochondrial large ribosomal subunit protein uL3m {ECO:0000303|PubMed:25278503};, PF00297;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold20 indexed_genome mRNA 16674629 16677243 . - . ID=transcript_4908;Q96DE0 B4E3B4 E9PED4 F5GYJ1 Q96N82,U8 snoRNA-decapping enzyme,IDP phosphatase;Inosine diphosphate phosphatase;Nucleoside diphosphate-linked moiety X motif 16;Nudix hydrolase 16;U8 snoRNA-binding protein H29K {ECO:0000303|PubMed:17567574};m7GpppN-mRNA hydrolase;, PF00293;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0031404;GO:0050897;GO:0097383;GO:0035870;GO:0005525;GO:0042802;GO:1990003;GO:1901641;GO:0050072;GO:0000287;GO:0030145;GO:0008235;GO:0003729;GO:0098519;GO:1990174;GO:0042803;GO:0030515;GO:1901640;GO:0006382;GO:0035863;GO:0046709;GO:0006402;GO:2000233;GO:0034656;GO:0090068;GO:0008284;GO:2000781;GO:0090502;GO:0016077;GO:1901639;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chloride ion binding; F:cobalt ion binding; F:dIDP diphosphatase activity; F:dITP diphosphatase activity; F:GTP binding; F:identical protein binding; F:inosine-diphosphatase activity; F:ITP binding; F:m7G(5')pppN diphosphatase activity; F:magnesium ion binding; F:manganese ion binding; F:metalloexopeptidase activity; F:mRNA binding; F:nucleotide phosphatase activity, acting on free nucleotides; F:phosphodiesterase decapping endonuclease activity; F:protein homodimerization activity; F:snoRNA binding; F:XTP binding;, P:adenosine to inosine editing; P:dITP catabolic process; P:IDP catabolic process; P:mRNA catabolic process; P:negative regulation of rRNA processing; P:nucleobase-containing small molecule catabolic process; P:positive regulation of cell cycle process; P:positive regulation of cell population proliferation; P:positive regulation of double-strand break repair; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:sno(s)RNA catabolic process; P:XDP catabolic process; scaffold20 indexed_genome mRNA 16689726 16972059 . - . ID=transcript_4909;Q8NG66 A6NHD7 Q5JPC0 Q8NG65 Q8TBY1 Q9H5F4,Serine/threonine-protein kinase Nek11,Never in mitosis A-related kinase 11;, PF00069;, GO:0005813;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0007059;GO:0016572;GO:0031573;GO:0035556;GO:0006468;GO:1901990;, C:centrosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:chromosome segregation; P:histone phosphorylation; P:intra-S DNA damage checkpoint; P:intracellular signal transduction; P:protein phosphorylation; P:regulation of mitotic cell cycle phase transition;|Q8NG66 A6NHD7 Q5JPC0 Q8NG65 Q8TBY1 Q9H5F4,Serine/threonine-protein kinase Nek11,Never in mitosis A-related kinase 11;, PF00069;, GO:0005813;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0007059;GO:0016572;GO:0031573;GO:0035556;GO:0006468;GO:1901990;, C:centrosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:chromosome segregation; P:histone phosphorylation; P:intra-S DNA damage checkpoint; P:intracellular signal transduction; P:protein phosphorylation; P:regulation of mitotic cell cycle phase transition; scaffold20 indexed_genome mRNA 16972102 16988920 . + . ID=transcript_4910;Q2TB18 B4DFL9 Q3MIB6 Q8N6G4 Q96JY1 Q9UHX6,Protein asteroid homolog 1,, PF12813;PF00752;, GO:0004518;, , F:nuclease activity; scaffold20 indexed_genome mRNA 16998731 17121210 . - . ID=transcript_4911;Q8N6V1 Q8NCJ7,Calcium-transporting ATPase type 2C member 1,ATP-dependent Ca(2+) pump PMR1;, PF00689;PF00690;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0005802;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030145;GO:0015410;GO:0046872;GO:0008553;GO:0031532;GO:0070588;GO:0006816;GO:0016339;GO:0006874;GO:0030026;GO:0008544;GO:0032468;GO:0032472;GO:0034220;GO:0006828;GO:0043123;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:manganese ion binding; F:manganese transmembrane transporter activity, phosphorylative mechanism; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:actin cytoskeleton reorganization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular calcium ion homeostasis; P:cellular manganese ion homeostasis; P:epidermis development; P:Golgi calcium ion homeostasis; P:Golgi calcium ion transport; P:ion transmembrane transport; P:manganese ion transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q8N6V1 Q8NCJ7,Calcium-transporting ATPase type 2C member 1,ATP-dependent Ca(2+) pump PMR1;, PF00689;PF00690;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0005802;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030145;GO:0015410;GO:0046872;GO:0008553;GO:0031532;GO:0070588;GO:0006816;GO:0016339;GO:0006874;GO:0030026;GO:0008544;GO:0032468;GO:0032472;GO:0034220;GO:0006828;GO:0043123;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:manganese ion binding; F:manganese transmembrane transporter activity, phosphorylative mechanism; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:actin cytoskeleton reorganization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular calcium ion homeostasis; P:cellular manganese ion homeostasis; P:epidermis development; P:Golgi calcium ion homeostasis; P:Golgi calcium ion transport; P:ion transmembrane transport; P:manganese ion transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q8N6V1 Q8NCJ7,Calcium-transporting ATPase type 2C member 1,ATP-dependent Ca(2+) pump PMR1;, PF00689;PF00690;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0005802;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030145;GO:0015410;GO:0046872;GO:0008553;GO:0031532;GO:0070588;GO:0006816;GO:0016339;GO:0006874;GO:0030026;GO:0008544;GO:0032468;GO:0032472;GO:0034220;GO:0006828;GO:0043123;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:manganese ion binding; F:manganese transmembrane transporter activity, phosphorylative mechanism; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:actin cytoskeleton reorganization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular calcium ion homeostasis; P:cellular manganese ion homeostasis; P:epidermis development; P:Golgi calcium ion homeostasis; P:Golgi calcium ion transport; P:ion transmembrane transport; P:manganese ion transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q8N6V1 Q8NCJ7,Calcium-transporting ATPase type 2C member 1,ATP-dependent Ca(2+) pump PMR1;, PF00689;PF00690;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0005802;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030145;GO:0015410;GO:0046872;GO:0008553;GO:0031532;GO:0070588;GO:0006816;GO:0016339;GO:0006874;GO:0030026;GO:0008544;GO:0032468;GO:0032472;GO:0034220;GO:0006828;GO:0043123;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:manganese ion binding; F:manganese transmembrane transporter activity, phosphorylative mechanism; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:actin cytoskeleton reorganization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular calcium ion homeostasis; P:cellular manganese ion homeostasis; P:epidermis development; P:Golgi calcium ion homeostasis; P:Golgi calcium ion transport; P:ion transmembrane transport; P:manganese ion transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q8N6V1 Q8NCJ7,Calcium-transporting ATPase type 2C member 1,ATP-dependent Ca(2+) pump PMR1;, PF00689;PF00690;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0005802;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030145;GO:0015410;GO:0046872;GO:0008553;GO:0031532;GO:0070588;GO:0006816;GO:0016339;GO:0006874;GO:0030026;GO:0008544;GO:0032468;GO:0032472;GO:0034220;GO:0006828;GO:0043123;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:manganese ion binding; F:manganese transmembrane transporter activity, phosphorylative mechanism; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:actin cytoskeleton reorganization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular calcium ion homeostasis; P:cellular manganese ion homeostasis; P:epidermis development; P:Golgi calcium ion homeostasis; P:Golgi calcium ion transport; P:ion transmembrane transport; P:manganese ion transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q8N6V1 Q8NCJ7,Calcium-transporting ATPase type 2C member 1,ATP-dependent Ca(2+) pump PMR1;, PF00689;PF00690;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0005802;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030145;GO:0015410;GO:0046872;GO:0008553;GO:0031532;GO:0070588;GO:0006816;GO:0016339;GO:0006874;GO:0030026;GO:0008544;GO:0032468;GO:0032472;GO:0034220;GO:0006828;GO:0043123;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:manganese ion binding; F:manganese transmembrane transporter activity, phosphorylative mechanism; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:actin cytoskeleton reorganization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular calcium ion homeostasis; P:cellular manganese ion homeostasis; P:epidermis development; P:Golgi calcium ion homeostasis; P:Golgi calcium ion transport; P:ion transmembrane transport; P:manganese ion transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q8N6V1 Q8NCJ7,Calcium-transporting ATPase type 2C member 1,ATP-dependent Ca(2+) pump PMR1;, PF00689;PF00690;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0005802;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030145;GO:0015410;GO:0046872;GO:0008553;GO:0031532;GO:0070588;GO:0006816;GO:0016339;GO:0006874;GO:0030026;GO:0008544;GO:0032468;GO:0032472;GO:0034220;GO:0006828;GO:0043123;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:manganese ion binding; F:manganese transmembrane transporter activity, phosphorylative mechanism; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:actin cytoskeleton reorganization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular calcium ion homeostasis; P:cellular manganese ion homeostasis; P:epidermis development; P:Golgi calcium ion homeostasis; P:Golgi calcium ion transport; P:ion transmembrane transport; P:manganese ion transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold20 indexed_genome mRNA 17355341 17356807 . + . ID=transcript_4912;O95456 B5BUN2 Q6FHA3 Q6FHD3 Q6S713,Proteasome assembly chaperone 1,Chromosome 21 leucine-rich protein;Down syndrome critical region protein 2;, PF16094;, GO:0101031;GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0005634;GO:0060090;GO:0070628;GO:0021930;GO:0051131;GO:0080129;, C:chaperone complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:molecular adaptor activity; F:proteasome binding;, P:cerebellar granule cell precursor proliferation; P:chaperone-mediated protein complex assembly; P:proteasome core complex assembly; scaffold20 indexed_genome mRNA 17356887 17367621 . - . ID=transcript_4913;O95456 B5BUN2 Q6FHA3 Q6FHD3 Q6S713,Proteasome assembly chaperone 1,Chromosome 21 leucine-rich protein;Down syndrome critical region protein 2;, PF16094;, GO:0101031;GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0005634;GO:0060090;GO:0070628;GO:0021930;GO:0051131;GO:0080129;, C:chaperone complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:molecular adaptor activity; F:proteasome binding;, P:cerebellar granule cell precursor proliferation; P:chaperone-mediated protein complex assembly; P:proteasome core complex assembly;|O95456 B5BUN2 Q6FHA3 Q6FHD3 Q6S713,Proteasome assembly chaperone 1,Chromosome 21 leucine-rich protein;Down syndrome critical region protein 2;, PF16094;, GO:0101031;GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0005634;GO:0060090;GO:0070628;GO:0021930;GO:0051131;GO:0080129;, C:chaperone complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:molecular adaptor activity; F:proteasome binding;, P:cerebellar granule cell precursor proliferation; P:chaperone-mediated protein complex assembly; P:proteasome core complex assembly;|O95456 B5BUN2 Q6FHA3 Q6FHD3 Q6S713,Proteasome assembly chaperone 1,Chromosome 21 leucine-rich protein;Down syndrome critical region protein 2;, PF16094;, GO:0101031;GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0005634;GO:0060090;GO:0070628;GO:0021930;GO:0051131;GO:0080129;, C:chaperone complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:molecular adaptor activity; F:proteasome binding;, P:cerebellar granule cell precursor proliferation; P:chaperone-mediated protein complex assembly; P:proteasome core complex assembly; scaffold20 indexed_genome mRNA 17367753 17375645 . + . ID=transcript_4914;Q9NUK1,Bromodomain and WD repeat-containing protein 1,WD repeat-containing protein 9;, PF00439;PF00400;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0006325;GO:0007010;GO:0038111;GO:0008360;GO:0006357;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:chromatin organization; P:cytoskeleton organization; P:interleukin-7-mediated signaling pathway; P:regulation of cell shape; P:regulation of transcription by RNA polymerase II; scaffold20 indexed_genome mRNA 17376287 17493820 . - . ID=transcript_4915;Q9NUK1,Bromodomain and WD repeat-containing protein 1,WD repeat-containing protein 9;, PF00439;PF00400;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0006325;GO:0007010;GO:0038111;GO:0008360;GO:0006357;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:chromatin organization; P:cytoskeleton organization; P:interleukin-7-mediated signaling pathway; P:regulation of cell shape; P:regulation of transcription by RNA polymerase II;|Q9NUK1,Bromodomain and WD repeat-containing protein 1,WD repeat-containing protein 9;, PF00439;PF00400;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0006325;GO:0007010;GO:0038111;GO:0008360;GO:0006357;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:chromatin organization; P:cytoskeleton organization; P:interleukin-7-mediated signaling pathway; P:regulation of cell shape; P:regulation of transcription by RNA polymerase II;|Q9NUK1,Bromodomain and WD repeat-containing protein 1,WD repeat-containing protein 9;, PF00439;PF00400;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0006325;GO:0007010;GO:0038111;GO:0008360;GO:0006357;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:chromatin organization; P:cytoskeleton organization; P:interleukin-7-mediated signaling pathway; P:regulation of cell shape; P:regulation of transcription by RNA polymerase II;|Q9NUK1,Bromodomain and WD repeat-containing protein 1,WD repeat-containing protein 9;, PF00439;PF00400;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0006325;GO:0007010;GO:0038111;GO:0008360;GO:0006357;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:chromatin organization; P:cytoskeleton organization; P:interleukin-7-mediated signaling pathway; P:regulation of cell shape; P:regulation of transcription by RNA polymerase II;|Q9NUK1,Bromodomain and WD repeat-containing protein 1,WD repeat-containing protein 9;, PF00439;PF00400;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0006325;GO:0007010;GO:0038111;GO:0008360;GO:0006357;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:chromatin organization; P:cytoskeleton organization; P:interleukin-7-mediated signaling pathway; P:regulation of cell shape; P:regulation of transcription by RNA polymerase II; scaffold20 indexed_genome mRNA 17525993 17574175 . - . ID=transcript_4916;P05114 Q3KQR8,Non-histone chromosomal protein HMG-14,High mobility group nucleosome-binding domain-containing protein 1;, PF01101;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0031492;GO:0006325;GO:0032786;GO:0006283;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:nucleosomal DNA binding;, P:chromatin organization; P:positive regulation of DNA-templated transcription, elongation; P:transcription-coupled nucleotide-excision repair;|P05114 Q3KQR8,Non-histone chromosomal protein HMG-14,High mobility group nucleosome-binding domain-containing protein 1;, PF01101;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0031492;GO:0006325;GO:0032786;GO:0006283;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:nucleosomal DNA binding;, P:chromatin organization; P:positive regulation of DNA-templated transcription, elongation; P:transcription-coupled nucleotide-excision repair;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|O00258 A8KAP8 A8MQ44 D3DSH9 O60740,Guided entry of tail-anchored proteins factor 1 {ECO:0000312|HGNC:HGNC:12790},Congenital heart disease 5 protein;Tail-anchored protein insertion receptor WRB;Tryptophan-rich basic protein;, PF04420;, GO:0005783;GO:0005789;GO:0043529;GO:0016021;GO:0005634;GO:0071816;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:GET complex; C:integral component of membrane; C:nucleus;, , P:tail-anchored membrane protein insertion into ER membrane; scaffold20 indexed_genome mRNA 17589572 17591345 . - . ID=transcript_4917;O95447 D3DSI0 Q3ZCT0,Lebercilin-like protein,Leber congenital amaurosis 5-like protein;, PF15619;, GO:0005930;GO:0042073;, C:axoneme;, , P:intraciliary transport; scaffold20 indexed_genome mRNA 17594196 17610229 . - . ID=transcript_4918;O95447 D3DSI0 Q3ZCT0,Lebercilin-like protein,Leber congenital amaurosis 5-like protein;, PF15619;, GO:0005930;GO:0042073;, C:axoneme;, , P:intraciliary transport; scaffold20 indexed_genome mRNA 17652879 17727040 . + . ID=transcript_4919;P55822 A6ND59 D3DSI2 Q9BRB8,SH3 domain-binding glutamic acid-rich protein,21-glutamic acid-rich protein;, PF04908;, GO:0005829;GO:0017124;GO:0065003;, C:cytosol;, F:SH3 domain binding;, P:protein-containing complex assembly; scaffold20 indexed_genome mRNA 17941117 17994156 . + . ID=transcript_4920;Q9NSI5,Immunoglobulin superfamily member 5,Junctional adhesion molecule 4;, PF07679;, GO:0016324;GO:0005923;GO:0009986;GO:0016021;GO:0098609;, C:apical plasma membrane; C:bicellular tight junction; C:cell surface; C:integral component of membrane;, , P:cell-cell adhesion;|Q9NSI5,Immunoglobulin superfamily member 5,Junctional adhesion molecule 4;, PF07679;, GO:0016324;GO:0005923;GO:0009986;GO:0016021;GO:0098609;, C:apical plasma membrane; C:bicellular tight junction; C:cell surface; C:integral component of membrane;, , P:cell-cell adhesion; scaffold20 indexed_genome mRNA 18054490 18119195 . + . ID=transcript_4921;P48539 A6NDJ9 Q6ICS4 Q93059,Calmodulin regulator protein PCP4 {ECO:0000305},Brain-specific polypeptide PEP-19 {ECO:0000303|PubMed:8931698};Purkinje cell protein 4 {ECO:0000312|HGNC:HGNC:8742};, , GO:0005737;GO:0005829;GO:0005634;GO:0032991;GO:0005509;GO:0005516;GO:0099004;GO:0045666;, C:cytoplasm; C:cytosol; C:nucleus; C:protein-containing complex;, F:calcium ion binding; F:calmodulin binding;, P:calmodulin dependent kinase signaling pathway; P:positive regulation of neuron differentiation; scaffold20 indexed_genome mRNA 18237782 18256473 . - . ID=transcript_4922;O60469 O60468,Down syndrome cell adhesion molecule,CHD2;, PF00041;PF07679;, GO:0030424;GO:0030425;GO:0005576;GO:0030426;GO:0005887;GO:0016020;GO:0043025;GO:0005886;GO:0045202;GO:0098632;GO:1990890;GO:1990782;GO:0007411;GO:0060219;GO:0007155;GO:0048813;GO:0070593;GO:0007156;GO:0007626;GO:0007162;GO:0007399;GO:0048842;GO:0042327;GO:0060060;GO:0010842;GO:0007416;, C:axon; C:dendrite; C:extracellular region; C:growth cone; C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:netrin receptor binding; F:protein tyrosine kinase binding;, P:axon guidance; P:camera-type eye photoreceptor cell differentiation; P:cell adhesion; P:dendrite morphogenesis; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:locomotory behavior; P:negative regulation of cell adhesion; P:nervous system development; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of phosphorylation; P:post-embryonic retina morphogenesis in camera-type eye; P:retina layer formation; P:synapse assembly; scaffold20 indexed_genome mRNA 18294300 18296553 . - . ID=transcript_4923;O60469 O60468,Down syndrome cell adhesion molecule,CHD2;, PF00041;PF07679;, GO:0030424;GO:0030425;GO:0005576;GO:0030426;GO:0005887;GO:0016020;GO:0043025;GO:0005886;GO:0045202;GO:0098632;GO:1990890;GO:1990782;GO:0007411;GO:0060219;GO:0007155;GO:0048813;GO:0070593;GO:0007156;GO:0007626;GO:0007162;GO:0007399;GO:0048842;GO:0042327;GO:0060060;GO:0010842;GO:0007416;, C:axon; C:dendrite; C:extracellular region; C:growth cone; C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:netrin receptor binding; F:protein tyrosine kinase binding;, P:axon guidance; P:camera-type eye photoreceptor cell differentiation; P:cell adhesion; P:dendrite morphogenesis; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:locomotory behavior; P:negative regulation of cell adhesion; P:nervous system development; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of phosphorylation; P:post-embryonic retina morphogenesis in camera-type eye; P:retina layer formation; P:synapse assembly; scaffold20 indexed_genome mRNA 18296623 18310388 . - . ID=transcript_4924;O60469 O60468,Down syndrome cell adhesion molecule,CHD2;, PF00041;PF07679;, GO:0030424;GO:0030425;GO:0005576;GO:0030426;GO:0005887;GO:0016020;GO:0043025;GO:0005886;GO:0045202;GO:0098632;GO:1990890;GO:1990782;GO:0007411;GO:0060219;GO:0007155;GO:0048813;GO:0070593;GO:0007156;GO:0007626;GO:0007162;GO:0007399;GO:0048842;GO:0042327;GO:0060060;GO:0010842;GO:0007416;, C:axon; C:dendrite; C:extracellular region; C:growth cone; C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:netrin receptor binding; F:protein tyrosine kinase binding;, P:axon guidance; P:camera-type eye photoreceptor cell differentiation; P:cell adhesion; P:dendrite morphogenesis; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:locomotory behavior; P:negative regulation of cell adhesion; P:nervous system development; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of phosphorylation; P:post-embryonic retina morphogenesis in camera-type eye; P:retina layer formation; P:synapse assembly; scaffold20 indexed_genome mRNA 18546052 18883708 . - . ID=transcript_4925;O60469 O60468,Down syndrome cell adhesion molecule,CHD2;, PF00041;PF07679;, GO:0030424;GO:0030425;GO:0005576;GO:0030426;GO:0005887;GO:0016020;GO:0043025;GO:0005886;GO:0045202;GO:0098632;GO:1990890;GO:1990782;GO:0007411;GO:0060219;GO:0007155;GO:0048813;GO:0070593;GO:0007156;GO:0007626;GO:0007162;GO:0007399;GO:0048842;GO:0042327;GO:0060060;GO:0010842;GO:0007416;, C:axon; C:dendrite; C:extracellular region; C:growth cone; C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:netrin receptor binding; F:protein tyrosine kinase binding;, P:axon guidance; P:camera-type eye photoreceptor cell differentiation; P:cell adhesion; P:dendrite morphogenesis; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:locomotory behavior; P:negative regulation of cell adhesion; P:nervous system development; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of phosphorylation; P:post-embryonic retina morphogenesis in camera-type eye; P:retina layer formation; P:synapse assembly; scaffold20 indexed_genome mRNA 19387123 19497443 . + . ID=transcript_4926;Q9Y5Z0 A8K7P1 Q5DIH8 Q8N2D4 Q9H2V8 Q9NZL1 Q9NZL2 Q9UJT6,Beta-secretase 2,Aspartic-like protease 56 kDa;Aspartyl protease 1;Beta-site amyloid precursor protein cleaving enzyme 2;Down region aspartic protease;Memapsin-1;Membrane-associated aspartic protease 1;Theta-secretase;, PF00026;, GO:0031045;GO:0005783;GO:0005768;GO:0005794;GO:0016021;GO:0016020;GO:0005886;GO:0005802;GO:0004190;GO:0050435;GO:0048143;GO:0042593;GO:0006509;GO:0042985;GO:0016486;GO:0006508;, C:dense core granule; C:endoplasmic reticulum; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:aspartic-type endopeptidase activity;, P:amyloid-beta metabolic process; P:astrocyte activation; P:glucose homeostasis; P:membrane protein ectodomain proteolysis; P:negative regulation of amyloid precursor protein biosynthetic process; P:peptide hormone processing; P:proteolysis; scaffold20 indexed_genome mRNA 19625052 19651689 . + . ID=transcript_4927;P20592 B7Z5D3 D3DSI7,Interferon-induced GTP-binding protein Mx2,Interferon-regulated resistance GTP-binding protein MxB;Myxovirus resistance protein 2;p78-related protein;, PF01031;PF00350;PF02212;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0044327;GO:0016020;GO:0015630;GO:0031966;GO:0005643;GO:0005634;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0005525;GO:0003924;GO:0008017;GO:0006952;GO:0051607;GO:0003374;GO:0061025;GO:0000266;GO:0051028;GO:0098884;GO:0031623;GO:0051726;GO:0046822;GO:0050803;GO:0035455;GO:0009615;GO:0016185;GO:0060337;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine head; C:membrane; C:microtubule cytoskeleton; C:mitochondrial membrane; C:nuclear pore; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:microtubule binding;, P:defense response; P:defense response to virus; P:dynamin family protein polymerization involved in mitochondrial fission; P:membrane fusion; P:mitochondrial fission; P:mRNA transport; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:regulation of cell cycle; P:regulation of nucleocytoplasmic transport; P:regulation of synapse structure or activity; P:response to interferon-alpha; P:response to virus; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:type I interferon signaling pathway; scaffold20 indexed_genome mRNA 19661123 19693171 . + . ID=transcript_4928;D3DSI8 Q86YP5 Q96CI3,Interferon-induced GTP-binding protein Mx1,Interferon-induced protein p78;Interferon-regulated resistance GTP-binding protein MxA;Myxoma resistance protein 1;Myxovirus resistance protein 1;, PF01031;PF00350;PF02212;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0044327;GO:0005789;GO:0016020;GO:0015630;GO:0031966;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0006915;GO:0006952;GO:0051607;GO:0003374;GO:0045087;GO:0061025;GO:0000266;GO:0045071;GO:0098884;GO:0031623;GO:0050803;GO:0034340;GO:0009615;GO:0007165;GO:0016185;GO:0060337;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine head; C:endoplasmic reticulum membrane; C:membrane; C:microtubule cytoskeleton; C:mitochondrial membrane; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding;, P:apoptotic process; P:defense response; P:defense response to virus; P:dynamin family protein polymerization involved in mitochondrial fission; P:innate immune response; P:membrane fusion; P:mitochondrial fission; P:negative regulation of viral genome replication; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:regulation of synapse structure or activity; P:response to type I interferon; P:response to virus; P:signal transduction; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:type I interferon signaling pathway; scaffold20 indexed_genome mRNA 19703053 19732528 . + . ID=transcript_4929;O15393 A8K6Z8 B2R8E5 B7Z459 D3DSJ2 F8WES1 Q6GTK7 Q9BXX1,Transmembrane protease serine 2 {ECO:0000305},Serine protease 10 {ECO:0000305};, PF15494;PF00089;, GO:0070062;GO:0005576;GO:0005887;GO:0005654;GO:0005886;GO:0005044;GO:0004252;GO:0008236;GO:0046598;GO:0016540;GO:0006508;, C:extracellular exosome; C:extracellular region; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:scavenger receptor activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:positive regulation of viral entry into host cell; P:protein autoprocessing; P:proteolysis; scaffold20 indexed_genome mRNA 19984135 19986889 . - . ID=transcript_4930;P57078 Q96KH0,Receptor-interacting serine/threonine-protein kinase 4,Ankyrin repeat domain-containing protein 3;PKC-delta-interacting protein kinase;, PF12796;PF00069;, GO:0005737;GO:0016020;GO:0005524;GO:0106310;GO:0106311;GO:0002009;GO:0051092;, C:cytoplasm; C:membrane;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:morphogenesis of an epithelium; P:positive regulation of NF-kappaB transcription factor activity; scaffold20 indexed_genome mRNA 19988606 20010322 . - . ID=transcript_4931;P57078 Q96KH0,Receptor-interacting serine/threonine-protein kinase 4,Ankyrin repeat domain-containing protein 3;PKC-delta-interacting protein kinase;, PF12796;PF00069;, GO:0005737;GO:0016020;GO:0005524;GO:0106310;GO:0106311;GO:0002009;GO:0051092;, C:cytoplasm; C:membrane;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:morphogenesis of an epithelium; P:positive regulation of NF-kappaB transcription factor activity; scaffold20 indexed_genome mRNA 20038024 20042676 . - . ID=transcript_4932;Q8NEX0 Q9NQV3,PR domain zinc finger protein 15 {ECO:0000305},PR domain-containing protein 15 {ECO:0000305};Zinc finger protein 298;, PF00096;, GO:0016604;GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0008168;GO:1990841;GO:0000978;GO:0032259;GO:0007275;GO:0043409;GO:0090263;GO:0045944;GO:2000035;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:methyltransferase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:methylation; P:multicellular organism development; P:negative regulation of MAPK cascade; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of stem cell division; P:regulation of transcription by RNA polymerase II; scaffold20 indexed_genome mRNA 20047638 20070964 . - . ID=transcript_4933;Q8NEX0 Q9NQV3,PR domain zinc finger protein 15 {ECO:0000305},PR domain-containing protein 15 {ECO:0000305};Zinc finger protein 298;, PF00096;, GO:0016604;GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0008168;GO:1990841;GO:0000978;GO:0032259;GO:0007275;GO:0043409;GO:0090263;GO:0045944;GO:2000035;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:methyltransferase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:methylation; P:multicellular organism development; P:negative regulation of MAPK cascade; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of stem cell division; P:regulation of transcription by RNA polymerase II;|Q8NEX0 Q9NQV3,PR domain zinc finger protein 15 {ECO:0000305},PR domain-containing protein 15 {ECO:0000305};Zinc finger protein 298;, PF00096;, GO:0016604;GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0008168;GO:1990841;GO:0000978;GO:0032259;GO:0007275;GO:0043409;GO:0090263;GO:0045944;GO:2000035;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:methyltransferase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:methylation; P:multicellular organism development; P:negative regulation of MAPK cascade; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of stem cell division; P:regulation of transcription by RNA polymerase II; scaffold20 indexed_genome mRNA 20110505 20176647 . - . ID=transcript_4934;Q9Y426 Q5R2V7 Q6AHX8 Q9NSE6,C2 domain-containing protein 2,Transmembrane protein 24-like;, PF00168;PF18696;, GO:0005829;GO:0016021;GO:0005634;, C:cytosol; C:integral component of membrane; C:nucleus; scaffold20 indexed_genome mRNA 20221216 20223757 . - . ID=transcript_4935;Q9ULJ3 Q5R2W1 Q5R2W2 Q6P4R0,Zinc finger and BTB domain-containing protein 21,Zinc finger protein 295;, PF00651;PF00096;PF18450;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0042802;GO:0046872;GO:0008327;GO:0031208;GO:0043565;GO:0000122;GO:0045892;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:methyl-CpG binding; F:POZ domain binding; F:sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9ULJ3 Q5R2W1 Q5R2W2 Q6P4R0,Zinc finger and BTB domain-containing protein 21,Zinc finger protein 295;, PF00651;PF00096;PF18450;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0042802;GO:0046872;GO:0008327;GO:0031208;GO:0043565;GO:0000122;GO:0045892;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:methyl-CpG binding; F:POZ domain binding; F:sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold20 indexed_genome mRNA 20223781 20236985 . - . ID=transcript_4936;Q9ULJ3 Q5R2W1 Q5R2W2 Q6P4R0,Zinc finger and BTB domain-containing protein 21,Zinc finger protein 295;, PF00651;PF00096;PF18450;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0042802;GO:0046872;GO:0008327;GO:0031208;GO:0043565;GO:0000122;GO:0045892;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:methyl-CpG binding; F:POZ domain binding; F:sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold20 indexed_genome mRNA 20471661 20539324 . + . ID=transcript_4937;Q9BXL2 Q9BXL3 Q9BXL4,ATP-binding cassette sub-family G member 1 {ECO:0000305},ATP-binding cassette transporter 8;White protein homolog;, PF01061;PF19055;PF00005;, GO:0005789;GO:0005768;GO:0009897;GO:0005794;GO:0000139;GO:0016021;GO:0005739;GO:0005886;GO:0055037;GO:0034041;GO:0043531;GO:0005524;GO:0016887;GO:0015485;GO:0120020;GO:0140328;GO:0090554;GO:0005543;GO:0046982;GO:0042803;GO:0019534;GO:0042987;GO:0033344;GO:0042632;GO:0008203;GO:0034436;GO:0034375;GO:0032367;GO:0030522;GO:0006869;GO:0034374;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:1902004;GO:0045542;GO:0050714;GO:0010872;GO:0033993;GO:0010033;GO:0043691;, C:endoplasmic reticulum membrane; C:endosome; C:external side of plasma membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:mitochondrion; C:plasma membrane; C:recycling endosome;, F:ABC-type sterol transporter activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:phosphatidylcholine floppase activity; F:phospholipid binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:toxin transmembrane transporter activity;, P:amyloid precursor protein catabolic process; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:glycoprotein transport; P:high-density lipoprotein particle remodeling; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:low-density lipoprotein particle remodeling; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:positive regulation of amyloid-beta formation; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of protein secretion; P:regulation of cholesterol esterification; P:response to lipid; P:response to organic substance; P:reverse cholesterol transport;|Q9BXL2 Q9BXL3 Q9BXL4,ATP-binding cassette sub-family G member 1 {ECO:0000305},ATP-binding cassette transporter 8;White protein homolog;, PF01061;PF19055;PF00005;, GO:0005789;GO:0005768;GO:0009897;GO:0005794;GO:0000139;GO:0016021;GO:0005739;GO:0005886;GO:0055037;GO:0034041;GO:0043531;GO:0005524;GO:0016887;GO:0015485;GO:0120020;GO:0140328;GO:0090554;GO:0005543;GO:0046982;GO:0042803;GO:0019534;GO:0042987;GO:0033344;GO:0042632;GO:0008203;GO:0034436;GO:0034375;GO:0032367;GO:0030522;GO:0006869;GO:0034374;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:1902004;GO:0045542;GO:0050714;GO:0010872;GO:0033993;GO:0010033;GO:0043691;, C:endoplasmic reticulum membrane; C:endosome; C:external side of plasma membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:mitochondrion; C:plasma membrane; C:recycling endosome;, F:ABC-type sterol transporter activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:phosphatidylcholine floppase activity; F:phospholipid binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:toxin transmembrane transporter activity;, P:amyloid precursor protein catabolic process; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:glycoprotein transport; P:high-density lipoprotein particle remodeling; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:low-density lipoprotein particle remodeling; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:positive regulation of amyloid-beta formation; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of protein secretion; P:regulation of cholesterol esterification; P:response to lipid; P:response to organic substance; P:reverse cholesterol transport; scaffold20 indexed_genome mRNA 20546310 20549666 . - . ID=transcript_4938;Q07654 A0A0A6YYJ4 E9PBB5 Q96NX0 Q9UDA5,Trefoil factor 3,Intestinal trefoil factor;Polypeptide P1.B;, PF00088;, GO:0005737;GO:0005576;GO:0005615;GO:0030277;, C:cytoplasm; C:extracellular region; C:extracellular space;, , P:maintenance of gastrointestinal epithelium; scaffold20 indexed_genome mRNA 20736088 20750225 . - . ID=transcript_4939;Q8WYR4 A8MWV0 B2RBN9 Q3MJA1,Radial spoke head 1 homolog,Cancer/testis antigen 79;Male meiotic metaphase chromosome-associated acidic protein;Meichroacidin;Testis-specific gene A2 protein;, PF02493;, GO:0000794;GO:0005829;GO:0072687;GO:0031514;GO:0005634;GO:0001520;GO:0035082;GO:0051321;GO:0007286;, C:condensed nuclear chromosome; C:cytosol; C:meiotic spindle; C:motile cilium; C:nucleus; C:outer dense fiber;, , P:axoneme assembly; P:meiotic cell cycle; P:spermatid development; scaffold20 indexed_genome mRNA 20796385 20851669 . + . ID=transcript_4940;P57057 D3DSJ7 Q9HAQ1,Glucose-6-phosphate exchanger SLC37A1 {ECO:0000305|PubMed:21949678},Glycerol-3-phosphate permease {ECO:0000303|PubMed:11112347};Solute carrier family 37 member 1 {ECO:0000312|HGNC:HGNC:11024};, PF07690;, GO:0005789;GO:0030176;GO:0016020;GO:0061513;GO:0008643;GO:0015760;GO:0035435;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:glucose 6-phosphate:inorganic phosphate antiporter activity;, P:carbohydrate transport; P:glucose-6-phosphate transport; P:phosphate ion transmembrane transport; scaffold20 indexed_genome mRNA 20943088 21002906 . + . ID=transcript_4941;Q86WN8 Q86WN9 Q86WP0,High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A {ECO:0000305},, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0043204;GO:0048471;GO:0005886;GO:0032587;GO:0042383;GO:0047555;GO:0004114;GO:0042802;GO:0046872;GO:0046069;GO:0046068;GO:0019934;GO:0010613;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:sarcolemma;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:metal ion binding;, P:cGMP catabolic process; P:cGMP metabolic process; P:cGMP-mediated signaling; P:positive regulation of cardiac muscle hypertrophy; P:signal transduction;|Q86WN8 Q86WN9 Q86WP0,High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A {ECO:0000305},, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0043204;GO:0048471;GO:0005886;GO:0032587;GO:0042383;GO:0047555;GO:0004114;GO:0042802;GO:0046872;GO:0046069;GO:0046068;GO:0019934;GO:0010613;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:sarcolemma;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:metal ion binding;, P:cGMP catabolic process; P:cGMP metabolic process; P:cGMP-mediated signaling; P:positive regulation of cardiac muscle hypertrophy; P:signal transduction; scaffold20 indexed_genome mRNA 21002939 21017594 . + . ID=transcript_4942;Q86WN8 Q86WN9 Q86WP0,High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A {ECO:0000305},, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0043204;GO:0048471;GO:0005886;GO:0032587;GO:0042383;GO:0047555;GO:0004114;GO:0042802;GO:0046872;GO:0046069;GO:0046068;GO:0019934;GO:0010613;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:sarcolemma;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:metal ion binding;, P:cGMP catabolic process; P:cGMP metabolic process; P:cGMP-mediated signaling; P:positive regulation of cardiac muscle hypertrophy; P:signal transduction;|Q86WN8 Q86WN9 Q86WP0,High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A {ECO:0000305},, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0043204;GO:0048471;GO:0005886;GO:0032587;GO:0042383;GO:0047555;GO:0004114;GO:0042802;GO:0046872;GO:0046069;GO:0046068;GO:0019934;GO:0010613;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:sarcolemma;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:metal ion binding;, P:cGMP catabolic process; P:cGMP metabolic process; P:cGMP-mediated signaling; P:positive regulation of cardiac muscle hypertrophy; P:signal transduction;|Q86WN8 Q86WN9 Q86WP0,High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A {ECO:0000305},, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0043204;GO:0048471;GO:0005886;GO:0032587;GO:0042383;GO:0047555;GO:0004114;GO:0042802;GO:0046872;GO:0046069;GO:0046068;GO:0019934;GO:0010613;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:sarcolemma;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:metal ion binding;, P:cGMP catabolic process; P:cGMP metabolic process; P:cGMP-mediated signaling; P:positive regulation of cardiac muscle hypertrophy; P:signal transduction;|Q86WN8 Q86WN9 Q86WP0,High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A {ECO:0000305},, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0043204;GO:0048471;GO:0005886;GO:0032587;GO:0042383;GO:0047555;GO:0004114;GO:0042802;GO:0046872;GO:0046069;GO:0046068;GO:0019934;GO:0010613;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:sarcolemma;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:metal ion binding;, P:cGMP catabolic process; P:cGMP metabolic process; P:cGMP-mediated signaling; P:positive regulation of cardiac muscle hypertrophy; P:signal transduction;|Q86WN8 Q86WN9 Q86WP0,High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A {ECO:0000305},, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0005654;GO:0043204;GO:0048471;GO:0005886;GO:0032587;GO:0042383;GO:0047555;GO:0004114;GO:0042802;GO:0046872;GO:0046069;GO:0046068;GO:0019934;GO:0010613;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:sarcolemma;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:identical protein binding; F:metal ion binding;, P:cGMP catabolic process; P:cGMP metabolic process; P:cGMP-mediated signaling; P:positive regulation of cardiac muscle hypertrophy; P:signal transduction; scaffold20 indexed_genome mRNA 21061160 21080139 . - . ID=transcript_4943;P57081 A8KA58 B2RCA3 B4DNQ7 D3DSK3 Q9BVM5 Q9HCR3,tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 {ECO:0000255|HAMAP-Rule:MF_03056},Protein Wuho homolog {ECO:0000303|PubMed:26751069};WD repeat-containing protein 4 {ECO:0000255|HAMAP-Rule:MF_03056};, PF00400;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0043527;GO:0006974;GO:0106004;GO:0006400;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus; C:tRNA methyltransferase complex;, , P:cellular response to DNA damage stimulus; P:tRNA (guanine-N7)-methylation; P:tRNA modification;|P57081 A8KA58 B2RCA3 B4DNQ7 D3DSK3 Q9BVM5 Q9HCR3,tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 {ECO:0000255|HAMAP-Rule:MF_03056},Protein Wuho homolog {ECO:0000303|PubMed:26751069};WD repeat-containing protein 4 {ECO:0000255|HAMAP-Rule:MF_03056};, PF00400;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0043527;GO:0006974;GO:0106004;GO:0006400;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus; C:tRNA methyltransferase complex;, , P:cellular response to DNA damage stimulus; P:tRNA (guanine-N7)-methylation; P:tRNA modification; scaffold20 indexed_genome mRNA 21099667 21100473 . - . ID=transcript_4944;P56181 A8K0M1 J3KNX7 Q6FGD3 Q8WU60 Q9HCR5,NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial,Complex I-9kD;NADH-ubiquinone oxidoreductase 9 kDa subunit;Renal carcinoma antigen NY-REN-4;, PF15880;, GO:0005743;GO:0005747;GO:0005739;GO:0008137;GO:0003723;GO:0042775;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity; F:RNA binding;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold20 indexed_genome mRNA 21153522 21182156 . + . ID=transcript_4945;P55347 O00528 Q8IWT7,Homeobox protein PKNOX1,Homeobox protein PREP-1;PBX/knotted homeobox 1;, PF05920;PF16493;, GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0003682;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0001525;GO:0043010;GO:0030218;GO:0045944;GO:0006357;GO:0030217;GO:0006366;, C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:camera-type eye development; P:erythrocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:T cell differentiation; P:transcription by RNA polymerase II;|P55347 O00528 Q8IWT7,Homeobox protein PKNOX1,Homeobox protein PREP-1;PBX/knotted homeobox 1;, PF05920;PF16493;, GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0003682;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0001525;GO:0043010;GO:0030218;GO:0045944;GO:0006357;GO:0030217;GO:0006366;, C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:camera-type eye development; P:erythrocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:T cell differentiation; P:transcription by RNA polymerase II;|P55347 O00528 Q8IWT7,Homeobox protein PKNOX1,Homeobox protein PREP-1;PBX/knotted homeobox 1;, PF05920;PF16493;, GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0003682;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0001525;GO:0043010;GO:0030218;GO:0045944;GO:0006357;GO:0030217;GO:0006366;, C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:camera-type eye development; P:erythrocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:T cell differentiation; P:transcription by RNA polymerase II; scaffold20 indexed_genome mRNA 21198695 21221765 . - . ID=transcript_4946;P0DN79,Cystathionine beta-synthase-like protein {ECO:0000305},Beta-thionase {ECO:0000250|UniProtKB:P35520};Serine sulfhydrase {ECO:0000250|UniProtKB:P35520};, PF00571;PF00291;, GO:0005737;GO:0005829;GO:0005634;GO:0004122;GO:0020037;GO:0046872;GO:0030170;GO:0006535;GO:0019343;GO:0070814;GO:0019346;, C:cytoplasm; C:cytosol; C:nucleus;, F:cystathionine beta-synthase activity; F:heme binding; F:metal ion binding; F:pyridoxal phosphate binding;, P:cysteine biosynthetic process from serine; P:cysteine biosynthetic process via cystathionine; P:hydrogen sulfide biosynthetic process; P:transsulfuration;|P0DN79,Cystathionine beta-synthase-like protein {ECO:0000305},Beta-thionase {ECO:0000250|UniProtKB:P35520};Serine sulfhydrase {ECO:0000250|UniProtKB:P35520};, PF00571;PF00291;, GO:0005737;GO:0005829;GO:0005634;GO:0004122;GO:0020037;GO:0046872;GO:0030170;GO:0006535;GO:0019343;GO:0070814;GO:0019346;, C:cytoplasm; C:cytosol; C:nucleus;, F:cystathionine beta-synthase activity; F:heme binding; F:metal ion binding; F:pyridoxal phosphate binding;, P:cysteine biosynthetic process from serine; P:cysteine biosynthetic process via cystathionine; P:hydrogen sulfide biosynthetic process; P:transsulfuration; scaffold20 indexed_genome mRNA 21240721 21250181 . - . ID=transcript_4947;Q01081 Q701P4 Q71RF1,Splicing factor U2AF 35 kDa subunit,U2 auxiliary factor 35 kDa subunit;U2 small nuclear RNA auxiliary factor 1;U2 snRNP auxiliary factor small subunit;, PF00076;PF00642;, GO:0015030;GO:0071013;GO:0016607;GO:0005654;GO:0005681;GO:0089701;GO:0046872;GO:0030628;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0006405;GO:0008380;, C:Cajal body; C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:spliceosomal complex; C:U2AF complex;, F:metal ion binding; F:pre-mRNA 3'-splice site binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing;|Q01081 Q701P4 Q71RF1,Splicing factor U2AF 35 kDa subunit,U2 auxiliary factor 35 kDa subunit;U2 small nuclear RNA auxiliary factor 1;U2 snRNP auxiliary factor small subunit;, PF00076;PF00642;, GO:0015030;GO:0071013;GO:0016607;GO:0005654;GO:0005681;GO:0089701;GO:0046872;GO:0030628;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0006405;GO:0008380;, C:Cajal body; C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:spliceosomal complex; C:U2AF complex;, F:metal ion binding; F:pre-mRNA 3'-splice site binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing;|Q01081 Q701P4 Q71RF1,Splicing factor U2AF 35 kDa subunit,U2 auxiliary factor 35 kDa subunit;U2 small nuclear RNA auxiliary factor 1;U2 snRNP auxiliary factor small subunit;, PF00076;PF00642;, GO:0015030;GO:0071013;GO:0016607;GO:0005654;GO:0005681;GO:0089701;GO:0046872;GO:0030628;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0006405;GO:0008380;, C:Cajal body; C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:spliceosomal complex; C:U2AF complex;, F:metal ion binding; F:pre-mRNA 3'-splice site binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing;|Q01081 Q701P4 Q71RF1,Splicing factor U2AF 35 kDa subunit,U2 auxiliary factor 35 kDa subunit;U2 small nuclear RNA auxiliary factor 1;U2 snRNP auxiliary factor small subunit;, PF00076;PF00642;, GO:0015030;GO:0071013;GO:0016607;GO:0005654;GO:0005681;GO:0089701;GO:0046872;GO:0030628;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0006405;GO:0008380;, C:Cajal body; C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:spliceosomal complex; C:U2AF complex;, F:metal ion binding; F:pre-mRNA 3'-splice site binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; scaffold20 indexed_genome mRNA 21485028 21491651 . - . ID=transcript_4948;P57059 A6NC84 Q5R2V5 Q6ZNL8 Q86YJ2,Serine/threonine-protein kinase SIK1,Salt-inducible kinase 1;Serine/threonine-protein kinase SNF1-like kinase 1;, PF00069;, GO:0005737;GO:0005634;GO:0071889;GO:0005524;GO:0008140;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0055007;GO:0007049;GO:0042149;GO:0043153;GO:0035556;GO:0032792;GO:0045721;GO:0010868;GO:2000210;GO:0046777;GO:0006468;GO:0045595;GO:0007346;GO:0010830;GO:0002028;GO:0048511;, C:cytoplasm; C:nucleus;, F:14-3-3 protein binding; F:ATP binding; F:cAMP response element binding protein binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell differentiation; P:cell cycle; P:cellular response to glucose starvation; P:entrainment of circadian clock by photoperiod; P:intracellular signal transduction; P:negative regulation of CREB transcription factor activity; P:negative regulation of gluconeogenesis; P:negative regulation of triglyceride biosynthetic process; P:positive regulation of anoikis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of mitotic cell cycle; P:regulation of myotube differentiation; P:regulation of sodium ion transport; P:rhythmic process;|A0A0B4J2F2,Probable serine/threonine-protein kinase SIK1B {ECO:0000305},Salt-inducible kinase 1B {ECO:0000305};, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0042149;GO:0035556;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to glucose starvation; P:intracellular signal transduction; P:protein phosphorylation;|P57059 A6NC84 Q5R2V5 Q6ZNL8 Q86YJ2,Serine/threonine-protein kinase SIK1,Salt-inducible kinase 1;Serine/threonine-protein kinase SNF1-like kinase 1;, PF00069;, GO:0005737;GO:0005634;GO:0071889;GO:0005524;GO:0008140;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0055007;GO:0007049;GO:0042149;GO:0043153;GO:0035556;GO:0032792;GO:0045721;GO:0010868;GO:2000210;GO:0046777;GO:0006468;GO:0045595;GO:0007346;GO:0010830;GO:0002028;GO:0048511;, C:cytoplasm; C:nucleus;, F:14-3-3 protein binding; F:ATP binding; F:cAMP response element binding protein binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell differentiation; P:cell cycle; P:cellular response to glucose starvation; P:entrainment of circadian clock by photoperiod; P:intracellular signal transduction; P:negative regulation of CREB transcription factor activity; P:negative regulation of gluconeogenesis; P:negative regulation of triglyceride biosynthetic process; P:positive regulation of anoikis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of mitotic cell cycle; P:regulation of myotube differentiation; P:regulation of sodium ion transport; P:rhythmic process; scaffold20 indexed_genome mRNA 21492549 21495610 . + . ID=transcript_4949;A0A0B4J2F2,Probable serine/threonine-protein kinase SIK1B {ECO:0000305},Salt-inducible kinase 1B {ECO:0000305};, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0042149;GO:0035556;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to glucose starvation; P:intracellular signal transduction; P:protein phosphorylation; scaffold20 indexed_genome mRNA 21623950 21702912 . + . ID=transcript_4950;O75031 B4DX36,Heat shock factor 2-binding protein {ECO:0000305},, , GO:0005694;GO:0005829;GO:1990918;GO:0007141;GO:0007283;GO:0006366;, C:chromosome; C:cytosol;, , P:double-strand break repair involved in meiotic recombination; P:male meiosis I; P:spermatogenesis; P:transcription by RNA polymerase II;|O75031 B4DX36,Heat shock factor 2-binding protein {ECO:0000305},, , GO:0005694;GO:0005829;GO:1990918;GO:0007141;GO:0007283;GO:0006366;, C:chromosome; C:cytosol;, , P:double-strand break repair involved in meiotic recombination; P:male meiosis I; P:spermatogenesis; P:transcription by RNA polymerase II; scaffold20 indexed_genome mRNA 21703132 21728803 . + . ID=transcript_4951;Q14684 Q8TBZ4,Ribosomal RNA processing protein 1 homolog B,RRP1-like protein B;, PF05997;, GO:0005694;GO:0005829;GO:0001652;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0030688;GO:0003723;GO:0003713;GO:0006915;GO:0098586;GO:0006397;GO:0034260;GO:0010923;GO:0043923;GO:0043065;GO:0045944;GO:0043484;GO:0008380;GO:0006364;GO:0016032;, C:chromosome; C:cytosol; C:granular component; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor; C:preribosome, small subunit precursor;, F:RNA binding; F:transcription coactivator activity;, P:apoptotic process; P:cellular response to virus; P:mRNA processing; P:negative regulation of GTPase activity; P:negative regulation of phosphatase activity; P:positive regulation by host of viral transcription; P:positive regulation of apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of RNA splicing; P:RNA splicing; P:rRNA processing; P:viral process;|Q14684 Q8TBZ4,Ribosomal RNA processing protein 1 homolog B,RRP1-like protein B;, PF05997;, GO:0005694;GO:0005829;GO:0001652;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0030688;GO:0003723;GO:0003713;GO:0006915;GO:0098586;GO:0006397;GO:0034260;GO:0010923;GO:0043923;GO:0043065;GO:0045944;GO:0043484;GO:0008380;GO:0006364;GO:0016032;, C:chromosome; C:cytosol; C:granular component; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor; C:preribosome, small subunit precursor;, F:RNA binding; F:transcription coactivator activity;, P:apoptotic process; P:cellular response to virus; P:mRNA processing; P:negative regulation of GTPase activity; P:negative regulation of phosphatase activity; P:positive regulation by host of viral transcription; P:positive regulation of apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of RNA splicing; P:RNA splicing; P:rRNA processing; P:viral process;|Q14684 Q8TBZ4,Ribosomal RNA processing protein 1 homolog B,RRP1-like protein B;, PF05997;, GO:0005694;GO:0005829;GO:0001652;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0030688;GO:0003723;GO:0003713;GO:0006915;GO:0098586;GO:0006397;GO:0034260;GO:0010923;GO:0043923;GO:0043065;GO:0045944;GO:0043484;GO:0008380;GO:0006364;GO:0016032;, C:chromosome; C:cytosol; C:granular component; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor; C:preribosome, small subunit precursor;, F:RNA binding; F:transcription coactivator activity;, P:apoptotic process; P:cellular response to virus; P:mRNA processing; P:negative regulation of GTPase activity; P:negative regulation of phosphatase activity; P:positive regulation by host of viral transcription; P:positive regulation of apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of RNA splicing; P:RNA splicing; P:rRNA processing; P:viral process;|Q14684 Q8TBZ4,Ribosomal RNA processing protein 1 homolog B,RRP1-like protein B;, PF05997;, GO:0005694;GO:0005829;GO:0001652;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0030688;GO:0003723;GO:0003713;GO:0006915;GO:0098586;GO:0006397;GO:0034260;GO:0010923;GO:0043923;GO:0043065;GO:0045944;GO:0043484;GO:0008380;GO:0006364;GO:0016032;, C:chromosome; C:cytosol; C:granular component; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor; C:preribosome, small subunit precursor;, F:RNA binding; F:transcription coactivator activity;, P:apoptotic process; P:cellular response to virus; P:mRNA processing; P:negative regulation of GTPase activity; P:negative regulation of phosphatase activity; P:positive regulation by host of viral transcription; P:positive regulation of apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of RNA splicing; P:RNA splicing; P:rRNA processing; P:viral process;|Q14684 Q8TBZ4,Ribosomal RNA processing protein 1 homolog B,RRP1-like protein B;, PF05997;, GO:0005694;GO:0005829;GO:0001652;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0030688;GO:0003723;GO:0003713;GO:0006915;GO:0098586;GO:0006397;GO:0034260;GO:0010923;GO:0043923;GO:0043065;GO:0045944;GO:0043484;GO:0008380;GO:0006364;GO:0016032;, C:chromosome; C:cytosol; C:granular component; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor; C:preribosome, small subunit precursor;, F:RNA binding; F:transcription coactivator activity;, P:apoptotic process; P:cellular response to virus; P:mRNA processing; P:negative regulation of GTPase activity; P:negative regulation of phosphatase activity; P:positive regulation by host of viral transcription; P:positive regulation of apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of RNA splicing; P:RNA splicing; P:rRNA processing; P:viral process; scaffold20 indexed_genome mRNA 21756865 21783812 . + . ID=transcript_4952;O00764 Q7Z2Y0 Q9BS02,Pyridoxal kinase,Pyridoxine kinase;, PF08543;, GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0005524;GO:0031403;GO:0000287;GO:0030955;GO:0042803;GO:0008478;GO:0030170;GO:0031402;GO:0008270;GO:0043312;GO:0009443;GO:0042816;, C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:ATP binding; F:lithium ion binding; F:magnesium ion binding; F:potassium ion binding; F:protein homodimerization activity; F:pyridoxal kinase activity; F:pyridoxal phosphate binding; F:sodium ion binding; F:zinc ion binding;, P:neutrophil degranulation; P:pyridoxal 5'-phosphate salvage; P:vitamin B6 metabolic process;|O00764 Q7Z2Y0 Q9BS02,Pyridoxal kinase,Pyridoxine kinase;, PF08543;, GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0005524;GO:0031403;GO:0000287;GO:0030955;GO:0042803;GO:0008478;GO:0030170;GO:0031402;GO:0008270;GO:0043312;GO:0009443;GO:0042816;, C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:ATP binding; F:lithium ion binding; F:magnesium ion binding; F:potassium ion binding; F:protein homodimerization activity; F:pyridoxal kinase activity; F:pyridoxal phosphate binding; F:sodium ion binding; F:zinc ion binding;, P:neutrophil degranulation; P:pyridoxal 5'-phosphate salvage; P:vitamin B6 metabolic process;|O00764 Q7Z2Y0 Q9BS02,Pyridoxal kinase,Pyridoxine kinase;, PF08543;, GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0034774;GO:0035580;GO:0005524;GO:0031403;GO:0000287;GO:0030955;GO:0042803;GO:0008478;GO:0030170;GO:0031402;GO:0008270;GO:0043312;GO:0009443;GO:0042816;, C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:specific granule lumen;, F:ATP binding; F:lithium ion binding; F:magnesium ion binding; F:potassium ion binding; F:protein homodimerization activity; F:pyridoxal kinase activity; F:pyridoxal phosphate binding; F:sodium ion binding; F:zinc ion binding;, P:neutrophil degranulation; P:pyridoxal 5'-phosphate salvage; P:vitamin B6 metabolic process; scaffold20 indexed_genome mRNA 21808128 21809766 . - . ID=transcript_4953;P04080,Cystatin-B,CPI-B;Liver thiol proteinase inhibitor;Stefin-B;, PF00031;, GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005730;GO:0005634;GO:0034774;GO:1904724;GO:0004869;GO:0004866;GO:0002020;GO:0003723;GO:0008344;GO:0010466;GO:0045861;GO:0043312;, C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:nucleolus; C:nucleus; C:secretory granule lumen; C:tertiary granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:protease binding; F:RNA binding;, P:adult locomotory behavior; P:negative regulation of peptidase activity; P:negative regulation of proteolysis; P:neutrophil degranulation; scaffold20 indexed_genome mRNA 21830976 21831920 . + . ID=transcript_4954;P56182 Q9NST5,Ribosomal RNA processing protein 1 homolog A,Novel nuclear protein 1;Nucleolar protein Nop52;RRP1-like protein;, PF05997;, GO:0005694;GO:0005730;GO:0005634;GO:0030687;GO:0030688;GO:0003723;GO:0006364;, C:chromosome; C:nucleolus; C:nucleus; C:preribosome, large subunit precursor; C:preribosome, small subunit precursor;, F:RNA binding;, P:rRNA processing; scaffold20 indexed_genome mRNA 21831973 21833491 . + . ID=transcript_4955;P56182 Q9NST5,Ribosomal RNA processing protein 1 homolog A,Novel nuclear protein 1;Nucleolar protein Nop52;RRP1-like protein;, PF05997;, GO:0005694;GO:0005730;GO:0005634;GO:0030687;GO:0030688;GO:0003723;GO:0006364;, C:chromosome; C:nucleolus; C:nucleus; C:preribosome, large subunit precursor; C:preribosome, small subunit precursor;, F:RNA binding;, P:rRNA processing; scaffold20 indexed_genome mRNA 21833543 21839368 . + . ID=transcript_4956;P56182 Q9NST5,Ribosomal RNA processing protein 1 homolog A,Novel nuclear protein 1;Nucleolar protein Nop52;RRP1-like protein;, PF05997;, GO:0005694;GO:0005730;GO:0005634;GO:0030687;GO:0030688;GO:0003723;GO:0006364;, C:chromosome; C:nucleolus; C:nucleus; C:preribosome, large subunit precursor; C:preribosome, small subunit precursor;, F:RNA binding;, P:rRNA processing; scaffold20 indexed_genome mRNA 21978657 22000501 . + . ID=transcript_4957;Q9NRZ7 D3DSL2 Q3ZCU2 Q6UWP6 Q6ZUC6 Q8N3Q7 Q9NRZ6,1-acyl-sn-glycerol-3-phosphate acyltransferase gamma,1-acylglycerol-3-phosphate O-acyltransferase 3;Lysophosphatidic acid acyltransferase gamma;, PF16076;PF01553;, GO:0012505;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0016020;GO:0005635;GO:0005886;GO:0003841;GO:0016746;GO:0016024;GO:0006654;GO:0008654;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nuclear envelope; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:CDP-diacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process;|Q9NRZ7 D3DSL2 Q3ZCU2 Q6UWP6 Q6ZUC6 Q8N3Q7 Q9NRZ6,1-acyl-sn-glycerol-3-phosphate acyltransferase gamma,1-acylglycerol-3-phosphate O-acyltransferase 3;Lysophosphatidic acid acyltransferase gamma;, PF16076;PF01553;, GO:0012505;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0016020;GO:0005635;GO:0005886;GO:0003841;GO:0016746;GO:0016024;GO:0006654;GO:0008654;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nuclear envelope; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:CDP-diacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; scaffold20 indexed_genome mRNA 22030010 22117884 . + . ID=transcript_4958;P48553 Q3MIR2 Q86SI7 Q9UMD4 Q9Y4L3,Trafficking protein particle complex subunit 10,Epilepsy holoprosencephaly candidate 1 protein;Protein GT334;Trafficking protein particle complex subunit TMEM1;Transport protein particle subunit TMEM1;, PF12584;, GO:0005829;GO:0030008;GO:1990071;GO:0048208;GO:0034498;GO:0006891;, C:cytosol; C:TRAPP complex; C:TRAPPII protein complex;, , P:COPII vesicle coating; P:early endosome to Golgi transport; P:intra-Golgi vesicle-mediated transport;|P48553 Q3MIR2 Q86SI7 Q9UMD4 Q9Y4L3,Trafficking protein particle complex subunit 10,Epilepsy holoprosencephaly candidate 1 protein;Protein GT334;Trafficking protein particle complex subunit TMEM1;Transport protein particle subunit TMEM1;, PF12584;, GO:0005829;GO:0030008;GO:1990071;GO:0048208;GO:0034498;GO:0006891;, C:cytosol; C:TRAPP complex; C:TRAPPII protein complex;, , P:COPII vesicle coating; P:early endosome to Golgi transport; P:intra-Golgi vesicle-mediated transport;|P48553 Q3MIR2 Q86SI7 Q9UMD4 Q9Y4L3,Trafficking protein particle complex subunit 10,Epilepsy holoprosencephaly candidate 1 protein;Protein GT334;Trafficking protein particle complex subunit TMEM1;Transport protein particle subunit TMEM1;, PF12584;, GO:0005829;GO:0030008;GO:1990071;GO:0048208;GO:0034498;GO:0006891;, C:cytosol; C:TRAPP complex; C:TRAPPII protein complex;, , P:COPII vesicle coating; P:early endosome to Golgi transport; P:intra-Golgi vesicle-mediated transport; scaffold20 indexed_genome mRNA 22119790 22132100 . + . ID=transcript_4959;Q15269 B2RAG8 Q96A77,Periodic tryptophan protein 2 homolog,, PF04003;PF00400;, GO:0005654;GO:0034388;GO:0032040;GO:0003723;GO:0000462;GO:0000028;GO:0006364;, C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit assembly; P:rRNA processing;|Q15269 B2RAG8 Q96A77,Periodic tryptophan protein 2 homolog,, PF04003;PF00400;, GO:0005654;GO:0034388;GO:0032040;GO:0003723;GO:0000462;GO:0000028;GO:0006364;, C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit assembly; P:rRNA processing;|Q15269 B2RAG8 Q96A77,Periodic tryptophan protein 2 homolog,, PF04003;PF00400;, GO:0005654;GO:0034388;GO:0032040;GO:0003723;GO:0000462;GO:0000028;GO:0006364;, C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit assembly; P:rRNA processing;|Q15269 B2RAG8 Q96A77,Periodic tryptophan protein 2 homolog,, PF04003;PF00400;, GO:0005654;GO:0034388;GO:0032040;GO:0003723;GO:0000462;GO:0000028;GO:0006364;, C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit assembly; P:rRNA processing;|Q15269 B2RAG8 Q96A77,Periodic tryptophan protein 2 homolog,, PF04003;PF00400;, GO:0005654;GO:0034388;GO:0032040;GO:0003723;GO:0000462;GO:0000028;GO:0006364;, C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit assembly; P:rRNA processing;|Q15269 B2RAG8 Q96A77,Periodic tryptophan protein 2 homolog,, PF04003;PF00400;, GO:0005654;GO:0034388;GO:0032040;GO:0003723;GO:0000462;GO:0000028;GO:0006364;, C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit assembly; P:rRNA processing; scaffold20 indexed_genome mRNA 22135976 22145501 . + . ID=transcript_4960;P78474 Q92505 Q92507,Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial,Keio novel protein-I {ECO:0000303|PubMed:8753807};Protein GT335 {ECO:0000303|PubMed:8975701};Protein HES1 {ECO:0000303|PubMed:9150728};, , GO:0005739;, C:mitochondrion;|P78474 Q92505 Q92507,Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial,Keio novel protein-I {ECO:0000303|PubMed:8753807};Protein GT335 {ECO:0000303|PubMed:8975701};Protein HES1 {ECO:0000303|PubMed:9150728};, , GO:0005739;, C:mitochondrion;|P78474 Q92505 Q92507,Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial,Keio novel protein-I {ECO:0000303|PubMed:8753807};Protein GT335 {ECO:0000303|PubMed:8975701};Protein HES1 {ECO:0000303|PubMed:9150728};, , GO:0005739;, C:mitochondrion;|P78474 Q92505 Q92507,Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial,Keio novel protein-I {ECO:0000303|PubMed:8753807};Protein GT335 {ECO:0000303|PubMed:8975701};Protein HES1 {ECO:0000303|PubMed:9150728};, , GO:0005739;, C:mitochondrion;|P78474 Q92505 Q92507,Glutamine amidotransferase-like class 1 domain-containing protein 3A, mitochondrial {ECO:0000305},, , GO:0005739;, C:mitochondrion; scaffold20 indexed_genome mRNA 22208322 22218297 . - . ID=transcript_4961;O75144 A8MUZ1 Q9HD18 Q9NRQ1,ICOS ligand,B7 homolog 2;B7-like protein Gl50;B7-related protein 1;, PF07686;, GO:0036464;GO:0009897;GO:0070062;GO:0016021;GO:0005886;GO:0042802;GO:0005102;GO:0002250;GO:0042113;GO:0006952;GO:0006972;GO:0042104;GO:0001817;GO:0007165;GO:0042110;GO:0031295;GO:0050852;, C:cytoplasmic ribonucleoprotein granule; C:external side of plasma membrane; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:signaling receptor binding;, P:adaptive immune response; P:B cell activation; P:defense response; P:hyperosmotic response; P:positive regulation of activated T cell proliferation; P:regulation of cytokine production; P:signal transduction; P:T cell activation; P:T cell costimulation; P:T cell receptor signaling pathway; scaffold20 indexed_genome mRNA 22264857 22268508 . + . ID=transcript_4962;O43918 B2RP50 O43922 O43932 O75745,Autoimmune regulator,Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein;, PF03172;PF00628;PF01342;, GO:0005737;GO:0016604;GO:0005634;GO:0003682;GO:0042393;GO:0042802;GO:0000977;GO:0045182;GO:0008270;GO:0002509;GO:0006959;GO:0006955;GO:0045060;GO:0002458;GO:0032722;GO:0045944;GO:0045893;GO:2000410;GO:0006355;GO:0097536;, C:cytoplasm; C:nuclear body; C:nucleus;, F:chromatin binding; F:histone binding; F:identical protein binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:translation regulator activity; F:zinc ion binding;, P:central tolerance induction to self antigen; P:humoral immune response; P:immune response; P:negative thymic T cell selection; P:peripheral T cell tolerance induction; P:positive regulation of chemokine production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of thymocyte migration; P:regulation of transcription, DNA-templated; P:thymus epithelium morphogenesis; scaffold20 indexed_genome mRNA 22274374 22275333 . - . ID=transcript_4963;O43918 B2RP50 O43922 O43932 O75745,Autoimmune regulator,Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein;, PF03172;PF00628;PF01342;, GO:0005737;GO:0016604;GO:0005634;GO:0003682;GO:0042393;GO:0042802;GO:0000977;GO:0045182;GO:0008270;GO:0002509;GO:0006959;GO:0006955;GO:0045060;GO:0002458;GO:0032722;GO:0045944;GO:0045893;GO:2000410;GO:0006355;GO:0097536;, C:cytoplasm; C:nuclear body; C:nucleus;, F:chromatin binding; F:histone binding; F:identical protein binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:translation regulator activity; F:zinc ion binding;, P:central tolerance induction to self antigen; P:humoral immune response; P:immune response; P:negative thymic T cell selection; P:peripheral T cell tolerance induction; P:positive regulation of chemokine production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of thymocyte migration; P:regulation of transcription, DNA-templated; P:thymus epithelium morphogenesis; scaffold20 indexed_genome mRNA 22301258 22313386 . + . ID=transcript_4964;P17858 Q96A64 Q96IH4 Q9BR91,ATP-dependent 6-phosphofructokinase, liver type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type B;Phosphofructo-1-kinase isozyme B;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0034774;GO:0003872;GO:0016208;GO:0005524;GO:0070061;GO:0070095;GO:0042802;GO:0019900;GO:0046872;GO:0048029;GO:0061621;GO:0030388;GO:0006002;GO:0006096;GO:0046676;GO:0043312;GO:0009749;, C:6-phosphofructokinase complex; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:secretory granule lumen;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose binding; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding; F:metal ion binding; F:monosaccharide binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:glycolytic process; P:negative regulation of insulin secretion; P:neutrophil degranulation; P:response to glucose;|P17858 Q96A64 Q96IH4 Q9BR91,ATP-dependent 6-phosphofructokinase, liver type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type B;Phosphofructo-1-kinase isozyme B;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0034774;GO:0003872;GO:0016208;GO:0005524;GO:0070061;GO:0070095;GO:0042802;GO:0019900;GO:0046872;GO:0048029;GO:0061621;GO:0030388;GO:0006002;GO:0006096;GO:0046676;GO:0043312;GO:0009749;, C:6-phosphofructokinase complex; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:secretory granule lumen;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose binding; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding; F:metal ion binding; F:monosaccharide binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:glycolytic process; P:negative regulation of insulin secretion; P:neutrophil degranulation; P:response to glucose;|P17858 Q96A64 Q96IH4 Q9BR91,ATP-dependent 6-phosphofructokinase, liver type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type B;Phosphofructo-1-kinase isozyme B;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0034774;GO:0003872;GO:0016208;GO:0005524;GO:0070061;GO:0070095;GO:0042802;GO:0019900;GO:0046872;GO:0048029;GO:0061621;GO:0030388;GO:0006002;GO:0006096;GO:0046676;GO:0043312;GO:0009749;, C:6-phosphofructokinase complex; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:secretory granule lumen;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose binding; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding; F:metal ion binding; F:monosaccharide binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:glycolytic process; P:negative regulation of insulin secretion; P:neutrophil degranulation; P:response to glucose; scaffold20 indexed_genome mRNA 22318236 22328963 . - . ID=transcript_4965;O43822 A8MPS9 O14993 Q8N5X6 Q99837 Q99838,Cilia- and flagella-associated protein 410 {ECO:0000312|HGNC:HGNC:1260},C21orf-HUMF09G8.5;Leucine-rich repeat-containing protein 76;YF5/A2;, , GO:0036064;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0032391;GO:0001750;GO:0005886;GO:0060271;GO:0007010;GO:0042769;GO:0008360;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:photoreceptor connecting cilium; C:photoreceptor outer segment; C:plasma membrane;, , P:cilium assembly; P:cytoskeleton organization; P:DNA damage response, detection of DNA damage; P:regulation of cell shape;|O43822 A8MPS9 O14993 Q8N5X6 Q99837 Q99838,Cilia- and flagella-associated protein 410 {ECO:0000312|HGNC:HGNC:1260},C21orf-HUMF09G8.5;Leucine-rich repeat-containing protein 76;YF5/A2;, , GO:0036064;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0032391;GO:0001750;GO:0005886;GO:0060271;GO:0007010;GO:0042769;GO:0008360;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:photoreceptor connecting cilium; C:photoreceptor outer segment; C:plasma membrane;, , P:cilium assembly; P:cytoskeleton organization; P:DNA damage response, detection of DNA damage; P:regulation of cell shape;|O43822 A8MPS9 O14993 Q8N5X6 Q99837 Q99838,Cilia- and flagella-associated protein 410 {ECO:0000312|HGNC:HGNC:1260},C21orf-HUMF09G8.5;Leucine-rich repeat-containing protein 76;YF5/A2;, , GO:0036064;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0032391;GO:0001750;GO:0005886;GO:0060271;GO:0007010;GO:0042769;GO:0008360;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:photoreceptor connecting cilium; C:photoreceptor outer segment; C:plasma membrane;, , P:cilium assembly; P:cytoskeleton organization; P:DNA damage response, detection of DNA damage; P:regulation of cell shape;|O43822 A8MPS9 O14993 Q8N5X6 Q99837 Q99838,Cilia- and flagella-associated protein 410 {ECO:0000312|HGNC:HGNC:1260},C21orf-HUMF09G8.5;Leucine-rich repeat-containing protein 76;YF5/A2;, , GO:0036064;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0032391;GO:0001750;GO:0005886;GO:0060271;GO:0007010;GO:0042769;GO:0008360;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:photoreceptor connecting cilium; C:photoreceptor outer segment; C:plasma membrane;, , P:cilium assembly; P:cytoskeleton organization; P:DNA damage response, detection of DNA damage; P:regulation of cell shape;|O43822 A8MPS9 O14993 Q8N5X6 Q99837 Q99838,Cilia- and flagella-associated protein 410 {ECO:0000312|HGNC:HGNC:1260},C21orf-HUMF09G8.5;Leucine-rich repeat-containing protein 76;YF5/A2;, , GO:0036064;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0032391;GO:0001750;GO:0005886;GO:0060271;GO:0007010;GO:0042769;GO:0008360;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:photoreceptor connecting cilium; C:photoreceptor outer segment; C:plasma membrane;, , P:cilium assembly; P:cytoskeleton organization; P:DNA damage response, detection of DNA damage; P:regulation of cell shape; scaffold20 indexed_genome mRNA 22343277 22359405 . + . ID=transcript_4966;O94759 D3DSL6 Q5KTC2 Q6J3P5 Q96KN6 Q96Q93,Transient receptor potential cation channel subfamily M member 2,Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};, PF00520;PF18139;, GO:0042995;GO:0030659;GO:0101003;GO:0005887;GO:0005765;GO:0005764;GO:0043204;GO:0005886;GO:0035579;GO:0070821;GO:0005262;GO:0005509;GO:0015278;GO:0005261;GO:0099604;GO:0072571;GO:0005272;GO:0098703;GO:0097553;GO:0070588;GO:0006816;GO:0035584;GO:0098655;GO:0071277;GO:0070301;GO:0071415;GO:0071502;GO:0002407;GO:0097028;GO:0030001;GO:0043312;GO:0051289;GO:2000249;GO:0051489;GO:0051209;GO:0014074;GO:0001659;GO:0071577;, C:cell projection; C:cytoplasmic vesicle membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perikaryon; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium channel activity; F:calcium ion binding; F:calcium-release channel activity; F:cation channel activity; F:ligand-gated calcium channel activity; F:mono-ADP-D-ribose binding; F:sodium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-mediated signaling using intracellular calcium source; P:cation transmembrane transport; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to purine-containing compound; P:cellular response to temperature stimulus; P:dendritic cell chemotaxis; P:dendritic cell differentiation; P:metal ion transport; P:neutrophil degranulation; P:protein homotetramerization; P:regulation of actin cytoskeleton reorganization; P:regulation of filopodium assembly; P:release of sequestered calcium ion into cytosol; P:response to purine-containing compound; P:temperature homeostasis; P:zinc ion transmembrane transport; scaffold20 indexed_genome mRNA 22366156 22367352 . + . ID=transcript_4967;O94759 D3DSL6 Q5KTC2 Q6J3P5 Q96KN6 Q96Q93,Transient receptor potential cation channel subfamily M member 2,Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};, PF00520;PF18139;, GO:0042995;GO:0030659;GO:0101003;GO:0005887;GO:0005765;GO:0005764;GO:0043204;GO:0005886;GO:0035579;GO:0070821;GO:0005262;GO:0005509;GO:0015278;GO:0005261;GO:0099604;GO:0072571;GO:0005272;GO:0098703;GO:0097553;GO:0070588;GO:0006816;GO:0035584;GO:0098655;GO:0071277;GO:0070301;GO:0071415;GO:0071502;GO:0002407;GO:0097028;GO:0030001;GO:0043312;GO:0051289;GO:2000249;GO:0051489;GO:0051209;GO:0014074;GO:0001659;GO:0071577;, C:cell projection; C:cytoplasmic vesicle membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perikaryon; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium channel activity; F:calcium ion binding; F:calcium-release channel activity; F:cation channel activity; F:ligand-gated calcium channel activity; F:mono-ADP-D-ribose binding; F:sodium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-mediated signaling using intracellular calcium source; P:cation transmembrane transport; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to purine-containing compound; P:cellular response to temperature stimulus; P:dendritic cell chemotaxis; P:dendritic cell differentiation; P:metal ion transport; P:neutrophil degranulation; P:protein homotetramerization; P:regulation of actin cytoskeleton reorganization; P:regulation of filopodium assembly; P:release of sequestered calcium ion into cytosol; P:response to purine-containing compound; P:temperature homeostasis; P:zinc ion transmembrane transport; scaffold20 indexed_genome mRNA 22374591 22384936 . + . ID=transcript_4968;O94759 D3DSL6 Q5KTC2 Q6J3P5 Q96KN6 Q96Q93,Transient receptor potential cation channel subfamily M member 2,Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};, PF00520;PF18139;, GO:0042995;GO:0030659;GO:0101003;GO:0005887;GO:0005765;GO:0005764;GO:0043204;GO:0005886;GO:0035579;GO:0070821;GO:0005262;GO:0005509;GO:0015278;GO:0005261;GO:0099604;GO:0072571;GO:0005272;GO:0098703;GO:0097553;GO:0070588;GO:0006816;GO:0035584;GO:0098655;GO:0071277;GO:0070301;GO:0071415;GO:0071502;GO:0002407;GO:0097028;GO:0030001;GO:0043312;GO:0051289;GO:2000249;GO:0051489;GO:0051209;GO:0014074;GO:0001659;GO:0071577;, C:cell projection; C:cytoplasmic vesicle membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perikaryon; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium channel activity; F:calcium ion binding; F:calcium-release channel activity; F:cation channel activity; F:ligand-gated calcium channel activity; F:mono-ADP-D-ribose binding; F:sodium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-mediated signaling using intracellular calcium source; P:cation transmembrane transport; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to purine-containing compound; P:cellular response to temperature stimulus; P:dendritic cell chemotaxis; P:dendritic cell differentiation; P:metal ion transport; P:neutrophil degranulation; P:protein homotetramerization; P:regulation of actin cytoskeleton reorganization; P:regulation of filopodium assembly; P:release of sequestered calcium ion into cytosol; P:response to purine-containing compound; P:temperature homeostasis; P:zinc ion transmembrane transport;|O94759 D3DSL6 Q5KTC2 Q6J3P5 Q96KN6 Q96Q93,Transient receptor potential cation channel subfamily M member 2,Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};, PF00520;PF18139;, GO:0042995;GO:0030659;GO:0101003;GO:0005887;GO:0005765;GO:0005764;GO:0043204;GO:0005886;GO:0035579;GO:0070821;GO:0005262;GO:0005509;GO:0015278;GO:0005261;GO:0099604;GO:0072571;GO:0005272;GO:0098703;GO:0097553;GO:0070588;GO:0006816;GO:0035584;GO:0098655;GO:0071277;GO:0070301;GO:0071415;GO:0071502;GO:0002407;GO:0097028;GO:0030001;GO:0043312;GO:0051289;GO:2000249;GO:0051489;GO:0051209;GO:0014074;GO:0001659;GO:0071577;, C:cell projection; C:cytoplasmic vesicle membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perikaryon; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium channel activity; F:calcium ion binding; F:calcium-release channel activity; F:cation channel activity; F:ligand-gated calcium channel activity; F:mono-ADP-D-ribose binding; F:sodium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-mediated signaling using intracellular calcium source; P:cation transmembrane transport; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to purine-containing compound; P:cellular response to temperature stimulus; P:dendritic cell chemotaxis; P:dendritic cell differentiation; P:metal ion transport; P:neutrophil degranulation; P:protein homotetramerization; P:regulation of actin cytoskeleton reorganization; P:regulation of filopodium assembly; P:release of sequestered calcium ion into cytosol; P:response to purine-containing compound; P:temperature homeostasis; P:zinc ion transmembrane transport;|O94759 D3DSL6 Q5KTC2 Q6J3P5 Q96KN6 Q96Q93,Transient receptor potential cation channel subfamily M member 2,Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};, PF00520;PF18139;, GO:0042995;GO:0030659;GO:0101003;GO:0005887;GO:0005765;GO:0005764;GO:0043204;GO:0005886;GO:0035579;GO:0070821;GO:0005262;GO:0005509;GO:0015278;GO:0005261;GO:0099604;GO:0072571;GO:0005272;GO:0098703;GO:0097553;GO:0070588;GO:0006816;GO:0035584;GO:0098655;GO:0071277;GO:0070301;GO:0071415;GO:0071502;GO:0002407;GO:0097028;GO:0030001;GO:0043312;GO:0051289;GO:2000249;GO:0051489;GO:0051209;GO:0014074;GO:0001659;GO:0071577;, C:cell projection; C:cytoplasmic vesicle membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perikaryon; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium channel activity; F:calcium ion binding; F:calcium-release channel activity; F:cation channel activity; F:ligand-gated calcium channel activity; F:mono-ADP-D-ribose binding; F:sodium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-mediated signaling using intracellular calcium source; P:cation transmembrane transport; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to purine-containing compound; P:cellular response to temperature stimulus; P:dendritic cell chemotaxis; P:dendritic cell differentiation; P:metal ion transport; P:neutrophil degranulation; P:protein homotetramerization; P:regulation of actin cytoskeleton reorganization; P:regulation of filopodium assembly; P:release of sequestered calcium ion into cytosol; P:response to purine-containing compound; P:temperature homeostasis; P:zinc ion transmembrane transport;|O94759 D3DSL6 Q5KTC2 Q6J3P5 Q96KN6 Q96Q93,Transient receptor potential cation channel subfamily M member 2,Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};, PF00520;PF18139;, GO:0042995;GO:0030659;GO:0101003;GO:0005887;GO:0005765;GO:0005764;GO:0043204;GO:0005886;GO:0035579;GO:0070821;GO:0005262;GO:0005509;GO:0015278;GO:0005261;GO:0099604;GO:0072571;GO:0005272;GO:0098703;GO:0097553;GO:0070588;GO:0006816;GO:0035584;GO:0098655;GO:0071277;GO:0070301;GO:0071415;GO:0071502;GO:0002407;GO:0097028;GO:0030001;GO:0043312;GO:0051289;GO:2000249;GO:0051489;GO:0051209;GO:0014074;GO:0001659;GO:0071577;, C:cell projection; C:cytoplasmic vesicle membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perikaryon; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium channel activity; F:calcium ion binding; F:calcium-release channel activity; F:cation channel activity; F:ligand-gated calcium channel activity; F:mono-ADP-D-ribose binding; F:sodium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-mediated signaling using intracellular calcium source; P:cation transmembrane transport; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to purine-containing compound; P:cellular response to temperature stimulus; P:dendritic cell chemotaxis; P:dendritic cell differentiation; P:metal ion transport; P:neutrophil degranulation; P:protein homotetramerization; P:regulation of actin cytoskeleton reorganization; P:regulation of filopodium assembly; P:release of sequestered calcium ion into cytosol; P:response to purine-containing compound; P:temperature homeostasis; P:zinc ion transmembrane transport;|O94759 D3DSL6 Q5KTC2 Q6J3P5 Q96KN6 Q96Q93,Transient receptor potential cation channel subfamily M member 2,Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};, PF00520;PF18139;, GO:0042995;GO:0030659;GO:0101003;GO:0005887;GO:0005765;GO:0005764;GO:0043204;GO:0005886;GO:0035579;GO:0070821;GO:0005262;GO:0005509;GO:0015278;GO:0005261;GO:0099604;GO:0072571;GO:0005272;GO:0098703;GO:0097553;GO:0070588;GO:0006816;GO:0035584;GO:0098655;GO:0071277;GO:0070301;GO:0071415;GO:0071502;GO:0002407;GO:0097028;GO:0030001;GO:0043312;GO:0051289;GO:2000249;GO:0051489;GO:0051209;GO:0014074;GO:0001659;GO:0071577;, C:cell projection; C:cytoplasmic vesicle membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perikaryon; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium channel activity; F:calcium ion binding; F:calcium-release channel activity; F:cation channel activity; F:ligand-gated calcium channel activity; F:mono-ADP-D-ribose binding; F:sodium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-mediated signaling using intracellular calcium source; P:cation transmembrane transport; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to purine-containing compound; P:cellular response to temperature stimulus; P:dendritic cell chemotaxis; P:dendritic cell differentiation; P:metal ion transport; P:neutrophil degranulation; P:protein homotetramerization; P:regulation of actin cytoskeleton reorganization; P:regulation of filopodium assembly; P:release of sequestered calcium ion into cytosol; P:response to purine-containing compound; P:temperature homeostasis; P:zinc ion transmembrane transport;|O94759 D3DSL6 Q5KTC2 Q6J3P5 Q96KN6 Q96Q93,Transient receptor potential cation channel subfamily M member 2,Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};, PF00520;PF18139;, GO:0042995;GO:0030659;GO:0101003;GO:0005887;GO:0005765;GO:0005764;GO:0043204;GO:0005886;GO:0035579;GO:0070821;GO:0005262;GO:0005509;GO:0015278;GO:0005261;GO:0099604;GO:0072571;GO:0005272;GO:0098703;GO:0097553;GO:0070588;GO:0006816;GO:0035584;GO:0098655;GO:0071277;GO:0070301;GO:0071415;GO:0071502;GO:0002407;GO:0097028;GO:0030001;GO:0043312;GO:0051289;GO:2000249;GO:0051489;GO:0051209;GO:0014074;GO:0001659;GO:0071577;, C:cell projection; C:cytoplasmic vesicle membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perikaryon; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium channel activity; F:calcium ion binding; F:calcium-release channel activity; F:cation channel activity; F:ligand-gated calcium channel activity; F:mono-ADP-D-ribose binding; F:sodium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-mediated signaling using intracellular calcium source; P:cation transmembrane transport; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to purine-containing compound; P:cellular response to temperature stimulus; P:dendritic cell chemotaxis; P:dendritic cell differentiation; P:metal ion transport; P:neutrophil degranulation; P:protein homotetramerization; P:regulation of actin cytoskeleton reorganization; P:regulation of filopodium assembly; P:release of sequestered calcium ion into cytosol; P:response to purine-containing compound; P:temperature homeostasis; P:zinc ion transmembrane transport;|O94759 D3DSL6 Q5KTC2 Q6J3P5 Q96KN6 Q96Q93,Transient receptor potential cation channel subfamily M member 2,Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};, PF00520;PF18139;, GO:0042995;GO:0030659;GO:0101003;GO:0005887;GO:0005765;GO:0005764;GO:0043204;GO:0005886;GO:0035579;GO:0070821;GO:0005262;GO:0005509;GO:0015278;GO:0005261;GO:0099604;GO:0072571;GO:0005272;GO:0098703;GO:0097553;GO:0070588;GO:0006816;GO:0035584;GO:0098655;GO:0071277;GO:0070301;GO:0071415;GO:0071502;GO:0002407;GO:0097028;GO:0030001;GO:0043312;GO:0051289;GO:2000249;GO:0051489;GO:0051209;GO:0014074;GO:0001659;GO:0071577;, C:cell projection; C:cytoplasmic vesicle membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perikaryon; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium channel activity; F:calcium ion binding; F:calcium-release channel activity; F:cation channel activity; F:ligand-gated calcium channel activity; F:mono-ADP-D-ribose binding; F:sodium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-mediated signaling using intracellular calcium source; P:cation transmembrane transport; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to purine-containing compound; P:cellular response to temperature stimulus; P:dendritic cell chemotaxis; P:dendritic cell differentiation; P:metal ion transport; P:neutrophil degranulation; P:protein homotetramerization; P:regulation of actin cytoskeleton reorganization; P:regulation of filopodium assembly; P:release of sequestered calcium ion into cytosol; P:response to purine-containing compound; P:temperature homeostasis; P:zinc ion transmembrane transport;|O94759 D3DSL6 Q5KTC2 Q6J3P5 Q96KN6 Q96Q93,Transient receptor potential cation channel subfamily M member 2,Estrogen-responsive element-associated gene 1 protein {ECO:0000303|Ref.9};Long transient receptor potential channel 2 {ECO:0000303|PubMed:11960981};Transient receptor potential channel 7 {ECO:0000303|PubMed:9806837};Transient receptor potential melastatin 2 {ECO:0000303|PubMed:27383051};, PF00520;PF18139;, GO:0042995;GO:0030659;GO:0101003;GO:0005887;GO:0005765;GO:0005764;GO:0043204;GO:0005886;GO:0035579;GO:0070821;GO:0005262;GO:0005509;GO:0015278;GO:0005261;GO:0099604;GO:0072571;GO:0005272;GO:0098703;GO:0097553;GO:0070588;GO:0006816;GO:0035584;GO:0098655;GO:0071277;GO:0070301;GO:0071415;GO:0071502;GO:0002407;GO:0097028;GO:0030001;GO:0043312;GO:0051289;GO:2000249;GO:0051489;GO:0051209;GO:0014074;GO:0001659;GO:0071577;, C:cell projection; C:cytoplasmic vesicle membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perikaryon; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium channel activity; F:calcium ion binding; F:calcium-release channel activity; F:cation channel activity; F:ligand-gated calcium channel activity; F:mono-ADP-D-ribose binding; F:sodium channel activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-mediated signaling using intracellular calcium source; P:cation transmembrane transport; P:cellular response to calcium ion; P:cellular response to hydrogen peroxide; P:cellular response to purine-containing compound; P:cellular response to temperature stimulus; P:dendritic cell chemotaxis; P:dendritic cell differentiation; P:metal ion transport; P:neutrophil degranulation; P:protein homotetramerization; P:regulation of actin cytoskeleton reorganization; P:regulation of filopodium assembly; P:release of sequestered calcium ion into cytosol; P:response to purine-containing compound; P:temperature homeostasis; P:zinc ion transmembrane transport; scaffold20 indexed_genome mRNA 22395592 22400854 . + . ID=transcript_4969;Q9BY71 Q0VDJ2,Leucine-rich repeat-containing protein 3,, PF00560;PF13855;PF01462;, GO:0016021;, C:integral component of membrane; scaffold20 indexed_genome mRNA 22592424 22610492 . - . ID=transcript_4970;P60604 A6NMQ7 A8K3L4 D3DSL7 P56554,Ubiquitin-conjugating enzyme E2 G2,E2 ubiquitin-conjugating enzyme G2;Ubiquitin carrier protein G2;Ubiquitin-protein ligase G2;, PF00179;, GO:0005829;GO:0005783;GO:0005811;GO:0005524;GO:0042802;GO:0061631;GO:0004842;GO:0044257;GO:0035458;GO:1904153;GO:0070936;GO:0000209;GO:0016567;GO:0030433;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:ATP binding; F:identical protein binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular protein catabolic process; P:cellular response to interferon-beta; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|P60604 A6NMQ7 A8K3L4 D3DSL7 P56554,Ubiquitin-conjugating enzyme E2 G2,E2 ubiquitin-conjugating enzyme G2;Ubiquitin carrier protein G2;Ubiquitin-protein ligase G2;, PF00179;, GO:0005829;GO:0005783;GO:0005811;GO:0005524;GO:0042802;GO:0061631;GO:0004842;GO:0044257;GO:0035458;GO:1904153;GO:0070936;GO:0000209;GO:0016567;GO:0030433;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:ATP binding; F:identical protein binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular protein catabolic process; P:cellular response to interferon-beta; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|P60604 A6NMQ7 A8K3L4 D3DSL7 P56554,Ubiquitin-conjugating enzyme E2 G2,E2 ubiquitin-conjugating enzyme G2;Ubiquitin carrier protein G2;Ubiquitin-protein ligase G2;, PF00179;, GO:0005829;GO:0005783;GO:0005811;GO:0005524;GO:0042802;GO:0061631;GO:0004842;GO:0044257;GO:0035458;GO:1904153;GO:0070936;GO:0000209;GO:0016567;GO:0030433;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:ATP binding; F:identical protein binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular protein catabolic process; P:cellular response to interferon-beta; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold20 indexed_genome mRNA 22621592 22628087 . + . ID=transcript_4971;P61956 B2R4I2 P55855 Q32Q42 Q6IPZ6 Q96HK1,Small ubiquitin-related modifier 2 {ECO:0000305},HSMT3 {ECO:0000303|PubMed:8630065};SMT3 homolog 2 {ECO:0000312|HGNC:HGNC:11125};SUMO-3 {ECO:0000303|PubMed:10692421};Sentrin-2 {ECO:0000303|PubMed:9556629};Ubiquitin-like protein SMT3B {ECO:0000305};, PF11976;, GO:0005654;GO:0005634;GO:0016605;GO:0031386;GO:0003723;GO:0031625;GO:0044389;GO:0032436;GO:0016925;, C:nucleoplasm; C:nucleus; C:PML body;, F:protein tag; F:RNA binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein sumoylation;|P55854 B2R5X4 B4DUW4 Q53HI9 Q6FGD4 Q9BWR4,Small ubiquitin-related modifier 3 {ECO:0000305},SMT3 homolog 1 {ECO:0000312|HGNC:HGNC:11124};SUMO-2 {ECO:0000303|PubMed:10692421};Ubiquitin-like protein SMT3A {ECO:0000303|PubMed:9119407};, PF11976;, GO:0005737;GO:0000776;GO:0005654;GO:0005634;GO:0016605;GO:0031386;GO:0044389;GO:0043392;GO:0016925;GO:1900180;, C:cytoplasm; C:kinetochore; C:nucleoplasm; C:nucleus; C:PML body;, F:protein tag; F:ubiquitin-like protein ligase binding;, P:negative regulation of DNA binding; P:protein sumoylation; P:regulation of protein localization to nucleus; scaffold20 indexed_genome mRNA 22646948 22657580 . - . ID=transcript_4972;P53801 B2RDP7 D3DSL9 Q9NS09,Pituitary tumor-transforming gene 1 protein-interacting protein,Pituitary tumor-transforming gene protein-binding factor;, , GO:0005737;GO:0070062;GO:0016021;GO:0016020;GO:0005654;GO:0005634;GO:0002039;GO:0043518;GO:1902254;GO:1903364;GO:0031398;GO:0006606;, C:cytoplasm; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleoplasm; C:nucleus;, F:p53 binding;, P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:positive regulation of cellular protein catabolic process; P:positive regulation of protein ubiquitination; P:protein import into nucleus; scaffold20 indexed_genome mRNA 22694293 22704464 . - . ID=transcript_4973;P05107 B3KTS8 D3DSM1 Q16418 Q53HS5 Q9UD72,Integrin beta-2,Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta;Complement receptor C3 subunit beta;, PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0009897;GO:0070062;GO:1903561;GO:0101003;GO:0005925;GO:0034687;GO:0034688;GO:0034689;GO:0008305;GO:0016020;GO:0005886;GO:0044853;GO:0043235;GO:0035579;GO:0070821;GO:0001540;GO:0050839;GO:0001851;GO:0031072;GO:0030369;GO:0005178;GO:0046872;GO:0019901;GO:0007568;GO:0097242;GO:0006915;GO:0007155;GO:0033627;GO:0016477;GO:0098609;GO:0098742;GO:0007267;GO:0007160;GO:0045123;GO:0071404;GO:0019221;GO:0035987;GO:0043542;GO:0030198;GO:0034113;GO:0006954;GO:0007229;GO:0007159;GO:0050900;GO:0002523;GO:0001774;GO:0030101;GO:0045963;GO:0030593;GO:0043312;GO:1990266;GO:0006911;GO:0045766;GO:1904996;GO:1901216;GO:0043315;GO:0051092;GO:0045429;GO:2000363;GO:0090314;GO:0032930;GO:0043113;GO:0031623;GO:0006898;GO:0008360;GO:0050776;GO:0050730;GO:0034142;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:extracellular vesicle; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integrin alphaL-beta2 complex; C:integrin alphaM-beta2 complex; C:integrin alphaX-beta2 complex; C:integrin complex; C:membrane; C:plasma membrane; C:plasma membrane raft; C:receptor complex; C:specific granule membrane; C:tertiary granule membrane;, F:amyloid-beta binding; F:cell adhesion molecule binding; F:complement component C3b binding; F:heat shock protein binding; F:ICAM-3 receptor activity; F:integrin binding; F:metal ion binding; F:protein kinase binding;, P:aging; P:amyloid-beta clearance; P:apoptotic process; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell signaling; P:cell-matrix adhesion; P:cellular extravasation; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:endodermal cell differentiation; P:endothelial cell migration; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:inflammatory response; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte migration involved in inflammatory response; P:microglial cell activation; P:natural killer cell activation; P:negative regulation of dopamine metabolic process; P:neutrophil chemotaxis; P:neutrophil degranulation; P:neutrophil migration; P:phagocytosis, engulfment; P:positive regulation of angiogenesis; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of neuron death; P:positive regulation of neutrophil degranulation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of prostaglandin-E synthase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of superoxide anion generation; P:receptor clustering; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of cell shape; P:regulation of immune response; P:regulation of peptidyl-tyrosine phosphorylation; P:toll-like receptor 4 signaling pathway;|P05107 B3KTS8 D3DSM1 Q16418 Q53HS5 Q9UD72,Integrin beta-2,Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta;Complement receptor C3 subunit beta;, PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0009897;GO:0070062;GO:1903561;GO:0101003;GO:0005925;GO:0034687;GO:0034688;GO:0034689;GO:0008305;GO:0016020;GO:0005886;GO:0044853;GO:0043235;GO:0035579;GO:0070821;GO:0001540;GO:0050839;GO:0001851;GO:0031072;GO:0030369;GO:0005178;GO:0046872;GO:0019901;GO:0007568;GO:0097242;GO:0006915;GO:0007155;GO:0033627;GO:0016477;GO:0098609;GO:0098742;GO:0007267;GO:0007160;GO:0045123;GO:0071404;GO:0019221;GO:0035987;GO:0043542;GO:0030198;GO:0034113;GO:0006954;GO:0007229;GO:0007159;GO:0050900;GO:0002523;GO:0001774;GO:0030101;GO:0045963;GO:0030593;GO:0043312;GO:1990266;GO:0006911;GO:0045766;GO:1904996;GO:1901216;GO:0043315;GO:0051092;GO:0045429;GO:2000363;GO:0090314;GO:0032930;GO:0043113;GO:0031623;GO:0006898;GO:0008360;GO:0050776;GO:0050730;GO:0034142;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:extracellular vesicle; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integrin alphaL-beta2 complex; C:integrin alphaM-beta2 complex; C:integrin alphaX-beta2 complex; C:integrin complex; C:membrane; C:plasma membrane; C:plasma membrane raft; C:receptor complex; C:specific granule membrane; C:tertiary granule membrane;, F:amyloid-beta binding; F:cell adhesion molecule binding; F:complement component C3b binding; F:heat shock protein binding; F:ICAM-3 receptor activity; F:integrin binding; F:metal ion binding; F:protein kinase binding;, P:aging; P:amyloid-beta clearance; P:apoptotic process; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell signaling; P:cell-matrix adhesion; P:cellular extravasation; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:endodermal cell differentiation; P:endothelial cell migration; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:inflammatory response; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte migration involved in inflammatory response; P:microglial cell activation; P:natural killer cell activation; P:negative regulation of dopamine metabolic process; P:neutrophil chemotaxis; P:neutrophil degranulation; P:neutrophil migration; P:phagocytosis, engulfment; P:positive regulation of angiogenesis; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of neuron death; P:positive regulation of neutrophil degranulation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of prostaglandin-E synthase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of superoxide anion generation; P:receptor clustering; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of cell shape; P:regulation of immune response; P:regulation of peptidyl-tyrosine phosphorylation; P:toll-like receptor 4 signaling pathway; scaffold20 indexed_genome mRNA 22704469 22724825 . - . ID=transcript_4974;P05107 B3KTS8 D3DSM1 Q16418 Q53HS5 Q9UD72,Integrin beta-2,Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta;Complement receptor C3 subunit beta;, PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0009897;GO:0070062;GO:1903561;GO:0101003;GO:0005925;GO:0034687;GO:0034688;GO:0034689;GO:0008305;GO:0016020;GO:0005886;GO:0044853;GO:0043235;GO:0035579;GO:0070821;GO:0001540;GO:0050839;GO:0001851;GO:0031072;GO:0030369;GO:0005178;GO:0046872;GO:0019901;GO:0007568;GO:0097242;GO:0006915;GO:0007155;GO:0033627;GO:0016477;GO:0098609;GO:0098742;GO:0007267;GO:0007160;GO:0045123;GO:0071404;GO:0019221;GO:0035987;GO:0043542;GO:0030198;GO:0034113;GO:0006954;GO:0007229;GO:0007159;GO:0050900;GO:0002523;GO:0001774;GO:0030101;GO:0045963;GO:0030593;GO:0043312;GO:1990266;GO:0006911;GO:0045766;GO:1904996;GO:1901216;GO:0043315;GO:0051092;GO:0045429;GO:2000363;GO:0090314;GO:0032930;GO:0043113;GO:0031623;GO:0006898;GO:0008360;GO:0050776;GO:0050730;GO:0034142;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:extracellular vesicle; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integrin alphaL-beta2 complex; C:integrin alphaM-beta2 complex; C:integrin alphaX-beta2 complex; C:integrin complex; C:membrane; C:plasma membrane; C:plasma membrane raft; C:receptor complex; C:specific granule membrane; C:tertiary granule membrane;, F:amyloid-beta binding; F:cell adhesion molecule binding; F:complement component C3b binding; F:heat shock protein binding; F:ICAM-3 receptor activity; F:integrin binding; F:metal ion binding; F:protein kinase binding;, P:aging; P:amyloid-beta clearance; P:apoptotic process; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell signaling; P:cell-matrix adhesion; P:cellular extravasation; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:endodermal cell differentiation; P:endothelial cell migration; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:inflammatory response; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte migration involved in inflammatory response; P:microglial cell activation; P:natural killer cell activation; P:negative regulation of dopamine metabolic process; P:neutrophil chemotaxis; P:neutrophil degranulation; P:neutrophil migration; P:phagocytosis, engulfment; P:positive regulation of angiogenesis; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of neuron death; P:positive regulation of neutrophil degranulation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of prostaglandin-E synthase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of superoxide anion generation; P:receptor clustering; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of cell shape; P:regulation of immune response; P:regulation of peptidyl-tyrosine phosphorylation; P:toll-like receptor 4 signaling pathway; scaffold20 indexed_genome mRNA 22748407 22789210 . + . ID=transcript_4975;Q9NSI2,Protein FAM207A,, PF15341;, GO:0030686;GO:0005730;GO:0030688;GO:0000462;, C:90S preribosome; C:nucleolus; C:preribosome, small subunit precursor;, , P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); scaffold20 indexed_genome mRNA 22916160 22979885 . + . ID=transcript_4976;O00691 O00692 P78555 Q4AE77 Q4AE79 Q6P0M9 Q8NFA1 Q8NFD1,Double-stranded RNA-specific editase 1 {ECO:0000305},RNA-editing deaminase 1;RNA-editing enzyme 1;dsRNA adenosine deaminase;, PF02137;PF00035;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003726;GO:0003725;GO:0042802;GO:0046872;GO:0003729;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0051607;GO:0021610;GO:0021618;GO:0045087;GO:0060384;GO:0061744;GO:0097049;GO:0006397;GO:0035264;GO:0060415;GO:0030336;GO:0008285;GO:0044387;GO:0050884;GO:0007274;GO:0045070;GO:0051726;GO:0006396;GO:0021965;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:identical protein binding; F:metal ion binding; F:mRNA binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:defense response to virus; P:facial nerve morphogenesis; P:hypoglossal nerve morphogenesis; P:innate immune response; P:innervation; P:motor behavior; P:motor neuron apoptotic process; P:mRNA processing; P:multicellular organism growth; P:muscle tissue morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:neuromuscular process controlling posture; P:neuromuscular synaptic transmission; P:positive regulation of viral genome replication; P:regulation of cell cycle; P:RNA processing; P:spinal cord ventral commissure morphogenesis;|O00691 O00692 P78555 Q4AE77 Q4AE79 Q6P0M9 Q8NFA1 Q8NFD1,Double-stranded RNA-specific editase 1 {ECO:0000305},RNA-editing deaminase 1;RNA-editing enzyme 1;dsRNA adenosine deaminase;, PF02137;PF00035;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003726;GO:0003725;GO:0042802;GO:0046872;GO:0003729;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0051607;GO:0021610;GO:0021618;GO:0045087;GO:0060384;GO:0061744;GO:0097049;GO:0006397;GO:0035264;GO:0060415;GO:0030336;GO:0008285;GO:0044387;GO:0050884;GO:0007274;GO:0045070;GO:0051726;GO:0006396;GO:0021965;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:identical protein binding; F:metal ion binding; F:mRNA binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:defense response to virus; P:facial nerve morphogenesis; P:hypoglossal nerve morphogenesis; P:innate immune response; P:innervation; P:motor behavior; P:motor neuron apoptotic process; P:mRNA processing; P:multicellular organism growth; P:muscle tissue morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:neuromuscular process controlling posture; P:neuromuscular synaptic transmission; P:positive regulation of viral genome replication; P:regulation of cell cycle; P:RNA processing; P:spinal cord ventral commissure morphogenesis;|O00691 O00692 P78555 Q4AE77 Q4AE79 Q6P0M9 Q8NFA1 Q8NFD1,Double-stranded RNA-specific editase 1 {ECO:0000305},RNA-editing deaminase 1;RNA-editing enzyme 1;dsRNA adenosine deaminase;, PF02137;PF00035;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003726;GO:0003725;GO:0042802;GO:0046872;GO:0003729;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0051607;GO:0021610;GO:0021618;GO:0045087;GO:0060384;GO:0061744;GO:0097049;GO:0006397;GO:0035264;GO:0060415;GO:0030336;GO:0008285;GO:0044387;GO:0050884;GO:0007274;GO:0045070;GO:0051726;GO:0006396;GO:0021965;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:identical protein binding; F:metal ion binding; F:mRNA binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:defense response to virus; P:facial nerve morphogenesis; P:hypoglossal nerve morphogenesis; P:innate immune response; P:innervation; P:motor behavior; P:motor neuron apoptotic process; P:mRNA processing; P:multicellular organism growth; P:muscle tissue morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:neuromuscular process controlling posture; P:neuromuscular synaptic transmission; P:positive regulation of viral genome replication; P:regulation of cell cycle; P:RNA processing; P:spinal cord ventral commissure morphogenesis;|O00691 O00692 P78555 Q4AE77 Q4AE79 Q6P0M9 Q8NFA1 Q8NFD1,Double-stranded RNA-specific editase 1 {ECO:0000305},RNA-editing deaminase 1;RNA-editing enzyme 1;dsRNA adenosine deaminase;, PF02137;PF00035;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003726;GO:0003725;GO:0042802;GO:0046872;GO:0003729;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0051607;GO:0021610;GO:0021618;GO:0045087;GO:0060384;GO:0061744;GO:0097049;GO:0006397;GO:0035264;GO:0060415;GO:0030336;GO:0008285;GO:0044387;GO:0050884;GO:0007274;GO:0045070;GO:0051726;GO:0006396;GO:0021965;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:identical protein binding; F:metal ion binding; F:mRNA binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:defense response to virus; P:facial nerve morphogenesis; P:hypoglossal nerve morphogenesis; P:innate immune response; P:innervation; P:motor behavior; P:motor neuron apoptotic process; P:mRNA processing; P:multicellular organism growth; P:muscle tissue morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:neuromuscular process controlling posture; P:neuromuscular synaptic transmission; P:positive regulation of viral genome replication; P:regulation of cell cycle; P:RNA processing; P:spinal cord ventral commissure morphogenesis;|O00691 O00692 P78555 Q4AE77 Q4AE79 Q6P0M9 Q8NFA1 Q8NFD1,Double-stranded RNA-specific editase 1 {ECO:0000305},RNA-editing deaminase 1;RNA-editing enzyme 1;dsRNA adenosine deaminase;, PF02137;PF00035;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003726;GO:0003725;GO:0042802;GO:0046872;GO:0003729;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0051607;GO:0021610;GO:0021618;GO:0045087;GO:0060384;GO:0061744;GO:0097049;GO:0006397;GO:0035264;GO:0060415;GO:0030336;GO:0008285;GO:0044387;GO:0050884;GO:0007274;GO:0045070;GO:0051726;GO:0006396;GO:0021965;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:identical protein binding; F:metal ion binding; F:mRNA binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:defense response to virus; P:facial nerve morphogenesis; P:hypoglossal nerve morphogenesis; P:innate immune response; P:innervation; P:motor behavior; P:motor neuron apoptotic process; P:mRNA processing; P:multicellular organism growth; P:muscle tissue morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:neuromuscular process controlling posture; P:neuromuscular synaptic transmission; P:positive regulation of viral genome replication; P:regulation of cell cycle; P:RNA processing; P:spinal cord ventral commissure morphogenesis; scaffold20 indexed_genome mRNA 23018987 23029785 . - . ID=transcript_4977;Q9Y2G5 Q6PJV1 Q7Z4N0 Q8WWU6 Q9BQS4 Q9BQS5 Q9UFY3,GDP-fucose protein O-fucosyltransferase 2,Peptide-O-fucosyltransferase 2;, PF10250;, GO:0005789;GO:0005794;GO:0046922;GO:0006004;GO:0001707;GO:1903334;GO:0036066;GO:0010717;GO:0010468;GO:0051046;, C:endoplasmic reticulum membrane; C:Golgi apparatus;, F:peptide-O-fucosyltransferase activity;, P:fucose metabolic process; P:mesoderm formation; P:positive regulation of protein folding; P:protein O-linked fucosylation; P:regulation of epithelial to mesenchymal transition; P:regulation of gene expression; P:regulation of secretion;|Q9Y2G5 Q6PJV1 Q7Z4N0 Q8WWU6 Q9BQS4 Q9BQS5 Q9UFY3,GDP-fucose protein O-fucosyltransferase 2,Peptide-O-fucosyltransferase 2;, PF10250;, GO:0005789;GO:0005794;GO:0046922;GO:0006004;GO:0001707;GO:1903334;GO:0036066;GO:0010717;GO:0010468;GO:0051046;, C:endoplasmic reticulum membrane; C:Golgi apparatus;, F:peptide-O-fucosyltransferase activity;, P:fucose metabolic process; P:mesoderm formation; P:positive regulation of protein folding; P:protein O-linked fucosylation; P:regulation of epithelial to mesenchymal transition; P:regulation of gene expression; P:regulation of secretion;|Q9Y2G5 Q6PJV1 Q7Z4N0 Q8WWU6 Q9BQS4 Q9BQS5 Q9UFY3,GDP-fucose protein O-fucosyltransferase 2,Peptide-O-fucosyltransferase 2;, PF10250;, GO:0005789;GO:0005794;GO:0046922;GO:0006004;GO:0001707;GO:1903334;GO:0036066;GO:0010717;GO:0010468;GO:0051046;, C:endoplasmic reticulum membrane; C:Golgi apparatus;, F:peptide-O-fucosyltransferase activity;, P:fucose metabolic process; P:mesoderm formation; P:positive regulation of protein folding; P:protein O-linked fucosylation; P:regulation of epithelial to mesenchymal transition; P:regulation of gene expression; P:regulation of secretion; scaffold20 indexed_genome mRNA 23139822 23262023 . + . ID=transcript_4978;Q9UK38 Q9Y6Q7 Q9Y6Q8,Collagen alpha-1(XVIII) chain {ECO:0000305},, PF01391;PF06121;PF06482;PF01392;, GO:0005604;GO:0005581;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0042802;GO:0046872;GO:0001525;GO:0009887;GO:0007155;GO:0030199;GO:0001886;GO:0030198;GO:0008285;GO:0042493;GO:0051599;GO:0007601;, C:basement membrane; C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:identical protein binding; F:metal ion binding;, P:angiogenesis; P:animal organ morphogenesis; P:cell adhesion; P:collagen fibril organization; P:endothelial cell morphogenesis; P:extracellular matrix organization; P:negative regulation of cell population proliferation; P:response to drug; P:response to hydrostatic pressure; P:visual perception;|Q9UK38 Q9Y6Q7 Q9Y6Q8,Collagen alpha-1(XVIII) chain {ECO:0000305},, PF01391;PF06121;PF06482;PF01392;, GO:0005604;GO:0005581;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0042802;GO:0046872;GO:0001525;GO:0009887;GO:0007155;GO:0030199;GO:0001886;GO:0030198;GO:0008285;GO:0042493;GO:0051599;GO:0007601;, C:basement membrane; C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:identical protein binding; F:metal ion binding;, P:angiogenesis; P:animal organ morphogenesis; P:cell adhesion; P:collagen fibril organization; P:endothelial cell morphogenesis; P:extracellular matrix organization; P:negative regulation of cell population proliferation; P:response to drug; P:response to hydrostatic pressure; P:visual perception;|Q9UK38 Q9Y6Q7 Q9Y6Q8,Collagen alpha-1(XVIII) chain {ECO:0000305},, PF01391;PF06121;PF06482;PF01392;, GO:0005604;GO:0005581;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0042802;GO:0046872;GO:0001525;GO:0009887;GO:0007155;GO:0030199;GO:0001886;GO:0030198;GO:0008285;GO:0042493;GO:0051599;GO:0007601;, C:basement membrane; C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:identical protein binding; F:metal ion binding;, P:angiogenesis; P:animal organ morphogenesis; P:cell adhesion; P:collagen fibril organization; P:endothelial cell morphogenesis; P:extracellular matrix organization; P:negative regulation of cell population proliferation; P:response to drug; P:response to hydrostatic pressure; P:visual perception;|Q9UK38 Q9Y6Q7 Q9Y6Q8,Collagen alpha-1(XVIII) chain {ECO:0000305},, PF01391;PF06121;PF06482;PF01392;, GO:0005604;GO:0005581;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0042802;GO:0046872;GO:0001525;GO:0009887;GO:0007155;GO:0030199;GO:0001886;GO:0030198;GO:0008285;GO:0042493;GO:0051599;GO:0007601;, C:basement membrane; C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:identical protein binding; F:metal ion binding;, P:angiogenesis; P:animal organ morphogenesis; P:cell adhesion; P:collagen fibril organization; P:endothelial cell morphogenesis; P:extracellular matrix organization; P:negative regulation of cell population proliferation; P:response to drug; P:response to hydrostatic pressure; P:visual perception;|P41440 B2R7U8 B7Z8C3 E9PFY4 O00553 O60227 Q13026 Q9BTX8,Reduced folate transporter {ECO:0000305},Intestinal folate carrier 1 {ECO:0000303|PubMed:9041240};Placental folate transporter {ECO:0000303|PubMed:7826387};Reduced folate carrier protein {ECO:0000303|PubMed:7615551};Reduced folate transporter 1 {ECO:0000303|PubMed:10787414};Solute carrier family 19 member 1 {ECO:0000305};, PF01770;, GO:0016324;GO:0016323;GO:0031526;GO:0005887;GO:0005886;GO:0061507;GO:0140360;GO:0008518;GO:0005542;GO:0008517;GO:0015350;GO:0008514;GO:0140361;GO:0007565;GO:1904447;GO:0098838;GO:0046655;GO:0015884;GO:0051958;GO:0015711;GO:0055085;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cyclic-GMP-AMP binding; F:cyclic-GMP-AMP transmembrane transporter activity; F:folate:anion antiporter activity; F:folic acid binding; F:folic acid transmembrane transporter activity; F:methotrexate transmembrane transporter activity; F:organic anion transmembrane transporter activity;, P:cyclic-GMP-AMP transmembrane import across plasma membrane; P:female pregnancy; P:folate import across plasma membrane; P:folate transmembrane transport; P:folic acid metabolic process; P:folic acid transport; P:methotrexate transport; P:organic anion transport; P:transmembrane transport; P:transport across blood-brain barrier; scaffold20 indexed_genome mRNA 23332709 23534885 . + . ID=transcript_4979;P57721 A8MPS2 A8MQ26 B7WNN9 B7WPC1 Q8N9K6 Q96EP6,Poly(rC)-binding protein 3,Alpha-CP3;PCBP3-overlapping transcript {ECO:0000312|HGNC:HGNC:8651};PCBP3-overlapping transcript 1 {ECO:0000312|HGNC:HGNC:8651};, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0003677;GO:0003729;GO:0003723;GO:0016071;GO:0010468;GO:0051252;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:mRNA metabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process; scaffold20 indexed_genome mRNA 23534922 23540082 . + . ID=transcript_4980;P57721 A8MPS2 A8MQ26 B7WNN9 B7WPC1 Q8N9K6 Q96EP6,Poly(rC)-binding protein 3,Alpha-CP3;PCBP3-overlapping transcript {ECO:0000312|HGNC:HGNC:8651};PCBP3-overlapping transcript 1 {ECO:0000312|HGNC:HGNC:8651};, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0003677;GO:0003729;GO:0003723;GO:0016071;GO:0010468;GO:0051252;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:mRNA metabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process;|P57721 A8MPS2 A8MQ26 B7WNN9 B7WPC1 Q8N9K6 Q96EP6,Poly(rC)-binding protein 3,Alpha-CP3;PCBP3-overlapping transcript {ECO:0000312|HGNC:HGNC:8651};PCBP3-overlapping transcript 1 {ECO:0000312|HGNC:HGNC:8651};, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0003677;GO:0003729;GO:0003723;GO:0016071;GO:0010468;GO:0051252;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:mRNA metabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process; scaffold20 indexed_genome mRNA 23541256 23556657 . + . ID=transcript_4981;P57721 A8MPS2 A8MQ26 B7WNN9 B7WPC1 Q8N9K6 Q96EP6,Poly(rC)-binding protein 3,Alpha-CP3;PCBP3-overlapping transcript {ECO:0000312|HGNC:HGNC:8651};PCBP3-overlapping transcript 1 {ECO:0000312|HGNC:HGNC:8651};, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0003677;GO:0003729;GO:0003723;GO:0016071;GO:0010468;GO:0051252;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:mRNA metabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process;|P57721 A8MPS2 A8MQ26 B7WNN9 B7WPC1 Q8N9K6 Q96EP6,Poly(rC)-binding protein 3,Alpha-CP3;PCBP3-overlapping transcript {ECO:0000312|HGNC:HGNC:8651};PCBP3-overlapping transcript 1 {ECO:0000312|HGNC:HGNC:8651};, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0003677;GO:0003729;GO:0003723;GO:0016071;GO:0010468;GO:0051252;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:mRNA metabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process;|P57721 A8MPS2 A8MQ26 B7WNN9 B7WPC1 Q8N9K6 Q96EP6,Poly(rC)-binding protein 3,Alpha-CP3;PCBP3-overlapping transcript {ECO:0000312|HGNC:HGNC:8651};PCBP3-overlapping transcript 1 {ECO:0000312|HGNC:HGNC:8651};, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0003677;GO:0003729;GO:0003723;GO:0016071;GO:0010468;GO:0051252;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:mRNA metabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process;|P57721 A8MPS2 A8MQ26 B7WNN9 B7WPC1 Q8N9K6 Q96EP6,Poly(rC)-binding protein 3,Alpha-CP3;PCBP3-overlapping transcript {ECO:0000312|HGNC:HGNC:8651};PCBP3-overlapping transcript 1 {ECO:0000312|HGNC:HGNC:8651};, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0003677;GO:0003729;GO:0003723;GO:0016071;GO:0010468;GO:0051252;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:mRNA metabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process; scaffold20 indexed_genome mRNA 23599058 23619984 . + . ID=transcript_4982;P12109 O00117 O00118 Q14040 Q14041 Q16258 Q7Z645 Q9BSA8,Collagen alpha-1(VI) chain,, PF01391;PF00092;, GO:0005589;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005765;GO:0016020;GO:0032991;GO:0042383;GO:0005518;GO:0030020;GO:0048407;GO:0007155;GO:0071230;GO:0030199;GO:0035987;GO:0030198;GO:0001649;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal membrane; C:membrane; C:protein-containing complex; C:sarcolemma;, F:collagen binding; F:extracellular matrix structural constituent conferring tensile strength; F:platelet-derived growth factor binding;, P:cell adhesion; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:endodermal cell differentiation; P:extracellular matrix organization; P:osteoblast differentiation;|P12109 O00117 O00118 Q14040 Q14041 Q16258 Q7Z645 Q9BSA8,Collagen alpha-1(VI) chain,, PF01391;PF00092;, GO:0005589;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005765;GO:0016020;GO:0032991;GO:0042383;GO:0005518;GO:0030020;GO:0048407;GO:0007155;GO:0071230;GO:0030199;GO:0035987;GO:0030198;GO:0001649;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal membrane; C:membrane; C:protein-containing complex; C:sarcolemma;, F:collagen binding; F:extracellular matrix structural constituent conferring tensile strength; F:platelet-derived growth factor binding;, P:cell adhesion; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:endodermal cell differentiation; P:extracellular matrix organization; P:osteoblast differentiation;|P12109 O00117 O00118 Q14040 Q14041 Q16258 Q7Z645 Q9BSA8,Collagen alpha-1(VI) chain,, PF01391;PF00092;, GO:0005589;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005765;GO:0016020;GO:0032991;GO:0042383;GO:0005518;GO:0030020;GO:0048407;GO:0007155;GO:0071230;GO:0030199;GO:0035987;GO:0030198;GO:0001649;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal membrane; C:membrane; C:protein-containing complex; C:sarcolemma;, F:collagen binding; F:extracellular matrix structural constituent conferring tensile strength; F:platelet-derived growth factor binding;, P:cell adhesion; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:endodermal cell differentiation; P:extracellular matrix organization; P:osteoblast differentiation;|P12109 O00117 O00118 Q14040 Q14041 Q16258 Q7Z645 Q9BSA8,Collagen alpha-1(VI) chain,, PF01391;PF00092;, GO:0005589;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005765;GO:0016020;GO:0032991;GO:0042383;GO:0005518;GO:0030020;GO:0048407;GO:0007155;GO:0071230;GO:0030199;GO:0035987;GO:0030198;GO:0001649;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal membrane; C:membrane; C:protein-containing complex; C:sarcolemma;, F:collagen binding; F:extracellular matrix structural constituent conferring tensile strength; F:platelet-derived growth factor binding;, P:cell adhesion; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:endodermal cell differentiation; P:extracellular matrix organization; P:osteoblast differentiation; scaffold20 indexed_genome mRNA 23722247 23749250 . + . ID=transcript_4983;Q9UML3 Q9Y4S8,Collagen alpha-2(VI) chain,, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0032991;GO:0042383;GO:0005518;GO:0030020;GO:0007155;GO:0030199;GO:0030198;GO:0009749;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:protein-containing complex; C:sarcolemma;, F:collagen binding; F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:response to glucose;|Q9UML3 Q9Y4S8,Collagen alpha-2(VI) chain,, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0032991;GO:0042383;GO:0005518;GO:0030020;GO:0007155;GO:0030199;GO:0030198;GO:0009749;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:protein-containing complex; C:sarcolemma;, F:collagen binding; F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:response to glucose;|Q9UML3 Q9Y4S8,Collagen alpha-2(VI) chain,, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0032991;GO:0042383;GO:0005518;GO:0030020;GO:0007155;GO:0030199;GO:0030198;GO:0009749;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:protein-containing complex; C:sarcolemma;, F:collagen binding; F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:response to glucose;|Q9UML3 Q9Y4S8,Collagen alpha-2(VI) chain,, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0032991;GO:0042383;GO:0005518;GO:0030020;GO:0007155;GO:0030199;GO:0030198;GO:0009749;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:protein-containing complex; C:sarcolemma;, F:collagen binding; F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:response to glucose; scaffold20 indexed_genome mRNA 23749302 23754015 . - . ID=transcript_4984;Q9UML3 Q9Y4S8,Collagen alpha-2(VI) chain,, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0032991;GO:0042383;GO:0005518;GO:0030020;GO:0007155;GO:0030199;GO:0030198;GO:0009749;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:protein-containing complex; C:sarcolemma;, F:collagen binding; F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:response to glucose; scaffold20 indexed_genome mRNA 23764985 23778296 . - . ID=transcript_4985;O95954 B9EGD0 Q86V03 Q9HCT4 Q9HCT5 Q9HCT6 Q9UHJ2,Formimidoyltransferase-cyclodeaminase,Formiminotransferase-cyclodeaminase;LCHC1;, PF02971;PF04961;PF07837;, GO:0005814;GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0070062;GO:0005794;GO:0000139;GO:0005886;GO:0030868;GO:0005542;GO:0030412;GO:0030407;GO:0030409;GO:0008017;GO:0007010;GO:0006760;GO:0006548;GO:0019556;GO:0019557;GO:0035999;, C:centriole; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane; C:smooth endoplasmic reticulum membrane;, F:folic acid binding; F:formimidoyltetrahydrofolate cyclodeaminase activity; F:formimidoyltransferase activity; F:glutamate formimidoyltransferase activity; F:microtubule binding;, P:cytoskeleton organization; P:folic acid-containing compound metabolic process; P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate; P:tetrahydrofolate interconversion;|O95954 B9EGD0 Q86V03 Q9HCT4 Q9HCT5 Q9HCT6 Q9UHJ2,Formimidoyltransferase-cyclodeaminase,Formiminotransferase-cyclodeaminase;LCHC1;, PF02971;PF04961;PF07837;, GO:0005814;GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0070062;GO:0005794;GO:0000139;GO:0005886;GO:0030868;GO:0005542;GO:0030412;GO:0030407;GO:0030409;GO:0008017;GO:0007010;GO:0006760;GO:0006548;GO:0019556;GO:0019557;GO:0035999;, C:centriole; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane; C:smooth endoplasmic reticulum membrane;, F:folic acid binding; F:formimidoyltetrahydrofolate cyclodeaminase activity; F:formimidoyltransferase activity; F:glutamate formimidoyltransferase activity; F:microtubule binding;, P:cytoskeleton organization; P:folic acid-containing compound metabolic process; P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate; P:tetrahydrofolate interconversion; scaffold20 indexed_genome mRNA 23778449 23779744 . - . ID=transcript_4986;O95954 B9EGD0 Q86V03 Q9HCT4 Q9HCT5 Q9HCT6 Q9UHJ2,Formimidoyltransferase-cyclodeaminase,Formiminotransferase-cyclodeaminase;LCHC1;, PF02971;PF04961;PF07837;, GO:0005814;GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0070062;GO:0005794;GO:0000139;GO:0005886;GO:0030868;GO:0005542;GO:0030412;GO:0030407;GO:0030409;GO:0008017;GO:0007010;GO:0006760;GO:0006548;GO:0019556;GO:0019557;GO:0035999;, C:centriole; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane; C:smooth endoplasmic reticulum membrane;, F:folic acid binding; F:formimidoyltetrahydrofolate cyclodeaminase activity; F:formimidoyltransferase activity; F:glutamate formimidoyltransferase activity; F:microtubule binding;, P:cytoskeleton organization; P:folic acid-containing compound metabolic process; P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate; P:tetrahydrofolate interconversion; scaffold20 indexed_genome mRNA 23781803 23793207 . + . ID=transcript_4987;Q9H0A9 B4E323 Q52LS9 Q6FIH5 Q6P0L3 Q9NSE5,Speriolin-like protein,Spermatogenesis and centriole-associated protein 1-like protein;, PF15059;PF15058;, GO:0005813;GO:0097224;GO:0042802;GO:0034237;GO:0008154;GO:2000481;GO:0010739;GO:0007283;, C:centrosome; C:sperm connecting piece;, F:identical protein binding; F:protein kinase A regulatory subunit binding;, P:actin polymerization or depolymerization; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of protein kinase A signaling; P:spermatogenesis;|Q9H0A9 B4E323 Q52LS9 Q6FIH5 Q6P0L3 Q9NSE5,Speriolin-like protein,Spermatogenesis and centriole-associated protein 1-like protein;, PF15059;PF15058;, GO:0005813;GO:0097224;GO:0042802;GO:0034237;GO:0008154;GO:2000481;GO:0010739;GO:0007283;, C:centrosome; C:sperm connecting piece;, F:identical protein binding; F:protein kinase A regulatory subunit binding;, P:actin polymerization or depolymerization; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of protein kinase A signaling; P:spermatogenesis; scaffold20 indexed_genome mRNA 23811408 23843238 . - . ID=transcript_4988;P48449 B4DJZ9 D3DSN0 E9PEI9 G5E9Q9 Q8IYL6 Q9UEZ1,Lanosterol synthase,2,3-epoxysqualene--lanosterol cyclase;Oxidosqualene--lanosterol cyclase;, PF13243;PF13249;, GO:0005789;GO:0005811;GO:0016020;GO:0042300;GO:0000250;GO:0006695;GO:0019216;GO:0031647;GO:0006694;GO:0016104;, C:endoplasmic reticulum membrane; C:lipid droplet; C:membrane;, F:beta-amyrin synthase activity; F:lanosterol synthase activity;, P:cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of protein stability; P:steroid biosynthetic process; P:triterpenoid biosynthetic process;|P48449 B4DJZ9 D3DSN0 E9PEI9 G5E9Q9 Q8IYL6 Q9UEZ1,Lanosterol synthase,2,3-epoxysqualene--lanosterol cyclase;Oxidosqualene--lanosterol cyclase;, PF13243;PF13249;, GO:0005789;GO:0005811;GO:0016020;GO:0042300;GO:0000250;GO:0006695;GO:0019216;GO:0031647;GO:0006694;GO:0016104;, C:endoplasmic reticulum membrane; C:lipid droplet; C:membrane;, F:beta-amyrin synthase activity; F:lanosterol synthase activity;, P:cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of protein stability; P:steroid biosynthetic process; P:triterpenoid biosynthetic process;|P48449 B4DJZ9 D3DSN0 E9PEI9 G5E9Q9 Q8IYL6 Q9UEZ1,Lanosterol synthase,2,3-epoxysqualene--lanosterol cyclase;Oxidosqualene--lanosterol cyclase;, PF13243;PF13249;, GO:0005789;GO:0005811;GO:0016020;GO:0042300;GO:0000250;GO:0006695;GO:0019216;GO:0031647;GO:0006694;GO:0016104;, C:endoplasmic reticulum membrane; C:lipid droplet; C:membrane;, F:beta-amyrin synthase activity; F:lanosterol synthase activity;, P:cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of protein stability; P:steroid biosynthetic process; P:triterpenoid biosynthetic process;|P48449 B4DJZ9 D3DSN0 E9PEI9 G5E9Q9 Q8IYL6 Q9UEZ1,Lanosterol synthase,2,3-epoxysqualene--lanosterol cyclase;Oxidosqualene--lanosterol cyclase;, PF13243;PF13249;, GO:0005789;GO:0005811;GO:0016020;GO:0042300;GO:0000250;GO:0006695;GO:0019216;GO:0031647;GO:0006694;GO:0016104;, C:endoplasmic reticulum membrane; C:lipid droplet; C:membrane;, F:beta-amyrin synthase activity; F:lanosterol synthase activity;, P:cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of protein stability; P:steroid biosynthetic process; P:triterpenoid biosynthetic process;|P48449 B4DJZ9 D3DSN0 E9PEI9 G5E9Q9 Q8IYL6 Q9UEZ1,Lanosterol synthase,2,3-epoxysqualene--lanosterol cyclase;Oxidosqualene--lanosterol cyclase;, PF13243;PF13249;, GO:0005789;GO:0005811;GO:0016020;GO:0042300;GO:0000250;GO:0006695;GO:0019216;GO:0031647;GO:0006694;GO:0016104;, C:endoplasmic reticulum membrane; C:lipid droplet; C:membrane;, F:beta-amyrin synthase activity; F:lanosterol synthase activity;, P:cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of protein stability; P:steroid biosynthetic process; P:triterpenoid biosynthetic process;|P48449 B4DJZ9 D3DSN0 E9PEI9 G5E9Q9 Q8IYL6 Q9UEZ1,Lanosterol synthase,2,3-epoxysqualene--lanosterol cyclase;Oxidosqualene--lanosterol cyclase;, PF13243;PF13249;, GO:0005789;GO:0005811;GO:0016020;GO:0042300;GO:0000250;GO:0006695;GO:0019216;GO:0031647;GO:0006694;GO:0016104;, C:endoplasmic reticulum membrane; C:lipid droplet; C:membrane;, F:beta-amyrin synthase activity; F:lanosterol synthase activity;, P:cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of protein stability; P:steroid biosynthetic process; P:triterpenoid biosynthetic process;|P48449 B4DJZ9 D3DSN0 E9PEI9 G5E9Q9 Q8IYL6 Q9UEZ1,Lanosterol synthase,2,3-epoxysqualene--lanosterol cyclase;Oxidosqualene--lanosterol cyclase;, PF13243;PF13249;, GO:0005789;GO:0005811;GO:0016020;GO:0042300;GO:0000250;GO:0006695;GO:0019216;GO:0031647;GO:0006694;GO:0016104;, C:endoplasmic reticulum membrane; C:lipid droplet; C:membrane;, F:beta-amyrin synthase activity; F:lanosterol synthase activity;, P:cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of protein stability; P:steroid biosynthetic process; P:triterpenoid biosynthetic process; scaffold20 indexed_genome mRNA 23850121 23902948 . - . ID=transcript_4989;O60318 C9JL56 Q2M3C1 Q6PJP6 Q9BSY5 Q9UMT4,Germinal-center associated nuclear protein,80 kDa MCM3-associated protein;MCM3 acetylating protein;MCM3 acetyltransferase;, PF16766;PF16769;PF16768;PF03399;, GO:0005694;GO:0005737;GO:0005829;GO:0031965;GO:0044615;GO:0005654;GO:0005634;GO:0070390;GO:0003682;GO:0010484;GO:0004402;GO:0042393;GO:0003676;GO:0006406;GO:0034728;GO:0016973;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:transcription export complex 2;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleic acid binding;, P:mRNA export from nucleus; P:nucleosome organization; P:poly(A)+ mRNA export from nucleus; P:somatic hypermutation of immunoglobulin genes;|O60318 C9JL56 Q2M3C1 Q6PJP6 Q9BSY5 Q9UMT4,Germinal-center associated nuclear protein,80 kDa MCM3-associated protein;MCM3 acetylating protein;MCM3 acetyltransferase;, PF16766;PF16769;PF16768;PF03399;, GO:0005694;GO:0005737;GO:0005829;GO:0031965;GO:0044615;GO:0005654;GO:0005634;GO:0070390;GO:0003682;GO:0010484;GO:0004402;GO:0042393;GO:0003676;GO:0006406;GO:0034728;GO:0016973;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:transcription export complex 2;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleic acid binding;, P:mRNA export from nucleus; P:nucleosome organization; P:poly(A)+ mRNA export from nucleus; P:somatic hypermutation of immunoglobulin genes;|O60318 C9JL56 Q2M3C1 Q6PJP6 Q9BSY5 Q9UMT4,Germinal-center associated nuclear protein,80 kDa MCM3-associated protein;MCM3 acetylating protein;MCM3 acetyltransferase;, PF16766;PF16769;PF16768;PF03399;, GO:0005694;GO:0005737;GO:0005829;GO:0031965;GO:0044615;GO:0005654;GO:0005634;GO:0070390;GO:0003682;GO:0010484;GO:0004402;GO:0042393;GO:0003676;GO:0006406;GO:0034728;GO:0016973;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:transcription export complex 2;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleic acid binding;, P:mRNA export from nucleus; P:nucleosome organization; P:poly(A)+ mRNA export from nucleus; P:somatic hypermutation of immunoglobulin genes;|O60318 C9JL56 Q2M3C1 Q6PJP6 Q9BSY5 Q9UMT4,Germinal-center associated nuclear protein,80 kDa MCM3-associated protein;MCM3 acetylating protein;MCM3 acetyltransferase;, PF16766;PF16769;PF16768;PF03399;, GO:0005694;GO:0005737;GO:0005829;GO:0031965;GO:0044615;GO:0005654;GO:0005634;GO:0070390;GO:0003682;GO:0010484;GO:0004402;GO:0042393;GO:0003676;GO:0006406;GO:0034728;GO:0016973;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:transcription export complex 2;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleic acid binding;, P:mRNA export from nucleus; P:nucleosome organization; P:poly(A)+ mRNA export from nucleus; P:somatic hypermutation of immunoglobulin genes;|O60318 C9JL56 Q2M3C1 Q6PJP6 Q9BSY5 Q9UMT4,Germinal-center associated nuclear protein,80 kDa MCM3-associated protein;MCM3 acetylating protein;MCM3 acetyltransferase;, PF16766;PF16769;PF16768;PF03399;, GO:0005694;GO:0005737;GO:0005829;GO:0031965;GO:0044615;GO:0005654;GO:0005634;GO:0070390;GO:0003682;GO:0010484;GO:0004402;GO:0042393;GO:0003676;GO:0006406;GO:0034728;GO:0016973;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:transcription export complex 2;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleic acid binding;, P:mRNA export from nucleus; P:nucleosome organization; P:poly(A)+ mRNA export from nucleus; P:somatic hypermutation of immunoglobulin genes;|O60318 C9JL56 Q2M3C1 Q6PJP6 Q9BSY5 Q9UMT4,Germinal-center associated nuclear protein,80 kDa MCM3-associated protein;MCM3 acetylating protein;MCM3 acetyltransferase;, PF16766;PF16769;PF16768;PF03399;, GO:0005694;GO:0005737;GO:0005829;GO:0031965;GO:0044615;GO:0005654;GO:0005634;GO:0070390;GO:0003682;GO:0010484;GO:0004402;GO:0042393;GO:0003676;GO:0006406;GO:0034728;GO:0016973;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:transcription export complex 2;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleic acid binding;, P:mRNA export from nucleus; P:nucleosome organization; P:poly(A)+ mRNA export from nucleus; P:somatic hypermutation of immunoglobulin genes;|O60318 C9JL56 Q2M3C1 Q6PJP6 Q9BSY5 Q9UMT4,Germinal-center associated nuclear protein,80 kDa MCM3-associated protein;MCM3 acetylating protein;MCM3 acetyltransferase;, PF16766;PF16769;PF16768;PF03399;, GO:0005694;GO:0005737;GO:0005829;GO:0031965;GO:0044615;GO:0005654;GO:0005634;GO:0070390;GO:0003682;GO:0010484;GO:0004402;GO:0042393;GO:0003676;GO:0006406;GO:0034728;GO:0016973;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:transcription export complex 2;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleic acid binding;, P:mRNA export from nucleus; P:nucleosome organization; P:poly(A)+ mRNA export from nucleus; P:somatic hypermutation of immunoglobulin genes;|O60318 C9JL56 Q2M3C1 Q6PJP6 Q9BSY5 Q9UMT4,Germinal-center associated nuclear protein,80 kDa MCM3-associated protein;MCM3 acetylating protein;MCM3 acetyltransferase;, PF16766;PF16769;PF16768;PF03399;, GO:0005694;GO:0005737;GO:0005829;GO:0031965;GO:0044615;GO:0005654;GO:0005634;GO:0070390;GO:0003682;GO:0010484;GO:0004402;GO:0042393;GO:0003676;GO:0006406;GO:0034728;GO:0016973;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:transcription export complex 2;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleic acid binding;, P:mRNA export from nucleus; P:nucleosome organization; P:poly(A)+ mRNA export from nucleus; P:somatic hypermutation of immunoglobulin genes;|O60318 C9JL56 Q2M3C1 Q6PJP6 Q9BSY5 Q9UMT4,Germinal-center associated nuclear protein,80 kDa MCM3-associated protein;MCM3 acetylating protein;MCM3 acetyltransferase;, PF16766;PF16769;PF16768;PF03399;, GO:0005694;GO:0005737;GO:0005829;GO:0031965;GO:0044615;GO:0005654;GO:0005634;GO:0070390;GO:0003682;GO:0010484;GO:0004402;GO:0042393;GO:0003676;GO:0006406;GO:0034728;GO:0016973;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:transcription export complex 2;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleic acid binding;, P:mRNA export from nucleus; P:nucleosome organization; P:poly(A)+ mRNA export from nucleus; P:somatic hypermutation of immunoglobulin genes;|O60318 C9JL56 Q2M3C1 Q6PJP6 Q9BSY5 Q9UMT4,Germinal-center associated nuclear protein,80 kDa MCM3-associated protein;MCM3 acetylating protein;MCM3 acetyltransferase;, PF16766;PF16769;PF16768;PF03399;, GO:0005694;GO:0005737;GO:0005829;GO:0031965;GO:0044615;GO:0005654;GO:0005634;GO:0070390;GO:0003682;GO:0010484;GO:0004402;GO:0042393;GO:0003676;GO:0006406;GO:0034728;GO:0016973;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:transcription export complex 2;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleic acid binding;, P:mRNA export from nucleus; P:nucleosome organization; P:poly(A)+ mRNA export from nucleus; P:somatic hypermutation of immunoglobulin genes;|P58557 B7WPA9 B7WPF7 D3DSN2,Endoribonuclease YbeY {ECO:0000305},, PF02130;, GO:0005634;GO:0004521;GO:0046872;GO:0004222;GO:0006364;, C:nucleus;, F:endoribonuclease activity; F:metal ion binding; F:metalloendopeptidase activity;, P:rRNA processing; scaffold20 indexed_genome mRNA 23924637 23971982 . + . ID=transcript_4990;O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction;|O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction; scaffold20 indexed_genome mRNA 23972412 24029266 . + . ID=transcript_4991;O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction;|O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction;|O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction;|O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction;|O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction;|O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction;|O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction;|O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction;|O95613 O43152 Q7Z7C9,Pericentrin,Kendrin;Pericentrin-B;, PF10495;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0016020;GO:0005874;GO:0005516;GO:0060090;GO:0035973;GO:0097711;GO:0060271;GO:0000086;GO:0000226;GO:0007052;GO:0090316;GO:0010389;GO:0007165;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:membrane; C:microtubule;, F:calmodulin binding; F:molecular adaptor activity;, P:aggrephagy; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:positive regulation of intracellular protein transport; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction; scaffold20 indexed_genome mRNA 24073257 24162042 . + . ID=transcript_4992;Q14689 A6P4T3 B4E0F0 E7EMA5 Q8IVA3 Q8N4S2 Q8TD89 Q96ML9,Disco-interacting protein 2 homolog A,, PF00501;PF06464;, GO:0009986;GO:0043197;GO:0016020;GO:0005739;GO:0005886;GO:0003987;GO:0006085;GO:0060997;GO:0010629;GO:2000758;, C:cell surface; C:dendritic spine; C:membrane; C:mitochondrion; C:plasma membrane;, F:acetate-CoA ligase activity;, P:acetyl-CoA biosynthetic process; P:dendritic spine morphogenesis; P:negative regulation of gene expression; P:positive regulation of peptidyl-lysine acetylation;|Q14689 A6P4T3 B4E0F0 E7EMA5 Q8IVA3 Q8N4S2 Q8TD89 Q96ML9,Disco-interacting protein 2 homolog A,, PF00501;PF06464;, GO:0009986;GO:0043197;GO:0016020;GO:0005739;GO:0005886;GO:0003987;GO:0006085;GO:0060997;GO:0010629;GO:2000758;, C:cell surface; C:dendritic spine; C:membrane; C:mitochondrion; C:plasma membrane;, F:acetate-CoA ligase activity;, P:acetyl-CoA biosynthetic process; P:dendritic spine morphogenesis; P:negative regulation of gene expression; P:positive regulation of peptidyl-lysine acetylation;|Q14689 A6P4T3 B4E0F0 E7EMA5 Q8IVA3 Q8N4S2 Q8TD89 Q96ML9,Disco-interacting protein 2 homolog A,, PF00501;PF06464;, GO:0009986;GO:0043197;GO:0016020;GO:0005739;GO:0005886;GO:0003987;GO:0006085;GO:0060997;GO:0010629;GO:2000758;, C:cell surface; C:dendritic spine; C:membrane; C:mitochondrion; C:plasma membrane;, F:acetate-CoA ligase activity;, P:acetyl-CoA biosynthetic process; P:dendritic spine morphogenesis; P:negative regulation of gene expression; P:positive regulation of peptidyl-lysine acetylation;|Q9Y2E4 B4DPI5 Q5SS78,Disco-interacting protein 2 homolog C,, PF00501;PF06464;|Q14689 A6P4T3 B4E0F0 E7EMA5 Q8IVA3 Q8N4S2 Q8TD89 Q96ML9,Disco-interacting protein 2 homolog A,, PF00501;PF06464;, GO:0009986;GO:0043197;GO:0016020;GO:0005739;GO:0005886;GO:0003987;GO:0006085;GO:0060997;GO:0010629;GO:2000758;, C:cell surface; C:dendritic spine; C:membrane; C:mitochondrion; C:plasma membrane;, F:acetate-CoA ligase activity;, P:acetyl-CoA biosynthetic process; P:dendritic spine morphogenesis; P:negative regulation of gene expression; P:positive regulation of peptidyl-lysine acetylation;|Q14689 A6P4T3 B4E0F0 E7EMA5 Q8IVA3 Q8N4S2 Q8TD89 Q96ML9,Disco-interacting protein 2 homolog A,, PF00501;PF06464;, GO:0009986;GO:0043197;GO:0016020;GO:0005739;GO:0005886;GO:0003987;GO:0006085;GO:0060997;GO:0010629;GO:2000758;, C:cell surface; C:dendritic spine; C:membrane; C:mitochondrion; C:plasma membrane;, F:acetate-CoA ligase activity;, P:acetyl-CoA biosynthetic process; P:dendritic spine morphogenesis; P:negative regulation of gene expression; P:positive regulation of peptidyl-lysine acetylation; scaffold20 indexed_genome mRNA 24176207 24180475 . - . ID=transcript_4993;P04271 D3DSN6,Protein S100-B,S-100 protein beta chain;S-100 protein subunit beta;S100 calcium-binding protein B;, PF00036;PF01023;, GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0043231;GO:0005654;GO:0005634;GO:0048471;GO:0001726;GO:0005509;GO:0048306;GO:0042802;GO:0042803;GO:0050786;GO:0044548;GO:0048156;GO:0008270;GO:0007409;GO:0007417;GO:0045087;GO:0007611;GO:0008284;GO:0043123;, C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:ruffle;, F:calcium ion binding; F:calcium-dependent protein binding; F:identical protein binding; F:protein homodimerization activity; F:RAGE receptor binding; F:S100 protein binding; F:tau protein binding; F:zinc ion binding;, P:axonogenesis; P:central nervous system development; P:innate immune response; P:learning or memory; P:positive regulation of cell population proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold20 indexed_genome mRNA 24221629 24243662 . + . ID=transcript_4994;Q9BW15 Q9UMC2,Protein arginine N-methyltransferase 2,Histone-arginine N-methyltransferase PRMT2;, PF05175;PF00018;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0050681;GO:0030331;GO:0042054;GO:0008469;GO:0042975;GO:0033142;GO:0042803;GO:0016274;GO:0035242;GO:0044877;GO:0042974;GO:0046966;GO:0003713;GO:0048588;GO:0016571;GO:2000134;GO:0032088;GO:0045892;GO:0043065;GO:0045893;GO:0006479;GO:0060765;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:estrogen receptor binding; F:histone methyltransferase activity; F:histone-arginine N-methyltransferase activity; F:peroxisome proliferator activated receptor binding; F:progesterone receptor binding; F:protein homodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-containing complex binding; F:retinoic acid receptor binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:developmental cell growth; P:histone methylation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein methylation; P:regulation of androgen receptor signaling pathway; P:signal transduction;|Q9BW15 Q9UMC2,Protein arginine N-methyltransferase 2,Histone-arginine N-methyltransferase PRMT2;, PF05175;PF00018;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0050681;GO:0030331;GO:0042054;GO:0008469;GO:0042975;GO:0033142;GO:0042803;GO:0016274;GO:0035242;GO:0044877;GO:0042974;GO:0046966;GO:0003713;GO:0048588;GO:0016571;GO:2000134;GO:0032088;GO:0045892;GO:0043065;GO:0045893;GO:0006479;GO:0060765;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:estrogen receptor binding; F:histone methyltransferase activity; F:histone-arginine N-methyltransferase activity; F:peroxisome proliferator activated receptor binding; F:progesterone receptor binding; F:protein homodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-containing complex binding; F:retinoic acid receptor binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:developmental cell growth; P:histone methylation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein methylation; P:regulation of androgen receptor signaling pathway; P:signal transduction;|Q9BW15 Q9UMC2,Protein arginine N-methyltransferase 2,Histone-arginine N-methyltransferase PRMT2;, PF05175;PF00018;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0050681;GO:0030331;GO:0042054;GO:0008469;GO:0042975;GO:0033142;GO:0042803;GO:0016274;GO:0035242;GO:0044877;GO:0042974;GO:0046966;GO:0003713;GO:0048588;GO:0016571;GO:2000134;GO:0032088;GO:0045892;GO:0043065;GO:0045893;GO:0006479;GO:0060765;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:estrogen receptor binding; F:histone methyltransferase activity; F:histone-arginine N-methyltransferase activity; F:peroxisome proliferator activated receptor binding; F:progesterone receptor binding; F:protein homodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-containing complex binding; F:retinoic acid receptor binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:developmental cell growth; P:histone methylation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein methylation; P:regulation of androgen receptor signaling pathway; P:signal transduction;|Q9BW15 Q9UMC2,Protein arginine N-methyltransferase 2,Histone-arginine N-methyltransferase PRMT2;, PF05175;PF00018;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0050681;GO:0030331;GO:0042054;GO:0008469;GO:0042975;GO:0033142;GO:0042803;GO:0016274;GO:0035242;GO:0044877;GO:0042974;GO:0046966;GO:0003713;GO:0048588;GO:0016571;GO:2000134;GO:0032088;GO:0045892;GO:0043065;GO:0045893;GO:0006479;GO:0060765;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:estrogen receptor binding; F:histone methyltransferase activity; F:histone-arginine N-methyltransferase activity; F:peroxisome proliferator activated receptor binding; F:progesterone receptor binding; F:protein homodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-containing complex binding; F:retinoic acid receptor binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:developmental cell growth; P:histone methylation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein methylation; P:regulation of androgen receptor signaling pathway; P:signal transduction; scaffold20 indexed_genome mRNA 24243698 24245667 . + . ID=transcript_4995;Q9BW15 Q9UMC2,Protein arginine N-methyltransferase 2,Histone-arginine N-methyltransferase PRMT2;, PF05175;PF00018;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0050681;GO:0030331;GO:0042054;GO:0008469;GO:0042975;GO:0033142;GO:0042803;GO:0016274;GO:0035242;GO:0044877;GO:0042974;GO:0046966;GO:0003713;GO:0048588;GO:0016571;GO:2000134;GO:0032088;GO:0045892;GO:0043065;GO:0045893;GO:0006479;GO:0060765;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:estrogen receptor binding; F:histone methyltransferase activity; F:histone-arginine N-methyltransferase activity; F:peroxisome proliferator activated receptor binding; F:progesterone receptor binding; F:protein homodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-containing complex binding; F:retinoic acid receptor binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:developmental cell growth; P:histone methylation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein methylation; P:regulation of androgen receptor signaling pathway; P:signal transduction;|Q9BW15 Q9UMC2,Protein arginine N-methyltransferase 2,Histone-arginine N-methyltransferase PRMT2;, PF05175;PF00018;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0050681;GO:0030331;GO:0042054;GO:0008469;GO:0042975;GO:0033142;GO:0042803;GO:0016274;GO:0035242;GO:0044877;GO:0042974;GO:0046966;GO:0003713;GO:0048588;GO:0016571;GO:2000134;GO:0032088;GO:0045892;GO:0043065;GO:0045893;GO:0006479;GO:0060765;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:estrogen receptor binding; F:histone methyltransferase activity; F:histone-arginine N-methyltransferase activity; F:peroxisome proliferator activated receptor binding; F:progesterone receptor binding; F:protein homodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-containing complex binding; F:retinoic acid receptor binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:developmental cell growth; P:histone methylation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein methylation; P:regulation of androgen receptor signaling pathway; P:signal transduction; scaffold20 indexed_genome mRNA 24410764 24411767 . + . ID=transcript_4996;Q8TCJ0 Q6PJ83 Q7Z4V4 Q9UKB8,F-box only protein 25,, , GO:0005634;GO:0019005;GO:0000151;GO:0003779;GO:0004842;GO:0016567;, C:nucleus; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:actin binding; F:ubiquitin-protein transferase activity;, P:protein ubiquitination; scaffold20 indexed_genome mRNA 24415407 24649437 . + . ID=transcript_4997;Q8TCJ0 Q6PJ83 Q7Z4V4 Q9UKB8,F-box only protein 25,, , GO:0005634;GO:0019005;GO:0000151;GO:0003779;GO:0004842;GO:0016567;, C:nucleus; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:actin binding; F:ubiquitin-protein transferase activity;, P:protein ubiquitination;|Q86YL5 B6VF03 B9EG53,Testis development-related protein,Protein INM01;, PF15683;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0007283;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, , P:spermatogenesis;|Q86YL5 B6VF03 B9EG53,Testis development-related protein,Protein INM01;, PF15683;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0007283;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, , P:spermatogenesis; scaffold20 indexed_genome mRNA 24722656 24729608 . - . ID=transcript_4998;Q16285 Q16286 Q16346 Q16347 Q92479,Runt-related transcription factor 1,Acute myeloid leukemia 1 protein;Core-binding factor subunit alpha-2;Oncogene AML-1;Polyomavirus enhancer-binding protein 2 alpha B subunit;SL3-3 enhancer factor 1 alpha B subunit;SL3/AKV core-binding factor alpha B subunit;, PF00853;PF08504;, GO:0000785;GO:0016513;GO:0043231;GO:0005654;GO:0005634;GO:0005524;GO:0005509;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:0008134;GO:0000976;GO:0061026;GO:0002062;GO:0071425;GO:0030097;GO:0030099;GO:0002573;GO:0043371;GO:0010629;GO:0030853;GO:0000122;GO:0030182;GO:0001503;GO:0048935;GO:0045766;GO:0043378;GO:0032967;GO:1903055;GO:0030854;GO:0032743;GO:0045944;GO:0045893;GO:0050855;GO:2000810;GO:0060043;GO:0045595;GO:1905203;GO:0001959;GO:1902036;GO:0033146;GO:0045616;GO:0045652;GO:0045637;GO:0010755;GO:0045589;GO:0006357;GO:0030111;, C:chromatin; C:core-binding factor complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium ion binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cardiac muscle tissue regeneration; P:chondrocyte differentiation; P:hematopoietic stem cell proliferation; P:hemopoiesis; P:myeloid cell differentiation; P:myeloid leukocyte differentiation; P:negative regulation of CD4-positive, alpha-beta T cell differentiation; P:negative regulation of gene expression; P:negative regulation of granulocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:ossification; P:peripheral nervous system neuron development; P:positive regulation of angiogenesis; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; P:positive regulation of collagen biosynthetic process; P:positive regulation of extracellular matrix organization; P:positive regulation of granulocyte differentiation; P:positive regulation of interleukin-2 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of bicellular tight junction assembly; P:regulation of cardiac muscle cell proliferation; P:regulation of cell differentiation; P:regulation of connective tissue replacement; P:regulation of cytokine-mediated signaling pathway; P:regulation of hematopoietic stem cell differentiation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of keratinocyte differentiation; P:regulation of megakaryocyte differentiation; P:regulation of myeloid cell differentiation; P:regulation of plasminogen activation; P:regulation of regulatory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of Wnt signaling pathway; scaffold20 indexed_genome mRNA 25979024 26016172 . - . ID=transcript_4999;Q9NVD3 B4DT14 D3DSG2 D3DSG4 Q8NE19 Q9BU46,SET domain-containing protein 4 {ECO:0000305},, PF09273;PF00856;, GO:0005829;GO:0005634;GO:0016279;GO:0018026;GO:0018023;, C:cytosol; C:nucleus;, F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation;|Q9NVD3 B4DT14 D3DSG2 D3DSG4 Q8NE19 Q9BU46,SET domain-containing protein 4 {ECO:0000305},, PF09273;PF00856;, GO:0005829;GO:0005634;GO:0016279;GO:0018026;GO:0018023;, C:cytosol; C:nucleus;, F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation;|Q9NVD3 B4DT14 D3DSG2 D3DSG4 Q8NE19 Q9BU46,SET domain-containing protein 4 {ECO:0000305},, PF09273;PF00856;, GO:0005829;GO:0005634;GO:0016279;GO:0018026;GO:0018023;, C:cytosol; C:nucleus;, F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation;|Q9NVD3 B4DT14 D3DSG2 D3DSG4 Q8NE19 Q9BU46,SET domain-containing protein 4 {ECO:0000305},, PF09273;PF00856;, GO:0005829;GO:0005634;GO:0016279;GO:0018026;GO:0018023;, C:cytosol; C:nucleus;, F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation;|Q9NVD3 B4DT14 D3DSG2 D3DSG4 Q8NE19 Q9BU46,SET domain-containing protein 4 {ECO:0000305},, PF09273;PF00856;, GO:0005829;GO:0005634;GO:0016279;GO:0018026;GO:0018023;, C:cytosol; C:nucleus;, F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation;|Q9NVD3 B4DT14 D3DSG2 D3DSG4 Q8NE19 Q9BU46,SET domain-containing protein 4 {ECO:0000305},, PF09273;PF00856;, GO:0005829;GO:0005634;GO:0016279;GO:0018026;GO:0018023;, C:cytosol; C:nucleus;, F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; scaffold20 indexed_genome mRNA 26024953 26028424 . + . ID=transcript_5000;P16152 B2RBZ7 B4DFK7 Q3LHW8,Carbonyl reductase [NADPH] 1 {ECO:0000305},15-hydroxyprostaglandin dehydrogenase [NADP(+)];20-beta-hydroxysteroid dehydrogenase;NADPH-dependent carbonyl reductase 1;Prostaglandin 9-ketoreductase {ECO:0000303|PubMed:1597188};Prostaglandin-E(2) 9-reductase {ECO:0000250|UniProtKB:Q28960};Short chain dehydrogenase/reductase family 21C member 1;, PF00106;, GO:0005829;GO:0070062;GO:1903561;GO:0047021;GO:0047020;GO:0004090;GO:0016655;GO:0050221;GO:0019371;GO:0017144;GO:0030855;GO:0042373;, C:cytosol; C:extracellular exosome; C:extracellular vesicle;, F:15-hydroxyprostaglandin dehydrogenase (NADP+) activity; F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:carbonyl reductase (NADPH) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:prostaglandin-E2 9-reductase activity;, P:cyclooxygenase pathway; P:drug metabolic process; P:epithelial cell differentiation; P:vitamin K metabolic process;|P16152 B2RBZ7 B4DFK7 Q3LHW8,Carbonyl reductase [NADPH] 1 {ECO:0000305},15-hydroxyprostaglandin dehydrogenase [NADP(+)];20-beta-hydroxysteroid dehydrogenase;NADPH-dependent carbonyl reductase 1;Prostaglandin 9-ketoreductase {ECO:0000303|PubMed:1597188};Prostaglandin-E(2) 9-reductase {ECO:0000250|UniProtKB:Q28960};Short chain dehydrogenase/reductase family 21C member 1;, PF00106;, GO:0005829;GO:0070062;GO:1903561;GO:0047021;GO:0047020;GO:0004090;GO:0016655;GO:0050221;GO:0019371;GO:0017144;GO:0030855;GO:0042373;, C:cytosol; C:extracellular exosome; C:extracellular vesicle;, F:15-hydroxyprostaglandin dehydrogenase (NADP+) activity; F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:carbonyl reductase (NADPH) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:prostaglandin-E2 9-reductase activity;, P:cyclooxygenase pathway; P:drug metabolic process; P:epithelial cell differentiation; P:vitamin K metabolic process; scaffold20 indexed_genome mRNA 26028930 26039793 . + . ID=transcript_5001;P16152 B2RBZ7 B4DFK7 Q3LHW8,Carbonyl reductase [NADPH] 1 {ECO:0000305},15-hydroxyprostaglandin dehydrogenase [NADP(+)];20-beta-hydroxysteroid dehydrogenase;NADPH-dependent carbonyl reductase 1;Prostaglandin 9-ketoreductase {ECO:0000303|PubMed:1597188};Prostaglandin-E(2) 9-reductase {ECO:0000250|UniProtKB:Q28960};Short chain dehydrogenase/reductase family 21C member 1;, PF00106;, GO:0005829;GO:0070062;GO:1903561;GO:0047021;GO:0047020;GO:0004090;GO:0016655;GO:0050221;GO:0019371;GO:0017144;GO:0030855;GO:0042373;, C:cytosol; C:extracellular exosome; C:extracellular vesicle;, F:15-hydroxyprostaglandin dehydrogenase (NADP+) activity; F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:carbonyl reductase (NADPH) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:prostaglandin-E2 9-reductase activity;, P:cyclooxygenase pathway; P:drug metabolic process; P:epithelial cell differentiation; P:vitamin K metabolic process;|P16152 B2RBZ7 B4DFK7 Q3LHW8,Carbonyl reductase [NADPH] 1 {ECO:0000305},15-hydroxyprostaglandin dehydrogenase [NADP(+)];20-beta-hydroxysteroid dehydrogenase;NADPH-dependent carbonyl reductase 1;Prostaglandin 9-ketoreductase {ECO:0000303|PubMed:1597188};Prostaglandin-E(2) 9-reductase {ECO:0000250|UniProtKB:Q28960};Short chain dehydrogenase/reductase family 21C member 1;, PF00106;, GO:0005829;GO:0070062;GO:1903561;GO:0047021;GO:0047020;GO:0004090;GO:0016655;GO:0050221;GO:0019371;GO:0017144;GO:0030855;GO:0042373;, C:cytosol; C:extracellular exosome; C:extracellular vesicle;, F:15-hydroxyprostaglandin dehydrogenase (NADP+) activity; F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:carbonyl reductase (NADPH) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:prostaglandin-E2 9-reductase activity;, P:cyclooxygenase pathway; P:drug metabolic process; P:epithelial cell differentiation; P:vitamin K metabolic process; scaffold20 indexed_genome mRNA 26107201 26108257 . + . ID=transcript_5002;O75828 Q6FHP2,Carbonyl reductase [NADPH] 3,NADPH-dependent carbonyl reductase 3;Short chain dehydrogenase/reductase family 21C member 2;, PF00106;, GO:0005829;GO:0005615;GO:0005654;GO:0000253;GO:0004090;GO:0070402;GO:0050890;GO:0042376;GO:0006805;, C:cytosol; C:extracellular space; C:nucleoplasm;, F:3-keto sterol reductase activity; F:carbonyl reductase (NADPH) activity; F:NADPH binding;, P:cognition; P:phylloquinone catabolic process; P:xenobiotic metabolic process; scaffold20 indexed_genome mRNA 26117219 26243314 . + . ID=transcript_5003;Q9Y3R5 D3DSG5 Q6PJQ7 Q9UEZ3,Protein dopey-2,, PF04118;, GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0000139;GO:0005802;GO:0050890;GO:0007029;GO:0006895;GO:0007275;GO:0015031;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:Golgi membrane; C:trans-Golgi network;, , P:cognition; P:endoplasmic reticulum organization; P:Golgi to endosome transport; P:multicellular organism development; P:protein transport;|Q9Y3R5 D3DSG5 Q6PJQ7 Q9UEZ3,Protein dopey-2,, PF04118;, GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0000139;GO:0005802;GO:0050890;GO:0007029;GO:0006895;GO:0007275;GO:0015031;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:Golgi membrane; C:trans-Golgi network;, , P:cognition; P:endoplasmic reticulum organization; P:Golgi to endosome transport; P:multicellular organism development; P:protein transport;|Q9Y3R5 D3DSG5 Q6PJQ7 Q9UEZ3,Protein dopey-2,, PF04118;, GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0000139;GO:0005802;GO:0050890;GO:0007029;GO:0006895;GO:0007275;GO:0015031;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:Golgi membrane; C:trans-Golgi network;, , P:cognition; P:endoplasmic reticulum organization; P:Golgi to endosome transport; P:multicellular organism development; P:protein transport;|Q9Y3R5 D3DSG5 Q6PJQ7 Q9UEZ3,Protein dopey-2,, PF04118;, GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0000139;GO:0005802;GO:0050890;GO:0007029;GO:0006895;GO:0007275;GO:0015031;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:Golgi membrane; C:trans-Golgi network;, , P:cognition; P:endoplasmic reticulum organization; P:Golgi to endosome transport; P:multicellular organism development; P:protein transport;|Q9Y3R5 D3DSG5 Q6PJQ7 Q9UEZ3,Protein dopey-2,, PF04118;, GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0000139;GO:0005802;GO:0050890;GO:0007029;GO:0006895;GO:0007275;GO:0015031;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:Golgi membrane; C:trans-Golgi network;, , P:cognition; P:endoplasmic reticulum organization; P:Golgi to endosome transport; P:multicellular organism development; P:protein transport;|Q9Y3R5 D3DSG5 Q6PJQ7 Q9UEZ3,Protein dopey-2,, PF04118;, GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0000139;GO:0005802;GO:0050890;GO:0007029;GO:0006895;GO:0007275;GO:0015031;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:Golgi membrane; C:trans-Golgi network;, , P:cognition; P:endoplasmic reticulum organization; P:Golgi to endosome transport; P:multicellular organism development; P:protein transport;|Q9Y3R5 D3DSG5 Q6PJQ7 Q9UEZ3,Protein dopey-2,, PF04118;, GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0000139;GO:0005802;GO:0050890;GO:0007029;GO:0006895;GO:0007275;GO:0015031;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:Golgi membrane; C:trans-Golgi network;, , P:cognition; P:endoplasmic reticulum organization; P:Golgi to endosome transport; P:multicellular organism development; P:protein transport;|Q9Y3R5 D3DSG5 Q6PJQ7 Q9UEZ3,Protein dopey-2,, PF04118;, GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0000139;GO:0005802;GO:0050890;GO:0007029;GO:0006895;GO:0007275;GO:0015031;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:Golgi membrane; C:trans-Golgi network;, , P:cognition; P:endoplasmic reticulum organization; P:Golgi to endosome transport; P:multicellular organism development; P:protein transport; scaffold20 indexed_genome mRNA 26255232 26302630 . + . ID=transcript_5004;Q14149 A8KA92 Q9UEZ2,MORC family CW-type zinc finger protein 3,Nuclear matrix protein 2 {ECO:0000303|PubMed:11927593};Zinc finger CW-type coiled-coil domain protein 3;, PF17942;PF07496;, GO:0016363;GO:0005654;GO:0016605;GO:0035064;GO:0003723;GO:0008270;GO:0007569;GO:0051457;GO:0048147;GO:0018105;GO:0009791;GO:0006468;GO:0050821;GO:0016032;, C:nuclear matrix; C:nucleoplasm; C:PML body;, F:methylated histone binding; F:RNA binding; F:zinc ion binding;, P:cell aging; P:maintenance of protein location in nucleus; P:negative regulation of fibroblast proliferation; P:peptidyl-serine phosphorylation; P:post-embryonic development; P:protein phosphorylation; P:protein stabilization; P:viral process;|Q14149 A8KA92 Q9UEZ2,MORC family CW-type zinc finger protein 3,Nuclear matrix protein 2 {ECO:0000303|PubMed:11927593};Zinc finger CW-type coiled-coil domain protein 3;, PF17942;PF07496;, GO:0016363;GO:0005654;GO:0016605;GO:0035064;GO:0003723;GO:0008270;GO:0007569;GO:0051457;GO:0048147;GO:0018105;GO:0009791;GO:0006468;GO:0050821;GO:0016032;, C:nuclear matrix; C:nucleoplasm; C:PML body;, F:methylated histone binding; F:RNA binding; F:zinc ion binding;, P:cell aging; P:maintenance of protein location in nucleus; P:negative regulation of fibroblast proliferation; P:peptidyl-serine phosphorylation; P:post-embryonic development; P:protein phosphorylation; P:protein stabilization; P:viral process;|Q14149 A8KA92 Q9UEZ2,MORC family CW-type zinc finger protein 3,Nuclear matrix protein 2 {ECO:0000303|PubMed:11927593};Zinc finger CW-type coiled-coil domain protein 3;, PF17942;PF07496;, GO:0016363;GO:0005654;GO:0016605;GO:0035064;GO:0003723;GO:0008270;GO:0007569;GO:0051457;GO:0048147;GO:0018105;GO:0009791;GO:0006468;GO:0050821;GO:0016032;, C:nuclear matrix; C:nucleoplasm; C:PML body;, F:methylated histone binding; F:RNA binding; F:zinc ion binding;, P:cell aging; P:maintenance of protein location in nucleus; P:negative regulation of fibroblast proliferation; P:peptidyl-serine phosphorylation; P:post-embryonic development; P:protein phosphorylation; P:protein stabilization; P:viral process;|Q14149 A8KA92 Q9UEZ2,MORC family CW-type zinc finger protein 3,Nuclear matrix protein 2 {ECO:0000303|PubMed:11927593};Zinc finger CW-type coiled-coil domain protein 3;, PF17942;PF07496;, GO:0016363;GO:0005654;GO:0016605;GO:0035064;GO:0003723;GO:0008270;GO:0007569;GO:0051457;GO:0048147;GO:0018105;GO:0009791;GO:0006468;GO:0050821;GO:0016032;, C:nuclear matrix; C:nucleoplasm; C:PML body;, F:methylated histone binding; F:RNA binding; F:zinc ion binding;, P:cell aging; P:maintenance of protein location in nucleus; P:negative regulation of fibroblast proliferation; P:peptidyl-serine phosphorylation; P:post-embryonic development; P:protein phosphorylation; P:protein stabilization; P:viral process; scaffold20 indexed_genome mRNA 26312283 26333623 . + . ID=transcript_5005;Q13112 Q99548,Chromatin assembly factor 1 subunit B {ECO:0000305},Chromatin assembly factor I p60 subunit;M-phase phosphoprotein 7;, PF15512;PF00400;, GO:0033186;GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0042393;GO:0051082;GO:0007049;GO:0031497;GO:0006281;GO:0006260;GO:0006335;GO:0006334;, C:CAF-1 complex; C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:histone binding; F:unfolded protein binding;, P:cell cycle; P:chromatin assembly; P:DNA repair; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:nucleosome assembly;|Q13112 Q99548,Chromatin assembly factor 1 subunit B {ECO:0000305},Chromatin assembly factor I p60 subunit;M-phase phosphoprotein 7;, PF15512;PF00400;, GO:0033186;GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0042393;GO:0051082;GO:0007049;GO:0031497;GO:0006281;GO:0006260;GO:0006335;GO:0006334;, C:CAF-1 complex; C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:histone binding; F:unfolded protein binding;, P:cell cycle; P:chromatin assembly; P:DNA repair; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:nucleosome assembly;|Q13112 Q99548,Chromatin assembly factor 1 subunit B {ECO:0000305},Chromatin assembly factor I p60 subunit;M-phase phosphoprotein 7;, PF15512;PF00400;, GO:0033186;GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0042393;GO:0051082;GO:0007049;GO:0031497;GO:0006281;GO:0006260;GO:0006335;GO:0006334;, C:CAF-1 complex; C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:histone binding; F:unfolded protein binding;, P:cell cycle; P:chromatin assembly; P:DNA repair; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:nucleosome assembly;|Q13112 Q99548,Chromatin assembly factor 1 subunit B {ECO:0000305},Chromatin assembly factor I p60 subunit;M-phase phosphoprotein 7;, PF15512;PF00400;, GO:0033186;GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0042393;GO:0051082;GO:0007049;GO:0031497;GO:0006281;GO:0006260;GO:0006335;GO:0006334;, C:CAF-1 complex; C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:histone binding; F:unfolded protein binding;, P:cell cycle; P:chromatin assembly; P:DNA repair; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:nucleosome assembly; scaffold20 indexed_genome mRNA 26335286 26338355 . + . ID=transcript_5006;Q13112 Q99548,Chromatin assembly factor 1 subunit B {ECO:0000305},Chromatin assembly factor I p60 subunit;M-phase phosphoprotein 7;, PF15512;PF00400;, GO:0033186;GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0042393;GO:0051082;GO:0007049;GO:0031497;GO:0006281;GO:0006260;GO:0006335;GO:0006334;, C:CAF-1 complex; C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:histone binding; F:unfolded protein binding;, P:cell cycle; P:chromatin assembly; P:DNA repair; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:nucleosome assembly; scaffold20 indexed_genome mRNA 26384020 26385543 . - . ID=transcript_5007;O95500,Claudin-14,, PF00822;, GO:0005923;GO:0005783;GO:0016021;GO:0005886;GO:0042802;GO:0005198;GO:0070830;GO:0016338;GO:0007155;GO:0065003;, C:bicellular tight junction; C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:structural molecule activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:protein-containing complex assembly; scaffold20 indexed_genome mRNA 26965884 26982226 . - . ID=transcript_5008;Q9NZA6,Phosphatidylinositol N-acetylglucosaminyltransferase subunit P {ECO:0000305},Down syndrome critical region protein 5;Down syndrome critical region protein C;Phosphatidylinositol-glycan biosynthesis class P protein;, PF08510;, GO:0005789;GO:0000506;GO:0016021;GO:0017176;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NZA6,Phosphatidylinositol N-acetylglucosaminyltransferase subunit P {ECO:0000305},Down syndrome critical region protein 5;Down syndrome critical region protein C;Phosphatidylinositol-glycan biosynthesis class P protein;, PF08510;, GO:0005789;GO:0000506;GO:0016021;GO:0017176;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NZA6,Phosphatidylinositol N-acetylglucosaminyltransferase subunit P {ECO:0000305},Down syndrome critical region protein 5;Down syndrome critical region protein C;Phosphatidylinositol-glycan biosynthesis class P protein;, PF08510;, GO:0005789;GO:0000506;GO:0016021;GO:0017176;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NZA6,Phosphatidylinositol N-acetylglucosaminyltransferase subunit P {ECO:0000305},Down syndrome critical region protein 5;Down syndrome critical region protein C;Phosphatidylinositol-glycan biosynthesis class P protein;, PF08510;, GO:0005789;GO:0000506;GO:0016021;GO:0017176;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NZA6,Phosphatidylinositol N-acetylglucosaminyltransferase subunit P {ECO:0000305},Down syndrome critical region protein 5;Down syndrome critical region protein C;Phosphatidylinositol-glycan biosynthesis class P protein;, PF08510;, GO:0005789;GO:0000506;GO:0016021;GO:0017176;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold20 indexed_genome mRNA 27004581 27111917 . + . ID=transcript_5009;Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q569I2 Q6P578 Q9UEK4,E3 ubiquitin-protein ligase TTC3,Protein DCRR1;RING finger protein 105;RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};TPR repeat protein D;Tetratricopeptide repeat protein 3;, PF19179;PF13639;, GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0070936;GO:0006511;, C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold20 indexed_genome mRNA 27132479 27166796 . - . ID=transcript_5010;O14972 B2R6T8 B7Z6B1 D3DSH4 Q2TAY6,Vacuolar protein sorting-associated protein 26C {ECO:0000305},Down syndrome critical region protein 3;Down syndrome critical region protein A;, PF03643;, GO:0005768;GO:0005634;GO:0032456;GO:0006886;GO:1990126;, C:endosome; C:nucleus;, , P:endocytic recycling; P:intracellular protein transport; P:retrograde transport, endosome to plasma membrane;|O14972 B2R6T8 B7Z6B1 D3DSH4 Q2TAY6,Vacuolar protein sorting-associated protein 26C {ECO:0000305},Down syndrome critical region protein 3;Down syndrome critical region protein A;, PF03643;, GO:0005768;GO:0005634;GO:0032456;GO:0006886;GO:1990126;, C:endosome; C:nucleus;, , P:endocytic recycling; P:intracellular protein transport; P:retrograde transport, endosome to plasma membrane;|O14972 B2R6T8 B7Z6B1 D3DSH4 Q2TAY6,Vacuolar protein sorting-associated protein 26C {ECO:0000305},Down syndrome critical region protein 3;Down syndrome critical region protein A;, PF03643;, GO:0005768;GO:0005634;GO:0032456;GO:0006886;GO:1990126;, C:endosome; C:nucleus;, , P:endocytic recycling; P:intracellular protein transport; P:retrograde transport, endosome to plasma membrane;|O14972 B2R6T8 B7Z6B1 D3DSH4 Q2TAY6,Vacuolar protein sorting-associated protein 26C {ECO:0000305},Down syndrome critical region protein 3;Down syndrome critical region protein A;, PF03643;, GO:0005768;GO:0005634;GO:0032456;GO:0006886;GO:1990126;, C:endosome; C:nucleus;, , P:endocytic recycling; P:intracellular protein transport; P:retrograde transport, endosome to plasma membrane; scaffold20 indexed_genome mRNA 27287300 27380350 . + . ID=transcript_5011;Q13627 O60769 Q92582 Q92810 Q9UNM5,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Dual specificity YAK1-related kinase;HP86;Protein kinase minibrain homolog;, PF00069;, GO:0030424;GO:0005737;GO:0005856;GO:0030425;GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0003779;GO:0005524;GO:0008092;GO:0042802;GO:0004715;GO:0004672;GO:0043621;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004713;GO:0048156;GO:0050321;GO:0003713;GO:0004714;GO:0015631;GO:0034205;GO:0007623;GO:0043518;GO:0031115;GO:0048025;GO:0007399;GO:0036289;GO:0018105;GO:0018107;GO:0038083;GO:0018108;GO:0090312;GO:0033120;GO:0045893;GO:0046777;GO:0006468;GO:0000381;GO:0016032;, C:axon; C:cytoplasm; C:cytoskeleton; C:dendrite; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:actin binding; F:ATP binding; F:cytoskeletal protein binding; F:identical protein binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:transcription coactivator activity; F:transmembrane receptor protein tyrosine kinase activity; F:tubulin binding;, P:amyloid-beta formation; P:circadian rhythm; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of microtubule polymerization; P:negative regulation of mRNA splicing, via spliceosome; P:nervous system development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of protein deacetylation; P:positive regulation of RNA splicing; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of alternative mRNA splicing, via spliceosome; P:viral process;|Q13627 O60769 Q92582 Q92810 Q9UNM5,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Dual specificity YAK1-related kinase;HP86;Protein kinase minibrain homolog;, PF00069;, GO:0030424;GO:0005737;GO:0005856;GO:0030425;GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0003779;GO:0005524;GO:0008092;GO:0042802;GO:0004715;GO:0004672;GO:0043621;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004713;GO:0048156;GO:0050321;GO:0003713;GO:0004714;GO:0015631;GO:0034205;GO:0007623;GO:0043518;GO:0031115;GO:0048025;GO:0007399;GO:0036289;GO:0018105;GO:0018107;GO:0038083;GO:0018108;GO:0090312;GO:0033120;GO:0045893;GO:0046777;GO:0006468;GO:0000381;GO:0016032;, C:axon; C:cytoplasm; C:cytoskeleton; C:dendrite; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:actin binding; F:ATP binding; F:cytoskeletal protein binding; F:identical protein binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:transcription coactivator activity; F:transmembrane receptor protein tyrosine kinase activity; F:tubulin binding;, P:amyloid-beta formation; P:circadian rhythm; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of microtubule polymerization; P:negative regulation of mRNA splicing, via spliceosome; P:nervous system development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of protein deacetylation; P:positive regulation of RNA splicing; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of alternative mRNA splicing, via spliceosome; P:viral process; scaffold20 indexed_genome mRNA 27550775 27551276 . + . ID=transcript_5012;P48051 Q3MJ74 Q53WW6,G protein-activated inward rectifier potassium channel 2,BIR1;Inward rectifier K(+) channel Kir3.2;KATP-2;Potassium channel, inwardly rectifying subfamily J member 6;, PF01007;PF17655;, GO:0005794;GO:0005886;GO:0008076;GO:0015467;GO:0005242;GO:1901381;GO:1990573;GO:0006813;GO:0034765;, C:Golgi apparatus; C:plasma membrane; C:voltage-gated potassium channel complex;, F:G-protein activated inward rectifier potassium channel activity; F:inward rectifier potassium channel activity;, P:positive regulation of potassium ion transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transport; P:regulation of ion transmembrane transport; scaffold20 indexed_genome mRNA 28083211 28083925 . - . ID=transcript_5013;Q6MZN2 Q6P2R8 Q86TF6 Q8IX92 Q8IX93 Q9H6C1,Melanoma inhibitory activity protein 2 {ECO:0000305},CTAGE family member 5 ER export factor {ECO:0000312|HGNC:HGNC:18432};Cutaneous T-cell lymphoma-associated antigen 5;Meningioma-expressed antigen 6/11 {ECO:0000303|PubMed:9356211};, PF07653;, GO:0005783;GO:0070971;GO:0005789;GO:0016021;GO:0016020;GO:0038024;GO:0008047;GO:0006888;GO:0042953;GO:0032527;GO:0070973;GO:0009306;GO:0035459;, C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:cargo receptor activity; F:enzyme activator activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:lipoprotein transport; P:protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein secretion; P:vesicle cargo loading; scaffold20 indexed_genome mRNA 28190152 28197078 . + . ID=transcript_5014;Q99712 D3DSH5 O00564 Q96L28 Q99446,ATP-sensitive inward rectifier potassium channel 15,Inward rectifier K(+) channel Kir1.3;Inward rectifier K(+) channel Kir4.2;Potassium channel, inwardly rectifying subfamily J member 15;, PF01007;PF17655;, GO:0005887;GO:0005886;GO:0005242;GO:1901381;GO:1990573;GO:0006813;GO:0034765;, C:integral component of plasma membrane; C:plasma membrane;, F:inward rectifier potassium channel activity;, P:positive regulation of potassium ion transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transport; P:regulation of ion transmembrane transport; scaffold20 indexed_genome mRNA 28260561 28270556 . - . ID=transcript_5015;Q01543 B2R8H2 B4DFV4 B4DTC6 G3V183 Q14319 Q92480 Q9UE07,Friend leukemia integration 1 transcription factor,Proto-oncogene Fli-1;Transcription factor ERGB;, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0009887;GO:0008015;GO:0030154;GO:0007599;GO:0035855;GO:0045893;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:animal organ morphogenesis; P:blood circulation; P:cell differentiation; P:hemostasis; P:megakaryocyte development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold20 indexed_genome mRNA 28705536 28711473 . + . ID=transcript_5016;P15036 A6NM68 D3DSH6 Q53Y89,Protein C-ets-2,, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0019904;GO:0000978;GO:1990837;GO:0030154;GO:0000122;GO:0045893;GO:0006357;GO:0001501;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal system development;|P15036 A6NM68 D3DSH6 Q53Y89,Protein C-ets-2,, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0019904;GO:0000978;GO:1990837;GO:0030154;GO:0000122;GO:0045893;GO:0006357;GO:0001501;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal system development;|P15036 A6NM68 D3DSH6 Q53Y89,Protein C-ets-2,, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0019904;GO:0000978;GO:1990837;GO:0030154;GO:0000122;GO:0045893;GO:0006357;GO:0001501;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal system development; scaffold20 indexed_genome mRNA 28711499 28716809 . - . ID=transcript_5017;P15036 A6NM68 D3DSH6 Q53Y89,Protein C-ets-2,, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0019904;GO:0000978;GO:1990837;GO:0030154;GO:0000122;GO:0045893;GO:0006357;GO:0001501;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal system development;|P15036 A6NM68 D3DSH6 Q53Y89,Protein C-ets-2,, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0019904;GO:0000978;GO:1990837;GO:0030154;GO:0000122;GO:0045893;GO:0006357;GO:0001501;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal system development; scaffold20 indexed_genome mRNA 28980627 29052528 . + . ID=transcript_5018;Q99570 Q2TBF4,Phosphoinositide 3-kinase regulatory subunit 4,PI3-kinase p150 subunit;Phosphoinositide 3-kinase adaptor protein;, PF00069;PF00400;, GO:0005776;GO:0005930;GO:0005829;GO:0043231;GO:0005770;GO:0016020;GO:0015630;GO:0071561;GO:0030670;GO:0035032;GO:0034271;GO:0034272;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0030242;GO:0042149;GO:0045324;GO:0016236;GO:0006661;GO:0043552;GO:0006468;GO:0006623;GO:0032801;GO:0032465;GO:0034162;, C:autophagosome; C:axoneme; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:membrane; C:microtubule cytoskeleton; C:nucleus-vacuole junction; C:phagocytic vesicle membrane; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy of peroxisome; P:cellular response to glucose starvation; P:late endosome to vacuole transport; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:protein phosphorylation; P:protein targeting to vacuole; P:receptor catabolic process; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway; scaffold20 indexed_genome mRNA 29055021 29057223 . - . ID=transcript_5019;Q99570 Q2TBF4,Phosphoinositide 3-kinase regulatory subunit 4,PI3-kinase p150 subunit;Phosphoinositide 3-kinase adaptor protein;, PF00069;PF00400;, GO:0005776;GO:0005930;GO:0005829;GO:0043231;GO:0005770;GO:0016020;GO:0015630;GO:0071561;GO:0030670;GO:0035032;GO:0034271;GO:0034272;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0030242;GO:0042149;GO:0045324;GO:0016236;GO:0006661;GO:0043552;GO:0006468;GO:0006623;GO:0032801;GO:0032465;GO:0034162;, C:autophagosome; C:axoneme; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:membrane; C:microtubule cytoskeleton; C:nucleus-vacuole junction; C:phagocytic vesicle membrane; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy of peroxisome; P:cellular response to glucose starvation; P:late endosome to vacuole transport; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:protein phosphorylation; P:protein targeting to vacuole; P:receptor catabolic process; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway; scaffold20 indexed_genome mRNA 29059343 29062602 . + . ID=transcript_5020;Q99570 Q2TBF4,Phosphoinositide 3-kinase regulatory subunit 4,PI3-kinase p150 subunit;Phosphoinositide 3-kinase adaptor protein;, PF00069;PF00400;, GO:0005776;GO:0005930;GO:0005829;GO:0043231;GO:0005770;GO:0016020;GO:0015630;GO:0071561;GO:0030670;GO:0035032;GO:0034271;GO:0034272;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0030242;GO:0042149;GO:0045324;GO:0016236;GO:0006661;GO:0043552;GO:0006468;GO:0006623;GO:0032801;GO:0032465;GO:0034162;, C:autophagosome; C:axoneme; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:membrane; C:microtubule cytoskeleton; C:nucleus-vacuole junction; C:phagocytic vesicle membrane; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy of peroxisome; P:cellular response to glucose starvation; P:late endosome to vacuole transport; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:protein phosphorylation; P:protein targeting to vacuole; P:receptor catabolic process; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway;|Q99570 Q2TBF4,Phosphoinositide 3-kinase regulatory subunit 4,PI3-kinase p150 subunit;Phosphoinositide 3-kinase adaptor protein;, PF00069;PF00400;, GO:0005776;GO:0005930;GO:0005829;GO:0043231;GO:0005770;GO:0016020;GO:0015630;GO:0071561;GO:0030670;GO:0035032;GO:0034271;GO:0034272;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0030242;GO:0042149;GO:0045324;GO:0016236;GO:0006661;GO:0043552;GO:0006468;GO:0006623;GO:0032801;GO:0032465;GO:0034162;, C:autophagosome; C:axoneme; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:membrane; C:microtubule cytoskeleton; C:nucleus-vacuole junction; C:phagocytic vesicle membrane; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy of peroxisome; P:cellular response to glucose starvation; P:late endosome to vacuole transport; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:protein phosphorylation; P:protein targeting to vacuole; P:receptor catabolic process; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway;|Q99570 Q2TBF4,Phosphoinositide 3-kinase regulatory subunit 4,PI3-kinase p150 subunit;Phosphoinositide 3-kinase adaptor protein;, PF00069;PF00400;, GO:0005776;GO:0005930;GO:0005829;GO:0043231;GO:0005770;GO:0016020;GO:0015630;GO:0071561;GO:0030670;GO:0035032;GO:0034271;GO:0034272;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0030242;GO:0042149;GO:0045324;GO:0016236;GO:0006661;GO:0043552;GO:0006468;GO:0006623;GO:0032801;GO:0032465;GO:0034162;, C:autophagosome; C:axoneme; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:membrane; C:microtubule cytoskeleton; C:nucleus-vacuole junction; C:phagocytic vesicle membrane; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy of peroxisome; P:cellular response to glucose starvation; P:late endosome to vacuole transport; P:macroautophagy; P:phosphatidylinositol biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:protein phosphorylation; P:protein targeting to vacuole; P:receptor catabolic process; P:regulation of cytokinesis; P:toll-like receptor 9 signaling pathway; scaffold20 indexed_genome mRNA 29065478 29080529 . - . ID=transcript_5021;A6NMZ7 A7DZQ0 A7DZQ1 A7DZQ2 Q69YT0,Collagen alpha-6(VI) chain,, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0031012;GO:0005576;GO:0007155;, C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, , P:cell adhesion; scaffold20 indexed_genome mRNA 29246967 29345660 . - . ID=transcript_5022;Q6ZW26 Q8NA36,Collagen alpha-5(VI) chain,Collagen alpha-1(XXIX) chain;von Willebrand factor A domain-containing protein 4;, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005576;GO:0030020;GO:0007155;, C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular region;, F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; scaffold20 indexed_genome mRNA 29345710 29347940 . - . ID=transcript_5023;Q6ZW26 Q8NA36,Collagen alpha-5(VI) chain,Collagen alpha-1(XXIX) chain;von Willebrand factor A domain-containing protein 4;, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005576;GO:0030020;GO:0007155;, C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular region;, F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; scaffold20 indexed_genome mRNA 29635882 29675704 . + . ID=transcript_5024;Q9Y6W3,Calpain-7,PalB homolog;, PF01067;PF04212;PF00648;, GO:0005813;GO:0005829;GO:0070062;GO:0005634;GO:0004198;GO:0004175;GO:0090541;GO:0010634;GO:0097264;, C:centrosome; C:cytosol; C:extracellular exosome; C:nucleus;, F:calcium-dependent cysteine-type endopeptidase activity; F:endopeptidase activity; F:MIT domain binding;, P:positive regulation of epithelial cell migration; P:self proteolysis;|Q9Y6W3,Calpain-7,PalB homolog;, PF01067;PF04212;PF00648;, GO:0005813;GO:0005829;GO:0070062;GO:0005634;GO:0004198;GO:0004175;GO:0090541;GO:0010634;GO:0097264;, C:centrosome; C:cytosol; C:extracellular exosome; C:nucleus;, F:calcium-dependent cysteine-type endopeptidase activity; F:endopeptidase activity; F:MIT domain binding;, P:positive regulation of epithelial cell migration; P:self proteolysis; scaffold20 indexed_genome mRNA 29675920 29680911 . + . ID=transcript_5025;Q9Y6W3,Calpain-7,PalB homolog;, PF01067;PF04212;PF00648;, GO:0005813;GO:0005829;GO:0070062;GO:0005634;GO:0004198;GO:0004175;GO:0090541;GO:0010634;GO:0097264;, C:centrosome; C:cytosol; C:extracellular exosome; C:nucleus;, F:calcium-dependent cysteine-type endopeptidase activity; F:endopeptidase activity; F:MIT domain binding;, P:positive regulation of epithelial cell migration; P:self proteolysis;|Q9Y6W3,Calpain-7,PalB homolog;, PF01067;PF04212;PF00648;, GO:0005813;GO:0005829;GO:0070062;GO:0005634;GO:0004198;GO:0004175;GO:0090541;GO:0010634;GO:0097264;, C:centrosome; C:cytosol; C:extracellular exosome; C:nucleus;, F:calcium-dependent cysteine-type endopeptidase activity; F:endopeptidase activity; F:MIT domain binding;, P:positive regulation of epithelial cell migration; P:self proteolysis;|Q9Y6W3,Calpain-7,PalB homolog;, PF01067;PF04212;PF00648;, GO:0005813;GO:0005829;GO:0070062;GO:0005634;GO:0004198;GO:0004175;GO:0090541;GO:0010634;GO:0097264;, C:centrosome; C:cytosol; C:extracellular exosome; C:nucleus;, F:calcium-dependent cysteine-type endopeptidase activity; F:endopeptidase activity; F:MIT domain binding;, P:positive regulation of epithelial cell migration; P:self proteolysis;|Q9Y6W3,Calpain-7,PalB homolog;, PF01067;PF04212;PF00648;, GO:0005813;GO:0005829;GO:0070062;GO:0005634;GO:0004198;GO:0004175;GO:0090541;GO:0010634;GO:0097264;, C:centrosome; C:cytosol; C:extracellular exosome; C:nucleus;, F:calcium-dependent cysteine-type endopeptidase activity; F:endopeptidase activity; F:MIT domain binding;, P:positive regulation of epithelial cell migration; P:self proteolysis; scaffold20 indexed_genome mRNA 29827985 29828715 . - . ID=transcript_5026;Q8TCB7 Q96LU4,tRNA N(3)-methylcytidine methyltransferase METTL6 {ECO:0000305},Methyltransferase-like protein 6 {ECO:0000305};, PF08242;, GO:0019899;GO:0052735;GO:0030488;, , F:enzyme binding; F:tRNA (cytosine-3-)-methyltransferase activity;, P:tRNA methylation; scaffold20 indexed_genome mRNA 29834807 29837307 . - . ID=transcript_5027;Q8TCB7 Q96LU4,tRNA N(3)-methylcytidine methyltransferase METTL6 {ECO:0000305},Methyltransferase-like protein 6 {ECO:0000305};, PF08242;, GO:0019899;GO:0052735;GO:0030488;, , F:enzyme binding; F:tRNA (cytosine-3-)-methyltransferase activity;, P:tRNA methylation;|Q8TCB7 Q96LU4,tRNA N(3)-methylcytidine methyltransferase METTL6 {ECO:0000305},Methyltransferase-like protein 6 {ECO:0000305};, PF08242;, GO:0019899;GO:0052735;GO:0030488;, , F:enzyme binding; F:tRNA (cytosine-3-)-methyltransferase activity;, P:tRNA methylation; scaffold20 indexed_genome mRNA 29841213 29842215 . - . ID=transcript_5028;Q8TCB7 Q96LU4,tRNA N(3)-methylcytidine methyltransferase METTL6 {ECO:0000305},Methyltransferase-like protein 6 {ECO:0000305};, PF08242;, GO:0019899;GO:0052735;GO:0030488;, , F:enzyme binding; F:tRNA (cytosine-3-)-methyltransferase activity;, P:tRNA methylation; scaffold20 indexed_genome mRNA 29844065 29847717 . - . ID=transcript_5029;Q96JC9 B4E3F5 Q8IW10,ELL-associated factor 1,, PF09816;, GO:0015030;GO:0045171;GO:0043231;GO:0016604;GO:0016607;GO:0005654;GO:0032783;GO:0008023;GO:0003711;GO:0034243;GO:0006366;GO:0006368;, C:Cajal body; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:super elongation complex; C:transcription elongation factor complex;, F:transcription elongation regulator activity;, P:regulation of transcription elongation from RNA polymerase II promoter; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q96JC9 B4E3F5 Q8IW10,ELL-associated factor 1,, PF09816;, GO:0015030;GO:0045171;GO:0043231;GO:0016604;GO:0016607;GO:0005654;GO:0032783;GO:0008023;GO:0003711;GO:0034243;GO:0006366;GO:0006368;, C:Cajal body; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:super elongation complex; C:transcription elongation factor complex;, F:transcription elongation regulator activity;, P:regulation of transcription elongation from RNA polymerase II promoter; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold20 indexed_genome mRNA 29848082 29857328 . + . ID=transcript_5030;Q96JC9 B4E3F5 Q8IW10,ELL-associated factor 1,, PF09816;, GO:0015030;GO:0045171;GO:0043231;GO:0016604;GO:0016607;GO:0005654;GO:0032783;GO:0008023;GO:0003711;GO:0034243;GO:0006366;GO:0006368;, C:Cajal body; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:super elongation complex; C:transcription elongation factor complex;, F:transcription elongation regulator activity;, P:regulation of transcription elongation from RNA polymerase II promoter; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q96JC9 B4E3F5 Q8IW10,ELL-associated factor 1,, PF09816;, GO:0015030;GO:0045171;GO:0043231;GO:0016604;GO:0016607;GO:0005654;GO:0032783;GO:0008023;GO:0003711;GO:0034243;GO:0006366;GO:0006368;, C:Cajal body; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:super elongation complex; C:transcription elongation factor complex;, F:transcription elongation regulator activity;, P:regulation of transcription elongation from RNA polymerase II promoter; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold20 indexed_genome mRNA 29870876 29888465 . - . ID=transcript_5031;Q9NP20 Q9NP21 Q9NP22 Q9NP23 Q9NP24 Q9UP88,Acetylcholinesterase collagenic tail peptide,AChE Q subunit;Acetylcholinesterase-associated collagen;, , GO:0005604;GO:0030054;GO:0005581;GO:0062023;GO:0031012;GO:0005615;GO:0005886;GO:0045202;GO:0043083;GO:0005201;GO:0008201;GO:0001507;GO:0030198;, C:basement membrane; C:cell junction; C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space; C:plasma membrane; C:synapse; C:synaptic cleft;, F:extracellular matrix structural constituent; F:heparin binding;, P:acetylcholine catabolic process in synaptic cleft; P:extracellular matrix organization; scaffold20 indexed_genome mRNA 29968787 30041828 . - . ID=transcript_5032;Q9UJ83 B4DWI1 B4DXI5 E9PEN4 Q9BV42 Q9P0A2,2-hydroxyacyl-CoA lyase 1,2-hydroxyphytanoyl-CoA lyase {ECO:0000303|PubMed:10468558};Phytanoyl-CoA 2-hydroxylase 2;, PF02775;PF00205;PF02776;, GO:0005829;GO:0043231;GO:0005654;GO:0005782;GO:0005777;GO:0005524;GO:0016830;GO:0042802;GO:0000287;GO:0030976;GO:0001561;GO:0006631;GO:0097089;GO:1903512;GO:0008104;GO:0006625;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:peroxisomal matrix; C:peroxisome;, F:ATP binding; F:carbon-carbon lyase activity; F:identical protein binding; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:fatty acid metabolic process; P:methyl-branched fatty acid metabolic process; P:phytanic acid metabolic process; P:protein localization; P:protein targeting to peroxisome;|Q9UJ83 B4DWI1 B4DXI5 E9PEN4 Q9BV42 Q9P0A2,2-hydroxyacyl-CoA lyase 1,2-hydroxyphytanoyl-CoA lyase {ECO:0000303|PubMed:10468558};Phytanoyl-CoA 2-hydroxylase 2;, PF02775;PF00205;PF02776;, GO:0005829;GO:0043231;GO:0005654;GO:0005782;GO:0005777;GO:0005524;GO:0016830;GO:0042802;GO:0000287;GO:0030976;GO:0001561;GO:0006631;GO:0097089;GO:1903512;GO:0008104;GO:0006625;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:peroxisomal matrix; C:peroxisome;, F:ATP binding; F:carbon-carbon lyase activity; F:identical protein binding; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:fatty acid metabolic process; P:methyl-branched fatty acid metabolic process; P:phytanic acid metabolic process; P:protein localization; P:protein targeting to peroxisome;|Q9UJ83 B4DWI1 B4DXI5 E9PEN4 Q9BV42 Q9P0A2,2-hydroxyacyl-CoA lyase 1,2-hydroxyphytanoyl-CoA lyase {ECO:0000303|PubMed:10468558};Phytanoyl-CoA 2-hydroxylase 2;, PF02775;PF00205;PF02776;, GO:0005829;GO:0043231;GO:0005654;GO:0005782;GO:0005777;GO:0005524;GO:0016830;GO:0042802;GO:0000287;GO:0030976;GO:0001561;GO:0006631;GO:0097089;GO:1903512;GO:0008104;GO:0006625;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:peroxisomal matrix; C:peroxisome;, F:ATP binding; F:carbon-carbon lyase activity; F:identical protein binding; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:fatty acid metabolic process; P:methyl-branched fatty acid metabolic process; P:phytanic acid metabolic process; P:protein localization; P:protein targeting to peroxisome;|Q9UJ83 B4DWI1 B4DXI5 E9PEN4 Q9BV42 Q9P0A2,2-hydroxyacyl-CoA lyase 1,2-hydroxyphytanoyl-CoA lyase {ECO:0000303|PubMed:10468558};Phytanoyl-CoA 2-hydroxylase 2;, PF02775;PF00205;PF02776;, GO:0005829;GO:0043231;GO:0005654;GO:0005782;GO:0005777;GO:0005524;GO:0016830;GO:0042802;GO:0000287;GO:0030976;GO:0001561;GO:0006631;GO:0097089;GO:1903512;GO:0008104;GO:0006625;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:peroxisomal matrix; C:peroxisome;, F:ATP binding; F:carbon-carbon lyase activity; F:identical protein binding; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:fatty acid metabolic process; P:methyl-branched fatty acid metabolic process; P:phytanic acid metabolic process; P:protein localization; P:protein targeting to peroxisome;|Q9UJ83 B4DWI1 B4DXI5 E9PEN4 Q9BV42 Q9P0A2,2-hydroxyacyl-CoA lyase 1,2-hydroxyphytanoyl-CoA lyase {ECO:0000303|PubMed:10468558};Phytanoyl-CoA 2-hydroxylase 2;, PF02775;PF00205;PF02776;, GO:0005829;GO:0043231;GO:0005654;GO:0005782;GO:0005777;GO:0005524;GO:0016830;GO:0042802;GO:0000287;GO:0030976;GO:0001561;GO:0006631;GO:0097089;GO:1903512;GO:0008104;GO:0006625;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:peroxisomal matrix; C:peroxisome;, F:ATP binding; F:carbon-carbon lyase activity; F:identical protein binding; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:fatty acid metabolic process; P:methyl-branched fatty acid metabolic process; P:phytanic acid metabolic process; P:protein localization; P:protein targeting to peroxisome;|P43251 A6NHF2 B2R865 B4DFX1 B4DLJ9 B7Z7C9 F8W1Q3 Q96EM9,Biotinidase,, PF00795;PF19018;, GO:0070062;GO:0005576;GO:0005615;GO:0005759;GO:0047708;GO:0006768;GO:0007417;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:mitochondrial matrix;, F:biotinidase activity;, P:biotin metabolic process; P:central nervous system development; scaffold20 indexed_genome mRNA 30067021 30069271 . - . ID=transcript_5033;O15084 B4DES5 Q1WWL4 Q29RW6 Q3B857 Q6ULS0 Q6ZT57,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A,Ankyrin repeat domain-containing protein 28;Phosphatase interactor targeting protein hnRNP K;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0048208;GO:0007004;, C:cytosol; C:nucleoplasm;, , P:COPII vesicle coating; P:telomere maintenance via telomerase;|O15084 B4DES5 Q1WWL4 Q29RW6 Q3B857 Q6ULS0 Q6ZT57,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A,Ankyrin repeat domain-containing protein 28;Phosphatase interactor targeting protein hnRNP K;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0048208;GO:0007004;, C:cytosol; C:nucleoplasm;, , P:COPII vesicle coating; P:telomere maintenance via telomerase; scaffold20 indexed_genome mRNA 30070412 30072552 . - . ID=transcript_5034;O15084 B4DES5 Q1WWL4 Q29RW6 Q3B857 Q6ULS0 Q6ZT57,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A,Ankyrin repeat domain-containing protein 28;Phosphatase interactor targeting protein hnRNP K;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0048208;GO:0007004;, C:cytosol; C:nucleoplasm;, , P:COPII vesicle coating; P:telomere maintenance via telomerase; scaffold20 indexed_genome mRNA 30089764 30090579 . + . ID=transcript_5035;O15084 B4DES5 Q1WWL4 Q29RW6 Q3B857 Q6ULS0 Q6ZT57,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A,Ankyrin repeat domain-containing protein 28;Phosphatase interactor targeting protein hnRNP K;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0048208;GO:0007004;, C:cytosol; C:nucleoplasm;, , P:COPII vesicle coating; P:telomere maintenance via telomerase; scaffold20 indexed_genome mRNA 30090668 30093995 . - . ID=transcript_5036;O15084 B4DES5 Q1WWL4 Q29RW6 Q3B857 Q6ULS0 Q6ZT57,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A,Ankyrin repeat domain-containing protein 28;Phosphatase interactor targeting protein hnRNP K;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0048208;GO:0007004;, C:cytosol; C:nucleoplasm;, , P:COPII vesicle coating; P:telomere maintenance via telomerase; scaffold20 indexed_genome mRNA 30103323 30104883 . + . ID=transcript_5037;O15084 B4DES5 Q1WWL4 Q29RW6 Q3B857 Q6ULS0 Q6ZT57,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A,Ankyrin repeat domain-containing protein 28;Phosphatase interactor targeting protein hnRNP K;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0048208;GO:0007004;, C:cytosol; C:nucleoplasm;, , P:COPII vesicle coating; P:telomere maintenance via telomerase; scaffold20 indexed_genome mRNA 30281971 30282523 . - . ID=transcript_5038;P40616 B4DWW1 P80417 Q53XB1,ADP-ribosylation factor-like protein 1,, PF00025;, GO:0005737;GO:0005829;GO:0005794;GO:0005802;GO:0032588;GO:0008047;GO:0005525;GO:0003924;GO:0046872;GO:0019904;GO:0031584;GO:0007030;GO:0006886;GO:0034067;GO:0042147;GO:0009404;GO:0016192;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:trans-Golgi network; C:trans-Golgi network membrane;, F:enzyme activator activity; F:GTP binding; F:GTPase activity; F:metal ion binding; F:protein domain specific binding;, P:activation of phospholipase D activity; P:Golgi organization; P:intracellular protein transport; P:protein localization to Golgi apparatus; P:retrograde transport, endosome to Golgi; P:toxin metabolic process; P:vesicle-mediated transport; scaffold20 indexed_genome mRNA 30303988 30307730 . - . ID=transcript_5039;Q96RI1 A1L4K5 B7Z412 B7ZM06 F8VYG8 Q8NFP5 Q8NFP6 Q92943,Bile acid receptor,Farnesoid X-activated receptor;Farnesol receptor HRR-1;Nuclear receptor subfamily 1 group H member 4;Retinoid X receptor-interacting protein 14;, PF00104;PF00105;, GO:0000785;GO:0000791;GO:0005654;GO:0043235;GO:0032052;GO:0038181;GO:1902122;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0016922;GO:0046965;GO:0000978;GO:0000977;GO:0043565;GO:0000976;GO:0008270;GO:0015721;GO:0008206;GO:0038183;GO:0030154;GO:0007043;GO:0001678;GO:1903413;GO:0071398;GO:0071222;GO:0071417;GO:0035356;GO:0042632;GO:0042742;GO:0055089;GO:0034971;GO:0006954;GO:0045087;GO:0038185;GO:0030522;GO:0043066;GO:0043124;GO:0050728;GO:0032689;GO:0032692;GO:0032703;GO:0032715;GO:0071638;GO:0032088;GO:0000122;GO:0032720;GO:0010804;GO:0010903;GO:0001080;GO:0007219;GO:1904179;GO:2001250;GO:2000213;GO:0046628;GO:0035774;GO:0032740;GO:1905695;GO:0045944;GO:0045893;GO:0070857;GO:0090181;GO:0061178;GO:0010988;GO:0006357;GO:0006355;GO:0034255;GO:0034142;GO:0034162;GO:0006367;, C:chromatin; C:euchromatin; C:nucleoplasm; C:receptor complex;, F:bile acid binding; F:bile acid receptor activity; F:chenodeoxycholic acid binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:nuclear receptor binding; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:bile acid signaling pathway; P:cell differentiation; P:cell-cell junction assembly; P:cellular glucose homeostasis; P:cellular response to bile acid; P:cellular response to fatty acid; P:cellular response to lipopolysaccharide; P:cellular response to organonitrogen compound; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:defense response to bacterium; P:fatty acid homeostasis; P:histone H3-R17 methylation; P:inflammatory response; P:innate immune response; P:intracellular bile acid receptor signaling pathway; P:intracellular receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 production; P:negative regulation of interleukin-2 production; P:negative regulation of interleukin-6 production; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:negative regulation of very-low-density lipoprotein particle remodeling; P:nitrogen catabolite activation of transcription from RNA polymerase II promoter; P:Notch signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of ammonia assimilation cycle; P:positive regulation of glutamate metabolic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of interleukin-17 production; P:positive regulation of phosphatidic acid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of bile acid biosynthetic process; P:regulation of cholesterol metabolic process; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of low-density lipoprotein particle clearance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of urea metabolic process; P:toll-like receptor 4 signaling pathway; P:toll-like receptor 9 signaling pathway; P:transcription initiation from RNA polymerase II promoter; scaffold20 indexed_genome mRNA 30349615 30361465 . + . ID=transcript_5040;Q9BRV8 Q5TEZ7 Q5TEZ9 Q68DZ4 Q9H778,Suppressor of IKBKE 1,Suppressor of IKK-epsilon;, PF05769;, GO:0005829;GO:0019901;GO:0031267;, C:cytosol;, F:protein kinase binding; F:small GTPase binding;|Q9BRV8 Q5TEZ7 Q5TEZ9 Q68DZ4 Q9H778,Suppressor of IKBKE 1,Suppressor of IKK-epsilon;, PF05769;, GO:0005829;GO:0019901;GO:0031267;, C:cytosol;, F:protein kinase binding; F:small GTPase binding; scaffold20 indexed_genome mRNA 30371565 30407087 . + . ID=transcript_5041;Q9Y2S4,Cold shock domain-containing protein E1 {ECO:0000305},N-ras upstream gene protein;Protein UNR;, PF00313;PF12901;, GO:0070937;GO:0010494;GO:0005829;GO:0005794;GO:0000932;GO:0005886;GO:0003723;GO:0035613;GO:0075522;GO:0008584;GO:0070966;GO:0006446;GO:0034063;, C:CRD-mediated mRNA stability complex; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:P-body; C:plasma membrane;, F:RNA binding; F:RNA stem-loop binding;, P:IRES-dependent viral translational initiation; P:male gonad development; P:nuclear-transcribed mRNA catabolic process, no-go decay; P:regulation of translational initiation; P:stress granule assembly;|Q9Y2S4,Cold shock domain-containing protein E1 {ECO:0000305},N-ras upstream gene protein;Protein UNR;, PF00313;PF12901;, GO:0070937;GO:0010494;GO:0005829;GO:0005794;GO:0000932;GO:0005886;GO:0003723;GO:0035613;GO:0075522;GO:0008584;GO:0070966;GO:0006446;GO:0034063;, C:CRD-mediated mRNA stability complex; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:P-body; C:plasma membrane;, F:RNA binding; F:RNA stem-loop binding;, P:IRES-dependent viral translational initiation; P:male gonad development; P:nuclear-transcribed mRNA catabolic process, no-go decay; P:regulation of translational initiation; P:stress granule assembly;|Q9Y2S4,Cold shock domain-containing protein E1 {ECO:0000305},N-ras upstream gene protein;Protein UNR;, PF00313;PF12901;, GO:0070937;GO:0010494;GO:0005829;GO:0005794;GO:0000932;GO:0005886;GO:0003723;GO:0035613;GO:0075522;GO:0008584;GO:0070966;GO:0006446;GO:0034063;, C:CRD-mediated mRNA stability complex; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:P-body; C:plasma membrane;, F:RNA binding; F:RNA stem-loop binding;, P:IRES-dependent viral translational initiation; P:male gonad development; P:nuclear-transcribed mRNA catabolic process, no-go decay; P:regulation of translational initiation; P:stress granule assembly;|Q9Y2S4,Cold shock domain-containing protein E1 {ECO:0000305},N-ras upstream gene protein;Protein UNR;, PF00313;PF12901;, GO:0070937;GO:0010494;GO:0005829;GO:0005794;GO:0000932;GO:0005886;GO:0003723;GO:0035613;GO:0075522;GO:0008584;GO:0070966;GO:0006446;GO:0034063;, C:CRD-mediated mRNA stability complex; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:P-body; C:plasma membrane;, F:RNA binding; F:RNA stem-loop binding;, P:IRES-dependent viral translational initiation; P:male gonad development; P:nuclear-transcribed mRNA catabolic process, no-go decay; P:regulation of translational initiation; P:stress granule assembly;|Q9Y2S4,Cold shock domain-containing protein E1 {ECO:0000305},N-ras upstream gene protein;Protein UNR;, PF00313;PF12901;, GO:0070937;GO:0010494;GO:0005829;GO:0005794;GO:0000932;GO:0005886;GO:0003723;GO:0035613;GO:0075522;GO:0008584;GO:0070966;GO:0006446;GO:0034063;, C:CRD-mediated mRNA stability complex; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:P-body; C:plasma membrane;, F:RNA binding; F:RNA stem-loop binding;, P:IRES-dependent viral translational initiation; P:male gonad development; P:nuclear-transcribed mRNA catabolic process, no-go decay; P:regulation of translational initiation; P:stress granule assembly;|Q9Y2S4,Cold shock domain-containing protein E1 {ECO:0000305},N-ras upstream gene protein;Protein UNR;, PF00313;PF12901;, GO:0070937;GO:0010494;GO:0005829;GO:0005794;GO:0000932;GO:0005886;GO:0003723;GO:0035613;GO:0075522;GO:0008584;GO:0070966;GO:0006446;GO:0034063;, C:CRD-mediated mRNA stability complex; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:P-body; C:plasma membrane;, F:RNA binding; F:RNA stem-loop binding;, P:IRES-dependent viral translational initiation; P:male gonad development; P:nuclear-transcribed mRNA catabolic process, no-go decay; P:regulation of translational initiation; P:stress granule assembly; scaffold20 indexed_genome mRNA 30407505 30416807 . + . ID=transcript_5042;P01111 Q14971 Q15104 Q15282,GTPase NRas,Transforming protein N-Ras;, PF00071;, GO:0005829;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0016020;GO:0005886;GO:0070821;GO:0019003;GO:0005525;GO:0003924;GO:0044877;GO:0000165;GO:0043312;GO:0001938;GO:0007265;GO:0002223;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:protein-containing complex binding;, P:MAPK cascade; P:neutrophil degranulation; P:positive regulation of endothelial cell proliferation; P:Ras protein signal transduction; P:stimulatory C-type lectin receptor signaling pathway;|P01111 Q14971 Q15104 Q15282,GTPase NRas,Transforming protein N-Ras;, PF00071;, GO:0005829;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0016020;GO:0005886;GO:0070821;GO:0019003;GO:0005525;GO:0003924;GO:0044877;GO:0000165;GO:0043312;GO:0001938;GO:0007265;GO:0002223;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:protein-containing complex binding;, P:MAPK cascade; P:neutrophil degranulation; P:positive regulation of endothelial cell proliferation; P:Ras protein signal transduction; P:stimulatory C-type lectin receptor signaling pathway;|P01111 Q14971 Q15104 Q15282,GTPase NRas,Transforming protein N-Ras;, PF00071;, GO:0005829;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0016020;GO:0005886;GO:0070821;GO:0019003;GO:0005525;GO:0003924;GO:0044877;GO:0000165;GO:0043312;GO:0001938;GO:0007265;GO:0002223;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:protein-containing complex binding;, P:MAPK cascade; P:neutrophil degranulation; P:positive regulation of endothelial cell proliferation; P:Ras protein signal transduction; P:stimulatory C-type lectin receptor signaling pathway; scaffold20 indexed_genome mRNA 30429979 30454188 . + . ID=transcript_5043;P23109 A8K5N4 B2RAM1 F2Z3B3 Q5TF00 Q5TF02,AMP deaminase 1,AMP deaminase isoform M;Myoadenylate deaminase;, PF00962;, GO:0005829;GO:0003876;GO:0042802;GO:0046872;GO:0032036;GO:0046033;GO:0006188;GO:0032264;GO:0043101;GO:0010033;, C:cytosol;, F:AMP deaminase activity; F:identical protein binding; F:metal ion binding; F:myosin heavy chain binding;, P:AMP metabolic process; P:IMP biosynthetic process; P:IMP salvage; P:purine-containing compound salvage; P:response to organic substance;|P23109 A8K5N4 B2RAM1 F2Z3B3 Q5TF00 Q5TF02,AMP deaminase 1,AMP deaminase isoform M;Myoadenylate deaminase;, PF00962;, GO:0005829;GO:0003876;GO:0042802;GO:0046872;GO:0032036;GO:0046033;GO:0006188;GO:0032264;GO:0043101;GO:0010033;, C:cytosol;, F:AMP deaminase activity; F:identical protein binding; F:metal ion binding; F:myosin heavy chain binding;, P:AMP metabolic process; P:IMP biosynthetic process; P:IMP salvage; P:purine-containing compound salvage; P:response to organic substance;|P23109 A8K5N4 B2RAM1 F2Z3B3 Q5TF00 Q5TF02,AMP deaminase 1,AMP deaminase isoform M;Myoadenylate deaminase;, PF00962;, GO:0005829;GO:0003876;GO:0042802;GO:0046872;GO:0032036;GO:0046033;GO:0006188;GO:0032264;GO:0043101;GO:0010033;, C:cytosol;, F:AMP deaminase activity; F:identical protein binding; F:metal ion binding; F:myosin heavy chain binding;, P:AMP metabolic process; P:IMP biosynthetic process; P:IMP salvage; P:purine-containing compound salvage; P:response to organic substance; scaffold20 indexed_genome mRNA 30455476 30542145 . - . ID=transcript_5044;Q68D51 B1AL26 Q5TCX6 Q6P3R3,DENN domain-containing protein 2C,, PF03455;PF02141;PF03456;, GO:0005654;GO:0005085;, C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;|Q68D51 B1AL26 Q5TCX6 Q6P3R3,DENN domain-containing protein 2C,, PF03455;PF02141;PF03456;, GO:0005654;GO:0005085;, C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity; scaffold20 indexed_genome mRNA 30552492 30553798 . + . ID=transcript_5045;O75934 Q6FGS0,Pre-mRNA-splicing factor SPF27,Breast carcinoma-amplified sequence 2;DNA amplified in mammary carcinoma 1 protein;Spliceosome-associated protein SPF 27;, PF05700;, GO:0071013;GO:0005813;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0000974;GO:0005681;GO:0071007;GO:0000398;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:centrosome; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, , P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold20 indexed_genome mRNA 30557185 30559211 . + . ID=transcript_5046;P62942 D3DVW6 P20071 Q4VC47 Q6FGD9 Q6LEU3 Q9H103 Q9H566,Peptidyl-prolyl cis-trans isomerase FKBP1A,12 kDa FK506-binding protein;Calstabin-1;FK506-binding protein 1A;Immunophilin FKBP12;Rotamase;, PF00254;, GO:0005737;GO:0098562;GO:0005829;GO:0031312;GO:0016020;GO:1990425;GO:0016529;GO:0014802;GO:0030018;GO:0048185;GO:0005528;GO:0044325;GO:0005527;GO:0003755;GO:0046332;GO:0005160;GO:0034713;GO:0006458;GO:1990000;GO:0070588;GO:0061077;GO:0003007;GO:0060347;GO:0032515;GO:1901393;GO:0043123;GO:0032092;GO:0031398;GO:0006457;GO:0022417;GO:0000413;GO:0042026;GO:0032925;GO:1902991;GO:0050776;GO:0032880;GO:0060314;GO:0007183;GO:0097435;GO:0042110;GO:0007179;GO:0055010;, C:cytoplasm; C:cytoplasmic side of membrane; C:cytosol; C:extrinsic component of organelle membrane; C:membrane; C:ryanodine receptor complex; C:sarcoplasmic reticulum; C:terminal cisterna; C:Z disc;, F:activin binding; F:FK506 binding; F:ion channel binding; F:macrolide binding; F:peptidyl-prolyl cis-trans isomerase activity; F:SMAD binding; F:transforming growth factor beta receptor binding; F:type I transforming growth factor beta receptor binding;, P:'de novo' protein folding; P:amyloid fibril formation; P:calcium ion transmembrane transport; P:chaperone-mediated protein folding; P:heart morphogenesis; P:heart trabecula formation; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of transforming growth factor beta1 activation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:protein folding; P:protein maturation by protein folding; P:protein peptidyl-prolyl isomerization; P:protein refolding; P:regulation of activin receptor signaling pathway; P:regulation of amyloid precursor protein catabolic process; P:regulation of immune response; P:regulation of protein localization; P:regulation of ryanodine-sensitive calcium-release channel activity; P:SMAD protein complex assembly; P:supramolecular fiber organization; P:T cell activation; P:transforming growth factor beta receptor signaling pathway; P:ventricular cardiac muscle tissue morphogenesis; scaffold20 indexed_genome mRNA 30559243 30561054 . + . ID=transcript_5047;O75934 Q6FGS0,Pre-mRNA-splicing factor SPF27,Breast carcinoma-amplified sequence 2;DNA amplified in mammary carcinoma 1 protein;Spliceosome-associated protein SPF 27;, PF05700;, GO:0071013;GO:0005813;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0000974;GO:0005681;GO:0071007;GO:0000398;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:centrosome; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, , P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold20 indexed_genome mRNA 30619175 30621288 . - . ID=transcript_5048;P99999 A4D166 B2R4I1 P00001 Q6NUR2 Q6NX69 Q96BV4,Cytochrome c,, PF00034;, GO:0005829;GO:0005743;GO:0005758;GO:0005739;GO:0005634;GO:0070469;GO:0009055;GO:0020037;GO:0046872;GO:0008635;GO:0006915;GO:0045333;GO:0034599;GO:0006123;GO:0006122;GO:0007005;GO:0043280;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus; C:respirasome;, F:electron transfer activity; F:heme binding; F:metal ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:apoptotic process; P:cellular respiration; P:cellular response to oxidative stress; P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:mitochondrion organization; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; scaffold20 indexed_genome mRNA 30628634 30766990 . + . ID=transcript_5049;Q9UPN9 O95855 Q5TG72 Q5TG73 Q5TG74 Q9C017 Q9UJ79,E3 ubiquitin-protein ligase TRIM33,Ectodermin homolog;RET-fused gene 7 protein;RING-type E3 ubiquitin transferase TRIM33 {ECO:0000305};Transcription intermediary factor 1-gamma;Tripartite motif-containing protein 33;, PF00439;PF00628;PF00643;PF13445;, GO:0005654;GO:0005634;GO:0070410;GO:0003677;GO:0070412;GO:0016740;GO:0008270;GO:0030514;GO:0000122;GO:0045892;GO:0016567;GO:0017015;, C:nucleoplasm; C:nucleus;, F:co-SMAD binding; F:DNA binding; F:R-SMAD binding; F:transferase activity; F:zinc ion binding;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9UPN9 O95855 Q5TG72 Q5TG73 Q5TG74 Q9C017 Q9UJ79,E3 ubiquitin-protein ligase TRIM33,Ectodermin homolog;RET-fused gene 7 protein;RING-type E3 ubiquitin transferase TRIM33 {ECO:0000305};Transcription intermediary factor 1-gamma;Tripartite motif-containing protein 33;, PF00439;PF00628;PF00643;PF13445;, GO:0005654;GO:0005634;GO:0070410;GO:0003677;GO:0070412;GO:0016740;GO:0008270;GO:0030514;GO:0000122;GO:0045892;GO:0016567;GO:0017015;, C:nucleoplasm; C:nucleus;, F:co-SMAD binding; F:DNA binding; F:R-SMAD binding; F:transferase activity; F:zinc ion binding;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway;|Q9UPN9 O95855 Q5TG72 Q5TG73 Q5TG74 Q9C017 Q9UJ79,E3 ubiquitin-protein ligase TRIM33,Ectodermin homolog;RET-fused gene 7 protein;RING-type E3 ubiquitin transferase TRIM33 {ECO:0000305};Transcription intermediary factor 1-gamma;Tripartite motif-containing protein 33;, PF00439;PF00628;PF00643;PF13445;, GO:0005654;GO:0005634;GO:0070410;GO:0003677;GO:0070412;GO:0016740;GO:0008270;GO:0030514;GO:0000122;GO:0045892;GO:0016567;GO:0017015;, C:nucleoplasm; C:nucleus;, F:co-SMAD binding; F:DNA binding; F:R-SMAD binding; F:transferase activity; F:zinc ion binding;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway;|Q9UPN9 O95855 Q5TG72 Q5TG73 Q5TG74 Q9C017 Q9UJ79,E3 ubiquitin-protein ligase TRIM33,Ectodermin homolog;RET-fused gene 7 protein;RING-type E3 ubiquitin transferase TRIM33 {ECO:0000305};Transcription intermediary factor 1-gamma;Tripartite motif-containing protein 33;, PF00439;PF00628;PF00643;PF13445;, GO:0005654;GO:0005634;GO:0070410;GO:0003677;GO:0070412;GO:0016740;GO:0008270;GO:0030514;GO:0000122;GO:0045892;GO:0016567;GO:0017015;, C:nucleoplasm; C:nucleus;, F:co-SMAD binding; F:DNA binding; F:R-SMAD binding; F:transferase activity; F:zinc ion binding;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway;|Q9UPN9 O95855 Q5TG72 Q5TG73 Q5TG74 Q9C017 Q9UJ79,E3 ubiquitin-protein ligase TRIM33,Ectodermin homolog;RET-fused gene 7 protein;RING-type E3 ubiquitin transferase TRIM33 {ECO:0000305};Transcription intermediary factor 1-gamma;Tripartite motif-containing protein 33;, PF00439;PF00628;PF00643;PF13445;, GO:0005654;GO:0005634;GO:0070410;GO:0003677;GO:0070412;GO:0016740;GO:0008270;GO:0030514;GO:0000122;GO:0045892;GO:0016567;GO:0017015;, C:nucleoplasm; C:nucleus;, F:co-SMAD binding; F:DNA binding; F:R-SMAD binding; F:transferase activity; F:zinc ion binding;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; scaffold20 indexed_genome mRNA 30771546 30772635 . - . ID=transcript_5050;Q14094 B2R6M0 B7Z6X4,Cyclin-I {ECO:0000305},, PF00134;, GO:0000307;GO:0005737;GO:0031965;GO:0005634;GO:0016538;GO:0044772;GO:0000079;GO:0007283;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nuclear membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis; scaffold20 indexed_genome mRNA 31075965 31082730 . + . ID=transcript_5051;Q5T7P8 B1AMB8 B3KPK1,Synaptotagmin-6,Synaptotagmin VI;, PF00168;, GO:0005829;GO:0070382;GO:0019898;GO:0098978;GO:0016021;GO:0099699;GO:0097038;GO:0005886;GO:0030672;GO:0005509;GO:0030276;GO:0001786;GO:0042803;GO:0000149;GO:0019905;GO:0060478;GO:0017156;GO:0071277;GO:0099525;GO:0017158;GO:0014059;GO:0016192;, C:cytosol; C:exocytic vesicle; C:extrinsic component of membrane; C:glutamatergic synapse; C:integral component of membrane; C:integral component of synaptic membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:clathrin binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:SNARE binding; F:syntaxin binding;, P:acrosomal vesicle exocytosis; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:presynaptic dense core vesicle exocytosis; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:vesicle-mediated transport; scaffold20 indexed_genome mRNA 31176003 31178913 . - . ID=transcript_5052;Q9NRN5 Q53FR1 Q53HV9 Q5SQL6 Q69AX9 Q8NBJ2,Olfactomedin-like protein 3,HNOEL-iso;hOLF44;, PF02191;, GO:1903561;GO:0007275;, C:extracellular vesicle;, , P:multicellular organism development; scaffold20 indexed_genome mRNA 31180613 31237062 . - . ID=transcript_5053;Q8TBZ1,Homeodomain-interacting protein kinase 1,Nuclear body-associated kinase 2;, PF00069;, GO:0005813;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0034333;GO:0009952;GO:0060216;GO:0048596;GO:0060059;GO:0072577;GO:0097191;GO:0001654;GO:0042771;GO:0061072;GO:0060235;GO:0030182;GO:0018105;GO:0018107;GO:0045766;GO:0008284;GO:0006468;GO:1901796;GO:0010803;GO:0010842;GO:0007224;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:adherens junction assembly; P:anterior/posterior pattern specification; P:definitive hemopoiesis; P:embryonic camera-type eye morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway; P:eye development; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:iris morphogenesis; P:lens induction in camera-type eye; P:neuron differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of tumor necrosis factor-mediated signaling pathway; P:retina layer formation; P:smoothened signaling pathway;|Q8TBZ1,Homeodomain-interacting protein kinase 1,Nuclear body-associated kinase 2;, PF00069;, GO:0005813;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0034333;GO:0009952;GO:0060216;GO:0048596;GO:0060059;GO:0072577;GO:0097191;GO:0001654;GO:0042771;GO:0061072;GO:0060235;GO:0030182;GO:0018105;GO:0018107;GO:0045766;GO:0008284;GO:0006468;GO:1901796;GO:0010803;GO:0010842;GO:0007224;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:adherens junction assembly; P:anterior/posterior pattern specification; P:definitive hemopoiesis; P:embryonic camera-type eye morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway; P:eye development; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:iris morphogenesis; P:lens induction in camera-type eye; P:neuron differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of tumor necrosis factor-mediated signaling pathway; P:retina layer formation; P:smoothened signaling pathway;|Q8TBZ1,Homeodomain-interacting protein kinase 1,Nuclear body-associated kinase 2;, PF00069;, GO:0005813;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0034333;GO:0009952;GO:0060216;GO:0048596;GO:0060059;GO:0072577;GO:0097191;GO:0001654;GO:0042771;GO:0061072;GO:0060235;GO:0030182;GO:0018105;GO:0018107;GO:0045766;GO:0008284;GO:0006468;GO:1901796;GO:0010803;GO:0010842;GO:0007224;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:adherens junction assembly; P:anterior/posterior pattern specification; P:definitive hemopoiesis; P:embryonic camera-type eye morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway; P:eye development; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:iris morphogenesis; P:lens induction in camera-type eye; P:neuron differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of tumor necrosis factor-mediated signaling pathway; P:retina layer formation; P:smoothened signaling pathway;|Q8TBZ1,Homeodomain-interacting protein kinase 1,Nuclear body-associated kinase 2;, PF00069;, GO:0005813;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0034333;GO:0009952;GO:0060216;GO:0048596;GO:0060059;GO:0072577;GO:0097191;GO:0001654;GO:0042771;GO:0061072;GO:0060235;GO:0030182;GO:0018105;GO:0018107;GO:0045766;GO:0008284;GO:0006468;GO:1901796;GO:0010803;GO:0010842;GO:0007224;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:adherens junction assembly; P:anterior/posterior pattern specification; P:definitive hemopoiesis; P:embryonic camera-type eye morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway; P:eye development; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:iris morphogenesis; P:lens induction in camera-type eye; P:neuron differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of tumor necrosis factor-mediated signaling pathway; P:retina layer formation; P:smoothened signaling pathway;|Q8TBZ1,Homeodomain-interacting protein kinase 1,Nuclear body-associated kinase 2;, PF00069;, GO:0005813;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0034333;GO:0009952;GO:0060216;GO:0048596;GO:0060059;GO:0072577;GO:0097191;GO:0001654;GO:0042771;GO:0061072;GO:0060235;GO:0030182;GO:0018105;GO:0018107;GO:0045766;GO:0008284;GO:0006468;GO:1901796;GO:0010803;GO:0010842;GO:0007224;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:adherens junction assembly; P:anterior/posterior pattern specification; P:definitive hemopoiesis; P:embryonic camera-type eye morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:endothelial cell apoptotic process; P:extrinsic apoptotic signaling pathway; P:eye development; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:iris morphogenesis; P:lens induction in camera-type eye; P:neuron differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of tumor necrosis factor-mediated signaling pathway; P:retina layer formation; P:smoothened signaling pathway; scaffold20 indexed_genome mRNA 31257197 31321015 . + . ID=transcript_5054;Q9H816 Q9H9E5,5' exonuclease Apollo,DNA cross-link repair 1B protein;SNM1 homolog B;, PF07522;, GO:0005813;GO:0000781;GO:0005737;GO:0016604;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0042803;GO:0044877;GO:0006303;GO:0036297;GO:0007093;GO:0031848;GO:0016233;GO:0000723;GO:0010833;GO:0031860;GO:0031627;, C:centrosome; C:chromosome, telomeric region; C:cytoplasm; C:nuclear body; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:mitotic cell cycle checkpoint; P:protection from non-homologous end joining at telomere; P:telomere capping; P:telomere maintenance; P:telomere maintenance via telomere lengthening; P:telomeric 3' overhang formation; P:telomeric loop formation;|Q9H816 Q9H9E5,5' exonuclease Apollo,DNA cross-link repair 1B protein;SNM1 homolog B;, PF07522;, GO:0005813;GO:0000781;GO:0005737;GO:0016604;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0042803;GO:0044877;GO:0006303;GO:0036297;GO:0007093;GO:0031848;GO:0016233;GO:0000723;GO:0010833;GO:0031860;GO:0031627;, C:centrosome; C:chromosome, telomeric region; C:cytoplasm; C:nuclear body; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:mitotic cell cycle checkpoint; P:protection from non-homologous end joining at telomere; P:telomere capping; P:telomere maintenance; P:telomere maintenance via telomere lengthening; P:telomeric 3' overhang formation; P:telomeric loop formation;|Q9Y6B7 B7Z4X3 Q59EJ4 Q96CL6,AP-4 complex subunit beta-1 {ECO:0000305},AP-4 adaptor complex subunit beta;Adaptor-related protein complex 4 subunit beta-1;Beta subunit of AP-4;Beta4-adaptin;, PF01602;PF09066;, GO:0030124;GO:0030131;GO:0005829;GO:0031904;GO:0019898;GO:0005802;GO:0032588;GO:0030276;GO:0006892;GO:0008104;GO:0006605;GO:0016192;, C:AP-4 adaptor complex; C:clathrin adaptor complex; C:cytosol; C:endosome lumen; C:extrinsic component of membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:clathrin binding;, P:post-Golgi vesicle-mediated transport; P:protein localization; P:protein targeting; P:vesicle-mediated transport;|Q9Y6B7 B7Z4X3 Q59EJ4 Q96CL6,AP-4 complex subunit beta-1 {ECO:0000305},AP-4 adaptor complex subunit beta;Adaptor-related protein complex 4 subunit beta-1;Beta subunit of AP-4;Beta4-adaptin;, PF01602;PF09066;, GO:0030124;GO:0030131;GO:0005829;GO:0031904;GO:0019898;GO:0005802;GO:0032588;GO:0030276;GO:0006892;GO:0008104;GO:0006605;GO:0016192;, C:AP-4 adaptor complex; C:clathrin adaptor complex; C:cytosol; C:endosome lumen; C:extrinsic component of membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:clathrin binding;, P:post-Golgi vesicle-mediated transport; P:protein localization; P:protein targeting; P:vesicle-mediated transport;|Q5TBC7 A0PJY6 A8K074 I6LA82,Bcl-2-like protein 15,, , GO:0005829;GO:0005634;GO:0006915;GO:0042981;, C:cytosol; C:nucleus;, , P:apoptotic process; P:regulation of apoptotic process; scaffold20 indexed_genome mRNA 31332865 31349018 . - . ID=transcript_5055;Q8WVM1,Tyrosine-protein phosphatase non-receptor type 22,Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP;Lymphoid phosphatase;PEST-domain phosphatase;, PF00102;, GO:0005737;GO:0009898;GO:0005829;GO:0005634;GO:0048471;GO:0019900;GO:0004726;GO:0016791;GO:0004725;GO:0017124;GO:0031625;GO:0006914;GO:0071225;GO:0031663;GO:0010507;GO:0010629;GO:0032715;GO:0032717;GO:0043508;GO:0070433;GO:1903753;GO:0050868;GO:0050860;GO:0032720;GO:0035335;GO:0035644;GO:2000566;GO:0002230;GO:0070374;GO:0010628;GO:0071663;GO:0032729;GO:1902523;GO:0034141;GO:0034145;GO:0034157;GO:0034165;GO:0032481;GO:0006470;GO:0050855;GO:0045088;GO:0032817;GO:1901222;GO:0032496;GO:0030217;GO:0050852;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:nucleus; C:perinuclear region of cytoplasm;, F:kinase binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:phosphatase activity; F:protein tyrosine phosphatase activity; F:SH3 domain binding; F:ubiquitin protein ligase binding;, P:autophagy; P:cellular response to muramyl dipeptide; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of autophagy; P:negative regulation of gene expression; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of JUN kinase activity; P:negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:negative regulation of p38MAPK cascade; P:negative regulation of T cell activation; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:peptidyl-tyrosine dephosphorylation; P:phosphoanandamide dephosphorylation; P:positive regulation of CD8-positive, alpha-beta T cell proliferation; P:positive regulation of defense response to virus by host; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of granzyme B production; P:positive regulation of interferon-gamma production; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 9 signaling pathway; P:positive regulation of type I interferon production; P:protein dephosphorylation; P:regulation of B cell receptor signaling pathway; P:regulation of innate immune response; P:regulation of natural killer cell proliferation; P:regulation of NIK/NF-kappaB signaling; P:response to lipopolysaccharide; P:T cell differentiation; P:T cell receptor signaling pathway;|Q8WVM1,Tyrosine-protein phosphatase non-receptor type 22,Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP;Lymphoid phosphatase;PEST-domain phosphatase;, PF00102;, GO:0005737;GO:0009898;GO:0005829;GO:0005634;GO:0048471;GO:0019900;GO:0004726;GO:0016791;GO:0004725;GO:0017124;GO:0031625;GO:0006914;GO:0071225;GO:0031663;GO:0010507;GO:0010629;GO:0032715;GO:0032717;GO:0043508;GO:0070433;GO:1903753;GO:0050868;GO:0050860;GO:0032720;GO:0035335;GO:0035644;GO:2000566;GO:0002230;GO:0070374;GO:0010628;GO:0071663;GO:0032729;GO:1902523;GO:0034141;GO:0034145;GO:0034157;GO:0034165;GO:0032481;GO:0006470;GO:0050855;GO:0045088;GO:0032817;GO:1901222;GO:0032496;GO:0030217;GO:0050852;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:nucleus; C:perinuclear region of cytoplasm;, F:kinase binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:phosphatase activity; F:protein tyrosine phosphatase activity; F:SH3 domain binding; F:ubiquitin protein ligase binding;, P:autophagy; P:cellular response to muramyl dipeptide; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of autophagy; P:negative regulation of gene expression; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of JUN kinase activity; P:negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:negative regulation of p38MAPK cascade; P:negative regulation of T cell activation; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:peptidyl-tyrosine dephosphorylation; P:phosphoanandamide dephosphorylation; P:positive regulation of CD8-positive, alpha-beta T cell proliferation; P:positive regulation of defense response to virus by host; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of granzyme B production; P:positive regulation of interferon-gamma production; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 9 signaling pathway; P:positive regulation of type I interferon production; P:protein dephosphorylation; P:regulation of B cell receptor signaling pathway; P:regulation of innate immune response; P:regulation of natural killer cell proliferation; P:regulation of NIK/NF-kappaB signaling; P:response to lipopolysaccharide; P:T cell differentiation; P:T cell receptor signaling pathway; scaffold20 indexed_genome mRNA 31351071 31390471 . + . ID=transcript_5056;Q5VWQ0 A8K937 Q6AI21 Q8TC33 Q9HA80 Q9NUP6,Lysine-specific demethylase 9 {ECO:0000250|UniProtKB:Q80T69},Round spermatid basic protein 1;, , GO:0005634;GO:0051213;GO:0046872;GO:0006325;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;, P:chromatin organization;|Q5VWQ0 A8K937 Q6AI21 Q8TC33 Q9HA80 Q9NUP6,Lysine-specific demethylase 9 {ECO:0000250|UniProtKB:Q80T69},Round spermatid basic protein 1;, , GO:0005634;GO:0051213;GO:0046872;GO:0006325;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;, P:chromatin organization;|Q5VWQ0 A8K937 Q6AI21 Q8TC33 Q9HA80 Q9NUP6,Lysine-specific demethylase 9 {ECO:0000250|UniProtKB:Q80T69},Round spermatid basic protein 1;, , GO:0005634;GO:0051213;GO:0046872;GO:0006325;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;, P:chromatin organization;|Q5VWQ0 A8K937 Q6AI21 Q8TC33 Q9HA80 Q9NUP6,Lysine-specific demethylase 9 {ECO:0000250|UniProtKB:Q80T69},Round spermatid basic protein 1;, , GO:0005634;GO:0051213;GO:0046872;GO:0006325;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;, P:chromatin organization;|Q5VWQ0 A8K937 Q6AI21 Q8TC33 Q9HA80 Q9NUP6,Lysine-specific demethylase 9 {ECO:0000250|UniProtKB:Q80T69},Round spermatid basic protein 1;, , GO:0005634;GO:0051213;GO:0046872;GO:0006325;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;, P:chromatin organization;|Q5VWQ0 A8K937 Q6AI21 Q8TC33 Q9HA80 Q9NUP6,Lysine-specific demethylase 9 {ECO:0000250|UniProtKB:Q80T69},Round spermatid basic protein 1;, , GO:0005634;GO:0051213;GO:0046872;GO:0006325;, C:nucleus;, F:dioxygenase activity; F:metal ion binding;, P:chromatin organization; scaffold20 indexed_genome mRNA 31396184 31465464 . + . ID=transcript_5057;Q9UMS5 Q5VWP7 Q5VWP8 Q9BUP2 Q9H1X8,Protein PHTF1 {ECO:0000305},, PF12129;, GO:0005801;GO:0005789;GO:0016021;, C:cis-Golgi network; C:endoplasmic reticulum membrane; C:integral component of membrane; scaffold20 indexed_genome mRNA 31471540 31725592 . - . ID=transcript_5058;Q9HCD8,Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3,Membrane-associated guanylate kinase inverted 3;, PF00625;PF00595;PF00397;, GO:0005923;GO:0030054;GO:0005911;GO:0005737;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0004385;GO:0060090;GO:0006915;GO:0035556;GO:0046328;GO:0007165;GO:0016032;, C:bicellular tight junction; C:cell junction; C:cell-cell junction; C:cytoplasm; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:guanylate kinase activity; F:molecular adaptor activity;, P:apoptotic process; P:intracellular signal transduction; P:regulation of JNK cascade; P:signal transduction; P:viral process;|Q9HCD8,Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3,Membrane-associated guanylate kinase inverted 3;, PF00625;PF00595;PF00397;, GO:0005923;GO:0030054;GO:0005911;GO:0005737;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0004385;GO:0060090;GO:0006915;GO:0035556;GO:0046328;GO:0007165;GO:0016032;, C:bicellular tight junction; C:cell junction; C:cell-cell junction; C:cytoplasm; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:guanylate kinase activity; F:molecular adaptor activity;, P:apoptotic process; P:intracellular signal transduction; P:regulation of JNK cascade; P:signal transduction; P:viral process;|Q9HCD8,Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3,Membrane-associated guanylate kinase inverted 3;, PF00625;PF00595;PF00397;, GO:0005923;GO:0030054;GO:0005911;GO:0005737;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0004385;GO:0060090;GO:0006915;GO:0035556;GO:0046328;GO:0007165;GO:0016032;, C:bicellular tight junction; C:cell junction; C:cell-cell junction; C:cytoplasm; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:guanylate kinase activity; F:molecular adaptor activity;, P:apoptotic process; P:intracellular signal transduction; P:regulation of JNK cascade; P:signal transduction; P:viral process; scaffold20 indexed_genome mRNA 31966214 32021163 . + . ID=transcript_5059;O94898 Q9NSN2,Leucine-rich repeats and immunoglobulin-like domains protein 2,, PF07679;PF13855;PF01463;, GO:0005737;GO:0031012;GO:0005615;GO:0030426;GO:0016021;GO:0097708;GO:0043025;GO:0005886;GO:0005102;GO:0060384;GO:0048681;GO:0051045;GO:2000010;GO:2001222;GO:0010640;GO:0007605;, C:cytoplasm; C:extracellular matrix; C:extracellular space; C:growth cone; C:integral component of membrane; C:intracellular vesicle; C:neuronal cell body; C:plasma membrane;, F:signaling receptor binding;, P:innervation; P:negative regulation of axon regeneration; P:negative regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein localization to cell surface; P:regulation of neuron migration; P:regulation of platelet-derived growth factor receptor signaling pathway; P:sensory perception of sound;|O94898 Q9NSN2,Leucine-rich repeats and immunoglobulin-like domains protein 2,, PF07679;PF13855;PF01463;, GO:0005737;GO:0031012;GO:0005615;GO:0030426;GO:0016021;GO:0097708;GO:0043025;GO:0005886;GO:0005102;GO:0060384;GO:0048681;GO:0051045;GO:2000010;GO:2001222;GO:0010640;GO:0007605;, C:cytoplasm; C:extracellular matrix; C:extracellular space; C:growth cone; C:integral component of membrane; C:intracellular vesicle; C:neuronal cell body; C:plasma membrane;, F:signaling receptor binding;, P:innervation; P:negative regulation of axon regeneration; P:negative regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein localization to cell surface; P:regulation of neuron migration; P:regulation of platelet-derived growth factor receptor signaling pathway; P:sensory perception of sound;|O94898 Q9NSN2,Leucine-rich repeats and immunoglobulin-like domains protein 2,, PF07679;PF13855;PF01463;, GO:0005737;GO:0031012;GO:0005615;GO:0030426;GO:0016021;GO:0097708;GO:0043025;GO:0005886;GO:0005102;GO:0060384;GO:0048681;GO:0051045;GO:2000010;GO:2001222;GO:0010640;GO:0007605;, C:cytoplasm; C:extracellular matrix; C:extracellular space; C:growth cone; C:integral component of membrane; C:intracellular vesicle; C:neuronal cell body; C:plasma membrane;, F:signaling receptor binding;, P:innervation; P:negative regulation of axon regeneration; P:negative regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein localization to cell surface; P:regulation of neuron migration; P:regulation of platelet-derived growth factor receptor signaling pathway; P:sensory perception of sound;|O94898 Q9NSN2,Leucine-rich repeats and immunoglobulin-like domains protein 2,, PF07679;PF13855;PF01463;, GO:0005737;GO:0031012;GO:0005615;GO:0030426;GO:0016021;GO:0097708;GO:0043025;GO:0005886;GO:0005102;GO:0060384;GO:0048681;GO:0051045;GO:2000010;GO:2001222;GO:0010640;GO:0007605;, C:cytoplasm; C:extracellular matrix; C:extracellular space; C:growth cone; C:integral component of membrane; C:intracellular vesicle; C:neuronal cell body; C:plasma membrane;, F:signaling receptor binding;, P:innervation; P:negative regulation of axon regeneration; P:negative regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein localization to cell surface; P:regulation of neuron migration; P:regulation of platelet-derived growth factor receptor signaling pathway; P:sensory perception of sound;|O94898 Q9NSN2,Leucine-rich repeats and immunoglobulin-like domains protein 2,, PF07679;PF13855;PF01463;, GO:0005737;GO:0031012;GO:0005615;GO:0030426;GO:0016021;GO:0097708;GO:0043025;GO:0005886;GO:0005102;GO:0060384;GO:0048681;GO:0051045;GO:2000010;GO:2001222;GO:0010640;GO:0007605;, C:cytoplasm; C:extracellular matrix; C:extracellular space; C:growth cone; C:integral component of membrane; C:intracellular vesicle; C:neuronal cell body; C:plasma membrane;, F:signaling receptor binding;, P:innervation; P:negative regulation of axon regeneration; P:negative regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein localization to cell surface; P:regulation of neuron migration; P:regulation of platelet-derived growth factor receptor signaling pathway; P:sensory perception of sound;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|O94898 Q9NSN2,Leucine-rich repeats and immunoglobulin-like domains protein 2,, PF07679;PF13855;PF01463;, GO:0005737;GO:0031012;GO:0005615;GO:0030426;GO:0016021;GO:0097708;GO:0043025;GO:0005886;GO:0005102;GO:0060384;GO:0048681;GO:0051045;GO:2000010;GO:2001222;GO:0010640;GO:0007605;, C:cytoplasm; C:extracellular matrix; C:extracellular space; C:growth cone; C:integral component of membrane; C:intracellular vesicle; C:neuronal cell body; C:plasma membrane;, F:signaling receptor binding;, P:innervation; P:negative regulation of axon regeneration; P:negative regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein localization to cell surface; P:regulation of neuron migration; P:regulation of platelet-derived growth factor receptor signaling pathway; P:sensory perception of sound; scaffold20 indexed_genome mRNA 32127422 32157621 . + . ID=transcript_5060;P53985 Q49A45 Q5T8R6 Q9NSJ9,Monocarboxylate transporter 1,Solute carrier family 16 member 1;, PF07690;, GO:0016324;GO:0009925;GO:0016323;GO:0030054;GO:0005813;GO:0070062;GO:0016021;GO:0005887;GO:0043231;GO:0016328;GO:0016020;GO:0005886;GO:0045202;GO:0046943;GO:0042802;GO:0015129;GO:0015130;GO:0008028;GO:0097159;GO:0015293;GO:0051780;GO:1905039;GO:0071407;GO:0007098;GO:0042593;GO:0050900;GO:0006629;GO:0015728;GO:0015718;GO:0035879;GO:0006090;GO:0050796;GO:0032094;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell junction; C:centrosome; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lateral plasma membrane; C:membrane; C:plasma membrane; C:synapse;, F:carboxylic acid transmembrane transporter activity; F:identical protein binding; F:lactate transmembrane transporter activity; F:mevalonate transmembrane transporter activity; F:monocarboxylic acid transmembrane transporter activity; F:organic cyclic compound binding; F:symporter activity;, P:behavioral response to nutrient; P:carboxylic acid transmembrane transport; P:cellular response to organic cyclic compound; P:centrosome cycle; P:glucose homeostasis; P:leukocyte migration; P:lipid metabolic process; P:mevalonate transport; P:monocarboxylic acid transport; P:plasma membrane lactate transport; P:pyruvate metabolic process; P:regulation of insulin secretion; P:response to food; P:transport across blood-brain barrier;|P53985 Q49A45 Q5T8R6 Q9NSJ9,Monocarboxylate transporter 1,Solute carrier family 16 member 1;, PF07690;, GO:0016324;GO:0009925;GO:0016323;GO:0030054;GO:0005813;GO:0070062;GO:0016021;GO:0005887;GO:0043231;GO:0016328;GO:0016020;GO:0005886;GO:0045202;GO:0046943;GO:0042802;GO:0015129;GO:0015130;GO:0008028;GO:0097159;GO:0015293;GO:0051780;GO:1905039;GO:0071407;GO:0007098;GO:0042593;GO:0050900;GO:0006629;GO:0015728;GO:0015718;GO:0035879;GO:0006090;GO:0050796;GO:0032094;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell junction; C:centrosome; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lateral plasma membrane; C:membrane; C:plasma membrane; C:synapse;, F:carboxylic acid transmembrane transporter activity; F:identical protein binding; F:lactate transmembrane transporter activity; F:mevalonate transmembrane transporter activity; F:monocarboxylic acid transmembrane transporter activity; F:organic cyclic compound binding; F:symporter activity;, P:behavioral response to nutrient; P:carboxylic acid transmembrane transport; P:cellular response to organic cyclic compound; P:centrosome cycle; P:glucose homeostasis; P:leukocyte migration; P:lipid metabolic process; P:mevalonate transport; P:monocarboxylic acid transport; P:plasma membrane lactate transport; P:pyruvate metabolic process; P:regulation of insulin secretion; P:response to food; P:transport across blood-brain barrier; scaffold20 indexed_genome mRNA 32233516 32264625 . + . ID=transcript_5061;P53985 Q49A45 Q5T8R6 Q9NSJ9,Monocarboxylate transporter 1,Solute carrier family 16 member 1;, PF07690;, GO:0016324;GO:0009925;GO:0016323;GO:0030054;GO:0005813;GO:0070062;GO:0016021;GO:0005887;GO:0043231;GO:0016328;GO:0016020;GO:0005886;GO:0045202;GO:0046943;GO:0042802;GO:0015129;GO:0015130;GO:0008028;GO:0097159;GO:0015293;GO:0051780;GO:1905039;GO:0071407;GO:0007098;GO:0042593;GO:0050900;GO:0006629;GO:0015728;GO:0015718;GO:0035879;GO:0006090;GO:0050796;GO:0032094;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell junction; C:centrosome; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lateral plasma membrane; C:membrane; C:plasma membrane; C:synapse;, F:carboxylic acid transmembrane transporter activity; F:identical protein binding; F:lactate transmembrane transporter activity; F:mevalonate transmembrane transporter activity; F:monocarboxylic acid transmembrane transporter activity; F:organic cyclic compound binding; F:symporter activity;, P:behavioral response to nutrient; P:carboxylic acid transmembrane transport; P:cellular response to organic cyclic compound; P:centrosome cycle; P:glucose homeostasis; P:leukocyte migration; P:lipid metabolic process; P:mevalonate transport; P:monocarboxylic acid transport; P:plasma membrane lactate transport; P:pyruvate metabolic process; P:regulation of insulin secretion; P:response to food; P:transport across blood-brain barrier;|O60669 Q8NEM3 Q9UPB3,Monocarboxylate transporter 2,Solute carrier family 16 member 7;, PF07690;, GO:0016021;GO:0005887;GO:0005654;GO:0005886;GO:0015129;GO:0008028;GO:0005477;GO:0050833;GO:0015293;GO:0035873;GO:0015718;GO:1901475;GO:0150104;, C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:lactate transmembrane transporter activity; F:monocarboxylic acid transmembrane transporter activity; F:pyruvate secondary active transmembrane transporter activity; F:pyruvate transmembrane transporter activity; F:symporter activity;, P:lactate transmembrane transport; P:monocarboxylic acid transport; P:pyruvate transmembrane transport; P:transport across blood-brain barrier;|P53985 Q49A45 Q5T8R6 Q9NSJ9,Monocarboxylate transporter 1,Solute carrier family 16 member 1;, PF07690;, GO:0016324;GO:0009925;GO:0016323;GO:0030054;GO:0005813;GO:0070062;GO:0016021;GO:0005887;GO:0043231;GO:0016328;GO:0016020;GO:0005886;GO:0045202;GO:0046943;GO:0042802;GO:0015129;GO:0015130;GO:0008028;GO:0097159;GO:0015293;GO:0051780;GO:1905039;GO:0071407;GO:0007098;GO:0042593;GO:0050900;GO:0006629;GO:0015728;GO:0015718;GO:0035879;GO:0006090;GO:0050796;GO:0032094;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell junction; C:centrosome; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lateral plasma membrane; C:membrane; C:plasma membrane; C:synapse;, F:carboxylic acid transmembrane transporter activity; F:identical protein binding; F:lactate transmembrane transporter activity; F:mevalonate transmembrane transporter activity; F:monocarboxylic acid transmembrane transporter activity; F:organic cyclic compound binding; F:symporter activity;, P:behavioral response to nutrient; P:carboxylic acid transmembrane transport; P:cellular response to organic cyclic compound; P:centrosome cycle; P:glucose homeostasis; P:leukocyte migration; P:lipid metabolic process; P:mevalonate transport; P:monocarboxylic acid transport; P:plasma membrane lactate transport; P:pyruvate metabolic process; P:regulation of insulin secretion; P:response to food; P:transport across blood-brain barrier; scaffold20 indexed_genome mRNA 32327531 32337261 . - . ID=transcript_5062;Q7Z5A8 B7ZLU0 Q2M1P9 Q7Z5A6,Chemokine-like protein TAFA-3 {ECO:0000305},, PF12020;, GO:0005615;GO:0048018;GO:1903979;GO:0014016;GO:1903980;GO:1902692;, C:extracellular space;, F:receptor ligand activity;, P:negative regulation of microglial cell activation; P:neuroblast differentiation; P:positive regulation of microglial cell activation; P:regulation of neuroblast proliferation; scaffold20 indexed_genome mRNA 32340362 32346061 . + . ID=transcript_5063;Q5JR12 B3KSB7 Q6DKJ7 Q96EZ7 Q9UF84,Protein phosphatase 1J,Protein phosphatase 2C isoform zeta;, PF00481;, GO:0004724;GO:0106306;GO:0106307;GO:0006470;, , F:magnesium-dependent protein serine/threonine phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation; scaffold20 indexed_genome mRNA 32348872 32355292 . + . ID=transcript_5064;P08134 B3KSW1 Q6ICN3,Rho-related GTP-binding protein RhoC,Rho cDNA clone 9;, PF00071;, GO:0005938;GO:0042995;GO:0032154;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0043005;GO:0005886;GO:0032420;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0043297;GO:0016477;GO:0030865;GO:0007163;GO:0007186;GO:0000281;GO:0030335;GO:0043123;GO:0060193;GO:0031334;GO:0051496;GO:0032956;GO:0008360;GO:0051056;GO:1902766;GO:0007264;GO:0044319;, C:cell cortex; C:cell projection; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:neuron projection; C:plasma membrane; C:stereocilium;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:apical junction assembly; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:G protein-coupled receptor signaling pathway; P:mitotic cytokinesis; P:positive regulation of cell migration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of lipase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:skeletal muscle satellite cell migration; P:small GTPase mediated signal transduction; P:wound healing, spreading of cells;|P08134 B3KSW1 Q6ICN3,Rho-related GTP-binding protein RhoC,Rho cDNA clone 9;, PF00071;, GO:0005938;GO:0042995;GO:0032154;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0043005;GO:0005886;GO:0032420;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0043297;GO:0016477;GO:0030865;GO:0007163;GO:0007186;GO:0000281;GO:0030335;GO:0043123;GO:0060193;GO:0031334;GO:0051496;GO:0032956;GO:0008360;GO:0051056;GO:1902766;GO:0007264;GO:0044319;, C:cell cortex; C:cell projection; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:neuron projection; C:plasma membrane; C:stereocilium;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:apical junction assembly; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:G protein-coupled receptor signaling pathway; P:mitotic cytokinesis; P:positive regulation of cell migration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of lipase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:skeletal muscle satellite cell migration; P:small GTPase mediated signal transduction; P:wound healing, spreading of cells;|P08134 B3KSW1 Q6ICN3,Rho-related GTP-binding protein RhoC,Rho cDNA clone 9;, PF00071;, GO:0005938;GO:0042995;GO:0032154;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0043005;GO:0005886;GO:0032420;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0043297;GO:0016477;GO:0030865;GO:0007163;GO:0007186;GO:0000281;GO:0030335;GO:0043123;GO:0060193;GO:0031334;GO:0051496;GO:0032956;GO:0008360;GO:0051056;GO:1902766;GO:0007264;GO:0044319;, C:cell cortex; C:cell projection; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:neuron projection; C:plasma membrane; C:stereocilium;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:apical junction assembly; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:G protein-coupled receptor signaling pathway; P:mitotic cytokinesis; P:positive regulation of cell migration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of lipase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:skeletal muscle satellite cell migration; P:small GTPase mediated signal transduction; P:wound healing, spreading of cells;|P08134 B3KSW1 Q6ICN3,Rho-related GTP-binding protein RhoC,Rho cDNA clone 9;, PF00071;, GO:0005938;GO:0042995;GO:0032154;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0043005;GO:0005886;GO:0032420;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0043297;GO:0016477;GO:0030865;GO:0007163;GO:0007186;GO:0000281;GO:0030335;GO:0043123;GO:0060193;GO:0031334;GO:0051496;GO:0032956;GO:0008360;GO:0051056;GO:1902766;GO:0007264;GO:0044319;, C:cell cortex; C:cell projection; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:neuron projection; C:plasma membrane; C:stereocilium;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:apical junction assembly; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:G protein-coupled receptor signaling pathway; P:mitotic cytokinesis; P:positive regulation of cell migration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of lipase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of stress fiber assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:skeletal muscle satellite cell migration; P:small GTPase mediated signal transduction; P:wound healing, spreading of cells; scaffold20 indexed_genome mRNA 32355709 32357699 . - . ID=transcript_5065;Q9HCE1 Q5JR03 Q8TEF0 Q9BSY3 Q9BUJ9,Helicase MOV-10 {ECO:0000305},Armitage homolog {ECO:0000303|PubMed:17507929};Moloney leukemia virus 10 protein;, PF13087;, GO:0036464;GO:0010494;GO:0005829;GO:0005615;GO:0005634;GO:0043186;GO:0000932;GO:0032574;GO:0005524;GO:0003723;GO:0061158;GO:0051607;GO:0035195;GO:0030522;GO:0035279;GO:0010629;GO:0010526;GO:0010628;GO:0061014;GO:0035194;GO:0045652;GO:0150011;GO:0060260;GO:0016032;GO:0007223;, C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:extracellular space; C:nucleus; C:P granule; C:P-body;, F:5'-3' RNA helicase activity; F:ATP binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:defense response to virus; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:mRNA cleavage involved in gene silencing by miRNA; P:negative regulation of gene expression; P:negative regulation of transposition, RNA-mediated; P:positive regulation of gene expression; P:positive regulation of mRNA catabolic process; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of neuron projection arborization; P:regulation of transcription initiation from RNA polymerase II promoter; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCE1 Q5JR03 Q8TEF0 Q9BSY3 Q9BUJ9,Helicase MOV-10 {ECO:0000305},Armitage homolog {ECO:0000303|PubMed:17507929};Moloney leukemia virus 10 protein;, PF13087;, GO:0036464;GO:0010494;GO:0005829;GO:0005615;GO:0005634;GO:0043186;GO:0000932;GO:0032574;GO:0005524;GO:0003723;GO:0061158;GO:0051607;GO:0035195;GO:0030522;GO:0035279;GO:0010629;GO:0010526;GO:0010628;GO:0061014;GO:0035194;GO:0045652;GO:0150011;GO:0060260;GO:0016032;GO:0007223;, C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:extracellular space; C:nucleus; C:P granule; C:P-body;, F:5'-3' RNA helicase activity; F:ATP binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:defense response to virus; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:mRNA cleavage involved in gene silencing by miRNA; P:negative regulation of gene expression; P:negative regulation of transposition, RNA-mediated; P:positive regulation of gene expression; P:positive regulation of mRNA catabolic process; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of neuron projection arborization; P:regulation of transcription initiation from RNA polymerase II promoter; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCE1 Q5JR03 Q8TEF0 Q9BSY3 Q9BUJ9,Helicase MOV-10 {ECO:0000305},Armitage homolog {ECO:0000303|PubMed:17507929};Moloney leukemia virus 10 protein;, PF13087;, GO:0036464;GO:0010494;GO:0005829;GO:0005615;GO:0005634;GO:0043186;GO:0000932;GO:0032574;GO:0005524;GO:0003723;GO:0061158;GO:0051607;GO:0035195;GO:0030522;GO:0035279;GO:0010629;GO:0010526;GO:0010628;GO:0061014;GO:0035194;GO:0045652;GO:0150011;GO:0060260;GO:0016032;GO:0007223;, C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:extracellular space; C:nucleus; C:P granule; C:P-body;, F:5'-3' RNA helicase activity; F:ATP binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:defense response to virus; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:mRNA cleavage involved in gene silencing by miRNA; P:negative regulation of gene expression; P:negative regulation of transposition, RNA-mediated; P:positive regulation of gene expression; P:positive regulation of mRNA catabolic process; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of neuron projection arborization; P:regulation of transcription initiation from RNA polymerase II promoter; P:viral process; P:Wnt signaling pathway, calcium modulating pathway; scaffold20 indexed_genome mRNA 32358079 32382297 . - . ID=transcript_5066;Q9HCE1 Q5JR03 Q8TEF0 Q9BSY3 Q9BUJ9,Helicase MOV-10 {ECO:0000305},Armitage homolog {ECO:0000303|PubMed:17507929};Moloney leukemia virus 10 protein;, PF13087;, GO:0036464;GO:0010494;GO:0005829;GO:0005615;GO:0005634;GO:0043186;GO:0000932;GO:0032574;GO:0005524;GO:0003723;GO:0061158;GO:0051607;GO:0035195;GO:0030522;GO:0035279;GO:0010629;GO:0010526;GO:0010628;GO:0061014;GO:0035194;GO:0045652;GO:0150011;GO:0060260;GO:0016032;GO:0007223;, C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:extracellular space; C:nucleus; C:P granule; C:P-body;, F:5'-3' RNA helicase activity; F:ATP binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:defense response to virus; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:mRNA cleavage involved in gene silencing by miRNA; P:negative regulation of gene expression; P:negative regulation of transposition, RNA-mediated; P:positive regulation of gene expression; P:positive regulation of mRNA catabolic process; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of neuron projection arborization; P:regulation of transcription initiation from RNA polymerase II promoter; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCE1 Q5JR03 Q8TEF0 Q9BSY3 Q9BUJ9,Helicase MOV-10 {ECO:0000305},Armitage homolog {ECO:0000303|PubMed:17507929};Moloney leukemia virus 10 protein;, PF13087;, GO:0036464;GO:0010494;GO:0005829;GO:0005615;GO:0005634;GO:0043186;GO:0000932;GO:0032574;GO:0005524;GO:0003723;GO:0061158;GO:0051607;GO:0035195;GO:0030522;GO:0035279;GO:0010629;GO:0010526;GO:0010628;GO:0061014;GO:0035194;GO:0045652;GO:0150011;GO:0060260;GO:0016032;GO:0007223;, C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:extracellular space; C:nucleus; C:P granule; C:P-body;, F:5'-3' RNA helicase activity; F:ATP binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:defense response to virus; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:mRNA cleavage involved in gene silencing by miRNA; P:negative regulation of gene expression; P:negative regulation of transposition, RNA-mediated; P:positive regulation of gene expression; P:positive regulation of mRNA catabolic process; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of neuron projection arborization; P:regulation of transcription initiation from RNA polymerase II promoter; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCE1 Q5JR03 Q8TEF0 Q9BSY3 Q9BUJ9,Helicase MOV-10 {ECO:0000305},Armitage homolog {ECO:0000303|PubMed:17507929};Moloney leukemia virus 10 protein;, PF13087;, GO:0036464;GO:0010494;GO:0005829;GO:0005615;GO:0005634;GO:0043186;GO:0000932;GO:0032574;GO:0005524;GO:0003723;GO:0061158;GO:0051607;GO:0035195;GO:0030522;GO:0035279;GO:0010629;GO:0010526;GO:0010628;GO:0061014;GO:0035194;GO:0045652;GO:0150011;GO:0060260;GO:0016032;GO:0007223;, C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:extracellular space; C:nucleus; C:P granule; C:P-body;, F:5'-3' RNA helicase activity; F:ATP binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:defense response to virus; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:mRNA cleavage involved in gene silencing by miRNA; P:negative regulation of gene expression; P:negative regulation of transposition, RNA-mediated; P:positive regulation of gene expression; P:positive regulation of mRNA catabolic process; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of neuron projection arborization; P:regulation of transcription initiation from RNA polymerase II promoter; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCE1 Q5JR03 Q8TEF0 Q9BSY3 Q9BUJ9,Helicase MOV-10 {ECO:0000305},Armitage homolog {ECO:0000303|PubMed:17507929};Moloney leukemia virus 10 protein;, PF13087;, GO:0036464;GO:0010494;GO:0005829;GO:0005615;GO:0005634;GO:0043186;GO:0000932;GO:0032574;GO:0005524;GO:0003723;GO:0061158;GO:0051607;GO:0035195;GO:0030522;GO:0035279;GO:0010629;GO:0010526;GO:0010628;GO:0061014;GO:0035194;GO:0045652;GO:0150011;GO:0060260;GO:0016032;GO:0007223;, C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:extracellular space; C:nucleus; C:P granule; C:P-body;, F:5'-3' RNA helicase activity; F:ATP binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:defense response to virus; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:mRNA cleavage involved in gene silencing by miRNA; P:negative regulation of gene expression; P:negative regulation of transposition, RNA-mediated; P:positive regulation of gene expression; P:positive regulation of mRNA catabolic process; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of neuron projection arborization; P:regulation of transcription initiation from RNA polymerase II promoter; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCE1 Q5JR03 Q8TEF0 Q9BSY3 Q9BUJ9,Helicase MOV-10 {ECO:0000305},Armitage homolog {ECO:0000303|PubMed:17507929};Moloney leukemia virus 10 protein;, PF13087;, GO:0036464;GO:0010494;GO:0005829;GO:0005615;GO:0005634;GO:0043186;GO:0000932;GO:0032574;GO:0005524;GO:0003723;GO:0061158;GO:0051607;GO:0035195;GO:0030522;GO:0035279;GO:0010629;GO:0010526;GO:0010628;GO:0061014;GO:0035194;GO:0045652;GO:0150011;GO:0060260;GO:0016032;GO:0007223;, C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:extracellular space; C:nucleus; C:P granule; C:P-body;, F:5'-3' RNA helicase activity; F:ATP binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:defense response to virus; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:mRNA cleavage involved in gene silencing by miRNA; P:negative regulation of gene expression; P:negative regulation of transposition, RNA-mediated; P:positive regulation of gene expression; P:positive regulation of mRNA catabolic process; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of neuron projection arborization; P:regulation of transcription initiation from RNA polymerase II promoter; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q9Y6A9 B3KNF8 Q9BVW1 X6R2S6,Signal peptidase complex subunit 1,Microsomal signal peptidase 12 kDa subunit;, PF06645;, GO:0005789;GO:0030176;GO:0005787;GO:0008233;GO:0043022;GO:0045047;GO:0006508;GO:0006465;GO:0019082;GO:0019068;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:signal peptidase complex;, F:peptidase activity; F:ribosome binding;, P:protein targeting to ER; P:proteolysis; P:signal peptide processing; P:viral protein processing; P:virion assembly; scaffold20 indexed_genome mRNA 32389050 32429618 . - . ID=transcript_5067;P52907 Q53FQ6 Q6FHD5,F-actin-capping protein subunit alpha-1,CapZ alpha-1;, PF01267;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0008290;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0034329;GO:0006888;GO:0045087;GO:0035722;GO:0065003;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:F-actin capping protein complex; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell junction assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:interleukin-12-mediated signaling pathway; P:protein-containing complex assembly;|P52907 Q53FQ6 Q6FHD5,F-actin-capping protein subunit alpha-1,CapZ alpha-1;, PF01267;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0008290;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0034329;GO:0006888;GO:0045087;GO:0035722;GO:0065003;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:F-actin capping protein complex; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell junction assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:interleukin-12-mediated signaling pathway; P:protein-containing complex assembly;|P52907 Q53FQ6 Q6FHD5,F-actin-capping protein subunit alpha-1,CapZ alpha-1;, PF01267;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0008290;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0034329;GO:0006888;GO:0045087;GO:0035722;GO:0065003;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:F-actin capping protein complex; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell junction assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:interleukin-12-mediated signaling pathway; P:protein-containing complex assembly;|P52907 Q53FQ6 Q6FHD5,F-actin-capping protein subunit alpha-1,CapZ alpha-1;, PF01267;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0008290;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0034329;GO:0006888;GO:0045087;GO:0035722;GO:0065003;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:F-actin capping protein complex; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell junction assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:interleukin-12-mediated signaling pathway; P:protein-containing complex assembly;|P52907 Q53FQ6 Q6FHD5,F-actin-capping protein subunit alpha-1,CapZ alpha-1;, PF01267;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0008290;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0034329;GO:0006888;GO:0045087;GO:0035722;GO:0065003;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:F-actin capping protein complex; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell junction assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:interleukin-12-mediated signaling pathway; P:protein-containing complex assembly;|P52907 Q53FQ6 Q6FHD5,F-actin-capping protein subunit alpha-1,CapZ alpha-1;, PF01267;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0008290;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0034329;GO:0006888;GO:0045087;GO:0035722;GO:0065003;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:F-actin capping protein complex; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell junction assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:interleukin-12-mediated signaling pathway; P:protein-containing complex assembly;|P52907 Q53FQ6 Q6FHD5,F-actin-capping protein subunit alpha-1,CapZ alpha-1;, PF01267;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0008290;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0034329;GO:0006888;GO:0045087;GO:0035722;GO:0065003;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:F-actin capping protein complex; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell junction assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:interleukin-12-mediated signaling pathway; P:protein-containing complex assembly; scaffold20 indexed_genome mRNA 32430329 32507366 . + . ID=transcript_5068;Q8TDW1 Q8TDW2 Q8TDW3 Q9NXF3,Suppressor of tumorigenicity 7 protein-like,ST7-related protein;, PF04184;, GO:0016021;GO:0030308;, C:integral component of membrane;, , P:negative regulation of cell growth;|Q8TDW1 Q8TDW2 Q8TDW3 Q9NXF3,Suppressor of tumorigenicity 7 protein-like,ST7-related protein;, PF04184;, GO:0016021;GO:0030308;, C:integral component of membrane;, , P:negative regulation of cell growth;|Q8TDW1 Q8TDW2 Q8TDW3 Q9NXF3,Suppressor of tumorigenicity 7 protein-like,ST7-related protein;, PF04184;, GO:0016021;GO:0030308;, C:integral component of membrane;, , P:negative regulation of cell growth;|Q8TDW1 Q8TDW2 Q8TDW3 Q9NXF3,Suppressor of tumorigenicity 7 protein-like,ST7-related protein;, PF04184;, GO:0016021;GO:0030308;, C:integral component of membrane;, , P:negative regulation of cell growth; scaffold20 indexed_genome mRNA 32519437 32526025 . - . ID=transcript_5069;Q93097 O14903 Q5TEH9 Q5TEI2 Q9HDC1 Q9HDC2,Protein Wnt-2b,Protein Wnt-13 {ECO:0000303|PubMed:8761309};, PF00110;, GO:0062023;GO:0005576;GO:0005615;GO:0043231;GO:0005125;GO:0005109;GO:0060070;GO:0045165;GO:0009267;GO:0002062;GO:0061303;GO:0021871;GO:0071425;GO:0061072;GO:0002088;GO:0060492;GO:0008584;GO:0060638;GO:0030182;GO:0090190;GO:0016055;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:cytokine activity; F:frizzled binding;, P:canonical Wnt signaling pathway; P:cell fate commitment; P:cellular response to starvation; P:chondrocyte differentiation; P:cornea development in camera-type eye; P:forebrain regionalization; P:hematopoietic stem cell proliferation; P:iris morphogenesis; P:lens development in camera-type eye; P:lung induction; P:male gonad development; P:mesenchymal-epithelial cell signaling; P:neuron differentiation; P:positive regulation of branching involved in ureteric bud morphogenesis; P:Wnt signaling pathway; scaffold20 indexed_genome mRNA 32560787 32570109 . - . ID=transcript_5070;Q9P2B4 B3KMS5 Q96B40,CTTNBP2 N-terminal-like protein,, PF09727;, GO:0015629;GO:0005737;GO:0030027;GO:0051721;GO:0034763;GO:0032410;GO:0006470;, C:actin cytoskeleton; C:cytoplasm; C:lamellipodium;, F:protein phosphatase 2A binding;, P:negative regulation of transmembrane transport; P:negative regulation of transporter activity; P:protein dephosphorylation; scaffold20 indexed_genome mRNA 33011146 33228644 . + . ID=transcript_5071;Q9UK17 O60576 O60577 Q14D71 Q5T0M0 Q9UH85 Q9UH86 Q9UK16,Potassium voltage-gated channel subfamily D member 3,Voltage-gated potassium channel subunit Kv4.3;, PF02214;PF11879;PF00520;PF11601;, GO:0043197;GO:0098982;GO:0016021;GO:0099060;GO:0043025;GO:0005886;GO:0014069;GO:0045211;GO:0042383;GO:0008076;GO:0005250;GO:0044325;GO:0046872;GO:0005249;GO:0061337;GO:0086009;GO:0086013;GO:0098915;GO:0097623;GO:0071805;GO:0006813;GO:0051260;GO:0086091;GO:0034765;GO:0099625;, C:dendritic spine; C:GABA-ergic synapse; C:integral component of membrane; C:integral component of postsynaptic specialization membrane; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:sarcolemma; C:voltage-gated potassium channel complex;, F:A-type (transient outward) potassium channel activity; F:ion channel binding; F:metal ion binding; F:voltage-gated potassium channel activity;, P:cardiac conduction; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:potassium ion export across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:ventricular cardiac muscle cell membrane repolarization;|Q9UK17 O60576 O60577 Q14D71 Q5T0M0 Q9UH85 Q9UH86 Q9UK16,Potassium voltage-gated channel subfamily D member 3,Voltage-gated potassium channel subunit Kv4.3;, PF02214;PF11879;PF00520;PF11601;, GO:0043197;GO:0098982;GO:0016021;GO:0099060;GO:0043025;GO:0005886;GO:0014069;GO:0045211;GO:0042383;GO:0008076;GO:0005250;GO:0044325;GO:0046872;GO:0005249;GO:0061337;GO:0086009;GO:0086013;GO:0098915;GO:0097623;GO:0071805;GO:0006813;GO:0051260;GO:0086091;GO:0034765;GO:0099625;, C:dendritic spine; C:GABA-ergic synapse; C:integral component of membrane; C:integral component of postsynaptic specialization membrane; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:sarcolemma; C:voltage-gated potassium channel complex;, F:A-type (transient outward) potassium channel activity; F:ion channel binding; F:metal ion binding; F:voltage-gated potassium channel activity;, P:cardiac conduction; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:potassium ion export across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:ventricular cardiac muscle cell membrane repolarization; scaffold20 indexed_genome mRNA 33236948 33239402 . - . ID=transcript_5072;Q9UHI6 B4DWV7 Q96F72 Q9NVM3 Q9UF59 Q9UIY0 Q9Y659,Probable ATP-dependent RNA helicase DDX20,Component of gems 3;DEAD box protein 20;DEAD box protein DP 103;Gemin-3;, PF00270;PF00271;, GO:0005737;GO:0005856;GO:0005829;GO:0097504;GO:0016020;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0005524;GO:0003677;GO:0070491;GO:0003723;GO:0003724;GO:0051170;GO:0000122;GO:0043065;GO:0006396;GO:0000387;GO:0000244;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:ATP binding; F:DNA binding; F:repressing transcription factor binding; F:RNA binding; F:RNA helicase activity;, P:import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:RNA processing; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly; scaffold20 indexed_genome mRNA 33242380 33247922 . - . ID=transcript_5073;Q9UHI6 B4DWV7 Q96F72 Q9NVM3 Q9UF59 Q9UIY0 Q9Y659,Probable ATP-dependent RNA helicase DDX20,Component of gems 3;DEAD box protein 20;DEAD box protein DP 103;Gemin-3;, PF00270;PF00271;, GO:0005737;GO:0005856;GO:0005829;GO:0097504;GO:0016020;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0005524;GO:0003677;GO:0070491;GO:0003723;GO:0003724;GO:0051170;GO:0000122;GO:0043065;GO:0006396;GO:0000387;GO:0000244;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:ATP binding; F:DNA binding; F:repressing transcription factor binding; F:RNA binding; F:RNA helicase activity;, P:import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:RNA processing; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly;|Q9UHI6 B4DWV7 Q96F72 Q9NVM3 Q9UF59 Q9UIY0 Q9Y659,Probable ATP-dependent RNA helicase DDX20,Component of gems 3;DEAD box protein 20;DEAD box protein DP 103;Gemin-3;, PF00270;PF00271;, GO:0005737;GO:0005856;GO:0005829;GO:0097504;GO:0016020;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0005524;GO:0003677;GO:0070491;GO:0003723;GO:0003724;GO:0051170;GO:0000122;GO:0043065;GO:0006396;GO:0000387;GO:0000244;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:ATP binding; F:DNA binding; F:repressing transcription factor binding; F:RNA binding; F:RNA helicase activity;, P:import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:RNA processing; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly;|Q9UHI6 B4DWV7 Q96F72 Q9NVM3 Q9UF59 Q9UIY0 Q9Y659,Probable ATP-dependent RNA helicase DDX20,Component of gems 3;DEAD box protein 20;DEAD box protein DP 103;Gemin-3;, PF00270;PF00271;, GO:0005737;GO:0005856;GO:0005829;GO:0097504;GO:0016020;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0005524;GO:0003677;GO:0070491;GO:0003723;GO:0003724;GO:0051170;GO:0000122;GO:0043065;GO:0006396;GO:0000387;GO:0000244;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Gemini of coiled bodies; C:membrane; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:ATP binding; F:DNA binding; F:repressing transcription factor binding; F:RNA binding; F:RNA helicase activity;, P:import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:RNA processing; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly; scaffold20 indexed_genome mRNA 33264706 33280221 . + . ID=transcript_5074;Q9NTI7 B3KP38 B4DF94 Q9NTI6,PAK4-inhibitor INKA2 {ECO:0000305},Induced in neural crest by AP2-alpha protein-related homolog {ECO:0000303|PubMed:17314132};Inka box actin regulator 2 {ECO:0000312|HGNC:HGNC:28045};, PF15342;, GO:0005654;GO:0005634;GO:0019901;GO:0030291;, C:nucleoplasm; C:nucleus;, F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; scaffold20 indexed_genome mRNA 33289610 33310552 . - . ID=transcript_5075;P62834 P10113,Ras-related protein Rap-1A,C21KG;G-22K;GTP-binding protein smg p21A;Ras-related protein Krev-1;, PF00071;, GO:0030054;GO:0005737;GO:0005829;GO:0005769;GO:0010008;GO:0070062;GO:0098978;GO:0032045;GO:0005770;GO:0043005;GO:0048471;GO:0045335;GO:0005886;GO:0035579;GO:0019003;GO:0005525;GO:0003924;GO:0005085;GO:0044877;GO:0031267;GO:0000186;GO:0002250;GO:0071320;GO:0035690;GO:1990090;GO:0061028;GO:0097421;GO:0032966;GO:2000301;GO:0038180;GO:0007399;GO:0043312;GO:0070374;GO:1905451;GO:0046326;GO:0043547;GO:0010976;GO:0045860;GO:2001214;GO:0072659;GO:0032486;GO:1901888;GO:0050796;GO:0098696;GO:0097327;GO:0009743;, C:cell junction; C:cytoplasm; C:cytosol; C:early endosome; C:endosome membrane; C:extracellular exosome; C:glutamatergic synapse; C:guanyl-nucleotide exchange factor complex; C:late endosome; C:neuron projection; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:specific granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding; F:small GTPase binding;, P:activation of MAPKK activity; P:adaptive immune response; P:cellular response to cAMP; P:cellular response to drug; P:cellular response to nerve growth factor stimulus; P:establishment of endothelial barrier; P:liver regeneration; P:negative regulation of collagen biosynthetic process; P:negative regulation of synaptic vesicle exocytosis; P:nerve growth factor signaling pathway; P:nervous system development; P:neutrophil degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of glucose import; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of protein kinase activity; P:positive regulation of vasculogenesis; P:protein localization to plasma membrane; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of insulin secretion; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:response to antineoplastic agent; P:response to carbohydrate;|P62834 P10113,Ras-related protein Rap-1A,C21KG;G-22K;GTP-binding protein smg p21A;Ras-related protein Krev-1;, PF00071;, GO:0030054;GO:0005737;GO:0005829;GO:0005769;GO:0010008;GO:0070062;GO:0098978;GO:0032045;GO:0005770;GO:0043005;GO:0048471;GO:0045335;GO:0005886;GO:0035579;GO:0019003;GO:0005525;GO:0003924;GO:0005085;GO:0044877;GO:0031267;GO:0000186;GO:0002250;GO:0071320;GO:0035690;GO:1990090;GO:0061028;GO:0097421;GO:0032966;GO:2000301;GO:0038180;GO:0007399;GO:0043312;GO:0070374;GO:1905451;GO:0046326;GO:0043547;GO:0010976;GO:0045860;GO:2001214;GO:0072659;GO:0032486;GO:1901888;GO:0050796;GO:0098696;GO:0097327;GO:0009743;, C:cell junction; C:cytoplasm; C:cytosol; C:early endosome; C:endosome membrane; C:extracellular exosome; C:glutamatergic synapse; C:guanyl-nucleotide exchange factor complex; C:late endosome; C:neuron projection; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:specific granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding; F:small GTPase binding;, P:activation of MAPKK activity; P:adaptive immune response; P:cellular response to cAMP; P:cellular response to drug; P:cellular response to nerve growth factor stimulus; P:establishment of endothelial barrier; P:liver regeneration; P:negative regulation of collagen biosynthetic process; P:negative regulation of synaptic vesicle exocytosis; P:nerve growth factor signaling pathway; P:nervous system development; P:neutrophil degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of glucose import; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of protein kinase activity; P:positive regulation of vasculogenesis; P:protein localization to plasma membrane; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of insulin secretion; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:response to antineoplastic agent; P:response to carbohydrate; scaffold20 indexed_genome mRNA 33513640 33516913 . + . ID=transcript_5076;P0DMS8 A2A3P4 P33765 Q6UWU0 Q9BYZ1,Adenosine receptor A3,, PF00001;, GO:0005887;GO:0005886;GO:0001609;GO:0007190;GO:0007186;GO:0006954;GO:0030336;GO:0008285;GO:0032088;GO:0008016;GO:0009611;GO:0007165;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled adenosine receptor activity;, P:activation of adenylate cyclase activity; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of NF-kappaB transcription factor activity; P:regulation of heart contraction; P:response to wounding; P:signal transduction; scaffold20 indexed_genome mRNA 33534958 33539982 . - . ID=transcript_5077;Q8NEQ5 Q5QNZ1,Transmembrane protein C1orf162,, , GO:0016021;, C:integral component of membrane; scaffold20 indexed_genome mRNA 33546665 33574744 . + . ID=transcript_5078;Q9BQA1 B3KMW6 B4DP38 Q3LID2 Q53FU2 Q6JZZ5 Q96GK4 Q9BWY3,Methylosome protein 50,Androgen receptor cofactor p44;WD repeat-containing protein 77;p44/Mep50;, PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0034709;GO:0005654;GO:0005634;GO:0045495;GO:0008327;GO:0030374;GO:0060770;GO:0007315;GO:0008284;GO:0006357;GO:0060528;GO:0000387;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:methylosome; C:nucleoplasm; C:nucleus; C:pole plasm;, F:methyl-CpG binding; F:nuclear receptor coactivator activity;, P:negative regulation of epithelial cell proliferation involved in prostate gland development; P:pole plasm assembly; P:positive regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; P:spliceosomal snRNP assembly;|P24539 Q9BQ68 Q9BRU8,ATP synthase F(0) complex subunit B1, mitochondrial {ECO:0000305},ATP synthase peripheral stalk-membrane subunit b {ECO:0000305};ATP synthase proton-transporting mitochondrial F(0) complex subunit B1;ATP synthase subunit b;, PF05405;, GO:0016020;GO:0005743;GO:0005759;GO:0005753;GO:0000276;GO:0005739;GO:0005654;GO:0005634;GO:0015078;GO:0006754;GO:0015986;GO:0042407;GO:0042776;GO:0021762;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion; C:nucleoplasm; C:nucleus;, F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:substantia nigra development;|P24539 Q9BQ68 Q9BRU8,ATP synthase F(0) complex subunit B1, mitochondrial {ECO:0000305},ATP synthase peripheral stalk-membrane subunit b {ECO:0000305};ATP synthase proton-transporting mitochondrial F(0) complex subunit B1;ATP synthase subunit b;, PF05405;, GO:0016020;GO:0005743;GO:0005759;GO:0005753;GO:0000276;GO:0005739;GO:0005654;GO:0005634;GO:0015078;GO:0006754;GO:0015986;GO:0042407;GO:0042776;GO:0021762;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion; C:nucleoplasm; C:nucleus;, F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:substantia nigra development;|P24539 Q9BQ68 Q9BRU8,ATP synthase F(0) complex subunit B1, mitochondrial {ECO:0000305},ATP synthase peripheral stalk-membrane subunit b {ECO:0000305};ATP synthase proton-transporting mitochondrial F(0) complex subunit B1;ATP synthase subunit b;, PF05405;, GO:0016020;GO:0005743;GO:0005759;GO:0005753;GO:0000276;GO:0005739;GO:0005654;GO:0005634;GO:0015078;GO:0006754;GO:0015986;GO:0042407;GO:0042776;GO:0021762;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion; C:nucleoplasm; C:nucleus;, F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:substantia nigra development;|Q969M7 A8K1Z8 B4DDT9 B4DFI1 B4DMK3 B4DZU2 B8ZZG2 C9J212 H9KVB9,NEDD8-conjugating enzyme UBE2F,NEDD8 carrier protein UBE2F;NEDD8 protein ligase UBE2F;NEDD8-conjugating enzyme 2;RING-type E3 NEDD8 transferase UBE2F;Ubiquitin-conjugating enzyme E2 F;, PF00179;, GO:0005829;GO:0005634;GO:0005524;GO:0061654;GO:0019788;GO:0043687;GO:0045116;, C:cytosol; C:nucleus;, F:ATP binding; F:NEDD8 conjugating enzyme activity; F:NEDD8 transferase activity;, P:post-translational protein modification; P:protein neddylation; scaffold20 indexed_genome mRNA 33591599 33598648 . + . ID=transcript_5079;Q12889 A0AV19 B9EGE1 Q15841,Oviduct-specific glycoprotein,Estrogen-dependent oviduct protein;Mucin-9;Oviductal glycoprotein;Oviductin;, PF00704;, GO:0005829;GO:0035805;GO:0005576;GO:0043231;GO:0015630;GO:0098595;GO:0030133;GO:0008061;GO:0004568;GO:0007339;GO:0005975;GO:0006032;GO:0007565;GO:2000360;, C:cytosol; C:egg coat; C:extracellular region; C:intracellular membrane-bounded organelle; C:microtubule cytoskeleton; C:perivitelline space; C:transport vesicle;, F:chitin binding; F:chitinase activity;, P:binding of sperm to zona pellucida; P:carbohydrate metabolic process; P:chitin catabolic process; P:female pregnancy; P:negative regulation of binding of sperm to zona pellucida; scaffold21 indexed_genome mRNA 259060 357304 . + . ID=transcript_5080;Q92576 A3KFI8 Q14CR5 Q5CZI1 Q5T1T6 Q9NQ16 Q9UI45,PHD finger protein 3,, PF00628;PF07744;PF07500;, GO:0046872;GO:0007275;GO:0006351;, , F:metal ion binding;, P:multicellular organism development; P:transcription, DNA-templated;|Q92576 A3KFI8 Q14CR5 Q5CZI1 Q5T1T6 Q9NQ16 Q9UI45,PHD finger protein 3,, PF00628;PF07744;PF07500;, GO:0046872;GO:0007275;GO:0006351;, , F:metal ion binding;, P:multicellular organism development; P:transcription, DNA-templated;|Q92576 A3KFI8 Q14CR5 Q5CZI1 Q5T1T6 Q9NQ16 Q9UI45,PHD finger protein 3,, PF00628;PF07744;PF07500;, GO:0046872;GO:0007275;GO:0006351;, , F:metal ion binding;, P:multicellular organism development; P:transcription, DNA-templated;|Q92576 A3KFI8 Q14CR5 Q5CZI1 Q5T1T6 Q9NQ16 Q9UI45,PHD finger protein 3,, PF00628;PF07744;PF07500;, GO:0046872;GO:0007275;GO:0006351;, , F:metal ion binding;, P:multicellular organism development; P:transcription, DNA-templated;|Q92576 A3KFI8 Q14CR5 Q5CZI1 Q5T1T6 Q9NQ16 Q9UI45,PHD finger protein 3,, PF00628;PF07744;PF07500;, GO:0046872;GO:0007275;GO:0006351;, , F:metal ion binding;, P:multicellular organism development; P:transcription, DNA-templated; scaffold21 indexed_genome mRNA 384516 385271 . + . ID=transcript_5081;P61567,Endogenous retrovirus group K member 7 Env polyprotein,Envelope polyprotein;HERV-K(III) envelope protein;HERV-K102 envelope protein;HERV-K_1q22 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity; scaffold21 indexed_genome mRNA 385443 387857 . - . ID=transcript_5082;P10266 P87890 Q14273,Endogenous retrovirus group K member 10 Pol protein,HERV-K10 Pol protein;HERV-K107 Pol protein;HERV-K_5q33.3 provirus ancestral Pol protein;, PF13804;PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold21 indexed_genome mRNA 389148 390115 . - . ID=transcript_5083;Q7LDI9 Q9UKH5 Q9Y6I1 Q9YNA6 Q9YNB0,Endogenous retrovirus group K member 6 Gag polyprotein,HERV-K(C7) Gag protein;HERV-K(HML-2.HOM) Gag protein;HERV-K108 Gag protein;HERV-K_7p22.1 provirus ancestral Gag polyprotein;, PF02337;PF00607;PF00098;, GO:0005886;GO:0003676;GO:0005198;GO:0008270;GO:0016032;, C:plasma membrane;, F:nucleic acid binding; F:structural molecule activity; F:zinc ion binding;, P:viral process; scaffold21 indexed_genome mRNA 6427135 7243114 . + . ID=transcript_5084;O60242 B7Z1K0 O60297 Q2NKN6 Q5VY37 Q9BX54,Adhesion G protein-coupled receptor B3 {ECO:0000303|PubMed:25713288},Brain-specific angiogenesis inhibitor 3;, PF00002;PF19188;PF16489;PF01825;PF02793;PF00090;, GO:0016021;GO:0005887;GO:0005886;GO:0098794;GO:0043083;GO:0004930;GO:0005096;GO:0007189;GO:0007166;GO:0007186;GO:0099558;GO:0061743;GO:0007520;GO:0016525;GO:0016322;GO:0051965;GO:0048814;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse; C:synaptic cleft;, F:G protein-coupled receptor activity; F:GTPase activator activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:maintenance of synapse structure; P:motor learning; P:myoblast fusion; P:negative regulation of angiogenesis; P:neuron remodeling; P:positive regulation of synapse assembly; P:regulation of dendrite morphogenesis; scaffold21 indexed_genome mRNA 7244163 7303042 . + . ID=transcript_5085;O60242 B7Z1K0 O60297 Q2NKN6 Q5VY37 Q9BX54,Adhesion G protein-coupled receptor B3 {ECO:0000303|PubMed:25713288},Brain-specific angiogenesis inhibitor 3;, PF00002;PF19188;PF16489;PF01825;PF02793;PF00090;, GO:0016021;GO:0005887;GO:0005886;GO:0098794;GO:0043083;GO:0004930;GO:0005096;GO:0007189;GO:0007166;GO:0007186;GO:0099558;GO:0061743;GO:0007520;GO:0016525;GO:0016322;GO:0051965;GO:0048814;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse; C:synaptic cleft;, F:G protein-coupled receptor activity; F:GTPase activator activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:maintenance of synapse structure; P:motor learning; P:myoblast fusion; P:negative regulation of angiogenesis; P:neuron remodeling; P:positive regulation of synapse assembly; P:regulation of dendrite morphogenesis;|O60242 B7Z1K0 O60297 Q2NKN6 Q5VY37 Q9BX54,Adhesion G protein-coupled receptor B3 {ECO:0000303|PubMed:25713288},Brain-specific angiogenesis inhibitor 3;, PF00002;PF19188;PF16489;PF01825;PF02793;PF00090;, GO:0016021;GO:0005887;GO:0005886;GO:0098794;GO:0043083;GO:0004930;GO:0005096;GO:0007189;GO:0007166;GO:0007186;GO:0099558;GO:0061743;GO:0007520;GO:0016525;GO:0016322;GO:0051965;GO:0048814;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse; C:synaptic cleft;, F:G protein-coupled receptor activity; F:GTPase activator activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:maintenance of synapse structure; P:motor learning; P:myoblast fusion; P:negative regulation of angiogenesis; P:neuron remodeling; P:positive regulation of synapse assembly; P:regulation of dendrite morphogenesis;|O60242 B7Z1K0 O60297 Q2NKN6 Q5VY37 Q9BX54,Adhesion G protein-coupled receptor B3 {ECO:0000303|PubMed:25713288},Brain-specific angiogenesis inhibitor 3;, PF00002;PF19188;PF16489;PF01825;PF02793;PF00090;, GO:0016021;GO:0005887;GO:0005886;GO:0098794;GO:0043083;GO:0004930;GO:0005096;GO:0007189;GO:0007166;GO:0007186;GO:0099558;GO:0061743;GO:0007520;GO:0016525;GO:0016322;GO:0051965;GO:0048814;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse; C:synaptic cleft;, F:G protein-coupled receptor activity; F:GTPase activator activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:maintenance of synapse structure; P:motor learning; P:myoblast fusion; P:negative regulation of angiogenesis; P:neuron remodeling; P:positive regulation of synapse assembly; P:regulation of dendrite morphogenesis;|O60242 B7Z1K0 O60297 Q2NKN6 Q5VY37 Q9BX54,Adhesion G protein-coupled receptor B3 {ECO:0000303|PubMed:25713288},Brain-specific angiogenesis inhibitor 3;, PF00002;PF19188;PF16489;PF01825;PF02793;PF00090;, GO:0016021;GO:0005887;GO:0005886;GO:0098794;GO:0043083;GO:0004930;GO:0005096;GO:0007189;GO:0007166;GO:0007186;GO:0099558;GO:0061743;GO:0007520;GO:0016525;GO:0016322;GO:0051965;GO:0048814;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse; C:synaptic cleft;, F:G protein-coupled receptor activity; F:GTPase activator activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:maintenance of synapse structure; P:motor learning; P:myoblast fusion; P:negative regulation of angiogenesis; P:neuron remodeling; P:positive regulation of synapse assembly; P:regulation of dendrite morphogenesis; scaffold21 indexed_genome mRNA 7649635 7790072 . - . ID=transcript_5086;Q9NUN5 A8K204 E1P531 Q5VUN6 Q86Y70 Q96FW4 Q9BY56 Q9NZD6,Lysosomal cobalamin transport escort protein LMBD1 {ECO:0000303|PubMed:27456980},HDAg-L-interacting protein NESI;LMBR1 domain-containing protein 1;Nuclear export signal-interacting protein;, PF04791;, GO:0005789;GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0031419;GO:0009235;GO:0015889;GO:0061462;GO:0016032;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane;, F:cobalamin binding;, P:cobalamin metabolic process; P:cobalamin transport; P:protein localization to lysosome; P:viral process;|Q9NUN5 A8K204 E1P531 Q5VUN6 Q86Y70 Q96FW4 Q9BY56 Q9NZD6,Lysosomal cobalamin transport escort protein LMBD1 {ECO:0000303|PubMed:27456980},HDAg-L-interacting protein NESI;LMBR1 domain-containing protein 1;Nuclear export signal-interacting protein;, PF04791;, GO:0005789;GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0031419;GO:0009235;GO:0015889;GO:0061462;GO:0016032;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane;, F:cobalamin binding;, P:cobalamin metabolic process; P:cobalamin transport; P:protein localization to lysosome; P:viral process;|Q9NUN5 A8K204 E1P531 Q5VUN6 Q86Y70 Q96FW4 Q9BY56 Q9NZD6,Lysosomal cobalamin transport escort protein LMBD1 {ECO:0000303|PubMed:27456980},HDAg-L-interacting protein NESI;LMBR1 domain-containing protein 1;Nuclear export signal-interacting protein;, PF04791;, GO:0005789;GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0031419;GO:0009235;GO:0015889;GO:0061462;GO:0016032;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane;, F:cobalamin binding;, P:cobalamin metabolic process; P:cobalamin transport; P:protein localization to lysosome; P:viral process;|Q9Y4L5 A8K3Y4 Q5T2V9 Q7Z2J2,E3 ubiquitin-protein ligase RNF115 {ECO:0000305},RING finger protein 115 {ECO:0000312|HGNC:HGNC:18154};RING-type E3 ubiquitin transferase RNF115 {ECO:0000305};Rabring 7 {ECO:0000250|UniProtKB:Q9D0C1};Zinc finger protein 364 {ECO:0000303|Ref.1};, PF13639;, GO:0005829;GO:0046872;GO:0061630;GO:0004842;GO:0042059;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0043162;, C:cytosol;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold21 indexed_genome mRNA 8326910 8344872 . - . ID=transcript_5087;Q9Y6P2 Q9Y6P3,Collagen alpha-1(IX) chain,, PF01391;, GO:0005604;GO:0005594;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0046872;GO:0009887;GO:0030199;GO:0030198;, C:basement membrane; C:collagen type IX trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding;, P:animal organ morphogenesis; P:collagen fibril organization; P:extracellular matrix organization; scaffold21 indexed_genome mRNA 8347844 8389572 . - . ID=transcript_5088;Q9Y6P2 Q9Y6P3,Collagen alpha-1(IX) chain,, PF01391;, GO:0005604;GO:0005594;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0046872;GO:0009887;GO:0030199;GO:0030198;, C:basement membrane; C:collagen type IX trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding;, P:animal organ morphogenesis; P:collagen fibril organization; P:extracellular matrix organization; scaffold21 indexed_genome mRNA 8605802 8671250 . + . ID=transcript_5089;Q9NUQ5 Q9NXL5,Protein FAM135A,, PF12394;PF05057;, GO:0044255;, , , P:cellular lipid metabolic process;|Q9NUQ5 Q9NXL5,Protein FAM135A,, PF12394;PF05057;, GO:0044255;, , , P:cellular lipid metabolic process;|Q9NUQ5 Q9NXL5,Protein FAM135A,, PF12394;PF05057;, GO:0044255;, , , P:cellular lipid metabolic process;|Q9NUQ5 Q9NXL5,Protein FAM135A,, PF12394;PF05057;, GO:0044255;, , , P:cellular lipid metabolic process;|Q9NUQ5 Q9NXL5,Protein FAM135A,, PF12394;PF05057;, GO:0044255;, , , P:cellular lipid metabolic process; scaffold21 indexed_genome mRNA 8696970 8712060 . + . ID=transcript_5090;Q5VUM1 E1P532,Succinate dehydrogenase assembly factor 4, mitochondrial {ECO:0000303|PubMed:24954416, ECO:0000312|HGNC:HGNC:20957},, PF07896;, GO:0005759;GO:0005749;GO:0005739;GO:0008177;GO:0045333;GO:0045087;GO:0034553;, C:mitochondrial matrix; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion;, F:succinate dehydrogenase (ubiquinone) activity;, P:cellular respiration; P:innate immune response; P:mitochondrial respiratory chain complex II assembly; scaffold21 indexed_genome mRNA 8869140 8870007 . + . ID=transcript_5091;Q8IYB5 Q53H70 Q5SYQ2 Q6PK24 Q8NDH4 Q96L38 Q96L39 Q9H8X4,Stromal membrane-associated protein 1,, PF01412;, GO:0005737;GO:0005886;GO:0030276;GO:0005096;GO:0046872;GO:0045648;GO:2000369;, C:cytoplasm; C:plasma membrane;, F:clathrin binding; F:GTPase activator activity; F:metal ion binding;, P:positive regulation of erythrocyte differentiation; P:regulation of clathrin-dependent endocytosis; scaffold21 indexed_genome mRNA 8940974 8942551 . - . ID=transcript_5092;Q8IYB5 Q53H70 Q5SYQ2 Q6PK24 Q8NDH4 Q96L38 Q96L39 Q9H8X4,Stromal membrane-associated protein 1,, PF01412;, GO:0005737;GO:0005886;GO:0030276;GO:0005096;GO:0046872;GO:0045648;GO:2000369;, C:cytoplasm; C:plasma membrane;, F:clathrin binding; F:GTPase activator activity; F:metal ion binding;, P:positive regulation of erythrocyte differentiation; P:regulation of clathrin-dependent endocytosis;|Q8IYB5 Q53H70 Q5SYQ2 Q6PK24 Q8NDH4 Q96L38 Q96L39 Q9H8X4,Stromal membrane-associated protein 1,, PF01412;, GO:0005737;GO:0005886;GO:0030276;GO:0005096;GO:0046872;GO:0045648;GO:2000369;, C:cytoplasm; C:plasma membrane;, F:clathrin binding; F:GTPase activator activity; F:metal ion binding;, P:positive regulation of erythrocyte differentiation; P:regulation of clathrin-dependent endocytosis; scaffold21 indexed_genome mRNA 9357711 9370694 . + . ID=transcript_5093;Q5TC84 Q2TAC1 Q8NEQ4 Q9H7B5,Opioid growth factor receptor-like protein 1,, PF04664;, GO:0016020;GO:0004985;, C:membrane;, F:opioid receptor activity;|Q5TC84 Q2TAC1 Q8NEQ4 Q9H7B5,Opioid growth factor receptor-like protein 1,, PF04664;, GO:0016020;GO:0004985;, C:membrane;, F:opioid receptor activity; scaffold21 indexed_genome mRNA 10244236 10249060 . + . ID=transcript_5094;Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception; scaffold21 indexed_genome mRNA 10365061 10576792 . + . ID=transcript_5095;Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9UQ26 B3KX91 F8WD47 O43413 Q86XL9 Q8IWV9 Q8IWW1,Regulating synaptic membrane exocytosis protein 2,Rab-3-interacting molecule 2;Rab-3-interacting protein 3;, PF00168;PF02318;PF17820;, GO:0042995;GO:0048788;GO:0070062;GO:0048786;GO:0042734;GO:0044325;GO:0046872;GO:0031267;GO:0048791;GO:0017156;GO:0019933;GO:0030154;GO:0030073;GO:0006886;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0017157;GO:0042391;GO:0048167;GO:2000300;GO:0061669;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:presynaptic active zone; C:presynaptic membrane;, F:ion channel binding; F:metal ion binding; F:small GTPase binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cAMP-mediated signaling; P:cell differentiation; P:insulin secretion; P:intracellular protein transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:regulation of exocytosis; P:regulation of membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:spontaneous neurotransmitter secretion;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception;|Q9HBA1 Q9HBA2 Q9HBA3 Q9HBA4 Q9HBA5 Q9HBA6,Regulating synaptic membrane exocytosis protein 1,Rab-3-interacting molecule 1;Rab-3-interacting protein 2;, PF00168;PF02318;PF00595;, GO:0042995;GO:0048788;GO:0005829;GO:0005886;GO:0048786;GO:0042734;GO:0030695;GO:0044325;GO:0046872;GO:0003723;GO:0031267;GO:0060478;GO:0048791;GO:0017156;GO:0030154;GO:0006886;GO:0061025;GO:0007269;GO:0006836;GO:1903861;GO:2000463;GO:0010628;GO:0097151;GO:0050806;GO:0065003;GO:0045055;GO:0042391;GO:0046928;GO:0048167;GO:2000300;GO:0050896;GO:0046903;GO:0016079;GO:0007601;, C:cell projection; C:cytoskeleton of presynaptic active zone; C:cytosol; C:plasma membrane; C:presynaptic active zone; C:presynaptic membrane;, F:GTPase regulator activity; F:ion channel binding; F:metal ion binding; F:RNA binding; F:small GTPase binding;, P:acrosomal vesicle exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:intracellular protein transport; P:membrane fusion; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of dendrite extension; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of synaptic transmission; P:protein-containing complex assembly; P:regulated exocytosis; P:regulation of membrane potential; P:regulation of neurotransmitter secretion; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:response to stimulus; P:secretion; P:synaptic vesicle exocytosis; P:visual perception; scaffold21 indexed_genome mRNA 11422687 11426476 . - . ID=transcript_5096;Q5VVP3 Q86W40 Q9NRN0 Q9NYA6,Potassium voltage-gated channel subfamily KQT member 5,KQT-like 5;Potassium channel subunit alpha KvLQT5;Voltage-gated potassium channel subunit Kv7.5;, PF00520;PF03520;, GO:0030118;GO:0016021;GO:0005887;GO:0005886;GO:0008076;GO:0005516;GO:0005251;GO:0005249;GO:0071805;GO:0034765;, C:clathrin coat; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calmodulin binding; F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; scaffold21 indexed_genome mRNA 11757142 11761621 . - . ID=transcript_5097;Q5VVP3 Q86W40 Q9NRN0 Q9NYA6,Potassium voltage-gated channel subfamily KQT member 5,KQT-like 5;Potassium channel subunit alpha KvLQT5;Voltage-gated potassium channel subunit Kv7.5;, PF00520;PF03520;, GO:0030118;GO:0016021;GO:0005887;GO:0005886;GO:0008076;GO:0005516;GO:0005251;GO:0005249;GO:0071805;GO:0034765;, C:clathrin coat; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calmodulin binding; F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; scaffold21 indexed_genome mRNA 12009777 12050320 . + . ID=transcript_5098;O15131 B2RAI5 Q86X23,Importin subunit alpha-6,Karyopherin subunit alpha-5;, PF00514;PF16186;PF01749;, GO:0005829;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0019054;GO:0006607;, C:cytosol; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; scaffold21 indexed_genome mRNA 12056646 12066154 . - . ID=transcript_5099;Q5T6X4 Q8IXW8,Protein FAM162B,, PF06388;, GO:0016021;, C:integral component of membrane; scaffold21 indexed_genome mRNA 12433643 12440198 . - . ID=transcript_5100;P08922 Q15368 Q5TDB5,Proto-oncogene tyrosine-protein kinase ROS,Proto-oncogene c-Ros;Proto-oncogene c-Ros-1;Receptor tyrosine kinase c-ros oncogene 1;c-Ros receptor tyrosine kinase;, PF00041;PF07714;, GO:0009986;GO:0005887;GO:0016020;GO:0048471;GO:0043235;GO:0005524;GO:0019903;GO:0004713;GO:0004714;GO:0030154;GO:0002066;GO:0010467;GO:0007275;GO:0010629;GO:0038083;GO:0033674;GO:0006468;GO:0001558;GO:0070372;GO:0010966;GO:0032006;GO:0007283;GO:0007169;, C:cell surface; C:integral component of plasma membrane; C:membrane; C:perinuclear region of cytoplasm; C:receptor complex;, F:ATP binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:columnar/cuboidal epithelial cell development; P:gene expression; P:multicellular organism development; P:negative regulation of gene expression; P:peptidyl-tyrosine autophosphorylation; P:positive regulation of kinase activity; P:protein phosphorylation; P:regulation of cell growth; P:regulation of ERK1 and ERK2 cascade; P:regulation of phosphate transport; P:regulation of TOR signaling; P:spermatogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold21 indexed_genome mRNA 12449266 12458307 . - . ID=transcript_5101;P08922 Q15368 Q5TDB5,Proto-oncogene tyrosine-protein kinase ROS,Proto-oncogene c-Ros;Proto-oncogene c-Ros-1;Receptor tyrosine kinase c-ros oncogene 1;c-Ros receptor tyrosine kinase;, PF00041;PF07714;, GO:0009986;GO:0005887;GO:0016020;GO:0048471;GO:0043235;GO:0005524;GO:0019903;GO:0004713;GO:0004714;GO:0030154;GO:0002066;GO:0010467;GO:0007275;GO:0010629;GO:0038083;GO:0033674;GO:0006468;GO:0001558;GO:0070372;GO:0010966;GO:0032006;GO:0007283;GO:0007169;, C:cell surface; C:integral component of plasma membrane; C:membrane; C:perinuclear region of cytoplasm; C:receptor complex;, F:ATP binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:columnar/cuboidal epithelial cell development; P:gene expression; P:multicellular organism development; P:negative regulation of gene expression; P:peptidyl-tyrosine autophosphorylation; P:positive regulation of kinase activity; P:protein phosphorylation; P:regulation of cell growth; P:regulation of ERK1 and ERK2 cascade; P:regulation of phosphate transport; P:regulation of TOR signaling; P:spermatogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold21 indexed_genome mRNA 12463432 12473756 . - . ID=transcript_5102;P08922 Q15368 Q5TDB5,Proto-oncogene tyrosine-protein kinase ROS,Proto-oncogene c-Ros;Proto-oncogene c-Ros-1;Receptor tyrosine kinase c-ros oncogene 1;c-Ros receptor tyrosine kinase;, PF00041;PF07714;, GO:0009986;GO:0005887;GO:0016020;GO:0048471;GO:0043235;GO:0005524;GO:0019903;GO:0004713;GO:0004714;GO:0030154;GO:0002066;GO:0010467;GO:0007275;GO:0010629;GO:0038083;GO:0033674;GO:0006468;GO:0001558;GO:0070372;GO:0010966;GO:0032006;GO:0007283;GO:0007169;, C:cell surface; C:integral component of plasma membrane; C:membrane; C:perinuclear region of cytoplasm; C:receptor complex;, F:ATP binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:columnar/cuboidal epithelial cell development; P:gene expression; P:multicellular organism development; P:negative regulation of gene expression; P:peptidyl-tyrosine autophosphorylation; P:positive regulation of kinase activity; P:protein phosphorylation; P:regulation of cell growth; P:regulation of ERK1 and ERK2 cascade; P:regulation of phosphate transport; P:regulation of TOR signaling; P:spermatogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold21 indexed_genome mRNA 12506495 12508040 . - . ID=transcript_5103;P08922 Q15368 Q5TDB5,Proto-oncogene tyrosine-protein kinase ROS,Proto-oncogene c-Ros;Proto-oncogene c-Ros-1;Receptor tyrosine kinase c-ros oncogene 1;c-Ros receptor tyrosine kinase;, PF00041;PF07714;, GO:0009986;GO:0005887;GO:0016020;GO:0048471;GO:0043235;GO:0005524;GO:0019903;GO:0004713;GO:0004714;GO:0030154;GO:0002066;GO:0010467;GO:0007275;GO:0010629;GO:0038083;GO:0033674;GO:0006468;GO:0001558;GO:0070372;GO:0010966;GO:0032006;GO:0007283;GO:0007169;, C:cell surface; C:integral component of plasma membrane; C:membrane; C:perinuclear region of cytoplasm; C:receptor complex;, F:ATP binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:columnar/cuboidal epithelial cell development; P:gene expression; P:multicellular organism development; P:negative regulation of gene expression; P:peptidyl-tyrosine autophosphorylation; P:positive regulation of kinase activity; P:protein phosphorylation; P:regulation of cell growth; P:regulation of ERK1 and ERK2 cascade; P:regulation of phosphate transport; P:regulation of TOR signaling; P:spermatogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold21 indexed_genome mRNA 12613825 12655897 . + . ID=transcript_5104;Q8N8Z6 Q5H992 Q8IYK5 Q8N7L9 Q96NH2,Discoidin, CUB and LCCL domain-containing protein 1,, PF00431;PF00754;PF03815;, GO:0016021;, C:integral component of membrane; scaffold21 indexed_genome mRNA 12676962 12692891 . - . ID=transcript_5105;Q9HD26 A6NM30 Q59FS4 Q969U8,Golgi-associated PDZ and coiled-coil motif-containing protein,CFTR-associated ligand;Fused in glioblastoma;PDZ protein interacting specifically with TC10;, PF00595;, GO:0005737;GO:0030425;GO:0005794;GO:0000139;GO:0030660;GO:0005765;GO:0016020;GO:0005886;GO:0014069;GO:0032991;GO:0030140;GO:0042802;GO:0044325;GO:0045176;GO:0043004;GO:0006888;GO:0006893;GO:0010360;GO:2000009;GO:0015031;, C:cytoplasm; C:dendrite; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:trans-Golgi network transport vesicle;, F:identical protein binding; F:ion channel binding;, P:apical protein localization; P:cytoplasmic sequestering of CFTR protein; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to plasma membrane transport; P:negative regulation of anion channel activity; P:negative regulation of protein localization to cell surface; P:protein transport;|Q9HD26 A6NM30 Q59FS4 Q969U8,Golgi-associated PDZ and coiled-coil motif-containing protein,CFTR-associated ligand;Fused in glioblastoma;PDZ protein interacting specifically with TC10;, PF00595;, GO:0005737;GO:0030425;GO:0005794;GO:0000139;GO:0030660;GO:0005765;GO:0016020;GO:0005886;GO:0014069;GO:0032991;GO:0030140;GO:0042802;GO:0044325;GO:0045176;GO:0043004;GO:0006888;GO:0006893;GO:0010360;GO:2000009;GO:0015031;, C:cytoplasm; C:dendrite; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:trans-Golgi network transport vesicle;, F:identical protein binding; F:ion channel binding;, P:apical protein localization; P:cytoplasmic sequestering of CFTR protein; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to plasma membrane transport; P:negative regulation of anion channel activity; P:negative regulation of protein localization to cell surface; P:protein transport; scaffold21 indexed_genome mRNA 12692915 12722666 . - . ID=transcript_5106;Q9HD26 A6NM30 Q59FS4 Q969U8,Golgi-associated PDZ and coiled-coil motif-containing protein,CFTR-associated ligand;Fused in glioblastoma;PDZ protein interacting specifically with TC10;, PF00595;, GO:0005737;GO:0030425;GO:0005794;GO:0000139;GO:0030660;GO:0005765;GO:0016020;GO:0005886;GO:0014069;GO:0032991;GO:0030140;GO:0042802;GO:0044325;GO:0045176;GO:0043004;GO:0006888;GO:0006893;GO:0010360;GO:2000009;GO:0015031;, C:cytoplasm; C:dendrite; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:trans-Golgi network transport vesicle;, F:identical protein binding; F:ion channel binding;, P:apical protein localization; P:cytoplasmic sequestering of CFTR protein; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to plasma membrane transport; P:negative regulation of anion channel activity; P:negative regulation of protein localization to cell surface; P:protein transport; scaffold21 indexed_genome mRNA 12772906 12797830 . + . ID=transcript_5107;Q96E22 B2RWQ4 O00251,Dehydrodolichyl diphosphate synthase complex subunit NUS1 {ECO:0000305},Cis-prenyltransferase subunit NgBR {ECO:0000303|PubMed:28842490};Nogo-B receptor {ECO:0000303|PubMed:16835300};Nuclear undecaprenyl pyrophosphate synthase 1 homolog {ECO:0000305};, PF01255;, GO:1904423;GO:0005789;GO:0016021;GO:0045547;GO:0046872;GO:0001525;GO:0030154;GO:0042632;GO:0019408;GO:0006489;GO:0043536;GO:0051000;GO:0006486;GO:0035268;GO:0032383;GO:0038084;, C:dehydrodolichyl diphosphate synthase complex; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:dehydrodolichyl diphosphate synthase activity; F:metal ion binding;, P:angiogenesis; P:cell differentiation; P:cholesterol homeostasis; P:dolichol biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of nitric-oxide synthase activity; P:protein glycosylation; P:protein mannosylation; P:regulation of intracellular cholesterol transport; P:vascular endothelial growth factor signaling pathway; scaffold21 indexed_genome mRNA 12900271 13307393 . + . ID=transcript_5108;Q5T1Q4 B4DJ02 E1P564 Q1RMG1 Q4G0U9 Q4G167 Q6N007,Solute carrier family 35 member F1,, PF06027;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold21 indexed_genome mRNA 13408851 13444336 . - . ID=transcript_5109;Q9H289,Centrosomal protein of 85 kDa-like {ECO:0000305},Serologically defined breast cancer antigen NY-BR-15;, , GO:0005813;GO:0005737;GO:0000242;GO:0001764;, C:centrosome; C:cytoplasm; C:pericentriolar material;, , P:neuron migration;|Q9H289,Centrosomal protein of 85 kDa-like {ECO:0000305},Serologically defined breast cancer antigen NY-BR-15;, , GO:0005813;GO:0005737;GO:0000242;GO:0001764;, C:centrosome; C:cytoplasm; C:pericentriolar material;, , P:neuron migration; scaffold21 indexed_genome mRNA 13487235 13540564 . - . ID=transcript_5110;Q9H289,Centrosomal protein of 85 kDa-like {ECO:0000305},Serologically defined breast cancer antigen NY-BR-15;, , GO:0005813;GO:0005737;GO:0000242;GO:0001764;, C:centrosome; C:cytoplasm; C:pericentriolar material;, , P:neuron migration; scaffold21 indexed_genome mRNA 13662290 13749201 . + . ID=transcript_5111;Q9NXL9 B4DR30 B9DI77 Q2KHJ0 Q8N5S5 Q9HCV5,DNA helicase MCM9,Mini-chromosome maintenance deficient domain-containing protein 1;Minichromosome maintenance 9;, PF00493;PF17855;PF17207;, GO:0005694;GO:0042555;GO:0097362;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0003688;GO:0019899;GO:0032406;GO:0032407;GO:0032408;GO:0044877;GO:0003697;GO:0006974;GO:0032508;GO:0000724;GO:0007292;GO:0070716;GO:0071168;GO:0036298;, C:chromosome; C:MCM complex; C:MCM8-MCM9 complex; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:DNA replication origin binding; F:enzyme binding; F:MutLbeta complex binding; F:MutSalpha complex binding; F:MutSbeta complex binding; F:protein-containing complex binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA duplex unwinding; P:double-strand break repair via homologous recombination; P:female gamete generation; P:mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication; P:protein localization to chromatin; P:recombinational interstrand cross-link repair;|Q9Y294 Q6IA08 Q9P014,Histone chaperone ASF1A,Anti-silencing function protein 1 homolog A;CCG1-interacting factor A;, PF04729;, GO:0000785;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0042393;GO:0006281;GO:0006335;GO:0006336;GO:0042692;GO:0031936;GO:0006334;GO:0001649;, C:chromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:histone binding;, P:DNA repair; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:muscle cell differentiation; P:negative regulation of chromatin silencing; P:nucleosome assembly; P:osteoblast differentiation;|Q9Y294 Q6IA08 Q9P014,Histone chaperone ASF1A,Anti-silencing function protein 1 homolog A;CCG1-interacting factor A;, PF04729;, GO:0000785;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0042393;GO:0006281;GO:0006335;GO:0006336;GO:0042692;GO:0031936;GO:0006334;GO:0001649;, C:chromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:histone binding;, P:DNA repair; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:muscle cell differentiation; P:negative regulation of chromatin silencing; P:nucleosome assembly; P:osteoblast differentiation;|Q9NXL9 B4DR30 B9DI77 Q2KHJ0 Q8N5S5 Q9HCV5,DNA helicase MCM9,Mini-chromosome maintenance deficient domain-containing protein 1;Minichromosome maintenance 9;, PF00493;PF17855;PF17207;, GO:0005694;GO:0042555;GO:0097362;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0003688;GO:0019899;GO:0032406;GO:0032407;GO:0032408;GO:0044877;GO:0003697;GO:0006974;GO:0032508;GO:0000724;GO:0007292;GO:0070716;GO:0071168;GO:0036298;, C:chromosome; C:MCM complex; C:MCM8-MCM9 complex; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:DNA replication origin binding; F:enzyme binding; F:MutLbeta complex binding; F:MutSalpha complex binding; F:MutSbeta complex binding; F:protein-containing complex binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA duplex unwinding; P:double-strand break repair via homologous recombination; P:female gamete generation; P:mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication; P:protein localization to chromatin; P:recombinational interstrand cross-link repair;|Q9NXL9 B4DR30 B9DI77 Q2KHJ0 Q8N5S5 Q9HCV5,DNA helicase MCM9,Mini-chromosome maintenance deficient domain-containing protein 1;Minichromosome maintenance 9;, PF00493;PF17855;PF17207;, GO:0005694;GO:0042555;GO:0097362;GO:0005634;GO:0005524;GO:0003682;GO:0003678;GO:0003688;GO:0019899;GO:0032406;GO:0032407;GO:0032408;GO:0044877;GO:0003697;GO:0006974;GO:0032508;GO:0000724;GO:0007292;GO:0070716;GO:0071168;GO:0036298;, C:chromosome; C:MCM complex; C:MCM8-MCM9 complex; C:nucleus;, F:ATP binding; F:chromatin binding; F:DNA helicase activity; F:DNA replication origin binding; F:enzyme binding; F:MutLbeta complex binding; F:MutSalpha complex binding; F:MutSbeta complex binding; F:protein-containing complex binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA duplex unwinding; P:double-strand break repair via homologous recombination; P:female gamete generation; P:mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication; P:protein localization to chromatin; P:recombinational interstrand cross-link repair; scaffold21 indexed_genome mRNA 13771214 13779691 . - . ID=transcript_5112;Q8NB25 B9DI75 F8W8D6 Q5TBS9 Q7Z323 Q96GY8 Q9H0J8 Q9H851,Protein FAM184A,, PF15665;, GO:0005615;, C:extracellular space;|Q8NB25 B9DI75 F8W8D6 Q5TBS9 Q7Z323 Q96GY8 Q9H0J8 Q9H851,Protein FAM184A,, PF15665;, GO:0005615;, C:extracellular space; scaffold21 indexed_genome mRNA 13786763 13789827 . - . ID=transcript_5113;Q8NB25 B9DI75 F8W8D6 Q5TBS9 Q7Z323 Q96GY8 Q9H0J8 Q9H851,Protein FAM184A,, PF15665;, GO:0005615;, C:extracellular space; scaffold21 indexed_genome mRNA 13793011 13891452 . - . ID=transcript_5114;Q8NB25 B9DI75 F8W8D6 Q5TBS9 Q7Z323 Q96GY8 Q9H0J8 Q9H851,Protein FAM184A,, PF15665;, GO:0005615;, C:extracellular space; scaffold21 indexed_genome mRNA 13993612 14166377 . - . ID=transcript_5115;P33908 E7EU32 Q6P052 Q9NU44 Q9UJI3,Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA,Man(9)-alpha-mannosidase;Mannosidase alpha class 1A member 1;Processing alpha-1,2-mannosidase IA;, PF01532;, GO:0031410;GO:0005829;GO:0005783;GO:0005793;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005509;GO:0015923;GO:0004571;GO:0005975;GO:1904381;GO:1904382;GO:0006491;GO:0006486;GO:0045047;GO:0030433;, C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:calcium ion binding; F:mannosidase activity; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:Golgi apparatus mannose trimming; P:mannose trimming involved in glycoprotein ERAD pathway; P:N-glycan processing; P:protein glycosylation; P:protein targeting to ER; P:ubiquitin-dependent ERAD pathway; scaffold21 indexed_genome mRNA 15684238 15863138 . - . ID=transcript_5116;Q96NH3 Q5SZD6 Q5SZM6 Q6ZMY4 Q6ZUR7 Q8NB47,Protein broad-minded,TBC1 domain family member 32;, PF14961;, GO:0005929;GO:0005737;GO:0007368;GO:0042733;GO:0007507;GO:0001822;GO:0002088;GO:1905515;GO:0061512;GO:0003406;GO:0060021;GO:0060831;, C:cilium; C:cytoplasm;, , P:determination of left/right symmetry; P:embryonic digit morphogenesis; P:heart development; P:kidney development; P:lens development in camera-type eye; P:non-motile cilium assembly; P:protein localization to cilium; P:retinal pigment epithelium development; P:roof of mouth development; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; scaffold21 indexed_genome mRNA 15917133 15930211 . + . ID=transcript_5117;P17302 B2R5U9 Q6FHU1 Q9Y5I8,Gap junction alpha-1 protein,Connexin-43;Gap junction 43 kDa heart protein;, PF00029;PF03508;, GO:0016324;GO:0030054;GO:0044291;GO:0005922;GO:0005737;GO:0005769;GO:0005789;GO:0005916;GO:0005925;GO:0005921;GO:0005794;GO:0000139;GO:0030660;GO:0005887;GO:0014704;GO:0043231;GO:0005764;GO:0045121;GO:0005741;GO:0005739;GO:0005771;GO:0005654;GO:0005634;GO:0005886;GO:0070160;GO:0043014;GO:0008013;GO:0071253;GO:0097718;GO:0015562;GO:0005243;GO:0086075;GO:1903763;GO:0055077;GO:0034634;GO:0015075;GO:0030165;GO:0017124;GO:0015631;GO:0006915;GO:0015867;GO:0086014;GO:0060348;GO:0046849;GO:0010644;GO:0086064;GO:0007267;GO:0034613;GO:1904646;GO:0071260;GO:0071374;GO:0002544;GO:0046697;GO:0003158;GO:1905867;GO:0000132;GO:0140115;GO:0016264;GO:0014047;GO:0007507;GO:0034220;GO:0035633;GO:0035437;GO:0099111;GO:0060044;GO:0030308;GO:2000279;GO:0001937;GO:0032277;GO:1901164;GO:0061045;GO:0048812;GO:2000987;GO:0010652;GO:0120162;GO:0007204;GO:0010628;GO:0003104;GO:0043123;GO:0032024;GO:1905772;GO:1905332;GO:0045732;GO:2000648;GO:1904707;GO:0045907;GO:0042981;GO:2000810;GO:0051924;GO:0010649;GO:0022898;GO:0032355;GO:0034405;GO:0009749;GO:0002931;GO:0032496;GO:0043434;GO:0009268;GO:0032526;GO:0007165;GO:0007283;GO:0010232;GO:0042908;, C:apical plasma membrane; C:cell junction; C:cell-cell contact zone; C:connexin complex; C:cytoplasm; C:early endosome; C:endoplasmic reticulum membrane; C:fascia adherens; C:focal adhesion; C:gap junction; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of plasma membrane; C:intercalated disc; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane raft; C:mitochondrial outer membrane; C:mitochondrion; C:multivesicular body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:tight junction;, F:alpha-tubulin binding; F:beta-catenin binding; F:connexin binding; F:disordered domain specific binding; F:efflux transmembrane transporter activity; F:gap junction channel activity; F:gap junction channel activity involved in cardiac conduction electrical coupling; F:gap junction channel activity involved in cell communication by electrical coupling; F:gap junction hemi-channel activity; F:glutathione transmembrane transporter activity; F:ion transmembrane transporter activity; F:PDZ domain binding; F:SH3 domain binding; F:tubulin binding;, P:apoptotic process; P:ATP transport; P:atrial cardiac muscle cell action potential; P:bone development; P:bone remodeling; P:cell communication by electrical coupling; P:cell communication by electrical coupling involved in cardiac conduction; P:cell-cell signaling; P:cellular protein localization; P:cellular response to amyloid-beta; P:cellular response to mechanical stimulus; P:cellular response to parathyroid hormone stimulus; P:chronic inflammatory response; P:decidualization; P:endothelium development; P:epididymis development; P:establishment of mitotic spindle orientation; P:export across plasma membrane; P:gap junction assembly; P:glutamate secretion; P:heart development; P:ion transmembrane transport; P:maintenance of blood-brain barrier; P:maintenance of protein localization in endoplasmic reticulum; P:microtubule-based transport; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell growth; P:negative regulation of DNA biosynthetic process; P:negative regulation of endothelial cell proliferation; P:negative regulation of gonadotropin secretion; P:negative regulation of trophoblast cell migration; P:negative regulation of wound healing; P:neuron projection morphogenesis; P:positive regulation of behavioral fear response; P:positive regulation of cell communication by chemical coupling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of gene expression; P:positive regulation of glomerular filtration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of insulin secretion; P:positive regulation of mesodermal cell differentiation; P:positive regulation of morphogenesis of an epithelium; P:positive regulation of protein catabolic process; P:positive regulation of stem cell proliferation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of vasoconstriction; P:regulation of apoptotic process; P:regulation of bicellular tight junction assembly; P:regulation of calcium ion transport; P:regulation of cell communication by electrical coupling; P:regulation of transmembrane transporter activity; P:response to estradiol; P:response to fluid shear stress; P:response to glucose; P:response to ischemia; P:response to lipopolysaccharide; P:response to peptide hormone; P:response to pH; P:response to retinoic acid; P:signal transduction; P:spermatogenesis; P:vascular transport; P:xenobiotic transport; scaffold21 indexed_genome mRNA 16802454 16849372 . + . ID=transcript_5118;Q03933 B4DGJ4 Q0VAH9 Q2M1K4 Q9H445,Heat shock factor protein 2,Heat shock transcription factor 2;, PF00447;PF06546;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0000978;GO:0001162;GO:0000977;GO:1990837;GO:0045944;GO:0006357;GO:0007283;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q03933 B4DGJ4 Q0VAH9 Q2M1K4 Q9H445,Heat shock factor protein 2,Heat shock transcription factor 2;, PF00447;PF06546;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0000978;GO:0001162;GO:0000977;GO:1990837;GO:0045944;GO:0006357;GO:0007283;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q03933 B4DGJ4 Q0VAH9 Q2M1K4 Q9H445,Heat shock factor protein 2,Heat shock transcription factor 2;, PF00447;PF06546;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0000978;GO:0001162;GO:0000977;GO:1990837;GO:0045944;GO:0006357;GO:0007283;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q03933 B4DGJ4 Q0VAH9 Q2M1K4 Q9H445,Heat shock factor protein 2,Heat shock transcription factor 2;, PF00447;PF06546;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0000978;GO:0001162;GO:0000977;GO:1990837;GO:0045944;GO:0006357;GO:0007283;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q03933 B4DGJ4 Q0VAH9 Q2M1K4 Q9H445,Heat shock factor protein 2,Heat shock transcription factor 2;, PF00447;PF06546;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0000978;GO:0001162;GO:0000977;GO:1990837;GO:0045944;GO:0006357;GO:0007283;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold21 indexed_genome mRNA 16854217 16858264 . - . ID=transcript_5119;Q9NRX5 B3KY69 E1P565 O75655 Q7Z2F5 Q8TAG1 Q9NTH8 Q9ULG7,Serine incorporator 1,Tumor differentially expressed protein 1-like;Tumor differentially expressed protein 2;, PF03348;, GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0019899;GO:0030674;GO:0044091;GO:0006658;GO:0008654;GO:1904219;GO:1904222;GO:0006665;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:enzyme binding; F:protein-macromolecule adaptor activity;, P:membrane biogenesis; P:phosphatidylserine metabolic process; P:phospholipid biosynthetic process; P:positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity; P:positive regulation of serine C-palmitoyltransferase activity; P:sphingolipid metabolic process;|Q9NRX5 B3KY69 E1P565 O75655 Q7Z2F5 Q8TAG1 Q9NTH8 Q9ULG7,Serine incorporator 1,Tumor differentially expressed protein 1-like;Tumor differentially expressed protein 2;, PF03348;, GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0019899;GO:0030674;GO:0044091;GO:0006658;GO:0008654;GO:1904219;GO:1904222;GO:0006665;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:enzyme binding; F:protein-macromolecule adaptor activity;, P:membrane biogenesis; P:phosphatidylserine metabolic process; P:phospholipid biosynthetic process; P:positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity; P:positive regulation of serine C-palmitoyltransferase activity; P:sphingolipid metabolic process; scaffold21 indexed_genome mRNA 16858280 16891278 . - . ID=transcript_5120;Q9NRX5 B3KY69 E1P565 O75655 Q7Z2F5 Q8TAG1 Q9NTH8 Q9ULG7,Serine incorporator 1,Tumor differentially expressed protein 1-like;Tumor differentially expressed protein 2;, PF03348;, GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0019899;GO:0030674;GO:0044091;GO:0006658;GO:0008654;GO:1904219;GO:1904222;GO:0006665;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:enzyme binding; F:protein-macromolecule adaptor activity;, P:membrane biogenesis; P:phosphatidylserine metabolic process; P:phospholipid biosynthetic process; P:positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity; P:positive regulation of serine C-palmitoyltransferase activity; P:sphingolipid metabolic process;|Q9NRX5 B3KY69 E1P565 O75655 Q7Z2F5 Q8TAG1 Q9NTH8 Q9ULG7,Serine incorporator 1,Tumor differentially expressed protein 1-like;Tumor differentially expressed protein 2;, PF03348;, GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0019899;GO:0030674;GO:0044091;GO:0006658;GO:0008654;GO:1904219;GO:1904222;GO:0006665;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:enzyme binding; F:protein-macromolecule adaptor activity;, P:membrane biogenesis; P:phosphatidylserine metabolic process; P:phospholipid biosynthetic process; P:positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity; P:positive regulation of serine C-palmitoyltransferase activity; P:sphingolipid metabolic process;|Q9NRX5 B3KY69 E1P565 O75655 Q7Z2F5 Q8TAG1 Q9NTH8 Q9ULG7,Serine incorporator 1,Tumor differentially expressed protein 1-like;Tumor differentially expressed protein 2;, PF03348;, GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0019899;GO:0030674;GO:0044091;GO:0006658;GO:0008654;GO:1904219;GO:1904222;GO:0006665;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:enzyme binding; F:protein-macromolecule adaptor activity;, P:membrane biogenesis; P:phosphatidylserine metabolic process; P:phospholipid biosynthetic process; P:positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity; P:positive regulation of serine C-palmitoyltransferase activity; P:sphingolipid metabolic process; scaffold21 indexed_genome mRNA 17079847 17086947 . + . ID=transcript_5121;Q9C010 B2RCK2 Q567T9 Q5T0Z7,cAMP-dependent protein kinase inhibitor beta,, PF02827;, GO:0005737;GO:0005634;GO:0004862;GO:2000480;GO:0051973;GO:1904355;GO:0032212;, C:cytoplasm; C:nucleus;, F:cAMP-dependent protein kinase inhibitor activity;, P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase;|Q9C010 B2RCK2 Q567T9 Q5T0Z7,cAMP-dependent protein kinase inhibitor beta,, PF02827;, GO:0005737;GO:0005634;GO:0004862;GO:2000480;GO:0051973;GO:1904355;GO:0032212;, C:cytoplasm; C:nucleus;, F:cAMP-dependent protein kinase inhibitor activity;, P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; scaffold21 indexed_genome mRNA 17127917 17130800 . + . ID=transcript_5122;O15540 B2R4L1 O14951 Q6IAU7 Q9H047,Fatty acid-binding protein, brain,Brain lipid-binding protein;Brain-type fatty acid-binding protein;Fatty acid-binding protein 7;Mammary-derived growth inhibitor related;, PF00061;, GO:0005829;GO:0005634;GO:0008289;GO:0050673;GO:0008285;GO:0007399;GO:0019433;, C:cytosol; C:nucleus;, F:lipid binding;, P:epithelial cell proliferation; P:negative regulation of cell population proliferation; P:nervous system development; P:triglyceride catabolic process;|O15540 B2R4L1 O14951 Q6IAU7 Q9H047,Fatty acid-binding protein, brain,Brain lipid-binding protein;Brain-type fatty acid-binding protein;Fatty acid-binding protein 7;Mammary-derived growth inhibitor related;, PF00061;, GO:0005829;GO:0005634;GO:0008289;GO:0050673;GO:0008285;GO:0007399;GO:0019433;, C:cytosol; C:nucleus;, F:lipid binding;, P:epithelial cell proliferation; P:negative regulation of cell population proliferation; P:nervous system development; P:triglyceride catabolic process; scaffold21 indexed_genome mRNA 17143053 17154448 . + . ID=transcript_5123;Q92484 B7Z729 Q8WV13,Acid sphingomyelinase-like phosphodiesterase 3a,, PF00149;, GO:0070062;GO:0005615;GO:0008081;GO:0008270;GO:0009143;, C:extracellular exosome; C:extracellular space;, F:phosphoric diester hydrolase activity; F:zinc ion binding;, P:nucleoside triphosphate catabolic process; scaffold21 indexed_genome mRNA 17255998 17333073 . + . ID=transcript_5124;Q5SYC1 B3KTG5 B4DHL0 C8UZT4 Q5SYC0,Clavesin-2,Retinaldehyde-binding protein 1-like 2;clathrin vesicle-associated Sec14 protein 2 {ECO:0000303|PubMed:19651769};, PF00650;PF03765;, GO:0030136;GO:0031901;GO:0005768;GO:0005802;GO:0032588;GO:1902936;GO:0080025;GO:0007040;GO:0006892;, C:clathrin-coated vesicle; C:early endosome membrane; C:endosome; C:trans-Golgi network; C:trans-Golgi network membrane;, F:phosphatidylinositol bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding;, P:lysosome organization; P:post-Golgi vesicle-mediated transport; scaffold21 indexed_genome mRNA 17448510 17842128 . - . ID=transcript_5125;Q13061 A5D6W5 F5H2W7 Q6NSB8,Triadin,, PF05279;, GO:0005829;GO:0005783;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0016529;GO:0033018;GO:0033017;GO:0044325;GO:0030674;GO:0005102;GO:0006874;GO:0031122;GO:0090158;GO:0060047;GO:0034220;GO:0006936;GO:0060315;GO:1901846;GO:0060316;GO:1903779;GO:0086036;GO:0010649;GO:0051279;GO:0010880;GO:0014808;GO:0009617;, C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:protein-macromolecule adaptor activity; F:signaling receptor binding;, P:cellular calcium ion homeostasis; P:cytoplasmic microtubule organization; P:endoplasmic reticulum membrane organization; P:heart contraction; P:ion transmembrane transport; P:muscle contraction; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of cell communication by electrical coupling involved in cardiac conduction; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cell communication by electrical coupling; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to bacterium;|Q13061 A5D6W5 F5H2W7 Q6NSB8,Triadin,, PF05279;, GO:0005829;GO:0005783;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0016529;GO:0033018;GO:0033017;GO:0044325;GO:0030674;GO:0005102;GO:0006874;GO:0031122;GO:0090158;GO:0060047;GO:0034220;GO:0006936;GO:0060315;GO:1901846;GO:0060316;GO:1903779;GO:0086036;GO:0010649;GO:0051279;GO:0010880;GO:0014808;GO:0009617;, C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:protein-macromolecule adaptor activity; F:signaling receptor binding;, P:cellular calcium ion homeostasis; P:cytoplasmic microtubule organization; P:endoplasmic reticulum membrane organization; P:heart contraction; P:ion transmembrane transport; P:muscle contraction; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of cell communication by electrical coupling involved in cardiac conduction; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cell communication by electrical coupling; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to bacterium;|Q13061 A5D6W5 F5H2W7 Q6NSB8,Triadin,, PF05279;, GO:0005829;GO:0005783;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0016529;GO:0033018;GO:0033017;GO:0044325;GO:0030674;GO:0005102;GO:0006874;GO:0031122;GO:0090158;GO:0060047;GO:0034220;GO:0006936;GO:0060315;GO:1901846;GO:0060316;GO:1903779;GO:0086036;GO:0010649;GO:0051279;GO:0010880;GO:0014808;GO:0009617;, C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:protein-macromolecule adaptor activity; F:signaling receptor binding;, P:cellular calcium ion homeostasis; P:cytoplasmic microtubule organization; P:endoplasmic reticulum membrane organization; P:heart contraction; P:ion transmembrane transport; P:muscle contraction; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of cell communication by electrical coupling involved in cardiac conduction; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cell communication by electrical coupling; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to bacterium;|Q13061 A5D6W5 F5H2W7 Q6NSB8,Triadin,, PF05279;, GO:0005829;GO:0005783;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0016529;GO:0033018;GO:0033017;GO:0044325;GO:0030674;GO:0005102;GO:0006874;GO:0031122;GO:0090158;GO:0060047;GO:0034220;GO:0006936;GO:0060315;GO:1901846;GO:0060316;GO:1903779;GO:0086036;GO:0010649;GO:0051279;GO:0010880;GO:0014808;GO:0009617;, C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:protein-macromolecule adaptor activity; F:signaling receptor binding;, P:cellular calcium ion homeostasis; P:cytoplasmic microtubule organization; P:endoplasmic reticulum membrane organization; P:heart contraction; P:ion transmembrane transport; P:muscle contraction; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of cell communication by electrical coupling involved in cardiac conduction; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cell communication by electrical coupling; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to bacterium;|Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response;|Q13061 A5D6W5 F5H2W7 Q6NSB8,Triadin,, PF05279;, GO:0005829;GO:0005783;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0016529;GO:0033018;GO:0033017;GO:0044325;GO:0030674;GO:0005102;GO:0006874;GO:0031122;GO:0090158;GO:0060047;GO:0034220;GO:0006936;GO:0060315;GO:1901846;GO:0060316;GO:1903779;GO:0086036;GO:0010649;GO:0051279;GO:0010880;GO:0014808;GO:0009617;, C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:protein-macromolecule adaptor activity; F:signaling receptor binding;, P:cellular calcium ion homeostasis; P:cytoplasmic microtubule organization; P:endoplasmic reticulum membrane organization; P:heart contraction; P:ion transmembrane transport; P:muscle contraction; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of cell communication by electrical coupling involved in cardiac conduction; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cell communication by electrical coupling; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to bacterium; scaffold21 indexed_genome mRNA 17992122 19114850 . + . ID=transcript_5126;Q5VXU1 Q8IYR4 Q8TF67,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2,Protein FAM77B;T-cell lymphoma breakpoint-associated target protein 1;, PF05640;, GO:0016021;GO:0005886;GO:0002028;, C:integral component of membrane; C:plasma membrane;, , P:regulation of sodium ion transport; scaffold21 indexed_genome mRNA 19234984 19357543 . + . ID=transcript_5127;Q8TC41 H7C5V4 Q5TCA4 Q9BX48,Probable E3 ubiquitin-protein ligase RNF217,IBR domain-containing protein 1;RING finger protein 217;, PF01485;, GO:0005737;GO:0005829;GO:0016021;GO:0000151;GO:0046872;GO:0031624;GO:0061630;GO:0004842;GO:0032436;GO:0000209;GO:0006511;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold21 indexed_genome mRNA 19383471 19477252 . + . ID=transcript_5128;Q5TDQ0 Q9BUQ6 Q9C054,Tumor protein D53,Tumor protein D52-like 1;, PF04201;, GO:0005737;GO:0048471;GO:0042802;GO:0042803;GO:0000086;GO:2001235;GO:0046330;GO:0043406;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:identical protein binding; F:protein homodimerization activity;, P:G2/M transition of mitotic cell cycle; P:positive regulation of apoptotic signaling pathway; P:positive regulation of JNK cascade; P:positive regulation of MAP kinase activity; scaffold21 indexed_genome mRNA 19481984 19499359 . - . ID=transcript_5129;Q7Z4H3 Q5TDQ4 Q6NZ49 Q9BTT2 Q9BV31 Q9Y3D1,5'-deoxynucleotidase HDDC2 {ECO:0000305},HD domain-containing protein 2;Hepatitis C virus NS5A-transactivated protein 2;, PF13023;, GO:0005737;GO:0002953;GO:0046872;, C:cytoplasm;, F:5'-deoxynucleotidase activity; F:metal ion binding;|Q7Z4H3 Q5TDQ4 Q6NZ49 Q9BTT2 Q9BV31 Q9Y3D1,5'-deoxynucleotidase HDDC2 {ECO:0000305},HD domain-containing protein 2;Hepatitis C virus NS5A-transactivated protein 2;, PF13023;, GO:0005737;GO:0002953;GO:0046872;, C:cytoplasm;, F:5'-deoxynucleotidase activity; F:metal ion binding; scaffold21 indexed_genome mRNA 19888664 19893153 . + . ID=transcript_5130;Q9UBP5,Hairy/enhancer-of-split related with YRPW motif protein 2,Cardiovascular helix-loop-helix factor 1;Class B basic helix-loop-helix protein 32;HES-related repressor protein 2;Hairy and enhancer of split-related protein 2;Hairy-related transcription factor 2;Protein gridlock homolog;, PF07527;PF00010;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0003700;GO:0000981;GO:0001227;GO:0042826;GO:0042802;GO:0046983;GO:0001102;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0009948;GO:0009952;GO:0003180;GO:0060842;GO:0035910;GO:0060413;GO:0060317;GO:0003214;GO:0014898;GO:0003215;GO:0060411;GO:0060948;GO:0003208;GO:0045165;GO:0072359;GO:0090102;GO:0060977;GO:0035912;GO:0003199;GO:0003198;GO:0060347;GO:0060716;GO:0014031;GO:0003150;GO:0070168;GO:0010667;GO:2000723;GO:0010629;GO:0045746;GO:0000122;GO:0010621;GO:2000820;GO:0060633;GO:2000678;GO:0045892;GO:0061314;GO:0007219;GO:0003151;GO:0060045;GO:0010628;GO:0010460;GO:0045944;GO:0045893;GO:0065004;GO:0061156;GO:0003184;GO:0045607;GO:0050767;GO:0006357;GO:2001212;GO:0051145;GO:0003195;GO:0003186;GO:0036304;GO:0097084;GO:0001570;GO:0055015;GO:0060412;GO:0003222;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:anterior/posterior axis specification; P:anterior/posterior pattern specification; P:aortic valve morphogenesis; P:arterial endothelial cell differentiation; P:ascending aorta morphogenesis; P:atrial septum morphogenesis; P:cardiac epithelial to mesenchymal transition; P:cardiac left ventricle morphogenesis; P:cardiac muscle hypertrophy in response to stress; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cardiac vascular smooth muscle cell development; P:cardiac ventricle morphogenesis; P:cell fate commitment; P:circulatory system development; P:cochlea development; P:coronary vasculature morphogenesis; P:dorsal aorta morphogenesis; P:endocardial cushion to mesenchymal transition involved in heart valve formation; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:heart trabecula formation; P:labyrinthine layer blood vessel development; P:mesenchymal cell development; P:muscular septum morphogenesis; P:negative regulation of biomineral tissue development; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cardiac vascular smooth muscle cell differentiation; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription by transcription factor localization; P:negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; P:negative regulation of transcription initiation from RNA polymerase II promoter; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:outflow tract morphogenesis; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of gene expression; P:positive regulation of heart rate; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein-DNA complex assembly; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of inner ear auditory receptor cell differentiation; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of vasculogenesis; P:smooth muscle cell differentiation; P:tricuspid valve formation; P:tricuspid valve morphogenesis; P:umbilical cord morphogenesis; P:vascular associated smooth muscle cell development; P:vasculogenesis; P:ventricular cardiac muscle cell development; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis; scaffold21 indexed_genome mRNA 19893192 19898595 . + . ID=transcript_5131;Q9UBP5,Hairy/enhancer-of-split related with YRPW motif protein 2,Cardiovascular helix-loop-helix factor 1;Class B basic helix-loop-helix protein 32;HES-related repressor protein 2;Hairy and enhancer of split-related protein 2;Hairy-related transcription factor 2;Protein gridlock homolog;, PF07527;PF00010;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0003700;GO:0000981;GO:0001227;GO:0042826;GO:0042802;GO:0046983;GO:0001102;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0009948;GO:0009952;GO:0003180;GO:0060842;GO:0035910;GO:0060413;GO:0060317;GO:0003214;GO:0014898;GO:0003215;GO:0060411;GO:0060948;GO:0003208;GO:0045165;GO:0072359;GO:0090102;GO:0060977;GO:0035912;GO:0003199;GO:0003198;GO:0060347;GO:0060716;GO:0014031;GO:0003150;GO:0070168;GO:0010667;GO:2000723;GO:0010629;GO:0045746;GO:0000122;GO:0010621;GO:2000820;GO:0060633;GO:2000678;GO:0045892;GO:0061314;GO:0007219;GO:0003151;GO:0060045;GO:0010628;GO:0010460;GO:0045944;GO:0045893;GO:0065004;GO:0061156;GO:0003184;GO:0045607;GO:0050767;GO:0006357;GO:2001212;GO:0051145;GO:0003195;GO:0003186;GO:0036304;GO:0097084;GO:0001570;GO:0055015;GO:0060412;GO:0003222;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:anterior/posterior axis specification; P:anterior/posterior pattern specification; P:aortic valve morphogenesis; P:arterial endothelial cell differentiation; P:ascending aorta morphogenesis; P:atrial septum morphogenesis; P:cardiac epithelial to mesenchymal transition; P:cardiac left ventricle morphogenesis; P:cardiac muscle hypertrophy in response to stress; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cardiac vascular smooth muscle cell development; P:cardiac ventricle morphogenesis; P:cell fate commitment; P:circulatory system development; P:cochlea development; P:coronary vasculature morphogenesis; P:dorsal aorta morphogenesis; P:endocardial cushion to mesenchymal transition involved in heart valve formation; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:heart trabecula formation; P:labyrinthine layer blood vessel development; P:mesenchymal cell development; P:muscular septum morphogenesis; P:negative regulation of biomineral tissue development; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cardiac vascular smooth muscle cell differentiation; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription by transcription factor localization; P:negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; P:negative regulation of transcription initiation from RNA polymerase II promoter; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:outflow tract morphogenesis; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of gene expression; P:positive regulation of heart rate; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein-DNA complex assembly; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of inner ear auditory receptor cell differentiation; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of vasculogenesis; P:smooth muscle cell differentiation; P:tricuspid valve formation; P:tricuspid valve morphogenesis; P:umbilical cord morphogenesis; P:vascular associated smooth muscle cell development; P:vasculogenesis; P:ventricular cardiac muscle cell development; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis;|Q9UBP5,Hairy/enhancer-of-split related with YRPW motif protein 2,Cardiovascular helix-loop-helix factor 1;Class B basic helix-loop-helix protein 32;HES-related repressor protein 2;Hairy and enhancer of split-related protein 2;Hairy-related transcription factor 2;Protein gridlock homolog;, PF07527;PF00010;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0003700;GO:0000981;GO:0001227;GO:0042826;GO:0042802;GO:0046983;GO:0001102;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0009948;GO:0009952;GO:0003180;GO:0060842;GO:0035910;GO:0060413;GO:0060317;GO:0003214;GO:0014898;GO:0003215;GO:0060411;GO:0060948;GO:0003208;GO:0045165;GO:0072359;GO:0090102;GO:0060977;GO:0035912;GO:0003199;GO:0003198;GO:0060347;GO:0060716;GO:0014031;GO:0003150;GO:0070168;GO:0010667;GO:2000723;GO:0010629;GO:0045746;GO:0000122;GO:0010621;GO:2000820;GO:0060633;GO:2000678;GO:0045892;GO:0061314;GO:0007219;GO:0003151;GO:0060045;GO:0010628;GO:0010460;GO:0045944;GO:0045893;GO:0065004;GO:0061156;GO:0003184;GO:0045607;GO:0050767;GO:0006357;GO:2001212;GO:0051145;GO:0003195;GO:0003186;GO:0036304;GO:0097084;GO:0001570;GO:0055015;GO:0060412;GO:0003222;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:anterior/posterior axis specification; P:anterior/posterior pattern specification; P:aortic valve morphogenesis; P:arterial endothelial cell differentiation; P:ascending aorta morphogenesis; P:atrial septum morphogenesis; P:cardiac epithelial to mesenchymal transition; P:cardiac left ventricle morphogenesis; P:cardiac muscle hypertrophy in response to stress; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cardiac vascular smooth muscle cell development; P:cardiac ventricle morphogenesis; P:cell fate commitment; P:circulatory system development; P:cochlea development; P:coronary vasculature morphogenesis; P:dorsal aorta morphogenesis; P:endocardial cushion to mesenchymal transition involved in heart valve formation; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:heart trabecula formation; P:labyrinthine layer blood vessel development; P:mesenchymal cell development; P:muscular septum morphogenesis; P:negative regulation of biomineral tissue development; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cardiac vascular smooth muscle cell differentiation; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription by transcription factor localization; P:negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; P:negative regulation of transcription initiation from RNA polymerase II promoter; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:outflow tract morphogenesis; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of gene expression; P:positive regulation of heart rate; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein-DNA complex assembly; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of inner ear auditory receptor cell differentiation; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of vasculogenesis; P:smooth muscle cell differentiation; P:tricuspid valve formation; P:tricuspid valve morphogenesis; P:umbilical cord morphogenesis; P:vascular associated smooth muscle cell development; P:vasculogenesis; P:ventricular cardiac muscle cell development; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis; scaffold21 indexed_genome mRNA 19927071 20079736 . + . ID=transcript_5132;Q6NE83 Q86T89 Q8N1W4,Nuclear receptor coactivator 7,140 kDa estrogen receptor-associated protein;Estrogen nuclear receptor coactivator 1;, PF01476;PF07534;, GO:0005634;GO:0035257;GO:0030374;GO:1900408;GO:1903204;GO:1902083;GO:0045944;GO:0006357;GO:0006979;, C:nucleus;, F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity;, P:negative regulation of cellular response to oxidative stress; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to oxidative stress;|Q6NE83 Q86T89 Q8N1W4,Nuclear receptor coactivator 7,140 kDa estrogen receptor-associated protein;Estrogen nuclear receptor coactivator 1;, PF01476;PF07534;, GO:0005634;GO:0035257;GO:0030374;GO:1900408;GO:1903204;GO:1902083;GO:0045944;GO:0006357;GO:0006979;, C:nucleus;, F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity;, P:negative regulation of cellular response to oxidative stress; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to oxidative stress;|Q6NE83 Q86T89 Q8N1W4,Nuclear receptor coactivator 7,140 kDa estrogen receptor-associated protein;Estrogen nuclear receptor coactivator 1;, PF01476;PF07534;, GO:0005634;GO:0035257;GO:0030374;GO:1900408;GO:1903204;GO:1902083;GO:0045944;GO:0006357;GO:0006979;, C:nucleus;, F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity;, P:negative regulation of cellular response to oxidative stress; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to oxidative stress;|Q6NE83 Q86T89 Q8N1W4,Nuclear receptor coactivator 7,140 kDa estrogen receptor-associated protein;Estrogen nuclear receptor coactivator 1;, PF01476;PF07534;, GO:0005634;GO:0035257;GO:0030374;GO:1900408;GO:1903204;GO:1902083;GO:0045944;GO:0006357;GO:0006979;, C:nucleus;, F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity;, P:negative regulation of cellular response to oxidative stress; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to oxidative stress;|Q6NE83 Q86T89 Q8N1W4,Nuclear receptor coactivator 7,140 kDa estrogen receptor-associated protein;Estrogen nuclear receptor coactivator 1;, PF01476;PF07534;, GO:0005634;GO:0035257;GO:0030374;GO:1900408;GO:1903204;GO:1902083;GO:0045944;GO:0006357;GO:0006979;, C:nucleus;, F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity;, P:negative regulation of cellular response to oxidative stress; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to oxidative stress;|Q6NE83 Q86T89 Q8N1W4,Nuclear receptor coactivator 7,140 kDa estrogen receptor-associated protein;Estrogen nuclear receptor coactivator 1;, PF01476;PF07534;, GO:0005634;GO:0035257;GO:0030374;GO:1900408;GO:1903204;GO:1902083;GO:0045944;GO:0006357;GO:0006979;, C:nucleus;, F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity;, P:negative regulation of cellular response to oxidative stress; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to oxidative stress; scaffold21 indexed_genome mRNA 20095872 20110584 . + . ID=transcript_5133;Q9NQE9 B3KQ91 Q8N0Y9,Histidine triad nucleotide-binding protein 3,, , GO:0005737;GO:0005634;GO:0043530;GO:0042802;GO:0000166;, C:cytoplasm; C:nucleus;, F:adenosine 5'-monophosphoramidase activity; F:identical protein binding; F:nucleotide binding;|Q9NQE9 B3KQ91 Q8N0Y9,Histidine triad nucleotide-binding protein 3,, , GO:0005737;GO:0005634;GO:0043530;GO:0042802;GO:0000166;, C:cytoplasm; C:nucleus;, F:adenosine 5'-monophosphoramidase activity; F:identical protein binding; F:nucleotide binding;|Q9NQE9 B3KQ91 Q8N0Y9,Histidine triad nucleotide-binding protein 3,, , GO:0005737;GO:0005634;GO:0043530;GO:0042802;GO:0000166;, C:cytoplasm; C:nucleus;, F:adenosine 5'-monophosphoramidase activity; F:identical protein binding; F:nucleotide binding; scaffold21 indexed_genome mRNA 20120193 20180030 . + . ID=transcript_5134;Q7Z4G4 E1P570 Q5JY11 Q6PGQ5 Q9HC13,tRNA (guanine(10)-N2)-methyltransferase homolog,tRNA guanosine-2'-O-methyltransferase TRM11 homolog;, PF01170;, GO:0005737;GO:0008168;GO:0004809;GO:0000049;, C:cytoplasm;, F:methyltransferase activity; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;|Q7Z4G4 E1P570 Q5JY11 Q6PGQ5 Q9HC13,tRNA (guanine(10)-N2)-methyltransferase homolog,tRNA guanosine-2'-O-methyltransferase TRM11 homolog;, PF01170;, GO:0005737;GO:0008168;GO:0004809;GO:0000049;, C:cytoplasm;, F:methyltransferase activity; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;|Q7Z4G4 E1P570 Q5JY11 Q6PGQ5 Q9HC13,tRNA (guanine(10)-N2)-methyltransferase homolog,tRNA guanosine-2'-O-methyltransferase TRM11 homolog;, PF01170;, GO:0005737;GO:0008168;GO:0004809;GO:0000049;, C:cytoplasm;, F:methyltransferase activity; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;|Q7Z4G4 E1P570 Q5JY11 Q6PGQ5 Q9HC13,tRNA (guanine(10)-N2)-methyltransferase homolog,tRNA guanosine-2'-O-methyltransferase TRM11 homolog;, PF01170;, GO:0005737;GO:0008168;GO:0004809;GO:0000049;, C:cytoplasm;, F:methyltransferase activity; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;|Q7Z4G4 E1P570 Q5JY11 Q6PGQ5 Q9HC13,tRNA (guanine(10)-N2)-methyltransferase homolog,tRNA guanosine-2'-O-methyltransferase TRM11 homolog;, PF01170;, GO:0005737;GO:0008168;GO:0004809;GO:0000049;, C:cytoplasm;, F:methyltransferase activity; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;|Q7Z4G4 E1P570 Q5JY11 Q6PGQ5 Q9HC13,tRNA (guanine(10)-N2)-methyltransferase homolog,tRNA guanosine-2'-O-methyltransferase TRM11 homolog;, PF01170;, GO:0005737;GO:0008168;GO:0004809;GO:0000049;, C:cytoplasm;, F:methyltransferase activity; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding; scaffold21 indexed_genome mRNA 20458063 20466756 . + . ID=transcript_5135;Q5EE01 A6NIR0 A6NJC2,Centromere protein W,Cancer-up-regulated gene 2 protein;, PF15510;, GO:0000775;GO:0000777;GO:0000776;GO:0016363;GO:0005730;GO:0005654;GO:0003677;GO:0046982;GO:0051301;GO:0034080;GO:0051276;GO:0007059;GO:0051382;GO:0000278;, C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:kinetochore; C:nuclear matrix; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:protein heterodimerization activity;, P:cell division; P:CENP-A containing nucleosome assembly; P:chromosome organization; P:chromosome segregation; P:kinetochore assembly; P:mitotic cell cycle; scaffold21 indexed_genome mRNA 21239746 21294290 . + . ID=transcript_5136;Q9BXY4 B2RC27 Q5VTV4 Q96K87,R-spondin-3,Protein with TSP type-1 repeat;Roof plate-specific spondin-3;Thrombospondin type-1 domain-containing protein 2;, PF15913;PF19028;, GO:0005576;GO:0005109;GO:0008201;GO:0005102;GO:0001974;GO:0060670;GO:0090263;GO:2000052;GO:0030177;GO:2000096;GO:0030111;GO:0002040;GO:0016055;, C:extracellular region;, F:frizzled binding; F:heparin binding; F:signaling receptor binding;, P:blood vessel remodeling; P:branching involved in labyrinthine layer morphogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of Wnt signaling pathway; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:regulation of Wnt signaling pathway; P:sprouting angiogenesis; P:Wnt signaling pathway; scaffold21 indexed_genome mRNA 21376558 21439029 . - . ID=transcript_5137;Q9NTX7 E1P572 Q6FIB2 Q7L8H4 Q96K03 Q96T06 Q9NTX6,E3 ubiquitin-protein ligase RNF146,Dactylidin;Iduna;RING finger protein 146;RING-type E3 ubiquitin transferase RNF146 {ECO:0000305};, PF02825;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0072572;GO:0061630;GO:0004842;GO:0008270;GO:0090263;GO:0051865;GO:0070936;GO:0006511;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:poly-ADP-D-ribose binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:positive regulation of canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q9NTX7 E1P572 Q6FIB2 Q7L8H4 Q96K03 Q96T06 Q9NTX6,E3 ubiquitin-protein ligase RNF146,Dactylidin;Iduna;RING finger protein 146;RING-type E3 ubiquitin transferase RNF146 {ECO:0000305};, PF02825;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0072572;GO:0061630;GO:0004842;GO:0008270;GO:0090263;GO:0051865;GO:0070936;GO:0006511;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:poly-ADP-D-ribose binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:positive regulation of canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q5TEG4 Q9NZ30 V9HW18,Ethylmalonyl-CoA decarboxylase,Enoyl-CoA hydratase domain-containing protein 1;Methylmalonyl-CoA decarboxylase;, PF00378;, GO:0005829;GO:0016831;GO:0004300;GO:0006635;, C:cytosol;, F:carboxy-lyase activity; F:enoyl-CoA hydratase activity;, P:fatty acid beta-oxidation; scaffold21 indexed_genome mRNA 21528618 21541961 . - . ID=transcript_5138;Q6ZU52 B3KRE5 E1P573 O43158 Q5TF20 Q7L2M2,Uncharacterized protein KIAA0408,, PF14818;|Q6ZU52 B3KRE5 E1P573 O43158 Q5TF20 Q7L2M2,Uncharacterized protein KIAA0408,, PF14818;|Q6ZU52 B3KRE5 E1P573 O43158 Q5TF20 Q7L2M2,Uncharacterized protein KIAA0408,, PF14818;|Q6ZU52 B3KRE5 E1P573 O43158 Q5TF20 Q7L2M2,Uncharacterized protein KIAA0408,, PF14818; scaffold21 indexed_genome mRNA 21559001 21603747 . - . ID=transcript_5139;Q5TF21,Protein SOGA3,, PF11365;, GO:0005615;GO:0016021;GO:0010506;, C:extracellular space; C:integral component of membrane;, , P:regulation of autophagy;|Q5TF21,Protein SOGA3,, PF11365;, GO:0005615;GO:0016021;GO:0010506;, C:extracellular space; C:integral component of membrane;, , P:regulation of autophagy; scaffold21 indexed_genome mRNA 21607934 21609523 . + . ID=transcript_5140;P08865 P11085 P12030 Q16471 Q6IPD1 Q6IPD2 Q6NSD1 Q6NXQ8 Q86VC0,40S ribosomal protein SA {ECO:0000255|HAMAP-Rule:MF_03016},37 kDa laminin receptor precursor {ECO:0000255|HAMAP-Rule:MF_03016};37/67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};Colon carcinoma laminin-binding protein;Laminin receptor 1 {ECO:0000255|HAMAP-Rule:MF_03016};Laminin-binding protein precursor p40 {ECO:0000255|HAMAP-Rule:MF_03016};Multidrug resistance-associated protein MGr1-Ag;NEM/1CHD4;Small ribosomal subunit protein uS2 {ECO:0000303|PubMed:24524803};, PF16122;PF00318;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0043236;GO:0005055;GO:0043022;GO:0003723;GO:0003735;GO:0001618;GO:0007155;GO:0002181;GO:0000184;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:laminin binding; F:laminin receptor activity; F:ribosome binding; F:RNA binding; F:structural constituent of ribosome; F:virus receptor activity;, P:cell adhesion; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold21 indexed_genome mRNA 21756564 21912331 . + . ID=transcript_5141;O60641 A8K0L7 E5RI02 Q5JX13 Q68DL9 Q6P9D3 Q9NTY7,Clathrin coat assembly protein AP180,91 kDa synaptosomal-associated protein;Clathrin coat-associated protein AP180;Phosphoprotein F1-20;, PF07651;, GO:0005905;GO:0030136;GO:0098894;GO:0008021;GO:0005545;GO:0032050;GO:0005546;GO:0019901;GO:0000149;GO:0048268;GO:0072583;GO:0015031;GO:2000369;GO:0016185;GO:0006900;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:extrinsic component of presynaptic endocytic zone membrane; C:synaptic vesicle;, F:1-phosphatidylinositol binding; F:clathrin heavy chain binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase binding; F:SNARE binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:protein transport; P:regulation of clathrin-dependent endocytosis; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:vesicle budding from membrane;|O60641 A8K0L7 E5RI02 Q5JX13 Q68DL9 Q6P9D3 Q9NTY7,Clathrin coat assembly protein AP180,91 kDa synaptosomal-associated protein;Clathrin coat-associated protein AP180;Phosphoprotein F1-20;, PF07651;, GO:0005905;GO:0030136;GO:0098894;GO:0008021;GO:0005545;GO:0032050;GO:0005546;GO:0019901;GO:0000149;GO:0048268;GO:0072583;GO:0015031;GO:2000369;GO:0016185;GO:0006900;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:extrinsic component of presynaptic endocytic zone membrane; C:synaptic vesicle;, F:1-phosphatidylinositol binding; F:clathrin heavy chain binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase binding; F:SNARE binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:protein transport; P:regulation of clathrin-dependent endocytosis; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:vesicle budding from membrane;|O60641 A8K0L7 E5RI02 Q5JX13 Q68DL9 Q6P9D3 Q9NTY7,Clathrin coat assembly protein AP180,91 kDa synaptosomal-associated protein;Clathrin coat-associated protein AP180;Phosphoprotein F1-20;, PF07651;, GO:0005905;GO:0030136;GO:0098894;GO:0008021;GO:0005545;GO:0032050;GO:0005546;GO:0019901;GO:0000149;GO:0048268;GO:0072583;GO:0015031;GO:2000369;GO:0016185;GO:0006900;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:extrinsic component of presynaptic endocytic zone membrane; C:synaptic vesicle;, F:1-phosphatidylinositol binding; F:clathrin heavy chain binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase binding; F:SNARE binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:protein transport; P:regulation of clathrin-dependent endocytosis; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:vesicle budding from membrane;|O60641 A8K0L7 E5RI02 Q5JX13 Q68DL9 Q6P9D3 Q9NTY7,Clathrin coat assembly protein AP180,91 kDa synaptosomal-associated protein;Clathrin coat-associated protein AP180;Phosphoprotein F1-20;, PF07651;, GO:0005905;GO:0030136;GO:0098894;GO:0008021;GO:0005545;GO:0032050;GO:0005546;GO:0019901;GO:0000149;GO:0048268;GO:0072583;GO:0015031;GO:2000369;GO:0016185;GO:0006900;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:extrinsic component of presynaptic endocytic zone membrane; C:synaptic vesicle;, F:1-phosphatidylinositol binding; F:clathrin heavy chain binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase binding; F:SNARE binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:protein transport; P:regulation of clathrin-dependent endocytosis; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:vesicle budding from membrane;|O60641 A8K0L7 E5RI02 Q5JX13 Q68DL9 Q6P9D3 Q9NTY7,Clathrin coat assembly protein AP180,91 kDa synaptosomal-associated protein;Clathrin coat-associated protein AP180;Phosphoprotein F1-20;, PF07651;, GO:0005905;GO:0030136;GO:0098894;GO:0008021;GO:0005545;GO:0032050;GO:0005546;GO:0019901;GO:0000149;GO:0048268;GO:0072583;GO:0015031;GO:2000369;GO:0016185;GO:0006900;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:extrinsic component of presynaptic endocytic zone membrane; C:synaptic vesicle;, F:1-phosphatidylinositol binding; F:clathrin heavy chain binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase binding; F:SNARE binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:protein transport; P:regulation of clathrin-dependent endocytosis; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:vesicle budding from membrane; scaffold21 indexed_genome mRNA 21930240 21947515 . - . ID=transcript_5142;Q8N3Z0 A8K7B3 Q9BQP6,Inactive serine protease 35,, PF00089;, GO:0005576;, C:extracellular region; scaffold21 indexed_genome mRNA 22026162 22232773 . + . ID=transcript_5143;P48163 B4DZ70 Q16797 Q16855 Q53F72 Q5VWA2 Q9BWX8 Q9H1W3 Q9UIY4,NADP-dependent malic enzyme,Malic enzyme 1;, PF00390;PF03949;, GO:0005829;GO:0005739;GO:0043531;GO:0009055;GO:0042802;GO:0004471;GO:0004473;GO:0004470;GO:0030145;GO:0051287;GO:0050661;GO:0008948;GO:0005975;GO:0006108;GO:0009165;GO:0006090;GO:0019222;GO:1902031;GO:0009743;GO:0009725;, C:cytosol; C:mitochondrion;, F:ADP binding; F:electron transfer activity; F:identical protein binding; F:malate dehydrogenase (decarboxylating) (NAD+) activity; F:malate dehydrogenase (decarboxylating) (NADP+) activity; F:malic enzyme activity; F:manganese ion binding; F:NAD binding; F:NADP binding; F:oxaloacetate decarboxylase activity;, P:carbohydrate metabolic process; P:malate metabolic process; P:nucleotide biosynthetic process; P:pyruvate metabolic process; P:regulation of metabolic process; P:regulation of NADP metabolic process; P:response to carbohydrate; P:response to hormone; scaffold21 indexed_genome mRNA 22242947 22246188 . - . ID=transcript_5144;Q9UIY3 B4DIQ3 E1P548 Q2M3R3 Q96FH1,RWD domain-containing protein 2A,, PF06544;PF05773; scaffold21 indexed_genome mRNA 22248105 22274392 . + . ID=transcript_5145;Q9NS94 Q9NTT6 Q9UFV5 Q9UIY2,Phosphoacetylglucosamine mutase {ECO:0000305},Acetylglucosamine phosphomutase {ECO:0000305};N-acetylglucosamine-phosphate mutase {ECO:0000303|PubMed:10721701};Phosphoglucomutase-3 {ECO:0000312|HGNC:HGNC:8907};, PF02878;PF00408;, GO:0005829;GO:0000287;GO:0004610;GO:0004614;GO:0005975;GO:0006041;GO:0019255;GO:0030097;GO:0006487;GO:0006493;GO:0007283;GO:0006048;, C:cytosol;, F:magnesium ion binding; F:phosphoacetylglucosamine mutase activity; F:phosphoglucomutase activity;, P:carbohydrate metabolic process; P:glucosamine metabolic process; P:glucose 1-phosphate metabolic process; P:hemopoiesis; P:protein N-linked glycosylation; P:protein O-linked glycosylation; P:spermatogenesis; P:UDP-N-acetylglucosamine biosynthetic process;|Q9NS94 Q9NTT6 Q9UFV5 Q9UIY2,Phosphoacetylglucosamine mutase {ECO:0000305},Acetylglucosamine phosphomutase {ECO:0000305};N-acetylglucosamine-phosphate mutase {ECO:0000303|PubMed:10721701};Phosphoglucomutase-3 {ECO:0000312|HGNC:HGNC:8907};, PF02878;PF00408;, GO:0005829;GO:0000287;GO:0004610;GO:0004614;GO:0005975;GO:0006041;GO:0019255;GO:0030097;GO:0006487;GO:0006493;GO:0007283;GO:0006048;, C:cytosol;, F:magnesium ion binding; F:phosphoacetylglucosamine mutase activity; F:phosphoglucomutase activity;, P:carbohydrate metabolic process; P:glucosamine metabolic process; P:glucose 1-phosphate metabolic process; P:hemopoiesis; P:protein N-linked glycosylation; P:protein O-linked glycosylation; P:spermatogenesis; P:UDP-N-acetylglucosamine biosynthetic process;|Q9NS94 Q9NTT6 Q9UFV5 Q9UIY2,Phosphoacetylglucosamine mutase {ECO:0000305},Acetylglucosamine phosphomutase {ECO:0000305};N-acetylglucosamine-phosphate mutase {ECO:0000303|PubMed:10721701};Phosphoglucomutase-3 {ECO:0000312|HGNC:HGNC:8907};, PF02878;PF00408;, GO:0005829;GO:0000287;GO:0004610;GO:0004614;GO:0005975;GO:0006041;GO:0019255;GO:0030097;GO:0006487;GO:0006493;GO:0007283;GO:0006048;, C:cytosol;, F:magnesium ion binding; F:phosphoacetylglucosamine mutase activity; F:phosphoglucomutase activity;, P:carbohydrate metabolic process; P:glucosamine metabolic process; P:glucose 1-phosphate metabolic process; P:hemopoiesis; P:protein N-linked glycosylation; P:protein O-linked glycosylation; P:spermatogenesis; P:UDP-N-acetylglucosamine biosynthetic process;|Q9NS94 Q9NTT6 Q9UFV5 Q9UIY2,Phosphoacetylglucosamine mutase {ECO:0000305},Acetylglucosamine phosphomutase {ECO:0000305};N-acetylglucosamine-phosphate mutase {ECO:0000303|PubMed:10721701};Phosphoglucomutase-3 {ECO:0000312|HGNC:HGNC:8907};, PF02878;PF00408;, GO:0005829;GO:0000287;GO:0004610;GO:0004614;GO:0005975;GO:0006041;GO:0019255;GO:0030097;GO:0006487;GO:0006493;GO:0007283;GO:0006048;, C:cytosol;, F:magnesium ion binding; F:phosphoacetylglucosamine mutase activity; F:phosphoglucomutase activity;, P:carbohydrate metabolic process; P:glucosamine metabolic process; P:glucose 1-phosphate metabolic process; P:hemopoiesis; P:protein N-linked glycosylation; P:protein O-linked glycosylation; P:spermatogenesis; P:UDP-N-acetylglucosamine biosynthetic process; scaffold21 indexed_genome mRNA 22274641 22383854 . + . ID=transcript_5146;Q5JWR5 Q86XV1 Q9H5J5 Q9NSL4 Q9UPN5 Q9Y414,Protein dopey-1 {ECO:0000305},, PF04118;, GO:0005829;GO:0005768;GO:0000139;GO:0005802;GO:0006895;GO:0015031;, C:cytosol; C:endosome; C:Golgi membrane; C:trans-Golgi network;, , P:Golgi to endosome transport; P:protein transport;|Q5JWR5 Q86XV1 Q9H5J5 Q9NSL4 Q9UPN5 Q9Y414,Protein dopey-1 {ECO:0000305},, PF04118;, GO:0005829;GO:0005768;GO:0000139;GO:0005802;GO:0006895;GO:0015031;, C:cytosol; C:endosome; C:Golgi membrane; C:trans-Golgi network;, , P:Golgi to endosome transport; P:protein transport;|Q5JWR5 Q86XV1 Q9H5J5 Q9NSL4 Q9UPN5 Q9Y414,Protein dopey-1 {ECO:0000305},, PF04118;, GO:0005829;GO:0005768;GO:0000139;GO:0005802;GO:0006895;GO:0015031;, C:cytosol; C:endosome; C:Golgi membrane; C:trans-Golgi network;, , P:Golgi to endosome transport; P:protein transport;|Q5JWR5 Q86XV1 Q9H5J5 Q9NSL4 Q9UPN5 Q9Y414,Protein dopey-1 {ECO:0000305},, PF04118;, GO:0005829;GO:0005768;GO:0000139;GO:0005802;GO:0006895;GO:0015031;, C:cytosol; C:endosome; C:Golgi membrane; C:trans-Golgi network;, , P:Golgi to endosome transport; P:protein transport; scaffold21 indexed_genome mRNA 22424360 22520818 . + . ID=transcript_5147;Q7Z6J8 B4DP63 Q5T4W2 Q6IPR4 Q75UG0 Q9NT42,E3 ubiquitin-protein ligase E3D,HECT-type E3 ubiquitin transferase E3D {ECO:0000305};UbcH10-binding protein with a HECT-like domain;Ubiquitin-conjugating enzyme E2C-binding protein;, PF09814;, GO:0005829;GO:0005634;GO:0000151;GO:0030332;GO:0031624;GO:0061630;GO:0044390;GO:0043161;GO:0051865;GO:0006513;GO:0000209;, C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:cyclin binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; scaffold21 indexed_genome mRNA 23130010 23133107 . - . ID=transcript_5148;Q13641 A8K555,Trophoblast glycoprotein,5T4 oncofetal antigen;5T4 oncofetal trophoblast glycoprotein;M6P1;Wnt-activated inhibitory factor 1;, PF13855;PF01463;PF01462;, GO:0043679;GO:0009986;GO:0030425;GO:0005783;GO:0005887;GO:0007155;GO:0060326;GO:0140059;GO:0090497;GO:0008285;GO:0008355;GO:0050921;GO:0070374;GO:0051897;GO:0051965;GO:0072659;GO:0051932;, C:axon terminus; C:cell surface; C:dendrite; C:endoplasmic reticulum; C:integral component of plasma membrane;, , P:cell adhesion; P:cell chemotaxis; P:dendrite arborization; P:mesenchymal cell migration; P:negative regulation of cell population proliferation; P:olfactory learning; P:positive regulation of chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein kinase B signaling; P:positive regulation of synapse assembly; P:protein localization to plasma membrane; P:synaptic transmission, GABAergic; scaffold21 indexed_genome mRNA 23244461 23329271 . + . ID=transcript_5149;Q9HBI8 Q9Y3T8,Inhibitor of Bruton tyrosine kinase,, PF12796;PF00651;PF00415;, GO:0005737;GO:0016020;GO:0005654;GO:0019901;GO:0030292;GO:0001933;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm;, F:protein kinase binding; F:protein tyrosine kinase inhibitor activity;, P:negative regulation of protein phosphorylation; P:release of sequestered calcium ion into cytosol;|Q9HBI8 Q9Y3T8,Inhibitor of Bruton tyrosine kinase,, PF12796;PF00651;PF00415;, GO:0005737;GO:0016020;GO:0005654;GO:0019901;GO:0030292;GO:0001933;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm;, F:protein kinase binding; F:protein tyrosine kinase inhibitor activity;, P:negative regulation of protein phosphorylation; P:release of sequestered calcium ion into cytosol;|Q9HBI8 Q9Y3T8,Inhibitor of Bruton tyrosine kinase,, PF12796;PF00651;PF00415;, GO:0005737;GO:0016020;GO:0005654;GO:0019901;GO:0030292;GO:0001933;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm;, F:protein kinase binding; F:protein tyrosine kinase inhibitor activity;, P:negative regulation of protein phosphorylation; P:release of sequestered calcium ion into cytosol; scaffold21 indexed_genome mRNA 23797671 23803287 . + . ID=transcript_5150;Q96IP4 A8K7U4 Q5TF86 Q8NFZ9 Q9BW32 Q9NXV5,Terminal nucleotidyltransferase 5A {ECO:0000305},HBV X-transactivated gene 11 protein {ECO:0000303|Ref.2};HBV XAg-transactivated protein 11 {ECO:0000303|Ref.2};, PF07984;, GO:1990817;GO:0003723;GO:0048255;, , F:RNA adenylyltransferase activity; F:RNA binding;, P:mRNA stabilization;|Q96IP4 A8K7U4 Q5TF86 Q8NFZ9 Q9BW32 Q9NXV5,Terminal nucleotidyltransferase 5A {ECO:0000305},HBV X-transactivated gene 11 protein {ECO:0000303|Ref.2};HBV XAg-transactivated protein 11 {ECO:0000303|Ref.2};, PF07984;, GO:1990817;GO:0003723;GO:0048255;, , F:RNA adenylyltransferase activity; F:RNA binding;, P:mRNA stabilization; scaffold21 indexed_genome mRNA 25117551 25381718 . - . ID=transcript_5151;P21953 Q5T2J3 Q9BQL0,2-oxoisovalerate dehydrogenase subunit beta, mitochondrial,Branched-chain alpha-keto acid dehydrogenase E1 component beta chain;, PF02779;PF02780;, GO:0005947;GO:0005759;GO:0005739;GO:0005730;GO:0003863;GO:0003826;GO:0009083;GO:0007584;, C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; F:alpha-ketoacid dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:response to nutrient;|P21953 Q5T2J3 Q9BQL0,2-oxoisovalerate dehydrogenase subunit beta, mitochondrial,Branched-chain alpha-keto acid dehydrogenase E1 component beta chain;, PF02779;PF02780;, GO:0005947;GO:0005759;GO:0005739;GO:0005730;GO:0003863;GO:0003826;GO:0009083;GO:0007584;, C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; F:alpha-ketoacid dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:response to nutrient;|P21953 Q5T2J3 Q9BQL0,2-oxoisovalerate dehydrogenase subunit beta, mitochondrial,Branched-chain alpha-keto acid dehydrogenase E1 component beta chain;, PF02779;PF02780;, GO:0005947;GO:0005759;GO:0005739;GO:0005730;GO:0003863;GO:0003826;GO:0009083;GO:0007584;, C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; F:alpha-ketoacid dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:response to nutrient; scaffold21 indexed_genome mRNA 25548778 25558411 . - . ID=transcript_5152;Q9GZR5 B2R6B5 Q5TCS2 Q86YJ1 Q9H139,Elongation of very long chain fatty acids protein 4 {ECO:0000255|HAMAP-Rule:MF_03204, ECO:0000305},3-keto acyl-CoA synthase ELOVL4 {ECO:0000255|HAMAP-Rule:MF_03204};ELOVL fatty acid elongase 4 {ECO:0000255|HAMAP-Rule:MF_03204};Very long chain 3-ketoacyl-CoA synthase 4 {ECO:0000255|HAMAP-Rule:MF_03204};Very long chain 3-oxoacyl-CoA synthase 4 {ECO:0000255|HAMAP-Rule:MF_03204};, PF01151;, GO:0005783;GO:0030176;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0008020;GO:0102756;GO:0006633;GO:0034625;GO:0034626;GO:0019367;GO:0035338;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:G protein-coupled photoreceptor activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:fatty acid biosynthetic process; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9GZR5 B2R6B5 Q5TCS2 Q86YJ1 Q9H139,Elongation of very long chain fatty acids protein 4 {ECO:0000255|HAMAP-Rule:MF_03204, ECO:0000305},3-keto acyl-CoA synthase ELOVL4 {ECO:0000255|HAMAP-Rule:MF_03204};ELOVL fatty acid elongase 4 {ECO:0000255|HAMAP-Rule:MF_03204};Very long chain 3-ketoacyl-CoA synthase 4 {ECO:0000255|HAMAP-Rule:MF_03204};Very long chain 3-oxoacyl-CoA synthase 4 {ECO:0000255|HAMAP-Rule:MF_03204};, PF01151;, GO:0005783;GO:0030176;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0008020;GO:0102756;GO:0006633;GO:0034625;GO:0034626;GO:0019367;GO:0035338;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:G protein-coupled photoreceptor activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:fatty acid biosynthetic process; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold21 indexed_genome mRNA 25820260 25892318 . - . ID=transcript_5153;Q9UJC5 A8MQU2 Q2VPC2 Q5VV96 Q6NSK8 Q6P9E8 Q7Z734 Q8IWD3 Q9BPY5,SH3 domain-binding glutamic acid-rich-like protein 2,Fovea-associated SH3 domain-binding protein;, PF04908;, GO:0031965;GO:0005654;GO:0017124;, C:nuclear membrane; C:nucleoplasm;, F:SH3 domain binding; scaffold21 indexed_genome mRNA 26003857 26049180 . + . ID=transcript_5154;Q86VQ0 E1P542 Q9BWX7,Lebercilin {ECO:0000303|PubMed:17546029},Leber congenital amaurosis 5 protein;, PF15619;, GO:0005930;GO:0036064;GO:0005929;GO:0032391;GO:0044877;GO:0042073;GO:0045494;, C:axoneme; C:ciliary basal body; C:cilium; C:photoreceptor connecting cilium;, F:protein-containing complex binding;, P:intraciliary transport; P:photoreceptor cell maintenance;|Q86VQ0 E1P542 Q9BWX7,Lebercilin {ECO:0000303|PubMed:17546029},Leber congenital amaurosis 5 protein;, PF15619;, GO:0005930;GO:0036064;GO:0005929;GO:0032391;GO:0044877;GO:0042073;GO:0045494;, C:axoneme; C:ciliary basal body; C:cilium; C:photoreceptor connecting cilium;, F:protein-containing complex binding;, P:intraciliary transport; P:photoreceptor cell maintenance;|Q86VQ0 E1P542 Q9BWX7,Lebercilin {ECO:0000303|PubMed:17546029},Leber congenital amaurosis 5 protein;, PF15619;, GO:0005930;GO:0036064;GO:0005929;GO:0032391;GO:0044877;GO:0042073;GO:0045494;, C:axoneme; C:ciliary basal body; C:cilium; C:photoreceptor connecting cilium;, F:protein-containing complex binding;, P:intraciliary transport; P:photoreceptor cell maintenance;|Q86VQ0 E1P542 Q9BWX7,Lebercilin {ECO:0000303|PubMed:17546029},Leber congenital amaurosis 5 protein;, PF15619;, GO:0005930;GO:0036064;GO:0005929;GO:0032391;GO:0044877;GO:0042073;GO:0045494;, C:axoneme; C:ciliary basal body; C:cilium; C:photoreceptor connecting cilium;, F:protein-containing complex binding;, P:intraciliary transport; P:photoreceptor cell maintenance; scaffold21 indexed_genome mRNA 26333678 26343444 . + . ID=transcript_5155;Q15651 B2RD37 Q5HYD3 Q7RTT0 Q969M5 Q9BZT7,High mobility group nucleosome-binding domain-containing protein 3,Thyroid receptor-interacting protein 7;, PF01101;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0031492;GO:0046966;GO:0006325;GO:0045944;GO:0061178;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:nucleosomal DNA binding; F:thyroid hormone receptor binding;, P:chromatin organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of insulin secretion involved in cellular response to glucose stimulus; scaffold21 indexed_genome mRNA 26344860 26345432 . + . ID=transcript_5156;Q15651 B2RD37 Q5HYD3 Q7RTT0 Q969M5 Q9BZT7,High mobility group nucleosome-binding domain-containing protein 3,Thyroid receptor-interacting protein 7;, PF01101;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0031492;GO:0046966;GO:0006325;GO:0045944;GO:0061178;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:nucleosomal DNA binding; F:thyroid hormone receptor binding;, P:chromatin organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of insulin secretion involved in cellular response to glucose stimulus; scaffold21 indexed_genome mRNA 26504116 26605073 . + . ID=transcript_5157;Q96ME2 Q9H261,PH-interacting protein,DDB1- and CUL4-associated factor 14;IRS-1 PH domain-binding protein;WD repeat-containing protein 11;, PF00439;PF00400;, GO:0005634;GO:0005158;GO:0070577;GO:0007010;GO:0008286;GO:0043066;GO:2001237;GO:0008284;GO:0043568;GO:0045840;GO:0045944;GO:0045893;GO:0022604;GO:0008360;GO:0001932;GO:0006357;, C:nucleus;, F:insulin receptor binding; F:lysine-acetylated histone binding;, P:cytoskeleton organization; P:insulin receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell morphogenesis; P:regulation of cell shape; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II;|Q96ME2 Q9H261,PH-interacting protein,DDB1- and CUL4-associated factor 14;IRS-1 PH domain-binding protein;WD repeat-containing protein 11;, PF00439;PF00400;, GO:0005634;GO:0005158;GO:0070577;GO:0007010;GO:0008286;GO:0043066;GO:2001237;GO:0008284;GO:0043568;GO:0045840;GO:0045944;GO:0045893;GO:0022604;GO:0008360;GO:0001932;GO:0006357;, C:nucleus;, F:insulin receptor binding; F:lysine-acetylated histone binding;, P:cytoskeleton organization; P:insulin receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell morphogenesis; P:regulation of cell shape; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II;|Q96ME2 Q9H261,PH-interacting protein,DDB1- and CUL4-associated factor 14;IRS-1 PH domain-binding protein;WD repeat-containing protein 11;, PF00439;PF00400;, GO:0005634;GO:0005158;GO:0070577;GO:0007010;GO:0008286;GO:0043066;GO:2001237;GO:0008284;GO:0043568;GO:0045840;GO:0045944;GO:0045893;GO:0022604;GO:0008360;GO:0001932;GO:0006357;, C:nucleus;, F:insulin receptor binding; F:lysine-acetylated histone binding;, P:cytoskeleton organization; P:insulin receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell morphogenesis; P:regulation of cell shape; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II;|Q96ME2 Q9H261,PH-interacting protein,DDB1- and CUL4-associated factor 14;IRS-1 PH domain-binding protein;WD repeat-containing protein 11;, PF00439;PF00400;, GO:0005634;GO:0005158;GO:0070577;GO:0007010;GO:0008286;GO:0043066;GO:2001237;GO:0008284;GO:0043568;GO:0045840;GO:0045944;GO:0045893;GO:0022604;GO:0008360;GO:0001932;GO:0006357;, C:nucleus;, F:insulin receptor binding; F:lysine-acetylated histone binding;, P:cytoskeleton organization; P:insulin receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell morphogenesis; P:regulation of cell shape; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II;|Q96ME2 Q9H261,PH-interacting protein,DDB1- and CUL4-associated factor 14;IRS-1 PH domain-binding protein;WD repeat-containing protein 11;, PF00439;PF00400;, GO:0005634;GO:0005158;GO:0070577;GO:0007010;GO:0008286;GO:0043066;GO:2001237;GO:0008284;GO:0043568;GO:0045840;GO:0045944;GO:0045893;GO:0022604;GO:0008360;GO:0001932;GO:0006357;, C:nucleus;, F:insulin receptor binding; F:lysine-acetylated histone binding;, P:cytoskeleton organization; P:insulin receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell morphogenesis; P:regulation of cell shape; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II;|Q96ME2 Q9H261,PH-interacting protein,DDB1- and CUL4-associated factor 14;IRS-1 PH domain-binding protein;WD repeat-containing protein 11;, PF00439;PF00400;, GO:0005634;GO:0005158;GO:0070577;GO:0007010;GO:0008286;GO:0043066;GO:2001237;GO:0008284;GO:0043568;GO:0045840;GO:0045944;GO:0045893;GO:0022604;GO:0008360;GO:0001932;GO:0006357;, C:nucleus;, F:insulin receptor binding; F:lysine-acetylated histone binding;, P:cytoskeleton organization; P:insulin receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell morphogenesis; P:regulation of cell shape; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II;|Q96ME2 Q9H261,PH-interacting protein,DDB1- and CUL4-associated factor 14;IRS-1 PH domain-binding protein;WD repeat-containing protein 11;, PF00439;PF00400;, GO:0005634;GO:0005158;GO:0070577;GO:0007010;GO:0008286;GO:0043066;GO:2001237;GO:0008284;GO:0043568;GO:0045840;GO:0045944;GO:0045893;GO:0022604;GO:0008360;GO:0001932;GO:0006357;, C:nucleus;, F:insulin receptor binding; F:lysine-acetylated histone binding;, P:cytoskeleton organization; P:insulin receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell morphogenesis; P:regulation of cell shape; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II;|Q96ME2 Q9H261,PH-interacting protein,DDB1- and CUL4-associated factor 14;IRS-1 PH domain-binding protein;WD repeat-containing protein 11;, PF00439;PF00400;, GO:0005634;GO:0005158;GO:0070577;GO:0007010;GO:0008286;GO:0043066;GO:2001237;GO:0008284;GO:0043568;GO:0045840;GO:0045944;GO:0045893;GO:0022604;GO:0008360;GO:0001932;GO:0006357;, C:nucleus;, F:insulin receptor binding; F:lysine-acetylated histone binding;, P:cytoskeleton organization; P:insulin receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell morphogenesis; P:regulation of cell shape; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II; scaffold21 indexed_genome mRNA 26639608 26652528 . - . ID=transcript_5158;Q5VVH5,Interleukin-1 receptor-associated kinase 1-binding protein 1,, PF04402;, GO:0005737;GO:0005634;GO:0007249;GO:0006955;, C:cytoplasm; C:nucleus;, , P:I-kappaB kinase/NF-kappaB signaling; P:immune response; scaffold21 indexed_genome mRNA 27465448 27693444 . - . ID=transcript_5159;A8MW99 R4GMV8,Meiosis-specific protein MEI4,, PF13971;, GO:0000800;GO:0006310;GO:0007129;GO:0042138;GO:0048477;GO:0007283;, C:lateral element;, , P:DNA recombination; P:homologous chromosome pairing at meiosis; P:meiotic DNA double-strand break formation; P:oogenesis; P:spermatogenesis; scaffold21 indexed_genome mRNA 27924072 27924680 . - . ID=transcript_5160;P28222 Q4VAY7,5-hydroxytryptamine receptor 1B,S12;Serotonin 1D beta receptor;Serotonin receptor 1B;, PF00001;, GO:0044305;GO:0005737;GO:0030425;GO:0098666;GO:0005887;GO:0099056;GO:0005886;GO:0099154;GO:0008144;GO:0004993;GO:0030594;GO:0051378;GO:0099626;GO:0007193;GO:0007198;GO:0046849;GO:0071312;GO:0035690;GO:0071502;GO:0007268;GO:0042756;GO:0002031;GO:0007186;GO:0007187;GO:0014053;GO:0014063;GO:0032229;GO:0051967;GO:1904707;GO:0099171;GO:0007205;GO:0050795;GO:0014059;GO:2000300;GO:0042220;GO:0045471;GO:0051385;GO:0042310;, C:calyx of Held; C:cytoplasm; C:dendrite; C:G protein-coupled serotonin receptor complex; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:serotonergic synapse;, F:drug binding; F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity; F:serotonin binding; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; P:bone remodeling; P:cellular response to alkaloid; P:cellular response to drug; P:cellular response to temperature stimulus; P:chemical synaptic transmission; P:drinking behavior; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:negative regulation of gamma-aminobutyric acid secretion; P:negative regulation of serotonin secretion; P:negative regulation of synaptic transmission, GABAergic; P:negative regulation of synaptic transmission, glutamatergic; P:positive regulation of vascular associated smooth muscle cell proliferation; P:presynaptic modulation of chemical synaptic transmission; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of behavior; P:regulation of dopamine secretion; P:regulation of synaptic vesicle exocytosis; P:response to cocaine; P:response to ethanol; P:response to mineralocorticoid; P:vasoconstriction; scaffold21 indexed_genome mRNA 27924740 27925573 . + . ID=transcript_5161;P28222 Q4VAY7,5-hydroxytryptamine receptor 1B,S12;Serotonin 1D beta receptor;Serotonin receptor 1B;, PF00001;, GO:0044305;GO:0005737;GO:0030425;GO:0098666;GO:0005887;GO:0099056;GO:0005886;GO:0099154;GO:0008144;GO:0004993;GO:0030594;GO:0051378;GO:0099626;GO:0007193;GO:0007198;GO:0046849;GO:0071312;GO:0035690;GO:0071502;GO:0007268;GO:0042756;GO:0002031;GO:0007186;GO:0007187;GO:0014053;GO:0014063;GO:0032229;GO:0051967;GO:1904707;GO:0099171;GO:0007205;GO:0050795;GO:0014059;GO:2000300;GO:0042220;GO:0045471;GO:0051385;GO:0042310;, C:calyx of Held; C:cytoplasm; C:dendrite; C:G protein-coupled serotonin receptor complex; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane; C:serotonergic synapse;, F:drug binding; F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity; F:serotonin binding; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; P:bone remodeling; P:cellular response to alkaloid; P:cellular response to drug; P:cellular response to temperature stimulus; P:chemical synaptic transmission; P:drinking behavior; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:negative regulation of gamma-aminobutyric acid secretion; P:negative regulation of serotonin secretion; P:negative regulation of synaptic transmission, GABAergic; P:negative regulation of synaptic transmission, glutamatergic; P:positive regulation of vascular associated smooth muscle cell proliferation; P:presynaptic modulation of chemical synaptic transmission; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of behavior; P:regulation of dopamine secretion; P:regulation of synaptic vesicle exocytosis; P:response to cocaine; P:response to ethanol; P:response to mineralocorticoid; P:vasoconstriction; scaffold21 indexed_genome mRNA 29281092 29287122 . - . ID=transcript_5162;Q9UM54 A6H8V4 E1P540 Q5TEM5 Q5TEM6 Q5TEM7 Q9BZZ7 Q9UEG2,Unconventional myosin-VI,Unconventional myosin-6;, PF16521;PF00063;, GO:0015629;GO:0005884;GO:0005938;GO:0005905;GO:0030665;GO:0005737;GO:0031410;GO:0005829;GO:0030139;GO:0070062;GO:0031941;GO:0030175;GO:0005794;GO:0005765;GO:0016020;GO:0005902;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0016591;GO:0001726;GO:0032587;GO:0016461;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0005516;GO:0042802;GO:0000146;GO:0060001;GO:0003774;GO:0007015;GO:0030048;GO:0030330;GO:0006897;GO:0042491;GO:0042472;GO:0006886;GO:0045944;GO:0051046;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:clathrin-coated pit; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle; C:extracellular exosome; C:filamentous actin; C:filopodium; C:Golgi apparatus; C:lysosomal membrane; C:membrane; C:microvillus; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:RNA polymerase II, holoenzyme; C:ruffle; C:ruffle membrane; C:unconventional myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:calmodulin binding; F:identical protein binding; F:microfilament motor activity; F:minus-end directed microfilament motor activity; F:motor activity;, P:actin filament organization; P:actin filament-based movement; P:DNA damage response, signal transduction by p53 class mediator; P:endocytosis; P:inner ear auditory receptor cell differentiation; P:inner ear morphogenesis; P:intracellular protein transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of secretion; P:sensory perception of sound; P:vesicle transport along actin filament; scaffold21 indexed_genome mRNA 29287137 29379809 . - . ID=transcript_5163;Q9UM54 A6H8V4 E1P540 Q5TEM5 Q5TEM6 Q5TEM7 Q9BZZ7 Q9UEG2,Unconventional myosin-VI,Unconventional myosin-6;, PF16521;PF00063;, GO:0015629;GO:0005884;GO:0005938;GO:0005905;GO:0030665;GO:0005737;GO:0031410;GO:0005829;GO:0030139;GO:0070062;GO:0031941;GO:0030175;GO:0005794;GO:0005765;GO:0016020;GO:0005902;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0016591;GO:0001726;GO:0032587;GO:0016461;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0005516;GO:0042802;GO:0000146;GO:0060001;GO:0003774;GO:0007015;GO:0030048;GO:0030330;GO:0006897;GO:0042491;GO:0042472;GO:0006886;GO:0045944;GO:0051046;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:clathrin-coated pit; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle; C:extracellular exosome; C:filamentous actin; C:filopodium; C:Golgi apparatus; C:lysosomal membrane; C:membrane; C:microvillus; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:RNA polymerase II, holoenzyme; C:ruffle; C:ruffle membrane; C:unconventional myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:calmodulin binding; F:identical protein binding; F:microfilament motor activity; F:minus-end directed microfilament motor activity; F:motor activity;, P:actin filament organization; P:actin filament-based movement; P:DNA damage response, signal transduction by p53 class mediator; P:endocytosis; P:inner ear auditory receptor cell differentiation; P:inner ear morphogenesis; P:intracellular protein transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of secretion; P:sensory perception of sound; P:vesicle transport along actin filament; scaffold21 indexed_genome mRNA 29465578 29566408 . - . ID=transcript_5164;Q9GZR1 A6NNY9 O94891 Q5VUL3 Q5VUL4 Q8TBY4 Q9UJV5,Sentrin-specific protease 6,SUMO-1-specific protease 1;Sentrin/SUMO-specific protease SENP6;, PF02902;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0070139;GO:0016926;GO:0070646;GO:0016925;GO:0090234;GO:0090169;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation; P:protein modification by small protein removal; P:protein sumoylation; P:regulation of kinetochore assembly; P:regulation of spindle assembly;|Q9GZR1 A6NNY9 O94891 Q5VUL3 Q5VUL4 Q8TBY4 Q9UJV5,Sentrin-specific protease 6,SUMO-1-specific protease 1;Sentrin/SUMO-specific protease SENP6;, PF02902;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0070139;GO:0016926;GO:0070646;GO:0016925;GO:0090234;GO:0090169;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation; P:protein modification by small protein removal; P:protein sumoylation; P:regulation of kinetochore assembly; P:regulation of spindle assembly;|Q9GZR1 A6NNY9 O94891 Q5VUL3 Q5VUL4 Q8TBY4 Q9UJV5,Sentrin-specific protease 6,SUMO-1-specific protease 1;Sentrin/SUMO-specific protease SENP6;, PF02902;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0070139;GO:0016926;GO:0070646;GO:0016925;GO:0090234;GO:0090169;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation; P:protein modification by small protein removal; P:protein sumoylation; P:regulation of kinetochore assembly; P:regulation of spindle assembly;|Q9GZR1 A6NNY9 O94891 Q5VUL3 Q5VUL4 Q8TBY4 Q9UJV5,Sentrin-specific protease 6,SUMO-1-specific protease 1;Sentrin/SUMO-specific protease SENP6;, PF02902;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0070139;GO:0016926;GO:0070646;GO:0016925;GO:0090234;GO:0090169;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation; P:protein modification by small protein removal; P:protein sumoylation; P:regulation of kinetochore assembly; P:regulation of spindle assembly;|Q9GZR1 A6NNY9 O94891 Q5VUL3 Q5VUL4 Q8TBY4 Q9UJV5,Sentrin-specific protease 6,SUMO-1-specific protease 1;Sentrin/SUMO-specific protease SENP6;, PF02902;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0070139;GO:0016926;GO:0070646;GO:0016925;GO:0090234;GO:0090169;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:SUMO-specific endopeptidase activity;, P:protein desumoylation; P:protein modification by small protein removal; P:protein sumoylation; P:regulation of kinetochore assembly; P:regulation of spindle assembly; scaffold21 indexed_genome mRNA 29850380 29925574 . + . ID=transcript_5165;Q7Z7B0 B2RMU6 Q5VUL6 Q86TC3 Q8N8B9 Q96SK6 Q9NVI8 Q9ULE5,Filamin-A-interacting protein 1,, PF09727;, GO:0015629;GO:0005737;GO:0005730;GO:0005886;, C:actin cytoskeleton; C:cytoplasm; C:nucleolus; C:plasma membrane;|Q7Z7B0 B2RMU6 Q5VUL6 Q86TC3 Q8N8B9 Q96SK6 Q9NVI8 Q9ULE5,Filamin-A-interacting protein 1,, PF09727;, GO:0015629;GO:0005737;GO:0005730;GO:0005886;, C:actin cytoskeleton; C:cytoplasm; C:nucleolus; C:plasma membrane;|Q7Z7B0 B2RMU6 Q5VUL6 Q86TC3 Q8N8B9 Q96SK6 Q9NVI8 Q9ULE5,Filamin-A-interacting protein 1,, PF09727;, GO:0015629;GO:0005737;GO:0005730;GO:0005886;, C:actin cytoskeleton; C:cytoplasm; C:nucleolus; C:plasma membrane; scaffold21 indexed_genome mRNA 29931731 29980907 . + . ID=transcript_5166;Q9NV96 A8K9V8 E1P539 Q658Z3 Q96H09 Q9NSL9,Cell cycle control protein 50A {ECO:0000305},P4-ATPase flippase complex beta subunit TMEM30A;Transmembrane protein 30A;, PF03381;, GO:0016324;GO:0035577;GO:0005783;GO:0005794;GO:0016021;GO:0016020;GO:1990531;GO:0005886;GO:0035579;GO:0030658;GO:0015247;GO:0015917;GO:0006855;GO:0043312;GO:0045332;GO:0010976;GO:0061092;GO:0070863;GO:0036010;, C:apical plasma membrane; C:azurophil granule membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:transport vesicle membrane;, F:aminophospholipid flippase activity;, P:aminophospholipid transport; P:drug transmembrane transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of neuron projection development; P:positive regulation of phospholipid translocation; P:positive regulation of protein exit from endoplasmic reticulum; P:protein localization to endosome;|Q9NV96 A8K9V8 E1P539 Q658Z3 Q96H09 Q9NSL9,Cell cycle control protein 50A {ECO:0000305},P4-ATPase flippase complex beta subunit TMEM30A;Transmembrane protein 30A;, PF03381;, GO:0016324;GO:0035577;GO:0005783;GO:0005794;GO:0016021;GO:0016020;GO:1990531;GO:0005886;GO:0035579;GO:0030658;GO:0015247;GO:0015917;GO:0006855;GO:0043312;GO:0045332;GO:0010976;GO:0061092;GO:0070863;GO:0036010;, C:apical plasma membrane; C:azurophil granule membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:transport vesicle membrane;, F:aminophospholipid flippase activity;, P:aminophospholipid transport; P:drug transmembrane transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of neuron projection development; P:positive regulation of phospholipid translocation; P:positive regulation of protein exit from endoplasmic reticulum; P:protein localization to endosome; scaffold21 indexed_genome mRNA 29984967 29998006 . + . ID=transcript_5167;O60397,Putative cytochrome c oxidase subunit 7A3, mitochondrial,Cytochrome c oxidase subunit VIIa 3;, PF02238;, GO:0005746;GO:0004129;GO:0097250;GO:0002082;, C:mitochondrial respirasome;, F:cytochrome-c oxidase activity;, P:mitochondrial respirasome assembly; P:regulation of oxidative phosphorylation;|P14406 B2R5E1 Q3MIH5 Q5TF59 Q6FGI2,Cytochrome c oxidase subunit 7A2, mitochondrial,Cytochrome c oxidase subunit VIIa-liver/heart;, PF02238;, GO:0016021;GO:0005746;GO:0004129;GO:0097250;GO:0006119;GO:0002082;, C:integral component of membrane; C:mitochondrial respirasome;, F:cytochrome-c oxidase activity;, P:mitochondrial respirasome assembly; P:oxidative phosphorylation; P:regulation of oxidative phosphorylation;|P14406 B2R5E1 Q3MIH5 Q5TF59 Q6FGI2,Cytochrome c oxidase subunit 7A2, mitochondrial,Cytochrome c oxidase subunit VIIa-liver/heart;, PF02238;, GO:0016021;GO:0005746;GO:0004129;GO:0097250;GO:0006119;GO:0002082;, C:integral component of membrane; C:mitochondrial respirasome;, F:cytochrome-c oxidase activity;, P:mitochondrial respirasome assembly; P:oxidative phosphorylation; P:regulation of oxidative phosphorylation; scaffold21 indexed_genome mRNA 30002439 30005053 . + . ID=transcript_5168;P60508,Syncytin-2,Endogenous retrovirus group FRD member 1;Envelope polyprotein;HERV-FRD;HERV-FRD_6p24.1 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;GO:0007520;GO:0006949;GO:0000768;, C:integral component of membrane; C:plasma membrane;, , P:myoblast fusion; P:syncytium formation; P:syncytium formation by plasma membrane fusion; scaffold21 indexed_genome mRNA 30051997 30066726 . + . ID=transcript_5169;Q99715 O43853 Q15955 Q5VYK1 Q5VYK2 Q71UR3 Q99716,Collagen alpha-1(XII) chain,, PF01391;PF00041;PF00092;, GO:0005595;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0030020;GO:0007155;GO:0030199;GO:0035987;, C:collagen type XII trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle;, F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; scaffold21 indexed_genome mRNA 30069211 30071658 . + . ID=transcript_5170;Q99715 O43853 Q15955 Q5VYK1 Q5VYK2 Q71UR3 Q99716,Collagen alpha-1(XII) chain,, PF01391;PF00041;PF00092;, GO:0005595;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0030020;GO:0007155;GO:0030199;GO:0035987;, C:collagen type XII trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle;, F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; scaffold21 indexed_genome mRNA 30092906 30097972 . + . ID=transcript_5171;Q99715 O43853 Q15955 Q5VYK1 Q5VYK2 Q71UR3 Q99716,Collagen alpha-1(XII) chain,, PF01391;PF00041;PF00092;, GO:0005595;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0030020;GO:0007155;GO:0030199;GO:0035987;, C:collagen type XII trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle;, F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; scaffold21 indexed_genome mRNA 30110604 30163742 . + . ID=transcript_5172;Q99715 O43853 Q15955 Q5VYK1 Q5VYK2 Q71UR3 Q99716,Collagen alpha-1(XII) chain,, PF01391;PF00041;PF00092;, GO:0005595;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0030020;GO:0007155;GO:0030199;GO:0035987;, C:collagen type XII trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle;, F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:endodermal cell differentiation; scaffold21 indexed_genome mRNA 31409971 31530763 . - . ID=transcript_5173;Q8N3A7 Q8N915 Q8TDJ2 Q8TDJ3,CD109 antigen,150 kDa TGF-beta-1-binding protein;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7;Platelet-specific Gov antigen;p180;r150;, PF00207;PF07703;PF07677;PF01835;PF17791;PF07678;, GO:0031225;GO:0009986;GO:0005829;GO:0005576;GO:0005615;GO:0005886;GO:0031092;GO:0004867;GO:0050431;GO:0001942;GO:0010839;GO:0001933;GO:0030512;GO:0061045;GO:0072675;GO:0002576;GO:0045616;, C:anchored component of membrane; C:cell surface; C:cytosol; C:extracellular region; C:extracellular space; C:plasma membrane; C:platelet alpha granule membrane;, F:serine-type endopeptidase inhibitor activity; F:transforming growth factor beta binding;, P:hair follicle development; P:negative regulation of keratinocyte proliferation; P:negative regulation of protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of wound healing; P:osteoclast fusion; P:platelet degranulation; P:regulation of keratinocyte differentiation; scaffold21 indexed_genome mRNA 31614979 31673033 . - . ID=transcript_5174;Q9NRA2 Q5SZ76 Q8NBR5 Q9UGH0,Sialin,H(+)/nitrate cotransporter;H(+)/sialic acid cotransporter;Membrane glycoprotein HP59;Solute carrier family 17 member 5;Vesicular H(+)/Aspartate-glutamate cotransporter;, PF07690;, GO:0005829;GO:0016021;GO:0005887;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0030672;GO:0005351;GO:0015136;GO:0022857;GO:0006865;GO:0006820;GO:0006811;GO:0009617;GO:0015739;, C:cytosol; C:integral component of membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:synaptic vesicle membrane;, F:carbohydrate:proton symporter activity; F:sialic acid transmembrane transporter activity; F:transmembrane transporter activity;, P:amino acid transport; P:anion transport; P:ion transport; P:response to bacterium; P:sialic acid transport;|Q9NRA2 Q5SZ76 Q8NBR5 Q9UGH0,Sialin,H(+)/nitrate cotransporter;H(+)/sialic acid cotransporter;Membrane glycoprotein HP59;Solute carrier family 17 member 5;Vesicular H(+)/Aspartate-glutamate cotransporter;, PF07690;, GO:0005829;GO:0016021;GO:0005887;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0030672;GO:0005351;GO:0015136;GO:0022857;GO:0006865;GO:0006820;GO:0006811;GO:0009617;GO:0015739;, C:cytosol; C:integral component of membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:synaptic vesicle membrane;, F:carbohydrate:proton symporter activity; F:sialic acid transmembrane transporter activity; F:transmembrane transporter activity;, P:amino acid transport; P:anion transport; P:ion transport; P:response to bacterium; P:sialic acid transport; scaffold21 indexed_genome mRNA 31738081 31743377 . + . ID=transcript_5175;P68104 P04719 P04720 Q6IQ15,Elongation factor 1-alpha 1,Elongation factor Tu;Eukaryotic elongation factor 1 A-1;Leukocyte receptor cluster member 7;, PF00009;PF03144;PF03143;, GO:0030864;GO:0005737;GO:0098574;GO:0005829;GO:0005853;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0016020;GO:0005730;GO:0005634;GO:0005886;GO:0032587;GO:0034774;GO:0005516;GO:0005525;GO:0003924;GO:0019900;GO:0019901;GO:0003723;GO:0003746;GO:0000049;GO:0071364;GO:0043312;GO:1904714;GO:1900022;GO:0006412;GO:0006414;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of lysosomal membrane; C:cytosol; C:eukaryotic translation elongation factor 1 complex; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:membrane; C:nucleolus; C:nucleus; C:plasma membrane; C:ruffle membrane; C:secretory granule lumen;, F:calmodulin binding; F:GTP binding; F:GTPase activity; F:kinase binding; F:protein kinase binding; F:RNA binding; F:translation elongation factor activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:neutrophil degranulation; P:regulation of chaperone-mediated autophagy; P:regulation of D-erythro-sphingosine kinase activity; P:translation; P:translational elongation; scaffold21 indexed_genome mRNA 31759065 31782085 . - . ID=transcript_5176;Q9Y2Z2 B3KQB5 Q5SWL2 Q5SWL3 Q5SWL4 Q8NDN7 Q8WZ57 Q96FE6 Q9BS06,Protein MTO1 homolog, mitochondrial,, PF01134;PF13932;, GO:0005739;GO:0050660;GO:0003723;GO:0070899;GO:0030488;GO:0002098;, C:mitochondrion;, F:flavin adenine dinucleotide binding; F:RNA binding;, P:mitochondrial tRNA wobble uridine modification; P:tRNA methylation; P:tRNA wobble uridine modification;|Q9Y2Z2 B3KQB5 Q5SWL2 Q5SWL3 Q5SWL4 Q8NDN7 Q8WZ57 Q96FE6 Q9BS06,Protein MTO1 homolog, mitochondrial,, PF01134;PF13932;, GO:0005739;GO:0050660;GO:0003723;GO:0070899;GO:0030488;GO:0002098;, C:mitochondrion;, F:flavin adenine dinucleotide binding; F:RNA binding;, P:mitochondrial tRNA wobble uridine modification; P:tRNA methylation; P:tRNA wobble uridine modification; scaffold21 indexed_genome mRNA 31794812 31797040 . - . ID=transcript_5177;Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45,Cyclic GMP-AMP synthase {ECO:0000303|PubMed:23258413},2'3'-cGAMP synthase {ECO:0000303|PubMed:23258413};Mab-21 domain-containing protein 1;, PF03281;, GO:0005829;GO:0005634;GO:0005886;GO:0035861;GO:0005524;GO:0003682;GO:0061501;GO:0003677;GO:0003690;GO:0005525;GO:0046872;GO:0005546;GO:0002218;GO:0006974;GO:0071360;GO:0051607;GO:0008340;GO:0006281;GO:0045087;GO:2000042;GO:0038001;GO:0043950;GO:2000774;GO:0010753;GO:0002230;GO:0032481;GO:0002637;GO:0050863;GO:0016032;, C:cytosol; C:nucleus; C:plasma membrane; C:site of double-strand break;, F:ATP binding; F:chromatin binding; F:cyclic-GMP-AMP synthase activity; F:DNA binding; F:double-stranded DNA binding; F:GTP binding; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:activation of innate immune response; P:cellular response to DNA damage stimulus; P:cellular response to exogenous dsRNA; P:defense response to virus; P:determination of adult lifespan; P:DNA repair; P:innate immune response; P:negative regulation of double-strand break repair via homologous recombination; P:paracrine signaling; P:positive regulation of cAMP-mediated signaling; P:positive regulation of cellular senescence; P:positive regulation of cGMP-mediated signaling; P:positive regulation of defense response to virus by host; P:positive regulation of type I interferon production; P:regulation of immunoglobulin production; P:regulation of T cell activation; P:viral process; scaffold21 indexed_genome mRNA 31809987 31812681 . + . ID=transcript_5178;Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45,Cyclic GMP-AMP synthase {ECO:0000303|PubMed:23258413},2'3'-cGAMP synthase {ECO:0000303|PubMed:23258413};Mab-21 domain-containing protein 1;, PF03281;, GO:0005829;GO:0005634;GO:0005886;GO:0035861;GO:0005524;GO:0003682;GO:0061501;GO:0003677;GO:0003690;GO:0005525;GO:0046872;GO:0005546;GO:0002218;GO:0006974;GO:0071360;GO:0051607;GO:0008340;GO:0006281;GO:0045087;GO:2000042;GO:0038001;GO:0043950;GO:2000774;GO:0010753;GO:0002230;GO:0032481;GO:0002637;GO:0050863;GO:0016032;, C:cytosol; C:nucleus; C:plasma membrane; C:site of double-strand break;, F:ATP binding; F:chromatin binding; F:cyclic-GMP-AMP synthase activity; F:DNA binding; F:double-stranded DNA binding; F:GTP binding; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:activation of innate immune response; P:cellular response to DNA damage stimulus; P:cellular response to exogenous dsRNA; P:defense response to virus; P:determination of adult lifespan; P:DNA repair; P:innate immune response; P:negative regulation of double-strand break repair via homologous recombination; P:paracrine signaling; P:positive regulation of cAMP-mediated signaling; P:positive regulation of cellular senescence; P:positive regulation of cGMP-mediated signaling; P:positive regulation of defense response to virus by host; P:positive regulation of type I interferon production; P:regulation of immunoglobulin production; P:regulation of T cell activation; P:viral process; scaffold21 indexed_genome mRNA 31860066 31861316 . + . ID=transcript_5179;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold22 indexed_genome mRNA 32872 41488 . - . ID=transcript_5180;Q9UKL9,Aldo-keto reductase family 1 member C3,17-beta-hydroxysteroid dehydrogenase type 5 {ECO:0000303|PubMed:11165022};3-alpha-HSD type II, brain;3-alpha-hydroxysteroid dehydrogenase type 2;Chlordecone reductase homolog HAKRb;Dihydrodiol dehydrogenase 3;Dihydrodiol dehydrogenase type I;HA1753;Prostaglandin F synthase {ECO:0000303|PubMed:10622721};Testosterone 17-beta-dehydrogenase 5;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0047020;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0047834;GO:0047787;GO:0035410;GO:0045550;GO:0045703;GO:0047086;GO:0016655;GO:0018636;GO:0036131;GO:0036130;GO:0047017;GO:0001758;GO:0004745;GO:0016229;GO:0047045;GO:0047035;GO:0071276;GO:0071277;GO:0071384;GO:0071395;GO:0071799;GO:0071379;GO:0034614;GO:0009267;GO:0019371;GO:0044597;GO:0044598;GO:0016488;GO:0007186;GO:0030216;GO:0043170;GO:0008584;GO:1900053;GO:0010942;GO:0008284;GO:2000353;GO:0051897;GO:2000379;GO:0042448;GO:0006693;GO:0048385;GO:2000224;GO:0070293;GO:0007584;GO:0042574;GO:0001523;GO:0042572;GO:0008202;GO:0061370;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:geranylgeranyl reductase activity; F:ketoreductase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:prostaglandin D2 11-ketoreductase activity; F:prostaglandin H2 endoperoxidase reductase activity; F:prostaglandin-F synthase activity; F:retinal dehydrogenase activity; F:retinol dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:cellular response to cadmium ion; P:cellular response to calcium ion; P:cellular response to corticosteroid stimulus; P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:cellular response to prostaglandin stimulus; P:cellular response to reactive oxygen species; P:cellular response to starvation; P:cyclooxygenase pathway; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:farnesol catabolic process; P:G protein-coupled receptor signaling pathway; P:keratinocyte differentiation; P:macromolecule metabolic process; P:male gonad development; P:negative regulation of retinoic acid biosynthetic process; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:regulation of retinoic acid receptor signaling pathway; P:regulation of testosterone biosynthetic process; P:renal absorption; P:response to nutrient; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:testosterone biosynthetic process;|P51857 A1L4P6 A8K060 B4DPN3 B4DPN8,Aldo-keto reductase family 1 member D1,3-oxo-5-beta-steroid 4-dehydrogenase;Delta(4)-3-ketosteroid 5-beta-reductase;Delta(4)-3-oxosteroid 5-beta-reductase;, PF00248;, GO:0005829;GO:0004032;GO:0047834;GO:0047787;GO:0047086;GO:0005496;GO:0016229;GO:0008209;GO:0006699;GO:0030573;GO:0008207;GO:0006707;GO:0007586;GO:0008202;, C:cytosol;, F:alditol:NADP+ 1-oxidoreductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:ketosteroid monooxygenase activity; F:steroid binding; F:steroid dehydrogenase activity;, P:androgen metabolic process; P:bile acid biosynthetic process; P:bile acid catabolic process; P:C21-steroid hormone metabolic process; P:cholesterol catabolic process; P:digestion; P:steroid metabolic process;|Q9UKL9,Aldo-keto reductase family 1 member C3,17-beta-hydroxysteroid dehydrogenase type 5 {ECO:0000303|PubMed:11165022};3-alpha-HSD type II, brain;3-alpha-hydroxysteroid dehydrogenase type 2;Chlordecone reductase homolog HAKRb;Dihydrodiol dehydrogenase 3;Dihydrodiol dehydrogenase type I;HA1753;Prostaglandin F synthase {ECO:0000303|PubMed:10622721};Testosterone 17-beta-dehydrogenase 5;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0047020;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0047834;GO:0047787;GO:0035410;GO:0045550;GO:0045703;GO:0047086;GO:0016655;GO:0018636;GO:0036131;GO:0036130;GO:0047017;GO:0001758;GO:0004745;GO:0016229;GO:0047045;GO:0047035;GO:0071276;GO:0071277;GO:0071384;GO:0071395;GO:0071799;GO:0071379;GO:0034614;GO:0009267;GO:0019371;GO:0044597;GO:0044598;GO:0016488;GO:0007186;GO:0030216;GO:0043170;GO:0008584;GO:1900053;GO:0010942;GO:0008284;GO:2000353;GO:0051897;GO:2000379;GO:0042448;GO:0006693;GO:0048385;GO:2000224;GO:0070293;GO:0007584;GO:0042574;GO:0001523;GO:0042572;GO:0008202;GO:0061370;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:geranylgeranyl reductase activity; F:ketoreductase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:prostaglandin D2 11-ketoreductase activity; F:prostaglandin H2 endoperoxidase reductase activity; F:prostaglandin-F synthase activity; F:retinal dehydrogenase activity; F:retinol dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:cellular response to cadmium ion; P:cellular response to calcium ion; P:cellular response to corticosteroid stimulus; P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:cellular response to prostaglandin stimulus; P:cellular response to reactive oxygen species; P:cellular response to starvation; P:cyclooxygenase pathway; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:farnesol catabolic process; P:G protein-coupled receptor signaling pathway; P:keratinocyte differentiation; P:macromolecule metabolic process; P:male gonad development; P:negative regulation of retinoic acid biosynthetic process; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:regulation of retinoic acid receptor signaling pathway; P:regulation of testosterone biosynthetic process; P:renal absorption; P:response to nutrient; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:testosterone biosynthetic process; scaffold22 indexed_genome mRNA 57293 70094 . - . ID=transcript_5181;Q04828 P52896 Q5SR15 Q7M4N2 Q9UCX2,Aldo-keto reductase family 1 member C1 {ECO:0000305},20-alpha-hydroxysteroid dehydrogenase {ECO:0000303|PubMed:11013348};Chlordecone reductase homolog HAKRC;Dihydrodiol dehydrogenase 1 {ECO:0000303|PubMed:8573067};High-affinity hepatic bile acid-binding protein;, PF00248;, GO:0005829;GO:0070062;GO:0047006;GO:0044594;GO:0072582;GO:0033703;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047042;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0035410;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047045;GO:0030283;GO:0047115;GO:0015721;GO:0008206;GO:0071395;GO:0042632;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0030299;GO:0042448;GO:0006693;GO:0046683;GO:0042574;GO:0001523;GO:0008202;GO:0006805;, C:cytosol; C:extracellular exosome;, F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3beta-hydroxy-5beta-steroid dehydrogenase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase (B-specific) activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:cellular response to jasmonic acid stimulus; P:cholesterol homeostasis; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:intestinal cholesterol absorption; P:progesterone metabolic process; P:prostaglandin metabolic process; P:response to organophosphorus; P:retinal metabolic process; P:retinoid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P52895 A8K2N9 B4DKR9 Q14133 Q5SR16 Q7M4N1 Q96A71,Aldo-keto reductase family 1 member C2 {ECO:0000305},3-alpha-HSD3;Chlordecone reductase homolog HAKRD;Dihydrodiol dehydrogenase 2 {ECO:0000303|PubMed:8573067};Dihydrodiol dehydrogenase/bile acid-binding protein;Type III 3-alpha-hydroxysteroid dehydrogenase;, PF00248;, GO:0005829;GO:0044594;GO:0072582;GO:0004032;GO:0047044;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047115;GO:0071395;GO:0071799;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0007186;GO:0008284;GO:0051897;GO:0042448;GO:0006693;GO:0008202;, C:cytosol;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:alditol:NADP+ 1-oxidoreductase activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of protein kinase B signaling; P:progesterone metabolic process; P:prostaglandin metabolic process; P:steroid metabolic process;|P17516 Q5T6A3 Q8WW84 Q9NS54,Aldo-keto reductase family 1 member C4,3-alpha-hydroxysteroid dehydrogenase type I {ECO:0000303|PubMed:11158055, ECO:0000303|PubMed:7650035};3alpha-hydroxysteroid 3-dehydrogenase;Chlordecone reductase {ECO:0000303|PubMed:2427522};Dihydrodiol dehydrogenase 4;HAKRA;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0015125;GO:0047743;GO:0047834;GO:0035410;GO:0009055;GO:0047086;GO:0016655;GO:0001758;GO:0016229;GO:0047045;GO:0047035;GO:0008209;GO:0015721;GO:0006699;GO:0071395;GO:0044597;GO:0044598;GO:0042448;GO:0006693;GO:0001523;GO:0008202;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:bile acid transmembrane transporter activity; F:chlordecone reductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:electron transfer activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:retinal dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:androgen metabolic process; P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:cellular response to jasmonic acid stimulus; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:retinoid metabolic process; P:steroid metabolic process; scaffold22 indexed_genome mRNA 156819 158814 . + . ID=transcript_5182;P63135,Endogenous retrovirus group K member 7 Pol protein,HERV-K(III) Pol protein;HERV-K102 Pol protein;HERV-K_1q22 provirus ancestral Pol protein;, PF00517;PF13804;PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0005198;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:structural molecule activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold22 indexed_genome mRNA 158829 159531 . + . ID=transcript_5183;Q9WJR5 O15312,Endogenous retrovirus group K member 19 Pol protein,HERV-K(C19) Pol protein;HERV-K_19q11 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold22 indexed_genome mRNA 159565 180120 . + . ID=transcript_5184;Q9HDB9,Endogenous retrovirus group K member 5 Gag polyprotein,HERV-K(II) Gag protein;HERV-K_3q12.3 provirus ancestral Gag polyprotein;, PF02337;PF00607;PF00098;, GO:0005886;GO:0003676;GO:0005198;GO:0008270;GO:0016032;, C:plasma membrane;, F:nucleic acid binding; F:structural molecule activity; F:zinc ion binding;, P:viral process;|Q9UKL9,Aldo-keto reductase family 1 member C3,17-beta-hydroxysteroid dehydrogenase type 5 {ECO:0000303|PubMed:11165022};3-alpha-HSD type II, brain;3-alpha-hydroxysteroid dehydrogenase type 2;Chlordecone reductase homolog HAKRb;Dihydrodiol dehydrogenase 3;Dihydrodiol dehydrogenase type I;HA1753;Prostaglandin F synthase {ECO:0000303|PubMed:10622721};Testosterone 17-beta-dehydrogenase 5;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0047020;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0047834;GO:0047787;GO:0035410;GO:0045550;GO:0045703;GO:0047086;GO:0016655;GO:0018636;GO:0036131;GO:0036130;GO:0047017;GO:0001758;GO:0004745;GO:0016229;GO:0047045;GO:0047035;GO:0071276;GO:0071277;GO:0071384;GO:0071395;GO:0071799;GO:0071379;GO:0034614;GO:0009267;GO:0019371;GO:0044597;GO:0044598;GO:0016488;GO:0007186;GO:0030216;GO:0043170;GO:0008584;GO:1900053;GO:0010942;GO:0008284;GO:2000353;GO:0051897;GO:2000379;GO:0042448;GO:0006693;GO:0048385;GO:2000224;GO:0070293;GO:0007584;GO:0042574;GO:0001523;GO:0042572;GO:0008202;GO:0061370;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:geranylgeranyl reductase activity; F:ketoreductase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:prostaglandin D2 11-ketoreductase activity; F:prostaglandin H2 endoperoxidase reductase activity; F:prostaglandin-F synthase activity; F:retinal dehydrogenase activity; F:retinol dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:cellular response to cadmium ion; P:cellular response to calcium ion; P:cellular response to corticosteroid stimulus; P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:cellular response to prostaglandin stimulus; P:cellular response to reactive oxygen species; P:cellular response to starvation; P:cyclooxygenase pathway; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:farnesol catabolic process; P:G protein-coupled receptor signaling pathway; P:keratinocyte differentiation; P:macromolecule metabolic process; P:male gonad development; P:negative regulation of retinoic acid biosynthetic process; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:regulation of retinoic acid receptor signaling pathway; P:regulation of testosterone biosynthetic process; P:renal absorption; P:response to nutrient; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:testosterone biosynthetic process;|P17516 Q5T6A3 Q8WW84 Q9NS54,Aldo-keto reductase family 1 member C4,3-alpha-hydroxysteroid dehydrogenase type I {ECO:0000303|PubMed:11158055, ECO:0000303|PubMed:7650035};3alpha-hydroxysteroid 3-dehydrogenase;Chlordecone reductase {ECO:0000303|PubMed:2427522};Dihydrodiol dehydrogenase 4;HAKRA;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0015125;GO:0047743;GO:0047834;GO:0035410;GO:0009055;GO:0047086;GO:0016655;GO:0001758;GO:0016229;GO:0047045;GO:0047035;GO:0008209;GO:0015721;GO:0006699;GO:0071395;GO:0044597;GO:0044598;GO:0042448;GO:0006693;GO:0001523;GO:0008202;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:bile acid transmembrane transporter activity; F:chlordecone reductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:electron transfer activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:retinal dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:androgen metabolic process; P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:cellular response to jasmonic acid stimulus; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:retinoid metabolic process; P:steroid metabolic process;|Q9UKL9,Aldo-keto reductase family 1 member C3,17-beta-hydroxysteroid dehydrogenase type 5 {ECO:0000303|PubMed:11165022};3-alpha-HSD type II, brain;3-alpha-hydroxysteroid dehydrogenase type 2;Chlordecone reductase homolog HAKRb;Dihydrodiol dehydrogenase 3;Dihydrodiol dehydrogenase type I;HA1753;Prostaglandin F synthase {ECO:0000303|PubMed:10622721};Testosterone 17-beta-dehydrogenase 5;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0047020;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0047834;GO:0047787;GO:0035410;GO:0045550;GO:0045703;GO:0047086;GO:0016655;GO:0018636;GO:0036131;GO:0036130;GO:0047017;GO:0001758;GO:0004745;GO:0016229;GO:0047045;GO:0047035;GO:0071276;GO:0071277;GO:0071384;GO:0071395;GO:0071799;GO:0071379;GO:0034614;GO:0009267;GO:0019371;GO:0044597;GO:0044598;GO:0016488;GO:0007186;GO:0030216;GO:0043170;GO:0008584;GO:1900053;GO:0010942;GO:0008284;GO:2000353;GO:0051897;GO:2000379;GO:0042448;GO:0006693;GO:0048385;GO:2000224;GO:0070293;GO:0007584;GO:0042574;GO:0001523;GO:0042572;GO:0008202;GO:0061370;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:geranylgeranyl reductase activity; F:ketoreductase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:prostaglandin D2 11-ketoreductase activity; F:prostaglandin H2 endoperoxidase reductase activity; F:prostaglandin-F synthase activity; F:retinal dehydrogenase activity; F:retinol dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:cellular response to cadmium ion; P:cellular response to calcium ion; P:cellular response to corticosteroid stimulus; P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:cellular response to prostaglandin stimulus; P:cellular response to reactive oxygen species; P:cellular response to starvation; P:cyclooxygenase pathway; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:farnesol catabolic process; P:G protein-coupled receptor signaling pathway; P:keratinocyte differentiation; P:macromolecule metabolic process; P:male gonad development; P:negative regulation of retinoic acid biosynthetic process; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:regulation of retinoic acid receptor signaling pathway; P:regulation of testosterone biosynthetic process; P:renal absorption; P:response to nutrient; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:testosterone biosynthetic process;|P17516 Q5T6A3 Q8WW84 Q9NS54,Aldo-keto reductase family 1 member C4,3-alpha-hydroxysteroid dehydrogenase type I {ECO:0000303|PubMed:11158055, ECO:0000303|PubMed:7650035};3alpha-hydroxysteroid 3-dehydrogenase;Chlordecone reductase {ECO:0000303|PubMed:2427522};Dihydrodiol dehydrogenase 4;HAKRA;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0015125;GO:0047743;GO:0047834;GO:0035410;GO:0009055;GO:0047086;GO:0016655;GO:0001758;GO:0016229;GO:0047045;GO:0047035;GO:0008209;GO:0015721;GO:0006699;GO:0071395;GO:0044597;GO:0044598;GO:0042448;GO:0006693;GO:0001523;GO:0008202;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:bile acid transmembrane transporter activity; F:chlordecone reductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:electron transfer activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:retinal dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:androgen metabolic process; P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:cellular response to jasmonic acid stimulus; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:retinoid metabolic process; P:steroid metabolic process;|P52895 A8K2N9 B4DKR9 Q14133 Q5SR16 Q7M4N1 Q96A71,Aldo-keto reductase family 1 member C2 {ECO:0000305},3-alpha-HSD3;Chlordecone reductase homolog HAKRD;Dihydrodiol dehydrogenase 2 {ECO:0000303|PubMed:8573067};Dihydrodiol dehydrogenase/bile acid-binding protein;Type III 3-alpha-hydroxysteroid dehydrogenase;, PF00248;, GO:0005829;GO:0044594;GO:0072582;GO:0004032;GO:0047044;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047115;GO:0071395;GO:0071799;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0007186;GO:0008284;GO:0051897;GO:0042448;GO:0006693;GO:0008202;, C:cytosol;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:alditol:NADP+ 1-oxidoreductase activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of protein kinase B signaling; P:progesterone metabolic process; P:prostaglandin metabolic process; P:steroid metabolic process; scaffold22 indexed_genome mRNA 234939 249902 . - . ID=transcript_5185;Q04828 P52896 Q5SR15 Q7M4N2 Q9UCX2,Aldo-keto reductase family 1 member C1 {ECO:0000305},20-alpha-hydroxysteroid dehydrogenase {ECO:0000303|PubMed:11013348};Chlordecone reductase homolog HAKRC;Dihydrodiol dehydrogenase 1 {ECO:0000303|PubMed:8573067};High-affinity hepatic bile acid-binding protein;, PF00248;, GO:0005829;GO:0070062;GO:0047006;GO:0044594;GO:0072582;GO:0033703;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047042;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0035410;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047045;GO:0030283;GO:0047115;GO:0015721;GO:0008206;GO:0071395;GO:0042632;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0030299;GO:0042448;GO:0006693;GO:0046683;GO:0042574;GO:0001523;GO:0008202;GO:0006805;, C:cytosol; C:extracellular exosome;, F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3beta-hydroxy-5beta-steroid dehydrogenase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase (B-specific) activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:cellular response to jasmonic acid stimulus; P:cholesterol homeostasis; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:intestinal cholesterol absorption; P:progesterone metabolic process; P:prostaglandin metabolic process; P:response to organophosphorus; P:retinal metabolic process; P:retinoid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P52895 A8K2N9 B4DKR9 Q14133 Q5SR16 Q7M4N1 Q96A71,Aldo-keto reductase family 1 member C2 {ECO:0000305},3-alpha-HSD3;Chlordecone reductase homolog HAKRD;Dihydrodiol dehydrogenase 2 {ECO:0000303|PubMed:8573067};Dihydrodiol dehydrogenase/bile acid-binding protein;Type III 3-alpha-hydroxysteroid dehydrogenase;, PF00248;, GO:0005829;GO:0044594;GO:0072582;GO:0004032;GO:0047044;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047115;GO:0071395;GO:0071799;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0007186;GO:0008284;GO:0051897;GO:0042448;GO:0006693;GO:0008202;, C:cytosol;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:alditol:NADP+ 1-oxidoreductase activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of protein kinase B signaling; P:progesterone metabolic process; P:prostaglandin metabolic process; P:steroid metabolic process; scaffold22 indexed_genome mRNA 286824 300730 . - . ID=transcript_5186;Q9UKL9,Aldo-keto reductase family 1 member C3,17-beta-hydroxysteroid dehydrogenase type 5 {ECO:0000303|PubMed:11165022};3-alpha-HSD type II, brain;3-alpha-hydroxysteroid dehydrogenase type 2;Chlordecone reductase homolog HAKRb;Dihydrodiol dehydrogenase 3;Dihydrodiol dehydrogenase type I;HA1753;Prostaglandin F synthase {ECO:0000303|PubMed:10622721};Testosterone 17-beta-dehydrogenase 5;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0047020;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0047834;GO:0047787;GO:0035410;GO:0045550;GO:0045703;GO:0047086;GO:0016655;GO:0018636;GO:0036131;GO:0036130;GO:0047017;GO:0001758;GO:0004745;GO:0016229;GO:0047045;GO:0047035;GO:0071276;GO:0071277;GO:0071384;GO:0071395;GO:0071799;GO:0071379;GO:0034614;GO:0009267;GO:0019371;GO:0044597;GO:0044598;GO:0016488;GO:0007186;GO:0030216;GO:0043170;GO:0008584;GO:1900053;GO:0010942;GO:0008284;GO:2000353;GO:0051897;GO:2000379;GO:0042448;GO:0006693;GO:0048385;GO:2000224;GO:0070293;GO:0007584;GO:0042574;GO:0001523;GO:0042572;GO:0008202;GO:0061370;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:geranylgeranyl reductase activity; F:ketoreductase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:prostaglandin D2 11-ketoreductase activity; F:prostaglandin H2 endoperoxidase reductase activity; F:prostaglandin-F synthase activity; F:retinal dehydrogenase activity; F:retinol dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:cellular response to cadmium ion; P:cellular response to calcium ion; P:cellular response to corticosteroid stimulus; P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:cellular response to prostaglandin stimulus; P:cellular response to reactive oxygen species; P:cellular response to starvation; P:cyclooxygenase pathway; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:farnesol catabolic process; P:G protein-coupled receptor signaling pathway; P:keratinocyte differentiation; P:macromolecule metabolic process; P:male gonad development; P:negative regulation of retinoic acid biosynthetic process; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:regulation of retinoic acid receptor signaling pathway; P:regulation of testosterone biosynthetic process; P:renal absorption; P:response to nutrient; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:testosterone biosynthetic process;|Q04828 P52896 Q5SR15 Q7M4N2 Q9UCX2,Aldo-keto reductase family 1 member C1 {ECO:0000305},20-alpha-hydroxysteroid dehydrogenase {ECO:0000303|PubMed:11013348};Chlordecone reductase homolog HAKRC;Dihydrodiol dehydrogenase 1 {ECO:0000303|PubMed:8573067};High-affinity hepatic bile acid-binding protein;, PF00248;, GO:0005829;GO:0070062;GO:0047006;GO:0044594;GO:0072582;GO:0033703;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047042;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0035410;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047045;GO:0030283;GO:0047115;GO:0015721;GO:0008206;GO:0071395;GO:0042632;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0030299;GO:0042448;GO:0006693;GO:0046683;GO:0042574;GO:0001523;GO:0008202;GO:0006805;, C:cytosol; C:extracellular exosome;, F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3beta-hydroxy-5beta-steroid dehydrogenase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase (B-specific) activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:cellular response to jasmonic acid stimulus; P:cholesterol homeostasis; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:intestinal cholesterol absorption; P:progesterone metabolic process; P:prostaglandin metabolic process; P:response to organophosphorus; P:retinal metabolic process; P:retinoid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P17516 Q5T6A3 Q8WW84 Q9NS54,Aldo-keto reductase family 1 member C4,3-alpha-hydroxysteroid dehydrogenase type I {ECO:0000303|PubMed:11158055, ECO:0000303|PubMed:7650035};3alpha-hydroxysteroid 3-dehydrogenase;Chlordecone reductase {ECO:0000303|PubMed:2427522};Dihydrodiol dehydrogenase 4;HAKRA;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0015125;GO:0047743;GO:0047834;GO:0035410;GO:0009055;GO:0047086;GO:0016655;GO:0001758;GO:0016229;GO:0047045;GO:0047035;GO:0008209;GO:0015721;GO:0006699;GO:0071395;GO:0044597;GO:0044598;GO:0042448;GO:0006693;GO:0001523;GO:0008202;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:bile acid transmembrane transporter activity; F:chlordecone reductase activity; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:electron transfer activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:retinal dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:androgen metabolic process; P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:cellular response to jasmonic acid stimulus; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:retinoid metabolic process; P:steroid metabolic process;|Q5T2L2 A6NF66 Q6ZN81,Putative aldo-keto reductase family 1 member C8,Aldo-keto reductase family 1 member C-like protein 1;, PF00248;, GO:0005737;GO:0047834;, C:cytoplasm;, F:D-threo-aldose 1-dehydrogenase activity;|Q04828 P52896 Q5SR15 Q7M4N2 Q9UCX2,Aldo-keto reductase family 1 member C1 {ECO:0000305},20-alpha-hydroxysteroid dehydrogenase {ECO:0000303|PubMed:11013348};Chlordecone reductase homolog HAKRC;Dihydrodiol dehydrogenase 1 {ECO:0000303|PubMed:8573067};High-affinity hepatic bile acid-binding protein;, PF00248;, GO:0005829;GO:0070062;GO:0047006;GO:0044594;GO:0072582;GO:0033703;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047042;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0035410;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047045;GO:0030283;GO:0047115;GO:0015721;GO:0008206;GO:0071395;GO:0042632;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0030299;GO:0042448;GO:0006693;GO:0046683;GO:0042574;GO:0001523;GO:0008202;GO:0006805;, C:cytosol; C:extracellular exosome;, F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3beta-hydroxy-5beta-steroid dehydrogenase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase (B-specific) activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:cellular response to jasmonic acid stimulus; P:cholesterol homeostasis; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:intestinal cholesterol absorption; P:progesterone metabolic process; P:prostaglandin metabolic process; P:response to organophosphorus; P:retinal metabolic process; P:retinoid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|Q04828 P52896 Q5SR15 Q7M4N2 Q9UCX2,Aldo-keto reductase family 1 member C1 {ECO:0000305},20-alpha-hydroxysteroid dehydrogenase {ECO:0000303|PubMed:11013348};Chlordecone reductase homolog HAKRC;Dihydrodiol dehydrogenase 1 {ECO:0000303|PubMed:8573067};High-affinity hepatic bile acid-binding protein;, PF00248;, GO:0005829;GO:0070062;GO:0047006;GO:0044594;GO:0072582;GO:0033703;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047042;GO:0047023;GO:0032052;GO:0031406;GO:0047834;GO:0035410;GO:0047718;GO:0047086;GO:0016655;GO:0018636;GO:0016229;GO:0047045;GO:0030283;GO:0047115;GO:0015721;GO:0008206;GO:0071395;GO:0042632;GO:0044597;GO:0007586;GO:0044598;GO:0030855;GO:0030299;GO:0042448;GO:0006693;GO:0046683;GO:0042574;GO:0001523;GO:0008202;GO:0006805;, C:cytosol; C:extracellular exosome;, F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3beta-hydroxy-5beta-steroid dehydrogenase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase (B-specific) activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:carboxylic acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:indanol dehydrogenase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:bile acid and bile salt transport; P:bile acid metabolic process; P:cellular response to jasmonic acid stimulus; P:cholesterol homeostasis; P:daunorubicin metabolic process; P:digestion; P:doxorubicin metabolic process; P:epithelial cell differentiation; P:intestinal cholesterol absorption; P:progesterone metabolic process; P:prostaglandin metabolic process; P:response to organophosphorus; P:retinal metabolic process; P:retinoid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|Q9UKL9,Aldo-keto reductase family 1 member C3,17-beta-hydroxysteroid dehydrogenase type 5 {ECO:0000303|PubMed:11165022};3-alpha-HSD type II, brain;3-alpha-hydroxysteroid dehydrogenase type 2;Chlordecone reductase homolog HAKRb;Dihydrodiol dehydrogenase 3;Dihydrodiol dehydrogenase type I;HA1753;Prostaglandin F synthase {ECO:0000303|PubMed:10622721};Testosterone 17-beta-dehydrogenase 5;, PF00248;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0047020;GO:0044594;GO:0072582;GO:0047024;GO:0004032;GO:0004033;GO:0047044;GO:0047023;GO:0032052;GO:0047834;GO:0047787;GO:0035410;GO:0045550;GO:0045703;GO:0047086;GO:0016655;GO:0018636;GO:0036131;GO:0036130;GO:0047017;GO:0001758;GO:0004745;GO:0016229;GO:0047045;GO:0047035;GO:0071276;GO:0071277;GO:0071384;GO:0071395;GO:0071799;GO:0071379;GO:0034614;GO:0009267;GO:0019371;GO:0044597;GO:0044598;GO:0016488;GO:0007186;GO:0030216;GO:0043170;GO:0008584;GO:1900053;GO:0010942;GO:0008284;GO:2000353;GO:0051897;GO:2000379;GO:0042448;GO:0006693;GO:0048385;GO:2000224;GO:0070293;GO:0007584;GO:0042574;GO:0001523;GO:0042572;GO:0008202;GO:0061370;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:alditol:NADP+ 1-oxidoreductase activity; F:aldo-keto reductase (NADP) activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:bile acid binding; F:D-threo-aldose 1-dehydrogenase activity; F:delta4-3-oxosteroid 5beta-reductase activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:geranylgeranyl reductase activity; F:ketoreductase activity; F:ketosteroid monooxygenase activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:phenanthrene 9,10-monooxygenase activity; F:prostaglandin D2 11-ketoreductase activity; F:prostaglandin H2 endoperoxidase reductase activity; F:prostaglandin-F synthase activity; F:retinal dehydrogenase activity; F:retinol dehydrogenase activity; F:steroid dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:cellular response to cadmium ion; P:cellular response to calcium ion; P:cellular response to corticosteroid stimulus; P:cellular response to jasmonic acid stimulus; P:cellular response to prostaglandin D stimulus; P:cellular response to prostaglandin stimulus; P:cellular response to reactive oxygen species; P:cellular response to starvation; P:cyclooxygenase pathway; P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:farnesol catabolic process; P:G protein-coupled receptor signaling pathway; P:keratinocyte differentiation; P:macromolecule metabolic process; P:male gonad development; P:negative regulation of retinoic acid biosynthetic process; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:progesterone metabolic process; P:prostaglandin metabolic process; P:regulation of retinoic acid receptor signaling pathway; P:regulation of testosterone biosynthetic process; P:renal absorption; P:response to nutrient; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:testosterone biosynthetic process; scaffold22 indexed_genome mRNA 426661 434086 . + . ID=transcript_5187;Q7Z628 Q12773 Q96D82 Q99903 Q9UEN6,Neuroepithelial cell-transforming gene 1 protein,Proto-oncogene p65 Net1;Rho guanine nucleotide exchange factor 8;, PF00169;PF00621;, GO:0005829;GO:0005634;GO:0005085;GO:0070301;GO:0071479;GO:0007186;GO:0035556;GO:0051451;GO:0043065;GO:0043547;GO:0035025;GO:0001558;GO:0051056;GO:0007165;, C:cytosol; C:nucleus;, F:guanyl-nucleotide exchange factor activity;, P:cellular response to hydrogen peroxide; P:cellular response to ionizing radiation; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:myoblast migration; P:positive regulation of apoptotic process; P:positive regulation of GTPase activity; P:positive regulation of Rho protein signal transduction; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q7Z628 Q12773 Q96D82 Q99903 Q9UEN6,Neuroepithelial cell-transforming gene 1 protein,Proto-oncogene p65 Net1;Rho guanine nucleotide exchange factor 8;, PF00169;PF00621;, GO:0005829;GO:0005634;GO:0005085;GO:0070301;GO:0071479;GO:0007186;GO:0035556;GO:0051451;GO:0043065;GO:0043547;GO:0035025;GO:0001558;GO:0051056;GO:0007165;, C:cytosol; C:nucleus;, F:guanyl-nucleotide exchange factor activity;, P:cellular response to hydrogen peroxide; P:cellular response to ionizing radiation; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:myoblast migration; P:positive regulation of apoptotic process; P:positive regulation of GTPase activity; P:positive regulation of Rho protein signal transduction; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold22 indexed_genome mRNA 540192 558756 . - . ID=transcript_5188;Q8WXK3 A8K7Q6 D3DRR2 Q96EP7 Q9H8Z1,Ankyrin repeat and SOCS box protein 13,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q8WXK3 A8K7Q6 D3DRR2 Q96EP7 Q9H8Z1,Ankyrin repeat and SOCS box protein 13,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q8WXK3 A8K7Q6 D3DRR2 Q96EP7 Q9H8Z1,Ankyrin repeat and SOCS box protein 13,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; scaffold22 indexed_genome mRNA 584815 668175 . + . ID=transcript_5189;Q9NXA1,Protein TASOR 2 {ECO:0000305},, PF12480;PF12509;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q9NXA1,Protein TASOR 2 {ECO:0000305},, PF12480;PF12509;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q9NXA1,Protein TASOR 2 {ECO:0000305},, PF12480;PF12509;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q9NXA1,Protein TASOR 2 {ECO:0000305},, PF12480;PF12509;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q9NXA1,Protein TASOR 2 {ECO:0000305},, PF12480;PF12509;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q9NXA1,Protein TASOR 2 {ECO:0000305},, PF12480;PF12509;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|P50395 O43928 Q5SX88 Q9UQM6,Rab GDP dissociation inhibitor beta,Guanosine diphosphate dissociation inhibitor 2;, PF00996;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0016020;GO:0034774;GO:0045202;GO:0031982;GO:0005096;GO:0005093;GO:0003723;GO:0031267;GO:0043312;GO:0015031;GO:0007165;GO:0007264;GO:0016192;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:membrane; C:secretory granule lumen; C:synapse; C:vesicle;, F:GTPase activator activity; F:Rab GDP-dissociation inhibitor activity; F:RNA binding; F:small GTPase binding;, P:neutrophil degranulation; P:protein transport; P:signal transduction; P:small GTPase mediated signal transduction; P:vesicle-mediated transport;|P50395 O43928 Q5SX88 Q9UQM6,Rab GDP dissociation inhibitor beta,Guanosine diphosphate dissociation inhibitor 2;, PF00996;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0016020;GO:0034774;GO:0045202;GO:0031982;GO:0005096;GO:0005093;GO:0003723;GO:0031267;GO:0043312;GO:0015031;GO:0007165;GO:0007264;GO:0016192;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:membrane; C:secretory granule lumen; C:synapse; C:vesicle;, F:GTPase activator activity; F:Rab GDP-dissociation inhibitor activity; F:RNA binding; F:small GTPase binding;, P:neutrophil degranulation; P:protein transport; P:signal transduction; P:small GTPase mediated signal transduction; P:vesicle-mediated transport;|P50395 O43928 Q5SX88 Q9UQM6,Rab GDP dissociation inhibitor beta,Guanosine diphosphate dissociation inhibitor 2;, PF00996;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0016020;GO:0034774;GO:0045202;GO:0031982;GO:0005096;GO:0005093;GO:0003723;GO:0031267;GO:0043312;GO:0015031;GO:0007165;GO:0007264;GO:0016192;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:membrane; C:secretory granule lumen; C:synapse; C:vesicle;, F:GTPase activator activity; F:Rab GDP-dissociation inhibitor activity; F:RNA binding; F:small GTPase binding;, P:neutrophil degranulation; P:protein transport; P:signal transduction; P:small GTPase mediated signal transduction; P:vesicle-mediated transport;|P50395 O43928 Q5SX88 Q9UQM6,Rab GDP dissociation inhibitor beta,Guanosine diphosphate dissociation inhibitor 2;, PF00996;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0016020;GO:0034774;GO:0045202;GO:0031982;GO:0005096;GO:0005093;GO:0003723;GO:0031267;GO:0043312;GO:0015031;GO:0007165;GO:0007264;GO:0016192;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:membrane; C:secretory granule lumen; C:synapse; C:vesicle;, F:GTPase activator activity; F:Rab GDP-dissociation inhibitor activity; F:RNA binding; F:small GTPase binding;, P:neutrophil degranulation; P:protein transport; P:signal transduction; P:small GTPase mediated signal transduction; P:vesicle-mediated transport; scaffold22 indexed_genome mRNA 687368 708289 . - . ID=transcript_5190;Q6P6B7 A6NEF0 F8WEI4 Q9NT01,Ankyrin repeat domain-containing protein 16 {ECO:0000305},, PF00023;PF12796;, GO:0005737;GO:0005634;GO:0006400;, C:cytoplasm; C:nucleus;, , P:tRNA modification;|Q6P6B7 A6NEF0 F8WEI4 Q9NT01,Ankyrin repeat domain-containing protein 16 {ECO:0000305},, PF00023;PF12796;, GO:0005737;GO:0005634;GO:0006400;, C:cytoplasm; C:nucleus;, , P:tRNA modification;|Q6P6B7 A6NEF0 F8WEI4 Q9NT01,Ankyrin repeat domain-containing protein 16 {ECO:0000305},, PF00023;PF12796;, GO:0005737;GO:0005634;GO:0006400;, C:cytoplasm; C:nucleus;, , P:tRNA modification;|Q6P6B7 A6NEF0 F8WEI4 Q9NT01,Ankyrin repeat domain-containing protein 16 {ECO:0000305},, PF00023;PF12796;, GO:0005737;GO:0005634;GO:0006400;, C:cytoplasm; C:nucleus;, , P:tRNA modification;|Q6P6B7 A6NEF0 F8WEI4 Q9NT01,Ankyrin repeat domain-containing protein 16 {ECO:0000305},, PF00023;PF12796;, GO:0005737;GO:0005634;GO:0006400;, C:cytoplasm; C:nucleus;, , P:tRNA modification; scaffold22 indexed_genome mRNA 723850 732351 . + . ID=transcript_5191;Q96SW7 Q9UFB2,F-box DNA helicase 1 {ECO:0000303|PubMed:11956208},F-box only protein 18 {ECO:0000312|HGNC:HGNC:13620};, PF12937;PF13361;, GO:0000785;GO:0005634;GO:0019005;GO:0043138;GO:0005524;GO:0003678;GO:0015616;GO:0003690;GO:0003697;GO:0008219;GO:0006974;GO:0000737;GO:0000724;GO:0035562;GO:2000042;GO:1902231;GO:0001934;GO:0016567;GO:0000725;GO:0031297;GO:0048478;GO:0072429;, C:chromatin; C:nucleus; C:SCF ubiquitin ligase complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:DNA translocase activity; F:double-stranded DNA binding; F:single-stranded DNA binding;, P:cell death; P:cellular response to DNA damage stimulus; P:DNA catabolic process, endonucleolytic; P:double-strand break repair via homologous recombination; P:negative regulation of chromatin binding; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of protein phosphorylation; P:protein ubiquitination; P:recombinational repair; P:replication fork processing; P:replication fork protection; P:response to intra-S DNA damage checkpoint signaling; scaffold22 indexed_genome mRNA 732464 733745 . - . ID=transcript_5192;Q6P6B7 A6NEF0 F8WEI4 Q9NT01,Ankyrin repeat domain-containing protein 16 {ECO:0000305},, PF00023;PF12796;, GO:0005737;GO:0005634;GO:0006400;, C:cytoplasm; C:nucleus;, , P:tRNA modification; scaffold22 indexed_genome mRNA 774155 833177 . + . ID=transcript_5193;Q9NPX7 Q9UFV6,Lysophosphatidylserine lipase ABHD12 {ECO:0000305},2-arachidonoylglycerol hydrolase ABHD12 {ECO:0000305};Abhydrolase domain-containing protein 12 {ECO:0000305};Monoacylglycerol lipase ABHD12 {ECO:0000305};Oxidized phosphatidylserine lipase ABHD12 {ECO:0000305};, PF12146;, GO:0032281;GO:0032839;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0047372;GO:0004622;GO:0008474;GO:0004620;GO:0046464;GO:0007628;GO:0046475;GO:0052651;GO:0006660;GO:0009395;GO:0002084;GO:0050727;GO:0010996;, C:AMPA glutamate receptor complex; C:dendrite cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:acylglycerol lipase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:acylglycerol catabolic process; P:adult walking behavior; P:glycerophospholipid catabolic process; P:monoacylglycerol catabolic process; P:phosphatidylserine catabolic process; P:phospholipid catabolic process; P:protein depalmitoylation; P:regulation of inflammatory response; P:response to auditory stimulus;|Q9NPX7 Q9UFV6,Lysophosphatidylserine lipase ABHD12 {ECO:0000305},2-arachidonoylglycerol hydrolase ABHD12 {ECO:0000305};Abhydrolase domain-containing protein 12 {ECO:0000305};Monoacylglycerol lipase ABHD12 {ECO:0000305};Oxidized phosphatidylserine lipase ABHD12 {ECO:0000305};, PF12146;, GO:0032281;GO:0032839;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0047372;GO:0004622;GO:0008474;GO:0004620;GO:0046464;GO:0007628;GO:0046475;GO:0052651;GO:0006660;GO:0009395;GO:0002084;GO:0050727;GO:0010996;, C:AMPA glutamate receptor complex; C:dendrite cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:acylglycerol lipase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:acylglycerol catabolic process; P:adult walking behavior; P:glycerophospholipid catabolic process; P:monoacylglycerol catabolic process; P:phosphatidylserine catabolic process; P:phospholipid catabolic process; P:protein depalmitoylation; P:regulation of inflammatory response; P:response to auditory stimulus;|Q9NPX7 Q9UFV6,Lysophosphatidylserine lipase ABHD12 {ECO:0000305},2-arachidonoylglycerol hydrolase ABHD12 {ECO:0000305};Abhydrolase domain-containing protein 12 {ECO:0000305};Monoacylglycerol lipase ABHD12 {ECO:0000305};Oxidized phosphatidylserine lipase ABHD12 {ECO:0000305};, PF12146;, GO:0032281;GO:0032839;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0047372;GO:0004622;GO:0008474;GO:0004620;GO:0046464;GO:0007628;GO:0046475;GO:0052651;GO:0006660;GO:0009395;GO:0002084;GO:0050727;GO:0010996;, C:AMPA glutamate receptor complex; C:dendrite cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:acylglycerol lipase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:acylglycerol catabolic process; P:adult walking behavior; P:glycerophospholipid catabolic process; P:monoacylglycerol catabolic process; P:phosphatidylserine catabolic process; P:phospholipid catabolic process; P:protein depalmitoylation; P:regulation of inflammatory response; P:response to auditory stimulus;|Q9NPX7 Q9UFV6,Lysophosphatidylserine lipase ABHD12 {ECO:0000305},2-arachidonoylglycerol hydrolase ABHD12 {ECO:0000305};Abhydrolase domain-containing protein 12 {ECO:0000305};Monoacylglycerol lipase ABHD12 {ECO:0000305};Oxidized phosphatidylserine lipase ABHD12 {ECO:0000305};, PF12146;, GO:0032281;GO:0032839;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0047372;GO:0004622;GO:0008474;GO:0004620;GO:0046464;GO:0007628;GO:0046475;GO:0052651;GO:0006660;GO:0009395;GO:0002084;GO:0050727;GO:0010996;, C:AMPA glutamate receptor complex; C:dendrite cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:acylglycerol lipase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:acylglycerol catabolic process; P:adult walking behavior; P:glycerophospholipid catabolic process; P:monoacylglycerol catabolic process; P:phosphatidylserine catabolic process; P:phospholipid catabolic process; P:protein depalmitoylation; P:regulation of inflammatory response; P:response to auditory stimulus;|P15954 Q6NR81,Cytochrome c oxidase subunit 7C, mitochondrial,Cytochrome c oxidase polypeptide VIIc;, PF02935;, GO:0016021;GO:0005743;GO:0005751;GO:0005739;GO:0004129;GO:0006091;GO:0006123;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV; C:mitochondrion;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation;|P11216 Q96AK1 Q9NPX8,Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228},, PF00343;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0008184;GO:0102250;GO:0030170;GO:0102499;GO:0005980;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:neutrophil degranulation; scaffold22 indexed_genome mRNA 846941 864923 . - . ID=transcript_5194;O75354 A6NCX6 D3DW49 Q5QPJ2 Q5QPJ5 Q7Z5B5 Q8N3H3 Q8TAS7 Q9UJD1,Ectonucleoside triphosphate diphosphohydrolase 6,CD39 antigen-like 2;, PF01150;, GO:0009986;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0036384;GO:0008894;GO:0004382;GO:1990003;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0051592;GO:0032026;, C:cell surface; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cytidine-diphosphatase activity; F:guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity; F:guanosine-diphosphatase activity; F:inosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:response to calcium ion; P:response to magnesium ion;|O75354 A6NCX6 D3DW49 Q5QPJ2 Q5QPJ5 Q7Z5B5 Q8N3H3 Q8TAS7 Q9UJD1,Ectonucleoside triphosphate diphosphohydrolase 6,CD39 antigen-like 2;, PF01150;, GO:0009986;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0036384;GO:0008894;GO:0004382;GO:1990003;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0051592;GO:0032026;, C:cell surface; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cytidine-diphosphatase activity; F:guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity; F:guanosine-diphosphatase activity; F:inosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:response to calcium ion; P:response to magnesium ion;|O75354 A6NCX6 D3DW49 Q5QPJ2 Q5QPJ5 Q7Z5B5 Q8N3H3 Q8TAS7 Q9UJD1,Ectonucleoside triphosphate diphosphohydrolase 6,CD39 antigen-like 2;, PF01150;, GO:0009986;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0036384;GO:0008894;GO:0004382;GO:1990003;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0051592;GO:0032026;, C:cell surface; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cytidine-diphosphatase activity; F:guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity; F:guanosine-diphosphatase activity; F:inosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:response to calcium ion; P:response to magnesium ion;|O75354 A6NCX6 D3DW49 Q5QPJ2 Q5QPJ5 Q7Z5B5 Q8N3H3 Q8TAS7 Q9UJD1,Ectonucleoside triphosphate diphosphohydrolase 6,CD39 antigen-like 2;, PF01150;, GO:0009986;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0036384;GO:0008894;GO:0004382;GO:1990003;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0051592;GO:0032026;, C:cell surface; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cytidine-diphosphatase activity; F:guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity; F:guanosine-diphosphatase activity; F:inosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:response to calcium ion; P:response to magnesium ion;|O75354 A6NCX6 D3DW49 Q5QPJ2 Q5QPJ5 Q7Z5B5 Q8N3H3 Q8TAS7 Q9UJD1,Ectonucleoside triphosphate diphosphohydrolase 6,CD39 antigen-like 2;, PF01150;, GO:0009986;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0036384;GO:0008894;GO:0004382;GO:1990003;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0051592;GO:0032026;, C:cell surface; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cytidine-diphosphatase activity; F:guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity; F:guanosine-diphosphatase activity; F:inosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:response to calcium ion; P:response to magnesium ion;|O75354 A6NCX6 D3DW49 Q5QPJ2 Q5QPJ5 Q7Z5B5 Q8N3H3 Q8TAS7 Q9UJD1,Ectonucleoside triphosphate diphosphohydrolase 6,CD39 antigen-like 2;, PF01150;, GO:0009986;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0036384;GO:0008894;GO:0004382;GO:1990003;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0051592;GO:0032026;, C:cell surface; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cytidine-diphosphatase activity; F:guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity; F:guanosine-diphosphatase activity; F:inosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:response to calcium ion; P:response to magnesium ion;|O75354 A6NCX6 D3DW49 Q5QPJ2 Q5QPJ5 Q7Z5B5 Q8N3H3 Q8TAS7 Q9UJD1,Ectonucleoside triphosphate diphosphohydrolase 6,CD39 antigen-like 2;, PF01150;, GO:0009986;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0036384;GO:0008894;GO:0004382;GO:1990003;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0051592;GO:0032026;, C:cell surface; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cytidine-diphosphatase activity; F:guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity; F:guanosine-diphosphatase activity; F:inosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:response to calcium ion; P:response to magnesium ion; scaffold22 indexed_genome mRNA 927343 970721 . + . ID=transcript_5195;Q96JI1 Q96JX6 Q9NU28,Acetyl-coenzyme A synthetase 2-like, mitochondrial,Acetate--CoA ligase 2;Acetyl-CoA synthetase 2 {ECO:0000303|PubMed:16788062};Acyl-CoA synthetase short-chain family member 1;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005759;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0006085;GO:0019427;GO:0006069;GO:0019542;, C:mitochondrial matrix;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:propionate biosynthetic process;|Q96JI1 Q96JX6 Q9NU28,Acetyl-coenzyme A synthetase 2-like, mitochondrial,Acetate--CoA ligase 2;Acetyl-CoA synthetase 2 {ECO:0000303|PubMed:16788062};Acyl-CoA synthetase short-chain family member 1;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005759;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0006085;GO:0019427;GO:0006069;GO:0019542;, C:mitochondrial matrix;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:propionate biosynthetic process;|Q96JI1 Q96JX6 Q9NU28,Acetyl-coenzyme A synthetase 2-like, mitochondrial,Acetate--CoA ligase 2;Acetyl-CoA synthetase 2 {ECO:0000303|PubMed:16788062};Acyl-CoA synthetase short-chain family member 1;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005759;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0006085;GO:0019427;GO:0006069;GO:0019542;, C:mitochondrial matrix;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:propionate biosynthetic process;|Q96JI1 Q96JX6 Q9NU28,Acetyl-coenzyme A synthetase 2-like, mitochondrial,Acetate--CoA ligase 2;Acetyl-CoA synthetase 2 {ECO:0000303|PubMed:16788062};Acyl-CoA synthetase short-chain family member 1;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005759;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0006085;GO:0019427;GO:0006069;GO:0019542;, C:mitochondrial matrix;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:propionate biosynthetic process;|Q96JI1 Q96JX6 Q9NU28,Acetyl-coenzyme A synthetase 2-like, mitochondrial,Acetate--CoA ligase 2;Acetyl-CoA synthetase 2 {ECO:0000303|PubMed:16788062};Acyl-CoA synthetase short-chain family member 1;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005759;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0006085;GO:0019427;GO:0006069;GO:0019542;, C:mitochondrial matrix;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:propionate biosynthetic process; scaffold22 indexed_genome mRNA 976035 1008678 . + . ID=transcript_5196;Q9HDC9 A8K514 B4DXG1 Q6UVZ8 Q9GZS8 Q9NUB2,Adipocyte plasma membrane-associated protein,Protein BSCv;, PF03088;, GO:0009986;GO:0016021;GO:0016020;GO:0004064;GO:0016844;GO:0009058;, C:cell surface; C:integral component of membrane; C:membrane;, F:arylesterase activity; F:strictosidine synthase activity;, P:biosynthetic process;|Q9HDC9 A8K514 B4DXG1 Q6UVZ8 Q9GZS8 Q9NUB2,Adipocyte plasma membrane-associated protein,Protein BSCv;, PF03088;, GO:0009986;GO:0016021;GO:0016020;GO:0004064;GO:0016844;GO:0009058;, C:cell surface; C:integral component of membrane; C:membrane;, F:arylesterase activity; F:strictosidine synthase activity;, P:biosynthetic process;|Q9HDC9 A8K514 B4DXG1 Q6UVZ8 Q9GZS8 Q9NUB2,Adipocyte plasma membrane-associated protein,Protein BSCv;, PF03088;, GO:0009986;GO:0016021;GO:0016020;GO:0004064;GO:0016844;GO:0009058;, C:cell surface; C:integral component of membrane; C:membrane;, F:arylesterase activity; F:strictosidine synthase activity;, P:biosynthetic process;|Q9HDC9 A8K514 B4DXG1 Q6UVZ8 Q9GZS8 Q9NUB2,Adipocyte plasma membrane-associated protein,Protein BSCv;, PF03088;, GO:0009986;GO:0016021;GO:0016020;GO:0004064;GO:0016844;GO:0009058;, C:cell surface; C:integral component of membrane; C:membrane;, F:arylesterase activity; F:strictosidine synthase activity;, P:biosynthetic process; scaffold22 indexed_genome mRNA 1402305 1408306 . + . ID=transcript_5197;P01034 B2R5J9 D3DW42 Q6FGW9,Cystatin-C,Cystatin-3;Gamma-trace;Neuroendocrine basic polypeptide;Post-gamma-globulin;, PF00031;, GO:0005783;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0005886;GO:1904724;GO:0001540;GO:0004869;GO:0004866;GO:0042802;GO:0030414;GO:0002020;GO:1990000;GO:0044267;GO:0006952;GO:0060313;GO:0010711;GO:0060311;GO:0010716;GO:0010466;GO:0045861;GO:0043312;GO:0043687;GO:0034103;GO:0097435;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:plasma membrane; C:tertiary granule lumen;, F:amyloid-beta binding; F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:identical protein binding; F:peptidase inhibitor activity; F:protease binding;, P:amyloid fibril formation; P:cellular protein metabolic process; P:defense response; P:negative regulation of blood vessel remodeling; P:negative regulation of collagen catabolic process; P:negative regulation of elastin catabolic process; P:negative regulation of extracellular matrix disassembly; P:negative regulation of peptidase activity; P:negative regulation of proteolysis; P:neutrophil degranulation; P:post-translational protein modification; P:regulation of tissue remodeling; P:supramolecular fiber organization; scaffold22 indexed_genome mRNA 1475918 1480255 . - . ID=transcript_5198;Q9H4G1 B2R5A1,Cystatin-9-like,Testatin {ECO:0000303|PubMed:11756564};, PF00031;, GO:0005615;GO:0004869;GO:0019730;, C:extracellular space;, F:cysteine-type endopeptidase inhibitor activity;, P:antimicrobial humoral response; scaffold22 indexed_genome mRNA 1507162 1550774 . + . ID=transcript_5199;Q9H115 B4DK44 Q4G0M0 Q4G187 Q5JXF9 Q8N3C4,Beta-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein beta;, , GO:0070062;GO:0031201;GO:0045202;GO:0070044;GO:0005774;GO:0005483;GO:0019905;GO:0006886;GO:0010807;GO:0035494;GO:0035249;, C:extracellular exosome; C:SNARE complex; C:synapse; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; C:vacuolar membrane;, F:soluble NSF attachment protein activity; F:syntaxin binding;, P:intracellular protein transport; P:regulation of synaptic vesicle priming; P:SNARE complex disassembly; P:synaptic transmission, glutamatergic;|Q9H115 B4DK44 Q4G0M0 Q4G187 Q5JXF9 Q8N3C4,Beta-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein beta;, , GO:0070062;GO:0031201;GO:0045202;GO:0070044;GO:0005774;GO:0005483;GO:0019905;GO:0006886;GO:0010807;GO:0035494;GO:0035249;, C:extracellular exosome; C:SNARE complex; C:synapse; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; C:vacuolar membrane;, F:soluble NSF attachment protein activity; F:syntaxin binding;, P:intracellular protein transport; P:regulation of synaptic vesicle priming; P:SNARE complex disassembly; P:synaptic transmission, glutamatergic;|Q9H115 B4DK44 Q4G0M0 Q4G187 Q5JXF9 Q8N3C4,Beta-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein beta;, , GO:0070062;GO:0031201;GO:0045202;GO:0070044;GO:0005774;GO:0005483;GO:0019905;GO:0006886;GO:0010807;GO:0035494;GO:0035249;, C:extracellular exosome; C:SNARE complex; C:synapse; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; C:vacuolar membrane;, F:soluble NSF attachment protein activity; F:syntaxin binding;, P:intracellular protein transport; P:regulation of synaptic vesicle priming; P:SNARE complex disassembly; P:synaptic transmission, glutamatergic;|Q9H115 B4DK44 Q4G0M0 Q4G187 Q5JXF9 Q8N3C4,Beta-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein beta;, , GO:0070062;GO:0031201;GO:0045202;GO:0070044;GO:0005774;GO:0005483;GO:0019905;GO:0006886;GO:0010807;GO:0035494;GO:0035249;, C:extracellular exosome; C:SNARE complex; C:synapse; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; C:vacuolar membrane;, F:soluble NSF attachment protein activity; F:syntaxin binding;, P:intracellular protein transport; P:regulation of synaptic vesicle priming; P:SNARE complex disassembly; P:synaptic transmission, glutamatergic;|Q9H117 Q9H6W6,GDNF-inducible zinc finger protein 1,Zinc finger and BTB domain-containing protein 23;Zinc finger protein 336;, PF00651;PF00096;, GO:0005737;GO:0005730;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001658;GO:0000122;GO:0045892;GO:0006355;, C:cytoplasm; C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:branching involved in ureteric bud morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9H117 Q9H6W6,GDNF-inducible zinc finger protein 1,Zinc finger and BTB domain-containing protein 23;Zinc finger protein 336;, PF00651;PF00096;, GO:0005737;GO:0005730;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001658;GO:0000122;GO:0045892;GO:0006355;, C:cytoplasm; C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:branching involved in ureteric bud morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9H117 Q9H6W6,GDNF-inducible zinc finger protein 1,Zinc finger and BTB domain-containing protein 23;Zinc finger protein 336;, PF00651;PF00096;, GO:0005737;GO:0005730;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001658;GO:0000122;GO:0045892;GO:0006355;, C:cytoplasm; C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:branching involved in ureteric bud morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold22 indexed_genome mRNA 1550805 1552301 . - . ID=transcript_5200;Q9H117 Q9H6W6,GDNF-inducible zinc finger protein 1,Zinc finger and BTB domain-containing protein 23;Zinc finger protein 336;, PF00651;PF00096;, GO:0005737;GO:0005730;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0001658;GO:0000122;GO:0045892;GO:0006355;, C:cytoplasm; C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:branching involved in ureteric bud morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold22 indexed_genome mRNA 1569037 1571897 . - . ID=transcript_5201;Q9UKK6,NTF2-related export protein 1,Protein p15;, PF02136;, GO:0005737;GO:0005829;GO:0005643;GO:0044613;GO:0016607;GO:0005654;GO:0031267;GO:0006406;GO:0006913;GO:0006606;, C:cytoplasm; C:cytosol; C:nuclear pore; C:nuclear pore central transport channel; C:nuclear speck; C:nucleoplasm;, F:small GTPase binding;, P:mRNA export from nucleus; P:nucleocytoplasmic transport; P:protein import into nucleus; scaffold22 indexed_genome mRNA 1699388 1703527 . + . ID=transcript_5202;Q9NPY3 O00274,Complement component C1q receptor,C1q/MBL/SPA receptor;CDw93;Complement component 1 q subcomponent receptor 1;Matrix-remodeling-associated protein 4;, PF12662;PF07645;PF00059;, GO:0009986;GO:0101003;GO:0016021;GO:0005886;GO:0030667;GO:0035579;GO:0070821;GO:0005509;GO:0030246;GO:0001849;GO:0038023;GO:0098609;GO:0042116;GO:0043312;GO:0006909;GO:0016032;, C:cell surface; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium ion binding; F:carbohydrate binding; F:complement component C1q complex binding; F:signaling receptor activity;, P:cell-cell adhesion; P:macrophage activation; P:neutrophil degranulation; P:phagocytosis; P:viral process; scaffold22 indexed_genome mRNA 1722926 1726671 . - . ID=transcript_5203;P07204 Q8IV29 Q9UC32,Thrombomodulin,Fetomodulin;, PF12662;PF07645;PF00059;PF09064;, GO:0016327;GO:0009986;GO:0009897;GO:0005615;GO:0005887;GO:0005886;GO:0005774;GO:0005509;GO:0038023;GO:0004888;GO:0007596;GO:0007565;GO:0050900;GO:0030195;GO:0051918;GO:0010544;GO:0051591;GO:0032496;GO:0010165;, C:apicolateral plasma membrane; C:cell surface; C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane; C:vacuolar membrane;, F:calcium ion binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:female pregnancy; P:leukocyte migration; P:negative regulation of blood coagulation; P:negative regulation of fibrinolysis; P:negative regulation of platelet activation; P:response to cAMP; P:response to lipopolysaccharide; P:response to X-ray; scaffold22 indexed_genome mRNA 2221841 2223353 . - . ID=transcript_5204;Q5MIZ7 Q6P9B0 Q86XB8 Q9BQJ0 Q9BRK2 Q9H913 Q9P2G0,Serine/threonine-protein phosphatase 4 regulatory subunit 3B,SMEK homolog 2;, PF04802;, GO:0005813;GO:0005737;GO:0016607;GO:0005654;GO:0030289;GO:0045722;GO:0006470;GO:0019216;, C:centrosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:protein phosphatase 4 complex;, , P:positive regulation of gluconeogenesis; P:protein dephosphorylation; P:regulation of lipid metabolic process; scaffold22 indexed_genome mRNA 2814085 2816753 . + . ID=transcript_5205;O95096,Homeobox protein Nkx-2.2,Homeobox protein NK-2 homolog B;, PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000987;GO:0001228;GO:0000981;GO:0000978;GO:0008134;GO:0048708;GO:0007420;GO:0030154;GO:0048565;GO:0031018;GO:0045665;GO:0048665;GO:0014003;GO:0021554;GO:0003326;GO:0003329;GO:0045666;GO:0048714;GO:0006357;GO:0009749;GO:0032570;GO:0007224;GO:0021522;GO:0021530;GO:0003323;GO:0003327;GO:0060580;, C:chromatin; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:astrocyte differentiation; P:brain development; P:cell differentiation; P:digestive tract development; P:endocrine pancreas development; P:negative regulation of neuron differentiation; P:neuron fate specification; P:oligodendrocyte development; P:optic nerve development; P:pancreatic A cell fate commitment; P:pancreatic PP cell fate commitment; P:positive regulation of neuron differentiation; P:positive regulation of oligodendrocyte differentiation; P:regulation of transcription by RNA polymerase II; P:response to glucose; P:response to progesterone; P:smoothened signaling pathway; P:spinal cord motor neuron differentiation; P:spinal cord oligodendrocyte cell fate specification; P:type B pancreatic cell development; P:type B pancreatic cell fate commitment; P:ventral spinal cord interneuron fate determination; scaffold22 indexed_genome mRNA 2896818 2935599 . - . ID=transcript_5206;Q9H0D6 Q3L8N4 Q6KGZ9 Q9BQL1 Q9NTW0 Q9NXS6 Q9UL53,5'-3' exoribonuclease 2,DHM1-like protein;, PF17846;PF03159;, GO:0016235;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008409;GO:0004534;GO:0042802;GO:0046872;GO:0004518;GO:0003723;GO:0001147;GO:0000738;GO:0006353;GO:0021766;GO:0006397;GO:0030182;GO:0000956;GO:0060041;GO:0006401;GO:0016070;GO:0006396;GO:0006364;GO:0007283;, C:aggresome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:5'-3' exonuclease activity; F:5'-3' exoribonuclease activity; F:identical protein binding; F:metal ion binding; F:nuclease activity; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:DNA catabolic process, exonucleolytic; P:DNA-templated transcription, termination; P:hippocampus development; P:mRNA processing; P:neuron differentiation; P:nuclear-transcribed mRNA catabolic process; P:retina development in camera-type eye; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing; P:rRNA processing; P:spermatogenesis;|Q9H0D6 Q3L8N4 Q6KGZ9 Q9BQL1 Q9NTW0 Q9NXS6 Q9UL53,5'-3' exoribonuclease 2,DHM1-like protein;, PF17846;PF03159;, GO:0016235;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008409;GO:0004534;GO:0042802;GO:0046872;GO:0004518;GO:0003723;GO:0001147;GO:0000738;GO:0006353;GO:0021766;GO:0006397;GO:0030182;GO:0000956;GO:0060041;GO:0006401;GO:0016070;GO:0006396;GO:0006364;GO:0007283;, C:aggresome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:5'-3' exonuclease activity; F:5'-3' exoribonuclease activity; F:identical protein binding; F:metal ion binding; F:nuclease activity; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:DNA catabolic process, exonucleolytic; P:DNA-templated transcription, termination; P:hippocampus development; P:mRNA processing; P:neuron differentiation; P:nuclear-transcribed mRNA catabolic process; P:retina development in camera-type eye; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing; P:rRNA processing; P:spermatogenesis;|Q9H0D6 Q3L8N4 Q6KGZ9 Q9BQL1 Q9NTW0 Q9NXS6 Q9UL53,5'-3' exoribonuclease 2,DHM1-like protein;, PF17846;PF03159;, GO:0016235;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008409;GO:0004534;GO:0042802;GO:0046872;GO:0004518;GO:0003723;GO:0001147;GO:0000738;GO:0006353;GO:0021766;GO:0006397;GO:0030182;GO:0000956;GO:0060041;GO:0006401;GO:0016070;GO:0006396;GO:0006364;GO:0007283;, C:aggresome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:5'-3' exonuclease activity; F:5'-3' exoribonuclease activity; F:identical protein binding; F:metal ion binding; F:nuclease activity; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:DNA catabolic process, exonucleolytic; P:DNA-templated transcription, termination; P:hippocampus development; P:mRNA processing; P:neuron differentiation; P:nuclear-transcribed mRNA catabolic process; P:retina development in camera-type eye; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing; P:rRNA processing; P:spermatogenesis;|Q9H0D6 Q3L8N4 Q6KGZ9 Q9BQL1 Q9NTW0 Q9NXS6 Q9UL53,5'-3' exoribonuclease 2,DHM1-like protein;, PF17846;PF03159;, GO:0016235;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008409;GO:0004534;GO:0042802;GO:0046872;GO:0004518;GO:0003723;GO:0001147;GO:0000738;GO:0006353;GO:0021766;GO:0006397;GO:0030182;GO:0000956;GO:0060041;GO:0006401;GO:0016070;GO:0006396;GO:0006364;GO:0007283;, C:aggresome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:5'-3' exonuclease activity; F:5'-3' exoribonuclease activity; F:identical protein binding; F:metal ion binding; F:nuclease activity; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:DNA catabolic process, exonucleolytic; P:DNA-templated transcription, termination; P:hippocampus development; P:mRNA processing; P:neuron differentiation; P:nuclear-transcribed mRNA catabolic process; P:retina development in camera-type eye; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing; P:rRNA processing; P:spermatogenesis;|Q9H0D6 Q3L8N4 Q6KGZ9 Q9BQL1 Q9NTW0 Q9NXS6 Q9UL53,5'-3' exoribonuclease 2,DHM1-like protein;, PF17846;PF03159;, GO:0016235;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008409;GO:0004534;GO:0042802;GO:0046872;GO:0004518;GO:0003723;GO:0001147;GO:0000738;GO:0006353;GO:0021766;GO:0006397;GO:0030182;GO:0000956;GO:0060041;GO:0006401;GO:0016070;GO:0006396;GO:0006364;GO:0007283;, C:aggresome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:5'-3' exonuclease activity; F:5'-3' exoribonuclease activity; F:identical protein binding; F:metal ion binding; F:nuclease activity; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:DNA catabolic process, exonucleolytic; P:DNA-templated transcription, termination; P:hippocampus development; P:mRNA processing; P:neuron differentiation; P:nuclear-transcribed mRNA catabolic process; P:retina development in camera-type eye; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing; P:rRNA processing; P:spermatogenesis;|Q9H0D6 Q3L8N4 Q6KGZ9 Q9BQL1 Q9NTW0 Q9NXS6 Q9UL53,5'-3' exoribonuclease 2,DHM1-like protein;, PF17846;PF03159;, GO:0016235;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008409;GO:0004534;GO:0042802;GO:0046872;GO:0004518;GO:0003723;GO:0001147;GO:0000738;GO:0006353;GO:0021766;GO:0006397;GO:0030182;GO:0000956;GO:0060041;GO:0006401;GO:0016070;GO:0006396;GO:0006364;GO:0007283;, C:aggresome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:5'-3' exonuclease activity; F:5'-3' exoribonuclease activity; F:identical protein binding; F:metal ion binding; F:nuclease activity; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:DNA catabolic process, exonucleolytic; P:DNA-templated transcription, termination; P:hippocampus development; P:mRNA processing; P:neuron differentiation; P:nuclear-transcribed mRNA catabolic process; P:retina development in camera-type eye; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing; P:rRNA processing; P:spermatogenesis; scaffold22 indexed_genome mRNA 2939179 2948549 . - . ID=transcript_5207;Q9H0D6 Q3L8N4 Q6KGZ9 Q9BQL1 Q9NTW0 Q9NXS6 Q9UL53,5'-3' exoribonuclease 2,DHM1-like protein;, PF17846;PF03159;, GO:0016235;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008409;GO:0004534;GO:0042802;GO:0046872;GO:0004518;GO:0003723;GO:0001147;GO:0000738;GO:0006353;GO:0021766;GO:0006397;GO:0030182;GO:0000956;GO:0060041;GO:0006401;GO:0016070;GO:0006396;GO:0006364;GO:0007283;, C:aggresome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:5'-3' exonuclease activity; F:5'-3' exoribonuclease activity; F:identical protein binding; F:metal ion binding; F:nuclease activity; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:DNA catabolic process, exonucleolytic; P:DNA-templated transcription, termination; P:hippocampus development; P:mRNA processing; P:neuron differentiation; P:nuclear-transcribed mRNA catabolic process; P:retina development in camera-type eye; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing; P:rRNA processing; P:spermatogenesis;|Q9H0D6 Q3L8N4 Q6KGZ9 Q9BQL1 Q9NTW0 Q9NXS6 Q9UL53,5'-3' exoribonuclease 2,DHM1-like protein;, PF17846;PF03159;, GO:0016235;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008409;GO:0004534;GO:0042802;GO:0046872;GO:0004518;GO:0003723;GO:0001147;GO:0000738;GO:0006353;GO:0021766;GO:0006397;GO:0030182;GO:0000956;GO:0060041;GO:0006401;GO:0016070;GO:0006396;GO:0006364;GO:0007283;, C:aggresome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:5'-3' exonuclease activity; F:5'-3' exoribonuclease activity; F:identical protein binding; F:metal ion binding; F:nuclease activity; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:DNA catabolic process, exonucleolytic; P:DNA-templated transcription, termination; P:hippocampus development; P:mRNA processing; P:neuron differentiation; P:nuclear-transcribed mRNA catabolic process; P:retina development in camera-type eye; P:RNA catabolic process; P:RNA metabolic process; P:RNA processing; P:rRNA processing; P:spermatogenesis; scaffold22 indexed_genome mRNA 3005451 3080803 . - . ID=transcript_5208;Q2M2Z5 B4DDE9 B4DK54 Q4G0M8 Q4G0S5 Q5BKY3 Q6P0M6 Q71ME0 Q9NZ35,Centrosomal protein kizuna,Polo-like kinase 1 substrate 1;, , GO:0042995;GO:0005813;GO:0005737;GO:0019901;GO:0007051;, C:cell projection; C:centrosome; C:cytoplasm;, F:protein kinase binding;, P:spindle organization; scaffold22 indexed_genome mRNA 3447267 3651771 . + . ID=transcript_5209;Q2PPJ7 Q4VXU6 Q5JUA3 Q5JUA4 Q5T9K3 Q96CX9 Q9BQT7 Q9H9D9 Q9ULE8,Ral GTPase-activating protein subunit alpha-2,250 kDa substrate of Akt;p220;, PF02145;, GO:0005737;GO:0005829;GO:0005615;GO:0005634;GO:0005886;GO:0005096;GO:0046982;GO:0090630;GO:0051056;, C:cytoplasm; C:cytosol; C:extracellular space; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold22 indexed_genome mRNA 3680935 3730431 . - . ID=transcript_5210;Q9NQH4 Q9UFV8 Q9Y4V7,Cilia- and flagella-associated protein 61 {ECO:0000312|HGNC:HGNC:15872},, PF16092;, GO:0005930;GO:0031514;GO:0003341;GO:0044782;, C:axoneme; C:motile cilium;, , P:cilium movement; P:cilium organization; scaffold22 indexed_genome mRNA 3916585 3922172 . + . ID=transcript_5211;Q9NQH5 Q9NYD8,Crooked neck-like protein 1,Crooked neck homolog;, PF02184;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071014;GO:0000974;GO:0005681;GO:0071007;GO:0003723;GO:0000398;GO:0000245;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:Prp19 complex; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q9NQH5 Q9NYD8,Crooked neck-like protein 1,Crooked neck homolog;, PF02184;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071014;GO:0000974;GO:0005681;GO:0071007;GO:0003723;GO:0000398;GO:0000245;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:Prp19 complex; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q9NQH5 Q9NYD8,Crooked neck-like protein 1,Crooked neck homolog;, PF02184;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071014;GO:0000974;GO:0005681;GO:0071007;GO:0003723;GO:0000398;GO:0000245;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:Prp19 complex; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q9NQH5 Q9NYD8,Crooked neck-like protein 1,Crooked neck homolog;, PF02184;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071014;GO:0000974;GO:0005681;GO:0071007;GO:0003723;GO:0000398;GO:0000245;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:Prp19 complex; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:spliceosomal complex assembly; scaffold22 indexed_genome mRNA 4192814 4584287 . - . ID=transcript_5212;Q9HC58 B1AKV7 Q9BQJ9 Q9BQL7 Q9BQY3 Q9H519,Sodium/potassium/calcium exchanger 3,Na(+)/K(+)/Ca(2+)-exchange protein 3;Solute carrier family 24 member 3;, PF01699;, GO:0071944;GO:0005887;GO:0005886;GO:0005262;GO:0008273;GO:0015293;GO:0030282;GO:0070588;GO:0006874;GO:0006811;GO:0010629;GO:0010628;GO:0071805;GO:0035725;GO:0150104;, C:cell periphery; C:integral component of plasma membrane; C:plasma membrane;, F:calcium channel activity; F:calcium, potassium:sodium antiporter activity; F:symporter activity;, P:bone mineralization; P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:ion transport; P:negative regulation of gene expression; P:positive regulation of gene expression; P:potassium ion transmembrane transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier; scaffold22 indexed_genome mRNA 4827852 4904205 . - . ID=transcript_5213;Q8TEA8 A8K5X5 D3DW37 Q496D1 Q5W184 Q8WXU8 Q9BW67 Q9H464 Q9H474,D-aminoacyl-tRNA deacylase 1 {ECO:0000250|UniProtKB:Q8IIS0},DNA-unwinding element-binding protein B {ECO:0000303|PubMed:15653697};Gly-tRNA(Ala) deacylase {ECO:0000250|UniProtKB:Q8IIS0};Histidyl-tRNA synthase-related;, PF02580;, GO:0005737;GO:0005634;GO:0051500;GO:0003677;GO:0046872;GO:0000049;GO:0006260;GO:0006399;, C:cytoplasm; C:nucleus;, F:D-tyrosyl-tRNA(Tyr) deacylase activity; F:DNA binding; F:metal ion binding; F:tRNA binding;, P:DNA replication; P:tRNA metabolic process; scaffold22 indexed_genome mRNA 4924449 4966333 . - . ID=transcript_5214;Q15437 D3DW33 Q503A9 Q5W183 Q9BS15 Q9BSI2 Q9H1D7,Protein transport protein Sec23B {ECO:0000305},SEC23-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0012505;GO:0005783;GO:0070971;GO:0005789;GO:0048471;GO:0005096;GO:0008270;GO:0090110;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:zinc ion binding;, P:COPII-coated vesicle cargo loading; P:intracellular protein transport;|Q15437 D3DW33 Q503A9 Q5W183 Q9BS15 Q9BSI2 Q9H1D7,Protein transport protein Sec23B {ECO:0000305},SEC23-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0012505;GO:0005783;GO:0070971;GO:0005789;GO:0048471;GO:0005096;GO:0008270;GO:0090110;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:zinc ion binding;, P:COPII-coated vesicle cargo loading; P:intracellular protein transport;|Q15437 D3DW33 Q503A9 Q5W183 Q9BS15 Q9BSI2 Q9H1D7,Protein transport protein Sec23B {ECO:0000305},SEC23-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0012505;GO:0005783;GO:0070971;GO:0005789;GO:0048471;GO:0005096;GO:0008270;GO:0090110;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:zinc ion binding;, P:COPII-coated vesicle cargo loading; P:intracellular protein transport;|O75884 D3DW31 Q5JPH9 Q9H1D8,Serine hydrolase RBBP9 {ECO:0000303|PubMed:20080647},B5T-overexpressed gene protein {ECO:0000250|UniProtKB:O88350};Retinoblastoma-binding protein 10;Retinoblastoma-binding protein 9;, PF06821;, GO:0005654;GO:0016787;GO:0042127;, C:nucleoplasm;, F:hydrolase activity;, P:regulation of cell population proliferation;|O75884 D3DW31 Q5JPH9 Q9H1D8,Serine hydrolase RBBP9 {ECO:0000303|PubMed:20080647},B5T-overexpressed gene protein {ECO:0000250|UniProtKB:O88350};Retinoblastoma-binding protein 10;Retinoblastoma-binding protein 9;, PF06821;, GO:0005654;GO:0016787;GO:0042127;, C:nucleoplasm;, F:hydrolase activity;, P:regulation of cell population proliferation; scaffold22 indexed_genome mRNA 4967825 4980923 . - . ID=transcript_5215;Q9H1D9 A8K4C7 O15319,DNA-directed RNA polymerase III subunit RPC6,DNA-directed RNA polymerase III subunit F;RNA polymerase III 39 kDa subunit;, PF05158;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003690;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006383;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:double-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription by RNA polymerase III;|Q9H1D9 A8K4C7 O15319,DNA-directed RNA polymerase III subunit RPC6,DNA-directed RNA polymerase III subunit F;RNA polymerase III 39 kDa subunit;, PF05158;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003690;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006383;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:double-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription by RNA polymerase III;|Q9H1D9 A8K4C7 O15319,DNA-directed RNA polymerase III subunit RPC6,DNA-directed RNA polymerase III subunit F;RNA polymerase III 39 kDa subunit;, PF05158;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003690;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006383;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:double-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription by RNA polymerase III;|Q9H1D9 A8K4C7 O15319,DNA-directed RNA polymerase III subunit RPC6,DNA-directed RNA polymerase III subunit F;RNA polymerase III 39 kDa subunit;, PF05158;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003690;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006383;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:double-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription by RNA polymerase III;|Q9H1D9 A8K4C7 O15319,DNA-directed RNA polymerase III subunit RPC6,DNA-directed RNA polymerase III subunit F;RNA polymerase III 39 kDa subunit;, PF05158;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003690;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006383;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:double-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription by RNA polymerase III; scaffold22 indexed_genome mRNA 4982910 5025952 . + . ID=transcript_5216;Q9H442,Double zinc ribbon and ankyrin repeat-containing protein 1,, PF12773;PF13287;, GO:0046872;, , F:metal ion binding;|Q9H442,Double zinc ribbon and ankyrin repeat-containing protein 1,, PF12773;PF13287;, GO:0046872;, , F:metal ion binding;|Q9H442,Double zinc ribbon and ankyrin repeat-containing protein 1,, PF12773;PF13287;, GO:0046872;, , F:metal ion binding;|Q9H442,Double zinc ribbon and ankyrin repeat-containing protein 1,, PF12773;PF13287;, GO:0046872;, , F:metal ion binding; scaffold22 indexed_genome mRNA 5035007 5049913 . - . ID=transcript_5217;Q5JXV8 Q9BUV2 Q9H443,Zinc finger protein 133,Zinc finger protein 150;, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q5JXV8 Q9BUV2 Q9H443,Zinc finger protein 133,Zinc finger protein 150;, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q5JXV8 Q9BUV2 Q9H443,Zinc finger protein 133,Zinc finger protein 150;, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold22 indexed_genome mRNA 5091202 5117871 . - . ID=transcript_5218;Q9H8E8 A2A2I5 Q96GW6 Q96IH3 Q9HBF0 Q9UIY5,Cysteine-rich protein 2-binding protein,ADA2A-containing complex subunit 2;CRP2-binding partner;Lysine acetyltransferase 14 {ECO:0000312|HGNC:HGNC:15904};, PF00583;, GO:0005671;GO:0005737;GO:0005634;GO:0004402;GO:0030274;GO:0043966;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytoplasm; C:nucleus;, F:histone acetyltransferase activity; F:LIM domain binding;, P:histone H3 acetylation;|Q9H8E8 A2A2I5 Q96GW6 Q96IH3 Q9HBF0 Q9UIY5,Cysteine-rich protein 2-binding protein,ADA2A-containing complex subunit 2;CRP2-binding partner;Lysine acetyltransferase 14 {ECO:0000312|HGNC:HGNC:15904};, PF00583;, GO:0005671;GO:0005737;GO:0005634;GO:0004402;GO:0030274;GO:0043966;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytoplasm; C:nucleus;, F:histone acetyltransferase activity; F:LIM domain binding;, P:histone H3 acetylation;|Q9H8E8 A2A2I5 Q96GW6 Q96IH3 Q9HBF0 Q9UIY5,Cysteine-rich protein 2-binding protein,ADA2A-containing complex subunit 2;CRP2-binding partner;Lysine acetyltransferase 14 {ECO:0000312|HGNC:HGNC:15904};, PF00583;, GO:0005671;GO:0005737;GO:0005634;GO:0004402;GO:0030274;GO:0043966;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytoplasm; C:nucleus;, F:histone acetyltransferase activity; F:LIM domain binding;, P:histone H3 acetylation;|Q9H8E8 A2A2I5 Q96GW6 Q96IH3 Q9HBF0 Q9UIY5,Cysteine-rich protein 2-binding protein,ADA2A-containing complex subunit 2;CRP2-binding partner;Lysine acetyltransferase 14 {ECO:0000312|HGNC:HGNC:15904};, PF00583;, GO:0005671;GO:0005737;GO:0005634;GO:0004402;GO:0030274;GO:0043966;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytoplasm; C:nucleus;, F:histone acetyltransferase activity; F:LIM domain binding;, P:histone H3 acetylation;|Q9H8E8 A2A2I5 Q96GW6 Q96IH3 Q9HBF0 Q9UIY5,Cysteine-rich protein 2-binding protein,ADA2A-containing complex subunit 2;CRP2-binding partner;Lysine acetyltransferase 14 {ECO:0000312|HGNC:HGNC:15904};, PF00583;, GO:0005671;GO:0005737;GO:0005634;GO:0004402;GO:0030274;GO:0043966;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytoplasm; C:nucleus;, F:histone acetyltransferase activity; F:LIM domain binding;, P:histone H3 acetylation; scaffold22 indexed_genome mRNA 5167599 5181746 . + . ID=transcript_5219;Q9BRP0 Q5T8B4 Q9BX22 Q9HA54 Q9Y4M0,Transcription factor Ovo-like 2,Zinc finger protein 339;, PF00096;, GO:0005634;GO:0003682;GO:0001228;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0000976;GO:0001525;GO:0071560;GO:0009953;GO:0048557;GO:0060214;GO:0009913;GO:0001947;GO:0060347;GO:0060716;GO:0010719;GO:0010629;GO:0045617;GO:0045746;GO:2000647;GO:0010944;GO:0001755;GO:0001842;GO:0010628;GO:0045618;GO:0051726;GO:0010837;GO:0060390;GO:0006357;, C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:cellular response to transforming growth factor beta stimulus; P:dorsal/ventral pattern formation; P:embryonic digestive tract morphogenesis; P:endocardium formation; P:epidermal cell differentiation; P:heart looping; P:heart trabecula formation; P:labyrinthine layer blood vessel development; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of gene expression; P:negative regulation of keratinocyte differentiation; P:negative regulation of Notch signaling pathway; P:negative regulation of stem cell proliferation; P:negative regulation of transcription by competitive promoter binding; P:neural crest cell migration; P:neural fold formation; P:positive regulation of gene expression; P:positive regulation of keratinocyte differentiation; P:regulation of cell cycle; P:regulation of keratinocyte proliferation; P:regulation of SMAD protein signal transduction; P:regulation of transcription by RNA polymerase II; scaffold22 indexed_genome mRNA 5202369 5207464 . + . ID=transcript_5220;Q9BQP7 B2RDG5 D3DW29 Q96SW3,Mitochondrial genome maintenance exonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03030},, PF12705;, GO:0005739;GO:0008297;GO:0043504;GO:0006264;GO:0000002;, C:mitochondrion;, F:single-stranded DNA exodeoxyribonuclease activity;, P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:mitochondrial genome maintenance;|Q9BQP7 B2RDG5 D3DW29 Q96SW3,Mitochondrial genome maintenance exonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03030},, PF12705;, GO:0005739;GO:0008297;GO:0043504;GO:0006264;GO:0000002;, C:mitochondrion;, F:single-stranded DNA exodeoxyribonuclease activity;, P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:mitochondrial genome maintenance;|Q9BQP7 B2RDG5 D3DW29 Q96SW3,Mitochondrial genome maintenance exonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03030},, PF12705;, GO:0005739;GO:0008297;GO:0043504;GO:0006264;GO:0000002;, C:mitochondrion;, F:single-stranded DNA exodeoxyribonuclease activity;, P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:mitochondrial genome maintenance; scaffold22 indexed_genome mRNA 5208836 5212639 . - . ID=transcript_5221;Q9BQP7 B2RDG5 D3DW29 Q96SW3,Mitochondrial genome maintenance exonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03030},, PF12705;, GO:0005739;GO:0008297;GO:0043504;GO:0006264;GO:0000002;, C:mitochondrion;, F:single-stranded DNA exodeoxyribonuclease activity;, P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:mitochondrial genome maintenance; scaffold22 indexed_genome mRNA 5224059 5236738 . + . ID=transcript_5222;Q9Y5X3 B7ZKN3 D3DW26 Q52LC4 Q7KZN0 Q9BWP0,Sorting nexin-5,, PF00787;PF09325;, GO:0005903;GO:0030659;GO:0005829;GO:0031901;GO:0005768;GO:0031234;GO:0031313;GO:0043231;GO:0070685;GO:0048471;GO:0001891;GO:0030904;GO:0030905;GO:0001726;GO:0097422;GO:0045296;GO:0031748;GO:0034452;GO:0035091;GO:0080025;GO:0070273;GO:0010314;GO:0007174;GO:0006886;GO:0045776;GO:0006907;GO:0046628;GO:0035815;GO:0045893;GO:0016241;GO:0042147;, C:brush border; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome membrane; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of endosome membrane; C:intracellular membrane-bounded organelle; C:macropinocytic cup; C:perinuclear region of cytoplasm; C:phagocytic cup; C:retromer complex; C:retromer, tubulation complex; C:ruffle; C:tubular endosome;, F:cadherin binding; F:D1 dopamine receptor binding; F:dynactin binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:epidermal growth factor catabolic process; P:intracellular protein transport; P:negative regulation of blood pressure; P:pinocytosis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of renal sodium excretion; P:positive regulation of transcription, DNA-templated; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi;|Q9Y5X3 B7ZKN3 D3DW26 Q52LC4 Q7KZN0 Q9BWP0,Sorting nexin-5,, PF00787;PF09325;, GO:0005903;GO:0030659;GO:0005829;GO:0031901;GO:0005768;GO:0031234;GO:0031313;GO:0043231;GO:0070685;GO:0048471;GO:0001891;GO:0030904;GO:0030905;GO:0001726;GO:0097422;GO:0045296;GO:0031748;GO:0034452;GO:0035091;GO:0080025;GO:0070273;GO:0010314;GO:0007174;GO:0006886;GO:0045776;GO:0006907;GO:0046628;GO:0035815;GO:0045893;GO:0016241;GO:0042147;, C:brush border; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome membrane; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of endosome membrane; C:intracellular membrane-bounded organelle; C:macropinocytic cup; C:perinuclear region of cytoplasm; C:phagocytic cup; C:retromer complex; C:retromer, tubulation complex; C:ruffle; C:tubular endosome;, F:cadherin binding; F:D1 dopamine receptor binding; F:dynactin binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:epidermal growth factor catabolic process; P:intracellular protein transport; P:negative regulation of blood pressure; P:pinocytosis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of renal sodium excretion; P:positive regulation of transcription, DNA-templated; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi;|Q9Y5X3 B7ZKN3 D3DW26 Q52LC4 Q7KZN0 Q9BWP0,Sorting nexin-5,, PF00787;PF09325;, GO:0005903;GO:0030659;GO:0005829;GO:0031901;GO:0005768;GO:0031234;GO:0031313;GO:0043231;GO:0070685;GO:0048471;GO:0001891;GO:0030904;GO:0030905;GO:0001726;GO:0097422;GO:0045296;GO:0031748;GO:0034452;GO:0035091;GO:0080025;GO:0070273;GO:0010314;GO:0007174;GO:0006886;GO:0045776;GO:0006907;GO:0046628;GO:0035815;GO:0045893;GO:0016241;GO:0042147;, C:brush border; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome membrane; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of endosome membrane; C:intracellular membrane-bounded organelle; C:macropinocytic cup; C:perinuclear region of cytoplasm; C:phagocytic cup; C:retromer complex; C:retromer, tubulation complex; C:ruffle; C:tubular endosome;, F:cadherin binding; F:D1 dopamine receptor binding; F:dynactin binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:epidermal growth factor catabolic process; P:intracellular protein transport; P:negative regulation of blood pressure; P:pinocytosis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of renal sodium excretion; P:positive regulation of transcription, DNA-templated; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi; scaffold22 indexed_genome mRNA 5464811 5465905 . - . ID=transcript_5223;Q9H476,Ribosome-binding protein 1,180 kDa ribosome receptor homolog;ES/130-related protein;Ribosome receptor protein;, PF05104;, GO:0005783;GO:0030176;GO:0016020;GO:0005840;GO:0003723;GO:0038023;GO:0001649;GO:0015031;GO:0006412;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:membrane; C:ribosome;, F:RNA binding; F:signaling receptor activity;, P:osteoblast differentiation; P:protein transport; P:translation; scaffold22 indexed_genome mRNA 5470672 5472051 . + . ID=transcript_5224;Q9H476,Ribosome-binding protein 1,180 kDa ribosome receptor homolog;ES/130-related protein;Ribosome receptor protein;, PF05104;, GO:0005783;GO:0030176;GO:0016020;GO:0005840;GO:0003723;GO:0038023;GO:0001649;GO:0015031;GO:0006412;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:membrane; C:ribosome;, F:RNA binding; F:signaling receptor activity;, P:osteoblast differentiation; P:protein transport; P:translation; scaffold22 indexed_genome mRNA 5475911 5481962 . - . ID=transcript_5225;P60981 B2R6N2 B4DYA6 P18282 Q5W166 Q6IAW2,Destrin,Actin-depolymerizing factor;, PF00241;, GO:0015629;GO:0030864;GO:0005737;GO:0070062;GO:0051015;GO:0030042;GO:0030043;GO:0051014;GO:0008154;GO:0048870;GO:0030836;, C:actin cytoskeleton; C:cortical actin cytoskeleton; C:cytoplasm; C:extracellular exosome;, F:actin filament binding;, P:actin filament depolymerization; P:actin filament fragmentation; P:actin filament severing; P:actin polymerization or depolymerization; P:cell motility; P:positive regulation of actin filament depolymerization;|P60981 B2R6N2 B4DYA6 P18282 Q5W166 Q6IAW2,Destrin,Actin-depolymerizing factor;, PF00241;, GO:0015629;GO:0030864;GO:0005737;GO:0070062;GO:0051015;GO:0030042;GO:0030043;GO:0051014;GO:0008154;GO:0048870;GO:0030836;, C:actin cytoskeleton; C:cortical actin cytoskeleton; C:cytoplasm; C:extracellular exosome;, F:actin filament binding;, P:actin filament depolymerization; P:actin filament fragmentation; P:actin filament severing; P:actin polymerization or depolymerization; P:cell motility; P:positive regulation of actin filament depolymerization; scaffold22 indexed_genome mRNA 5541673 5581188 . + . ID=transcript_5226;Q12934 F5H0G1 O43595 O76034 O95676 Q8IVZ6 Q9HBX4,Filensin,Beaded filament structural protein 1;Lens fiber cell beaded-filament structural protein CP 115;Lens intermediate filament-like heavy;, PF00038;, GO:0005938;GO:0005737;GO:0005882;GO:0005886;GO:0005200;GO:0005212;GO:0048469;GO:0045109;GO:0070307;, C:cell cortex; C:cytoplasm; C:intermediate filament; C:plasma membrane;, F:structural constituent of cytoskeleton; F:structural constituent of eye lens;, P:cell maturation; P:intermediate filament organization; P:lens fiber cell development; scaffold22 indexed_genome mRNA 5660834 5759459 . - . ID=transcript_5227;P16519 B1ANH9 B4DFQ3 Q14927 Q5JYQ1 Q8IWA8 Q9NQG3 Q9NUG1 Q9UJC6,Neuroendocrine convertase 2,KEX2-like endoprotease 2;Prohormone convertase 2;Proprotein convertase 2;, PF01483;PF00082;PF16470;, GO:0030425;GO:0005615;GO:0043231;GO:0016020;GO:0043005;GO:0005654;GO:0043204;GO:0030141;GO:0030133;GO:0044877;GO:0004252;GO:0034230;GO:0030070;GO:0034231;GO:0007399;GO:0016486;GO:0016540;GO:0016485;GO:0006508;, C:dendrite; C:extracellular space; C:intracellular membrane-bounded organelle; C:membrane; C:neuron projection; C:nucleoplasm; C:perikaryon; C:secretory granule; C:transport vesicle;, F:protein-containing complex binding; F:serine-type endopeptidase activity;, P:enkephalin processing; P:insulin processing; P:islet amyloid polypeptide processing; P:nervous system development; P:peptide hormone processing; P:protein autoprocessing; P:protein processing; P:proteolysis;|P16519 B1ANH9 B4DFQ3 Q14927 Q5JYQ1 Q8IWA8 Q9NQG3 Q9NUG1 Q9UJC6,Neuroendocrine convertase 2,KEX2-like endoprotease 2;Prohormone convertase 2;Proprotein convertase 2;, PF01483;PF00082;PF16470;, GO:0030425;GO:0005615;GO:0043231;GO:0016020;GO:0043005;GO:0005654;GO:0043204;GO:0030141;GO:0030133;GO:0044877;GO:0004252;GO:0034230;GO:0030070;GO:0034231;GO:0007399;GO:0016486;GO:0016540;GO:0016485;GO:0006508;, C:dendrite; C:extracellular space; C:intracellular membrane-bounded organelle; C:membrane; C:neuron projection; C:nucleoplasm; C:perikaryon; C:secretory granule; C:transport vesicle;, F:protein-containing complex binding; F:serine-type endopeptidase activity;, P:enkephalin processing; P:insulin processing; P:islet amyloid polypeptide processing; P:nervous system development; P:peptide hormone processing; P:protein autoprocessing; P:protein processing; P:proteolysis;|P16519 B1ANH9 B4DFQ3 Q14927 Q5JYQ1 Q8IWA8 Q9NQG3 Q9NUG1 Q9UJC6,Neuroendocrine convertase 2,KEX2-like endoprotease 2;Prohormone convertase 2;Proprotein convertase 2;, PF01483;PF00082;PF16470;, GO:0030425;GO:0005615;GO:0043231;GO:0016020;GO:0043005;GO:0005654;GO:0043204;GO:0030141;GO:0030133;GO:0044877;GO:0004252;GO:0034230;GO:0030070;GO:0034231;GO:0007399;GO:0016486;GO:0016540;GO:0016485;GO:0006508;, C:dendrite; C:extracellular space; C:intracellular membrane-bounded organelle; C:membrane; C:neuron projection; C:nucleoplasm; C:perikaryon; C:secretory granule; C:transport vesicle;, F:protein-containing complex binding; F:serine-type endopeptidase activity;, P:enkephalin processing; P:insulin processing; P:islet amyloid polypeptide processing; P:nervous system development; P:peptide hormone processing; P:protein autoprocessing; P:protein processing; P:proteolysis; scaffold22 indexed_genome mRNA 6382790 6415891 . + . ID=transcript_5228;Q9NP72 B3KMC7 B7Z333 D3DRW1 Q53FX8 Q56UN9 Q6FIH1,Ras-related protein Rab-18,, PF00071;, GO:0016324;GO:0005829;GO:0012505;GO:0005789;GO:0071782;GO:0005794;GO:0005811;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0003924;GO:0007420;GO:0071786;GO:0001654;GO:0006886;GO:0034389;GO:0043312;GO:0007264;GO:0016032;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:Golgi apparatus; C:lipid droplet; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:brain development; P:endoplasmic reticulum tubular network organization; P:eye development; P:intracellular protein transport; P:lipid droplet organization; P:neutrophil degranulation; P:small GTPase mediated signal transduction; P:viral process;|Q9NP72 B3KMC7 B7Z333 D3DRW1 Q53FX8 Q56UN9 Q6FIH1,Ras-related protein Rab-18,, PF00071;, GO:0016324;GO:0005829;GO:0012505;GO:0005789;GO:0071782;GO:0005794;GO:0005811;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0003924;GO:0007420;GO:0071786;GO:0001654;GO:0006886;GO:0034389;GO:0043312;GO:0007264;GO:0016032;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:Golgi apparatus; C:lipid droplet; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:brain development; P:endoplasmic reticulum tubular network organization; P:eye development; P:intracellular protein transport; P:lipid droplet organization; P:neutrophil degranulation; P:small GTPase mediated signal transduction; P:viral process;|Q9NP72 B3KMC7 B7Z333 D3DRW1 Q53FX8 Q56UN9 Q6FIH1,Ras-related protein Rab-18,, PF00071;, GO:0016324;GO:0005829;GO:0012505;GO:0005789;GO:0071782;GO:0005794;GO:0005811;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0003924;GO:0007420;GO:0071786;GO:0001654;GO:0006886;GO:0034389;GO:0043312;GO:0007264;GO:0016032;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:Golgi apparatus; C:lipid droplet; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:brain development; P:endoplasmic reticulum tubular network organization; P:eye development; P:intracellular protein transport; P:lipid droplet organization; P:neutrophil degranulation; P:small GTPase mediated signal transduction; P:viral process;|Q9NP72 B3KMC7 B7Z333 D3DRW1 Q53FX8 Q56UN9 Q6FIH1,Ras-related protein Rab-18,, PF00071;, GO:0016324;GO:0005829;GO:0012505;GO:0005789;GO:0071782;GO:0005794;GO:0005811;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0003924;GO:0007420;GO:0071786;GO:0001654;GO:0006886;GO:0034389;GO:0043312;GO:0007264;GO:0016032;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:Golgi apparatus; C:lipid droplet; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:brain development; P:endoplasmic reticulum tubular network organization; P:eye development; P:intracellular protein transport; P:lipid droplet organization; P:neutrophil degranulation; P:small GTPase mediated signal transduction; P:viral process; scaffold22 indexed_genome mRNA 6815660 6816223 . - . ID=transcript_5229;Q5T2T1 B2RCC9 B4DWL9 B5MDZ3 D3DRW3 Q5T2T0 Q8IY28,MAGUK p55 subfamily member 7,, PF00625;PF02828;PF00595;PF00018;, GO:0005912;GO:0005923;GO:0005938;GO:0030054;GO:0016328;GO:0097025;GO:0005654;GO:0045296;GO:0060090;GO:0019904;GO:0035591;GO:0070830;GO:0030010;GO:0031334;GO:0071896;, C:adherens junction; C:bicellular tight junction; C:cell cortex; C:cell junction; C:lateral plasma membrane; C:MPP7-DLG1-LIN7 complex; C:nucleoplasm;, F:cadherin binding; F:molecular adaptor activity; F:protein domain specific binding; F:signaling adaptor activity;, P:bicellular tight junction assembly; P:establishment of cell polarity; P:positive regulation of protein-containing complex assembly; P:protein localization to adherens junction; scaffold22 indexed_genome mRNA 6869698 6974156 . - . ID=transcript_5230;Q5T2T1 B2RCC9 B4DWL9 B5MDZ3 D3DRW3 Q5T2T0 Q8IY28,MAGUK p55 subfamily member 7,, PF00625;PF02828;PF00595;PF00018;, GO:0005912;GO:0005923;GO:0005938;GO:0030054;GO:0016328;GO:0097025;GO:0005654;GO:0045296;GO:0060090;GO:0019904;GO:0035591;GO:0070830;GO:0030010;GO:0031334;GO:0071896;, C:adherens junction; C:bicellular tight junction; C:cell cortex; C:cell junction; C:lateral plasma membrane; C:MPP7-DLG1-LIN7 complex; C:nucleoplasm;, F:cadherin binding; F:molecular adaptor activity; F:protein domain specific binding; F:signaling adaptor activity;, P:bicellular tight junction assembly; P:establishment of cell polarity; P:positive regulation of protein-containing complex assembly; P:protein localization to adherens junction;|Q5T2T1 B2RCC9 B4DWL9 B5MDZ3 D3DRW3 Q5T2T0 Q8IY28,MAGUK p55 subfamily member 7,, PF00625;PF02828;PF00595;PF00018;, GO:0005912;GO:0005923;GO:0005938;GO:0030054;GO:0016328;GO:0097025;GO:0005654;GO:0045296;GO:0060090;GO:0019904;GO:0035591;GO:0070830;GO:0030010;GO:0031334;GO:0071896;, C:adherens junction; C:bicellular tight junction; C:cell cortex; C:cell junction; C:lateral plasma membrane; C:MPP7-DLG1-LIN7 complex; C:nucleoplasm;, F:cadherin binding; F:molecular adaptor activity; F:protein domain specific binding; F:signaling adaptor activity;, P:bicellular tight junction assembly; P:establishment of cell polarity; P:positive regulation of protein-containing complex assembly; P:protein localization to adherens junction; scaffold22 indexed_genome mRNA 7162054 7274729 . + . ID=transcript_5231;Q5VXK0 Q5VXK2 Q8TCK1 Q96DP3 Q96FW6 Q96JI3,WW domain-containing adapter protein with coiled-coil,, PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0000993;GO:0006974;GO:0044783;GO:0071894;GO:0010390;GO:0032435;GO:0016239;GO:0045893;GO:0016567;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA polymerase II complex binding;, P:cellular response to DNA damage stimulus; P:G1 DNA damage checkpoint; P:histone H2B conserved C-terminal lysine ubiquitination; P:histone monoubiquitination; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of macroautophagy; P:positive regulation of transcription, DNA-templated; P:protein ubiquitination;|Q5VXK0 Q5VXK2 Q8TCK1 Q96DP3 Q96FW6 Q96JI3,WW domain-containing adapter protein with coiled-coil,, PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0000993;GO:0006974;GO:0044783;GO:0071894;GO:0010390;GO:0032435;GO:0016239;GO:0045893;GO:0016567;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA polymerase II complex binding;, P:cellular response to DNA damage stimulus; P:G1 DNA damage checkpoint; P:histone H2B conserved C-terminal lysine ubiquitination; P:histone monoubiquitination; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of macroautophagy; P:positive regulation of transcription, DNA-templated; P:protein ubiquitination;|Q5VXK0 Q5VXK2 Q8TCK1 Q96DP3 Q96FW6 Q96JI3,WW domain-containing adapter protein with coiled-coil,, PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0000993;GO:0006974;GO:0044783;GO:0071894;GO:0010390;GO:0032435;GO:0016239;GO:0045893;GO:0016567;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA polymerase II complex binding;, P:cellular response to DNA damage stimulus; P:G1 DNA damage checkpoint; P:histone H2B conserved C-terminal lysine ubiquitination; P:histone monoubiquitination; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of macroautophagy; P:positive regulation of transcription, DNA-templated; P:protein ubiquitination;|Q5VXK0 Q5VXK2 Q8TCK1 Q96DP3 Q96FW6 Q96JI3,WW domain-containing adapter protein with coiled-coil,, PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0000993;GO:0006974;GO:0044783;GO:0071894;GO:0010390;GO:0032435;GO:0016239;GO:0045893;GO:0016567;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA polymerase II complex binding;, P:cellular response to DNA damage stimulus; P:G1 DNA damage checkpoint; P:histone H2B conserved C-terminal lysine ubiquitination; P:histone monoubiquitination; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of macroautophagy; P:positive regulation of transcription, DNA-templated; P:protein ubiquitination;|Q5VXK0 Q5VXK2 Q8TCK1 Q96DP3 Q96FW6 Q96JI3,WW domain-containing adapter protein with coiled-coil,, PF00397;, GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0000993;GO:0006974;GO:0044783;GO:0071894;GO:0010390;GO:0032435;GO:0016239;GO:0045893;GO:0016567;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA polymerase II complex binding;, P:cellular response to DNA damage stimulus; P:G1 DNA damage checkpoint; P:histone H2B conserved C-terminal lysine ubiquitination; P:histone monoubiquitination; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of macroautophagy; P:positive regulation of transcription, DNA-templated; P:protein ubiquitination; scaffold22 indexed_genome mRNA 7318470 7325272 . - . ID=transcript_5232;Q13145,BMP and activin membrane-bound inhibitor homolog,Non-metastatic gene A protein;Putative transmembrane protein NMA;, PF06211;, GO:0005737;GO:0016021;GO:0005886;GO:0005109;GO:0005114;GO:0016477;GO:0030514;GO:0045668;GO:0030512;GO:0090263;GO:0008284;GO:0010718;GO:0032092;GO:0045893;GO:0008360;GO:0007179;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:frizzled binding; F:type II transforming growth factor beta receptor binding;, P:cell migration; P:negative regulation of BMP signaling pathway; P:negative regulation of osteoblast differentiation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of protein binding; P:positive regulation of transcription, DNA-templated; P:regulation of cell shape; P:transforming growth factor beta receptor signaling pathway;|Q13145,BMP and activin membrane-bound inhibitor homolog,Non-metastatic gene A protein;Putative transmembrane protein NMA;, PF06211;, GO:0005737;GO:0016021;GO:0005886;GO:0005109;GO:0005114;GO:0016477;GO:0030514;GO:0045668;GO:0030512;GO:0090263;GO:0008284;GO:0010718;GO:0032092;GO:0045893;GO:0008360;GO:0007179;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:frizzled binding; F:type II transforming growth factor beta receptor binding;, P:cell migration; P:negative regulation of BMP signaling pathway; P:negative regulation of osteoblast differentiation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of protein binding; P:positive regulation of transcription, DNA-templated; P:regulation of cell shape; P:transforming growth factor beta receptor signaling pathway; scaffold22 indexed_genome mRNA 8006221 8032216 . - . ID=transcript_5233;P41279 A8K2Q5 D3DRX1 Q14275 Q5T855 Q9HC81,Mitogen-activated protein kinase kinase kinase 8,Cancer Osaka thyroid oncogene;Proto-oncogene c-Cot;Serine/threonine-protein kinase cot;Tumor progression locus 2;, PF00069;, GO:0005829;GO:0005524;GO:0000287;GO:0004709;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0070498;GO:0006468;GO:0051403;GO:0031295;, C:cytosol;, F:ATP binding; F:magnesium ion binding; F:MAP kinase kinase kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:interleukin-1-mediated signaling pathway; P:protein phosphorylation; P:stress-activated MAPK cascade; P:T cell costimulation; scaffold22 indexed_genome mRNA 8079216 8093975 . + . ID=transcript_5234;Q9NVV4 D3DRX0 Q659E3 Q6P7E5 Q9HA74,Poly(A) RNA polymerase, mitochondrial,PAP-associated domain-containing protein 1;Polynucleotide adenylyltransferase;Terminal uridylyltransferase 1;mtPAP;, PF03828;PF17797;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005524;GO:0042802;GO:0000287;GO:0030145;GO:0016779;GO:0004652;GO:0042803;GO:0003723;GO:0002134;GO:0071044;GO:0006378;GO:0006397;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:manganese ion binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:protein homodimerization activity; F:RNA binding; F:UTP binding;, P:histone mRNA catabolic process; P:mRNA polyadenylation; P:mRNA processing;|Q9NVV4 D3DRX0 Q659E3 Q6P7E5 Q9HA74,Poly(A) RNA polymerase, mitochondrial,PAP-associated domain-containing protein 1;Polynucleotide adenylyltransferase;Terminal uridylyltransferase 1;mtPAP;, PF03828;PF17797;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005524;GO:0042802;GO:0000287;GO:0030145;GO:0016779;GO:0004652;GO:0042803;GO:0003723;GO:0002134;GO:0071044;GO:0006378;GO:0006397;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:manganese ion binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:protein homodimerization activity; F:RNA binding; F:UTP binding;, P:histone mRNA catabolic process; P:mRNA polyadenylation; P:mRNA processing;|Q9NVV4 D3DRX0 Q659E3 Q6P7E5 Q9HA74,Poly(A) RNA polymerase, mitochondrial,PAP-associated domain-containing protein 1;Polynucleotide adenylyltransferase;Terminal uridylyltransferase 1;mtPAP;, PF03828;PF17797;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005524;GO:0042802;GO:0000287;GO:0030145;GO:0016779;GO:0004652;GO:0042803;GO:0003723;GO:0002134;GO:0071044;GO:0006378;GO:0006397;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:manganese ion binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:protein homodimerization activity; F:RNA binding; F:UTP binding;, P:histone mRNA catabolic process; P:mRNA polyadenylation; P:mRNA processing; scaffold22 indexed_genome mRNA 8284365 8295269 . + . ID=transcript_5235;Q9P266 Q5HYA7 Q5T992 Q86WZ9 Q9BYJ2,Junctional protein associated with coronary artery disease,, PF15351;, GO:0005912;GO:0048471;GO:0032587;GO:0007155;GO:1903589;GO:0090050;GO:0043410;GO:1903672;GO:1900748;, C:adherens junction; C:perinuclear region of cytoplasm; C:ruffle membrane;, , P:cell adhesion; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of MAPK cascade; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial growth factor signaling pathway; scaffold22 indexed_genome mRNA 8651998 8750471 . + . ID=transcript_5236;O95425 D3DRW9 M1J557 O60611 O60612 Q5VZK5 Q5VZK6 Q9H1R7,Supervillin {ECO:0000303|PubMed:9867483},Archvillin {ECO:0000303|PubMed:12711699};p205/p250 {ECO:0000303|PubMed:12711699, ECO:0000303|PubMed:9867483};, PF00626;PF02209;, GO:0015629;GO:0042995;GO:0032154;GO:0043034;GO:0005737;GO:0005829;GO:0005925;GO:0036449;GO:0030496;GO:0005634;GO:0005886;GO:0002102;GO:0051015;GO:0005546;GO:0051014;GO:0008154;GO:0051016;GO:0032467;GO:0007519;, C:actin cytoskeleton; C:cell projection; C:cleavage furrow; C:costamere; C:cytoplasm; C:cytosol; C:focal adhesion; C:microtubule minus-end; C:midbody; C:nucleus; C:plasma membrane; C:podosome;, F:actin filament binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:positive regulation of cytokinesis; P:skeletal muscle tissue development;|O95425 D3DRW9 M1J557 O60611 O60612 Q5VZK5 Q5VZK6 Q9H1R7,Supervillin {ECO:0000303|PubMed:9867483},Archvillin {ECO:0000303|PubMed:12711699};p205/p250 {ECO:0000303|PubMed:12711699, ECO:0000303|PubMed:9867483};, PF00626;PF02209;, GO:0015629;GO:0042995;GO:0032154;GO:0043034;GO:0005737;GO:0005829;GO:0005925;GO:0036449;GO:0030496;GO:0005634;GO:0005886;GO:0002102;GO:0051015;GO:0005546;GO:0051014;GO:0008154;GO:0051016;GO:0032467;GO:0007519;, C:actin cytoskeleton; C:cell projection; C:cleavage furrow; C:costamere; C:cytoplasm; C:cytosol; C:focal adhesion; C:microtubule minus-end; C:midbody; C:nucleus; C:plasma membrane; C:podosome;, F:actin filament binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:positive regulation of cytokinesis; P:skeletal muscle tissue development;|O95425 D3DRW9 M1J557 O60611 O60612 Q5VZK5 Q5VZK6 Q9H1R7,Supervillin {ECO:0000303|PubMed:9867483},Archvillin {ECO:0000303|PubMed:12711699};p205/p250 {ECO:0000303|PubMed:12711699, ECO:0000303|PubMed:9867483};, PF00626;PF02209;, GO:0015629;GO:0042995;GO:0032154;GO:0043034;GO:0005737;GO:0005829;GO:0005925;GO:0036449;GO:0030496;GO:0005634;GO:0005886;GO:0002102;GO:0051015;GO:0005546;GO:0051014;GO:0008154;GO:0051016;GO:0032467;GO:0007519;, C:actin cytoskeleton; C:cell projection; C:cleavage furrow; C:costamere; C:cytoplasm; C:cytosol; C:focal adhesion; C:microtubule minus-end; C:midbody; C:nucleus; C:plasma membrane; C:podosome;, F:actin filament binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:positive regulation of cytokinesis; P:skeletal muscle tissue development;|O95425 D3DRW9 M1J557 O60611 O60612 Q5VZK5 Q5VZK6 Q9H1R7,Supervillin {ECO:0000303|PubMed:9867483},Archvillin {ECO:0000303|PubMed:12711699};p205/p250 {ECO:0000303|PubMed:12711699, ECO:0000303|PubMed:9867483};, PF00626;PF02209;, GO:0015629;GO:0042995;GO:0032154;GO:0043034;GO:0005737;GO:0005829;GO:0005925;GO:0036449;GO:0030496;GO:0005634;GO:0005886;GO:0002102;GO:0051015;GO:0005546;GO:0051014;GO:0008154;GO:0051016;GO:0032467;GO:0007519;, C:actin cytoskeleton; C:cell projection; C:cleavage furrow; C:costamere; C:cytoplasm; C:cytosol; C:focal adhesion; C:microtubule minus-end; C:midbody; C:nucleus; C:plasma membrane; C:podosome;, F:actin filament binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:positive regulation of cytokinesis; P:skeletal muscle tissue development; scaffold22 indexed_genome mRNA 8887811 8891342 . + . ID=transcript_5237;Q7Z4V0 A2A3J4 A8K9L5 Q5T426 Q658Q4 Q6ZN65,Zinc finger protein 438,, , GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0046872;GO:0000978;GO:0045892;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold22 indexed_genome mRNA 8891364 8921302 . - . ID=transcript_5238;Q7Z4V0 A2A3J4 A8K9L5 Q5T426 Q658Q4 Q6ZN65,Zinc finger protein 438,, , GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0046872;GO:0000978;GO:0045892;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold22 indexed_genome mRNA 9336064 9470678 . + . ID=transcript_5239;Q5VZ84 Q8NB68,Zinc finger E-box-binding homeobox 1,NIL-2-A zinc finger protein;Negative regulator of IL2;Transcription factor 8;, PF00096;PF05605;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0000978;GO:0008270;GO:0048856;GO:0030154;GO:0019221;GO:0045602;GO:0000122;GO:0045892;GO:0007399;GO:0045666;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:cytokine-mediated signaling pathway; P:negative regulation of endothelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of neuron differentiation; P:regulation of transcription by RNA polymerase II; scaffold22 indexed_genome mRNA 9505172 9524058 . - . ID=transcript_5240;Q5VZ84 Q8NB68,Zinc finger E-box-binding homeobox 1,NIL-2-A zinc finger protein;Negative regulator of IL2;Transcription factor 8;, PF00096;PF05605;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0000978;GO:0008270;GO:0048856;GO:0030154;GO:0019221;GO:0045602;GO:0000122;GO:0045892;GO:0007399;GO:0045666;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:cytokine-mediated signaling pathway; P:negative regulation of endothelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of neuron differentiation; P:regulation of transcription by RNA polymerase II;|Q5VZ84 Q8NB68,Zinc finger E-box-binding homeobox 1,NIL-2-A zinc finger protein;Negative regulator of IL2;Transcription factor 8;, PF00096;PF05605;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0000978;GO:0008270;GO:0048856;GO:0030154;GO:0019221;GO:0045602;GO:0000122;GO:0045892;GO:0007399;GO:0045666;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:cytokine-mediated signaling pathway; P:negative regulation of endothelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of neuron differentiation; P:regulation of transcription by RNA polymerase II;|Q5VZ84 Q8NB68,Zinc finger E-box-binding homeobox 1,NIL-2-A zinc finger protein;Negative regulator of IL2;Transcription factor 8;, PF00096;PF05605;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0000978;GO:0008270;GO:0048856;GO:0030154;GO:0019221;GO:0045602;GO:0000122;GO:0045892;GO:0007399;GO:0045666;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:cytokine-mediated signaling pathway; P:negative regulation of endothelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of neuron differentiation; P:regulation of transcription by RNA polymerase II; scaffold22 indexed_genome mRNA 9758898 9759583 . - . ID=transcript_5241;Q8IWW6 B1ANY0 B1ANY1 B1ANY2 Q504X1 Q86UB3 Q8IWW7 Q8N3L1 Q9NT76,Rho GTPase-activating protein 12,Rho-type GTPase-activating protein 12;, PF00169;PF00620;PF14604;, GO:0005737;GO:0005829;GO:0001891;GO:0005096;GO:0007015;GO:0002011;GO:0051058;GO:0006911;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:phagocytic cup;, F:GTPase activator activity;, P:actin filament organization; P:morphogenesis of an epithelial sheet; P:negative regulation of small GTPase mediated signal transduction; P:phagocytosis, engulfment; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold22 indexed_genome mRNA 9762772 9763292 . - . ID=transcript_5242;Q8IWW6 B1ANY0 B1ANY1 B1ANY2 Q504X1 Q86UB3 Q8IWW7 Q8N3L1 Q9NT76,Rho GTPase-activating protein 12,Rho-type GTPase-activating protein 12;, PF00169;PF00620;PF14604;, GO:0005737;GO:0005829;GO:0001891;GO:0005096;GO:0007015;GO:0002011;GO:0051058;GO:0006911;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:phagocytic cup;, F:GTPase activator activity;, P:actin filament organization; P:morphogenesis of an epithelial sheet; P:negative regulation of small GTPase mediated signal transduction; P:phagocytosis, engulfment; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold22 indexed_genome mRNA 9776189 9785863 . - . ID=transcript_5243;Q8IWW6 B1ANY0 B1ANY1 B1ANY2 Q504X1 Q86UB3 Q8IWW7 Q8N3L1 Q9NT76,Rho GTPase-activating protein 12,Rho-type GTPase-activating protein 12;, PF00169;PF00620;PF14604;, GO:0005737;GO:0005829;GO:0001891;GO:0005096;GO:0007015;GO:0002011;GO:0051058;GO:0006911;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:phagocytic cup;, F:GTPase activator activity;, P:actin filament organization; P:morphogenesis of an epithelial sheet; P:negative regulation of small GTPase mediated signal transduction; P:phagocytosis, engulfment; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold22 indexed_genome mRNA 9934202 9974904 . - . ID=transcript_5244;P33176 A0AVB2 Q5VZ85,Kinesin-1 heavy chain,Conventional kinesin heavy chain;Ubiquitous kinesin heavy chain;, PF00225;, GO:1904115;GO:0044295;GO:0034451;GO:0035253;GO:0005829;GO:0032839;GO:0005871;GO:0016020;GO:0005874;GO:0048471;GO:0045335;GO:0031982;GO:0005524;GO:0008574;GO:0016887;GO:0045296;GO:0042802;GO:0008432;GO:0008017;GO:0099609;GO:0003777;GO:0099641;GO:0098971;GO:1990048;GO:0007411;GO:0071346;GO:0051642;GO:0007028;GO:0030705;GO:0021766;GO:0007018;GO:0072383;GO:0035774;GO:0090316;GO:0043268;GO:1903078;GO:0032230;GO:0031340;GO:1905152;GO:0042391;GO:1990049;GO:0035617;GO:0048489;GO:0047496;, C:axon cytoplasm; C:axonal growth cone; C:centriolar satellite; C:ciliary rootlet; C:cytosol; C:dendrite cytoplasm; C:kinesin complex; C:membrane; C:microtubule; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:cadherin binding; F:identical protein binding; F:JUN kinase binding; F:microtubule binding; F:microtubule lateral binding; F:microtubule motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:anterograde neuronal dense core vesicle transport; P:axon guidance; P:cellular response to interferon-gamma; P:centrosome localization; P:cytoplasm organization; P:cytoskeleton-dependent intracellular transport; P:hippocampus development; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of intracellular protein transport; P:positive regulation of potassium ion transport; P:positive regulation of protein localization to plasma membrane; P:positive regulation of synaptic transmission, GABAergic; P:positive regulation of vesicle fusion; P:positive regulation of voltage-gated sodium channel activity; P:regulation of membrane potential; P:retrograde neuronal dense core vesicle transport; P:stress granule disassembly; P:synaptic vesicle transport; P:vesicle transport along microtubule;|P33176 A0AVB2 Q5VZ85,Kinesin-1 heavy chain,Conventional kinesin heavy chain;Ubiquitous kinesin heavy chain;, PF00225;, GO:1904115;GO:0044295;GO:0034451;GO:0035253;GO:0005829;GO:0032839;GO:0005871;GO:0016020;GO:0005874;GO:0048471;GO:0045335;GO:0031982;GO:0005524;GO:0008574;GO:0016887;GO:0045296;GO:0042802;GO:0008432;GO:0008017;GO:0099609;GO:0003777;GO:0099641;GO:0098971;GO:1990048;GO:0007411;GO:0071346;GO:0051642;GO:0007028;GO:0030705;GO:0021766;GO:0007018;GO:0072383;GO:0035774;GO:0090316;GO:0043268;GO:1903078;GO:0032230;GO:0031340;GO:1905152;GO:0042391;GO:1990049;GO:0035617;GO:0048489;GO:0047496;, C:axon cytoplasm; C:axonal growth cone; C:centriolar satellite; C:ciliary rootlet; C:cytosol; C:dendrite cytoplasm; C:kinesin complex; C:membrane; C:microtubule; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:cadherin binding; F:identical protein binding; F:JUN kinase binding; F:microtubule binding; F:microtubule lateral binding; F:microtubule motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:anterograde neuronal dense core vesicle transport; P:axon guidance; P:cellular response to interferon-gamma; P:centrosome localization; P:cytoplasm organization; P:cytoskeleton-dependent intracellular transport; P:hippocampus development; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of intracellular protein transport; P:positive regulation of potassium ion transport; P:positive regulation of protein localization to plasma membrane; P:positive regulation of synaptic transmission, GABAergic; P:positive regulation of vesicle fusion; P:positive regulation of voltage-gated sodium channel activity; P:regulation of membrane potential; P:retrograde neuronal dense core vesicle transport; P:stress granule disassembly; P:synaptic vesicle transport; P:vesicle transport along microtubule; scaffold22 indexed_genome mRNA 10067406 10085283 . - . ID=transcript_5245;Q96RR6 Q9H7T7,Enhancer of polycomb homolog 1,, PF06752;PF10513;, GO:0043231;GO:0035267;GO:0031965;GO:0005654;GO:0005634;GO:0032777;GO:0043968;GO:0043967;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0040008;GO:0006357;GO:0006351;GO:0035886;, C:intracellular membrane-bounded organelle; C:NuA4 histone acetyltransferase complex; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:Piccolo NuA4 histone acetyltransferase complex;, , P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:vascular associated smooth muscle cell differentiation;|Q96RR6 Q9H7T7,Enhancer of polycomb homolog 1,, PF06752;PF10513;, GO:0043231;GO:0035267;GO:0031965;GO:0005654;GO:0005634;GO:0032777;GO:0043968;GO:0043967;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0040008;GO:0006357;GO:0006351;GO:0035886;, C:intracellular membrane-bounded organelle; C:NuA4 histone acetyltransferase complex; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:Piccolo NuA4 histone acetyltransferase complex;, , P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:vascular associated smooth muscle cell differentiation;|Q96RR6 Q9H7T7,Enhancer of polycomb homolog 1,, PF06752;PF10513;, GO:0043231;GO:0035267;GO:0031965;GO:0005654;GO:0005634;GO:0032777;GO:0043968;GO:0043967;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0040008;GO:0006357;GO:0006351;GO:0035886;, C:intracellular membrane-bounded organelle; C:NuA4 histone acetyltransferase complex; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:Piccolo NuA4 histone acetyltransferase complex;, , P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:vascular associated smooth muscle cell differentiation;|Q96RR6 Q9H7T7,Enhancer of polycomb homolog 1,, PF06752;PF10513;, GO:0043231;GO:0035267;GO:0031965;GO:0005654;GO:0005634;GO:0032777;GO:0043968;GO:0043967;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0040008;GO:0006357;GO:0006351;GO:0035886;, C:intracellular membrane-bounded organelle; C:NuA4 histone acetyltransferase complex; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:Piccolo NuA4 histone acetyltransferase complex;, , P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:vascular associated smooth muscle cell differentiation;|Q96RR6 Q9H7T7,Enhancer of polycomb homolog 1,, PF06752;PF10513;, GO:0043231;GO:0035267;GO:0031965;GO:0005654;GO:0005634;GO:0032777;GO:0043968;GO:0043967;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0040008;GO:0006357;GO:0006351;GO:0035886;, C:intracellular membrane-bounded organelle; C:NuA4 histone acetyltransferase complex; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:Piccolo NuA4 histone acetyltransferase complex;, , P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:vascular associated smooth muscle cell differentiation;|Q96RR6 Q9H7T7,Enhancer of polycomb homolog 1,, PF06752;PF10513;, GO:0043231;GO:0035267;GO:0031965;GO:0005654;GO:0005634;GO:0032777;GO:0043968;GO:0043967;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0040008;GO:0006357;GO:0006351;GO:0035886;, C:intracellular membrane-bounded organelle; C:NuA4 histone acetyltransferase complex; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:Piccolo NuA4 histone acetyltransferase complex;, , P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:vascular associated smooth muscle cell differentiation; scaffold22 indexed_genome mRNA 10225363 10307670 . + . ID=transcript_5246;Q8TEA1 B0YJ54,tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 {ECO:0000305},NOL1/NOP2/Sun and PUA domain-containing protein 1;NOL1/NOP2/Sun domain family member 6;, PF01189;, GO:0005737;GO:0005829;GO:0016428;GO:0000049;GO:0001510;GO:0002946;GO:0030488;GO:0006400;, C:cytoplasm; C:cytosol;, F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA binding;, P:RNA methylation; P:tRNA C5-cytosine methylation; P:tRNA methylation; P:tRNA modification;|Q9HD32 Q9Y340 Q9Y341,Voltage-dependent L-type calcium channel subunit beta-2,Calcium channel voltage-dependent subunit beta 2;Lambert-Eaton myasthenic syndrome antigen B;, PF00625;PF12052;, GO:0005887;GO:1990454;GO:0098684;GO:0005886;GO:0098793;GO:0005891;GO:0051015;GO:0005262;GO:0005245;GO:0099635;GO:0070509;GO:0061337;GO:0007268;GO:0098912;GO:0086045;GO:0007528;GO:1904879;GO:0051928;GO:1901843;GO:0072659;GO:0086091;GO:1901385;GO:0007601;, C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynapse; C:voltage-gated calcium channel complex;, F:actin filament binding; F:calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;, P:calcium ion import; P:cardiac conduction; P:chemical synaptic transmission; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:neuromuscular junction development; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:positive regulation of calcium ion transport; P:positive regulation of high voltage-gated calcium channel activity; P:protein localization to plasma membrane; P:regulation of heart rate by cardiac conduction; P:regulation of voltage-gated calcium channel activity; P:visual perception;|Q9HD32 Q9Y340 Q9Y341,Voltage-dependent L-type calcium channel subunit beta-2,Calcium channel voltage-dependent subunit beta 2;Lambert-Eaton myasthenic syndrome antigen B;, PF00625;PF12052;, GO:0005887;GO:1990454;GO:0098684;GO:0005886;GO:0098793;GO:0005891;GO:0051015;GO:0005262;GO:0005245;GO:0099635;GO:0070509;GO:0061337;GO:0007268;GO:0098912;GO:0086045;GO:0007528;GO:1904879;GO:0051928;GO:1901843;GO:0072659;GO:0086091;GO:1901385;GO:0007601;, C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynapse; C:voltage-gated calcium channel complex;, F:actin filament binding; F:calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;, P:calcium ion import; P:cardiac conduction; P:chemical synaptic transmission; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:neuromuscular junction development; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:positive regulation of calcium ion transport; P:positive regulation of high voltage-gated calcium channel activity; P:protein localization to plasma membrane; P:regulation of heart rate by cardiac conduction; P:regulation of voltage-gated calcium channel activity; P:visual perception;|Q9HD32 Q9Y340 Q9Y341,Voltage-dependent L-type calcium channel subunit beta-2,Calcium channel voltage-dependent subunit beta 2;Lambert-Eaton myasthenic syndrome antigen B;, PF00625;PF12052;, GO:0005887;GO:1990454;GO:0098684;GO:0005886;GO:0098793;GO:0005891;GO:0051015;GO:0005262;GO:0005245;GO:0099635;GO:0070509;GO:0061337;GO:0007268;GO:0098912;GO:0086045;GO:0007528;GO:1904879;GO:0051928;GO:1901843;GO:0072659;GO:0086091;GO:1901385;GO:0007601;, C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynapse; C:voltage-gated calcium channel complex;, F:actin filament binding; F:calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;, P:calcium ion import; P:cardiac conduction; P:chemical synaptic transmission; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:neuromuscular junction development; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:positive regulation of calcium ion transport; P:positive regulation of high voltage-gated calcium channel activity; P:protein localization to plasma membrane; P:regulation of heart rate by cardiac conduction; P:regulation of voltage-gated calcium channel activity; P:visual perception; scaffold22 indexed_genome mRNA 10331714 10332414 . - . ID=transcript_5247;Q9HD32 Q9Y340 Q9Y341,Voltage-dependent L-type calcium channel subunit beta-2,Calcium channel voltage-dependent subunit beta 2;Lambert-Eaton myasthenic syndrome antigen B;, PF00625;PF12052;, GO:0005887;GO:1990454;GO:0098684;GO:0005886;GO:0098793;GO:0005891;GO:0051015;GO:0005262;GO:0005245;GO:0099635;GO:0070509;GO:0061337;GO:0007268;GO:0098912;GO:0086045;GO:0007528;GO:1904879;GO:0051928;GO:1901843;GO:0072659;GO:0086091;GO:1901385;GO:0007601;, C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynapse; C:voltage-gated calcium channel complex;, F:actin filament binding; F:calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;, P:calcium ion import; P:cardiac conduction; P:chemical synaptic transmission; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:neuromuscular junction development; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:positive regulation of calcium ion transport; P:positive regulation of high voltage-gated calcium channel activity; P:protein localization to plasma membrane; P:regulation of heart rate by cardiac conduction; P:regulation of voltage-gated calcium channel activity; P:visual perception; scaffold22 indexed_genome mRNA 10429841 10431382 . - . ID=transcript_5248;O00305 A7BJ74 A8K1Y4 B4DG40 O60515 Q6B000 Q96L40,Voltage-dependent L-type calcium channel subunit beta-4 {ECO:0000305},Calcium channel voltage-dependent subunit beta 4 {ECO:0000305};, PF00625;PF12052;, GO:0009898;GO:0005829;GO:0005886;GO:0045202;GO:0005891;GO:0005245;GO:0007268;GO:0051899;GO:0007528;GO:1901385;, C:cytoplasmic side of plasma membrane; C:cytosol; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:voltage-gated calcium channel activity;, P:chemical synaptic transmission; P:membrane depolarization; P:neuromuscular junction development; P:regulation of voltage-gated calcium channel activity; scaffold22 indexed_genome mRNA 10811463 10891553 . - . ID=transcript_5249;Q6NZY5 Q96NN4,Zinc transporter ZIP12,LIV-1 subfamily of ZIP zinc transporter 8;Solute carrier family 39 member 12;Zrt- and Irt-like protein 12;, PF02535;PF18292;, GO:1903561;GO:0005887;GO:0048471;GO:0005385;GO:0006882;GO:1903672;GO:0031113;GO:0010975;GO:0036293;GO:0007165;GO:0071578;, C:extracellular vesicle; C:integral component of plasma membrane; C:perinuclear region of cytoplasm;, F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:positive regulation of sprouting angiogenesis; P:regulation of microtubule polymerization; P:regulation of neuron projection development; P:response to decreased oxygen levels; P:signal transduction; P:zinc ion import across plasma membrane;|Q6NZY5 Q96NN4,Zinc transporter ZIP12,LIV-1 subfamily of ZIP zinc transporter 8;Solute carrier family 39 member 12;Zrt- and Irt-like protein 12;, PF02535;PF18292;, GO:1903561;GO:0005887;GO:0048471;GO:0005385;GO:0006882;GO:1903672;GO:0031113;GO:0010975;GO:0036293;GO:0007165;GO:0071578;, C:extracellular vesicle; C:integral component of plasma membrane; C:perinuclear region of cytoplasm;, F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:positive regulation of sprouting angiogenesis; P:regulation of microtubule polymerization; P:regulation of neuron projection development; P:response to decreased oxygen levels; P:signal transduction; P:zinc ion import across plasma membrane; scaffold22 indexed_genome mRNA 10912751 11009060 . - . ID=transcript_5250;P22897 A5PKW3 Q5VSJ2 Q5VSK2,Macrophage mannose receptor 1,C-type lectin domain family 13 member D;C-type lectin domain family 13 member D-like;Human mannose receptor;Macrophage mannose receptor 1-like protein 1;, PF00040;PF00059;PF00652;, GO:0009986;GO:0010008;GO:0005887;GO:0005886;GO:0038024;GO:0005537;GO:0038023;GO:0004888;GO:0001618;GO:0071346;GO:0071353;GO:0071222;GO:0052031;GO:0006898;, C:cell surface; C:endosome membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cargo receptor activity; F:mannose binding; F:signaling receptor activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:cellular response to interferon-gamma; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:modulation by symbiont of host defense response; P:receptor-mediated endocytosis;|P22897 A5PKW3 Q5VSJ2 Q5VSK2,Macrophage mannose receptor 1,C-type lectin domain family 13 member D;C-type lectin domain family 13 member D-like;Human mannose receptor;Macrophage mannose receptor 1-like protein 1;, PF00040;PF00059;PF00652;, GO:0009986;GO:0010008;GO:0005887;GO:0005886;GO:0038024;GO:0005537;GO:0038023;GO:0004888;GO:0001618;GO:0071346;GO:0071353;GO:0071222;GO:0052031;GO:0006898;, C:cell surface; C:endosome membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cargo receptor activity; F:mannose binding; F:signaling receptor activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:cellular response to interferon-gamma; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:modulation by symbiont of host defense response; P:receptor-mediated endocytosis; scaffold22 indexed_genome mRNA 11093263 11155434 . - . ID=transcript_5251;Q92783 B0YJ99 D3DRU5 Q8N6D9,Signal transducing adapter molecule 1,, PF00018;PF02809;PF00790;, GO:0005829;GO:0031901;GO:0033565;GO:0043231;GO:0044389;GO:0016197;GO:0016236;GO:0061024;GO:0036258;GO:0042059;GO:1903543;GO:0016579;GO:0043328;GO:1903551;GO:0007165;, C:cytosol; C:early endosome membrane; C:ESCRT-0 complex; C:intracellular membrane-bounded organelle;, F:ubiquitin-like protein ligase binding;, P:endosomal transport; P:macroautophagy; P:membrane organization; P:multivesicular body assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of exosomal secretion; P:protein deubiquitination; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:regulation of extracellular exosome assembly; P:signal transduction;|Q92783 B0YJ99 D3DRU5 Q8N6D9,Signal transducing adapter molecule 1,, PF00018;PF02809;PF00790;, GO:0005829;GO:0031901;GO:0033565;GO:0043231;GO:0044389;GO:0016197;GO:0016236;GO:0061024;GO:0036258;GO:0042059;GO:1903543;GO:0016579;GO:0043328;GO:1903551;GO:0007165;, C:cytosol; C:early endosome membrane; C:ESCRT-0 complex; C:intracellular membrane-bounded organelle;, F:ubiquitin-like protein ligase binding;, P:endosomal transport; P:macroautophagy; P:membrane organization; P:multivesicular body assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of exosomal secretion; P:protein deubiquitination; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:regulation of extracellular exosome assembly; P:signal transduction; scaffold22 indexed_genome mRNA 11174819 11204369 . + . ID=transcript_5252;B0YJ81 B0YJ80 Q6JIC5 Q96FW7 Q9HB93 Q9UHX2,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 1 {ECO:0000303|PubMed:18554506};Cementum-attachment protein {ECO:0000303|PubMed:22067203};Protein-tyrosine phosphatase-like member A {ECO:0000312|HGNC:HGNC:9639};, PF04387;, GO:0005783;GO:0005789;GO:0030176;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0046848;GO:0102158;GO:0034622;GO:0071529;GO:0030497;GO:0035338;GO:0007275;GO:0010811;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:hydroxyapatite binding; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:cellular protein-containing complex assembly; P:cementum mineralization; P:fatty acid elongation; P:long-chain fatty-acyl-CoA biosynthetic process; P:multicellular organism development; P:positive regulation of cell-substrate adhesion; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|B0YJ81 B0YJ80 Q6JIC5 Q96FW7 Q9HB93 Q9UHX2,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 1 {ECO:0000303|PubMed:18554506};Cementum-attachment protein {ECO:0000303|PubMed:22067203};Protein-tyrosine phosphatase-like member A {ECO:0000312|HGNC:HGNC:9639};, PF04387;, GO:0005783;GO:0005789;GO:0030176;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0046848;GO:0102158;GO:0034622;GO:0071529;GO:0030497;GO:0035338;GO:0007275;GO:0010811;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:hydroxyapatite binding; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:cellular protein-containing complex assembly; P:cementum mineralization; P:fatty acid elongation; P:long-chain fatty-acyl-CoA biosynthetic process; P:multicellular organism development; P:positive regulation of cell-substrate adhesion; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold22 indexed_genome mRNA 11561391 11570686 . - . ID=transcript_5253;Q96ML2 Q9NTM3,Vimentin,, PF00038;PF04732;, GO:0031252;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005882;GO:0045111;GO:0005815;GO:0043005;GO:0016363;GO:0005777;GO:0045335;GO:0005886;GO:0005844;GO:1990904;GO:0003725;GO:0042802;GO:1990254;GO:0019904;GO:0097110;GO:0005200;GO:0005212;GO:0035973;GO:0014002;GO:0060020;GO:0071346;GO:0071222;GO:0071225;GO:0019221;GO:0045109;GO:0070307;GO:0030049;GO:0010977;GO:0032967;GO:0045727;GO:0043488;GO:0060395;GO:0016032;, C:cell leading edge; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:intermediate filament; C:intermediate filament cytoskeleton; C:microtubule organizing center; C:neuron projection; C:nuclear matrix; C:peroxisome; C:phagocytic vesicle; C:plasma membrane; C:polysome; C:ribonucleoprotein complex;, F:double-stranded RNA binding; F:identical protein binding; F:keratin filament binding; F:protein domain specific binding; F:scaffold protein binding; F:structural constituent of cytoskeleton; F:structural constituent of eye lens;, P:aggrephagy; P:astrocyte development; P:Bergmann glial cell differentiation; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:cytokine-mediated signaling pathway; P:intermediate filament organization; P:lens fiber cell development; P:muscle filament sliding; P:negative regulation of neuron projection development; P:positive regulation of collagen biosynthetic process; P:positive regulation of translation; P:regulation of mRNA stability; P:SMAD protein signal transduction; P:viral process;|Q96ML2 Q9NTM3,Vimentin,, PF00038;PF04732;, GO:0031252;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005882;GO:0045111;GO:0005815;GO:0043005;GO:0016363;GO:0005777;GO:0045335;GO:0005886;GO:0005844;GO:1990904;GO:0003725;GO:0042802;GO:1990254;GO:0019904;GO:0097110;GO:0005200;GO:0005212;GO:0035973;GO:0014002;GO:0060020;GO:0071346;GO:0071222;GO:0071225;GO:0019221;GO:0045109;GO:0070307;GO:0030049;GO:0010977;GO:0032967;GO:0045727;GO:0043488;GO:0060395;GO:0016032;, C:cell leading edge; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:intermediate filament; C:intermediate filament cytoskeleton; C:microtubule organizing center; C:neuron projection; C:nuclear matrix; C:peroxisome; C:phagocytic vesicle; C:plasma membrane; C:polysome; C:ribonucleoprotein complex;, F:double-stranded RNA binding; F:identical protein binding; F:keratin filament binding; F:protein domain specific binding; F:scaffold protein binding; F:structural constituent of cytoskeleton; F:structural constituent of eye lens;, P:aggrephagy; P:astrocyte development; P:Bergmann glial cell differentiation; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:cytokine-mediated signaling pathway; P:intermediate filament organization; P:lens fiber cell development; P:muscle filament sliding; P:negative regulation of neuron projection development; P:positive regulation of collagen biosynthetic process; P:positive regulation of translation; P:regulation of mRNA stability; P:SMAD protein signal transduction; P:viral process;|Q96ML2 Q9NTM3,Vimentin,, PF00038;PF04732;, GO:0031252;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005882;GO:0045111;GO:0005815;GO:0043005;GO:0016363;GO:0005777;GO:0045335;GO:0005886;GO:0005844;GO:1990904;GO:0003725;GO:0042802;GO:1990254;GO:0019904;GO:0097110;GO:0005200;GO:0005212;GO:0035973;GO:0014002;GO:0060020;GO:0071346;GO:0071222;GO:0071225;GO:0019221;GO:0045109;GO:0070307;GO:0030049;GO:0010977;GO:0032967;GO:0045727;GO:0043488;GO:0060395;GO:0016032;, C:cell leading edge; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:intermediate filament; C:intermediate filament cytoskeleton; C:microtubule organizing center; C:neuron projection; C:nuclear matrix; C:peroxisome; C:phagocytic vesicle; C:plasma membrane; C:polysome; C:ribonucleoprotein complex;, F:double-stranded RNA binding; F:identical protein binding; F:keratin filament binding; F:protein domain specific binding; F:scaffold protein binding; F:structural constituent of cytoskeleton; F:structural constituent of eye lens;, P:aggrephagy; P:astrocyte development; P:Bergmann glial cell differentiation; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:cytokine-mediated signaling pathway; P:intermediate filament organization; P:lens fiber cell development; P:muscle filament sliding; P:negative regulation of neuron projection development; P:positive regulation of collagen biosynthetic process; P:positive regulation of translation; P:regulation of mRNA stability; P:SMAD protein signal transduction; P:viral process;|Q96ML2 Q9NTM3,Vimentin,, PF00038;PF04732;, GO:0031252;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005882;GO:0045111;GO:0005815;GO:0043005;GO:0016363;GO:0005777;GO:0045335;GO:0005886;GO:0005844;GO:1990904;GO:0003725;GO:0042802;GO:1990254;GO:0019904;GO:0097110;GO:0005200;GO:0005212;GO:0035973;GO:0014002;GO:0060020;GO:0071346;GO:0071222;GO:0071225;GO:0019221;GO:0045109;GO:0070307;GO:0030049;GO:0010977;GO:0032967;GO:0045727;GO:0043488;GO:0060395;GO:0016032;, C:cell leading edge; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:intermediate filament; C:intermediate filament cytoskeleton; C:microtubule organizing center; C:neuron projection; C:nuclear matrix; C:peroxisome; C:phagocytic vesicle; C:plasma membrane; C:polysome; C:ribonucleoprotein complex;, F:double-stranded RNA binding; F:identical protein binding; F:keratin filament binding; F:protein domain specific binding; F:scaffold protein binding; F:structural constituent of cytoskeleton; F:structural constituent of eye lens;, P:aggrephagy; P:astrocyte development; P:Bergmann glial cell differentiation; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:cytokine-mediated signaling pathway; P:intermediate filament organization; P:lens fiber cell development; P:muscle filament sliding; P:negative regulation of neuron projection development; P:positive regulation of collagen biosynthetic process; P:positive regulation of translation; P:regulation of mRNA stability; P:SMAD protein signal transduction; P:viral process; scaffold22 indexed_genome mRNA 11607823 11658684 . + . ID=transcript_5254;O14717 B0YJ02 B0YJ03 B0YJ07 B0YJ08 O43669 Q86WW6,tRNA (cytosine(38)-C(5))-methyltransferase,DNA (cytosine-5)-methyltransferase-like protein 2 {ECO:0000303|PubMed:16424344};DNA methyltransferase homolog HsaIIP;PuMet;, PF00145;, GO:0005737;GO:0005654;GO:0003723;GO:0016428;GO:0008175;GO:0001975;GO:0030488;GO:0006400;GO:0036416;, C:cytoplasm; C:nucleoplasm;, F:RNA binding; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA methyltransferase activity;, P:response to amphetamine; P:tRNA methylation; P:tRNA modification; P:tRNA stabilization;|O14717 B0YJ02 B0YJ03 B0YJ07 B0YJ08 O43669 Q86WW6,tRNA (cytosine(38)-C(5))-methyltransferase,DNA (cytosine-5)-methyltransferase-like protein 2 {ECO:0000303|PubMed:16424344};DNA methyltransferase homolog HsaIIP;PuMet;, PF00145;, GO:0005737;GO:0005654;GO:0003723;GO:0016428;GO:0008175;GO:0001975;GO:0030488;GO:0006400;GO:0036416;, C:cytoplasm; C:nucleoplasm;, F:RNA binding; F:tRNA (cytosine-5-)-methyltransferase activity; F:tRNA methyltransferase activity;, P:response to amphetamine; P:tRNA methylation; P:tRNA modification; P:tRNA stabilization; scaffold22 indexed_genome mRNA 11938954 12133054 . + . ID=transcript_5255;Q15404 A8KA46 D3DRU3 Q6FI17,Ras suppressor protein 1,, PF13855;, GO:0005829;GO:0070062;GO:0005925;GO:0010811;GO:0043547;GO:0007165;, C:cytosol; C:extracellular exosome; C:focal adhesion;, , P:positive regulation of cell-substrate adhesion; P:positive regulation of GTPase activity; P:signal transduction; scaffold22 indexed_genome mRNA 12196801 12269575 . - . ID=transcript_5256;Q96BW5 B0YJ77 B3KTF5 D3DRU0 Q9BY46,Phosphotriesterase-related protein,Parathion hydrolase-related protein;, PF02126;, GO:0070062;GO:0016788;GO:0008270;GO:0009056;GO:0030855;, C:extracellular exosome;, F:hydrolase activity, acting on ester bonds; F:zinc ion binding;, P:catabolic process; P:epithelial cell differentiation; scaffold22 indexed_genome mRNA 12775207 12850718 . + . ID=transcript_5257;Q9H8M7 Q5SZ68 Q5SZ69 Q5SZ70 Q6IA40 Q6P7P0 Q7Z2S1 Q8WUF1 Q9H3I4,Ubiquitin carboxyl-terminal hydrolase MINDY-3,Dermal papilla-derived protein 5;Deubiquitinating enzyme MINDY-3;Protein CARP;, PF13898;, GO:0031965;GO:0005654;GO:0008234;GO:1990380;GO:0004843;GO:0006915;, C:nuclear membrane; C:nucleoplasm;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:apoptotic process;|Q9H8M7 Q5SZ68 Q5SZ69 Q5SZ70 Q6IA40 Q6P7P0 Q7Z2S1 Q8WUF1 Q9H3I4,Ubiquitin carboxyl-terminal hydrolase MINDY-3,Dermal papilla-derived protein 5;Deubiquitinating enzyme MINDY-3;Protein CARP;, PF13898;, GO:0031965;GO:0005654;GO:0008234;GO:1990380;GO:0004843;GO:0006915;, C:nuclear membrane; C:nucleoplasm;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:apoptotic process;|Q9H8M7 Q5SZ68 Q5SZ69 Q5SZ70 Q6IA40 Q6P7P0 Q7Z2S1 Q8WUF1 Q9H3I4,Ubiquitin carboxyl-terminal hydrolase MINDY-3,Dermal papilla-derived protein 5;Deubiquitinating enzyme MINDY-3;Protein CARP;, PF13898;, GO:0031965;GO:0005654;GO:0008234;GO:1990380;GO:0004843;GO:0006915;, C:nuclear membrane; C:nucleoplasm;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:apoptotic process;|Q9H8M7 Q5SZ68 Q5SZ69 Q5SZ70 Q6IA40 Q6P7P0 Q7Z2S1 Q8WUF1 Q9H3I4,Ubiquitin carboxyl-terminal hydrolase MINDY-3,Dermal papilla-derived protein 5;Deubiquitinating enzyme MINDY-3;Protein CARP;, PF13898;, GO:0031965;GO:0005654;GO:0008234;GO:1990380;GO:0004843;GO:0006915;, C:nuclear membrane; C:nucleoplasm;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:apoptotic process;|Q9H8M7 Q5SZ68 Q5SZ69 Q5SZ70 Q6IA40 Q6P7P0 Q7Z2S1 Q8WUF1 Q9H3I4,Ubiquitin carboxyl-terminal hydrolase MINDY-3,Dermal papilla-derived protein 5;Deubiquitinating enzyme MINDY-3;Protein CARP;, PF13898;, GO:0031965;GO:0005654;GO:0008234;GO:1990380;GO:0004843;GO:0006915;, C:nuclear membrane; C:nucleoplasm;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:apoptotic process;|Q9H8M7 Q5SZ68 Q5SZ69 Q5SZ70 Q6IA40 Q6P7P0 Q7Z2S1 Q8WUF1 Q9H3I4,Ubiquitin carboxyl-terminal hydrolase MINDY-3,Dermal papilla-derived protein 5;Deubiquitinating enzyme MINDY-3;Protein CARP;, PF13898;, GO:0031965;GO:0005654;GO:0008234;GO:1990380;GO:0004843;GO:0006915;, C:nuclear membrane; C:nucleoplasm;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:apoptotic process;|Q9H8M7 Q5SZ68 Q5SZ69 Q5SZ70 Q6IA40 Q6P7P0 Q7Z2S1 Q8WUF1 Q9H3I4,Ubiquitin carboxyl-terminal hydrolase MINDY-3,Dermal papilla-derived protein 5;Deubiquitinating enzyme MINDY-3;Protein CARP;, PF13898;, GO:0031965;GO:0005654;GO:0008234;GO:1990380;GO:0004843;GO:0006915;, C:nuclear membrane; C:nucleoplasm;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:apoptotic process;|Q9H8M7 Q5SZ68 Q5SZ69 Q5SZ70 Q6IA40 Q6P7P0 Q7Z2S1 Q8WUF1 Q9H3I4,Ubiquitin carboxyl-terminal hydrolase MINDY-3,Dermal papilla-derived protein 5;Deubiquitinating enzyme MINDY-3;Protein CARP;, PF13898;, GO:0031965;GO:0005654;GO:0008234;GO:1990380;GO:0004843;GO:0006915;, C:nuclear membrane; C:nucleoplasm;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:apoptotic process; scaffold22 indexed_genome mRNA 12931259 13094358 . + . ID=transcript_5258;P53708 B0YJ31 Q5VX94,Integrin alpha-8,, PF01839;PF00357;PF08441;, GO:0009986;GO:0032591;GO:0005783;GO:0005925;GO:0034678;GO:0008305;GO:0043204;GO:0005886;GO:0014069;GO:0046872;GO:0007420;GO:0098609;GO:0007160;GO:0030198;GO:0007229;GO:0001822;GO:0048333;GO:0034446;, C:cell surface; C:dendritic spine membrane; C:endoplasmic reticulum; C:focal adhesion; C:integrin alpha8-beta1 complex; C:integrin complex; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:metal ion binding;, P:brain development; P:cell-cell adhesion; P:cell-matrix adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:kidney development; P:mesodermal cell differentiation; P:substrate adhesion-dependent cell spreading;|P53708 B0YJ31 Q5VX94,Integrin alpha-8,, PF01839;PF00357;PF08441;, GO:0009986;GO:0032591;GO:0005783;GO:0005925;GO:0034678;GO:0008305;GO:0043204;GO:0005886;GO:0014069;GO:0046872;GO:0007420;GO:0098609;GO:0007160;GO:0030198;GO:0007229;GO:0001822;GO:0048333;GO:0034446;, C:cell surface; C:dendritic spine membrane; C:endoplasmic reticulum; C:focal adhesion; C:integrin alpha8-beta1 complex; C:integrin complex; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:metal ion binding;, P:brain development; P:cell-cell adhesion; P:cell-matrix adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:kidney development; P:mesodermal cell differentiation; P:substrate adhesion-dependent cell spreading; scaffold22 indexed_genome mRNA 13116410 13121781 . + . ID=transcript_5259;P53708 B0YJ31 Q5VX94,Integrin alpha-8,, PF01839;PF00357;PF08441;, GO:0009986;GO:0032591;GO:0005783;GO:0005925;GO:0034678;GO:0008305;GO:0043204;GO:0005886;GO:0014069;GO:0046872;GO:0007420;GO:0098609;GO:0007160;GO:0030198;GO:0007229;GO:0001822;GO:0048333;GO:0034446;, C:cell surface; C:dendritic spine membrane; C:endoplasmic reticulum; C:focal adhesion; C:integrin alpha8-beta1 complex; C:integrin complex; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:metal ion binding;, P:brain development; P:cell-cell adhesion; P:cell-matrix adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:kidney development; P:mesodermal cell differentiation; P:substrate adhesion-dependent cell spreading; scaffold22 indexed_genome mRNA 13335861 13389835 . + . ID=transcript_5260;Q5VUB5 D3DRT9 Q32M49 Q8N4I0,Protein FAM171A1 {ECO:0000305},Astroprincin {ECO:0000303|PubMed:30312582};, PF10577;, GO:0016021;GO:0005886;GO:0008360;GO:0043149;, C:integral component of membrane; C:plasma membrane;, , P:regulation of cell shape; P:stress fiber assembly;|Q5VUB5 D3DRT9 Q32M49 Q8N4I0,Protein FAM171A1 {ECO:0000305},Astroprincin {ECO:0000303|PubMed:30312582};, PF10577;, GO:0016021;GO:0005886;GO:0008360;GO:0043149;, C:integral component of membrane; C:plasma membrane;, , P:regulation of cell shape; P:stress fiber assembly;|Q5VUB5 D3DRT9 Q32M49 Q8N4I0,Protein FAM171A1 {ECO:0000305},Astroprincin {ECO:0000303|PubMed:30312582};, PF10577;, GO:0016021;GO:0005886;GO:0008360;GO:0043149;, C:integral component of membrane; C:plasma membrane;, , P:regulation of cell shape; P:stress fiber assembly; scaffold22 indexed_genome mRNA 13459601 13481985 . + . ID=transcript_5261;O60551 B0YJ49 Q53Y38 Q5VUC8 Q9BRB4,Glycylpeptide N-tetradecanoyltransferase 2,Myristoyl-CoA:protein N-myristoyltransferase 2;Peptide N-myristoyltransferase 2;Type II N-myristoyltransferase;, PF01233;PF02799;, GO:0005737;GO:0005829;GO:0019898;GO:0005794;GO:0043657;GO:0005886;GO:0004379;GO:0075733;GO:0018008;GO:0022400;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:Golgi apparatus; C:host cell; C:plasma membrane;, F:glycylpeptide N-tetradecanoyltransferase activity;, P:intracellular transport of virus; P:N-terminal peptidyl-glycine N-myristoylation; P:regulation of rhodopsin mediated signaling pathway; scaffold22 indexed_genome mRNA 13485163 13489802 . + . ID=transcript_5262;O60551 B0YJ49 Q53Y38 Q5VUC8 Q9BRB4,Glycylpeptide N-tetradecanoyltransferase 2,Myristoyl-CoA:protein N-myristoyltransferase 2;Peptide N-myristoyltransferase 2;Type II N-myristoyltransferase;, PF01233;PF02799;, GO:0005737;GO:0005829;GO:0019898;GO:0005794;GO:0043657;GO:0005886;GO:0004379;GO:0075733;GO:0018008;GO:0022400;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:Golgi apparatus; C:host cell; C:plasma membrane;, F:glycylpeptide N-tetradecanoyltransferase activity;, P:intracellular transport of virus; P:N-terminal peptidyl-glycine N-myristoylation; P:regulation of rhodopsin mediated signaling pathway;|O60551 B0YJ49 Q53Y38 Q5VUC8 Q9BRB4,Glycylpeptide N-tetradecanoyltransferase 2,Myristoyl-CoA:protein N-myristoyltransferase 2;Peptide N-myristoyltransferase 2;Type II N-myristoyltransferase;, PF01233;PF02799;, GO:0005737;GO:0005829;GO:0019898;GO:0005794;GO:0043657;GO:0005886;GO:0004379;GO:0075733;GO:0018008;GO:0022400;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:Golgi apparatus; C:host cell; C:plasma membrane;, F:glycylpeptide N-tetradecanoyltransferase activity;, P:intracellular transport of virus; P:N-terminal peptidyl-glycine N-myristoylation; P:regulation of rhodopsin mediated signaling pathway; scaffold22 indexed_genome mRNA 13490025 13497891 . - . ID=transcript_5263;P78345 B3KPY0 D3DRT8 Q53F71 Q8NHS8,Ribonuclease P protein subunit p38,, PF01248;, GO:0001650;GO:0030681;GO:0005730;GO:0005654;GO:0004526;GO:0033204;GO:0006364;GO:0001682;, C:fibrillar center; C:multimeric ribonuclease P complex; C:nucleolus; C:nucleoplasm;, F:ribonuclease P activity; F:ribonuclease P RNA binding;, P:rRNA processing; P:tRNA 5'-leader removal; scaffold22 indexed_genome mRNA 13512445 13524442 . + . ID=transcript_5264;Q8N6N7 A6NCI2 B3KTG8,Acyl-CoA-binding domain-containing protein 7,, PF00887;, GO:0000062;GO:0008289;, , F:fatty-acyl-CoA binding; F:lipid binding;|P63135,Endogenous retrovirus group K member 7 Pol protein,HERV-K(III) Pol protein;HERV-K102 Pol protein;HERV-K_1q22 provirus ancestral Pol protein;, PF00517;PF13804;PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0005198;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:structural molecule activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination;|Q8N6N7 A6NCI2 B3KTG8,Acyl-CoA-binding domain-containing protein 7,, PF00887;, GO:0000062;GO:0008289;, , F:fatty-acyl-CoA binding; F:lipid binding; scaffold22 indexed_genome mRNA 13525379 13527668 . - . ID=transcript_5265;Q9NV23 Q5VUB6 Q9NUW1,S-acyl fatty acid synthase thioesterase, medium chain,Augmented in rheumatoid arthritis 1;Oleoyl-ACP hydrolase;Thioesterase 2 {ECO:0000303|PubMed:26663084};Thioesterase II;Thioesterase domain-containing protein 1;, PF00975;, GO:0005829;GO:0047381;GO:0016295;GO:0102991;GO:0004320;GO:0016296;GO:0016290;GO:0008610;GO:0051792;, C:cytosol;, F:dodecanoyl-[acyl-carrier-protein] hydrolase activity; F:myristoyl-[acyl-carrier-protein] hydrolase activity; F:myristoyl-CoA hydrolase activity; F:oleoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:lipid biosynthetic process; P:medium-chain fatty acid biosynthetic process;|Q9NV23 Q5VUB6 Q9NUW1,S-acyl fatty acid synthase thioesterase, medium chain,Augmented in rheumatoid arthritis 1;Oleoyl-ACP hydrolase;Thioesterase 2 {ECO:0000303|PubMed:26663084};Thioesterase II;Thioesterase domain-containing protein 1;, PF00975;, GO:0005829;GO:0047381;GO:0016295;GO:0102991;GO:0004320;GO:0016296;GO:0016290;GO:0008610;GO:0051792;, C:cytosol;, F:dodecanoyl-[acyl-carrier-protein] hydrolase activity; F:myristoyl-[acyl-carrier-protein] hydrolase activity; F:myristoyl-CoA hydrolase activity; F:oleoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:lipid biosynthetic process; P:medium-chain fatty acid biosynthetic process; scaffold22 indexed_genome mRNA 13532918 13551282 . - . ID=transcript_5266;Q9NV23 Q5VUB6 Q9NUW1,S-acyl fatty acid synthase thioesterase, medium chain,Augmented in rheumatoid arthritis 1;Oleoyl-ACP hydrolase;Thioesterase 2 {ECO:0000303|PubMed:26663084};Thioesterase II;Thioesterase domain-containing protein 1;, PF00975;, GO:0005829;GO:0047381;GO:0016295;GO:0102991;GO:0004320;GO:0016296;GO:0016290;GO:0008610;GO:0051792;, C:cytosol;, F:dodecanoyl-[acyl-carrier-protein] hydrolase activity; F:myristoyl-[acyl-carrier-protein] hydrolase activity; F:myristoyl-CoA hydrolase activity; F:oleoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:lipid biosynthetic process; P:medium-chain fatty acid biosynthetic process;|Q9NV23 Q5VUB6 Q9NUW1,S-acyl fatty acid synthase thioesterase, medium chain,Augmented in rheumatoid arthritis 1;Oleoyl-ACP hydrolase;Thioesterase 2 {ECO:0000303|PubMed:26663084};Thioesterase II;Thioesterase domain-containing protein 1;, PF00975;, GO:0005829;GO:0047381;GO:0016295;GO:0102991;GO:0004320;GO:0016296;GO:0016290;GO:0008610;GO:0051792;, C:cytosol;, F:dodecanoyl-[acyl-carrier-protein] hydrolase activity; F:myristoyl-[acyl-carrier-protein] hydrolase activity; F:myristoyl-CoA hydrolase activity; F:oleoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:lipid biosynthetic process; P:medium-chain fatty acid biosynthetic process; scaffold22 indexed_genome mRNA 13568086 13583869 . - . ID=transcript_5267;Q5JSS6,Meiosis expressed gene 1 protein homolog,, PF15163;, GO:0005829;GO:0002177;GO:0005634;GO:0034613;GO:1905198;GO:0007288;, C:cytosol; C:manchette; C:nucleus;, , P:cellular protein localization; P:manchette assembly; P:sperm axoneme assembly; scaffold22 indexed_genome mRNA 13592887 13607526 . + . ID=transcript_5268;Q5JSS7 Q6PK14 Q8N101 Q8N132 Q8TBW9 Q9BVW9 Q9HAM4,Protein artemis,DNA cross-link repair 1C protein;Protein A-SCID;SNM1 homolog C;SNM1-like protein;, PF07522;, GO:0005794;GO:0070419;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0000014;GO:0002250;GO:0030183;GO:0006303;GO:0036297;GO:0031848;GO:0010212;GO:0033151;, C:Golgi apparatus; C:nonhomologous end joining complex; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:adaptive immune response; P:B cell differentiation; P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:protection from non-homologous end joining at telomere; P:response to ionizing radiation; P:V(D)J recombination; scaffold22 indexed_genome mRNA 13607572 13609230 . + . ID=transcript_5269;Q5JSS7 Q6PK14 Q8N101 Q8N132 Q8TBW9 Q9BVW9 Q9HAM4,Protein artemis,DNA cross-link repair 1C protein;Protein A-SCID;SNM1 homolog C;SNM1-like protein;, PF07522;, GO:0005794;GO:0070419;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0000014;GO:0002250;GO:0030183;GO:0006303;GO:0036297;GO:0031848;GO:0010212;GO:0033151;, C:Golgi apparatus; C:nonhomologous end joining complex; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:adaptive immune response; P:B cell differentiation; P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:protection from non-homologous end joining at telomere; P:response to ionizing radiation; P:V(D)J recombination;|Q5JSS7 Q6PK14 Q8N101 Q8N132 Q8TBW9 Q9BVW9 Q9HAM4,Protein artemis,DNA cross-link repair 1C protein;Protein A-SCID;SNM1 homolog C;SNM1-like protein;, PF07522;, GO:0005794;GO:0070419;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0000014;GO:0002250;GO:0030183;GO:0006303;GO:0036297;GO:0031848;GO:0010212;GO:0033151;, C:Golgi apparatus; C:nonhomologous end joining complex; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:adaptive immune response; P:B cell differentiation; P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:protection from non-homologous end joining at telomere; P:response to ionizing radiation; P:V(D)J recombination; scaffold22 indexed_genome mRNA 13609459 13628666 . + . ID=transcript_5270;Q5JSS7 Q6PK14 Q8N101 Q8N132 Q8TBW9 Q9BVW9 Q9HAM4,Protein artemis,DNA cross-link repair 1C protein;Protein A-SCID;SNM1 homolog C;SNM1-like protein;, PF07522;, GO:0005794;GO:0070419;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0000014;GO:0002250;GO:0030183;GO:0006303;GO:0036297;GO:0031848;GO:0010212;GO:0033151;, C:Golgi apparatus; C:nonhomologous end joining complex; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:adaptive immune response; P:B cell differentiation; P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:protection from non-homologous end joining at telomere; P:response to ionizing radiation; P:V(D)J recombination;|Q5JSS7 Q6PK14 Q8N101 Q8N132 Q8TBW9 Q9BVW9 Q9HAM4,Protein artemis,DNA cross-link repair 1C protein;Protein A-SCID;SNM1 homolog C;SNM1-like protein;, PF07522;, GO:0005794;GO:0070419;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0000014;GO:0002250;GO:0030183;GO:0006303;GO:0036297;GO:0031848;GO:0010212;GO:0033151;, C:Golgi apparatus; C:nonhomologous end joining complex; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:adaptive immune response; P:B cell differentiation; P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:protection from non-homologous end joining at telomere; P:response to ionizing radiation; P:V(D)J recombination;|Q5JSS7 Q6PK14 Q8N101 Q8N132 Q8TBW9 Q9BVW9 Q9HAM4,Protein artemis,DNA cross-link repair 1C protein;Protein A-SCID;SNM1 homolog C;SNM1-like protein;, PF07522;, GO:0005794;GO:0070419;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0000014;GO:0002250;GO:0030183;GO:0006303;GO:0036297;GO:0031848;GO:0010212;GO:0033151;, C:Golgi apparatus; C:nonhomologous end joining complex; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:adaptive immune response; P:B cell differentiation; P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:protection from non-homologous end joining at telomere; P:response to ionizing radiation; P:V(D)J recombination;|Q5JSS7 Q6PK14 Q8N101 Q8N132 Q8TBW9 Q9BVW9 Q9HAM4,Protein artemis,DNA cross-link repair 1C protein;Protein A-SCID;SNM1 homolog C;SNM1-like protein;, PF07522;, GO:0005794;GO:0070419;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0000014;GO:0002250;GO:0030183;GO:0006303;GO:0036297;GO:0031848;GO:0010212;GO:0033151;, C:Golgi apparatus; C:nonhomologous end joining complex; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:adaptive immune response; P:B cell differentiation; P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:protection from non-homologous end joining at telomere; P:response to ionizing radiation; P:V(D)J recombination;|Q5JSS7 Q6PK14 Q8N101 Q8N132 Q8TBW9 Q9BVW9 Q9HAM4,Protein artemis,DNA cross-link repair 1C protein;Protein A-SCID;SNM1 homolog C;SNM1-like protein;, PF07522;, GO:0005794;GO:0070419;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0000014;GO:0002250;GO:0030183;GO:0006303;GO:0036297;GO:0031848;GO:0010212;GO:0033151;, C:Golgi apparatus; C:nonhomologous end joining complex; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:adaptive immune response; P:B cell differentiation; P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:protection from non-homologous end joining at telomere; P:response to ionizing radiation; P:V(D)J recombination;|Q5JSS7 Q6PK14 Q8N101 Q8N132 Q8TBW9 Q9BVW9 Q9HAM4,Protein artemis,DNA cross-link repair 1C protein;Protein A-SCID;SNM1 homolog C;SNM1-like protein;, PF07522;, GO:0005794;GO:0070419;GO:0005654;GO:0035312;GO:0008409;GO:0003684;GO:0000014;GO:0002250;GO:0030183;GO:0006303;GO:0036297;GO:0031848;GO:0010212;GO:0033151;, C:Golgi apparatus; C:nonhomologous end joining complex; C:nucleoplasm;, F:5'-3' exodeoxyribonuclease activity; F:5'-3' exonuclease activity; F:damaged DNA binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:adaptive immune response; P:B cell differentiation; P:double-strand break repair via nonhomologous end joining; P:interstrand cross-link repair; P:protection from non-homologous end joining at telomere; P:response to ionizing radiation; P:V(D)J recombination; scaffold22 indexed_genome mRNA 13628699 13635901 . - . ID=transcript_5271;Q9H5I1 D3DRT4 Q5JSS4 Q5JSS5 Q6I9Y3 Q8ND06,Histone-lysine N-methyltransferase SUV39H2,Histone H3-K9 methyltransferase 2;Lysine N-methyltransferase 1B;Suppressor of variegation 3-9 homolog 2;, PF00385;PF05033;PF00856;, GO:0000785;GO:0000775;GO:0005654;GO:0005634;GO:0046974;GO:1904047;GO:0000976;GO:0008270;GO:0007049;GO:0030154;GO:0071456;GO:0006333;GO:0006338;GO:0036123;GO:0036124;GO:0034968;GO:0042754;GO:0000122;GO:0045892;GO:0048511;, C:chromatin; C:chromosome, centromeric region; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K9 specific); F:S-adenosyl-L-methionine binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell cycle; P:cell differentiation; P:cellular response to hypoxia; P:chromatin assembly or disassembly; P:chromatin remodeling; P:histone H3-K9 dimethylation; P:histone H3-K9 trimethylation; P:histone lysine methylation; P:negative regulation of circadian rhythm; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:rhythmic process; scaffold22 indexed_genome mRNA 13635936 13639810 . - . ID=transcript_5272;Q9H5I1 D3DRT4 Q5JSS4 Q5JSS5 Q6I9Y3 Q8ND06,Histone-lysine N-methyltransferase SUV39H2,Histone H3-K9 methyltransferase 2;Lysine N-methyltransferase 1B;Suppressor of variegation 3-9 homolog 2;, PF00385;PF05033;PF00856;, GO:0000785;GO:0000775;GO:0005654;GO:0005634;GO:0046974;GO:1904047;GO:0000976;GO:0008270;GO:0007049;GO:0030154;GO:0071456;GO:0006333;GO:0006338;GO:0036123;GO:0036124;GO:0034968;GO:0042754;GO:0000122;GO:0045892;GO:0048511;, C:chromatin; C:chromosome, centromeric region; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K9 specific); F:S-adenosyl-L-methionine binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell cycle; P:cell differentiation; P:cellular response to hypoxia; P:chromatin assembly or disassembly; P:chromatin remodeling; P:histone H3-K9 dimethylation; P:histone H3-K9 trimethylation; P:histone lysine methylation; P:negative regulation of circadian rhythm; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:rhythmic process; scaffold22 indexed_genome mRNA 13665494 13682284 . + . ID=transcript_5273;Q0VDF9 A8K8F8 B0YIY9 Q9P0X2 Q9UI07,Heat shock 70 kDa protein 14,HSP70-like protein 1;Heat shock protein HSP60;, PF00012;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0051083;GO:0034620;GO:0051085;GO:0042026;GO:0016192;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:'de novo' cotranslational protein folding; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; P:vesicle-mediated transport;|Q0VDF9 A8K8F8 B0YIY9 Q9P0X2 Q9UI07,Heat shock 70 kDa protein 14,HSP70-like protein 1;Heat shock protein HSP60;, PF00012;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0051083;GO:0034620;GO:0051085;GO:0042026;GO:0016192;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:'de novo' cotranslational protein folding; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; P:vesicle-mediated transport;|Q0VDF9 A8K8F8 B0YIY9 Q9P0X2 Q9UI07,Heat shock 70 kDa protein 14,HSP70-like protein 1;Heat shock protein HSP60;, PF00012;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0051083;GO:0034620;GO:0051085;GO:0042026;GO:0016192;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:'de novo' cotranslational protein folding; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; P:vesicle-mediated transport;|Q0VDF9 A8K8F8 B0YIY9 Q9P0X2 Q9UI07,Heat shock 70 kDa protein 14,HSP70-like protein 1;Heat shock protein HSP60;, PF00012;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0051083;GO:0034620;GO:0051085;GO:0042026;GO:0016192;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:'de novo' cotranslational protein folding; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; P:vesicle-mediated transport;|Q0VDF9 A8K8F8 B0YIY9 Q9P0X2 Q9UI07,Heat shock 70 kDa protein 14,HSP70-like protein 1;Heat shock protein HSP60;, PF00012;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0051083;GO:0034620;GO:0051085;GO:0042026;GO:0016192;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:'de novo' cotranslational protein folding; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; P:vesicle-mediated transport;|Q0VDF9 A8K8F8 B0YIY9 Q9P0X2 Q9UI07,Heat shock 70 kDa protein 14,HSP70-like protein 1;Heat shock protein HSP60;, PF00012;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0051083;GO:0034620;GO:0051085;GO:0042026;GO:0016192;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:'de novo' cotranslational protein folding; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; P:vesicle-mediated transport;|Q0VDF9 A8K8F8 B0YIY9 Q9P0X2 Q9UI07,Heat shock 70 kDa protein 14,HSP70-like protein 1;Heat shock protein HSP60;, PF00012;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0051083;GO:0034620;GO:0051085;GO:0042026;GO:0016192;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:'de novo' cotranslational protein folding; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; P:vesicle-mediated transport;|Q0VDF9 A8K8F8 B0YIY9 Q9P0X2 Q9UI07,Heat shock 70 kDa protein 14,HSP70-like protein 1;Heat shock protein HSP60;, PF00012;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0051083;GO:0034620;GO:0051085;GO:0042026;GO:0016192;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:'de novo' cotranslational protein folding; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; P:vesicle-mediated transport; scaffold22 indexed_genome mRNA 13682300 13689665 . - . ID=transcript_5274;Q0VDF9 A8K8F8 B0YIY9 Q9P0X2 Q9UI07,Heat shock 70 kDa protein 14,HSP70-like protein 1;Heat shock protein HSP60;, PF00012;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0051083;GO:0034620;GO:0051085;GO:0042026;GO:0016192;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:'de novo' cotranslational protein folding; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; P:vesicle-mediated transport;|Q0VDF9 A8K8F8 B0YIY9 Q9P0X2 Q9UI07,Heat shock 70 kDa protein 14,HSP70-like protein 1;Heat shock protein HSP60;, PF00012;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0051082;GO:0051083;GO:0034620;GO:0051085;GO:0042026;GO:0016192;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:unfolded protein binding;, P:'de novo' cotranslational protein folding; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:protein refolding; P:vesicle-mediated transport; scaffold22 indexed_genome mRNA 13691218 13709212 . + . ID=transcript_5275;Q49AH0 A2RUU0 B4DVW3,Cerebral dopamine neurotrophic factor,ARMET-like protein 1;Conserved dopamine neurotrophic factor;, PF10208;, GO:0005783;GO:0005615;GO:0008083;GO:0071542;GO:0031175;, C:endoplasmic reticulum; C:extracellular space;, F:growth factor activity;, P:dopaminergic neuron differentiation; P:neuron projection development; scaffold22 indexed_genome mRNA 13941051 13953954 . + . ID=transcript_5276;Q9H098 A8K1P4 D3DRT2 Q5T9K7 Q5T9K8 Q6ZSI4,Protein FAM107B {ECO:0000305},, PF06625; scaffold22 indexed_genome mRNA 14579200 14829644 . + . ID=transcript_5277;Q9P2Q2 A7E2Y3 Q5T377,FERM domain-containing protein 4A,, PF11819;PF09380;PF00373;PF09379;, GO:0005912;GO:0005923;GO:0005737;GO:0005856;GO:0030674;GO:0090162;GO:0050709;GO:0050714;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton;, F:protein-macromolecule adaptor activity;, P:establishment of epithelial cell polarity; P:negative regulation of protein secretion; P:positive regulation of protein secretion;|Q9P2Q2 A7E2Y3 Q5T377,FERM domain-containing protein 4A,, PF11819;PF09380;PF00373;PF09379;, GO:0005912;GO:0005923;GO:0005737;GO:0005856;GO:0030674;GO:0090162;GO:0050709;GO:0050714;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton;, F:protein-macromolecule adaptor activity;, P:establishment of epithelial cell polarity; P:negative regulation of protein secretion; P:positive regulation of protein secretion; scaffold22 indexed_genome mRNA 14840016 14874460 . - . ID=transcript_5278;Q99633 Q5T9P9 Q9BUI9,Pre-mRNA-splicing factor 18,PRP18 homolog;, PF02840;PF08799;, GO:0016607;GO:0005634;GO:0005681;GO:0071021;GO:0046540;GO:0005682;GO:0000350;GO:0006397;GO:0071048;GO:0008380;, C:nuclear speck; C:nucleus; C:spliceosomal complex; C:U2-type post-spliceosomal complex; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, , P:generation of catalytic spliceosome for second transesterification step; P:mRNA processing; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:RNA splicing; scaffold22 indexed_genome mRNA 14978278 15022792 . + . ID=transcript_5279;Q8N7W2 Q5SYY7 Q5SYY8 Q5SYY9 Q8N5T7,BEN domain-containing protein 7,, PF10523;, GO:0070062;, C:extracellular exosome; scaffold22 indexed_genome mRNA 15030371 15032324 . - . ID=transcript_5280;O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4,Mitotic checkpoint serine/threonine-protein kinase BUB1,BUB1A;, PF08311;PF00069;, GO:0000777;GO:0000778;GO:0000942;GO:0005829;GO:0043231;GO:0000776;GO:0016020;GO:0005654;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0006915;GO:0051301;GO:0008283;GO:0051754;GO:0007093;GO:0007094;GO:0007052;GO:0051983;GO:0007063;GO:0016032;, C:condensed chromosome kinetochore; C:condensed nuclear chromosome kinetochore; C:condensed nuclear chromosome outer kinetochore; C:cytosol; C:intracellular membrane-bounded organelle; C:kinetochore; C:membrane; C:nucleoplasm;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cell division; P:cell population proliferation; P:meiotic sister chromatid cohesion, centromeric; P:mitotic cell cycle checkpoint; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:regulation of chromosome segregation; P:regulation of sister chromatid cohesion; P:viral process; scaffold22 indexed_genome mRNA 15144651 15167056 . - . ID=transcript_5281;P49903 B4DWK0 D3DRS9 D6PSQ9 Q5T5U8 Q5T5U9 Q9BVT4,Selenide, water dikinase 1,Selenium donor protein 1;Selenophosphate synthase 1;, PF00586;PF02769;, GO:0005737;GO:0031965;GO:0005886;GO:0005524;GO:0005525;GO:0042802;GO:0046872;GO:0046982;GO:0042803;GO:0004756;GO:0006464;GO:0016260;, C:cytoplasm; C:nuclear membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:identical protein binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:selenide, water dikinase activity;, P:cellular protein modification process; P:selenocysteine biosynthetic process;|P49903 B4DWK0 D3DRS9 D6PSQ9 Q5T5U8 Q5T5U9 Q9BVT4,Selenide, water dikinase 1,Selenium donor protein 1;Selenophosphate synthase 1;, PF00586;PF02769;, GO:0005737;GO:0031965;GO:0005886;GO:0005524;GO:0005525;GO:0042802;GO:0046872;GO:0046982;GO:0042803;GO:0004756;GO:0006464;GO:0016260;, C:cytoplasm; C:nuclear membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:identical protein binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:selenide, water dikinase activity;, P:cellular protein modification process; P:selenocysteine biosynthetic process;|P49903 B4DWK0 D3DRS9 D6PSQ9 Q5T5U8 Q5T5U9 Q9BVT4,Selenide, water dikinase 1,Selenium donor protein 1;Selenophosphate synthase 1;, PF00586;PF02769;, GO:0005737;GO:0031965;GO:0005886;GO:0005524;GO:0005525;GO:0042802;GO:0046872;GO:0046982;GO:0042803;GO:0004756;GO:0006464;GO:0016260;, C:cytoplasm; C:nuclear membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:identical protein binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:selenide, water dikinase activity;, P:cellular protein modification process; P:selenocysteine biosynthetic process;|P49903 B4DWK0 D3DRS9 D6PSQ9 Q5T5U8 Q5T5U9 Q9BVT4,Selenide, water dikinase 1,Selenium donor protein 1;Selenophosphate synthase 1;, PF00586;PF02769;, GO:0005737;GO:0031965;GO:0005886;GO:0005524;GO:0005525;GO:0042802;GO:0046872;GO:0046982;GO:0042803;GO:0004756;GO:0006464;GO:0016260;, C:cytoplasm; C:nuclear membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:identical protein binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:selenide, water dikinase activity;, P:cellular protein modification process; P:selenocysteine biosynthetic process;|P49903 B4DWK0 D3DRS9 D6PSQ9 Q5T5U8 Q5T5U9 Q9BVT4,Selenide, water dikinase 1,Selenium donor protein 1;Selenophosphate synthase 1;, PF00586;PF02769;, GO:0005737;GO:0031965;GO:0005886;GO:0005524;GO:0005525;GO:0042802;GO:0046872;GO:0046982;GO:0042803;GO:0004756;GO:0006464;GO:0016260;, C:cytoplasm; C:nuclear membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:identical protein binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:selenide, water dikinase activity;, P:cellular protein modification process; P:selenocysteine biosynthetic process; scaffold22 indexed_genome mRNA 15194117 15197327 . + . ID=transcript_5282;O14832 A8MTS8 B1ALH5,Phytanoyl-CoA dioxygenase, peroxisomal,Phytanic acid oxidase;Phytanoyl-CoA alpha-hydroxylase;, PF05721;, GO:0097731;GO:0005829;GO:0005739;GO:0005782;GO:0005777;GO:0031406;GO:0008198;GO:0031418;GO:0048244;GO:0019606;GO:0006103;GO:0001561;GO:0006720;GO:0097089;GO:0008104;, C:9+0 non-motile cilium; C:cytosol; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:carboxylic acid binding; F:ferrous iron binding; F:L-ascorbic acid binding; F:phytanoyl-CoA dioxygenase activity;, P:2-oxobutyrate catabolic process; P:2-oxoglutarate metabolic process; P:fatty acid alpha-oxidation; P:isoprenoid metabolic process; P:methyl-branched fatty acid metabolic process; P:protein localization; scaffold22 indexed_genome mRNA 15326909 15333827 . + . ID=transcript_5283;Q8N562 Q9UET9 Q9UEV4 Q9Y218,Optineurin,E3-14.7K-interacting protein;FIP-2;Huntingtin yeast partner L;Huntingtin-interacting protein 7;Huntingtin-interacting protein L;NEMO-related protein;Optic neuropathy-inducing protein;Transcription factor IIIA-interacting protein;, PF16516;PF11577;, GO:0005776;GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0005654;GO:0005634;GO:0048471;GO:0055038;GO:0005802;GO:0042802;GO:0070530;GO:0046872;GO:0031593;GO:0008022;GO:0030674;GO:0031267;GO:0006914;GO:0008219;GO:0034620;GO:0050829;GO:0000086;GO:0007030;GO:0090161;GO:0043001;GO:0045087;GO:0043124;GO:0001920;GO:0061734;GO:0010508;GO:1904417;GO:0034067;GO:0043122;GO:0007165;GO:0016032;, C:autophagosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome membrane; C:trans-Golgi network;, F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein C-terminus binding; F:protein-macromolecule adaptor activity; F:small GTPase binding;, P:autophagy; P:cell death; P:cellular response to unfolded protein; P:defense response to Gram-negative bacterium; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:Golgi ribbon formation; P:Golgi to plasma membrane protein transport; P:innate immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of receptor recycling; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of autophagy; P:positive regulation of xenophagy; P:protein localization to Golgi apparatus; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction; P:viral process; scaffold22 indexed_genome mRNA 15333842 15366215 . - . ID=transcript_5284;Q8N562 Q9UET9 Q9UEV4 Q9Y218,Optineurin,E3-14.7K-interacting protein;FIP-2;Huntingtin yeast partner L;Huntingtin-interacting protein 7;Huntingtin-interacting protein L;NEMO-related protein;Optic neuropathy-inducing protein;Transcription factor IIIA-interacting protein;, PF16516;PF11577;, GO:0005776;GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0005654;GO:0005634;GO:0048471;GO:0055038;GO:0005802;GO:0042802;GO:0070530;GO:0046872;GO:0031593;GO:0008022;GO:0030674;GO:0031267;GO:0006914;GO:0008219;GO:0034620;GO:0050829;GO:0000086;GO:0007030;GO:0090161;GO:0043001;GO:0045087;GO:0043124;GO:0001920;GO:0061734;GO:0010508;GO:1904417;GO:0034067;GO:0043122;GO:0007165;GO:0016032;, C:autophagosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome membrane; C:trans-Golgi network;, F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein C-terminus binding; F:protein-macromolecule adaptor activity; F:small GTPase binding;, P:autophagy; P:cell death; P:cellular response to unfolded protein; P:defense response to Gram-negative bacterium; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:Golgi ribbon formation; P:Golgi to plasma membrane protein transport; P:innate immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of receptor recycling; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of autophagy; P:positive regulation of xenophagy; P:protein localization to Golgi apparatus; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction; P:viral process;|Q8N562 Q9UET9 Q9UEV4 Q9Y218,Optineurin,E3-14.7K-interacting protein;FIP-2;Huntingtin yeast partner L;Huntingtin-interacting protein 7;Huntingtin-interacting protein L;NEMO-related protein;Optic neuropathy-inducing protein;Transcription factor IIIA-interacting protein;, PF16516;PF11577;, GO:0005776;GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0005654;GO:0005634;GO:0048471;GO:0055038;GO:0005802;GO:0042802;GO:0070530;GO:0046872;GO:0031593;GO:0008022;GO:0030674;GO:0031267;GO:0006914;GO:0008219;GO:0034620;GO:0050829;GO:0000086;GO:0007030;GO:0090161;GO:0043001;GO:0045087;GO:0043124;GO:0001920;GO:0061734;GO:0010508;GO:1904417;GO:0034067;GO:0043122;GO:0007165;GO:0016032;, C:autophagosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome membrane; C:trans-Golgi network;, F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein C-terminus binding; F:protein-macromolecule adaptor activity; F:small GTPase binding;, P:autophagy; P:cell death; P:cellular response to unfolded protein; P:defense response to Gram-negative bacterium; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:Golgi ribbon formation; P:Golgi to plasma membrane protein transport; P:innate immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of receptor recycling; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of autophagy; P:positive regulation of xenophagy; P:protein localization to Golgi apparatus; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction; P:viral process;|Q8N562 Q9UET9 Q9UEV4 Q9Y218,Optineurin,E3-14.7K-interacting protein;FIP-2;Huntingtin yeast partner L;Huntingtin-interacting protein 7;Huntingtin-interacting protein L;NEMO-related protein;Optic neuropathy-inducing protein;Transcription factor IIIA-interacting protein;, PF16516;PF11577;, GO:0005776;GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0005654;GO:0005634;GO:0048471;GO:0055038;GO:0005802;GO:0042802;GO:0070530;GO:0046872;GO:0031593;GO:0008022;GO:0030674;GO:0031267;GO:0006914;GO:0008219;GO:0034620;GO:0050829;GO:0000086;GO:0007030;GO:0090161;GO:0043001;GO:0045087;GO:0043124;GO:0001920;GO:0061734;GO:0010508;GO:1904417;GO:0034067;GO:0043122;GO:0007165;GO:0016032;, C:autophagosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome membrane; C:trans-Golgi network;, F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein C-terminus binding; F:protein-macromolecule adaptor activity; F:small GTPase binding;, P:autophagy; P:cell death; P:cellular response to unfolded protein; P:defense response to Gram-negative bacterium; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:Golgi ribbon formation; P:Golgi to plasma membrane protein transport; P:innate immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of receptor recycling; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of autophagy; P:positive regulation of xenophagy; P:protein localization to Golgi apparatus; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction; P:viral process;|Q8N562 Q9UET9 Q9UEV4 Q9Y218,Optineurin,E3-14.7K-interacting protein;FIP-2;Huntingtin yeast partner L;Huntingtin-interacting protein 7;Huntingtin-interacting protein L;NEMO-related protein;Optic neuropathy-inducing protein;Transcription factor IIIA-interacting protein;, PF16516;PF11577;, GO:0005776;GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0005654;GO:0005634;GO:0048471;GO:0055038;GO:0005802;GO:0042802;GO:0070530;GO:0046872;GO:0031593;GO:0008022;GO:0030674;GO:0031267;GO:0006914;GO:0008219;GO:0034620;GO:0050829;GO:0000086;GO:0007030;GO:0090161;GO:0043001;GO:0045087;GO:0043124;GO:0001920;GO:0061734;GO:0010508;GO:1904417;GO:0034067;GO:0043122;GO:0007165;GO:0016032;, C:autophagosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome membrane; C:trans-Golgi network;, F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein C-terminus binding; F:protein-macromolecule adaptor activity; F:small GTPase binding;, P:autophagy; P:cell death; P:cellular response to unfolded protein; P:defense response to Gram-negative bacterium; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:Golgi ribbon formation; P:Golgi to plasma membrane protein transport; P:innate immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of receptor recycling; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of autophagy; P:positive regulation of xenophagy; P:protein localization to Golgi apparatus; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction; P:viral process;|Q8N562 Q9UET9 Q9UEV4 Q9Y218,Optineurin,E3-14.7K-interacting protein;FIP-2;Huntingtin yeast partner L;Huntingtin-interacting protein 7;Huntingtin-interacting protein L;NEMO-related protein;Optic neuropathy-inducing protein;Transcription factor IIIA-interacting protein;, PF16516;PF11577;, GO:0005776;GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0005654;GO:0005634;GO:0048471;GO:0055038;GO:0005802;GO:0042802;GO:0070530;GO:0046872;GO:0031593;GO:0008022;GO:0030674;GO:0031267;GO:0006914;GO:0008219;GO:0034620;GO:0050829;GO:0000086;GO:0007030;GO:0090161;GO:0043001;GO:0045087;GO:0043124;GO:0001920;GO:0061734;GO:0010508;GO:1904417;GO:0034067;GO:0043122;GO:0007165;GO:0016032;, C:autophagosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome membrane; C:trans-Golgi network;, F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein C-terminus binding; F:protein-macromolecule adaptor activity; F:small GTPase binding;, P:autophagy; P:cell death; P:cellular response to unfolded protein; P:defense response to Gram-negative bacterium; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:Golgi ribbon formation; P:Golgi to plasma membrane protein transport; P:innate immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of receptor recycling; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of autophagy; P:positive regulation of xenophagy; P:protein localization to Golgi apparatus; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction; P:viral process;|Q8N562 Q9UET9 Q9UEV4 Q9Y218,Optineurin,E3-14.7K-interacting protein;FIP-2;Huntingtin yeast partner L;Huntingtin-interacting protein 7;Huntingtin-interacting protein L;NEMO-related protein;Optic neuropathy-inducing protein;Transcription factor IIIA-interacting protein;, PF16516;PF11577;, GO:0005776;GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0005654;GO:0005634;GO:0048471;GO:0055038;GO:0005802;GO:0042802;GO:0070530;GO:0046872;GO:0031593;GO:0008022;GO:0030674;GO:0031267;GO:0006914;GO:0008219;GO:0034620;GO:0050829;GO:0000086;GO:0007030;GO:0090161;GO:0043001;GO:0045087;GO:0043124;GO:0001920;GO:0061734;GO:0010508;GO:1904417;GO:0034067;GO:0043122;GO:0007165;GO:0016032;, C:autophagosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome membrane; C:trans-Golgi network;, F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein C-terminus binding; F:protein-macromolecule adaptor activity; F:small GTPase binding;, P:autophagy; P:cell death; P:cellular response to unfolded protein; P:defense response to Gram-negative bacterium; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:Golgi ribbon formation; P:Golgi to plasma membrane protein transport; P:innate immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of receptor recycling; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of autophagy; P:positive regulation of xenophagy; P:protein localization to Golgi apparatus; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction; P:viral process; scaffold22 indexed_genome mRNA 16375737 16437899 . - . ID=transcript_5285;Q05329 Q9UD87,Glutamate decarboxylase 2,65 kDa glutamic acid decarboxylase;Glutamate decarboxylase 65 kDa isoform;, PF00282;, GO:0031225;GO:0030424;GO:0061202;GO:0005829;GO:0000139;GO:0060077;GO:0048471;GO:0005886;GO:0042734;GO:0030672;GO:0016595;GO:0004351;GO:0044877;GO:0030170;GO:0007268;GO:0009449;GO:0006540;GO:0042136;GO:0007269;GO:0042493;, C:anchored component of membrane; C:axon; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:cytosol; C:Golgi membrane; C:inhibitory synapse; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynaptic membrane; C:synaptic vesicle membrane;, F:glutamate binding; F:glutamate decarboxylase activity; F:protein-containing complex binding; F:pyridoxal phosphate binding;, P:chemical synaptic transmission; P:gamma-aminobutyric acid biosynthetic process; P:glutamate decarboxylation to succinate; P:neurotransmitter biosynthetic process; P:neurotransmitter secretion; P:response to drug; scaffold22 indexed_genome mRNA 16804563 16808886 . + . ID=transcript_5286;Q5T848 Q6QR81 Q9ULT3,Probable G-protein coupled receptor 158,, PF00003;, GO:0016021;GO:0005886;GO:0004930;GO:0072659;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:protein localization to plasma membrane; scaffold22 indexed_genome mRNA 16809885 17092900 . - . ID=transcript_5287;Q5T848 Q6QR81 Q9ULT3,Probable G-protein coupled receptor 158,, PF00003;, GO:0016021;GO:0005886;GO:0004930;GO:0072659;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:protein localization to plasma membrane;|Q5T848 Q6QR81 Q9ULT3,Probable G-protein coupled receptor 158,, PF00003;, GO:0016021;GO:0005886;GO:0004930;GO:0072659;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:protein localization to plasma membrane; scaffold22 indexed_genome mRNA 17188809 17191921 . + . ID=transcript_5288;Q8IYQ7 B3KWL1 D3DRV3 Q5VV21,Threonine synthase-like 1,, PF01202;PF14821; scaffold22 indexed_genome mRNA 17199754 17230163 . + . ID=transcript_5289;Q8TC29 A8K8Y0 D3DRV2,Enkurin,, PF13864;, GO:0097728;GO:0097729;GO:0001669;GO:0097228;GO:0005516;GO:0017124;GO:0061966;GO:0030317;, C:9+0 motile cilium; C:9+2 motile cilium; C:acrosomal vesicle; C:sperm principal piece;, F:calmodulin binding; F:SH3 domain binding;, P:establishment of left/right asymmetry; P:flagellated sperm motility; scaffold22 indexed_genome mRNA 17257228 17359304 . + . ID=transcript_5290;Q9NRG1 B7Z1Z3 Q53HA7 Q59EL9 Q5VV18 Q5VV20,Phosphoribosyltransferase domain-containing protein 1,, PF00156;, GO:0000287;GO:0000166;GO:0042803;GO:0006166;, , F:magnesium ion binding; F:nucleotide binding; F:protein homodimerization activity;, P:purine ribonucleoside salvage;|Q9NRG1 B7Z1Z3 Q53HA7 Q59EL9 Q5VV18 Q5VV20,Phosphoribosyltransferase domain-containing protein 1,, PF00156;, GO:0000287;GO:0000166;GO:0042803;GO:0006166;, , F:magnesium ion binding; F:nucleotide binding; F:protein homodimerization activity;, P:purine ribonucleoside salvage;|Q9NRG1 B7Z1Z3 Q53HA7 Q59EL9 Q5VV18 Q5VV20,Phosphoribosyltransferase domain-containing protein 1,, PF00156;, GO:0000287;GO:0000166;GO:0042803;GO:0006166;, , F:magnesium ion binding; F:nucleotide binding; F:protein homodimerization activity;, P:purine ribonucleoside salvage;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold22 indexed_genome mRNA 17489679 17573813 . + . ID=transcript_5291;Q5T5U3 Q0VF98 Q7Z3P7 Q8N3A2 Q8NI19 Q8TBV5 Q9P2C3,Rho GTPase-activating protein 21,Rho GTPase-activating protein 10;Rho-type GTPase-activating protein 21;, PF17820;PF00169;PF00620;, GO:0015629;GO:0030054;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0051683;GO:0051645;GO:0007030;GO:0051684;GO:0072384;GO:0051056;GO:0007165;, C:actin cytoskeleton; C:cell junction; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity;, P:establishment of Golgi localization; P:Golgi localization; P:Golgi organization; P:maintenance of Golgi location; P:organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q5T5U3 Q0VF98 Q7Z3P7 Q8N3A2 Q8NI19 Q8TBV5 Q9P2C3,Rho GTPase-activating protein 21,Rho GTPase-activating protein 10;Rho-type GTPase-activating protein 21;, PF17820;PF00169;PF00620;, GO:0015629;GO:0030054;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0051683;GO:0051645;GO:0007030;GO:0051684;GO:0072384;GO:0051056;GO:0007165;, C:actin cytoskeleton; C:cell junction; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity;, P:establishment of Golgi localization; P:Golgi localization; P:Golgi organization; P:maintenance of Golgi location; P:organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q5T5U3 Q0VF98 Q7Z3P7 Q8N3A2 Q8NI19 Q8TBV5 Q9P2C3,Rho GTPase-activating protein 21,Rho GTPase-activating protein 10;Rho-type GTPase-activating protein 21;, PF17820;PF00169;PF00620;, GO:0015629;GO:0030054;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0051683;GO:0051645;GO:0007030;GO:0051684;GO:0072384;GO:0051056;GO:0007165;, C:actin cytoskeleton; C:cell junction; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity;, P:establishment of Golgi localization; P:Golgi localization; P:Golgi organization; P:maintenance of Golgi location; P:organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q5T5U3 Q0VF98 Q7Z3P7 Q8N3A2 Q8NI19 Q8TBV5 Q9P2C3,Rho GTPase-activating protein 21,Rho GTPase-activating protein 10;Rho-type GTPase-activating protein 21;, PF17820;PF00169;PF00620;, GO:0015629;GO:0030054;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0051683;GO:0051645;GO:0007030;GO:0051684;GO:0072384;GO:0051056;GO:0007165;, C:actin cytoskeleton; C:cell junction; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity;, P:establishment of Golgi localization; P:Golgi localization; P:Golgi organization; P:maintenance of Golgi location; P:organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q5T5U3 Q0VF98 Q7Z3P7 Q8N3A2 Q8NI19 Q8TBV5 Q9P2C3,Rho GTPase-activating protein 21,Rho GTPase-activating protein 10;Rho-type GTPase-activating protein 21;, PF17820;PF00169;PF00620;, GO:0015629;GO:0030054;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0051683;GO:0051645;GO:0007030;GO:0051684;GO:0072384;GO:0051056;GO:0007165;, C:actin cytoskeleton; C:cell junction; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity;, P:establishment of Golgi localization; P:Golgi localization; P:Golgi organization; P:maintenance of Golgi location; P:organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q5T5U3 Q0VF98 Q7Z3P7 Q8N3A2 Q8NI19 Q8TBV5 Q9P2C3,Rho GTPase-activating protein 21,Rho GTPase-activating protein 10;Rho-type GTPase-activating protein 21;, PF17820;PF00169;PF00620;, GO:0015629;GO:0030054;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0051683;GO:0051645;GO:0007030;GO:0051684;GO:0072384;GO:0051056;GO:0007165;, C:actin cytoskeleton; C:cell junction; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity;, P:establishment of Golgi localization; P:Golgi localization; P:Golgi organization; P:maintenance of Golgi location; P:organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q5T5U3 Q0VF98 Q7Z3P7 Q8N3A2 Q8NI19 Q8TBV5 Q9P2C3,Rho GTPase-activating protein 21,Rho GTPase-activating protein 10;Rho-type GTPase-activating protein 21;, PF17820;PF00169;PF00620;, GO:0015629;GO:0030054;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0005886;GO:0005096;GO:0051683;GO:0051645;GO:0007030;GO:0051684;GO:0072384;GO:0051056;GO:0007165;, C:actin cytoskeleton; C:cell junction; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTPase activator activity;, P:establishment of Golgi localization; P:Golgi localization; P:Golgi organization; P:maintenance of Golgi location; P:organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold22 indexed_genome mRNA 17612433 18409348 . - . ID=transcript_5292;Q5T7H3 Q6MZZ6 Q6ZUI4 Q8WV45 Q9NSR2 Q9ULK3,Sickle tail protein homolog,, PF03915;, GO:0005737;GO:0030234;GO:0048706;, C:cytoplasm;, F:enzyme regulator activity;, P:embryonic skeletal system development;|Q5T7H3 Q6MZZ6 Q6ZUI4 Q8WV45 Q9NSR2 Q9ULK3,Sickle tail protein homolog,, PF03915;, GO:0005737;GO:0030234;GO:0048706;, C:cytoplasm;, F:enzyme regulator activity;, P:embryonic skeletal system development;|Q5T7H3 Q6MZZ6 Q6ZUI4 Q8WV45 Q9NSR2 Q9ULK3,Sickle tail protein homolog,, PF03915;, GO:0005737;GO:0030234;GO:0048706;, C:cytoplasm;, F:enzyme regulator activity;, P:embryonic skeletal system development; scaffold22 indexed_genome mRNA 18829858 18830390 . + . ID=transcript_5293;P18077 Q08ES9 Q9BVN7,60S ribosomal protein L35a,Cell growth-inhibiting gene 33 protein;Large ribosomal subunit protein eL33 {ECO:0000303|PubMed:24524803};, PF01247;, GO:0005829;GO:0022625;GO:0070062;GO:0016020;GO:0003723;GO:0003735;GO:0000049;GO:0002181;GO:0000184;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:membrane;, F:RNA binding; F:structural constituent of ribosome; F:tRNA binding;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold22 indexed_genome mRNA 18832599 18833615 . - . ID=transcript_5294;Q9Y3D2 Q17R44 Q4G1C7 Q9Y5W6,Methionine-R-sulfoxide reductase B2, mitochondrial,, PF01641;, GO:0005737;GO:0005829;GO:0005739;GO:0003779;GO:0033745;GO:0033743;GO:0008270;GO:0030041;GO:0030091;GO:0006979;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:actin binding; F:L-methionine-(R)-S-oxide reductase activity; F:peptide-methionine (R)-S-oxide reductase activity; F:zinc ion binding;, P:actin filament polymerization; P:protein repair; P:response to oxidative stress; scaffold22 indexed_genome mRNA 18837783 18845382 . - . ID=transcript_5295;Q9Y3D2 Q17R44 Q4G1C7 Q9Y5W6,Methionine-R-sulfoxide reductase B2, mitochondrial,, PF01641;, GO:0005737;GO:0005829;GO:0005739;GO:0003779;GO:0033745;GO:0033743;GO:0008270;GO:0030041;GO:0030091;GO:0006979;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:actin binding; F:L-methionine-(R)-S-oxide reductase activity; F:peptide-methionine (R)-S-oxide reductase activity; F:zinc ion binding;, P:actin filament polymerization; P:protein repair; P:response to oxidative stress; scaffold22 indexed_genome mRNA 18911265 18996506 . - . ID=transcript_5296;Q5W041 A0PG76 A6NH64 B4DZL3 B7ZBN6 B7ZBN7 Q8IXS5 Q8N7B0 Q96M49,Armadillo repeat-containing protein 3,Beta-catenin-like protein;Cancer/testis antigen 81;KU-CT-1;, PF00514;, GO:0070062;, C:extracellular exosome;|Q5W041 A0PG76 A6NH64 B4DZL3 B7ZBN6 B7ZBN7 Q8IXS5 Q8N7B0 Q96M49,Armadillo repeat-containing protein 3,Beta-catenin-like protein;Cancer/testis antigen 81;KU-CT-1;, PF00514;, GO:0070062;, C:extracellular exosome;|Q5W041 A0PG76 A6NH64 B4DZL3 B7ZBN6 B7ZBN7 Q8IXS5 Q8N7B0 Q96M49,Armadillo repeat-containing protein 3,Beta-catenin-like protein;Cancer/testis antigen 81;KU-CT-1;, PF00514;, GO:0070062;, C:extracellular exosome; scaffold22 indexed_genome mRNA 19264965 19351963 . + . ID=transcript_5297;P48426 B0YJ66 B4DGX2 D3DRV1 P53807 Q5VUX3,Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha {ECO:0000305},1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha;Diphosphoinositide kinase 2-alpha;PIP5KIII;Phosphatidylinositol 5-Phosphate 4-Kinase;Phosphatidylinositol 5-phosphate 4-kinase type II alpha;PtdIns(4)P-5-kinase B isoform;PtdIns(4)P-5-kinase C isoform;PtdIns(5)P-4-kinase isoform 2-alpha;, PF01504;, GO:0005776;GO:0005829;GO:0005764;GO:0005654;GO:0001917;GO:0001750;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0042803;GO:1902635;GO:0061909;GO:0035855;GO:0090217;GO:0046627;GO:0006661;GO:0006644;GO:2000786;GO:0010506;GO:0014066;GO:1901796;GO:0090119;, C:autophagosome; C:cytosol; C:lysosome; C:nucleoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:protein homodimerization activity;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:autophagosome-lysosome fusion; P:megakaryocyte development; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phospholipid metabolic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of signal transduction by p53 class mediator; P:vesicle-mediated cholesterol transport; scaffold22 indexed_genome mRNA 19449969 19468714 . - . ID=transcript_5298;O75602 A8K1I8 B4DXZ4 Q5VUX5 Q5VUX6 Q5VUX7 Q6FI74 Q8NHQ6,Sperm-associated antigen 6,Protein PF16 homolog;Repro-SA-1;Sperm flagellar protein;, PF00514;, GO:0005930;GO:0005874;GO:0015630;GO:0005634;GO:0097228;GO:0030030;, C:axoneme; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:sperm principal piece;, , P:cell projection organization; scaffold22 indexed_genome mRNA 19468734 19513049 . - . ID=transcript_5299;O75602 A8K1I8 B4DXZ4 Q5VUX5 Q5VUX6 Q5VUX7 Q6FI74 Q8NHQ6,Sperm-associated antigen 6,Protein PF16 homolog;Repro-SA-1;Sperm flagellar protein;, PF00514;, GO:0005930;GO:0005874;GO:0015630;GO:0005634;GO:0097228;GO:0030030;, C:axoneme; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:sperm principal piece;, , P:cell projection organization; scaffold22 indexed_genome mRNA 19526640 19532875 . - . ID=transcript_5300;P35226 Q16030 Q5T8Z3 Q96F37,Polycomb complex protein BMI-1,Polycomb group RING finger protein 4;RING finger protein 51;, PF16207;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0000151;GO:1990841;GO:0071535;GO:0008270;GO:0006342;GO:0030097;GO:0036353;GO:0070317;GO:0045814;GO:0000122;GO:0048146;GO:0051443;GO:0010468;GO:0007379;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:ubiquitin ligase complex;, F:promoter-specific chromatin binding; F:RING-like zinc finger domain binding; F:zinc ion binding;, P:chromatin silencing; P:hemopoiesis; P:histone H2A-K119 monoubiquitination; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of fibroblast proliferation; P:positive regulation of ubiquitin-protein transferase activity; P:regulation of gene expression; P:segment specification;|P35226 Q16030 Q5T8Z3 Q96F37,Polycomb complex protein BMI-1,Polycomb group RING finger protein 4;RING finger protein 51;, PF16207;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0000151;GO:1990841;GO:0071535;GO:0008270;GO:0006342;GO:0030097;GO:0036353;GO:0070317;GO:0045814;GO:0000122;GO:0048146;GO:0051443;GO:0010468;GO:0007379;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:ubiquitin ligase complex;, F:promoter-specific chromatin binding; F:RING-like zinc finger domain binding; F:zinc ion binding;, P:chromatin silencing; P:hemopoiesis; P:histone H2A-K119 monoubiquitination; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of fibroblast proliferation; P:positive regulation of ubiquitin-protein transferase activity; P:regulation of gene expression; P:segment specification;|P35226 Q16030 Q5T8Z3 Q96F37,Polycomb complex protein BMI-1,Polycomb group RING finger protein 4;RING finger protein 51;, PF16207;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0000151;GO:1990841;GO:0071535;GO:0008270;GO:0006342;GO:0030097;GO:0036353;GO:0070317;GO:0045814;GO:0000122;GO:0048146;GO:0051443;GO:0010468;GO:0007379;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:ubiquitin ligase complex;, F:promoter-specific chromatin binding; F:RING-like zinc finger domain binding; F:zinc ion binding;, P:chromatin silencing; P:hemopoiesis; P:histone H2A-K119 monoubiquitination; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of fibroblast proliferation; P:positive regulation of ubiquitin-protein transferase activity; P:regulation of gene expression; P:segment specification; scaffold22 indexed_genome mRNA 19538474 19542838 . - . ID=transcript_5301;Q9UBI1 D3DRU7 Q5T8Y9,COMM domain-containing protein 3,Protein Bup;Protein PIL;, PF07258;, GO:0005576;GO:1904813;GO:0005634;GO:0043312;GO:0006814;, C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus;, , P:neutrophil degranulation; P:sodium ion transport;|Q9UBI1 D3DRU7 Q5T8Y9,COMM domain-containing protein 3,Protein Bup;Protein PIL;, PF07258;, GO:0005576;GO:1904813;GO:0005634;GO:0043312;GO:0006814;, C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus;, , P:neutrophil degranulation; P:sodium ion transport; scaffold22 indexed_genome mRNA 19798417 19984012 . + . ID=transcript_5302;Q96KC8 B0YIZ8 Q5VX89 Q9H6B8,DnaJ homolog subfamily C member 1,DnaJ protein homolog MTJ1;, PF00226;PF00249;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0031965;GO:0005886;GO:0001671;GO:0051087;GO:0003677;GO:0045861;GO:0006457;GO:0050708;GO:0006417;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear membrane; C:plasma membrane;, F:ATPase activator activity; F:chaperone binding; F:DNA binding;, P:negative regulation of proteolysis; P:protein folding; P:regulation of protein secretion; P:regulation of translation;|Q96KC8 B0YIZ8 Q5VX89 Q9H6B8,DnaJ homolog subfamily C member 1,DnaJ protein homolog MTJ1;, PF00226;PF00249;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0031965;GO:0005886;GO:0001671;GO:0051087;GO:0003677;GO:0045861;GO:0006457;GO:0050708;GO:0006417;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear membrane; C:plasma membrane;, F:ATPase activator activity; F:chaperone binding; F:DNA binding;, P:negative regulation of proteolysis; P:protein folding; P:regulation of protein secretion; P:regulation of translation;|Q96KC8 B0YIZ8 Q5VX89 Q9H6B8,DnaJ homolog subfamily C member 1,DnaJ protein homolog MTJ1;, PF00226;PF00249;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0031965;GO:0005886;GO:0001671;GO:0051087;GO:0003677;GO:0045861;GO:0006457;GO:0050708;GO:0006417;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear membrane; C:plasma membrane;, F:ATPase activator activity; F:chaperone binding; F:DNA binding;, P:negative regulation of proteolysis; P:protein folding; P:regulation of protein secretion; P:regulation of translation;|Q96KC8 B0YIZ8 Q5VX89 Q9H6B8,DnaJ homolog subfamily C member 1,DnaJ protein homolog MTJ1;, PF00226;PF00249;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0031965;GO:0005886;GO:0001671;GO:0051087;GO:0003677;GO:0045861;GO:0006457;GO:0050708;GO:0006417;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear membrane; C:plasma membrane;, F:ATPase activator activity; F:chaperone binding; F:DNA binding;, P:negative regulation of proteolysis; P:protein folding; P:regulation of protein secretion; P:regulation of translation;|Q96KC8 B0YIZ8 Q5VX89 Q9H6B8,DnaJ homolog subfamily C member 1,DnaJ protein homolog MTJ1;, PF00226;PF00249;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0031965;GO:0005886;GO:0001671;GO:0051087;GO:0003677;GO:0045861;GO:0006457;GO:0050708;GO:0006417;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear membrane; C:plasma membrane;, F:ATPase activator activity; F:chaperone binding; F:DNA binding;, P:negative regulation of proteolysis; P:protein folding; P:regulation of protein secretion; P:regulation of translation; scaffold22 indexed_genome mRNA 19996198 20008555 . - . ID=transcript_5303;P55197 B1ANA8 Q5JT37 Q5VX90 Q66K63,Protein AF-10 {ECO:0000305},ALL1-fused gene from chromosome 10 protein;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0046872;GO:0031491;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:metal ion binding; F:nucleosome binding;, P:positive regulation of transcription by RNA polymerase II;|P55197 B1ANA8 Q5JT37 Q5VX90 Q66K63,Protein AF-10 {ECO:0000305},ALL1-fused gene from chromosome 10 protein;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0046872;GO:0031491;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:metal ion binding; F:nucleosome binding;, P:positive regulation of transcription by RNA polymerase II;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|P55197 B1ANA8 Q5JT37 Q5VX90 Q66K63,Protein AF-10 {ECO:0000305},ALL1-fused gene from chromosome 10 protein;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0046872;GO:0031491;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:metal ion binding; F:nucleosome binding;, P:positive regulation of transcription by RNA polymerase II; scaffold22 indexed_genome mRNA 20008638 20143384 . - . ID=transcript_5304;P55197 B1ANA8 Q5JT37 Q5VX90 Q66K63,Protein AF-10 {ECO:0000305},ALL1-fused gene from chromosome 10 protein;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0046872;GO:0031491;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:metal ion binding; F:nucleosome binding;, P:positive regulation of transcription by RNA polymerase II;|P55197 B1ANA8 Q5JT37 Q5VX90 Q66K63,Protein AF-10 {ECO:0000305},ALL1-fused gene from chromosome 10 protein;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0046872;GO:0031491;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:metal ion binding; F:nucleosome binding;, P:positive regulation of transcription by RNA polymerase II;|P55197 B1ANA8 Q5JT37 Q5VX90 Q66K63,Protein AF-10 {ECO:0000305},ALL1-fused gene from chromosome 10 protein;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0046872;GO:0031491;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:metal ion binding; F:nucleosome binding;, P:positive regulation of transcription by RNA polymerase II;|P55197 B1ANA8 Q5JT37 Q5VX90 Q66K63,Protein AF-10 {ECO:0000305},ALL1-fused gene from chromosome 10 protein;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0046872;GO:0031491;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:metal ion binding; F:nucleosome binding;, P:positive regulation of transcription by RNA polymerase II;|P55197 B1ANA8 Q5JT37 Q5VX90 Q66K63,Protein AF-10 {ECO:0000305},ALL1-fused gene from chromosome 10 protein;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0046872;GO:0031491;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:metal ion binding; F:nucleosome binding;, P:positive regulation of transcription by RNA polymerase II;|P55197 B1ANA8 Q5JT37 Q5VX90 Q66K63,Protein AF-10 {ECO:0000305},ALL1-fused gene from chromosome 10 protein;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0046872;GO:0031491;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:metal ion binding; F:nucleosome binding;, P:positive regulation of transcription by RNA polymerase II;|P55197 B1ANA8 Q5JT37 Q5VX90 Q66K63,Protein AF-10 {ECO:0000305},ALL1-fused gene from chromosome 10 protein;, , GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0046872;GO:0031491;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:metal ion binding; F:nucleosome binding;, P:positive regulation of transcription by RNA polymerase II; scaffold22 indexed_genome mRNA 20232469 20234075 . + . ID=transcript_5305;Q1XH10 B1ANA5 E9PAX1 F5H7M0 Q6ZMX4 Q8N3C3,SKI/DACH domain-containing protein 1,Protein DLN-1;, PF15223;PF02437;|Q1XH10 B1ANA5 E9PAX1 F5H7M0 Q6ZMX4 Q8N3C3,SKI/DACH domain-containing protein 1,Protein DLN-1;, PF15223;PF02437; scaffold22 indexed_genome mRNA 20673255 20803713 . + . ID=transcript_5306;O76041 B0YJ45 Q2TBD0 Q70I54 Q9UIC4,Nebulette,Actin-binding Z-disk protein;, PF00880;PF14604;, GO:0070062;GO:0031674;GO:0001725;GO:0030018;GO:0051015;GO:0008092;GO:0031005;GO:0008307;GO:0005523;GO:0071691;GO:0048747;, C:extracellular exosome; C:I band; C:stress fiber; C:Z disc;, F:actin filament binding; F:cytoskeletal protein binding; F:filamin binding; F:structural constituent of muscle; F:tropomyosin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development;|O76041 B0YJ45 Q2TBD0 Q70I54 Q9UIC4,Nebulette,Actin-binding Z-disk protein;, PF00880;PF14604;, GO:0070062;GO:0031674;GO:0001725;GO:0030018;GO:0051015;GO:0008092;GO:0031005;GO:0008307;GO:0005523;GO:0071691;GO:0048747;, C:extracellular exosome; C:I band; C:stress fiber; C:Z disc;, F:actin filament binding; F:cytoskeletal protein binding; F:filamin binding; F:structural constituent of muscle; F:tropomyosin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development; scaffold22 indexed_genome mRNA 20803765 20844751 . + . ID=transcript_5307;O76041 B0YJ45 Q2TBD0 Q70I54 Q9UIC4,Nebulette,Actin-binding Z-disk protein;, PF00880;PF14604;, GO:0070062;GO:0031674;GO:0001725;GO:0030018;GO:0051015;GO:0008092;GO:0031005;GO:0008307;GO:0005523;GO:0071691;GO:0048747;, C:extracellular exosome; C:I band; C:stress fiber; C:Z disc;, F:actin filament binding; F:cytoskeletal protein binding; F:filamin binding; F:structural constituent of muscle; F:tropomyosin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development;|O76041 B0YJ45 Q2TBD0 Q70I54 Q9UIC4,Nebulette,Actin-binding Z-disk protein;, PF00880;PF14604;, GO:0070062;GO:0031674;GO:0001725;GO:0030018;GO:0051015;GO:0008092;GO:0031005;GO:0008307;GO:0005523;GO:0071691;GO:0048747;, C:extracellular exosome; C:I band; C:stress fiber; C:Z disc;, F:actin filament binding; F:cytoskeletal protein binding; F:filamin binding; F:structural constituent of muscle; F:tropomyosin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development;|O76041 B0YJ45 Q2TBD0 Q70I54 Q9UIC4,Nebulette,Actin-binding Z-disk protein;, PF00880;PF14604;, GO:0070062;GO:0031674;GO:0001725;GO:0030018;GO:0051015;GO:0008092;GO:0031005;GO:0008307;GO:0005523;GO:0071691;GO:0048747;, C:extracellular exosome; C:I band; C:stress fiber; C:Z disc;, F:actin filament binding; F:cytoskeletal protein binding; F:filamin binding; F:structural constituent of muscle; F:tropomyosin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development;|O76041 B0YJ45 Q2TBD0 Q70I54 Q9UIC4,Nebulette,Actin-binding Z-disk protein;, PF00880;PF14604;, GO:0070062;GO:0031674;GO:0001725;GO:0030018;GO:0051015;GO:0008092;GO:0031005;GO:0008307;GO:0005523;GO:0071691;GO:0048747;, C:extracellular exosome; C:I band; C:stress fiber; C:Z disc;, F:actin filament binding; F:cytoskeletal protein binding; F:filamin binding; F:structural constituent of muscle; F:tropomyosin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development;|O76041 B0YJ45 Q2TBD0 Q70I54 Q9UIC4,Nebulette,Actin-binding Z-disk protein;, PF00880;PF14604;, GO:0070062;GO:0031674;GO:0001725;GO:0030018;GO:0051015;GO:0008092;GO:0031005;GO:0008307;GO:0005523;GO:0071691;GO:0048747;, C:extracellular exosome; C:I band; C:stress fiber; C:Z disc;, F:actin filament binding; F:cytoskeletal protein binding; F:filamin binding; F:structural constituent of muscle; F:tropomyosin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development;|O76041 B0YJ45 Q2TBD0 Q70I54 Q9UIC4,Nebulette,Actin-binding Z-disk protein;, PF00880;PF14604;, GO:0070062;GO:0031674;GO:0001725;GO:0030018;GO:0051015;GO:0008092;GO:0031005;GO:0008307;GO:0005523;GO:0071691;GO:0048747;, C:extracellular exosome; C:I band; C:stress fiber; C:Z disc;, F:actin filament binding; F:cytoskeletal protein binding; F:filamin binding; F:structural constituent of muscle; F:tropomyosin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development;|O76041 B0YJ45 Q2TBD0 Q70I54 Q9UIC4,Nebulette,Actin-binding Z-disk protein;, PF00880;PF14604;, GO:0070062;GO:0031674;GO:0001725;GO:0030018;GO:0051015;GO:0008092;GO:0031005;GO:0008307;GO:0005523;GO:0071691;GO:0048747;, C:extracellular exosome; C:I band; C:stress fiber; C:Z disc;, F:actin filament binding; F:cytoskeletal protein binding; F:filamin binding; F:structural constituent of muscle; F:tropomyosin binding;, P:cardiac muscle thin filament assembly; P:muscle fiber development; scaffold22 indexed_genome mRNA 21190131 21599173 . - . ID=transcript_5308;Q6UX71 Q96E59 Q96PD9 Q96SU9,Plexin domain-containing protein 2,Tumor endothelial marker 7-related protein;, PF01437;, GO:0016021;, C:integral component of membrane; scaffold22 indexed_genome mRNA 22509594 22534524 . - . ID=transcript_5309;Q96KC2,ADP-ribosylation factor-like protein 5B,ADP-ribosylation factor-like protein 8;, PF00025;, GO:0005802;GO:0005525;GO:0006886;GO:1903292;GO:0016192;, C:trans-Golgi network;, F:GTP binding;, P:intracellular protein transport; P:protein localization to Golgi membrane; P:vesicle-mediated transport; scaffold22 indexed_genome mRNA 22838094 22866848 . - . ID=transcript_5310;Q13090 Q13091 Q13212 Q14622 Q14647 Q29RW2 Q7Z3V1 Q8WUM6,Integrin beta-1 {ECO:0000305},Fibronectin receptor subunit beta;Glycoprotein IIa;VLA-4 subunit beta;, PF07974;PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0032154;GO:0005737;GO:0010008;GO:0070062;GO:0030175;GO:0005925;GO:0097386;GO:0034665;GO:0034680;GO:0034681;GO:0034666;GO:0034667;GO:0034668;GO:0034674;GO:0034678;GO:0030027;GO:0042470;GO:0016020;GO:0045121;GO:0031594;GO:0005886;GO:0043235;GO:0055037;GO:0001726;GO:0032587;GO:0042383;GO:0003779;GO:0045296;GO:0050839;GO:0098639;GO:0015026;GO:0001968;GO:0005178;GO:0046872;GO:0002020;GO:0046982;GO:1990782;GO:0044877;GO:0001618;GO:0030183;GO:0007161;GO:0023035;GO:0007155;GO:0033627;GO:0016477;GO:0030030;GO:0033631;GO:0007160;GO:0031589;GO:0006968;GO:0071404;GO:0019221;GO:0000132;GO:0030198;GO:0034113;GO:0007156;GO:0007229;GO:0030032;GO:0007159;GO:0050900;GO:0050901;GO:0035633;GO:0048333;GO:2000811;GO:0006909;GO:0045766;GO:0043065;GO:0030335;GO:0010763;GO:0051951;GO:0043547;GO:0051897;GO:1903078;GO:2000273;GO:0090303;GO:0150103;GO:0031623;GO:0010710;GO:0050776;GO:1901979;GO:0150003;GO:0046718;GO:0019058;, C:cell surface; C:cleavage furrow; C:cytoplasm; C:endosome membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:glial cell projection; C:integrin alpha1-beta1 complex; C:integrin alpha10-beta1 complex; C:integrin alpha11-beta1 complex; C:integrin alpha2-beta1 complex; C:integrin alpha3-beta1 complex; C:integrin alpha4-beta1 complex; C:integrin alpha5-beta1 complex; C:integrin alpha8-beta1 complex; C:lamellipodium; C:melanosome; C:membrane; C:membrane raft; C:neuromuscular junction; C:plasma membrane; C:receptor complex; C:recycling endosome; C:ruffle; C:ruffle membrane; C:sarcolemma;, F:actin binding; F:cadherin binding; F:cell adhesion molecule binding; F:collagen binding involved in cell-matrix adhesion; F:coreceptor activity; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:protease binding; F:protein heterodimerization activity; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:virus receptor activity;, P:B cell differentiation; P:calcium-independent cell-matrix adhesion; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell projection organization; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-substrate adhesion; P:cellular defense response; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:establishment of mitotic spindle orientation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:integrin-mediated signaling pathway; P:lamellipodium assembly; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:maintenance of blood-brain barrier; P:mesodermal cell differentiation; P:negative regulation of anoikis; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of fibroblast migration; P:positive regulation of glutamate uptake involved in transmission of nerve impulse; P:positive regulation of GTPase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of signaling receptor activity; P:positive regulation of wound healing; P:reactive gliosis; P:receptor internalization; P:regulation of collagen catabolic process; P:regulation of immune response; P:regulation of inward rectifier potassium channel activity; P:regulation of spontaneous synaptic transmission; P:viral entry into host cell; P:viral life cycle;|Q13090 Q13091 Q13212 Q14622 Q14647 Q29RW2 Q7Z3V1 Q8WUM6,Integrin beta-1 {ECO:0000305},Fibronectin receptor subunit beta;Glycoprotein IIa;VLA-4 subunit beta;, PF07974;PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0032154;GO:0005737;GO:0010008;GO:0070062;GO:0030175;GO:0005925;GO:0097386;GO:0034665;GO:0034680;GO:0034681;GO:0034666;GO:0034667;GO:0034668;GO:0034674;GO:0034678;GO:0030027;GO:0042470;GO:0016020;GO:0045121;GO:0031594;GO:0005886;GO:0043235;GO:0055037;GO:0001726;GO:0032587;GO:0042383;GO:0003779;GO:0045296;GO:0050839;GO:0098639;GO:0015026;GO:0001968;GO:0005178;GO:0046872;GO:0002020;GO:0046982;GO:1990782;GO:0044877;GO:0001618;GO:0030183;GO:0007161;GO:0023035;GO:0007155;GO:0033627;GO:0016477;GO:0030030;GO:0033631;GO:0007160;GO:0031589;GO:0006968;GO:0071404;GO:0019221;GO:0000132;GO:0030198;GO:0034113;GO:0007156;GO:0007229;GO:0030032;GO:0007159;GO:0050900;GO:0050901;GO:0035633;GO:0048333;GO:2000811;GO:0006909;GO:0045766;GO:0043065;GO:0030335;GO:0010763;GO:0051951;GO:0043547;GO:0051897;GO:1903078;GO:2000273;GO:0090303;GO:0150103;GO:0031623;GO:0010710;GO:0050776;GO:1901979;GO:0150003;GO:0046718;GO:0019058;, C:cell surface; C:cleavage furrow; C:cytoplasm; C:endosome membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:glial cell projection; C:integrin alpha1-beta1 complex; C:integrin alpha10-beta1 complex; C:integrin alpha11-beta1 complex; C:integrin alpha2-beta1 complex; C:integrin alpha3-beta1 complex; C:integrin alpha4-beta1 complex; C:integrin alpha5-beta1 complex; C:integrin alpha8-beta1 complex; C:lamellipodium; C:melanosome; C:membrane; C:membrane raft; C:neuromuscular junction; C:plasma membrane; C:receptor complex; C:recycling endosome; C:ruffle; C:ruffle membrane; C:sarcolemma;, F:actin binding; F:cadherin binding; F:cell adhesion molecule binding; F:collagen binding involved in cell-matrix adhesion; F:coreceptor activity; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:protease binding; F:protein heterodimerization activity; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:virus receptor activity;, P:B cell differentiation; P:calcium-independent cell-matrix adhesion; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell projection organization; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-substrate adhesion; P:cellular defense response; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:establishment of mitotic spindle orientation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:integrin-mediated signaling pathway; P:lamellipodium assembly; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:maintenance of blood-brain barrier; P:mesodermal cell differentiation; P:negative regulation of anoikis; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of fibroblast migration; P:positive regulation of glutamate uptake involved in transmission of nerve impulse; P:positive regulation of GTPase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of signaling receptor activity; P:positive regulation of wound healing; P:reactive gliosis; P:receptor internalization; P:regulation of collagen catabolic process; P:regulation of immune response; P:regulation of inward rectifier potassium channel activity; P:regulation of spontaneous synaptic transmission; P:viral entry into host cell; P:viral life cycle;|Q13090 Q13091 Q13212 Q14622 Q14647 Q29RW2 Q7Z3V1 Q8WUM6,Integrin beta-1 {ECO:0000305},Fibronectin receptor subunit beta;Glycoprotein IIa;VLA-4 subunit beta;, PF07974;PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0032154;GO:0005737;GO:0010008;GO:0070062;GO:0030175;GO:0005925;GO:0097386;GO:0034665;GO:0034680;GO:0034681;GO:0034666;GO:0034667;GO:0034668;GO:0034674;GO:0034678;GO:0030027;GO:0042470;GO:0016020;GO:0045121;GO:0031594;GO:0005886;GO:0043235;GO:0055037;GO:0001726;GO:0032587;GO:0042383;GO:0003779;GO:0045296;GO:0050839;GO:0098639;GO:0015026;GO:0001968;GO:0005178;GO:0046872;GO:0002020;GO:0046982;GO:1990782;GO:0044877;GO:0001618;GO:0030183;GO:0007161;GO:0023035;GO:0007155;GO:0033627;GO:0016477;GO:0030030;GO:0033631;GO:0007160;GO:0031589;GO:0006968;GO:0071404;GO:0019221;GO:0000132;GO:0030198;GO:0034113;GO:0007156;GO:0007229;GO:0030032;GO:0007159;GO:0050900;GO:0050901;GO:0035633;GO:0048333;GO:2000811;GO:0006909;GO:0045766;GO:0043065;GO:0030335;GO:0010763;GO:0051951;GO:0043547;GO:0051897;GO:1903078;GO:2000273;GO:0090303;GO:0150103;GO:0031623;GO:0010710;GO:0050776;GO:1901979;GO:0150003;GO:0046718;GO:0019058;, C:cell surface; C:cleavage furrow; C:cytoplasm; C:endosome membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:glial cell projection; C:integrin alpha1-beta1 complex; C:integrin alpha10-beta1 complex; C:integrin alpha11-beta1 complex; C:integrin alpha2-beta1 complex; C:integrin alpha3-beta1 complex; C:integrin alpha4-beta1 complex; C:integrin alpha5-beta1 complex; C:integrin alpha8-beta1 complex; C:lamellipodium; C:melanosome; C:membrane; C:membrane raft; C:neuromuscular junction; C:plasma membrane; C:receptor complex; C:recycling endosome; C:ruffle; C:ruffle membrane; C:sarcolemma;, F:actin binding; F:cadherin binding; F:cell adhesion molecule binding; F:collagen binding involved in cell-matrix adhesion; F:coreceptor activity; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:protease binding; F:protein heterodimerization activity; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:virus receptor activity;, P:B cell differentiation; P:calcium-independent cell-matrix adhesion; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell projection organization; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-substrate adhesion; P:cellular defense response; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:establishment of mitotic spindle orientation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:integrin-mediated signaling pathway; P:lamellipodium assembly; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:maintenance of blood-brain barrier; P:mesodermal cell differentiation; P:negative regulation of anoikis; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of fibroblast migration; P:positive regulation of glutamate uptake involved in transmission of nerve impulse; P:positive regulation of GTPase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of signaling receptor activity; P:positive regulation of wound healing; P:reactive gliosis; P:receptor internalization; P:regulation of collagen catabolic process; P:regulation of immune response; P:regulation of inward rectifier potassium channel activity; P:regulation of spontaneous synaptic transmission; P:viral entry into host cell; P:viral life cycle;|Q13090 Q13091 Q13212 Q14622 Q14647 Q29RW2 Q7Z3V1 Q8WUM6,Integrin beta-1 {ECO:0000305},Fibronectin receptor subunit beta;Glycoprotein IIa;VLA-4 subunit beta;, PF07974;PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0032154;GO:0005737;GO:0010008;GO:0070062;GO:0030175;GO:0005925;GO:0097386;GO:0034665;GO:0034680;GO:0034681;GO:0034666;GO:0034667;GO:0034668;GO:0034674;GO:0034678;GO:0030027;GO:0042470;GO:0016020;GO:0045121;GO:0031594;GO:0005886;GO:0043235;GO:0055037;GO:0001726;GO:0032587;GO:0042383;GO:0003779;GO:0045296;GO:0050839;GO:0098639;GO:0015026;GO:0001968;GO:0005178;GO:0046872;GO:0002020;GO:0046982;GO:1990782;GO:0044877;GO:0001618;GO:0030183;GO:0007161;GO:0023035;GO:0007155;GO:0033627;GO:0016477;GO:0030030;GO:0033631;GO:0007160;GO:0031589;GO:0006968;GO:0071404;GO:0019221;GO:0000132;GO:0030198;GO:0034113;GO:0007156;GO:0007229;GO:0030032;GO:0007159;GO:0050900;GO:0050901;GO:0035633;GO:0048333;GO:2000811;GO:0006909;GO:0045766;GO:0043065;GO:0030335;GO:0010763;GO:0051951;GO:0043547;GO:0051897;GO:1903078;GO:2000273;GO:0090303;GO:0150103;GO:0031623;GO:0010710;GO:0050776;GO:1901979;GO:0150003;GO:0046718;GO:0019058;, C:cell surface; C:cleavage furrow; C:cytoplasm; C:endosome membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:glial cell projection; C:integrin alpha1-beta1 complex; C:integrin alpha10-beta1 complex; C:integrin alpha11-beta1 complex; C:integrin alpha2-beta1 complex; C:integrin alpha3-beta1 complex; C:integrin alpha4-beta1 complex; C:integrin alpha5-beta1 complex; C:integrin alpha8-beta1 complex; C:lamellipodium; C:melanosome; C:membrane; C:membrane raft; C:neuromuscular junction; C:plasma membrane; C:receptor complex; C:recycling endosome; C:ruffle; C:ruffle membrane; C:sarcolemma;, F:actin binding; F:cadherin binding; F:cell adhesion molecule binding; F:collagen binding involved in cell-matrix adhesion; F:coreceptor activity; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:protease binding; F:protein heterodimerization activity; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:virus receptor activity;, P:B cell differentiation; P:calcium-independent cell-matrix adhesion; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell projection organization; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-substrate adhesion; P:cellular defense response; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:establishment of mitotic spindle orientation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:integrin-mediated signaling pathway; P:lamellipodium assembly; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:maintenance of blood-brain barrier; P:mesodermal cell differentiation; P:negative regulation of anoikis; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of fibroblast migration; P:positive regulation of glutamate uptake involved in transmission of nerve impulse; P:positive regulation of GTPase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of signaling receptor activity; P:positive regulation of wound healing; P:reactive gliosis; P:receptor internalization; P:regulation of collagen catabolic process; P:regulation of immune response; P:regulation of inward rectifier potassium channel activity; P:regulation of spontaneous synaptic transmission; P:viral entry into host cell; P:viral life cycle;|Q13090 Q13091 Q13212 Q14622 Q14647 Q29RW2 Q7Z3V1 Q8WUM6,Integrin beta-1 {ECO:0000305},Fibronectin receptor subunit beta;Glycoprotein IIa;VLA-4 subunit beta;, PF07974;PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0032154;GO:0005737;GO:0010008;GO:0070062;GO:0030175;GO:0005925;GO:0097386;GO:0034665;GO:0034680;GO:0034681;GO:0034666;GO:0034667;GO:0034668;GO:0034674;GO:0034678;GO:0030027;GO:0042470;GO:0016020;GO:0045121;GO:0031594;GO:0005886;GO:0043235;GO:0055037;GO:0001726;GO:0032587;GO:0042383;GO:0003779;GO:0045296;GO:0050839;GO:0098639;GO:0015026;GO:0001968;GO:0005178;GO:0046872;GO:0002020;GO:0046982;GO:1990782;GO:0044877;GO:0001618;GO:0030183;GO:0007161;GO:0023035;GO:0007155;GO:0033627;GO:0016477;GO:0030030;GO:0033631;GO:0007160;GO:0031589;GO:0006968;GO:0071404;GO:0019221;GO:0000132;GO:0030198;GO:0034113;GO:0007156;GO:0007229;GO:0030032;GO:0007159;GO:0050900;GO:0050901;GO:0035633;GO:0048333;GO:2000811;GO:0006909;GO:0045766;GO:0043065;GO:0030335;GO:0010763;GO:0051951;GO:0043547;GO:0051897;GO:1903078;GO:2000273;GO:0090303;GO:0150103;GO:0031623;GO:0010710;GO:0050776;GO:1901979;GO:0150003;GO:0046718;GO:0019058;, C:cell surface; C:cleavage furrow; C:cytoplasm; C:endosome membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:glial cell projection; C:integrin alpha1-beta1 complex; C:integrin alpha10-beta1 complex; C:integrin alpha11-beta1 complex; C:integrin alpha2-beta1 complex; C:integrin alpha3-beta1 complex; C:integrin alpha4-beta1 complex; C:integrin alpha5-beta1 complex; C:integrin alpha8-beta1 complex; C:lamellipodium; C:melanosome; C:membrane; C:membrane raft; C:neuromuscular junction; C:plasma membrane; C:receptor complex; C:recycling endosome; C:ruffle; C:ruffle membrane; C:sarcolemma;, F:actin binding; F:cadherin binding; F:cell adhesion molecule binding; F:collagen binding involved in cell-matrix adhesion; F:coreceptor activity; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:protease binding; F:protein heterodimerization activity; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:virus receptor activity;, P:B cell differentiation; P:calcium-independent cell-matrix adhesion; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell projection organization; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-substrate adhesion; P:cellular defense response; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:establishment of mitotic spindle orientation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:integrin-mediated signaling pathway; P:lamellipodium assembly; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:maintenance of blood-brain barrier; P:mesodermal cell differentiation; P:negative regulation of anoikis; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of fibroblast migration; P:positive regulation of glutamate uptake involved in transmission of nerve impulse; P:positive regulation of GTPase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of signaling receptor activity; P:positive regulation of wound healing; P:reactive gliosis; P:receptor internalization; P:regulation of collagen catabolic process; P:regulation of immune response; P:regulation of inward rectifier potassium channel activity; P:regulation of spontaneous synaptic transmission; P:viral entry into host cell; P:viral life cycle;|Q13090 Q13091 Q13212 Q14622 Q14647 Q29RW2 Q7Z3V1 Q8WUM6,Integrin beta-1 {ECO:0000305},Fibronectin receptor subunit beta;Glycoprotein IIa;VLA-4 subunit beta;, PF07974;PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0032154;GO:0005737;GO:0010008;GO:0070062;GO:0030175;GO:0005925;GO:0097386;GO:0034665;GO:0034680;GO:0034681;GO:0034666;GO:0034667;GO:0034668;GO:0034674;GO:0034678;GO:0030027;GO:0042470;GO:0016020;GO:0045121;GO:0031594;GO:0005886;GO:0043235;GO:0055037;GO:0001726;GO:0032587;GO:0042383;GO:0003779;GO:0045296;GO:0050839;GO:0098639;GO:0015026;GO:0001968;GO:0005178;GO:0046872;GO:0002020;GO:0046982;GO:1990782;GO:0044877;GO:0001618;GO:0030183;GO:0007161;GO:0023035;GO:0007155;GO:0033627;GO:0016477;GO:0030030;GO:0033631;GO:0007160;GO:0031589;GO:0006968;GO:0071404;GO:0019221;GO:0000132;GO:0030198;GO:0034113;GO:0007156;GO:0007229;GO:0030032;GO:0007159;GO:0050900;GO:0050901;GO:0035633;GO:0048333;GO:2000811;GO:0006909;GO:0045766;GO:0043065;GO:0030335;GO:0010763;GO:0051951;GO:0043547;GO:0051897;GO:1903078;GO:2000273;GO:0090303;GO:0150103;GO:0031623;GO:0010710;GO:0050776;GO:1901979;GO:0150003;GO:0046718;GO:0019058;, C:cell surface; C:cleavage furrow; C:cytoplasm; C:endosome membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:glial cell projection; C:integrin alpha1-beta1 complex; C:integrin alpha10-beta1 complex; C:integrin alpha11-beta1 complex; C:integrin alpha2-beta1 complex; C:integrin alpha3-beta1 complex; C:integrin alpha4-beta1 complex; C:integrin alpha5-beta1 complex; C:integrin alpha8-beta1 complex; C:lamellipodium; C:melanosome; C:membrane; C:membrane raft; C:neuromuscular junction; C:plasma membrane; C:receptor complex; C:recycling endosome; C:ruffle; C:ruffle membrane; C:sarcolemma;, F:actin binding; F:cadherin binding; F:cell adhesion molecule binding; F:collagen binding involved in cell-matrix adhesion; F:coreceptor activity; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:protease binding; F:protein heterodimerization activity; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:virus receptor activity;, P:B cell differentiation; P:calcium-independent cell-matrix adhesion; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell projection organization; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-substrate adhesion; P:cellular defense response; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:establishment of mitotic spindle orientation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:integrin-mediated signaling pathway; P:lamellipodium assembly; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:maintenance of blood-brain barrier; P:mesodermal cell differentiation; P:negative regulation of anoikis; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of fibroblast migration; P:positive regulation of glutamate uptake involved in transmission of nerve impulse; P:positive regulation of GTPase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of signaling receptor activity; P:positive regulation of wound healing; P:reactive gliosis; P:receptor internalization; P:regulation of collagen catabolic process; P:regulation of immune response; P:regulation of inward rectifier potassium channel activity; P:regulation of spontaneous synaptic transmission; P:viral entry into host cell; P:viral life cycle;|Q13090 Q13091 Q13212 Q14622 Q14647 Q29RW2 Q7Z3V1 Q8WUM6,Integrin beta-1 {ECO:0000305},Fibronectin receptor subunit beta;Glycoprotein IIa;VLA-4 subunit beta;, PF07974;PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0032154;GO:0005737;GO:0010008;GO:0070062;GO:0030175;GO:0005925;GO:0097386;GO:0034665;GO:0034680;GO:0034681;GO:0034666;GO:0034667;GO:0034668;GO:0034674;GO:0034678;GO:0030027;GO:0042470;GO:0016020;GO:0045121;GO:0031594;GO:0005886;GO:0043235;GO:0055037;GO:0001726;GO:0032587;GO:0042383;GO:0003779;GO:0045296;GO:0050839;GO:0098639;GO:0015026;GO:0001968;GO:0005178;GO:0046872;GO:0002020;GO:0046982;GO:1990782;GO:0044877;GO:0001618;GO:0030183;GO:0007161;GO:0023035;GO:0007155;GO:0033627;GO:0016477;GO:0030030;GO:0033631;GO:0007160;GO:0031589;GO:0006968;GO:0071404;GO:0019221;GO:0000132;GO:0030198;GO:0034113;GO:0007156;GO:0007229;GO:0030032;GO:0007159;GO:0050900;GO:0050901;GO:0035633;GO:0048333;GO:2000811;GO:0006909;GO:0045766;GO:0043065;GO:0030335;GO:0010763;GO:0051951;GO:0043547;GO:0051897;GO:1903078;GO:2000273;GO:0090303;GO:0150103;GO:0031623;GO:0010710;GO:0050776;GO:1901979;GO:0150003;GO:0046718;GO:0019058;, C:cell surface; C:cleavage furrow; C:cytoplasm; C:endosome membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:glial cell projection; C:integrin alpha1-beta1 complex; C:integrin alpha10-beta1 complex; C:integrin alpha11-beta1 complex; C:integrin alpha2-beta1 complex; C:integrin alpha3-beta1 complex; C:integrin alpha4-beta1 complex; C:integrin alpha5-beta1 complex; C:integrin alpha8-beta1 complex; C:lamellipodium; C:melanosome; C:membrane; C:membrane raft; C:neuromuscular junction; C:plasma membrane; C:receptor complex; C:recycling endosome; C:ruffle; C:ruffle membrane; C:sarcolemma;, F:actin binding; F:cadherin binding; F:cell adhesion molecule binding; F:collagen binding involved in cell-matrix adhesion; F:coreceptor activity; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:protease binding; F:protein heterodimerization activity; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:virus receptor activity;, P:B cell differentiation; P:calcium-independent cell-matrix adhesion; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell projection organization; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-substrate adhesion; P:cellular defense response; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:establishment of mitotic spindle orientation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:integrin-mediated signaling pathway; P:lamellipodium assembly; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:maintenance of blood-brain barrier; P:mesodermal cell differentiation; P:negative regulation of anoikis; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of fibroblast migration; P:positive regulation of glutamate uptake involved in transmission of nerve impulse; P:positive regulation of GTPase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of signaling receptor activity; P:positive regulation of wound healing; P:reactive gliosis; P:receptor internalization; P:regulation of collagen catabolic process; P:regulation of immune response; P:regulation of inward rectifier potassium channel activity; P:regulation of spontaneous synaptic transmission; P:viral entry into host cell; P:viral life cycle;|Q13090 Q13091 Q13212 Q14622 Q14647 Q29RW2 Q7Z3V1 Q8WUM6,Integrin beta-1 {ECO:0000305},Fibronectin receptor subunit beta;Glycoprotein IIa;VLA-4 subunit beta;, PF07974;PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0032154;GO:0005737;GO:0010008;GO:0070062;GO:0030175;GO:0005925;GO:0097386;GO:0034665;GO:0034680;GO:0034681;GO:0034666;GO:0034667;GO:0034668;GO:0034674;GO:0034678;GO:0030027;GO:0042470;GO:0016020;GO:0045121;GO:0031594;GO:0005886;GO:0043235;GO:0055037;GO:0001726;GO:0032587;GO:0042383;GO:0003779;GO:0045296;GO:0050839;GO:0098639;GO:0015026;GO:0001968;GO:0005178;GO:0046872;GO:0002020;GO:0046982;GO:1990782;GO:0044877;GO:0001618;GO:0030183;GO:0007161;GO:0023035;GO:0007155;GO:0033627;GO:0016477;GO:0030030;GO:0033631;GO:0007160;GO:0031589;GO:0006968;GO:0071404;GO:0019221;GO:0000132;GO:0030198;GO:0034113;GO:0007156;GO:0007229;GO:0030032;GO:0007159;GO:0050900;GO:0050901;GO:0035633;GO:0048333;GO:2000811;GO:0006909;GO:0045766;GO:0043065;GO:0030335;GO:0010763;GO:0051951;GO:0043547;GO:0051897;GO:1903078;GO:2000273;GO:0090303;GO:0150103;GO:0031623;GO:0010710;GO:0050776;GO:1901979;GO:0150003;GO:0046718;GO:0019058;, C:cell surface; C:cleavage furrow; C:cytoplasm; C:endosome membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:glial cell projection; C:integrin alpha1-beta1 complex; C:integrin alpha10-beta1 complex; C:integrin alpha11-beta1 complex; C:integrin alpha2-beta1 complex; C:integrin alpha3-beta1 complex; C:integrin alpha4-beta1 complex; C:integrin alpha5-beta1 complex; C:integrin alpha8-beta1 complex; C:lamellipodium; C:melanosome; C:membrane; C:membrane raft; C:neuromuscular junction; C:plasma membrane; C:receptor complex; C:recycling endosome; C:ruffle; C:ruffle membrane; C:sarcolemma;, F:actin binding; F:cadherin binding; F:cell adhesion molecule binding; F:collagen binding involved in cell-matrix adhesion; F:coreceptor activity; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:protease binding; F:protein heterodimerization activity; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:virus receptor activity;, P:B cell differentiation; P:calcium-independent cell-matrix adhesion; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell projection organization; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-substrate adhesion; P:cellular defense response; P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:establishment of mitotic spindle orientation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:integrin-mediated signaling pathway; P:lamellipodium assembly; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:maintenance of blood-brain barrier; P:mesodermal cell differentiation; P:negative regulation of anoikis; P:phagocytosis; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of fibroblast migration; P:positive regulation of glutamate uptake involved in transmission of nerve impulse; P:positive regulation of GTPase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of signaling receptor activity; P:positive regulation of wound healing; P:reactive gliosis; P:receptor internalization; P:regulation of collagen catabolic process; P:regulation of immune response; P:regulation of inward rectifier potassium channel activity; P:regulation of spontaneous synaptic transmission; P:viral entry into host cell; P:viral life cycle; scaffold22 indexed_genome mRNA 23060829 23205457 . - . ID=transcript_5311;O14786 B0LPG9 O60461 Q5T7F1 Q5T7F2 Q5T7F3 Q86T59 Q96I90 Q96IH5,Neuropilin-1 {ECO:0000305},Vascular endothelial cell growth factor 165 receptor;, PF00431;PF11980;PF00754;PF00629;, GO:0030424;GO:0009986;GO:0031410;GO:0005829;GO:0005769;GO:0005615;GO:0005925;GO:0030426;GO:0016021;GO:0031966;GO:0043005;GO:0043025;GO:0005886;GO:0043235;GO:0002116;GO:0097443;GO:0015026;GO:0019955;GO:0019838;GO:0005096;GO:0008201;GO:0046872;GO:0017154;GO:0038085;GO:0005021;GO:0031532;GO:0001525;GO:0060978;GO:0009887;GO:0048844;GO:0048846;GO:0007411;GO:0060385;GO:0150020;GO:0150018;GO:0001569;GO:0002042;GO:0007267;GO:0035729;GO:0035924;GO:0071679;GO:0035767;GO:0043542;GO:0097102;GO:0048012;GO:0007229;GO:0097475;GO:0048843;GO:0021675;GO:1901166;GO:0001764;GO:0038189;GO:0003148;GO:0048008;GO:0050918;GO:2000251;GO:0048842;GO:0060301;GO:0010595;GO:0001938;GO:0070374;GO:0051491;GO:0051894;GO:0050731;GO:0042327;GO:1902336;GO:0014911;GO:0051496;GO:1900026;GO:1902946;GO:0032489;GO:0090259;GO:0060627;GO:0009611;GO:0061299;GO:0031290;GO:0071526;GO:1902285;GO:0007165;GO:0002040;GO:0034446;GO:0006930;GO:0061549;GO:0097490;GO:0097491;GO:0048010;GO:0038190;GO:0046718;, C:axon; C:cell surface; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:extracellular space; C:focal adhesion; C:growth cone; C:integral component of membrane; C:mitochondrial membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:receptor complex; C:semaphorin receptor complex; C:sorting endosome;, F:coreceptor activity; F:cytokine binding; F:growth factor binding; F:GTPase activator activity; F:heparin binding; F:metal ion binding; F:semaphorin receptor activity; F:vascular endothelial growth factor binding; F:vascular endothelial growth factor-activated receptor activity;, P:actin cytoskeleton reorganization; P:angiogenesis; P:angiogenesis involved in coronary vascular morphogenesis; P:animal organ morphogenesis; P:artery morphogenesis; P:axon extension involved in axon guidance; P:axon guidance; P:axonogenesis involved in innervation; P:basal dendrite arborization; P:basal dendrite development; P:branching involved in blood vessel morphogenesis; P:cell migration involved in sprouting angiogenesis; P:cell-cell signaling; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:commissural neuron axon guidance; P:endothelial cell chemotaxis; P:endothelial cell migration; P:endothelial tip cell fate specification; P:hepatocyte growth factor receptor signaling pathway; P:integrin-mediated signaling pathway; P:motor neuron migration; P:negative regulation of axon extension involved in axon guidance; P:nerve development; P:neural crest cell migration involved in autonomic nervous system development; P:neuron migration; P:neuropilin signaling pathway; P:outflow tract septum morphogenesis; P:platelet-derived growth factor receptor signaling pathway; P:positive chemotaxis; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of cytokine activity; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of filopodium assembly; P:positive regulation of focal adhesion assembly; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphorylation; P:positive regulation of retinal ganglion cell axon guidance; P:positive regulation of smooth muscle cell migration; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to early endosome; P:regulation of Cdc42 protein signal transduction; P:regulation of retinal ganglion cell axon guidance; P:regulation of vesicle-mediated transport; P:response to wounding; P:retina vasculature morphogenesis in camera-type eye; P:retinal ganglion cell axon guidance; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:substrate-dependent cell migration, cell extension; P:sympathetic ganglion development; P:sympathetic neuron projection extension; P:sympathetic neuron projection guidance; P:vascular endothelial growth factor receptor signaling pathway; P:VEGF-activated neuropilin signaling pathway; P:viral entry into host cell; scaffold22 indexed_genome mRNA 23773471 23982971 . - . ID=transcript_5312;Q9BY57 Q9BY58 Q9HC48 Q9NWL4 Q9NYE6,Partitioning defective 3 homolog,Atypical PKC isotype-specific-interacting protein;CTCL tumor antigen se2-5;PAR3-alpha;, PF12053;PF00595;, GO:0005912;GO:0043296;GO:0016324;GO:0044295;GO:0005923;GO:0005938;GO:0030054;GO:0005911;GO:0005856;GO:0005829;GO:0012505;GO:0033269;GO:0043025;GO:0005886;GO:0032991;GO:0042802;GO:0035091;GO:0005547;GO:0032266;GO:0005546;GO:0019903;GO:0008356;GO:0007409;GO:0070830;GO:0007155;GO:0007049;GO:0030010;GO:0051660;GO:0090162;GO:0007163;GO:0045197;GO:0000226;GO:0022011;GO:0010801;GO:0031643;GO:0007205;GO:0008104;GO:0006612;GO:0065003;GO:0060341;GO:0007179;, C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:axonal growth cone; C:bicellular tight junction; C:cell cortex; C:cell junction; C:cell-cell junction; C:cytoskeleton; C:cytosol; C:endomembrane system; C:internode region of axon; C:neuronal cell body; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein phosphatase binding;, P:asymmetric cell division; P:axonogenesis; P:bicellular tight junction assembly; P:cell adhesion; P:cell cycle; P:establishment of cell polarity; P:establishment of centrosome localization; P:establishment of epithelial cell polarity; P:establishment or maintenance of cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:microtubule cytoskeleton organization; P:myelination in peripheral nervous system; P:negative regulation of peptidyl-threonine phosphorylation; P:positive regulation of myelination; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein localization; P:protein targeting to membrane; P:protein-containing complex assembly; P:regulation of cellular localization; P:transforming growth factor beta receptor signaling pathway;|Q9BY57 Q9BY58 Q9HC48 Q9NWL4 Q9NYE6,Partitioning defective 3 homolog,Atypical PKC isotype-specific-interacting protein;CTCL tumor antigen se2-5;PAR3-alpha;, PF12053;PF00595;, GO:0005912;GO:0043296;GO:0016324;GO:0044295;GO:0005923;GO:0005938;GO:0030054;GO:0005911;GO:0005856;GO:0005829;GO:0012505;GO:0033269;GO:0043025;GO:0005886;GO:0032991;GO:0042802;GO:0035091;GO:0005547;GO:0032266;GO:0005546;GO:0019903;GO:0008356;GO:0007409;GO:0070830;GO:0007155;GO:0007049;GO:0030010;GO:0051660;GO:0090162;GO:0007163;GO:0045197;GO:0000226;GO:0022011;GO:0010801;GO:0031643;GO:0007205;GO:0008104;GO:0006612;GO:0065003;GO:0060341;GO:0007179;, C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:axonal growth cone; C:bicellular tight junction; C:cell cortex; C:cell junction; C:cell-cell junction; C:cytoskeleton; C:cytosol; C:endomembrane system; C:internode region of axon; C:neuronal cell body; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein phosphatase binding;, P:asymmetric cell division; P:axonogenesis; P:bicellular tight junction assembly; P:cell adhesion; P:cell cycle; P:establishment of cell polarity; P:establishment of centrosome localization; P:establishment of epithelial cell polarity; P:establishment or maintenance of cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:microtubule cytoskeleton organization; P:myelination in peripheral nervous system; P:negative regulation of peptidyl-threonine phosphorylation; P:positive regulation of myelination; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein localization; P:protein targeting to membrane; P:protein-containing complex assembly; P:regulation of cellular localization; P:transforming growth factor beta receptor signaling pathway; scaffold22 indexed_genome mRNA 24426915 24496764 . - . ID=transcript_5313;Q13617 B3KT95 B7Z6K8 D3DRY6 G3V1S2 O00200 Q5T2B6 Q9UNF9,Cullin-2,, PF00888;PF10557;, GO:0031462;GO:0031461;GO:0005829;GO:0005654;GO:0019005;GO:0030891;GO:0044877;GO:0031625;GO:0004842;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0061418;GO:0031146;GO:0016032;, C:Cul2-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex; C:VCB complex;, F:protein-containing complex binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q13617 B3KT95 B7Z6K8 D3DRY6 G3V1S2 O00200 Q5T2B6 Q9UNF9,Cullin-2,, PF00888;PF10557;, GO:0031462;GO:0031461;GO:0005829;GO:0005654;GO:0019005;GO:0030891;GO:0044877;GO:0031625;GO:0004842;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0061418;GO:0031146;GO:0016032;, C:Cul2-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex; C:VCB complex;, F:protein-containing complex binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q13617 B3KT95 B7Z6K8 D3DRY6 G3V1S2 O00200 Q5T2B6 Q9UNF9,Cullin-2,, PF00888;PF10557;, GO:0031462;GO:0031461;GO:0005829;GO:0005654;GO:0019005;GO:0030891;GO:0044877;GO:0031625;GO:0004842;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0061418;GO:0031146;GO:0016032;, C:Cul2-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex; C:VCB complex;, F:protein-containing complex binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q13617 B3KT95 B7Z6K8 D3DRY6 G3V1S2 O00200 Q5T2B6 Q9UNF9,Cullin-2,, PF00888;PF10557;, GO:0031462;GO:0031461;GO:0005829;GO:0005654;GO:0019005;GO:0030891;GO:0044877;GO:0031625;GO:0004842;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0061418;GO:0031146;GO:0016032;, C:Cul2-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex; C:VCB complex;, F:protein-containing complex binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q13617 B3KT95 B7Z6K8 D3DRY6 G3V1S2 O00200 Q5T2B6 Q9UNF9,Cullin-2,, PF00888;PF10557;, GO:0031462;GO:0031461;GO:0005829;GO:0005654;GO:0019005;GO:0030891;GO:0044877;GO:0031625;GO:0004842;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0061418;GO:0031146;GO:0016032;, C:Cul2-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:SCF ubiquitin ligase complex; C:VCB complex;, F:protein-containing complex binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process; scaffold22 indexed_genome mRNA 24538730 24567968 . + . ID=transcript_5314;Q8IVD4 Q96AG7 Q9NZ98 Q9NZ99 Q9NZB9,cAMP-responsive element modulator {ECO:0000305},Inducible cAMP early repressor;, PF00170;PF02173;, GO:1990589;GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0008140;GO:0003677;GO:0000981;GO:0001227;GO:0000978;GO:0000977;GO:1990837;GO:0030154;GO:0006631;GO:0006006;GO:0007275;GO:0000122;GO:0042752;GO:0006357;GO:0006355;GO:0048384;GO:0048511;GO:0007165;GO:0007283;, C:ATF4-CREB1 transcription factor complex; C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:cAMP response element binding protein binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:fatty acid metabolic process; P:glucose metabolic process; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:retinoic acid receptor signaling pathway; P:rhythmic process; P:signal transduction; P:spermatogenesis; scaffold22 indexed_genome mRNA 24587060 24591444 . - . ID=transcript_5315;Q8IVD4 Q96AG7 Q9NZ98 Q9NZ99 Q9NZB9,cAMP-responsive element modulator {ECO:0000305},Inducible cAMP early repressor;, PF00170;PF02173;, GO:1990589;GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0008140;GO:0003677;GO:0000981;GO:0001227;GO:0000978;GO:0000977;GO:1990837;GO:0030154;GO:0006631;GO:0006006;GO:0007275;GO:0000122;GO:0042752;GO:0006357;GO:0006355;GO:0048384;GO:0048511;GO:0007165;GO:0007283;, C:ATF4-CREB1 transcription factor complex; C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:cAMP response element binding protein binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:fatty acid metabolic process; P:glucose metabolic process; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:retinoic acid receptor signaling pathway; P:rhythmic process; P:signal transduction; P:spermatogenesis;|Q8IVD4 Q96AG7 Q9NZ98 Q9NZ99 Q9NZB9,cAMP-responsive element modulator {ECO:0000305},Inducible cAMP early repressor;, PF00170;PF02173;, GO:1990589;GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0008140;GO:0003677;GO:0000981;GO:0001227;GO:0000978;GO:0000977;GO:1990837;GO:0030154;GO:0006631;GO:0006006;GO:0007275;GO:0000122;GO:0042752;GO:0006357;GO:0006355;GO:0048384;GO:0048511;GO:0007165;GO:0007283;, C:ATF4-CREB1 transcription factor complex; C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:cAMP response element binding protein binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:fatty acid metabolic process; P:glucose metabolic process; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:retinoic acid receptor signaling pathway; P:rhythmic process; P:signal transduction; P:spermatogenesis; scaffold22 indexed_genome mRNA 24594143 24595668 . - . ID=transcript_5316;P16220 P21934 Q6V963 Q9UMA7,Cyclic AMP-responsive element-binding protein 1,, PF00170;PF02173;, GO:1990589;GO:0030424;GO:0000785;GO:0000791;GO:0005759;GO:0005654;GO:0005634;GO:0005667;GO:1990763;GO:0035497;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0035035;GO:0030544;GO:0042802;GO:0001102;GO:0000978;GO:0001225;GO:1990837;GO:0007568;GO:0007409;GO:0071398;GO:0035729;GO:1990314;GO:1990830;GO:1990090;GO:0036120;GO:0071300;GO:0071294;GO:0034670;GO:0007623;GO:0007595;GO:0060430;GO:0007613;GO:0002862;GO:1901215;GO:0010944;GO:0021983;GO:0043065;GO:0055025;GO:0045600;GO:0046887;GO:0046889;GO:1900273;GO:0040018;GO:0045672;GO:0045899;GO:0045944;GO:0045893;GO:0032916;GO:0006468;GO:0050821;GO:0008361;GO:0042752;GO:0048145;GO:0060251;GO:0006357;GO:0014823;GO:0042493;GO:0033762;GO:0001666;GO:1902065;GO:0035094;GO:0010033;GO:0033363;GO:0007165;GO:0006366;GO:0007179;GO:0060509;GO:0016032;GO:0008542;, C:ATF4-CREB1 transcription factor complex; C:axon; C:chromatin; C:euchromatin; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:arrestin family protein binding; F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone acetyltransferase binding; F:Hsp70 protein binding; F:identical protein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:sequence-specific double-stranded DNA binding;, P:aging; P:axonogenesis; P:cellular response to fatty acid; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to nerve growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to retinoic acid; P:cellular response to zinc ion; P:chemotaxis to arachidonic acid; P:circadian rhythm; P:lactation; P:lung saccule development; P:memory; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron death; P:negative regulation of transcription by competitive promoter binding; P:pituitary gland development; P:positive regulation of apoptotic process; P:positive regulation of cardiac muscle tissue development; P:positive regulation of fat cell differentiation; P:positive regulation of hormone secretion; P:positive regulation of lipid biosynthetic process; P:positive regulation of long-term synaptic potentiation; P:positive regulation of multicellular organism growth; P:positive regulation of osteoclast differentiation; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta3 production; P:protein phosphorylation; P:protein stabilization; P:regulation of cell size; P:regulation of circadian rhythm; P:regulation of fibroblast proliferation; P:regulation of glial cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to drug; P:response to glucagon; P:response to hypoxia; P:response to L-glutamate; P:response to nicotine; P:response to organic substance; P:secretory granule organization; P:signal transduction; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; P:type I pneumocyte differentiation; P:viral process; P:visual learning; scaffold22 indexed_genome mRNA 24610773 24735247 . + . ID=transcript_5317;Q96M99 Q96P45,Cyclin-Y,Cyclin box protein 1;Cyclin fold protein 1;cyclin-X;, PF00134;, GO:0005737;GO:0000308;GO:0005634;GO:0005886;GO:0016538;GO:0019901;GO:0051301;GO:0000086;GO:0045737;GO:0060828;GO:0016055;, C:cytoplasm; C:cytoplasmic cyclin-dependent protein kinase holoenzyme complex; C:nucleus; C:plasma membrane;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:G2/M transition of mitotic cell cycle; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q96M99 Q96P45,Cyclin-Y,Cyclin box protein 1;Cyclin fold protein 1;cyclin-X;, PF00134;, GO:0005737;GO:0000308;GO:0005634;GO:0005886;GO:0016538;GO:0019901;GO:0051301;GO:0000086;GO:0045737;GO:0060828;GO:0016055;, C:cytoplasm; C:cytoplasmic cyclin-dependent protein kinase holoenzyme complex; C:nucleus; C:plasma membrane;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:G2/M transition of mitotic cell cycle; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q96M99 Q96P45,Cyclin-Y,Cyclin box protein 1;Cyclin fold protein 1;cyclin-X;, PF00134;, GO:0005737;GO:0000308;GO:0005634;GO:0005886;GO:0016538;GO:0019901;GO:0051301;GO:0000086;GO:0045737;GO:0060828;GO:0016055;, C:cytoplasm; C:cytoplasmic cyclin-dependent protein kinase holoenzyme complex; C:nucleus; C:plasma membrane;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:G2/M transition of mitotic cell cycle; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q96M99 Q96P45,Cyclin-Y,Cyclin box protein 1;Cyclin fold protein 1;cyclin-X;, PF00134;, GO:0005737;GO:0000308;GO:0005634;GO:0005886;GO:0016538;GO:0019901;GO:0051301;GO:0000086;GO:0045737;GO:0060828;GO:0016055;, C:cytoplasm; C:cytoplasmic cyclin-dependent protein kinase holoenzyme complex; C:nucleus; C:plasma membrane;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:G2/M transition of mitotic cell cycle; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q96M99 Q96P45,Cyclin-Y,Cyclin box protein 1;Cyclin fold protein 1;cyclin-X;, PF00134;, GO:0005737;GO:0000308;GO:0005634;GO:0005886;GO:0016538;GO:0019901;GO:0051301;GO:0000086;GO:0045737;GO:0060828;GO:0016055;, C:cytoplasm; C:cytoplasmic cyclin-dependent protein kinase holoenzyme complex; C:nucleus; C:plasma membrane;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:G2/M transition of mitotic cell cycle; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold22 indexed_genome mRNA 24757838 24831158 . + . ID=transcript_5318;Q7Z5R6 Q8IWS8 Q8IYL7 Q8IZZ7,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,APBB1-interacting protein 1;Proline-rich EVH1 ligand 1;Proline-rich protein 73;Rap1-GTP-interacting adapter molecule;Retinoic acid-responsive proline-rich protein 1;, PF00169;PF00788;, GO:0005856;GO:0005829;GO:0005925;GO:0030027;GO:0005886;GO:0042101;GO:0045785;GO:0007165;GO:0002291;, C:cytoskeleton; C:cytosol; C:focal adhesion; C:lamellipodium; C:plasma membrane; C:T cell receptor complex;, , P:positive regulation of cell adhesion; P:signal transduction; P:T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; scaffold22 indexed_genome mRNA 24833143 24849958 . - . ID=transcript_5319;Q9BVL4 Q2TAL2 Q5JZ81 Q8WUI0,Protein adenylyltransferase SelO, mitochondrial {ECO:0000305},Selenoprotein O {ECO:0000303|PubMed:27645994};, PF02696;, GO:0005694;GO:0005739;GO:0005524;GO:0046872;GO:0070733;GO:0018117;, C:chromosome; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:protein adenylyltransferase activity;, P:protein adenylylation;|Q9BVL4 Q2TAL2 Q5JZ81 Q8WUI0,Protein adenylyltransferase SelO, mitochondrial {ECO:0000305},Selenoprotein O {ECO:0000303|PubMed:27645994};, PF02696;, GO:0005694;GO:0005739;GO:0005524;GO:0046872;GO:0070733;GO:0018117;, C:chromosome; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:protein adenylyltransferase activity;, P:protein adenylylation; scaffold22 indexed_genome mRNA 24858978 24890982 . + . ID=transcript_5320;Q5T2R2 Q53F75 Q6P473 Q86WQ8 Q9Y2W5,All trans-polyprenyl-diphosphate synthase PDSS1 {ECO:0000305},All-trans-decaprenyl-diphosphate synthase subunit 1;Decaprenyl pyrophosphate synthase subunit 1;Decaprenyl-diphosphate synthase subunit 1 {ECO:0000312|HGNC:HGNC:17759};Solanesyl-diphosphate synthase subunit 1;Trans-prenyltransferase 1;, PF00348;, GO:0005759;GO:1990234;GO:0097269;GO:0046872;GO:0004659;GO:0046982;GO:0000010;GO:0050347;GO:0008299;GO:0006744;, C:mitochondrial matrix; C:transferase complex;, F:all-trans-decaprenyl-diphosphate synthase activity; F:metal ion binding; F:prenyltransferase activity; F:protein heterodimerization activity; F:trans-hexaprenyltranstransferase activity; F:trans-octaprenyltranstransferase activity;, P:isoprenoid biosynthetic process; P:ubiquinone biosynthetic process; scaffold22 indexed_genome mRNA 24898469 24909901 . - . ID=transcript_5321;Q9NYB8,Abl interactor 1,Abelson interactor 1;Abl-binding protein 4;Eps8 SH3 domain-binding protein;Nap1-binding protein;Spectrin SH3 domain-binding protein 1;e3B1;, PF07815;PF00018;, GO:0005856;GO:0005829;GO:0005783;GO:0070062;GO:0032433;GO:0030426;GO:0030027;GO:0005634;GO:0014069;GO:0031209;GO:0045296;GO:0008092;GO:0030296;GO:0017124;GO:0035591;GO:0008154;GO:0038096;GO:0008285;GO:0018108;GO:0007169;GO:0048010;GO:0016032;, C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:filopodium tip; C:growth cone; C:lamellipodium; C:nucleus; C:postsynaptic density; C:SCAR complex;, F:cadherin binding; F:cytoskeletal protein binding; F:protein tyrosine kinase activator activity; F:SH3 domain binding; F:signaling adaptor activity;, P:actin polymerization or depolymerization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of cell population proliferation; P:peptidyl-tyrosine phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|Q9NYB8,Abl interactor 1,Abelson interactor 1;Abl-binding protein 4;Eps8 SH3 domain-binding protein;Nap1-binding protein;Spectrin SH3 domain-binding protein 1;e3B1;, PF07815;PF00018;, GO:0005856;GO:0005829;GO:0005783;GO:0070062;GO:0032433;GO:0030426;GO:0030027;GO:0005634;GO:0014069;GO:0031209;GO:0045296;GO:0008092;GO:0030296;GO:0017124;GO:0035591;GO:0008154;GO:0038096;GO:0008285;GO:0018108;GO:0007169;GO:0048010;GO:0016032;, C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:filopodium tip; C:growth cone; C:lamellipodium; C:nucleus; C:postsynaptic density; C:SCAR complex;, F:cadherin binding; F:cytoskeletal protein binding; F:protein tyrosine kinase activator activity; F:SH3 domain binding; F:signaling adaptor activity;, P:actin polymerization or depolymerization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of cell population proliferation; P:peptidyl-tyrosine phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|Q9NYB8,Abl interactor 1,Abelson interactor 1;Abl-binding protein 4;Eps8 SH3 domain-binding protein;Nap1-binding protein;Spectrin SH3 domain-binding protein 1;e3B1;, PF07815;PF00018;, GO:0005856;GO:0005829;GO:0005783;GO:0070062;GO:0032433;GO:0030426;GO:0030027;GO:0005634;GO:0014069;GO:0031209;GO:0045296;GO:0008092;GO:0030296;GO:0017124;GO:0035591;GO:0008154;GO:0038096;GO:0008285;GO:0018108;GO:0007169;GO:0048010;GO:0016032;, C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:filopodium tip; C:growth cone; C:lamellipodium; C:nucleus; C:postsynaptic density; C:SCAR complex;, F:cadherin binding; F:cytoskeletal protein binding; F:protein tyrosine kinase activator activity; F:SH3 domain binding; F:signaling adaptor activity;, P:actin polymerization or depolymerization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of cell population proliferation; P:peptidyl-tyrosine phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; scaffold22 indexed_genome mRNA 24911353 24980586 . - . ID=transcript_5322;Q9NYB8,Abl interactor 1,Abelson interactor 1;Abl-binding protein 4;Eps8 SH3 domain-binding protein;Nap1-binding protein;Spectrin SH3 domain-binding protein 1;e3B1;, PF07815;PF00018;, GO:0005856;GO:0005829;GO:0005783;GO:0070062;GO:0032433;GO:0030426;GO:0030027;GO:0005634;GO:0014069;GO:0031209;GO:0045296;GO:0008092;GO:0030296;GO:0017124;GO:0035591;GO:0008154;GO:0038096;GO:0008285;GO:0018108;GO:0007169;GO:0048010;GO:0016032;, C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:filopodium tip; C:growth cone; C:lamellipodium; C:nucleus; C:postsynaptic density; C:SCAR complex;, F:cadherin binding; F:cytoskeletal protein binding; F:protein tyrosine kinase activator activity; F:SH3 domain binding; F:signaling adaptor activity;, P:actin polymerization or depolymerization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of cell population proliferation; P:peptidyl-tyrosine phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|Q9NYB8,Abl interactor 1,Abelson interactor 1;Abl-binding protein 4;Eps8 SH3 domain-binding protein;Nap1-binding protein;Spectrin SH3 domain-binding protein 1;e3B1;, PF07815;PF00018;, GO:0005856;GO:0005829;GO:0005783;GO:0070062;GO:0032433;GO:0030426;GO:0030027;GO:0005634;GO:0014069;GO:0031209;GO:0045296;GO:0008092;GO:0030296;GO:0017124;GO:0035591;GO:0008154;GO:0038096;GO:0008285;GO:0018108;GO:0007169;GO:0048010;GO:0016032;, C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:filopodium tip; C:growth cone; C:lamellipodium; C:nucleus; C:postsynaptic density; C:SCAR complex;, F:cadherin binding; F:cytoskeletal protein binding; F:protein tyrosine kinase activator activity; F:SH3 domain binding; F:signaling adaptor activity;, P:actin polymerization or depolymerization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of cell population proliferation; P:peptidyl-tyrosine phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|Q9NYB8,Abl interactor 1,Abelson interactor 1;Abl-binding protein 4;Eps8 SH3 domain-binding protein;Nap1-binding protein;Spectrin SH3 domain-binding protein 1;e3B1;, PF07815;PF00018;, GO:0005856;GO:0005829;GO:0005783;GO:0070062;GO:0032433;GO:0030426;GO:0030027;GO:0005634;GO:0014069;GO:0031209;GO:0045296;GO:0008092;GO:0030296;GO:0017124;GO:0035591;GO:0008154;GO:0038096;GO:0008285;GO:0018108;GO:0007169;GO:0048010;GO:0016032;, C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:filopodium tip; C:growth cone; C:lamellipodium; C:nucleus; C:postsynaptic density; C:SCAR complex;, F:cadherin binding; F:cytoskeletal protein binding; F:protein tyrosine kinase activator activity; F:SH3 domain binding; F:signaling adaptor activity;, P:actin polymerization or depolymerization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of cell population proliferation; P:peptidyl-tyrosine phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; scaffold22 indexed_genome mRNA 24998680 25027670 . + . ID=transcript_5323;Q5T8D3 B3KQ56 D3DRW0 Q5T8D4 Q5T8E1 Q5T8E2 Q86UV1 Q8N6E3 Q9UFB5,Acyl-CoA-binding domain-containing protein 5,, PF00887;, GO:0005829;GO:0016021;GO:0016020;GO:0005654;GO:0005778;GO:0005777;GO:0000062;GO:0008289;GO:0030242;GO:0009062;GO:0045046;, C:cytosol; C:integral component of membrane; C:membrane; C:nucleoplasm; C:peroxisomal membrane; C:peroxisome;, F:fatty-acyl-CoA binding; F:lipid binding;, P:autophagy of peroxisome; P:fatty acid catabolic process; P:protein import into peroxisome membrane;|Q5T8D3 B3KQ56 D3DRW0 Q5T8D4 Q5T8E1 Q5T8E2 Q86UV1 Q8N6E3 Q9UFB5,Acyl-CoA-binding domain-containing protein 5,, PF00887;, GO:0005829;GO:0016021;GO:0016020;GO:0005654;GO:0005778;GO:0005777;GO:0000062;GO:0008289;GO:0030242;GO:0009062;GO:0045046;, C:cytosol; C:integral component of membrane; C:membrane; C:nucleoplasm; C:peroxisomal membrane; C:peroxisome;, F:fatty-acyl-CoA binding; F:lipid binding;, P:autophagy of peroxisome; P:fatty acid catabolic process; P:protein import into peroxisome membrane;|Q5T8D3 B3KQ56 D3DRW0 Q5T8D4 Q5T8E1 Q5T8E2 Q86UV1 Q8N6E3 Q9UFB5,Acyl-CoA-binding domain-containing protein 5,, PF00887;, GO:0005829;GO:0016021;GO:0016020;GO:0005654;GO:0005778;GO:0005777;GO:0000062;GO:0008289;GO:0030242;GO:0009062;GO:0045046;, C:cytosol; C:integral component of membrane; C:membrane; C:nucleoplasm; C:peroxisomal membrane; C:peroxisome;, F:fatty-acyl-CoA binding; F:lipid binding;, P:autophagy of peroxisome; P:fatty acid catabolic process; P:protein import into peroxisome membrane;|Q5T8D3 B3KQ56 D3DRW0 Q5T8D4 Q5T8E1 Q5T8E2 Q86UV1 Q8N6E3 Q9UFB5,Acyl-CoA-binding domain-containing protein 5,, PF00887;, GO:0005829;GO:0016021;GO:0016020;GO:0005654;GO:0005778;GO:0005777;GO:0000062;GO:0008289;GO:0030242;GO:0009062;GO:0045046;, C:cytosol; C:integral component of membrane; C:membrane; C:nucleoplasm; C:peroxisomal membrane; C:peroxisome;, F:fatty-acyl-CoA binding; F:lipid binding;, P:autophagy of peroxisome; P:fatty acid catabolic process; P:protein import into peroxisome membrane; scaffold22 indexed_genome mRNA 25061938 25091389 . + . ID=transcript_5324;Q96TA2 B4DNM1 D3DRV8 D3DRV9 Q5T8D9 Q9H1Q0 Q9UMR9,ATP-dependent zinc metalloprotease YME1L1,ATP-dependent metalloprotease FtsH1;Meg-4;Presenilin-associated metalloprotease;YME1-like protein 1;, PF00004;PF17862;PF01434;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0016604;GO:0005524;GO:0004176;GO:0046872;GO:0004222;GO:0008283;GO:0006851;GO:0035694;GO:0034982;GO:0007005;GO:0043066;GO:0034214;GO:0006515;GO:0006508;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nuclear body;, F:ATP binding; F:ATP-dependent peptidase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:cell population proliferation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial protein catabolic process; P:mitochondrial protein processing; P:mitochondrion organization; P:negative regulation of apoptotic process; P:protein hexamerization; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis;|Q96TA2 B4DNM1 D3DRV8 D3DRV9 Q5T8D9 Q9H1Q0 Q9UMR9,ATP-dependent zinc metalloprotease YME1L1,ATP-dependent metalloprotease FtsH1;Meg-4;Presenilin-associated metalloprotease;YME1-like protein 1;, PF00004;PF17862;PF01434;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0016604;GO:0005524;GO:0004176;GO:0046872;GO:0004222;GO:0008283;GO:0006851;GO:0035694;GO:0034982;GO:0007005;GO:0043066;GO:0034214;GO:0006515;GO:0006508;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nuclear body;, F:ATP binding; F:ATP-dependent peptidase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:cell population proliferation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial protein catabolic process; P:mitochondrial protein processing; P:mitochondrion organization; P:negative regulation of apoptotic process; P:protein hexamerization; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis;|Q96TA2 B4DNM1 D3DRV8 D3DRV9 Q5T8D9 Q9H1Q0 Q9UMR9,ATP-dependent zinc metalloprotease YME1L1,ATP-dependent metalloprotease FtsH1;Meg-4;Presenilin-associated metalloprotease;YME1-like protein 1;, PF00004;PF17862;PF01434;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0016604;GO:0005524;GO:0004176;GO:0046872;GO:0004222;GO:0008283;GO:0006851;GO:0035694;GO:0034982;GO:0007005;GO:0043066;GO:0034214;GO:0006515;GO:0006508;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nuclear body;, F:ATP binding; F:ATP-dependent peptidase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:cell population proliferation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial protein catabolic process; P:mitochondrial protein processing; P:mitochondrion organization; P:negative regulation of apoptotic process; P:protein hexamerization; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis;|Q96TA2 B4DNM1 D3DRV8 D3DRV9 Q5T8D9 Q9H1Q0 Q9UMR9,ATP-dependent zinc metalloprotease YME1L1,ATP-dependent metalloprotease FtsH1;Meg-4;Presenilin-associated metalloprotease;YME1-like protein 1;, PF00004;PF17862;PF01434;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0016604;GO:0005524;GO:0004176;GO:0046872;GO:0004222;GO:0008283;GO:0006851;GO:0035694;GO:0034982;GO:0007005;GO:0043066;GO:0034214;GO:0006515;GO:0006508;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nuclear body;, F:ATP binding; F:ATP-dependent peptidase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:cell population proliferation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial protein catabolic process; P:mitochondrial protein processing; P:mitochondrion organization; P:negative regulation of apoptotic process; P:protein hexamerization; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis;|Q96TA2 B4DNM1 D3DRV8 D3DRV9 Q5T8D9 Q9H1Q0 Q9UMR9,ATP-dependent zinc metalloprotease YME1L1,ATP-dependent metalloprotease FtsH1;Meg-4;Presenilin-associated metalloprotease;YME1-like protein 1;, PF00004;PF17862;PF01434;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0016604;GO:0005524;GO:0004176;GO:0046872;GO:0004222;GO:0008283;GO:0006851;GO:0035694;GO:0034982;GO:0007005;GO:0043066;GO:0034214;GO:0006515;GO:0006508;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nuclear body;, F:ATP binding; F:ATP-dependent peptidase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:cell population proliferation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial protein catabolic process; P:mitochondrial protein processing; P:mitochondrion organization; P:negative regulation of apoptotic process; P:protein hexamerization; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis;|Q96TA2 B4DNM1 D3DRV8 D3DRV9 Q5T8D9 Q9H1Q0 Q9UMR9,ATP-dependent zinc metalloprotease YME1L1,ATP-dependent metalloprotease FtsH1;Meg-4;Presenilin-associated metalloprotease;YME1-like protein 1;, PF00004;PF17862;PF01434;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0016604;GO:0005524;GO:0004176;GO:0046872;GO:0004222;GO:0008283;GO:0006851;GO:0035694;GO:0034982;GO:0007005;GO:0043066;GO:0034214;GO:0006515;GO:0006508;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nuclear body;, F:ATP binding; F:ATP-dependent peptidase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:cell population proliferation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial protein catabolic process; P:mitochondrial protein processing; P:mitochondrion organization; P:negative regulation of apoptotic process; P:protein hexamerization; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis; scaffold22 indexed_genome mRNA 25097568 25098155 . + . ID=transcript_5325;P0C842,Putative uncharacterized protein encoded by LINC00614,, PF00109;, GO:0016746;, , F:transferase activity, transferring acyl groups; scaffold22 indexed_genome mRNA 25100226 25171298 . + . ID=transcript_5326;Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation;|Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation; scaffold22 indexed_genome mRNA 25171328 25198153 . + . ID=transcript_5327;Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation;|Q5CZ79 A6NC18,Ankyrin repeat domain-containing protein 20B,Ankyrin repeat domain-containing protein 20A pseudogene;, PF12796;PF14915; scaffold22 indexed_genome mRNA 25198171 25229070 . + . ID=transcript_5328;Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation;|Q3MJ40 Q6P5Q3 Q8N200,Coiled-coil domain-containing protein 144B|Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation; scaffold22 indexed_genome mRNA 25269229 25361570 . + . ID=transcript_5329;Q9BQI4 Q5VYV8 Q5VYV9,Coiled-coil domain-containing protein 3,Fat/vessel-derived secretory protein;, , GO:0005783;GO:0005576;GO:0010629;GO:0051055;GO:0045833;GO:0010804;GO:0045600;GO:0046889;, C:endoplasmic reticulum; C:extracellular region;, , P:negative regulation of gene expression; P:negative regulation of lipid biosynthetic process; P:negative regulation of lipid metabolic process; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of fat cell differentiation; P:positive regulation of lipid biosynthetic process; scaffold22 indexed_genome mRNA 25447685 25452140 . - . ID=transcript_5330;Q8IU85 B0YIY0 Q9HD31,Calcium/calmodulin-dependent protein kinase type 1D,CaM kinase I delta;CaMKI-like protein kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0006954;GO:0043066;GO:0007399;GO:0018105;GO:0043065;GO:0032793;GO:0010976;GO:0090023;GO:0050766;GO:0060267;GO:0050773;GO:0071622;, C:cytoplasm; C:nucleus;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:inflammatory response; P:negative regulation of apoptotic process; P:nervous system development; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of CREB transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neutrophil chemotaxis; P:positive regulation of phagocytosis; P:positive regulation of respiratory burst; P:regulation of dendrite development; P:regulation of granulocyte chemotaxis;|Q8IU85 B0YIY0 Q9HD31,Calcium/calmodulin-dependent protein kinase type 1D,CaM kinase I delta;CaMKI-like protein kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0006954;GO:0043066;GO:0007399;GO:0018105;GO:0043065;GO:0032793;GO:0010976;GO:0090023;GO:0050766;GO:0060267;GO:0050773;GO:0071622;, C:cytoplasm; C:nucleus;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:inflammatory response; P:negative regulation of apoptotic process; P:nervous system development; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of CREB transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neutrophil chemotaxis; P:positive regulation of phagocytosis; P:positive regulation of respiratory burst; P:regulation of dendrite development; P:regulation of granulocyte chemotaxis;|Q8IU85 B0YIY0 Q9HD31,Calcium/calmodulin-dependent protein kinase type 1D,CaM kinase I delta;CaMKI-like protein kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0006954;GO:0043066;GO:0007399;GO:0018105;GO:0043065;GO:0032793;GO:0010976;GO:0090023;GO:0050766;GO:0060267;GO:0050773;GO:0071622;, C:cytoplasm; C:nucleus;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:inflammatory response; P:negative regulation of apoptotic process; P:nervous system development; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of CREB transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neutrophil chemotaxis; P:positive regulation of phagocytosis; P:positive regulation of respiratory burst; P:regulation of dendrite development; P:regulation of granulocyte chemotaxis; scaffold22 indexed_genome mRNA 25850561 25851064 . - . ID=transcript_5331;Q8IU85 B0YIY0 Q9HD31,Calcium/calmodulin-dependent protein kinase type 1D,CaM kinase I delta;CaMKI-like protein kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0006954;GO:0043066;GO:0007399;GO:0018105;GO:0043065;GO:0032793;GO:0010976;GO:0090023;GO:0050766;GO:0060267;GO:0050773;GO:0071622;, C:cytoplasm; C:nucleus;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:inflammatory response; P:negative regulation of apoptotic process; P:nervous system development; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of CREB transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neutrophil chemotaxis; P:positive regulation of phagocytosis; P:positive regulation of respiratory burst; P:regulation of dendrite development; P:regulation of granulocyte chemotaxis; scaffold22 indexed_genome mRNA 25928279 25936587 . - . ID=transcript_5332;O75794 A8JZZ7 Q14107 Q5T0L4 Q5T0L5 Q5T0L7 Q5T0L8 Q5T0L9,Cell division cycle protein 123 homolog,HT-1080;PZ32;, PF07065;, GO:0005737;GO:0007050;GO:0051301;GO:1905143;GO:0008284;GO:0045948;, C:cytoplasm;, , P:cell cycle arrest; P:cell division; P:eukaryotic translation initiation factor 2 complex assembly; P:positive regulation of cell population proliferation; P:positive regulation of translational initiation;|O75794 A8JZZ7 Q14107 Q5T0L4 Q5T0L5 Q5T0L7 Q5T0L8 Q5T0L9,Cell division cycle protein 123 homolog,HT-1080;PZ32;, PF07065;, GO:0005737;GO:0007050;GO:0051301;GO:1905143;GO:0008284;GO:0045948;, C:cytoplasm;, , P:cell cycle arrest; P:cell division; P:eukaryotic translation initiation factor 2 complex assembly; P:positive regulation of cell population proliferation; P:positive regulation of translational initiation; scaffold22 indexed_genome mRNA 25944844 25953677 . - . ID=transcript_5333;O75794 A8JZZ7 Q14107 Q5T0L4 Q5T0L5 Q5T0L7 Q5T0L8 Q5T0L9,Cell division cycle protein 123 homolog,HT-1080;PZ32;, PF07065;, GO:0005737;GO:0007050;GO:0051301;GO:1905143;GO:0008284;GO:0045948;, C:cytoplasm;, , P:cell cycle arrest; P:cell division; P:eukaryotic translation initiation factor 2 complex assembly; P:positive regulation of cell population proliferation; P:positive regulation of translational initiation; scaffold22 indexed_genome mRNA 25958683 25959694 . + . ID=transcript_5334;O75794 A8JZZ7 Q14107 Q5T0L4 Q5T0L5 Q5T0L7 Q5T0L8 Q5T0L9,Cell division cycle protein 123 homolog,HT-1080;PZ32;, PF07065;, GO:0005737;GO:0007050;GO:0051301;GO:1905143;GO:0008284;GO:0045948;, C:cytoplasm;, , P:cell cycle arrest; P:cell division; P:eukaryotic translation initiation factor 2 complex assembly; P:positive regulation of cell population proliferation; P:positive regulation of translational initiation; scaffold22 indexed_genome mRNA 25974230 26015619 . + . ID=transcript_5335;Q9UKK9 A8K516 Q6IAG0 Q9UH49,ADP-sugar pyrophosphatase,8-oxo-dGDP phosphatase;Nuclear ATP-synthesis protein NUDIX5 {ECO:0000305|PubMed:27257257};Nucleoside diphosphate-linked moiety X motif 5 {ECO:0000305};YSA1H {ECO:0000303|PubMed:10567213};, PF00293;, GO:0005829;GO:0070062;GO:0005634;GO:0044715;GO:0044716;GO:0047631;GO:0019144;GO:0042802;GO:0000287;GO:0016779;GO:0042803;GO:0030515;GO:1990966;GO:0006338;GO:0019303;GO:0034656;GO:0006753;GO:0009117;GO:0009191;GO:0019693;, C:cytosol; C:extracellular exosome; C:nucleus;, F:8-oxo-dGDP phosphatase activity; F:8-oxo-GDP phosphatase activity; F:ADP-ribose diphosphatase activity; F:ADP-sugar diphosphatase activity; F:identical protein binding; F:magnesium ion binding; F:nucleotidyltransferase activity; F:protein homodimerization activity; F:snoRNA binding;, P:ATP generation from poly-ADP-D-ribose; P:chromatin remodeling; P:D-ribose catabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside phosphate metabolic process; P:nucleotide metabolic process; P:ribonucleoside diphosphate catabolic process; P:ribose phosphate metabolic process;|Q9UKK9 A8K516 Q6IAG0 Q9UH49,ADP-sugar pyrophosphatase,8-oxo-dGDP phosphatase;Nuclear ATP-synthesis protein NUDIX5 {ECO:0000305|PubMed:27257257};Nucleoside diphosphate-linked moiety X motif 5 {ECO:0000305};YSA1H {ECO:0000303|PubMed:10567213};, PF00293;, GO:0005829;GO:0070062;GO:0005634;GO:0044715;GO:0044716;GO:0047631;GO:0019144;GO:0042802;GO:0000287;GO:0016779;GO:0042803;GO:0030515;GO:1990966;GO:0006338;GO:0019303;GO:0034656;GO:0006753;GO:0009117;GO:0009191;GO:0019693;, C:cytosol; C:extracellular exosome; C:nucleus;, F:8-oxo-dGDP phosphatase activity; F:8-oxo-GDP phosphatase activity; F:ADP-ribose diphosphatase activity; F:ADP-sugar diphosphatase activity; F:identical protein binding; F:magnesium ion binding; F:nucleotidyltransferase activity; F:protein homodimerization activity; F:snoRNA binding;, P:ATP generation from poly-ADP-D-ribose; P:chromatin remodeling; P:D-ribose catabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside phosphate metabolic process; P:nucleotide metabolic process; P:ribonucleoside diphosphate catabolic process; P:ribose phosphate metabolic process;|Q9UKK9 A8K516 Q6IAG0 Q9UH49,ADP-sugar pyrophosphatase,8-oxo-dGDP phosphatase;Nuclear ATP-synthesis protein NUDIX5 {ECO:0000305|PubMed:27257257};Nucleoside diphosphate-linked moiety X motif 5 {ECO:0000305};YSA1H {ECO:0000303|PubMed:10567213};, PF00293;, GO:0005829;GO:0070062;GO:0005634;GO:0044715;GO:0044716;GO:0047631;GO:0019144;GO:0042802;GO:0000287;GO:0016779;GO:0042803;GO:0030515;GO:1990966;GO:0006338;GO:0019303;GO:0034656;GO:0006753;GO:0009117;GO:0009191;GO:0019693;, C:cytosol; C:extracellular exosome; C:nucleus;, F:8-oxo-dGDP phosphatase activity; F:8-oxo-GDP phosphatase activity; F:ADP-ribose diphosphatase activity; F:ADP-sugar diphosphatase activity; F:identical protein binding; F:magnesium ion binding; F:nucleotidyltransferase activity; F:protein homodimerization activity; F:snoRNA binding;, P:ATP generation from poly-ADP-D-ribose; P:chromatin remodeling; P:D-ribose catabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside phosphate metabolic process; P:nucleotide metabolic process; P:ribonucleoside diphosphate catabolic process; P:ribose phosphate metabolic process;|Q9H9S3 A8K8D0 B4DX72 F8W773,Protein transport protein Sec61 subunit alpha isoform 2,, PF10559;PF00344;, GO:0016021;GO:0005784;GO:0008320;GO:0043022;GO:0005048;GO:0031204;GO:0006616;, C:integral component of membrane; C:Sec61 translocon complex;, F:protein transmembrane transporter activity; F:ribosome binding; F:signal sequence binding;, P:posttranslational protein targeting to membrane, translocation; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61619 P38378 P57726 Q5JPF8 Q8N0Z4 Q8N3U3 Q8NC71 Q9BU16 Q9Y2R3,Protein transport protein Sec61 subunit alpha isoform 1,, PF10559;PF00344;, GO:0005789;GO:0030176;GO:0016020;GO:0005784;GO:0005262;GO:0008320;GO:0043022;GO:0005048;GO:0006613;GO:0007029;GO:0006620;GO:0031204;GO:0039019;GO:0045047;GO:0006614;GO:0006616;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:Sec61 translocon complex;, F:calcium channel activity; F:protein transmembrane transporter activity; F:ribosome binding; F:signal sequence binding;, P:cotranslational protein targeting to membrane; P:endoplasmic reticulum organization; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:pronephric nephron development; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|Q9H9S3 A8K8D0 B4DX72 F8W773,Protein transport protein Sec61 subunit alpha isoform 2,, PF10559;PF00344;, GO:0016021;GO:0005784;GO:0008320;GO:0043022;GO:0005048;GO:0031204;GO:0006616;, C:integral component of membrane; C:Sec61 translocon complex;, F:protein transmembrane transporter activity; F:ribosome binding; F:signal sequence binding;, P:posttranslational protein targeting to membrane, translocation; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|Q9H9S3 A8K8D0 B4DX72 F8W773,Protein transport protein Sec61 subunit alpha isoform 2,, PF10559;PF00344;, GO:0016021;GO:0005784;GO:0008320;GO:0043022;GO:0005048;GO:0031204;GO:0006616;, C:integral component of membrane; C:Sec61 translocon complex;, F:protein transmembrane transporter activity; F:ribosome binding; F:signal sequence binding;, P:posttranslational protein targeting to membrane, translocation; P:SRP-dependent cotranslational protein targeting to membrane, translocation; scaffold22 indexed_genome mRNA 26025667 26029441 . + . ID=transcript_5336;Q96HY7 Q68CU5 Q9BUM8 Q9HCE2,Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial,Dehydrogenase E1 and transketolase domain-containing protein 1;, PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0004591;GO:0030976;GO:0006091;GO:0006096;GO:0002244;GO:0006099;, C:mitochondrial matrix; C:mitochondrion;, F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:generation of precursor metabolites and energy; P:glycolytic process; P:hematopoietic progenitor cell differentiation; P:tricarboxylic acid cycle; scaffold22 indexed_genome mRNA 26032916 26061244 . - . ID=transcript_5337;Q96HY7 Q68CU5 Q9BUM8 Q9HCE2,Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial,Dehydrogenase E1 and transketolase domain-containing protein 1;, PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0004591;GO:0030976;GO:0006091;GO:0006096;GO:0002244;GO:0006099;, C:mitochondrial matrix; C:mitochondrion;, F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:generation of precursor metabolites and energy; P:glycolytic process; P:hematopoietic progenitor cell differentiation; P:tricarboxylic acid cycle;|Q96HY7 Q68CU5 Q9BUM8 Q9HCE2,Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial,Dehydrogenase E1 and transketolase domain-containing protein 1;, PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0004591;GO:0030976;GO:0006091;GO:0006096;GO:0002244;GO:0006099;, C:mitochondrial matrix; C:mitochondrion;, F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:generation of precursor metabolites and energy; P:glycolytic process; P:hematopoietic progenitor cell differentiation; P:tricarboxylic acid cycle;|Q96HY7 Q68CU5 Q9BUM8 Q9HCE2,Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial,Dehydrogenase E1 and transketolase domain-containing protein 1;, PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0004591;GO:0030976;GO:0006091;GO:0006096;GO:0002244;GO:0006099;, C:mitochondrial matrix; C:mitochondrion;, F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:generation of precursor metabolites and energy; P:glycolytic process; P:hematopoietic progenitor cell differentiation; P:tricarboxylic acid cycle;|Q96HY7 Q68CU5 Q9BUM8 Q9HCE2,Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial,Dehydrogenase E1 and transketolase domain-containing protein 1;, PF00676;PF16870;PF02779;, GO:0005759;GO:0005739;GO:0004591;GO:0030976;GO:0006091;GO:0006096;GO:0002244;GO:0006099;, C:mitochondrial matrix; C:mitochondrion;, F:oxoglutarate dehydrogenase (succinyl-transferring) activity; F:thiamine pyrophosphate binding;, P:generation of precursor metabolites and energy; P:glycolytic process; P:hematopoietic progenitor cell differentiation; P:tricarboxylic acid cycle; scaffold22 indexed_genome mRNA 26080317 26173570 . + . ID=transcript_5338;Q9Y4M9,Regulator of nonsense transcripts 2,Nonsense mRNA reducing factor 2;Up-frameshift suppressor 2 homolog;, PF02854;PF04050;, GO:0005737;GO:0036464;GO:0005829;GO:0035145;GO:0005634;GO:0048471;GO:0005844;GO:0003723;GO:0042162;GO:0031100;GO:0001889;GO:0006406;GO:0000184;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:exon-exon junction complex; C:nucleus; C:perinuclear region of cytoplasm; C:polysome;, F:RNA binding; F:telomeric DNA binding;, P:animal organ regeneration; P:liver development; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;|Q9Y4M9,Regulator of nonsense transcripts 2,Nonsense mRNA reducing factor 2;Up-frameshift suppressor 2 homolog;, PF02854;PF04050;, GO:0005737;GO:0036464;GO:0005829;GO:0035145;GO:0005634;GO:0048471;GO:0005844;GO:0003723;GO:0042162;GO:0031100;GO:0001889;GO:0006406;GO:0000184;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:exon-exon junction complex; C:nucleus; C:perinuclear region of cytoplasm; C:polysome;, F:RNA binding; F:telomeric DNA binding;, P:animal organ regeneration; P:liver development; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;|Q9Y4M9,Regulator of nonsense transcripts 2,Nonsense mRNA reducing factor 2;Up-frameshift suppressor 2 homolog;, PF02854;PF04050;, GO:0005737;GO:0036464;GO:0005829;GO:0035145;GO:0005634;GO:0048471;GO:0005844;GO:0003723;GO:0042162;GO:0031100;GO:0001889;GO:0006406;GO:0000184;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:exon-exon junction complex; C:nucleus; C:perinuclear region of cytoplasm; C:polysome;, F:RNA binding; F:telomeric DNA binding;, P:animal organ regeneration; P:liver development; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; scaffold22 indexed_genome mRNA 26212636 26255463 . - . ID=transcript_5339;Q86WR7 D3DRR8 Q5W0J9 Q5W0K0 Q5W0K1 Q5W0K2 Q6PJC8 Q8N317,Proline and serine-rich protein 2 scaffold22 indexed_genome mRNA 26307210 26322984 . - . ID=transcript_5340;Q96DC8 Q53HR9 Q5W0J7 Q8WYY8 Q9BVL8 Q9H7G4,Enoyl-CoA hydratase domain-containing protein 3, mitochondrial {ECO:0000305},, PF00378;, GO:0005739;GO:0004300;GO:0006631;GO:1900078;, C:mitochondrion;, F:enoyl-CoA hydratase activity;, P:fatty acid metabolic process; P:positive regulation of cellular response to insulin stimulus;|Q96DC8 Q53HR9 Q5W0J7 Q8WYY8 Q9BVL8 Q9H7G4,Enoyl-CoA hydratase domain-containing protein 3, mitochondrial {ECO:0000305},, PF00378;, GO:0005739;GO:0004300;GO:0006631;GO:1900078;, C:mitochondrion;, F:enoyl-CoA hydratase activity;, P:fatty acid metabolic process; P:positive regulation of cellular response to insulin stimulus; scaffold22 indexed_genome mRNA 26475842 26528268 . + . ID=transcript_5341;Q92738 A8KA79 Q15400 Q5VV10 Q7L0K9,USP6 N-terminal-like protein,Related to the N-terminus of tre;, PF00566;, GO:0031410;GO:0005829;GO:0005886;GO:0032588;GO:0005096;GO:0031267;GO:0090630;GO:0007030;GO:0006886;GO:0048227;GO:0043547;GO:1903358;GO:0035526;GO:0019068;, C:cytoplasmic vesicle; C:cytosol; C:plasma membrane; C:trans-Golgi network membrane;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:Golgi organization; P:intracellular protein transport; P:plasma membrane to endosome transport; P:positive regulation of GTPase activity; P:regulation of Golgi organization; P:retrograde transport, plasma membrane to Golgi; P:virion assembly; scaffold22 indexed_genome mRNA 26625766 26634461 . - . ID=transcript_5342;O95319 B7ZAN9 Q7KYU4 Q8N499 Q92950 Q96NW9 Q96RQ5 Q96RQ6 Q9UL67,CUGBP Elav-like family member 2,Bruno-like protein 3;CUG triplet repeat RNA-binding protein 2;CUG-BP- and ETR-3-like factor 2;ELAV-type RNA-binding protein 3;Neuroblastoma apoptosis-related RNA-binding protein;RNA-binding protein BRUNOL-3;, PF00076;, GO:0005737;GO:0090543;GO:0043231;GO:0005654;GO:0005634;GO:1990904;GO:0003730;GO:0003729;GO:0036002;GO:0003723;GO:0006376;GO:0000381;GO:0008016;GO:0006396;, C:cytoplasm; C:Flemming body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of heart contraction; P:RNA processing;|O95319 B7ZAN9 Q7KYU4 Q8N499 Q92950 Q96NW9 Q96RQ5 Q96RQ6 Q9UL67,CUGBP Elav-like family member 2,Bruno-like protein 3;CUG triplet repeat RNA-binding protein 2;CUG-BP- and ETR-3-like factor 2;ELAV-type RNA-binding protein 3;Neuroblastoma apoptosis-related RNA-binding protein;RNA-binding protein BRUNOL-3;, PF00076;, GO:0005737;GO:0090543;GO:0043231;GO:0005654;GO:0005634;GO:1990904;GO:0003730;GO:0003729;GO:0036002;GO:0003723;GO:0006376;GO:0000381;GO:0008016;GO:0006396;, C:cytoplasm; C:Flemming body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of heart contraction; P:RNA processing; scaffold22 indexed_genome mRNA 26638315 26782260 . - . ID=transcript_5343;O95319 B7ZAN9 Q7KYU4 Q8N499 Q92950 Q96NW9 Q96RQ5 Q96RQ6 Q9UL67,CUGBP Elav-like family member 2,Bruno-like protein 3;CUG triplet repeat RNA-binding protein 2;CUG-BP- and ETR-3-like factor 2;ELAV-type RNA-binding protein 3;Neuroblastoma apoptosis-related RNA-binding protein;RNA-binding protein BRUNOL-3;, PF00076;, GO:0005737;GO:0090543;GO:0043231;GO:0005654;GO:0005634;GO:1990904;GO:0003730;GO:0003729;GO:0036002;GO:0003723;GO:0006376;GO:0000381;GO:0008016;GO:0006396;, C:cytoplasm; C:Flemming body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of heart contraction; P:RNA processing; scaffold22 indexed_genome mRNA 29498973 29517204 . - . ID=transcript_5344;P23771 Q5VWG7 Q5VWG8 Q96J16,Trans-acting T-cell-specific transcription factor GATA-3,GATA-binding factor 3;, PF00320;, GO:0000785;GO:0005654;GO:0005634;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0071837;GO:0042802;GO:0005134;GO:0000978;GO:1990837;GO:0008134;GO:0000976;GO:0008270;GO:0048646;GO:0009653;GO:0003180;GO:0007411;GO:0007596;GO:0061290;GO:0003215;GO:0045165;GO:0001709;GO:0048469;GO:0071773;GO:0035457;GO:0071353;GO:0071356;GO:0006338;GO:0090102;GO:0019221;GO:0006952;GO:0048589;GO:0043583;GO:0035162;GO:0048568;GO:0030218;GO:0006959;GO:0002520;GO:0001701;GO:0045087;GO:0042472;GO:0001822;GO:0002088;GO:0072676;GO:0008584;GO:0060374;GO:0060231;GO:0001823;GO:0045786;GO:2000146;GO:0008285;GO:2000607;GO:1901536;GO:2000352;GO:0010719;GO:0045599;GO:2000703;GO:2000734;GO:0050728;GO:0032689;GO:0032703;GO:0033600;GO:0000122;GO:0045892;GO:0072179;GO:0072178;GO:0001764;GO:0042421;GO:0071599;GO:0060017;GO:0035898;GO:0060037;GO:0014065;GO:0010595;GO:0071442;GO:2000617;GO:0032736;GO:0032753;GO:0032754;GO:1902895;GO:0051897;GO:0009967;GO:0045582;GO:2000553;GO:2000611;GO:0045944;GO:2000679;GO:0045893;GO:0072107;GO:0009791;GO:0002572;GO:0016579;GO:0043370;GO:2000683;GO:0001817;GO:0030856;GO:2000114;GO:1902036;GO:0061085;GO:0051569;GO:0072182;GO:0043523;GO:0010975;GO:0006357;GO:0042493;GO:0043627;GO:0045471;GO:0010332;GO:0009615;GO:0007165;GO:0048485;GO:0030217;GO:0050852;GO:0045064;GO:0045061;GO:0048538;GO:0031929;GO:0001806;GO:0035799;GO:0072197;GO:0060676;GO:0060065;GO:0003281;, C:chromatin; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:HMG box domain binding; F:identical protein binding; F:interleukin-2 receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure formation involved in morphogenesis; P:anatomical structure morphogenesis; P:aortic valve morphogenesis; P:axon guidance; P:blood coagulation; P:canonical Wnt signaling pathway involved in metanephric kidney development; P:cardiac right ventricle morphogenesis; P:cell fate commitment; P:cell fate determination; P:cell maturation; P:cellular response to BMP stimulus; P:cellular response to interferon-alpha; P:cellular response to interleukin-4; P:cellular response to tumor necrosis factor; P:chromatin remodeling; P:cochlea development; P:cytokine-mediated signaling pathway; P:defense response; P:developmental growth; P:ear development; P:embryonic hemopoiesis; P:embryonic organ development; P:erythrocyte differentiation; P:humoral immune response; P:immune system development; P:in utero embryonic development; P:innate immune response; P:inner ear morphogenesis; P:kidney development; P:lens development in camera-type eye; P:lymphocyte migration; P:male gonad development; P:mast cell differentiation; P:mesenchymal to epithelial transition; P:mesonephros development; P:negative regulation of cell cycle; P:negative regulation of cell motility; P:negative regulation of cell population proliferation; P:negative regulation of cell proliferation involved in mesonephros development; P:negative regulation of DNA demethylation; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of fat cell differentiation; P:negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation; P:negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation; P:negative regulation of inflammatory response; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-2 production; P:negative regulation of mammary gland epithelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nephric duct formation; P:nephric duct morphogenesis; P:neuron migration; P:norepinephrine biosynthetic process; P:otic vesicle development; P:parathyroid gland development; P:parathyroid hormone secretion; P:pharyngeal system development; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of endothelial cell migration; P:positive regulation of histone H3-K14 acetylation; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein kinase B signaling; P:positive regulation of signal transduction; P:positive regulation of T cell differentiation; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of thyroid hormone generation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated; P:positive regulation of ureteric bud formation; P:post-embryonic development; P:pro-T cell differentiation; P:protein deubiquitination; P:regulation of CD4-positive, alpha-beta T cell differentiation; P:regulation of cellular response to X-ray; P:regulation of cytokine production; P:regulation of epithelial cell differentiation; P:regulation of establishment of cell polarity; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone H3-K27 methylation; P:regulation of histone H3-K4 methylation; P:regulation of nephron tubule epithelial cell differentiation; P:regulation of neuron apoptotic process; P:regulation of neuron projection development; P:regulation of transcription by RNA polymerase II; P:response to drug; P:response to estrogen; P:response to ethanol; P:response to gamma radiation; P:response to virus; P:signal transduction; P:sympathetic nervous system development; P:T cell differentiation; P:T cell receptor signaling pathway; P:T-helper 2 cell differentiation; P:thymic T cell selection; P:thymus development; P:TOR signaling; P:type IV hypersensitivity; P:ureter maturation; P:ureter morphogenesis; P:ureteric bud formation; P:uterus development; P:ventricular septum development; scaffold22 indexed_genome mRNA 29555390 29561942 . - . ID=transcript_5345;Q5VWG9 Q05DA0 Q6GMS5 Q6P6B5 Q86VY6 Q9BQS9 Q9UFI8,Transcription initiation factor TFIID subunit 3,140 kDa TATA box-binding protein-associated factor;TBP-associated factor 3;Transcription initiation factor TFIID 140 kDa subunit;, PF07524;PF00628;, GO:0031965;GO:0005654;GO:0005634;GO:0005669;GO:0046872;GO:0002039;GO:0046982;GO:0016251;GO:0140416;GO:0051457;GO:0043433;GO:0000122;GO:1901796;GO:0006366;GO:0006367;, C:nuclear membrane; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex;, F:metal ion binding; F:p53 binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription regulator inhibitor activity;, P:maintenance of protein location in nucleus; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold22 indexed_genome mRNA 29581300 29674330 . - . ID=transcript_5346;Q5VWG9 Q05DA0 Q6GMS5 Q6P6B5 Q86VY6 Q9BQS9 Q9UFI8,Transcription initiation factor TFIID subunit 3,140 kDa TATA box-binding protein-associated factor;TBP-associated factor 3;Transcription initiation factor TFIID 140 kDa subunit;, PF07524;PF00628;, GO:0031965;GO:0005654;GO:0005634;GO:0005669;GO:0046872;GO:0002039;GO:0046982;GO:0016251;GO:0140416;GO:0051457;GO:0043433;GO:0000122;GO:1901796;GO:0006366;GO:0006367;, C:nuclear membrane; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex;, F:metal ion binding; F:p53 binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription regulator inhibitor activity;, P:maintenance of protein location in nucleus; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold22 indexed_genome mRNA 29680676 29686105 . - . ID=transcript_5347;P36542 A8KA31 Q5VYP3 Q6I9V2 Q96AS8,ATP synthase subunit gamma, mitochondrial {ECO:0000305},ATP synthase F1 subunit gamma {ECO:0000312|HGNC:HGNC:833};F-ATPase gamma subunit;, PF00231;, GO:0016020;GO:0005743;GO:0005759;GO:0005753;GO:0000275;GO:0005739;GO:0046933;GO:0003723;GO:0006754;GO:0015986;GO:0042407;GO:0042776;GO:0006119;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1); C:mitochondrion;, F:proton-transporting ATP synthase activity, rotational mechanism; F:RNA binding;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:oxidative phosphorylation;|P36542 A8KA31 Q5VYP3 Q6I9V2 Q96AS8,ATP synthase subunit gamma, mitochondrial {ECO:0000305},ATP synthase F1 subunit gamma {ECO:0000312|HGNC:HGNC:833};F-ATPase gamma subunit;, PF00231;, GO:0016020;GO:0005743;GO:0005759;GO:0005753;GO:0000275;GO:0005739;GO:0046933;GO:0003723;GO:0006754;GO:0015986;GO:0042407;GO:0042776;GO:0006119;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1); C:mitochondrion;, F:proton-transporting ATP synthase activity, rotational mechanism; F:RNA binding;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:oxidative phosphorylation; scaffold22 indexed_genome mRNA 29686851 29689018 . - . ID=transcript_5348;P36542 A8KA31 Q5VYP3 Q6I9V2 Q96AS8,ATP synthase subunit gamma, mitochondrial {ECO:0000305},ATP synthase F1 subunit gamma {ECO:0000312|HGNC:HGNC:833};F-ATPase gamma subunit;, PF00231;, GO:0016020;GO:0005743;GO:0005759;GO:0005753;GO:0000275;GO:0005739;GO:0046933;GO:0003723;GO:0006754;GO:0015986;GO:0042407;GO:0042776;GO:0006119;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1); C:mitochondrion;, F:proton-transporting ATP synthase activity, rotational mechanism; F:RNA binding;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:oxidative phosphorylation; scaffold22 indexed_genome mRNA 29694372 29716740 . + . ID=transcript_5349;O60870 B4DX32,DNA/RNA-binding protein KIN17,Binding to curved DNA;KIN, antigenic determinant of recA protein homolog;, PF10357;PF18131;, GO:0005737;GO:0043231;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0003690;GO:0046872;GO:0003723;GO:0006974;GO:0006310;GO:0006281;GO:0006260;GO:0006397;GO:0016032;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:double-stranded DNA binding; F:metal ion binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:DNA replication; P:mRNA processing; P:viral process;|O60870 B4DX32,DNA/RNA-binding protein KIN17,Binding to curved DNA;KIN, antigenic determinant of recA protein homolog;, PF10357;PF18131;, GO:0005737;GO:0043231;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0003690;GO:0046872;GO:0003723;GO:0006974;GO:0006310;GO:0006281;GO:0006260;GO:0006397;GO:0016032;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:double-stranded DNA binding; F:metal ion binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:DNA replication; P:mRNA processing; P:viral process;|O60870 B4DX32,DNA/RNA-binding protein KIN17,Binding to curved DNA;KIN, antigenic determinant of recA protein homolog;, PF10357;PF18131;, GO:0005737;GO:0043231;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0003690;GO:0046872;GO:0003723;GO:0006974;GO:0006310;GO:0006281;GO:0006260;GO:0006397;GO:0016032;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:double-stranded DNA binding; F:metal ion binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:DNA replication; P:mRNA processing; P:viral process;|O60870 B4DX32,DNA/RNA-binding protein KIN17,Binding to curved DNA;KIN, antigenic determinant of recA protein homolog;, PF10357;PF18131;, GO:0005737;GO:0043231;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0003690;GO:0046872;GO:0003723;GO:0006974;GO:0006310;GO:0006281;GO:0006260;GO:0006397;GO:0016032;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:double-stranded DNA binding; F:metal ion binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:DNA replication; P:mRNA processing; P:viral process;|O60870 B4DX32,DNA/RNA-binding protein KIN17,Binding to curved DNA;KIN, antigenic determinant of recA protein homolog;, PF10357;PF18131;, GO:0005737;GO:0043231;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0003690;GO:0046872;GO:0003723;GO:0006974;GO:0006310;GO:0006281;GO:0006260;GO:0006397;GO:0016032;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:double-stranded DNA binding; F:metal ion binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:DNA replication; P:mRNA processing; P:viral process;|O60870 B4DX32,DNA/RNA-binding protein KIN17,Binding to curved DNA;KIN, antigenic determinant of recA protein homolog;, PF10357;PF18131;, GO:0005737;GO:0043231;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0003690;GO:0046872;GO:0003723;GO:0006974;GO:0006310;GO:0006281;GO:0006260;GO:0006397;GO:0016032;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:double-stranded DNA binding; F:metal ion binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:DNA replication; P:mRNA processing; P:viral process;|O60870 B4DX32,DNA/RNA-binding protein KIN17,Binding to curved DNA;KIN, antigenic determinant of recA protein homolog;, PF10357;PF18131;, GO:0005737;GO:0043231;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0003690;GO:0046872;GO:0003723;GO:0006974;GO:0006310;GO:0006281;GO:0006260;GO:0006397;GO:0016032;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:double-stranded DNA binding; F:metal ion binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:DNA replication; P:mRNA processing; P:viral process; scaffold22 indexed_genome mRNA 29721155 29752582 . - . ID=transcript_5350;P19823 Q14659 Q15484 Q5T986,Inter-alpha-trypsin inhibitor heavy chain H2,Inter-alpha-trypsin inhibitor complex component II;Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0004866;GO:0004867;GO:0044267;GO:0030212;GO:0043687;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:cellular protein metabolic process; P:hyaluronan metabolic process; P:post-translational protein modification;|P19823 Q14659 Q15484 Q5T986,Inter-alpha-trypsin inhibitor heavy chain H2,Inter-alpha-trypsin inhibitor complex component II;Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0004866;GO:0004867;GO:0044267;GO:0030212;GO:0043687;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:cellular protein metabolic process; P:hyaluronan metabolic process; P:post-translational protein modification;|P19823 Q14659 Q15484 Q5T986,Inter-alpha-trypsin inhibitor heavy chain H2,Inter-alpha-trypsin inhibitor complex component II;Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0004866;GO:0004867;GO:0044267;GO:0030212;GO:0043687;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:cellular protein metabolic process; P:hyaluronan metabolic process; P:post-translational protein modification; scaffold22 indexed_genome mRNA 29781629 29865878 . + . ID=transcript_5351;Q86UX2 Q5T664 Q5T665 Q5T666 Q6AI60 Q6UXB7 Q8TF48 Q8WYV2 Q96K70,Inter-alpha-trypsin inhibitor heavy chain H5,, PF06668;PF08487;PF00092;, GO:0062023;GO:0005576;GO:0004867;GO:0030212;, C:collagen-containing extracellular matrix; C:extracellular region;, F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process; scaffold22 indexed_genome mRNA 29986137 30135716 . + . ID=transcript_5352;Q5VUG0 A7MD09 Q9HCF5,Scm-like with four MBT domains protein 2,, PF02820;PF00536;PF12140;, GO:0016235;GO:0005829;GO:0043231;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0003714;GO:0010629;GO:0045892;, C:aggresome; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:transcription corepressor activity;, P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; scaffold22 indexed_genome mRNA 30551702 30635886 . + . ID=transcript_5353;Q04759 B4DF52 Q14DH6 Q3MJF1 Q64FY5 Q9H508 Q9H549,Protein kinase C theta type,nPKC-theta;, PF00130;PF00069;PF00433;, GO:0016235;GO:0034451;GO:0005829;GO:0001772;GO:0005886;GO:0005524;GO:0004698;GO:0046872;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0060326;GO:0038095;GO:0006954;GO:0035556;GO:0000165;GO:0006509;GO:0046627;GO:0070233;GO:0018105;GO:0030168;GO:0032740;GO:0032743;GO:0032753;GO:0051092;GO:0050870;GO:0042102;GO:2000318;GO:2000570;GO:0051973;GO:1904355;GO:0032212;GO:0001558;GO:0045652;GO:0090330;GO:0006355;GO:0050852;, C:aggresome; C:centriolar satellite; C:cytosol; C:immunological synapse; C:plasma membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:cell chemotaxis; P:Fc-epsilon receptor signaling pathway; P:inflammatory response; P:intracellular signal transduction; P:MAPK cascade; P:membrane protein ectodomain proteolysis; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of T cell apoptotic process; P:peptidyl-serine phosphorylation; P:platelet activation; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-4 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T cell activation; P:positive regulation of T cell proliferation; P:positive regulation of T-helper 17 type immune response; P:positive regulation of T-helper 2 cell activation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:regulation of cell growth; P:regulation of megakaryocyte differentiation; P:regulation of platelet aggregation; P:regulation of transcription, DNA-templated; P:T cell receptor signaling pathway; scaffold22 indexed_genome mRNA 30823195 30846871 . - . ID=transcript_5354;Q16875 B7Z955 O43622 O75902 Q5VX15 Q5VX18 Q5VX19,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3,6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme;Renal carcinoma antigen NY-REN-56;iPFK-2;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0006003;GO:0006000;GO:0045821;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:positive regulation of glycolytic process;|Q16875 B7Z955 O43622 O75902 Q5VX15 Q5VX18 Q5VX19,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3,6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme;Renal carcinoma antigen NY-REN-56;iPFK-2;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0006003;GO:0006000;GO:0045821;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:positive regulation of glycolytic process;|Q16875 B7Z955 O43622 O75902 Q5VX15 Q5VX18 Q5VX19,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3,6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme;Renal carcinoma antigen NY-REN-56;iPFK-2;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0006003;GO:0006000;GO:0045821;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:positive regulation of glycolytic process;|Q16875 B7Z955 O43622 O75902 Q5VX15 Q5VX18 Q5VX19,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3,6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme;Renal carcinoma antigen NY-REN-56;iPFK-2;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0006003;GO:0006000;GO:0045821;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:positive regulation of glycolytic process; scaffold22 indexed_genome mRNA 30936831 30950604 . - . ID=transcript_5355;Q96I25 Q96GY6,Splicing factor 45,45 kDa-splicing factor;RNA-binding motif protein 17;, PF01585;PF00076;, GO:0005654;GO:0005681;GO:0003723;GO:0000380;GO:0000398;GO:0043484;, C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing;|Q96I25 Q96GY6,Splicing factor 45,45 kDa-splicing factor;RNA-binding motif protein 17;, PF01585;PF00076;, GO:0005654;GO:0005681;GO:0003723;GO:0000380;GO:0000398;GO:0043484;, C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing;|Q96I25 Q96GY6,Splicing factor 45,45 kDa-splicing factor;RNA-binding motif protein 17;, PF01585;PF00076;, GO:0005654;GO:0005681;GO:0003723;GO:0000380;GO:0000398;GO:0043484;, C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; scaffold22 indexed_genome mRNA 30996400 31033277 . + . ID=transcript_5356;P01589 Q5W007,Interleukin-2 receptor subunit alpha,TAC antigen;p55;, PF00084;, GO:0009897;GO:0005893;GO:0005886;GO:0019976;GO:0004911;GO:0006924;GO:0006915;GO:0007166;GO:0019221;GO:0006955;GO:0006954;GO:0002437;GO:0038110;GO:0000165;GO:0050687;GO:0050777;GO:0050728;GO:0042130;GO:0007219;GO:0042104;GO:0045582;GO:0045589;GO:0046013;GO:0002664;, C:external side of plasma membrane; C:interleukin-2 receptor complex; C:plasma membrane;, F:interleukin-2 binding; F:interleukin-2 receptor activity;, P:activation-induced cell death of T cells; P:apoptotic process; P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:inflammatory response to antigenic stimulus; P:interleukin-2-mediated signaling pathway; P:MAPK cascade; P:negative regulation of defense response to virus; P:negative regulation of immune response; P:negative regulation of inflammatory response; P:negative regulation of T cell proliferation; P:Notch signaling pathway; P:positive regulation of activated T cell proliferation; P:positive regulation of T cell differentiation; P:regulation of regulatory T cell differentiation; P:regulation of T cell homeostatic proliferation; P:regulation of T cell tolerance induction; scaffold22 indexed_genome mRNA 31081027 31084178 . + . ID=transcript_5357;Q13261 B4E2C2 Q3B769 Q5JVA1 Q5JVA2 Q5JVA4 Q6B0J2 Q7LDR4 Q7Z609,Interleukin-15 receptor subunit alpha,, , GO:0009986;GO:0030659;GO:0005789;GO:0005768;GO:0005615;GO:0000139;GO:0016021;GO:0031965;GO:0005886;GO:0004896;GO:0042010;GO:0019901;GO:0035723;GO:0050766;, C:cell surface; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:endosome; C:extracellular space; C:Golgi membrane; C:integral component of membrane; C:nuclear membrane; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-15 receptor activity; F:protein kinase binding;, P:interleukin-15-mediated signaling pathway; P:positive regulation of phagocytosis; scaffold22 indexed_genome mRNA 31106584 31132448 . - . ID=transcript_5358;Q96SW7 Q9UFB2,F-box DNA helicase 1 {ECO:0000303|PubMed:11956208},F-box only protein 18 {ECO:0000312|HGNC:HGNC:13620};, PF12937;PF13361;, GO:0000785;GO:0005634;GO:0019005;GO:0043138;GO:0005524;GO:0003678;GO:0015616;GO:0003690;GO:0003697;GO:0008219;GO:0006974;GO:0000737;GO:0000724;GO:0035562;GO:2000042;GO:1902231;GO:0001934;GO:0016567;GO:0000725;GO:0031297;GO:0048478;GO:0072429;, C:chromatin; C:nucleus; C:SCF ubiquitin ligase complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:DNA translocase activity; F:double-stranded DNA binding; F:single-stranded DNA binding;, P:cell death; P:cellular response to DNA damage stimulus; P:DNA catabolic process, endonucleolytic; P:double-strand break repair via homologous recombination; P:negative regulation of chromatin binding; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of protein phosphorylation; P:protein ubiquitination; P:recombinational repair; P:replication fork processing; P:replication fork protection; P:response to intra-S DNA damage checkpoint signaling;|Q96SW7 Q9UFB2,F-box DNA helicase 1 {ECO:0000303|PubMed:11956208},F-box only protein 18 {ECO:0000312|HGNC:HGNC:13620};, PF12937;PF13361;, GO:0000785;GO:0005634;GO:0019005;GO:0043138;GO:0005524;GO:0003678;GO:0015616;GO:0003690;GO:0003697;GO:0008219;GO:0006974;GO:0000737;GO:0000724;GO:0035562;GO:2000042;GO:1902231;GO:0001934;GO:0016567;GO:0000725;GO:0031297;GO:0048478;GO:0072429;, C:chromatin; C:nucleus; C:SCF ubiquitin ligase complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:DNA translocase activity; F:double-stranded DNA binding; F:single-stranded DNA binding;, P:cell death; P:cellular response to DNA damage stimulus; P:DNA catabolic process, endonucleolytic; P:double-strand break repair via homologous recombination; P:negative regulation of chromatin binding; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of protein phosphorylation; P:protein ubiquitination; P:recombinational repair; P:replication fork processing; P:replication fork protection; P:response to intra-S DNA damage checkpoint signaling;|Q96SW7 Q9UFB2,F-box DNA helicase 1 {ECO:0000303|PubMed:11956208},F-box only protein 18 {ECO:0000312|HGNC:HGNC:13620};, PF12937;PF13361;, GO:0000785;GO:0005634;GO:0019005;GO:0043138;GO:0005524;GO:0003678;GO:0015616;GO:0003690;GO:0003697;GO:0008219;GO:0006974;GO:0000737;GO:0000724;GO:0035562;GO:2000042;GO:1902231;GO:0001934;GO:0016567;GO:0000725;GO:0031297;GO:0048478;GO:0072429;, C:chromatin; C:nucleus; C:SCF ubiquitin ligase complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:DNA translocase activity; F:double-stranded DNA binding; F:single-stranded DNA binding;, P:cell death; P:cellular response to DNA damage stimulus; P:DNA catabolic process, endonucleolytic; P:double-strand break repair via homologous recombination; P:negative regulation of chromatin binding; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of protein phosphorylation; P:protein ubiquitination; P:recombinational repair; P:replication fork processing; P:replication fork protection; P:response to intra-S DNA damage checkpoint signaling;|Q96SW7 Q9UFB2,F-box DNA helicase 1 {ECO:0000303|PubMed:11956208},F-box only protein 18 {ECO:0000312|HGNC:HGNC:13620};, PF12937;PF13361;, GO:0000785;GO:0005634;GO:0019005;GO:0043138;GO:0005524;GO:0003678;GO:0015616;GO:0003690;GO:0003697;GO:0008219;GO:0006974;GO:0000737;GO:0000724;GO:0035562;GO:2000042;GO:1902231;GO:0001934;GO:0016567;GO:0000725;GO:0031297;GO:0048478;GO:0072429;, C:chromatin; C:nucleus; C:SCF ubiquitin ligase complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:DNA translocase activity; F:double-stranded DNA binding; F:single-stranded DNA binding;, P:cell death; P:cellular response to DNA damage stimulus; P:DNA catabolic process, endonucleolytic; P:double-strand break repair via homologous recombination; P:negative regulation of chromatin binding; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of protein phosphorylation; P:protein ubiquitination; P:recombinational repair; P:replication fork processing; P:replication fork protection; P:response to intra-S DNA damage checkpoint signaling;|Q96SW7 Q9UFB2,F-box DNA helicase 1 {ECO:0000303|PubMed:11956208},F-box only protein 18 {ECO:0000312|HGNC:HGNC:13620};, PF12937;PF13361;, GO:0000785;GO:0005634;GO:0019005;GO:0043138;GO:0005524;GO:0003678;GO:0015616;GO:0003690;GO:0003697;GO:0008219;GO:0006974;GO:0000737;GO:0000724;GO:0035562;GO:2000042;GO:1902231;GO:0001934;GO:0016567;GO:0000725;GO:0031297;GO:0048478;GO:0072429;, C:chromatin; C:nucleus; C:SCF ubiquitin ligase complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:DNA translocase activity; F:double-stranded DNA binding; F:single-stranded DNA binding;, P:cell death; P:cellular response to DNA damage stimulus; P:DNA catabolic process, endonucleolytic; P:double-strand break repair via homologous recombination; P:negative regulation of chromatin binding; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of protein phosphorylation; P:protein ubiquitination; P:recombinational repair; P:replication fork processing; P:replication fork protection; P:response to intra-S DNA damage checkpoint signaling;|Q96SW7 Q9UFB2,F-box DNA helicase 1 {ECO:0000303|PubMed:11956208},F-box only protein 18 {ECO:0000312|HGNC:HGNC:13620};, PF12937;PF13361;, GO:0000785;GO:0005634;GO:0019005;GO:0043138;GO:0005524;GO:0003678;GO:0015616;GO:0003690;GO:0003697;GO:0008219;GO:0006974;GO:0000737;GO:0000724;GO:0035562;GO:2000042;GO:1902231;GO:0001934;GO:0016567;GO:0000725;GO:0031297;GO:0048478;GO:0072429;, C:chromatin; C:nucleus; C:SCF ubiquitin ligase complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:DNA translocase activity; F:double-stranded DNA binding; F:single-stranded DNA binding;, P:cell death; P:cellular response to DNA damage stimulus; P:DNA catabolic process, endonucleolytic; P:double-strand break repair via homologous recombination; P:negative regulation of chromatin binding; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of protein phosphorylation; P:protein ubiquitination; P:recombinational repair; P:replication fork processing; P:replication fork protection; P:response to intra-S DNA damage checkpoint signaling; scaffold22 indexed_genome mRNA 31132589 31147346 . - . ID=transcript_5359;Q96SW7 Q9UFB2,F-box DNA helicase 1 {ECO:0000303|PubMed:11956208},F-box only protein 18 {ECO:0000312|HGNC:HGNC:13620};, PF12937;PF13361;, GO:0000785;GO:0005634;GO:0019005;GO:0043138;GO:0005524;GO:0003678;GO:0015616;GO:0003690;GO:0003697;GO:0008219;GO:0006974;GO:0000737;GO:0000724;GO:0035562;GO:2000042;GO:1902231;GO:0001934;GO:0016567;GO:0000725;GO:0031297;GO:0048478;GO:0072429;, C:chromatin; C:nucleus; C:SCF ubiquitin ligase complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:DNA translocase activity; F:double-stranded DNA binding; F:single-stranded DNA binding;, P:cell death; P:cellular response to DNA damage stimulus; P:DNA catabolic process, endonucleolytic; P:double-strand break repair via homologous recombination; P:negative regulation of chromatin binding; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of protein phosphorylation; P:protein ubiquitination; P:recombinational repair; P:replication fork processing; P:replication fork protection; P:response to intra-S DNA damage checkpoint signaling;|Q96SW7 Q9UFB2,F-box DNA helicase 1 {ECO:0000303|PubMed:11956208},F-box only protein 18 {ECO:0000312|HGNC:HGNC:13620};, PF12937;PF13361;, GO:0000785;GO:0005634;GO:0019005;GO:0043138;GO:0005524;GO:0003678;GO:0015616;GO:0003690;GO:0003697;GO:0008219;GO:0006974;GO:0000737;GO:0000724;GO:0035562;GO:2000042;GO:1902231;GO:0001934;GO:0016567;GO:0000725;GO:0031297;GO:0048478;GO:0072429;, C:chromatin; C:nucleus; C:SCF ubiquitin ligase complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:DNA translocase activity; F:double-stranded DNA binding; F:single-stranded DNA binding;, P:cell death; P:cellular response to DNA damage stimulus; P:DNA catabolic process, endonucleolytic; P:double-strand break repair via homologous recombination; P:negative regulation of chromatin binding; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of protein phosphorylation; P:protein ubiquitination; P:recombinational repair; P:replication fork processing; P:replication fork protection; P:response to intra-S DNA damage checkpoint signaling; scaffold22 indexed_genome mRNA 31179719 31181888 . + . ID=transcript_5360;Q96IX9,Putative ankyrin repeat domain-containing protein 26-like 1,Ankyrin repeat domain-containing protein 36B pseudogene 1;, PF14915; scaffold22 indexed_genome mRNA 31186107 31225115 . - . ID=transcript_5361;Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation; scaffold22 indexed_genome mRNA 31252503 31254358 . + . ID=transcript_5362;Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation; scaffold22 indexed_genome mRNA 31261662 31263148 . + . ID=transcript_5363;Q9Y2I6 A6NJN0 B3V9H6 B7Z1V8 Q5JYP0 Q8NE38 Q9NQE3,Ninein-like protein,, PF13499;, GO:0005813;GO:0005829;GO:0045171;GO:0005874;GO:0015630;GO:0005509;GO:0097711;GO:0000086;GO:0034454;GO:0010389;, C:centrosome; C:cytosol; C:intercellular bridge; C:microtubule; C:microtubule cytoskeleton;, F:calcium ion binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring at centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q9Y2I6 A6NJN0 B3V9H6 B7Z1V8 Q5JYP0 Q8NE38 Q9NQE3,Ninein-like protein,, PF13499;, GO:0005813;GO:0005829;GO:0045171;GO:0005874;GO:0015630;GO:0005509;GO:0097711;GO:0000086;GO:0034454;GO:0010389;, C:centrosome; C:cytosol; C:intercellular bridge; C:microtubule; C:microtubule cytoskeleton;, F:calcium ion binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring at centrosome; P:regulation of G2/M transition of mitotic cell cycle; scaffold22 indexed_genome mRNA 31434125 31437644 . - . ID=transcript_5364;Q9Y2I6 A6NJN0 B3V9H6 B7Z1V8 Q5JYP0 Q8NE38 Q9NQE3,Ninein-like protein,, PF13499;, GO:0005813;GO:0005829;GO:0045171;GO:0005874;GO:0015630;GO:0005509;GO:0097711;GO:0000086;GO:0034454;GO:0010389;, C:centrosome; C:cytosol; C:intercellular bridge; C:microtubule; C:microtubule cytoskeleton;, F:calcium ion binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring at centrosome; P:regulation of G2/M transition of mitotic cell cycle; scaffold23 indexed_genome mRNA 12762 19009 . - . ID=transcript_5365;P04899 B3KTZ0 B4DYA0 B4E2X5 Q6B6N3 Q8IZ71,Guanine nucleotide-binding protein G(i) subunit alpha-2,Adenylate cyclase-inhibiting G alpha protein;, PF00503;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1903561;GO:0005834;GO:0016020;GO:0045121;GO:0030496;GO:0005654;GO:0005886;GO:0045202;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007189;GO:0007193;GO:0007188;GO:0007049;GO:0051301;GO:0008283;GO:0007213;GO:0001973;GO:0007186;GO:0007214;GO:0007194;GO:0140199;GO:2001234;GO:0045955;GO:1903614;GO:0050805;GO:0030168;GO:0030335;GO:0008284;GO:0070374;GO:0046628;GO:0033864;GO:2000179;GO:0035815;GO:0032930;GO:0035810;GO:1904707;GO:0006457;GO:0051924;GO:0007584;GO:0007165;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular vesicle; C:heterotrimeric G-protein complex; C:membrane; C:membrane raft; C:midbody; C:nucleoplasm; C:plasma membrane; C:synapse;, F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell cycle; P:cell division; P:cell population proliferation; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled adenosine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:negative regulation of adenylate cyclase activity; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of protein tyrosine phosphatase activity; P:negative regulation of synaptic transmission; P:platelet activation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of neural precursor cell proliferation; P:positive regulation of renal sodium excretion; P:positive regulation of superoxide anion generation; P:positive regulation of urine volume; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein folding; P:regulation of calcium ion transport; P:response to nutrient; P:signal transduction;|P04899 B3KTZ0 B4DYA0 B4E2X5 Q6B6N3 Q8IZ71,Guanine nucleotide-binding protein G(i) subunit alpha-2,Adenylate cyclase-inhibiting G alpha protein;, PF00503;, GO:0044297;GO:0005813;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1903561;GO:0005834;GO:0016020;GO:0045121;GO:0030496;GO:0005654;GO:0005886;GO:0045202;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007189;GO:0007193;GO:0007188;GO:0007049;GO:0051301;GO:0008283;GO:0007213;GO:0001973;GO:0007186;GO:0007214;GO:0007194;GO:0140199;GO:2001234;GO:0045955;GO:1903614;GO:0050805;GO:0030168;GO:0030335;GO:0008284;GO:0070374;GO:0046628;GO:0033864;GO:2000179;GO:0035815;GO:0032930;GO:0035810;GO:1904707;GO:0006457;GO:0051924;GO:0007584;GO:0007165;, C:cell body; C:centrosome; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular vesicle; C:heterotrimeric G-protein complex; C:membrane; C:membrane raft; C:midbody; C:nucleoplasm; C:plasma membrane; C:synapse;, F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell cycle; P:cell division; P:cell population proliferation; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled adenosine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:negative regulation of adenylate cyclase activity; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of protein tyrosine phosphatase activity; P:negative regulation of synaptic transmission; P:platelet activation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of neural precursor cell proliferation; P:positive regulation of renal sodium excretion; P:positive regulation of superoxide anion generation; P:positive regulation of urine volume; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein folding; P:regulation of calcium ion transport; P:response to nutrient; P:signal transduction; scaffold23 indexed_genome mRNA 27151 30560 . + . ID=transcript_5366;Q13214 Q6GU46 Q8TB71 Q8TDV7 Q93018 Q96GX0,Semaphorin-3B,Sema A(V);Semaphorin-V;, PF00047;PF01403;, GO:0062023;GO:0005783;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007267;GO:0061643;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell-cell signaling; P:chemorepulsion of axon; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q13214 Q6GU46 Q8TB71 Q8TDV7 Q93018 Q96GX0,Semaphorin-3B,Sema A(V);Semaphorin-V;, PF00047;PF01403;, GO:0062023;GO:0005783;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007267;GO:0061643;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell-cell signaling; P:chemorepulsion of axon; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q13214 Q6GU46 Q8TB71 Q8TDV7 Q93018 Q96GX0,Semaphorin-3B,Sema A(V);Semaphorin-V;, PF00047;PF01403;, GO:0062023;GO:0005783;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007267;GO:0061643;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell-cell signaling; P:chemorepulsion of axon; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold23 indexed_genome mRNA 31250 35489 . + . ID=transcript_5367;Q13214 Q6GU46 Q8TB71 Q8TDV7 Q93018 Q96GX0,Semaphorin-3B,Sema A(V);Semaphorin-V;, PF00047;PF01403;, GO:0062023;GO:0005783;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007267;GO:0061643;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell-cell signaling; P:chemorepulsion of axon; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q13214 Q6GU46 Q8TB71 Q8TDV7 Q93018 Q96GX0,Semaphorin-3B,Sema A(V);Semaphorin-V;, PF00047;PF01403;, GO:0062023;GO:0005783;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007267;GO:0061643;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell-cell signaling; P:chemorepulsion of axon; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q13214 Q6GU46 Q8TB71 Q8TDV7 Q93018 Q96GX0,Semaphorin-3B,Sema A(V);Semaphorin-V;, PF00047;PF01403;, GO:0062023;GO:0005783;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007267;GO:0061643;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell-cell signaling; P:chemorepulsion of axon; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q13214 Q6GU46 Q8TB71 Q8TDV7 Q93018 Q96GX0,Semaphorin-3B,Sema A(V);Semaphorin-V;, PF00047;PF01403;, GO:0062023;GO:0005783;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007267;GO:0061643;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:cell-cell signaling; P:chemorepulsion of axon; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold23 indexed_genome mRNA 51563 84422 . + . ID=transcript_5368;Q8N112,Leucine-rich single-pass membrane protein 2,, PF15833;, GO:0016021;, C:integral component of membrane;|Q12894 Q9BVB4 Q9UJ88,Interferon-related developmental regulator 2,Protein SKMC15;, PF05004;PF04836;, GO:0005634;, C:nucleus;|Q12894 Q9BVB4 Q9UJ88,Interferon-related developmental regulator 2,Protein SKMC15;, PF05004;PF04836;, GO:0005634;, C:nucleus;|Q12894 Q9BVB4 Q9UJ88,Interferon-related developmental regulator 2,Protein SKMC15;, PF05004;PF04836;, GO:0005634;, C:nucleus;|Q12894 Q9BVB4 Q9UJ88,Interferon-related developmental regulator 2,Protein SKMC15;, PF05004;PF04836;, GO:0005634;, C:nucleus;|Q12894 Q9BVB4 Q9UJ88,Interferon-related developmental regulator 2,Protein SKMC15;, PF05004;PF04836;, GO:0005634;, C:nucleus;|O43820 O60540 Q8NFK2 Q8NFK3 Q8NFK4 Q96E56 Q9BRW9,Hyaluronidase-3,Hyaluronoglucosaminidase-3;Lung carcinoma protein 3;, PF01630;, GO:0002080;GO:0001669;GO:0031410;GO:0005769;GO:0005783;GO:0005576;GO:0005764;GO:0005886;GO:0097225;GO:0033906;GO:0004415;GO:0005975;GO:0051216;GO:0071347;GO:0071356;GO:0071493;GO:0030214;GO:0006954;GO:2000355;GO:0001552;GO:0007341;GO:2000368;GO:0046677;GO:0009615;GO:0046718;, C:acrosomal membrane; C:acrosomal vesicle; C:cytoplasmic vesicle; C:early endosome; C:endoplasmic reticulum; C:extracellular region; C:lysosome; C:plasma membrane; C:sperm midpiece;, F:hyaluronoglucuronidase activity; F:hyalurononglucosaminidase activity;, P:carbohydrate metabolic process; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to UV-B; P:hyaluronan catabolic process; P:inflammatory response; P:negative regulation of ovarian follicle development; P:ovarian follicle atresia; P:penetration of zona pellucida; P:positive regulation of acrosomal vesicle exocytosis; P:response to antibiotic; P:response to virus; P:viral entry into host cell;|Q93015 Q93014,N-alpha-acetyltransferase 80,N-acetyltransferase 6 {ECO:0000303|PubMed:30028079};Protein fusion-2 {ECO:0000303|PubMed:10644992};, PF00583;, GO:0005737;GO:0005829;GO:1905502;GO:0008080;GO:0004596;GO:0030047;GO:0017190;GO:0018002;GO:0006473;GO:0008064;, C:cytoplasm; C:cytosol;, F:acetyl-CoA binding; F:N-acetyltransferase activity; F:peptide alpha-N-acetyltransferase activity;, P:actin modification; P:N-terminal peptidyl-aspartic acid acetylation; P:N-terminal peptidyl-glutamic acid acetylation; P:protein acetylation; P:regulation of actin polymerization or depolymerization; scaffold23 indexed_genome mRNA 84751 88091 . - . ID=transcript_5369;Q8NFK9 Q93013 Q9UKD5 Q9UNI8,Hyaluronidase-1,Hyaluronoglucosaminidase-1;Lung carcinoma protein 1;, PF01630;, GO:0005737;GO:0031410;GO:0070062;GO:0005615;GO:0036117;GO:0043202;GO:0005764;GO:0050501;GO:0004415;GO:0008134;GO:0005975;GO:0051216;GO:0044344;GO:0071347;GO:0071467;GO:0036120;GO:0071356;GO:0071493;GO:0030207;GO:0060272;GO:0030213;GO:0030214;GO:0030212;GO:0006954;GO:0030308;GO:0045766;GO:0045785;GO:0030307;GO:0010634;GO:0050679;GO:1900087;GO:0045927;GO:1900106;GO:0046677;GO:0000302;GO:0009615;GO:0046718;, C:cytoplasm; C:cytoplasmic vesicle; C:extracellular exosome; C:extracellular space; C:hyaluranon cable; C:lysosomal lumen; C:lysosome;, F:hyaluronan synthase activity; F:hyalurononglucosaminidase activity; F:transcription factor binding;, P:carbohydrate metabolic process; P:cartilage development; P:cellular response to fibroblast growth factor stimulus; P:cellular response to interleukin-1; P:cellular response to pH; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to tumor necrosis factor; P:cellular response to UV-B; P:chondroitin sulfate catabolic process; P:embryonic skeletal joint morphogenesis; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:hyaluronan metabolic process; P:inflammatory response; P:negative regulation of cell growth; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:positive regulation of cell growth; P:positive regulation of epithelial cell migration; P:positive regulation of epithelial cell proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of growth; P:positive regulation of hyaluranon cable assembly; P:response to antibiotic; P:response to reactive oxygen species; P:response to virus; P:viral entry into host cell; scaffold23 indexed_genome mRNA 90984 101459 . + . ID=transcript_5370;Q12891 B3KRZ2 O15177 Q9BW29,Hyaluronidase-2,Hyaluronoglucosaminidase-2;Lung carcinoma protein 2;, PF01630;, GO:0031362;GO:0046658;GO:0016324;GO:0009986;GO:0005737;GO:0031410;GO:0005829;GO:0030139;GO:0005783;GO:0000139;GO:0005764;GO:0045121;GO:0005902;GO:0048471;GO:0005886;GO:0090575;GO:0019899;GO:0005540;GO:0033906;GO:0004415;GO:0030294;GO:0030971;GO:0003713;GO:0050431;GO:0001618;GO:0005975;GO:0051216;GO:0044344;GO:0071347;GO:0071560;GO:0071356;GO:0071493;GO:0051607;GO:0019064;GO:0006027;GO:0002244;GO:0030214;GO:0001822;GO:0042117;GO:0010259;GO:0060586;GO:0030308;GO:0010764;GO:0043407;GO:0051898;GO:0061099;GO:2001238;GO:0050729;GO:0032755;GO:0032757;GO:0042307;GO:0045944;GO:0035810;GO:0070295;GO:0046677;GO:0000302;GO:0009615;GO:0048705;GO:0019087;GO:0046718;, C:anchored component of external side of plasma membrane; C:anchored component of plasma membrane; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:Golgi membrane; C:lysosome; C:membrane raft; C:microvillus; C:perinuclear region of cytoplasm; C:plasma membrane; C:RNA polymerase II transcription regulator complex;, F:enzyme binding; F:hyaluronic acid binding; F:hyaluronoglucuronidase activity; F:hyalurononglucosaminidase activity; F:receptor signaling protein tyrosine kinase inhibitor activity; F:receptor tyrosine kinase binding; F:transcription coactivator activity; F:transforming growth factor beta binding; F:virus receptor activity;, P:carbohydrate metabolic process; P:cartilage development; P:cellular response to fibroblast growth factor stimulus; P:cellular response to interleukin-1; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:cellular response to UV-B; P:defense response to virus; P:fusion of virus membrane with host plasma membrane; P:glycosaminoglycan catabolic process; P:hematopoietic progenitor cell differentiation; P:hyaluronan catabolic process; P:kidney development; P:monocyte activation; P:multicellular organism aging; P:multicellular organismal iron ion homeostasis; P:negative regulation of cell growth; P:negative regulation of fibroblast migration; P:negative regulation of MAP kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein tyrosine kinase activity; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of protein import into nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of urine volume; P:renal water absorption; P:response to antibiotic; P:response to reactive oxygen species; P:response to virus; P:skeletal system morphogenesis; P:transformation of host cell by virus; P:viral entry into host cell;|O75896 B2R4Y9,Tumor suppressor candidate 2,Fusion 1 protein;PDGFA-associated protein 2;, PF15000;, GO:0005739;GO:0007049;GO:0048469;GO:0006954;GO:0001779;GO:0032700;GO:0070945;GO:0006909;GO:0032733;GO:0051881;GO:2000377;, C:mitochondrion;, , P:cell cycle; P:cell maturation; P:inflammatory response; P:natural killer cell differentiation; P:negative regulation of interleukin-17 production; P:neutrophil-mediated killing of gram-negative bacterium; P:phagocytosis; P:positive regulation of interleukin-10 production; P:regulation of mitochondrial membrane potential; P:regulation of reactive oxygen species metabolic process;|O75896 B2R4Y9,Tumor suppressor candidate 2,Fusion 1 protein;PDGFA-associated protein 2;, PF15000;, GO:0005739;GO:0007049;GO:0048469;GO:0006954;GO:0001779;GO:0032700;GO:0070945;GO:0006909;GO:0032733;GO:0051881;GO:2000377;, C:mitochondrion;, , P:cell cycle; P:cell maturation; P:inflammatory response; P:natural killer cell differentiation; P:negative regulation of interleukin-17 production; P:neutrophil-mediated killing of gram-negative bacterium; P:phagocytosis; P:positive regulation of interleukin-10 production; P:regulation of mitochondrial membrane potential; P:regulation of reactive oxygen species metabolic process; scaffold23 indexed_genome mRNA 102186 108146 . - . ID=transcript_5371;Q9NS22 Q9UND4 Q9UND5,Ras association domain-containing protein 1,, PF16517;PF00788;, GO:0005737;GO:0005874;GO:0015630;GO:0005815;GO:0005634;GO:0000922;GO:0042802;GO:0047485;GO:0008270;GO:0007050;GO:0006974;GO:0071157;GO:0031398;GO:0050821;GO:0007265;GO:0070507;GO:0007165;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:nucleus; C:spindle pole;, F:identical protein binding; F:protein N-terminus binding; F:zinc ion binding;, P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:negative regulation of cell cycle arrest; P:positive regulation of protein ubiquitination; P:protein stabilization; P:Ras protein signal transduction; P:regulation of microtubule cytoskeleton organization; P:signal transduction;|Q9NS22 Q9UND4 Q9UND5,Ras association domain-containing protein 1,, PF16517;PF00788;, GO:0005737;GO:0005874;GO:0015630;GO:0005815;GO:0005634;GO:0000922;GO:0042802;GO:0047485;GO:0008270;GO:0007050;GO:0006974;GO:0071157;GO:0031398;GO:0050821;GO:0007265;GO:0070507;GO:0007165;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:nucleus; C:spindle pole;, F:identical protein binding; F:protein N-terminus binding; F:zinc ion binding;, P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:negative regulation of cell cycle arrest; P:positive regulation of protein ubiquitination; P:protein stabilization; P:Ras protein signal transduction; P:regulation of microtubule cytoskeleton organization; P:signal transduction;|Q9NS22 Q9UND4 Q9UND5,Ras association domain-containing protein 1,, PF16517;PF00788;, GO:0005737;GO:0005874;GO:0015630;GO:0005815;GO:0005634;GO:0000922;GO:0042802;GO:0047485;GO:0008270;GO:0007050;GO:0006974;GO:0071157;GO:0031398;GO:0050821;GO:0007265;GO:0070507;GO:0007165;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:nucleus; C:spindle pole;, F:identical protein binding; F:protein N-terminus binding; F:zinc ion binding;, P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:negative regulation of cell cycle arrest; P:positive regulation of protein ubiquitination; P:protein stabilization; P:Ras protein signal transduction; P:regulation of microtubule cytoskeleton organization; P:signal transduction; scaffold23 indexed_genome mRNA 111357 115691 . + . ID=transcript_5372;O75800 A6NK41 B3KU54 O14570 O75801 Q53FE6 Q8N4R6 Q8NDN6,Zinc finger MYND domain-containing protein 10 {ECO:0000305},Protein BLu {ECO:0000303|Ref.1};, PF01753;, GO:0016324;GO:0034451;GO:0005737;GO:0046872;GO:0060090;GO:0044183;GO:0003341;GO:0036159;GO:0044458;GO:0036158;GO:1905505;GO:0061512;, C:apical plasma membrane; C:centriolar satellite; C:cytoplasm;, F:metal ion binding; F:molecular adaptor activity; F:protein folding chaperone;, P:cilium movement; P:inner dynein arm assembly; P:motile cilium assembly; P:outer dynein arm assembly; P:positive regulation of motile cilium assembly; P:protein localization to cilium; scaffold23 indexed_genome mRNA 117235 123327 . - . ID=transcript_5373;Q8WTW4 A8K831 Q6FGS2 Q9Y249 Q9Y497,GATOR complex protein NPRL2 {ECO:0000305},Gene 21 protein {ECO:0000303|Ref.1};Nitrogen permease regulator 2-like protein {ECO:0000303|PubMed:11085536};Tumor suppressor candidate 4 {ECO:0000303|PubMed:18616680};, PF06218;, GO:1990130;GO:0005765;GO:0005096;GO:0004672;GO:0034198;GO:0006995;GO:0033673;GO:0032007;GO:0010508;GO:2000785;, C:GATOR1 complex; C:lysosomal membrane;, F:GTPase activator activity; F:protein kinase activity;, P:cellular response to amino acid starvation; P:cellular response to nitrogen starvation; P:negative regulation of kinase activity; P:negative regulation of TOR signaling; P:positive regulation of autophagy; P:regulation of autophagosome assembly;|Q8WTW4 A8K831 Q6FGS2 Q9Y249 Q9Y497,GATOR complex protein NPRL2 {ECO:0000305},Gene 21 protein {ECO:0000303|Ref.1};Nitrogen permease regulator 2-like protein {ECO:0000303|PubMed:11085536};Tumor suppressor candidate 4 {ECO:0000303|PubMed:18616680};, PF06218;, GO:1990130;GO:0005765;GO:0005096;GO:0004672;GO:0034198;GO:0006995;GO:0033673;GO:0032007;GO:0010508;GO:2000785;, C:GATOR1 complex; C:lysosomal membrane;, F:GTPase activator activity; F:protein kinase activity;, P:cellular response to amino acid starvation; P:cellular response to nitrogen starvation; P:negative regulation of kinase activity; P:negative regulation of TOR signaling; P:positive regulation of autophagy; P:regulation of autophagosome assembly;|Q8WTW4 A8K831 Q6FGS2 Q9Y249 Q9Y497,GATOR complex protein NPRL2 {ECO:0000305},Gene 21 protein {ECO:0000303|Ref.1};Nitrogen permease regulator 2-like protein {ECO:0000303|PubMed:11085536};Tumor suppressor candidate 4 {ECO:0000303|PubMed:18616680};, PF06218;, GO:1990130;GO:0005765;GO:0005096;GO:0004672;GO:0034198;GO:0006995;GO:0033673;GO:0032007;GO:0010508;GO:2000785;, C:GATOR1 complex; C:lysosomal membrane;, F:GTPase activator activity; F:protein kinase activity;, P:cellular response to amino acid starvation; P:cellular response to nitrogen starvation; P:negative regulation of kinase activity; P:negative regulation of TOR signaling; P:positive regulation of autophagy; P:regulation of autophagosome assembly;|Q8WTW4 A8K831 Q6FGS2 Q9Y249 Q9Y497,GATOR complex protein NPRL2 {ECO:0000305},Gene 21 protein {ECO:0000303|Ref.1};Nitrogen permease regulator 2-like protein {ECO:0000303|PubMed:11085536};Tumor suppressor candidate 4 {ECO:0000303|PubMed:18616680};, PF06218;, GO:1990130;GO:0005765;GO:0005096;GO:0004672;GO:0034198;GO:0006995;GO:0033673;GO:0032007;GO:0010508;GO:2000785;, C:GATOR1 complex; C:lysosomal membrane;, F:GTPase activator activity; F:protein kinase activity;, P:cellular response to amino acid starvation; P:cellular response to nitrogen starvation; P:negative regulation of kinase activity; P:negative regulation of TOR signaling; P:positive regulation of autophagy; P:regulation of autophagosome assembly;|Q8WTW4 A8K831 Q6FGS2 Q9Y249 Q9Y497,GATOR complex protein NPRL2 {ECO:0000305},Gene 21 protein {ECO:0000303|Ref.1};Nitrogen permease regulator 2-like protein {ECO:0000303|PubMed:11085536};Tumor suppressor candidate 4 {ECO:0000303|PubMed:18616680};, PF06218;, GO:1990130;GO:0005765;GO:0005096;GO:0004672;GO:0034198;GO:0006995;GO:0033673;GO:0032007;GO:0010508;GO:2000785;, C:GATOR1 complex; C:lysosomal membrane;, F:GTPase activator activity; F:protein kinase activity;, P:cellular response to amino acid starvation; P:cellular response to nitrogen starvation; P:negative regulation of kinase activity; P:negative regulation of TOR signaling; P:positive regulation of autophagy; P:regulation of autophagosome assembly;|O14569 A8K552,Cytochrome b561 domain-containing protein 2,Putative tumor suppressor protein 101F6 {ECO:0000303|PubMed:19734123};Transmembrane ascorbate ferrireductase {ECO:0000305|PubMed:23235316, ECO:0000305|PubMed:23641721};, PF03188;, GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0031982;GO:0004322;GO:0020037;GO:0046872;GO:0016491;GO:0140571;, C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:vesicle;, F:ferroxidase activity; F:heme binding; F:metal ion binding; F:oxidoreductase activity; F:transmembrane ascorbate ferrireductase activity;|O14569 A8K552,Cytochrome b561 domain-containing protein 2,Putative tumor suppressor protein 101F6 {ECO:0000303|PubMed:19734123};Transmembrane ascorbate ferrireductase {ECO:0000305|PubMed:23235316, ECO:0000305|PubMed:23641721};, PF03188;, GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0031982;GO:0004322;GO:0020037;GO:0046872;GO:0016491;GO:0140571;, C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:vesicle;, F:ferroxidase activity; F:heme binding; F:metal ion binding; F:oxidoreductase activity; F:transmembrane ascorbate ferrireductase activity; scaffold23 indexed_genome mRNA 124090 129550 . - . ID=transcript_5374;Q12893 A2IDB7 O14568 Q6IAY4 Q9UIX3,Transmembrane protein 115 {ECO:0000305},Placental protein 6 {ECO:0000305};Protein PL6 {ECO:0000305};, PF08551;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0005634;GO:0042802;GO:0006888;GO:0008285;GO:0015031;GO:0006890;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:nucleus;, F:identical protein binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of cell population proliferation; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold23 indexed_genome mRNA 131776 148327 . - . ID=transcript_5375;Q9NY47 A7MD15 Q9NY48 Q9UEW0 Q9Y268,Voltage-dependent calcium channel subunit alpha-2/delta-2,Voltage-gated calcium channel subunit alpha-2/delta-2;, PF08473;PF00092;PF08399;, GO:0005886;GO:0005891;GO:0046872;GO:0005245;GO:0061337;GO:0050796;GO:0034765;, C:plasma membrane; C:voltage-gated calcium channel complex;, F:metal ion binding; F:voltage-gated calcium channel activity;, P:cardiac conduction; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; scaffold23 indexed_genome mRNA 316532 325039 . - . ID=transcript_5376;Q9UK00 C9JNP0,Uncharacterized protein C3orf18,Protein G20;, , GO:0016021;, C:integral component of membrane;|Q9UK00 C9JNP0,Uncharacterized protein C3orf18,Protein G20;, , GO:0016021;, C:integral component of membrane;|Q9UK00 C9JNP0,Uncharacterized protein C3orf18,Protein G20;, , GO:0016021;, C:integral component of membrane; scaffold23 indexed_genome mRNA 326516 331745 . - . ID=transcript_5377;Q9Y5R4,MTRF1L release factor glutamine methyltransferase {ECO:0000303|PubMed:18541145},HemK methyltransferase family member 1;M.HsaHemKP;, PF05175;PF17827;, GO:0005739;GO:0003677;GO:0008170;GO:0008276;GO:0102559;GO:0006306;, C:mitochondrion;, F:DNA binding; F:N-methyltransferase activity; F:protein methyltransferase activity; F:protein-(glutamine-N5) methyltransferase activity;, P:DNA methylation;|Q9Y5R4,MTRF1L release factor glutamine methyltransferase {ECO:0000303|PubMed:18541145},HemK methyltransferase family member 1;M.HsaHemKP;, PF05175;PF17827;, GO:0005739;GO:0003677;GO:0008170;GO:0008276;GO:0102559;GO:0006306;, C:mitochondrion;, F:DNA binding; F:N-methyltransferase activity; F:protein methyltransferase activity; F:protein-(glutamine-N5) methyltransferase activity;, P:DNA methylation;|Q9Y5R4,MTRF1L release factor glutamine methyltransferase {ECO:0000303|PubMed:18541145},HemK methyltransferase family member 1;M.HsaHemKP;, PF05175;PF17827;, GO:0005739;GO:0003677;GO:0008170;GO:0008276;GO:0102559;GO:0006306;, C:mitochondrion;, F:DNA binding; F:N-methyltransferase activity; F:protein methyltransferase activity; F:protein-(glutamine-N5) methyltransferase activity;, P:DNA methylation; scaffold23 indexed_genome mRNA 333439 336762 . + . ID=transcript_5378;Q9Y5R4,MTRF1L release factor glutamine methyltransferase {ECO:0000303|PubMed:18541145},HemK methyltransferase family member 1;M.HsaHemKP;, PF05175;PF17827;, GO:0005739;GO:0003677;GO:0008170;GO:0008276;GO:0102559;GO:0006306;, C:mitochondrion;, F:DNA binding; F:N-methyltransferase activity; F:protein methyltransferase activity; F:protein-(glutamine-N5) methyltransferase activity;, P:DNA methylation;|Q9Y5R4,MTRF1L release factor glutamine methyltransferase {ECO:0000303|PubMed:18541145},HemK methyltransferase family member 1;M.HsaHemKP;, PF05175;PF17827;, GO:0005739;GO:0003677;GO:0008170;GO:0008276;GO:0102559;GO:0006306;, C:mitochondrion;, F:DNA binding; F:N-methyltransferase activity; F:protein methyltransferase activity; F:protein-(glutamine-N5) methyltransferase activity;, P:DNA methylation; scaffold23 indexed_genome mRNA 359163 364562 . - . ID=transcript_5379;Q9NSE2 B2R9N1 G5E9R1 Q9NS38 Q9Y5R1,Cytokine-inducible SH2-containing protein,CIS-1;Protein G18;Suppressor of cytokine signaling;, PF00017;PF07525;, GO:0005829;GO:0005942;GO:0005886;GO:0046935;GO:0038111;GO:0035556;GO:0009968;GO:0046854;GO:0043687;GO:0007205;GO:0016567;GO:0001558;, C:cytosol; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity;, P:interleukin-7-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:phosphatidylinositol phosphorylation; P:post-translational protein modification; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein ubiquitination; P:regulation of cell growth;|Q9NSE2 B2R9N1 G5E9R1 Q9NS38 Q9Y5R1,Cytokine-inducible SH2-containing protein,CIS-1;Protein G18;Suppressor of cytokine signaling;, PF00017;PF07525;, GO:0005829;GO:0005942;GO:0005886;GO:0046935;GO:0038111;GO:0035556;GO:0009968;GO:0046854;GO:0043687;GO:0007205;GO:0016567;GO:0001558;, C:cytosol; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity;, P:interleukin-7-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:phosphatidylinositol phosphorylation; P:post-translational protein modification; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein ubiquitination; P:regulation of cell growth;|Q9NSE2 B2R9N1 G5E9R1 Q9NS38 Q9Y5R1,Cytokine-inducible SH2-containing protein,CIS-1;Protein G18;Suppressor of cytokine signaling;, PF00017;PF07525;, GO:0005829;GO:0005942;GO:0005886;GO:0046935;GO:0038111;GO:0035556;GO:0009968;GO:0046854;GO:0043687;GO:0007205;GO:0016567;GO:0001558;, C:cytosol; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity;, P:interleukin-7-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:phosphatidylinositol phosphorylation; P:post-translational protein modification; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein ubiquitination; P:regulation of cell growth; scaffold23 indexed_genome mRNA 376743 405163 . - . ID=transcript_5380;Q16644 B5BU67,MAP kinase-activated protein kinase 3,Chromosome 3p kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0106310;GO:0004674;GO:0106311;GO:0000187;GO:0035556;GO:0044351;GO:0018105;GO:0046777;GO:0034097;GO:0032496;GO:0007165;GO:0002224;GO:0048010;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:intracellular signal transduction; P:macropinocytosis; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:response to cytokine; P:response to lipopolysaccharide; P:signal transduction; P:toll-like receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q16644 B5BU67,MAP kinase-activated protein kinase 3,Chromosome 3p kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0106310;GO:0004674;GO:0106311;GO:0000187;GO:0035556;GO:0044351;GO:0018105;GO:0046777;GO:0034097;GO:0032496;GO:0007165;GO:0002224;GO:0048010;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:intracellular signal transduction; P:macropinocytosis; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:response to cytokine; P:response to lipopolysaccharide; P:signal transduction; P:toll-like receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q16644 B5BU67,MAP kinase-activated protein kinase 3,Chromosome 3p kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0106310;GO:0004674;GO:0106311;GO:0000187;GO:0035556;GO:0044351;GO:0018105;GO:0046777;GO:0034097;GO:0032496;GO:0007165;GO:0002224;GO:0048010;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:intracellular signal transduction; P:macropinocytosis; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:response to cytokine; P:response to lipopolysaccharide; P:signal transduction; P:toll-like receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q16644 B5BU67,MAP kinase-activated protein kinase 3,Chromosome 3p kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0106310;GO:0004674;GO:0106311;GO:0000187;GO:0035556;GO:0044351;GO:0018105;GO:0046777;GO:0034097;GO:0032496;GO:0007165;GO:0002224;GO:0048010;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:intracellular signal transduction; P:macropinocytosis; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:response to cytokine; P:response to lipopolysaccharide; P:signal transduction; P:toll-like receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold23 indexed_genome mRNA 459976 674594 . + . ID=transcript_5381;Q8IZD9 O15017,Dedicator of cytokinesis protein 3,Modifier of cell adhesion;Presenilin-binding protein;, PF06920;PF14429;PF16172;PF07653;, GO:0005829;GO:0005085;GO:0017124;GO:1903997;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:small GTPase mediated signal transduction;|Q8IZD9 O15017,Dedicator of cytokinesis protein 3,Modifier of cell adhesion;Presenilin-binding protein;, PF06920;PF14429;PF16172;PF07653;, GO:0005829;GO:0005085;GO:0017124;GO:1903997;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:small GTPase mediated signal transduction;|Q8IZD9 O15017,Dedicator of cytokinesis protein 3,Modifier of cell adhesion;Presenilin-binding protein;, PF06920;PF14429;PF16172;PF07653;, GO:0005829;GO:0005085;GO:0017124;GO:1903997;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:small GTPase mediated signal transduction;|Q8IZD9 O15017,Dedicator of cytokinesis protein 3,Modifier of cell adhesion;Presenilin-binding protein;, PF06920;PF14429;PF16172;PF07653;, GO:0005829;GO:0005085;GO:0017124;GO:1903997;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:small GTPase mediated signal transduction; scaffold23 indexed_genome mRNA 678274 690470 . + . ID=transcript_5382;Q8IZD9 O15017,Dedicator of cytokinesis protein 3,Modifier of cell adhesion;Presenilin-binding protein;, PF06920;PF14429;PF16172;PF07653;, GO:0005829;GO:0005085;GO:0017124;GO:1903997;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:small GTPase mediated signal transduction;|Q8IZD9 O15017,Dedicator of cytokinesis protein 3,Modifier of cell adhesion;Presenilin-binding protein;, PF06920;PF14429;PF16172;PF07653;, GO:0005829;GO:0005085;GO:0017124;GO:1903997;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:small GTPase mediated signal transduction; scaffold23 indexed_genome mRNA 690657 694574 . + . ID=transcript_5383;P55145 Q14CX4 Q86U67 Q96IS4,Mesencephalic astrocyte-derived neurotrophic factor,Arginine-rich protein;Protein ARMET;, PF10208;, GO:0005829;GO:0005783;GO:0005788;GO:0005576;GO:0005615;GO:0005634;GO:0048471;GO:0033018;GO:0008083;GO:0003723;GO:0120146;GO:0071542;GO:0031175;GO:0002576;GO:1905897;GO:0006986;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:nucleus; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum lumen;, F:growth factor activity; F:RNA binding; F:sulfatide binding;, P:dopaminergic neuron differentiation; P:neuron projection development; P:platelet degranulation; P:regulation of response to endoplasmic reticulum stress; P:response to unfolded protein; scaffold23 indexed_genome mRNA 703800 727710 . - . ID=transcript_5384;Q9Y4B6 Q2YD74 Q8TBD9 Q9HCA1 Q9UG37,DDB1- and CUL4-associated factor 1 {ECO:0000312|HGNC:HGNC:30911},HIV-1 Vpr-binding protein;Serine/threonine-protein kinase VPRBP;Vpr-interacting protein;, , GO:0080008;GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0030331;GO:1990244;GO:0106310;GO:0106311;GO:0030183;GO:0035212;GO:1990245;GO:0000122;GO:0016567;GO:0033151;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:estrogen receptor binding; F:histone kinase activity (H2A-T120 specific); F:protein serine kinase activity; F:protein threonine kinase activity;, P:B cell differentiation; P:cell competition in a multicellular organism; P:histone H2A-T120 phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:protein ubiquitination; P:V(D)J recombination; P:viral process;|Q9Y4B6 Q2YD74 Q8TBD9 Q9HCA1 Q9UG37,DDB1- and CUL4-associated factor 1 {ECO:0000312|HGNC:HGNC:30911},HIV-1 Vpr-binding protein;Serine/threonine-protein kinase VPRBP;Vpr-interacting protein;, , GO:0080008;GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0030331;GO:1990244;GO:0106310;GO:0106311;GO:0030183;GO:0035212;GO:1990245;GO:0000122;GO:0016567;GO:0033151;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:estrogen receptor binding; F:histone kinase activity (H2A-T120 specific); F:protein serine kinase activity; F:protein threonine kinase activity;, P:B cell differentiation; P:cell competition in a multicellular organism; P:histone H2A-T120 phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:protein ubiquitination; P:V(D)J recombination; P:viral process;|Q9Y4B6 Q2YD74 Q8TBD9 Q9HCA1 Q9UG37,DDB1- and CUL4-associated factor 1 {ECO:0000312|HGNC:HGNC:30911},HIV-1 Vpr-binding protein;Serine/threonine-protein kinase VPRBP;Vpr-interacting protein;, , GO:0080008;GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0030331;GO:1990244;GO:0106310;GO:0106311;GO:0030183;GO:0035212;GO:1990245;GO:0000122;GO:0016567;GO:0033151;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:estrogen receptor binding; F:histone kinase activity (H2A-T120 specific); F:protein serine kinase activity; F:protein threonine kinase activity;, P:B cell differentiation; P:cell competition in a multicellular organism; P:histone H2A-T120 phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:protein ubiquitination; P:V(D)J recombination; P:viral process;|Q9Y4B6 Q2YD74 Q8TBD9 Q9HCA1 Q9UG37,DDB1- and CUL4-associated factor 1 {ECO:0000312|HGNC:HGNC:30911},HIV-1 Vpr-binding protein;Serine/threonine-protein kinase VPRBP;Vpr-interacting protein;, , GO:0080008;GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0030331;GO:1990244;GO:0106310;GO:0106311;GO:0030183;GO:0035212;GO:1990245;GO:0000122;GO:0016567;GO:0033151;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:estrogen receptor binding; F:histone kinase activity (H2A-T120 specific); F:protein serine kinase activity; F:protein threonine kinase activity;, P:B cell differentiation; P:cell competition in a multicellular organism; P:histone H2A-T120 phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:protein ubiquitination; P:V(D)J recombination; P:viral process; scaffold23 indexed_genome mRNA 729250 796247 . + . ID=transcript_5385;Q9Y4B6 Q2YD74 Q8TBD9 Q9HCA1 Q9UG37,DDB1- and CUL4-associated factor 1 {ECO:0000312|HGNC:HGNC:30911},HIV-1 Vpr-binding protein;Serine/threonine-protein kinase VPRBP;Vpr-interacting protein;, , GO:0080008;GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0030331;GO:1990244;GO:0106310;GO:0106311;GO:0030183;GO:0035212;GO:1990245;GO:0000122;GO:0016567;GO:0033151;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:estrogen receptor binding; F:histone kinase activity (H2A-T120 specific); F:protein serine kinase activity; F:protein threonine kinase activity;, P:B cell differentiation; P:cell competition in a multicellular organism; P:histone H2A-T120 phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:protein ubiquitination; P:V(D)J recombination; P:viral process;|Q9Y4B6 Q2YD74 Q8TBD9 Q9HCA1 Q9UG37,DDB1- and CUL4-associated factor 1 {ECO:0000312|HGNC:HGNC:30911},HIV-1 Vpr-binding protein;Serine/threonine-protein kinase VPRBP;Vpr-interacting protein;, , GO:0080008;GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0030331;GO:1990244;GO:0106310;GO:0106311;GO:0030183;GO:0035212;GO:1990245;GO:0000122;GO:0016567;GO:0033151;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:estrogen receptor binding; F:histone kinase activity (H2A-T120 specific); F:protein serine kinase activity; F:protein threonine kinase activity;, P:B cell differentiation; P:cell competition in a multicellular organism; P:histone H2A-T120 phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:protein ubiquitination; P:V(D)J recombination; P:viral process; scaffold23 indexed_genome mRNA 886373 910794 . + . ID=transcript_5386;Q9Y4B4 Q8TB57 Q9BV54,Helicase ARIP4,Androgen receptor-interacting protein 4;RAD54-like protein 2;, PF00271;PF00176;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0070615;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity;|Q9Y4B4 Q8TB57 Q9BV54,Helicase ARIP4,Androgen receptor-interacting protein 4;RAD54-like protein 2;, PF00271;PF00176;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0070615;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity;|Q9Y4B4 Q8TB57 Q9BV54,Helicase ARIP4,Androgen receptor-interacting protein 4;RAD54-like protein 2;, PF00271;PF00176;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0070615;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; scaffold23 indexed_genome mRNA 918335 948103 . + . ID=transcript_5387;Q9Y6I9 B3KN87 Q9UKD7,Testis-expressed protein 264 {ECO:0000305},Putative secreted protein Zsig11 {ECO:0000303|Ref.1};, , GO:0000421;GO:0005829;GO:0005789;GO:0005576;GO:0016021;GO:0005634;GO:0031093;GO:0005657;GO:0038023;GO:0002576;GO:0106300;GO:0061709;, C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:integral component of membrane; C:nucleus; C:platelet alpha granule lumen; C:replication fork;, F:signaling receptor activity;, P:platelet degranulation; P:protein-DNA covalent cross-linking repair; P:reticulophagy; scaffold23 indexed_genome mRNA 950618 961604 . + . ID=transcript_5388;Q14416 B0M0K7 Q14CU5 Q52MC6 Q9H3N6,Metabotropic glutamate receptor 2,, PF00003;PF01094;PF07562;, GO:0097449;GO:0030424;GO:0030425;GO:0005887;GO:0099055;GO:0005886;GO:0042734;GO:0001640;GO:0005246;GO:0004930;GO:0008066;GO:0001641;GO:0097110;GO:0007268;GO:0007216;GO:0007186;GO:0010467;GO:0090461;GO:0014047;GO:0007194;GO:0051896;GO:0051966;, C:astrocyte projection; C:axon; C:dendrite; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:presynaptic membrane;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:calcium channel regulator activity; F:G protein-coupled receptor activity; F:glutamate receptor activity; F:group II metabotropic glutamate receptor activity; F:scaffold protein binding;, P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gene expression; P:glutamate homeostasis; P:glutamate secretion; P:negative regulation of adenylate cyclase activity; P:regulation of protein kinase B signaling; P:regulation of synaptic transmission, glutamatergic; scaffold23 indexed_genome mRNA 1021187 1025260 . + . ID=transcript_5389;A8MTL0,IQ domain-containing protein F5,, PF00612;, GO:0005516;, , F:calmodulin binding; scaffold23 indexed_genome mRNA 1076477 1084298 . - . ID=transcript_5390;O43818 B2R996 Q8IZ30,U3 small nucleolar RNA-interacting protein 2,RRP9 homolog;U3 small nucleolar ribonucleoprotein-associated 55 kDa protein {ECO:0000303|PubMed:26867678};, PF00400;, GO:0031428;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0030515;GO:0034511;GO:0006364;, C:box C/D RNP complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding; F:snoRNA binding; F:U3 snoRNA binding;, P:rRNA processing;|O43818 B2R996 Q8IZ30,U3 small nucleolar RNA-interacting protein 2,RRP9 homolog;U3 small nucleolar ribonucleoprotein-associated 55 kDa protein {ECO:0000303|PubMed:26867678};, PF00400;, GO:0031428;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0030515;GO:0034511;GO:0006364;, C:box C/D RNP complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding; F:snoRNA binding; F:U3 snoRNA binding;, P:rRNA processing; scaffold23 indexed_genome mRNA 1085568 1092783 . + . ID=transcript_5391;Q9Y6F1 Q8NER9 Q96CG2 Q9UG81,Protein mono-ADP-ribosyltransferase PARP3 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 3 {ECO:0000303|PubMed:20106667};DNA ADP-ribosyltransferase PARP3 {ECO:0000305};IRT1;NAD(+) ADP-ribosyltransferase 3 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 3 {ECO:0000303|PubMed:12640039, ECO:0000303|PubMed:20106667};Poly[ADP-ribose] synthase 3 {ECO:0000303|PubMed:20106667};, PF00644;PF02877;PF05406;, GO:0005814;GO:0005737;GO:0045171;GO:0016604;GO:0005730;GO:0005654;GO:0035861;GO:0003824;GO:0140294;GO:0003950;GO:1990404;GO:0030592;GO:0006281;GO:0006302;GO:0045829;GO:1905662;GO:0051106;GO:2001034;GO:0006471;GO:0070213;GO:1990166;GO:0140289;GO:0070212;GO:0060236;GO:0000723;, C:centriole; C:cytoplasm; C:intercellular bridge; C:nuclear body; C:nucleolus; C:nucleoplasm; C:site of double-strand break;, F:catalytic activity; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:DNA ADP-ribosylation; P:DNA repair; P:double-strand break repair; P:negative regulation of isotype switching; P:negative regulation of telomerase RNA reverse transcriptase activity; P:positive regulation of DNA ligation; P:positive regulation of double-strand break repair via nonhomologous end joining; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to site of double-strand break; P:protein mono-ADP-ribosylation; P:protein poly-ADP-ribosylation; P:regulation of mitotic spindle organization; P:telomere maintenance;|Q9Y6F1 Q8NER9 Q96CG2 Q9UG81,Protein mono-ADP-ribosyltransferase PARP3 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 3 {ECO:0000303|PubMed:20106667};DNA ADP-ribosyltransferase PARP3 {ECO:0000305};IRT1;NAD(+) ADP-ribosyltransferase 3 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 3 {ECO:0000303|PubMed:12640039, ECO:0000303|PubMed:20106667};Poly[ADP-ribose] synthase 3 {ECO:0000303|PubMed:20106667};, PF00644;PF02877;PF05406;, GO:0005814;GO:0005737;GO:0045171;GO:0016604;GO:0005730;GO:0005654;GO:0035861;GO:0003824;GO:0140294;GO:0003950;GO:1990404;GO:0030592;GO:0006281;GO:0006302;GO:0045829;GO:1905662;GO:0051106;GO:2001034;GO:0006471;GO:0070213;GO:1990166;GO:0140289;GO:0070212;GO:0060236;GO:0000723;, C:centriole; C:cytoplasm; C:intercellular bridge; C:nuclear body; C:nucleolus; C:nucleoplasm; C:site of double-strand break;, F:catalytic activity; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:DNA ADP-ribosylation; P:DNA repair; P:double-strand break repair; P:negative regulation of isotype switching; P:negative regulation of telomerase RNA reverse transcriptase activity; P:positive regulation of DNA ligation; P:positive regulation of double-strand break repair via nonhomologous end joining; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to site of double-strand break; P:protein mono-ADP-ribosylation; P:protein poly-ADP-ribosylation; P:regulation of mitotic spindle organization; P:telomere maintenance;|Q9Y6F1 Q8NER9 Q96CG2 Q9UG81,Protein mono-ADP-ribosyltransferase PARP3 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 3 {ECO:0000303|PubMed:20106667};DNA ADP-ribosyltransferase PARP3 {ECO:0000305};IRT1;NAD(+) ADP-ribosyltransferase 3 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 3 {ECO:0000303|PubMed:12640039, ECO:0000303|PubMed:20106667};Poly[ADP-ribose] synthase 3 {ECO:0000303|PubMed:20106667};, PF00644;PF02877;PF05406;, GO:0005814;GO:0005737;GO:0045171;GO:0016604;GO:0005730;GO:0005654;GO:0035861;GO:0003824;GO:0140294;GO:0003950;GO:1990404;GO:0030592;GO:0006281;GO:0006302;GO:0045829;GO:1905662;GO:0051106;GO:2001034;GO:0006471;GO:0070213;GO:1990166;GO:0140289;GO:0070212;GO:0060236;GO:0000723;, C:centriole; C:cytoplasm; C:intercellular bridge; C:nuclear body; C:nucleolus; C:nucleoplasm; C:site of double-strand break;, F:catalytic activity; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:DNA ADP-ribosylation; P:DNA repair; P:double-strand break repair; P:negative regulation of isotype switching; P:negative regulation of telomerase RNA reverse transcriptase activity; P:positive regulation of DNA ligation; P:positive regulation of double-strand break repair via nonhomologous end joining; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to site of double-strand break; P:protein mono-ADP-ribosylation; P:protein poly-ADP-ribosylation; P:regulation of mitotic spindle organization; P:telomere maintenance; scaffold23 indexed_genome mRNA 1098410 1098983 . + . ID=transcript_5392;P57723 Q96AH7,Poly(rC)-binding protein 4,Alpha-CP4;, PF00013;, GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0003730;GO:0003729;GO:0003723;GO:0006977;GO:0048025;GO:0010468;GO:0043488;GO:0051252;, C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:negative regulation of mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of RNA metabolic process; scaffold23 indexed_genome mRNA 1100287 1101150 . - . ID=transcript_5393;P57723 Q96AH7,Poly(rC)-binding protein 4,Alpha-CP4;, PF00013;, GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0003730;GO:0003729;GO:0003723;GO:0006977;GO:0048025;GO:0010468;GO:0043488;GO:0051252;, C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:negative regulation of mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of RNA metabolic process; scaffold23 indexed_genome mRNA 1108488 1112510 . - . ID=transcript_5394;Q96IU4 Q86VK8 Q8N8W5,Protein ABHD14B {ECO:0000305},Alpha/beta hydrolase domain-containing protein 14B {ECO:0000305};CCG1-interacting factor B;, PF12697;, GO:0005737;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0016787;GO:0050427;GO:0045944;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:hydrolase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:positive regulation of transcription by RNA polymerase II;|Q96IU4 Q86VK8 Q8N8W5,Protein ABHD14B {ECO:0000305},Alpha/beta hydrolase domain-containing protein 14B {ECO:0000305};CCG1-interacting factor B;, PF12697;, GO:0005737;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0016787;GO:0050427;GO:0045944;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:hydrolase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:positive regulation of transcription by RNA polymerase II;|Q96IU4 Q86VK8 Q8N8W5,Protein ABHD14B {ECO:0000305},Alpha/beta hydrolase domain-containing protein 14B {ECO:0000305};CCG1-interacting factor B;, PF12697;, GO:0005737;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0016787;GO:0050427;GO:0045944;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:hydrolase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:positive regulation of transcription by RNA polymerase II;|Q96IU4 Q86VK8 Q8N8W5,Protein ABHD14B {ECO:0000305},Alpha/beta hydrolase domain-containing protein 14B {ECO:0000305};CCG1-interacting factor B;, PF12697;, GO:0005737;GO:0005829;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0016787;GO:0050427;GO:0045944;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:hydrolase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:positive regulation of transcription by RNA polymerase II; scaffold23 indexed_genome mRNA 1113858 1129449 . + . ID=transcript_5395;Q9BUJ0 Q6UXU8 Q9Y3T7,Protein ABHD14A {ECO:0000305},Alpha/beta hydrolase domain-containing protein 14A {ECO:0000305};, PF12697;, GO:0005737;GO:0016021;GO:0016787;, C:cytoplasm; C:integral component of membrane;, F:hydrolase activity;|Q9BUJ0 Q6UXU8 Q9Y3T7,Protein ABHD14A {ECO:0000305},Alpha/beta hydrolase domain-containing protein 14A {ECO:0000305};, PF12697;, GO:0005737;GO:0016021;GO:0016787;, C:cytoplasm; C:integral component of membrane;, F:hydrolase activity;|Q9BUJ0 Q6UXU8 Q9Y3T7,Protein ABHD14A {ECO:0000305},Alpha/beta hydrolase domain-containing protein 14A {ECO:0000305};, PF12697;, GO:0005737;GO:0016021;GO:0016787;, C:cytoplasm; C:integral component of membrane;, F:hydrolase activity;|Q03154 C9J6I6 C9J9D8 C9JWD4,Aminoacylase-1,N-acyl-L-amino-acid amidohydrolase;, PF07687;PF01546;, GO:0005829;GO:0070062;GO:0004046;GO:0042802;GO:0046872;GO:0046222;GO:0006520;, C:cytosol; C:extracellular exosome;, F:aminoacylase activity; F:identical protein binding; F:metal ion binding;, P:aflatoxin metabolic process; P:cellular amino acid metabolic process;|Q03154 C9J6I6 C9J9D8 C9JWD4,Aminoacylase-1,N-acyl-L-amino-acid amidohydrolase;, PF07687;PF01546;, GO:0005829;GO:0070062;GO:0004046;GO:0042802;GO:0046872;GO:0046222;GO:0006520;, C:cytosol; C:extracellular exosome;, F:aminoacylase activity; F:identical protein binding; F:metal ion binding;, P:aflatoxin metabolic process; P:cellular amino acid metabolic process;|Q03154 C9J6I6 C9J9D8 C9JWD4,Aminoacylase-1,N-acyl-L-amino-acid amidohydrolase;, PF07687;PF01546;, GO:0005829;GO:0070062;GO:0004046;GO:0042802;GO:0046872;GO:0046222;GO:0006520;, C:cytosol; C:extracellular exosome;, F:aminoacylase activity; F:identical protein binding; F:metal ion binding;, P:aflatoxin metabolic process; P:cellular amino acid metabolic process;|Q03154 C9J6I6 C9J9D8 C9JWD4,Aminoacylase-1,N-acyl-L-amino-acid amidohydrolase;, PF07687;PF01546;, GO:0005829;GO:0070062;GO:0004046;GO:0042802;GO:0046872;GO:0046222;GO:0006520;, C:cytosol; C:extracellular exosome;, F:aminoacylase activity; F:identical protein binding; F:metal ion binding;, P:aflatoxin metabolic process; P:cellular amino acid metabolic process;|P47914 A8K0H3 B2R4M8 Q6IPY3,60S ribosomal protein L29,Cell surface heparin-binding protein HIP;Large ribosomal subunit protein eL29 {ECO:0000303|PubMed:24524803};, PF01779;, GO:0005829;GO:0022625;GO:0016020;GO:0045296;GO:0008201;GO:0003723;GO:0003735;GO:0002181;GO:0007566;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:membrane;, F:cadherin binding; F:heparin binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:embryo implantation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P47914 A8K0H3 B2R4M8 Q6IPY3,60S ribosomal protein L29,Cell surface heparin-binding protein HIP;Large ribosomal subunit protein eL29 {ECO:0000303|PubMed:24524803};, PF01779;, GO:0005829;GO:0022625;GO:0016020;GO:0045296;GO:0008201;GO:0003723;GO:0003735;GO:0002181;GO:0007566;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:membrane;, F:cadherin binding; F:heparin binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:embryo implantation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold23 indexed_genome mRNA 1224423 1225904 . - . ID=transcript_5396;Q16829 Q2M3J7 Q8NFJ0,Dual specificity protein phosphatase 7 {ECO:0000312|HGNC:HGNC:3073},Dual specificity protein phosphatase PYST2 {ECO:0000303|PubMed:9788880};, PF00581;, GO:0005737;GO:0005829;GO:0005654;GO:0017017;GO:0051019;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0000187;GO:0000188;GO:0000165;GO:0043407;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:activation of MAPK activity; P:inactivation of MAPK activity; P:MAPK cascade; P:negative regulation of MAP kinase activity; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; scaffold23 indexed_genome mRNA 1226193 1227309 . - . ID=transcript_5397;Q16829 Q2M3J7 Q8NFJ0,Dual specificity protein phosphatase 7 {ECO:0000312|HGNC:HGNC:3073},Dual specificity protein phosphatase PYST2 {ECO:0000303|PubMed:9788880};, PF00581;, GO:0005737;GO:0005829;GO:0005654;GO:0017017;GO:0051019;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0000187;GO:0000188;GO:0000165;GO:0043407;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:activation of MAPK activity; P:inactivation of MAPK activity; P:MAPK cascade; P:negative regulation of MAP kinase activity; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; scaffold23 indexed_genome mRNA 1228519 1229220 . + . ID=transcript_5398;Q16829 Q2M3J7 Q8NFJ0,Dual specificity protein phosphatase 7 {ECO:0000312|HGNC:HGNC:3073},Dual specificity protein phosphatase PYST2 {ECO:0000303|PubMed:9788880};, PF00581;, GO:0005737;GO:0005829;GO:0005654;GO:0017017;GO:0051019;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0000187;GO:0000188;GO:0000165;GO:0043407;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:activation of MAPK activity; P:inactivation of MAPK activity; P:MAPK cascade; P:negative regulation of MAP kinase activity; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; scaffold23 indexed_genome mRNA 1248202 1322623 . - . ID=transcript_5399;Q8NBT0 A4FUW4 E9PFC6 Q0VDF8 Q2TAK6 Q96IK6 Q9UFJ8,POC1 centriolar protein homolog A,Pix2;Proteome of centriole protein 1A;WD repeat-containing protein 51A;, PF00400;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0000922;GO:0030030;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:spindle pole;, , P:cell projection organization; scaffold23 indexed_genome mRNA 1351283 1365456 . - . ID=transcript_5400;P13196,5-aminolevulinate synthase, nonspecific, mitochondrial,5-aminolevulinic acid synthase 1;Delta-ALA synthase 1;Delta-aminolevulinate synthase 1;, PF00155;PF09029;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0003870;GO:0042802;GO:0030170;GO:0048821;GO:0006783;GO:0042541;GO:0007005;GO:0006782;GO:0019222;GO:0001666;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:5-aminolevulinate synthase activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:erythrocyte development; P:heme biosynthetic process; P:hemoglobin biosynthetic process; P:mitochondrion organization; P:protoporphyrinogen IX biosynthetic process; P:regulation of metabolic process; P:response to hypoxia;|P13196,5-aminolevulinate synthase, nonspecific, mitochondrial,5-aminolevulinic acid synthase 1;Delta-ALA synthase 1;Delta-aminolevulinate synthase 1;, PF00155;PF09029;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0003870;GO:0042802;GO:0030170;GO:0048821;GO:0006783;GO:0042541;GO:0007005;GO:0006782;GO:0019222;GO:0001666;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:5-aminolevulinate synthase activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:erythrocyte development; P:heme biosynthetic process; P:hemoglobin biosynthetic process; P:mitochondrion organization; P:protoporphyrinogen IX biosynthetic process; P:regulation of metabolic process; P:response to hypoxia;|P13196,5-aminolevulinate synthase, nonspecific, mitochondrial,5-aminolevulinic acid synthase 1;Delta-ALA synthase 1;Delta-aminolevulinate synthase 1;, PF00155;PF09029;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0003870;GO:0042802;GO:0030170;GO:0048821;GO:0006783;GO:0042541;GO:0007005;GO:0006782;GO:0019222;GO:0001666;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:5-aminolevulinate synthase activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:erythrocyte development; P:heme biosynthetic process; P:hemoglobin biosynthetic process; P:mitochondrion organization; P:protoporphyrinogen IX biosynthetic process; P:regulation of metabolic process; P:response to hypoxia;|P13196,5-aminolevulinate synthase, nonspecific, mitochondrial,5-aminolevulinic acid synthase 1;Delta-ALA synthase 1;Delta-aminolevulinate synthase 1;, PF00155;PF09029;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0003870;GO:0042802;GO:0030170;GO:0048821;GO:0006783;GO:0042541;GO:0007005;GO:0006782;GO:0019222;GO:0001666;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:5-aminolevulinate synthase activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:erythrocyte development; P:heme biosynthetic process; P:hemoglobin biosynthetic process; P:mitochondrion organization; P:protoporphyrinogen IX biosynthetic process; P:regulation of metabolic process; P:response to hypoxia;|P13196,5-aminolevulinate synthase, nonspecific, mitochondrial,5-aminolevulinic acid synthase 1;Delta-ALA synthase 1;Delta-aminolevulinate synthase 1;, PF00155;PF09029;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0003870;GO:0042802;GO:0030170;GO:0048821;GO:0006783;GO:0042541;GO:0007005;GO:0006782;GO:0019222;GO:0001666;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:5-aminolevulinate synthase activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:erythrocyte development; P:heme biosynthetic process; P:hemoglobin biosynthetic process; P:mitochondrion organization; P:protoporphyrinogen IX biosynthetic process; P:regulation of metabolic process; P:response to hypoxia;|P13196,5-aminolevulinate synthase, nonspecific, mitochondrial,5-aminolevulinic acid synthase 1;Delta-ALA synthase 1;Delta-aminolevulinate synthase 1;, PF00155;PF09029;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0003870;GO:0042802;GO:0030170;GO:0048821;GO:0006783;GO:0042541;GO:0007005;GO:0006782;GO:0019222;GO:0001666;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:5-aminolevulinate synthase activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:erythrocyte development; P:heme biosynthetic process; P:hemoglobin biosynthetic process; P:mitochondrion organization; P:protoporphyrinogen IX biosynthetic process; P:regulation of metabolic process; P:response to hypoxia;|P13196,5-aminolevulinate synthase, nonspecific, mitochondrial,5-aminolevulinic acid synthase 1;Delta-ALA synthase 1;Delta-aminolevulinate synthase 1;, PF00155;PF09029;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0003870;GO:0042802;GO:0030170;GO:0048821;GO:0006783;GO:0042541;GO:0007005;GO:0006782;GO:0019222;GO:0001666;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:5-aminolevulinate synthase activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:erythrocyte development; P:heme biosynthetic process; P:hemoglobin biosynthetic process; P:mitochondrion organization; P:protoporphyrinogen IX biosynthetic process; P:regulation of metabolic process; P:response to hypoxia;|P13196,5-aminolevulinate synthase, nonspecific, mitochondrial,5-aminolevulinic acid synthase 1;Delta-ALA synthase 1;Delta-aminolevulinate synthase 1;, PF00155;PF09029;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0003870;GO:0042802;GO:0030170;GO:0048821;GO:0006783;GO:0042541;GO:0007005;GO:0006782;GO:0019222;GO:0001666;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:5-aminolevulinate synthase activity; F:identical protein binding; F:pyridoxal phosphate binding;, P:erythrocyte development; P:heme biosynthetic process; P:hemoglobin biosynthetic process; P:mitochondrion organization; P:protoporphyrinogen IX biosynthetic process; P:regulation of metabolic process; P:response to hypoxia; scaffold23 indexed_genome mRNA 1381753 1387751 . - . ID=transcript_5401;Q6IBS0 Q9Y3F5,Twinfilin-2,A6-related protein;Protein tyrosine kinase 9-like;Twinfilin-1-like protein;, PF00241;, GO:0005884;GO:0005737;GO:0070062;GO:0030175;GO:0030426;GO:0030027;GO:0030016;GO:0048471;GO:0032420;GO:0051015;GO:0003785;GO:0005524;GO:0045296;GO:0005546;GO:0005080;GO:0003723;GO:0030042;GO:0051016;GO:0030030;GO:0071363;GO:0071300;GO:0030837;GO:0045773;GO:0010592;GO:0010976;GO:0032956;GO:0010591;GO:0032532;GO:0042989;, C:actin filament; C:cytoplasm; C:extracellular exosome; C:filopodium; C:growth cone; C:lamellipodium; C:myofibril; C:perinuclear region of cytoplasm; C:stereocilium;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase C binding; F:RNA binding;, P:actin filament depolymerization; P:barbed-end actin filament capping; P:cell projection organization; P:cellular response to growth factor stimulus; P:cellular response to retinoic acid; P:negative regulation of actin filament polymerization; P:positive regulation of axon extension; P:positive regulation of lamellipodium assembly; P:positive regulation of neuron projection development; P:regulation of actin cytoskeleton organization; P:regulation of lamellipodium assembly; P:regulation of microvillus length; P:sequestering of actin monomers;|Q6IBS0 Q9Y3F5,Twinfilin-2,A6-related protein;Protein tyrosine kinase 9-like;Twinfilin-1-like protein;, PF00241;, GO:0005884;GO:0005737;GO:0070062;GO:0030175;GO:0030426;GO:0030027;GO:0030016;GO:0048471;GO:0032420;GO:0051015;GO:0003785;GO:0005524;GO:0045296;GO:0005546;GO:0005080;GO:0003723;GO:0030042;GO:0051016;GO:0030030;GO:0071363;GO:0071300;GO:0030837;GO:0045773;GO:0010592;GO:0010976;GO:0032956;GO:0010591;GO:0032532;GO:0042989;, C:actin filament; C:cytoplasm; C:extracellular exosome; C:filopodium; C:growth cone; C:lamellipodium; C:myofibril; C:perinuclear region of cytoplasm; C:stereocilium;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase C binding; F:RNA binding;, P:actin filament depolymerization; P:barbed-end actin filament capping; P:cell projection organization; P:cellular response to growth factor stimulus; P:cellular response to retinoic acid; P:negative regulation of actin filament polymerization; P:positive regulation of axon extension; P:positive regulation of lamellipodium assembly; P:positive regulation of neuron projection development; P:regulation of actin cytoskeleton organization; P:regulation of lamellipodium assembly; P:regulation of microvillus length; P:sequestering of actin monomers;|Q6IBS0 Q9Y3F5,Twinfilin-2,A6-related protein;Protein tyrosine kinase 9-like;Twinfilin-1-like protein;, PF00241;, GO:0005884;GO:0005737;GO:0070062;GO:0030175;GO:0030426;GO:0030027;GO:0030016;GO:0048471;GO:0032420;GO:0051015;GO:0003785;GO:0005524;GO:0045296;GO:0005546;GO:0005080;GO:0003723;GO:0030042;GO:0051016;GO:0030030;GO:0071363;GO:0071300;GO:0030837;GO:0045773;GO:0010592;GO:0010976;GO:0032956;GO:0010591;GO:0032532;GO:0042989;, C:actin filament; C:cytoplasm; C:extracellular exosome; C:filopodium; C:growth cone; C:lamellipodium; C:myofibril; C:perinuclear region of cytoplasm; C:stereocilium;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase C binding; F:RNA binding;, P:actin filament depolymerization; P:barbed-end actin filament capping; P:cell projection organization; P:cellular response to growth factor stimulus; P:cellular response to retinoic acid; P:negative regulation of actin filament polymerization; P:positive regulation of axon extension; P:positive regulation of lamellipodium assembly; P:positive regulation of neuron projection development; P:regulation of actin cytoskeleton organization; P:regulation of lamellipodium assembly; P:regulation of microvillus length; P:sequestering of actin monomers; scaffold23 indexed_genome mRNA 1405216 1405791 . - . ID=transcript_5402;Q96MI6 Q8N8J9 Q96DB8,Protein phosphatase 1M,Protein phosphatase 2C isoform eta;, PF00481;, GO:0005634;GO:0004724;GO:0030145;GO:0106306;GO:0106307;GO:0006470;, C:nucleus;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:manganese ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation; scaffold23 indexed_genome mRNA 1406118 1407676 . + . ID=transcript_5403;Q96MI6 Q8N8J9 Q96DB8,Protein phosphatase 1M,Protein phosphatase 2C isoform eta;, PF00481;, GO:0005634;GO:0004724;GO:0030145;GO:0106306;GO:0106307;GO:0006470;, C:nucleus;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:manganese ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation;|Q96MI6 Q8N8J9 Q96DB8,Protein phosphatase 1M,Protein phosphatase 2C isoform eta;, PF00481;, GO:0005634;GO:0004724;GO:0030145;GO:0106306;GO:0106307;GO:0006470;, C:nucleus;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:manganese ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation; scaffold23 indexed_genome mRNA 1409276 1427853 . - . ID=transcript_5404;Q6UXN9 A8K5R5 Q8TEB2,WD repeat-containing protein 82,Protein TMEM113;Swd2;, PF00400;, GO:0000785;GO:0035097;GO:0005730;GO:0072357;GO:0048188;GO:0003682;GO:0051568;GO:0080182;, C:chromatin; C:histone methyltransferase complex; C:nucleolus; C:PTW/PP1 phosphatase complex; C:Set1C/COMPASS complex;, F:chromatin binding;, P:histone H3-K4 methylation; P:histone H3-K4 trimethylation;|Q6UXN9 A8K5R5 Q8TEB2,WD repeat-containing protein 82,Protein TMEM113;Swd2;, PF00400;, GO:0000785;GO:0035097;GO:0005730;GO:0072357;GO:0048188;GO:0003682;GO:0051568;GO:0080182;, C:chromatin; C:histone methyltransferase complex; C:nucleolus; C:PTW/PP1 phosphatase complex; C:Set1C/COMPASS complex;, F:chromatin binding;, P:histone H3-K4 methylation; P:histone H3-K4 trimethylation;|Q6UXN9 A8K5R5 Q8TEB2,WD repeat-containing protein 82,Protein TMEM113;Swd2;, PF00400;, GO:0000785;GO:0035097;GO:0005730;GO:0072357;GO:0048188;GO:0003682;GO:0051568;GO:0080182;, C:chromatin; C:histone methyltransferase complex; C:nucleolus; C:PTW/PP1 phosphatase complex; C:Set1C/COMPASS complex;, F:chromatin binding;, P:histone H3-K4 methylation; P:histone H3-K4 trimethylation;|P33316 A8K650 B4DPR5 O14785 Q16708 Q16860 Q6FHN1 Q6NSA3 Q96Q81,Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial {ECO:0000303|PubMed:8631816},dUTP pyrophosphatase;, PF00692;, GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0004170;GO:0042802;GO:0000287;GO:0042975;GO:0032556;GO:0030547;GO:0003723;GO:0006260;GO:0006226;GO:0046081;GO:0001889;GO:0006139;GO:0015949;GO:0043254;GO:0014070;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:dUTP diphosphatase activity; F:identical protein binding; F:magnesium ion binding; F:peroxisome proliferator activated receptor binding; F:pyrimidine deoxyribonucleotide binding; F:receptor inhibitor activity; F:RNA binding;, P:DNA replication; P:dUMP biosynthetic process; P:dUTP catabolic process; P:liver development; P:nucleobase-containing compound metabolic process; P:nucleobase-containing small molecule interconversion; P:regulation of protein-containing complex assembly; P:response to organic cyclic compound;|Q6UXN9 A8K5R5 Q8TEB2,WD repeat-containing protein 82,Protein TMEM113;Swd2;, PF00400;, GO:0000785;GO:0035097;GO:0005730;GO:0072357;GO:0048188;GO:0003682;GO:0051568;GO:0080182;, C:chromatin; C:histone methyltransferase complex; C:nucleolus; C:PTW/PP1 phosphatase complex; C:Set1C/COMPASS complex;, F:chromatin binding;, P:histone H3-K4 methylation; P:histone H3-K4 trimethylation;|Q6UXN9 A8K5R5 Q8TEB2,WD repeat-containing protein 82,Protein TMEM113;Swd2;, PF00400;, GO:0000785;GO:0035097;GO:0005730;GO:0072357;GO:0048188;GO:0003682;GO:0051568;GO:0080182;, C:chromatin; C:histone methyltransferase complex; C:nucleolus; C:PTW/PP1 phosphatase complex; C:Set1C/COMPASS complex;, F:chromatin binding;, P:histone H3-K4 methylation; P:histone H3-K4 trimethylation;|Q6UXN9 A8K5R5 Q8TEB2,WD repeat-containing protein 82,Protein TMEM113;Swd2;, PF00400;, GO:0000785;GO:0035097;GO:0005730;GO:0072357;GO:0048188;GO:0003682;GO:0051568;GO:0080182;, C:chromatin; C:histone methyltransferase complex; C:nucleolus; C:PTW/PP1 phosphatase complex; C:Set1C/COMPASS complex;, F:chromatin binding;, P:histone H3-K4 methylation; P:histone H3-K4 trimethylation; scaffold23 indexed_genome mRNA 1460446 1464822 . + . ID=transcript_5405;Q8IVS8 Q0P630 Q2EZ43 Q6Y2K6 Q7Z6G5 Q86YR8 Q8TED2 Q8WTY2,Glycerate kinase,HBeAg-binding protein 4;, PF13660;PF05161;, GO:0005737;GO:0005829;GO:0005794;GO:0005739;GO:0005524;GO:0008887;GO:0061624;GO:0006468;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:mitochondrion;, F:ATP binding; F:glycerate kinase activity;, P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:protein phosphorylation; scaffold23 indexed_genome mRNA 1553575 1555477 . + . ID=transcript_5406;Q9H8E6 Q9UFW6 Q9Y4Z7,Dynein heavy chain 1, axonemal,Axonemal beta dynein heavy chain 1;Ciliary dynein heavy chain 1;Heat shock regulated protein 1;hDHC7;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0036156;GO:0005874;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0030317;GO:0036159;GO:0007018;GO:0007288;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:inner dynein arm; C:microtubule; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:flagellated sperm motility; P:inner dynein arm assembly; P:microtubule-based movement; P:sperm axoneme assembly; scaffold23 indexed_genome mRNA 1559155 1561568 . + . ID=transcript_5407;Q9H8E6 Q9UFW6 Q9Y4Z7,Dynein heavy chain 1, axonemal,Axonemal beta dynein heavy chain 1;Ciliary dynein heavy chain 1;Heat shock regulated protein 1;hDHC7;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0036156;GO:0005874;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0030317;GO:0036159;GO:0007018;GO:0007288;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:inner dynein arm; C:microtubule; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:flagellated sperm motility; P:inner dynein arm assembly; P:microtubule-based movement; P:sperm axoneme assembly;|Q9H8E6 Q9UFW6 Q9Y4Z7,Dynein heavy chain 1, axonemal,Axonemal beta dynein heavy chain 1;Ciliary dynein heavy chain 1;Heat shock regulated protein 1;hDHC7;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0036156;GO:0005874;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0030317;GO:0036159;GO:0007018;GO:0007288;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:inner dynein arm; C:microtubule; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:flagellated sperm motility; P:inner dynein arm assembly; P:microtubule-based movement; P:sperm axoneme assembly; scaffold23 indexed_genome mRNA 1562919 1571484 . - . ID=transcript_5408;Q92560 A8K993 Q6LEM0 Q7Z5E8,Ubiquitin carboxyl-terminal hydrolase BAP1 {ECO:0000305},BRCA1-associated protein 1 {ECO:0000303|PubMed:9528852};Cerebral protein 6 {ECO:0000303|Ref.2};, PF01088;PF18031;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035517;GO:0003682;GO:0008234;GO:0008233;GO:0004843;GO:0006464;GO:0006302;GO:0061519;GO:0035522;GO:0035520;GO:0008285;GO:0045892;GO:1903955;GO:0016579;GO:0071108;GO:0051726;GO:0001558;GO:1900015;GO:0050727;GO:0010035;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:PR-DUB complex;, F:chromatin binding; F:cysteine-type peptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular protein modification process; P:double-strand break repair; P:macrophage homeostasis; P:monoubiquitinated histone H2A deubiquitination; P:monoubiquitinated protein deubiquitination; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein targeting to mitochondrion; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:regulation of cell cycle; P:regulation of cell growth; P:regulation of cytokine production involved in inflammatory response; P:regulation of inflammatory response; P:response to inorganic substance; P:ubiquitin-dependent protein catabolic process;|Q92560 A8K993 Q6LEM0 Q7Z5E8,Ubiquitin carboxyl-terminal hydrolase BAP1 {ECO:0000305},BRCA1-associated protein 1 {ECO:0000303|PubMed:9528852};Cerebral protein 6 {ECO:0000303|Ref.2};, PF01088;PF18031;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035517;GO:0003682;GO:0008234;GO:0008233;GO:0004843;GO:0006464;GO:0006302;GO:0061519;GO:0035522;GO:0035520;GO:0008285;GO:0045892;GO:1903955;GO:0016579;GO:0071108;GO:0051726;GO:0001558;GO:1900015;GO:0050727;GO:0010035;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:PR-DUB complex;, F:chromatin binding; F:cysteine-type peptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular protein modification process; P:double-strand break repair; P:macrophage homeostasis; P:monoubiquitinated histone H2A deubiquitination; P:monoubiquitinated protein deubiquitination; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein targeting to mitochondrion; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:regulation of cell cycle; P:regulation of cell growth; P:regulation of cytokine production involved in inflammatory response; P:regulation of inflammatory response; P:response to inorganic substance; P:ubiquitin-dependent protein catabolic process;|Q92560 A8K993 Q6LEM0 Q7Z5E8,Ubiquitin carboxyl-terminal hydrolase BAP1 {ECO:0000305},BRCA1-associated protein 1 {ECO:0000303|PubMed:9528852};Cerebral protein 6 {ECO:0000303|Ref.2};, PF01088;PF18031;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035517;GO:0003682;GO:0008234;GO:0008233;GO:0004843;GO:0006464;GO:0006302;GO:0061519;GO:0035522;GO:0035520;GO:0008285;GO:0045892;GO:1903955;GO:0016579;GO:0071108;GO:0051726;GO:0001558;GO:1900015;GO:0050727;GO:0010035;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:PR-DUB complex;, F:chromatin binding; F:cysteine-type peptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular protein modification process; P:double-strand break repair; P:macrophage homeostasis; P:monoubiquitinated histone H2A deubiquitination; P:monoubiquitinated protein deubiquitination; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein targeting to mitochondrion; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:regulation of cell cycle; P:regulation of cell growth; P:regulation of cytokine production involved in inflammatory response; P:regulation of inflammatory response; P:response to inorganic substance; P:ubiquitin-dependent protein catabolic process;|Q92560 A8K993 Q6LEM0 Q7Z5E8,Ubiquitin carboxyl-terminal hydrolase BAP1 {ECO:0000305},BRCA1-associated protein 1 {ECO:0000303|PubMed:9528852};Cerebral protein 6 {ECO:0000303|Ref.2};, PF01088;PF18031;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035517;GO:0003682;GO:0008234;GO:0008233;GO:0004843;GO:0006464;GO:0006302;GO:0061519;GO:0035522;GO:0035520;GO:0008285;GO:0045892;GO:1903955;GO:0016579;GO:0071108;GO:0051726;GO:0001558;GO:1900015;GO:0050727;GO:0010035;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:PR-DUB complex;, F:chromatin binding; F:cysteine-type peptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular protein modification process; P:double-strand break repair; P:macrophage homeostasis; P:monoubiquitinated histone H2A deubiquitination; P:monoubiquitinated protein deubiquitination; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein targeting to mitochondrion; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:regulation of cell cycle; P:regulation of cell growth; P:regulation of cytokine production involved in inflammatory response; P:regulation of inflammatory response; P:response to inorganic substance; P:ubiquitin-dependent protein catabolic process;|Q92560 A8K993 Q6LEM0 Q7Z5E8,Ubiquitin carboxyl-terminal hydrolase BAP1 {ECO:0000305},BRCA1-associated protein 1 {ECO:0000303|PubMed:9528852};Cerebral protein 6 {ECO:0000303|Ref.2};, PF01088;PF18031;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035517;GO:0003682;GO:0008234;GO:0008233;GO:0004843;GO:0006464;GO:0006302;GO:0061519;GO:0035522;GO:0035520;GO:0008285;GO:0045892;GO:1903955;GO:0016579;GO:0071108;GO:0051726;GO:0001558;GO:1900015;GO:0050727;GO:0010035;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:PR-DUB complex;, F:chromatin binding; F:cysteine-type peptidase activity; F:peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular protein modification process; P:double-strand break repair; P:macrophage homeostasis; P:monoubiquitinated histone H2A deubiquitination; P:monoubiquitinated protein deubiquitination; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein targeting to mitochondrion; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:regulation of cell cycle; P:regulation of cell growth; P:regulation of cytokine production involved in inflammatory response; P:regulation of inflammatory response; P:response to inorganic substance; P:ubiquitin-dependent protein catabolic process; scaffold23 indexed_genome mRNA 1579314 1603467 . + . ID=transcript_5409;Q9BWX1 K4DI82,PHD finger protein 7,Testis development protein NYD-SP6;, , GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding;|Q9BWX1 K4DI82,PHD finger protein 7,Testis development protein NYD-SP6;, , GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding;|Q9NS98 Q7L9D9 Q9H7Q3,Semaphorin-3G,Semaphorin sem2;, PF00047;PF01403;, GO:0070062;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0005102;GO:0007411;GO:0050919;GO:0030517;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding; F:signaling receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold23 indexed_genome mRNA 1620578 1683227 . + . ID=transcript_5410;Q9Y2I1 C9J245 Q6PGP3 Q6PIB4 Q7L8M3 Q7Z2X6 Q9UES6 Q9UEU4 Q9UFW3,Nischarin,Imidazoline receptor 1;Imidazoline receptor antisera-selected protein;Imidazoline-1 receptor;Imidazoline-1 receptor candidate protein;, PF00787;, GO:0005737;GO:0005829;GO:0005769;GO:0045171;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005886;GO:0055037;GO:0042802;GO:0005178;GO:0035091;GO:0019901;GO:0030036;GO:0006915;GO:0006006;GO:0030336;GO:0048243;GO:0016601;GO:0008217;GO:0032228;, C:cytoplasm; C:cytosol; C:early endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:integrin binding; F:phosphatidylinositol binding; F:protein kinase binding;, P:actin cytoskeleton organization; P:apoptotic process; P:glucose metabolic process; P:negative regulation of cell migration; P:norepinephrine secretion; P:Rac protein signal transduction; P:regulation of blood pressure; P:regulation of synaptic transmission, GABAergic;|Q9Y2I1 C9J245 Q6PGP3 Q6PIB4 Q7L8M3 Q7Z2X6 Q9UES6 Q9UEU4 Q9UFW3,Nischarin,Imidazoline receptor 1;Imidazoline receptor antisera-selected protein;Imidazoline-1 receptor;Imidazoline-1 receptor candidate protein;, PF00787;, GO:0005737;GO:0005829;GO:0005769;GO:0045171;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005886;GO:0055037;GO:0042802;GO:0005178;GO:0035091;GO:0019901;GO:0030036;GO:0006915;GO:0006006;GO:0030336;GO:0048243;GO:0016601;GO:0008217;GO:0032228;, C:cytoplasm; C:cytosol; C:early endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:integrin binding; F:phosphatidylinositol binding; F:protein kinase binding;, P:actin cytoskeleton organization; P:apoptotic process; P:glucose metabolic process; P:negative regulation of cell migration; P:norepinephrine secretion; P:Rac protein signal transduction; P:regulation of blood pressure; P:regulation of synaptic transmission, GABAergic;|Q9Y2I1 C9J245 Q6PGP3 Q6PIB4 Q7L8M3 Q7Z2X6 Q9UES6 Q9UEU4 Q9UFW3,Nischarin,Imidazoline receptor 1;Imidazoline receptor antisera-selected protein;Imidazoline-1 receptor;Imidazoline-1 receptor candidate protein;, PF00787;, GO:0005737;GO:0005829;GO:0005769;GO:0045171;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005886;GO:0055037;GO:0042802;GO:0005178;GO:0035091;GO:0019901;GO:0030036;GO:0006915;GO:0006006;GO:0030336;GO:0048243;GO:0016601;GO:0008217;GO:0032228;, C:cytoplasm; C:cytosol; C:early endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:integrin binding; F:phosphatidylinositol binding; F:protein kinase binding;, P:actin cytoskeleton organization; P:apoptotic process; P:glucose metabolic process; P:negative regulation of cell migration; P:norepinephrine secretion; P:Rac protein signal transduction; P:regulation of blood pressure; P:regulation of synaptic transmission, GABAergic;|Q9Y2I1 C9J245 Q6PGP3 Q6PIB4 Q7L8M3 Q7Z2X6 Q9UES6 Q9UEU4 Q9UFW3,Nischarin,Imidazoline receptor 1;Imidazoline receptor antisera-selected protein;Imidazoline-1 receptor;Imidazoline-1 receptor candidate protein;, PF00787;, GO:0005737;GO:0005829;GO:0005769;GO:0045171;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005886;GO:0055037;GO:0042802;GO:0005178;GO:0035091;GO:0019901;GO:0030036;GO:0006915;GO:0006006;GO:0030336;GO:0048243;GO:0016601;GO:0008217;GO:0032228;, C:cytoplasm; C:cytosol; C:early endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:integrin binding; F:phosphatidylinositol binding; F:protein kinase binding;, P:actin cytoskeleton organization; P:apoptotic process; P:glucose metabolic process; P:negative regulation of cell migration; P:norepinephrine secretion; P:Rac protein signal transduction; P:regulation of blood pressure; P:regulation of synaptic transmission, GABAergic;|Q9Y2I1 C9J245 Q6PGP3 Q6PIB4 Q7L8M3 Q7Z2X6 Q9UES6 Q9UEU4 Q9UFW3,Nischarin,Imidazoline receptor 1;Imidazoline receptor antisera-selected protein;Imidazoline-1 receptor;Imidazoline-1 receptor candidate protein;, PF00787;, GO:0005737;GO:0005829;GO:0005769;GO:0045171;GO:0043231;GO:0016020;GO:0015630;GO:0005654;GO:0005886;GO:0055037;GO:0042802;GO:0005178;GO:0035091;GO:0019901;GO:0030036;GO:0006915;GO:0006006;GO:0030336;GO:0048243;GO:0016601;GO:0008217;GO:0032228;, C:cytoplasm; C:cytosol; C:early endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:integrin binding; F:phosphatidylinositol binding; F:protein kinase binding;, P:actin cytoskeleton organization; P:apoptotic process; P:glucose metabolic process; P:negative regulation of cell migration; P:norepinephrine secretion; P:Rac protein signal transduction; P:regulation of blood pressure; P:regulation of synaptic transmission, GABAergic; scaffold23 indexed_genome mRNA 1685405 1703253 . + . ID=transcript_5411;Q9NY15 A7E297 Q8IUH0 Q8IUH1 Q93072,Stabilin-1,Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1;MS-1 antigen;, PF12947;PF02469;PF00193;, GO:0030666;GO:0005887;GO:0005886;GO:0005509;GO:0005540;GO:0030169;GO:0005041;GO:0015035;GO:0005044;GO:0007155;GO:0007267;GO:0042742;GO:0006954;GO:0016525;GO:0006898;, C:endocytic vesicle membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:hyaluronic acid binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:protein disulfide oxidoreductase activity; F:scavenger receptor activity;, P:cell adhesion; P:cell-cell signaling; P:defense response to bacterium; P:inflammatory response; P:negative regulation of angiogenesis; P:receptor-mediated endocytosis;|Q9NY15 A7E297 Q8IUH0 Q8IUH1 Q93072,Stabilin-1,Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1;MS-1 antigen;, PF12947;PF02469;PF00193;, GO:0030666;GO:0005887;GO:0005886;GO:0005509;GO:0005540;GO:0030169;GO:0005041;GO:0015035;GO:0005044;GO:0007155;GO:0007267;GO:0042742;GO:0006954;GO:0016525;GO:0006898;, C:endocytic vesicle membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:hyaluronic acid binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:protein disulfide oxidoreductase activity; F:scavenger receptor activity;, P:cell adhesion; P:cell-cell signaling; P:defense response to bacterium; P:inflammatory response; P:negative regulation of angiogenesis; P:receptor-mediated endocytosis; scaffold23 indexed_genome mRNA 1704002 1716309 . + . ID=transcript_5412;Q9NY15 A7E297 Q8IUH0 Q8IUH1 Q93072,Stabilin-1,Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1;MS-1 antigen;, PF12947;PF02469;PF00193;, GO:0030666;GO:0005887;GO:0005886;GO:0005509;GO:0005540;GO:0030169;GO:0005041;GO:0015035;GO:0005044;GO:0007155;GO:0007267;GO:0042742;GO:0006954;GO:0016525;GO:0006898;, C:endocytic vesicle membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:hyaluronic acid binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:protein disulfide oxidoreductase activity; F:scavenger receptor activity;, P:cell adhesion; P:cell-cell signaling; P:defense response to bacterium; P:inflammatory response; P:negative regulation of angiogenesis; P:receptor-mediated endocytosis;|Q9H857 C9JTZ6 E9PAL9 O95888 Q96C80 Q9H9Z8,5'-nucleotidase domain-containing protein 2,, PF05761;, GO:0008253;GO:0046872;, , F:5'-nucleotidase activity; F:metal ion binding;|Q9H857 C9JTZ6 E9PAL9 O95888 Q96C80 Q9H9Z8,5'-nucleotidase domain-containing protein 2,, PF05761;, GO:0008253;GO:0046872;, , F:5'-nucleotidase activity; F:metal ion binding;|Q9H857 C9JTZ6 E9PAL9 O95888 Q96C80 Q9H9Z8,5'-nucleotidase domain-containing protein 2,, PF05761;, GO:0008253;GO:0046872;, , F:5'-nucleotidase activity; F:metal ion binding;|Q9H857 C9JTZ6 E9PAL9 O95888 Q96C80 Q9H9Z8,5'-nucleotidase domain-containing protein 2,, PF05761;, GO:0008253;GO:0046872;, , F:5'-nucleotidase activity; F:metal ion binding;|Q9H857 C9JTZ6 E9PAL9 O95888 Q96C80 Q9H9Z8,5'-nucleotidase domain-containing protein 2,, PF05761;, GO:0008253;GO:0046872;, , F:5'-nucleotidase activity; F:metal ion binding; scaffold23 indexed_genome mRNA 1775281 1781851 . + . ID=transcript_5413;Q8WVI0,Small integral membrane protein 4,, PF15114;, GO:0016021;, C:integral component of membrane; scaffold23 indexed_genome mRNA 1782872 1879878 . - . ID=transcript_5414;Q9H2T5 Q9H301 Q9H314,Protein polybromo-1,BRG1-associated factor 180;Polybromo-1D;, PF01426;PF00439;PF00505;, GO:0000228;GO:0005654;GO:0016586;GO:0003682;GO:0003677;GO:0043044;GO:0006338;GO:0000278;GO:0008285;, C:nuclear chromosome; C:nucleoplasm; C:RSC-type complex;, F:chromatin binding; F:DNA binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:mitotic cell cycle; P:negative regulation of cell population proliferation;|Q9H2T5 Q9H301 Q9H314,Protein polybromo-1,BRG1-associated factor 180;Polybromo-1D;, PF01426;PF00439;PF00505;, GO:0000228;GO:0005654;GO:0016586;GO:0003682;GO:0003677;GO:0043044;GO:0006338;GO:0000278;GO:0008285;, C:nuclear chromosome; C:nucleoplasm; C:RSC-type complex;, F:chromatin binding; F:DNA binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:mitotic cell cycle; P:negative regulation of cell population proliferation;|Q9H2T5 Q9H301 Q9H314,Protein polybromo-1,BRG1-associated factor 180;Polybromo-1D;, PF01426;PF00439;PF00505;, GO:0000228;GO:0005654;GO:0016586;GO:0003682;GO:0003677;GO:0043044;GO:0006338;GO:0000278;GO:0008285;, C:nuclear chromosome; C:nucleoplasm; C:RSC-type complex;, F:chromatin binding; F:DNA binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:mitotic cell cycle; P:negative regulation of cell population proliferation;|Q9H2T5 Q9H301 Q9H314,Protein polybromo-1,BRG1-associated factor 180;Polybromo-1D;, PF01426;PF00439;PF00505;, GO:0000228;GO:0005654;GO:0016586;GO:0003682;GO:0003677;GO:0043044;GO:0006338;GO:0000278;GO:0008285;, C:nuclear chromosome; C:nucleoplasm; C:RSC-type complex;, F:chromatin binding; F:DNA binding;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:mitotic cell cycle; P:negative regulation of cell population proliferation; scaffold23 indexed_genome mRNA 1893478 1904765 . - . ID=transcript_5415;Q68CQ7 Q7Z4D1 Q8N2J6 Q9P0I5,Glycosyltransferase 8 domain-containing protein 1,, PF01501;, GO:0005794;GO:0016021;GO:0016020;GO:0016757;, C:Golgi apparatus; C:integral component of membrane; C:membrane;, F:transferase activity, transferring glycosyl groups;|Q9BVP2 B2RDC1 Q5PU80 Q96SV6 Q96SV7 Q9UJY0,Guanine nucleotide-binding protein-like 3,E2-induced gene 3 protein;Novel nucleolar protein 47;Nucleolar GTP-binding protein 3;Nucleostemin;, PF08701;PF01926;, GO:0005694;GO:0005615;GO:0016020;GO:0030496;GO:0016604;GO:0005730;GO:0005634;GO:0005525;GO:0048027;GO:0003723;GO:0008283;GO:1902895;GO:1904816;GO:0033235;GO:0032206;GO:0042127;GO:0017145;GO:0019827;, C:chromosome; C:extracellular space; C:membrane; C:midbody; C:nuclear body; C:nucleolus; C:nucleus;, F:GTP binding; F:mRNA 5'-UTR binding; F:RNA binding;, P:cell population proliferation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein localization to chromosome, telomeric region; P:positive regulation of protein sumoylation; P:positive regulation of telomere maintenance; P:regulation of cell population proliferation; P:stem cell division; P:stem cell population maintenance;|Q9BVP2 B2RDC1 Q5PU80 Q96SV6 Q96SV7 Q9UJY0,Guanine nucleotide-binding protein-like 3,E2-induced gene 3 protein;Novel nucleolar protein 47;Nucleolar GTP-binding protein 3;Nucleostemin;, PF08701;PF01926;, GO:0005694;GO:0005615;GO:0016020;GO:0030496;GO:0016604;GO:0005730;GO:0005634;GO:0005525;GO:0048027;GO:0003723;GO:0008283;GO:1902895;GO:1904816;GO:0033235;GO:0032206;GO:0042127;GO:0017145;GO:0019827;, C:chromosome; C:extracellular space; C:membrane; C:midbody; C:nuclear body; C:nucleolus; C:nucleus;, F:GTP binding; F:mRNA 5'-UTR binding; F:RNA binding;, P:cell population proliferation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein localization to chromosome, telomeric region; P:positive regulation of protein sumoylation; P:positive regulation of telomere maintenance; P:regulation of cell population proliferation; P:stem cell division; P:stem cell population maintenance;|Q9BVP2 B2RDC1 Q5PU80 Q96SV6 Q96SV7 Q9UJY0,Guanine nucleotide-binding protein-like 3,E2-induced gene 3 protein;Novel nucleolar protein 47;Nucleolar GTP-binding protein 3;Nucleostemin;, PF08701;PF01926;, GO:0005694;GO:0005615;GO:0016020;GO:0030496;GO:0016604;GO:0005730;GO:0005634;GO:0005525;GO:0048027;GO:0003723;GO:0008283;GO:1902895;GO:1904816;GO:0033235;GO:0032206;GO:0042127;GO:0017145;GO:0019827;, C:chromosome; C:extracellular space; C:membrane; C:midbody; C:nuclear body; C:nucleolus; C:nucleus;, F:GTP binding; F:mRNA 5'-UTR binding; F:RNA binding;, P:cell population proliferation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein localization to chromosome, telomeric region; P:positive regulation of protein sumoylation; P:positive regulation of telomere maintenance; P:regulation of cell population proliferation; P:stem cell division; P:stem cell population maintenance;|Q9BVP2 B2RDC1 Q5PU80 Q96SV6 Q96SV7 Q9UJY0,Guanine nucleotide-binding protein-like 3,E2-induced gene 3 protein;Novel nucleolar protein 47;Nucleolar GTP-binding protein 3;Nucleostemin;, PF08701;PF01926;, GO:0005694;GO:0005615;GO:0016020;GO:0030496;GO:0016604;GO:0005730;GO:0005634;GO:0005525;GO:0048027;GO:0003723;GO:0008283;GO:1902895;GO:1904816;GO:0033235;GO:0032206;GO:0042127;GO:0017145;GO:0019827;, C:chromosome; C:extracellular space; C:membrane; C:midbody; C:nuclear body; C:nucleolus; C:nucleus;, F:GTP binding; F:mRNA 5'-UTR binding; F:RNA binding;, P:cell population proliferation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein localization to chromosome, telomeric region; P:positive regulation of protein sumoylation; P:positive regulation of telomere maintenance; P:regulation of cell population proliferation; P:stem cell division; P:stem cell population maintenance;|Q68CQ7 Q7Z4D1 Q8N2J6 Q9P0I5,Glycosyltransferase 8 domain-containing protein 1,, PF01501;, GO:0005794;GO:0016021;GO:0016020;GO:0016757;, C:Golgi apparatus; C:integral component of membrane; C:membrane;, F:transferase activity, transferring glycosyl groups;|Q68CQ7 Q7Z4D1 Q8N2J6 Q9P0I5,Glycosyltransferase 8 domain-containing protein 1,, PF01501;, GO:0005794;GO:0016021;GO:0016020;GO:0016757;, C:Golgi apparatus; C:integral component of membrane; C:membrane;, F:transferase activity, transferring glycosyl groups;|Q68CQ7 Q7Z4D1 Q8N2J6 Q9P0I5,Glycosyltransferase 8 domain-containing protein 1,, PF01501;, GO:0005794;GO:0016021;GO:0016020;GO:0016757;, C:Golgi apparatus; C:integral component of membrane; C:membrane;, F:transferase activity, transferring glycosyl groups; scaffold23 indexed_genome mRNA 1915962 1917285 . - . ID=transcript_5416;Q9Y6A9 B3KNF8 Q9BVW1 X6R2S6,Signal peptidase complex subunit 1,Microsomal signal peptidase 12 kDa subunit;, PF06645;, GO:0005789;GO:0030176;GO:0005787;GO:0008233;GO:0043022;GO:0045047;GO:0006508;GO:0006465;GO:0019082;GO:0019068;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:signal peptidase complex;, F:peptidase activity; F:ribosome binding;, P:protein targeting to ER; P:proteolysis; P:signal peptide processing; P:viral protein processing; P:virion assembly; scaffold23 indexed_genome mRNA 1920728 1947274 . - . ID=transcript_5417;P51957 A5YM70 B2R633 B7Z200 Q6P576,Serine/threonine-protein kinase Nek4,Never in mitosis A-related kinase 4;Serine/threonine-protein kinase 2;Serine/threonine-protein kinase NRK2;, PF00069;, GO:0036064;GO:0097014;GO:0035253;GO:0035869;GO:0005737;GO:0005829;GO:0005524;GO:0030145;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0006974;GO:0000278;GO:0045893;GO:0006468;GO:2000772;GO:2001020;, C:ciliary basal body; C:ciliary plasm; C:ciliary rootlet; C:ciliary transition zone; C:cytoplasm; C:cytosol;, F:ATP binding; F:manganese ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular response to DNA damage stimulus; P:mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of cellular senescence; P:regulation of response to DNA damage stimulus;|P51957 A5YM70 B2R633 B7Z200 Q6P576,Serine/threonine-protein kinase Nek4,Never in mitosis A-related kinase 4;Serine/threonine-protein kinase 2;Serine/threonine-protein kinase NRK2;, PF00069;, GO:0036064;GO:0097014;GO:0035253;GO:0035869;GO:0005737;GO:0005829;GO:0005524;GO:0030145;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0006974;GO:0000278;GO:0045893;GO:0006468;GO:2000772;GO:2001020;, C:ciliary basal body; C:ciliary plasm; C:ciliary rootlet; C:ciliary transition zone; C:cytoplasm; C:cytosol;, F:ATP binding; F:manganese ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular response to DNA damage stimulus; P:mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of cellular senescence; P:regulation of response to DNA damage stimulus;|P51957 A5YM70 B2R633 B7Z200 Q6P576,Serine/threonine-protein kinase Nek4,Never in mitosis A-related kinase 4;Serine/threonine-protein kinase 2;Serine/threonine-protein kinase NRK2;, PF00069;, GO:0036064;GO:0097014;GO:0035253;GO:0035869;GO:0005737;GO:0005829;GO:0005524;GO:0030145;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0006974;GO:0000278;GO:0045893;GO:0006468;GO:2000772;GO:2001020;, C:ciliary basal body; C:ciliary plasm; C:ciliary rootlet; C:ciliary transition zone; C:cytoplasm; C:cytosol;, F:ATP binding; F:manganese ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular response to DNA damage stimulus; P:mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of cellular senescence; P:regulation of response to DNA damage stimulus;|P51957 A5YM70 B2R633 B7Z200 Q6P576,Serine/threonine-protein kinase Nek4,Never in mitosis A-related kinase 4;Serine/threonine-protein kinase 2;Serine/threonine-protein kinase NRK2;, PF00069;, GO:0036064;GO:0097014;GO:0035253;GO:0035869;GO:0005737;GO:0005829;GO:0005524;GO:0030145;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0006974;GO:0000278;GO:0045893;GO:0006468;GO:2000772;GO:2001020;, C:ciliary basal body; C:ciliary plasm; C:ciliary rootlet; C:ciliary transition zone; C:cytoplasm; C:cytosol;, F:ATP binding; F:manganese ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular response to DNA damage stimulus; P:mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of cellular senescence; P:regulation of response to DNA damage stimulus; scaffold23 indexed_genome mRNA 1958926 1994310 . + . ID=transcript_5418;Q562G1,Inter-alpha-trypsin inhibitor heavy chain H1,Inter-alpha-trypsin inhibitor complex component III;Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005509;GO:0004867;GO:0030212;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:calcium ion binding; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process;|Q562G1,Inter-alpha-trypsin inhibitor heavy chain H1,Inter-alpha-trypsin inhibitor complex component III;Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005509;GO:0004867;GO:0030212;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:calcium ion binding; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process;|Q562G1,Inter-alpha-trypsin inhibitor heavy chain H1,Inter-alpha-trypsin inhibitor complex component III;Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005509;GO:0004867;GO:0030212;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:calcium ion binding; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process;|Q06033 Q3B7H5 Q53F06 Q6LAM2 Q99085,Inter-alpha-trypsin inhibitor heavy chain H3,Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0030212;GO:0002576;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process; P:platelet degranulation;|Q06033 Q3B7H5 Q53F06 Q6LAM2 Q99085,Inter-alpha-trypsin inhibitor heavy chain H3,Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0030212;GO:0002576;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process; P:platelet degranulation;|Q06033 Q3B7H5 Q53F06 Q6LAM2 Q99085,Inter-alpha-trypsin inhibitor heavy chain H3,Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0030212;GO:0002576;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process; P:platelet degranulation;|Q06033 Q3B7H5 Q53F06 Q6LAM2 Q99085,Inter-alpha-trypsin inhibitor heavy chain H3,Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0030212;GO:0002576;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process; P:platelet degranulation;|Q06033 Q3B7H5 Q53F06 Q6LAM2 Q99085,Inter-alpha-trypsin inhibitor heavy chain H3,Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0030212;GO:0002576;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process; P:platelet degranulation;|Q06033 Q3B7H5 Q53F06 Q6LAM2 Q99085,Inter-alpha-trypsin inhibitor heavy chain H3,Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0030212;GO:0002576;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process; P:platelet degranulation;|Q06033 Q3B7H5 Q53F06 Q6LAM2 Q99085,Inter-alpha-trypsin inhibitor heavy chain H3,Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0030212;GO:0002576;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process; P:platelet degranulation;|Q06033 Q3B7H5 Q53F06 Q6LAM2 Q99085,Inter-alpha-trypsin inhibitor heavy chain H3,Serum-derived hyaluronan-associated protein;, PF06668;PF08487;PF00092;, GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0030212;GO:0002576;, C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:hyaluronan metabolic process; P:platelet degranulation; scaffold23 indexed_genome mRNA 1996845 2012712 . - . ID=transcript_5419;Q14624 B7Z545 E9PGN5 Q15135 Q9P190 Q9UQ54,Inter-alpha-trypsin inhibitor heavy chain H4,Inter-alpha-trypsin inhibitor family heavy chain-related protein;Plasma kallikrein sensitive glycoprotein 120;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0006953;GO:0030212;GO:0002576;GO:0034097;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:hyaluronan metabolic process; P:platelet degranulation; P:response to cytokine;|Q14624 B7Z545 E9PGN5 Q15135 Q9P190 Q9UQ54,Inter-alpha-trypsin inhibitor heavy chain H4,Inter-alpha-trypsin inhibitor family heavy chain-related protein;Plasma kallikrein sensitive glycoprotein 120;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0006953;GO:0030212;GO:0002576;GO:0034097;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:hyaluronan metabolic process; P:platelet degranulation; P:response to cytokine;|Q14624 B7Z545 E9PGN5 Q15135 Q9P190 Q9UQ54,Inter-alpha-trypsin inhibitor heavy chain H4,Inter-alpha-trypsin inhibitor family heavy chain-related protein;Plasma kallikrein sensitive glycoprotein 120;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0006953;GO:0030212;GO:0002576;GO:0034097;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:hyaluronan metabolic process; P:platelet degranulation; P:response to cytokine;|Q14624 B7Z545 E9PGN5 Q15135 Q9P190 Q9UQ54,Inter-alpha-trypsin inhibitor heavy chain H4,Inter-alpha-trypsin inhibitor family heavy chain-related protein;Plasma kallikrein sensitive glycoprotein 120;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0006953;GO:0030212;GO:0002576;GO:0034097;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:hyaluronan metabolic process; P:platelet degranulation; P:response to cytokine;|Q14624 B7Z545 E9PGN5 Q15135 Q9P190 Q9UQ54,Inter-alpha-trypsin inhibitor heavy chain H4,Inter-alpha-trypsin inhibitor family heavy chain-related protein;Plasma kallikrein sensitive glycoprotein 120;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0006953;GO:0030212;GO:0002576;GO:0034097;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:hyaluronan metabolic process; P:platelet degranulation; P:response to cytokine;|Q14624 B7Z545 E9PGN5 Q15135 Q9P190 Q9UQ54,Inter-alpha-trypsin inhibitor heavy chain H4,Inter-alpha-trypsin inhibitor family heavy chain-related protein;Plasma kallikrein sensitive glycoprotein 120;, PF06668;PF08487;PF00092;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0031089;GO:0004866;GO:0004867;GO:0006953;GO:0030212;GO:0002576;GO:0034097;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:hyaluronan metabolic process; P:platelet degranulation; P:response to cytokine; scaffold23 indexed_genome mRNA 2014939 2016565 . - . ID=transcript_5420;Q8IVN3,Musculoskeletal embryonic nuclear protein 1,, PF15682;, GO:0005634;GO:0002062;GO:0035988;GO:0042246;, C:nucleus;, , P:chondrocyte differentiation; P:chondrocyte proliferation; P:tissue regeneration; scaffold23 indexed_genome mRNA 2017581 2079196 . + . ID=transcript_5421;Q86TL2,Store-operated calcium entry regulator STIMATE {ECO:0000305|PubMed:26322679},STIM-activating enhancer encoded by TMEM110 {ECO:0000303|PubMed:26322679};Transmembrane protein 110 {ECO:0000305};, PF12400;, GO:0032541;GO:0005789;GO:0140268;GO:0016021;GO:0016020;GO:0005246;GO:0032237;GO:0035584;GO:0070886;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:membrane;, F:calcium channel regulator activity;, P:activation of store-operated calcium channel activity; P:calcium-mediated signaling using intracellular calcium source; P:positive regulation of calcineurin-NFAT signaling cascade;|Q86TL2,Store-operated calcium entry regulator STIMATE {ECO:0000305|PubMed:26322679},STIM-activating enhancer encoded by TMEM110 {ECO:0000303|PubMed:26322679};Transmembrane protein 110 {ECO:0000305};, PF12400;, GO:0032541;GO:0005789;GO:0140268;GO:0016021;GO:0016020;GO:0005246;GO:0032237;GO:0035584;GO:0070886;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:membrane;, F:calcium channel regulator activity;, P:activation of store-operated calcium channel activity; P:calcium-mediated signaling using intracellular calcium source; P:positive regulation of calcineurin-NFAT signaling cascade; scaffold23 indexed_genome mRNA 2085650 2115246 . - . ID=transcript_5422;Q9UHJ3 Q402F7 Q96C73 Q9Y4Q9,Scm-like with four MBT domains protein 1,Renal ubiquitous protein 1;, PF02820;PF00536;PF12140;, GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0003714;GO:0030154;GO:0006325;GO:0048635;GO:0045892;GO:0007283;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:transcription corepressor activity;, P:cell differentiation; P:chromatin organization; P:negative regulation of muscle organ development; P:negative regulation of transcription, DNA-templated; P:spermatogenesis; scaffold23 indexed_genome mRNA 2117005 2120967 . + . ID=transcript_5423;Q9UHJ3 Q402F7 Q96C73 Q9Y4Q9,Scm-like with four MBT domains protein 1,Renal ubiquitous protein 1;, PF02820;PF00536;PF12140;, GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0003714;GO:0030154;GO:0006325;GO:0048635;GO:0045892;GO:0007283;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:transcription corepressor activity;, P:cell differentiation; P:chromatin organization; P:negative regulation of muscle organ development; P:negative regulation of transcription, DNA-templated; P:spermatogenesis; scaffold23 indexed_genome mRNA 2121235 2138214 . - . ID=transcript_5424;Q9UHJ3 Q402F7 Q96C73 Q9Y4Q9,Scm-like with four MBT domains protein 1,Renal ubiquitous protein 1;, PF02820;PF00536;PF12140;, GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0003714;GO:0030154;GO:0006325;GO:0048635;GO:0045892;GO:0007283;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:transcription corepressor activity;, P:cell differentiation; P:chromatin organization; P:negative regulation of muscle organ development; P:negative regulation of transcription, DNA-templated; P:spermatogenesis; scaffold23 indexed_genome mRNA 2209417 2238912 . - . ID=transcript_5425;Q96AA3 Q96J03,Protein RFT1 homolog,, PF04506;, GO:0005789;GO:0016021;GO:0008643;GO:0006488;GO:0034203;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:carbohydrate transport; P:dolichol-linked oligosaccharide biosynthetic process; P:glycolipid translocation;|Q96AA3 Q96J03,Protein RFT1 homolog,, PF04506;, GO:0005789;GO:0016021;GO:0008643;GO:0006488;GO:0034203;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:carbohydrate transport; P:dolichol-linked oligosaccharide biosynthetic process; P:glycolipid translocation;|Q96AA3 Q96J03,Protein RFT1 homolog,, PF04506;, GO:0005789;GO:0016021;GO:0008643;GO:0006488;GO:0034203;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:carbohydrate transport; P:dolichol-linked oligosaccharide biosynthetic process; P:glycolipid translocation; scaffold23 indexed_genome mRNA 2290701 2317690 . + . ID=transcript_5426;Q05655 B0KZ81 B2R834 Q15144 Q86XJ6,Protein kinase C delta type {ECO:0000305},Tyrosine-protein kinase PRKCD;nPKC-delta;, PF00130;PF00069;PF00433;, GO:0035578;GO:0005911;GO:0005737;GO:0005829;GO:0036019;GO:0005783;GO:0070062;GO:0005576;GO:0005739;GO:0016363;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0004698;GO:0004699;GO:0008047;GO:0019899;GO:0043560;GO:0019900;GO:0046872;GO:0004715;GO:0004672;GO:0019901;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0004714;GO:0032147;GO:0006915;GO:0042100;GO:0060326;GO:0007049;GO:1904385;GO:0070301;GO:0071447;GO:0034644;GO:0090398;GO:0042742;GO:0038096;GO:0016572;GO:0016064;GO:0060333;GO:0035556;GO:0008631;GO:0030837;GO:0051490;GO:0034351;GO:0050728;GO:0046627;GO:0043407;GO:0050732;GO:0090331;GO:0032091;GO:0042119;GO:0043312;GO:0018105;GO:0018107;GO:0030168;GO:2001235;GO:2000304;GO:0032079;GO:2000753;GO:1900163;GO:0035307;GO:0042307;GO:2001022;GO:2000755;GO:0032930;GO:0006468;GO:0050821;GO:0032956;GO:2000303;GO:0043488;GO:0010469;GO:0007165;GO:0002223;GO:0023021;, C:azurophil granule lumen; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endolysosome; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:mitochondrion; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:calcium-independent protein kinase C activity; F:enzyme activator activity; F:enzyme binding; F:insulin receptor substrate binding; F:kinase binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:B cell proliferation; P:cell chemotaxis; P:cell cycle; P:cellular response to angiotensin; P:cellular response to hydrogen peroxide; P:cellular response to hydroperoxide; P:cellular response to UV; P:cellular senescence; P:defense response to bacterium; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:histone phosphorylation; P:immunoglobulin mediated immune response; P:interferon-gamma-mediated signaling pathway; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:negative regulation of actin filament polymerization; P:negative regulation of filopodium assembly; P:negative regulation of glial cell apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of platelet aggregation; P:negative regulation of protein binding; P:neutrophil activation; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of ceramide biosynthetic process; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of glucosylceramide catabolic process; P:positive regulation of phospholipid scramblase activity; P:positive regulation of protein dephosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of response to DNA damage stimulus; P:positive regulation of sphingomyelin catabolic process; P:positive regulation of superoxide anion generation; P:protein phosphorylation; P:protein stabilization; P:regulation of actin cytoskeleton organization; P:regulation of ceramide biosynthetic process; P:regulation of mRNA stability; P:regulation of signaling receptor activity; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:termination of signal transduction;|Q05655 B0KZ81 B2R834 Q15144 Q86XJ6,Protein kinase C delta type {ECO:0000305},Tyrosine-protein kinase PRKCD;nPKC-delta;, PF00130;PF00069;PF00433;, GO:0035578;GO:0005911;GO:0005737;GO:0005829;GO:0036019;GO:0005783;GO:0070062;GO:0005576;GO:0005739;GO:0016363;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0004698;GO:0004699;GO:0008047;GO:0019899;GO:0043560;GO:0019900;GO:0046872;GO:0004715;GO:0004672;GO:0019901;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0004714;GO:0032147;GO:0006915;GO:0042100;GO:0060326;GO:0007049;GO:1904385;GO:0070301;GO:0071447;GO:0034644;GO:0090398;GO:0042742;GO:0038096;GO:0016572;GO:0016064;GO:0060333;GO:0035556;GO:0008631;GO:0030837;GO:0051490;GO:0034351;GO:0050728;GO:0046627;GO:0043407;GO:0050732;GO:0090331;GO:0032091;GO:0042119;GO:0043312;GO:0018105;GO:0018107;GO:0030168;GO:2001235;GO:2000304;GO:0032079;GO:2000753;GO:1900163;GO:0035307;GO:0042307;GO:2001022;GO:2000755;GO:0032930;GO:0006468;GO:0050821;GO:0032956;GO:2000303;GO:0043488;GO:0010469;GO:0007165;GO:0002223;GO:0023021;, C:azurophil granule lumen; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endolysosome; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:mitochondrion; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:calcium-independent protein kinase C activity; F:enzyme activator activity; F:enzyme binding; F:insulin receptor substrate binding; F:kinase binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:B cell proliferation; P:cell chemotaxis; P:cell cycle; P:cellular response to angiotensin; P:cellular response to hydrogen peroxide; P:cellular response to hydroperoxide; P:cellular response to UV; P:cellular senescence; P:defense response to bacterium; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:histone phosphorylation; P:immunoglobulin mediated immune response; P:interferon-gamma-mediated signaling pathway; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:negative regulation of actin filament polymerization; P:negative regulation of filopodium assembly; P:negative regulation of glial cell apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of platelet aggregation; P:negative regulation of protein binding; P:neutrophil activation; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of ceramide biosynthetic process; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of glucosylceramide catabolic process; P:positive regulation of phospholipid scramblase activity; P:positive regulation of protein dephosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of response to DNA damage stimulus; P:positive regulation of sphingomyelin catabolic process; P:positive regulation of superoxide anion generation; P:protein phosphorylation; P:protein stabilization; P:regulation of actin cytoskeleton organization; P:regulation of ceramide biosynthetic process; P:regulation of mRNA stability; P:regulation of signaling receptor activity; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:termination of signal transduction;|Q05655 B0KZ81 B2R834 Q15144 Q86XJ6,Protein kinase C delta type {ECO:0000305},Tyrosine-protein kinase PRKCD;nPKC-delta;, PF00130;PF00069;PF00433;, GO:0035578;GO:0005911;GO:0005737;GO:0005829;GO:0036019;GO:0005783;GO:0070062;GO:0005576;GO:0005739;GO:0016363;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0004698;GO:0004699;GO:0008047;GO:0019899;GO:0043560;GO:0019900;GO:0046872;GO:0004715;GO:0004672;GO:0019901;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0004714;GO:0032147;GO:0006915;GO:0042100;GO:0060326;GO:0007049;GO:1904385;GO:0070301;GO:0071447;GO:0034644;GO:0090398;GO:0042742;GO:0038096;GO:0016572;GO:0016064;GO:0060333;GO:0035556;GO:0008631;GO:0030837;GO:0051490;GO:0034351;GO:0050728;GO:0046627;GO:0043407;GO:0050732;GO:0090331;GO:0032091;GO:0042119;GO:0043312;GO:0018105;GO:0018107;GO:0030168;GO:2001235;GO:2000304;GO:0032079;GO:2000753;GO:1900163;GO:0035307;GO:0042307;GO:2001022;GO:2000755;GO:0032930;GO:0006468;GO:0050821;GO:0032956;GO:2000303;GO:0043488;GO:0010469;GO:0007165;GO:0002223;GO:0023021;, C:azurophil granule lumen; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endolysosome; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:mitochondrion; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:calcium-independent protein kinase C activity; F:enzyme activator activity; F:enzyme binding; F:insulin receptor substrate binding; F:kinase binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:B cell proliferation; P:cell chemotaxis; P:cell cycle; P:cellular response to angiotensin; P:cellular response to hydrogen peroxide; P:cellular response to hydroperoxide; P:cellular response to UV; P:cellular senescence; P:defense response to bacterium; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:histone phosphorylation; P:immunoglobulin mediated immune response; P:interferon-gamma-mediated signaling pathway; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:negative regulation of actin filament polymerization; P:negative regulation of filopodium assembly; P:negative regulation of glial cell apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of platelet aggregation; P:negative regulation of protein binding; P:neutrophil activation; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of ceramide biosynthetic process; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of glucosylceramide catabolic process; P:positive regulation of phospholipid scramblase activity; P:positive regulation of protein dephosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of response to DNA damage stimulus; P:positive regulation of sphingomyelin catabolic process; P:positive regulation of superoxide anion generation; P:protein phosphorylation; P:protein stabilization; P:regulation of actin cytoskeleton organization; P:regulation of ceramide biosynthetic process; P:regulation of mRNA stability; P:regulation of signaling receptor activity; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:termination of signal transduction; scaffold23 indexed_genome mRNA 2322016 2323597 . + . ID=transcript_5427;Q9Y3B1 E1P5I8 Q5JX17 Q9NUL0,PRELI domain containing protein 3B,Protein slowmo homolog 2;, PF04707;, GO:0005758;GO:1990050;GO:0015914;, C:mitochondrial intermembrane space;, F:phosphatidic acid transfer activity;, P:phospholipid transport;|Q9Y3B1 E1P5I8 Q5JX17 Q9NUL0,PRELI domain containing protein 3B,Protein slowmo homolog 2;, PF04707;, GO:0005758;GO:1990050;GO:0015914;, C:mitochondrial intermembrane space;, F:phosphatidic acid transfer activity;, P:phospholipid transport; scaffold23 indexed_genome mRNA 2337319 2360523 . - . ID=transcript_5428;P29401 A8K089 B4DE31 E7EPA7 Q8TBA3 Q96HH3,Transketolase,, PF02779;PF02780;PF00456;, GO:0005829;GO:0005789;GO:0070062;GO:0016604;GO:0005654;GO:0005777;GO:0031982;GO:0005509;GO:0000287;GO:0042803;GO:0030976;GO:0004802;GO:0046166;GO:0006098;GO:0009052;GO:0040008;GO:0046390;GO:0005999;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:nuclear body; C:nucleoplasm; C:peroxisome; C:vesicle;, F:calcium ion binding; F:magnesium ion binding; F:protein homodimerization activity; F:thiamine pyrophosphate binding; F:transketolase activity;, P:glyceraldehyde-3-phosphate biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:regulation of growth; P:ribose phosphate biosynthetic process; P:xylulose biosynthetic process;|P29401 A8K089 B4DE31 E7EPA7 Q8TBA3 Q96HH3,Transketolase,, PF02779;PF02780;PF00456;, GO:0005829;GO:0005789;GO:0070062;GO:0016604;GO:0005654;GO:0005777;GO:0031982;GO:0005509;GO:0000287;GO:0042803;GO:0030976;GO:0004802;GO:0046166;GO:0006098;GO:0009052;GO:0040008;GO:0046390;GO:0005999;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:nuclear body; C:nucleoplasm; C:peroxisome; C:vesicle;, F:calcium ion binding; F:magnesium ion binding; F:protein homodimerization activity; F:thiamine pyrophosphate binding; F:transketolase activity;, P:glyceraldehyde-3-phosphate biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:regulation of growth; P:ribose phosphate biosynthetic process; P:xylulose biosynthetic process;|P29401 A8K089 B4DE31 E7EPA7 Q8TBA3 Q96HH3,Transketolase,, PF02779;PF02780;PF00456;, GO:0005829;GO:0005789;GO:0070062;GO:0016604;GO:0005654;GO:0005777;GO:0031982;GO:0005509;GO:0000287;GO:0042803;GO:0030976;GO:0004802;GO:0046166;GO:0006098;GO:0009052;GO:0040008;GO:0046390;GO:0005999;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:nuclear body; C:nucleoplasm; C:peroxisome; C:vesicle;, F:calcium ion binding; F:magnesium ion binding; F:protein homodimerization activity; F:thiamine pyrophosphate binding; F:transketolase activity;, P:glyceraldehyde-3-phosphate biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:regulation of growth; P:ribose phosphate biosynthetic process; P:xylulose biosynthetic process; scaffold23 indexed_genome mRNA 2375219 2415895 . + . ID=transcript_5429;Q9NPI6 B4DHN9 U3KQM8,mRNA-decapping enzyme 1A,Smad4-interacting transcriptional co-activator;Transcription factor SMIF;, PF06058;PF16741;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0008047;GO:0030234;GO:0016787;GO:0042802;GO:0019894;GO:0003729;GO:0000290;GO:0031087;GO:0043928;GO:0000184;GO:0043085;GO:1903608;GO:0043488;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleus; C:P-body;, F:enzyme activator activity; F:enzyme regulator activity; F:hydrolase activity; F:identical protein binding; F:kinesin binding; F:mRNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of catalytic activity; P:protein localization to cytoplasmic stress granule; P:regulation of mRNA stability;|Q9NPI6 B4DHN9 U3KQM8,mRNA-decapping enzyme 1A,Smad4-interacting transcriptional co-activator;Transcription factor SMIF;, PF06058;PF16741;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0008047;GO:0030234;GO:0016787;GO:0042802;GO:0019894;GO:0003729;GO:0000290;GO:0031087;GO:0043928;GO:0000184;GO:0043085;GO:1903608;GO:0043488;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleus; C:P-body;, F:enzyme activator activity; F:enzyme regulator activity; F:hydrolase activity; F:identical protein binding; F:kinesin binding; F:mRNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of catalytic activity; P:protein localization to cytoplasmic stress granule; P:regulation of mRNA stability;|Q9NPI6 B4DHN9 U3KQM8,mRNA-decapping enzyme 1A,Smad4-interacting transcriptional co-activator;Transcription factor SMIF;, PF06058;PF16741;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0008047;GO:0030234;GO:0016787;GO:0042802;GO:0019894;GO:0003729;GO:0000290;GO:0031087;GO:0043928;GO:0000184;GO:0043085;GO:1903608;GO:0043488;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleus; C:P-body;, F:enzyme activator activity; F:enzyme regulator activity; F:hydrolase activity; F:identical protein binding; F:kinesin binding; F:mRNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of catalytic activity; P:protein localization to cytoplasmic stress granule; P:regulation of mRNA stability; scaffold23 indexed_genome mRNA 2548449 2798833 . + . ID=transcript_5430;Q01668 B0FYA3 Q13916 Q13931 Q71UT1 Q9UDC3,Voltage-dependent L-type calcium channel subunit alpha-1D,Calcium channel, L type, alpha-1 polypeptide, isoform 2;Voltage-gated calcium channel subunit alpha Cav1.3;, PF08763;PF16885;PF16905;PF00520;, GO:1990454;GO:0005886;GO:0005891;GO:0030018;GO:0051393;GO:0030506;GO:0005262;GO:0046872;GO:0005245;GO:0086007;GO:0086059;GO:0007188;GO:0070509;GO:0070588;GO:0006816;GO:0086002;GO:0086012;GO:0086046;GO:0045762;GO:0051928;GO:0060372;GO:0086091;GO:0050796;GO:1901379;GO:1901016;GO:0007605;, C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:ankyrin binding; F:calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cardiac muscle cell action potential involved in contraction; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during SA node cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion transport; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of potassium ion transmembrane transport; P:regulation of potassium ion transmembrane transporter activity; P:sensory perception of sound; scaffold23 indexed_genome mRNA 2798842 2883792 . + . ID=transcript_5431;Q01668 B0FYA3 Q13916 Q13931 Q71UT1 Q9UDC3,Voltage-dependent L-type calcium channel subunit alpha-1D,Calcium channel, L type, alpha-1 polypeptide, isoform 2;Voltage-gated calcium channel subunit alpha Cav1.3;, PF08763;PF16885;PF16905;PF00520;, GO:1990454;GO:0005886;GO:0005891;GO:0030018;GO:0051393;GO:0030506;GO:0005262;GO:0046872;GO:0005245;GO:0086007;GO:0086059;GO:0007188;GO:0070509;GO:0070588;GO:0006816;GO:0086002;GO:0086012;GO:0086046;GO:0045762;GO:0051928;GO:0060372;GO:0086091;GO:0050796;GO:1901379;GO:1901016;GO:0007605;, C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:ankyrin binding; F:calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cardiac muscle cell action potential involved in contraction; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during SA node cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion transport; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of potassium ion transmembrane transport; P:regulation of potassium ion transmembrane transporter activity; P:sensory perception of sound;|Q01668 B0FYA3 Q13916 Q13931 Q71UT1 Q9UDC3,Voltage-dependent L-type calcium channel subunit alpha-1D,Calcium channel, L type, alpha-1 polypeptide, isoform 2;Voltage-gated calcium channel subunit alpha Cav1.3;, PF08763;PF16885;PF16905;PF00520;, GO:1990454;GO:0005886;GO:0005891;GO:0030018;GO:0051393;GO:0030506;GO:0005262;GO:0046872;GO:0005245;GO:0086007;GO:0086059;GO:0007188;GO:0070509;GO:0070588;GO:0006816;GO:0086002;GO:0086012;GO:0086046;GO:0045762;GO:0051928;GO:0060372;GO:0086091;GO:0050796;GO:1901379;GO:1901016;GO:0007605;, C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:ankyrin binding; F:calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cardiac muscle cell action potential involved in contraction; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during SA node cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion transport; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of potassium ion transmembrane transport; P:regulation of potassium ion transmembrane transporter activity; P:sensory perception of sound;|Q01668 B0FYA3 Q13916 Q13931 Q71UT1 Q9UDC3,Voltage-dependent L-type calcium channel subunit alpha-1D,Calcium channel, L type, alpha-1 polypeptide, isoform 2;Voltage-gated calcium channel subunit alpha Cav1.3;, PF08763;PF16885;PF16905;PF00520;, GO:1990454;GO:0005886;GO:0005891;GO:0030018;GO:0051393;GO:0030506;GO:0005262;GO:0046872;GO:0005245;GO:0086007;GO:0086059;GO:0007188;GO:0070509;GO:0070588;GO:0006816;GO:0086002;GO:0086012;GO:0086046;GO:0045762;GO:0051928;GO:0060372;GO:0086091;GO:0050796;GO:1901379;GO:1901016;GO:0007605;, C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:ankyrin binding; F:calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cardiac muscle cell action potential involved in contraction; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during SA node cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion transport; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of potassium ion transmembrane transport; P:regulation of potassium ion transmembrane transporter activity; P:sensory perception of sound;|Q01668 B0FYA3 Q13916 Q13931 Q71UT1 Q9UDC3,Voltage-dependent L-type calcium channel subunit alpha-1D,Calcium channel, L type, alpha-1 polypeptide, isoform 2;Voltage-gated calcium channel subunit alpha Cav1.3;, PF08763;PF16885;PF16905;PF00520;, GO:1990454;GO:0005886;GO:0005891;GO:0030018;GO:0051393;GO:0030506;GO:0005262;GO:0046872;GO:0005245;GO:0086007;GO:0086059;GO:0007188;GO:0070509;GO:0070588;GO:0006816;GO:0086002;GO:0086012;GO:0086046;GO:0045762;GO:0051928;GO:0060372;GO:0086091;GO:0050796;GO:1901379;GO:1901016;GO:0007605;, C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:ankyrin binding; F:calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cardiac muscle cell action potential involved in contraction; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during SA node cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion transport; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of potassium ion transmembrane transport; P:regulation of potassium ion transmembrane transporter activity; P:sensory perception of sound;|Q01668 B0FYA3 Q13916 Q13931 Q71UT1 Q9UDC3,Voltage-dependent L-type calcium channel subunit alpha-1D,Calcium channel, L type, alpha-1 polypeptide, isoform 2;Voltage-gated calcium channel subunit alpha Cav1.3;, PF08763;PF16885;PF16905;PF00520;, GO:1990454;GO:0005886;GO:0005891;GO:0030018;GO:0051393;GO:0030506;GO:0005262;GO:0046872;GO:0005245;GO:0086007;GO:0086059;GO:0007188;GO:0070509;GO:0070588;GO:0006816;GO:0086002;GO:0086012;GO:0086046;GO:0045762;GO:0051928;GO:0060372;GO:0086091;GO:0050796;GO:1901379;GO:1901016;GO:0007605;, C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:ankyrin binding; F:calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cardiac muscle cell action potential involved in contraction; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during SA node cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion transport; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of potassium ion transmembrane transport; P:regulation of potassium ion transmembrane transporter activity; P:sensory perception of sound;|Q01668 B0FYA3 Q13916 Q13931 Q71UT1 Q9UDC3,Voltage-dependent L-type calcium channel subunit alpha-1D,Calcium channel, L type, alpha-1 polypeptide, isoform 2;Voltage-gated calcium channel subunit alpha Cav1.3;, PF08763;PF16885;PF16905;PF00520;, GO:1990454;GO:0005886;GO:0005891;GO:0030018;GO:0051393;GO:0030506;GO:0005262;GO:0046872;GO:0005245;GO:0086007;GO:0086059;GO:0007188;GO:0070509;GO:0070588;GO:0006816;GO:0086002;GO:0086012;GO:0086046;GO:0045762;GO:0051928;GO:0060372;GO:0086091;GO:0050796;GO:1901379;GO:1901016;GO:0007605;, C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:ankyrin binding; F:calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cardiac muscle cell action potential involved in contraction; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during SA node cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion transport; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of potassium ion transmembrane transport; P:regulation of potassium ion transmembrane transporter activity; P:sensory perception of sound; scaffold23 indexed_genome mRNA 2883812 2910886 . - . ID=transcript_5432;Q8NE62 Q9NY17,Choline dehydrogenase, mitochondrial,, PF05199;PF00732;, GO:0005743;GO:0008812;GO:0050660;GO:0016491;GO:0042426;GO:0019285;, C:mitochondrial inner membrane;, F:choline dehydrogenase activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:choline catabolic process; P:glycine betaine biosynthetic process from choline;|Q8NE62 Q9NY17,Choline dehydrogenase, mitochondrial,, PF05199;PF00732;, GO:0005743;GO:0008812;GO:0050660;GO:0016491;GO:0042426;GO:0019285;, C:mitochondrial inner membrane;, F:choline dehydrogenase activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:choline catabolic process; P:glycine betaine biosynthetic process from choline;|P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q9B2Z0 Q9B2Z4 Q9T6H6 Q9T9Y0 Q9TEH4,Cytochrome b,Complex III subunit 3;Complex III subunit III;Cytochrome b-c1 complex subunit 3;Ubiquinol-cytochrome-c reductase complex cytochrome b subunit;, PF00032;PF00033;, GO:0031305;GO:0005743;GO:0005750;GO:0005739;GO:0046872;GO:0044877;GO:0008121;GO:0031100;GO:0015990;GO:0042538;GO:0006122;GO:0046686;GO:0051592;GO:0033590;GO:0046688;GO:0042493;GO:0045471;GO:0033762;GO:0009408;GO:0055093;GO:0001666;GO:0046689;GO:0009636;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:metal ion binding; F:protein-containing complex binding; F:ubiquinol-cytochrome-c reductase activity;, P:animal organ regeneration; P:electron transport coupled proton transport; P:hyperosmotic salinity response; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:response to cadmium ion; P:response to calcium ion; P:response to cobalamin; P:response to copper ion; P:response to drug; P:response to ethanol; P:response to glucagon; P:response to heat; P:response to hyperoxia; P:response to hypoxia; P:response to mercury ion; P:response to toxic substance;|P03886 C0JKH6 Q37523,NADH-ubiquinone oxidoreductase chain 1,NADH dehydrogenase subunit 1;, PF00146;, GO:0030425;GO:0016021;GO:0005743;GO:0031966;GO:0005747;GO:0043025;GO:0008137;GO:0009060;GO:0006120;GO:0032981;GO:0042493;GO:0033194;GO:0014070;, C:dendrite; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:neuronal cell body;, F:NADH dehydrogenase (ubiquinone) activity;, P:aerobic respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to drug; P:response to hydroperoxide; P:response to organic cyclic compound;|P00395 Q34770,Cytochrome c oxidase subunit 1,Cytochrome c oxidase polypeptide I;, PF00115;, GO:0016021;GO:0005743;GO:0005750;GO:0005751;GO:0045277;GO:0004129;GO:0020037;GO:0046872;GO:0009060;GO:0007568;GO:0021549;GO:0015990;GO:0006123;GO:0022904;GO:0046688;GO:0051602;GO:0006979;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:heme binding; F:metal ion binding;, P:aerobic respiration; P:aging; P:cerebellum development; P:electron transport coupled proton transport; P:mitochondrial electron transport, cytochrome c to oxygen; P:respiratory electron transport chain; P:response to copper ion; P:response to electrical stimulus; P:response to oxidative stress;|Q8NE62 Q9NY17,Choline dehydrogenase, mitochondrial,, PF05199;PF00732;, GO:0005743;GO:0008812;GO:0050660;GO:0016491;GO:0042426;GO:0019285;, C:mitochondrial inner membrane;, F:choline dehydrogenase activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:choline catabolic process; P:glycine betaine biosynthetic process from choline;|Q8NE62 Q9NY17,Choline dehydrogenase, mitochondrial,, PF05199;PF00732;, GO:0005743;GO:0008812;GO:0050660;GO:0016491;GO:0042426;GO:0019285;, C:mitochondrial inner membrane;, F:choline dehydrogenase activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:choline catabolic process; P:glycine betaine biosynthetic process from choline; scaffold23 indexed_genome mRNA 2973269 2989479 . + . ID=transcript_5433;Q9NRM6 Q9BPZ0 Q9NRL4 Q9NRM5,Interleukin-17 receptor B,Cytokine receptor-like 4;IL-17 receptor homolog 1;Interleukin-17B receptor;, PF16556;PF08357;, GO:0034451;GO:0005576;GO:0005887;GO:0016020;GO:0072686;GO:0005654;GO:0005886;GO:0004896;GO:0030368;GO:0006952;GO:0097400;GO:0001558;, C:centriolar satellite; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:mitotic spindle; C:nucleoplasm; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-17 receptor activity;, P:defense response; P:interleukin-17-mediated signaling pathway; P:regulation of cell growth;|Q9NRM6 Q9BPZ0 Q9NRL4 Q9NRM5,Interleukin-17 receptor B,Cytokine receptor-like 4;IL-17 receptor homolog 1;Interleukin-17B receptor;, PF16556;PF08357;, GO:0034451;GO:0005576;GO:0005887;GO:0016020;GO:0072686;GO:0005654;GO:0005886;GO:0004896;GO:0030368;GO:0006952;GO:0097400;GO:0001558;, C:centriolar satellite; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:mitotic spindle; C:nucleoplasm; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-17 receptor activity;, P:defense response; P:interleukin-17-mediated signaling pathway; P:regulation of cell growth;|Q9NRM6 Q9BPZ0 Q9NRL4 Q9NRM5,Interleukin-17 receptor B,Cytokine receptor-like 4;IL-17 receptor homolog 1;Interleukin-17B receptor;, PF16556;PF08357;, GO:0034451;GO:0005576;GO:0005887;GO:0016020;GO:0072686;GO:0005654;GO:0005886;GO:0004896;GO:0030368;GO:0006952;GO:0097400;GO:0001558;, C:centriolar satellite; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:mitotic spindle; C:nucleoplasm; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-17 receptor activity;, P:defense response; P:interleukin-17-mediated signaling pathway; P:regulation of cell growth; scaffold23 indexed_genome mRNA 2990520 3006954 . - . ID=transcript_5434;Q9H981 B3KSW7 Q8N566 Q9H663,Actin-related protein 8,INO80 complex subunit N;, PF00022;, GO:0005813;GO:0031011;GO:0005654;GO:0005634;GO:0005524;GO:0043044;GO:0007049;GO:0051301;GO:0006310;GO:0006302;GO:0016579;GO:0006355;, C:centrosome; C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:ATP binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:cell division; P:DNA recombination; P:double-strand break repair; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9H981 B3KSW7 Q8N566 Q9H663,Actin-related protein 8,INO80 complex subunit N;, PF00022;, GO:0005813;GO:0031011;GO:0005654;GO:0005634;GO:0005524;GO:0043044;GO:0007049;GO:0051301;GO:0006310;GO:0006302;GO:0016579;GO:0006355;, C:centrosome; C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:ATP binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:cell division; P:DNA recombination; P:double-strand break repair; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9H981 B3KSW7 Q8N566 Q9H663,Actin-related protein 8,INO80 complex subunit N;, PF00022;, GO:0005813;GO:0031011;GO:0005654;GO:0005634;GO:0005524;GO:0043044;GO:0007049;GO:0051301;GO:0006310;GO:0006302;GO:0016579;GO:0006355;, C:centrosome; C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:ATP binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:cell division; P:DNA recombination; P:double-strand break repair; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9H981 B3KSW7 Q8N566 Q9H663,Actin-related protein 8,INO80 complex subunit N;, PF00022;, GO:0005813;GO:0031011;GO:0005654;GO:0005634;GO:0005524;GO:0043044;GO:0007049;GO:0051301;GO:0006310;GO:0006302;GO:0016579;GO:0006355;, C:centrosome; C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:ATP binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:cell division; P:DNA recombination; P:double-strand break repair; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9H981 B3KSW7 Q8N566 Q9H663,Actin-related protein 8,INO80 complex subunit N;, PF00022;, GO:0005813;GO:0031011;GO:0005654;GO:0005634;GO:0005524;GO:0043044;GO:0007049;GO:0051301;GO:0006310;GO:0006302;GO:0016579;GO:0006355;, C:centrosome; C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:ATP binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:cell division; P:DNA recombination; P:double-strand break repair; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9H981 B3KSW7 Q8N566 Q9H663,Actin-related protein 8,INO80 complex subunit N;, PF00022;, GO:0005813;GO:0031011;GO:0005654;GO:0005634;GO:0005524;GO:0043044;GO:0007049;GO:0051301;GO:0006310;GO:0006302;GO:0016579;GO:0006355;, C:centrosome; C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:ATP binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:cell division; P:DNA recombination; P:double-strand break repair; P:protein deubiquitination; P:regulation of transcription, DNA-templated; scaffold23 indexed_genome mRNA 3008076 3016279 . - . ID=transcript_5435;Q9Y6D0 Q8IZQ3 Q9P085,Selenoprotein K {ECO:0000303|PubMed:27645994},, PF10961;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005886;GO:0042802;GO:0006816;GO:0032469;GO:0070059;GO:0010742;GO:0002230;GO:0032755;GO:0071639;GO:2000406;GO:0042102;GO:0032760;GO:0018345;GO:0050848;GO:0051223;GO:0045728;GO:0006979;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:identical protein binding;, P:calcium ion transport; P:endoplasmic reticulum calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:macrophage derived foam cell differentiation; P:positive regulation of defense response to virus by host; P:positive regulation of interleukin-6 production; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of T cell migration; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:protein palmitoylation; P:regulation of calcium-mediated signaling; P:regulation of protein transport; P:respiratory burst after phagocytosis; P:response to oxidative stress; scaffold23 indexed_genome mRNA 3879243 4080537 . + . ID=transcript_5436;Q8IZS8 B2RPL6 Q9NY16 Q9NY18,Voltage-dependent calcium channel subunit alpha-2/delta-3,Voltage-gated calcium channel subunit alpha-2/delta-3;, PF08473;PF13768;PF08399;, GO:0005891;GO:0046872;GO:0005245;GO:0034765;, C:voltage-gated calcium channel complex;, F:metal ion binding; F:voltage-gated calcium channel activity;, P:regulation of ion transmembrane transport;|Q8IZS8 B2RPL6 Q9NY16 Q9NY18,Voltage-dependent calcium channel subunit alpha-2/delta-3,Voltage-gated calcium channel subunit alpha-2/delta-3;, PF08473;PF13768;PF08399;, GO:0005891;GO:0046872;GO:0005245;GO:0034765;, C:voltage-gated calcium channel complex;, F:metal ion binding; F:voltage-gated calcium channel activity;, P:regulation of ion transmembrane transport;|Q8IZS8 B2RPL6 Q9NY16 Q9NY18,Voltage-dependent calcium channel subunit alpha-2/delta-3,Voltage-gated calcium channel subunit alpha-2/delta-3;, PF08473;PF13768;PF08399;, GO:0005891;GO:0046872;GO:0005245;GO:0034765;, C:voltage-gated calcium channel complex;, F:metal ion binding; F:voltage-gated calcium channel activity;, P:regulation of ion transmembrane transport; scaffold23 indexed_genome mRNA 4417724 4433829 . - . ID=transcript_5437;P41221 A8K4A4 Q6P278,Protein Wnt-5a,, PF00110;, GO:0009986;GO:0030669;GO:0030666;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0098978;GO:0005796;GO:0005886;GO:0098794;GO:1902379;GO:0005125;GO:0005109;GO:0005543;GO:0019904;GO:0048018;GO:0005115;GO:0090630;GO:0007257;GO:0000187;GO:0032148;GO:0008595;GO:0003283;GO:0007411;GO:0060070;GO:0051216;GO:0045165;GO:0034613;GO:0071277;GO:0071346;GO:0071222;GO:0071300;GO:0071560;GO:0060067;GO:0036517;GO:0036518;GO:0090103;GO:0060028;GO:0060029;GO:0042733;GO:0048706;GO:0060750;GO:0001837;GO:0045198;GO:0001736;GO:1904861;GO:0060324;GO:0048806;GO:0001947;GO:0071425;GO:0007442;GO:0048850;GO:1904862;GO:0030216;GO:0001822;GO:0060599;GO:0002088;GO:0030324;GO:0008584;GO:0060744;GO:0097325;GO:0061024;GO:0060638;GO:0060809;GO:0007494;GO:0043066;GO:0048843;GO:0030514;GO:0090090;GO:1904934;GO:0050680;GO:0045599;GO:0040037;GO:0048022;GO:0072201;GO:0060686;GO:0051964;GO:0045892;GO:0030182;GO:0035567;GO:0038031;GO:0048570;GO:0021891;GO:0003408;GO:0048341;GO:0003402;GO:1904938;GO:0061350;GO:0061349;GO:0060775;GO:1904955;GO:0090179;GO:0061347;GO:0061354;GO:0061348;GO:0045766;GO:0061036;GO:0031343;GO:2000049;GO:0032722;GO:0002720;GO:0045807;GO:0010595;GO:0001938;GO:0048146;GO:0010628;GO:0090082;GO:0050729;GO:0032729;GO:0032731;GO:0032755;GO:0032757;GO:0046330;GO:0043032;GO:0060907;GO:0045836;GO:0002053;GO:1901216;GO:0150012;GO:0010976;GO:0051092;GO:2000052;GO:0045778;GO:0033138;GO:0010800;GO:0032092;GO:0045732;GO:1900020;GO:0090037;GO:1902474;GO:0060760;GO:0010820;GO:0070245;GO:0051885;GO:0045944;GO:0045893;GO:0032760;GO:0060340;GO:0036342;GO:0099068;GO:0099054;GO:0003138;GO:0090009;GO:0006468;GO:0060762;GO:1903827;GO:0043122;GO:0050727;GO:0099175;GO:0099566;GO:0050807;GO:0010033;GO:0003139;GO:0062009;GO:0001756;GO:0003323;GO:0060157;GO:0060065;GO:0060068;GO:0016055;GO:1904953;GO:0007223;GO:0060071;GO:0042060;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:Golgi lumen; C:plasma membrane; C:postsynapse;, F:chemoattractant activity involved in axon guidance; F:cytokine activity; F:frizzled binding; F:phospholipid binding; F:protein domain specific binding; F:receptor ligand activity; F:receptor tyrosine kinase-like orphan receptor binding;, P:activation of GTPase activity; P:activation of JUN kinase activity; P:activation of MAPK activity; P:activation of protein kinase B activity; P:anterior/posterior axis specification, embryo; P:atrial septum development; P:axon guidance; P:canonical Wnt signaling pathway; P:cartilage development; P:cell fate commitment; P:cellular protein localization; P:cellular response to calcium ion; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:cervix development; P:chemoattraction of serotonergic neuron axon; P:chemorepulsion of dopaminergic neuron axon; P:cochlea morphogenesis; P:convergent extension involved in axis elongation; P:convergent extension involved in organogenesis; P:embryonic digit morphogenesis; P:embryonic skeletal system development; P:epithelial cell proliferation involved in mammary gland duct elongation; P:epithelial to mesenchymal transition; P:establishment of epithelial cell apical/basal polarity; P:establishment of planar polarity; P:excitatory synapse assembly; P:face development; P:genitalia development; P:heart looping; P:hematopoietic stem cell proliferation; P:hindgut morphogenesis; P:hypophysis morphogenesis; P:inhibitory synapse assembly; P:keratinocyte differentiation; P:kidney development; P:lateral sprouting involved in mammary gland duct morphogenesis; P:lens development in camera-type eye; P:lung development; P:male gonad development; P:mammary gland branching involved in thelarche; P:melanocyte proliferation; P:membrane organization; P:mesenchymal-epithelial cell signaling; P:mesodermal to mesenchymal transition involved in gastrulation; P:midgut development; P:negative regulation of apoptotic process; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of BMP signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell proliferation in midbrain; P:negative regulation of epithelial cell proliferation; P:negative regulation of fat cell differentiation; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of melanin biosynthetic process; P:negative regulation of mesenchymal cell proliferation; P:negative regulation of prostatic bud formation; P:negative regulation of synapse assembly; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:non-canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway via JNK cascade; P:notochord morphogenesis; P:olfactory bulb interneuron development; P:optic cup formation involved in camera-type eye development; P:paraxial mesoderm formation; P:planar cell polarity pathway involved in axis elongation; P:planar cell polarity pathway involved in axon guidance; P:planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; P:planar cell polarity pathway involved in cardiac right atrium morphogenesis; P:planar cell polarity pathway involved in gastrula mediolateral intercalation; P:planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation; P:planar cell polarity pathway involved in neural tube closure; P:planar cell polarity pathway involved in outflow tract morphogenesis; P:planar cell polarity pathway involved in pericardium morphogenesis; P:planar cell polarity pathway involved in ventricular septum morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of cartilage development; P:positive regulation of cell killing; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of chemokine production; P:positive regulation of cytokine production involved in immune response; P:positive regulation of endocytosis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage activation; P:positive regulation of macrophage cytokine production; P:positive regulation of meiotic nuclear division; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of neuron death; P:positive regulation of neuron projection arborization; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of ossification; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:positive regulation of protein kinase C activity; P:positive regulation of protein kinase C signaling; P:positive regulation of protein localization to synapse; P:positive regulation of response to cytokine stimulus; P:positive regulation of T cell chemotaxis; P:positive regulation of thymocyte apoptotic process; P:positive regulation of timing of anagen; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon-mediated signaling pathway; P:post-anal tail morphogenesis; P:postsynapse assembly; P:presynapse assembly; P:primary heart field specification; P:primitive streak formation; P:protein phosphorylation; P:regulation of branching involved in mammary gland duct morphogenesis; P:regulation of cellular protein localization; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of inflammatory response; P:regulation of postsynapse organization; P:regulation of postsynaptic cytosolic calcium ion concentration; P:regulation of synapse organization; P:response to organic substance; P:secondary heart field specification; P:secondary palate development; P:somitogenesis; P:type B pancreatic cell development; P:urinary bladder development; P:uterus development; P:vagina development; P:Wnt signaling pathway; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing;|P41221 A8K4A4 Q6P278,Protein Wnt-5a,, PF00110;, GO:0009986;GO:0030669;GO:0030666;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0098978;GO:0005796;GO:0005886;GO:0098794;GO:1902379;GO:0005125;GO:0005109;GO:0005543;GO:0019904;GO:0048018;GO:0005115;GO:0090630;GO:0007257;GO:0000187;GO:0032148;GO:0008595;GO:0003283;GO:0007411;GO:0060070;GO:0051216;GO:0045165;GO:0034613;GO:0071277;GO:0071346;GO:0071222;GO:0071300;GO:0071560;GO:0060067;GO:0036517;GO:0036518;GO:0090103;GO:0060028;GO:0060029;GO:0042733;GO:0048706;GO:0060750;GO:0001837;GO:0045198;GO:0001736;GO:1904861;GO:0060324;GO:0048806;GO:0001947;GO:0071425;GO:0007442;GO:0048850;GO:1904862;GO:0030216;GO:0001822;GO:0060599;GO:0002088;GO:0030324;GO:0008584;GO:0060744;GO:0097325;GO:0061024;GO:0060638;GO:0060809;GO:0007494;GO:0043066;GO:0048843;GO:0030514;GO:0090090;GO:1904934;GO:0050680;GO:0045599;GO:0040037;GO:0048022;GO:0072201;GO:0060686;GO:0051964;GO:0045892;GO:0030182;GO:0035567;GO:0038031;GO:0048570;GO:0021891;GO:0003408;GO:0048341;GO:0003402;GO:1904938;GO:0061350;GO:0061349;GO:0060775;GO:1904955;GO:0090179;GO:0061347;GO:0061354;GO:0061348;GO:0045766;GO:0061036;GO:0031343;GO:2000049;GO:0032722;GO:0002720;GO:0045807;GO:0010595;GO:0001938;GO:0048146;GO:0010628;GO:0090082;GO:0050729;GO:0032729;GO:0032731;GO:0032755;GO:0032757;GO:0046330;GO:0043032;GO:0060907;GO:0045836;GO:0002053;GO:1901216;GO:0150012;GO:0010976;GO:0051092;GO:2000052;GO:0045778;GO:0033138;GO:0010800;GO:0032092;GO:0045732;GO:1900020;GO:0090037;GO:1902474;GO:0060760;GO:0010820;GO:0070245;GO:0051885;GO:0045944;GO:0045893;GO:0032760;GO:0060340;GO:0036342;GO:0099068;GO:0099054;GO:0003138;GO:0090009;GO:0006468;GO:0060762;GO:1903827;GO:0043122;GO:0050727;GO:0099175;GO:0099566;GO:0050807;GO:0010033;GO:0003139;GO:0062009;GO:0001756;GO:0003323;GO:0060157;GO:0060065;GO:0060068;GO:0016055;GO:1904953;GO:0007223;GO:0060071;GO:0042060;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:Golgi lumen; C:plasma membrane; C:postsynapse;, F:chemoattractant activity involved in axon guidance; F:cytokine activity; F:frizzled binding; F:phospholipid binding; F:protein domain specific binding; F:receptor ligand activity; F:receptor tyrosine kinase-like orphan receptor binding;, P:activation of GTPase activity; P:activation of JUN kinase activity; P:activation of MAPK activity; P:activation of protein kinase B activity; P:anterior/posterior axis specification, embryo; P:atrial septum development; P:axon guidance; P:canonical Wnt signaling pathway; P:cartilage development; P:cell fate commitment; P:cellular protein localization; P:cellular response to calcium ion; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:cervix development; P:chemoattraction of serotonergic neuron axon; P:chemorepulsion of dopaminergic neuron axon; P:cochlea morphogenesis; P:convergent extension involved in axis elongation; P:convergent extension involved in organogenesis; P:embryonic digit morphogenesis; P:embryonic skeletal system development; P:epithelial cell proliferation involved in mammary gland duct elongation; P:epithelial to mesenchymal transition; P:establishment of epithelial cell apical/basal polarity; P:establishment of planar polarity; P:excitatory synapse assembly; P:face development; P:genitalia development; P:heart looping; P:hematopoietic stem cell proliferation; P:hindgut morphogenesis; P:hypophysis morphogenesis; P:inhibitory synapse assembly; P:keratinocyte differentiation; P:kidney development; P:lateral sprouting involved in mammary gland duct morphogenesis; P:lens development in camera-type eye; P:lung development; P:male gonad development; P:mammary gland branching involved in thelarche; P:melanocyte proliferation; P:membrane organization; P:mesenchymal-epithelial cell signaling; P:mesodermal to mesenchymal transition involved in gastrulation; P:midgut development; P:negative regulation of apoptotic process; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of BMP signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell proliferation in midbrain; P:negative regulation of epithelial cell proliferation; P:negative regulation of fat cell differentiation; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of melanin biosynthetic process; P:negative regulation of mesenchymal cell proliferation; P:negative regulation of prostatic bud formation; P:negative regulation of synapse assembly; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:non-canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway via JNK cascade; P:notochord morphogenesis; P:olfactory bulb interneuron development; P:optic cup formation involved in camera-type eye development; P:paraxial mesoderm formation; P:planar cell polarity pathway involved in axis elongation; P:planar cell polarity pathway involved in axon guidance; P:planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; P:planar cell polarity pathway involved in cardiac right atrium morphogenesis; P:planar cell polarity pathway involved in gastrula mediolateral intercalation; P:planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation; P:planar cell polarity pathway involved in neural tube closure; P:planar cell polarity pathway involved in outflow tract morphogenesis; P:planar cell polarity pathway involved in pericardium morphogenesis; P:planar cell polarity pathway involved in ventricular septum morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of cartilage development; P:positive regulation of cell killing; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of chemokine production; P:positive regulation of cytokine production involved in immune response; P:positive regulation of endocytosis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage activation; P:positive regulation of macrophage cytokine production; P:positive regulation of meiotic nuclear division; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of neuron death; P:positive regulation of neuron projection arborization; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of ossification; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:positive regulation of protein kinase C activity; P:positive regulation of protein kinase C signaling; P:positive regulation of protein localization to synapse; P:positive regulation of response to cytokine stimulus; P:positive regulation of T cell chemotaxis; P:positive regulation of thymocyte apoptotic process; P:positive regulation of timing of anagen; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon-mediated signaling pathway; P:post-anal tail morphogenesis; P:postsynapse assembly; P:presynapse assembly; P:primary heart field specification; P:primitive streak formation; P:protein phosphorylation; P:regulation of branching involved in mammary gland duct morphogenesis; P:regulation of cellular protein localization; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of inflammatory response; P:regulation of postsynapse organization; P:regulation of postsynaptic cytosolic calcium ion concentration; P:regulation of synapse organization; P:response to organic substance; P:secondary heart field specification; P:secondary palate development; P:somitogenesis; P:type B pancreatic cell development; P:urinary bladder development; P:uterus development; P:vagina development; P:Wnt signaling pathway; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing;|P41221 A8K4A4 Q6P278,Protein Wnt-5a,, PF00110;, GO:0009986;GO:0030669;GO:0030666;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0098978;GO:0005796;GO:0005886;GO:0098794;GO:1902379;GO:0005125;GO:0005109;GO:0005543;GO:0019904;GO:0048018;GO:0005115;GO:0090630;GO:0007257;GO:0000187;GO:0032148;GO:0008595;GO:0003283;GO:0007411;GO:0060070;GO:0051216;GO:0045165;GO:0034613;GO:0071277;GO:0071346;GO:0071222;GO:0071300;GO:0071560;GO:0060067;GO:0036517;GO:0036518;GO:0090103;GO:0060028;GO:0060029;GO:0042733;GO:0048706;GO:0060750;GO:0001837;GO:0045198;GO:0001736;GO:1904861;GO:0060324;GO:0048806;GO:0001947;GO:0071425;GO:0007442;GO:0048850;GO:1904862;GO:0030216;GO:0001822;GO:0060599;GO:0002088;GO:0030324;GO:0008584;GO:0060744;GO:0097325;GO:0061024;GO:0060638;GO:0060809;GO:0007494;GO:0043066;GO:0048843;GO:0030514;GO:0090090;GO:1904934;GO:0050680;GO:0045599;GO:0040037;GO:0048022;GO:0072201;GO:0060686;GO:0051964;GO:0045892;GO:0030182;GO:0035567;GO:0038031;GO:0048570;GO:0021891;GO:0003408;GO:0048341;GO:0003402;GO:1904938;GO:0061350;GO:0061349;GO:0060775;GO:1904955;GO:0090179;GO:0061347;GO:0061354;GO:0061348;GO:0045766;GO:0061036;GO:0031343;GO:2000049;GO:0032722;GO:0002720;GO:0045807;GO:0010595;GO:0001938;GO:0048146;GO:0010628;GO:0090082;GO:0050729;GO:0032729;GO:0032731;GO:0032755;GO:0032757;GO:0046330;GO:0043032;GO:0060907;GO:0045836;GO:0002053;GO:1901216;GO:0150012;GO:0010976;GO:0051092;GO:2000052;GO:0045778;GO:0033138;GO:0010800;GO:0032092;GO:0045732;GO:1900020;GO:0090037;GO:1902474;GO:0060760;GO:0010820;GO:0070245;GO:0051885;GO:0045944;GO:0045893;GO:0032760;GO:0060340;GO:0036342;GO:0099068;GO:0099054;GO:0003138;GO:0090009;GO:0006468;GO:0060762;GO:1903827;GO:0043122;GO:0050727;GO:0099175;GO:0099566;GO:0050807;GO:0010033;GO:0003139;GO:0062009;GO:0001756;GO:0003323;GO:0060157;GO:0060065;GO:0060068;GO:0016055;GO:1904953;GO:0007223;GO:0060071;GO:0042060;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:Golgi lumen; C:plasma membrane; C:postsynapse;, F:chemoattractant activity involved in axon guidance; F:cytokine activity; F:frizzled binding; F:phospholipid binding; F:protein domain specific binding; F:receptor ligand activity; F:receptor tyrosine kinase-like orphan receptor binding;, P:activation of GTPase activity; P:activation of JUN kinase activity; P:activation of MAPK activity; P:activation of protein kinase B activity; P:anterior/posterior axis specification, embryo; P:atrial septum development; P:axon guidance; P:canonical Wnt signaling pathway; P:cartilage development; P:cell fate commitment; P:cellular protein localization; P:cellular response to calcium ion; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:cervix development; P:chemoattraction of serotonergic neuron axon; P:chemorepulsion of dopaminergic neuron axon; P:cochlea morphogenesis; P:convergent extension involved in axis elongation; P:convergent extension involved in organogenesis; P:embryonic digit morphogenesis; P:embryonic skeletal system development; P:epithelial cell proliferation involved in mammary gland duct elongation; P:epithelial to mesenchymal transition; P:establishment of epithelial cell apical/basal polarity; P:establishment of planar polarity; P:excitatory synapse assembly; P:face development; P:genitalia development; P:heart looping; P:hematopoietic stem cell proliferation; P:hindgut morphogenesis; P:hypophysis morphogenesis; P:inhibitory synapse assembly; P:keratinocyte differentiation; P:kidney development; P:lateral sprouting involved in mammary gland duct morphogenesis; P:lens development in camera-type eye; P:lung development; P:male gonad development; P:mammary gland branching involved in thelarche; P:melanocyte proliferation; P:membrane organization; P:mesenchymal-epithelial cell signaling; P:mesodermal to mesenchymal transition involved in gastrulation; P:midgut development; P:negative regulation of apoptotic process; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of BMP signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell proliferation in midbrain; P:negative regulation of epithelial cell proliferation; P:negative regulation of fat cell differentiation; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of melanin biosynthetic process; P:negative regulation of mesenchymal cell proliferation; P:negative regulation of prostatic bud formation; P:negative regulation of synapse assembly; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:non-canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway via JNK cascade; P:notochord morphogenesis; P:olfactory bulb interneuron development; P:optic cup formation involved in camera-type eye development; P:paraxial mesoderm formation; P:planar cell polarity pathway involved in axis elongation; P:planar cell polarity pathway involved in axon guidance; P:planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; P:planar cell polarity pathway involved in cardiac right atrium morphogenesis; P:planar cell polarity pathway involved in gastrula mediolateral intercalation; P:planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation; P:planar cell polarity pathway involved in neural tube closure; P:planar cell polarity pathway involved in outflow tract morphogenesis; P:planar cell polarity pathway involved in pericardium morphogenesis; P:planar cell polarity pathway involved in ventricular septum morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of cartilage development; P:positive regulation of cell killing; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of chemokine production; P:positive regulation of cytokine production involved in immune response; P:positive regulation of endocytosis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage activation; P:positive regulation of macrophage cytokine production; P:positive regulation of meiotic nuclear division; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of neuron death; P:positive regulation of neuron projection arborization; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of ossification; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:positive regulation of protein kinase C activity; P:positive regulation of protein kinase C signaling; P:positive regulation of protein localization to synapse; P:positive regulation of response to cytokine stimulus; P:positive regulation of T cell chemotaxis; P:positive regulation of thymocyte apoptotic process; P:positive regulation of timing of anagen; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon-mediated signaling pathway; P:post-anal tail morphogenesis; P:postsynapse assembly; P:presynapse assembly; P:primary heart field specification; P:primitive streak formation; P:protein phosphorylation; P:regulation of branching involved in mammary gland duct morphogenesis; P:regulation of cellular protein localization; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of inflammatory response; P:regulation of postsynapse organization; P:regulation of postsynaptic cytosolic calcium ion concentration; P:regulation of synapse organization; P:response to organic substance; P:secondary heart field specification; P:secondary palate development; P:somitogenesis; P:type B pancreatic cell development; P:urinary bladder development; P:uterus development; P:vagina development; P:Wnt signaling pathway; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing; scaffold23 indexed_genome mRNA 4682874 4948167 . - . ID=transcript_5438;O15083 Q2T9F6 Q86TK4,ERC protein 2,, PF10174;, GO:0005856;GO:0098982;GO:0098978;GO:0030426;GO:0048786;GO:0098831;GO:0042734;GO:0098882;GO:0016082;, C:cytoskeleton; C:GABA-ergic synapse; C:glutamatergic synapse; C:growth cone; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane;, F:structural constituent of presynaptic active zone;, P:synaptic vesicle priming; scaffold23 indexed_genome mRNA 4958769 5113672 . - . ID=transcript_5439;O15083 Q2T9F6 Q86TK4,ERC protein 2,, PF10174;, GO:0005856;GO:0098982;GO:0098978;GO:0030426;GO:0048786;GO:0098831;GO:0042734;GO:0098882;GO:0016082;, C:cytoskeleton; C:GABA-ergic synapse; C:glutamatergic synapse; C:growth cone; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane;, F:structural constituent of presynaptic active zone;, P:synaptic vesicle priming; scaffold23 indexed_genome mRNA 5385915 5386484 . + . ID=transcript_5440;O15083 Q2T9F6 Q86TK4,ERC protein 2,, PF10174;, GO:0005856;GO:0098982;GO:0098978;GO:0030426;GO:0048786;GO:0098831;GO:0042734;GO:0098882;GO:0016082;, C:cytoskeleton; C:GABA-ergic synapse; C:glutamatergic synapse; C:growth cone; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane;, F:structural constituent of presynaptic active zone;, P:synaptic vesicle priming; scaffold23 indexed_genome mRNA 5526402 5534311 . + . ID=transcript_5441;A2RUB6 B3KWL8 Q4VC34 Q8N949,Coiled-coil domain-containing protein 66 {ECO:0000305},, PF15236;, GO:0030054;GO:0034451;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0090543;GO:0005874;GO:0001917;GO:0001750;GO:0008017;GO:0042803;GO:0060271;GO:0050908;GO:0001578;GO:1903564;GO:0001895;, C:cell junction; C:centriolar satellite; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:Flemming body; C:microtubule; C:photoreceptor inner segment; C:photoreceptor outer segment;, F:microtubule binding; F:protein homodimerization activity;, P:cilium assembly; P:detection of light stimulus involved in visual perception; P:microtubule bundle formation; P:regulation of protein localization to cilium; P:retina homeostasis; scaffold23 indexed_genome mRNA 5553989 5583512 . + . ID=transcript_5442;A2RUB6 B3KWL8 Q4VC34 Q8N949,Coiled-coil domain-containing protein 66 {ECO:0000305},, PF15236;, GO:0030054;GO:0034451;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0090543;GO:0005874;GO:0001917;GO:0001750;GO:0008017;GO:0042803;GO:0060271;GO:0050908;GO:0001578;GO:1903564;GO:0001895;, C:cell junction; C:centriolar satellite; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:Flemming body; C:microtubule; C:photoreceptor inner segment; C:photoreceptor outer segment;, F:microtubule binding; F:protein homodimerization activity;, P:cilium assembly; P:detection of light stimulus involved in visual perception; P:microtubule bundle formation; P:regulation of protein localization to cilium; P:retina homeostasis;|A2RUB6 B3KWL8 Q4VC34 Q8N949,Coiled-coil domain-containing protein 66 {ECO:0000305},, PF15236;, GO:0030054;GO:0034451;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0090543;GO:0005874;GO:0001917;GO:0001750;GO:0008017;GO:0042803;GO:0060271;GO:0050908;GO:0001578;GO:1903564;GO:0001895;, C:cell junction; C:centriolar satellite; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:Flemming body; C:microtubule; C:photoreceptor inner segment; C:photoreceptor outer segment;, F:microtubule binding; F:protein homodimerization activity;, P:cilium assembly; P:detection of light stimulus involved in visual perception; P:microtubule bundle formation; P:regulation of protein localization to cilium; P:retina homeostasis;|Q9UK61 A1L3A4 B5ME28 Q9H2F7 Q9UPP7,Protein TASOR {ECO:0000305},CTCL tumor antigen se89-1 {ECO:0000303|PubMed:11149944};Retinoblastoma-associated protein RAP140 {ECO:0000303|PubMed:18726359};Transgene activation suppressor protein {ECO:0000303|PubMed:26022416};, PF12509;, GO:0000792;GO:0005654;GO:0003682;GO:0003723;GO:0008595;GO:0001701;GO:0060809;GO:0090307;GO:0045814;GO:0045869;GO:0090309;GO:0097355;, C:heterochromatin; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:anterior/posterior axis specification, embryo; P:in utero embryonic development; P:mesodermal to mesenchymal transition involved in gastrulation; P:mitotic spindle assembly; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin;|Q9UK61 A1L3A4 B5ME28 Q9H2F7 Q9UPP7,Protein TASOR {ECO:0000305},CTCL tumor antigen se89-1 {ECO:0000303|PubMed:11149944};Retinoblastoma-associated protein RAP140 {ECO:0000303|PubMed:18726359};Transgene activation suppressor protein {ECO:0000303|PubMed:26022416};, PF12509;, GO:0000792;GO:0005654;GO:0003682;GO:0003723;GO:0008595;GO:0001701;GO:0060809;GO:0090307;GO:0045814;GO:0045869;GO:0090309;GO:0097355;, C:heterochromatin; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:anterior/posterior axis specification, embryo; P:in utero embryonic development; P:mesodermal to mesenchymal transition involved in gastrulation; P:mitotic spindle assembly; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin;|Q9UK61 A1L3A4 B5ME28 Q9H2F7 Q9UPP7,Protein TASOR {ECO:0000305},CTCL tumor antigen se89-1 {ECO:0000303|PubMed:11149944};Retinoblastoma-associated protein RAP140 {ECO:0000303|PubMed:18726359};Transgene activation suppressor protein {ECO:0000303|PubMed:26022416};, PF12509;, GO:0000792;GO:0005654;GO:0003682;GO:0003723;GO:0008595;GO:0001701;GO:0060809;GO:0090307;GO:0045814;GO:0045869;GO:0090309;GO:0097355;, C:heterochromatin; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:anterior/posterior axis specification, embryo; P:in utero embryonic development; P:mesodermal to mesenchymal transition involved in gastrulation; P:mitotic spindle assembly; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin;|Q9UK61 A1L3A4 B5ME28 Q9H2F7 Q9UPP7,Protein TASOR {ECO:0000305},CTCL tumor antigen se89-1 {ECO:0000303|PubMed:11149944};Retinoblastoma-associated protein RAP140 {ECO:0000303|PubMed:18726359};Transgene activation suppressor protein {ECO:0000303|PubMed:26022416};, PF12509;, GO:0000792;GO:0005654;GO:0003682;GO:0003723;GO:0008595;GO:0001701;GO:0060809;GO:0090307;GO:0045814;GO:0045869;GO:0090309;GO:0097355;, C:heterochromatin; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:anterior/posterior axis specification, embryo; P:in utero embryonic development; P:mesodermal to mesenchymal transition involved in gastrulation; P:mitotic spindle assembly; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin; scaffold23 indexed_genome mRNA 5583542 5617178 . + . ID=transcript_5443;Q9UK61 A1L3A4 B5ME28 Q9H2F7 Q9UPP7,Protein TASOR {ECO:0000305},CTCL tumor antigen se89-1 {ECO:0000303|PubMed:11149944};Retinoblastoma-associated protein RAP140 {ECO:0000303|PubMed:18726359};Transgene activation suppressor protein {ECO:0000303|PubMed:26022416};, PF12509;, GO:0000792;GO:0005654;GO:0003682;GO:0003723;GO:0008595;GO:0001701;GO:0060809;GO:0090307;GO:0045814;GO:0045869;GO:0090309;GO:0097355;, C:heterochromatin; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:anterior/posterior axis specification, embryo; P:in utero embryonic development; P:mesodermal to mesenchymal transition involved in gastrulation; P:mitotic spindle assembly; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin;|Q9UK61 A1L3A4 B5ME28 Q9H2F7 Q9UPP7,Protein TASOR {ECO:0000305},CTCL tumor antigen se89-1 {ECO:0000303|PubMed:11149944};Retinoblastoma-associated protein RAP140 {ECO:0000303|PubMed:18726359};Transgene activation suppressor protein {ECO:0000303|PubMed:26022416};, PF12509;, GO:0000792;GO:0005654;GO:0003682;GO:0003723;GO:0008595;GO:0001701;GO:0060809;GO:0090307;GO:0045814;GO:0045869;GO:0090309;GO:0097355;, C:heterochromatin; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:anterior/posterior axis specification, embryo; P:in utero embryonic development; P:mesodermal to mesenchymal transition involved in gastrulation; P:mitotic spindle assembly; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin;|Q9UK61 A1L3A4 B5ME28 Q9H2F7 Q9UPP7,Protein TASOR {ECO:0000305},CTCL tumor antigen se89-1 {ECO:0000303|PubMed:11149944};Retinoblastoma-associated protein RAP140 {ECO:0000303|PubMed:18726359};Transgene activation suppressor protein {ECO:0000303|PubMed:26022416};, PF12509;, GO:0000792;GO:0005654;GO:0003682;GO:0003723;GO:0008595;GO:0001701;GO:0060809;GO:0090307;GO:0045814;GO:0045869;GO:0090309;GO:0097355;, C:heterochromatin; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:anterior/posterior axis specification, embryo; P:in utero embryonic development; P:mesodermal to mesenchymal transition involved in gastrulation; P:mitotic spindle assembly; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin;|Q9UK61 A1L3A4 B5ME28 Q9H2F7 Q9UPP7,Protein TASOR {ECO:0000305},CTCL tumor antigen se89-1 {ECO:0000303|PubMed:11149944};Retinoblastoma-associated protein RAP140 {ECO:0000303|PubMed:18726359};Transgene activation suppressor protein {ECO:0000303|PubMed:26022416};, PF12509;, GO:0000792;GO:0005654;GO:0003682;GO:0003723;GO:0008595;GO:0001701;GO:0060809;GO:0090307;GO:0045814;GO:0045869;GO:0090309;GO:0097355;, C:heterochromatin; C:nucleoplasm;, F:chromatin binding; F:RNA binding;, P:anterior/posterior axis specification, embryo; P:in utero embryonic development; P:mesodermal to mesenchymal transition involved in gastrulation; P:mitotic spindle assembly; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin; scaffold23 indexed_genome mRNA 5638022 5642989 . - . ID=transcript_5444;Q9H7T4,Rho guanine nucleotide exchange factor 3,Exchange factor found in platelets and leukemic and neuronal tissues;, PF00621;, GO:0005829;GO:0005085;GO:0007186;GO:0043065;GO:0035025;GO:0051056;GO:0007266;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q9H7T4,Rho guanine nucleotide exchange factor 3,Exchange factor found in platelets and leukemic and neuronal tissues;, PF00621;, GO:0005829;GO:0005085;GO:0007186;GO:0043065;GO:0035025;GO:0051056;GO:0007266;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q9H7T4,Rho guanine nucleotide exchange factor 3,Exchange factor found in platelets and leukemic and neuronal tissues;, PF00621;, GO:0005829;GO:0005085;GO:0007186;GO:0043065;GO:0035025;GO:0051056;GO:0007266;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold23 indexed_genome mRNA 5645966 5708733 . - . ID=transcript_5445;Q9H7T4,Rho guanine nucleotide exchange factor 3,Exchange factor found in platelets and leukemic and neuronal tissues;, PF00621;, GO:0005829;GO:0005085;GO:0007186;GO:0043065;GO:0035025;GO:0051056;GO:0007266;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q9H7T4,Rho guanine nucleotide exchange factor 3,Exchange factor found in platelets and leukemic and neuronal tissues;, PF00621;, GO:0005829;GO:0005085;GO:0007186;GO:0043065;GO:0035025;GO:0051056;GO:0007266;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold23 indexed_genome mRNA 5962805 6026268 . - . ID=transcript_5446;Q8NFM7 Q2NKP7 Q58EZ7 Q6RVF4 Q6UWI5 Q8N113 Q8NFS0 Q9UFA0,Interleukin-17 receptor D,IL17Rhom;Interleukin-17 receptor-like protein;Sef homolog;, PF16742;PF08357;, GO:0005794;GO:0000139;GO:0016021;GO:0005654;GO:0005886;GO:0030368;GO:0000165;GO:0010719;GO:0030512;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:interleukin-17 receptor activity;, P:MAPK cascade; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of transforming growth factor beta receptor signaling pathway; scaffold23 indexed_genome mRNA 6062148 6065806 . - . ID=transcript_5447;Q9UBX0 Q52LC5 Q99667,Homeobox expressed in ES cells 1,Homeobox protein ANF;, PF00046;, GO:0000785;GO:0005634;GO:0003682;GO:0003677;GO:0000981;GO:0001227;GO:0008022;GO:0042803;GO:0047485;GO:0000978;GO:0000977;GO:1990837;GO:0007420;GO:0043010;GO:0060070;GO:0071276;GO:0070371;GO:0048853;GO:0010467;GO:0008406;GO:0048861;GO:0035264;GO:0000122;GO:0043584;GO:0030916;GO:0021983;GO:0045995;GO:0006357;GO:0048863;GO:0019827;GO:0030878;, C:chromatin; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein C-terminus binding; F:protein homodimerization activity; F:protein N-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:camera-type eye development; P:canonical Wnt signaling pathway; P:cellular response to cadmium ion; P:ERK1 and ERK2 cascade; P:forebrain morphogenesis; P:gene expression; P:gonad development; P:leukemia inhibitory factor signaling pathway; P:multicellular organism growth; P:negative regulation of transcription by RNA polymerase II; P:nose development; P:otic vesicle formation; P:pituitary gland development; P:regulation of embryonic development; P:regulation of transcription by RNA polymerase II; P:stem cell differentiation; P:stem cell population maintenance; P:thyroid gland development; scaffold23 indexed_genome mRNA 6099825 6101281 . + . ID=transcript_5448;Q9UKG1 Q9P2B9,DCC-interacting protein 13-alpha {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 1 {ECO:0000305};, PF00169;PF00640;, GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0031901;GO:0032009;GO:0005768;GO:0010008;GO:0070062;GO:0097708;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0012506;GO:0048487;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0043422;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0097192;GO:0008286;GO:1905450;GO:1900017;GO:0046326;GO:1905303;GO:0048023;GO:0006606;GO:0010762;GO:2000045;GO:0046324;GO:0045088;GO:1903076;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:early endosome membrane; C:early phagosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular vesicle; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:vesicle membrane;, F:beta-tubulin binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:extrinsic apoptotic signaling pathway in absence of ligand; P:insulin receptor signaling pathway; P:negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of glucose import; P:positive regulation of macropinocytosis; P:positive regulation of melanin biosynthetic process; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of glucose import; P:regulation of innate immune response; P:regulation of protein localization to plasma membrane; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway; scaffold23 indexed_genome mRNA 6102802 6115434 . + . ID=transcript_5449;Q9UKG1 Q9P2B9,DCC-interacting protein 13-alpha {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 1 {ECO:0000305};, PF00169;PF00640;, GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0031901;GO:0032009;GO:0005768;GO:0010008;GO:0070062;GO:0097708;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0012506;GO:0048487;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0043422;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0097192;GO:0008286;GO:1905450;GO:1900017;GO:0046326;GO:1905303;GO:0048023;GO:0006606;GO:0010762;GO:2000045;GO:0046324;GO:0045088;GO:1903076;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:early endosome membrane; C:early phagosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular vesicle; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:vesicle membrane;, F:beta-tubulin binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:extrinsic apoptotic signaling pathway in absence of ligand; P:insulin receptor signaling pathway; P:negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of glucose import; P:positive regulation of macropinocytosis; P:positive regulation of melanin biosynthetic process; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of glucose import; P:regulation of innate immune response; P:regulation of protein localization to plasma membrane; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway;|Q9UKG1 Q9P2B9,DCC-interacting protein 13-alpha {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 1 {ECO:0000305};, PF00169;PF00640;, GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0031901;GO:0032009;GO:0005768;GO:0010008;GO:0070062;GO:0097708;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0012506;GO:0048487;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0043422;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0097192;GO:0008286;GO:1905450;GO:1900017;GO:0046326;GO:1905303;GO:0048023;GO:0006606;GO:0010762;GO:2000045;GO:0046324;GO:0045088;GO:1903076;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:early endosome membrane; C:early phagosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular vesicle; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:vesicle membrane;, F:beta-tubulin binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:extrinsic apoptotic signaling pathway in absence of ligand; P:insulin receptor signaling pathway; P:negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of glucose import; P:positive regulation of macropinocytosis; P:positive regulation of melanin biosynthetic process; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of glucose import; P:regulation of innate immune response; P:regulation of protein localization to plasma membrane; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway;|Q9UKG1 Q9P2B9,DCC-interacting protein 13-alpha {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 1 {ECO:0000305};, PF00169;PF00640;, GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0031901;GO:0032009;GO:0005768;GO:0010008;GO:0070062;GO:0097708;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0012506;GO:0048487;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0043422;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0097192;GO:0008286;GO:1905450;GO:1900017;GO:0046326;GO:1905303;GO:0048023;GO:0006606;GO:0010762;GO:2000045;GO:0046324;GO:0045088;GO:1903076;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:early endosome membrane; C:early phagosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular vesicle; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:vesicle membrane;, F:beta-tubulin binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:extrinsic apoptotic signaling pathway in absence of ligand; P:insulin receptor signaling pathway; P:negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of glucose import; P:positive regulation of macropinocytosis; P:positive regulation of melanin biosynthetic process; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of glucose import; P:regulation of innate immune response; P:regulation of protein localization to plasma membrane; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway; scaffold23 indexed_genome mRNA 6115447 6138108 . + . ID=transcript_5450;Q9UKG1 Q9P2B9,DCC-interacting protein 13-alpha {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 1 {ECO:0000305};, PF00169;PF00640;, GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0031901;GO:0032009;GO:0005768;GO:0010008;GO:0070062;GO:0097708;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0012506;GO:0048487;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0043422;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0097192;GO:0008286;GO:1905450;GO:1900017;GO:0046326;GO:1905303;GO:0048023;GO:0006606;GO:0010762;GO:2000045;GO:0046324;GO:0045088;GO:1903076;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:early endosome membrane; C:early phagosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular vesicle; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:vesicle membrane;, F:beta-tubulin binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:extrinsic apoptotic signaling pathway in absence of ligand; P:insulin receptor signaling pathway; P:negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of glucose import; P:positive regulation of macropinocytosis; P:positive regulation of melanin biosynthetic process; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of glucose import; P:regulation of innate immune response; P:regulation of protein localization to plasma membrane; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway;|Q9UKG1 Q9P2B9,DCC-interacting protein 13-alpha {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 1 {ECO:0000305};, PF00169;PF00640;, GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0031901;GO:0032009;GO:0005768;GO:0010008;GO:0070062;GO:0097708;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0012506;GO:0048487;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0043422;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0097192;GO:0008286;GO:1905450;GO:1900017;GO:0046326;GO:1905303;GO:0048023;GO:0006606;GO:0010762;GO:2000045;GO:0046324;GO:0045088;GO:1903076;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:early endosome membrane; C:early phagosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular vesicle; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:vesicle membrane;, F:beta-tubulin binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:extrinsic apoptotic signaling pathway in absence of ligand; P:insulin receptor signaling pathway; P:negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of glucose import; P:positive regulation of macropinocytosis; P:positive regulation of melanin biosynthetic process; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of glucose import; P:regulation of innate immune response; P:regulation of protein localization to plasma membrane; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway;|Q9UKG1 Q9P2B9,DCC-interacting protein 13-alpha {ECO:0000305},Adapter protein containing PH domain, PTB domain and leucine zipper motif 1 {ECO:0000305};, PF00169;PF00640;, GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0031901;GO:0032009;GO:0005768;GO:0010008;GO:0070062;GO:0097708;GO:0044354;GO:0016020;GO:0005634;GO:0005886;GO:0001726;GO:0012506;GO:0048487;GO:0042802;GO:0035091;GO:0001786;GO:0042803;GO:0043422;GO:0044877;GO:0033211;GO:0007049;GO:0035729;GO:0097192;GO:0008286;GO:1905450;GO:1900017;GO:0046326;GO:1905303;GO:0048023;GO:0006606;GO:0010762;GO:2000045;GO:0046324;GO:0045088;GO:1903076;GO:0034143;GO:0007165;GO:0023052;GO:0007179;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:early endosome membrane; C:early phagosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular vesicle; C:macropinosome; C:membrane; C:nucleus; C:plasma membrane; C:ruffle; C:vesicle membrane;, F:beta-tubulin binding; F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:protein kinase B binding; F:protein-containing complex binding;, P:adiponectin-activated signaling pathway; P:cell cycle; P:cellular response to hepatocyte growth factor stimulus; P:extrinsic apoptotic signaling pathway in absence of ligand; P:insulin receptor signaling pathway; P:negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of glucose import; P:positive regulation of macropinocytosis; P:positive regulation of melanin biosynthetic process; P:protein import into nucleus; P:regulation of fibroblast migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of glucose import; P:regulation of innate immune response; P:regulation of protein localization to plasma membrane; P:regulation of toll-like receptor 4 signaling pathway; P:signal transduction; P:signaling; P:transforming growth factor beta receptor signaling pathway;|A6NK59 C9JX97 Q8WXK2 Q92816,Ankyrin repeat and SOCS box protein 14,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|A6NK59 C9JX97 Q8WXK2 Q92816,Ankyrin repeat and SOCS box protein 14,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; scaffold23 indexed_genome mRNA 6139145 6192868 . - . ID=transcript_5451;Q8N1Z2 Q9UMS3 Q9Y2F3,Dynein heavy chain 7, axonemal,Axonemal beta dynein heavy chain 7;Ciliary dynein heavy chain 7;Dynein heavy chain-like protein 2;hDHC2;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005929;GO:0005829;GO:0030286;GO:0036156;GO:0005874;GO:0005524;GO:0008569;GO:0005509;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0036159;GO:0007018;, C:axonemal dynein complex; C:cilium; C:cytosol; C:dynein complex; C:inner dynein arm; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:calcium ion binding; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:inner dynein arm assembly; P:microtubule-based movement; scaffold23 indexed_genome mRNA 6239652 6248126 . - . ID=transcript_5452;Q6ZR08 A6NGI2 Q6ZTR8 Q8N7R9 Q8WXK2 Q92816,Dynein heavy chain 12, axonemal,Axonemal beta dynein heavy chain 12;Axonemal dynein heavy chain 12-like protein;Axonemal dynein heavy chain 7-like protein;Ciliary dynein heavy chain 12;Dynein heavy chain 7-like, axonemal;Dynein heavy chain domain-containing protein 2;, PF12774;PF12780;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;, GO:0005929;GO:0005737;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0007018;, C:cilium; C:cytoplasm; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed;, P:microtubule-based movement; scaffold23 indexed_genome mRNA 6318994 6322893 . + . ID=transcript_5453;Q6L8Q7 B4DTU8 Q8IYU3 Q8NDU2 Q8TE78,2',5'-phosphodiesterase 12,Mitochondrial deadenylase;, PF03372;, GO:0005829;GO:0005759;GO:0005739;GO:0000175;GO:0004527;GO:0046872;GO:0004535;GO:0071359;GO:0035457;GO:0071346;GO:0051607;GO:0000958;GO:0006397;GO:0060548;GO:0090324;GO:0000288;GO:0090305;GO:0045070;GO:0044528;GO:0090503;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:3'-5'-exoribonuclease activity; F:exonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity;, P:cellular response to dsRNA; P:cellular response to interferon-alpha; P:cellular response to interferon-gamma; P:defense response to virus; P:mitochondrial mRNA catabolic process; P:mRNA processing; P:negative regulation of cell death; P:negative regulation of oxidative phosphorylation; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of viral genome replication; P:regulation of mitochondrial mRNA stability; P:RNA phosphodiester bond hydrolysis, exonucleolytic; scaffold23 indexed_genome mRNA 6331538 6350728 . - . ID=transcript_5454;P18085 B2R7J7 P21371,ADP-ribosylation factor 4,, PF00025;, GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0005794;GO:0016020;GO:0005886;GO:0032587;GO:0005154;GO:0005525;GO:0031584;GO:0045176;GO:0007420;GO:0016477;GO:0060271;GO:0060996;GO:0006888;GO:0007173;GO:0045197;GO:0006886;GO:0007612;GO:0043066;GO:0045944;GO:0006471;GO:0061512;GO:0099175;GO:2000377;GO:0048678;GO:0006890;GO:0016192;, C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:membrane; C:plasma membrane; C:ruffle membrane;, F:epidermal growth factor receptor binding; F:GTP binding;, P:activation of phospholipase D activity; P:apical protein localization; P:brain development; P:cell migration; P:cilium assembly; P:dendritic spine development; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:epidermal growth factor receptor signaling pathway; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular protein transport; P:learning; P:negative regulation of apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:protein ADP-ribosylation; P:protein localization to cilium; P:regulation of postsynapse organization; P:regulation of reactive oxygen species metabolic process; P:response to axon injury; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport;|P18085 B2R7J7 P21371,ADP-ribosylation factor 4,, PF00025;, GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0005794;GO:0016020;GO:0005886;GO:0032587;GO:0005154;GO:0005525;GO:0031584;GO:0045176;GO:0007420;GO:0016477;GO:0060271;GO:0060996;GO:0006888;GO:0007173;GO:0045197;GO:0006886;GO:0007612;GO:0043066;GO:0045944;GO:0006471;GO:0061512;GO:0099175;GO:2000377;GO:0048678;GO:0006890;GO:0016192;, C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:membrane; C:plasma membrane; C:ruffle membrane;, F:epidermal growth factor receptor binding; F:GTP binding;, P:activation of phospholipase D activity; P:apical protein localization; P:brain development; P:cell migration; P:cilium assembly; P:dendritic spine development; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:epidermal growth factor receptor signaling pathway; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular protein transport; P:learning; P:negative regulation of apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:protein ADP-ribosylation; P:protein localization to cilium; P:regulation of postsynapse organization; P:regulation of reactive oxygen species metabolic process; P:response to axon injury; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport;|P84085 P26437,ADP-ribosylation factor 5,, PF00025;, GO:0070062;GO:0005794;GO:0048471;GO:0005886;GO:0005525;GO:0003924;GO:0006886;GO:0006890;GO:0016192;, C:extracellular exosome; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport;|P84085 P26437,ADP-ribosylation factor 5,, PF00025;, GO:0070062;GO:0005794;GO:0048471;GO:0005886;GO:0005525;GO:0003924;GO:0006886;GO:0006890;GO:0016192;, C:extracellular exosome; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport; scaffold23 indexed_genome mRNA 6374706 6413067 . + . ID=transcript_5455;Q06055 B3KQQ6,ATP synthase F(0) complex subunit C2, mitochondrial {ECO:0000305},ATP synthase lipid-binding protein;ATP synthase membrane subunit c locus 2 {ECO:0000312|HGNC:HGNC:842};ATP synthase proteolipid P2;ATP synthase proton-transporting mitochondrial F(0) complex subunit C2;ATPase protein 9;ATPase subunit c;, PF00137;, GO:0016021;GO:0005741;GO:0000276;GO:0045263;GO:0008289;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:proton-transporting ATP synthase complex, coupling factor F(o);, F:lipid binding; F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport;|Q8IWF6 Q7Z5T4 Q8N235 Q8TEG8,Protein DENND6A,DENN domain-containing protein 6A;, PF09794;, GO:0005737;GO:0005829;GO:0043231;GO:0055037;GO:0005085;GO:2000049;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of cell-cell adhesion mediated by cadherin;|Q8IWF6 Q7Z5T4 Q8N235 Q8TEG8,Protein DENND6A,DENN domain-containing protein 6A;, PF09794;, GO:0005737;GO:0005829;GO:0043231;GO:0055037;GO:0005085;GO:2000049;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of cell-cell adhesion mediated by cadherin;|Q8IWF6 Q7Z5T4 Q8N235 Q8TEG8,Protein DENND6A,DENN domain-containing protein 6A;, PF09794;, GO:0005737;GO:0005829;GO:0043231;GO:0055037;GO:0005085;GO:2000049;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of cell-cell adhesion mediated by cadherin;|Q8IWF6 Q7Z5T4 Q8N235 Q8TEG8,Protein DENND6A,DENN domain-containing protein 6A;, PF09794;, GO:0005737;GO:0005829;GO:0043231;GO:0055037;GO:0005085;GO:2000049;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of cell-cell adhesion mediated by cadherin;|Q8IWF6 Q7Z5T4 Q8N235 Q8TEG8,Protein DENND6A,DENN domain-containing protein 6A;, PF09794;, GO:0005737;GO:0005829;GO:0043231;GO:0055037;GO:0005085;GO:2000049;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of cell-cell adhesion mediated by cadherin; scaffold23 indexed_genome mRNA 6430718 6577587 . + . ID=transcript_5456;Q14BN4 Q14C95 Q6AI54 Q6UXC9 Q6ZVQ8 Q8NCW9 Q9H297 Q9HCH1 Q9Y681,Sarcolemmal membrane-associated protein,, PF00498;, GO:0005887;GO:0005815;GO:0042383;GO:0005790;GO:0006936;GO:0072659;GO:1900825;GO:1902305;GO:1905150;, C:integral component of plasma membrane; C:microtubule organizing center; C:sarcolemma; C:smooth endoplasmic reticulum;, , P:muscle contraction; P:protein localization to plasma membrane; P:regulation of membrane depolarization during cardiac muscle cell action potential; P:regulation of sodium ion transmembrane transport; P:regulation of voltage-gated sodium channel activity;|Q14BN4 Q14C95 Q6AI54 Q6UXC9 Q6ZVQ8 Q8NCW9 Q9H297 Q9HCH1 Q9Y681,Sarcolemmal membrane-associated protein,, PF00498;, GO:0005887;GO:0005815;GO:0042383;GO:0005790;GO:0006936;GO:0072659;GO:1900825;GO:1902305;GO:1905150;, C:integral component of plasma membrane; C:microtubule organizing center; C:sarcolemma; C:smooth endoplasmic reticulum;, , P:muscle contraction; P:protein localization to plasma membrane; P:regulation of membrane depolarization during cardiac muscle cell action potential; P:regulation of sodium ion transmembrane transport; P:regulation of voltage-gated sodium channel activity;|Q14BN4 Q14C95 Q6AI54 Q6UXC9 Q6ZVQ8 Q8NCW9 Q9H297 Q9HCH1 Q9Y681,Sarcolemmal membrane-associated protein,, PF00498;, GO:0005887;GO:0005815;GO:0042383;GO:0005790;GO:0006936;GO:0072659;GO:1900825;GO:1902305;GO:1905150;, C:integral component of plasma membrane; C:microtubule organizing center; C:sarcolemma; C:smooth endoplasmic reticulum;, , P:muscle contraction; P:protein localization to plasma membrane; P:regulation of membrane depolarization during cardiac muscle cell action potential; P:regulation of sodium ion transmembrane transport; P:regulation of voltage-gated sodium channel activity;|Q14BN4 Q14C95 Q6AI54 Q6UXC9 Q6ZVQ8 Q8NCW9 Q9H297 Q9HCH1 Q9Y681,Sarcolemmal membrane-associated protein,, PF00498;, GO:0005887;GO:0005815;GO:0042383;GO:0005790;GO:0006936;GO:0072659;GO:1900825;GO:1902305;GO:1905150;, C:integral component of plasma membrane; C:microtubule organizing center; C:sarcolemma; C:smooth endoplasmic reticulum;, , P:muscle contraction; P:protein localization to plasma membrane; P:regulation of membrane depolarization during cardiac muscle cell action potential; P:regulation of sodium ion transmembrane transport; P:regulation of voltage-gated sodium channel activity; scaffold23 indexed_genome mRNA 6624585 6762775 . + . ID=transcript_5457;Q6MZJ1 Q8WXS9 Q8WXT0 Q8WXT1 Q8WXT2 Q8WXT3 Q9NRB5 Q9NT26 Q9UEV9,Filamin-B,ABP-278;ABP-280 homolog;Actin-binding-like protein;Beta-filamin;Filamin homolog 1;Filamin-3;Thyroid autoantigen;Truncated actin-binding protein;, PF00307;PF00630;, GO:0015629;GO:0005938;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0043005;GO:0043025;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0042802;GO:0003723;GO:0030036;GO:0030154;GO:0007517;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:identical protein binding; F:RNA binding;, P:actin cytoskeleton organization; P:cell differentiation; P:muscle organ development; P:signal transduction;|Q6MZJ1 Q8WXS9 Q8WXT0 Q8WXT1 Q8WXT2 Q8WXT3 Q9NRB5 Q9NT26 Q9UEV9,Filamin-B,ABP-278;ABP-280 homolog;Actin-binding-like protein;Beta-filamin;Filamin homolog 1;Filamin-3;Thyroid autoantigen;Truncated actin-binding protein;, PF00307;PF00630;, GO:0015629;GO:0005938;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0043005;GO:0043025;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0042802;GO:0003723;GO:0030036;GO:0030154;GO:0007517;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:identical protein binding; F:RNA binding;, P:actin cytoskeleton organization; P:cell differentiation; P:muscle organ development; P:signal transduction;|Q6MZJ1 Q8WXS9 Q8WXT0 Q8WXT1 Q8WXT2 Q8WXT3 Q9NRB5 Q9NT26 Q9UEV9,Filamin-B,ABP-278;ABP-280 homolog;Actin-binding-like protein;Beta-filamin;Filamin homolog 1;Filamin-3;Thyroid autoantigen;Truncated actin-binding protein;, PF00307;PF00630;, GO:0015629;GO:0005938;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0043005;GO:0043025;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0042802;GO:0003723;GO:0030036;GO:0030154;GO:0007517;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:identical protein binding; F:RNA binding;, P:actin cytoskeleton organization; P:cell differentiation; P:muscle organ development; P:signal transduction;|Q6MZJ1 Q8WXS9 Q8WXT0 Q8WXT1 Q8WXT2 Q8WXT3 Q9NRB5 Q9NT26 Q9UEV9,Filamin-B,ABP-278;ABP-280 homolog;Actin-binding-like protein;Beta-filamin;Filamin homolog 1;Filamin-3;Thyroid autoantigen;Truncated actin-binding protein;, PF00307;PF00630;, GO:0015629;GO:0005938;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0043005;GO:0043025;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0042802;GO:0003723;GO:0030036;GO:0030154;GO:0007517;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:identical protein binding; F:RNA binding;, P:actin cytoskeleton organization; P:cell differentiation; P:muscle organ development; P:signal transduction;|Q6MZJ1 Q8WXS9 Q8WXT0 Q8WXT1 Q8WXT2 Q8WXT3 Q9NRB5 Q9NT26 Q9UEV9,Filamin-B,ABP-278;ABP-280 homolog;Actin-binding-like protein;Beta-filamin;Filamin homolog 1;Filamin-3;Thyroid autoantigen;Truncated actin-binding protein;, PF00307;PF00630;, GO:0015629;GO:0005938;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0043005;GO:0043025;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0042802;GO:0003723;GO:0030036;GO:0030154;GO:0007517;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:identical protein binding; F:RNA binding;, P:actin cytoskeleton organization; P:cell differentiation; P:muscle organ development; P:signal transduction;|Q6MZJ1 Q8WXS9 Q8WXT0 Q8WXT1 Q8WXT2 Q8WXT3 Q9NRB5 Q9NT26 Q9UEV9,Filamin-B,ABP-278;ABP-280 homolog;Actin-binding-like protein;Beta-filamin;Filamin homolog 1;Filamin-3;Thyroid autoantigen;Truncated actin-binding protein;, PF00307;PF00630;, GO:0015629;GO:0005938;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0043005;GO:0043025;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0042802;GO:0003723;GO:0030036;GO:0030154;GO:0007517;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:identical protein binding; F:RNA binding;, P:actin cytoskeleton organization; P:cell differentiation; P:muscle organ development; P:signal transduction;|Q6MZJ1 Q8WXS9 Q8WXT0 Q8WXT1 Q8WXT2 Q8WXT3 Q9NRB5 Q9NT26 Q9UEV9,Filamin-B,ABP-278;ABP-280 homolog;Actin-binding-like protein;Beta-filamin;Filamin homolog 1;Filamin-3;Thyroid autoantigen;Truncated actin-binding protein;, PF00307;PF00630;, GO:0015629;GO:0005938;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0043005;GO:0043025;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0042802;GO:0003723;GO:0030036;GO:0030154;GO:0007517;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:identical protein binding; F:RNA binding;, P:actin cytoskeleton organization; P:cell differentiation; P:muscle organ development; P:signal transduction;|Q6MZJ1 Q8WXS9 Q8WXT0 Q8WXT1 Q8WXT2 Q8WXT3 Q9NRB5 Q9NT26 Q9UEV9,Filamin-B,ABP-278;ABP-280 homolog;Actin-binding-like protein;Beta-filamin;Filamin homolog 1;Filamin-3;Thyroid autoantigen;Truncated actin-binding protein;, PF00307;PF00630;, GO:0015629;GO:0005938;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0043005;GO:0043025;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0042802;GO:0003723;GO:0030036;GO:0030154;GO:0007517;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:identical protein binding; F:RNA binding;, P:actin cytoskeleton organization; P:cell differentiation; P:muscle organ development; P:signal transduction;|Q6MZJ1 Q8WXS9 Q8WXT0 Q8WXT1 Q8WXT2 Q8WXT3 Q9NRB5 Q9NT26 Q9UEV9,Filamin-B,ABP-278;ABP-280 homolog;Actin-binding-like protein;Beta-filamin;Filamin homolog 1;Filamin-3;Thyroid autoantigen;Truncated actin-binding protein;, PF00307;PF00630;, GO:0015629;GO:0005938;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0043005;GO:0043025;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0042802;GO:0003723;GO:0030036;GO:0030154;GO:0007517;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:identical protein binding; F:RNA binding;, P:actin cytoskeleton organization; P:cell differentiation; P:muscle organ development; P:signal transduction;|Q6MZJ1 Q8WXS9 Q8WXT0 Q8WXT1 Q8WXT2 Q8WXT3 Q9NRB5 Q9NT26 Q9UEV9,Filamin-B,ABP-278;ABP-280 homolog;Actin-binding-like protein;Beta-filamin;Filamin homolog 1;Filamin-3;Thyroid autoantigen;Truncated actin-binding protein;, PF00307;PF00630;, GO:0015629;GO:0005938;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016021;GO:0043005;GO:0043025;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0042802;GO:0003723;GO:0030036;GO:0030154;GO:0007517;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:identical protein binding; F:RNA binding;, P:actin cytoskeleton organization; P:cell differentiation; P:muscle organ development; P:signal transduction; scaffold23 indexed_genome mRNA 6777879 6865213 . - . ID=transcript_5458;Q13609 B2R8B1 B7Z707 O75803,Deoxyribonuclease gamma,DNase I homolog protein DHP2;Deoxyribonuclease I-like 3;Liver and spleen DNase;, PF03372;, GO:0005783;GO:0005576;GO:0005634;GO:0005509;GO:0004536;GO:0004530;GO:0003677;GO:0006309;GO:0006308;GO:0000737;GO:0006259;GO:0002283;GO:0010623;GO:0002673;GO:0070948;, C:endoplasmic reticulum; C:extracellular region; C:nucleus;, F:calcium ion binding; F:deoxyribonuclease activity; F:deoxyribonuclease I activity; F:DNA binding;, P:apoptotic DNA fragmentation; P:DNA catabolic process; P:DNA catabolic process, endonucleolytic; P:DNA metabolic process; P:neutrophil activation involved in immune response; P:programmed cell death involved in cell development; P:regulation of acute inflammatory response; P:regulation of neutrophil mediated cytotoxicity;|Q13609 B2R8B1 B7Z707 O75803,Deoxyribonuclease gamma,DNase I homolog protein DHP2;Deoxyribonuclease I-like 3;Liver and spleen DNase;, PF03372;, GO:0005783;GO:0005576;GO:0005634;GO:0005509;GO:0004536;GO:0004530;GO:0003677;GO:0006309;GO:0006308;GO:0000737;GO:0006259;GO:0002283;GO:0010623;GO:0002673;GO:0070948;, C:endoplasmic reticulum; C:extracellular region; C:nucleus;, F:calcium ion binding; F:deoxyribonuclease activity; F:deoxyribonuclease I activity; F:DNA binding;, P:apoptotic DNA fragmentation; P:DNA catabolic process; P:DNA catabolic process, endonucleolytic; P:DNA metabolic process; P:neutrophil activation involved in immune response; P:programmed cell death involved in cell development; P:regulation of acute inflammatory response; P:regulation of neutrophil mediated cytotoxicity;|Q13609 B2R8B1 B7Z707 O75803,Deoxyribonuclease gamma,DNase I homolog protein DHP2;Deoxyribonuclease I-like 3;Liver and spleen DNase;, PF03372;, GO:0005783;GO:0005576;GO:0005634;GO:0005509;GO:0004536;GO:0004530;GO:0003677;GO:0006309;GO:0006308;GO:0000737;GO:0006259;GO:0002283;GO:0010623;GO:0002673;GO:0070948;, C:endoplasmic reticulum; C:extracellular region; C:nucleus;, F:calcium ion binding; F:deoxyribonuclease activity; F:deoxyribonuclease I activity; F:DNA binding;, P:apoptotic DNA fragmentation; P:DNA catabolic process; P:DNA catabolic process, endonucleolytic; P:DNA metabolic process; P:neutrophil activation involved in immune response; P:programmed cell death involved in cell development; P:regulation of acute inflammatory response; P:regulation of neutrophil mediated cytotoxicity;|Q9BV23 B2R7Y9 Q6ZMF7,Monoacylglycerol lipase ABHD6 {ECO:0000305},2-arachidonoylglycerol hydrolase {ECO:0000250|UniProtKB:Q8R2Y0};Abhydrolase domain-containing protein 6 {ECO:0000312|HGNC:HGNC:21398};, PF00561;, GO:0032281;GO:0098982;GO:0098978;GO:0016021;GO:0099055;GO:0031902;GO:0005765;GO:0031966;GO:0005739;GO:0005886;GO:0047372;GO:0004620;GO:0046464;GO:0060292;GO:2001311;GO:0052651;GO:0030336;GO:0120163;GO:0009395;GO:0046889;GO:2000124;, C:AMPA glutamate receptor complex; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic membrane; C:late endosome membrane; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrion; C:plasma membrane;, F:acylglycerol lipase activity; F:phospholipase activity;, P:acylglycerol catabolic process; P:long-term synaptic depression; P:lysobisphosphatidic acid metabolic process; P:monoacylglycerol catabolic process; P:negative regulation of cell migration; P:negative regulation of cold-induced thermogenesis; P:phospholipid catabolic process; P:positive regulation of lipid biosynthetic process; P:regulation of endocannabinoid signaling pathway;|Q13609 B2R8B1 B7Z707 O75803,Deoxyribonuclease gamma,DNase I homolog protein DHP2;Deoxyribonuclease I-like 3;Liver and spleen DNase;, PF03372;, GO:0005783;GO:0005576;GO:0005634;GO:0005509;GO:0004536;GO:0004530;GO:0003677;GO:0006309;GO:0006308;GO:0000737;GO:0006259;GO:0002283;GO:0010623;GO:0002673;GO:0070948;, C:endoplasmic reticulum; C:extracellular region; C:nucleus;, F:calcium ion binding; F:deoxyribonuclease activity; F:deoxyribonuclease I activity; F:DNA binding;, P:apoptotic DNA fragmentation; P:DNA catabolic process; P:DNA catabolic process, endonucleolytic; P:DNA metabolic process; P:neutrophil activation involved in immune response; P:programmed cell death involved in cell development; P:regulation of acute inflammatory response; P:regulation of neutrophil mediated cytotoxicity;|Q9BV23 B2R7Y9 Q6ZMF7,Monoacylglycerol lipase ABHD6 {ECO:0000305},2-arachidonoylglycerol hydrolase {ECO:0000250|UniProtKB:Q8R2Y0};Abhydrolase domain-containing protein 6 {ECO:0000312|HGNC:HGNC:21398};, PF00561;, GO:0032281;GO:0098982;GO:0098978;GO:0016021;GO:0099055;GO:0031902;GO:0005765;GO:0031966;GO:0005739;GO:0005886;GO:0047372;GO:0004620;GO:0046464;GO:0060292;GO:2001311;GO:0052651;GO:0030336;GO:0120163;GO:0009395;GO:0046889;GO:2000124;, C:AMPA glutamate receptor complex; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic membrane; C:late endosome membrane; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrion; C:plasma membrane;, F:acylglycerol lipase activity; F:phospholipase activity;, P:acylglycerol catabolic process; P:long-term synaptic depression; P:lysobisphosphatidic acid metabolic process; P:monoacylglycerol catabolic process; P:negative regulation of cell migration; P:negative regulation of cold-induced thermogenesis; P:phospholipid catabolic process; P:positive regulation of lipid biosynthetic process; P:regulation of endocannabinoid signaling pathway;|O00567 Q2M3T6 Q9NQ05,Nucleolar protein 56,Nucleolar protein 5A;, PF01798;PF08156;, GO:0031428;GO:0005737;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0070761;GO:0032040;GO:0005732;GO:0045296;GO:1990226;GO:0003723;GO:0030515;GO:0006364;, C:box C/D RNP complex; C:cytoplasm; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:pre-snoRNP complex; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:cadherin binding; F:histone methyltransferase binding; F:RNA binding; F:snoRNA binding;, P:rRNA processing;|Q9BV23 B2R7Y9 Q6ZMF7,Monoacylglycerol lipase ABHD6 {ECO:0000305},2-arachidonoylglycerol hydrolase {ECO:0000250|UniProtKB:Q8R2Y0};Abhydrolase domain-containing protein 6 {ECO:0000312|HGNC:HGNC:21398};, PF00561;, GO:0032281;GO:0098982;GO:0098978;GO:0016021;GO:0099055;GO:0031902;GO:0005765;GO:0031966;GO:0005739;GO:0005886;GO:0047372;GO:0004620;GO:0046464;GO:0060292;GO:2001311;GO:0052651;GO:0030336;GO:0120163;GO:0009395;GO:0046889;GO:2000124;, C:AMPA glutamate receptor complex; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic membrane; C:late endosome membrane; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrion; C:plasma membrane;, F:acylglycerol lipase activity; F:phospholipase activity;, P:acylglycerol catabolic process; P:long-term synaptic depression; P:lysobisphosphatidic acid metabolic process; P:monoacylglycerol catabolic process; P:negative regulation of cell migration; P:negative regulation of cold-induced thermogenesis; P:phospholipid catabolic process; P:positive regulation of lipid biosynthetic process; P:regulation of endocannabinoid signaling pathway;|Q9BV23 B2R7Y9 Q6ZMF7,Monoacylglycerol lipase ABHD6 {ECO:0000305},2-arachidonoylglycerol hydrolase {ECO:0000250|UniProtKB:Q8R2Y0};Abhydrolase domain-containing protein 6 {ECO:0000312|HGNC:HGNC:21398};, PF00561;, GO:0032281;GO:0098982;GO:0098978;GO:0016021;GO:0099055;GO:0031902;GO:0005765;GO:0031966;GO:0005739;GO:0005886;GO:0047372;GO:0004620;GO:0046464;GO:0060292;GO:2001311;GO:0052651;GO:0030336;GO:0120163;GO:0009395;GO:0046889;GO:2000124;, C:AMPA glutamate receptor complex; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic membrane; C:late endosome membrane; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrion; C:plasma membrane;, F:acylglycerol lipase activity; F:phospholipase activity;, P:acylglycerol catabolic process; P:long-term synaptic depression; P:lysobisphosphatidic acid metabolic process; P:monoacylglycerol catabolic process; P:negative regulation of cell migration; P:negative regulation of cold-induced thermogenesis; P:phospholipid catabolic process; P:positive regulation of lipid biosynthetic process; P:regulation of endocannabinoid signaling pathway;|Q9BV23 B2R7Y9 Q6ZMF7,Monoacylglycerol lipase ABHD6 {ECO:0000305},2-arachidonoylglycerol hydrolase {ECO:0000250|UniProtKB:Q8R2Y0};Abhydrolase domain-containing protein 6 {ECO:0000312|HGNC:HGNC:21398};, PF00561;, GO:0032281;GO:0098982;GO:0098978;GO:0016021;GO:0099055;GO:0031902;GO:0005765;GO:0031966;GO:0005739;GO:0005886;GO:0047372;GO:0004620;GO:0046464;GO:0060292;GO:2001311;GO:0052651;GO:0030336;GO:0120163;GO:0009395;GO:0046889;GO:2000124;, C:AMPA glutamate receptor complex; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic membrane; C:late endosome membrane; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrion; C:plasma membrane;, F:acylglycerol lipase activity; F:phospholipase activity;, P:acylglycerol catabolic process; P:long-term synaptic depression; P:lysobisphosphatidic acid metabolic process; P:monoacylglycerol catabolic process; P:negative regulation of cell migration; P:negative regulation of cold-induced thermogenesis; P:phospholipid catabolic process; P:positive regulation of lipid biosynthetic process; P:regulation of endocannabinoid signaling pathway;|Q9BV23 B2R7Y9 Q6ZMF7,Monoacylglycerol lipase ABHD6 {ECO:0000305},2-arachidonoylglycerol hydrolase {ECO:0000250|UniProtKB:Q8R2Y0};Abhydrolase domain-containing protein 6 {ECO:0000312|HGNC:HGNC:21398};, PF00561;, GO:0032281;GO:0098982;GO:0098978;GO:0016021;GO:0099055;GO:0031902;GO:0005765;GO:0031966;GO:0005739;GO:0005886;GO:0047372;GO:0004620;GO:0046464;GO:0060292;GO:2001311;GO:0052651;GO:0030336;GO:0120163;GO:0009395;GO:0046889;GO:2000124;, C:AMPA glutamate receptor complex; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic membrane; C:late endosome membrane; C:lysosomal membrane; C:mitochondrial membrane; C:mitochondrion; C:plasma membrane;, F:acylglycerol lipase activity; F:phospholipase activity;, P:acylglycerol catabolic process; P:long-term synaptic depression; P:lysobisphosphatidic acid metabolic process; P:monoacylglycerol catabolic process; P:negative regulation of cell migration; P:negative regulation of cold-induced thermogenesis; P:phospholipid catabolic process; P:positive regulation of lipid biosynthetic process; P:regulation of endocannabinoid signaling pathway; scaffold23 indexed_genome mRNA 6874322 6874995 . + . ID=transcript_5459;O95059 Q53X97,Ribonuclease P protein subunit p14,, PF01900;, GO:0030681;GO:0005730;GO:0005654;GO:0004526;GO:0033204;GO:0001682;, C:multimeric ribonuclease P complex; C:nucleolus; C:nucleoplasm;, F:ribonuclease P activity; F:ribonuclease P RNA binding;, P:tRNA 5'-leader removal; scaffold23 indexed_genome mRNA 6911523 6971987 . + . ID=transcript_5460;Q96CA3 Q96R07 Q9NXB8,PX domain-containing protein kinase-like protein,Modulator of Na,K-ATPase;, PF00787;PF02205;, GO:0034451;GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0032991;GO:0003779;GO:0035091;GO:0008022;GO:0006954;GO:0050804;GO:0032780;GO:0043271;GO:0006468;GO:0042391;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:actin binding; F:phosphatidylinositol binding; F:protein C-terminus binding;, P:inflammatory response; P:modulation of chemical synaptic transmission; P:negative regulation of ATPase activity; P:negative regulation of ion transport; P:protein phosphorylation; P:regulation of membrane potential;|P11177 B2R7L0 B4DDD7 Q6FH45 Q9BQ27 Q9UFK3,Pyruvate dehydrogenase E1 component subunit beta, mitochondrial,, PF02779;PF02780;, GO:0005759;GO:0005967;GO:0005739;GO:0005654;GO:0005634;GO:0045254;GO:0004739;GO:0006086;GO:0006006;GO:0061732;GO:0006090;GO:0006099;, C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:pyruvate dehydrogenase complex;, F:pyruvate dehydrogenase (acetyl-transferring) activity;, P:acetyl-CoA biosynthetic process from pyruvate; P:glucose metabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:pyruvate metabolic process; P:tricarboxylic acid cycle;|P11177 B2R7L0 B4DDD7 Q6FH45 Q9BQ27 Q9UFK3,Pyruvate dehydrogenase E1 component subunit beta, mitochondrial,, PF02779;PF02780;, GO:0005759;GO:0005967;GO:0005739;GO:0005654;GO:0005634;GO:0045254;GO:0004739;GO:0006086;GO:0006006;GO:0061732;GO:0006090;GO:0006099;, C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:pyruvate dehydrogenase complex;, F:pyruvate dehydrogenase (acetyl-transferring) activity;, P:acetyl-CoA biosynthetic process from pyruvate; P:glucose metabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:pyruvate metabolic process; P:tricarboxylic acid cycle;|P11177 B2R7L0 B4DDD7 Q6FH45 Q9BQ27 Q9UFK3,Pyruvate dehydrogenase E1 component subunit beta, mitochondrial,, PF02779;PF02780;, GO:0005759;GO:0005967;GO:0005739;GO:0005654;GO:0005634;GO:0045254;GO:0004739;GO:0006086;GO:0006006;GO:0061732;GO:0006090;GO:0006099;, C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:pyruvate dehydrogenase complex;, F:pyruvate dehydrogenase (acetyl-transferring) activity;, P:acetyl-CoA biosynthetic process from pyruvate; P:glucose metabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:pyruvate metabolic process; P:tricarboxylic acid cycle;|P11177 B2R7L0 B4DDD7 Q6FH45 Q9BQ27 Q9UFK3,Pyruvate dehydrogenase E1 component subunit beta, mitochondrial,, PF02779;PF02780;, GO:0005759;GO:0005967;GO:0005739;GO:0005654;GO:0005634;GO:0045254;GO:0004739;GO:0006086;GO:0006006;GO:0061732;GO:0006090;GO:0006099;, C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:pyruvate dehydrogenase complex;, F:pyruvate dehydrogenase (acetyl-transferring) activity;, P:acetyl-CoA biosynthetic process from pyruvate; P:glucose metabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:pyruvate metabolic process; P:tricarboxylic acid cycle; scaffold23 indexed_genome mRNA 7020525 7022880 . - . ID=transcript_5461;Q8NC69 B3KNI5 Q8NBS6 Q8TCA6,BTB/POZ domain-containing protein KCTD6,KCASH3 protein {ECO:0000303|PubMed:21472142};Potassium channel tetramerization domain-containing protein 6;, PF02214;, GO:0005829;GO:0031430;GO:0030506;GO:0097602;GO:0042802;GO:0045879;GO:0043687;GO:0051260;GO:0016567;GO:0040008;GO:0033146;GO:0006511;, C:cytosol; C:M band;, F:ankyrin binding; F:cullin family protein binding; F:identical protein binding;, P:negative regulation of smoothened signaling pathway; P:post-translational protein modification; P:protein homooligomerization; P:protein ubiquitination; P:regulation of growth; P:regulation of intracellular estrogen receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold23 indexed_genome mRNA 7025464 7053749 . - . ID=transcript_5462;Q99424 A6NF16 B2R8U5,Peroxisomal acyl-coenzyme A oxidase 2 {ECO:0000303|PubMed:14702039},3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA 24-hydroxylase;3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA oxidase {ECO:0000250|UniProtKB:O02767};Trihydroxycoprostanoyl-CoA oxidase {ECO:0000250|UniProtKB:P97562};, PF01756;PF02770;PF14749;, GO:0005829;GO:0043231;GO:0005782;GO:0005777;GO:0033791;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0042803;GO:0006699;GO:0033540;GO:0055088;GO:0010942;GO:1902884;GO:0008104;GO:0000038;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisomal matrix; C:peroxisome;, F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity; F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:protein homodimerization activity;, P:bile acid biosynthetic process; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:lipid homeostasis; P:positive regulation of cell death; P:positive regulation of response to oxidative stress; P:protein localization; P:very long-chain fatty acid metabolic process;|Q99424 A6NF16 B2R8U5,Peroxisomal acyl-coenzyme A oxidase 2 {ECO:0000303|PubMed:14702039},3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA 24-hydroxylase;3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA oxidase {ECO:0000250|UniProtKB:O02767};Trihydroxycoprostanoyl-CoA oxidase {ECO:0000250|UniProtKB:P97562};, PF01756;PF02770;PF14749;, GO:0005829;GO:0043231;GO:0005782;GO:0005777;GO:0033791;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0042803;GO:0006699;GO:0033540;GO:0055088;GO:0010942;GO:1902884;GO:0008104;GO:0000038;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisomal matrix; C:peroxisome;, F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity; F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:protein homodimerization activity;, P:bile acid biosynthetic process; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:lipid homeostasis; P:positive regulation of cell death; P:positive regulation of response to oxidative stress; P:protein localization; P:very long-chain fatty acid metabolic process;|Q99424 A6NF16 B2R8U5,Peroxisomal acyl-coenzyme A oxidase 2 {ECO:0000303|PubMed:14702039},3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA 24-hydroxylase;3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA oxidase {ECO:0000250|UniProtKB:O02767};Trihydroxycoprostanoyl-CoA oxidase {ECO:0000250|UniProtKB:P97562};, PF01756;PF02770;PF14749;, GO:0005829;GO:0043231;GO:0005782;GO:0005777;GO:0033791;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0042803;GO:0006699;GO:0033540;GO:0055088;GO:0010942;GO:1902884;GO:0008104;GO:0000038;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisomal matrix; C:peroxisome;, F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity; F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:protein homodimerization activity;, P:bile acid biosynthetic process; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:lipid homeostasis; P:positive regulation of cell death; P:positive regulation of response to oxidative stress; P:protein localization; P:very long-chain fatty acid metabolic process;|Q99424 A6NF16 B2R8U5,Peroxisomal acyl-coenzyme A oxidase 2 {ECO:0000303|PubMed:14702039},3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA 24-hydroxylase;3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA oxidase {ECO:0000250|UniProtKB:O02767};Trihydroxycoprostanoyl-CoA oxidase {ECO:0000250|UniProtKB:P97562};, PF01756;PF02770;PF14749;, GO:0005829;GO:0043231;GO:0005782;GO:0005777;GO:0033791;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0042803;GO:0006699;GO:0033540;GO:0055088;GO:0010942;GO:1902884;GO:0008104;GO:0000038;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisomal matrix; C:peroxisome;, F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity; F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:protein homodimerization activity;, P:bile acid biosynthetic process; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:lipid homeostasis; P:positive regulation of cell death; P:positive regulation of response to oxidative stress; P:protein localization; P:very long-chain fatty acid metabolic process; scaffold23 indexed_genome mRNA 7072876 7091353 . + . ID=transcript_5463;O95990 B3KNQ4 B7ZAY5 J3KR61 Q96NH4,Actin-associated protein FAM107A {ECO:0000305},Down-regulated in renal cell carcinoma 1 {ECO:0000303|PubMed:10564580};Protein TU3A {ECO:0000303|PubMed:10702698};, PF06625;, GO:0015629;GO:0005737;GO:0005925;GO:0043005;GO:0016607;GO:0005634;GO:0032587;GO:0001725;GO:0045202;GO:0003779;GO:0051017;GO:0030041;GO:0007049;GO:0071385;GO:0031669;GO:0050890;GO:0051895;GO:2000134;GO:1900272;GO:0030335;GO:0031398;GO:0032956;GO:0001558;GO:0070507;GO:0031647;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:neuron projection; C:nuclear speck; C:nucleus; C:ruffle membrane; C:stress fiber; C:synapse;, F:actin binding;, P:actin filament bundle assembly; P:actin filament polymerization; P:cell cycle; P:cellular response to glucocorticoid stimulus; P:cellular response to nutrient levels; P:cognition; P:negative regulation of focal adhesion assembly; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of long-term synaptic potentiation; P:positive regulation of cell migration; P:positive regulation of protein ubiquitination; P:regulation of actin cytoskeleton organization; P:regulation of cell growth; P:regulation of microtubule cytoskeleton organization; P:regulation of protein stability;|O95990 B3KNQ4 B7ZAY5 J3KR61 Q96NH4,Actin-associated protein FAM107A {ECO:0000305},Down-regulated in renal cell carcinoma 1 {ECO:0000303|PubMed:10564580};Protein TU3A {ECO:0000303|PubMed:10702698};, PF06625;, GO:0015629;GO:0005737;GO:0005925;GO:0043005;GO:0016607;GO:0005634;GO:0032587;GO:0001725;GO:0045202;GO:0003779;GO:0051017;GO:0030041;GO:0007049;GO:0071385;GO:0031669;GO:0050890;GO:0051895;GO:2000134;GO:1900272;GO:0030335;GO:0031398;GO:0032956;GO:0001558;GO:0070507;GO:0031647;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:neuron projection; C:nuclear speck; C:nucleus; C:ruffle membrane; C:stress fiber; C:synapse;, F:actin binding;, P:actin filament bundle assembly; P:actin filament polymerization; P:cell cycle; P:cellular response to glucocorticoid stimulus; P:cellular response to nutrient levels; P:cognition; P:negative regulation of focal adhesion assembly; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of long-term synaptic potentiation; P:positive regulation of cell migration; P:positive regulation of protein ubiquitination; P:regulation of actin cytoskeleton organization; P:regulation of cell growth; P:regulation of microtubule cytoskeleton organization; P:regulation of protein stability; scaffold23 indexed_genome mRNA 7156807 7161316 . - . ID=transcript_5464;O95990 B3KNQ4 B7ZAY5 J3KR61 Q96NH4,Actin-associated protein FAM107A {ECO:0000305},Down-regulated in renal cell carcinoma 1 {ECO:0000303|PubMed:10564580};Protein TU3A {ECO:0000303|PubMed:10702698};, PF06625;, GO:0015629;GO:0005737;GO:0005925;GO:0043005;GO:0016607;GO:0005634;GO:0032587;GO:0001725;GO:0045202;GO:0003779;GO:0051017;GO:0030041;GO:0007049;GO:0071385;GO:0031669;GO:0050890;GO:0051895;GO:2000134;GO:1900272;GO:0030335;GO:0031398;GO:0032956;GO:0001558;GO:0070507;GO:0031647;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:neuron projection; C:nuclear speck; C:nucleus; C:ruffle membrane; C:stress fiber; C:synapse;, F:actin binding;, P:actin filament bundle assembly; P:actin filament polymerization; P:cell cycle; P:cellular response to glucocorticoid stimulus; P:cellular response to nutrient levels; P:cognition; P:negative regulation of focal adhesion assembly; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of long-term synaptic potentiation; P:positive regulation of cell migration; P:positive regulation of protein ubiquitination; P:regulation of actin cytoskeleton organization; P:regulation of cell growth; P:regulation of microtubule cytoskeleton organization; P:regulation of protein stability; scaffold23 indexed_genome mRNA 7162102 7164339 . + . ID=transcript_5465;Q96BQ1 Q547G2,Protein FAM3D,, PF15711;, GO:0005576;GO:0005615;GO:0005125;GO:0070093;GO:0046676;, C:extracellular region; C:extracellular space;, F:cytokine activity;, P:negative regulation of glucagon secretion; P:negative regulation of insulin secretion; scaffold23 indexed_genome mRNA 7272639 7402664 . - . ID=transcript_5466;Q6ZVT6 B9EKV6 Q6ZV69,Protein CFAP20DC {ECO:0000305},Uncharacterized protein C3orf67;, PF05018; scaffold23 indexed_genome mRNA 8193772 9684057 . - . ID=transcript_5467;P49789 A2IAS9 A2IAT0 A2IAT6 A8K1A9 Q45QG9 Q6IU12,Bis(5'-adenosyl)-triphosphatase,AP3A hydrolase;Diadenosine 5',5'''-P1,P3-triphosphate hydrolase;Dinucleosidetriphosphatase;Fragile histidine triad protein;, PF01230;, GO:0005737;GO:0005829;GO:0001650;GO:0005739;GO:0005634;GO:0005886;GO:0047710;GO:0042802;GO:0000166;GO:0031625;GO:0015964;GO:0072332;GO:0032435;GO:0006163;, C:cytoplasm; C:cytosol; C:fibrillar center; C:mitochondrion; C:nucleus; C:plasma membrane;, F:bis(5'-adenosyl)-triphosphatase activity; F:identical protein binding; F:nucleotide binding; F:ubiquitin protein ligase binding;, P:diadenosine triphosphate catabolic process; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:purine nucleotide metabolic process; scaffold23 indexed_genome mRNA 9973713 10725567 . + . ID=transcript_5468;P23470 B2RU12 B7ZLX5 Q15623 Q59EE0 Q68DU5,Receptor-type tyrosine-protein phosphatase gamma,, PF00194;PF00041;PF00102;, GO:0070062;GO:0005887;GO:0042802;GO:0004725;GO:0005001;GO:0007420;GO:0010633;GO:0010977;GO:0006470;GO:0007169;, C:extracellular exosome; C:integral component of plasma membrane;, F:identical protein binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:brain development; P:negative regulation of epithelial cell migration; P:negative regulation of neuron projection development; P:protein dephosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P23470 B2RU12 B7ZLX5 Q15623 Q59EE0 Q68DU5,Receptor-type tyrosine-protein phosphatase gamma,, PF00194;PF00041;PF00102;, GO:0070062;GO:0005887;GO:0042802;GO:0004725;GO:0005001;GO:0007420;GO:0010633;GO:0010977;GO:0006470;GO:0007169;, C:extracellular exosome; C:integral component of plasma membrane;, F:identical protein binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:brain development; P:negative regulation of epithelial cell migration; P:negative regulation of neuron projection development; P:protein dephosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P23470 B2RU12 B7ZLX5 Q15623 Q59EE0 Q68DU5,Receptor-type tyrosine-protein phosphatase gamma,, PF00194;PF00041;PF00102;, GO:0070062;GO:0005887;GO:0042802;GO:0004725;GO:0005001;GO:0007420;GO:0010633;GO:0010977;GO:0006470;GO:0007169;, C:extracellular exosome; C:integral component of plasma membrane;, F:identical protein binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:brain development; P:negative regulation of epithelial cell migration; P:negative regulation of neuron projection development; P:protein dephosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P23471 A4D0W5 C9JFM0 O76043 Q9UDR6,Receptor-type tyrosine-protein phosphatase zeta,Protein-tyrosine phosphatase receptor type Z polypeptide 1;Protein-tyrosine phosphatase receptor type Z polypeptide 2;R-PTP-zeta-2;, PF00194;PF00041;PF00102;, GO:0005576;GO:0005887;GO:0031226;GO:0005886;GO:0005178;GO:0004725;GO:0005001;GO:0007417;GO:0019221;GO:0007611;GO:0043524;GO:0048709;GO:0035335;GO:0048714;GO:0006470;GO:0031641;GO:0070445;, C:extracellular region; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:integrin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:central nervous system development; P:cytokine-mediated signaling pathway; P:learning or memory; P:negative regulation of neuron apoptotic process; P:oligodendrocyte differentiation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of oligodendrocyte differentiation; P:protein dephosphorylation; P:regulation of myelination; P:regulation of oligodendrocyte progenitor proliferation; scaffold23 indexed_genome mRNA 10782500 10787882 . + . ID=transcript_5469;Q9HBI5 B2R9U0,Uncharacterized protein C3orf14,, PF15134; scaffold23 indexed_genome mRNA 10858985 10974205 . + . ID=transcript_5470;Q9ULU8 A6NF60 Q13339 Q6GQQ6 Q8N2Z5 Q8N3M7 Q8NFR0 Q96BC2,Calcium-dependent secretion activator 1,Calcium-dependent activator protein for secretion 1;, PF06292;PF00169;, GO:0005829;GO:0098978;GO:0099012;GO:0098793;GO:0008289;GO:0046872;GO:0019901;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytosol; C:glutamatergic synapse; C:neuronal dense core vesicle membrane; C:presynapse;, F:lipid binding; F:metal ion binding; F:protein kinase binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis;|Q9ULU8 A6NF60 Q13339 Q6GQQ6 Q8N2Z5 Q8N3M7 Q8NFR0 Q96BC2,Calcium-dependent secretion activator 1,Calcium-dependent activator protein for secretion 1;, PF06292;PF00169;, GO:0005829;GO:0098978;GO:0099012;GO:0098793;GO:0008289;GO:0046872;GO:0019901;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytosol; C:glutamatergic synapse; C:neuronal dense core vesicle membrane; C:presynapse;, F:lipid binding; F:metal ion binding; F:protein kinase binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis;|Q9ULU8 A6NF60 Q13339 Q6GQQ6 Q8N2Z5 Q8N3M7 Q8NFR0 Q96BC2,Calcium-dependent secretion activator 1,Calcium-dependent activator protein for secretion 1;, PF06292;PF00169;, GO:0005829;GO:0098978;GO:0099012;GO:0098793;GO:0008289;GO:0046872;GO:0019901;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytosol; C:glutamatergic synapse; C:neuronal dense core vesicle membrane; C:presynapse;, F:lipid binding; F:metal ion binding; F:protein kinase binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis;|Q9ULU8 A6NF60 Q13339 Q6GQQ6 Q8N2Z5 Q8N3M7 Q8NFR0 Q96BC2,Calcium-dependent secretion activator 1,Calcium-dependent activator protein for secretion 1;, PF06292;PF00169;, GO:0005829;GO:0098978;GO:0099012;GO:0098793;GO:0008289;GO:0046872;GO:0019901;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytosol; C:glutamatergic synapse; C:neuronal dense core vesicle membrane; C:presynapse;, F:lipid binding; F:metal ion binding; F:protein kinase binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis;|Q9ULU8 A6NF60 Q13339 Q6GQQ6 Q8N2Z5 Q8N3M7 Q8NFR0 Q96BC2,Calcium-dependent secretion activator 1,Calcium-dependent activator protein for secretion 1;, PF06292;PF00169;, GO:0005829;GO:0098978;GO:0099012;GO:0098793;GO:0008289;GO:0046872;GO:0019901;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytosol; C:glutamatergic synapse; C:neuronal dense core vesicle membrane; C:presynapse;, F:lipid binding; F:metal ion binding; F:protein kinase binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis; scaffold23 indexed_genome mRNA 10974218 11208557 . - . ID=transcript_5471;Q9ULU8 A6NF60 Q13339 Q6GQQ6 Q8N2Z5 Q8N3M7 Q8NFR0 Q96BC2,Calcium-dependent secretion activator 1,Calcium-dependent activator protein for secretion 1;, PF06292;PF00169;, GO:0005829;GO:0098978;GO:0099012;GO:0098793;GO:0008289;GO:0046872;GO:0019901;GO:1990504;GO:0006887;GO:0045921;GO:0015031;GO:0016079;, C:cytosol; C:glutamatergic synapse; C:neuronal dense core vesicle membrane; C:presynapse;, F:lipid binding; F:metal ion binding; F:protein kinase binding;, P:dense core granule exocytosis; P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:synaptic vesicle exocytosis; scaffold23 indexed_genome mRNA 11651304 12016582 . + . ID=transcript_5472;Q8TBG9 B2R675 G5E9W4,Synaptoporin,, PF01284;, GO:0030285;GO:0043005;GO:0030672;GO:0017075;, C:integral component of synaptic vesicle membrane; C:neuron projection; C:synaptic vesicle membrane;, F:syntaxin-1 binding;|Q8TBG9 B2R675 G5E9W4,Synaptoporin,, PF01284;, GO:0030285;GO:0043005;GO:0030672;GO:0017075;, C:integral component of synaptic vesicle membrane; C:neuron projection; C:synaptic vesicle membrane;, F:syntaxin-1 binding; scaffold23 indexed_genome mRNA 12076981 12082370 . + . ID=transcript_5473;Q96BT1,Putative uncharacterized protein C3orf49 scaffold23 indexed_genome mRNA 12083309 12103402 . + . ID=transcript_5474;Q96BT1,Putative uncharacterized protein C3orf49|Q96BT1,Putative uncharacterized protein C3orf49|Q96BT1,Putative uncharacterized protein C3orf49|Q6I9Y2 Q6P1L3 Q8WUF2 Q9H5H0,THO complex subunit 7 homolog,Functional spliceosome-associated protein 24;Ngg1-interacting factor 3-like protein 1-binding protein 1;hTREX30;, PF05615;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003723;GO:0031124;GO:0006406;GO:0006405;GO:0008380;GO:0046784;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q6I9Y2 Q6P1L3 Q8WUF2 Q9H5H0,THO complex subunit 7 homolog,Functional spliceosome-associated protein 24;Ngg1-interacting factor 3-like protein 1-binding protein 1;hTREX30;, PF05615;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003723;GO:0031124;GO:0006406;GO:0006405;GO:0008380;GO:0046784;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q6I9Y2 Q6P1L3 Q8WUF2 Q9H5H0,THO complex subunit 7 homolog,Functional spliceosome-associated protein 24;Ngg1-interacting factor 3-like protein 1-binding protein 1;hTREX30;, PF05615;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003723;GO:0031124;GO:0006406;GO:0006405;GO:0008380;GO:0046784;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus; scaffold23 indexed_genome mRNA 12156964 12246319 . + . ID=transcript_5475;O15265 B4E207 E9PHP9 O75328 O75329 Q9Y6P8,Ataxin-7,Spinocerebellar ataxia type 7 protein;, PF08313;, GO:0005829;GO:0015630;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0016578;GO:0000226;GO:0007026;GO:0006997;GO:0016579;GO:0007601;, C:cytosol; C:microtubule cytoskeleton; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:histone deubiquitination; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:nucleus organization; P:protein deubiquitination; P:visual perception;|O15265 B4E207 E9PHP9 O75328 O75329 Q9Y6P8,Ataxin-7,Spinocerebellar ataxia type 7 protein;, PF08313;, GO:0005829;GO:0015630;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0016578;GO:0000226;GO:0007026;GO:0006997;GO:0016579;GO:0007601;, C:cytosol; C:microtubule cytoskeleton; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:histone deubiquitination; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:nucleus organization; P:protein deubiquitination; P:visual perception; scaffold23 indexed_genome mRNA 12269041 12271942 . + . ID=transcript_5476;Q15008 A8K2E0 E9PHI9 Q6UV22,26S proteasome non-ATPase regulatory subunit 6,26S proteasome regulatory subunit RPN7;26S proteasome regulatory subunit S10;Breast cancer-associated protein SGA-113M;Phosphonoformate immuno-associated protein 4;Proteasome regulatory particle subunit p44S10;p42A;, PF01399;PF10602;, GO:0005829;GO:0005576;GO:1904813;GO:0005654;GO:0022624;GO:0000502;GO:0005838;GO:0034774;GO:0016887;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006508;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:secretory granule lumen;, F:ATPase activity; F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold23 indexed_genome mRNA 12271967 12287318 . + . ID=transcript_5477;Q15008 A8K2E0 E9PHI9 Q6UV22,26S proteasome non-ATPase regulatory subunit 6,26S proteasome regulatory subunit RPN7;26S proteasome regulatory subunit S10;Breast cancer-associated protein SGA-113M;Phosphonoformate immuno-associated protein 4;Proteasome regulatory particle subunit p44S10;p42A;, PF01399;PF10602;, GO:0005829;GO:0005576;GO:1904813;GO:0005654;GO:0022624;GO:0000502;GO:0005838;GO:0034774;GO:0016887;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006508;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:secretory granule lumen;, F:ATPase activity; F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q15008 A8K2E0 E9PHI9 Q6UV22,26S proteasome non-ATPase regulatory subunit 6,26S proteasome regulatory subunit RPN7;26S proteasome regulatory subunit S10;Breast cancer-associated protein SGA-113M;Phosphonoformate immuno-associated protein 4;Proteasome regulatory particle subunit p44S10;p42A;, PF01399;PF10602;, GO:0005829;GO:0005576;GO:1904813;GO:0005654;GO:0022624;GO:0000502;GO:0005838;GO:0034774;GO:0016887;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006508;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:secretory granule lumen;, F:ATPase activity; F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q15008 A8K2E0 E9PHI9 Q6UV22,26S proteasome non-ATPase regulatory subunit 6,26S proteasome regulatory subunit RPN7;26S proteasome regulatory subunit S10;Breast cancer-associated protein SGA-113M;Phosphonoformate immuno-associated protein 4;Proteasome regulatory particle subunit p44S10;p42A;, PF01399;PF10602;, GO:0005829;GO:0005576;GO:1904813;GO:0005654;GO:0022624;GO:0000502;GO:0005838;GO:0034774;GO:0016887;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006508;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:secretory granule lumen;, F:ATPase activity; F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold23 indexed_genome mRNA 12367540 12372095 . + . ID=transcript_5478;Q7Z3G6 Q0VF44,Prickle-like protein 2,, PF00412;PF06297;, GO:0005737;GO:0031965;GO:0008270;GO:0060071;, C:cytoplasm; C:nuclear membrane;, F:zinc ion binding;, P:Wnt signaling pathway, planar cell polarity pathway; scaffold23 indexed_genome mRNA 12373012 12492550 . - . ID=transcript_5479;Q7Z3G6 Q0VF44,Prickle-like protein 2,, PF00412;PF06297;, GO:0005737;GO:0031965;GO:0008270;GO:0060071;, C:cytoplasm; C:nuclear membrane;, F:zinc ion binding;, P:Wnt signaling pathway, planar cell polarity pathway; scaffold23 indexed_genome mRNA 12773902 12851293 . - . ID=transcript_5480;Q9P2N4 A1L4L0 B7ZVX9 B9ZVN0 Q9NR29,A disintegrin and metalloproteinase with thrombospondin motifs 9,, PF17771;PF05986;PF08685;PF01562;PF01421;PF00090;, GO:0005783;GO:0031012;GO:0005576;GO:0043231;GO:0004222;GO:0008237;GO:0008270;GO:0035909;GO:0090673;GO:0030198;GO:0006516;GO:0003179;GO:0007275;GO:0010596;GO:1903671;GO:0015031;GO:0006508;GO:0003229;GO:0016192;, C:endoplasmic reticulum; C:extracellular matrix; C:extracellular region; C:intracellular membrane-bounded organelle;, F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:aorta morphogenesis; P:endothelial cell-matrix adhesion; P:extracellular matrix organization; P:glycoprotein catabolic process; P:heart valve morphogenesis; P:multicellular organism development; P:negative regulation of endothelial cell migration; P:negative regulation of sprouting angiogenesis; P:protein transport; P:proteolysis; P:ventricular cardiac muscle tissue development; P:vesicle-mediated transport; scaffold23 indexed_genome mRNA 12851326 12865618 . - . ID=transcript_5481;Q9P2N4 A1L4L0 B7ZVX9 B9ZVN0 Q9NR29,A disintegrin and metalloproteinase with thrombospondin motifs 9,, PF17771;PF05986;PF08685;PF01562;PF01421;PF00090;, GO:0005783;GO:0031012;GO:0005576;GO:0043231;GO:0004222;GO:0008237;GO:0008270;GO:0035909;GO:0090673;GO:0030198;GO:0006516;GO:0003179;GO:0007275;GO:0010596;GO:1903671;GO:0015031;GO:0006508;GO:0003229;GO:0016192;, C:endoplasmic reticulum; C:extracellular matrix; C:extracellular region; C:intracellular membrane-bounded organelle;, F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:aorta morphogenesis; P:endothelial cell-matrix adhesion; P:extracellular matrix organization; P:glycoprotein catabolic process; P:heart valve morphogenesis; P:multicellular organism development; P:negative regulation of endothelial cell migration; P:negative regulation of sprouting angiogenesis; P:protein transport; P:proteolysis; P:ventricular cardiac muscle tissue development; P:vesicle-mediated transport; scaffold23 indexed_genome mRNA 12866499 12888459 . - . ID=transcript_5482;Q9P2N4 A1L4L0 B7ZVX9 B9ZVN0 Q9NR29,A disintegrin and metalloproteinase with thrombospondin motifs 9,, PF17771;PF05986;PF08685;PF01562;PF01421;PF00090;, GO:0005783;GO:0031012;GO:0005576;GO:0043231;GO:0004222;GO:0008237;GO:0008270;GO:0035909;GO:0090673;GO:0030198;GO:0006516;GO:0003179;GO:0007275;GO:0010596;GO:1903671;GO:0015031;GO:0006508;GO:0003229;GO:0016192;, C:endoplasmic reticulum; C:extracellular matrix; C:extracellular region; C:intracellular membrane-bounded organelle;, F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:aorta morphogenesis; P:endothelial cell-matrix adhesion; P:extracellular matrix organization; P:glycoprotein catabolic process; P:heart valve morphogenesis; P:multicellular organism development; P:negative regulation of endothelial cell migration; P:negative regulation of sprouting angiogenesis; P:protein transport; P:proteolysis; P:ventricular cardiac muscle tissue development; P:vesicle-mediated transport; scaffold23 indexed_genome mRNA 13601120 13710881 . - . ID=transcript_5483;Q96QZ7 A8K188 O00309 O43863 O75085 Q96QZ8 Q96QZ9,Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,Atrophin-1-interacting protein 3;BAI1-associated protein 1;Membrane-associated guanylate kinase inverted 1;Trinucleotide repeat-containing gene 19 protein;WW domain-containing protein 3;, PF00625;PF00595;PF00397;, GO:0005912;GO:0005923;GO:0030054;GO:0071944;GO:0042995;GO:0005911;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0051393;GO:0005524;GO:0060090;GO:0008022;GO:0007155;GO:0007166;GO:0022409;GO:0065003;GO:0007165;, C:adherens junction; C:bicellular tight junction; C:cell junction; C:cell periphery; C:cell projection; C:cell-cell junction; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:alpha-actinin binding; F:ATP binding; F:molecular adaptor activity; F:protein C-terminus binding;, P:cell adhesion; P:cell surface receptor signaling pathway; P:positive regulation of cell-cell adhesion; P:protein-containing complex assembly; P:signal transduction;|Q96QZ7 A8K188 O00309 O43863 O75085 Q96QZ8 Q96QZ9,Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,Atrophin-1-interacting protein 3;BAI1-associated protein 1;Membrane-associated guanylate kinase inverted 1;Trinucleotide repeat-containing gene 19 protein;WW domain-containing protein 3;, PF00625;PF00595;PF00397;, GO:0005912;GO:0005923;GO:0030054;GO:0071944;GO:0042995;GO:0005911;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0051393;GO:0005524;GO:0060090;GO:0008022;GO:0007155;GO:0007166;GO:0022409;GO:0065003;GO:0007165;, C:adherens junction; C:bicellular tight junction; C:cell junction; C:cell periphery; C:cell projection; C:cell-cell junction; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:alpha-actinin binding; F:ATP binding; F:molecular adaptor activity; F:protein C-terminus binding;, P:cell adhesion; P:cell surface receptor signaling pathway; P:positive regulation of cell-cell adhesion; P:protein-containing complex assembly; P:signal transduction;|Q96QZ7 A8K188 O00309 O43863 O75085 Q96QZ8 Q96QZ9,Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,Atrophin-1-interacting protein 3;BAI1-associated protein 1;Membrane-associated guanylate kinase inverted 1;Trinucleotide repeat-containing gene 19 protein;WW domain-containing protein 3;, PF00625;PF00595;PF00397;, GO:0005912;GO:0005923;GO:0030054;GO:0071944;GO:0042995;GO:0005911;GO:0005737;GO:0005730;GO:0005654;GO:0005886;GO:0051393;GO:0005524;GO:0060090;GO:0008022;GO:0007155;GO:0007166;GO:0022409;GO:0065003;GO:0007165;, C:adherens junction; C:bicellular tight junction; C:cell junction; C:cell periphery; C:cell projection; C:cell-cell junction; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:alpha-actinin binding; F:ATP binding; F:molecular adaptor activity; F:protein C-terminus binding;, P:cell adhesion; P:cell surface receptor signaling pathway; P:positive regulation of cell-cell adhesion; P:protein-containing complex assembly; P:signal transduction; scaffold23 indexed_genome mRNA 14382001 14634094 . - . ID=transcript_5484;Q96JA1 Q6IQ51 Q96CF9 Q9BYB8 Q9UFI4,Leucine-rich repeats and immunoglobulin-like domains protein 1,, PF07679;PF13855;PF01463;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0022405;GO:0060384;GO:0032474;GO:0007605;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:hair cycle process; P:innervation; P:otolith morphogenesis; P:sensory perception of sound;|Q70HW3 A8K758 B3KRZ7 F8WAB8 Q7Z786 Q96E68,S-adenosylmethionine mitochondrial carrier protein,Mitochondrial S-adenosylmethionine transporter;Solute carrier family 25 member 26;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0000095;GO:0006811;GO:0015805;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:S-adenosyl-L-methionine transmembrane transporter activity;, P:ion transport; P:S-adenosyl-L-methionine transport;|Q96JA1 Q6IQ51 Q96CF9 Q9BYB8 Q9UFI4,Leucine-rich repeats and immunoglobulin-like domains protein 1,, PF07679;PF13855;PF01463;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0022405;GO:0060384;GO:0032474;GO:0007605;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:hair cycle process; P:innervation; P:otolith morphogenesis; P:sensory perception of sound;|Q96JA1 Q6IQ51 Q96CF9 Q9BYB8 Q9UFI4,Leucine-rich repeats and immunoglobulin-like domains protein 1,, PF07679;PF13855;PF01463;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0022405;GO:0060384;GO:0032474;GO:0007605;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:hair cycle process; P:innervation; P:otolith morphogenesis; P:sensory perception of sound;|Q96JA1 Q6IQ51 Q96CF9 Q9BYB8 Q9UFI4,Leucine-rich repeats and immunoglobulin-like domains protein 1,, PF07679;PF13855;PF01463;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0022405;GO:0060384;GO:0032474;GO:0007605;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:hair cycle process; P:innervation; P:otolith morphogenesis; P:sensory perception of sound;|Q96JA1 Q6IQ51 Q96CF9 Q9BYB8 Q9UFI4,Leucine-rich repeats and immunoglobulin-like domains protein 1,, PF07679;PF13855;PF01463;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0022405;GO:0060384;GO:0032474;GO:0007605;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:hair cycle process; P:innervation; P:otolith morphogenesis; P:sensory perception of sound; scaffold23 indexed_genome mRNA 15062316 15495990 . - . ID=transcript_5485;Q96I99 C9JVT2 O95195 Q6NUH7 Q86VX8 Q8WUQ1,Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03221},GTP-specific succinyl-CoA synthetase subunit beta {ECO:0000255|HAMAP-Rule:MF_03221};Succinyl-CoA synthetase beta-G chain {ECO:0000255|HAMAP-Rule:MF_03221};, PF08442;PF00549;, GO:0005759;GO:0005739;GO:0005886;GO:0042709;GO:0045244;GO:0005524;GO:0019003;GO:0005525;GO:0000287;GO:0044877;GO:0004775;GO:0004776;GO:0006105;GO:0006104;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:succinate-CoA ligase complex; C:succinate-CoA ligase complex (GDP-forming);, F:ATP binding; F:GDP binding; F:GTP binding; F:magnesium ion binding; F:protein-containing complex binding; F:succinate-CoA ligase (ADP-forming) activity; F:succinate-CoA ligase (GDP-forming) activity;, P:succinate metabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle;|Q8NFY9 B4DTW6 Q96JI5,Kelch repeat and BTB domain-containing protein 8,T-cell activation kelch repeat protein;, PF07707;PF00651;PF01344;, GO:0031463;GO:0005829;GO:0005794;GO:0005819;GO:0014032;GO:0014029;GO:0043687;GO:0006513;GO:0006417;, C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:Golgi apparatus; C:spindle;, , P:neural crest cell development; P:neural crest formation; P:post-translational protein modification; P:protein monoubiquitination; P:regulation of translation;|Q8NFY9 B4DTW6 Q96JI5,Kelch repeat and BTB domain-containing protein 8,T-cell activation kelch repeat protein;, PF07707;PF00651;PF01344;, GO:0031463;GO:0005829;GO:0005794;GO:0005819;GO:0014032;GO:0014029;GO:0043687;GO:0006513;GO:0006417;, C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:Golgi apparatus; C:spindle;, , P:neural crest cell development; P:neural crest formation; P:post-translational protein modification; P:protein monoubiquitination; P:regulation of translation;|Q96I99 C9JVT2 O95195 Q6NUH7 Q86VX8 Q8WUQ1,Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03221},GTP-specific succinyl-CoA synthetase subunit beta {ECO:0000255|HAMAP-Rule:MF_03221};Succinyl-CoA synthetase beta-G chain {ECO:0000255|HAMAP-Rule:MF_03221};, PF08442;PF00549;, GO:0005759;GO:0005739;GO:0005886;GO:0042709;GO:0045244;GO:0005524;GO:0019003;GO:0005525;GO:0000287;GO:0044877;GO:0004775;GO:0004776;GO:0006105;GO:0006104;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:succinate-CoA ligase complex; C:succinate-CoA ligase complex (GDP-forming);, F:ATP binding; F:GDP binding; F:GTP binding; F:magnesium ion binding; F:protein-containing complex binding; F:succinate-CoA ligase (ADP-forming) activity; F:succinate-CoA ligase (GDP-forming) activity;, P:succinate metabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle;|Q96I99 C9JVT2 O95195 Q6NUH7 Q86VX8 Q8WUQ1,Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03221},GTP-specific succinyl-CoA synthetase subunit beta {ECO:0000255|HAMAP-Rule:MF_03221};Succinyl-CoA synthetase beta-G chain {ECO:0000255|HAMAP-Rule:MF_03221};, PF08442;PF00549;, GO:0005759;GO:0005739;GO:0005886;GO:0042709;GO:0045244;GO:0005524;GO:0019003;GO:0005525;GO:0000287;GO:0044877;GO:0004775;GO:0004776;GO:0006105;GO:0006104;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:succinate-CoA ligase complex; C:succinate-CoA ligase complex (GDP-forming);, F:ATP binding; F:GDP binding; F:GTP binding; F:magnesium ion binding; F:protein-containing complex binding; F:succinate-CoA ligase (ADP-forming) activity; F:succinate-CoA ligase (GDP-forming) activity;, P:succinate metabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle; scaffold23 indexed_genome mRNA 16028250 16540498 . + . ID=transcript_5486;Q7Z5A9 A8K0V3 Q8TCL8,Chemokine-like protein TAFA-1 {ECO:0000305},, PF12020;, GO:0005783;GO:0005615;GO:0048018;GO:0014016;GO:1902692;GO:0010469;, C:endoplasmic reticulum; C:extracellular space;, F:receptor ligand activity;, P:neuroblast differentiation; P:regulation of neuroblast proliferation; P:regulation of signaling receptor activity; scaffold23 indexed_genome mRNA 16707473 16715730 . - . ID=transcript_5487;Q96LR4 A8MVT2,Chemokine-like protein TAFA-4 {ECO:0000305},, PF12020;, GO:0005615;GO:0048018;GO:0048246;GO:0006909;GO:0042391;GO:0051930;GO:0010469;GO:0042554;, C:extracellular space;, F:receptor ligand activity;, P:macrophage chemotaxis; P:phagocytosis; P:regulation of membrane potential; P:regulation of sensory perception of pain; P:regulation of signaling receptor activity; P:superoxide anion generation; scaffold23 indexed_genome mRNA 16913726 16958511 . - . ID=transcript_5488;Q5NDL2 A8K2U1 B4DFH5 L7X1M5 Q6MZY0 Q6P985 Q6ZTV0,EGF domain-specific O-linked N-acetylglucosamine transferase,Extracellular O-linked N-acetylglucosamine transferase;, PF04577;, GO:0005788;GO:0016262;GO:0097363;GO:0016757;GO:0097370;GO:0006493;, C:endoplasmic reticulum lumen;, F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity; F:transferase activity, transferring glycosyl groups;, P:protein O-GlcNAcylation via threonine; P:protein O-linked glycosylation;|Q5NDL2 A8K2U1 B4DFH5 L7X1M5 Q6MZY0 Q6P985 Q6ZTV0,EGF domain-specific O-linked N-acetylglucosamine transferase,Extracellular O-linked N-acetylglucosamine transferase;, PF04577;, GO:0005788;GO:0016262;GO:0097363;GO:0016757;GO:0097370;GO:0006493;, C:endoplasmic reticulum lumen;, F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity; F:transferase activity, transferring glycosyl groups;, P:protein O-GlcNAcylation via threonine; P:protein O-linked glycosylation;|Q5NDL2 A8K2U1 B4DFH5 L7X1M5 Q6MZY0 Q6P985 Q6ZTV0,EGF domain-specific O-linked N-acetylglucosamine transferase,Extracellular O-linked N-acetylglucosamine transferase;, PF04577;, GO:0005788;GO:0016262;GO:0097363;GO:0016757;GO:0097370;GO:0006493;, C:endoplasmic reticulum lumen;, F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity; F:transferase activity, transferring glycosyl groups;, P:protein O-GlcNAcylation via threonine; P:protein O-linked glycosylation;|Q5NDL2 A8K2U1 B4DFH5 L7X1M5 Q6MZY0 Q6P985 Q6ZTV0,EGF domain-specific O-linked N-acetylglucosamine transferase,Extracellular O-linked N-acetylglucosamine transferase;, PF04577;, GO:0005788;GO:0016262;GO:0097363;GO:0016757;GO:0097370;GO:0006493;, C:endoplasmic reticulum lumen;, F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity; F:transferase activity, transferring glycosyl groups;, P:protein O-GlcNAcylation via threonine; P:protein O-linked glycosylation;|Q5NDL2 A8K2U1 B4DFH5 L7X1M5 Q6MZY0 Q6P985 Q6ZTV0,EGF domain-specific O-linked N-acetylglucosamine transferase,Extracellular O-linked N-acetylglucosamine transferase;, PF04577;, GO:0005788;GO:0016262;GO:0097363;GO:0016757;GO:0097370;GO:0006493;, C:endoplasmic reticulum lumen;, F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity; F:transferase activity, transferring glycosyl groups;, P:protein O-GlcNAcylation via threonine; P:protein O-linked glycosylation;|Q5NDL2 A8K2U1 B4DFH5 L7X1M5 Q6MZY0 Q6P985 Q6ZTV0,EGF domain-specific O-linked N-acetylglucosamine transferase,Extracellular O-linked N-acetylglucosamine transferase;, PF04577;, GO:0005788;GO:0016262;GO:0097363;GO:0016757;GO:0097370;GO:0006493;, C:endoplasmic reticulum lumen;, F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity; F:transferase activity, transferring glycosyl groups;, P:protein O-GlcNAcylation via threonine; P:protein O-linked glycosylation;|Q5NDL2 A8K2U1 B4DFH5 L7X1M5 Q6MZY0 Q6P985 Q6ZTV0,EGF domain-specific O-linked N-acetylglucosamine transferase,Extracellular O-linked N-acetylglucosamine transferase;, PF04577;, GO:0005788;GO:0016262;GO:0097363;GO:0016757;GO:0097370;GO:0006493;, C:endoplasmic reticulum lumen;, F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity; F:transferase activity, transferring glycosyl groups;, P:protein O-GlcNAcylation via threonine; P:protein O-linked glycosylation;|Q5NDL2 A8K2U1 B4DFH5 L7X1M5 Q6MZY0 Q6P985 Q6ZTV0,EGF domain-specific O-linked N-acetylglucosamine transferase,Extracellular O-linked N-acetylglucosamine transferase;, PF04577;, GO:0005788;GO:0016262;GO:0097363;GO:0016757;GO:0097370;GO:0006493;, C:endoplasmic reticulum lumen;, F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity; F:transferase activity, transferring glycosyl groups;, P:protein O-GlcNAcylation via threonine; P:protein O-linked glycosylation;|Q5NDL2 A8K2U1 B4DFH5 L7X1M5 Q6MZY0 Q6P985 Q6ZTV0,EGF domain-specific O-linked N-acetylglucosamine transferase,Extracellular O-linked N-acetylglucosamine transferase;, PF04577;, GO:0005788;GO:0016262;GO:0097363;GO:0016757;GO:0097370;GO:0006493;, C:endoplasmic reticulum lumen;, F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity; F:transferase activity, transferring glycosyl groups;, P:protein O-GlcNAcylation via threonine; P:protein O-linked glycosylation; scaffold23 indexed_genome mRNA 16967929 16973697 . - . ID=transcript_5489;P82094 B7ZLJ2 Q17R87 Q59GK0,TATA element modulatory factor,Androgen receptor coactivator 160 kDa protein;Androgen receptor-associated protein of 160 kDa;, PF12329;PF12325;, GO:0005829;GO:0005783;GO:0005794;GO:0000139;GO:0005634;GO:0050681;GO:0003677;GO:0030374;GO:0001675;GO:0030521;GO:0042742;GO:0030317;GO:0033327;GO:0032275;GO:0043066;GO:0010629;GO:0001819;GO:2000845;GO:0045944;GO:0061136;GO:0007289;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:nucleus;, F:androgen receptor binding; F:DNA binding; F:nuclear receptor coactivator activity;, P:acrosome assembly; P:androgen receptor signaling pathway; P:defense response to bacterium; P:flagellated sperm motility; P:Leydig cell differentiation; P:luteinizing hormone secretion; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of cytokine production; P:positive regulation of testosterone secretion; P:positive regulation of transcription by RNA polymerase II; P:regulation of proteasomal protein catabolic process; P:spermatid nucleus differentiation;|P82094 B7ZLJ2 Q17R87 Q59GK0,TATA element modulatory factor,Androgen receptor coactivator 160 kDa protein;Androgen receptor-associated protein of 160 kDa;, PF12329;PF12325;, GO:0005829;GO:0005783;GO:0005794;GO:0000139;GO:0005634;GO:0050681;GO:0003677;GO:0030374;GO:0001675;GO:0030521;GO:0042742;GO:0030317;GO:0033327;GO:0032275;GO:0043066;GO:0010629;GO:0001819;GO:2000845;GO:0045944;GO:0061136;GO:0007289;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:nucleus;, F:androgen receptor binding; F:DNA binding; F:nuclear receptor coactivator activity;, P:acrosome assembly; P:androgen receptor signaling pathway; P:defense response to bacterium; P:flagellated sperm motility; P:Leydig cell differentiation; P:luteinizing hormone secretion; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of cytokine production; P:positive regulation of testosterone secretion; P:positive regulation of transcription by RNA polymerase II; P:regulation of proteasomal protein catabolic process; P:spermatid nucleus differentiation;|P82094 B7ZLJ2 Q17R87 Q59GK0,TATA element modulatory factor,Androgen receptor coactivator 160 kDa protein;Androgen receptor-associated protein of 160 kDa;, PF12329;PF12325;, GO:0005829;GO:0005783;GO:0005794;GO:0000139;GO:0005634;GO:0050681;GO:0003677;GO:0030374;GO:0001675;GO:0030521;GO:0042742;GO:0030317;GO:0033327;GO:0032275;GO:0043066;GO:0010629;GO:0001819;GO:2000845;GO:0045944;GO:0061136;GO:0007289;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:nucleus;, F:androgen receptor binding; F:DNA binding; F:nuclear receptor coactivator activity;, P:acrosome assembly; P:androgen receptor signaling pathway; P:defense response to bacterium; P:flagellated sperm motility; P:Leydig cell differentiation; P:luteinizing hormone secretion; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of cytokine production; P:positive regulation of testosterone secretion; P:positive regulation of transcription by RNA polymerase II; P:regulation of proteasomal protein catabolic process; P:spermatid nucleus differentiation;|P82094 B7ZLJ2 Q17R87 Q59GK0,TATA element modulatory factor,Androgen receptor coactivator 160 kDa protein;Androgen receptor-associated protein of 160 kDa;, PF12329;PF12325;, GO:0005829;GO:0005783;GO:0005794;GO:0000139;GO:0005634;GO:0050681;GO:0003677;GO:0030374;GO:0001675;GO:0030521;GO:0042742;GO:0030317;GO:0033327;GO:0032275;GO:0043066;GO:0010629;GO:0001819;GO:2000845;GO:0045944;GO:0061136;GO:0007289;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:nucleus;, F:androgen receptor binding; F:DNA binding; F:nuclear receptor coactivator activity;, P:acrosome assembly; P:androgen receptor signaling pathway; P:defense response to bacterium; P:flagellated sperm motility; P:Leydig cell differentiation; P:luteinizing hormone secretion; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of cytokine production; P:positive regulation of testosterone secretion; P:positive regulation of transcription by RNA polymerase II; P:regulation of proteasomal protein catabolic process; P:spermatid nucleus differentiation;|P82094 B7ZLJ2 Q17R87 Q59GK0,TATA element modulatory factor,Androgen receptor coactivator 160 kDa protein;Androgen receptor-associated protein of 160 kDa;, PF12329;PF12325;, GO:0005829;GO:0005783;GO:0005794;GO:0000139;GO:0005634;GO:0050681;GO:0003677;GO:0030374;GO:0001675;GO:0030521;GO:0042742;GO:0030317;GO:0033327;GO:0032275;GO:0043066;GO:0010629;GO:0001819;GO:2000845;GO:0045944;GO:0061136;GO:0007289;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:nucleus;, F:androgen receptor binding; F:DNA binding; F:nuclear receptor coactivator activity;, P:acrosome assembly; P:androgen receptor signaling pathway; P:defense response to bacterium; P:flagellated sperm motility; P:Leydig cell differentiation; P:luteinizing hormone secretion; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of cytokine production; P:positive regulation of testosterone secretion; P:positive regulation of transcription by RNA polymerase II; P:regulation of proteasomal protein catabolic process; P:spermatid nucleus differentiation; scaffold23 indexed_genome mRNA 16976284 16996027 . - . ID=transcript_5490;P82094 B7ZLJ2 Q17R87 Q59GK0,TATA element modulatory factor,Androgen receptor coactivator 160 kDa protein;Androgen receptor-associated protein of 160 kDa;, PF12329;PF12325;, GO:0005829;GO:0005783;GO:0005794;GO:0000139;GO:0005634;GO:0050681;GO:0003677;GO:0030374;GO:0001675;GO:0030521;GO:0042742;GO:0030317;GO:0033327;GO:0032275;GO:0043066;GO:0010629;GO:0001819;GO:2000845;GO:0045944;GO:0061136;GO:0007289;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:nucleus;, F:androgen receptor binding; F:DNA binding; F:nuclear receptor coactivator activity;, P:acrosome assembly; P:androgen receptor signaling pathway; P:defense response to bacterium; P:flagellated sperm motility; P:Leydig cell differentiation; P:luteinizing hormone secretion; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of cytokine production; P:positive regulation of testosterone secretion; P:positive regulation of transcription by RNA polymerase II; P:regulation of proteasomal protein catabolic process; P:spermatid nucleus differentiation; scaffold23 indexed_genome mRNA 16998148 17020201 . - . ID=transcript_5491;Q8TBC4 A6NLB5 A8K027 O76088 Q9NTU3,NEDD8-activating enzyme E1 catalytic subunit,NEDD8-activating enzyme E1C;Ubiquitin-activating enzyme E1C;Ubiquitin-like modifier-activating enzyme 3;, PF08825;PF00899;, GO:0005737;GO:0005829;GO:0005634;GO:0032991;GO:0005524;GO:0042802;GO:0019781;GO:0016922;GO:0046982;GO:0044877;GO:0006464;GO:0007113;GO:0045892;GO:0043687;GO:0032446;GO:0045116;GO:0006508;GO:0051726;, C:cytoplasm; C:cytosol; C:nucleus; C:protein-containing complex;, F:ATP binding; F:identical protein binding; F:NEDD8 activating enzyme activity; F:nuclear receptor binding; F:protein heterodimerization activity; F:protein-containing complex binding;, P:cellular protein modification process; P:endomitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:proteolysis; P:regulation of cell cycle;|Q8TBC4 A6NLB5 A8K027 O76088 Q9NTU3,NEDD8-activating enzyme E1 catalytic subunit,NEDD8-activating enzyme E1C;Ubiquitin-activating enzyme E1C;Ubiquitin-like modifier-activating enzyme 3;, PF08825;PF00899;, GO:0005737;GO:0005829;GO:0005634;GO:0032991;GO:0005524;GO:0042802;GO:0019781;GO:0016922;GO:0046982;GO:0044877;GO:0006464;GO:0007113;GO:0045892;GO:0043687;GO:0032446;GO:0045116;GO:0006508;GO:0051726;, C:cytoplasm; C:cytosol; C:nucleus; C:protein-containing complex;, F:ATP binding; F:identical protein binding; F:NEDD8 activating enzyme activity; F:nuclear receptor binding; F:protein heterodimerization activity; F:protein-containing complex binding;, P:cellular protein modification process; P:endomitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:proteolysis; P:regulation of cell cycle;|Q8TBC4 A6NLB5 A8K027 O76088 Q9NTU3,NEDD8-activating enzyme E1 catalytic subunit,NEDD8-activating enzyme E1C;Ubiquitin-activating enzyme E1C;Ubiquitin-like modifier-activating enzyme 3;, PF08825;PF00899;, GO:0005737;GO:0005829;GO:0005634;GO:0032991;GO:0005524;GO:0042802;GO:0019781;GO:0016922;GO:0046982;GO:0044877;GO:0006464;GO:0007113;GO:0045892;GO:0043687;GO:0032446;GO:0045116;GO:0006508;GO:0051726;, C:cytoplasm; C:cytosol; C:nucleus; C:protein-containing complex;, F:ATP binding; F:identical protein binding; F:NEDD8 activating enzyme activity; F:nuclear receptor binding; F:protein heterodimerization activity; F:protein-containing complex binding;, P:cellular protein modification process; P:endomitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:proteolysis; P:regulation of cell cycle;|Q8TBC4 A6NLB5 A8K027 O76088 Q9NTU3,NEDD8-activating enzyme E1 catalytic subunit,NEDD8-activating enzyme E1C;Ubiquitin-activating enzyme E1C;Ubiquitin-like modifier-activating enzyme 3;, PF08825;PF00899;, GO:0005737;GO:0005829;GO:0005634;GO:0032991;GO:0005524;GO:0042802;GO:0019781;GO:0016922;GO:0046982;GO:0044877;GO:0006464;GO:0007113;GO:0045892;GO:0043687;GO:0032446;GO:0045116;GO:0006508;GO:0051726;, C:cytoplasm; C:cytosol; C:nucleus; C:protein-containing complex;, F:ATP binding; F:identical protein binding; F:NEDD8 activating enzyme activity; F:nuclear receptor binding; F:protein heterodimerization activity; F:protein-containing complex binding;, P:cellular protein modification process; P:endomitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein neddylation; P:proteolysis; P:regulation of cell cycle; scaffold23 indexed_genome mRNA 17031149 17070720 . - . ID=transcript_5492;O75915 B2R6V5 Q53ES3 Q5KU08,PRA1 family protein 3,ADP-ribosylation factor-like protein 6-interacting protein 5;Cytoskeleton-related vitamin A-responsive protein;Dermal papilla-derived protein 11;GTRAP3-18;Glutamate transporter EAAC1-interacting protein;JM5;Prenylated Rab acceptor protein 2;Protein JWa;Putative MAPK-activating protein PM27;, PF03208;, GO:0005856;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0071407;GO:0006749;GO:0008631;GO:0098712;GO:0015813;GO:0007611;GO:0002037;GO:0010917;GO:0051051;GO:0036475;GO:0043065;GO:0043280;GO:0032874;GO:0072659;GO:0015031;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:cellular response to organic cyclic compound; P:glutathione metabolic process; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:learning or memory; P:negative regulation of L-glutamate import across plasma membrane; P:negative regulation of mitochondrial membrane potential; P:negative regulation of transport; P:neuron death in response to oxidative stress; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of stress-activated MAPK cascade; P:protein localization to plasma membrane; P:protein transport;|O75915 B2R6V5 Q53ES3 Q5KU08,PRA1 family protein 3,ADP-ribosylation factor-like protein 6-interacting protein 5;Cytoskeleton-related vitamin A-responsive protein;Dermal papilla-derived protein 11;GTRAP3-18;Glutamate transporter EAAC1-interacting protein;JM5;Prenylated Rab acceptor protein 2;Protein JWa;Putative MAPK-activating protein PM27;, PF03208;, GO:0005856;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0071407;GO:0006749;GO:0008631;GO:0098712;GO:0015813;GO:0007611;GO:0002037;GO:0010917;GO:0051051;GO:0036475;GO:0043065;GO:0043280;GO:0032874;GO:0072659;GO:0015031;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:cellular response to organic cyclic compound; P:glutathione metabolic process; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:learning or memory; P:negative regulation of L-glutamate import across plasma membrane; P:negative regulation of mitochondrial membrane potential; P:negative regulation of transport; P:neuron death in response to oxidative stress; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of stress-activated MAPK cascade; P:protein localization to plasma membrane; P:protein transport;|Q0VAK6 B4DT85 Q0JTT2 Q5JPG6 Q8IUK4 Q96LS4,Leiomodin-3,Leiomodin, fetal form;, PF03250;, GO:0005737;GO:0005856;GO:0031430;GO:0030016;GO:0005865;GO:0003785;GO:0005523;GO:0007015;GO:0045010;GO:0006936;GO:0030239;GO:0051694;GO:0048743;GO:0048741;GO:0030240;GO:0006941;, C:cytoplasm; C:cytoskeleton; C:M band; C:myofibril; C:striated muscle thin filament;, F:actin monomer binding; F:tropomyosin binding;, P:actin filament organization; P:actin nucleation; P:muscle contraction; P:myofibril assembly; P:pointed-end actin filament capping; P:positive regulation of skeletal muscle fiber development; P:skeletal muscle fiber development; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q0VAK6 B4DT85 Q0JTT2 Q5JPG6 Q8IUK4 Q96LS4,Leiomodin-3,Leiomodin, fetal form;, PF03250;, GO:0005737;GO:0005856;GO:0031430;GO:0030016;GO:0005865;GO:0003785;GO:0005523;GO:0007015;GO:0045010;GO:0006936;GO:0030239;GO:0051694;GO:0048743;GO:0048741;GO:0030240;GO:0006941;, C:cytoplasm; C:cytoskeleton; C:M band; C:myofibril; C:striated muscle thin filament;, F:actin monomer binding; F:tropomyosin binding;, P:actin filament organization; P:actin nucleation; P:muscle contraction; P:myofibril assembly; P:pointed-end actin filament capping; P:positive regulation of skeletal muscle fiber development; P:skeletal muscle fiber development; P:skeletal muscle thin filament assembly; P:striated muscle contraction; scaffold23 indexed_genome mRNA 17104110 17179320 . - . ID=transcript_5493;Q9Y2L6 Q8TAI3,FERM domain-containing protein 4B,GRP1-binding protein GRSP1;, PF11819;PF09380;PF00373;PF09379;, GO:0005912;GO:0005923;GO:0005737;GO:0005856;GO:0005615;GO:0001726;GO:0090162;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:ruffle;, , P:establishment of epithelial cell polarity;|Q9Y2L6 Q8TAI3,FERM domain-containing protein 4B,GRP1-binding protein GRSP1;, PF11819;PF09380;PF00373;PF09379;, GO:0005912;GO:0005923;GO:0005737;GO:0005856;GO:0005615;GO:0001726;GO:0090162;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:ruffle;, , P:establishment of epithelial cell polarity;|Q9Y2L6 Q8TAI3,FERM domain-containing protein 4B,GRP1-binding protein GRSP1;, PF11819;PF09380;PF00373;PF09379;, GO:0005912;GO:0005923;GO:0005737;GO:0005856;GO:0005615;GO:0001726;GO:0090162;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:ruffle;, , P:establishment of epithelial cell polarity; scaffold23 indexed_genome mRNA 17237618 17296991 . - . ID=transcript_5494;Q9Y2L6 Q8TAI3,FERM domain-containing protein 4B,GRP1-binding protein GRSP1;, PF11819;PF09380;PF00373;PF09379;, GO:0005912;GO:0005923;GO:0005737;GO:0005856;GO:0005615;GO:0001726;GO:0090162;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:ruffle;, , P:establishment of epithelial cell polarity; scaffold23 indexed_genome mRNA 17641448 17773955 . + . ID=transcript_5495;O75030 B4DJL2 D3K197 E9PFN0 Q14841 Q9P2V0 Q9P2V1 Q9P2V2 Q9P2Y8,Microphthalmia-associated transcription factor,Class E basic helix-loop-helix protein 32;, PF11851;PF00010;PF15951;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0001228;GO:0000981;GO:0001227;GO:0070888;GO:0046983;GO:0000978;GO:0046849;GO:0043010;GO:0044336;GO:0045165;GO:0030318;GO:0030336;GO:0000122;GO:0030316;GO:2000144;GO:0010628;GO:0045944;GO:0045893;GO:0065003;GO:0042127;GO:0045670;GO:2001141;GO:0006357;GO:0006355;GO:0006351;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:bone remodeling; P:camera-type eye development; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; P:cell fate commitment; P:melanocyte differentiation; P:negative regulation of cell migration; P:negative regulation of transcription by RNA polymerase II; P:osteoclast differentiation; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:regulation of cell population proliferation; P:regulation of osteoclast differentiation; P:regulation of RNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold23 indexed_genome mRNA 17827913 17861601 . + . ID=transcript_5496;O75030 B4DJL2 D3K197 E9PFN0 Q14841 Q9P2V0 Q9P2V1 Q9P2V2 Q9P2Y8,Microphthalmia-associated transcription factor,Class E basic helix-loop-helix protein 32;, PF11851;PF00010;PF15951;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0001228;GO:0000981;GO:0001227;GO:0070888;GO:0046983;GO:0000978;GO:0046849;GO:0043010;GO:0044336;GO:0045165;GO:0030318;GO:0030336;GO:0000122;GO:0030316;GO:2000144;GO:0010628;GO:0045944;GO:0045893;GO:0065003;GO:0042127;GO:0045670;GO:2001141;GO:0006357;GO:0006355;GO:0006351;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:bone remodeling; P:camera-type eye development; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; P:cell fate commitment; P:melanocyte differentiation; P:negative regulation of cell migration; P:negative regulation of transcription by RNA polymerase II; P:osteoclast differentiation; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:regulation of cell population proliferation; P:regulation of osteoclast differentiation; P:regulation of RNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold23 indexed_genome mRNA 18764203 18854805 . - . ID=transcript_5497;Q9H334 A3QVP8 B3KV70 G5E9V8 Q8NAN6 Q9BSG9 Q9H332 Q9H333 Q9P0R1,Forkhead box protein P1,Mac-1-regulated forkhead {ECO:0000303|PubMed:15286807};, PF00250;PF16159;, GO:0000785;GO:0005654;GO:0005634;GO:0050681;GO:0001046;GO:0000981;GO:0001227;GO:0046872;GO:0043621;GO:0000978;GO:1990837;GO:0006974;GO:0042118;GO:0042116;GO:0042117;GO:0060766;GO:0002903;GO:0010629;GO:0000122;GO:0045892;GO:0036035;GO:0030316;GO:0050861;GO:0010595;GO:0032745;GO:0048661;GO:2000341;GO:1900424;GO:1901509;GO:0010468;GO:0050727;GO:0032651;GO:0032655;GO:1901256;GO:0045655;GO:0006357;GO:0032680;GO:0032496;GO:0035019;GO:0061470;, C:chromatin; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:core promoter sequence-specific DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:endothelial cell activation; P:macrophage activation; P:monocyte activation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of B cell apoptotic process; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoclast development; P:osteoclast differentiation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of interleukin-21 production; P:positive regulation of smooth muscle cell proliferation; P:regulation of chemokine (C-X-C motif) ligand 2 production; P:regulation of defense response to bacterium; P:regulation of endothelial tube morphogenesis; P:regulation of gene expression; P:regulation of inflammatory response; P:regulation of interleukin-1 beta production; P:regulation of interleukin-12 production; P:regulation of macrophage colony-stimulating factor production; P:regulation of monocyte differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of tumor necrosis factor production; P:response to lipopolysaccharide; P:somatic stem cell population maintenance; P:T follicular helper cell differentiation;|Q9H334 A3QVP8 B3KV70 G5E9V8 Q8NAN6 Q9BSG9 Q9H332 Q9H333 Q9P0R1,Forkhead box protein P1,Mac-1-regulated forkhead {ECO:0000303|PubMed:15286807};, PF00250;PF16159;, GO:0000785;GO:0005654;GO:0005634;GO:0050681;GO:0001046;GO:0000981;GO:0001227;GO:0046872;GO:0043621;GO:0000978;GO:1990837;GO:0006974;GO:0042118;GO:0042116;GO:0042117;GO:0060766;GO:0002903;GO:0010629;GO:0000122;GO:0045892;GO:0036035;GO:0030316;GO:0050861;GO:0010595;GO:0032745;GO:0048661;GO:2000341;GO:1900424;GO:1901509;GO:0010468;GO:0050727;GO:0032651;GO:0032655;GO:1901256;GO:0045655;GO:0006357;GO:0032680;GO:0032496;GO:0035019;GO:0061470;, C:chromatin; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:core promoter sequence-specific DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:endothelial cell activation; P:macrophage activation; P:monocyte activation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of B cell apoptotic process; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoclast development; P:osteoclast differentiation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of interleukin-21 production; P:positive regulation of smooth muscle cell proliferation; P:regulation of chemokine (C-X-C motif) ligand 2 production; P:regulation of defense response to bacterium; P:regulation of endothelial tube morphogenesis; P:regulation of gene expression; P:regulation of inflammatory response; P:regulation of interleukin-1 beta production; P:regulation of interleukin-12 production; P:regulation of macrophage colony-stimulating factor production; P:regulation of monocyte differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of tumor necrosis factor production; P:response to lipopolysaccharide; P:somatic stem cell population maintenance; P:T follicular helper cell differentiation;|Q9H334 A3QVP8 B3KV70 G5E9V8 Q8NAN6 Q9BSG9 Q9H332 Q9H333 Q9P0R1,Forkhead box protein P1,Mac-1-regulated forkhead {ECO:0000303|PubMed:15286807};, PF00250;PF16159;, GO:0000785;GO:0005654;GO:0005634;GO:0050681;GO:0001046;GO:0000981;GO:0001227;GO:0046872;GO:0043621;GO:0000978;GO:1990837;GO:0006974;GO:0042118;GO:0042116;GO:0042117;GO:0060766;GO:0002903;GO:0010629;GO:0000122;GO:0045892;GO:0036035;GO:0030316;GO:0050861;GO:0010595;GO:0032745;GO:0048661;GO:2000341;GO:1900424;GO:1901509;GO:0010468;GO:0050727;GO:0032651;GO:0032655;GO:1901256;GO:0045655;GO:0006357;GO:0032680;GO:0032496;GO:0035019;GO:0061470;, C:chromatin; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:core promoter sequence-specific DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:endothelial cell activation; P:macrophage activation; P:monocyte activation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of B cell apoptotic process; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoclast development; P:osteoclast differentiation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of interleukin-21 production; P:positive regulation of smooth muscle cell proliferation; P:regulation of chemokine (C-X-C motif) ligand 2 production; P:regulation of defense response to bacterium; P:regulation of endothelial tube morphogenesis; P:regulation of gene expression; P:regulation of inflammatory response; P:regulation of interleukin-1 beta production; P:regulation of interleukin-12 production; P:regulation of macrophage colony-stimulating factor production; P:regulation of monocyte differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of tumor necrosis factor production; P:response to lipopolysaccharide; P:somatic stem cell population maintenance; P:T follicular helper cell differentiation; scaffold23 indexed_genome mRNA 19476853 19523841 . - . ID=transcript_5498;Q8N5X7 B2R963 Q6NUT1,Eukaryotic translation initiation factor 4E type 3,, PF01652;, GO:0005829;GO:0016281;GO:0005845;GO:0000340;GO:0003743;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:mRNA cap binding complex;, F:RNA 7-methylguanosine cap binding; F:translation initiation factor activity;|Q8N5X7 B2R963 Q6NUT1,Eukaryotic translation initiation factor 4E type 3,, PF01652;, GO:0005829;GO:0016281;GO:0005845;GO:0000340;GO:0003743;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:mRNA cap binding complex;, F:RNA 7-methylguanosine cap binding; F:translation initiation factor activity;|Q8N5X7 B2R963 Q6NUT1,Eukaryotic translation initiation factor 4E type 3,, PF01652;, GO:0005829;GO:0016281;GO:0005845;GO:0000340;GO:0003743;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:mRNA cap binding complex;, F:RNA 7-methylguanosine cap binding; F:translation initiation factor activity; scaffold23 indexed_genome mRNA 20105947 20167454 . - . ID=transcript_5499;Q8N488 Q9P2W5 Q9UMW4,RING1 and YY1-binding protein,Apoptin-associating protein 1;Death effector domain-associated factor;YY1 and E4TF1-associated factor 1;, PF17219;PF00641;, GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003712;GO:0003714;GO:0006915;GO:0035518;GO:0007275;GO:0070317;GO:0032435;GO:0000122;GO:0043065;GO:0045893;GO:0006355;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity;, P:apoptotic process; P:histone H2A monoubiquitination; P:multicellular organism development; P:negative regulation of G0 to G1 transition; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold23 indexed_genome mRNA 20418892 20525410 . - . ID=transcript_5500;Q6PI26 B4DL05 Q6MZJ4 Q7Z748 Q9H7E5 Q9NVS8,Protein SHQ1 homolog,, PF04925;, GO:0005737;GO:0005829;GO:0005654;GO:0051082;GO:0000493;GO:2000233;GO:0043065;GO:1904874;GO:0022618;GO:0007004;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:unfolded protein binding;, P:box H/ACA snoRNP assembly; P:negative regulation of rRNA processing; P:positive regulation of apoptotic process; P:positive regulation of telomerase RNA localization to Cajal body; P:ribonucleoprotein complex assembly; P:telomere maintenance via telomerase; scaffold23 indexed_genome mRNA 20687176 20705050 . + . ID=transcript_5501;Q9NY27 A8K1I6 Q2TAJ9 Q498B8 Q8WXX6,Serine/threonine-protein phosphatase 4 regulatory subunit 2,, PF09184;, GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0030289;GO:0019888;GO:0030674;GO:0006464;GO:0006397;GO:0006470;GO:0010569;GO:0008380;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein phosphatase 4 complex;, F:protein phosphatase regulator activity; F:protein-macromolecule adaptor activity;, P:cellular protein modification process; P:mRNA processing; P:protein dephosphorylation; P:regulation of double-strand break repair via homologous recombination; P:RNA splicing;|Q9NY27 A8K1I6 Q2TAJ9 Q498B8 Q8WXX6,Serine/threonine-protein phosphatase 4 regulatory subunit 2,, PF09184;, GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0030289;GO:0019888;GO:0030674;GO:0006464;GO:0006397;GO:0006470;GO:0010569;GO:0008380;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein phosphatase 4 complex;, F:protein phosphatase regulator activity; F:protein-macromolecule adaptor activity;, P:cellular protein modification process; P:mRNA processing; P:protein dephosphorylation; P:regulation of double-strand break repair via homologous recombination; P:RNA splicing;|Q9NY27 A8K1I6 Q2TAJ9 Q498B8 Q8WXX6,Serine/threonine-protein phosphatase 4 regulatory subunit 2,, PF09184;, GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0030289;GO:0019888;GO:0030674;GO:0006464;GO:0006397;GO:0006470;GO:0010569;GO:0008380;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein phosphatase 4 complex;, F:protein phosphatase regulator activity; F:protein-macromolecule adaptor activity;, P:cellular protein modification process; P:mRNA processing; P:protein dephosphorylation; P:regulation of double-strand break repair via homologous recombination; P:RNA splicing;|Q9NY27 A8K1I6 Q2TAJ9 Q498B8 Q8WXX6,Serine/threonine-protein phosphatase 4 regulatory subunit 2,, PF09184;, GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0030289;GO:0019888;GO:0030674;GO:0006464;GO:0006397;GO:0006470;GO:0010569;GO:0008380;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein phosphatase 4 complex;, F:protein phosphatase regulator activity; F:protein-macromolecule adaptor activity;, P:cellular protein modification process; P:mRNA processing; P:protein dephosphorylation; P:regulation of double-strand break repair via homologous recombination; P:RNA splicing; scaffold23 indexed_genome mRNA 20970849 20976024 . - . ID=transcript_5502;Q9UPQ7 A7MCZ6 Q8N2N7 Q96CC2 Q9NSQ2,E3 ubiquitin-protein ligase PDZRN3,Ligand of Numb protein X 3;PDZ domain-containing RING finger protein 3;RING-type E3 ubiquitin transferase PDZRN3 {ECO:0000305};Semaphorin cytoplasmic domain-associated protein 3;, PF00595;, GO:0005737;GO:0031594;GO:0061630;GO:0004842;GO:0008270;GO:0007528;GO:0016567;, C:cytoplasm; C:neuromuscular junction;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:neuromuscular junction development; P:protein ubiquitination;|Q9UPQ7 A7MCZ6 Q8N2N7 Q96CC2 Q9NSQ2,E3 ubiquitin-protein ligase PDZRN3,Ligand of Numb protein X 3;PDZ domain-containing RING finger protein 3;RING-type E3 ubiquitin transferase PDZRN3 {ECO:0000305};Semaphorin cytoplasmic domain-associated protein 3;, PF00595;, GO:0005737;GO:0031594;GO:0061630;GO:0004842;GO:0008270;GO:0007528;GO:0016567;, C:cytoplasm; C:neuromuscular junction;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:neuromuscular junction development; P:protein ubiquitination; scaffold23 indexed_genome mRNA 21900466 22156703 . - . ID=transcript_5503;Q9P232 B9EK50 Q9H039,Contactin-3,Brain-derived immunoglobulin superfamily protein 1;Plasmacytoma-associated neuronal glycoprotein;, PF00041;PF07679;, GO:0031225;GO:0005576;GO:0043005;GO:0005886;GO:0007155;GO:0007399;, C:anchored component of membrane; C:extracellular region; C:neuron projection; C:plasma membrane;, , P:cell adhesion; P:nervous system development;|Q9P232 B9EK50 Q9H039,Contactin-3,Brain-derived immunoglobulin superfamily protein 1;Plasmacytoma-associated neuronal glycoprotein;, PF00041;PF07679;, GO:0031225;GO:0005576;GO:0043005;GO:0005886;GO:0007155;GO:0007399;, C:anchored component of membrane; C:extracellular region; C:neuron projection; C:plasma membrane;, , P:cell adhesion; P:nervous system development;|Q9P232 B9EK50 Q9H039,Contactin-3,Brain-derived immunoglobulin superfamily protein 1;Plasmacytoma-associated neuronal glycoprotein;, PF00041;PF07679;, GO:0031225;GO:0005576;GO:0043005;GO:0005886;GO:0007155;GO:0007399;, C:anchored component of membrane; C:extracellular region; C:neuron projection; C:plasma membrane;, , P:cell adhesion; P:nervous system development; scaffold23 indexed_genome mRNA 23062957 23240310 . + . ID=transcript_5504;O00533 B7ZL03 Q2M3G2 Q59FY0,Neural cell adhesion molecule L1-like protein,Close homolog of L1;, PF13882;PF00041;PF07679;PF00047;, GO:0070062;GO:0016021;GO:0005886;GO:0007411;GO:0031103;GO:0007155;GO:0007165;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:axon guidance; P:axon regeneration; P:cell adhesion; P:signal transduction;|Q3ZCU0 Q8N9C3,Protein GVQW3 {ECO:0000305},GVQW motif-containing protein 3 {ECO:0000305};, PF17906;|O00533 B7ZL03 Q2M3G2 Q59FY0,Neural cell adhesion molecule L1-like protein,Close homolog of L1;, PF13882;PF00041;PF07679;PF00047;, GO:0070062;GO:0016021;GO:0005886;GO:0007411;GO:0031103;GO:0007155;GO:0007165;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:axon guidance; P:axon regeneration; P:cell adhesion; P:signal transduction;|O00533 B7ZL03 Q2M3G2 Q59FY0,Neural cell adhesion molecule L1-like protein,Close homolog of L1;, PF13882;PF00041;PF07679;PF00047;, GO:0070062;GO:0016021;GO:0005886;GO:0007411;GO:0031103;GO:0007155;GO:0007165;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:axon guidance; P:axon regeneration; P:cell adhesion; P:signal transduction;|O00533 B7ZL03 Q2M3G2 Q59FY0,Neural cell adhesion molecule L1-like protein,Close homolog of L1;, PF13882;PF00041;PF07679;PF00047;, GO:0070062;GO:0016021;GO:0005886;GO:0007411;GO:0031103;GO:0007155;GO:0007165;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:axon guidance; P:axon regeneration; P:cell adhesion; P:signal transduction;|O00533 B7ZL03 Q2M3G2 Q59FY0,Neural cell adhesion molecule L1-like protein,Close homolog of L1;, PF13882;PF00041;PF07679;PF00047;, GO:0070062;GO:0016021;GO:0005886;GO:0007411;GO:0031103;GO:0007155;GO:0007165;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:axon guidance; P:axon regeneration; P:cell adhesion; P:signal transduction;|O00533 B7ZL03 Q2M3G2 Q59FY0,Neural cell adhesion molecule L1-like protein,Close homolog of L1;, PF13882;PF00041;PF07679;PF00047;, GO:0070062;GO:0016021;GO:0005886;GO:0007411;GO:0031103;GO:0007155;GO:0007165;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:axon guidance; P:axon regeneration; P:cell adhesion; P:signal transduction;|O00533 B7ZL03 Q2M3G2 Q59FY0,Neural cell adhesion molecule L1-like protein,Close homolog of L1;, PF13882;PF00041;PF07679;PF00047;, GO:0070062;GO:0016021;GO:0005886;GO:0007411;GO:0031103;GO:0007155;GO:0007165;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:axon guidance; P:axon regeneration; P:cell adhesion; P:signal transduction;|O00533 B7ZL03 Q2M3G2 Q59FY0,Neural cell adhesion molecule L1-like protein,Close homolog of L1;, PF13882;PF00041;PF07679;PF00047;, GO:0070062;GO:0016021;GO:0005886;GO:0007411;GO:0031103;GO:0007155;GO:0007165;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:axon guidance; P:axon regeneration; P:cell adhesion; P:signal transduction;|O00533 B7ZL03 Q2M3G2 Q59FY0,Neural cell adhesion molecule L1-like protein,Close homolog of L1;, PF13882;PF00041;PF07679;PF00047;, GO:0070062;GO:0016021;GO:0005886;GO:0007411;GO:0031103;GO:0007155;GO:0007165;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:axon guidance; P:axon regeneration; P:cell adhesion; P:signal transduction; scaffold23 indexed_genome mRNA 23902455 24102527 . + . ID=transcript_5505;Q9UQ52 Q2KHM2,Contactin-6,Neural recognition molecule NB-3;, PF00041;PF07679;, GO:0099026;GO:0030424;GO:0098688;GO:0005886;GO:0098632;GO:0007411;GO:0007155;GO:0007417;GO:0070593;GO:0007156;GO:0007219;GO:0045747;, C:anchored component of presynaptic membrane; C:axon; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:cell adhesion; P:central nervous system development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; scaffold23 indexed_genome mRNA 24120991 24131300 . + . ID=transcript_5506;Q9UQ52 Q2KHM2,Contactin-6,Neural recognition molecule NB-3;, PF00041;PF07679;, GO:0099026;GO:0030424;GO:0098688;GO:0005886;GO:0098632;GO:0007411;GO:0007155;GO:0007417;GO:0070593;GO:0007156;GO:0007219;GO:0045747;, C:anchored component of presynaptic membrane; C:axon; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:cell adhesion; P:central nervous system development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; scaffold23 indexed_genome mRNA 24159882 24208966 . - . ID=transcript_5507;Q9UQ52 Q2KHM2,Contactin-6,Neural recognition molecule NB-3;, PF00041;PF07679;, GO:0099026;GO:0030424;GO:0098688;GO:0005886;GO:0098632;GO:0007411;GO:0007155;GO:0007417;GO:0070593;GO:0007156;GO:0007219;GO:0045747;, C:anchored component of presynaptic membrane; C:axon; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:cell adhesion; P:central nervous system development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway;|Q9UQ52 Q2KHM2,Contactin-6,Neural recognition molecule NB-3;, PF00041;PF07679;, GO:0099026;GO:0030424;GO:0098688;GO:0005886;GO:0098632;GO:0007411;GO:0007155;GO:0007417;GO:0070593;GO:0007156;GO:0007219;GO:0045747;, C:anchored component of presynaptic membrane; C:axon; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:cell adhesion; P:central nervous system development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway;|Q9UQ52 Q2KHM2,Contactin-6,Neural recognition molecule NB-3;, PF00041;PF07679;, GO:0099026;GO:0030424;GO:0098688;GO:0005886;GO:0098632;GO:0007411;GO:0007155;GO:0007417;GO:0070593;GO:0007156;GO:0007219;GO:0045747;, C:anchored component of presynaptic membrane; C:axon; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:cell adhesion; P:central nervous system development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway;|Q9UQ52 Q2KHM2,Contactin-6,Neural recognition molecule NB-3;, PF00041;PF07679;, GO:0099026;GO:0030424;GO:0098688;GO:0005886;GO:0098632;GO:0007411;GO:0007155;GO:0007417;GO:0070593;GO:0007156;GO:0007219;GO:0045747;, C:anchored component of presynaptic membrane; C:axon; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:cell adhesion; P:central nervous system development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway;|Q9UQ52 Q2KHM2,Contactin-6,Neural recognition molecule NB-3;, PF00041;PF07679;, GO:0099026;GO:0030424;GO:0098688;GO:0005886;GO:0098632;GO:0007411;GO:0007155;GO:0007417;GO:0070593;GO:0007156;GO:0007219;GO:0045747;, C:anchored component of presynaptic membrane; C:axon; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:cell adhesion; P:central nervous system development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway;|Q9UQ52 Q2KHM2,Contactin-6,Neural recognition molecule NB-3;, PF00041;PF07679;, GO:0099026;GO:0030424;GO:0098688;GO:0005886;GO:0098632;GO:0007411;GO:0007155;GO:0007417;GO:0070593;GO:0007156;GO:0007219;GO:0045747;, C:anchored component of presynaptic membrane; C:axon; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:cell adhesion; P:central nervous system development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway;|Q9UQ52 Q2KHM2,Contactin-6,Neural recognition molecule NB-3;, PF00041;PF07679;, GO:0099026;GO:0030424;GO:0098688;GO:0005886;GO:0098632;GO:0007411;GO:0007155;GO:0007417;GO:0070593;GO:0007156;GO:0007219;GO:0045747;, C:anchored component of presynaptic membrane; C:axon; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:cell adhesion; P:central nervous system development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway;|Q9UQ52 Q2KHM2,Contactin-6,Neural recognition molecule NB-3;, PF00041;PF07679;, GO:0099026;GO:0030424;GO:0098688;GO:0005886;GO:0098632;GO:0007411;GO:0007155;GO:0007417;GO:0070593;GO:0007156;GO:0007219;GO:0045747;, C:anchored component of presynaptic membrane; C:axon; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:cell adhesion; P:central nervous system development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; scaffold23 indexed_genome mRNA 25278635 25568552 . + . ID=transcript_5508;Q8IWV2 B2RAX3 Q8IX14 Q8TC35,Contactin-4,Brain-derived immunoglobulin superfamily protein 2;, PF00041;PF07679;, GO:0031225;GO:0030424;GO:0005576;GO:0005886;GO:0098632;GO:0007411;GO:0007413;GO:0007409;GO:0007420;GO:0070593;GO:0007156;GO:0045665;GO:0007399;GO:0007158;GO:0031175;GO:0048167;, C:anchored component of membrane; C:axon; C:extracellular region; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:axonal fasciculation; P:axonogenesis; P:brain development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of neuron differentiation; P:nervous system development; P:neuron cell-cell adhesion; P:neuron projection development; P:regulation of synaptic plasticity; scaffold23 indexed_genome mRNA 25587256 25776057 . + . ID=transcript_5509;Q8IWV2 B2RAX3 Q8IX14 Q8TC35,Contactin-4,Brain-derived immunoglobulin superfamily protein 2;, PF00041;PF07679;, GO:0031225;GO:0030424;GO:0005576;GO:0005886;GO:0098632;GO:0007411;GO:0007413;GO:0007409;GO:0007420;GO:0070593;GO:0007156;GO:0045665;GO:0007399;GO:0007158;GO:0031175;GO:0048167;, C:anchored component of membrane; C:axon; C:extracellular region; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:axonal fasciculation; P:axonogenesis; P:brain development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of neuron differentiation; P:nervous system development; P:neuron cell-cell adhesion; P:neuron projection development; P:regulation of synaptic plasticity;|Q8IWV2 B2RAX3 Q8IX14 Q8TC35,Contactin-4,Brain-derived immunoglobulin superfamily protein 2;, PF00041;PF07679;, GO:0031225;GO:0030424;GO:0005576;GO:0005886;GO:0098632;GO:0007411;GO:0007413;GO:0007409;GO:0007420;GO:0070593;GO:0007156;GO:0045665;GO:0007399;GO:0007158;GO:0031175;GO:0048167;, C:anchored component of membrane; C:axon; C:extracellular region; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:axonal fasciculation; P:axonogenesis; P:brain development; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of neuron differentiation; P:nervous system development; P:neuron cell-cell adhesion; P:neuron projection development; P:regulation of synaptic plasticity; scaffold23 indexed_genome mRNA 25847323 25888863 . + . ID=transcript_5510;Q96SW2 B2R6H4 C9IZA9 C9JAH6 Q6AI62 Q6NVZ0 Q9UHW4,Protein cereblon,, PF02190;PF03226;, GO:0031464;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0046872;GO:0043161;GO:0016567;, C:Cul4A-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:metal ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q96Q11 A8K2Z6 B7WP13 C9JKA2 Q8ND57 Q9BS97 Q9Y362,CCA tRNA nucleotidyltransferase 1, mitochondrial,Mitochondrial tRNA nucleotidyl transferase, CCA-adding;mt CCA-adding enzyme;mt tRNA CCA-diphosphorylase;mt tRNA CCA-pyrophosphorylase;mt tRNA adenylyltransferase;, PF01743;PF12627;, GO:0005759;GO:0005739;GO:0005654;GO:0005524;GO:0052929;GO:0052928;GO:0052927;GO:0000049;GO:1990180;GO:0042780;GO:0001680;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity; F:CTP:3'-cytidine-tRNA cytidylyltransferase activity; F:CTP:tRNA cytidylyltransferase activity; F:tRNA binding;, F:ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity; F:CTP:3'-cytidine-tRNA cytidylyltransferase activity; F:CTP:tRNA cytidylyltransferase activity; P:mitochondrial tRNA 3'-end processing; P:tRNA 3'-end processing; P:tRNA 3'-terminal CCA addition;|Q96SW2 B2R6H4 C9IZA9 C9JAH6 Q6AI62 Q6NVZ0 Q9UHW4,Protein cereblon,, PF02190;PF03226;, GO:0031464;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0046872;GO:0043161;GO:0016567;, C:Cul4A-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:metal ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q96SW2 B2R6H4 C9IZA9 C9JAH6 Q6AI62 Q6NVZ0 Q9UHW4,Protein cereblon,, PF02190;PF03226;, GO:0031464;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0046872;GO:0043161;GO:0016567;, C:Cul4A-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:metal ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q96SW2 B2R6H4 C9IZA9 C9JAH6 Q6AI62 Q6NVZ0 Q9UHW4,Protein cereblon,, PF02190;PF03226;, GO:0031464;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0046872;GO:0043161;GO:0016567;, C:Cul4A-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:metal ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q96SW2 B2R6H4 C9IZA9 C9JAH6 Q6AI62 Q6NVZ0 Q9UHW4,Protein cereblon,, PF02190;PF03226;, GO:0031464;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0046872;GO:0043161;GO:0016567;, C:Cul4A-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:metal ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q96SW2 B2R6H4 C9IZA9 C9JAH6 Q6AI62 Q6NVZ0 Q9UHW4,Protein cereblon,, PF02190;PF03226;, GO:0031464;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0046872;GO:0043161;GO:0016567;, C:Cul4A-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:metal ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; scaffold23 indexed_genome mRNA 26486465 26533269 . + . ID=transcript_5511;Q6UXK5 Q3LID5 Q8IYV5 Q9H8V1 Q9P231,Leucine-rich repeat neuronal protein 1,Neuronal leucine-rich repeat protein 1;, PF07679;PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0051965;, C:extracellular matrix; C:extracellular space; C:integral component of membrane;, , P:positive regulation of synapse assembly; scaffold23 indexed_genome mRNA 26917781 26919034 . - . ID=transcript_5512;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold23 indexed_genome mRNA 26940833 27027566 . - . ID=transcript_5513;Q6UY39 Q96AK5 Q96DK8,Formylglycine-generating enzyme {ECO:0000303|PubMed:12757705},C-alpha-formylglycine-generating enzyme 1 {ECO:0000303|PubMed:12757705};Sulfatase-modifying factor 1 {ECO:0000303|PubMed:12757706};, PF03781;, GO:0005783;GO:0005788;GO:1903135;GO:0120147;GO:0042802;GO:0006687;GO:0043687;GO:0018158;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:cupric ion binding; F:Formylglycine-generating oxidase activity; F:identical protein binding;, P:glycosphingolipid metabolic process; P:post-translational protein modification; P:protein oxidation;|Q6UY39 Q96AK5 Q96DK8,Formylglycine-generating enzyme {ECO:0000303|PubMed:12757705},C-alpha-formylglycine-generating enzyme 1 {ECO:0000303|PubMed:12757705};Sulfatase-modifying factor 1 {ECO:0000303|PubMed:12757706};, PF03781;, GO:0005783;GO:0005788;GO:1903135;GO:0120147;GO:0042802;GO:0006687;GO:0043687;GO:0018158;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:cupric ion binding; F:Formylglycine-generating oxidase activity; F:identical protein binding;, P:glycosphingolipid metabolic process; P:post-translational protein modification; P:protein oxidation;|Q6UY39 Q96AK5 Q96DK8,Formylglycine-generating enzyme {ECO:0000303|PubMed:12757705},C-alpha-formylglycine-generating enzyme 1 {ECO:0000303|PubMed:12757705};Sulfatase-modifying factor 1 {ECO:0000303|PubMed:12757706};, PF03781;, GO:0005783;GO:0005788;GO:1903135;GO:0120147;GO:0042802;GO:0006687;GO:0043687;GO:0018158;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:cupric ion binding; F:Formylglycine-generating oxidase activity; F:identical protein binding;, P:glycosphingolipid metabolic process; P:post-translational protein modification; P:protein oxidation; scaffold23 indexed_genome mRNA 27057006 27412584 . + . ID=transcript_5514;Q14643 E7EPX7 E9PDE9 Q14660 Q99897,Inositol 1,4,5-trisphosphate receptor type 1,IP3 receptor isoform 1;Type 1 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0005955;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005637;GO:0005730;GO:0048471;GO:0005886;GO:0031088;GO:0031094;GO:0031095;GO:0014069;GO:0016529;GO:0098685;GO:0030667;GO:0030658;GO:0019855;GO:0005509;GO:0015085;GO:0015278;GO:0070679;GO:0098695;GO:0005220;GO:0035091;GO:0006816;GO:0032469;GO:0042045;GO:0070059;GO:0050849;GO:0030168;GO:0009791;GO:0010506;GO:1903779;GO:0050796;GO:0051209;GO:0001666;GO:0007165;GO:0050882;, C:calcineurin complex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:nucleolus; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense granule membrane; C:platelet dense tubular network; C:platelet dense tubular network membrane; C:postsynaptic density; C:sarcoplasmic reticulum; C:Schaffer collateral - CA1 synapse; C:secretory granule membrane; C:transport vesicle membrane;, F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium ion transmembrane transporter activity; F:calcium-release channel activity; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:phosphatidylinositol binding;, P:calcium ion transport; P:endoplasmic reticulum calcium ion homeostasis; P:epithelial fluid transport; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of calcium-mediated signaling; P:platelet activation; P:post-embryonic development; P:regulation of autophagy; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to hypoxia; P:signal transduction; P:voluntary musculoskeletal movement;|Q14643 E7EPX7 E9PDE9 Q14660 Q99897,Inositol 1,4,5-trisphosphate receptor type 1,IP3 receptor isoform 1;Type 1 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0005955;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005637;GO:0005730;GO:0048471;GO:0005886;GO:0031088;GO:0031094;GO:0031095;GO:0014069;GO:0016529;GO:0098685;GO:0030667;GO:0030658;GO:0019855;GO:0005509;GO:0015085;GO:0015278;GO:0070679;GO:0098695;GO:0005220;GO:0035091;GO:0006816;GO:0032469;GO:0042045;GO:0070059;GO:0050849;GO:0030168;GO:0009791;GO:0010506;GO:1903779;GO:0050796;GO:0051209;GO:0001666;GO:0007165;GO:0050882;, C:calcineurin complex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:nucleolus; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense granule membrane; C:platelet dense tubular network; C:platelet dense tubular network membrane; C:postsynaptic density; C:sarcoplasmic reticulum; C:Schaffer collateral - CA1 synapse; C:secretory granule membrane; C:transport vesicle membrane;, F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium ion transmembrane transporter activity; F:calcium-release channel activity; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:phosphatidylinositol binding;, P:calcium ion transport; P:endoplasmic reticulum calcium ion homeostasis; P:epithelial fluid transport; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of calcium-mediated signaling; P:platelet activation; P:post-embryonic development; P:regulation of autophagy; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to hypoxia; P:signal transduction; P:voluntary musculoskeletal movement;|Q14643 E7EPX7 E9PDE9 Q14660 Q99897,Inositol 1,4,5-trisphosphate receptor type 1,IP3 receptor isoform 1;Type 1 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0005955;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005637;GO:0005730;GO:0048471;GO:0005886;GO:0031088;GO:0031094;GO:0031095;GO:0014069;GO:0016529;GO:0098685;GO:0030667;GO:0030658;GO:0019855;GO:0005509;GO:0015085;GO:0015278;GO:0070679;GO:0098695;GO:0005220;GO:0035091;GO:0006816;GO:0032469;GO:0042045;GO:0070059;GO:0050849;GO:0030168;GO:0009791;GO:0010506;GO:1903779;GO:0050796;GO:0051209;GO:0001666;GO:0007165;GO:0050882;, C:calcineurin complex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:nucleolus; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense granule membrane; C:platelet dense tubular network; C:platelet dense tubular network membrane; C:postsynaptic density; C:sarcoplasmic reticulum; C:Schaffer collateral - CA1 synapse; C:secretory granule membrane; C:transport vesicle membrane;, F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium ion transmembrane transporter activity; F:calcium-release channel activity; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:phosphatidylinositol binding;, P:calcium ion transport; P:endoplasmic reticulum calcium ion homeostasis; P:epithelial fluid transport; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of calcium-mediated signaling; P:platelet activation; P:post-embryonic development; P:regulation of autophagy; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to hypoxia; P:signal transduction; P:voluntary musculoskeletal movement;|Q14643 E7EPX7 E9PDE9 Q14660 Q99897,Inositol 1,4,5-trisphosphate receptor type 1,IP3 receptor isoform 1;Type 1 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0005955;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005637;GO:0005730;GO:0048471;GO:0005886;GO:0031088;GO:0031094;GO:0031095;GO:0014069;GO:0016529;GO:0098685;GO:0030667;GO:0030658;GO:0019855;GO:0005509;GO:0015085;GO:0015278;GO:0070679;GO:0098695;GO:0005220;GO:0035091;GO:0006816;GO:0032469;GO:0042045;GO:0070059;GO:0050849;GO:0030168;GO:0009791;GO:0010506;GO:1903779;GO:0050796;GO:0051209;GO:0001666;GO:0007165;GO:0050882;, C:calcineurin complex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:nucleolus; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense granule membrane; C:platelet dense tubular network; C:platelet dense tubular network membrane; C:postsynaptic density; C:sarcoplasmic reticulum; C:Schaffer collateral - CA1 synapse; C:secretory granule membrane; C:transport vesicle membrane;, F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium ion transmembrane transporter activity; F:calcium-release channel activity; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:phosphatidylinositol binding;, P:calcium ion transport; P:endoplasmic reticulum calcium ion homeostasis; P:epithelial fluid transport; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of calcium-mediated signaling; P:platelet activation; P:post-embryonic development; P:regulation of autophagy; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to hypoxia; P:signal transduction; P:voluntary musculoskeletal movement;|Q14643 E7EPX7 E9PDE9 Q14660 Q99897,Inositol 1,4,5-trisphosphate receptor type 1,IP3 receptor isoform 1;Type 1 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0005955;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005637;GO:0005730;GO:0048471;GO:0005886;GO:0031088;GO:0031094;GO:0031095;GO:0014069;GO:0016529;GO:0098685;GO:0030667;GO:0030658;GO:0019855;GO:0005509;GO:0015085;GO:0015278;GO:0070679;GO:0098695;GO:0005220;GO:0035091;GO:0006816;GO:0032469;GO:0042045;GO:0070059;GO:0050849;GO:0030168;GO:0009791;GO:0010506;GO:1903779;GO:0050796;GO:0051209;GO:0001666;GO:0007165;GO:0050882;, C:calcineurin complex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:nucleolus; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense granule membrane; C:platelet dense tubular network; C:platelet dense tubular network membrane; C:postsynaptic density; C:sarcoplasmic reticulum; C:Schaffer collateral - CA1 synapse; C:secretory granule membrane; C:transport vesicle membrane;, F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium ion transmembrane transporter activity; F:calcium-release channel activity; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:phosphatidylinositol binding;, P:calcium ion transport; P:endoplasmic reticulum calcium ion homeostasis; P:epithelial fluid transport; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of calcium-mediated signaling; P:platelet activation; P:post-embryonic development; P:regulation of autophagy; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to hypoxia; P:signal transduction; P:voluntary musculoskeletal movement;|Q14643 E7EPX7 E9PDE9 Q14660 Q99897,Inositol 1,4,5-trisphosphate receptor type 1,IP3 receptor isoform 1;Type 1 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0005955;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005637;GO:0005730;GO:0048471;GO:0005886;GO:0031088;GO:0031094;GO:0031095;GO:0014069;GO:0016529;GO:0098685;GO:0030667;GO:0030658;GO:0019855;GO:0005509;GO:0015085;GO:0015278;GO:0070679;GO:0098695;GO:0005220;GO:0035091;GO:0006816;GO:0032469;GO:0042045;GO:0070059;GO:0050849;GO:0030168;GO:0009791;GO:0010506;GO:1903779;GO:0050796;GO:0051209;GO:0001666;GO:0007165;GO:0050882;, C:calcineurin complex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:nucleolus; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense granule membrane; C:platelet dense tubular network; C:platelet dense tubular network membrane; C:postsynaptic density; C:sarcoplasmic reticulum; C:Schaffer collateral - CA1 synapse; C:secretory granule membrane; C:transport vesicle membrane;, F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium ion transmembrane transporter activity; F:calcium-release channel activity; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:phosphatidylinositol binding;, P:calcium ion transport; P:endoplasmic reticulum calcium ion homeostasis; P:epithelial fluid transport; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of calcium-mediated signaling; P:platelet activation; P:post-embryonic development; P:regulation of autophagy; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to hypoxia; P:signal transduction; P:voluntary musculoskeletal movement;|Q14643 E7EPX7 E9PDE9 Q14660 Q99897,Inositol 1,4,5-trisphosphate receptor type 1,IP3 receptor isoform 1;Type 1 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0005955;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005637;GO:0005730;GO:0048471;GO:0005886;GO:0031088;GO:0031094;GO:0031095;GO:0014069;GO:0016529;GO:0098685;GO:0030667;GO:0030658;GO:0019855;GO:0005509;GO:0015085;GO:0015278;GO:0070679;GO:0098695;GO:0005220;GO:0035091;GO:0006816;GO:0032469;GO:0042045;GO:0070059;GO:0050849;GO:0030168;GO:0009791;GO:0010506;GO:1903779;GO:0050796;GO:0051209;GO:0001666;GO:0007165;GO:0050882;, C:calcineurin complex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:nucleolus; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense granule membrane; C:platelet dense tubular network; C:platelet dense tubular network membrane; C:postsynaptic density; C:sarcoplasmic reticulum; C:Schaffer collateral - CA1 synapse; C:secretory granule membrane; C:transport vesicle membrane;, F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium ion transmembrane transporter activity; F:calcium-release channel activity; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:phosphatidylinositol binding;, P:calcium ion transport; P:endoplasmic reticulum calcium ion homeostasis; P:epithelial fluid transport; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of calcium-mediated signaling; P:platelet activation; P:post-embryonic development; P:regulation of autophagy; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to hypoxia; P:signal transduction; P:voluntary musculoskeletal movement; scaffold23 indexed_genome mRNA 27539444 27545020 . + . ID=transcript_5515;O14503 Q96TD3,Class E basic helix-loop-helix protein 40,Class B basic helix-loop-helix protein 2;Differentially expressed in chondrocytes protein 1 {ECO:0000303|PubMed:28797635, ECO:0000303|PubMed:30012868};Enhancer-of-split and hairy-related protein 2;Stimulated by retinoic acid gene 13 protein;, PF07527;PF00010;, GO:0000785;GO:0005737;GO:0016604;GO:0005634;GO:0043425;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0043426;GO:0019904;GO:0046982;GO:0042803;GO:0001102;GO:0000978;GO:1990837;GO:0009952;GO:0032922;GO:0007623;GO:0043153;GO:0043433;GO:0000122;GO:0045892;GO:0042752;GO:0050767;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:nuclear body; C:nucleus;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:MRF binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:circadian regulation of gene expression; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|O14503 Q96TD3,Class E basic helix-loop-helix protein 40,Class B basic helix-loop-helix protein 2;Differentially expressed in chondrocytes protein 1 {ECO:0000303|PubMed:28797635, ECO:0000303|PubMed:30012868};Enhancer-of-split and hairy-related protein 2;Stimulated by retinoic acid gene 13 protein;, PF07527;PF00010;, GO:0000785;GO:0005737;GO:0016604;GO:0005634;GO:0043425;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0043426;GO:0019904;GO:0046982;GO:0042803;GO:0001102;GO:0000978;GO:1990837;GO:0009952;GO:0032922;GO:0007623;GO:0043153;GO:0043433;GO:0000122;GO:0045892;GO:0042752;GO:0050767;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:nuclear body; C:nucleus;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:MRF binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:circadian regulation of gene expression; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold23 indexed_genome mRNA 27662377 27689173 . + . ID=transcript_5516;Q92611 A8K9C8 B4DXP3,ER degradation-enhancing alpha-mannosidase-like protein 1,, PF01532;, GO:0016235;GO:0005783;GO:0044322;GO:0030176;GO:0005509;GO:0004571;GO:0051787;GO:0005975;GO:0036498;GO:1904382;GO:1904154;GO:0045047;GO:0036510;GO:0030433;GO:0097466;, C:aggresome; C:endoplasmic reticulum; C:endoplasmic reticulum quality control compartment; C:integral component of endoplasmic reticulum membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; F:misfolded protein binding;, P:carbohydrate metabolic process; P:IRE1-mediated unfolded protein response; P:mannose trimming involved in glycoprotein ERAD pathway; P:positive regulation of retrograde protein transport, ER to cytosol; P:protein targeting to ER; P:trimming of terminal mannose on C branch; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent glycoprotein ERAD pathway; scaffold23 indexed_genome mRNA 30761581 30817687 . + . ID=transcript_5517;Q9NZU5 B4DG80,LIM and cysteine-rich domains protein 1,Dyxin;, PF00412;PF06297;, GO:0005737;GO:0005654;GO:0005634;GO:0003714;GO:0008270;GO:0044267;GO:0000122;GO:0070886;GO:0010611;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:transcription corepressor activity; F:zinc ion binding;, P:cellular protein metabolic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of calcineurin-NFAT signaling cascade; P:regulation of cardiac muscle hypertrophy;|Q9NZU5 B4DG80,LIM and cysteine-rich domains protein 1,Dyxin;, PF00412;PF06297;, GO:0005737;GO:0005654;GO:0005634;GO:0003714;GO:0008270;GO:0044267;GO:0000122;GO:0070886;GO:0010611;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:transcription corepressor activity; F:zinc ion binding;, P:cellular protein metabolic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of calcineurin-NFAT signaling cascade; P:regulation of cardiac muscle hypertrophy;|Q9NZU5 B4DG80,LIM and cysteine-rich domains protein 1,Dyxin;, PF00412;PF06297;, GO:0005737;GO:0005654;GO:0005634;GO:0003714;GO:0008270;GO:0044267;GO:0000122;GO:0070886;GO:0010611;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:transcription corepressor activity; F:zinc ion binding;, P:cellular protein metabolic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of calcineurin-NFAT signaling cascade; P:regulation of cardiac muscle hypertrophy;|Q9NZU5 B4DG80,LIM and cysteine-rich domains protein 1,Dyxin;, PF00412;PF06297;, GO:0005737;GO:0005654;GO:0005634;GO:0003714;GO:0008270;GO:0044267;GO:0000122;GO:0070886;GO:0010611;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:transcription corepressor activity; F:zinc ion binding;, P:cellular protein metabolic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of calcineurin-NFAT signaling cascade; P:regulation of cardiac muscle hypertrophy;|Q9NZU5 B4DG80,LIM and cysteine-rich domains protein 1,Dyxin;, PF00412;PF06297;, GO:0005737;GO:0005654;GO:0005634;GO:0003714;GO:0008270;GO:0044267;GO:0000122;GO:0070886;GO:0010611;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:transcription corepressor activity; F:zinc ion binding;, P:cellular protein metabolic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of calcineurin-NFAT signaling cascade; P:regulation of cardiac muscle hypertrophy; scaffold23 indexed_genome mRNA 30930057 30942743 . + . ID=transcript_5518;P56539 A8K777 Q3T1A4,Caveolin-3,M-caveolin;, PF01146;, GO:0005901;GO:0009986;GO:0016010;GO:0005783;GO:0000139;GO:0005887;GO:0014704;GO:0043231;GO:0045121;GO:0031594;GO:0005886;GO:0042383;GO:0030315;GO:0031982;GO:0030018;GO:0043014;GO:0005246;GO:0071253;GO:0044325;GO:0060090;GO:0050998;GO:0019870;GO:0008022;GO:0044877;GO:0017080;GO:0007015;GO:0055013;GO:0070836;GO:0030154;GO:0071417;GO:0042632;GO:0031122;GO:0035995;GO:0006897;GO:0042593;GO:0060347;GO:0031579;GO:0046716;GO:0006936;GO:0007517;GO:0007520;GO:0051926;GO:0010614;GO:0061052;GO:0045792;GO:0043407;GO:0043409;GO:1900826;GO:0051001;GO:1901380;GO:1901017;GO:0006469;GO:2000009;GO:0060299;GO:0051647;GO:0007009;GO:0001778;GO:2001288;GO:0008284;GO:0007204;GO:0031116;GO:0010831;GO:2000060;GO:0008104;GO:0072659;GO:0060762;GO:0090279;GO:1901019;GO:0098909;GO:0055117;GO:0051480;GO:0008016;GO:0002027;GO:1900825;GO:0042391;GO:0051394;GO:1900744;GO:0051896;GO:0038009;GO:0014819;GO:2000649;GO:0017015;GO:0060373;GO:0060307;GO:0033292;GO:0006641;GO:0086005;, C:caveola; C:cell surface; C:dystrophin-associated glycoprotein complex; C:endoplasmic reticulum; C:Golgi membrane; C:integral component of plasma membrane; C:intercalated disc; C:intracellular membrane-bounded organelle; C:membrane raft; C:neuromuscular junction; C:plasma membrane; C:sarcolemma; C:T-tubule; C:vesicle; C:Z disc;, F:alpha-tubulin binding; F:calcium channel regulator activity; F:connexin binding; F:ion channel binding; F:molecular adaptor activity; F:nitric-oxide synthase binding; F:potassium channel inhibitor activity; F:protein C-terminus binding; F:protein-containing complex binding; F:sodium channel regulator activity;, P:actin filament organization; P:cardiac muscle cell development; P:caveola assembly; P:cell differentiation; P:cellular response to organonitrogen compound; P:cholesterol homeostasis; P:cytoplasmic microtubule organization; P:detection of muscle stretch; P:endocytosis; P:glucose homeostasis; P:heart trabecula formation; P:membrane raft organization; P:muscle cell cellular homeostasis; P:muscle contraction; P:muscle organ development; P:myoblast fusion; P:negative regulation of calcium ion transport; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of cell size; P:negative regulation of MAP kinase activity; P:negative regulation of MAPK cascade; P:negative regulation of membrane depolarization during cardiac muscle cell action potential; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein kinase activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sarcomere organization; P:nucleus localization; P:plasma membrane organization; P:plasma membrane repair; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of microtubule polymerization; P:positive regulation of myotube differentiation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein localization; P:protein localization to plasma membrane; P:regulation of branching involved in mammary gland duct morphogenesis; P:regulation of calcium ion import; P:regulation of calcium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle contraction; P:regulation of cytosolic calcium ion concentration; P:regulation of heart contraction; P:regulation of heart rate; P:regulation of membrane depolarization during cardiac muscle cell action potential; P:regulation of membrane potential; P:regulation of nerve growth factor receptor activity; P:regulation of p38MAPK cascade; P:regulation of protein kinase B signaling; P:regulation of signal transduction by receptor internalization; P:regulation of skeletal muscle contraction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:T-tubule organization; P:triglyceride metabolic process; P:ventricular cardiac muscle cell action potential; scaffold23 indexed_genome mRNA 31026810 31119562 . - . ID=transcript_5519;Q9NS91 Q58F55 Q9NRT6,E3 ubiquitin-protein ligase RAD18,Postreplication repair protein RAD18;RING finger protein 73;RING-type E3 ubiquitin transferase RAD18 {ECO:0000305};, PF02037;, GO:0005813;GO:0005737;GO:0016604;GO:0042405;GO:0005654;GO:0005634;GO:0097505;GO:0005657;GO:0035861;GO:0003684;GO:0042802;GO:0046872;GO:0031593;GO:0044877;GO:0003697;GO:0061630;GO:0031625;GO:0000403;GO:0006974;GO:0042769;GO:0006281;GO:0060548;GO:0051984;GO:0006301;GO:0051865;GO:0006513;GO:0016567;GO:0009411;, C:centrosome; C:cytoplasm; C:nuclear body; C:nuclear inclusion body; C:nucleoplasm; C:nucleus; C:Rad6-Rad18 complex; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:identical protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein-containing complex binding; F:single-stranded DNA binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:Y-form DNA binding;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:negative regulation of cell death; P:positive regulation of chromosome segregation; P:postreplication repair; P:protein autoubiquitination; P:protein monoubiquitination; P:protein ubiquitination; P:response to UV; scaffold23 indexed_genome mRNA 31170534 31378805 . - . ID=transcript_5520;O43295 Q8IX13 Q8IZV8,SLIT-ROBO Rho GTPase-activating protein 3,Mental disorder-associated GAP;Rho GTPase-activating protein 14;WAVE-associated Rac GTPase-activating protein;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0005096;GO:0030336;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol;, F:GTPase activator activity;, P:negative regulation of cell migration; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|O43295 Q8IX13 Q8IZV8,SLIT-ROBO Rho GTPase-activating protein 3,Mental disorder-associated GAP;Rho GTPase-activating protein 14;WAVE-associated Rac GTPase-activating protein;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0005096;GO:0030336;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol;, F:GTPase activator activity;, P:negative regulation of cell migration; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|O43295 Q8IX13 Q8IZV8,SLIT-ROBO Rho GTPase-activating protein 3,Mental disorder-associated GAP;Rho GTPase-activating protein 14;WAVE-associated Rac GTPase-activating protein;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0005096;GO:0030336;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol;, F:GTPase activator activity;, P:negative regulation of cell migration; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold24 indexed_genome mRNA 95316 95917 . - . ID=transcript_5521;Q01740 A8K248 B7Z3P4 Q5QPT2 Q9UJC2,Dimethylaniline monooxygenase [N-oxide-forming] 1,Dimethylaniline oxidase 1;Fetal hepatic flavin-containing monooxygenase 1;, PF00743;, GO:0005788;GO:0005789;GO:0016021;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0017144;GO:0070995;GO:0006082;GO:0032496;GO:0006970;GO:0009404;GO:0006805;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding;, P:drug metabolic process; P:NADPH oxidation; P:organic acid metabolic process; P:response to lipopolysaccharide; P:response to osmotic stress; P:toxin metabolic process; P:xenobiotic metabolic process; scaffold24 indexed_genome mRNA 123331 159812 . - . ID=transcript_5522;Q99518 Q5EBX4 Q86U73 Q9BRX1,Dimethylaniline monooxygenase [N-oxide-forming] 2,Dimethylaniline oxidase 2;FMO 1B1;Pulmonary flavin-containing monooxygenase 2;, PF00743;, GO:0005789;GO:0016021;GO:0016020;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0017144;GO:0006739;GO:0070995;GO:0006082;GO:0072592;GO:0009404;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding;, P:drug metabolic process; P:NADP metabolic process; P:NADPH oxidation; P:organic acid metabolic process; P:oxygen metabolic process; P:toxin metabolic process; P:xenobiotic metabolic process; scaffold24 indexed_genome mRNA 262863 289989 . - . ID=transcript_5523;P31513 B2R816 Q14854 Q8N5N5,Dimethylaniline monooxygenase [N-oxide-forming] 3,Dimethylaniline oxidase 3;FMO II;FMO form 2;Hepatic flavin-containing monooxygenase 3;Trimethylamine monooxygenase;, PF00743;, GO:0005789;GO:0016021;GO:0043231;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0034899;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:trimethylamine monooxygenase activity;, P:xenobiotic metabolic process;|P31513 B2R816 Q14854 Q8N5N5,Dimethylaniline monooxygenase [N-oxide-forming] 3,Dimethylaniline oxidase 3;FMO II;FMO form 2;Hepatic flavin-containing monooxygenase 3;Trimethylamine monooxygenase;, PF00743;, GO:0005789;GO:0016021;GO:0043231;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0034899;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:trimethylamine monooxygenase activity;, P:xenobiotic metabolic process;|P31513 B2R816 Q14854 Q8N5N5,Dimethylaniline monooxygenase [N-oxide-forming] 3,Dimethylaniline oxidase 3;FMO II;FMO form 2;Hepatic flavin-containing monooxygenase 3;Trimethylamine monooxygenase;, PF00743;, GO:0005789;GO:0016021;GO:0043231;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0034899;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:trimethylamine monooxygenase activity;, P:xenobiotic metabolic process;|P31513 B2R816 Q14854 Q8N5N5,Dimethylaniline monooxygenase [N-oxide-forming] 3,Dimethylaniline oxidase 3;FMO II;FMO form 2;Hepatic flavin-containing monooxygenase 3;Trimethylamine monooxygenase;, PF00743;, GO:0005789;GO:0016021;GO:0043231;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0034899;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:trimethylamine monooxygenase activity;, P:xenobiotic metabolic process; scaffold24 indexed_genome mRNA 625741 702153 . - . ID=transcript_5524;P54821 B5BUM7 O60807,Paired mesoderm homeobox protein 1,Homeobox protein PHOX1;Paired-related homeobox protein 1;, PF00046;PF03826;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0001227;GO:0071837;GO:0001102;GO:0000978;GO:0048844;GO:0051216;GO:0048701;GO:0030326;GO:0042472;GO:0042474;GO:0048664;GO:0097150;GO:0100026;GO:0002053;GO:0045880;GO:0070570;GO:0006357;GO:0060021;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:HMG box domain binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:artery morphogenesis; P:cartilage development; P:embryonic cranial skeleton morphogenesis; P:embryonic limb morphogenesis; P:inner ear morphogenesis; P:middle ear morphogenesis; P:neuron fate determination; P:neuronal stem cell population maintenance; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of smoothened signaling pathway; P:regulation of neuron projection regeneration; P:regulation of transcription by RNA polymerase II; P:roof of mouth development;|P54821 B5BUM7 O60807,Paired mesoderm homeobox protein 1,Homeobox protein PHOX1;Paired-related homeobox protein 1;, PF00046;PF03826;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0001227;GO:0071837;GO:0001102;GO:0000978;GO:0048844;GO:0051216;GO:0048701;GO:0030326;GO:0042472;GO:0042474;GO:0048664;GO:0097150;GO:0100026;GO:0002053;GO:0045880;GO:0070570;GO:0006357;GO:0060021;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:HMG box domain binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:artery morphogenesis; P:cartilage development; P:embryonic cranial skeleton morphogenesis; P:embryonic limb morphogenesis; P:inner ear morphogenesis; P:middle ear morphogenesis; P:neuron fate determination; P:neuronal stem cell population maintenance; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of smoothened signaling pathway; P:regulation of neuron projection regeneration; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; scaffold24 indexed_genome mRNA 791288 816702 . - . ID=transcript_5525;Q5T7V8 Q49A22 Q6P1P9 Q9HAE6 Q9Y350,RAB6-interacting golgin,N-terminal kinase-like-binding protein 1;SCY1-like 1-binding protein 1;, PF04949;, GO:0005737;GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0031069;GO:1905515;GO:1901622;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm;, , P:hair follicle morphogenesis; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning;|Q5T7V8 Q49A22 Q6P1P9 Q9HAE6 Q9Y350,RAB6-interacting golgin,N-terminal kinase-like-binding protein 1;SCY1-like 1-binding protein 1;, PF04949;, GO:0005737;GO:0005829;GO:0005794;GO:0005730;GO:0005654;GO:0031069;GO:1905515;GO:1901622;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleoplasm;, , P:hair follicle morphogenesis; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; scaffold24 indexed_genome mRNA 1114268 1121598 . - . ID=transcript_5526;Q5VVY1 B2RXI0,Alpha N-terminal protein methyltransferase 1B,Methyltransferase-like protein 11B;X-Pro-Lys N-terminal protein methyltransferase 1B;, PF05891;, GO:0005737;GO:0005634;GO:0008168;GO:0071885;GO:0006480;, C:cytoplasm; C:nucleus;, F:methyltransferase activity; F:N-terminal protein N-methyltransferase activity;, P:N-terminal protein amino acid methylation; scaffold24 indexed_genome mRNA 1189570 1332047 . + . ID=transcript_5527;Q92845 B1AKU4 B1AKU5 B2RDL1 B7Z8A3 F5H591 Q8NHU7 Q9H416,Kinesin-associated protein 3,Smg GDS-associated protein;, , GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0035869;GO:0005929;GO:0000794;GO:0005829;GO:0005783;GO:0005794;GO:0016939;GO:0015630;GO:1990075;GO:0032391;GO:0120170;GO:0019894;GO:0019903;GO:0019886;GO:0044782;GO:0035735;GO:0007018;GO:0007017;GO:0043066;GO:0008285;GO:0072383;GO:0046587;GO:0065003;GO:0006890;GO:0007165;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:ciliary transition zone; C:cilium; C:condensed nuclear chromosome; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:kinesin II complex; C:microtubule cytoskeleton; C:periciliary membrane compartment; C:photoreceptor connecting cilium;, F:intraciliary transport particle B binding; F:kinesin binding; F:protein phosphatase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium organization; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:microtubule-based process; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:plus-end-directed vesicle transport along microtubule; P:positive regulation of calcium-dependent cell-cell adhesion; P:protein-containing complex assembly; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:signal transduction;|Q92845 B1AKU4 B1AKU5 B2RDL1 B7Z8A3 F5H591 Q8NHU7 Q9H416,Kinesin-associated protein 3,Smg GDS-associated protein;, , GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0035869;GO:0005929;GO:0000794;GO:0005829;GO:0005783;GO:0005794;GO:0016939;GO:0015630;GO:1990075;GO:0032391;GO:0120170;GO:0019894;GO:0019903;GO:0019886;GO:0044782;GO:0035735;GO:0007018;GO:0007017;GO:0043066;GO:0008285;GO:0072383;GO:0046587;GO:0065003;GO:0006890;GO:0007165;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:ciliary transition zone; C:cilium; C:condensed nuclear chromosome; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:kinesin II complex; C:microtubule cytoskeleton; C:periciliary membrane compartment; C:photoreceptor connecting cilium;, F:intraciliary transport particle B binding; F:kinesin binding; F:protein phosphatase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium organization; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:microtubule-based process; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:plus-end-directed vesicle transport along microtubule; P:positive regulation of calcium-dependent cell-cell adhesion; P:protein-containing complex assembly; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:signal transduction;|Q92845 B1AKU4 B1AKU5 B2RDL1 B7Z8A3 F5H591 Q8NHU7 Q9H416,Kinesin-associated protein 3,Smg GDS-associated protein;, , GO:0005930;GO:0005813;GO:0036064;GO:0097542;GO:0035869;GO:0005929;GO:0000794;GO:0005829;GO:0005783;GO:0005794;GO:0016939;GO:0015630;GO:1990075;GO:0032391;GO:0120170;GO:0019894;GO:0019903;GO:0019886;GO:0044782;GO:0035735;GO:0007018;GO:0007017;GO:0043066;GO:0008285;GO:0072383;GO:0046587;GO:0065003;GO:0006890;GO:0007165;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary tip; C:ciliary transition zone; C:cilium; C:condensed nuclear chromosome; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:kinesin II complex; C:microtubule cytoskeleton; C:periciliary membrane compartment; C:photoreceptor connecting cilium;, F:intraciliary transport particle B binding; F:kinesin binding; F:protein phosphatase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium organization; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:microtubule-based process; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:plus-end-directed vesicle transport along microtubule; P:positive regulation of calcium-dependent cell-cell adhesion; P:protein-containing complex assembly; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:signal transduction; scaffold24 indexed_genome mRNA 1343753 1345953 . + . ID=transcript_5528;Q9HCI6 A8K4M3 Q8IW25,E3 SUMO-protein ligase KIAA1586 {ECO:0000305},E3 SUMO-protein transferase KIAA1586 {ECO:0000305};, , GO:0061665;GO:0016925;, , F:SUMO ligase activity;, P:protein sumoylation; scaffold24 indexed_genome mRNA 1349946 1389694 . + . ID=transcript_5529;Q8IZE3 A8K8Z2 Q5THA6 Q5THA8 Q8IZN9 Q96C56 Q9UBK6,Protein-associating with the carboxyl-terminal domain of ezrin,Ezrin-binding protein PACE-1;SCY1-like protein 3;, , GO:0005737;GO:0005794;GO:0000139;GO:0030027;GO:0005524;GO:0042802;GO:0016477;GO:0034613;GO:0006954;GO:0048666;GO:0006468;GO:0021522;, C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:lamellipodium;, F:ATP binding; F:identical protein binding;, P:cell migration; P:cellular protein localization; P:inflammatory response; P:neuron development; P:protein phosphorylation; P:spinal cord motor neuron differentiation;|Q8IZE3 A8K8Z2 Q5THA6 Q5THA8 Q8IZN9 Q96C56 Q9UBK6,Protein-associating with the carboxyl-terminal domain of ezrin,Ezrin-binding protein PACE-1;SCY1-like protein 3;, , GO:0005737;GO:0005794;GO:0000139;GO:0030027;GO:0005524;GO:0042802;GO:0016477;GO:0034613;GO:0006954;GO:0048666;GO:0006468;GO:0021522;, C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:lamellipodium;, F:ATP binding; F:identical protein binding;, P:cell migration; P:cellular protein localization; P:inflammatory response; P:neuron development; P:protein phosphorylation; P:spinal cord motor neuron differentiation;|Q8IZE3 A8K8Z2 Q5THA6 Q5THA8 Q8IZN9 Q96C56 Q9UBK6,Protein-associating with the carboxyl-terminal domain of ezrin,Ezrin-binding protein PACE-1;SCY1-like protein 3;, , GO:0005737;GO:0005794;GO:0000139;GO:0030027;GO:0005524;GO:0042802;GO:0016477;GO:0034613;GO:0006954;GO:0048666;GO:0006468;GO:0021522;, C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:lamellipodium;, F:ATP binding; F:identical protein binding;, P:cell migration; P:cellular protein localization; P:inflammatory response; P:neuron development; P:protein phosphorylation; P:spinal cord motor neuron differentiation;|Q8IZE3 A8K8Z2 Q5THA6 Q5THA8 Q8IZN9 Q96C56 Q9UBK6,Protein-associating with the carboxyl-terminal domain of ezrin,Ezrin-binding protein PACE-1;SCY1-like protein 3;, , GO:0005737;GO:0005794;GO:0000139;GO:0030027;GO:0005524;GO:0042802;GO:0016477;GO:0034613;GO:0006954;GO:0048666;GO:0006468;GO:0021522;, C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:lamellipodium;, F:ATP binding; F:identical protein binding;, P:cell migration; P:cellular protein localization; P:inflammatory response; P:neuron development; P:protein phosphorylation; P:spinal cord motor neuron differentiation;|Q8IZE3 A8K8Z2 Q5THA6 Q5THA8 Q8IZN9 Q96C56 Q9UBK6,Protein-associating with the carboxyl-terminal domain of ezrin,Ezrin-binding protein PACE-1;SCY1-like protein 3;, , GO:0005737;GO:0005794;GO:0000139;GO:0030027;GO:0005524;GO:0042802;GO:0016477;GO:0034613;GO:0006954;GO:0048666;GO:0006468;GO:0021522;, C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:lamellipodium;, F:ATP binding; F:identical protein binding;, P:cell migration; P:cellular protein localization; P:inflammatory response; P:neuron development; P:protein phosphorylation; P:spinal cord motor neuron differentiation; scaffold24 indexed_genome mRNA 1389721 1444319 . + . ID=transcript_5530;Q8IZE3 A8K8Z2 Q5THA6 Q5THA8 Q8IZN9 Q96C56 Q9UBK6,Protein-associating with the carboxyl-terminal domain of ezrin,Ezrin-binding protein PACE-1;SCY1-like protein 3;, , GO:0005737;GO:0005794;GO:0000139;GO:0030027;GO:0005524;GO:0042802;GO:0016477;GO:0034613;GO:0006954;GO:0048666;GO:0006468;GO:0021522;, C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:lamellipodium;, F:ATP binding; F:identical protein binding;, P:cell migration; P:cellular protein localization; P:inflammatory response; P:neuron development; P:protein phosphorylation; P:spinal cord motor neuron differentiation;|Q8IZE3 A8K8Z2 Q5THA6 Q5THA8 Q8IZN9 Q96C56 Q9UBK6,Protein-associating with the carboxyl-terminal domain of ezrin,Ezrin-binding protein PACE-1;SCY1-like protein 3;, , GO:0005737;GO:0005794;GO:0000139;GO:0030027;GO:0005524;GO:0042802;GO:0016477;GO:0034613;GO:0006954;GO:0048666;GO:0006468;GO:0021522;, C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:lamellipodium;, F:ATP binding; F:identical protein binding;, P:cell migration; P:cellular protein localization; P:inflammatory response; P:neuron development; P:protein phosphorylation; P:spinal cord motor neuron differentiation;|Q9NSG2 A6NFP1 B3KU42 Q3KNQ1 Q9H8L5 Q9NVJ0,Uncharacterized protein C1orf112,, PF14868; scaffold24 indexed_genome mRNA 1520485 1542262 . + . ID=transcript_5531;P14151 A0A024R8Z0 B2R6Q8 P15023 Q9UJ43,L-selectin,CD62 antigen-like family member L;Leukocyte adhesion molecule 1;Leukocyte surface antigen Leu-8;Leukocyte-endothelial cell adhesion molecule 1;Lymph node homing receptor {ECO:0000303|PubMed:2663882};TQ1 {ECO:0000303|PubMed:1692315, ECO:0000303|PubMed:2509939};gp90-MEL;, PF00059;PF00084;, GO:0005887;GO:0005886;GO:0030667;GO:0005509;GO:0030246;GO:0043208;GO:0008201;GO:0070492;GO:0002020;GO:0016339;GO:0007155;GO:0050900;GO:0050901;GO:0043312;GO:0050776;, C:integral component of plasma membrane; C:plasma membrane; C:secretory granule membrane;, F:calcium ion binding; F:carbohydrate binding; F:glycosphingolipid binding; F:heparin binding; F:oligosaccharide binding; F:protease binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:neutrophil degranulation; P:regulation of immune response; scaffold24 indexed_genome mRNA 1601418 1636060 . + . ID=transcript_5532;P16109 Q5R344 Q8IVD1,P-selectin,CD62 antigen-like family member P;Granule membrane protein 140;Leukocyte-endothelial cell adhesion molecule 3;Platelet activation dependent granule-external membrane protein;, PF00059;PF00084;, GO:0009897;GO:0005615;GO:0005887;GO:0005886;GO:0031092;GO:0031088;GO:0005509;GO:0048306;GO:0042806;GO:0043208;GO:0008201;GO:0001530;GO:0070492;GO:0033691;GO:0016339;GO:0035584;GO:0007155;GO:0050829;GO:0007157;GO:0006954;GO:0007159;GO:0050900;GO:0050901;GO:0002576;GO:0002687;GO:1903238;GO:0014068;GO:0010572;GO:0033623;GO:0032496;, C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane; C:platelet alpha granule membrane; C:platelet dense granule membrane;, F:calcium ion binding; F:calcium-dependent protein binding; F:fucose binding; F:glycosphingolipid binding; F:heparin binding; F:lipopolysaccharide binding; F:oligosaccharide binding; F:sialic acid binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:calcium-mediated signaling using intracellular calcium source; P:cell adhesion; P:defense response to Gram-negative bacterium; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:inflammatory response; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:platelet degranulation; P:positive regulation of leukocyte migration; P:positive regulation of leukocyte tethering or rolling; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of platelet activation; P:regulation of integrin activation; P:response to lipopolysaccharide; scaffold24 indexed_genome mRNA 1639202 1720837 . + . ID=transcript_5533;P12259 A8K6E8 Q14285 Q2EHR5 Q5R346 Q5R347 Q6UPU6 Q8WWQ6,Coagulation factor V,Activated protein C cofactor;Proaccelerin, labile factor;, PF07732;PF00754;PF06049;, GO:0030134;GO:0005788;GO:0033116;GO:0005576;GO:1903561;GO:0016020;GO:0005886;GO:0031091;GO:0031093;GO:0005507;GO:0008015;GO:0007596;GO:0044267;GO:0048208;GO:0006888;GO:0002576;GO:0043687;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular region; C:extracellular vesicle; C:membrane; C:plasma membrane; C:platelet alpha granule; C:platelet alpha granule lumen;, F:copper ion binding;, P:blood circulation; P:blood coagulation; P:cellular protein metabolic process; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:platelet degranulation; P:post-translational protein modification; scaffold24 indexed_genome mRNA 1743515 1779260 . + . ID=transcript_5534;O60779 B2R9H0 B4E1X4 Q8WV87 Q9UBL7 Q9UKJ2 Q9UN31 Q9UN43,Thiamine transporter 1,Solute carrier family 19 member 2;Thiamine carrier 1;, PF01770;, GO:0016021;GO:0005886;GO:0008517;GO:0015234;GO:0071934;GO:0015888;GO:0042723;GO:0055085;, C:integral component of membrane; C:plasma membrane;, F:folic acid transmembrane transporter activity; F:thiamine transmembrane transporter activity;, P:thiamine transmembrane transport; P:thiamine transport; P:thiamine-containing compound metabolic process; P:transmembrane transport;|O60779 B2R9H0 B4E1X4 Q8WV87 Q9UBL7 Q9UKJ2 Q9UN31 Q9UN43,Thiamine transporter 1,Solute carrier family 19 member 2;Thiamine carrier 1;, PF01770;, GO:0016021;GO:0005886;GO:0008517;GO:0015234;GO:0071934;GO:0015888;GO:0042723;GO:0055085;, C:integral component of membrane; C:plasma membrane;, F:folic acid transmembrane transporter activity; F:thiamine transmembrane transporter activity;, P:thiamine transmembrane transport; P:thiamine transport; P:thiamine-containing compound metabolic process; P:transmembrane transport; scaffold24 indexed_genome mRNA 1780613 1812163 . + . ID=transcript_5535;Q5TID7 O60780 Q53FD5 Q5TID9 Q8TC48,Coiled-coil domain-containing protein 181 {ECO:0000305},, , GO:0005737;GO:0002177;GO:0005874;GO:0036126;GO:0008017;, C:cytoplasm; C:manchette; C:microtubule; C:sperm flagellum;, F:microtubule binding;|Q5TID7 O60780 Q53FD5 Q5TID9 Q8TC48,Coiled-coil domain-containing protein 181 {ECO:0000305},, , GO:0005737;GO:0002177;GO:0005874;GO:0036126;GO:0008017;, C:cytoplasm; C:manchette; C:microtubule; C:sperm flagellum;, F:microtubule binding; scaffold24 indexed_genome mRNA 1815059 1819254 . - . ID=transcript_5536;Q9H2G9 O15298 Q5T531 Q5T533 Q9GZX4,Golgin-45,Basic leucine zipper nuclear factor 1;JEM-1 {ECO:0000303|PubMed:11056056, ECO:0000303|PubMed:9129147};p45 basic leucine-zipper nuclear factor;, PF08227;, GO:0005737;GO:0005794;GO:0000139;GO:0005654;GO:0005634;GO:0019899;GO:0031625;GO:0007030;GO:0043001;, C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:ubiquitin protein ligase binding;, P:Golgi organization; P:Golgi to plasma membrane protein transport; scaffold24 indexed_genome mRNA 1819335 1838981 . - . ID=transcript_5537;Q9H2G9 O15298 Q5T531 Q5T533 Q9GZX4,Golgin-45,Basic leucine zipper nuclear factor 1;JEM-1 {ECO:0000303|PubMed:11056056, ECO:0000303|PubMed:9129147};p45 basic leucine-zipper nuclear factor;, PF08227;, GO:0005737;GO:0005794;GO:0000139;GO:0005654;GO:0005634;GO:0019899;GO:0031625;GO:0007030;GO:0043001;, C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:ubiquitin protein ligase binding;, P:Golgi organization; P:Golgi to plasma membrane protein transport; scaffold24 indexed_genome mRNA 1881510 2080241 . + . ID=transcript_5538;Q9Y5B8 A8K3T6 A8MY09 B3KSW9 Q5TGZ4,Nucleoside diphosphate kinase 7,nm23-H7;, PF00334;, GO:0005813;GO:0005829;GO:0005524;GO:0046872;GO:0004550;GO:0006241;GO:0006183;GO:0006228;, C:centrosome; C:cytosol;, F:ATP binding; F:metal ion binding; F:nucleoside diphosphate kinase activity;, P:CTP biosynthetic process; P:GTP biosynthetic process; P:UTP biosynthetic process;|P05026 Q5TGZ3,Sodium/potassium-transporting ATPase subunit beta-1,Sodium/potassium-dependent ATPase subunit beta-1;, PF00287;, GO:0016324;GO:0016323;GO:0005901;GO:0070062;GO:1903561;GO:0014704;GO:0016328;GO:0016020;GO:0031090;GO:0005886;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0001671;GO:0051117;GO:0023026;GO:0005391;GO:0008022;GO:0046982;GO:0019901;GO:0030674;GO:0046034;GO:0060048;GO:0098655;GO:0007155;GO:0086064;GO:0006874;GO:0030007;GO:0006883;GO:0010248;GO:0034220;GO:0050900;GO:0086009;GO:0086013;GO:0032781;GO:1903281;GO:1903288;GO:1901018;GO:1903278;GO:1903408;GO:1990573;GO:0072659;GO:0050821;GO:0044861;GO:1903779;GO:0010882;GO:0010468;GO:0055119;GO:0001666;GO:0036376;GO:0035725;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:extracellular exosome; C:extracellular vesicle; C:intercalated disc; C:lateral plasma membrane; C:membrane; C:organelle membrane; C:plasma membrane; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ATPase activator activity; F:ATPase binding; F:MHC class II protein complex binding; F:P-type sodium:potassium-exchanging ATPase activity; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity;, P:ATP metabolic process; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell adhesion; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:ion transmembrane transport; P:leukocyte migration; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:positive regulation of ATPase activity; P:positive regulation of calcium:sodium antiporter activity; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of sodium ion export across plasma membrane; P:positive regulation of sodium:potassium-exchanging ATPase activity; P:potassium ion import across plasma membrane; P:protein localization to plasma membrane; P:protein stabilization; P:protein transport into plasma membrane raft; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of gene expression; P:relaxation of cardiac muscle; P:response to hypoxia; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; scaffold24 indexed_genome mRNA 2081636 2085410 . + . ID=transcript_5539;P05026 Q5TGZ3,Sodium/potassium-transporting ATPase subunit beta-1,Sodium/potassium-dependent ATPase subunit beta-1;, PF00287;, GO:0016324;GO:0016323;GO:0005901;GO:0070062;GO:1903561;GO:0014704;GO:0016328;GO:0016020;GO:0031090;GO:0005886;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0001671;GO:0051117;GO:0023026;GO:0005391;GO:0008022;GO:0046982;GO:0019901;GO:0030674;GO:0046034;GO:0060048;GO:0098655;GO:0007155;GO:0086064;GO:0006874;GO:0030007;GO:0006883;GO:0010248;GO:0034220;GO:0050900;GO:0086009;GO:0086013;GO:0032781;GO:1903281;GO:1903288;GO:1901018;GO:1903278;GO:1903408;GO:1990573;GO:0072659;GO:0050821;GO:0044861;GO:1903779;GO:0010882;GO:0010468;GO:0055119;GO:0001666;GO:0036376;GO:0035725;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:extracellular exosome; C:extracellular vesicle; C:intercalated disc; C:lateral plasma membrane; C:membrane; C:organelle membrane; C:plasma membrane; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ATPase activator activity; F:ATPase binding; F:MHC class II protein complex binding; F:P-type sodium:potassium-exchanging ATPase activity; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity;, P:ATP metabolic process; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell adhesion; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:ion transmembrane transport; P:leukocyte migration; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:positive regulation of ATPase activity; P:positive regulation of calcium:sodium antiporter activity; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of sodium ion export across plasma membrane; P:positive regulation of sodium:potassium-exchanging ATPase activity; P:potassium ion import across plasma membrane; P:protein localization to plasma membrane; P:protein stabilization; P:protein transport into plasma membrane raft; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of gene expression; P:relaxation of cardiac muscle; P:response to hypoxia; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport;|P05026 Q5TGZ3,Sodium/potassium-transporting ATPase subunit beta-1,Sodium/potassium-dependent ATPase subunit beta-1;, PF00287;, GO:0016324;GO:0016323;GO:0005901;GO:0070062;GO:1903561;GO:0014704;GO:0016328;GO:0016020;GO:0031090;GO:0005886;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0001671;GO:0051117;GO:0023026;GO:0005391;GO:0008022;GO:0046982;GO:0019901;GO:0030674;GO:0046034;GO:0060048;GO:0098655;GO:0007155;GO:0086064;GO:0006874;GO:0030007;GO:0006883;GO:0010248;GO:0034220;GO:0050900;GO:0086009;GO:0086013;GO:0032781;GO:1903281;GO:1903288;GO:1901018;GO:1903278;GO:1903408;GO:1990573;GO:0072659;GO:0050821;GO:0044861;GO:1903779;GO:0010882;GO:0010468;GO:0055119;GO:0001666;GO:0036376;GO:0035725;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:extracellular exosome; C:extracellular vesicle; C:intercalated disc; C:lateral plasma membrane; C:membrane; C:organelle membrane; C:plasma membrane; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ATPase activator activity; F:ATPase binding; F:MHC class II protein complex binding; F:P-type sodium:potassium-exchanging ATPase activity; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein-macromolecule adaptor activity;, P:ATP metabolic process; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell adhesion; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:ion transmembrane transport; P:leukocyte migration; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:positive regulation of ATPase activity; P:positive regulation of calcium:sodium antiporter activity; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of sodium ion export across plasma membrane; P:positive regulation of sodium:potassium-exchanging ATPase activity; P:potassium ion import across plasma membrane; P:protein localization to plasma membrane; P:protein stabilization; P:protein transport into plasma membrane raft; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of gene expression; P:relaxation of cardiac muscle; P:response to hypoxia; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; scaffold24 indexed_genome mRNA 2463963 2497919 . + . ID=transcript_5540;Q07507 A8K981 Q8N4R2 Q9UIX8,Dermatopontin,Tyrosine-rich acidic matrix protein;, PF14704;, GO:0062023;GO:0005615;GO:0005201;GO:0007155;GO:0030199;GO:0008285;, C:collagen-containing extracellular matrix; C:extracellular space;, F:extracellular matrix structural constituent;, P:cell adhesion; P:collagen fibril organization; P:negative regulation of cell population proliferation; scaffold24 indexed_genome mRNA 2887646 2966902 . - . ID=transcript_5541;Q8TE22 Q9UDS8 Q9UDT0 Q9Y245 Q9Y647,Regulator of G-protein signaling 6,S914;, PF00610;PF00631;PF00615;PF18148;, GO:0005829;GO:0019898;GO:0005634;GO:0005886;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0043547;GO:0008277;, C:cytosol; C:extrinsic component of membrane; C:nucleus; C:plasma membrane;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of G protein-coupled receptor signaling pathway;|P49802 Q5T3H4 Q8TD66 Q8TD67 Q8WW09 Q9UNU7 Q9Y6B9,Regulator of G-protein signaling 7,, PF00610;PF00631;PF00615;PF18148;, GO:0005829;GO:0005886;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0043547;GO:0006457;, C:cytosol; C:plasma membrane;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:protein folding;|P49802 Q5T3H4 Q8TD66 Q8TD67 Q8WW09 Q9UNU7 Q9Y6B9,Regulator of G-protein signaling 7,, PF00610;PF00631;PF00615;PF18148;, GO:0005829;GO:0005886;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0043547;GO:0006457;, C:cytosol; C:plasma membrane;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:protein folding; scaffold24 indexed_genome mRNA 3054232 3330810 . - . ID=transcript_5542;P49802 Q5T3H4 Q8TD66 Q8TD67 Q8WW09 Q9UNU7 Q9Y6B9,Regulator of G-protein signaling 7,, PF00610;PF00631;PF00615;PF18148;, GO:0005829;GO:0005886;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0043547;GO:0006457;, C:cytosol; C:plasma membrane;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:protein folding;|O95376 Q9HBZ6 Q9UEM9,E3 ubiquitin-protein ligase ARIH2,RING-type E3 ubiquitin transferase ARIH2 {ECO:0000305};Triad1 protein {ECO:0000303|PubMed:10422847};, PF01485;, GO:0005737;GO:0005654;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0004842;GO:0008270;GO:0048588;GO:0071425;GO:0007275;GO:0032436;GO:1903955;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:developmental cell growth; P:hematopoietic stem cell proliferation; P:multicellular organism development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold24 indexed_genome mRNA 3435869 3461343 . - . ID=transcript_5543;P07954 B1ANK7,Fumarate hydratase, mitochondrial {ECO:0000303|PubMed:21445611, ECO:0000303|PubMed:27037871},, PF10415;PF00206;, GO:0005694;GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0035861;GO:0045239;GO:0004333;GO:0042393;GO:0006974;GO:0006281;GO:0006106;GO:0048873;GO:0006108;GO:0000415;GO:0120162;GO:2001034;GO:0000821;GO:0006099;GO:0000050;, C:chromosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:site of double-strand break; C:tricarboxylic acid cycle enzyme complex;, F:fumarate hydratase activity; F:histone binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:fumarate metabolic process; P:homeostasis of number of cells within a tissue; P:malate metabolic process; P:negative regulation of histone H3-K36 methylation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of double-strand break repair via nonhomologous end joining; P:regulation of arginine metabolic process; P:tricarboxylic acid cycle; P:urea cycle; scaffold24 indexed_genome mRNA 3473330 3536697 . + . ID=transcript_5544;O15229 A2A2U8 A2A2U9 A2A2V0 Q5SY07 Q5SY08 Q5SY09,Kynurenine 3-monooxygenase {ECO:0000255|HAMAP-Rule:MF_03018},Kynurenine 3-hydroxylase {ECO:0000255|HAMAP-Rule:MF_03018};, PF01494;, GO:0005829;GO:0005615;GO:0016021;GO:0005741;GO:0071949;GO:0050660;GO:0004502;GO:0016174;GO:0034354;GO:0007568;GO:0043420;GO:0071347;GO:0071222;GO:0034276;GO:0070189;GO:0097052;GO:0019674;GO:1903296;GO:1901216;GO:0019805;GO:0009651;GO:0006569;, C:cytosol; C:extracellular space; C:integral component of membrane; C:mitochondrial outer membrane;, F:FAD binding; F:flavin adenine dinucleotide binding; F:kynurenine 3-monooxygenase activity; F:NAD(P)H oxidase H2O2-forming activity;, P:'de novo' NAD biosynthetic process from tryptophan; P:aging; P:anthranilate metabolic process; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:kynurenic acid biosynthetic process; P:kynurenine metabolic process; P:L-kynurenine metabolic process; P:NAD metabolic process; P:positive regulation of glutamate secretion, neurotransmission; P:positive regulation of neuron death; P:quinolinate biosynthetic process; P:response to salt stress; P:tryptophan catabolic process;|O15229 A2A2U8 A2A2U9 A2A2V0 Q5SY07 Q5SY08 Q5SY09,Kynurenine 3-monooxygenase {ECO:0000255|HAMAP-Rule:MF_03018},Kynurenine 3-hydroxylase {ECO:0000255|HAMAP-Rule:MF_03018};, PF01494;, GO:0005829;GO:0005615;GO:0016021;GO:0005741;GO:0071949;GO:0050660;GO:0004502;GO:0016174;GO:0034354;GO:0007568;GO:0043420;GO:0071347;GO:0071222;GO:0034276;GO:0070189;GO:0097052;GO:0019674;GO:1903296;GO:1901216;GO:0019805;GO:0009651;GO:0006569;, C:cytosol; C:extracellular space; C:integral component of membrane; C:mitochondrial outer membrane;, F:FAD binding; F:flavin adenine dinucleotide binding; F:kynurenine 3-monooxygenase activity; F:NAD(P)H oxidase H2O2-forming activity;, P:'de novo' NAD biosynthetic process from tryptophan; P:aging; P:anthranilate metabolic process; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:kynurenic acid biosynthetic process; P:kynurenine metabolic process; P:L-kynurenine metabolic process; P:NAD metabolic process; P:positive regulation of glutamate secretion, neurotransmission; P:positive regulation of neuron death; P:quinolinate biosynthetic process; P:response to salt stress; P:tryptophan catabolic process;|O15229 A2A2U8 A2A2U9 A2A2V0 Q5SY07 Q5SY08 Q5SY09,Kynurenine 3-monooxygenase {ECO:0000255|HAMAP-Rule:MF_03018},Kynurenine 3-hydroxylase {ECO:0000255|HAMAP-Rule:MF_03018};, PF01494;, GO:0005829;GO:0005615;GO:0016021;GO:0005741;GO:0071949;GO:0050660;GO:0004502;GO:0016174;GO:0034354;GO:0007568;GO:0043420;GO:0071347;GO:0071222;GO:0034276;GO:0070189;GO:0097052;GO:0019674;GO:1903296;GO:1901216;GO:0019805;GO:0009651;GO:0006569;, C:cytosol; C:extracellular space; C:integral component of membrane; C:mitochondrial outer membrane;, F:FAD binding; F:flavin adenine dinucleotide binding; F:kynurenine 3-monooxygenase activity; F:NAD(P)H oxidase H2O2-forming activity;, P:'de novo' NAD biosynthetic process from tryptophan; P:aging; P:anthranilate metabolic process; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:kynurenic acid biosynthetic process; P:kynurenine metabolic process; P:L-kynurenine metabolic process; P:NAD metabolic process; P:positive regulation of glutamate secretion, neurotransmission; P:positive regulation of neuron death; P:quinolinate biosynthetic process; P:response to salt stress; P:tryptophan catabolic process;|O15229 A2A2U8 A2A2U9 A2A2V0 Q5SY07 Q5SY08 Q5SY09,Kynurenine 3-monooxygenase {ECO:0000255|HAMAP-Rule:MF_03018},Kynurenine 3-hydroxylase {ECO:0000255|HAMAP-Rule:MF_03018};, PF01494;, GO:0005829;GO:0005615;GO:0016021;GO:0005741;GO:0071949;GO:0050660;GO:0004502;GO:0016174;GO:0034354;GO:0007568;GO:0043420;GO:0071347;GO:0071222;GO:0034276;GO:0070189;GO:0097052;GO:0019674;GO:1903296;GO:1901216;GO:0019805;GO:0009651;GO:0006569;, C:cytosol; C:extracellular space; C:integral component of membrane; C:mitochondrial outer membrane;, F:FAD binding; F:flavin adenine dinucleotide binding; F:kynurenine 3-monooxygenase activity; F:NAD(P)H oxidase H2O2-forming activity;, P:'de novo' NAD biosynthetic process from tryptophan; P:aging; P:anthranilate metabolic process; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:kynurenic acid biosynthetic process; P:kynurenine metabolic process; P:L-kynurenine metabolic process; P:NAD metabolic process; P:positive regulation of glutamate secretion, neurotransmission; P:positive regulation of neuron death; P:quinolinate biosynthetic process; P:response to salt stress; P:tryptophan catabolic process; scaffold24 indexed_genome mRNA 3568461 3577841 . - . ID=transcript_5545;P26374 B2RAB9 Q17RE0 Q9H1Y4,Rab proteins geranylgeranyltransferase component A 2,Choroideremia-like protein;Rab escort protein 2;, PF00996;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005968;GO:0005092;GO:0005096;GO:0031267;GO:0006886;GO:0043687;GO:0018344;GO:0007264;GO:0016192;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Rab-protein geranylgeranyltransferase complex;, F:GDP-dissociation inhibitor activity; F:GTPase activator activity; F:small GTPase binding;, P:intracellular protein transport; P:post-translational protein modification; P:protein geranylgeranylation; P:small GTPase mediated signal transduction; P:vesicle-mediated transport; scaffold24 indexed_genome mRNA 3885347 4020838 . - . ID=transcript_5546;Q8N7P1 A1KXV0 B7Z324 Q494U9 Q8NB22,Inactive phospholipase D5,Inactive choline phosphatase 5;Inactive phosphatidylcholine-hydrolyzing phospholipase D5;PLDc;, PF13918;, GO:0016021;GO:0003824;, C:integral component of membrane;, F:catalytic activity; scaffold24 indexed_genome mRNA 4209001 4209968 . - . ID=transcript_5547;Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold24 indexed_genome mRNA 4673351 4687444 . - . ID=transcript_5548;Q96L14,Cep170-like protein,CEP170 pseudogene 1;, PF15308;, GO:0042802;, , F:identical protein binding; scaffold24 indexed_genome mRNA 4696666 4809142 . - . ID=transcript_5549;Q5SW79 O75058 Q5SW77 Q5SW78 Q7LGA9 Q86W31 Q9UQ08 Q9UQ09,Centrosomal protein of 170 kDa,KARP-1-binding protein;, PF15308;PF00498;, GO:0120103;GO:0005814;GO:0005813;GO:0005829;GO:0005874;GO:0072686;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytosol; C:microtubule; C:mitotic spindle;|Q5SW79 O75058 Q5SW77 Q5SW78 Q7LGA9 Q86W31 Q9UQ08 Q9UQ09,Centrosomal protein of 170 kDa,KARP-1-binding protein;, PF15308;PF00498;, GO:0120103;GO:0005814;GO:0005813;GO:0005829;GO:0005874;GO:0072686;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytosol; C:microtubule; C:mitotic spindle;|Q5SW79 O75058 Q5SW77 Q5SW78 Q7LGA9 Q86W31 Q9UQ08 Q9UQ09,Centrosomal protein of 170 kDa,KARP-1-binding protein;, PF15308;PF00498;, GO:0120103;GO:0005814;GO:0005813;GO:0005829;GO:0005874;GO:0072686;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytosol; C:microtubule; C:mitotic spindle; scaffold24 indexed_genome mRNA 4821666 5051962 . + . ID=transcript_5550;Q86SQ7 O60527 Q3ZCR6 Q8N5F2 Q9P0F1,Serologically defined colon cancer antigen 8,Antigen NY-CO-8;Centrosomal colon cancer autoantigen protein;, PF15964;, GO:0005911;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0097733;GO:0007098;GO:0097711;GO:0030010;GO:0000086;GO:0031023;GO:0001764;GO:1902017;GO:0010389;GO:0035148;, C:cell-cell junction; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:photoreceptor cell cilium;, , P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:establishment of cell polarity; P:G2/M transition of mitotic cell cycle; P:microtubule organizing center organization; P:neuron migration; P:regulation of cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; P:tube formation;|Q86SQ7 O60527 Q3ZCR6 Q8N5F2 Q9P0F1,Serologically defined colon cancer antigen 8,Antigen NY-CO-8;Centrosomal colon cancer autoantigen protein;, PF15964;, GO:0005911;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0097733;GO:0007098;GO:0097711;GO:0030010;GO:0000086;GO:0031023;GO:0001764;GO:1902017;GO:0010389;GO:0035148;, C:cell-cell junction; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:photoreceptor cell cilium;, , P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:establishment of cell polarity; P:G2/M transition of mitotic cell cycle; P:microtubule organizing center organization; P:neuron migration; P:regulation of cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; P:tube formation;|Q86SQ7 O60527 Q3ZCR6 Q8N5F2 Q9P0F1,Serologically defined colon cancer antigen 8,Antigen NY-CO-8;Centrosomal colon cancer autoantigen protein;, PF15964;, GO:0005911;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0097733;GO:0007098;GO:0097711;GO:0030010;GO:0000086;GO:0031023;GO:0001764;GO:1902017;GO:0010389;GO:0035148;, C:cell-cell junction; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:photoreceptor cell cilium;, , P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:establishment of cell polarity; P:G2/M transition of mitotic cell cycle; P:microtubule organizing center organization; P:neuron migration; P:regulation of cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; P:tube formation; scaffold24 indexed_genome mRNA 5059063 5239017 . - . ID=transcript_5551;Q9Y243 Q0VAA6 Q5VTI1 Q5VTI2 Q96QV3 Q9UFP5,RAC-gamma serine/threonine-protein kinase,Protein kinase Akt-3;Protein kinase B gamma;RAC-PK-gamma;STK-2;, PF00169;PF00069;PF00433;, GO:0005737;GO:0016020;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0048854;GO:0048873;GO:0035556;GO:0000002;GO:2000773;GO:0018105;GO:0045766;GO:1905653;GO:0043536;GO:0090050;GO:0045793;GO:0001938;GO:0032008;GO:1905564;GO:0006468;GO:0007165;, C:cytoplasm; C:membrane; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain morphogenesis; P:homeostasis of number of cells within a tissue; P:intracellular signal transduction; P:mitochondrial genome maintenance; P:negative regulation of cellular senescence; P:peptidyl-serine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of artery morphogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell size; P:positive regulation of endothelial cell proliferation; P:positive regulation of TOR signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein phosphorylation; P:signal transduction;|Q9Y243 Q0VAA6 Q5VTI1 Q5VTI2 Q96QV3 Q9UFP5,RAC-gamma serine/threonine-protein kinase,Protein kinase Akt-3;Protein kinase B gamma;RAC-PK-gamma;STK-2;, PF00169;PF00069;PF00433;, GO:0005737;GO:0016020;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0048854;GO:0048873;GO:0035556;GO:0000002;GO:2000773;GO:0018105;GO:0045766;GO:1905653;GO:0043536;GO:0090050;GO:0045793;GO:0001938;GO:0032008;GO:1905564;GO:0006468;GO:0007165;, C:cytoplasm; C:membrane; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain morphogenesis; P:homeostasis of number of cells within a tissue; P:intracellular signal transduction; P:mitochondrial genome maintenance; P:negative regulation of cellular senescence; P:peptidyl-serine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of artery morphogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell size; P:positive regulation of endothelial cell proliferation; P:positive regulation of TOR signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein phosphorylation; P:signal transduction;|Q9Y243 Q0VAA6 Q5VTI1 Q5VTI2 Q96QV3 Q9UFP5,RAC-gamma serine/threonine-protein kinase,Protein kinase Akt-3;Protein kinase B gamma;RAC-PK-gamma;STK-2;, PF00169;PF00069;PF00433;, GO:0005737;GO:0016020;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0048854;GO:0048873;GO:0035556;GO:0000002;GO:2000773;GO:0018105;GO:0045766;GO:1905653;GO:0043536;GO:0090050;GO:0045793;GO:0001938;GO:0032008;GO:1905564;GO:0006468;GO:0007165;, C:cytoplasm; C:membrane; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain morphogenesis; P:homeostasis of number of cells within a tissue; P:intracellular signal transduction; P:mitochondrial genome maintenance; P:negative regulation of cellular senescence; P:peptidyl-serine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of artery morphogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell size; P:positive regulation of endothelial cell proliferation; P:positive regulation of TOR signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein phosphorylation; P:signal transduction;|Q9Y243 Q0VAA6 Q5VTI1 Q5VTI2 Q96QV3 Q9UFP5,RAC-gamma serine/threonine-protein kinase,Protein kinase Akt-3;Protein kinase B gamma;RAC-PK-gamma;STK-2;, PF00169;PF00069;PF00433;, GO:0005737;GO:0016020;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0048854;GO:0048873;GO:0035556;GO:0000002;GO:2000773;GO:0018105;GO:0045766;GO:1905653;GO:0043536;GO:0090050;GO:0045793;GO:0001938;GO:0032008;GO:1905564;GO:0006468;GO:0007165;, C:cytoplasm; C:membrane; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain morphogenesis; P:homeostasis of number of cells within a tissue; P:intracellular signal transduction; P:mitochondrial genome maintenance; P:negative regulation of cellular senescence; P:peptidyl-serine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of artery morphogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell size; P:positive regulation of endothelial cell proliferation; P:positive regulation of TOR signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein phosphorylation; P:signal transduction;|Q9Y243 Q0VAA6 Q5VTI1 Q5VTI2 Q96QV3 Q9UFP5,RAC-gamma serine/threonine-protein kinase,Protein kinase Akt-3;Protein kinase B gamma;RAC-PK-gamma;STK-2;, PF00169;PF00069;PF00433;, GO:0005737;GO:0016020;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0048854;GO:0048873;GO:0035556;GO:0000002;GO:2000773;GO:0018105;GO:0045766;GO:1905653;GO:0043536;GO:0090050;GO:0045793;GO:0001938;GO:0032008;GO:1905564;GO:0006468;GO:0007165;, C:cytoplasm; C:membrane; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain morphogenesis; P:homeostasis of number of cells within a tissue; P:intracellular signal transduction; P:mitochondrial genome maintenance; P:negative regulation of cellular senescence; P:peptidyl-serine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of artery morphogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell size; P:positive regulation of endothelial cell proliferation; P:positive regulation of TOR signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein phosphorylation; P:signal transduction; scaffold24 indexed_genome mRNA 5547326 5562611 . + . ID=transcript_5552;Q99592 A8K5U3 Q13397 Q5VU40 Q8N463 Q9UD99,Zinc finger and BTB domain-containing protein 18,58 kDa repressor protein;Transcriptional repressor RP58;Translin-associated zinc finger protein 1;Zinc finger protein 238;Zinc finger protein C2H2-171;, PF00651;PF00096;, GO:0000792;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:0045892;GO:0045944;GO:0006357;GO:0007519;, C:heterochromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:skeletal muscle tissue development;|Q99592 A8K5U3 Q13397 Q5VU40 Q8N463 Q9UD99,Zinc finger and BTB domain-containing protein 18,58 kDa repressor protein;Transcriptional repressor RP58;Translin-associated zinc finger protein 1;Zinc finger protein 238;Zinc finger protein C2H2-171;, PF00651;PF00096;, GO:0000792;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:0045892;GO:0045944;GO:0006357;GO:0007519;, C:heterochromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:skeletal muscle tissue development; scaffold24 indexed_genome mRNA 5883084 5883766 . - . ID=transcript_5553;Q5SVJ3 Q5SVJ4,Uncharacterized protein C1orf100,, PF17670; scaffold24 indexed_genome mRNA 5885143 5917477 . - . ID=transcript_5554;P30520 B1AQM5 Q96EG7,Adenylosuccinate synthetase isozyme 2 {ECO:0000255|HAMAP-Rule:MF_03127},Adenylosuccinate synthetase, acidic isozyme {ECO:0000255|HAMAP-Rule:MF_03127};Adenylosuccinate synthetase, liver isozyme {ECO:0000255|HAMAP-Rule:MF_03127};IMP--aspartate ligase 2 {ECO:0000255|HAMAP-Rule:MF_03127};, PF00709;, GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0004019;GO:0005525;GO:0000287;GO:0042301;GO:0044208;GO:0006167;GO:0006531;GO:0071257;GO:0002376;GO:0046040;GO:0009168;GO:0060359;GO:0014074;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion;, F:adenylosuccinate synthase activity; F:GTP binding; F:magnesium ion binding; F:phosphate ion binding;, P:'de novo' AMP biosynthetic process; P:AMP biosynthetic process; P:aspartate metabolic process; P:cellular response to electrical stimulus; P:immune system process; P:IMP metabolic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to ammonium ion; P:response to purine-containing compound;|P30520 B1AQM5 Q96EG7,Adenylosuccinate synthetase isozyme 2 {ECO:0000255|HAMAP-Rule:MF_03127},Adenylosuccinate synthetase, acidic isozyme {ECO:0000255|HAMAP-Rule:MF_03127};Adenylosuccinate synthetase, liver isozyme {ECO:0000255|HAMAP-Rule:MF_03127};IMP--aspartate ligase 2 {ECO:0000255|HAMAP-Rule:MF_03127};, PF00709;, GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0004019;GO:0005525;GO:0000287;GO:0042301;GO:0044208;GO:0006167;GO:0006531;GO:0071257;GO:0002376;GO:0046040;GO:0009168;GO:0060359;GO:0014074;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion;, F:adenylosuccinate synthase activity; F:GTP binding; F:magnesium ion binding; F:phosphate ion binding;, P:'de novo' AMP biosynthetic process; P:AMP biosynthetic process; P:aspartate metabolic process; P:cellular response to electrical stimulus; P:immune system process; P:IMP metabolic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to ammonium ion; P:response to purine-containing compound;|P30520 B1AQM5 Q96EG7,Adenylosuccinate synthetase isozyme 2 {ECO:0000255|HAMAP-Rule:MF_03127},Adenylosuccinate synthetase, acidic isozyme {ECO:0000255|HAMAP-Rule:MF_03127};Adenylosuccinate synthetase, liver isozyme {ECO:0000255|HAMAP-Rule:MF_03127};IMP--aspartate ligase 2 {ECO:0000255|HAMAP-Rule:MF_03127};, PF00709;, GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0004019;GO:0005525;GO:0000287;GO:0042301;GO:0044208;GO:0006167;GO:0006531;GO:0071257;GO:0002376;GO:0046040;GO:0009168;GO:0060359;GO:0014074;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion;, F:adenylosuccinate synthase activity; F:GTP binding; F:magnesium ion binding; F:phosphate ion binding;, P:'de novo' AMP biosynthetic process; P:AMP biosynthetic process; P:aspartate metabolic process; P:cellular response to electrical stimulus; P:immune system process; P:IMP metabolic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to ammonium ion; P:response to purine-containing compound;|P30520 B1AQM5 Q96EG7,Adenylosuccinate synthetase isozyme 2 {ECO:0000255|HAMAP-Rule:MF_03127},Adenylosuccinate synthetase, acidic isozyme {ECO:0000255|HAMAP-Rule:MF_03127};Adenylosuccinate synthetase, liver isozyme {ECO:0000255|HAMAP-Rule:MF_03127};IMP--aspartate ligase 2 {ECO:0000255|HAMAP-Rule:MF_03127};, PF00709;, GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0004019;GO:0005525;GO:0000287;GO:0042301;GO:0044208;GO:0006167;GO:0006531;GO:0071257;GO:0002376;GO:0046040;GO:0009168;GO:0060359;GO:0014074;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion;, F:adenylosuccinate synthase activity; F:GTP binding; F:magnesium ion binding; F:phosphate ion binding;, P:'de novo' AMP biosynthetic process; P:AMP biosynthetic process; P:aspartate metabolic process; P:cellular response to electrical stimulus; P:immune system process; P:IMP metabolic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to ammonium ion; P:response to purine-containing compound; scaffold24 indexed_genome mRNA 6099813 6143139 . + . ID=transcript_5555;Q9BSY9 B1APK6 Q5VVC6 Q9NYS2 Q9Y3E4,Deubiquitinase DESI2 {ECO:0000305},Desumoylating isopeptidase 2;PPPDE peptidase domain-containing protein 1 {ECO:0000303|PubMed:28483520};Protein FAM152A;, PF05903;, GO:0005737;GO:1990380;GO:0061578;GO:0004843;GO:0101005;GO:0016579;GO:0070646;, C:cytoplasm;, F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:protein deubiquitination; P:protein modification by small protein removal;|Q9BSY9 B1APK6 Q5VVC6 Q9NYS2 Q9Y3E4,Deubiquitinase DESI2 {ECO:0000305},Desumoylating isopeptidase 2;PPPDE peptidase domain-containing protein 1 {ECO:0000303|PubMed:28483520};Protein FAM152A;, PF05903;, GO:0005737;GO:1990380;GO:0061578;GO:0004843;GO:0101005;GO:0016579;GO:0070646;, C:cytoplasm;, F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:protein deubiquitination; P:protein modification by small protein removal;|Q9BSY9 B1APK6 Q5VVC6 Q9NYS2 Q9Y3E4,Deubiquitinase DESI2 {ECO:0000305},Desumoylating isopeptidase 2;PPPDE peptidase domain-containing protein 1 {ECO:0000303|PubMed:28483520};Protein FAM152A;, PF05903;, GO:0005737;GO:1990380;GO:0061578;GO:0004843;GO:0101005;GO:0016579;GO:0070646;, C:cytoplasm;, F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:protein deubiquitination; P:protein modification by small protein removal;|Q9BSY9 B1APK6 Q5VVC6 Q9NYS2 Q9Y3E4,Deubiquitinase DESI2 {ECO:0000305},Desumoylating isopeptidase 2;PPPDE peptidase domain-containing protein 1 {ECO:0000303|PubMed:28483520};Protein FAM152A;, PF05903;, GO:0005737;GO:1990380;GO:0061578;GO:0004843;GO:0101005;GO:0016579;GO:0070646;, C:cytoplasm;, F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:protein deubiquitination; P:protein modification by small protein removal; scaffold24 indexed_genome mRNA 6245580 6271504 . - . ID=transcript_5556;Q00839 O75507 Q8N174 Q96HY9 Q9BQ09,Heterogeneous nuclear ribonucleoprotein U {ECO:0000303|PubMed:1628625},GRIP120 {ECO:0000303|PubMed:9353307};Nuclear p120 ribonucleoprotein {ECO:0000303|PubMed:7753047};Scaffold-attachment factor A {ECO:0000303|PubMed:1324173, ECO:0000303|Ref.3};p120 {ECO:0000303|PubMed:7993898};pp120 {ECO:0000303|PubMed:7993898};, PF02037;PF00622;, GO:0071013;GO:0009986;GO:0005813;GO:0000777;GO:0070937;GO:0036464;GO:0032839;GO:0098577;GO:0000776;GO:0016020;GO:0030496;GO:0072686;GO:1990498;GO:1990023;GO:0000228;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0000922;GO:0005697;GO:0003779;GO:0005524;GO:0003682;GO:0031490;GO:0003677;GO:0003690;GO:0003725;GO:0042802;GO:0003730;GO:0008143;GO:0017130;GO:0034046;GO:0036002;GO:1990841;GO:0044877;GO:0043021;GO:0003723;GO:0099122;GO:0000978;GO:0000993;GO:1990837;GO:0003697;GO:0003727;GO:0017069;GO:0070034;GO:0001097;GO:0003714;GO:1990845;GO:0055013;GO:0007049;GO:0051301;GO:0071385;GO:1990830;GO:0006325;GO:0032922;GO:0070934;GO:0098963;GO:0009048;GO:0051457;GO:0000398;GO:0048255;GO:0033673;GO:2000737;GO:0032211;GO:0000122;GO:0034244;GO:0001649;GO:1902425;GO:0090336;GO:2000373;GO:2000648;GO:0045944;GO:1902889;GO:0000381;GO:1902275;GO:0007346;GO:1901673;GO:1990280;GO:0016070;GO:0006396;GO:0016032;, C:catalytic step 2 spliceosome; C:cell surface; C:centrosome; C:condensed chromosome kinetochore; C:CRD-mediated mRNA stability complex; C:cytoplasmic ribonucleoprotein granule; C:dendrite cytoplasm; C:inactive sex chromosome; C:kinetochore; C:membrane; C:midbody; C:mitotic spindle; C:mitotic spindle microtubule; C:mitotic spindle midzone; C:nuclear chromosome; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex; C:spindle pole; C:telomerase holoenzyme complex;, F:actin binding; F:ATP binding; F:chromatin binding; F:chromatin DNA binding; F:DNA binding; F:double-stranded DNA binding; F:double-stranded RNA binding; F:identical protein binding; F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(C) RNA binding; F:poly(G) binding; F:pre-mRNA binding; F:promoter-specific chromatin binding; F:protein-containing complex binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:sequence-specific double-stranded DNA binding; F:single-stranded DNA binding; F:single-stranded RNA binding; F:snRNA binding; F:telomerase RNA binding; F:TFIIH-class transcription factor complex binding; F:transcription corepressor activity;, P:adaptive thermogenesis; P:cardiac muscle cell development; P:cell cycle; P:cell division; P:cellular response to glucocorticoid stimulus; P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:circadian regulation of gene expression; P:CRD-mediated mRNA stabilization; P:dendritic transport of messenger ribonucleoprotein complex; P:dosage compensation by inactivation of X chromosome; P:maintenance of protein location in nucleus; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:negative regulation of kinase activity; P:negative regulation of stem cell differentiation; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:osteoblast differentiation; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; P:positive regulation of brown fat cell differentiation; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to spindle microtubule; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of chromatin organization; P:regulation of mitotic cell cycle; P:regulation of mitotic spindle assembly; P:RNA localization to chromatin; P:RNA metabolic process; P:RNA processing; P:viral process; scaffold24 indexed_genome mRNA 6353593 6459953 . + . ID=transcript_5557;Q5VUJ9 B4DZE9 Q59G23 Q9BS36,Dynein regulatory complex protein 8 {ECO:0000250|UniProtKB:A8J3A0},EF-hand calcium-binding domain-containing protein 2;, , GO:0005737;GO:0005856;GO:0031514;GO:0005509;, C:cytoplasm; C:cytoskeleton; C:motile cilium;, F:calcium ion binding;|Q5VUJ9 B4DZE9 Q59G23 Q9BS36,Dynein regulatory complex protein 8 {ECO:0000250|UniProtKB:A8J3A0},EF-hand calcium-binding domain-containing protein 2;, , GO:0005737;GO:0005856;GO:0031514;GO:0005509;, C:cytoplasm; C:cytoskeleton; C:motile cilium;, F:calcium ion binding; scaffold24 indexed_genome mRNA 6911124 6978324 . + . ID=transcript_5558;Q2KJY2 Q6ZQR9 Q6ZUZ0 Q8IUN3 Q8IVR1 Q9NWB4,Kinesin-like protein KIF26B,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0005524;GO:0008017;GO:0003777;GO:0030010;GO:0022409;GO:0072092;, C:cytoplasm; C:kinesin complex; C:microtubule;, F:ATP binding; F:microtubule binding; F:microtubule motor activity;, P:establishment of cell polarity; P:positive regulation of cell-cell adhesion; P:ureteric bud invasion; scaffold24 indexed_genome mRNA 6979070 6979631 . - . ID=transcript_5559;Q2KJY2 Q6ZQR9 Q6ZUZ0 Q8IUN3 Q8IVR1 Q9NWB4,Kinesin-like protein KIF26B,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0005524;GO:0008017;GO:0003777;GO:0030010;GO:0022409;GO:0072092;, C:cytoplasm; C:kinesin complex; C:microtubule;, F:ATP binding; F:microtubule binding; F:microtubule motor activity;, P:establishment of cell polarity; P:positive regulation of cell-cell adhesion; P:ureteric bud invasion; scaffold24 indexed_genome mRNA 6981833 6999392 . + . ID=transcript_5560;Q2KJY2 Q6ZQR9 Q6ZUZ0 Q8IUN3 Q8IVR1 Q9NWB4,Kinesin-like protein KIF26B,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0005524;GO:0008017;GO:0003777;GO:0030010;GO:0022409;GO:0072092;, C:cytoplasm; C:kinesin complex; C:microtubule;, F:ATP binding; F:microtubule binding; F:microtubule motor activity;, P:establishment of cell polarity; P:positive regulation of cell-cell adhesion; P:ureteric bud invasion; scaffold24 indexed_genome mRNA 7712175 7730748 . - . ID=transcript_5561;Q9H5Q4 Q9H626,Dimethyladenosine transferase 2, mitochondrial {ECO:0000305},Hepatitis C virus NS5A-transactivated protein 5;Mitochondrial 12S rRNA dimethylase 2;Mitochondrial transcription factor B2;S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2;, PF00398;, GO:0005759;GO:0042645;GO:0005739;GO:0034246;GO:0003723;GO:0000179;GO:0003712;GO:0006390;GO:0007005;GO:0031167;GO:0006391;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:mitochondrial transcription factor activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; F:transcription coregulator activity;, P:mitochondrial transcription; P:mitochondrion organization; P:rRNA methylation; P:transcription initiation from mitochondrial promoter;|Q9H5Q4 Q9H626,Dimethyladenosine transferase 2, mitochondrial {ECO:0000305},Hepatitis C virus NS5A-transactivated protein 5;Mitochondrial 12S rRNA dimethylase 2;Mitochondrial transcription factor B2;S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2;, PF00398;, GO:0005759;GO:0042645;GO:0005739;GO:0034246;GO:0003723;GO:0000179;GO:0003712;GO:0006390;GO:0007005;GO:0031167;GO:0006391;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:mitochondrial transcription factor activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; F:transcription coregulator activity;, P:mitochondrial transcription; P:mitochondrion organization; P:rRNA methylation; P:transcription initiation from mitochondrial promoter;|Q9H5Q4 Q9H626,Dimethyladenosine transferase 2, mitochondrial {ECO:0000305},Hepatitis C virus NS5A-transactivated protein 5;Mitochondrial 12S rRNA dimethylase 2;Mitochondrial transcription factor B2;S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2;, PF00398;, GO:0005759;GO:0042645;GO:0005739;GO:0034246;GO:0003723;GO:0000179;GO:0003712;GO:0006390;GO:0007005;GO:0031167;GO:0006391;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:mitochondrial transcription factor activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; F:transcription coregulator activity;, P:mitochondrial transcription; P:mitochondrion organization; P:rRNA methylation; P:transcription initiation from mitochondrial promoter;|Q9H5Q4 Q9H626,Dimethyladenosine transferase 2, mitochondrial {ECO:0000305},Hepatitis C virus NS5A-transactivated protein 5;Mitochondrial 12S rRNA dimethylase 2;Mitochondrial transcription factor B2;S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2;, PF00398;, GO:0005759;GO:0042645;GO:0005739;GO:0034246;GO:0003723;GO:0000179;GO:0003712;GO:0006390;GO:0007005;GO:0031167;GO:0006391;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:mitochondrial transcription factor activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; F:transcription coregulator activity;, P:mitochondrial transcription; P:mitochondrion organization; P:rRNA methylation; P:transcription initiation from mitochondrial promoter; scaffold24 indexed_genome mRNA 7782354 7829192 . + . ID=transcript_5562;Q6PJW8 Q5VSY9 Q5VTM7 Q8IYA9 Q8N3L5 Q8NB09 Q8TEI2 Q96MR5,Consortin,, PF15281;, GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0032991;GO:0005802;GO:0030133;GO:0071253;GO:0019902;GO:0010923;GO:0042998;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:protein-containing complex; C:trans-Golgi network; C:transport vesicle;, F:connexin binding; F:phosphatase binding;, P:negative regulation of phosphatase activity; P:positive regulation of Golgi to plasma membrane protein transport; scaffold24 indexed_genome mRNA 7915415 7948886 . + . ID=transcript_5563;Q8NBX0 Q8TAR0 Q9Y363,Saccharopine dehydrogenase-like oxidoreductase,, PF16653;PF03435;, GO:0005576;GO:0005811;GO:0016020;GO:0030496;GO:0005739;GO:0005634;GO:0005886;GO:0031093;GO:0016491;GO:0009247;GO:0002576;, C:extracellular region; C:lipid droplet; C:membrane; C:midbody; C:mitochondrion; C:nucleus; C:plasma membrane; C:platelet alpha granule lumen;, F:oxidoreductase activity;, P:glycolipid biosynthetic process; P:platelet degranulation;|Q8NBX0 Q8TAR0 Q9Y363,Saccharopine dehydrogenase-like oxidoreductase,, PF16653;PF03435;, GO:0005576;GO:0005811;GO:0016020;GO:0030496;GO:0005739;GO:0005634;GO:0005886;GO:0031093;GO:0016491;GO:0009247;GO:0002576;, C:extracellular region; C:lipid droplet; C:membrane; C:midbody; C:mitochondrion; C:nucleus; C:plasma membrane; C:platelet alpha granule lumen;, F:oxidoreductase activity;, P:glycolipid biosynthetic process; P:platelet degranulation;|Q8NBX0 Q8TAR0 Q9Y363,Saccharopine dehydrogenase-like oxidoreductase,, PF16653;PF03435;, GO:0005576;GO:0005811;GO:0016020;GO:0030496;GO:0005739;GO:0005634;GO:0005886;GO:0031093;GO:0016491;GO:0009247;GO:0002576;, C:extracellular region; C:lipid droplet; C:membrane; C:midbody; C:mitochondrion; C:nucleus; C:plasma membrane; C:platelet alpha granule lumen;, F:oxidoreductase activity;, P:glycolipid biosynthetic process; P:platelet degranulation; scaffold24 indexed_genome mRNA 8018335 8112399 . + . ID=transcript_5564;Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis;|Q8WYP5 A6NGM0 A8MSG9 A8MZ86 Q7Z4E3 Q8IZA4 Q96EH9 Q9Y4Q6,Protein ELYS,Embryonic large molecule derived from yolk sac;Protein MEL-28;Putative AT-hook-containing transcription factor 1;, PF13934;PF16687;, GO:0000777;GO:0005829;GO:0070062;GO:0016363;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0003677;GO:0051301;GO:0007084;GO:0007052;GO:0051028;GO:0051292;GO:0015031;GO:0032465;, C:condensed chromosome kinetochore; C:cytosol; C:extracellular exosome; C:nuclear matrix; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell division; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA transport; P:nuclear pore complex assembly; P:protein transport; P:regulation of cytokinesis; scaffold24 indexed_genome mRNA 8273715 8584450 . + . ID=transcript_5565;Q99646,Serine/threonine-protein kinase MRCK alpha,CDC42-binding protein kinase alpha;DMPK-like alpha;Myotonic dystrophy kinase-related CDC42-binding kinase alpha;, PF00130;PF00780;PF08826;PF15796;PF00069;PF00433;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005524;GO:0042802;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0016477;GO:0035556;GO:0018107;GO:0006468;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q99646,Serine/threonine-protein kinase MRCK alpha,CDC42-binding protein kinase alpha;DMPK-like alpha;Myotonic dystrophy kinase-related CDC42-binding kinase alpha;, PF00130;PF00780;PF08826;PF15796;PF00069;PF00433;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005524;GO:0042802;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0016477;GO:0035556;GO:0018107;GO:0006468;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q99646,Serine/threonine-protein kinase MRCK alpha,CDC42-binding protein kinase alpha;DMPK-like alpha;Myotonic dystrophy kinase-related CDC42-binding kinase alpha;, PF00130;PF00780;PF08826;PF15796;PF00069;PF00433;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005524;GO:0042802;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0016477;GO:0035556;GO:0018107;GO:0006468;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q99646,Serine/threonine-protein kinase MRCK alpha,CDC42-binding protein kinase alpha;DMPK-like alpha;Myotonic dystrophy kinase-related CDC42-binding kinase alpha;, PF00130;PF00780;PF08826;PF15796;PF00069;PF00433;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005524;GO:0042802;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0016477;GO:0035556;GO:0018107;GO:0006468;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q99646,Serine/threonine-protein kinase MRCK alpha,CDC42-binding protein kinase alpha;DMPK-like alpha;Myotonic dystrophy kinase-related CDC42-binding kinase alpha;, PF00130;PF00780;PF08826;PF15796;PF00069;PF00433;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005524;GO:0042802;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0016477;GO:0035556;GO:0018107;GO:0006468;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q99646,Serine/threonine-protein kinase MRCK alpha,CDC42-binding protein kinase alpha;DMPK-like alpha;Myotonic dystrophy kinase-related CDC42-binding kinase alpha;, PF00130;PF00780;PF08826;PF15796;PF00069;PF00433;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005524;GO:0042802;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0016477;GO:0035556;GO:0018107;GO:0006468;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q99646,Serine/threonine-protein kinase MRCK alpha,CDC42-binding protein kinase alpha;DMPK-like alpha;Myotonic dystrophy kinase-related CDC42-binding kinase alpha;, PF00130;PF00780;PF08826;PF15796;PF00069;PF00433;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005524;GO:0042802;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0016477;GO:0035556;GO:0018107;GO:0006468;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q8NI60 Q5T7A5 Q63HK0 Q8NCJ6 Q9HBQ1 Q9NQ67,Atypical kinase COQ8A, mitochondrial {ECO:0000305},Chaperone activity of bc1 complex-like {ECO:0000303|PubMed:11888884};Coenzyme Q protein 8A {ECO:0000305};aarF domain-containing protein kinase 3 {ECO:0000312|HGNC:HGNC:16812};, PF03109;, GO:0031314;GO:0016021;GO:0005739;GO:0043531;GO:0005524;GO:0016301;GO:0016310;GO:0006468;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:mitochondrion;, F:ADP binding; F:ATP binding; F:kinase activity;, P:phosphorylation; P:protein phosphorylation; P:ubiquinone biosynthetic process;|Q8NI60 Q5T7A5 Q63HK0 Q8NCJ6 Q9HBQ1 Q9NQ67,Atypical kinase COQ8A, mitochondrial {ECO:0000305},Chaperone activity of bc1 complex-like {ECO:0000303|PubMed:11888884};Coenzyme Q protein 8A {ECO:0000305};aarF domain-containing protein kinase 3 {ECO:0000312|HGNC:HGNC:16812};, PF03109;, GO:0031314;GO:0016021;GO:0005739;GO:0043531;GO:0005524;GO:0016301;GO:0016310;GO:0006468;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:mitochondrion;, F:ADP binding; F:ATP binding; F:kinase activity;, P:phosphorylation; P:protein phosphorylation; P:ubiquinone biosynthetic process;|Q8NI60 Q5T7A5 Q63HK0 Q8NCJ6 Q9HBQ1 Q9NQ67,Atypical kinase COQ8A, mitochondrial {ECO:0000305},Chaperone activity of bc1 complex-like {ECO:0000303|PubMed:11888884};Coenzyme Q protein 8A {ECO:0000305};aarF domain-containing protein kinase 3 {ECO:0000312|HGNC:HGNC:16812};, PF03109;, GO:0031314;GO:0016021;GO:0005739;GO:0043531;GO:0005524;GO:0016301;GO:0016310;GO:0006468;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:mitochondrion;, F:ADP binding; F:ATP binding; F:kinase activity;, P:phosphorylation; P:protein phosphorylation; P:ubiquinone biosynthetic process;|Q8NI60 Q5T7A5 Q63HK0 Q8NCJ6 Q9HBQ1 Q9NQ67,Atypical kinase COQ8A, mitochondrial {ECO:0000305},Chaperone activity of bc1 complex-like {ECO:0000303|PubMed:11888884};Coenzyme Q protein 8A {ECO:0000305};aarF domain-containing protein kinase 3 {ECO:0000312|HGNC:HGNC:16812};, PF03109;, GO:0031314;GO:0016021;GO:0005739;GO:0043531;GO:0005524;GO:0016301;GO:0016310;GO:0006468;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:mitochondrion;, F:ADP binding; F:ATP binding; F:kinase activity;, P:phosphorylation; P:protein phosphorylation; P:ubiquinone biosynthetic process; scaffold24 indexed_genome mRNA 8636815 8653021 . - . ID=transcript_5566;P49810 A8K8D4 B1AP21 Q96P32,Presenilin-2,AD3LP;AD5;E5-1;STM-2;, PF01080;, GO:0016324;GO:0005938;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0005887;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0031594;GO:0043025;GO:0005637;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030018;GO:0042500;GO:0004175;GO:0042987;GO:0034205;GO:0050435;GO:0006816;GO:0048013;GO:0035556;GO:0006509;GO:0031293;GO:1990456;GO:0043066;GO:0007220;GO:0035333;GO:0043065;GO:0043085;GO:0016485;GO:0110097;, C:apical plasma membrane; C:cell cortex; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of plasma membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:neuromuscular junction; C:neuronal cell body; C:nuclear inner membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:endopeptidase activity;, P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:calcium ion transport; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of apoptotic process; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:protein processing; P:regulation of calcium import into the mitochondrion;|P49810 A8K8D4 B1AP21 Q96P32,Presenilin-2,AD3LP;AD5;E5-1;STM-2;, PF01080;, GO:0016324;GO:0005938;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0005887;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0031594;GO:0043025;GO:0005637;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030018;GO:0042500;GO:0004175;GO:0042987;GO:0034205;GO:0050435;GO:0006816;GO:0048013;GO:0035556;GO:0006509;GO:0031293;GO:1990456;GO:0043066;GO:0007220;GO:0035333;GO:0043065;GO:0043085;GO:0016485;GO:0110097;, C:apical plasma membrane; C:cell cortex; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of plasma membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:neuromuscular junction; C:neuronal cell body; C:nuclear inner membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:endopeptidase activity;, P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:calcium ion transport; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of apoptotic process; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:protein processing; P:regulation of calcium import into the mitochondrion;|P49810 A8K8D4 B1AP21 Q96P32,Presenilin-2,AD3LP;AD5;E5-1;STM-2;, PF01080;, GO:0016324;GO:0005938;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0005887;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0031594;GO:0043025;GO:0005637;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030018;GO:0042500;GO:0004175;GO:0042987;GO:0034205;GO:0050435;GO:0006816;GO:0048013;GO:0035556;GO:0006509;GO:0031293;GO:1990456;GO:0043066;GO:0007220;GO:0035333;GO:0043065;GO:0043085;GO:0016485;GO:0110097;, C:apical plasma membrane; C:cell cortex; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of plasma membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:neuromuscular junction; C:neuronal cell body; C:nuclear inner membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:endopeptidase activity;, P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:calcium ion transport; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of apoptotic process; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:protein processing; P:regulation of calcium import into the mitochondrion;|P49810 A8K8D4 B1AP21 Q96P32,Presenilin-2,AD3LP;AD5;E5-1;STM-2;, PF01080;, GO:0016324;GO:0005938;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0005887;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0031594;GO:0043025;GO:0005637;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030018;GO:0042500;GO:0004175;GO:0042987;GO:0034205;GO:0050435;GO:0006816;GO:0048013;GO:0035556;GO:0006509;GO:0031293;GO:1990456;GO:0043066;GO:0007220;GO:0035333;GO:0043065;GO:0043085;GO:0016485;GO:0110097;, C:apical plasma membrane; C:cell cortex; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of plasma membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:neuromuscular junction; C:neuronal cell body; C:nuclear inner membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:endopeptidase activity;, P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:calcium ion transport; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of apoptotic process; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:protein processing; P:regulation of calcium import into the mitochondrion;|P49810 A8K8D4 B1AP21 Q96P32,Presenilin-2,AD3LP;AD5;E5-1;STM-2;, PF01080;, GO:0016324;GO:0005938;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0005887;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0031594;GO:0043025;GO:0005637;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030018;GO:0042500;GO:0004175;GO:0042987;GO:0034205;GO:0050435;GO:0006816;GO:0048013;GO:0035556;GO:0006509;GO:0031293;GO:1990456;GO:0043066;GO:0007220;GO:0035333;GO:0043065;GO:0043085;GO:0016485;GO:0110097;, C:apical plasma membrane; C:cell cortex; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of plasma membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:neuromuscular junction; C:neuronal cell body; C:nuclear inner membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:endopeptidase activity;, P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:calcium ion transport; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of apoptotic process; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:protein processing; P:regulation of calcium import into the mitochondrion;|P49810 A8K8D4 B1AP21 Q96P32,Presenilin-2,AD3LP;AD5;E5-1;STM-2;, PF01080;, GO:0016324;GO:0005938;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0005887;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0031594;GO:0043025;GO:0005637;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030018;GO:0042500;GO:0004175;GO:0042987;GO:0034205;GO:0050435;GO:0006816;GO:0048013;GO:0035556;GO:0006509;GO:0031293;GO:1990456;GO:0043066;GO:0007220;GO:0035333;GO:0043065;GO:0043085;GO:0016485;GO:0110097;, C:apical plasma membrane; C:cell cortex; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of plasma membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:neuromuscular junction; C:neuronal cell body; C:nuclear inner membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:endopeptidase activity;, P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:calcium ion transport; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of apoptotic process; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:protein processing; P:regulation of calcium import into the mitochondrion;|P49810 A8K8D4 B1AP21 Q96P32,Presenilin-2,AD3LP;AD5;E5-1;STM-2;, PF01080;, GO:0016324;GO:0005938;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0005887;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0031594;GO:0043025;GO:0005637;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030018;GO:0042500;GO:0004175;GO:0042987;GO:0034205;GO:0050435;GO:0006816;GO:0048013;GO:0035556;GO:0006509;GO:0031293;GO:1990456;GO:0043066;GO:0007220;GO:0035333;GO:0043065;GO:0043085;GO:0016485;GO:0110097;, C:apical plasma membrane; C:cell cortex; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of plasma membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:neuromuscular junction; C:neuronal cell body; C:nuclear inner membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:endopeptidase activity;, P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:calcium ion transport; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of apoptotic process; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:protein processing; P:regulation of calcium import into the mitochondrion;|P49810 A8K8D4 B1AP21 Q96P32,Presenilin-2,AD3LP;AD5;E5-1;STM-2;, PF01080;, GO:0016324;GO:0005938;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0005887;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0031594;GO:0043025;GO:0005637;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030018;GO:0042500;GO:0004175;GO:0042987;GO:0034205;GO:0050435;GO:0006816;GO:0048013;GO:0035556;GO:0006509;GO:0031293;GO:1990456;GO:0043066;GO:0007220;GO:0035333;GO:0043065;GO:0043085;GO:0016485;GO:0110097;, C:apical plasma membrane; C:cell cortex; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of plasma membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:neuromuscular junction; C:neuronal cell body; C:nuclear inner membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:endopeptidase activity;, P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:calcium ion transport; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of apoptotic process; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:protein processing; P:regulation of calcium import into the mitochondrion; scaffold24 indexed_genome mRNA 8867812 8869513 . - . ID=transcript_5567;P27987 Q5VWL9 Q5VWM0 Q96BZ2 Q96JS1 Q9UH47,Inositol-trisphosphate 3-kinase B,Inositol 1,4,5-trisphosphate 3-kinase B;, PF03770;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005524;GO:0005516;GO:0000828;GO:0008440;GO:0016301;GO:0007166;GO:0071277;GO:0035726;GO:0032958;GO:0043647;GO:0032957;GO:0000165;GO:0002262;GO:0045638;GO:0033030;GO:0046854;GO:0046638;GO:0046579;GO:0045059;GO:0001932;GO:0007165;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:ATP binding; F:calmodulin binding; F:inositol hexakisphosphate kinase activity; F:inositol-1,4,5-trisphosphate 3-kinase activity; F:kinase activity;, P:cell surface receptor signaling pathway; P:cellular response to calcium ion; P:common myeloid progenitor cell proliferation; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:inositol trisphosphate metabolic process; P:MAPK cascade; P:myeloid cell homeostasis; P:negative regulation of myeloid cell differentiation; P:negative regulation of neutrophil apoptotic process; P:phosphatidylinositol phosphorylation; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of Ras protein signal transduction; P:positive thymic T cell selection; P:regulation of protein phosphorylation; P:signal transduction; scaffold24 indexed_genome mRNA 9083328 9118625 . + . ID=transcript_5568;P09874 B1ANJ4 Q8IUZ9,Poly [ADP-ribose] polymerase 1,ADP-ribosyltransferase diphtheria toxin-like 1 {ECO:0000303|PubMed:29954836};DNA ADP-ribosyltransferase PARP1 {ECO:0000305};NAD(+) ADP-ribosyltransferase 1 {ECO:0000303|Ref.11};Poly[ADP-ribose] synthase 1;Protein poly-ADP-ribosyltransferase PARP1 {ECO:0000305};, PF00533;PF08063;PF00644;PF02877;PF05406;PF00645;, GO:0000781;GO:0016020;GO:0005739;GO:0016604;GO:0005635;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0090734;GO:0035861;GO:0005667;GO:0003677;GO:0019899;GO:0030331;GO:0042826;GO:0042802;GO:0051287;GO:0140294;GO:0003950;GO:1990404;GO:0019901;GO:0047485;GO:0070412;GO:0003723;GO:0008134;GO:0008270;GO:0006915;GO:1990966;GO:0006287;GO:1904646;GO:0006974;GO:0032869;GO:0034599;GO:0034644;GO:0071294;GO:0030592;GO:0042769;GO:0006281;GO:0006302;GO:0000724;GO:0070911;GO:0030225;GO:0032042;GO:0043504;GO:0007005;GO:2001170;GO:1904357;GO:0000122;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0018424;GO:0018312;GO:0010613;GO:1905168;GO:0033148;GO:0051901;GO:1904762;GO:1901216;GO:1900182;GO:1903518;GO:0060391;GO:0045944;GO:2000679;GO:0006471;GO:0070213;GO:0016540;GO:0036211;GO:0070212;GO:0050790;GO:1903827;GO:0044030;GO:1903376;GO:0010990;GO:1904044;GO:0010332;GO:0023019;GO:0000723;GO:0006366;GO:0007179;, C:chromosome, telomeric region; C:membrane; C:mitochondrion; C:nuclear body; C:nuclear envelope; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:site of DNA damage; C:site of double-strand break; C:transcription regulator complex;, F:DNA binding; F:enzyme binding; F:estrogen receptor binding; F:histone deacetylase binding; F:identical protein binding; F:NAD binding; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:protein kinase binding; F:protein N-terminus binding; F:R-SMAD binding; F:RNA binding; F:transcription factor binding; F:zinc ion binding;, P:apoptotic process; P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cellular response to oxidative stress; P:cellular response to UV; P:cellular response to zinc ion; P:DNA ADP-ribosylation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:global genome nucleotide-excision repair; P:macrophage differentiation; P:mitochondrial DNA metabolic process; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of ATP biosynthetic process; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:peptidyl-glutamic acid poly-ADP-ribosylation; P:peptidyl-serine ADP-ribosylation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of mitochondrial depolarization; P:positive regulation of myofibroblast differentiation; P:positive regulation of neuron death; P:positive regulation of protein localization to nucleus; P:positive regulation of single strand break repair; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein autoprocessing; P:protein modification process; P:protein poly-ADP-ribosylation; P:regulation of catalytic activity; P:regulation of cellular protein localization; P:regulation of DNA methylation; P:regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:regulation of SMAD protein complex assembly; P:response to aldosterone; P:response to gamma radiation; P:signal transduction involved in regulation of gene expression; P:telomere maintenance; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway;|P09874 B1ANJ4 Q8IUZ9,Poly [ADP-ribose] polymerase 1,ADP-ribosyltransferase diphtheria toxin-like 1 {ECO:0000303|PubMed:29954836};DNA ADP-ribosyltransferase PARP1 {ECO:0000305};NAD(+) ADP-ribosyltransferase 1 {ECO:0000303|Ref.11};Poly[ADP-ribose] synthase 1;Protein poly-ADP-ribosyltransferase PARP1 {ECO:0000305};, PF00533;PF08063;PF00644;PF02877;PF05406;PF00645;, GO:0000781;GO:0016020;GO:0005739;GO:0016604;GO:0005635;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0090734;GO:0035861;GO:0005667;GO:0003677;GO:0019899;GO:0030331;GO:0042826;GO:0042802;GO:0051287;GO:0140294;GO:0003950;GO:1990404;GO:0019901;GO:0047485;GO:0070412;GO:0003723;GO:0008134;GO:0008270;GO:0006915;GO:1990966;GO:0006287;GO:1904646;GO:0006974;GO:0032869;GO:0034599;GO:0034644;GO:0071294;GO:0030592;GO:0042769;GO:0006281;GO:0006302;GO:0000724;GO:0070911;GO:0030225;GO:0032042;GO:0043504;GO:0007005;GO:2001170;GO:1904357;GO:0000122;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0018424;GO:0018312;GO:0010613;GO:1905168;GO:0033148;GO:0051901;GO:1904762;GO:1901216;GO:1900182;GO:1903518;GO:0060391;GO:0045944;GO:2000679;GO:0006471;GO:0070213;GO:0016540;GO:0036211;GO:0070212;GO:0050790;GO:1903827;GO:0044030;GO:1903376;GO:0010990;GO:1904044;GO:0010332;GO:0023019;GO:0000723;GO:0006366;GO:0007179;, C:chromosome, telomeric region; C:membrane; C:mitochondrion; C:nuclear body; C:nuclear envelope; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:site of DNA damage; C:site of double-strand break; C:transcription regulator complex;, F:DNA binding; F:enzyme binding; F:estrogen receptor binding; F:histone deacetylase binding; F:identical protein binding; F:NAD binding; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:protein kinase binding; F:protein N-terminus binding; F:R-SMAD binding; F:RNA binding; F:transcription factor binding; F:zinc ion binding;, P:apoptotic process; P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cellular response to oxidative stress; P:cellular response to UV; P:cellular response to zinc ion; P:DNA ADP-ribosylation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:global genome nucleotide-excision repair; P:macrophage differentiation; P:mitochondrial DNA metabolic process; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of ATP biosynthetic process; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:peptidyl-glutamic acid poly-ADP-ribosylation; P:peptidyl-serine ADP-ribosylation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of mitochondrial depolarization; P:positive regulation of myofibroblast differentiation; P:positive regulation of neuron death; P:positive regulation of protein localization to nucleus; P:positive regulation of single strand break repair; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein autoprocessing; P:protein modification process; P:protein poly-ADP-ribosylation; P:regulation of catalytic activity; P:regulation of cellular protein localization; P:regulation of DNA methylation; P:regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:regulation of SMAD protein complex assembly; P:response to aldosterone; P:response to gamma radiation; P:signal transduction involved in regulation of gene expression; P:telomere maintenance; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway;|P09874 B1ANJ4 Q8IUZ9,Poly [ADP-ribose] polymerase 1,ADP-ribosyltransferase diphtheria toxin-like 1 {ECO:0000303|PubMed:29954836};DNA ADP-ribosyltransferase PARP1 {ECO:0000305};NAD(+) ADP-ribosyltransferase 1 {ECO:0000303|Ref.11};Poly[ADP-ribose] synthase 1;Protein poly-ADP-ribosyltransferase PARP1 {ECO:0000305};, PF00533;PF08063;PF00644;PF02877;PF05406;PF00645;, GO:0000781;GO:0016020;GO:0005739;GO:0016604;GO:0005635;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0090734;GO:0035861;GO:0005667;GO:0003677;GO:0019899;GO:0030331;GO:0042826;GO:0042802;GO:0051287;GO:0140294;GO:0003950;GO:1990404;GO:0019901;GO:0047485;GO:0070412;GO:0003723;GO:0008134;GO:0008270;GO:0006915;GO:1990966;GO:0006287;GO:1904646;GO:0006974;GO:0032869;GO:0034599;GO:0034644;GO:0071294;GO:0030592;GO:0042769;GO:0006281;GO:0006302;GO:0000724;GO:0070911;GO:0030225;GO:0032042;GO:0043504;GO:0007005;GO:2001170;GO:1904357;GO:0000122;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0018424;GO:0018312;GO:0010613;GO:1905168;GO:0033148;GO:0051901;GO:1904762;GO:1901216;GO:1900182;GO:1903518;GO:0060391;GO:0045944;GO:2000679;GO:0006471;GO:0070213;GO:0016540;GO:0036211;GO:0070212;GO:0050790;GO:1903827;GO:0044030;GO:1903376;GO:0010990;GO:1904044;GO:0010332;GO:0023019;GO:0000723;GO:0006366;GO:0007179;, C:chromosome, telomeric region; C:membrane; C:mitochondrion; C:nuclear body; C:nuclear envelope; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:site of DNA damage; C:site of double-strand break; C:transcription regulator complex;, F:DNA binding; F:enzyme binding; F:estrogen receptor binding; F:histone deacetylase binding; F:identical protein binding; F:NAD binding; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:protein kinase binding; F:protein N-terminus binding; F:R-SMAD binding; F:RNA binding; F:transcription factor binding; F:zinc ion binding;, P:apoptotic process; P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cellular response to oxidative stress; P:cellular response to UV; P:cellular response to zinc ion; P:DNA ADP-ribosylation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:global genome nucleotide-excision repair; P:macrophage differentiation; P:mitochondrial DNA metabolic process; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of ATP biosynthetic process; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:peptidyl-glutamic acid poly-ADP-ribosylation; P:peptidyl-serine ADP-ribosylation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of mitochondrial depolarization; P:positive regulation of myofibroblast differentiation; P:positive regulation of neuron death; P:positive regulation of protein localization to nucleus; P:positive regulation of single strand break repair; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein autoprocessing; P:protein modification process; P:protein poly-ADP-ribosylation; P:regulation of catalytic activity; P:regulation of cellular protein localization; P:regulation of DNA methylation; P:regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:regulation of SMAD protein complex assembly; P:response to aldosterone; P:response to gamma radiation; P:signal transduction involved in regulation of gene expression; P:telomere maintenance; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway;|P09874 B1ANJ4 Q8IUZ9,Poly [ADP-ribose] polymerase 1,ADP-ribosyltransferase diphtheria toxin-like 1 {ECO:0000303|PubMed:29954836};DNA ADP-ribosyltransferase PARP1 {ECO:0000305};NAD(+) ADP-ribosyltransferase 1 {ECO:0000303|Ref.11};Poly[ADP-ribose] synthase 1;Protein poly-ADP-ribosyltransferase PARP1 {ECO:0000305};, PF00533;PF08063;PF00644;PF02877;PF05406;PF00645;, GO:0000781;GO:0016020;GO:0005739;GO:0016604;GO:0005635;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0090734;GO:0035861;GO:0005667;GO:0003677;GO:0019899;GO:0030331;GO:0042826;GO:0042802;GO:0051287;GO:0140294;GO:0003950;GO:1990404;GO:0019901;GO:0047485;GO:0070412;GO:0003723;GO:0008134;GO:0008270;GO:0006915;GO:1990966;GO:0006287;GO:1904646;GO:0006974;GO:0032869;GO:0034599;GO:0034644;GO:0071294;GO:0030592;GO:0042769;GO:0006281;GO:0006302;GO:0000724;GO:0070911;GO:0030225;GO:0032042;GO:0043504;GO:0007005;GO:2001170;GO:1904357;GO:0000122;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0018424;GO:0018312;GO:0010613;GO:1905168;GO:0033148;GO:0051901;GO:1904762;GO:1901216;GO:1900182;GO:1903518;GO:0060391;GO:0045944;GO:2000679;GO:0006471;GO:0070213;GO:0016540;GO:0036211;GO:0070212;GO:0050790;GO:1903827;GO:0044030;GO:1903376;GO:0010990;GO:1904044;GO:0010332;GO:0023019;GO:0000723;GO:0006366;GO:0007179;, C:chromosome, telomeric region; C:membrane; C:mitochondrion; C:nuclear body; C:nuclear envelope; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:site of DNA damage; C:site of double-strand break; C:transcription regulator complex;, F:DNA binding; F:enzyme binding; F:estrogen receptor binding; F:histone deacetylase binding; F:identical protein binding; F:NAD binding; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:protein kinase binding; F:protein N-terminus binding; F:R-SMAD binding; F:RNA binding; F:transcription factor binding; F:zinc ion binding;, P:apoptotic process; P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cellular response to oxidative stress; P:cellular response to UV; P:cellular response to zinc ion; P:DNA ADP-ribosylation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:global genome nucleotide-excision repair; P:macrophage differentiation; P:mitochondrial DNA metabolic process; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of ATP biosynthetic process; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:peptidyl-glutamic acid poly-ADP-ribosylation; P:peptidyl-serine ADP-ribosylation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of mitochondrial depolarization; P:positive regulation of myofibroblast differentiation; P:positive regulation of neuron death; P:positive regulation of protein localization to nucleus; P:positive regulation of single strand break repair; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein autoprocessing; P:protein modification process; P:protein poly-ADP-ribosylation; P:regulation of catalytic activity; P:regulation of cellular protein localization; P:regulation of DNA methylation; P:regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:regulation of SMAD protein complex assembly; P:response to aldosterone; P:response to gamma radiation; P:signal transduction involved in regulation of gene expression; P:telomere maintenance; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway;|P09874 B1ANJ4 Q8IUZ9,Poly [ADP-ribose] polymerase 1,ADP-ribosyltransferase diphtheria toxin-like 1 {ECO:0000303|PubMed:29954836};DNA ADP-ribosyltransferase PARP1 {ECO:0000305};NAD(+) ADP-ribosyltransferase 1 {ECO:0000303|Ref.11};Poly[ADP-ribose] synthase 1;Protein poly-ADP-ribosyltransferase PARP1 {ECO:0000305};, PF00533;PF08063;PF00644;PF02877;PF05406;PF00645;, GO:0000781;GO:0016020;GO:0005739;GO:0016604;GO:0005635;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0090734;GO:0035861;GO:0005667;GO:0003677;GO:0019899;GO:0030331;GO:0042826;GO:0042802;GO:0051287;GO:0140294;GO:0003950;GO:1990404;GO:0019901;GO:0047485;GO:0070412;GO:0003723;GO:0008134;GO:0008270;GO:0006915;GO:1990966;GO:0006287;GO:1904646;GO:0006974;GO:0032869;GO:0034599;GO:0034644;GO:0071294;GO:0030592;GO:0042769;GO:0006281;GO:0006302;GO:0000724;GO:0070911;GO:0030225;GO:0032042;GO:0043504;GO:0007005;GO:2001170;GO:1904357;GO:0000122;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0018424;GO:0018312;GO:0010613;GO:1905168;GO:0033148;GO:0051901;GO:1904762;GO:1901216;GO:1900182;GO:1903518;GO:0060391;GO:0045944;GO:2000679;GO:0006471;GO:0070213;GO:0016540;GO:0036211;GO:0070212;GO:0050790;GO:1903827;GO:0044030;GO:1903376;GO:0010990;GO:1904044;GO:0010332;GO:0023019;GO:0000723;GO:0006366;GO:0007179;, C:chromosome, telomeric region; C:membrane; C:mitochondrion; C:nuclear body; C:nuclear envelope; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:site of DNA damage; C:site of double-strand break; C:transcription regulator complex;, F:DNA binding; F:enzyme binding; F:estrogen receptor binding; F:histone deacetylase binding; F:identical protein binding; F:NAD binding; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:protein kinase binding; F:protein N-terminus binding; F:R-SMAD binding; F:RNA binding; F:transcription factor binding; F:zinc ion binding;, P:apoptotic process; P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cellular response to oxidative stress; P:cellular response to UV; P:cellular response to zinc ion; P:DNA ADP-ribosylation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:global genome nucleotide-excision repair; P:macrophage differentiation; P:mitochondrial DNA metabolic process; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of ATP biosynthetic process; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:peptidyl-glutamic acid poly-ADP-ribosylation; P:peptidyl-serine ADP-ribosylation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of mitochondrial depolarization; P:positive regulation of myofibroblast differentiation; P:positive regulation of neuron death; P:positive regulation of protein localization to nucleus; P:positive regulation of single strand break repair; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein autoprocessing; P:protein modification process; P:protein poly-ADP-ribosylation; P:regulation of catalytic activity; P:regulation of cellular protein localization; P:regulation of DNA methylation; P:regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:regulation of SMAD protein complex assembly; P:response to aldosterone; P:response to gamma radiation; P:signal transduction involved in regulation of gene expression; P:telomere maintenance; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway;|P09874 B1ANJ4 Q8IUZ9,Poly [ADP-ribose] polymerase 1,ADP-ribosyltransferase diphtheria toxin-like 1 {ECO:0000303|PubMed:29954836};DNA ADP-ribosyltransferase PARP1 {ECO:0000305};NAD(+) ADP-ribosyltransferase 1 {ECO:0000303|Ref.11};Poly[ADP-ribose] synthase 1;Protein poly-ADP-ribosyltransferase PARP1 {ECO:0000305};, PF00533;PF08063;PF00644;PF02877;PF05406;PF00645;, GO:0000781;GO:0016020;GO:0005739;GO:0016604;GO:0005635;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0090734;GO:0035861;GO:0005667;GO:0003677;GO:0019899;GO:0030331;GO:0042826;GO:0042802;GO:0051287;GO:0140294;GO:0003950;GO:1990404;GO:0019901;GO:0047485;GO:0070412;GO:0003723;GO:0008134;GO:0008270;GO:0006915;GO:1990966;GO:0006287;GO:1904646;GO:0006974;GO:0032869;GO:0034599;GO:0034644;GO:0071294;GO:0030592;GO:0042769;GO:0006281;GO:0006302;GO:0000724;GO:0070911;GO:0030225;GO:0032042;GO:0043504;GO:0007005;GO:2001170;GO:1904357;GO:0000122;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0018424;GO:0018312;GO:0010613;GO:1905168;GO:0033148;GO:0051901;GO:1904762;GO:1901216;GO:1900182;GO:1903518;GO:0060391;GO:0045944;GO:2000679;GO:0006471;GO:0070213;GO:0016540;GO:0036211;GO:0070212;GO:0050790;GO:1903827;GO:0044030;GO:1903376;GO:0010990;GO:1904044;GO:0010332;GO:0023019;GO:0000723;GO:0006366;GO:0007179;, C:chromosome, telomeric region; C:membrane; C:mitochondrion; C:nuclear body; C:nuclear envelope; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:site of DNA damage; C:site of double-strand break; C:transcription regulator complex;, F:DNA binding; F:enzyme binding; F:estrogen receptor binding; F:histone deacetylase binding; F:identical protein binding; F:NAD binding; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:protein kinase binding; F:protein N-terminus binding; F:R-SMAD binding; F:RNA binding; F:transcription factor binding; F:zinc ion binding;, P:apoptotic process; P:ATP generation from poly-ADP-D-ribose; P:base-excision repair, gap-filling; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cellular response to oxidative stress; P:cellular response to UV; P:cellular response to zinc ion; P:DNA ADP-ribosylation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:global genome nucleotide-excision repair; P:macrophage differentiation; P:mitochondrial DNA metabolic process; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of ATP biosynthetic process; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of transcription by RNA polymerase II; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:peptidyl-glutamic acid poly-ADP-ribosylation; P:peptidyl-serine ADP-ribosylation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of mitochondrial depolarization; P:positive regulation of myofibroblast differentiation; P:positive regulation of neuron death; P:positive regulation of protein localization to nucleus; P:positive regulation of single strand break repair; P:positive regulation of SMAD protein signal transduction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein autoprocessing; P:protein modification process; P:protein poly-ADP-ribosylation; P:regulation of catalytic activity; P:regulation of cellular protein localization; P:regulation of DNA methylation; P:regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:regulation of SMAD protein complex assembly; P:response to aldosterone; P:response to gamma radiation; P:signal transduction involved in regulation of gene expression; P:telomere maintenance; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; scaffold24 indexed_genome mRNA 9171198 9257110 . + . ID=transcript_5569;Q5TKA1 Q5U5L8 Q5U7E1 Q6PI55 Q6ZTV4 Q7Z3J1,Protein lin-9 homolog,Beta subunit-associated regulator of apoptosis;TUDOR gene similar protein;Type I interferon receptor beta chain-associated protein;pRB-associated protein;, PF06584;, GO:0005654;GO:0017053;GO:0003677;GO:0007049;GO:0071897;GO:0051726;GO:0006357;GO:0000003;GO:0006351;, C:nucleoplasm; C:transcription repressor complex;, F:DNA binding;, P:cell cycle; P:DNA biosynthetic process; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:reproduction; P:transcription, DNA-templated; scaffold24 indexed_genome mRNA 9302663 9320654 . + . ID=transcript_5570;Q9H3P7 B2RB29 Q5VTJ0 Q6P9F1 Q8IZC5 Q8N4D6 Q9H6U3,Golgi resident protein GCP60,Acyl-CoA-binding domain-containing protein 3;Golgi complex-associated protein 1;Golgi phosphoprotein 1;PBR- and PKA-associated protein 7;Peripheral benzodiazepine receptor-associated protein PAP7;, PF00887;PF13897;, GO:0005794;GO:0000139;GO:0016020;GO:0005739;GO:0000062;GO:0034237;GO:0006892;GO:0006694;GO:0016032;, C:Golgi apparatus; C:Golgi membrane; C:membrane; C:mitochondrion;, F:fatty-acyl-CoA binding; F:protein kinase A regulatory subunit binding;, P:post-Golgi vesicle-mediated transport; P:steroid biosynthetic process; P:viral process; scaffold24 indexed_genome mRNA 9320735 9338615 . + . ID=transcript_5571;Q9H3P7 B2RB29 Q5VTJ0 Q6P9F1 Q8IZC5 Q8N4D6 Q9H6U3,Golgi resident protein GCP60,Acyl-CoA-binding domain-containing protein 3;Golgi complex-associated protein 1;Golgi phosphoprotein 1;PBR- and PKA-associated protein 7;Peripheral benzodiazepine receptor-associated protein PAP7;, PF00887;PF13897;, GO:0005794;GO:0000139;GO:0016020;GO:0005739;GO:0000062;GO:0034237;GO:0006892;GO:0006694;GO:0016032;, C:Golgi apparatus; C:Golgi membrane; C:membrane; C:mitochondrion;, F:fatty-acyl-CoA binding; F:protein kinase A regulatory subunit binding;, P:post-Golgi vesicle-mediated transport; P:steroid biosynthetic process; P:viral process;|Q9H3P7 B2RB29 Q5VTJ0 Q6P9F1 Q8IZC5 Q8N4D6 Q9H6U3,Golgi resident protein GCP60,Acyl-CoA-binding domain-containing protein 3;Golgi complex-associated protein 1;Golgi phosphoprotein 1;PBR- and PKA-associated protein 7;Peripheral benzodiazepine receptor-associated protein PAP7;, PF00887;PF13897;, GO:0005794;GO:0000139;GO:0016020;GO:0005739;GO:0000062;GO:0034237;GO:0006892;GO:0006694;GO:0016032;, C:Golgi apparatus; C:Golgi membrane; C:membrane; C:mitochondrion;, F:fatty-acyl-CoA binding; F:protein kinase A regulatory subunit binding;, P:post-Golgi vesicle-mediated transport; P:steroid biosynthetic process; P:viral process;|Q9H3P7 B2RB29 Q5VTJ0 Q6P9F1 Q8IZC5 Q8N4D6 Q9H6U3,Golgi resident protein GCP60,Acyl-CoA-binding domain-containing protein 3;Golgi complex-associated protein 1;Golgi phosphoprotein 1;PBR- and PKA-associated protein 7;Peripheral benzodiazepine receptor-associated protein PAP7;, PF00887;PF13897;, GO:0005794;GO:0000139;GO:0016020;GO:0005739;GO:0000062;GO:0034237;GO:0006892;GO:0006694;GO:0016032;, C:Golgi apparatus; C:Golgi membrane; C:membrane; C:mitochondrion;, F:fatty-acyl-CoA binding; F:protein kinase A regulatory subunit binding;, P:post-Golgi vesicle-mediated transport; P:steroid biosynthetic process; P:viral process;|Q9H3P7 B2RB29 Q5VTJ0 Q6P9F1 Q8IZC5 Q8N4D6 Q9H6U3,Golgi resident protein GCP60,Acyl-CoA-binding domain-containing protein 3;Golgi complex-associated protein 1;Golgi phosphoprotein 1;PBR- and PKA-associated protein 7;Peripheral benzodiazepine receptor-associated protein PAP7;, PF00887;PF13897;, GO:0005794;GO:0000139;GO:0016020;GO:0005739;GO:0000062;GO:0034237;GO:0006892;GO:0006694;GO:0016032;, C:Golgi apparatus; C:Golgi membrane; C:membrane; C:mitochondrion;, F:fatty-acyl-CoA binding; F:protein kinase A regulatory subunit binding;, P:post-Golgi vesicle-mediated transport; P:steroid biosynthetic process; P:viral process; scaffold24 indexed_genome mRNA 9409988 9418103 . - . ID=transcript_5572;P84243 P06351 P33155 Q5VV55 Q5VV56 Q66I33 Q9V3W4,Histone H3.3,, PF00125;, GO:0001740;GO:0000781;GO:0070062;GO:0005576;GO:0000228;GO:0005654;GO:0000786;GO:0005634;GO:0032991;GO:0031492;GO:0046982;GO:0000978;GO:0000979;GO:1990000;GO:0007596;GO:0008283;GO:0006336;GO:0007566;GO:0008584;GO:0035264;GO:0042692;GO:1902340;GO:0045814;GO:0006334;GO:0006997;GO:0048477;GO:0001649;GO:0031508;GO:0030307;GO:1900051;GO:0000183;GO:0060765;GO:0090230;GO:0060964;GO:0045652;GO:0007338;GO:0007286;GO:0031509;GO:0032200;, C:Barr body; C:chromosome, telomeric region; C:extracellular exosome; C:extracellular region; C:nuclear chromosome; C:nucleoplasm; C:nucleosome; C:nucleus; C:protein-containing complex;, F:nucleosomal DNA binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding;, P:amyloid fibril formation; P:blood coagulation; P:cell population proliferation; P:DNA replication-independent nucleosome assembly; P:embryo implantation; P:male gonad development; P:multicellular organism growth; P:muscle cell differentiation; P:negative regulation of chromosome condensation; P:negative regulation of gene expression, epigenetic; P:nucleosome assembly; P:nucleus organization; P:oogenesis; P:osteoblast differentiation; P:pericentric heterochromatin assembly; P:positive regulation of cell growth; P:positive regulation of histone exchange; P:rDNA heterochromatin assembly; P:regulation of androgen receptor signaling pathway; P:regulation of centromere complex assembly; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:single fertilization; P:spermatid development; P:subtelomeric heterochromatin assembly; P:telomere organization;|Q71DI3 A2BDF6 A6NFS4 Q6B053,Histone H3.2,H3-clustered histone 13 {ECO:0000312|HGNC:HGNC:25311};H3-clustered histone 14 {ECO:0000312|HGNC:HGNC:20503};H3-clustered histone 15 {ECO:0000312|HGNC:HGNC:20505};Histone H3/m;Histone H3/o;, PF00125;, GO:0070062;GO:0005576;GO:0005654;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:1990000;GO:0007596;GO:0006325;GO:0038111;GO:0045814;GO:0006334;GO:0000183;GO:0060765;GO:0060964;GO:0045652;, C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:amyloid fibril formation; P:blood coagulation; P:chromatin organization; P:interleukin-7-mediated signaling pathway; P:negative regulation of gene expression, epigenetic; P:nucleosome assembly; P:rDNA heterochromatin assembly; P:regulation of androgen receptor signaling pathway; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation;|P84243 P06351 P33155 Q5VV55 Q5VV56 Q66I33 Q9V3W4,Histone H3.3,, PF00125;, GO:0001740;GO:0000781;GO:0070062;GO:0005576;GO:0000228;GO:0005654;GO:0000786;GO:0005634;GO:0032991;GO:0031492;GO:0046982;GO:0000978;GO:0000979;GO:1990000;GO:0007596;GO:0008283;GO:0006336;GO:0007566;GO:0008584;GO:0035264;GO:0042692;GO:1902340;GO:0045814;GO:0006334;GO:0006997;GO:0048477;GO:0001649;GO:0031508;GO:0030307;GO:1900051;GO:0000183;GO:0060765;GO:0090230;GO:0060964;GO:0045652;GO:0007338;GO:0007286;GO:0031509;GO:0032200;, C:Barr body; C:chromosome, telomeric region; C:extracellular exosome; C:extracellular region; C:nuclear chromosome; C:nucleoplasm; C:nucleosome; C:nucleus; C:protein-containing complex;, F:nucleosomal DNA binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding;, P:amyloid fibril formation; P:blood coagulation; P:cell population proliferation; P:DNA replication-independent nucleosome assembly; P:embryo implantation; P:male gonad development; P:multicellular organism growth; P:muscle cell differentiation; P:negative regulation of chromosome condensation; P:negative regulation of gene expression, epigenetic; P:nucleosome assembly; P:nucleus organization; P:oogenesis; P:osteoblast differentiation; P:pericentric heterochromatin assembly; P:positive regulation of cell growth; P:positive regulation of histone exchange; P:rDNA heterochromatin assembly; P:regulation of androgen receptor signaling pathway; P:regulation of centromere complex assembly; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:single fertilization; P:spermatid development; P:subtelomeric heterochromatin assembly; P:telomere organization;|P84243 P06351 P33155 Q5VV55 Q5VV56 Q66I33 Q9V3W4,Histone H3.3,, PF00125;, GO:0001740;GO:0000781;GO:0070062;GO:0005576;GO:0000228;GO:0005654;GO:0000786;GO:0005634;GO:0032991;GO:0031492;GO:0046982;GO:0000978;GO:0000979;GO:1990000;GO:0007596;GO:0008283;GO:0006336;GO:0007566;GO:0008584;GO:0035264;GO:0042692;GO:1902340;GO:0045814;GO:0006334;GO:0006997;GO:0048477;GO:0001649;GO:0031508;GO:0030307;GO:1900051;GO:0000183;GO:0060765;GO:0090230;GO:0060964;GO:0045652;GO:0007338;GO:0007286;GO:0031509;GO:0032200;, C:Barr body; C:chromosome, telomeric region; C:extracellular exosome; C:extracellular region; C:nuclear chromosome; C:nucleoplasm; C:nucleosome; C:nucleus; C:protein-containing complex;, F:nucleosomal DNA binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding;, P:amyloid fibril formation; P:blood coagulation; P:cell population proliferation; P:DNA replication-independent nucleosome assembly; P:embryo implantation; P:male gonad development; P:multicellular organism growth; P:muscle cell differentiation; P:negative regulation of chromosome condensation; P:negative regulation of gene expression, epigenetic; P:nucleosome assembly; P:nucleus organization; P:oogenesis; P:osteoblast differentiation; P:pericentric heterochromatin assembly; P:positive regulation of cell growth; P:positive regulation of histone exchange; P:rDNA heterochromatin assembly; P:regulation of androgen receptor signaling pathway; P:regulation of centromere complex assembly; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:single fertilization; P:spermatid development; P:subtelomeric heterochromatin assembly; P:telomere organization; scaffold24 indexed_genome mRNA 9471117 9487291 . + . ID=transcript_5573;Q6IQ49 A8K4P3 Q5TD36 Q6ZS26 Q8NAG7,Replication stress response regulator SDE2 {ECO:0000305},, PF13019;, GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0003684;GO:0007049;GO:0051301;GO:0034644;GO:0006260;GO:0016485;GO:0016567;GO:0071156;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:damaged DNA binding;, P:cell cycle; P:cell division; P:cellular response to UV; P:DNA replication; P:protein processing; P:protein ubiquitination; P:regulation of cell cycle arrest;|Q6IQ49 A8K4P3 Q5TD36 Q6ZS26 Q8NAG7,Replication stress response regulator SDE2 {ECO:0000305},, PF13019;, GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0003684;GO:0007049;GO:0051301;GO:0034644;GO:0006260;GO:0016485;GO:0016567;GO:0071156;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:damaged DNA binding;, P:cell cycle; P:cell division; P:cellular response to UV; P:DNA replication; P:protein processing; P:protein ubiquitination; P:regulation of cell cycle arrest; scaffold24 indexed_genome mRNA 9530116 9614262 . + . ID=transcript_5574;O94886 Q53GI7 Q5TE96 Q8N2U2,CSC1-like protein 1,Transmembrane protein 63A;, PF14703;PF02714;PF13967;, GO:0034451;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0005227;GO:0008381;GO:0003676;GO:1990760;GO:0043312;, C:centriolar satellite; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:nucleic acid binding; F:osmolarity-sensing cation channel activity;, P:neutrophil degranulation;|O94886 Q53GI7 Q5TE96 Q8N2U2,CSC1-like protein 1,Transmembrane protein 63A;, PF14703;PF02714;PF13967;, GO:0034451;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0005227;GO:0008381;GO:0003676;GO:1990760;GO:0043312;, C:centriolar satellite; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:nucleic acid binding; F:osmolarity-sensing cation channel activity;, P:neutrophil degranulation;|O94886 Q53GI7 Q5TE96 Q8N2U2,CSC1-like protein 1,Transmembrane protein 63A;, PF14703;PF02714;PF13967;, GO:0034451;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0005227;GO:0008381;GO:0003676;GO:1990760;GO:0043312;, C:centriolar satellite; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:nucleic acid binding; F:osmolarity-sensing cation channel activity;, P:neutrophil degranulation;|O94886 Q53GI7 Q5TE96 Q8N2U2,CSC1-like protein 1,Transmembrane protein 63A;, PF14703;PF02714;PF13967;, GO:0034451;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0005227;GO:0008381;GO:0003676;GO:1990760;GO:0043312;, C:centriolar satellite; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:nucleic acid binding; F:osmolarity-sensing cation channel activity;, P:neutrophil degranulation;|O94886 Q53GI7 Q5TE96 Q8N2U2,CSC1-like protein 1,Transmembrane protein 63A;, PF14703;PF02714;PF13967;, GO:0034451;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0005227;GO:0008381;GO:0003676;GO:1990760;GO:0043312;, C:centriolar satellite; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:nucleic acid binding; F:osmolarity-sensing cation channel activity;, P:neutrophil degranulation;|O94886 Q53GI7 Q5TE96 Q8N2U2,CSC1-like protein 1,Transmembrane protein 63A;, PF14703;PF02714;PF13967;, GO:0034451;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0005227;GO:0008381;GO:0003676;GO:1990760;GO:0043312;, C:centriolar satellite; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:nucleic acid binding; F:osmolarity-sensing cation channel activity;, P:neutrophil degranulation;|O94886 Q53GI7 Q5TE96 Q8N2U2,CSC1-like protein 1,Transmembrane protein 63A;, PF14703;PF02714;PF13967;, GO:0034451;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0005227;GO:0008381;GO:0003676;GO:1990760;GO:0043312;, C:centriolar satellite; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:nucleic acid binding; F:osmolarity-sensing cation channel activity;, P:neutrophil degranulation;|Q9NQV0 Q9NQV1 Q9NQV2,Epoxide hydrolase 1 {ECO:0000305},Epoxide hydratase;Microsomal epoxide hydrolase;, PF00561;, GO:0005789;GO:0016021;GO:0033961;GO:0004301;GO:0019369;GO:0019439;GO:0097176;GO:0009636;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cis-stilbene-oxide hydrolase activity; F:epoxide hydrolase activity;, P:arachidonic acid metabolic process; P:aromatic compound catabolic process; P:epoxide metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q9NQV0 Q9NQV1 Q9NQV2,Epoxide hydrolase 1 {ECO:0000305},Epoxide hydratase;Microsomal epoxide hydrolase;, PF00561;, GO:0005789;GO:0016021;GO:0033961;GO:0004301;GO:0019369;GO:0019439;GO:0097176;GO:0009636;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cis-stilbene-oxide hydrolase activity; F:epoxide hydrolase activity;, P:arachidonic acid metabolic process; P:aromatic compound catabolic process; P:epoxide metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q9NQV0 Q9NQV1 Q9NQV2,Epoxide hydrolase 1 {ECO:0000305},Epoxide hydratase;Microsomal epoxide hydrolase;, PF00561;, GO:0005789;GO:0016021;GO:0033961;GO:0004301;GO:0019369;GO:0019439;GO:0097176;GO:0009636;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cis-stilbene-oxide hydrolase activity; F:epoxide hydrolase activity;, P:arachidonic acid metabolic process; P:aromatic compound catabolic process; P:epoxide metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q9NQV0 Q9NQV1 Q9NQV2,Epoxide hydrolase 1 {ECO:0000305},Epoxide hydratase;Microsomal epoxide hydrolase;, PF00561;, GO:0005789;GO:0016021;GO:0033961;GO:0004301;GO:0019369;GO:0019439;GO:0097176;GO:0009636;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cis-stilbene-oxide hydrolase activity; F:epoxide hydrolase activity;, P:arachidonic acid metabolic process; P:aromatic compound catabolic process; P:epoxide metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q9NQV0 Q9NQV1 Q9NQV2,Epoxide hydrolase 1 {ECO:0000305},Epoxide hydratase;Microsomal epoxide hydrolase;, PF00561;, GO:0005789;GO:0016021;GO:0033961;GO:0004301;GO:0019369;GO:0019439;GO:0097176;GO:0009636;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cis-stilbene-oxide hydrolase activity; F:epoxide hydrolase activity;, P:arachidonic acid metabolic process; P:aromatic compound catabolic process; P:epoxide metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q9NQV0 Q9NQV1 Q9NQV2,Epoxide hydrolase 1 {ECO:0000305},Epoxide hydratase;Microsomal epoxide hydrolase;, PF00561;, GO:0005789;GO:0016021;GO:0033961;GO:0004301;GO:0019369;GO:0019439;GO:0097176;GO:0009636;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cis-stilbene-oxide hydrolase activity; F:epoxide hydrolase activity;, P:arachidonic acid metabolic process; P:aromatic compound catabolic process; P:epoxide metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q9NQV0 Q9NQV1 Q9NQV2,Epoxide hydrolase 1 {ECO:0000305},Epoxide hydratase;Microsomal epoxide hydrolase;, PF00561;, GO:0005789;GO:0016021;GO:0033961;GO:0004301;GO:0019369;GO:0019439;GO:0097176;GO:0009636;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cis-stilbene-oxide hydrolase activity; F:epoxide hydrolase activity;, P:arachidonic acid metabolic process; P:aromatic compound catabolic process; P:epoxide metabolic process; P:response to toxic substance; P:xenobiotic metabolic process; scaffold24 indexed_genome mRNA 9635304 9646312 . - . ID=transcript_5575;P49458 A8K0N0 Q6NVX0 Q8WTW0,Signal recognition particle 9 kDa protein,, PF05486;, GO:0005829;GO:0005785;GO:0005786;GO:0008312;GO:0003723;GO:0005047;GO:0045900;GO:0006614;, C:cytosol; C:signal recognition particle receptor complex; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:RNA binding; F:signal recognition particle binding;, P:negative regulation of translational elongation; P:SRP-dependent cotranslational protein targeting to membrane;|P49458 A8K0N0 Q6NVX0 Q8WTW0,Signal recognition particle 9 kDa protein,, PF05486;, GO:0005829;GO:0005785;GO:0005786;GO:0008312;GO:0003723;GO:0005047;GO:0045900;GO:0006614;, C:cytosol; C:signal recognition particle receptor complex; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:RNA binding; F:signal recognition particle binding;, P:negative regulation of translational elongation; P:SRP-dependent cotranslational protein targeting to membrane; scaffold24 indexed_genome mRNA 9892642 9917997 . + . ID=transcript_5576;Q8N8S7 D0PQI2 Q502W5 Q5T5M7 Q5VTQ9 Q5VTR0 Q9NVF3 Q9UFB8,Protein enabled homolog,, PF08776;PF00568;, GO:0030054;GO:0005856;GO:0005829;GO:0030175;GO:0005925;GO:0030027;GO:0005886;GO:0045202;GO:0003779;GO:0005522;GO:0017124;GO:0050699;GO:0008154;GO:0070358;GO:0007411;, C:cell junction; C:cytoskeleton; C:cytosol; C:filopodium; C:focal adhesion; C:lamellipodium; C:plasma membrane; C:synapse;, F:actin binding; F:profilin binding; F:SH3 domain binding; F:WW domain binding;, P:actin polymerization or depolymerization; P:actin polymerization-dependent cell motility; P:axon guidance;|Q8N8S7 D0PQI2 Q502W5 Q5T5M7 Q5VTQ9 Q5VTR0 Q9NVF3 Q9UFB8,Protein enabled homolog,, PF08776;PF00568;, GO:0030054;GO:0005856;GO:0005829;GO:0030175;GO:0005925;GO:0030027;GO:0005886;GO:0045202;GO:0003779;GO:0005522;GO:0017124;GO:0050699;GO:0008154;GO:0070358;GO:0007411;, C:cell junction; C:cytoskeleton; C:cytosol; C:filopodium; C:focal adhesion; C:lamellipodium; C:plasma membrane; C:synapse;, F:actin binding; F:profilin binding; F:SH3 domain binding; F:WW domain binding;, P:actin polymerization or depolymerization; P:actin polymerization-dependent cell motility; P:axon guidance; scaffold24 indexed_genome mRNA 9975760 10004305 . + . ID=transcript_5577;Q14739 B2R5P3 Q14740 Q53GU7 Q59FE6,Delta(14)-sterol reductase LBR,3-beta-hydroxysterol Delta (14)-reductase {ECO:0000303|PubMed:16784888};C-14 sterol reductase;Integral nuclear envelope inner membrane protein {ECO:0000303|PubMed:10828963};LMN2R;Lamin-B receptor {ECO:0000303|PubMed:8157662, ECO:0000303|PubMed:8157663};Sterol C14-reductase;, PF01222;PF09465;, GO:0005737;GO:0005789;GO:0016021;GO:0005639;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0005634;GO:0070087;GO:0050613;GO:0003677;GO:0005521;GO:0070402;GO:0016627;GO:0003723;GO:0006695;GO:0007084;GO:0030223;GO:0016126;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of nuclear inner membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nucleus;, F:chromo shadow domain binding; F:delta14-sterol reductase activity; F:DNA binding; F:lamin binding; F:NADPH binding; F:oxidoreductase activity, acting on the CH-CH group of donors; F:RNA binding;, P:cholesterol biosynthetic process; P:mitotic nuclear envelope reassembly; P:neutrophil differentiation; P:sterol biosynthetic process;|Q14739 B2R5P3 Q14740 Q53GU7 Q59FE6,Delta(14)-sterol reductase LBR,3-beta-hydroxysterol Delta (14)-reductase {ECO:0000303|PubMed:16784888};C-14 sterol reductase;Integral nuclear envelope inner membrane protein {ECO:0000303|PubMed:10828963};LMN2R;Lamin-B receptor {ECO:0000303|PubMed:8157662, ECO:0000303|PubMed:8157663};Sterol C14-reductase;, PF01222;PF09465;, GO:0005737;GO:0005789;GO:0016021;GO:0005639;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0005634;GO:0070087;GO:0050613;GO:0003677;GO:0005521;GO:0070402;GO:0016627;GO:0003723;GO:0006695;GO:0007084;GO:0030223;GO:0016126;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of nuclear inner membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nucleus;, F:chromo shadow domain binding; F:delta14-sterol reductase activity; F:DNA binding; F:lamin binding; F:NADPH binding; F:oxidoreductase activity, acting on the CH-CH group of donors; F:RNA binding;, P:cholesterol biosynthetic process; P:mitotic nuclear envelope reassembly; P:neutrophil differentiation; P:sterol biosynthetic process;|Q14739 B2R5P3 Q14740 Q53GU7 Q59FE6,Delta(14)-sterol reductase LBR,3-beta-hydroxysterol Delta (14)-reductase {ECO:0000303|PubMed:16784888};C-14 sterol reductase;Integral nuclear envelope inner membrane protein {ECO:0000303|PubMed:10828963};LMN2R;Lamin-B receptor {ECO:0000303|PubMed:8157662, ECO:0000303|PubMed:8157663};Sterol C14-reductase;, PF01222;PF09465;, GO:0005737;GO:0005789;GO:0016021;GO:0005639;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0005634;GO:0070087;GO:0050613;GO:0003677;GO:0005521;GO:0070402;GO:0016627;GO:0003723;GO:0006695;GO:0007084;GO:0030223;GO:0016126;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of nuclear inner membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nucleus;, F:chromo shadow domain binding; F:delta14-sterol reductase activity; F:DNA binding; F:lamin binding; F:NADPH binding; F:oxidoreductase activity, acting on the CH-CH group of donors; F:RNA binding;, P:cholesterol biosynthetic process; P:mitotic nuclear envelope reassembly; P:neutrophil differentiation; P:sterol biosynthetic process; scaffold24 indexed_genome mRNA 10095248 10117468 . - . ID=transcript_5578;Q0VDD8 A6NG62 A6NNL2 Q0VDD9 Q4VXC7 Q4VXG4 Q4VXG5 Q5VU33 Q5VU34,Dynein heavy chain 14, axonemal,Axonemal beta dynein heavy chain 14;Ciliary dynein heavy chain 14;, PF12774;PF12780;PF12781;PF17852;PF18199;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium-dependent cell motility; P:microtubule-based movement;|Q0VDD8 A6NG62 A6NNL2 Q0VDD9 Q4VXC7 Q4VXG4 Q4VXG5 Q5VU33 Q5VU34,Dynein heavy chain 14, axonemal,Axonemal beta dynein heavy chain 14;Ciliary dynein heavy chain 14;, PF12774;PF12780;PF12781;PF17852;PF18199;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium-dependent cell motility; P:microtubule-based movement;|Q0VDD8 A6NG62 A6NNL2 Q0VDD9 Q4VXC7 Q4VXG4 Q4VXG5 Q5VU33 Q5VU34,Dynein heavy chain 14, axonemal,Axonemal beta dynein heavy chain 14;Ciliary dynein heavy chain 14;, PF12774;PF12780;PF12781;PF17852;PF18199;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium-dependent cell motility; P:microtubule-based movement;|Q0VDD8 A6NG62 A6NNL2 Q0VDD9 Q4VXC7 Q4VXG4 Q4VXG5 Q5VU33 Q5VU34,Dynein heavy chain 14, axonemal,Axonemal beta dynein heavy chain 14;Ciliary dynein heavy chain 14;, PF12774;PF12780;PF12781;PF17852;PF18199;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium-dependent cell motility; P:microtubule-based movement; scaffold24 indexed_genome mRNA 10603907 10769502 . - . ID=transcript_5579;Q8TBE1,Protein cornichon homolog 3,Cornichon family AMPA receptor auxiliary protein 3;, PF03311;, GO:0032281;GO:0030425;GO:0043198;GO:0005789;GO:0033116;GO:0012507;GO:0045211;GO:0045202;GO:0016247;GO:0048208;GO:0006888;GO:2000311;GO:0042391;GO:0035249;, C:AMPA glutamate receptor complex; C:dendrite; C:dendritic shaft; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:postsynaptic membrane; C:synapse;, F:channel regulator activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:regulation of AMPA receptor activity; P:regulation of membrane potential; P:synaptic transmission, glutamatergic; scaffold24 indexed_genome mRNA 10873788 10874632 . - . ID=transcript_5580;Q9H7D7 A0MNN3 Q4G100 Q59EC4 Q5GLZ9 Q86UY4 Q9H3C2,WD repeat-containing protein 26,CUL4- and DDB1-associated WDR protein 2;Myocardial ischemic preconditioning up-regulated protein 2;, PF00400;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000151;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex; scaffold24 indexed_genome mRNA 10898666 10913980 . + . ID=transcript_5581;Q9H7D7 A0MNN3 Q4G100 Q59EC4 Q5GLZ9 Q86UY4 Q9H3C2,WD repeat-containing protein 26,CUL4- and DDB1-associated WDR protein 2;Myocardial ischemic preconditioning up-regulated protein 2;, PF00400;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000151;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;|Q9H7D7 A0MNN3 Q4G100 Q59EC4 Q5GLZ9 Q86UY4 Q9H3C2,WD repeat-containing protein 26,CUL4- and DDB1-associated WDR protein 2;Myocardial ischemic preconditioning up-regulated protein 2;, PF00400;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000151;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;|Q9H7D7 A0MNN3 Q4G100 Q59EC4 Q5GLZ9 Q86UY4 Q9H3C2,WD repeat-containing protein 26,CUL4- and DDB1-associated WDR protein 2;Myocardial ischemic preconditioning up-regulated protein 2;, PF00400;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000151;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;|Q9H7D7 A0MNN3 Q4G100 Q59EC4 Q5GLZ9 Q86UY4 Q9H3C2,WD repeat-containing protein 26,CUL4- and DDB1-associated WDR protein 2;Myocardial ischemic preconditioning up-regulated protein 2;, PF00400;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000151;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;|Q9H7D7 A0MNN3 Q4G100 Q59EC4 Q5GLZ9 Q86UY4 Q9H3C2,WD repeat-containing protein 26,CUL4- and DDB1-associated WDR protein 2;Myocardial ischemic preconditioning up-regulated protein 2;, PF00400;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000151;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex; scaffold24 indexed_genome mRNA 10917898 10933778 . - . ID=transcript_5582;Q9P003 A8K1Q8 B2R553 Q9H0X8,Protein cornichon homolog 4,Cornichon family AMPA receptor auxiliary protein 4;, PF03311;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0016021;GO:0031730;GO:0006888;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:integral component of membrane;, F:CCR5 chemokine receptor binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport;|Q9P003 A8K1Q8 B2R553 Q9H0X8,Protein cornichon homolog 4,Cornichon family AMPA receptor auxiliary protein 4;, PF03311;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0016021;GO:0031730;GO:0006888;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:integral component of membrane;, F:CCR5 chemokine receptor binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport;|Q9P003 A8K1Q8 B2R553 Q9H0X8,Protein cornichon homolog 4,Cornichon family AMPA receptor auxiliary protein 4;, PF03311;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0016021;GO:0031730;GO:0006888;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:integral component of membrane;, F:CCR5 chemokine receptor binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport;|Q9P003 A8K1Q8 B2R553 Q9H0X8,Protein cornichon homolog 4,Cornichon family AMPA receptor auxiliary protein 4;, PF03311;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0016021;GO:0031730;GO:0006888;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:integral component of membrane;, F:CCR5 chemokine receptor binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport;|Q9P003 A8K1Q8 B2R553 Q9H0X8,Protein cornichon homolog 4,Cornichon family AMPA receptor auxiliary protein 4;, PF03311;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0016021;GO:0031730;GO:0006888;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:integral component of membrane;, F:CCR5 chemokine receptor binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; scaffold24 indexed_genome mRNA 10975809 11054971 . + . ID=transcript_5583;O15381 B4DMC4 B4DP98 Q96EM7,Nuclear valosin-containing protein-like {ECO:0000305},, PF00004;PF17862;PF16725;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0005524;GO:0016887;GO:1990275;GO:0003723;GO:0032092;GO:0051973;GO:1904749;GO:0042273;GO:0042254;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:ATP binding; F:ATPase activity; F:preribosome binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of telomerase activity; P:regulation of protein localization to nucleolus; P:ribosomal large subunit biogenesis; P:ribosome biogenesis; P:rRNA processing;|O15381 B4DMC4 B4DP98 Q96EM7,Nuclear valosin-containing protein-like {ECO:0000305},, PF00004;PF17862;PF16725;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0005524;GO:0016887;GO:1990275;GO:0003723;GO:0032092;GO:0051973;GO:1904749;GO:0042273;GO:0042254;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:ATP binding; F:ATPase activity; F:preribosome binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of telomerase activity; P:regulation of protein localization to nucleolus; P:ribosomal large subunit biogenesis; P:ribosome biogenesis; P:rRNA processing;|O15381 B4DMC4 B4DP98 Q96EM7,Nuclear valosin-containing protein-like {ECO:0000305},, PF00004;PF17862;PF16725;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0005524;GO:0016887;GO:1990275;GO:0003723;GO:0032092;GO:0051973;GO:1904749;GO:0042273;GO:0042254;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:ATP binding; F:ATPase activity; F:preribosome binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of telomerase activity; P:regulation of protein localization to nucleolus; P:ribosomal large subunit biogenesis; P:ribosome biogenesis; P:rRNA processing;|O15381 B4DMC4 B4DP98 Q96EM7,Nuclear valosin-containing protein-like {ECO:0000305},, PF00004;PF17862;PF16725;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0005524;GO:0016887;GO:1990275;GO:0003723;GO:0032092;GO:0051973;GO:1904749;GO:0042273;GO:0042254;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:ATP binding; F:ATPase activity; F:preribosome binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of telomerase activity; P:regulation of protein localization to nucleolus; P:ribosomal large subunit biogenesis; P:ribosome biogenesis; P:rRNA processing;|O15381 B4DMC4 B4DP98 Q96EM7,Nuclear valosin-containing protein-like {ECO:0000305},, PF00004;PF17862;PF16725;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0005524;GO:0016887;GO:1990275;GO:0003723;GO:0032092;GO:0051973;GO:1904749;GO:0042273;GO:0042254;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:ATP binding; F:ATPase activity; F:preribosome binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of telomerase activity; P:regulation of protein localization to nucleolus; P:ribosomal large subunit biogenesis; P:ribosome biogenesis; P:rRNA processing;|O15381 B4DMC4 B4DP98 Q96EM7,Nuclear valosin-containing protein-like {ECO:0000305},, PF00004;PF17862;PF16725;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0005524;GO:0016887;GO:1990275;GO:0003723;GO:0032092;GO:0051973;GO:1904749;GO:0042273;GO:0042254;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:ATP binding; F:ATPase activity; F:preribosome binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of telomerase activity; P:regulation of protein localization to nucleolus; P:ribosomal large subunit biogenesis; P:ribosome biogenesis; P:rRNA processing;|O15381 B4DMC4 B4DP98 Q96EM7,Nuclear valosin-containing protein-like {ECO:0000305},, PF00004;PF17862;PF16725;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0005524;GO:0016887;GO:1990275;GO:0003723;GO:0032092;GO:0051973;GO:1904749;GO:0042273;GO:0042254;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:ATP binding; F:ATPase activity; F:preribosome binding; F:RNA binding;, P:positive regulation of protein binding; P:positive regulation of telomerase activity; P:regulation of protein localization to nucleolus; P:ribosomal large subunit biogenesis; P:ribosome biogenesis; P:rRNA processing;|Q6PML9 Q4W5B6 Q7Z5I7 Q8TBB2 Q9Y6R2,Zinc transporter 9,Human embryonic lung protein {ECO:0000303|PubMed:10409434};Solute carrier family 30 member 9;, PF01545;, GO:0031410;GO:0005856;GO:0005783;GO:0016021;GO:0005634;GO:0008324;GO:0003682;GO:0016922;GO:0030374;GO:0006882;GO:0006289;GO:0045944;GO:0006829;, C:cytoplasmic vesicle; C:cytoskeleton; C:endoplasmic reticulum; C:integral component of membrane; C:nucleus;, F:cation transmembrane transporter activity; F:chromatin binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity;, P:cellular zinc ion homeostasis; P:nucleotide-excision repair; P:positive regulation of transcription by RNA polymerase II; P:zinc ion transport;|Q6PML9 Q4W5B6 Q7Z5I7 Q8TBB2 Q9Y6R2,Zinc transporter 9,Human embryonic lung protein {ECO:0000303|PubMed:10409434};Solute carrier family 30 member 9;, PF01545;, GO:0031410;GO:0005856;GO:0005783;GO:0016021;GO:0005634;GO:0008324;GO:0003682;GO:0016922;GO:0030374;GO:0006882;GO:0006289;GO:0045944;GO:0006829;, C:cytoplasmic vesicle; C:cytoskeleton; C:endoplasmic reticulum; C:integral component of membrane; C:nucleus;, F:cation transmembrane transporter activity; F:chromatin binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity;, P:cellular zinc ion homeostasis; P:nucleotide-excision repair; P:positive regulation of transcription by RNA polymerase II; P:zinc ion transport; scaffold24 indexed_genome mRNA 11092288 11098341 . - . ID=transcript_5584;O15121,Sphingolipid delta(4)-desaturase DES1 {ECO:0000305},Cell migration-inducing gene 15 protein;Degenerative spermatocyte homolog 1;Dihydroceramide desaturase-1;Membrane lipid desaturase;, PF00487;PF08557;, GO:0005783;GO:0005789;GO:0005887;GO:0016020;GO:0031966;GO:0005739;GO:0005886;GO:0035579;GO:0009055;GO:0050251;GO:0042284;GO:0046513;GO:0043217;GO:0043312;GO:0030148;GO:0006636;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion; C:plasma membrane; C:specific granule membrane;, F:electron transfer activity; F:retinol isomerase activity; F:sphingolipid delta-4 desaturase activity;, P:ceramide biosynthetic process; P:myelin maintenance; P:neutrophil degranulation; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process;|O15121,Sphingolipid delta(4)-desaturase DES1 {ECO:0000305},Cell migration-inducing gene 15 protein;Degenerative spermatocyte homolog 1;Dihydroceramide desaturase-1;Membrane lipid desaturase;, PF00487;PF08557;, GO:0005783;GO:0005789;GO:0005887;GO:0016020;GO:0031966;GO:0005739;GO:0005886;GO:0035579;GO:0009055;GO:0050251;GO:0042284;GO:0046513;GO:0043217;GO:0043312;GO:0030148;GO:0006636;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion; C:plasma membrane; C:specific granule membrane;, F:electron transfer activity; F:retinol isomerase activity; F:sphingolipid delta-4 desaturase activity;, P:ceramide biosynthetic process; P:myelin maintenance; P:neutrophil degranulation; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; scaffold24 indexed_genome mRNA 11142159 11167821 . - . ID=transcript_5585;Q9NVF7 E9PEM8 O75070,F-box only protein 28,, PF00646;, GO:0000777;GO:0000776;GO:0042802;GO:0000209;, C:condensed chromosome kinetochore; C:kinetochore;, F:identical protein binding;, P:protein polyubiquitination;|Q9NVF7 E9PEM8 O75070,F-box only protein 28,, PF00646;, GO:0000777;GO:0000776;GO:0042802;GO:0000209;, C:condensed chromosome kinetochore; C:kinetochore;, F:identical protein binding;, P:protein polyubiquitination;|Q9NVF7 E9PEM8 O75070,F-box only protein 28,, PF00646;, GO:0000777;GO:0000776;GO:0042802;GO:0000209;, C:condensed chromosome kinetochore; C:kinetochore;, F:identical protein binding;, P:protein polyubiquitination;|Q9NVF7 E9PEM8 O75070,F-box only protein 28,, PF00646;, GO:0000777;GO:0000776;GO:0042802;GO:0000209;, C:condensed chromosome kinetochore; C:kinetochore;, F:identical protein binding;, P:protein polyubiquitination; scaffold24 indexed_genome mRNA 11258467 11300457 . + . ID=transcript_5586;Q13625 B4DG66 Q12892 Q86X75 Q96KQ3,Apoptosis-stimulating of p53 protein 2,Bcl2-binding protein;Renal carcinoma antigen NY-REN-51;Tumor suppressor p53-binding protein 2;, PF12796;PF00018;, GO:0030054;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0042802;GO:0051059;GO:0002039;GO:0017124;GO:0007049;GO:0072332;GO:0045786;GO:1900119;GO:1901216;GO:1900740;GO:0042981;GO:1901796;GO:0007165;, C:cell junction; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:identical protein binding; F:NF-kappaB binding; F:p53 binding; F:SH3 domain binding;, P:cell cycle; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of execution phase of apoptosis; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction; scaffold24 indexed_genome mRNA 11301169 11317327 . + . ID=transcript_5587;Q13625 B4DG66 Q12892 Q86X75 Q96KQ3,Apoptosis-stimulating of p53 protein 2,Bcl2-binding protein;Renal carcinoma antigen NY-REN-51;Tumor suppressor p53-binding protein 2;, PF12796;PF00018;, GO:0030054;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0042802;GO:0051059;GO:0002039;GO:0017124;GO:0007049;GO:0072332;GO:0045786;GO:1900119;GO:1901216;GO:1900740;GO:0042981;GO:1901796;GO:0007165;, C:cell junction; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:identical protein binding; F:NF-kappaB binding; F:p53 binding; F:SH3 domain binding;, P:cell cycle; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of execution phase of apoptosis; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction; scaffold24 indexed_genome mRNA 11319765 11389059 . - . ID=transcript_5588;P17655 A6NDG7 B7ZA96 E7ES58 Q16738 Q6PJT3 Q8WU26 Q9HBB1,Calpain-2 catalytic subunit,Calcium-activated neutral proteinase 2;Calpain M-type;Calpain large polypeptide L2;Calpain-2 large subunit;Millimolar-calpain;, PF01067;PF13833;PF00648;, GO:0000785;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0005783;GO:0009897;GO:0070062;GO:0005925;GO:0005794;GO:0005764;GO:0045121;GO:0005758;GO:0043025;GO:0005634;GO:0097038;GO:0005886;GO:0031143;GO:0005509;GO:0004198;GO:0008234;GO:0008092;GO:0019899;GO:0044877;GO:0048266;GO:0001824;GO:0071230;GO:0035458;GO:0071222;GO:0022617;GO:0007565;GO:0007520;GO:0010666;GO:1901741;GO:1901216;GO:2001247;GO:0016540;GO:0006508;GO:0051603;GO:0051493;GO:0032675;GO:0042542;GO:0001666;, C:chromatin; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:lysosome; C:membrane raft; C:mitochondrial intermembrane space; C:neuronal cell body; C:nucleus; C:perinuclear endoplasmic reticulum; C:plasma membrane; C:pseudopodium;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:cytoskeletal protein binding; F:enzyme binding; F:protein-containing complex binding;, P:behavioral response to pain; P:blastocyst development; P:cellular response to amino acid stimulus; P:cellular response to interferon-beta; P:cellular response to lipopolysaccharide; P:extracellular matrix disassembly; P:female pregnancy; P:myoblast fusion; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of myoblast fusion; P:positive regulation of neuron death; P:positive regulation of phosphatidylcholine biosynthetic process; P:protein autoprocessing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of cytoskeleton organization; P:regulation of interleukin-6 production; P:response to hydrogen peroxide; P:response to hypoxia;|Q13625 B4DG66 Q12892 Q86X75 Q96KQ3,Apoptosis-stimulating of p53 protein 2,Bcl2-binding protein;Renal carcinoma antigen NY-REN-51;Tumor suppressor p53-binding protein 2;, PF12796;PF00018;, GO:0030054;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0042802;GO:0051059;GO:0002039;GO:0017124;GO:0007049;GO:0072332;GO:0045786;GO:1900119;GO:1901216;GO:1900740;GO:0042981;GO:1901796;GO:0007165;, C:cell junction; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:identical protein binding; F:NF-kappaB binding; F:p53 binding; F:SH3 domain binding;, P:cell cycle; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of execution phase of apoptosis; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction;|P17655 A6NDG7 B7ZA96 E7ES58 Q16738 Q6PJT3 Q8WU26 Q9HBB1,Calpain-2 catalytic subunit,Calcium-activated neutral proteinase 2;Calpain M-type;Calpain large polypeptide L2;Calpain-2 large subunit;Millimolar-calpain;, PF01067;PF13833;PF00648;, GO:0000785;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0005783;GO:0009897;GO:0070062;GO:0005925;GO:0005794;GO:0005764;GO:0045121;GO:0005758;GO:0043025;GO:0005634;GO:0097038;GO:0005886;GO:0031143;GO:0005509;GO:0004198;GO:0008234;GO:0008092;GO:0019899;GO:0044877;GO:0048266;GO:0001824;GO:0071230;GO:0035458;GO:0071222;GO:0022617;GO:0007565;GO:0007520;GO:0010666;GO:1901741;GO:1901216;GO:2001247;GO:0016540;GO:0006508;GO:0051603;GO:0051493;GO:0032675;GO:0042542;GO:0001666;, C:chromatin; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:lysosome; C:membrane raft; C:mitochondrial intermembrane space; C:neuronal cell body; C:nucleus; C:perinuclear endoplasmic reticulum; C:plasma membrane; C:pseudopodium;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:cytoskeletal protein binding; F:enzyme binding; F:protein-containing complex binding;, P:behavioral response to pain; P:blastocyst development; P:cellular response to amino acid stimulus; P:cellular response to interferon-beta; P:cellular response to lipopolysaccharide; P:extracellular matrix disassembly; P:female pregnancy; P:myoblast fusion; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of myoblast fusion; P:positive regulation of neuron death; P:positive regulation of phosphatidylcholine biosynthetic process; P:protein autoprocessing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of cytoskeleton organization; P:regulation of interleukin-6 production; P:response to hydrogen peroxide; P:response to hypoxia;|P17655 A6NDG7 B7ZA96 E7ES58 Q16738 Q6PJT3 Q8WU26 Q9HBB1,Calpain-2 catalytic subunit,Calcium-activated neutral proteinase 2;Calpain M-type;Calpain large polypeptide L2;Calpain-2 large subunit;Millimolar-calpain;, PF01067;PF13833;PF00648;, GO:0000785;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0005783;GO:0009897;GO:0070062;GO:0005925;GO:0005794;GO:0005764;GO:0045121;GO:0005758;GO:0043025;GO:0005634;GO:0097038;GO:0005886;GO:0031143;GO:0005509;GO:0004198;GO:0008234;GO:0008092;GO:0019899;GO:0044877;GO:0048266;GO:0001824;GO:0071230;GO:0035458;GO:0071222;GO:0022617;GO:0007565;GO:0007520;GO:0010666;GO:1901741;GO:1901216;GO:2001247;GO:0016540;GO:0006508;GO:0051603;GO:0051493;GO:0032675;GO:0042542;GO:0001666;, C:chromatin; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:lysosome; C:membrane raft; C:mitochondrial intermembrane space; C:neuronal cell body; C:nucleus; C:perinuclear endoplasmic reticulum; C:plasma membrane; C:pseudopodium;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:cytoskeletal protein binding; F:enzyme binding; F:protein-containing complex binding;, P:behavioral response to pain; P:blastocyst development; P:cellular response to amino acid stimulus; P:cellular response to interferon-beta; P:cellular response to lipopolysaccharide; P:extracellular matrix disassembly; P:female pregnancy; P:myoblast fusion; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of myoblast fusion; P:positive regulation of neuron death; P:positive regulation of phosphatidylcholine biosynthetic process; P:protein autoprocessing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of cytoskeleton organization; P:regulation of interleukin-6 production; P:response to hydrogen peroxide; P:response to hypoxia;|P17655 A6NDG7 B7ZA96 E7ES58 Q16738 Q6PJT3 Q8WU26 Q9HBB1,Calpain-2 catalytic subunit,Calcium-activated neutral proteinase 2;Calpain M-type;Calpain large polypeptide L2;Calpain-2 large subunit;Millimolar-calpain;, PF01067;PF13833;PF00648;, GO:0000785;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0005783;GO:0009897;GO:0070062;GO:0005925;GO:0005794;GO:0005764;GO:0045121;GO:0005758;GO:0043025;GO:0005634;GO:0097038;GO:0005886;GO:0031143;GO:0005509;GO:0004198;GO:0008234;GO:0008092;GO:0019899;GO:0044877;GO:0048266;GO:0001824;GO:0071230;GO:0035458;GO:0071222;GO:0022617;GO:0007565;GO:0007520;GO:0010666;GO:1901741;GO:1901216;GO:2001247;GO:0016540;GO:0006508;GO:0051603;GO:0051493;GO:0032675;GO:0042542;GO:0001666;, C:chromatin; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:lysosome; C:membrane raft; C:mitochondrial intermembrane space; C:neuronal cell body; C:nucleus; C:perinuclear endoplasmic reticulum; C:plasma membrane; C:pseudopodium;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:cytoskeletal protein binding; F:enzyme binding; F:protein-containing complex binding;, P:behavioral response to pain; P:blastocyst development; P:cellular response to amino acid stimulus; P:cellular response to interferon-beta; P:cellular response to lipopolysaccharide; P:extracellular matrix disassembly; P:female pregnancy; P:myoblast fusion; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of myoblast fusion; P:positive regulation of neuron death; P:positive regulation of phosphatidylcholine biosynthetic process; P:protein autoprocessing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of cytoskeleton organization; P:regulation of interleukin-6 production; P:response to hydrogen peroxide; P:response to hypoxia;|P17655 A6NDG7 B7ZA96 E7ES58 Q16738 Q6PJT3 Q8WU26 Q9HBB1,Calpain-2 catalytic subunit,Calcium-activated neutral proteinase 2;Calpain M-type;Calpain large polypeptide L2;Calpain-2 large subunit;Millimolar-calpain;, PF01067;PF13833;PF00648;, GO:0000785;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0005783;GO:0009897;GO:0070062;GO:0005925;GO:0005794;GO:0005764;GO:0045121;GO:0005758;GO:0043025;GO:0005634;GO:0097038;GO:0005886;GO:0031143;GO:0005509;GO:0004198;GO:0008234;GO:0008092;GO:0019899;GO:0044877;GO:0048266;GO:0001824;GO:0071230;GO:0035458;GO:0071222;GO:0022617;GO:0007565;GO:0007520;GO:0010666;GO:1901741;GO:1901216;GO:2001247;GO:0016540;GO:0006508;GO:0051603;GO:0051493;GO:0032675;GO:0042542;GO:0001666;, C:chromatin; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:lysosome; C:membrane raft; C:mitochondrial intermembrane space; C:neuronal cell body; C:nucleus; C:perinuclear endoplasmic reticulum; C:plasma membrane; C:pseudopodium;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:cytoskeletal protein binding; F:enzyme binding; F:protein-containing complex binding;, P:behavioral response to pain; P:blastocyst development; P:cellular response to amino acid stimulus; P:cellular response to interferon-beta; P:cellular response to lipopolysaccharide; P:extracellular matrix disassembly; P:female pregnancy; P:myoblast fusion; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of myoblast fusion; P:positive regulation of neuron death; P:positive regulation of phosphatidylcholine biosynthetic process; P:protein autoprocessing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of cytoskeleton organization; P:regulation of interleukin-6 production; P:response to hydrogen peroxide; P:response to hypoxia;|P17655 A6NDG7 B7ZA96 E7ES58 Q16738 Q6PJT3 Q8WU26 Q9HBB1,Calpain-2 catalytic subunit,Calcium-activated neutral proteinase 2;Calpain M-type;Calpain large polypeptide L2;Calpain-2 large subunit;Millimolar-calpain;, PF01067;PF13833;PF00648;, GO:0000785;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0005783;GO:0009897;GO:0070062;GO:0005925;GO:0005794;GO:0005764;GO:0045121;GO:0005758;GO:0043025;GO:0005634;GO:0097038;GO:0005886;GO:0031143;GO:0005509;GO:0004198;GO:0008234;GO:0008092;GO:0019899;GO:0044877;GO:0048266;GO:0001824;GO:0071230;GO:0035458;GO:0071222;GO:0022617;GO:0007565;GO:0007520;GO:0010666;GO:1901741;GO:1901216;GO:2001247;GO:0016540;GO:0006508;GO:0051603;GO:0051493;GO:0032675;GO:0042542;GO:0001666;, C:chromatin; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:lysosome; C:membrane raft; C:mitochondrial intermembrane space; C:neuronal cell body; C:nucleus; C:perinuclear endoplasmic reticulum; C:plasma membrane; C:pseudopodium;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:cytoskeletal protein binding; F:enzyme binding; F:protein-containing complex binding;, P:behavioral response to pain; P:blastocyst development; P:cellular response to amino acid stimulus; P:cellular response to interferon-beta; P:cellular response to lipopolysaccharide; P:extracellular matrix disassembly; P:female pregnancy; P:myoblast fusion; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of myoblast fusion; P:positive regulation of neuron death; P:positive regulation of phosphatidylcholine biosynthetic process; P:protein autoprocessing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of cytoskeleton organization; P:regulation of interleukin-6 production; P:response to hydrogen peroxide; P:response to hypoxia;|P17655 A6NDG7 B7ZA96 E7ES58 Q16738 Q6PJT3 Q8WU26 Q9HBB1,Calpain-2 catalytic subunit,Calcium-activated neutral proteinase 2;Calpain M-type;Calpain large polypeptide L2;Calpain-2 large subunit;Millimolar-calpain;, PF01067;PF13833;PF00648;, GO:0000785;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0005783;GO:0009897;GO:0070062;GO:0005925;GO:0005794;GO:0005764;GO:0045121;GO:0005758;GO:0043025;GO:0005634;GO:0097038;GO:0005886;GO:0031143;GO:0005509;GO:0004198;GO:0008234;GO:0008092;GO:0019899;GO:0044877;GO:0048266;GO:0001824;GO:0071230;GO:0035458;GO:0071222;GO:0022617;GO:0007565;GO:0007520;GO:0010666;GO:1901741;GO:1901216;GO:2001247;GO:0016540;GO:0006508;GO:0051603;GO:0051493;GO:0032675;GO:0042542;GO:0001666;, C:chromatin; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:lysosome; C:membrane raft; C:mitochondrial intermembrane space; C:neuronal cell body; C:nucleus; C:perinuclear endoplasmic reticulum; C:plasma membrane; C:pseudopodium;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:cytoskeletal protein binding; F:enzyme binding; F:protein-containing complex binding;, P:behavioral response to pain; P:blastocyst development; P:cellular response to amino acid stimulus; P:cellular response to interferon-beta; P:cellular response to lipopolysaccharide; P:extracellular matrix disassembly; P:female pregnancy; P:myoblast fusion; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of myoblast fusion; P:positive regulation of neuron death; P:positive regulation of phosphatidylcholine biosynthetic process; P:protein autoprocessing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of cytoskeleton organization; P:regulation of interleukin-6 production; P:response to hydrogen peroxide; P:response to hypoxia;|P17655 A6NDG7 B7ZA96 E7ES58 Q16738 Q6PJT3 Q8WU26 Q9HBB1,Calpain-2 catalytic subunit,Calcium-activated neutral proteinase 2;Calpain M-type;Calpain large polypeptide L2;Calpain-2 large subunit;Millimolar-calpain;, PF01067;PF13833;PF00648;, GO:0000785;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0005783;GO:0009897;GO:0070062;GO:0005925;GO:0005794;GO:0005764;GO:0045121;GO:0005758;GO:0043025;GO:0005634;GO:0097038;GO:0005886;GO:0031143;GO:0005509;GO:0004198;GO:0008234;GO:0008092;GO:0019899;GO:0044877;GO:0048266;GO:0001824;GO:0071230;GO:0035458;GO:0071222;GO:0022617;GO:0007565;GO:0007520;GO:0010666;GO:1901741;GO:1901216;GO:2001247;GO:0016540;GO:0006508;GO:0051603;GO:0051493;GO:0032675;GO:0042542;GO:0001666;, C:chromatin; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:lysosome; C:membrane raft; C:mitochondrial intermembrane space; C:neuronal cell body; C:nucleus; C:perinuclear endoplasmic reticulum; C:plasma membrane; C:pseudopodium;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:cytoskeletal protein binding; F:enzyme binding; F:protein-containing complex binding;, P:behavioral response to pain; P:blastocyst development; P:cellular response to amino acid stimulus; P:cellular response to interferon-beta; P:cellular response to lipopolysaccharide; P:extracellular matrix disassembly; P:female pregnancy; P:myoblast fusion; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of myoblast fusion; P:positive regulation of neuron death; P:positive regulation of phosphatidylcholine biosynthetic process; P:protein autoprocessing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of cytoskeleton organization; P:regulation of interleukin-6 production; P:response to hydrogen peroxide; P:response to hypoxia; scaffold24 indexed_genome mRNA 11473116 11485932 . + . ID=transcript_5589;A6NHC0 B2RXL2,Calpain-8,New calpain 2;Stomach-specific M-type calpain;, PF01067;PF00648;, GO:0005737;GO:0005794;GO:0005509;GO:0004198;GO:0007586;GO:0006508;, C:cytoplasm; C:Golgi apparatus;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity;, P:digestion; P:proteolysis; scaffold24 indexed_genome mRNA 11771684 11778464 . + . ID=transcript_5590;Q5VX71 D3DTB9 Q6UX62 Q9BSR0 Q9NWG0,Sushi domain-containing protein 4,, PF00084;, GO:0005576;GO:0016021;GO:0006958;GO:0045087;GO:0045957;GO:0045959;GO:0030449;, C:extracellular region; C:integral component of membrane;, , P:complement activation, classical pathway; P:innate immune response; P:negative regulation of complement activation, alternative pathway; P:negative regulation of complement activation, classical pathway; P:regulation of complement activation;|Q5VX71 D3DTB9 Q6UX62 Q9BSR0 Q9NWG0,Sushi domain-containing protein 4,, PF00084;, GO:0005576;GO:0016021;GO:0006958;GO:0045087;GO:0045957;GO:0045959;GO:0030449;, C:extracellular region; C:integral component of membrane;, , P:complement activation, classical pathway; P:innate immune response; P:negative regulation of complement activation, alternative pathway; P:negative regulation of complement activation, classical pathway; P:regulation of complement activation; scaffold24 indexed_genome mRNA 11845842 11857831 . + . ID=transcript_5591;O60602 B1AZ05 B3Y633 B9VJ63 D1CS80 D3DTB8 O15456 Q32MI2 Q32MI3,Toll-like receptor 5,Toll/interleukin-1 receptor-like protein 3;, PF13855;PF01582;, GO:0005887;GO:0005886;GO:0005149;GO:0038023;GO:0004888;GO:0071260;GO:0042742;GO:0006954;GO:0045087;GO:0002755;GO:0032757;GO:0034123;GO:0034146;GO:0002224;, C:integral component of plasma membrane; C:plasma membrane;, F:interleukin-1 receptor binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:cellular response to mechanical stimulus; P:defense response to bacterium; P:inflammatory response; P:innate immune response; P:MyD88-dependent toll-like receptor signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of toll-like receptor signaling pathway; P:toll-like receptor 5 signaling pathway; P:toll-like receptor signaling pathway;|O60602 B1AZ05 B3Y633 B9VJ63 D1CS80 D3DTB8 O15456 Q32MI2 Q32MI3,Toll-like receptor 5,Toll/interleukin-1 receptor-like protein 3;, PF13855;PF01582;, GO:0005887;GO:0005886;GO:0005149;GO:0038023;GO:0004888;GO:0071260;GO:0042742;GO:0006954;GO:0045087;GO:0002755;GO:0032757;GO:0034123;GO:0034146;GO:0002224;, C:integral component of plasma membrane; C:plasma membrane;, F:interleukin-1 receptor binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:cellular response to mechanical stimulus; P:defense response to bacterium; P:inflammatory response; P:innate immune response; P:MyD88-dependent toll-like receptor signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of toll-like receptor signaling pathway; P:toll-like receptor 5 signaling pathway; P:toll-like receptor signaling pathway; scaffold24 indexed_genome mRNA 11857878 11860721 . + . ID=transcript_5592;O60602 B1AZ05 B3Y633 B9VJ63 D1CS80 D3DTB8 O15456 Q32MI2 Q32MI3,Toll-like receptor 5,Toll/interleukin-1 receptor-like protein 3;, PF13855;PF01582;, GO:0005887;GO:0005886;GO:0005149;GO:0038023;GO:0004888;GO:0071260;GO:0042742;GO:0006954;GO:0045087;GO:0002755;GO:0032757;GO:0034123;GO:0034146;GO:0002224;, C:integral component of plasma membrane; C:plasma membrane;, F:interleukin-1 receptor binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:cellular response to mechanical stimulus; P:defense response to bacterium; P:inflammatory response; P:innate immune response; P:MyD88-dependent toll-like receptor signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of toll-like receptor signaling pathway; P:toll-like receptor 5 signaling pathway; P:toll-like receptor signaling pathway; scaffold24 indexed_genome mRNA 11934859 12013594 . - . ID=transcript_5593;Q96F81 Q8N7C2 Q96I92 Q9H698 Q9H8H9 Q9UFA2,Protein dispatched homolog 1,, PF02460;, GO:0016323;GO:0016021;GO:1904680;GO:0060539;GO:0015833;GO:0070207;GO:0050708;, C:basolateral plasma membrane; C:integral component of membrane;, F:peptide transmembrane transporter activity;, P:diaphragm development; P:peptide transport; P:protein homotrimerization; P:regulation of protein secretion;|Q96F81 Q8N7C2 Q96I92 Q9H698 Q9H8H9 Q9UFA2,Protein dispatched homolog 1,, PF02460;, GO:0016323;GO:0016021;GO:1904680;GO:0060539;GO:0015833;GO:0070207;GO:0050708;, C:basolateral plasma membrane; C:integral component of membrane;, F:peptide transmembrane transporter activity;, P:diaphragm development; P:peptide transport; P:protein homotrimerization; P:regulation of protein secretion; scaffold24 indexed_genome mRNA 12225313 12246578 . - . ID=transcript_5594;Q5VW32 B7Z9G5 Q96MG1,BRO1 domain-containing protein BROX,BRO1 domain- and CAAX motif-containing protein;, PF03097;, GO:0070062;GO:0016020;, C:extracellular exosome; C:membrane;|Q5VW32 B7Z9G5 Q96MG1,BRO1 domain-containing protein BROX,BRO1 domain- and CAAX motif-containing protein;, PF03097;, GO:0070062;GO:0016020;, C:extracellular exosome; C:membrane;|Q5VW32 B7Z9G5 Q96MG1,BRO1 domain-containing protein BROX,BRO1 domain- and CAAX motif-containing protein;, PF03097;, GO:0070062;GO:0016020;, C:extracellular exosome; C:membrane; scaffold24 indexed_genome mRNA 12253006 12296601 . + . ID=transcript_5595;Q96BJ3 A8K1F0 Q49A81 Q5JRA4 Q658P1 Q9H9E8,Axin interactor, dorsalization-associated protein,Axin interaction partner and dorsalization antagonist;, PF14186;PF08910;, GO:0005737;GO:0016020;GO:0035091;GO:0019904;GO:0048264;GO:0009953;GO:0046329;GO:0043508;GO:0031333;, C:cytoplasm; C:membrane;, F:phosphatidylinositol binding; F:protein domain specific binding;, P:determination of ventral identity; P:dorsal/ventral pattern formation; P:negative regulation of JNK cascade; P:negative regulation of JUN kinase activity; P:negative regulation of protein-containing complex assembly; scaffold24 indexed_genome mRNA 12296606 12350233 . - . ID=transcript_5596;Q5JRB1 Q5JRB2 Q6UVY8 Q86Y60 Q8N8M5 Q92580,Transport and Golgi organization protein 1 homolog {ECO:0000305},C219-reactive peptide {ECO:0000303|PubMed:7758977};D320 {ECO:0000303|PubMed:7758977};Melanoma inhibitory activity protein 3 {ECO:0000312|HGNC:HGNC:24008};, PF07653;, GO:0070971;GO:0005788;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0038024;GO:0002042;GO:0044267;GO:0140052;GO:0090110;GO:0007029;GO:0006888;GO:0006887;GO:0042953;GO:0007162;GO:0030336;GO:1903038;GO:2000402;GO:0002687;GO:0043687;GO:0070973;GO:0009306;GO:0015031;GO:0035459;GO:0042060;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cargo receptor activity;, P:cell migration involved in sprouting angiogenesis; P:cellular protein metabolic process; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:lipoprotein transport; P:negative regulation of cell adhesion; P:negative regulation of cell migration; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of lymphocyte migration; P:positive regulation of leukocyte migration; P:post-translational protein modification; P:protein localization to endoplasmic reticulum exit site; P:protein secretion; P:protein transport; P:vesicle cargo loading; P:wound healing;|Q5JRB1 Q5JRB2 Q6UVY8 Q86Y60 Q8N8M5 Q92580,Transport and Golgi organization protein 1 homolog {ECO:0000305},C219-reactive peptide {ECO:0000303|PubMed:7758977};D320 {ECO:0000303|PubMed:7758977};Melanoma inhibitory activity protein 3 {ECO:0000312|HGNC:HGNC:24008};, PF07653;, GO:0070971;GO:0005788;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0038024;GO:0002042;GO:0044267;GO:0140052;GO:0090110;GO:0007029;GO:0006888;GO:0006887;GO:0042953;GO:0007162;GO:0030336;GO:1903038;GO:2000402;GO:0002687;GO:0043687;GO:0070973;GO:0009306;GO:0015031;GO:0035459;GO:0042060;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cargo receptor activity;, P:cell migration involved in sprouting angiogenesis; P:cellular protein metabolic process; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:lipoprotein transport; P:negative regulation of cell adhesion; P:negative regulation of cell migration; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of lymphocyte migration; P:positive regulation of leukocyte migration; P:post-translational protein modification; P:protein localization to endoplasmic reticulum exit site; P:protein secretion; P:protein transport; P:vesicle cargo loading; P:wound healing;|Q5JRB1 Q5JRB2 Q6UVY8 Q86Y60 Q8N8M5 Q92580,Transport and Golgi organization protein 1 homolog {ECO:0000305},C219-reactive peptide {ECO:0000303|PubMed:7758977};D320 {ECO:0000303|PubMed:7758977};Melanoma inhibitory activity protein 3 {ECO:0000312|HGNC:HGNC:24008};, PF07653;, GO:0070971;GO:0005788;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0038024;GO:0002042;GO:0044267;GO:0140052;GO:0090110;GO:0007029;GO:0006888;GO:0006887;GO:0042953;GO:0007162;GO:0030336;GO:1903038;GO:2000402;GO:0002687;GO:0043687;GO:0070973;GO:0009306;GO:0015031;GO:0035459;GO:0042060;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cargo receptor activity;, P:cell migration involved in sprouting angiogenesis; P:cellular protein metabolic process; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:lipoprotein transport; P:negative regulation of cell adhesion; P:negative regulation of cell migration; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of lymphocyte migration; P:positive regulation of leukocyte migration; P:post-translational protein modification; P:protein localization to endoplasmic reticulum exit site; P:protein secretion; P:protein transport; P:vesicle cargo loading; P:wound healing;|Q5JRB1 Q5JRB2 Q6UVY8 Q86Y60 Q8N8M5 Q92580,Transport and Golgi organization protein 1 homolog {ECO:0000305},C219-reactive peptide {ECO:0000303|PubMed:7758977};D320 {ECO:0000303|PubMed:7758977};Melanoma inhibitory activity protein 3 {ECO:0000312|HGNC:HGNC:24008};, PF07653;, GO:0070971;GO:0005788;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0038024;GO:0002042;GO:0044267;GO:0140052;GO:0090110;GO:0007029;GO:0006888;GO:0006887;GO:0042953;GO:0007162;GO:0030336;GO:1903038;GO:2000402;GO:0002687;GO:0043687;GO:0070973;GO:0009306;GO:0015031;GO:0035459;GO:0042060;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cargo receptor activity;, P:cell migration involved in sprouting angiogenesis; P:cellular protein metabolic process; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:lipoprotein transport; P:negative regulation of cell adhesion; P:negative regulation of cell migration; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of lymphocyte migration; P:positive regulation of leukocyte migration; P:post-translational protein modification; P:protein localization to endoplasmic reticulum exit site; P:protein secretion; P:protein transport; P:vesicle cargo loading; P:wound healing;|Q5JRB1 Q5JRB2 Q6UVY8 Q86Y60 Q8N8M5 Q92580,Transport and Golgi organization protein 1 homolog {ECO:0000305},C219-reactive peptide {ECO:0000303|PubMed:7758977};D320 {ECO:0000303|PubMed:7758977};Melanoma inhibitory activity protein 3 {ECO:0000312|HGNC:HGNC:24008};, PF07653;, GO:0070971;GO:0005788;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0038024;GO:0002042;GO:0044267;GO:0140052;GO:0090110;GO:0007029;GO:0006888;GO:0006887;GO:0042953;GO:0007162;GO:0030336;GO:1903038;GO:2000402;GO:0002687;GO:0043687;GO:0070973;GO:0009306;GO:0015031;GO:0035459;GO:0042060;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cargo receptor activity;, P:cell migration involved in sprouting angiogenesis; P:cellular protein metabolic process; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:lipoprotein transport; P:negative regulation of cell adhesion; P:negative regulation of cell migration; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of lymphocyte migration; P:positive regulation of leukocyte migration; P:post-translational protein modification; P:protein localization to endoplasmic reticulum exit site; P:protein secretion; P:protein transport; P:vesicle cargo loading; P:wound healing;|Q5JRB1 Q5JRB2 Q6UVY8 Q86Y60 Q8N8M5 Q92580,Transport and Golgi organization protein 1 homolog {ECO:0000305},C219-reactive peptide {ECO:0000303|PubMed:7758977};D320 {ECO:0000303|PubMed:7758977};Melanoma inhibitory activity protein 3 {ECO:0000312|HGNC:HGNC:24008};, PF07653;, GO:0070971;GO:0005788;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0038024;GO:0002042;GO:0044267;GO:0140052;GO:0090110;GO:0007029;GO:0006888;GO:0006887;GO:0042953;GO:0007162;GO:0030336;GO:1903038;GO:2000402;GO:0002687;GO:0043687;GO:0070973;GO:0009306;GO:0015031;GO:0035459;GO:0042060;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cargo receptor activity;, P:cell migration involved in sprouting angiogenesis; P:cellular protein metabolic process; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:lipoprotein transport; P:negative regulation of cell adhesion; P:negative regulation of cell migration; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of lymphocyte migration; P:positive regulation of leukocyte migration; P:post-translational protein modification; P:protein localization to endoplasmic reticulum exit site; P:protein secretion; P:protein transport; P:vesicle cargo loading; P:wound healing; scaffold24 indexed_genome mRNA 12377463 12408734 . + . ID=transcript_5597;Q15573 B2RDZ8 D3DTB7 Q9NWA1,TATA box-binding protein-associated factor RNA polymerase I subunit A,RNA polymerase I-specific TBP-associated factor 48 kDa;TATA box-binding protein-associated factor 1A;Transcription factor SL1;Transcription initiation factor SL1/TIF-IB subunit A;, PF14929;, GO:0015630;GO:0005654;GO:0000120;GO:0003677;GO:0045815;GO:0006363;GO:0006360;GO:0006366;GO:0006361;, C:microtubule cytoskeleton; C:nucleoplasm; C:RNA polymerase I transcription regulator complex;, F:DNA binding;, P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase I promoter;|Q15573 B2RDZ8 D3DTB7 Q9NWA1,TATA box-binding protein-associated factor RNA polymerase I subunit A,RNA polymerase I-specific TBP-associated factor 48 kDa;TATA box-binding protein-associated factor 1A;Transcription factor SL1;Transcription initiation factor SL1/TIF-IB subunit A;, PF14929;, GO:0015630;GO:0005654;GO:0000120;GO:0003677;GO:0045815;GO:0006363;GO:0006360;GO:0006366;GO:0006361;, C:microtubule cytoskeleton; C:nucleoplasm; C:RNA polymerase I transcription regulator complex;, F:DNA binding;, P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase I promoter;|Q15573 B2RDZ8 D3DTB7 Q9NWA1,TATA box-binding protein-associated factor RNA polymerase I subunit A,RNA polymerase I-specific TBP-associated factor 48 kDa;TATA box-binding protein-associated factor 1A;Transcription factor SL1;Transcription initiation factor SL1/TIF-IB subunit A;, PF14929;, GO:0015630;GO:0005654;GO:0000120;GO:0003677;GO:0045815;GO:0006363;GO:0006360;GO:0006366;GO:0006361;, C:microtubule cytoskeleton; C:nucleoplasm; C:RNA polymerase I transcription regulator complex;, F:DNA binding;, P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase I promoter;|Q15573 B2RDZ8 D3DTB7 Q9NWA1,TATA box-binding protein-associated factor RNA polymerase I subunit A,RNA polymerase I-specific TBP-associated factor 48 kDa;TATA box-binding protein-associated factor 1A;Transcription factor SL1;Transcription initiation factor SL1/TIF-IB subunit A;, PF14929;, GO:0015630;GO:0005654;GO:0000120;GO:0003677;GO:0045815;GO:0006363;GO:0006360;GO:0006366;GO:0006361;, C:microtubule cytoskeleton; C:nucleoplasm; C:RNA polymerase I transcription regulator complex;, F:DNA binding;, P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase I promoter;|Q15573 B2RDZ8 D3DTB7 Q9NWA1,TATA box-binding protein-associated factor RNA polymerase I subunit A,RNA polymerase I-specific TBP-associated factor 48 kDa;TATA box-binding protein-associated factor 1A;Transcription factor SL1;Transcription initiation factor SL1/TIF-IB subunit A;, PF14929;, GO:0015630;GO:0005654;GO:0000120;GO:0003677;GO:0045815;GO:0006363;GO:0006360;GO:0006366;GO:0006361;, C:microtubule cytoskeleton; C:nucleoplasm; C:RNA polymerase I transcription regulator complex;, F:DNA binding;, P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase I promoter; scaffold24 indexed_genome mRNA 12420008 12421866 . + . ID=transcript_5598;Q6UWX4 Q6GU65 Q96BT4 Q96BU5 Q9H8A0,HHIP-like protein 2,, PF03024;PF07995;, GO:0005576;GO:0003824;, C:extracellular region;, F:catalytic activity;|Q6UWX4 Q6GU65 Q96BT4 Q96BU5 Q9H8A0,HHIP-like protein 2,, PF03024;PF07995;, GO:0005576;GO:0003824;, C:extracellular region;, F:catalytic activity; scaffold24 indexed_genome mRNA 13139851 13178946 . + . ID=transcript_5599;Q9Y6W6 D3DTB4 Q6GSI4 Q9H9Z5,Dual specificity protein phosphatase 10,Mitogen-activated protein kinase phosphatase 5;, PF00581;, GO:0005737;GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0008432;GO:0033549;GO:0017017;GO:0051019;GO:0048273;GO:0016791;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0016311;GO:0000188;GO:0030336;GO:0010633;GO:0050680;GO:1905042;GO:0070373;GO:0046329;GO:0043508;GO:0048715;GO:1903753;GO:0044387;GO:0060266;GO:0048709;GO:0035970;GO:0035335;GO:1990264;GO:0045591;GO:0006470;GO:0002819;GO:0090335;GO:0032496;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:JUN kinase binding; F:MAP kinase phosphatase activity; F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:mitogen-activated protein kinase p38 binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:dephosphorylation; P:inactivation of MAPK activity; P:negative regulation of cell migration; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelium regeneration; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of JNK cascade; P:negative regulation of JUN kinase activity; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of p38MAPK cascade; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of respiratory burst involved in inflammatory response; P:oligodendrocyte differentiation; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:positive regulation of regulatory T cell differentiation; P:protein dephosphorylation; P:regulation of adaptive immune response; P:regulation of brown fat cell differentiation; P:response to lipopolysaccharide; scaffold24 indexed_genome mRNA 13976748 13982389 . - . ID=transcript_5600;Q14774 B2R8A8 Q15988 Q59HE7 Q9NZ75,H2.0-like homeobox protein,Homeobox protein HB24;Homeobox protein HLX1;, PF00046;, GO:0000785;GO:0005634;GO:0000981;GO:0043565;GO:0030154;GO:0048557;GO:0048484;GO:0001889;GO:0007275;GO:0045629;GO:0008284;GO:0046622;GO:0045627;GO:0007519;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding;, P:cell differentiation; P:embryonic digestive tract morphogenesis; P:enteric nervous system development; P:liver development; P:multicellular organism development; P:negative regulation of T-helper 2 cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of organ growth; P:positive regulation of T-helper 1 cell differentiation; P:skeletal muscle tissue development;|Q14774 B2R8A8 Q15988 Q59HE7 Q9NZ75,H2.0-like homeobox protein,Homeobox protein HB24;Homeobox protein HLX1;, PF00046;, GO:0000785;GO:0005634;GO:0000981;GO:0043565;GO:0030154;GO:0048557;GO:0048484;GO:0001889;GO:0007275;GO:0045629;GO:0008284;GO:0046622;GO:0045627;GO:0007519;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding;, P:cell differentiation; P:embryonic digestive tract morphogenesis; P:enteric nervous system development; P:liver development; P:multicellular organism development; P:negative regulation of T-helper 2 cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of organ growth; P:positive regulation of T-helper 1 cell differentiation; P:skeletal muscle tissue development; scaffold24 indexed_genome mRNA 14039697 14061459 . - . ID=transcript_5601;Q5VT66 A8K447 B2D078 Q5VVS9 Q5VVT0 Q5VVT1 Q8N9P5 Q96FN8 Q9H6C7,Mitochondrial amidoxime-reducing component 1 {ECO:0000303|PubMed:21029045},Molybdenum cofactor sulfurase C-terminal domain-containing protein 1 {ECO:0000303|PubMed:30397129};, PF03473;PF03476;, GO:0016021;GO:0005741;GO:0005739;GO:1903958;GO:0030151;GO:0043546;GO:0008940;GO:0098809;GO:0016661;GO:0030170;GO:0070458;GO:0051410;GO:0042126;GO:0006809;GO:0006805;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nitric-oxide synthase complex;, F:molybdenum ion binding; F:molybdopterin cofactor binding; F:nitrate reductase activity; F:nitrite reductase activity; F:oxidoreductase activity, acting on other nitrogenous compounds as donors; F:pyridoxal phosphate binding;, P:cellular detoxification of nitrogen compound; P:detoxification of nitrogen compound; P:nitrate metabolic process; P:nitric oxide biosynthetic process; P:xenobiotic metabolic process;|Q5VT66 A8K447 B2D078 Q5VVS9 Q5VVT0 Q5VVT1 Q8N9P5 Q96FN8 Q9H6C7,Mitochondrial amidoxime-reducing component 1 {ECO:0000303|PubMed:21029045},Molybdenum cofactor sulfurase C-terminal domain-containing protein 1 {ECO:0000303|PubMed:30397129};, PF03473;PF03476;, GO:0016021;GO:0005741;GO:0005739;GO:1903958;GO:0030151;GO:0043546;GO:0008940;GO:0098809;GO:0016661;GO:0030170;GO:0070458;GO:0051410;GO:0042126;GO:0006809;GO:0006805;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nitric-oxide synthase complex;, F:molybdenum ion binding; F:molybdopterin cofactor binding; F:nitrate reductase activity; F:nitrite reductase activity; F:oxidoreductase activity, acting on other nitrogenous compounds as donors; F:pyridoxal phosphate binding;, P:cellular detoxification of nitrogen compound; P:detoxification of nitrogen compound; P:nitrate metabolic process; P:nitric oxide biosynthetic process; P:xenobiotic metabolic process; scaffold24 indexed_genome mRNA 14063960 14105522 . - . ID=transcript_5602;Q969Z3 B2D0R5 D3DTB3 Q0JSK7 Q5VT67 Q5VXC7 Q7L317 Q9H066 Q9NWU0,Mitochondrial amidoxime reducing component 2 {ECO:0000303|PubMed:21029045},Molybdenum cofactor sulfurase C-terminal domain-containing protein 2;, PF03473;PF03476;, GO:0005741;GO:0005739;GO:0005777;GO:0030151;GO:0043546;GO:0008940;GO:0098809;GO:0016661;GO:0030170;GO:0070458;GO:0051410;GO:0042126;GO:0006809;GO:0006805;, C:mitochondrial outer membrane; C:mitochondrion; C:peroxisome;, F:molybdenum ion binding; F:molybdopterin cofactor binding; F:nitrate reductase activity; F:nitrite reductase activity; F:oxidoreductase activity, acting on other nitrogenous compounds as donors; F:pyridoxal phosphate binding;, P:cellular detoxification of nitrogen compound; P:detoxification of nitrogen compound; P:nitrate metabolic process; P:nitric oxide biosynthetic process; P:xenobiotic metabolic process;|Q969Z3 B2D0R5 D3DTB3 Q0JSK7 Q5VT67 Q5VXC7 Q7L317 Q9H066 Q9NWU0,Mitochondrial amidoxime reducing component 2 {ECO:0000303|PubMed:21029045},Molybdenum cofactor sulfurase C-terminal domain-containing protein 2;, PF03473;PF03476;, GO:0005741;GO:0005739;GO:0005777;GO:0030151;GO:0043546;GO:0008940;GO:0098809;GO:0016661;GO:0030170;GO:0070458;GO:0051410;GO:0042126;GO:0006809;GO:0006805;, C:mitochondrial outer membrane; C:mitochondrion; C:peroxisome;, F:molybdenum ion binding; F:molybdopterin cofactor binding; F:nitrate reductase activity; F:nitrite reductase activity; F:oxidoreductase activity, acting on other nitrogenous compounds as donors; F:pyridoxal phosphate binding;, P:cellular detoxification of nitrogen compound; P:detoxification of nitrogen compound; P:nitrate metabolic process; P:nitric oxide biosynthetic process; P:xenobiotic metabolic process; scaffold24 indexed_genome mRNA 14169259 14303555 . - . ID=transcript_5603;Q9P0L2 D3DTB0 D3DTB1 Q2HIY1 Q5VTF9 Q5VTG0 Q96SW9 Q9P251,Serine/threonine-protein kinase MARK1,MAP/microtubule affinity-regulating kinase 1;PAR1 homolog c;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005856;GO:0030425;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0070300;GO:0005546;GO:0001786;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0007010;GO:0051654;GO:0035556;GO:0000226;GO:0001764;GO:0018105;GO:0006468;GO:0050773;GO:0010975;GO:0016055;, C:cytoplasm; C:cytoskeleton; C:dendrite; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:cytoskeleton organization; P:establishment of mitochondrion localization; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:neuron migration; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of dendrite development; P:regulation of neuron projection development; P:Wnt signaling pathway;|Q9P0L2 D3DTB0 D3DTB1 Q2HIY1 Q5VTF9 Q5VTG0 Q96SW9 Q9P251,Serine/threonine-protein kinase MARK1,MAP/microtubule affinity-regulating kinase 1;PAR1 homolog c;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005856;GO:0030425;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0070300;GO:0005546;GO:0001786;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0007010;GO:0051654;GO:0035556;GO:0000226;GO:0001764;GO:0018105;GO:0006468;GO:0050773;GO:0010975;GO:0016055;, C:cytoplasm; C:cytoskeleton; C:dendrite; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:cytoskeleton organization; P:establishment of mitochondrion localization; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:neuron migration; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of dendrite development; P:regulation of neuron projection development; P:Wnt signaling pathway;|Q9P0L2 D3DTB0 D3DTB1 Q2HIY1 Q5VTF9 Q5VTG0 Q96SW9 Q9P251,Serine/threonine-protein kinase MARK1,MAP/microtubule affinity-regulating kinase 1;PAR1 homolog c;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005856;GO:0030425;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0070300;GO:0005546;GO:0001786;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0007010;GO:0051654;GO:0035556;GO:0000226;GO:0001764;GO:0018105;GO:0006468;GO:0050773;GO:0010975;GO:0016055;, C:cytoplasm; C:cytoskeleton; C:dendrite; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:cytoskeleton organization; P:establishment of mitochondrion localization; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:neuron migration; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of dendrite development; P:regulation of neuron projection development; P:Wnt signaling pathway; scaffold24 indexed_genome mRNA 14558341 14712430 . + . ID=transcript_5604;Q9H2M9 A6H8V0 O75872 Q9HAB0 Q9UFJ7 Q9UQ15,Rab3 GTPase-activating protein non-catalytic subunit,RGAP-iso;Rab3 GTPase-activating protein 150 kDa subunit;Rab3-GAP p150;Rab3-GAP regulatory subunit;, PF14656;PF14655;, GO:0005829;GO:0005789;GO:0005886;GO:0032991;GO:0008047;GO:0030234;GO:0005096;GO:0031267;GO:0097051;GO:0006886;GO:2000786;GO:1903373;GO:1903061;GO:0043087;, C:cytosol; C:endoplasmic reticulum membrane; C:plasma membrane; C:protein-containing complex;, F:enzyme activator activity; F:enzyme regulator activity; F:GTPase activator activity; F:small GTPase binding;, P:establishment of protein localization to endoplasmic reticulum membrane; P:intracellular protein transport; P:positive regulation of autophagosome assembly; P:positive regulation of endoplasmic reticulum tubular network organization; P:positive regulation of protein lipidation; P:regulation of GTPase activity;|Q9H2M9 A6H8V0 O75872 Q9HAB0 Q9UFJ7 Q9UQ15,Rab3 GTPase-activating protein non-catalytic subunit,RGAP-iso;Rab3 GTPase-activating protein 150 kDa subunit;Rab3-GAP p150;Rab3-GAP regulatory subunit;, PF14656;PF14655;, GO:0005829;GO:0005789;GO:0005886;GO:0032991;GO:0008047;GO:0030234;GO:0005096;GO:0031267;GO:0097051;GO:0006886;GO:2000786;GO:1903373;GO:1903061;GO:0043087;, C:cytosol; C:endoplasmic reticulum membrane; C:plasma membrane; C:protein-containing complex;, F:enzyme activator activity; F:enzyme regulator activity; F:GTPase activator activity; F:small GTPase binding;, P:establishment of protein localization to endoplasmic reticulum membrane; P:intracellular protein transport; P:positive regulation of autophagosome assembly; P:positive regulation of endoplasmic reticulum tubular network organization; P:positive regulation of protein lipidation; P:regulation of GTPase activity;|Q9H2M9 A6H8V0 O75872 Q9HAB0 Q9UFJ7 Q9UQ15,Rab3 GTPase-activating protein non-catalytic subunit,RGAP-iso;Rab3 GTPase-activating protein 150 kDa subunit;Rab3-GAP p150;Rab3-GAP regulatory subunit;, PF14656;PF14655;, GO:0005829;GO:0005789;GO:0005886;GO:0032991;GO:0008047;GO:0030234;GO:0005096;GO:0031267;GO:0097051;GO:0006886;GO:2000786;GO:1903373;GO:1903061;GO:0043087;, C:cytosol; C:endoplasmic reticulum membrane; C:plasma membrane; C:protein-containing complex;, F:enzyme activator activity; F:enzyme regulator activity; F:GTPase activator activity; F:small GTPase binding;, P:establishment of protein localization to endoplasmic reticulum membrane; P:intracellular protein transport; P:positive regulation of autophagosome assembly; P:positive regulation of endoplasmic reticulum tubular network organization; P:positive regulation of protein lipidation; P:regulation of GTPase activity;|Q9H2M9 A6H8V0 O75872 Q9HAB0 Q9UFJ7 Q9UQ15,Rab3 GTPase-activating protein non-catalytic subunit,RGAP-iso;Rab3 GTPase-activating protein 150 kDa subunit;Rab3-GAP p150;Rab3-GAP regulatory subunit;, PF14656;PF14655;, GO:0005829;GO:0005789;GO:0005886;GO:0032991;GO:0008047;GO:0030234;GO:0005096;GO:0031267;GO:0097051;GO:0006886;GO:2000786;GO:1903373;GO:1903061;GO:0043087;, C:cytosol; C:endoplasmic reticulum membrane; C:plasma membrane; C:protein-containing complex;, F:enzyme activator activity; F:enzyme regulator activity; F:GTPase activator activity; F:small GTPase binding;, P:establishment of protein localization to endoplasmic reticulum membrane; P:intracellular protein transport; P:positive regulation of autophagosome assembly; P:positive regulation of endoplasmic reticulum tubular network organization; P:positive regulation of protein lipidation; P:regulation of GTPase activity;|Q9NSE4 B2RPG8 Q1M2P9 Q6PI85 Q7L439 Q86WU9 Q96D91 Q9H9Q8 Q9NW42,Isoleucine--tRNA ligase, mitochondrial,Isoleucyl-tRNA synthetase;, PF08264;PF00133;PF06827;, GO:0005759;GO:0005739;GO:0002161;GO:0005524;GO:0004822;GO:0000049;GO:0006428;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|Q9NSE4 B2RPG8 Q1M2P9 Q6PI85 Q7L439 Q86WU9 Q96D91 Q9H9Q8 Q9NW42,Isoleucine--tRNA ligase, mitochondrial,Isoleucyl-tRNA synthetase;, PF08264;PF00133;PF06827;, GO:0005759;GO:0005739;GO:0002161;GO:0005524;GO:0004822;GO:0000049;GO:0006428;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|Q9NSE4 B2RPG8 Q1M2P9 Q6PI85 Q7L439 Q86WU9 Q96D91 Q9H9Q8 Q9NW42,Isoleucine--tRNA ligase, mitochondrial,Isoleucyl-tRNA synthetase;, PF08264;PF00133;PF06827;, GO:0005759;GO:0005739;GO:0002161;GO:0005524;GO:0004822;GO:0000049;GO:0006428;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|Q9NSE4 B2RPG8 Q1M2P9 Q6PI85 Q7L439 Q86WU9 Q96D91 Q9H9Q8 Q9NW42,Isoleucine--tRNA ligase, mitochondrial,Isoleucyl-tRNA synthetase;, PF08264;PF00133;PF06827;, GO:0005759;GO:0005739;GO:0002161;GO:0005524;GO:0004822;GO:0000049;GO:0006428;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|Q9NSE4 B2RPG8 Q1M2P9 Q6PI85 Q7L439 Q86WU9 Q96D91 Q9H9Q8 Q9NW42,Isoleucine--tRNA ligase, mitochondrial,Isoleucyl-tRNA synthetase;, PF08264;PF00133;PF06827;, GO:0005759;GO:0005739;GO:0002161;GO:0005524;GO:0004822;GO:0000049;GO:0006428;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|P62753 P08227 P10660 Q4VBY7 Q8N6Z7,40S ribosomal protein S6 {ECO:0000303|PubMed:29563586},Phosphoprotein NP33;Small ribosomal subunit protein eS6 {ECO:0000303|PubMed:24524803};, PF01092;, GO:0044297;GO:0036464;GO:0005829;GO:0022627;GO:0030425;GO:0005783;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005844;GO:1990904;GO:0015935;GO:0019901;GO:0003723;GO:0003735;GO:0006924;GO:0048821;GO:0000082;GO:0007369;GO:0042593;GO:0022605;GO:0043066;GO:0000184;GO:0001890;GO:0043065;GO:0008284;GO:0042274;GO:0006364;GO:0006614;GO:0033077;GO:0002309;GO:0031929;GO:0006412;GO:0006413;GO:0019083;, C:cell body; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic small ribosomal subunit; C:dendrite; C:endoplasmic reticulum; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:small ribosomal subunit;, F:protein kinase binding; F:RNA binding; F:structural constituent of ribosome;, P:activation-induced cell death of T cells; P:erythrocyte development; P:G1/S transition of mitotic cell cycle; P:gastrulation; P:glucose homeostasis; P:mammalian oogenesis stage; P:negative regulation of apoptotic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:placenta development; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:T cell differentiation in thymus; P:T cell proliferation involved in immune response; P:TOR signaling; P:translation; P:translational initiation; P:viral transcription;|Q9NSE4 B2RPG8 Q1M2P9 Q6PI85 Q7L439 Q86WU9 Q96D91 Q9H9Q8 Q9NW42,Isoleucine--tRNA ligase, mitochondrial,Isoleucyl-tRNA synthetase;, PF08264;PF00133;PF06827;, GO:0005759;GO:0005739;GO:0002161;GO:0005524;GO:0004822;GO:0000049;GO:0006428;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation; scaffold24 indexed_genome mRNA 14715305 14738197 . + . ID=transcript_5605;O95861 A8K7C8 B4DPS5 B4DUS9 D3DTA9 Q8WVL5 Q9UGJ3,3'(2'),5'-bisphosphate nucleotidase 1,Bisphosphate 3'-nucleotidase 1;PAP-inositol 1,4-phosphatase;, PF00459;, GO:0005829;GO:0008441;GO:0046872;GO:0050427;GO:0046855;GO:0007399;GO:0006139;GO:0046854;, C:cytosol;, F:3'(2'),5'-bisphosphate nucleotidase activity; F:metal ion binding;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:inositol phosphate dephosphorylation; P:nervous system development; P:nucleobase-containing compound metabolic process; P:phosphatidylinositol phosphorylation;|O95861 A8K7C8 B4DPS5 B4DUS9 D3DTA9 Q8WVL5 Q9UGJ3,3'(2'),5'-bisphosphate nucleotidase 1,Bisphosphate 3'-nucleotidase 1;PAP-inositol 1,4-phosphatase;, PF00459;, GO:0005829;GO:0008441;GO:0046872;GO:0050427;GO:0046855;GO:0007399;GO:0006139;GO:0046854;, C:cytosol;, F:3'(2'),5'-bisphosphate nucleotidase activity; F:metal ion binding;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:inositol phosphate dephosphorylation; P:nervous system development; P:nucleobase-containing compound metabolic process; P:phosphatidylinositol phosphorylation;|O95861 A8K7C8 B4DPS5 B4DUS9 D3DTA9 Q8WVL5 Q9UGJ3,3'(2'),5'-bisphosphate nucleotidase 1,Bisphosphate 3'-nucleotidase 1;PAP-inositol 1,4-phosphatase;, PF00459;, GO:0005829;GO:0008441;GO:0046872;GO:0050427;GO:0046855;GO:0007399;GO:0006139;GO:0046854;, C:cytosol;, F:3'(2'),5'-bisphosphate nucleotidase activity; F:metal ion binding;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:inositol phosphate dephosphorylation; P:nervous system development; P:nucleobase-containing compound metabolic process; P:phosphatidylinositol phosphorylation; scaffold24 indexed_genome mRNA 14760403 14821376 . + . ID=transcript_5606;P07814 A0AVA9 B9EGH3 Q05BP6 Q05DF8 Q5DSM1 Q5H9S5 Q6PD57 Q86X73,Bifunctional glutamate/proline--tRNA ligase,Bifunctional aminoacyl-tRNA synthetase;Cell proliferation-inducing gene 32 protein;Glutamatyl-prolyl-tRNA synthetase;, PF00043;PF03129;PF09180;PF00749;PF03950;PF00587;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0097452;GO:0016020;GO:0005886;GO:1990904;GO:0005524;GO:0004818;GO:0051020;GO:0042802;GO:0004827;GO:0042803;GO:0035613;GO:0008270;GO:0032869;GO:0071346;GO:0006424;GO:0017148;GO:0006433;GO:0065003;GO:0140212;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:GAIT complex; C:membrane; C:plasma membrane; C:ribonucleoprotein complex;, F:ATP binding; F:glutamate-tRNA ligase activity; F:GTPase binding; F:identical protein binding; F:proline-tRNA ligase activity; F:protein homodimerization activity; F:RNA stem-loop binding; F:zinc ion binding;, P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:glutamyl-tRNA aminoacylation; P:negative regulation of translation; P:prolyl-tRNA aminoacylation; P:protein-containing complex assembly; P:regulation of long-chain fatty acid import into cell; P:tRNA aminoacylation for protein translation;|P07814 A0AVA9 B9EGH3 Q05BP6 Q05DF8 Q5DSM1 Q5H9S5 Q6PD57 Q86X73,Bifunctional glutamate/proline--tRNA ligase,Bifunctional aminoacyl-tRNA synthetase;Cell proliferation-inducing gene 32 protein;Glutamatyl-prolyl-tRNA synthetase;, PF00043;PF03129;PF09180;PF00749;PF03950;PF00587;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0097452;GO:0016020;GO:0005886;GO:1990904;GO:0005524;GO:0004818;GO:0051020;GO:0042802;GO:0004827;GO:0042803;GO:0035613;GO:0008270;GO:0032869;GO:0071346;GO:0006424;GO:0017148;GO:0006433;GO:0065003;GO:0140212;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:GAIT complex; C:membrane; C:plasma membrane; C:ribonucleoprotein complex;, F:ATP binding; F:glutamate-tRNA ligase activity; F:GTPase binding; F:identical protein binding; F:proline-tRNA ligase activity; F:protein homodimerization activity; F:RNA stem-loop binding; F:zinc ion binding;, P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:glutamyl-tRNA aminoacylation; P:negative regulation of translation; P:prolyl-tRNA aminoacylation; P:protein-containing complex assembly; P:regulation of long-chain fatty acid import into cell; P:tRNA aminoacylation for protein translation;|P07814 A0AVA9 B9EGH3 Q05BP6 Q05DF8 Q5DSM1 Q5H9S5 Q6PD57 Q86X73,Bifunctional glutamate/proline--tRNA ligase,Bifunctional aminoacyl-tRNA synthetase;Cell proliferation-inducing gene 32 protein;Glutamatyl-prolyl-tRNA synthetase;, PF00043;PF03129;PF09180;PF00749;PF03950;PF00587;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0097452;GO:0016020;GO:0005886;GO:1990904;GO:0005524;GO:0004818;GO:0051020;GO:0042802;GO:0004827;GO:0042803;GO:0035613;GO:0008270;GO:0032869;GO:0071346;GO:0006424;GO:0017148;GO:0006433;GO:0065003;GO:0140212;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:GAIT complex; C:membrane; C:plasma membrane; C:ribonucleoprotein complex;, F:ATP binding; F:glutamate-tRNA ligase activity; F:GTPase binding; F:identical protein binding; F:proline-tRNA ligase activity; F:protein homodimerization activity; F:RNA stem-loop binding; F:zinc ion binding;, P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:glutamyl-tRNA aminoacylation; P:negative regulation of translation; P:prolyl-tRNA aminoacylation; P:protein-containing complex assembly; P:regulation of long-chain fatty acid import into cell; P:tRNA aminoacylation for protein translation;|P07814 A0AVA9 B9EGH3 Q05BP6 Q05DF8 Q5DSM1 Q5H9S5 Q6PD57 Q86X73,Bifunctional glutamate/proline--tRNA ligase,Bifunctional aminoacyl-tRNA synthetase;Cell proliferation-inducing gene 32 protein;Glutamatyl-prolyl-tRNA synthetase;, PF00043;PF03129;PF09180;PF00749;PF03950;PF00587;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0097452;GO:0016020;GO:0005886;GO:1990904;GO:0005524;GO:0004818;GO:0051020;GO:0042802;GO:0004827;GO:0042803;GO:0035613;GO:0008270;GO:0032869;GO:0071346;GO:0006424;GO:0017148;GO:0006433;GO:0065003;GO:0140212;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:GAIT complex; C:membrane; C:plasma membrane; C:ribonucleoprotein complex;, F:ATP binding; F:glutamate-tRNA ligase activity; F:GTPase binding; F:identical protein binding; F:proline-tRNA ligase activity; F:protein homodimerization activity; F:RNA stem-loop binding; F:zinc ion binding;, P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:glutamyl-tRNA aminoacylation; P:negative regulation of translation; P:prolyl-tRNA aminoacylation; P:protein-containing complex assembly; P:regulation of long-chain fatty acid import into cell; P:tRNA aminoacylation for protein translation; scaffold24 indexed_genome mRNA 14854516 14871896 . + . ID=transcript_5607;Q6XR72 Q49AL9 Q9NPW0,Zinc transporter 10,Manganese transporter SLC30A10;Solute carrier family 30 member 10;, PF01545;, GO:0005769;GO:0005794;GO:0016021;GO:0005886;GO:0055037;GO:0005385;GO:1904385;GO:0006882;GO:0007173;GO:0071421;GO:0006828;GO:2000773;GO:0043524;GO:1903427;GO:0070374;GO:1905802;GO:0071579;GO:0071577;, C:early endosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:recycling endosome;, F:zinc ion transmembrane transporter activity;, P:cellular response to angiotensin; P:cellular zinc ion homeostasis; P:epidermal growth factor receptor signaling pathway; P:manganese ion transmembrane transport; P:manganese ion transport; P:negative regulation of cellular senescence; P:negative regulation of neuron apoptotic process; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:regulation of cellular response to manganese ion; P:regulation of zinc ion transport; P:zinc ion transmembrane transport; scaffold24 indexed_genome mRNA 15558892 15593075 . - . ID=transcript_5608;Q5VWZ2 A8K677 Q5VWZ3 Q7Z4A3 Q96AV0,Lysophospholipase-like protein 1,, PF02230;, GO:0005737;GO:0005829;GO:0052689;GO:0004622;GO:0008474;GO:0002084;, C:cytoplasm; C:cytosol;, F:carboxylic ester hydrolase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity;, P:protein depalmitoylation;|Q5VWZ2 A8K677 Q5VWZ3 Q7Z4A3 Q96AV0,Lysophospholipase-like protein 1,, PF02230;, GO:0005737;GO:0005829;GO:0052689;GO:0004622;GO:0008474;GO:0002084;, C:cytoplasm; C:cytosol;, F:carboxylic ester hydrolase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity;, P:protein depalmitoylation; scaffold24 indexed_genome mRNA 16269282 16359325 . - . ID=transcript_5609;P61812 B4DKC5 P08112 Q15579 Q15581 Q4VAV9,Transforming growth factor beta-2 proprotein,Cetermin;Glioblastoma-derived T-cell suppressor factor {ECO:0000303|PubMed:3322813};, PF00019;PF00688;, GO:0030424;GO:0062023;GO:0005576;GO:0005615;GO:0043025;GO:0031093;GO:0001540;GO:0005125;GO:0008083;GO:0042803;GO:0005102;GO:0005160;GO:0005114;GO:0034714;GO:0032147;GO:0035910;GO:0060413;GO:0003289;GO:0003181;GO:0030509;GO:0060317;GO:0060038;GO:0003215;GO:0010002;GO:0007050;GO:0008219;GO:0016477;GO:0000902;GO:0045216;GO:0030199;GO:1904888;GO:0042416;GO:0009792;GO:0048566;GO:0030326;GO:0003274;GO:0003203;GO:0001837;GO:0097191;GO:0001654;GO:0048699;GO:0008347;GO:0001942;GO:0031069;GO:0007507;GO:0003007;GO:0003179;GO:0030097;GO:0048839;GO:0001822;GO:0008584;GO:0003149;GO:0010693;GO:0016525;GO:0030308;GO:0008285;GO:0050680;GO:1905006;GO:0010629;GO:0010936;GO:0046580;GO:0003407;GO:0001843;GO:0048666;GO:0030593;GO:0042476;GO:0003148;GO:0060389;GO:0061626;GO:0002576;GO:0051891;GO:0033630;GO:0045787;GO:0051781;GO:0030307;GO:0008284;GO:0010634;GO:0010718;GO:1905007;GO:0045823;GO:0050778;GO:0045726;GO:0043525;GO:0045747;GO:0045778;GO:0010862;GO:0014068;GO:1902895;GO:0050714;GO:0032874;GO:0051795;GO:0006468;GO:0003184;GO:1902256;GO:0042127;GO:0051794;GO:0032909;GO:0042493;GO:0001666;GO:0032570;GO:0009611;GO:0007435;GO:0062009;GO:0001501;GO:0060395;GO:0048103;GO:1903701;GO:0007179;GO:0042704;GO:0060065;GO:0060412;GO:0003222;GO:0042060;, C:axon; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:neuronal cell body; C:platelet alpha granule lumen;, F:amyloid-beta binding; F:cytokine activity; F:growth factor activity; F:protein homodimerization activity; F:signaling receptor binding; F:transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding; F:type III transforming growth factor beta receptor binding;, P:activation of protein kinase activity; P:ascending aorta morphogenesis; P:atrial septum morphogenesis; P:atrial septum primum morphogenesis; P:atrioventricular valve morphogenesis; P:BMP signaling pathway; P:cardiac epithelial to mesenchymal transition; P:cardiac muscle cell proliferation; P:cardiac right ventricle morphogenesis; P:cardioblast differentiation; P:cell cycle arrest; P:cell death; P:cell migration; P:cell morphogenesis; P:cell-cell junction organization; P:collagen fibril organization; P:cranial skeletal system development; P:dopamine biosynthetic process; P:embryo development ending in birth or egg hatching; P:embryonic digestive tract development; P:embryonic limb morphogenesis; P:endocardial cushion fusion; P:endocardial cushion morphogenesis; P:epithelial to mesenchymal transition; P:extrinsic apoptotic signaling pathway; P:eye development; P:generation of neurons; P:glial cell migration; P:hair follicle development; P:hair follicle morphogenesis; P:heart development; P:heart morphogenesis; P:heart valve morphogenesis; P:hemopoiesis; P:inner ear development; P:kidney development; P:male gonad development; P:membranous septum morphogenesis; P:negative regulation of alkaline phosphatase activity; P:negative regulation of angiogenesis; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:negative regulation of gene expression; P:negative regulation of macrophage cytokine production; P:negative regulation of Ras protein signal transduction; P:neural retina development; P:neural tube closure; P:neuron development; P:neutrophil chemotaxis; P:odontogenesis; P:outflow tract septum morphogenesis; P:pathway-restricted SMAD protein phosphorylation; P:pharyngeal arch artery morphogenesis; P:platelet degranulation; P:positive regulation of cardioblast differentiation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell cycle; P:positive regulation of cell division; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of heart contraction; P:positive regulation of immune response; P:positive regulation of integrin biosynthetic process; P:positive regulation of neuron apoptotic process; P:positive regulation of Notch signaling pathway; P:positive regulation of ossification; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein secretion; P:positive regulation of stress-activated MAPK cascade; P:positive regulation of timing of catagen; P:protein phosphorylation; P:pulmonary valve morphogenesis; P:regulation of apoptotic process involved in outflow tract morphogenesis; P:regulation of cell population proliferation; P:regulation of timing of catagen; P:regulation of transforming growth factor beta2 production; P:response to drug; P:response to hypoxia; P:response to progesterone; P:response to wounding; P:salivary gland morphogenesis; P:secondary palate development; P:skeletal system development; P:SMAD protein signal transduction; P:somatic stem cell division; P:substantia propria of cornea development; P:transforming growth factor beta receptor signaling pathway; P:uterine wall breakdown; P:uterus development; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis; P:wound healing; scaffold24 indexed_genome mRNA 16383444 16439103 . - . ID=transcript_5610;Q9Y3B9,RRP15-like protein,Ribosomal RNA-processing protein 15;, PF07890;, GO:0030687;GO:0000460;GO:0000470;, C:preribosome, large subunit precursor;, , P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA;|Q9Y3B9,RRP15-like protein,Ribosomal RNA-processing protein 15;, PF07890;, GO:0030687;GO:0000460;GO:0000470;, C:preribosome, large subunit precursor;, , P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; scaffold24 indexed_genome mRNA 17021330 17046843 . + . ID=transcript_5611;Q9NW75 Q5VYK7 Q5VYK8 Q86YE7,G patch domain-containing protein 2,, PF01585;, GO:0016607;GO:0005730;GO:0003676;GO:0010923;, C:nuclear speck; C:nucleolus;, F:nucleic acid binding;, P:negative regulation of phosphatase activity; scaffold24 indexed_genome mRNA 17151884 17212713 . + . ID=transcript_5612;Q9NW75 Q5VYK7 Q5VYK8 Q86YE7,G patch domain-containing protein 2,, PF01585;, GO:0016607;GO:0005730;GO:0003676;GO:0010923;, C:nuclear speck; C:nucleolus;, F:nucleic acid binding;, P:negative regulation of phosphatase activity; scaffold24 indexed_genome mRNA 18134046 18202985 . + . ID=transcript_5613;Q6P274 Q6PK28 Q6TS38 Q9R1F3 Q9UNJ4,Estrogen-related receptor gamma,ERR gamma-2;Estrogen receptor-related protein 3;Nuclear receptor subfamily 3 group B member 3;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0050682;GO:0001228;GO:0000981;GO:0042802;GO:0004879;GO:0000978;GO:1990837;GO:0005496;GO:0003707;GO:0008270;GO:0120162;GO:0045893;GO:0006357;GO:0006355;GO:0048384;GO:0006367;, C:chromatin; C:nucleoplasm;, F:AF-2 domain binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; scaffold24 indexed_genome mRNA 19219306 19285410 . + . ID=transcript_5614;Q9Y597 A0AV15 D3DTA6 Q49AG7 Q504Q9 Q6PJN6 Q8ND58 Q8NDJ0 Q8WX16,BTB/POZ domain-containing protein KCTD3,Renal carcinoma antigen NY-REN-45;, PF02214;, GO:0005886;GO:0051260;, C:plasma membrane;, , P:protein homooligomerization;|Q9Y597 A0AV15 D3DTA6 Q49AG7 Q504Q9 Q6PJN6 Q8ND58 Q8NDJ0 Q8WX16,BTB/POZ domain-containing protein KCTD3,Renal carcinoma antigen NY-REN-45;, PF02214;, GO:0005886;GO:0051260;, C:plasma membrane;, , P:protein homooligomerization;|Q9Y597 A0AV15 D3DTA6 Q49AG7 Q504Q9 Q6PJN6 Q8ND58 Q8NDJ0 Q8WX16,BTB/POZ domain-containing protein KCTD3,Renal carcinoma antigen NY-REN-45;, PF02214;, GO:0005886;GO:0051260;, C:plasma membrane;, , P:protein homooligomerization;|Q9Y597 A0AV15 D3DTA6 Q49AG7 Q504Q9 Q6PJN6 Q8ND58 Q8NDJ0 Q8WX16,BTB/POZ domain-containing protein KCTD3,Renal carcinoma antigen NY-REN-45;, PF02214;, GO:0005886;GO:0051260;, C:plasma membrane;, , P:protein homooligomerization; scaffold24 indexed_genome mRNA 22221522 22676586 . - . ID=transcript_5615;Q76B58 B3KVP1 B7Z260 O95726 Q2M330,BMP/retinoic acid-inducible neural-specific protein 3,DBCCR1-like protein 1;, PF19052;PF01823;, GO:0030425;GO:0005783;GO:0005576;GO:0005739;GO:0043025;GO:0007050;GO:0071300;GO:0045930;GO:0007399;GO:0045666;, C:dendrite; C:endoplasmic reticulum; C:extracellular region; C:mitochondrion; C:neuronal cell body;, , P:cell cycle arrest; P:cellular response to retinoic acid; P:negative regulation of mitotic cell cycle; P:nervous system development; P:positive regulation of neuron differentiation; scaffold24 indexed_genome mRNA 24543423 24571580 . + . ID=transcript_5616;Q9NS28 B2RD23,Regulator of G-protein signaling 18,, PF00615;, GO:0005737;GO:0005886;GO:0005096;GO:0007186;GO:0009968;GO:0008277;, C:cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway;|Q9NS28 B2RD23,Regulator of G-protein signaling 18,, PF00615;, GO:0005737;GO:0005886;GO:0005096;GO:0007186;GO:0009968;GO:0008277;, C:cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway;|Q9NS28 B2RD23,Regulator of G-protein signaling 18,, PF00615;, GO:0005737;GO:0005886;GO:0005096;GO:0007186;GO:0009968;GO:0008277;, C:cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway; scaffold24 indexed_genome mRNA 24971344 24975578 . + . ID=transcript_5617;Q08116 B2RDM9 B4DZY0 Q07918 Q9H1W2,Regulator of G-protein signaling 1,B-cell activation protein BL34 {ECO:0000303|PubMed:8473738};Early response protein 1R20;, PF00615;, GO:0005829;GO:0031234;GO:0005886;GO:0005516;GO:0001965;GO:0005096;GO:0007193;GO:0007186;GO:0006955;GO:0061737;GO:0009968;GO:0043547;GO:0008277;GO:0009617;GO:0007165;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:calmodulin binding; F:G-protein alpha-subunit binding; F:GTPase activator activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:immune response; P:leukotriene signaling pathway; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of G protein-coupled receptor signaling pathway; P:response to bacterium; P:signal transduction;|Q08116 B2RDM9 B4DZY0 Q07918 Q9H1W2,Regulator of G-protein signaling 1,B-cell activation protein BL34 {ECO:0000303|PubMed:8473738};Early response protein 1R20;, PF00615;, GO:0005829;GO:0031234;GO:0005886;GO:0005516;GO:0001965;GO:0005096;GO:0007193;GO:0007186;GO:0006955;GO:0061737;GO:0009968;GO:0043547;GO:0008277;GO:0009617;GO:0007165;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:calmodulin binding; F:G-protein alpha-subunit binding; F:GTPase activator activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:immune response; P:leukotriene signaling pathway; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of G protein-coupled receptor signaling pathway; P:response to bacterium; P:signal transduction;|Q08116 B2RDM9 B4DZY0 Q07918 Q9H1W2,Regulator of G-protein signaling 1,B-cell activation protein BL34 {ECO:0000303|PubMed:8473738};Early response protein 1R20;, PF00615;, GO:0005829;GO:0031234;GO:0005886;GO:0005516;GO:0001965;GO:0005096;GO:0007193;GO:0007186;GO:0006955;GO:0061737;GO:0009968;GO:0043547;GO:0008277;GO:0009617;GO:0007165;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:calmodulin binding; F:G-protein alpha-subunit binding; F:GTPase activator activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:immune response; P:leukotriene signaling pathway; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of G protein-coupled receptor signaling pathway; P:response to bacterium; P:signal transduction;|Q08116 B2RDM9 B4DZY0 Q07918 Q9H1W2,Regulator of G-protein signaling 1,B-cell activation protein BL34 {ECO:0000303|PubMed:8473738};Early response protein 1R20;, PF00615;, GO:0005829;GO:0031234;GO:0005886;GO:0005516;GO:0001965;GO:0005096;GO:0007193;GO:0007186;GO:0006955;GO:0061737;GO:0009968;GO:0043547;GO:0008277;GO:0009617;GO:0007165;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:calmodulin binding; F:G-protein alpha-subunit binding; F:GTPase activator activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:immune response; P:leukotriene signaling pathway; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of G protein-coupled receptor signaling pathway; P:response to bacterium; P:signal transduction; scaffold24 indexed_genome mRNA 25232535 25235082 . + . ID=transcript_5618;P41220 Q6I9U5,Regulator of G-protein signaling 2,Cell growth-inhibiting gene 31 protein;G0/G1 switch regulatory protein 8;, PF00615;, GO:0005737;GO:0009898;GO:0005829;GO:0005739;GO:0043005;GO:0005730;GO:0005634;GO:0005886;GO:0048487;GO:0005516;GO:0001965;GO:0005096;GO:0007420;GO:0050873;GO:0007049;GO:0007186;GO:0060135;GO:0140194;GO:0043951;GO:0010614;GO:0061052;GO:0045744;GO:1900924;GO:0043407;GO:0010519;GO:0017148;GO:0030728;GO:0060452;GO:0010976;GO:0008277;GO:0055119;GO:0060087;GO:0001975;GO:0045471;GO:0007283;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:mitochondrion; C:neuron projection; C:nucleolus; C:nucleus; C:plasma membrane;, F:beta-tubulin binding; F:calmodulin binding; F:G-protein alpha-subunit binding; F:GTPase activator activity;, P:brain development; P:brown fat cell differentiation; P:cell cycle; P:G protein-coupled receptor signaling pathway; P:maternal process involved in female pregnancy; P:negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of glycine import across plasma membrane; P:negative regulation of MAP kinase activity; P:negative regulation of phospholipase activity; P:negative regulation of translation; P:ovulation; P:positive regulation of cardiac muscle contraction; P:positive regulation of neuron projection development; P:regulation of G protein-coupled receptor signaling pathway; P:relaxation of cardiac muscle; P:relaxation of vascular associated smooth muscle; P:response to amphetamine; P:response to ethanol; P:spermatogenesis;|P41220 Q6I9U5,Regulator of G-protein signaling 2,Cell growth-inhibiting gene 31 protein;G0/G1 switch regulatory protein 8;, PF00615;, GO:0005737;GO:0009898;GO:0005829;GO:0005739;GO:0043005;GO:0005730;GO:0005634;GO:0005886;GO:0048487;GO:0005516;GO:0001965;GO:0005096;GO:0007420;GO:0050873;GO:0007049;GO:0007186;GO:0060135;GO:0140194;GO:0043951;GO:0010614;GO:0061052;GO:0045744;GO:1900924;GO:0043407;GO:0010519;GO:0017148;GO:0030728;GO:0060452;GO:0010976;GO:0008277;GO:0055119;GO:0060087;GO:0001975;GO:0045471;GO:0007283;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:mitochondrion; C:neuron projection; C:nucleolus; C:nucleus; C:plasma membrane;, F:beta-tubulin binding; F:calmodulin binding; F:G-protein alpha-subunit binding; F:GTPase activator activity;, P:brain development; P:brown fat cell differentiation; P:cell cycle; P:G protein-coupled receptor signaling pathway; P:maternal process involved in female pregnancy; P:negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of glycine import across plasma membrane; P:negative regulation of MAP kinase activity; P:negative regulation of phospholipase activity; P:negative regulation of translation; P:ovulation; P:positive regulation of cardiac muscle contraction; P:positive regulation of neuron projection development; P:regulation of G protein-coupled receptor signaling pathway; P:relaxation of cardiac muscle; P:relaxation of vascular associated smooth muscle; P:response to amphetamine; P:response to ethanol; P:spermatogenesis; scaffold24 indexed_genome mRNA 25424825 25484277 . - . ID=transcript_5619;Q9Y5K5 Q5LJA6 Q5LJA7 Q8TBS4 Q96BJ9 Q9H1W5 Q9P0I3 Q9UQN2,Ubiquitin carboxyl-terminal hydrolase isozyme L5,Ubiquitin C-terminal hydrolase UCH37;Ubiquitin thioesterase L5;, PF01088;PF18031;, GO:0005737;GO:0005829;GO:0031011;GO:0005730;GO:0005654;GO:0005634;GO:0000502;GO:0008234;GO:0004866;GO:0070628;GO:0003723;GO:0004843;GO:0006310;GO:0006281;GO:0032435;GO:0045880;GO:0016579;GO:0061136;GO:0006511;, C:cytoplasm; C:cytosol; C:Ino80 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:cysteine-type peptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA recombination; P:DNA repair; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of smoothened signaling pathway; P:protein deubiquitination; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9Y5K5 Q5LJA6 Q5LJA7 Q8TBS4 Q96BJ9 Q9H1W5 Q9P0I3 Q9UQN2,Ubiquitin carboxyl-terminal hydrolase isozyme L5,Ubiquitin C-terminal hydrolase UCH37;Ubiquitin thioesterase L5;, PF01088;PF18031;, GO:0005737;GO:0005829;GO:0031011;GO:0005730;GO:0005654;GO:0005634;GO:0000502;GO:0008234;GO:0004866;GO:0070628;GO:0003723;GO:0004843;GO:0006310;GO:0006281;GO:0032435;GO:0045880;GO:0016579;GO:0061136;GO:0006511;, C:cytoplasm; C:cytosol; C:Ino80 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:cysteine-type peptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA recombination; P:DNA repair; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of smoothened signaling pathway; P:protein deubiquitination; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9Y5K5 Q5LJA6 Q5LJA7 Q8TBS4 Q96BJ9 Q9H1W5 Q9P0I3 Q9UQN2,Ubiquitin carboxyl-terminal hydrolase isozyme L5,Ubiquitin C-terminal hydrolase UCH37;Ubiquitin thioesterase L5;, PF01088;PF18031;, GO:0005737;GO:0005829;GO:0031011;GO:0005730;GO:0005654;GO:0005634;GO:0000502;GO:0008234;GO:0004866;GO:0070628;GO:0003723;GO:0004843;GO:0006310;GO:0006281;GO:0032435;GO:0045880;GO:0016579;GO:0061136;GO:0006511;, C:cytoplasm; C:cytosol; C:Ino80 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:cysteine-type peptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA recombination; P:DNA repair; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of smoothened signaling pathway; P:protein deubiquitination; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9Y5K5 Q5LJA6 Q5LJA7 Q8TBS4 Q96BJ9 Q9H1W5 Q9P0I3 Q9UQN2,Ubiquitin carboxyl-terminal hydrolase isozyme L5,Ubiquitin C-terminal hydrolase UCH37;Ubiquitin thioesterase L5;, PF01088;PF18031;, GO:0005737;GO:0005829;GO:0031011;GO:0005730;GO:0005654;GO:0005634;GO:0000502;GO:0008234;GO:0004866;GO:0070628;GO:0003723;GO:0004843;GO:0006310;GO:0006281;GO:0032435;GO:0045880;GO:0016579;GO:0061136;GO:0006511;, C:cytoplasm; C:cytosol; C:Ino80 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:cysteine-type peptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA recombination; P:DNA repair; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of smoothened signaling pathway; P:protein deubiquitination; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9Y5K5 Q5LJA6 Q5LJA7 Q8TBS4 Q96BJ9 Q9H1W5 Q9P0I3 Q9UQN2,Ubiquitin carboxyl-terminal hydrolase isozyme L5,Ubiquitin C-terminal hydrolase UCH37;Ubiquitin thioesterase L5;, PF01088;PF18031;, GO:0005737;GO:0005829;GO:0031011;GO:0005730;GO:0005654;GO:0005634;GO:0000502;GO:0008234;GO:0004866;GO:0070628;GO:0003723;GO:0004843;GO:0006310;GO:0006281;GO:0032435;GO:0045880;GO:0016579;GO:0061136;GO:0006511;, C:cytoplasm; C:cytosol; C:Ino80 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:cysteine-type peptidase activity; F:endopeptidase inhibitor activity; F:proteasome binding; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:DNA recombination; P:DNA repair; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of smoothened signaling pathway; P:protein deubiquitination; P:regulation of proteasomal protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9NS18 Q3LR69 Q7L1N7 Q96JC0 Q9Y3D4,Glutaredoxin-2, mitochondrial,, PF00462;, GO:0030425;GO:0043231;GO:0005759;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0051537;GO:0008794;GO:0009055;GO:0015038;GO:0046872;GO:0003756;GO:0015035;GO:0007568;GO:0006915;GO:0030154;GO:0045454;GO:0071451;GO:0042262;GO:0006749;GO:0009966;GO:0006355;GO:0042542;GO:0010033;GO:0051775;GO:0009266;, C:dendrite; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus;, F:2 iron, 2 sulfur cluster binding; F:arsenate reductase (glutaredoxin) activity; F:electron transfer activity; F:glutathione disulfide oxidoreductase activity; F:metal ion binding; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity;, P:aging; P:apoptotic process; P:cell differentiation; P:cell redox homeostasis; P:cellular response to superoxide; P:DNA protection; P:glutathione metabolic process; P:regulation of signal transduction; P:regulation of transcription, DNA-templated; P:response to hydrogen peroxide; P:response to organic substance; P:response to redox state; P:response to temperature stimulus; scaffold24 indexed_genome mRNA 25484454 25493722 . + . ID=transcript_5620;P10155 B2RBB9 Q5LJ98 Q5LJ99 Q5LJA0 Q86WL3 Q86WL4 Q92787 Q9H1W6,60 kDa SS-A/Ro ribonucleoprotein {ECO:0000305},Ro 60 kDa autoantigen;Sjoegren syndrome antigen A2;Sjoegren syndrome type A antigen;TROVE domain family member 2;, PF05731;, GO:0005829;GO:0005654;GO:1990904;GO:0046872;GO:0003723;GO:0030620;GO:0035457;GO:0060271;GO:0002520;GO:0010468;GO:0009411;GO:0007224;GO:0006383;, C:cytosol; C:nucleoplasm; C:ribonucleoprotein complex;, F:metal ion binding; F:RNA binding; F:U2 snRNA binding;, P:cellular response to interferon-alpha; P:cilium assembly; P:immune system development; P:regulation of gene expression; P:response to UV; P:smoothened signaling pathway; P:transcription by RNA polymerase III;|P10155 B2RBB9 Q5LJ98 Q5LJ99 Q5LJA0 Q86WL3 Q86WL4 Q92787 Q9H1W6,60 kDa SS-A/Ro ribonucleoprotein {ECO:0000305},Ro 60 kDa autoantigen;Sjoegren syndrome antigen A2;Sjoegren syndrome type A antigen;TROVE domain family member 2;, PF05731;, GO:0005829;GO:0005654;GO:1990904;GO:0046872;GO:0003723;GO:0030620;GO:0035457;GO:0060271;GO:0002520;GO:0010468;GO:0009411;GO:0007224;GO:0006383;, C:cytosol; C:nucleoplasm; C:ribonucleoprotein complex;, F:metal ion binding; F:RNA binding; F:U2 snRNA binding;, P:cellular response to interferon-alpha; P:cilium assembly; P:immune system development; P:regulation of gene expression; P:response to UV; P:smoothened signaling pathway; P:transcription by RNA polymerase III;|P10155 B2RBB9 Q5LJ98 Q5LJ99 Q5LJA0 Q86WL3 Q86WL4 Q92787 Q9H1W6,60 kDa SS-A/Ro ribonucleoprotein {ECO:0000305},Ro 60 kDa autoantigen;Sjoegren syndrome antigen A2;Sjoegren syndrome type A antigen;TROVE domain family member 2;, PF05731;, GO:0005829;GO:0005654;GO:1990904;GO:0046872;GO:0003723;GO:0030620;GO:0035457;GO:0060271;GO:0002520;GO:0010468;GO:0009411;GO:0007224;GO:0006383;, C:cytosol; C:nucleoplasm; C:ribonucleoprotein complex;, F:metal ion binding; F:RNA binding; F:U2 snRNA binding;, P:cellular response to interferon-alpha; P:cilium assembly; P:immune system development; P:regulation of gene expression; P:response to UV; P:smoothened signaling pathway; P:transcription by RNA polymerase III;|P10155 B2RBB9 Q5LJ98 Q5LJ99 Q5LJA0 Q86WL3 Q86WL4 Q92787 Q9H1W6,60 kDa SS-A/Ro ribonucleoprotein {ECO:0000305},Ro 60 kDa autoantigen;Sjoegren syndrome antigen A2;Sjoegren syndrome type A antigen;TROVE domain family member 2;, PF05731;, GO:0005829;GO:0005654;GO:1990904;GO:0046872;GO:0003723;GO:0030620;GO:0035457;GO:0060271;GO:0002520;GO:0010468;GO:0009411;GO:0007224;GO:0006383;, C:cytosol; C:nucleoplasm; C:ribonucleoprotein complex;, F:metal ion binding; F:RNA binding; F:U2 snRNA binding;, P:cellular response to interferon-alpha; P:cilium assembly; P:immune system development; P:regulation of gene expression; P:response to UV; P:smoothened signaling pathway; P:transcription by RNA polymerase III; scaffold24 indexed_genome mRNA 25504049 25512918 . - . ID=transcript_5621;Q9NS18 Q3LR69 Q7L1N7 Q96JC0 Q9Y3D4,Glutaredoxin-2, mitochondrial,, PF00462;, GO:0030425;GO:0043231;GO:0005759;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0051537;GO:0008794;GO:0009055;GO:0015038;GO:0046872;GO:0003756;GO:0015035;GO:0007568;GO:0006915;GO:0030154;GO:0045454;GO:0071451;GO:0042262;GO:0006749;GO:0009966;GO:0006355;GO:0042542;GO:0010033;GO:0051775;GO:0009266;, C:dendrite; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus;, F:2 iron, 2 sulfur cluster binding; F:arsenate reductase (glutaredoxin) activity; F:electron transfer activity; F:glutathione disulfide oxidoreductase activity; F:metal ion binding; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity;, P:aging; P:apoptotic process; P:cell differentiation; P:cell redox homeostasis; P:cellular response to superoxide; P:DNA protection; P:glutathione metabolic process; P:regulation of signal transduction; P:regulation of transcription, DNA-templated; P:response to hydrogen peroxide; P:response to organic substance; P:response to redox state; P:response to temperature stimulus;|Q9NS18 Q3LR69 Q7L1N7 Q96JC0 Q9Y3D4,Glutaredoxin-2, mitochondrial,, PF00462;, GO:0030425;GO:0043231;GO:0005759;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0051537;GO:0008794;GO:0009055;GO:0015038;GO:0046872;GO:0003756;GO:0015035;GO:0007568;GO:0006915;GO:0030154;GO:0045454;GO:0071451;GO:0042262;GO:0006749;GO:0009966;GO:0006355;GO:0042542;GO:0010033;GO:0051775;GO:0009266;, C:dendrite; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus;, F:2 iron, 2 sulfur cluster binding; F:arsenate reductase (glutaredoxin) activity; F:electron transfer activity; F:glutathione disulfide oxidoreductase activity; F:metal ion binding; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity;, P:aging; P:apoptotic process; P:cell differentiation; P:cell redox homeostasis; P:cellular response to superoxide; P:DNA protection; P:glutathione metabolic process; P:regulation of signal transduction; P:regulation of transcription, DNA-templated; P:response to hydrogen peroxide; P:response to organic substance; P:response to redox state; P:response to temperature stimulus; scaffold24 indexed_genome mRNA 25543895 25643324 . + . ID=transcript_5622;Q6P1J9 A6NLZ8 B2RBR2 Q6PK51 Q96A07 Q9H245 Q9H5L7,Parafibromin,Cell division cycle protein 73 homolog;Hyperparathyroidism 2 protein;, PF05179;PF16050;, GO:0016593;GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0000993;GO:1904837;GO:0007049;GO:0071222;GO:0001711;GO:0033523;GO:0010390;GO:0006378;GO:0043066;GO:0008285;GO:0050680;GO:0048147;GO:2000134;GO:0045638;GO:0000122;GO:1902808;GO:0031442;GO:0032968;GO:0030177;GO:0031648;GO:0016567;GO:0034402;GO:0001558;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus;, F:RNA polymerase II complex binding;, P:beta-catenin-TCF complex assembly; P:cell cycle; P:cellular response to lipopolysaccharide; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone monoubiquitination; P:mRNA polyadenylation; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of epithelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of mRNA 3'-end processing; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of Wnt signaling pathway; P:protein destabilization; P:protein ubiquitination; P:recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex; P:regulation of cell growth; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|O43825 B2RAB1 Q9BZQ9,Beta-1,3-galactosyltransferase 2 {ECO:0000305},UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2;, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0047275;GO:0008532;GO:0008499;GO:0006682;GO:0009312;GO:0030311;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity;, P:galactosylceramide biosynthetic process; P:oligosaccharide biosynthetic process; P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation; scaffold25 indexed_genome mRNA 21928 137360 . + . ID=transcript_5623;Q9BZW3 Q9H421 Q9H4J6 Q9NZ22,PHD finger protein 20,Glioma-expressed antigen 2;Hepatocellular carcinoma-associated antigen 58;Novel zinc finger protein;Transcription factor TZP;, PF12618;PF18115;, GO:0005829;GO:0000123;GO:0071339;GO:0044545;GO:0031965;GO:0005654;GO:0003677;GO:0046872;GO:0016573;GO:0043984;GO:0043981;GO:0043982;GO:1901796;GO:0006357;, C:cytosol; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nuclear membrane; C:nucleoplasm;, F:DNA binding; F:metal ion binding;, P:histone acetylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q9BZW3 Q9H421 Q9H4J6 Q9NZ22,PHD finger protein 20,Glioma-expressed antigen 2;Hepatocellular carcinoma-associated antigen 58;Novel zinc finger protein;Transcription factor TZP;, PF12618;PF18115;, GO:0005829;GO:0000123;GO:0071339;GO:0044545;GO:0031965;GO:0005654;GO:0003677;GO:0046872;GO:0016573;GO:0043984;GO:0043981;GO:0043982;GO:1901796;GO:0006357;, C:cytosol; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nuclear membrane; C:nucleoplasm;, F:DNA binding; F:metal ion binding;, P:histone acetylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q9BZW3 Q9H421 Q9H4J6 Q9NZ22,PHD finger protein 20,Glioma-expressed antigen 2;Hepatocellular carcinoma-associated antigen 58;Novel zinc finger protein;Transcription factor TZP;, PF12618;PF18115;, GO:0005829;GO:0000123;GO:0071339;GO:0044545;GO:0031965;GO:0005654;GO:0003677;GO:0046872;GO:0016573;GO:0043984;GO:0043981;GO:0043982;GO:1901796;GO:0006357;, C:cytosol; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nuclear membrane; C:nucleoplasm;, F:DNA binding; F:metal ion binding;, P:histone acetylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q9BZW3 Q9H421 Q9H4J6 Q9NZ22,PHD finger protein 20,Glioma-expressed antigen 2;Hepatocellular carcinoma-associated antigen 58;Novel zinc finger protein;Transcription factor TZP;, PF12618;PF18115;, GO:0005829;GO:0000123;GO:0071339;GO:0044545;GO:0031965;GO:0005654;GO:0003677;GO:0046872;GO:0016573;GO:0043984;GO:0043981;GO:0043982;GO:1901796;GO:0006357;, C:cytosol; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nuclear membrane; C:nucleoplasm;, F:DNA binding; F:metal ion binding;, P:histone acetylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 138620 159573 . - . ID=transcript_5624;P57086 Q6IAG7,SCAN domain-containing protein 1,, PF02023;, GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated;|Q96M20 Q14C79 Q5JWY7 Q5T3S1 Q9BR36 Q9BWY5,Cyclic nucleotide-binding domain-containing protein 2,, PF00027;, GO:0005829;GO:0030552;GO:0007283;, C:cytosol;, F:cAMP binding;, P:spermatogenesis; scaffold25 indexed_genome mRNA 172462 203288 . + . ID=transcript_5625;Q96M20 Q14C79 Q5JWY7 Q5T3S1 Q9BR36 Q9BWY5,Cyclic nucleotide-binding domain-containing protein 2,, PF00027;, GO:0005829;GO:0030552;GO:0007283;, C:cytosol;, F:cAMP binding;, P:spermatogenesis;|Q76KX8 Q76KX9,Zinc finger protein 534,KRAB domain only protein 3;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 338190 378120 . + . ID=transcript_5626;Q96L65,Band 4.1-like protein 1,Erythrocyte membrane protein band 4.1-like 1 {ECO:0000312|HGNC:HGNC:3378};Neuronal protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0005856;GO:0005829;GO:0005886;GO:0003779;GO:0005198;GO:0031032;GO:0030866;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:actin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cortical actin cytoskeleton organization; scaffold25 indexed_genome mRNA 388720 411245 . + . ID=transcript_5627;Q96L65,Band 4.1-like protein 1,Erythrocyte membrane protein band 4.1-like 1 {ECO:0000312|HGNC:HGNC:3378};Neuronal protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0005856;GO:0005829;GO:0005886;GO:0003779;GO:0005198;GO:0031032;GO:0030866;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:actin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cortical actin cytoskeleton organization;|Q96L65,Band 4.1-like protein 1,Erythrocyte membrane protein band 4.1-like 1 {ECO:0000312|HGNC:HGNC:3378};Neuronal protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0005856;GO:0005829;GO:0005886;GO:0003779;GO:0005198;GO:0031032;GO:0030866;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:actin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cortical actin cytoskeleton organization;|Q96L65,Band 4.1-like protein 1,Erythrocyte membrane protein band 4.1-like 1 {ECO:0000312|HGNC:HGNC:3378};Neuronal protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0005856;GO:0005829;GO:0005886;GO:0003779;GO:0005198;GO:0031032;GO:0030866;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:actin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cortical actin cytoskeleton organization;|Q96L65,Band 4.1-like protein 1,Erythrocyte membrane protein band 4.1-like 1 {ECO:0000312|HGNC:HGNC:3378};Neuronal protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0005856;GO:0005829;GO:0005886;GO:0003779;GO:0005198;GO:0031032;GO:0030866;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:actin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cortical actin cytoskeleton organization; scaffold25 indexed_genome mRNA 414386 434223 . + . ID=transcript_5628;Q9Y312 E1P5S7 Q9H4F9 Q9P1P3 Q9UFK9,Protein AAR2 homolog,AAR2 splicing factor homolog;, PF05282;, GO:0005681;GO:0005682;GO:0000244;, C:spliceosomal complex; C:U5 snRNP;, , P:spliceosomal tri-snRNP complex assembly;|Q9Y312 E1P5S7 Q9H4F9 Q9P1P3 Q9UFK9,Protein AAR2 homolog,AAR2 splicing factor homolog;, PF05282;, GO:0005681;GO:0005682;GO:0000244;, C:spliceosomal complex; C:U5 snRNP;, , P:spliceosomal tri-snRNP complex assembly; scaffold25 indexed_genome mRNA 487122 609354 . + . ID=transcript_5629;Q9Y2H0 E1P5T5 Q5QPG4 Q5T2Y4 Q5T2Y5 Q9H137 Q9H138 Q9H1L7,Disks large-associated protein 4,PSD-95/SAP90-binding protein 4;SAP90/PSD-95-associated protein 4;, PF03359;, GO:0098981;GO:0098978;GO:0031594;GO:0005886;GO:0099572;GO:0060090;GO:0098962;GO:0023052;, C:cholinergic synapse; C:glutamatergic synapse; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization;, F:molecular adaptor activity;, P:regulation of postsynaptic neurotransmitter receptor activity; P:signaling; scaffold25 indexed_genome mRNA 639393 660243 . + . ID=transcript_5630;Q9Y2H0 E1P5T5 Q5QPG4 Q5T2Y4 Q5T2Y5 Q9H137 Q9H138 Q9H1L7,Disks large-associated protein 4,PSD-95/SAP90-binding protein 4;SAP90/PSD-95-associated protein 4;, PF03359;, GO:0098981;GO:0098978;GO:0031594;GO:0005886;GO:0099572;GO:0060090;GO:0098962;GO:0023052;, C:cholinergic synapse; C:glutamatergic synapse; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization;, F:molecular adaptor activity;, P:regulation of postsynaptic neurotransmitter receptor activity; P:signaling;|Q9Y2H0 E1P5T5 Q5QPG4 Q5T2Y4 Q5T2Y5 Q9H137 Q9H138 Q9H1L7,Disks large-associated protein 4,PSD-95/SAP90-binding protein 4;SAP90/PSD-95-associated protein 4;, PF03359;, GO:0098981;GO:0098978;GO:0031594;GO:0005886;GO:0099572;GO:0060090;GO:0098962;GO:0023052;, C:cholinergic synapse; C:glutamatergic synapse; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization;, F:molecular adaptor activity;, P:regulation of postsynaptic neurotransmitter receptor activity; P:signaling; scaffold25 indexed_genome mRNA 660314 693718 . - . ID=transcript_5631;Q9Y2H0 E1P5T5 Q5QPG4 Q5T2Y4 Q5T2Y5 Q9H137 Q9H138 Q9H1L7,Disks large-associated protein 4,PSD-95/SAP90-binding protein 4;SAP90/PSD-95-associated protein 4;, PF03359;, GO:0098981;GO:0098978;GO:0031594;GO:0005886;GO:0099572;GO:0060090;GO:0098962;GO:0023052;, C:cholinergic synapse; C:glutamatergic synapse; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization;, F:molecular adaptor activity;, P:regulation of postsynaptic neurotransmitter receptor activity; P:signaling;|Q9Y2H0 E1P5T5 Q5QPG4 Q5T2Y4 Q5T2Y5 Q9H137 Q9H138 Q9H1L7,Disks large-associated protein 4,PSD-95/SAP90-binding protein 4;SAP90/PSD-95-associated protein 4;, PF03359;, GO:0098981;GO:0098978;GO:0031594;GO:0005886;GO:0099572;GO:0060090;GO:0098962;GO:0023052;, C:cholinergic synapse; C:glutamatergic synapse; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization;, F:molecular adaptor activity;, P:regulation of postsynaptic neurotransmitter receptor activity; P:signaling;|Q9Y2H0 E1P5T5 Q5QPG4 Q5T2Y4 Q5T2Y5 Q9H137 Q9H138 Q9H1L7,Disks large-associated protein 4,PSD-95/SAP90-binding protein 4;SAP90/PSD-95-associated protein 4;, PF03359;, GO:0098981;GO:0098978;GO:0031594;GO:0005886;GO:0099572;GO:0060090;GO:0098962;GO:0023052;, C:cholinergic synapse; C:glutamatergic synapse; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization;, F:molecular adaptor activity;, P:regulation of postsynaptic neurotransmitter receptor activity; P:signaling;|Q9Y2H0 E1P5T5 Q5QPG4 Q5T2Y4 Q5T2Y5 Q9H137 Q9H138 Q9H1L7,Disks large-associated protein 4,PSD-95/SAP90-binding protein 4;SAP90/PSD-95-associated protein 4;, PF03359;, GO:0098981;GO:0098978;GO:0031594;GO:0005886;GO:0099572;GO:0060090;GO:0098962;GO:0023052;, C:cholinergic synapse; C:glutamatergic synapse; C:neuromuscular junction; C:plasma membrane; C:postsynaptic specialization;, F:molecular adaptor activity;, P:regulation of postsynaptic neurotransmitter receptor activity; P:signaling; scaffold25 indexed_genome mRNA 706990 712956 . + . ID=transcript_5632;P24844 E1P5T6 Q9BQL9 Q9BUF9 Q9H136,Myosin regulatory light polypeptide 9,20 kDa myosin light chain;MLC-2C;Myosin RLC;Myosin regulatory light chain 2, smooth muscle isoform;Myosin regulatory light chain 9;Myosin regulatory light chain MRLC1;, PF13405;PF13833;, GO:0005829;GO:0005859;GO:0001725;GO:0030018;GO:0005509;GO:0032036;GO:0008307;GO:0006936;GO:0070527;GO:0045652;GO:0006937;, C:cytosol; C:muscle myosin complex; C:stress fiber; C:Z disc;, F:calcium ion binding; F:myosin heavy chain binding; F:structural constituent of muscle;, P:muscle contraction; P:platelet aggregation; P:regulation of megakaryocyte differentiation; P:regulation of muscle contraction; scaffold25 indexed_genome mRNA 740142 754128 . + . ID=transcript_5633;Q9GZN2 B2R9U3 E1P5T9 H0YNI0,Homeobox protein TGIF2,5'-TG-3'-interacting factor 2;TGF-beta-induced transcription factor 2;, PF05920;, GO:0005813;GO:0000785;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000122;GO:0038092;GO:0045666;GO:0010470;GO:0006357;GO:0006355;GO:0060041;, C:centrosome; C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:nodal signaling pathway; P:positive regulation of neuron differentiation; P:regulation of gastrulation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:retina development in camera-type eye; scaffold25 indexed_genome mRNA 764904 866319 . + . ID=transcript_5634;Q9BUV8 E1P5U0 O00605 Q5QPG6 Q5QPG7 Q9BT03 Q9BZU7 Q9UI05,Respirasome Complex Assembly Factor 1 {ECO:0000303|PubMed:31536960},Rab5-interacting protein {ECO:0000312|HGNC:HGNC:15870};, PF07019;, GO:0016021;GO:0005746;GO:0097250;, C:integral component of membrane; C:mitochondrial respirasome;, , P:mitochondrial respirasome assembly;|Q9BUV8 E1P5U0 O00605 Q5QPG6 Q5QPG7 Q9BT03 Q9BZU7 Q9UI05,Respirasome Complex Assembly Factor 1 {ECO:0000303|PubMed:31536960},Rab5-interacting protein {ECO:0000312|HGNC:HGNC:15870};, PF07019;, GO:0016021;GO:0005746;GO:0097250;, C:integral component of membrane; C:mitochondrial respirasome;, , P:mitochondrial respirasome assembly;|Q9BUV8 E1P5U0 O00605 Q5QPG6 Q5QPG7 Q9BT03 Q9BZU7 Q9UI05,Respirasome Complex Assembly Factor 1 {ECO:0000303|PubMed:31536960},Rab5-interacting protein {ECO:0000312|HGNC:HGNC:15870};, PF07019;, GO:0016021;GO:0005746;GO:0097250;, C:integral component of membrane; C:mitochondrial respirasome;, , P:mitochondrial respirasome assembly;|Q9H6Q3 A8K648 E1P5U1 E1P5U2 Q5TH27 Q5TH28 Q8WY18 Q96QI4 Q9H135,Src-like-adapter 2,Modulator of antigen receptor signaling;Src-like adapter protein 2;, PF00017;PF00018;, GO:0005737;GO:0005829;GO:0010008;GO:0005794;GO:0043231;GO:0005770;GO:0005654;GO:0005942;GO:0005886;GO:0046935;GO:0047485;GO:0035591;GO:0050851;GO:0019724;GO:0019221;GO:0050849;GO:0050860;GO:0000122;GO:0046854;GO:0050776;GO:0042110;, C:cytoplasm; C:cytosol; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:late endosome; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:protein N-terminus binding; F:signaling adaptor activity;, P:antigen receptor-mediated signaling pathway; P:B cell mediated immunity; P:cytokine-mediated signaling pathway; P:negative regulation of calcium-mediated signaling; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylinositol phosphorylation; P:regulation of immune response; P:T cell activation;|Q9H6Q3 A8K648 E1P5U1 E1P5U2 Q5TH27 Q5TH28 Q8WY18 Q96QI4 Q9H135,Src-like-adapter 2,Modulator of antigen receptor signaling;Src-like adapter protein 2;, PF00017;PF00018;, GO:0005737;GO:0005829;GO:0010008;GO:0005794;GO:0043231;GO:0005770;GO:0005654;GO:0005942;GO:0005886;GO:0046935;GO:0047485;GO:0035591;GO:0050851;GO:0019724;GO:0019221;GO:0050849;GO:0050860;GO:0000122;GO:0046854;GO:0050776;GO:0042110;, C:cytoplasm; C:cytosol; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:late endosome; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:protein N-terminus binding; F:signaling adaptor activity;, P:antigen receptor-mediated signaling pathway; P:B cell mediated immunity; P:cytokine-mediated signaling pathway; P:negative regulation of calcium-mediated signaling; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylinositol phosphorylation; P:regulation of immune response; P:T cell activation;|Q9H6Q3 A8K648 E1P5U1 E1P5U2 Q5TH27 Q5TH28 Q8WY18 Q96QI4 Q9H135,Src-like-adapter 2,Modulator of antigen receptor signaling;Src-like adapter protein 2;, PF00017;PF00018;, GO:0005737;GO:0005829;GO:0010008;GO:0005794;GO:0043231;GO:0005770;GO:0005654;GO:0005942;GO:0005886;GO:0046935;GO:0047485;GO:0035591;GO:0050851;GO:0019724;GO:0019221;GO:0050849;GO:0050860;GO:0000122;GO:0046854;GO:0050776;GO:0042110;, C:cytoplasm; C:cytosol; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:late endosome; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:protein N-terminus binding; F:signaling adaptor activity;, P:antigen receptor-mediated signaling pathway; P:B cell mediated immunity; P:cytokine-mediated signaling pathway; P:negative regulation of calcium-mediated signaling; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylinositol phosphorylation; P:regulation of immune response; P:T cell activation;|Q9H6Q3 A8K648 E1P5U1 E1P5U2 Q5TH27 Q5TH28 Q8WY18 Q96QI4 Q9H135,Src-like-adapter 2,Modulator of antigen receptor signaling;Src-like adapter protein 2;, PF00017;PF00018;, GO:0005737;GO:0005829;GO:0010008;GO:0005794;GO:0043231;GO:0005770;GO:0005654;GO:0005942;GO:0005886;GO:0046935;GO:0047485;GO:0035591;GO:0050851;GO:0019724;GO:0019221;GO:0050849;GO:0050860;GO:0000122;GO:0046854;GO:0050776;GO:0042110;, C:cytoplasm; C:cytosol; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:late endosome; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:protein N-terminus binding; F:signaling adaptor activity;, P:antigen receptor-mediated signaling pathway; P:B cell mediated immunity; P:cytokine-mediated signaling pathway; P:negative regulation of calcium-mediated signaling; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylinositol phosphorylation; P:regulation of immune response; P:T cell activation;|Q9H411 Q9H8J6,Protein NDRG3,N-myc downstream-regulated gene 3 protein;, PF03096;, GO:0005737;GO:0070062;GO:0030154;GO:0030308;GO:0007165;GO:0007283;, C:cytoplasm; C:extracellular exosome;, , P:cell differentiation; P:negative regulation of cell growth; P:signal transduction; P:spermatogenesis; scaffold25 indexed_genome mRNA 873131 889155 . - . ID=transcript_5635;Q9H410 B4DWT2 E1P5U9 Q5JW55 Q5JW56 Q9H8P4,Kinetochore-associated protein DSN1 homolog,, PF08202;, GO:0035578;GO:0000777;GO:0000941;GO:0005829;GO:0005576;GO:0001650;GO:0000776;GO:0000444;GO:0016604;GO:0000818;GO:0005730;GO:0005654;GO:0051301;GO:0000070;GO:0007052;GO:0043312;, C:azurophil granule lumen; C:condensed chromosome kinetochore; C:condensed nuclear chromosome inner kinetochore; C:cytosol; C:extracellular region; C:fibrillar center; C:kinetochore; C:MIS12/MIND type complex; C:nuclear body; C:nuclear MIS12/MIND complex; C:nucleolus; C:nucleoplasm;, , P:cell division; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:neutrophil degranulation;|Q9H410 B4DWT2 E1P5U9 Q5JW55 Q5JW56 Q9H8P4,Kinetochore-associated protein DSN1 homolog,, PF08202;, GO:0035578;GO:0000777;GO:0000941;GO:0005829;GO:0005576;GO:0001650;GO:0000776;GO:0000444;GO:0016604;GO:0000818;GO:0005730;GO:0005654;GO:0051301;GO:0000070;GO:0007052;GO:0043312;, C:azurophil granule lumen; C:condensed chromosome kinetochore; C:condensed nuclear chromosome inner kinetochore; C:cytosol; C:extracellular region; C:fibrillar center; C:kinetochore; C:MIS12/MIND type complex; C:nuclear body; C:nuclear MIS12/MIND complex; C:nucleolus; C:nucleoplasm;, , P:cell division; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:neutrophil degranulation;|Q9H410 B4DWT2 E1P5U9 Q5JW55 Q5JW56 Q9H8P4,Kinetochore-associated protein DSN1 homolog,, PF08202;, GO:0035578;GO:0000777;GO:0000941;GO:0005829;GO:0005576;GO:0001650;GO:0000776;GO:0000444;GO:0016604;GO:0000818;GO:0005730;GO:0005654;GO:0051301;GO:0000070;GO:0007052;GO:0043312;, C:azurophil granule lumen; C:condensed chromosome kinetochore; C:condensed nuclear chromosome inner kinetochore; C:cytosol; C:extracellular region; C:fibrillar center; C:kinetochore; C:MIS12/MIND type complex; C:nuclear body; C:nuclear MIS12/MIND complex; C:nucleolus; C:nucleoplasm;, , P:cell division; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:neutrophil degranulation; scaffold25 indexed_genome mRNA 898263 936437 . + . ID=transcript_5636;O94964 A6NK10 Q14DB2 Q5JW51 Q6ZTG8,Protein SOGA1,SOGA family member 1;Suppressor of glucose by autophagy;Suppressor of glucose, autophagy-associated protein 1;, PF14818;PF11365;, GO:0070062;GO:0005615;GO:0008286;GO:0045721;GO:0010506;, C:extracellular exosome; C:extracellular space;, , P:insulin receptor signaling pathway; P:negative regulation of gluconeogenesis; P:regulation of autophagy;|O94964 A6NK10 Q14DB2 Q5JW51 Q6ZTG8,Protein SOGA1,SOGA family member 1;Suppressor of glucose by autophagy;Suppressor of glucose, autophagy-associated protein 1;, PF14818;PF11365;, GO:0070062;GO:0005615;GO:0008286;GO:0045721;GO:0010506;, C:extracellular exosome; C:extracellular space;, , P:insulin receptor signaling pathway; P:negative regulation of gluconeogenesis; P:regulation of autophagy;|O94964 A6NK10 Q14DB2 Q5JW51 Q6ZTG8,Protein SOGA1,SOGA family member 1;Suppressor of glucose by autophagy;Suppressor of glucose, autophagy-associated protein 1;, PF14818;PF11365;, GO:0070062;GO:0005615;GO:0008286;GO:0045721;GO:0010506;, C:extracellular exosome; C:extracellular space;, , P:insulin receptor signaling pathway; P:negative regulation of gluconeogenesis; P:regulation of autophagy;|O94964 A6NK10 Q14DB2 Q5JW51 Q6ZTG8,Protein SOGA1,SOGA family member 1;Suppressor of glucose by autophagy;Suppressor of glucose, autophagy-associated protein 1;, PF14818;PF11365;, GO:0070062;GO:0005615;GO:0008286;GO:0045721;GO:0010506;, C:extracellular exosome; C:extracellular space;, , P:insulin receptor signaling pathway; P:negative regulation of gluconeogenesis; P:regulation of autophagy;|O94964 A6NK10 Q14DB2 Q5JW51 Q6ZTG8,Protein SOGA1,SOGA family member 1;Suppressor of glucose by autophagy;Suppressor of glucose, autophagy-associated protein 1;, PF14818;PF11365;, GO:0070062;GO:0005615;GO:0008286;GO:0045721;GO:0010506;, C:extracellular exosome; C:extracellular space;, , P:insulin receptor signaling pathway; P:negative regulation of gluconeogenesis; P:regulation of autophagy;|O94964 A6NK10 Q14DB2 Q5JW51 Q6ZTG8,Protein SOGA1,SOGA family member 1;Suppressor of glucose by autophagy;Suppressor of glucose, autophagy-associated protein 1;, PF14818;PF11365;, GO:0070062;GO:0005615;GO:0008286;GO:0045721;GO:0010506;, C:extracellular exosome; C:extracellular space;, , P:insulin receptor signaling pathway; P:negative regulation of gluconeogenesis; P:regulation of autophagy; scaffold25 indexed_genome mRNA 982661 983285 . - . ID=transcript_5637;A0PJX2 B3KVU8,TLD domain-containing protein 2,TBC/LysM-associated domain-containing protein 2;, PF07534;, GO:0005634;GO:0006979;, C:nucleus;, , P:response to oxidative stress; scaffold25 indexed_genome mRNA 987368 1045573 . + . ID=transcript_5638;A0PJX2 B3KVU8,TLD domain-containing protein 2,TBC/LysM-associated domain-containing protein 2;, PF07534;, GO:0005634;GO:0006979;, C:nucleus;, , P:response to oxidative stress;|Q9Y3Z3 B4E2A5 E1P5V2 Q5JXG8 Q8N491 Q9H004 Q9H005 Q9H3U9,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 {ECO:0000305},Dendritic cell-derived IFNG-induced protein {ECO:0000303|PubMed:11064105};Monocyte protein 5 {ECO:0000303|Ref.2};SAM domain and HD domain-containing protein 1 {ECO:0000305};, PF01966;PF07647;, GO:0005654;GO:0005634;GO:0005886;GO:0035861;GO:0097197;GO:0032567;GO:0008832;GO:0005525;GO:0042802;GO:0003676;GO:0004540;GO:0003723;GO:0003697;GO:0016793;GO:0008270;GO:0006974;GO:0046061;GO:0051607;GO:0009264;GO:0006203;GO:0110025;GO:0000724;GO:0006955;GO:0060339;GO:0051289;GO:0045088;GO:0016446;GO:0060337;GO:0016032;, C:nucleoplasm; C:nucleus; C:plasma membrane; C:site of double-strand break; C:tetraspanin-enriched microdomain;, F:dGTP binding; F:dGTPase activity; F:GTP binding; F:identical protein binding; F:nucleic acid binding; F:ribonuclease activity; F:RNA binding; F:single-stranded DNA binding; F:triphosphoric monoester hydrolase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:dATP catabolic process; P:defense response to virus; P:deoxyribonucleotide catabolic process; P:dGTP catabolic process; P:DNA strand resection involved in replication fork processing; P:double-strand break repair via homologous recombination; P:immune response; P:negative regulation of type I interferon-mediated signaling pathway; P:protein homotetramerization; P:regulation of innate immune response; P:somatic hypermutation of immunoglobulin genes; P:type I interferon signaling pathway; P:viral process;|Q9Y3Z3 B4E2A5 E1P5V2 Q5JXG8 Q8N491 Q9H004 Q9H005 Q9H3U9,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 {ECO:0000305},Dendritic cell-derived IFNG-induced protein {ECO:0000303|PubMed:11064105};Monocyte protein 5 {ECO:0000303|Ref.2};SAM domain and HD domain-containing protein 1 {ECO:0000305};, PF01966;PF07647;, GO:0005654;GO:0005634;GO:0005886;GO:0035861;GO:0097197;GO:0032567;GO:0008832;GO:0005525;GO:0042802;GO:0003676;GO:0004540;GO:0003723;GO:0003697;GO:0016793;GO:0008270;GO:0006974;GO:0046061;GO:0051607;GO:0009264;GO:0006203;GO:0110025;GO:0000724;GO:0006955;GO:0060339;GO:0051289;GO:0045088;GO:0016446;GO:0060337;GO:0016032;, C:nucleoplasm; C:nucleus; C:plasma membrane; C:site of double-strand break; C:tetraspanin-enriched microdomain;, F:dGTP binding; F:dGTPase activity; F:GTP binding; F:identical protein binding; F:nucleic acid binding; F:ribonuclease activity; F:RNA binding; F:single-stranded DNA binding; F:triphosphoric monoester hydrolase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:dATP catabolic process; P:defense response to virus; P:deoxyribonucleotide catabolic process; P:dGTP catabolic process; P:DNA strand resection involved in replication fork processing; P:double-strand break repair via homologous recombination; P:immune response; P:negative regulation of type I interferon-mediated signaling pathway; P:protein homotetramerization; P:regulation of innate immune response; P:somatic hypermutation of immunoglobulin genes; P:type I interferon signaling pathway; P:viral process;|Q9Y3Z3 B4E2A5 E1P5V2 Q5JXG8 Q8N491 Q9H004 Q9H005 Q9H3U9,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 {ECO:0000305},Dendritic cell-derived IFNG-induced protein {ECO:0000303|PubMed:11064105};Monocyte protein 5 {ECO:0000303|Ref.2};SAM domain and HD domain-containing protein 1 {ECO:0000305};, PF01966;PF07647;, GO:0005654;GO:0005634;GO:0005886;GO:0035861;GO:0097197;GO:0032567;GO:0008832;GO:0005525;GO:0042802;GO:0003676;GO:0004540;GO:0003723;GO:0003697;GO:0016793;GO:0008270;GO:0006974;GO:0046061;GO:0051607;GO:0009264;GO:0006203;GO:0110025;GO:0000724;GO:0006955;GO:0060339;GO:0051289;GO:0045088;GO:0016446;GO:0060337;GO:0016032;, C:nucleoplasm; C:nucleus; C:plasma membrane; C:site of double-strand break; C:tetraspanin-enriched microdomain;, F:dGTP binding; F:dGTPase activity; F:GTP binding; F:identical protein binding; F:nucleic acid binding; F:ribonuclease activity; F:RNA binding; F:single-stranded DNA binding; F:triphosphoric monoester hydrolase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:dATP catabolic process; P:defense response to virus; P:deoxyribonucleotide catabolic process; P:dGTP catabolic process; P:DNA strand resection involved in replication fork processing; P:double-strand break repair via homologous recombination; P:immune response; P:negative regulation of type I interferon-mediated signaling pathway; P:protein homotetramerization; P:regulation of innate immune response; P:somatic hypermutation of immunoglobulin genes; P:type I interferon signaling pathway; P:viral process;|Q9Y3Z3 B4E2A5 E1P5V2 Q5JXG8 Q8N491 Q9H004 Q9H005 Q9H3U9,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 {ECO:0000305},Dendritic cell-derived IFNG-induced protein {ECO:0000303|PubMed:11064105};Monocyte protein 5 {ECO:0000303|Ref.2};SAM domain and HD domain-containing protein 1 {ECO:0000305};, PF01966;PF07647;, GO:0005654;GO:0005634;GO:0005886;GO:0035861;GO:0097197;GO:0032567;GO:0008832;GO:0005525;GO:0042802;GO:0003676;GO:0004540;GO:0003723;GO:0003697;GO:0016793;GO:0008270;GO:0006974;GO:0046061;GO:0051607;GO:0009264;GO:0006203;GO:0110025;GO:0000724;GO:0006955;GO:0060339;GO:0051289;GO:0045088;GO:0016446;GO:0060337;GO:0016032;, C:nucleoplasm; C:nucleus; C:plasma membrane; C:site of double-strand break; C:tetraspanin-enriched microdomain;, F:dGTP binding; F:dGTPase activity; F:GTP binding; F:identical protein binding; F:nucleic acid binding; F:ribonuclease activity; F:RNA binding; F:single-stranded DNA binding; F:triphosphoric monoester hydrolase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:dATP catabolic process; P:defense response to virus; P:deoxyribonucleotide catabolic process; P:dGTP catabolic process; P:DNA strand resection involved in replication fork processing; P:double-strand break repair via homologous recombination; P:immune response; P:negative regulation of type I interferon-mediated signaling pathway; P:protein homotetramerization; P:regulation of innate immune response; P:somatic hypermutation of immunoglobulin genes; P:type I interferon signaling pathway; P:viral process;|Q9Y3Z3 B4E2A5 E1P5V2 Q5JXG8 Q8N491 Q9H004 Q9H005 Q9H3U9,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 {ECO:0000305},Dendritic cell-derived IFNG-induced protein {ECO:0000303|PubMed:11064105};Monocyte protein 5 {ECO:0000303|Ref.2};SAM domain and HD domain-containing protein 1 {ECO:0000305};, PF01966;PF07647;, GO:0005654;GO:0005634;GO:0005886;GO:0035861;GO:0097197;GO:0032567;GO:0008832;GO:0005525;GO:0042802;GO:0003676;GO:0004540;GO:0003723;GO:0003697;GO:0016793;GO:0008270;GO:0006974;GO:0046061;GO:0051607;GO:0009264;GO:0006203;GO:0110025;GO:0000724;GO:0006955;GO:0060339;GO:0051289;GO:0045088;GO:0016446;GO:0060337;GO:0016032;, C:nucleoplasm; C:nucleus; C:plasma membrane; C:site of double-strand break; C:tetraspanin-enriched microdomain;, F:dGTP binding; F:dGTPase activity; F:GTP binding; F:identical protein binding; F:nucleic acid binding; F:ribonuclease activity; F:RNA binding; F:single-stranded DNA binding; F:triphosphoric monoester hydrolase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:dATP catabolic process; P:defense response to virus; P:deoxyribonucleotide catabolic process; P:dGTP catabolic process; P:DNA strand resection involved in replication fork processing; P:double-strand break repair via homologous recombination; P:immune response; P:negative regulation of type I interferon-mediated signaling pathway; P:protein homotetramerization; P:regulation of innate immune response; P:somatic hypermutation of immunoglobulin genes; P:type I interferon signaling pathway; P:viral process; scaffold25 indexed_genome mRNA 1072738 1114516 . - . ID=transcript_5639;P28749 A8K2W5 Q4VXA0 Q8N5K6 Q9H1L5 Q9H1M1,Retinoblastoma-like protein 1,107 kDa retinoblastoma-associated protein;pRb1;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0008134;GO:0007049;GO:0030154;GO:0006325;GO:2000773;GO:2000134;GO:0010629;GO:0000122;GO:0045944;GO:0051302;GO:0043550;GO:0016032;, C:chromatin; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:cell cycle; P:cell differentiation; P:chromatin organization; P:negative regulation of cellular senescence; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell division; P:regulation of lipid kinase activity; P:viral process;|P28749 A8K2W5 Q4VXA0 Q8N5K6 Q9H1L5 Q9H1M1,Retinoblastoma-like protein 1,107 kDa retinoblastoma-associated protein;pRb1;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0008134;GO:0007049;GO:0030154;GO:0006325;GO:2000773;GO:2000134;GO:0010629;GO:0000122;GO:0045944;GO:0051302;GO:0043550;GO:0016032;, C:chromatin; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:cell cycle; P:cell differentiation; P:chromatin organization; P:negative regulation of cellular senescence; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell division; P:regulation of lipid kinase activity; P:viral process; scaffold25 indexed_genome mRNA 1115568 1127969 . - . ID=transcript_5640;P28749 A8K2W5 Q4VXA0 Q8N5K6 Q9H1L5 Q9H1M1,Retinoblastoma-like protein 1,107 kDa retinoblastoma-associated protein;pRb1;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0008134;GO:0007049;GO:0030154;GO:0006325;GO:2000773;GO:2000134;GO:0010629;GO:0000122;GO:0045944;GO:0051302;GO:0043550;GO:0016032;, C:chromatin; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:cell cycle; P:cell differentiation; P:chromatin organization; P:negative regulation of cellular senescence; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell division; P:regulation of lipid kinase activity; P:viral process;|P28749 A8K2W5 Q4VXA0 Q8N5K6 Q9H1L5 Q9H1M1,Retinoblastoma-like protein 1,107 kDa retinoblastoma-associated protein;pRb1;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0008134;GO:0007049;GO:0030154;GO:0006325;GO:2000773;GO:2000134;GO:0010629;GO:0000122;GO:0045944;GO:0051302;GO:0043550;GO:0016032;, C:chromatin; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:cell cycle; P:cell differentiation; P:chromatin organization; P:negative regulation of cellular senescence; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell division; P:regulation of lipid kinase activity; P:viral process; scaffold25 indexed_genome mRNA 1136847 1148498 . - . ID=transcript_5641;Q68CQ1 A0AUX8 Q5TA99 Q6ZP40 Q6ZRH6 Q8N311 Q8NA14,Maestro heat-like repeat-containing protein family member 7,HEAT repeat-containing protein 8;, , GO:0005615;GO:0016021;, C:extracellular space; C:integral component of membrane; scaffold25 indexed_genome mRNA 1148932 1150200 . - . ID=transcript_5642;Q68CQ1 A0AUX8 Q5TA99 Q6ZP40 Q6ZRH6 Q8N311 Q8NA14,Maestro heat-like repeat-containing protein family member 7,HEAT repeat-containing protein 8;, , GO:0005615;GO:0016021;, C:extracellular space; C:integral component of membrane; scaffold25 indexed_genome mRNA 1194203 1244460 . + . ID=transcript_5643;P04844 Q5JYR6 Q6IBA5 Q96E21 Q9BUQ3 Q9UBE1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit;RIBIIR;Ribophorin II;Ribophorin-2;, PF05817;, GO:0000421;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0016604;GO:0008250;GO:0005791;GO:0043022;GO:0007568;GO:0006464;GO:0006487;GO:0018279;GO:0042493;GO:0019082;, C:autophagosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear body; C:oligosaccharyltransferase complex; C:rough endoplasmic reticulum;, F:ribosome binding;, P:aging; P:cellular protein modification process; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:response to drug; P:viral protein processing;|P04844 Q5JYR6 Q6IBA5 Q96E21 Q9BUQ3 Q9UBE1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit;RIBIIR;Ribophorin II;Ribophorin-2;, PF05817;, GO:0000421;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0016604;GO:0008250;GO:0005791;GO:0043022;GO:0007568;GO:0006464;GO:0006487;GO:0018279;GO:0042493;GO:0019082;, C:autophagosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear body; C:oligosaccharyltransferase complex; C:rough endoplasmic reticulum;, F:ribosome binding;, P:aging; P:cellular protein modification process; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:response to drug; P:viral protein processing;|P04844 Q5JYR6 Q6IBA5 Q96E21 Q9BUQ3 Q9UBE1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit;RIBIIR;Ribophorin II;Ribophorin-2;, PF05817;, GO:0000421;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0016604;GO:0008250;GO:0005791;GO:0043022;GO:0007568;GO:0006464;GO:0006487;GO:0018279;GO:0042493;GO:0019082;, C:autophagosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear body; C:oligosaccharyltransferase complex; C:rough endoplasmic reticulum;, F:ribosome binding;, P:aging; P:cellular protein modification process; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:response to drug; P:viral protein processing; scaffold25 indexed_genome mRNA 1287042 1313022 . + . ID=transcript_5644;Q9NQG1 A8KAA6 E1P5V3,Protein MANBAL,, PF06783;, GO:0016021;, C:integral component of membrane; scaffold25 indexed_genome mRNA 1370662 1390411 . + . ID=transcript_5645;P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8,Proto-oncogene tyrosine-protein kinase Src {ECO:0000305},Proto-oncogene c-Src;pp60c-src;, PF07714;PF00017;PF00018;, GO:0005884;GO:0005901;GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0098978;GO:0005770;GO:0005764;GO:0045121;GO:0005743;GO:0005739;GO:0043005;GO:0005654;GO:0048471;GO:0005886;GO:0002102;GO:0014069;GO:0099091;GO:0032587;GO:0005524;GO:0051117;GO:0070700;GO:0045296;GO:0071253;GO:0019899;GO:0046875;GO:0030331;GO:0070851;GO:0020037;GO:0005158;GO:0005178;GO:0044325;GO:0019900;GO:0004715;GO:0051219;GO:0008022;GO:0004672;GO:0005080;GO:0004713;GO:0097110;GO:0042169;GO:0005102;GO:0004714;GO:0031625;GO:0032148;GO:0034332;GO:0086098;GO:0007411;GO:0045453;GO:0060444;GO:0007155;GO:0007049;GO:0030154;GO:0008283;GO:0098609;GO:0071398;GO:0071498;GO:0070301;GO:0071456;GO:0032869;GO:0071222;GO:0071375;GO:0036120;GO:0071393;GO:0035635;GO:0048013;GO:0007173;GO:0038128;GO:0038096;GO:0048041;GO:0030900;GO:0007186;GO:0045087;GO:0007229;GO:0070102;GO:0060576;GO:0035556;GO:0050900;GO:0016236;GO:2000811;GO:0043066;GO:0043154;GO:2001237;GO:0051895;GO:0002862;GO:2001243;GO:0051902;GO:0031333;GO:0051974;GO:0032211;GO:0045892;GO:0048011;GO:0042476;GO:0048477;GO:0036035;GO:0018105;GO:0038083;GO:0018108;GO:0030168;GO:0043065;GO:0090263;GO:0045737;GO:0035306;GO:2000573;GO:0010634;GO:0070374;GO:0010907;GO:0046628;GO:0033625;GO:2000394;GO:0043406;GO:1903997;GO:0045747;GO:2000386;GO:0050731;GO:0043552;GO:0014068;GO:2000588;GO:0071803;GO:0031954;GO:0051897;GO:1900182;GO:0010954;GO:0071902;GO:0051222;GO:0051057;GO:0014911;GO:0045893;GO:0001545;GO:0050847;GO:0046777;GO:0031648;GO:0045124;GO:2001286;GO:0060491;GO:0022407;GO:2000641;GO:0010632;GO:0033146;GO:0098962;GO:0043393;GO:0043114;GO:0010447;GO:0042493;GO:0051602;GO:0070555;GO:0009612;GO:0051385;GO:0031667;GO:0009615;GO:0007172;GO:0007165;GO:0002223;GO:0043149;GO:0034446;GO:0031295;GO:0045056;GO:0007179;GO:0007169;GO:0060065;GO:0048010;GO:0016032;, C:actin filament; C:caveola; C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:late endosome; C:lysosome; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:podosome; C:postsynaptic density; C:postsynaptic specialization, intracellular component; C:ruffle membrane;, F:ATP binding; F:ATPase binding; F:BMP receptor binding; F:cadherin binding; F:connexin binding; F:enzyme binding; F:ephrin receptor binding; F:estrogen receptor binding; F:growth factor receptor binding; F:heme binding; F:insulin receptor binding; F:integrin binding; F:ion channel binding; F:kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphoprotein binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase C binding; F:protein tyrosine kinase activity; F:scaffold protein binding; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:activation of protein kinase B activity; P:adherens junction organization; P:angiotensin-activated signaling pathway involved in heart process; P:axon guidance; P:bone resorption; P:branching involved in mammary gland duct morphogenesis; P:cell adhesion; P:cell cycle; P:cell differentiation; P:cell population proliferation; P:cell-cell adhesion; P:cellular response to fatty acid; P:cellular response to fluid shear stress; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:cellular response to peptide hormone stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to progesterone stimulus; P:entry of bacterium into host cell; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:focal adhesion assembly; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell development; P:intracellular signal transduction; P:leukocyte migration; P:macroautophagy; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of focal adhesion assembly; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of mitochondrial depolarization; P:negative regulation of protein-containing complex assembly; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of transcription, DNA-templated; P:neurotrophin TRK receptor signaling pathway; P:odontogenesis; P:oogenesis; P:osteoclast development; P:peptidyl-serine phosphorylation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of dephosphorylation; P:positive regulation of DNA biosynthetic process; P:positive regulation of epithelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glucose metabolic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of integrin activation; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of MAP kinase activity; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of Notch signaling pathway; P:positive regulation of ovarian follicle development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of podosome assembly; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein processing; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein transport; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of smooth muscle cell migration; P:positive regulation of transcription, DNA-templated; P:primary ovarian follicle growth; P:progesterone receptor signaling pathway; P:protein autophosphorylation; P:protein destabilization; P:regulation of bone resorption; P:regulation of caveolin-mediated endocytosis; P:regulation of cell projection assembly; P:regulation of cell-cell adhesion; P:regulation of early endosome to late endosome transport; P:regulation of epithelial cell migration; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of protein binding; P:regulation of vascular permeability; P:response to acidic pH; P:response to drug; P:response to electrical stimulus; P:response to interleukin-1; P:response to mechanical stimulus; P:response to mineralocorticoid; P:response to nutrient levels; P:response to virus; P:signal complex assembly; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress fiber assembly; P:substrate adhesion-dependent cell spreading; P:T cell costimulation; P:transcytosis; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:uterus development; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8,Proto-oncogene tyrosine-protein kinase Src {ECO:0000305},Proto-oncogene c-Src;pp60c-src;, PF07714;PF00017;PF00018;, GO:0005884;GO:0005901;GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0098978;GO:0005770;GO:0005764;GO:0045121;GO:0005743;GO:0005739;GO:0043005;GO:0005654;GO:0048471;GO:0005886;GO:0002102;GO:0014069;GO:0099091;GO:0032587;GO:0005524;GO:0051117;GO:0070700;GO:0045296;GO:0071253;GO:0019899;GO:0046875;GO:0030331;GO:0070851;GO:0020037;GO:0005158;GO:0005178;GO:0044325;GO:0019900;GO:0004715;GO:0051219;GO:0008022;GO:0004672;GO:0005080;GO:0004713;GO:0097110;GO:0042169;GO:0005102;GO:0004714;GO:0031625;GO:0032148;GO:0034332;GO:0086098;GO:0007411;GO:0045453;GO:0060444;GO:0007155;GO:0007049;GO:0030154;GO:0008283;GO:0098609;GO:0071398;GO:0071498;GO:0070301;GO:0071456;GO:0032869;GO:0071222;GO:0071375;GO:0036120;GO:0071393;GO:0035635;GO:0048013;GO:0007173;GO:0038128;GO:0038096;GO:0048041;GO:0030900;GO:0007186;GO:0045087;GO:0007229;GO:0070102;GO:0060576;GO:0035556;GO:0050900;GO:0016236;GO:2000811;GO:0043066;GO:0043154;GO:2001237;GO:0051895;GO:0002862;GO:2001243;GO:0051902;GO:0031333;GO:0051974;GO:0032211;GO:0045892;GO:0048011;GO:0042476;GO:0048477;GO:0036035;GO:0018105;GO:0038083;GO:0018108;GO:0030168;GO:0043065;GO:0090263;GO:0045737;GO:0035306;GO:2000573;GO:0010634;GO:0070374;GO:0010907;GO:0046628;GO:0033625;GO:2000394;GO:0043406;GO:1903997;GO:0045747;GO:2000386;GO:0050731;GO:0043552;GO:0014068;GO:2000588;GO:0071803;GO:0031954;GO:0051897;GO:1900182;GO:0010954;GO:0071902;GO:0051222;GO:0051057;GO:0014911;GO:0045893;GO:0001545;GO:0050847;GO:0046777;GO:0031648;GO:0045124;GO:2001286;GO:0060491;GO:0022407;GO:2000641;GO:0010632;GO:0033146;GO:0098962;GO:0043393;GO:0043114;GO:0010447;GO:0042493;GO:0051602;GO:0070555;GO:0009612;GO:0051385;GO:0031667;GO:0009615;GO:0007172;GO:0007165;GO:0002223;GO:0043149;GO:0034446;GO:0031295;GO:0045056;GO:0007179;GO:0007169;GO:0060065;GO:0048010;GO:0016032;, C:actin filament; C:caveola; C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:late endosome; C:lysosome; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:podosome; C:postsynaptic density; C:postsynaptic specialization, intracellular component; C:ruffle membrane;, F:ATP binding; F:ATPase binding; F:BMP receptor binding; F:cadherin binding; F:connexin binding; F:enzyme binding; F:ephrin receptor binding; F:estrogen receptor binding; F:growth factor receptor binding; F:heme binding; F:insulin receptor binding; F:integrin binding; F:ion channel binding; F:kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphoprotein binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase C binding; F:protein tyrosine kinase activity; F:scaffold protein binding; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:activation of protein kinase B activity; P:adherens junction organization; P:angiotensin-activated signaling pathway involved in heart process; P:axon guidance; P:bone resorption; P:branching involved in mammary gland duct morphogenesis; P:cell adhesion; P:cell cycle; P:cell differentiation; P:cell population proliferation; P:cell-cell adhesion; P:cellular response to fatty acid; P:cellular response to fluid shear stress; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:cellular response to peptide hormone stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to progesterone stimulus; P:entry of bacterium into host cell; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:focal adhesion assembly; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell development; P:intracellular signal transduction; P:leukocyte migration; P:macroautophagy; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of focal adhesion assembly; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of mitochondrial depolarization; P:negative regulation of protein-containing complex assembly; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of transcription, DNA-templated; P:neurotrophin TRK receptor signaling pathway; P:odontogenesis; P:oogenesis; P:osteoclast development; P:peptidyl-serine phosphorylation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of dephosphorylation; P:positive regulation of DNA biosynthetic process; P:positive regulation of epithelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glucose metabolic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of integrin activation; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of MAP kinase activity; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of Notch signaling pathway; P:positive regulation of ovarian follicle development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of podosome assembly; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein processing; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein transport; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of smooth muscle cell migration; P:positive regulation of transcription, DNA-templated; P:primary ovarian follicle growth; P:progesterone receptor signaling pathway; P:protein autophosphorylation; P:protein destabilization; P:regulation of bone resorption; P:regulation of caveolin-mediated endocytosis; P:regulation of cell projection assembly; P:regulation of cell-cell adhesion; P:regulation of early endosome to late endosome transport; P:regulation of epithelial cell migration; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of protein binding; P:regulation of vascular permeability; P:response to acidic pH; P:response to drug; P:response to electrical stimulus; P:response to interleukin-1; P:response to mechanical stimulus; P:response to mineralocorticoid; P:response to nutrient levels; P:response to virus; P:signal complex assembly; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress fiber assembly; P:substrate adhesion-dependent cell spreading; P:T cell costimulation; P:transcytosis; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:uterus development; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8,Proto-oncogene tyrosine-protein kinase Src {ECO:0000305},Proto-oncogene c-Src;pp60c-src;, PF07714;PF00017;PF00018;, GO:0005884;GO:0005901;GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0098978;GO:0005770;GO:0005764;GO:0045121;GO:0005743;GO:0005739;GO:0043005;GO:0005654;GO:0048471;GO:0005886;GO:0002102;GO:0014069;GO:0099091;GO:0032587;GO:0005524;GO:0051117;GO:0070700;GO:0045296;GO:0071253;GO:0019899;GO:0046875;GO:0030331;GO:0070851;GO:0020037;GO:0005158;GO:0005178;GO:0044325;GO:0019900;GO:0004715;GO:0051219;GO:0008022;GO:0004672;GO:0005080;GO:0004713;GO:0097110;GO:0042169;GO:0005102;GO:0004714;GO:0031625;GO:0032148;GO:0034332;GO:0086098;GO:0007411;GO:0045453;GO:0060444;GO:0007155;GO:0007049;GO:0030154;GO:0008283;GO:0098609;GO:0071398;GO:0071498;GO:0070301;GO:0071456;GO:0032869;GO:0071222;GO:0071375;GO:0036120;GO:0071393;GO:0035635;GO:0048013;GO:0007173;GO:0038128;GO:0038096;GO:0048041;GO:0030900;GO:0007186;GO:0045087;GO:0007229;GO:0070102;GO:0060576;GO:0035556;GO:0050900;GO:0016236;GO:2000811;GO:0043066;GO:0043154;GO:2001237;GO:0051895;GO:0002862;GO:2001243;GO:0051902;GO:0031333;GO:0051974;GO:0032211;GO:0045892;GO:0048011;GO:0042476;GO:0048477;GO:0036035;GO:0018105;GO:0038083;GO:0018108;GO:0030168;GO:0043065;GO:0090263;GO:0045737;GO:0035306;GO:2000573;GO:0010634;GO:0070374;GO:0010907;GO:0046628;GO:0033625;GO:2000394;GO:0043406;GO:1903997;GO:0045747;GO:2000386;GO:0050731;GO:0043552;GO:0014068;GO:2000588;GO:0071803;GO:0031954;GO:0051897;GO:1900182;GO:0010954;GO:0071902;GO:0051222;GO:0051057;GO:0014911;GO:0045893;GO:0001545;GO:0050847;GO:0046777;GO:0031648;GO:0045124;GO:2001286;GO:0060491;GO:0022407;GO:2000641;GO:0010632;GO:0033146;GO:0098962;GO:0043393;GO:0043114;GO:0010447;GO:0042493;GO:0051602;GO:0070555;GO:0009612;GO:0051385;GO:0031667;GO:0009615;GO:0007172;GO:0007165;GO:0002223;GO:0043149;GO:0034446;GO:0031295;GO:0045056;GO:0007179;GO:0007169;GO:0060065;GO:0048010;GO:0016032;, C:actin filament; C:caveola; C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:late endosome; C:lysosome; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:podosome; C:postsynaptic density; C:postsynaptic specialization, intracellular component; C:ruffle membrane;, F:ATP binding; F:ATPase binding; F:BMP receptor binding; F:cadherin binding; F:connexin binding; F:enzyme binding; F:ephrin receptor binding; F:estrogen receptor binding; F:growth factor receptor binding; F:heme binding; F:insulin receptor binding; F:integrin binding; F:ion channel binding; F:kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphoprotein binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase C binding; F:protein tyrosine kinase activity; F:scaffold protein binding; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:activation of protein kinase B activity; P:adherens junction organization; P:angiotensin-activated signaling pathway involved in heart process; P:axon guidance; P:bone resorption; P:branching involved in mammary gland duct morphogenesis; P:cell adhesion; P:cell cycle; P:cell differentiation; P:cell population proliferation; P:cell-cell adhesion; P:cellular response to fatty acid; P:cellular response to fluid shear stress; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:cellular response to peptide hormone stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to progesterone stimulus; P:entry of bacterium into host cell; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:focal adhesion assembly; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell development; P:intracellular signal transduction; P:leukocyte migration; P:macroautophagy; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of focal adhesion assembly; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of mitochondrial depolarization; P:negative regulation of protein-containing complex assembly; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of transcription, DNA-templated; P:neurotrophin TRK receptor signaling pathway; P:odontogenesis; P:oogenesis; P:osteoclast development; P:peptidyl-serine phosphorylation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of dephosphorylation; P:positive regulation of DNA biosynthetic process; P:positive regulation of epithelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glucose metabolic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of integrin activation; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of MAP kinase activity; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of Notch signaling pathway; P:positive regulation of ovarian follicle development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of podosome assembly; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein processing; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein transport; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of smooth muscle cell migration; P:positive regulation of transcription, DNA-templated; P:primary ovarian follicle growth; P:progesterone receptor signaling pathway; P:protein autophosphorylation; P:protein destabilization; P:regulation of bone resorption; P:regulation of caveolin-mediated endocytosis; P:regulation of cell projection assembly; P:regulation of cell-cell adhesion; P:regulation of early endosome to late endosome transport; P:regulation of epithelial cell migration; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of protein binding; P:regulation of vascular permeability; P:response to acidic pH; P:response to drug; P:response to electrical stimulus; P:response to interleukin-1; P:response to mechanical stimulus; P:response to mineralocorticoid; P:response to nutrient levels; P:response to virus; P:signal complex assembly; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress fiber assembly; P:substrate adhesion-dependent cell spreading; P:T cell costimulation; P:transcytosis; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:uterus development; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; scaffold25 indexed_genome mRNA 1390417 1393145 . + . ID=transcript_5646;P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8,Proto-oncogene tyrosine-protein kinase Src {ECO:0000305},Proto-oncogene c-Src;pp60c-src;, PF07714;PF00017;PF00018;, GO:0005884;GO:0005901;GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0098978;GO:0005770;GO:0005764;GO:0045121;GO:0005743;GO:0005739;GO:0043005;GO:0005654;GO:0048471;GO:0005886;GO:0002102;GO:0014069;GO:0099091;GO:0032587;GO:0005524;GO:0051117;GO:0070700;GO:0045296;GO:0071253;GO:0019899;GO:0046875;GO:0030331;GO:0070851;GO:0020037;GO:0005158;GO:0005178;GO:0044325;GO:0019900;GO:0004715;GO:0051219;GO:0008022;GO:0004672;GO:0005080;GO:0004713;GO:0097110;GO:0042169;GO:0005102;GO:0004714;GO:0031625;GO:0032148;GO:0034332;GO:0086098;GO:0007411;GO:0045453;GO:0060444;GO:0007155;GO:0007049;GO:0030154;GO:0008283;GO:0098609;GO:0071398;GO:0071498;GO:0070301;GO:0071456;GO:0032869;GO:0071222;GO:0071375;GO:0036120;GO:0071393;GO:0035635;GO:0048013;GO:0007173;GO:0038128;GO:0038096;GO:0048041;GO:0030900;GO:0007186;GO:0045087;GO:0007229;GO:0070102;GO:0060576;GO:0035556;GO:0050900;GO:0016236;GO:2000811;GO:0043066;GO:0043154;GO:2001237;GO:0051895;GO:0002862;GO:2001243;GO:0051902;GO:0031333;GO:0051974;GO:0032211;GO:0045892;GO:0048011;GO:0042476;GO:0048477;GO:0036035;GO:0018105;GO:0038083;GO:0018108;GO:0030168;GO:0043065;GO:0090263;GO:0045737;GO:0035306;GO:2000573;GO:0010634;GO:0070374;GO:0010907;GO:0046628;GO:0033625;GO:2000394;GO:0043406;GO:1903997;GO:0045747;GO:2000386;GO:0050731;GO:0043552;GO:0014068;GO:2000588;GO:0071803;GO:0031954;GO:0051897;GO:1900182;GO:0010954;GO:0071902;GO:0051222;GO:0051057;GO:0014911;GO:0045893;GO:0001545;GO:0050847;GO:0046777;GO:0031648;GO:0045124;GO:2001286;GO:0060491;GO:0022407;GO:2000641;GO:0010632;GO:0033146;GO:0098962;GO:0043393;GO:0043114;GO:0010447;GO:0042493;GO:0051602;GO:0070555;GO:0009612;GO:0051385;GO:0031667;GO:0009615;GO:0007172;GO:0007165;GO:0002223;GO:0043149;GO:0034446;GO:0031295;GO:0045056;GO:0007179;GO:0007169;GO:0060065;GO:0048010;GO:0016032;, C:actin filament; C:caveola; C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:late endosome; C:lysosome; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:podosome; C:postsynaptic density; C:postsynaptic specialization, intracellular component; C:ruffle membrane;, F:ATP binding; F:ATPase binding; F:BMP receptor binding; F:cadherin binding; F:connexin binding; F:enzyme binding; F:ephrin receptor binding; F:estrogen receptor binding; F:growth factor receptor binding; F:heme binding; F:insulin receptor binding; F:integrin binding; F:ion channel binding; F:kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphoprotein binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase C binding; F:protein tyrosine kinase activity; F:scaffold protein binding; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:activation of protein kinase B activity; P:adherens junction organization; P:angiotensin-activated signaling pathway involved in heart process; P:axon guidance; P:bone resorption; P:branching involved in mammary gland duct morphogenesis; P:cell adhesion; P:cell cycle; P:cell differentiation; P:cell population proliferation; P:cell-cell adhesion; P:cellular response to fatty acid; P:cellular response to fluid shear stress; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:cellular response to peptide hormone stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to progesterone stimulus; P:entry of bacterium into host cell; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:focal adhesion assembly; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell development; P:intracellular signal transduction; P:leukocyte migration; P:macroautophagy; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of focal adhesion assembly; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of mitochondrial depolarization; P:negative regulation of protein-containing complex assembly; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of transcription, DNA-templated; P:neurotrophin TRK receptor signaling pathway; P:odontogenesis; P:oogenesis; P:osteoclast development; P:peptidyl-serine phosphorylation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of dephosphorylation; P:positive regulation of DNA biosynthetic process; P:positive regulation of epithelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glucose metabolic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of integrin activation; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of MAP kinase activity; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of Notch signaling pathway; P:positive regulation of ovarian follicle development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of podosome assembly; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein processing; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein transport; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of smooth muscle cell migration; P:positive regulation of transcription, DNA-templated; P:primary ovarian follicle growth; P:progesterone receptor signaling pathway; P:protein autophosphorylation; P:protein destabilization; P:regulation of bone resorption; P:regulation of caveolin-mediated endocytosis; P:regulation of cell projection assembly; P:regulation of cell-cell adhesion; P:regulation of early endosome to late endosome transport; P:regulation of epithelial cell migration; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of protein binding; P:regulation of vascular permeability; P:response to acidic pH; P:response to drug; P:response to electrical stimulus; P:response to interleukin-1; P:response to mechanical stimulus; P:response to mineralocorticoid; P:response to nutrient levels; P:response to virus; P:signal complex assembly; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:stress fiber assembly; P:substrate adhesion-dependent cell spreading; P:T cell costimulation; P:transcytosis; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:uterus development; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; scaffold25 indexed_genome mRNA 1503019 1518187 . - . ID=transcript_5647;P62952 A2A2K7 O60629 Q9D3B5,Bladder cancer-associated protein,Bladder cancer 10 kDa protein;, , GO:0016021;GO:0030262;GO:0007049;, C:integral component of membrane;, , P:apoptotic nuclear changes; P:cell cycle;|Q16517 B2R558 E1P5V6 Q16596 Q5U0N3,Neuronatin,, , GO:0005737;GO:0007420;GO:0032024;GO:0009249;, C:cytoplasm;, , P:brain development; P:positive regulation of insulin secretion; P:protein lipoylation; scaffold25 indexed_genome mRNA 1674541 1805866 . + . ID=transcript_5648;Q8N454 Q8NCL2 Q8TBD6 Q96KD2 Q9H7A5 Q9NQF9 Q9NTX0 Q9Y3M7,Beta-catenin-like protein 1,Nuclear-associated protein;Testis development protein NYD-SP19;, PF08216;, GO:0005813;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000974;GO:0005681;GO:0019899;GO:0006915;GO:0000398;GO:0043065;GO:0016445;, C:centrosome; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:spliceosomal complex;, F:enzyme binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:somatic diversification of immunoglobulins;|Q8N454 Q8NCL2 Q8TBD6 Q96KD2 Q9H7A5 Q9NQF9 Q9NTX0 Q9Y3M7,Beta-catenin-like protein 1,Nuclear-associated protein;Testis development protein NYD-SP19;, PF08216;, GO:0005813;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000974;GO:0005681;GO:0019899;GO:0006915;GO:0000398;GO:0043065;GO:0016445;, C:centrosome; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:spliceosomal complex;, F:enzyme binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:somatic diversification of immunoglobulins; scaffold25 indexed_genome mRNA 1813327 1817090 . + . ID=transcript_5649;Q8N454 Q8NCL2 Q8TBD6 Q96KD2 Q9H7A5 Q9NQF9 Q9NTX0 Q9Y3M7,Beta-catenin-like protein 1,Nuclear-associated protein;Testis development protein NYD-SP19;, PF08216;, GO:0005813;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000974;GO:0005681;GO:0019899;GO:0006915;GO:0000398;GO:0043065;GO:0016445;, C:centrosome; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:spliceosomal complex;, F:enzyme binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:somatic diversification of immunoglobulins; scaffold25 indexed_genome mRNA 1885355 1888226 . - . ID=transcript_5650;Q96N03 E1P5V7 Q5JWZ4 Q5JWZ5 Q8ND45 Q9BR37,V-set and transmembrane domain-containing protein 2-like protein,, PF07686;, GO:0030424;GO:0005737;GO:0005576;GO:0005886;GO:0098632;GO:0007411;GO:0070593;GO:0007156;GO:0043524;, C:axon; C:cytoplasm; C:extracellular region; C:plasma membrane;, F:cell-cell adhesion mediator activity;, P:axon guidance; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of neuron apoptotic process; scaffold25 indexed_genome mRNA 1918477 1948740 . - . ID=transcript_5651;O43156 D6W4K3 Q5JX67 Q96A38 Q9BR47 Q9H4K0,TELO2-interacting protein 1 homolog,Protein SMG10;, , GO:0070209;GO:0005737;GO:0031931;GO:0031932;GO:0032006;, C:ASTRA complex; C:cytoplasm; C:TORC1 complex; C:TORC2 complex;, , P:regulation of TOR signaling;|O43156 D6W4K3 Q5JX67 Q96A38 Q9BR47 Q9H4K0,TELO2-interacting protein 1 homolog,Protein SMG10;, , GO:0070209;GO:0005737;GO:0031931;GO:0031932;GO:0032006;, C:ASTRA complex; C:cytoplasm; C:TORC1 complex; C:TORC2 complex;, , P:regulation of TOR signaling; scaffold25 indexed_genome mRNA 1959786 2013233 . + . ID=transcript_5652;Q9NQG5 Q1WDE7 Q6PKF4,Regulation of nuclear pre-mRNA domain-containing protein 1B,Cell cycle-related and expression-elevated protein in tumor;, PF04818;PF16566;, GO:0005654;GO:0005634;GO:0016591;GO:0042802;GO:0000993;GO:0070940;GO:0031124;GO:0008284;GO:0045944;GO:0010564;GO:0042795;, C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:identical protein binding; F:RNA polymerase II complex binding;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:mRNA 3'-end processing; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle process; P:snRNA transcription by RNA polymerase II;|Q9NQG5 Q1WDE7 Q6PKF4,Regulation of nuclear pre-mRNA domain-containing protein 1B,Cell cycle-related and expression-elevated protein in tumor;, PF04818;PF16566;, GO:0005654;GO:0005634;GO:0016591;GO:0042802;GO:0000993;GO:0070940;GO:0031124;GO:0008284;GO:0045944;GO:0010564;GO:0042795;, C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:identical protein binding; F:RNA polymerase II complex binding;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:mRNA 3'-end processing; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle process; P:snRNA transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 2050510 2085467 . - . ID=transcript_5653;P21980 E1P5V9 Q16436 Q6B838 Q9BTN7 Q9H035 Q9UH35,Protein-glutamine gamma-glutamyltransferase 2 {ECO:0000305},Erythrocyte transglutaminase {ECO:0000303|PubMed:2903073};Heart G alpha(h) {ECO:0000303|PubMed:7592956};Isopeptidase TGM2 {ECO:0000305};Protein G alpha(h) {ECO:0000303|PubMed:8943303};Protein-glutamine deamidase TGM2 {ECO:0000305};Protein-glutamine dopaminyltransferase TGM2 {ECO:0000305};Protein-glutamine histaminyltransferase TGM2 {ECO:0000305};Protein-glutamine noradrenalinyltransferase TGM2 {ECO:0000305};Protein-glutamine serotonyltransferase TGM2 {ECO:0000305};Tissue transglutaminase {ECO:0000303|PubMed:1358880, ECO:0000303|PubMed:1670766, ECO:0000303|PubMed:7935379, ECO:0000303|PubMed:9212111};Transglutaminase C {ECO:0000303|PubMed:11390390};Transglutaminase H {ECO:0000303|PubMed:1358880};Transglutaminase II {ECO:0000303|PubMed:7592956};Transglutaminase-2 {ECO:0000303|PubMed:24349085, ECO:0000303|PubMed:30458214};, PF00927;PF01841;PF00868;, GO:0062023;GO:0005829;GO:0005783;GO:0070062;GO:0005925;GO:0031226;GO:0005739;GO:0005886;GO:0005525;GO:0042802;GO:0046872;GO:0019904;GO:0003810;GO:0043277;GO:0001974;GO:0060445;GO:0018153;GO:0032471;GO:0018149;GO:0043065;GO:0045785;GO:0051482;GO:0043123;GO:0050729;GO:0051561;GO:0048661;GO:0060662;, C:collagen-containing extracellular matrix; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:intrinsic component of plasma membrane; C:mitochondrion; C:plasma membrane;, F:GTP binding; F:identical protein binding; F:metal ion binding; F:protein domain specific binding; F:protein-glutamine gamma-glutamyltransferase activity;, P:apoptotic cell clearance; P:blood vessel remodeling; P:branching involved in salivary gland morphogenesis; P:isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:peptide cross-linking; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of smooth muscle cell proliferation; P:salivary gland cavitation; scaffold25 indexed_genome mRNA 2133517 2146274 . - . ID=transcript_5654;Q5JYT7 Q9C0A8,Uncharacterized protein KIAA1755 scaffold25 indexed_genome mRNA 2152223 2153392 . - . ID=transcript_5655;Q5JYT7 Q9C0A8,Uncharacterized protein KIAA1755 scaffold25 indexed_genome mRNA 2153437 2154062 . - . ID=transcript_5656;Q5JYT7 Q9C0A8,Uncharacterized protein KIAA1755 scaffold25 indexed_genome mRNA 2214469 2244634 . + . ID=transcript_5657;Q9UCT4 Q9UD65,Bactericidal permeability-increasing protein,CAP 57;, PF01273;PF02886;, GO:0035578;GO:0010494;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0035580;GO:0001530;GO:0019731;GO:0061844;GO:0019730;GO:0071222;GO:0050829;GO:0045087;GO:0031663;GO:0032715;GO:0032717;GO:0043031;GO:0032720;GO:0043312;, C:azurophil granule lumen; C:cytoplasmic stress granule; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:specific granule lumen;, F:lipopolysaccharide binding;, P:antibacterial humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:antimicrobial humoral response; P:cellular response to lipopolysaccharide; P:defense response to Gram-negative bacterium; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of macrophage activation; P:negative regulation of tumor necrosis factor production; P:neutrophil degranulation; scaffold25 indexed_genome mRNA 2255289 2287183 . + . ID=transcript_5658;P18428 B2R938 O43438 Q92672 Q9H403 Q9UD66,Lipopolysaccharide-binding protein,, PF01273;PF02886;, GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0071723;GO:0001530;GO:0070891;GO:0005102;GO:0006953;GO:0006968;GO:0071222;GO:0071223;GO:0019221;GO:0050829;GO:0050830;GO:0032490;GO:0045087;GO:0002232;GO:0015920;GO:0031663;GO:0033036;GO:0002281;GO:0032720;GO:0008228;GO:0032722;GO:0045919;GO:0032755;GO:0032757;GO:0043032;GO:0090023;GO:0060265;GO:0034145;GO:0032760;GO:0032496;GO:0034142;GO:0002224;, C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane;, F:lipopeptide binding; F:lipopolysaccharide binding; F:lipoteichoic acid binding; F:signaling receptor binding;, P:acute-phase response; P:cellular defense response; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cytokine-mediated signaling pathway; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:detection of molecule of bacterial origin; P:innate immune response; P:leukocyte chemotaxis involved in inflammatory response; P:lipopolysaccharide transport; P:lipopolysaccharide-mediated signaling pathway; P:macromolecule localization; P:macrophage activation involved in immune response; P:negative regulation of tumor necrosis factor production; P:opsonization; P:positive regulation of chemokine production; P:positive regulation of cytolysis; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of macrophage activation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of respiratory burst involved in inflammatory response; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of tumor necrosis factor production; P:response to lipopolysaccharide; P:toll-like receptor 4 signaling pathway; P:toll-like receptor signaling pathway;|P18428 B2R938 O43438 Q92672 Q9H403 Q9UD66,Lipopolysaccharide-binding protein,, PF01273;PF02886;, GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0071723;GO:0001530;GO:0070891;GO:0005102;GO:0006953;GO:0006968;GO:0071222;GO:0071223;GO:0019221;GO:0050829;GO:0050830;GO:0032490;GO:0045087;GO:0002232;GO:0015920;GO:0031663;GO:0033036;GO:0002281;GO:0032720;GO:0008228;GO:0032722;GO:0045919;GO:0032755;GO:0032757;GO:0043032;GO:0090023;GO:0060265;GO:0034145;GO:0032760;GO:0032496;GO:0034142;GO:0002224;, C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane;, F:lipopeptide binding; F:lipopolysaccharide binding; F:lipoteichoic acid binding; F:signaling receptor binding;, P:acute-phase response; P:cellular defense response; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cytokine-mediated signaling pathway; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:detection of molecule of bacterial origin; P:innate immune response; P:leukocyte chemotaxis involved in inflammatory response; P:lipopolysaccharide transport; P:lipopolysaccharide-mediated signaling pathway; P:macromolecule localization; P:macrophage activation involved in immune response; P:negative regulation of tumor necrosis factor production; P:opsonization; P:positive regulation of chemokine production; P:positive regulation of cytolysis; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of macrophage activation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of respiratory burst involved in inflammatory response; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of tumor necrosis factor production; P:response to lipopolysaccharide; P:toll-like receptor 4 signaling pathway; P:toll-like receptor signaling pathway;|P18428 B2R938 O43438 Q92672 Q9H403 Q9UD66,Lipopolysaccharide-binding protein,, PF01273;PF02886;, GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0071723;GO:0001530;GO:0070891;GO:0005102;GO:0006953;GO:0006968;GO:0071222;GO:0071223;GO:0019221;GO:0050829;GO:0050830;GO:0032490;GO:0045087;GO:0002232;GO:0015920;GO:0031663;GO:0033036;GO:0002281;GO:0032720;GO:0008228;GO:0032722;GO:0045919;GO:0032755;GO:0032757;GO:0043032;GO:0090023;GO:0060265;GO:0034145;GO:0032760;GO:0032496;GO:0034142;GO:0002224;, C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane;, F:lipopeptide binding; F:lipopolysaccharide binding; F:lipoteichoic acid binding; F:signaling receptor binding;, P:acute-phase response; P:cellular defense response; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cytokine-mediated signaling pathway; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:detection of molecule of bacterial origin; P:innate immune response; P:leukocyte chemotaxis involved in inflammatory response; P:lipopolysaccharide transport; P:lipopolysaccharide-mediated signaling pathway; P:macromolecule localization; P:macrophage activation involved in immune response; P:negative regulation of tumor necrosis factor production; P:opsonization; P:positive regulation of chemokine production; P:positive regulation of cytolysis; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of macrophage activation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of respiratory burst involved in inflammatory response; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of tumor necrosis factor production; P:response to lipopolysaccharide; P:toll-like receptor 4 signaling pathway; P:toll-like receptor signaling pathway; scaffold25 indexed_genome mRNA 2357578 2358115 . - . ID=transcript_5659;P18428 B2R938 O43438 Q92672 Q9H403 Q9UD66,Lipopolysaccharide-binding protein,, PF01273;PF02886;, GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0071723;GO:0001530;GO:0070891;GO:0005102;GO:0006953;GO:0006968;GO:0071222;GO:0071223;GO:0019221;GO:0050829;GO:0050830;GO:0032490;GO:0045087;GO:0002232;GO:0015920;GO:0031663;GO:0033036;GO:0002281;GO:0032720;GO:0008228;GO:0032722;GO:0045919;GO:0032755;GO:0032757;GO:0043032;GO:0090023;GO:0060265;GO:0034145;GO:0032760;GO:0032496;GO:0034142;GO:0002224;, C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane;, F:lipopeptide binding; F:lipopolysaccharide binding; F:lipoteichoic acid binding; F:signaling receptor binding;, P:acute-phase response; P:cellular defense response; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cytokine-mediated signaling pathway; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:detection of molecule of bacterial origin; P:innate immune response; P:leukocyte chemotaxis involved in inflammatory response; P:lipopolysaccharide transport; P:lipopolysaccharide-mediated signaling pathway; P:macromolecule localization; P:macrophage activation involved in immune response; P:negative regulation of tumor necrosis factor production; P:opsonization; P:positive regulation of chemokine production; P:positive regulation of cytolysis; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of macrophage activation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of respiratory burst involved in inflammatory response; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of tumor necrosis factor production; P:response to lipopolysaccharide; P:toll-like receptor 4 signaling pathway; P:toll-like receptor signaling pathway; scaffold25 indexed_genome mRNA 2407484 2433117 . + . ID=transcript_5660;Q9Y3G9,Ral GTPase-activating protein subunit beta,p170;, , GO:0005096;GO:0046982;GO:0090630;GO:0051056;, , F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold25 indexed_genome mRNA 2433132 2495769 . + . ID=transcript_5661;Q9Y3G9,Ral GTPase-activating protein subunit beta,p170;, , GO:0005096;GO:0046982;GO:0090630;GO:0051056;, , F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9Y3G9,Ral GTPase-activating protein subunit beta,p170;, , GO:0005096;GO:0046982;GO:0090630;GO:0051056;, , F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9Y3G9,Ral GTPase-activating protein subunit beta,p170;, , GO:0005096;GO:0046982;GO:0090630;GO:0051056;, , F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9Y3G9,Ral GTPase-activating protein subunit beta,p170;, , GO:0005096;GO:0046982;GO:0090630;GO:0051056;, , F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9Y3G9,Ral GTPase-activating protein subunit beta,p170;, , GO:0005096;GO:0046982;GO:0090630;GO:0051056;, , F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9Y3G9,Ral GTPase-activating protein subunit beta,p170;, , GO:0005096;GO:0046982;GO:0090630;GO:0051056;, , F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9Y3G9,Ral GTPase-activating protein subunit beta,p170;, , GO:0005096;GO:0046982;GO:0090630;GO:0051056;, , F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold25 indexed_genome mRNA 2580960 2585477 . + . ID=transcript_5662;Q9H598 Q8N489,Vesicular inhibitory amino acid transporter,GABA and glycine transporter;Solute carrier family 32 member 1;Vesicular GABA transporter;, PF01490;, GO:0051286;GO:0061202;GO:0044316;GO:0030425;GO:0044292;GO:0098982;GO:0060077;GO:0030285;GO:0043229;GO:0043005;GO:0044306;GO:0005886;GO:0048786;GO:0030672;GO:0015495;GO:0015187;GO:0007568;GO:0021766;GO:0006811;GO:0098700;GO:0007269;, C:cell tip; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:cone cell pedicle; C:dendrite; C:dendrite terminus; C:GABA-ergic synapse; C:inhibitory synapse; C:integral component of synaptic vesicle membrane; C:intracellular organelle; C:neuron projection; C:neuron projection terminus; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle membrane;, F:gamma-aminobutyric acid:proton symporter activity; F:glycine transmembrane transporter activity;, P:aging; P:hippocampus development; P:ion transport; P:neurotransmitter loading into synaptic vesicle; P:neurotransmitter secretion; scaffold25 indexed_genome mRNA 2647557 2751404 . + . ID=transcript_5663;Q96T49 A2RRR6 E9PFS8 O94912 Q5W9G4 Q9NQG4,Protein phosphatase 1 regulatory inhibitor subunit 16B,Ankyrin repeat domain-containing protein 4;CAAX box protein TIMAP;TGF-beta-inhibited membrane-associated protein;, PF12796;, GO:0042995;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0017020;GO:0008157;GO:0019888;GO:0061028;GO:1902309;GO:0035308;GO:1903589;GO:0001938;GO:0035307;GO:0051489;GO:0014066;GO:0035304;GO:1903670;, C:cell projection; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:myosin phosphatase regulator activity; F:protein phosphatase 1 binding; F:protein phosphatase regulator activity;, P:establishment of endothelial barrier; P:negative regulation of peptidyl-serine dephosphorylation; P:negative regulation of protein dephosphorylation; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of protein dephosphorylation; P:regulation of filopodium assembly; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein dephosphorylation; P:regulation of sprouting angiogenesis;|Q96T49 A2RRR6 E9PFS8 O94912 Q5W9G4 Q9NQG4,Protein phosphatase 1 regulatory inhibitor subunit 16B,Ankyrin repeat domain-containing protein 4;CAAX box protein TIMAP;TGF-beta-inhibited membrane-associated protein;, PF12796;, GO:0042995;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0017020;GO:0008157;GO:0019888;GO:0061028;GO:1902309;GO:0035308;GO:1903589;GO:0001938;GO:0035307;GO:0051489;GO:0014066;GO:0035304;GO:1903670;, C:cell projection; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:myosin phosphatase regulator activity; F:protein phosphatase 1 binding; F:protein phosphatase regulator activity;, P:establishment of endothelial barrier; P:negative regulation of peptidyl-serine dephosphorylation; P:negative regulation of protein dephosphorylation; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of protein dephosphorylation; P:regulation of filopodium assembly; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein dephosphorylation; P:regulation of sprouting angiogenesis;|Q96T49 A2RRR6 E9PFS8 O94912 Q5W9G4 Q9NQG4,Protein phosphatase 1 regulatory inhibitor subunit 16B,Ankyrin repeat domain-containing protein 4;CAAX box protein TIMAP;TGF-beta-inhibited membrane-associated protein;, PF12796;, GO:0042995;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0017020;GO:0008157;GO:0019888;GO:0061028;GO:1902309;GO:0035308;GO:1903589;GO:0001938;GO:0035307;GO:0051489;GO:0014066;GO:0035304;GO:1903670;, C:cell projection; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:myosin phosphatase regulator activity; F:protein phosphatase 1 binding; F:protein phosphatase regulator activity;, P:establishment of endothelial barrier; P:negative regulation of peptidyl-serine dephosphorylation; P:negative regulation of protein dephosphorylation; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of protein dephosphorylation; P:regulation of filopodium assembly; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein dephosphorylation; P:regulation of sprouting angiogenesis;|Q96T49 A2RRR6 E9PFS8 O94912 Q5W9G4 Q9NQG4,Protein phosphatase 1 regulatory inhibitor subunit 16B,Ankyrin repeat domain-containing protein 4;CAAX box protein TIMAP;TGF-beta-inhibited membrane-associated protein;, PF12796;, GO:0042995;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0017020;GO:0008157;GO:0019888;GO:0061028;GO:1902309;GO:0035308;GO:1903589;GO:0001938;GO:0035307;GO:0051489;GO:0014066;GO:0035304;GO:1903670;, C:cell projection; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:myosin phosphatase regulator activity; F:protein phosphatase 1 binding; F:protein phosphatase regulator activity;, P:establishment of endothelial barrier; P:negative regulation of peptidyl-serine dephosphorylation; P:negative regulation of protein dephosphorylation; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of protein dephosphorylation; P:regulation of filopodium assembly; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein dephosphorylation; P:regulation of sprouting angiogenesis;|Q96T49 A2RRR6 E9PFS8 O94912 Q5W9G4 Q9NQG4,Protein phosphatase 1 regulatory inhibitor subunit 16B,Ankyrin repeat domain-containing protein 4;CAAX box protein TIMAP;TGF-beta-inhibited membrane-associated protein;, PF12796;, GO:0042995;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0017020;GO:0008157;GO:0019888;GO:0061028;GO:1902309;GO:0035308;GO:1903589;GO:0001938;GO:0035307;GO:0051489;GO:0014066;GO:0035304;GO:1903670;, C:cell projection; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:myosin phosphatase regulator activity; F:protein phosphatase 1 binding; F:protein phosphatase regulator activity;, P:establishment of endothelial barrier; P:negative regulation of peptidyl-serine dephosphorylation; P:negative regulation of protein dephosphorylation; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of protein dephosphorylation; P:regulation of filopodium assembly; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein dephosphorylation; P:regulation of sprouting angiogenesis; scaffold25 indexed_genome mRNA 2788144 2855034 . + . ID=transcript_5664;Q9H5Z1 A2RTX3 B4E0J0 F5GXM6 Q5THR0 Q9H4H7 Q9H6T6,Probable ATP-dependent RNA helicase DHX35,DEAH box protein 35;, PF04408;PF00271;PF07717;, GO:0071013;GO:0005524;GO:0003723;GO:0003724;GO:0001701;GO:0000398;, C:catalytic step 2 spliceosome;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:in utero embryonic development; P:mRNA splicing, via spliceosome;|Q9H5Z1 A2RTX3 B4E0J0 F5GXM6 Q5THR0 Q9H4H7 Q9H6T6,Probable ATP-dependent RNA helicase DHX35,DEAH box protein 35;, PF04408;PF00271;PF07717;, GO:0071013;GO:0005524;GO:0003723;GO:0003724;GO:0001701;GO:0000398;, C:catalytic step 2 spliceosome;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:in utero embryonic development; P:mRNA splicing, via spliceosome;|Q9H5Z1 A2RTX3 B4E0J0 F5GXM6 Q5THR0 Q9H4H7 Q9H6T6,Probable ATP-dependent RNA helicase DHX35,DEAH box protein 35;, PF04408;PF00271;PF07717;, GO:0071013;GO:0005524;GO:0003723;GO:0003724;GO:0001701;GO:0000398;, C:catalytic step 2 spliceosome;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:in utero embryonic development; P:mRNA splicing, via spliceosome;|Q9H5Z1 A2RTX3 B4E0J0 F5GXM6 Q5THR0 Q9H4H7 Q9H6T6,Probable ATP-dependent RNA helicase DHX35,DEAH box protein 35;, PF04408;PF00271;PF07717;, GO:0071013;GO:0005524;GO:0003723;GO:0003724;GO:0001701;GO:0000398;, C:catalytic step 2 spliceosome;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:in utero embryonic development; P:mRNA splicing, via spliceosome;|Q9H5Z1 A2RTX3 B4E0J0 F5GXM6 Q5THR0 Q9H4H7 Q9H6T6,Probable ATP-dependent RNA helicase DHX35,DEAH box protein 35;, PF04408;PF00271;PF07717;, GO:0071013;GO:0005524;GO:0003723;GO:0003724;GO:0001701;GO:0000398;, C:catalytic step 2 spliceosome;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:in utero embryonic development; P:mRNA splicing, via spliceosome; scaffold25 indexed_genome mRNA 4671104 4762105 . + . ID=transcript_5665;P11387 A8KA78 E1P5W3 O43256 Q12855 Q12856 Q15610 Q5TFY3 Q9UJN0,DNA topoisomerase 1,DNA topoisomerase I;, PF14370;PF01028;PF02919;, GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0043204;GO:0032993;GO:0005524;GO:0003682;GO:0003677;GO:0003917;GO:0003690;GO:0019904;GO:0004674;GO:0003723;GO:0000978;GO:0003697;GO:0097100;GO:0006338;GO:0007059;GO:0032922;GO:0007623;GO:0006260;GO:0006265;GO:0040016;GO:0018105;GO:0016310;GO:0012501;GO:0042493;GO:0016032;, C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:perikaryon; C:protein-DNA complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:double-stranded DNA binding; F:protein domain specific binding; F:protein serine/threonine kinase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:supercoiled DNA binding;, P:chromatin remodeling; P:chromosome segregation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA replication; P:DNA topological change; P:embryonic cleavage; P:peptidyl-serine phosphorylation; P:phosphorylation; P:programmed cell death; P:response to drug; P:viral process;|P11387 A8KA78 E1P5W3 O43256 Q12855 Q12856 Q15610 Q5TFY3 Q9UJN0,DNA topoisomerase 1,DNA topoisomerase I;, PF14370;PF01028;PF02919;, GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0043204;GO:0032993;GO:0005524;GO:0003682;GO:0003677;GO:0003917;GO:0003690;GO:0019904;GO:0004674;GO:0003723;GO:0000978;GO:0003697;GO:0097100;GO:0006338;GO:0007059;GO:0032922;GO:0007623;GO:0006260;GO:0006265;GO:0040016;GO:0018105;GO:0016310;GO:0012501;GO:0042493;GO:0016032;, C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:perikaryon; C:protein-DNA complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:double-stranded DNA binding; F:protein domain specific binding; F:protein serine/threonine kinase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:supercoiled DNA binding;, P:chromatin remodeling; P:chromosome segregation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA replication; P:DNA topological change; P:embryonic cleavage; P:peptidyl-serine phosphorylation; P:phosphorylation; P:programmed cell death; P:response to drug; P:viral process;|P11387 A8KA78 E1P5W3 O43256 Q12855 Q12856 Q15610 Q5TFY3 Q9UJN0,DNA topoisomerase 1,DNA topoisomerase I;, PF14370;PF01028;PF02919;, GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0043204;GO:0032993;GO:0005524;GO:0003682;GO:0003677;GO:0003917;GO:0003690;GO:0019904;GO:0004674;GO:0003723;GO:0000978;GO:0003697;GO:0097100;GO:0006338;GO:0007059;GO:0032922;GO:0007623;GO:0006260;GO:0006265;GO:0040016;GO:0018105;GO:0016310;GO:0012501;GO:0042493;GO:0016032;, C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:perikaryon; C:protein-DNA complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:double-stranded DNA binding; F:protein domain specific binding; F:protein serine/threonine kinase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:supercoiled DNA binding;, P:chromatin remodeling; P:chromosome segregation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA replication; P:DNA topological change; P:embryonic cleavage; P:peptidyl-serine phosphorylation; P:phosphorylation; P:programmed cell death; P:response to drug; P:viral process;|P11387 A8KA78 E1P5W3 O43256 Q12855 Q12856 Q15610 Q5TFY3 Q9UJN0,DNA topoisomerase 1,DNA topoisomerase I;, PF14370;PF01028;PF02919;, GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0043204;GO:0032993;GO:0005524;GO:0003682;GO:0003677;GO:0003917;GO:0003690;GO:0019904;GO:0004674;GO:0003723;GO:0000978;GO:0003697;GO:0097100;GO:0006338;GO:0007059;GO:0032922;GO:0007623;GO:0006260;GO:0006265;GO:0040016;GO:0018105;GO:0016310;GO:0012501;GO:0042493;GO:0016032;, C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:perikaryon; C:protein-DNA complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:double-stranded DNA binding; F:protein domain specific binding; F:protein serine/threonine kinase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:supercoiled DNA binding;, P:chromatin remodeling; P:chromosome segregation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA replication; P:DNA topological change; P:embryonic cleavage; P:peptidyl-serine phosphorylation; P:phosphorylation; P:programmed cell death; P:response to drug; P:viral process;|P11387 A8KA78 E1P5W3 O43256 Q12855 Q12856 Q15610 Q5TFY3 Q9UJN0,DNA topoisomerase 1,DNA topoisomerase I;, PF14370;PF01028;PF02919;, GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0043204;GO:0032993;GO:0005524;GO:0003682;GO:0003677;GO:0003917;GO:0003690;GO:0019904;GO:0004674;GO:0003723;GO:0000978;GO:0003697;GO:0097100;GO:0006338;GO:0007059;GO:0032922;GO:0007623;GO:0006260;GO:0006265;GO:0040016;GO:0018105;GO:0016310;GO:0012501;GO:0042493;GO:0016032;, C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:perikaryon; C:protein-DNA complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:double-stranded DNA binding; F:protein domain specific binding; F:protein serine/threonine kinase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:supercoiled DNA binding;, P:chromatin remodeling; P:chromosome segregation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA replication; P:DNA topological change; P:embryonic cleavage; P:peptidyl-serine phosphorylation; P:phosphorylation; P:programmed cell death; P:response to drug; P:viral process;|P11387 A8KA78 E1P5W3 O43256 Q12855 Q12856 Q15610 Q5TFY3 Q9UJN0,DNA topoisomerase 1,DNA topoisomerase I;, PF14370;PF01028;PF02919;, GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0043204;GO:0032993;GO:0005524;GO:0003682;GO:0003677;GO:0003917;GO:0003690;GO:0019904;GO:0004674;GO:0003723;GO:0000978;GO:0003697;GO:0097100;GO:0006338;GO:0007059;GO:0032922;GO:0007623;GO:0006260;GO:0006265;GO:0040016;GO:0018105;GO:0016310;GO:0012501;GO:0042493;GO:0016032;, C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:perikaryon; C:protein-DNA complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:double-stranded DNA binding; F:protein domain specific binding; F:protein serine/threonine kinase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:supercoiled DNA binding;, P:chromatin remodeling; P:chromosome segregation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA replication; P:DNA topological change; P:embryonic cleavage; P:peptidyl-serine phosphorylation; P:phosphorylation; P:programmed cell death; P:response to drug; P:viral process;|P11387 A8KA78 E1P5W3 O43256 Q12855 Q12856 Q15610 Q5TFY3 Q9UJN0,DNA topoisomerase 1,DNA topoisomerase I;, PF14370;PF01028;PF02919;, GO:0005694;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0043204;GO:0032993;GO:0005524;GO:0003682;GO:0003677;GO:0003917;GO:0003690;GO:0019904;GO:0004674;GO:0003723;GO:0000978;GO:0003697;GO:0097100;GO:0006338;GO:0007059;GO:0032922;GO:0007623;GO:0006260;GO:0006265;GO:0040016;GO:0018105;GO:0016310;GO:0012501;GO:0042493;GO:0016032;, C:chromosome; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:perikaryon; C:protein-DNA complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:double-stranded DNA binding; F:protein domain specific binding; F:protein serine/threonine kinase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:supercoiled DNA binding;, P:chromatin remodeling; P:chromosome segregation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA replication; P:DNA topological change; P:embryonic cleavage; P:peptidyl-serine phosphorylation; P:phosphorylation; P:programmed cell death; P:response to drug; P:viral process; scaffold25 indexed_genome mRNA 4807404 4825210 . + . ID=transcript_5666;P19174 B7ZLY7 B9EGH4 E1P5W4 Q2V575,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 {ECO:0000305},PLC-148;Phosphoinositide phospholipase C-gamma-1;Phospholipase C-II;Phospholipase C-gamma-1;, PF00168;PF00388;PF00387;PF00017;PF00018;, GO:0042995;GO:0005911;GO:0008180;GO:0005737;GO:0005829;GO:0098978;GO:0030027;GO:0005886;GO:0001726;GO:0098685;GO:0005509;GO:0050429;GO:0035254;GO:0005168;GO:0004435;GO:0019901;GO:0030971;GO:0007202;GO:0007411;GO:0019722;GO:0016477;GO:0071364;GO:0007173;GO:0038095;GO:0038096;GO:0001701;GO:0043647;GO:0050900;GO:0050804;GO:0002862;GO:0046488;GO:0009395;GO:0045766;GO:0043536;GO:2000353;GO:0010634;GO:0010863;GO:0051281;GO:1905564;GO:0007165;GO:0050852;GO:0016032;, C:cell projection; C:cell-cell junction; C:COP9 signalosome; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:lamellipodium; C:plasma membrane; C:ruffle; C:Schaffer collateral - CA1 synapse;, F:calcium ion binding; F:calcium-dependent phospholipase C activity; F:glutamate receptor binding; F:neurotrophin TRKA receptor binding; F:phosphatidylinositol phospholipase C activity; F:protein kinase binding; F:receptor tyrosine kinase binding;, P:activation of phospholipase C activity; P:axon guidance; P:calcium-mediated signaling; P:cell migration; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:in utero embryonic development; P:inositol phosphate metabolic process; P:leukocyte migration; P:modulation of chemical synaptic transmission; P:negative regulation of inflammatory response to antigenic stimulus; P:phosphatidylinositol metabolic process; P:phospholipid catabolic process; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of epithelial cell migration; P:positive regulation of phospholipase C activity; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of vascular endothelial cell proliferation; P:signal transduction; P:T cell receptor signaling pathway; P:viral process;|P19174 B7ZLY7 B9EGH4 E1P5W4 Q2V575,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 {ECO:0000305},PLC-148;Phosphoinositide phospholipase C-gamma-1;Phospholipase C-II;Phospholipase C-gamma-1;, PF00168;PF00388;PF00387;PF00017;PF00018;, GO:0042995;GO:0005911;GO:0008180;GO:0005737;GO:0005829;GO:0098978;GO:0030027;GO:0005886;GO:0001726;GO:0098685;GO:0005509;GO:0050429;GO:0035254;GO:0005168;GO:0004435;GO:0019901;GO:0030971;GO:0007202;GO:0007411;GO:0019722;GO:0016477;GO:0071364;GO:0007173;GO:0038095;GO:0038096;GO:0001701;GO:0043647;GO:0050900;GO:0050804;GO:0002862;GO:0046488;GO:0009395;GO:0045766;GO:0043536;GO:2000353;GO:0010634;GO:0010863;GO:0051281;GO:1905564;GO:0007165;GO:0050852;GO:0016032;, C:cell projection; C:cell-cell junction; C:COP9 signalosome; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:lamellipodium; C:plasma membrane; C:ruffle; C:Schaffer collateral - CA1 synapse;, F:calcium ion binding; F:calcium-dependent phospholipase C activity; F:glutamate receptor binding; F:neurotrophin TRKA receptor binding; F:phosphatidylinositol phospholipase C activity; F:protein kinase binding; F:receptor tyrosine kinase binding;, P:activation of phospholipase C activity; P:axon guidance; P:calcium-mediated signaling; P:cell migration; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:in utero embryonic development; P:inositol phosphate metabolic process; P:leukocyte migration; P:modulation of chemical synaptic transmission; P:negative regulation of inflammatory response to antigenic stimulus; P:phosphatidylinositol metabolic process; P:phospholipid catabolic process; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of epithelial cell migration; P:positive regulation of phospholipase C activity; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of vascular endothelial cell proliferation; P:signal transduction; P:T cell receptor signaling pathway; P:viral process;|P19174 B7ZLY7 B9EGH4 E1P5W4 Q2V575,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 {ECO:0000305},PLC-148;Phosphoinositide phospholipase C-gamma-1;Phospholipase C-II;Phospholipase C-gamma-1;, PF00168;PF00388;PF00387;PF00017;PF00018;, GO:0042995;GO:0005911;GO:0008180;GO:0005737;GO:0005829;GO:0098978;GO:0030027;GO:0005886;GO:0001726;GO:0098685;GO:0005509;GO:0050429;GO:0035254;GO:0005168;GO:0004435;GO:0019901;GO:0030971;GO:0007202;GO:0007411;GO:0019722;GO:0016477;GO:0071364;GO:0007173;GO:0038095;GO:0038096;GO:0001701;GO:0043647;GO:0050900;GO:0050804;GO:0002862;GO:0046488;GO:0009395;GO:0045766;GO:0043536;GO:2000353;GO:0010634;GO:0010863;GO:0051281;GO:1905564;GO:0007165;GO:0050852;GO:0016032;, C:cell projection; C:cell-cell junction; C:COP9 signalosome; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:lamellipodium; C:plasma membrane; C:ruffle; C:Schaffer collateral - CA1 synapse;, F:calcium ion binding; F:calcium-dependent phospholipase C activity; F:glutamate receptor binding; F:neurotrophin TRKA receptor binding; F:phosphatidylinositol phospholipase C activity; F:protein kinase binding; F:receptor tyrosine kinase binding;, P:activation of phospholipase C activity; P:axon guidance; P:calcium-mediated signaling; P:cell migration; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:in utero embryonic development; P:inositol phosphate metabolic process; P:leukocyte migration; P:modulation of chemical synaptic transmission; P:negative regulation of inflammatory response to antigenic stimulus; P:phosphatidylinositol metabolic process; P:phospholipid catabolic process; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of epithelial cell migration; P:positive regulation of phospholipase C activity; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of vascular endothelial cell proliferation; P:signal transduction; P:T cell receptor signaling pathway; P:viral process;|P19174 B7ZLY7 B9EGH4 E1P5W4 Q2V575,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 {ECO:0000305},PLC-148;Phosphoinositide phospholipase C-gamma-1;Phospholipase C-II;Phospholipase C-gamma-1;, PF00168;PF00388;PF00387;PF00017;PF00018;, GO:0042995;GO:0005911;GO:0008180;GO:0005737;GO:0005829;GO:0098978;GO:0030027;GO:0005886;GO:0001726;GO:0098685;GO:0005509;GO:0050429;GO:0035254;GO:0005168;GO:0004435;GO:0019901;GO:0030971;GO:0007202;GO:0007411;GO:0019722;GO:0016477;GO:0071364;GO:0007173;GO:0038095;GO:0038096;GO:0001701;GO:0043647;GO:0050900;GO:0050804;GO:0002862;GO:0046488;GO:0009395;GO:0045766;GO:0043536;GO:2000353;GO:0010634;GO:0010863;GO:0051281;GO:1905564;GO:0007165;GO:0050852;GO:0016032;, C:cell projection; C:cell-cell junction; C:COP9 signalosome; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:lamellipodium; C:plasma membrane; C:ruffle; C:Schaffer collateral - CA1 synapse;, F:calcium ion binding; F:calcium-dependent phospholipase C activity; F:glutamate receptor binding; F:neurotrophin TRKA receptor binding; F:phosphatidylinositol phospholipase C activity; F:protein kinase binding; F:receptor tyrosine kinase binding;, P:activation of phospholipase C activity; P:axon guidance; P:calcium-mediated signaling; P:cell migration; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:in utero embryonic development; P:inositol phosphate metabolic process; P:leukocyte migration; P:modulation of chemical synaptic transmission; P:negative regulation of inflammatory response to antigenic stimulus; P:phosphatidylinositol metabolic process; P:phospholipid catabolic process; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of epithelial cell migration; P:positive regulation of phospholipase C activity; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of vascular endothelial cell proliferation; P:signal transduction; P:T cell receptor signaling pathway; P:viral process;|P19174 B7ZLY7 B9EGH4 E1P5W4 Q2V575,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 {ECO:0000305},PLC-148;Phosphoinositide phospholipase C-gamma-1;Phospholipase C-II;Phospholipase C-gamma-1;, PF00168;PF00388;PF00387;PF00017;PF00018;, GO:0042995;GO:0005911;GO:0008180;GO:0005737;GO:0005829;GO:0098978;GO:0030027;GO:0005886;GO:0001726;GO:0098685;GO:0005509;GO:0050429;GO:0035254;GO:0005168;GO:0004435;GO:0019901;GO:0030971;GO:0007202;GO:0007411;GO:0019722;GO:0016477;GO:0071364;GO:0007173;GO:0038095;GO:0038096;GO:0001701;GO:0043647;GO:0050900;GO:0050804;GO:0002862;GO:0046488;GO:0009395;GO:0045766;GO:0043536;GO:2000353;GO:0010634;GO:0010863;GO:0051281;GO:1905564;GO:0007165;GO:0050852;GO:0016032;, C:cell projection; C:cell-cell junction; C:COP9 signalosome; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:lamellipodium; C:plasma membrane; C:ruffle; C:Schaffer collateral - CA1 synapse;, F:calcium ion binding; F:calcium-dependent phospholipase C activity; F:glutamate receptor binding; F:neurotrophin TRKA receptor binding; F:phosphatidylinositol phospholipase C activity; F:protein kinase binding; F:receptor tyrosine kinase binding;, P:activation of phospholipase C activity; P:axon guidance; P:calcium-mediated signaling; P:cell migration; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:in utero embryonic development; P:inositol phosphate metabolic process; P:leukocyte migration; P:modulation of chemical synaptic transmission; P:negative regulation of inflammatory response to antigenic stimulus; P:phosphatidylinositol metabolic process; P:phospholipid catabolic process; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of epithelial cell migration; P:positive regulation of phospholipase C activity; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of vascular endothelial cell proliferation; P:signal transduction; P:T cell receptor signaling pathway; P:viral process; scaffold25 indexed_genome mRNA 4825227 4832454 . - . ID=transcript_5667;Q9H4I2 E1P5W5 F5H820 O43145 Q6NUJ7,Zinc fingers and homeoboxes protein 3,Triple homeobox protein 1;Zinc finger and homeodomain protein 3;, PF00046;PF11569;PF18387;, GO:0000785;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0046982;GO:0042803;GO:0000977;GO:0030154;GO:0000122;GO:0045892;GO:0045669;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of osteoblast differentiation; P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 4962788 4976076 . + . ID=transcript_5668;Q9BQK8 B2RTT5 Q5TDB9 Q9NPY8 Q9UJE5,Phosphatidate phosphatase LPIN3 {ECO:0000305},Lipin-3;Lipin-3-like;, PF16876;PF04571;PF08235;, GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process;|Q9BQK8 B2RTT5 Q5TDB9 Q9NPY8 Q9UJE5,Phosphatidate phosphatase LPIN3 {ECO:0000305},Lipin-3;Lipin-3-like;, PF16876;PF04571;PF08235;, GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process;|Q9BQK8 B2RTT5 Q5TDB9 Q9NPY8 Q9UJE5,Phosphatidate phosphatase LPIN3 {ECO:0000305},Lipin-3;Lipin-3-like;, PF16876;PF04571;PF08235;, GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process; scaffold25 indexed_genome mRNA 4977293 4978552 . + . ID=transcript_5669;Q9BQK8 B2RTT5 Q5TDB9 Q9NPY8 Q9UJE5,Phosphatidate phosphatase LPIN3 {ECO:0000305},Lipin-3;Lipin-3-like;, PF16876;PF04571;PF08235;, GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process; scaffold25 indexed_genome mRNA 4978712 4982121 . + . ID=transcript_5670;Q9BQK8 B2RTT5 Q5TDB9 Q9NPY8 Q9UJE5,Phosphatidate phosphatase LPIN3 {ECO:0000305},Lipin-3;Lipin-3-like;, PF16876;PF04571;PF08235;, GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process;|Q9BQK8 B2RTT5 Q5TDB9 Q9NPY8 Q9UJE5,Phosphatidate phosphatase LPIN3 {ECO:0000305},Lipin-3;Lipin-3-like;, PF16876;PF04571;PF08235;, GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process; scaffold25 indexed_genome mRNA 4982168 4982780 . + . ID=transcript_5671;Q9NT22 Q495S5 Q495S6 Q495S7 Q76KT4,EMILIN-3,EMILIN-5;Elastin microfibril interface-located protein 3;Elastin microfibril interface-located protein 5;, PF07546;, GO:0062023;GO:0005737;GO:0005576;GO:0030023;GO:0042802;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular region;, F:extracellular matrix constituent conferring elasticity; F:identical protein binding; scaffold25 indexed_genome mRNA 4983221 4983797 . - . ID=transcript_5672;Q9NT22 Q495S5 Q495S6 Q495S7 Q76KT4,EMILIN-3,EMILIN-5;Elastin microfibril interface-located protein 3;Elastin microfibril interface-located protein 5;, PF07546;, GO:0062023;GO:0005737;GO:0005576;GO:0030023;GO:0042802;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular region;, F:extracellular matrix constituent conferring elasticity; F:identical protein binding; scaffold25 indexed_genome mRNA 5023067 5129063 . - . ID=transcript_5673;Q9NTT7 Q9P2L1,Chromodomain-helicase-DNA-binding protein 6,ATP-dependent helicase CHD6;Radiation-induced gene B protein;, PF00385;PF00271;PF00176;, GO:0005654;GO:0005524;GO:0003677;GO:0003678;GO:0008094;GO:0070615;GO:0001221;GO:0006325;GO:0036091;GO:0016032;, C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator binding;, P:chromatin organization; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:viral process;|Q9NTT7 Q9P2L1,Chromodomain-helicase-DNA-binding protein 6,ATP-dependent helicase CHD6;Radiation-induced gene B protein;, PF00385;PF00271;PF00176;, GO:0005654;GO:0005524;GO:0003677;GO:0003678;GO:0008094;GO:0070615;GO:0001221;GO:0006325;GO:0036091;GO:0016032;, C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator binding;, P:chromatin organization; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:viral process;|Q9NTT7 Q9P2L1,Chromodomain-helicase-DNA-binding protein 6,ATP-dependent helicase CHD6;Radiation-induced gene B protein;, PF00385;PF00271;PF00176;, GO:0005654;GO:0005524;GO:0003677;GO:0003678;GO:0008094;GO:0070615;GO:0001221;GO:0006325;GO:0036091;GO:0016032;, C:nucleoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:nucleosome-dependent ATPase activity; F:transcription coregulator binding;, P:chromatin organization; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:viral process; scaffold25 indexed_genome mRNA 5668192 5689573 . - . ID=transcript_5674;Q9NTL1 Q9NU72 Q9UBD2 Q9UJL7,Receptor-type tyrosine-protein phosphatase T,Receptor-type tyrosine-protein phosphatase rho;, PF00041;PF00629;PF18861;PF00102;, GO:0009986;GO:0098978;GO:0016021;GO:0005887;GO:0099061;GO:0005886;GO:0051393;GO:0045294;GO:0008013;GO:0045296;GO:0070097;GO:0045295;GO:0042803;GO:0019903;GO:0004725;GO:0097677;GO:0016790;GO:0005001;GO:0007155;GO:0071354;GO:0007156;GO:0030336;GO:1904893;GO:0035335;GO:1990264;GO:0006470;GO:0050807;GO:0007165;GO:0007169;, C:cell surface; C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:plasma membrane;, F:alpha-actinin binding; F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:delta-catenin binding; F:gamma-catenin binding; F:protein homodimerization activity; F:protein phosphatase binding; F:protein tyrosine phosphatase activity; F:STAT family protein binding; F:thiolester hydrolase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:cell adhesion; P:cellular response to interleukin-6; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell migration; P:negative regulation of receptor signaling pathway via STAT; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:protein dephosphorylation; P:regulation of synapse organization; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold25 indexed_genome mRNA 6985728 6992320 . + . ID=transcript_5675;Q13247 B7Z6J3 E1P5W6 Q13244 Q13245 Q96J06 Q9UJB8 Q9Y3N7,Serine/arginine-rich splicing factor 6,Pre-mRNA-splicing factor SRP55;Splicing factor, arginine/serine-rich 6;, PF00076;, GO:0016607;GO:0005654;GO:0003729;GO:0036002;GO:0003723;GO:0000380;GO:0031124;GO:0006406;GO:0006376;GO:0000398;GO:0060548;GO:0045617;GO:0048025;GO:2000675;GO:0060501;GO:0000381;GO:0010837;GO:0061041;GO:0032868;GO:0006405;, C:nuclear speck; C:nucleoplasm;, F:mRNA binding; F:pre-mRNA binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of cell death; P:negative regulation of keratinocyte differentiation; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of type B pancreatic cell apoptotic process; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of keratinocyte proliferation; P:regulation of wound healing; P:response to insulin; P:RNA export from nucleus; scaffold25 indexed_genome mRNA 6997503 7028246 . + . ID=transcript_5676;Q9UJB9 Q9Y4C9,Lethal(3)malignant brain tumor-like protein 1,L(3)mbt protein homolog;L3MBTL1;, PF02820;PF01530;, GO:0000785;GO:0000793;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0042393;GO:0042802;GO:0035064;GO:0031493;GO:0031491;GO:0032093;GO:0008270;GO:0006325;GO:0030097;GO:0045892;GO:0051726;GO:0045652;GO:0007088;GO:1901796;, C:chromatin; C:condensed chromosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:histone binding; F:identical protein binding; F:methylated histone binding; F:nucleosomal histone binding; F:nucleosome binding; F:SAM domain binding; F:zinc ion binding;, P:chromatin organization; P:hemopoiesis; P:negative regulation of transcription, DNA-templated; P:regulation of cell cycle; P:regulation of megakaryocyte differentiation; P:regulation of mitotic nuclear division; P:regulation of signal transduction by p53 class mediator;|Q9UJB9 Q9Y4C9,Lethal(3)malignant brain tumor-like protein 1,L(3)mbt protein homolog;L3MBTL1;, PF02820;PF01530;, GO:0000785;GO:0000793;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0042393;GO:0042802;GO:0035064;GO:0031493;GO:0031491;GO:0032093;GO:0008270;GO:0006325;GO:0030097;GO:0045892;GO:0051726;GO:0045652;GO:0007088;GO:1901796;, C:chromatin; C:condensed chromosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:histone binding; F:identical protein binding; F:methylated histone binding; F:nucleosomal histone binding; F:nucleosome binding; F:SAM domain binding; F:zinc ion binding;, P:chromatin organization; P:hemopoiesis; P:negative regulation of transcription, DNA-templated; P:regulation of cell cycle; P:regulation of megakaryocyte differentiation; P:regulation of mitotic nuclear division; P:regulation of signal transduction by p53 class mediator;|Q9UJB9 Q9Y4C9,Lethal(3)malignant brain tumor-like protein 1,L(3)mbt protein homolog;L3MBTL1;, PF02820;PF01530;, GO:0000785;GO:0000793;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0042393;GO:0042802;GO:0035064;GO:0031493;GO:0031491;GO:0032093;GO:0008270;GO:0006325;GO:0030097;GO:0045892;GO:0051726;GO:0045652;GO:0007088;GO:1901796;, C:chromatin; C:condensed chromosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:histone binding; F:identical protein binding; F:methylated histone binding; F:nucleosomal histone binding; F:nucleosome binding; F:SAM domain binding; F:zinc ion binding;, P:chromatin organization; P:hemopoiesis; P:negative regulation of transcription, DNA-templated; P:regulation of cell cycle; P:regulation of megakaryocyte differentiation; P:regulation of mitotic nuclear division; P:regulation of signal transduction by p53 class mediator;|Q9UJB9 Q9Y4C9,Lethal(3)malignant brain tumor-like protein 1,L(3)mbt protein homolog;L3MBTL1;, PF02820;PF01530;, GO:0000785;GO:0000793;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0042393;GO:0042802;GO:0035064;GO:0031493;GO:0031491;GO:0032093;GO:0008270;GO:0006325;GO:0030097;GO:0045892;GO:0051726;GO:0045652;GO:0007088;GO:1901796;, C:chromatin; C:condensed chromosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:histone binding; F:identical protein binding; F:methylated histone binding; F:nucleosomal histone binding; F:nucleosome binding; F:SAM domain binding; F:zinc ion binding;, P:chromatin organization; P:hemopoiesis; P:negative regulation of transcription, DNA-templated; P:regulation of cell cycle; P:regulation of megakaryocyte differentiation; P:regulation of mitotic nuclear division; P:regulation of signal transduction by p53 class mediator;|Q8NA19 A8MTL8 Q8IXS3,Lethal(3)malignant brain tumor-like protein 4,, PF02820;PF00536;PF01530;, GO:0005634;GO:0003682;GO:0042393;GO:0008270;GO:0006325;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding; F:zinc ion binding;, P:chromatin organization; P:negative regulation of transcription, DNA-templated; scaffold25 indexed_genome mRNA 7036356 7046408 . + . ID=transcript_5677;Q9HBY8 Q52PK5 Q5H8Y6 Q5H8Z1 Q5TZR3 Q9UKG6,Serine/threonine-protein kinase Sgk2,Serum/glucocorticoid-regulated kinase 2;, PF00069;PF00433;, GO:0005829;GO:0005654;GO:0005524;GO:0015459;GO:0106310;GO:0004674;GO:0106311;GO:0017080;GO:0035556;GO:0034220;GO:0018105;GO:0032411;GO:0006468;GO:0001558;GO:0042127;GO:0006979;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:potassium channel regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:intracellular signal transduction; P:ion transmembrane transport; P:peptidyl-serine phosphorylation; P:positive regulation of transporter activity; P:protein phosphorylation; P:regulation of cell growth; P:regulation of cell population proliferation; P:response to oxidative stress; scaffold25 indexed_genome mRNA 7046425 7065833 . + . ID=transcript_5678;Q9HBY8 Q52PK5 Q5H8Y6 Q5H8Z1 Q5TZR3 Q9UKG6,Serine/threonine-protein kinase Sgk2,Serum/glucocorticoid-regulated kinase 2;, PF00069;PF00433;, GO:0005829;GO:0005654;GO:0005524;GO:0015459;GO:0106310;GO:0004674;GO:0106311;GO:0017080;GO:0035556;GO:0034220;GO:0018105;GO:0032411;GO:0006468;GO:0001558;GO:0042127;GO:0006979;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:potassium channel regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:intracellular signal transduction; P:ion transmembrane transport; P:peptidyl-serine phosphorylation; P:positive regulation of transporter activity; P:protein phosphorylation; P:regulation of cell growth; P:regulation of cell population proliferation; P:response to oxidative stress; scaffold25 indexed_genome mRNA 7067183 7086722 . + . ID=transcript_5679;Q9Y366 B3KMA1 E1P5W9 Q5H8Z0 Q9H1G3 Q9H1G4 Q9H1H2,Intraflagellar transport protein 52 homolog,Protein NGD5 homolog;, PF09822;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0044292;GO:0030992;GO:0031514;GO:0032391;GO:0008022;GO:0060271;GO:0009953;GO:0042733;GO:0001947;GO:0035720;GO:0042073;GO:0035735;GO:0050680;GO:0001841;GO:1905515;GO:0070613;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:dendrite terminus; C:intraciliary transport particle B; C:motile cilium; C:photoreceptor connecting cilium;, F:protein C-terminus binding;, P:cilium assembly; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:heart looping; P:intraciliary anterograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube formation; P:non-motile cilium assembly; P:regulation of protein processing; P:smoothened signaling pathway;|Q9Y366 B3KMA1 E1P5W9 Q5H8Z0 Q9H1G3 Q9H1G4 Q9H1H2,Intraflagellar transport protein 52 homolog,Protein NGD5 homolog;, PF09822;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0044292;GO:0030992;GO:0031514;GO:0032391;GO:0008022;GO:0060271;GO:0009953;GO:0042733;GO:0001947;GO:0035720;GO:0042073;GO:0035735;GO:0050680;GO:0001841;GO:1905515;GO:0070613;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:dendrite terminus; C:intraciliary transport particle B; C:motile cilium; C:photoreceptor connecting cilium;, F:protein C-terminus binding;, P:cilium assembly; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:heart looping; P:intraciliary anterograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube formation; P:non-motile cilium assembly; P:regulation of protein processing; P:smoothened signaling pathway;|Q9Y366 B3KMA1 E1P5W9 Q5H8Z0 Q9H1G3 Q9H1G4 Q9H1H2,Intraflagellar transport protein 52 homolog,Protein NGD5 homolog;, PF09822;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0044292;GO:0030992;GO:0031514;GO:0032391;GO:0008022;GO:0060271;GO:0009953;GO:0042733;GO:0001947;GO:0035720;GO:0042073;GO:0035735;GO:0050680;GO:0001841;GO:1905515;GO:0070613;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:dendrite terminus; C:intraciliary transport particle B; C:motile cilium; C:photoreceptor connecting cilium;, F:protein C-terminus binding;, P:cilium assembly; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:heart looping; P:intraciliary anterograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube formation; P:non-motile cilium assembly; P:regulation of protein processing; P:smoothened signaling pathway;|Q9Y366 B3KMA1 E1P5W9 Q5H8Z0 Q9H1G3 Q9H1G4 Q9H1H2,Intraflagellar transport protein 52 homolog,Protein NGD5 homolog;, PF09822;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0044292;GO:0030992;GO:0031514;GO:0032391;GO:0008022;GO:0060271;GO:0009953;GO:0042733;GO:0001947;GO:0035720;GO:0042073;GO:0035735;GO:0050680;GO:0001841;GO:1905515;GO:0070613;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:dendrite terminus; C:intraciliary transport particle B; C:motile cilium; C:photoreceptor connecting cilium;, F:protein C-terminus binding;, P:cilium assembly; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:heart looping; P:intraciliary anterograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube formation; P:non-motile cilium assembly; P:regulation of protein processing; P:smoothened signaling pathway; scaffold25 indexed_genome mRNA 7089349 7089887 . - . ID=transcript_5680;Q9Y366 B3KMA1 E1P5W9 Q5H8Z0 Q9H1G3 Q9H1G4 Q9H1H2,Intraflagellar transport protein 52 homolog,Protein NGD5 homolog;, PF09822;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0044292;GO:0030992;GO:0031514;GO:0032391;GO:0008022;GO:0060271;GO:0009953;GO:0042733;GO:0001947;GO:0035720;GO:0042073;GO:0035735;GO:0050680;GO:0001841;GO:1905515;GO:0070613;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:dendrite terminus; C:intraciliary transport particle B; C:motile cilium; C:photoreceptor connecting cilium;, F:protein C-terminus binding;, P:cilium assembly; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:heart looping; P:intraciliary anterograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube formation; P:non-motile cilium assembly; P:regulation of protein processing; P:smoothened signaling pathway; scaffold25 indexed_genome mRNA 7091008 7093798 . - . ID=transcript_5681;Q9Y366 B3KMA1 E1P5W9 Q5H8Z0 Q9H1G3 Q9H1G4 Q9H1H2,Intraflagellar transport protein 52 homolog,Protein NGD5 homolog;, PF09822;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0044292;GO:0030992;GO:0031514;GO:0032391;GO:0008022;GO:0060271;GO:0009953;GO:0042733;GO:0001947;GO:0035720;GO:0042073;GO:0035735;GO:0050680;GO:0001841;GO:1905515;GO:0070613;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:dendrite terminus; C:intraciliary transport particle B; C:motile cilium; C:photoreceptor connecting cilium;, F:protein C-terminus binding;, P:cilium assembly; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:heart looping; P:intraciliary anterograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube formation; P:non-motile cilium assembly; P:regulation of protein processing; P:smoothened signaling pathway;|Q9Y366 B3KMA1 E1P5W9 Q5H8Z0 Q9H1G3 Q9H1G4 Q9H1H2,Intraflagellar transport protein 52 homolog,Protein NGD5 homolog;, PF09822;, GO:0005814;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0044292;GO:0030992;GO:0031514;GO:0032391;GO:0008022;GO:0060271;GO:0009953;GO:0042733;GO:0001947;GO:0035720;GO:0042073;GO:0035735;GO:0050680;GO:0001841;GO:1905515;GO:0070613;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:dendrite terminus; C:intraciliary transport particle B; C:motile cilium; C:photoreceptor connecting cilium;, F:protein C-terminus binding;, P:cilium assembly; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:heart looping; P:intraciliary anterograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:negative regulation of epithelial cell proliferation; P:neural tube formation; P:non-motile cilium assembly; P:regulation of protein processing; P:smoothened signaling pathway; scaffold25 indexed_genome mRNA 7098998 7132929 . + . ID=transcript_5682;P10244 B2RBS5 B7Z8D9 F8W6N6 Q53F07,Myb-related protein B,Myb-like protein 2;, PF09316;PF00249;, GO:0031523;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:1990830;GO:0000278;GO:0090307;GO:0043525;GO:0045944;GO:0051726;GO:0006357;GO:0006355;, C:Myb complex; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to leukemia inhibitory factor; P:mitotic cell cycle; P:mitotic spindle assembly; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P10244 B2RBS5 B7Z8D9 F8W6N6 Q53F07,Myb-related protein B,Myb-like protein 2;, PF09316;PF00249;, GO:0031523;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:1990830;GO:0000278;GO:0090307;GO:0043525;GO:0045944;GO:0051726;GO:0006357;GO:0006355;, C:Myb complex; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to leukemia inhibitory factor; P:mitotic cell cycle; P:mitotic spindle assembly; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P10244 B2RBS5 B7Z8D9 F8W6N6 Q53F07,Myb-related protein B,Myb-like protein 2;, PF09316;PF00249;, GO:0031523;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:1990830;GO:0000278;GO:0090307;GO:0043525;GO:0045944;GO:0051726;GO:0006357;GO:0006355;, C:Myb complex; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to leukemia inhibitory factor; P:mitotic cell cycle; P:mitotic spindle assembly; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P10244 B2RBS5 B7Z8D9 F8W6N6 Q53F07,Myb-related protein B,Myb-like protein 2;, PF09316;PF00249;, GO:0031523;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:1990830;GO:0000278;GO:0090307;GO:0043525;GO:0045944;GO:0051726;GO:0006357;GO:0006355;, C:Myb complex; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to leukemia inhibitory factor; P:mitotic cell cycle; P:mitotic spindle assembly; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P10244 B2RBS5 B7Z8D9 F8W6N6 Q53F07,Myb-related protein B,Myb-like protein 2;, PF09316;PF00249;, GO:0031523;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:1990830;GO:0000278;GO:0090307;GO:0043525;GO:0045944;GO:0051726;GO:0006357;GO:0006355;, C:Myb complex; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to leukemia inhibitory factor; P:mitotic cell cycle; P:mitotic spindle assembly; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P10244 B2RBS5 B7Z8D9 F8W6N6 Q53F07,Myb-related protein B,Myb-like protein 2;, PF09316;PF00249;, GO:0031523;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:1990830;GO:0000278;GO:0090307;GO:0043525;GO:0045944;GO:0051726;GO:0006357;GO:0006355;, C:Myb complex; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to leukemia inhibitory factor; P:mitotic cell cycle; P:mitotic spindle assembly; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold25 indexed_genome mRNA 7365022 7416231 . + . ID=transcript_5683;Q96NM4 A8K1J1 E1P5X0 G3XAC7 Q5TE33 Q5TE34 Q5TE35 Q96IC9 Q9BQN5,TOX high mobility group box family member 2,Granulosa cell HMG box protein 1;, PF00505;, GO:0005654;GO:0005634;GO:0031490;GO:0003713;GO:0045944;GO:0006357;, C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:transcription coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 7432021 7503444 . - . ID=transcript_5684;Q9BR39 E1P5X1 O95913 Q5JY74 Q9UJN4,Junctophilin-2 {ECO:0000303|PubMed:10891348},Junctophilin type 2 {ECO:0000303|PubMed:10891348};, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005634;GO:0005886;GO:0016529;GO:0030018;GO:0001046;GO:0003677;GO:0001227;GO:0070300;GO:0005547;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0001786;GO:0055074;GO:0060402;GO:0007275;GO:0000122;GO:0045892;GO:0060316;GO:0055024;GO:0060314;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:nucleus; C:plasma membrane; C:sarcoplasmic reticulum; C:Z disc;, F:core promoter sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:phosphatidic acid binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:phosphatidylserine binding;, P:calcium ion homeostasis; P:calcium ion transport into cytosol; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle tissue development; P:regulation of ryanodine-sensitive calcium-release channel activity;|Q9BR39 E1P5X1 O95913 Q5JY74 Q9UJN4,Junctophilin-2 {ECO:0000303|PubMed:10891348},Junctophilin type 2 {ECO:0000303|PubMed:10891348};, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005634;GO:0005886;GO:0016529;GO:0030018;GO:0001046;GO:0003677;GO:0001227;GO:0070300;GO:0005547;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0001786;GO:0055074;GO:0060402;GO:0007275;GO:0000122;GO:0045892;GO:0060316;GO:0055024;GO:0060314;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:nucleus; C:plasma membrane; C:sarcoplasmic reticulum; C:Z disc;, F:core promoter sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:phosphatidic acid binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:phosphatidylserine binding;, P:calcium ion homeostasis; P:calcium ion transport into cytosol; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle tissue development; P:regulation of ryanodine-sensitive calcium-release channel activity;|Q9BR39 E1P5X1 O95913 Q5JY74 Q9UJN4,Junctophilin-2 {ECO:0000303|PubMed:10891348},Junctophilin type 2 {ECO:0000303|PubMed:10891348};, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005634;GO:0005886;GO:0016529;GO:0030018;GO:0001046;GO:0003677;GO:0001227;GO:0070300;GO:0005547;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0001786;GO:0055074;GO:0060402;GO:0007275;GO:0000122;GO:0045892;GO:0060316;GO:0055024;GO:0060314;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:nucleus; C:plasma membrane; C:sarcoplasmic reticulum; C:Z disc;, F:core promoter sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:phosphatidic acid binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:phosphatidylserine binding;, P:calcium ion homeostasis; P:calcium ion transport into cytosol; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle tissue development; P:regulation of ryanodine-sensitive calcium-release channel activity;|Q9BR39 E1P5X1 O95913 Q5JY74 Q9UJN4,Junctophilin-2 {ECO:0000303|PubMed:10891348},Junctophilin type 2 {ECO:0000303|PubMed:10891348};, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005634;GO:0005886;GO:0016529;GO:0030018;GO:0001046;GO:0003677;GO:0001227;GO:0070300;GO:0005547;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0001786;GO:0055074;GO:0060402;GO:0007275;GO:0000122;GO:0045892;GO:0060316;GO:0055024;GO:0060314;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:nucleus; C:plasma membrane; C:sarcoplasmic reticulum; C:Z disc;, F:core promoter sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:phosphatidic acid binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:phosphatidylserine binding;, P:calcium ion homeostasis; P:calcium ion transport into cytosol; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle tissue development; P:regulation of ryanodine-sensitive calcium-release channel activity; scaffold25 indexed_genome mRNA 7510988 7521077 . - . ID=transcript_5685;Q9NX31 B2RCK4 O95912 Q9NZ84 Q9P0R8,Oxidative stress-responsive serine-rich protein 1,Oxidative stress-responsive protein 1;Peroxide-inducible transcript 1 protein;, PF05604;, GO:0070301;, , , P:cellular response to hydrogen peroxide;|Q9NX31 B2RCK4 O95912 Q9NZ84 Q9P0R8,Oxidative stress-responsive serine-rich protein 1,Oxidative stress-responsive protein 1;Peroxide-inducible transcript 1 protein;, PF05604;, GO:0070301;, , , P:cellular response to hydrogen peroxide;|Q9NX31 B2RCK4 O95912 Q9NZ84 Q9P0R8,Oxidative stress-responsive serine-rich protein 1,Oxidative stress-responsive protein 1;Peroxide-inducible transcript 1 protein;, PF05604;, GO:0070301;, , , P:cellular response to hydrogen peroxide;|Q9NX31 B2RCK4 O95912 Q9NZ84 Q9P0R8,Oxidative stress-responsive serine-rich protein 1,Oxidative stress-responsive protein 1;Peroxide-inducible transcript 1 protein;, PF05604;, GO:0070301;, , , P:cellular response to hydrogen peroxide;|Q9NX31 B2RCK4 O95912 Q9NZ84 Q9P0R8,Oxidative stress-responsive serine-rich protein 1,Oxidative stress-responsive protein 1;Peroxide-inducible transcript 1 protein;, PF05604;, GO:0070301;, , , P:cellular response to hydrogen peroxide; scaffold25 indexed_genome mRNA 7545892 7569785 . + . ID=transcript_5686;Q96MZ0 B7Z621 Q5TE60 Q68CW7 Q9BQJ7 Q9BQV4 Q9BWJ4 Q9H3Y2 Q9H4G5,Ganglioside-induced differentiation-associated protein 1-like 1,, PF13417;, GO:0006749;, , , P:glutathione metabolic process;|Q96MZ0 B7Z621 Q5TE60 Q68CW7 Q9BQJ7 Q9BQV4 Q9BWJ4 Q9H3Y2 Q9H4G5,Ganglioside-induced differentiation-associated protein 1-like 1,, PF13417;, GO:0006749;, , , P:glutathione metabolic process;|Q96MZ0 B7Z621 Q5TE60 Q68CW7 Q9BQJ7 Q9BQV4 Q9BWJ4 Q9H3Y2 Q9H4G5,Ganglioside-induced differentiation-associated protein 1-like 1,, PF13417;, GO:0006749;, , , P:glutathione metabolic process;|Q96MZ0 B7Z621 Q5TE60 Q68CW7 Q9BQJ7 Q9BQV4 Q9BWJ4 Q9H3Y2 Q9H4G5,Ganglioside-induced differentiation-associated protein 1-like 1,, PF13417;, GO:0006749;, , , P:glutathione metabolic process; scaffold25 indexed_genome mRNA 7578616 7584830 . - . ID=transcript_5687;Q8N6M3 A1L492 B9EGQ4 Q5TE59 Q9H3Y1,Acyl-coenzyme A diphosphatase FITM2 {ECO:0000255|HAMAP-Rule:MF_03230, ECO:0000303|PubMed:32915949},Fat storage-inducing transmembrane protein 2 {ECO:0000255|HAMAP-Rule:MF_03230};Fat-inducing protein 2 {ECO:0000255|HAMAP-Rule:MF_03230};, PF10261;, GO:0005789;GO:0030176;GO:0019992;GO:0016787;GO:0017129;GO:0035356;GO:0007010;GO:0036115;GO:0140042;GO:0034389;GO:0055088;GO:0019915;GO:0008654;GO:0010890;GO:0022604;GO:0010866;GO:0030730;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:diacylglycerol binding; F:hydrolase activity; F:triglyceride binding;, P:cellular triglyceride homeostasis; P:cytoskeleton organization; P:fatty-acyl-CoA catabolic process; P:lipid droplet formation; P:lipid droplet organization; P:lipid homeostasis; P:lipid storage; P:phospholipid biosynthetic process; P:positive regulation of sequestering of triglyceride; P:regulation of cell morphogenesis; P:regulation of triglyceride biosynthetic process; P:sequestering of triglyceride; scaffold25 indexed_genome mRNA 7654854 7684435 . + . ID=transcript_5688;Q6B4V7 Q92653 Q92654 Q92655 Q99864 Q9NQH0,Hepatocyte nuclear factor 4-alpha,Nuclear receptor subfamily 2 group A member 1;Transcription factor 14;Transcription factor HNF-4;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0005504;GO:0004879;GO:0042803;GO:0001102;GO:0000978;GO:1990837;GO:0005102;GO:0000976;GO:0008270;GO:0048856;GO:0007596;GO:0030154;GO:0042632;GO:0042593;GO:0070365;GO:0055088;GO:0006629;GO:0030308;GO:0008285;GO:0045892;GO:0006591;GO:0055091;GO:0045944;GO:0045893;GO:0042752;GO:0010470;GO:0060398;GO:0050796;GO:0019216;GO:0006357;GO:0009749;GO:0048511;GO:0007548;GO:0023019;GO:0060395;GO:0006367;GO:0070328;GO:0003323;GO:0006805;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:fatty acid binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:blood coagulation; P:cell differentiation; P:cholesterol homeostasis; P:glucose homeostasis; P:hepatocyte differentiation; P:lipid homeostasis; P:lipid metabolic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:ornithine metabolic process; P:phospholipid homeostasis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of gastrulation; P:regulation of growth hormone receptor signaling pathway; P:regulation of insulin secretion; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to glucose; P:rhythmic process; P:sex differentiation; P:signal transduction involved in regulation of gene expression; P:SMAD protein signal transduction; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis; P:type B pancreatic cell development; P:xenobiotic metabolic process;|Q6B4V7 Q92653 Q92654 Q92655 Q99864 Q9NQH0,Hepatocyte nuclear factor 4-alpha,Nuclear receptor subfamily 2 group A member 1;Transcription factor 14;Transcription factor HNF-4;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0005504;GO:0004879;GO:0042803;GO:0001102;GO:0000978;GO:1990837;GO:0005102;GO:0000976;GO:0008270;GO:0048856;GO:0007596;GO:0030154;GO:0042632;GO:0042593;GO:0070365;GO:0055088;GO:0006629;GO:0030308;GO:0008285;GO:0045892;GO:0006591;GO:0055091;GO:0045944;GO:0045893;GO:0042752;GO:0010470;GO:0060398;GO:0050796;GO:0019216;GO:0006357;GO:0009749;GO:0048511;GO:0007548;GO:0023019;GO:0060395;GO:0006367;GO:0070328;GO:0003323;GO:0006805;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:fatty acid binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:blood coagulation; P:cell differentiation; P:cholesterol homeostasis; P:glucose homeostasis; P:hepatocyte differentiation; P:lipid homeostasis; P:lipid metabolic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:ornithine metabolic process; P:phospholipid homeostasis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of gastrulation; P:regulation of growth hormone receptor signaling pathway; P:regulation of insulin secretion; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to glucose; P:rhythmic process; P:sex differentiation; P:signal transduction involved in regulation of gene expression; P:SMAD protein signal transduction; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis; P:type B pancreatic cell development; P:xenobiotic metabolic process;|Q6B4V7 Q92653 Q92654 Q92655 Q99864 Q9NQH0,Hepatocyte nuclear factor 4-alpha,Nuclear receptor subfamily 2 group A member 1;Transcription factor 14;Transcription factor HNF-4;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0005504;GO:0004879;GO:0042803;GO:0001102;GO:0000978;GO:1990837;GO:0005102;GO:0000976;GO:0008270;GO:0048856;GO:0007596;GO:0030154;GO:0042632;GO:0042593;GO:0070365;GO:0055088;GO:0006629;GO:0030308;GO:0008285;GO:0045892;GO:0006591;GO:0055091;GO:0045944;GO:0045893;GO:0042752;GO:0010470;GO:0060398;GO:0050796;GO:0019216;GO:0006357;GO:0009749;GO:0048511;GO:0007548;GO:0023019;GO:0060395;GO:0006367;GO:0070328;GO:0003323;GO:0006805;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:fatty acid binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:blood coagulation; P:cell differentiation; P:cholesterol homeostasis; P:glucose homeostasis; P:hepatocyte differentiation; P:lipid homeostasis; P:lipid metabolic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:ornithine metabolic process; P:phospholipid homeostasis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of gastrulation; P:regulation of growth hormone receptor signaling pathway; P:regulation of insulin secretion; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to glucose; P:rhythmic process; P:sex differentiation; P:signal transduction involved in regulation of gene expression; P:SMAD protein signal transduction; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis; P:type B pancreatic cell development; P:xenobiotic metabolic process;|Q6B4V7 Q92653 Q92654 Q92655 Q99864 Q9NQH0,Hepatocyte nuclear factor 4-alpha,Nuclear receptor subfamily 2 group A member 1;Transcription factor 14;Transcription factor HNF-4;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0005504;GO:0004879;GO:0042803;GO:0001102;GO:0000978;GO:1990837;GO:0005102;GO:0000976;GO:0008270;GO:0048856;GO:0007596;GO:0030154;GO:0042632;GO:0042593;GO:0070365;GO:0055088;GO:0006629;GO:0030308;GO:0008285;GO:0045892;GO:0006591;GO:0055091;GO:0045944;GO:0045893;GO:0042752;GO:0010470;GO:0060398;GO:0050796;GO:0019216;GO:0006357;GO:0009749;GO:0048511;GO:0007548;GO:0023019;GO:0060395;GO:0006367;GO:0070328;GO:0003323;GO:0006805;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:fatty acid binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:blood coagulation; P:cell differentiation; P:cholesterol homeostasis; P:glucose homeostasis; P:hepatocyte differentiation; P:lipid homeostasis; P:lipid metabolic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:ornithine metabolic process; P:phospholipid homeostasis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of gastrulation; P:regulation of growth hormone receptor signaling pathway; P:regulation of insulin secretion; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to glucose; P:rhythmic process; P:sex differentiation; P:signal transduction involved in regulation of gene expression; P:SMAD protein signal transduction; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis; P:type B pancreatic cell development; P:xenobiotic metabolic process; scaffold25 indexed_genome mRNA 7733557 7739705 . + . ID=transcript_5689;Q9BTX7 E1P5X3 Q5QPC1 Q9H1G2 Q9NQG8,Alpha-tocopherol transfer protein-like,, PF00650;PF03765;, GO:0016020;GO:1902936;, C:membrane;, F:phosphatidylinositol bisphosphate binding; scaffold25 indexed_genome mRNA 7747807 7760167 . - . ID=transcript_5690;Q13530 B4DUE9 O43717 Q9BR33,Serine incorporator 3,Tumor differentially expressed protein 1 {ECO:0000303|PubMed:10559794};, PF03348;, GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0005886;GO:0051607;GO:0009597;GO:0045087;GO:0006564;GO:0006658;GO:1902237;GO:0006665;GO:0016032;, C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:defense response to virus; P:detection of virus; P:innate immune response; P:L-serine biosynthetic process; P:phosphatidylserine metabolic process; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:sphingolipid metabolic process; P:viral process;|Q13530 B4DUE9 O43717 Q9BR33,Serine incorporator 3,Tumor differentially expressed protein 1 {ECO:0000303|PubMed:10559794};, PF03348;, GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0005886;GO:0051607;GO:0009597;GO:0045087;GO:0006564;GO:0006658;GO:1902237;GO:0006665;GO:0016032;, C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:defense response to virus; P:detection of virus; P:innate immune response; P:L-serine biosynthetic process; P:phosphatidylserine metabolic process; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:sphingolipid metabolic process; P:viral process;|Q13530 B4DUE9 O43717 Q9BR33,Serine incorporator 3,Tumor differentially expressed protein 1 {ECO:0000303|PubMed:10559794};, PF03348;, GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0005886;GO:0051607;GO:0009597;GO:0045087;GO:0006564;GO:0006658;GO:1902237;GO:0006665;GO:0016032;, C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:defense response to virus; P:detection of virus; P:innate immune response; P:L-serine biosynthetic process; P:phosphatidylserine metabolic process; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:sphingolipid metabolic process; P:viral process;|Q13530 B4DUE9 O43717 Q9BR33,Serine incorporator 3,Tumor differentially expressed protein 1 {ECO:0000303|PubMed:10559794};, PF03348;, GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0005886;GO:0051607;GO:0009597;GO:0045087;GO:0006564;GO:0006658;GO:1902237;GO:0006665;GO:0016032;, C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:defense response to virus; P:detection of virus; P:innate immune response; P:L-serine biosynthetic process; P:phosphatidylserine metabolic process; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:sphingolipid metabolic process; P:viral process;|Q13530 B4DUE9 O43717 Q9BR33,Serine incorporator 3,Tumor differentially expressed protein 1 {ECO:0000303|PubMed:10559794};, PF03348;, GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0005886;GO:0051607;GO:0009597;GO:0045087;GO:0006564;GO:0006658;GO:1902237;GO:0006665;GO:0016032;, C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:defense response to virus; P:detection of virus; P:innate immune response; P:L-serine biosynthetic process; P:phosphatidylserine metabolic process; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:sphingolipid metabolic process; P:viral process; scaffold25 indexed_genome mRNA 7825992 7858370 . + . ID=transcript_5691;Q9Y2B9,cAMP-dependent protein kinase inhibitor gamma,, PF02827;, GO:0005737;GO:0005634;GO:0004862;GO:2000480;GO:0042308;GO:0000122;GO:0007165;, C:cytoplasm; C:nucleus;, F:cAMP-dependent protein kinase inhibitor activity;, P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of protein import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:signal transduction;|Q9Y2B9,cAMP-dependent protein kinase inhibitor gamma,, PF02827;, GO:0005737;GO:0005634;GO:0004862;GO:2000480;GO:0042308;GO:0000122;GO:0007165;, C:cytoplasm; C:nucleus;, F:cAMP-dependent protein kinase inhibitor activity;, P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of protein import into nucleus; P:negative regulation of transcription by RNA polymerase II; P:signal transduction; scaffold25 indexed_genome mRNA 7863552 7885306 . - . ID=transcript_5692;P00813 Q53F92 Q6LA59,Adenosine deaminase,Adenosine aminohydrolase;, PF00962;, GO:0030054;GO:0009986;GO:0060205;GO:0005829;GO:0032839;GO:0009897;GO:0005615;GO:0005764;GO:0016020;GO:0043025;GO:0005886;GO:0004000;GO:0001883;GO:0008270;GO:0006154;GO:0007568;GO:0006196;GO:0007155;GO:0046059;GO:0046061;GO:0006157;GO:0048566;GO:0002314;GO:0001821;GO:0043103;GO:0046103;GO:0001889;GO:0048286;GO:0060169;GO:0042323;GO:0050728;GO:0002686;GO:0002906;GO:0070256;GO:0060407;GO:0070244;GO:0048541;GO:0001890;GO:0046638;GO:0030890;GO:0050850;GO:0002636;GO:0010460;GO:0045987;GO:0033089;GO:0050862;GO:0032261;GO:0009168;GO:0043101;GO:0033632;GO:0042493;GO:0042542;GO:0001666;GO:0043278;GO:0033197;GO:0042110;GO:0001829;GO:0046111;, C:cell junction; C:cell surface; C:cytoplasmic vesicle lumen; C:cytosol; C:dendrite cytoplasm; C:external side of plasma membrane; C:extracellular space; C:lysosome; C:membrane; C:neuronal cell body; C:plasma membrane;, F:adenosine deaminase activity; F:purine nucleoside binding; F:zinc ion binding;, P:adenosine catabolic process; P:aging; P:AMP catabolic process; P:cell adhesion; P:dAMP catabolic process; P:dATP catabolic process; P:deoxyadenosine catabolic process; P:embryonic digestive tract development; P:germinal center B cell differentiation; P:histamine secretion; P:hypoxanthine salvage; P:inosine biosynthetic process; P:liver development; P:lung alveolus development; P:negative regulation of adenosine receptor signaling pathway; P:negative regulation of circadian sleep/wake cycle, non-REM sleep; P:negative regulation of inflammatory response; P:negative regulation of leukocyte migration; P:negative regulation of mature B cell apoptotic process; P:negative regulation of mucus secretion; P:negative regulation of penile erection; P:negative regulation of thymocyte apoptotic process; P:Peyer's patch development; P:placenta development; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of B cell proliferation; P:positive regulation of calcium-mediated signaling; P:positive regulation of germinal center formation; P:positive regulation of heart rate; P:positive regulation of smooth muscle contraction; P:positive regulation of T cell differentiation in thymus; P:positive regulation of T cell receptor signaling pathway; P:purine nucleotide salvage; P:purine ribonucleoside monophosphate biosynthetic process; P:purine-containing compound salvage; P:regulation of cell-cell adhesion mediated by integrin; P:response to drug; P:response to hydrogen peroxide; P:response to hypoxia; P:response to morphine; P:response to vitamin E; P:T cell activation; P:trophectodermal cell differentiation; P:xanthine biosynthetic process; scaffold25 indexed_genome mRNA 7943247 7954739 . + . ID=transcript_5693;O76076 B2R9N4 E1P612 Q6PEG3,CCN family member 5,Connective tissue growth factor-like protein;Connective tissue growth factor-related protein 58;WNT1-inducible-signaling pathway protein 2;, PF00219;PF19035;PF00093;, GO:0031012;GO:0005615;GO:0005634;GO:0008201;GO:0005520;GO:0005178;GO:0007155;GO:0007267;GO:0060548;GO:0007165;, C:extracellular matrix; C:extracellular space; C:nucleus;, F:heparin binding; F:insulin-like growth factor binding; F:integrin binding;, P:cell adhesion; P:cell-cell signaling; P:negative regulation of cell death; P:signal transduction; scaffold25 indexed_genome mRNA 7954959 7958289 . + . ID=transcript_5694;O76076 B2R9N4 E1P612 Q6PEG3,CCN family member 5,Connective tissue growth factor-like protein;Connective tissue growth factor-related protein 58;WNT1-inducible-signaling pathway protein 2;, PF00219;PF19035;PF00093;, GO:0031012;GO:0005615;GO:0005634;GO:0008201;GO:0005520;GO:0005178;GO:0007155;GO:0007267;GO:0060548;GO:0007165;, C:extracellular matrix; C:extracellular space; C:nucleus;, F:heparin binding; F:insulin-like growth factor binding; F:integrin binding;, P:cell adhesion; P:cell-cell signaling; P:negative regulation of cell death; P:signal transduction;|O76076 B2R9N4 E1P612 Q6PEG3,CCN family member 5,Connective tissue growth factor-like protein;Connective tissue growth factor-related protein 58;WNT1-inducible-signaling pathway protein 2;, PF00219;PF19035;PF00093;, GO:0031012;GO:0005615;GO:0005634;GO:0008201;GO:0005520;GO:0005178;GO:0007155;GO:0007267;GO:0060548;GO:0007165;, C:extracellular matrix; C:extracellular space; C:nucleus;, F:heparin binding; F:insulin-like growth factor binding; F:integrin binding;, P:cell adhesion; P:cell-cell signaling; P:negative regulation of cell death; P:signal transduction; scaffold25 indexed_genome mRNA 7984855 8055915 . - . ID=transcript_5695;Q9H426 A4FU94 E1P613 Q3MI44 Q5JWT7,Regulating synaptic membrane exocytosis protein 4,RIM4 gamma;Rab3-interacting molecule 4;, PF00168;, GO:0048786;GO:0097060;GO:0044325;GO:0031267;GO:0006887;GO:0006836;GO:0042391;GO:2000300;, C:presynaptic active zone; C:synaptic membrane;, F:ion channel binding; F:small GTPase binding;, P:exocytosis; P:neurotransmitter transport; P:regulation of membrane potential; P:regulation of synaptic vesicle exocytosis;|Q9H426 A4FU94 E1P613 Q3MI44 Q5JWT7,Regulating synaptic membrane exocytosis protein 4,RIM4 gamma;Rab3-interacting molecule 4;, PF00168;, GO:0048786;GO:0097060;GO:0044325;GO:0031267;GO:0006887;GO:0006836;GO:0042391;GO:2000300;, C:presynaptic active zone; C:synaptic membrane;, F:ion channel binding; F:small GTPase binding;, P:exocytosis; P:neurotransmitter transport; P:regulation of membrane potential; P:regulation of synaptic vesicle exocytosis; scaffold25 indexed_genome mRNA 8111786 8138905 . + . ID=transcript_5696;P31946 A8K9K2 E1P616,14-3-3 protein beta/alpha,Protein 1054;Protein kinase C inhibitor protein 1;, PF00244;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0042470;GO:0016020;GO:0005739;GO:0005634;GO:0048471;GO:0017053;GO:0005774;GO:0045296;GO:0019899;GO:0042826;GO:0042802;GO:0051219;GO:0050815;GO:0008022;GO:0019904;GO:0004860;GO:0044877;GO:0000186;GO:0002250;GO:0051220;GO:0035329;GO:0000165;GO:0045744;GO:0035308;GO:0045892;GO:0043085;GO:1900740;GO:0006605;GO:0043488;GO:0016032;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:melanosome; C:membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:transcription repressor complex; C:vacuolar membrane;, F:cadherin binding; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:phosphoprotein binding; F:phosphoserine residue binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase inhibitor activity; F:protein-containing complex binding;, P:activation of MAPKK activity; P:adaptive immune response; P:cytoplasmic sequestering of protein; P:hippo signaling; P:MAPK cascade; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of protein dephosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of catalytic activity; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein targeting; P:regulation of mRNA stability; P:viral process;|P31946 A8K9K2 E1P616,14-3-3 protein beta/alpha,Protein 1054;Protein kinase C inhibitor protein 1;, PF00244;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0042470;GO:0016020;GO:0005739;GO:0005634;GO:0048471;GO:0017053;GO:0005774;GO:0045296;GO:0019899;GO:0042826;GO:0042802;GO:0051219;GO:0050815;GO:0008022;GO:0019904;GO:0004860;GO:0044877;GO:0000186;GO:0002250;GO:0051220;GO:0035329;GO:0000165;GO:0045744;GO:0035308;GO:0045892;GO:0043085;GO:1900740;GO:0006605;GO:0043488;GO:0016032;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:melanosome; C:membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:transcription repressor complex; C:vacuolar membrane;, F:cadherin binding; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:phosphoprotein binding; F:phosphoserine residue binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase inhibitor activity; F:protein-containing complex binding;, P:activation of MAPKK activity; P:adaptive immune response; P:cytoplasmic sequestering of protein; P:hippo signaling; P:MAPK cascade; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of protein dephosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of catalytic activity; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein targeting; P:regulation of mRNA stability; P:viral process;|P31946 A8K9K2 E1P616,14-3-3 protein beta/alpha,Protein 1054;Protein kinase C inhibitor protein 1;, PF00244;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0042470;GO:0016020;GO:0005739;GO:0005634;GO:0048471;GO:0017053;GO:0005774;GO:0045296;GO:0019899;GO:0042826;GO:0042802;GO:0051219;GO:0050815;GO:0008022;GO:0019904;GO:0004860;GO:0044877;GO:0000186;GO:0002250;GO:0051220;GO:0035329;GO:0000165;GO:0045744;GO:0035308;GO:0045892;GO:0043085;GO:1900740;GO:0006605;GO:0043488;GO:0016032;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:melanosome; C:membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:transcription repressor complex; C:vacuolar membrane;, F:cadherin binding; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:phosphoprotein binding; F:phosphoserine residue binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase inhibitor activity; F:protein-containing complex binding;, P:activation of MAPKK activity; P:adaptive immune response; P:cytoplasmic sequestering of protein; P:hippo signaling; P:MAPK cascade; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of protein dephosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of catalytic activity; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein targeting; P:regulation of mRNA stability; P:viral process;|P31946 A8K9K2 E1P616,14-3-3 protein beta/alpha,Protein 1054;Protein kinase C inhibitor protein 1;, PF00244;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0042470;GO:0016020;GO:0005739;GO:0005634;GO:0048471;GO:0017053;GO:0005774;GO:0045296;GO:0019899;GO:0042826;GO:0042802;GO:0051219;GO:0050815;GO:0008022;GO:0019904;GO:0004860;GO:0044877;GO:0000186;GO:0002250;GO:0051220;GO:0035329;GO:0000165;GO:0045744;GO:0035308;GO:0045892;GO:0043085;GO:1900740;GO:0006605;GO:0043488;GO:0016032;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:melanosome; C:membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:transcription repressor complex; C:vacuolar membrane;, F:cadherin binding; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:phosphoprotein binding; F:phosphoserine residue binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase inhibitor activity; F:protein-containing complex binding;, P:activation of MAPKK activity; P:adaptive immune response; P:cytoplasmic sequestering of protein; P:hippo signaling; P:MAPK cascade; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of protein dephosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of catalytic activity; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein targeting; P:regulation of mRNA stability; P:viral process; scaffold25 indexed_genome mRNA 8140849 8164454 . + . ID=transcript_5697;Q4VXU2 Q4VY17,Polyadenylate-binding protein 1-like,, PF00658;PF00076;, GO:0010494;GO:0005829;GO:0070062;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0006338;GO:0048096;GO:0006378;GO:0051647;GO:0001556;, C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:mRNA polyadenylation; P:nucleus localization; P:oocyte maturation; scaffold25 indexed_genome mRNA 8165763 8181924 . - . ID=transcript_5698;Q15785 Q53GH9 Q6IBN7 Q9NTZ3,Mitochondrial import receptor subunit TOM34,Translocase of outer membrane 34 kDa subunit;, PF00515;, GO:0005829;GO:0016021;GO:0043231;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0031072;GO:0006626;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:heat shock protein binding;, P:protein targeting to mitochondrion;|Q15785 Q53GH9 Q6IBN7 Q9NTZ3,Mitochondrial import receptor subunit TOM34,Translocase of outer membrane 34 kDa subunit;, PF00515;, GO:0005829;GO:0016021;GO:0043231;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0031072;GO:0006626;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:heat shock protein binding;, P:protein targeting to mitochondrion;|Q15785 Q53GH9 Q6IBN7 Q9NTZ3,Mitochondrial import receptor subunit TOM34,Translocase of outer membrane 34 kDa subunit;, PF00515;, GO:0005829;GO:0016021;GO:0043231;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0031072;GO:0006626;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:heat shock protein binding;, P:protein targeting to mitochondrion;|Q15785 Q53GH9 Q6IBN7 Q9NTZ3,Mitochondrial import receptor subunit TOM34,Translocase of outer membrane 34 kDa subunit;, PF00515;, GO:0005829;GO:0016021;GO:0043231;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0031072;GO:0006626;, C:cytosol; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:heat shock protein binding;, P:protein targeting to mitochondrion; scaffold25 indexed_genome mRNA 8202599 8279644 . + . ID=transcript_5699;Q13043 B2RCR8 Q15802 Q4G156 Q5H982 Q6PD60 Q9BR32 Q9NTZ4,Serine/threonine-protein kinase 4,Mammalian STE20-like protein kinase 1;STE20-like kinase MST1;Serine/threonine-protein kinase Krs-2;, PF11629;PF00069;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0042802;GO:0000287;GO:0042803;GO:0004672;GO:0106310;GO:0043539;GO:0004674;GO:0106311;GO:0008134;GO:0032147;GO:0006915;GO:0001569;GO:0060706;GO:0000902;GO:0007417;GO:0003157;GO:0097284;GO:0035329;GO:0035556;GO:0030216;GO:0090090;GO:0008285;GO:0046621;GO:0001841;GO:0018105;GO:0043065;GO:1902043;GO:0045600;GO:0033138;GO:0032092;GO:0001934;GO:1904237;GO:1905461;GO:0060215;GO:0046777;GO:0006468;GO:0050821;GO:0060800;GO:0007165;GO:0031098;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transcription factor binding;, P:activation of protein kinase activity; P:apoptotic process; P:branching involved in blood vessel morphogenesis; P:cell differentiation involved in embryonic placenta development; P:cell morphogenesis; P:central nervous system development; P:endocardium development; P:hepatocyte apoptotic process; P:hippo signaling; P:intracellular signal transduction; P:keratinocyte differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of organ growth; P:neural tube formation; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of fat cell differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:primitive hemopoiesis; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of cell differentiation involved in embryonic placenta development; P:signal transduction; P:stress-activated protein kinase signaling cascade;|Q13043 B2RCR8 Q15802 Q4G156 Q5H982 Q6PD60 Q9BR32 Q9NTZ4,Serine/threonine-protein kinase 4,Mammalian STE20-like protein kinase 1;STE20-like kinase MST1;Serine/threonine-protein kinase Krs-2;, PF11629;PF00069;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0042802;GO:0000287;GO:0042803;GO:0004672;GO:0106310;GO:0043539;GO:0004674;GO:0106311;GO:0008134;GO:0032147;GO:0006915;GO:0001569;GO:0060706;GO:0000902;GO:0007417;GO:0003157;GO:0097284;GO:0035329;GO:0035556;GO:0030216;GO:0090090;GO:0008285;GO:0046621;GO:0001841;GO:0018105;GO:0043065;GO:1902043;GO:0045600;GO:0033138;GO:0032092;GO:0001934;GO:1904237;GO:1905461;GO:0060215;GO:0046777;GO:0006468;GO:0050821;GO:0060800;GO:0007165;GO:0031098;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transcription factor binding;, P:activation of protein kinase activity; P:apoptotic process; P:branching involved in blood vessel morphogenesis; P:cell differentiation involved in embryonic placenta development; P:cell morphogenesis; P:central nervous system development; P:endocardium development; P:hepatocyte apoptotic process; P:hippo signaling; P:intracellular signal transduction; P:keratinocyte differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of organ growth; P:neural tube formation; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of fat cell differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:primitive hemopoiesis; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of cell differentiation involved in embryonic placenta development; P:signal transduction; P:stress-activated protein kinase signaling cascade;|Q13043 B2RCR8 Q15802 Q4G156 Q5H982 Q6PD60 Q9BR32 Q9NTZ4,Serine/threonine-protein kinase 4,Mammalian STE20-like protein kinase 1;STE20-like kinase MST1;Serine/threonine-protein kinase Krs-2;, PF11629;PF00069;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0042802;GO:0000287;GO:0042803;GO:0004672;GO:0106310;GO:0043539;GO:0004674;GO:0106311;GO:0008134;GO:0032147;GO:0006915;GO:0001569;GO:0060706;GO:0000902;GO:0007417;GO:0003157;GO:0097284;GO:0035329;GO:0035556;GO:0030216;GO:0090090;GO:0008285;GO:0046621;GO:0001841;GO:0018105;GO:0043065;GO:1902043;GO:0045600;GO:0033138;GO:0032092;GO:0001934;GO:1904237;GO:1905461;GO:0060215;GO:0046777;GO:0006468;GO:0050821;GO:0060800;GO:0007165;GO:0031098;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transcription factor binding;, P:activation of protein kinase activity; P:apoptotic process; P:branching involved in blood vessel morphogenesis; P:cell differentiation involved in embryonic placenta development; P:cell morphogenesis; P:central nervous system development; P:endocardium development; P:hepatocyte apoptotic process; P:hippo signaling; P:intracellular signal transduction; P:keratinocyte differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of organ growth; P:neural tube formation; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of fat cell differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:primitive hemopoiesis; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of cell differentiation involved in embryonic placenta development; P:signal transduction; P:stress-activated protein kinase signaling cascade; scaffold25 indexed_genome mRNA 8377954 8401802 . + . ID=transcript_5700;Q9Y496 A8MSW9 Q59EN1 Q86XE9 Q9Y6V4,Kinesin-like protein KIF3A,Microtubule plus end-directed kinesin motor 3A;, PF00225;, GO:1904115;GO:0005814;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0005874;GO:0015630;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0019903;GO:0031267;GO:0030507;GO:0008089;GO:0019886;GO:0010457;GO:0060271;GO:0035735;GO:0034454;GO:0007018;GO:0006996;GO:0072383;GO:1902414;GO:0015031;GO:0006890;, C:axon cytoplasm; C:centriole; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein phosphatase binding; F:small GTPase binding; F:spectrin binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:centriole-centriole cohesion; P:cilium assembly; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring at centrosome; P:microtubule-based movement; P:organelle organization; P:plus-end-directed vesicle transport along microtubule; P:protein localization to cell junction; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y496 A8MSW9 Q59EN1 Q86XE9 Q9Y6V4,Kinesin-like protein KIF3A,Microtubule plus end-directed kinesin motor 3A;, PF00225;, GO:1904115;GO:0005814;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0005874;GO:0015630;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0019903;GO:0031267;GO:0030507;GO:0008089;GO:0019886;GO:0010457;GO:0060271;GO:0035735;GO:0034454;GO:0007018;GO:0006996;GO:0072383;GO:1902414;GO:0015031;GO:0006890;, C:axon cytoplasm; C:centriole; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein phosphatase binding; F:small GTPase binding; F:spectrin binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:centriole-centriole cohesion; P:cilium assembly; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring at centrosome; P:microtubule-based movement; P:organelle organization; P:plus-end-directed vesicle transport along microtubule; P:protein localization to cell junction; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y496 A8MSW9 Q59EN1 Q86XE9 Q9Y6V4,Kinesin-like protein KIF3A,Microtubule plus end-directed kinesin motor 3A;, PF00225;, GO:1904115;GO:0005814;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0005874;GO:0015630;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0019903;GO:0031267;GO:0030507;GO:0008089;GO:0019886;GO:0010457;GO:0060271;GO:0035735;GO:0034454;GO:0007018;GO:0006996;GO:0072383;GO:1902414;GO:0015031;GO:0006890;, C:axon cytoplasm; C:centriole; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein phosphatase binding; F:small GTPase binding; F:spectrin binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:centriole-centriole cohesion; P:cilium assembly; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring at centrosome; P:microtubule-based movement; P:organelle organization; P:plus-end-directed vesicle transport along microtubule; P:protein localization to cell junction; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y496 A8MSW9 Q59EN1 Q86XE9 Q9Y6V4,Kinesin-like protein KIF3A,Microtubule plus end-directed kinesin motor 3A;, PF00225;, GO:1904115;GO:0005814;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0005874;GO:0015630;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0019903;GO:0031267;GO:0030507;GO:0008089;GO:0019886;GO:0010457;GO:0060271;GO:0035735;GO:0034454;GO:0007018;GO:0006996;GO:0072383;GO:1902414;GO:0015031;GO:0006890;, C:axon cytoplasm; C:centriole; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein phosphatase binding; F:small GTPase binding; F:spectrin binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:centriole-centriole cohesion; P:cilium assembly; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring at centrosome; P:microtubule-based movement; P:organelle organization; P:plus-end-directed vesicle transport along microtubule; P:protein localization to cell junction; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y496 A8MSW9 Q59EN1 Q86XE9 Q9Y6V4,Kinesin-like protein KIF3A,Microtubule plus end-directed kinesin motor 3A;, PF00225;, GO:1904115;GO:0005814;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0005874;GO:0015630;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0019903;GO:0031267;GO:0030507;GO:0008089;GO:0019886;GO:0010457;GO:0060271;GO:0035735;GO:0034454;GO:0007018;GO:0006996;GO:0072383;GO:1902414;GO:0015031;GO:0006890;, C:axon cytoplasm; C:centriole; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein phosphatase binding; F:small GTPase binding; F:spectrin binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:centriole-centriole cohesion; P:cilium assembly; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring at centrosome; P:microtubule-based movement; P:organelle organization; P:plus-end-directed vesicle transport along microtubule; P:protein localization to cell junction; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y496 A8MSW9 Q59EN1 Q86XE9 Q9Y6V4,Kinesin-like protein KIF3A,Microtubule plus end-directed kinesin motor 3A;, PF00225;, GO:1904115;GO:0005814;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0005874;GO:0015630;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0019903;GO:0031267;GO:0030507;GO:0008089;GO:0019886;GO:0010457;GO:0060271;GO:0035735;GO:0034454;GO:0007018;GO:0006996;GO:0072383;GO:1902414;GO:0015031;GO:0006890;, C:axon cytoplasm; C:centriole; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein phosphatase binding; F:small GTPase binding; F:spectrin binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:centriole-centriole cohesion; P:cilium assembly; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring at centrosome; P:microtubule-based movement; P:organelle organization; P:plus-end-directed vesicle transport along microtubule; P:protein localization to cell junction; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y496 A8MSW9 Q59EN1 Q86XE9 Q9Y6V4,Kinesin-like protein KIF3A,Microtubule plus end-directed kinesin motor 3A;, PF00225;, GO:1904115;GO:0005814;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0005874;GO:0015630;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0019903;GO:0031267;GO:0030507;GO:0008089;GO:0019886;GO:0010457;GO:0060271;GO:0035735;GO:0034454;GO:0007018;GO:0006996;GO:0072383;GO:1902414;GO:0015031;GO:0006890;, C:axon cytoplasm; C:centriole; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein phosphatase binding; F:small GTPase binding; F:spectrin binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:centriole-centriole cohesion; P:cilium assembly; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring at centrosome; P:microtubule-based movement; P:organelle organization; P:plus-end-directed vesicle transport along microtubule; P:protein localization to cell junction; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold25 indexed_genome mRNA 8432316 8433680 . - . ID=transcript_5701;P35225 O43644 Q4VB52 Q9UDC7,Interleukin-13,, PF03487;, GO:0005737;GO:0009897;GO:0005576;GO:0005615;GO:0005125;GO:0005144;GO:0071260;GO:0019221;GO:0006955;GO:0006954;GO:0042116;GO:0001774;GO:1903660;GO:2000352;GO:0050728;GO:1901247;GO:0033861;GO:1901215;GO:0071635;GO:0030890;GO:0120162;GO:0032723;GO:0010628;GO:0002639;GO:0032733;GO:1901251;GO:0043032;GO:0043306;GO:2000231;GO:0050714;GO:0051281;GO:0048661;GO:0042531;GO:0010155;GO:0045471;GO:0032496;GO:0035094;, C:cytoplasm; C:external side of plasma membrane; C:extracellular region; C:extracellular space;, F:cytokine activity; F:interleukin-13 receptor binding;, P:cellular response to mechanical stimulus; P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:macrophage activation; P:microglial cell activation; P:negative regulation of complement-dependent cytotoxicity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of lung ciliated cell differentiation; P:negative regulation of NAD(P)H oxidase activity; P:negative regulation of neuron death; P:negative regulation of transforming growth factor beta production; P:positive regulation of B cell proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of connective tissue growth factor production; P:positive regulation of gene expression; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-10 production; P:positive regulation of lung goblet cell differentiation; P:positive regulation of macrophage activation; P:positive regulation of mast cell degranulation; P:positive regulation of pancreatic stellate cell proliferation; P:positive regulation of protein secretion; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of proton transport; P:response to ethanol; P:response to lipopolysaccharide; P:response to nicotine; scaffold25 indexed_genome mRNA 8433894 8589618 . + . ID=transcript_5702;P35225 O43644 Q4VB52 Q9UDC7,Interleukin-13,, PF03487;, GO:0005737;GO:0009897;GO:0005576;GO:0005615;GO:0005125;GO:0005144;GO:0071260;GO:0019221;GO:0006955;GO:0006954;GO:0042116;GO:0001774;GO:1903660;GO:2000352;GO:0050728;GO:1901247;GO:0033861;GO:1901215;GO:0071635;GO:0030890;GO:0120162;GO:0032723;GO:0010628;GO:0002639;GO:0032733;GO:1901251;GO:0043032;GO:0043306;GO:2000231;GO:0050714;GO:0051281;GO:0048661;GO:0042531;GO:0010155;GO:0045471;GO:0032496;GO:0035094;, C:cytoplasm; C:external side of plasma membrane; C:extracellular region; C:extracellular space;, F:cytokine activity; F:interleukin-13 receptor binding;, P:cellular response to mechanical stimulus; P:cytokine-mediated signaling pathway; P:immune response; P:inflammatory response; P:macrophage activation; P:microglial cell activation; P:negative regulation of complement-dependent cytotoxicity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of lung ciliated cell differentiation; P:negative regulation of NAD(P)H oxidase activity; P:negative regulation of neuron death; P:negative regulation of transforming growth factor beta production; P:positive regulation of B cell proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of connective tissue growth factor production; P:positive regulation of gene expression; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-10 production; P:positive regulation of lung goblet cell differentiation; P:positive regulation of macrophage activation; P:positive regulation of mast cell degranulation; P:positive regulation of pancreatic stellate cell proliferation; P:positive regulation of protein secretion; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of proton transport; P:response to ethanol; P:response to lipopolysaccharide; P:response to nicotine;|Q92878 B9EGF5 O43254 Q6GMT7 Q6P5X3 Q9UP86,DNA repair protein RAD50,, PF13476;PF04423;, GO:0000781;GO:0000794;GO:0016020;GO:0030870;GO:0005654;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0003691;GO:0051880;GO:0042802;GO:0046872;GO:0030674;GO:0043047;GO:0006974;GO:0070192;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:1904354;GO:0090305;GO:0033674;GO:0031954;GO:0032206;GO:0007131;GO:0000019;GO:1901796;GO:0000723;GO:0000722;GO:0007004;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:membrane; C:Mre11 complex; C:nucleoplasm; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:double-stranded telomeric DNA binding; F:G-quadruplex DNA binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:single-stranded telomeric DNA binding;, P:cellular response to DNA damage stimulus; P:chromosome organization involved in meiotic cell cycle; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:negative regulation of telomere capping; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:reciprocal meiotic recombination; P:regulation of mitotic recombination; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via recombination; P:telomere maintenance via telomerase; P:telomeric 3' overhang formation; P:viral process;|Q92878 B9EGF5 O43254 Q6GMT7 Q6P5X3 Q9UP86,DNA repair protein RAD50,, PF13476;PF04423;, GO:0000781;GO:0000794;GO:0016020;GO:0030870;GO:0005654;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0003691;GO:0051880;GO:0042802;GO:0046872;GO:0030674;GO:0043047;GO:0006974;GO:0070192;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:1904354;GO:0090305;GO:0033674;GO:0031954;GO:0032206;GO:0007131;GO:0000019;GO:1901796;GO:0000723;GO:0000722;GO:0007004;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:membrane; C:Mre11 complex; C:nucleoplasm; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:double-stranded telomeric DNA binding; F:G-quadruplex DNA binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:single-stranded telomeric DNA binding;, P:cellular response to DNA damage stimulus; P:chromosome organization involved in meiotic cell cycle; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:negative regulation of telomere capping; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:reciprocal meiotic recombination; P:regulation of mitotic recombination; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via recombination; P:telomere maintenance via telomerase; P:telomeric 3' overhang formation; P:viral process;|Q92878 B9EGF5 O43254 Q6GMT7 Q6P5X3 Q9UP86,DNA repair protein RAD50,, PF13476;PF04423;, GO:0000781;GO:0000794;GO:0016020;GO:0030870;GO:0005654;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0003691;GO:0051880;GO:0042802;GO:0046872;GO:0030674;GO:0043047;GO:0006974;GO:0070192;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:1904354;GO:0090305;GO:0033674;GO:0031954;GO:0032206;GO:0007131;GO:0000019;GO:1901796;GO:0000723;GO:0000722;GO:0007004;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:membrane; C:Mre11 complex; C:nucleoplasm; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:double-stranded telomeric DNA binding; F:G-quadruplex DNA binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:single-stranded telomeric DNA binding;, P:cellular response to DNA damage stimulus; P:chromosome organization involved in meiotic cell cycle; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:negative regulation of telomere capping; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:reciprocal meiotic recombination; P:regulation of mitotic recombination; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via recombination; P:telomere maintenance via telomerase; P:telomeric 3' overhang formation; P:viral process;|Q92878 B9EGF5 O43254 Q6GMT7 Q6P5X3 Q9UP86,DNA repair protein RAD50,, PF13476;PF04423;, GO:0000781;GO:0000794;GO:0016020;GO:0030870;GO:0005654;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0003691;GO:0051880;GO:0042802;GO:0046872;GO:0030674;GO:0043047;GO:0006974;GO:0070192;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:1904354;GO:0090305;GO:0033674;GO:0031954;GO:0032206;GO:0007131;GO:0000019;GO:1901796;GO:0000723;GO:0000722;GO:0007004;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:membrane; C:Mre11 complex; C:nucleoplasm; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:double-stranded telomeric DNA binding; F:G-quadruplex DNA binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:single-stranded telomeric DNA binding;, P:cellular response to DNA damage stimulus; P:chromosome organization involved in meiotic cell cycle; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:negative regulation of telomere capping; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:reciprocal meiotic recombination; P:regulation of mitotic recombination; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via recombination; P:telomere maintenance via telomerase; P:telomeric 3' overhang formation; P:viral process;|Q92878 B9EGF5 O43254 Q6GMT7 Q6P5X3 Q9UP86,DNA repair protein RAD50,, PF13476;PF04423;, GO:0000781;GO:0000794;GO:0016020;GO:0030870;GO:0005654;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0003691;GO:0051880;GO:0042802;GO:0046872;GO:0030674;GO:0043047;GO:0006974;GO:0070192;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:1904354;GO:0090305;GO:0033674;GO:0031954;GO:0032206;GO:0007131;GO:0000019;GO:1901796;GO:0000723;GO:0000722;GO:0007004;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:membrane; C:Mre11 complex; C:nucleoplasm; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:double-stranded telomeric DNA binding; F:G-quadruplex DNA binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:single-stranded telomeric DNA binding;, P:cellular response to DNA damage stimulus; P:chromosome organization involved in meiotic cell cycle; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:negative regulation of telomere capping; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:reciprocal meiotic recombination; P:regulation of mitotic recombination; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via recombination; P:telomere maintenance via telomerase; P:telomeric 3' overhang formation; P:viral process;|Q92878 B9EGF5 O43254 Q6GMT7 Q6P5X3 Q9UP86,DNA repair protein RAD50,, PF13476;PF04423;, GO:0000781;GO:0000794;GO:0016020;GO:0030870;GO:0005654;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0003691;GO:0051880;GO:0042802;GO:0046872;GO:0030674;GO:0043047;GO:0006974;GO:0070192;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:1904354;GO:0090305;GO:0033674;GO:0031954;GO:0032206;GO:0007131;GO:0000019;GO:1901796;GO:0000723;GO:0000722;GO:0007004;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:membrane; C:Mre11 complex; C:nucleoplasm; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:double-stranded telomeric DNA binding; F:G-quadruplex DNA binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:single-stranded telomeric DNA binding;, P:cellular response to DNA damage stimulus; P:chromosome organization involved in meiotic cell cycle; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:negative regulation of telomere capping; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:reciprocal meiotic recombination; P:regulation of mitotic recombination; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via recombination; P:telomere maintenance via telomerase; P:telomeric 3' overhang formation; P:viral process;|Q92878 B9EGF5 O43254 Q6GMT7 Q6P5X3 Q9UP86,DNA repair protein RAD50,, PF13476;PF04423;, GO:0000781;GO:0000794;GO:0016020;GO:0030870;GO:0005654;GO:0035861;GO:0005524;GO:0016887;GO:0003677;GO:0003691;GO:0051880;GO:0042802;GO:0046872;GO:0030674;GO:0043047;GO:0006974;GO:0070192;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:1904354;GO:0090305;GO:0033674;GO:0031954;GO:0032206;GO:0007131;GO:0000019;GO:1901796;GO:0000723;GO:0000722;GO:0007004;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:membrane; C:Mre11 complex; C:nucleoplasm; C:site of double-strand break;, F:ATP binding; F:ATPase activity; F:DNA binding; F:double-stranded telomeric DNA binding; F:G-quadruplex DNA binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:single-stranded telomeric DNA binding;, P:cellular response to DNA damage stimulus; P:chromosome organization involved in meiotic cell cycle; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:negative regulation of telomere capping; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:reciprocal meiotic recombination; P:regulation of mitotic recombination; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via recombination; P:telomere maintenance via telomerase; P:telomeric 3' overhang formation; P:viral process; scaffold25 indexed_genome mRNA 8648145 8733385 . + . ID=transcript_5703;P10914 Q96GG7,Interferon regulatory factor 1,, PF00605;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0000976;GO:0006915;GO:0007596;GO:0043374;GO:0007050;GO:0035458;GO:0071260;GO:0051607;GO:0002376;GO:0060333;GO:0008285;GO:0045590;GO:0045892;GO:0032728;GO:0032735;GO:0045944;GO:0045893;GO:0032481;GO:0002819;GO:2000564;GO:0051726;GO:0045088;GO:0034124;GO:0006357;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:blood coagulation; P:CD8-positive, alpha-beta T cell differentiation; P:cell cycle arrest; P:cellular response to interferon-beta; P:cellular response to mechanical stimulus; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of regulatory T cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-12 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of adaptive immune response; P:regulation of CD8-positive, alpha-beta T cell proliferation; P:regulation of cell cycle; P:regulation of innate immune response; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:type I interferon signaling pathway;|P10914 Q96GG7,Interferon regulatory factor 1,, PF00605;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0000976;GO:0006915;GO:0007596;GO:0043374;GO:0007050;GO:0035458;GO:0071260;GO:0051607;GO:0002376;GO:0060333;GO:0008285;GO:0045590;GO:0045892;GO:0032728;GO:0032735;GO:0045944;GO:0045893;GO:0032481;GO:0002819;GO:2000564;GO:0051726;GO:0045088;GO:0034124;GO:0006357;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:blood coagulation; P:CD8-positive, alpha-beta T cell differentiation; P:cell cycle arrest; P:cellular response to interferon-beta; P:cellular response to mechanical stimulus; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of regulatory T cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-12 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of adaptive immune response; P:regulation of CD8-positive, alpha-beta T cell proliferation; P:regulation of cell cycle; P:regulation of innate immune response; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:type I interferon signaling pathway;|P10914 Q96GG7,Interferon regulatory factor 1,, PF00605;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0000976;GO:0006915;GO:0007596;GO:0043374;GO:0007050;GO:0035458;GO:0071260;GO:0051607;GO:0002376;GO:0060333;GO:0008285;GO:0045590;GO:0045892;GO:0032728;GO:0032735;GO:0045944;GO:0045893;GO:0032481;GO:0002819;GO:2000564;GO:0051726;GO:0045088;GO:0034124;GO:0006357;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:blood coagulation; P:CD8-positive, alpha-beta T cell differentiation; P:cell cycle arrest; P:cellular response to interferon-beta; P:cellular response to mechanical stimulus; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of regulatory T cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-12 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of adaptive immune response; P:regulation of CD8-positive, alpha-beta T cell proliferation; P:regulation of cell cycle; P:regulation of innate immune response; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:type I interferon signaling pathway;|P10914 Q96GG7,Interferon regulatory factor 1,, PF00605;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0000976;GO:0006915;GO:0007596;GO:0043374;GO:0007050;GO:0035458;GO:0071260;GO:0051607;GO:0002376;GO:0060333;GO:0008285;GO:0045590;GO:0045892;GO:0032728;GO:0032735;GO:0045944;GO:0045893;GO:0032481;GO:0002819;GO:2000564;GO:0051726;GO:0045088;GO:0034124;GO:0006357;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:blood coagulation; P:CD8-positive, alpha-beta T cell differentiation; P:cell cycle arrest; P:cellular response to interferon-beta; P:cellular response to mechanical stimulus; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of regulatory T cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-12 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of adaptive immune response; P:regulation of CD8-positive, alpha-beta T cell proliferation; P:regulation of cell cycle; P:regulation of innate immune response; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:type I interferon signaling pathway;|Q9UBU7 A4D1D8 A8K954 O75226 Q75MS6 Q75N01 Q9Y2M6,Protein DBF4 homolog A,Activator of S phase kinase;Chiffon homolog A;DBF4-type zinc finger-containing protein 1;, PF07535;, GO:0031431;GO:0016604;GO:0005654;GO:0005634;GO:0008047;GO:0003676;GO:0043539;GO:0008270;GO:0006260;GO:0006270;GO:0000082;GO:0010571;GO:1901987;, C:Dbf4-dependent protein kinase complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:enzyme activator activity; F:nucleic acid binding; F:protein serine/threonine kinase activator activity; F:zinc ion binding;, P:DNA replication; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication; P:regulation of cell cycle phase transition; scaffold25 indexed_genome mRNA 8738361 8750366 . - . ID=transcript_5704;O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane; scaffold25 indexed_genome mRNA 8750386 8758868 . - . ID=transcript_5705;O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane; scaffold25 indexed_genome mRNA 8758887 8766520 . - . ID=transcript_5706;O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O76082 A2Q0V1 B2R844 D3DQ87 Q6ZQZ8 Q96EH6,Solute carrier family 22 member 5,High-affinity sodium-dependent carnitine cotransporter;Organic cation/carnitine transporter 2;, PF00083;, GO:0016324;GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0016021;GO:0005886;GO:1901235;GO:0005524;GO:0015226;GO:0030165;GO:0015651;GO:0015293;GO:0042910;GO:1902270;GO:1902603;GO:0015879;GO:0060731;GO:0015697;GO:0009609;GO:0006814;GO:0070715;GO:0150104;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:(R)-carnitine transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:symporter activity; F:xenobiotic transmembrane transporter activity;, P:(R)-carnitine transmembrane transport; P:carnitine transmembrane transport; P:carnitine transport; P:positive regulation of intestinal epithelial structure maintenance; P:quaternary ammonium group transport; P:response to symbiotic bacterium; P:sodium ion transport; P:sodium-dependent organic cation transport; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane; scaffold25 indexed_genome mRNA 8807338 8834229 . - . ID=transcript_5707;Q9H015 O14546,Solute carrier family 22 member 4,Ergothioneine transporter;Organic cation/carnitine transporter 1;, PF00083;, GO:0016324;GO:0005887;GO:0005739;GO:0005886;GO:0015171;GO:0005524;GO:0015226;GO:0015491;GO:0000166;GO:0030165;GO:0015651;GO:0008513;GO:0015293;GO:0089718;GO:0007589;GO:0009437;GO:0015879;GO:0015695;GO:0015697;GO:0006814;GO:0006641;GO:0042908;, C:apical plasma membrane; C:integral component of plasma membrane; C:mitochondrion; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:ATP binding; F:carnitine transmembrane transporter activity; F:cation:cation antiporter activity; F:nucleotide binding; F:PDZ domain binding; F:quaternary ammonium group transmembrane transporter activity; F:secondary active organic cation transmembrane transporter activity; F:symporter activity;, P:amino acid import across plasma membrane; P:body fluid secretion; P:carnitine metabolic process; P:carnitine transport; P:organic cation transport; P:quaternary ammonium group transport; P:sodium ion transport; P:triglyceride metabolic process; P:xenobiotic transport; scaffold25 indexed_genome mRNA 8868001 8882380 . - . ID=transcript_5708;P50479 B2R8U1 Q53Y39 Q96AT8 Q9BTW8 Q9Y292,PDZ and LIM domain protein 4,LIM protein RIL;Reversion-induced LIM protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005737;GO:0005856;GO:0043197;GO:0031905;GO:0031901;GO:0031941;GO:0030027;GO:0005634;GO:0048471;GO:0045211;GO:0034777;GO:0055038;GO:0001725;GO:0030018;GO:0003779;GO:0051393;GO:0046872;GO:0051371;GO:0042803;GO:0019903;GO:0030036;GO:0031532;GO:0098976;GO:0007507;GO:0061061;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:dendritic spine; C:early endosome lumen; C:early endosome membrane; C:filamentous actin; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:recycling endosome lumen; C:recycling endosome membrane; C:stress fiber; C:Z disc;, F:actin binding; F:alpha-actinin binding; F:metal ion binding; F:muscle alpha-actinin binding; F:protein homodimerization activity; F:protein phosphatase binding;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:excitatory chemical synaptic transmission; P:heart development; P:muscle structure development;|P50479 B2R8U1 Q53Y39 Q96AT8 Q9BTW8 Q9Y292,PDZ and LIM domain protein 4,LIM protein RIL;Reversion-induced LIM protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005737;GO:0005856;GO:0043197;GO:0031905;GO:0031901;GO:0031941;GO:0030027;GO:0005634;GO:0048471;GO:0045211;GO:0034777;GO:0055038;GO:0001725;GO:0030018;GO:0003779;GO:0051393;GO:0046872;GO:0051371;GO:0042803;GO:0019903;GO:0030036;GO:0031532;GO:0098976;GO:0007507;GO:0061061;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:dendritic spine; C:early endosome lumen; C:early endosome membrane; C:filamentous actin; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:recycling endosome lumen; C:recycling endosome membrane; C:stress fiber; C:Z disc;, F:actin binding; F:alpha-actinin binding; F:metal ion binding; F:muscle alpha-actinin binding; F:protein homodimerization activity; F:protein phosphatase binding;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:excitatory chemical synaptic transmission; P:heart development; P:muscle structure development;|P50479 B2R8U1 Q53Y39 Q96AT8 Q9BTW8 Q9Y292,PDZ and LIM domain protein 4,LIM protein RIL;Reversion-induced LIM protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005737;GO:0005856;GO:0043197;GO:0031905;GO:0031901;GO:0031941;GO:0030027;GO:0005634;GO:0048471;GO:0045211;GO:0034777;GO:0055038;GO:0001725;GO:0030018;GO:0003779;GO:0051393;GO:0046872;GO:0051371;GO:0042803;GO:0019903;GO:0030036;GO:0031532;GO:0098976;GO:0007507;GO:0061061;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:dendritic spine; C:early endosome lumen; C:early endosome membrane; C:filamentous actin; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:recycling endosome lumen; C:recycling endosome membrane; C:stress fiber; C:Z disc;, F:actin binding; F:alpha-actinin binding; F:metal ion binding; F:muscle alpha-actinin binding; F:protein homodimerization activity; F:protein phosphatase binding;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:excitatory chemical synaptic transmission; P:heart development; P:muscle structure development;|P50479 B2R8U1 Q53Y39 Q96AT8 Q9BTW8 Q9Y292,PDZ and LIM domain protein 4,LIM protein RIL;Reversion-induced LIM protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005737;GO:0005856;GO:0043197;GO:0031905;GO:0031901;GO:0031941;GO:0030027;GO:0005634;GO:0048471;GO:0045211;GO:0034777;GO:0055038;GO:0001725;GO:0030018;GO:0003779;GO:0051393;GO:0046872;GO:0051371;GO:0042803;GO:0019903;GO:0030036;GO:0031532;GO:0098976;GO:0007507;GO:0061061;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:dendritic spine; C:early endosome lumen; C:early endosome membrane; C:filamentous actin; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:recycling endosome lumen; C:recycling endosome membrane; C:stress fiber; C:Z disc;, F:actin binding; F:alpha-actinin binding; F:metal ion binding; F:muscle alpha-actinin binding; F:protein homodimerization activity; F:protein phosphatase binding;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:excitatory chemical synaptic transmission; P:heart development; P:muscle structure development; scaffold25 indexed_genome mRNA 8918543 8950467 . + . ID=transcript_5709;O15460 D3DQ85 D3DQ86 Q8WWN0,Prolyl 4-hydroxylase subunit alpha-2,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2;, PF13640;PF08336;, GO:0005829;GO:0005783;GO:0005788;GO:0043231;GO:0005654;GO:0009055;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:electron transfer activity; F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline;|O15460 D3DQ85 D3DQ86 Q8WWN0,Prolyl 4-hydroxylase subunit alpha-2,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2;, PF13640;PF08336;, GO:0005829;GO:0005783;GO:0005788;GO:0043231;GO:0005654;GO:0009055;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:electron transfer activity; F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline;|O15460 D3DQ85 D3DQ86 Q8WWN0,Prolyl 4-hydroxylase subunit alpha-2,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2;, PF13640;PF08336;, GO:0005829;GO:0005783;GO:0005788;GO:0043231;GO:0005654;GO:0009055;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:electron transfer activity; F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; scaffold25 indexed_genome mRNA 9004256 9160664 . + . ID=transcript_5710;O15460 D3DQ85 D3DQ86 Q8WWN0,Prolyl 4-hydroxylase subunit alpha-2,Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2;, PF13640;PF08336;, GO:0005829;GO:0005783;GO:0005788;GO:0043231;GO:0005654;GO:0009055;GO:0005506;GO:0031418;GO:0016702;GO:0004656;GO:0030199;GO:0018401;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:electron transfer activity; F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:procollagen-proline 4-dioxygenase activity;, P:collagen fibril organization; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline;|P04141 Q14CE8 Q2VPI8 Q8NFI6,Granulocyte-macrophage colony-stimulating factor,Colony-stimulating factor;Molgramostin;Sargramostim;, PF01109;, GO:0005576;GO:0005615;GO:0043231;GO:0005125;GO:0005129;GO:0008083;GO:0097011;GO:0071222;GO:0019221;GO:0097028;GO:0001892;GO:0042045;GO:0001821;GO:0006955;GO:0042116;GO:0030225;GO:0000165;GO:0030224;GO:0030099;GO:0043011;GO:2001240;GO:0045892;GO:0030223;GO:0008284;GO:0010628;GO:0032747;GO:0010744;GO:0071803;GO:0042531;GO:0045187;GO:0045637;GO:0034405;GO:0034021;, C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:cytokine activity; F:granulocyte macrophage colony-stimulating factor receptor binding; F:growth factor activity;, P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to lipopolysaccharide; P:cytokine-mediated signaling pathway; P:dendritic cell differentiation; P:embryonic placenta development; P:epithelial fluid transport; P:histamine secretion; P:immune response; P:macrophage activation; P:macrophage differentiation; P:MAPK cascade; P:monocyte differentiation; P:myeloid cell differentiation; P:myeloid dendritic cell differentiation; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of transcription, DNA-templated; P:neutrophil differentiation; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of interleukin-23 production; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of podosome assembly; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of circadian sleep/wake cycle, sleep; P:regulation of myeloid cell differentiation; P:response to fluid shear stress; P:response to silicon dioxide; scaffold25 indexed_genome mRNA 9238842 9242439 . + . ID=transcript_5711;Q9UKU0 J3KPG3 O94924 O95829 Q108M9 Q108N0 Q4G191 Q86TN7,Long-chain-fatty-acid--CoA ligase 6 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000305};Long-chain acyl-CoA synthetase 6;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0019899;GO:0004467;GO:0042803;GO:0006637;GO:0008610;GO:0001676;GO:0035338;GO:0000038;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:enzyme binding; F:long-chain fatty acid-CoA ligase activity; F:protein homodimerization activity;, P:acyl-CoA metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:very long-chain fatty acid metabolic process; scaffold25 indexed_genome mRNA 9244379 9279620 . + . ID=transcript_5712;Q9UKU0 J3KPG3 O94924 O95829 Q108M9 Q108N0 Q4G191 Q86TN7,Long-chain-fatty-acid--CoA ligase 6 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000305};Long-chain acyl-CoA synthetase 6;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0019899;GO:0004467;GO:0042803;GO:0006637;GO:0008610;GO:0001676;GO:0035338;GO:0000038;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:enzyme binding; F:long-chain fatty acid-CoA ligase activity; F:protein homodimerization activity;, P:acyl-CoA metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:very long-chain fatty acid metabolic process;|Q9UKU0 J3KPG3 O94924 O95829 Q108M9 Q108N0 Q4G191 Q86TN7,Long-chain-fatty-acid--CoA ligase 6 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000305};Long-chain acyl-CoA synthetase 6;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0019899;GO:0004467;GO:0042803;GO:0006637;GO:0008610;GO:0001676;GO:0035338;GO:0000038;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:enzyme binding; F:long-chain fatty acid-CoA ligase activity; F:protein homodimerization activity;, P:acyl-CoA metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:very long-chain fatty acid metabolic process;|Q9UKU0 J3KPG3 O94924 O95829 Q108M9 Q108N0 Q4G191 Q86TN7,Long-chain-fatty-acid--CoA ligase 6 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000305};Long-chain acyl-CoA synthetase 6;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0019899;GO:0004467;GO:0042803;GO:0006637;GO:0008610;GO:0001676;GO:0035338;GO:0000038;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:enzyme binding; F:long-chain fatty acid-CoA ligase activity; F:protein homodimerization activity;, P:acyl-CoA metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:very long-chain fatty acid metabolic process;|Q9UKU0 J3KPG3 O94924 O95829 Q108M9 Q108N0 Q4G191 Q86TN7,Long-chain-fatty-acid--CoA ligase 6 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000305};Long-chain acyl-CoA synthetase 6;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0019899;GO:0004467;GO:0042803;GO:0006637;GO:0008610;GO:0001676;GO:0035338;GO:0000038;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:enzyme binding; F:long-chain fatty acid-CoA ligase activity; F:protein homodimerization activity;, P:acyl-CoA metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:very long-chain fatty acid metabolic process;|Q9UKU0 J3KPG3 O94924 O95829 Q108M9 Q108N0 Q4G191 Q86TN7,Long-chain-fatty-acid--CoA ligase 6 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000305};Long-chain acyl-CoA synthetase 6;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0019899;GO:0004467;GO:0042803;GO:0006637;GO:0008610;GO:0001676;GO:0035338;GO:0000038;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:enzyme binding; F:long-chain fatty acid-CoA ligase activity; F:protein homodimerization activity;, P:acyl-CoA metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:very long-chain fatty acid metabolic process; scaffold25 indexed_genome mRNA 9429178 9504687 . + . ID=transcript_5713;Q8TF40 D6RJH5 Q86T47 Q9BUT0,Folliculin-interacting protein 1 {ECO:0000303|PubMed:17028174},, PF14638;PF14637;PF14636;, GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0019899;GO:0005085;GO:0009267;GO:0002327;GO:0043154;GO:0032007;GO:0000122;GO:0002904;GO:0033138;GO:0001934;GO:0031334;GO:0032008;GO:2000973;GO:0001932;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding; F:enzyme binding; F:guanyl-nucleotide exchange factor activity;, P:cellular response to starvation; P:immature B cell differentiation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of B cell apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of TOR signaling; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:TOR signaling;|Q8TF40 D6RJH5 Q86T47 Q9BUT0,Folliculin-interacting protein 1 {ECO:0000303|PubMed:17028174},, PF14638;PF14637;PF14636;, GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0019899;GO:0005085;GO:0009267;GO:0002327;GO:0043154;GO:0032007;GO:0000122;GO:0002904;GO:0033138;GO:0001934;GO:0031334;GO:0032008;GO:2000973;GO:0001932;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding; F:enzyme binding; F:guanyl-nucleotide exchange factor activity;, P:cellular response to starvation; P:immature B cell differentiation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of B cell apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of TOR signaling; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:TOR signaling;|Q8TF40 D6RJH5 Q86T47 Q9BUT0,Folliculin-interacting protein 1 {ECO:0000303|PubMed:17028174},, PF14638;PF14637;PF14636;, GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0019899;GO:0005085;GO:0009267;GO:0002327;GO:0043154;GO:0032007;GO:0000122;GO:0002904;GO:0033138;GO:0001934;GO:0031334;GO:0032008;GO:2000973;GO:0001932;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding; F:enzyme binding; F:guanyl-nucleotide exchange factor activity;, P:cellular response to starvation; P:immature B cell differentiation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of B cell apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of TOR signaling; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:TOR signaling; scaffold25 indexed_genome mRNA 9524014 9527471 . + . ID=transcript_5714;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold25 indexed_genome mRNA 9527543 9550821 . - . ID=transcript_5715;Q8TF40 D6RJH5 Q86T47 Q9BUT0,Folliculin-interacting protein 1 {ECO:0000303|PubMed:17028174},, PF14638;PF14637;PF14636;, GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0019899;GO:0005085;GO:0009267;GO:0002327;GO:0043154;GO:0032007;GO:0000122;GO:0002904;GO:0033138;GO:0001934;GO:0031334;GO:0032008;GO:2000973;GO:0001932;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding; F:enzyme binding; F:guanyl-nucleotide exchange factor activity;, P:cellular response to starvation; P:immature B cell differentiation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of B cell apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of TOR signaling; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:TOR signaling;|Q8TF40 D6RJH5 Q86T47 Q9BUT0,Folliculin-interacting protein 1 {ECO:0000303|PubMed:17028174},, PF14638;PF14637;PF14636;, GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0019899;GO:0005085;GO:0009267;GO:0002327;GO:0043154;GO:0032007;GO:0000122;GO:0002904;GO:0033138;GO:0001934;GO:0031334;GO:0032008;GO:2000973;GO:0001932;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding; F:enzyme binding; F:guanyl-nucleotide exchange factor activity;, P:cellular response to starvation; P:immature B cell differentiation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of B cell apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of TOR signaling; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:TOR signaling;|Q8TF40 D6RJH5 Q86T47 Q9BUT0,Folliculin-interacting protein 1 {ECO:0000303|PubMed:17028174},, PF14638;PF14637;PF14636;, GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0019899;GO:0005085;GO:0009267;GO:0002327;GO:0043154;GO:0032007;GO:0000122;GO:0002904;GO:0033138;GO:0001934;GO:0031334;GO:0032008;GO:2000973;GO:0001932;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding; F:enzyme binding; F:guanyl-nucleotide exchange factor activity;, P:cellular response to starvation; P:immature B cell differentiation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of B cell apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of TOR signaling; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:TOR signaling;|Q8TF40 D6RJH5 Q86T47 Q9BUT0,Folliculin-interacting protein 1 {ECO:0000303|PubMed:17028174},, PF14638;PF14637;PF14636;, GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0019899;GO:0005085;GO:0009267;GO:0002327;GO:0043154;GO:0032007;GO:0000122;GO:0002904;GO:0033138;GO:0001934;GO:0031334;GO:0032008;GO:2000973;GO:0001932;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding; F:enzyme binding; F:guanyl-nucleotide exchange factor activity;, P:cellular response to starvation; P:immature B cell differentiation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of B cell apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of TOR signaling; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:TOR signaling;|Q8TF40 D6RJH5 Q86T47 Q9BUT0,Folliculin-interacting protein 1 {ECO:0000303|PubMed:17028174},, PF14638;PF14637;PF14636;, GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0019899;GO:0005085;GO:0009267;GO:0002327;GO:0043154;GO:0032007;GO:0000122;GO:0002904;GO:0033138;GO:0001934;GO:0031334;GO:0032008;GO:2000973;GO:0001932;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding; F:enzyme binding; F:guanyl-nucleotide exchange factor activity;, P:cellular response to starvation; P:immature B cell differentiation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of B cell apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of TOR signaling; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:TOR signaling;|Q8TF40 D6RJH5 Q86T47 Q9BUT0,Folliculin-interacting protein 1 {ECO:0000303|PubMed:17028174},, PF14638;PF14637;PF14636;, GO:0005737;GO:0005829;GO:0005765;GO:0042030;GO:0051087;GO:0019899;GO:0005085;GO:0009267;GO:0002327;GO:0043154;GO:0032007;GO:0000122;GO:0002904;GO:0033138;GO:0001934;GO:0031334;GO:0032008;GO:2000973;GO:0001932;GO:0031929;, C:cytoplasm; C:cytosol; C:lysosomal membrane;, F:ATPase inhibitor activity; F:chaperone binding; F:enzyme binding; F:guanyl-nucleotide exchange factor activity;, P:cellular response to starvation; P:immature B cell differentiation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of B cell apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of TOR signaling; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:TOR signaling; scaffold25 indexed_genome mRNA 9556211 9644114 . + . ID=transcript_5716;Q8TEU7 A3KN82 A5PLL6 B7ZML2 E9PDV7 Q8NI21 Q8TEU6 Q96PC1,Rap guanine nucleotide exchange factor 6,PDZ domain-containing guanine nucleotide exchange factor 2;RA-GEF-2;, PF00027;PF00595;PF00788;PF00617;PF00618;, GO:0016324;GO:0005813;GO:0005829;GO:0030139;GO:0005886;GO:0030742;GO:0005085;GO:0070300;GO:0031267;GO:0030033;GO:0043547;GO:0072659;GO:0007265;GO:0043087;, C:apical plasma membrane; C:centrosome; C:cytosol; C:endocytic vesicle; C:plasma membrane;, F:GTP-dependent protein binding; F:guanyl-nucleotide exchange factor activity; F:phosphatidic acid binding; F:small GTPase binding;, P:microvillus assembly; P:positive regulation of GTPase activity; P:protein localization to plasma membrane; P:Ras protein signal transduction; P:regulation of GTPase activity; scaffold25 indexed_genome mRNA 9693137 9782076 . + . ID=transcript_5717;Q8TEU7 A3KN82 A5PLL6 B7ZML2 E9PDV7 Q8NI21 Q8TEU6 Q96PC1,Rap guanine nucleotide exchange factor 6,PDZ domain-containing guanine nucleotide exchange factor 2;RA-GEF-2;, PF00027;PF00595;PF00788;PF00617;PF00618;, GO:0016324;GO:0005813;GO:0005829;GO:0030139;GO:0005886;GO:0030742;GO:0005085;GO:0070300;GO:0031267;GO:0030033;GO:0043547;GO:0072659;GO:0007265;GO:0043087;, C:apical plasma membrane; C:centrosome; C:cytosol; C:endocytic vesicle; C:plasma membrane;, F:GTP-dependent protein binding; F:guanyl-nucleotide exchange factor activity; F:phosphatidic acid binding; F:small GTPase binding;, P:microvillus assembly; P:positive regulation of GTPase activity; P:protein localization to plasma membrane; P:Ras protein signal transduction; P:regulation of GTPase activity; scaffold25 indexed_genome mRNA 9799562 9811528 . - . ID=transcript_5718;Q9NRR3 B2R622 Q4KMT9,CDC42 small effector protein 2,Small effector of CDC42 protein 2;, PF00786;, GO:0042995;GO:0005737;GO:0005856;GO:0001891;GO:0005886;GO:0035591;GO:0031267;GO:0006909;GO:0008360;GO:0035023;GO:0009966;, C:cell projection; C:cytoplasm; C:cytoskeleton; C:phagocytic cup; C:plasma membrane;, F:signaling adaptor activity; F:small GTPase binding;, P:phagocytosis; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:regulation of signal transduction; scaffold25 indexed_genome mRNA 9962334 9987327 . - . ID=transcript_5719;Q5U5X0 A8MPQ9 Q86Y68,Complex III assembly factor LYRM7,LYR motif-containing protein 7;, PF05347;, GO:0005759;GO:0031966;GO:0045333;GO:0034551;, C:mitochondrial matrix; C:mitochondrial membrane;, , P:cellular respiration; P:mitochondrial respiratory chain complex III assembly; scaffold25 indexed_genome mRNA 9992847 10008889 . + . ID=transcript_5720;P49773 Q9H5W8,Histidine triad nucleotide-binding protein 1,Adenosine 5'-monophosphoramidase;Protein kinase C inhibitor 1;Protein kinase C-interacting protein 1;, PF01230;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0000118;GO:0005654;GO:0005634;GO:0005886;GO:0043530;GO:0016787;GO:0000166;GO:0005080;GO:0072332;GO:0009154;GO:0006355;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:adenosine 5'-monophosphoramidase activity; F:hydrolase activity; F:nucleotide binding; F:protein kinase C binding;, P:intrinsic apoptotic signaling pathway by p53 class mediator; P:purine ribonucleotide catabolic process; P:regulation of transcription, DNA-templated; P:signal transduction; scaffold25 indexed_genome mRNA 10654868 10930187 . + . ID=transcript_5721;Q70JA7 B2RP97 Q76L22 Q86Y52,Chondroitin sulfate synthase 3,Carbohydrate synthase 2;Chondroitin glucuronyltransferase 3;Chondroitin synthase 2;Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 3;N-acetylgalactosaminyltransferase 3;, PF05679;, GO:0032580;GO:0000139;GO:0016021;GO:0008376;GO:0047238;GO:0046872;GO:0050510;GO:0030206;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:metal ion binding; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity;, P:chondroitin sulfate biosynthetic process;|Q70JA7 B2RP97 Q76L22 Q86Y52,Chondroitin sulfate synthase 3,Carbohydrate synthase 2;Chondroitin glucuronyltransferase 3;Chondroitin synthase 2;Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 3;N-acetylgalactosaminyltransferase 3;, PF05679;, GO:0032580;GO:0000139;GO:0016021;GO:0008376;GO:0047238;GO:0046872;GO:0050510;GO:0030206;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:metal ion binding; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity;, P:chondroitin sulfate biosynthetic process; scaffold25 indexed_genome mRNA 10932908 10933656 . + . ID=transcript_5722;Q70JA7 B2RP97 Q76L22 Q86Y52,Chondroitin sulfate synthase 3,Carbohydrate synthase 2;Chondroitin glucuronyltransferase 3;Chondroitin synthase 2;Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 3;N-acetylgalactosaminyltransferase 3;, PF05679;, GO:0032580;GO:0000139;GO:0016021;GO:0008376;GO:0047238;GO:0046872;GO:0050510;GO:0030206;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:metal ion binding; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity;, P:chondroitin sulfate biosynthetic process; scaffold25 indexed_genome mRNA 11046602 11060235 . - . ID=transcript_5723;P59773 H3BM78,Major intrinsically disordered NOTCH2-binding receptor 1-like,Membrane integral NOTCH2-associated receptor 2 {ECO:0000312|HGNC:HGNC:33914};, PF06789;, GO:0016021;, C:integral component of membrane; scaffold25 indexed_genome mRNA 11069748 11152137 . - . ID=transcript_5724;Q8TE59,A disintegrin and metalloproteinase with thrombospondin motifs 19,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold25 indexed_genome mRNA 11153057 11153899 . + . ID=transcript_5725;Q8TE59,A disintegrin and metalloproteinase with thrombospondin motifs 19,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold25 indexed_genome mRNA 11158586 11254075 . - . ID=transcript_5726;Q8TE59,A disintegrin and metalloproteinase with thrombospondin motifs 19,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold25 indexed_genome mRNA 11601214 11625027 . - . ID=transcript_5727;Q96CN7 Q7Z770,Isochorismatase domain-containing protein 1,, PF00857;, GO:0005737;GO:0005777;, C:cytoplasm; C:peroxisome; scaffold25 indexed_genome mRNA 11663697 11736424 . - . ID=transcript_5728;Q9Y2P4 Q6IAM5 Q7Z6E6 Q86YF6,Long-chain fatty acid transport protein 6,Arachidonate--CoA ligase {ECO:0000250|UniProtKB:E9Q9W4};Fatty-acid-coenzyme A ligase, very long-chain 2 {ECO:0000250|UniProtKB:E9Q9W4};Solute carrier family 27 member 6;Very long-chain acyl-CoA synthetase homolog 1;, PF00501;PF13193;, GO:0016021;GO:0005886;GO:0042383;GO:0047676;GO:0005324;GO:0004467;GO:0000166;GO:1901480;GO:0031957;GO:0015909;GO:0000038;, C:integral component of membrane; C:plasma membrane; C:sarcolemma;, F:arachidonate-CoA ligase activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:nucleotide binding; F:oleate transmembrane transporter activity; F:very long-chain fatty acid-CoA ligase activity;, P:long-chain fatty acid transport; P:very long-chain fatty acid metabolic process; scaffold25 indexed_genome mRNA 12351423 12449608 . - . ID=transcript_5729;P55011 Q8N713 Q8WWH7,Solute carrier family 12 member 2,Basolateral Na-K-Cl symporter;Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2;, PF00324;PF08403;PF03522;, GO:0016324;GO:0009925;GO:0044297;GO:0044298;GO:0071944;GO:0042995;GO:0031253;GO:0030659;GO:0005829;GO:0070062;GO:1903561;GO:0005887;GO:0016328;GO:0016020;GO:0043005;GO:0043025;GO:0005886;GO:0008519;GO:0015377;GO:0051087;GO:0051879;GO:0046873;GO:0015079;GO:0015379;GO:0019901;GO:0008511;GO:0007568;GO:0015696;GO:0006884;GO:0030644;GO:0030007;GO:1990869;GO:0035865;GO:0006883;GO:0055064;GO:1902476;GO:0007214;GO:0006972;GO:0098658;GO:0098659;GO:0006811;GO:0035633;GO:0061044;GO:1904450;GO:0045795;GO:0055075;GO:1990573;GO:1904464;GO:0150003;GO:0055078;GO:0098719;GO:0035725;GO:0010818;GO:0070634;GO:0030321;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:cell body; C:cell body membrane; C:cell periphery; C:cell projection; C:cell projection membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extracellular vesicle; C:integral component of plasma membrane; C:lateral plasma membrane; C:membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:ammonium transmembrane transporter activity; F:cation:chloride symporter activity; F:chaperone binding; F:Hsp90 protein binding; F:metal ion transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding; F:sodium:potassium:chloride symporter activity;, P:aging; P:ammonium transport; P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular potassium ion homeostasis; P:cellular response to chemokine; P:cellular response to potassium ion; P:cellular sodium ion homeostasis; P:chloride ion homeostasis; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:hyperosmotic response; P:inorganic anion import across plasma membrane; P:inorganic cation import across plasma membrane; P:ion transport; P:maintenance of blood-brain barrier; P:negative regulation of vascular wound healing; P:positive regulation of aspartate secretion; P:positive regulation of cell volume; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:regulation of matrix metallopeptidase secretion; P:regulation of spontaneous synaptic transmission; P:sodium ion homeostasis; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport; P:T cell chemotaxis; P:transepithelial ammonium transport; P:transepithelial chloride transport; P:transport across blood-brain barrier;|P55011 Q8N713 Q8WWH7,Solute carrier family 12 member 2,Basolateral Na-K-Cl symporter;Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2;, PF00324;PF08403;PF03522;, GO:0016324;GO:0009925;GO:0044297;GO:0044298;GO:0071944;GO:0042995;GO:0031253;GO:0030659;GO:0005829;GO:0070062;GO:1903561;GO:0005887;GO:0016328;GO:0016020;GO:0043005;GO:0043025;GO:0005886;GO:0008519;GO:0015377;GO:0051087;GO:0051879;GO:0046873;GO:0015079;GO:0015379;GO:0019901;GO:0008511;GO:0007568;GO:0015696;GO:0006884;GO:0030644;GO:0030007;GO:1990869;GO:0035865;GO:0006883;GO:0055064;GO:1902476;GO:0007214;GO:0006972;GO:0098658;GO:0098659;GO:0006811;GO:0035633;GO:0061044;GO:1904450;GO:0045795;GO:0055075;GO:1990573;GO:1904464;GO:0150003;GO:0055078;GO:0098719;GO:0035725;GO:0010818;GO:0070634;GO:0030321;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:cell body; C:cell body membrane; C:cell periphery; C:cell projection; C:cell projection membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extracellular vesicle; C:integral component of plasma membrane; C:lateral plasma membrane; C:membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:ammonium transmembrane transporter activity; F:cation:chloride symporter activity; F:chaperone binding; F:Hsp90 protein binding; F:metal ion transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding; F:sodium:potassium:chloride symporter activity;, P:aging; P:ammonium transport; P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular potassium ion homeostasis; P:cellular response to chemokine; P:cellular response to potassium ion; P:cellular sodium ion homeostasis; P:chloride ion homeostasis; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:hyperosmotic response; P:inorganic anion import across plasma membrane; P:inorganic cation import across plasma membrane; P:ion transport; P:maintenance of blood-brain barrier; P:negative regulation of vascular wound healing; P:positive regulation of aspartate secretion; P:positive regulation of cell volume; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:regulation of matrix metallopeptidase secretion; P:regulation of spontaneous synaptic transmission; P:sodium ion homeostasis; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport; P:T cell chemotaxis; P:transepithelial ammonium transport; P:transepithelial chloride transport; P:transport across blood-brain barrier;|P55011 Q8N713 Q8WWH7,Solute carrier family 12 member 2,Basolateral Na-K-Cl symporter;Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2;, PF00324;PF08403;PF03522;, GO:0016324;GO:0009925;GO:0044297;GO:0044298;GO:0071944;GO:0042995;GO:0031253;GO:0030659;GO:0005829;GO:0070062;GO:1903561;GO:0005887;GO:0016328;GO:0016020;GO:0043005;GO:0043025;GO:0005886;GO:0008519;GO:0015377;GO:0051087;GO:0051879;GO:0046873;GO:0015079;GO:0015379;GO:0019901;GO:0008511;GO:0007568;GO:0015696;GO:0006884;GO:0030644;GO:0030007;GO:1990869;GO:0035865;GO:0006883;GO:0055064;GO:1902476;GO:0007214;GO:0006972;GO:0098658;GO:0098659;GO:0006811;GO:0035633;GO:0061044;GO:1904450;GO:0045795;GO:0055075;GO:1990573;GO:1904464;GO:0150003;GO:0055078;GO:0098719;GO:0035725;GO:0010818;GO:0070634;GO:0030321;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:cell body; C:cell body membrane; C:cell periphery; C:cell projection; C:cell projection membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extracellular vesicle; C:integral component of plasma membrane; C:lateral plasma membrane; C:membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:ammonium transmembrane transporter activity; F:cation:chloride symporter activity; F:chaperone binding; F:Hsp90 protein binding; F:metal ion transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding; F:sodium:potassium:chloride symporter activity;, P:aging; P:ammonium transport; P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular potassium ion homeostasis; P:cellular response to chemokine; P:cellular response to potassium ion; P:cellular sodium ion homeostasis; P:chloride ion homeostasis; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:hyperosmotic response; P:inorganic anion import across plasma membrane; P:inorganic cation import across plasma membrane; P:ion transport; P:maintenance of blood-brain barrier; P:negative regulation of vascular wound healing; P:positive regulation of aspartate secretion; P:positive regulation of cell volume; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:regulation of matrix metallopeptidase secretion; P:regulation of spontaneous synaptic transmission; P:sodium ion homeostasis; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport; P:T cell chemotaxis; P:transepithelial ammonium transport; P:transepithelial chloride transport; P:transport across blood-brain barrier;|Q13427 D3DPC5 D3DPC6 O00706 Q53R40 Q53SN4 Q96DG9,Peptidyl-prolyl cis-trans isomerase G,CASP10;Clk-associating RS-cyclophilin;Cyclophilin G;Rotamase G;, PF00160;, GO:0005737;GO:0005829;GO:0043231;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0016018;GO:0003755;GO:0003723;GO:0006457;GO:0000413;GO:0008380;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:protein folding; P:protein peptidyl-prolyl isomerization; P:RNA splicing;|P55011 Q8N713 Q8WWH7,Solute carrier family 12 member 2,Basolateral Na-K-Cl symporter;Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2;, PF00324;PF08403;PF03522;, GO:0016324;GO:0009925;GO:0044297;GO:0044298;GO:0071944;GO:0042995;GO:0031253;GO:0030659;GO:0005829;GO:0070062;GO:1903561;GO:0005887;GO:0016328;GO:0016020;GO:0043005;GO:0043025;GO:0005886;GO:0008519;GO:0015377;GO:0051087;GO:0051879;GO:0046873;GO:0015079;GO:0015379;GO:0019901;GO:0008511;GO:0007568;GO:0015696;GO:0006884;GO:0030644;GO:0030007;GO:1990869;GO:0035865;GO:0006883;GO:0055064;GO:1902476;GO:0007214;GO:0006972;GO:0098658;GO:0098659;GO:0006811;GO:0035633;GO:0061044;GO:1904450;GO:0045795;GO:0055075;GO:1990573;GO:1904464;GO:0150003;GO:0055078;GO:0098719;GO:0035725;GO:0010818;GO:0070634;GO:0030321;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:cell body; C:cell body membrane; C:cell periphery; C:cell projection; C:cell projection membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extracellular vesicle; C:integral component of plasma membrane; C:lateral plasma membrane; C:membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:ammonium transmembrane transporter activity; F:cation:chloride symporter activity; F:chaperone binding; F:Hsp90 protein binding; F:metal ion transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding; F:sodium:potassium:chloride symporter activity;, P:aging; P:ammonium transport; P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular potassium ion homeostasis; P:cellular response to chemokine; P:cellular response to potassium ion; P:cellular sodium ion homeostasis; P:chloride ion homeostasis; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:hyperosmotic response; P:inorganic anion import across plasma membrane; P:inorganic cation import across plasma membrane; P:ion transport; P:maintenance of blood-brain barrier; P:negative regulation of vascular wound healing; P:positive regulation of aspartate secretion; P:positive regulation of cell volume; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:regulation of matrix metallopeptidase secretion; P:regulation of spontaneous synaptic transmission; P:sodium ion homeostasis; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport; P:T cell chemotaxis; P:transepithelial ammonium transport; P:transepithelial chloride transport; P:transport across blood-brain barrier; scaffold25 indexed_genome mRNA 12609587 12755121 . - . ID=transcript_5730;P0DO97,Coiled-coil domain-containing protein 192 {ECO:0000305} scaffold25 indexed_genome mRNA 12978221 13017758 . - . ID=transcript_5731;Q96M27 Q69YM8 Q7L2U7 Q86Y42 Q8IVJ4 Q8IVL4 Q8NEZ7 Q96AJ3,Protein PRRC1,Proline-rich and coiled-coil-containing protein 1;, PF01931;, GO:0005737;GO:0005794;GO:0042802;GO:0034237;GO:0034199;, C:cytoplasm; C:Golgi apparatus;, F:identical protein binding; F:protein kinase A regulatory subunit binding;, P:activation of protein kinase A activity;|Q96M27 Q69YM8 Q7L2U7 Q86Y42 Q8IVJ4 Q8IVL4 Q8NEZ7 Q96AJ3,Protein PRRC1,Proline-rich and coiled-coil-containing protein 1;, PF01931;, GO:0005737;GO:0005794;GO:0042802;GO:0034237;GO:0034199;, C:cytoplasm; C:Golgi apparatus;, F:identical protein binding; F:protein kinase A regulatory subunit binding;, P:activation of protein kinase A activity;|Q96M27 Q69YM8 Q7L2U7 Q86Y42 Q8IVJ4 Q8IVL4 Q8NEZ7 Q96AJ3,Protein PRRC1,Proline-rich and coiled-coil-containing protein 1;, PF01931;, GO:0005737;GO:0005794;GO:0042802;GO:0034237;GO:0034199;, C:cytoplasm; C:Golgi apparatus;, F:identical protein binding; F:protein kinase A regulatory subunit binding;, P:activation of protein kinase A activity; scaffold25 indexed_genome mRNA 13086048 13260345 . - . ID=transcript_5732;Q96KG7 Q68DE5 Q8WUL3,Multiple epidermal growth factor-like domains protein 10 {ECO:0000312|HGNC:HGNC:29634},, PF12661;PF00053;, GO:0042995;GO:0016021;GO:0001891;GO:0005886;GO:0001849;GO:0005112;GO:0005044;GO:0043277;GO:1902742;GO:0043652;GO:0034109;GO:0055001;GO:0033002;GO:0048627;GO:0051451;GO:0022409;GO:2000288;GO:0043654;GO:0051147;GO:0048641;GO:0014719;GO:0014816;GO:0014841;, C:cell projection; C:integral component of membrane; C:phagocytic cup; C:plasma membrane;, F:complement component C1q complex binding; F:Notch binding; F:scavenger receptor activity;, P:apoptotic cell clearance; P:apoptotic process involved in development; P:engulfment of apoptotic cell; P:homotypic cell-cell adhesion; P:muscle cell development; P:muscle cell proliferation; P:myoblast development; P:myoblast migration; P:positive regulation of cell-cell adhesion; P:positive regulation of myoblast proliferation; P:recognition of apoptotic cell; P:regulation of muscle cell differentiation; P:regulation of skeletal muscle tissue development; P:skeletal muscle satellite cell activation; P:skeletal muscle satellite cell differentiation; P:skeletal muscle satellite cell proliferation;|Q96KG7 Q68DE5 Q8WUL3,Multiple epidermal growth factor-like domains protein 10 {ECO:0000312|HGNC:HGNC:29634},, PF12661;PF00053;, GO:0042995;GO:0016021;GO:0001891;GO:0005886;GO:0001849;GO:0005112;GO:0005044;GO:0043277;GO:1902742;GO:0043652;GO:0034109;GO:0055001;GO:0033002;GO:0048627;GO:0051451;GO:0022409;GO:2000288;GO:0043654;GO:0051147;GO:0048641;GO:0014719;GO:0014816;GO:0014841;, C:cell projection; C:integral component of membrane; C:phagocytic cup; C:plasma membrane;, F:complement component C1q complex binding; F:Notch binding; F:scavenger receptor activity;, P:apoptotic cell clearance; P:apoptotic process involved in development; P:engulfment of apoptotic cell; P:homotypic cell-cell adhesion; P:muscle cell development; P:muscle cell proliferation; P:myoblast development; P:myoblast migration; P:positive regulation of cell-cell adhesion; P:positive regulation of myoblast proliferation; P:recognition of apoptotic cell; P:regulation of muscle cell differentiation; P:regulation of skeletal muscle tissue development; P:skeletal muscle satellite cell activation; P:skeletal muscle satellite cell differentiation; P:skeletal muscle satellite cell proliferation; scaffold25 indexed_genome mRNA 13429243 13454859 . + . ID=transcript_5733;A6NC05 G3V557,Glutaredoxin-like protein C5orf63,, PF05768; scaffold25 indexed_genome mRNA 13479322 13625054 . + . ID=transcript_5734;Q86UD3 A8K264 B9EJE7,E3 ubiquitin-protein ligase MARCHF3,Membrane-associated RING finger protein 3;Membrane-associated RING-CH protein III;RING finger protein 173;RING-type E3 ubiquitin transferase MARCHF3 {ECO:0000305};, PF12906;, GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0043231;GO:0005764;GO:0004842;GO:0008270;GO:0006897;GO:0016567;, C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosome;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:endocytosis; P:protein ubiquitination;|Q86UD3 A8K264 B9EJE7,E3 ubiquitin-protein ligase MARCHF3,Membrane-associated RING finger protein 3;Membrane-associated RING-CH protein III;RING finger protein 173;RING-type E3 ubiquitin transferase MARCHF3 {ECO:0000305};, PF12906;, GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0043231;GO:0005764;GO:0004842;GO:0008270;GO:0006897;GO:0016567;, C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosome;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:endocytosis; P:protein ubiquitination;|Q86UD3 A8K264 B9EJE7,E3 ubiquitin-protein ligase MARCHF3,Membrane-associated RING finger protein 3;Membrane-associated RING-CH protein III;RING finger protein 173;RING-type E3 ubiquitin transferase MARCHF3 {ECO:0000305};, PF12906;, GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0043231;GO:0005764;GO:0004842;GO:0008270;GO:0006897;GO:0016567;, C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosome;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:endocytosis; P:protein ubiquitination; scaffold25 indexed_genome mRNA 13653021 13698449 . - . ID=transcript_5735;P20700 B2R6J6 Q3SYN7 Q96EI6,Lamin-B1,, PF00038;PF00932;, GO:0005638;GO:0016020;GO:0005635;GO:0005637;GO:0016363;GO:0031965;GO:0005654;GO:0005634;GO:0043274;GO:1990837;GO:0005198;GO:0035722;, C:lamin filament; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear matrix; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:phospholipase binding; F:sequence-specific double-stranded DNA binding; F:structural molecule activity;, P:interleukin-12-mediated signaling pathway; scaffold25 indexed_genome mRNA 13781239 13795379 . - . ID=transcript_5736;Q9H814 Q9H8W1,Phosphorylated adapter RNA export protein,RNA U small nuclear RNA export adapter protein;, PF10258;, GO:0015030;GO:0005813;GO:0005829;GO:0043025;GO:0005654;GO:0005634;GO:0003723;GO:0015643;GO:0051168;GO:0015031;GO:0006408;GO:0042795;, C:Cajal body; C:centrosome; C:cytosol; C:neuronal cell body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:toxic substance binding;, P:nuclear export; P:protein transport; P:snRNA export from nucleus; P:snRNA transcription by RNA polymerase II;|Q9H814 Q9H8W1,Phosphorylated adapter RNA export protein,RNA U small nuclear RNA export adapter protein;, PF10258;, GO:0015030;GO:0005813;GO:0005829;GO:0043025;GO:0005654;GO:0005634;GO:0003723;GO:0015643;GO:0051168;GO:0015031;GO:0006408;GO:0042795;, C:Cajal body; C:centrosome; C:cytosol; C:neuronal cell body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:toxic substance binding;, P:nuclear export; P:protein transport; P:snRNA export from nucleus; P:snRNA transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 13799218 13838415 . + . ID=transcript_5737;P49419 B2R669 B4DIC7 B4DMA0 E7EPT3 O14619 Q6IPU8 Q9BUL4,Alpha-aminoadipic semialdehyde dehydrogenase,Aldehyde dehydrogenase family 7 member A1;Antiquitin-1;Betaine aldehyde dehydrogenase;Delta1-piperideine-6-carboxylate dehydrogenase;, PF00171;, GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0004029;GO:0008802;GO:0043878;GO:0042802;GO:0004043;GO:0006081;GO:0042426;GO:0019285;GO:0006554;GO:0007605;, C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:aldehyde dehydrogenase (NAD+) activity; F:betaine-aldehyde dehydrogenase activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:identical protein binding; F:L-aminoadipate-semialdehyde dehydrogenase activity;, P:cellular aldehyde metabolic process; P:choline catabolic process; P:glycine betaine biosynthetic process from choline; P:lysine catabolic process; P:sensory perception of sound;|P49419 B2R669 B4DIC7 B4DMA0 E7EPT3 O14619 Q6IPU8 Q9BUL4,Alpha-aminoadipic semialdehyde dehydrogenase,Aldehyde dehydrogenase family 7 member A1;Antiquitin-1;Betaine aldehyde dehydrogenase;Delta1-piperideine-6-carboxylate dehydrogenase;, PF00171;, GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0004029;GO:0008802;GO:0043878;GO:0042802;GO:0004043;GO:0006081;GO:0042426;GO:0019285;GO:0006554;GO:0007605;, C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:aldehyde dehydrogenase (NAD+) activity; F:betaine-aldehyde dehydrogenase activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:identical protein binding; F:L-aminoadipate-semialdehyde dehydrogenase activity;, P:cellular aldehyde metabolic process; P:choline catabolic process; P:glycine betaine biosynthetic process from choline; P:lysine catabolic process; P:sensory perception of sound;|P49419 B2R669 B4DIC7 B4DMA0 E7EPT3 O14619 Q6IPU8 Q9BUL4,Alpha-aminoadipic semialdehyde dehydrogenase,Aldehyde dehydrogenase family 7 member A1;Antiquitin-1;Betaine aldehyde dehydrogenase;Delta1-piperideine-6-carboxylate dehydrogenase;, PF00171;, GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0004029;GO:0008802;GO:0043878;GO:0042802;GO:0004043;GO:0006081;GO:0042426;GO:0019285;GO:0006554;GO:0007605;, C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:aldehyde dehydrogenase (NAD+) activity; F:betaine-aldehyde dehydrogenase activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:identical protein binding; F:L-aminoadipate-semialdehyde dehydrogenase activity;, P:cellular aldehyde metabolic process; P:choline catabolic process; P:glycine betaine biosynthetic process from choline; P:lysine catabolic process; P:sensory perception of sound;|P49419 B2R669 B4DIC7 B4DMA0 E7EPT3 O14619 Q6IPU8 Q9BUL4,Alpha-aminoadipic semialdehyde dehydrogenase,Aldehyde dehydrogenase family 7 member A1;Antiquitin-1;Betaine aldehyde dehydrogenase;Delta1-piperideine-6-carboxylate dehydrogenase;, PF00171;, GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0004029;GO:0008802;GO:0043878;GO:0042802;GO:0004043;GO:0006081;GO:0042426;GO:0019285;GO:0006554;GO:0007605;, C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:aldehyde dehydrogenase (NAD+) activity; F:betaine-aldehyde dehydrogenase activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:identical protein binding; F:L-aminoadipate-semialdehyde dehydrogenase activity;, P:cellular aldehyde metabolic process; P:choline catabolic process; P:glycine betaine biosynthetic process from choline; P:lysine catabolic process; P:sensory perception of sound; scaffold25 indexed_genome mRNA 13876587 13953567 . - . ID=transcript_5738;Q96HH9 B7Z1F2 B7Z3R1 B7Z6D8 B7Z8T2 D3DSZ3 Q9H753,GRAM domain-containing protein 2B,HCV NS3-transactivated protein 2;, PF02893;, GO:0005881;GO:0042802;, C:cytoplasmic microtubule;, F:identical protein binding;|Q96HH9 B7Z1F2 B7Z3R1 B7Z6D8 B7Z8T2 D3DSZ3 Q9H753,GRAM domain-containing protein 2B,HCV NS3-transactivated protein 2;, PF02893;, GO:0005881;GO:0042802;, C:cytoplasmic microtubule;, F:identical protein binding;|Q96HH9 B7Z1F2 B7Z3R1 B7Z6D8 B7Z8T2 D3DSZ3 Q9H753,GRAM domain-containing protein 2B,HCV NS3-transactivated protein 2;, PF02893;, GO:0005881;GO:0042802;, C:cytoplasmic microtubule;, F:identical protein binding;|P61254 B2R4F0 D3DTR8 Q02877 Q6IPY2,60S ribosomal protein L26,Large ribosomal subunit protein uL24 {ECO:0000303|PubMed:24524803};, PF00467;PF16906;, GO:0005737;GO:0005829;GO:0022625;GO:0022626;GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:1990904;GO:0048027;GO:0003723;GO:0003735;GO:0071480;GO:0034644;GO:0002181;GO:0006977;GO:0000184;GO:1902164;GO:1902167;GO:0045727;GO:1904803;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:cytosolic ribosome; C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 5'-UTR binding; F:RNA binding; F:structural constituent of ribosome;, P:cellular response to gamma radiation; P:cellular response to UV; P:cytoplasmic translation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:positive regulation of translation; P:regulation of translation involved in cellular response to UV; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q96HH9 B7Z1F2 B7Z3R1 B7Z6D8 B7Z8T2 D3DSZ3 Q9H753,GRAM domain-containing protein 2B,HCV NS3-transactivated protein 2;, PF02893;, GO:0005881;GO:0042802;, C:cytoplasmic microtubule;, F:identical protein binding; scaffold25 indexed_genome mRNA 15438491 15538939 . + . ID=transcript_5739;Q9ULD9 A7E2W9 Q3SYM6 Q68D12 Q8IY05 Q9Y5A1,Zinc finger protein 608,Renal carcinoma antigen NY-REN-36;, , GO:0005634;GO:0046872;GO:0000122;GO:0006357;, C:nucleus;, F:metal ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9ULD9 A7E2W9 Q3SYM6 Q68D12 Q8IY05 Q9Y5A1,Zinc finger protein 608,Renal carcinoma antigen NY-REN-36;, , GO:0005634;GO:0046872;GO:0000122;GO:0006357;, C:nucleus;, F:metal ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 16496086 16619476 . - . ID=transcript_5740;Q9Y6M4 A8K040 B4DSH2 B7Z9Q4 E7EVD0 Q86WZ7 Q9Y6M3,Casein kinase I isoform gamma-3,, PF12605;PF00069;, GO:0005737;GO:0005634;GO:0005886;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006464;GO:0006897;GO:0018105;GO:0090263;GO:0007165;GO:0016055;, C:cytoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular protein modification process; P:endocytosis; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:signal transduction; P:Wnt signaling pathway; scaffold25 indexed_genome mRNA 16720970 16754699 . + . ID=transcript_5741;Q8N960 Q6AI52 Q6AW89 Q8IWB5 Q8N9Y0 Q8NDE8,Centrosomal protein of 120 kDa,Coiled-coil domain-containing protein 100;, PF00168;PF12416;, GO:0005814;GO:0005813;GO:0005737;GO:0008022;GO:0030953;GO:0007098;GO:0021987;GO:0022027;GO:0022008;GO:1903724;GO:0010825;GO:0045724;GO:1904951;, C:centriole; C:centrosome; C:cytoplasm;, F:protein C-terminus binding;, P:astral microtubule organization; P:centrosome cycle; P:cerebral cortex development; P:interkinetic nuclear migration; P:neurogenesis; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of cilium assembly; P:positive regulation of establishment of protein localization; scaffold25 indexed_genome mRNA 16755333 16802099 . + . ID=transcript_5742;Q8N960 Q6AI52 Q6AW89 Q8IWB5 Q8N9Y0 Q8NDE8,Centrosomal protein of 120 kDa,Coiled-coil domain-containing protein 100;, PF00168;PF12416;, GO:0005814;GO:0005813;GO:0005737;GO:0008022;GO:0030953;GO:0007098;GO:0021987;GO:0022027;GO:0022008;GO:1903724;GO:0010825;GO:0045724;GO:1904951;, C:centriole; C:centrosome; C:cytoplasm;, F:protein C-terminus binding;, P:astral microtubule organization; P:centrosome cycle; P:cerebral cortex development; P:interkinetic nuclear migration; P:neurogenesis; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of cilium assembly; P:positive regulation of establishment of protein localization;|Q8N960 Q6AI52 Q6AW89 Q8IWB5 Q8N9Y0 Q8NDE8,Centrosomal protein of 120 kDa,Coiled-coil domain-containing protein 100;, PF00168;PF12416;, GO:0005814;GO:0005813;GO:0005737;GO:0008022;GO:0030953;GO:0007098;GO:0021987;GO:0022027;GO:0022008;GO:1903724;GO:0010825;GO:0045724;GO:1904951;, C:centriole; C:centrosome; C:cytoplasm;, F:protein C-terminus binding;, P:astral microtubule organization; P:centrosome cycle; P:cerebral cortex development; P:interkinetic nuclear migration; P:neurogenesis; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of cilium assembly; P:positive regulation of establishment of protein localization;|Q8N960 Q6AI52 Q6AW89 Q8IWB5 Q8N9Y0 Q8NDE8,Centrosomal protein of 120 kDa,Coiled-coil domain-containing protein 100;, PF00168;PF12416;, GO:0005814;GO:0005813;GO:0005737;GO:0008022;GO:0030953;GO:0007098;GO:0021987;GO:0022027;GO:0022008;GO:1903724;GO:0010825;GO:0045724;GO:1904951;, C:centriole; C:centrosome; C:cytoplasm;, F:protein C-terminus binding;, P:astral microtubule organization; P:centrosome cycle; P:cerebral cortex development; P:interkinetic nuclear migration; P:neurogenesis; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of cilium assembly; P:positive regulation of establishment of protein localization; scaffold25 indexed_genome mRNA 17129380 17143424 . - . ID=transcript_5743;P45877 A4LBB5,Peptidyl-prolyl cis-trans isomerase C {ECO:0000305},Cyclophilin C {ECO:0000303|PubMed:8031755};Rotamase C;, PF00160;, GO:0005737;GO:0070062;GO:0043231;GO:0016018;GO:0003755;GO:0006457;GO:0000413;, C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding; P:protein peptidyl-prolyl isomerization; scaffold25 indexed_genome mRNA 17155819 17329551 . - . ID=transcript_5744;Q9Y343 Q6UY33,Sorting nexin-24,, PF00787;, GO:0030659;GO:1901981;GO:0015031;, C:cytoplasmic vesicle membrane;, F:phosphatidylinositol phosphate binding;, P:protein transport; scaffold25 indexed_genome mRNA 17346498 17409213 . - . ID=transcript_5745;O60749 B3KN44 B4DEK4 B7Z408 O43650 P82862 Q53XK8 Q597H6 Q9BTS8,Sorting nexin-2,Transformation-related gene 9 protein;, PF00787;PF03700;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0030027;GO:0005764;GO:0016020;GO:0032991;GO:0030904;GO:0030905;GO:0045296;GO:0005154;GO:0042802;GO:0005158;GO:1990460;GO:0035091;GO:0046982;GO:0042803;GO:1990459;GO:0034498;GO:0006897;GO:0006886;GO:0072673;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:lamellipodium; C:lysosome; C:membrane; C:protein-containing complex; C:retromer complex; C:retromer, tubulation complex;, F:cadherin binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferrin receptor binding;, P:early endosome to Golgi transport; P:endocytosis; P:intracellular protein transport; P:lamellipodium morphogenesis; P:retrograde transport, endosome to Golgi;|O60749 B3KN44 B4DEK4 B7Z408 O43650 P82862 Q53XK8 Q597H6 Q9BTS8,Sorting nexin-2,Transformation-related gene 9 protein;, PF00787;PF03700;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0030027;GO:0005764;GO:0016020;GO:0032991;GO:0030904;GO:0030905;GO:0045296;GO:0005154;GO:0042802;GO:0005158;GO:1990460;GO:0035091;GO:0046982;GO:0042803;GO:1990459;GO:0034498;GO:0006897;GO:0006886;GO:0072673;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:lamellipodium; C:lysosome; C:membrane; C:protein-containing complex; C:retromer complex; C:retromer, tubulation complex;, F:cadherin binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferrin receptor binding;, P:early endosome to Golgi transport; P:endocytosis; P:intracellular protein transport; P:lamellipodium morphogenesis; P:retrograde transport, endosome to Golgi;|O60749 B3KN44 B4DEK4 B7Z408 O43650 P82862 Q53XK8 Q597H6 Q9BTS8,Sorting nexin-2,Transformation-related gene 9 protein;, PF00787;PF03700;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0030027;GO:0005764;GO:0016020;GO:0032991;GO:0030904;GO:0030905;GO:0045296;GO:0005154;GO:0042802;GO:0005158;GO:1990460;GO:0035091;GO:0046982;GO:0042803;GO:1990459;GO:0034498;GO:0006897;GO:0006886;GO:0072673;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:lamellipodium; C:lysosome; C:membrane; C:protein-containing complex; C:retromer complex; C:retromer, tubulation complex;, F:cadherin binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferrin receptor binding;, P:early endosome to Golgi transport; P:endocytosis; P:intracellular protein transport; P:lamellipodium morphogenesis; P:retrograde transport, endosome to Golgi;|O60749 B3KN44 B4DEK4 B7Z408 O43650 P82862 Q53XK8 Q597H6 Q9BTS8,Sorting nexin-2,Transformation-related gene 9 protein;, PF00787;PF03700;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0030027;GO:0005764;GO:0016020;GO:0032991;GO:0030904;GO:0030905;GO:0045296;GO:0005154;GO:0042802;GO:0005158;GO:1990460;GO:0035091;GO:0046982;GO:0042803;GO:1990459;GO:0034498;GO:0006897;GO:0006886;GO:0072673;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:lamellipodium; C:lysosome; C:membrane; C:protein-containing complex; C:retromer complex; C:retromer, tubulation complex;, F:cadherin binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferrin receptor binding;, P:early endosome to Golgi transport; P:endocytosis; P:intracellular protein transport; P:lamellipodium morphogenesis; P:retrograde transport, endosome to Golgi; scaffold25 indexed_genome mRNA 17703465 17715800 . - . ID=transcript_5746;Q9HC59,Synphilin-1,Alpha-synuclein-interacting protein;, PF12796;PF16700;, GO:0005737;GO:0036464;GO:0005829;GO:0043025;GO:0005654;GO:0042734;GO:0008021;GO:0042802;GO:0031625;GO:1990000;GO:0008219;GO:0042417;GO:0090083;GO:0046928;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:neuronal cell body; C:nucleoplasm; C:presynaptic membrane; C:synaptic vesicle;, F:identical protein binding; F:ubiquitin protein ligase binding;, P:amyloid fibril formation; P:cell death; P:dopamine metabolic process; P:regulation of inclusion body assembly; P:regulation of neurotransmitter secretion; scaffold25 indexed_genome mRNA 17715865 18144041 . - . ID=transcript_5747;Q9HC59,Synphilin-1,Alpha-synuclein-interacting protein;, PF12796;PF16700;, GO:0005737;GO:0036464;GO:0005829;GO:0043025;GO:0005654;GO:0042734;GO:0008021;GO:0042802;GO:0031625;GO:1990000;GO:0008219;GO:0042417;GO:0090083;GO:0046928;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:neuronal cell body; C:nucleoplasm; C:presynaptic membrane; C:synaptic vesicle;, F:identical protein binding; F:ubiquitin protein ligase binding;, P:amyloid fibril formation; P:cell death; P:dopamine metabolic process; P:regulation of inclusion body assembly; P:regulation of neurotransmitter secretion;|Q8NEF9 Q5QFI2 Q96AH4 Q96DK2,Serum response factor-binding protein 1,SRF-dependent transcription regulation-associated protein;p49/STRAP;, PF09073;, GO:0030686;GO:0005634;GO:0048471;GO:0003723;GO:0030490;, C:90S preribosome; C:nucleus; C:perinuclear region of cytoplasm;, F:RNA binding;, P:maturation of SSU-rRNA;|Q6S9Z5 A8K4M0 Q96M07,Zinc finger protein 474,Testis-specific zinc finger protein;, , GO:0046872;, , F:metal ion binding;|P28300 B2R5Q3 Q5FWF0,Protein-lysine 6-oxidase,Lysyl oxidase;, PF01186;, GO:0005581;GO:0031012;GO:0005576;GO:0005615;GO:0005634;GO:0005518;GO:0005507;GO:0004720;GO:0035905;GO:0048514;GO:0030282;GO:0060326;GO:0006464;GO:1990869;GO:0030199;GO:0061448;GO:0035906;GO:0071897;GO:0048251;GO:0030198;GO:0007507;GO:0030324;GO:0046716;GO:0048747;GO:0001649;GO:0018057;GO:0035791;GO:0043491;GO:0042981;GO:1903010;GO:0010468;GO:0045652;GO:2000586;GO:0001932;GO:1900120;GO:0016202;GO:0017015;GO:0042493;GO:0048545;GO:0042060;, C:collagen trimer; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nucleus;, F:collagen binding; F:copper ion binding; F:protein-lysine 6-oxidase activity;, P:ascending aorta development; P:blood vessel morphogenesis; P:bone mineralization; P:cell chemotaxis; P:cellular protein modification process; P:cellular response to chemokine; P:collagen fibril organization; P:connective tissue development; P:descending aorta development; P:DNA biosynthetic process; P:elastic fiber assembly; P:extracellular matrix organization; P:heart development; P:lung development; P:muscle cell cellular homeostasis; P:muscle fiber development; P:osteoblast differentiation; P:peptidyl-lysine oxidation; P:platelet-derived growth factor receptor-beta signaling pathway; P:protein kinase B signaling; P:regulation of apoptotic process; P:regulation of bone development; P:regulation of gene expression; P:regulation of megakaryocyte differentiation; P:regulation of platelet-derived growth factor receptor-beta signaling pathway; P:regulation of protein phosphorylation; P:regulation of receptor binding; P:regulation of striated muscle tissue development; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to drug; P:response to steroid hormone; P:wound healing;|P28300 B2R5Q3 Q5FWF0,Protein-lysine 6-oxidase,Lysyl oxidase;, PF01186;, GO:0005581;GO:0031012;GO:0005576;GO:0005615;GO:0005634;GO:0005518;GO:0005507;GO:0004720;GO:0035905;GO:0048514;GO:0030282;GO:0060326;GO:0006464;GO:1990869;GO:0030199;GO:0061448;GO:0035906;GO:0071897;GO:0048251;GO:0030198;GO:0007507;GO:0030324;GO:0046716;GO:0048747;GO:0001649;GO:0018057;GO:0035791;GO:0043491;GO:0042981;GO:1903010;GO:0010468;GO:0045652;GO:2000586;GO:0001932;GO:1900120;GO:0016202;GO:0017015;GO:0042493;GO:0048545;GO:0042060;, C:collagen trimer; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nucleus;, F:collagen binding; F:copper ion binding; F:protein-lysine 6-oxidase activity;, P:ascending aorta development; P:blood vessel morphogenesis; P:bone mineralization; P:cell chemotaxis; P:cellular protein modification process; P:cellular response to chemokine; P:collagen fibril organization; P:connective tissue development; P:descending aorta development; P:DNA biosynthetic process; P:elastic fiber assembly; P:extracellular matrix organization; P:heart development; P:lung development; P:muscle cell cellular homeostasis; P:muscle fiber development; P:osteoblast differentiation; P:peptidyl-lysine oxidation; P:platelet-derived growth factor receptor-beta signaling pathway; P:protein kinase B signaling; P:regulation of apoptotic process; P:regulation of bone development; P:regulation of gene expression; P:regulation of megakaryocyte differentiation; P:regulation of platelet-derived growth factor receptor-beta signaling pathway; P:regulation of protein phosphorylation; P:regulation of receptor binding; P:regulation of striated muscle tissue development; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to drug; P:response to steroid hormone; P:wound healing; scaffold25 indexed_genome mRNA 20451178 20560881 . - . ID=transcript_5748;P51659 B4DNV1 B4DVS5 E9PB82 F5HE57,Peroxisomal multifunctional enzyme type 2 {ECO:0000305},17-beta-hydroxysteroid dehydrogenase 4;D-bifunctional protein {ECO:0000303|PubMed:15060085};Multifunctional protein 2;Short chain dehydrogenase/reductase family 8C member 1;, PF00106;PF01575;PF02036;, GO:0005829;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0044594;GO:0003857;GO:0033989;GO:0004300;GO:0016853;GO:0016508;GO:0042803;GO:0036109;GO:0008209;GO:0006699;GO:0008210;GO:0006635;GO:0033540;GO:0036112;GO:0001649;GO:0008104;GO:0060009;GO:0000038;GO:0036111;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:3-hydroxyacyl-CoA dehydrogenase activity; F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; F:enoyl-CoA hydratase activity; F:isomerase activity; F:long-chain-enoyl-CoA hydratase activity; F:protein homodimerization activity;, P:alpha-linolenic acid metabolic process; P:androgen metabolic process; P:bile acid biosynthetic process; P:estrogen metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:medium-chain fatty-acyl-CoA metabolic process; P:osteoblast differentiation; P:protein localization; P:Sertoli cell development; P:very long-chain fatty acid metabolic process; P:very long-chain fatty-acyl-CoA metabolic process;|P51659 B4DNV1 B4DVS5 E9PB82 F5HE57,Peroxisomal multifunctional enzyme type 2 {ECO:0000305},17-beta-hydroxysteroid dehydrogenase 4;D-bifunctional protein {ECO:0000303|PubMed:15060085};Multifunctional protein 2;Short chain dehydrogenase/reductase family 8C member 1;, PF00106;PF01575;PF02036;, GO:0005829;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0044594;GO:0003857;GO:0033989;GO:0004300;GO:0016853;GO:0016508;GO:0042803;GO:0036109;GO:0008209;GO:0006699;GO:0008210;GO:0006635;GO:0033540;GO:0036112;GO:0001649;GO:0008104;GO:0060009;GO:0000038;GO:0036111;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:3-hydroxyacyl-CoA dehydrogenase activity; F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; F:enoyl-CoA hydratase activity; F:isomerase activity; F:long-chain-enoyl-CoA hydratase activity; F:protein homodimerization activity;, P:alpha-linolenic acid metabolic process; P:androgen metabolic process; P:bile acid biosynthetic process; P:estrogen metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:medium-chain fatty-acyl-CoA metabolic process; P:osteoblast differentiation; P:protein localization; P:Sertoli cell development; P:very long-chain fatty acid metabolic process; P:very long-chain fatty-acyl-CoA metabolic process;|P51659 B4DNV1 B4DVS5 E9PB82 F5HE57,Peroxisomal multifunctional enzyme type 2 {ECO:0000305},17-beta-hydroxysteroid dehydrogenase 4;D-bifunctional protein {ECO:0000303|PubMed:15060085};Multifunctional protein 2;Short chain dehydrogenase/reductase family 8C member 1;, PF00106;PF01575;PF02036;, GO:0005829;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0044594;GO:0003857;GO:0033989;GO:0004300;GO:0016853;GO:0016508;GO:0042803;GO:0036109;GO:0008209;GO:0006699;GO:0008210;GO:0006635;GO:0033540;GO:0036112;GO:0001649;GO:0008104;GO:0060009;GO:0000038;GO:0036111;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:3-hydroxyacyl-CoA dehydrogenase activity; F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; F:enoyl-CoA hydratase activity; F:isomerase activity; F:long-chain-enoyl-CoA hydratase activity; F:protein homodimerization activity;, P:alpha-linolenic acid metabolic process; P:androgen metabolic process; P:bile acid biosynthetic process; P:estrogen metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:medium-chain fatty-acyl-CoA metabolic process; P:osteoblast differentiation; P:protein localization; P:Sertoli cell development; P:very long-chain fatty acid metabolic process; P:very long-chain fatty-acyl-CoA metabolic process; scaffold25 indexed_genome mRNA 20599625 20601294 . + . ID=transcript_5749;O95379 B3KMH1 B3KMI2 B7Z713 Q9P1Q1 Q9UER5 Q9UP47,Tumor necrosis factor alpha-induced protein 8,Head and neck tumor and metastasis-related protein;MDC-3.13;NF-kappa-B-inducible DED-containing protein;SCC-S2;TNF-induced protein GG2-1;, PF05527;, GO:0005737;GO:0005654;GO:0043027;GO:0043066;GO:0043065;, C:cytoplasm; C:nucleoplasm;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process;, P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; scaffold25 indexed_genome mRNA 20753340 20890162 . - . ID=transcript_5750;Q9Y485,DmX-like protein 1,, PF12234;PF00400;, GO:0043291;GO:0007035;, C:RAVE complex;, , P:vacuolar acidification;|Q9Y485,DmX-like protein 1,, PF12234;PF00400;, GO:0043291;GO:0007035;, C:RAVE complex;, , P:vacuolar acidification;|Q9Y485,DmX-like protein 1,, PF12234;PF00400;, GO:0043291;GO:0007035;, C:RAVE complex;, , P:vacuolar acidification;|Q9Y485,DmX-like protein 1,, PF12234;PF00400;, GO:0043291;GO:0007035;, C:RAVE complex;, , P:vacuolar acidification;|Q9Y485,DmX-like protein 1,, PF12234;PF00400;, GO:0043291;GO:0007035;, C:RAVE complex;, , P:vacuolar acidification;|Q9Y485,DmX-like protein 1,, PF12234;PF00400;, GO:0043291;GO:0007035;, C:RAVE complex;, , P:vacuolar acidification;|Q9Y485,DmX-like protein 1,, PF12234;PF00400;, GO:0043291;GO:0007035;, C:RAVE complex;, , P:vacuolar acidification; scaffold25 indexed_genome mRNA 20976095 21066198 . + . ID=transcript_5751;Q8NBA8 J3KND6,tRNA-uridine aminocarboxypropyltransferase 2 {ECO:0000305},DTW domain-containing protein 2;, PF03942;, GO:0005737;GO:0005634;GO:0016432;GO:0006400;, C:cytoplasm; C:nucleus;, F:tRNA-uridine aminocarboxypropyltransferase activity;, P:tRNA modification; scaffold25 indexed_genome mRNA 22748732 23886785 . - . ID=transcript_5752;Q9Y3C1 B4DV13 D6RGD3 Q05D05 Q6IAI6 Q6PIM0 Q8IXL5,Nucleolar protein 16,HBV pre-S2 trans-regulated protein 3;, PF09420;, GO:0043231;GO:0005730;GO:0005654;GO:0003723;GO:0042273;, C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:ribosomal large subunit biogenesis;|Q9H2E6 Q9P2H9,Semaphorin-6A,Semaphorin VIA;Semaphorin-6A-1;, PF01437;PF01403;, GO:0030424;GO:0005615;GO:0016021;GO:0005887;GO:0045499;GO:0030215;GO:0009887;GO:0006915;GO:0007411;GO:0007166;GO:0035924;GO:0007010;GO:0050919;GO:0016525;GO:0048843;GO:0106089;GO:0070373;GO:1903671;GO:1900747;GO:0007399;GO:0001755;GO:0030335;GO:2001224;GO:0071526;, C:axon; C:extracellular space; C:integral component of membrane; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:animal organ morphogenesis; P:apoptotic process; P:axon guidance; P:cell surface receptor signaling pathway; P:cellular response to vascular endothelial growth factor stimulus; P:cytoskeleton organization; P:negative chemotaxis; P:negative regulation of angiogenesis; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of cell adhesion involved in sprouting angiogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of sprouting angiogenesis; P:negative regulation of vascular endothelial growth factor signaling pathway; P:nervous system development; P:neural crest cell migration; P:positive regulation of cell migration; P:positive regulation of neuron migration; P:semaphorin-plexin signaling pathway;|Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated;|Q9Y6G5 D3DT07 Q9P077,COMM domain-containing protein 10,, PF07258;, GO:0005737;GO:0005654;, C:cytoplasm; C:nucleoplasm;|Q9Y6G5 D3DT07 Q9P077,COMM domain-containing protein 10,, PF07258;, GO:0005737;GO:0005654;, C:cytoplasm; C:nucleoplasm;|Q8N8L6,ADP-ribosylation factor-like protein 10,, PF00025;, GO:0005525;, , F:GTP binding;|Q9Y3C1 B4DV13 D6RGD3 Q05D05 Q6IAI6 Q6PIM0 Q8IXL5,Nucleolar protein 16,HBV pre-S2 trans-regulated protein 3;, PF09420;, GO:0043231;GO:0005730;GO:0005654;GO:0003723;GO:0042273;, C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:ribosomal large subunit biogenesis;|Q9BW72,HIG1 domain family member 2A, mitochondrial,RCF1 homolog B;, PF04588;, GO:0016021;GO:0005743;GO:0005739;GO:0070469;GO:0097250;GO:0043066;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:respirasome;, , P:mitochondrial respirasome assembly; P:negative regulation of apoptotic process; scaffold25 indexed_genome mRNA 23887508 23908740 . - . ID=transcript_5753;P09497 Q53Y37 Q6FHW1,Clathrin light chain B,, PF01086;, GO:0060170;GO:0030118;GO:0030132;GO:0030130;GO:0030125;GO:0045334;GO:0005829;GO:0043231;GO:0005886;GO:0099631;GO:0098835;GO:0030672;GO:0005802;GO:0032050;GO:0042277;GO:0005198;GO:0048268;GO:0072583;GO:0006886;GO:0061024;, C:ciliary membrane; C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin vesicle coat; C:clathrin-coated endocytic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic endocytic zone cytoplasmic component; C:presynaptic endocytic zone membrane; C:synaptic vesicle membrane; C:trans-Golgi network;, F:clathrin heavy chain binding; F:peptide binding; F:structural molecule activity;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:membrane organization;|P09497 Q53Y37 Q6FHW1,Clathrin light chain B,, PF01086;, GO:0060170;GO:0030118;GO:0030132;GO:0030130;GO:0030125;GO:0045334;GO:0005829;GO:0043231;GO:0005886;GO:0099631;GO:0098835;GO:0030672;GO:0005802;GO:0032050;GO:0042277;GO:0005198;GO:0048268;GO:0072583;GO:0006886;GO:0061024;, C:ciliary membrane; C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin vesicle coat; C:clathrin-coated endocytic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic endocytic zone cytoplasmic component; C:presynaptic endocytic zone membrane; C:synaptic vesicle membrane; C:trans-Golgi network;, F:clathrin heavy chain binding; F:peptide binding; F:structural molecule activity;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:membrane organization;|P09497 Q53Y37 Q6FHW1,Clathrin light chain B,, PF01086;, GO:0060170;GO:0030118;GO:0030132;GO:0030130;GO:0030125;GO:0045334;GO:0005829;GO:0043231;GO:0005886;GO:0099631;GO:0098835;GO:0030672;GO:0005802;GO:0032050;GO:0042277;GO:0005198;GO:0048268;GO:0072583;GO:0006886;GO:0061024;, C:ciliary membrane; C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin vesicle coat; C:clathrin-coated endocytic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic endocytic zone cytoplasmic component; C:presynaptic endocytic zone membrane; C:synaptic vesicle membrane; C:trans-Golgi network;, F:clathrin heavy chain binding; F:peptide binding; F:structural molecule activity;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:membrane organization;|P09497 Q53Y37 Q6FHW1,Clathrin light chain B,, PF01086;, GO:0060170;GO:0030118;GO:0030132;GO:0030130;GO:0030125;GO:0045334;GO:0005829;GO:0043231;GO:0005886;GO:0099631;GO:0098835;GO:0030672;GO:0005802;GO:0032050;GO:0042277;GO:0005198;GO:0048268;GO:0072583;GO:0006886;GO:0061024;, C:ciliary membrane; C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin vesicle coat; C:clathrin-coated endocytic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic endocytic zone cytoplasmic component; C:presynaptic endocytic zone membrane; C:synaptic vesicle membrane; C:trans-Golgi network;, F:clathrin heavy chain binding; F:peptide binding; F:structural molecule activity;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:membrane organization;|P09497 Q53Y37 Q6FHW1,Clathrin light chain B,, PF01086;, GO:0060170;GO:0030118;GO:0030132;GO:0030130;GO:0030125;GO:0045334;GO:0005829;GO:0043231;GO:0005886;GO:0099631;GO:0098835;GO:0030672;GO:0005802;GO:0032050;GO:0042277;GO:0005198;GO:0048268;GO:0072583;GO:0006886;GO:0061024;, C:ciliary membrane; C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin vesicle coat; C:clathrin-coated endocytic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic endocytic zone cytoplasmic component; C:presynaptic endocytic zone membrane; C:synaptic vesicle membrane; C:trans-Golgi network;, F:clathrin heavy chain binding; F:peptide binding; F:structural molecule activity;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:membrane organization; scaffold25 indexed_genome mRNA 23950462 24008557 . + . ID=transcript_5754;Q96CS3 O94963 Q8IUF2 Q9BRP2 Q9BVM7,FAS-associated factor 2,Protein ETEA;UBX domain-containing protein 3B;UBX domain-containing protein 8;, PF00789;, GO:0035578;GO:0005783;GO:0005576;GO:0005811;GO:0034098;GO:0035473;GO:0055102;GO:0043130;GO:0031625;GO:0034389;GO:0043312;GO:0006986;GO:0030970;GO:0030433;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular region; C:lipid droplet; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:lipase binding; F:lipase inhibitor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:lipid droplet organization; P:neutrophil degranulation; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway;|Q96CS3 O94963 Q8IUF2 Q9BRP2 Q9BVM7,FAS-associated factor 2,Protein ETEA;UBX domain-containing protein 3B;UBX domain-containing protein 8;, PF00789;, GO:0035578;GO:0005783;GO:0005576;GO:0005811;GO:0034098;GO:0035473;GO:0055102;GO:0043130;GO:0031625;GO:0034389;GO:0043312;GO:0006986;GO:0030970;GO:0030433;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular region; C:lipid droplet; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:lipase binding; F:lipase inhibitor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:lipid droplet organization; P:neutrophil degranulation; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway;|Q96CS3 O94963 Q8IUF2 Q9BRP2 Q9BVM7,FAS-associated factor 2,Protein ETEA;UBX domain-containing protein 3B;UBX domain-containing protein 8;, PF00789;, GO:0035578;GO:0005783;GO:0005576;GO:0005811;GO:0034098;GO:0035473;GO:0055102;GO:0043130;GO:0031625;GO:0034389;GO:0043312;GO:0006986;GO:0030970;GO:0030433;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular region; C:lipid droplet; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:lipase binding; F:lipase inhibitor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:lipid droplet organization; P:neutrophil degranulation; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway;|Q96CS3 O94963 Q8IUF2 Q9BRP2 Q9BVM7,FAS-associated factor 2,Protein ETEA;UBX domain-containing protein 3B;UBX domain-containing protein 8;, PF00789;, GO:0035578;GO:0005783;GO:0005576;GO:0005811;GO:0034098;GO:0035473;GO:0055102;GO:0043130;GO:0031625;GO:0034389;GO:0043312;GO:0006986;GO:0030970;GO:0030433;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular region; C:lipid droplet; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:lipase binding; F:lipase inhibitor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:lipid droplet organization; P:neutrophil degranulation; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway;|Q96CS3 O94963 Q8IUF2 Q9BRP2 Q9BVM7,FAS-associated factor 2,Protein ETEA;UBX domain-containing protein 3B;UBX domain-containing protein 8;, PF00789;, GO:0035578;GO:0005783;GO:0005576;GO:0005811;GO:0034098;GO:0035473;GO:0055102;GO:0043130;GO:0031625;GO:0034389;GO:0043312;GO:0006986;GO:0030970;GO:0030433;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular region; C:lipid droplet; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:lipase binding; F:lipase inhibitor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:lipid droplet organization; P:neutrophil degranulation; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway;|Q96CS3 O94963 Q8IUF2 Q9BRP2 Q9BVM7,FAS-associated factor 2,Protein ETEA;UBX domain-containing protein 3B;UBX domain-containing protein 8;, PF00789;, GO:0035578;GO:0005783;GO:0005576;GO:0005811;GO:0034098;GO:0035473;GO:0055102;GO:0043130;GO:0031625;GO:0034389;GO:0043312;GO:0006986;GO:0030970;GO:0030433;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular region; C:lipid droplet; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:lipase binding; F:lipase inhibitor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:lipid droplet organization; P:neutrophil degranulation; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; scaffold25 indexed_genome mRNA 24023016 24032575 . - . ID=transcript_5755;Q7L0R7 B4DYE0 Q8ND05 Q9UPQ2,RING finger protein 44,, PF13639;, GO:0046872;, , F:metal ion binding;|Q7L0R7 B4DYE0 Q8ND05 Q9UPQ2,RING finger protein 44,, PF13639;, GO:0046872;, , F:metal ion binding; scaffold25 indexed_genome mRNA 24107412 24118055 . - . ID=transcript_5756;Q7Z2K8 C9JM70 Q8ND74 Q96PZ4,G protein-regulated inducer of neurite outgrowth 1,, PF15235;, GO:0030426;GO:0005886;GO:0051219;GO:0031175;, C:growth cone; C:plasma membrane;, F:phosphoprotein binding;, P:neuron projection development; scaffold25 indexed_genome mRNA 24154360 24164859 . + . ID=transcript_5757;Q96FV3 Q6NXF7 Q96S98 Q9UKB9,Tetraspanin-17,F-box only protein 23;Tetraspan protein SB134;Transmembrane 4 superfamily member 17;, PF00335;, GO:0005887;GO:0000151;GO:0019899;GO:0004842;GO:0072594;GO:0072659;GO:0051604;GO:0016567;, C:integral component of plasma membrane; C:ubiquitin ligase complex;, F:enzyme binding; F:ubiquitin-protein transferase activity;, P:establishment of protein localization to organelle; P:protein localization to plasma membrane; P:protein maturation; P:protein ubiquitination;|Q96FV3 Q6NXF7 Q96S98 Q9UKB9,Tetraspanin-17,F-box only protein 23;Tetraspan protein SB134;Transmembrane 4 superfamily member 17;, PF00335;, GO:0005887;GO:0000151;GO:0019899;GO:0004842;GO:0072594;GO:0072659;GO:0051604;GO:0016567;, C:integral component of plasma membrane; C:ubiquitin ligase complex;, F:enzyme binding; F:ubiquitin-protein transferase activity;, P:establishment of protein localization to organelle; P:protein localization to plasma membrane; P:protein maturation; P:protein ubiquitination; scaffold25 indexed_genome mRNA 24361534 24362302 . + . ID=transcript_5758;Q6ZN44 B2RXE6 Q8TF26 Q96GP4,Netrin receptor UNC5A,Protein unc-5 homolog 1;Protein unc-5 homolog A;, PF00531;PF07679;PF17217;PF00791;, GO:0016021;GO:0031226;GO:0045121;GO:0032589;GO:0032809;GO:0005886;GO:0005042;GO:0033564;GO:0006915;GO:0007411;GO:0038007;GO:0031175;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane raft; C:neuron projection membrane; C:neuronal cell body membrane; C:plasma membrane;, F:netrin receptor activity;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:netrin-activated signaling pathway; P:neuron projection development; scaffold25 indexed_genome mRNA 24362400 24782340 . + . ID=transcript_5759;Q6ZN44 B2RXE6 Q8TF26 Q96GP4,Netrin receptor UNC5A,Protein unc-5 homolog 1;Protein unc-5 homolog A;, PF00531;PF07679;PF17217;PF00791;, GO:0016021;GO:0031226;GO:0045121;GO:0032589;GO:0032809;GO:0005886;GO:0005042;GO:0033564;GO:0006915;GO:0007411;GO:0038007;GO:0031175;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane raft; C:neuron projection membrane; C:neuronal cell body membrane; C:plasma membrane;, F:netrin receptor activity;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:netrin-activated signaling pathway; P:neuron projection development;|Q6ZN44 B2RXE6 Q8TF26 Q96GP4,Netrin receptor UNC5A,Protein unc-5 homolog 1;Protein unc-5 homolog A;, PF00531;PF07679;PF17217;PF00791;, GO:0016021;GO:0031226;GO:0045121;GO:0032589;GO:0032809;GO:0005886;GO:0005042;GO:0033564;GO:0006915;GO:0007411;GO:0038007;GO:0031175;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane raft; C:neuron projection membrane; C:neuronal cell body membrane; C:plasma membrane;, F:netrin receptor activity;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:netrin-activated signaling pathway; P:neuron projection development;|Q6ZN44 B2RXE6 Q8TF26 Q96GP4,Netrin receptor UNC5A,Protein unc-5 homolog 1;Protein unc-5 homolog A;, PF00531;PF07679;PF17217;PF00791;, GO:0016021;GO:0031226;GO:0045121;GO:0032589;GO:0032809;GO:0005886;GO:0005042;GO:0033564;GO:0006915;GO:0007411;GO:0038007;GO:0031175;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane raft; C:neuron projection membrane; C:neuronal cell body membrane; C:plasma membrane;, F:netrin receptor activity;, P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:netrin-activated signaling pathway; P:neuron projection development;|P52790 Q8N1E7,Hexokinase-3 {ECO:0000305},Hexokinase type III {ECO:0000303|PubMed:8812439};Hexokinase-C {ECO:0000250|UniProtKB:P27926};, PF00349;PF03727;, GO:0005829;GO:0005576;GO:1904813;GO:0005739;GO:0034774;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0004396;GO:0019158;GO:0061621;GO:0001678;GO:0006002;GO:0051156;GO:0006096;GO:0043312;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:mitochondrion; C:secretory granule lumen;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:hexokinase activity; F:mannokinase activity;, P:canonical glycolysis; P:cellular glucose homeostasis; P:fructose 6-phosphate metabolic process; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:neutrophil degranulation;|P52790 Q8N1E7,Hexokinase-3 {ECO:0000305},Hexokinase type III {ECO:0000303|PubMed:8812439};Hexokinase-C {ECO:0000250|UniProtKB:P27926};, PF00349;PF03727;, GO:0005829;GO:0005576;GO:1904813;GO:0005739;GO:0034774;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0004396;GO:0019158;GO:0061621;GO:0001678;GO:0006002;GO:0051156;GO:0006096;GO:0043312;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:mitochondrion; C:secretory granule lumen;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:hexokinase activity; F:mannokinase activity;, P:canonical glycolysis; P:cellular glucose homeostasis; P:fructose 6-phosphate metabolic process; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:neutrophil degranulation;|P52790 Q8N1E7,Hexokinase-3 {ECO:0000305},Hexokinase type III {ECO:0000303|PubMed:8812439};Hexokinase-C {ECO:0000250|UniProtKB:P27926};, PF00349;PF03727;, GO:0005829;GO:0005576;GO:1904813;GO:0005739;GO:0034774;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0004396;GO:0019158;GO:0061621;GO:0001678;GO:0006002;GO:0051156;GO:0006096;GO:0043312;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:mitochondrion; C:secretory granule lumen;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:hexokinase activity; F:mannokinase activity;, P:canonical glycolysis; P:cellular glucose homeostasis; P:fructose 6-phosphate metabolic process; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:neutrophil degranulation;|P52790 Q8N1E7,Hexokinase-3 {ECO:0000305},Hexokinase type III {ECO:0000303|PubMed:8812439};Hexokinase-C {ECO:0000250|UniProtKB:P27926};, PF00349;PF03727;, GO:0005829;GO:0005576;GO:1904813;GO:0005739;GO:0034774;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0004396;GO:0019158;GO:0061621;GO:0001678;GO:0006002;GO:0051156;GO:0006096;GO:0043312;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:mitochondrion; C:secretory granule lumen;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:hexokinase activity; F:mannokinase activity;, P:canonical glycolysis; P:cellular glucose homeostasis; P:fructose 6-phosphate metabolic process; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:neutrophil degranulation;|P52790 Q8N1E7,Hexokinase-3 {ECO:0000305},Hexokinase type III {ECO:0000303|PubMed:8812439};Hexokinase-C {ECO:0000250|UniProtKB:P27926};, PF00349;PF03727;, GO:0005829;GO:0005576;GO:1904813;GO:0005739;GO:0034774;GO:0005524;GO:0008865;GO:0004340;GO:0005536;GO:0004396;GO:0019158;GO:0061621;GO:0001678;GO:0006002;GO:0051156;GO:0006096;GO:0043312;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:mitochondrion; C:secretory granule lumen;, F:ATP binding; F:fructokinase activity; F:glucokinase activity; F:glucose binding; F:hexokinase activity; F:mannokinase activity;, P:canonical glycolysis; P:cellular glucose homeostasis; P:fructose 6-phosphate metabolic process; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:neutrophil degranulation;|Q9UHX7,BRCA1-A complex subunit RAP80,Receptor-associated protein 80;Retinoid X receptor-interacting protein 110;Ubiquitin interaction motif-containing protein 1;, PF18282;, GO:0070531;GO:0016604;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0070530;GO:0046872;GO:0006302;GO:0006303;GO:0070537;GO:0045892;GO:0045739;GO:0016579;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding;, P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H2A K63-linked deubiquitination; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA repair; P:protein deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q9UL40 B7Z367 Q68CV9 Q6ZMW1,Zinc finger protein 346,Just another zinc finger protein;, , GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003725;GO:0019899;GO:0035198;GO:0003723;GO:0008270;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:enzyme binding; F:miRNA binding; F:RNA binding; F:zinc ion binding;|Q9UL40 B7Z367 Q68CV9 Q6ZMW1,Zinc finger protein 346,Just another zinc finger protein;, , GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003725;GO:0019899;GO:0035198;GO:0003723;GO:0008270;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:enzyme binding; F:miRNA binding; F:RNA binding; F:zinc ion binding;|Q9UL40 B7Z367 Q68CV9 Q6ZMW1,Zinc finger protein 346,Just another zinc finger protein;, , GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003725;GO:0019899;GO:0035198;GO:0003723;GO:0008270;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:enzyme binding; F:miRNA binding; F:RNA binding; F:zinc ion binding;|Q9UL40 B7Z367 Q68CV9 Q6ZMW1,Zinc finger protein 346,Just another zinc finger protein;, , GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003725;GO:0019899;GO:0035198;GO:0003723;GO:0008270;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:enzyme binding; F:miRNA binding; F:RNA binding; F:zinc ion binding;|Q96KE5,Fibroblast growth factor receptor 4,, PF07679;PF07714;, GO:0005783;GO:0005768;GO:0005576;GO:0005794;GO:0005887;GO:0005886;GO:0043235;GO:0030133;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0004714;GO:0016477;GO:0042632;GO:0008543;GO:0042593;GO:0000165;GO:0007275;GO:0018108;GO:0055062;GO:0043085;GO:0008284;GO:2000573;GO:0070374;GO:0010628;GO:0033674;GO:0051897;GO:0045862;GO:0046777;GO:0070857;GO:0010715;GO:0019216;GO:0007169;, C:endoplasmic reticulum; C:endosome; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:transport vesicle;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:cholesterol homeostasis; P:fibroblast growth factor receptor signaling pathway; P:glucose homeostasis; P:MAPK cascade; P:multicellular organism development; P:peptidyl-tyrosine phosphorylation; P:phosphate ion homeostasis; P:positive regulation of catalytic activity; P:positive regulation of cell population proliferation; P:positive regulation of DNA biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of proteolysis; P:protein autophosphorylation; P:regulation of bile acid biosynthetic process; P:regulation of extracellular matrix disassembly; P:regulation of lipid metabolic process; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q96L73 Q96PD8 Q96RN7,Histone-lysine N-methyltransferase, H3 lysine-36 specific,Androgen receptor coactivator 267 kDa protein;Androgen receptor-associated protein of 267 kDa;H3-K36-HMTase;Lysine N-methyltransferase 3B;Nuclear receptor-binding SET domain-containing protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0050681;GO:0003682;GO:0030331;GO:0046975;GO:0042799;GO:0042974;GO:0046965;GO:0000978;GO:0046966;GO:0003712;GO:0003714;GO:0008270;GO:0016571;GO:0000122;GO:0045893;GO:0000414;GO:0033135;GO:1903025;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:chromatin binding; F:estrogen receptor binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H4-K20 specific); F:retinoic acid receptor binding; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coregulator activity; F:transcription corepressor activity; F:zinc ion binding;, P:histone methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of histone H3-K36 methylation; P:regulation of peptidyl-serine phosphorylation; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of transcription, DNA-templated;|Q96L73 Q96PD8 Q96RN7,Histone-lysine N-methyltransferase, H3 lysine-36 specific,Androgen receptor coactivator 267 kDa protein;Androgen receptor-associated protein of 267 kDa;H3-K36-HMTase;Lysine N-methyltransferase 3B;Nuclear receptor-binding SET domain-containing protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0050681;GO:0003682;GO:0030331;GO:0046975;GO:0042799;GO:0042974;GO:0046965;GO:0000978;GO:0046966;GO:0003712;GO:0003714;GO:0008270;GO:0016571;GO:0000122;GO:0045893;GO:0000414;GO:0033135;GO:1903025;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:chromatin binding; F:estrogen receptor binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H4-K20 specific); F:retinoic acid receptor binding; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coregulator activity; F:transcription corepressor activity; F:zinc ion binding;, P:histone methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of histone H3-K36 methylation; P:regulation of peptidyl-serine phosphorylation; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of transcription, DNA-templated;|Q96L73 Q96PD8 Q96RN7,Histone-lysine N-methyltransferase, H3 lysine-36 specific,Androgen receptor coactivator 267 kDa protein;Androgen receptor-associated protein of 267 kDa;H3-K36-HMTase;Lysine N-methyltransferase 3B;Nuclear receptor-binding SET domain-containing protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0050681;GO:0003682;GO:0030331;GO:0046975;GO:0042799;GO:0042974;GO:0046965;GO:0000978;GO:0046966;GO:0003712;GO:0003714;GO:0008270;GO:0016571;GO:0000122;GO:0045893;GO:0000414;GO:0033135;GO:1903025;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:chromatin binding; F:estrogen receptor binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H4-K20 specific); F:retinoic acid receptor binding; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coregulator activity; F:transcription corepressor activity; F:zinc ion binding;, P:histone methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of histone H3-K36 methylation; P:regulation of peptidyl-serine phosphorylation; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of transcription, DNA-templated;|Q96L73 Q96PD8 Q96RN7,Histone-lysine N-methyltransferase, H3 lysine-36 specific,Androgen receptor coactivator 267 kDa protein;Androgen receptor-associated protein of 267 kDa;H3-K36-HMTase;Lysine N-methyltransferase 3B;Nuclear receptor-binding SET domain-containing protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0050681;GO:0003682;GO:0030331;GO:0046975;GO:0042799;GO:0042974;GO:0046965;GO:0000978;GO:0046966;GO:0003712;GO:0003714;GO:0008270;GO:0016571;GO:0000122;GO:0045893;GO:0000414;GO:0033135;GO:1903025;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:chromatin binding; F:estrogen receptor binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H4-K20 specific); F:retinoic acid receptor binding; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coregulator activity; F:transcription corepressor activity; F:zinc ion binding;, P:histone methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of histone H3-K36 methylation; P:regulation of peptidyl-serine phosphorylation; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of transcription, DNA-templated;|Q96L73 Q96PD8 Q96RN7,Histone-lysine N-methyltransferase, H3 lysine-36 specific,Androgen receptor coactivator 267 kDa protein;Androgen receptor-associated protein of 267 kDa;H3-K36-HMTase;Lysine N-methyltransferase 3B;Nuclear receptor-binding SET domain-containing protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0050681;GO:0003682;GO:0030331;GO:0046975;GO:0042799;GO:0042974;GO:0046965;GO:0000978;GO:0046966;GO:0003712;GO:0003714;GO:0008270;GO:0016571;GO:0000122;GO:0045893;GO:0000414;GO:0033135;GO:1903025;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:chromatin binding; F:estrogen receptor binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H4-K20 specific); F:retinoic acid receptor binding; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coregulator activity; F:transcription corepressor activity; F:zinc ion binding;, P:histone methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of histone H3-K36 methylation; P:regulation of peptidyl-serine phosphorylation; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of transcription, DNA-templated;|Q969Q5 A0A024R7N9 Q7Z4Z7,Ras-related protein Rab-24,, PF00071;, GO:0005776;GO:0005829;GO:0030139;GO:0012505;GO:0005768;GO:0005886;GO:0030667;GO:0005525;GO:0003924;GO:0006914;GO:0006886;GO:0043312;, C:autophagosome; C:cytosol; C:endocytic vesicle; C:endomembrane system; C:endosome; C:plasma membrane; C:secretory granule membrane;, F:GTP binding; F:GTPase activity;, P:autophagy; P:intracellular protein transport; P:neutrophil degranulation; scaffold25 indexed_genome mRNA 24782407 24785967 . - . ID=transcript_5760;Q9Y255 B2R5F7 D6RD25 Q549N2 Q9UI13 Q9UJS9,PRELI domain-containing protein 1, mitochondrial,25 kDa protein of relevant evolutionary and lymphoid interest;Px19-like protein;, PF04707;, GO:0005758;GO:0005739;GO:0005654;GO:0032991;GO:0006915;GO:0006955;GO:0120009;GO:0007275;GO:0043066;GO:0010917;GO:0090201;GO:0015914;GO:1901857;GO:0010950;GO:2001140;GO:0070234;GO:0042981;GO:0097035;GO:0051881;GO:0045580;, C:mitochondrial intermembrane space; C:mitochondrion; C:nucleoplasm; C:protein-containing complex;, , P:apoptotic process; P:immune response; P:intermembrane lipid transfer; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial membrane potential; P:negative regulation of release of cytochrome c from mitochondria; P:phospholipid transport; P:positive regulation of cellular respiration; P:positive regulation of endopeptidase activity; P:positive regulation of phospholipid transport; P:positive regulation of T cell apoptotic process; P:regulation of apoptotic process; P:regulation of membrane lipid distribution; P:regulation of mitochondrial membrane potential; P:regulation of T cell differentiation;|Q9Y255 B2R5F7 D6RD25 Q549N2 Q9UI13 Q9UJS9,PRELI domain-containing protein 1, mitochondrial,25 kDa protein of relevant evolutionary and lymphoid interest;Px19-like protein;, PF04707;, GO:0005758;GO:0005739;GO:0005654;GO:0032991;GO:0006915;GO:0006955;GO:0120009;GO:0007275;GO:0043066;GO:0010917;GO:0090201;GO:0015914;GO:1901857;GO:0010950;GO:2001140;GO:0070234;GO:0042981;GO:0097035;GO:0051881;GO:0045580;, C:mitochondrial intermembrane space; C:mitochondrion; C:nucleoplasm; C:protein-containing complex;, , P:apoptotic process; P:immune response; P:intermembrane lipid transfer; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial membrane potential; P:negative regulation of release of cytochrome c from mitochondria; P:phospholipid transport; P:positive regulation of cellular respiration; P:positive regulation of endopeptidase activity; P:positive regulation of phospholipid transport; P:positive regulation of T cell apoptotic process; P:regulation of apoptotic process; P:regulation of membrane lipid distribution; P:regulation of mitochondrial membrane potential; P:regulation of T cell differentiation;|Q9Y255 B2R5F7 D6RD25 Q549N2 Q9UI13 Q9UJS9,PRELI domain-containing protein 1, mitochondrial,25 kDa protein of relevant evolutionary and lymphoid interest;Px19-like protein;, PF04707;, GO:0005758;GO:0005739;GO:0005654;GO:0032991;GO:0006915;GO:0006955;GO:0120009;GO:0007275;GO:0043066;GO:0010917;GO:0090201;GO:0015914;GO:1901857;GO:0010950;GO:2001140;GO:0070234;GO:0042981;GO:0097035;GO:0051881;GO:0045580;, C:mitochondrial intermembrane space; C:mitochondrion; C:nucleoplasm; C:protein-containing complex;, , P:apoptotic process; P:immune response; P:intermembrane lipid transfer; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial membrane potential; P:negative regulation of release of cytochrome c from mitochondria; P:phospholipid transport; P:positive regulation of cellular respiration; P:positive regulation of endopeptidase activity; P:positive regulation of phospholipid transport; P:positive regulation of T cell apoptotic process; P:regulation of apoptotic process; P:regulation of membrane lipid distribution; P:regulation of mitochondrial membrane potential; P:regulation of T cell differentiation;|Q9Y255 B2R5F7 D6RD25 Q549N2 Q9UI13 Q9UJS9,PRELI domain-containing protein 1, mitochondrial,25 kDa protein of relevant evolutionary and lymphoid interest;Px19-like protein;, PF04707;, GO:0005758;GO:0005739;GO:0005654;GO:0032991;GO:0006915;GO:0006955;GO:0120009;GO:0007275;GO:0043066;GO:0010917;GO:0090201;GO:0015914;GO:1901857;GO:0010950;GO:2001140;GO:0070234;GO:0042981;GO:0097035;GO:0051881;GO:0045580;, C:mitochondrial intermembrane space; C:mitochondrion; C:nucleoplasm; C:protein-containing complex;, , P:apoptotic process; P:immune response; P:intermembrane lipid transfer; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial membrane potential; P:negative regulation of release of cytochrome c from mitochondria; P:phospholipid transport; P:positive regulation of cellular respiration; P:positive regulation of endopeptidase activity; P:positive regulation of phospholipid transport; P:positive regulation of T cell apoptotic process; P:regulation of apoptotic process; P:regulation of membrane lipid distribution; P:regulation of mitochondrial membrane potential; P:regulation of T cell differentiation; scaffold25 indexed_genome mRNA 24786216 24790671 . - . ID=transcript_5761;Q9BW11 B4E0J1 Q53HK1 Q7Z4Y0 Q8NDJ7 Q96ME3,Max dimerization protein 3,Class C basic helix-loop-helix protein 13;Max-associated protein 3;Max-interacting transcriptional repressor MAD3;Myx;, PF00010;, GO:0000785;GO:0005634;GO:0000981;GO:0046983;GO:0000978;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9BW11 B4E0J1 Q53HK1 Q7Z4Y0 Q8NDJ7 Q96ME3,Max dimerization protein 3,Class C basic helix-loop-helix protein 13;Max-associated protein 3;Max-interacting transcriptional repressor MAD3;Myx;, PF00010;, GO:0000785;GO:0005634;GO:0000981;GO:0046983;GO:0000978;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 24831371 24850671 . - . ID=transcript_5762;Q12907 Q53HH1,Vesicular integral-membrane protein VIP36,Glycoprotein GP36b;Lectin mannose-binding 2;Vesicular integral-membrane protein 36;, PF03388;, GO:0009986;GO:0030134;GO:0005789;GO:0005793;GO:0033116;GO:0070062;GO:0005615;GO:0005794;GO:0000139;GO:0005887;GO:0030246;GO:0031072;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0050766;GO:0015031;GO:0006890;, C:cell surface; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane;, F:carbohydrate binding; F:heat shock protein binding; F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:positive regulation of phagocytosis; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q12907 Q53HH1,Vesicular integral-membrane protein VIP36,Glycoprotein GP36b;Lectin mannose-binding 2;Vesicular integral-membrane protein 36;, PF03388;, GO:0009986;GO:0030134;GO:0005789;GO:0005793;GO:0033116;GO:0070062;GO:0005615;GO:0005794;GO:0000139;GO:0005887;GO:0030246;GO:0031072;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0050766;GO:0015031;GO:0006890;, C:cell surface; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane;, F:carbohydrate binding; F:heat shock protein binding; F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:positive regulation of phagocytosis; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q12907 Q53HH1,Vesicular integral-membrane protein VIP36,Glycoprotein GP36b;Lectin mannose-binding 2;Vesicular integral-membrane protein 36;, PF03388;, GO:0009986;GO:0030134;GO:0005789;GO:0005793;GO:0033116;GO:0070062;GO:0005615;GO:0005794;GO:0000139;GO:0005887;GO:0030246;GO:0031072;GO:0005537;GO:0046872;GO:0007029;GO:0006888;GO:0007030;GO:0050766;GO:0015031;GO:0006890;, C:cell surface; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane;, F:carbohydrate binding; F:heat shock protein binding; F:mannose binding; F:metal ion binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:positive regulation of phagocytosis; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold25 indexed_genome mRNA 24856368 24871548 . + . ID=transcript_5763;O43566 O43565 Q506M1 Q6ZWA4 Q8TD62,Regulator of G-protein signaling 14,, PF02188;PF02196;PF00615;, GO:0005813;GO:0005737;GO:0030425;GO:0043197;GO:0098978;GO:0005874;GO:0016604;GO:0005634;GO:0005886;GO:0016605;GO:0014069;GO:0005819;GO:0000922;GO:0001965;GO:0005092;GO:0032794;GO:0005096;GO:0008017;GO:0019901;GO:0030159;GO:0051301;GO:0007059;GO:0007186;GO:0035556;GO:0007612;GO:0007616;GO:0060291;GO:0000278;GO:0070373;GO:0045744;GO:0043407;GO:0031914;GO:0006913;GO:0048008;GO:0050769;GO:0043620;GO:0008277;GO:0006979;GO:0007051;GO:0008542;GO:0010070;, C:centrosome; C:cytoplasm; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:microtubule; C:nuclear body; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic density; C:spindle; C:spindle pole;, F:G-protein alpha-subunit binding; F:GDP-dissociation inhibitor activity; F:GTPase activating protein binding; F:GTPase activator activity; F:microtubule binding; F:protein kinase binding; F:signaling receptor complex adaptor activity;, P:cell division; P:chromosome segregation; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:learning; P:long-term memory; P:long-term synaptic potentiation; P:mitotic cell cycle; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of synaptic plasticity; P:nucleocytoplasmic transport; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of neurogenesis; P:regulation of DNA-templated transcription in response to stress; P:regulation of G protein-coupled receptor signaling pathway; P:response to oxidative stress; P:spindle organization; P:visual learning; P:zygote asymmetric cell division;|O43566 O43565 Q506M1 Q6ZWA4 Q8TD62,Regulator of G-protein signaling 14,, PF02188;PF02196;PF00615;, GO:0005813;GO:0005737;GO:0030425;GO:0043197;GO:0098978;GO:0005874;GO:0016604;GO:0005634;GO:0005886;GO:0016605;GO:0014069;GO:0005819;GO:0000922;GO:0001965;GO:0005092;GO:0032794;GO:0005096;GO:0008017;GO:0019901;GO:0030159;GO:0051301;GO:0007059;GO:0007186;GO:0035556;GO:0007612;GO:0007616;GO:0060291;GO:0000278;GO:0070373;GO:0045744;GO:0043407;GO:0031914;GO:0006913;GO:0048008;GO:0050769;GO:0043620;GO:0008277;GO:0006979;GO:0007051;GO:0008542;GO:0010070;, C:centrosome; C:cytoplasm; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:microtubule; C:nuclear body; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic density; C:spindle; C:spindle pole;, F:G-protein alpha-subunit binding; F:GDP-dissociation inhibitor activity; F:GTPase activating protein binding; F:GTPase activator activity; F:microtubule binding; F:protein kinase binding; F:signaling receptor complex adaptor activity;, P:cell division; P:chromosome segregation; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:learning; P:long-term memory; P:long-term synaptic potentiation; P:mitotic cell cycle; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of synaptic plasticity; P:nucleocytoplasmic transport; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of neurogenesis; P:regulation of DNA-templated transcription in response to stress; P:regulation of G protein-coupled receptor signaling pathway; P:response to oxidative stress; P:spindle organization; P:visual learning; P:zygote asymmetric cell division;|O43566 O43565 Q506M1 Q6ZWA4 Q8TD62,Regulator of G-protein signaling 14,, PF02188;PF02196;PF00615;, GO:0005813;GO:0005737;GO:0030425;GO:0043197;GO:0098978;GO:0005874;GO:0016604;GO:0005634;GO:0005886;GO:0016605;GO:0014069;GO:0005819;GO:0000922;GO:0001965;GO:0005092;GO:0032794;GO:0005096;GO:0008017;GO:0019901;GO:0030159;GO:0051301;GO:0007059;GO:0007186;GO:0035556;GO:0007612;GO:0007616;GO:0060291;GO:0000278;GO:0070373;GO:0045744;GO:0043407;GO:0031914;GO:0006913;GO:0048008;GO:0050769;GO:0043620;GO:0008277;GO:0006979;GO:0007051;GO:0008542;GO:0010070;, C:centrosome; C:cytoplasm; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:microtubule; C:nuclear body; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic density; C:spindle; C:spindle pole;, F:G-protein alpha-subunit binding; F:GDP-dissociation inhibitor activity; F:GTPase activating protein binding; F:GTPase activator activity; F:microtubule binding; F:protein kinase binding; F:signaling receptor complex adaptor activity;, P:cell division; P:chromosome segregation; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:learning; P:long-term memory; P:long-term synaptic potentiation; P:mitotic cell cycle; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of synaptic plasticity; P:nucleocytoplasmic transport; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of neurogenesis; P:regulation of DNA-templated transcription in response to stress; P:regulation of G protein-coupled receptor signaling pathway; P:response to oxidative stress; P:spindle organization; P:visual learning; P:zygote asymmetric cell division; scaffold25 indexed_genome mRNA 24899650 24908043 . - . ID=transcript_5764;P00748 P78339,Coagulation factor XII,Hageman factor;, PF00008;PF00039;PF00040;PF00051;PF00089;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0005791;GO:0005509;GO:0051787;GO:0004252;GO:0007596;GO:0007597;GO:0002542;GO:0042730;GO:0045087;GO:2000267;GO:0002353;GO:0030194;GO:0051919;GO:0010756;GO:0016540;GO:0016485;GO:0006508;GO:0051788;GO:0031638;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:rough endoplasmic reticulum;, F:calcium ion binding; F:misfolded protein binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:blood coagulation, intrinsic pathway; P:Factor XII activation; P:fibrinolysis; P:innate immune response; P:negative regulation of blood coagulation, intrinsic pathway; P:plasma kallikrein-kinin cascade; P:positive regulation of blood coagulation; P:positive regulation of fibrinolysis; P:positive regulation of plasminogen activation; P:protein autoprocessing; P:protein processing; P:proteolysis; P:response to misfolded protein; P:zymogen activation;|P00748 P78339,Coagulation factor XII,Hageman factor;, PF00008;PF00039;PF00040;PF00051;PF00089;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0005791;GO:0005509;GO:0051787;GO:0004252;GO:0007596;GO:0007597;GO:0002542;GO:0042730;GO:0045087;GO:2000267;GO:0002353;GO:0030194;GO:0051919;GO:0010756;GO:0016540;GO:0016485;GO:0006508;GO:0051788;GO:0031638;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:rough endoplasmic reticulum;, F:calcium ion binding; F:misfolded protein binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:blood coagulation, intrinsic pathway; P:Factor XII activation; P:fibrinolysis; P:innate immune response; P:negative regulation of blood coagulation, intrinsic pathway; P:plasma kallikrein-kinin cascade; P:positive regulation of blood coagulation; P:positive regulation of fibrinolysis; P:positive regulation of plasminogen activation; P:protein autoprocessing; P:protein processing; P:proteolysis; P:response to misfolded protein; P:zymogen activation; scaffold25 indexed_genome mRNA 24925728 24936654 . + . ID=transcript_5765;P43250 O60541 Q13652,G protein-coupled receptor kinase 6,G protein-coupled receptor kinase GRK6;, PF00069;PF00615;, GO:0016020;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0007186;GO:0008277;GO:0016055;, C:membrane; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity;, P:G protein-coupled receptor signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; P:Wnt signaling pathway; scaffold25 indexed_genome mRNA 24940515 24950016 . + . ID=transcript_5766;Q8TB68 Q8WU53 Q9BTA7,Proline-rich protein 7,Synaptic proline-rich membrane protein;, , GO:0005829;GO:0030425;GO:0098978;GO:0016021;GO:0005654;GO:0048471;GO:0005886;GO:0098839;GO:0099092;GO:0036041;GO:1990782;GO:0044877;GO:0044389;GO:0002250;GO:0046632;GO:0031397;GO:0043065;GO:0010942;GO:2001269;GO:0099527;GO:0033077;, C:cytosol; C:dendrite; C:glutamatergic synapse; C:integral component of membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density membrane; C:postsynaptic density, intracellular component;, F:long-chain fatty acid binding; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:ubiquitin-like protein ligase binding;, P:adaptive immune response; P:alpha-beta T cell differentiation; P:negative regulation of protein ubiquitination; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:postsynapse to nucleus signaling pathway; P:T cell differentiation in thymus; scaffold25 indexed_genome mRNA 24951214 24958685 . - . ID=transcript_5767;Q16643 A8MV58 B2RBG0 Q9UFZ5,Drebrin,Developmentally-regulated brain protein;, PF00241;, GO:0015629;GO:0042641;GO:0030864;GO:0030863;GO:0005737;GO:0005856;GO:0030425;GO:0005921;GO:0098978;GO:0030426;GO:0030027;GO:0005886;GO:0099524;GO:0014069;GO:0045211;GO:0030427;GO:0003779;GO:0051015;GO:0045296;GO:0005522;GO:0007015;GO:0010643;GO:0010644;GO:0051220;GO:0001701;GO:0032507;GO:0061351;GO:0048812;GO:0045773;GO:0061003;GO:1902685;GO:0031915;GO:0098974;GO:0030833;GO:0050773;GO:0048168;, C:actin cytoskeleton; C:actomyosin; C:cortical actin cytoskeleton; C:cortical cytoskeleton; C:cytoplasm; C:cytoskeleton; C:dendrite; C:gap junction; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic density; C:postsynaptic membrane; C:site of polarized growth;, F:actin binding; F:actin filament binding; F:cadherin binding; F:profilin binding;, P:actin filament organization; P:cell communication by chemical coupling; P:cell communication by electrical coupling; P:cytoplasmic sequestering of protein; P:in utero embryonic development; P:maintenance of protein location in cell; P:neural precursor cell proliferation; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of receptor localization to synapse; P:positive regulation of synaptic plasticity; P:postsynaptic actin cytoskeleton organization; P:regulation of actin filament polymerization; P:regulation of dendrite development; P:regulation of neuronal synaptic plasticity;|Q16643 A8MV58 B2RBG0 Q9UFZ5,Drebrin,Developmentally-regulated brain protein;, PF00241;, GO:0015629;GO:0042641;GO:0030864;GO:0030863;GO:0005737;GO:0005856;GO:0030425;GO:0005921;GO:0098978;GO:0030426;GO:0030027;GO:0005886;GO:0099524;GO:0014069;GO:0045211;GO:0030427;GO:0003779;GO:0051015;GO:0045296;GO:0005522;GO:0007015;GO:0010643;GO:0010644;GO:0051220;GO:0001701;GO:0032507;GO:0061351;GO:0048812;GO:0045773;GO:0061003;GO:1902685;GO:0031915;GO:0098974;GO:0030833;GO:0050773;GO:0048168;, C:actin cytoskeleton; C:actomyosin; C:cortical actin cytoskeleton; C:cortical cytoskeleton; C:cytoplasm; C:cytoskeleton; C:dendrite; C:gap junction; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic density; C:postsynaptic membrane; C:site of polarized growth;, F:actin binding; F:actin filament binding; F:cadherin binding; F:profilin binding;, P:actin filament organization; P:cell communication by chemical coupling; P:cell communication by electrical coupling; P:cytoplasmic sequestering of protein; P:in utero embryonic development; P:maintenance of protein location in cell; P:neural precursor cell proliferation; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of receptor localization to synapse; P:positive regulation of synaptic plasticity; P:postsynaptic actin cytoskeleton organization; P:regulation of actin filament polymerization; P:regulation of dendrite development; P:regulation of neuronal synaptic plasticity;|Q16643 A8MV58 B2RBG0 Q9UFZ5,Drebrin,Developmentally-regulated brain protein;, PF00241;, GO:0015629;GO:0042641;GO:0030864;GO:0030863;GO:0005737;GO:0005856;GO:0030425;GO:0005921;GO:0098978;GO:0030426;GO:0030027;GO:0005886;GO:0099524;GO:0014069;GO:0045211;GO:0030427;GO:0003779;GO:0051015;GO:0045296;GO:0005522;GO:0007015;GO:0010643;GO:0010644;GO:0051220;GO:0001701;GO:0032507;GO:0061351;GO:0048812;GO:0045773;GO:0061003;GO:1902685;GO:0031915;GO:0098974;GO:0030833;GO:0050773;GO:0048168;, C:actin cytoskeleton; C:actomyosin; C:cortical actin cytoskeleton; C:cortical cytoskeleton; C:cytoplasm; C:cytoskeleton; C:dendrite; C:gap junction; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic density; C:postsynaptic membrane; C:site of polarized growth;, F:actin binding; F:actin filament binding; F:cadherin binding; F:profilin binding;, P:actin filament organization; P:cell communication by chemical coupling; P:cell communication by electrical coupling; P:cytoplasmic sequestering of protein; P:in utero embryonic development; P:maintenance of protein location in cell; P:neural precursor cell proliferation; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of receptor localization to synapse; P:positive regulation of synaptic plasticity; P:postsynaptic actin cytoskeleton organization; P:regulation of actin filament polymerization; P:regulation of dendrite development; P:regulation of neuronal synaptic plasticity;|Q16643 A8MV58 B2RBG0 Q9UFZ5,Drebrin,Developmentally-regulated brain protein;, PF00241;, GO:0015629;GO:0042641;GO:0030864;GO:0030863;GO:0005737;GO:0005856;GO:0030425;GO:0005921;GO:0098978;GO:0030426;GO:0030027;GO:0005886;GO:0099524;GO:0014069;GO:0045211;GO:0030427;GO:0003779;GO:0051015;GO:0045296;GO:0005522;GO:0007015;GO:0010643;GO:0010644;GO:0051220;GO:0001701;GO:0032507;GO:0061351;GO:0048812;GO:0045773;GO:0061003;GO:1902685;GO:0031915;GO:0098974;GO:0030833;GO:0050773;GO:0048168;, C:actin cytoskeleton; C:actomyosin; C:cortical actin cytoskeleton; C:cortical cytoskeleton; C:cytoplasm; C:cytoskeleton; C:dendrite; C:gap junction; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic density; C:postsynaptic membrane; C:site of polarized growth;, F:actin binding; F:actin filament binding; F:cadherin binding; F:profilin binding;, P:actin filament organization; P:cell communication by chemical coupling; P:cell communication by electrical coupling; P:cytoplasmic sequestering of protein; P:in utero embryonic development; P:maintenance of protein location in cell; P:neural precursor cell proliferation; P:neuron projection morphogenesis; P:positive regulation of axon extension; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of receptor localization to synapse; P:positive regulation of synaptic plasticity; P:postsynaptic actin cytoskeleton organization; P:regulation of actin filament polymerization; P:regulation of dendrite development; P:regulation of neuronal synaptic plasticity; scaffold25 indexed_genome mRNA 24976410 24992985 . + . ID=transcript_5768;Q9NR12 Q14250 Q5XG82 Q6NVZ5 Q96C91 Q9BXB8 Q9BXB9,PDZ and LIM domain protein 7,LIM mineralization protein;Protein enigma;, PF00412;PF00595;, GO:0015629;GO:0005912;GO:0005829;GO:0031941;GO:0005925;GO:0005654;GO:0001726;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0051371;GO:0030036;GO:0007411;GO:0007507;GO:0061061;GO:0001503;GO:0045669;GO:0006898;, C:actin cytoskeleton; C:adherens junction; C:cytosol; C:filamentous actin; C:focal adhesion; C:nucleoplasm; C:ruffle; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:axon guidance; P:heart development; P:muscle structure development; P:ossification; P:positive regulation of osteoblast differentiation; P:receptor-mediated endocytosis;|Q9NR12 Q14250 Q5XG82 Q6NVZ5 Q96C91 Q9BXB8 Q9BXB9,PDZ and LIM domain protein 7,LIM mineralization protein;Protein enigma;, PF00412;PF00595;, GO:0015629;GO:0005912;GO:0005829;GO:0031941;GO:0005925;GO:0005654;GO:0001726;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0051371;GO:0030036;GO:0007411;GO:0007507;GO:0061061;GO:0001503;GO:0045669;GO:0006898;, C:actin cytoskeleton; C:adherens junction; C:cytosol; C:filamentous actin; C:focal adhesion; C:nucleoplasm; C:ruffle; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:axon guidance; P:heart development; P:muscle structure development; P:ossification; P:positive regulation of osteoblast differentiation; P:receptor-mediated endocytosis;|Q9NR12 Q14250 Q5XG82 Q6NVZ5 Q96C91 Q9BXB8 Q9BXB9,PDZ and LIM domain protein 7,LIM mineralization protein;Protein enigma;, PF00412;PF00595;, GO:0015629;GO:0005912;GO:0005829;GO:0031941;GO:0005925;GO:0005654;GO:0001726;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0051371;GO:0030036;GO:0007411;GO:0007507;GO:0061061;GO:0001503;GO:0045669;GO:0006898;, C:actin cytoskeleton; C:adherens junction; C:cytosol; C:filamentous actin; C:focal adhesion; C:nucleoplasm; C:ruffle; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:axon guidance; P:heart development; P:muscle structure development; P:ossification; P:positive regulation of osteoblast differentiation; P:receptor-mediated endocytosis; scaffold25 indexed_genome mRNA 24993635 24995018 . + . ID=transcript_5769;Q9NR12 Q14250 Q5XG82 Q6NVZ5 Q96C91 Q9BXB8 Q9BXB9,PDZ and LIM domain protein 7,LIM mineralization protein;Protein enigma;, PF00412;PF00595;, GO:0015629;GO:0005912;GO:0005829;GO:0031941;GO:0005925;GO:0005654;GO:0001726;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0051371;GO:0030036;GO:0007411;GO:0007507;GO:0061061;GO:0001503;GO:0045669;GO:0006898;, C:actin cytoskeleton; C:adherens junction; C:cytosol; C:filamentous actin; C:focal adhesion; C:nucleoplasm; C:ruffle; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:axon guidance; P:heart development; P:muscle structure development; P:ossification; P:positive regulation of osteoblast differentiation; P:receptor-mediated endocytosis; scaffold25 indexed_genome mRNA 25014222 25019835 . - . ID=transcript_5770;Q9UJV9 B2RDC8 Q96BK6 Q96K05 Q9NT96 Q9NW04,Probable ATP-dependent RNA helicase DDX41,DEAD box protein 41;DEAD box protein abstrakt homolog;, PF00270;PF00271;, GO:0071013;GO:0005829;GO:0016020;GO:0005634;GO:0005524;GO:0046872;GO:0003723;GO:0003724;GO:0006915;GO:0030154;GO:0008283;GO:0000398;GO:0032481;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleus;, F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;, P:apoptotic process; P:cell differentiation; P:cell population proliferation; P:mRNA splicing, via spliceosome; P:positive regulation of type I interferon production;|Q9UJV9 B2RDC8 Q96BK6 Q96K05 Q9NT96 Q9NW04,Probable ATP-dependent RNA helicase DDX41,DEAD box protein 41;DEAD box protein abstrakt homolog;, PF00270;PF00271;, GO:0071013;GO:0005829;GO:0016020;GO:0005634;GO:0005524;GO:0046872;GO:0003723;GO:0003724;GO:0006915;GO:0030154;GO:0008283;GO:0000398;GO:0032481;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleus;, F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;, P:apoptotic process; P:cell differentiation; P:cell population proliferation; P:mRNA splicing, via spliceosome; P:positive regulation of type I interferon production;|Q9UJV9 B2RDC8 Q96BK6 Q96K05 Q9NT96 Q9NW04,Probable ATP-dependent RNA helicase DDX41,DEAD box protein 41;DEAD box protein abstrakt homolog;, PF00270;PF00271;, GO:0071013;GO:0005829;GO:0016020;GO:0005634;GO:0005524;GO:0046872;GO:0003723;GO:0003724;GO:0006915;GO:0030154;GO:0008283;GO:0000398;GO:0032481;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleus;, F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;, P:apoptotic process; P:cell differentiation; P:cell population proliferation; P:mRNA splicing, via spliceosome; P:positive regulation of type I interferon production;|Q9UJV9 B2RDC8 Q96BK6 Q96K05 Q9NT96 Q9NW04,Probable ATP-dependent RNA helicase DDX41,DEAD box protein 41;DEAD box protein abstrakt homolog;, PF00270;PF00271;, GO:0071013;GO:0005829;GO:0016020;GO:0005634;GO:0005524;GO:0046872;GO:0003723;GO:0003724;GO:0006915;GO:0030154;GO:0008283;GO:0000398;GO:0032481;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleus;, F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;, P:apoptotic process; P:cell differentiation; P:cell population proliferation; P:mRNA splicing, via spliceosome; P:positive regulation of type I interferon production;|Q9UJV9 B2RDC8 Q96BK6 Q96K05 Q9NT96 Q9NW04,Probable ATP-dependent RNA helicase DDX41,DEAD box protein 41;DEAD box protein abstrakt homolog;, PF00270;PF00271;, GO:0071013;GO:0005829;GO:0016020;GO:0005634;GO:0005524;GO:0046872;GO:0003723;GO:0003724;GO:0006915;GO:0030154;GO:0008283;GO:0000398;GO:0032481;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleus;, F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;, P:apoptotic process; P:cell differentiation; P:cell population proliferation; P:mRNA splicing, via spliceosome; P:positive regulation of type I interferon production; scaffold25 indexed_genome mRNA 25024106 25054988 . - . ID=transcript_5771;Q96PV7 E9PET5 Q9NW00,Protein FAM193B,, PF15914;, GO:0005737;GO:0016607;GO:0005730;GO:0005654;GO:0005634;, C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;|Q96PV7 E9PET5 Q9NW00,Protein FAM193B,, PF15914;, GO:0005737;GO:0016607;GO:0005730;GO:0005654;GO:0005634;, C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;|Q96PV7 E9PET5 Q9NW00,Protein FAM193B,, PF15914;, GO:0005737;GO:0016607;GO:0005730;GO:0005654;GO:0005634;, C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;|Q96PV7 E9PET5 Q9NW00,Protein FAM193B,, PF15914;, GO:0005737;GO:0016607;GO:0005730;GO:0005654;GO:0005634;, C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; scaffold25 indexed_genome mRNA 25089039 25092662 . - . ID=transcript_5772;Q9BVK6 Q14437 Q8WZ61,Transmembrane emp24 domain-containing protein 9,GMP25;Glycoprotein 25L2;p24 family protein alpha-2;p25;, PF01105;, GO:0030134;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0008021;GO:0030140;GO:0030133;GO:0019905;GO:0048205;GO:0006888;GO:0007030;GO:0006886;GO:0010638;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:synaptic vesicle; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:syntaxin binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:positive regulation of organelle organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold25 indexed_genome mRNA 25118707 25122405 . + . ID=transcript_5773;Q9BVK6 Q14437 Q8WZ61,Transmembrane emp24 domain-containing protein 9,GMP25;Glycoprotein 25L2;p24 family protein alpha-2;p25;, PF01105;, GO:0030134;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0008021;GO:0030140;GO:0030133;GO:0019905;GO:0048205;GO:0006888;GO:0007030;GO:0006886;GO:0010638;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:synaptic vesicle; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:syntaxin binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:positive regulation of organelle organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9BVK6 Q14437 Q8WZ61,Transmembrane emp24 domain-containing protein 9,GMP25;Glycoprotein 25L2;p24 family protein alpha-2;p25;, PF01105;, GO:0030134;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0008021;GO:0030140;GO:0030133;GO:0019905;GO:0048205;GO:0006888;GO:0007030;GO:0006886;GO:0010638;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:synaptic vesicle; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:syntaxin binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:positive regulation of organelle organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold25 indexed_genome mRNA 25127516 25139037 . + . ID=transcript_5774;Q9UBV7 B3KN39 Q9UHN2,Beta-1,4-galactosyltransferase 7,Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I;UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7;UDP-galactose:beta-xylose beta-1,4-galactosyltransferase;XGPT;XGalT-1;Xylosylprotein 4-beta-galactosyltransferase;Xylosylprotein beta-1,4-galactosyltransferase;, PF02709;PF13733;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0003831;GO:0008378;GO:0030145;GO:0046525;GO:0005975;GO:0006464;GO:0006024;GO:0030203;GO:0048147;GO:0006487;GO:0006029;GO:0097435;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; F:galactosyltransferase activity; F:manganese ion binding; F:xylosylprotein 4-beta-galactosyltransferase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:negative regulation of fibroblast proliferation; P:protein N-linked glycosylation; P:proteoglycan metabolic process; P:supramolecular fiber organization;|Q9UBV7 B3KN39 Q9UHN2,Beta-1,4-galactosyltransferase 7,Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I;UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7;UDP-galactose:beta-xylose beta-1,4-galactosyltransferase;XGPT;XGalT-1;Xylosylprotein 4-beta-galactosyltransferase;Xylosylprotein beta-1,4-galactosyltransferase;, PF02709;PF13733;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0003831;GO:0008378;GO:0030145;GO:0046525;GO:0005975;GO:0006464;GO:0006024;GO:0030203;GO:0048147;GO:0006487;GO:0006029;GO:0097435;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; F:galactosyltransferase activity; F:manganese ion binding; F:xylosylprotein 4-beta-galactosyltransferase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:negative regulation of fibroblast proliferation; P:protein N-linked glycosylation; P:proteoglycan metabolic process; P:supramolecular fiber organization;|Q9UBV7 B3KN39 Q9UHN2,Beta-1,4-galactosyltransferase 7,Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I;UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7;UDP-galactose:beta-xylose beta-1,4-galactosyltransferase;XGPT;XGalT-1;Xylosylprotein 4-beta-galactosyltransferase;Xylosylprotein beta-1,4-galactosyltransferase;, PF02709;PF13733;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0003831;GO:0008378;GO:0030145;GO:0046525;GO:0005975;GO:0006464;GO:0006024;GO:0030203;GO:0048147;GO:0006487;GO:0006029;GO:0097435;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; F:galactosyltransferase activity; F:manganese ion binding; F:xylosylprotein 4-beta-galactosyltransferase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:negative regulation of fibroblast proliferation; P:protein N-linked glycosylation; P:proteoglycan metabolic process; P:supramolecular fiber organization; scaffold25 indexed_genome mRNA 25215604 25223676 . + . ID=transcript_5775;O15049 B4DIL3 D3DWP3 Q6ZSQ6 Q7Z6I3,NEDD4-binding protein 3,, , GO:0030424;GO:0031410;GO:0030425;GO:0007399;, C:axon; C:cytoplasmic vesicle; C:dendrite;, , P:nervous system development; scaffold25 indexed_genome mRNA 25229841 25235390 . - . ID=transcript_5776;Q96G75 Q1HE27 Q6UVY7 Q9H6F6,E3 ubiquitin-protein transferase RMND5B,Protein RMD5 homolog B;, PF10607;, GO:0005737;GO:0005829;GO:0034657;GO:0005634;GO:0046872;GO:0061630;GO:0043161;, C:cytoplasm; C:cytosol; C:GID complex; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q13901 A8K336 D6W5F8 Q05D64,Nuclear nucleic acid-binding protein C1D,, PF04000;, GO:0005737;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0006915;GO:0000460;GO:0010468;GO:0006364;, C:cytoplasm; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding;, P:apoptotic process; P:maturation of 5.8S rRNA; P:regulation of gene expression; P:rRNA processing; scaffold25 indexed_genome mRNA 25237448 25245413 . + . ID=transcript_5777;Q96G75 Q1HE27 Q6UVY7 Q9H6F6,E3 ubiquitin-protein transferase RMND5B,Protein RMD5 homolog B;, PF10607;, GO:0005737;GO:0005829;GO:0034657;GO:0005634;GO:0046872;GO:0061630;GO:0043161;, C:cytoplasm; C:cytosol; C:GID complex; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q96G75 Q1HE27 Q6UVY7 Q9H6F6,E3 ubiquitin-protein transferase RMND5B,Protein RMD5 homolog B;, PF10607;, GO:0005737;GO:0005829;GO:0034657;GO:0005634;GO:0046872;GO:0061630;GO:0043161;, C:cytoplasm; C:cytosol; C:GID complex; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q96G75 Q1HE27 Q6UVY7 Q9H6F6,E3 ubiquitin-protein transferase RMND5B,Protein RMD5 homolog B;, PF10607;, GO:0005737;GO:0005829;GO:0034657;GO:0005634;GO:0046872;GO:0061630;GO:0043161;, C:cytoplasm; C:cytosol; C:GID complex; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q96G75 Q1HE27 Q6UVY7 Q9H6F6,E3 ubiquitin-protein transferase RMND5B,Protein RMD5 homolog B;, PF10607;, GO:0005737;GO:0005829;GO:0034657;GO:0005634;GO:0046872;GO:0061630;GO:0043161;, C:cytoplasm; C:cytosol; C:GID complex; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q96G75 Q1HE27 Q6UVY7 Q9H6F6,E3 ubiquitin-protein transferase RMND5B,Protein RMD5 homolog B;, PF10607;, GO:0005737;GO:0005829;GO:0034657;GO:0005634;GO:0046872;GO:0061630;GO:0043161;, C:cytoplasm; C:cytosol; C:GID complex; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; scaffold25 indexed_genome mRNA 25245451 25249809 . - . ID=transcript_5778;Q9NX24 A6NKY8 Q9P095,H/ACA ribonucleoprotein complex subunit 2,Nucleolar protein family A member 2;snoRNP protein NHP2;, PF01248;, GO:0072589;GO:0031429;GO:0090661;GO:0000781;GO:0005654;GO:0005732;GO:0005697;GO:0034513;GO:0003723;GO:0070034;GO:0000469;GO:0000470;GO:1904874;GO:0031118;GO:0031120;GO:0007004;, C:box H/ACA scaRNP complex; C:box H/ACA snoRNP complex; C:box H/ACA telomerase RNP complex; C:chromosome, telomeric region; C:nucleoplasm; C:sno(s)RNA-containing ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:box H/ACA snoRNA binding; F:RNA binding; F:telomerase RNA binding;, P:cleavage involved in rRNA processing; P:maturation of LSU-rRNA; P:positive regulation of telomerase RNA localization to Cajal body; P:rRNA pseudouridine synthesis; P:snRNA pseudouridine synthesis; P:telomere maintenance via telomerase;|Q9NX24 A6NKY8 Q9P095,H/ACA ribonucleoprotein complex subunit 2,Nucleolar protein family A member 2;snoRNP protein NHP2;, PF01248;, GO:0072589;GO:0031429;GO:0090661;GO:0000781;GO:0005654;GO:0005732;GO:0005697;GO:0034513;GO:0003723;GO:0070034;GO:0000469;GO:0000470;GO:1904874;GO:0031118;GO:0031120;GO:0007004;, C:box H/ACA scaRNP complex; C:box H/ACA snoRNP complex; C:box H/ACA telomerase RNP complex; C:chromosome, telomeric region; C:nucleoplasm; C:sno(s)RNA-containing ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:box H/ACA snoRNA binding; F:RNA binding; F:telomerase RNA binding;, P:cleavage involved in rRNA processing; P:maturation of LSU-rRNA; P:positive regulation of telomerase RNA localization to Cajal body; P:rRNA pseudouridine synthesis; P:snRNA pseudouridine synthesis; P:telomere maintenance via telomerase; scaffold25 indexed_genome mRNA 25280719 25311853 . + . ID=transcript_5779;Q99729 B3KNN5 D3DWP7 Q04150 Q8N7U3 Q9BQ99,Heterogeneous nuclear ribonucleoprotein A/B,APOBEC1-binding protein 1;, PF08143;PF00076;, GO:0005737;GO:0005654;GO:0005634;GO:1990904;GO:0090575;GO:0003729;GO:0003723;GO:0001837;GO:0045893;GO:0010468;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:RNA polymerase II transcription regulator complex;, F:mRNA binding; F:RNA binding;, P:epithelial to mesenchymal transition; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression;|Q99729 B3KNN5 D3DWP7 Q04150 Q8N7U3 Q9BQ99,Heterogeneous nuclear ribonucleoprotein A/B,APOBEC1-binding protein 1;, PF08143;PF00076;, GO:0005737;GO:0005654;GO:0005634;GO:1990904;GO:0090575;GO:0003729;GO:0003723;GO:0001837;GO:0045893;GO:0010468;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:RNA polymerase II transcription regulator complex;, F:mRNA binding; F:RNA binding;, P:epithelial to mesenchymal transition; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression;|Q99729 B3KNN5 D3DWP7 Q04150 Q8N7U3 Q9BQ99,Heterogeneous nuclear ribonucleoprotein A/B,APOBEC1-binding protein 1;, PF08143;PF00076;, GO:0005737;GO:0005654;GO:0005634;GO:1990904;GO:0090575;GO:0003729;GO:0003723;GO:0001837;GO:0045893;GO:0010468;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:RNA polymerase II transcription regulator complex;, F:mRNA binding; F:RNA binding;, P:epithelial to mesenchymal transition; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression;|Q99729 B3KNN5 D3DWP7 Q04150 Q8N7U3 Q9BQ99,Heterogeneous nuclear ribonucleoprotein A/B,APOBEC1-binding protein 1;, PF08143;PF00076;, GO:0005737;GO:0005654;GO:0005634;GO:1990904;GO:0090575;GO:0003729;GO:0003723;GO:0001837;GO:0045893;GO:0010468;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:RNA polymerase II transcription regulator complex;, F:mRNA binding; F:RNA binding;, P:epithelial to mesenchymal transition; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression;|Q8IUZ5 A8K7P6 B3KN36 D3DWP9 Q8WYS6 Q96HW8,5-phosphohydroxy-L-lysine phospho-lyase,Alanine--glyoxylate aminotransferase 2-like 2;, PF00202;, GO:0005759;GO:0042802;GO:0016829;GO:0030170;GO:0008483;GO:0030574;GO:0006554;, C:mitochondrial matrix;, F:identical protein binding; F:lyase activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:collagen catabolic process; P:lysine catabolic process;|Q8IUZ5 A8K7P6 B3KN36 D3DWP9 Q8WYS6 Q96HW8,5-phosphohydroxy-L-lysine phospho-lyase,Alanine--glyoxylate aminotransferase 2-like 2;, PF00202;, GO:0005759;GO:0042802;GO:0016829;GO:0030170;GO:0008483;GO:0030574;GO:0006554;, C:mitochondrial matrix;, F:identical protein binding; F:lyase activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:collagen catabolic process; P:lysine catabolic process;|Q8IUZ5 A8K7P6 B3KN36 D3DWP9 Q8WYS6 Q96HW8,5-phosphohydroxy-L-lysine phospho-lyase,Alanine--glyoxylate aminotransferase 2-like 2;, PF00202;, GO:0005759;GO:0042802;GO:0016829;GO:0030170;GO:0008483;GO:0030574;GO:0006554;, C:mitochondrial matrix;, F:identical protein binding; F:lyase activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:collagen catabolic process; P:lysine catabolic process;|Q8IUZ5 A8K7P6 B3KN36 D3DWP9 Q8WYS6 Q96HW8,5-phosphohydroxy-L-lysine phospho-lyase,Alanine--glyoxylate aminotransferase 2-like 2;, PF00202;, GO:0005759;GO:0042802;GO:0016829;GO:0030170;GO:0008483;GO:0030574;GO:0006554;, C:mitochondrial matrix;, F:identical protein binding; F:lyase activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:collagen catabolic process; P:lysine catabolic process; scaffold25 indexed_genome mRNA 25327978 25382682 . - . ID=transcript_5780;Q86Y22 Q8IVR4 Q9NT93,Collagen alpha-1(XXIII) chain,, PF01391;, GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0005201;GO:0030199;GO:0030198;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:extracellular matrix structural constituent;, P:collagen fibril organization; P:extracellular matrix organization; scaffold25 indexed_genome mRNA 25710044 25786962 . - . ID=transcript_5781;Q9HAZ1,Dual specificity protein kinase CLK4,CDC-like kinase 4;, PF00069;, GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0046777;GO:0043484;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:regulation of RNA splicing;|Q9HAZ1,Dual specificity protein kinase CLK4,CDC-like kinase 4;, PF00069;, GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0046777;GO:0043484;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:regulation of RNA splicing;|Q9HAZ1,Dual specificity protein kinase CLK4,CDC-like kinase 4;, PF00069;, GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0046777;GO:0043484;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:regulation of RNA splicing;|Q9HAZ1,Dual specificity protein kinase CLK4,CDC-like kinase 4;, PF00069;, GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0046777;GO:0043484;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:regulation of RNA splicing;|Q9HAZ1,Dual specificity protein kinase CLK4,CDC-like kinase 4;, PF00069;, GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0046777;GO:0043484;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:regulation of RNA splicing;|Q9HAZ1,Dual specificity protein kinase CLK4,CDC-like kinase 4;, PF00069;, GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0046777;GO:0043484;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:regulation of RNA splicing;|O60765 Q9UNJ8,Zinc finger protein 354A,Transcription factor 17;Zinc finger protein eZNF;, PF01352;PF00096;PF16622;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0001822;GO:0000122;GO:0007576;GO:0006357;GO:0051593;GO:0001666;GO:0007605;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:kidney development; P:negative regulation of transcription by RNA polymerase II; P:nucleolar fragmentation; P:regulation of transcription by RNA polymerase II; P:response to folic acid; P:response to hypoxia; P:sensory perception of sound;|Q96LW1 A8K0V2 Q5U5Z4,Zinc finger protein 354B,, PF01352;PF00096;PF16622;, GO:0005634;GO:0003682;GO:0000981;GO:0046872;GO:0000978;GO:0000122;GO:0006357;, C:nucleus;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O60765 Q9UNJ8,Zinc finger protein 354A,Transcription factor 17;Zinc finger protein eZNF;, PF01352;PF00096;PF16622;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0001822;GO:0000122;GO:0007576;GO:0006357;GO:0051593;GO:0001666;GO:0007605;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:kidney development; P:negative regulation of transcription by RNA polymerase II; P:nucleolar fragmentation; P:regulation of transcription by RNA polymerase II; P:response to folic acid; P:response to hypoxia; P:sensory perception of sound; scaffold25 indexed_genome mRNA 25977118 25978712 . - . ID=transcript_5782;P26572 A8K404 B3KRU8 D3DWR1 Q6IBE3,Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase,N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I {ECO:0000303|PubMed:1702225};, PF03071;, GO:0033116;GO:0070062;GO:1903561;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0048471;GO:0003827;GO:0030145;GO:0001701;GO:0006486;GO:0006487;GO:0018279;GO:0006049;GO:0019082;, C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm;, F:alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; F:manganese ion binding;, P:in utero embryonic development; P:protein glycosylation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:UDP-N-acetylglucosamine catabolic process; P:viral protein processing; scaffold25 indexed_genome mRNA 26045646 26061400 . - . ID=transcript_5783;Q8NB50 B4DIP6 B4E0N3 B5MDX6 B7ZVZ2 B9EIP6 E9PFT8 J3QTA9,Zinc finger protein 62 homolog,, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 26099248 26120439 . + . ID=transcript_5784;Q6UXG8 A6NL42 Q6P660 Q96DM5,Butyrophilin-like protein 9,, PF13765;PF00622;PF07686;, GO:0009897;GO:0016021;GO:0005886;GO:0005102;GO:0002250;GO:0001817;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, F:signaling receptor binding;, P:adaptive immune response; P:regulation of cytokine production; P:T cell receptor signaling pathway; scaffold25 indexed_genome mRNA 26328704 26342246 . - . ID=transcript_5785;Q9C029 A2RUE4 D3DWR7 Q969F5 Q96F67 Q96J89 Q96J90,E3 ubiquitin-protein ligase TRIM7 {ECO:0000305},Glycogenin-interacting protein;RING finger protein 90;Tripartite motif-containing protein 7;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005794;GO:0005634;GO:0061630;GO:0008270;GO:0016567;, C:cytoplasm; C:Golgi apparatus; C:nucleus;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:protein ubiquitination; scaffold25 indexed_genome mRNA 26363423 26373578 . + . ID=transcript_5786;Q8WV44 B3KNJ6 D3DWR9 Q5BKT0 Q7L484 Q96Q10 Q9BSL8,E3 ubiquitin-protein ligase TRIM41,RING finger-interacting protein with C kinase;RING-type E3 ubiquitin transferase TRIM41 {ECO:0000305};Tripartite motif-containing protein 41;, PF13765;PF00622;PF00643;, GO:0005737;GO:0016604;GO:0005730;GO:0042802;GO:0061630;GO:0008270;GO:0071222;GO:0071225;GO:0051091;GO:0016567;, C:cytoplasm; C:nuclear body; C:nucleolus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination;|Q8WV44 B3KNJ6 D3DWR9 Q5BKT0 Q7L484 Q96Q10 Q9BSL8,E3 ubiquitin-protein ligase TRIM41,RING finger-interacting protein with C kinase;RING-type E3 ubiquitin transferase TRIM41 {ECO:0000305};Tripartite motif-containing protein 41;, PF13765;PF00622;PF00643;, GO:0005737;GO:0016604;GO:0005730;GO:0042802;GO:0061630;GO:0008270;GO:0071222;GO:0071225;GO:0051091;GO:0016567;, C:cytoplasm; C:nuclear body; C:nucleolus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination;|Q8WV44 B3KNJ6 D3DWR9 Q5BKT0 Q7L484 Q96Q10 Q9BSL8,E3 ubiquitin-protein ligase TRIM41,RING finger-interacting protein with C kinase;RING-type E3 ubiquitin transferase TRIM41 {ECO:0000305};Tripartite motif-containing protein 41;, PF13765;PF00622;PF00643;, GO:0005737;GO:0016604;GO:0005730;GO:0042802;GO:0061630;GO:0008270;GO:0071222;GO:0071225;GO:0051091;GO:0016567;, C:cytoplasm; C:nuclear body; C:nucleolus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination;|Q8WV44 B3KNJ6 D3DWR9 Q5BKT0 Q7L484 Q96Q10 Q9BSL8,E3 ubiquitin-protein ligase TRIM41,RING finger-interacting protein with C kinase;RING-type E3 ubiquitin transferase TRIM41 {ECO:0000305};Tripartite motif-containing protein 41;, PF13765;PF00622;PF00643;, GO:0005737;GO:0016604;GO:0005730;GO:0042802;GO:0061630;GO:0008270;GO:0071222;GO:0071225;GO:0051091;GO:0016567;, C:cytoplasm; C:nuclear body; C:nucleolus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination;|Q8WV44 B3KNJ6 D3DWR9 Q5BKT0 Q7L484 Q96Q10 Q9BSL8,E3 ubiquitin-protein ligase TRIM41,RING finger-interacting protein with C kinase;RING-type E3 ubiquitin transferase TRIM41 {ECO:0000305};Tripartite motif-containing protein 41;, PF13765;PF00622;PF00643;, GO:0005737;GO:0016604;GO:0005730;GO:0042802;GO:0061630;GO:0008270;GO:0071222;GO:0071225;GO:0051091;GO:0016567;, C:cytoplasm; C:nuclear body; C:nucleolus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination;|Q8WV44 B3KNJ6 D3DWR9 Q5BKT0 Q7L484 Q96Q10 Q9BSL8,E3 ubiquitin-protein ligase TRIM41,RING finger-interacting protein with C kinase;RING-type E3 ubiquitin transferase TRIM41 {ECO:0000305};Tripartite motif-containing protein 41;, PF13765;PF00622;PF00643;, GO:0005737;GO:0016604;GO:0005730;GO:0042802;GO:0061630;GO:0008270;GO:0071222;GO:0071225;GO:0051091;GO:0016567;, C:cytoplasm; C:nuclear body; C:nucleolus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination; scaffold25 indexed_genome mRNA 26373837 26379149 . - . ID=transcript_5787;P63244 B3KTJ0 D3DWS0 P25388 P99049 Q53HU2 Q5J8M6 Q5VLR4 Q6FH47,Receptor of activated protein C kinase 1,Cell proliferation-inducing gene 21 protein;Guanine nucleotide-binding protein subunit beta-2-like 1;Guanine nucleotide-binding protein subunit beta-like protein 12.3;Human lung cancer oncogene 7 protein;Receptor for activated C kinase;Small ribosomal subunit protein RACK1 {ECO:0000303|PubMed:24524803};, PF00400;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1990630;GO:0030496;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0001891;GO:0015935;GO:0051434;GO:0045296;GO:0030332;GO:0008656;GO:0019899;GO:0008200;GO:0060090;GO:0042803;GO:0005080;GO:0019903;GO:0030292;GO:0030971;GO:0043022;GO:0003723;GO:0042169;GO:0035591;GO:0005102;GO:0006919;GO:0007049;GO:0071333;GO:0071363;GO:0007369;GO:0030308;GO:1900102;GO:0010629;GO:1903208;GO:0033137;GO:0050765;GO:0032091;GO:0051898;GO:0045879;GO:0017148;GO:0030178;GO:0043065;GO:0030335;GO:2000304;GO:0051343;GO:2000543;GO:0042998;GO:0043547;GO:2001244;GO:0051901;GO:0032436;GO:0001934;GO:0031334;GO:0016567;GO:0051726;GO:0051302;GO:2000114;GO:0032880;GO:0010803;GO:0072344;GO:0048511;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:IRE1-RACK1-PP2A complex; C:midbody; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:phagocytic cup; C:small ribosomal subunit;, F:BH3 domain binding; F:cadherin binding; F:cyclin binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:enzyme binding; F:ion channel inhibitor activity; F:molecular adaptor activity; F:protein homodimerization activity; F:protein kinase C binding; F:protein phosphatase binding; F:protein tyrosine kinase inhibitor activity; F:receptor tyrosine kinase binding; F:ribosome binding; F:RNA binding; F:SH2 domain binding; F:signaling adaptor activity; F:signaling receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:cell cycle; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:gastrulation; P:negative regulation of cell growth; P:negative regulation of endoplasmic reticulum unfolded protein response; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of phagocytosis; P:negative regulation of protein binding; P:negative regulation of protein kinase B signaling; P:negative regulation of smoothened signaling pathway; P:negative regulation of translation; P:negative regulation of Wnt signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of ceramide biosynthetic process; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of gastrulation; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of GTPase activity; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial depolarization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:protein ubiquitination; P:regulation of cell cycle; P:regulation of cell division; P:regulation of establishment of cell polarity; P:regulation of protein localization; P:regulation of tumor necrosis factor-mediated signaling pathway; P:rescue of stalled ribosome; P:rhythmic process; P:viral process;|P63244 B3KTJ0 D3DWS0 P25388 P99049 Q53HU2 Q5J8M6 Q5VLR4 Q6FH47,Receptor of activated protein C kinase 1,Cell proliferation-inducing gene 21 protein;Guanine nucleotide-binding protein subunit beta-2-like 1;Guanine nucleotide-binding protein subunit beta-like protein 12.3;Human lung cancer oncogene 7 protein;Receptor for activated C kinase;Small ribosomal subunit protein RACK1 {ECO:0000303|PubMed:24524803};, PF00400;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1990630;GO:0030496;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0001891;GO:0015935;GO:0051434;GO:0045296;GO:0030332;GO:0008656;GO:0019899;GO:0008200;GO:0060090;GO:0042803;GO:0005080;GO:0019903;GO:0030292;GO:0030971;GO:0043022;GO:0003723;GO:0042169;GO:0035591;GO:0005102;GO:0006919;GO:0007049;GO:0071333;GO:0071363;GO:0007369;GO:0030308;GO:1900102;GO:0010629;GO:1903208;GO:0033137;GO:0050765;GO:0032091;GO:0051898;GO:0045879;GO:0017148;GO:0030178;GO:0043065;GO:0030335;GO:2000304;GO:0051343;GO:2000543;GO:0042998;GO:0043547;GO:2001244;GO:0051901;GO:0032436;GO:0001934;GO:0031334;GO:0016567;GO:0051726;GO:0051302;GO:2000114;GO:0032880;GO:0010803;GO:0072344;GO:0048511;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:IRE1-RACK1-PP2A complex; C:midbody; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:phagocytic cup; C:small ribosomal subunit;, F:BH3 domain binding; F:cadherin binding; F:cyclin binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:enzyme binding; F:ion channel inhibitor activity; F:molecular adaptor activity; F:protein homodimerization activity; F:protein kinase C binding; F:protein phosphatase binding; F:protein tyrosine kinase inhibitor activity; F:receptor tyrosine kinase binding; F:ribosome binding; F:RNA binding; F:SH2 domain binding; F:signaling adaptor activity; F:signaling receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:cell cycle; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:gastrulation; P:negative regulation of cell growth; P:negative regulation of endoplasmic reticulum unfolded protein response; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of phagocytosis; P:negative regulation of protein binding; P:negative regulation of protein kinase B signaling; P:negative regulation of smoothened signaling pathway; P:negative regulation of translation; P:negative regulation of Wnt signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of ceramide biosynthetic process; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of gastrulation; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of GTPase activity; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial depolarization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:protein ubiquitination; P:regulation of cell cycle; P:regulation of cell division; P:regulation of establishment of cell polarity; P:regulation of protein localization; P:regulation of tumor necrosis factor-mediated signaling pathway; P:rescue of stalled ribosome; P:rhythmic process; P:viral process;|P63244 B3KTJ0 D3DWS0 P25388 P99049 Q53HU2 Q5J8M6 Q5VLR4 Q6FH47,Receptor of activated protein C kinase 1,Cell proliferation-inducing gene 21 protein;Guanine nucleotide-binding protein subunit beta-2-like 1;Guanine nucleotide-binding protein subunit beta-like protein 12.3;Human lung cancer oncogene 7 protein;Receptor for activated C kinase;Small ribosomal subunit protein RACK1 {ECO:0000303|PubMed:24524803};, PF00400;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1990630;GO:0030496;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0001891;GO:0015935;GO:0051434;GO:0045296;GO:0030332;GO:0008656;GO:0019899;GO:0008200;GO:0060090;GO:0042803;GO:0005080;GO:0019903;GO:0030292;GO:0030971;GO:0043022;GO:0003723;GO:0042169;GO:0035591;GO:0005102;GO:0006919;GO:0007049;GO:0071333;GO:0071363;GO:0007369;GO:0030308;GO:1900102;GO:0010629;GO:1903208;GO:0033137;GO:0050765;GO:0032091;GO:0051898;GO:0045879;GO:0017148;GO:0030178;GO:0043065;GO:0030335;GO:2000304;GO:0051343;GO:2000543;GO:0042998;GO:0043547;GO:2001244;GO:0051901;GO:0032436;GO:0001934;GO:0031334;GO:0016567;GO:0051726;GO:0051302;GO:2000114;GO:0032880;GO:0010803;GO:0072344;GO:0048511;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:IRE1-RACK1-PP2A complex; C:midbody; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:phagocytic cup; C:small ribosomal subunit;, F:BH3 domain binding; F:cadherin binding; F:cyclin binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:enzyme binding; F:ion channel inhibitor activity; F:molecular adaptor activity; F:protein homodimerization activity; F:protein kinase C binding; F:protein phosphatase binding; F:protein tyrosine kinase inhibitor activity; F:receptor tyrosine kinase binding; F:ribosome binding; F:RNA binding; F:SH2 domain binding; F:signaling adaptor activity; F:signaling receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:cell cycle; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:gastrulation; P:negative regulation of cell growth; P:negative regulation of endoplasmic reticulum unfolded protein response; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of phagocytosis; P:negative regulation of protein binding; P:negative regulation of protein kinase B signaling; P:negative regulation of smoothened signaling pathway; P:negative regulation of translation; P:negative regulation of Wnt signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of ceramide biosynthetic process; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of gastrulation; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of GTPase activity; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial depolarization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:protein ubiquitination; P:regulation of cell cycle; P:regulation of cell division; P:regulation of establishment of cell polarity; P:regulation of protein localization; P:regulation of tumor necrosis factor-mediated signaling pathway; P:rescue of stalled ribosome; P:rhythmic process; P:viral process;|P63244 B3KTJ0 D3DWS0 P25388 P99049 Q53HU2 Q5J8M6 Q5VLR4 Q6FH47,Receptor of activated protein C kinase 1,Cell proliferation-inducing gene 21 protein;Guanine nucleotide-binding protein subunit beta-2-like 1;Guanine nucleotide-binding protein subunit beta-like protein 12.3;Human lung cancer oncogene 7 protein;Receptor for activated C kinase;Small ribosomal subunit protein RACK1 {ECO:0000303|PubMed:24524803};, PF00400;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1990630;GO:0030496;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0001891;GO:0015935;GO:0051434;GO:0045296;GO:0030332;GO:0008656;GO:0019899;GO:0008200;GO:0060090;GO:0042803;GO:0005080;GO:0019903;GO:0030292;GO:0030971;GO:0043022;GO:0003723;GO:0042169;GO:0035591;GO:0005102;GO:0006919;GO:0007049;GO:0071333;GO:0071363;GO:0007369;GO:0030308;GO:1900102;GO:0010629;GO:1903208;GO:0033137;GO:0050765;GO:0032091;GO:0051898;GO:0045879;GO:0017148;GO:0030178;GO:0043065;GO:0030335;GO:2000304;GO:0051343;GO:2000543;GO:0042998;GO:0043547;GO:2001244;GO:0051901;GO:0032436;GO:0001934;GO:0031334;GO:0016567;GO:0051726;GO:0051302;GO:2000114;GO:0032880;GO:0010803;GO:0072344;GO:0048511;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:IRE1-RACK1-PP2A complex; C:midbody; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:phagocytic cup; C:small ribosomal subunit;, F:BH3 domain binding; F:cadherin binding; F:cyclin binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:enzyme binding; F:ion channel inhibitor activity; F:molecular adaptor activity; F:protein homodimerization activity; F:protein kinase C binding; F:protein phosphatase binding; F:protein tyrosine kinase inhibitor activity; F:receptor tyrosine kinase binding; F:ribosome binding; F:RNA binding; F:SH2 domain binding; F:signaling adaptor activity; F:signaling receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:cell cycle; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:gastrulation; P:negative regulation of cell growth; P:negative regulation of endoplasmic reticulum unfolded protein response; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of phagocytosis; P:negative regulation of protein binding; P:negative regulation of protein kinase B signaling; P:negative regulation of smoothened signaling pathway; P:negative regulation of translation; P:negative regulation of Wnt signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of ceramide biosynthetic process; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of gastrulation; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of GTPase activity; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial depolarization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:protein ubiquitination; P:regulation of cell cycle; P:regulation of cell division; P:regulation of establishment of cell polarity; P:regulation of protein localization; P:regulation of tumor necrosis factor-mediated signaling pathway; P:rescue of stalled ribosome; P:rhythmic process; P:viral process; scaffold25 indexed_genome mRNA 26390892 26395031 . - . ID=transcript_5788;Q96A61 L0CQ38 Q59G66,E3 ubiquitin-protein ligase TRIM52,RING finger protein 102;Tripartite motif-containing protein 52;, PF00643;, GO:0005737;GO:0005829;GO:0016604;GO:0005634;GO:0003713;GO:0061630;GO:0008270;GO:0051607;GO:0051091;GO:0043123;GO:0051092;GO:0051865;GO:0016567;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleus;, F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:defense response to virus; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoubiquitination; P:protein ubiquitination; scaffold25 indexed_genome mRNA 26401007 26404043 . - . ID=transcript_5789;Q9UQU7,HLA class I histocompatibility antigen, A alpha chain,Human leukocyte antigen A;, PF07654;PF00129;PF06623;, GO:0009986;GO:0031901;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0070062;GO:0005794;GO:0005797;GO:0000139;GO:0071556;GO:0005887;GO:0016020;GO:0042824;GO:0042612;GO:0030670;GO:0005886;GO:0055038;GO:0030881;GO:0042610;GO:0042605;GO:0003723;GO:0005102;GO:0042608;GO:0046977;GO:0062061;GO:0019731;GO:0019885;GO:0002485;GO:0002486;GO:0042590;GO:0002479;GO:0002480;GO:0002474;GO:0036037;GO:0050830;GO:0016045;GO:0006955;GO:0060333;GO:2001187;GO:2000566;GO:0032729;GO:2000568;GO:0002726;GO:0001916;GO:0042270;GO:0016567;GO:0050776;GO:0001913;GO:0002419;GO:0050852;GO:0060337;GO:0016032;, C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane; C:MHC class I peptide loading complex; C:MHC class I protein complex; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome membrane;, F:beta-2-microglobulin binding; F:CD8 receptor binding; F:peptide antigen binding; F:RNA binding; F:signaling receptor binding; F:T cell receptor binding; F:TAP binding; F:TAP complex binding;, P:antibacterial humoral response; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; P:antigen processing and presentation of peptide antigen via MHC class I; P:CD8-positive, alpha-beta T cell activation; P:defense response to Gram-positive bacterium; P:detection of bacterium; P:immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of CD8-positive, alpha-beta T cell activation; P:positive regulation of CD8-positive, alpha-beta T cell proliferation; P:positive regulation of interferon-gamma production; P:positive regulation of memory T cell activation; P:positive regulation of T cell cytokine production; P:positive regulation of T cell mediated cytotoxicity; P:protection from natural killer cell mediated cytotoxicity; P:protein ubiquitination; P:regulation of immune response; P:T cell mediated cytotoxicity; P:T cell mediated cytotoxicity directed against tumor cell target; P:T cell receptor signaling pathway; P:type I interferon signaling pathway; P:viral process; scaffold25 indexed_genome mRNA 26408989 26418160 . - . ID=transcript_5790;Q9TQB3 Q9TQB9 Q9TQK3,Major histocompatibility complex class I-related gene protein,Class I histocompatibility antigen-like protein;, PF07654;PF00129;, GO:0031901;GO:0005783;GO:0005789;GO:0009897;GO:0005615;GO:0000139;GO:0016021;GO:0031902;GO:0042612;GO:0005886;GO:0030881;GO:0032393;GO:0042608;GO:0019884;GO:0002474;GO:0050829;GO:0050830;GO:0006955;GO:0045087;GO:0002854;GO:0033077;, C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi membrane; C:integral component of membrane; C:late endosome membrane; C:MHC class I protein complex; C:plasma membrane;, F:beta-2-microglobulin binding; F:MHC class I receptor activity; F:T cell receptor binding;, P:antigen processing and presentation of exogenous antigen; P:antigen processing and presentation of peptide antigen via MHC class I; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:immune response; P:innate immune response; P:positive regulation of T cell mediated cytotoxicity directed against tumor cell target; P:T cell differentiation in thymus; scaffold25 indexed_genome mRNA 26454728 26456352 . - . ID=transcript_5791;Q6NXR0 Q05BR8,Interferon-inducible GTPase 5,Immunity-related GTPase cinema 1;, PF05049;, GO:0005789;GO:0005525;GO:0003924;GO:0035458;GO:0006952;, C:endoplasmic reticulum membrane;, F:GTP binding; F:GTPase activity;, P:cellular response to interferon-beta; P:defense response; scaffold25 indexed_genome mRNA 26569676 26615260 . - . ID=transcript_5792;Q96IT1 Q8TBS2,Zinc finger protein 496,Zinc finger protein with KRAB and SCAN domains 17;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:0045893;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q96IT1 Q8TBS2,Zinc finger protein 496,Zinc finger protein with KRAB and SCAN domains 17;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:0045893;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 26664885 26670130 . + . ID=transcript_5793;Q5JQS8 Q5JQS9 Q6TG35 Q8TCW0 Q8TEU9 Q8WXH9,NACHT, LRR and PYD domains-containing protein 3,Angiotensin/vasopressin receptor AII/AVP-like;Caterpiller protein 1.1;Cold-induced autoinflammatory syndrome 1 protein;Cryopyrin;PYRIN-containing APAF1-like protein 1;, PF14484;PF13516;PF05729;PF17776;PF17779;PF02758;, GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0000139;GO:0072559;GO:0005634;GO:0005524;GO:0042802;GO:0042834;GO:0043565;GO:0008134;GO:0006915;GO:0071222;GO:0006952;GO:0009595;GO:0006954;GO:0045087;GO:0002523;GO:0002674;GO:0050728;GO:0032691;GO:0032088;GO:1901223;GO:0043280;GO:0032731;GO:0032753;GO:0051092;GO:2000553;GO:0045630;GO:0045944;GO:0002830;GO:0016579;GO:0035590;GO:0045471;GO:0014070;GO:0007165;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:Golgi membrane; C:NLRP3 inflammasome complex; C:nucleus;, F:ATP binding; F:identical protein binding; F:peptidoglycan binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:apoptotic process; P:cellular response to lipopolysaccharide; P:defense response; P:detection of biotic stimulus; P:inflammatory response; P:innate immune response; P:leukocyte migration involved in inflammatory response; P:negative regulation of acute inflammatory response; P:negative regulation of inflammatory response; P:negative regulation of interleukin-1 beta production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-4 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type 2 immune response; P:protein deubiquitination; P:purinergic nucleotide receptor signaling pathway; P:response to ethanol; P:response to organic cyclic compound; P:signal transduction; scaffold25 indexed_genome mRNA 26670547 26677521 . + . ID=transcript_5794;Q5JQS8 Q5JQS9 Q6TG35 Q8TCW0 Q8TEU9 Q8WXH9,NACHT, LRR and PYD domains-containing protein 3,Angiotensin/vasopressin receptor AII/AVP-like;Caterpiller protein 1.1;Cold-induced autoinflammatory syndrome 1 protein;Cryopyrin;PYRIN-containing APAF1-like protein 1;, PF14484;PF13516;PF05729;PF17776;PF17779;PF02758;, GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0000139;GO:0072559;GO:0005634;GO:0005524;GO:0042802;GO:0042834;GO:0043565;GO:0008134;GO:0006915;GO:0071222;GO:0006952;GO:0009595;GO:0006954;GO:0045087;GO:0002523;GO:0002674;GO:0050728;GO:0032691;GO:0032088;GO:1901223;GO:0043280;GO:0032731;GO:0032753;GO:0051092;GO:2000553;GO:0045630;GO:0045944;GO:0002830;GO:0016579;GO:0035590;GO:0045471;GO:0014070;GO:0007165;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:Golgi membrane; C:NLRP3 inflammasome complex; C:nucleus;, F:ATP binding; F:identical protein binding; F:peptidoglycan binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:apoptotic process; P:cellular response to lipopolysaccharide; P:defense response; P:detection of biotic stimulus; P:inflammatory response; P:innate immune response; P:leukocyte migration involved in inflammatory response; P:negative regulation of acute inflammatory response; P:negative regulation of inflammatory response; P:negative regulation of interleukin-1 beta production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-4 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type 2 immune response; P:protein deubiquitination; P:purinergic nucleotide receptor signaling pathway; P:response to ethanol; P:response to organic cyclic compound; P:signal transduction;|Q5JQS8 Q5JQS9 Q6TG35 Q8TCW0 Q8TEU9 Q8WXH9,NACHT, LRR and PYD domains-containing protein 3,Angiotensin/vasopressin receptor AII/AVP-like;Caterpiller protein 1.1;Cold-induced autoinflammatory syndrome 1 protein;Cryopyrin;PYRIN-containing APAF1-like protein 1;, PF14484;PF13516;PF05729;PF17776;PF17779;PF02758;, GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0000139;GO:0072559;GO:0005634;GO:0005524;GO:0042802;GO:0042834;GO:0043565;GO:0008134;GO:0006915;GO:0071222;GO:0006952;GO:0009595;GO:0006954;GO:0045087;GO:0002523;GO:0002674;GO:0050728;GO:0032691;GO:0032088;GO:1901223;GO:0043280;GO:0032731;GO:0032753;GO:0051092;GO:2000553;GO:0045630;GO:0045944;GO:0002830;GO:0016579;GO:0035590;GO:0045471;GO:0014070;GO:0007165;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:Golgi membrane; C:NLRP3 inflammasome complex; C:nucleus;, F:ATP binding; F:identical protein binding; F:peptidoglycan binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:apoptotic process; P:cellular response to lipopolysaccharide; P:defense response; P:detection of biotic stimulus; P:inflammatory response; P:innate immune response; P:leukocyte migration involved in inflammatory response; P:negative regulation of acute inflammatory response; P:negative regulation of inflammatory response; P:negative regulation of interleukin-1 beta production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-4 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type 2 immune response; P:protein deubiquitination; P:purinergic nucleotide receptor signaling pathway; P:response to ethanol; P:response to organic cyclic compound; P:signal transduction; scaffold25 indexed_genome mRNA 26683516 26709815 . + . ID=transcript_5795;Q5JQS8 Q5JQS9 Q6TG35 Q8TCW0 Q8TEU9 Q8WXH9,NACHT, LRR and PYD domains-containing protein 3,Angiotensin/vasopressin receptor AII/AVP-like;Caterpiller protein 1.1;Cold-induced autoinflammatory syndrome 1 protein;Cryopyrin;PYRIN-containing APAF1-like protein 1;, PF14484;PF13516;PF05729;PF17776;PF17779;PF02758;, GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0000139;GO:0072559;GO:0005634;GO:0005524;GO:0042802;GO:0042834;GO:0043565;GO:0008134;GO:0006915;GO:0071222;GO:0006952;GO:0009595;GO:0006954;GO:0045087;GO:0002523;GO:0002674;GO:0050728;GO:0032691;GO:0032088;GO:1901223;GO:0043280;GO:0032731;GO:0032753;GO:0051092;GO:2000553;GO:0045630;GO:0045944;GO:0002830;GO:0016579;GO:0035590;GO:0045471;GO:0014070;GO:0007165;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:Golgi membrane; C:NLRP3 inflammasome complex; C:nucleus;, F:ATP binding; F:identical protein binding; F:peptidoglycan binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:apoptotic process; P:cellular response to lipopolysaccharide; P:defense response; P:detection of biotic stimulus; P:inflammatory response; P:innate immune response; P:leukocyte migration involved in inflammatory response; P:negative regulation of acute inflammatory response; P:negative regulation of inflammatory response; P:negative regulation of interleukin-1 beta production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-4 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type 2 immune response; P:protein deubiquitination; P:purinergic nucleotide receptor signaling pathway; P:response to ethanol; P:response to organic cyclic compound; P:signal transduction; scaffold25 indexed_genome mRNA 28662882 28679657 . + . ID=transcript_5796;Q6UX82 A0A075B722 K7ELG6,Ly6/PLAUR domain-containing protein 8 {ECO:0000305},, PF00021;, GO:0031225;GO:0005576;GO:0005615;GO:0005886;GO:0050829;, C:anchored component of membrane; C:extracellular region; C:extracellular space; C:plasma membrane;, , P:defense response to Gram-negative bacterium;|Q6UX82 A0A075B722 K7ELG6,Ly6/PLAUR domain-containing protein 8 {ECO:0000305},, PF00021;, GO:0031225;GO:0005576;GO:0005615;GO:0005886;GO:0050829;, C:anchored component of membrane; C:extracellular region; C:extracellular space; C:plasma membrane;, , P:defense response to Gram-negative bacterium; scaffold25 indexed_genome mRNA 28741183 28755565 . - . ID=transcript_5797;Q7L8J4 B4DQ94 Q96FI5 Q9BQH8 Q9C0E3,SH3 domain-binding protein 5-like,, PF05276;, GO:0005737;GO:0005085;GO:0004860;GO:0035556;GO:0061099;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:protein kinase inhibitor activity;, P:intracellular signal transduction; P:negative regulation of protein tyrosine kinase activity;|Q7L8J4 B4DQ94 Q96FI5 Q9BQH8 Q9C0E3,SH3 domain-binding protein 5-like,, PF05276;, GO:0005737;GO:0005085;GO:0004860;GO:0035556;GO:0061099;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:protein kinase inhibitor activity;, P:intracellular signal transduction; P:negative regulation of protein tyrosine kinase activity;|Q7L8J4 B4DQ94 Q96FI5 Q9BQH8 Q9C0E3,SH3 domain-binding protein 5-like,, PF05276;, GO:0005737;GO:0005085;GO:0004860;GO:0035556;GO:0061099;, C:cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:protein kinase inhibitor activity;, P:intracellular signal transduction; P:negative regulation of protein tyrosine kinase activity; scaffold25 indexed_genome mRNA 28773199 28784577 . - . ID=transcript_5798;Q499Z4 Q96H65 Q96IM3 Q9H6G5,Zinc finger protein 672 {ECO:0000305},, PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0043565;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9BU19 B4DXZ0 Q5SRA5 Q5SRA6 Q9HBC9 Q9NW93 Q9NWY6 Q9UF97,Zinc finger protein 692,, PF00096;, GO:0005730;GO:0005654;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0000122;GO:0006357;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BU19 B4DXZ0 Q5SRA5 Q5SRA6 Q9HBC9 Q9NW93 Q9NWY6 Q9UF97,Zinc finger protein 692,, PF00096;, GO:0005730;GO:0005654;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0000122;GO:0006357;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BU19 B4DXZ0 Q5SRA5 Q5SRA6 Q9HBC9 Q9NW93 Q9NWY6 Q9UF97,Zinc finger protein 692,, PF00096;, GO:0005730;GO:0005654;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0000122;GO:0006357;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BU19 B4DXZ0 Q5SRA5 Q5SRA6 Q9HBC9 Q9NW93 Q9NWY6 Q9UF97,Zinc finger protein 692,, PF00096;, GO:0005730;GO:0005654;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0000122;GO:0006357;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BU19 B4DXZ0 Q5SRA5 Q5SRA6 Q9HBC9 Q9NW93 Q9NWY6 Q9UF97,Zinc finger protein 692,, PF00096;, GO:0005730;GO:0005654;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0000122;GO:0006357;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 28879079 28879608 . + . ID=transcript_5799;P52292 B9EJD6 Q53YE3 Q6NVW7 Q9BRU5,Importin subunit alpha-1 {ECO:0000305},Karyopherin subunit alpha-2;RAG cohort protein 1;SRP1-alpha;, PF00514;PF16186;PF01749;, GO:0005737;GO:0005829;GO:0005789;GO:0098892;GO:0098978;GO:0000139;GO:0043657;GO:0016020;GO:0005654;GO:0005634;GO:0042826;GO:0061608;GO:0008139;GO:0003723;GO:0006259;GO:0006302;GO:0075506;GO:0019054;GO:0006607;GO:1903902;GO:0099527;GO:0000018;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of postsynaptic specialization membrane; C:glutamatergic synapse; C:Golgi membrane; C:host cell; C:membrane; C:nucleoplasm; C:nucleus;, F:histone deacetylase binding; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:RNA binding;, P:DNA metabolic process; P:double-strand break repair; P:entry of viral genome into host nucleus through nuclear pore complex via importin; P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:positive regulation of viral life cycle; P:postsynapse to nucleus signaling pathway; P:regulation of DNA recombination; scaffold25 indexed_genome mRNA 29220946 29231127 . - . ID=transcript_5800;O43688 A6NLV0 E9PAY8,Phospholipid phosphatase 2 {ECO:0000305},Lipid phosphate phosphohydrolase 2;PAP2-gamma;Phosphatidate phosphohydrolase type 2c {ECO:0000303|PubMed:9607309};Phosphatidic acid phosphatase 2c {ECO:0000303|PubMed:9607309};, PF01569;, GO:0005901;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0016021;GO:0005887;GO:0005886;GO:0106235;GO:0042577;GO:0008195;GO:0042392;GO:0006672;GO:0046839;GO:0006644;GO:1902806;GO:0007165;GO:0030148;GO:0006670;, C:caveola; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:ceramide-1-phosphate phosphatase activity; F:lipid phosphatase activity; F:phosphatidate phosphatase activity; F:sphingosine-1-phosphate phosphatase activity;, P:ceramide metabolic process; P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:regulation of cell cycle G1/S phase transition; P:signal transduction; P:sphingolipid biosynthetic process; P:sphingosine metabolic process; scaffold25 indexed_genome mRNA 29241138 29256874 . - . ID=transcript_5801;Q8N344 Q9ULM7,Mesoderm induction early response protein 2,, PF01448;PF00249;, GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II;|Q8N344 Q9ULM7,Mesoderm induction early response protein 2,, PF01448;PF00249;, GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II;|Q8N344 Q9ULM7,Mesoderm induction early response protein 2,, PF01448;PF00249;, GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 29319563 29331138 . - . ID=transcript_5802;P98077 O60230 Q9NPL5 Q9UCX4,SHC-transforming protein 2,Protein Sck;SHC-transforming protein B;Src homology 2 domain-containing-transforming protein C2;, PF00640;PF00017;, GO:0005829;GO:0005886;GO:0019901;GO:0030971;GO:0000187;GO:0000165;GO:0007265;GO:0007169;GO:0048010;, C:cytosol; C:plasma membrane;, F:protein kinase binding; F:receptor tyrosine kinase binding;, P:activation of MAPK activity; P:MAPK cascade; P:Ras protein signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold25 indexed_genome mRNA 29331181 29350204 . - . ID=transcript_5803;P98077 O60230 Q9NPL5 Q9UCX4,SHC-transforming protein 2,Protein Sck;SHC-transforming protein B;Src homology 2 domain-containing-transforming protein C2;, PF00640;PF00017;, GO:0005829;GO:0005886;GO:0019901;GO:0030971;GO:0000187;GO:0000165;GO:0007265;GO:0007169;GO:0048010;, C:cytosol; C:plasma membrane;, F:protein kinase binding; F:receptor tyrosine kinase binding;, P:activation of MAPK activity; P:MAPK cascade; P:Ras protein signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P98077 O60230 Q9NPL5 Q9UCX4,SHC-transforming protein 2,Protein Sck;SHC-transforming protein B;Src homology 2 domain-containing-transforming protein C2;, PF00640;PF00017;, GO:0005829;GO:0005886;GO:0019901;GO:0030971;GO:0000187;GO:0000165;GO:0007265;GO:0007169;GO:0048010;, C:cytosol; C:plasma membrane;, F:protein kinase binding; F:receptor tyrosine kinase binding;, P:activation of MAPK activity; P:MAPK cascade; P:Ras protein signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P98077 O60230 Q9NPL5 Q9UCX4,SHC-transforming protein 2,Protein Sck;SHC-transforming protein B;Src homology 2 domain-containing-transforming protein C2;, PF00640;PF00017;, GO:0005829;GO:0005886;GO:0019901;GO:0030971;GO:0000187;GO:0000165;GO:0007265;GO:0007169;GO:0048010;, C:cytosol; C:plasma membrane;, F:protein kinase binding; F:receptor tyrosine kinase binding;, P:activation of MAPK activity; P:MAPK cascade; P:Ras protein signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold25 indexed_genome mRNA 29375568 29376868 . + . ID=transcript_5804;Q6ZTW0 Q96GE2,Tubulin polyglutamylase complex subunit 1,, , GO:0030424;GO:0005813;GO:0005737;GO:0030425;GO:0005874;GO:0031514;GO:0045202;GO:0008017;GO:0070740;GO:0030534;GO:0007268;GO:0007275;GO:0018095;GO:0007288;GO:0051648;, C:axon; C:centrosome; C:cytoplasm; C:dendrite; C:microtubule; C:motile cilium; C:synapse;, F:microtubule binding; F:tubulin-glutamic acid ligase activity;, P:adult behavior; P:chemical synaptic transmission; P:multicellular organism development; P:protein polyglutamylation; P:sperm axoneme assembly; P:vesicle localization; scaffold25 indexed_genome mRNA 29392706 29393581 . - . ID=transcript_5805;P49427 A8K689,Ubiquitin-conjugating enzyme E2 R1,(E3-independent) E2 ubiquitin-conjugating enzyme R1;E2 ubiquitin-conjugating enzyme R1;Ubiquitin-conjugating enzyme E2-32 kDa complementing;Ubiquitin-conjugating enzyme E2-CDC34;Ubiquitin-protein ligase R1;, PF00179;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0061631;GO:0004842;GO:0006464;GO:0035458;GO:0006270;GO:0000082;GO:0043951;GO:0090261;GO:0043525;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0070848;GO:0006511;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:cellular response to interferon-beta; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:negative regulation of cAMP-mediated signaling; P:positive regulation of inclusion body assembly; P:positive regulation of neuron apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:response to growth factor; P:ubiquitin-dependent protein catabolic process; scaffold25 indexed_genome mRNA 29393676 29395853 . + . ID=transcript_5806;P49427 A8K689,Ubiquitin-conjugating enzyme E2 R1,(E3-independent) E2 ubiquitin-conjugating enzyme R1;E2 ubiquitin-conjugating enzyme R1;Ubiquitin-conjugating enzyme E2-32 kDa complementing;Ubiquitin-conjugating enzyme E2-CDC34;Ubiquitin-protein ligase R1;, PF00179;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0061631;GO:0004842;GO:0006464;GO:0035458;GO:0006270;GO:0000082;GO:0043951;GO:0090261;GO:0043525;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0070848;GO:0006511;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:cellular response to interferon-beta; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:negative regulation of cAMP-mediated signaling; P:positive regulation of inclusion body assembly; P:positive regulation of neuron apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:response to growth factor; P:ubiquitin-dependent protein catabolic process; scaffold25 indexed_genome mRNA 29396201 29399911 . + . ID=transcript_5807;P49427 A8K689,Ubiquitin-conjugating enzyme E2 R1,(E3-independent) E2 ubiquitin-conjugating enzyme R1;E2 ubiquitin-conjugating enzyme R1;Ubiquitin-conjugating enzyme E2-32 kDa complementing;Ubiquitin-conjugating enzyme E2-CDC34;Ubiquitin-protein ligase R1;, PF00179;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0061631;GO:0004842;GO:0006464;GO:0035458;GO:0006270;GO:0000082;GO:0043951;GO:0090261;GO:0043525;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0070848;GO:0006511;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:cellular response to interferon-beta; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:negative regulation of cAMP-mediated signaling; P:positive regulation of inclusion body assembly; P:positive regulation of neuron apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:response to growth factor; P:ubiquitin-dependent protein catabolic process;|P49427 A8K689,Ubiquitin-conjugating enzyme E2 R1,(E3-independent) E2 ubiquitin-conjugating enzyme R1;E2 ubiquitin-conjugating enzyme R1;Ubiquitin-conjugating enzyme E2-32 kDa complementing;Ubiquitin-conjugating enzyme E2-CDC34;Ubiquitin-protein ligase R1;, PF00179;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0061631;GO:0004842;GO:0006464;GO:0035458;GO:0006270;GO:0000082;GO:0043951;GO:0090261;GO:0043525;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0070848;GO:0006511;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:cellular response to interferon-beta; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:negative regulation of cAMP-mediated signaling; P:positive regulation of inclusion body assembly; P:positive regulation of neuron apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:response to growth factor; P:ubiquitin-dependent protein catabolic process; scaffold25 indexed_genome mRNA 29401036 29407088 . + . ID=transcript_5808;P51124,Granzyme M,Met-1 serine protease;Met-ase;Natural killer cell granular protease;, PF00089;, GO:0005576;GO:0016020;GO:0004252;GO:0008236;GO:0006915;GO:0008219;GO:0019835;GO:0045087;GO:0001913;, C:extracellular region; C:membrane;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:cell death; P:cytolysis; P:innate immune response; P:T cell mediated cytotoxicity;|P51124,Granzyme M,Met-1 serine protease;Met-ase;Natural killer cell granular protease;, PF00089;, GO:0005576;GO:0016020;GO:0004252;GO:0008236;GO:0006915;GO:0008219;GO:0019835;GO:0045087;GO:0001913;, C:extracellular region; C:membrane;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:cell death; P:cytolysis; P:innate immune response; P:T cell mediated cytotoxicity;|P51124,Granzyme M,Met-1 serine protease;Met-ase;Natural killer cell granular protease;, PF00089;, GO:0005576;GO:0016020;GO:0004252;GO:0008236;GO:0006915;GO:0008219;GO:0019835;GO:0045087;GO:0001913;, C:extracellular region; C:membrane;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:cell death; P:cytolysis; P:innate immune response; P:T cell mediated cytotoxicity; scaffold25 indexed_genome mRNA 29420341 29427305 . + . ID=transcript_5809;P35613 A6NJW1 D3YLG5 Q7Z796 Q8IZL7,Basigin {ECO:0000305},5F7;Collagenase stimulatory factor;Extracellular matrix metalloproteinase inducer;Hepatoma-associated antigen {ECO:0000303|PubMed:15688292};Leukocyte activation antigen M6;OK blood group antigen;Tumor cell-derived collagenase stimulatory factor;, , GO:0002080;GO:0030424;GO:0016323;GO:0005789;GO:0005768;GO:0070062;GO:0005925;GO:0000139;GO:0005887;GO:0043231;GO:0042470;GO:0016020;GO:0045121;GO:0005739;GO:0001917;GO:0001750;GO:0005886;GO:0042383;GO:0045296;GO:0098632;GO:0005537;GO:0038023;GO:0001618;GO:0001525;GO:0007411;GO:0007166;GO:0046697;GO:0070593;GO:0007566;GO:0061154;GO:0022617;GO:0030198;GO:0007156;GO:0050900;GO:0003407;GO:0030593;GO:0042475;GO:0045494;GO:0010595;GO:0032755;GO:1904466;GO:0010575;GO:0046598;GO:0072659;GO:0006090;GO:0051591;GO:0046689;GO:0043434;, C:acrosomal membrane; C:axon; C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:membrane raft; C:mitochondrion; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:sarcolemma;, F:cadherin binding; F:cell-cell adhesion mediator activity; F:mannose binding; F:signaling receptor activity; F:virus receptor activity;, P:angiogenesis; P:axon guidance; P:cell surface receptor signaling pathway; P:decidualization; P:dendrite self-avoidance; P:embryo implantation; P:endothelial tube morphogenesis; P:extracellular matrix disassembly; P:extracellular matrix organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte migration; P:neural retina development; P:neutrophil chemotaxis; P:odontogenesis of dentin-containing tooth; P:photoreceptor cell maintenance; P:positive regulation of endothelial cell migration; P:positive regulation of interleukin-6 production; P:positive regulation of matrix metallopeptidase secretion; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of viral entry into host cell; P:protein localization to plasma membrane; P:pyruvate metabolic process; P:response to cAMP; P:response to mercury ion; P:response to peptide hormone;|P35613 A6NJW1 D3YLG5 Q7Z796 Q8IZL7,Basigin {ECO:0000305},5F7;Collagenase stimulatory factor;Extracellular matrix metalloproteinase inducer;Hepatoma-associated antigen {ECO:0000303|PubMed:15688292};Leukocyte activation antigen M6;OK blood group antigen;Tumor cell-derived collagenase stimulatory factor;, , GO:0002080;GO:0030424;GO:0016323;GO:0005789;GO:0005768;GO:0070062;GO:0005925;GO:0000139;GO:0005887;GO:0043231;GO:0042470;GO:0016020;GO:0045121;GO:0005739;GO:0001917;GO:0001750;GO:0005886;GO:0042383;GO:0045296;GO:0098632;GO:0005537;GO:0038023;GO:0001618;GO:0001525;GO:0007411;GO:0007166;GO:0046697;GO:0070593;GO:0007566;GO:0061154;GO:0022617;GO:0030198;GO:0007156;GO:0050900;GO:0003407;GO:0030593;GO:0042475;GO:0045494;GO:0010595;GO:0032755;GO:1904466;GO:0010575;GO:0046598;GO:0072659;GO:0006090;GO:0051591;GO:0046689;GO:0043434;, C:acrosomal membrane; C:axon; C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:membrane raft; C:mitochondrion; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:sarcolemma;, F:cadherin binding; F:cell-cell adhesion mediator activity; F:mannose binding; F:signaling receptor activity; F:virus receptor activity;, P:angiogenesis; P:axon guidance; P:cell surface receptor signaling pathway; P:decidualization; P:dendrite self-avoidance; P:embryo implantation; P:endothelial tube morphogenesis; P:extracellular matrix disassembly; P:extracellular matrix organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte migration; P:neural retina development; P:neutrophil chemotaxis; P:odontogenesis of dentin-containing tooth; P:photoreceptor cell maintenance; P:positive regulation of endothelial cell migration; P:positive regulation of interleukin-6 production; P:positive regulation of matrix metallopeptidase secretion; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of viral entry into host cell; P:protein localization to plasma membrane; P:pyruvate metabolic process; P:response to cAMP; P:response to mercury ion; P:response to peptide hormone; scaffold25 indexed_genome mRNA 29437304 29455943 . + . ID=transcript_5810;Q9UL51 O60742 O60743 O75267 Q9UBS2,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Brain cyclic nucleotide-gated channel 2;, PF00027;PF00520;PF08412;, GO:0098855;GO:0005887;GO:0005886;GO:0008076;GO:0030552;GO:0042802;GO:0005222;GO:0005249;GO:0005248;GO:0007267;GO:0071320;GO:0071321;GO:0086012;GO:1990573;GO:0071805;GO:0034765;GO:0042391;GO:0098719;GO:0035725;, C:HCN channel complex; C:integral component of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:cAMP binding; F:identical protein binding; F:intracellular cAMP-activated cation channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:cell-cell signaling; P:cellular response to cAMP; P:cellular response to cGMP; P:membrane depolarization during cardiac muscle cell action potential; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport;|Q9UL51 O60742 O60743 O75267 Q9UBS2,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Brain cyclic nucleotide-gated channel 2;, PF00027;PF00520;PF08412;, GO:0098855;GO:0005887;GO:0005886;GO:0008076;GO:0030552;GO:0042802;GO:0005222;GO:0005249;GO:0005248;GO:0007267;GO:0071320;GO:0071321;GO:0086012;GO:1990573;GO:0071805;GO:0034765;GO:0042391;GO:0098719;GO:0035725;, C:HCN channel complex; C:integral component of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:cAMP binding; F:identical protein binding; F:intracellular cAMP-activated cation channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:cell-cell signaling; P:cellular response to cAMP; P:cellular response to cGMP; P:membrane depolarization during cardiac muscle cell action potential; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport;|Q9UL51 O60742 O60743 O75267 Q9UBS2,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Brain cyclic nucleotide-gated channel 2;, PF00027;PF00520;PF08412;, GO:0098855;GO:0005887;GO:0005886;GO:0008076;GO:0030552;GO:0042802;GO:0005222;GO:0005249;GO:0005248;GO:0007267;GO:0071320;GO:0071321;GO:0086012;GO:1990573;GO:0071805;GO:0034765;GO:0042391;GO:0098719;GO:0035725;, C:HCN channel complex; C:integral component of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:cAMP binding; F:identical protein binding; F:intracellular cAMP-activated cation channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:cell-cell signaling; P:cellular response to cAMP; P:cellular response to cGMP; P:membrane depolarization during cardiac muscle cell action potential; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport;|Q9UL51 O60742 O60743 O75267 Q9UBS2,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Brain cyclic nucleotide-gated channel 2;, PF00027;PF00520;PF08412;, GO:0098855;GO:0005887;GO:0005886;GO:0008076;GO:0030552;GO:0042802;GO:0005222;GO:0005249;GO:0005248;GO:0007267;GO:0071320;GO:0071321;GO:0086012;GO:1990573;GO:0071805;GO:0034765;GO:0042391;GO:0098719;GO:0035725;, C:HCN channel complex; C:integral component of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:cAMP binding; F:identical protein binding; F:intracellular cAMP-activated cation channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:cell-cell signaling; P:cellular response to cAMP; P:cellular response to cGMP; P:membrane depolarization during cardiac muscle cell action potential; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport; scaffold25 indexed_genome mRNA 29461865 29475483 . - . ID=transcript_5811;O00411 O60370,DNA-directed RNA polymerase, mitochondrial {ECO:0000305},, PF00940;PF14700;, GO:0034245;GO:0005759;GO:0042645;GO:0005739;GO:0032991;GO:0003899;GO:0001018;GO:0003723;GO:0043565;GO:0006390;GO:0007005;GO:0006391;, C:mitochondrial DNA-directed RNA polymerase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:protein-containing complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:mitochondrial promoter sequence-specific DNA binding; F:RNA binding; F:sequence-specific DNA binding;, P:mitochondrial transcription; P:mitochondrion organization; P:transcription initiation from mitochondrial promoter;|O00411 O60370,DNA-directed RNA polymerase, mitochondrial {ECO:0000305},, PF00940;PF14700;, GO:0034245;GO:0005759;GO:0042645;GO:0005739;GO:0032991;GO:0003899;GO:0001018;GO:0003723;GO:0043565;GO:0006390;GO:0007005;GO:0006391;, C:mitochondrial DNA-directed RNA polymerase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:protein-containing complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:mitochondrial promoter sequence-specific DNA binding; F:RNA binding; F:sequence-specific DNA binding;, P:mitochondrial transcription; P:mitochondrion organization; P:transcription initiation from mitochondrial promoter;|O00411 O60370,DNA-directed RNA polymerase, mitochondrial {ECO:0000305},, PF00940;PF14700;, GO:0034245;GO:0005759;GO:0042645;GO:0005739;GO:0032991;GO:0003899;GO:0001018;GO:0003723;GO:0043565;GO:0006390;GO:0007005;GO:0006391;, C:mitochondrial DNA-directed RNA polymerase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:protein-containing complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:mitochondrial promoter sequence-specific DNA binding; F:RNA binding; F:sequence-specific DNA binding;, P:mitochondrial transcription; P:mitochondrion organization; P:transcription initiation from mitochondrial promoter; scaffold25 indexed_genome mRNA 29490557 29491987 . - . ID=transcript_5812;Q9BV68 Q9NWX1,E3 ubiquitin-protein ligase RNF126 {ECO:0000305},RING finger protein 126 {ECO:0000312|HGNC:HGNC:21151};, PF13639;PF14369;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005154;GO:0046872;GO:0061630;GO:0071629;GO:0042059;GO:0043161;GO:0070936;GO:0070534;GO:0006513;GO:0042127;GO:0042147;GO:0006511;GO:0043162;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:epidermal growth factor receptor binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:cytoplasm protein quality control by the ubiquitin-proteasome system; P:negative regulation of epidermal growth factor receptor signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:regulation of cell population proliferation; P:retrograde transport, endosome to Golgi; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold25 indexed_genome mRNA 29491989 29496626 . - . ID=transcript_5813;Q9BV68 Q9NWX1,E3 ubiquitin-protein ligase RNF126 {ECO:0000305},RING finger protein 126 {ECO:0000312|HGNC:HGNC:21151};, PF13639;PF14369;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005154;GO:0046872;GO:0061630;GO:0071629;GO:0042059;GO:0043161;GO:0070936;GO:0070534;GO:0006513;GO:0042127;GO:0042147;GO:0006511;GO:0043162;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:epidermal growth factor receptor binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:cytoplasm protein quality control by the ubiquitin-proteasome system; P:negative regulation of epidermal growth factor receptor signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:regulation of cell population proliferation; P:retrograde transport, endosome to Golgi; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold25 indexed_genome mRNA 29506267 29512531 . + . ID=transcript_5814;O95633 A8K7E3,Follistatin-related protein 3,Follistatin-like protein 3;Follistatin-related gene protein;, PF09289;PF07648;, GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0044306;GO:0005654;GO:0005634;GO:0030141;GO:0048185;GO:0001968;GO:0030325;GO:0030154;GO:0044267;GO:0071248;GO:0002244;GO:0001822;GO:0030324;GO:0008584;GO:0007275;GO:0032926;GO:0030514;GO:0045671;GO:0090101;GO:0001503;GO:0022409;GO:0045944;GO:0043687;GO:0030510;GO:0006357;GO:0007283;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:neuron projection terminus; C:nucleoplasm; C:nucleus; C:secretory granule;, F:activin binding; F:fibronectin binding;, P:adrenal gland development; P:cell differentiation; P:cellular protein metabolic process; P:cellular response to metal ion; P:hematopoietic progenitor cell differentiation; P:kidney development; P:lung development; P:male gonad development; P:multicellular organism development; P:negative regulation of activin receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of osteoclast differentiation; P:negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway; P:ossification; P:positive regulation of cell-cell adhesion; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:regulation of BMP signaling pathway; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|O95633 A8K7E3,Follistatin-related protein 3,Follistatin-like protein 3;Follistatin-related gene protein;, PF09289;PF07648;, GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0044306;GO:0005654;GO:0005634;GO:0030141;GO:0048185;GO:0001968;GO:0030325;GO:0030154;GO:0044267;GO:0071248;GO:0002244;GO:0001822;GO:0030324;GO:0008584;GO:0007275;GO:0032926;GO:0030514;GO:0045671;GO:0090101;GO:0001503;GO:0022409;GO:0045944;GO:0043687;GO:0030510;GO:0006357;GO:0007283;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:neuron projection terminus; C:nucleoplasm; C:nucleus; C:secretory granule;, F:activin binding; F:fibronectin binding;, P:adrenal gland development; P:cell differentiation; P:cellular protein metabolic process; P:cellular response to metal ion; P:hematopoietic progenitor cell differentiation; P:kidney development; P:lung development; P:male gonad development; P:multicellular organism development; P:negative regulation of activin receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of osteoclast differentiation; P:negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway; P:ossification; P:positive regulation of cell-cell adhesion; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:regulation of BMP signaling pathway; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|O95633 A8K7E3,Follistatin-related protein 3,Follistatin-like protein 3;Follistatin-related gene protein;, PF09289;PF07648;, GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0044306;GO:0005654;GO:0005634;GO:0030141;GO:0048185;GO:0001968;GO:0030325;GO:0030154;GO:0044267;GO:0071248;GO:0002244;GO:0001822;GO:0030324;GO:0008584;GO:0007275;GO:0032926;GO:0030514;GO:0045671;GO:0090101;GO:0001503;GO:0022409;GO:0045944;GO:0043687;GO:0030510;GO:0006357;GO:0007283;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:neuron projection terminus; C:nucleoplasm; C:nucleus; C:secretory granule;, F:activin binding; F:fibronectin binding;, P:adrenal gland development; P:cell differentiation; P:cellular protein metabolic process; P:cellular response to metal ion; P:hematopoietic progenitor cell differentiation; P:kidney development; P:lung development; P:male gonad development; P:multicellular organism development; P:negative regulation of activin receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of osteoclast differentiation; P:negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway; P:ossification; P:positive regulation of cell-cell adhesion; P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:regulation of BMP signaling pathway; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold25 indexed_genome mRNA 29534774 29549743 . + . ID=transcript_5815;O75781 O43359 O95673 Q92559 Q9UPJ4 Q9UQS2 Q9UQS3,Paralemmin-1,Paralemmin;, PF03285;, GO:0016327;GO:0030424;GO:0016323;GO:0031410;GO:0032591;GO:0031527;GO:0031235;GO:0005654;GO:0005886;GO:0014069;GO:0031750;GO:0007193;GO:0071257;GO:0007010;GO:0007194;GO:0060160;GO:0051491;GO:0072659;GO:0008360;GO:0060074;, C:apicolateral plasma membrane; C:axon; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:dendritic spine membrane; C:filopodium membrane; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density;, F:D3 dopamine receptor binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cellular response to electrical stimulus; P:cytoskeleton organization; P:negative regulation of adenylate cyclase activity; P:negative regulation of dopamine receptor signaling pathway; P:positive regulation of filopodium assembly; P:protein localization to plasma membrane; P:regulation of cell shape; P:synapse maturation;|O75781 O43359 O95673 Q92559 Q9UPJ4 Q9UQS2 Q9UQS3,Paralemmin-1,Paralemmin;, PF03285;, GO:0016327;GO:0030424;GO:0016323;GO:0031410;GO:0032591;GO:0031527;GO:0031235;GO:0005654;GO:0005886;GO:0014069;GO:0031750;GO:0007193;GO:0071257;GO:0007010;GO:0007194;GO:0060160;GO:0051491;GO:0072659;GO:0008360;GO:0060074;, C:apicolateral plasma membrane; C:axon; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:dendritic spine membrane; C:filopodium membrane; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density;, F:D3 dopamine receptor binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cellular response to electrical stimulus; P:cytoskeleton organization; P:negative regulation of adenylate cyclase activity; P:negative regulation of dopamine receptor signaling pathway; P:positive regulation of filopodium assembly; P:protein localization to plasma membrane; P:regulation of cell shape; P:synapse maturation;|O75781 O43359 O95673 Q92559 Q9UPJ4 Q9UQS2 Q9UQS3,Paralemmin-1,Paralemmin;, PF03285;, GO:0016327;GO:0030424;GO:0016323;GO:0031410;GO:0032591;GO:0031527;GO:0031235;GO:0005654;GO:0005886;GO:0014069;GO:0031750;GO:0007193;GO:0071257;GO:0007010;GO:0007194;GO:0060160;GO:0051491;GO:0072659;GO:0008360;GO:0060074;, C:apicolateral plasma membrane; C:axon; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:dendritic spine membrane; C:filopodium membrane; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density;, F:D3 dopamine receptor binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cellular response to electrical stimulus; P:cytoskeleton organization; P:negative regulation of adenylate cyclase activity; P:negative regulation of dopamine receptor signaling pathway; P:positive regulation of filopodium assembly; P:protein localization to plasma membrane; P:regulation of cell shape; P:synapse maturation;|O75781 O43359 O95673 Q92559 Q9UPJ4 Q9UQS2 Q9UQS3,Paralemmin-1,Paralemmin;, PF03285;, GO:0016327;GO:0030424;GO:0016323;GO:0031410;GO:0032591;GO:0031527;GO:0031235;GO:0005654;GO:0005886;GO:0014069;GO:0031750;GO:0007193;GO:0071257;GO:0007010;GO:0007194;GO:0060160;GO:0051491;GO:0072659;GO:0008360;GO:0060074;, C:apicolateral plasma membrane; C:axon; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:dendritic spine membrane; C:filopodium membrane; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density;, F:D3 dopamine receptor binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cellular response to electrical stimulus; P:cytoskeleton organization; P:negative regulation of adenylate cyclase activity; P:negative regulation of dopamine receptor signaling pathway; P:positive regulation of filopodium assembly; P:protein localization to plasma membrane; P:regulation of cell shape; P:synapse maturation;|O75781 O43359 O95673 Q92559 Q9UPJ4 Q9UQS2 Q9UQS3,Paralemmin-1,Paralemmin;, PF03285;, GO:0016327;GO:0030424;GO:0016323;GO:0031410;GO:0032591;GO:0031527;GO:0031235;GO:0005654;GO:0005886;GO:0014069;GO:0031750;GO:0007193;GO:0071257;GO:0007010;GO:0007194;GO:0060160;GO:0051491;GO:0072659;GO:0008360;GO:0060074;, C:apicolateral plasma membrane; C:axon; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:dendritic spine membrane; C:filopodium membrane; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density;, F:D3 dopamine receptor binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cellular response to electrical stimulus; P:cytoskeleton organization; P:negative regulation of adenylate cyclase activity; P:negative regulation of dopamine receptor signaling pathway; P:positive regulation of filopodium assembly; P:protein localization to plasma membrane; P:regulation of cell shape; P:synapse maturation; scaffold25 indexed_genome mRNA 29549846 29555811 . + . ID=transcript_5816;Q8IVT2,Mitotic interactor and substrate of PLK1 {ECO:0000303|PubMed:23574715},Mitotic spindle positioning protein {ECO:0000312|HGNC:HGNC:27000};, PF15304;, GO:0005884;GO:0005938;GO:0005925;GO:0043231;GO:0005886;GO:0031616;GO:0051015;GO:0051301;GO:0016477;GO:0051660;GO:0000132;GO:0090307;GO:0051640;GO:1904776;, C:actin filament; C:cell cortex; C:focal adhesion; C:intracellular membrane-bounded organelle; C:plasma membrane; C:spindle pole centrosome;, F:actin filament binding;, P:cell division; P:cell migration; P:establishment of centrosome localization; P:establishment of mitotic spindle orientation; P:mitotic spindle assembly; P:organelle localization; P:regulation of protein localization to cell cortex; scaffold25 indexed_genome mRNA 29556090 29560201 . + . ID=transcript_5817;Q8IVT2,Mitotic interactor and substrate of PLK1 {ECO:0000303|PubMed:23574715},Mitotic spindle positioning protein {ECO:0000312|HGNC:HGNC:27000};, PF15304;, GO:0005884;GO:0005938;GO:0005925;GO:0043231;GO:0005886;GO:0031616;GO:0051015;GO:0051301;GO:0016477;GO:0051660;GO:0000132;GO:0090307;GO:0051640;GO:1904776;, C:actin filament; C:cell cortex; C:focal adhesion; C:intracellular membrane-bounded organelle; C:plasma membrane; C:spindle pole centrosome;, F:actin filament binding;, P:cell division; P:cell migration; P:establishment of centrosome localization; P:establishment of mitotic spindle orientation; P:mitotic spindle assembly; P:organelle localization; P:regulation of protein localization to cell cortex; scaffold25 indexed_genome mRNA 29591140 29613124 . + . ID=transcript_5818;P26599 Q9BUQ0,Polypyrimidine tract-binding protein 1,57 kDa RNA-binding protein PPTB-1;Heterogeneous nuclear ribonucleoprotein I;, PF00076;PF11835;, GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0003729;GO:0008187;GO:0036002;GO:0003723;GO:0008543;GO:0075522;GO:0006397;GO:0000398;GO:0048025;GO:0051148;GO:0033119;GO:0070886;GO:0035307;GO:0000381;GO:0045595;GO:0043484;GO:0016070;GO:0008380;, C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:poly-pyrimidine tract binding; F:pre-mRNA binding; F:RNA binding;, P:fibroblast growth factor receptor signaling pathway; P:IRES-dependent viral translational initiation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of muscle cell differentiation; P:negative regulation of RNA splicing; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of protein dephosphorylation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of cell differentiation; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA splicing;|P26599 Q9BUQ0,Polypyrimidine tract-binding protein 1,57 kDa RNA-binding protein PPTB-1;Heterogeneous nuclear ribonucleoprotein I;, PF00076;PF11835;, GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0003729;GO:0008187;GO:0036002;GO:0003723;GO:0008543;GO:0075522;GO:0006397;GO:0000398;GO:0048025;GO:0051148;GO:0033119;GO:0070886;GO:0035307;GO:0000381;GO:0045595;GO:0043484;GO:0016070;GO:0008380;, C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:poly-pyrimidine tract binding; F:pre-mRNA binding; F:RNA binding;, P:fibroblast growth factor receptor signaling pathway; P:IRES-dependent viral translational initiation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of muscle cell differentiation; P:negative regulation of RNA splicing; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of protein dephosphorylation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of cell differentiation; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA splicing;|P26599 Q9BUQ0,Polypyrimidine tract-binding protein 1,57 kDa RNA-binding protein PPTB-1;Heterogeneous nuclear ribonucleoprotein I;, PF00076;PF11835;, GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0003729;GO:0008187;GO:0036002;GO:0003723;GO:0008543;GO:0075522;GO:0006397;GO:0000398;GO:0048025;GO:0051148;GO:0033119;GO:0070886;GO:0035307;GO:0000381;GO:0045595;GO:0043484;GO:0016070;GO:0008380;, C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:poly-pyrimidine tract binding; F:pre-mRNA binding; F:RNA binding;, P:fibroblast growth factor receptor signaling pathway; P:IRES-dependent viral translational initiation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of muscle cell differentiation; P:negative regulation of RNA splicing; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of protein dephosphorylation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of cell differentiation; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA splicing;|Q6T4P5 Q86XQ4 Q96EH1 Q9BQF9 Q9HAJ4,Phospholipid phosphatase-related protein type 3 {ECO:0000305},Lipid phosphate phosphatase-related protein type 3 {ECO:0000303|Ref.3};PAP-2-like protein 2 {ECO:0000303|Ref.2};Plasticity-related gene 2 protein {ECO:0000305|PubMed:12730698};, PF01569;, GO:0005887;GO:0042577;GO:0008195;GO:0046839;GO:0006644;GO:0007165;, C:integral component of plasma membrane;, F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:signal transduction;|P26599 Q9BUQ0,Polypyrimidine tract-binding protein 1,57 kDa RNA-binding protein PPTB-1;Heterogeneous nuclear ribonucleoprotein I;, PF00076;PF11835;, GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0003729;GO:0008187;GO:0036002;GO:0003723;GO:0008543;GO:0075522;GO:0006397;GO:0000398;GO:0048025;GO:0051148;GO:0033119;GO:0070886;GO:0035307;GO:0000381;GO:0045595;GO:0043484;GO:0016070;GO:0008380;, C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:poly-pyrimidine tract binding; F:pre-mRNA binding; F:RNA binding;, P:fibroblast growth factor receptor signaling pathway; P:IRES-dependent viral translational initiation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of muscle cell differentiation; P:negative regulation of RNA splicing; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of protein dephosphorylation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of cell differentiation; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA splicing;|Q6T4P5 Q86XQ4 Q96EH1 Q9BQF9 Q9HAJ4,Phospholipid phosphatase-related protein type 3 {ECO:0000305},Lipid phosphate phosphatase-related protein type 3 {ECO:0000303|Ref.3};PAP-2-like protein 2 {ECO:0000303|Ref.2};Plasticity-related gene 2 protein {ECO:0000305|PubMed:12730698};, PF01569;, GO:0005887;GO:0042577;GO:0008195;GO:0046839;GO:0006644;GO:0007165;, C:integral component of plasma membrane;, F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:signal transduction;|Q6T4P5 Q86XQ4 Q96EH1 Q9BQF9 Q9HAJ4,Phospholipid phosphatase-related protein type 3 {ECO:0000305},Lipid phosphate phosphatase-related protein type 3 {ECO:0000303|Ref.3};PAP-2-like protein 2 {ECO:0000303|Ref.2};Plasticity-related gene 2 protein {ECO:0000305|PubMed:12730698};, PF01569;, GO:0005887;GO:0042577;GO:0008195;GO:0046839;GO:0006644;GO:0007165;, C:integral component of plasma membrane;, F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:signal transduction; scaffold25 indexed_genome mRNA 29641140 29643672 . + . ID=transcript_5819;P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4,Complement factor D,Adipsin;C3 convertase activator;Properdin factor D;, PF00089;, GO:0070062;GO:0005576;GO:1904813;GO:0031093;GO:0034774;GO:0004252;GO:0008236;GO:0006956;GO:0006957;GO:0043312;GO:0007219;GO:0002576;GO:0006508;, C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:platelet alpha granule lumen; C:secretory granule lumen;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:complement activation; P:complement activation, alternative pathway; P:neutrophil degranulation; P:Notch signaling pathway; P:platelet degranulation; P:proteolysis; scaffold25 indexed_genome mRNA 29648332 29660504 . - . ID=transcript_5820;Q9Y2X0 Q6PJT2 Q96AD4 Q96I35 Q9Y652,Mediator of RNA polymerase II transcription subunit 16,Mediator complex subunit 16;Thyroid hormone receptor-associated protein 5;Thyroid hormone receptor-associated protein complex 95 kDa component;Vitamin D3 receptor-interacting protein complex 92 kDa component;, PF11635;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0003824;GO:0046966;GO:0003713;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:catalytic activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II;|Q9Y2X0 Q6PJT2 Q96AD4 Q96I35 Q9Y652,Mediator of RNA polymerase II transcription subunit 16,Mediator complex subunit 16;Thyroid hormone receptor-associated protein 5;Thyroid hormone receptor-associated protein complex 95 kDa component;Vitamin D3 receptor-interacting protein complex 92 kDa component;, PF11635;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0003824;GO:0046966;GO:0003713;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:catalytic activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II;|Q9Y2X0 Q6PJT2 Q96AD4 Q96I35 Q9Y652,Mediator of RNA polymerase II transcription subunit 16,Mediator complex subunit 16;Thyroid hormone receptor-associated protein 5;Thyroid hormone receptor-associated protein complex 95 kDa component;Vitamin D3 receptor-interacting protein complex 92 kDa component;, PF11635;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0003824;GO:0046966;GO:0003713;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:catalytic activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II;|Q9Y2X0 Q6PJT2 Q96AD4 Q96I35 Q9Y652,Mediator of RNA polymerase II transcription subunit 16,Mediator complex subunit 16;Thyroid hormone receptor-associated protein 5;Thyroid hormone receptor-associated protein complex 95 kDa component;Vitamin D3 receptor-interacting protein complex 92 kDa component;, PF11635;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0003824;GO:0046966;GO:0003713;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:catalytic activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II;|Q9Y2X0 Q6PJT2 Q96AD4 Q96I35 Q9Y652,Mediator of RNA polymerase II transcription subunit 16,Mediator complex subunit 16;Thyroid hormone receptor-associated protein 5;Thyroid hormone receptor-associated protein complex 95 kDa component;Vitamin D3 receptor-interacting protein complex 92 kDa component;, PF11635;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0003824;GO:0046966;GO:0003713;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:catalytic activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 29663542 29681155 . - . ID=transcript_5821;Q96D70,R3H domain-containing protein 4,, PF01424;PF13902;, GO:0005634;GO:0003676;, C:nucleus;, F:nucleic acid binding;|Q96D70,R3H domain-containing protein 4,, PF01424;PF13902;, GO:0005634;GO:0003676;, C:nucleus;, F:nucleic acid binding;|Q969F8 A5D8U2 B2RTV1 Q96QG0,KiSS-1 receptor,G-protein coupled receptor 54;G-protein coupled receptor OT7T175;Hypogonadotropin-1;Kisspeptins receptor;Metastin receptor;, PF00001;, GO:0009986;GO:0005929;GO:0016021;GO:0005887;GO:0043231;GO:0005886;GO:0008528;GO:0008188;GO:0007186;GO:0007218;, C:cell surface; C:cilium; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:neuropeptide receptor activity;, P:G protein-coupled receptor signaling pathway; P:neuropeptide signaling pathway; scaffold25 indexed_genome mRNA 29698969 29718565 . + . ID=transcript_5822;Q99856 Q5I858 Q6P9C6 Q8IZA7 Q8N4Z3,AT-rich interactive domain-containing protein 3A,B-cell regulator of IgH transcription;Dead ringer-like protein 1;E2F-binding protein 1;, PF01388;, GO:0005829;GO:0045121;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0042802;GO:0003712;GO:0006977;GO:0045944;GO:0006357;, C:cytosol; C:membrane raft; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:identical protein binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 29720425 29726522 . + . ID=transcript_5823;Q99856 Q5I858 Q6P9C6 Q8IZA7 Q8N4Z3,AT-rich interactive domain-containing protein 3A,B-cell regulator of IgH transcription;Dead ringer-like protein 1;E2F-binding protein 1;, PF01388;, GO:0005829;GO:0045121;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0042802;GO:0003712;GO:0006977;GO:0045944;GO:0006357;, C:cytosol; C:membrane raft; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:identical protein binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold25 indexed_genome mRNA 29732844 29740609 . + . ID=transcript_5824;Q9BV38 O60390 Q9BWR2,WD repeat-containing protein 18,, PF00400;PF14077;, GO:0005737;GO:0005656;GO:0005730;GO:0005654;GO:0097344;GO:0007275;GO:0030174;GO:0006364;, C:cytoplasm; C:nuclear pre-replicative complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:multicellular organism development; P:regulation of DNA-dependent DNA replication initiation; P:rRNA processing;|Q9BV38 O60390 Q9BWR2,WD repeat-containing protein 18,, PF00400;PF14077;, GO:0005737;GO:0005656;GO:0005730;GO:0005654;GO:0097344;GO:0007275;GO:0030174;GO:0006364;, C:cytoplasm; C:nuclear pre-replicative complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:multicellular organism development; P:regulation of DNA-dependent DNA replication initiation; P:rRNA processing;|Q9BV38 O60390 Q9BWR2,WD repeat-containing protein 18,, PF00400;PF14077;, GO:0005737;GO:0005656;GO:0005730;GO:0005654;GO:0097344;GO:0007275;GO:0030174;GO:0006364;, C:cytoplasm; C:nuclear pre-replicative complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:multicellular organism development; P:regulation of DNA-dependent DNA replication initiation; P:rRNA processing; scaffold25 indexed_genome mRNA 29744688 29758374 . - . ID=transcript_5825;O60391 Q5EAK7 Q7RTW9,Glutamate receptor ionotropic, NMDA 3B,N-methyl-D-aspartate receptor subtype 3B;, PF00060;PF10613;, GO:0043025;GO:0017146;GO:0005886;GO:0045211;GO:0005262;GO:0005261;GO:0016594;GO:0004970;GO:0015276;GO:0042165;GO:0030594;GO:0038023;GO:0035235;GO:0051205;GO:0051924;, C:neuronal cell body; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic membrane;, F:calcium channel activity; F:cation channel activity; F:glycine binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:neurotransmitter binding; F:neurotransmitter receptor activity; F:signaling receptor activity;, P:ionotropic glutamate receptor signaling pathway; P:protein insertion into membrane; P:regulation of calcium ion transport;|Q4ZIN3 O60392 Q8NF79 Q96H30,Membralin,Transmembrane protein 259;, PF09746;, GO:0005783;GO:0005789;GO:0016021;GO:1901215;GO:1904294;GO:0034976;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:negative regulation of neuron death; P:positive regulation of ERAD pathway; P:response to endoplasmic reticulum stress;|Q4ZIN3 O60392 Q8NF79 Q96H30,Membralin,Transmembrane protein 259;, PF09746;, GO:0005783;GO:0005789;GO:0016021;GO:1901215;GO:1904294;GO:0034976;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:negative regulation of neuron death; P:positive regulation of ERAD pathway; P:response to endoplasmic reticulum stress; scaffold25 indexed_genome mRNA 29766343 29775488 . + . ID=transcript_5826;Q99439 A5D8U8 A6NFI4 D6W5X9 Q92578,Calponin-2,Calponin H2, smooth muscle;Neutral calponin;, PF00402;PF00307;, GO:0005911;GO:0005856;GO:0005576;GO:0005925;GO:0016020;GO:0035580;GO:0001725;GO:1904724;GO:0003779;GO:0045296;GO:0005516;GO:0031032;GO:0071260;GO:0007010;GO:0035722;GO:0043312;GO:0032970;, C:cell-cell junction; C:cytoskeleton; C:extracellular region; C:focal adhesion; C:membrane; C:specific granule lumen; C:stress fiber; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calmodulin binding;, P:actomyosin structure organization; P:cellular response to mechanical stimulus; P:cytoskeleton organization; P:interleukin-12-mediated signaling pathway; P:neutrophil degranulation; P:regulation of actin filament-based process;|Q99439 A5D8U8 A6NFI4 D6W5X9 Q92578,Calponin-2,Calponin H2, smooth muscle;Neutral calponin;, PF00402;PF00307;, GO:0005911;GO:0005856;GO:0005576;GO:0005925;GO:0016020;GO:0035580;GO:0001725;GO:1904724;GO:0003779;GO:0045296;GO:0005516;GO:0031032;GO:0071260;GO:0007010;GO:0035722;GO:0043312;GO:0032970;, C:cell-cell junction; C:cytoskeleton; C:extracellular region; C:focal adhesion; C:membrane; C:specific granule lumen; C:stress fiber; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calmodulin binding;, P:actomyosin structure organization; P:cellular response to mechanical stimulus; P:cytoskeleton organization; P:interleukin-12-mediated signaling pathway; P:neutrophil degranulation; P:regulation of actin filament-based process;|Q99439 A5D8U8 A6NFI4 D6W5X9 Q92578,Calponin-2,Calponin H2, smooth muscle;Neutral calponin;, PF00402;PF00307;, GO:0005911;GO:0005856;GO:0005576;GO:0005925;GO:0016020;GO:0035580;GO:0001725;GO:1904724;GO:0003779;GO:0045296;GO:0005516;GO:0031032;GO:0071260;GO:0007010;GO:0035722;GO:0043312;GO:0032970;, C:cell-cell junction; C:cytoskeleton; C:extracellular region; C:focal adhesion; C:membrane; C:specific granule lumen; C:stress fiber; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:calmodulin binding;, P:actomyosin structure organization; P:cellular response to mechanical stimulus; P:cytoskeleton organization; P:interleukin-12-mediated signaling pathway; P:neutrophil degranulation; P:regulation of actin filament-based process; scaffold25 indexed_genome mRNA 29784627 29785826 . - . ID=transcript_5827;P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold25 indexed_genome mRNA 29786709 29801382 . + . ID=transcript_5828;Q8IZY2 Q96S58 Q9BZC4 Q9NR73 Q9UKP8,Phospholipid-transporting ATPase ABCA7 {ECO:0000305},ABCA-SSN {ECO:0000303|PubMed:11355874};ATP-binding cassette sub-family A member 7 {ECO:0000305};Autoantigen SS-N {ECO:0000303|Ref.6};Macrophage ABC transporter {ECO:0000303|PubMed:10873640};, PF00005;, GO:0030054;GO:0009986;GO:0031901;GO:0005783;GO:0097386;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0001891;GO:0005886;GO:0032587;GO:0034188;GO:0005524;GO:0016887;GO:0042626;GO:0140328;GO:0005319;GO:0090554;GO:0090556;GO:0005548;GO:0150094;GO:0034205;GO:0038027;GO:0033344;GO:0034380;GO:0006869;GO:0007613;GO:0042985;GO:1902430;GO:0045806;GO:0043409;GO:1903898;GO:0018149;GO:0006909;GO:0033700;GO:0045332;GO:0044857;GO:1900223;GO:0010875;GO:1901076;GO:0070374;GO:0050766;GO:1902995;GO:2000010;GO:0034504;GO:1902991;GO:0019216;GO:0008542;, C:cell junction; C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:glial cell projection; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:phagocytic cup; C:plasma membrane; C:ruffle membrane;, F:apolipoprotein A-I receptor activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity;, P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta formation; P:apolipoprotein A-I-mediated signaling pathway; P:cholesterol efflux; P:high-density lipoprotein particle assembly; P:lipid transport; P:memory; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of amyloid-beta formation; P:negative regulation of endocytosis; P:negative regulation of MAPK cascade; P:negative regulation of PERK-mediated unfolded protein response; P:peptide cross-linking; P:phagocytosis; P:phospholipid efflux; P:phospholipid translocation; P:plasma membrane raft organization; P:positive regulation of amyloid-beta clearance; P:positive regulation of cholesterol efflux; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phagocytosis; P:positive regulation of phospholipid efflux; P:positive regulation of protein localization to cell surface; P:protein localization to nucleus; P:regulation of amyloid precursor protein catabolic process; P:regulation of lipid metabolic process; P:visual learning;|Q8IZY2 Q96S58 Q9BZC4 Q9NR73 Q9UKP8,Phospholipid-transporting ATPase ABCA7 {ECO:0000305},ABCA-SSN {ECO:0000303|PubMed:11355874};ATP-binding cassette sub-family A member 7 {ECO:0000305};Autoantigen SS-N {ECO:0000303|Ref.6};Macrophage ABC transporter {ECO:0000303|PubMed:10873640};, PF00005;, GO:0030054;GO:0009986;GO:0031901;GO:0005783;GO:0097386;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0001891;GO:0005886;GO:0032587;GO:0034188;GO:0005524;GO:0016887;GO:0042626;GO:0140328;GO:0005319;GO:0090554;GO:0090556;GO:0005548;GO:0150094;GO:0034205;GO:0038027;GO:0033344;GO:0034380;GO:0006869;GO:0007613;GO:0042985;GO:1902430;GO:0045806;GO:0043409;GO:1903898;GO:0018149;GO:0006909;GO:0033700;GO:0045332;GO:0044857;GO:1900223;GO:0010875;GO:1901076;GO:0070374;GO:0050766;GO:1902995;GO:2000010;GO:0034504;GO:1902991;GO:0019216;GO:0008542;, C:cell junction; C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:glial cell projection; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:phagocytic cup; C:plasma membrane; C:ruffle membrane;, F:apolipoprotein A-I receptor activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity;, P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta formation; P:apolipoprotein A-I-mediated signaling pathway; P:cholesterol efflux; P:high-density lipoprotein particle assembly; P:lipid transport; P:memory; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of amyloid-beta formation; P:negative regulation of endocytosis; P:negative regulation of MAPK cascade; P:negative regulation of PERK-mediated unfolded protein response; P:peptide cross-linking; P:phagocytosis; P:phospholipid efflux; P:phospholipid translocation; P:plasma membrane raft organization; P:positive regulation of amyloid-beta clearance; P:positive regulation of cholesterol efflux; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phagocytosis; P:positive regulation of phospholipid efflux; P:positive regulation of protein localization to cell surface; P:protein localization to nucleus; P:regulation of amyloid precursor protein catabolic process; P:regulation of lipid metabolic process; P:visual learning;|Q8IZY2 Q96S58 Q9BZC4 Q9NR73 Q9UKP8,Phospholipid-transporting ATPase ABCA7 {ECO:0000305},ABCA-SSN {ECO:0000303|PubMed:11355874};ATP-binding cassette sub-family A member 7 {ECO:0000305};Autoantigen SS-N {ECO:0000303|Ref.6};Macrophage ABC transporter {ECO:0000303|PubMed:10873640};, PF00005;, GO:0030054;GO:0009986;GO:0031901;GO:0005783;GO:0097386;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0001891;GO:0005886;GO:0032587;GO:0034188;GO:0005524;GO:0016887;GO:0042626;GO:0140328;GO:0005319;GO:0090554;GO:0090556;GO:0005548;GO:0150094;GO:0034205;GO:0038027;GO:0033344;GO:0034380;GO:0006869;GO:0007613;GO:0042985;GO:1902430;GO:0045806;GO:0043409;GO:1903898;GO:0018149;GO:0006909;GO:0033700;GO:0045332;GO:0044857;GO:1900223;GO:0010875;GO:1901076;GO:0070374;GO:0050766;GO:1902995;GO:2000010;GO:0034504;GO:1902991;GO:0019216;GO:0008542;, C:cell junction; C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:glial cell projection; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:phagocytic cup; C:plasma membrane; C:ruffle membrane;, F:apolipoprotein A-I receptor activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity;, P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta formation; P:apolipoprotein A-I-mediated signaling pathway; P:cholesterol efflux; P:high-density lipoprotein particle assembly; P:lipid transport; P:memory; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of amyloid-beta formation; P:negative regulation of endocytosis; P:negative regulation of MAPK cascade; P:negative regulation of PERK-mediated unfolded protein response; P:peptide cross-linking; P:phagocytosis; P:phospholipid efflux; P:phospholipid translocation; P:plasma membrane raft organization; P:positive regulation of amyloid-beta clearance; P:positive regulation of cholesterol efflux; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phagocytosis; P:positive regulation of phospholipid efflux; P:positive regulation of protein localization to cell surface; P:protein localization to nucleus; P:regulation of amyloid precursor protein catabolic process; P:regulation of lipid metabolic process; P:visual learning;|Q8IZY2 Q96S58 Q9BZC4 Q9NR73 Q9UKP8,Phospholipid-transporting ATPase ABCA7 {ECO:0000305},ABCA-SSN {ECO:0000303|PubMed:11355874};ATP-binding cassette sub-family A member 7 {ECO:0000305};Autoantigen SS-N {ECO:0000303|Ref.6};Macrophage ABC transporter {ECO:0000303|PubMed:10873640};, PF00005;, GO:0030054;GO:0009986;GO:0031901;GO:0005783;GO:0097386;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0001891;GO:0005886;GO:0032587;GO:0034188;GO:0005524;GO:0016887;GO:0042626;GO:0140328;GO:0005319;GO:0090554;GO:0090556;GO:0005548;GO:0150094;GO:0034205;GO:0038027;GO:0033344;GO:0034380;GO:0006869;GO:0007613;GO:0042985;GO:1902430;GO:0045806;GO:0043409;GO:1903898;GO:0018149;GO:0006909;GO:0033700;GO:0045332;GO:0044857;GO:1900223;GO:0010875;GO:1901076;GO:0070374;GO:0050766;GO:1902995;GO:2000010;GO:0034504;GO:1902991;GO:0019216;GO:0008542;, C:cell junction; C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:glial cell projection; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:phagocytic cup; C:plasma membrane; C:ruffle membrane;, F:apolipoprotein A-I receptor activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity;, P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta formation; P:apolipoprotein A-I-mediated signaling pathway; P:cholesterol efflux; P:high-density lipoprotein particle assembly; P:lipid transport; P:memory; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of amyloid-beta formation; P:negative regulation of endocytosis; P:negative regulation of MAPK cascade; P:negative regulation of PERK-mediated unfolded protein response; P:peptide cross-linking; P:phagocytosis; P:phospholipid efflux; P:phospholipid translocation; P:plasma membrane raft organization; P:positive regulation of amyloid-beta clearance; P:positive regulation of cholesterol efflux; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phagocytosis; P:positive regulation of phospholipid efflux; P:positive regulation of protein localization to cell surface; P:protein localization to nucleus; P:regulation of amyloid precursor protein catabolic process; P:regulation of lipid metabolic process; P:visual learning;|Q8IZY2 Q96S58 Q9BZC4 Q9NR73 Q9UKP8,Phospholipid-transporting ATPase ABCA7 {ECO:0000305},ABCA-SSN {ECO:0000303|PubMed:11355874};ATP-binding cassette sub-family A member 7 {ECO:0000305};Autoantigen SS-N {ECO:0000303|Ref.6};Macrophage ABC transporter {ECO:0000303|PubMed:10873640};, PF00005;, GO:0030054;GO:0009986;GO:0031901;GO:0005783;GO:0097386;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0001891;GO:0005886;GO:0032587;GO:0034188;GO:0005524;GO:0016887;GO:0042626;GO:0140328;GO:0005319;GO:0090554;GO:0090556;GO:0005548;GO:0150094;GO:0034205;GO:0038027;GO:0033344;GO:0034380;GO:0006869;GO:0007613;GO:0042985;GO:1902430;GO:0045806;GO:0043409;GO:1903898;GO:0018149;GO:0006909;GO:0033700;GO:0045332;GO:0044857;GO:1900223;GO:0010875;GO:1901076;GO:0070374;GO:0050766;GO:1902995;GO:2000010;GO:0034504;GO:1902991;GO:0019216;GO:0008542;, C:cell junction; C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:glial cell projection; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:phagocytic cup; C:plasma membrane; C:ruffle membrane;, F:apolipoprotein A-I receptor activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity;, P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta formation; P:apolipoprotein A-I-mediated signaling pathway; P:cholesterol efflux; P:high-density lipoprotein particle assembly; P:lipid transport; P:memory; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of amyloid-beta formation; P:negative regulation of endocytosis; P:negative regulation of MAPK cascade; P:negative regulation of PERK-mediated unfolded protein response; P:peptide cross-linking; P:phagocytosis; P:phospholipid efflux; P:phospholipid translocation; P:plasma membrane raft organization; P:positive regulation of amyloid-beta clearance; P:positive regulation of cholesterol efflux; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phagocytosis; P:positive regulation of phospholipid efflux; P:positive regulation of protein localization to cell surface; P:protein localization to nucleus; P:regulation of amyloid precursor protein catabolic process; P:regulation of lipid metabolic process; P:visual learning;|Q8IZY2 Q96S58 Q9BZC4 Q9NR73 Q9UKP8,Phospholipid-transporting ATPase ABCA7 {ECO:0000305},ABCA-SSN {ECO:0000303|PubMed:11355874};ATP-binding cassette sub-family A member 7 {ECO:0000305};Autoantigen SS-N {ECO:0000303|Ref.6};Macrophage ABC transporter {ECO:0000303|PubMed:10873640};, PF00005;, GO:0030054;GO:0009986;GO:0031901;GO:0005783;GO:0097386;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0001891;GO:0005886;GO:0032587;GO:0034188;GO:0005524;GO:0016887;GO:0042626;GO:0140328;GO:0005319;GO:0090554;GO:0090556;GO:0005548;GO:0150094;GO:0034205;GO:0038027;GO:0033344;GO:0034380;GO:0006869;GO:0007613;GO:0042985;GO:1902430;GO:0045806;GO:0043409;GO:1903898;GO:0018149;GO:0006909;GO:0033700;GO:0045332;GO:0044857;GO:1900223;GO:0010875;GO:1901076;GO:0070374;GO:0050766;GO:1902995;GO:2000010;GO:0034504;GO:1902991;GO:0019216;GO:0008542;, C:cell junction; C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:glial cell projection; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:phagocytic cup; C:plasma membrane; C:ruffle membrane;, F:apolipoprotein A-I receptor activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity;, P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta formation; P:apolipoprotein A-I-mediated signaling pathway; P:cholesterol efflux; P:high-density lipoprotein particle assembly; P:lipid transport; P:memory; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of amyloid-beta formation; P:negative regulation of endocytosis; P:negative regulation of MAPK cascade; P:negative regulation of PERK-mediated unfolded protein response; P:peptide cross-linking; P:phagocytosis; P:phospholipid efflux; P:phospholipid translocation; P:plasma membrane raft organization; P:positive regulation of amyloid-beta clearance; P:positive regulation of cholesterol efflux; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phagocytosis; P:positive regulation of phospholipid efflux; P:positive regulation of protein localization to cell surface; P:protein localization to nucleus; P:regulation of amyloid precursor protein catabolic process; P:regulation of lipid metabolic process; P:visual learning;|Q8IZY2 Q96S58 Q9BZC4 Q9NR73 Q9UKP8,Phospholipid-transporting ATPase ABCA7 {ECO:0000305},ABCA-SSN {ECO:0000303|PubMed:11355874};ATP-binding cassette sub-family A member 7 {ECO:0000305};Autoantigen SS-N {ECO:0000303|Ref.6};Macrophage ABC transporter {ECO:0000303|PubMed:10873640};, PF00005;, GO:0030054;GO:0009986;GO:0031901;GO:0005783;GO:0097386;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0001891;GO:0005886;GO:0032587;GO:0034188;GO:0005524;GO:0016887;GO:0042626;GO:0140328;GO:0005319;GO:0090554;GO:0090556;GO:0005548;GO:0150094;GO:0034205;GO:0038027;GO:0033344;GO:0034380;GO:0006869;GO:0007613;GO:0042985;GO:1902430;GO:0045806;GO:0043409;GO:1903898;GO:0018149;GO:0006909;GO:0033700;GO:0045332;GO:0044857;GO:1900223;GO:0010875;GO:1901076;GO:0070374;GO:0050766;GO:1902995;GO:2000010;GO:0034504;GO:1902991;GO:0019216;GO:0008542;, C:cell junction; C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:glial cell projection; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:phagocytic cup; C:plasma membrane; C:ruffle membrane;, F:apolipoprotein A-I receptor activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity;, P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta formation; P:apolipoprotein A-I-mediated signaling pathway; P:cholesterol efflux; P:high-density lipoprotein particle assembly; P:lipid transport; P:memory; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of amyloid-beta formation; P:negative regulation of endocytosis; P:negative regulation of MAPK cascade; P:negative regulation of PERK-mediated unfolded protein response; P:peptide cross-linking; P:phagocytosis; P:phospholipid efflux; P:phospholipid translocation; P:plasma membrane raft organization; P:positive regulation of amyloid-beta clearance; P:positive regulation of cholesterol efflux; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phagocytosis; P:positive regulation of phospholipid efflux; P:positive regulation of protein localization to cell surface; P:protein localization to nucleus; P:regulation of amyloid precursor protein catabolic process; P:regulation of lipid metabolic process; P:visual learning;|Q8IZY2 Q96S58 Q9BZC4 Q9NR73 Q9UKP8,Phospholipid-transporting ATPase ABCA7 {ECO:0000305},ABCA-SSN {ECO:0000303|PubMed:11355874};ATP-binding cassette sub-family A member 7 {ECO:0000305};Autoantigen SS-N {ECO:0000303|Ref.6};Macrophage ABC transporter {ECO:0000303|PubMed:10873640};, PF00005;, GO:0030054;GO:0009986;GO:0031901;GO:0005783;GO:0097386;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0001891;GO:0005886;GO:0032587;GO:0034188;GO:0005524;GO:0016887;GO:0042626;GO:0140328;GO:0005319;GO:0090554;GO:0090556;GO:0005548;GO:0150094;GO:0034205;GO:0038027;GO:0033344;GO:0034380;GO:0006869;GO:0007613;GO:0042985;GO:1902430;GO:0045806;GO:0043409;GO:1903898;GO:0018149;GO:0006909;GO:0033700;GO:0045332;GO:0044857;GO:1900223;GO:0010875;GO:1901076;GO:0070374;GO:0050766;GO:1902995;GO:2000010;GO:0034504;GO:1902991;GO:0019216;GO:0008542;, C:cell junction; C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:glial cell projection; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:phagocytic cup; C:plasma membrane; C:ruffle membrane;, F:apolipoprotein A-I receptor activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity;, P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta formation; P:apolipoprotein A-I-mediated signaling pathway; P:cholesterol efflux; P:high-density lipoprotein particle assembly; P:lipid transport; P:memory; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of amyloid-beta formation; P:negative regulation of endocytosis; P:negative regulation of MAPK cascade; P:negative regulation of PERK-mediated unfolded protein response; P:peptide cross-linking; P:phagocytosis; P:phospholipid efflux; P:phospholipid translocation; P:plasma membrane raft organization; P:positive regulation of amyloid-beta clearance; P:positive regulation of cholesterol efflux; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phagocytosis; P:positive regulation of phospholipid efflux; P:positive regulation of protein localization to cell surface; P:protein localization to nucleus; P:regulation of amyloid precursor protein catabolic process; P:regulation of lipid metabolic process; P:visual learning; scaffold25 indexed_genome mRNA 29802260 29804428 . + . ID=transcript_5829;Q8IZY2 Q96S58 Q9BZC4 Q9NR73 Q9UKP8,Phospholipid-transporting ATPase ABCA7 {ECO:0000305},ABCA-SSN {ECO:0000303|PubMed:11355874};ATP-binding cassette sub-family A member 7 {ECO:0000305};Autoantigen SS-N {ECO:0000303|Ref.6};Macrophage ABC transporter {ECO:0000303|PubMed:10873640};, PF00005;, GO:0030054;GO:0009986;GO:0031901;GO:0005783;GO:0097386;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0001891;GO:0005886;GO:0032587;GO:0034188;GO:0005524;GO:0016887;GO:0042626;GO:0140328;GO:0005319;GO:0090554;GO:0090556;GO:0005548;GO:0150094;GO:0034205;GO:0038027;GO:0033344;GO:0034380;GO:0006869;GO:0007613;GO:0042985;GO:1902430;GO:0045806;GO:0043409;GO:1903898;GO:0018149;GO:0006909;GO:0033700;GO:0045332;GO:0044857;GO:1900223;GO:0010875;GO:1901076;GO:0070374;GO:0050766;GO:1902995;GO:2000010;GO:0034504;GO:1902991;GO:0019216;GO:0008542;, C:cell junction; C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:glial cell projection; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:phagocytic cup; C:plasma membrane; C:ruffle membrane;, F:apolipoprotein A-I receptor activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity;, P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta formation; P:apolipoprotein A-I-mediated signaling pathway; P:cholesterol efflux; P:high-density lipoprotein particle assembly; P:lipid transport; P:memory; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of amyloid-beta formation; P:negative regulation of endocytosis; P:negative regulation of MAPK cascade; P:negative regulation of PERK-mediated unfolded protein response; P:peptide cross-linking; P:phagocytosis; P:phospholipid efflux; P:phospholipid translocation; P:plasma membrane raft organization; P:positive regulation of amyloid-beta clearance; P:positive regulation of cholesterol efflux; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phagocytosis; P:positive regulation of phospholipid efflux; P:positive regulation of protein localization to cell surface; P:protein localization to nucleus; P:regulation of amyloid precursor protein catabolic process; P:regulation of lipid metabolic process; P:visual learning;|Q8IZY2 Q96S58 Q9BZC4 Q9NR73 Q9UKP8,Phospholipid-transporting ATPase ABCA7 {ECO:0000305},ABCA-SSN {ECO:0000303|PubMed:11355874};ATP-binding cassette sub-family A member 7 {ECO:0000305};Autoantigen SS-N {ECO:0000303|Ref.6};Macrophage ABC transporter {ECO:0000303|PubMed:10873640};, PF00005;, GO:0030054;GO:0009986;GO:0031901;GO:0005783;GO:0097386;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0001891;GO:0005886;GO:0032587;GO:0034188;GO:0005524;GO:0016887;GO:0042626;GO:0140328;GO:0005319;GO:0090554;GO:0090556;GO:0005548;GO:0150094;GO:0034205;GO:0038027;GO:0033344;GO:0034380;GO:0006869;GO:0007613;GO:0042985;GO:1902430;GO:0045806;GO:0043409;GO:1903898;GO:0018149;GO:0006909;GO:0033700;GO:0045332;GO:0044857;GO:1900223;GO:0010875;GO:1901076;GO:0070374;GO:0050766;GO:1902995;GO:2000010;GO:0034504;GO:1902991;GO:0019216;GO:0008542;, C:cell junction; C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:glial cell projection; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:phagocytic cup; C:plasma membrane; C:ruffle membrane;, F:apolipoprotein A-I receptor activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity;, P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta formation; P:apolipoprotein A-I-mediated signaling pathway; P:cholesterol efflux; P:high-density lipoprotein particle assembly; P:lipid transport; P:memory; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of amyloid-beta formation; P:negative regulation of endocytosis; P:negative regulation of MAPK cascade; P:negative regulation of PERK-mediated unfolded protein response; P:peptide cross-linking; P:phagocytosis; P:phospholipid efflux; P:phospholipid translocation; P:plasma membrane raft organization; P:positive regulation of amyloid-beta clearance; P:positive regulation of cholesterol efflux; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phagocytosis; P:positive regulation of phospholipid efflux; P:positive regulation of protein localization to cell surface; P:protein localization to nucleus; P:regulation of amyloid precursor protein catabolic process; P:regulation of lipid metabolic process; P:visual learning; scaffold25 indexed_genome mRNA 29804478 29818457 . - . ID=transcript_5830;Q9GJP1 Q9MY24,Rho GTPase-activating protein 45 {ECO:0000312|HGNC:HGNC:17102},, PF00620;, GO:0035578;GO:0005829;GO:0005576;GO:0016020;GO:0032587;GO:0034774;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0043312;GO:0051056;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:membrane; C:ruffle membrane; C:secretory granule lumen;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:neutrophil degranulation; P:regulation of small GTPase mediated signal transduction;|Q9GJP1 Q9MY24,Rho GTPase-activating protein 45 {ECO:0000312|HGNC:HGNC:17102},, PF00620;, GO:0035578;GO:0005829;GO:0005576;GO:0016020;GO:0032587;GO:0034774;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0043312;GO:0051056;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:membrane; C:ruffle membrane; C:secretory granule lumen;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:neutrophil degranulation; P:regulation of small GTPase mediated signal transduction;|Q9GJP1 Q9MY24,Rho GTPase-activating protein 45 {ECO:0000312|HGNC:HGNC:17102},, PF00620;, GO:0035578;GO:0005829;GO:0005576;GO:0016020;GO:0032587;GO:0034774;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0043312;GO:0051056;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:membrane; C:ruffle membrane; C:secretory granule lumen;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:neutrophil degranulation; P:regulation of small GTPase mediated signal transduction;|Q9GJP1 Q9MY24,Rho GTPase-activating protein 45 {ECO:0000312|HGNC:HGNC:17102},, PF00620;, GO:0035578;GO:0005829;GO:0005576;GO:0016020;GO:0032587;GO:0034774;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0043312;GO:0051056;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:membrane; C:ruffle membrane; C:secretory granule lumen;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:neutrophil degranulation; P:regulation of small GTPase mediated signal transduction;|Q9GJP1 Q9MY24,Rho GTPase-activating protein 45 {ECO:0000312|HGNC:HGNC:17102},, PF00620;, GO:0035578;GO:0005829;GO:0005576;GO:0016020;GO:0032587;GO:0034774;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0043312;GO:0051056;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:membrane; C:ruffle membrane; C:secretory granule lumen;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:neutrophil degranulation; P:regulation of small GTPase mediated signal transduction;|Q9GJP1 Q9MY24,Rho GTPase-activating protein 45 {ECO:0000312|HGNC:HGNC:17102},, PF00620;, GO:0035578;GO:0005829;GO:0005576;GO:0016020;GO:0032587;GO:0034774;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0043312;GO:0051056;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:membrane; C:ruffle membrane; C:secretory granule lumen;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:neutrophil degranulation; P:regulation of small GTPase mediated signal transduction;|Q9GJP1 Q9MY24,Rho GTPase-activating protein 45 {ECO:0000312|HGNC:HGNC:17102},, PF00620;, GO:0035578;GO:0005829;GO:0005576;GO:0016020;GO:0032587;GO:0034774;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0043312;GO:0051056;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:membrane; C:ruffle membrane; C:secretory granule lumen;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:neutrophil degranulation; P:regulation of small GTPase mediated signal transduction; scaffold25 indexed_genome mRNA 29819774 29825854 . - . ID=transcript_5831;P19388 B2R6L4 D6W5Y1 O43380 Q6PIH5 Q9BT06,DNA-directed RNA polymerases I, II, and III subunit RPABC1,DNA-directed RNA polymerase II 23 kDa polypeptide;DNA-directed RNA polymerase II subunit E;RPB5 homolog;XAP4;, PF01191;PF03871;, GO:0005829;GO:0005654;GO:0005634;GO:0005736;GO:0005665;GO:0005666;GO:0003677;GO:0003899;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;GO:0016032;, C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; P:viral process;|P19388 B2R6L4 D6W5Y1 O43380 Q6PIH5 Q9BT06,DNA-directed RNA polymerases I, II, and III subunit RPABC1,DNA-directed RNA polymerase II 23 kDa polypeptide;DNA-directed RNA polymerase II subunit E;RPB5 homolog;XAP4;, PF01191;PF03871;, GO:0005829;GO:0005654;GO:0005634;GO:0005736;GO:0005665;GO:0005666;GO:0003677;GO:0003899;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;GO:0016032;, C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; P:viral process;|P19388 B2R6L4 D6W5Y1 O43380 Q6PIH5 Q9BT06,DNA-directed RNA polymerases I, II, and III subunit RPABC1,DNA-directed RNA polymerase II 23 kDa polypeptide;DNA-directed RNA polymerase II subunit E;RPB5 homolog;XAP4;, PF01191;PF03871;, GO:0005829;GO:0005654;GO:0005634;GO:0005736;GO:0005665;GO:0005666;GO:0003677;GO:0003899;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;GO:0016032;, C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; P:viral process; scaffold25 indexed_genome mRNA 29832220 29832890 . + . ID=transcript_5832;P36969 O43381 Q6PJ59 Q9UPK2,Phospholipid hydroperoxide glutathione peroxidase,Glutathione peroxidase 4 {ECO:0000303|PubMed:9705830};, PF00255;, GO:0005829;GO:0070062;GO:0005739;GO:0005634;GO:0032991;GO:0004602;GO:0042802;GO:0004601;GO:0047066;GO:0019369;GO:0019372;GO:0042759;GO:0007275;GO:0110076;GO:0006644;GO:0051258;GO:0006979;GO:0007283;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleus; C:protein-containing complex;, F:glutathione peroxidase activity; F:identical protein binding; F:peroxidase activity; F:phospholipid-hydroperoxide glutathione peroxidase activity;, P:arachidonic acid metabolic process; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:multicellular organism development; P:negative regulation of ferroptosis; P:phospholipid metabolic process; P:protein polymerization; P:response to oxidative stress; P:spermatogenesis; scaffold25 indexed_genome mRNA 29833878 29853562 . - . ID=transcript_5833;Q9Y2G9 A8K8P2 B3KWJ1 O75257 Q3KQX0 Q8TEM0,Protein strawberry notch homolog 2,, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0030282;GO:0061430;GO:0071348;GO:0071354;GO:1990830;GO:0071222;GO:0002281;GO:0045892;GO:0030316;GO:0072675;GO:0045944;GO:0050727;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:bone mineralization; P:bone trabecula morphogenesis; P:cellular response to interleukin-11; P:cellular response to interleukin-6; P:cellular response to leukemia inhibitory factor; P:cellular response to lipopolysaccharide; P:macrophage activation involved in immune response; P:negative regulation of transcription, DNA-templated; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response; P:regulation of transcription, DNA-templated;|Q9Y2G9 A8K8P2 B3KWJ1 O75257 Q3KQX0 Q8TEM0,Protein strawberry notch homolog 2,, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0030282;GO:0061430;GO:0071348;GO:0071354;GO:1990830;GO:0071222;GO:0002281;GO:0045892;GO:0030316;GO:0072675;GO:0045944;GO:0050727;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:bone mineralization; P:bone trabecula morphogenesis; P:cellular response to interleukin-11; P:cellular response to interleukin-6; P:cellular response to leukemia inhibitory factor; P:cellular response to lipopolysaccharide; P:macrophage activation involved in immune response; P:negative regulation of transcription, DNA-templated; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response; P:regulation of transcription, DNA-templated;|Q9Y2G9 A8K8P2 B3KWJ1 O75257 Q3KQX0 Q8TEM0,Protein strawberry notch homolog 2,, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0030282;GO:0061430;GO:0071348;GO:0071354;GO:1990830;GO:0071222;GO:0002281;GO:0045892;GO:0030316;GO:0072675;GO:0045944;GO:0050727;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:bone mineralization; P:bone trabecula morphogenesis; P:cellular response to interleukin-11; P:cellular response to interleukin-6; P:cellular response to leukemia inhibitory factor; P:cellular response to lipopolysaccharide; P:macrophage activation involved in immune response; P:negative regulation of transcription, DNA-templated; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response; P:regulation of transcription, DNA-templated;|A3KN83 Q05C06 Q3ZTS3 Q9H3T8 Q9NVB2,Protein strawberry notch homolog 1,Monocyte protein 3;, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:regulation of transcription, DNA-templated;|Q9Y2G9 A8K8P2 B3KWJ1 O75257 Q3KQX0 Q8TEM0,Protein strawberry notch homolog 2,, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0030282;GO:0061430;GO:0071348;GO:0071354;GO:1990830;GO:0071222;GO:0002281;GO:0045892;GO:0030316;GO:0072675;GO:0045944;GO:0050727;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:bone mineralization; P:bone trabecula morphogenesis; P:cellular response to interleukin-11; P:cellular response to interleukin-6; P:cellular response to leukemia inhibitory factor; P:cellular response to lipopolysaccharide; P:macrophage activation involved in immune response; P:negative regulation of transcription, DNA-templated; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response; P:regulation of transcription, DNA-templated;|Q9Y2G9 A8K8P2 B3KWJ1 O75257 Q3KQX0 Q8TEM0,Protein strawberry notch homolog 2,, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0030282;GO:0061430;GO:0071348;GO:0071354;GO:1990830;GO:0071222;GO:0002281;GO:0045892;GO:0030316;GO:0072675;GO:0045944;GO:0050727;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:bone mineralization; P:bone trabecula morphogenesis; P:cellular response to interleukin-11; P:cellular response to interleukin-6; P:cellular response to leukemia inhibitory factor; P:cellular response to lipopolysaccharide; P:macrophage activation involved in immune response; P:negative regulation of transcription, DNA-templated; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response; P:regulation of transcription, DNA-templated;|Q9Y2G9 A8K8P2 B3KWJ1 O75257 Q3KQX0 Q8TEM0,Protein strawberry notch homolog 2,, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0030282;GO:0061430;GO:0071348;GO:0071354;GO:1990830;GO:0071222;GO:0002281;GO:0045892;GO:0030316;GO:0072675;GO:0045944;GO:0050727;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:bone mineralization; P:bone trabecula morphogenesis; P:cellular response to interleukin-11; P:cellular response to interleukin-6; P:cellular response to leukemia inhibitory factor; P:cellular response to lipopolysaccharide; P:macrophage activation involved in immune response; P:negative regulation of transcription, DNA-templated; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response; P:regulation of transcription, DNA-templated;|Q9Y2G9 A8K8P2 B3KWJ1 O75257 Q3KQX0 Q8TEM0,Protein strawberry notch homolog 2,, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0030282;GO:0061430;GO:0071348;GO:0071354;GO:1990830;GO:0071222;GO:0002281;GO:0045892;GO:0030316;GO:0072675;GO:0045944;GO:0050727;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:bone mineralization; P:bone trabecula morphogenesis; P:cellular response to interleukin-11; P:cellular response to interleukin-6; P:cellular response to leukemia inhibitory factor; P:cellular response to lipopolysaccharide; P:macrophage activation involved in immune response; P:negative regulation of transcription, DNA-templated; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response; P:regulation of transcription, DNA-templated;|Q9Y2G9 A8K8P2 B3KWJ1 O75257 Q3KQX0 Q8TEM0,Protein strawberry notch homolog 2,, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0030282;GO:0061430;GO:0071348;GO:0071354;GO:1990830;GO:0071222;GO:0002281;GO:0045892;GO:0030316;GO:0072675;GO:0045944;GO:0050727;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:bone mineralization; P:bone trabecula morphogenesis; P:cellular response to interleukin-11; P:cellular response to interleukin-6; P:cellular response to leukemia inhibitory factor; P:cellular response to lipopolysaccharide; P:macrophage activation involved in immune response; P:negative regulation of transcription, DNA-templated; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response; P:regulation of transcription, DNA-templated; scaffold25 indexed_genome mRNA 29881333 29881939 . + . ID=transcript_5834;Q15831 B2RBX7 E7EW76,Serine/threonine-protein kinase STK11 {ECO:0000305},Liver kinase B1;Renal carcinoma antigen NY-REN-19;, PF00069;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0030275;GO:0000287;GO:0002039;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0043276;GO:0006914;GO:0007409;GO:0060070;GO:0007050;GO:0006974;GO:0071493;GO:0097484;GO:0030010;GO:0042593;GO:0051645;GO:0072332;GO:0090090;GO:0030308;GO:0008285;GO:0120163;GO:0060770;GO:1904262;GO:0010508;GO:0050772;GO:1900182;GO:0030511;GO:1901610;GO:0045059;GO:0046777;GO:0006470;GO:0006468;GO:0001558;GO:0048814;GO:0051896;GO:1901796;GO:0010212;GO:0007283;GO:0050852;GO:0001894;GO:0001944;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:LRR domain binding; F:magnesium ion binding; F:p53 binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:anoikis; P:autophagy; P:axonogenesis; P:canonical Wnt signaling pathway; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to UV-B; P:dendrite extension; P:establishment of cell polarity; P:glucose homeostasis; P:Golgi localization; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of epithelial cell proliferation involved in prostate gland development; P:negative regulation of TORC1 signaling; P:positive regulation of autophagy; P:positive regulation of axonogenesis; P:positive regulation of protein localization to nucleus; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of vesicle transport along microtubule; P:positive thymic T cell selection; P:protein autophosphorylation; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of cell growth; P:regulation of dendrite morphogenesis; P:regulation of protein kinase B signaling; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; P:spermatogenesis; P:T cell receptor signaling pathway; P:tissue homeostasis; P:vasculature development; scaffold25 indexed_genome mRNA 29888128 29903672 . + . ID=transcript_5835;Q15831 B2RBX7 E7EW76,Serine/threonine-protein kinase STK11 {ECO:0000305},Liver kinase B1;Renal carcinoma antigen NY-REN-19;, PF00069;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0030275;GO:0000287;GO:0002039;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0043276;GO:0006914;GO:0007409;GO:0060070;GO:0007050;GO:0006974;GO:0071493;GO:0097484;GO:0030010;GO:0042593;GO:0051645;GO:0072332;GO:0090090;GO:0030308;GO:0008285;GO:0120163;GO:0060770;GO:1904262;GO:0010508;GO:0050772;GO:1900182;GO:0030511;GO:1901610;GO:0045059;GO:0046777;GO:0006470;GO:0006468;GO:0001558;GO:0048814;GO:0051896;GO:1901796;GO:0010212;GO:0007283;GO:0050852;GO:0001894;GO:0001944;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:LRR domain binding; F:magnesium ion binding; F:p53 binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:anoikis; P:autophagy; P:axonogenesis; P:canonical Wnt signaling pathway; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to UV-B; P:dendrite extension; P:establishment of cell polarity; P:glucose homeostasis; P:Golgi localization; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of epithelial cell proliferation involved in prostate gland development; P:negative regulation of TORC1 signaling; P:positive regulation of autophagy; P:positive regulation of axonogenesis; P:positive regulation of protein localization to nucleus; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of vesicle transport along microtubule; P:positive thymic T cell selection; P:protein autophosphorylation; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of cell growth; P:regulation of dendrite morphogenesis; P:regulation of protein kinase B signaling; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; P:spermatogenesis; P:T cell receptor signaling pathway; P:tissue homeostasis; P:vasculature development;|Q15831 B2RBX7 E7EW76,Serine/threonine-protein kinase STK11 {ECO:0000305},Liver kinase B1;Renal carcinoma antigen NY-REN-19;, PF00069;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0030275;GO:0000287;GO:0002039;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0043276;GO:0006914;GO:0007409;GO:0060070;GO:0007050;GO:0006974;GO:0071493;GO:0097484;GO:0030010;GO:0042593;GO:0051645;GO:0072332;GO:0090090;GO:0030308;GO:0008285;GO:0120163;GO:0060770;GO:1904262;GO:0010508;GO:0050772;GO:1900182;GO:0030511;GO:1901610;GO:0045059;GO:0046777;GO:0006470;GO:0006468;GO:0001558;GO:0048814;GO:0051896;GO:1901796;GO:0010212;GO:0007283;GO:0050852;GO:0001894;GO:0001944;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:LRR domain binding; F:magnesium ion binding; F:p53 binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:anoikis; P:autophagy; P:axonogenesis; P:canonical Wnt signaling pathway; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to UV-B; P:dendrite extension; P:establishment of cell polarity; P:glucose homeostasis; P:Golgi localization; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of epithelial cell proliferation involved in prostate gland development; P:negative regulation of TORC1 signaling; P:positive regulation of autophagy; P:positive regulation of axonogenesis; P:positive regulation of protein localization to nucleus; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of vesicle transport along microtubule; P:positive thymic T cell selection; P:protein autophosphorylation; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of cell growth; P:regulation of dendrite morphogenesis; P:regulation of protein kinase B signaling; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; P:spermatogenesis; P:T cell receptor signaling pathway; P:tissue homeostasis; P:vasculature development;|Q15831 B2RBX7 E7EW76,Serine/threonine-protein kinase STK11 {ECO:0000305},Liver kinase B1;Renal carcinoma antigen NY-REN-19;, PF00069;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0030275;GO:0000287;GO:0002039;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0043276;GO:0006914;GO:0007409;GO:0060070;GO:0007050;GO:0006974;GO:0071493;GO:0097484;GO:0030010;GO:0042593;GO:0051645;GO:0072332;GO:0090090;GO:0030308;GO:0008285;GO:0120163;GO:0060770;GO:1904262;GO:0010508;GO:0050772;GO:1900182;GO:0030511;GO:1901610;GO:0045059;GO:0046777;GO:0006470;GO:0006468;GO:0001558;GO:0048814;GO:0051896;GO:1901796;GO:0010212;GO:0007283;GO:0050852;GO:0001894;GO:0001944;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:LRR domain binding; F:magnesium ion binding; F:p53 binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:anoikis; P:autophagy; P:axonogenesis; P:canonical Wnt signaling pathway; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to UV-B; P:dendrite extension; P:establishment of cell polarity; P:glucose homeostasis; P:Golgi localization; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of epithelial cell proliferation involved in prostate gland development; P:negative regulation of TORC1 signaling; P:positive regulation of autophagy; P:positive regulation of axonogenesis; P:positive regulation of protein localization to nucleus; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of vesicle transport along microtubule; P:positive thymic T cell selection; P:protein autophosphorylation; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of cell growth; P:regulation of dendrite morphogenesis; P:regulation of protein kinase B signaling; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; P:spermatogenesis; P:T cell receptor signaling pathway; P:tissue homeostasis; P:vasculature development;|Q8N350 K7EJP2 O43385,Voltage-dependent calcium channel beta subunit-associated regulatory protein {ECO:0000305},, , GO:0030426;GO:0016021;GO:0005886;GO:0030141;GO:0030672;GO:0044325;GO:1903170;GO:0045955;GO:1901386;, C:growth cone; C:integral component of membrane; C:plasma membrane; C:secretory granule; C:synaptic vesicle membrane;, F:ion channel binding;, P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of voltage-gated calcium channel activity;|Q8N350 K7EJP2 O43385,Voltage-dependent calcium channel beta subunit-associated regulatory protein {ECO:0000305},, , GO:0030426;GO:0016021;GO:0005886;GO:0030141;GO:0030672;GO:0044325;GO:1903170;GO:0045955;GO:1901386;, C:growth cone; C:integral component of membrane; C:plasma membrane; C:secretory granule; C:synaptic vesicle membrane;, F:ion channel binding;, P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of voltage-gated calcium channel activity; scaffold25 indexed_genome mRNA 29903721 29904691 . - . ID=transcript_5836;Q8N350 K7EJP2 O43385,Voltage-dependent calcium channel beta subunit-associated regulatory protein {ECO:0000305},, , GO:0030426;GO:0016021;GO:0005886;GO:0030141;GO:0030672;GO:0044325;GO:1903170;GO:0045955;GO:1901386;, C:growth cone; C:integral component of membrane; C:plasma membrane; C:secretory granule; C:synaptic vesicle membrane;, F:ion channel binding;, P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of voltage-gated calcium channel activity; scaffold26 indexed_genome mRNA 1018682 1372883 . - . ID=transcript_5837;Q9H6B1,Zinc finger protein 385D,Zinc finger protein 659;, , GO:0005634;GO:1990837;GO:0008270;, C:nucleus;, F:sequence-specific double-stranded DNA binding; F:zinc ion binding;|Q9H6B1,Zinc finger protein 385D,Zinc finger protein 659;, , GO:0005634;GO:1990837;GO:0008270;, C:nucleus;, F:sequence-specific double-stranded DNA binding; F:zinc ion binding;|Q9H6B1,Zinc finger protein 385D,Zinc finger protein 659;, , GO:0005634;GO:1990837;GO:0008270;, C:nucleus;, F:sequence-specific double-stranded DNA binding; F:zinc ion binding;|Q9H6B1,Zinc finger protein 385D,Zinc finger protein 659;, , GO:0005634;GO:1990837;GO:0008270;, C:nucleus;, F:sequence-specific double-stranded DNA binding; F:zinc ion binding;|Q9H6B1,Zinc finger protein 385D,Zinc finger protein 659;, , GO:0005634;GO:1990837;GO:0008270;, C:nucleus;, F:sequence-specific double-stranded DNA binding; F:zinc ion binding; scaffold26 indexed_genome mRNA 2700794 3048430 . + . ID=transcript_5838;Q96LR5,Ubiquitin-conjugating enzyme E2 E2,E2 ubiquitin-conjugating enzyme E2;UbcH8;Ubiquitin carrier protein E2;Ubiquitin-protein ligase E2;, PF00179;, GO:0005634;GO:0005524;GO:0042296;GO:0061631;GO:0004842;GO:0006974;GO:0032020;GO:1900087;GO:0070979;GO:0070936;GO:0070534;GO:0000209;, C:nucleus;, F:ATP binding; F:ISG15 transferase activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:ISG15-protein conjugation; P:positive regulation of G1/S transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; scaffold26 indexed_genome mRNA 3292979 3298065 . + . ID=transcript_5839;P51965 B2RBX4 C9J8K2 K4DI90,Ubiquitin-conjugating enzyme E2 E1,(E3-independent) E2 ubiquitin-conjugating enzyme E1;E2 ubiquitin-conjugating enzyme E1;UbcH6;Ubiquitin carrier protein E1;Ubiquitin-protein ligase E1;, PF00179;, GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0005524;GO:0042296;GO:0061631;GO:0004842;GO:0031145;GO:0033523;GO:0010390;GO:0032020;GO:0070936;GO:0000209;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ISG15 transferase activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:histone H2B ubiquitination; P:histone monoubiquitination; P:ISG15-protein conjugation; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q96LR5,Ubiquitin-conjugating enzyme E2 E2,E2 ubiquitin-conjugating enzyme E2;UbcH8;Ubiquitin carrier protein E2;Ubiquitin-protein ligase E2;, PF00179;, GO:0005634;GO:0005524;GO:0042296;GO:0061631;GO:0004842;GO:0006974;GO:0032020;GO:1900087;GO:0070979;GO:0070936;GO:0070534;GO:0000209;, C:nucleus;, F:ATP binding; F:ISG15 transferase activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:ISG15-protein conjugation; P:positive regulation of G1/S transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; scaffold26 indexed_genome mRNA 3299264 3312236 . - . ID=transcript_5840;Q9NYS0 Q96K18,NF-kappa-B inhibitor-interacting Ras-like protein 1,I-kappa-B-interacting Ras-like protein 1;, PF00071;, GO:0005829;GO:0005783;GO:0005525;GO:0003924;GO:0007249;, C:cytosol; C:endoplasmic reticulum;, F:GTP binding; F:GTPase activity;, P:I-kappaB kinase/NF-kappaB signaling;|Q9NYS0 Q96K18,NF-kappa-B inhibitor-interacting Ras-like protein 1,I-kappa-B-interacting Ras-like protein 1;, PF00071;, GO:0005829;GO:0005783;GO:0005525;GO:0003924;GO:0007249;, C:cytosol; C:endoplasmic reticulum;, F:GTP binding; F:GTPase activity;, P:I-kappaB kinase/NF-kappaB signaling;|Q9NYS0 Q96K18,NF-kappa-B inhibitor-interacting Ras-like protein 1,I-kappa-B-interacting Ras-like protein 1;, PF00071;, GO:0005829;GO:0005783;GO:0005525;GO:0003924;GO:0007249;, C:cytosol; C:endoplasmic reticulum;, F:GTP binding; F:GTPase activity;, P:I-kappaB kinase/NF-kappaB signaling; scaffold26 indexed_genome mRNA 3325309 3329272 . + . ID=transcript_5841;P61313 P39030 P41051 Q5U0C0 Q642I1 Q6IPX6 Q8WYP2 Q96C44 Q9H2E5,60S ribosomal protein L15,Large ribosomal subunit protein eL15 {ECO:0000303|PubMed:24524803};, PF00827;, GO:0031672;GO:0005829;GO:0022625;GO:0016020;GO:0005634;GO:0005840;GO:0045296;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0045471;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:A band; C:cytosol; C:cytosolic large ribosomal subunit; C:membrane; C:nucleus; C:ribosome;, F:cadherin binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:response to ethanol; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P61313 P39030 P41051 Q5U0C0 Q642I1 Q6IPX6 Q8WYP2 Q96C44 Q9H2E5,60S ribosomal protein L15,Large ribosomal subunit protein eL15 {ECO:0000303|PubMed:24524803};, PF00827;, GO:0031672;GO:0005829;GO:0022625;GO:0016020;GO:0005634;GO:0005840;GO:0045296;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0045471;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:A band; C:cytosol; C:cytosolic large ribosomal subunit; C:membrane; C:nucleus; C:ribosome;, F:cadherin binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:response to ethanol; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold26 indexed_genome mRNA 3374279 3386261 . + . ID=transcript_5842;Q14995 B2R8Q3 O00402 Q86XD4,Nuclear receptor subfamily 1 group D member 2,Orphan nuclear hormone receptor BD73;Rev-erb alpha-related receptor;Rev-erb-beta;V-erbA-related protein 1-related;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0004879;GO:0000978;GO:1990837;GO:0008270;GO:0030154;GO:0048512;GO:0097009;GO:0009755;GO:0055088;GO:0050728;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0042752;GO:0050727;GO:0019216;GO:2001014;GO:0006355;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell differentiation; P:circadian behavior; P:energy homeostasis; P:hormone-mediated signaling pathway; P:lipid homeostasis; P:negative regulation of inflammatory response; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of inflammatory response; P:regulation of lipid metabolic process; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q14995 B2R8Q3 O00402 Q86XD4,Nuclear receptor subfamily 1 group D member 2,Orphan nuclear hormone receptor BD73;Rev-erb alpha-related receptor;Rev-erb-beta;V-erbA-related protein 1-related;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0004879;GO:0000978;GO:1990837;GO:0008270;GO:0030154;GO:0048512;GO:0097009;GO:0009755;GO:0055088;GO:0050728;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0042752;GO:0050727;GO:0019216;GO:2001014;GO:0006355;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell differentiation; P:circadian behavior; P:energy homeostasis; P:hormone-mediated signaling pathway; P:lipid homeostasis; P:negative regulation of inflammatory response; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of inflammatory response; P:regulation of lipid metabolic process; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q14995 B2R8Q3 O00402 Q86XD4,Nuclear receptor subfamily 1 group D member 2,Orphan nuclear hormone receptor BD73;Rev-erb alpha-related receptor;Rev-erb-beta;V-erbA-related protein 1-related;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0004879;GO:0000978;GO:1990837;GO:0008270;GO:0030154;GO:0048512;GO:0097009;GO:0009755;GO:0055088;GO:0050728;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0042752;GO:0050727;GO:0019216;GO:2001014;GO:0006355;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell differentiation; P:circadian behavior; P:energy homeostasis; P:hormone-mediated signaling pathway; P:lipid homeostasis; P:negative regulation of inflammatory response; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of inflammatory response; P:regulation of lipid metabolic process; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter; scaffold26 indexed_genome mRNA 3386339 3394057 . - . ID=transcript_5843;Q14995 B2R8Q3 O00402 Q86XD4,Nuclear receptor subfamily 1 group D member 2,Orphan nuclear hormone receptor BD73;Rev-erb alpha-related receptor;Rev-erb-beta;V-erbA-related protein 1-related;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0004879;GO:0000978;GO:1990837;GO:0008270;GO:0030154;GO:0048512;GO:0097009;GO:0009755;GO:0055088;GO:0050728;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0042752;GO:0050727;GO:0019216;GO:2001014;GO:0006355;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell differentiation; P:circadian behavior; P:energy homeostasis; P:hormone-mediated signaling pathway; P:lipid homeostasis; P:negative regulation of inflammatory response; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of inflammatory response; P:regulation of lipid metabolic process; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter; scaffold26 indexed_genome mRNA 3473609 3551799 . - . ID=transcript_5844;P10828 B3KU79 P37243 Q13986 Q3KP35 Q6WGL2 Q9UD41,Thyroid hormone receptor beta,Nuclear receptor subfamily 1 group A member 2;c-erbA-2;c-erbA-beta;, PF00104;PF00105;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0031490;GO:0003677;GO:0003700;GO:0000981;GO:0019899;GO:0004879;GO:0000978;GO:0001225;GO:1990837;GO:0070324;GO:0008270;GO:0030154;GO:0097067;GO:0008050;GO:0009755;GO:0007621;GO:0000122;GO:0045944;GO:0008016;GO:0097474;GO:0046549;GO:0007605;GO:0002154;GO:0006367;GO:0006351;GO:0060509;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:sequence-specific double-stranded DNA binding; F:thyroid hormone binding; F:zinc ion binding;, P:cell differentiation; P:cellular response to thyroid hormone stimulus; P:female courtship behavior; P:hormone-mediated signaling pathway; P:negative regulation of female receptivity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of heart contraction; P:retinal cone cell apoptotic process; P:retinal cone cell development; P:sensory perception of sound; P:thyroid hormone mediated signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:type I pneumocyte differentiation; scaffold26 indexed_genome mRNA 5064435 5140214 . - . ID=transcript_5845;P10826 P12891 Q00989 Q15298 Q9UN48,Retinoic acid receptor beta,HBV-activated protein;Nuclear receptor subfamily 1 group B member 2;RAR-epsilon;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0008144;GO:0004879;GO:0044877;GO:0046965;GO:0000978;GO:1990837;GO:0008270;GO:0030154;GO:0048566;GO:0048048;GO:0035116;GO:0002068;GO:0003417;GO:0009755;GO:0035264;GO:0043066;GO:0008285;GO:0032331;GO:0000122;GO:0022008;GO:0003148;GO:0043065;GO:0045666;GO:0045944;GO:0031641;GO:0048384;GO:0007165;GO:0021756;GO:0006367;GO:0001657;GO:0055012;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:drug binding; F:nuclear receptor activity; F:protein-containing complex binding; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell differentiation; P:embryonic digestive tract development; P:embryonic eye morphogenesis; P:embryonic hindlimb morphogenesis; P:glandular epithelial cell development; P:growth plate cartilage development; P:hormone-mediated signaling pathway; P:multicellular organism growth; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of chondrocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:neurogenesis; P:outflow tract septum morphogenesis; P:positive regulation of apoptotic process; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of myelination; P:retinoic acid receptor signaling pathway; P:signal transduction; P:striatum development; P:transcription initiation from RNA polymerase II promoter; P:ureteric bud development; P:ventricular cardiac muscle cell differentiation;|Q02880 Q13600 Q9UMG8 Q9UQP8,DNA topoisomerase 2-beta,DNA topoisomerase II, beta isozyme;, PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003682;GO:0003677;GO:0003918;GO:0019899;GO:0042826;GO:0046872;GO:0008022;GO:0046982;GO:0005080;GO:0007409;GO:0006265;GO:0030900;GO:0001764;GO:0045870;GO:0000712;GO:0000819;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; F:enzyme binding; F:histone deacetylase binding; F:metal ion binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase C binding;, P:axonogenesis; P:DNA topological change; P:forebrain development; P:neuron migration; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:resolution of meiotic recombination intermediates; P:sister chromatid segregation;|Q02880 Q13600 Q9UMG8 Q9UQP8,DNA topoisomerase 2-beta,DNA topoisomerase II, beta isozyme;, PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003682;GO:0003677;GO:0003918;GO:0019899;GO:0042826;GO:0046872;GO:0008022;GO:0046982;GO:0005080;GO:0007409;GO:0006265;GO:0030900;GO:0001764;GO:0045870;GO:0000712;GO:0000819;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; F:enzyme binding; F:histone deacetylase binding; F:metal ion binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase C binding;, P:axonogenesis; P:DNA topological change; P:forebrain development; P:neuron migration; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:resolution of meiotic recombination intermediates; P:sister chromatid segregation;|Q02880 Q13600 Q9UMG8 Q9UQP8,DNA topoisomerase 2-beta,DNA topoisomerase II, beta isozyme;, PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003682;GO:0003677;GO:0003918;GO:0019899;GO:0042826;GO:0046872;GO:0008022;GO:0046982;GO:0005080;GO:0007409;GO:0006265;GO:0030900;GO:0001764;GO:0045870;GO:0000712;GO:0000819;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; F:enzyme binding; F:histone deacetylase binding; F:metal ion binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase C binding;, P:axonogenesis; P:DNA topological change; P:forebrain development; P:neuron migration; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:resolution of meiotic recombination intermediates; P:sister chromatid segregation;|Q02880 Q13600 Q9UMG8 Q9UQP8,DNA topoisomerase 2-beta,DNA topoisomerase II, beta isozyme;, PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003682;GO:0003677;GO:0003918;GO:0019899;GO:0042826;GO:0046872;GO:0008022;GO:0046982;GO:0005080;GO:0007409;GO:0006265;GO:0030900;GO:0001764;GO:0045870;GO:0000712;GO:0000819;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; F:enzyme binding; F:histone deacetylase binding; F:metal ion binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase C binding;, P:axonogenesis; P:DNA topological change; P:forebrain development; P:neuron migration; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:resolution of meiotic recombination intermediates; P:sister chromatid segregation;|Q02880 Q13600 Q9UMG8 Q9UQP8,DNA topoisomerase 2-beta,DNA topoisomerase II, beta isozyme;, PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003682;GO:0003677;GO:0003918;GO:0019899;GO:0042826;GO:0046872;GO:0008022;GO:0046982;GO:0005080;GO:0007409;GO:0006265;GO:0030900;GO:0001764;GO:0045870;GO:0000712;GO:0000819;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; F:enzyme binding; F:histone deacetylase binding; F:metal ion binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase C binding;, P:axonogenesis; P:DNA topological change; P:forebrain development; P:neuron migration; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:resolution of meiotic recombination intermediates; P:sister chromatid segregation;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q02880 Q13600 Q9UMG8 Q9UQP8,DNA topoisomerase 2-beta,DNA topoisomerase II, beta isozyme;, PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003682;GO:0003677;GO:0003918;GO:0019899;GO:0042826;GO:0046872;GO:0008022;GO:0046982;GO:0005080;GO:0007409;GO:0006265;GO:0030900;GO:0001764;GO:0045870;GO:0000712;GO:0000819;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; F:enzyme binding; F:histone deacetylase binding; F:metal ion binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase C binding;, P:axonogenesis; P:DNA topological change; P:forebrain development; P:neuron migration; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:resolution of meiotic recombination intermediates; P:sister chromatid segregation;|Q02880 Q13600 Q9UMG8 Q9UQP8,DNA topoisomerase 2-beta,DNA topoisomerase II, beta isozyme;, PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003682;GO:0003677;GO:0003918;GO:0019899;GO:0042826;GO:0046872;GO:0008022;GO:0046982;GO:0005080;GO:0007409;GO:0006265;GO:0030900;GO:0001764;GO:0045870;GO:0000712;GO:0000819;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; F:enzyme binding; F:histone deacetylase binding; F:metal ion binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase C binding;, P:axonogenesis; P:DNA topological change; P:forebrain development; P:neuron migration; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:resolution of meiotic recombination intermediates; P:sister chromatid segregation;|Q02880 Q13600 Q9UMG8 Q9UQP8,DNA topoisomerase 2-beta,DNA topoisomerase II, beta isozyme;, PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003682;GO:0003677;GO:0003918;GO:0019899;GO:0042826;GO:0046872;GO:0008022;GO:0046982;GO:0005080;GO:0007409;GO:0006265;GO:0030900;GO:0001764;GO:0045870;GO:0000712;GO:0000819;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; F:enzyme binding; F:histone deacetylase binding; F:metal ion binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein kinase C binding;, P:axonogenesis; P:DNA topological change; P:forebrain development; P:neuron migration; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:resolution of meiotic recombination intermediates; P:sister chromatid segregation; scaffold26 indexed_genome mRNA 5218610 5261054 . - . ID=transcript_5846;Q96IV0 B4DJE9 Q59FB1 Q6PJD8 Q9BVR8 Q9NR70,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase,N-glycanase 1;Peptide:N-glycanase;, PF04721;PF09409;PF01841;, GO:0005737;GO:0005829;GO:0005634;GO:0046872;GO:0000224;GO:0006516;GO:0006517;GO:0006457;GO:0006515;, C:cytoplasm; C:cytosol; C:nucleus;, F:metal ion binding; F:peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity;, P:glycoprotein catabolic process; P:protein deglycosylation; P:protein folding; P:protein quality control for misfolded or incompletely synthesized proteins;|Q96IV0 B4DJE9 Q59FB1 Q6PJD8 Q9BVR8 Q9NR70,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase,N-glycanase 1;Peptide:N-glycanase;, PF04721;PF09409;PF01841;, GO:0005737;GO:0005829;GO:0005634;GO:0046872;GO:0000224;GO:0006516;GO:0006517;GO:0006457;GO:0006515;, C:cytoplasm; C:cytosol; C:nucleus;, F:metal ion binding; F:peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity;, P:glycoprotein catabolic process; P:protein deglycosylation; P:protein folding; P:protein quality control for misfolded or incompletely synthesized proteins;|Q96IV0 B4DJE9 Q59FB1 Q6PJD8 Q9BVR8 Q9NR70,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase,N-glycanase 1;Peptide:N-glycanase;, PF04721;PF09409;PF01841;, GO:0005737;GO:0005829;GO:0005634;GO:0046872;GO:0000224;GO:0006516;GO:0006517;GO:0006457;GO:0006515;, C:cytoplasm; C:cytosol; C:nucleus;, F:metal ion binding; F:peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity;, P:glycoprotein catabolic process; P:protein deglycosylation; P:protein folding; P:protein quality control for misfolded or incompletely synthesized proteins;|Q96IV0 B4DJE9 Q59FB1 Q6PJD8 Q9BVR8 Q9NR70,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase,N-glycanase 1;Peptide:N-glycanase;, PF04721;PF09409;PF01841;, GO:0005737;GO:0005829;GO:0005634;GO:0046872;GO:0000224;GO:0006516;GO:0006517;GO:0006457;GO:0006515;, C:cytoplasm; C:cytosol; C:nucleus;, F:metal ion binding; F:peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity;, P:glycoprotein catabolic process; P:protein deglycosylation; P:protein folding; P:protein quality control for misfolded or incompletely synthesized proteins;|Q96IV0 B4DJE9 Q59FB1 Q6PJD8 Q9BVR8 Q9NR70,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase,N-glycanase 1;Peptide:N-glycanase;, PF04721;PF09409;PF01841;, GO:0005737;GO:0005829;GO:0005634;GO:0046872;GO:0000224;GO:0006516;GO:0006517;GO:0006457;GO:0006515;, C:cytoplasm; C:cytosol; C:nucleus;, F:metal ion binding; F:peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity;, P:glycoprotein catabolic process; P:protein deglycosylation; P:protein folding; P:protein quality control for misfolded or incompletely synthesized proteins; scaffold26 indexed_genome mRNA 5959045 5960314 . - . ID=transcript_5847;Q96PB8 Q5M8T0,Leucine-rich repeat-containing protein 3B,Leucine-rich repeat protein 15;, PF00560;PF13855;PF01462;, GO:0031012;GO:0005615;GO:0016021;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; scaffold26 indexed_genome mRNA 6207878 6210997 . + . ID=transcript_5848;P18440 A8K4E7 O15159 O15300 Q546N1 Q96TE9,Arylamine N-acetyltransferase 1,Arylamide acetylase 1;Monomorphic arylamine N-acetyltransferase;N-acetyltransferase type 1;, PF00797;, GO:0005829;GO:0004060;GO:0006805;, C:cytosol;, F:arylamine N-acetyltransferase activity;, P:xenobiotic metabolic process; scaffold26 indexed_genome mRNA 6260065 6304319 . - . ID=transcript_5849;Q9NYI0 A6NFQ4 E9KL50 Q6B003 Q9Y2F1,PH and SEC7 domain-containing protein 3,Epididymis tissue protein Li 20mP;Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D;Hepatocellular carcinoma-associated antigen 67;Pleckstrin homology and SEC7 domain-containing protein 3;, PF15410;PF01369;, GO:0014069;GO:0032587;GO:0005085;GO:0032012;, C:postsynaptic density; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity;, P:regulation of ARF protein signal transduction; scaffold26 indexed_genome mRNA 6357894 6404966 . - . ID=transcript_5850;Q9NYI0 A6NFQ4 E9KL50 Q6B003 Q9Y2F1,PH and SEC7 domain-containing protein 3,Epididymis tissue protein Li 20mP;Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D;Hepatocellular carcinoma-associated antigen 67;Pleckstrin homology and SEC7 domain-containing protein 3;, PF15410;PF01369;, GO:0014069;GO:0032587;GO:0005085;GO:0032012;, C:postsynaptic density; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity;, P:regulation of ARF protein signal transduction; scaffold26 indexed_genome mRNA 6487529 6564713 . - . ID=transcript_5851;Q9NYI0 A6NFQ4 E9KL50 Q6B003 Q9Y2F1,PH and SEC7 domain-containing protein 3,Epididymis tissue protein Li 20mP;Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D;Hepatocellular carcinoma-associated antigen 67;Pleckstrin homology and SEC7 domain-containing protein 3;, PF15410;PF01369;, GO:0014069;GO:0032587;GO:0005085;GO:0032012;, C:postsynaptic density; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity;, P:regulation of ARF protein signal transduction; scaffold26 indexed_genome mRNA 6961785 7041388 . - . ID=transcript_5852;Q8TDX6 B2RBE4 Q6P9G6 Q8IUF9 Q9NSQ7 Q9NUM9,Chondroitin sulfate N-acetylgalactosaminyltransferase 1 {ECO:0000305},Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1;, PF05679;, GO:0032580;GO:0000139;GO:0030173;GO:0008376;GO:0047238;GO:0015020;GO:0047237;GO:0046872;GO:0008955;GO:0051216;GO:0030206;GO:0050650;GO:0050653;GO:0050651;GO:0001958;GO:0030198;GO:0015014;GO:0030210;GO:0030166;GO:0046398;GO:0019276;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of Golgi membrane;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:glucuronosyltransferase activity; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:metal ion binding; F:peptidoglycan glycosyltransferase activity;, P:cartilage development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:dermatan sulfate proteoglycan biosynthetic process; P:endochondral ossification; P:extracellular matrix organization; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:proteoglycan biosynthetic process; P:UDP-glucuronate metabolic process; P:UDP-N-acetylgalactosamine metabolic process; scaffold26 indexed_genome mRNA 7338767 7348380 . + . ID=transcript_5853;Q9NVR2 Q6IA93 Q7L538 Q7L8C8 Q9H3W8,Integrator complex subunit 10,, , GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NVR2 Q6IA93 Q7L538 Q7L8C8 Q9H3W8,Integrator complex subunit 10,, , GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NVR2 Q6IA93 Q7L538 Q7L8C8 Q9H3W8,Integrator complex subunit 10,, , GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NVR2 Q6IA93 Q7L538 Q7L8C8 Q9H3W8,Integrator complex subunit 10,, , GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold26 indexed_genome mRNA 7348385 7367702 . + . ID=transcript_5854;Q9NVR2 Q6IA93 Q7L538 Q7L8C8 Q9H3W8,Integrator complex subunit 10,, , GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NVR2 Q6IA93 Q7L538 Q7L8C8 Q9H3W8,Integrator complex subunit 10,, , GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NVR2 Q6IA93 Q7L538 Q7L8C8 Q9H3W8,Integrator complex subunit 10,, , GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold26 indexed_genome mRNA 7371309 7402847 . - . ID=transcript_5855;Q68CP4 B4E2V0,Heparan-alpha-glucosaminide N-acetyltransferase,Transmembrane protein 76;, PF07786;, GO:0016021;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0015019;GO:0016746;GO:0006027;GO:0007041;GO:0043312;GO:0051259;, C:integral component of membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:heparan-alpha-glucosaminide N-acetyltransferase activity; F:transferase activity, transferring acyl groups;, P:glycosaminoglycan catabolic process; P:lysosomal transport; P:neutrophil degranulation; P:protein complex oligomerization;|Q68CP4 B4E2V0,Heparan-alpha-glucosaminide N-acetyltransferase,Transmembrane protein 76;, PF07786;, GO:0016021;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0015019;GO:0016746;GO:0006027;GO:0007041;GO:0043312;GO:0051259;, C:integral component of membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:heparan-alpha-glucosaminide N-acetyltransferase activity; F:transferase activity, transferring acyl groups;, P:glycosaminoglycan catabolic process; P:lysosomal transport; P:neutrophil degranulation; P:protein complex oligomerization;|Q68CP4 B4E2V0,Heparan-alpha-glucosaminide N-acetyltransferase,Transmembrane protein 76;, PF07786;, GO:0016021;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0015019;GO:0016746;GO:0006027;GO:0007041;GO:0043312;GO:0051259;, C:integral component of membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:heparan-alpha-glucosaminide N-acetyltransferase activity; F:transferase activity, transferring acyl groups;, P:glycosaminoglycan catabolic process; P:lysosomal transport; P:neutrophil degranulation; P:protein complex oligomerization;|Q68CP4 B4E2V0,Heparan-alpha-glucosaminide N-acetyltransferase,Transmembrane protein 76;, PF07786;, GO:0016021;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0015019;GO:0016746;GO:0006027;GO:0007041;GO:0043312;GO:0051259;, C:integral component of membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:heparan-alpha-glucosaminide N-acetyltransferase activity; F:transferase activity, transferring acyl groups;, P:glycosaminoglycan catabolic process; P:lysosomal transport; P:neutrophil degranulation; P:protein complex oligomerization;|Q68CP4 B4E2V0,Heparan-alpha-glucosaminide N-acetyltransferase,Transmembrane protein 76;, PF07786;, GO:0016021;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0015019;GO:0016746;GO:0006027;GO:0007041;GO:0043312;GO:0051259;, C:integral component of membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:heparan-alpha-glucosaminide N-acetyltransferase activity; F:transferase activity, transferring acyl groups;, P:glycosaminoglycan catabolic process; P:lysosomal transport; P:neutrophil degranulation; P:protein complex oligomerization;|Q68CP4 B4E2V0,Heparan-alpha-glucosaminide N-acetyltransferase,Transmembrane protein 76;, PF07786;, GO:0016021;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0015019;GO:0016746;GO:0006027;GO:0007041;GO:0043312;GO:0051259;, C:integral component of membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:heparan-alpha-glucosaminide N-acetyltransferase activity; F:transferase activity, transferring acyl groups;, P:glycosaminoglycan catabolic process; P:lysosomal transport; P:neutrophil degranulation; P:protein complex oligomerization;|Q68CP4 B4E2V0,Heparan-alpha-glucosaminide N-acetyltransferase,Transmembrane protein 76;, PF07786;, GO:0016021;GO:0005765;GO:0005886;GO:0035579;GO:0070821;GO:0015019;GO:0016746;GO:0006027;GO:0007041;GO:0043312;GO:0051259;, C:integral component of membrane; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:heparan-alpha-glucosaminide N-acetyltransferase activity; F:transferase activity, transferring acyl groups;, P:glycosaminoglycan catabolic process; P:lysosomal transport; P:neutrophil degranulation; P:protein complex oligomerization; scaffold26 indexed_genome mRNA 7422971 7435006 . - . ID=transcript_5856;Q9H5K3,Protein O-mannose kinase,Protein kinase-like protein SgK196;Sugen kinase 196;, PF07714;, GO:0005789;GO:0016021;GO:0005524;GO:0019200;GO:0016773;GO:0004672;GO:0007420;GO:0046835;GO:0006493;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:ATP binding; F:carbohydrate kinase activity; F:phosphotransferase activity, alcohol group as acceptor; F:protein kinase activity;, P:brain development; P:carbohydrate phosphorylation; P:protein O-linked glycosylation; scaffold26 indexed_genome mRNA 7444987 7466916 . - . ID=transcript_5857;P49354 A6NJW0 Q53XJ9 Q9UDC1,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,CAAX farnesyltransferase subunit alpha;FTase-alpha;Ras proteins prenyltransferase subunit alpha;Type I protein geranyl-geranyltransferase subunit alpha;, PF01239;, GO:0005953;GO:0005737;GO:0005829;GO:0005875;GO:0005886;GO:0005965;GO:0030548;GO:0043014;GO:0004662;GO:0008017;GO:0004660;GO:0004661;GO:0004663;GO:0030971;GO:0000165;GO:0045213;GO:0090045;GO:0090044;GO:0018343;GO:0018344;GO:0022400;GO:0071340;GO:0007179;, C:CAAX-protein geranylgeranyltransferase complex; C:cytoplasm; C:cytosol; C:microtubule associated complex; C:plasma membrane; C:protein farnesyltransferase complex;, F:acetylcholine receptor regulator activity; F:alpha-tubulin binding; F:CAAX-protein geranylgeranyltransferase activity; F:microtubule binding; F:protein farnesyltransferase activity; F:protein geranylgeranyltransferase activity; F:Rab geranylgeranyltransferase activity; F:receptor tyrosine kinase binding;, P:MAPK cascade; P:neurotransmitter receptor metabolic process; P:positive regulation of deacetylase activity; P:positive regulation of tubulin deacetylation; P:protein farnesylation; P:protein geranylgeranylation; P:regulation of rhodopsin mediated signaling pathway; P:skeletal muscle acetylcholine-gated channel clustering; P:transforming growth factor beta receptor signaling pathway;|P49354 A6NJW0 Q53XJ9 Q9UDC1,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,CAAX farnesyltransferase subunit alpha;FTase-alpha;Ras proteins prenyltransferase subunit alpha;Type I protein geranyl-geranyltransferase subunit alpha;, PF01239;, GO:0005953;GO:0005737;GO:0005829;GO:0005875;GO:0005886;GO:0005965;GO:0030548;GO:0043014;GO:0004662;GO:0008017;GO:0004660;GO:0004661;GO:0004663;GO:0030971;GO:0000165;GO:0045213;GO:0090045;GO:0090044;GO:0018343;GO:0018344;GO:0022400;GO:0071340;GO:0007179;, C:CAAX-protein geranylgeranyltransferase complex; C:cytoplasm; C:cytosol; C:microtubule associated complex; C:plasma membrane; C:protein farnesyltransferase complex;, F:acetylcholine receptor regulator activity; F:alpha-tubulin binding; F:CAAX-protein geranylgeranyltransferase activity; F:microtubule binding; F:protein farnesyltransferase activity; F:protein geranylgeranyltransferase activity; F:Rab geranylgeranyltransferase activity; F:receptor tyrosine kinase binding;, P:MAPK cascade; P:neurotransmitter receptor metabolic process; P:positive regulation of deacetylase activity; P:positive regulation of tubulin deacetylation; P:protein farnesylation; P:protein geranylgeranylation; P:regulation of rhodopsin mediated signaling pathway; P:skeletal muscle acetylcholine-gated channel clustering; P:transforming growth factor beta receptor signaling pathway;|P49354 A6NJW0 Q53XJ9 Q9UDC1,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,CAAX farnesyltransferase subunit alpha;FTase-alpha;Ras proteins prenyltransferase subunit alpha;Type I protein geranyl-geranyltransferase subunit alpha;, PF01239;, GO:0005953;GO:0005737;GO:0005829;GO:0005875;GO:0005886;GO:0005965;GO:0030548;GO:0043014;GO:0004662;GO:0008017;GO:0004660;GO:0004661;GO:0004663;GO:0030971;GO:0000165;GO:0045213;GO:0090045;GO:0090044;GO:0018343;GO:0018344;GO:0022400;GO:0071340;GO:0007179;, C:CAAX-protein geranylgeranyltransferase complex; C:cytoplasm; C:cytosol; C:microtubule associated complex; C:plasma membrane; C:protein farnesyltransferase complex;, F:acetylcholine receptor regulator activity; F:alpha-tubulin binding; F:CAAX-protein geranylgeranyltransferase activity; F:microtubule binding; F:protein farnesyltransferase activity; F:protein geranylgeranyltransferase activity; F:Rab geranylgeranyltransferase activity; F:receptor tyrosine kinase binding;, P:MAPK cascade; P:neurotransmitter receptor metabolic process; P:positive regulation of deacetylase activity; P:positive regulation of tubulin deacetylation; P:protein farnesylation; P:protein geranylgeranylation; P:regulation of rhodopsin mediated signaling pathway; P:skeletal muscle acetylcholine-gated channel clustering; P:transforming growth factor beta receptor signaling pathway;|P49354 A6NJW0 Q53XJ9 Q9UDC1,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,CAAX farnesyltransferase subunit alpha;FTase-alpha;Ras proteins prenyltransferase subunit alpha;Type I protein geranyl-geranyltransferase subunit alpha;, PF01239;, GO:0005953;GO:0005737;GO:0005829;GO:0005875;GO:0005886;GO:0005965;GO:0030548;GO:0043014;GO:0004662;GO:0008017;GO:0004660;GO:0004661;GO:0004663;GO:0030971;GO:0000165;GO:0045213;GO:0090045;GO:0090044;GO:0018343;GO:0018344;GO:0022400;GO:0071340;GO:0007179;, C:CAAX-protein geranylgeranyltransferase complex; C:cytoplasm; C:cytosol; C:microtubule associated complex; C:plasma membrane; C:protein farnesyltransferase complex;, F:acetylcholine receptor regulator activity; F:alpha-tubulin binding; F:CAAX-protein geranylgeranyltransferase activity; F:microtubule binding; F:protein farnesyltransferase activity; F:protein geranylgeranyltransferase activity; F:Rab geranylgeranyltransferase activity; F:receptor tyrosine kinase binding;, P:MAPK cascade; P:neurotransmitter receptor metabolic process; P:positive regulation of deacetylase activity; P:positive regulation of tubulin deacetylation; P:protein farnesylation; P:protein geranylgeranylation; P:regulation of rhodopsin mediated signaling pathway; P:skeletal muscle acetylcholine-gated channel clustering; P:transforming growth factor beta receptor signaling pathway; scaffold26 indexed_genome mRNA 7495172 7553108 . - . ID=transcript_5858;Q86VS8 D3DSY8 Q8NBH0 Q9BY13,Protein Hook homolog 3,, PF05622;PF19047;, GO:0034451;GO:0005813;GO:0005801;GO:0005737;GO:0005829;GO:0070695;GO:0005874;GO:0000242;GO:0034452;GO:0045505;GO:0045503;GO:0051959;GO:0042802;GO:0008017;GO:0031122;GO:0030705;GO:0045022;GO:0007032;GO:0008333;GO:0051645;GO:0022027;GO:0007040;GO:0034454;GO:0050768;GO:0097150;GO:0071539;GO:0015031;, C:centriolar satellite; C:centrosome; C:cis-Golgi network; C:cytoplasm; C:cytosol; C:FHF complex; C:microtubule; C:pericentriolar material;, F:dynactin binding; F:dynein intermediate chain binding; F:dynein light chain binding; F:dynein light intermediate chain binding; F:identical protein binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:Golgi localization; P:interkinetic nuclear migration; P:lysosome organization; P:microtubule anchoring at centrosome; P:negative regulation of neurogenesis; P:neuronal stem cell population maintenance; P:protein localization to centrosome; P:protein transport;|Q86VS8 D3DSY8 Q8NBH0 Q9BY13,Protein Hook homolog 3,, PF05622;PF19047;, GO:0034451;GO:0005813;GO:0005801;GO:0005737;GO:0005829;GO:0070695;GO:0005874;GO:0000242;GO:0034452;GO:0045505;GO:0045503;GO:0051959;GO:0042802;GO:0008017;GO:0031122;GO:0030705;GO:0045022;GO:0007032;GO:0008333;GO:0051645;GO:0022027;GO:0007040;GO:0034454;GO:0050768;GO:0097150;GO:0071539;GO:0015031;, C:centriolar satellite; C:centrosome; C:cis-Golgi network; C:cytoplasm; C:cytosol; C:FHF complex; C:microtubule; C:pericentriolar material;, F:dynactin binding; F:dynein intermediate chain binding; F:dynein light chain binding; F:dynein light intermediate chain binding; F:identical protein binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:early endosome to late endosome transport; P:endosome organization; P:endosome to lysosome transport; P:Golgi localization; P:interkinetic nuclear migration; P:lysosome organization; P:microtubule anchoring at centrosome; P:negative regulation of neurogenesis; P:neuronal stem cell population maintenance; P:protein localization to centrosome; P:protein transport; scaffold26 indexed_genome mRNA 7585655 7613943 . + . ID=transcript_5859;Q9H0V6,E3 ubiquitin-protein ligase RNF170,Putative LAG1-interacting protein;RING finger protein 170;RING-type E3 ubiquitin transferase RNF170 {ECO:0000305};, PF06803;PF00097;, GO:0005789;GO:0016021;GO:0046872;GO:0061630;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;|Q9H0V6,E3 ubiquitin-protein ligase RNF170,Putative LAG1-interacting protein;RING finger protein 170;RING-type E3 ubiquitin transferase RNF170 {ECO:0000305};, PF06803;PF00097;, GO:0005789;GO:0016021;GO:0046872;GO:0061630;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;|Q9H0V6,E3 ubiquitin-protein ligase RNF170,Putative LAG1-interacting protein;RING finger protein 170;RING-type E3 ubiquitin transferase RNF170 {ECO:0000305};, PF06803;PF00097;, GO:0005789;GO:0016021;GO:0046872;GO:0061630;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;|Q9H0V6,E3 ubiquitin-protein ligase RNF170,Putative LAG1-interacting protein;RING finger protein 170;RING-type E3 ubiquitin transferase RNF170 {ECO:0000305};, PF06803;PF00097;, GO:0005789;GO:0016021;GO:0046872;GO:0061630;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; scaffold26 indexed_genome mRNA 7614905 7616515 . + . ID=transcript_5860;Q9NVV9 A6NCB6 D3DSY5 H9KV49 Q53FQ1 Q6IA99,THAP domain-containing protein 1,, PF05485;, GO:0000785;GO:0001650;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0003700;GO:0000981;GO:0001227;GO:0042802;GO:0042803;GO:0000978;GO:0043565;GO:0008270;GO:0007049;GO:0001935;GO:0000122;GO:0007346;GO:0006357;GO:0006355;GO:0006351;, C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:zinc ion binding;, P:cell cycle; P:endothelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:regulation of mitotic cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold26 indexed_genome mRNA 7628031 7634305 . + . ID=transcript_5861;Q9NVV9 A6NCB6 D3DSY5 H9KV49 Q53FQ1 Q6IA99,THAP domain-containing protein 1,, PF05485;, GO:0000785;GO:0001650;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0003700;GO:0000981;GO:0001227;GO:0042802;GO:0042803;GO:0000978;GO:0043565;GO:0008270;GO:0007049;GO:0001935;GO:0000122;GO:0007346;GO:0006357;GO:0006355;GO:0006351;, C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:zinc ion binding;, P:cell cycle; P:endothelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:regulation of mitotic cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q9NVV9 A6NCB6 D3DSY5 H9KV49 Q53FQ1 Q6IA99,THAP domain-containing protein 1,, PF05485;, GO:0000785;GO:0001650;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0003700;GO:0000981;GO:0001227;GO:0042802;GO:0042803;GO:0000978;GO:0043565;GO:0008270;GO:0007049;GO:0001935;GO:0000122;GO:0007346;GO:0006357;GO:0006355;GO:0006351;, C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:zinc ion binding;, P:cell cycle; P:endothelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:regulation of mitotic cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold26 indexed_genome mRNA 7663671 7678370 . + . ID=transcript_5862;Q15825 B2R8V4 B4DQH1,Neuronal acetylcholine receptor subunit alpha-6,, PF02931;PF02932;, GO:0005892;GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0015464;GO:0022848;GO:0030594;GO:0007268;GO:0034220;GO:0050877;GO:0042391;GO:0007165;, C:acetylcholine-gated channel complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:neurotransmitter receptor activity;, P:chemical synaptic transmission; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:signal transduction; scaffold26 indexed_genome mRNA 7692290 7693178 . - . ID=transcript_5863;Q05901 Q15827,Neuronal acetylcholine receptor subunit beta-3,, PF02931;PF02932;, GO:0005892;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0042166;GO:0022848;GO:0015267;GO:0030594;GO:0004888;GO:0007268;GO:0034220;GO:0050877;GO:0042391;GO:0035094;GO:0007165;GO:0007271;, C:acetylcholine-gated channel complex; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine binding; F:acetylcholine-gated cation-selective channel activity; F:channel activity; F:neurotransmitter receptor activity; F:transmembrane signaling receptor activity;, P:chemical synaptic transmission; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:response to nicotine; P:signal transduction; P:synaptic transmission, cholinergic; scaffold26 indexed_genome mRNA 7801882 7828747 . + . ID=transcript_5864;Q96E16 B2R4S6 D3DSY4,Small integral membrane protein 19,, PF15117;, GO:0016021;, C:integral component of membrane;|Q96E16 B2R4S6 D3DSY4,Small integral membrane protein 19,, PF15117;, GO:0016021;, C:integral component of membrane;|Q96E16 B2R4S6 D3DSY4,Small integral membrane protein 19,, PF15117;, GO:0016021;, C:integral component of membrane;|Q96E16 B2R4S6 D3DSY4,Small integral membrane protein 19,, PF15117;, GO:0016021;, C:integral component of membrane;|Q96E16 B2R4S6 D3DSY4,Small integral membrane protein 19,, PF15117;, GO:0016021;, C:integral component of membrane; scaffold26 indexed_genome mRNA 7854770 7934069 . + . ID=transcript_5865;Q08357,Sodium-dependent phosphate transporter 2,Gibbon ape leukemia virus receptor 2;Phosphate transporter 2;Solute carrier family 20 member 2;, PF01384;, GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005315;GO:0038023;GO:0005436;GO:0001618;GO:0006811;GO:0035435;, C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:inorganic phosphate transmembrane transporter activity; F:signaling receptor activity; F:sodium:phosphate symporter activity; F:virus receptor activity;, P:ion transport; P:phosphate ion transmembrane transport;|Q08357,Sodium-dependent phosphate transporter 2,Gibbon ape leukemia virus receptor 2;Phosphate transporter 2;Solute carrier family 20 member 2;, PF01384;, GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005315;GO:0038023;GO:0005436;GO:0001618;GO:0006811;GO:0035435;, C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:inorganic phosphate transmembrane transporter activity; F:signaling receptor activity; F:sodium:phosphate symporter activity; F:virus receptor activity;, P:ion transport; P:phosphate ion transmembrane transport;|Q08357,Sodium-dependent phosphate transporter 2,Gibbon ape leukemia virus receptor 2;Phosphate transporter 2;Solute carrier family 20 member 2;, PF01384;, GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005315;GO:0038023;GO:0005436;GO:0001618;GO:0006811;GO:0035435;, C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:inorganic phosphate transmembrane transporter activity; F:signaling receptor activity; F:sodium:phosphate symporter activity; F:virus receptor activity;, P:ion transport; P:phosphate ion transmembrane transport;|Q08357,Sodium-dependent phosphate transporter 2,Gibbon ape leukemia virus receptor 2;Phosphate transporter 2;Solute carrier family 20 member 2;, PF01384;, GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005315;GO:0038023;GO:0005436;GO:0001618;GO:0006811;GO:0035435;, C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:inorganic phosphate transmembrane transporter activity; F:signaling receptor activity; F:sodium:phosphate symporter activity; F:virus receptor activity;, P:ion transport; P:phosphate ion transmembrane transport;|Q08357,Sodium-dependent phosphate transporter 2,Gibbon ape leukemia virus receptor 2;Phosphate transporter 2;Solute carrier family 20 member 2;, PF01384;, GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005315;GO:0038023;GO:0005436;GO:0001618;GO:0006811;GO:0035435;, C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:inorganic phosphate transmembrane transporter activity; F:signaling receptor activity; F:sodium:phosphate symporter activity; F:virus receptor activity;, P:ion transport; P:phosphate ion transmembrane transport;|Q08357,Sodium-dependent phosphate transporter 2,Gibbon ape leukemia virus receptor 2;Phosphate transporter 2;Solute carrier family 20 member 2;, PF01384;, GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005315;GO:0038023;GO:0005436;GO:0001618;GO:0006811;GO:0035435;, C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:inorganic phosphate transmembrane transporter activity; F:signaling receptor activity; F:sodium:phosphate symporter activity; F:virus receptor activity;, P:ion transport; P:phosphate ion transmembrane transport; scaffold26 indexed_genome mRNA 7938928 7950068 . - . ID=transcript_5866;Q9Y277 Q9UIS0,Voltage-dependent anion-selective channel protein 3,Outer mitochondrial membrane protein porin 3;, PF01459;, GO:0070062;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0000166;GO:0015288;GO:0008308;GO:0015853;GO:1902017;, C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex;, F:nucleotide binding; F:porin activity; F:voltage-gated anion channel activity;, P:adenine transport; P:regulation of cilium assembly;|Q9Y277 Q9UIS0,Voltage-dependent anion-selective channel protein 3,Outer mitochondrial membrane protein porin 3;, PF01459;, GO:0070062;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0000166;GO:0015288;GO:0008308;GO:0015853;GO:1902017;, C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex;, F:nucleotide binding; F:porin activity; F:voltage-gated anion channel activity;, P:adenine transport; P:regulation of cilium assembly;|Q9Y277 Q9UIS0,Voltage-dependent anion-selective channel protein 3,Outer mitochondrial membrane protein porin 3;, PF01459;, GO:0070062;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0000166;GO:0015288;GO:0008308;GO:0015853;GO:1902017;, C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex;, F:nucleotide binding; F:porin activity; F:voltage-gated anion channel activity;, P:adenine transport; P:regulation of cilium assembly;|Q9Y277 Q9UIS0,Voltage-dependent anion-selective channel protein 3,Outer mitochondrial membrane protein porin 3;, PF01459;, GO:0070062;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0000166;GO:0015288;GO:0008308;GO:0015853;GO:1902017;, C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex;, F:nucleotide binding; F:porin activity; F:voltage-gated anion channel activity;, P:adenine transport; P:regulation of cilium assembly;|Q9Y277 Q9UIS0,Voltage-dependent anion-selective channel protein 3,Outer mitochondrial membrane protein porin 3;, PF01459;, GO:0070062;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0000166;GO:0015288;GO:0008308;GO:0015853;GO:1902017;, C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex;, F:nucleotide binding; F:porin activity; F:voltage-gated anion channel activity;, P:adenine transport; P:regulation of cilium assembly; scaffold26 indexed_genome mRNA 7973370 7997216 . - . ID=transcript_5867;P06746 B2RC78 Q3KP48 Q6FI34,DNA polymerase beta,, PF14792;PF14791;PF10391;PF14716;, GO:0005737;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0005876;GO:0003684;GO:0003887;GO:0019899;GO:0016829;GO:0046872;GO:0008017;GO:0007568;GO:0006284;GO:0006286;GO:0006288;GO:0006287;GO:0006974;GO:0006281;GO:0006261;GO:0006303;GO:0048872;GO:0071707;GO:0001701;GO:0006954;GO:0008630;GO:0048535;GO:0051402;GO:0016579;GO:0006290;GO:0045471;GO:0010332;GO:0055093;GO:0007435;GO:0016446;GO:0048536;, C:cytoplasm; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle microtubule;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:enzyme binding; F:lyase activity; F:metal ion binding; F:microtubule binding;, P:aging; P:base-excision repair; P:base-excision repair, base-free sugar-phosphate removal; P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA repair; P:DNA-dependent DNA replication; P:double-strand break repair via nonhomologous end joining; P:homeostasis of number of cells; P:immunoglobulin heavy chain V-D-J recombination; P:in utero embryonic development; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lymph node development; P:neuron apoptotic process; P:protein deubiquitination; P:pyrimidine dimer repair; P:response to ethanol; P:response to gamma radiation; P:response to hyperoxia; P:salivary gland morphogenesis; P:somatic hypermutation of immunoglobulin genes; P:spleen development;|P06746 B2RC78 Q3KP48 Q6FI34,DNA polymerase beta,, PF14792;PF14791;PF10391;PF14716;, GO:0005737;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0005876;GO:0003684;GO:0003887;GO:0019899;GO:0016829;GO:0046872;GO:0008017;GO:0007568;GO:0006284;GO:0006286;GO:0006288;GO:0006287;GO:0006974;GO:0006281;GO:0006261;GO:0006303;GO:0048872;GO:0071707;GO:0001701;GO:0006954;GO:0008630;GO:0048535;GO:0051402;GO:0016579;GO:0006290;GO:0045471;GO:0010332;GO:0055093;GO:0007435;GO:0016446;GO:0048536;, C:cytoplasm; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle microtubule;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:enzyme binding; F:lyase activity; F:metal ion binding; F:microtubule binding;, P:aging; P:base-excision repair; P:base-excision repair, base-free sugar-phosphate removal; P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA repair; P:DNA-dependent DNA replication; P:double-strand break repair via nonhomologous end joining; P:homeostasis of number of cells; P:immunoglobulin heavy chain V-D-J recombination; P:in utero embryonic development; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lymph node development; P:neuron apoptotic process; P:protein deubiquitination; P:pyrimidine dimer repair; P:response to ethanol; P:response to gamma radiation; P:response to hyperoxia; P:salivary gland morphogenesis; P:somatic hypermutation of immunoglobulin genes; P:spleen development;|P06746 B2RC78 Q3KP48 Q6FI34,DNA polymerase beta,, PF14792;PF14791;PF10391;PF14716;, GO:0005737;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0005876;GO:0003684;GO:0003887;GO:0019899;GO:0016829;GO:0046872;GO:0008017;GO:0007568;GO:0006284;GO:0006286;GO:0006288;GO:0006287;GO:0006974;GO:0006281;GO:0006261;GO:0006303;GO:0048872;GO:0071707;GO:0001701;GO:0006954;GO:0008630;GO:0048535;GO:0051402;GO:0016579;GO:0006290;GO:0045471;GO:0010332;GO:0055093;GO:0007435;GO:0016446;GO:0048536;, C:cytoplasm; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle microtubule;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:enzyme binding; F:lyase activity; F:metal ion binding; F:microtubule binding;, P:aging; P:base-excision repair; P:base-excision repair, base-free sugar-phosphate removal; P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA repair; P:DNA-dependent DNA replication; P:double-strand break repair via nonhomologous end joining; P:homeostasis of number of cells; P:immunoglobulin heavy chain V-D-J recombination; P:in utero embryonic development; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lymph node development; P:neuron apoptotic process; P:protein deubiquitination; P:pyrimidine dimer repair; P:response to ethanol; P:response to gamma radiation; P:response to hyperoxia; P:salivary gland morphogenesis; P:somatic hypermutation of immunoglobulin genes; P:spleen development;|P06746 B2RC78 Q3KP48 Q6FI34,DNA polymerase beta,, PF14792;PF14791;PF10391;PF14716;, GO:0005737;GO:0005874;GO:0005654;GO:0005634;GO:0032991;GO:0005876;GO:0003684;GO:0003887;GO:0019899;GO:0016829;GO:0046872;GO:0008017;GO:0007568;GO:0006284;GO:0006286;GO:0006288;GO:0006287;GO:0006974;GO:0006281;GO:0006261;GO:0006303;GO:0048872;GO:0071707;GO:0001701;GO:0006954;GO:0008630;GO:0048535;GO:0051402;GO:0016579;GO:0006290;GO:0045471;GO:0010332;GO:0055093;GO:0007435;GO:0016446;GO:0048536;, C:cytoplasm; C:microtubule; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle microtubule;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:enzyme binding; F:lyase activity; F:metal ion binding; F:microtubule binding;, P:aging; P:base-excision repair; P:base-excision repair, base-free sugar-phosphate removal; P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA repair; P:DNA-dependent DNA replication; P:double-strand break repair via nonhomologous end joining; P:homeostasis of number of cells; P:immunoglobulin heavy chain V-D-J recombination; P:in utero embryonic development; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lymph node development; P:neuron apoptotic process; P:protein deubiquitination; P:pyrimidine dimer repair; P:response to ethanol; P:response to gamma radiation; P:response to hyperoxia; P:salivary gland morphogenesis; P:somatic hypermutation of immunoglobulin genes; P:spleen development; scaffold26 indexed_genome mRNA 8001859 8004016 . - . ID=transcript_5868;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold26 indexed_genome mRNA 8004506 8059176 . - . ID=transcript_5869;O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|O14920 B4DZ30 B4E0U4 O75327,Inhibitor of nuclear factor kappa-B kinase subunit beta,I-kappa-B kinase 2;Nuclear factor NF-kappa-B inhibitor kinase beta;Serine/threonine protein kinase IKBKB;, PF18397;PF12179;PF00069;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0008385;GO:0045121;GO:0005634;GO:0005524;GO:0042802;GO:0008384;GO:0046982;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:1990459;GO:0002479;GO:0071356;GO:0030866;GO:0038095;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0002756;GO:0043066;GO:1903347;GO:0035509;GO:0018105;GO:0043123;GO:0051092;GO:0045944;GO:0045893;GO:0072659;GO:0006468;GO:1903140;GO:0042325;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0033209;GO:0016032;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:IkappaB kinase complex; C:membrane raft; C:nucleus;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transferrin receptor binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cellular response to tumor necrosis factor; P:cortical actin cytoskeleton organization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of bicellular tight junction assembly; P:negative regulation of myosin-light-chain-phosphatase activity; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of establishment of endothelial barrier; P:regulation of phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process; scaffold26 indexed_genome mRNA 8116174 8126181 . + . ID=transcript_5870;Q9BZW1,Tissue-type plasminogen activator {ECO:0000305},, PF00008;PF00039;PF00051;PF00089;, GO:0009986;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0051219;GO:0004252;GO:0005102;GO:0007596;GO:0006464;GO:0042730;GO:0045861;GO:0031639;GO:0048008;GO:0060468;GO:0006508;GO:0014909;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:phosphoprotein binding; F:serine-type endopeptidase activity; F:signaling receptor binding;, P:blood coagulation; P:cellular protein modification process; P:fibrinolysis; P:negative regulation of proteolysis; P:plasminogen activation; P:platelet-derived growth factor receptor signaling pathway; P:prevention of polyspermy; P:proteolysis; P:smooth muscle cell migration;|Q9BZW1,Tissue-type plasminogen activator {ECO:0000305},, PF00008;PF00039;PF00051;PF00089;, GO:0009986;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0051219;GO:0004252;GO:0005102;GO:0007596;GO:0006464;GO:0042730;GO:0045861;GO:0031639;GO:0048008;GO:0060468;GO:0006508;GO:0014909;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:phosphoprotein binding; F:serine-type endopeptidase activity; F:signaling receptor binding;, P:blood coagulation; P:cellular protein modification process; P:fibrinolysis; P:negative regulation of proteolysis; P:plasminogen activation; P:platelet-derived growth factor receptor signaling pathway; P:prevention of polyspermy; P:proteolysis; P:smooth muscle cell migration;|Q9BZW1,Tissue-type plasminogen activator {ECO:0000305},, PF00008;PF00039;PF00051;PF00089;, GO:0009986;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0051219;GO:0004252;GO:0005102;GO:0007596;GO:0006464;GO:0042730;GO:0045861;GO:0031639;GO:0048008;GO:0060468;GO:0006508;GO:0014909;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:phosphoprotein binding; F:serine-type endopeptidase activity; F:signaling receptor binding;, P:blood coagulation; P:cellular protein modification process; P:fibrinolysis; P:negative regulation of proteolysis; P:plasminogen activation; P:platelet-derived growth factor receptor signaling pathway; P:prevention of polyspermy; P:proteolysis; P:smooth muscle cell migration;|Q9BZW1,Tissue-type plasminogen activator {ECO:0000305},, PF00008;PF00039;PF00051;PF00089;, GO:0009986;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0051219;GO:0004252;GO:0005102;GO:0007596;GO:0006464;GO:0042730;GO:0045861;GO:0031639;GO:0048008;GO:0060468;GO:0006508;GO:0014909;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:phosphoprotein binding; F:serine-type endopeptidase activity; F:signaling receptor binding;, P:blood coagulation; P:cellular protein modification process; P:fibrinolysis; P:negative regulation of proteolysis; P:plasminogen activation; P:platelet-derived growth factor receptor signaling pathway; P:prevention of polyspermy; P:proteolysis; P:smooth muscle cell migration;|Q9BZW1,Tissue-type plasminogen activator {ECO:0000305},, PF00008;PF00039;PF00051;PF00089;, GO:0009986;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0051219;GO:0004252;GO:0005102;GO:0007596;GO:0006464;GO:0042730;GO:0045861;GO:0031639;GO:0048008;GO:0060468;GO:0006508;GO:0014909;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:phosphoprotein binding; F:serine-type endopeptidase activity; F:signaling receptor binding;, P:blood coagulation; P:cellular protein modification process; P:fibrinolysis; P:negative regulation of proteolysis; P:plasminogen activation; P:platelet-derived growth factor receptor signaling pathway; P:prevention of polyspermy; P:proteolysis; P:smooth muscle cell migration;|Q9BZW1,Tissue-type plasminogen activator {ECO:0000305},, PF00008;PF00039;PF00051;PF00089;, GO:0009986;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0051219;GO:0004252;GO:0005102;GO:0007596;GO:0006464;GO:0042730;GO:0045861;GO:0031639;GO:0048008;GO:0060468;GO:0006508;GO:0014909;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:phosphoprotein binding; F:serine-type endopeptidase activity; F:signaling receptor binding;, P:blood coagulation; P:cellular protein modification process; P:fibrinolysis; P:negative regulation of proteolysis; P:plasminogen activation; P:platelet-derived growth factor receptor signaling pathway; P:prevention of polyspermy; P:proteolysis; P:smooth muscle cell migration; scaffold26 indexed_genome mRNA 8133789 8153102 . - . ID=transcript_5871;P53677 B2RCR0 D3DSY2 Q7Z472,AP-3 complex subunit mu-2,Adaptor-related protein complex 3 subunit mu-2;Clathrin assembly protein assembly protein complex 3 mu-2 medium chain;Clathrin coat assembly protein AP47 homolog 2;Clathrin coat-associated protein AP47 homolog 2;Golgi adaptor AP-1 47 kDa protein homolog 2;HA1 47 kDa subunit homolog 2;Mu3B-adaptin;P47B;, PF00928;PF01217;, GO:0030119;GO:1904115;GO:0030131;GO:0031410;GO:0030659;GO:0005794;GO:0043231;GO:0008089;GO:0048490;GO:0006897;GO:0006886;GO:0016192;, C:AP-type membrane coat adaptor complex; C:axon cytoplasm; C:clathrin adaptor complex; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endocytosis; P:intracellular protein transport; P:vesicle-mediated transport; scaffold26 indexed_genome mRNA 8236868 8326636 . + . ID=transcript_5872;Q92794 Q76L81,Histone acetyltransferase KAT6A,MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3;Monocytic leukemia zinc finger protein;Runt-related transcription factor-binding protein 2;Zinc finger protein 220;, PF01853;PF00628;PF17772;, GO:0005829;GO:0070776;GO:0016607;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0016605;GO:0016407;GO:0003677;GO:0004402;GO:0042393;GO:0003713;GO:0003712;GO:0008134;GO:0008270;GO:0090398;GO:0006323;GO:0016573;GO:0043966;GO:0030099;GO:0045892;GO:0006334;GO:0045944;GO:0045893;GO:0006473;GO:1901796;, C:cytosol; C:MOZ/MORF histone acetyltransferase complex; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:PML body;, F:acetyltransferase activity; F:DNA binding; F:histone acetyltransferase activity; F:histone binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding; F:zinc ion binding;, P:cellular senescence; P:DNA packaging; P:histone acetylation; P:histone H3 acetylation; P:myeloid cell differentiation; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein acetylation; P:regulation of signal transduction by p53 class mediator; scaffold26 indexed_genome mRNA 8326853 8329035 . + . ID=transcript_5873;Q92794 Q76L81,Histone acetyltransferase KAT6A,MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3;Monocytic leukemia zinc finger protein;Runt-related transcription factor-binding protein 2;Zinc finger protein 220;, PF01853;PF00628;PF17772;, GO:0005829;GO:0070776;GO:0016607;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0016605;GO:0016407;GO:0003677;GO:0004402;GO:0042393;GO:0003713;GO:0003712;GO:0008134;GO:0008270;GO:0090398;GO:0006323;GO:0016573;GO:0043966;GO:0030099;GO:0045892;GO:0006334;GO:0045944;GO:0045893;GO:0006473;GO:1901796;, C:cytosol; C:MOZ/MORF histone acetyltransferase complex; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:PML body;, F:acetyltransferase activity; F:DNA binding; F:histone acetyltransferase activity; F:histone binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding; F:zinc ion binding;, P:cellular senescence; P:DNA packaging; P:histone acetylation; P:histone H3 acetylation; P:myeloid cell differentiation; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein acetylation; P:regulation of signal transduction by p53 class mediator; scaffold26 indexed_genome mRNA 8329389 8338092 . - . ID=transcript_5874;Q92794 Q76L81,Histone acetyltransferase KAT6A,MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3;Monocytic leukemia zinc finger protein;Runt-related transcription factor-binding protein 2;Zinc finger protein 220;, PF01853;PF00628;PF17772;, GO:0005829;GO:0070776;GO:0016607;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0016605;GO:0016407;GO:0003677;GO:0004402;GO:0042393;GO:0003713;GO:0003712;GO:0008134;GO:0008270;GO:0090398;GO:0006323;GO:0016573;GO:0043966;GO:0030099;GO:0045892;GO:0006334;GO:0045944;GO:0045893;GO:0006473;GO:1901796;, C:cytosol; C:MOZ/MORF histone acetyltransferase complex; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:PML body;, F:acetyltransferase activity; F:DNA binding; F:histone acetyltransferase activity; F:histone binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding; F:zinc ion binding;, P:cellular senescence; P:DNA packaging; P:histone acetylation; P:histone H3 acetylation; P:myeloid cell differentiation; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein acetylation; P:regulation of signal transduction by p53 class mediator; scaffold26 indexed_genome mRNA 8510708 8580564 . - . ID=transcript_5875;Q99407,Ankyrin-1,Ankyrin-R;Erythrocyte ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0030673;GO:0016323;GO:0009898;GO:0005856;GO:0005829;GO:0031430;GO:0043005;GO:0005634;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0019903;GO:0030507;GO:0005200;GO:0005198;GO:0007010;GO:0006888;GO:0006887;GO:0045199;GO:0010638;GO:0072659;GO:0007165;, C:axolemma; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:M band; C:neuron projection; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:protein phosphatase binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoskeleton organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:maintenance of epithelial cell apical/basal polarity; P:positive regulation of organelle organization; P:protein localization to plasma membrane; P:signal transduction;|Q99407,Ankyrin-1,Ankyrin-R;Erythrocyte ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0030673;GO:0016323;GO:0009898;GO:0005856;GO:0005829;GO:0031430;GO:0043005;GO:0005634;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0019903;GO:0030507;GO:0005200;GO:0005198;GO:0007010;GO:0006888;GO:0006887;GO:0045199;GO:0010638;GO:0072659;GO:0007165;, C:axolemma; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:M band; C:neuron projection; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:protein phosphatase binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoskeleton organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:maintenance of epithelial cell apical/basal polarity; P:positive regulation of organelle organization; P:protein localization to plasma membrane; P:signal transduction;|Q99407,Ankyrin-1,Ankyrin-R;Erythrocyte ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0030673;GO:0016323;GO:0009898;GO:0005856;GO:0005829;GO:0031430;GO:0043005;GO:0005634;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0019903;GO:0030507;GO:0005200;GO:0005198;GO:0007010;GO:0006888;GO:0006887;GO:0045199;GO:0010638;GO:0072659;GO:0007165;, C:axolemma; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:M band; C:neuron projection; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:protein phosphatase binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoskeleton organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:maintenance of epithelial cell apical/basal polarity; P:positive regulation of organelle organization; P:protein localization to plasma membrane; P:signal transduction;|Q99407,Ankyrin-1,Ankyrin-R;Erythrocyte ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0030673;GO:0016323;GO:0009898;GO:0005856;GO:0005829;GO:0031430;GO:0043005;GO:0005634;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0019903;GO:0030507;GO:0005200;GO:0005198;GO:0007010;GO:0006888;GO:0006887;GO:0045199;GO:0010638;GO:0072659;GO:0007165;, C:axolemma; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:M band; C:neuron projection; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:protein phosphatase binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoskeleton organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:maintenance of epithelial cell apical/basal polarity; P:positive regulation of organelle organization; P:protein localization to plasma membrane; P:signal transduction; scaffold26 indexed_genome mRNA 8599339 8615151 . + . ID=transcript_5876;Q99407,Ankyrin-1,Ankyrin-R;Erythrocyte ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0030673;GO:0016323;GO:0009898;GO:0005856;GO:0005829;GO:0031430;GO:0043005;GO:0005634;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0019903;GO:0030507;GO:0005200;GO:0005198;GO:0007010;GO:0006888;GO:0006887;GO:0045199;GO:0010638;GO:0072659;GO:0007165;, C:axolemma; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:M band; C:neuron projection; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:protein phosphatase binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoskeleton organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:maintenance of epithelial cell apical/basal polarity; P:positive regulation of organelle organization; P:protein localization to plasma membrane; P:signal transduction;|Q99407,Ankyrin-1,Ankyrin-R;Erythrocyte ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0030673;GO:0016323;GO:0009898;GO:0005856;GO:0005829;GO:0031430;GO:0043005;GO:0005634;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0019903;GO:0030507;GO:0005200;GO:0005198;GO:0007010;GO:0006888;GO:0006887;GO:0045199;GO:0010638;GO:0072659;GO:0007165;, C:axolemma; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:M band; C:neuron projection; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:protein phosphatase binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoskeleton organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:maintenance of epithelial cell apical/basal polarity; P:positive regulation of organelle organization; P:protein localization to plasma membrane; P:signal transduction;|Q99407,Ankyrin-1,Ankyrin-R;Erythrocyte ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0030673;GO:0016323;GO:0009898;GO:0005856;GO:0005829;GO:0031430;GO:0043005;GO:0005634;GO:0005886;GO:0045211;GO:0042383;GO:0016529;GO:0014731;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0019903;GO:0030507;GO:0005200;GO:0005198;GO:0007010;GO:0006888;GO:0006887;GO:0045199;GO:0010638;GO:0072659;GO:0007165;, C:axolemma; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:M band; C:neuron projection; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:spectrin-associated cytoskeleton; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:protein phosphatase binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoskeleton organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:maintenance of epithelial cell apical/basal polarity; P:positive regulation of organelle organization; P:protein localization to plasma membrane; P:signal transduction; scaffold26 indexed_genome mRNA 8642124 8659508 . - . ID=transcript_5877;Q86UL3 Q2TU73 Q86V89,Glycerol-3-phosphate acyltransferase 4 {ECO:0000312|HGNC:HGNC:20880},1-acylglycerol-3-phosphate O-acyltransferase 6;Acyl-CoA:glycerol-3-phosphate acyltransferase 4;Lysophosphatidic acid acyltransferase zeta;Testis spermatogenesis apoptosis-related protein 7 {ECO:0000303|PubMed:16625827};, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0004366;GO:0102420;GO:0006637;GO:0016024;GO:0046339;GO:0006631;GO:0002071;GO:0007595;GO:0008610;GO:0006654;GO:0006656;GO:0040014;GO:0019432;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:acyl-CoA metabolic process; P:CDP-diacylglycerol biosynthetic process; P:diacylglycerol metabolic process; P:fatty acid metabolic process; P:glandular epithelial cell maturation; P:lactation; P:lipid biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine biosynthetic process; P:regulation of multicellular organism growth; P:triglyceride biosynthetic process;|Q86UL3 Q2TU73 Q86V89,Glycerol-3-phosphate acyltransferase 4 {ECO:0000312|HGNC:HGNC:20880},1-acylglycerol-3-phosphate O-acyltransferase 6;Acyl-CoA:glycerol-3-phosphate acyltransferase 4;Lysophosphatidic acid acyltransferase zeta;Testis spermatogenesis apoptosis-related protein 7 {ECO:0000303|PubMed:16625827};, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0004366;GO:0102420;GO:0006637;GO:0016024;GO:0046339;GO:0006631;GO:0002071;GO:0007595;GO:0008610;GO:0006654;GO:0006656;GO:0040014;GO:0019432;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:acyl-CoA metabolic process; P:CDP-diacylglycerol biosynthetic process; P:diacylglycerol metabolic process; P:fatty acid metabolic process; P:glandular epithelial cell maturation; P:lactation; P:lipid biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine biosynthetic process; P:regulation of multicellular organism growth; P:triglyceride biosynthetic process;|Q86UL3 Q2TU73 Q86V89,Glycerol-3-phosphate acyltransferase 4 {ECO:0000312|HGNC:HGNC:20880},1-acylglycerol-3-phosphate O-acyltransferase 6;Acyl-CoA:glycerol-3-phosphate acyltransferase 4;Lysophosphatidic acid acyltransferase zeta;Testis spermatogenesis apoptosis-related protein 7 {ECO:0000303|PubMed:16625827};, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0004366;GO:0102420;GO:0006637;GO:0016024;GO:0046339;GO:0006631;GO:0002071;GO:0007595;GO:0008610;GO:0006654;GO:0006656;GO:0040014;GO:0019432;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:acyl-CoA metabolic process; P:CDP-diacylglycerol biosynthetic process; P:diacylglycerol metabolic process; P:fatty acid metabolic process; P:glandular epithelial cell maturation; P:lactation; P:lipid biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine biosynthetic process; P:regulation of multicellular organism growth; P:triglyceride biosynthetic process;|Q86UL3 Q2TU73 Q86V89,Glycerol-3-phosphate acyltransferase 4 {ECO:0000312|HGNC:HGNC:20880},1-acylglycerol-3-phosphate O-acyltransferase 6;Acyl-CoA:glycerol-3-phosphate acyltransferase 4;Lysophosphatidic acid acyltransferase zeta;Testis spermatogenesis apoptosis-related protein 7 {ECO:0000303|PubMed:16625827};, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0004366;GO:0102420;GO:0006637;GO:0016024;GO:0046339;GO:0006631;GO:0002071;GO:0007595;GO:0008610;GO:0006654;GO:0006656;GO:0040014;GO:0019432;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:acyl-CoA metabolic process; P:CDP-diacylglycerol biosynthetic process; P:diacylglycerol metabolic process; P:fatty acid metabolic process; P:glandular epithelial cell maturation; P:lactation; P:lipid biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine biosynthetic process; P:regulation of multicellular organism growth; P:triglyceride biosynthetic process; scaffold26 indexed_genome mRNA 8719624 8727077 . - . ID=transcript_5878;Q9BRT9 B2R8H5 D3DSY0 Q8N648,DNA replication complex GINS protein SLD5,GINS complex subunit 4;, PF05916;PF16922;, GO:0071162;GO:0005737;GO:0000811;GO:0005654;GO:0006271;GO:0000727;GO:0001833;, C:CMG complex; C:cytoplasm; C:GINS complex; C:nucleoplasm;, , P:DNA strand elongation involved in DNA replication; P:double-strand break repair via break-induced replication; P:inner cell mass cell proliferation; scaffold26 indexed_genome mRNA 8748468 8765126 . - . ID=transcript_5879;Q7Z5G4 D3DSX9 J3KQ24 Q96EQ4 Q9P1S0 Q9Y5U7,Golgin subfamily A member 7,Golgi complex-associated protein of 16 kDa;, PF10256;, GO:0070062;GO:0005576;GO:0000139;GO:0005795;GO:0031228;GO:0002178;GO:1904724;GO:0043001;GO:0006893;GO:0000165;GO:0043312;GO:0018230;GO:0018215;GO:0050821;GO:0006612;, C:extracellular exosome; C:extracellular region; C:Golgi membrane; C:Golgi stack; C:intrinsic component of Golgi membrane; C:palmitoyltransferase complex; C:tertiary granule lumen;, , P:Golgi to plasma membrane protein transport; P:Golgi to plasma membrane transport; P:MAPK cascade; P:neutrophil degranulation; P:peptidyl-L-cysteine S-palmitoylation; P:protein phosphopantetheinylation; P:protein stabilization; P:protein targeting to membrane;|Q7Z5G4 D3DSX9 J3KQ24 Q96EQ4 Q9P1S0 Q9Y5U7,Golgin subfamily A member 7,Golgi complex-associated protein of 16 kDa;, PF10256;, GO:0070062;GO:0005576;GO:0000139;GO:0005795;GO:0031228;GO:0002178;GO:1904724;GO:0043001;GO:0006893;GO:0000165;GO:0043312;GO:0018230;GO:0018215;GO:0050821;GO:0006612;, C:extracellular exosome; C:extracellular region; C:Golgi membrane; C:Golgi stack; C:intrinsic component of Golgi membrane; C:palmitoyltransferase complex; C:tertiary granule lumen;, , P:Golgi to plasma membrane protein transport; P:Golgi to plasma membrane transport; P:MAPK cascade; P:neutrophil degranulation; P:peptidyl-L-cysteine S-palmitoylation; P:protein phosphopantetheinylation; P:protein stabilization; P:protein targeting to membrane; scaffold26 indexed_genome mRNA 9889385 9891334 . - . ID=transcript_5880;Q9NR00,Transcriptional and immune response regulator {ECO:0000312|HGNC:HGNC:1357},Thyroid cancer protein 1;, PF15063;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005112;GO:0006915;GO:0034605;GO:0002264;GO:0043066;GO:0045746;GO:1901224;GO:0010739;GO:1900020;GO:1902806;GO:0043620;GO:1903706;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:Notch binding;, P:apoptotic process; P:cellular response to heat; P:endothelial cell activation involved in immune response; P:negative regulation of apoptotic process; P:negative regulation of Notch signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase C activity; P:regulation of cell cycle G1/S phase transition; P:regulation of DNA-templated transcription in response to stress; P:regulation of hemopoiesis; scaffold26 indexed_genome mRNA 10013088 10078070 . - . ID=transcript_5881;Q6ZQW0 A4UD41 F5H5G0,Indoleamine 2,3-dioxygenase 2,Indoleamine 2,3-dioxygenase-like protein 1;Indoleamine-pyrrole 2,3-dioxygenase-like protein 1;, PF01231;, GO:0005737;GO:0005829;GO:0020037;GO:0033754;GO:0046872;GO:0004833;GO:0034354;GO:0002376;GO:0006569;GO:0019441;, C:cytoplasm; C:cytosol;, F:heme binding; F:indoleamine 2,3-dioxygenase activity; F:metal ion binding; F:tryptophan 2,3-dioxygenase activity;, P:'de novo' NAD biosynthetic process from tryptophan; P:immune system process; P:tryptophan catabolic process; P:tryptophan catabolic process to kynurenine;|Q6ZQW0 A4UD41 F5H5G0,Indoleamine 2,3-dioxygenase 2,Indoleamine 2,3-dioxygenase-like protein 1;Indoleamine-pyrrole 2,3-dioxygenase-like protein 1;, PF01231;, GO:0005737;GO:0005829;GO:0020037;GO:0033754;GO:0046872;GO:0004833;GO:0034354;GO:0002376;GO:0006569;GO:0019441;, C:cytoplasm; C:cytosol;, F:heme binding; F:indoleamine 2,3-dioxygenase activity; F:metal ion binding; F:tryptophan 2,3-dioxygenase activity;, P:'de novo' NAD biosynthetic process from tryptophan; P:immune system process; P:tryptophan catabolic process; P:tryptophan catabolic process to kynurenine; scaffold26 indexed_genome mRNA 10087415 10095041 . - . ID=transcript_5882;P14902 E5RGR8 F6M9T7 Q540B4,Indoleamine 2,3-dioxygenase 1,Indoleamine-pyrrole 2,3-dioxygenase;, PF01231;, GO:0005737;GO:0005829;GO:0030485;GO:0032421;GO:0009055;GO:0020037;GO:0033754;GO:0046872;GO:0004833;GO:0034354;GO:0007565;GO:0002376;GO:0006954;GO:0034276;GO:0033555;GO:0032693;GO:0070233;GO:0042130;GO:0002678;GO:0032735;GO:0070234;GO:0002666;GO:0002830;GO:0032496;GO:0036269;GO:0006569;GO:0019441;, C:cytoplasm; C:cytosol; C:smooth muscle contractile fiber; C:stereocilium bundle;, F:electron transfer activity; F:heme binding; F:indoleamine 2,3-dioxygenase activity; F:metal ion binding; F:tryptophan 2,3-dioxygenase activity;, P:'de novo' NAD biosynthetic process from tryptophan; P:female pregnancy; P:immune system process; P:inflammatory response; P:kynurenic acid biosynthetic process; P:multicellular organismal response to stress; P:negative regulation of interleukin-10 production; P:negative regulation of T cell apoptotic process; P:negative regulation of T cell proliferation; P:positive regulation of chronic inflammatory response; P:positive regulation of interleukin-12 production; P:positive regulation of T cell apoptotic process; P:positive regulation of T cell tolerance induction; P:positive regulation of type 2 immune response; P:response to lipopolysaccharide; P:swimming behavior; P:tryptophan catabolic process; P:tryptophan catabolic process to kynurenine; scaffold26 indexed_genome mRNA 11003920 11020746 . - . ID=transcript_5883;Q8TC27 Q8TC42,Disintegrin and metalloproteinase domain-containing protein 32,, PF08516;PF00200;PF01562;PF01421;, GO:0016021;GO:0004222;GO:0007339;GO:0007155;, C:integral component of membrane;, F:metalloendopeptidase activity;, P:binding of sperm to zona pellucida; P:cell adhesion;|Q8TC27 Q8TC42,Disintegrin and metalloproteinase domain-containing protein 32,, PF08516;PF00200;PF01562;PF01421;, GO:0016021;GO:0004222;GO:0007339;GO:0007155;, C:integral component of membrane;, F:metalloendopeptidase activity;, P:binding of sperm to zona pellucida; P:cell adhesion; scaffold26 indexed_genome mRNA 11035462 11080811 . - . ID=transcript_5884;Q8TC27 Q8TC42,Disintegrin and metalloproteinase domain-containing protein 32,, PF08516;PF00200;PF01562;PF01421;, GO:0016021;GO:0004222;GO:0007339;GO:0007155;, C:integral component of membrane;, F:metalloendopeptidase activity;, P:binding of sperm to zona pellucida; P:cell adhesion;|Q8TC27 Q8TC42,Disintegrin and metalloproteinase domain-containing protein 32,, PF08516;PF00200;PF01562;PF01421;, GO:0016021;GO:0004222;GO:0007339;GO:0007155;, C:integral component of membrane;, F:metalloendopeptidase activity;, P:binding of sperm to zona pellucida; P:cell adhesion;|Q8TC27 Q8TC42,Disintegrin and metalloproteinase domain-containing protein 32,, PF08516;PF00200;PF01562;PF01421;, GO:0016021;GO:0004222;GO:0007339;GO:0007155;, C:integral component of membrane;, F:metalloendopeptidase activity;, P:binding of sperm to zona pellucida; P:cell adhesion; scaffold26 indexed_genome mRNA 11089414 11181760 . - . ID=transcript_5885;Q13443 B7ZLN7 Q10718 Q8NFM6,Disintegrin and metalloproteinase domain-containing protein 9,Cellular disintegrin-related protein;Meltrin-gamma;Metalloprotease/disintegrin/cysteine-rich protein 9;Myeloma cell metalloproteinase;, PF08516;PF00200;PF01562;PF01421;, GO:0009986;GO:0070062;GO:0005615;GO:0005925;GO:0016021;GO:0031233;GO:0005518;GO:0005178;GO:0043236;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005080;GO:0017124;GO:0000186;GO:0042987;GO:0007155;GO:0033627;GO:0016477;GO:0033631;GO:0007160;GO:0071222;GO:0007229;GO:0030216;GO:0006509;GO:0031293;GO:0042117;GO:0033630;GO:0030335;GO:0051549;GO:0034241;GO:0051044;GO:0050714;GO:0016485;GO:0051592;GO:0051384;GO:0042542;GO:0010042;GO:0034612;GO:0007179;, C:cell surface; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:intrinsic component of external side of plasma membrane;, F:collagen binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:protein kinase C binding; F:SH3 domain binding;, P:activation of MAPKK activity; P:amyloid precursor protein catabolic process; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cellular response to lipopolysaccharide; P:integrin-mediated signaling pathway; P:keratinocyte differentiation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:monocyte activation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell migration; P:positive regulation of keratinocyte migration; P:positive regulation of macrophage fusion; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein secretion; P:protein processing; P:response to calcium ion; P:response to glucocorticoid; P:response to hydrogen peroxide; P:response to manganese ion; P:response to tumor necrosis factor; P:transforming growth factor beta receptor signaling pathway;|Q13443 B7ZLN7 Q10718 Q8NFM6,Disintegrin and metalloproteinase domain-containing protein 9,Cellular disintegrin-related protein;Meltrin-gamma;Metalloprotease/disintegrin/cysteine-rich protein 9;Myeloma cell metalloproteinase;, PF08516;PF00200;PF01562;PF01421;, GO:0009986;GO:0070062;GO:0005615;GO:0005925;GO:0016021;GO:0031233;GO:0005518;GO:0005178;GO:0043236;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005080;GO:0017124;GO:0000186;GO:0042987;GO:0007155;GO:0033627;GO:0016477;GO:0033631;GO:0007160;GO:0071222;GO:0007229;GO:0030216;GO:0006509;GO:0031293;GO:0042117;GO:0033630;GO:0030335;GO:0051549;GO:0034241;GO:0051044;GO:0050714;GO:0016485;GO:0051592;GO:0051384;GO:0042542;GO:0010042;GO:0034612;GO:0007179;, C:cell surface; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:intrinsic component of external side of plasma membrane;, F:collagen binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:protein kinase C binding; F:SH3 domain binding;, P:activation of MAPKK activity; P:amyloid precursor protein catabolic process; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cellular response to lipopolysaccharide; P:integrin-mediated signaling pathway; P:keratinocyte differentiation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:monocyte activation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell migration; P:positive regulation of keratinocyte migration; P:positive regulation of macrophage fusion; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein secretion; P:protein processing; P:response to calcium ion; P:response to glucocorticoid; P:response to hydrogen peroxide; P:response to manganese ion; P:response to tumor necrosis factor; P:transforming growth factor beta receptor signaling pathway;|Q13443 B7ZLN7 Q10718 Q8NFM6,Disintegrin and metalloproteinase domain-containing protein 9,Cellular disintegrin-related protein;Meltrin-gamma;Metalloprotease/disintegrin/cysteine-rich protein 9;Myeloma cell metalloproteinase;, PF08516;PF00200;PF01562;PF01421;, GO:0009986;GO:0070062;GO:0005615;GO:0005925;GO:0016021;GO:0031233;GO:0005518;GO:0005178;GO:0043236;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005080;GO:0017124;GO:0000186;GO:0042987;GO:0007155;GO:0033627;GO:0016477;GO:0033631;GO:0007160;GO:0071222;GO:0007229;GO:0030216;GO:0006509;GO:0031293;GO:0042117;GO:0033630;GO:0030335;GO:0051549;GO:0034241;GO:0051044;GO:0050714;GO:0016485;GO:0051592;GO:0051384;GO:0042542;GO:0010042;GO:0034612;GO:0007179;, C:cell surface; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:intrinsic component of external side of plasma membrane;, F:collagen binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:protein kinase C binding; F:SH3 domain binding;, P:activation of MAPKK activity; P:amyloid precursor protein catabolic process; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cellular response to lipopolysaccharide; P:integrin-mediated signaling pathway; P:keratinocyte differentiation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:monocyte activation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell migration; P:positive regulation of keratinocyte migration; P:positive regulation of macrophage fusion; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein secretion; P:protein processing; P:response to calcium ion; P:response to glucocorticoid; P:response to hydrogen peroxide; P:response to manganese ion; P:response to tumor necrosis factor; P:transforming growth factor beta receptor signaling pathway; scaffold26 indexed_genome mRNA 11182002 11189261 . + . ID=transcript_5886;Q9BX73 B2RBK4 D3DSX8 Q8N0X9,TM2 domain-containing protein 2,Beta-amyloid-binding protein-like protein 1;, PF05154;, GO:0016021;, C:integral component of membrane;|Q9BX73 B2RBK4 D3DSX8 Q8N0X9,TM2 domain-containing protein 2,Beta-amyloid-binding protein-like protein 1;, PF05154;, GO:0016021;, C:integral component of membrane;|Q9BX73 B2RBK4 D3DSX8 Q8N0X9,TM2 domain-containing protein 2,Beta-amyloid-binding protein-like protein 1;, PF05154;, GO:0016021;, C:integral component of membrane; scaffold26 indexed_genome mRNA 11189424 11193438 . - . ID=transcript_5887;P83105 Q542Z4 Q6PF13,Serine protease HTRA4,High-temperature requirement factor A4;, PF00219;PF07648;PF13180;, GO:0005576;GO:0004175;GO:0042802;GO:0005520;GO:0004252;GO:0030512;GO:0006508;, C:extracellular region;, F:endopeptidase activity; F:identical protein binding; F:insulin-like growth factor binding; F:serine-type endopeptidase activity;, P:negative regulation of transforming growth factor beta receptor signaling pathway; P:proteolysis; scaffold26 indexed_genome mRNA 11200475 11257906 . - . ID=transcript_5888;Q9HB19,Pleckstrin homology domain-containing family A member 2,Tandem PH domain-containing protein 2;, PF00169;, GO:0005737;GO:0016020;GO:0005634;GO:0005886;GO:0032991;GO:0001968;GO:0043236;GO:0008289;GO:0030165;GO:0043325;GO:0006661;GO:0001954;, C:cytoplasm; C:membrane; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:fibronectin binding; F:laminin binding; F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:phosphatidylinositol biosynthetic process; P:positive regulation of cell-matrix adhesion;|Q9HB19,Pleckstrin homology domain-containing family A member 2,Tandem PH domain-containing protein 2;, PF00169;, GO:0005737;GO:0016020;GO:0005634;GO:0005886;GO:0032991;GO:0001968;GO:0043236;GO:0008289;GO:0030165;GO:0043325;GO:0006661;GO:0001954;, C:cytoplasm; C:membrane; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:fibronectin binding; F:laminin binding; F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4-bisphosphate binding;, P:phosphatidylinositol biosynthetic process; P:positive regulation of cell-matrix adhesion; scaffold26 indexed_genome mRNA 11328932 11329838 . + . ID=transcript_5889;Q8IZG2 Q8NEY7 Q9UPP9,Transforming acidic coiled-coil-containing protein 1,Gastric cancer antigen Ga55;Taxin-1;, PF05010;, GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0030331;GO:0035259;GO:0016922;GO:0030374;GO:0042975;GO:0042974;GO:0046965;GO:0046966;GO:0051301;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus;, F:estrogen receptor binding; F:glucocorticoid receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:retinoic acid receptor binding; F:retinoid X receptor binding; F:thyroid hormone receptor binding;, P:cell division; P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization; scaffold26 indexed_genome mRNA 11333623 11384307 . + . ID=transcript_5890;Q8IZG2 Q8NEY7 Q9UPP9,Transforming acidic coiled-coil-containing protein 1,Gastric cancer antigen Ga55;Taxin-1;, PF05010;, GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0030331;GO:0035259;GO:0016922;GO:0030374;GO:0042975;GO:0042974;GO:0046965;GO:0046966;GO:0051301;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus;, F:estrogen receptor binding; F:glucocorticoid receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:retinoic acid receptor binding; F:retinoid X receptor binding; F:thyroid hormone receptor binding;, P:cell division; P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q8IZG2 Q8NEY7 Q9UPP9,Transforming acidic coiled-coil-containing protein 1,Gastric cancer antigen Ga55;Taxin-1;, PF05010;, GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0030331;GO:0035259;GO:0016922;GO:0030374;GO:0042975;GO:0042974;GO:0046965;GO:0046966;GO:0051301;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus;, F:estrogen receptor binding; F:glucocorticoid receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:retinoic acid receptor binding; F:retinoid X receptor binding; F:thyroid hormone receptor binding;, P:cell division; P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q8IZG2 Q8NEY7 Q9UPP9,Transforming acidic coiled-coil-containing protein 1,Gastric cancer antigen Ga55;Taxin-1;, PF05010;, GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0030331;GO:0035259;GO:0016922;GO:0030374;GO:0042975;GO:0042974;GO:0046965;GO:0046966;GO:0051301;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus;, F:estrogen receptor binding; F:glucocorticoid receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:retinoic acid receptor binding; F:retinoid X receptor binding; F:thyroid hormone receptor binding;, P:cell division; P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q8IZG2 Q8NEY7 Q9UPP9,Transforming acidic coiled-coil-containing protein 1,Gastric cancer antigen Ga55;Taxin-1;, PF05010;, GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0030331;GO:0035259;GO:0016922;GO:0030374;GO:0042975;GO:0042974;GO:0046965;GO:0046966;GO:0051301;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus;, F:estrogen receptor binding; F:glucocorticoid receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:retinoic acid receptor binding; F:retinoid X receptor binding; F:thyroid hormone receptor binding;, P:cell division; P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q8IZG2 Q8NEY7 Q9UPP9,Transforming acidic coiled-coil-containing protein 1,Gastric cancer antigen Ga55;Taxin-1;, PF05010;, GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0030331;GO:0035259;GO:0016922;GO:0030374;GO:0042975;GO:0042974;GO:0046965;GO:0046966;GO:0051301;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus;, F:estrogen receptor binding; F:glucocorticoid receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:retinoic acid receptor binding; F:retinoid X receptor binding; F:thyroid hormone receptor binding;, P:cell division; P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization;|Q8IZG2 Q8NEY7 Q9UPP9,Transforming acidic coiled-coil-containing protein 1,Gastric cancer antigen Ga55;Taxin-1;, PF05010;, GO:0005737;GO:0005829;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0030331;GO:0035259;GO:0016922;GO:0030374;GO:0042975;GO:0042974;GO:0046965;GO:0046966;GO:0051301;GO:0008283;GO:0021987;GO:0000226;GO:0007052;, C:cytoplasm; C:cytosol; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus;, F:estrogen receptor binding; F:glucocorticoid receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:retinoic acid receptor binding; F:retinoid X receptor binding; F:thyroid hormone receptor binding;, P:cell division; P:cell population proliferation; P:cerebral cortex development; P:microtubule cytoskeleton organization; P:mitotic spindle organization; scaffold26 indexed_genome mRNA 11710885 11742518 . + . ID=transcript_5891;Q53H63 Q59H40 Q5BJG2 Q8N685 Q9UD50 Q9UDF0 Q9UDF1 Q9UDF2,Fibroblast growth factor receptor 1,Basic fibroblast growth factor receptor 1;Fms-like tyrosine kinase 2;N-sam;Proto-oncogene c-Fgr;, PF18123;PF07679;PF00047;PF07714;, GO:0031410;GO:0005829;GO:0005576;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0090722;GO:0004714;GO:0016477;GO:0043009;GO:0001837;GO:0008543;GO:0000165;GO:0007275;GO:0001764;GO:0018108;GO:0048015;GO:0043536;GO:0045597;GO:0008284;GO:2000546;GO:0033674;GO:0043406;GO:0043410;GO:0045666;GO:0014068;GO:0010518;GO:0010863;GO:0051897;GO:1905564;GO:0046777;GO:0006468;GO:0045595;GO:2001239;GO:0001501;GO:0048705;GO:0007169;, C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:receptor-receptor interaction; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:chordate embryonic development; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase activity; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:skeletal system development; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q53H63 Q59H40 Q5BJG2 Q8N685 Q9UD50 Q9UDF0 Q9UDF1 Q9UDF2,Fibroblast growth factor receptor 1,Basic fibroblast growth factor receptor 1;Fms-like tyrosine kinase 2;N-sam;Proto-oncogene c-Fgr;, PF18123;PF07679;PF00047;PF07714;, GO:0031410;GO:0005829;GO:0005576;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0090722;GO:0004714;GO:0016477;GO:0043009;GO:0001837;GO:0008543;GO:0000165;GO:0007275;GO:0001764;GO:0018108;GO:0048015;GO:0043536;GO:0045597;GO:0008284;GO:2000546;GO:0033674;GO:0043406;GO:0043410;GO:0045666;GO:0014068;GO:0010518;GO:0010863;GO:0051897;GO:1905564;GO:0046777;GO:0006468;GO:0045595;GO:2001239;GO:0001501;GO:0048705;GO:0007169;, C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:receptor-receptor interaction; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:chordate embryonic development; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase activity; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:skeletal system development; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q53H63 Q59H40 Q5BJG2 Q8N685 Q9UD50 Q9UDF0 Q9UDF1 Q9UDF2,Fibroblast growth factor receptor 1,Basic fibroblast growth factor receptor 1;Fms-like tyrosine kinase 2;N-sam;Proto-oncogene c-Fgr;, PF18123;PF07679;PF00047;PF07714;, GO:0031410;GO:0005829;GO:0005576;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0090722;GO:0004714;GO:0016477;GO:0043009;GO:0001837;GO:0008543;GO:0000165;GO:0007275;GO:0001764;GO:0018108;GO:0048015;GO:0043536;GO:0045597;GO:0008284;GO:2000546;GO:0033674;GO:0043406;GO:0043410;GO:0045666;GO:0014068;GO:0010518;GO:0010863;GO:0051897;GO:1905564;GO:0046777;GO:0006468;GO:0045595;GO:2001239;GO:0001501;GO:0048705;GO:0007169;, C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:receptor-receptor interaction; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:chordate embryonic development; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase activity; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:skeletal system development; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q53H63 Q59H40 Q5BJG2 Q8N685 Q9UD50 Q9UDF0 Q9UDF1 Q9UDF2,Fibroblast growth factor receptor 1,Basic fibroblast growth factor receptor 1;Fms-like tyrosine kinase 2;N-sam;Proto-oncogene c-Fgr;, PF18123;PF07679;PF00047;PF07714;, GO:0031410;GO:0005829;GO:0005576;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0090722;GO:0004714;GO:0016477;GO:0043009;GO:0001837;GO:0008543;GO:0000165;GO:0007275;GO:0001764;GO:0018108;GO:0048015;GO:0043536;GO:0045597;GO:0008284;GO:2000546;GO:0033674;GO:0043406;GO:0043410;GO:0045666;GO:0014068;GO:0010518;GO:0010863;GO:0051897;GO:1905564;GO:0046777;GO:0006468;GO:0045595;GO:2001239;GO:0001501;GO:0048705;GO:0007169;, C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:receptor-receptor interaction; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:chordate embryonic development; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase activity; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:skeletal system development; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q53H63 Q59H40 Q5BJG2 Q8N685 Q9UD50 Q9UDF0 Q9UDF1 Q9UDF2,Fibroblast growth factor receptor 1,Basic fibroblast growth factor receptor 1;Fms-like tyrosine kinase 2;N-sam;Proto-oncogene c-Fgr;, PF18123;PF07679;PF00047;PF07714;, GO:0031410;GO:0005829;GO:0005576;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0090722;GO:0004714;GO:0016477;GO:0043009;GO:0001837;GO:0008543;GO:0000165;GO:0007275;GO:0001764;GO:0018108;GO:0048015;GO:0043536;GO:0045597;GO:0008284;GO:2000546;GO:0033674;GO:0043406;GO:0043410;GO:0045666;GO:0014068;GO:0010518;GO:0010863;GO:0051897;GO:1905564;GO:0046777;GO:0006468;GO:0045595;GO:2001239;GO:0001501;GO:0048705;GO:0007169;, C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:receptor-receptor interaction; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:chordate embryonic development; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase activity; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:skeletal system development; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold26 indexed_genome mRNA 11743386 11757329 . - . ID=transcript_5892;Q53H63 Q59H40 Q5BJG2 Q8N685 Q9UD50 Q9UDF0 Q9UDF1 Q9UDF2,Fibroblast growth factor receptor 1,Basic fibroblast growth factor receptor 1;Fms-like tyrosine kinase 2;N-sam;Proto-oncogene c-Fgr;, PF18123;PF07679;PF00047;PF07714;, GO:0031410;GO:0005829;GO:0005576;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0090722;GO:0004714;GO:0016477;GO:0043009;GO:0001837;GO:0008543;GO:0000165;GO:0007275;GO:0001764;GO:0018108;GO:0048015;GO:0043536;GO:0045597;GO:0008284;GO:2000546;GO:0033674;GO:0043406;GO:0043410;GO:0045666;GO:0014068;GO:0010518;GO:0010863;GO:0051897;GO:1905564;GO:0046777;GO:0006468;GO:0045595;GO:2001239;GO:0001501;GO:0048705;GO:0007169;, C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:receptor-receptor interaction; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:chordate embryonic development; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase activity; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:skeletal system development; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q53H63 Q59H40 Q5BJG2 Q8N685 Q9UD50 Q9UDF0 Q9UDF1 Q9UDF2,Fibroblast growth factor receptor 1,Basic fibroblast growth factor receptor 1;Fms-like tyrosine kinase 2;N-sam;Proto-oncogene c-Fgr;, PF18123;PF07679;PF00047;PF07714;, GO:0031410;GO:0005829;GO:0005576;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0090722;GO:0004714;GO:0016477;GO:0043009;GO:0001837;GO:0008543;GO:0000165;GO:0007275;GO:0001764;GO:0018108;GO:0048015;GO:0043536;GO:0045597;GO:0008284;GO:2000546;GO:0033674;GO:0043406;GO:0043410;GO:0045666;GO:0014068;GO:0010518;GO:0010863;GO:0051897;GO:1905564;GO:0046777;GO:0006468;GO:0045595;GO:2001239;GO:0001501;GO:0048705;GO:0007169;, C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:receptor-receptor interaction; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:chordate embryonic development; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase activity; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:skeletal system development; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q53H63 Q59H40 Q5BJG2 Q8N685 Q9UD50 Q9UDF0 Q9UDF1 Q9UDF2,Fibroblast growth factor receptor 1,Basic fibroblast growth factor receptor 1;Fms-like tyrosine kinase 2;N-sam;Proto-oncogene c-Fgr;, PF18123;PF07679;PF00047;PF07714;, GO:0031410;GO:0005829;GO:0005576;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0090722;GO:0004714;GO:0016477;GO:0043009;GO:0001837;GO:0008543;GO:0000165;GO:0007275;GO:0001764;GO:0018108;GO:0048015;GO:0043536;GO:0045597;GO:0008284;GO:2000546;GO:0033674;GO:0043406;GO:0043410;GO:0045666;GO:0014068;GO:0010518;GO:0010863;GO:0051897;GO:1905564;GO:0046777;GO:0006468;GO:0045595;GO:2001239;GO:0001501;GO:0048705;GO:0007169;, C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:receptor-receptor interaction; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:chordate embryonic development; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase activity; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:skeletal system development; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q53H63 Q59H40 Q5BJG2 Q8N685 Q9UD50 Q9UDF0 Q9UDF1 Q9UDF2,Fibroblast growth factor receptor 1,Basic fibroblast growth factor receptor 1;Fms-like tyrosine kinase 2;N-sam;Proto-oncogene c-Fgr;, PF18123;PF07679;PF00047;PF07714;, GO:0031410;GO:0005829;GO:0005576;GO:0016021;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0005524;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0042803;GO:0004713;GO:0090722;GO:0004714;GO:0016477;GO:0043009;GO:0001837;GO:0008543;GO:0000165;GO:0007275;GO:0001764;GO:0018108;GO:0048015;GO:0043536;GO:0045597;GO:0008284;GO:2000546;GO:0033674;GO:0043406;GO:0043410;GO:0045666;GO:0014068;GO:0010518;GO:0010863;GO:0051897;GO:1905564;GO:0046777;GO:0006468;GO:0045595;GO:2001239;GO:0001501;GO:0048705;GO:0007169;, C:cytoplasmic vesicle; C:cytosol; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:receptor-receptor interaction; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:chordate embryonic development; P:epithelial to mesenchymal transition; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase activity; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:skeletal system development; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold26 indexed_genome mRNA 11763303 11765586 . - . ID=transcript_5893;Q2VYF4 A6NMG3 Q8NCR2 Q96LL1,LETM1 domain-containing protein LETM2, mitochondrial,LETM1 and EF-hand domain-containing protein 2;Leucine zipper-EF-hand-containing transmembrane protein 1-like;, PF07766;, GO:0016021;GO:0005743;GO:0043022;GO:0006875;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ribosome binding;, P:cellular metal ion homeostasis; scaffold26 indexed_genome mRNA 11768698 11772116 . - . ID=transcript_5894;Q2VYF4 A6NMG3 Q8NCR2 Q96LL1,LETM1 domain-containing protein LETM2, mitochondrial,LETM1 and EF-hand domain-containing protein 2;Leucine zipper-EF-hand-containing transmembrane protein 1-like;, PF07766;, GO:0016021;GO:0005743;GO:0043022;GO:0006875;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ribosome binding;, P:cellular metal ion homeostasis; scaffold26 indexed_genome mRNA 11775665 11877025 . + . ID=transcript_5895;Q9H9W9 Q9NXA6,Histone-lysine N-methyltransferase NSD3,Nuclear SET domain-containing protein 3;Protein whistle;WHSC1-like 1 isoform 9 with methyltransferase activity to lysine;Wolf-Hirschhorn syndrome candidate 1-like protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0140537;GO:0016571;GO:2001255;GO:0045893;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:transcription regulator activator activity;, P:histone methylation; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9H9W9 Q9NXA6,Histone-lysine N-methyltransferase NSD3,Nuclear SET domain-containing protein 3;Protein whistle;WHSC1-like 1 isoform 9 with methyltransferase activity to lysine;Wolf-Hirschhorn syndrome candidate 1-like protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0140537;GO:0016571;GO:2001255;GO:0045893;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:transcription regulator activator activity;, P:histone methylation; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9H9W9 Q9NXA6,Histone-lysine N-methyltransferase NSD3,Nuclear SET domain-containing protein 3;Protein whistle;WHSC1-like 1 isoform 9 with methyltransferase activity to lysine;Wolf-Hirschhorn syndrome candidate 1-like protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0140537;GO:0016571;GO:2001255;GO:0045893;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:transcription regulator activator activity;, P:histone methylation; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9H9W9 Q9NXA6,Histone-lysine N-methyltransferase NSD3,Nuclear SET domain-containing protein 3;Protein whistle;WHSC1-like 1 isoform 9 with methyltransferase activity to lysine;Wolf-Hirschhorn syndrome candidate 1-like protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0140537;GO:0016571;GO:2001255;GO:0045893;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:transcription regulator activator activity;, P:histone methylation; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9H9W9 Q9NXA6,Histone-lysine N-methyltransferase NSD3,Nuclear SET domain-containing protein 3;Protein whistle;WHSC1-like 1 isoform 9 with methyltransferase activity to lysine;Wolf-Hirschhorn syndrome candidate 1-like protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0140537;GO:0016571;GO:2001255;GO:0045893;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:transcription regulator activator activity;, P:histone methylation; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9H9W9 Q9NXA6,Histone-lysine N-methyltransferase NSD3,Nuclear SET domain-containing protein 3;Protein whistle;WHSC1-like 1 isoform 9 with methyltransferase activity to lysine;Wolf-Hirschhorn syndrome candidate 1-like protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0140537;GO:0016571;GO:2001255;GO:0045893;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:transcription regulator activator activity;, P:histone methylation; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9H9W9 Q9NXA6,Histone-lysine N-methyltransferase NSD3,Nuclear SET domain-containing protein 3;Protein whistle;WHSC1-like 1 isoform 9 with methyltransferase activity to lysine;Wolf-Hirschhorn syndrome candidate 1-like protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0140537;GO:0016571;GO:2001255;GO:0045893;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:transcription regulator activator activity;, P:histone methylation; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q9H9W9 Q9NXA6,Histone-lysine N-methyltransferase NSD3,Nuclear SET domain-containing protein 3;Protein whistle;WHSC1-like 1 isoform 9 with methyltransferase activity to lysine;Wolf-Hirschhorn syndrome candidate 1-like protein 1;, PF17907;PF17982;PF00855;PF00856;, GO:0000785;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0140537;GO:0016571;GO:2001255;GO:0045893;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:transcription regulator activator activity;, P:histone methylation; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold26 indexed_genome mRNA 11877735 11883572 . + . ID=transcript_5896;Q8NEB5 C9JKF5 Q3KQX6 Q9BY45,Phospholipid phosphatase 5 {ECO:0000312|HGNC:HGNC:25026},Phosphatidic acid phosphatase type 2 domain-containing protein 1B {ECO:0000312|HGNC:HGNC:25026};, PF01569;, GO:0005737;GO:0016021;GO:0005886;GO:0000810;GO:0042577;GO:0008195;GO:0046839;GO:0006644;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:diacylglycerol diphosphate phosphatase activity; F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process;|Q8NEB5 C9JKF5 Q3KQX6 Q9BY45,Phospholipid phosphatase 5 {ECO:0000312|HGNC:HGNC:25026},Phosphatidic acid phosphatase type 2 domain-containing protein 1B {ECO:0000312|HGNC:HGNC:25026};, PF01569;, GO:0005737;GO:0016021;GO:0005886;GO:0000810;GO:0042577;GO:0008195;GO:0046839;GO:0006644;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:diacylglycerol diphosphate phosphatase activity; F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process;|Q8NEB5 C9JKF5 Q3KQX6 Q9BY45,Phospholipid phosphatase 5 {ECO:0000312|HGNC:HGNC:25026},Phosphatidic acid phosphatase type 2 domain-containing protein 1B {ECO:0000312|HGNC:HGNC:25026};, PF01569;, GO:0005737;GO:0016021;GO:0005886;GO:0000810;GO:0042577;GO:0008195;GO:0046839;GO:0006644;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:diacylglycerol diphosphate phosphatase activity; F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process; scaffold26 indexed_genome mRNA 11883602 11914449 . - . ID=transcript_5897;Q8NEB5 C9JKF5 Q3KQX6 Q9BY45,Phospholipid phosphatase 5 {ECO:0000312|HGNC:HGNC:25026},Phosphatidic acid phosphatase type 2 domain-containing protein 1B {ECO:0000312|HGNC:HGNC:25026};, PF01569;, GO:0005737;GO:0016021;GO:0005886;GO:0000810;GO:0042577;GO:0008195;GO:0046839;GO:0006644;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:diacylglycerol diphosphate phosphatase activity; F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process;|O94830 B3KWV2 B3KXB5 Q9H8X7,Phospholipase DDHD2 {ECO:0000305},DDHD domain-containing protein 2;KIAA0725p;SAM, WWE and DDHD domain-containing protein 1;, PF02862;PF00536;PF02825;, GO:0034451;GO:0030134;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0046872;GO:0004620;GO:0004806;GO:0034389;GO:0007626;GO:0006654;GO:0090141;GO:0019433;GO:0008542;, C:centriolar satellite; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane;, F:metal ion binding; F:phospholipase activity; F:triglyceride lipase activity;, P:lipid droplet organization; P:locomotory behavior; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; P:triglyceride catabolic process; P:visual learning;|Q8NEB5 C9JKF5 Q3KQX6 Q9BY45,Phospholipid phosphatase 5 {ECO:0000312|HGNC:HGNC:25026},Phosphatidic acid phosphatase type 2 domain-containing protein 1B {ECO:0000312|HGNC:HGNC:25026};, PF01569;, GO:0005737;GO:0016021;GO:0005886;GO:0000810;GO:0042577;GO:0008195;GO:0046839;GO:0006644;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:diacylglycerol diphosphate phosphatase activity; F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process;|O94830 B3KWV2 B3KXB5 Q9H8X7,Phospholipase DDHD2 {ECO:0000305},DDHD domain-containing protein 2;KIAA0725p;SAM, WWE and DDHD domain-containing protein 1;, PF02862;PF00536;PF02825;, GO:0034451;GO:0030134;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0046872;GO:0004620;GO:0004806;GO:0034389;GO:0007626;GO:0006654;GO:0090141;GO:0019433;GO:0008542;, C:centriolar satellite; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane;, F:metal ion binding; F:phospholipase activity; F:triglyceride lipase activity;, P:lipid droplet organization; P:locomotory behavior; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; P:triglyceride catabolic process; P:visual learning;|O94830 B3KWV2 B3KXB5 Q9H8X7,Phospholipase DDHD2 {ECO:0000305},DDHD domain-containing protein 2;KIAA0725p;SAM, WWE and DDHD domain-containing protein 1;, PF02862;PF00536;PF02825;, GO:0034451;GO:0030134;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0046872;GO:0004620;GO:0004806;GO:0034389;GO:0007626;GO:0006654;GO:0090141;GO:0019433;GO:0008542;, C:centriolar satellite; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane;, F:metal ion binding; F:phospholipase activity; F:triglyceride lipase activity;, P:lipid droplet organization; P:locomotory behavior; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; P:triglyceride catabolic process; P:visual learning;|O94830 B3KWV2 B3KXB5 Q9H8X7,Phospholipase DDHD2 {ECO:0000305},DDHD domain-containing protein 2;KIAA0725p;SAM, WWE and DDHD domain-containing protein 1;, PF02862;PF00536;PF02825;, GO:0034451;GO:0030134;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0046872;GO:0004620;GO:0004806;GO:0034389;GO:0007626;GO:0006654;GO:0090141;GO:0019433;GO:0008542;, C:centriolar satellite; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane;, F:metal ion binding; F:phospholipase activity; F:triglyceride lipase activity;, P:lipid droplet organization; P:locomotory behavior; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; P:triglyceride catabolic process; P:visual learning;|O94830 B3KWV2 B3KXB5 Q9H8X7,Phospholipase DDHD2 {ECO:0000305},DDHD domain-containing protein 2;KIAA0725p;SAM, WWE and DDHD domain-containing protein 1;, PF02862;PF00536;PF02825;, GO:0034451;GO:0030134;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0046872;GO:0004620;GO:0004806;GO:0034389;GO:0007626;GO:0006654;GO:0090141;GO:0019433;GO:0008542;, C:centriolar satellite; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane;, F:metal ion binding; F:phospholipase activity; F:triglyceride lipase activity;, P:lipid droplet organization; P:locomotory behavior; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; P:triglyceride catabolic process; P:visual learning;|O94830 B3KWV2 B3KXB5 Q9H8X7,Phospholipase DDHD2 {ECO:0000305},DDHD domain-containing protein 2;KIAA0725p;SAM, WWE and DDHD domain-containing protein 1;, PF02862;PF00536;PF02825;, GO:0034451;GO:0030134;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0046872;GO:0004620;GO:0004806;GO:0034389;GO:0007626;GO:0006654;GO:0090141;GO:0019433;GO:0008542;, C:centriolar satellite; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane;, F:metal ion binding; F:phospholipase activity; F:triglyceride lipase activity;, P:lipid droplet organization; P:locomotory behavior; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; P:triglyceride catabolic process; P:visual learning;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|O94830 B3KWV2 B3KXB5 Q9H8X7,Phospholipase DDHD2 {ECO:0000305},DDHD domain-containing protein 2;KIAA0725p;SAM, WWE and DDHD domain-containing protein 1;, PF02862;PF00536;PF02825;, GO:0034451;GO:0030134;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0046872;GO:0004620;GO:0004806;GO:0034389;GO:0007626;GO:0006654;GO:0090141;GO:0019433;GO:0008542;, C:centriolar satellite; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane;, F:metal ion binding; F:phospholipase activity; F:triglyceride lipase activity;, P:lipid droplet organization; P:locomotory behavior; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; P:triglyceride catabolic process; P:visual learning;|O94830 B3KWV2 B3KXB5 Q9H8X7,Phospholipase DDHD2 {ECO:0000305},DDHD domain-containing protein 2;KIAA0725p;SAM, WWE and DDHD domain-containing protein 1;, PF02862;PF00536;PF02825;, GO:0034451;GO:0030134;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0046872;GO:0004620;GO:0004806;GO:0034389;GO:0007626;GO:0006654;GO:0090141;GO:0019433;GO:0008542;, C:centriolar satellite; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane;, F:metal ion binding; F:phospholipase activity; F:triglyceride lipase activity;, P:lipid droplet organization; P:locomotory behavior; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; P:triglyceride catabolic process; P:visual learning;|O94830 B3KWV2 B3KXB5 Q9H8X7,Phospholipase DDHD2 {ECO:0000305},DDHD domain-containing protein 2;KIAA0725p;SAM, WWE and DDHD domain-containing protein 1;, PF02862;PF00536;PF02825;, GO:0034451;GO:0030134;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0046872;GO:0004620;GO:0004806;GO:0034389;GO:0007626;GO:0006654;GO:0090141;GO:0019433;GO:0008542;, C:centriolar satellite; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane;, F:metal ion binding; F:phospholipase activity; F:triglyceride lipase activity;, P:lipid droplet organization; P:locomotory behavior; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; P:triglyceride catabolic process; P:visual learning; scaffold26 indexed_genome mRNA 11919743 11929731 . - . ID=transcript_5898;O95429 B4E217 O95818,BAG family molecular chaperone regulator 4,Bcl-2-associated athanogene 4;Silencer of death domains;, PF02179;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0000774;GO:0051087;GO:0031072;GO:0044877;GO:0003723;GO:0031625;GO:0071364;GO:0071356;GO:0043066;GO:0090367;GO:2001145;GO:1903215;GO:0030838;GO:0045785;GO:0010763;GO:0033138;GO:0051897;GO:0051496;GO:0006457;GO:0072659;GO:0050821;GO:1900034;GO:0097178;GO:0033209;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:heat shock protein binding; F:protein-containing complex binding; F:RNA binding; F:ubiquitin protein ligase binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to tumor necrosis factor; P:negative regulation of apoptotic process; P:negative regulation of mRNA modification; P:negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; P:negative regulation of protein targeting to mitochondrion; P:positive regulation of actin filament polymerization; P:positive regulation of cell adhesion; P:positive regulation of fibroblast migration; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of stress fiber assembly; P:protein folding; P:protein localization to plasma membrane; P:protein stabilization; P:regulation of cellular response to heat; P:ruffle assembly; P:tumor necrosis factor-mediated signaling pathway; scaffold26 indexed_genome mRNA 11930625 11932421 . + . ID=transcript_5899;Q9UNT6,Origin recognition complex subunit 3,Origin recognition complex subunit Latheo;, PF07034;PF18137;, GO:0000785;GO:0000781;GO:0031261;GO:0016604;GO:0005664;GO:0005656;GO:0005654;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0061351;GO:0036388;GO:0006267;GO:0006275;, C:chromatin; C:chromosome, telomeric region; C:DNA replication preinitiation complex; C:nuclear body; C:nuclear origin of replication recognition complex; C:nuclear pre-replicative complex; C:nucleoplasm; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:neural precursor cell proliferation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; P:regulation of DNA replication; scaffold26 indexed_genome mRNA 11948344 11999641 . + . ID=transcript_5900;O15116 B2R5E6,U6 snRNA-associated Sm-like protein LSm1,Cancer-associated Sm-like;Small nuclear ribonuclear CaSm;, PF01423;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:1990726;GO:1990124;GO:0043025;GO:0005634;GO:0000932;GO:0003729;GO:0036002;GO:0003723;GO:0000339;GO:0000290;GO:0043928;GO:0071044;GO:0006397;GO:0045665;GO:0016070;GO:0008380;GO:0000375;GO:0019827;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:Lsm1-7-Pat1 complex; C:messenger ribonucleoprotein complex; C:neuronal cell body; C:nucleus; C:P-body;, F:mRNA binding; F:pre-mRNA binding; F:RNA binding; F:RNA cap binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:histone mRNA catabolic process; P:mRNA processing; P:negative regulation of neuron differentiation; P:RNA metabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:stem cell population maintenance;|P49675 Q16396,Steroidogenic acute regulatory protein, mitochondrial,START domain-containing protein 1;, PF01852;, GO:0005829;GO:0030061;GO:0005758;GO:0043005;GO:0043025;GO:0015485;GO:0120020;GO:0006699;GO:0018879;GO:0007420;GO:0006700;GO:0071312;GO:0071236;GO:0071276;GO:0071320;GO:0071549;GO:0071872;GO:0044344;GO:0071372;GO:0071333;GO:0071378;GO:0032869;GO:0035457;GO:0071346;GO:0071222;GO:0071373;GO:0071560;GO:0008203;GO:0042747;GO:0018894;GO:0016101;GO:0006703;GO:0008211;GO:0017143;GO:0032367;GO:0008584;GO:0043524;GO:0018958;GO:0018963;GO:0070859;GO:0010628;GO:0050769;GO:0048168;GO:0050810;GO:0014823;GO:0051412;GO:0042493;GO:0043627;GO:0045471;GO:0060992;GO:0009635;GO:0042542;GO:0010212;GO:0010288;GO:0044321;GO:0035094;GO:0007584;GO:0006694;GO:0061370;, C:cytosol; C:mitochondrial crista; C:mitochondrial intermembrane space; C:neuron projection; C:neuronal cell body;, F:cholesterol binding; F:cholesterol transfer activity;, P:bile acid biosynthetic process; P:biphenyl metabolic process; P:brain development; P:C21-steroid hormone biosynthetic process; P:cellular response to alkaloid; P:cellular response to antibiotic; P:cellular response to cadmium ion; P:cellular response to cAMP; P:cellular response to dexamethasone stimulus; P:cellular response to epinephrine stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to glucose stimulus; P:cellular response to growth hormone stimulus; P:cellular response to insulin stimulus; P:cellular response to interferon-alpha; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to luteinizing hormone stimulus; P:cellular response to transforming growth factor beta stimulus; P:cholesterol metabolic process; P:circadian sleep/wake cycle, REM sleep; P:dibenzo-p-dioxin metabolic process; P:diterpenoid metabolic process; P:estrogen biosynthetic process; P:glucocorticoid metabolic process; P:insecticide metabolic process; P:intracellular cholesterol transport; P:male gonad development; P:negative regulation of neuron apoptotic process; P:phenol-containing compound metabolic process; P:phthalate metabolic process; P:positive regulation of bile acid biosynthetic process; P:positive regulation of gene expression; P:positive regulation of neurogenesis; P:regulation of neuronal synaptic plasticity; P:regulation of steroid biosynthetic process; P:response to activity; P:response to corticosterone; P:response to drug; P:response to estrogen; P:response to ethanol; P:response to fungicide; P:response to herbicide; P:response to hydrogen peroxide; P:response to ionizing radiation; P:response to lead ion; P:response to leptin; P:response to nicotine; P:response to nutrient; P:steroid biosynthetic process; P:testosterone biosynthetic process;|O15116 B2R5E6,U6 snRNA-associated Sm-like protein LSm1,Cancer-associated Sm-like;Small nuclear ribonuclear CaSm;, PF01423;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:1990726;GO:1990124;GO:0043025;GO:0005634;GO:0000932;GO:0003729;GO:0036002;GO:0003723;GO:0000339;GO:0000290;GO:0043928;GO:0071044;GO:0006397;GO:0045665;GO:0016070;GO:0008380;GO:0000375;GO:0019827;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:Lsm1-7-Pat1 complex; C:messenger ribonucleoprotein complex; C:neuronal cell body; C:nucleus; C:P-body;, F:mRNA binding; F:pre-mRNA binding; F:RNA binding; F:RNA cap binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:histone mRNA catabolic process; P:mRNA processing; P:negative regulation of neuron differentiation; P:RNA metabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:stem cell population maintenance;|Q9UBL3 A8K7C3 D3DSW9 O60659 O60660 Q96B62,Set1/Ash2 histone methyltransferase complex subunit ASH2,ASH2-like protein;, PF00622;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0046872;GO:0000976;GO:1904837;GO:0006974;GO:0030097;GO:0051568;GO:0008284;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:hemopoiesis; P:histone H3-K4 methylation; P:positive regulation of cell population proliferation; P:regulation of megakaryocyte differentiation; P:response to estrogen;|Q9UBL3 A8K7C3 D3DSW9 O60659 O60660 Q96B62,Set1/Ash2 histone methyltransferase complex subunit ASH2,ASH2-like protein;, PF00622;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0046872;GO:0000976;GO:1904837;GO:0006974;GO:0030097;GO:0051568;GO:0008284;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:hemopoiesis; P:histone H3-K4 methylation; P:positive regulation of cell population proliferation; P:regulation of megakaryocyte differentiation; P:response to estrogen;|Q9UBL3 A8K7C3 D3DSW9 O60659 O60660 Q96B62,Set1/Ash2 histone methyltransferase complex subunit ASH2,ASH2-like protein;, PF00622;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0046872;GO:0000976;GO:1904837;GO:0006974;GO:0030097;GO:0051568;GO:0008284;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:hemopoiesis; P:histone H3-K4 methylation; P:positive regulation of cell population proliferation; P:regulation of megakaryocyte differentiation; P:response to estrogen; scaffold26 indexed_genome mRNA 12000593 12017363 . - . ID=transcript_5901;Q9UBL3 A8K7C3 D3DSW9 O60659 O60660 Q96B62,Set1/Ash2 histone methyltransferase complex subunit ASH2,ASH2-like protein;, PF00622;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0046872;GO:0000976;GO:1904837;GO:0006974;GO:0030097;GO:0051568;GO:0008284;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:hemopoiesis; P:histone H3-K4 methylation; P:positive regulation of cell population proliferation; P:regulation of megakaryocyte differentiation; P:response to estrogen;|Q9UBL3 A8K7C3 D3DSW9 O60659 O60660 Q96B62,Set1/Ash2 histone methyltransferase complex subunit ASH2,ASH2-like protein;, PF00622;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0046872;GO:0000976;GO:1904837;GO:0006974;GO:0030097;GO:0051568;GO:0008284;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:hemopoiesis; P:histone H3-K4 methylation; P:positive regulation of cell population proliferation; P:regulation of megakaryocyte differentiation; P:response to estrogen;|Q9UBL3 A8K7C3 D3DSW9 O60659 O60660 Q96B62,Set1/Ash2 histone methyltransferase complex subunit ASH2,ASH2-like protein;, PF00622;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0046872;GO:0000976;GO:1904837;GO:0006974;GO:0030097;GO:0051568;GO:0008284;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:hemopoiesis; P:histone H3-K4 methylation; P:positive regulation of cell population proliferation; P:regulation of megakaryocyte differentiation; P:response to estrogen;|Q9UBL3 A8K7C3 D3DSW9 O60659 O60660 Q96B62,Set1/Ash2 histone methyltransferase complex subunit ASH2,ASH2-like protein;, PF00622;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0046872;GO:0000976;GO:1904837;GO:0006974;GO:0030097;GO:0051568;GO:0008284;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:hemopoiesis; P:histone H3-K4 methylation; P:positive regulation of cell population proliferation; P:regulation of megakaryocyte differentiation; P:response to estrogen;|O75159 Q53SD4 Q8IYZ4,Suppressor of cytokine signaling 5,Cytokine-inducible SH2 protein 6;Cytokine-inducible SH2-containing protein 5;, PF00017;PF12610;PF07525;, GO:0005829;GO:0005942;GO:0046935;GO:0005154;GO:0030971;GO:0071404;GO:0019221;GO:0007173;GO:0035556;GO:0007175;GO:0050728;GO:0032715;GO:0071638;GO:0009968;GO:0045629;GO:0046854;GO:0032436;GO:0045627;GO:0043687;GO:0016567;GO:0007259;GO:0040008;GO:0097699;, C:cytosol; C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase regulator activity; F:epidermal growth factor receptor binding; F:receptor tyrosine kinase binding;, P:cellular response to low-density lipoprotein particle stimulus; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of inflammatory response; P:negative regulation of interleukin-6 production; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of signal transduction; P:negative regulation of T-helper 2 cell differentiation; P:phosphatidylinositol phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of T-helper 1 cell differentiation; P:post-translational protein modification; P:protein ubiquitination; P:receptor signaling pathway via JAK-STAT; P:regulation of growth; P:vascular endothelial cell response to fluid shear stress;|Q9UBL3 A8K7C3 D3DSW9 O60659 O60660 Q96B62,Set1/Ash2 histone methyltransferase complex subunit ASH2,ASH2-like protein;, PF00622;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0046872;GO:0000976;GO:1904837;GO:0006974;GO:0030097;GO:0051568;GO:0008284;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:hemopoiesis; P:histone H3-K4 methylation; P:positive regulation of cell population proliferation; P:regulation of megakaryocyte differentiation; P:response to estrogen;|Q9UBL3 A8K7C3 D3DSW9 O60659 O60660 Q96B62,Set1/Ash2 histone methyltransferase complex subunit ASH2,ASH2-like protein;, PF00622;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0046872;GO:0000976;GO:1904837;GO:0006974;GO:0030097;GO:0051568;GO:0008284;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:hemopoiesis; P:histone H3-K4 methylation; P:positive regulation of cell population proliferation; P:regulation of megakaryocyte differentiation; P:response to estrogen; scaffold26 indexed_genome mRNA 12030281 12052975 . - . ID=transcript_5902;Q13541 B2R502 D3DSW8 Q6IBN3,Eukaryotic translation initiation factor 4E-binding protein 1,Phosphorylated heat- and acid-stable protein regulated by insulin 1;, PF05456;, GO:0005737;GO:0005829;GO:0098978;GO:0005634;GO:0099524;GO:0032991;GO:0008190;GO:0051721;GO:0030371;GO:0071456;GO:0000082;GO:0030324;GO:0031333;GO:0045947;GO:0045931;GO:1990928;GO:0045471;GO:0002931;GO:0031929;, C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:nucleus; C:postsynaptic cytosol; C:protein-containing complex;, F:eukaryotic initiation factor 4E binding; F:protein phosphatase 2A binding; F:translation repressor activity;, P:cellular response to hypoxia; P:G1/S transition of mitotic cell cycle; P:lung development; P:negative regulation of protein-containing complex assembly; P:negative regulation of translational initiation; P:positive regulation of mitotic cell cycle; P:response to amino acid starvation; P:response to ethanol; P:response to ischemia; P:TOR signaling; scaffold26 indexed_genome mRNA 12175201 12182430 . - . ID=transcript_5903;O94903 Q6FI94,Pyridoxal phosphate homeostasis protein {ECO:0000255|HAMAP-Rule:MF_03225},Proline synthase co-transcribed bacterial homolog protein {ECO:0000255|HAMAP-Rule:MF_03225};Pyridoxal phosphate-binding protein {ECO:0000312|HGNC:HGNC:9457};, PF01168;, GO:0005737;GO:0005829;GO:0030170;, C:cytoplasm; C:cytosol;, F:pyridoxal phosphate binding;|O94903 Q6FI94,Pyridoxal phosphate homeostasis protein {ECO:0000255|HAMAP-Rule:MF_03225},Proline synthase co-transcribed bacterial homolog protein {ECO:0000255|HAMAP-Rule:MF_03225};Pyridoxal phosphate-binding protein {ECO:0000312|HGNC:HGNC:9457};, PF01168;, GO:0005737;GO:0005829;GO:0030170;, C:cytoplasm; C:cytosol;, F:pyridoxal phosphate binding;|O94903 Q6FI94,Pyridoxal phosphate homeostasis protein {ECO:0000255|HAMAP-Rule:MF_03225},Proline synthase co-transcribed bacterial homolog protein {ECO:0000255|HAMAP-Rule:MF_03225};Pyridoxal phosphate-binding protein {ECO:0000312|HGNC:HGNC:9457};, PF01168;, GO:0005737;GO:0005829;GO:0030170;, C:cytoplasm; C:cytosol;, F:pyridoxal phosphate binding;|O94903 Q6FI94,Pyridoxal phosphate homeostasis protein {ECO:0000255|HAMAP-Rule:MF_03225},Proline synthase co-transcribed bacterial homolog protein {ECO:0000255|HAMAP-Rule:MF_03225};Pyridoxal phosphate-binding protein {ECO:0000312|HGNC:HGNC:9457};, PF01168;, GO:0005737;GO:0005829;GO:0030170;, C:cytoplasm; C:cytosol;, F:pyridoxal phosphate binding; scaffold26 indexed_genome mRNA 12191164 12210008 . - . ID=transcript_5904;O94905 A0JLQ1 A8K5S9 B4DM38 D3DSW0 Q6NW21 Q86VS6 Q86W49,Erlin-2,Endoplasmic reticulum lipid raft-associated protein 2;Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2;, PF01145;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0045121;GO:0005886;GO:0032991;GO:0015485;GO:0031625;GO:0008203;GO:0045541;GO:0045717;GO:0032933;GO:0055085;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane raft; C:plasma membrane; C:protein-containing complex;, F:cholesterol binding; F:ubiquitin protein ligase binding;, P:cholesterol metabolic process; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of fatty acid biosynthetic process; P:SREBP signaling pathway; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|O94905 A0JLQ1 A8K5S9 B4DM38 D3DSW0 Q6NW21 Q86VS6 Q86W49,Erlin-2,Endoplasmic reticulum lipid raft-associated protein 2;Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2;, PF01145;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0045121;GO:0005886;GO:0032991;GO:0015485;GO:0031625;GO:0008203;GO:0045541;GO:0045717;GO:0032933;GO:0055085;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane raft; C:plasma membrane; C:protein-containing complex;, F:cholesterol binding; F:ubiquitin protein ligase binding;, P:cholesterol metabolic process; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of fatty acid biosynthetic process; P:SREBP signaling pathway; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway;|O94905 A0JLQ1 A8K5S9 B4DM38 D3DSW0 Q6NW21 Q86VS6 Q86W49,Erlin-2,Endoplasmic reticulum lipid raft-associated protein 2;Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2;, PF01145;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0045121;GO:0005886;GO:0032991;GO:0015485;GO:0031625;GO:0008203;GO:0045541;GO:0045717;GO:0032933;GO:0055085;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane raft; C:plasma membrane; C:protein-containing complex;, F:cholesterol binding; F:ubiquitin protein ligase binding;, P:cholesterol metabolic process; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of fatty acid biosynthetic process; P:SREBP signaling pathway; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; scaffold26 indexed_genome mRNA 13737875 13760805 . - . ID=transcript_5905;Q6UXZ4 Q8WYP7,Netrin receptor UNC5D,Protein unc-5 homolog 4;Protein unc-5 homolog D;, PF00531;PF07679;PF00090;PF17217;PF00791;, GO:0016021;GO:0005886;GO:0005042;GO:0006915;GO:0007411;GO:0098742;, C:integral component of membrane; C:plasma membrane;, F:netrin receptor activity;, P:apoptotic process; P:axon guidance; P:cell-cell adhesion via plasma-membrane adhesion molecules; scaffold26 indexed_genome mRNA 15687236 15690700 . - . ID=transcript_5906;Q9BV47 D3DSV8 Q9BTW0,Dual specificity protein phosphatase 26,Dual specificity phosphatase SKRP3;Low-molecular-mass dual-specificity phosphatase 4;Mitogen-activated protein kinase phosphatase 8;Novel amplified gene in thyroid anaplastic cancer;, , GO:0005737;GO:0070062;GO:0005794;GO:0005654;GO:0005634;GO:0002039;GO:0004721;GO:0004647;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0001102;GO:0070373;GO:0044387;GO:0000122;GO:0045785;GO:1902310;GO:0006470;, C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:p53 binding; F:phosphoprotein phosphatase activity; F:phosphoserine phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell adhesion; P:positive regulation of peptidyl-serine dephosphorylation; P:protein dephosphorylation; scaffold26 indexed_genome mRNA 15707953 15724785 . + . ID=transcript_5907;Q9H9V4 Q52LK3,RING finger protein 122,, PF13639;, GO:0005737;GO:0012505;GO:0005783;GO:0005794;GO:0016021;GO:0046872;GO:0061630;GO:0010917;GO:0043065;GO:0043161;GO:0051865;, C:cytoplasm; C:endomembrane system; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:negative regulation of mitochondrial membrane potential; P:positive regulation of apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination;|Q9H9V4 Q52LK3,RING finger protein 122,, PF13639;, GO:0005737;GO:0012505;GO:0005783;GO:0005794;GO:0016021;GO:0046872;GO:0061630;GO:0010917;GO:0043065;GO:0043161;GO:0051865;, C:cytoplasm; C:endomembrane system; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:negative regulation of mitochondrial membrane potential; P:positive regulation of apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination;|Q9H9V4 Q52LK3,RING finger protein 122,, PF13639;, GO:0005737;GO:0012505;GO:0005783;GO:0005794;GO:0016021;GO:0046872;GO:0061630;GO:0010917;GO:0043065;GO:0043161;GO:0051865;, C:cytoplasm; C:endomembrane system; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:negative regulation of mitochondrial membrane potential; P:positive regulation of apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination;|Q9H9V4 Q52LK3,RING finger protein 122,, PF13639;, GO:0005737;GO:0012505;GO:0005783;GO:0005794;GO:0016021;GO:0046872;GO:0061630;GO:0010917;GO:0043065;GO:0043161;GO:0051865;, C:cytoplasm; C:endomembrane system; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:negative regulation of mitochondrial membrane potential; P:positive regulation of apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; scaffold26 indexed_genome mRNA 15746693 15764728 . + . ID=transcript_5908;Q6NXR4 D3DSV7 Q96IM2 Q9H5N4,TELO2-interacting protein 2,, PF10521;, GO:0070209;GO:0005813;GO:0005829;GO:0005654;, C:ASTRA complex; C:centrosome; C:cytosol; C:nucleoplasm;|Q6NXR4 D3DSV7 Q96IM2 Q9H5N4,TELO2-interacting protein 2,, PF10521;, GO:0070209;GO:0005813;GO:0005829;GO:0005654;, C:ASTRA complex; C:centrosome; C:cytosol; C:nucleoplasm;|Q9BXY0 B2RB44 Q5U5T1 Q86UC4 Q96SY6,Protein MAK16 homolog,NNP78;Protein RBM13;, PF04874;PF01778;, GO:0043231;GO:0005730;GO:0030687;GO:0003723;GO:0000460;GO:0000470;, C:intracellular membrane-bounded organelle; C:nucleolus; C:preribosome, large subunit precursor;, F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA;|Q9BXY0 B2RB44 Q5U5T1 Q86UC4 Q96SY6,Protein MAK16 homolog,NNP78;Protein RBM13;, PF04874;PF01778;, GO:0043231;GO:0005730;GO:0030687;GO:0003723;GO:0000460;GO:0000470;, C:intracellular membrane-bounded organelle; C:nucleolus; C:preribosome, large subunit precursor;, F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; scaffold26 indexed_genome mRNA 15772212 15837104 . + . ID=transcript_5909;Q6P4F1 A8KAC8 Q70GG3 Q8IVI6 Q8IVI7 Q8IVJ3 Q8TE43 Q9BSR3,Alpha-(1,3)-fucosyltransferase 10,Fucosyltransferase X;Galactoside 3-L-fucosyltransferase 10;, PF17039;PF00852;, GO:0005783;GO:0005794;GO:0032580;GO:0016021;GO:0005654;GO:0046920;GO:0009566;GO:0036065;GO:0030097;GO:0042355;GO:0007399;GO:0006457;GO:0006486;GO:0006605;GO:0042060;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:nucleoplasm;, F:alpha-(1->3)-fucosyltransferase activity;, P:fertilization; P:fucosylation; P:hemopoiesis; P:L-fucose catabolic process; P:nervous system development; P:protein folding; P:protein glycosylation; P:protein targeting; P:wound healing; scaffold26 indexed_genome mRNA 15837129 15848029 . + . ID=transcript_5910;Q6P4F1 A8KAC8 Q70GG3 Q8IVI6 Q8IVI7 Q8IVJ3 Q8TE43 Q9BSR3,Alpha-(1,3)-fucosyltransferase 10,Fucosyltransferase X;Galactoside 3-L-fucosyltransferase 10;, PF17039;PF00852;, GO:0005783;GO:0005794;GO:0032580;GO:0016021;GO:0005654;GO:0046920;GO:0009566;GO:0036065;GO:0030097;GO:0042355;GO:0007399;GO:0006457;GO:0006486;GO:0006605;GO:0042060;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:nucleoplasm;, F:alpha-(1->3)-fucosyltransferase activity;, P:fertilization; P:fucosylation; P:hemopoiesis; P:L-fucose catabolic process; P:nervous system development; P:protein folding; P:protein glycosylation; P:protein targeting; P:wound healing; scaffold26 indexed_genome mRNA 15853947 15854513 . - . ID=transcript_5911;Q8N3R9 A1L380 Q7Z631 Q86T98 Q8N7I5 Q9H9Q0,MAGUK p55 subfamily member 5,, PF00625;PF02828;PF09060;PF00595;PF07653;, GO:0005912;GO:0016324;GO:0030424;GO:0005923;GO:0005737;GO:0005793;GO:0070062;GO:0005794;GO:0043219;GO:0035749;GO:0043204;GO:0005886;GO:0032991;GO:0043220;GO:0005524;GO:0019904;GO:0070830;GO:0021954;GO:0021987;GO:0010467;GO:0002011;GO:0032288;GO:0032287;GO:0035750;GO:0072659;GO:0017015;, C:adherens junction; C:apical plasma membrane; C:axon; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:lateral loop; C:myelin sheath adaxonal region; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:Schmidt-Lanterman incisure;, F:ATP binding; F:protein domain specific binding;, P:bicellular tight junction assembly; P:central nervous system neuron development; P:cerebral cortex development; P:gene expression; P:morphogenesis of an epithelial sheet; P:myelin assembly; P:peripheral nervous system myelin maintenance; P:protein localization to myelin sheath abaxonal region; P:protein localization to plasma membrane; P:regulation of transforming growth factor beta receptor signaling pathway; scaffold26 indexed_genome mRNA 16300716 16301721 . + . ID=transcript_5912;Q15491 Q7RTV9 Q7RTW0 Q7RTW1 Q7RTW2 Q8NFN1 Q8NFN2 Q8NFN3 Q9UPE3,Pro-neuregulin-1, membrane-bound isoform,, PF00008;PF07679;PF02158;, GO:0016324;GO:0005576;GO:0005615;GO:0098978;GO:0016021;GO:0099061;GO:0099059;GO:0016020;GO:0005654;GO:0005886;GO:0045499;GO:0005125;GO:0043125;GO:0008083;GO:0005178;GO:0030296;GO:0030971;GO:0005102;GO:0003712;GO:0030297;GO:0000187;GO:0032148;GO:0007171;GO:0048513;GO:0055007;GO:0060379;GO:0007154;GO:0030154;GO:0008283;GO:0043624;GO:0060956;GO:0038127;GO:0038128;GO:0038129;GO:0038130;GO:0035556;GO:0030879;GO:0000165;GO:0010667;GO:2001240;GO:0051048;GO:0045892;GO:0007399;GO:0014032;GO:0060045;GO:0045785;GO:0030307;GO:0008284;GO:1900086;GO:0051897;GO:0031334;GO:0051155;GO:2000145;GO:0099149;GO:0099560;GO:0007169;GO:0055012;GO:0003222;GO:0042060;, C:apical plasma membrane; C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic active zone membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:chemorepellent activity; F:cytokine activity; F:ErbB-3 class receptor binding; F:growth factor activity; F:integrin binding; F:protein tyrosine kinase activator activity; F:receptor tyrosine kinase binding; F:signaling receptor binding; F:transcription coregulator activity; F:transmembrane receptor protein tyrosine kinase activator activity;, P:activation of MAPK activity; P:activation of protein kinase B activity; P:activation of transmembrane receptor protein tyrosine kinase activity; P:animal organ development; P:cardiac muscle cell differentiation; P:cardiac muscle cell myoblast differentiation; P:cell communication; P:cell differentiation; P:cell population proliferation; P:cellular protein complex disassembly; P:endocardial cell differentiation; P:ERBB signaling pathway; P:ERBB2 signaling pathway; P:ERBB3 signaling pathway; P:ERBB4 signaling pathway; P:intracellular signal transduction; P:mammary gland development; P:MAPK cascade; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of secretion; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neural crest cell development; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell adhesion; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein-containing complex assembly; P:positive regulation of striated muscle cell differentiation; P:regulation of cell motility; P:regulation of postsynaptic neurotransmitter receptor internalization; P:synaptic membrane adhesion; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:ventricular cardiac muscle cell differentiation; P:ventricular trabecula myocardium morphogenesis; P:wound healing; scaffold26 indexed_genome mRNA 17637510 17697252 . - . ID=transcript_5913;Q14191 A1KYY9,Werner syndrome ATP-dependent helicase,DNA helicase, RecQ-like type 3;Exonuclease WRN;RecQ protein-like 2;, PF00270;PF01612;PF00271;PF00570;PF14493;PF16124;PF09382;, GO:0005813;GO:0005694;GO:0000781;GO:0005737;GO:0043005;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005657;GO:0043138;GO:0008408;GO:0070337;GO:1905773;GO:0005524;GO:0016887;GO:0000405;GO:0003682;GO:0003677;GO:0003678;GO:0004527;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0000287;GO:0030145;GO:0032405;GO:0042803;GO:0044877;GO:0061821;GO:0061849;GO:0000403;GO:0007568;GO:0006284;GO:0007420;GO:0007569;GO:0006974;GO:0071480;GO:0009267;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0000731;GO:0006268;GO:0006302;GO:0000724;GO:0044806;GO:0010259;GO:0051345;GO:0098530;GO:1902570;GO:0042981;GO:0040009;GO:1901796;GO:0031297;GO:0090399;GO:0006979;GO:0010225;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:centrosome; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:neuron projection; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:replication fork;, F:3'-5' DNA helicase activity; F:3'-5' exonuclease activity; F:3'-flap-structured DNA binding; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:exonuclease activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:magnesium ion binding; F:manganese ion binding; F:MutLalpha complex binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding;, P:aging; P:base-excision repair; P:brain development; P:cell aging; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to starvation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:DNA unwinding involved in DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:multicellular organism aging; P:positive regulation of hydrolase activity; P:positive regulation of strand invasion; P:protein localization to nucleolus; P:regulation of apoptotic process; P:regulation of growth rate; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to oxidative stress; P:response to UV-C; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly;|Q14191 A1KYY9,Werner syndrome ATP-dependent helicase,DNA helicase, RecQ-like type 3;Exonuclease WRN;RecQ protein-like 2;, PF00270;PF01612;PF00271;PF00570;PF14493;PF16124;PF09382;, GO:0005813;GO:0005694;GO:0000781;GO:0005737;GO:0043005;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005657;GO:0043138;GO:0008408;GO:0070337;GO:1905773;GO:0005524;GO:0016887;GO:0000405;GO:0003682;GO:0003677;GO:0003678;GO:0004527;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0000287;GO:0030145;GO:0032405;GO:0042803;GO:0044877;GO:0061821;GO:0061849;GO:0000403;GO:0007568;GO:0006284;GO:0007420;GO:0007569;GO:0006974;GO:0071480;GO:0009267;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0000731;GO:0006268;GO:0006302;GO:0000724;GO:0044806;GO:0010259;GO:0051345;GO:0098530;GO:1902570;GO:0042981;GO:0040009;GO:1901796;GO:0031297;GO:0090399;GO:0006979;GO:0010225;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:centrosome; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:neuron projection; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:replication fork;, F:3'-5' DNA helicase activity; F:3'-5' exonuclease activity; F:3'-flap-structured DNA binding; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:exonuclease activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:magnesium ion binding; F:manganese ion binding; F:MutLalpha complex binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding;, P:aging; P:base-excision repair; P:brain development; P:cell aging; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to starvation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:DNA unwinding involved in DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:multicellular organism aging; P:positive regulation of hydrolase activity; P:positive regulation of strand invasion; P:protein localization to nucleolus; P:regulation of apoptotic process; P:regulation of growth rate; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to oxidative stress; P:response to UV-C; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly;|Q14191 A1KYY9,Werner syndrome ATP-dependent helicase,DNA helicase, RecQ-like type 3;Exonuclease WRN;RecQ protein-like 2;, PF00270;PF01612;PF00271;PF00570;PF14493;PF16124;PF09382;, GO:0005813;GO:0005694;GO:0000781;GO:0005737;GO:0043005;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005657;GO:0043138;GO:0008408;GO:0070337;GO:1905773;GO:0005524;GO:0016887;GO:0000405;GO:0003682;GO:0003677;GO:0003678;GO:0004527;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0000287;GO:0030145;GO:0032405;GO:0042803;GO:0044877;GO:0061821;GO:0061849;GO:0000403;GO:0007568;GO:0006284;GO:0007420;GO:0007569;GO:0006974;GO:0071480;GO:0009267;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0000731;GO:0006268;GO:0006302;GO:0000724;GO:0044806;GO:0010259;GO:0051345;GO:0098530;GO:1902570;GO:0042981;GO:0040009;GO:1901796;GO:0031297;GO:0090399;GO:0006979;GO:0010225;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:centrosome; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:neuron projection; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:replication fork;, F:3'-5' DNA helicase activity; F:3'-5' exonuclease activity; F:3'-flap-structured DNA binding; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:exonuclease activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:magnesium ion binding; F:manganese ion binding; F:MutLalpha complex binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding;, P:aging; P:base-excision repair; P:brain development; P:cell aging; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to starvation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:DNA unwinding involved in DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:multicellular organism aging; P:positive regulation of hydrolase activity; P:positive regulation of strand invasion; P:protein localization to nucleolus; P:regulation of apoptotic process; P:regulation of growth rate; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to oxidative stress; P:response to UV-C; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly;|Q14191 A1KYY9,Werner syndrome ATP-dependent helicase,DNA helicase, RecQ-like type 3;Exonuclease WRN;RecQ protein-like 2;, PF00270;PF01612;PF00271;PF00570;PF14493;PF16124;PF09382;, GO:0005813;GO:0005694;GO:0000781;GO:0005737;GO:0043005;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005657;GO:0043138;GO:0008408;GO:0070337;GO:1905773;GO:0005524;GO:0016887;GO:0000405;GO:0003682;GO:0003677;GO:0003678;GO:0004527;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0000287;GO:0030145;GO:0032405;GO:0042803;GO:0044877;GO:0061821;GO:0061849;GO:0000403;GO:0007568;GO:0006284;GO:0007420;GO:0007569;GO:0006974;GO:0071480;GO:0009267;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0000731;GO:0006268;GO:0006302;GO:0000724;GO:0044806;GO:0010259;GO:0051345;GO:0098530;GO:1902570;GO:0042981;GO:0040009;GO:1901796;GO:0031297;GO:0090399;GO:0006979;GO:0010225;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:centrosome; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:neuron projection; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:replication fork;, F:3'-5' DNA helicase activity; F:3'-5' exonuclease activity; F:3'-flap-structured DNA binding; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:exonuclease activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:magnesium ion binding; F:manganese ion binding; F:MutLalpha complex binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding;, P:aging; P:base-excision repair; P:brain development; P:cell aging; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to starvation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:DNA unwinding involved in DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:multicellular organism aging; P:positive regulation of hydrolase activity; P:positive regulation of strand invasion; P:protein localization to nucleolus; P:regulation of apoptotic process; P:regulation of growth rate; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to oxidative stress; P:response to UV-C; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly;|Q14191 A1KYY9,Werner syndrome ATP-dependent helicase,DNA helicase, RecQ-like type 3;Exonuclease WRN;RecQ protein-like 2;, PF00270;PF01612;PF00271;PF00570;PF14493;PF16124;PF09382;, GO:0005813;GO:0005694;GO:0000781;GO:0005737;GO:0043005;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005657;GO:0043138;GO:0008408;GO:0070337;GO:1905773;GO:0005524;GO:0016887;GO:0000405;GO:0003682;GO:0003677;GO:0003678;GO:0004527;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0000287;GO:0030145;GO:0032405;GO:0042803;GO:0044877;GO:0061821;GO:0061849;GO:0000403;GO:0007568;GO:0006284;GO:0007420;GO:0007569;GO:0006974;GO:0071480;GO:0009267;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0000731;GO:0006268;GO:0006302;GO:0000724;GO:0044806;GO:0010259;GO:0051345;GO:0098530;GO:1902570;GO:0042981;GO:0040009;GO:1901796;GO:0031297;GO:0090399;GO:0006979;GO:0010225;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:centrosome; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:neuron projection; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:replication fork;, F:3'-5' DNA helicase activity; F:3'-5' exonuclease activity; F:3'-flap-structured DNA binding; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:exonuclease activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:magnesium ion binding; F:manganese ion binding; F:MutLalpha complex binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding;, P:aging; P:base-excision repair; P:brain development; P:cell aging; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to starvation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:DNA unwinding involved in DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:multicellular organism aging; P:positive regulation of hydrolase activity; P:positive regulation of strand invasion; P:protein localization to nucleolus; P:regulation of apoptotic process; P:regulation of growth rate; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to oxidative stress; P:response to UV-C; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly;|Q14191 A1KYY9,Werner syndrome ATP-dependent helicase,DNA helicase, RecQ-like type 3;Exonuclease WRN;RecQ protein-like 2;, PF00270;PF01612;PF00271;PF00570;PF14493;PF16124;PF09382;, GO:0005813;GO:0005694;GO:0000781;GO:0005737;GO:0043005;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005657;GO:0043138;GO:0008408;GO:0070337;GO:1905773;GO:0005524;GO:0016887;GO:0000405;GO:0003682;GO:0003677;GO:0003678;GO:0004527;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0000287;GO:0030145;GO:0032405;GO:0042803;GO:0044877;GO:0061821;GO:0061849;GO:0000403;GO:0007568;GO:0006284;GO:0007420;GO:0007569;GO:0006974;GO:0071480;GO:0009267;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0000731;GO:0006268;GO:0006302;GO:0000724;GO:0044806;GO:0010259;GO:0051345;GO:0098530;GO:1902570;GO:0042981;GO:0040009;GO:1901796;GO:0031297;GO:0090399;GO:0006979;GO:0010225;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:centrosome; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:neuron projection; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:replication fork;, F:3'-5' DNA helicase activity; F:3'-5' exonuclease activity; F:3'-flap-structured DNA binding; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:exonuclease activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:magnesium ion binding; F:manganese ion binding; F:MutLalpha complex binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding;, P:aging; P:base-excision repair; P:brain development; P:cell aging; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to starvation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:DNA unwinding involved in DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:multicellular organism aging; P:positive regulation of hydrolase activity; P:positive regulation of strand invasion; P:protein localization to nucleolus; P:regulation of apoptotic process; P:regulation of growth rate; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to oxidative stress; P:response to UV-C; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly;|Q14191 A1KYY9,Werner syndrome ATP-dependent helicase,DNA helicase, RecQ-like type 3;Exonuclease WRN;RecQ protein-like 2;, PF00270;PF01612;PF00271;PF00570;PF14493;PF16124;PF09382;, GO:0005813;GO:0005694;GO:0000781;GO:0005737;GO:0043005;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005657;GO:0043138;GO:0008408;GO:0070337;GO:1905773;GO:0005524;GO:0016887;GO:0000405;GO:0003682;GO:0003677;GO:0003678;GO:0004527;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0000287;GO:0030145;GO:0032405;GO:0042803;GO:0044877;GO:0061821;GO:0061849;GO:0000403;GO:0007568;GO:0006284;GO:0007420;GO:0007569;GO:0006974;GO:0071480;GO:0009267;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0000731;GO:0006268;GO:0006302;GO:0000724;GO:0044806;GO:0010259;GO:0051345;GO:0098530;GO:1902570;GO:0042981;GO:0040009;GO:1901796;GO:0031297;GO:0090399;GO:0006979;GO:0010225;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:centrosome; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:neuron projection; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:replication fork;, F:3'-5' DNA helicase activity; F:3'-5' exonuclease activity; F:3'-flap-structured DNA binding; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:exonuclease activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:magnesium ion binding; F:manganese ion binding; F:MutLalpha complex binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding;, P:aging; P:base-excision repair; P:brain development; P:cell aging; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to starvation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:DNA unwinding involved in DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:multicellular organism aging; P:positive regulation of hydrolase activity; P:positive regulation of strand invasion; P:protein localization to nucleolus; P:regulation of apoptotic process; P:regulation of growth rate; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to oxidative stress; P:response to UV-C; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly; scaffold26 indexed_genome mRNA 17697301 17757473 . - . ID=transcript_5914;Q14191 A1KYY9,Werner syndrome ATP-dependent helicase,DNA helicase, RecQ-like type 3;Exonuclease WRN;RecQ protein-like 2;, PF00270;PF01612;PF00271;PF00570;PF14493;PF16124;PF09382;, GO:0005813;GO:0005694;GO:0000781;GO:0005737;GO:0043005;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005657;GO:0043138;GO:0008408;GO:0070337;GO:1905773;GO:0005524;GO:0016887;GO:0000405;GO:0003682;GO:0003677;GO:0003678;GO:0004527;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0000287;GO:0030145;GO:0032405;GO:0042803;GO:0044877;GO:0061821;GO:0061849;GO:0000403;GO:0007568;GO:0006284;GO:0007420;GO:0007569;GO:0006974;GO:0071480;GO:0009267;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0000731;GO:0006268;GO:0006302;GO:0000724;GO:0044806;GO:0010259;GO:0051345;GO:0098530;GO:1902570;GO:0042981;GO:0040009;GO:1901796;GO:0031297;GO:0090399;GO:0006979;GO:0010225;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:centrosome; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:neuron projection; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:replication fork;, F:3'-5' DNA helicase activity; F:3'-5' exonuclease activity; F:3'-flap-structured DNA binding; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:exonuclease activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:magnesium ion binding; F:manganese ion binding; F:MutLalpha complex binding; F:protein homodimerization activity; F:protein-containing complex binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding;, P:aging; P:base-excision repair; P:brain development; P:cell aging; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to starvation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:DNA unwinding involved in DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:multicellular organism aging; P:positive regulation of hydrolase activity; P:positive regulation of strand invasion; P:protein localization to nucleolus; P:regulation of apoptotic process; P:regulation of growth rate; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replicative senescence; P:response to oxidative stress; P:response to UV-C; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly; scaffold26 indexed_genome mRNA 17763024 17800753 . + . ID=transcript_5915;Q9UJV8 Q8TE64,Purine-rich element-binding protein gamma,, PF04845;, GO:0005634;GO:0000981;GO:0032422;GO:0003723;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:purine-rich negative regulatory element binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9UJV8 Q8TE64,Purine-rich element-binding protein gamma,, PF04845;, GO:0005634;GO:0000981;GO:0032422;GO:0003723;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:purine-rich negative regulatory element binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold26 indexed_genome mRNA 17927060 17931160 . + . ID=transcript_5916;Q9BXT5,Testis-expressed protein 15,Cancer/testis antigen 42;, PF15326;, GO:0005737;GO:0005634;GO:0030154;GO:0006306;GO:0006281;GO:0031047;GO:0007129;GO:0007140;GO:0010529;GO:0010569;GO:0007283;, C:cytoplasm; C:nucleus;, , P:cell differentiation; P:DNA methylation; P:DNA repair; P:gene silencing by RNA; P:homologous chromosome pairing at meiosis; P:male meiotic nuclear division; P:negative regulation of transposition; P:regulation of double-strand break repair via homologous recombination; P:spermatogenesis; scaffold26 indexed_genome mRNA 17948845 17971912 . + . ID=transcript_5917;P62714 D3DSV4 P11082 Q6FHK5,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform,, PF00149;, GO:0000775;GO:0005829;GO:0005634;GO:0000159;GO:0000922;GO:0046872;GO:0008022;GO:0106306;GO:0004722;GO:0106307;GO:0048156;GO:0008637;GO:0046580;GO:0070262;GO:0035970;GO:1904528;GO:0043161;GO:0006470;GO:0010468;GO:0046677;GO:0034976;GO:0042542;GO:0010288;, C:chromosome, centromeric region; C:cytosol; C:nucleus; C:protein phosphatase type 2A complex; C:spindle pole;, F:metal ion binding; F:protein C-terminus binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:tau protein binding;, P:apoptotic mitochondrial changes; P:negative regulation of Ras protein signal transduction; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of microtubule binding; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:regulation of gene expression; P:response to antibiotic; P:response to endoplasmic reticulum stress; P:response to hydrogen peroxide; P:response to lead ion;|P67775 P05323 P13197,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,Replication protein C;, PF00149;, GO:0000775;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0015630;GO:0005739;GO:0005634;GO:0005886;GO:0000159;GO:0000922;GO:0045202;GO:0050811;GO:0046872;GO:0004721;GO:0008022;GO:0046982;GO:0106306;GO:0004722;GO:0106307;GO:0048156;GO:0006915;GO:0006672;GO:0000188;GO:0051321;GO:0007498;GO:0007084;GO:0030308;GO:0010719;GO:0042532;GO:0000184;GO:0070262;GO:0035970;GO:1904528;GO:0071902;GO:0006470;GO:0030155;GO:0045595;GO:0006275;GO:0040008;GO:1904526;GO:0001932;GO:0006355;GO:0030111;GO:0010288;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:plasma membrane; C:protein phosphatase type 2A complex; C:spindle pole; C:synapse;, F:GABA receptor binding; F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:tau protein binding;, P:apoptotic process; P:ceramide metabolic process; P:inactivation of MAPK activity; P:meiotic cell cycle; P:mesoderm development; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of microtubule binding; P:positive regulation of protein serine/threonine kinase activity; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of growth; P:regulation of microtubule binding; P:regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to lead ion; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling;|P67775 P05323 P13197,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,Replication protein C;, PF00149;, GO:0000775;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0015630;GO:0005739;GO:0005634;GO:0005886;GO:0000159;GO:0000922;GO:0045202;GO:0050811;GO:0046872;GO:0004721;GO:0008022;GO:0046982;GO:0106306;GO:0004722;GO:0106307;GO:0048156;GO:0006915;GO:0006672;GO:0000188;GO:0051321;GO:0007498;GO:0007084;GO:0030308;GO:0010719;GO:0042532;GO:0000184;GO:0070262;GO:0035970;GO:1904528;GO:0071902;GO:0006470;GO:0030155;GO:0045595;GO:0006275;GO:0040008;GO:1904526;GO:0001932;GO:0006355;GO:0030111;GO:0010288;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:plasma membrane; C:protein phosphatase type 2A complex; C:spindle pole; C:synapse;, F:GABA receptor binding; F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:tau protein binding;, P:apoptotic process; P:ceramide metabolic process; P:inactivation of MAPK activity; P:meiotic cell cycle; P:mesoderm development; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of microtubule binding; P:positive regulation of protein serine/threonine kinase activity; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of growth; P:regulation of microtubule binding; P:regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to lead ion; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling; scaffold26 indexed_genome mRNA 17987335 18004232 . - . ID=transcript_5918;O00124 Q7Z6F2,UBX domain-containing protein 8,Reproduction 8 protein;UBX domain-containing protein 6;, PF00789;, GO:0005783;GO:0030176;GO:0005730;GO:0005654;GO:0000151;GO:0030674;GO:0007338;GO:0030433;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:nucleolus; C:nucleoplasm; C:ubiquitin ligase complex;, F:protein-macromolecule adaptor activity;, P:single fertilization; P:ubiquitin-dependent ERAD pathway;|O00124 Q7Z6F2,UBX domain-containing protein 8,Reproduction 8 protein;UBX domain-containing protein 6;, PF00789;, GO:0005783;GO:0030176;GO:0005730;GO:0005654;GO:0000151;GO:0030674;GO:0007338;GO:0030433;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:nucleolus; C:nucleoplasm; C:ubiquitin ligase complex;, F:protein-macromolecule adaptor activity;, P:single fertilization; P:ubiquitin-dependent ERAD pathway;|O00124 Q7Z6F2,UBX domain-containing protein 8,Reproduction 8 protein;UBX domain-containing protein 6;, PF00789;, GO:0005783;GO:0030176;GO:0005730;GO:0005654;GO:0000151;GO:0030674;GO:0007338;GO:0030433;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:nucleolus; C:nucleoplasm; C:ubiquitin ligase complex;, F:protein-macromolecule adaptor activity;, P:single fertilization; P:ubiquitin-dependent ERAD pathway; scaffold26 indexed_genome mRNA 18024464 18070181 . + . ID=transcript_5919;P00390 C8KIL8 C8KIL9 C8KIM0 D3DSV3 Q7Z5C9 Q9NP63,Glutathione reductase, mitochondrial,, PF07992;PF02852;, GO:0005829;GO:0009897;GO:0070062;GO:0005759;GO:0005739;GO:0009055;GO:0050660;GO:0004362;GO:0050661;GO:0045454;GO:0034599;GO:0006749;GO:0015949;, C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:glutathione-disulfide reductase activity; F:NADP binding;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:glutathione metabolic process; P:nucleobase-containing small molecule interconversion;|P00390 C8KIL8 C8KIL9 C8KIM0 D3DSV3 Q7Z5C9 Q9NP63,Glutathione reductase, mitochondrial,, PF07992;PF02852;, GO:0005829;GO:0009897;GO:0070062;GO:0005759;GO:0005739;GO:0009055;GO:0050660;GO:0004362;GO:0050661;GO:0045454;GO:0034599;GO:0006749;GO:0015949;, C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:glutathione-disulfide reductase activity; F:NADP binding;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:glutathione metabolic process; P:nucleobase-containing small molecule interconversion;|P00390 C8KIL8 C8KIL9 C8KIM0 D3DSV3 Q7Z5C9 Q9NP63,Glutathione reductase, mitochondrial,, PF07992;PF02852;, GO:0005829;GO:0009897;GO:0070062;GO:0005759;GO:0005739;GO:0009055;GO:0050660;GO:0004362;GO:0050661;GO:0045454;GO:0034599;GO:0006749;GO:0015949;, C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:glutathione-disulfide reductase activity; F:NADP binding;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:glutathione metabolic process; P:nucleobase-containing small molecule interconversion; scaffold26 indexed_genome mRNA 18087455 18141271 . + . ID=transcript_5920;P29084 D3DSV2 Q9H2B9,Transcription initiation factor IIE subunit beta,General transcription factor IIE subunit 2;, PF18121;PF02186;, GO:0005829;GO:0016607;GO:0005654;GO:0005669;GO:0005673;GO:0003677;GO:0003723;GO:0016251;GO:0042795;GO:0006366;GO:0006367;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFIIE complex;, F:DNA binding; F:RNA binding; F:RNA polymerase II general transcription initiation factor activity;, P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P0DKX4,Small integral membrane protein 18,, PF15831;, GO:0016021;, C:integral component of membrane;|P0DKX4,Small integral membrane protein 18,, PF15831;, GO:0016021;, C:integral component of membrane; scaffold26 indexed_genome mRNA 18144611 18167753 . + . ID=transcript_5921;P29084 D3DSV2 Q9H2B9,Transcription initiation factor IIE subunit beta,General transcription factor IIE subunit 2;, PF18121;PF02186;, GO:0005829;GO:0016607;GO:0005654;GO:0005669;GO:0005673;GO:0003677;GO:0003723;GO:0016251;GO:0042795;GO:0006366;GO:0006367;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFIIE complex;, F:DNA binding; F:RNA binding; F:RNA polymerase II general transcription initiation factor activity;, P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold26 indexed_genome mRNA 18173350 18370292 . - . ID=transcript_5922;Q93062 D3DSU9 Q92516 Q92517 Q92518 Q96J26,RNA-binding protein with multiple splicing,Heart and RRM expressed sequence;, PF00076;, GO:0010494;GO:0005829;GO:0005654;GO:0000932;GO:0003729;GO:0008143;GO:0042803;GO:0003723;GO:0003713;GO:0010862;GO:0060391;GO:0006979;GO:0006396;, C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm; C:P-body;, F:mRNA binding; F:poly(A) binding; F:protein homodimerization activity; F:RNA binding; F:transcription coactivator activity;, P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of SMAD protein signal transduction; P:response to oxidative stress; P:RNA processing; scaffold26 indexed_genome mRNA 18518104 18531372 . + . ID=transcript_5923;O00399 B2RAC1,Dynactin subunit 6,Dynactin subunit p27;Protein WS-3;, PF00132;, GO:0005813;GO:0000777;GO:0005829;GO:0005869;GO:0070840;GO:0019886;GO:0006888;GO:0007052;, C:centrosome; C:condensed chromosome kinetochore; C:cytosol; C:dynactin complex;, F:dynein complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:mitotic spindle organization;|O00399 B2RAC1,Dynactin subunit 6,Dynactin subunit p27;Protein WS-3;, PF00132;, GO:0005813;GO:0000777;GO:0005829;GO:0005869;GO:0070840;GO:0019886;GO:0006888;GO:0007052;, C:centrosome; C:condensed chromosome kinetochore; C:cytosol; C:dynactin complex;, F:dynein complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:mitotic spindle organization;|O00399 B2RAC1,Dynactin subunit 6,Dynactin subunit p27;Protein WS-3;, PF00132;, GO:0005813;GO:0000777;GO:0005829;GO:0005869;GO:0070840;GO:0019886;GO:0006888;GO:0007052;, C:centrosome; C:condensed chromosome kinetochore; C:cytosol; C:dynactin complex;, F:dynein complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:mitotic spindle organization; scaffold26 indexed_genome mRNA 18571699 18577671 . - . ID=transcript_5924;O95214 E9PHP8 Q9BW48,Leptin receptor overlapping transcript-like 1,Endospanin-2;, PF04133;, GO:0005768;GO:0016021;GO:0042802;GO:0032511;GO:2000009;, C:endosome; C:integral component of membrane;, F:identical protein binding;, P:late endosome to vacuole transport via multivesicular body sorting pathway; P:negative regulation of protein localization to cell surface;|O95214 E9PHP8 Q9BW48,Leptin receptor overlapping transcript-like 1,Endospanin-2;, PF04133;, GO:0005768;GO:0016021;GO:0042802;GO:0032511;GO:2000009;, C:endosome; C:integral component of membrane;, F:identical protein binding;, P:late endosome to vacuole transport via multivesicular body sorting pathway; P:negative regulation of protein localization to cell surface; scaffold26 indexed_genome mRNA 18591524 18611073 . + . ID=transcript_5925;Q96BY9 B3KQQ4 B7Z9J1 D3DSU7 H9MHJ8 H9MHJ9 Q53HE8 Q9UNZ3 Q9Y683,Store-operated calcium entry-associated regulatory factor,HBV X-transactivated gene 3 protein;HBV XAg-transactivated protein 3;Protein FOAP-7;Transmembrane protein 66;, PF06682;, GO:0005783;GO:0140268;GO:0030176;GO:0006816;GO:2001256;, C:endoplasmic reticulum; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of endoplasmic reticulum membrane;, , P:calcium ion transport; P:regulation of store-operated calcium entry;|Q96BY9 B3KQQ4 B7Z9J1 D3DSU7 H9MHJ8 H9MHJ9 Q53HE8 Q9UNZ3 Q9Y683,Store-operated calcium entry-associated regulatory factor,HBV X-transactivated gene 3 protein;HBV XAg-transactivated protein 3;Protein FOAP-7;Transmembrane protein 66;, PF06682;, GO:0005783;GO:0140268;GO:0030176;GO:0006816;GO:2001256;, C:endoplasmic reticulum; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of endoplasmic reticulum membrane;, , P:calcium ion transport; P:regulation of store-operated calcium entry;|Q96BY9 B3KQQ4 B7Z9J1 D3DSU7 H9MHJ8 H9MHJ9 Q53HE8 Q9UNZ3 Q9Y683,Store-operated calcium entry-associated regulatory factor,HBV X-transactivated gene 3 protein;HBV XAg-transactivated protein 3;Protein FOAP-7;Transmembrane protein 66;, PF06682;, GO:0005783;GO:0140268;GO:0030176;GO:0006816;GO:2001256;, C:endoplasmic reticulum; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of endoplasmic reticulum membrane;, , P:calcium ion transport; P:regulation of store-operated calcium entry;|Q96BY9 B3KQQ4 B7Z9J1 D3DSU7 H9MHJ8 H9MHJ9 Q53HE8 Q9UNZ3 Q9Y683,Store-operated calcium entry-associated regulatory factor,HBV X-transactivated gene 3 protein;HBV XAg-transactivated protein 3;Protein FOAP-7;Transmembrane protein 66;, PF06682;, GO:0005783;GO:0140268;GO:0030176;GO:0006816;GO:2001256;, C:endoplasmic reticulum; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of endoplasmic reticulum membrane;, , P:calcium ion transport; P:regulation of store-operated calcium entry; scaffold26 indexed_genome mRNA 19153813 19166949 . + . ID=transcript_5926;Q13115 B2RBU5 D3DSU4 G5E930 Q13524,Dual specificity protein phosphatase 4,Dual specificity protein phosphatase hVH2;Mitogen-activated protein kinase phosphatase 2;, PF00581;, GO:0005737;GO:0005654;GO:0005634;GO:1990439;GO:0017017;GO:0051019;GO:0016791;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0016311;GO:0001706;GO:0000188;GO:0070373;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:MAP kinase serine/threonine phosphatase activity; F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:dephosphorylation; P:endoderm formation; P:inactivation of MAPK activity; P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; scaffold26 indexed_genome mRNA 19184271 19342211 . - . ID=transcript_5927;O95271 O95272 Q4G0F2,Poly [ADP-ribose] polymerase tankyrase-1 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 5 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 5A {ECO:0000303|PubMed:20106667};Protein poly-ADP-ribosyltransferase tankyrase-1 {ECO:0000305};TNKS-1;TRF1-interacting ankyrin-related ADP-ribose polymerase;Tankyrase I;Tankyrase-1 {ECO:0000303|PubMed:9822378};, PF00023;PF12796;PF13606;PF00644;PF07647;, GO:0000781;GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0097431;GO:0016604;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0000242;GO:0042393;GO:0003950;GO:1990404;GO:0008270;GO:0051301;GO:0031670;GO:0007052;GO:0051028;GO:1904908;GO:1904357;GO:1904743;GO:0018105;GO:0018107;GO:0090263;GO:0051973;GO:1904355;GO:0032212;GO:0045944;GO:0006471;GO:0070213;GO:0070198;GO:0070212;GO:0000209;GO:0015031;GO:0032210;GO:0051225;GO:0016055;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:mitotic spindle pole; C:nuclear body; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:pericentriolar material;, F:histone binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:zinc ion binding;, P:cell division; P:cellular response to nutrient; P:mitotic spindle organization; P:mRNA transport; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of telomeric DNA binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to chromosome, telomeric region; P:protein poly-ADP-ribosylation; P:protein polyubiquitination; P:protein transport; P:regulation of telomere maintenance via telomerase; P:spindle assembly; P:Wnt signaling pathway;|O95271 O95272 Q4G0F2,Poly [ADP-ribose] polymerase tankyrase-1 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 5 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 5A {ECO:0000303|PubMed:20106667};Protein poly-ADP-ribosyltransferase tankyrase-1 {ECO:0000305};TNKS-1;TRF1-interacting ankyrin-related ADP-ribose polymerase;Tankyrase I;Tankyrase-1 {ECO:0000303|PubMed:9822378};, PF00023;PF12796;PF13606;PF00644;PF07647;, GO:0000781;GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0097431;GO:0016604;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0000242;GO:0042393;GO:0003950;GO:1990404;GO:0008270;GO:0051301;GO:0031670;GO:0007052;GO:0051028;GO:1904908;GO:1904357;GO:1904743;GO:0018105;GO:0018107;GO:0090263;GO:0051973;GO:1904355;GO:0032212;GO:0045944;GO:0006471;GO:0070213;GO:0070198;GO:0070212;GO:0000209;GO:0015031;GO:0032210;GO:0051225;GO:0016055;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:mitotic spindle pole; C:nuclear body; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:pericentriolar material;, F:histone binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:zinc ion binding;, P:cell division; P:cellular response to nutrient; P:mitotic spindle organization; P:mRNA transport; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; P:negative regulation of telomere maintenance via telomere lengthening; P:negative regulation of telomeric DNA binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to chromosome, telomeric region; P:protein poly-ADP-ribosylation; P:protein polyubiquitination; P:protein transport; P:regulation of telomere maintenance via telomerase; P:spindle assembly; P:Wnt signaling pathway; scaffold26 indexed_genome mRNA 19645930 19654556 . - . ID=transcript_5928;Q86XI6 B3KTV3 Q9H812,Protein phosphatase 1 regulatory subunit 3B,Hepatic glycogen-targeting protein phosphatase 1 regulatory subunit GL;Protein phosphatase 1 regulatory subunit 4;Protein phosphatase 1 subunit GL;, PF03370;, GO:0042587;GO:0043231;GO:0000164;GO:0050196;GO:2001069;GO:0008157;GO:0019888;GO:0005977;GO:0005979;GO:0005981;, C:glycogen granule; C:intracellular membrane-bounded organelle; C:protein phosphatase type 1 complex;, F:[phosphorylase] phosphatase activity; F:glycogen binding; F:protein phosphatase 1 binding; F:protein phosphatase regulator activity;, P:glycogen metabolic process; P:regulation of glycogen biosynthetic process; P:regulation of glycogen catabolic process; scaffold26 indexed_genome mRNA 19750709 19766699 . - . ID=transcript_5929;Q8IV48 A8K4U7 Q9NSX3,3'-5' exoribonuclease 1,3'-5' exonuclease ERI1;Eri-1 homolog;Histone mRNA 3'-end-specific exoribonuclease;Histone mRNA 3'-exonuclease 1;Protein 3'hExo;, PF00929;PF02037;, GO:0005737;GO:0071204;GO:0005730;GO:0005634;GO:0008408;GO:0000175;GO:0071207;GO:0046872;GO:0043022;GO:0019843;GO:0000738;GO:0000467;GO:0031047;GO:0031125;, C:cytoplasm; C:histone pre-mRNA 3'end processing complex; C:nucleolus; C:nucleus;, F:3'-5' exonuclease activity; F:3'-5'-exoribonuclease activity; F:histone pre-mRNA stem-loop binding; F:metal ion binding; F:ribosome binding; F:rRNA binding;, P:DNA catabolic process, exonucleolytic; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:gene silencing by RNA; P:rRNA 3'-end processing; scaffold26 indexed_genome mRNA 20041806 20067740 . + . ID=transcript_5930;O75096 B2RN39 Q4AC85 Q5KTZ5,Low-density lipoprotein receptor-related protein 4,Multiple epidermal growth factor-like domains 7;, PF12662;PF00057;PF00058;, GO:0009986;GO:0030425;GO:0016021;GO:0031594;GO:0043025;GO:0005886;GO:0044853;GO:0014069;GO:0097060;GO:0034185;GO:0005509;GO:0042803;GO:0030971;GO:0097110;GO:0150094;GO:0048813;GO:0009953;GO:0042733;GO:0006897;GO:0001942;GO:0001822;GO:0060173;GO:0050771;GO:0090090;GO:0030279;GO:0042475;GO:0050731;GO:1901631;GO:1904395;GO:0097104;GO:0097105;GO:0009954;GO:0071340;GO:0050808;GO:0051124;GO:0016055;, C:cell surface; C:dendrite; C:integral component of membrane; C:neuromuscular junction; C:neuronal cell body; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:synaptic membrane;, F:apolipoprotein binding; F:calcium ion binding; F:protein homodimerization activity; F:receptor tyrosine kinase binding; F:scaffold protein binding;, P:amyloid-beta clearance by cellular catabolic process; P:dendrite morphogenesis; P:dorsal/ventral pattern formation; P:embryonic digit morphogenesis; P:endocytosis; P:hair follicle development; P:kidney development; P:limb development; P:negative regulation of axonogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ossification; P:odontogenesis of dentin-containing tooth; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of presynaptic membrane organization; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; P:postsynaptic membrane assembly; P:presynaptic membrane assembly; P:proximal/distal pattern formation; P:skeletal muscle acetylcholine-gated channel clustering; P:synapse organization; P:synaptic growth at neuromuscular junction; P:Wnt signaling pathway; scaffold26 indexed_genome mRNA 20069097 20080056 . + . ID=transcript_5931;O75197 Q96TD6 Q9UES7 Q9UP66,Low-density lipoprotein receptor-related protein 5 {ECO:0000303|PubMed:24706814},Low-density lipoprotein receptor-related protein 7 {ECO:0000250|UniProtKB:Q91VN0};, PF00057;PF00058;, GO:0005783;GO:0016021;GO:0005886;GO:0043235;GO:1990909;GO:1990851;GO:0015026;GO:1904928;GO:0071936;GO:0042813;GO:0017147;GO:0060612;GO:0060033;GO:0009952;GO:1902262;GO:0048539;GO:0060349;GO:0046849;GO:0060444;GO:0060070;GO:0042074;GO:0060764;GO:0042632;GO:0008203;GO:0042733;GO:0006897;GO:0035426;GO:0001702;GO:0006007;GO:0045668;GO:0071901;GO:0110135;GO:0002076;GO:0008284;GO:0051091;GO:0045600;GO:0002053;GO:0045840;GO:0045669;GO:0033690;GO:0045944;GO:0045893;GO:0042981;GO:0008217;GO:0061178;GO:0043434;GO:0009314;GO:0060042;GO:0061304;GO:0035019;GO:1901998;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane; C:receptor complex; C:Wnt signalosome; C:Wnt-Frizzled-LRP5/6 complex;, F:coreceptor activity; F:coreceptor activity involved in canonical Wnt signaling pathway; F:coreceptor activity involved in Wnt signaling pathway; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:adipose tissue development; P:anatomical structure regression; P:anterior/posterior pattern specification; P:apoptotic process involved in blood vessel morphogenesis; P:bone marrow development; P:bone morphogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:canonical Wnt signaling pathway; P:cell migration involved in gastrulation; P:cell-cell signaling involved in mammary gland development; P:cholesterol homeostasis; P:cholesterol metabolic process; P:embryonic digit morphogenesis; P:endocytosis; P:extracellular matrix-cell signaling; P:gastrulation with mouth forming second; P:glucose catabolic process; P:negative regulation of osteoblast differentiation; P:negative regulation of protein serine/threonine kinase activity; P:Norrin signaling pathway; P:osteoblast development; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of fat cell differentiation; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of mitotic nuclear division; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:response to peptide hormone; P:response to radiation; P:retina morphogenesis in camera-type eye; P:retinal blood vessel morphogenesis; P:somatic stem cell population maintenance; P:toxin transport; scaffold26 indexed_genome mRNA 20091298 20092209 . + . ID=transcript_5932;Q96B33 Q08AJ3,Claudin-23,, PF00822;, GO:0005923;GO:0016021;GO:0005886;GO:0042802;GO:0005198;GO:0070830;GO:0016338;GO:0007155;, C:bicellular tight junction; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:structural molecule activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; scaffold26 indexed_genome mRNA 20352782 20378993 . + . ID=transcript_5933;Q86YV5 Q8N3N5,Inactive tyrosine-protein kinase PRAG1 {ECO:0000305},PEAK1-related kinase-activating pseudokinase 1;Pragmin {ECO:0000303|PubMed:27116701};Sugen kinase 223 {ECO:0000303|PubMed:29079850};, PF00069;, GO:0005737;GO:0005925;GO:0005634;GO:0042802;GO:0004672;GO:0016477;GO:0010977;GO:0035025;GO:0006468;GO:2000145;GO:0008360;GO:0008593;, C:cytoplasm; C:focal adhesion; C:nucleus;, F:identical protein binding; F:protein kinase activity;, P:cell migration; P:negative regulation of neuron projection development; P:positive regulation of Rho protein signal transduction; P:protein phosphorylation; P:regulation of cell motility; P:regulation of cell shape; P:regulation of Notch signaling pathway;|Q86YV5 Q8N3N5,Inactive tyrosine-protein kinase PRAG1 {ECO:0000305},PEAK1-related kinase-activating pseudokinase 1;Pragmin {ECO:0000303|PubMed:27116701};Sugen kinase 223 {ECO:0000303|PubMed:29079850};, PF00069;, GO:0005737;GO:0005925;GO:0005634;GO:0042802;GO:0004672;GO:0016477;GO:0010977;GO:0035025;GO:0006468;GO:2000145;GO:0008360;GO:0008593;, C:cytoplasm; C:focal adhesion; C:nucleus;, F:identical protein binding; F:protein kinase activity;, P:cell migration; P:negative regulation of neuron projection development; P:positive regulation of Rho protein signal transduction; P:protein phosphorylation; P:regulation of cell motility; P:regulation of cell shape; P:regulation of Notch signaling pathway;|Q86YV5 Q8N3N5,Inactive tyrosine-protein kinase PRAG1 {ECO:0000305},PEAK1-related kinase-activating pseudokinase 1;Pragmin {ECO:0000303|PubMed:27116701};Sugen kinase 223 {ECO:0000303|PubMed:29079850};, PF00069;, GO:0005737;GO:0005925;GO:0005634;GO:0042802;GO:0004672;GO:0016477;GO:0010977;GO:0035025;GO:0006468;GO:2000145;GO:0008360;GO:0008593;, C:cytoplasm; C:focal adhesion; C:nucleus;, F:identical protein binding; F:protein kinase activity;, P:cell migration; P:negative regulation of neuron projection development; P:positive regulation of Rho protein signal transduction; P:protein phosphorylation; P:regulation of cell motility; P:regulation of cell shape; P:regulation of Notch signaling pathway;|Q86YV5 Q8N3N5,Inactive tyrosine-protein kinase PRAG1 {ECO:0000305},PEAK1-related kinase-activating pseudokinase 1;Pragmin {ECO:0000303|PubMed:27116701};Sugen kinase 223 {ECO:0000303|PubMed:29079850};, PF00069;, GO:0005737;GO:0005925;GO:0005634;GO:0042802;GO:0004672;GO:0016477;GO:0010977;GO:0035025;GO:0006468;GO:2000145;GO:0008360;GO:0008593;, C:cytoplasm; C:focal adhesion; C:nucleus;, F:identical protein binding; F:protein kinase activity;, P:cell migration; P:negative regulation of neuron projection development; P:positive regulation of Rho protein signal transduction; P:protein phosphorylation; P:regulation of cell motility; P:regulation of cell shape; P:regulation of Notch signaling pathway; scaffold26 indexed_genome mRNA 20389580 20390898 . - . ID=transcript_5934;Q86YV5 Q8N3N5,Inactive tyrosine-protein kinase PRAG1 {ECO:0000305},PEAK1-related kinase-activating pseudokinase 1;Pragmin {ECO:0000303|PubMed:27116701};Sugen kinase 223 {ECO:0000303|PubMed:29079850};, PF00069;, GO:0005737;GO:0005925;GO:0005634;GO:0042802;GO:0004672;GO:0016477;GO:0010977;GO:0035025;GO:0006468;GO:2000145;GO:0008360;GO:0008593;, C:cytoplasm; C:focal adhesion; C:nucleus;, F:identical protein binding; F:protein kinase activity;, P:cell migration; P:negative regulation of neuron projection development; P:positive regulation of Rho protein signal transduction; P:protein phosphorylation; P:regulation of cell motility; P:regulation of cell shape; P:regulation of Notch signaling pathway; scaffold26 indexed_genome mRNA 20397321 20398374 . - . ID=transcript_5935;Q86YV5 Q8N3N5,Inactive tyrosine-protein kinase PRAG1 {ECO:0000305},PEAK1-related kinase-activating pseudokinase 1;Pragmin {ECO:0000303|PubMed:27116701};Sugen kinase 223 {ECO:0000303|PubMed:29079850};, PF00069;, GO:0005737;GO:0005925;GO:0005634;GO:0042802;GO:0004672;GO:0016477;GO:0010977;GO:0035025;GO:0006468;GO:2000145;GO:0008360;GO:0008593;, C:cytoplasm; C:focal adhesion; C:nucleus;, F:identical protein binding; F:protein kinase activity;, P:cell migration; P:negative regulation of neuron projection development; P:positive regulation of Rho protein signal transduction; P:protein phosphorylation; P:regulation of cell motility; P:regulation of cell shape; P:regulation of Notch signaling pathway; scaffold26 indexed_genome mRNA 20524551 20534902 . - . ID=transcript_5936;Q17RB8 B4DM29 B4DU84 Q8TEA0 Q9BSV1,LON peptidase N-terminal domain and RING finger protein 1,RING finger protein 191;, PF02190;PF13445;, GO:0005829;GO:0046872;GO:0000209;, C:cytosol;, F:metal ion binding;, P:protein polyubiquitination;|Q17RB8 B4DM29 B4DU84 Q8TEA0 Q9BSV1,LON peptidase N-terminal domain and RING finger protein 1,RING finger protein 191;, PF02190;PF13445;, GO:0005829;GO:0046872;GO:0000209;, C:cytosol;, F:metal ion binding;, P:protein polyubiquitination;|Q17RB8 B4DM29 B4DU84 Q8TEA0 Q9BSV1,LON peptidase N-terminal domain and RING finger protein 1,RING finger protein 191;, PF02190;PF13445;, GO:0005829;GO:0046872;GO:0000209;, C:cytosol;, F:metal ion binding;, P:protein polyubiquitination; scaffold26 indexed_genome mRNA 20535335 20537012 . - . ID=transcript_5937;Q17RB8 B4DM29 B4DU84 Q8TEA0 Q9BSV1,LON peptidase N-terminal domain and RING finger protein 1,RING finger protein 191;, PF02190;PF13445;, GO:0005829;GO:0046872;GO:0000209;, C:cytosol;, F:metal ion binding;, P:protein polyubiquitination; scaffold26 indexed_genome mRNA 20537282 20538537 . + . ID=transcript_5938;Q17RB8 B4DM29 B4DU84 Q8TEA0 Q9BSV1,LON peptidase N-terminal domain and RING finger protein 1,RING finger protein 191;, PF02190;PF13445;, GO:0005829;GO:0046872;GO:0000209;, C:cytosol;, F:metal ion binding;, P:protein polyubiquitination; scaffold26 indexed_genome mRNA 20791160 20796343 . - . ID=transcript_5939;Q9P272 K7EM26 Q8N9K7 Q96AW6,Probable tRNA methyltransferase 9B {ECO:0000305},Probable tRNA methyltransferase 9-like protein {ECO:0000303|PubMed:23381944};, PF08241;, GO:0005737;GO:0005634;GO:0016300;GO:0000049;GO:0008175;GO:0006400;GO:0002098;, C:cytoplasm; C:nucleus;, F:tRNA (uracil) methyltransferase activity; F:tRNA binding; F:tRNA methyltransferase activity;, P:tRNA modification; P:tRNA wobble uridine modification;|Q9P272 K7EM26 Q8N9K7 Q96AW6,Probable tRNA methyltransferase 9B {ECO:0000305},Probable tRNA methyltransferase 9-like protein {ECO:0000303|PubMed:23381944};, PF08241;, GO:0005737;GO:0005634;GO:0016300;GO:0000049;GO:0008175;GO:0006400;GO:0002098;, C:cytoplasm; C:nucleus;, F:tRNA (uracil) methyltransferase activity; F:tRNA binding; F:tRNA methyltransferase activity;, P:tRNA modification; P:tRNA wobble uridine modification; scaffold26 indexed_genome mRNA 20862160 21276336 . + . ID=transcript_5940;Q86UC6 Q9C0E0 Q9H7A2,Rho GTPase-activating protein 7,Deleted in liver cancer 1 protein;HP protein;Rho-type GTPase-activating protein 7;START domain-containing protein 12;StAR-related lipid transfer protein 12;, PF00620;PF07647;PF01852;, GO:0005901;GO:0030864;GO:0005737;GO:0005829;GO:0005925;GO:0045121;GO:0005634;GO:0032587;GO:0005096;GO:0008289;GO:0042169;GO:0030036;GO:0006919;GO:0006915;GO:0048041;GO:0030900;GO:0003007;GO:0021575;GO:0030336;GO:0008285;GO:0051895;GO:0035024;GO:0051497;GO:0001843;GO:1900119;GO:0035307;GO:0032956;GO:0008360;GO:0035023;GO:0051056;GO:0007165;, C:caveola; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane raft; C:nucleus; C:ruffle membrane;, F:GTPase activator activity; F:lipid binding; F:SH2 domain binding;, P:actin cytoskeleton organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:focal adhesion assembly; P:forebrain development; P:heart morphogenesis; P:hindbrain morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of focal adhesion assembly; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:neural tube closure; P:positive regulation of execution phase of apoptosis; P:positive regulation of protein dephosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q86UC6 Q9C0E0 Q9H7A2,Rho GTPase-activating protein 7,Deleted in liver cancer 1 protein;HP protein;Rho-type GTPase-activating protein 7;START domain-containing protein 12;StAR-related lipid transfer protein 12;, PF00620;PF07647;PF01852;, GO:0005901;GO:0030864;GO:0005737;GO:0005829;GO:0005925;GO:0045121;GO:0005634;GO:0032587;GO:0005096;GO:0008289;GO:0042169;GO:0030036;GO:0006919;GO:0006915;GO:0048041;GO:0030900;GO:0003007;GO:0021575;GO:0030336;GO:0008285;GO:0051895;GO:0035024;GO:0051497;GO:0001843;GO:1900119;GO:0035307;GO:0032956;GO:0008360;GO:0035023;GO:0051056;GO:0007165;, C:caveola; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane raft; C:nucleus; C:ruffle membrane;, F:GTPase activator activity; F:lipid binding; F:SH2 domain binding;, P:actin cytoskeleton organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:focal adhesion assembly; P:forebrain development; P:heart morphogenesis; P:hindbrain morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of focal adhesion assembly; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:neural tube closure; P:positive regulation of execution phase of apoptosis; P:positive regulation of protein dephosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q86UC6 Q9C0E0 Q9H7A2,Rho GTPase-activating protein 7,Deleted in liver cancer 1 protein;HP protein;Rho-type GTPase-activating protein 7;START domain-containing protein 12;StAR-related lipid transfer protein 12;, PF00620;PF07647;PF01852;, GO:0005901;GO:0030864;GO:0005737;GO:0005829;GO:0005925;GO:0045121;GO:0005634;GO:0032587;GO:0005096;GO:0008289;GO:0042169;GO:0030036;GO:0006919;GO:0006915;GO:0048041;GO:0030900;GO:0003007;GO:0021575;GO:0030336;GO:0008285;GO:0051895;GO:0035024;GO:0051497;GO:0001843;GO:1900119;GO:0035307;GO:0032956;GO:0008360;GO:0035023;GO:0051056;GO:0007165;, C:caveola; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane raft; C:nucleus; C:ruffle membrane;, F:GTPase activator activity; F:lipid binding; F:SH2 domain binding;, P:actin cytoskeleton organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:focal adhesion assembly; P:forebrain development; P:heart morphogenesis; P:hindbrain morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of focal adhesion assembly; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:neural tube closure; P:positive regulation of execution phase of apoptosis; P:positive regulation of protein dephosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q86UC6 Q9C0E0 Q9H7A2,Rho GTPase-activating protein 7,Deleted in liver cancer 1 protein;HP protein;Rho-type GTPase-activating protein 7;START domain-containing protein 12;StAR-related lipid transfer protein 12;, PF00620;PF07647;PF01852;, GO:0005901;GO:0030864;GO:0005737;GO:0005829;GO:0005925;GO:0045121;GO:0005634;GO:0032587;GO:0005096;GO:0008289;GO:0042169;GO:0030036;GO:0006919;GO:0006915;GO:0048041;GO:0030900;GO:0003007;GO:0021575;GO:0030336;GO:0008285;GO:0051895;GO:0035024;GO:0051497;GO:0001843;GO:1900119;GO:0035307;GO:0032956;GO:0008360;GO:0035023;GO:0051056;GO:0007165;, C:caveola; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane raft; C:nucleus; C:ruffle membrane;, F:GTPase activator activity; F:lipid binding; F:SH2 domain binding;, P:actin cytoskeleton organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:focal adhesion assembly; P:forebrain development; P:heart morphogenesis; P:hindbrain morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of focal adhesion assembly; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:neural tube closure; P:positive regulation of execution phase of apoptosis; P:positive regulation of protein dephosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q86UC6 Q9C0E0 Q9H7A2,Rho GTPase-activating protein 7,Deleted in liver cancer 1 protein;HP protein;Rho-type GTPase-activating protein 7;START domain-containing protein 12;StAR-related lipid transfer protein 12;, PF00620;PF07647;PF01852;, GO:0005901;GO:0030864;GO:0005737;GO:0005829;GO:0005925;GO:0045121;GO:0005634;GO:0032587;GO:0005096;GO:0008289;GO:0042169;GO:0030036;GO:0006919;GO:0006915;GO:0048041;GO:0030900;GO:0003007;GO:0021575;GO:0030336;GO:0008285;GO:0051895;GO:0035024;GO:0051497;GO:0001843;GO:1900119;GO:0035307;GO:0032956;GO:0008360;GO:0035023;GO:0051056;GO:0007165;, C:caveola; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane raft; C:nucleus; C:ruffle membrane;, F:GTPase activator activity; F:lipid binding; F:SH2 domain binding;, P:actin cytoskeleton organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:focal adhesion assembly; P:forebrain development; P:heart morphogenesis; P:hindbrain morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of focal adhesion assembly; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:neural tube closure; P:positive regulation of execution phase of apoptosis; P:positive regulation of protein dephosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q86UC6 Q9C0E0 Q9H7A2,Rho GTPase-activating protein 7,Deleted in liver cancer 1 protein;HP protein;Rho-type GTPase-activating protein 7;START domain-containing protein 12;StAR-related lipid transfer protein 12;, PF00620;PF07647;PF01852;, GO:0005901;GO:0030864;GO:0005737;GO:0005829;GO:0005925;GO:0045121;GO:0005634;GO:0032587;GO:0005096;GO:0008289;GO:0042169;GO:0030036;GO:0006919;GO:0006915;GO:0048041;GO:0030900;GO:0003007;GO:0021575;GO:0030336;GO:0008285;GO:0051895;GO:0035024;GO:0051497;GO:0001843;GO:1900119;GO:0035307;GO:0032956;GO:0008360;GO:0035023;GO:0051056;GO:0007165;, C:caveola; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane raft; C:nucleus; C:ruffle membrane;, F:GTPase activator activity; F:lipid binding; F:SH2 domain binding;, P:actin cytoskeleton organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:focal adhesion assembly; P:forebrain development; P:heart morphogenesis; P:hindbrain morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of focal adhesion assembly; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:neural tube closure; P:positive regulation of execution phase of apoptosis; P:positive regulation of protein dephosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q86UC6 Q9C0E0 Q9H7A2,Rho GTPase-activating protein 7,Deleted in liver cancer 1 protein;HP protein;Rho-type GTPase-activating protein 7;START domain-containing protein 12;StAR-related lipid transfer protein 12;, PF00620;PF07647;PF01852;, GO:0005901;GO:0030864;GO:0005737;GO:0005829;GO:0005925;GO:0045121;GO:0005634;GO:0032587;GO:0005096;GO:0008289;GO:0042169;GO:0030036;GO:0006919;GO:0006915;GO:0048041;GO:0030900;GO:0003007;GO:0021575;GO:0030336;GO:0008285;GO:0051895;GO:0035024;GO:0051497;GO:0001843;GO:1900119;GO:0035307;GO:0032956;GO:0008360;GO:0035023;GO:0051056;GO:0007165;, C:caveola; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane raft; C:nucleus; C:ruffle membrane;, F:GTPase activator activity; F:lipid binding; F:SH2 domain binding;, P:actin cytoskeleton organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:focal adhesion assembly; P:forebrain development; P:heart morphogenesis; P:hindbrain morphogenesis; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of focal adhesion assembly; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:neural tube closure; P:positive regulation of execution phase of apoptosis; P:positive regulation of protein dephosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold26 indexed_genome mRNA 21326166 21328968 . - . ID=transcript_5941;Q96LL4 Q96LJ9,Uncharacterized protein C8orf48,, PF15379; scaffold26 indexed_genome mRNA 23056730 23269156 . + . ID=transcript_5942;Q13454 A8MSM0 D3DSP2 Q14911 Q14912 Q96FW0,Tumor suppressor candidate 3,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3;Magnesium uptake/transporter TUSC3;Protein N33;, PF04756;, GO:0005789;GO:0005887;GO:0005739;GO:0008250;GO:0005886;GO:0015095;GO:0050890;GO:0015693;GO:0006487;GO:0018279;GO:0055085;GO:0019082;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:mitochondrion; C:oligosaccharyltransferase complex; C:plasma membrane;, F:magnesium ion transmembrane transporter activity;, P:cognition; P:magnesium ion transport; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:transmembrane transport; P:viral protein processing; scaffold26 indexed_genome mRNA 23603136 23681676 . - . ID=transcript_5943;P21757 D3DSP3 O60505 P21759 Q45F10,Macrophage scavenger receptor types I and II,Macrophage acetylated LDL receptor I and II;Scavenger receptor class A member 1;, PF01391;PF03523;PF00530;, GO:0005581;GO:0030666;GO:0009897;GO:0016021;GO:0005887;GO:0034362;GO:0005886;GO:0001540;GO:0038024;GO:0030169;GO:0005044;GO:0097242;GO:0030301;GO:0010629;GO:0006911;GO:0034381;GO:0010886;GO:0010744;GO:0006898;, C:collagen trimer; C:endocytic vesicle membrane; C:external side of plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:low-density lipoprotein particle; C:plasma membrane;, F:amyloid-beta binding; F:cargo receptor activity; F:low-density lipoprotein particle binding; F:scavenger receptor activity;, P:amyloid-beta clearance; P:cholesterol transport; P:negative regulation of gene expression; P:phagocytosis, engulfment; P:plasma lipoprotein particle clearance; P:positive regulation of cholesterol storage; P:positive regulation of macrophage derived foam cell differentiation; P:receptor-mediated endocytosis;|P21757 D3DSP3 O60505 P21759 Q45F10,Macrophage scavenger receptor types I and II,Macrophage acetylated LDL receptor I and II;Scavenger receptor class A member 1;, PF01391;PF03523;PF00530;, GO:0005581;GO:0030666;GO:0009897;GO:0016021;GO:0005887;GO:0034362;GO:0005886;GO:0001540;GO:0038024;GO:0030169;GO:0005044;GO:0097242;GO:0030301;GO:0010629;GO:0006911;GO:0034381;GO:0010886;GO:0010744;GO:0006898;, C:collagen trimer; C:endocytic vesicle membrane; C:external side of plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:low-density lipoprotein particle; C:plasma membrane;, F:amyloid-beta binding; F:cargo receptor activity; F:low-density lipoprotein particle binding; F:scavenger receptor activity;, P:amyloid-beta clearance; P:cholesterol transport; P:negative regulation of gene expression; P:phagocytosis, engulfment; P:plasma lipoprotein particle clearance; P:positive regulation of cholesterol storage; P:positive regulation of macrophage derived foam cell differentiation; P:receptor-mediated endocytosis; scaffold26 indexed_genome mRNA 24310323 24315075 . - . ID=transcript_5944;Q9NP95 B2RPH5,Fibroblast growth factor 20,, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0043395;GO:0090722;GO:0005102;GO:0009887;GO:0030154;GO:0007267;GO:0008543;GO:0060113;GO:0000165;GO:0043524;GO:0008284;GO:1904340;GO:0070374;GO:0010628;GO:0051897;GO:0001934;GO:0060043;GO:0030334;GO:0014059;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparan sulfate proteoglycan binding; F:receptor-receptor interaction; F:signaling receptor binding;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:fibroblast growth factor receptor signaling pathway; P:inner ear receptor cell differentiation; P:MAPK cascade; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of dopaminergic neuron differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:regulation of cardiac muscle cell proliferation; P:regulation of cell migration; P:regulation of dopamine secretion; P:signal transduction;|Q9NP95 B2RPH5,Fibroblast growth factor 20,, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0043395;GO:0090722;GO:0005102;GO:0009887;GO:0030154;GO:0007267;GO:0008543;GO:0060113;GO:0000165;GO:0043524;GO:0008284;GO:1904340;GO:0070374;GO:0010628;GO:0051897;GO:0001934;GO:0060043;GO:0030334;GO:0014059;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparan sulfate proteoglycan binding; F:receptor-receptor interaction; F:signaling receptor binding;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:fibroblast growth factor receptor signaling pathway; P:inner ear receptor cell differentiation; P:MAPK cascade; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of dopaminergic neuron differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:regulation of cardiac muscle cell proliferation; P:regulation of cell migration; P:regulation of dopamine secretion; P:signal transduction;|Q9NP95 B2RPH5,Fibroblast growth factor 20,, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0043395;GO:0090722;GO:0005102;GO:0009887;GO:0030154;GO:0007267;GO:0008543;GO:0060113;GO:0000165;GO:0043524;GO:0008284;GO:1904340;GO:0070374;GO:0010628;GO:0051897;GO:0001934;GO:0060043;GO:0030334;GO:0014059;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparan sulfate proteoglycan binding; F:receptor-receptor interaction; F:signaling receptor binding;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:fibroblast growth factor receptor signaling pathway; P:inner ear receptor cell differentiation; P:MAPK cascade; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of dopaminergic neuron differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:regulation of cardiac muscle cell proliferation; P:regulation of cell migration; P:regulation of dopamine secretion; P:signal transduction;|Q9NP95 B2RPH5,Fibroblast growth factor 20,, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0043395;GO:0090722;GO:0005102;GO:0009887;GO:0030154;GO:0007267;GO:0008543;GO:0060113;GO:0000165;GO:0043524;GO:0008284;GO:1904340;GO:0070374;GO:0010628;GO:0051897;GO:0001934;GO:0060043;GO:0030334;GO:0014059;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparan sulfate proteoglycan binding; F:receptor-receptor interaction; F:signaling receptor binding;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:fibroblast growth factor receptor signaling pathway; P:inner ear receptor cell differentiation; P:MAPK cascade; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of dopaminergic neuron differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:regulation of cardiac muscle cell proliferation; P:regulation of cell migration; P:regulation of dopamine secretion; P:signal transduction; scaffold26 indexed_genome mRNA 24394528 24418224 . + . ID=transcript_5945;Q86XE3 Q8IYZ3,Calcium uptake protein 3, mitochondrial,EF-hand domain-containing family member A2;, PF13833;, GO:0005743;GO:1990246;GO:0005509;GO:0036444;GO:0051560;GO:0006851;, C:mitochondrial inner membrane; C:uniplex complex;, F:calcium ion binding;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport;|Q86XE3 Q8IYZ3,Calcium uptake protein 3, mitochondrial,EF-hand domain-containing family member A2;, PF13833;, GO:0005743;GO:1990246;GO:0005509;GO:0036444;GO:0051560;GO:0006851;, C:mitochondrial inner membrane; C:uniplex complex;, F:calcium ion binding;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport;|Q86XE3 Q8IYZ3,Calcium uptake protein 3, mitochondrial,EF-hand domain-containing family member A2;, PF13833;, GO:0005743;GO:1990246;GO:0005509;GO:0036444;GO:0051560;GO:0006851;, C:mitochondrial inner membrane; C:uniplex complex;, F:calcium ion binding;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport;|Q86XE3 Q8IYZ3,Calcium uptake protein 3, mitochondrial,EF-hand domain-containing family member A2;, PF13833;, GO:0005743;GO:1990246;GO:0005509;GO:0036444;GO:0051560;GO:0006851;, C:mitochondrial inner membrane; C:uniplex complex;, F:calcium ion binding;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport;|Q86XE3 Q8IYZ3,Calcium uptake protein 3, mitochondrial,EF-hand domain-containing family member A2;, PF13833;, GO:0005743;GO:1990246;GO:0005509;GO:0036444;GO:0051560;GO:0006851;, C:mitochondrial inner membrane; C:uniplex complex;, F:calcium ion binding;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport;|Q86XE3 Q8IYZ3,Calcium uptake protein 3, mitochondrial,EF-hand domain-containing family member A2;, PF13833;, GO:0005743;GO:1990246;GO:0005509;GO:0036444;GO:0051560;GO:0006851;, C:mitochondrial inner membrane; C:uniplex complex;, F:calcium ion binding;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; scaffold26 indexed_genome mRNA 24418243 24430516 . + . ID=transcript_5946;Q86XE3 Q8IYZ3,Calcium uptake protein 3, mitochondrial,EF-hand domain-containing family member A2;, PF13833;, GO:0005743;GO:1990246;GO:0005509;GO:0036444;GO:0051560;GO:0006851;, C:mitochondrial inner membrane; C:uniplex complex;, F:calcium ion binding;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport;|Q86XE3 Q8IYZ3,Calcium uptake protein 3, mitochondrial,EF-hand domain-containing family member A2;, PF13833;, GO:0005743;GO:1990246;GO:0005509;GO:0036444;GO:0051560;GO:0006851;, C:mitochondrial inner membrane; C:uniplex complex;, F:calcium ion binding;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; scaffold26 indexed_genome mRNA 24483129 24518301 . + . ID=transcript_5947;Q9UIJ5 D3DSP5,Palmitoyltransferase ZDHHC2 {ECO:0000305},Acyltransferase ZDHHC2 {ECO:0000250|UniProtKB:P59267};Reduced expression associated with metastasis protein;Reduced expression in cancer protein;Zinc finger DHHC domain-containing protein 2 {ECO:0000312|HGNC:HGNC:18469};Zinc finger protein 372;, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0005887;GO:0005886;GO:0014069;GO:0098837;GO:0055038;GO:0016409;GO:0042803;GO:0019705;GO:0019706;GO:0140439;GO:0044267;GO:0018230;GO:1904719;GO:1905751;GO:1900273;GO:0072659;GO:1903539;GO:0018345;GO:0006612;GO:0022407;GO:0048168;GO:0042176;GO:1903076;GO:0016188;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic density; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:palmitoyltransferase activity; F:protein homodimerization activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity;, P:cellular protein metabolic process; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of endosome to plasma membrane protein transport; P:positive regulation of long-term synaptic potentiation; P:protein localization to plasma membrane; P:protein localization to postsynaptic membrane; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of cell-cell adhesion; P:regulation of neuronal synaptic plasticity; P:regulation of protein catabolic process; P:regulation of protein localization to plasma membrane; P:synaptic vesicle maturation;|Q9UIJ5 D3DSP5,Palmitoyltransferase ZDHHC2 {ECO:0000305},Acyltransferase ZDHHC2 {ECO:0000250|UniProtKB:P59267};Reduced expression associated with metastasis protein;Reduced expression in cancer protein;Zinc finger DHHC domain-containing protein 2 {ECO:0000312|HGNC:HGNC:18469};Zinc finger protein 372;, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0005887;GO:0005886;GO:0014069;GO:0098837;GO:0055038;GO:0016409;GO:0042803;GO:0019705;GO:0019706;GO:0140439;GO:0044267;GO:0018230;GO:1904719;GO:1905751;GO:1900273;GO:0072659;GO:1903539;GO:0018345;GO:0006612;GO:0022407;GO:0048168;GO:0042176;GO:1903076;GO:0016188;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic density; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:palmitoyltransferase activity; F:protein homodimerization activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity;, P:cellular protein metabolic process; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of endosome to plasma membrane protein transport; P:positive regulation of long-term synaptic potentiation; P:protein localization to plasma membrane; P:protein localization to postsynaptic membrane; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of cell-cell adhesion; P:regulation of neuronal synaptic plasticity; P:regulation of protein catabolic process; P:regulation of protein localization to plasma membrane; P:synaptic vesicle maturation;|Q9UIJ5 D3DSP5,Palmitoyltransferase ZDHHC2 {ECO:0000305},Acyltransferase ZDHHC2 {ECO:0000250|UniProtKB:P59267};Reduced expression associated with metastasis protein;Reduced expression in cancer protein;Zinc finger DHHC domain-containing protein 2 {ECO:0000312|HGNC:HGNC:18469};Zinc finger protein 372;, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0005887;GO:0005886;GO:0014069;GO:0098837;GO:0055038;GO:0016409;GO:0042803;GO:0019705;GO:0019706;GO:0140439;GO:0044267;GO:0018230;GO:1904719;GO:1905751;GO:1900273;GO:0072659;GO:1903539;GO:0018345;GO:0006612;GO:0022407;GO:0048168;GO:0042176;GO:1903076;GO:0016188;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic density; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:palmitoyltransferase activity; F:protein homodimerization activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity;, P:cellular protein metabolic process; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of endosome to plasma membrane protein transport; P:positive regulation of long-term synaptic potentiation; P:protein localization to plasma membrane; P:protein localization to postsynaptic membrane; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of cell-cell adhesion; P:regulation of neuronal synaptic plasticity; P:regulation of protein catabolic process; P:regulation of protein localization to plasma membrane; P:synaptic vesicle maturation;|Q9UIJ5 D3DSP5,Palmitoyltransferase ZDHHC2 {ECO:0000305},Acyltransferase ZDHHC2 {ECO:0000250|UniProtKB:P59267};Reduced expression associated with metastasis protein;Reduced expression in cancer protein;Zinc finger DHHC domain-containing protein 2 {ECO:0000312|HGNC:HGNC:18469};Zinc finger protein 372;, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0005887;GO:0005886;GO:0014069;GO:0098837;GO:0055038;GO:0016409;GO:0042803;GO:0019705;GO:0019706;GO:0140439;GO:0044267;GO:0018230;GO:1904719;GO:1905751;GO:1900273;GO:0072659;GO:1903539;GO:0018345;GO:0006612;GO:0022407;GO:0048168;GO:0042176;GO:1903076;GO:0016188;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic density; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:palmitoyltransferase activity; F:protein homodimerization activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity;, P:cellular protein metabolic process; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of endosome to plasma membrane protein transport; P:positive regulation of long-term synaptic potentiation; P:protein localization to plasma membrane; P:protein localization to postsynaptic membrane; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of cell-cell adhesion; P:regulation of neuronal synaptic plasticity; P:regulation of protein catabolic process; P:regulation of protein localization to plasma membrane; P:synaptic vesicle maturation;|Q9UIJ5 D3DSP5,Palmitoyltransferase ZDHHC2 {ECO:0000305},Acyltransferase ZDHHC2 {ECO:0000250|UniProtKB:P59267};Reduced expression associated with metastasis protein;Reduced expression in cancer protein;Zinc finger DHHC domain-containing protein 2 {ECO:0000312|HGNC:HGNC:18469};Zinc finger protein 372;, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0005887;GO:0005886;GO:0014069;GO:0098837;GO:0055038;GO:0016409;GO:0042803;GO:0019705;GO:0019706;GO:0140439;GO:0044267;GO:0018230;GO:1904719;GO:1905751;GO:1900273;GO:0072659;GO:1903539;GO:0018345;GO:0006612;GO:0022407;GO:0048168;GO:0042176;GO:1903076;GO:0016188;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic density; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:palmitoyltransferase activity; F:protein homodimerization activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity;, P:cellular protein metabolic process; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of endosome to plasma membrane protein transport; P:positive regulation of long-term synaptic potentiation; P:protein localization to plasma membrane; P:protein localization to postsynaptic membrane; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of cell-cell adhesion; P:regulation of neuronal synaptic plasticity; P:regulation of protein catabolic process; P:regulation of protein localization to plasma membrane; P:synaptic vesicle maturation; scaffold26 indexed_genome mRNA 24520981 24537221 . - . ID=transcript_5948;Q9UIV1 A8MZM5 B3KMP1 B3KN35 D3DSP6 G3V108 Q7Z530,CCR4-NOT transcription complex subunit 7,BTG1-binding factor 1;CCR4-associated factor 1;Caf1a;, PF04857;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0016607;GO:0005634;GO:0000932;GO:0000175;GO:0004532;GO:0046872;GO:0004535;GO:0003723;GO:0003714;GO:0008134;GO:0000290;GO:0051607;GO:0006977;GO:0043928;GO:0035195;GO:0031047;GO:0008285;GO:0010629;GO:0045892;GO:0017148;GO:0060339;GO:0000289;GO:0033962;GO:0008284;GO:0061014;GO:1900153;GO:0060213;GO:0045944;GO:0045070;GO:0042509;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear speck; C:nucleus; C:P-body;, F:3'-5'-exoribonuclease activity; F:exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:defense response to virus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:exonucleolytic catabolism of deadenylated mRNA; P:gene silencing by miRNA; P:gene silencing by RNA; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of type I interferon-mediated signaling pathway; P:nuclear-transcribed mRNA poly(A) tail shortening; P:P-body assembly; P:positive regulation of cell population proliferation; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral genome replication; P:regulation of tyrosine phosphorylation of STAT protein;|Q9UIV1 A8MZM5 B3KMP1 B3KN35 D3DSP6 G3V108 Q7Z530,CCR4-NOT transcription complex subunit 7,BTG1-binding factor 1;CCR4-associated factor 1;Caf1a;, PF04857;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0016607;GO:0005634;GO:0000932;GO:0000175;GO:0004532;GO:0046872;GO:0004535;GO:0003723;GO:0003714;GO:0008134;GO:0000290;GO:0051607;GO:0006977;GO:0043928;GO:0035195;GO:0031047;GO:0008285;GO:0010629;GO:0045892;GO:0017148;GO:0060339;GO:0000289;GO:0033962;GO:0008284;GO:0061014;GO:1900153;GO:0060213;GO:0045944;GO:0045070;GO:0042509;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear speck; C:nucleus; C:P-body;, F:3'-5'-exoribonuclease activity; F:exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:defense response to virus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:exonucleolytic catabolism of deadenylated mRNA; P:gene silencing by miRNA; P:gene silencing by RNA; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of type I interferon-mediated signaling pathway; P:nuclear-transcribed mRNA poly(A) tail shortening; P:P-body assembly; P:positive regulation of cell population proliferation; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral genome replication; P:regulation of tyrosine phosphorylation of STAT protein;|Q9UIV1 A8MZM5 B3KMP1 B3KN35 D3DSP6 G3V108 Q7Z530,CCR4-NOT transcription complex subunit 7,BTG1-binding factor 1;CCR4-associated factor 1;Caf1a;, PF04857;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0016607;GO:0005634;GO:0000932;GO:0000175;GO:0004532;GO:0046872;GO:0004535;GO:0003723;GO:0003714;GO:0008134;GO:0000290;GO:0051607;GO:0006977;GO:0043928;GO:0035195;GO:0031047;GO:0008285;GO:0010629;GO:0045892;GO:0017148;GO:0060339;GO:0000289;GO:0033962;GO:0008284;GO:0061014;GO:1900153;GO:0060213;GO:0045944;GO:0045070;GO:0042509;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear speck; C:nucleus; C:P-body;, F:3'-5'-exoribonuclease activity; F:exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:defense response to virus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:exonucleolytic catabolism of deadenylated mRNA; P:gene silencing by miRNA; P:gene silencing by RNA; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of type I interferon-mediated signaling pathway; P:nuclear-transcribed mRNA poly(A) tail shortening; P:P-body assembly; P:positive regulation of cell population proliferation; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral genome replication; P:regulation of tyrosine phosphorylation of STAT protein;|Q9UIV1 A8MZM5 B3KMP1 B3KN35 D3DSP6 G3V108 Q7Z530,CCR4-NOT transcription complex subunit 7,BTG1-binding factor 1;CCR4-associated factor 1;Caf1a;, PF04857;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0016607;GO:0005634;GO:0000932;GO:0000175;GO:0004532;GO:0046872;GO:0004535;GO:0003723;GO:0003714;GO:0008134;GO:0000290;GO:0051607;GO:0006977;GO:0043928;GO:0035195;GO:0031047;GO:0008285;GO:0010629;GO:0045892;GO:0017148;GO:0060339;GO:0000289;GO:0033962;GO:0008284;GO:0061014;GO:1900153;GO:0060213;GO:0045944;GO:0045070;GO:0042509;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear speck; C:nucleus; C:P-body;, F:3'-5'-exoribonuclease activity; F:exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:defense response to virus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:exonucleolytic catabolism of deadenylated mRNA; P:gene silencing by miRNA; P:gene silencing by RNA; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of type I interferon-mediated signaling pathway; P:nuclear-transcribed mRNA poly(A) tail shortening; P:P-body assembly; P:positive regulation of cell population proliferation; P:positive regulation of mRNA catabolic process; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral genome replication; P:regulation of tyrosine phosphorylation of STAT protein; scaffold26 indexed_genome mRNA 24537260 24571136 . + . ID=transcript_5949;Q8NEZ2 Q336D5 Q6NW27 Q8N3D7 Q8TBL7 Q96DL9,Vacuolar protein sorting-associated protein 37A,ESCRT-I complex subunit VPS37A;Hepatocellular carcinoma-related protein 1;, PF07200;, GO:0005813;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0031902;GO:0005654;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;, C:centrosome; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:nucleoplasm;, , P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8NEZ2 Q336D5 Q6NW27 Q8N3D7 Q8TBL7 Q96DL9,Vacuolar protein sorting-associated protein 37A,ESCRT-I complex subunit VPS37A;Hepatocellular carcinoma-related protein 1;, PF07200;, GO:0005813;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0031902;GO:0005654;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;, C:centrosome; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:nucleoplasm;, , P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8NEZ2 Q336D5 Q6NW27 Q8N3D7 Q8TBL7 Q96DL9,Vacuolar protein sorting-associated protein 37A,ESCRT-I complex subunit VPS37A;Hepatocellular carcinoma-related protein 1;, PF07200;, GO:0005813;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0031902;GO:0005654;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;, C:centrosome; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:nucleoplasm;, , P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8NEZ2 Q336D5 Q6NW27 Q8N3D7 Q8TBL7 Q96DL9,Vacuolar protein sorting-associated protein 37A,ESCRT-I complex subunit VPS37A;Hepatocellular carcinoma-related protein 1;, PF07200;, GO:0005813;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0031902;GO:0005654;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;, C:centrosome; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:nucleoplasm;, , P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle;|Q9Y4Y9,U6 snRNA-associated Sm-like protein LSm5,, PF01423;, GO:0005737;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0071005;GO:0046540;GO:0005688;GO:0046982;GO:0003723;GO:0043928;GO:0006402;GO:0006397;GO:0000398;GO:0009617;, C:cytoplasm; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:protein heterodimerization activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA catabolic process; P:mRNA processing; P:mRNA splicing, via spliceosome; P:response to bacterium;|Q8NEZ2 Q336D5 Q6NW27 Q8N3D7 Q8TBL7 Q96DL9,Vacuolar protein sorting-associated protein 37A,ESCRT-I complex subunit VPS37A;Hepatocellular carcinoma-related protein 1;, PF07200;, GO:0005813;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0031902;GO:0005654;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;, C:centrosome; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:nucleoplasm;, , P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8NEZ2 Q336D5 Q6NW27 Q8N3D7 Q8TBL7 Q96DL9,Vacuolar protein sorting-associated protein 37A,ESCRT-I complex subunit VPS37A;Hepatocellular carcinoma-related protein 1;, PF07200;, GO:0005813;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0031902;GO:0005654;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;, C:centrosome; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:nucleoplasm;, , P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold26 indexed_genome mRNA 24571163 24632074 . - . ID=transcript_5950;Q9Y216 A1L4K9 B4DG87 Q68DX4,Myotubularin-related protein 7,Inositol 1,3-bisphosphate phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0016312;GO:0004438;GO:0004725;GO:0046855;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:inositol bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:inositol phosphate dephosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation;|Q9Y216 A1L4K9 B4DG87 Q68DX4,Myotubularin-related protein 7,Inositol 1,3-bisphosphate phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0016312;GO:0004438;GO:0004725;GO:0046855;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:inositol bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:inositol phosphate dephosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation;|Q9Y216 A1L4K9 B4DG87 Q68DX4,Myotubularin-related protein 7,Inositol 1,3-bisphosphate phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0016312;GO:0004438;GO:0004725;GO:0046855;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:inositol bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:inositol phosphate dephosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation;|Q9Y216 A1L4K9 B4DG87 Q68DX4,Myotubularin-related protein 7,Inositol 1,3-bisphosphate phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0016312;GO:0004438;GO:0004725;GO:0046855;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:inositol bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:inositol phosphate dephosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation;|Q9Y216 A1L4K9 B4DG87 Q68DX4,Myotubularin-related protein 7,Inositol 1,3-bisphosphate phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0016312;GO:0004438;GO:0004725;GO:0046855;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:inositol bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:inositol phosphate dephosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation;|Q9Y216 A1L4K9 B4DG87 Q68DX4,Myotubularin-related protein 7,Inositol 1,3-bisphosphate phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0016312;GO:0004438;GO:0004725;GO:0046855;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:inositol bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:inositol phosphate dephosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation;|Q9Y216 A1L4K9 B4DG87 Q68DX4,Myotubularin-related protein 7,Inositol 1,3-bisphosphate phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0016312;GO:0004438;GO:0004725;GO:0046855;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:inositol bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:inositol phosphate dephosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation;|Q9Y216 A1L4K9 B4DG87 Q68DX4,Myotubularin-related protein 7,Inositol 1,3-bisphosphate phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0016312;GO:0004438;GO:0004725;GO:0046855;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:inositol bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:inositol phosphate dephosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation;|Q9Y216 A1L4K9 B4DG87 Q68DX4,Myotubularin-related protein 7,Inositol 1,3-bisphosphate phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0016312;GO:0004438;GO:0004725;GO:0046855;GO:0006661;GO:0046856;GO:0006470;, C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:inositol bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:inositol phosphate dephosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; scaffold26 indexed_genome mRNA 24731550 24800009 . + . ID=transcript_5951;P52569 B7ZL54 O15291 O15292 Q14CQ6 Q6NSZ7 Q86TC6,Cationic amino acid transporter 2,Low affinity cationic amino acid transporter 2;Solute carrier family 7 member 2;, PF13520;PF13906;, GO:0030054;GO:0005887;GO:0005886;GO:0015171;GO:0015181;GO:0015174;GO:0015179;GO:0061459;GO:0015189;GO:0000064;GO:0089718;GO:0006865;GO:1902475;GO:0015807;GO:0097638;GO:1903352;GO:0150104;, C:cell junction; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:arginine transmembrane transporter activity; F:basic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-arginine transmembrane transporter activity; F:L-lysine transmembrane transporter activity; F:L-ornithine transmembrane transporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:L-alpha-amino acid transmembrane transport; P:L-amino acid transport; P:L-arginine import across plasma membrane; P:L-ornithine transmembrane transport; P:transport across blood-brain barrier;|P52569 B7ZL54 O15291 O15292 Q14CQ6 Q6NSZ7 Q86TC6,Cationic amino acid transporter 2,Low affinity cationic amino acid transporter 2;Solute carrier family 7 member 2;, PF13520;PF13906;, GO:0030054;GO:0005887;GO:0005886;GO:0015171;GO:0015181;GO:0015174;GO:0015179;GO:0061459;GO:0015189;GO:0000064;GO:0089718;GO:0006865;GO:1902475;GO:0015807;GO:0097638;GO:1903352;GO:0150104;, C:cell junction; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:arginine transmembrane transporter activity; F:basic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-arginine transmembrane transporter activity; F:L-lysine transmembrane transporter activity; F:L-ornithine transmembrane transporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:L-alpha-amino acid transmembrane transport; P:L-amino acid transport; P:L-arginine import across plasma membrane; P:L-ornithine transmembrane transport; P:transport across blood-brain barrier;|P52569 B7ZL54 O15291 O15292 Q14CQ6 Q6NSZ7 Q86TC6,Cationic amino acid transporter 2,Low affinity cationic amino acid transporter 2;Solute carrier family 7 member 2;, PF13520;PF13906;, GO:0030054;GO:0005887;GO:0005886;GO:0015171;GO:0015181;GO:0015174;GO:0015179;GO:0061459;GO:0015189;GO:0000064;GO:0089718;GO:0006865;GO:1902475;GO:0015807;GO:0097638;GO:1903352;GO:0150104;, C:cell junction; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:arginine transmembrane transporter activity; F:basic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-arginine transmembrane transporter activity; F:L-lysine transmembrane transporter activity; F:L-ornithine transmembrane transporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:L-alpha-amino acid transmembrane transport; P:L-amino acid transport; P:L-arginine import across plasma membrane; P:L-ornithine transmembrane transport; P:transport across blood-brain barrier;|P52569 B7ZL54 O15291 O15292 Q14CQ6 Q6NSZ7 Q86TC6,Cationic amino acid transporter 2,Low affinity cationic amino acid transporter 2;Solute carrier family 7 member 2;, PF13520;PF13906;, GO:0030054;GO:0005887;GO:0005886;GO:0015171;GO:0015181;GO:0015174;GO:0015179;GO:0061459;GO:0015189;GO:0000064;GO:0089718;GO:0006865;GO:1902475;GO:0015807;GO:0097638;GO:1903352;GO:0150104;, C:cell junction; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:arginine transmembrane transporter activity; F:basic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-arginine transmembrane transporter activity; F:L-lysine transmembrane transporter activity; F:L-ornithine transmembrane transporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:L-alpha-amino acid transmembrane transport; P:L-amino acid transport; P:L-arginine import across plasma membrane; P:L-ornithine transmembrane transport; P:transport across blood-brain barrier; scaffold26 indexed_genome mRNA 24808985 24887399 . + . ID=transcript_5952;Q15198 A8K085 Q6FH04,Platelet-derived growth factor receptor-like protein,PDGF receptor beta-like tumor suppressor;, , GO:0005576;GO:0004992;GO:0005019;, C:extracellular region;, F:platelet activating factor receptor activity; F:platelet-derived growth factor beta-receptor activity; scaffold26 indexed_genome mRNA 24888058 25071630 . - . ID=transcript_5953;Q6PK49 Q6URW7 Q8N4M6 Q8WTT9 Q9H7T2,Microtubule-associated tumor suppressor 1,AT2 receptor-binding protein;Angiotensin-II type 2 receptor-interacting protein;Mitochondrial tumor suppressor 1;, , GO:0005615;GO:0005794;GO:0005874;GO:0015630;GO:0005815;GO:0005739;GO:0005730;GO:0005634;GO:0005886;GO:0005819;GO:0008017;GO:0010758;, C:extracellular space; C:Golgi apparatus; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:mitochondrion; C:nucleolus; C:nucleus; C:plasma membrane; C:spindle;, F:microtubule binding;, P:regulation of macrophage chemotaxis;|Q6PK49 Q6URW7 Q8N4M6 Q8WTT9 Q9H7T2,Microtubule-associated tumor suppressor 1,AT2 receptor-binding protein;Angiotensin-II type 2 receptor-interacting protein;Mitochondrial tumor suppressor 1;, , GO:0005615;GO:0005794;GO:0005874;GO:0015630;GO:0005815;GO:0005739;GO:0005730;GO:0005634;GO:0005886;GO:0005819;GO:0008017;GO:0010758;, C:extracellular space; C:Golgi apparatus; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:mitochondrion; C:nucleolus; C:nucleus; C:plasma membrane; C:spindle;, F:microtubule binding;, P:regulation of macrophage chemotaxis;|Q6PK49 Q6URW7 Q8N4M6 Q8WTT9 Q9H7T2,Microtubule-associated tumor suppressor 1,AT2 receptor-binding protein;Angiotensin-II type 2 receptor-interacting protein;Mitochondrial tumor suppressor 1;, , GO:0005615;GO:0005794;GO:0005874;GO:0015630;GO:0005815;GO:0005739;GO:0005730;GO:0005634;GO:0005886;GO:0005819;GO:0008017;GO:0010758;, C:extracellular space; C:Golgi apparatus; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:mitochondrion; C:nucleolus; C:nucleus; C:plasma membrane; C:spindle;, F:microtubule binding;, P:regulation of macrophage chemotaxis;|Q6PK49 Q6URW7 Q8N4M6 Q8WTT9 Q9H7T2,Microtubule-associated tumor suppressor 1,AT2 receptor-binding protein;Angiotensin-II type 2 receptor-interacting protein;Mitochondrial tumor suppressor 1;, , GO:0005615;GO:0005794;GO:0005874;GO:0015630;GO:0005815;GO:0005739;GO:0005730;GO:0005634;GO:0005886;GO:0005819;GO:0008017;GO:0010758;, C:extracellular space; C:Golgi apparatus; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:mitochondrion; C:nucleolus; C:nucleus; C:plasma membrane; C:spindle;, F:microtubule binding;, P:regulation of macrophage chemotaxis;|Q6PK49 Q6URW7 Q8N4M6 Q8WTT9 Q9H7T2,Microtubule-associated tumor suppressor 1,AT2 receptor-binding protein;Angiotensin-II type 2 receptor-interacting protein;Mitochondrial tumor suppressor 1;, , GO:0005615;GO:0005794;GO:0005874;GO:0015630;GO:0005815;GO:0005739;GO:0005730;GO:0005634;GO:0005886;GO:0005819;GO:0008017;GO:0010758;, C:extracellular space; C:Golgi apparatus; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:mitochondrion; C:nucleolus; C:nucleus; C:plasma membrane; C:spindle;, F:microtubule binding;, P:regulation of macrophage chemotaxis;|Q6PK49 Q6URW7 Q8N4M6 Q8WTT9 Q9H7T2,Microtubule-associated tumor suppressor 1,AT2 receptor-binding protein;Angiotensin-II type 2 receptor-interacting protein;Mitochondrial tumor suppressor 1;, , GO:0005615;GO:0005794;GO:0005874;GO:0015630;GO:0005815;GO:0005739;GO:0005730;GO:0005634;GO:0005886;GO:0005819;GO:0008017;GO:0010758;, C:extracellular space; C:Golgi apparatus; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:mitochondrion; C:nucleolus; C:nucleus; C:plasma membrane; C:spindle;, F:microtubule binding;, P:regulation of macrophage chemotaxis; scaffold26 indexed_genome mRNA 25113224 25142100 . - . ID=transcript_5954;Q08830 A6NKU4 Q4PJH9 Q53YF1 Q8NG32 Q96KW6 Q96QM6,Fibrinogen-like protein 1 {ECO:0000303|PubMed:18039467},HP-041 {ECO:0000303|PubMed:11470158};Hepassocin {ECO:0000303|PubMed:11470158};Hepatocyte-derived fibrinogen-related protein 1 {ECO:0000303|PubMed:8390249};Liver fibrinogen-related protein 1 {ECO:0000303|Ref.3};, PF00147;, GO:0062023;GO:0005576;GO:0005615;GO:0005577;GO:0005102;GO:0002250;GO:0072574;GO:0050868;GO:0050776;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex;, F:signaling receptor binding;, P:adaptive immune response; P:hepatocyte proliferation; P:negative regulation of T cell activation; P:regulation of immune response; scaffold26 indexed_genome mRNA 25157360 25311725 . + . ID=transcript_5955;Q13510 E9PDS0 Q6W898 Q96AS2,Acid ceramidase {ECO:0000303|PubMed:29692406, ECO:0000303|PubMed:8955159, ECO:0000305},Acylsphingosine deacylase;N-acylethanolamine hydrolase ASAH1 {ECO:0000305|PubMed:15655246};N-acylsphingosine amidohydrolase;Putative 32 kDa heart protein;, PF02275;PF15508;, GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005764;GO:0005634;GO:1904724;GO:0102121;GO:0017064;GO:0016810;GO:0016811;GO:0017040;GO:0016922;GO:0003714;GO:0071356;GO:0046513;GO:0046514;GO:0006631;GO:0006687;GO:0030216;GO:1903507;GO:0043312;GO:0062098;GO:0050810;GO:0046512;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosome; C:nucleus; C:tertiary granule lumen;, F:ceramidase activity; F:fatty acid amide hydrolase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acylsphingosine amidohydrolase activity; F:nuclear receptor binding; F:transcription corepressor activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:ceramide catabolic process; P:fatty acid metabolic process; P:glycosphingolipid metabolic process; P:keratinocyte differentiation; P:negative regulation of nucleic acid-templated transcription; P:neutrophil degranulation; P:regulation of programmed necrotic cell death; P:regulation of steroid biosynthetic process; P:sphingosine biosynthetic process;|Q9H4A2,Pericentriolar material 1 protein,, PF15717;, GO:0045177;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0035869;GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0000242;GO:0032991;GO:0042802;GO:0007098;GO:0097711;GO:0060271;GO:0031122;GO:0000086;GO:0022027;GO:0035735;GO:0034453;GO:0034454;GO:0050768;GO:0001764;GO:0097150;GO:1905515;GO:0090316;GO:0071539;GO:0010389;GO:0035176;, C:apical part of cell; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:pericentriolar material; C:protein-containing complex;, F:identical protein binding;, P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:cytoplasmic microtubule organization; P:G2/M transition of mitotic cell cycle; P:interkinetic nuclear migration; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring; P:microtubule anchoring at centrosome; P:negative regulation of neurogenesis; P:neuron migration; P:neuronal stem cell population maintenance; P:non-motile cilium assembly; P:positive regulation of intracellular protein transport; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; P:social behavior;|Q9H4A2,Pericentriolar material 1 protein,, PF15717;, GO:0045177;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0035869;GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0000242;GO:0032991;GO:0042802;GO:0007098;GO:0097711;GO:0060271;GO:0031122;GO:0000086;GO:0022027;GO:0035735;GO:0034453;GO:0034454;GO:0050768;GO:0001764;GO:0097150;GO:1905515;GO:0090316;GO:0071539;GO:0010389;GO:0035176;, C:apical part of cell; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:pericentriolar material; C:protein-containing complex;, F:identical protein binding;, P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:cytoplasmic microtubule organization; P:G2/M transition of mitotic cell cycle; P:interkinetic nuclear migration; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring; P:microtubule anchoring at centrosome; P:negative regulation of neurogenesis; P:neuron migration; P:neuronal stem cell population maintenance; P:non-motile cilium assembly; P:positive regulation of intracellular protein transport; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; P:social behavior;|Q9H4A2,Pericentriolar material 1 protein,, PF15717;, GO:0045177;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0035869;GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0000242;GO:0032991;GO:0042802;GO:0007098;GO:0097711;GO:0060271;GO:0031122;GO:0000086;GO:0022027;GO:0035735;GO:0034453;GO:0034454;GO:0050768;GO:0001764;GO:0097150;GO:1905515;GO:0090316;GO:0071539;GO:0010389;GO:0035176;, C:apical part of cell; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:pericentriolar material; C:protein-containing complex;, F:identical protein binding;, P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:cytoplasmic microtubule organization; P:G2/M transition of mitotic cell cycle; P:interkinetic nuclear migration; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring; P:microtubule anchoring at centrosome; P:negative regulation of neurogenesis; P:neuron migration; P:neuronal stem cell population maintenance; P:non-motile cilium assembly; P:positive regulation of intracellular protein transport; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; P:social behavior;|Q9H4A2,Pericentriolar material 1 protein,, PF15717;, GO:0045177;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0035869;GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0000242;GO:0032991;GO:0042802;GO:0007098;GO:0097711;GO:0060271;GO:0031122;GO:0000086;GO:0022027;GO:0035735;GO:0034453;GO:0034454;GO:0050768;GO:0001764;GO:0097150;GO:1905515;GO:0090316;GO:0071539;GO:0010389;GO:0035176;, C:apical part of cell; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:pericentriolar material; C:protein-containing complex;, F:identical protein binding;, P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:cytoplasmic microtubule organization; P:G2/M transition of mitotic cell cycle; P:interkinetic nuclear migration; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring; P:microtubule anchoring at centrosome; P:negative regulation of neurogenesis; P:neuron migration; P:neuronal stem cell population maintenance; P:non-motile cilium assembly; P:positive regulation of intracellular protein transport; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; P:social behavior;|Q9H4A2,Pericentriolar material 1 protein,, PF15717;, GO:0045177;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0035869;GO:0005737;GO:0005829;GO:0016020;GO:0031965;GO:0000242;GO:0032991;GO:0042802;GO:0007098;GO:0097711;GO:0060271;GO:0031122;GO:0000086;GO:0022027;GO:0035735;GO:0034453;GO:0034454;GO:0050768;GO:0001764;GO:0097150;GO:1905515;GO:0090316;GO:0071539;GO:0010389;GO:0035176;, C:apical part of cell; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:membrane; C:nuclear membrane; C:pericentriolar material; C:protein-containing complex;, F:identical protein binding;, P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:cytoplasmic microtubule organization; P:G2/M transition of mitotic cell cycle; P:interkinetic nuclear migration; P:intraciliary transport involved in cilium assembly; P:microtubule anchoring; P:microtubule anchoring at centrosome; P:negative regulation of neurogenesis; P:neuron migration; P:neuronal stem cell population maintenance; P:non-motile cilium assembly; P:positive regulation of intracellular protein transport; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; P:social behavior;|Q13510 E9PDS0 Q6W898 Q96AS2,Acid ceramidase {ECO:0000303|PubMed:29692406, ECO:0000303|PubMed:8955159, ECO:0000305},Acylsphingosine deacylase;N-acylethanolamine hydrolase ASAH1 {ECO:0000305|PubMed:15655246};N-acylsphingosine amidohydrolase;Putative 32 kDa heart protein;, PF02275;PF15508;, GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005764;GO:0005634;GO:1904724;GO:0102121;GO:0017064;GO:0016810;GO:0016811;GO:0017040;GO:0016922;GO:0003714;GO:0071356;GO:0046513;GO:0046514;GO:0006631;GO:0006687;GO:0030216;GO:1903507;GO:0043312;GO:0062098;GO:0050810;GO:0046512;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosome; C:nucleus; C:tertiary granule lumen;, F:ceramidase activity; F:fatty acid amide hydrolase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acylsphingosine amidohydrolase activity; F:nuclear receptor binding; F:transcription corepressor activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:ceramide catabolic process; P:fatty acid metabolic process; P:glycosphingolipid metabolic process; P:keratinocyte differentiation; P:negative regulation of nucleic acid-templated transcription; P:neutrophil degranulation; P:regulation of programmed necrotic cell death; P:regulation of steroid biosynthetic process; P:sphingosine biosynthetic process;|Q13510 E9PDS0 Q6W898 Q96AS2,Acid ceramidase {ECO:0000303|PubMed:29692406, ECO:0000303|PubMed:8955159, ECO:0000305},Acylsphingosine deacylase;N-acylethanolamine hydrolase ASAH1 {ECO:0000305|PubMed:15655246};N-acylsphingosine amidohydrolase;Putative 32 kDa heart protein;, PF02275;PF15508;, GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005764;GO:0005634;GO:1904724;GO:0102121;GO:0017064;GO:0016810;GO:0016811;GO:0017040;GO:0016922;GO:0003714;GO:0071356;GO:0046513;GO:0046514;GO:0006631;GO:0006687;GO:0030216;GO:1903507;GO:0043312;GO:0062098;GO:0050810;GO:0046512;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosome; C:nucleus; C:tertiary granule lumen;, F:ceramidase activity; F:fatty acid amide hydrolase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acylsphingosine amidohydrolase activity; F:nuclear receptor binding; F:transcription corepressor activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:ceramide catabolic process; P:fatty acid metabolic process; P:glycosphingolipid metabolic process; P:keratinocyte differentiation; P:negative regulation of nucleic acid-templated transcription; P:neutrophil degranulation; P:regulation of programmed necrotic cell death; P:regulation of steroid biosynthetic process; P:sphingosine biosynthetic process;|Q13510 E9PDS0 Q6W898 Q96AS2,Acid ceramidase {ECO:0000303|PubMed:29692406, ECO:0000303|PubMed:8955159, ECO:0000305},Acylsphingosine deacylase;N-acylethanolamine hydrolase ASAH1 {ECO:0000305|PubMed:15655246};N-acylsphingosine amidohydrolase;Putative 32 kDa heart protein;, PF02275;PF15508;, GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005764;GO:0005634;GO:1904724;GO:0102121;GO:0017064;GO:0016810;GO:0016811;GO:0017040;GO:0016922;GO:0003714;GO:0071356;GO:0046513;GO:0046514;GO:0006631;GO:0006687;GO:0030216;GO:1903507;GO:0043312;GO:0062098;GO:0050810;GO:0046512;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosome; C:nucleus; C:tertiary granule lumen;, F:ceramidase activity; F:fatty acid amide hydrolase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acylsphingosine amidohydrolase activity; F:nuclear receptor binding; F:transcription corepressor activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:ceramide catabolic process; P:fatty acid metabolic process; P:glycosphingolipid metabolic process; P:keratinocyte differentiation; P:negative regulation of nucleic acid-templated transcription; P:neutrophil degranulation; P:regulation of programmed necrotic cell death; P:regulation of steroid biosynthetic process; P:sphingosine biosynthetic process;|Q13510 E9PDS0 Q6W898 Q96AS2,Acid ceramidase {ECO:0000303|PubMed:29692406, ECO:0000303|PubMed:8955159, ECO:0000305},Acylsphingosine deacylase;N-acylethanolamine hydrolase ASAH1 {ECO:0000305|PubMed:15655246};N-acylsphingosine amidohydrolase;Putative 32 kDa heart protein;, PF02275;PF15508;, GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005764;GO:0005634;GO:1904724;GO:0102121;GO:0017064;GO:0016810;GO:0016811;GO:0017040;GO:0016922;GO:0003714;GO:0071356;GO:0046513;GO:0046514;GO:0006631;GO:0006687;GO:0030216;GO:1903507;GO:0043312;GO:0062098;GO:0050810;GO:0046512;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosome; C:nucleus; C:tertiary granule lumen;, F:ceramidase activity; F:fatty acid amide hydrolase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acylsphingosine amidohydrolase activity; F:nuclear receptor binding; F:transcription corepressor activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:ceramide catabolic process; P:fatty acid metabolic process; P:glycosphingolipid metabolic process; P:keratinocyte differentiation; P:negative regulation of nucleic acid-templated transcription; P:neutrophil degranulation; P:regulation of programmed necrotic cell death; P:regulation of steroid biosynthetic process; P:sphingosine biosynthetic process;|Q13510 E9PDS0 Q6W898 Q96AS2,Acid ceramidase {ECO:0000303|PubMed:29692406, ECO:0000303|PubMed:8955159, ECO:0000305},Acylsphingosine deacylase;N-acylethanolamine hydrolase ASAH1 {ECO:0000305|PubMed:15655246};N-acylsphingosine amidohydrolase;Putative 32 kDa heart protein;, PF02275;PF15508;, GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005764;GO:0005634;GO:1904724;GO:0102121;GO:0017064;GO:0016810;GO:0016811;GO:0017040;GO:0016922;GO:0003714;GO:0071356;GO:0046513;GO:0046514;GO:0006631;GO:0006687;GO:0030216;GO:1903507;GO:0043312;GO:0062098;GO:0050810;GO:0046512;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosome; C:nucleus; C:tertiary granule lumen;, F:ceramidase activity; F:fatty acid amide hydrolase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acylsphingosine amidohydrolase activity; F:nuclear receptor binding; F:transcription corepressor activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:ceramide catabolic process; P:fatty acid metabolic process; P:glycosphingolipid metabolic process; P:keratinocyte differentiation; P:negative regulation of nucleic acid-templated transcription; P:neutrophil degranulation; P:regulation of programmed necrotic cell death; P:regulation of steroid biosynthetic process; P:sphingosine biosynthetic process;|Q13510 E9PDS0 Q6W898 Q96AS2,Acid ceramidase {ECO:0000303|PubMed:29692406, ECO:0000303|PubMed:8955159, ECO:0000305},Acylsphingosine deacylase;N-acylethanolamine hydrolase ASAH1 {ECO:0000305|PubMed:15655246};N-acylsphingosine amidohydrolase;Putative 32 kDa heart protein;, PF02275;PF15508;, GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005764;GO:0005634;GO:1904724;GO:0102121;GO:0017064;GO:0016810;GO:0016811;GO:0017040;GO:0016922;GO:0003714;GO:0071356;GO:0046513;GO:0046514;GO:0006631;GO:0006687;GO:0030216;GO:1903507;GO:0043312;GO:0062098;GO:0050810;GO:0046512;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosome; C:nucleus; C:tertiary granule lumen;, F:ceramidase activity; F:fatty acid amide hydrolase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acylsphingosine amidohydrolase activity; F:nuclear receptor binding; F:transcription corepressor activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:ceramide catabolic process; P:fatty acid metabolic process; P:glycosphingolipid metabolic process; P:keratinocyte differentiation; P:negative regulation of nucleic acid-templated transcription; P:neutrophil degranulation; P:regulation of programmed necrotic cell death; P:regulation of steroid biosynthetic process; P:sphingosine biosynthetic process;|Q13510 E9PDS0 Q6W898 Q96AS2,Acid ceramidase {ECO:0000303|PubMed:29692406, ECO:0000303|PubMed:8955159, ECO:0000305},Acylsphingosine deacylase;N-acylethanolamine hydrolase ASAH1 {ECO:0000305|PubMed:15655246};N-acylsphingosine amidohydrolase;Putative 32 kDa heart protein;, PF02275;PF15508;, GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005764;GO:0005634;GO:1904724;GO:0102121;GO:0017064;GO:0016810;GO:0016811;GO:0017040;GO:0016922;GO:0003714;GO:0071356;GO:0046513;GO:0046514;GO:0006631;GO:0006687;GO:0030216;GO:1903507;GO:0043312;GO:0062098;GO:0050810;GO:0046512;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosome; C:nucleus; C:tertiary granule lumen;, F:ceramidase activity; F:fatty acid amide hydrolase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acylsphingosine amidohydrolase activity; F:nuclear receptor binding; F:transcription corepressor activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:ceramide catabolic process; P:fatty acid metabolic process; P:glycosphingolipid metabolic process; P:keratinocyte differentiation; P:negative regulation of nucleic acid-templated transcription; P:neutrophil degranulation; P:regulation of programmed necrotic cell death; P:regulation of steroid biosynthetic process; P:sphingosine biosynthetic process; scaffold26 indexed_genome mRNA 25314548 25315783 . - . ID=transcript_5956;Q9HB71 B2ZWH2 B3KSF1 O60666 Q5R370 Q5R371,Calcyclin-binding protein,S100A6-binding protein;Siah-interacting protein;, PF04969;PF05002;PF09032;, GO:0030877;GO:0044297;GO:0005829;GO:0070062;GO:0043005;GO:0005641;GO:0005654;GO:0005634;GO:0019005;GO:0019904;GO:0042803;GO:0044548;GO:0015631;GO:0031625;GO:0007568;GO:0055007;GO:0071277;GO:1990830;GO:0007507;GO:0060548;GO:0045740;GO:0060416;, C:beta-catenin destruction complex; C:cell body; C:cytosol; C:extracellular exosome; C:neuron projection; C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:protein domain specific binding; F:protein homodimerization activity; F:S100 protein binding; F:tubulin binding; F:ubiquitin protein ligase binding;, P:aging; P:cardiac muscle cell differentiation; P:cellular response to calcium ion; P:cellular response to leukemia inhibitory factor; P:heart development; P:negative regulation of cell death; P:positive regulation of DNA replication; P:response to growth hormone; scaffold26 indexed_genome mRNA 25330884 25333080 . - . ID=transcript_5957;Q14331 A8K775,Protein FRG1,FSHD region gene 1 protein;, PF06229;, GO:0015030;GO:0071013;GO:0005730;GO:0055120;GO:0030018;GO:0051015;GO:0003723;GO:0000398;GO:0007517;GO:0006364;, C:Cajal body; C:catalytic step 2 spliceosome; C:nucleolus; C:striated muscle dense body; C:Z disc;, F:actin filament binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:muscle organ development; P:rRNA processing; scaffold26 indexed_genome mRNA 27845205 27971579 . + . ID=transcript_5958;Q14517,Protocadherin Fat 1,Cadherin family member 7;Cadherin-related tumor suppressor homolog;Protein fat homolog;, PF00028;PF00008;PF02210;, GO:0005911;GO:0070062;GO:0005925;GO:0005887;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0007015;GO:0009653;GO:0007155;GO:0016477;GO:0098609;GO:0007267;GO:0007163;GO:0007156;, C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding;, P:actin filament organization; P:anatomical structure morphogenesis; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-cell signaling; P:establishment or maintenance of cell polarity; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q14517,Protocadherin Fat 1,Cadherin family member 7;Cadherin-related tumor suppressor homolog;Protein fat homolog;, PF00028;PF00008;PF02210;, GO:0005911;GO:0070062;GO:0005925;GO:0005887;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0007015;GO:0009653;GO:0007155;GO:0016477;GO:0098609;GO:0007267;GO:0007163;GO:0007156;, C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding;, P:actin filament organization; P:anatomical structure morphogenesis; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-cell signaling; P:establishment or maintenance of cell polarity; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q14517,Protocadherin Fat 1,Cadherin family member 7;Cadherin-related tumor suppressor homolog;Protein fat homolog;, PF00028;PF00008;PF02210;, GO:0005911;GO:0070062;GO:0005925;GO:0005887;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0007015;GO:0009653;GO:0007155;GO:0016477;GO:0098609;GO:0007267;GO:0007163;GO:0007156;, C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding;, P:actin filament organization; P:anatomical structure morphogenesis; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-cell signaling; P:establishment or maintenance of cell polarity; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q14517,Protocadherin Fat 1,Cadherin family member 7;Cadherin-related tumor suppressor homolog;Protein fat homolog;, PF00028;PF00008;PF02210;, GO:0005911;GO:0070062;GO:0005925;GO:0005887;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0007015;GO:0009653;GO:0007155;GO:0016477;GO:0098609;GO:0007267;GO:0007163;GO:0007156;, C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding;, P:actin filament organization; P:anatomical structure morphogenesis; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-cell signaling; P:establishment or maintenance of cell polarity; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q14517,Protocadherin Fat 1,Cadherin family member 7;Cadherin-related tumor suppressor homolog;Protein fat homolog;, PF00028;PF00008;PF02210;, GO:0005911;GO:0070062;GO:0005925;GO:0005887;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0007015;GO:0009653;GO:0007155;GO:0016477;GO:0098609;GO:0007267;GO:0007163;GO:0007156;, C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding;, P:actin filament organization; P:anatomical structure morphogenesis; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-cell signaling; P:establishment or maintenance of cell polarity; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q14517,Protocadherin Fat 1,Cadherin family member 7;Cadherin-related tumor suppressor homolog;Protein fat homolog;, PF00028;PF00008;PF02210;, GO:0005911;GO:0070062;GO:0005925;GO:0005887;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0007015;GO:0009653;GO:0007155;GO:0016477;GO:0098609;GO:0007267;GO:0007163;GO:0007156;, C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding;, P:actin filament organization; P:anatomical structure morphogenesis; P:cell adhesion; P:cell migration; P:cell-cell adhesion; P:cell-cell signaling; P:establishment or maintenance of cell polarity; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold26 indexed_genome mRNA 28077690 28108049 . - . ID=transcript_5959;P03951 D3DP64 Q4W5C2 Q9Y495,Coagulation factor XI,Plasma thromboplastin antecedent;, PF00024;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005886;GO:0008201;GO:0042802;GO:0070009;GO:0004252;GO:0007596;GO:0007597;GO:0031639;GO:0051919;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:plasma membrane;, F:heparin binding; F:identical protein binding; F:serine-type aminopeptidase activity; F:serine-type endopeptidase activity;, P:blood coagulation; P:blood coagulation, intrinsic pathway; P:plasminogen activation; P:positive regulation of fibrinolysis; scaffold26 indexed_genome mRNA 28111468 28126626 . - . ID=transcript_5960;P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3,Plasma kallikrein,Fletcher factor;Kininogenin;Plasma prekallikrein;, PF00024;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004252;GO:0007597;GO:0022617;GO:0002542;GO:0042730;GO:2000267;GO:0031639;GO:0051919;GO:0006508;GO:0031638;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase activity;, P:blood coagulation, intrinsic pathway; P:extracellular matrix disassembly; P:Factor XII activation; P:fibrinolysis; P:negative regulation of blood coagulation, intrinsic pathway; P:plasminogen activation; P:positive regulation of fibrinolysis; P:proteolysis; P:zymogen activation;|P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3,Plasma kallikrein,Fletcher factor;Kininogenin;Plasma prekallikrein;, PF00024;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004252;GO:0007597;GO:0022617;GO:0002542;GO:0042730;GO:2000267;GO:0031639;GO:0051919;GO:0006508;GO:0031638;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase activity;, P:blood coagulation, intrinsic pathway; P:extracellular matrix disassembly; P:Factor XII activation; P:fibrinolysis; P:negative regulation of blood coagulation, intrinsic pathway; P:plasminogen activation; P:positive regulation of fibrinolysis; P:proteolysis; P:zymogen activation;|P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3,Plasma kallikrein,Fletcher factor;Kininogenin;Plasma prekallikrein;, PF00024;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004252;GO:0007597;GO:0022617;GO:0002542;GO:0042730;GO:2000267;GO:0031639;GO:0051919;GO:0006508;GO:0031638;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase activity;, P:blood coagulation, intrinsic pathway; P:extracellular matrix disassembly; P:Factor XII activation; P:fibrinolysis; P:negative regulation of blood coagulation, intrinsic pathway; P:plasminogen activation; P:positive regulation of fibrinolysis; P:proteolysis; P:zymogen activation;|P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3,Plasma kallikrein,Fletcher factor;Kininogenin;Plasma prekallikrein;, PF00024;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004252;GO:0007597;GO:0022617;GO:0002542;GO:0042730;GO:2000267;GO:0031639;GO:0051919;GO:0006508;GO:0031638;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase activity;, P:blood coagulation, intrinsic pathway; P:extracellular matrix disassembly; P:Factor XII activation; P:fibrinolysis; P:negative regulation of blood coagulation, intrinsic pathway; P:plasminogen activation; P:positive regulation of fibrinolysis; P:proteolysis; P:zymogen activation;|P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3,Plasma kallikrein,Fletcher factor;Kininogenin;Plasma prekallikrein;, PF00024;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004252;GO:0007597;GO:0022617;GO:0002542;GO:0042730;GO:2000267;GO:0031639;GO:0051919;GO:0006508;GO:0031638;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase activity;, P:blood coagulation, intrinsic pathway; P:extracellular matrix disassembly; P:Factor XII activation; P:fibrinolysis; P:negative regulation of blood coagulation, intrinsic pathway; P:plasminogen activation; P:positive regulation of fibrinolysis; P:proteolysis; P:zymogen activation; scaffold26 indexed_genome mRNA 28136329 28147959 . - . ID=transcript_5961;Q6ZWL3 B7U6W2 Q6ZTM4,Cytochrome P450 4V2,Docosahexaenoic acid omega-hydroxylase CYP4V2 {ECO:0000305|PubMed:22772592};Long-chain fatty acid omega-monooxygenase {ECO:0000305|PubMed:19661213};, PF00067;, GO:0005789;GO:0016021;GO:0020037;GO:0005506;GO:0102033;GO:0004497;GO:0010430;GO:0050896;GO:0001523;GO:0016125;GO:0007601;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:heme binding; F:iron ion binding; F:long-chain fatty acid omega-hydroxylase activity; F:monooxygenase activity;, P:fatty acid omega-oxidation; P:response to stimulus; P:retinoid metabolic process; P:sterol metabolic process; P:visual perception;|Q6ZWL3 B7U6W2 Q6ZTM4,Cytochrome P450 4V2,Docosahexaenoic acid omega-hydroxylase CYP4V2 {ECO:0000305|PubMed:22772592};Long-chain fatty acid omega-monooxygenase {ECO:0000305|PubMed:19661213};, PF00067;, GO:0005789;GO:0016021;GO:0020037;GO:0005506;GO:0102033;GO:0004497;GO:0010430;GO:0050896;GO:0001523;GO:0016125;GO:0007601;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:heme binding; F:iron ion binding; F:long-chain fatty acid omega-hydroxylase activity; F:monooxygenase activity;, P:fatty acid omega-oxidation; P:response to stimulus; P:retinoid metabolic process; P:sterol metabolic process; P:visual perception;|Q6ZWL3 B7U6W2 Q6ZTM4,Cytochrome P450 4V2,Docosahexaenoic acid omega-hydroxylase CYP4V2 {ECO:0000305|PubMed:22772592};Long-chain fatty acid omega-monooxygenase {ECO:0000305|PubMed:19661213};, PF00067;, GO:0005789;GO:0016021;GO:0020037;GO:0005506;GO:0102033;GO:0004497;GO:0010430;GO:0050896;GO:0001523;GO:0016125;GO:0007601;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:heme binding; F:iron ion binding; F:long-chain fatty acid omega-hydroxylase activity; F:monooxygenase activity;, P:fatty acid omega-oxidation; P:response to stimulus; P:retinoid metabolic process; P:sterol metabolic process; P:visual perception;|Q6ZWL3 B7U6W2 Q6ZTM4,Cytochrome P450 4V2,Docosahexaenoic acid omega-hydroxylase CYP4V2 {ECO:0000305|PubMed:22772592};Long-chain fatty acid omega-monooxygenase {ECO:0000305|PubMed:19661213};, PF00067;, GO:0005789;GO:0016021;GO:0020037;GO:0005506;GO:0102033;GO:0004497;GO:0010430;GO:0050896;GO:0001523;GO:0016125;GO:0007601;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:heme binding; F:iron ion binding; F:long-chain fatty acid omega-hydroxylase activity; F:monooxygenase activity;, P:fatty acid omega-oxidation; P:response to stimulus; P:retinoid metabolic process; P:sterol metabolic process; P:visual perception; scaffold26 indexed_genome mRNA 28149587 28194059 . + . ID=transcript_5962;Q6ZWL3 B7U6W2 Q6ZTM4,Cytochrome P450 4V2,Docosahexaenoic acid omega-hydroxylase CYP4V2 {ECO:0000305|PubMed:22772592};Long-chain fatty acid omega-monooxygenase {ECO:0000305|PubMed:19661213};, PF00067;, GO:0005789;GO:0016021;GO:0020037;GO:0005506;GO:0102033;GO:0004497;GO:0010430;GO:0050896;GO:0001523;GO:0016125;GO:0007601;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:heme binding; F:iron ion binding; F:long-chain fatty acid omega-hydroxylase activity; F:monooxygenase activity;, P:fatty acid omega-oxidation; P:response to stimulus; P:retinoid metabolic process; P:sterol metabolic process; P:visual perception;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516;|A5PLN7 B5MDB8 Q2TAN6 Q7Z2S5 Q9Y4T9,Protein FAM149A,, PF12516; scaffold26 indexed_genome mRNA 28207722 28228270 . - . ID=transcript_5963;O15455 B2RAI7 B7Z7K0 E6Y0F0 E6Y0F1 E9PGH4 Q4VAL2 Q504W0,Toll-like receptor 3,, PF13516;PF13855;PF01582;PF17968;, GO:0005737;GO:0005769;GO:0036020;GO:0005789;GO:0010008;GO:0031012;GO:0005615;GO:0000139;GO:0005887;GO:0005765;GO:0016020;GO:0003725;GO:0042802;GO:0038023;GO:0004888;GO:0007250;GO:0097190;GO:0035690;GO:0071360;GO:0035458;GO:0071346;GO:0071260;GO:0042742;GO:0051607;GO:0009597;GO:0097191;GO:0006972;GO:0007249;GO:0007252;GO:0006954;GO:0045087;GO:0008584;GO:0001774;GO:0002756;GO:0070266;GO:0097527;GO:0034128;GO:0045671;GO:0045766;GO:0043065;GO:0032722;GO:0010628;GO:0043123;GO:0050729;GO:0032727;GO:0032728;GO:0032729;GO:0032735;GO:0032755;GO:0032757;GO:0046330;GO:0051092;GO:1901224;GO:0034123;GO:0045944;GO:0032760;GO:0034346;GO:0002730;GO:0043331;GO:0043330;GO:0007165;GO:0034138;GO:0002224;GO:0035666;, C:cytoplasm; C:early endosome; C:endolysosome membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular matrix; C:extracellular space; C:Golgi membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane;, F:double-stranded RNA binding; F:identical protein binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic signaling pathway; P:cellular response to drug; P:cellular response to exogenous dsRNA; P:cellular response to interferon-beta; P:cellular response to interferon-gamma; P:cellular response to mechanical stimulus; P:defense response to bacterium; P:defense response to virus; P:detection of virus; P:extrinsic apoptotic signaling pathway; P:hyperosmotic response; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:inflammatory response; P:innate immune response; P:male gonad development; P:microglial cell activation; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of MyD88-independent toll-like receptor signaling pathway; P:negative regulation of osteoclast differentiation; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of chemokine production; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of toll-like receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type III interferon production; P:regulation of dendritic cell cytokine production; P:response to dsRNA; P:response to exogenous dsRNA; P:signal transduction; P:toll-like receptor 3 signaling pathway; P:toll-like receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway;|O15455 B2RAI7 B7Z7K0 E6Y0F0 E6Y0F1 E9PGH4 Q4VAL2 Q504W0,Toll-like receptor 3,, PF13516;PF13855;PF01582;PF17968;, GO:0005737;GO:0005769;GO:0036020;GO:0005789;GO:0010008;GO:0031012;GO:0005615;GO:0000139;GO:0005887;GO:0005765;GO:0016020;GO:0003725;GO:0042802;GO:0038023;GO:0004888;GO:0007250;GO:0097190;GO:0035690;GO:0071360;GO:0035458;GO:0071346;GO:0071260;GO:0042742;GO:0051607;GO:0009597;GO:0097191;GO:0006972;GO:0007249;GO:0007252;GO:0006954;GO:0045087;GO:0008584;GO:0001774;GO:0002756;GO:0070266;GO:0097527;GO:0034128;GO:0045671;GO:0045766;GO:0043065;GO:0032722;GO:0010628;GO:0043123;GO:0050729;GO:0032727;GO:0032728;GO:0032729;GO:0032735;GO:0032755;GO:0032757;GO:0046330;GO:0051092;GO:1901224;GO:0034123;GO:0045944;GO:0032760;GO:0034346;GO:0002730;GO:0043331;GO:0043330;GO:0007165;GO:0034138;GO:0002224;GO:0035666;, C:cytoplasm; C:early endosome; C:endolysosome membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular matrix; C:extracellular space; C:Golgi membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane;, F:double-stranded RNA binding; F:identical protein binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic signaling pathway; P:cellular response to drug; P:cellular response to exogenous dsRNA; P:cellular response to interferon-beta; P:cellular response to interferon-gamma; P:cellular response to mechanical stimulus; P:defense response to bacterium; P:defense response to virus; P:detection of virus; P:extrinsic apoptotic signaling pathway; P:hyperosmotic response; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:inflammatory response; P:innate immune response; P:male gonad development; P:microglial cell activation; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of MyD88-independent toll-like receptor signaling pathway; P:negative regulation of osteoclast differentiation; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of chemokine production; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of toll-like receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type III interferon production; P:regulation of dendritic cell cytokine production; P:response to dsRNA; P:response to exogenous dsRNA; P:signal transduction; P:toll-like receptor 3 signaling pathway; P:toll-like receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; scaffold26 indexed_genome mRNA 28395031 28599689 . + . ID=transcript_5964;E9PAW4 G3XAI0 H7BXR4 J3KNZ5 O60592 O60593 Q96EX0,Sorbin and SH3 domain-containing protein 2,Arg-binding protein 2;Arg/Abl-interacting protein 2;Sorbin;, PF00018;PF14604;PF02208;, GO:0015629;GO:0016324;GO:0005925;GO:0030027;GO:0005634;GO:0048471;GO:0005886;GO:0030018;GO:0008093;GO:0042802;GO:0003723;GO:0005200;GO:0008307;GO:0007015;GO:0061049;GO:0007219;, C:actin cytoskeleton; C:apical plasma membrane; C:focal adhesion; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:Z disc;, F:cytoskeletal anchor activity; F:identical protein binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cell growth involved in cardiac muscle cell development; P:Notch signaling pathway;|E9PAW4 G3XAI0 H7BXR4 J3KNZ5 O60592 O60593 Q96EX0,Sorbin and SH3 domain-containing protein 2,Arg-binding protein 2;Arg/Abl-interacting protein 2;Sorbin;, PF00018;PF14604;PF02208;, GO:0015629;GO:0016324;GO:0005925;GO:0030027;GO:0005634;GO:0048471;GO:0005886;GO:0030018;GO:0008093;GO:0042802;GO:0003723;GO:0005200;GO:0008307;GO:0007015;GO:0061049;GO:0007219;, C:actin cytoskeleton; C:apical plasma membrane; C:focal adhesion; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:Z disc;, F:cytoskeletal anchor activity; F:identical protein binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cell growth involved in cardiac muscle cell development; P:Notch signaling pathway;|E9PAW4 G3XAI0 H7BXR4 J3KNZ5 O60592 O60593 Q96EX0,Sorbin and SH3 domain-containing protein 2,Arg-binding protein 2;Arg/Abl-interacting protein 2;Sorbin;, PF00018;PF14604;PF02208;, GO:0015629;GO:0016324;GO:0005925;GO:0030027;GO:0005634;GO:0048471;GO:0005886;GO:0030018;GO:0008093;GO:0042802;GO:0003723;GO:0005200;GO:0008307;GO:0007015;GO:0061049;GO:0007219;, C:actin cytoskeleton; C:apical plasma membrane; C:focal adhesion; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:Z disc;, F:cytoskeletal anchor activity; F:identical protein binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cell growth involved in cardiac muscle cell development; P:Notch signaling pathway;|E9PAW4 G3XAI0 H7BXR4 J3KNZ5 O60592 O60593 Q96EX0,Sorbin and SH3 domain-containing protein 2,Arg-binding protein 2;Arg/Abl-interacting protein 2;Sorbin;, PF00018;PF14604;PF02208;, GO:0015629;GO:0016324;GO:0005925;GO:0030027;GO:0005634;GO:0048471;GO:0005886;GO:0030018;GO:0008093;GO:0042802;GO:0003723;GO:0005200;GO:0008307;GO:0007015;GO:0061049;GO:0007219;, C:actin cytoskeleton; C:apical plasma membrane; C:focal adhesion; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:Z disc;, F:cytoskeletal anchor activity; F:identical protein binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cell growth involved in cardiac muscle cell development; P:Notch signaling pathway;|E9PAW4 G3XAI0 H7BXR4 J3KNZ5 O60592 O60593 Q96EX0,Sorbin and SH3 domain-containing protein 2,Arg-binding protein 2;Arg/Abl-interacting protein 2;Sorbin;, PF00018;PF14604;PF02208;, GO:0015629;GO:0016324;GO:0005925;GO:0030027;GO:0005634;GO:0048471;GO:0005886;GO:0030018;GO:0008093;GO:0042802;GO:0003723;GO:0005200;GO:0008307;GO:0007015;GO:0061049;GO:0007219;, C:actin cytoskeleton; C:apical plasma membrane; C:focal adhesion; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:Z disc;, F:cytoskeletal anchor activity; F:identical protein binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cell growth involved in cardiac muscle cell development; P:Notch signaling pathway;|E9PAW4 G3XAI0 H7BXR4 J3KNZ5 O60592 O60593 Q96EX0,Sorbin and SH3 domain-containing protein 2,Arg-binding protein 2;Arg/Abl-interacting protein 2;Sorbin;, PF00018;PF14604;PF02208;, GO:0015629;GO:0016324;GO:0005925;GO:0030027;GO:0005634;GO:0048471;GO:0005886;GO:0030018;GO:0008093;GO:0042802;GO:0003723;GO:0005200;GO:0008307;GO:0007015;GO:0061049;GO:0007219;, C:actin cytoskeleton; C:apical plasma membrane; C:focal adhesion; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:Z disc;, F:cytoskeletal anchor activity; F:identical protein binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cell growth involved in cardiac muscle cell development; P:Notch signaling pathway;|E9PAW4 G3XAI0 H7BXR4 J3KNZ5 O60592 O60593 Q96EX0,Sorbin and SH3 domain-containing protein 2,Arg-binding protein 2;Arg/Abl-interacting protein 2;Sorbin;, PF00018;PF14604;PF02208;, GO:0015629;GO:0016324;GO:0005925;GO:0030027;GO:0005634;GO:0048471;GO:0005886;GO:0030018;GO:0008093;GO:0042802;GO:0003723;GO:0005200;GO:0008307;GO:0007015;GO:0061049;GO:0007219;, C:actin cytoskeleton; C:apical plasma membrane; C:focal adhesion; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:Z disc;, F:cytoskeletal anchor activity; F:identical protein binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cell growth involved in cardiac muscle cell development; P:Notch signaling pathway;|E9PAW4 G3XAI0 H7BXR4 J3KNZ5 O60592 O60593 Q96EX0,Sorbin and SH3 domain-containing protein 2,Arg-binding protein 2;Arg/Abl-interacting protein 2;Sorbin;, PF00018;PF14604;PF02208;, GO:0015629;GO:0016324;GO:0005925;GO:0030027;GO:0005634;GO:0048471;GO:0005886;GO:0030018;GO:0008093;GO:0042802;GO:0003723;GO:0005200;GO:0008307;GO:0007015;GO:0061049;GO:0007219;, C:actin cytoskeleton; C:apical plasma membrane; C:focal adhesion; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:Z disc;, F:cytoskeletal anchor activity; F:identical protein binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cell growth involved in cardiac muscle cell development; P:Notch signaling pathway; scaffold26 indexed_genome mRNA 28643523 28675229 . + . ID=transcript_5965;Q53GG5 B2R866 O43590 O60439 O60440 Q8N6Y6 Q9BVP4,PDZ and LIM domain protein 3,Actinin-associated LIM protein;Alpha-actinin-2-associated LIM protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005829;GO:0031941;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0051371;GO:0030036;GO:0007507;GO:0061061;, C:adherens junction; C:cytosol; C:filamentous actin; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development;|Q53GG5 B2R866 O43590 O60439 O60440 Q8N6Y6 Q9BVP4,PDZ and LIM domain protein 3,Actinin-associated LIM protein;Alpha-actinin-2-associated LIM protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005829;GO:0031941;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0051371;GO:0030036;GO:0007507;GO:0061061;, C:adherens junction; C:cytosol; C:filamentous actin; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development;|Q53GG5 B2R866 O43590 O60439 O60440 Q8N6Y6 Q9BVP4,PDZ and LIM domain protein 3,Actinin-associated LIM protein;Alpha-actinin-2-associated LIM protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005829;GO:0031941;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0051371;GO:0030036;GO:0007507;GO:0061061;, C:adherens junction; C:cytosol; C:filamentous actin; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development;|Q53GG5 B2R866 O43590 O60439 O60440 Q8N6Y6 Q9BVP4,PDZ and LIM domain protein 3,Actinin-associated LIM protein;Alpha-actinin-2-associated LIM protein;, PF15936;PF00412;PF00595;, GO:0005912;GO:0005829;GO:0031941;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0051371;GO:0030036;GO:0007507;GO:0061061;, C:adherens junction; C:cytosol; C:filamentous actin; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development; scaffold26 indexed_genome mRNA 28695795 28697562 . + . ID=transcript_5966;Q8TBZ0 Q86YI9 Q8N7W0,Coiled-coil domain-containing protein 110,Cancer/testis antigen 52;Cancer/testis antigen KM-HN-1;, , GO:0005856;GO:0005634;, C:cytoskeleton; C:nucleus; scaffold26 indexed_genome mRNA 28700608 28703978 . + . ID=transcript_5967;A7E2U8 Q5BLP7,UPF0602 protein C4orf47,, PF15239;, GO:0097731;GO:0005813;GO:0005881;, C:9+0 non-motile cilium; C:centrosome; C:cytoplasmic microtubule; scaffold26 indexed_genome mRNA 28704774 28713929 . - . ID=transcript_5968;A7E2U8 Q5BLP7,UPF0602 protein C4orf47,, PF15239;, GO:0097731;GO:0005813;GO:0005881;, C:9+0 non-motile cilium; C:centrosome; C:cytoplasmic microtubule; scaffold26 indexed_genome mRNA 28715172 28731636 . + . ID=transcript_5969;Q9NUQ7 Q6IA77 Q96FS3,Ufm1-specific protease 2 {ECO:0000303|PubMed:26428751},, PF07910;, GO:0005737;GO:0005783;GO:0005634;GO:0016790;GO:0071567;GO:0006508;GO:0033146;, C:cytoplasm; C:endoplasmic reticulum; C:nucleus;, F:thiolester hydrolase activity; F:UFM1 hydrolase activity;, P:proteolysis; P:regulation of intracellular estrogen receptor signaling pathway;|Q9NUQ7 Q6IA77 Q96FS3,Ufm1-specific protease 2 {ECO:0000303|PubMed:26428751},, PF07910;, GO:0005737;GO:0005783;GO:0005634;GO:0016790;GO:0071567;GO:0006508;GO:0033146;, C:cytoplasm; C:endoplasmic reticulum; C:nucleus;, F:thiolester hydrolase activity; F:UFM1 hydrolase activity;, P:proteolysis; P:regulation of intracellular estrogen receptor signaling pathway;|Q9NUQ7 Q6IA77 Q96FS3,Ufm1-specific protease 2 {ECO:0000303|PubMed:26428751},, PF07910;, GO:0005737;GO:0005783;GO:0005634;GO:0016790;GO:0071567;GO:0006508;GO:0033146;, C:cytoplasm; C:endoplasmic reticulum; C:nucleus;, F:thiolester hydrolase activity; F:UFM1 hydrolase activity;, P:proteolysis; P:regulation of intracellular estrogen receptor signaling pathway;|Q9NUQ7 Q6IA77 Q96FS3,Ufm1-specific protease 2 {ECO:0000303|PubMed:26428751},, PF07910;, GO:0005737;GO:0005783;GO:0005634;GO:0016790;GO:0071567;GO:0006508;GO:0033146;, C:cytoplasm; C:endoplasmic reticulum; C:nucleus;, F:thiolester hydrolase activity; F:UFM1 hydrolase activity;, P:proteolysis; P:regulation of intracellular estrogen receptor signaling pathway;|Q9NUQ7 Q6IA77 Q96FS3,Ufm1-specific protease 2 {ECO:0000303|PubMed:26428751},, PF07910;, GO:0005737;GO:0005783;GO:0005634;GO:0016790;GO:0071567;GO:0006508;GO:0033146;, C:cytoplasm; C:endoplasmic reticulum; C:nucleus;, F:thiolester hydrolase activity; F:UFM1 hydrolase activity;, P:proteolysis; P:regulation of intracellular estrogen receptor signaling pathway;|Q9NUQ7 Q6IA77 Q96FS3,Ufm1-specific protease 2 {ECO:0000303|PubMed:26428751},, PF07910;, GO:0005737;GO:0005783;GO:0005634;GO:0016790;GO:0071567;GO:0006508;GO:0033146;, C:cytoplasm; C:endoplasmic reticulum; C:nucleus;, F:thiolester hydrolase activity; F:UFM1 hydrolase activity;, P:proteolysis; P:regulation of intracellular estrogen receptor signaling pathway;|Q9NUQ7 Q6IA77 Q96FS3,Ufm1-specific protease 2 {ECO:0000303|PubMed:26428751},, PF07910;, GO:0005737;GO:0005783;GO:0005634;GO:0016790;GO:0071567;GO:0006508;GO:0033146;, C:cytoplasm; C:endoplasmic reticulum; C:nucleus;, F:thiolester hydrolase activity; F:UFM1 hydrolase activity;, P:proteolysis; P:regulation of intracellular estrogen receptor signaling pathway;|Q9NUQ7 Q6IA77 Q96FS3,Ufm1-specific protease 2 {ECO:0000303|PubMed:26428751},, PF07910;, GO:0005737;GO:0005783;GO:0005634;GO:0016790;GO:0071567;GO:0006508;GO:0033146;, C:cytoplasm; C:endoplasmic reticulum; C:nucleus;, F:thiolester hydrolase activity; F:UFM1 hydrolase activity;, P:proteolysis; P:regulation of intracellular estrogen receptor signaling pathway; scaffold26 indexed_genome mRNA 28731708 28733932 . - . ID=transcript_5970;Q7Z713,Ankyrin repeat domain-containing protein 37,Low-density lipoprotein receptor-related protein 2-binding protein;, , GO:0005829;GO:0005739;GO:0005654;, C:cytosol; C:mitochondrion; C:nucleoplasm;|Q7Z713,Ankyrin repeat domain-containing protein 37,Low-density lipoprotein receptor-related protein 2-binding protein;, , GO:0005829;GO:0005739;GO:0005654;, C:cytosol; C:mitochondrion; C:nucleoplasm;|Q7Z713,Ankyrin repeat domain-containing protein 37,Low-density lipoprotein receptor-related protein 2-binding protein;, , GO:0005829;GO:0005739;GO:0005654;, C:cytosol; C:mitochondrion; C:nucleoplasm; scaffold26 indexed_genome mRNA 28735944 28746884 . + . ID=transcript_5971;Q9P2M1 A6NJR7 A7E219 B3KX83 Q9NSN6,LRP2-binding protein,Megalin-binding protein;, PF08238;, GO:0005737;, C:cytoplasm; scaffold26 indexed_genome mRNA 28753250 28761244 . + . ID=transcript_5972;Q9P2M1 A6NJR7 A7E219 B3KX83 Q9NSN6,LRP2-binding protein,Megalin-binding protein;, PF08238;, GO:0005737;, C:cytoplasm; scaffold26 indexed_genome mRNA 28762734 28827827 . - . ID=transcript_5973;Q9H3E2 Q3ZT30 Q8N6K3,Sorting nexin-25,, PF08628;PF00787;PF02194;PF00615;, GO:0010008;GO:0043231;GO:0035091;GO:0060394;GO:0030512;GO:0015031;GO:0032801;, C:endosome membrane; C:intracellular membrane-bounded organelle;, F:phosphatidylinositol binding;, P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:protein transport; P:receptor catabolic process;|Q9H3E2 Q3ZT30 Q8N6K3,Sorting nexin-25,, PF08628;PF00787;PF02194;PF00615;, GO:0010008;GO:0043231;GO:0035091;GO:0060394;GO:0030512;GO:0015031;GO:0032801;, C:endosome membrane; C:intracellular membrane-bounded organelle;, F:phosphatidylinositol binding;, P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:protein transport; P:receptor catabolic process;|Q9H3E2 Q3ZT30 Q8N6K3,Sorting nexin-25,, PF08628;PF00787;PF02194;PF00615;, GO:0010008;GO:0043231;GO:0035091;GO:0060394;GO:0030512;GO:0015031;GO:0032801;, C:endosome membrane; C:intracellular membrane-bounded organelle;, F:phosphatidylinositol binding;, P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:protein transport; P:receptor catabolic process;|Q9H3E2 Q3ZT30 Q8N6K3,Sorting nexin-25,, PF08628;PF00787;PF02194;PF00615;, GO:0010008;GO:0043231;GO:0035091;GO:0060394;GO:0030512;GO:0015031;GO:0032801;, C:endosome membrane; C:intracellular membrane-bounded organelle;, F:phosphatidylinositol binding;, P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:protein transport; P:receptor catabolic process;|Q9H3E2 Q3ZT30 Q8N6K3,Sorting nexin-25,, PF08628;PF00787;PF02194;PF00615;, GO:0010008;GO:0043231;GO:0035091;GO:0060394;GO:0030512;GO:0015031;GO:0032801;, C:endosome membrane; C:intracellular membrane-bounded organelle;, F:phosphatidylinositol binding;, P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:protein transport; P:receptor catabolic process;|Q9H3E2 Q3ZT30 Q8N6K3,Sorting nexin-25,, PF08628;PF00787;PF02194;PF00615;, GO:0010008;GO:0043231;GO:0035091;GO:0060394;GO:0030512;GO:0015031;GO:0032801;, C:endosome membrane; C:intracellular membrane-bounded organelle;, F:phosphatidylinositol binding;, P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:protein transport; P:receptor catabolic process;|Q9H3E2 Q3ZT30 Q8N6K3,Sorting nexin-25,, PF08628;PF00787;PF02194;PF00615;, GO:0010008;GO:0043231;GO:0035091;GO:0060394;GO:0030512;GO:0015031;GO:0032801;, C:endosome membrane; C:intracellular membrane-bounded organelle;, F:phosphatidylinositol binding;, P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:protein transport; P:receptor catabolic process;|Q9H3E2 Q3ZT30 Q8N6K3,Sorting nexin-25,, PF08628;PF00787;PF02194;PF00615;, GO:0010008;GO:0043231;GO:0035091;GO:0060394;GO:0030512;GO:0015031;GO:0032801;, C:endosome membrane; C:intracellular membrane-bounded organelle;, F:phosphatidylinositol binding;, P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:protein transport; P:receptor catabolic process; scaffold26 indexed_genome mRNA 28866171 28885039 . + . ID=transcript_5974;Q9P2B7 B3KRP7 D3DP60 Q05CU1 Q4W5M4 Q8N6E7 Q9UF45,Cilia- and flagella-associated protein 97 {ECO:0000312|HGNC:HGNC:29276},, PF13879; scaffold26 indexed_genome mRNA 28891052 28892825 . - . ID=transcript_5975;P12235 D3DP59,ADP/ATP translocase 1 {ECO:0000305},ADP,ATP carrier protein 1 {ECO:0000250|UniProtKB:P48962};ADP,ATP carrier protein, heart/skeletal muscle isoform T1 {ECO:0000303|PubMed:2541251};Adenine nucleotide translocator 1 {ECO:0000303|PubMed:2823266};Solute carrier family 25 member 4 {ECO:0000305};, PF00153;, GO:0032592;GO:0005887;GO:0016020;GO:0005743;GO:0005757;GO:0005739;GO:0015207;GO:0005471;GO:0017077;GO:0015078;GO:1990845;GO:0015866;GO:0008637;GO:0006091;GO:0140021;GO:1990544;GO:0000002;GO:0060546;GO:1901526;GO:0046902;GO:0016032;, C:integral component of mitochondrial membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion;, F:adenine transmembrane transporter activity; F:ATP:ADP antiporter activity; F:oxidative phosphorylation uncoupler activity; F:proton transmembrane transporter activity;, F:ATP:ADP antiporter activity; P:adaptive thermogenesis; P:ADP transport; P:apoptotic mitochondrial changes; P:generation of precursor metabolites and energy; P:mitochondrial ADP transmembrane transport; P:mitochondrial ATP transmembrane transport; P:mitochondrial genome maintenance; P:negative regulation of necroptotic process; P:positive regulation of mitophagy; P:regulation of mitochondrial membrane permeability; P:viral process; scaffold26 indexed_genome mRNA 29057051 29057621 . + . ID=transcript_5976;Q92819 Q32MM3,Hyaluronan synthase 2,Hyaluronate synthase 2;Hyaluronic acid synthase 2;, , GO:0031410;GO:0005887;GO:0044853;GO:0050501;GO:0036302;GO:0060349;GO:0071498;GO:0071347;GO:0036120;GO:0071356;GO:0090500;GO:0044849;GO:0085029;GO:0045226;GO:0030213;GO:0001822;GO:0030335;GO:0008284;GO:1900127;GO:0051549;GO:0010838;GO:1900625;GO:0014911;GO:1900026;GO:0035810;GO:1901201;GO:0070295;GO:0001570;, C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane raft;, F:hyaluronan synthase activity;, P:atrioventricular canal development; P:bone morphogenesis; P:cellular response to fluid shear stress; P:cellular response to interleukin-1; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to tumor necrosis factor; P:endocardial cushion to mesenchymal transition; P:estrous cycle; P:extracellular matrix assembly; P:extracellular polysaccharide biosynthetic process; P:hyaluronan biosynthetic process; P:kidney development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of keratinocyte migration; P:positive regulation of keratinocyte proliferation; P:positive regulation of monocyte aggregation; P:positive regulation of smooth muscle cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of urine volume; P:regulation of extracellular matrix assembly; P:renal water absorption; P:vasculogenesis; scaffold26 indexed_genome mRNA 29156642 29207366 . + . ID=transcript_5977;P33121 B7Z452 D3DP57 P41215 Q8N8V7 Q8TA99,Long-chain-fatty-acid--CoA ligase 1 {ECO:0000305},Acyl-CoA synthetase 1;Arachidonate--CoA ligase;Long-chain acyl-CoA synthetase 1;Long-chain acyl-CoA synthetase 2;Long-chain fatty acid-CoA ligase 2;Palmitoyl-CoA ligase 1;Palmitoyl-CoA ligase 2;Phytanate--CoA ligase;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0090434;GO:0050197;GO:0070251;GO:0033211;GO:0036109;GO:0015908;GO:0043651;GO:0008610;GO:0044539;GO:0001676;GO:0035338;GO:0120162;GO:0010747;GO:0071902;GO:0019222;GO:0042493;GO:0007584;GO:0034201;GO:0014070;GO:0019432;GO:0000038;GO:0042178;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:oleoyl-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:alpha-linolenic acid metabolic process; P:fatty acid transport; P:linoleic acid metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of long-chain fatty acid import across plasma membrane; P:positive regulation of protein serine/threonine kinase activity; P:regulation of metabolic process; P:response to drug; P:response to nutrient; P:response to oleic acid; P:response to organic cyclic compound; P:triglyceride biosynthetic process; P:very long-chain fatty acid metabolic process; P:xenobiotic catabolic process;|P33121 B7Z452 D3DP57 P41215 Q8N8V7 Q8TA99,Long-chain-fatty-acid--CoA ligase 1 {ECO:0000305},Acyl-CoA synthetase 1;Arachidonate--CoA ligase;Long-chain acyl-CoA synthetase 1;Long-chain acyl-CoA synthetase 2;Long-chain fatty acid-CoA ligase 2;Palmitoyl-CoA ligase 1;Palmitoyl-CoA ligase 2;Phytanate--CoA ligase;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0090434;GO:0050197;GO:0070251;GO:0033211;GO:0036109;GO:0015908;GO:0043651;GO:0008610;GO:0044539;GO:0001676;GO:0035338;GO:0120162;GO:0010747;GO:0071902;GO:0019222;GO:0042493;GO:0007584;GO:0034201;GO:0014070;GO:0019432;GO:0000038;GO:0042178;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:oleoyl-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:alpha-linolenic acid metabolic process; P:fatty acid transport; P:linoleic acid metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of long-chain fatty acid import across plasma membrane; P:positive regulation of protein serine/threonine kinase activity; P:regulation of metabolic process; P:response to drug; P:response to nutrient; P:response to oleic acid; P:response to organic cyclic compound; P:triglyceride biosynthetic process; P:very long-chain fatty acid metabolic process; P:xenobiotic catabolic process;|P33121 B7Z452 D3DP57 P41215 Q8N8V7 Q8TA99,Long-chain-fatty-acid--CoA ligase 1 {ECO:0000305},Acyl-CoA synthetase 1;Arachidonate--CoA ligase;Long-chain acyl-CoA synthetase 1;Long-chain acyl-CoA synthetase 2;Long-chain fatty acid-CoA ligase 2;Palmitoyl-CoA ligase 1;Palmitoyl-CoA ligase 2;Phytanate--CoA ligase;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0090434;GO:0050197;GO:0070251;GO:0033211;GO:0036109;GO:0015908;GO:0043651;GO:0008610;GO:0044539;GO:0001676;GO:0035338;GO:0120162;GO:0010747;GO:0071902;GO:0019222;GO:0042493;GO:0007584;GO:0034201;GO:0014070;GO:0019432;GO:0000038;GO:0042178;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:oleoyl-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:alpha-linolenic acid metabolic process; P:fatty acid transport; P:linoleic acid metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of long-chain fatty acid import across plasma membrane; P:positive regulation of protein serine/threonine kinase activity; P:regulation of metabolic process; P:response to drug; P:response to nutrient; P:response to oleic acid; P:response to organic cyclic compound; P:triglyceride biosynthetic process; P:very long-chain fatty acid metabolic process; P:xenobiotic catabolic process;|P33121 B7Z452 D3DP57 P41215 Q8N8V7 Q8TA99,Long-chain-fatty-acid--CoA ligase 1 {ECO:0000305},Acyl-CoA synthetase 1;Arachidonate--CoA ligase;Long-chain acyl-CoA synthetase 1;Long-chain acyl-CoA synthetase 2;Long-chain fatty acid-CoA ligase 2;Palmitoyl-CoA ligase 1;Palmitoyl-CoA ligase 2;Phytanate--CoA ligase;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0090434;GO:0050197;GO:0070251;GO:0033211;GO:0036109;GO:0015908;GO:0043651;GO:0008610;GO:0044539;GO:0001676;GO:0035338;GO:0120162;GO:0010747;GO:0071902;GO:0019222;GO:0042493;GO:0007584;GO:0034201;GO:0014070;GO:0019432;GO:0000038;GO:0042178;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:oleoyl-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:alpha-linolenic acid metabolic process; P:fatty acid transport; P:linoleic acid metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of long-chain fatty acid import across plasma membrane; P:positive regulation of protein serine/threonine kinase activity; P:regulation of metabolic process; P:response to drug; P:response to nutrient; P:response to oleic acid; P:response to organic cyclic compound; P:triglyceride biosynthetic process; P:very long-chain fatty acid metabolic process; P:xenobiotic catabolic process;|P33121 B7Z452 D3DP57 P41215 Q8N8V7 Q8TA99,Long-chain-fatty-acid--CoA ligase 1 {ECO:0000305},Acyl-CoA synthetase 1;Arachidonate--CoA ligase;Long-chain acyl-CoA synthetase 1;Long-chain acyl-CoA synthetase 2;Long-chain fatty acid-CoA ligase 2;Palmitoyl-CoA ligase 1;Palmitoyl-CoA ligase 2;Phytanate--CoA ligase;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0090434;GO:0050197;GO:0070251;GO:0033211;GO:0036109;GO:0015908;GO:0043651;GO:0008610;GO:0044539;GO:0001676;GO:0035338;GO:0120162;GO:0010747;GO:0071902;GO:0019222;GO:0042493;GO:0007584;GO:0034201;GO:0014070;GO:0019432;GO:0000038;GO:0042178;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:oleoyl-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:alpha-linolenic acid metabolic process; P:fatty acid transport; P:linoleic acid metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of long-chain fatty acid import across plasma membrane; P:positive regulation of protein serine/threonine kinase activity; P:regulation of metabolic process; P:response to drug; P:response to nutrient; P:response to oleic acid; P:response to organic cyclic compound; P:triglyceride biosynthetic process; P:very long-chain fatty acid metabolic process; P:xenobiotic catabolic process;|P33121 B7Z452 D3DP57 P41215 Q8N8V7 Q8TA99,Long-chain-fatty-acid--CoA ligase 1 {ECO:0000305},Acyl-CoA synthetase 1;Arachidonate--CoA ligase;Long-chain acyl-CoA synthetase 1;Long-chain acyl-CoA synthetase 2;Long-chain fatty acid-CoA ligase 2;Palmitoyl-CoA ligase 1;Palmitoyl-CoA ligase 2;Phytanate--CoA ligase;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0090434;GO:0050197;GO:0070251;GO:0033211;GO:0036109;GO:0015908;GO:0043651;GO:0008610;GO:0044539;GO:0001676;GO:0035338;GO:0120162;GO:0010747;GO:0071902;GO:0019222;GO:0042493;GO:0007584;GO:0034201;GO:0014070;GO:0019432;GO:0000038;GO:0042178;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:oleoyl-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:alpha-linolenic acid metabolic process; P:fatty acid transport; P:linoleic acid metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of long-chain fatty acid import across plasma membrane; P:positive regulation of protein serine/threonine kinase activity; P:regulation of metabolic process; P:response to drug; P:response to nutrient; P:response to oleic acid; P:response to organic cyclic compound; P:triglyceride biosynthetic process; P:very long-chain fatty acid metabolic process; P:xenobiotic catabolic process;|P33121 B7Z452 D3DP57 P41215 Q8N8V7 Q8TA99,Long-chain-fatty-acid--CoA ligase 1 {ECO:0000305},Acyl-CoA synthetase 1;Arachidonate--CoA ligase;Long-chain acyl-CoA synthetase 1;Long-chain acyl-CoA synthetase 2;Long-chain fatty acid-CoA ligase 2;Palmitoyl-CoA ligase 1;Palmitoyl-CoA ligase 2;Phytanate--CoA ligase;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0090434;GO:0050197;GO:0070251;GO:0033211;GO:0036109;GO:0015908;GO:0043651;GO:0008610;GO:0044539;GO:0001676;GO:0035338;GO:0120162;GO:0010747;GO:0071902;GO:0019222;GO:0042493;GO:0007584;GO:0034201;GO:0014070;GO:0019432;GO:0000038;GO:0042178;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:oleoyl-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:alpha-linolenic acid metabolic process; P:fatty acid transport; P:linoleic acid metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of long-chain fatty acid import across plasma membrane; P:positive regulation of protein serine/threonine kinase activity; P:regulation of metabolic process; P:response to drug; P:response to nutrient; P:response to oleic acid; P:response to organic cyclic compound; P:triglyceride biosynthetic process; P:very long-chain fatty acid metabolic process; P:xenobiotic catabolic process;|P33121 B7Z452 D3DP57 P41215 Q8N8V7 Q8TA99,Long-chain-fatty-acid--CoA ligase 1 {ECO:0000305},Acyl-CoA synthetase 1;Arachidonate--CoA ligase;Long-chain acyl-CoA synthetase 1;Long-chain acyl-CoA synthetase 2;Long-chain fatty acid-CoA ligase 2;Palmitoyl-CoA ligase 1;Palmitoyl-CoA ligase 2;Phytanate--CoA ligase;, PF00501;PF13193;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0090434;GO:0050197;GO:0070251;GO:0033211;GO:0036109;GO:0015908;GO:0043651;GO:0008610;GO:0044539;GO:0001676;GO:0035338;GO:0120162;GO:0010747;GO:0071902;GO:0019222;GO:0042493;GO:0007584;GO:0034201;GO:0014070;GO:0019432;GO:0000038;GO:0042178;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:oleoyl-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:alpha-linolenic acid metabolic process; P:fatty acid transport; P:linoleic acid metabolic process; P:lipid biosynthetic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of long-chain fatty acid import across plasma membrane; P:positive regulation of protein serine/threonine kinase activity; P:regulation of metabolic process; P:response to drug; P:response to nutrient; P:response to oleic acid; P:response to organic cyclic compound; P:triglyceride biosynthetic process; P:very long-chain fatty acid metabolic process; P:xenobiotic catabolic process; scaffold26 indexed_genome mRNA 29219784 29222956 . + . ID=transcript_5978;Q71F23 A2RRD9 Q09GN2 Q32Q71 Q9H5G1,Centromere protein U,Centromere protein of 50 kDa;Interphase centromere complex protein 24;KSHV latent nuclear antigen-interacting protein 1;MLF1-interacting protein;Polo-box-interacting protein 1;, PF13097;, GO:0034451;GO:0000777;GO:0005829;GO:0005654;GO:0005634;GO:0034080;GO:0043009;GO:0007052;GO:0016032;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytosol; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:chordate embryonic development; P:mitotic spindle organization; P:viral process; scaffold27 indexed_genome mRNA 369782 635643 . - . ID=transcript_5979;Q8NFX7 D3DS78 Q8N3H1 Q8N8D5 Q96GF3 Q9P008,Syntaxin-binding protein 6,Amisyn;, PF15277;PF00957;, GO:0005912;GO:0000145;GO:0016021;GO:0005886;GO:0098641;GO:0005546;GO:0006887;GO:0006893;GO:0045920;GO:0035542;, C:adherens junction; C:exocyst; C:integral component of membrane; C:plasma membrane;, F:cadherin binding involved in cell-cell adhesion; F:phosphatidylinositol-4,5-bisphosphate binding;, P:exocytosis; P:Golgi to plasma membrane transport; P:negative regulation of exocytosis; P:regulation of SNARE complex assembly; scaffold27 indexed_genome mRNA 2004795 2011859 . - . ID=transcript_5980;P51513 A8K0S4 A8K4Q7 D3DS81 D3DS82 Q6B004,RNA-binding protein Nova-1,Neuro-oncological ventral antigen 1;Onconeural ventral antigen 1;Paraneoplastic Ri antigen;Ventral neuron-specific protein 1;, PF00013;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0007268;GO:0007626;GO:0000398;GO:0120163;GO:0000381;GO:0010468;GO:0051252;GO:0006396;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding;, P:chemical synaptic transmission; P:locomotory behavior; P:mRNA splicing, via spliceosome; P:negative regulation of cold-induced thermogenesis; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA processing; P:RNA splicing;|P51513 A8K0S4 A8K4Q7 D3DS81 D3DS82 Q6B004,RNA-binding protein Nova-1,Neuro-oncological ventral antigen 1;Onconeural ventral antigen 1;Paraneoplastic Ri antigen;Ventral neuron-specific protein 1;, PF00013;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0007268;GO:0007626;GO:0000398;GO:0120163;GO:0000381;GO:0010468;GO:0051252;GO:0006396;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding;, P:chemical synaptic transmission; P:locomotory behavior; P:mRNA splicing, via spliceosome; P:negative regulation of cold-induced thermogenesis; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA processing; P:RNA splicing; scaffold27 indexed_genome mRNA 2030603 2042209 . - . ID=transcript_5981;P51513 A8K0S4 A8K4Q7 D3DS81 D3DS82 Q6B004,RNA-binding protein Nova-1,Neuro-oncological ventral antigen 1;Onconeural ventral antigen 1;Paraneoplastic Ri antigen;Ventral neuron-specific protein 1;, PF00013;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0007268;GO:0007626;GO:0000398;GO:0120163;GO:0000381;GO:0010468;GO:0051252;GO:0006396;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding;, P:chemical synaptic transmission; P:locomotory behavior; P:mRNA splicing, via spliceosome; P:negative regulation of cold-induced thermogenesis; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA processing; P:RNA splicing; scaffold27 indexed_genome mRNA 2112393 2114338 . + . ID=transcript_5982;P51513 A8K0S4 A8K4Q7 D3DS81 D3DS82 Q6B004,RNA-binding protein Nova-1,Neuro-oncological ventral antigen 1;Onconeural ventral antigen 1;Paraneoplastic Ri antigen;Ventral neuron-specific protein 1;, PF00013;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0007268;GO:0007626;GO:0000398;GO:0120163;GO:0000381;GO:0010468;GO:0051252;GO:0006396;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding;, P:chemical synaptic transmission; P:locomotory behavior; P:mRNA splicing, via spliceosome; P:negative regulation of cold-induced thermogenesis; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA processing; P:RNA splicing; scaffold27 indexed_genome mRNA 2153605 2162182 . - . ID=transcript_5983;Q9UNW9 O43267 Q9UEA1,RNA-binding protein Nova-2,Astrocytic NOVA1-like RNA-binding protein;Neuro-oncological ventral antigen 2;, PF00013;, GO:0005737;GO:0005634;GO:0003729;GO:0003723;GO:0000398;GO:0120163;GO:0000381;GO:0010468;GO:0051252;, C:cytoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of cold-induced thermogenesis; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of RNA metabolic process;|P51513 A8K0S4 A8K4Q7 D3DS81 D3DS82 Q6B004,RNA-binding protein Nova-1,Neuro-oncological ventral antigen 1;Onconeural ventral antigen 1;Paraneoplastic Ri antigen;Ventral neuron-specific protein 1;, PF00013;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0007268;GO:0007626;GO:0000398;GO:0120163;GO:0000381;GO:0010468;GO:0051252;GO:0006396;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding;, P:chemical synaptic transmission; P:locomotory behavior; P:mRNA splicing, via spliceosome; P:negative regulation of cold-induced thermogenesis; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA processing; P:RNA splicing;|P51513 A8K0S4 A8K4Q7 D3DS81 D3DS82 Q6B004,RNA-binding protein Nova-1,Neuro-oncological ventral antigen 1;Onconeural ventral antigen 1;Paraneoplastic Ri antigen;Ventral neuron-specific protein 1;, PF00013;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0007268;GO:0007626;GO:0000398;GO:0120163;GO:0000381;GO:0010468;GO:0051252;GO:0006396;GO:0008380;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding;, P:chemical synaptic transmission; P:locomotory behavior; P:mRNA splicing, via spliceosome; P:negative regulation of cold-induced thermogenesis; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA processing; P:RNA splicing; scaffold27 indexed_genome mRNA 5119386 5200743 . - . ID=transcript_5984;Q15139 A6NL64 B2RAF6,Serine/threonine-protein kinase D1,Protein kinase C mu type;Protein kinase D;nPKC-D1;nPKC-mu;, PF00130;PF00169;PF00069;, GO:0000421;GO:0005829;GO:0005794;GO:0005886;GO:0005802;GO:0005524;GO:0004698;GO:0042802;GO:0016301;GO:0046872;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0001525;GO:0006915;GO:0030154;GO:0034198;GO:0071447;GO:0034599;GO:0035924;GO:0007030;GO:0048193;GO:0006954;GO:0045087;GO:0007229;GO:0035556;GO:0060548;GO:0045806;GO:0007399;GO:0018105;GO:0018107;GO:0045766;GO:0010508;GO:0043536;GO:0032793;GO:2001028;GO:0038033;GO:0010595;GO:0001938;GO:1901727;GO:0043123;GO:0010976;GO:0051092;GO:0045669;GO:0033138;GO:0043552;GO:0045944;GO:0046777;GO:0089700;GO:0006468;GO:0007265;GO:2001044;GO:0010837;GO:0031647;GO:0007165;GO:0030148;GO:0048010;, C:autophagosome membrane; C:cytosol; C:Golgi apparatus; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:identical protein binding; F:kinase activity; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:angiogenesis; P:apoptotic process; P:cell differentiation; P:cellular response to amino acid starvation; P:cellular response to hydroperoxide; P:cellular response to oxidative stress; P:cellular response to vascular endothelial growth factor stimulus; P:Golgi organization; P:Golgi vesicle transport; P:inflammatory response; P:innate immune response; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell death; P:negative regulation of endocytosis; P:nervous system development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of CREB transcription factor activity; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of histone deacetylase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of osteoblast differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of transcription by RNA polymerase II; P:protein autophosphorylation; P:protein kinase D signaling; P:protein phosphorylation; P:Ras protein signal transduction; P:regulation of integrin-mediated signaling pathway; P:regulation of keratinocyte proliferation; P:regulation of protein stability; P:signal transduction; P:sphingolipid biosynthetic process; P:vascular endothelial growth factor receptor signaling pathway; scaffold27 indexed_genome mRNA 6097082 6127347 . + . ID=transcript_5985;Q7L622 Q9BVR2 Q9H9E9 Q9NXC0 Q9P2L3,G2/M phase-specific E3 ubiquitin-protein ligase,G2/M phase-specific HECT-type E3 ubiquitin transferase;, PF00632;, GO:0005829;GO:0005794;GO:0043231;GO:0005730;GO:0005634;GO:0046872;GO:0004842;GO:0006915;GO:0007275;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:multicellular organism development; scaffold27 indexed_genome mRNA 6128151 6129275 . - . ID=transcript_5986;Q7L622 Q9BVR2 Q9H9E9 Q9NXC0 Q9P2L3,G2/M phase-specific E3 ubiquitin-protein ligase,G2/M phase-specific HECT-type E3 ubiquitin transferase;, PF00632;, GO:0005829;GO:0005794;GO:0043231;GO:0005730;GO:0005634;GO:0046872;GO:0004842;GO:0006915;GO:0007275;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:multicellular organism development; scaffold27 indexed_genome mRNA 6129283 6133103 . + . ID=transcript_5987;Q7L622 Q9BVR2 Q9H9E9 Q9NXC0 Q9P2L3,G2/M phase-specific E3 ubiquitin-protein ligase,G2/M phase-specific HECT-type E3 ubiquitin transferase;, PF00632;, GO:0005829;GO:0005794;GO:0043231;GO:0005730;GO:0005634;GO:0046872;GO:0004842;GO:0006915;GO:0007275;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:multicellular organism development;|Q7L622 Q9BVR2 Q9H9E9 Q9NXC0 Q9P2L3,G2/M phase-specific E3 ubiquitin-protein ligase,G2/M phase-specific HECT-type E3 ubiquitin transferase;, PF00632;, GO:0005829;GO:0005794;GO:0043231;GO:0005730;GO:0005634;GO:0046872;GO:0004842;GO:0006915;GO:0007275;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:multicellular organism development; scaffold27 indexed_genome mRNA 6136430 6162869 . + . ID=transcript_5988;Q7L622 Q9BVR2 Q9H9E9 Q9NXC0 Q9P2L3,G2/M phase-specific E3 ubiquitin-protein ligase,G2/M phase-specific HECT-type E3 ubiquitin transferase;, PF00632;, GO:0005829;GO:0005794;GO:0043231;GO:0005730;GO:0005634;GO:0046872;GO:0004842;GO:0006915;GO:0007275;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:multicellular organism development; scaffold27 indexed_genome mRNA 6167313 6276758 . + . ID=transcript_5989;Q9Y6A8,Sec1 family domain-containing protein 1,SLY1 homolog;Syntaxin-binding protein 1-like 2;, PF00995;, GO:0005801;GO:0005829;GO:0005789;GO:0032580;GO:0000139;GO:0005798;GO:0005886;GO:0047485;GO:0044877;GO:0019905;GO:0000902;GO:0048208;GO:0006888;GO:0006886;GO:1902902;GO:0006892;GO:0060628;GO:0051223;GO:0001666;GO:0009636;GO:0006890;GO:1901998;GO:0016192;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi-associated vesicle; C:plasma membrane;, F:protein N-terminus binding; F:protein-containing complex binding; F:syntaxin binding;, P:cell morphogenesis; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:negative regulation of autophagosome assembly; P:post-Golgi vesicle-mediated transport; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of protein transport; P:response to hypoxia; P:response to toxic substance; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:toxin transport; P:vesicle-mediated transport;|Q9Y6A8,Sec1 family domain-containing protein 1,SLY1 homolog;Syntaxin-binding protein 1-like 2;, PF00995;, GO:0005801;GO:0005829;GO:0005789;GO:0032580;GO:0000139;GO:0005798;GO:0005886;GO:0047485;GO:0044877;GO:0019905;GO:0000902;GO:0048208;GO:0006888;GO:0006886;GO:1902902;GO:0006892;GO:0060628;GO:0051223;GO:0001666;GO:0009636;GO:0006890;GO:1901998;GO:0016192;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi-associated vesicle; C:plasma membrane;, F:protein N-terminus binding; F:protein-containing complex binding; F:syntaxin binding;, P:cell morphogenesis; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:negative regulation of autophagosome assembly; P:post-Golgi vesicle-mediated transport; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of protein transport; P:response to hypoxia; P:response to toxic substance; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:toxin transport; P:vesicle-mediated transport; scaffold27 indexed_genome mRNA 6429345 6432907 . + . ID=transcript_5990;O43405 A8K9K9 D3DS84 Q96IU6,Cochlin,COCH-5B2;, PF03815;PF00092;, GO:0062023;GO:0005576;GO:0005518;GO:0042742;GO:0045089;GO:0008360;GO:0007605;, C:collagen-containing extracellular matrix; C:extracellular region;, F:collagen binding;, P:defense response to bacterium; P:positive regulation of innate immune response; P:regulation of cell shape; P:sensory perception of sound; scaffold27 indexed_genome mRNA 6433603 6728793 . - . ID=transcript_5991;Q13033 A2RTX7 A6NHZ7 Q9NRA5,Striatin-3,Cell cycle autoantigen SG2NA;S/G2 antigen;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0090443;GO:0005794;GO:0043025;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0070016;GO:0005516;GO:0051721;GO:0044877;GO:0031267;GO:0033147;GO:0000122;GO:0045892;GO:0045944;GO:0032355;, C:cytoplasm; C:dendrite; C:FAR/SIN/STRIPAK complex; C:Golgi apparatus; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:small GTPase binding;, P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:response to estradiol;|Q13033 A2RTX7 A6NHZ7 Q9NRA5,Striatin-3,Cell cycle autoantigen SG2NA;S/G2 antigen;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0090443;GO:0005794;GO:0043025;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0070016;GO:0005516;GO:0051721;GO:0044877;GO:0031267;GO:0033147;GO:0000122;GO:0045892;GO:0045944;GO:0032355;, C:cytoplasm; C:dendrite; C:FAR/SIN/STRIPAK complex; C:Golgi apparatus; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:small GTPase binding;, P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:response to estradiol;|Q13033 A2RTX7 A6NHZ7 Q9NRA5,Striatin-3,Cell cycle autoantigen SG2NA;S/G2 antigen;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0090443;GO:0005794;GO:0043025;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0070016;GO:0005516;GO:0051721;GO:0044877;GO:0031267;GO:0033147;GO:0000122;GO:0045892;GO:0045944;GO:0032355;, C:cytoplasm; C:dendrite; C:FAR/SIN/STRIPAK complex; C:Golgi apparatus; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:small GTPase binding;, P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:response to estradiol;|Q13033 A2RTX7 A6NHZ7 Q9NRA5,Striatin-3,Cell cycle autoantigen SG2NA;S/G2 antigen;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0090443;GO:0005794;GO:0043025;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0070016;GO:0005516;GO:0051721;GO:0044877;GO:0031267;GO:0033147;GO:0000122;GO:0045892;GO:0045944;GO:0032355;, C:cytoplasm; C:dendrite; C:FAR/SIN/STRIPAK complex; C:Golgi apparatus; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:small GTPase binding;, P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:response to estradiol;|Q13033 A2RTX7 A6NHZ7 Q9NRA5,Striatin-3,Cell cycle autoantigen SG2NA;S/G2 antigen;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0090443;GO:0005794;GO:0043025;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0070016;GO:0005516;GO:0051721;GO:0044877;GO:0031267;GO:0033147;GO:0000122;GO:0045892;GO:0045944;GO:0032355;, C:cytoplasm; C:dendrite; C:FAR/SIN/STRIPAK complex; C:Golgi apparatus; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:small GTPase binding;, P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:response to estradiol;|Q13033 A2RTX7 A6NHZ7 Q9NRA5,Striatin-3,Cell cycle autoantigen SG2NA;S/G2 antigen;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0090443;GO:0005794;GO:0043025;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0070016;GO:0005516;GO:0051721;GO:0044877;GO:0031267;GO:0033147;GO:0000122;GO:0045892;GO:0045944;GO:0032355;, C:cytoplasm; C:dendrite; C:FAR/SIN/STRIPAK complex; C:Golgi apparatus; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:small GTPase binding;, P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:response to estradiol;|Q13033 A2RTX7 A6NHZ7 Q9NRA5,Striatin-3,Cell cycle autoantigen SG2NA;S/G2 antigen;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0090443;GO:0005794;GO:0043025;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0070016;GO:0005516;GO:0051721;GO:0044877;GO:0031267;GO:0033147;GO:0000122;GO:0045892;GO:0045944;GO:0032355;, C:cytoplasm; C:dendrite; C:FAR/SIN/STRIPAK complex; C:Golgi apparatus; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:small GTPase binding;, P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:response to estradiol;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9Y587 G3V2N8 Q6IAQ4 Q86U36 Q9BVE7,AP-4 complex subunit sigma-1 {ECO:0000305},AP-4 adaptor complex subunit sigma-1;Adaptor-related protein complex 4 subunit sigma-1;Sigma-1 subunit of AP-4;Sigma-4-adaptin;, PF01217;, GO:0030124;GO:0031904;GO:0043231;GO:0032588;GO:0006892;GO:0008104;GO:0006605;GO:0016192;, C:AP-4 adaptor complex; C:endosome lumen; C:intracellular membrane-bounded organelle; C:trans-Golgi network membrane;, , P:post-Golgi vesicle-mediated transport; P:protein localization; P:protein targeting; P:vesicle-mediated transport;|Q9Y587 G3V2N8 Q6IAQ4 Q86U36 Q9BVE7,AP-4 complex subunit sigma-1 {ECO:0000305},AP-4 adaptor complex subunit sigma-1;Adaptor-related protein complex 4 subunit sigma-1;Sigma-1 subunit of AP-4;Sigma-4-adaptin;, PF01217;, GO:0030124;GO:0031904;GO:0043231;GO:0032588;GO:0006892;GO:0008104;GO:0006605;GO:0016192;, C:AP-4 adaptor complex; C:endosome lumen; C:intracellular membrane-bounded organelle; C:trans-Golgi network membrane;, , P:post-Golgi vesicle-mediated transport; P:protein localization; P:protein targeting; P:vesicle-mediated transport;|Q9ULT8 D3DS86 Q6P445 Q86VJ1 Q96F34 Q9UFZ7,E3 ubiquitin-protein ligase HECTD1,E3 ligase for inhibin receptor;EULIR;HECT domain-containing protein 1;HECT-type E3 ubiquitin transferase HECTD1;, PF12796;PF18410;PF00632;PF06701;PF07738;, GO:0046872;GO:0061630;GO:0048856;GO:0035904;GO:0003170;GO:0032436;GO:0070534;GO:0003281;, , F:metal ion binding; F:ubiquitin protein ligase activity;, P:anatomical structure development; P:aorta development; P:heart valve development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein K63-linked ubiquitination; P:ventricular septum development;|Q9ULT8 D3DS86 Q6P445 Q86VJ1 Q96F34 Q9UFZ7,E3 ubiquitin-protein ligase HECTD1,E3 ligase for inhibin receptor;EULIR;HECT domain-containing protein 1;HECT-type E3 ubiquitin transferase HECTD1;, PF12796;PF18410;PF00632;PF06701;PF07738;, GO:0046872;GO:0061630;GO:0048856;GO:0035904;GO:0003170;GO:0032436;GO:0070534;GO:0003281;, , F:metal ion binding; F:ubiquitin protein ligase activity;, P:anatomical structure development; P:aorta development; P:heart valve development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein K63-linked ubiquitination; P:ventricular septum development;|Q9ULT8 D3DS86 Q6P445 Q86VJ1 Q96F34 Q9UFZ7,E3 ubiquitin-protein ligase HECTD1,E3 ligase for inhibin receptor;EULIR;HECT domain-containing protein 1;HECT-type E3 ubiquitin transferase HECTD1;, PF12796;PF18410;PF00632;PF06701;PF07738;, GO:0046872;GO:0061630;GO:0048856;GO:0035904;GO:0003170;GO:0032436;GO:0070534;GO:0003281;, , F:metal ion binding; F:ubiquitin protein ligase activity;, P:anatomical structure development; P:aorta development; P:heart valve development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein K63-linked ubiquitination; P:ventricular septum development;|Q9ULT8 D3DS86 Q6P445 Q86VJ1 Q96F34 Q9UFZ7,E3 ubiquitin-protein ligase HECTD1,E3 ligase for inhibin receptor;EULIR;HECT domain-containing protein 1;HECT-type E3 ubiquitin transferase HECTD1;, PF12796;PF18410;PF00632;PF06701;PF07738;, GO:0046872;GO:0061630;GO:0048856;GO:0035904;GO:0003170;GO:0032436;GO:0070534;GO:0003281;, , F:metal ion binding; F:ubiquitin protein ligase activity;, P:anatomical structure development; P:aorta development; P:heart valve development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein K63-linked ubiquitination; P:ventricular septum development;|Q9ULT8 D3DS86 Q6P445 Q86VJ1 Q96F34 Q9UFZ7,E3 ubiquitin-protein ligase HECTD1,E3 ligase for inhibin receptor;EULIR;HECT domain-containing protein 1;HECT-type E3 ubiquitin transferase HECTD1;, PF12796;PF18410;PF00632;PF06701;PF07738;, GO:0046872;GO:0061630;GO:0048856;GO:0035904;GO:0003170;GO:0032436;GO:0070534;GO:0003281;, , F:metal ion binding; F:ubiquitin protein ligase activity;, P:anatomical structure development; P:aorta development; P:heart valve development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein K63-linked ubiquitination; P:ventricular septum development;|Q9ULT8 D3DS86 Q6P445 Q86VJ1 Q96F34 Q9UFZ7,E3 ubiquitin-protein ligase HECTD1,E3 ligase for inhibin receptor;EULIR;HECT domain-containing protein 1;HECT-type E3 ubiquitin transferase HECTD1;, PF12796;PF18410;PF00632;PF06701;PF07738;, GO:0046872;GO:0061630;GO:0048856;GO:0035904;GO:0003170;GO:0032436;GO:0070534;GO:0003281;, , F:metal ion binding; F:ubiquitin protein ligase activity;, P:anatomical structure development; P:aorta development; P:heart valve development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein K63-linked ubiquitination; P:ventricular septum development;|Q9ULT8 D3DS86 Q6P445 Q86VJ1 Q96F34 Q9UFZ7,E3 ubiquitin-protein ligase HECTD1,E3 ligase for inhibin receptor;EULIR;HECT domain-containing protein 1;HECT-type E3 ubiquitin transferase HECTD1;, PF12796;PF18410;PF00632;PF06701;PF07738;, GO:0046872;GO:0061630;GO:0048856;GO:0035904;GO:0003170;GO:0032436;GO:0070534;GO:0003281;, , F:metal ion binding; F:ubiquitin protein ligase activity;, P:anatomical structure development; P:aorta development; P:heart valve development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein K63-linked ubiquitination; P:ventricular septum development;|Q9ULT8 D3DS86 Q6P445 Q86VJ1 Q96F34 Q9UFZ7,E3 ubiquitin-protein ligase HECTD1,E3 ligase for inhibin receptor;EULIR;HECT domain-containing protein 1;HECT-type E3 ubiquitin transferase HECTD1;, PF12796;PF18410;PF00632;PF06701;PF07738;, GO:0046872;GO:0061630;GO:0048856;GO:0035904;GO:0003170;GO:0032436;GO:0070534;GO:0003281;, , F:metal ion binding; F:ubiquitin protein ligase activity;, P:anatomical structure development; P:aorta development; P:heart valve development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein K63-linked ubiquitination; P:ventricular septum development;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi; scaffold27 indexed_genome mRNA 6728906 6808175 . - . ID=transcript_5992;Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi;|Q86XA9 Q68DD8 Q6P3S5 Q6P5R9 Q9H8D7 Q9NXB7 Q9P2N0 Q9UFQ3,HEAT repeat-containing protein 5A,, , GO:0005829;GO:0030139;GO:0006897;GO:0008104;GO:0042147;, C:cytosol; C:endocytic vesicle;, , P:endocytosis; P:protein localization; P:retrograde transport, endosome to Golgi; scaffold27 indexed_genome mRNA 6832242 6847847 . - . ID=transcript_5993;Q96FN9 D3DS87,D-aminoacyl-tRNA deacylase 2 {ECO:0000305},Animalia-specific tRNA deacylase {ECO:0000303|PubMed:29410408};D-tyrosyl-tRNA(Tyr) deacylase 2 {ECO:0000305};L-alanyl-tRNA deacylase {ECO:0000305|PubMed:29410408};, PF02580;, GO:0005737;GO:0106105;GO:0051500;GO:0000049;GO:0106074;GO:0006399;, C:cytoplasm;, F:Ala-tRNA(Thr) hydrolase activity; F:D-tyrosyl-tRNA(Tyr) deacylase activity; F:tRNA binding;, P:aminoacyl-tRNA metabolism involved in translational fidelity; P:tRNA metabolic process;|Q96FN9 D3DS87,D-aminoacyl-tRNA deacylase 2 {ECO:0000305},Animalia-specific tRNA deacylase {ECO:0000303|PubMed:29410408};D-tyrosyl-tRNA(Tyr) deacylase 2 {ECO:0000305};L-alanyl-tRNA deacylase {ECO:0000305|PubMed:29410408};, PF02580;, GO:0005737;GO:0106105;GO:0051500;GO:0000049;GO:0106074;GO:0006399;, C:cytoplasm;, F:Ala-tRNA(Thr) hydrolase activity; F:D-tyrosyl-tRNA(Tyr) deacylase activity; F:tRNA binding;, P:aminoacyl-tRNA metabolism involved in translational fidelity; P:tRNA metabolic process;|Q96FN9 D3DS87,D-aminoacyl-tRNA deacylase 2 {ECO:0000305},Animalia-specific tRNA deacylase {ECO:0000303|PubMed:29410408};D-tyrosyl-tRNA(Tyr) deacylase 2 {ECO:0000305};L-alanyl-tRNA deacylase {ECO:0000305|PubMed:29410408};, PF02580;, GO:0005737;GO:0106105;GO:0051500;GO:0000049;GO:0106074;GO:0006399;, C:cytoplasm;, F:Ala-tRNA(Thr) hydrolase activity; F:D-tyrosyl-tRNA(Tyr) deacylase activity; F:tRNA binding;, P:aminoacyl-tRNA metabolism involved in translational fidelity; P:tRNA metabolic process; scaffold27 indexed_genome mRNA 6934176 7161246 . + . ID=transcript_5994;Q8TB37 B4DHZ1 Q86TZ4 Q9H9M2,Iron-sulfur protein NUBPL,IND1 homolog;Nucleotide-binding protein-like;huInd1;, PF10609;, GO:0005759;GO:0005739;GO:0005886;GO:0051539;GO:0005524;GO:0016887;GO:0046872;GO:0016226;GO:0032981;GO:0070584;, C:mitochondrial matrix; C:mitochondrion; C:plasma membrane;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:metal ion binding;, P:iron-sulfur cluster assembly; P:mitochondrial respiratory chain complex I assembly; P:mitochondrion morphogenesis; scaffold27 indexed_genome mRNA 7379489 7438051 . + . ID=transcript_5995;Q6DHZ3,Rho GTPase-activating protein 5,Rho-type GTPase-activating protein 5;p190-B {ECO:0000303|PubMed:28894085, ECO:0000303|PubMed:8537347};, PF01846;PF00071;PF00620;PF16512;, GO:0005737;GO:0005829;GO:0005783;GO:0005886;GO:0005525;GO:0005096;GO:0003924;GO:0042169;GO:0007155;GO:0030879;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:plasma membrane;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:SH2 domain binding;, P:cell adhesion; P:mammary gland development; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold27 indexed_genome mRNA 7778372 8067099 . + . ID=transcript_5996;Q13023 A7E242 A7E2D4 O15028,A-kinase anchor protein 6,A-kinase anchor protein 100 kDa;Protein kinase A-anchoring protein 6;mAKAP;, , GO:0034704;GO:0005901;GO:0005737;GO:0014704;GO:0014701;GO:0005635;GO:0031965;GO:0048471;GO:0016529;GO:0030315;GO:0008179;GO:0044325;GO:0060090;GO:0051018;GO:0034237;GO:0043495;GO:0001508;GO:0019933;GO:0071320;GO:0071345;GO:0070886;GO:0030307;GO:0061051;GO:1902261;GO:1901381;GO:0051281;GO:0060316;GO:0006605;GO:0060306;GO:0010738;GO:0010880;, C:calcium channel complex; C:caveola; C:cytoplasm; C:intercalated disc; C:junctional sarcoplasmic reticulum membrane; C:nuclear envelope; C:nuclear membrane; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum; C:T-tubule;, F:adenylate cyclase binding; F:ion channel binding; F:molecular adaptor activity; F:protein kinase A binding; F:protein kinase A regulatory subunit binding; F:protein-membrane adaptor activity;, P:action potential; P:cAMP-mediated signaling; P:cellular response to cAMP; P:cellular response to cytokine stimulus; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cell growth; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of delayed rectifier potassium channel activity; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:protein targeting; P:regulation of membrane repolarization; P:regulation of protein kinase A signaling; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; scaffold27 indexed_genome mRNA 9188031 9217956 . - . ID=transcript_5997;Q9H6Z9 Q2TA79 Q3B8N4 Q6P1R2,Prolyl hydroxylase EGLN3 {ECO:0000305},Egl nine homolog 3;HPH-1;Hypoxia-inducible factor prolyl hydroxylase 3;Prolyl hydroxylase domain-containing protein 3 {ECO:0000303|PubMed:12181324};, PF13640;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016706;GO:0008198;GO:0031418;GO:0031545;GO:0031543;GO:0006919;GO:0006915;GO:0006974;GO:0071456;GO:0018401;GO:0018126;GO:0042127;GO:0043523;GO:0061418;GO:0001666;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:ferrous iron binding; F:L-ascorbic acid binding; F:peptidyl-proline 4-dioxygenase activity; F:peptidyl-proline dioxygenase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:protein hydroxylation; P:regulation of cell population proliferation; P:regulation of neuron apoptotic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to hypoxia; scaffold27 indexed_genome mRNA 9710491 9712466 . - . ID=transcript_5998;Q969W0 B2RD54 D3DS93 Q8WTZ7,Serine palmitoyltransferase small subunit A {ECO:0000305},Small subunit of serine palmitoyltransferase A;, PF11779;, GO:0005783;GO:0005789;GO:0016021;GO:0017059;GO:0004758;GO:0046513;GO:0008104;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:serine C-palmitoyltransferase complex;, F:serine C-palmitoyltransferase activity;, P:ceramide biosynthetic process; P:protein localization; P:sphingolipid biosynthetic process; scaffold27 indexed_genome mRNA 9763831 9780863 . - . ID=transcript_5999;Q56P03 Q9BVF4 Q9NWV5 Q9NZ86,E2F-associated phosphoprotein,, PF10238;, GO:0005737;GO:0005634;GO:0034244;GO:0008284;GO:0032968;, C:cytoplasm; C:nucleus;, , P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of cell population proliferation; P:positive regulation of transcription elongation from RNA polymerase II promoter; scaffold27 indexed_genome mRNA 9829320 9873608 . - . ID=transcript_6000;Q9UNH7 C0H5W9 Q9Y449,Sorting nexin-6,TRAF4-associated factor 2;, PF00787;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0005634;GO:0030904;GO:0030905;GO:0097422;GO:0034452;GO:0035091;GO:0042803;GO:1904646;GO:0006886;GO:0007175;GO:0043524;GO:0045892;GO:0030512;GO:0016241;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:nucleus; C:retromer complex; C:retromer, tubulation complex; C:tubular endosome;, F:dynactin binding; F:phosphatidylinositol binding; F:protein homodimerization activity;, P:cellular response to amyloid-beta; P:intracellular protein transport; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi;|Q9UNH7 C0H5W9 Q9Y449,Sorting nexin-6,TRAF4-associated factor 2;, PF00787;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0005634;GO:0030904;GO:0030905;GO:0097422;GO:0034452;GO:0035091;GO:0042803;GO:1904646;GO:0006886;GO:0007175;GO:0043524;GO:0045892;GO:0030512;GO:0016241;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:nucleus; C:retromer complex; C:retromer, tubulation complex; C:tubular endosome;, F:dynactin binding; F:phosphatidylinositol binding; F:protein homodimerization activity;, P:cellular response to amyloid-beta; P:intracellular protein transport; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi;|Q9UNH7 C0H5W9 Q9Y449,Sorting nexin-6,TRAF4-associated factor 2;, PF00787;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0005634;GO:0030904;GO:0030905;GO:0097422;GO:0034452;GO:0035091;GO:0042803;GO:1904646;GO:0006886;GO:0007175;GO:0043524;GO:0045892;GO:0030512;GO:0016241;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:nucleus; C:retromer complex; C:retromer, tubulation complex; C:tubular endosome;, F:dynactin binding; F:phosphatidylinositol binding; F:protein homodimerization activity;, P:cellular response to amyloid-beta; P:intracellular protein transport; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi; scaffold27 indexed_genome mRNA 9922764 9926975 . - . ID=transcript_6001;Q9Y281 G3V5P4,Cofilin-2,Cofilin, muscle isoform;, PF00241;, GO:0015629;GO:0005737;GO:0070062;GO:0005615;GO:0031674;GO:0016363;GO:0030018;GO:0051015;GO:0030042;GO:0030043;GO:0051014;GO:0048870;GO:0046716;GO:0030836;GO:0045214;GO:0007519;, C:actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:I band; C:nuclear matrix; C:Z disc;, F:actin filament binding;, P:actin filament depolymerization; P:actin filament fragmentation; P:actin filament severing; P:cell motility; P:muscle cell cellular homeostasis; P:positive regulation of actin filament depolymerization; P:sarcomere organization; P:skeletal muscle tissue development; scaffold27 indexed_genome mRNA 9938913 9984514 . - . ID=transcript_6002;Q9NRL2 Q9NZ15 Q9P065 Q9UIG1 Q9Y3V3,Bromodomain adjacent to zinc finger domain protein 1A,ATP-dependent chromatin-remodeling protein;ATP-utilizing chromatin assembly and remodeling factor 1;CHRAC subunit ACF1;Williams syndrome transcription factor-related chromatin-remodeling factor 180;hWALp1;, PF00439;PF02791;PF00628;PF10537;PF15612;PF15613;, GO:0016590;GO:0008623;GO:0000228;GO:0046872;GO:0006338;GO:0006261;GO:0016573;GO:0006357;, C:ACF complex; C:CHRAC; C:nuclear chromosome;, F:metal ion binding;, P:chromatin remodeling; P:DNA-dependent DNA replication; P:histone acetylation; P:regulation of transcription by RNA polymerase II; scaffold27 indexed_genome mRNA 10033090 10034115 . + . ID=transcript_6003;Q9NRL2 Q9NZ15 Q9P065 Q9UIG1 Q9Y3V3,Bromodomain adjacent to zinc finger domain protein 1A,ATP-dependent chromatin-remodeling protein;ATP-utilizing chromatin assembly and remodeling factor 1;CHRAC subunit ACF1;Williams syndrome transcription factor-related chromatin-remodeling factor 180;hWALp1;, PF00439;PF02791;PF00628;PF10537;PF15612;PF15613;, GO:0016590;GO:0008623;GO:0000228;GO:0046872;GO:0006338;GO:0006261;GO:0016573;GO:0006357;, C:ACF complex; C:CHRAC; C:nuclear chromosome;, F:metal ion binding;, P:chromatin remodeling; P:DNA-dependent DNA replication; P:histone acetylation; P:regulation of transcription by RNA polymerase II; scaffold27 indexed_genome mRNA 10126160 10168088 . + . ID=transcript_6004;P61011 B2R759 B4DUW6 P13624,Signal recognition particle 54 kDa protein {ECO:0000305},, PF00448;PF02881;PF02978;, GO:0005737;GO:0005829;GO:0005783;GO:0016607;GO:0005634;GO:0005786;GO:0008312;GO:0030942;GO:0019003;GO:0005525;GO:0003924;GO:0043021;GO:0003723;GO:0031017;GO:0030851;GO:0030593;GO:0045047;GO:0006614;GO:0006617;GO:0006616;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear speck; C:nucleus; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ribonucleoprotein complex binding; F:RNA binding;, P:exocrine pancreas development; P:granulocyte differentiation; P:neutrophil chemotaxis; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61011 B2R759 B4DUW6 P13624,Signal recognition particle 54 kDa protein {ECO:0000305},, PF00448;PF02881;PF02978;, GO:0005737;GO:0005829;GO:0005783;GO:0016607;GO:0005634;GO:0005786;GO:0008312;GO:0030942;GO:0019003;GO:0005525;GO:0003924;GO:0043021;GO:0003723;GO:0031017;GO:0030851;GO:0030593;GO:0045047;GO:0006614;GO:0006617;GO:0006616;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear speck; C:nucleus; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ribonucleoprotein complex binding; F:RNA binding;, P:exocrine pancreas development; P:granulocyte differentiation; P:neutrophil chemotaxis; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61011 B2R759 B4DUW6 P13624,Signal recognition particle 54 kDa protein {ECO:0000305},, PF00448;PF02881;PF02978;, GO:0005737;GO:0005829;GO:0005783;GO:0016607;GO:0005634;GO:0005786;GO:0008312;GO:0030942;GO:0019003;GO:0005525;GO:0003924;GO:0043021;GO:0003723;GO:0031017;GO:0030851;GO:0030593;GO:0045047;GO:0006614;GO:0006617;GO:0006616;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear speck; C:nucleus; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ribonucleoprotein complex binding; F:RNA binding;, P:exocrine pancreas development; P:granulocyte differentiation; P:neutrophil chemotaxis; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61011 B2R759 B4DUW6 P13624,Signal recognition particle 54 kDa protein {ECO:0000305},, PF00448;PF02881;PF02978;, GO:0005737;GO:0005829;GO:0005783;GO:0016607;GO:0005634;GO:0005786;GO:0008312;GO:0030942;GO:0019003;GO:0005525;GO:0003924;GO:0043021;GO:0003723;GO:0031017;GO:0030851;GO:0030593;GO:0045047;GO:0006614;GO:0006617;GO:0006616;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear speck; C:nucleus; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ribonucleoprotein complex binding; F:RNA binding;, P:exocrine pancreas development; P:granulocyte differentiation; P:neutrophil chemotaxis; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61011 B2R759 B4DUW6 P13624,Signal recognition particle 54 kDa protein {ECO:0000305},, PF00448;PF02881;PF02978;, GO:0005737;GO:0005829;GO:0005783;GO:0016607;GO:0005634;GO:0005786;GO:0008312;GO:0030942;GO:0019003;GO:0005525;GO:0003924;GO:0043021;GO:0003723;GO:0031017;GO:0030851;GO:0030593;GO:0045047;GO:0006614;GO:0006617;GO:0006616;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear speck; C:nucleus; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ribonucleoprotein complex binding; F:RNA binding;, P:exocrine pancreas development; P:granulocyte differentiation; P:neutrophil chemotaxis; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61011 B2R759 B4DUW6 P13624,Signal recognition particle 54 kDa protein {ECO:0000305},, PF00448;PF02881;PF02978;, GO:0005737;GO:0005829;GO:0005783;GO:0016607;GO:0005634;GO:0005786;GO:0008312;GO:0030942;GO:0019003;GO:0005525;GO:0003924;GO:0043021;GO:0003723;GO:0031017;GO:0030851;GO:0030593;GO:0045047;GO:0006614;GO:0006617;GO:0006616;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear speck; C:nucleus; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ribonucleoprotein complex binding; F:RNA binding;, P:exocrine pancreas development; P:granulocyte differentiation; P:neutrophil chemotaxis; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; P:SRP-dependent cotranslational protein targeting to membrane, translocation; scaffold27 indexed_genome mRNA 10177999 10217050 . + . ID=transcript_6005;Q969Q6 B4DEN7 D3DS97 D3DS98 Q5GJ55 Q5GJ56 Q6P4G2 Q86TZ3 Q9NWR9,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma,Protein phosphatase subunit G5PR;Rhabdomyosarcoma antigen MU-RMS-40.6A/6C;, PF17958;, GO:0005813;GO:0005829;GO:0005794;GO:0005654;GO:0005819;GO:0046872;GO:0032147;GO:0001782;GO:0030865;GO:0000226;GO:0045579;GO:0002759;GO:0035303;GO:0051900;GO:0048536;GO:0043029;, C:centrosome; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:spindle;, F:metal ion binding;, P:activation of protein kinase activity; P:B cell homeostasis; P:cortical cytoskeleton organization; P:microtubule cytoskeleton organization; P:positive regulation of B cell differentiation; P:regulation of antimicrobial humoral response; P:regulation of dephosphorylation; P:regulation of mitochondrial depolarization; P:spleen development; P:T cell homeostasis;|Q8N128 Q68CT2,Protein FAM177A1,, PF14774;|Q8N128 Q68CT2,Protein FAM177A1,, PF14774;|Q8N128 Q68CT2,Protein FAM177A1,, PF14774;|Q969Q6 B4DEN7 D3DS97 D3DS98 Q5GJ55 Q5GJ56 Q6P4G2 Q86TZ3 Q9NWR9,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma,Protein phosphatase subunit G5PR;Rhabdomyosarcoma antigen MU-RMS-40.6A/6C;, PF17958;, GO:0005813;GO:0005829;GO:0005794;GO:0005654;GO:0005819;GO:0046872;GO:0032147;GO:0001782;GO:0030865;GO:0000226;GO:0045579;GO:0002759;GO:0035303;GO:0051900;GO:0048536;GO:0043029;, C:centrosome; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:spindle;, F:metal ion binding;, P:activation of protein kinase activity; P:B cell homeostasis; P:cortical cytoskeleton organization; P:microtubule cytoskeleton organization; P:positive regulation of B cell differentiation; P:regulation of antimicrobial humoral response; P:regulation of dephosphorylation; P:regulation of mitochondrial depolarization; P:spleen development; P:T cell homeostasis;|Q969Q6 B4DEN7 D3DS97 D3DS98 Q5GJ55 Q5GJ56 Q6P4G2 Q86TZ3 Q9NWR9,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma,Protein phosphatase subunit G5PR;Rhabdomyosarcoma antigen MU-RMS-40.6A/6C;, PF17958;, GO:0005813;GO:0005829;GO:0005794;GO:0005654;GO:0005819;GO:0046872;GO:0032147;GO:0001782;GO:0030865;GO:0000226;GO:0045579;GO:0002759;GO:0035303;GO:0051900;GO:0048536;GO:0043029;, C:centrosome; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:spindle;, F:metal ion binding;, P:activation of protein kinase activity; P:B cell homeostasis; P:cortical cytoskeleton organization; P:microtubule cytoskeleton organization; P:positive regulation of B cell differentiation; P:regulation of antimicrobial humoral response; P:regulation of dephosphorylation; P:regulation of mitochondrial depolarization; P:spleen development; P:T cell homeostasis;|Q969Q6 B4DEN7 D3DS97 D3DS98 Q5GJ55 Q5GJ56 Q6P4G2 Q86TZ3 Q9NWR9,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma,Protein phosphatase subunit G5PR;Rhabdomyosarcoma antigen MU-RMS-40.6A/6C;, PF17958;, GO:0005813;GO:0005829;GO:0005794;GO:0005654;GO:0005819;GO:0046872;GO:0032147;GO:0001782;GO:0030865;GO:0000226;GO:0045579;GO:0002759;GO:0035303;GO:0051900;GO:0048536;GO:0043029;, C:centrosome; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:spindle;, F:metal ion binding;, P:activation of protein kinase activity; P:B cell homeostasis; P:cortical cytoskeleton organization; P:microtubule cytoskeleton organization; P:positive regulation of B cell differentiation; P:regulation of antimicrobial humoral response; P:regulation of dephosphorylation; P:regulation of mitochondrial depolarization; P:spleen development; P:T cell homeostasis;|Q969Q6 B4DEN7 D3DS97 D3DS98 Q5GJ55 Q5GJ56 Q6P4G2 Q86TZ3 Q9NWR9,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma,Protein phosphatase subunit G5PR;Rhabdomyosarcoma antigen MU-RMS-40.6A/6C;, PF17958;, GO:0005813;GO:0005829;GO:0005794;GO:0005654;GO:0005819;GO:0046872;GO:0032147;GO:0001782;GO:0030865;GO:0000226;GO:0045579;GO:0002759;GO:0035303;GO:0051900;GO:0048536;GO:0043029;, C:centrosome; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:spindle;, F:metal ion binding;, P:activation of protein kinase activity; P:B cell homeostasis; P:cortical cytoskeleton organization; P:microtubule cytoskeleton organization; P:positive regulation of B cell differentiation; P:regulation of antimicrobial humoral response; P:regulation of dephosphorylation; P:regulation of mitochondrial depolarization; P:spleen development; P:T cell homeostasis; scaffold27 indexed_genome mRNA 10367509 10368439 . - . ID=transcript_6006;P60900 B2R7J9 B4DQR4 B4DXJ9 P34062 Q6IB60,Proteasome subunit alpha type-6,27 kDa prosomal protein;Macropain iota chain;Multicatalytic endopeptidase complex iota chain;Proteasome iota chain;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0030016;GO:0016363;GO:0005654;GO:0005634;GO:0000932;GO:0005844;GO:0000502;GO:0005839;GO:0019773;GO:0030017;GO:0004175;GO:0051059;GO:0035639;GO:0003723;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0051092;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0051603;GO:0006521;GO:1902036;GO:0050727;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:myofibril; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:P-body; C:polysome; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:sarcomere;, F:endopeptidase activity; F:NF-kappaB binding; F:purine ribonucleoside triphosphate binding; F:RNA binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis involved in cellular protein catabolic process; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of inflammatory response; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold27 indexed_genome mRNA 10368940 10371789 . - . ID=transcript_6007;P60900 B2R7J9 B4DQR4 B4DXJ9 P34062 Q6IB60,Proteasome subunit alpha type-6,27 kDa prosomal protein;Macropain iota chain;Multicatalytic endopeptidase complex iota chain;Proteasome iota chain;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0030016;GO:0016363;GO:0005654;GO:0005634;GO:0000932;GO:0005844;GO:0000502;GO:0005839;GO:0019773;GO:0030017;GO:0004175;GO:0051059;GO:0035639;GO:0003723;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0051092;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0051603;GO:0006521;GO:1902036;GO:0050727;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:myofibril; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:P-body; C:polysome; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:sarcomere;, F:endopeptidase activity; F:NF-kappaB binding; F:purine ribonucleoside triphosphate binding; F:RNA binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis involved in cellular protein catabolic process; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of inflammatory response; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P60900 B2R7J9 B4DQR4 B4DXJ9 P34062 Q6IB60,Proteasome subunit alpha type-6,27 kDa prosomal protein;Macropain iota chain;Multicatalytic endopeptidase complex iota chain;Proteasome iota chain;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0030016;GO:0016363;GO:0005654;GO:0005634;GO:0000932;GO:0005844;GO:0000502;GO:0005839;GO:0019773;GO:0030017;GO:0004175;GO:0051059;GO:0035639;GO:0003723;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0051092;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0051603;GO:0006521;GO:1902036;GO:0050727;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:myofibril; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:P-body; C:polysome; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:sarcomere;, F:endopeptidase activity; F:NF-kappaB binding; F:purine ribonucleoside triphosphate binding; F:RNA binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis involved in cellular protein catabolic process; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of inflammatory response; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold27 indexed_genome mRNA 10371845 10374196 . + . ID=transcript_6008;P60900 B2R7J9 B4DQR4 B4DXJ9 P34062 Q6IB60,Proteasome subunit alpha type-6,27 kDa prosomal protein;Macropain iota chain;Multicatalytic endopeptidase complex iota chain;Proteasome iota chain;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0030016;GO:0016363;GO:0005654;GO:0005634;GO:0000932;GO:0005844;GO:0000502;GO:0005839;GO:0019773;GO:0030017;GO:0004175;GO:0051059;GO:0035639;GO:0003723;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0051092;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0051603;GO:0006521;GO:1902036;GO:0050727;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:myofibril; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:P-body; C:polysome; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:sarcomere;, F:endopeptidase activity; F:NF-kappaB binding; F:purine ribonucleoside triphosphate binding; F:RNA binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis involved in cellular protein catabolic process; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of inflammatory response; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold27 indexed_genome mRNA 10439351 10440841 . - . ID=transcript_6009;P25963 B2R8L6,NF-kappa-B inhibitor alpha,I-kappa-B-alpha;Major histocompatibility complex enhancer-binding protein MAD3;, PF00023;PF12796;, GO:0005737;GO:0005829;GO:0033256;GO:0005654;GO:0005634;GO:0005886;GO:0019899;GO:0042802;GO:0051059;GO:0008139;GO:0008134;GO:0031625;GO:0006915;GO:0070417;GO:0007253;GO:0042994;GO:0007249;GO:0070498;GO:0031663;GO:0043066;GO:0043392;GO:0010888;GO:0010745;GO:0045638;GO:0032088;GO:0045746;GO:0070427;GO:0070431;GO:0032270;GO:0010875;GO:0050729;GO:0051092;GO:0045944;GO:0016579;GO:0006606;GO:0042127;GO:1901222;GO:0043330;GO:0032495;GO:0035994;GO:0034142;GO:0033209;GO:0016032;, C:cytoplasm; C:cytosol; C:I-kappaB/NF-kappaB complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:enzyme binding; F:identical protein binding; F:NF-kappaB binding; F:nuclear localization sequence binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cellular response to cold; P:cytoplasmic sequestering of NF-kappaB; P:cytoplasmic sequestering of transcription factor; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of DNA binding; P:negative regulation of lipid storage; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of myeloid cell differentiation; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of Notch signaling pathway; P:nucleotide-binding oligomerization domain containing 1 signaling pathway; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol efflux; P:positive regulation of inflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein import into nucleus; P:regulation of cell population proliferation; P:regulation of NIK/NF-kappaB signaling; P:response to exogenous dsRNA; P:response to muramyl dipeptide; P:response to muscle stretch; P:toll-like receptor 4 signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|P25963 B2R8L6,NF-kappa-B inhibitor alpha,I-kappa-B-alpha;Major histocompatibility complex enhancer-binding protein MAD3;, PF00023;PF12796;, GO:0005737;GO:0005829;GO:0033256;GO:0005654;GO:0005634;GO:0005886;GO:0019899;GO:0042802;GO:0051059;GO:0008139;GO:0008134;GO:0031625;GO:0006915;GO:0070417;GO:0007253;GO:0042994;GO:0007249;GO:0070498;GO:0031663;GO:0043066;GO:0043392;GO:0010888;GO:0010745;GO:0045638;GO:0032088;GO:0045746;GO:0070427;GO:0070431;GO:0032270;GO:0010875;GO:0050729;GO:0051092;GO:0045944;GO:0016579;GO:0006606;GO:0042127;GO:1901222;GO:0043330;GO:0032495;GO:0035994;GO:0034142;GO:0033209;GO:0016032;, C:cytoplasm; C:cytosol; C:I-kappaB/NF-kappaB complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:enzyme binding; F:identical protein binding; F:NF-kappaB binding; F:nuclear localization sequence binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cellular response to cold; P:cytoplasmic sequestering of NF-kappaB; P:cytoplasmic sequestering of transcription factor; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of DNA binding; P:negative regulation of lipid storage; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of myeloid cell differentiation; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of Notch signaling pathway; P:nucleotide-binding oligomerization domain containing 1 signaling pathway; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol efflux; P:positive regulation of inflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein import into nucleus; P:regulation of cell population proliferation; P:regulation of NIK/NF-kappaB signaling; P:response to exogenous dsRNA; P:response to muramyl dipeptide; P:response to muscle stretch; P:toll-like receptor 4 signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process; scaffold27 indexed_genome mRNA 10565907 10764260 . - . ID=transcript_6010;Q8ND69,Ral GTPase-activating protein subunit alpha-1,GAP-related-interacting partner to E12;GTPase-activating Rap/Ran-GAP domain-like 1;Tuberin-like protein 1;p240;, PF02145;, GO:0005737;GO:0005634;GO:0005096;GO:0046982;GO:0090630;GO:0051056;, C:cytoplasm; C:nucleus;, F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q8ND69,Ral GTPase-activating protein subunit alpha-1,GAP-related-interacting partner to E12;GTPase-activating Rap/Ran-GAP domain-like 1;Tuberin-like protein 1;p240;, PF02145;, GO:0005737;GO:0005634;GO:0005096;GO:0046982;GO:0090630;GO:0051056;, C:cytoplasm; C:nucleus;, F:GTPase activator activity; F:protein heterodimerization activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold27 indexed_genome mRNA 10785225 10826098 . + . ID=transcript_6011;Q5PSV4 A6NFW5 A6NH45 B2RD65 Q9BRI4,Breast cancer metastasis-suppressor 1-like protein,BRMS1-homolog protein p40;BRMS1-like protein p40;, PF08598;, GO:0070822;GO:0042826;GO:0016575;GO:0000122;GO:0040008;, C:Sin3-type complex;, F:histone deacetylase binding;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of growth;|Q5PSV4 A6NFW5 A6NH45 B2RD65 Q9BRI4,Breast cancer metastasis-suppressor 1-like protein,BRMS1-homolog protein p40;BRMS1-like protein p40;, PF08598;, GO:0070822;GO:0042826;GO:0016575;GO:0000122;GO:0040008;, C:Sin3-type complex;, F:histone deacetylase binding;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of growth;|Q5PSV4 A6NFW5 A6NH45 B2RD65 Q9BRI4,Breast cancer metastasis-suppressor 1-like protein,BRMS1-homolog protein p40;BRMS1-like protein p40;, PF08598;, GO:0070822;GO:0042826;GO:0016575;GO:0000122;GO:0040008;, C:Sin3-type complex;, F:histone deacetylase binding;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of growth; scaffold27 indexed_genome mRNA 11182602 11225491 . + . ID=transcript_6012;Q9NS73 Q86TZ2 Q96AS5 Q9BS93 Q9NZE1,MAP3K12-binding inhibitory protein 1,MAPK upstream kinase-binding inhibitory protein;, , GO:0005671;GO:0005829;GO:0005730;GO:0005654;GO:0042802;GO:0004860;GO:0043966;GO:0000173;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytosol; C:nucleolus; C:nucleoplasm;, F:identical protein binding; F:protein kinase inhibitor activity;, P:histone H3 acetylation; P:inactivation of MAPK activity involved in osmosensory signaling pathway;|Q9NS73 Q86TZ2 Q96AS5 Q9BS93 Q9NZE1,MAP3K12-binding inhibitory protein 1,MAPK upstream kinase-binding inhibitory protein;, , GO:0005671;GO:0005829;GO:0005730;GO:0005654;GO:0042802;GO:0004860;GO:0043966;GO:0000173;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytosol; C:nucleolus; C:nucleoplasm;, F:identical protein binding; F:protein kinase inhibitor activity;, P:histone H3 acetylation; P:inactivation of MAPK activity involved in osmosensory signaling pathway; scaffold27 indexed_genome mRNA 11225529 11232726 . + . ID=transcript_6013;Q9NS73 Q86TZ2 Q96AS5 Q9BS93 Q9NZE1,MAP3K12-binding inhibitory protein 1,MAPK upstream kinase-binding inhibitory protein;, , GO:0005671;GO:0005829;GO:0005730;GO:0005654;GO:0042802;GO:0004860;GO:0043966;GO:0000173;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytosol; C:nucleolus; C:nucleoplasm;, F:identical protein binding; F:protein kinase inhibitor activity;, P:histone H3 acetylation; P:inactivation of MAPK activity involved in osmosensory signaling pathway;|Q9NS73 Q86TZ2 Q96AS5 Q9BS93 Q9NZE1,MAP3K12-binding inhibitory protein 1,MAPK upstream kinase-binding inhibitory protein;, , GO:0005671;GO:0005829;GO:0005730;GO:0005654;GO:0042802;GO:0004860;GO:0043966;GO:0000173;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytosol; C:nucleolus; C:nucleoplasm;, F:identical protein binding; F:protein kinase inhibitor activity;, P:histone H3 acetylation; P:inactivation of MAPK activity involved in osmosensory signaling pathway;|Q9NS73 Q86TZ2 Q96AS5 Q9BS93 Q9NZE1,MAP3K12-binding inhibitory protein 1,MAPK upstream kinase-binding inhibitory protein;, , GO:0005671;GO:0005829;GO:0005730;GO:0005654;GO:0042802;GO:0004860;GO:0043966;GO:0000173;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytosol; C:nucleolus; C:nucleoplasm;, F:identical protein binding; F:protein kinase inhibitor activity;, P:histone H3 acetylation; P:inactivation of MAPK activity involved in osmosensory signaling pathway;|Q9NS73 Q86TZ2 Q96AS5 Q9BS93 Q9NZE1,MAP3K12-binding inhibitory protein 1,MAPK upstream kinase-binding inhibitory protein;, , GO:0005671;GO:0005829;GO:0005730;GO:0005654;GO:0042802;GO:0004860;GO:0043966;GO:0000173;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytosol; C:nucleolus; C:nucleoplasm;, F:identical protein binding; F:protein kinase inhibitor activity;, P:histone H3 acetylation; P:inactivation of MAPK activity involved in osmosensory signaling pathway; scaffold27 indexed_genome mRNA 11387842 11422127 . - . ID=transcript_6014;P0C7M3,Surfactant-associated protein 3,Surfactant-associated protein H;, , GO:0045334;GO:0005737;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0044267;GO:0042060;, C:clathrin-coated endocytic vesicle; C:cytoplasm; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body;, , P:cellular protein metabolic process; P:wound healing; scaffold27 indexed_genome mRNA 11607017 12123779 . - . ID=transcript_6015;Q9BQT8 A8K0L0 G3V4L5 Q3MJ99,Mitochondrial 2-oxodicarboxylate carrier,Solute carrier family 25 member 21;, PF00153;, GO:0016021;GO:0005743;GO:0015139;GO:0006554;GO:1990550;, C:integral component of membrane; C:mitochondrial inner membrane;, F:alpha-ketoglutarate transmembrane transporter activity;, P:lysine catabolic process; P:mitochondrial alpha-ketoglutarate transmembrane transport;|Q9BQT8 A8K0L0 G3V4L5 Q3MJ99,Mitochondrial 2-oxodicarboxylate carrier,Solute carrier family 25 member 21;, PF00153;, GO:0016021;GO:0005743;GO:0015139;GO:0006554;GO:1990550;, C:integral component of membrane; C:mitochondrial inner membrane;, F:alpha-ketoglutarate transmembrane transporter activity;, P:lysine catabolic process; P:mitochondrial alpha-ketoglutarate transmembrane transport;|Q9BQT8 A8K0L0 G3V4L5 Q3MJ99,Mitochondrial 2-oxodicarboxylate carrier,Solute carrier family 25 member 21;, PF00153;, GO:0016021;GO:0005743;GO:0015139;GO:0006554;GO:1990550;, C:integral component of membrane; C:mitochondrial inner membrane;, F:alpha-ketoglutarate transmembrane transporter activity;, P:lysine catabolic process; P:mitochondrial alpha-ketoglutarate transmembrane transport; scaffold27 indexed_genome mRNA 12142172 12437885 . + . ID=transcript_6016;Q8TD10 D3DSA4 Q7Z3J0 Q8IV14,Mirror-image polydactyly gene 1 protein,, , GO:0005634;GO:0042802;, C:nucleus;, F:identical protein binding; scaffold27 indexed_genome mRNA 12477329 12483252 . - . ID=transcript_6017;P55317 B2R9H6 B7ZAP5 Q9H2A0,Hepatocyte nuclear factor 3-alpha,Forkhead box protein A1;Transcription factor 3A;, PF00250;PF08430;PF09354;, GO:0000785;GO:0001650;GO:0005902;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0019904;GO:0000978;GO:1990837;GO:0008134;GO:0000976;GO:0061144;GO:0048646;GO:0009653;GO:0030154;GO:0006338;GO:0071542;GO:0021904;GO:0060743;GO:0060441;GO:0060738;GO:0042593;GO:0042445;GO:0060487;GO:0010719;GO:0000122;GO:0048665;GO:0007219;GO:0043065;GO:2000049;GO:0051091;GO:0033148;GO:0045931;GO:0045666;GO:0045880;GO:0045944;GO:0060740;GO:0060741;GO:0006357;GO:1902691;GO:0032355;GO:0060528;, C:chromatin; C:fibrillar center; C:microvillus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:alveolar secondary septum development; P:anatomical structure formation involved in morphogenesis; P:anatomical structure morphogenesis; P:cell differentiation; P:chromatin remodeling; P:dopaminergic neuron differentiation; P:dorsal/ventral neural tube patterning; P:epithelial cell maturation involved in prostate gland development; P:epithelial tube branching involved in lung morphogenesis; P:epithelial-mesenchymal signaling involved in prostate gland development; P:glucose homeostasis; P:hormone metabolic process; P:lung epithelial cell differentiation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of transcription by RNA polymerase II; P:neuron fate specification; P:Notch signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of mitotic cell cycle; P:positive regulation of neuron differentiation; P:positive regulation of smoothened signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:prostate gland epithelium morphogenesis; P:prostate gland stromal morphogenesis; P:regulation of transcription by RNA polymerase II; P:respiratory basal cell differentiation; P:response to estradiol; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; scaffold27 indexed_genome mRNA 13057695 13060552 . - . ID=transcript_6018;Q86T13 Q695G9 Q6PWT6 Q8N5V5,C-type lectin domain family 14 member A,Epidermal growth factor receptor 5;, , GO:0062023;GO:0009897;GO:0016021;GO:0030246;GO:0050840;GO:1990430;GO:0016477;GO:0002042;GO:0001946;GO:0036324;GO:0036325;, C:collagen-containing extracellular matrix; C:external side of plasma membrane; C:integral component of membrane;, F:carbohydrate binding; F:extracellular matrix binding; F:extracellular matrix protein binding;, P:cell migration; P:cell migration involved in sprouting angiogenesis; P:lymphangiogenesis; P:vascular endothelial growth factor receptor-2 signaling pathway; P:vascular endothelial growth factor receptor-3 signaling pathway; scaffold27 indexed_genome mRNA 13663844 13724597 . - . ID=transcript_6019;Q15436 B2R5P4 B3KXI2 Q8NE16,Protein transport protein Sec23A {ECO:0000305},SEC23-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0019898;GO:0000139;GO:0048471;GO:0005096;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;GO:0072659;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extrinsic component of membrane; C:Golgi membrane; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein localization to plasma membrane;|Q15436 B2R5P4 B3KXI2 Q8NE16,Protein transport protein Sec23A {ECO:0000305},SEC23-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0019898;GO:0000139;GO:0048471;GO:0005096;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;GO:0072659;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extrinsic component of membrane; C:Golgi membrane; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein localization to plasma membrane;|Q15436 B2R5P4 B3KXI2 Q8NE16,Protein transport protein Sec23A {ECO:0000305},SEC23-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0019898;GO:0000139;GO:0048471;GO:0005096;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;GO:0072659;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extrinsic component of membrane; C:Golgi membrane; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein localization to plasma membrane;|Q15436 B2R5P4 B3KXI2 Q8NE16,Protein transport protein Sec23A {ECO:0000305},SEC23-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0019898;GO:0000139;GO:0048471;GO:0005096;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;GO:0072659;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extrinsic component of membrane; C:Golgi membrane; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein localization to plasma membrane;|Q15436 B2R5P4 B3KXI2 Q8NE16,Protein transport protein Sec23A {ECO:0000305},SEC23-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0019898;GO:0000139;GO:0048471;GO:0005096;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;GO:0072659;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extrinsic component of membrane; C:Golgi membrane; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein localization to plasma membrane;|Q15436 B2R5P4 B3KXI2 Q8NE16,Protein transport protein Sec23A {ECO:0000305},SEC23-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0019898;GO:0000139;GO:0048471;GO:0005096;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;GO:0072659;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extrinsic component of membrane; C:Golgi membrane; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein localization to plasma membrane;|Q15436 B2R5P4 B3KXI2 Q8NE16,Protein transport protein Sec23A {ECO:0000305},SEC23-related protein A;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0019898;GO:0000139;GO:0048471;GO:0005096;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0006886;GO:0072659;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extrinsic component of membrane; C:Golgi membrane; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein localization to plasma membrane; scaffold27 indexed_genome mRNA 13737756 13744004 . + . ID=transcript_6020;O14893 B2R9W8 Q2M3B3 Q9H4F5 Q9NS77 Q9NS78 Q9NS79,Gem-associated protein 2,Component of gems 2;Survival of motor neuron protein-interacting protein 1;, PF04938;, GO:0005829;GO:0097504;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0005681;GO:0051170;GO:0006397;GO:0008380;GO:0000375;GO:0000245;GO:0000387;, C:cytosol; C:Gemini of coiled bodies; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex; C:spliceosomal complex;, , P:import into nucleus; P:mRNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly;|O14893 B2R9W8 Q2M3B3 Q9H4F5 Q9NS77 Q9NS78 Q9NS79,Gem-associated protein 2,Component of gems 2;Survival of motor neuron protein-interacting protein 1;, PF04938;, GO:0005829;GO:0097504;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0005681;GO:0051170;GO:0006397;GO:0008380;GO:0000375;GO:0000245;GO:0000387;, C:cytosol; C:Gemini of coiled bodies; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex; C:spliceosomal complex;, , P:import into nucleus; P:mRNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly; scaffold27 indexed_genome mRNA 13744037 13769146 . + . ID=transcript_6021;O14893 B2R9W8 Q2M3B3 Q9H4F5 Q9NS77 Q9NS78 Q9NS79,Gem-associated protein 2,Component of gems 2;Survival of motor neuron protein-interacting protein 1;, PF04938;, GO:0005829;GO:0097504;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0005681;GO:0051170;GO:0006397;GO:0008380;GO:0000375;GO:0000245;GO:0000387;, C:cytosol; C:Gemini of coiled bodies; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex; C:spliceosomal complex;, , P:import into nucleus; P:mRNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly;|O14893 B2R9W8 Q2M3B3 Q9H4F5 Q9NS77 Q9NS78 Q9NS79,Gem-associated protein 2,Component of gems 2;Survival of motor neuron protein-interacting protein 1;, PF04938;, GO:0005829;GO:0097504;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0005681;GO:0051170;GO:0006397;GO:0008380;GO:0000375;GO:0000245;GO:0000387;, C:cytosol; C:Gemini of coiled bodies; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex; C:spliceosomal complex;, , P:import into nucleus; P:mRNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly;|Q86SZ2 B3KPS2 Q5JPD6 Q86U35 Q86X35,Trafficking protein particle complex subunit 6B {ECO:0000303|PubMed:28626029},, PF04051;, GO:0005801;GO:0005829;GO:0005783;GO:0005802;GO:0030008;GO:0048208;GO:0006888;GO:0007399;GO:0043087;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum; C:trans-Golgi network; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:nervous system development; P:regulation of GTPase activity;|Q86SZ2 B3KPS2 Q5JPD6 Q86U35 Q86X35,Trafficking protein particle complex subunit 6B {ECO:0000303|PubMed:28626029},, PF04051;, GO:0005801;GO:0005829;GO:0005783;GO:0005802;GO:0030008;GO:0048208;GO:0006888;GO:0007399;GO:0043087;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum; C:trans-Golgi network; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:nervous system development; P:regulation of GTPase activity;|Q86SZ2 B3KPS2 Q5JPD6 Q86U35 Q86X35,Trafficking protein particle complex subunit 6B {ECO:0000303|PubMed:28626029},, PF04051;, GO:0005801;GO:0005829;GO:0005783;GO:0005802;GO:0030008;GO:0048208;GO:0006888;GO:0007399;GO:0043087;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum; C:trans-Golgi network; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:nervous system development; P:regulation of GTPase activity; scaffold27 indexed_genome mRNA 13772257 13781483 . + . ID=transcript_6022;Q9H307 B4DZX8 O60899 Q53EM7 Q6P5X4 Q7KYL1 Q99738 Q9UHZ9 Q9UQR9,Pinin,140 kDa nuclear and cell adhesion-related phosphoprotein;Desmosome-associated protein;Domain-rich serine protein;Melanoma metastasis clone A protein;Nuclear protein SDK3;SR-like protein;, PF04696;PF04697;, GO:0071013;GO:0005911;GO:0030057;GO:0005882;GO:0016020;GO:0016607;GO:0005886;GO:0003677;GO:0003723;GO:0005198;GO:0007155;GO:0000398;, C:catalytic step 2 spliceosome; C:cell-cell junction; C:desmosome; C:intermediate filament; C:membrane; C:nuclear speck; C:plasma membrane;, F:DNA binding; F:RNA binding; F:structural molecule activity;, P:cell adhesion; P:mRNA splicing, via spliceosome;|Q9H307 B4DZX8 O60899 Q53EM7 Q6P5X4 Q7KYL1 Q99738 Q9UHZ9 Q9UQR9,Pinin,140 kDa nuclear and cell adhesion-related phosphoprotein;Desmosome-associated protein;Domain-rich serine protein;Melanoma metastasis clone A protein;Nuclear protein SDK3;SR-like protein;, PF04696;PF04697;, GO:0071013;GO:0005911;GO:0030057;GO:0005882;GO:0016020;GO:0016607;GO:0005886;GO:0003677;GO:0003723;GO:0005198;GO:0007155;GO:0000398;, C:catalytic step 2 spliceosome; C:cell-cell junction; C:desmosome; C:intermediate filament; C:membrane; C:nuclear speck; C:plasma membrane;, F:DNA binding; F:RNA binding; F:structural molecule activity;, P:cell adhesion; P:mRNA splicing, via spliceosome;|Q9H307 B4DZX8 O60899 Q53EM7 Q6P5X4 Q7KYL1 Q99738 Q9UHZ9 Q9UQR9,Pinin,140 kDa nuclear and cell adhesion-related phosphoprotein;Desmosome-associated protein;Domain-rich serine protein;Melanoma metastasis clone A protein;Nuclear protein SDK3;SR-like protein;, PF04696;PF04697;, GO:0071013;GO:0005911;GO:0030057;GO:0005882;GO:0016020;GO:0016607;GO:0005886;GO:0003677;GO:0003723;GO:0005198;GO:0007155;GO:0000398;, C:catalytic step 2 spliceosome; C:cell-cell junction; C:desmosome; C:intermediate filament; C:membrane; C:nuclear speck; C:plasma membrane;, F:DNA binding; F:RNA binding; F:structural molecule activity;, P:cell adhesion; P:mRNA splicing, via spliceosome; scaffold27 indexed_genome mRNA 13797081 13839368 . + . ID=transcript_6023;Q6MZN2 Q6P2R8 Q86TF6 Q8IX92 Q8IX93 Q9H6C1,Melanoma inhibitory activity protein 2 {ECO:0000305},CTAGE family member 5 ER export factor {ECO:0000312|HGNC:HGNC:18432};Cutaneous T-cell lymphoma-associated antigen 5;Meningioma-expressed antigen 6/11 {ECO:0000303|PubMed:9356211};, PF07653;, GO:0005783;GO:0070971;GO:0005789;GO:0016021;GO:0016020;GO:0038024;GO:0008047;GO:0006888;GO:0042953;GO:0032527;GO:0070973;GO:0009306;GO:0035459;, C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:cargo receptor activity; F:enzyme activator activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:lipoprotein transport; P:protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein secretion; P:vesicle cargo loading;|Q6MZN2 Q6P2R8 Q86TF6 Q8IX92 Q8IX93 Q9H6C1,Melanoma inhibitory activity protein 2 {ECO:0000305},CTAGE family member 5 ER export factor {ECO:0000312|HGNC:HGNC:18432};Cutaneous T-cell lymphoma-associated antigen 5;Meningioma-expressed antigen 6/11 {ECO:0000303|PubMed:9356211};, PF07653;, GO:0005783;GO:0070971;GO:0005789;GO:0016021;GO:0016020;GO:0038024;GO:0008047;GO:0006888;GO:0042953;GO:0032527;GO:0070973;GO:0009306;GO:0035459;, C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:cargo receptor activity; F:enzyme activator activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:lipoprotein transport; P:protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein secretion; P:vesicle cargo loading;|Q8IX94 A8K871 O95046,cTAGE family member 4,, , GO:0070971;GO:0005789;GO:0016021;GO:0006888;GO:0009306;GO:0035459;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein secretion; P:vesicle cargo loading; scaffold27 indexed_genome mRNA 13844336 13888873 . + . ID=transcript_6024;Q6MZN2 Q6P2R8 Q86TF6 Q8IX92 Q8IX93 Q9H6C1,Melanoma inhibitory activity protein 2 {ECO:0000305},CTAGE family member 5 ER export factor {ECO:0000312|HGNC:HGNC:18432};Cutaneous T-cell lymphoma-associated antigen 5;Meningioma-expressed antigen 6/11 {ECO:0000303|PubMed:9356211};, PF07653;, GO:0005783;GO:0070971;GO:0005789;GO:0016021;GO:0016020;GO:0038024;GO:0008047;GO:0006888;GO:0042953;GO:0032527;GO:0070973;GO:0009306;GO:0035459;, C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:cargo receptor activity; F:enzyme activator activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:lipoprotein transport; P:protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein secretion; P:vesicle cargo loading;|Q96RT6 A2RUF2,cTAGE family member 2,Cancer/testis antigen 21.2;, , GO:0070971;GO:0005789;GO:0016021;GO:0006888;GO:0009306;GO:0035459;, C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein secretion; P:vesicle cargo loading; scaffold27 indexed_genome mRNA 13897036 13898641 . + . ID=transcript_6025;Q7Z6M2 Q6PIR2 Q86TR2 Q86YE0,F-box only protein 33,, PF12937;, GO:0019005;GO:0016567;GO:0031146;, C:SCF ubiquitin ligase complex;, , P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold27 indexed_genome mRNA 13898718 13899315 . - . ID=transcript_6026;Q7Z6M2 Q6PIR2 Q86TR2 Q86YE0,F-box only protein 33,, PF12937;, GO:0019005;GO:0016567;GO:0031146;, C:SCF ubiquitin ligase complex;, , P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold27 indexed_genome mRNA 13899903 13901175 . + . ID=transcript_6027;Q7Z6M2 Q6PIR2 Q86TR2 Q86YE0,F-box only protein 33,, PF12937;, GO:0019005;GO:0016567;GO:0031146;, C:SCF ubiquitin ligase complex;, , P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold27 indexed_genome mRNA 13907706 13909837 . - . ID=transcript_6028;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold27 indexed_genome mRNA 15780011 16071707 . + . ID=transcript_6029;Q96NI6 B3KU78 Q86XL2,Leucine-rich repeat and fibronectin type-III domain-containing protein 5,, PF07679;PF13306;, GO:0009986;GO:0098982;GO:0098978;GO:0099061;GO:0050728;GO:0043031;GO:1905606;GO:0099560;, C:cell surface; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of postsynaptic density membrane;, , P:negative regulation of inflammatory response; P:negative regulation of macrophage activation; P:regulation of presynapse assembly; P:synaptic membrane adhesion; scaffold27 indexed_genome mRNA 18881181 18882412 . - . ID=transcript_6030;Q4W4Y0,Uncharacterized protein C14orf28,Dopamine receptor-interacting protein 1;|Q4W4Y0,Uncharacterized protein C14orf28,Dopamine receptor-interacting protein 1; scaffold27 indexed_genome mRNA 18882445 18888065 . - . ID=transcript_6031;Q4W4Y0,Uncharacterized protein C14orf28,Dopamine receptor-interacting protein 1;|Q4W4Y0,Uncharacterized protein C14orf28,Dopamine receptor-interacting protein 1;|Q4W4Y0,Uncharacterized protein C14orf28,Dopamine receptor-interacting protein 1; scaffold27 indexed_genome mRNA 18897157 18909225 . - . ID=transcript_6032;Q9NXS3 Q0VAL5,Kelch-like protein 28,BTB/POZ domain-containing protein 5;, PF07707;PF00651;PF01344;|Q9NXS3 Q0VAL5,Kelch-like protein 28,BTB/POZ domain-containing protein 5;, PF07707;PF00651;PF01344;|Q9NXS3 Q0VAL5,Kelch-like protein 28,BTB/POZ domain-containing protein 5;, PF07707;PF00651;PF01344;|Q9NXS3 Q0VAL5,Kelch-like protein 28,BTB/POZ domain-containing protein 5;, PF07707;PF00651;PF01344;|Q9NXS3 Q0VAL5,Kelch-like protein 28,BTB/POZ domain-containing protein 5;, PF07707;PF00651;PF01344;|Q9NXS3 Q0VAL5,Kelch-like protein 28,BTB/POZ domain-containing protein 5;, PF07707;PF00651;PF01344;|Q9NXS3 Q0VAL5,Kelch-like protein 28,BTB/POZ domain-containing protein 5;, PF07707;PF00651;PF01344; scaffold27 indexed_genome mRNA 18925776 18998762 . + . ID=transcript_6033;Q9Y4F4 Q68D66 Q6PG27,TOG array regulator of axonemal microtubules protein 1 {ECO:0000312|HGNC:HGNC:19959},Crescerin-1 {ECO:0000305};Protein FAM179B;, , GO:0036064;GO:0005929;GO:0005881;GO:0005815;GO:0072686;GO:0005876;GO:0008017;GO:0035082;GO:0000226;GO:0090307;GO:1905515;GO:0031116;, C:ciliary basal body; C:cilium; C:cytoplasmic microtubule; C:microtubule organizing center; C:mitotic spindle; C:spindle microtubule;, F:microtubule binding;, P:axoneme assembly; P:microtubule cytoskeleton organization; P:mitotic spindle assembly; P:non-motile cilium assembly; P:positive regulation of microtubule polymerization;|P60896 Q13437 Q61067,26S proteasome complex subunit SEM1,26S proteasome complex subunit DSS1;Deleted in split hand/split foot protein 1;Split hand/foot deleted protein 1;Split hand/foot malformation type 1 protein;, PF05160;, GO:0005829;GO:0005654;GO:0000502;GO:0008541;GO:0032991;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0006406;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:protein-containing complex;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:mRNA export from nucleus; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold27 indexed_genome mRNA 19000552 19005200 . + . ID=transcript_6034;Q9Y4F4 Q68D66 Q6PG27,TOG array regulator of axonemal microtubules protein 1 {ECO:0000312|HGNC:HGNC:19959},Crescerin-1 {ECO:0000305};Protein FAM179B;, , GO:0036064;GO:0005929;GO:0005881;GO:0005815;GO:0072686;GO:0005876;GO:0008017;GO:0035082;GO:0000226;GO:0090307;GO:1905515;GO:0031116;, C:ciliary basal body; C:cilium; C:cytoplasmic microtubule; C:microtubule organizing center; C:mitotic spindle; C:spindle microtubule;, F:microtubule binding;, P:axoneme assembly; P:microtubule cytoskeleton organization; P:mitotic spindle assembly; P:non-motile cilium assembly; P:positive regulation of microtubule polymerization;|Q9Y4F4 Q68D66 Q6PG27,TOG array regulator of axonemal microtubules protein 1 {ECO:0000312|HGNC:HGNC:19959},Crescerin-1 {ECO:0000305};Protein FAM179B;, , GO:0036064;GO:0005929;GO:0005881;GO:0005815;GO:0072686;GO:0005876;GO:0008017;GO:0035082;GO:0000226;GO:0090307;GO:1905515;GO:0031116;, C:ciliary basal body; C:cilium; C:cytoplasmic microtubule; C:microtubule organizing center; C:mitotic spindle; C:spindle microtubule;, F:microtubule binding;, P:axoneme assembly; P:microtubule cytoskeleton organization; P:mitotic spindle assembly; P:non-motile cilium assembly; P:positive regulation of microtubule polymerization; scaffold27 indexed_genome mRNA 19007151 19051819 . + . ID=transcript_6035;Q86UA1 Q08AL1 Q08AL2 Q9NUU5,Pre-mRNA-processing factor 39,PRP39 homolog;, , GO:0000243;GO:0005685;GO:0071004;GO:0000395;, C:commitment complex; C:U1 snRNP; C:U2-type prespliceosome;, , P:mRNA 5'-splice site recognition;|Q86UA1 Q08AL1 Q08AL2 Q9NUU5,Pre-mRNA-processing factor 39,PRP39 homolog;, , GO:0000243;GO:0005685;GO:0071004;GO:0000395;, C:commitment complex; C:U1 snRNP; C:U2-type prespliceosome;, , P:mRNA 5'-splice site recognition;|Q86UA1 Q08AL1 Q08AL2 Q9NUU5,Pre-mRNA-processing factor 39,PRP39 homolog;, , GO:0000243;GO:0005685;GO:0071004;GO:0000395;, C:commitment complex; C:U1 snRNP; C:U2-type prespliceosome;, , P:mRNA 5'-splice site recognition;|Q86UA1 Q08AL1 Q08AL2 Q9NUU5,Pre-mRNA-processing factor 39,PRP39 homolog;, , GO:0000243;GO:0005685;GO:0071004;GO:0000395;, C:commitment complex; C:U1 snRNP; C:U2-type prespliceosome;, , P:mRNA 5'-splice site recognition;|Q86UA1 Q08AL1 Q08AL2 Q9NUU5,Pre-mRNA-processing factor 39,PRP39 homolog;, , GO:0000243;GO:0005685;GO:0071004;GO:0000395;, C:commitment complex; C:U1 snRNP; C:U2-type prespliceosome;, , P:mRNA 5'-splice site recognition;|Q00688 B2R4Q9 Q14317,Peptidyl-prolyl cis-trans isomerase FKBP3,25 kDa FK506-binding protein;FK506-binding protein 3;Immunophilin FKBP25;Rapamycin-selective 25 kDa immunophilin;Rotamase;, PF18410;PF00254;, GO:0005634;GO:0005528;GO:0003755;GO:0003723;GO:0038023;, C:nucleus;, F:FK506 binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding; F:signaling receptor activity;|Q86UA1 Q08AL1 Q08AL2 Q9NUU5,Pre-mRNA-processing factor 39,PRP39 homolog;, , GO:0000243;GO:0005685;GO:0071004;GO:0000395;, C:commitment complex; C:U1 snRNP; C:U2-type prespliceosome;, , P:mRNA 5'-splice site recognition;|Q86UA1 Q08AL1 Q08AL2 Q9NUU5,Pre-mRNA-processing factor 39,PRP39 homolog;, , GO:0000243;GO:0005685;GO:0071004;GO:0000395;, C:commitment complex; C:U1 snRNP; C:U2-type prespliceosome;, , P:mRNA 5'-splice site recognition;|Q00688 B2R4Q9 Q14317,Peptidyl-prolyl cis-trans isomerase FKBP3,25 kDa FK506-binding protein;FK506-binding protein 3;Immunophilin FKBP25;Rapamycin-selective 25 kDa immunophilin;Rotamase;, PF18410;PF00254;, GO:0005634;GO:0005528;GO:0003755;GO:0003723;GO:0038023;, C:nucleus;, F:FK506 binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding; F:signaling receptor activity;|Q00688 B2R4Q9 Q14317,Peptidyl-prolyl cis-trans isomerase FKBP3,25 kDa FK506-binding protein;FK506-binding protein 3;Immunophilin FKBP25;Rapamycin-selective 25 kDa immunophilin;Rotamase;, PF18410;PF00254;, GO:0005634;GO:0005528;GO:0003755;GO:0003723;GO:0038023;, C:nucleus;, F:FK506 binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding; F:signaling receptor activity; scaffold27 indexed_genome mRNA 19053910 19118209 . + . ID=transcript_6036;Q8IYD8 B2RTQ9 Q3YFH9 Q8N9X6 Q9HCH6,Fanconi anemia group M protein,ATP-dependent RNA helicase FANCM;Fanconi anemia-associated polypeptide of 250 kDa;Protein Hef ortholog {ECO:0000303|PubMed:16116422, ECO:0000303|PubMed:16116434};, PF02732;PF16783;PF00271;PF04851;, GO:0071821;GO:0043240;GO:0005654;GO:0043138;GO:0005524;GO:0003682;GO:0000400;GO:0009378;GO:0004518;GO:0003724;GO:0045003;GO:0036297;GO:1902527;GO:0031297;GO:0071932;GO:0000712;, C:FANCM-MHF complex; C:Fanconi anaemia nuclear complex; C:nucleoplasm;, F:3'-5' DNA helicase activity; F:ATP binding; F:chromatin binding; F:four-way junction DNA binding; F:four-way junction helicase activity; F:nuclease activity; F:RNA helicase activity;, P:double-strand break repair via synthesis-dependent strand annealing; P:interstrand cross-link repair; P:positive regulation of protein monoubiquitination; P:replication fork processing; P:replication fork reversal; P:resolution of meiotic recombination intermediates;|Q8IYD8 B2RTQ9 Q3YFH9 Q8N9X6 Q9HCH6,Fanconi anemia group M protein,ATP-dependent RNA helicase FANCM;Fanconi anemia-associated polypeptide of 250 kDa;Protein Hef ortholog {ECO:0000303|PubMed:16116422, ECO:0000303|PubMed:16116434};, PF02732;PF16783;PF00271;PF04851;, GO:0071821;GO:0043240;GO:0005654;GO:0043138;GO:0005524;GO:0003682;GO:0000400;GO:0009378;GO:0004518;GO:0003724;GO:0045003;GO:0036297;GO:1902527;GO:0031297;GO:0071932;GO:0000712;, C:FANCM-MHF complex; C:Fanconi anaemia nuclear complex; C:nucleoplasm;, F:3'-5' DNA helicase activity; F:ATP binding; F:chromatin binding; F:four-way junction DNA binding; F:four-way junction helicase activity; F:nuclease activity; F:RNA helicase activity;, P:double-strand break repair via synthesis-dependent strand annealing; P:interstrand cross-link repair; P:positive regulation of protein monoubiquitination; P:replication fork processing; P:replication fork reversal; P:resolution of meiotic recombination intermediates;|Q8IYD8 B2RTQ9 Q3YFH9 Q8N9X6 Q9HCH6,Fanconi anemia group M protein,ATP-dependent RNA helicase FANCM;Fanconi anemia-associated polypeptide of 250 kDa;Protein Hef ortholog {ECO:0000303|PubMed:16116422, ECO:0000303|PubMed:16116434};, PF02732;PF16783;PF00271;PF04851;, GO:0071821;GO:0043240;GO:0005654;GO:0043138;GO:0005524;GO:0003682;GO:0000400;GO:0009378;GO:0004518;GO:0003724;GO:0045003;GO:0036297;GO:1902527;GO:0031297;GO:0071932;GO:0000712;, C:FANCM-MHF complex; C:Fanconi anaemia nuclear complex; C:nucleoplasm;, F:3'-5' DNA helicase activity; F:ATP binding; F:chromatin binding; F:four-way junction DNA binding; F:four-way junction helicase activity; F:nuclease activity; F:RNA helicase activity;, P:double-strand break repair via synthesis-dependent strand annealing; P:interstrand cross-link repair; P:positive regulation of protein monoubiquitination; P:replication fork processing; P:replication fork reversal; P:resolution of meiotic recombination intermediates; scaffold27 indexed_genome mRNA 19125079 19127265 . - . ID=transcript_6037;Q6P0N0 D3DSA7 Q86V14 Q96PY4 Q9NUR5 Q9Y4X9,Mis18-binding protein 1,Kinetochore-associated protein KNL-2 homolog {ECO:0000303|PubMed:17339379};P243;, PF00249;PF09133;, GO:0000778;GO:0005654;GO:0003677;GO:0007049;GO:0051301;GO:0034080;, C:condensed nuclear chromosome kinetochore; C:nucleoplasm;, F:DNA binding;, P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; scaffold27 indexed_genome mRNA 19140864 19145169 . - . ID=transcript_6038;Q6P0N0 D3DSA7 Q86V14 Q96PY4 Q9NUR5 Q9Y4X9,Mis18-binding protein 1,Kinetochore-associated protein KNL-2 homolog {ECO:0000303|PubMed:17339379};P243;, PF00249;PF09133;, GO:0000778;GO:0005654;GO:0003677;GO:0007049;GO:0051301;GO:0034080;, C:condensed nuclear chromosome kinetochore; C:nucleoplasm;, F:DNA binding;, P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; scaffold27 indexed_genome mRNA 19293324 19294925 . + . ID=transcript_6039;O60294 Q4JFT6 Q96B55 Q9NR10,tRNA wybutosine-synthesizing protein 4,Leucine carboxyl methyltransferase 2;tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase;tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase;, PF04072;, GO:0005737;GO:0008175;GO:0030488;GO:0006400;GO:0031591;, C:cytoplasm;, F:tRNA methyltransferase activity;, P:tRNA methylation; P:tRNA modification; P:wybutosine biosynthetic process;|O60294 Q4JFT6 Q96B55 Q9NR10,tRNA wybutosine-synthesizing protein 4,Leucine carboxyl methyltransferase 2;tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase;tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase;, PF04072;, GO:0005737;GO:0008175;GO:0030488;GO:0006400;GO:0031591;, C:cytoplasm;, F:tRNA methyltransferase activity;, P:tRNA methylation; P:tRNA modification; P:wybutosine biosynthetic process; scaffold27 indexed_genome mRNA 19295366 19317419 . + . ID=transcript_6040;Q6DHV7 A6NHZ3 B4DQM8,Adenosine deaminase-like protein,Adenosine deaminase-like protein isoform 1 {ECO:0000303|PubMed:21755941};N6-mAMP deaminase {ECO:0000303|PubMed:29884623};N6-methyl-AMP aminohydrolase {ECO:0000303|PubMed:21755941};, PF00962;, GO:0005829;GO:0004000;GO:0046872;GO:0062154;GO:0006154;GO:0017144;GO:0046103;GO:0009117;GO:0043101;, C:cytosol;, F:adenosine deaminase activity; F:metal ion binding; F:N6-mAMP deaminase activity;, P:adenosine catabolic process; P:drug metabolic process; P:inosine biosynthetic process; P:nucleotide metabolic process; P:purine-containing compound salvage;|Q6DHV7 A6NHZ3 B4DQM8,Adenosine deaminase-like protein,Adenosine deaminase-like protein isoform 1 {ECO:0000303|PubMed:21755941};N6-mAMP deaminase {ECO:0000303|PubMed:29884623};N6-methyl-AMP aminohydrolase {ECO:0000303|PubMed:21755941};, PF00962;, GO:0005829;GO:0004000;GO:0046872;GO:0062154;GO:0006154;GO:0017144;GO:0046103;GO:0009117;GO:0043101;, C:cytosol;, F:adenosine deaminase activity; F:metal ion binding; F:N6-mAMP deaminase activity;, P:adenosine catabolic process; P:drug metabolic process; P:inosine biosynthetic process; P:nucleotide metabolic process; P:purine-containing compound salvage;|Q6DHV7 A6NHZ3 B4DQM8,Adenosine deaminase-like protein,Adenosine deaminase-like protein isoform 1 {ECO:0000303|PubMed:21755941};N6-mAMP deaminase {ECO:0000303|PubMed:29884623};N6-methyl-AMP aminohydrolase {ECO:0000303|PubMed:21755941};, PF00962;, GO:0005829;GO:0004000;GO:0046872;GO:0062154;GO:0006154;GO:0017144;GO:0046103;GO:0009117;GO:0043101;, C:cytosol;, F:adenosine deaminase activity; F:metal ion binding; F:N6-mAMP deaminase activity;, P:adenosine catabolic process; P:drug metabolic process; P:inosine biosynthetic process; P:nucleotide metabolic process; P:purine-containing compound salvage; scaffold27 indexed_genome mRNA 19317814 19320233 . + . ID=transcript_6041;Q6DHV7 A6NHZ3 B4DQM8,Adenosine deaminase-like protein,Adenosine deaminase-like protein isoform 1 {ECO:0000303|PubMed:21755941};N6-mAMP deaminase {ECO:0000303|PubMed:29884623};N6-methyl-AMP aminohydrolase {ECO:0000303|PubMed:21755941};, PF00962;, GO:0005829;GO:0004000;GO:0046872;GO:0062154;GO:0006154;GO:0017144;GO:0046103;GO:0009117;GO:0043101;, C:cytosol;, F:adenosine deaminase activity; F:metal ion binding; F:N6-mAMP deaminase activity;, P:adenosine catabolic process; P:drug metabolic process; P:inosine biosynthetic process; P:nucleotide metabolic process; P:purine-containing compound salvage;|Q6DHV7 A6NHZ3 B4DQM8,Adenosine deaminase-like protein,Adenosine deaminase-like protein isoform 1 {ECO:0000303|PubMed:21755941};N6-mAMP deaminase {ECO:0000303|PubMed:29884623};N6-methyl-AMP aminohydrolase {ECO:0000303|PubMed:21755941};, PF00962;, GO:0005829;GO:0004000;GO:0046872;GO:0062154;GO:0006154;GO:0017144;GO:0046103;GO:0009117;GO:0043101;, C:cytosol;, F:adenosine deaminase activity; F:metal ion binding; F:N6-mAMP deaminase activity;, P:adenosine catabolic process; P:drug metabolic process; P:inosine biosynthetic process; P:nucleotide metabolic process; P:purine-containing compound salvage; scaffold27 indexed_genome mRNA 19320439 19325467 . - . ID=transcript_6042;Q8IWY8 B3KVB9 Q32M75 Q32M76 Q8NA40,Zinc finger and SCAN domain-containing protein 29,Zinc finger protein 690;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold27 indexed_genome mRNA 19325736 19377464 . - . ID=transcript_6043;Q8IWY8 B3KVB9 Q32M75 Q32M76 Q8NA40,Zinc finger and SCAN domain-containing protein 29,Zinc finger protein 690;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8IWY8 B3KVB9 Q32M75 Q32M76 Q8NA40,Zinc finger and SCAN domain-containing protein 29,Zinc finger protein 690;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9UGJ1 B3KNK6 Q969X3 Q9NVF0,Gamma-tubulin complex component 4,Gamma-ring complex protein 76 kDa;, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0016020;GO:0005874;GO:0015630;GO:0055037;GO:0000922;GO:0043015;GO:0005200;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0065003;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:recycling endosome; C:spindle pole;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:protein-containing complex assembly; P:spindle assembly;|Q9UGJ1 B3KNK6 Q969X3 Q9NVF0,Gamma-tubulin complex component 4,Gamma-ring complex protein 76 kDa;, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0016020;GO:0005874;GO:0015630;GO:0055037;GO:0000922;GO:0043015;GO:0005200;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0065003;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:recycling endosome; C:spindle pole;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:protein-containing complex assembly; P:spindle assembly;|Q9UGJ1 B3KNK6 Q969X3 Q9NVF0,Gamma-tubulin complex component 4,Gamma-ring complex protein 76 kDa;, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0016020;GO:0005874;GO:0015630;GO:0055037;GO:0000922;GO:0043015;GO:0005200;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0065003;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:recycling endosome; C:spindle pole;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:protein-containing complex assembly; P:spindle assembly;|Q9UGJ1 B3KNK6 Q969X3 Q9NVF0,Gamma-tubulin complex component 4,Gamma-ring complex protein 76 kDa;, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0016020;GO:0005874;GO:0015630;GO:0055037;GO:0000922;GO:0043015;GO:0005200;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0065003;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:recycling endosome; C:spindle pole;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:protein-containing complex assembly; P:spindle assembly;|Q9UGJ1 B3KNK6 Q969X3 Q9NVF0,Gamma-tubulin complex component 4,Gamma-ring complex protein 76 kDa;, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0016020;GO:0005874;GO:0015630;GO:0055037;GO:0000922;GO:0043015;GO:0005200;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0065003;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:recycling endosome; C:spindle pole;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:protein-containing complex assembly; P:spindle assembly;|Q9UGJ1 B3KNK6 Q969X3 Q9NVF0,Gamma-tubulin complex component 4,Gamma-ring complex protein 76 kDa;, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0016020;GO:0005874;GO:0015630;GO:0055037;GO:0000922;GO:0043015;GO:0005200;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0065003;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:recycling endosome; C:spindle pole;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:protein-containing complex assembly; P:spindle assembly;|Q9UGJ1 B3KNK6 Q969X3 Q9NVF0,Gamma-tubulin complex component 4,Gamma-ring complex protein 76 kDa;, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0016020;GO:0005874;GO:0015630;GO:0055037;GO:0000922;GO:0043015;GO:0005200;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0065003;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:recycling endosome; C:spindle pole;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:protein-containing complex assembly; P:spindle assembly;|Q9UGJ1 B3KNK6 Q969X3 Q9NVF0,Gamma-tubulin complex component 4,Gamma-ring complex protein 76 kDa;, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0016020;GO:0005874;GO:0015630;GO:0055037;GO:0000922;GO:0043015;GO:0005200;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0065003;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:recycling endosome; C:spindle pole;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:protein-containing complex assembly; P:spindle assembly;|Q12888 F8VY86 Q2M1Z7 Q4LE46 Q5FWZ3 Q7Z3U4,TP53-binding protein 1 {ECO:0000305},, PF09038;, GO:0000781;GO:0000777;GO:0005737;GO:1990391;GO:0016604;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0042393;GO:0035064;GO:0002039;GO:0001102;GO:0042162;GO:0003712;GO:0061649;GO:0006974;GO:0071481;GO:0000077;GO:0006302;GO:0006303;GO:2000042;GO:0051091;GO:0045830;GO:0045944;GO:0045893;GO:0051260;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:cytoplasm; C:DNA repair complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:histone binding; F:methylated histone binding; F:p53 binding; F:RNA polymerase II activating transcription factor binding; F:telomeric DNA binding; F:transcription coregulator activity; F:ubiquitin modification-dependent histone binding;, P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:DNA damage checkpoint; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of isotype switching; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein homooligomerization;|Q9UGJ1 B3KNK6 Q969X3 Q9NVF0,Gamma-tubulin complex component 4,Gamma-ring complex protein 76 kDa;, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0016020;GO:0005874;GO:0015630;GO:0055037;GO:0000922;GO:0043015;GO:0005200;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0065003;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:recycling endosome; C:spindle pole;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:protein-containing complex assembly; P:spindle assembly;|Q9UGJ1 B3KNK6 Q969X3 Q9NVF0,Gamma-tubulin complex component 4,Gamma-ring complex protein 76 kDa;, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0016020;GO:0005874;GO:0015630;GO:0055037;GO:0000922;GO:0043015;GO:0005200;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0065003;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:recycling endosome; C:spindle pole;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:protein-containing complex assembly; P:spindle assembly;|Q12888 F8VY86 Q2M1Z7 Q4LE46 Q5FWZ3 Q7Z3U4,TP53-binding protein 1 {ECO:0000305},, PF09038;, GO:0000781;GO:0000777;GO:0005737;GO:1990391;GO:0016604;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0042393;GO:0035064;GO:0002039;GO:0001102;GO:0042162;GO:0003712;GO:0061649;GO:0006974;GO:0071481;GO:0000077;GO:0006302;GO:0006303;GO:2000042;GO:0051091;GO:0045830;GO:0045944;GO:0045893;GO:0051260;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:cytoplasm; C:DNA repair complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:histone binding; F:methylated histone binding; F:p53 binding; F:RNA polymerase II activating transcription factor binding; F:telomeric DNA binding; F:transcription coregulator activity; F:ubiquitin modification-dependent histone binding;, P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:DNA damage checkpoint; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of isotype switching; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein homooligomerization;|Q12888 F8VY86 Q2M1Z7 Q4LE46 Q5FWZ3 Q7Z3U4,TP53-binding protein 1 {ECO:0000305},, PF09038;, GO:0000781;GO:0000777;GO:0005737;GO:1990391;GO:0016604;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0042393;GO:0035064;GO:0002039;GO:0001102;GO:0042162;GO:0003712;GO:0061649;GO:0006974;GO:0071481;GO:0000077;GO:0006302;GO:0006303;GO:2000042;GO:0051091;GO:0045830;GO:0045944;GO:0045893;GO:0051260;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:cytoplasm; C:DNA repair complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:histone binding; F:methylated histone binding; F:p53 binding; F:RNA polymerase II activating transcription factor binding; F:telomeric DNA binding; F:transcription coregulator activity; F:ubiquitin modification-dependent histone binding;, P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:DNA damage checkpoint; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of isotype switching; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein homooligomerization; scaffold27 indexed_genome mRNA 19377465 19380534 . - . ID=transcript_6044;Q12888 F8VY86 Q2M1Z7 Q4LE46 Q5FWZ3 Q7Z3U4,TP53-binding protein 1 {ECO:0000305},, PF09038;, GO:0000781;GO:0000777;GO:0005737;GO:1990391;GO:0016604;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0042393;GO:0035064;GO:0002039;GO:0001102;GO:0042162;GO:0003712;GO:0061649;GO:0006974;GO:0071481;GO:0000077;GO:0006302;GO:0006303;GO:2000042;GO:0051091;GO:0045830;GO:0045944;GO:0045893;GO:0051260;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:cytoplasm; C:DNA repair complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:histone binding; F:methylated histone binding; F:p53 binding; F:RNA polymerase II activating transcription factor binding; F:telomeric DNA binding; F:transcription coregulator activity; F:ubiquitin modification-dependent histone binding;, P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:DNA damage checkpoint; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of isotype switching; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein homooligomerization; scaffold27 indexed_genome mRNA 19380793 19397381 . - . ID=transcript_6045;Q12888 F8VY86 Q2M1Z7 Q4LE46 Q5FWZ3 Q7Z3U4,TP53-binding protein 1 {ECO:0000305},, PF09038;, GO:0000781;GO:0000777;GO:0005737;GO:1990391;GO:0016604;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0042393;GO:0035064;GO:0002039;GO:0001102;GO:0042162;GO:0003712;GO:0061649;GO:0006974;GO:0071481;GO:0000077;GO:0006302;GO:0006303;GO:2000042;GO:0051091;GO:0045830;GO:0045944;GO:0045893;GO:0051260;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:cytoplasm; C:DNA repair complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:histone binding; F:methylated histone binding; F:p53 binding; F:RNA polymerase II activating transcription factor binding; F:telomeric DNA binding; F:transcription coregulator activity; F:ubiquitin modification-dependent histone binding;, P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:DNA damage checkpoint; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of isotype switching; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein homooligomerization;|Q12888 F8VY86 Q2M1Z7 Q4LE46 Q5FWZ3 Q7Z3U4,TP53-binding protein 1 {ECO:0000305},, PF09038;, GO:0000781;GO:0000777;GO:0005737;GO:1990391;GO:0016604;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0042393;GO:0035064;GO:0002039;GO:0001102;GO:0042162;GO:0003712;GO:0061649;GO:0006974;GO:0071481;GO:0000077;GO:0006302;GO:0006303;GO:2000042;GO:0051091;GO:0045830;GO:0045944;GO:0045893;GO:0051260;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:cytoplasm; C:DNA repair complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:histone binding; F:methylated histone binding; F:p53 binding; F:RNA polymerase II activating transcription factor binding; F:telomeric DNA binding; F:transcription coregulator activity; F:ubiquitin modification-dependent histone binding;, P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:DNA damage checkpoint; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of isotype switching; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein homooligomerization; scaffold27 indexed_genome mRNA 19444020 19464549 . + . ID=transcript_6046;P78559 O95643 Q12973 Q15882 Q9UJT4,Microtubule-associated protein 1A,Proliferation-related protein p80;, , GO:0030424;GO:1904115;GO:0043194;GO:0005737;GO:0005829;GO:0030425;GO:0044307;GO:1901588;GO:0043198;GO:0005874;GO:0005875;GO:0043005;GO:0043025;GO:0150001;GO:0045202;GO:0003779;GO:0008093;GO:0008017;GO:0005198;GO:0048156;GO:0015631;GO:0099641;GO:0008306;GO:0007409;GO:0016358;GO:0007613;GO:0000226;GO:0032435;GO:1902817;GO:0070050;GO:1990535;GO:1903829;GO:2000010;GO:0031114;GO:0048167;GO:0099642;GO:0050882;, C:axon; C:axon cytoplasm; C:axon initial segment; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic branch; C:dendritic microtubule; C:dendritic shaft; C:microtubule; C:microtubule associated complex; C:neuron projection; C:neuronal cell body; C:primary dendrite; C:synapse;, F:actin binding; F:cytoskeletal anchor activity; F:microtubule binding; F:structural molecule activity; F:tau protein binding; F:tubulin binding;, P:anterograde axonal protein transport; P:associative learning; P:axonogenesis; P:dendrite development; P:memory; P:microtubule cytoskeleton organization; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein localization to microtubule; P:neuron cellular homeostasis; P:neuron projection maintenance; P:positive regulation of cellular protein localization; P:positive regulation of protein localization to cell surface; P:regulation of microtubule depolymerization; P:regulation of synaptic plasticity; P:retrograde axonal protein transport; P:voluntary musculoskeletal movement; scaffold27 indexed_genome mRNA 19465528 19503737 . - . ID=transcript_6047;Q6PFW1 O15082 Q5HYF8 Q7Z3A7 Q86TE7 Q86UV3 Q86UV4 Q86XW8 Q8IZN0,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1,Diphosphoinositol pentakisphosphate kinase 1;Histidine acid phosphatase domain-containing protein 2A;IP6 kinase;Inositol pyrophosphate synthase 1;InsP6 and PP-IP5 kinase 1;VIP1 homolog;, PF00328;PF18086;, GO:0005829;GO:0005886;GO:0102092;GO:0005524;GO:0033857;GO:0000829;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0006020;GO:0032958;GO:0043647;, C:cytosol; C:plasma membrane;, F:5-diphosphoinositol pentakisphosphate 3-kinase activity; F:ATP binding; F:diphosphoinositol-pentakisphosphate kinase activity; F:inositol heptakisphosphate kinase activity; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity;, P:inositol metabolic process; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process;|Q6PFW1 O15082 Q5HYF8 Q7Z3A7 Q86TE7 Q86UV3 Q86UV4 Q86XW8 Q8IZN0,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1,Diphosphoinositol pentakisphosphate kinase 1;Histidine acid phosphatase domain-containing protein 2A;IP6 kinase;Inositol pyrophosphate synthase 1;InsP6 and PP-IP5 kinase 1;VIP1 homolog;, PF00328;PF18086;, GO:0005829;GO:0005886;GO:0102092;GO:0005524;GO:0033857;GO:0000829;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0006020;GO:0032958;GO:0043647;, C:cytosol; C:plasma membrane;, F:5-diphosphoinositol pentakisphosphate 3-kinase activity; F:ATP binding; F:diphosphoinositol-pentakisphosphate kinase activity; F:inositol heptakisphosphate kinase activity; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity;, P:inositol metabolic process; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; scaffold27 indexed_genome mRNA 19511584 19516741 . + . ID=transcript_6048;P12532 B4DIT8 B7ZA09 Q0VAM3 Q32NF6 Q53FC4,Creatine kinase U-type, mitochondrial,Acidic-type mitochondrial creatine kinase;Ubiquitous mitochondrial creatine kinase;, PF00217;PF02807;, GO:0005743;GO:0005739;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0046314;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:phosphocreatine biosynthetic process;|P12532 B4DIT8 B7ZA09 Q0VAM3 Q32NF6 Q53FC4,Creatine kinase U-type, mitochondrial,Acidic-type mitochondrial creatine kinase;Ubiquitous mitochondrial creatine kinase;, PF00217;PF02807;, GO:0005743;GO:0005739;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0046314;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:phosphocreatine biosynthetic process;|P12532 B4DIT8 B7ZA09 Q0VAM3 Q32NF6 Q53FC4,Creatine kinase U-type, mitochondrial,Acidic-type mitochondrial creatine kinase;Ubiquitous mitochondrial creatine kinase;, PF00217;PF02807;, GO:0005743;GO:0005739;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0046314;, C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:phosphocreatine biosynthetic process; scaffold27 indexed_genome mRNA 19541326 19550782 . - . ID=transcript_6049;Q96P56 Q8NHT9 Q96P54 Q96P55,Cation channel sperm-associated protein 2,, PF00520;, GO:0036128;GO:0031514;GO:0005886;GO:0005227;GO:0005262;GO:0005244;GO:0009566;GO:0030317;GO:0007275;GO:0034765;GO:0032570;GO:0048240;GO:0035036;, C:CatSper complex; C:motile cilium; C:plasma membrane;, F:calcium activated cation channel activity; F:calcium channel activity; F:voltage-gated ion channel activity;, P:fertilization; P:flagellated sperm motility; P:multicellular organism development; P:regulation of ion transmembrane transport; P:response to progesterone; P:sperm capacitation; P:sperm-egg recognition; scaffold27 indexed_genome mRNA 19555477 19556219 . - . ID=transcript_6050;Q96P56 Q8NHT9 Q96P54 Q96P55,Cation channel sperm-associated protein 2,, PF00520;, GO:0036128;GO:0031514;GO:0005886;GO:0005227;GO:0005262;GO:0005244;GO:0009566;GO:0030317;GO:0007275;GO:0034765;GO:0032570;GO:0048240;GO:0035036;, C:CatSper complex; C:motile cilium; C:plasma membrane;, F:calcium activated cation channel activity; F:calcium channel activity; F:voltage-gated ion channel activity;, P:fertilization; P:flagellated sperm motility; P:multicellular organism development; P:regulation of ion transmembrane transport; P:response to progesterone; P:sperm capacitation; P:sperm-egg recognition; scaffold27 indexed_genome mRNA 19561676 19581014 . + . ID=transcript_6051;P30101 Q13453 Q14255 Q8IYF8 Q9UMU7,Protein disulfide-isomerase A3,58 kDa glucose-regulated protein;58 kDa microsomal protein;Disulfide isomerase ER-60;Endoplasmic reticulum resident protein 57;Endoplasmic reticulum resident protein 60;, PF00085;, GO:0009986;GO:0005783;GO:0005788;GO:0070062;GO:0005615;GO:0005925;GO:0042470;GO:0042824;GO:0005634;GO:0045335;GO:0055038;GO:0004197;GO:0015036;GO:0042802;GO:0015037;GO:0004629;GO:0003756;GO:0003723;GO:0002479;GO:0002474;GO:0098761;GO:2001238;GO:0006457;GO:0034975;GO:0034976;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:melanosome; C:MHC class I peptide loading complex; C:nucleus; C:phagocytic vesicle; C:recycling endosome membrane;, F:cysteine-type endopeptidase activity; F:disulfide oxidoreductase activity; F:identical protein binding; F:peptide disulfide oxidoreductase activity; F:phospholipase C activity; F:protein disulfide isomerase activity; F:RNA binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cellular response to interleukin-7; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress;|P30101 Q13453 Q14255 Q8IYF8 Q9UMU7,Protein disulfide-isomerase A3,58 kDa glucose-regulated protein;58 kDa microsomal protein;Disulfide isomerase ER-60;Endoplasmic reticulum resident protein 57;Endoplasmic reticulum resident protein 60;, PF00085;, GO:0009986;GO:0005783;GO:0005788;GO:0070062;GO:0005615;GO:0005925;GO:0042470;GO:0042824;GO:0005634;GO:0045335;GO:0055038;GO:0004197;GO:0015036;GO:0042802;GO:0015037;GO:0004629;GO:0003756;GO:0003723;GO:0002479;GO:0002474;GO:0098761;GO:2001238;GO:0006457;GO:0034975;GO:0034976;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:melanosome; C:MHC class I peptide loading complex; C:nucleus; C:phagocytic vesicle; C:recycling endosome membrane;, F:cysteine-type endopeptidase activity; F:disulfide oxidoreductase activity; F:identical protein binding; F:peptide disulfide oxidoreductase activity; F:phospholipase C activity; F:protein disulfide isomerase activity; F:RNA binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cellular response to interleukin-7; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress;|P30101 Q13453 Q14255 Q8IYF8 Q9UMU7,Protein disulfide-isomerase A3,58 kDa glucose-regulated protein;58 kDa microsomal protein;Disulfide isomerase ER-60;Endoplasmic reticulum resident protein 57;Endoplasmic reticulum resident protein 60;, PF00085;, GO:0009986;GO:0005783;GO:0005788;GO:0070062;GO:0005615;GO:0005925;GO:0042470;GO:0042824;GO:0005634;GO:0045335;GO:0055038;GO:0004197;GO:0015036;GO:0042802;GO:0015037;GO:0004629;GO:0003756;GO:0003723;GO:0002479;GO:0002474;GO:0098761;GO:2001238;GO:0006457;GO:0034975;GO:0034976;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:melanosome; C:MHC class I peptide loading complex; C:nucleus; C:phagocytic vesicle; C:recycling endosome membrane;, F:cysteine-type endopeptidase activity; F:disulfide oxidoreductase activity; F:identical protein binding; F:peptide disulfide oxidoreductase activity; F:phospholipase C activity; F:protein disulfide isomerase activity; F:RNA binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cellular response to interleukin-7; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress;|P30101 Q13453 Q14255 Q8IYF8 Q9UMU7,Protein disulfide-isomerase A3,58 kDa glucose-regulated protein;58 kDa microsomal protein;Disulfide isomerase ER-60;Endoplasmic reticulum resident protein 57;Endoplasmic reticulum resident protein 60;, PF00085;, GO:0009986;GO:0005783;GO:0005788;GO:0070062;GO:0005615;GO:0005925;GO:0042470;GO:0042824;GO:0005634;GO:0045335;GO:0055038;GO:0004197;GO:0015036;GO:0042802;GO:0015037;GO:0004629;GO:0003756;GO:0003723;GO:0002479;GO:0002474;GO:0098761;GO:2001238;GO:0006457;GO:0034975;GO:0034976;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:melanosome; C:MHC class I peptide loading complex; C:nucleus; C:phagocytic vesicle; C:recycling endosome membrane;, F:cysteine-type endopeptidase activity; F:disulfide oxidoreductase activity; F:identical protein binding; F:peptide disulfide oxidoreductase activity; F:phospholipase C activity; F:protein disulfide isomerase activity; F:RNA binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cellular response to interleukin-7; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress;|P30101 Q13453 Q14255 Q8IYF8 Q9UMU7,Protein disulfide-isomerase A3,58 kDa glucose-regulated protein;58 kDa microsomal protein;Disulfide isomerase ER-60;Endoplasmic reticulum resident protein 57;Endoplasmic reticulum resident protein 60;, PF00085;, GO:0009986;GO:0005783;GO:0005788;GO:0070062;GO:0005615;GO:0005925;GO:0042470;GO:0042824;GO:0005634;GO:0045335;GO:0055038;GO:0004197;GO:0015036;GO:0042802;GO:0015037;GO:0004629;GO:0003756;GO:0003723;GO:0002479;GO:0002474;GO:0098761;GO:2001238;GO:0006457;GO:0034975;GO:0034976;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:melanosome; C:MHC class I peptide loading complex; C:nucleus; C:phagocytic vesicle; C:recycling endosome membrane;, F:cysteine-type endopeptidase activity; F:disulfide oxidoreductase activity; F:identical protein binding; F:peptide disulfide oxidoreductase activity; F:phospholipase C activity; F:protein disulfide isomerase activity; F:RNA binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cellular response to interleukin-7; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress;|P30101 Q13453 Q14255 Q8IYF8 Q9UMU7,Protein disulfide-isomerase A3,58 kDa glucose-regulated protein;58 kDa microsomal protein;Disulfide isomerase ER-60;Endoplasmic reticulum resident protein 57;Endoplasmic reticulum resident protein 60;, PF00085;, GO:0009986;GO:0005783;GO:0005788;GO:0070062;GO:0005615;GO:0005925;GO:0042470;GO:0042824;GO:0005634;GO:0045335;GO:0055038;GO:0004197;GO:0015036;GO:0042802;GO:0015037;GO:0004629;GO:0003756;GO:0003723;GO:0002479;GO:0002474;GO:0098761;GO:2001238;GO:0006457;GO:0034975;GO:0034976;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:melanosome; C:MHC class I peptide loading complex; C:nucleus; C:phagocytic vesicle; C:recycling endosome membrane;, F:cysteine-type endopeptidase activity; F:disulfide oxidoreductase activity; F:identical protein binding; F:peptide disulfide oxidoreductase activity; F:phospholipase C activity; F:protein disulfide isomerase activity; F:RNA binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cellular response to interleukin-7; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress;|P30101 Q13453 Q14255 Q8IYF8 Q9UMU7,Protein disulfide-isomerase A3,58 kDa glucose-regulated protein;58 kDa microsomal protein;Disulfide isomerase ER-60;Endoplasmic reticulum resident protein 57;Endoplasmic reticulum resident protein 60;, PF00085;, GO:0009986;GO:0005783;GO:0005788;GO:0070062;GO:0005615;GO:0005925;GO:0042470;GO:0042824;GO:0005634;GO:0045335;GO:0055038;GO:0004197;GO:0015036;GO:0042802;GO:0015037;GO:0004629;GO:0003756;GO:0003723;GO:0002479;GO:0002474;GO:0098761;GO:2001238;GO:0006457;GO:0034975;GO:0034976;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:melanosome; C:MHC class I peptide loading complex; C:nucleus; C:phagocytic vesicle; C:recycling endosome membrane;, F:cysteine-type endopeptidase activity; F:disulfide oxidoreductase activity; F:identical protein binding; F:peptide disulfide oxidoreductase activity; F:phospholipase C activity; F:protein disulfide isomerase activity; F:RNA binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cellular response to interleukin-7; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress;|P30101 Q13453 Q14255 Q8IYF8 Q9UMU7,Protein disulfide-isomerase A3,58 kDa glucose-regulated protein;58 kDa microsomal protein;Disulfide isomerase ER-60;Endoplasmic reticulum resident protein 57;Endoplasmic reticulum resident protein 60;, PF00085;, GO:0009986;GO:0005783;GO:0005788;GO:0070062;GO:0005615;GO:0005925;GO:0042470;GO:0042824;GO:0005634;GO:0045335;GO:0055038;GO:0004197;GO:0015036;GO:0042802;GO:0015037;GO:0004629;GO:0003756;GO:0003723;GO:0002479;GO:0002474;GO:0098761;GO:2001238;GO:0006457;GO:0034975;GO:0034976;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:melanosome; C:MHC class I peptide loading complex; C:nucleus; C:phagocytic vesicle; C:recycling endosome membrane;, F:cysteine-type endopeptidase activity; F:disulfide oxidoreductase activity; F:identical protein binding; F:peptide disulfide oxidoreductase activity; F:phospholipase C activity; F:protein disulfide isomerase activity; F:RNA binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cellular response to interleukin-7; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress;|P30101 Q13453 Q14255 Q8IYF8 Q9UMU7,Protein disulfide-isomerase A3,58 kDa glucose-regulated protein;58 kDa microsomal protein;Disulfide isomerase ER-60;Endoplasmic reticulum resident protein 57;Endoplasmic reticulum resident protein 60;, PF00085;, GO:0009986;GO:0005783;GO:0005788;GO:0070062;GO:0005615;GO:0005925;GO:0042470;GO:0042824;GO:0005634;GO:0045335;GO:0055038;GO:0004197;GO:0015036;GO:0042802;GO:0015037;GO:0004629;GO:0003756;GO:0003723;GO:0002479;GO:0002474;GO:0098761;GO:2001238;GO:0006457;GO:0034975;GO:0034976;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:melanosome; C:MHC class I peptide loading complex; C:nucleus; C:phagocytic vesicle; C:recycling endosome membrane;, F:cysteine-type endopeptidase activity; F:disulfide oxidoreductase activity; F:identical protein binding; F:peptide disulfide oxidoreductase activity; F:phospholipase C activity; F:protein disulfide isomerase activity; F:RNA binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cellular response to interleukin-7; P:positive regulation of extrinsic apoptotic signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress; scaffold27 indexed_genome mRNA 19582141 19585692 . - . ID=transcript_6052;Q9HB65 B3KQ66 B3KX08 Q6I9Z7 Q9H634,RNA polymerase II elongation factor ELL3,, PF10390;PF07303;, GO:0030054;GO:0005694;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0008023;GO:0000987;GO:0006354;GO:1902166;GO:0032786;GO:2000179;GO:0050769;GO:0045944;GO:0010717;GO:0042795;GO:0007283;GO:0048863;GO:0006366;GO:0006368;, C:cell junction; C:chromosome; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription elongation factor complex;, F:cis-regulatory region sequence-specific DNA binding;, P:DNA-templated transcription, elongation; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neurogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of epithelial to mesenchymal transition; P:snRNA transcription by RNA polymerase II; P:spermatogenesis; P:stem cell differentiation; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold27 indexed_genome mRNA 19601157 19682876 . + . ID=transcript_6053;Q9NX55 C9JKJ0 O75408 Q8WUW8 Q9P024,Huntingtin-interacting protein K,Huntingtin yeast partner K;, PF19026;, GO:0005737;GO:0015630;GO:0005654;GO:0005634;GO:0032991;GO:0047485;GO:0043066;GO:0050821;, C:cytoplasm; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:protein N-terminus binding;, P:negative regulation of apoptotic process; P:protein stabilization;|Q9NX55 C9JKJ0 O75408 Q8WUW8 Q9P024,Huntingtin-interacting protein K,Huntingtin yeast partner K;, PF19026;, GO:0005737;GO:0015630;GO:0005654;GO:0005634;GO:0032991;GO:0047485;GO:0043066;GO:0050821;, C:cytoplasm; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:protein N-terminus binding;, P:negative regulation of apoptotic process; P:protein stabilization;|P55081 Q86TG6,Microfibrillar-associated protein 1 {ECO:0000312|HGNC:HGNC:7032},Spliceosome B complex protein MFAP1 {ECO:0000303|PubMed:28781166};, PF06991;, GO:0005813;GO:0005576;GO:0001527;GO:0005654;GO:0005634;GO:0071005;GO:0005684;GO:0003723;GO:0000398;, C:centrosome; C:extracellular region; C:microfibril; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q9H967 A0MNP5 Q05CI4,WD repeat-containing protein 76,, , GO:0000792;GO:0005634;GO:0090734;GO:0003677;GO:0019899;GO:0006974;GO:2000001;, C:heterochromatin; C:nucleus; C:site of DNA damage;, F:DNA binding; F:enzyme binding;, P:cellular response to DNA damage stimulus; P:regulation of DNA damage checkpoint; scaffold27 indexed_genome mRNA 19685931 19730832 . - . ID=transcript_6054;Q7Z6J6 Q8NBG4,FERM domain-containing protein 5,, PF08736;PF09380;PF00373;PF09379;, GO:0005912;GO:0005856;GO:0016021;GO:0008092;GO:0005178;GO:0019901;GO:0031032;GO:2000146;GO:0045785;GO:0030334;, C:adherens junction; C:cytoskeleton; C:integral component of membrane;, F:cytoskeletal protein binding; F:integrin binding; F:protein kinase binding;, P:actomyosin structure organization; P:negative regulation of cell motility; P:positive regulation of cell adhesion; P:regulation of cell migration;|Q7Z6J6 Q8NBG4,FERM domain-containing protein 5,, PF08736;PF09380;PF00373;PF09379;, GO:0005912;GO:0005856;GO:0016021;GO:0008092;GO:0005178;GO:0019901;GO:0031032;GO:2000146;GO:0045785;GO:0030334;, C:adherens junction; C:cytoskeleton; C:integral component of membrane;, F:cytoskeletal protein binding; F:integrin binding; F:protein kinase binding;, P:actomyosin structure organization; P:negative regulation of cell motility; P:positive regulation of cell adhesion; P:regulation of cell migration;|Q7Z6J6 Q8NBG4,FERM domain-containing protein 5,, PF08736;PF09380;PF00373;PF09379;, GO:0005912;GO:0005856;GO:0016021;GO:0008092;GO:0005178;GO:0019901;GO:0031032;GO:2000146;GO:0045785;GO:0030334;, C:adherens junction; C:cytoskeleton; C:integral component of membrane;, F:cytoskeletal protein binding; F:integrin binding; F:protein kinase binding;, P:actomyosin structure organization; P:negative regulation of cell motility; P:positive regulation of cell adhesion; P:regulation of cell migration;|Q7Z6J6 Q8NBG4,FERM domain-containing protein 5,, PF08736;PF09380;PF00373;PF09379;, GO:0005912;GO:0005856;GO:0016021;GO:0008092;GO:0005178;GO:0019901;GO:0031032;GO:2000146;GO:0045785;GO:0030334;, C:adherens junction; C:cytoskeleton; C:integral component of membrane;, F:cytoskeletal protein binding; F:integrin binding; F:protein kinase binding;, P:actomyosin structure organization; P:negative regulation of cell motility; P:positive regulation of cell adhesion; P:regulation of cell migration;|Q7Z6J6 Q8NBG4,FERM domain-containing protein 5,, PF08736;PF09380;PF00373;PF09379;, GO:0005912;GO:0005856;GO:0016021;GO:0008092;GO:0005178;GO:0019901;GO:0031032;GO:2000146;GO:0045785;GO:0030334;, C:adherens junction; C:cytoskeleton; C:integral component of membrane;, F:cytoskeletal protein binding; F:integrin binding; F:protein kinase binding;, P:actomyosin structure organization; P:negative regulation of cell motility; P:positive regulation of cell adhesion; P:regulation of cell migration;|P62891 P02404 P39025 Q9BYF2,60S ribosomal protein L39,Large ribosomal subunit protein eL39 {ECO:0000303|PubMed:24524803};, PF00832;, GO:0005829;GO:0022625;GO:0005615;GO:0042788;GO:0003723;GO:0003735;GO:0019731;GO:0061844;GO:0002181;GO:0050830;GO:0002227;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular space; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:antibacterial humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cytoplasmic translation; P:defense response to Gram-positive bacterium; P:innate immune response in mucosa; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold27 indexed_genome mRNA 20152204 20187127 . - . ID=transcript_6055;Q15743 Q13334 Q4VBB4 Q6IX34,Ovarian cancer G-protein coupled receptor 1,G-protein coupled receptor 68;GPR12A;Sphingosylphosphorylcholine receptor;, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0071467;GO:0007186;GO:0006954;GO:0045656;GO:0035774;GO:2001206;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:cellular response to pH; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of monocyte differentiation; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of osteoclast development; scaffold27 indexed_genome mRNA 20190669 20331821 . - . ID=transcript_6056;Q9P219 Q69YK1 Q7L1M2 Q86SX7 Q8IYG8,Protein Daple,Coiled-coil domain-containing protein 88C;Dvl-associating protein with a high frequency of leucine residues;Hook-related protein 2;, PF19047;, GO:0030054;GO:0005813;GO:0005737;GO:0051959;GO:0005109;GO:0001965;GO:0005085;GO:0042802;GO:0008017;GO:0030165;GO:0043621;GO:0003383;GO:0031122;GO:0030705;GO:0090090;GO:0035567;GO:0031648;GO:0001932;GO:0007264;GO:0031098;, C:cell junction; C:centrosome; C:cytoplasm;, F:dynein light intermediate chain binding; F:frizzled binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:microtubule binding; F:PDZ domain binding; F:protein self-association;, P:apical constriction; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:negative regulation of canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway; P:protein destabilization; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:stress-activated protein kinase signaling cascade;|Q9P219 Q69YK1 Q7L1M2 Q86SX7 Q8IYG8,Protein Daple,Coiled-coil domain-containing protein 88C;Dvl-associating protein with a high frequency of leucine residues;Hook-related protein 2;, PF19047;, GO:0030054;GO:0005813;GO:0005737;GO:0051959;GO:0005109;GO:0001965;GO:0005085;GO:0042802;GO:0008017;GO:0030165;GO:0043621;GO:0003383;GO:0031122;GO:0030705;GO:0090090;GO:0035567;GO:0031648;GO:0001932;GO:0007264;GO:0031098;, C:cell junction; C:centrosome; C:cytoplasm;, F:dynein light intermediate chain binding; F:frizzled binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:microtubule binding; F:PDZ domain binding; F:protein self-association;, P:apical constriction; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:negative regulation of canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway; P:protein destabilization; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:stress-activated protein kinase signaling cascade;|Q9P219 Q69YK1 Q7L1M2 Q86SX7 Q8IYG8,Protein Daple,Coiled-coil domain-containing protein 88C;Dvl-associating protein with a high frequency of leucine residues;Hook-related protein 2;, PF19047;, GO:0030054;GO:0005813;GO:0005737;GO:0051959;GO:0005109;GO:0001965;GO:0005085;GO:0042802;GO:0008017;GO:0030165;GO:0043621;GO:0003383;GO:0031122;GO:0030705;GO:0090090;GO:0035567;GO:0031648;GO:0001932;GO:0007264;GO:0031098;, C:cell junction; C:centrosome; C:cytoplasm;, F:dynein light intermediate chain binding; F:frizzled binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:microtubule binding; F:PDZ domain binding; F:protein self-association;, P:apical constriction; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:negative regulation of canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway; P:protein destabilization; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:stress-activated protein kinase signaling cascade;|Q9P219 Q69YK1 Q7L1M2 Q86SX7 Q8IYG8,Protein Daple,Coiled-coil domain-containing protein 88C;Dvl-associating protein with a high frequency of leucine residues;Hook-related protein 2;, PF19047;, GO:0030054;GO:0005813;GO:0005737;GO:0051959;GO:0005109;GO:0001965;GO:0005085;GO:0042802;GO:0008017;GO:0030165;GO:0043621;GO:0003383;GO:0031122;GO:0030705;GO:0090090;GO:0035567;GO:0031648;GO:0001932;GO:0007264;GO:0031098;, C:cell junction; C:centrosome; C:cytoplasm;, F:dynein light intermediate chain binding; F:frizzled binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:microtubule binding; F:PDZ domain binding; F:protein self-association;, P:apical constriction; P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:negative regulation of canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway; P:protein destabilization; P:regulation of protein phosphorylation; P:small GTPase mediated signal transduction; P:stress-activated protein kinase signaling cascade; scaffold27 indexed_genome mRNA 20364294 20374817 . - . ID=transcript_6057;Q6IN85 Q69YK6 Q86U23 Q86YI7 Q8IVG1 Q9H3F1 Q9H7U8 Q9NV01 Q9NWP1,Serine/threonine-protein phosphatase 4 regulatory subunit 3A {ECO:0000312|HGNC:HGNC:20219},SMEK homolog 1;, PF04802;, GO:0005829;GO:0005815;GO:0016607;GO:0005654;, C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleoplasm;|Q6IN85 Q69YK6 Q86U23 Q86YI7 Q8IVG1 Q9H3F1 Q9H7U8 Q9NV01 Q9NWP1,Serine/threonine-protein phosphatase 4 regulatory subunit 3A {ECO:0000312|HGNC:HGNC:20219},SMEK homolog 1;, PF04802;, GO:0005829;GO:0005815;GO:0016607;GO:0005654;, C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleoplasm;|Q6IN85 Q69YK6 Q86U23 Q86YI7 Q8IVG1 Q9H3F1 Q9H7U8 Q9NV01 Q9NWP1,Serine/threonine-protein phosphatase 4 regulatory subunit 3A {ECO:0000312|HGNC:HGNC:20219},SMEK homolog 1;, PF04802;, GO:0005829;GO:0005815;GO:0016607;GO:0005654;, C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleoplasm; scaffold27 indexed_genome mRNA 20374847 20402502 . + . ID=transcript_6058;Q6IN85 Q69YK6 Q86U23 Q86YI7 Q8IVG1 Q9H3F1 Q9H7U8 Q9NV01 Q9NWP1,Serine/threonine-protein phosphatase 4 regulatory subunit 3A {ECO:0000312|HGNC:HGNC:20219},SMEK homolog 1;, PF04802;, GO:0005829;GO:0005815;GO:0016607;GO:0005654;, C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleoplasm;|Q6IN85 Q69YK6 Q86U23 Q86YI7 Q8IVG1 Q9H3F1 Q9H7U8 Q9NV01 Q9NWP1,Serine/threonine-protein phosphatase 4 regulatory subunit 3A {ECO:0000312|HGNC:HGNC:20219},SMEK homolog 1;, PF04802;, GO:0005829;GO:0005815;GO:0016607;GO:0005654;, C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleoplasm;|Q6IN85 Q69YK6 Q86U23 Q86YI7 Q8IVG1 Q9H3F1 Q9H7U8 Q9NV01 Q9NWP1,Serine/threonine-protein phosphatase 4 regulatory subunit 3A {ECO:0000312|HGNC:HGNC:20219},SMEK homolog 1;, PF04802;, GO:0005829;GO:0005815;GO:0016607;GO:0005654;, C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleoplasm;|Q5MIZ7 Q6P9B0 Q86XB8 Q9BQJ0 Q9BRK2 Q9H913 Q9P2G0,Serine/threonine-protein phosphatase 4 regulatory subunit 3B,SMEK homolog 2;, PF04802;, GO:0005813;GO:0005737;GO:0016607;GO:0005654;GO:0030289;GO:0045722;GO:0006470;GO:0019216;, C:centrosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:protein phosphatase 4 complex;, , P:positive regulation of gluconeogenesis; P:protein dephosphorylation; P:regulation of lipid metabolic process; scaffold27 indexed_genome mRNA 20602713 20632664 . - . ID=transcript_6059;Q8N9U0,Tandem C2 domains nuclear protein,Membrane targeting tandem C2 domain-containing protein 1;Tandem C2 protein in nucleus;, PF00168;, GO:0005634;, C:nucleus; scaffold27 indexed_genome mRNA 20670910 20761093 . - . ID=transcript_6060;Q9UBX5 O75966 Q6IAL4 Q6UWA3,Fibulin-5,Developmental arteries and neural crest EGF-like protein;Urine p50 protein;, PF12662;PF07645;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005509;GO:0005178;GO:0008022;GO:0042803;GO:0007160;GO:0048251;GO:0030198;GO:0034394;GO:2000121;GO:0046903;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:integrin binding; F:protein C-terminus binding; F:protein homodimerization activity;, P:cell-matrix adhesion; P:elastic fiber assembly; P:extracellular matrix organization; P:protein localization to cell surface; P:regulation of removal of superoxide radicals; P:secretion; scaffold27 indexed_genome mRNA 20777324 20785169 . - . ID=transcript_6061;Q15643 B2RUT2 O14689 O15154 O95949 Q6MZL5,Thyroid receptor-interacting protein 11,Clonal evolution-related gene on chromosome 14 protein;Golgi-associated microtubule-binding protein 210;Trip230;, , GO:0005929;GO:0005801;GO:0005856;GO:0005793;GO:0033116;GO:0005794;GO:0000139;GO:0002079;GO:0016607;GO:0005654;GO:0002081;GO:0030133;GO:0003713;GO:0051216;GO:0003413;GO:0090161;GO:0060122;GO:0035735;GO:0006486;GO:0006366;GO:0003281;GO:0099041;, C:cilium; C:cis-Golgi network; C:cytoskeleton; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi membrane; C:inner acrosomal membrane; C:nuclear speck; C:nucleoplasm; C:outer acrosomal membrane; C:transport vesicle;, F:transcription coactivator activity;, P:cartilage development; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:Golgi ribbon formation; P:inner ear receptor cell stereocilium organization; P:intraciliary transport involved in cilium assembly; P:protein glycosylation; P:transcription by RNA polymerase II; P:ventricular septum development; P:vesicle tethering to Golgi; scaffold27 indexed_genome mRNA 20785190 20860484 . - . ID=transcript_6062;Q15643 B2RUT2 O14689 O15154 O95949 Q6MZL5,Thyroid receptor-interacting protein 11,Clonal evolution-related gene on chromosome 14 protein;Golgi-associated microtubule-binding protein 210;Trip230;, , GO:0005929;GO:0005801;GO:0005856;GO:0005793;GO:0033116;GO:0005794;GO:0000139;GO:0002079;GO:0016607;GO:0005654;GO:0002081;GO:0030133;GO:0003713;GO:0051216;GO:0003413;GO:0090161;GO:0060122;GO:0035735;GO:0006486;GO:0006366;GO:0003281;GO:0099041;, C:cilium; C:cis-Golgi network; C:cytoskeleton; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi membrane; C:inner acrosomal membrane; C:nuclear speck; C:nucleoplasm; C:outer acrosomal membrane; C:transport vesicle;, F:transcription coactivator activity;, P:cartilage development; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:Golgi ribbon formation; P:inner ear receptor cell stereocilium organization; P:intraciliary transport involved in cilium assembly; P:protein glycosylation; P:transcription by RNA polymerase II; P:ventricular septum development; P:vesicle tethering to Golgi;|Q15643 B2RUT2 O14689 O15154 O95949 Q6MZL5,Thyroid receptor-interacting protein 11,Clonal evolution-related gene on chromosome 14 protein;Golgi-associated microtubule-binding protein 210;Trip230;, , GO:0005929;GO:0005801;GO:0005856;GO:0005793;GO:0033116;GO:0005794;GO:0000139;GO:0002079;GO:0016607;GO:0005654;GO:0002081;GO:0030133;GO:0003713;GO:0051216;GO:0003413;GO:0090161;GO:0060122;GO:0035735;GO:0006486;GO:0006366;GO:0003281;GO:0099041;, C:cilium; C:cis-Golgi network; C:cytoskeleton; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi membrane; C:inner acrosomal membrane; C:nuclear speck; C:nucleoplasm; C:outer acrosomal membrane; C:transport vesicle;, F:transcription coactivator activity;, P:cartilage development; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:Golgi ribbon formation; P:inner ear receptor cell stereocilium organization; P:intraciliary transport involved in cilium assembly; P:protein glycosylation; P:transcription by RNA polymerase II; P:ventricular septum development; P:vesicle tethering to Golgi;|Q15643 B2RUT2 O14689 O15154 O95949 Q6MZL5,Thyroid receptor-interacting protein 11,Clonal evolution-related gene on chromosome 14 protein;Golgi-associated microtubule-binding protein 210;Trip230;, , GO:0005929;GO:0005801;GO:0005856;GO:0005793;GO:0033116;GO:0005794;GO:0000139;GO:0002079;GO:0016607;GO:0005654;GO:0002081;GO:0030133;GO:0003713;GO:0051216;GO:0003413;GO:0090161;GO:0060122;GO:0035735;GO:0006486;GO:0006366;GO:0003281;GO:0099041;, C:cilium; C:cis-Golgi network; C:cytoskeleton; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi membrane; C:inner acrosomal membrane; C:nuclear speck; C:nucleoplasm; C:outer acrosomal membrane; C:transport vesicle;, F:transcription coactivator activity;, P:cartilage development; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:Golgi ribbon formation; P:inner ear receptor cell stereocilium organization; P:intraciliary transport involved in cilium assembly; P:protein glycosylation; P:transcription by RNA polymerase II; P:ventricular septum development; P:vesicle tethering to Golgi; scaffold27 indexed_genome mRNA 20871253 20918198 . - . ID=transcript_6063;Q96TC4 Q9H3N0,Ataxin-3,Machado-Joseph disease protein 1;Spinocerebellar ataxia type 3 protein;, PF02099;PF02809;, GO:0005737;GO:0005829;GO:0005759;GO:0031966;GO:0042405;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0051117;GO:0008234;GO:0042802;GO:1990380;GO:0061578;GO:0004843;GO:0031625;GO:0030036;GO:0034605;GO:0071218;GO:0007268;GO:0045104;GO:0000226;GO:0035520;GO:0007399;GO:0006289;GO:1904294;GO:0043161;GO:0016579;GO:0071108;GO:0070536;GO:1904379;GO:0006515;GO:0010810;GO:0006511;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrial membrane; C:nuclear inclusion body; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:ATPase binding; F:cysteine-type peptidase activity; F:identical protein binding; F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin protein ligase binding;, P:actin cytoskeleton organization; P:cellular response to heat; P:cellular response to misfolded protein; P:chemical synaptic transmission; P:intermediate filament cytoskeleton organization; P:microtubule cytoskeleton organization; P:monoubiquitinated protein deubiquitination; P:nervous system development; P:nucleotide-excision repair; P:positive regulation of ERAD pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein quality control for misfolded or incompletely synthesized proteins; P:regulation of cell-substrate adhesion; P:ubiquitin-dependent protein catabolic process;|Q96TC4 Q9H3N0,Ataxin-3,Machado-Joseph disease protein 1;Spinocerebellar ataxia type 3 protein;, PF02099;PF02809;, GO:0005737;GO:0005829;GO:0005759;GO:0031966;GO:0042405;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0051117;GO:0008234;GO:0042802;GO:1990380;GO:0061578;GO:0004843;GO:0031625;GO:0030036;GO:0034605;GO:0071218;GO:0007268;GO:0045104;GO:0000226;GO:0035520;GO:0007399;GO:0006289;GO:1904294;GO:0043161;GO:0016579;GO:0071108;GO:0070536;GO:1904379;GO:0006515;GO:0010810;GO:0006511;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrial membrane; C:nuclear inclusion body; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:ATPase binding; F:cysteine-type peptidase activity; F:identical protein binding; F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin protein ligase binding;, P:actin cytoskeleton organization; P:cellular response to heat; P:cellular response to misfolded protein; P:chemical synaptic transmission; P:intermediate filament cytoskeleton organization; P:microtubule cytoskeleton organization; P:monoubiquitinated protein deubiquitination; P:nervous system development; P:nucleotide-excision repair; P:positive regulation of ERAD pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein quality control for misfolded or incompletely synthesized proteins; P:regulation of cell-substrate adhesion; P:ubiquitin-dependent protein catabolic process; scaffold27 indexed_genome mRNA 20924881 20931838 . - . ID=transcript_6064;O75438 A0AV68,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1,Complex I-MNLL;NADH-ubiquinone oxidoreductase MNLL subunit;, PF08040;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0016607;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nuclear speck;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O75438 A0AV68,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1,Complex I-MNLL;NADH-ubiquinone oxidoreductase MNLL subunit;, PF08040;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0016607;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nuclear speck;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold27 indexed_genome mRNA 20932888 20966934 . + . ID=transcript_6065;Q9P2I0 B3KME1 Q6NSJ1 Q9H3W7,Cleavage and polyadenylation specificity factor subunit 2,Cleavage and polyadenylation specificity factor 100 kDa subunit;, PF10996;PF13299;PF16661;PF07521;, GO:0016020;GO:0005847;GO:0005654;GO:0003723;GO:0031124;GO:0006398;GO:0006406;GO:0006378;GO:0000398;GO:0098789;GO:0006369;, C:membrane; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription;|Q9P2I0 B3KME1 Q6NSJ1 Q9H3W7,Cleavage and polyadenylation specificity factor subunit 2,Cleavage and polyadenylation specificity factor 100 kDa subunit;, PF10996;PF13299;PF16661;PF07521;, GO:0016020;GO:0005847;GO:0005654;GO:0003723;GO:0031124;GO:0006398;GO:0006406;GO:0006378;GO:0000398;GO:0098789;GO:0006369;, C:membrane; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; scaffold27 indexed_genome mRNA 21340172 21441803 . + . ID=transcript_6066;Q8TB24 Q76LB3 Q8NF30 Q8TEE8 Q8WYP4 Q9H6A5 Q9HAG1,Ras and Rab interactor 3,Ras interaction/interference protein 3;, PF02204;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005769;GO:0030139;GO:0043025;GO:0031982;GO:0005096;GO:0005085;GO:0031267;GO:0006897;GO:0060755;GO:0002091;GO:0097494;GO:0007165;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:early endosome; C:endocytic vesicle; C:neuronal cell body; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:endocytosis; P:negative regulation of mast cell chemotaxis; P:negative regulation of receptor internalization; P:regulation of vesicle size; P:signal transduction; scaffold27 indexed_genome mRNA 21441897 21468531 . + . ID=transcript_6067;Q8TB24 Q76LB3 Q8NF30 Q8TEE8 Q8WYP4 Q9H6A5 Q9HAG1,Ras and Rab interactor 3,Ras interaction/interference protein 3;, PF02204;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005769;GO:0030139;GO:0043025;GO:0031982;GO:0005096;GO:0005085;GO:0031267;GO:0006897;GO:0060755;GO:0002091;GO:0097494;GO:0007165;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:early endosome; C:endocytic vesicle; C:neuronal cell body; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:endocytosis; P:negative regulation of mast cell chemotaxis; P:negative regulation of receptor internalization; P:regulation of vesicle size; P:signal transduction; scaffold27 indexed_genome mRNA 21475622 21511703 . - . ID=transcript_6068;Q99538 O00123 Q86TV2 Q86TV3 Q9BTY1,Legumain,Asparaginyl endopeptidase;Protease, cysteine 1;, PF01650;, GO:0045177;GO:0005737;GO:0036021;GO:0070062;GO:0005576;GO:0005770;GO:0043202;GO:0005764;GO:0048471;GO:0004197;GO:0008233;GO:0048156;GO:0097202;GO:0019886;GO:0008306;GO:1904646;GO:0071277;GO:0035729;GO:0097061;GO:0007613;GO:1901185;GO:0010629;GO:0040015;GO:0043524;GO:0008284;GO:2001028;GO:1900273;GO:0045931;GO:0090026;GO:0006508;GO:0051603;GO:0032801;GO:0003014;GO:0010447;GO:0097264;GO:0002224;GO:0006624;GO:0042359;, C:apical part of cell; C:cytoplasm; C:endolysosome lumen; C:extracellular exosome; C:extracellular region; C:late endosome; C:lysosomal lumen; C:lysosome; C:perinuclear region of cytoplasm;, F:cysteine-type endopeptidase activity; F:peptidase activity; F:tau protein binding;, P:activation of cysteine-type endopeptidase activity; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:associative learning; P:cellular response to amyloid-beta; P:cellular response to calcium ion; P:cellular response to hepatocyte growth factor stimulus; P:dendritic spine organization; P:memory; P:negative regulation of ERBB signaling pathway; P:negative regulation of gene expression; P:negative regulation of multicellular organism growth; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of long-term synaptic potentiation; P:positive regulation of mitotic cell cycle; P:positive regulation of monocyte chemotaxis; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:receptor catabolic process; P:renal system process; P:response to acidic pH; P:self proteolysis; P:toll-like receptor signaling pathway; P:vacuolar protein processing; P:vitamin D metabolic process;|Q99538 O00123 Q86TV2 Q86TV3 Q9BTY1,Legumain,Asparaginyl endopeptidase;Protease, cysteine 1;, PF01650;, GO:0045177;GO:0005737;GO:0036021;GO:0070062;GO:0005576;GO:0005770;GO:0043202;GO:0005764;GO:0048471;GO:0004197;GO:0008233;GO:0048156;GO:0097202;GO:0019886;GO:0008306;GO:1904646;GO:0071277;GO:0035729;GO:0097061;GO:0007613;GO:1901185;GO:0010629;GO:0040015;GO:0043524;GO:0008284;GO:2001028;GO:1900273;GO:0045931;GO:0090026;GO:0006508;GO:0051603;GO:0032801;GO:0003014;GO:0010447;GO:0097264;GO:0002224;GO:0006624;GO:0042359;, C:apical part of cell; C:cytoplasm; C:endolysosome lumen; C:extracellular exosome; C:extracellular region; C:late endosome; C:lysosomal lumen; C:lysosome; C:perinuclear region of cytoplasm;, F:cysteine-type endopeptidase activity; F:peptidase activity; F:tau protein binding;, P:activation of cysteine-type endopeptidase activity; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:associative learning; P:cellular response to amyloid-beta; P:cellular response to calcium ion; P:cellular response to hepatocyte growth factor stimulus; P:dendritic spine organization; P:memory; P:negative regulation of ERBB signaling pathway; P:negative regulation of gene expression; P:negative regulation of multicellular organism growth; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of long-term synaptic potentiation; P:positive regulation of mitotic cell cycle; P:positive regulation of monocyte chemotaxis; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:receptor catabolic process; P:renal system process; P:response to acidic pH; P:self proteolysis; P:toll-like receptor signaling pathway; P:vacuolar protein processing; P:vitamin D metabolic process;|Q99538 O00123 Q86TV2 Q86TV3 Q9BTY1,Legumain,Asparaginyl endopeptidase;Protease, cysteine 1;, PF01650;, GO:0045177;GO:0005737;GO:0036021;GO:0070062;GO:0005576;GO:0005770;GO:0043202;GO:0005764;GO:0048471;GO:0004197;GO:0008233;GO:0048156;GO:0097202;GO:0019886;GO:0008306;GO:1904646;GO:0071277;GO:0035729;GO:0097061;GO:0007613;GO:1901185;GO:0010629;GO:0040015;GO:0043524;GO:0008284;GO:2001028;GO:1900273;GO:0045931;GO:0090026;GO:0006508;GO:0051603;GO:0032801;GO:0003014;GO:0010447;GO:0097264;GO:0002224;GO:0006624;GO:0042359;, C:apical part of cell; C:cytoplasm; C:endolysosome lumen; C:extracellular exosome; C:extracellular region; C:late endosome; C:lysosomal lumen; C:lysosome; C:perinuclear region of cytoplasm;, F:cysteine-type endopeptidase activity; F:peptidase activity; F:tau protein binding;, P:activation of cysteine-type endopeptidase activity; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:associative learning; P:cellular response to amyloid-beta; P:cellular response to calcium ion; P:cellular response to hepatocyte growth factor stimulus; P:dendritic spine organization; P:memory; P:negative regulation of ERBB signaling pathway; P:negative regulation of gene expression; P:negative regulation of multicellular organism growth; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of long-term synaptic potentiation; P:positive regulation of mitotic cell cycle; P:positive regulation of monocyte chemotaxis; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:receptor catabolic process; P:renal system process; P:response to acidic pH; P:self proteolysis; P:toll-like receptor signaling pathway; P:vacuolar protein processing; P:vitamin D metabolic process;|Q99538 O00123 Q86TV2 Q86TV3 Q9BTY1,Legumain,Asparaginyl endopeptidase;Protease, cysteine 1;, PF01650;, GO:0045177;GO:0005737;GO:0036021;GO:0070062;GO:0005576;GO:0005770;GO:0043202;GO:0005764;GO:0048471;GO:0004197;GO:0008233;GO:0048156;GO:0097202;GO:0019886;GO:0008306;GO:1904646;GO:0071277;GO:0035729;GO:0097061;GO:0007613;GO:1901185;GO:0010629;GO:0040015;GO:0043524;GO:0008284;GO:2001028;GO:1900273;GO:0045931;GO:0090026;GO:0006508;GO:0051603;GO:0032801;GO:0003014;GO:0010447;GO:0097264;GO:0002224;GO:0006624;GO:0042359;, C:apical part of cell; C:cytoplasm; C:endolysosome lumen; C:extracellular exosome; C:extracellular region; C:late endosome; C:lysosomal lumen; C:lysosome; C:perinuclear region of cytoplasm;, F:cysteine-type endopeptidase activity; F:peptidase activity; F:tau protein binding;, P:activation of cysteine-type endopeptidase activity; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:associative learning; P:cellular response to amyloid-beta; P:cellular response to calcium ion; P:cellular response to hepatocyte growth factor stimulus; P:dendritic spine organization; P:memory; P:negative regulation of ERBB signaling pathway; P:negative regulation of gene expression; P:negative regulation of multicellular organism growth; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of long-term synaptic potentiation; P:positive regulation of mitotic cell cycle; P:positive regulation of monocyte chemotaxis; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:receptor catabolic process; P:renal system process; P:response to acidic pH; P:self proteolysis; P:toll-like receptor signaling pathway; P:vacuolar protein processing; P:vitamin D metabolic process; scaffold27 indexed_genome mRNA 21561328 21588662 . + . ID=transcript_6069;Q8TBA6 C9JRU1 O95287 Q03962 Q2TS49 Q9UQQ7,Golgin subfamily A member 5,Cell proliferation-inducing gene 31 protein;Golgin-84;Protein Ret-II;RET-fused gene 5 protein;, PF09787;, GO:0005801;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0016020;GO:0030133;GO:0042803;GO:0031267;GO:0007030;GO:0048193;GO:0000301;, C:cis-Golgi network; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:membrane; C:transport vesicle;, F:protein homodimerization activity; F:small GTPase binding;, P:Golgi organization; P:Golgi vesicle transport; P:retrograde transport, vesicle recycling within Golgi;|Q8TBA6 C9JRU1 O95287 Q03962 Q2TS49 Q9UQQ7,Golgin subfamily A member 5,Cell proliferation-inducing gene 31 protein;Golgin-84;Protein Ret-II;RET-fused gene 5 protein;, PF09787;, GO:0005801;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0016020;GO:0030133;GO:0042803;GO:0031267;GO:0007030;GO:0048193;GO:0000301;, C:cis-Golgi network; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:membrane; C:transport vesicle;, F:protein homodimerization activity; F:small GTPase binding;, P:Golgi organization; P:Golgi vesicle transport; P:retrograde transport, vesicle recycling within Golgi;|Q8TBA6 C9JRU1 O95287 Q03962 Q2TS49 Q9UQQ7,Golgin subfamily A member 5,Cell proliferation-inducing gene 31 protein;Golgin-84;Protein Ret-II;RET-fused gene 5 protein;, PF09787;, GO:0005801;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0016020;GO:0030133;GO:0042803;GO:0031267;GO:0007030;GO:0048193;GO:0000301;, C:cis-Golgi network; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:membrane; C:transport vesicle;, F:protein homodimerization activity; F:small GTPase binding;, P:Golgi organization; P:Golgi vesicle transport; P:retrograde transport, vesicle recycling within Golgi;|Q8TBA6 C9JRU1 O95287 Q03962 Q2TS49 Q9UQQ7,Golgin subfamily A member 5,Cell proliferation-inducing gene 31 protein;Golgin-84;Protein Ret-II;RET-fused gene 5 protein;, PF09787;, GO:0005801;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0016020;GO:0030133;GO:0042803;GO:0031267;GO:0007030;GO:0048193;GO:0000301;, C:cis-Golgi network; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:membrane; C:transport vesicle;, F:protein homodimerization activity; F:small GTPase binding;, P:Golgi organization; P:Golgi vesicle transport; P:retrograde transport, vesicle recycling within Golgi; scaffold27 indexed_genome mRNA 21653695 21666787 . + . ID=transcript_6070;P10645 B2R9E9 Q53FA8 Q6NR84 Q96E84 Q96GL7 Q9BQB5,Chromogranin-A,Pituitary secretory protein I;, PF01271;, GO:0042583;GO:0005576;GO:0005615;GO:0098992;GO:0048471;GO:0030141;GO:0030133;GO:0086030;GO:0019730;GO:0042742;GO:0050832;GO:0050829;GO:0050830;GO:0045087;GO:0031640;GO:0045576;GO:0002551;GO:0043303;GO:0033604;GO:0046676;GO:1901215;GO:0006996;GO:0060452;GO:2000707;GO:1900738;GO:1901899;GO:0033366;GO:0008217;GO:0002026;, C:chromaffin granule; C:extracellular region; C:extracellular space; C:neuronal dense core vesicle; C:perinuclear region of cytoplasm; C:secretory granule; C:transport vesicle;, , P:adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation; P:antimicrobial humoral response; P:defense response to bacterium; P:defense response to fungus; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:innate immune response; P:killing of cells of other organism; P:mast cell activation; P:mast cell chemotaxis; P:mast cell degranulation; P:negative regulation of catecholamine secretion; P:negative regulation of insulin secretion; P:negative regulation of neuron death; P:organelle organization; P:positive regulation of cardiac muscle contraction; P:positive regulation of dense core granule biogenesis; P:positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of relaxation of cardiac muscle; P:protein localization to secretory granule; P:regulation of blood pressure; P:regulation of the force of heart contraction; scaffold27 indexed_genome mRNA 21898148 21899883 . + . ID=transcript_6071;Q96BY2 B2RDF6 Q9H833 Q9HAS1,Modulator of apoptosis 1,Paraneoplastic antigen Ma4;, PF14893;, GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0031625;GO:0097190;GO:0097192;GO:0008625;GO:0008630;GO:0043065;GO:0090200;GO:0001844;GO:0042981;, C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:ubiquitin protein ligase binding;, P:apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of apoptotic process; P:positive regulation of release of cytochrome c from mitochondria; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; scaffold27 indexed_genome mRNA 21899919 21903436 . + . ID=transcript_6072;Q8N6I4 J3KQ65 Q9Y4S5,Transmembrane protein 251,, PF15190;, GO:0016021;, C:integral component of membrane; scaffold27 indexed_genome mRNA 21911033 21920112 . - . ID=transcript_6073;Q9BXV9 Q0D2N1 Q0P6C4 Q3B7W5,EKC/KEOPS complex subunit GON7 {ECO:0000305},, PF15387;, GO:0005829;GO:0000408;GO:0005730;GO:0005654;GO:0005634;, C:cytosol; C:EKC/KEOPS complex; C:nucleolus; C:nucleoplasm; C:nucleus; scaffold27 indexed_genome mRNA 21920249 21939888 . + . ID=transcript_6074;Q8N806 Q86U21 Q86UA9 Q96BY0 Q9NVV6,Putative E3 ubiquitin-protein ligase UBR7,N-recognin-7;RING-type E3 ubiquitin transferase UBR7;, PF02207;, GO:0005737;GO:0061630;GO:0008270;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;|Q8N806 Q86U21 Q86UA9 Q96BY0 Q9NVV6,Putative E3 ubiquitin-protein ligase UBR7,N-recognin-7;RING-type E3 ubiquitin transferase UBR7;, PF02207;, GO:0005737;GO:0061630;GO:0008270;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;|Q8N806 Q86U21 Q86UA9 Q96BY0 Q9NVV6,Putative E3 ubiquitin-protein ligase UBR7,N-recognin-7;RING-type E3 ubiquitin transferase UBR7;, PF02207;, GO:0005737;GO:0061630;GO:0008270;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;|Q8N806 Q86U21 Q86UA9 Q96BY0 Q9NVV6,Putative E3 ubiquitin-protein ligase UBR7,N-recognin-7;RING-type E3 ubiquitin transferase UBR7;, PF02207;, GO:0005737;GO:0061630;GO:0008270;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;|Q8N806 Q86U21 Q86UA9 Q96BY0 Q9NVV6,Putative E3 ubiquitin-protein ligase UBR7,N-recognin-7;RING-type E3 ubiquitin transferase UBR7;, PF02207;, GO:0005737;GO:0061630;GO:0008270;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;|Q8N806 Q86U21 Q86UA9 Q96BY0 Q9NVV6,Putative E3 ubiquitin-protein ligase UBR7,N-recognin-7;RING-type E3 ubiquitin transferase UBR7;, PF02207;, GO:0005737;GO:0061630;GO:0008270;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;|Q8N806 Q86U21 Q86UA9 Q96BY0 Q9NVV6,Putative E3 ubiquitin-protein ligase UBR7,N-recognin-7;RING-type E3 ubiquitin transferase UBR7;, PF02207;, GO:0005737;GO:0061630;GO:0008270;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;|Q8N806 Q86U21 Q86UA9 Q96BY0 Q9NVV6,Putative E3 ubiquitin-protein ligase UBR7,N-recognin-7;RING-type E3 ubiquitin transferase UBR7;, PF02207;, GO:0005737;GO:0061630;GO:0008270;, C:cytoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding; scaffold27 indexed_genome mRNA 21952484 22016195 . - . ID=transcript_6075;Q9P203 A8K5V7 Q69Z05 Q7Z308 Q86TS0 Q9HAA4 Q9NVM0,BTB/POZ domain-containing protein 7,, PF07707;PF00651;, GO:0005634;GO:0061138;GO:0007275;GO:0060693;, C:nucleus;, , P:morphogenesis of a branching epithelium; P:multicellular organism development; P:regulation of branching involved in salivary gland morphogenesis; scaffold27 indexed_genome mRNA 22175099 22305574 . + . ID=transcript_6076;Q9P2D8 B5MDL6 Q6ZUT7,Protein unc-79 homolog,, , GO:0016021;GO:0005886;GO:0034220;, C:integral component of membrane; C:plasma membrane;, , P:ion transmembrane transport;|Q9P2D8 B5MDL6 Q6ZUT7,Protein unc-79 homolog,, , GO:0016021;GO:0005886;GO:0034220;, C:integral component of membrane; C:plasma membrane;, , P:ion transmembrane transport;|Q9P2D8 B5MDL6 Q6ZUT7,Protein unc-79 homolog,, , GO:0016021;GO:0005886;GO:0034220;, C:integral component of membrane; C:plasma membrane;, , P:ion transmembrane transport; scaffold27 indexed_genome mRNA 22305612 22306133 . + . ID=transcript_6077;Q9P2D8 B5MDL6 Q6ZUT7,Protein unc-79 homolog,, , GO:0016021;GO:0005886;GO:0034220;, C:integral component of membrane; C:plasma membrane;, , P:ion transmembrane transport; scaffold27 indexed_genome mRNA 22306145 22393676 . + . ID=transcript_6078;Q9P2D8 B5MDL6 Q6ZUT7,Protein unc-79 homolog,, , GO:0016021;GO:0005886;GO:0034220;, C:integral component of membrane; C:plasma membrane;, , P:ion transmembrane transport;|Q9P2D8 B5MDL6 Q6ZUT7,Protein unc-79 homolog,, , GO:0016021;GO:0005886;GO:0034220;, C:integral component of membrane; C:plasma membrane;, , P:ion transmembrane transport; scaffold27 indexed_genome mRNA 22582191 22584280 . + . ID=transcript_6079;Q8N9Y4 B2RD39 Q96GY1,Protein FAM181A,, PF15238; scaffold27 indexed_genome mRNA 22589430 22598501 . - . ID=transcript_6080;Q96Q27 B2RDP9 B4E166 Q9NSU5 Q9Y567,Ankyrin repeat and SOCS box protein 2,, PF12796;PF13606;PF07525;, GO:0005829;GO:0000151;GO:0035556;GO:0043687;GO:0016567;GO:0007165;GO:0035914;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; P:signal transduction; P:skeletal muscle cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q96Q27 B2RDP9 B4E166 Q9NSU5 Q9Y567,Ankyrin repeat and SOCS box protein 2,, PF12796;PF13606;PF07525;, GO:0005829;GO:0000151;GO:0035556;GO:0043687;GO:0016567;GO:0007165;GO:0035914;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; P:signal transduction; P:skeletal muscle cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q96Q27 B2RDP9 B4E166 Q9NSU5 Q9Y567,Ankyrin repeat and SOCS box protein 2,, PF12796;PF13606;PF07525;, GO:0005829;GO:0000151;GO:0035556;GO:0043687;GO:0016567;GO:0007165;GO:0035914;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; P:signal transduction; P:skeletal muscle cell differentiation; P:ubiquitin-dependent protein catabolic process; scaffold27 indexed_genome mRNA 22602897 22644630 . - . ID=transcript_6081;Q96Q27 B2RDP9 B4E166 Q9NSU5 Q9Y567,Ankyrin repeat and SOCS box protein 2,, PF12796;PF13606;PF07525;, GO:0005829;GO:0000151;GO:0035556;GO:0043687;GO:0016567;GO:0007165;GO:0035914;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; P:signal transduction; P:skeletal muscle cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q96Q27 B2RDP9 B4E166 Q9NSU5 Q9Y567,Ankyrin repeat and SOCS box protein 2,, PF12796;PF13606;PF07525;, GO:0005829;GO:0000151;GO:0035556;GO:0043687;GO:0016567;GO:0007165;GO:0035914;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; P:signal transduction; P:skeletal muscle cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q96Q27 B2RDP9 B4E166 Q9NSU5 Q9Y567,Ankyrin repeat and SOCS box protein 2,, PF12796;PF13606;PF07525;, GO:0005829;GO:0000151;GO:0035556;GO:0043687;GO:0016567;GO:0007165;GO:0035914;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; P:signal transduction; P:skeletal muscle cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q96Q27 B2RDP9 B4E166 Q9NSU5 Q9Y567,Ankyrin repeat and SOCS box protein 2,, PF12796;PF13606;PF07525;, GO:0005829;GO:0000151;GO:0035556;GO:0043687;GO:0016567;GO:0007165;GO:0035914;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; P:signal transduction; P:skeletal muscle cell differentiation; P:ubiquitin-dependent protein catabolic process; scaffold27 indexed_genome mRNA 22699377 22708481 . + . ID=transcript_6082;Q96DC9 Q6IA10 Q9H6T1,Ubiquitin thioesterase OTUB2,Deubiquitinating enzyme OTUB2;OTU domain-containing ubiquitin aldehyde-binding protein 2;Otubain-2;Ubiquitin-specific-processing protease OTUB2;, PF10275;, GO:0005634;GO:0019784;GO:0004843;GO:0043130;GO:2000780;GO:1901315;GO:0016579;GO:0035871;GO:0071108;GO:0070536;, C:nucleus;, F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding;, P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; scaffold27 indexed_genome mRNA 22710346 22730602 . - . ID=transcript_6083;Q9GZR7 E7EMJ4 Q4V9L5,ATP-dependent RNA helicase DDX24,DEAD box protein 24;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0016070;, C:membrane; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:RNA metabolic process;|Q9GZR7 E7EMJ4 Q4V9L5,ATP-dependent RNA helicase DDX24,DEAD box protein 24;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0016070;, C:membrane; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:RNA metabolic process;|Q9GZR7 E7EMJ4 Q4V9L5,ATP-dependent RNA helicase DDX24,DEAD box protein 24;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0016070;, C:membrane; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:RNA metabolic process;|Q9GZR7 E7EMJ4 Q4V9L5,ATP-dependent RNA helicase DDX24,DEAD box protein 24;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0016070;, C:membrane; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:RNA metabolic process; scaffold27 indexed_genome mRNA 22799138 22912401 . + . ID=transcript_6084;Q6NUP7 Q9BUF8 Q9HCF0,Serine/threonine-protein phosphatase 4 regulatory subunit 4,, , GO:0005737;GO:0005829;GO:0008287;GO:0019888;GO:0001835;GO:0032515;GO:0080163;, C:cytoplasm; C:cytosol; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:blastocyst hatching; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of protein serine/threonine phosphatase activity;|Q6NUP7 Q9BUF8 Q9HCF0,Serine/threonine-protein phosphatase 4 regulatory subunit 4,, , GO:0005737;GO:0005829;GO:0008287;GO:0019888;GO:0001835;GO:0032515;GO:0080163;, C:cytoplasm; C:cytosol; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:blastocyst hatching; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of protein serine/threonine phosphatase activity;|Q6NUP7 Q9BUF8 Q9HCF0,Serine/threonine-protein phosphatase 4 regulatory subunit 4,, , GO:0005737;GO:0005829;GO:0008287;GO:0019888;GO:0001835;GO:0032515;GO:0080163;, C:cytoplasm; C:cytosol; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:blastocyst hatching; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of protein serine/threonine phosphatase activity;|Q6NUP7 Q9BUF8 Q9HCF0,Serine/threonine-protein phosphatase 4 regulatory subunit 4,, , GO:0005737;GO:0005829;GO:0008287;GO:0019888;GO:0001835;GO:0032515;GO:0080163;, C:cytoplasm; C:cytosol; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:blastocyst hatching; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of protein serine/threonine phosphatase activity;|Q6NUP7 Q9BUF8 Q9HCF0,Serine/threonine-protein phosphatase 4 regulatory subunit 4,, , GO:0005737;GO:0005829;GO:0008287;GO:0019888;GO:0001835;GO:0032515;GO:0080163;, C:cytoplasm; C:cytosol; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:blastocyst hatching; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of protein serine/threonine phosphatase activity;|Q6NUP7 Q9BUF8 Q9HCF0,Serine/threonine-protein phosphatase 4 regulatory subunit 4,, , GO:0005737;GO:0005829;GO:0008287;GO:0019888;GO:0001835;GO:0032515;GO:0080163;, C:cytoplasm; C:cytosol; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:blastocyst hatching; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of protein serine/threonine phosphatase activity;|Q6NUP7 Q9BUF8 Q9HCF0,Serine/threonine-protein phosphatase 4 regulatory subunit 4,, , GO:0005737;GO:0005829;GO:0008287;GO:0019888;GO:0001835;GO:0032515;GO:0080163;, C:cytoplasm; C:cytosol; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:blastocyst hatching; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of protein serine/threonine phosphatase activity;|Q6NUP7 Q9BUF8 Q9HCF0,Serine/threonine-protein phosphatase 4 regulatory subunit 4,, , GO:0005737;GO:0005829;GO:0008287;GO:0019888;GO:0001835;GO:0032515;GO:0080163;, C:cytoplasm; C:cytosol; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:blastocyst hatching; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of protein serine/threonine phosphatase activity;|Q9UK55 A5Z2A5 Q6UWX9 Q86U20,Protein Z-dependent protease inhibitor,Serpin A10;, PF00079;, GO:0005788;GO:0070062;GO:0005615;GO:0008201;GO:0004867;GO:0007596;GO:0044267;GO:0010951;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space;, F:heparin binding; F:serine-type endopeptidase inhibitor activity;, P:blood coagulation; P:cellular protein metabolic process; P:negative regulation of endopeptidase activity; P:post-translational protein modification;|Q9UK55 A5Z2A5 Q6UWX9 Q86U20,Protein Z-dependent protease inhibitor,Serpin A10;, PF00079;, GO:0005788;GO:0070062;GO:0005615;GO:0008201;GO:0004867;GO:0007596;GO:0044267;GO:0010951;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space;, F:heparin binding; F:serine-type endopeptidase inhibitor activity;, P:blood coagulation; P:cellular protein metabolic process; P:negative regulation of endopeptidase activity; P:post-translational protein modification; scaffold27 indexed_genome mRNA 22984188 22988023 . - . ID=transcript_6085;Q86U19 Q96BF9 Q96ES1 Q9P1P0 Q9UCE6 Q9UCM3,Alpha-1-antitrypsin {ECO:0000305},Alpha-1 protease inhibitor;Alpha-1-antiproteinase;Serpin A1;, PF00079;, GO:0062023;GO:0030134;GO:0005783;GO:0005788;GO:0033116;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0043231;GO:0031093;GO:0042802;GO:0002020;GO:0004867;GO:0006953;GO:0007596;GO:0044267;GO:0048208;GO:0006888;GO:0010951;GO:0043312;GO:0002576;GO:0043687;, C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:platelet alpha granule lumen;, F:identical protein binding; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:blood coagulation; P:cellular protein metabolic process; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:post-translational protein modification;|Q86U19 Q96BF9 Q96ES1 Q9P1P0 Q9UCE6 Q9UCM3,Alpha-1-antitrypsin {ECO:0000305},Alpha-1 protease inhibitor;Alpha-1-antiproteinase;Serpin A1;, PF00079;, GO:0062023;GO:0030134;GO:0005783;GO:0005788;GO:0033116;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005794;GO:0043231;GO:0031093;GO:0042802;GO:0002020;GO:0004867;GO:0006953;GO:0007596;GO:0044267;GO:0048208;GO:0006888;GO:0010951;GO:0043312;GO:0002576;GO:0043687;, C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:platelet alpha granule lumen;, F:identical protein binding; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:blood coagulation; P:cellular protein metabolic process; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:post-translational protein modification; scaffold27 indexed_genome mRNA 23048141 23059766 . - . ID=transcript_6086;Q86U17 B2RV07,Serpin A11,, PF00079;, GO:0005615;GO:0004867;GO:0010951;, C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity; scaffold27 indexed_genome mRNA 23175673 23188009 . + . ID=transcript_6087;P05154 Q07616 Q9UG30,Plasma serine protease inhibitor,Acrosomal serine protease inhibitor;Plasminogen activator inhibitor 3;Protein C inhibitor;Serpin A5;, PF00079;, GO:0002080;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0031091;GO:0031094;GO:0097181;GO:0097182;GO:0097183;GO:0036029;GO:0036030;GO:0036026;GO:0036027;GO:0036028;GO:0036025;GO:0036024;GO:0032991;GO:0032190;GO:0005539;GO:0008201;GO:0031210;GO:0002020;GO:0001972;GO:0004867;GO:0007596;GO:0007342;GO:0006869;GO:0010951;GO:0051346;GO:0061107;GO:0007283;, C:acrosomal membrane; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:platelet alpha granule; C:platelet dense tubular network; C:protein C inhibitor-coagulation factor V complex; C:protein C inhibitor-coagulation factor Xa complex; C:protein C inhibitor-coagulation factor XI complex; C:protein C inhibitor-KLK3 complex; C:protein C inhibitor-plasma kallikrein complex; C:protein C inhibitor-PLAT complex; C:protein C inhibitor-PLAU complex; C:protein C inhibitor-thrombin complex; C:protein C inhibitor-TMPRSS11E complex; C:protein C inhibitor-TMPRSS7 complex; C:protein-containing complex;, F:acrosin binding; F:glycosaminoglycan binding; F:heparin binding; F:phosphatidylcholine binding; F:protease binding; F:retinoic acid binding; F:serine-type endopeptidase inhibitor activity;, P:blood coagulation; P:fusion of sperm to egg plasma membrane involved in single fertilization; P:lipid transport; P:negative regulation of endopeptidase activity; P:negative regulation of hydrolase activity; P:seminal vesicle development; P:spermatogenesis; scaffold27 indexed_genome mRNA 23205226 23209575 . + . ID=transcript_6088;Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process;|Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process; scaffold27 indexed_genome mRNA 23210608 23213202 . - . ID=transcript_6089;Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process;|Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process;|Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process; scaffold27 indexed_genome mRNA 23232198 23240535 . + . ID=transcript_6090;Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process;|Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process; scaffold27 indexed_genome mRNA 23268290 23271696 . + . ID=transcript_6091;Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process;|Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process; scaffold27 indexed_genome mRNA 23290654 23298358 . + . ID=transcript_6092;Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process;|Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process; scaffold27 indexed_genome mRNA 23305315 23308679 . + . ID=transcript_6093;Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process;|Q8N177 Q96DW8 Q9UC47 Q9UNU9,Alpha-1-antichymotrypsin,Cell growth-inhibiting gene 24/25 protein;Serpin A3;, PF00079;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0031093;GO:0034774;GO:0003677;GO:0004867;GO:0006953;GO:0006954;GO:0030277;GO:0010951;GO:0043312;GO:0002576;GO:0019216;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen;, F:DNA binding; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:inflammatory response; P:maintenance of gastrointestinal epithelium; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:platelet degranulation; P:regulation of lipid metabolic process; scaffold27 indexed_genome mRNA 23764211 23812056 . - . ID=transcript_6094;Q9UPY3 A7E2D3 B3KRG4 E0AD28 O95943 Q9UQ02,Endoribonuclease Dicer,Helicase with RNase motif;, PF00271;PF02170;PF04851;PF00636;, GO:0033167;GO:0005737;GO:0005829;GO:0030425;GO:0005793;GO:0070062;GO:0030426;GO:0005634;GO:0048471;GO:0016442;GO:0070578;GO:0005524;GO:0004530;GO:0003677;GO:0003725;GO:0004521;GO:0004386;GO:0046872;GO:0070883;GO:0019904;GO:0004525;GO:0003723;GO:0035197;GO:0006309;GO:0036404;GO:0033168;GO:0035280;GO:0010586;GO:0010629;GO:0010626;GO:0000122;GO:0032720;GO:0021675;GO:0048812;GO:0038061;GO:0032290;GO:0031643;GO:0014040;GO:0031054;GO:0035196;GO:0030422;GO:0090501;GO:0090502;GO:0035087;GO:0030423;GO:0016032;, C:ARC complex; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:growth cone; C:nucleus; C:perinuclear region of cytoplasm; C:RISC complex; C:RISC-loading complex;, F:ATP binding; F:deoxyribonuclease I activity; F:DNA binding; F:double-stranded RNA binding; F:endoribonuclease activity; F:helicase activity; F:metal ion binding; F:pre-miRNA binding; F:protein domain specific binding; F:ribonuclease III activity; F:RNA binding; F:siRNA binding;, P:apoptotic DNA fragmentation; P:conversion of ds siRNA to ss siRNA; P:conversion of ds siRNA to ss siRNA involved in RNA interference; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA metabolic process; P:negative regulation of gene expression; P:negative regulation of Schwann cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor production; P:nerve development; P:neuron projection morphogenesis; P:NIK/NF-kappaB signaling; P:peripheral nervous system myelin formation; P:positive regulation of myelination; P:positive regulation of Schwann cell differentiation; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:RNA phosphodiester bond hydrolysis; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:siRNA loading onto RISC involved in RNA interference; P:targeting of mRNA for destruction involved in RNA interference; P:viral process;|Q9UPY3 A7E2D3 B3KRG4 E0AD28 O95943 Q9UQ02,Endoribonuclease Dicer,Helicase with RNase motif;, PF00271;PF02170;PF04851;PF00636;, GO:0033167;GO:0005737;GO:0005829;GO:0030425;GO:0005793;GO:0070062;GO:0030426;GO:0005634;GO:0048471;GO:0016442;GO:0070578;GO:0005524;GO:0004530;GO:0003677;GO:0003725;GO:0004521;GO:0004386;GO:0046872;GO:0070883;GO:0019904;GO:0004525;GO:0003723;GO:0035197;GO:0006309;GO:0036404;GO:0033168;GO:0035280;GO:0010586;GO:0010629;GO:0010626;GO:0000122;GO:0032720;GO:0021675;GO:0048812;GO:0038061;GO:0032290;GO:0031643;GO:0014040;GO:0031054;GO:0035196;GO:0030422;GO:0090501;GO:0090502;GO:0035087;GO:0030423;GO:0016032;, C:ARC complex; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:growth cone; C:nucleus; C:perinuclear region of cytoplasm; C:RISC complex; C:RISC-loading complex;, F:ATP binding; F:deoxyribonuclease I activity; F:DNA binding; F:double-stranded RNA binding; F:endoribonuclease activity; F:helicase activity; F:metal ion binding; F:pre-miRNA binding; F:protein domain specific binding; F:ribonuclease III activity; F:RNA binding; F:siRNA binding;, P:apoptotic DNA fragmentation; P:conversion of ds siRNA to ss siRNA; P:conversion of ds siRNA to ss siRNA involved in RNA interference; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA metabolic process; P:negative regulation of gene expression; P:negative regulation of Schwann cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor production; P:nerve development; P:neuron projection morphogenesis; P:NIK/NF-kappaB signaling; P:peripheral nervous system myelin formation; P:positive regulation of myelination; P:positive regulation of Schwann cell differentiation; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:RNA phosphodiester bond hydrolysis; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:siRNA loading onto RISC involved in RNA interference; P:targeting of mRNA for destruction involved in RNA interference; P:viral process;|Q9UPY3 A7E2D3 B3KRG4 E0AD28 O95943 Q9UQ02,Endoribonuclease Dicer,Helicase with RNase motif;, PF00271;PF02170;PF04851;PF00636;, GO:0033167;GO:0005737;GO:0005829;GO:0030425;GO:0005793;GO:0070062;GO:0030426;GO:0005634;GO:0048471;GO:0016442;GO:0070578;GO:0005524;GO:0004530;GO:0003677;GO:0003725;GO:0004521;GO:0004386;GO:0046872;GO:0070883;GO:0019904;GO:0004525;GO:0003723;GO:0035197;GO:0006309;GO:0036404;GO:0033168;GO:0035280;GO:0010586;GO:0010629;GO:0010626;GO:0000122;GO:0032720;GO:0021675;GO:0048812;GO:0038061;GO:0032290;GO:0031643;GO:0014040;GO:0031054;GO:0035196;GO:0030422;GO:0090501;GO:0090502;GO:0035087;GO:0030423;GO:0016032;, C:ARC complex; C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:growth cone; C:nucleus; C:perinuclear region of cytoplasm; C:RISC complex; C:RISC-loading complex;, F:ATP binding; F:deoxyribonuclease I activity; F:DNA binding; F:double-stranded RNA binding; F:endoribonuclease activity; F:helicase activity; F:metal ion binding; F:pre-miRNA binding; F:protein domain specific binding; F:ribonuclease III activity; F:RNA binding; F:siRNA binding;, P:apoptotic DNA fragmentation; P:conversion of ds siRNA to ss siRNA; P:conversion of ds siRNA to ss siRNA involved in RNA interference; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA metabolic process; P:negative regulation of gene expression; P:negative regulation of Schwann cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor production; P:nerve development; P:neuron projection morphogenesis; P:NIK/NF-kappaB signaling; P:peripheral nervous system myelin formation; P:positive regulation of myelination; P:positive regulation of Schwann cell differentiation; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:RNA phosphodiester bond hydrolysis; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:siRNA loading onto RISC involved in RNA interference; P:targeting of mRNA for destruction involved in RNA interference; P:viral process; scaffold27 indexed_genome mRNA 23877989 23990512 . - . ID=transcript_6095;Q96JQ2 B2RAR7 Q9H713 Q9HA23 Q9HA57 Q9UFP4 Q9ULN2,Calmin,Calponin-like transmembrane domain protein;, PF00307;, GO:0005737;GO:0016021;GO:0034993;GO:0005640;GO:0051015;GO:0008285;GO:0031175;GO:0007097;, C:cytoplasm; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear outer membrane;, F:actin filament binding;, P:negative regulation of cell population proliferation; P:neuron projection development; P:nuclear migration; scaffold27 indexed_genome mRNA 24085094 24190834 . - . ID=transcript_6096;Q6ZMZ3 A6H8H3 Q86SX5 Q8N7G8,Nesprin-3,KASH domain-containing protein 3;Nuclear envelope spectrin repeat protein 3;, PF10541;PF00435;, GO:0005737;GO:0016021;GO:0034993;GO:0016020;GO:0005635;GO:0031965;GO:0005640;GO:0005791;GO:0051015;GO:0140444;GO:0007010;GO:0090150;GO:0007097;GO:0008360;, C:cytoplasm; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:rough endoplasmic reticulum;, F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:cytoskeleton organization; P:establishment of protein localization to membrane; P:nuclear migration; P:regulation of cell shape; scaffold27 indexed_genome mRNA 24210240 24220286 . + . ID=transcript_6097;Q86SX6 Q0X088 Q3YML0 Q86WY3 Q8IZ54,Glutaredoxin-related protein 5, mitochondrial,Monothiol glutaredoxin-5;, PF00462;, GO:0030425;GO:0005759;GO:0005739;GO:0043025;GO:0005634;GO:0051537;GO:0046872;GO:0015035;GO:0044571;GO:0030097;GO:0016226;GO:0106034;GO:0106035;, C:dendrite; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleus;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding; F:protein disulfide oxidoreductase activity;, P:[2Fe-2S] cluster assembly; P:hemopoiesis; P:iron-sulfur cluster assembly; P:protein maturation by [2Fe-2S] cluster transfer; P:protein maturation by [4Fe-4S] cluster transfer; scaffold27 indexed_genome mRNA 24570353 24572325 . + . ID=transcript_6098;Q5T160 B2RDT7 Q96FU5 Q9H8K8,Probable arginine--tRNA ligase, mitochondrial,Arginyl-tRNA synthetase;, PF05746;PF00750;, GO:0005759;GO:0005739;GO:0004814;GO:0005524;GO:0003723;GO:0006420;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:arginine-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:arginyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation; scaffold27 indexed_genome mRNA 24864519 24892250 . + . ID=transcript_6099;P30411,B2 bradykinin receptor,, PF00001;, GO:0005768;GO:0005794;GO:0005887;GO:0043231;GO:0005886;GO:0004947;GO:0004930;GO:0004435;GO:0002020;GO:0046982;GO:0031702;GO:0050482;GO:0008015;GO:0007166;GO:0007186;GO:0006954;GO:1902239;GO:0033137;GO:0007204;GO:0043114;GO:0019229;GO:0009651;GO:0006939;GO:0007169;GO:0042310;GO:0042311;, C:endosome; C:Golgi apparatus; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:bradykinin receptor activity; F:G protein-coupled receptor activity; F:phosphatidylinositol phospholipase C activity; F:protease binding; F:protein heterodimerization activity; F:type 1 angiotensin receptor binding;, P:arachidonic acid secretion; P:blood circulation; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator; P:negative regulation of peptidyl-serine phosphorylation; P:positive regulation of cytosolic calcium ion concentration; P:regulation of vascular permeability; P:regulation of vasoconstriction; P:response to salt stress; P:smooth muscle contraction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasoconstriction; P:vasodilation; scaffold27 indexed_genome mRNA 24910749 24920477 . + . ID=transcript_6100;P46663 A8K7F5 Q546S7 Q8N0Y8,B1 bradykinin receptor,, PF00001;, GO:0005783;GO:0005887;GO:0043005;GO:0005886;GO:0004947;GO:0004930;GO:0042277;GO:0016477;GO:0007186;GO:0006954;GO:0045776;GO:0030308;GO:0001933;GO:0007204;GO:0002687;GO:0051281;GO:0007205;GO:0032496;GO:0009612;GO:0019233;, C:endoplasmic reticulum; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:bradykinin receptor activity; F:G protein-coupled receptor activity; F:peptide binding;, P:cell migration; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of blood pressure; P:negative regulation of cell growth; P:negative regulation of protein phosphorylation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of leukocyte migration; P:positive regulation of release of sequestered calcium ion into cytosol; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:sensory perception of pain;|P46663 A8K7F5 Q546S7 Q8N0Y8,B1 bradykinin receptor,, PF00001;, GO:0005783;GO:0005887;GO:0043005;GO:0005886;GO:0004947;GO:0004930;GO:0042277;GO:0016477;GO:0007186;GO:0006954;GO:0045776;GO:0030308;GO:0001933;GO:0007204;GO:0002687;GO:0051281;GO:0007205;GO:0032496;GO:0009612;GO:0019233;, C:endoplasmic reticulum; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:bradykinin receptor activity; F:G protein-coupled receptor activity; F:peptide binding;, P:cell migration; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of blood pressure; P:negative regulation of cell growth; P:negative regulation of protein phosphorylation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of leukocyte migration; P:positive regulation of release of sequestered calcium ion into cytosol; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:sensory perception of pain; scaffold27 indexed_genome mRNA 24933295 24944863 . - . ID=transcript_6101;Q96BY7 Q6ZRE7 Q96DQ3 Q9NW80,Autophagy-related protein 2 homolog B,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0005654;GO:0000407;GO:0034045;GO:0120013;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane;, F:lipid transfer activity; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy;|Q96BY7 Q6ZRE7 Q96DQ3 Q9NW80,Autophagy-related protein 2 homolog B,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0005654;GO:0000407;GO:0034045;GO:0120013;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane;, F:lipid transfer activity; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy;|Q96BY7 Q6ZRE7 Q96DQ3 Q9NW80,Autophagy-related protein 2 homolog B,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0005654;GO:0000407;GO:0034045;GO:0120013;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane;, F:lipid transfer activity; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy;|Q96BY7 Q6ZRE7 Q96DQ3 Q9NW80,Autophagy-related protein 2 homolog B,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0005654;GO:0000407;GO:0034045;GO:0120013;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane;, F:lipid transfer activity; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy;|Q96BY7 Q6ZRE7 Q96DQ3 Q9NW80,Autophagy-related protein 2 homolog B,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0005654;GO:0000407;GO:0034045;GO:0120013;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane;, F:lipid transfer activity; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy;|Q96BY7 Q6ZRE7 Q96DQ3 Q9NW80,Autophagy-related protein 2 homolog B,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0005654;GO:0000407;GO:0034045;GO:0120013;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane;, F:lipid transfer activity; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy; scaffold27 indexed_genome mRNA 24946709 25007634 . - . ID=transcript_6102;Q96BY7 Q6ZRE7 Q96DQ3 Q9NW80,Autophagy-related protein 2 homolog B,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0005654;GO:0000407;GO:0034045;GO:0120013;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane;, F:lipid transfer activity; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy;|Q96BY7 Q6ZRE7 Q96DQ3 Q9NW80,Autophagy-related protein 2 homolog B,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0005654;GO:0000407;GO:0034045;GO:0120013;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane;, F:lipid transfer activity; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy; scaffold27 indexed_genome mRNA 25018151 25043903 . + . ID=transcript_6103;Q9P0R6 B3KSZ0 Q9BST1 Q9NWK0,GSK3B-interacting protein {ECO:0000312|HGNC:HGNC:20343},GSK3beta interaction protein {ECO:0000312|HGNC:HGNC:20343};, PF05303;, GO:0005737;GO:0005634;GO:0019207;GO:0051018;GO:0034237;GO:0019901;GO:0004860;GO:0008631;GO:0006469;GO:0090263;GO:0030111;, C:cytoplasm; C:nucleus;, F:kinase regulator activity; F:protein kinase A binding; F:protein kinase A regulatory subunit binding; F:protein kinase binding; F:protein kinase inhibitor activity;, P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:negative regulation of protein kinase activity; P:positive regulation of canonical Wnt signaling pathway; P:regulation of Wnt signaling pathway; scaffold27 indexed_genome mRNA 25044045 25052888 . + . ID=transcript_6104;Q96M32 Q8IYP6,Adenylate kinase 7,ATP-AMP transphosphorylase 7;, PF05186;, GO:0005737;GO:0005829;GO:0031514;GO:0004017;GO:0005524;GO:0004127;GO:0004550;GO:0030030;GO:0015949;GO:0006165;GO:0009142;, C:cytoplasm; C:cytosol; C:motile cilium;, F:adenylate kinase activity; F:ATP binding; F:cytidylate kinase activity; F:nucleoside diphosphate kinase activity;, P:cell projection organization; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; scaffold27 indexed_genome mRNA 25082185 25103812 . + . ID=transcript_6105;Q96M32 Q8IYP6,Adenylate kinase 7,ATP-AMP transphosphorylase 7;, PF05186;, GO:0005737;GO:0005829;GO:0031514;GO:0004017;GO:0005524;GO:0004127;GO:0004550;GO:0030030;GO:0015949;GO:0006165;GO:0009142;, C:cytoplasm; C:cytosol; C:motile cilium;, F:adenylate kinase activity; F:ATP binding; F:cytidylate kinase activity; F:nucleoside diphosphate kinase activity;, P:cell projection organization; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; scaffold27 indexed_genome mRNA 25105188 25106097 . - . ID=transcript_6106;Q96M32 Q8IYP6,Adenylate kinase 7,ATP-AMP transphosphorylase 7;, PF05186;, GO:0005737;GO:0005829;GO:0031514;GO:0004017;GO:0005524;GO:0004127;GO:0004550;GO:0030030;GO:0015949;GO:0006165;GO:0009142;, C:cytoplasm; C:cytosol; C:motile cilium;, F:adenylate kinase activity; F:ATP binding; F:cytidylate kinase activity; F:nucleoside diphosphate kinase activity;, P:cell projection organization; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; scaffold27 indexed_genome mRNA 25119919 25172376 . + . ID=transcript_6107;P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription;|P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription;|P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription;|Q9NRJ5 Q75LH1 Q8NE14,Poly(A) polymerase beta,Polynucleotide adenylyltransferase beta;Testis-specific poly(A) polymerase;, PF01909;PF04928;PF04926;, GO:0005634;GO:0005524;GO:0046872;GO:0004652;GO:0003723;GO:0006378;, C:nucleus;, F:ATP binding; F:metal ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA polyadenylation;|P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription;|P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription;|P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription;|P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription;|P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription; scaffold27 indexed_genome mRNA 25172424 25173971 . - . ID=transcript_6108;P62273 A8MZ73 P30054,40S ribosomal protein S29,Small ribosomal subunit protein uS14 {ECO:0000303|PubMed:24524803};, PF00253;, GO:0098556;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0005654;GO:0042788;GO:0015935;GO:0003735;GO:0008270;GO:0002181;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic side of rough endoplasmic reticulum membrane; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:nucleoplasm; C:polysomal ribosome; C:small ribosomal subunit;, F:structural constituent of ribosome; F:zinc ion binding;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold27 indexed_genome mRNA 25437058 25438601 . - . ID=transcript_6109;Q99986 Q3SYL2,Serine/threonine-protein kinase VRK1,Vaccinia-related kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005795;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:0005524;GO:0035175;GO:0072354;GO:0031493;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0090166;GO:0043987;GO:0072355;GO:0007077;GO:0007084;GO:0018105;GO:0046777;GO:0006468;, C:cytoplasm; C:cytosol; C:Golgi stack; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;, F:ATP binding; F:histone kinase activity (H3-S10 specific); F:histone kinase activity (H3-T3 specific); F:nucleosomal histone binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:Golgi disassembly; P:histone H3-S10 phosphorylation; P:histone H3-T3 phosphorylation; P:mitotic nuclear envelope disassembly; P:mitotic nuclear envelope reassembly; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; scaffold27 indexed_genome mRNA 27184143 28718934 . + . ID=transcript_6110;P25490 Q14935,Transcriptional repressor protein YY1,Delta transcription factor;INO80 complex subunit S;NF-E1;Yin and yang 1;, PF00096;, GO:0005677;GO:0005737;GO:0031011;GO:0016363;GO:0005654;GO:0005634;GO:0031519;GO:0005667;GO:0003682;GO:0000987;GO:0003677;GO:0000981;GO:0001217;GO:0001227;GO:0000400;GO:0046872;GO:0003723;GO:0000978;GO:1990837;GO:0046332;GO:0000976;GO:0009952;GO:0030183;GO:0048593;GO:0048468;GO:0006974;GO:0071347;GO:0034644;GO:0051276;GO:0000724;GO:0071707;GO:0061052;GO:0010629;GO:0032688;GO:1902894;GO:0000122;GO:0045944;GO:0016579;GO:0006357;GO:0034696;GO:0010225;GO:0006403;GO:0007283;, C:chromatin silencing complex; C:cytoplasm; C:Ino80 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:transcription regulator complex;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:four-way junction DNA binding; F:metal ion binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SMAD binding; F:transcription regulatory region sequence-specific DNA binding;, P:anterior/posterior pattern specification; P:B cell differentiation; P:camera-type eye morphogenesis; P:cell development; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:cellular response to UV; P:chromosome organization; P:double-strand break repair via homologous recombination; P:immunoglobulin heavy chain V-D-J recombination; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of gene expression; P:negative regulation of interferon-beta production; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of transcription by RNA polymerase II; P:response to prostaglandin F; P:response to UV-C; P:RNA localization; P:spermatogenesis;|Q86TU7 A0PJU3 A5PLP0 B4DZE8 Q0VAQ2 Q659C0 Q86TU8 Q96GY9 Q9H5U5,Actin-histidine N-methyltransferase {ECO:0000305},SET domain-containing protein 3 {ECO:0000305};, PF09273;PF00856;, GO:0000785;GO:0005737;GO:0005654;GO:0003779;GO:0046975;GO:0042800;GO:0018064;GO:0001102;GO:0003713;GO:0030047;GO:0010452;GO:0018021;GO:0018027;GO:0018026;GO:0018023;GO:0051149;GO:0045944;GO:0045893;GO:0070472;, C:chromatin; C:cytoplasm; C:nucleoplasm;, F:actin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein-histidine N-methyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity;, P:actin modification; P:histone H3-K36 methylation; P:peptidyl-histidine methylation; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of uterine smooth muscle contraction;|Q86TU7 A0PJU3 A5PLP0 B4DZE8 Q0VAQ2 Q659C0 Q86TU8 Q96GY9 Q9H5U5,Actin-histidine N-methyltransferase {ECO:0000305},SET domain-containing protein 3 {ECO:0000305};, PF09273;PF00856;, GO:0000785;GO:0005737;GO:0005654;GO:0003779;GO:0046975;GO:0042800;GO:0018064;GO:0001102;GO:0003713;GO:0030047;GO:0010452;GO:0018021;GO:0018027;GO:0018026;GO:0018023;GO:0051149;GO:0045944;GO:0045893;GO:0070472;, C:chromatin; C:cytoplasm; C:nucleoplasm;, F:actin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein-histidine N-methyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity;, P:actin modification; P:histone H3-K36 methylation; P:peptidyl-histidine methylation; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of uterine smooth muscle contraction;|Q86TU7 A0PJU3 A5PLP0 B4DZE8 Q0VAQ2 Q659C0 Q86TU8 Q96GY9 Q9H5U5,Actin-histidine N-methyltransferase {ECO:0000305},SET domain-containing protein 3 {ECO:0000305};, PF09273;PF00856;, GO:0000785;GO:0005737;GO:0005654;GO:0003779;GO:0046975;GO:0042800;GO:0018064;GO:0001102;GO:0003713;GO:0030047;GO:0010452;GO:0018021;GO:0018027;GO:0018026;GO:0018023;GO:0051149;GO:0045944;GO:0045893;GO:0070472;, C:chromatin; C:cytoplasm; C:nucleoplasm;, F:actin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein-histidine N-methyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity;, P:actin modification; P:histone H3-K36 methylation; P:peptidyl-histidine methylation; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of uterine smooth muscle contraction;|Q86TU7 A0PJU3 A5PLP0 B4DZE8 Q0VAQ2 Q659C0 Q86TU8 Q96GY9 Q9H5U5,Actin-histidine N-methyltransferase {ECO:0000305},SET domain-containing protein 3 {ECO:0000305};, PF09273;PF00856;, GO:0000785;GO:0005737;GO:0005654;GO:0003779;GO:0046975;GO:0042800;GO:0018064;GO:0001102;GO:0003713;GO:0030047;GO:0010452;GO:0018021;GO:0018027;GO:0018026;GO:0018023;GO:0051149;GO:0045944;GO:0045893;GO:0070472;, C:chromatin; C:cytoplasm; C:nucleoplasm;, F:actin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein-histidine N-methyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity;, P:actin modification; P:histone H3-K36 methylation; P:peptidyl-histidine methylation; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of uterine smooth muscle contraction;|Q86TU7 A0PJU3 A5PLP0 B4DZE8 Q0VAQ2 Q659C0 Q86TU8 Q96GY9 Q9H5U5,Actin-histidine N-methyltransferase {ECO:0000305},SET domain-containing protein 3 {ECO:0000305};, PF09273;PF00856;, GO:0000785;GO:0005737;GO:0005654;GO:0003779;GO:0046975;GO:0042800;GO:0018064;GO:0001102;GO:0003713;GO:0030047;GO:0010452;GO:0018021;GO:0018027;GO:0018026;GO:0018023;GO:0051149;GO:0045944;GO:0045893;GO:0070472;, C:chromatin; C:cytoplasm; C:nucleoplasm;, F:actin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein-histidine N-methyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity;, P:actin modification; P:histone H3-K36 methylation; P:peptidyl-histidine methylation; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of uterine smooth muscle contraction;|Q86TU7 A0PJU3 A5PLP0 B4DZE8 Q0VAQ2 Q659C0 Q86TU8 Q96GY9 Q9H5U5,Actin-histidine N-methyltransferase {ECO:0000305},SET domain-containing protein 3 {ECO:0000305};, PF09273;PF00856;, GO:0000785;GO:0005737;GO:0005654;GO:0003779;GO:0046975;GO:0042800;GO:0018064;GO:0001102;GO:0003713;GO:0030047;GO:0010452;GO:0018021;GO:0018027;GO:0018026;GO:0018023;GO:0051149;GO:0045944;GO:0045893;GO:0070472;, C:chromatin; C:cytoplasm; C:nucleoplasm;, F:actin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein-histidine N-methyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity;, P:actin modification; P:histone H3-K36 methylation; P:peptidyl-histidine methylation; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of uterine smooth muscle contraction;|Q86TU7 A0PJU3 A5PLP0 B4DZE8 Q0VAQ2 Q659C0 Q86TU8 Q96GY9 Q9H5U5,Actin-histidine N-methyltransferase {ECO:0000305},SET domain-containing protein 3 {ECO:0000305};, PF09273;PF00856;, GO:0000785;GO:0005737;GO:0005654;GO:0003779;GO:0046975;GO:0042800;GO:0018064;GO:0001102;GO:0003713;GO:0030047;GO:0010452;GO:0018021;GO:0018027;GO:0018026;GO:0018023;GO:0051149;GO:0045944;GO:0045893;GO:0070472;, C:chromatin; C:cytoplasm; C:nucleoplasm;, F:actin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein-histidine N-methyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity;, P:actin modification; P:histone H3-K36 methylation; P:peptidyl-histidine methylation; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of uterine smooth muscle contraction;|Q9Y6A2 B4DHP8 E7EQG9 Q8N2B0,Cholesterol 24-hydroxylase {ECO:0000305|PubMed:14640697},Cholesterol 24-monooxygenase;Cholesterol 24S-hydroxylase {ECO:0000303|PubMed:10377398};Cytochrome P450 46A1 {ECO:0000303|PubMed:14640697};, PF00067;, GO:0030425;GO:0005783;GO:0005789;GO:0016021;GO:0098794;GO:0098793;GO:0033781;GO:0020037;GO:0005506;GO:0008395;GO:0062184;GO:0006699;GO:0006707;GO:0007399;GO:0042448;GO:1903044;GO:1900271;GO:0016125;GO:0006805;, C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:postsynapse; C:presynapse;, F:cholesterol 24-hydroxylase activity; F:heme binding; F:iron ion binding; F:steroid hydroxylase activity; F:testosterone 16-beta-hydroxylase activity;, P:bile acid biosynthetic process; P:cholesterol catabolic process; P:nervous system development; P:progesterone metabolic process; P:protein localization to membrane raft; P:regulation of long-term synaptic potentiation; P:sterol metabolic process; P:xenobiotic metabolic process;|Q9Y6A2 B4DHP8 E7EQG9 Q8N2B0,Cholesterol 24-hydroxylase {ECO:0000305|PubMed:14640697},Cholesterol 24-monooxygenase;Cholesterol 24S-hydroxylase {ECO:0000303|PubMed:10377398};Cytochrome P450 46A1 {ECO:0000303|PubMed:14640697};, PF00067;, GO:0030425;GO:0005783;GO:0005789;GO:0016021;GO:0098794;GO:0098793;GO:0033781;GO:0020037;GO:0005506;GO:0008395;GO:0062184;GO:0006699;GO:0006707;GO:0007399;GO:0042448;GO:1903044;GO:1900271;GO:0016125;GO:0006805;, C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:postsynapse; C:presynapse;, F:cholesterol 24-hydroxylase activity; F:heme binding; F:iron ion binding; F:steroid hydroxylase activity; F:testosterone 16-beta-hydroxylase activity;, P:bile acid biosynthetic process; P:cholesterol catabolic process; P:nervous system development; P:progesterone metabolic process; P:protein localization to membrane raft; P:regulation of long-term synaptic potentiation; P:sterol metabolic process; P:xenobiotic metabolic process;|O00423 Q86U15 Q8N536 Q8N5C4 Q8WWL6,Echinoderm microtubule-associated protein-like 1,, PF03451;PF00400;, GO:0005829;GO:0005874;GO:0005875;GO:0048471;GO:0005509;GO:0008017;GO:0015631;GO:0007420;GO:0000226;GO:0007052;GO:0007405;, C:cytosol; C:microtubule; C:microtubule associated complex; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:microtubule binding; F:tubulin binding;, P:brain development; P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:neuroblast proliferation;|Q9UI08 A8K105 B7Z3I5 O95884 Q7Z522 Q8TBV1 Q9UF25 Q9UIC2,Ena/VASP-like protein,Ena/vasodilator-stimulated phosphoprotein-like;, PF08776;PF00568;, GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0003779;GO:0005522;GO:0017124;GO:0007015;GO:0045010;GO:0008154;GO:0009887;GO:0007411;GO:0007166;GO:0010633;GO:1900028;GO:0007399;GO:0030838;GO:0051496;GO:0051289;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane;, F:actin binding; F:profilin binding; F:SH3 domain binding;, P:actin filament organization; P:actin nucleation; P:actin polymerization or depolymerization; P:animal organ morphogenesis; P:axon guidance; P:cell surface receptor signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of ruffle assembly; P:nervous system development; P:positive regulation of actin filament polymerization; P:positive regulation of stress fiber assembly; P:protein homotetramerization;|Q9UI08 A8K105 B7Z3I5 O95884 Q7Z522 Q8TBV1 Q9UF25 Q9UIC2,Ena/VASP-like protein,Ena/vasodilator-stimulated phosphoprotein-like;, PF08776;PF00568;, GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0003779;GO:0005522;GO:0017124;GO:0007015;GO:0045010;GO:0008154;GO:0009887;GO:0007411;GO:0007166;GO:0010633;GO:1900028;GO:0007399;GO:0030838;GO:0051496;GO:0051289;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane;, F:actin binding; F:profilin binding; F:SH3 domain binding;, P:actin filament organization; P:actin nucleation; P:actin polymerization or depolymerization; P:animal organ morphogenesis; P:axon guidance; P:cell surface receptor signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of ruffle assembly; P:nervous system development; P:positive regulation of actin filament polymerization; P:positive regulation of stress fiber assembly; P:protein homotetramerization;|Q9UI08 A8K105 B7Z3I5 O95884 Q7Z522 Q8TBV1 Q9UF25 Q9UIC2,Ena/VASP-like protein,Ena/vasodilator-stimulated phosphoprotein-like;, PF08776;PF00568;, GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0003779;GO:0005522;GO:0017124;GO:0007015;GO:0045010;GO:0008154;GO:0009887;GO:0007411;GO:0007166;GO:0010633;GO:1900028;GO:0007399;GO:0030838;GO:0051496;GO:0051289;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane;, F:actin binding; F:profilin binding; F:SH3 domain binding;, P:actin filament organization; P:actin nucleation; P:actin polymerization or depolymerization; P:animal organ morphogenesis; P:axon guidance; P:cell surface receptor signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of ruffle assembly; P:nervous system development; P:positive regulation of actin filament polymerization; P:positive regulation of stress fiber assembly; P:protein homotetramerization;|Q6QHC5 Q6P492,Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2,Degenerative spermatocyte homolog 2;Sphingolipid 4-desaturase;Sphingolipid C4-monooxygenase;, PF00487;PF08557;, GO:0005789;GO:0016021;GO:0042284;GO:0000170;GO:0046513;GO:0006667;GO:0030148;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:sphingolipid delta-4 desaturase activity; F:sphingosine hydroxylase activity;, P:ceramide biosynthetic process; P:sphinganine metabolic process; P:sphingolipid biosynthetic process;|Q6QHC5 Q6P492,Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2,Degenerative spermatocyte homolog 2;Sphingolipid 4-desaturase;Sphingolipid C4-monooxygenase;, PF00487;PF08557;, GO:0005789;GO:0016021;GO:0042284;GO:0000170;GO:0046513;GO:0006667;GO:0030148;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:sphingolipid delta-4 desaturase activity; F:sphingosine hydroxylase activity;, P:ceramide biosynthetic process; P:sphinganine metabolic process; P:sphingolipid biosynthetic process;|Q6QHC5 Q6P492,Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2,Degenerative spermatocyte homolog 2;Sphingolipid 4-desaturase;Sphingolipid C4-monooxygenase;, PF00487;PF08557;, GO:0005789;GO:0016021;GO:0042284;GO:0000170;GO:0046513;GO:0006667;GO:0030148;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:sphingolipid delta-4 desaturase activity; F:sphingosine hydroxylase activity;, P:ceramide biosynthetic process; P:sphinganine metabolic process; P:sphingolipid biosynthetic process;|P25490 Q14935,Transcriptional repressor protein YY1,Delta transcription factor;INO80 complex subunit S;NF-E1;Yin and yang 1;, PF00096;, GO:0005677;GO:0005737;GO:0031011;GO:0016363;GO:0005654;GO:0005634;GO:0031519;GO:0005667;GO:0003682;GO:0000987;GO:0003677;GO:0000981;GO:0001217;GO:0001227;GO:0000400;GO:0046872;GO:0003723;GO:0000978;GO:1990837;GO:0046332;GO:0000976;GO:0009952;GO:0030183;GO:0048593;GO:0048468;GO:0006974;GO:0071347;GO:0034644;GO:0051276;GO:0000724;GO:0071707;GO:0061052;GO:0010629;GO:0032688;GO:1902894;GO:0000122;GO:0045944;GO:0016579;GO:0006357;GO:0034696;GO:0010225;GO:0006403;GO:0007283;, C:chromatin silencing complex; C:cytoplasm; C:Ino80 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:transcription regulator complex;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:four-way junction DNA binding; F:metal ion binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SMAD binding; F:transcription regulatory region sequence-specific DNA binding;, P:anterior/posterior pattern specification; P:B cell differentiation; P:camera-type eye morphogenesis; P:cell development; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:cellular response to UV; P:chromosome organization; P:double-strand break repair via homologous recombination; P:immunoglobulin heavy chain V-D-J recombination; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of gene expression; P:negative regulation of interferon-beta production; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of transcription by RNA polymerase II; P:response to prostaglandin F; P:response to UV-C; P:RNA localization; P:spermatogenesis;|P25490 Q14935,Transcriptional repressor protein YY1,Delta transcription factor;INO80 complex subunit S;NF-E1;Yin and yang 1;, PF00096;, GO:0005677;GO:0005737;GO:0031011;GO:0016363;GO:0005654;GO:0005634;GO:0031519;GO:0005667;GO:0003682;GO:0000987;GO:0003677;GO:0000981;GO:0001217;GO:0001227;GO:0000400;GO:0046872;GO:0003723;GO:0000978;GO:1990837;GO:0046332;GO:0000976;GO:0009952;GO:0030183;GO:0048593;GO:0048468;GO:0006974;GO:0071347;GO:0034644;GO:0051276;GO:0000724;GO:0071707;GO:0061052;GO:0010629;GO:0032688;GO:1902894;GO:0000122;GO:0045944;GO:0016579;GO:0006357;GO:0034696;GO:0010225;GO:0006403;GO:0007283;, C:chromatin silencing complex; C:cytoplasm; C:Ino80 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:transcription regulator complex;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:four-way junction DNA binding; F:metal ion binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SMAD binding; F:transcription regulatory region sequence-specific DNA binding;, P:anterior/posterior pattern specification; P:B cell differentiation; P:camera-type eye morphogenesis; P:cell development; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:cellular response to UV; P:chromosome organization; P:double-strand break repair via homologous recombination; P:immunoglobulin heavy chain V-D-J recombination; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of gene expression; P:negative regulation of interferon-beta production; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of transcription by RNA polymerase II; P:response to prostaglandin F; P:response to UV-C; P:RNA localization; P:spermatogenesis;|P25490 Q14935,Transcriptional repressor protein YY1,Delta transcription factor;INO80 complex subunit S;NF-E1;Yin and yang 1;, PF00096;, GO:0005677;GO:0005737;GO:0031011;GO:0016363;GO:0005654;GO:0005634;GO:0031519;GO:0005667;GO:0003682;GO:0000987;GO:0003677;GO:0000981;GO:0001217;GO:0001227;GO:0000400;GO:0046872;GO:0003723;GO:0000978;GO:1990837;GO:0046332;GO:0000976;GO:0009952;GO:0030183;GO:0048593;GO:0048468;GO:0006974;GO:0071347;GO:0034644;GO:0051276;GO:0000724;GO:0071707;GO:0061052;GO:0010629;GO:0032688;GO:1902894;GO:0000122;GO:0045944;GO:0016579;GO:0006357;GO:0034696;GO:0010225;GO:0006403;GO:0007283;, C:chromatin silencing complex; C:cytoplasm; C:Ino80 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:transcription regulator complex;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:four-way junction DNA binding; F:metal ion binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SMAD binding; F:transcription regulatory region sequence-specific DNA binding;, P:anterior/posterior pattern specification; P:B cell differentiation; P:camera-type eye morphogenesis; P:cell development; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:cellular response to UV; P:chromosome organization; P:double-strand break repair via homologous recombination; P:immunoglobulin heavy chain V-D-J recombination; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of gene expression; P:negative regulation of interferon-beta production; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of transcription by RNA polymerase II; P:response to prostaglandin F; P:response to UV-C; P:RNA localization; P:spermatogenesis; scaffold27 indexed_genome mRNA 28729070 28736739 . - . ID=transcript_6111;Q8N8R3 A3KMR5 Q541V0,Mitochondrial basic amino acids transporter,Carnitine/acylcarnitine translocase-like;Mitochondrial carnitine/acylcarnitine carrier protein CACL;Mitochondrial ornithine transporter 3;Solute carrier family 25 member 29;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015174;GO:0005289;GO:0005292;GO:1902616;GO:0006844;GO:0006865;GO:1903400;GO:0089709;GO:1903401;GO:1990575;GO:0015822;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:basic amino acid transmembrane transporter activity; F:high-affinity arginine transmembrane transporter activity; F:high-affinity lysine transmembrane transporter activity;, P:acyl carnitine transmembrane transport; P:acyl carnitine transport; P:amino acid transport; P:L-arginine transmembrane transport; P:L-histidine transmembrane transport; P:L-lysine transmembrane transport; P:mitochondrial L-ornithine transmembrane transport; P:ornithine transport; scaffold27 indexed_genome mRNA 28754601 28760106 . + . ID=transcript_6112;Q6Q0C1 B2RP39 Q68CL2 Q6PZD8 Q86U14,Solute carrier family 25 member 47,Hepatocellular carcinoma down-regulated mitochondrial carrier protein;, PF00153;, GO:0016021;GO:0005743;GO:0015227;GO:0006844;GO:0006865;, C:integral component of membrane; C:mitochondrial inner membrane;, F:acyl carnitine transmembrane transporter activity;, P:acyl carnitine transport; P:amino acid transport; scaffold27 indexed_genome mRNA 28763308 28790782 . - . ID=transcript_6113;P23381 A6NGN1 A6NID3 P78535 Q502Y0 Q53XB6 Q9UDI5 Q9UDL3,Tryptophan--tRNA ligase, cytoplasmic {ECO:0000305},Interferon-induced protein 53;Tryptophanyl-tRNA synthetase;, PF00579;PF00458;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0032991;GO:0005524;GO:0019210;GO:0019904;GO:0042803;GO:0019901;GO:0004830;GO:0001525;GO:0008285;GO:0006469;GO:0001933;GO:0010628;GO:0031334;GO:0045765;GO:0010835;GO:0006412;GO:0006418;GO:0006436;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus; C:protein-containing complex;, F:ATP binding; F:kinase inhibitor activity; F:protein domain specific binding; F:protein homodimerization activity; F:protein kinase binding; F:tryptophan-tRNA ligase activity;, P:angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:positive regulation of gene expression; P:positive regulation of protein-containing complex assembly; P:regulation of angiogenesis; P:regulation of protein ADP-ribosylation; P:translation; P:tRNA aminoacylation for protein translation; P:tryptophanyl-tRNA aminoacylation;|P23381 A6NGN1 A6NID3 P78535 Q502Y0 Q53XB6 Q9UDI5 Q9UDL3,Tryptophan--tRNA ligase, cytoplasmic {ECO:0000305},Interferon-induced protein 53;Tryptophanyl-tRNA synthetase;, PF00579;PF00458;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0032991;GO:0005524;GO:0019210;GO:0019904;GO:0042803;GO:0019901;GO:0004830;GO:0001525;GO:0008285;GO:0006469;GO:0001933;GO:0010628;GO:0031334;GO:0045765;GO:0010835;GO:0006412;GO:0006418;GO:0006436;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus; C:protein-containing complex;, F:ATP binding; F:kinase inhibitor activity; F:protein domain specific binding; F:protein homodimerization activity; F:protein kinase binding; F:tryptophan-tRNA ligase activity;, P:angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:positive regulation of gene expression; P:positive regulation of protein-containing complex assembly; P:regulation of angiogenesis; P:regulation of protein ADP-ribosylation; P:translation; P:tRNA aminoacylation for protein translation; P:tryptophanyl-tRNA aminoacylation;|P23381 A6NGN1 A6NID3 P78535 Q502Y0 Q53XB6 Q9UDI5 Q9UDL3,Tryptophan--tRNA ligase, cytoplasmic {ECO:0000305},Interferon-induced protein 53;Tryptophanyl-tRNA synthetase;, PF00579;PF00458;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0032991;GO:0005524;GO:0019210;GO:0019904;GO:0042803;GO:0019901;GO:0004830;GO:0001525;GO:0008285;GO:0006469;GO:0001933;GO:0010628;GO:0031334;GO:0045765;GO:0010835;GO:0006412;GO:0006418;GO:0006436;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus; C:protein-containing complex;, F:ATP binding; F:kinase inhibitor activity; F:protein domain specific binding; F:protein homodimerization activity; F:protein kinase binding; F:tryptophan-tRNA ligase activity;, P:angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:positive regulation of gene expression; P:positive regulation of protein-containing complex assembly; P:regulation of angiogenesis; P:regulation of protein ADP-ribosylation; P:translation; P:tRNA aminoacylation for protein translation; P:tryptophanyl-tRNA aminoacylation;|P23381 A6NGN1 A6NID3 P78535 Q502Y0 Q53XB6 Q9UDI5 Q9UDL3,Tryptophan--tRNA ligase, cytoplasmic {ECO:0000305},Interferon-induced protein 53;Tryptophanyl-tRNA synthetase;, PF00579;PF00458;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0032991;GO:0005524;GO:0019210;GO:0019904;GO:0042803;GO:0019901;GO:0004830;GO:0001525;GO:0008285;GO:0006469;GO:0001933;GO:0010628;GO:0031334;GO:0045765;GO:0010835;GO:0006412;GO:0006418;GO:0006436;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus; C:protein-containing complex;, F:ATP binding; F:kinase inhibitor activity; F:protein domain specific binding; F:protein homodimerization activity; F:protein kinase binding; F:tryptophan-tRNA ligase activity;, P:angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:positive regulation of gene expression; P:positive regulation of protein-containing complex assembly; P:regulation of angiogenesis; P:regulation of protein ADP-ribosylation; P:translation; P:tRNA aminoacylation for protein translation; P:tryptophanyl-tRNA aminoacylation;|P23381 A6NGN1 A6NID3 P78535 Q502Y0 Q53XB6 Q9UDI5 Q9UDL3,Tryptophan--tRNA ligase, cytoplasmic {ECO:0000305},Interferon-induced protein 53;Tryptophanyl-tRNA synthetase;, PF00579;PF00458;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0032991;GO:0005524;GO:0019210;GO:0019904;GO:0042803;GO:0019901;GO:0004830;GO:0001525;GO:0008285;GO:0006469;GO:0001933;GO:0010628;GO:0031334;GO:0045765;GO:0010835;GO:0006412;GO:0006418;GO:0006436;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus; C:protein-containing complex;, F:ATP binding; F:kinase inhibitor activity; F:protein domain specific binding; F:protein homodimerization activity; F:protein kinase binding; F:tryptophan-tRNA ligase activity;, P:angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:positive regulation of gene expression; P:positive regulation of protein-containing complex assembly; P:regulation of angiogenesis; P:regulation of protein ADP-ribosylation; P:translation; P:tRNA aminoacylation for protein translation; P:tryptophanyl-tRNA aminoacylation; scaffold27 indexed_genome mRNA 28791777 28930740 . + . ID=transcript_6114;Q64LD2 A8K7E5 Q6NVV6 Q86TQ4 Q9BTK5,WD repeat-containing protein 25,, PF00400;|Q64LD2 A8K7E5 Q6NVV6 Q86TQ4 Q9BTK5,WD repeat-containing protein 25,, PF00400;|Q64LD2 A8K7E5 Q6NVV6 Q86TQ4 Q9BTK5,WD repeat-containing protein 25,, PF00400;|Q64LD2 A8K7E5 Q6NVV6 Q86TQ4 Q9BTK5,WD repeat-containing protein 25,, PF00400; scaffold27 indexed_genome mRNA 28937312 28938471 . - . ID=transcript_6115;Q9BUH8 Q9NPU3 Q9P282,Brain-enriched guanylate kinase-associated protein,, , GO:0005737;GO:0016020;GO:0045202;GO:0098962;, C:cytoplasm; C:membrane; C:synapse;, , P:regulation of postsynaptic neurotransmitter receptor activity; scaffold27 indexed_genome mRNA 28938472 28942670 . - . ID=transcript_6116;Q9BUH8 Q9NPU3 Q9P282,Brain-enriched guanylate kinase-associated protein,, , GO:0005737;GO:0016020;GO:0045202;GO:0098962;, C:cytoplasm; C:membrane; C:synapse;, , P:regulation of postsynaptic neurotransmitter receptor activity; scaffold28 indexed_genome mRNA 240993 311444 . - . ID=transcript_6117;Q53HC9 D6W4Y1 O43179 Q53S19 Q53SG2,EARP and GARP complex-interacting protein 1 {ECO:0000305|PubMed:27440922},Endosome-associated recycling protein-interacting protein {ECO:0000305|PubMed:27440922};Golgi-associated retrograde protein-interacting protein {ECO:0000305|PubMed:27440922};Tumor-suppressing STF cDNA 1 protein;Tumor-suppressing subchromosomal transferable fragment candidate gene 1 protein {ECO:0000303|PubMed:27440922};, PF00400;, GO:0005802;GO:0032456;GO:2001137;GO:1905281;GO:0016567;GO:0050796;, C:trans-Golgi network;, , P:endocytic recycling; P:positive regulation of endocytic recycling; P:positive regulation of retrograde transport, endosome to Golgi; P:protein ubiquitination; P:regulation of insulin secretion; scaffold28 indexed_genome mRNA 334425 334956 . - . ID=transcript_6118;Q8WVT3 B3KV01 D6W4Y2 Q8WVW1 Q9Y395,Trafficking protein particle complex subunit 12 {ECO:0000305},Tetratricopeptide repeat protein 15 {ECO:0000303|PubMed:21525244};Trafficking of membranes and mitosis {ECO:0000303|PubMed:25918224};, , GO:0005829;GO:0005793;GO:0005794;GO:0000776;GO:0005654;GO:0005634;GO:0030008;GO:0004175;GO:0006888;GO:0007030;GO:0051310;GO:1905342;GO:0090234;, C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:kinetochore; C:nucleoplasm; C:nucleus; C:TRAPP complex;, F:endopeptidase activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:metaphase plate congression; P:positive regulation of protein localization to kinetochore; P:regulation of kinetochore assembly; scaffold28 indexed_genome mRNA 338992 339646 . - . ID=transcript_6119;Q8WVT3 B3KV01 D6W4Y2 Q8WVW1 Q9Y395,Trafficking protein particle complex subunit 12 {ECO:0000305},Tetratricopeptide repeat protein 15 {ECO:0000303|PubMed:21525244};Trafficking of membranes and mitosis {ECO:0000303|PubMed:25918224};, , GO:0005829;GO:0005793;GO:0005794;GO:0000776;GO:0005654;GO:0005634;GO:0030008;GO:0004175;GO:0006888;GO:0007030;GO:0051310;GO:1905342;GO:0090234;, C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:kinetochore; C:nucleoplasm; C:nucleus; C:TRAPP complex;, F:endopeptidase activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:metaphase plate congression; P:positive regulation of protein localization to kinetochore; P:regulation of kinetochore assembly; scaffold28 indexed_genome mRNA 532754 564293 . + . ID=transcript_6120;P27105 B1AM77 Q14087 Q15609 Q5VX96 Q96FK4,Stomatin {ECO:0000312|HGNC:HGNC:3383},Erythrocyte band 7 integral membrane protein {ECO:0000303|PubMed:1883838};Erythrocyte membrane protein band 7.2 {ECO:0000312|HGNC:HGNC:3383};Protein 7.2b {ECO:0000303|PubMed:8825639};, PF01145;, GO:0035577;GO:0072562;GO:0005856;GO:0005783;GO:0070062;GO:0005615;GO:0005887;GO:0042470;GO:0016020;GO:0045121;GO:0005739;GO:0048471;GO:0005886;GO:0035579;GO:0070821;GO:0031982;GO:0042802;GO:0042803;GO:0070063;GO:0043312;GO:0044829;GO:0090314;GO:0048524;GO:1901585;, C:azurophil granule membrane; C:blood microparticle; C:cytoskeleton; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:melanosome; C:membrane; C:membrane raft; C:mitochondrion; C:perinuclear region of cytoplasm; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane; C:vesicle;, F:identical protein binding; F:protein homodimerization activity; F:RNA polymerase binding;, P:neutrophil degranulation; P:positive regulation by host of viral genome replication; P:positive regulation of protein targeting to membrane; P:positive regulation of viral process; P:regulation of acid-sensing ion channel activity; scaffold28 indexed_genome mRNA 569535 597137 . - . ID=transcript_6121;P06396 A2A418 A8MUD1 A8MYN7 B7Z373 B7Z5V1 F5H1A8 Q5T0I2 Q8WVV7,Gelsolin,AGEL;Actin-depolymerizing factor;Brevin;, PF00626;, GO:0030478;GO:0015629;GO:0072562;GO:0030864;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0030027;GO:0043209;GO:0048471;GO:0045335;GO:0005886;GO:0002102;GO:0032991;GO:0001726;GO:0016528;GO:0034774;GO:0003779;GO:0051015;GO:0005509;GO:0045159;GO:0036313;GO:0005546;GO:0051693;GO:0030042;GO:0030041;GO:0090527;GO:0051014;GO:0045010;GO:0008154;GO:0007568;GO:1990000;GO:0051016;GO:0086003;GO:0030031;GO:0071276;GO:0071346;GO:0007417;GO:0060271;GO:0097284;GO:0046597;GO:0043312;GO:0014003;GO:0006911;GO:0048015;GO:0051127;GO:2001269;GO:0010628;GO:1902174;GO:1903923;GO:0031648;GO:0030155;GO:1903903;GO:1903906;GO:0071801;GO:1903909;GO:0055119;GO:0097017;GO:0045471;GO:0051593;GO:0035994;GO:0042989;GO:0014891;GO:0042246;GO:0042060;, C:actin cap; C:actin cytoskeleton; C:blood microparticle; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:myelin sheath; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:podosome; C:protein-containing complex; C:ruffle; C:sarcoplasm; C:secretory granule lumen;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:myosin II binding; F:phosphatidylinositol 3-kinase catalytic subunit binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament capping; P:actin filament depolymerization; P:actin filament polymerization; P:actin filament reorganization; P:actin filament severing; P:actin nucleation; P:actin polymerization or depolymerization; P:aging; P:amyloid fibril formation; P:barbed-end actin filament capping; P:cardiac muscle cell contraction; P:cell projection assembly; P:cellular response to cadmium ion; P:cellular response to interferon-gamma; P:central nervous system development; P:cilium assembly; P:hepatocyte apoptotic process; P:negative regulation of viral entry into host cell; P:neutrophil degranulation; P:oligodendrocyte development; P:phagocytosis, engulfment; P:phosphatidylinositol-mediated signaling; P:positive regulation of actin nucleation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of protein processing in phagocytic vesicle; P:protein destabilization; P:regulation of cell adhesion; P:regulation of establishment of T cell polarity; P:regulation of plasma membrane raft polarization; P:regulation of podosome assembly; P:regulation of receptor clustering; P:relaxation of cardiac muscle; P:renal protein absorption; P:response to ethanol; P:response to folic acid; P:response to muscle stretch; P:sequestering of actin monomers; P:striated muscle atrophy; P:tissue regeneration; P:wound healing;|P06396 A2A418 A8MUD1 A8MYN7 B7Z373 B7Z5V1 F5H1A8 Q5T0I2 Q8WVV7,Gelsolin,AGEL;Actin-depolymerizing factor;Brevin;, PF00626;, GO:0030478;GO:0015629;GO:0072562;GO:0030864;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0030027;GO:0043209;GO:0048471;GO:0045335;GO:0005886;GO:0002102;GO:0032991;GO:0001726;GO:0016528;GO:0034774;GO:0003779;GO:0051015;GO:0005509;GO:0045159;GO:0036313;GO:0005546;GO:0051693;GO:0030042;GO:0030041;GO:0090527;GO:0051014;GO:0045010;GO:0008154;GO:0007568;GO:1990000;GO:0051016;GO:0086003;GO:0030031;GO:0071276;GO:0071346;GO:0007417;GO:0060271;GO:0097284;GO:0046597;GO:0043312;GO:0014003;GO:0006911;GO:0048015;GO:0051127;GO:2001269;GO:0010628;GO:1902174;GO:1903923;GO:0031648;GO:0030155;GO:1903903;GO:1903906;GO:0071801;GO:1903909;GO:0055119;GO:0097017;GO:0045471;GO:0051593;GO:0035994;GO:0042989;GO:0014891;GO:0042246;GO:0042060;, C:actin cap; C:actin cytoskeleton; C:blood microparticle; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:myelin sheath; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:podosome; C:protein-containing complex; C:ruffle; C:sarcoplasm; C:secretory granule lumen;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:myosin II binding; F:phosphatidylinositol 3-kinase catalytic subunit binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament capping; P:actin filament depolymerization; P:actin filament polymerization; P:actin filament reorganization; P:actin filament severing; P:actin nucleation; P:actin polymerization or depolymerization; P:aging; P:amyloid fibril formation; P:barbed-end actin filament capping; P:cardiac muscle cell contraction; P:cell projection assembly; P:cellular response to cadmium ion; P:cellular response to interferon-gamma; P:central nervous system development; P:cilium assembly; P:hepatocyte apoptotic process; P:negative regulation of viral entry into host cell; P:neutrophil degranulation; P:oligodendrocyte development; P:phagocytosis, engulfment; P:phosphatidylinositol-mediated signaling; P:positive regulation of actin nucleation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of protein processing in phagocytic vesicle; P:protein destabilization; P:regulation of cell adhesion; P:regulation of establishment of T cell polarity; P:regulation of plasma membrane raft polarization; P:regulation of podosome assembly; P:regulation of receptor clustering; P:relaxation of cardiac muscle; P:renal protein absorption; P:response to ethanol; P:response to folic acid; P:response to muscle stretch; P:sequestering of actin monomers; P:striated muscle atrophy; P:tissue regeneration; P:wound healing;|P06396 A2A418 A8MUD1 A8MYN7 B7Z373 B7Z5V1 F5H1A8 Q5T0I2 Q8WVV7,Gelsolin,AGEL;Actin-depolymerizing factor;Brevin;, PF00626;, GO:0030478;GO:0015629;GO:0072562;GO:0030864;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0030027;GO:0043209;GO:0048471;GO:0045335;GO:0005886;GO:0002102;GO:0032991;GO:0001726;GO:0016528;GO:0034774;GO:0003779;GO:0051015;GO:0005509;GO:0045159;GO:0036313;GO:0005546;GO:0051693;GO:0030042;GO:0030041;GO:0090527;GO:0051014;GO:0045010;GO:0008154;GO:0007568;GO:1990000;GO:0051016;GO:0086003;GO:0030031;GO:0071276;GO:0071346;GO:0007417;GO:0060271;GO:0097284;GO:0046597;GO:0043312;GO:0014003;GO:0006911;GO:0048015;GO:0051127;GO:2001269;GO:0010628;GO:1902174;GO:1903923;GO:0031648;GO:0030155;GO:1903903;GO:1903906;GO:0071801;GO:1903909;GO:0055119;GO:0097017;GO:0045471;GO:0051593;GO:0035994;GO:0042989;GO:0014891;GO:0042246;GO:0042060;, C:actin cap; C:actin cytoskeleton; C:blood microparticle; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:myelin sheath; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:podosome; C:protein-containing complex; C:ruffle; C:sarcoplasm; C:secretory granule lumen;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:myosin II binding; F:phosphatidylinositol 3-kinase catalytic subunit binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament capping; P:actin filament depolymerization; P:actin filament polymerization; P:actin filament reorganization; P:actin filament severing; P:actin nucleation; P:actin polymerization or depolymerization; P:aging; P:amyloid fibril formation; P:barbed-end actin filament capping; P:cardiac muscle cell contraction; P:cell projection assembly; P:cellular response to cadmium ion; P:cellular response to interferon-gamma; P:central nervous system development; P:cilium assembly; P:hepatocyte apoptotic process; P:negative regulation of viral entry into host cell; P:neutrophil degranulation; P:oligodendrocyte development; P:phagocytosis, engulfment; P:phosphatidylinositol-mediated signaling; P:positive regulation of actin nucleation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of protein processing in phagocytic vesicle; P:protein destabilization; P:regulation of cell adhesion; P:regulation of establishment of T cell polarity; P:regulation of plasma membrane raft polarization; P:regulation of podosome assembly; P:regulation of receptor clustering; P:relaxation of cardiac muscle; P:renal protein absorption; P:response to ethanol; P:response to folic acid; P:response to muscle stretch; P:sequestering of actin monomers; P:striated muscle atrophy; P:tissue regeneration; P:wound healing;|P06396 A2A418 A8MUD1 A8MYN7 B7Z373 B7Z5V1 F5H1A8 Q5T0I2 Q8WVV7,Gelsolin,AGEL;Actin-depolymerizing factor;Brevin;, PF00626;, GO:0030478;GO:0015629;GO:0072562;GO:0030864;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0030027;GO:0043209;GO:0048471;GO:0045335;GO:0005886;GO:0002102;GO:0032991;GO:0001726;GO:0016528;GO:0034774;GO:0003779;GO:0051015;GO:0005509;GO:0045159;GO:0036313;GO:0005546;GO:0051693;GO:0030042;GO:0030041;GO:0090527;GO:0051014;GO:0045010;GO:0008154;GO:0007568;GO:1990000;GO:0051016;GO:0086003;GO:0030031;GO:0071276;GO:0071346;GO:0007417;GO:0060271;GO:0097284;GO:0046597;GO:0043312;GO:0014003;GO:0006911;GO:0048015;GO:0051127;GO:2001269;GO:0010628;GO:1902174;GO:1903923;GO:0031648;GO:0030155;GO:1903903;GO:1903906;GO:0071801;GO:1903909;GO:0055119;GO:0097017;GO:0045471;GO:0051593;GO:0035994;GO:0042989;GO:0014891;GO:0042246;GO:0042060;, C:actin cap; C:actin cytoskeleton; C:blood microparticle; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:myelin sheath; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:podosome; C:protein-containing complex; C:ruffle; C:sarcoplasm; C:secretory granule lumen;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:myosin II binding; F:phosphatidylinositol 3-kinase catalytic subunit binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament capping; P:actin filament depolymerization; P:actin filament polymerization; P:actin filament reorganization; P:actin filament severing; P:actin nucleation; P:actin polymerization or depolymerization; P:aging; P:amyloid fibril formation; P:barbed-end actin filament capping; P:cardiac muscle cell contraction; P:cell projection assembly; P:cellular response to cadmium ion; P:cellular response to interferon-gamma; P:central nervous system development; P:cilium assembly; P:hepatocyte apoptotic process; P:negative regulation of viral entry into host cell; P:neutrophil degranulation; P:oligodendrocyte development; P:phagocytosis, engulfment; P:phosphatidylinositol-mediated signaling; P:positive regulation of actin nucleation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of protein processing in phagocytic vesicle; P:protein destabilization; P:regulation of cell adhesion; P:regulation of establishment of T cell polarity; P:regulation of plasma membrane raft polarization; P:regulation of podosome assembly; P:regulation of receptor clustering; P:relaxation of cardiac muscle; P:renal protein absorption; P:response to ethanol; P:response to folic acid; P:response to muscle stretch; P:sequestering of actin monomers; P:striated muscle atrophy; P:tissue regeneration; P:wound healing;|P06396 A2A418 A8MUD1 A8MYN7 B7Z373 B7Z5V1 F5H1A8 Q5T0I2 Q8WVV7,Gelsolin,AGEL;Actin-depolymerizing factor;Brevin;, PF00626;, GO:0030478;GO:0015629;GO:0072562;GO:0030864;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0030027;GO:0043209;GO:0048471;GO:0045335;GO:0005886;GO:0002102;GO:0032991;GO:0001726;GO:0016528;GO:0034774;GO:0003779;GO:0051015;GO:0005509;GO:0045159;GO:0036313;GO:0005546;GO:0051693;GO:0030042;GO:0030041;GO:0090527;GO:0051014;GO:0045010;GO:0008154;GO:0007568;GO:1990000;GO:0051016;GO:0086003;GO:0030031;GO:0071276;GO:0071346;GO:0007417;GO:0060271;GO:0097284;GO:0046597;GO:0043312;GO:0014003;GO:0006911;GO:0048015;GO:0051127;GO:2001269;GO:0010628;GO:1902174;GO:1903923;GO:0031648;GO:0030155;GO:1903903;GO:1903906;GO:0071801;GO:1903909;GO:0055119;GO:0097017;GO:0045471;GO:0051593;GO:0035994;GO:0042989;GO:0014891;GO:0042246;GO:0042060;, C:actin cap; C:actin cytoskeleton; C:blood microparticle; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:myelin sheath; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:podosome; C:protein-containing complex; C:ruffle; C:sarcoplasm; C:secretory granule lumen;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:myosin II binding; F:phosphatidylinositol 3-kinase catalytic subunit binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament capping; P:actin filament depolymerization; P:actin filament polymerization; P:actin filament reorganization; P:actin filament severing; P:actin nucleation; P:actin polymerization or depolymerization; P:aging; P:amyloid fibril formation; P:barbed-end actin filament capping; P:cardiac muscle cell contraction; P:cell projection assembly; P:cellular response to cadmium ion; P:cellular response to interferon-gamma; P:central nervous system development; P:cilium assembly; P:hepatocyte apoptotic process; P:negative regulation of viral entry into host cell; P:neutrophil degranulation; P:oligodendrocyte development; P:phagocytosis, engulfment; P:phosphatidylinositol-mediated signaling; P:positive regulation of actin nucleation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of protein processing in phagocytic vesicle; P:protein destabilization; P:regulation of cell adhesion; P:regulation of establishment of T cell polarity; P:regulation of plasma membrane raft polarization; P:regulation of podosome assembly; P:regulation of receptor clustering; P:relaxation of cardiac muscle; P:renal protein absorption; P:response to ethanol; P:response to folic acid; P:response to muscle stretch; P:sequestering of actin monomers; P:striated muscle atrophy; P:tissue regeneration; P:wound healing;|P06396 A2A418 A8MUD1 A8MYN7 B7Z373 B7Z5V1 F5H1A8 Q5T0I2 Q8WVV7,Gelsolin,AGEL;Actin-depolymerizing factor;Brevin;, PF00626;, GO:0030478;GO:0015629;GO:0072562;GO:0030864;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0030027;GO:0043209;GO:0048471;GO:0045335;GO:0005886;GO:0002102;GO:0032991;GO:0001726;GO:0016528;GO:0034774;GO:0003779;GO:0051015;GO:0005509;GO:0045159;GO:0036313;GO:0005546;GO:0051693;GO:0030042;GO:0030041;GO:0090527;GO:0051014;GO:0045010;GO:0008154;GO:0007568;GO:1990000;GO:0051016;GO:0086003;GO:0030031;GO:0071276;GO:0071346;GO:0007417;GO:0060271;GO:0097284;GO:0046597;GO:0043312;GO:0014003;GO:0006911;GO:0048015;GO:0051127;GO:2001269;GO:0010628;GO:1902174;GO:1903923;GO:0031648;GO:0030155;GO:1903903;GO:1903906;GO:0071801;GO:1903909;GO:0055119;GO:0097017;GO:0045471;GO:0051593;GO:0035994;GO:0042989;GO:0014891;GO:0042246;GO:0042060;, C:actin cap; C:actin cytoskeleton; C:blood microparticle; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:myelin sheath; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:podosome; C:protein-containing complex; C:ruffle; C:sarcoplasm; C:secretory granule lumen;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:myosin II binding; F:phosphatidylinositol 3-kinase catalytic subunit binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament capping; P:actin filament depolymerization; P:actin filament polymerization; P:actin filament reorganization; P:actin filament severing; P:actin nucleation; P:actin polymerization or depolymerization; P:aging; P:amyloid fibril formation; P:barbed-end actin filament capping; P:cardiac muscle cell contraction; P:cell projection assembly; P:cellular response to cadmium ion; P:cellular response to interferon-gamma; P:central nervous system development; P:cilium assembly; P:hepatocyte apoptotic process; P:negative regulation of viral entry into host cell; P:neutrophil degranulation; P:oligodendrocyte development; P:phagocytosis, engulfment; P:phosphatidylinositol-mediated signaling; P:positive regulation of actin nucleation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of protein processing in phagocytic vesicle; P:protein destabilization; P:regulation of cell adhesion; P:regulation of establishment of T cell polarity; P:regulation of plasma membrane raft polarization; P:regulation of podosome assembly; P:regulation of receptor clustering; P:relaxation of cardiac muscle; P:renal protein absorption; P:response to ethanol; P:response to folic acid; P:response to muscle stretch; P:sequestering of actin monomers; P:striated muscle atrophy; P:tissue regeneration; P:wound healing;|P06396 A2A418 A8MUD1 A8MYN7 B7Z373 B7Z5V1 F5H1A8 Q5T0I2 Q8WVV7,Gelsolin,AGEL;Actin-depolymerizing factor;Brevin;, PF00626;, GO:0030478;GO:0015629;GO:0072562;GO:0030864;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0030027;GO:0043209;GO:0048471;GO:0045335;GO:0005886;GO:0002102;GO:0032991;GO:0001726;GO:0016528;GO:0034774;GO:0003779;GO:0051015;GO:0005509;GO:0045159;GO:0036313;GO:0005546;GO:0051693;GO:0030042;GO:0030041;GO:0090527;GO:0051014;GO:0045010;GO:0008154;GO:0007568;GO:1990000;GO:0051016;GO:0086003;GO:0030031;GO:0071276;GO:0071346;GO:0007417;GO:0060271;GO:0097284;GO:0046597;GO:0043312;GO:0014003;GO:0006911;GO:0048015;GO:0051127;GO:2001269;GO:0010628;GO:1902174;GO:1903923;GO:0031648;GO:0030155;GO:1903903;GO:1903906;GO:0071801;GO:1903909;GO:0055119;GO:0097017;GO:0045471;GO:0051593;GO:0035994;GO:0042989;GO:0014891;GO:0042246;GO:0042060;, C:actin cap; C:actin cytoskeleton; C:blood microparticle; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lamellipodium; C:myelin sheath; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:podosome; C:protein-containing complex; C:ruffle; C:sarcoplasm; C:secretory granule lumen;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:myosin II binding; F:phosphatidylinositol 3-kinase catalytic subunit binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament capping; P:actin filament depolymerization; P:actin filament polymerization; P:actin filament reorganization; P:actin filament severing; P:actin nucleation; P:actin polymerization or depolymerization; P:aging; P:amyloid fibril formation; P:barbed-end actin filament capping; P:cardiac muscle cell contraction; P:cell projection assembly; P:cellular response to cadmium ion; P:cellular response to interferon-gamma; P:central nervous system development; P:cilium assembly; P:hepatocyte apoptotic process; P:negative regulation of viral entry into host cell; P:neutrophil degranulation; P:oligodendrocyte development; P:phagocytosis, engulfment; P:phosphatidylinositol-mediated signaling; P:positive regulation of actin nucleation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of protein processing in phagocytic vesicle; P:protein destabilization; P:regulation of cell adhesion; P:regulation of establishment of T cell polarity; P:regulation of plasma membrane raft polarization; P:regulation of podosome assembly; P:regulation of receptor clustering; P:relaxation of cardiac muscle; P:renal protein absorption; P:response to ethanol; P:response to folic acid; P:response to muscle stretch; P:sequestering of actin monomers; P:striated muscle atrophy; P:tissue regeneration; P:wound healing; scaffold28 indexed_genome mRNA 676265 695463 . + . ID=transcript_6122;P61106 B3KR31 P35287 Q5JVD4 Q6Q7K5 Q969L0 Q9UI11,Ras-related protein Rab-14,, PF00071;, GO:0005829;GO:0005769;GO:0031901;GO:0012505;GO:0070062;GO:0000139;GO:0005795;GO:0043231;GO:0005770;GO:0005765;GO:0005764;GO:0042175;GO:0048471;GO:0045335;GO:0005886;GO:0055037;GO:0055038;GO:0005791;GO:0070821;GO:0005802;GO:0030140;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0042742;GO:0032456;GO:0008543;GO:0006895;GO:0006886;GO:0046907;GO:0043312;GO:0090387;GO:0090382;GO:0006661;GO:0045995;GO:0032880;GO:0016192;, C:cytosol; C:early endosome; C:early endosome membrane; C:endomembrane system; C:extracellular exosome; C:Golgi membrane; C:Golgi stack; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal membrane; C:lysosome; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:rough endoplasmic reticulum; C:tertiary granule membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding;, P:defense response to bacterium; P:endocytic recycling; P:fibroblast growth factor receptor signaling pathway; P:Golgi to endosome transport; P:intracellular protein transport; P:intracellular transport; P:neutrophil degranulation; P:phagolysosome assembly involved in apoptotic cell clearance; P:phagosome maturation; P:phosphatidylinositol biosynthetic process; P:regulation of embryonic development; P:regulation of protein localization; P:vesicle-mediated transport;|P61106 B3KR31 P35287 Q5JVD4 Q6Q7K5 Q969L0 Q9UI11,Ras-related protein Rab-14,, PF00071;, GO:0005829;GO:0005769;GO:0031901;GO:0012505;GO:0070062;GO:0000139;GO:0005795;GO:0043231;GO:0005770;GO:0005765;GO:0005764;GO:0042175;GO:0048471;GO:0045335;GO:0005886;GO:0055037;GO:0055038;GO:0005791;GO:0070821;GO:0005802;GO:0030140;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0042742;GO:0032456;GO:0008543;GO:0006895;GO:0006886;GO:0046907;GO:0043312;GO:0090387;GO:0090382;GO:0006661;GO:0045995;GO:0032880;GO:0016192;, C:cytosol; C:early endosome; C:early endosome membrane; C:endomembrane system; C:extracellular exosome; C:Golgi membrane; C:Golgi stack; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal membrane; C:lysosome; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:rough endoplasmic reticulum; C:tertiary granule membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding;, P:defense response to bacterium; P:endocytic recycling; P:fibroblast growth factor receptor signaling pathway; P:Golgi to endosome transport; P:intracellular protein transport; P:intracellular transport; P:neutrophil degranulation; P:phagolysosome assembly involved in apoptotic cell clearance; P:phagosome maturation; P:phosphatidylinositol biosynthetic process; P:regulation of embryonic development; P:regulation of protein localization; P:vesicle-mediated transport;|P61106 B3KR31 P35287 Q5JVD4 Q6Q7K5 Q969L0 Q9UI11,Ras-related protein Rab-14,, PF00071;, GO:0005829;GO:0005769;GO:0031901;GO:0012505;GO:0070062;GO:0000139;GO:0005795;GO:0043231;GO:0005770;GO:0005765;GO:0005764;GO:0042175;GO:0048471;GO:0045335;GO:0005886;GO:0055037;GO:0055038;GO:0005791;GO:0070821;GO:0005802;GO:0030140;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0042742;GO:0032456;GO:0008543;GO:0006895;GO:0006886;GO:0046907;GO:0043312;GO:0090387;GO:0090382;GO:0006661;GO:0045995;GO:0032880;GO:0016192;, C:cytosol; C:early endosome; C:early endosome membrane; C:endomembrane system; C:extracellular exosome; C:Golgi membrane; C:Golgi stack; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal membrane; C:lysosome; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:rough endoplasmic reticulum; C:tertiary granule membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding;, P:defense response to bacterium; P:endocytic recycling; P:fibroblast growth factor receptor signaling pathway; P:Golgi to endosome transport; P:intracellular protein transport; P:intracellular transport; P:neutrophil degranulation; P:phagolysosome assembly involved in apoptotic cell clearance; P:phagosome maturation; P:phosphatidylinositol biosynthetic process; P:regulation of embryonic development; P:regulation of protein localization; P:vesicle-mediated transport; scaffold28 indexed_genome mRNA 697348 708940 . - . ID=transcript_6123;Q9Y489,Centriolin,Centrosomal protein 1;Centrosomal protein of 110 kDa;, , GO:0120103;GO:0005813;GO:0005829;GO:0090543;GO:0090619;GO:0016020;GO:0005815;GO:0097431;GO:0048471;GO:0008092;GO:0035904;GO:0051301;GO:0097711;GO:0060976;GO:0000086;GO:0001822;GO:0051493;GO:0010389;GO:0003281;, C:centriolar subdistal appendage; C:centrosome; C:cytosol; C:Flemming body; C:meiotic spindle pole; C:membrane; C:microtubule organizing center; C:mitotic spindle pole; C:perinuclear region of cytoplasm;, F:cytoskeletal protein binding;, P:aorta development; P:cell division; P:ciliary basal body-plasma membrane docking; P:coronary vasculature development; P:G2/M transition of mitotic cell cycle; P:kidney development; P:regulation of cytoskeleton organization; P:regulation of G2/M transition of mitotic cell cycle; P:ventricular septum development;|Q9Y489,Centriolin,Centrosomal protein 1;Centrosomal protein of 110 kDa;, , GO:0120103;GO:0005813;GO:0005829;GO:0090543;GO:0090619;GO:0016020;GO:0005815;GO:0097431;GO:0048471;GO:0008092;GO:0035904;GO:0051301;GO:0097711;GO:0060976;GO:0000086;GO:0001822;GO:0051493;GO:0010389;GO:0003281;, C:centriolar subdistal appendage; C:centrosome; C:cytosol; C:Flemming body; C:meiotic spindle pole; C:membrane; C:microtubule organizing center; C:mitotic spindle pole; C:perinuclear region of cytoplasm;, F:cytoskeletal protein binding;, P:aorta development; P:cell division; P:ciliary basal body-plasma membrane docking; P:coronary vasculature development; P:G2/M transition of mitotic cell cycle; P:kidney development; P:regulation of cytoskeleton organization; P:regulation of G2/M transition of mitotic cell cycle; P:ventricular septum development;|Q9Y489,Centriolin,Centrosomal protein 1;Centrosomal protein of 110 kDa;, , GO:0120103;GO:0005813;GO:0005829;GO:0090543;GO:0090619;GO:0016020;GO:0005815;GO:0097431;GO:0048471;GO:0008092;GO:0035904;GO:0051301;GO:0097711;GO:0060976;GO:0000086;GO:0001822;GO:0051493;GO:0010389;GO:0003281;, C:centriolar subdistal appendage; C:centrosome; C:cytosol; C:Flemming body; C:meiotic spindle pole; C:membrane; C:microtubule organizing center; C:mitotic spindle pole; C:perinuclear region of cytoplasm;, F:cytoskeletal protein binding;, P:aorta development; P:cell division; P:ciliary basal body-plasma membrane docking; P:coronary vasculature development; P:G2/M transition of mitotic cell cycle; P:kidney development; P:regulation of cytoskeleton organization; P:regulation of G2/M transition of mitotic cell cycle; P:ventricular septum development;|Q9Y489,Centriolin,Centrosomal protein 1;Centrosomal protein of 110 kDa;, , GO:0120103;GO:0005813;GO:0005829;GO:0090543;GO:0090619;GO:0016020;GO:0005815;GO:0097431;GO:0048471;GO:0008092;GO:0035904;GO:0051301;GO:0097711;GO:0060976;GO:0000086;GO:0001822;GO:0051493;GO:0010389;GO:0003281;, C:centriolar subdistal appendage; C:centrosome; C:cytosol; C:Flemming body; C:meiotic spindle pole; C:membrane; C:microtubule organizing center; C:mitotic spindle pole; C:perinuclear region of cytoplasm;, F:cytoskeletal protein binding;, P:aorta development; P:cell division; P:ciliary basal body-plasma membrane docking; P:coronary vasculature development; P:G2/M transition of mitotic cell cycle; P:kidney development; P:regulation of cytoskeleton organization; P:regulation of G2/M transition of mitotic cell cycle; P:ventricular septum development;|Q9Y489,Centriolin,Centrosomal protein 1;Centrosomal protein of 110 kDa;, , GO:0120103;GO:0005813;GO:0005829;GO:0090543;GO:0090619;GO:0016020;GO:0005815;GO:0097431;GO:0048471;GO:0008092;GO:0035904;GO:0051301;GO:0097711;GO:0060976;GO:0000086;GO:0001822;GO:0051493;GO:0010389;GO:0003281;, C:centriolar subdistal appendage; C:centrosome; C:cytosol; C:Flemming body; C:meiotic spindle pole; C:membrane; C:microtubule organizing center; C:mitotic spindle pole; C:perinuclear region of cytoplasm;, F:cytoskeletal protein binding;, P:aorta development; P:cell division; P:ciliary basal body-plasma membrane docking; P:coronary vasculature development; P:G2/M transition of mitotic cell cycle; P:kidney development; P:regulation of cytoskeleton organization; P:regulation of G2/M transition of mitotic cell cycle; P:ventricular septum development;|Q9Y489,Centriolin,Centrosomal protein 1;Centrosomal protein of 110 kDa;, , GO:0120103;GO:0005813;GO:0005829;GO:0090543;GO:0090619;GO:0016020;GO:0005815;GO:0097431;GO:0048471;GO:0008092;GO:0035904;GO:0051301;GO:0097711;GO:0060976;GO:0000086;GO:0001822;GO:0051493;GO:0010389;GO:0003281;, C:centriolar subdistal appendage; C:centrosome; C:cytosol; C:Flemming body; C:meiotic spindle pole; C:membrane; C:microtubule organizing center; C:mitotic spindle pole; C:perinuclear region of cytoplasm;, F:cytoskeletal protein binding;, P:aorta development; P:cell division; P:ciliary basal body-plasma membrane docking; P:coronary vasculature development; P:G2/M transition of mitotic cell cycle; P:kidney development; P:regulation of cytoskeleton organization; P:regulation of G2/M transition of mitotic cell cycle; P:ventricular septum development;|Q9Y489,Centriolin,Centrosomal protein 1;Centrosomal protein of 110 kDa;, , GO:0120103;GO:0005813;GO:0005829;GO:0090543;GO:0090619;GO:0016020;GO:0005815;GO:0097431;GO:0048471;GO:0008092;GO:0035904;GO:0051301;GO:0097711;GO:0060976;GO:0000086;GO:0001822;GO:0051493;GO:0010389;GO:0003281;, C:centriolar subdistal appendage; C:centrosome; C:cytosol; C:Flemming body; C:meiotic spindle pole; C:membrane; C:microtubule organizing center; C:mitotic spindle pole; C:perinuclear region of cytoplasm;, F:cytoskeletal protein binding;, P:aorta development; P:cell division; P:ciliary basal body-plasma membrane docking; P:coronary vasculature development; P:G2/M transition of mitotic cell cycle; P:kidney development; P:regulation of cytoskeleton organization; P:regulation of G2/M transition of mitotic cell cycle; P:ventricular septum development; scaffold28 indexed_genome mRNA 710645 776828 . - . ID=transcript_6124;Q9Y489,Centriolin,Centrosomal protein 1;Centrosomal protein of 110 kDa;, , GO:0120103;GO:0005813;GO:0005829;GO:0090543;GO:0090619;GO:0016020;GO:0005815;GO:0097431;GO:0048471;GO:0008092;GO:0035904;GO:0051301;GO:0097711;GO:0060976;GO:0000086;GO:0001822;GO:0051493;GO:0010389;GO:0003281;, C:centriolar subdistal appendage; C:centrosome; C:cytosol; C:Flemming body; C:meiotic spindle pole; C:membrane; C:microtubule organizing center; C:mitotic spindle pole; C:perinuclear region of cytoplasm;, F:cytoskeletal protein binding;, P:aorta development; P:cell division; P:ciliary basal body-plasma membrane docking; P:coronary vasculature development; P:G2/M transition of mitotic cell cycle; P:kidney development; P:regulation of cytoskeleton organization; P:regulation of G2/M transition of mitotic cell cycle; P:ventricular septum development;|Q9Y489,Centriolin,Centrosomal protein 1;Centrosomal protein of 110 kDa;, , GO:0120103;GO:0005813;GO:0005829;GO:0090543;GO:0090619;GO:0016020;GO:0005815;GO:0097431;GO:0048471;GO:0008092;GO:0035904;GO:0051301;GO:0097711;GO:0060976;GO:0000086;GO:0001822;GO:0051493;GO:0010389;GO:0003281;, C:centriolar subdistal appendage; C:centrosome; C:cytosol; C:Flemming body; C:meiotic spindle pole; C:membrane; C:microtubule organizing center; C:mitotic spindle pole; C:perinuclear region of cytoplasm;, F:cytoskeletal protein binding;, P:aorta development; P:cell division; P:ciliary basal body-plasma membrane docking; P:coronary vasculature development; P:G2/M transition of mitotic cell cycle; P:kidney development; P:regulation of cytoskeleton organization; P:regulation of G2/M transition of mitotic cell cycle; P:ventricular septum development;|Q9Y489,Centriolin,Centrosomal protein 1;Centrosomal protein of 110 kDa;, , GO:0120103;GO:0005813;GO:0005829;GO:0090543;GO:0090619;GO:0016020;GO:0005815;GO:0097431;GO:0048471;GO:0008092;GO:0035904;GO:0051301;GO:0097711;GO:0060976;GO:0000086;GO:0001822;GO:0051493;GO:0010389;GO:0003281;, C:centriolar subdistal appendage; C:centrosome; C:cytosol; C:Flemming body; C:meiotic spindle pole; C:membrane; C:microtubule organizing center; C:mitotic spindle pole; C:perinuclear region of cytoplasm;, F:cytoskeletal protein binding;, P:aorta development; P:cell division; P:ciliary basal body-plasma membrane docking; P:coronary vasculature development; P:G2/M transition of mitotic cell cycle; P:kidney development; P:regulation of cytoskeleton organization; P:regulation of G2/M transition of mitotic cell cycle; P:ventricular septum development; scaffold28 indexed_genome mRNA 832474 917984 . + . ID=transcript_6125;P01031 Q14CJ0 Q27I61,Complement C5,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0070062;GO:0005576;GO:0005615;GO:0005579;GO:0008009;GO:0004866;GO:0005102;GO:0000187;GO:0007166;GO:0006935;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0007186;GO:0001701;GO:0006954;GO:0010760;GO:0045766;GO:0032722;GO:0010575;GO:0030449;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane attack complex;, F:chemokine activity; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:chemotaxis; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:inflammatory response; P:negative regulation of macrophage chemotaxis; P:positive regulation of angiogenesis; P:positive regulation of chemokine production; P:positive regulation of vascular endothelial growth factor production; P:regulation of complement activation;|P01031 Q14CJ0 Q27I61,Complement C5,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0070062;GO:0005576;GO:0005615;GO:0005579;GO:0008009;GO:0004866;GO:0005102;GO:0000187;GO:0007166;GO:0006935;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0007186;GO:0001701;GO:0006954;GO:0010760;GO:0045766;GO:0032722;GO:0010575;GO:0030449;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane attack complex;, F:chemokine activity; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:chemotaxis; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:inflammatory response; P:negative regulation of macrophage chemotaxis; P:positive regulation of angiogenesis; P:positive regulation of chemokine production; P:positive regulation of vascular endothelial growth factor production; P:regulation of complement activation;|P01031 Q14CJ0 Q27I61,Complement C5,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0070062;GO:0005576;GO:0005615;GO:0005579;GO:0008009;GO:0004866;GO:0005102;GO:0000187;GO:0007166;GO:0006935;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0007186;GO:0001701;GO:0006954;GO:0010760;GO:0045766;GO:0032722;GO:0010575;GO:0030449;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane attack complex;, F:chemokine activity; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:chemotaxis; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:inflammatory response; P:negative regulation of macrophage chemotaxis; P:positive regulation of angiogenesis; P:positive regulation of chemokine production; P:positive regulation of vascular endothelial growth factor production; P:regulation of complement activation;|P01031 Q14CJ0 Q27I61,Complement C5,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0070062;GO:0005576;GO:0005615;GO:0005579;GO:0008009;GO:0004866;GO:0005102;GO:0000187;GO:0007166;GO:0006935;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0007186;GO:0001701;GO:0006954;GO:0010760;GO:0045766;GO:0032722;GO:0010575;GO:0030449;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane attack complex;, F:chemokine activity; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:chemotaxis; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:inflammatory response; P:negative regulation of macrophage chemotaxis; P:positive regulation of angiogenesis; P:positive regulation of chemokine production; P:positive regulation of vascular endothelial growth factor production; P:regulation of complement activation;|P01031 Q14CJ0 Q27I61,Complement C5,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0070062;GO:0005576;GO:0005615;GO:0005579;GO:0008009;GO:0004866;GO:0005102;GO:0000187;GO:0007166;GO:0006935;GO:0006956;GO:0006957;GO:0006958;GO:0019835;GO:0007186;GO:0001701;GO:0006954;GO:0010760;GO:0045766;GO:0032722;GO:0010575;GO:0030449;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane attack complex;, F:chemokine activity; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:activation of MAPK activity; P:cell surface receptor signaling pathway; P:chemotaxis; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:cytolysis; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:inflammatory response; P:negative regulation of macrophage chemotaxis; P:positive regulation of angiogenesis; P:positive regulation of chemokine production; P:positive regulation of vascular endothelial growth factor production; P:regulation of complement activation; scaffold28 indexed_genome mRNA 951356 972028 . + . ID=transcript_6126;Q13077 B4DJ77 Q658U1 Q8NF13,TNF receptor-associated factor 1,Epstein-Barr virus-induced protein 6;, PF16673;, GO:0005737;GO:0009898;GO:0005829;GO:0042802;GO:0031996;GO:0005164;GO:0031625;GO:0008270;GO:0006915;GO:0046330;GO:0051092;GO:0070534;GO:0065003;GO:2001236;GO:0043122;GO:0010803;GO:0033209;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol;, F:identical protein binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein-containing complex assembly; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of tumor necrosis factor-mediated signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13077 B4DJ77 Q658U1 Q8NF13,TNF receptor-associated factor 1,Epstein-Barr virus-induced protein 6;, PF16673;, GO:0005737;GO:0009898;GO:0005829;GO:0042802;GO:0031996;GO:0005164;GO:0031625;GO:0008270;GO:0006915;GO:0046330;GO:0051092;GO:0070534;GO:0065003;GO:2001236;GO:0043122;GO:0010803;GO:0033209;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol;, F:identical protein binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein-containing complex assembly; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of tumor necrosis factor-mediated signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13077 B4DJ77 Q658U1 Q8NF13,TNF receptor-associated factor 1,Epstein-Barr virus-induced protein 6;, PF16673;, GO:0005737;GO:0009898;GO:0005829;GO:0042802;GO:0031996;GO:0005164;GO:0031625;GO:0008270;GO:0006915;GO:0046330;GO:0051092;GO:0070534;GO:0065003;GO:2001236;GO:0043122;GO:0010803;GO:0033209;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol;, F:identical protein binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein-containing complex assembly; P:regulation of extrinsic apoptotic signaling pathway; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of tumor necrosis factor-mediated signaling pathway; P:tumor necrosis factor-mediated signaling pathway; scaffold28 indexed_genome mRNA 1007548 1025990 . + . ID=transcript_6127;Q5T6S3 Q32NF2 Q5T6S4 Q6N038 Q8TBL6 Q9UFS9,PHD finger protein 19,Polycomb-like protein 3;, PF14061;PF00628;PF18104;, GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0006325;GO:0045814;GO:0061087;GO:0006355;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding;, P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:positive regulation of histone H3-K27 methylation; P:regulation of transcription, DNA-templated;|Q5T6S3 Q32NF2 Q5T6S4 Q6N038 Q8TBL6 Q9UFS9,PHD finger protein 19,Polycomb-like protein 3;, PF14061;PF00628;PF18104;, GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0006325;GO:0045814;GO:0061087;GO:0006355;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding;, P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:positive regulation of histone H3-K27 methylation; P:regulation of transcription, DNA-templated;|Q5T6S3 Q32NF2 Q5T6S4 Q6N038 Q8TBL6 Q9UFS9,PHD finger protein 19,Polycomb-like protein 3;, PF14061;PF00628;PF18104;, GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0006325;GO:0045814;GO:0061087;GO:0006355;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding;, P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:positive regulation of histone H3-K27 methylation; P:regulation of transcription, DNA-templated;|Q5T6S3 Q32NF2 Q5T6S4 Q6N038 Q8TBL6 Q9UFS9,PHD finger protein 19,Polycomb-like protein 3;, PF14061;PF00628;PF18104;, GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0006325;GO:0045814;GO:0061087;GO:0006355;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding;, P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:positive regulation of histone H3-K27 methylation; P:regulation of transcription, DNA-templated;|Q5T6S3 Q32NF2 Q5T6S4 Q6N038 Q8TBL6 Q9UFS9,PHD finger protein 19,Polycomb-like protein 3;, PF14061;PF00628;PF18104;, GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0006325;GO:0045814;GO:0061087;GO:0006355;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding;, P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:positive regulation of histone H3-K27 methylation; P:regulation of transcription, DNA-templated; scaffold28 indexed_genome mRNA 1027384 1049476 . + . ID=transcript_6128;O60888 A2AB26 A2BEL4 Q3B784 Q5JXM9 Q5SU05 Q9NYQ9,Protein CutA,Acetylcholinesterase-associated protein;Brain acetylcholinesterase putative membrane anchor;, PF03091;, GO:0070062;GO:0016020;GO:0005507;GO:0019899;GO:0008104;GO:0010038;, C:extracellular exosome; C:membrane;, F:copper ion binding; F:enzyme binding;, P:protein localization; P:response to metal ion;|O60888 A2AB26 A2BEL4 Q3B784 Q5JXM9 Q5SU05 Q9NYQ9,Protein CutA,Acetylcholinesterase-associated protein;Brain acetylcholinesterase putative membrane anchor;, PF03091;, GO:0070062;GO:0016020;GO:0005507;GO:0019899;GO:0008104;GO:0010038;, C:extracellular exosome; C:membrane;, F:copper ion binding; F:enzyme binding;, P:protein localization; P:response to metal ion;|O60888 A2AB26 A2BEL4 Q3B784 Q5JXM9 Q5SU05 Q9NYQ9,Protein CutA,Acetylcholinesterase-associated protein;Brain acetylcholinesterase putative membrane anchor;, PF03091;, GO:0070062;GO:0016020;GO:0005507;GO:0019899;GO:0008104;GO:0010038;, C:extracellular exosome; C:membrane;, F:copper ion binding; F:enzyme binding;, P:protein localization; P:response to metal ion; scaffold28 indexed_genome mRNA 1049514 1070013 . + . ID=transcript_6129;Q16401 B4DZM8 Q15045 Q4VXG8,26S proteasome non-ATPase regulatory subunit 5,26S protease subunit S5 basic;26S proteasome subunit S5B;, PF10508;, GO:0005829;GO:0005654;GO:0022624;GO:0000502;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q16401 B4DZM8 Q15045 Q4VXG8,26S proteasome non-ATPase regulatory subunit 5,26S protease subunit S5 basic;26S proteasome subunit S5B;, PF10508;, GO:0005829;GO:0005654;GO:0022624;GO:0000502;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q16401 B4DZM8 Q15045 Q4VXG8,26S proteasome non-ATPase regulatory subunit 5,26S protease subunit S5 basic;26S proteasome subunit S5B;, PF10508;, GO:0005829;GO:0005654;GO:0022624;GO:0000502;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q16401 B4DZM8 Q15045 Q4VXG8,26S proteasome non-ATPase regulatory subunit 5,26S protease subunit S5 basic;26S proteasome subunit S5B;, PF10508;, GO:0005829;GO:0005654;GO:0022624;GO:0000502;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q16401 B4DZM8 Q15045 Q4VXG8,26S proteasome non-ATPase regulatory subunit 5,26S protease subunit S5 basic;26S proteasome subunit S5B;, PF10508;, GO:0005829;GO:0005654;GO:0022624;GO:0000502;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold28 indexed_genome mRNA 1075800 1108520 . + . ID=transcript_6130;Q9UKT8 B3KRL8 Q4VXH2 Q7Z4V6 Q8WV51 Q9HA09 Q9UKA3,F-box/WD repeat-containing protein 2,F-box and WD-40 domain-containing protein 2;Protein MD6;, PF12937;PF00400;, GO:0005829;GO:0004842;GO:0006464;GO:0043687;GO:0000209;GO:0006508;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:proteolysis;|Q9UKT8 B3KRL8 Q4VXH2 Q7Z4V6 Q8WV51 Q9HA09 Q9UKA3,F-box/WD repeat-containing protein 2,F-box and WD-40 domain-containing protein 2;Protein MD6;, PF12937;PF00400;, GO:0005829;GO:0004842;GO:0006464;GO:0043687;GO:0000209;GO:0006508;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:proteolysis;|Q9UKT8 B3KRL8 Q4VXH2 Q7Z4V6 Q8WV51 Q9HA09 Q9UKA3,F-box/WD repeat-containing protein 2,F-box and WD-40 domain-containing protein 2;Protein MD6;, PF12937;PF00400;, GO:0005829;GO:0004842;GO:0006464;GO:0043687;GO:0000209;GO:0006508;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:proteolysis;|Q9UKT8 B3KRL8 Q4VXH2 Q7Z4V6 Q8WV51 Q9HA09 Q9UKA3,F-box/WD repeat-containing protein 2,F-box and WD-40 domain-containing protein 2;Protein MD6;, PF12937;PF00400;, GO:0005829;GO:0004842;GO:0006464;GO:0043687;GO:0000209;GO:0006508;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:proteolysis;|Q9UKT8 B3KRL8 Q4VXH2 Q7Z4V6 Q8WV51 Q9HA09 Q9UKA3,F-box/WD repeat-containing protein 2,F-box and WD-40 domain-containing protein 2;Protein MD6;, PF12937;PF00400;, GO:0005829;GO:0004842;GO:0006464;GO:0043687;GO:0000209;GO:0006508;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:proteolysis;|Q9UKT8 B3KRL8 Q4VXH2 Q7Z4V6 Q8WV51 Q9HA09 Q9UKA3,F-box/WD repeat-containing protein 2,F-box and WD-40 domain-containing protein 2;Protein MD6;, PF12937;PF00400;, GO:0005829;GO:0004842;GO:0006464;GO:0043687;GO:0000209;GO:0006508;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:proteolysis;|Q9UKT8 B3KRL8 Q4VXH2 Q7Z4V6 Q8WV51 Q9HA09 Q9UKA3,F-box/WD repeat-containing protein 2,F-box and WD-40 domain-containing protein 2;Protein MD6;, PF12937;PF00400;, GO:0005829;GO:0004842;GO:0006464;GO:0043687;GO:0000209;GO:0006508;, C:cytosol;, F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:post-translational protein modification; P:protein polyubiquitination; P:proteolysis; scaffold28 indexed_genome mRNA 1232754 1239279 . + . ID=transcript_6131;Q9H1U4 B7Z315 O75098,Multiple epidermal growth factor-like domains protein 9,Epidermal growth factor-like protein 5;, PF00053;, GO:0005604;GO:0016021;GO:0009887;GO:0016477;GO:0034446;GO:0009888;, C:basement membrane; C:integral component of membrane;, , P:animal organ morphogenesis; P:cell migration; P:substrate adhesion-dependent cell spreading; P:tissue development;|Q9H1U4 B7Z315 O75098,Multiple epidermal growth factor-like domains protein 9,Epidermal growth factor-like protein 5;, PF00053;, GO:0005604;GO:0016021;GO:0009887;GO:0016477;GO:0034446;GO:0009888;, C:basement membrane; C:integral component of membrane;, , P:animal organ morphogenesis; P:cell migration; P:substrate adhesion-dependent cell spreading; P:tissue development; scaffold28 indexed_genome mRNA 1251729 1426508 . + . ID=transcript_6132;Q9UIW9,CDK5 regulatory subunit-associated protein 2,CDK5 activator-binding protein C48;Centrosome-associated protein 215;, PF07989;, GO:0030054;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0005874;GO:0035371;GO:0097431;GO:0000242;GO:0048471;GO:0000922;GO:0005516;GO:0043015;GO:0008017;GO:0019901;GO:0000976;GO:0015631;GO:0007420;GO:0007099;GO:0007098;GO:0007059;GO:0097711;GO:0000132;GO:0000086;GO:0001578;GO:0000226;GO:0031023;GO:0046600;GO:0045665;GO:0022008;GO:0031116;GO:0045893;GO:0010389;GO:0090266;GO:0045664;, C:cell junction; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:microtubule plus-end; C:mitotic spindle pole; C:pericentriolar material; C:perinuclear region of cytoplasm; C:spindle pole;, F:calmodulin binding; F:gamma-tubulin binding; F:microtubule binding; F:protein kinase binding; F:transcription regulatory region sequence-specific DNA binding; F:tubulin binding;, P:brain development; P:centriole replication; P:centrosome cycle; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:negative regulation of centriole replication; P:negative regulation of neuron differentiation; P:neurogenesis; P:positive regulation of microtubule polymerization; P:positive regulation of transcription, DNA-templated; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of neuron differentiation;|Q9UIW9,CDK5 regulatory subunit-associated protein 2,CDK5 activator-binding protein C48;Centrosome-associated protein 215;, PF07989;, GO:0030054;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0005874;GO:0035371;GO:0097431;GO:0000242;GO:0048471;GO:0000922;GO:0005516;GO:0043015;GO:0008017;GO:0019901;GO:0000976;GO:0015631;GO:0007420;GO:0007099;GO:0007098;GO:0007059;GO:0097711;GO:0000132;GO:0000086;GO:0001578;GO:0000226;GO:0031023;GO:0046600;GO:0045665;GO:0022008;GO:0031116;GO:0045893;GO:0010389;GO:0090266;GO:0045664;, C:cell junction; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:microtubule plus-end; C:mitotic spindle pole; C:pericentriolar material; C:perinuclear region of cytoplasm; C:spindle pole;, F:calmodulin binding; F:gamma-tubulin binding; F:microtubule binding; F:protein kinase binding; F:transcription regulatory region sequence-specific DNA binding; F:tubulin binding;, P:brain development; P:centriole replication; P:centrosome cycle; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:negative regulation of centriole replication; P:negative regulation of neuron differentiation; P:neurogenesis; P:positive regulation of microtubule polymerization; P:positive regulation of transcription, DNA-templated; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of neuron differentiation;|Q9UIW9,CDK5 regulatory subunit-associated protein 2,CDK5 activator-binding protein C48;Centrosome-associated protein 215;, PF07989;, GO:0030054;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0005874;GO:0035371;GO:0097431;GO:0000242;GO:0048471;GO:0000922;GO:0005516;GO:0043015;GO:0008017;GO:0019901;GO:0000976;GO:0015631;GO:0007420;GO:0007099;GO:0007098;GO:0007059;GO:0097711;GO:0000132;GO:0000086;GO:0001578;GO:0000226;GO:0031023;GO:0046600;GO:0045665;GO:0022008;GO:0031116;GO:0045893;GO:0010389;GO:0090266;GO:0045664;, C:cell junction; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:microtubule plus-end; C:mitotic spindle pole; C:pericentriolar material; C:perinuclear region of cytoplasm; C:spindle pole;, F:calmodulin binding; F:gamma-tubulin binding; F:microtubule binding; F:protein kinase binding; F:transcription regulatory region sequence-specific DNA binding; F:tubulin binding;, P:brain development; P:centriole replication; P:centrosome cycle; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:negative regulation of centriole replication; P:negative regulation of neuron differentiation; P:neurogenesis; P:positive regulation of microtubule polymerization; P:positive regulation of transcription, DNA-templated; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of neuron differentiation;|Q9UIW9,CDK5 regulatory subunit-associated protein 2,CDK5 activator-binding protein C48;Centrosome-associated protein 215;, PF07989;, GO:0030054;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0005874;GO:0035371;GO:0097431;GO:0000242;GO:0048471;GO:0000922;GO:0005516;GO:0043015;GO:0008017;GO:0019901;GO:0000976;GO:0015631;GO:0007420;GO:0007099;GO:0007098;GO:0007059;GO:0097711;GO:0000132;GO:0000086;GO:0001578;GO:0000226;GO:0031023;GO:0046600;GO:0045665;GO:0022008;GO:0031116;GO:0045893;GO:0010389;GO:0090266;GO:0045664;, C:cell junction; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:microtubule plus-end; C:mitotic spindle pole; C:pericentriolar material; C:perinuclear region of cytoplasm; C:spindle pole;, F:calmodulin binding; F:gamma-tubulin binding; F:microtubule binding; F:protein kinase binding; F:transcription regulatory region sequence-specific DNA binding; F:tubulin binding;, P:brain development; P:centriole replication; P:centrosome cycle; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:negative regulation of centriole replication; P:negative regulation of neuron differentiation; P:neurogenesis; P:positive regulation of microtubule polymerization; P:positive regulation of transcription, DNA-templated; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of neuron differentiation;|Q9UIW9,CDK5 regulatory subunit-associated protein 2,CDK5 activator-binding protein C48;Centrosome-associated protein 215;, PF07989;, GO:0030054;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0005874;GO:0035371;GO:0097431;GO:0000242;GO:0048471;GO:0000922;GO:0005516;GO:0043015;GO:0008017;GO:0019901;GO:0000976;GO:0015631;GO:0007420;GO:0007099;GO:0007098;GO:0007059;GO:0097711;GO:0000132;GO:0000086;GO:0001578;GO:0000226;GO:0031023;GO:0046600;GO:0045665;GO:0022008;GO:0031116;GO:0045893;GO:0010389;GO:0090266;GO:0045664;, C:cell junction; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:microtubule plus-end; C:mitotic spindle pole; C:pericentriolar material; C:perinuclear region of cytoplasm; C:spindle pole;, F:calmodulin binding; F:gamma-tubulin binding; F:microtubule binding; F:protein kinase binding; F:transcription regulatory region sequence-specific DNA binding; F:tubulin binding;, P:brain development; P:centriole replication; P:centrosome cycle; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:negative regulation of centriole replication; P:negative regulation of neuron differentiation; P:neurogenesis; P:positive regulation of microtubule polymerization; P:positive regulation of transcription, DNA-templated; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of neuron differentiation;|Q9UIW9,CDK5 regulatory subunit-associated protein 2,CDK5 activator-binding protein C48;Centrosome-associated protein 215;, PF07989;, GO:0030054;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0005874;GO:0035371;GO:0097431;GO:0000242;GO:0048471;GO:0000922;GO:0005516;GO:0043015;GO:0008017;GO:0019901;GO:0000976;GO:0015631;GO:0007420;GO:0007099;GO:0007098;GO:0007059;GO:0097711;GO:0000132;GO:0000086;GO:0001578;GO:0000226;GO:0031023;GO:0046600;GO:0045665;GO:0022008;GO:0031116;GO:0045893;GO:0010389;GO:0090266;GO:0045664;, C:cell junction; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:microtubule plus-end; C:mitotic spindle pole; C:pericentriolar material; C:perinuclear region of cytoplasm; C:spindle pole;, F:calmodulin binding; F:gamma-tubulin binding; F:microtubule binding; F:protein kinase binding; F:transcription regulatory region sequence-specific DNA binding; F:tubulin binding;, P:brain development; P:centriole replication; P:centrosome cycle; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:negative regulation of centriole replication; P:negative regulation of neuron differentiation; P:neurogenesis; P:positive regulation of microtubule polymerization; P:positive regulation of transcription, DNA-templated; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of neuron differentiation; scaffold28 indexed_genome mRNA 2399402 2588804 . + . ID=transcript_6133;O60477 Q6IPV6 Q6P1A0 Q8WU22,BMP/retinoic acid-inducible neural-specific protein 1,Deleted in bladder cancer protein 1;, PF19052;PF01823;, GO:0005737;GO:0030425;GO:0005783;GO:0043025;GO:0001662;GO:0007050;GO:0008219;GO:0071300;GO:0035640;GO:0042711;GO:0045786;GO:0045930;GO:0050768;GO:0045666;GO:0007614;GO:0035176;GO:0071625;, C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:neuronal cell body;, , P:behavioral fear response; P:cell cycle arrest; P:cell death; P:cellular response to retinoic acid; P:exploration behavior; P:maternal behavior; P:negative regulation of cell cycle; P:negative regulation of mitotic cell cycle; P:negative regulation of neurogenesis; P:positive regulation of neuron differentiation; P:short-term memory; P:social behavior; P:vocalization behavior;|O60477 Q6IPV6 Q6P1A0 Q8WU22,BMP/retinoic acid-inducible neural-specific protein 1,Deleted in bladder cancer protein 1;, PF19052;PF01823;, GO:0005737;GO:0030425;GO:0005783;GO:0043025;GO:0001662;GO:0007050;GO:0008219;GO:0071300;GO:0035640;GO:0042711;GO:0045786;GO:0045930;GO:0050768;GO:0045666;GO:0007614;GO:0035176;GO:0071625;, C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:neuronal cell body;, , P:behavioral fear response; P:cell cycle arrest; P:cell death; P:cellular response to retinoic acid; P:exploration behavior; P:maternal behavior; P:negative regulation of cell cycle; P:negative regulation of mitotic cell cycle; P:negative regulation of neurogenesis; P:positive regulation of neuron differentiation; P:short-term memory; P:social behavior; P:vocalization behavior;|O60477 Q6IPV6 Q6P1A0 Q8WU22,BMP/retinoic acid-inducible neural-specific protein 1,Deleted in bladder cancer protein 1;, PF19052;PF01823;, GO:0005737;GO:0030425;GO:0005783;GO:0043025;GO:0001662;GO:0007050;GO:0008219;GO:0071300;GO:0035640;GO:0042711;GO:0045786;GO:0045930;GO:0050768;GO:0045666;GO:0007614;GO:0035176;GO:0071625;, C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:neuronal cell body;, , P:behavioral fear response; P:cell cycle arrest; P:cell death; P:cellular response to retinoic acid; P:exploration behavior; P:maternal behavior; P:negative regulation of cell cycle; P:negative regulation of mitotic cell cycle; P:negative regulation of neurogenesis; P:positive regulation of neuron differentiation; P:short-term memory; P:social behavior; P:vocalization behavior;|O60477 Q6IPV6 Q6P1A0 Q8WU22,BMP/retinoic acid-inducible neural-specific protein 1,Deleted in bladder cancer protein 1;, PF19052;PF01823;, GO:0005737;GO:0030425;GO:0005783;GO:0043025;GO:0001662;GO:0007050;GO:0008219;GO:0071300;GO:0035640;GO:0042711;GO:0045786;GO:0045930;GO:0050768;GO:0045666;GO:0007614;GO:0035176;GO:0071625;, C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:neuronal cell body;, , P:behavioral fear response; P:cell cycle arrest; P:cell death; P:cellular response to retinoic acid; P:exploration behavior; P:maternal behavior; P:negative regulation of cell cycle; P:negative regulation of mitotic cell cycle; P:negative regulation of neurogenesis; P:positive regulation of neuron differentiation; P:short-term memory; P:social behavior; P:vocalization behavior; scaffold28 indexed_genome mRNA 3997941 4008931 . - . ID=transcript_6134;Q5VZI9 Q9UK78 Q9UM57,Toll-like receptor 4,hToll;, PF13855;PF01582;, GO:0009986;GO:0005737;GO:0005769;GO:0010008;GO:0009897;GO:0005794;GO:0005887;GO:0031226;GO:0046696;GO:0048471;GO:0001891;GO:0005886;GO:0043235;GO:0001726;GO:0001540;GO:0042802;GO:0001530;GO:0001875;GO:0050135;GO:0061809;GO:0046982;GO:0038023;GO:0005102;GO:0004888;GO:0002218;GO:0000187;GO:0097190;GO:0014002;GO:0002322;GO:1904646;GO:0071346;GO:0071222;GO:0071223;GO:0071260;GO:0140052;GO:0042742;GO:0050829;GO:0016046;GO:0032497;GO:0007249;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0060729;GO:0031663;GO:0042116;GO:0002755;GO:0002756;GO:0070266;GO:0120163;GO:0070373;GO:0032689;GO:0032700;GO:0032707;GO:0032715;GO:0034128;GO:0045671;GO:0032720;GO:0002537;GO:0006909;GO:0030890;GO:1903974;GO:2000343;GO:0032722;GO:1900017;GO:0070374;GO:0010628;GO:0043123;GO:0050729;GO:0032727;GO:0032728;GO:0032729;GO:0032731;GO:0032732;GO:0032733;GO:0032735;GO:0032755;GO:0032757;GO:0046330;GO:0010838;GO:0043032;GO:0060907;GO:1904466;GO:0045348;GO:0051092;GO:1901224;GO:0045429;GO:0051770;GO:1900227;GO:0070430;GO:0070434;GO:1903223;GO:0010572;GO:1903428;GO:0045944;GO:0032760;GO:0002730;GO:0032496;GO:0042088;GO:0034142;GO:0002224;GO:0035666;, C:cell surface; C:cytoplasm; C:early endosome; C:endosome membrane; C:external side of plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:lipopolysaccharide receptor complex; C:perinuclear region of cytoplasm; C:phagocytic cup; C:plasma membrane; C:receptor complex; C:ruffle;, F:amyloid-beta binding; F:identical protein binding; F:lipopolysaccharide binding; F:lipopolysaccharide immune receptor activity; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:protein heterodimerization activity; F:signaling receptor activity; F:signaling receptor binding; F:transmembrane signaling receptor activity;, P:activation of innate immune response; P:activation of MAPK activity; P:apoptotic signaling pathway; P:astrocyte development; P:B cell proliferation involved in immune response; P:cellular response to amyloid-beta; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to mechanical stimulus; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:detection of fungus; P:detection of lipopolysaccharide; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:intestinal epithelial structure maintenance; P:lipopolysaccharide-mediated signaling pathway; P:macrophage activation; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-23 production; P:negative regulation of interleukin-6 production; P:negative regulation of MyD88-independent toll-like receptor signaling pathway; P:negative regulation of osteoclast differentiation; P:negative regulation of tumor necrosis factor production; P:nitric oxide production involved in inflammatory response; P:phagocytosis; P:positive regulation of B cell proliferation; P:positive regulation of cellular response to macrophage colony-stimulating factor stimulus; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of chemokine production; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-1 production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of keratinocyte proliferation; P:positive regulation of macrophage activation; P:positive regulation of macrophage cytokine production; P:positive regulation of matrix metallopeptidase secretion; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of oxidative stress-induced neuron death; P:positive regulation of platelet activation; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of dendritic cell cytokine production; P:response to lipopolysaccharide; P:T-helper 1 type immune response; P:toll-like receptor 4 signaling pathway; P:toll-like receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; scaffold28 indexed_genome mRNA 4663093 5312722 . + . ID=transcript_6135;Q8N6P8 Q8WV47 Q96FL4 Q9UHW6,Astrotactin-2,, PF18411;PF18577;PF01823;, GO:0005938;GO:0060187;GO:0030136;GO:0005769;GO:0005768;GO:0016021;GO:0005770;GO:0043204;GO:0005509;GO:0043533;GO:0048105;GO:2000009;GO:0007158;GO:0001764;GO:0015031;, C:cell cortex; C:cell pole; C:clathrin-coated vesicle; C:early endosome; C:endosome; C:integral component of membrane; C:late endosome; C:perikaryon;, F:calcium ion binding; F:inositol 1,3,4,5 tetrakisphosphate binding;, P:establishment of body hair planar orientation; P:negative regulation of protein localization to cell surface; P:neuron cell-cell adhesion; P:neuron migration; P:protein transport;|Q8N6P8 Q8WV47 Q96FL4 Q9UHW6,Astrotactin-2,, PF18411;PF18577;PF01823;, GO:0005938;GO:0060187;GO:0030136;GO:0005769;GO:0005768;GO:0016021;GO:0005770;GO:0043204;GO:0005509;GO:0043533;GO:0048105;GO:2000009;GO:0007158;GO:0001764;GO:0015031;, C:cell cortex; C:cell pole; C:clathrin-coated vesicle; C:early endosome; C:endosome; C:integral component of membrane; C:late endosome; C:perikaryon;, F:calcium ion binding; F:inositol 1,3,4,5 tetrakisphosphate binding;, P:establishment of body hair planar orientation; P:negative regulation of protein localization to cell surface; P:neuron cell-cell adhesion; P:neuron migration; P:protein transport;|Q13049 Q9NQP8,E3 ubiquitin-protein ligase TRIM32,72 kDa Tat-interacting protein;RING-type E3 ubiquitin transferase TRIM32 {ECO:0000305};Tripartite motif-containing protein 32;Zinc finger protein HT2A;, PF01436;PF13445;, GO:0005737;GO:0005829;GO:0005634;GO:0005863;GO:0042802;GO:0017022;GO:0043621;GO:0003723;GO:0030957;GO:0003713;GO:0031369;GO:0043130;GO:0061630;GO:0004842;GO:0008270;GO:0007014;GO:0061564;GO:0045444;GO:0045087;GO:0046716;GO:0048147;GO:1902230;GO:1902187;GO:0032897;GO:0045787;GO:0030307;GO:0030335;GO:2000147;GO:1903886;GO:0051091;GO:0043123;GO:1903883;GO:0050769;GO:0045666;GO:0051092;GO:0045732;GO:0045862;GO:0051155;GO:1903265;GO:0070936;GO:0000209;GO:0016567;GO:0032479;GO:0034612;GO:0009411;GO:0001894;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleus; C:striated muscle myosin thick filament;, F:identical protein binding; F:myosin binding; F:protein self-association; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:translation initiation factor binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:actin ubiquitination; P:axon development; P:fat cell differentiation; P:innate immune response; P:muscle cell cellular homeostasis; P:negative regulation of fibroblast proliferation; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of viral release from host cell; P:negative regulation of viral transcription; P:positive regulation of cell cycle; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of chemokine (C-C motif) ligand 20 production; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-17-mediated signaling pathway; P:positive regulation of neurogenesis; P:positive regulation of neuron differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein catabolic process; P:positive regulation of proteolysis; P:positive regulation of striated muscle cell differentiation; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of type I interferon production; P:response to tumor necrosis factor; P:response to UV; P:tissue homeostasis; P:ubiquitin-dependent protein catabolic process; scaffold28 indexed_genome mRNA 6570591 6671159 . + . ID=transcript_6136;P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing;|P24821 C9IYT7 C9J575 C9J6D9 C9J848 Q14583 Q15567 Q5T7S3,Tenascin,Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;, PF07974;PF18720;PF00147;PF00041;, GO:0005604;GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005925;GO:0005614;GO:0016020;GO:0098966;GO:0005201;GO:0045545;GO:0060447;GO:0007155;GO:0044267;GO:0071799;GO:0071300;GO:0071305;GO:0030198;GO:0060739;GO:0007162;GO:0007528;GO:0042475;GO:0001649;GO:0014012;GO:0008284;GO:0010628;GO:0043687;GO:0060740;GO:0045471;GO:0071774;GO:0009612;GO:0009611;GO:0042060;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:focal adhesion; C:interstitial matrix; C:membrane; C:perisynaptic extracellular matrix;, F:extracellular matrix structural constituent; F:syndecan binding;, P:bud outgrowth involved in lung branching; P:cell adhesion; P:cellular protein metabolic process; P:cellular response to prostaglandin D stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin D; P:extracellular matrix organization; P:mesenchymal-epithelial cell signaling involved in prostate gland development; P:negative regulation of cell adhesion; P:neuromuscular junction development; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:peripheral nervous system axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:post-translational protein modification; P:prostate gland epithelium morphogenesis; P:response to ethanol; P:response to fibroblast growth factor; P:response to mechanical stimulus; P:response to wounding; P:wound healing; scaffold28 indexed_genome mRNA 6756323 6782922 . + . ID=transcript_6137;P32971 O43404,Tumor necrosis factor ligand superfamily member 8,CD30 ligand;, PF00229;, GO:0005615;GO:0005887;GO:0005886;GO:0005125;GO:0005102;GO:0005164;GO:0043374;GO:0007267;GO:0050830;GO:0006955;GO:0045944;GO:0042129;GO:0033209;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine activity; F:signaling receptor binding; F:tumor necrosis factor receptor binding;, P:CD8-positive, alpha-beta T cell differentiation; P:cell-cell signaling; P:defense response to Gram-positive bacterium; P:immune response; P:positive regulation of transcription by RNA polymerase II; P:regulation of T cell proliferation; P:tumor necrosis factor-mediated signaling pathway; scaffold28 indexed_genome mRNA 7031830 7051231 . - . ID=transcript_6138;Q5VZI3 A0PJA3 Q3KNS4 Q5VZI2 Q6P5Z7 Q8N1P3 Q8ND43,Transmembrane protein 268 {ECO:0000312|HGNC:HGNC:24513},, PF14800;, GO:0016021;, C:integral component of membrane; scaffold28 indexed_genome mRNA 7162400 7201361 . + . ID=transcript_6139;Q9H9F4 Q9UFZ3,Whirlin {ECO:0000305},Autosomal recessive deafness type 31 protein {ECO:0000305};, PF00595;, GO:0005884;GO:0036064;GO:0005737;GO:0030426;GO:1990075;GO:0032391;GO:0001917;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:0045202;GO:1990696;GO:0042802;GO:0060088;GO:0021694;GO:0050910;GO:0045184;GO:0060122;GO:1990227;GO:0010628;GO:0001895;GO:0050953;GO:0007605;, C:actin filament; C:ciliary basal body; C:cytoplasm; C:growth cone; C:periciliary membrane compartment; C:photoreceptor connecting cilium; C:photoreceptor inner segment; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:synapse; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell stereocilium organization; P:cerebellar Purkinje cell layer formation; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:inner ear receptor cell stereocilium organization; P:paranodal junction maintenance; P:positive regulation of gene expression; P:retina homeostasis; P:sensory perception of light stimulus; P:sensory perception of sound; scaffold28 indexed_genome mRNA 7201376 7221610 . + . ID=transcript_6140;Q9H9F4 Q9UFZ3,Whirlin {ECO:0000305},Autosomal recessive deafness type 31 protein {ECO:0000305};, PF00595;, GO:0005884;GO:0036064;GO:0005737;GO:0030426;GO:1990075;GO:0032391;GO:0001917;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:0045202;GO:1990696;GO:0042802;GO:0060088;GO:0021694;GO:0050910;GO:0045184;GO:0060122;GO:1990227;GO:0010628;GO:0001895;GO:0050953;GO:0007605;, C:actin filament; C:ciliary basal body; C:cytoplasm; C:growth cone; C:periciliary membrane compartment; C:photoreceptor connecting cilium; C:photoreceptor inner segment; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:synapse; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell stereocilium organization; P:cerebellar Purkinje cell layer formation; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:inner ear receptor cell stereocilium organization; P:paranodal junction maintenance; P:positive regulation of gene expression; P:retina homeostasis; P:sensory perception of light stimulus; P:sensory perception of sound;|Q9H9F4 Q9UFZ3,Whirlin {ECO:0000305},Autosomal recessive deafness type 31 protein {ECO:0000305};, PF00595;, GO:0005884;GO:0036064;GO:0005737;GO:0030426;GO:1990075;GO:0032391;GO:0001917;GO:0005886;GO:0002141;GO:0002142;GO:0032420;GO:0032426;GO:0045202;GO:1990696;GO:0042802;GO:0060088;GO:0021694;GO:0050910;GO:0045184;GO:0060122;GO:1990227;GO:0010628;GO:0001895;GO:0050953;GO:0007605;, C:actin filament; C:ciliary basal body; C:cytoplasm; C:growth cone; C:periciliary membrane compartment; C:photoreceptor connecting cilium; C:photoreceptor inner segment; C:plasma membrane; C:stereocilia ankle link; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:synapse; C:USH2 complex;, F:identical protein binding;, P:auditory receptor cell stereocilium organization; P:cerebellar Purkinje cell layer formation; P:detection of mechanical stimulus involved in sensory perception of sound; P:establishment of protein localization; P:inner ear receptor cell stereocilium organization; P:paranodal junction maintenance; P:positive regulation of gene expression; P:retina homeostasis; P:sensory perception of light stimulus; P:sensory perception of sound; scaffold28 indexed_genome mRNA 7236379 7283119 . + . ID=transcript_6141;Q6ZMK0 Q6ZNL2 Q6ZTX0 Q8TET1 Q8TF33 Q96RR9 Q9H7P7,Microtubule organization protein AKNA {ECO:0000305},AT-hook-containing transcription factor {ECO:0000303|PubMed:15869410};, PF12443;, GO:0005814;GO:0005813;GO:0005829;GO:0001650;GO:0043231;GO:0016020;GO:0005874;GO:0005654;GO:0003677;GO:0060232;GO:0001837;GO:0060234;GO:0021849;GO:0045944;GO:0050727;, C:centriole; C:centrosome; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:nucleoplasm;, F:DNA binding;, P:delamination; P:epithelial to mesenchymal transition; P:neuroblast delamination; P:neuroblast division in subventricular zone; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response;|Q6ZMK0 Q6ZNL2 Q6ZTX0 Q8TET1 Q8TF33 Q96RR9 Q9H7P7,Microtubule organization protein AKNA {ECO:0000305},AT-hook-containing transcription factor {ECO:0000303|PubMed:15869410};, PF12443;, GO:0005814;GO:0005813;GO:0005829;GO:0001650;GO:0043231;GO:0016020;GO:0005874;GO:0005654;GO:0003677;GO:0060232;GO:0001837;GO:0060234;GO:0021849;GO:0045944;GO:0050727;, C:centriole; C:centrosome; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:nucleoplasm;, F:DNA binding;, P:delamination; P:epithelial to mesenchymal transition; P:neuroblast delamination; P:neuroblast division in subventricular zone; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response;|Q6ZMK0 Q6ZNL2 Q6ZTX0 Q8TET1 Q8TF33 Q96RR9 Q9H7P7,Microtubule organization protein AKNA {ECO:0000305},AT-hook-containing transcription factor {ECO:0000303|PubMed:15869410};, PF12443;, GO:0005814;GO:0005813;GO:0005829;GO:0001650;GO:0043231;GO:0016020;GO:0005874;GO:0005654;GO:0003677;GO:0060232;GO:0001837;GO:0060234;GO:0021849;GO:0045944;GO:0050727;, C:centriole; C:centrosome; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:nucleoplasm;, F:DNA binding;, P:delamination; P:epithelial to mesenchymal transition; P:neuroblast delamination; P:neuroblast division in subventricular zone; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response; scaffold28 indexed_genome mRNA 7285830 7289411 . - . ID=transcript_6142;P19652 B2R5L2 Q16571 Q5T538 Q6IB74,Alpha-1-acid glycoprotein 2,Orosomucoid-2;, PF00061;, GO:0035578;GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0035580;GO:0006953;GO:0043312;GO:0002576;GO:0032731;GO:0032732;GO:0032760;GO:0002682;, C:azurophil granule lumen; C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen; C:specific granule lumen;, , P:acute-phase response; P:neutrophil degranulation; P:platelet degranulation; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-1 production; P:positive regulation of tumor necrosis factor production; P:regulation of immune system process;|P02763 B7ZKQ5 Q5T539 Q5U067 Q8TC16,Alpha-1-acid glycoprotein 1,Orosomucoid-1;, PF00061;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0035580;GO:1904724;GO:0006953;GO:0006954;GO:0032715;GO:0032720;GO:0043312;GO:0002576;GO:0032731;GO:0032732;GO:0032760;GO:0002682;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen; C:specific granule lumen; C:tertiary granule lumen;, , P:acute-phase response; P:inflammatory response; P:negative regulation of interleukin-6 production; P:negative regulation of tumor necrosis factor production; P:neutrophil degranulation; P:platelet degranulation; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-1 production; P:positive regulation of tumor necrosis factor production; P:regulation of immune system process; scaffold28 indexed_genome mRNA 7301262 7323882 . - . ID=transcript_6143;Q8IZC6 Q66K43 Q96JF7,Collagen alpha-1(XXVII) chain,, PF01410;PF01391;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005583;GO:0005201;GO:0030020;GO:0046872;GO:0030199;GO:0030198;GO:0003431;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrillar collagen trimer;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding;, P:collagen fibril organization; P:extracellular matrix organization; P:growth plate cartilage chondrocyte development;|Q8IZC6 Q66K43 Q96JF7,Collagen alpha-1(XXVII) chain,, PF01410;PF01391;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005583;GO:0005201;GO:0030020;GO:0046872;GO:0030199;GO:0030198;GO:0003431;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrillar collagen trimer;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding;, P:collagen fibril organization; P:extracellular matrix organization; P:growth plate cartilage chondrocyte development; scaffold28 indexed_genome mRNA 7324675 7442235 . - . ID=transcript_6144;Q8IZC6 Q66K43 Q96JF7,Collagen alpha-1(XXVII) chain,, PF01410;PF01391;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005583;GO:0005201;GO:0030020;GO:0046872;GO:0030199;GO:0030198;GO:0003431;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrillar collagen trimer;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding;, P:collagen fibril organization; P:extracellular matrix organization; P:growth plate cartilage chondrocyte development;|Q8IZC6 Q66K43 Q96JF7,Collagen alpha-1(XXVII) chain,, PF01410;PF01391;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005583;GO:0005201;GO:0030020;GO:0046872;GO:0030199;GO:0030198;GO:0003431;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrillar collagen trimer;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding;, P:collagen fibril organization; P:extracellular matrix organization; P:growth plate cartilage chondrocyte development;|Q8IZC6 Q66K43 Q96JF7,Collagen alpha-1(XXVII) chain,, PF01410;PF01391;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005583;GO:0005201;GO:0030020;GO:0046872;GO:0030199;GO:0030198;GO:0003431;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrillar collagen trimer;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding;, P:collagen fibril organization; P:extracellular matrix organization; P:growth plate cartilage chondrocyte development;|Q8IZC6 Q66K43 Q96JF7,Collagen alpha-1(XXVII) chain,, PF01410;PF01391;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005583;GO:0005201;GO:0030020;GO:0046872;GO:0030199;GO:0030198;GO:0003431;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrillar collagen trimer;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding;, P:collagen fibril organization; P:extracellular matrix organization; P:growth plate cartilage chondrocyte development;|Q8IZC6 Q66K43 Q96JF7,Collagen alpha-1(XXVII) chain,, PF01410;PF01391;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005583;GO:0005201;GO:0030020;GO:0046872;GO:0030199;GO:0030198;GO:0003431;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrillar collagen trimer;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding;, P:collagen fibril organization; P:extracellular matrix organization; P:growth plate cartilage chondrocyte development;|Q8IZC6 Q66K43 Q96JF7,Collagen alpha-1(XXVII) chain,, PF01410;PF01391;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005583;GO:0005201;GO:0030020;GO:0046872;GO:0030199;GO:0030198;GO:0003431;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrillar collagen trimer;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding;, P:collagen fibril organization; P:extracellular matrix organization; P:growth plate cartilage chondrocyte development; scaffold28 indexed_genome mRNA 7509530 7511257 . + . ID=transcript_6145;Q96FN5 Q5TBE0,Kinesin-like protein KIF12,, PF00225;, GO:0005737;GO:0070062;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytoplasm; C:extracellular exosome; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; scaffold28 indexed_genome mRNA 7525810 7533185 . + . ID=transcript_6146;P02760 P00977 P02759 P78491 Q2TU33 Q5TBD7 Q9UC58 Q9UDI8,Protein AMBP,, PF00014;PF00061;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005886;GO:0019855;GO:0046904;GO:0020037;GO:0019862;GO:0042803;GO:0004867;GO:0007155;GO:0007565;GO:0042167;GO:0050777;GO:0046329;GO:0030163;GO:0018298;GO:0006898;GO:0016032;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:calcium channel inhibitor activity; F:calcium oxalate binding; F:heme binding; F:IgA binding; F:protein homodimerization activity; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:female pregnancy; P:heme catabolic process; P:negative regulation of immune response; P:negative regulation of JNK cascade; P:protein catabolic process; P:protein-chromophore linkage; P:receptor-mediated endocytosis; P:viral process;|P02760 P00977 P02759 P78491 Q2TU33 Q5TBD7 Q9UC58 Q9UDI8,Protein AMBP,, PF00014;PF00061;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005886;GO:0019855;GO:0046904;GO:0020037;GO:0019862;GO:0042803;GO:0004867;GO:0007155;GO:0007565;GO:0042167;GO:0050777;GO:0046329;GO:0030163;GO:0018298;GO:0006898;GO:0016032;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:calcium channel inhibitor activity; F:calcium oxalate binding; F:heme binding; F:IgA binding; F:protein homodimerization activity; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:female pregnancy; P:heme catabolic process; P:negative regulation of immune response; P:negative regulation of JNK cascade; P:protein catabolic process; P:protein-chromophore linkage; P:receptor-mediated endocytosis; P:viral process;|P02760 P00977 P02759 P78491 Q2TU33 Q5TBD7 Q9UC58 Q9UDI8,Protein AMBP,, PF00014;PF00061;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005886;GO:0019855;GO:0046904;GO:0020037;GO:0019862;GO:0042803;GO:0004867;GO:0007155;GO:0007565;GO:0042167;GO:0050777;GO:0046329;GO:0030163;GO:0018298;GO:0006898;GO:0016032;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:calcium channel inhibitor activity; F:calcium oxalate binding; F:heme binding; F:IgA binding; F:protein homodimerization activity; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:female pregnancy; P:heme catabolic process; P:negative regulation of immune response; P:negative regulation of JNK cascade; P:protein catabolic process; P:protein-chromophore linkage; P:receptor-mediated endocytosis; P:viral process; scaffold28 indexed_genome mRNA 7533401 7537765 . + . ID=transcript_6147;P02760 P00977 P02759 P78491 Q2TU33 Q5TBD7 Q9UC58 Q9UDI8,Protein AMBP,, PF00014;PF00061;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005886;GO:0019855;GO:0046904;GO:0020037;GO:0019862;GO:0042803;GO:0004867;GO:0007155;GO:0007565;GO:0042167;GO:0050777;GO:0046329;GO:0030163;GO:0018298;GO:0006898;GO:0016032;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:calcium channel inhibitor activity; F:calcium oxalate binding; F:heme binding; F:IgA binding; F:protein homodimerization activity; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:female pregnancy; P:heme catabolic process; P:negative regulation of immune response; P:negative regulation of JNK cascade; P:protein catabolic process; P:protein-chromophore linkage; P:receptor-mediated endocytosis; P:viral process; scaffold28 indexed_genome mRNA 7547836 7549244 . - . ID=transcript_6148;Q5T7W0 B9EG82 Q4G0X6 Q5T7W1 Q6ZT53 Q7Z6B9 Q8TF49 Q96E49,Zinc finger protein 618,, , GO:0005634;GO:0005721;GO:0003677;GO:0003700;GO:0042802;GO:0046872;GO:0008134;GO:0035563;, C:nucleus; C:pericentric heterochromatin;, F:DNA binding; F:DNA-binding transcription factor activity; F:identical protein binding; F:metal ion binding; F:transcription factor binding;, P:positive regulation of chromatin binding; scaffold28 indexed_genome mRNA 7549338 7583364 . - . ID=transcript_6149;Q5T7W0 B9EG82 Q4G0X6 Q5T7W1 Q6ZT53 Q7Z6B9 Q8TF49 Q96E49,Zinc finger protein 618,, , GO:0005634;GO:0005721;GO:0003677;GO:0003700;GO:0042802;GO:0046872;GO:0008134;GO:0035563;, C:nucleus; C:pericentric heterochromatin;, F:DNA binding; F:DNA-binding transcription factor activity; F:identical protein binding; F:metal ion binding; F:transcription factor binding;, P:positive regulation of chromatin binding; scaffold28 indexed_genome mRNA 7612295 7630324 . + . ID=transcript_6150;Q5T7W0 B9EG82 Q4G0X6 Q5T7W1 Q6ZT53 Q7Z6B9 Q8TF49 Q96E49,Zinc finger protein 618,, , GO:0005634;GO:0005721;GO:0003677;GO:0003700;GO:0042802;GO:0046872;GO:0008134;GO:0035563;, C:nucleus; C:pericentric heterochromatin;, F:DNA binding; F:DNA-binding transcription factor activity; F:identical protein binding; F:metal ion binding; F:transcription factor binding;, P:positive regulation of chromatin binding; scaffold28 indexed_genome mRNA 7994134 8086236 . - . ID=transcript_6151;Q8IUQ1 Q8NC47 Q8NFN4 Q8NFN5 Q8NFN6 Q8TD59 Q8TD68 Q8WV02 Q8WXA0,Regulator of G-protein signaling 3,, PF00168;PF00595;PF00615;, GO:0005829;GO:0005634;GO:0005886;GO:0005096;GO:0007186;GO:0000188;GO:0008277;GO:0007165;, C:cytosol; C:nucleus; C:plasma membrane;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:inactivation of MAPK activity; P:regulation of G protein-coupled receptor signaling pathway; P:signal transduction;|Q8IUQ1 Q8NC47 Q8NFN4 Q8NFN5 Q8NFN6 Q8TD59 Q8TD68 Q8WV02 Q8WXA0,Regulator of G-protein signaling 3,, PF00168;PF00595;PF00615;, GO:0005829;GO:0005634;GO:0005886;GO:0005096;GO:0007186;GO:0000188;GO:0008277;GO:0007165;, C:cytosol; C:nucleus; C:plasma membrane;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:inactivation of MAPK activity; P:regulation of G protein-coupled receptor signaling pathway; P:signal transduction;|Q8IUQ1 Q8NC47 Q8NFN4 Q8NFN5 Q8NFN6 Q8TD59 Q8TD68 Q8WV02 Q8WXA0,Regulator of G-protein signaling 3,, PF00168;PF00595;PF00615;, GO:0005829;GO:0005634;GO:0005886;GO:0005096;GO:0007186;GO:0000188;GO:0008277;GO:0007165;, C:cytosol; C:nucleus; C:plasma membrane;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:inactivation of MAPK activity; P:regulation of G protein-coupled receptor signaling pathway; P:signal transduction; scaffold28 indexed_genome mRNA 8086281 8093411 . - . ID=transcript_6152;Q8IUQ1 Q8NC47 Q8NFN4 Q8NFN5 Q8NFN6 Q8TD59 Q8TD68 Q8WV02 Q8WXA0,Regulator of G-protein signaling 3,, PF00168;PF00595;PF00615;, GO:0005829;GO:0005634;GO:0005886;GO:0005096;GO:0007186;GO:0000188;GO:0008277;GO:0007165;, C:cytosol; C:nucleus; C:plasma membrane;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:inactivation of MAPK activity; P:regulation of G protein-coupled receptor signaling pathway; P:signal transduction;|Q8IUQ1 Q8NC47 Q8NFN4 Q8NFN5 Q8NFN6 Q8TD59 Q8TD68 Q8WV02 Q8WXA0,Regulator of G-protein signaling 3,, PF00168;PF00595;PF00615;, GO:0005829;GO:0005634;GO:0005886;GO:0005096;GO:0007186;GO:0000188;GO:0008277;GO:0007165;, C:cytosol; C:nucleus; C:plasma membrane;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:inactivation of MAPK activity; P:regulation of G protein-coupled receptor signaling pathway; P:signal transduction; scaffold28 indexed_genome mRNA 8130272 8159540 . - . ID=transcript_6153;Q8TAL5,Uncharacterized protein C9orf43,, PF15504; scaffold28 indexed_genome mRNA 8186044 8194933 . + . ID=transcript_6154;P13716 A8K375 B2R6F2 Q16870 Q16871 Q9BVQ9,Delta-aminolevulinic acid dehydratase,Porphobilinogen synthase;, PF00490;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0003824;GO:0042802;GO:0004655;GO:1904854;GO:0008270;GO:0071353;GO:0071284;GO:0006783;GO:1901799;GO:0043312;GO:0051260;GO:0006782;GO:0014823;GO:0010044;GO:0043200;GO:0046685;GO:0046686;GO:0032025;GO:0042493;GO:0045471;GO:0070542;GO:0051384;GO:0009635;GO:0001666;GO:0010212;GO:0010039;GO:0032496;GO:0046689;GO:0051597;GO:0006979;GO:0070541;GO:0010269;GO:0010266;GO:0033197;GO:0010043;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:catalytic activity; F:identical protein binding; F:porphobilinogen synthase activity; F:proteasome core complex binding; F:zinc ion binding;, P:cellular response to interleukin-4; P:cellular response to lead ion; P:heme biosynthetic process; P:negative regulation of proteasomal protein catabolic process; P:neutrophil degranulation; P:protein homooligomerization; P:protoporphyrinogen IX biosynthetic process; P:response to activity; P:response to aluminum ion; P:response to amino acid; P:response to arsenic-containing substance; P:response to cadmium ion; P:response to cobalt ion; P:response to drug; P:response to ethanol; P:response to fatty acid; P:response to glucocorticoid; P:response to herbicide; P:response to hypoxia; P:response to ionizing radiation; P:response to iron ion; P:response to lipopolysaccharide; P:response to mercury ion; P:response to methylmercury; P:response to oxidative stress; P:response to platinum ion; P:response to selenium ion; P:response to vitamin B1; P:response to vitamin E; P:response to zinc ion;|P13716 A8K375 B2R6F2 Q16870 Q16871 Q9BVQ9,Delta-aminolevulinic acid dehydratase,Porphobilinogen synthase;, PF00490;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0003824;GO:0042802;GO:0004655;GO:1904854;GO:0008270;GO:0071353;GO:0071284;GO:0006783;GO:1901799;GO:0043312;GO:0051260;GO:0006782;GO:0014823;GO:0010044;GO:0043200;GO:0046685;GO:0046686;GO:0032025;GO:0042493;GO:0045471;GO:0070542;GO:0051384;GO:0009635;GO:0001666;GO:0010212;GO:0010039;GO:0032496;GO:0046689;GO:0051597;GO:0006979;GO:0070541;GO:0010269;GO:0010266;GO:0033197;GO:0010043;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:catalytic activity; F:identical protein binding; F:porphobilinogen synthase activity; F:proteasome core complex binding; F:zinc ion binding;, P:cellular response to interleukin-4; P:cellular response to lead ion; P:heme biosynthetic process; P:negative regulation of proteasomal protein catabolic process; P:neutrophil degranulation; P:protein homooligomerization; P:protoporphyrinogen IX biosynthetic process; P:response to activity; P:response to aluminum ion; P:response to amino acid; P:response to arsenic-containing substance; P:response to cadmium ion; P:response to cobalt ion; P:response to drug; P:response to ethanol; P:response to fatty acid; P:response to glucocorticoid; P:response to herbicide; P:response to hypoxia; P:response to ionizing radiation; P:response to iron ion; P:response to lipopolysaccharide; P:response to mercury ion; P:response to methylmercury; P:response to oxidative stress; P:response to platinum ion; P:response to selenium ion; P:response to vitamin B1; P:response to vitamin E; P:response to zinc ion;|P13716 A8K375 B2R6F2 Q16870 Q16871 Q9BVQ9,Delta-aminolevulinic acid dehydratase,Porphobilinogen synthase;, PF00490;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0003824;GO:0042802;GO:0004655;GO:1904854;GO:0008270;GO:0071353;GO:0071284;GO:0006783;GO:1901799;GO:0043312;GO:0051260;GO:0006782;GO:0014823;GO:0010044;GO:0043200;GO:0046685;GO:0046686;GO:0032025;GO:0042493;GO:0045471;GO:0070542;GO:0051384;GO:0009635;GO:0001666;GO:0010212;GO:0010039;GO:0032496;GO:0046689;GO:0051597;GO:0006979;GO:0070541;GO:0010269;GO:0010266;GO:0033197;GO:0010043;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:catalytic activity; F:identical protein binding; F:porphobilinogen synthase activity; F:proteasome core complex binding; F:zinc ion binding;, P:cellular response to interleukin-4; P:cellular response to lead ion; P:heme biosynthetic process; P:negative regulation of proteasomal protein catabolic process; P:neutrophil degranulation; P:protein homooligomerization; P:protoporphyrinogen IX biosynthetic process; P:response to activity; P:response to aluminum ion; P:response to amino acid; P:response to arsenic-containing substance; P:response to cadmium ion; P:response to cobalt ion; P:response to drug; P:response to ethanol; P:response to fatty acid; P:response to glucocorticoid; P:response to herbicide; P:response to hypoxia; P:response to ionizing radiation; P:response to iron ion; P:response to lipopolysaccharide; P:response to mercury ion; P:response to methylmercury; P:response to oxidative stress; P:response to platinum ion; P:response to selenium ion; P:response to vitamin B1; P:response to vitamin E; P:response to zinc ion; scaffold28 indexed_genome mRNA 8210210 8212493 . - . ID=transcript_6155;Q9BSH5 B2RD47,Haloacid dehalogenase-like hydrolase domain-containing protein 3,, PF13419;, GO:0043231;GO:0005730;GO:0016787;, C:intracellular membrane-bounded organelle; C:nucleolus;, F:hydrolase activity; scaffold28 indexed_genome mRNA 8212796 8234478 . - . ID=transcript_6156;Q5W0U4 B3KS19 Q96DJ2 Q9H4E4 Q9NXN0,B box and SPRY domain-containing protein,, PF13765;PF00622;, GO:0031252;GO:0005737;GO:0016020;GO:0048471;GO:0046872;GO:0061630;GO:0006816;GO:1990830;GO:0016567;, C:cell leading edge; C:cytoplasm; C:membrane; C:perinuclear region of cytoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:calcium ion transport; P:cellular response to leukemia inhibitory factor; P:protein ubiquitination; scaffold28 indexed_genome mRNA 8256699 8267323 . + . ID=transcript_6157;Q8NA23 Q5W0T9 Q96EG8,WD repeat-containing protein 31,, PF00400; scaffold28 indexed_genome mRNA 8286661 8287767 . - . ID=transcript_6158;Q96D59,E3 ubiquitin-protein ligase RNF183,, PF13639;, GO:0033106;GO:0005783;GO:0030176;GO:0005765;GO:0046872;GO:0061630;GO:0006915;GO:1902237;GO:0051865;GO:0000209;GO:0034976;, C:cis-Golgi network membrane; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:lysosomal membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:apoptotic process; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:protein autoubiquitination; P:protein polyubiquitination; P:response to endoplasmic reticulum stress; scaffold28 indexed_genome mRNA 8291437 8332454 . - . ID=transcript_6159;O43172 O43445 O43864 Q5T1M8 Q96DG2 Q96IK4,U4/U6 small nuclear ribonucleoprotein Prp4,PRP4 homolog;U4/U6 snRNP 60 kDa protein;WD splicing factor Prp4;, PF08799;PF00400;, GO:0015030;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0097525;GO:0071005;GO:0071001;GO:0046540;GO:0030621;GO:0017070;GO:0000398;GO:0006396;GO:0008380;GO:0000375;, C:Cajal body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:spliceosomal snRNP complex; C:U2-type precatalytic spliceosome; C:U4/U6 snRNP; C:U4/U6 x U5 tri-snRNP complex;, F:U4 snRNA binding; F:U6 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions;|O43172 O43445 O43864 Q5T1M8 Q96DG2 Q96IK4,U4/U6 small nuclear ribonucleoprotein Prp4,PRP4 homolog;U4/U6 snRNP 60 kDa protein;WD splicing factor Prp4;, PF08799;PF00400;, GO:0015030;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0097525;GO:0071005;GO:0071001;GO:0046540;GO:0030621;GO:0017070;GO:0000398;GO:0006396;GO:0008380;GO:0000375;, C:Cajal body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:spliceosomal snRNP complex; C:U2-type precatalytic spliceosome; C:U4/U6 snRNP; C:U4/U6 x U5 tri-snRNP complex;, F:U4 snRNA binding; F:U6 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions;|O43172 O43445 O43864 Q5T1M8 Q96DG2 Q96IK4,U4/U6 small nuclear ribonucleoprotein Prp4,PRP4 homolog;U4/U6 snRNP 60 kDa protein;WD splicing factor Prp4;, PF08799;PF00400;, GO:0015030;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0097525;GO:0071005;GO:0071001;GO:0046540;GO:0030621;GO:0017070;GO:0000398;GO:0006396;GO:0008380;GO:0000375;, C:Cajal body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:spliceosomal snRNP complex; C:U2-type precatalytic spliceosome; C:U4/U6 snRNP; C:U4/U6 x U5 tri-snRNP complex;, F:U4 snRNA binding; F:U6 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions;|O43172 O43445 O43864 Q5T1M8 Q96DG2 Q96IK4,U4/U6 small nuclear ribonucleoprotein Prp4,PRP4 homolog;U4/U6 snRNP 60 kDa protein;WD splicing factor Prp4;, PF08799;PF00400;, GO:0015030;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0097525;GO:0071005;GO:0071001;GO:0046540;GO:0030621;GO:0017070;GO:0000398;GO:0006396;GO:0008380;GO:0000375;, C:Cajal body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:spliceosomal snRNP complex; C:U2-type precatalytic spliceosome; C:U4/U6 snRNP; C:U4/U6 x U5 tri-snRNP complex;, F:U4 snRNA binding; F:U6 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions;|O43172 O43445 O43864 Q5T1M8 Q96DG2 Q96IK4,U4/U6 small nuclear ribonucleoprotein Prp4,PRP4 homolog;U4/U6 snRNP 60 kDa protein;WD splicing factor Prp4;, PF08799;PF00400;, GO:0015030;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0097525;GO:0071005;GO:0071001;GO:0046540;GO:0030621;GO:0017070;GO:0000398;GO:0006396;GO:0008380;GO:0000375;, C:Cajal body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:spliceosomal snRNP complex; C:U2-type precatalytic spliceosome; C:U4/U6 snRNP; C:U4/U6 x U5 tri-snRNP complex;, F:U4 snRNA binding; F:U6 snRNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q8NHZ8,Anaphase-promoting complex subunit CDC26,Anaphase-promoting complex subunit 12;Cell division cycle protein 26 homolog;, PF10471;, GO:0005680;GO:0005829;GO:0005654;GO:0031145;GO:0007049;GO:0051301;GO:0070979;GO:0007096;GO:0007346;GO:1901990;GO:0030071;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic metaphase/anaphase transition; P:ubiquitin-dependent protein catabolic process; scaffold28 indexed_genome mRNA 8333415 8366616 . - . ID=transcript_6160;O15431 A8K8Z6 Q53GR5 Q5T1M4,High affinity copper uptake protein 1,Copper transporter 1;Solute carrier family 31 member 1;, PF04145;, GO:0005887;GO:0005770;GO:0043025;GO:0005886;GO:0055037;GO:0005375;GO:0042802;GO:0006878;GO:0072719;GO:0098705;GO:0006825;, C:integral component of plasma membrane; C:late endosome; C:neuronal cell body; C:plasma membrane; C:recycling endosome;, F:copper ion transmembrane transporter activity; F:identical protein binding;, P:cellular copper ion homeostasis; P:cellular response to cisplatin; P:copper ion import across plasma membrane; P:copper ion transport; scaffold28 indexed_genome mRNA 8366886 8406038 . + . ID=transcript_6161;Q5T1M5 Q05DK8 Q5T1M2 Q6DD85 Q9Y4D0,FK506-binding protein 15,133 kDa FK506-binding protein;WASP- and FKBP-like protein;, PF00254;, GO:0015629;GO:0005769;GO:0030426;GO:0016020;GO:0003779;GO:0003755;GO:0006897;GO:0010923;, C:actin cytoskeleton; C:early endosome; C:growth cone; C:membrane;, F:actin binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:endocytosis; P:negative regulation of phosphatase activity;|Q5T1M5 Q05DK8 Q5T1M2 Q6DD85 Q9Y4D0,FK506-binding protein 15,133 kDa FK506-binding protein;WASP- and FKBP-like protein;, PF00254;, GO:0015629;GO:0005769;GO:0030426;GO:0016020;GO:0003779;GO:0003755;GO:0006897;GO:0010923;, C:actin cytoskeleton; C:early endosome; C:growth cone; C:membrane;, F:actin binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:endocytosis; P:negative regulation of phosphatase activity;|Q5T1M5 Q05DK8 Q5T1M2 Q6DD85 Q9Y4D0,FK506-binding protein 15,133 kDa FK506-binding protein;WASP- and FKBP-like protein;, PF00254;, GO:0015629;GO:0005769;GO:0030426;GO:0016020;GO:0003779;GO:0003755;GO:0006897;GO:0010923;, C:actin cytoskeleton; C:early endosome; C:growth cone; C:membrane;, F:actin binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:endocytosis; P:negative regulation of phosphatase activity;|Q5T1M5 Q05DK8 Q5T1M2 Q6DD85 Q9Y4D0,FK506-binding protein 15,133 kDa FK506-binding protein;WASP- and FKBP-like protein;, PF00254;, GO:0015629;GO:0005769;GO:0030426;GO:0016020;GO:0003779;GO:0003755;GO:0006897;GO:0010923;, C:actin cytoskeleton; C:early endosome; C:growth cone; C:membrane;, F:actin binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:endocytosis; P:negative regulation of phosphatase activity; scaffold28 indexed_genome mRNA 8414549 8435412 . - . ID=transcript_6162;Q5T1M5 Q05DK8 Q5T1M2 Q6DD85 Q9Y4D0,FK506-binding protein 15,133 kDa FK506-binding protein;WASP- and FKBP-like protein;, PF00254;, GO:0015629;GO:0005769;GO:0030426;GO:0016020;GO:0003779;GO:0003755;GO:0006897;GO:0010923;, C:actin cytoskeleton; C:early endosome; C:growth cone; C:membrane;, F:actin binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:endocytosis; P:negative regulation of phosphatase activity;|Q5T1M5 Q05DK8 Q5T1M2 Q6DD85 Q9Y4D0,FK506-binding protein 15,133 kDa FK506-binding protein;WASP- and FKBP-like protein;, PF00254;, GO:0015629;GO:0005769;GO:0030426;GO:0016020;GO:0003779;GO:0003755;GO:0006897;GO:0010923;, C:actin cytoskeleton; C:early endosome; C:growth cone; C:membrane;, F:actin binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:endocytosis; P:negative regulation of phosphatase activity;|Q5T1M5 Q05DK8 Q5T1M2 Q6DD85 Q9Y4D0,FK506-binding protein 15,133 kDa FK506-binding protein;WASP- and FKBP-like protein;, PF00254;, GO:0015629;GO:0005769;GO:0030426;GO:0016020;GO:0003779;GO:0003755;GO:0006897;GO:0010923;, C:actin cytoskeleton; C:early endosome; C:growth cone; C:membrane;, F:actin binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:endocytosis; P:negative regulation of phosphatase activity;|Q5T1M5 Q05DK8 Q5T1M2 Q6DD85 Q9Y4D0,FK506-binding protein 15,133 kDa FK506-binding protein;WASP- and FKBP-like protein;, PF00254;, GO:0015629;GO:0005769;GO:0030426;GO:0016020;GO:0003779;GO:0003755;GO:0006897;GO:0010923;, C:actin cytoskeleton; C:early endosome; C:growth cone; C:membrane;, F:actin binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:endocytosis; P:negative regulation of phosphatase activity;|O15432,Probable low affinity copper uptake protein 2,Copper transporter 2;Solute carrier family 31 member 2;, PF04145;, GO:0005887;GO:0005770;GO:0005886;GO:0055037;GO:0005375;GO:0006878;GO:0006825;GO:1902311;, C:integral component of plasma membrane; C:late endosome; C:plasma membrane; C:recycling endosome;, F:copper ion transmembrane transporter activity;, P:cellular copper ion homeostasis; P:copper ion transport; P:regulation of copper ion transmembrane transport;|O15432,Probable low affinity copper uptake protein 2,Copper transporter 2;Solute carrier family 31 member 2;, PF04145;, GO:0005887;GO:0005770;GO:0005886;GO:0055037;GO:0005375;GO:0006878;GO:0006825;GO:1902311;, C:integral component of plasma membrane; C:late endosome; C:plasma membrane; C:recycling endosome;, F:copper ion transmembrane transporter activity;, P:cellular copper ion homeostasis; P:copper ion transport; P:regulation of copper ion transmembrane transport; scaffold28 indexed_genome mRNA 8576831 8578199 . - . ID=transcript_6163;Q9BY10 B1ALK1 Q86VT0 Q96NE2,Thymic stromal cotransporter homolog,Solute carrier family 46 member 2;, PF07690;, GO:0009986;GO:0016021;GO:0005886;GO:0015293;GO:0070233;GO:0070430;GO:0045580;GO:0043029;GO:0048538;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:symporter activity;, P:negative regulation of T cell apoptotic process; P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:regulation of T cell differentiation; P:T cell homeostasis; P:thymus development; scaffold28 indexed_genome mRNA 8578413 8579557 . + . ID=transcript_6164;Q9BY10 B1ALK1 Q86VT0 Q96NE2,Thymic stromal cotransporter homolog,Solute carrier family 46 member 2;, PF07690;, GO:0009986;GO:0016021;GO:0005886;GO:0015293;GO:0070233;GO:0070430;GO:0045580;GO:0043029;GO:0048538;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:symporter activity;, P:negative regulation of T cell apoptotic process; P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:regulation of T cell differentiation; P:T cell homeostasis; P:thymus development; scaffold28 indexed_genome mRNA 8579631 8584937 . - . ID=transcript_6165;Q9BY10 B1ALK1 Q86VT0 Q96NE2,Thymic stromal cotransporter homolog,Solute carrier family 46 member 2;, PF07690;, GO:0009986;GO:0016021;GO:0005886;GO:0015293;GO:0070233;GO:0070430;GO:0045580;GO:0043029;GO:0048538;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:symporter activity;, P:negative regulation of T cell apoptotic process; P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:regulation of T cell differentiation; P:T cell homeostasis; P:thymus development; scaffold28 indexed_genome mRNA 8591988 8695428 . - . ID=transcript_6166;Q5VWJ9,Sorting nexin-30,, PF00787;, GO:0035091;GO:0015031;, , F:phosphatidylinositol binding;, P:protein transport;|Q5VWJ9,Sorting nexin-30,, PF00787;, GO:0035091;GO:0015031;, , F:phosphatidylinositol binding;, P:protein transport;|Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated;|Q5VWJ9,Sorting nexin-30,, PF00787;, GO:0035091;GO:0015031;, , F:phosphatidylinositol binding;, P:protein transport;|Q5VWJ9,Sorting nexin-30,, PF00787;, GO:0035091;GO:0015031;, , F:phosphatidylinositol binding;, P:protein transport;|Q5VWJ9,Sorting nexin-30,, PF00787;, GO:0035091;GO:0015031;, , F:phosphatidylinositol binding;, P:protein transport; scaffold28 indexed_genome mRNA 8716724 8734344 . + . ID=transcript_6167;Q9NRY2 Q5VWJ7 Q96E04 Q9P090,SOSS complex subunit C,INTS3- and NABP-interacting protein;Sensor of single-strand DNA complex subunit C;Sensor of ssDNA subunit C;Single-stranded DNA-binding protein-interacting protein 1;, PF15925;, GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0010212;, C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:response to ionizing radiation;|Q9NRY2 Q5VWJ7 Q96E04 Q9P090,SOSS complex subunit C,INTS3- and NABP-interacting protein;Sensor of single-strand DNA complex subunit C;Sensor of ssDNA subunit C;Single-stranded DNA-binding protein-interacting protein 1;, PF15925;, GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0010212;, C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:response to ionizing radiation; scaffold28 indexed_genome mRNA 8752642 8759036 . - . ID=transcript_6168;Q8N8K9 B7ZKW6 Q2M336 Q5T252 Q8TF43 Q96N02,Uncharacterized protein KIAA1958,, PF12012; scaffold28 indexed_genome mRNA 8759142 8759716 . + . ID=transcript_6169;Q8N8K9 B7ZKW6 Q2M336 Q5T252 Q8TF43 Q96N02,Uncharacterized protein KIAA1958,, PF12012; scaffold28 indexed_genome mRNA 8788269 8819697 . - . ID=transcript_6170;Q8N8K9 B7ZKW6 Q2M336 Q5T252 Q8TF43 Q96N02,Uncharacterized protein KIAA1958,, PF12012; scaffold28 indexed_genome mRNA 8887652 8897039 . - . ID=transcript_6171;Q6YN16 A8K1L4 A8K8X1 A8MSV3 Q658M8 Q9BT58,Hydroxysteroid dehydrogenase-like protein 2,Short chain dehydrogenase/reductase family 13C member 1;, PF00106;PF02036;, GO:0016020;GO:0005739;GO:0005777;GO:0016491;, C:membrane; C:mitochondrion; C:peroxisome;, F:oxidoreductase activity;|Q6YN16 A8K1L4 A8K8X1 A8MSV3 Q658M8 Q9BT58,Hydroxysteroid dehydrogenase-like protein 2,Short chain dehydrogenase/reductase family 13C member 1;, PF00106;PF02036;, GO:0016020;GO:0005739;GO:0005777;GO:0016491;, C:membrane; C:mitochondrion; C:peroxisome;, F:oxidoreductase activity; scaffold28 indexed_genome mRNA 8917756 8920225 . + . ID=transcript_6172;Q6YN16 A8K1L4 A8K8X1 A8MSV3 Q658M8 Q9BT58,Hydroxysteroid dehydrogenase-like protein 2,Short chain dehydrogenase/reductase family 13C member 1;, PF00106;PF02036;, GO:0016020;GO:0005739;GO:0005777;GO:0016491;, C:membrane; C:mitochondrion; C:peroxisome;, F:oxidoreductase activity;|Q6YN16 A8K1L4 A8K8X1 A8MSV3 Q658M8 Q9BT58,Hydroxysteroid dehydrogenase-like protein 2,Short chain dehydrogenase/reductase family 13C member 1;, PF00106;PF02036;, GO:0016020;GO:0005739;GO:0005777;GO:0016491;, C:membrane; C:mitochondrion; C:peroxisome;, F:oxidoreductase activity; scaffold28 indexed_genome mRNA 8972291 9013501 . + . ID=transcript_6173;P78318 Q8TAB2,Immunoglobulin-binding protein 1,B-cell signal transduction molecule alpha 4;CD79a-binding protein 1;Protein phosphatase 2/4/6 regulatory subunit;Renal carcinoma antigen NY-REN-16;, PF04177;, GO:0005737;GO:0005829;GO:0051721;GO:0019888;GO:0042113;GO:0043154;GO:0032873;GO:0000122;GO:0035303;GO:0060632;GO:0070555;GO:0034612;GO:0007165;, C:cytoplasm; C:cytosol;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity;, P:B cell activation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription by RNA polymerase II; P:regulation of dephosphorylation; P:regulation of microtubule-based movement; P:response to interleukin-1; P:response to tumor necrosis factor; P:signal transduction; scaffold28 indexed_genome mRNA 9013784 9014541 . + . ID=transcript_6174;P78318 Q8TAB2,Immunoglobulin-binding protein 1,B-cell signal transduction molecule alpha 4;CD79a-binding protein 1;Protein phosphatase 2/4/6 regulatory subunit;Renal carcinoma antigen NY-REN-16;, PF04177;, GO:0005737;GO:0005829;GO:0051721;GO:0019888;GO:0042113;GO:0043154;GO:0032873;GO:0000122;GO:0035303;GO:0060632;GO:0070555;GO:0034612;GO:0007165;, C:cytoplasm; C:cytosol;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity;, P:B cell activation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription by RNA polymerase II; P:regulation of dephosphorylation; P:regulation of microtubule-based movement; P:response to interleukin-1; P:response to tumor necrosis factor; P:signal transduction; scaffold28 indexed_genome mRNA 9122880 9153473 . + . ID=transcript_6175;Q9NTA7,Sushi domain-containing protein 1,, PF07645;PF18861;PF00084;, GO:0016021;GO:0005509;, C:integral component of membrane;, F:calcium ion binding; scaffold28 indexed_genome mRNA 9232107 9233835 . + . ID=transcript_6176;Q9NTA7,Sushi domain-containing protein 1,, PF07645;PF18861;PF00084;, GO:0016021;GO:0005509;, C:integral component of membrane;, F:calcium ion binding; scaffold28 indexed_genome mRNA 9357851 9393417 . - . ID=transcript_6177;Q16739 Q5T258,Ceramide glucosyltransferase {ECO:0000305},GLCT-1;Glucosylceramide synthase;UDP-glucose ceramide glucosyltransferase;UDP-glucose:N-acylsphingosine D-glucosyltransferase;, PF13506;, GO:0000139;GO:0016021;GO:0016020;GO:0008120;GO:0102769;GO:0030154;GO:1903575;GO:0008544;GO:0061436;GO:0006679;GO:0006687;GO:0098856;GO:0030216;GO:0033210;GO:0048666;GO:0006497;GO:0009966;, C:Golgi membrane; C:integral component of membrane; C:membrane;, F:ceramide glucosyltransferase activity; F:dihydroceramide glucosyltransferase activity;, P:cell differentiation; P:cornified envelope assembly; P:epidermis development; P:establishment of skin barrier; P:glucosylceramide biosynthetic process; P:glycosphingolipid metabolic process; P:intestinal lipid absorption; P:keratinocyte differentiation; P:leptin-mediated signaling pathway; P:neuron development; P:protein lipidation; P:regulation of signal transduction;|Q16739 Q5T258,Ceramide glucosyltransferase {ECO:0000305},GLCT-1;Glucosylceramide synthase;UDP-glucose ceramide glucosyltransferase;UDP-glucose:N-acylsphingosine D-glucosyltransferase;, PF13506;, GO:0000139;GO:0016021;GO:0016020;GO:0008120;GO:0102769;GO:0030154;GO:1903575;GO:0008544;GO:0061436;GO:0006679;GO:0006687;GO:0098856;GO:0030216;GO:0033210;GO:0048666;GO:0006497;GO:0009966;, C:Golgi membrane; C:integral component of membrane; C:membrane;, F:ceramide glucosyltransferase activity; F:dihydroceramide glucosyltransferase activity;, P:cell differentiation; P:cornified envelope assembly; P:epidermis development; P:establishment of skin barrier; P:glucosylceramide biosynthetic process; P:glycosphingolipid metabolic process; P:intestinal lipid absorption; P:keratinocyte differentiation; P:leptin-mediated signaling pathway; P:neuron development; P:protein lipidation; P:regulation of signal transduction;|Q16739 Q5T258,Ceramide glucosyltransferase {ECO:0000305},GLCT-1;Glucosylceramide synthase;UDP-glucose ceramide glucosyltransferase;UDP-glucose:N-acylsphingosine D-glucosyltransferase;, PF13506;, GO:0000139;GO:0016021;GO:0016020;GO:0008120;GO:0102769;GO:0030154;GO:1903575;GO:0008544;GO:0061436;GO:0006679;GO:0006687;GO:0098856;GO:0030216;GO:0033210;GO:0048666;GO:0006497;GO:0009966;, C:Golgi membrane; C:integral component of membrane; C:membrane;, F:ceramide glucosyltransferase activity; F:dihydroceramide glucosyltransferase activity;, P:cell differentiation; P:cornified envelope assembly; P:epidermis development; P:establishment of skin barrier; P:glucosylceramide biosynthetic process; P:glycosphingolipid metabolic process; P:intestinal lipid absorption; P:keratinocyte differentiation; P:leptin-mediated signaling pathway; P:neuron development; P:protein lipidation; P:regulation of signal transduction; scaffold28 indexed_genome mRNA 9579878 9585185 . - . ID=transcript_6178;P50151 Q3B7K2 Q4VC27,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10,, PF00631;, GO:0031680;GO:0005834;GO:0005886;GO:0031681;GO:0003924;GO:0007186;GO:0007165;, C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:plasma membrane;, F:G-protein beta-subunit binding; F:GTPase activity;, P:G protein-coupled receptor signaling pathway; P:signal transduction;|P50151 Q3B7K2 Q4VC27,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10,, PF00631;, GO:0031680;GO:0005834;GO:0005886;GO:0031681;GO:0003924;GO:0007186;GO:0007165;, C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:plasma membrane;, F:G-protein beta-subunit binding; F:GTPase activity;, P:G protein-coupled receptor signaling pathway; P:signal transduction; scaffold28 indexed_genome mRNA 9591698 9612946 . - . ID=transcript_6179;Q9H1X3 Q5QTD8 Q96BN9,DnaJ homolog subfamily C member 25,, PF00226;, GO:0005789;GO:0016021;GO:0006457;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:protein folding; scaffold28 indexed_genome mRNA 9666873 9701291 . + . ID=transcript_6180;Q14914 A8K0N2 B4DPK3 F5GY50 Q8IYQ0 Q9H1X6,Prostaglandin reductase 1 {ECO:0000303|PubMed:25619643},15-oxoprostaglandin 13-reductase {ECO:0000250|UniProtKB:Q29073};Dithiolethione-inducible gene 1 protein {ECO:0000250|UniProtKB:P97584};Leukotriene B4 12-hydroxydehydrogenase {ECO:0000303|PubMed:25619643};NAD(P)H-dependent alkenal/one oxidoreductase {ECO:0000303|PubMed:25619643};, PF16884;PF00107;, GO:0005737;GO:0070062;GO:0036185;GO:0036132;GO:0047522;GO:0035798;GO:0097257;GO:0036102;GO:0006691;GO:2001302;GO:0006693;GO:0097327;, C:cytoplasm; C:extracellular exosome;, F:13-lipoxin reductase activity; F:13-prostaglandin reductase activity; F:15-oxoprostaglandin 13-oxidase activity; F:2-alkenal reductase (NADP+) activity; F:leukotriene B4 12-hydroxy dehydrogenase activity;, P:leukotriene B4 metabolic process; P:leukotriene metabolic process; P:lipoxin A4 metabolic process; P:prostaglandin metabolic process; P:response to antineoplastic agent;|Q14914 A8K0N2 B4DPK3 F5GY50 Q8IYQ0 Q9H1X6,Prostaglandin reductase 1 {ECO:0000303|PubMed:25619643},15-oxoprostaglandin 13-reductase {ECO:0000250|UniProtKB:Q29073};Dithiolethione-inducible gene 1 protein {ECO:0000250|UniProtKB:P97584};Leukotriene B4 12-hydroxydehydrogenase {ECO:0000303|PubMed:25619643};NAD(P)H-dependent alkenal/one oxidoreductase {ECO:0000303|PubMed:25619643};, PF16884;PF00107;, GO:0005737;GO:0070062;GO:0036185;GO:0036132;GO:0047522;GO:0035798;GO:0097257;GO:0036102;GO:0006691;GO:2001302;GO:0006693;GO:0097327;, C:cytoplasm; C:extracellular exosome;, F:13-lipoxin reductase activity; F:13-prostaglandin reductase activity; F:15-oxoprostaglandin 13-oxidase activity; F:2-alkenal reductase (NADP+) activity; F:leukotriene B4 12-hydroxy dehydrogenase activity;, P:leukotriene B4 metabolic process; P:leukotriene metabolic process; P:lipoxin A4 metabolic process; P:prostaglandin metabolic process; P:response to antineoplastic agent;|Q14914 A8K0N2 B4DPK3 F5GY50 Q8IYQ0 Q9H1X6,Prostaglandin reductase 1 {ECO:0000303|PubMed:25619643},15-oxoprostaglandin 13-reductase {ECO:0000250|UniProtKB:Q29073};Dithiolethione-inducible gene 1 protein {ECO:0000250|UniProtKB:P97584};Leukotriene B4 12-hydroxydehydrogenase {ECO:0000303|PubMed:25619643};NAD(P)H-dependent alkenal/one oxidoreductase {ECO:0000303|PubMed:25619643};, PF16884;PF00107;, GO:0005737;GO:0070062;GO:0036185;GO:0036132;GO:0047522;GO:0035798;GO:0097257;GO:0036102;GO:0006691;GO:2001302;GO:0006693;GO:0097327;, C:cytoplasm; C:extracellular exosome;, F:13-lipoxin reductase activity; F:13-prostaglandin reductase activity; F:15-oxoprostaglandin 13-oxidase activity; F:2-alkenal reductase (NADP+) activity; F:leukotriene B4 12-hydroxy dehydrogenase activity;, P:leukotriene B4 metabolic process; P:leukotriene metabolic process; P:lipoxin A4 metabolic process; P:prostaglandin metabolic process; P:response to antineoplastic agent;|Q14914 A8K0N2 B4DPK3 F5GY50 Q8IYQ0 Q9H1X6,Prostaglandin reductase 1 {ECO:0000303|PubMed:25619643},15-oxoprostaglandin 13-reductase {ECO:0000250|UniProtKB:Q29073};Dithiolethione-inducible gene 1 protein {ECO:0000250|UniProtKB:P97584};Leukotriene B4 12-hydroxydehydrogenase {ECO:0000303|PubMed:25619643};NAD(P)H-dependent alkenal/one oxidoreductase {ECO:0000303|PubMed:25619643};, PF16884;PF00107;, GO:0005737;GO:0070062;GO:0036185;GO:0036132;GO:0047522;GO:0035798;GO:0097257;GO:0036102;GO:0006691;GO:2001302;GO:0006693;GO:0097327;, C:cytoplasm; C:extracellular exosome;, F:13-lipoxin reductase activity; F:13-prostaglandin reductase activity; F:15-oxoprostaglandin 13-oxidase activity; F:2-alkenal reductase (NADP+) activity; F:leukotriene B4 12-hydroxy dehydrogenase activity;, P:leukotriene B4 metabolic process; P:leukotriene metabolic process; P:lipoxin A4 metabolic process; P:prostaglandin metabolic process; P:response to antineoplastic agent;|Q14914 A8K0N2 B4DPK3 F5GY50 Q8IYQ0 Q9H1X6,Prostaglandin reductase 1 {ECO:0000303|PubMed:25619643},15-oxoprostaglandin 13-reductase {ECO:0000250|UniProtKB:Q29073};Dithiolethione-inducible gene 1 protein {ECO:0000250|UniProtKB:P97584};Leukotriene B4 12-hydroxydehydrogenase {ECO:0000303|PubMed:25619643};NAD(P)H-dependent alkenal/one oxidoreductase {ECO:0000303|PubMed:25619643};, PF16884;PF00107;, GO:0005737;GO:0070062;GO:0036185;GO:0036132;GO:0047522;GO:0035798;GO:0097257;GO:0036102;GO:0006691;GO:2001302;GO:0006693;GO:0097327;, C:cytoplasm; C:extracellular exosome;, F:13-lipoxin reductase activity; F:13-prostaglandin reductase activity; F:15-oxoprostaglandin 13-oxidase activity; F:2-alkenal reductase (NADP+) activity; F:leukotriene B4 12-hydroxy dehydrogenase activity;, P:leukotriene B4 metabolic process; P:leukotriene metabolic process; P:lipoxin A4 metabolic process; P:prostaglandin metabolic process; P:response to antineoplastic agent; scaffold28 indexed_genome mRNA 9711928 9725287 . - . ID=transcript_6181;Q8TF39 Q5VZN2 Q8NAE1,Zinc finger protein 483,Zinc finger protein with KRAB and SCAN domains 16;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8TF39 Q5VZN2 Q8NAE1,Zinc finger protein 483,Zinc finger protein with KRAB and SCAN domains 16;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 9773669 9848796 . + . ID=transcript_6182;Q5VYK3 O15074 Q8WU82,Proteasome adapter and scaffold protein ECM29 {ECO:0000305},Ecm29 proteasome adapter and scaffold {ECO:0000312|HGNC:HGNC:29020};Proteasome-associated protein ECM29 homolog;, PF13001;, GO:0005813;GO:0030134;GO:0031410;GO:0005769;GO:0030139;GO:0005783;GO:0005793;GO:0005770;GO:0016020;GO:0005771;GO:0005654;GO:0005634;GO:0000502;GO:0060090;GO:0070628;GO:0043248;GO:0030433;, C:centrosome; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:late endosome; C:membrane; C:multivesicular body; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:molecular adaptor activity; F:proteasome binding;, P:proteasome assembly; P:ubiquitin-dependent ERAD pathway;|Q5VYK3 O15074 Q8WU82,Proteasome adapter and scaffold protein ECM29 {ECO:0000305},Ecm29 proteasome adapter and scaffold {ECO:0000312|HGNC:HGNC:29020};Proteasome-associated protein ECM29 homolog;, PF13001;, GO:0005813;GO:0030134;GO:0031410;GO:0005769;GO:0030139;GO:0005783;GO:0005793;GO:0005770;GO:0016020;GO:0005771;GO:0005654;GO:0005634;GO:0000502;GO:0060090;GO:0070628;GO:0043248;GO:0030433;, C:centrosome; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:late endosome; C:membrane; C:multivesicular body; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:molecular adaptor activity; F:proteasome binding;, P:proteasome assembly; P:ubiquitin-dependent ERAD pathway;|Q5VYK3 O15074 Q8WU82,Proteasome adapter and scaffold protein ECM29 {ECO:0000305},Ecm29 proteasome adapter and scaffold {ECO:0000312|HGNC:HGNC:29020};Proteasome-associated protein ECM29 homolog;, PF13001;, GO:0005813;GO:0030134;GO:0031410;GO:0005769;GO:0030139;GO:0005783;GO:0005793;GO:0005770;GO:0016020;GO:0005771;GO:0005654;GO:0005634;GO:0000502;GO:0060090;GO:0070628;GO:0043248;GO:0030433;, C:centrosome; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:late endosome; C:membrane; C:multivesicular body; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:molecular adaptor activity; F:proteasome binding;, P:proteasome assembly; P:ubiquitin-dependent ERAD pathway;|Q5VYK3 O15074 Q8WU82,Proteasome adapter and scaffold protein ECM29 {ECO:0000305},Ecm29 proteasome adapter and scaffold {ECO:0000312|HGNC:HGNC:29020};Proteasome-associated protein ECM29 homolog;, PF13001;, GO:0005813;GO:0030134;GO:0031410;GO:0005769;GO:0030139;GO:0005783;GO:0005793;GO:0005770;GO:0016020;GO:0005771;GO:0005654;GO:0005634;GO:0000502;GO:0060090;GO:0070628;GO:0043248;GO:0030433;, C:centrosome; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:late endosome; C:membrane; C:multivesicular body; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:molecular adaptor activity; F:proteasome binding;, P:proteasome assembly; P:ubiquitin-dependent ERAD pathway;|Q5VYK3 O15074 Q8WU82,Proteasome adapter and scaffold protein ECM29 {ECO:0000305},Ecm29 proteasome adapter and scaffold {ECO:0000312|HGNC:HGNC:29020};Proteasome-associated protein ECM29 homolog;, PF13001;, GO:0005813;GO:0030134;GO:0031410;GO:0005769;GO:0030139;GO:0005783;GO:0005793;GO:0005770;GO:0016020;GO:0005771;GO:0005654;GO:0005634;GO:0000502;GO:0060090;GO:0070628;GO:0043248;GO:0030433;, C:centrosome; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:late endosome; C:membrane; C:multivesicular body; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:molecular adaptor activity; F:proteasome binding;, P:proteasome assembly; P:ubiquitin-dependent ERAD pathway;|Q5VYK3 O15074 Q8WU82,Proteasome adapter and scaffold protein ECM29 {ECO:0000305},Ecm29 proteasome adapter and scaffold {ECO:0000312|HGNC:HGNC:29020};Proteasome-associated protein ECM29 homolog;, PF13001;, GO:0005813;GO:0030134;GO:0031410;GO:0005769;GO:0030139;GO:0005783;GO:0005793;GO:0005770;GO:0016020;GO:0005771;GO:0005654;GO:0005634;GO:0000502;GO:0060090;GO:0070628;GO:0043248;GO:0030433;, C:centrosome; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:late endosome; C:membrane; C:multivesicular body; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:molecular adaptor activity; F:proteasome binding;, P:proteasome assembly; P:ubiquitin-dependent ERAD pathway; scaffold28 indexed_genome mRNA 9848819 9853565 . + . ID=transcript_6183;Q5VYK3 O15074 Q8WU82,Proteasome adapter and scaffold protein ECM29 {ECO:0000305},Ecm29 proteasome adapter and scaffold {ECO:0000312|HGNC:HGNC:29020};Proteasome-associated protein ECM29 homolog;, PF13001;, GO:0005813;GO:0030134;GO:0031410;GO:0005769;GO:0030139;GO:0005783;GO:0005793;GO:0005770;GO:0016020;GO:0005771;GO:0005654;GO:0005634;GO:0000502;GO:0060090;GO:0070628;GO:0043248;GO:0030433;, C:centrosome; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:early endosome; C:endocytic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:late endosome; C:membrane; C:multivesicular body; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:molecular adaptor activity; F:proteasome binding;, P:proteasome assembly; P:ubiquitin-dependent ERAD pathway; scaffold28 indexed_genome mRNA 10198489 10258393 . + . ID=transcript_6184;Q92633 B4DK36 O00656 O00722 P78351,Lysophosphatidic acid receptor 1,Lysophosphatidic acid receptor Edg-2 {ECO:0000303|PubMed:9070858};, PF00001;, GO:0009986;GO:0005737;GO:0043198;GO:0043197;GO:0005768;GO:0005887;GO:0043025;GO:0005886;GO:0004930;GO:0001965;GO:0035727;GO:0070915;GO:0030165;GO:0000187;GO:0007202;GO:0007189;GO:0007193;GO:0032060;GO:0060326;GO:1904566;GO:0071453;GO:0021549;GO:0022038;GO:0007186;GO:0042552;GO:0043951;GO:0010977;GO:0022008;GO:0014003;GO:0021554;GO:0043065;GO:0007204;GO:0051482;GO:0060999;GO:0043123;GO:0043410;GO:0035025;GO:0071673;GO:0051496;GO:0008360;GO:0019222;, C:cell surface; C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:endosome; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane;, F:G protein-coupled receptor activity; F:G-protein alpha-subunit binding; F:lysophosphatidic acid binding; F:lysophosphatidic acid receptor activity; F:PDZ domain binding;, P:activation of MAPK activity; P:activation of phospholipase C activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:bleb assembly; P:cell chemotaxis; P:cellular response to 1-oleoyl-sn-glycerol 3-phosphate; P:cellular response to oxygen levels; P:cerebellum development; P:corpus callosum development; P:G protein-coupled receptor signaling pathway; P:myelination; P:negative regulation of cAMP-mediated signaling; P:negative regulation of neuron projection development; P:neurogenesis; P:oligodendrocyte development; P:optic nerve development; P:positive regulation of apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of dendritic spine development; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAPK cascade; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle cell chemotaxis; P:positive regulation of stress fiber assembly; P:regulation of cell shape; P:regulation of metabolic process; scaffold28 indexed_genome mRNA 10556242 10616241 . + . ID=transcript_6185;Q96JU7 Q9H284 Q9H8J9,Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1,CCP module-containing protein 22;Polydom;Selectin-like osteoblast-derived protein;Serologically defined breast cancer antigen NY-BR-38;, PF00008;PF07645;PF07699;PF12661;PF02494;PF00354;PF00084;PF00092;, GO:0005737;GO:0005576;GO:0016020;GO:0005634;GO:0005509;GO:0007155;, C:cytoplasm; C:extracellular region; C:membrane; C:nucleus;, F:calcium ion binding;, P:cell adhesion; scaffold28 indexed_genome mRNA 10616290 10631301 . + . ID=transcript_6186;Q96JU7 Q9H284 Q9H8J9,Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1,CCP module-containing protein 22;Polydom;Selectin-like osteoblast-derived protein;Serologically defined breast cancer antigen NY-BR-38;, PF00008;PF07645;PF07699;PF12661;PF02494;PF00354;PF00084;PF00092;, GO:0005737;GO:0005576;GO:0016020;GO:0005634;GO:0005509;GO:0007155;, C:cytoplasm; C:extracellular region; C:membrane; C:nucleus;, F:calcium ion binding;, P:cell adhesion; scaffold28 indexed_genome mRNA 10642036 10676455 . + . ID=transcript_6187;Q96JU7 Q9H284 Q9H8J9,Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1,CCP module-containing protein 22;Polydom;Selectin-like osteoblast-derived protein;Serologically defined breast cancer antigen NY-BR-38;, PF00008;PF07645;PF07699;PF12661;PF02494;PF00354;PF00084;PF00092;, GO:0005737;GO:0005576;GO:0016020;GO:0005634;GO:0005509;GO:0007155;, C:cytoplasm; C:extracellular region; C:membrane; C:nucleus;, F:calcium ion binding;, P:cell adhesion; scaffold28 indexed_genome mRNA 10701846 10719360 . + . ID=transcript_6188;Q6A555 A1L4I2 A6NDK7 Q5T934,Thioredoxin domain-containing protein 8,Spermatid-specific thioredoxin-3;Thioredoxin-6;, PF00085;, GO:0001669;GO:0005737;GO:0070062;GO:0005794;GO:0036126;GO:0001675;GO:0007275;GO:0007283;, C:acrosomal vesicle; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:sperm flagellum;, , P:acrosome assembly; P:multicellular organism development; P:spermatogenesis; scaffold28 indexed_genome mRNA 10741236 10777476 . + . ID=transcript_6189;P10599 B1ALW1 O60744 Q53X69 Q96KI3 Q9UDG5,Thioredoxin,ATL-derived factor;Surface-associated sulphydryl protein;, PF00085;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0015037;GO:0015035;GO:0042803;GO:0047134;GO:0003723;GO:0032148;GO:0045454;GO:0098869;GO:0006662;GO:1903206;GO:0046826;GO:0000122;GO:0043388;GO:2000170;GO:0033138;GO:0051897;GO:0035590;GO:0071731;GO:0009314;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus;, F:peptide disulfide oxidoreductase activity; F:protein disulfide oxidoreductase activity; F:protein homodimerization activity; F:protein-disulfide reductase activity; F:RNA binding;, P:activation of protein kinase B activity; P:cell redox homeostasis; P:cellular oxidant detoxification; P:glycerol ether metabolic process; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of protein export from nucleus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA binding; P:positive regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:purinergic nucleotide receptor signaling pathway; P:response to nitric oxide; P:response to radiation;|P10599 B1ALW1 O60744 Q53X69 Q96KI3 Q9UDG5,Thioredoxin,ATL-derived factor;Surface-associated sulphydryl protein;, PF00085;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0015037;GO:0015035;GO:0042803;GO:0047134;GO:0003723;GO:0032148;GO:0045454;GO:0098869;GO:0006662;GO:1903206;GO:0046826;GO:0000122;GO:0043388;GO:2000170;GO:0033138;GO:0051897;GO:0035590;GO:0071731;GO:0009314;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus;, F:peptide disulfide oxidoreductase activity; F:protein disulfide oxidoreductase activity; F:protein homodimerization activity; F:protein-disulfide reductase activity; F:RNA binding;, P:activation of protein kinase B activity; P:cell redox homeostasis; P:cellular oxidant detoxification; P:glycerol ether metabolic process; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of protein export from nucleus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA binding; P:positive regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:purinergic nucleotide receptor signaling pathway; P:response to nitric oxide; P:response to radiation; scaffold28 indexed_genome mRNA 10851341 11135488 . - . ID=transcript_6190;Q9Y2D5 B1ALX9 B2RTU4 B3KQ00 B4DTZ2 B7ZW07 B9EJB5 Q9UG26,A-kinase anchor protein 2,AKAP-KL;Protein kinase A-anchoring protein 2;, PF15304;|Q9Y2D5 B1ALX9 B2RTU4 B3KQ00 B4DTZ2 B7ZW07 B9EJB5 Q9UG26,A-kinase anchor protein 2,AKAP-KL;Protein kinase A-anchoring protein 2;, PF15304;|Q8IXS6 A9Z1X9 Q8N9D5 Q96DU1,Paralemmin-2,, PF03285;, GO:0005886;GO:0008360;, C:plasma membrane;, , P:regulation of cell shape; scaffold28 indexed_genome mRNA 11511811 11575670 . + . ID=transcript_6191;P26045 A0AUW9 E7EN99 E9PGU7,Tyrosine-protein phosphatase non-receptor type 3,Protein-tyrosine phosphatase H1;, PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0005737;GO:0009898;GO:0005856;GO:0005829;GO:0005886;GO:0051117;GO:0008092;GO:0001784;GO:0004725;GO:0017080;GO:0097421;GO:0000165;GO:0042059;GO:0051045;GO:0045930;GO:0006470;GO:0098902;GO:2000649;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:ATPase binding; F:cytoskeletal protein binding; F:phosphotyrosine residue binding; F:protein tyrosine phosphatase activity; F:sodium channel regulator activity;, P:liver regeneration; P:MAPK cascade; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of mitotic cell cycle; P:protein dephosphorylation; P:regulation of membrane depolarization during action potential; P:regulation of sodium ion transmembrane transporter activity; scaffold28 indexed_genome mRNA 11581683 11617967 . + . ID=transcript_6192;P26045 A0AUW9 E7EN99 E9PGU7,Tyrosine-protein phosphatase non-receptor type 3,Protein-tyrosine phosphatase H1;, PF09380;PF00373;PF09379;PF00595;PF00102;, GO:0005737;GO:0009898;GO:0005856;GO:0005829;GO:0005886;GO:0051117;GO:0008092;GO:0001784;GO:0004725;GO:0017080;GO:0097421;GO:0000165;GO:0042059;GO:0051045;GO:0045930;GO:0006470;GO:0098902;GO:2000649;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:ATPase binding; F:cytoskeletal protein binding; F:phosphotyrosine residue binding; F:protein tyrosine phosphatase activity; F:sodium channel regulator activity;, P:liver regeneration; P:MAPK cascade; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of mitotic cell cycle; P:protein dephosphorylation; P:regulation of membrane depolarization during action potential; P:regulation of sodium ion transmembrane transporter activity; scaffold28 indexed_genome mRNA 11648003 11651430 . - . ID=transcript_6193;P23458 Q59GQ2 Q9UD26,Tyrosine-protein kinase JAK1,Janus kinase 1;, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0005768;GO:0005925;GO:0016020;GO:0005634;GO:0005524;GO:0031730;GO:0005131;GO:0046872;GO:0004715;GO:0019903;GO:0004713;GO:0004714;GO:0031625;GO:0019221;GO:0060333;GO:0035722;GO:0035723;GO:0038110;GO:0038114;GO:0070106;GO:0070757;GO:0070102;GO:0038111;GO:0038113;GO:0035556;GO:0000165;GO:0034112;GO:1903672;GO:0150105;GO:0006468;GO:0060334;GO:0046677;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome; C:focal adhesion; C:membrane; C:nucleus;, F:ATP binding; F:CCR5 chemokine receptor binding; F:growth hormone receptor binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of sprouting angiogenesis; P:protein localization to cell-cell junction; P:protein phosphorylation; P:regulation of interferon-gamma-mediated signaling pathway; P:response to antibiotic; P:type I interferon signaling pathway; scaffold28 indexed_genome mRNA 11739581 11740277 . + . ID=transcript_6194;Q9H329 Q5T4G5 Q5T4G6 Q9H328 Q9P2V3,Band 4.1-like protein 4B,Erythrocyte membrane protein band 4.1-like 4B {ECO:0000312|HGNC:HGNC:19818};FERM-containing protein CG1;Protein EHM2;, PF08736;PF09380;PF00373;PF09379;, GO:0045177;GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008092;GO:0005200;GO:0031032;GO:0045785;GO:0010628;GO:0051549;GO:0042060;, C:apical part of cell; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cytoskeletal protein binding; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:positive regulation of cell adhesion; P:positive regulation of gene expression; P:positive regulation of keratinocyte migration; P:wound healing; scaffold28 indexed_genome mRNA 11742642 11801981 . + . ID=transcript_6195;Q9H329 Q5T4G5 Q5T4G6 Q9H328 Q9P2V3,Band 4.1-like protein 4B,Erythrocyte membrane protein band 4.1-like 4B {ECO:0000312|HGNC:HGNC:19818};FERM-containing protein CG1;Protein EHM2;, PF08736;PF09380;PF00373;PF09379;, GO:0045177;GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008092;GO:0005200;GO:0031032;GO:0045785;GO:0010628;GO:0051549;GO:0042060;, C:apical part of cell; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cytoskeletal protein binding; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:positive regulation of cell adhesion; P:positive regulation of gene expression; P:positive regulation of keratinocyte migration; P:wound healing;|Q9H329 Q5T4G5 Q5T4G6 Q9H328 Q9P2V3,Band 4.1-like protein 4B,Erythrocyte membrane protein band 4.1-like 4B {ECO:0000312|HGNC:HGNC:19818};FERM-containing protein CG1;Protein EHM2;, PF08736;PF09380;PF00373;PF09379;, GO:0045177;GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008092;GO:0005200;GO:0031032;GO:0045785;GO:0010628;GO:0051549;GO:0042060;, C:apical part of cell; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cytoskeletal protein binding; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:positive regulation of cell adhesion; P:positive regulation of gene expression; P:positive regulation of keratinocyte migration; P:wound healing; scaffold28 indexed_genome mRNA 11801997 11818864 . + . ID=transcript_6196;Q9H329 Q5T4G5 Q5T4G6 Q9H328 Q9P2V3,Band 4.1-like protein 4B,Erythrocyte membrane protein band 4.1-like 4B {ECO:0000312|HGNC:HGNC:19818};FERM-containing protein CG1;Protein EHM2;, PF08736;PF09380;PF00373;PF09379;, GO:0045177;GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008092;GO:0005200;GO:0031032;GO:0045785;GO:0010628;GO:0051549;GO:0042060;, C:apical part of cell; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cytoskeletal protein binding; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:positive regulation of cell adhesion; P:positive regulation of gene expression; P:positive regulation of keratinocyte migration; P:wound healing;|Q9H329 Q5T4G5 Q5T4G6 Q9H328 Q9P2V3,Band 4.1-like protein 4B,Erythrocyte membrane protein band 4.1-like 4B {ECO:0000312|HGNC:HGNC:19818};FERM-containing protein CG1;Protein EHM2;, PF08736;PF09380;PF00373;PF09379;, GO:0045177;GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008092;GO:0005200;GO:0031032;GO:0045785;GO:0010628;GO:0051549;GO:0042060;, C:apical part of cell; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cytoskeletal protein binding; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:positive regulation of cell adhesion; P:positive regulation of gene expression; P:positive regulation of keratinocyte migration; P:wound healing;|Q9H329 Q5T4G5 Q5T4G6 Q9H328 Q9P2V3,Band 4.1-like protein 4B,Erythrocyte membrane protein band 4.1-like 4B {ECO:0000312|HGNC:HGNC:19818};FERM-containing protein CG1;Protein EHM2;, PF08736;PF09380;PF00373;PF09379;, GO:0045177;GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008092;GO:0005200;GO:0031032;GO:0045785;GO:0010628;GO:0051549;GO:0042060;, C:apical part of cell; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cytoskeletal protein binding; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:positive regulation of cell adhesion; P:positive regulation of gene expression; P:positive regulation of keratinocyte migration; P:wound healing; scaffold28 indexed_genome mRNA 11838378 11840096 . - . ID=transcript_6197;Q9P0K9 Q5T4G4,DOMON domain-containing protein FRRS1L,Brain protein CG-6;Ferric-chelate reductase 1-like protein;, PF03351;, GO:0016021;GO:0005886;GO:0045202;GO:1900449;GO:0099072;, C:integral component of membrane; C:plasma membrane; C:synapse;, , P:regulation of glutamate receptor signaling pathway; P:regulation of postsynaptic membrane neurotransmitter receptor levels; scaffold28 indexed_genome mRNA 11840541 11841729 . - . ID=transcript_6198;Q9P0K9 Q5T4G4,DOMON domain-containing protein FRRS1L,Brain protein CG-6;Ferric-chelate reductase 1-like protein;, PF03351;, GO:0016021;GO:0005886;GO:0045202;GO:1900449;GO:0099072;, C:integral component of membrane; C:plasma membrane; C:synapse;, , P:regulation of glutamate receptor signaling pathway; P:regulation of postsynaptic membrane neurotransmitter receptor levels; scaffold28 indexed_genome mRNA 11845934 11854729 . - . ID=transcript_6199;Q9P0K9 Q5T4G4,DOMON domain-containing protein FRRS1L,Brain protein CG-6;Ferric-chelate reductase 1-like protein;, PF03351;, GO:0016021;GO:0005886;GO:0045202;GO:1900449;GO:0099072;, C:integral component of membrane; C:plasma membrane; C:synapse;, , P:regulation of glutamate receptor signaling pathway; P:regulation of postsynaptic membrane neurotransmitter receptor levels;|Q9P0K9 Q5T4G4,DOMON domain-containing protein FRRS1L,Brain protein CG-6;Ferric-chelate reductase 1-like protein;, PF03351;, GO:0016021;GO:0005886;GO:0045202;GO:1900449;GO:0099072;, C:integral component of membrane; C:plasma membrane; C:synapse;, , P:regulation of glutamate receptor signaling pathway; P:regulation of postsynaptic membrane neurotransmitter receptor levels;|Q9P0K9 Q5T4G4,DOMON domain-containing protein FRRS1L,Brain protein CG-6;Ferric-chelate reductase 1-like protein;, PF03351;, GO:0016021;GO:0005886;GO:0045202;GO:1900449;GO:0099072;, C:integral component of membrane; C:plasma membrane; C:synapse;, , P:regulation of glutamate receptor signaling pathway; P:regulation of postsynaptic membrane neurotransmitter receptor levels; scaffold28 indexed_genome mRNA 11860631 11941022 . + . ID=transcript_6200;Q9H330 B4DSW7 Q5JTQ5 Q5SS43 Q6ZME3 Q8NDJ5 Q96CG6,Transmembrane protein 245,Protein CG-2;, PF01594;, GO:0016021;, C:integral component of membrane;|Q9H330 B4DSW7 Q5JTQ5 Q5SS43 Q6ZME3 Q8NDJ5 Q96CG6,Transmembrane protein 245,Protein CG-2;, PF01594;, GO:0016021;, C:integral component of membrane;|Q9H330 B4DSW7 Q5JTQ5 Q5SS43 Q6ZME3 Q8NDJ5 Q96CG6,Transmembrane protein 245,Protein CG-2;, PF01594;, GO:0016021;, C:integral component of membrane;|Q9H330 B4DSW7 Q5JTQ5 Q5SS43 Q6ZME3 Q8NDJ5 Q96CG6,Transmembrane protein 245,Protein CG-2;, PF01594;, GO:0016021;, C:integral component of membrane; scaffold28 indexed_genome mRNA 11957285 12005311 . + . ID=transcript_6201;Q9UBT7 B5BU47 O76084 Q53FQ2 Q5JTQ7 Q5JTQ8 Q9Y401,Alpha-catulin,Alpha-catenin-related protein;Catenin alpha-like protein 1;, PF01044;, GO:0005856;GO:0005829;GO:0005886;GO:0051015;GO:0045296;GO:0007155;GO:0007266;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:actin filament binding; F:cadherin binding;, P:cell adhesion; P:Rho protein signal transduction; scaffold28 indexed_genome mRNA 12005336 12011164 . - . ID=transcript_6202;Q9NX38 Q5JTR0 Q5JTR1,Protein Abitram {ECO:0000305},Actin-binding transcription modulator {ECO:0000312|HGNC:HGNC:1364};Protein Simiate {ECO:0000305};, PF01597;, GO:0030425;GO:0032433;GO:0030426;GO:0030027;GO:0016607;GO:0005634;GO:0051015;GO:0003785;GO:0048813;GO:0030833;GO:0051489;, C:dendrite; C:filopodium tip; C:growth cone; C:lamellipodium; C:nuclear speck; C:nucleus;, F:actin filament binding; F:actin monomer binding;, P:dendrite morphogenesis; P:regulation of actin filament polymerization; P:regulation of filopodium assembly;|Q9NX38 Q5JTR0 Q5JTR1,Protein Abitram {ECO:0000305},Actin-binding transcription modulator {ECO:0000312|HGNC:HGNC:1364};Protein Simiate {ECO:0000305};, PF01597;, GO:0030425;GO:0032433;GO:0030426;GO:0030027;GO:0016607;GO:0005634;GO:0051015;GO:0003785;GO:0048813;GO:0030833;GO:0051489;, C:dendrite; C:filopodium tip; C:growth cone; C:lamellipodium; C:nuclear speck; C:nucleus;, F:actin filament binding; F:actin monomer binding;, P:dendrite morphogenesis; P:regulation of actin filament polymerization; P:regulation of filopodium assembly; scaffold28 indexed_genome mRNA 12011267 12061175 . + . ID=transcript_6203;O95163 Q5JSV2 Q9H327 Q9UG87,Elongator complex protein 1,IkappaB kinase complex-associated protein {ECO:0000303|PubMed:9751059};p150;, PF04762;, GO:0005737;GO:0005829;GO:0033588;GO:0005634;GO:0000049;GO:0002926;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleus;, F:tRNA binding;, P:tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation;|O95163 Q5JSV2 Q9H327 Q9UG87,Elongator complex protein 1,IkappaB kinase complex-associated protein {ECO:0000303|PubMed:9751059};p150;, PF04762;, GO:0005737;GO:0005829;GO:0033588;GO:0005634;GO:0000049;GO:0002926;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleus;, F:tRNA binding;, P:tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation;|O95163 Q5JSV2 Q9H327 Q9UG87,Elongator complex protein 1,IkappaB kinase complex-associated protein {ECO:0000303|PubMed:9751059};p150;, PF04762;, GO:0005737;GO:0005829;GO:0033588;GO:0005634;GO:0000049;GO:0002926;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleus;, F:tRNA binding;, P:tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation;|O95163 Q5JSV2 Q9H327 Q9UG87,Elongator complex protein 1,IkappaB kinase complex-associated protein {ECO:0000303|PubMed:9751059};p150;, PF04762;, GO:0005737;GO:0005829;GO:0033588;GO:0005634;GO:0000049;GO:0002926;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleus;, F:tRNA binding;, P:tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation; scaffold28 indexed_genome mRNA 13303956 13304710 . - . ID=transcript_6204;Q9UNP3,Krueppel-like factor 4,Epithelial zinc finger protein EZF;Gut-enriched krueppel-like factor;, PF00096;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005667;GO:0008013;GO:0000987;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0035014;GO:1990841;GO:0000978;GO:0001010;GO:0001085;GO:1990837;GO:0001221;GO:0000976;GO:0008270;GO:0060070;GO:0071409;GO:0071363;GO:0070301;GO:0071499;GO:1990830;GO:1901653;GO:0071300;GO:0002357;GO:0009913;GO:0048730;GO:0045444;GO:0007500;GO:0016525;GO:0090051;GO:0008285;GO:2000342;GO:0043154;GO:0070373;GO:2000134;GO:0010629;GO:0034115;GO:0050728;GO:0032717;GO:1904998;GO:0014740;GO:0032088;GO:0014067;GO:0051898;GO:0060761;GO:0048662;GO:0000122;GO:0045892;GO:0032270;GO:1904798;GO:0010628;GO:0046985;GO:0045429;GO:1902895;GO:0051247;GO:1903672;GO:0051973;GO:0045944;GO:0045893;GO:0031077;GO:0035166;GO:0048679;GO:0120222;GO:0045595;GO:0006357;GO:0035019;GO:0019827;GO:0006351;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:transcription regulator complex;, F:beta-catenin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:phosphatidylinositol 3-kinase regulator activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity; F:RNA polymerase II transcription factor binding; F:sequence-specific double-stranded DNA binding; F:transcription coregulator binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:canonical Wnt signaling pathway; P:cellular response to cycloheximide; P:cellular response to growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to laminar fluid shear stress; P:cellular response to leukemia inhibitory factor; P:cellular response to peptide; P:cellular response to retinoic acid; P:defense response to tumor cell; P:epidermal cell differentiation; P:epidermis morphogenesis; P:fat cell differentiation; P:mesodermal cell fate determination; P:negative regulation of angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of chemokine (C-X-C motif) ligand 2 production; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of inflammatory response; P:negative regulation of interleukin-8 production; P:negative regulation of leukocyte adhesion to arterial endothelial cell; P:negative regulation of muscle hyperplasia; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein kinase B signaling; P:negative regulation of response to cytokine stimulus; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cellular protein metabolic process; P:positive regulation of core promoter binding; P:positive regulation of gene expression; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein metabolic process; P:positive regulation of sprouting angiogenesis; P:positive regulation of telomerase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:post-embryonic camera-type eye development; P:post-embryonic hemopoiesis; P:regulation of axon regeneration; P:regulation of blastocyst development; P:regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; P:somatic stem cell population maintenance; P:stem cell population maintenance; P:transcription, DNA-templated; scaffold28 indexed_genome mRNA 13434306 13434833 . - . ID=transcript_6205;P54727 B3KWK8 G5E9P0 Q7Z5K8 Q8WUB0,UV excision repair protein RAD23 homolog B,XP-C repair-complementing complex 58 kDa protein;, PF00627;PF00240;PF09280;, GO:0005829;GO:0005654;GO:0005634;GO:0000502;GO:0071942;GO:0003684;GO:0031593;GO:0070628;GO:0000978;GO:0003697;GO:0043130;GO:0098761;GO:0048568;GO:0070911;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0043161;GO:0016579;GO:0006457;GO:0032434;GO:0007283;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome complex; C:XPC complex;, F:damaged DNA binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to interleukin-7; P:embryonic organ development; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein folding; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis; scaffold28 indexed_genome mRNA 13439417 13486239 . - . ID=transcript_6206;P54727 B3KWK8 G5E9P0 Q7Z5K8 Q8WUB0,UV excision repair protein RAD23 homolog B,XP-C repair-complementing complex 58 kDa protein;, PF00627;PF00240;PF09280;, GO:0005829;GO:0005654;GO:0005634;GO:0000502;GO:0071942;GO:0003684;GO:0031593;GO:0070628;GO:0000978;GO:0003697;GO:0043130;GO:0098761;GO:0048568;GO:0070911;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0043161;GO:0016579;GO:0006457;GO:0032434;GO:0007283;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome complex; C:XPC complex;, F:damaged DNA binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to interleukin-7; P:embryonic organ development; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein folding; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis;|P54727 B3KWK8 G5E9P0 Q7Z5K8 Q8WUB0,UV excision repair protein RAD23 homolog B,XP-C repair-complementing complex 58 kDa protein;, PF00627;PF00240;PF09280;, GO:0005829;GO:0005654;GO:0005634;GO:0000502;GO:0071942;GO:0003684;GO:0031593;GO:0070628;GO:0000978;GO:0003697;GO:0043130;GO:0098761;GO:0048568;GO:0070911;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0043161;GO:0016579;GO:0006457;GO:0032434;GO:0007283;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome complex; C:XPC complex;, F:damaged DNA binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to interleukin-7; P:embryonic organ development; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein folding; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis;|P54727 B3KWK8 G5E9P0 Q7Z5K8 Q8WUB0,UV excision repair protein RAD23 homolog B,XP-C repair-complementing complex 58 kDa protein;, PF00627;PF00240;PF09280;, GO:0005829;GO:0005654;GO:0005634;GO:0000502;GO:0071942;GO:0003684;GO:0031593;GO:0070628;GO:0000978;GO:0003697;GO:0043130;GO:0098761;GO:0048568;GO:0070911;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0043161;GO:0016579;GO:0006457;GO:0032434;GO:0007283;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome complex; C:XPC complex;, F:damaged DNA binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to interleukin-7; P:embryonic organ development; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein folding; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis;|P54727 B3KWK8 G5E9P0 Q7Z5K8 Q8WUB0,UV excision repair protein RAD23 homolog B,XP-C repair-complementing complex 58 kDa protein;, PF00627;PF00240;PF09280;, GO:0005829;GO:0005654;GO:0005634;GO:0000502;GO:0071942;GO:0003684;GO:0031593;GO:0070628;GO:0000978;GO:0003697;GO:0043130;GO:0098761;GO:0048568;GO:0070911;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0043161;GO:0016579;GO:0006457;GO:0032434;GO:0007283;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome complex; C:XPC complex;, F:damaged DNA binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to interleukin-7; P:embryonic organ development; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein folding; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:spermatogenesis; scaffold28 indexed_genome mRNA 13725692 13732094 . - . ID=transcript_6207;Q96JM2 Q5T0T4 Q8N408,Zinc finger protein 462 {ECO:0000305},Zinc finger PBX1-interacting protein {ECO:0000250|UniProtKB:B1AWL2};, , GO:0005634;GO:0003677;GO:0046872;GO:0006325;GO:0043392;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin organization; P:negative regulation of DNA binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression;|Q96JM2 Q5T0T4 Q8N408,Zinc finger protein 462 {ECO:0000305},Zinc finger PBX1-interacting protein {ECO:0000250|UniProtKB:B1AWL2};, , GO:0005634;GO:0003677;GO:0046872;GO:0006325;GO:0043392;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin organization; P:negative regulation of DNA binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold28 indexed_genome mRNA 13763703 13815091 . - . ID=transcript_6208;Q96JM2 Q5T0T4 Q8N408,Zinc finger protein 462 {ECO:0000305},Zinc finger PBX1-interacting protein {ECO:0000250|UniProtKB:B1AWL2};, , GO:0005634;GO:0003677;GO:0046872;GO:0006325;GO:0043392;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin organization; P:negative regulation of DNA binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression;|Q96JM2 Q5T0T4 Q8N408,Zinc finger protein 462 {ECO:0000305},Zinc finger PBX1-interacting protein {ECO:0000250|UniProtKB:B1AWL2};, , GO:0005634;GO:0003677;GO:0046872;GO:0006325;GO:0043392;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin organization; P:negative regulation of DNA binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression;|Q96JM2 Q5T0T4 Q8N408,Zinc finger protein 462 {ECO:0000305},Zinc finger PBX1-interacting protein {ECO:0000250|UniProtKB:B1AWL2};, , GO:0005634;GO:0003677;GO:0046872;GO:0006325;GO:0043392;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin organization; P:negative regulation of DNA binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold28 indexed_genome mRNA 13815117 13817164 . + . ID=transcript_6209;Q96JM2 Q5T0T4 Q8N408,Zinc finger protein 462 {ECO:0000305},Zinc finger PBX1-interacting protein {ECO:0000250|UniProtKB:B1AWL2};, , GO:0005634;GO:0003677;GO:0046872;GO:0006325;GO:0043392;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin organization; P:negative regulation of DNA binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold28 indexed_genome mRNA 13817172 13874271 . - . ID=transcript_6210;Q96JM2 Q5T0T4 Q8N408,Zinc finger protein 462 {ECO:0000305},Zinc finger PBX1-interacting protein {ECO:0000250|UniProtKB:B1AWL2};, , GO:0005634;GO:0003677;GO:0046872;GO:0006325;GO:0043392;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:chromatin organization; P:negative regulation of DNA binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold28 indexed_genome mRNA 14806867 14839123 . - . ID=transcript_6211;Q9NVV0 Q5JR63 Q5SVN5 Q5SVN6 Q5VTE2 Q6IA97,Trimeric intracellular cation channel type B,Transmembrane protein 38B;, PF05197;, GO:0016021;GO:0031965;GO:0005634;GO:0033017;GO:0005267;GO:0060348;GO:0030282;GO:0071313;GO:0007029;GO:0070278;GO:0048286;GO:0060487;GO:0008654;GO:0010881;GO:0014808;GO:0061033;, C:integral component of membrane; C:nuclear membrane; C:nucleus; C:sarcoplasmic reticulum membrane;, F:potassium channel activity;, P:bone development; P:bone mineralization; P:cellular response to caffeine; P:endoplasmic reticulum organization; P:extracellular matrix constituent secretion; P:lung alveolus development; P:lung epithelial cell differentiation; P:phospholipid biosynthetic process; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:secretion by lung epithelial cell involved in lung growth;|Q9NVV0 Q5JR63 Q5SVN5 Q5SVN6 Q5VTE2 Q6IA97,Trimeric intracellular cation channel type B,Transmembrane protein 38B;, PF05197;, GO:0016021;GO:0031965;GO:0005634;GO:0033017;GO:0005267;GO:0060348;GO:0030282;GO:0071313;GO:0007029;GO:0070278;GO:0048286;GO:0060487;GO:0008654;GO:0010881;GO:0014808;GO:0061033;, C:integral component of membrane; C:nuclear membrane; C:nucleus; C:sarcoplasmic reticulum membrane;, F:potassium channel activity;, P:bone development; P:bone mineralization; P:cellular response to caffeine; P:endoplasmic reticulum organization; P:extracellular matrix constituent secretion; P:lung alveolus development; P:lung epithelial cell differentiation; P:phospholipid biosynthetic process; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:secretion by lung epithelial cell involved in lung growth;|Q9NVV0 Q5JR63 Q5SVN5 Q5SVN6 Q5VTE2 Q6IA97,Trimeric intracellular cation channel type B,Transmembrane protein 38B;, PF05197;, GO:0016021;GO:0031965;GO:0005634;GO:0033017;GO:0005267;GO:0060348;GO:0030282;GO:0071313;GO:0007029;GO:0070278;GO:0048286;GO:0060487;GO:0008654;GO:0010881;GO:0014808;GO:0061033;, C:integral component of membrane; C:nuclear membrane; C:nucleus; C:sarcoplasmic reticulum membrane;, F:potassium channel activity;, P:bone development; P:bone mineralization; P:cellular response to caffeine; P:endoplasmic reticulum organization; P:extracellular matrix constituent secretion; P:lung alveolus development; P:lung epithelial cell differentiation; P:phospholipid biosynthetic process; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:secretion by lung epithelial cell involved in lung growth; scaffold28 indexed_genome mRNA 14911583 14915758 . - . ID=transcript_6212;Q16559 A0AVI7,T-cell acute lymphocytic leukemia protein 2,Class A basic helix-loop-helix protein 19;, PF00010;, GO:0000785;GO:0003677;GO:0000981;GO:0046983;GO:0000978;GO:0030901;GO:0035264;GO:0009791;GO:0006357;GO:0021794;, C:chromatin;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:midbrain development; P:multicellular organism growth; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:thalamus development; scaffold28 indexed_genome mRNA 14947853 14993183 . - . ID=transcript_6213;O75072 B4DUX9 J3KP13 Q3MIJ1 Q96TE1 Q9P295,Fukutin {ECO:0000303|PubMed:9690476},Fukuyama-type congenital muscular dystrophy protein {ECO:0000303|PubMed:9690476};Ribitol-5-phosphate transferase {ECO:0000303|PubMed:26923585};, PF04991;, GO:0005801;GO:0005783;GO:0005615;GO:0005794;GO:0030173;GO:0005634;GO:0016740;GO:0007517;GO:0008285;GO:0046329;GO:0007399;GO:0006493;GO:0035269;GO:0060049;, C:cis-Golgi network; C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nucleus;, F:transferase activity;, P:muscle organ development; P:negative regulation of cell population proliferation; P:negative regulation of JNK cascade; P:nervous system development; P:protein O-linked glycosylation; P:protein O-linked mannosylation; P:regulation of protein glycosylation;|O75072 B4DUX9 J3KP13 Q3MIJ1 Q96TE1 Q9P295,Fukutin {ECO:0000303|PubMed:9690476},Fukuyama-type congenital muscular dystrophy protein {ECO:0000303|PubMed:9690476};Ribitol-5-phosphate transferase {ECO:0000303|PubMed:26923585};, PF04991;, GO:0005801;GO:0005783;GO:0005615;GO:0005794;GO:0030173;GO:0005634;GO:0016740;GO:0007517;GO:0008285;GO:0046329;GO:0007399;GO:0006493;GO:0035269;GO:0060049;, C:cis-Golgi network; C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nucleus;, F:transferase activity;, P:muscle organ development; P:negative regulation of cell population proliferation; P:negative regulation of JNK cascade; P:nervous system development; P:protein O-linked glycosylation; P:protein O-linked mannosylation; P:regulation of protein glycosylation;|O75072 B4DUX9 J3KP13 Q3MIJ1 Q96TE1 Q9P295,Fukutin {ECO:0000303|PubMed:9690476},Fukuyama-type congenital muscular dystrophy protein {ECO:0000303|PubMed:9690476};Ribitol-5-phosphate transferase {ECO:0000303|PubMed:26923585};, PF04991;, GO:0005801;GO:0005783;GO:0005615;GO:0005794;GO:0030173;GO:0005634;GO:0016740;GO:0007517;GO:0008285;GO:0046329;GO:0007399;GO:0006493;GO:0035269;GO:0060049;, C:cis-Golgi network; C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nucleus;, F:transferase activity;, P:muscle organ development; P:negative regulation of cell population proliferation; P:negative regulation of JNK cascade; P:nervous system development; P:protein O-linked glycosylation; P:protein O-linked mannosylation; P:regulation of protein glycosylation; scaffold28 indexed_genome mRNA 15015611 15057623 . - . ID=transcript_6214;Q9BXM9 A2A338 A6NKH7 B7Z5S6 B7Z5W3 Q5T879 Q5T880,FSD1-like protein,Coiled-coil domain-containing protein 10;FSD1 N-terminal-like protein;, PF00622; scaffold28 indexed_genome mRNA 15087420 15240757 . - . ID=transcript_6215;Q8WWI5 A6NLZ9 Q5VUB3 Q8WVB0 Q96KU3 Q9NY69,Choline transporter-like protein 1,CDw92;Solute carrier family 44 member 1;, PF04515;, GO:0005829;GO:0070062;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005654;GO:0005886;GO:0015220;GO:0022857;GO:0042426;GO:0015871;GO:0006656;GO:0055085;GO:0150104;, C:cytosol; C:extracellular exosome; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:choline transmembrane transporter activity; F:transmembrane transporter activity;, P:choline catabolic process; P:choline transport; P:phosphatidylcholine biosynthetic process; P:transmembrane transport; P:transport across blood-brain barrier;|Q8WWI5 A6NLZ9 Q5VUB3 Q8WVB0 Q96KU3 Q9NY69,Choline transporter-like protein 1,CDw92;Solute carrier family 44 member 1;, PF04515;, GO:0005829;GO:0070062;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005654;GO:0005886;GO:0015220;GO:0022857;GO:0042426;GO:0015871;GO:0006656;GO:0055085;GO:0150104;, C:cytosol; C:extracellular exosome; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:choline transmembrane transporter activity; F:transmembrane transporter activity;, P:choline catabolic process; P:choline transport; P:phosphatidylcholine biosynthetic process; P:transmembrane transport; P:transport across blood-brain barrier; scaffold28 indexed_genome mRNA 15619054 15722945 . + . ID=transcript_6216;O95477 Q5VX33 Q96S56 Q96T85 Q9NQV4 Q9UN06 Q9UN07 Q9UN08 Q9UN09,Phospholipid-transporting ATPase ABCA1 {ECO:0000305},ATP-binding cassette sub-family A member 1;ATP-binding cassette transporter 1;Cholesterol efflux regulatory protein;, PF00005;, GO:0030139;GO:0005789;GO:0005768;GO:0005887;GO:0043231;GO:0097708;GO:0045121;GO:0048471;GO:0045335;GO:0005886;GO:0034186;GO:0034188;GO:0034185;GO:0005524;GO:0016887;GO:0051117;GO:0042626;GO:0015485;GO:0120020;GO:0140328;GO:0005319;GO:0031210;GO:0090554;GO:0090556;GO:0005548;GO:0008320;GO:0005102;GO:0031267;GO:0046623;GO:0019905;GO:0007189;GO:0071404;GO:0033344;GO:0042632;GO:0008203;GO:0016197;GO:0140115;GO:0007186;GO:0034380;GO:0032367;GO:0030522;GO:0006869;GO:0007040;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:0045332;GO:0060155;GO:0010875;GO:0090108;GO:0009306;GO:0071806;GO:0032489;GO:0090107;GO:0019222;GO:0034616;GO:0043691;GO:0023061;, C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane;, F:apolipoprotein A-I binding; F:apolipoprotein A-I receptor activity; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity; F:protein transmembrane transporter activity; F:signaling receptor binding; F:small GTPase binding; F:sphingolipid floppase activity; F:syntaxin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:endosomal transport; P:export across plasma membrane; P:G protein-coupled receptor signaling pathway; P:high-density lipoprotein particle assembly; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:lysosome organization; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:phospholipid translocation; P:platelet dense granule organization; P:positive regulation of cholesterol efflux; P:positive regulation of high-density lipoprotein particle assembly; P:protein secretion; P:protein transmembrane transport; P:regulation of Cdc42 protein signal transduction; P:regulation of high-density lipoprotein particle assembly; P:regulation of metabolic process; P:response to laminar fluid shear stress; P:reverse cholesterol transport; P:signal release;|O95477 Q5VX33 Q96S56 Q96T85 Q9NQV4 Q9UN06 Q9UN07 Q9UN08 Q9UN09,Phospholipid-transporting ATPase ABCA1 {ECO:0000305},ATP-binding cassette sub-family A member 1;ATP-binding cassette transporter 1;Cholesterol efflux regulatory protein;, PF00005;, GO:0030139;GO:0005789;GO:0005768;GO:0005887;GO:0043231;GO:0097708;GO:0045121;GO:0048471;GO:0045335;GO:0005886;GO:0034186;GO:0034188;GO:0034185;GO:0005524;GO:0016887;GO:0051117;GO:0042626;GO:0015485;GO:0120020;GO:0140328;GO:0005319;GO:0031210;GO:0090554;GO:0090556;GO:0005548;GO:0008320;GO:0005102;GO:0031267;GO:0046623;GO:0019905;GO:0007189;GO:0071404;GO:0033344;GO:0042632;GO:0008203;GO:0016197;GO:0140115;GO:0007186;GO:0034380;GO:0032367;GO:0030522;GO:0006869;GO:0007040;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:0045332;GO:0060155;GO:0010875;GO:0090108;GO:0009306;GO:0071806;GO:0032489;GO:0090107;GO:0019222;GO:0034616;GO:0043691;GO:0023061;, C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane;, F:apolipoprotein A-I binding; F:apolipoprotein A-I receptor activity; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity; F:protein transmembrane transporter activity; F:signaling receptor binding; F:small GTPase binding; F:sphingolipid floppase activity; F:syntaxin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:endosomal transport; P:export across plasma membrane; P:G protein-coupled receptor signaling pathway; P:high-density lipoprotein particle assembly; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:lysosome organization; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:phospholipid translocation; P:platelet dense granule organization; P:positive regulation of cholesterol efflux; P:positive regulation of high-density lipoprotein particle assembly; P:protein secretion; P:protein transmembrane transport; P:regulation of Cdc42 protein signal transduction; P:regulation of high-density lipoprotein particle assembly; P:regulation of metabolic process; P:response to laminar fluid shear stress; P:reverse cholesterol transport; P:signal release;|O95477 Q5VX33 Q96S56 Q96T85 Q9NQV4 Q9UN06 Q9UN07 Q9UN08 Q9UN09,Phospholipid-transporting ATPase ABCA1 {ECO:0000305},ATP-binding cassette sub-family A member 1;ATP-binding cassette transporter 1;Cholesterol efflux regulatory protein;, PF00005;, GO:0030139;GO:0005789;GO:0005768;GO:0005887;GO:0043231;GO:0097708;GO:0045121;GO:0048471;GO:0045335;GO:0005886;GO:0034186;GO:0034188;GO:0034185;GO:0005524;GO:0016887;GO:0051117;GO:0042626;GO:0015485;GO:0120020;GO:0140328;GO:0005319;GO:0031210;GO:0090554;GO:0090556;GO:0005548;GO:0008320;GO:0005102;GO:0031267;GO:0046623;GO:0019905;GO:0007189;GO:0071404;GO:0033344;GO:0042632;GO:0008203;GO:0016197;GO:0140115;GO:0007186;GO:0034380;GO:0032367;GO:0030522;GO:0006869;GO:0007040;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:0045332;GO:0060155;GO:0010875;GO:0090108;GO:0009306;GO:0071806;GO:0032489;GO:0090107;GO:0019222;GO:0034616;GO:0043691;GO:0023061;, C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane;, F:apolipoprotein A-I binding; F:apolipoprotein A-I receptor activity; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity; F:protein transmembrane transporter activity; F:signaling receptor binding; F:small GTPase binding; F:sphingolipid floppase activity; F:syntaxin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:endosomal transport; P:export across plasma membrane; P:G protein-coupled receptor signaling pathway; P:high-density lipoprotein particle assembly; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:lysosome organization; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:phospholipid translocation; P:platelet dense granule organization; P:positive regulation of cholesterol efflux; P:positive regulation of high-density lipoprotein particle assembly; P:protein secretion; P:protein transmembrane transport; P:regulation of Cdc42 protein signal transduction; P:regulation of high-density lipoprotein particle assembly; P:regulation of metabolic process; P:response to laminar fluid shear stress; P:reverse cholesterol transport; P:signal release;|O95477 Q5VX33 Q96S56 Q96T85 Q9NQV4 Q9UN06 Q9UN07 Q9UN08 Q9UN09,Phospholipid-transporting ATPase ABCA1 {ECO:0000305},ATP-binding cassette sub-family A member 1;ATP-binding cassette transporter 1;Cholesterol efflux regulatory protein;, PF00005;, GO:0030139;GO:0005789;GO:0005768;GO:0005887;GO:0043231;GO:0097708;GO:0045121;GO:0048471;GO:0045335;GO:0005886;GO:0034186;GO:0034188;GO:0034185;GO:0005524;GO:0016887;GO:0051117;GO:0042626;GO:0015485;GO:0120020;GO:0140328;GO:0005319;GO:0031210;GO:0090554;GO:0090556;GO:0005548;GO:0008320;GO:0005102;GO:0031267;GO:0046623;GO:0019905;GO:0007189;GO:0071404;GO:0033344;GO:0042632;GO:0008203;GO:0016197;GO:0140115;GO:0007186;GO:0034380;GO:0032367;GO:0030522;GO:0006869;GO:0007040;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:0045332;GO:0060155;GO:0010875;GO:0090108;GO:0009306;GO:0071806;GO:0032489;GO:0090107;GO:0019222;GO:0034616;GO:0043691;GO:0023061;, C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane;, F:apolipoprotein A-I binding; F:apolipoprotein A-I receptor activity; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity; F:protein transmembrane transporter activity; F:signaling receptor binding; F:small GTPase binding; F:sphingolipid floppase activity; F:syntaxin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:endosomal transport; P:export across plasma membrane; P:G protein-coupled receptor signaling pathway; P:high-density lipoprotein particle assembly; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:lysosome organization; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:phospholipid translocation; P:platelet dense granule organization; P:positive regulation of cholesterol efflux; P:positive regulation of high-density lipoprotein particle assembly; P:protein secretion; P:protein transmembrane transport; P:regulation of Cdc42 protein signal transduction; P:regulation of high-density lipoprotein particle assembly; P:regulation of metabolic process; P:response to laminar fluid shear stress; P:reverse cholesterol transport; P:signal release;|O95477 Q5VX33 Q96S56 Q96T85 Q9NQV4 Q9UN06 Q9UN07 Q9UN08 Q9UN09,Phospholipid-transporting ATPase ABCA1 {ECO:0000305},ATP-binding cassette sub-family A member 1;ATP-binding cassette transporter 1;Cholesterol efflux regulatory protein;, PF00005;, GO:0030139;GO:0005789;GO:0005768;GO:0005887;GO:0043231;GO:0097708;GO:0045121;GO:0048471;GO:0045335;GO:0005886;GO:0034186;GO:0034188;GO:0034185;GO:0005524;GO:0016887;GO:0051117;GO:0042626;GO:0015485;GO:0120020;GO:0140328;GO:0005319;GO:0031210;GO:0090554;GO:0090556;GO:0005548;GO:0008320;GO:0005102;GO:0031267;GO:0046623;GO:0019905;GO:0007189;GO:0071404;GO:0033344;GO:0042632;GO:0008203;GO:0016197;GO:0140115;GO:0007186;GO:0034380;GO:0032367;GO:0030522;GO:0006869;GO:0007040;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:0045332;GO:0060155;GO:0010875;GO:0090108;GO:0009306;GO:0071806;GO:0032489;GO:0090107;GO:0019222;GO:0034616;GO:0043691;GO:0023061;, C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane;, F:apolipoprotein A-I binding; F:apolipoprotein A-I receptor activity; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity; F:protein transmembrane transporter activity; F:signaling receptor binding; F:small GTPase binding; F:sphingolipid floppase activity; F:syntaxin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:endosomal transport; P:export across plasma membrane; P:G protein-coupled receptor signaling pathway; P:high-density lipoprotein particle assembly; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:lysosome organization; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:phospholipid translocation; P:platelet dense granule organization; P:positive regulation of cholesterol efflux; P:positive regulation of high-density lipoprotein particle assembly; P:protein secretion; P:protein transmembrane transport; P:regulation of Cdc42 protein signal transduction; P:regulation of high-density lipoprotein particle assembly; P:regulation of metabolic process; P:response to laminar fluid shear stress; P:reverse cholesterol transport; P:signal release;|O95477 Q5VX33 Q96S56 Q96T85 Q9NQV4 Q9UN06 Q9UN07 Q9UN08 Q9UN09,Phospholipid-transporting ATPase ABCA1 {ECO:0000305},ATP-binding cassette sub-family A member 1;ATP-binding cassette transporter 1;Cholesterol efflux regulatory protein;, PF00005;, GO:0030139;GO:0005789;GO:0005768;GO:0005887;GO:0043231;GO:0097708;GO:0045121;GO:0048471;GO:0045335;GO:0005886;GO:0034186;GO:0034188;GO:0034185;GO:0005524;GO:0016887;GO:0051117;GO:0042626;GO:0015485;GO:0120020;GO:0140328;GO:0005319;GO:0031210;GO:0090554;GO:0090556;GO:0005548;GO:0008320;GO:0005102;GO:0031267;GO:0046623;GO:0019905;GO:0007189;GO:0071404;GO:0033344;GO:0042632;GO:0008203;GO:0016197;GO:0140115;GO:0007186;GO:0034380;GO:0032367;GO:0030522;GO:0006869;GO:0007040;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:0045332;GO:0060155;GO:0010875;GO:0090108;GO:0009306;GO:0071806;GO:0032489;GO:0090107;GO:0019222;GO:0034616;GO:0043691;GO:0023061;, C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane;, F:apolipoprotein A-I binding; F:apolipoprotein A-I receptor activity; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity; F:protein transmembrane transporter activity; F:signaling receptor binding; F:small GTPase binding; F:sphingolipid floppase activity; F:syntaxin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:endosomal transport; P:export across plasma membrane; P:G protein-coupled receptor signaling pathway; P:high-density lipoprotein particle assembly; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:lysosome organization; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:phospholipid translocation; P:platelet dense granule organization; P:positive regulation of cholesterol efflux; P:positive regulation of high-density lipoprotein particle assembly; P:protein secretion; P:protein transmembrane transport; P:regulation of Cdc42 protein signal transduction; P:regulation of high-density lipoprotein particle assembly; P:regulation of metabolic process; P:response to laminar fluid shear stress; P:reverse cholesterol transport; P:signal release;|O95477 Q5VX33 Q96S56 Q96T85 Q9NQV4 Q9UN06 Q9UN07 Q9UN08 Q9UN09,Phospholipid-transporting ATPase ABCA1 {ECO:0000305},ATP-binding cassette sub-family A member 1;ATP-binding cassette transporter 1;Cholesterol efflux regulatory protein;, PF00005;, GO:0030139;GO:0005789;GO:0005768;GO:0005887;GO:0043231;GO:0097708;GO:0045121;GO:0048471;GO:0045335;GO:0005886;GO:0034186;GO:0034188;GO:0034185;GO:0005524;GO:0016887;GO:0051117;GO:0042626;GO:0015485;GO:0120020;GO:0140328;GO:0005319;GO:0031210;GO:0090554;GO:0090556;GO:0005548;GO:0008320;GO:0005102;GO:0031267;GO:0046623;GO:0019905;GO:0007189;GO:0071404;GO:0033344;GO:0042632;GO:0008203;GO:0016197;GO:0140115;GO:0007186;GO:0034380;GO:0032367;GO:0030522;GO:0006869;GO:0007040;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:0045332;GO:0060155;GO:0010875;GO:0090108;GO:0009306;GO:0071806;GO:0032489;GO:0090107;GO:0019222;GO:0034616;GO:0043691;GO:0023061;, C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane;, F:apolipoprotein A-I binding; F:apolipoprotein A-I receptor activity; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity; F:protein transmembrane transporter activity; F:signaling receptor binding; F:small GTPase binding; F:sphingolipid floppase activity; F:syntaxin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:endosomal transport; P:export across plasma membrane; P:G protein-coupled receptor signaling pathway; P:high-density lipoprotein particle assembly; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:lysosome organization; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:phospholipid translocation; P:platelet dense granule organization; P:positive regulation of cholesterol efflux; P:positive regulation of high-density lipoprotein particle assembly; P:protein secretion; P:protein transmembrane transport; P:regulation of Cdc42 protein signal transduction; P:regulation of high-density lipoprotein particle assembly; P:regulation of metabolic process; P:response to laminar fluid shear stress; P:reverse cholesterol transport; P:signal release;|O95477 Q5VX33 Q96S56 Q96T85 Q9NQV4 Q9UN06 Q9UN07 Q9UN08 Q9UN09,Phospholipid-transporting ATPase ABCA1 {ECO:0000305},ATP-binding cassette sub-family A member 1;ATP-binding cassette transporter 1;Cholesterol efflux regulatory protein;, PF00005;, GO:0030139;GO:0005789;GO:0005768;GO:0005887;GO:0043231;GO:0097708;GO:0045121;GO:0048471;GO:0045335;GO:0005886;GO:0034186;GO:0034188;GO:0034185;GO:0005524;GO:0016887;GO:0051117;GO:0042626;GO:0015485;GO:0120020;GO:0140328;GO:0005319;GO:0031210;GO:0090554;GO:0090556;GO:0005548;GO:0008320;GO:0005102;GO:0031267;GO:0046623;GO:0019905;GO:0007189;GO:0071404;GO:0033344;GO:0042632;GO:0008203;GO:0016197;GO:0140115;GO:0007186;GO:0034380;GO:0032367;GO:0030522;GO:0006869;GO:0007040;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:0045332;GO:0060155;GO:0010875;GO:0090108;GO:0009306;GO:0071806;GO:0032489;GO:0090107;GO:0019222;GO:0034616;GO:0043691;GO:0023061;, C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane;, F:apolipoprotein A-I binding; F:apolipoprotein A-I receptor activity; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity; F:protein transmembrane transporter activity; F:signaling receptor binding; F:small GTPase binding; F:sphingolipid floppase activity; F:syntaxin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:endosomal transport; P:export across plasma membrane; P:G protein-coupled receptor signaling pathway; P:high-density lipoprotein particle assembly; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:lysosome organization; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:phospholipid translocation; P:platelet dense granule organization; P:positive regulation of cholesterol efflux; P:positive regulation of high-density lipoprotein particle assembly; P:protein secretion; P:protein transmembrane transport; P:regulation of Cdc42 protein signal transduction; P:regulation of high-density lipoprotein particle assembly; P:regulation of metabolic process; P:response to laminar fluid shear stress; P:reverse cholesterol transport; P:signal release;|O95477 Q5VX33 Q96S56 Q96T85 Q9NQV4 Q9UN06 Q9UN07 Q9UN08 Q9UN09,Phospholipid-transporting ATPase ABCA1 {ECO:0000305},ATP-binding cassette sub-family A member 1;ATP-binding cassette transporter 1;Cholesterol efflux regulatory protein;, PF00005;, GO:0030139;GO:0005789;GO:0005768;GO:0005887;GO:0043231;GO:0097708;GO:0045121;GO:0048471;GO:0045335;GO:0005886;GO:0034186;GO:0034188;GO:0034185;GO:0005524;GO:0016887;GO:0051117;GO:0042626;GO:0015485;GO:0120020;GO:0140328;GO:0005319;GO:0031210;GO:0090554;GO:0090556;GO:0005548;GO:0008320;GO:0005102;GO:0031267;GO:0046623;GO:0019905;GO:0007189;GO:0071404;GO:0033344;GO:0042632;GO:0008203;GO:0016197;GO:0140115;GO:0007186;GO:0034380;GO:0032367;GO:0030522;GO:0006869;GO:0007040;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:0045332;GO:0060155;GO:0010875;GO:0090108;GO:0009306;GO:0071806;GO:0032489;GO:0090107;GO:0019222;GO:0034616;GO:0043691;GO:0023061;, C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane;, F:apolipoprotein A-I binding; F:apolipoprotein A-I receptor activity; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity; F:protein transmembrane transporter activity; F:signaling receptor binding; F:small GTPase binding; F:sphingolipid floppase activity; F:syntaxin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:endosomal transport; P:export across plasma membrane; P:G protein-coupled receptor signaling pathway; P:high-density lipoprotein particle assembly; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:lysosome organization; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:phospholipid translocation; P:platelet dense granule organization; P:positive regulation of cholesterol efflux; P:positive regulation of high-density lipoprotein particle assembly; P:protein secretion; P:protein transmembrane transport; P:regulation of Cdc42 protein signal transduction; P:regulation of high-density lipoprotein particle assembly; P:regulation of metabolic process; P:response to laminar fluid shear stress; P:reverse cholesterol transport; P:signal release;|O95477 Q5VX33 Q96S56 Q96T85 Q9NQV4 Q9UN06 Q9UN07 Q9UN08 Q9UN09,Phospholipid-transporting ATPase ABCA1 {ECO:0000305},ATP-binding cassette sub-family A member 1;ATP-binding cassette transporter 1;Cholesterol efflux regulatory protein;, PF00005;, GO:0030139;GO:0005789;GO:0005768;GO:0005887;GO:0043231;GO:0097708;GO:0045121;GO:0048471;GO:0045335;GO:0005886;GO:0034186;GO:0034188;GO:0034185;GO:0005524;GO:0016887;GO:0051117;GO:0042626;GO:0015485;GO:0120020;GO:0140328;GO:0005319;GO:0031210;GO:0090554;GO:0090556;GO:0005548;GO:0008320;GO:0005102;GO:0031267;GO:0046623;GO:0019905;GO:0007189;GO:0071404;GO:0033344;GO:0042632;GO:0008203;GO:0016197;GO:0140115;GO:0007186;GO:0034380;GO:0032367;GO:0030522;GO:0006869;GO:0007040;GO:0010887;GO:0010745;GO:0033700;GO:0055091;GO:0045332;GO:0060155;GO:0010875;GO:0090108;GO:0009306;GO:0071806;GO:0032489;GO:0090107;GO:0019222;GO:0034616;GO:0043691;GO:0023061;, C:endocytic vesicle; C:endoplasmic reticulum membrane; C:endosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane;, F:apolipoprotein A-I binding; F:apolipoprotein A-I receptor activity; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:ATPase-coupled transmembrane transporter activity; F:cholesterol binding; F:cholesterol transfer activity; F:floppase activity; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine floppase activity; F:phosphatidylserine floppase activity; F:phospholipid transporter activity; F:protein transmembrane transporter activity; F:signaling receptor binding; F:small GTPase binding; F:sphingolipid floppase activity; F:syntaxin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:endosomal transport; P:export across plasma membrane; P:G protein-coupled receptor signaling pathway; P:high-density lipoprotein particle assembly; P:intracellular cholesterol transport; P:intracellular receptor signaling pathway; P:lipid transport; P:lysosome organization; P:negative regulation of cholesterol storage; P:negative regulation of macrophage derived foam cell differentiation; P:phospholipid efflux; P:phospholipid homeostasis; P:phospholipid translocation; P:platelet dense granule organization; P:positive regulation of cholesterol efflux; P:positive regulation of high-density lipoprotein particle assembly; P:protein secretion; P:protein transmembrane transport; P:regulation of Cdc42 protein signal transduction; P:regulation of high-density lipoprotein particle assembly; P:regulation of metabolic process; P:response to laminar fluid shear stress; P:reverse cholesterol transport; P:signal release; scaffold28 indexed_genome mRNA 15726645 15727738 . - . ID=transcript_6217;Q9UFN0 A6NM55 Q5VX32 Q9BRV7 Q9H843 Q9P083,Protein NipSnap homolog 3A,Protein NipSnap homolog 4;Target for Salmonella secreted protein C;, PF07978;, GO:0005829;GO:0005739;GO:0005634;, C:cytosol; C:mitochondrion; C:nucleus; scaffold28 indexed_genome mRNA 15741181 15752150 . - . ID=transcript_6218;Q9UFN0 A6NM55 Q5VX32 Q9BRV7 Q9H843 Q9P083,Protein NipSnap homolog 3A,Protein NipSnap homolog 4;Target for Salmonella secreted protein C;, PF07978;, GO:0005829;GO:0005739;GO:0005634;, C:cytosol; C:mitochondrion; C:nucleus;|Q9UFN0 A6NM55 Q5VX32 Q9BRV7 Q9H843 Q9P083,Protein NipSnap homolog 3A,Protein NipSnap homolog 4;Target for Salmonella secreted protein C;, PF07978;, GO:0005829;GO:0005739;GO:0005634;, C:cytosol; C:mitochondrion; C:nucleus;|Q9UFN0 A6NM55 Q5VX32 Q9BRV7 Q9H843 Q9P083,Protein NipSnap homolog 3A,Protein NipSnap homolog 4;Target for Salmonella secreted protein C;, PF07978;, GO:0005829;GO:0005739;GO:0005634;, C:cytosol; C:mitochondrion; C:nucleus;|Q9UFN0 A6NM55 Q5VX32 Q9BRV7 Q9H843 Q9P083,Protein NipSnap homolog 3A,Protein NipSnap homolog 4;Target for Salmonella secreted protein C;, PF07978;, GO:0005829;GO:0005739;GO:0005634;, C:cytosol; C:mitochondrion; C:nucleus;|Q9UFN0 A6NM55 Q5VX32 Q9BRV7 Q9H843 Q9P083,Protein NipSnap homolog 3A,Protein NipSnap homolog 4;Target for Salmonella secreted protein C;, PF07978;, GO:0005829;GO:0005739;GO:0005634;, C:cytosol; C:mitochondrion; C:nucleus;|Q9BS92 Q5VX30 Q9NUM2,Protein NipSnap homolog 3B,SNAP1;, PF07978;, GO:0005739;, C:mitochondrion; scaffold28 indexed_genome mRNA 16337594 16385021 . - . ID=transcript_6219;O95347 Q6IEE0 Q9P1P2,Structural maintenance of chromosomes protein 2,Chromosome-associated protein E;XCAP-E homolog;, PF06470;PF02463;, GO:0000793;GO:0000796;GO:0005737;GO:0005829;GO:0070062;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0003697;GO:0051301;GO:0051383;GO:0010032;GO:0045132;GO:0007076;, C:condensed chromosome; C:condensin complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:single-stranded DNA binding;, P:cell division; P:kinetochore organization; P:meiotic chromosome condensation; P:meiotic chromosome segregation; P:mitotic chromosome condensation;|O95347 Q6IEE0 Q9P1P2,Structural maintenance of chromosomes protein 2,Chromosome-associated protein E;XCAP-E homolog;, PF06470;PF02463;, GO:0000793;GO:0000796;GO:0005737;GO:0005829;GO:0070062;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0003697;GO:0051301;GO:0051383;GO:0010032;GO:0045132;GO:0007076;, C:condensed chromosome; C:condensin complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:single-stranded DNA binding;, P:cell division; P:kinetochore organization; P:meiotic chromosome condensation; P:meiotic chromosome segregation; P:mitotic chromosome condensation;|O95347 Q6IEE0 Q9P1P2,Structural maintenance of chromosomes protein 2,Chromosome-associated protein E;XCAP-E homolog;, PF06470;PF02463;, GO:0000793;GO:0000796;GO:0005737;GO:0005829;GO:0070062;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0003697;GO:0051301;GO:0051383;GO:0010032;GO:0045132;GO:0007076;, C:condensed chromosome; C:condensin complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:single-stranded DNA binding;, P:cell division; P:kinetochore organization; P:meiotic chromosome condensation; P:meiotic chromosome segregation; P:mitotic chromosome condensation; scaffold28 indexed_genome mRNA 18445639 18504173 . + . ID=transcript_6220;Q8TCU5 B3DLF9 Q5VTR3 Q8TF29 Q8WXI6,Glutamate receptor ionotropic, NMDA 3A,N-methyl-D-aspartate receptor subtype 3A;NMDAR-L;, PF00060;PF10613;, GO:0005789;GO:0098978;GO:0016021;GO:0016020;GO:0043005;GO:0043025;GO:0017146;GO:0005886;GO:0014069;GO:0045211;GO:0045202;GO:0005262;GO:0016594;GO:0042802;GO:0015276;GO:0004972;GO:0051721;GO:0038023;GO:1904315;GO:0006816;GO:0016358;GO:0035235;GO:0061000;GO:0060134;GO:2000300;GO:0045471;, C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of membrane; C:membrane; C:neuron projection; C:neuronal cell body; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:synapse;, F:calcium channel activity; F:glycine binding; F:identical protein binding; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:protein phosphatase 2A binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:calcium ion transport; P:dendrite development; P:ionotropic glutamate receptor signaling pathway; P:negative regulation of dendritic spine development; P:prepulse inhibition; P:regulation of synaptic vesicle exocytosis; P:response to ethanol; scaffold28 indexed_genome mRNA 18522551 18534438 . - . ID=transcript_6221;Q9NUR4 Q9NWQ3 Q9NX83,E3 ubiquitin-protein ligase BRE1A,RING finger protein 20;RING-type E3 ubiquitin transferase BRE1A {ECO:0000305};, , GO:0033503;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0003682;GO:0042393;GO:0042802;GO:0046872;GO:0003730;GO:0002039;GO:0003713;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:0030336;GO:1900364;GO:2001168;GO:0031062;GO:0045893;GO:0000209;GO:0016567;GO:0006355;GO:0006511;, C:HULC complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:chromatin binding; F:histone binding; F:identical protein binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:p53 binding; F:transcription coactivator activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of cell migration; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone methylation; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process;|Q9NUR4 Q9NWQ3 Q9NX83,E3 ubiquitin-protein ligase BRE1A,RING finger protein 20;RING-type E3 ubiquitin transferase BRE1A {ECO:0000305};, , GO:0033503;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0003682;GO:0042393;GO:0042802;GO:0046872;GO:0003730;GO:0002039;GO:0003713;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:0030336;GO:1900364;GO:2001168;GO:0031062;GO:0045893;GO:0000209;GO:0016567;GO:0006355;GO:0006511;, C:HULC complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:chromatin binding; F:histone binding; F:identical protein binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:p53 binding; F:transcription coactivator activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of cell migration; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone methylation; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process;|Q9NUR4 Q9NWQ3 Q9NX83,E3 ubiquitin-protein ligase BRE1A,RING finger protein 20;RING-type E3 ubiquitin transferase BRE1A {ECO:0000305};, , GO:0033503;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0003682;GO:0042393;GO:0042802;GO:0046872;GO:0003730;GO:0002039;GO:0003713;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:0030336;GO:1900364;GO:2001168;GO:0031062;GO:0045893;GO:0000209;GO:0016567;GO:0006355;GO:0006511;, C:HULC complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:chromatin binding; F:histone binding; F:identical protein binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:p53 binding; F:transcription coactivator activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of cell migration; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone methylation; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process; scaffold28 indexed_genome mRNA 18534618 18546905 . + . ID=transcript_6222;Q9NUR4 Q9NWQ3 Q9NX83,E3 ubiquitin-protein ligase BRE1A,RING finger protein 20;RING-type E3 ubiquitin transferase BRE1A {ECO:0000305};, , GO:0033503;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0003682;GO:0042393;GO:0042802;GO:0046872;GO:0003730;GO:0002039;GO:0003713;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:0030336;GO:1900364;GO:2001168;GO:0031062;GO:0045893;GO:0000209;GO:0016567;GO:0006355;GO:0006511;, C:HULC complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:chromatin binding; F:histone binding; F:identical protein binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:p53 binding; F:transcription coactivator activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of cell migration; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone methylation; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process;|Q9NUR4 Q9NWQ3 Q9NX83,E3 ubiquitin-protein ligase BRE1A,RING finger protein 20;RING-type E3 ubiquitin transferase BRE1A {ECO:0000305};, , GO:0033503;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0003682;GO:0042393;GO:0042802;GO:0046872;GO:0003730;GO:0002039;GO:0003713;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:0030336;GO:1900364;GO:2001168;GO:0031062;GO:0045893;GO:0000209;GO:0016567;GO:0006355;GO:0006511;, C:HULC complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:chromatin binding; F:histone binding; F:identical protein binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:p53 binding; F:transcription coactivator activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of cell migration; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone methylation; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process;|Q9NUR4 Q9NWQ3 Q9NX83,E3 ubiquitin-protein ligase BRE1A,RING finger protein 20;RING-type E3 ubiquitin transferase BRE1A {ECO:0000305};, , GO:0033503;GO:0005730;GO:0005654;GO:0005634;GO:0000151;GO:0003682;GO:0042393;GO:0042802;GO:0046872;GO:0003730;GO:0002039;GO:0003713;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:0030336;GO:1900364;GO:2001168;GO:0031062;GO:0045893;GO:0000209;GO:0016567;GO:0006355;GO:0006511;, C:HULC complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:chromatin binding; F:histone binding; F:identical protein binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:p53 binding; F:transcription coactivator activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of cell migration; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone methylation; P:positive regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process; scaffold28 indexed_genome mRNA 18589404 18620989 . + . ID=transcript_6223;Q9BRR3 Q49AQ4,Post-GPI attachment to proteins factor 4 {ECO:0000305},Post-GPI attachment to proteins GalNAc transferase 4 {ECO:0000312|HGNC:HGNC:28180};Transmembrane protein 246;, , GO:0000139;GO:0016021;GO:0016757;GO:0006506;, C:Golgi membrane; C:integral component of membrane;, F:transferase activity, transferring glycosyl groups;, P:GPI anchor biosynthetic process; scaffold28 indexed_genome mRNA 18662414 18679483 . + . ID=transcript_6224;P05062 Q13741 Q13742 Q5T7D6,Fructose-bisphosphate aldolase B,Liver-type aldolase;, PF00274;, GO:0034451;GO:0005829;GO:0070062;GO:0005815;GO:0051117;GO:0008092;GO:0070061;GO:0061609;GO:0004332;GO:0042802;GO:0061621;GO:0030388;GO:0061624;GO:0006000;GO:0006094;GO:0006096;GO:0006116;GO:0032781;GO:0070072;, C:centriolar satellite; C:cytosol; C:extracellular exosome; C:microtubule organizing center;, F:ATPase binding; F:cytoskeletal protein binding; F:fructose binding; F:fructose-1-phosphate aldolase activity; F:fructose-bisphosphate aldolase activity; F:identical protein binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:NADH oxidation; P:positive regulation of ATPase activity; P:vacuolar proton-transporting V-type ATPase complex assembly;|P05062 Q13741 Q13742 Q5T7D6,Fructose-bisphosphate aldolase B,Liver-type aldolase;, PF00274;, GO:0034451;GO:0005829;GO:0070062;GO:0005815;GO:0051117;GO:0008092;GO:0070061;GO:0061609;GO:0004332;GO:0042802;GO:0061621;GO:0030388;GO:0061624;GO:0006000;GO:0006094;GO:0006096;GO:0006116;GO:0032781;GO:0070072;, C:centriolar satellite; C:cytosol; C:extracellular exosome; C:microtubule organizing center;, F:ATPase binding; F:cytoskeletal protein binding; F:fructose binding; F:fructose-1-phosphate aldolase activity; F:fructose-bisphosphate aldolase activity; F:identical protein binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:NADH oxidation; P:positive regulation of ATPase activity; P:vacuolar proton-transporting V-type ATPase complex assembly;|P05062 Q13741 Q13742 Q5T7D6,Fructose-bisphosphate aldolase B,Liver-type aldolase;, PF00274;, GO:0034451;GO:0005829;GO:0070062;GO:0005815;GO:0051117;GO:0008092;GO:0070061;GO:0061609;GO:0004332;GO:0042802;GO:0061621;GO:0030388;GO:0061624;GO:0006000;GO:0006094;GO:0006096;GO:0006116;GO:0032781;GO:0070072;, C:centriolar satellite; C:cytosol; C:extracellular exosome; C:microtubule organizing center;, F:ATPase binding; F:cytoskeletal protein binding; F:fructose binding; F:fructose-1-phosphate aldolase activity; F:fructose-bisphosphate aldolase activity; F:identical protein binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:NADH oxidation; P:positive regulation of ATPase activity; P:vacuolar proton-transporting V-type ATPase complex assembly;|P05062 Q13741 Q13742 Q5T7D6,Fructose-bisphosphate aldolase B,Liver-type aldolase;, PF00274;, GO:0034451;GO:0005829;GO:0070062;GO:0005815;GO:0051117;GO:0008092;GO:0070061;GO:0061609;GO:0004332;GO:0042802;GO:0061621;GO:0030388;GO:0061624;GO:0006000;GO:0006094;GO:0006096;GO:0006116;GO:0032781;GO:0070072;, C:centriolar satellite; C:cytosol; C:extracellular exosome; C:microtubule organizing center;, F:ATPase binding; F:cytoskeletal protein binding; F:fructose binding; F:fructose-1-phosphate aldolase activity; F:fructose-bisphosphate aldolase activity; F:identical protein binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:NADH oxidation; P:positive regulation of ATPase activity; P:vacuolar proton-transporting V-type ATPase complex assembly;|P05062 Q13741 Q13742 Q5T7D6,Fructose-bisphosphate aldolase B,Liver-type aldolase;, PF00274;, GO:0034451;GO:0005829;GO:0070062;GO:0005815;GO:0051117;GO:0008092;GO:0070061;GO:0061609;GO:0004332;GO:0042802;GO:0061621;GO:0030388;GO:0061624;GO:0006000;GO:0006094;GO:0006096;GO:0006116;GO:0032781;GO:0070072;, C:centriolar satellite; C:cytosol; C:extracellular exosome; C:microtubule organizing center;, F:ATPase binding; F:cytoskeletal protein binding; F:fructose binding; F:fructose-1-phosphate aldolase activity; F:fructose-bisphosphate aldolase activity; F:identical protein binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:NADH oxidation; P:positive regulation of ATPase activity; P:vacuolar proton-transporting V-type ATPase complex assembly; scaffold28 indexed_genome mRNA 18685303 18696029 . - . ID=transcript_6225;O75820 O75802 Q5T7D7 Q5T7D8 Q5T7D9 Q9UBL4 Q9UPE9 Q9UPF0 Q9UPF1,Zinc finger protein 189,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 18696399 18705418 . + . ID=transcript_6226;Q8N5N7 B7Z358 Q5T7E0 Q9NX15,39S ribosomal protein L50, mitochondrial,Mitochondrial large ribosomal subunit protein mL50 {ECO:0000303|PubMed:25278503};, PF10501;, GO:0005743;GO:0005762;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold28 indexed_genome mRNA 18750386 18762086 . + . ID=transcript_6227;Q14032 Q3B7W9 Q96L31,Bile acid-CoA:amino acid N-acyltransferase {ECO:0000303|PubMed:8034703},Bile acid-CoA thioesterase {ECO:0000303|PubMed:12239217, ECO:0000303|PubMed:12810727};Choloyl-CoA hydrolase;Glycine N-choloyltransferase;Long-chain fatty-acyl-CoA hydrolase {ECO:0000303|PubMed:12810727};, PF08840;PF04775;, GO:0005829;GO:0005782;GO:0005777;GO:0047617;GO:0052689;GO:0033882;GO:0047963;GO:0052816;GO:0052815;GO:0102991;GO:0016410;GO:0016290;GO:0052817;GO:0006637;GO:0031100;GO:0006699;GO:0002152;GO:0008206;GO:0006631;GO:0006544;GO:0001889;GO:0008104;GO:0019530;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:choloyl-CoA hydrolase activity; F:glycine N-choloyltransferase activity; F:long-chain acyl-CoA hydrolase activity; F:medium-chain acyl-CoA hydrolase activity; F:myristoyl-CoA hydrolase activity; F:N-acyltransferase activity; F:palmitoyl-CoA hydrolase activity; F:very long chain acyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:animal organ regeneration; P:bile acid biosynthetic process; P:bile acid conjugation; P:bile acid metabolic process; P:fatty acid metabolic process; P:glycine metabolic process; P:liver development; P:protein localization; P:taurine metabolic process; scaffold28 indexed_genome mRNA 18787888 19065187 . - . ID=transcript_6228;Q8TBJ4 Q5VX23 Q9NXE2,Phospholipid phosphatase-related protein type 1 {ECO:0000305},Lipid phosphate phosphatase-related protein type 1 {ECO:0000303|Ref.2};Plasticity-related gene 3 protein {ECO:0000305|PubMed:14750979};, PF01569;, GO:0005887;GO:0005654;GO:0042577;GO:0008195;GO:0007399;GO:0046839;GO:0006644;GO:0007165;, C:integral component of plasma membrane; C:nucleoplasm;, F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:nervous system development; P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:signal transduction; scaffold28 indexed_genome mRNA 19215300 19261162 . - . ID=transcript_6229;Q6X9E4 E9PG36 Q494Y9 Q494Z0,F-box/WD repeat-containing protein 12,F-box and WD-40 domain-containing protein 12;F-box only protein 35;, PF12937;, GO:0005829;GO:0043687;GO:0000209;, C:cytosol;, , P:post-translational protein modification; P:protein polyubiquitination;|Q6X9E4 E9PG36 Q494Y9 Q494Z0,F-box/WD repeat-containing protein 12,F-box and WD-40 domain-containing protein 12;F-box only protein 35;, PF12937;, GO:0005829;GO:0043687;GO:0000209;, C:cytosol;, , P:post-translational protein modification; P:protein polyubiquitination;|Q8IZL9 A2A389 A2A390 B4DQX1 O95137 Q5EDC4 Q5VYW1 Q9BUF4,Cyclin-dependent kinase 20,CDK-activating kinase p42;Cell cycle-related kinase;Cell division protein kinase 20;Cyclin-dependent protein kinase H;Cyclin-kinase-activating kinase p42;, PF00069;, GO:0005929;GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0007049;GO:0051301;GO:0007275;GO:0006468;, C:cilium; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cell division; P:multicellular organism development; P:protein phosphorylation; scaffold28 indexed_genome mRNA 19594349 19596708 . - . ID=transcript_6230;Q9Y657 A8K0X6 B3KRQ4 Q7KZJ8 Q9GZT2 Q9H0N7,Spindlin-1,Ovarian cancer-related protein;Spindlin1;, PF02513;, GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0035064;GO:0006325;GO:0007276;GO:0051321;GO:0007275;GO:0045893;GO:0030177;GO:0006355;GO:0009303;GO:0016055;, C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:methylated histone binding;, P:chromatin organization; P:gamete generation; P:meiotic cell cycle; P:multicellular organism development; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription, DNA-templated; P:rRNA transcription; P:Wnt signaling pathway; scaffold28 indexed_genome mRNA 19622973 19654317 . + . ID=transcript_6231;Q9Y657 A8K0X6 B3KRQ4 Q7KZJ8 Q9GZT2 Q9H0N7,Spindlin-1,Ovarian cancer-related protein;Spindlin1;, PF02513;, GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0035064;GO:0006325;GO:0007276;GO:0051321;GO:0007275;GO:0045893;GO:0030177;GO:0006355;GO:0009303;GO:0016055;, C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:methylated histone binding;, P:chromatin organization; P:gamete generation; P:meiotic cell cycle; P:multicellular organism development; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription, DNA-templated; P:rRNA transcription; P:Wnt signaling pathway; scaffold28 indexed_genome mRNA 19656839 19668032 . + . ID=transcript_6232;Q9Y657 A8K0X6 B3KRQ4 Q7KZJ8 Q9GZT2 Q9H0N7,Spindlin-1,Ovarian cancer-related protein;Spindlin1;, PF02513;, GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0035064;GO:0006325;GO:0007276;GO:0051321;GO:0007275;GO:0045893;GO:0030177;GO:0006355;GO:0009303;GO:0016055;, C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:methylated histone binding;, P:chromatin organization; P:gamete generation; P:meiotic cell cycle; P:multicellular organism development; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription, DNA-templated; P:rRNA transcription; P:Wnt signaling pathway; scaffold28 indexed_genome mRNA 19716993 19717636 . - . ID=transcript_6233;Q5VZ03 B1AMD0 Q8TBG6,Nucleoredoxin-like protein 2,Rod-derived cone viability factor 2;, PF13905;, GO:0045494;GO:0007600;, , , P:photoreceptor cell maintenance; P:sensory perception; scaffold28 indexed_genome mRNA 20140042 20152934 . + . ID=transcript_6234;Q99500 Q5SQD8 Q7Z5I2,Sphingosine 1-phosphate receptor 3,Endothelial differentiation G-protein coupled receptor 3;Sphingosine 1-phosphate receptor Edg-3;, PF00001;, GO:0005737;GO:0005887;GO:0005886;GO:0004930;GO:0005178;GO:0008289;GO:0038036;GO:0007189;GO:0007193;GO:0009653;GO:0007186;GO:0006954;GO:1903141;GO:0007219;GO:0008284;GO:0007204;GO:0032651;GO:0019222;, C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:integrin binding; F:lipid binding; F:sphingosine-1-phosphate receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:anatomical structure morphogenesis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of establishment of endothelial barrier; P:Notch signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:regulation of interleukin-1 beta production; P:regulation of metabolic process; scaffold28 indexed_genome mRNA 20161617 20199361 . - . ID=transcript_6235;Q92529 Q5T7I7 Q8TAP2 Q9UCX5,SHC-transforming protein 3,Neuronal Shc;Protein Rai;SHC-transforming protein C;Src homology 2 domain-containing-transforming protein C3;, PF00640;PF00017;, GO:0005829;GO:0005886;GO:0001784;GO:0019901;GO:0030971;GO:0007411;GO:0007417;GO:0007173;GO:0000165;GO:0007265;GO:0007169;, C:cytosol; C:plasma membrane;, F:phosphotyrosine residue binding; F:protein kinase binding; F:receptor tyrosine kinase binding;, P:axon guidance; P:central nervous system development; P:epidermal growth factor receptor signaling pathway; P:MAPK cascade; P:Ras protein signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold28 indexed_genome mRNA 20470465 20475488 . + . ID=transcript_6236;P33552 Q6FGI9 Q6LET5,Cyclin-dependent kinases regulatory subunit 2,, PF01111;, GO:0000307;GO:0019005;GO:0003682;GO:0061575;GO:0042393;GO:0019901;GO:0043130;GO:0051301;GO:0008283;GO:0007127;GO:0044772;GO:0007346;GO:0006357;, C:cyclin-dependent protein kinase holoenzyme complex; C:SCF ubiquitin ligase complex;, F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase activator activity; F:histone binding; F:protein kinase binding; F:ubiquitin binding;, P:cell division; P:cell population proliferation; P:meiosis I; P:mitotic cell cycle phase transition; P:regulation of mitotic cell cycle; P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 20476777 20494021 . + . ID=transcript_6237;Q96T21 F8W892 Q5HYY1 Q7L1Z0 Q8IYC0 Q9H0A1,Selenocysteine insertion sequence-binding protein 2,, PF01248;, GO:0005739;GO:0005654;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:2000623;GO:0048666;GO:0001514;GO:0021756;, C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:selenocysteine incorporation; P:striatum development;|Q96T21 F8W892 Q5HYY1 Q7L1Z0 Q8IYC0 Q9H0A1,Selenocysteine insertion sequence-binding protein 2,, PF01248;, GO:0005739;GO:0005654;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:2000623;GO:0048666;GO:0001514;GO:0021756;, C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:selenocysteine incorporation; P:striatum development; scaffold28 indexed_genome mRNA 20494108 20514554 . + . ID=transcript_6238;Q96T21 F8W892 Q5HYY1 Q7L1Z0 Q8IYC0 Q9H0A1,Selenocysteine insertion sequence-binding protein 2,, PF01248;, GO:0005739;GO:0005654;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:2000623;GO:0048666;GO:0001514;GO:0021756;, C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:selenocysteine incorporation; P:striatum development;|Q96T21 F8W892 Q5HYY1 Q7L1Z0 Q8IYC0 Q9H0A1,Selenocysteine insertion sequence-binding protein 2,, PF01248;, GO:0005739;GO:0005654;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:2000623;GO:0048666;GO:0001514;GO:0021756;, C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:selenocysteine incorporation; P:striatum development;|Q96T21 F8W892 Q5HYY1 Q7L1Z0 Q8IYC0 Q9H0A1,Selenocysteine insertion sequence-binding protein 2,, PF01248;, GO:0005739;GO:0005654;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:2000623;GO:0048666;GO:0001514;GO:0021756;, C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:selenocysteine incorporation; P:striatum development;|Q96T21 F8W892 Q5HYY1 Q7L1Z0 Q8IYC0 Q9H0A1,Selenocysteine insertion sequence-binding protein 2,, PF01248;, GO:0005739;GO:0005654;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:2000623;GO:0048666;GO:0001514;GO:0021756;, C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:selenocysteine incorporation; P:striatum development;|Q96T21 F8W892 Q5HYY1 Q7L1Z0 Q8IYC0 Q9H0A1,Selenocysteine insertion sequence-binding protein 2,, PF01248;, GO:0005739;GO:0005654;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:2000623;GO:0048666;GO:0001514;GO:0021756;, C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:selenocysteine incorporation; P:striatum development;|Q96T21 F8W892 Q5HYY1 Q7L1Z0 Q8IYC0 Q9H0A1,Selenocysteine insertion sequence-binding protein 2,, PF01248;, GO:0005739;GO:0005654;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:2000623;GO:0048666;GO:0001514;GO:0021756;, C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:selenocysteine incorporation; P:striatum development;|Q96T21 F8W892 Q5HYY1 Q7L1Z0 Q8IYC0 Q9H0A1,Selenocysteine insertion sequence-binding protein 2,, PF01248;, GO:0005739;GO:0005654;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:2000623;GO:0048666;GO:0001514;GO:0021756;, C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:selenocysteine incorporation; P:striatum development;|Q96T21 F8W892 Q5HYY1 Q7L1Z0 Q8IYC0 Q9H0A1,Selenocysteine insertion sequence-binding protein 2,, PF01248;, GO:0005739;GO:0005654;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:2000623;GO:0048666;GO:0001514;GO:0021756;, C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:selenocysteine incorporation; P:striatum development; scaffold28 indexed_genome mRNA 20527634 20653263 . + . ID=transcript_6239;Q92854 B2RPM6 Q7Z5S4 Q8N8B0,Semaphorin-4D,A8;BB18;GR3;, PF00047;PF01437;PF01403;, GO:0005615;GO:0005887;GO:0005886;GO:0045499;GO:0042802;GO:0030215;GO:0038023;GO:0005102;GO:0004888;GO:0007411;GO:0007155;GO:0006955;GO:0070486;GO:0050919;GO:0010693;GO:0043066;GO:0048843;GO:0007162;GO:0045668;GO:0050732;GO:0000122;GO:0001755;GO:0043931;GO:0030335;GO:0048672;GO:0043547;GO:1905704;GO:0050731;GO:0014068;GO:0001934;GO:0031344;GO:0008360;GO:0048814;GO:0071526;GO:1900220;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:identical protein binding; F:semaphorin receptor binding; F:signaling receptor activity; F:signaling receptor binding; F:transmembrane signaling receptor activity;, P:axon guidance; P:cell adhesion; P:immune response; P:leukocyte aggregation; P:negative chemotaxis; P:negative regulation of alkaline phosphatase activity; P:negative regulation of apoptotic process; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of cell adhesion; P:negative regulation of osteoblast differentiation; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:neural crest cell migration; P:ossification involved in bone maturation; P:positive regulation of cell migration; P:positive regulation of collateral sprouting; P:positive regulation of GTPase activity; P:positive regulation of inhibitory synapse assembly; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:regulation of cell projection organization; P:regulation of cell shape; P:regulation of dendrite morphogenesis; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis;|Q92854 B2RPM6 Q7Z5S4 Q8N8B0,Semaphorin-4D,A8;BB18;GR3;, PF00047;PF01437;PF01403;, GO:0005615;GO:0005887;GO:0005886;GO:0045499;GO:0042802;GO:0030215;GO:0038023;GO:0005102;GO:0004888;GO:0007411;GO:0007155;GO:0006955;GO:0070486;GO:0050919;GO:0010693;GO:0043066;GO:0048843;GO:0007162;GO:0045668;GO:0050732;GO:0000122;GO:0001755;GO:0043931;GO:0030335;GO:0048672;GO:0043547;GO:1905704;GO:0050731;GO:0014068;GO:0001934;GO:0031344;GO:0008360;GO:0048814;GO:0071526;GO:1900220;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:identical protein binding; F:semaphorin receptor binding; F:signaling receptor activity; F:signaling receptor binding; F:transmembrane signaling receptor activity;, P:axon guidance; P:cell adhesion; P:immune response; P:leukocyte aggregation; P:negative chemotaxis; P:negative regulation of alkaline phosphatase activity; P:negative regulation of apoptotic process; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of cell adhesion; P:negative regulation of osteoblast differentiation; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:neural crest cell migration; P:ossification involved in bone maturation; P:positive regulation of cell migration; P:positive regulation of collateral sprouting; P:positive regulation of GTPase activity; P:positive regulation of inhibitory synapse assembly; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:regulation of cell projection organization; P:regulation of cell shape; P:regulation of dendrite morphogenesis; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis;|Q92854 B2RPM6 Q7Z5S4 Q8N8B0,Semaphorin-4D,A8;BB18;GR3;, PF00047;PF01437;PF01403;, GO:0005615;GO:0005887;GO:0005886;GO:0045499;GO:0042802;GO:0030215;GO:0038023;GO:0005102;GO:0004888;GO:0007411;GO:0007155;GO:0006955;GO:0070486;GO:0050919;GO:0010693;GO:0043066;GO:0048843;GO:0007162;GO:0045668;GO:0050732;GO:0000122;GO:0001755;GO:0043931;GO:0030335;GO:0048672;GO:0043547;GO:1905704;GO:0050731;GO:0014068;GO:0001934;GO:0031344;GO:0008360;GO:0048814;GO:0071526;GO:1900220;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:identical protein binding; F:semaphorin receptor binding; F:signaling receptor activity; F:signaling receptor binding; F:transmembrane signaling receptor activity;, P:axon guidance; P:cell adhesion; P:immune response; P:leukocyte aggregation; P:negative chemotaxis; P:negative regulation of alkaline phosphatase activity; P:negative regulation of apoptotic process; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of cell adhesion; P:negative regulation of osteoblast differentiation; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:neural crest cell migration; P:ossification involved in bone maturation; P:positive regulation of cell migration; P:positive regulation of collateral sprouting; P:positive regulation of GTPase activity; P:positive regulation of inhibitory synapse assembly; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:regulation of cell projection organization; P:regulation of cell shape; P:regulation of dendrite morphogenesis; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis;|Q92854 B2RPM6 Q7Z5S4 Q8N8B0,Semaphorin-4D,A8;BB18;GR3;, PF00047;PF01437;PF01403;, GO:0005615;GO:0005887;GO:0005886;GO:0045499;GO:0042802;GO:0030215;GO:0038023;GO:0005102;GO:0004888;GO:0007411;GO:0007155;GO:0006955;GO:0070486;GO:0050919;GO:0010693;GO:0043066;GO:0048843;GO:0007162;GO:0045668;GO:0050732;GO:0000122;GO:0001755;GO:0043931;GO:0030335;GO:0048672;GO:0043547;GO:1905704;GO:0050731;GO:0014068;GO:0001934;GO:0031344;GO:0008360;GO:0048814;GO:0071526;GO:1900220;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:identical protein binding; F:semaphorin receptor binding; F:signaling receptor activity; F:signaling receptor binding; F:transmembrane signaling receptor activity;, P:axon guidance; P:cell adhesion; P:immune response; P:leukocyte aggregation; P:negative chemotaxis; P:negative regulation of alkaline phosphatase activity; P:negative regulation of apoptotic process; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of cell adhesion; P:negative regulation of osteoblast differentiation; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:neural crest cell migration; P:ossification involved in bone maturation; P:positive regulation of cell migration; P:positive regulation of collateral sprouting; P:positive regulation of GTPase activity; P:positive regulation of inhibitory synapse assembly; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:regulation of cell projection organization; P:regulation of cell shape; P:regulation of dendrite morphogenesis; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis; scaffold28 indexed_genome mRNA 20759861 20761458 . + . ID=transcript_6240;O95257 Q5VZ87 Q9C076,Growth arrest and DNA damage-inducible protein GADD45 gamma,Cytokine-responsive protein CR6;DNA damage-inducible transcript 2 protein;, PF01248;, GO:0005737;GO:0005634;GO:0000185;GO:0006915;GO:0030154;GO:0007275;GO:0043065;GO:0120162;GO:0046330;GO:1900745;GO:0051726;, C:cytoplasm; C:nucleus;, , P:activation of MAPKKK activity; P:apoptotic process; P:cell differentiation; P:multicellular organism development; P:positive regulation of apoptotic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:regulation of cell cycle;|O95257 Q5VZ87 Q9C076,Growth arrest and DNA damage-inducible protein GADD45 gamma,Cytokine-responsive protein CR6;DNA damage-inducible transcript 2 protein;, PF01248;, GO:0005737;GO:0005634;GO:0000185;GO:0006915;GO:0030154;GO:0007275;GO:0043065;GO:0120162;GO:0046330;GO:1900745;GO:0051726;, C:cytoplasm; C:nucleus;, , P:activation of MAPKKK activity; P:apoptotic process; P:cell differentiation; P:multicellular organism development; P:positive regulation of apoptotic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:regulation of cell cycle; scaffold28 indexed_genome mRNA 21920334 21925952 . - . ID=transcript_6241;Q96HU8 B3KVM2,GTP-binding protein Di-Ras2,Distinct subgroup of the Ras family member 2;, PF00071;, GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0007165;, C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:signal transduction; scaffold28 indexed_genome mRNA 22118828 22175263 . + . ID=transcript_6242;P43405,Tyrosine-protein kinase SYK,Spleen tyrosine kinase;p72-Syk;, PF07714;PF00017;, GO:0019815;GO:0005737;GO:0005829;GO:0032009;GO:0031234;GO:0005634;GO:0005886;GO:0032991;GO:0042101;GO:0005524;GO:0005178;GO:0016170;GO:0004715;GO:0019902;GO:0001784;GO:0004672;GO:0019901;GO:0004674;GO:0004713;GO:0042169;GO:0005102;GO:0035325;GO:0004714;GO:0007257;GO:0002250;GO:0001525;GO:0009887;GO:0050853;GO:0043366;GO:0048514;GO:0030154;GO:0071404;GO:0071226;GO:0038063;GO:0019221;GO:0042742;GO:0038095;GO:0038096;GO:0045087;GO:0007229;GO:0038110;GO:0038156;GO:0002366;GO:0007159;GO:0019370;GO:0001945;GO:0002281;GO:0002862;GO:0002283;GO:0030593;GO:0018105;GO:0018108;GO:0030168;GO:0046638;GO:0046641;GO:0045579;GO:0045780;GO:0050850;GO:0033630;GO:0120162;GO:0043280;GO:0045588;GO:0032725;GO:0032733;GO:0032735;GO:0032752;GO:0032753;GO:0032755;GO:0032757;GO:0051712;GO:0043306;GO:0071639;GO:0050731;GO:0031334;GO:0002092;GO:0032930;GO:0032760;GO:0032481;GO:0046777;GO:0006606;GO:0006468;GO:0031623;GO:0090237;GO:0051090;GO:0070372;GO:0043313;GO:0050764;GO:0010543;GO:0090330;GO:0032928;GO:0010803;GO:0002554;GO:0002223;GO:0007169;GO:0016032;, C:B cell receptor complex; C:cytoplasm; C:cytosol; C:early phagosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleus; C:plasma membrane; C:protein-containing complex; C:T cell receptor complex;, F:ATP binding; F:integrin binding; F:interleukin-15 receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphatase binding; F:phosphotyrosine residue binding; F:protein kinase activity; F:protein kinase binding; F:protein serine/threonine kinase activity; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:Toll-like receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of JUN kinase activity; P:adaptive immune response; P:angiogenesis; P:animal organ morphogenesis; P:B cell receptor signaling pathway; P:beta selection; P:blood vessel morphogenesis; P:cell differentiation; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to molecule of fungal origin; P:collagen-activated tyrosine kinase receptor signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-3-mediated signaling pathway; P:leukocyte activation involved in immune response; P:leukocyte cell-cell adhesion; P:leukotriene biosynthetic process; P:lymph vessel development; P:macrophage activation involved in immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:neutrophil activation involved in immune response; P:neutrophil chemotaxis; P:peptidyl-serine phosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of B cell differentiation; P:positive regulation of bone resorption; P:positive regulation of calcium-mediated signaling; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-3 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of killing of cells of other organism; P:positive regulation of mast cell degranulation; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of receptor internalization; P:positive regulation of superoxide anion generation; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:protein autophosphorylation; P:protein import into nucleus; P:protein phosphorylation; P:receptor internalization; P:regulation of arachidonic acid secretion; P:regulation of DNA-binding transcription factor activity; P:regulation of ERK1 and ERK2 cascade; P:regulation of neutrophil degranulation; P:regulation of phagocytosis; P:regulation of platelet activation; P:regulation of platelet aggregation; P:regulation of superoxide anion generation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:serotonin secretion by platelet; P:stimulatory C-type lectin receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|P43405,Tyrosine-protein kinase SYK,Spleen tyrosine kinase;p72-Syk;, PF07714;PF00017;, GO:0019815;GO:0005737;GO:0005829;GO:0032009;GO:0031234;GO:0005634;GO:0005886;GO:0032991;GO:0042101;GO:0005524;GO:0005178;GO:0016170;GO:0004715;GO:0019902;GO:0001784;GO:0004672;GO:0019901;GO:0004674;GO:0004713;GO:0042169;GO:0005102;GO:0035325;GO:0004714;GO:0007257;GO:0002250;GO:0001525;GO:0009887;GO:0050853;GO:0043366;GO:0048514;GO:0030154;GO:0071404;GO:0071226;GO:0038063;GO:0019221;GO:0042742;GO:0038095;GO:0038096;GO:0045087;GO:0007229;GO:0038110;GO:0038156;GO:0002366;GO:0007159;GO:0019370;GO:0001945;GO:0002281;GO:0002862;GO:0002283;GO:0030593;GO:0018105;GO:0018108;GO:0030168;GO:0046638;GO:0046641;GO:0045579;GO:0045780;GO:0050850;GO:0033630;GO:0120162;GO:0043280;GO:0045588;GO:0032725;GO:0032733;GO:0032735;GO:0032752;GO:0032753;GO:0032755;GO:0032757;GO:0051712;GO:0043306;GO:0071639;GO:0050731;GO:0031334;GO:0002092;GO:0032930;GO:0032760;GO:0032481;GO:0046777;GO:0006606;GO:0006468;GO:0031623;GO:0090237;GO:0051090;GO:0070372;GO:0043313;GO:0050764;GO:0010543;GO:0090330;GO:0032928;GO:0010803;GO:0002554;GO:0002223;GO:0007169;GO:0016032;, C:B cell receptor complex; C:cytoplasm; C:cytosol; C:early phagosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleus; C:plasma membrane; C:protein-containing complex; C:T cell receptor complex;, F:ATP binding; F:integrin binding; F:interleukin-15 receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphatase binding; F:phosphotyrosine residue binding; F:protein kinase activity; F:protein kinase binding; F:protein serine/threonine kinase activity; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:Toll-like receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of JUN kinase activity; P:adaptive immune response; P:angiogenesis; P:animal organ morphogenesis; P:B cell receptor signaling pathway; P:beta selection; P:blood vessel morphogenesis; P:cell differentiation; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to molecule of fungal origin; P:collagen-activated tyrosine kinase receptor signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-3-mediated signaling pathway; P:leukocyte activation involved in immune response; P:leukocyte cell-cell adhesion; P:leukotriene biosynthetic process; P:lymph vessel development; P:macrophage activation involved in immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:neutrophil activation involved in immune response; P:neutrophil chemotaxis; P:peptidyl-serine phosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of B cell differentiation; P:positive regulation of bone resorption; P:positive regulation of calcium-mediated signaling; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-3 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of killing of cells of other organism; P:positive regulation of mast cell degranulation; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of receptor internalization; P:positive regulation of superoxide anion generation; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:protein autophosphorylation; P:protein import into nucleus; P:protein phosphorylation; P:receptor internalization; P:regulation of arachidonic acid secretion; P:regulation of DNA-binding transcription factor activity; P:regulation of ERK1 and ERK2 cascade; P:regulation of neutrophil degranulation; P:regulation of phagocytosis; P:regulation of platelet activation; P:regulation of platelet aggregation; P:regulation of superoxide anion generation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:serotonin secretion by platelet; P:stimulatory C-type lectin receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process; scaffold28 indexed_genome mRNA 22460184 22665486 . - . ID=transcript_6243;Q13825 B1ALV7 B1ALV8 Q8WUE4,Methylglutaconyl-CoA hydratase, mitochondrial,AU-specific RNA-binding enoyl-CoA hydratase;Itaconyl-CoA hydratase {ECO:0000303|PubMed:29056341};, PF00378;, GO:0005759;GO:0005739;GO:0004300;GO:0050011;GO:0004490;GO:0003730;GO:0009083;GO:0006635;GO:0006552;, C:mitochondrial matrix; C:mitochondrion;, F:enoyl-CoA hydratase activity; F:itaconyl-CoA hydratase activity; F:methylglutaconyl-CoA hydratase activity; F:mRNA 3'-UTR binding;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation; P:leucine catabolic process;|Q13825 B1ALV7 B1ALV8 Q8WUE4,Methylglutaconyl-CoA hydratase, mitochondrial,AU-specific RNA-binding enoyl-CoA hydratase;Itaconyl-CoA hydratase {ECO:0000303|PubMed:29056341};, PF00378;, GO:0005759;GO:0005739;GO:0004300;GO:0050011;GO:0004490;GO:0003730;GO:0009083;GO:0006635;GO:0006552;, C:mitochondrial matrix; C:mitochondrion;, F:enoyl-CoA hydratase activity; F:itaconyl-CoA hydratase activity; F:methylglutaconyl-CoA hydratase activity; F:mRNA 3'-UTR binding;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation; P:leucine catabolic process;|Q13825 B1ALV7 B1ALV8 Q8WUE4,Methylglutaconyl-CoA hydratase, mitochondrial,AU-specific RNA-binding enoyl-CoA hydratase;Itaconyl-CoA hydratase {ECO:0000303|PubMed:29056341};, PF00378;, GO:0005759;GO:0005739;GO:0004300;GO:0050011;GO:0004490;GO:0003730;GO:0009083;GO:0006635;GO:0006552;, C:mitochondrial matrix; C:mitochondrion;, F:enoyl-CoA hydratase activity; F:itaconyl-CoA hydratase activity; F:methylglutaconyl-CoA hydratase activity; F:mRNA 3'-UTR binding;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation; P:leucine catabolic process;|Q6EKJ0 B2RNE9 Q69GU6 Q8N979 Q9H739,General transcription factor II-I repeat domain-containing protein 2B,Transcription factor GTF2IRD2-beta;, PF02946;PF18658;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold28 indexed_genome mRNA 22712372 22714235 . + . ID=transcript_6244;Q16649 B2R9Y8 Q14211 Q6FGQ8 Q96HS0,Nuclear factor interleukin-3-regulated protein,E4 promoter-binding protein 4;Interleukin-3 promoter transcriptional activator;Interleukin-3-binding protein 1;Transcriptional activator NF-IL3A;, PF07716;PF06529;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0000977;GO:0071353;GO:0007623;GO:0006955;GO:0000122;GO:0045892;GO:0045893;GO:0006355;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cellular response to interleukin-4; P:circadian rhythm; P:immune response; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 23314973 23374071 . - . ID=transcript_6245;O15269 A8K681 Q5VWB4 Q96IX6,Serine palmitoyltransferase 1,Long chain base biosynthesis protein 1;Serine-palmitoyl-CoA transferase 1;, PF00155;, GO:0005783;GO:0005789;GO:0016021;GO:0017059;GO:0035339;GO:0030170;GO:0004758;GO:0046513;GO:1904504;GO:1904649;GO:0030148;GO:0006665;GO:0046512;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:serine C-palmitoyltransferase complex; C:SPOTS complex;, F:pyridoxal phosphate binding; F:serine C-palmitoyltransferase activity;, P:ceramide biosynthetic process; P:positive regulation of lipophagy; P:regulation of fat cell apoptotic process; P:sphingolipid biosynthetic process; P:sphingolipid metabolic process; P:sphingosine biosynthetic process;|O15269 A8K681 Q5VWB4 Q96IX6,Serine palmitoyltransferase 1,Long chain base biosynthesis protein 1;Serine-palmitoyl-CoA transferase 1;, PF00155;, GO:0005783;GO:0005789;GO:0016021;GO:0017059;GO:0035339;GO:0030170;GO:0004758;GO:0046513;GO:1904504;GO:1904649;GO:0030148;GO:0006665;GO:0046512;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:serine C-palmitoyltransferase complex; C:SPOTS complex;, F:pyridoxal phosphate binding; F:serine C-palmitoyltransferase activity;, P:ceramide biosynthetic process; P:positive regulation of lipophagy; P:regulation of fat cell apoptotic process; P:sphingolipid biosynthetic process; P:sphingolipid metabolic process; P:sphingosine biosynthetic process;|O15269 A8K681 Q5VWB4 Q96IX6,Serine palmitoyltransferase 1,Long chain base biosynthesis protein 1;Serine-palmitoyl-CoA transferase 1;, PF00155;, GO:0005783;GO:0005789;GO:0016021;GO:0017059;GO:0035339;GO:0030170;GO:0004758;GO:0046513;GO:1904504;GO:1904649;GO:0030148;GO:0006665;GO:0046512;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:serine C-palmitoyltransferase complex; C:SPOTS complex;, F:pyridoxal phosphate binding; F:serine C-palmitoyltransferase activity;, P:ceramide biosynthetic process; P:positive regulation of lipophagy; P:regulation of fat cell apoptotic process; P:sphingolipid biosynthetic process; P:sphingolipid metabolic process; P:sphingosine biosynthetic process; scaffold28 indexed_genome mRNA 23615465 23663187 . - . ID=transcript_6246;Q14929 A2AGP5 A8K127 Q6PI28,Zinc finger protein 169,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14929 A2AGP5 A8K127 Q6PI28,Zinc finger protein 169,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 23761200 23831875 . + . ID=transcript_6247;A2A3K4 Q5T3M4 Q6NXE8 Q8IWM1 Q8N1X4 Q8N9F5,Protein tyrosine phosphatase domain-containing protein 1,, , GO:0005737;GO:0005654;GO:0004725;GO:0008138;GO:0060271;, C:cytoplasm; C:nucleoplasm;, F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cilium assembly;|A2A3K4 Q5T3M4 Q6NXE8 Q8IWM1 Q8N1X4 Q8N9F5,Protein tyrosine phosphatase domain-containing protein 1,, , GO:0005737;GO:0005654;GO:0004725;GO:0008138;GO:0060271;, C:cytoplasm; C:nucleoplasm;, F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cilium assembly;|A2A3K4 Q5T3M4 Q6NXE8 Q8IWM1 Q8N1X4 Q8N9F5,Protein tyrosine phosphatase domain-containing protein 1,, , GO:0005737;GO:0005654;GO:0004725;GO:0008138;GO:0060271;, C:cytoplasm; C:nucleoplasm;, F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cilium assembly;|A2A3K4 Q5T3M4 Q6NXE8 Q8IWM1 Q8N1X4 Q8N9F5,Protein tyrosine phosphatase domain-containing protein 1,, , GO:0005737;GO:0005654;GO:0004725;GO:0008138;GO:0060271;, C:cytoplasm; C:nucleoplasm;, F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cilium assembly;|A2A3K4 Q5T3M4 Q6NXE8 Q8IWM1 Q8N1X4 Q8N9F5,Protein tyrosine phosphatase domain-containing protein 1,, , GO:0005737;GO:0005654;GO:0004725;GO:0008138;GO:0060271;, C:cytoplasm; C:nucleoplasm;, F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cilium assembly; scaffold28 indexed_genome mRNA 24135639 24151499 . - . ID=transcript_6248;O75151 Q4VXG0 Q8N3K2 Q9Y6N4,Lysine-specific demethylase PHF2,GRC5;PHD finger protein 2;, PF17811;PF02373;PF00628;, GO:0000777;GO:0000776;GO:0005730;GO:0005654;GO:0005634;GO:0051213;GO:0032454;GO:0005506;GO:0035064;GO:0003713;GO:0003712;GO:0008270;GO:0001889;GO:0061188;GO:0006482;GO:0006357;, C:condensed chromosome kinetochore; C:kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:iron ion binding; F:methylated histone binding; F:transcription coactivator activity; F:transcription coregulator activity; F:zinc ion binding;, P:liver development; P:negative regulation of ribosomal DNA heterochromatin assembly; P:protein demethylation; P:regulation of transcription by RNA polymerase II;|O75151 Q4VXG0 Q8N3K2 Q9Y6N4,Lysine-specific demethylase PHF2,GRC5;PHD finger protein 2;, PF17811;PF02373;PF00628;, GO:0000777;GO:0000776;GO:0005730;GO:0005654;GO:0005634;GO:0051213;GO:0032454;GO:0005506;GO:0035064;GO:0003713;GO:0003712;GO:0008270;GO:0001889;GO:0061188;GO:0006482;GO:0006357;, C:condensed chromosome kinetochore; C:kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:iron ion binding; F:methylated histone binding; F:transcription coactivator activity; F:transcription coregulator activity; F:zinc ion binding;, P:liver development; P:negative regulation of ribosomal DNA heterochromatin assembly; P:protein demethylation; P:regulation of transcription by RNA polymerase II;|O75151 Q4VXG0 Q8N3K2 Q9Y6N4,Lysine-specific demethylase PHF2,GRC5;PHD finger protein 2;, PF17811;PF02373;PF00628;, GO:0000777;GO:0000776;GO:0005730;GO:0005654;GO:0005634;GO:0051213;GO:0032454;GO:0005506;GO:0035064;GO:0003713;GO:0003712;GO:0008270;GO:0001889;GO:0061188;GO:0006482;GO:0006357;, C:condensed chromosome kinetochore; C:kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:iron ion binding; F:methylated histone binding; F:transcription coactivator activity; F:transcription coregulator activity; F:zinc ion binding;, P:liver development; P:negative regulation of ribosomal DNA heterochromatin assembly; P:protein demethylation; P:regulation of transcription by RNA polymerase II;|O75151 Q4VXG0 Q8N3K2 Q9Y6N4,Lysine-specific demethylase PHF2,GRC5;PHD finger protein 2;, PF17811;PF02373;PF00628;, GO:0000777;GO:0000776;GO:0005730;GO:0005654;GO:0005634;GO:0051213;GO:0032454;GO:0005506;GO:0035064;GO:0003713;GO:0003712;GO:0008270;GO:0001889;GO:0061188;GO:0006482;GO:0006357;, C:condensed chromosome kinetochore; C:kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:iron ion binding; F:methylated histone binding; F:transcription coactivator activity; F:transcription coregulator activity; F:zinc ion binding;, P:liver development; P:negative regulation of ribosomal DNA heterochromatin assembly; P:protein demethylation; P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 24236484 24351062 . - . ID=transcript_6249;Q96I21 Q9NZB1,Constitutive coactivator of PPAR-gamma-like protein 1,Oxidative stress-associated Src activator;Protein FAM120A;, , GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0003723;, C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:RNA binding;|Q96I21 Q9NZB1,Constitutive coactivator of PPAR-gamma-like protein 1,Oxidative stress-associated Src activator;Protein FAM120A;, , GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0003723;, C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:RNA binding;|Q96I21 Q9NZB1,Constitutive coactivator of PPAR-gamma-like protein 1,Oxidative stress-associated Src activator;Protein FAM120A;, , GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0003723;, C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:RNA binding;|Q96I21 Q9NZB1,Constitutive coactivator of PPAR-gamma-like protein 1,Oxidative stress-associated Src activator;Protein FAM120A;, , GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0003723;, C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:RNA binding; scaffold28 indexed_genome mRNA 24404220 24504384 . - . ID=transcript_6250;Q9Y3S1 Q5VWF1 Q5VWF2 Q8IY36 Q9C0A3 Q9H3P4,Serine/threonine-protein kinase WNK2 {ECO:0000305},Antigen NY-CO-43;Protein kinase lysine-deficient 2 {ECO:0000312|HGNC:HGNC:14542};Protein kinase with no lysine 2 {ECO:0000303|PubMed:11571656};Serologically defined colon cancer antigen 43;, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0005886;GO:0005524;GO:0019869;GO:0019870;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0050801;GO:0008285;GO:0070373;GO:0010766;GO:0090263;GO:1903288;GO:2000651;GO:0046777;GO:0006468;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:ion homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of sodium ion transport; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:protein autophosphorylation; P:protein phosphorylation;|Q9Y3S1 Q5VWF1 Q5VWF2 Q8IY36 Q9C0A3 Q9H3P4,Serine/threonine-protein kinase WNK2 {ECO:0000305},Antigen NY-CO-43;Protein kinase lysine-deficient 2 {ECO:0000312|HGNC:HGNC:14542};Protein kinase with no lysine 2 {ECO:0000303|PubMed:11571656};Serologically defined colon cancer antigen 43;, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0005886;GO:0005524;GO:0019869;GO:0019870;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0050801;GO:0008285;GO:0070373;GO:0010766;GO:0090263;GO:1903288;GO:2000651;GO:0046777;GO:0006468;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:ion homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of sodium ion transport; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:protein autophosphorylation; P:protein phosphorylation;|Q9Y3S1 Q5VWF1 Q5VWF2 Q8IY36 Q9C0A3 Q9H3P4,Serine/threonine-protein kinase WNK2 {ECO:0000305},Antigen NY-CO-43;Protein kinase lysine-deficient 2 {ECO:0000312|HGNC:HGNC:14542};Protein kinase with no lysine 2 {ECO:0000303|PubMed:11571656};Serologically defined colon cancer antigen 43;, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0005886;GO:0005524;GO:0019869;GO:0019870;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0050801;GO:0008285;GO:0070373;GO:0010766;GO:0090263;GO:1903288;GO:2000651;GO:0046777;GO:0006468;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:ion homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of sodium ion transport; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:protein autophosphorylation; P:protein phosphorylation;|Q9Y3S1 Q5VWF1 Q5VWF2 Q8IY36 Q9C0A3 Q9H3P4,Serine/threonine-protein kinase WNK2 {ECO:0000305},Antigen NY-CO-43;Protein kinase lysine-deficient 2 {ECO:0000312|HGNC:HGNC:14542};Protein kinase with no lysine 2 {ECO:0000303|PubMed:11571656};Serologically defined colon cancer antigen 43;, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0005886;GO:0005524;GO:0019869;GO:0019870;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0050801;GO:0008285;GO:0070373;GO:0010766;GO:0090263;GO:1903288;GO:2000651;GO:0046777;GO:0006468;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:ion homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of sodium ion transport; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:protein autophosphorylation; P:protein phosphorylation; scaffold28 indexed_genome mRNA 24594797 24596104 . - . ID=transcript_6251;Q92982 Q6GU89 Q8WUV5 Q9BT07,Ninjurin-1,Nerve injury-induced protein 1;, PF04923;, GO:0016021;GO:0007155;GO:0007399;GO:0042246;, C:integral component of membrane;, , P:cell adhesion; P:nervous system development; P:tissue regeneration; scaffold28 indexed_genome mRNA 24603854 24608786 . - . ID=transcript_6252;Q96LW7 Q5BJH8 Q9BSY2,Caspase recruitment domain-containing protein 19,Bcl10-interacting CARD protein;, , GO:0005829;GO:0005789;GO:0016021;GO:0031966;GO:0005739;GO:0005634;GO:0050700;GO:0043124;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:CARD domain binding;, P:negative regulation of I-kappaB kinase/NF-kappaB signaling; scaffold28 indexed_genome mRNA 24639154 24658569 . - . ID=transcript_6253;Q96L08 Q49AA6 Q6UXV7,Sushi domain-containing protein 3,, PF00084;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold28 indexed_genome mRNA 24675848 24716554 . - . ID=transcript_6254;Q5JSP0 F8W7P2 Q4VX84 Q7Z7D9 Q8N5G1,FYVE, RhoGEF and PH domain-containing protein 3,Zinc finger FYVE domain-containing protein 5;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5JSP0 F8W7P2 Q4VX84 Q7Z7D9 Q8N5G1,FYVE, RhoGEF and PH domain-containing protein 3,Zinc finger FYVE domain-containing protein 5;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5JSP0 F8W7P2 Q4VX84 Q7Z7D9 Q8N5G1,FYVE, RhoGEF and PH domain-containing protein 3,Zinc finger FYVE domain-containing protein 5;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5JSP0 F8W7P2 Q4VX84 Q7Z7D9 Q8N5G1,FYVE, RhoGEF and PH domain-containing protein 3,Zinc finger FYVE domain-containing protein 5;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5JSP0 F8W7P2 Q4VX84 Q7Z7D9 Q8N5G1,FYVE, RhoGEF and PH domain-containing protein 3,Zinc finger FYVE domain-containing protein 5;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q5JSP0 F8W7P2 Q4VX84 Q7Z7D9 Q8N5G1,FYVE, RhoGEF and PH domain-containing protein 3,Zinc finger FYVE domain-containing protein 5;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold28 indexed_genome mRNA 24776988 24833593 . + . ID=transcript_6255;Q8TD16 O75181 Q5TBQ2 Q5TBQ3 Q96LH2 Q9BT84 Q9H561,Protein bicaudal D homolog 2,, PF09730;, GO:0005642;GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0005794;GO:0005635;GO:0005643;GO:0005886;GO:0008093;GO:0034452;GO:0070840;GO:0051959;GO:0031267;GO:0051642;GO:0072393;GO:0007018;GO:0072385;GO:0051028;GO:0034067;GO:0033365;GO:0015031;GO:0070507;GO:0006890;, C:annulate lamellae; C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nuclear envelope; C:nuclear pore; C:plasma membrane;, F:cytoskeletal anchor activity; F:dynactin binding; F:dynein complex binding; F:dynein light intermediate chain binding; F:small GTPase binding;, P:centrosome localization; P:microtubule anchoring at microtubule organizing center; P:microtubule-based movement; P:minus-end-directed organelle transport along microtubule; P:mRNA transport; P:protein localization to Golgi apparatus; P:protein localization to organelle; P:protein transport; P:regulation of microtubule cytoskeleton organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold28 indexed_genome mRNA 24844053 25123121 . + . ID=transcript_6256;Q9H8X2 Q5T9F7 Q9H7V8,Inositol-pentakisphosphate 2-kinase,IPK1 homolog;Inositol-1,3,4,5,6-pentakisphosphate 2-kinase;Ins(1,3,4,5,6)P5 2-kinase;, PF06090;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0035299;GO:0060090;GO:0032958;GO:0043647;GO:0052746;GO:1901838;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:inositol pentakisphosphate 2-kinase activity; F:molecular adaptor activity;, P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:inositol phosphorylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;|Q9H8X2 Q5T9F7 Q9H7V8,Inositol-pentakisphosphate 2-kinase,IPK1 homolog;Inositol-1,3,4,5,6-pentakisphosphate 2-kinase;Ins(1,3,4,5,6)P5 2-kinase;, PF06090;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0035299;GO:0060090;GO:0032958;GO:0043647;GO:0052746;GO:1901838;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:inositol pentakisphosphate 2-kinase activity; F:molecular adaptor activity;, P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:inositol phosphorylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;|Q6IPU0 B3KRA5 B3KS17 Q5T9F8 Q5T9F9,Centromere protein P,, PF13096;, GO:0000775;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0034080;GO:0007052;, C:chromosome, centromeric region; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:mitotic spindle organization;|Q9H8X2 Q5T9F7 Q9H7V8,Inositol-pentakisphosphate 2-kinase,IPK1 homolog;Inositol-1,3,4,5,6-pentakisphosphate 2-kinase;Ins(1,3,4,5,6)P5 2-kinase;, PF06090;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0035299;GO:0060090;GO:0032958;GO:0043647;GO:0052746;GO:1901838;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:inositol pentakisphosphate 2-kinase activity; F:molecular adaptor activity;, P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:inositol phosphorylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;|Q6IPU0 B3KRA5 B3KS17 Q5T9F8 Q5T9F9,Centromere protein P,, PF13096;, GO:0000775;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0034080;GO:0007052;, C:chromosome, centromeric region; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:mitotic spindle organization;|O94769 B2R730 E2PU11 Q5T9F2 Q7Z3D0,Extracellular matrix protein 2,Matrix glycoprotein SC1/ECM2;, PF13855;PF00093;, GO:0031012;GO:0005576;GO:0070052;GO:0008201;GO:0005178;GO:0007160;GO:0030198;GO:0010811;, C:extracellular matrix; C:extracellular region;, F:collagen V binding; F:heparin binding; F:integrin binding;, P:cell-matrix adhesion; P:extracellular matrix organization; P:positive regulation of cell-substrate adhesion;|Q9BXN1 Q5TBF3 Q96K79 Q96LD0 Q9NXP3,Asporin,Periodontal ligament-associated protein 1;, PF13855;PF01462;, GO:0062023;GO:0031012;GO:0005615;GO:0005509;GO:0005518;GO:0030282;GO:0070171;GO:0030512;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:calcium ion binding; F:collagen binding;, P:bone mineralization; P:negative regulation of tooth mineralization; P:negative regulation of transforming growth factor beta receptor signaling pathway;|Q9BXN1 Q5TBF3 Q96K79 Q96LD0 Q9NXP3,Asporin,Periodontal ligament-associated protein 1;, PF13855;PF01462;, GO:0062023;GO:0031012;GO:0005615;GO:0005509;GO:0005518;GO:0030282;GO:0070171;GO:0030512;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:calcium ion binding; F:collagen binding;, P:bone mineralization; P:negative regulation of tooth mineralization; P:negative regulation of transforming growth factor beta receptor signaling pathway;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9BXN1 Q5TBF3 Q96K79 Q96LD0 Q9NXP3,Asporin,Periodontal ligament-associated protein 1;, PF13855;PF01462;, GO:0062023;GO:0031012;GO:0005615;GO:0005509;GO:0005518;GO:0030282;GO:0070171;GO:0030512;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:calcium ion binding; F:collagen binding;, P:bone mineralization; P:negative regulation of tooth mineralization; P:negative regulation of transforming growth factor beta receptor signaling pathway;|Q9BXN1 Q5TBF3 Q96K79 Q96LD0 Q9NXP3,Asporin,Periodontal ligament-associated protein 1;, PF13855;PF01462;, GO:0062023;GO:0031012;GO:0005615;GO:0005509;GO:0005518;GO:0030282;GO:0070171;GO:0030512;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:calcium ion binding; F:collagen binding;, P:bone mineralization; P:negative regulation of tooth mineralization; P:negative regulation of transforming growth factor beta receptor signaling pathway;|P20774 Q6FIB0 Q9UF90 Q9UNK5,Mimecan,Osteoglycin;Osteoinductive factor;, PF13855;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005796;GO:0043202;GO:0008083;GO:0018146;GO:0042340;GO:0048662;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:Golgi lumen; C:lysosomal lumen;, F:growth factor activity;, P:keratan sulfate biosynthetic process; P:keratan sulfate catabolic process; P:negative regulation of smooth muscle cell proliferation;|P20774 Q6FIB0 Q9UF90 Q9UNK5,Mimecan,Osteoglycin;Osteoinductive factor;, PF13855;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:1903561;GO:0005796;GO:0043202;GO:0008083;GO:0018146;GO:0042340;GO:0048662;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:Golgi lumen; C:lysosomal lumen;, F:growth factor activity;, P:keratan sulfate biosynthetic process; P:keratan sulfate catabolic process; P:negative regulation of smooth muscle cell proliferation; scaffold28 indexed_genome mRNA 25124693 25125966 . + . ID=transcript_6257;Q9H586 Q9H795 Q9H7W7 Q9H9J6 Q9NWA4 Q9NWM4,Nucleolar protein 8,Nucleolar protein Nop132;, PF00076;, GO:0005694;GO:0005730;GO:0003723;GO:1902570;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding;, P:protein localization to nucleolus; P:rRNA processing; scaffold28 indexed_genome mRNA 25125998 25129737 . + . ID=transcript_6258;Q9H586 Q9H795 Q9H7W7 Q9H9J6 Q9NWA4 Q9NWM4,Nucleolar protein 8,Nucleolar protein Nop132;, PF00076;, GO:0005694;GO:0005730;GO:0003723;GO:1902570;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding;, P:protein localization to nucleolus; P:rRNA processing; scaffold28 indexed_genome mRNA 25129743 25135377 . + . ID=transcript_6259;Q9H586 Q9H795 Q9H7W7 Q9H9J6 Q9NWA4 Q9NWM4,Nucleolar protein 8,Nucleolar protein Nop132;, PF00076;, GO:0005694;GO:0005730;GO:0003723;GO:1902570;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding;, P:protein localization to nucleolus; P:rRNA processing;|Q9H586 Q9H795 Q9H7W7 Q9H9J6 Q9NWA4 Q9NWM4,Nucleolar protein 8,Nucleolar protein Nop132;, PF00076;, GO:0005694;GO:0005730;GO:0003723;GO:1902570;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding;, P:protein localization to nucleolus; P:rRNA processing;|Q9H586 Q9H795 Q9H7W7 Q9H9J6 Q9NWA4 Q9NWM4,Nucleolar protein 8,Nucleolar protein Nop132;, PF00076;, GO:0005694;GO:0005730;GO:0003723;GO:1902570;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding;, P:protein localization to nucleolus; P:rRNA processing; scaffold28 indexed_genome mRNA 25137681 25145135 . - . ID=transcript_6260;Q9H586 Q9H795 Q9H7W7 Q9H9J6 Q9NWA4 Q9NWM4,Nucleolar protein 8,Nucleolar protein Nop132;, PF00076;, GO:0005694;GO:0005730;GO:0003723;GO:1902570;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding;, P:protein localization to nucleolus; P:rRNA processing;|Q9H586 Q9H795 Q9H7W7 Q9H9J6 Q9NWA4 Q9NWM4,Nucleolar protein 8,Nucleolar protein Nop132;, PF00076;, GO:0005694;GO:0005730;GO:0003723;GO:1902570;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding;, P:protein localization to nucleolus; P:rRNA processing;|Q9H586 Q9H795 Q9H7W7 Q9H9J6 Q9NWA4 Q9NWM4,Nucleolar protein 8,Nucleolar protein Nop132;, PF00076;, GO:0005694;GO:0005730;GO:0003723;GO:1902570;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding;, P:protein localization to nucleolus; P:rRNA processing;|Q9H586 Q9H795 Q9H7W7 Q9H9J6 Q9NWA4 Q9NWM4,Nucleolar protein 8,Nucleolar protein Nop132;, PF00076;, GO:0005694;GO:0005730;GO:0003723;GO:1902570;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding;, P:protein localization to nucleolus; P:rRNA processing;|Q9H586 Q9H795 Q9H7W7 Q9H9J6 Q9NWA4 Q9NWM4,Nucleolar protein 8,Nucleolar protein Nop132;, PF00076;, GO:0005694;GO:0005730;GO:0003723;GO:1902570;GO:0006364;, C:chromosome; C:nucleolus;, F:RNA binding;, P:protein localization to nucleolus; P:rRNA processing; scaffold28 indexed_genome mRNA 25150294 25204517 . + . ID=transcript_6261;P41252 A8KAE9 Q5TCD0 Q7Z3T4 Q9H588,Isoleucine--tRNA ligase, cytoplasmic,Isoleucyl-tRNA synthetase;, PF08264;PF00133;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0002161;GO:0005524;GO:0051020;GO:0004822;GO:0000049;GO:0006428;GO:0001649;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:GTPase binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:osteoblast differentiation; P:tRNA aminoacylation for protein translation;|P41252 A8KAE9 Q5TCD0 Q7Z3T4 Q9H588,Isoleucine--tRNA ligase, cytoplasmic,Isoleucyl-tRNA synthetase;, PF08264;PF00133;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0002161;GO:0005524;GO:0051020;GO:0004822;GO:0000049;GO:0006428;GO:0001649;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:GTPase binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:osteoblast differentiation; P:tRNA aminoacylation for protein translation;|P41252 A8KAE9 Q5TCD0 Q7Z3T4 Q9H588,Isoleucine--tRNA ligase, cytoplasmic,Isoleucyl-tRNA synthetase;, PF08264;PF00133;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0002161;GO:0005524;GO:0051020;GO:0004822;GO:0000049;GO:0006428;GO:0001649;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:GTPase binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:osteoblast differentiation; P:tRNA aminoacylation for protein translation;|P41252 A8KAE9 Q5TCD0 Q7Z3T4 Q9H588,Isoleucine--tRNA ligase, cytoplasmic,Isoleucyl-tRNA synthetase;, PF08264;PF00133;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0002161;GO:0005524;GO:0051020;GO:0004822;GO:0000049;GO:0006428;GO:0001649;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:GTPase binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:osteoblast differentiation; P:tRNA aminoacylation for protein translation;|P41252 A8KAE9 Q5TCD0 Q7Z3T4 Q9H588,Isoleucine--tRNA ligase, cytoplasmic,Isoleucyl-tRNA synthetase;, PF08264;PF00133;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0002161;GO:0005524;GO:0051020;GO:0004822;GO:0000049;GO:0006428;GO:0001649;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:GTPase binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:osteoblast differentiation; P:tRNA aminoacylation for protein translation;|P41252 A8KAE9 Q5TCD0 Q7Z3T4 Q9H588,Isoleucine--tRNA ligase, cytoplasmic,Isoleucyl-tRNA synthetase;, PF08264;PF00133;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0002161;GO:0005524;GO:0051020;GO:0004822;GO:0000049;GO:0006428;GO:0001649;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:GTPase binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:osteoblast differentiation; P:tRNA aminoacylation for protein translation; scaffold28 indexed_genome mRNA 25204843 25226561 . + . ID=transcript_6262;P41252 A8KAE9 Q5TCD0 Q7Z3T4 Q9H588,Isoleucine--tRNA ligase, cytoplasmic,Isoleucyl-tRNA synthetase;, PF08264;PF00133;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0002161;GO:0005524;GO:0051020;GO:0004822;GO:0000049;GO:0006428;GO:0001649;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:GTPase binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:osteoblast differentiation; P:tRNA aminoacylation for protein translation;|P41252 A8KAE9 Q5TCD0 Q7Z3T4 Q9H588,Isoleucine--tRNA ligase, cytoplasmic,Isoleucyl-tRNA synthetase;, PF08264;PF00133;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0002161;GO:0005524;GO:0051020;GO:0004822;GO:0000049;GO:0006428;GO:0001649;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:GTPase binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:osteoblast differentiation; P:tRNA aminoacylation for protein translation;|P41252 A8KAE9 Q5TCD0 Q7Z3T4 Q9H588,Isoleucine--tRNA ligase, cytoplasmic,Isoleucyl-tRNA synthetase;, PF08264;PF00133;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0002161;GO:0005524;GO:0051020;GO:0004822;GO:0000049;GO:0006428;GO:0001649;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:GTPase binding; F:isoleucine-tRNA ligase activity; F:tRNA binding;, P:isoleucyl-tRNA aminoacylation; P:osteoblast differentiation; P:tRNA aminoacylation for protein translation; scaffold28 indexed_genome mRNA 25260685 25274875 . - . ID=transcript_6263;Q96SR6 A3KMP6 A8MT55 C9K0V5 Q53ZY8 Q5JPJ2,Zinc finger protein 382,KRAB/zinc finger suppressor protein 1;Multiple zinc finger and krueppel-associated box protein KS1;, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5JVG2 B1AL89 B4DRI2,Zinc finger protein 484,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 25370546 25380565 . + . ID=transcript_6264;A0A1B0GVZ2,Protein FAM240B {ECO:0000305} scaffold28 indexed_genome mRNA 25500588 25507160 . + . ID=transcript_6265;O60911 O60233 Q2TB86 Q5T1U0,Cathepsin L2,Cathepsin U;Cathepsin V;, PF08246;PF00112;, GO:0005576;GO:0005615;GO:0043202;GO:0005764;GO:0004197;GO:0008234;GO:0019886;GO:0022617;GO:0006955;GO:0051603;GO:0045616;, C:extracellular region; C:extracellular space; C:lysosomal lumen; C:lysosome;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:extracellular matrix disassembly; P:immune response; P:proteolysis involved in cellular protein catabolic process; P:regulation of keratinocyte differentiation;|O60911 O60233 Q2TB86 Q5T1U0,Cathepsin L2,Cathepsin U;Cathepsin V;, PF08246;PF00112;, GO:0005576;GO:0005615;GO:0043202;GO:0005764;GO:0004197;GO:0008234;GO:0019886;GO:0022617;GO:0006955;GO:0051603;GO:0045616;, C:extracellular region; C:extracellular space; C:lysosomal lumen; C:lysosome;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:extracellular matrix disassembly; P:immune response; P:proteolysis involved in cellular protein catabolic process; P:regulation of keratinocyte differentiation;|O60911 O60233 Q2TB86 Q5T1U0,Cathepsin L2,Cathepsin U;Cathepsin V;, PF08246;PF00112;, GO:0005576;GO:0005615;GO:0043202;GO:0005764;GO:0004197;GO:0008234;GO:0019886;GO:0022617;GO:0006955;GO:0051603;GO:0045616;, C:extracellular region; C:extracellular space; C:lysosomal lumen; C:lysosome;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:extracellular matrix disassembly; P:immune response; P:proteolysis involved in cellular protein catabolic process; P:regulation of keratinocyte differentiation; scaffold28 indexed_genome mRNA 25561460 25562141 . - . ID=transcript_6266;Q9Y2H8 Q5SZP5,Zinc finger protein 510,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 25594775 25603934 . + . ID=transcript_6267;Q6ZMW2 B2RNR0,Zinc finger protein 782,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 25656744 25659827 . + . ID=transcript_6268;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold28 indexed_genome mRNA 25707428 25830300 . + . ID=transcript_6269;O60729 A6N5X8 A8MQ20 B1AL31 B1AL32 O43183 O60730 Q5JU08,Dual specificity protein phosphatase CDC14B,CDC14 cell division cycle 14 homolog B;, PF14671;, GO:0005813;GO:0005737;GO:0072686;GO:0005730;GO:0005654;GO:0005634;GO:0000922;GO:0106306;GO:0004722;GO:0106307;GO:0004725;GO:0008138;GO:0060271;GO:0006281;GO:0000226;GO:0000278;GO:0071850;GO:0032467;GO:1904668;GO:0006470;GO:0007096;GO:0072425;, C:centrosome; C:cytoplasm; C:mitotic spindle; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle pole;, F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cilium assembly; P:DNA repair; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:mitotic cell cycle arrest; P:positive regulation of cytokinesis; P:positive regulation of ubiquitin protein ligase activity; P:protein dephosphorylation; P:regulation of exit from mitosis; P:signal transduction involved in G2 DNA damage checkpoint; scaffold28 indexed_genome mRNA 25840154 25847703 . - . ID=transcript_6270;Q5JVS0 O75804 Q8WV33 Q9NYJ2,Intracellular hyaluronan-binding protein 4 {ECO:0000303|PubMed:10887182},Hyaluronan-binding protein 4 {ECO:0000312|HGNC:HGNC:17062};Ki-1/57 intracellular antigen {ECO:0000303|PubMed:10887182, ECO:0000303|PubMed:28695742};, PF04774;PF16174;, GO:0015030;GO:0005737;GO:0010494;GO:0005829;GO:0005576;GO:0097504;GO:0005794;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0030017;GO:0016528;GO:0003723;GO:0032183;GO:0071260;GO:0006397;GO:0043392;GO:0002576;GO:0030578;GO:0033120;GO:0045948;GO:0008380;, C:Cajal body; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular region; C:Gemini of coiled bodies; C:Golgi apparatus; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:sarcomere; C:sarcoplasm;, F:RNA binding; F:SUMO binding;, P:cellular response to mechanical stimulus; P:mRNA processing; P:negative regulation of DNA binding; P:platelet degranulation; P:PML body organization; P:positive regulation of RNA splicing; P:positive regulation of translational initiation; P:RNA splicing;|Q5JVS0 O75804 Q8WV33 Q9NYJ2,Intracellular hyaluronan-binding protein 4 {ECO:0000303|PubMed:10887182},Hyaluronan-binding protein 4 {ECO:0000312|HGNC:HGNC:17062};Ki-1/57 intracellular antigen {ECO:0000303|PubMed:10887182, ECO:0000303|PubMed:28695742};, PF04774;PF16174;, GO:0015030;GO:0005737;GO:0010494;GO:0005829;GO:0005576;GO:0097504;GO:0005794;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0030017;GO:0016528;GO:0003723;GO:0032183;GO:0071260;GO:0006397;GO:0043392;GO:0002576;GO:0030578;GO:0033120;GO:0045948;GO:0008380;, C:Cajal body; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular region; C:Gemini of coiled bodies; C:Golgi apparatus; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:sarcomere; C:sarcoplasm;, F:RNA binding; F:SUMO binding;, P:cellular response to mechanical stimulus; P:mRNA processing; P:negative regulation of DNA binding; P:platelet degranulation; P:PML body organization; P:positive regulation of RNA splicing; P:positive regulation of translational initiation; P:RNA splicing; scaffold28 indexed_genome mRNA 25862390 25863336 . + . ID=transcript_6271;Q5JVS0 O75804 Q8WV33 Q9NYJ2,Intracellular hyaluronan-binding protein 4 {ECO:0000303|PubMed:10887182},Hyaluronan-binding protein 4 {ECO:0000312|HGNC:HGNC:17062};Ki-1/57 intracellular antigen {ECO:0000303|PubMed:10887182, ECO:0000303|PubMed:28695742};, PF04774;PF16174;, GO:0015030;GO:0005737;GO:0010494;GO:0005829;GO:0005576;GO:0097504;GO:0005794;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0030017;GO:0016528;GO:0003723;GO:0032183;GO:0071260;GO:0006397;GO:0043392;GO:0002576;GO:0030578;GO:0033120;GO:0045948;GO:0008380;, C:Cajal body; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular region; C:Gemini of coiled bodies; C:Golgi apparatus; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:sarcomere; C:sarcoplasm;, F:RNA binding; F:SUMO binding;, P:cellular response to mechanical stimulus; P:mRNA processing; P:negative regulation of DNA binding; P:platelet degranulation; P:PML body organization; P:positive regulation of RNA splicing; P:positive regulation of translational initiation; P:RNA splicing; scaffold28 indexed_genome mRNA 25927464 25949997 . + . ID=transcript_6272;Q7RTV3 Q6Q7C8,Zinc finger protein 367,C2H2 zinc finger protein ZFF29;, PF00096;, GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 25951681 26008553 . + . ID=transcript_6273;Q76EJ3 O95454 Q498C1 Q75W21 Q7Z5X5,UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter,Homolog of Fringe connection protein 1;SQV7-like protein;Solute carrier family 35 member D2;UDP-galactose transporter-related protein 8;, PF03151;, GO:0005794;GO:0000139;GO:0016021;GO:0015297;GO:0005338;GO:0005461;GO:0005463;GO:0005462;GO:0008643;GO:0006024;GO:0018146;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:antiporter activity; F:nucleotide-sugar transmembrane transporter activity; F:UDP-glucuronic acid transmembrane transporter activity; F:UDP-N-acetylgalactosamine transmembrane transporter activity; F:UDP-N-acetylglucosamine transmembrane transporter activity;, P:carbohydrate transport; P:glycosaminoglycan biosynthetic process; P:keratan sulfate biosynthetic process;|Q76EJ3 O95454 Q498C1 Q75W21 Q7Z5X5,UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter,Homolog of Fringe connection protein 1;SQV7-like protein;Solute carrier family 35 member D2;UDP-galactose transporter-related protein 8;, PF03151;, GO:0005794;GO:0000139;GO:0016021;GO:0015297;GO:0005338;GO:0005461;GO:0005463;GO:0005462;GO:0008643;GO:0006024;GO:0018146;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:antiporter activity; F:nucleotide-sugar transmembrane transporter activity; F:UDP-glucuronic acid transmembrane transporter activity; F:UDP-N-acetylgalactosamine transmembrane transporter activity; F:UDP-N-acetylglucosamine transmembrane transporter activity;, P:carbohydrate transport; P:glycosaminoglycan biosynthetic process; P:keratan sulfate biosynthetic process; scaffold28 indexed_genome mRNA 26333683 26366879 . - . ID=transcript_6274;Q5T890 A4D997 B2RTP8 Q49AM9 Q5T892 Q8N663 Q8N9D0 Q9NPM7,DNA excision repair protein ERCC-6-like 2,DNA repair and recombination protein RAD26-like;, PF00271;PF00176;PF14773;, GO:0005737;GO:0005815;GO:0005739;GO:0005634;GO:0032991;GO:0005524;GO:0003677;GO:0004386;GO:0070615;GO:0019901;GO:0034614;GO:0036297;, C:cytoplasm; C:microtubule organizing center; C:mitochondrion; C:nucleus; C:protein-containing complex;, F:ATP binding; F:DNA binding; F:helicase activity; F:nucleosome-dependent ATPase activity; F:protein kinase binding;, P:cellular response to reactive oxygen species; P:interstrand cross-link repair; scaffold28 indexed_genome mRNA 26370908 26425458 . - . ID=transcript_6275;Q5T890 A4D997 B2RTP8 Q49AM9 Q5T892 Q8N663 Q8N9D0 Q9NPM7,DNA excision repair protein ERCC-6-like 2,DNA repair and recombination protein RAD26-like;, PF00271;PF00176;PF14773;, GO:0005737;GO:0005815;GO:0005739;GO:0005634;GO:0032991;GO:0005524;GO:0003677;GO:0004386;GO:0070615;GO:0019901;GO:0034614;GO:0036297;, C:cytoplasm; C:microtubule organizing center; C:mitochondrion; C:nucleus; C:protein-containing complex;, F:ATP binding; F:DNA binding; F:helicase activity; F:nucleosome-dependent ATPase activity; F:protein kinase binding;, P:cellular response to reactive oxygen species; P:interstrand cross-link repair; scaffold28 indexed_genome mRNA 26916872 26917810 . - . ID=transcript_6276;Q86XG7,Protein patched homolog 1,, PF02460;, GO:0045177;GO:0044295;GO:0005901;GO:0060170;GO:0044294;GO:0030666;GO:0016021;GO:0043231;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0015485;GO:0030332;GO:0097108;GO:0008158;GO:0008201;GO:0005113;GO:0044877;GO:0005119;GO:0009887;GO:0007420;GO:0001658;GO:0061005;GO:0001709;GO:0072203;GO:0071397;GO:0071679;GO:0009953;GO:0030326;GO:0048568;GO:0009957;GO:0042593;GO:0003007;GO:0035137;GO:0001701;GO:0043616;GO:0035108;GO:0097421;GO:0060603;GO:0060644;GO:0072205;GO:0051782;GO:0043433;GO:0050680;GO:0040015;GO:0045668;GO:0045879;GO:0000122;GO:0021997;GO:0001843;GO:0021532;GO:0060037;GO:0010875;GO:0045606;GO:0045893;GO:0030850;GO:0072659;GO:0016485;GO:0007346;GO:0032880;GO:0008589;GO:0010157;GO:0042493;GO:0032355;GO:0009612;GO:0032526;GO:0048745;GO:0007224;GO:0060831;GO:0061053;GO:0021522;, C:apical part of cell; C:axonal growth cone; C:caveola; C:ciliary membrane; C:dendritic growth cone; C:endocytic vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:cholesterol binding; F:cyclin binding; F:hedgehog family protein binding; F:hedgehog receptor activity; F:heparin binding; F:patched binding; F:protein-containing complex binding; F:smoothened binding;, P:animal organ morphogenesis; P:brain development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation involved in kidney development; P:cell fate determination; P:cell proliferation involved in metanephros development; P:cellular response to cholesterol; P:commissural neuron axon guidance; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:embryonic organ development; P:epidermal cell fate specification; P:glucose homeostasis; P:heart morphogenesis; P:hindlimb morphogenesis; P:in utero embryonic development; P:keratinocyte proliferation; P:limb morphogenesis; P:liver regeneration; P:mammary gland duct morphogenesis; P:mammary gland epithelial cell differentiation; P:metanephric collecting duct development; P:negative regulation of cell division; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of multicellular organism growth; P:negative regulation of osteoblast differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neural plate axis specification; P:neural tube closure; P:neural tube patterning; P:pharyngeal system development; P:positive regulation of cholesterol efflux; P:positive regulation of epidermal cell differentiation; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:protein localization to plasma membrane; P:protein processing; P:regulation of mitotic cell cycle; P:regulation of protein localization; P:regulation of smoothened signaling pathway; P:response to chlorate; P:response to drug; P:response to estradiol; P:response to mechanical stimulus; P:response to retinoic acid; P:smooth muscle tissue development; P:smoothened signaling pathway; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:somite development; P:spinal cord motor neuron differentiation; scaffold28 indexed_genome mRNA 26934983 26935705 . + . ID=transcript_6277;Q86XG7,Protein patched homolog 1,, PF02460;, GO:0045177;GO:0044295;GO:0005901;GO:0060170;GO:0044294;GO:0030666;GO:0016021;GO:0043231;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0015485;GO:0030332;GO:0097108;GO:0008158;GO:0008201;GO:0005113;GO:0044877;GO:0005119;GO:0009887;GO:0007420;GO:0001658;GO:0061005;GO:0001709;GO:0072203;GO:0071397;GO:0071679;GO:0009953;GO:0030326;GO:0048568;GO:0009957;GO:0042593;GO:0003007;GO:0035137;GO:0001701;GO:0043616;GO:0035108;GO:0097421;GO:0060603;GO:0060644;GO:0072205;GO:0051782;GO:0043433;GO:0050680;GO:0040015;GO:0045668;GO:0045879;GO:0000122;GO:0021997;GO:0001843;GO:0021532;GO:0060037;GO:0010875;GO:0045606;GO:0045893;GO:0030850;GO:0072659;GO:0016485;GO:0007346;GO:0032880;GO:0008589;GO:0010157;GO:0042493;GO:0032355;GO:0009612;GO:0032526;GO:0048745;GO:0007224;GO:0060831;GO:0061053;GO:0021522;, C:apical part of cell; C:axonal growth cone; C:caveola; C:ciliary membrane; C:dendritic growth cone; C:endocytic vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:cholesterol binding; F:cyclin binding; F:hedgehog family protein binding; F:hedgehog receptor activity; F:heparin binding; F:patched binding; F:protein-containing complex binding; F:smoothened binding;, P:animal organ morphogenesis; P:brain development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation involved in kidney development; P:cell fate determination; P:cell proliferation involved in metanephros development; P:cellular response to cholesterol; P:commissural neuron axon guidance; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:embryonic organ development; P:epidermal cell fate specification; P:glucose homeostasis; P:heart morphogenesis; P:hindlimb morphogenesis; P:in utero embryonic development; P:keratinocyte proliferation; P:limb morphogenesis; P:liver regeneration; P:mammary gland duct morphogenesis; P:mammary gland epithelial cell differentiation; P:metanephric collecting duct development; P:negative regulation of cell division; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of multicellular organism growth; P:negative regulation of osteoblast differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neural plate axis specification; P:neural tube closure; P:neural tube patterning; P:pharyngeal system development; P:positive regulation of cholesterol efflux; P:positive regulation of epidermal cell differentiation; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:protein localization to plasma membrane; P:protein processing; P:regulation of mitotic cell cycle; P:regulation of protein localization; P:regulation of smoothened signaling pathway; P:response to chlorate; P:response to drug; P:response to estradiol; P:response to mechanical stimulus; P:response to retinoic acid; P:smooth muscle tissue development; P:smoothened signaling pathway; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:somite development; P:spinal cord motor neuron differentiation; scaffold28 indexed_genome mRNA 26936710 26937945 . - . ID=transcript_6278;Q86XG7,Protein patched homolog 1,, PF02460;, GO:0045177;GO:0044295;GO:0005901;GO:0060170;GO:0044294;GO:0030666;GO:0016021;GO:0043231;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0015485;GO:0030332;GO:0097108;GO:0008158;GO:0008201;GO:0005113;GO:0044877;GO:0005119;GO:0009887;GO:0007420;GO:0001658;GO:0061005;GO:0001709;GO:0072203;GO:0071397;GO:0071679;GO:0009953;GO:0030326;GO:0048568;GO:0009957;GO:0042593;GO:0003007;GO:0035137;GO:0001701;GO:0043616;GO:0035108;GO:0097421;GO:0060603;GO:0060644;GO:0072205;GO:0051782;GO:0043433;GO:0050680;GO:0040015;GO:0045668;GO:0045879;GO:0000122;GO:0021997;GO:0001843;GO:0021532;GO:0060037;GO:0010875;GO:0045606;GO:0045893;GO:0030850;GO:0072659;GO:0016485;GO:0007346;GO:0032880;GO:0008589;GO:0010157;GO:0042493;GO:0032355;GO:0009612;GO:0032526;GO:0048745;GO:0007224;GO:0060831;GO:0061053;GO:0021522;, C:apical part of cell; C:axonal growth cone; C:caveola; C:ciliary membrane; C:dendritic growth cone; C:endocytic vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:cholesterol binding; F:cyclin binding; F:hedgehog family protein binding; F:hedgehog receptor activity; F:heparin binding; F:patched binding; F:protein-containing complex binding; F:smoothened binding;, P:animal organ morphogenesis; P:brain development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation involved in kidney development; P:cell fate determination; P:cell proliferation involved in metanephros development; P:cellular response to cholesterol; P:commissural neuron axon guidance; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:embryonic organ development; P:epidermal cell fate specification; P:glucose homeostasis; P:heart morphogenesis; P:hindlimb morphogenesis; P:in utero embryonic development; P:keratinocyte proliferation; P:limb morphogenesis; P:liver regeneration; P:mammary gland duct morphogenesis; P:mammary gland epithelial cell differentiation; P:metanephric collecting duct development; P:negative regulation of cell division; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of multicellular organism growth; P:negative regulation of osteoblast differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neural plate axis specification; P:neural tube closure; P:neural tube patterning; P:pharyngeal system development; P:positive regulation of cholesterol efflux; P:positive regulation of epidermal cell differentiation; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:protein localization to plasma membrane; P:protein processing; P:regulation of mitotic cell cycle; P:regulation of protein localization; P:regulation of smoothened signaling pathway; P:response to chlorate; P:response to drug; P:response to estradiol; P:response to mechanical stimulus; P:response to retinoic acid; P:smooth muscle tissue development; P:smoothened signaling pathway; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:somite development; P:spinal cord motor neuron differentiation; scaffold28 indexed_genome mRNA 26938269 26951880 . + . ID=transcript_6279;Q86XG7,Protein patched homolog 1,, PF02460;, GO:0045177;GO:0044295;GO:0005901;GO:0060170;GO:0044294;GO:0030666;GO:0016021;GO:0043231;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0015485;GO:0030332;GO:0097108;GO:0008158;GO:0008201;GO:0005113;GO:0044877;GO:0005119;GO:0009887;GO:0007420;GO:0001658;GO:0061005;GO:0001709;GO:0072203;GO:0071397;GO:0071679;GO:0009953;GO:0030326;GO:0048568;GO:0009957;GO:0042593;GO:0003007;GO:0035137;GO:0001701;GO:0043616;GO:0035108;GO:0097421;GO:0060603;GO:0060644;GO:0072205;GO:0051782;GO:0043433;GO:0050680;GO:0040015;GO:0045668;GO:0045879;GO:0000122;GO:0021997;GO:0001843;GO:0021532;GO:0060037;GO:0010875;GO:0045606;GO:0045893;GO:0030850;GO:0072659;GO:0016485;GO:0007346;GO:0032880;GO:0008589;GO:0010157;GO:0042493;GO:0032355;GO:0009612;GO:0032526;GO:0048745;GO:0007224;GO:0060831;GO:0061053;GO:0021522;, C:apical part of cell; C:axonal growth cone; C:caveola; C:ciliary membrane; C:dendritic growth cone; C:endocytic vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:cholesterol binding; F:cyclin binding; F:hedgehog family protein binding; F:hedgehog receptor activity; F:heparin binding; F:patched binding; F:protein-containing complex binding; F:smoothened binding;, P:animal organ morphogenesis; P:brain development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation involved in kidney development; P:cell fate determination; P:cell proliferation involved in metanephros development; P:cellular response to cholesterol; P:commissural neuron axon guidance; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:embryonic organ development; P:epidermal cell fate specification; P:glucose homeostasis; P:heart morphogenesis; P:hindlimb morphogenesis; P:in utero embryonic development; P:keratinocyte proliferation; P:limb morphogenesis; P:liver regeneration; P:mammary gland duct morphogenesis; P:mammary gland epithelial cell differentiation; P:metanephric collecting duct development; P:negative regulation of cell division; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of multicellular organism growth; P:negative regulation of osteoblast differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neural plate axis specification; P:neural tube closure; P:neural tube patterning; P:pharyngeal system development; P:positive regulation of cholesterol efflux; P:positive regulation of epidermal cell differentiation; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:protein localization to plasma membrane; P:protein processing; P:regulation of mitotic cell cycle; P:regulation of protein localization; P:regulation of smoothened signaling pathway; P:response to chlorate; P:response to drug; P:response to estradiol; P:response to mechanical stimulus; P:response to retinoic acid; P:smooth muscle tissue development; P:smoothened signaling pathway; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:somite development; P:spinal cord motor neuron differentiation;|Q86XG7,Protein patched homolog 1,, PF02460;, GO:0045177;GO:0044295;GO:0005901;GO:0060170;GO:0044294;GO:0030666;GO:0016021;GO:0043231;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0015485;GO:0030332;GO:0097108;GO:0008158;GO:0008201;GO:0005113;GO:0044877;GO:0005119;GO:0009887;GO:0007420;GO:0001658;GO:0061005;GO:0001709;GO:0072203;GO:0071397;GO:0071679;GO:0009953;GO:0030326;GO:0048568;GO:0009957;GO:0042593;GO:0003007;GO:0035137;GO:0001701;GO:0043616;GO:0035108;GO:0097421;GO:0060603;GO:0060644;GO:0072205;GO:0051782;GO:0043433;GO:0050680;GO:0040015;GO:0045668;GO:0045879;GO:0000122;GO:0021997;GO:0001843;GO:0021532;GO:0060037;GO:0010875;GO:0045606;GO:0045893;GO:0030850;GO:0072659;GO:0016485;GO:0007346;GO:0032880;GO:0008589;GO:0010157;GO:0042493;GO:0032355;GO:0009612;GO:0032526;GO:0048745;GO:0007224;GO:0060831;GO:0061053;GO:0021522;, C:apical part of cell; C:axonal growth cone; C:caveola; C:ciliary membrane; C:dendritic growth cone; C:endocytic vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:cholesterol binding; F:cyclin binding; F:hedgehog family protein binding; F:hedgehog receptor activity; F:heparin binding; F:patched binding; F:protein-containing complex binding; F:smoothened binding;, P:animal organ morphogenesis; P:brain development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation involved in kidney development; P:cell fate determination; P:cell proliferation involved in metanephros development; P:cellular response to cholesterol; P:commissural neuron axon guidance; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:embryonic organ development; P:epidermal cell fate specification; P:glucose homeostasis; P:heart morphogenesis; P:hindlimb morphogenesis; P:in utero embryonic development; P:keratinocyte proliferation; P:limb morphogenesis; P:liver regeneration; P:mammary gland duct morphogenesis; P:mammary gland epithelial cell differentiation; P:metanephric collecting duct development; P:negative regulation of cell division; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of multicellular organism growth; P:negative regulation of osteoblast differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neural plate axis specification; P:neural tube closure; P:neural tube patterning; P:pharyngeal system development; P:positive regulation of cholesterol efflux; P:positive regulation of epidermal cell differentiation; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:protein localization to plasma membrane; P:protein processing; P:regulation of mitotic cell cycle; P:regulation of protein localization; P:regulation of smoothened signaling pathway; P:response to chlorate; P:response to drug; P:response to estradiol; P:response to mechanical stimulus; P:response to retinoic acid; P:smooth muscle tissue development; P:smoothened signaling pathway; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:somite development; P:spinal cord motor neuron differentiation;|Q86XG7,Protein patched homolog 1,, PF02460;, GO:0045177;GO:0044295;GO:0005901;GO:0060170;GO:0044294;GO:0030666;GO:0016021;GO:0043231;GO:0030496;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0015485;GO:0030332;GO:0097108;GO:0008158;GO:0008201;GO:0005113;GO:0044877;GO:0005119;GO:0009887;GO:0007420;GO:0001658;GO:0061005;GO:0001709;GO:0072203;GO:0071397;GO:0071679;GO:0009953;GO:0030326;GO:0048568;GO:0009957;GO:0042593;GO:0003007;GO:0035137;GO:0001701;GO:0043616;GO:0035108;GO:0097421;GO:0060603;GO:0060644;GO:0072205;GO:0051782;GO:0043433;GO:0050680;GO:0040015;GO:0045668;GO:0045879;GO:0000122;GO:0021997;GO:0001843;GO:0021532;GO:0060037;GO:0010875;GO:0045606;GO:0045893;GO:0030850;GO:0072659;GO:0016485;GO:0007346;GO:0032880;GO:0008589;GO:0010157;GO:0042493;GO:0032355;GO:0009612;GO:0032526;GO:0048745;GO:0007224;GO:0060831;GO:0061053;GO:0021522;, C:apical part of cell; C:axonal growth cone; C:caveola; C:ciliary membrane; C:dendritic growth cone; C:endocytic vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:cholesterol binding; F:cyclin binding; F:hedgehog family protein binding; F:hedgehog receptor activity; F:heparin binding; F:patched binding; F:protein-containing complex binding; F:smoothened binding;, P:animal organ morphogenesis; P:brain development; P:branching involved in ureteric bud morphogenesis; P:cell differentiation involved in kidney development; P:cell fate determination; P:cell proliferation involved in metanephros development; P:cellular response to cholesterol; P:commissural neuron axon guidance; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:embryonic organ development; P:epidermal cell fate specification; P:glucose homeostasis; P:heart morphogenesis; P:hindlimb morphogenesis; P:in utero embryonic development; P:keratinocyte proliferation; P:limb morphogenesis; P:liver regeneration; P:mammary gland duct morphogenesis; P:mammary gland epithelial cell differentiation; P:metanephric collecting duct development; P:negative regulation of cell division; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of multicellular organism growth; P:negative regulation of osteoblast differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neural plate axis specification; P:neural tube closure; P:neural tube patterning; P:pharyngeal system development; P:positive regulation of cholesterol efflux; P:positive regulation of epidermal cell differentiation; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:protein localization to plasma membrane; P:protein processing; P:regulation of mitotic cell cycle; P:regulation of protein localization; P:regulation of smoothened signaling pathway; P:response to chlorate; P:response to drug; P:response to estradiol; P:response to mechanical stimulus; P:response to retinoic acid; P:smooth muscle tissue development; P:smoothened signaling pathway; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:somite development; P:spinal cord motor neuron differentiation; scaffold28 indexed_genome mRNA 27169233 27375696 . + . ID=transcript_6280;Q00597 B1ALR8,Fanconi anemia group C protein,, PF02106;, GO:0005737;GO:0005829;GO:0043240;GO:0005654;GO:0005634;GO:0048854;GO:0034599;GO:0006281;GO:0007281;GO:0036297;GO:0002262;GO:0097150;GO:0006289;GO:0065003;GO:0019430;, C:cytoplasm; C:cytosol; C:Fanconi anaemia nuclear complex; C:nucleoplasm; C:nucleus;, , P:brain morphogenesis; P:cellular response to oxidative stress; P:DNA repair; P:germ cell development; P:interstrand cross-link repair; P:myeloid cell homeostasis; P:neuronal stem cell population maintenance; P:nucleotide-excision repair; P:protein-containing complex assembly; P:removal of superoxide radicals;|Q00597 B1ALR8,Fanconi anemia group C protein,, PF02106;, GO:0005737;GO:0005829;GO:0043240;GO:0005654;GO:0005634;GO:0048854;GO:0034599;GO:0006281;GO:0007281;GO:0036297;GO:0002262;GO:0097150;GO:0006289;GO:0065003;GO:0019430;, C:cytoplasm; C:cytosol; C:Fanconi anaemia nuclear complex; C:nucleoplasm; C:nucleus;, , P:brain morphogenesis; P:cellular response to oxidative stress; P:DNA repair; P:germ cell development; P:interstrand cross-link repair; P:myeloid cell homeostasis; P:neuronal stem cell population maintenance; P:nucleotide-excision repair; P:protein-containing complex assembly; P:removal of superoxide radicals; scaffold28 indexed_genome mRNA 27387105 27676502 . - . ID=transcript_6281;Q8N6M6 Q5T9B1 Q5T9B3 Q5T9B4 Q8WUL6 Q96M23 Q96SS1,Aminopeptidase O {ECO:0000305},, PF09127;PF01433;, GO:0005829;GO:0005730;GO:0070006;GO:0008270;GO:0002003;, C:cytosol; C:nucleolus;, F:metalloaminopeptidase activity; F:zinc ion binding;, P:angiotensin maturation;|Q8N6M6 Q5T9B1 Q5T9B3 Q5T9B4 Q8WUL6 Q96M23 Q96SS1,Aminopeptidase O {ECO:0000305},, PF09127;PF01433;, GO:0005829;GO:0005730;GO:0070006;GO:0008270;GO:0002003;, C:cytosol; C:nucleolus;, F:metalloaminopeptidase activity; F:zinc ion binding;, P:angiotensin maturation;|Q8N6M6 Q5T9B1 Q5T9B3 Q5T9B4 Q8WUL6 Q96M23 Q96SS1,Aminopeptidase O {ECO:0000305},, PF09127;PF01433;, GO:0005829;GO:0005730;GO:0070006;GO:0008270;GO:0002003;, C:cytosol; C:nucleolus;, F:metalloaminopeptidase activity; F:zinc ion binding;, P:angiotensin maturation; scaffold28 indexed_genome mRNA 27709216 27712215 . - . ID=transcript_6282;Q8N6M6 Q5T9B1 Q5T9B3 Q5T9B4 Q8WUL6 Q96M23 Q96SS1,Aminopeptidase O {ECO:0000305},, PF09127;PF01433;, GO:0005829;GO:0005730;GO:0070006;GO:0008270;GO:0002003;, C:cytosol; C:nucleolus;, F:metalloaminopeptidase activity; F:zinc ion binding;, P:angiotensin maturation; scaffold28 indexed_genome mRNA 27890828 27919759 . + . ID=transcript_6283;P09467 O75571 Q53F94 Q96E46,Fructose-1,6-bisphosphatase 1,D-fructose-1,6-bisphosphate 1-phosphohydrolase 1;Liver FBPase;, PF00316;PF18913;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0016208;GO:0042132;GO:0042802;GO:0046872;GO:0048029;GO:0001085;GO:0035690;GO:0071286;GO:0016311;GO:0030388;GO:0006002;GO:0006000;GO:0006094;GO:0030308;GO:0045820;GO:0046580;GO:0000122;GO:0006111;GO:0005986;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:AMP binding; F:fructose 1,6-bisphosphate 1-phosphatase activity; F:identical protein binding; F:metal ion binding; F:monosaccharide binding; F:RNA polymerase II transcription factor binding;, P:cellular response to drug; P:cellular response to magnesium ion; P:dephosphorylation; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:negative regulation of cell growth; P:negative regulation of glycolytic process; P:negative regulation of Ras protein signal transduction; P:negative regulation of transcription by RNA polymerase II; P:regulation of gluconeogenesis; P:sucrose biosynthetic process;|P09467 O75571 Q53F94 Q96E46,Fructose-1,6-bisphosphatase 1,D-fructose-1,6-bisphosphate 1-phosphohydrolase 1;Liver FBPase;, PF00316;PF18913;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0016208;GO:0042132;GO:0042802;GO:0046872;GO:0048029;GO:0001085;GO:0035690;GO:0071286;GO:0016311;GO:0030388;GO:0006002;GO:0006000;GO:0006094;GO:0030308;GO:0045820;GO:0046580;GO:0000122;GO:0006111;GO:0005986;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:AMP binding; F:fructose 1,6-bisphosphate 1-phosphatase activity; F:identical protein binding; F:metal ion binding; F:monosaccharide binding; F:RNA polymerase II transcription factor binding;, P:cellular response to drug; P:cellular response to magnesium ion; P:dephosphorylation; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:negative regulation of cell growth; P:negative regulation of glycolytic process; P:negative regulation of Ras protein signal transduction; P:negative regulation of transcription by RNA polymerase II; P:regulation of gluconeogenesis; P:sucrose biosynthetic process;|P09467 O75571 Q53F94 Q96E46,Fructose-1,6-bisphosphatase 1,D-fructose-1,6-bisphosphate 1-phosphohydrolase 1;Liver FBPase;, PF00316;PF18913;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0016208;GO:0042132;GO:0042802;GO:0046872;GO:0048029;GO:0001085;GO:0035690;GO:0071286;GO:0016311;GO:0030388;GO:0006002;GO:0006000;GO:0006094;GO:0030308;GO:0045820;GO:0046580;GO:0000122;GO:0006111;GO:0005986;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:AMP binding; F:fructose 1,6-bisphosphate 1-phosphatase activity; F:identical protein binding; F:metal ion binding; F:monosaccharide binding; F:RNA polymerase II transcription factor binding;, P:cellular response to drug; P:cellular response to magnesium ion; P:dephosphorylation; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:negative regulation of cell growth; P:negative regulation of glycolytic process; P:negative regulation of Ras protein signal transduction; P:negative regulation of transcription by RNA polymerase II; P:regulation of gluconeogenesis; P:sucrose biosynthetic process; scaffold28 indexed_genome mRNA 27937872 27980906 . + . ID=transcript_6284;O00757 Q17R39 Q6FI53,Fructose-1,6-bisphosphatase isozyme 2,D-fructose-1,6-bisphosphate 1-phosphohydrolase 2;Muscle FBPase;, PF00316;PF18913;, GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0030018;GO:0042132;GO:0042802;GO:0046872;GO:0030388;GO:0006002;GO:0006000;GO:0006094;GO:0005986;, C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:Z disc;, F:fructose 1,6-bisphosphate 1-phosphatase activity; F:identical protein binding; F:metal ion binding;, P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:sucrose biosynthetic process; scaffold28 indexed_genome mRNA 27995902 28000789 . - . ID=transcript_6285;P07711 Q6IAV1 Q96QJ0,Procathepsin L {ECO:0000305},Cathepsin L1 {ECO:0000305};Major excreted protein;, PF08246;PF00112;, GO:0016324;GO:0042583;GO:0062023;GO:0071682;GO:0036021;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0043231;GO:0043202;GO:0005764;GO:0005771;GO:0005634;GO:0005886;GO:0005518;GO:0004197;GO:0008234;GO:0001968;GO:0042393;GO:0043394;GO:0097655;GO:0002250;GO:0019882;GO:0019886;GO:0048002;GO:0043373;GO:0097067;GO:0030574;GO:0060309;GO:0034230;GO:0022617;GO:0039654;GO:0019064;GO:0006955;GO:0071888;GO:0016540;GO:0006508;GO:0051603;GO:0019065;GO:0045616;GO:0002224;GO:0046718;GO:0031638;, C:apical plasma membrane; C:chromaffin granule; C:collagen-containing extracellular matrix; C:endocytic vesicle lumen; C:endolysosome lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:multivesicular body; C:nucleus; C:plasma membrane;, F:collagen binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:fibronectin binding; F:histone binding; F:proteoglycan binding; F:serpin family protein binding;, P:adaptive immune response; P:antigen processing and presentation; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen; P:CD4-positive, alpha-beta T cell lineage commitment; P:cellular response to thyroid hormone stimulus; P:collagen catabolic process; P:elastin catabolic process; P:enkephalin processing; P:extracellular matrix disassembly; P:fusion of virus membrane with host endosome membrane; P:fusion of virus membrane with host plasma membrane; P:immune response; P:macrophage apoptotic process; P:protein autoprocessing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:receptor-mediated endocytosis of virus by host cell; P:regulation of keratinocyte differentiation; P:toll-like receptor signaling pathway; P:viral entry into host cell; P:zymogen activation; scaffold28 indexed_genome mRNA 28065278 28269778 . - . ID=transcript_6286;P53355 B7ZLD2 B7ZLE7 Q14CQ7 Q1W5W0 Q68CP8 Q6ZRZ3 Q9BTL8,Death-associated protein kinase 1,, PF12796;PF00531;PF00069;, GO:0015629;GO:0005737;GO:0005634;GO:0005886;GO:0005524;GO:0005516;GO:0004683;GO:0005525;GO:0042802;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0017075;GO:0006915;GO:0097190;GO:0071447;GO:0071346;GO:0002357;GO:0035556;GO:0017148;GO:0043065;GO:0010508;GO:0043280;GO:0046777;GO:0006468;GO:0042981;GO:0010506;GO:2000310;, C:actin cytoskeleton; C:cytoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:GTP binding; F:identical protein binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:syntaxin-1 binding;, P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to hydroperoxide; P:cellular response to interferon-gamma; P:defense response to tumor cell; P:intracellular signal transduction; P:negative regulation of translation; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of NMDA receptor activity;|P53355 B7ZLD2 B7ZLE7 Q14CQ7 Q1W5W0 Q68CP8 Q6ZRZ3 Q9BTL8,Death-associated protein kinase 1,, PF12796;PF00531;PF00069;, GO:0015629;GO:0005737;GO:0005634;GO:0005886;GO:0005524;GO:0005516;GO:0004683;GO:0005525;GO:0042802;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0017075;GO:0006915;GO:0097190;GO:0071447;GO:0071346;GO:0002357;GO:0035556;GO:0017148;GO:0043065;GO:0010508;GO:0043280;GO:0046777;GO:0006468;GO:0042981;GO:0010506;GO:2000310;, C:actin cytoskeleton; C:cytoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:GTP binding; F:identical protein binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:syntaxin-1 binding;, P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to hydroperoxide; P:cellular response to interferon-gamma; P:defense response to tumor cell; P:intracellular signal transduction; P:negative regulation of translation; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of NMDA receptor activity;|P53355 B7ZLD2 B7ZLE7 Q14CQ7 Q1W5W0 Q68CP8 Q6ZRZ3 Q9BTL8,Death-associated protein kinase 1,, PF12796;PF00531;PF00069;, GO:0015629;GO:0005737;GO:0005634;GO:0005886;GO:0005524;GO:0005516;GO:0004683;GO:0005525;GO:0042802;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0017075;GO:0006915;GO:0097190;GO:0071447;GO:0071346;GO:0002357;GO:0035556;GO:0017148;GO:0043065;GO:0010508;GO:0043280;GO:0046777;GO:0006468;GO:0042981;GO:0010506;GO:2000310;, C:actin cytoskeleton; C:cytoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:GTP binding; F:identical protein binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:syntaxin-1 binding;, P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to hydroperoxide; P:cellular response to interferon-gamma; P:defense response to tumor cell; P:intracellular signal transduction; P:negative regulation of translation; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of NMDA receptor activity;|P53355 B7ZLD2 B7ZLE7 Q14CQ7 Q1W5W0 Q68CP8 Q6ZRZ3 Q9BTL8,Death-associated protein kinase 1,, PF12796;PF00531;PF00069;, GO:0015629;GO:0005737;GO:0005634;GO:0005886;GO:0005524;GO:0005516;GO:0004683;GO:0005525;GO:0042802;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0017075;GO:0006915;GO:0097190;GO:0071447;GO:0071346;GO:0002357;GO:0035556;GO:0017148;GO:0043065;GO:0010508;GO:0043280;GO:0046777;GO:0006468;GO:0042981;GO:0010506;GO:2000310;, C:actin cytoskeleton; C:cytoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:GTP binding; F:identical protein binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:syntaxin-1 binding;, P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to hydroperoxide; P:cellular response to interferon-gamma; P:defense response to tumor cell; P:intracellular signal transduction; P:negative regulation of translation; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of NMDA receptor activity; scaffold28 indexed_genome mRNA 29384276 29441925 . + . ID=transcript_6287;Q96NE8 Q9C0F2 Q9H8M6,Terminal uridylyltransferase 7 {ECO:0000305},Zinc finger CCHC domain-containing protein 6;, PF03828;PF00098;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035198;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0070569;GO:0008270;GO:0010586;GO:0006378;GO:0006397;GO:0010526;GO:0000289;GO:0001556;GO:1990074;GO:0031054;GO:0071076;GO:0031123;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:miRNA binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:uridylyltransferase activity; F:zinc ion binding;, P:miRNA metabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of transposition, RNA-mediated; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oocyte maturation; P:polyuridylation-dependent mRNA catabolic process; P:pre-miRNA processing; P:RNA 3' uridylation; P:RNA 3'-end processing;|Q96NE8 Q9C0F2 Q9H8M6,Terminal uridylyltransferase 7 {ECO:0000305},Zinc finger CCHC domain-containing protein 6;, PF03828;PF00098;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035198;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0070569;GO:0008270;GO:0010586;GO:0006378;GO:0006397;GO:0010526;GO:0000289;GO:0001556;GO:1990074;GO:0031054;GO:0071076;GO:0031123;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:miRNA binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:uridylyltransferase activity; F:zinc ion binding;, P:miRNA metabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of transposition, RNA-mediated; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oocyte maturation; P:polyuridylation-dependent mRNA catabolic process; P:pre-miRNA processing; P:RNA 3' uridylation; P:RNA 3'-end processing;|Q96NE8 Q9C0F2 Q9H8M6,Terminal uridylyltransferase 7 {ECO:0000305},Zinc finger CCHC domain-containing protein 6;, PF03828;PF00098;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035198;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0070569;GO:0008270;GO:0010586;GO:0006378;GO:0006397;GO:0010526;GO:0000289;GO:0001556;GO:1990074;GO:0031054;GO:0071076;GO:0031123;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:miRNA binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:uridylyltransferase activity; F:zinc ion binding;, P:miRNA metabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of transposition, RNA-mediated; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oocyte maturation; P:polyuridylation-dependent mRNA catabolic process; P:pre-miRNA processing; P:RNA 3' uridylation; P:RNA 3'-end processing;|Q96NE8 Q9C0F2 Q9H8M6,Terminal uridylyltransferase 7 {ECO:0000305},Zinc finger CCHC domain-containing protein 6;, PF03828;PF00098;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0035198;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0070569;GO:0008270;GO:0010586;GO:0006378;GO:0006397;GO:0010526;GO:0000289;GO:0001556;GO:1990074;GO:0031054;GO:0071076;GO:0031123;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:miRNA binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:uridylyltransferase activity; F:zinc ion binding;, P:miRNA metabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of transposition, RNA-mediated; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oocyte maturation; P:polyuridylation-dependent mRNA catabolic process; P:pre-miRNA processing; P:RNA 3' uridylation; P:RNA 3'-end processing; scaffold28 indexed_genome mRNA 29446921 29459581 . + . ID=transcript_6288;Q9BUE6 B3KP34 B4DJI5 Q8ND75 Q9BZR2,Iron-sulfur cluster assembly 1 homolog, mitochondrial,HESB-like domain-containing protein 2;Iron-sulfur assembly protein IscA;, PF01521;, GO:0005737;GO:0005759;GO:0005739;GO:0051537;GO:0046872;GO:0016226;GO:0097428;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding;, P:iron-sulfur cluster assembly; P:protein maturation by iron-sulfur cluster transfer;|Q9BUE6 B3KP34 B4DJI5 Q8ND75 Q9BZR2,Iron-sulfur cluster assembly 1 homolog, mitochondrial,HESB-like domain-containing protein 2;Iron-sulfur assembly protein IscA;, PF01521;, GO:0005737;GO:0005759;GO:0005739;GO:0051537;GO:0046872;GO:0016226;GO:0097428;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding;, P:iron-sulfur cluster assembly; P:protein maturation by iron-sulfur cluster transfer; scaffold28 indexed_genome mRNA 29630930 29646593 . + . ID=transcript_6289;Q8NBJ4 Q6IAF4 Q9NRB9,Golgi membrane protein 1,Golgi membrane protein GP73;Golgi phosphoprotein 2;, , GO:0005788;GO:0005615;GO:0005794;GO:0005887;GO:0044267;GO:0006997;GO:0043687;GO:0019216;, C:endoplasmic reticulum lumen; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane;, , P:cellular protein metabolic process; P:nucleus organization; P:post-translational protein modification; P:regulation of lipid metabolic process;|Q8NBJ4 Q6IAF4 Q9NRB9,Golgi membrane protein 1,Golgi membrane protein GP73;Golgi phosphoprotein 2;, , GO:0005788;GO:0005615;GO:0005794;GO:0005887;GO:0044267;GO:0006997;GO:0043687;GO:0019216;, C:endoplasmic reticulum lumen; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane;, , P:cellular protein metabolic process; P:nucleus organization; P:post-translational protein modification; P:regulation of lipid metabolic process; scaffold28 indexed_genome mRNA 29648558 29742199 . - . ID=transcript_6290;Q5VZE5 Q5VZE6 Q9H631 Q9H703,N-alpha-acetyltransferase 35, NatC auxiliary subunit,Embryonic growth-associated protein homolog;Protein MAK10 homolog;, PF04112;, GO:0005737;GO:0005829;GO:0031417;GO:0005654;GO:0005886;GO:0017196;GO:0006474;GO:0043066;GO:0048659;, C:cytoplasm; C:cytosol; C:NatC complex; C:nucleoplasm; C:plasma membrane;, , P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:smooth muscle cell proliferation;|Q5VZE5 Q5VZE6 Q9H631 Q9H703,N-alpha-acetyltransferase 35, NatC auxiliary subunit,Embryonic growth-associated protein homolog;Protein MAK10 homolog;, PF04112;, GO:0005737;GO:0005829;GO:0031417;GO:0005654;GO:0005886;GO:0017196;GO:0006474;GO:0043066;GO:0048659;, C:cytoplasm; C:cytosol; C:NatC complex; C:nucleoplasm; C:plasma membrane;, , P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:smooth muscle cell proliferation;|Q5VZE5 Q5VZE6 Q9H631 Q9H703,N-alpha-acetyltransferase 35, NatC auxiliary subunit,Embryonic growth-associated protein homolog;Protein MAK10 homolog;, PF04112;, GO:0005737;GO:0005829;GO:0031417;GO:0005654;GO:0005886;GO:0017196;GO:0006474;GO:0043066;GO:0048659;, C:cytoplasm; C:cytosol; C:NatC complex; C:nucleoplasm; C:plasma membrane;, , P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:smooth muscle cell proliferation;|Q5VZE5 Q5VZE6 Q9H631 Q9H703,N-alpha-acetyltransferase 35, NatC auxiliary subunit,Embryonic growth-associated protein homolog;Protein MAK10 homolog;, PF04112;, GO:0005737;GO:0005829;GO:0031417;GO:0005654;GO:0005886;GO:0017196;GO:0006474;GO:0043066;GO:0048659;, C:cytoplasm; C:cytosol; C:NatC complex; C:nucleoplasm; C:plasma membrane;, , P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:smooth muscle cell proliferation; scaffold28 indexed_genome mRNA 29844166 30043981 . + . ID=transcript_6291;Q9NVK1,Cytosolic carboxypeptidase 1,ATP/GTP-binding protein 1;Nervous system nuclear protein induced by axotomy protein 1 homolog;, PF18027;PF00246;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005730;GO:0005634;GO:0004181;GO:0015631;GO:0008270;GO:0035609;GO:0021702;GO:0001754;GO:0007005;GO:0050905;GO:0021772;GO:0035608;GO:0035610;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleolus; C:nucleus;, F:metallocarboxypeptidase activity; F:tubulin binding; F:zinc ion binding;, P:C-terminal protein deglutamylation; P:cerebellar Purkinje cell differentiation; P:eye photoreceptor cell differentiation; P:mitochondrion organization; P:neuromuscular process; P:olfactory bulb development; P:protein deglutamylation; P:protein side chain deglutamylation;|Q9NVK1,Cytosolic carboxypeptidase 1,ATP/GTP-binding protein 1;Nervous system nuclear protein induced by axotomy protein 1 homolog;, PF18027;PF00246;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005730;GO:0005634;GO:0004181;GO:0015631;GO:0008270;GO:0035609;GO:0021702;GO:0001754;GO:0007005;GO:0050905;GO:0021772;GO:0035608;GO:0035610;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleolus; C:nucleus;, F:metallocarboxypeptidase activity; F:tubulin binding; F:zinc ion binding;, P:C-terminal protein deglutamylation; P:cerebellar Purkinje cell differentiation; P:eye photoreceptor cell differentiation; P:mitochondrion organization; P:neuromuscular process; P:olfactory bulb development; P:protein deglutamylation; P:protein side chain deglutamylation; scaffold28 indexed_genome mRNA 30510568 30894180 . - . ID=transcript_6292;Q16620 B1ANZ4 B4DFV9 Q16675 Q59GJ1 Q8WXJ5 Q8WXJ6 Q8WXJ7,BDNF/NT-3 growth factors receptor,GP145-TrkB;Neurotrophic tyrosine kinase receptor type 2;TrkB tyrosine kinase;Tropomyosin-related kinase B;, PF07679;PF13855;PF01462;PF07714;PF16920;, GO:0030424;GO:0043679;GO:0005829;GO:0030425;GO:0043197;GO:0005769;GO:0031901;GO:0005887;GO:0048471;GO:0005886;GO:0014069;GO:0043235;GO:0043195;GO:0005524;GO:0048403;GO:0060175;GO:0043121;GO:0005030;GO:0002020;GO:0042803;GO:0004714;GO:0007202;GO:0031547;GO:0071230;GO:1990416;GO:1990090;GO:0021954;GO:0021987;GO:0007623;GO:0007631;GO:0014047;GO:0007612;GO:0060291;GO:0042490;GO:0007275;GO:0022011;GO:1902430;GO:2000811;GO:0043524;GO:0030182;GO:0001764;GO:0019227;GO:0048011;GO:0048709;GO:0048935;GO:0050772;GO:0008284;GO:0010628;GO:0033674;GO:0043410;GO:0010976;GO:1903997;GO:0033138;GO:0014068;GO:0001934;GO:0051965;GO:0046777;GO:0043087;GO:0051896;GO:0046548;GO:0099183;GO:0099551;GO:0007169;GO:0001570;, C:axon; C:axon terminus; C:cytosol; C:dendrite; C:dendritic spine; C:early endosome; C:early endosome membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:receptor complex; C:terminal bouton;, F:ATP binding; F:brain-derived neurotrophic factor binding; F:brain-derived neurotrophic factor-activated receptor activity; F:neurotrophin binding; F:neurotrophin receptor activity; F:protease binding; F:protein homodimerization activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of phospholipase C activity; P:brain-derived neurotrophic factor receptor signaling pathway; P:cellular response to amino acid stimulus; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to nerve growth factor stimulus; P:central nervous system neuron development; P:cerebral cortex development; P:circadian rhythm; P:feeding behavior; P:glutamate secretion; P:learning; P:long-term synaptic potentiation; P:mechanoreceptor differentiation; P:multicellular organism development; P:myelination in peripheral nervous system; P:negative regulation of amyloid-beta formation; P:negative regulation of anoikis; P:negative regulation of neuron apoptotic process; P:neuron differentiation; P:neuron migration; P:neuronal action potential propagation; P:neurotrophin TRK receptor signaling pathway; P:oligodendrocyte differentiation; P:peripheral nervous system neuron development; P:positive regulation of axonogenesis; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron projection development; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of GTPase activity; P:regulation of protein kinase B signaling; P:retinal rod cell development; P:trans-synaptic signaling by BDNF, modulating synaptic transmission; P:trans-synaptic signaling by neuropeptide, modulating synaptic transmission; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|Q16620 B1ANZ4 B4DFV9 Q16675 Q59GJ1 Q8WXJ5 Q8WXJ6 Q8WXJ7,BDNF/NT-3 growth factors receptor,GP145-TrkB;Neurotrophic tyrosine kinase receptor type 2;TrkB tyrosine kinase;Tropomyosin-related kinase B;, PF07679;PF13855;PF01462;PF07714;PF16920;, GO:0030424;GO:0043679;GO:0005829;GO:0030425;GO:0043197;GO:0005769;GO:0031901;GO:0005887;GO:0048471;GO:0005886;GO:0014069;GO:0043235;GO:0043195;GO:0005524;GO:0048403;GO:0060175;GO:0043121;GO:0005030;GO:0002020;GO:0042803;GO:0004714;GO:0007202;GO:0031547;GO:0071230;GO:1990416;GO:1990090;GO:0021954;GO:0021987;GO:0007623;GO:0007631;GO:0014047;GO:0007612;GO:0060291;GO:0042490;GO:0007275;GO:0022011;GO:1902430;GO:2000811;GO:0043524;GO:0030182;GO:0001764;GO:0019227;GO:0048011;GO:0048709;GO:0048935;GO:0050772;GO:0008284;GO:0010628;GO:0033674;GO:0043410;GO:0010976;GO:1903997;GO:0033138;GO:0014068;GO:0001934;GO:0051965;GO:0046777;GO:0043087;GO:0051896;GO:0046548;GO:0099183;GO:0099551;GO:0007169;GO:0001570;, C:axon; C:axon terminus; C:cytosol; C:dendrite; C:dendritic spine; C:early endosome; C:early endosome membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:receptor complex; C:terminal bouton;, F:ATP binding; F:brain-derived neurotrophic factor binding; F:brain-derived neurotrophic factor-activated receptor activity; F:neurotrophin binding; F:neurotrophin receptor activity; F:protease binding; F:protein homodimerization activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of phospholipase C activity; P:brain-derived neurotrophic factor receptor signaling pathway; P:cellular response to amino acid stimulus; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to nerve growth factor stimulus; P:central nervous system neuron development; P:cerebral cortex development; P:circadian rhythm; P:feeding behavior; P:glutamate secretion; P:learning; P:long-term synaptic potentiation; P:mechanoreceptor differentiation; P:multicellular organism development; P:myelination in peripheral nervous system; P:negative regulation of amyloid-beta formation; P:negative regulation of anoikis; P:negative regulation of neuron apoptotic process; P:neuron differentiation; P:neuron migration; P:neuronal action potential propagation; P:neurotrophin TRK receptor signaling pathway; P:oligodendrocyte differentiation; P:peripheral nervous system neuron development; P:positive regulation of axonogenesis; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron projection development; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of GTPase activity; P:regulation of protein kinase B signaling; P:retinal rod cell development; P:trans-synaptic signaling by BDNF, modulating synaptic transmission; P:trans-synaptic signaling by neuropeptide, modulating synaptic transmission; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis; scaffold28 indexed_genome mRNA 31410045 31764126 . + . ID=transcript_6293;Q9UJ21,Sodium/potassium-transporting ATPase subunit alpha-1,Sodium pump subunit alpha-1;, PF00689;PF00690;, GO:0016324;GO:0016323;GO:0005901;GO:0005783;GO:0005768;GO:0070062;GO:1903561;GO:0005794;GO:0016021;GO:0014704;GO:0016328;GO:0042470;GO:0016020;GO:0045121;GO:0031090;GO:0060342;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0043531;GO:0030506;GO:0005524;GO:0051087;GO:0005391;GO:0016791;GO:0043548;GO:0030955;GO:0008556;GO:0019904;GO:0046982;GO:0019901;GO:0031402;GO:1990239;GO:0086002;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0060081;GO:0086009;GO:0086013;GO:0031947;GO:0045822;GO:0045823;GO:0045989;GO:1990573;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0002028;GO:0002026;GO:0055119;GO:0042493;GO:1903416;GO:0036376;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:melanosome; C:membrane; C:membrane raft; C:organelle membrane; C:photoreceptor inner segment membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ADP binding; F:ankyrin binding; F:ATP binding; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:phosphatidylinositol 3-kinase binding; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:sodium ion binding; F:steroid hormone binding;, P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:membrane hyperpolarization; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of glucocorticoid biosynthetic process; P:negative regulation of heart contraction; P:positive regulation of heart contraction; P:positive regulation of striated muscle contraction; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to drug; P:response to glycoside; P:sodium ion export across plasma membrane;|Q9H9A7 Q05BX1 Q05CW3 Q5SQG8 Q5SQG9 Q6P1Q4 Q6PI89 Q7Z6L6,RecQ-mediated genome instability protein 1,BLM-associated protein of 75 kDa;FAAP75;, PF16099;PF08585;, GO:0016604;GO:0005654;GO:0031422;GO:0000166;GO:0006260;GO:0000724;GO:0042593;GO:0035264;GO:0002023;GO:1901796;GO:0000712;GO:0009749;, C:nuclear body; C:nucleoplasm; C:RecQ family helicase-topoisomerase III complex;, F:nucleotide binding;, P:DNA replication; P:double-strand break repair via homologous recombination; P:glucose homeostasis; P:multicellular organism growth; P:reduction of food intake in response to dietary excess; P:regulation of signal transduction by p53 class mediator; P:resolution of meiotic recombination intermediates; P:response to glucose;|O75348 Q6IB33,V-type proton ATPase subunit G 1,V-ATPase 13 kDa subunit 1;Vacuolar proton pump subunit G 1;Vacuolar proton pump subunit M16;, PF03179;, GO:0005829;GO:0070062;GO:0005765;GO:0005886;GO:0016471;GO:0016887;GO:0051117;GO:0046961;GO:0006879;GO:0034198;GO:0036295;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;, C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:plasma membrane; C:vacuolar proton-transporting V-type ATPase complex;, F:ATPase activity; F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to amino acid starvation; P:cellular response to increased oxygen levels; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport;|P61978 Q07244 Q15671 Q59F98 Q5T6W4 Q60577 Q6IBN1 Q922Y7 Q96J62,Heterogeneous nuclear ribonucleoprotein K,Transformation up-regulated nuclear protein;, PF00013;PF08067;, GO:0071013;GO:0042995;GO:0000785;GO:0005737;GO:0010494;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0002102;GO:0045296;GO:0003677;GO:0042802;GO:0003729;GO:0019904;GO:0003723;GO:0000398;GO:0043066;GO:0048025;GO:1905599;GO:0048260;GO:0045944;GO:0010468;GO:1902165;GO:0010988;GO:0048024;GO:0006357;GO:0016070;GO:0006396;GO:0007165;GO:0019058;, C:catalytic step 2 spliceosome; C:cell projection; C:chromatin; C:cytoplasm; C:cytoplasmic stress granule; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:podosome;, F:cadherin binding; F:DNA binding; F:identical protein binding; F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of apoptotic process; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:regulation of low-density lipoprotein particle clearance; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription by RNA polymerase II; P:RNA metabolic process; P:RNA processing; P:signal transduction; P:viral life cycle;|P61978 Q07244 Q15671 Q59F98 Q5T6W4 Q60577 Q6IBN1 Q922Y7 Q96J62,Heterogeneous nuclear ribonucleoprotein K,Transformation up-regulated nuclear protein;, PF00013;PF08067;, GO:0071013;GO:0042995;GO:0000785;GO:0005737;GO:0010494;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0002102;GO:0045296;GO:0003677;GO:0042802;GO:0003729;GO:0019904;GO:0003723;GO:0000398;GO:0043066;GO:0048025;GO:1905599;GO:0048260;GO:0045944;GO:0010468;GO:1902165;GO:0010988;GO:0048024;GO:0006357;GO:0016070;GO:0006396;GO:0007165;GO:0019058;, C:catalytic step 2 spliceosome; C:cell projection; C:chromatin; C:cytoplasm; C:cytoplasmic stress granule; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:podosome;, F:cadherin binding; F:DNA binding; F:identical protein binding; F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of apoptotic process; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:regulation of low-density lipoprotein particle clearance; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription by RNA polymerase II; P:RNA metabolic process; P:RNA processing; P:signal transduction; P:viral life cycle;|P61978 Q07244 Q15671 Q59F98 Q5T6W4 Q60577 Q6IBN1 Q922Y7 Q96J62,Heterogeneous nuclear ribonucleoprotein K,Transformation up-regulated nuclear protein;, PF00013;PF08067;, GO:0071013;GO:0042995;GO:0000785;GO:0005737;GO:0010494;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0002102;GO:0045296;GO:0003677;GO:0042802;GO:0003729;GO:0019904;GO:0003723;GO:0000398;GO:0043066;GO:0048025;GO:1905599;GO:0048260;GO:0045944;GO:0010468;GO:1902165;GO:0010988;GO:0048024;GO:0006357;GO:0016070;GO:0006396;GO:0007165;GO:0019058;, C:catalytic step 2 spliceosome; C:cell projection; C:chromatin; C:cytoplasm; C:cytoplasmic stress granule; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:podosome;, F:cadherin binding; F:DNA binding; F:identical protein binding; F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of apoptotic process; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:regulation of low-density lipoprotein particle clearance; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription by RNA polymerase II; P:RNA metabolic process; P:RNA processing; P:signal transduction; P:viral life cycle;|P61978 Q07244 Q15671 Q59F98 Q5T6W4 Q60577 Q6IBN1 Q922Y7 Q96J62,Heterogeneous nuclear ribonucleoprotein K,Transformation up-regulated nuclear protein;, PF00013;PF08067;, GO:0071013;GO:0042995;GO:0000785;GO:0005737;GO:0010494;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0002102;GO:0045296;GO:0003677;GO:0042802;GO:0003729;GO:0019904;GO:0003723;GO:0000398;GO:0043066;GO:0048025;GO:1905599;GO:0048260;GO:0045944;GO:0010468;GO:1902165;GO:0010988;GO:0048024;GO:0006357;GO:0016070;GO:0006396;GO:0007165;GO:0019058;, C:catalytic step 2 spliceosome; C:cell projection; C:chromatin; C:cytoplasm; C:cytoplasmic stress granule; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:podosome;, F:cadherin binding; F:DNA binding; F:identical protein binding; F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of apoptotic process; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:regulation of low-density lipoprotein particle clearance; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription by RNA polymerase II; P:RNA metabolic process; P:RNA processing; P:signal transduction; P:viral life cycle;|P61978 Q07244 Q15671 Q59F98 Q5T6W4 Q60577 Q6IBN1 Q922Y7 Q96J62,Heterogeneous nuclear ribonucleoprotein K,Transformation up-regulated nuclear protein;, PF00013;PF08067;, GO:0071013;GO:0042995;GO:0000785;GO:0005737;GO:0010494;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0002102;GO:0045296;GO:0003677;GO:0042802;GO:0003729;GO:0019904;GO:0003723;GO:0000398;GO:0043066;GO:0048025;GO:1905599;GO:0048260;GO:0045944;GO:0010468;GO:1902165;GO:0010988;GO:0048024;GO:0006357;GO:0016070;GO:0006396;GO:0007165;GO:0019058;, C:catalytic step 2 spliceosome; C:cell projection; C:chromatin; C:cytoplasm; C:cytoplasmic stress granule; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:podosome;, F:cadherin binding; F:DNA binding; F:identical protein binding; F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of apoptotic process; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:regulation of low-density lipoprotein particle clearance; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription by RNA polymerase II; P:RNA metabolic process; P:RNA processing; P:signal transduction; P:viral life cycle;|P61978 Q07244 Q15671 Q59F98 Q5T6W4 Q60577 Q6IBN1 Q922Y7 Q96J62,Heterogeneous nuclear ribonucleoprotein K,Transformation up-regulated nuclear protein;, PF00013;PF08067;, GO:0071013;GO:0042995;GO:0000785;GO:0005737;GO:0010494;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0002102;GO:0045296;GO:0003677;GO:0042802;GO:0003729;GO:0019904;GO:0003723;GO:0000398;GO:0043066;GO:0048025;GO:1905599;GO:0048260;GO:0045944;GO:0010468;GO:1902165;GO:0010988;GO:0048024;GO:0006357;GO:0016070;GO:0006396;GO:0007165;GO:0019058;, C:catalytic step 2 spliceosome; C:cell projection; C:chromatin; C:cytoplasm; C:cytoplasmic stress granule; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:podosome;, F:cadherin binding; F:DNA binding; F:identical protein binding; F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of apoptotic process; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:regulation of low-density lipoprotein particle clearance; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription by RNA polymerase II; P:RNA metabolic process; P:RNA processing; P:signal transduction; P:viral life cycle;|P61978 Q07244 Q15671 Q59F98 Q5T6W4 Q60577 Q6IBN1 Q922Y7 Q96J62,Heterogeneous nuclear ribonucleoprotein K,Transformation up-regulated nuclear protein;, PF00013;PF08067;, GO:0071013;GO:0042995;GO:0000785;GO:0005737;GO:0010494;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0002102;GO:0045296;GO:0003677;GO:0042802;GO:0003729;GO:0019904;GO:0003723;GO:0000398;GO:0043066;GO:0048025;GO:1905599;GO:0048260;GO:0045944;GO:0010468;GO:1902165;GO:0010988;GO:0048024;GO:0006357;GO:0016070;GO:0006396;GO:0007165;GO:0019058;, C:catalytic step 2 spliceosome; C:cell projection; C:chromatin; C:cytoplasm; C:cytoplasmic stress granule; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:podosome;, F:cadherin binding; F:DNA binding; F:identical protein binding; F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of apoptotic process; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:regulation of low-density lipoprotein particle clearance; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription by RNA polymerase II; P:RNA metabolic process; P:RNA processing; P:signal transduction; P:viral life cycle;|Q5T6V5 B2RPI6 Q8N2B1 Q9BT18,Queuosine salvage protein {ECO:0000303|PubMed:24911101},, PF10343;, GO:0006400;GO:0101030;, , , P:tRNA modification; P:tRNA-guanine transglycosylation;|Q86VH2 B2RTR8 Q5T6W0 Q86VH0 Q86VH1 Q9UF54,Kinesin-like protein KIF27,, PF00225;, GO:0005929;GO:0005737;GO:0005576;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0060271;GO:0003351;GO:0007018;GO:0021591;, C:cilium; C:cytoplasm; C:extracellular region; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cilium assembly; P:epithelial cilium movement involved in extracellular fluid movement; P:microtubule-based movement; P:ventricular system development;|Q86VH2 B2RTR8 Q5T6W0 Q86VH0 Q86VH1 Q9UF54,Kinesin-like protein KIF27,, PF00225;, GO:0005929;GO:0005737;GO:0005576;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0060271;GO:0003351;GO:0007018;GO:0021591;, C:cilium; C:cytoplasm; C:extracellular region; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cilium assembly; P:epithelial cilium movement involved in extracellular fluid movement; P:microtubule-based movement; P:ventricular system development;|Q86VH2 B2RTR8 Q5T6W0 Q86VH0 Q86VH1 Q9UF54,Kinesin-like protein KIF27,, PF00225;, GO:0005929;GO:0005737;GO:0005576;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0060271;GO:0003351;GO:0007018;GO:0021591;, C:cilium; C:cytoplasm; C:extracellular region; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cilium assembly; P:epithelial cilium movement involved in extracellular fluid movement; P:microtubule-based movement; P:ventricular system development; scaffold28 indexed_genome mRNA 31791245 31846793 . + . ID=transcript_6294;Q5VSY0 Q96LI0 Q9BYI1 Q9BYI2 Q9H225,G kinase-anchoring protein 1,cGMP-dependent protein kinase-anchoring protein of 42 kDa;, , GO:0005794;GO:0042802;GO:0046628;GO:0007165;, C:Golgi apparatus;, F:identical protein binding;, P:positive regulation of insulin receptor signaling pathway; P:signal transduction; scaffold28 indexed_genome mRNA 31849558 31850905 . + . ID=transcript_6295;Q5VSY0 Q96LI0 Q9BYI1 Q9BYI2 Q9H225,G kinase-anchoring protein 1,cGMP-dependent protein kinase-anchoring protein of 42 kDa;, , GO:0005794;GO:0042802;GO:0046628;GO:0007165;, C:Golgi apparatus;, F:identical protein binding;, P:positive regulation of insulin receptor signaling pathway; P:signal transduction; scaffold28 indexed_genome mRNA 31851893 31853797 . + . ID=transcript_6296;Q5VSY0 Q96LI0 Q9BYI1 Q9BYI2 Q9H225,G kinase-anchoring protein 1,cGMP-dependent protein kinase-anchoring protein of 42 kDa;, , GO:0005794;GO:0042802;GO:0046628;GO:0007165;, C:Golgi apparatus;, F:identical protein binding;, P:positive regulation of insulin receptor signaling pathway; P:signal transduction; scaffold28 indexed_genome mRNA 31900650 31968116 . + . ID=transcript_6297;Q9UMX0 A0A024R284 Q5T6J5 Q5T6J9 Q8IXS9 Q8N2Q3 Q9H0T8 Q9H3R4 Q9HAZ5,Ubiquilin-1,Protein linking IAP with cytoskeleton 1;, PF00627;PF00240;, GO:0016235;GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005654;GO:0048471;GO:0005886;GO:0000502;GO:0032991;GO:0042802;GO:0019900;GO:0031593;GO:0035973;GO:0000045;GO:0097352;GO:0071456;GO:0016236;GO:1901340;GO:1903071;GO:0031398;GO:0016241;GO:1902175;GO:0031396;GO:0034976;GO:0030433;GO:0006511;, C:aggresome; C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:proteasome complex; C:protein-containing complex;, F:identical protein binding; F:kinase binding; F:polyubiquitin modification-dependent protein binding;, P:aggrephagy; P:autophagosome assembly; P:autophagosome maturation; P:cellular response to hypoxia; P:macroautophagy; P:negative regulation of store-operated calcium channel activity; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:regulation of macroautophagy; P:regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:regulation of protein ubiquitination; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q9UMX0 A0A024R284 Q5T6J5 Q5T6J9 Q8IXS9 Q8N2Q3 Q9H0T8 Q9H3R4 Q9HAZ5,Ubiquilin-1,Protein linking IAP with cytoskeleton 1;, PF00627;PF00240;, GO:0016235;GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005654;GO:0048471;GO:0005886;GO:0000502;GO:0032991;GO:0042802;GO:0019900;GO:0031593;GO:0035973;GO:0000045;GO:0097352;GO:0071456;GO:0016236;GO:1901340;GO:1903071;GO:0031398;GO:0016241;GO:1902175;GO:0031396;GO:0034976;GO:0030433;GO:0006511;, C:aggresome; C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:proteasome complex; C:protein-containing complex;, F:identical protein binding; F:kinase binding; F:polyubiquitin modification-dependent protein binding;, P:aggrephagy; P:autophagosome assembly; P:autophagosome maturation; P:cellular response to hypoxia; P:macroautophagy; P:negative regulation of store-operated calcium channel activity; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:regulation of macroautophagy; P:regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:regulation of protein ubiquitination; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q9UMX0 A0A024R284 Q5T6J5 Q5T6J9 Q8IXS9 Q8N2Q3 Q9H0T8 Q9H3R4 Q9HAZ5,Ubiquilin-1,Protein linking IAP with cytoskeleton 1;, PF00627;PF00240;, GO:0016235;GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005654;GO:0048471;GO:0005886;GO:0000502;GO:0032991;GO:0042802;GO:0019900;GO:0031593;GO:0035973;GO:0000045;GO:0097352;GO:0071456;GO:0016236;GO:1901340;GO:1903071;GO:0031398;GO:0016241;GO:1902175;GO:0031396;GO:0034976;GO:0030433;GO:0006511;, C:aggresome; C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:proteasome complex; C:protein-containing complex;, F:identical protein binding; F:kinase binding; F:polyubiquitin modification-dependent protein binding;, P:aggrephagy; P:autophagosome assembly; P:autophagosome maturation; P:cellular response to hypoxia; P:macroautophagy; P:negative regulation of store-operated calcium channel activity; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:regulation of macroautophagy; P:regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:regulation of protein ubiquitination; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold28 indexed_genome mRNA 31986231 31987863 . - . ID=transcript_6298;Q5T6J7 A5PLN6 Q5T6J6,Probable gluconokinase,Gluconate kinase;, PF01202;, GO:0005524;GO:0046316;GO:0046177;, , F:ATP binding; F:gluconokinase activity;, P:D-gluconate catabolic process; scaffold28 indexed_genome mRNA 31987904 31999454 . - . ID=transcript_6299;Q5T6J7 A5PLN6 Q5T6J6,Probable gluconokinase,Gluconate kinase;, PF01202;, GO:0005524;GO:0046316;GO:0046177;, , F:ATP binding; F:gluconokinase activity;, P:D-gluconate catabolic process; scaffold28 indexed_genome mRNA 32067880 32329738 . + . ID=transcript_6300;Q8N9L2,FERM domain-containing protein 3,Band 4.1-like protein 4O;Ovary type protein 4.1;, PF08736;PF09380;PF00373;PF09379;, GO:0005856;GO:0016021;GO:0008092;GO:0031032;, C:cytoskeleton; C:integral component of membrane;, F:cytoskeletal protein binding;, P:actomyosin structure organization; scaffold28 indexed_genome mRNA 32354915 32399295 . + . ID=transcript_6301;Q8N9L2,FERM domain-containing protein 3,Band 4.1-like protein 4O;Ovary type protein 4.1;, PF08736;PF09380;PF00373;PF09379;, GO:0005856;GO:0016021;GO:0008092;GO:0031032;, C:cytoskeleton; C:integral component of membrane;, F:cytoskeletal protein binding;, P:actomyosin structure organization; scaffold28 indexed_genome mRNA 32619872 32649117 . + . ID=transcript_6302;Q8IZ41 A6NC29 Q96N04,Ras and EF-hand domain-containing protein,Ras-related protein Rab-45;, PF13499;PF00071;, GO:0005829;GO:0048471;GO:0005509;GO:0019003;GO:0005525;GO:0003924;GO:0042802;, C:cytosol; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:identical protein binding; scaffold28 indexed_genome mRNA 32682115 32707391 . + . ID=transcript_6303;Q6IN85 Q69YK6 Q86U23 Q86YI7 Q8IVG1 Q9H3F1 Q9H7U8 Q9NV01 Q9NWP1,Serine/threonine-protein phosphatase 4 regulatory subunit 3A {ECO:0000312|HGNC:HGNC:20219},SMEK homolog 1;, PF04802;, GO:0005829;GO:0005815;GO:0016607;GO:0005654;, C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleoplasm; scaffold28 indexed_genome mRNA 32744079 32745252 . + . ID=transcript_6304;O00585 Q6ICR7,C-C motif chemokine 21,6Ckine;Beta-chemokine exodus-2;Secondary lymphoid-tissue chemokine;Small-inducible cytokine A21;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0031732;GO:0008009;GO:0042379;GO:0090630;GO:0061844;GO:0060326;GO:0048469;GO:0007267;GO:1990869;GO:0071346;GO:0071347;GO:0071356;GO:0038116;GO:0070098;GO:0002407;GO:0097026;GO:0048245;GO:0001768;GO:0007186;GO:0006955;GO:0001771;GO:0006954;GO:0031640;GO:0048247;GO:0035759;GO:0002548;GO:2000669;GO:2000548;GO:1903237;GO:0030593;GO:0030838;GO:0033630;GO:2000147;GO:0001954;GO:0050921;GO:0002606;GO:0070374;GO:0051491;GO:0010560;GO:0043547;GO:0043123;GO:0046330;GO:2000529;GO:0090023;GO:0043552;GO:0045860;GO:0051897;GO:0031274;GO:0048260;GO:0010820;GO:2000406;GO:0051209;GO:0034695;GO:0031529;GO:0031295;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:CCR7 chemokine receptor binding; F:chemokine activity; F:chemokine receptor binding;, P:activation of GTPase activity; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell chemotaxis; P:cell maturation; P:cell-cell signaling; P:cellular response to chemokine; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine (C-C motif) ligand 21 signaling pathway; P:chemokine-mediated signaling pathway; P:dendritic cell chemotaxis; P:dendritic cell dendrite assembly; P:eosinophil chemotaxis; P:establishment of T cell polarity; P:G protein-coupled receptor signaling pathway; P:immune response; P:immunological synapse formation; P:inflammatory response; P:killing of cells of other organism; P:lymphocyte chemotaxis; P:mesangial cell-matrix adhesion; P:monocyte chemotaxis; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of dendritic cell dendrite assembly; P:negative regulation of leukocyte tethering or rolling; P:neutrophil chemotaxis; P:positive regulation of actin filament polymerization; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell motility; P:positive regulation of cell-matrix adhesion; P:positive regulation of chemotaxis; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of filopodium assembly; P:positive regulation of glycoprotein biosynthetic process; P:positive regulation of GTPase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of JNK cascade; P:positive regulation of myeloid dendritic cell chemotaxis; P:positive regulation of neutrophil chemotaxis; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of pseudopodium assembly; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of T cell chemotaxis; P:positive regulation of T cell migration; P:release of sequestered calcium ion into cytosol; P:response to prostaglandin E; P:ruffle organization; P:T cell costimulation; scaffold28 indexed_genome mRNA 32765418 32767370 . + . ID=transcript_6305;Q99731 O00697 O00736,C-C motif chemokine 19,Beta-chemokine exodus-3;CK beta-11;Epstein-Barr virus-induced molecule 1 ligand chemokine;Macrophage inflammatory protein 3 beta;Small-inducible cytokine A19;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0031735;GO:0031732;GO:0008009;GO:0042379;GO:0007257;GO:0061844;GO:0007154;GO:0048469;GO:0006874;GO:0071346;GO:0071347;GO:0071356;GO:0098586;GO:0070098;GO:0019221;GO:0002407;GO:0001768;GO:0007186;GO:0006955;GO:0001771;GO:0006954;GO:0031640;GO:0048247;GO:0097029;GO:0002548;GO:0002408;GO:2000669;GO:0030593;GO:2000147;GO:0050921;GO:0002606;GO:2000549;GO:0045807;GO:0070374;GO:0010560;GO:0043547;GO:0043123;GO:0032731;GO:0032735;GO:0046330;GO:0090023;GO:1901224;GO:0043552;GO:0045860;GO:0051897;GO:0048260;GO:0042102;GO:0045627;GO:0032760;GO:0060491;GO:0051209;GO:0071731;GO:0034695;GO:0009615;GO:0031295;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:CCR10 chemokine receptor binding; F:CCR7 chemokine receptor binding; F:chemokine activity; F:chemokine receptor binding;, P:activation of JUN kinase activity; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell communication; P:cell maturation; P:cellular calcium ion homeostasis; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to virus; P:chemokine-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:dendritic cell chemotaxis; P:establishment of T cell polarity; P:G protein-coupled receptor signaling pathway; P:immune response; P:immunological synapse formation; P:inflammatory response; P:killing of cells of other organism; P:lymphocyte chemotaxis; P:mature conventional dendritic cell differentiation; P:monocyte chemotaxis; P:myeloid dendritic cell chemotaxis; P:negative regulation of dendritic cell apoptotic process; P:neutrophil chemotaxis; P:positive regulation of cell motility; P:positive regulation of chemotaxis; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of dendritic cell dendrite assembly; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glycoprotein biosynthetic process; P:positive regulation of GTPase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of JNK cascade; P:positive regulation of neutrophil chemotaxis; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of T cell proliferation; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of tumor necrosis factor production; P:regulation of cell projection assembly; P:release of sequestered calcium ion into cytosol; P:response to nitric oxide; P:response to prostaglandin E; P:response to virus; P:T cell costimulation; scaffold28 indexed_genome mRNA 32783954 32790890 . + . ID=transcript_6306;Q9Y4X3,C-C motif chemokine 27,CC chemokine ILC;Cutaneous T-cell-attracting chemokine;ESkine;IL-11 R-alpha-locus chemokine;Skinkine;Small-inducible cytokine A27;, PF00048;, GO:0005576;GO:0005615;GO:0031728;GO:0008009;GO:0061844;GO:0007267;GO:0006935;GO:0007186;GO:0006955;GO:0031640;GO:2000251;GO:0010820;, C:extracellular region; C:extracellular space;, F:CCR3 chemokine receptor binding; F:chemokine activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell-cell signaling; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:killing of cells of other organism; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of T cell chemotaxis;|Q14626 Q16542 Q5VZ80 Q7KYJ7,Interleukin-11 receptor subunit alpha {ECO:0000305},, , GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0019970;GO:0004921;GO:0004888;GO:0019221;GO:0032502;GO:0060322;GO:0008284;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-11 binding; F:interleukin-11 receptor activity; F:transmembrane signaling receptor activity;, P:cytokine-mediated signaling pathway; P:developmental process; P:head development; P:positive regulation of cell population proliferation;|Q14626 Q16542 Q5VZ80 Q7KYJ7,Interleukin-11 receptor subunit alpha {ECO:0000305},, , GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0019970;GO:0004921;GO:0004888;GO:0019221;GO:0032502;GO:0060322;GO:0008284;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-11 binding; F:interleukin-11 receptor activity; F:transmembrane signaling receptor activity;, P:cytokine-mediated signaling pathway; P:developmental process; P:head development; P:positive regulation of cell population proliferation; scaffold28 indexed_genome mRNA 32790916 32798495 . + . ID=transcript_6307;Q14626 Q16542 Q5VZ80 Q7KYJ7,Interleukin-11 receptor subunit alpha {ECO:0000305},, , GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0019970;GO:0004921;GO:0004888;GO:0019221;GO:0032502;GO:0060322;GO:0008284;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-11 binding; F:interleukin-11 receptor activity; F:transmembrane signaling receptor activity;, P:cytokine-mediated signaling pathway; P:developmental process; P:head development; P:positive regulation of cell population proliferation;|Q14626 Q16542 Q5VZ80 Q7KYJ7,Interleukin-11 receptor subunit alpha {ECO:0000305},, , GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0019970;GO:0004921;GO:0004888;GO:0019221;GO:0032502;GO:0060322;GO:0008284;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-11 binding; F:interleukin-11 receptor activity; F:transmembrane signaling receptor activity;, P:cytokine-mediated signaling pathway; P:developmental process; P:head development; P:positive regulation of cell population proliferation;|Q14626 Q16542 Q5VZ80 Q7KYJ7,Interleukin-11 receptor subunit alpha {ECO:0000305},, , GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0019970;GO:0004921;GO:0004888;GO:0019221;GO:0032502;GO:0060322;GO:0008284;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-11 binding; F:interleukin-11 receptor activity; F:transmembrane signaling receptor activity;, P:cytokine-mediated signaling pathway; P:developmental process; P:head development; P:positive regulation of cell population proliferation;|Q14626 Q16542 Q5VZ80 Q7KYJ7,Interleukin-11 receptor subunit alpha {ECO:0000305},, , GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0019970;GO:0004921;GO:0004888;GO:0019221;GO:0032502;GO:0060322;GO:0008284;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-11 binding; F:interleukin-11 receptor activity; F:transmembrane signaling receptor activity;, P:cytokine-mediated signaling pathway; P:developmental process; P:head development; P:positive regulation of cell population proliferation; scaffold28 indexed_genome mRNA 32799565 32800888 . - . ID=transcript_6308;Q14385 Q14386 Q14387 Q14389 Q16766 Q53XK1 Q5VZ81 Q96BY1,Galactose-1-phosphate uridylyltransferase,UDP-glucose--hexose-1-phosphate uridylyltransferase;, PF02744;PF01087;, GO:0005737;GO:0005829;GO:0005794;GO:0008108;GO:0008270;GO:0019388;GO:0033499;GO:0006012;GO:0006258;GO:0006011;, C:cytoplasm; C:cytosol; C:Golgi apparatus;, F:UDP-glucose:hexose-1-phosphate uridylyltransferase activity; F:zinc ion binding;, P:galactose catabolic process; P:galactose catabolic process via UDP-galactose; P:galactose metabolic process; P:UDP-glucose catabolic process; P:UDP-glucose metabolic process;|Q14385 Q14386 Q14387 Q14389 Q16766 Q53XK1 Q5VZ81 Q96BY1,Galactose-1-phosphate uridylyltransferase,UDP-glucose--hexose-1-phosphate uridylyltransferase;, PF02744;PF01087;, GO:0005737;GO:0005829;GO:0005794;GO:0008108;GO:0008270;GO:0019388;GO:0033499;GO:0006012;GO:0006258;GO:0006011;, C:cytoplasm; C:cytosol; C:Golgi apparatus;, F:UDP-glucose:hexose-1-phosphate uridylyltransferase activity; F:zinc ion binding;, P:galactose catabolic process; P:galactose catabolic process via UDP-galactose; P:galactose metabolic process; P:UDP-glucose catabolic process; P:UDP-glucose metabolic process; scaffold28 indexed_genome mRNA 32800926 32803207 . - . ID=transcript_6309;Q14385 Q14386 Q14387 Q14389 Q16766 Q53XK1 Q5VZ81 Q96BY1,Galactose-1-phosphate uridylyltransferase,UDP-glucose--hexose-1-phosphate uridylyltransferase;, PF02744;PF01087;, GO:0005737;GO:0005829;GO:0005794;GO:0008108;GO:0008270;GO:0019388;GO:0033499;GO:0006012;GO:0006258;GO:0006011;, C:cytoplasm; C:cytosol; C:Golgi apparatus;, F:UDP-glucose:hexose-1-phosphate uridylyltransferase activity; F:zinc ion binding;, P:galactose catabolic process; P:galactose catabolic process via UDP-galactose; P:galactose metabolic process; P:UDP-glucose catabolic process; P:UDP-glucose metabolic process;|Q14385 Q14386 Q14387 Q14389 Q16766 Q53XK1 Q5VZ81 Q96BY1,Galactose-1-phosphate uridylyltransferase,UDP-glucose--hexose-1-phosphate uridylyltransferase;, PF02744;PF01087;, GO:0005737;GO:0005829;GO:0005794;GO:0008108;GO:0008270;GO:0019388;GO:0033499;GO:0006012;GO:0006258;GO:0006011;, C:cytoplasm; C:cytosol; C:Golgi apparatus;, F:UDP-glucose:hexose-1-phosphate uridylyltransferase activity; F:zinc ion binding;, P:galactose catabolic process; P:galactose catabolic process via UDP-galactose; P:galactose metabolic process; P:UDP-glucose catabolic process; P:UDP-glucose metabolic process; scaffold28 indexed_genome mRNA 32807566 32810369 . + . ID=transcript_6310;Q8N7H3 Q9NYX0,Sigma non-opioid intracellular receptor 1,Aging-associated gene 8 protein;SR31747-binding protein;Sigma 1-type opioid receptor;, PF04622;, GO:0031410;GO:0005829;GO:0005783;GO:0005789;GO:0030426;GO:0016021;GO:0005811;GO:0016020;GO:0005635;GO:0005637;GO:0005640;GO:0014069;GO:0098839;GO:0042802;GO:0004985;GO:0036474;GO:0006869;GO:0007399;GO:0070207;GO:0043523;, C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:growth cone; C:integral component of membrane; C:lipid droplet; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear outer membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:identical protein binding; F:opioid receptor activity;, P:cell death in response to hydrogen peroxide; P:lipid transport; P:nervous system development; P:protein homotrimerization; P:regulation of neuron apoptotic process;|Q8N7H3 Q9NYX0,Sigma non-opioid intracellular receptor 1,Aging-associated gene 8 protein;SR31747-binding protein;Sigma 1-type opioid receptor;, PF04622;, GO:0031410;GO:0005829;GO:0005783;GO:0005789;GO:0030426;GO:0016021;GO:0005811;GO:0016020;GO:0005635;GO:0005637;GO:0005640;GO:0014069;GO:0098839;GO:0042802;GO:0004985;GO:0036474;GO:0006869;GO:0007399;GO:0070207;GO:0043523;, C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:growth cone; C:integral component of membrane; C:lipid droplet; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear outer membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:identical protein binding; F:opioid receptor activity;, P:cell death in response to hydrogen peroxide; P:lipid transport; P:nervous system development; P:protein homotrimerization; P:regulation of neuron apoptotic process;|Q8N7H3 Q9NYX0,Sigma non-opioid intracellular receptor 1,Aging-associated gene 8 protein;SR31747-binding protein;Sigma 1-type opioid receptor;, PF04622;, GO:0031410;GO:0005829;GO:0005783;GO:0005789;GO:0030426;GO:0016021;GO:0005811;GO:0016020;GO:0005635;GO:0005637;GO:0005640;GO:0014069;GO:0098839;GO:0042802;GO:0004985;GO:0036474;GO:0006869;GO:0007399;GO:0070207;GO:0043523;, C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:growth cone; C:integral component of membrane; C:lipid droplet; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear outer membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:identical protein binding; F:opioid receptor activity;, P:cell death in response to hydrogen peroxide; P:lipid transport; P:nervous system development; P:protein homotrimerization; P:regulation of neuron apoptotic process; scaffold28 indexed_genome mRNA 32824587 32832125 . + . ID=transcript_6311;O75935 A6NII7 B2RBM5 Q5T1I5 Q5T1I7 Q5T8G3 Q9BPU8,Dynactin subunit 3,Dynactin complex subunit 22 kDa subunit;, PF07426;, GO:0005813;GO:0032154;GO:0000777;GO:0005829;GO:0005869;GO:0005874;GO:0030496;GO:0005730;GO:0048471;GO:0005819;GO:0005198;GO:0019886;GO:0097711;GO:0061640;GO:0006888;GO:0000086;GO:0007017;GO:0000278;GO:0010389;, C:centrosome; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytosol; C:dynactin complex; C:microtubule; C:midbody; C:nucleolus; C:perinuclear region of cytoplasm; C:spindle;, F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:microtubule-based process; P:mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|O75935 A6NII7 B2RBM5 Q5T1I5 Q5T1I7 Q5T8G3 Q9BPU8,Dynactin subunit 3,Dynactin complex subunit 22 kDa subunit;, PF07426;, GO:0005813;GO:0032154;GO:0000777;GO:0005829;GO:0005869;GO:0005874;GO:0030496;GO:0005730;GO:0048471;GO:0005819;GO:0005198;GO:0019886;GO:0097711;GO:0061640;GO:0006888;GO:0000086;GO:0007017;GO:0000278;GO:0010389;, C:centrosome; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytosol; C:dynactin complex; C:microtubule; C:midbody; C:nucleolus; C:perinuclear region of cytoplasm; C:spindle;, F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:microtubule-based process; P:mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|O75935 A6NII7 B2RBM5 Q5T1I5 Q5T1I7 Q5T8G3 Q9BPU8,Dynactin subunit 3,Dynactin complex subunit 22 kDa subunit;, PF07426;, GO:0005813;GO:0032154;GO:0000777;GO:0005829;GO:0005869;GO:0005874;GO:0030496;GO:0005730;GO:0048471;GO:0005819;GO:0005198;GO:0019886;GO:0097711;GO:0061640;GO:0006888;GO:0000086;GO:0007017;GO:0000278;GO:0010389;, C:centrosome; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytosol; C:dynactin complex; C:microtubule; C:midbody; C:nucleolus; C:perinuclear region of cytoplasm; C:spindle;, F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:cytoskeleton-dependent cytokinesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:microtubule-based process; P:mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; scaffold28 indexed_genome mRNA 32834135 32835932 . + . ID=transcript_6312;Q8N5L8 D3DRM5,Ribonuclease P protein subunit p25-like protein,Rpp25-like protein;, PF01918;, GO:0005634;GO:0000172;GO:0003723;GO:0001682;, C:nucleus; C:ribonuclease MRP complex;, F:RNA binding;, P:tRNA 5'-leader removal; scaffold28 indexed_genome mRNA 32866802 32896427 . + . ID=transcript_6313;P26992 Q5U050,Ciliary neurotrophic factor receptor subunit alpha,, PF00041;, GO:0031225;GO:0016324;GO:0070110;GO:0097059;GO:0009897;GO:0019898;GO:0005886;GO:0043235;GO:0004897;GO:0019955;GO:0004896;GO:0005102;GO:0003360;GO:0070120;GO:0019221;GO:0043524;GO:0007399;GO:0008284;GO:0007548;GO:0007165;GO:0060538;GO:0001967;, C:anchored component of membrane; C:apical plasma membrane; C:ciliary neurotrophic factor receptor complex; C:CNTFR-CLCF1 complex; C:external side of plasma membrane; C:extrinsic component of membrane; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor activity; F:cytokine binding; F:cytokine receptor activity; F:signaling receptor binding;, P:brainstem development; P:ciliary neurotrophic factor-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:negative regulation of neuron apoptotic process; P:nervous system development; P:positive regulation of cell population proliferation; P:sex differentiation; P:signal transduction; P:skeletal muscle organ development; P:suckling behavior;|P26992 Q5U050,Ciliary neurotrophic factor receptor subunit alpha,, PF00041;, GO:0031225;GO:0016324;GO:0070110;GO:0097059;GO:0009897;GO:0019898;GO:0005886;GO:0043235;GO:0004897;GO:0019955;GO:0004896;GO:0005102;GO:0003360;GO:0070120;GO:0019221;GO:0043524;GO:0007399;GO:0008284;GO:0007548;GO:0007165;GO:0060538;GO:0001967;, C:anchored component of membrane; C:apical plasma membrane; C:ciliary neurotrophic factor receptor complex; C:CNTFR-CLCF1 complex; C:external side of plasma membrane; C:extrinsic component of membrane; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor activity; F:cytokine binding; F:cytokine receptor activity; F:signaling receptor binding;, P:brainstem development; P:ciliary neurotrophic factor-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:negative regulation of neuron apoptotic process; P:nervous system development; P:positive regulation of cell population proliferation; P:sex differentiation; P:signal transduction; P:skeletal muscle organ development; P:suckling behavior; scaffold28 indexed_genome mRNA 32939143 32939658 . - . ID=transcript_6314;Q9UI46 B7Z7U1 Q5T8G7 Q8NHQ7 Q9UEZ8,Dynein intermediate chain 1, axonemal,Axonemal dynein intermediate chain 1;, PF00400;, GO:0005929;GO:0005856;GO:0005874;GO:0036157;GO:0045504;GO:0045503;GO:0003774;GO:0003341;GO:0007368;GO:0030317;GO:0007018;GO:0036158;, C:cilium; C:cytoskeleton; C:microtubule; C:outer dynein arm;, F:dynein heavy chain binding; F:dynein light chain binding; F:motor activity;, P:cilium movement; P:determination of left/right symmetry; P:flagellated sperm motility; P:microtubule-based movement; P:outer dynein arm assembly; scaffold28 indexed_genome mRNA 32941547 32942815 . + . ID=transcript_6315;Q9UI46 B7Z7U1 Q5T8G7 Q8NHQ7 Q9UEZ8,Dynein intermediate chain 1, axonemal,Axonemal dynein intermediate chain 1;, PF00400;, GO:0005929;GO:0005856;GO:0005874;GO:0036157;GO:0045504;GO:0045503;GO:0003774;GO:0003341;GO:0007368;GO:0030317;GO:0007018;GO:0036158;, C:cilium; C:cytoskeleton; C:microtubule; C:outer dynein arm;, F:dynein heavy chain binding; F:dynein light chain binding; F:motor activity;, P:cilium movement; P:determination of left/right symmetry; P:flagellated sperm motility; P:microtubule-based movement; P:outer dynein arm assembly; scaffold28 indexed_genome mRNA 33006155 33079764 . + . ID=transcript_6316;Q8TAZ8,Protein FAM219A,, PF15260;|Q8TAZ8,Protein FAM219A,, PF15260;|Q8NCR6 Q5T598 Q5T599 Q5T5A0 Q8N9G4 Q96KD1 Q96LN1,Spermatid-specific manchette-related protein 1,Ciliated bronchial epithelial protein 1;Testis development protein NYD-SP22;, PF15181;, GO:0005829;GO:0002177;GO:0005654;GO:0005634;GO:0048471;GO:0043014;GO:0030154;GO:0034622;GO:0007283;, C:cytosol; C:manchette; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:alpha-tubulin binding;, P:cell differentiation; P:cellular protein-containing complex assembly; P:spermatogenesis; scaffold28 indexed_genome mRNA 33088728 33090963 . + . ID=transcript_6317;Q8NCR6 Q5T598 Q5T599 Q5T5A0 Q8N9G4 Q96KD1 Q96LN1,Spermatid-specific manchette-related protein 1,Ciliated bronchial epithelial protein 1;Testis development protein NYD-SP22;, PF15181;, GO:0005829;GO:0002177;GO:0005654;GO:0005634;GO:0048471;GO:0043014;GO:0030154;GO:0034622;GO:0007283;, C:cytosol; C:manchette; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:alpha-tubulin binding;, P:cell differentiation; P:cellular protein-containing complex assembly; P:spermatogenesis; scaffold28 indexed_genome mRNA 33095595 33100899 . + . ID=transcript_6318;Q6NSJ0 Q5T587 Q5T588 Q9ULQ9,Myogenesis-regulating glycosidase {ECO:0000312|HGNC:HGNC:19918},Uncharacterized family 31 glucosidase KIAA1161;, PF01055;, GO:0005789;GO:0016021;GO:0031965;GO:0004553;GO:0005975;GO:0043568;GO:0051897;GO:0048741;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, F:hydrolase activity, hydrolyzing O-glycosyl compounds;, P:carbohydrate metabolic process; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of protein kinase B signaling; P:skeletal muscle fiber development; scaffold28 indexed_genome mRNA 33108174 33118895 . - . ID=transcript_6319;P50583 D3DRM0 Q5T589,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase;Nucleoside diphosphate-linked moiety X motif 2;, PF00293;, GO:0005759;GO:0004081;GO:0008803;GO:0005525;GO:0006167;GO:0006915;GO:0006754;GO:0034599;GO:0006139;, C:mitochondrial matrix;, F:bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity; F:bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity; F:GTP binding;, P:AMP biosynthetic process; P:apoptotic process; P:ATP biosynthetic process; P:cellular response to oxidative stress; P:nucleobase-containing compound metabolic process; scaffold28 indexed_genome mRNA 33141494 33158335 . + . ID=transcript_6320;Q5T7B8 Q2TB93 Q5T7B5 Q5T7B7 Q6ZU97 Q6ZUZ2 Q86XZ0 Q9NV43,Kinesin-like protein KIF24,, PF00225;PF00536;, GO:0005814;GO:0005829;GO:0005874;GO:0032991;GO:0005524;GO:1990939;GO:0042802;GO:0008017;GO:0003777;GO:0097711;GO:0060271;GO:0007019;GO:0007018;, C:centriole; C:cytosol; C:microtubule; C:protein-containing complex;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:microtubule depolymerization; P:microtubule-based movement; scaffold28 indexed_genome mRNA 33165788 33178266 . + . ID=transcript_6321;Q5T7B8 Q2TB93 Q5T7B5 Q5T7B7 Q6ZU97 Q6ZUZ2 Q86XZ0 Q9NV43,Kinesin-like protein KIF24,, PF00225;PF00536;, GO:0005814;GO:0005829;GO:0005874;GO:0032991;GO:0005524;GO:1990939;GO:0042802;GO:0008017;GO:0003777;GO:0097711;GO:0060271;GO:0007019;GO:0007018;, C:centriole; C:cytosol; C:microtubule; C:protein-containing complex;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:microtubule depolymerization; P:microtubule-based movement; scaffold28 indexed_genome mRNA 33183889 33189211 . - . ID=transcript_6322;Q6FI75 Q8NC52 Q8NCG6 Q8NCH9,Ubiquitin-associated protein 1 {ECO:0000303|PubMed:11599797},Nasopharyngeal carcinoma-associated gene 20 protein;, , GO:0005737;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0005886;GO:0043130;GO:0016197;GO:0075733;GO:0015031;GO:0043162;GO:0019058;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ubiquitin binding;, P:endosomal transport; P:intracellular transport of virus; P:protein transport; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral life cycle;|Q6FI75 Q8NC52 Q8NCG6 Q8NCH9,Ubiquitin-associated protein 1 {ECO:0000303|PubMed:11599797},Nasopharyngeal carcinoma-associated gene 20 protein;, , GO:0005737;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0005886;GO:0043130;GO:0016197;GO:0075733;GO:0015031;GO:0043162;GO:0019058;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ubiquitin binding;, P:endosomal transport; P:intracellular transport of virus; P:protein transport; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral life cycle;|Q6FI75 Q8NC52 Q8NCG6 Q8NCH9,Ubiquitin-associated protein 1 {ECO:0000303|PubMed:11599797},Nasopharyngeal carcinoma-associated gene 20 protein;, , GO:0005737;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0005886;GO:0043130;GO:0016197;GO:0075733;GO:0015031;GO:0043162;GO:0019058;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ubiquitin binding;, P:endosomal transport; P:intracellular transport of virus; P:protein transport; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral life cycle;|Q6FI75 Q8NC52 Q8NCG6 Q8NCH9,Ubiquitin-associated protein 1 {ECO:0000303|PubMed:11599797},Nasopharyngeal carcinoma-associated gene 20 protein;, , GO:0005737;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0005886;GO:0043130;GO:0016197;GO:0075733;GO:0015031;GO:0043162;GO:0019058;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ubiquitin binding;, P:endosomal transport; P:intracellular transport of virus; P:protein transport; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral life cycle; scaffold28 indexed_genome mRNA 33193429 33255014 . - . ID=transcript_6323;Q6FI75 Q8NC52 Q8NCG6 Q8NCH9,Ubiquitin-associated protein 1 {ECO:0000303|PubMed:11599797},Nasopharyngeal carcinoma-associated gene 20 protein;, , GO:0005737;GO:0005829;GO:0010008;GO:0000813;GO:0043657;GO:0043231;GO:0005886;GO:0043130;GO:0016197;GO:0075733;GO:0015031;GO:0043162;GO:0019058;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:host cell; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ubiquitin binding;, P:endosomal transport; P:intracellular transport of virus; P:protein transport; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral life cycle; scaffold28 indexed_genome mRNA 33309795 33346501 . + . ID=transcript_6324;Q9UFJ1,DDB1- and CUL4-associated factor 12,Centrosome-related protein TCC52;Testis cancer centrosome-related protein;WD repeat-containing protein 40A;, , GO:0005813;GO:0080008;GO:0005737;GO:0016567;, C:centrosome; C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm;, , P:protein ubiquitination;|Q9UFJ1,DDB1- and CUL4-associated factor 12,Centrosome-related protein TCC52;Testis cancer centrosome-related protein;WD repeat-containing protein 40A;, , GO:0005813;GO:0080008;GO:0005737;GO:0016567;, C:centrosome; C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm;, , P:protein ubiquitination;|Q9UFJ1,DDB1- and CUL4-associated factor 12,Centrosome-related protein TCC52;Testis cancer centrosome-related protein;WD repeat-containing protein 40A;, , GO:0005813;GO:0080008;GO:0005737;GO:0016567;, C:centrosome; C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm;, , P:protein ubiquitination;|Q9UFJ1,DDB1- and CUL4-associated factor 12,Centrosome-related protein TCC52;Testis cancer centrosome-related protein;WD repeat-containing protein 40A;, , GO:0005813;GO:0080008;GO:0005737;GO:0016567;, C:centrosome; C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm;, , P:protein ubiquitination; scaffold28 indexed_genome mRNA 33417960 33501058 . + . ID=transcript_6325;Q5T6F2 Q2M2R4 Q5JV03 Q6PK34 Q8NC94 Q9P237,Ubiquitin-associated protein 2,, PF12478;, GO:0005737;GO:0005634;GO:0000932;GO:0045296;GO:0003723;GO:0010468;, C:cytoplasm; C:nucleus; C:P-body;, F:cadherin binding; F:RNA binding;, P:regulation of gene expression;|Q5T6F2 Q2M2R4 Q5JV03 Q6PK34 Q8NC94 Q9P237,Ubiquitin-associated protein 2,, PF12478;, GO:0005737;GO:0005634;GO:0000932;GO:0045296;GO:0003723;GO:0010468;, C:cytoplasm; C:nucleus; C:P-body;, F:cadherin binding; F:RNA binding;, P:regulation of gene expression;|Q5T6F2 Q2M2R4 Q5JV03 Q6PK34 Q8NC94 Q9P237,Ubiquitin-associated protein 2,, PF12478;, GO:0005737;GO:0005634;GO:0000932;GO:0045296;GO:0003723;GO:0010468;, C:cytoplasm; C:nucleus; C:P-body;, F:cadherin binding; F:RNA binding;, P:regulation of gene expression;|Q5T6F2 Q2M2R4 Q5JV03 Q6PK34 Q8NC94 Q9P237,Ubiquitin-associated protein 2,, PF12478;, GO:0005737;GO:0005634;GO:0000932;GO:0045296;GO:0003723;GO:0010468;, C:cytoplasm; C:nucleus; C:P-body;, F:cadherin binding; F:RNA binding;, P:regulation of gene expression;|Q5T6F2 Q2M2R4 Q5JV03 Q6PK34 Q8NC94 Q9P237,Ubiquitin-associated protein 2,, PF12478;, GO:0005737;GO:0005634;GO:0000932;GO:0045296;GO:0003723;GO:0010468;, C:cytoplasm; C:nucleus; C:P-body;, F:cadherin binding; F:RNA binding;, P:regulation of gene expression;|Q5T6F2 Q2M2R4 Q5JV03 Q6PK34 Q8NC94 Q9P237,Ubiquitin-associated protein 2,, PF12478;, GO:0005737;GO:0005634;GO:0000932;GO:0045296;GO:0003723;GO:0010468;, C:cytoplasm; C:nucleus; C:P-body;, F:cadherin binding; F:RNA binding;, P:regulation of gene expression;|Q5T6F2 Q2M2R4 Q5JV03 Q6PK34 Q8NC94 Q9P237,Ubiquitin-associated protein 2,, PF12478;, GO:0005737;GO:0005634;GO:0000932;GO:0045296;GO:0003723;GO:0010468;, C:cytoplasm; C:nucleus; C:P-body;, F:cadherin binding; F:RNA binding;, P:regulation of gene expression; scaffold28 indexed_genome mRNA 33502139 33596727 . - . ID=transcript_6326;Q712K3 D3DRL5 Q9NX64,Ubiquitin-conjugating enzyme E2 R2,E2 ubiquitin-conjugating enzyme R2;Ubiquitin carrier protein R2;Ubiquitin-conjugating enzyme E2-CDC34B;Ubiquitin-protein ligase R2;, PF00179;, GO:0005829;GO:0005524;GO:0061631;GO:0004842;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:0006511;, C:cytosol;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q712K3 D3DRL5 Q9NX64,Ubiquitin-conjugating enzyme E2 R2,E2 ubiquitin-conjugating enzyme R2;Ubiquitin carrier protein R2;Ubiquitin-conjugating enzyme E2-CDC34B;Ubiquitin-protein ligase R2;, PF00179;, GO:0005829;GO:0005524;GO:0061631;GO:0004842;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:0006511;, C:cytosol;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q712K3 D3DRL5 Q9NX64,Ubiquitin-conjugating enzyme E2 R2,E2 ubiquitin-conjugating enzyme R2;Ubiquitin carrier protein R2;Ubiquitin-conjugating enzyme E2-CDC34B;Ubiquitin-protein ligase R2;, PF00179;, GO:0005829;GO:0005524;GO:0061631;GO:0004842;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:0006511;, C:cytosol;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold28 indexed_genome mRNA 33609684 33619187 . + . ID=transcript_6327;Q9H6R4 Q5T5M3 Q5T5M4 Q7L4G6 Q8N6I0 Q8TEY9 Q8TEZ0 Q8TEZ1 Q9H675,Nucleolar protein 6,Nucleolar RNA-associated protein;, PF03813;PF17403;PF17404;PF17405;PF17406;PF17407;, GO:0000794;GO:0032545;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034456;GO:0003723;GO:0006364;GO:0006409;, C:condensed nuclear chromosome; C:CURI complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:UTP-C complex;, F:RNA binding;, P:rRNA processing; P:tRNA export from nucleus;|Q9H6R4 Q5T5M3 Q5T5M4 Q7L4G6 Q8N6I0 Q8TEY9 Q8TEZ0 Q8TEZ1 Q9H675,Nucleolar protein 6,Nucleolar RNA-associated protein;, PF03813;PF17403;PF17404;PF17405;PF17406;PF17407;, GO:0000794;GO:0032545;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034456;GO:0003723;GO:0006364;GO:0006409;, C:condensed nuclear chromosome; C:CURI complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:UTP-C complex;, F:RNA binding;, P:rRNA processing; P:tRNA export from nucleus;|Q9H6R4 Q5T5M3 Q5T5M4 Q7L4G6 Q8N6I0 Q8TEY9 Q8TEZ0 Q8TEZ1 Q9H675,Nucleolar protein 6,Nucleolar RNA-associated protein;, PF03813;PF17403;PF17404;PF17405;PF17406;PF17407;, GO:0000794;GO:0032545;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034456;GO:0003723;GO:0006364;GO:0006409;, C:condensed nuclear chromosome; C:CURI complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:UTP-C complex;, F:RNA binding;, P:rRNA processing; P:tRNA export from nucleus;|Q9H6R4 Q5T5M3 Q5T5M4 Q7L4G6 Q8N6I0 Q8TEY9 Q8TEZ0 Q8TEZ1 Q9H675,Nucleolar protein 6,Nucleolar RNA-associated protein;, PF03813;PF17403;PF17404;PF17405;PF17406;PF17407;, GO:0000794;GO:0032545;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034456;GO:0003723;GO:0006364;GO:0006409;, C:condensed nuclear chromosome; C:CURI complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:UTP-C complex;, F:RNA binding;, P:rRNA processing; P:tRNA export from nucleus; scaffold28 indexed_genome mRNA 33619427 33622724 . + . ID=transcript_6328;Q9H6R4 Q5T5M3 Q5T5M4 Q7L4G6 Q8N6I0 Q8TEY9 Q8TEZ0 Q8TEZ1 Q9H675,Nucleolar protein 6,Nucleolar RNA-associated protein;, PF03813;PF17403;PF17404;PF17405;PF17406;PF17407;, GO:0000794;GO:0032545;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034456;GO:0003723;GO:0006364;GO:0006409;, C:condensed nuclear chromosome; C:CURI complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:UTP-C complex;, F:RNA binding;, P:rRNA processing; P:tRNA export from nucleus; scaffold28 indexed_genome mRNA 33631810 33637289 . + . ID=transcript_6329;Q92482 A8K843 B2RE16 D3DRL3 O00108 Q6FGT2 Q6FGW6,Aquaporin-3,Aquaglyceroporin-3;, PF00230;, GO:0016323;GO:0005911;GO:0005737;GO:0016021;GO:0005654;GO:0005886;GO:0015254;GO:0042802;GO:0015204;GO:0015250;GO:0071456;GO:0090650;GO:0015793;GO:0042476;GO:0002684;GO:0045616;GO:0070295;GO:0003091;GO:0051592;GO:0032526;GO:0033280;GO:0006833;, C:basolateral plasma membrane; C:cell-cell junction; C:cytoplasm; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:glycerol channel activity; F:identical protein binding; F:urea transmembrane transporter activity; F:water channel activity;, P:cellular response to hypoxia; P:cellular response to oxygen-glucose deprivation; P:glycerol transport; P:odontogenesis; P:positive regulation of immune system process; P:regulation of keratinocyte differentiation; P:renal water absorption; P:renal water homeostasis; P:response to calcium ion; P:response to retinoic acid; P:response to vitamin D; P:water transport; scaffold28 indexed_genome mRNA 33678104 33695012 . + . ID=transcript_6330;O14520 Q08E94 Q5T5L9 Q8NHM3,Aquaporin-7,Aquaglyceroporin-7;Aquaporin adipose {ECO:0000303|PubMed:11952783};Aquaporin-7-like;, PF00230;, GO:0005938;GO:0005911;GO:0005737;GO:0030659;GO:0005887;GO:0005811;GO:0005886;GO:0015254;GO:0015204;GO:0015250;GO:0015793;GO:0006833;, C:cell cortex; C:cell-cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:integral component of plasma membrane; C:lipid droplet; C:plasma membrane;, F:glycerol channel activity; F:urea transmembrane transporter activity; F:water channel activity;, P:glycerol transport; P:water transport;|O14520 Q08E94 Q5T5L9 Q8NHM3,Aquaporin-7,Aquaglyceroporin-7;Aquaporin adipose {ECO:0000303|PubMed:11952783};Aquaporin-7-like;, PF00230;, GO:0005938;GO:0005911;GO:0005737;GO:0030659;GO:0005887;GO:0005811;GO:0005886;GO:0015254;GO:0015204;GO:0015250;GO:0015793;GO:0006833;, C:cell cortex; C:cell-cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:integral component of plasma membrane; C:lipid droplet; C:plasma membrane;, F:glycerol channel activity; F:urea transmembrane transporter activity; F:water channel activity;, P:glycerol transport; P:water transport;|O14520 Q08E94 Q5T5L9 Q8NHM3,Aquaporin-7,Aquaglyceroporin-7;Aquaporin adipose {ECO:0000303|PubMed:11952783};Aquaporin-7-like;, PF00230;, GO:0005938;GO:0005911;GO:0005737;GO:0030659;GO:0005887;GO:0005811;GO:0005886;GO:0015254;GO:0015204;GO:0015250;GO:0015793;GO:0006833;, C:cell cortex; C:cell-cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:integral component of plasma membrane; C:lipid droplet; C:plasma membrane;, F:glycerol channel activity; F:urea transmembrane transporter activity; F:water channel activity;, P:glycerol transport; P:water transport; scaffold28 indexed_genome mRNA 33709410 33772625 . - . ID=transcript_6331;Q12986 A8K6H8 Q5VXW6 Q96EL5 Q9BXI1,Transcriptional repressor NF-X1,Nuclear transcription factor, X box-binding protein 1;, PF01424;PF01422;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0000981;GO:0001227;GO:0003723;GO:0000977;GO:0061630;GO:0008270;GO:0006954;GO:0045347;GO:0000122;GO:0051865;GO:0016567;GO:0006355;GO:0006366;GO:0016032;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:inflammatory response; P:negative regulation of MHC class II biosynthetic process; P:negative regulation of transcription by RNA polymerase II; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; P:viral process;|Q12986 A8K6H8 Q5VXW6 Q96EL5 Q9BXI1,Transcriptional repressor NF-X1,Nuclear transcription factor, X box-binding protein 1;, PF01424;PF01422;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0000981;GO:0001227;GO:0003723;GO:0000977;GO:0061630;GO:0008270;GO:0006954;GO:0045347;GO:0000122;GO:0051865;GO:0016567;GO:0006355;GO:0006366;GO:0016032;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:inflammatory response; P:negative regulation of MHC class II biosynthetic process; P:negative regulation of transcription by RNA polymerase II; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; P:viral process; scaffold28 indexed_genome mRNA 33782066 33807887 . - . ID=transcript_6332;Q9NZZ3 B2RD95 B4DIR6 Q5VXW2 Q96AV2 Q9HB68 Q9NYS4 Q9Y323,Charged multivesicular body protein 5,Chromatin-modifying protein 5;SNF7 domain-containing protein 2;Vacuolar protein sorting-associated protein 60;, PF03357;, GO:0005829;GO:0010008;GO:0070062;GO:0005771;GO:0005634;GO:0045296;GO:0071222;GO:0071225;GO:0016197;GO:0008333;GO:1904903;GO:0032511;GO:0007040;GO:0061952;GO:0007080;GO:0036258;GO:0071985;GO:0006997;GO:0015031;GO:0010824;GO:1901673;GO:0001919;GO:0006900;GO:0046755;GO:0019058;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:multivesicular body; C:nucleus;, F:cadherin binding;, P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:endosomal transport; P:endosome to lysosome transport; P:ESCRT III complex disassembly; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:lysosome organization; P:midbody abscission; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:nucleus organization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of receptor recycling; P:vesicle budding from membrane; P:viral budding; P:viral life cycle;|Q9NZZ3 B2RD95 B4DIR6 Q5VXW2 Q96AV2 Q9HB68 Q9NYS4 Q9Y323,Charged multivesicular body protein 5,Chromatin-modifying protein 5;SNF7 domain-containing protein 2;Vacuolar protein sorting-associated protein 60;, PF03357;, GO:0005829;GO:0010008;GO:0070062;GO:0005771;GO:0005634;GO:0045296;GO:0071222;GO:0071225;GO:0016197;GO:0008333;GO:1904903;GO:0032511;GO:0007040;GO:0061952;GO:0007080;GO:0036258;GO:0071985;GO:0006997;GO:0015031;GO:0010824;GO:1901673;GO:0001919;GO:0006900;GO:0046755;GO:0019058;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:multivesicular body; C:nucleus;, F:cadherin binding;, P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:endosomal transport; P:endosome to lysosome transport; P:ESCRT III complex disassembly; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:lysosome organization; P:midbody abscission; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:nucleus organization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of receptor recycling; P:vesicle budding from membrane; P:viral budding; P:viral life cycle;|Q9NZZ3 B2RD95 B4DIR6 Q5VXW2 Q96AV2 Q9HB68 Q9NYS4 Q9Y323,Charged multivesicular body protein 5,Chromatin-modifying protein 5;SNF7 domain-containing protein 2;Vacuolar protein sorting-associated protein 60;, PF03357;, GO:0005829;GO:0010008;GO:0070062;GO:0005771;GO:0005634;GO:0045296;GO:0071222;GO:0071225;GO:0016197;GO:0008333;GO:1904903;GO:0032511;GO:0007040;GO:0061952;GO:0007080;GO:0036258;GO:0071985;GO:0006997;GO:0015031;GO:0010824;GO:1901673;GO:0001919;GO:0006900;GO:0046755;GO:0019058;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:multivesicular body; C:nucleus;, F:cadherin binding;, P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:endosomal transport; P:endosome to lysosome transport; P:ESCRT III complex disassembly; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:lysosome organization; P:midbody abscission; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:nucleus organization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of receptor recycling; P:vesicle budding from membrane; P:viral budding; P:viral life cycle;|Q9NZZ3 B2RD95 B4DIR6 Q5VXW2 Q96AV2 Q9HB68 Q9NYS4 Q9Y323,Charged multivesicular body protein 5,Chromatin-modifying protein 5;SNF7 domain-containing protein 2;Vacuolar protein sorting-associated protein 60;, PF03357;, GO:0005829;GO:0010008;GO:0070062;GO:0005771;GO:0005634;GO:0045296;GO:0071222;GO:0071225;GO:0016197;GO:0008333;GO:1904903;GO:0032511;GO:0007040;GO:0061952;GO:0007080;GO:0036258;GO:0071985;GO:0006997;GO:0015031;GO:0010824;GO:1901673;GO:0001919;GO:0006900;GO:0046755;GO:0019058;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:multivesicular body; C:nucleus;, F:cadherin binding;, P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:endosomal transport; P:endosome to lysosome transport; P:ESCRT III complex disassembly; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:lysosome organization; P:midbody abscission; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:nucleus organization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of receptor recycling; P:vesicle budding from membrane; P:viral budding; P:viral life cycle;|Q99933 O75315 Q14414 Q53H32 Q5VZE8 Q5VZE9 Q5VZF0 Q96TG2 Q9Y2V4,BAG family molecular chaperone regulator 1,Bcl-2-associated athanogene 1;, PF02179;PF00240;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0000774;GO:0051087;GO:0031072;GO:0031625;GO:0006915;GO:0007166;GO:0051085;GO:0043066;GO:0050821;GO:1900034;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:heat shock protein binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell surface receptor signaling pathway; P:chaperone cofactor-dependent protein refolding; P:negative regulation of apoptotic process; P:protein stabilization; P:regulation of cellular response to heat;|Q99933 O75315 Q14414 Q53H32 Q5VZE8 Q5VZE9 Q5VZF0 Q96TG2 Q9Y2V4,BAG family molecular chaperone regulator 1,Bcl-2-associated athanogene 1;, PF02179;PF00240;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0000774;GO:0051087;GO:0031072;GO:0031625;GO:0006915;GO:0007166;GO:0051085;GO:0043066;GO:0050821;GO:1900034;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:heat shock protein binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell surface receptor signaling pathway; P:chaperone cofactor-dependent protein refolding; P:negative regulation of apoptotic process; P:protein stabilization; P:regulation of cellular response to heat;|Q99933 O75315 Q14414 Q53H32 Q5VZE8 Q5VZE9 Q5VZF0 Q96TG2 Q9Y2V4,BAG family molecular chaperone regulator 1,Bcl-2-associated athanogene 1;, PF02179;PF00240;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0000774;GO:0051087;GO:0031072;GO:0031625;GO:0006915;GO:0007166;GO:0051085;GO:0043066;GO:0050821;GO:1900034;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:heat shock protein binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell surface receptor signaling pathway; P:chaperone cofactor-dependent protein refolding; P:negative regulation of apoptotic process; P:protein stabilization; P:regulation of cellular response to heat; scaffold28 indexed_genome mRNA 33941961 33942740 . + . ID=transcript_6333;P15291 B2R710 D3DRL2 Q12909 Q12910 Q12911 Q14456 Q14509 Q14523,Beta-1,4-galactosyltransferase 1 {ECO:0000305},Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase;Lactose synthase A protein;N-acetyllactosamine synthase;Nal synthase;Neolactotriaosylceramide beta-1,4-galactosyltransferase;UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1;, PF02709;PF13733;, GO:0035577;GO:0016323;GO:0031526;GO:0030057;GO:0009897;GO:0070062;GO:0005615;GO:0030175;GO:0005794;GO:0032580;GO:0000139;GO:0000138;GO:0016021;GO:0016020;GO:0005886;GO:0030667;GO:0043014;GO:0003831;GO:0048487;GO:0008378;GO:0042802;GO:0004461;GO:0030145;GO:0003945;GO:0035250;GO:0002526;GO:0060055;GO:0007339;GO:0007155;GO:0045136;GO:0002064;GO:0030198;GO:0006012;GO:0018146;GO:0005989;GO:0050900;GO:0008285;GO:0043312;GO:0009312;GO:0007341;GO:0043065;GO:0060054;GO:0006487;GO:0060046;, C:azurophil granule membrane; C:basolateral plasma membrane; C:brush border membrane; C:desmosome; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:filopodium; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, F:alpha-tubulin binding; F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; F:beta-tubulin binding; F:galactosyltransferase activity; F:identical protein binding; F:lactose synthase activity; F:manganese ion binding; F:N-acetyllactosamine synthase activity; F:UDP-galactosyltransferase activity;, P:acute inflammatory response; P:angiogenesis involved in wound healing; P:binding of sperm to zona pellucida; P:cell adhesion; P:development of secondary sexual characteristics; P:epithelial cell development; P:extracellular matrix organization; P:galactose metabolic process; P:keratan sulfate biosynthetic process; P:lactose biosynthetic process; P:leukocyte migration; P:negative regulation of cell population proliferation; P:neutrophil degranulation; P:oligosaccharide biosynthetic process; P:penetration of zona pellucida; P:positive regulation of apoptotic process; P:positive regulation of epithelial cell proliferation involved in wound healing; P:protein N-linked glycosylation; P:regulation of acrosome reaction; scaffold28 indexed_genome mRNA 33943208 33945700 . + . ID=transcript_6334;P15291 B2R710 D3DRL2 Q12909 Q12910 Q12911 Q14456 Q14509 Q14523,Beta-1,4-galactosyltransferase 1 {ECO:0000305},Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase;Lactose synthase A protein;N-acetyllactosamine synthase;Nal synthase;Neolactotriaosylceramide beta-1,4-galactosyltransferase;UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1;, PF02709;PF13733;, GO:0035577;GO:0016323;GO:0031526;GO:0030057;GO:0009897;GO:0070062;GO:0005615;GO:0030175;GO:0005794;GO:0032580;GO:0000139;GO:0000138;GO:0016021;GO:0016020;GO:0005886;GO:0030667;GO:0043014;GO:0003831;GO:0048487;GO:0008378;GO:0042802;GO:0004461;GO:0030145;GO:0003945;GO:0035250;GO:0002526;GO:0060055;GO:0007339;GO:0007155;GO:0045136;GO:0002064;GO:0030198;GO:0006012;GO:0018146;GO:0005989;GO:0050900;GO:0008285;GO:0043312;GO:0009312;GO:0007341;GO:0043065;GO:0060054;GO:0006487;GO:0060046;, C:azurophil granule membrane; C:basolateral plasma membrane; C:brush border membrane; C:desmosome; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:filopodium; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, F:alpha-tubulin binding; F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; F:beta-tubulin binding; F:galactosyltransferase activity; F:identical protein binding; F:lactose synthase activity; F:manganese ion binding; F:N-acetyllactosamine synthase activity; F:UDP-galactosyltransferase activity;, P:acute inflammatory response; P:angiogenesis involved in wound healing; P:binding of sperm to zona pellucida; P:cell adhesion; P:development of secondary sexual characteristics; P:epithelial cell development; P:extracellular matrix organization; P:galactose metabolic process; P:keratan sulfate biosynthetic process; P:lactose biosynthetic process; P:leukocyte migration; P:negative regulation of cell population proliferation; P:neutrophil degranulation; P:oligosaccharide biosynthetic process; P:penetration of zona pellucida; P:positive regulation of apoptotic process; P:positive regulation of epithelial cell proliferation involved in wound healing; P:protein N-linked glycosylation; P:regulation of acrosome reaction; scaffold28 indexed_genome mRNA 33972361 34002366 . + . ID=transcript_6335;Q2TAY7 B4E3L0 Q9BU59 Q9HA96 Q9NVD1,WD40 repeat-containing protein SMU1,Smu-1 suppressor of mec-8 and unc-52 protein homolog;, PF00400;, GO:0005737;GO:0016607;GO:0005634;GO:0071011;GO:0071005;GO:0000398;GO:0000381;GO:0008380;GO:0016032;, C:cytoplasm; C:nuclear speck; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome;, , P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:viral process;|Q2TAY7 B4E3L0 Q9BU59 Q9HA96 Q9NVD1,WD40 repeat-containing protein SMU1,Smu-1 suppressor of mec-8 and unc-52 protein homolog;, PF00400;, GO:0005737;GO:0016607;GO:0005634;GO:0071011;GO:0071005;GO:0000398;GO:0000381;GO:0008380;GO:0016032;, C:cytoplasm; C:nuclear speck; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome;, , P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:viral process;|Q2TAY7 B4E3L0 Q9BU59 Q9HA96 Q9NVD1,WD40 repeat-containing protein SMU1,Smu-1 suppressor of mec-8 and unc-52 protein homolog;, PF00400;, GO:0005737;GO:0016607;GO:0005634;GO:0071011;GO:0071005;GO:0000398;GO:0000381;GO:0008380;GO:0016032;, C:cytoplasm; C:nuclear speck; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome;, , P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:viral process;|Q2TAY7 B4E3L0 Q9BU59 Q9HA96 Q9NVD1,WD40 repeat-containing protein SMU1,Smu-1 suppressor of mec-8 and unc-52 protein homolog;, PF00400;, GO:0005737;GO:0016607;GO:0005634;GO:0071011;GO:0071005;GO:0000398;GO:0000381;GO:0008380;GO:0016032;, C:cytoplasm; C:nuclear speck; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome;, , P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:viral process; scaffold28 indexed_genome mRNA 34006607 34015188 . + . ID=transcript_6336;P31689 Q5T7Q0 Q86TL9,DnaJ homolog subfamily A member 1,DnaJ protein homolog 2;HSDJ;Heat shock 40 kDa protein 4;Heat shock protein J2;Human DnaJ protein 2;, PF00226;PF01556;PF00684;, GO:0098554;GO:0005829;GO:0070062;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0048471;GO:0005524;GO:0001671;GO:0055131;GO:0051087;GO:0001664;GO:0030544;GO:0050750;GO:0046872;GO:0030957;GO:0031625;GO:0051082;GO:0030521;GO:0042769;GO:0030317;GO:0043066;GO:1903748;GO:0043508;GO:1905259;GO:0031397;GO:0043065;GO:0006457;GO:0070585;GO:0051223;GO:0009408;GO:0006986;GO:0007283;GO:1901998;, C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:extracellular exosome; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activator activity; F:C3HC4-type RING finger domain binding; F:chaperone binding; F:G protein-coupled receptor binding; F:Hsp70 protein binding; F:low-density lipoprotein particle receptor binding; F:metal ion binding; F:Tat protein binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:androgen receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:flagellated sperm motility; P:negative regulation of apoptotic process; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of JUN kinase activity; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein ubiquitination; P:positive regulation of apoptotic process; P:protein folding; P:protein localization to mitochondrion; P:regulation of protein transport; P:response to heat; P:response to unfolded protein; P:spermatogenesis; P:toxin transport;|P31689 Q5T7Q0 Q86TL9,DnaJ homolog subfamily A member 1,DnaJ protein homolog 2;HSDJ;Heat shock 40 kDa protein 4;Heat shock protein J2;Human DnaJ protein 2;, PF00226;PF01556;PF00684;, GO:0098554;GO:0005829;GO:0070062;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0048471;GO:0005524;GO:0001671;GO:0055131;GO:0051087;GO:0001664;GO:0030544;GO:0050750;GO:0046872;GO:0030957;GO:0031625;GO:0051082;GO:0030521;GO:0042769;GO:0030317;GO:0043066;GO:1903748;GO:0043508;GO:1905259;GO:0031397;GO:0043065;GO:0006457;GO:0070585;GO:0051223;GO:0009408;GO:0006986;GO:0007283;GO:1901998;, C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:extracellular exosome; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activator activity; F:C3HC4-type RING finger domain binding; F:chaperone binding; F:G protein-coupled receptor binding; F:Hsp70 protein binding; F:low-density lipoprotein particle receptor binding; F:metal ion binding; F:Tat protein binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:androgen receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:flagellated sperm motility; P:negative regulation of apoptotic process; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of JUN kinase activity; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein ubiquitination; P:positive regulation of apoptotic process; P:protein folding; P:protein localization to mitochondrion; P:regulation of protein transport; P:response to heat; P:response to unfolded protein; P:spermatogenesis; P:toxin transport;|P31689 Q5T7Q0 Q86TL9,DnaJ homolog subfamily A member 1,DnaJ protein homolog 2;HSDJ;Heat shock 40 kDa protein 4;Heat shock protein J2;Human DnaJ protein 2;, PF00226;PF01556;PF00684;, GO:0098554;GO:0005829;GO:0070062;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0048471;GO:0005524;GO:0001671;GO:0055131;GO:0051087;GO:0001664;GO:0030544;GO:0050750;GO:0046872;GO:0030957;GO:0031625;GO:0051082;GO:0030521;GO:0042769;GO:0030317;GO:0043066;GO:1903748;GO:0043508;GO:1905259;GO:0031397;GO:0043065;GO:0006457;GO:0070585;GO:0051223;GO:0009408;GO:0006986;GO:0007283;GO:1901998;, C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:extracellular exosome; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activator activity; F:C3HC4-type RING finger domain binding; F:chaperone binding; F:G protein-coupled receptor binding; F:Hsp70 protein binding; F:low-density lipoprotein particle receptor binding; F:metal ion binding; F:Tat protein binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:androgen receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:flagellated sperm motility; P:negative regulation of apoptotic process; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of JUN kinase activity; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein ubiquitination; P:positive regulation of apoptotic process; P:protein folding; P:protein localization to mitochondrion; P:regulation of protein transport; P:response to heat; P:response to unfolded protein; P:spermatogenesis; P:toxin transport;|P31689 Q5T7Q0 Q86TL9,DnaJ homolog subfamily A member 1,DnaJ protein homolog 2;HSDJ;Heat shock 40 kDa protein 4;Heat shock protein J2;Human DnaJ protein 2;, PF00226;PF01556;PF00684;, GO:0098554;GO:0005829;GO:0070062;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0048471;GO:0005524;GO:0001671;GO:0055131;GO:0051087;GO:0001664;GO:0030544;GO:0050750;GO:0046872;GO:0030957;GO:0031625;GO:0051082;GO:0030521;GO:0042769;GO:0030317;GO:0043066;GO:1903748;GO:0043508;GO:1905259;GO:0031397;GO:0043065;GO:0006457;GO:0070585;GO:0051223;GO:0009408;GO:0006986;GO:0007283;GO:1901998;, C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:extracellular exosome; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activator activity; F:C3HC4-type RING finger domain binding; F:chaperone binding; F:G protein-coupled receptor binding; F:Hsp70 protein binding; F:low-density lipoprotein particle receptor binding; F:metal ion binding; F:Tat protein binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:androgen receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:flagellated sperm motility; P:negative regulation of apoptotic process; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of JUN kinase activity; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein ubiquitination; P:positive regulation of apoptotic process; P:protein folding; P:protein localization to mitochondrion; P:regulation of protein transport; P:response to heat; P:response to unfolded protein; P:spermatogenesis; P:toxin transport; scaffold28 indexed_genome mRNA 34040373 34055756 . + . ID=transcript_6337;Q6JV82 Q6JV85 Q7Z2F3 Q7Z336 Q7Z5R5 Q7Z6V7 Q7Z6V8 Q9NXM5,Aprataxin,Forkhead-associated domain histidine triad-like protein;, PF17913;PF16278;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0003684;GO:0033699;GO:0120108;GO:0003690;GO:0003725;GO:0046872;GO:0030983;GO:0008967;GO:0051219;GO:0046403;GO:0047485;GO:1990165;GO:0003697;GO:0006974;GO:0006266;GO:0006302;GO:0031647;GO:0042542;GO:0000012;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:damaged DNA binding; F:DNA 5'-adenosine monophosphate hydrolase activity; F:DNA-3'-diphospho-5'-guanosine diphosphatase; F:double-stranded DNA binding; F:double-stranded RNA binding; F:metal ion binding; F:mismatched DNA binding; F:phosphoglycolate phosphatase activity; F:phosphoprotein binding; F:polynucleotide 3'-phosphatase activity; F:protein N-terminus binding; F:single-strand break-containing DNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA ligation; P:double-strand break repair; P:regulation of protein stability; P:response to hydrogen peroxide; P:single strand break repair;|Q6JV82 Q6JV85 Q7Z2F3 Q7Z336 Q7Z5R5 Q7Z6V7 Q7Z6V8 Q9NXM5,Aprataxin,Forkhead-associated domain histidine triad-like protein;, PF17913;PF16278;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0003684;GO:0033699;GO:0120108;GO:0003690;GO:0003725;GO:0046872;GO:0030983;GO:0008967;GO:0051219;GO:0046403;GO:0047485;GO:1990165;GO:0003697;GO:0006974;GO:0006266;GO:0006302;GO:0031647;GO:0042542;GO:0000012;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:damaged DNA binding; F:DNA 5'-adenosine monophosphate hydrolase activity; F:DNA-3'-diphospho-5'-guanosine diphosphatase; F:double-stranded DNA binding; F:double-stranded RNA binding; F:metal ion binding; F:mismatched DNA binding; F:phosphoglycolate phosphatase activity; F:phosphoprotein binding; F:polynucleotide 3'-phosphatase activity; F:protein N-terminus binding; F:single-strand break-containing DNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA ligation; P:double-strand break repair; P:regulation of protein stability; P:response to hydrogen peroxide; P:single strand break repair;|Q6JV82 Q6JV85 Q7Z2F3 Q7Z336 Q7Z5R5 Q7Z6V7 Q7Z6V8 Q9NXM5,Aprataxin,Forkhead-associated domain histidine triad-like protein;, PF17913;PF16278;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0003684;GO:0033699;GO:0120108;GO:0003690;GO:0003725;GO:0046872;GO:0030983;GO:0008967;GO:0051219;GO:0046403;GO:0047485;GO:1990165;GO:0003697;GO:0006974;GO:0006266;GO:0006302;GO:0031647;GO:0042542;GO:0000012;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:damaged DNA binding; F:DNA 5'-adenosine monophosphate hydrolase activity; F:DNA-3'-diphospho-5'-guanosine diphosphatase; F:double-stranded DNA binding; F:double-stranded RNA binding; F:metal ion binding; F:mismatched DNA binding; F:phosphoglycolate phosphatase activity; F:phosphoprotein binding; F:polynucleotide 3'-phosphatase activity; F:protein N-terminus binding; F:single-strand break-containing DNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA ligation; P:double-strand break repair; P:regulation of protein stability; P:response to hydrogen peroxide; P:single strand break repair; scaffold28 indexed_genome mRNA 34110843 34135522 . - . ID=transcript_6338;Q15392 B7Z817 D3DQ51 Q9HBA8,Delta(24)-sterol reductase,24-dehydrocholesterol reductase;3-beta-hydroxysterol Delta-24-reductase;Diminuto/dwarf1 homolog;Seladin-1 {ECO:0000303|PubMed:11007892};, PF01565;, GO:0005737;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0016020;GO:0005634;GO:0000246;GO:0050614;GO:0019899;GO:0071949;GO:0016628;GO:0042605;GO:0006915;GO:0007050;GO:0006695;GO:0033489;GO:0033490;GO:0043066;GO:0043154;GO:1901214;GO:0006979;GO:0043588;GO:0008202;GO:0009888;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nucleus;, F:delta24(24-1) sterol reductase activity; F:delta24-sterol reductase activity; F:enzyme binding; F:FAD binding; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; F:peptide antigen binding;, P:apoptotic process; P:cell cycle arrest; P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of neuron death; P:response to oxidative stress; P:skin development; P:steroid metabolic process; P:tissue development; scaffold28 indexed_genome mRNA 34146210 34201588 . - . ID=transcript_6339;P34913 B2Z3B1 B3KTU8 B3KUA0 G3V134 J3KPH7 Q16764 Q9HBJ1 Q9HBJ2,Bifunctional epoxide hydrolase 2 {ECO:0000305},, PF00561;PF13419;, GO:0005829;GO:0070062;GO:0005782;GO:0005777;GO:0033885;GO:0004301;GO:0016787;GO:0042577;GO:0052642;GO:0000287;GO:0016791;GO:0042803;GO:0015643;GO:0042632;GO:0016311;GO:0097176;GO:0019373;GO:0042759;GO:0046839;GO:0010628;GO:0008104;GO:0090181;GO:0009636;GO:0046272;, C:cytosol; C:extracellular exosome; C:peroxisomal matrix; C:peroxisome;, F:10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity; F:epoxide hydrolase activity; F:hydrolase activity; F:lipid phosphatase activity; F:lysophosphatidic acid phosphatase activity; F:magnesium ion binding; F:phosphatase activity; F:protein homodimerization activity; F:toxic substance binding;, P:cholesterol homeostasis; P:dephosphorylation; P:epoxide metabolic process; P:epoxygenase P450 pathway; P:long-chain fatty acid biosynthetic process; P:phospholipid dephosphorylation; P:positive regulation of gene expression; P:protein localization; P:regulation of cholesterol metabolic process; P:response to toxic substance; P:stilbene catabolic process;|P34913 B2Z3B1 B3KTU8 B3KUA0 G3V134 J3KPH7 Q16764 Q9HBJ1 Q9HBJ2,Bifunctional epoxide hydrolase 2 {ECO:0000305},, PF00561;PF13419;, GO:0005829;GO:0070062;GO:0005782;GO:0005777;GO:0033885;GO:0004301;GO:0016787;GO:0042577;GO:0052642;GO:0000287;GO:0016791;GO:0042803;GO:0015643;GO:0042632;GO:0016311;GO:0097176;GO:0019373;GO:0042759;GO:0046839;GO:0010628;GO:0008104;GO:0090181;GO:0009636;GO:0046272;, C:cytosol; C:extracellular exosome; C:peroxisomal matrix; C:peroxisome;, F:10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity; F:epoxide hydrolase activity; F:hydrolase activity; F:lipid phosphatase activity; F:lysophosphatidic acid phosphatase activity; F:magnesium ion binding; F:phosphatase activity; F:protein homodimerization activity; F:toxic substance binding;, P:cholesterol homeostasis; P:dephosphorylation; P:epoxide metabolic process; P:epoxygenase P450 pathway; P:long-chain fatty acid biosynthetic process; P:phospholipid dephosphorylation; P:positive regulation of gene expression; P:protein localization; P:regulation of cholesterol metabolic process; P:response to toxic substance; P:stilbene catabolic process;|P34913 B2Z3B1 B3KTU8 B3KUA0 G3V134 J3KPH7 Q16764 Q9HBJ1 Q9HBJ2,Bifunctional epoxide hydrolase 2 {ECO:0000305},, PF00561;PF13419;, GO:0005829;GO:0070062;GO:0005782;GO:0005777;GO:0033885;GO:0004301;GO:0016787;GO:0042577;GO:0052642;GO:0000287;GO:0016791;GO:0042803;GO:0015643;GO:0042632;GO:0016311;GO:0097176;GO:0019373;GO:0042759;GO:0046839;GO:0010628;GO:0008104;GO:0090181;GO:0009636;GO:0046272;, C:cytosol; C:extracellular exosome; C:peroxisomal matrix; C:peroxisome;, F:10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity; F:epoxide hydrolase activity; F:hydrolase activity; F:lipid phosphatase activity; F:lysophosphatidic acid phosphatase activity; F:magnesium ion binding; F:phosphatase activity; F:protein homodimerization activity; F:toxic substance binding;, P:cholesterol homeostasis; P:dephosphorylation; P:epoxide metabolic process; P:epoxygenase P450 pathway; P:long-chain fatty acid biosynthetic process; P:phospholipid dephosphorylation; P:positive regulation of gene expression; P:protein localization; P:regulation of cholesterol metabolic process; P:response to toxic substance; P:stilbene catabolic process; scaffold28 indexed_genome mRNA 34228973 34265074 . - . ID=transcript_6340;Q14289 D3DST0 Q13475 Q14290 Q16709 Q6PID4,Protein-tyrosine kinase 2-beta,Calcium-dependent tyrosine kinase;Calcium-regulated non-receptor proline-rich tyrosine kinase;Cell adhesion kinase beta;Focal adhesion kinase 2;Proline-rich tyrosine kinase 2;Related adhesion focal tyrosine kinase;, PF00373;PF18038;PF03623;PF07714;, GO:0097440;GO:0044297;GO:0005938;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0031234;GO:0005925;GO:0098978;GO:0030426;GO:0030027;GO:0045121;GO:0043025;GO:0017146;GO:0005634;GO:0048471;GO:0014069;GO:0043423;GO:0005524;GO:0004683;GO:0004972;GO:0004715;GO:0008022;GO:0004713;GO:0044877;GO:0005102;GO:0004714;GO:0031625;GO:0090630;GO:0042976;GO:0002250;GO:0001525;GO:0006915;GO:0043534;GO:0045453;GO:0030154;GO:0007166;GO:0006968;GO:0071498;GO:0071300;GO:0070098;GO:0086100;GO:0007173;GO:0048041;GO:0014009;GO:0045087;GO:0007229;GO:0038110;GO:0035235;GO:0060292;GO:0060291;GO:0000165;GO:0002315;GO:0043066;GO:0030502;GO:0008285;GO:0010656;GO:0045638;GO:0043524;GO:0043267;GO:0031175;GO:0001556;GO:0038083;GO:0018108;GO:0030838;GO:0045766;GO:2000538;GO:0030307;GO:0030335;GO:0008284;GO:0001954;GO:0007204;GO:2000573;GO:0010595;GO:0070374;GO:2000463;GO:0046330;GO:0043507;GO:0010976;GO:0045429;GO:0051000;GO:0050731;GO:0043552;GO:0045860;GO:0051968;GO:0045727;GO:2000060;GO:0046777;GO:0006468;GO:0065003;GO:2000249;GO:0050848;GO:0030155;GO:0008360;GO:0010752;GO:2000114;GO:0032960;GO:0010758;GO:2000310;GO:0051279;GO:0048167;GO:2000058;GO:0051592;GO:0051591;GO:0042220;GO:0042493;GO:0045471;GO:0009749;GO:0009725;GO:0042542;GO:0001666;GO:0035902;GO:0010226;GO:0009612;GO:0006970;GO:0007172;GO:0007165;GO:0002040;GO:0043149;GO:0007169;GO:0033209;GO:0048010;, C:apical dendrite; C:cell body; C:cell cortex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:membrane raft; C:neuronal cell body; C:NMDA selective glutamate receptor complex; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase binding; F:ATP binding; F:calmodulin-dependent protein kinase activity; F:NMDA glutamate receptor activity; F:non-membrane spanning protein tyrosine kinase activity; F:protein C-terminus binding; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:activation of Janus kinase activity; P:adaptive immune response; P:angiogenesis; P:apoptotic process; P:blood vessel endothelial cell migration; P:bone resorption; P:cell differentiation; P:cell surface receptor signaling pathway; P:cellular defense response; P:cellular response to fluid shear stress; P:cellular response to retinoic acid; P:chemokine-mediated signaling pathway; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:focal adhesion assembly; P:glial cell proliferation; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:ionotropic glutamate receptor signaling pathway; P:long-term synaptic depression; P:long-term synaptic potentiation; P:MAPK cascade; P:marginal zone B cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of bone mineralization; P:negative regulation of cell population proliferation; P:negative regulation of muscle cell apoptotic process; P:negative regulation of myeloid cell differentiation; P:negative regulation of neuron apoptotic process; P:negative regulation of potassium ion transport; P:neuron projection development; P:oocyte maturation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of angiogenesis; P:positive regulation of B cell chemotaxis; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase activity; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of translation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein autophosphorylation; P:protein phosphorylation; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of calcium-mediated signaling; P:regulation of cell adhesion; P:regulation of cell shape; P:regulation of cGMP-mediated signaling; P:regulation of establishment of cell polarity; P:regulation of inositol trisphosphate biosynthetic process; P:regulation of macrophage chemotaxis; P:regulation of NMDA receptor activity; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of synaptic plasticity; P:regulation of ubiquitin-dependent protein catabolic process; P:response to calcium ion; P:response to cAMP; P:response to cocaine; P:response to drug; P:response to ethanol; P:response to glucose; P:response to hormone; P:response to hydrogen peroxide; P:response to hypoxia; P:response to immobilization stress; P:response to lithium ion; P:response to mechanical stimulus; P:response to osmotic stress; P:signal complex assembly; P:signal transduction; P:sprouting angiogenesis; P:stress fiber assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q14289 D3DST0 Q13475 Q14290 Q16709 Q6PID4,Protein-tyrosine kinase 2-beta,Calcium-dependent tyrosine kinase;Calcium-regulated non-receptor proline-rich tyrosine kinase;Cell adhesion kinase beta;Focal adhesion kinase 2;Proline-rich tyrosine kinase 2;Related adhesion focal tyrosine kinase;, PF00373;PF18038;PF03623;PF07714;, GO:0097440;GO:0044297;GO:0005938;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0031234;GO:0005925;GO:0098978;GO:0030426;GO:0030027;GO:0045121;GO:0043025;GO:0017146;GO:0005634;GO:0048471;GO:0014069;GO:0043423;GO:0005524;GO:0004683;GO:0004972;GO:0004715;GO:0008022;GO:0004713;GO:0044877;GO:0005102;GO:0004714;GO:0031625;GO:0090630;GO:0042976;GO:0002250;GO:0001525;GO:0006915;GO:0043534;GO:0045453;GO:0030154;GO:0007166;GO:0006968;GO:0071498;GO:0071300;GO:0070098;GO:0086100;GO:0007173;GO:0048041;GO:0014009;GO:0045087;GO:0007229;GO:0038110;GO:0035235;GO:0060292;GO:0060291;GO:0000165;GO:0002315;GO:0043066;GO:0030502;GO:0008285;GO:0010656;GO:0045638;GO:0043524;GO:0043267;GO:0031175;GO:0001556;GO:0038083;GO:0018108;GO:0030838;GO:0045766;GO:2000538;GO:0030307;GO:0030335;GO:0008284;GO:0001954;GO:0007204;GO:2000573;GO:0010595;GO:0070374;GO:2000463;GO:0046330;GO:0043507;GO:0010976;GO:0045429;GO:0051000;GO:0050731;GO:0043552;GO:0045860;GO:0051968;GO:0045727;GO:2000060;GO:0046777;GO:0006468;GO:0065003;GO:2000249;GO:0050848;GO:0030155;GO:0008360;GO:0010752;GO:2000114;GO:0032960;GO:0010758;GO:2000310;GO:0051279;GO:0048167;GO:2000058;GO:0051592;GO:0051591;GO:0042220;GO:0042493;GO:0045471;GO:0009749;GO:0009725;GO:0042542;GO:0001666;GO:0035902;GO:0010226;GO:0009612;GO:0006970;GO:0007172;GO:0007165;GO:0002040;GO:0043149;GO:0007169;GO:0033209;GO:0048010;, C:apical dendrite; C:cell body; C:cell cortex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:membrane raft; C:neuronal cell body; C:NMDA selective glutamate receptor complex; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase binding; F:ATP binding; F:calmodulin-dependent protein kinase activity; F:NMDA glutamate receptor activity; F:non-membrane spanning protein tyrosine kinase activity; F:protein C-terminus binding; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:activation of Janus kinase activity; P:adaptive immune response; P:angiogenesis; P:apoptotic process; P:blood vessel endothelial cell migration; P:bone resorption; P:cell differentiation; P:cell surface receptor signaling pathway; P:cellular defense response; P:cellular response to fluid shear stress; P:cellular response to retinoic acid; P:chemokine-mediated signaling pathway; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:focal adhesion assembly; P:glial cell proliferation; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:ionotropic glutamate receptor signaling pathway; P:long-term synaptic depression; P:long-term synaptic potentiation; P:MAPK cascade; P:marginal zone B cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of bone mineralization; P:negative regulation of cell population proliferation; P:negative regulation of muscle cell apoptotic process; P:negative regulation of myeloid cell differentiation; P:negative regulation of neuron apoptotic process; P:negative regulation of potassium ion transport; P:neuron projection development; P:oocyte maturation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of angiogenesis; P:positive regulation of B cell chemotaxis; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase activity; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of translation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein autophosphorylation; P:protein phosphorylation; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of calcium-mediated signaling; P:regulation of cell adhesion; P:regulation of cell shape; P:regulation of cGMP-mediated signaling; P:regulation of establishment of cell polarity; P:regulation of inositol trisphosphate biosynthetic process; P:regulation of macrophage chemotaxis; P:regulation of NMDA receptor activity; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of synaptic plasticity; P:regulation of ubiquitin-dependent protein catabolic process; P:response to calcium ion; P:response to cAMP; P:response to cocaine; P:response to drug; P:response to ethanol; P:response to glucose; P:response to hormone; P:response to hydrogen peroxide; P:response to hypoxia; P:response to immobilization stress; P:response to lithium ion; P:response to mechanical stimulus; P:response to osmotic stress; P:signal complex assembly; P:signal transduction; P:sprouting angiogenesis; P:stress fiber assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q14289 D3DST0 Q13475 Q14290 Q16709 Q6PID4,Protein-tyrosine kinase 2-beta,Calcium-dependent tyrosine kinase;Calcium-regulated non-receptor proline-rich tyrosine kinase;Cell adhesion kinase beta;Focal adhesion kinase 2;Proline-rich tyrosine kinase 2;Related adhesion focal tyrosine kinase;, PF00373;PF18038;PF03623;PF07714;, GO:0097440;GO:0044297;GO:0005938;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0031234;GO:0005925;GO:0098978;GO:0030426;GO:0030027;GO:0045121;GO:0043025;GO:0017146;GO:0005634;GO:0048471;GO:0014069;GO:0043423;GO:0005524;GO:0004683;GO:0004972;GO:0004715;GO:0008022;GO:0004713;GO:0044877;GO:0005102;GO:0004714;GO:0031625;GO:0090630;GO:0042976;GO:0002250;GO:0001525;GO:0006915;GO:0043534;GO:0045453;GO:0030154;GO:0007166;GO:0006968;GO:0071498;GO:0071300;GO:0070098;GO:0086100;GO:0007173;GO:0048041;GO:0014009;GO:0045087;GO:0007229;GO:0038110;GO:0035235;GO:0060292;GO:0060291;GO:0000165;GO:0002315;GO:0043066;GO:0030502;GO:0008285;GO:0010656;GO:0045638;GO:0043524;GO:0043267;GO:0031175;GO:0001556;GO:0038083;GO:0018108;GO:0030838;GO:0045766;GO:2000538;GO:0030307;GO:0030335;GO:0008284;GO:0001954;GO:0007204;GO:2000573;GO:0010595;GO:0070374;GO:2000463;GO:0046330;GO:0043507;GO:0010976;GO:0045429;GO:0051000;GO:0050731;GO:0043552;GO:0045860;GO:0051968;GO:0045727;GO:2000060;GO:0046777;GO:0006468;GO:0065003;GO:2000249;GO:0050848;GO:0030155;GO:0008360;GO:0010752;GO:2000114;GO:0032960;GO:0010758;GO:2000310;GO:0051279;GO:0048167;GO:2000058;GO:0051592;GO:0051591;GO:0042220;GO:0042493;GO:0045471;GO:0009749;GO:0009725;GO:0042542;GO:0001666;GO:0035902;GO:0010226;GO:0009612;GO:0006970;GO:0007172;GO:0007165;GO:0002040;GO:0043149;GO:0007169;GO:0033209;GO:0048010;, C:apical dendrite; C:cell body; C:cell cortex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:membrane raft; C:neuronal cell body; C:NMDA selective glutamate receptor complex; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase binding; F:ATP binding; F:calmodulin-dependent protein kinase activity; F:NMDA glutamate receptor activity; F:non-membrane spanning protein tyrosine kinase activity; F:protein C-terminus binding; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:activation of Janus kinase activity; P:adaptive immune response; P:angiogenesis; P:apoptotic process; P:blood vessel endothelial cell migration; P:bone resorption; P:cell differentiation; P:cell surface receptor signaling pathway; P:cellular defense response; P:cellular response to fluid shear stress; P:cellular response to retinoic acid; P:chemokine-mediated signaling pathway; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:focal adhesion assembly; P:glial cell proliferation; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:ionotropic glutamate receptor signaling pathway; P:long-term synaptic depression; P:long-term synaptic potentiation; P:MAPK cascade; P:marginal zone B cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of bone mineralization; P:negative regulation of cell population proliferation; P:negative regulation of muscle cell apoptotic process; P:negative regulation of myeloid cell differentiation; P:negative regulation of neuron apoptotic process; P:negative regulation of potassium ion transport; P:neuron projection development; P:oocyte maturation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of angiogenesis; P:positive regulation of B cell chemotaxis; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase activity; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of translation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein autophosphorylation; P:protein phosphorylation; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of calcium-mediated signaling; P:regulation of cell adhesion; P:regulation of cell shape; P:regulation of cGMP-mediated signaling; P:regulation of establishment of cell polarity; P:regulation of inositol trisphosphate biosynthetic process; P:regulation of macrophage chemotaxis; P:regulation of NMDA receptor activity; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of synaptic plasticity; P:regulation of ubiquitin-dependent protein catabolic process; P:response to calcium ion; P:response to cAMP; P:response to cocaine; P:response to drug; P:response to ethanol; P:response to glucose; P:response to hormone; P:response to hydrogen peroxide; P:response to hypoxia; P:response to immobilization stress; P:response to lithium ion; P:response to mechanical stimulus; P:response to osmotic stress; P:signal complex assembly; P:signal transduction; P:sprouting angiogenesis; P:stress fiber assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q14289 D3DST0 Q13475 Q14290 Q16709 Q6PID4,Protein-tyrosine kinase 2-beta,Calcium-dependent tyrosine kinase;Calcium-regulated non-receptor proline-rich tyrosine kinase;Cell adhesion kinase beta;Focal adhesion kinase 2;Proline-rich tyrosine kinase 2;Related adhesion focal tyrosine kinase;, PF00373;PF18038;PF03623;PF07714;, GO:0097440;GO:0044297;GO:0005938;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0031234;GO:0005925;GO:0098978;GO:0030426;GO:0030027;GO:0045121;GO:0043025;GO:0017146;GO:0005634;GO:0048471;GO:0014069;GO:0043423;GO:0005524;GO:0004683;GO:0004972;GO:0004715;GO:0008022;GO:0004713;GO:0044877;GO:0005102;GO:0004714;GO:0031625;GO:0090630;GO:0042976;GO:0002250;GO:0001525;GO:0006915;GO:0043534;GO:0045453;GO:0030154;GO:0007166;GO:0006968;GO:0071498;GO:0071300;GO:0070098;GO:0086100;GO:0007173;GO:0048041;GO:0014009;GO:0045087;GO:0007229;GO:0038110;GO:0035235;GO:0060292;GO:0060291;GO:0000165;GO:0002315;GO:0043066;GO:0030502;GO:0008285;GO:0010656;GO:0045638;GO:0043524;GO:0043267;GO:0031175;GO:0001556;GO:0038083;GO:0018108;GO:0030838;GO:0045766;GO:2000538;GO:0030307;GO:0030335;GO:0008284;GO:0001954;GO:0007204;GO:2000573;GO:0010595;GO:0070374;GO:2000463;GO:0046330;GO:0043507;GO:0010976;GO:0045429;GO:0051000;GO:0050731;GO:0043552;GO:0045860;GO:0051968;GO:0045727;GO:2000060;GO:0046777;GO:0006468;GO:0065003;GO:2000249;GO:0050848;GO:0030155;GO:0008360;GO:0010752;GO:2000114;GO:0032960;GO:0010758;GO:2000310;GO:0051279;GO:0048167;GO:2000058;GO:0051592;GO:0051591;GO:0042220;GO:0042493;GO:0045471;GO:0009749;GO:0009725;GO:0042542;GO:0001666;GO:0035902;GO:0010226;GO:0009612;GO:0006970;GO:0007172;GO:0007165;GO:0002040;GO:0043149;GO:0007169;GO:0033209;GO:0048010;, C:apical dendrite; C:cell body; C:cell cortex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:membrane raft; C:neuronal cell body; C:NMDA selective glutamate receptor complex; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase binding; F:ATP binding; F:calmodulin-dependent protein kinase activity; F:NMDA glutamate receptor activity; F:non-membrane spanning protein tyrosine kinase activity; F:protein C-terminus binding; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:activation of Janus kinase activity; P:adaptive immune response; P:angiogenesis; P:apoptotic process; P:blood vessel endothelial cell migration; P:bone resorption; P:cell differentiation; P:cell surface receptor signaling pathway; P:cellular defense response; P:cellular response to fluid shear stress; P:cellular response to retinoic acid; P:chemokine-mediated signaling pathway; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:focal adhesion assembly; P:glial cell proliferation; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:ionotropic glutamate receptor signaling pathway; P:long-term synaptic depression; P:long-term synaptic potentiation; P:MAPK cascade; P:marginal zone B cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of bone mineralization; P:negative regulation of cell population proliferation; P:negative regulation of muscle cell apoptotic process; P:negative regulation of myeloid cell differentiation; P:negative regulation of neuron apoptotic process; P:negative regulation of potassium ion transport; P:neuron projection development; P:oocyte maturation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of angiogenesis; P:positive regulation of B cell chemotaxis; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase activity; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of translation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein autophosphorylation; P:protein phosphorylation; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of calcium-mediated signaling; P:regulation of cell adhesion; P:regulation of cell shape; P:regulation of cGMP-mediated signaling; P:regulation of establishment of cell polarity; P:regulation of inositol trisphosphate biosynthetic process; P:regulation of macrophage chemotaxis; P:regulation of NMDA receptor activity; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of synaptic plasticity; P:regulation of ubiquitin-dependent protein catabolic process; P:response to calcium ion; P:response to cAMP; P:response to cocaine; P:response to drug; P:response to ethanol; P:response to glucose; P:response to hormone; P:response to hydrogen peroxide; P:response to hypoxia; P:response to immobilization stress; P:response to lithium ion; P:response to mechanical stimulus; P:response to osmotic stress; P:signal complex assembly; P:signal transduction; P:sprouting angiogenesis; P:stress fiber assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q14289 D3DST0 Q13475 Q14290 Q16709 Q6PID4,Protein-tyrosine kinase 2-beta,Calcium-dependent tyrosine kinase;Calcium-regulated non-receptor proline-rich tyrosine kinase;Cell adhesion kinase beta;Focal adhesion kinase 2;Proline-rich tyrosine kinase 2;Related adhesion focal tyrosine kinase;, PF00373;PF18038;PF03623;PF07714;, GO:0097440;GO:0044297;GO:0005938;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0031234;GO:0005925;GO:0098978;GO:0030426;GO:0030027;GO:0045121;GO:0043025;GO:0017146;GO:0005634;GO:0048471;GO:0014069;GO:0043423;GO:0005524;GO:0004683;GO:0004972;GO:0004715;GO:0008022;GO:0004713;GO:0044877;GO:0005102;GO:0004714;GO:0031625;GO:0090630;GO:0042976;GO:0002250;GO:0001525;GO:0006915;GO:0043534;GO:0045453;GO:0030154;GO:0007166;GO:0006968;GO:0071498;GO:0071300;GO:0070098;GO:0086100;GO:0007173;GO:0048041;GO:0014009;GO:0045087;GO:0007229;GO:0038110;GO:0035235;GO:0060292;GO:0060291;GO:0000165;GO:0002315;GO:0043066;GO:0030502;GO:0008285;GO:0010656;GO:0045638;GO:0043524;GO:0043267;GO:0031175;GO:0001556;GO:0038083;GO:0018108;GO:0030838;GO:0045766;GO:2000538;GO:0030307;GO:0030335;GO:0008284;GO:0001954;GO:0007204;GO:2000573;GO:0010595;GO:0070374;GO:2000463;GO:0046330;GO:0043507;GO:0010976;GO:0045429;GO:0051000;GO:0050731;GO:0043552;GO:0045860;GO:0051968;GO:0045727;GO:2000060;GO:0046777;GO:0006468;GO:0065003;GO:2000249;GO:0050848;GO:0030155;GO:0008360;GO:0010752;GO:2000114;GO:0032960;GO:0010758;GO:2000310;GO:0051279;GO:0048167;GO:2000058;GO:0051592;GO:0051591;GO:0042220;GO:0042493;GO:0045471;GO:0009749;GO:0009725;GO:0042542;GO:0001666;GO:0035902;GO:0010226;GO:0009612;GO:0006970;GO:0007172;GO:0007165;GO:0002040;GO:0043149;GO:0007169;GO:0033209;GO:0048010;, C:apical dendrite; C:cell body; C:cell cortex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:membrane raft; C:neuronal cell body; C:NMDA selective glutamate receptor complex; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase binding; F:ATP binding; F:calmodulin-dependent protein kinase activity; F:NMDA glutamate receptor activity; F:non-membrane spanning protein tyrosine kinase activity; F:protein C-terminus binding; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:activation of Janus kinase activity; P:adaptive immune response; P:angiogenesis; P:apoptotic process; P:blood vessel endothelial cell migration; P:bone resorption; P:cell differentiation; P:cell surface receptor signaling pathway; P:cellular defense response; P:cellular response to fluid shear stress; P:cellular response to retinoic acid; P:chemokine-mediated signaling pathway; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:focal adhesion assembly; P:glial cell proliferation; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:ionotropic glutamate receptor signaling pathway; P:long-term synaptic depression; P:long-term synaptic potentiation; P:MAPK cascade; P:marginal zone B cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of bone mineralization; P:negative regulation of cell population proliferation; P:negative regulation of muscle cell apoptotic process; P:negative regulation of myeloid cell differentiation; P:negative regulation of neuron apoptotic process; P:negative regulation of potassium ion transport; P:neuron projection development; P:oocyte maturation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of angiogenesis; P:positive regulation of B cell chemotaxis; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase activity; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of translation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein autophosphorylation; P:protein phosphorylation; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of calcium-mediated signaling; P:regulation of cell adhesion; P:regulation of cell shape; P:regulation of cGMP-mediated signaling; P:regulation of establishment of cell polarity; P:regulation of inositol trisphosphate biosynthetic process; P:regulation of macrophage chemotaxis; P:regulation of NMDA receptor activity; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of synaptic plasticity; P:regulation of ubiquitin-dependent protein catabolic process; P:response to calcium ion; P:response to cAMP; P:response to cocaine; P:response to drug; P:response to ethanol; P:response to glucose; P:response to hormone; P:response to hydrogen peroxide; P:response to hypoxia; P:response to immobilization stress; P:response to lithium ion; P:response to mechanical stimulus; P:response to osmotic stress; P:signal complex assembly; P:signal transduction; P:sprouting angiogenesis; P:stress fiber assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q14289 D3DST0 Q13475 Q14290 Q16709 Q6PID4,Protein-tyrosine kinase 2-beta,Calcium-dependent tyrosine kinase;Calcium-regulated non-receptor proline-rich tyrosine kinase;Cell adhesion kinase beta;Focal adhesion kinase 2;Proline-rich tyrosine kinase 2;Related adhesion focal tyrosine kinase;, PF00373;PF18038;PF03623;PF07714;, GO:0097440;GO:0044297;GO:0005938;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0031234;GO:0005925;GO:0098978;GO:0030426;GO:0030027;GO:0045121;GO:0043025;GO:0017146;GO:0005634;GO:0048471;GO:0014069;GO:0043423;GO:0005524;GO:0004683;GO:0004972;GO:0004715;GO:0008022;GO:0004713;GO:0044877;GO:0005102;GO:0004714;GO:0031625;GO:0090630;GO:0042976;GO:0002250;GO:0001525;GO:0006915;GO:0043534;GO:0045453;GO:0030154;GO:0007166;GO:0006968;GO:0071498;GO:0071300;GO:0070098;GO:0086100;GO:0007173;GO:0048041;GO:0014009;GO:0045087;GO:0007229;GO:0038110;GO:0035235;GO:0060292;GO:0060291;GO:0000165;GO:0002315;GO:0043066;GO:0030502;GO:0008285;GO:0010656;GO:0045638;GO:0043524;GO:0043267;GO:0031175;GO:0001556;GO:0038083;GO:0018108;GO:0030838;GO:0045766;GO:2000538;GO:0030307;GO:0030335;GO:0008284;GO:0001954;GO:0007204;GO:2000573;GO:0010595;GO:0070374;GO:2000463;GO:0046330;GO:0043507;GO:0010976;GO:0045429;GO:0051000;GO:0050731;GO:0043552;GO:0045860;GO:0051968;GO:0045727;GO:2000060;GO:0046777;GO:0006468;GO:0065003;GO:2000249;GO:0050848;GO:0030155;GO:0008360;GO:0010752;GO:2000114;GO:0032960;GO:0010758;GO:2000310;GO:0051279;GO:0048167;GO:2000058;GO:0051592;GO:0051591;GO:0042220;GO:0042493;GO:0045471;GO:0009749;GO:0009725;GO:0042542;GO:0001666;GO:0035902;GO:0010226;GO:0009612;GO:0006970;GO:0007172;GO:0007165;GO:0002040;GO:0043149;GO:0007169;GO:0033209;GO:0048010;, C:apical dendrite; C:cell body; C:cell cortex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:membrane raft; C:neuronal cell body; C:NMDA selective glutamate receptor complex; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase binding; F:ATP binding; F:calmodulin-dependent protein kinase activity; F:NMDA glutamate receptor activity; F:non-membrane spanning protein tyrosine kinase activity; F:protein C-terminus binding; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:activation of Janus kinase activity; P:adaptive immune response; P:angiogenesis; P:apoptotic process; P:blood vessel endothelial cell migration; P:bone resorption; P:cell differentiation; P:cell surface receptor signaling pathway; P:cellular defense response; P:cellular response to fluid shear stress; P:cellular response to retinoic acid; P:chemokine-mediated signaling pathway; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:focal adhesion assembly; P:glial cell proliferation; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:ionotropic glutamate receptor signaling pathway; P:long-term synaptic depression; P:long-term synaptic potentiation; P:MAPK cascade; P:marginal zone B cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of bone mineralization; P:negative regulation of cell population proliferation; P:negative regulation of muscle cell apoptotic process; P:negative regulation of myeloid cell differentiation; P:negative regulation of neuron apoptotic process; P:negative regulation of potassium ion transport; P:neuron projection development; P:oocyte maturation; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of angiogenesis; P:positive regulation of B cell chemotaxis; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase activity; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of translation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein autophosphorylation; P:protein phosphorylation; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of calcium-mediated signaling; P:regulation of cell adhesion; P:regulation of cell shape; P:regulation of cGMP-mediated signaling; P:regulation of establishment of cell polarity; P:regulation of inositol trisphosphate biosynthetic process; P:regulation of macrophage chemotaxis; P:regulation of NMDA receptor activity; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of synaptic plasticity; P:regulation of ubiquitin-dependent protein catabolic process; P:response to calcium ion; P:response to cAMP; P:response to cocaine; P:response to drug; P:response to ethanol; P:response to glucose; P:response to hormone; P:response to hydrogen peroxide; P:response to hypoxia; P:response to immobilization stress; P:response to lithium ion; P:response to mechanical stimulus; P:response to osmotic stress; P:signal complex assembly; P:signal transduction; P:sprouting angiogenesis; P:stress fiber assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold28 indexed_genome mRNA 34377627 34396859 . + . ID=transcript_6341;Q9UPQ4 Q86XQ0 Q8WVA4,E3 ubiquitin-protein ligase TRIM35 {ECO:0000303|PubMed:32562145},Hemopoietic lineage switch protein 5;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005634;GO:0061630;GO:0008270;GO:0006915;GO:0045087;GO:0045930;GO:1902187;GO:0043065;GO:0016567;, C:cytoplasm; C:nucleus;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:apoptotic process; P:innate immune response; P:negative regulation of mitotic cell cycle; P:negative regulation of viral release from host cell; P:positive regulation of apoptotic process; P:protein ubiquitination;|Q9UPQ4 Q86XQ0 Q8WVA4,E3 ubiquitin-protein ligase TRIM35 {ECO:0000303|PubMed:32562145},Hemopoietic lineage switch protein 5;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005634;GO:0061630;GO:0008270;GO:0006915;GO:0045087;GO:0045930;GO:1902187;GO:0043065;GO:0016567;, C:cytoplasm; C:nucleus;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:apoptotic process; P:innate immune response; P:negative regulation of mitotic cell cycle; P:negative regulation of viral release from host cell; P:positive regulation of apoptotic process; P:protein ubiquitination;|Q9UPQ4 Q86XQ0 Q8WVA4,E3 ubiquitin-protein ligase TRIM35 {ECO:0000303|PubMed:32562145},Hemopoietic lineage switch protein 5;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005634;GO:0061630;GO:0008270;GO:0006915;GO:0045087;GO:0045930;GO:1902187;GO:0043065;GO:0016567;, C:cytoplasm; C:nucleus;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:apoptotic process; P:innate immune response; P:negative regulation of mitotic cell cycle; P:negative regulation of viral release from host cell; P:positive regulation of apoptotic process; P:protein ubiquitination; scaffold28 indexed_genome mRNA 34432570 34476285 . + . ID=transcript_6342;Q9H169 B7Z2Z7 B7Z4I9 D3DSS8 D3DSS9 G5EA16 Q2TAB9,Stathmin-4,Stathmin-like protein B3;, PF00836;, GO:0005737;GO:0005794;GO:0030426;GO:0043005;GO:0015631;GO:0007019;GO:0031175;GO:0031110;, C:cytoplasm; C:Golgi apparatus; C:growth cone; C:neuron projection;, F:tubulin binding;, P:microtubule depolymerization; P:neuron projection development; P:regulation of microtubule polymerization or depolymerization;|Q9H169 B7Z2Z7 B7Z4I9 D3DSS8 D3DSS9 G5EA16 Q2TAB9,Stathmin-4,Stathmin-like protein B3;, PF00836;, GO:0005737;GO:0005794;GO:0030426;GO:0043005;GO:0015631;GO:0007019;GO:0031175;GO:0031110;, C:cytoplasm; C:Golgi apparatus; C:growth cone; C:neuron projection;, F:tubulin binding;, P:microtubule depolymerization; P:neuron projection development; P:regulation of microtubule polymerization or depolymerization;|Q9H169 B7Z2Z7 B7Z4I9 D3DSS8 D3DSS9 G5EA16 Q2TAB9,Stathmin-4,Stathmin-like protein B3;, PF00836;, GO:0005737;GO:0005794;GO:0030426;GO:0043005;GO:0015631;GO:0007019;GO:0031175;GO:0031110;, C:cytoplasm; C:Golgi apparatus; C:growth cone; C:neuron projection;, F:tubulin binding;, P:microtubule depolymerization; P:neuron projection development; P:regulation of microtubule polymerization or depolymerization; scaffold28 indexed_genome mRNA 34723362 34835625 . + . ID=transcript_6343;Q96RE8 Q9UD63 Q9UD67,Alpha-1A adrenergic receptor,Alpha-1A adrenoreceptor;Alpha-1C adrenergic receptor;Alpha-adrenergic receptor 1c;, PF00001;, GO:0005901;GO:0005737;GO:0005829;GO:0098691;GO:0098982;GO:0098978;GO:0005887;GO:0099055;GO:0099056;GO:0043231;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0030315;GO:0030018;GO:0004937;GO:0004930;GO:0046982;GO:0007202;GO:0071880;GO:0007512;GO:0007568;GO:0006915;GO:0060402;GO:0061049;GO:0007267;GO:0007186;GO:0035556;GO:0060073;GO:0010507;GO:0008285;GO:0001985;GO:0035024;GO:0150099;GO:0001994;GO:0007200;GO:0097195;GO:0045760;GO:0060452;GO:0010613;GO:0007204;GO:0070374;GO:0001996;GO:0043410;GO:1903997;GO:0090037;GO:0045987;GO:0032230;GO:0003084;GO:0001997;GO:0045907;GO:2000300;GO:0042493;GO:0009725;GO:0007165;GO:0006939;, C:caveola; C:cytoplasm; C:cytosol; C:dopaminergic synapse; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:intracellular membrane-bounded organelle; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:T-tubule; C:Z disc;, F:alpha1-adrenergic receptor activity; F:G protein-coupled receptor activity; F:protein heterodimerization activity;, P:activation of phospholipase C activity; P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:adult heart development; P:aging; P:apoptotic process; P:calcium ion transport into cytosol; P:cell growth involved in cardiac muscle cell development; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:micturition; P:negative regulation of autophagy; P:negative regulation of cell population proliferation; P:negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure; P:negative regulation of Rho protein signal transduction; P:neuron-glial cell signaling; P:norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:pilomotor reflex; P:positive regulation of action potential; P:positive regulation of cardiac muscle contraction; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heart rate by epinephrine-norepinephrine; P:positive regulation of MAPK cascade; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of protein kinase C signaling; P:positive regulation of smooth muscle contraction; P:positive regulation of synaptic transmission, GABAergic; P:positive regulation of systemic arterial blood pressure; P:positive regulation of the force of heart contraction by epinephrine-norepinephrine; P:positive regulation of vasoconstriction; P:regulation of synaptic vesicle exocytosis; P:response to drug; P:response to hormone; P:signal transduction; P:smooth muscle contraction; scaffold28 indexed_genome mRNA 34935510 34936938 . - . ID=transcript_6344;Q16555 A8K5H2 B4DR31 D3DSS7 O00424,Dihydropyrimidinase-related protein 2,Collapsin response mediator protein 2;N2A3;Unc-33-like phosphoprotein 2;, PF01979;, GO:0005856;GO:0005829;GO:0070062;GO:0005886;GO:0004157;GO:0042802;GO:0008017;GO:0007411;GO:0007420;GO:0007010;GO:0006897;GO:0007399;GO:0006139;GO:0030516;GO:0045664;GO:0007165;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:plasma membrane;, F:dihydropyrimidinase activity; F:identical protein binding; F:microtubule binding;, P:axon guidance; P:brain development; P:cytoskeleton organization; P:endocytosis; P:nervous system development; P:nucleobase-containing compound metabolic process; P:regulation of axon extension; P:regulation of neuron differentiation; P:signal transduction; scaffold28 indexed_genome mRNA 34936942 34940185 . - . ID=transcript_6345;Q16555 A8K5H2 B4DR31 D3DSS7 O00424,Dihydropyrimidinase-related protein 2,Collapsin response mediator protein 2;N2A3;Unc-33-like phosphoprotein 2;, PF01979;, GO:0005856;GO:0005829;GO:0070062;GO:0005886;GO:0004157;GO:0042802;GO:0008017;GO:0007411;GO:0007420;GO:0007010;GO:0006897;GO:0007399;GO:0006139;GO:0030516;GO:0045664;GO:0007165;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:plasma membrane;, F:dihydropyrimidinase activity; F:identical protein binding; F:microtubule binding;, P:axon guidance; P:brain development; P:cytoskeleton organization; P:endocytosis; P:nervous system development; P:nucleobase-containing compound metabolic process; P:regulation of axon extension; P:regulation of neuron differentiation; P:signal transduction;|Q16555 A8K5H2 B4DR31 D3DSS7 O00424,Dihydropyrimidinase-related protein 2,Collapsin response mediator protein 2;N2A3;Unc-33-like phosphoprotein 2;, PF01979;, GO:0005856;GO:0005829;GO:0070062;GO:0005886;GO:0004157;GO:0042802;GO:0008017;GO:0007411;GO:0007420;GO:0007010;GO:0006897;GO:0007399;GO:0006139;GO:0030516;GO:0045664;GO:0007165;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:plasma membrane;, F:dihydropyrimidinase activity; F:identical protein binding; F:microtubule binding;, P:axon guidance; P:brain development; P:cytoskeleton organization; P:endocytosis; P:nervous system development; P:nucleobase-containing compound metabolic process; P:regulation of axon extension; P:regulation of neuron differentiation; P:signal transduction; scaffold28 indexed_genome mRNA 34943714 35014563 . - . ID=transcript_6346;Q14195 B3SXQ8 Q93012,Dihydropyrimidinase-related protein 3,Collapsin response mediator protein 4;Unc-33-like phosphoprotein 1;, PF01979;, GO:0044297;GO:0005829;GO:0070382;GO:0005615;GO:0031941;GO:0030426;GO:0030027;GO:0045202;GO:0035374;GO:0031005;GO:0016810;GO:0042802;GO:0017124;GO:0051764;GO:0051017;GO:0071345;GO:0030336;GO:0010977;GO:0048666;GO:0051491;GO:0010976;GO:0048678;, C:cell body; C:cytosol; C:exocytic vesicle; C:extracellular space; C:filamentous actin; C:growth cone; C:lamellipodium; C:synapse;, F:chondroitin sulfate binding; F:filamin binding; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:identical protein binding; F:SH3 domain binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:cellular response to cytokine stimulus; P:negative regulation of cell migration; P:negative regulation of neuron projection development; P:neuron development; P:positive regulation of filopodium assembly; P:positive regulation of neuron projection development; P:response to axon injury;|Q16555 A8K5H2 B4DR31 D3DSS7 O00424,Dihydropyrimidinase-related protein 2,Collapsin response mediator protein 2;N2A3;Unc-33-like phosphoprotein 2;, PF01979;, GO:0005856;GO:0005829;GO:0070062;GO:0005886;GO:0004157;GO:0042802;GO:0008017;GO:0007411;GO:0007420;GO:0007010;GO:0006897;GO:0007399;GO:0006139;GO:0030516;GO:0045664;GO:0007165;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:plasma membrane;, F:dihydropyrimidinase activity; F:identical protein binding; F:microtubule binding;, P:axon guidance; P:brain development; P:cytoskeleton organization; P:endocytosis; P:nervous system development; P:nucleobase-containing compound metabolic process; P:regulation of axon extension; P:regulation of neuron differentiation; P:signal transduction; scaffold28 indexed_genome mRNA 35056791 35064497 . + . ID=transcript_6347;Q9UL42 B3KNY9 O94959 O95145 Q49A18 Q9UL43,Paraneoplastic antigen Ma2,40 kDa neuronal protein;Onconeuronal antigen Ma2;Paraneoplastic neuronal antigen MM2;, PF14893;, GO:0005730;GO:0043065;, C:nucleolus;, , P:positive regulation of apoptotic process; scaffold28 indexed_genome mRNA 35157055 35172269 . - . ID=transcript_6348;O60238 B0AZS9 Q5JW63 Q8NF87,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Adenovirus E1B19K-binding protein B5;BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A;NIP3-like protein X;, PF06553;, GO:0005829;GO:0005783;GO:0016021;GO:0031224;GO:0005741;GO:0005739;GO:0005635;GO:0016607;GO:0005634;GO:0042802;GO:0005521;GO:0042803;GO:0071456;GO:0051607;GO:0097345;GO:0035694;GO:0043066;GO:0060548;GO:0010917;GO:0043065;GO:0016239;GO:0042981;GO:1903146;GO:0043067;GO:1903214;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:intrinsic component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope; C:nuclear speck; C:nucleus;, F:identical protein binding; F:lamin binding; F:protein homodimerization activity;, P:cellular response to hypoxia; P:defense response to virus; P:mitochondrial outer membrane permeabilization; P:mitochondrial protein catabolic process; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of mitochondrial membrane potential; P:positive regulation of apoptotic process; P:positive regulation of macroautophagy; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of programmed cell death; P:regulation of protein targeting to mitochondrion; P:viral process;|O60238 B0AZS9 Q5JW63 Q8NF87,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Adenovirus E1B19K-binding protein B5;BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A;NIP3-like protein X;, PF06553;, GO:0005829;GO:0005783;GO:0016021;GO:0031224;GO:0005741;GO:0005739;GO:0005635;GO:0016607;GO:0005634;GO:0042802;GO:0005521;GO:0042803;GO:0071456;GO:0051607;GO:0097345;GO:0035694;GO:0043066;GO:0060548;GO:0010917;GO:0043065;GO:0016239;GO:0042981;GO:1903146;GO:0043067;GO:1903214;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:intrinsic component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope; C:nuclear speck; C:nucleus;, F:identical protein binding; F:lamin binding; F:protein homodimerization activity;, P:cellular response to hypoxia; P:defense response to virus; P:mitochondrial outer membrane permeabilization; P:mitochondrial protein catabolic process; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of mitochondrial membrane potential; P:positive regulation of apoptotic process; P:positive regulation of macroautophagy; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of programmed cell death; P:regulation of protein targeting to mitochondrion; P:viral process; scaffold28 indexed_genome mRNA 35183652 35195258 . - . ID=transcript_6349;P63151 B2RBU8 B4E1T7 P50409 Q00007,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform,PP2A subunit B isoform B55-alpha;PP2A subunit B isoform PR55-alpha;PP2A subunit B isoform R2-alpha;PP2A subunit B isoform alpha;, , GO:0005829;GO:0098978;GO:0005654;GO:0000159;GO:0051721;GO:0019888;GO:0044877;GO:0048156;GO:0000086;GO:0007084;GO:0000184;GO:0070262;GO:0006470;GO:0043278;, C:cytosol; C:glutamatergic synapse; C:nucleoplasm; C:protein phosphatase type 2A complex;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein-containing complex binding; F:tau protein binding;, P:G2/M transition of mitotic cell cycle; P:mitotic nuclear envelope reassembly; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine dephosphorylation; P:protein dephosphorylation; P:response to morphine;|P63151 B2RBU8 B4E1T7 P50409 Q00007,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform,PP2A subunit B isoform B55-alpha;PP2A subunit B isoform PR55-alpha;PP2A subunit B isoform R2-alpha;PP2A subunit B isoform alpha;, , GO:0005829;GO:0098978;GO:0005654;GO:0000159;GO:0051721;GO:0019888;GO:0044877;GO:0048156;GO:0000086;GO:0007084;GO:0000184;GO:0070262;GO:0006470;GO:0043278;, C:cytosol; C:glutamatergic synapse; C:nucleoplasm; C:protein phosphatase type 2A complex;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein-containing complex binding; F:tau protein binding;, P:G2/M transition of mitotic cell cycle; P:mitotic nuclear envelope reassembly; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine dephosphorylation; P:protein dephosphorylation; P:response to morphine;|P63151 B2RBU8 B4E1T7 P50409 Q00007,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform,PP2A subunit B isoform B55-alpha;PP2A subunit B isoform PR55-alpha;PP2A subunit B isoform R2-alpha;PP2A subunit B isoform alpha;, , GO:0005829;GO:0098978;GO:0005654;GO:0000159;GO:0051721;GO:0019888;GO:0044877;GO:0048156;GO:0000086;GO:0007084;GO:0000184;GO:0070262;GO:0006470;GO:0043278;, C:cytosol; C:glutamatergic synapse; C:nucleoplasm; C:protein phosphatase type 2A complex;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein-containing complex binding; F:tau protein binding;, P:G2/M transition of mitotic cell cycle; P:mitotic nuclear envelope reassembly; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine dephosphorylation; P:protein dephosphorylation; P:response to morphine; scaffold28 indexed_genome mRNA 35198560 35269176 . - . ID=transcript_6350;P63151 B2RBU8 B4E1T7 P50409 Q00007,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform,PP2A subunit B isoform B55-alpha;PP2A subunit B isoform PR55-alpha;PP2A subunit B isoform R2-alpha;PP2A subunit B isoform alpha;, , GO:0005829;GO:0098978;GO:0005654;GO:0000159;GO:0051721;GO:0019888;GO:0044877;GO:0048156;GO:0000086;GO:0007084;GO:0000184;GO:0070262;GO:0006470;GO:0043278;, C:cytosol; C:glutamatergic synapse; C:nucleoplasm; C:protein phosphatase type 2A complex;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity; F:protein-containing complex binding; F:tau protein binding;, P:G2/M transition of mitotic cell cycle; P:mitotic nuclear envelope reassembly; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine dephosphorylation; P:protein dephosphorylation; P:response to morphine; scaffold28 indexed_genome mRNA 35454187 35670293 . + . ID=transcript_6351;Q9HAK2 A0PJM4 A6NMF7 F5H645 Q66VZ3 Q6DK36 Q6IS86 Q6ISA4,Transcription factor COE2,Early B-cell factor 2;, PF16422;PF16423;PF01833;, GO:0000785;GO:0005634;GO:0003682;GO:0001228;GO:0000981;GO:0046872;GO:0046983;GO:0000978;GO:0060612;GO:0050873;GO:0001709;GO:0035563;GO:0120162;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adipose tissue development; P:brown fat cell differentiation; P:cell fate determination; P:positive regulation of chromatin binding; P:positive regulation of cold-induced thermogenesis; P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 36008465 36067007 . + . ID=transcript_6352;Q7L273 Q6NUM8 Q9NXV4,BTB/POZ domain-containing protein KCTD9,, PF02214;PF11834;PF00805;, GO:0097602;GO:0042802;GO:0043621;GO:0035556;GO:0051260;GO:0016567;, , F:cullin family protein binding; F:identical protein binding; F:protein self-association;, P:intracellular signal transduction; P:protein homooligomerization; P:protein ubiquitination;|Q7L273 Q6NUM8 Q9NXV4,BTB/POZ domain-containing protein KCTD9,, PF02214;PF11834;PF00805;, GO:0097602;GO:0042802;GO:0043621;GO:0035556;GO:0051260;GO:0016567;, , F:cullin family protein binding; F:identical protein binding; F:protein self-association;, P:intracellular signal transduction; P:protein homooligomerization; P:protein ubiquitination; scaffold28 indexed_genome mRNA 36095619 36219001 . - . ID=transcript_6353;Q9H7D0 B2RNY0 Q5XKD5 Q6AI11 Q6PJS6 Q6ZTS6,Dedicator of cytokinesis protein 5,, PF06920;PF14429;PF16172;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0005096;GO:0005085;GO:0016477;GO:1904694;GO:0010634;GO:1900026;GO:1904754;GO:0007264;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:cell migration; P:negative regulation of vascular associated smooth muscle contraction; P:positive regulation of epithelial cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vascular associated smooth muscle cell migration; P:small GTPase mediated signal transduction;|Q9H7D0 B2RNY0 Q5XKD5 Q6AI11 Q6PJS6 Q6ZTS6,Dedicator of cytokinesis protein 5,, PF06920;PF14429;PF16172;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0005096;GO:0005085;GO:0016477;GO:1904694;GO:0010634;GO:1900026;GO:1904754;GO:0007264;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:cell migration; P:negative regulation of vascular associated smooth muscle contraction; P:positive regulation of epithelial cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vascular associated smooth muscle cell migration; P:small GTPase mediated signal transduction; scaffold28 indexed_genome mRNA 36219046 36288602 . - . ID=transcript_6354;Q9H7D0 B2RNY0 Q5XKD5 Q6AI11 Q6PJS6 Q6ZTS6,Dedicator of cytokinesis protein 5,, PF06920;PF14429;PF16172;PF00018;, GO:0005737;GO:0005829;GO:0005886;GO:0005096;GO:0005085;GO:0016477;GO:1904694;GO:0010634;GO:1900026;GO:1904754;GO:0007264;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:cell migration; P:negative regulation of vascular associated smooth muscle contraction; P:positive regulation of epithelial cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of vascular associated smooth muscle cell migration; P:small GTPase mediated signal transduction; scaffold28 indexed_genome mRNA 36567208 36572094 . + . ID=transcript_6355;P07196 B9ZVN2 Q16154 Q8IU72,Neurofilament light polypeptide,68 kDa neurofilament protein;Neurofilament triplet L protein;, PF00038;PF04732;, GO:0030424;GO:1904115;GO:0098981;GO:0005737;GO:0005829;GO:0030426;GO:0005883;GO:0031594;GO:0099160;GO:0099182;GO:0098685;GO:0042802;GO:0043274;GO:0008022;GO:0019904;GO:0044877;GO:0030674;GO:0005200;GO:0099184;GO:0008089;GO:0019896;GO:0021987;GO:0021766;GO:0045109;GO:0045105;GO:0040011;GO:0000165;GO:0000226;GO:0043524;GO:0033693;GO:0060052;GO:0050885;GO:0048812;GO:0014012;GO:0050772;GO:0051258;GO:0031133;GO:2000310;GO:1903937;GO:0051412;GO:0043434;GO:1903935;GO:0009636;GO:0008090;GO:0021510;GO:0060074;, C:axon; C:axon cytoplasm; C:cholinergic synapse; C:cytoplasm; C:cytosol; C:growth cone; C:neurofilament; C:neuromuscular junction; C:postsynaptic intermediate filament cytoskeleton; C:presynaptic intermediate filament cytoskeleton; C:Schaffer collateral - CA1 synapse;, F:identical protein binding; F:phospholipase binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:structural constituent of cytoskeleton; F:structural constituent of postsynaptic intermediate filament cytoskeleton;, P:anterograde axonal transport; P:axonal transport of mitochondrion; P:cerebral cortex development; P:hippocampus development; P:intermediate filament organization; P:intermediate filament polymerization or depolymerization; P:locomotion; P:MAPK cascade; P:microtubule cytoskeleton organization; P:negative regulation of neuron apoptotic process; P:neurofilament bundle assembly; P:neurofilament cytoskeleton organization; P:neuromuscular process controlling balance; P:neuron projection morphogenesis; P:peripheral nervous system axon regeneration; P:positive regulation of axonogenesis; P:protein polymerization; P:regulation of axon diameter; P:regulation of NMDA receptor activity; P:response to acrylamide; P:response to corticosterone; P:response to peptide hormone; P:response to sodium arsenite; P:response to toxic substance; P:retrograde axonal transport; P:spinal cord development; P:synapse maturation; scaffold28 indexed_genome mRNA 36596829 36602207 . - . ID=transcript_6356;P07197 B4DGN2 E9PBF7 Q4QRK6,Neurofilament medium polypeptide,160 kDa neurofilament protein;Neurofilament 3;Neurofilament triplet M protein;, PF00038;PF04732;, GO:0030424;GO:0045111;GO:0097418;GO:0005883;GO:0008017;GO:0005200;GO:0033693;, C:axon; C:intermediate filament cytoskeleton; C:neurofibrillary tangle; C:neurofilament;, F:microtubule binding; F:structural constituent of cytoskeleton;, P:neurofilament bundle assembly;|Q16352 B1AQK0 Q9BRC5,Alpha-internexin,66 kDa neurofilament protein;Neurofilament 5;, PF00038;PF04732;, GO:0036464;GO:0005615;GO:0005883;GO:0098794;GO:0098685;GO:0005200;GO:0098973;GO:0099184;GO:0030154;GO:1990830;GO:0060052;GO:0021762;, C:cytoplasmic ribonucleoprotein granule; C:extracellular space; C:neurofilament; C:postsynapse; C:Schaffer collateral - CA1 synapse;, F:structural constituent of cytoskeleton; F:structural constituent of postsynaptic actin cytoskeleton; F:structural constituent of postsynaptic intermediate filament cytoskeleton;, P:cell differentiation; P:cellular response to leukemia inhibitory factor; P:neurofilament cytoskeleton organization; P:substantia nigra development; scaffold28 indexed_genome mRNA 37082697 37104521 . - . ID=transcript_6357;O15204 B7ZAK5,ADAM DEC1,A disintegrin and metalloproteinase domain-like protein decysin-1;, PF01562;PF01421;, GO:0062023;GO:0005576;GO:0004222;GO:0008270;GO:0006955;GO:0007162;, C:collagen-containing extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity; F:zinc ion binding;, P:immune response; P:negative regulation of cell adhesion;|O15204 B7ZAK5,ADAM DEC1,A disintegrin and metalloproteinase domain-like protein decysin-1;, PF01562;PF01421;, GO:0062023;GO:0005576;GO:0004222;GO:0008270;GO:0006955;GO:0007162;, C:collagen-containing extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity; F:zinc ion binding;, P:immune response; P:negative regulation of cell adhesion; scaffold28 indexed_genome mRNA 37135299 38777683 . - . ID=transcript_6358;Q9HD12 Q9NT55,Cell cycle and apoptosis regulator protein 2,Cell division cycle and apoptosis regulator protein 2;DBIRD complex subunit KIAA1967;Deleted in breast cancer gene 1 protein;NET35;p30 DBC;, PF14443;PF14444;, GO:0000785;GO:0005737;GO:0044609;GO:0005759;GO:0005654;GO:0005634;GO:0005819;GO:0019899;GO:0004857;GO:0030374;GO:0003723;GO:0000993;GO:0007049;GO:0006974;GO:0043653;GO:0006397;GO:0043086;GO:0030308;GO:1902230;GO:0032435;GO:0045892;GO:0043065;GO:0090263;GO:2000003;GO:1900034;GO:0042752;GO:0032784;GO:0090311;GO:0031647;GO:0006355;GO:0009411;GO:0048511;GO:0008380;GO:0016055;, C:chromatin; C:cytoplasm; C:DBIRD complex; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:spindle;, F:enzyme binding; F:enzyme inhibitor activity; F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II complex binding;, P:cell cycle; P:cellular response to DNA damage stimulus; P:mitochondrial fragmentation involved in apoptotic process; P:mRNA processing; P:negative regulation of catalytic activity; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of DNA damage checkpoint; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of DNA-templated transcription, elongation; P:regulation of protein deacetylation; P:regulation of protein stability; P:regulation of transcription, DNA-templated; P:response to UV; P:rhythmic process; P:RNA splicing; P:Wnt signaling pathway;|Q9UKQ2 B2RMV5 Q9Y339 Q9Y3S0,Disintegrin and metalloproteinase domain-containing protein 28,Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L;, PF08516;PF00200;PF01562;PF01421;, GO:0005576;GO:0016021;GO:0005739;GO:0005886;GO:0004175;GO:0046872;GO:0004222;GO:0008237;GO:0007283;, C:extracellular region; C:integral component of membrane; C:mitochondrion; C:plasma membrane;, F:endopeptidase activity; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:spermatogenesis;|Q9UKQ2 B2RMV5 Q9Y339 Q9Y3S0,Disintegrin and metalloproteinase domain-containing protein 28,Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L;, PF08516;PF00200;PF01562;PF01421;, GO:0005576;GO:0016021;GO:0005739;GO:0005886;GO:0004175;GO:0046872;GO:0004222;GO:0008237;GO:0007283;, C:extracellular region; C:integral component of membrane; C:mitochondrion; C:plasma membrane;, F:endopeptidase activity; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:spermatogenesis;|P52823 B4DN22 Q71UE5,Stanniocalcin-1,, PF03298;, GO:0016324;GO:0005737;GO:0005615;GO:0005634;GO:0005179;GO:0042802;GO:0060348;GO:0006874;GO:0071320;GO:0071385;GO:0071456;GO:0035988;GO:0046697;GO:0007566;GO:0001886;GO:0003421;GO:0051926;GO:0030336;GO:0010596;GO:1903403;GO:0001503;GO:0090280;GO:0044070;GO:0086004;GO:0033280;, C:apical plasma membrane; C:cytoplasm; C:extracellular space; C:nucleus;, F:hormone activity; F:identical protein binding;, P:bone development; P:cellular calcium ion homeostasis; P:cellular response to cAMP; P:cellular response to glucocorticoid stimulus; P:cellular response to hypoxia; P:chondrocyte proliferation; P:decidualization; P:embryo implantation; P:endothelial cell morphogenesis; P:growth plate cartilage axis specification; P:negative regulation of calcium ion transport; P:negative regulation of cell migration; P:negative regulation of endothelial cell migration; P:negative regulation of renal phosphate excretion; P:ossification; P:positive regulation of calcium ion import; P:regulation of anion transport; P:regulation of cardiac muscle cell contraction; P:response to vitamin D;|Q99801 O15465 Q9H2P4 Q9H2P5 Q9H2P6 Q9H2P7 Q9HBG0,Homeobox protein Nkx-3.1,Homeobox protein NK-3 homolog A;, PF00046;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0090734;GO:0008656;GO:0003700;GO:0000981;GO:0030284;GO:0030331;GO:0042826;GO:0097162;GO:0004879;GO:0043621;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0000976;GO:0006919;GO:0030521;GO:0060442;GO:0048754;GO:0030154;GO:0035690;GO:0071456;GO:0071347;GO:0071383;GO:0071356;GO:0035907;GO:0060664;GO:0007507;GO:0008584;GO:0001656;GO:0071850;GO:0007275;GO:0008285;GO:0050680;GO:0060770;GO:0071899;GO:0010629;GO:0043569;GO:0045930;GO:0045892;GO:0060037;GO:2000836;GO:2001235;GO:0010942;GO:0051781;GO:0008284;GO:0043280;GO:0051091;GO:0010628;GO:2001244;GO:0045931;GO:0014068;GO:0001934;GO:2001022;GO:0045944;GO:0045893;GO:0043491;GO:0032880;GO:0006357;GO:0006355;GO:0033574;GO:0007431;GO:0001756;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:estrogen receptor activity; F:estrogen receptor binding; F:histone deacetylase binding; F:MADS box domain binding; F:nuclear receptor activity; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:androgen receptor signaling pathway; P:branching involved in prostate gland morphogenesis; P:branching morphogenesis of an epithelial tube; P:cell differentiation; P:cellular response to drug; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to steroid hormone stimulus; P:cellular response to tumor necrosis factor; P:dorsal aorta development; P:epithelial cell proliferation involved in salivary gland morphogenesis; P:heart development; P:male gonad development; P:metanephros development; P:mitotic cell cycle arrest; P:multicellular organism development; P:negative regulation of cell population proliferation; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial cell proliferation involved in prostate gland development; P:negative regulation of estrogen receptor binding; P:negative regulation of gene expression; P:negative regulation of insulin-like growth factor receptor signaling pathway; P:negative regulation of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:pharyngeal system development; P:positive regulation of androgen secretion; P:positive regulation of apoptotic signaling pathway; P:positive regulation of cell death; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitotic cell cycle; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein kinase B signaling; P:regulation of protein localization; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to testosterone; P:salivary gland development; P:somitogenesis;|Q9NYZ2 A2RU93 Q53FT7 Q69YJ8 Q969S1 Q9P0J2,Mitoferrin-1,Mitochondrial iron transporter 1;Mitochondrial solute carrier protein;Solute carrier family 25 member 37;, PF00153;, GO:0016021;GO:0005743;GO:0005381;GO:0048250;GO:0055072;, C:integral component of membrane; C:mitochondrial inner membrane;, F:iron ion transmembrane transporter activity;, P:iron import into the mitochondrion; P:iron ion homeostasis;|Q9NYZ2 A2RU93 Q53FT7 Q69YJ8 Q969S1 Q9P0J2,Mitoferrin-1,Mitochondrial iron transporter 1;Mitochondrial solute carrier protein;Solute carrier family 25 member 37;, PF00153;, GO:0016021;GO:0005743;GO:0005381;GO:0048250;GO:0055072;, C:integral component of membrane; C:mitochondrial inner membrane;, F:iron ion transmembrane transporter activity;, P:iron import into the mitochondrion; P:iron ion homeostasis;|Q9NYZ2 A2RU93 Q53FT7 Q69YJ8 Q969S1 Q9P0J2,Mitoferrin-1,Mitochondrial iron transporter 1;Mitochondrial solute carrier protein;Solute carrier family 25 member 37;, PF00153;, GO:0016021;GO:0005743;GO:0005381;GO:0048250;GO:0055072;, C:integral component of membrane; C:mitochondrial inner membrane;, F:iron ion transmembrane transporter activity;, P:iron import into the mitochondrion; P:iron ion homeostasis;|Q9Y227 D3DSS3 O15092,Ectonucleoside triphosphate diphosphohydrolase 4,Golgi UDPase {ECO:0000303|PubMed:9556635};Lysosomal apyrase-like protein of 70 kDa {ECO:0000303|PubMed:10393803};Uridine-diphosphatase {ECO:0000303|PubMed:9556635};, PF01150;, GO:0000421;GO:0031410;GO:0005794;GO:0000139;GO:0097637;GO:0030173;GO:0005765;GO:0016020;GO:0043273;GO:0036384;GO:0003924;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0046036;GO:0046712;GO:0034656;GO:0009134;GO:0006256;, C:autophagosome membrane; C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of autophagosome membrane; C:integral component of Golgi membrane; C:lysosomal membrane; C:membrane;, F:CTPase activity; F:cytidine-diphosphatase activity; F:GTPase activity; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:CTP metabolic process; P:GDP catabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:UDP catabolic process;|Q9Y227 D3DSS3 O15092,Ectonucleoside triphosphate diphosphohydrolase 4,Golgi UDPase {ECO:0000303|PubMed:9556635};Lysosomal apyrase-like protein of 70 kDa {ECO:0000303|PubMed:10393803};Uridine-diphosphatase {ECO:0000303|PubMed:9556635};, PF01150;, GO:0000421;GO:0031410;GO:0005794;GO:0000139;GO:0097637;GO:0030173;GO:0005765;GO:0016020;GO:0043273;GO:0036384;GO:0003924;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0046036;GO:0046712;GO:0034656;GO:0009134;GO:0006256;, C:autophagosome membrane; C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of autophagosome membrane; C:integral component of Golgi membrane; C:lysosomal membrane; C:membrane;, F:CTPase activity; F:cytidine-diphosphatase activity; F:GTPase activity; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:CTP metabolic process; P:GDP catabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:UDP catabolic process;|Q9Y227 D3DSS3 O15092,Ectonucleoside triphosphate diphosphohydrolase 4,Golgi UDPase {ECO:0000303|PubMed:9556635};Lysosomal apyrase-like protein of 70 kDa {ECO:0000303|PubMed:10393803};Uridine-diphosphatase {ECO:0000303|PubMed:9556635};, PF01150;, GO:0000421;GO:0031410;GO:0005794;GO:0000139;GO:0097637;GO:0030173;GO:0005765;GO:0016020;GO:0043273;GO:0036384;GO:0003924;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0046036;GO:0046712;GO:0034656;GO:0009134;GO:0006256;, C:autophagosome membrane; C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of autophagosome membrane; C:integral component of Golgi membrane; C:lysosomal membrane; C:membrane;, F:CTPase activity; F:cytidine-diphosphatase activity; F:GTPase activity; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:CTP metabolic process; P:GDP catabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:UDP catabolic process;|Q9Y227 D3DSS3 O15092,Ectonucleoside triphosphate diphosphohydrolase 4,Golgi UDPase {ECO:0000303|PubMed:9556635};Lysosomal apyrase-like protein of 70 kDa {ECO:0000303|PubMed:10393803};Uridine-diphosphatase {ECO:0000303|PubMed:9556635};, PF01150;, GO:0000421;GO:0031410;GO:0005794;GO:0000139;GO:0097637;GO:0030173;GO:0005765;GO:0016020;GO:0043273;GO:0036384;GO:0003924;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0046036;GO:0046712;GO:0034656;GO:0009134;GO:0006256;, C:autophagosome membrane; C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of autophagosome membrane; C:integral component of Golgi membrane; C:lysosomal membrane; C:membrane;, F:CTPase activity; F:cytidine-diphosphatase activity; F:GTPase activity; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:CTP metabolic process; P:GDP catabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:UDP catabolic process;|Q9Y227 D3DSS3 O15092,Ectonucleoside triphosphate diphosphohydrolase 4,Golgi UDPase {ECO:0000303|PubMed:9556635};Lysosomal apyrase-like protein of 70 kDa {ECO:0000303|PubMed:10393803};Uridine-diphosphatase {ECO:0000303|PubMed:9556635};, PF01150;, GO:0000421;GO:0031410;GO:0005794;GO:0000139;GO:0097637;GO:0030173;GO:0005765;GO:0016020;GO:0043273;GO:0036384;GO:0003924;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0046036;GO:0046712;GO:0034656;GO:0009134;GO:0006256;, C:autophagosome membrane; C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of autophagosome membrane; C:integral component of Golgi membrane; C:lysosomal membrane; C:membrane;, F:CTPase activity; F:cytidine-diphosphatase activity; F:GTPase activity; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:CTP metabolic process; P:GDP catabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:UDP catabolic process;|Q9Y4K0 B2R5Q0 Q53HV3 Q9BW70 Q9Y5Y8,Lysyl oxidase homolog 2,Lysyl oxidase-like protein 2;Lysyl oxidase-related protein 2;Lysyl oxidase-related protein WS9-14;, PF01186;PF00530;, GO:0005604;GO:0000785;GO:0062023;GO:0005783;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0005509;GO:0005507;GO:0009055;GO:0070492;GO:0004720;GO:0005044;GO:0007568;GO:0007155;GO:0006464;GO:0030199;GO:0043542;GO:0001935;GO:0001837;GO:0070828;GO:1902455;GO:0000122;GO:0045892;GO:0018057;GO:0032332;GO:0010718;GO:0046688;GO:0001666;GO:0002040;, C:basement membrane; C:chromatin; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:copper ion binding; F:electron transfer activity; F:oligosaccharide binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:aging; P:cell adhesion; P:cellular protein modification process; P:collagen fibril organization; P:endothelial cell migration; P:endothelial cell proliferation; P:epithelial to mesenchymal transition; P:heterochromatin organization; P:negative regulation of stem cell population maintenance; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine oxidation; P:positive regulation of chondrocyte differentiation; P:positive regulation of epithelial to mesenchymal transition; P:response to copper ion; P:response to hypoxia; P:sprouting angiogenesis;|Q9Y4K0 B2R5Q0 Q53HV3 Q9BW70 Q9Y5Y8,Lysyl oxidase homolog 2,Lysyl oxidase-like protein 2;Lysyl oxidase-related protein 2;Lysyl oxidase-related protein WS9-14;, PF01186;PF00530;, GO:0005604;GO:0000785;GO:0062023;GO:0005783;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0005509;GO:0005507;GO:0009055;GO:0070492;GO:0004720;GO:0005044;GO:0007568;GO:0007155;GO:0006464;GO:0030199;GO:0043542;GO:0001935;GO:0001837;GO:0070828;GO:1902455;GO:0000122;GO:0045892;GO:0018057;GO:0032332;GO:0010718;GO:0046688;GO:0001666;GO:0002040;, C:basement membrane; C:chromatin; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:copper ion binding; F:electron transfer activity; F:oligosaccharide binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:aging; P:cell adhesion; P:cellular protein modification process; P:collagen fibril organization; P:endothelial cell migration; P:endothelial cell proliferation; P:epithelial to mesenchymal transition; P:heterochromatin organization; P:negative regulation of stem cell population maintenance; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine oxidation; P:positive regulation of chondrocyte differentiation; P:positive regulation of epithelial to mesenchymal transition; P:response to copper ion; P:response to hypoxia; P:sprouting angiogenesis;|Q9Y4K0 B2R5Q0 Q53HV3 Q9BW70 Q9Y5Y8,Lysyl oxidase homolog 2,Lysyl oxidase-like protein 2;Lysyl oxidase-related protein 2;Lysyl oxidase-related protein WS9-14;, PF01186;PF00530;, GO:0005604;GO:0000785;GO:0062023;GO:0005783;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0005509;GO:0005507;GO:0009055;GO:0070492;GO:0004720;GO:0005044;GO:0007568;GO:0007155;GO:0006464;GO:0030199;GO:0043542;GO:0001935;GO:0001837;GO:0070828;GO:1902455;GO:0000122;GO:0045892;GO:0018057;GO:0032332;GO:0010718;GO:0046688;GO:0001666;GO:0002040;, C:basement membrane; C:chromatin; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:copper ion binding; F:electron transfer activity; F:oligosaccharide binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:aging; P:cell adhesion; P:cellular protein modification process; P:collagen fibril organization; P:endothelial cell migration; P:endothelial cell proliferation; P:epithelial to mesenchymal transition; P:heterochromatin organization; P:negative regulation of stem cell population maintenance; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine oxidation; P:positive regulation of chondrocyte differentiation; P:positive regulation of epithelial to mesenchymal transition; P:response to copper ion; P:response to hypoxia; P:sprouting angiogenesis;|Q9Y4K0 B2R5Q0 Q53HV3 Q9BW70 Q9Y5Y8,Lysyl oxidase homolog 2,Lysyl oxidase-like protein 2;Lysyl oxidase-related protein 2;Lysyl oxidase-related protein WS9-14;, PF01186;PF00530;, GO:0005604;GO:0000785;GO:0062023;GO:0005783;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0005509;GO:0005507;GO:0009055;GO:0070492;GO:0004720;GO:0005044;GO:0007568;GO:0007155;GO:0006464;GO:0030199;GO:0043542;GO:0001935;GO:0001837;GO:0070828;GO:1902455;GO:0000122;GO:0045892;GO:0018057;GO:0032332;GO:0010718;GO:0046688;GO:0001666;GO:0002040;, C:basement membrane; C:chromatin; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:copper ion binding; F:electron transfer activity; F:oligosaccharide binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:aging; P:cell adhesion; P:cellular protein modification process; P:collagen fibril organization; P:endothelial cell migration; P:endothelial cell proliferation; P:epithelial to mesenchymal transition; P:heterochromatin organization; P:negative regulation of stem cell population maintenance; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine oxidation; P:positive regulation of chondrocyte differentiation; P:positive regulation of epithelial to mesenchymal transition; P:response to copper ion; P:response to hypoxia; P:sprouting angiogenesis;|Q9Y4K0 B2R5Q0 Q53HV3 Q9BW70 Q9Y5Y8,Lysyl oxidase homolog 2,Lysyl oxidase-like protein 2;Lysyl oxidase-related protein 2;Lysyl oxidase-related protein WS9-14;, PF01186;PF00530;, GO:0005604;GO:0000785;GO:0062023;GO:0005783;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0005509;GO:0005507;GO:0009055;GO:0070492;GO:0004720;GO:0005044;GO:0007568;GO:0007155;GO:0006464;GO:0030199;GO:0043542;GO:0001935;GO:0001837;GO:0070828;GO:1902455;GO:0000122;GO:0045892;GO:0018057;GO:0032332;GO:0010718;GO:0046688;GO:0001666;GO:0002040;, C:basement membrane; C:chromatin; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:copper ion binding; F:electron transfer activity; F:oligosaccharide binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:aging; P:cell adhesion; P:cellular protein modification process; P:collagen fibril organization; P:endothelial cell migration; P:endothelial cell proliferation; P:epithelial to mesenchymal transition; P:heterochromatin organization; P:negative regulation of stem cell population maintenance; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine oxidation; P:positive regulation of chondrocyte differentiation; P:positive regulation of epithelial to mesenchymal transition; P:response to copper ion; P:response to hypoxia; P:sprouting angiogenesis;|Q9Y4K0 B2R5Q0 Q53HV3 Q9BW70 Q9Y5Y8,Lysyl oxidase homolog 2,Lysyl oxidase-like protein 2;Lysyl oxidase-related protein 2;Lysyl oxidase-related protein WS9-14;, PF01186;PF00530;, GO:0005604;GO:0000785;GO:0062023;GO:0005783;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0005509;GO:0005507;GO:0009055;GO:0070492;GO:0004720;GO:0005044;GO:0007568;GO:0007155;GO:0006464;GO:0030199;GO:0043542;GO:0001935;GO:0001837;GO:0070828;GO:1902455;GO:0000122;GO:0045892;GO:0018057;GO:0032332;GO:0010718;GO:0046688;GO:0001666;GO:0002040;, C:basement membrane; C:chromatin; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:copper ion binding; F:electron transfer activity; F:oligosaccharide binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:aging; P:cell adhesion; P:cellular protein modification process; P:collagen fibril organization; P:endothelial cell migration; P:endothelial cell proliferation; P:epithelial to mesenchymal transition; P:heterochromatin organization; P:negative regulation of stem cell population maintenance; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine oxidation; P:positive regulation of chondrocyte differentiation; P:positive regulation of epithelial to mesenchymal transition; P:response to copper ion; P:response to hypoxia; P:sprouting angiogenesis;|Q9Y4K0 B2R5Q0 Q53HV3 Q9BW70 Q9Y5Y8,Lysyl oxidase homolog 2,Lysyl oxidase-like protein 2;Lysyl oxidase-related protein 2;Lysyl oxidase-related protein WS9-14;, PF01186;PF00530;, GO:0005604;GO:0000785;GO:0062023;GO:0005783;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0005509;GO:0005507;GO:0009055;GO:0070492;GO:0004720;GO:0005044;GO:0007568;GO:0007155;GO:0006464;GO:0030199;GO:0043542;GO:0001935;GO:0001837;GO:0070828;GO:1902455;GO:0000122;GO:0045892;GO:0018057;GO:0032332;GO:0010718;GO:0046688;GO:0001666;GO:0002040;, C:basement membrane; C:chromatin; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:copper ion binding; F:electron transfer activity; F:oligosaccharide binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:aging; P:cell adhesion; P:cellular protein modification process; P:collagen fibril organization; P:endothelial cell migration; P:endothelial cell proliferation; P:epithelial to mesenchymal transition; P:heterochromatin organization; P:negative regulation of stem cell population maintenance; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine oxidation; P:positive regulation of chondrocyte differentiation; P:positive regulation of epithelial to mesenchymal transition; P:response to copper ion; P:response to hypoxia; P:sprouting angiogenesis;|Q9Y4K0 B2R5Q0 Q53HV3 Q9BW70 Q9Y5Y8,Lysyl oxidase homolog 2,Lysyl oxidase-like protein 2;Lysyl oxidase-related protein 2;Lysyl oxidase-related protein WS9-14;, PF01186;PF00530;, GO:0005604;GO:0000785;GO:0062023;GO:0005783;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0005509;GO:0005507;GO:0009055;GO:0070492;GO:0004720;GO:0005044;GO:0007568;GO:0007155;GO:0006464;GO:0030199;GO:0043542;GO:0001935;GO:0001837;GO:0070828;GO:1902455;GO:0000122;GO:0045892;GO:0018057;GO:0032332;GO:0010718;GO:0046688;GO:0001666;GO:0002040;, C:basement membrane; C:chromatin; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus;, F:calcium ion binding; F:copper ion binding; F:electron transfer activity; F:oligosaccharide binding; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity;, P:aging; P:cell adhesion; P:cellular protein modification process; P:collagen fibril organization; P:endothelial cell migration; P:endothelial cell proliferation; P:epithelial to mesenchymal transition; P:heterochromatin organization; P:negative regulation of stem cell population maintenance; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine oxidation; P:positive regulation of chondrocyte differentiation; P:positive regulation of epithelial to mesenchymal transition; P:response to copper ion; P:response to hypoxia; P:sprouting angiogenesis;|Q9Y3T6 B7ZLI1,R3H and coiled-coil domain-containing protein 1 {ECO:0000312|HGNC:HGNC:27329},, PF01424;, GO:0003676;, , F:nucleic acid binding;|Q9Y3T6 B7ZLI1,R3H and coiled-coil domain-containing protein 1 {ECO:0000312|HGNC:HGNC:27329},, PF01424;, GO:0003676;, , F:nucleic acid binding;|Q9Y3T6 B7ZLI1,R3H and coiled-coil domain-containing protein 1 {ECO:0000312|HGNC:HGNC:27329},, PF01424;, GO:0003676;, , F:nucleic acid binding;|Q9Y3T6 B7ZLI1,R3H and coiled-coil domain-containing protein 1 {ECO:0000312|HGNC:HGNC:27329},, PF01424;, GO:0003676;, , F:nucleic acid binding;|Q8WUX9 B2RDT3 B4DKJ6 D3DSS1 Q8NDM1 Q9BT50,Charged multivesicular body protein 7,Chromatin-modifying protein 7;, PF03357;, GO:0005829;GO:0000815;GO:0005771;GO:0005635;GO:0005654;GO:0016197;GO:1904903;GO:0010458;GO:0045324;GO:0032511;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0031468;GO:0006997;GO:0071168;GO:0015031;GO:0006900;GO:0039702;GO:0019058;, C:cytosol; C:ESCRT III complex; C:multivesicular body; C:nuclear envelope; C:nucleoplasm;, , P:endosomal transport; P:ESCRT III complex disassembly; P:exit from mitosis; P:late endosome to vacuole transport; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:nuclear envelope reassembly; P:nucleus organization; P:protein localization to chromatin; P:protein transport; P:vesicle budding from membrane; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8WUX9 B2RDT3 B4DKJ6 D3DSS1 Q8NDM1 Q9BT50,Charged multivesicular body protein 7,Chromatin-modifying protein 7;, PF03357;, GO:0005829;GO:0000815;GO:0005771;GO:0005635;GO:0005654;GO:0016197;GO:1904903;GO:0010458;GO:0045324;GO:0032511;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0031468;GO:0006997;GO:0071168;GO:0015031;GO:0006900;GO:0039702;GO:0019058;, C:cytosol; C:ESCRT III complex; C:multivesicular body; C:nuclear envelope; C:nucleoplasm;, , P:endosomal transport; P:ESCRT III complex disassembly; P:exit from mitosis; P:late endosome to vacuole transport; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:nuclear envelope reassembly; P:nucleus organization; P:protein localization to chromatin; P:protein transport; P:vesicle budding from membrane; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8WUX9 B2RDT3 B4DKJ6 D3DSS1 Q8NDM1 Q9BT50,Charged multivesicular body protein 7,Chromatin-modifying protein 7;, PF03357;, GO:0005829;GO:0000815;GO:0005771;GO:0005635;GO:0005654;GO:0016197;GO:1904903;GO:0010458;GO:0045324;GO:0032511;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0031468;GO:0006997;GO:0071168;GO:0015031;GO:0006900;GO:0039702;GO:0019058;, C:cytosol; C:ESCRT III complex; C:multivesicular body; C:nuclear envelope; C:nucleoplasm;, , P:endosomal transport; P:ESCRT III complex disassembly; P:exit from mitosis; P:late endosome to vacuole transport; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:nuclear envelope reassembly; P:nucleus organization; P:protein localization to chromatin; P:protein transport; P:vesicle budding from membrane; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8WUX9 B2RDT3 B4DKJ6 D3DSS1 Q8NDM1 Q9BT50,Charged multivesicular body protein 7,Chromatin-modifying protein 7;, PF03357;, GO:0005829;GO:0000815;GO:0005771;GO:0005635;GO:0005654;GO:0016197;GO:1904903;GO:0010458;GO:0045324;GO:0032511;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0031468;GO:0006997;GO:0071168;GO:0015031;GO:0006900;GO:0039702;GO:0019058;, C:cytosol; C:ESCRT III complex; C:multivesicular body; C:nuclear envelope; C:nucleoplasm;, , P:endosomal transport; P:ESCRT III complex disassembly; P:exit from mitosis; P:late endosome to vacuole transport; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:nuclear envelope reassembly; P:nucleus organization; P:protein localization to chromatin; P:protein transport; P:vesicle budding from membrane; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8WUX9 B2RDT3 B4DKJ6 D3DSS1 Q8NDM1 Q9BT50,Charged multivesicular body protein 7,Chromatin-modifying protein 7;, PF03357;, GO:0005829;GO:0000815;GO:0005771;GO:0005635;GO:0005654;GO:0016197;GO:1904903;GO:0010458;GO:0045324;GO:0032511;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0031468;GO:0006997;GO:0071168;GO:0015031;GO:0006900;GO:0039702;GO:0019058;, C:cytosol; C:ESCRT III complex; C:multivesicular body; C:nuclear envelope; C:nucleoplasm;, , P:endosomal transport; P:ESCRT III complex disassembly; P:exit from mitosis; P:late endosome to vacuole transport; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:nuclear envelope reassembly; P:nucleus organization; P:protein localization to chromatin; P:protein transport; P:vesicle budding from membrane; P:viral budding via host ESCRT complex; P:viral life cycle;|Q9BYZ6 A8K9Z8 D3DSR8 E9PBU2 E9PEI7 O94825 Q8N4A8 Q9BZK6,Rho-related BTB domain-containing protein 2,Deleted in breast cancer 2 gene protein;p83;, PF00651;PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0010008;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0030865;GO:0043652;GO:0007163;GO:0032956;GO:0008360;GO:0007264;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:endosome membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:cortical cytoskeleton organization; P:engulfment of apoptotic cell; P:establishment or maintenance of cell polarity; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:small GTPase mediated signal transduction;|Q96S96 Q5EVA1 Q8WW74,Phosphatidylethanolamine-binding protein 4,Protein cousin-of-RKIP 1;, PF01161;, GO:0070062;GO:0005764;, C:extracellular exosome; C:lysosome;|Q06889 A8K8U9 B4DHJ5 E7EW38 Q2M3W2,Early growth response protein 3,Zinc finger protein pilot;, PF11928;PF00096;, GO:0000785;GO:0005654;GO:0045202;GO:0001228;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0002042;GO:0044344;GO:0035924;GO:0007623;GO:0035767;GO:0007517;GO:0043066;GO:0007274;GO:0007422;GO:0001938;GO:0033089;GO:0045586;GO:0006357;, C:chromatin; C:nucleoplasm; C:synapse;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell migration involved in sprouting angiogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:circadian rhythm; P:endothelial cell chemotaxis; P:muscle organ development; P:negative regulation of apoptotic process; P:neuromuscular synaptic transmission; P:peripheral nervous system development; P:positive regulation of endothelial cell proliferation; P:positive regulation of T cell differentiation in thymus; P:regulation of gamma-delta T cell differentiation; P:regulation of transcription by RNA polymerase II;|Q9NQY0 Q9BVG2 Q9NVY9,Bridging integrator 3,, PF03114;, GO:0015629;GO:0005737;GO:0008093;GO:0051666;GO:0007015;GO:0061640;GO:0000917;GO:0006897;GO:0014839;GO:0097320;GO:0008104;GO:0010591;GO:0048741;GO:0009826;, C:actin cytoskeleton; C:cytoplasm;, F:cytoskeletal anchor activity;, P:actin cortical patch localization; P:actin filament organization; P:cytoskeleton-dependent cytokinesis; P:division septum assembly; P:endocytosis; P:myoblast migration involved in skeletal muscle regeneration; P:plasma membrane tubulation; P:protein localization; P:regulation of lamellipodium assembly; P:skeletal muscle fiber development; P:unidimensional cell growth;|Q9UQB9 O60681 O75442 Q6AZY8 Q6DLZ0 Q9UPK5,Aurora kinase C,Aurora 3;Aurora/IPL1-related kinase 3;Aurora/IPL1/Eg2 protein 2;Serine/threonine-protein kinase 13;Serine/threonine-protein kinase aurora-C;, PF00069;, GO:0032133;GO:0000775;GO:0000793;GO:0005737;GO:0030496;GO:0005634;GO:0005819;GO:0005876;GO:0051233;GO:0031616;GO:0005524;GO:0035174;GO:0004672;GO:0106310;GO:0004712;GO:0106311;GO:0008608;GO:0051301;GO:0016570;GO:0051321;GO:0051256;GO:0007052;GO:0048599;GO:0032467;GO:0006468;GO:0032465;GO:0007283;, C:chromosome passenger complex; C:chromosome, centromeric region; C:condensed chromosome; C:cytoplasm; C:midbody; C:nucleus; C:spindle; C:spindle microtubule; C:spindle midzone; C:spindle pole centrosome;, F:ATP binding; F:histone serine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:histone modification; P:meiotic cell cycle; P:mitotic spindle midzone assembly; P:mitotic spindle organization; P:oocyte development; P:positive regulation of cytokinesis; P:protein phosphorylation; P:regulation of cytokinesis; P:spermatogenesis;|Q9NQY0 Q9BVG2 Q9NVY9,Bridging integrator 3,, PF03114;, GO:0015629;GO:0005737;GO:0008093;GO:0051666;GO:0007015;GO:0061640;GO:0000917;GO:0006897;GO:0014839;GO:0097320;GO:0008104;GO:0010591;GO:0048741;GO:0009826;, C:actin cytoskeleton; C:cytoplasm;, F:cytoskeletal anchor activity;, P:actin cortical patch localization; P:actin filament organization; P:cytoskeleton-dependent cytokinesis; P:division septum assembly; P:endocytosis; P:myoblast migration involved in skeletal muscle regeneration; P:plasma membrane tubulation; P:protein localization; P:regulation of lamellipodium assembly; P:skeletal muscle fiber development; P:unidimensional cell growth;|Q9NQY0 Q9BVG2 Q9NVY9,Bridging integrator 3,, PF03114;, GO:0015629;GO:0005737;GO:0008093;GO:0051666;GO:0007015;GO:0061640;GO:0000917;GO:0006897;GO:0014839;GO:0097320;GO:0008104;GO:0010591;GO:0048741;GO:0009826;, C:actin cytoskeleton; C:cytoplasm;, F:cytoskeletal anchor activity;, P:actin cortical patch localization; P:actin filament organization; P:cytoskeleton-dependent cytokinesis; P:division septum assembly; P:endocytosis; P:myoblast migration involved in skeletal muscle regeneration; P:plasma membrane tubulation; P:protein localization; P:regulation of lamellipodium assembly; P:skeletal muscle fiber development; P:unidimensional cell growth;|Q9HD12 Q9NT55,Cell cycle and apoptosis regulator protein 2,Cell division cycle and apoptosis regulator protein 2;DBIRD complex subunit KIAA1967;Deleted in breast cancer gene 1 protein;NET35;p30 DBC;, PF14443;PF14444;, GO:0000785;GO:0005737;GO:0044609;GO:0005759;GO:0005654;GO:0005634;GO:0005819;GO:0019899;GO:0004857;GO:0030374;GO:0003723;GO:0000993;GO:0007049;GO:0006974;GO:0043653;GO:0006397;GO:0043086;GO:0030308;GO:1902230;GO:0032435;GO:0045892;GO:0043065;GO:0090263;GO:2000003;GO:1900034;GO:0042752;GO:0032784;GO:0090311;GO:0031647;GO:0006355;GO:0009411;GO:0048511;GO:0008380;GO:0016055;, C:chromatin; C:cytoplasm; C:DBIRD complex; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:spindle;, F:enzyme binding; F:enzyme inhibitor activity; F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II complex binding;, P:cell cycle; P:cellular response to DNA damage stimulus; P:mitochondrial fragmentation involved in apoptotic process; P:mRNA processing; P:negative regulation of catalytic activity; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of DNA damage checkpoint; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of DNA-templated transcription, elongation; P:regulation of protein deacetylation; P:regulation of protein stability; P:regulation of transcription, DNA-templated; P:response to UV; P:rhythmic process; P:RNA splicing; P:Wnt signaling pathway;|Q9HD12 Q9NT55,Cell cycle and apoptosis regulator protein 2,Cell division cycle and apoptosis regulator protein 2;DBIRD complex subunit KIAA1967;Deleted in breast cancer gene 1 protein;NET35;p30 DBC;, PF14443;PF14444;, GO:0000785;GO:0005737;GO:0044609;GO:0005759;GO:0005654;GO:0005634;GO:0005819;GO:0019899;GO:0004857;GO:0030374;GO:0003723;GO:0000993;GO:0007049;GO:0006974;GO:0043653;GO:0006397;GO:0043086;GO:0030308;GO:1902230;GO:0032435;GO:0045892;GO:0043065;GO:0090263;GO:2000003;GO:1900034;GO:0042752;GO:0032784;GO:0090311;GO:0031647;GO:0006355;GO:0009411;GO:0048511;GO:0008380;GO:0016055;, C:chromatin; C:cytoplasm; C:DBIRD complex; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:spindle;, F:enzyme binding; F:enzyme inhibitor activity; F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II complex binding;, P:cell cycle; P:cellular response to DNA damage stimulus; P:mitochondrial fragmentation involved in apoptotic process; P:mRNA processing; P:negative regulation of catalytic activity; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of DNA damage checkpoint; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of DNA-templated transcription, elongation; P:regulation of protein deacetylation; P:regulation of protein stability; P:regulation of transcription, DNA-templated; P:response to UV; P:rhythmic process; P:RNA splicing; P:Wnt signaling pathway;|Q9HD12 Q9NT55,Cell cycle and apoptosis regulator protein 2,Cell division cycle and apoptosis regulator protein 2;DBIRD complex subunit KIAA1967;Deleted in breast cancer gene 1 protein;NET35;p30 DBC;, PF14443;PF14444;, GO:0000785;GO:0005737;GO:0044609;GO:0005759;GO:0005654;GO:0005634;GO:0005819;GO:0019899;GO:0004857;GO:0030374;GO:0003723;GO:0000993;GO:0007049;GO:0006974;GO:0043653;GO:0006397;GO:0043086;GO:0030308;GO:1902230;GO:0032435;GO:0045892;GO:0043065;GO:0090263;GO:2000003;GO:1900034;GO:0042752;GO:0032784;GO:0090311;GO:0031647;GO:0006355;GO:0009411;GO:0048511;GO:0008380;GO:0016055;, C:chromatin; C:cytoplasm; C:DBIRD complex; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:spindle;, F:enzyme binding; F:enzyme inhibitor activity; F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II complex binding;, P:cell cycle; P:cellular response to DNA damage stimulus; P:mitochondrial fragmentation involved in apoptotic process; P:mRNA processing; P:negative regulation of catalytic activity; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of DNA damage checkpoint; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of DNA-templated transcription, elongation; P:regulation of protein deacetylation; P:regulation of protein stability; P:regulation of transcription, DNA-templated; P:response to UV; P:rhythmic process; P:RNA splicing; P:Wnt signaling pathway;|Q9HD12 Q9NT55,Cell cycle and apoptosis regulator protein 2,Cell division cycle and apoptosis regulator protein 2;DBIRD complex subunit KIAA1967;Deleted in breast cancer gene 1 protein;NET35;p30 DBC;, PF14443;PF14444;, GO:0000785;GO:0005737;GO:0044609;GO:0005759;GO:0005654;GO:0005634;GO:0005819;GO:0019899;GO:0004857;GO:0030374;GO:0003723;GO:0000993;GO:0007049;GO:0006974;GO:0043653;GO:0006397;GO:0043086;GO:0030308;GO:1902230;GO:0032435;GO:0045892;GO:0043065;GO:0090263;GO:2000003;GO:1900034;GO:0042752;GO:0032784;GO:0090311;GO:0031647;GO:0006355;GO:0009411;GO:0048511;GO:0008380;GO:0016055;, C:chromatin; C:cytoplasm; C:DBIRD complex; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:spindle;, F:enzyme binding; F:enzyme inhibitor activity; F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II complex binding;, P:cell cycle; P:cellular response to DNA damage stimulus; P:mitochondrial fragmentation involved in apoptotic process; P:mRNA processing; P:negative regulation of catalytic activity; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of DNA damage checkpoint; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of DNA-templated transcription, elongation; P:regulation of protein deacetylation; P:regulation of protein stability; P:regulation of transcription, DNA-templated; P:response to UV; P:rhythmic process; P:RNA splicing; P:Wnt signaling pathway;|Q9HD12 Q9NT55,Cell cycle and apoptosis regulator protein 2,Cell division cycle and apoptosis regulator protein 2;DBIRD complex subunit KIAA1967;Deleted in breast cancer gene 1 protein;NET35;p30 DBC;, PF14443;PF14444;, GO:0000785;GO:0005737;GO:0044609;GO:0005759;GO:0005654;GO:0005634;GO:0005819;GO:0019899;GO:0004857;GO:0030374;GO:0003723;GO:0000993;GO:0007049;GO:0006974;GO:0043653;GO:0006397;GO:0043086;GO:0030308;GO:1902230;GO:0032435;GO:0045892;GO:0043065;GO:0090263;GO:2000003;GO:1900034;GO:0042752;GO:0032784;GO:0090311;GO:0031647;GO:0006355;GO:0009411;GO:0048511;GO:0008380;GO:0016055;, C:chromatin; C:cytoplasm; C:DBIRD complex; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:spindle;, F:enzyme binding; F:enzyme inhibitor activity; F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II complex binding;, P:cell cycle; P:cellular response to DNA damage stimulus; P:mitochondrial fragmentation involved in apoptotic process; P:mRNA processing; P:negative regulation of catalytic activity; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of DNA damage checkpoint; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of DNA-templated transcription, elongation; P:regulation of protein deacetylation; P:regulation of protein stability; P:regulation of transcription, DNA-templated; P:response to UV; P:rhythmic process; P:RNA splicing; P:Wnt signaling pathway;|Q9HD12 Q9NT55,Cell cycle and apoptosis regulator protein 2,Cell division cycle and apoptosis regulator protein 2;DBIRD complex subunit KIAA1967;Deleted in breast cancer gene 1 protein;NET35;p30 DBC;, PF14443;PF14444;, GO:0000785;GO:0005737;GO:0044609;GO:0005759;GO:0005654;GO:0005634;GO:0005819;GO:0019899;GO:0004857;GO:0030374;GO:0003723;GO:0000993;GO:0007049;GO:0006974;GO:0043653;GO:0006397;GO:0043086;GO:0030308;GO:1902230;GO:0032435;GO:0045892;GO:0043065;GO:0090263;GO:2000003;GO:1900034;GO:0042752;GO:0032784;GO:0090311;GO:0031647;GO:0006355;GO:0009411;GO:0048511;GO:0008380;GO:0016055;, C:chromatin; C:cytoplasm; C:DBIRD complex; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:spindle;, F:enzyme binding; F:enzyme inhibitor activity; F:nuclear receptor coactivator activity; F:RNA binding; F:RNA polymerase II complex binding;, P:cell cycle; P:cellular response to DNA damage stimulus; P:mitochondrial fragmentation involved in apoptotic process; P:mRNA processing; P:negative regulation of catalytic activity; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of DNA damage checkpoint; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of DNA-templated transcription, elongation; P:regulation of protein deacetylation; P:regulation of protein stability; P:regulation of transcription, DNA-templated; P:response to UV; P:rhythmic process; P:RNA splicing; P:Wnt signaling pathway; scaffold28 indexed_genome mRNA 38779083 38785420 . - . ID=transcript_6359;Q8NAV2 B4DI44,Uncharacterized protein C8orf58,, PF15552;|Q8NAV2 B4DI44,Uncharacterized protein C8orf58,, PF15552; scaffold28 indexed_genome mRNA 38790402 38803509 . - . ID=transcript_6360;Q96JY6 D3DSR5 J3KNH4 Q7Z584 Q86WM8 Q8WZ29 Q9H4L9 Q9H7I2,PDZ and LIM domain protein 2,PDZ-LIM protein mystique;, PF15936;PF00412;PF00595;, GO:0005912;GO:0031941;GO:0005634;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0051371;GO:0030036;GO:0007507;GO:0061061;, C:adherens junction; C:filamentous actin; C:nucleus; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development;|Q96JY6 D3DSR5 J3KNH4 Q7Z584 Q86WM8 Q8WZ29 Q9H4L9 Q9H7I2,PDZ and LIM domain protein 2,PDZ-LIM protein mystique;, PF15936;PF00412;PF00595;, GO:0005912;GO:0031941;GO:0005634;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0051371;GO:0030036;GO:0007507;GO:0061061;, C:adherens junction; C:filamentous actin; C:nucleus; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development; scaffold28 indexed_genome mRNA 38812018 38814579 . - . ID=transcript_6361;O60504 Q5BJE4 Q6NX54 Q96FY4 Q9UQE4,Vinexin,SH3-containing adapter molecule 1;Sorbin and SH3 domain-containing protein 3;, PF00018;PF14604;PF02208;, GO:0005856;GO:0005829;GO:0005925;GO:0005634;GO:0005200;GO:0008134;GO:0017166;GO:0007015;GO:0007155;GO:0031589;GO:0006936;GO:0000122;GO:0051495;GO:0043410;GO:0051496;, C:cytoskeleton; C:cytosol; C:focal adhesion; C:nucleus;, F:structural constituent of cytoskeleton; F:transcription factor binding; F:vinculin binding;, P:actin filament organization; P:cell adhesion; P:cell-substrate adhesion; P:muscle contraction; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cytoskeleton organization; P:positive regulation of MAPK cascade; P:positive regulation of stress fiber assembly; scaffold28 indexed_genome mRNA 38818638 38823579 . - . ID=transcript_6362;O60504 Q5BJE4 Q6NX54 Q96FY4 Q9UQE4,Vinexin,SH3-containing adapter molecule 1;Sorbin and SH3 domain-containing protein 3;, PF00018;PF14604;PF02208;, GO:0005856;GO:0005829;GO:0005925;GO:0005634;GO:0005200;GO:0008134;GO:0017166;GO:0007015;GO:0007155;GO:0031589;GO:0006936;GO:0000122;GO:0051495;GO:0043410;GO:0051496;, C:cytoskeleton; C:cytosol; C:focal adhesion; C:nucleus;, F:structural constituent of cytoskeleton; F:transcription factor binding; F:vinculin binding;, P:actin filament organization; P:cell adhesion; P:cell-substrate adhesion; P:muscle contraction; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cytoskeleton organization; P:positive regulation of MAPK cascade; P:positive regulation of stress fiber assembly; scaffold28 indexed_genome mRNA 38823844 38834115 . - . ID=transcript_6363;O60504 Q5BJE4 Q6NX54 Q96FY4 Q9UQE4,Vinexin,SH3-containing adapter molecule 1;Sorbin and SH3 domain-containing protein 3;, PF00018;PF14604;PF02208;, GO:0005856;GO:0005829;GO:0005925;GO:0005634;GO:0005200;GO:0008134;GO:0017166;GO:0007015;GO:0007155;GO:0031589;GO:0006936;GO:0000122;GO:0051495;GO:0043410;GO:0051496;, C:cytoskeleton; C:cytosol; C:focal adhesion; C:nucleus;, F:structural constituent of cytoskeleton; F:transcription factor binding; F:vinculin binding;, P:actin filament organization; P:cell adhesion; P:cell-substrate adhesion; P:muscle contraction; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cytoskeleton organization; P:positive regulation of MAPK cascade; P:positive regulation of stress fiber assembly; scaffold28 indexed_genome mRNA 38836549 38838482 . + . ID=transcript_6364;O60504 Q5BJE4 Q6NX54 Q96FY4 Q9UQE4,Vinexin,SH3-containing adapter molecule 1;Sorbin and SH3 domain-containing protein 3;, PF00018;PF14604;PF02208;, GO:0005856;GO:0005829;GO:0005925;GO:0005634;GO:0005200;GO:0008134;GO:0017166;GO:0007015;GO:0007155;GO:0031589;GO:0006936;GO:0000122;GO:0051495;GO:0043410;GO:0051496;, C:cytoskeleton; C:cytosol; C:focal adhesion; C:nucleus;, F:structural constituent of cytoskeleton; F:transcription factor binding; F:vinculin binding;, P:actin filament organization; P:cell adhesion; P:cell-substrate adhesion; P:muscle contraction; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cytoskeleton organization; P:positive regulation of MAPK cascade; P:positive regulation of stress fiber assembly; scaffold28 indexed_genome mRNA 38850413 38869408 . - . ID=transcript_6365;P48454 B4DRT5 Q9BSS6 Q9H4M5,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,CAM-PRP catalytic subunit;Calcineurin, testis-specific catalytic subunit;Calmodulin-dependent calcineurin A subunit gamma isoform;, PF00149;, GO:0005955;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0098793;GO:0005516;GO:0033192;GO:0046872;GO:0106306;GO:0106307;GO:0007420;GO:0097720;GO:0033173;GO:1900740;GO:1900244;GO:0006470;, C:calcineurin complex; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion; C:presynapse;, F:calmodulin binding; F:calmodulin-dependent protein phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:brain development; P:calcineurin-mediated signaling; P:calcineurin-NFAT signaling cascade; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of synaptic vesicle endocytosis; P:protein dephosphorylation;|P48454 B4DRT5 Q9BSS6 Q9H4M5,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,CAM-PRP catalytic subunit;Calcineurin, testis-specific catalytic subunit;Calmodulin-dependent calcineurin A subunit gamma isoform;, PF00149;, GO:0005955;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0098793;GO:0005516;GO:0033192;GO:0046872;GO:0106306;GO:0106307;GO:0007420;GO:0097720;GO:0033173;GO:1900740;GO:1900244;GO:0006470;, C:calcineurin complex; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion; C:presynapse;, F:calmodulin binding; F:calmodulin-dependent protein phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:brain development; P:calcineurin-mediated signaling; P:calcineurin-NFAT signaling cascade; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of synaptic vesicle endocytosis; P:protein dephosphorylation;|P48454 B4DRT5 Q9BSS6 Q9H4M5,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,CAM-PRP catalytic subunit;Calcineurin, testis-specific catalytic subunit;Calmodulin-dependent calcineurin A subunit gamma isoform;, PF00149;, GO:0005955;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0098793;GO:0005516;GO:0033192;GO:0046872;GO:0106306;GO:0106307;GO:0007420;GO:0097720;GO:0033173;GO:1900740;GO:1900244;GO:0006470;, C:calcineurin complex; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion; C:presynapse;, F:calmodulin binding; F:calmodulin-dependent protein phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:brain development; P:calcineurin-mediated signaling; P:calcineurin-NFAT signaling cascade; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of synaptic vesicle endocytosis; P:protein dephosphorylation; scaffold28 indexed_genome mRNA 38869908 38873971 . - . ID=transcript_6366;Q9H0N5 Q8TD40,Pterin-4-alpha-carbinolamine dehydratase 2,4-alpha-hydroxy-tetrahydropterin dehydratase 2;DcoH-like protein DCoHm;Dimerization cofactor of hepatocyte nuclear factor 1 from muscle;HNF-1-alpha dimerization cofactor;, PF01329;, GO:0005634;GO:0008124;GO:0042802;GO:0004505;GO:0045893;GO:0006729;, C:nucleus;, F:4-alpha-hydroxytetrahydrobiopterin dehydratase activity; F:identical protein binding; F:phenylalanine 4-monooxygenase activity;, P:positive regulation of transcription, DNA-templated; P:tetrahydrobiopterin biosynthetic process; scaffold28 indexed_genome mRNA 38876541 38937908 . - . ID=transcript_6367;P48454 B4DRT5 Q9BSS6 Q9H4M5,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,CAM-PRP catalytic subunit;Calcineurin, testis-specific catalytic subunit;Calmodulin-dependent calcineurin A subunit gamma isoform;, PF00149;, GO:0005955;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0098793;GO:0005516;GO:0033192;GO:0046872;GO:0106306;GO:0106307;GO:0007420;GO:0097720;GO:0033173;GO:1900740;GO:1900244;GO:0006470;, C:calcineurin complex; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion; C:presynapse;, F:calmodulin binding; F:calmodulin-dependent protein phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:brain development; P:calcineurin-mediated signaling; P:calcineurin-NFAT signaling cascade; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of synaptic vesicle endocytosis; P:protein dephosphorylation; scaffold28 indexed_genome mRNA 38945814 38946353 . + . ID=transcript_6368;Q12798 B2R536,Centrin-1 {ECO:0000305},Caltractin isoform 2;, PF13499;, GO:0005814;GO:0005813;GO:0005829;GO:0032391;GO:0000922;GO:0005509;GO:0035973;GO:0051301;GO:0007099;GO:0000278;GO:0006289;, C:centriole; C:centrosome; C:cytosol; C:photoreceptor connecting cilium; C:spindle pole;, F:calcium ion binding;, P:aggrephagy; P:cell division; P:centriole replication; P:mitotic cell cycle; P:nucleotide-excision repair; scaffold28 indexed_genome mRNA 38961551 38992281 . - . ID=transcript_6369;Q15043 A6NH98 B4DIW3 B6EU88 D3DSR4 Q6ZME8 Q96BB3,Metal cation symporter ZIP14 {ECO:0000305|PubMed:18270315},LIV-1 subfamily of ZIP zinc transporter 4 {ECO:0000303|PubMed:12659941};Solute carrier family 39 member 14 {ECO:0000312|HGNC:HGNC:20858};Zrt- and Irt-like protein 14 {ECO:0000303|PubMed:15642354};, PF02535;, GO:0016324;GO:0016323;GO:0031901;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005886;GO:0015296;GO:0015086;GO:0015093;GO:0005381;GO:0005384;GO:0005385;GO:0070574;GO:0071333;GO:0032869;GO:0006882;GO:0002062;GO:0006094;GO:0098739;GO:0008286;GO:0033212;GO:0034755;GO:0055071;GO:0071421;GO:0051344;GO:0045745;GO:0010817;GO:0071578;GO:0071577;, C:apical plasma membrane; C:basolateral plasma membrane; C:early endosome membrane; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:anion:cation symporter activity; F:cadmium ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:zinc ion transmembrane transporter activity;, P:cadmium ion transmembrane transport; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:cellular zinc ion homeostasis; P:chondrocyte differentiation; P:gluconeogenesis; P:import across plasma membrane; P:insulin receptor signaling pathway; P:iron import into cell; P:iron ion transmembrane transport; P:manganese ion homeostasis; P:manganese ion transmembrane transport; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of G protein-coupled receptor signaling pathway; P:regulation of hormone levels; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport;|Q15043 A6NH98 B4DIW3 B6EU88 D3DSR4 Q6ZME8 Q96BB3,Metal cation symporter ZIP14 {ECO:0000305|PubMed:18270315},LIV-1 subfamily of ZIP zinc transporter 4 {ECO:0000303|PubMed:12659941};Solute carrier family 39 member 14 {ECO:0000312|HGNC:HGNC:20858};Zrt- and Irt-like protein 14 {ECO:0000303|PubMed:15642354};, PF02535;, GO:0016324;GO:0016323;GO:0031901;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005886;GO:0015296;GO:0015086;GO:0015093;GO:0005381;GO:0005384;GO:0005385;GO:0070574;GO:0071333;GO:0032869;GO:0006882;GO:0002062;GO:0006094;GO:0098739;GO:0008286;GO:0033212;GO:0034755;GO:0055071;GO:0071421;GO:0051344;GO:0045745;GO:0010817;GO:0071578;GO:0071577;, C:apical plasma membrane; C:basolateral plasma membrane; C:early endosome membrane; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:anion:cation symporter activity; F:cadmium ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:zinc ion transmembrane transporter activity;, P:cadmium ion transmembrane transport; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:cellular zinc ion homeostasis; P:chondrocyte differentiation; P:gluconeogenesis; P:import across plasma membrane; P:insulin receptor signaling pathway; P:iron import into cell; P:iron ion transmembrane transport; P:manganese ion homeostasis; P:manganese ion transmembrane transport; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of G protein-coupled receptor signaling pathway; P:regulation of hormone levels; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport;|Q15043 A6NH98 B4DIW3 B6EU88 D3DSR4 Q6ZME8 Q96BB3,Metal cation symporter ZIP14 {ECO:0000305|PubMed:18270315},LIV-1 subfamily of ZIP zinc transporter 4 {ECO:0000303|PubMed:12659941};Solute carrier family 39 member 14 {ECO:0000312|HGNC:HGNC:20858};Zrt- and Irt-like protein 14 {ECO:0000303|PubMed:15642354};, PF02535;, GO:0016324;GO:0016323;GO:0031901;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005886;GO:0015296;GO:0015086;GO:0015093;GO:0005381;GO:0005384;GO:0005385;GO:0070574;GO:0071333;GO:0032869;GO:0006882;GO:0002062;GO:0006094;GO:0098739;GO:0008286;GO:0033212;GO:0034755;GO:0055071;GO:0071421;GO:0051344;GO:0045745;GO:0010817;GO:0071578;GO:0071577;, C:apical plasma membrane; C:basolateral plasma membrane; C:early endosome membrane; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:anion:cation symporter activity; F:cadmium ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:zinc ion transmembrane transporter activity;, P:cadmium ion transmembrane transport; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:cellular zinc ion homeostasis; P:chondrocyte differentiation; P:gluconeogenesis; P:import across plasma membrane; P:insulin receptor signaling pathway; P:iron import into cell; P:iron ion transmembrane transport; P:manganese ion homeostasis; P:manganese ion transmembrane transport; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of G protein-coupled receptor signaling pathway; P:regulation of hormone levels; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport;|Q15043 A6NH98 B4DIW3 B6EU88 D3DSR4 Q6ZME8 Q96BB3,Metal cation symporter ZIP14 {ECO:0000305|PubMed:18270315},LIV-1 subfamily of ZIP zinc transporter 4 {ECO:0000303|PubMed:12659941};Solute carrier family 39 member 14 {ECO:0000312|HGNC:HGNC:20858};Zrt- and Irt-like protein 14 {ECO:0000303|PubMed:15642354};, PF02535;, GO:0016324;GO:0016323;GO:0031901;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005886;GO:0015296;GO:0015086;GO:0015093;GO:0005381;GO:0005384;GO:0005385;GO:0070574;GO:0071333;GO:0032869;GO:0006882;GO:0002062;GO:0006094;GO:0098739;GO:0008286;GO:0033212;GO:0034755;GO:0055071;GO:0071421;GO:0051344;GO:0045745;GO:0010817;GO:0071578;GO:0071577;, C:apical plasma membrane; C:basolateral plasma membrane; C:early endosome membrane; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:anion:cation symporter activity; F:cadmium ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:zinc ion transmembrane transporter activity;, P:cadmium ion transmembrane transport; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:cellular zinc ion homeostasis; P:chondrocyte differentiation; P:gluconeogenesis; P:import across plasma membrane; P:insulin receptor signaling pathway; P:iron import into cell; P:iron ion transmembrane transport; P:manganese ion homeostasis; P:manganese ion transmembrane transport; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of G protein-coupled receptor signaling pathway; P:regulation of hormone levels; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport;|Q9C0K1 B4E2H3 Q96SM9 Q9BVC0 Q9NSA4,Metal cation symporter ZIP8 {ECO:0000305|PubMed:12504855},BCG-induced integral membrane protein in monocyte clone 103 protein {ECO:0000303|PubMed:12504855};LIV-1 subfamily of ZIP zinc transporter 6;Solute carrier family 39 member 8 {ECO:0000312|HGNC:HGNC:20862};Zrt- and Irt-like protein 8 {ECO:0000250|UniProtKB:Q91W10};, PF02535;, GO:0016324;GO:0016323;GO:0005887;GO:0005765;GO:0031090;GO:0005886;GO:0015296;GO:0015106;GO:0015086;GO:0015087;GO:0005381;GO:0005384;GO:0097079;GO:0005385;GO:0140412;GO:0006525;GO:0015701;GO:0070574;GO:1990079;GO:0006876;GO:0030026;GO:0006882;GO:0006824;GO:0030198;GO:0098711;GO:0061757;GO:0071421;GO:1990540;GO:0097080;GO:0006487;GO:0042391;GO:0006355;GO:0006351;GO:0071578;GO:0071577;GO:0006829;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:organelle membrane; C:plasma membrane;, F:anion:cation symporter activity; F:bicarbonate transmembrane transporter activity; F:cadmium ion transmembrane transporter activity; F:cobalt ion transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:selenite:proton symporter activity; F:zinc ion transmembrane transporter activity; F:zinc:bicarbonate symporter activity;, P:arginine metabolic process; P:bicarbonate transport; P:cadmium ion transmembrane transport; P:cartilage homeostasis; P:cellular cadmium ion homeostasis; P:cellular manganese ion homeostasis; P:cellular zinc ion homeostasis; P:cobalt ion transport; P:extracellular matrix organization; P:iron ion import across plasma membrane; P:leukocyte adhesion to arterial endothelial cell; P:manganese ion transmembrane transport; P:mitochondrial manganese ion transmembrane transport; P:plasma membrane selenite transport; P:protein N-linked glycosylation; P:regulation of membrane potential; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport; P:zinc ion transport;|Q15043 A6NH98 B4DIW3 B6EU88 D3DSR4 Q6ZME8 Q96BB3,Metal cation symporter ZIP14 {ECO:0000305|PubMed:18270315},LIV-1 subfamily of ZIP zinc transporter 4 {ECO:0000303|PubMed:12659941};Solute carrier family 39 member 14 {ECO:0000312|HGNC:HGNC:20858};Zrt- and Irt-like protein 14 {ECO:0000303|PubMed:15642354};, PF02535;, GO:0016324;GO:0016323;GO:0031901;GO:0016021;GO:0005887;GO:0031902;GO:0005765;GO:0005886;GO:0015296;GO:0015086;GO:0015093;GO:0005381;GO:0005384;GO:0005385;GO:0070574;GO:0071333;GO:0032869;GO:0006882;GO:0002062;GO:0006094;GO:0098739;GO:0008286;GO:0033212;GO:0034755;GO:0055071;GO:0071421;GO:0051344;GO:0045745;GO:0010817;GO:0071578;GO:0071577;, C:apical plasma membrane; C:basolateral plasma membrane; C:early endosome membrane; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:anion:cation symporter activity; F:cadmium ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:zinc ion transmembrane transporter activity;, P:cadmium ion transmembrane transport; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:cellular zinc ion homeostasis; P:chondrocyte differentiation; P:gluconeogenesis; P:import across plasma membrane; P:insulin receptor signaling pathway; P:iron import into cell; P:iron ion transmembrane transport; P:manganese ion homeostasis; P:manganese ion transmembrane transport; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of G protein-coupled receptor signaling pathway; P:regulation of hormone levels; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport; scaffold28 indexed_genome mRNA 39114278 39121481 . - . ID=transcript_6370;P05423 Q6FI28 Q9BPV7 Q9BPZ1 Q9BXB3,DNA-directed RNA polymerase III subunit RPC4,DNA-directed RNA polymerase III subunit D;Protein BN51;RNA polymerase III 47 kDa subunit;RPC53 homolog;, PF05132;, GO:0005829;GO:0005654;GO:0005666;GO:0003682;GO:0003677;GO:0003899;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006383;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:chromatin binding; F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:transcription by RNA polymerase III;|P05423 Q6FI28 Q9BPV7 Q9BPZ1 Q9BXB3,DNA-directed RNA polymerase III subunit RPC4,DNA-directed RNA polymerase III subunit D;Protein BN51;RNA polymerase III 47 kDa subunit;RPC53 homolog;, PF05132;, GO:0005829;GO:0005654;GO:0005666;GO:0003682;GO:0003677;GO:0003899;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006383;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:chromatin binding; F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:transcription by RNA polymerase III; scaffold28 indexed_genome mRNA 39135155 39149300 . - . ID=transcript_6371;Q92561 D3DSR1 Q8N4I9,Phytanoyl-CoA hydroxylase-interacting protein,Phytanoyl-CoA hydroxylase-associated protein 1;, , GO:0005737;GO:1990782;GO:0008104;, C:cytoplasm;, F:protein tyrosine kinase binding;, P:protein localization;|Q92561 D3DSR1 Q8N4I9,Phytanoyl-CoA hydroxylase-interacting protein,Phytanoyl-CoA hydroxylase-associated protein 1;, , GO:0005737;GO:1990782;GO:0008104;, C:cytoplasm;, F:protein tyrosine kinase binding;, P:protein localization;|Q92561 D3DSR1 Q8N4I9,Phytanoyl-CoA hydroxylase-interacting protein,Phytanoyl-CoA hydroxylase-associated protein 1;, , GO:0005737;GO:1990782;GO:0008104;, C:cytoplasm;, F:protein tyrosine kinase binding;, P:protein localization;|Q92561 D3DSR1 Q8N4I9,Phytanoyl-CoA hydroxylase-interacting protein,Phytanoyl-CoA hydroxylase-associated protein 1;, , GO:0005737;GO:1990782;GO:0008104;, C:cytoplasm;, F:protein tyrosine kinase binding;, P:protein localization;|Q92561 D3DSR1 Q8N4I9,Phytanoyl-CoA hydroxylase-interacting protein,Phytanoyl-CoA hydroxylase-associated protein 1;, , GO:0005737;GO:1990782;GO:0008104;, C:cytoplasm;, F:protein tyrosine kinase binding;, P:protein localization; scaffold28 indexed_genome mRNA 39154208 39200280 . - . ID=transcript_6372;Q99423 Q9UL38,Bone morphogenetic protein 1,Mammalian tolloid protein;Procollagen C-proteinase;, PF01400;PF00431;PF07645;, GO:0005576;GO:0005615;GO:0005794;GO:0031982;GO:0005509;GO:0005125;GO:0008083;GO:0042802;GO:0004222;GO:0008237;GO:0008233;GO:0008270;GO:0001502;GO:0030154;GO:0030199;GO:0022617;GO:0034380;GO:0007275;GO:0001503;GO:0061036;GO:0006508;GO:0001501;, C:extracellular region; C:extracellular space; C:Golgi apparatus; C:vesicle;, F:calcium ion binding; F:cytokine activity; F:growth factor activity; F:identical protein binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:high-density lipoprotein particle assembly; P:multicellular organism development; P:ossification; P:positive regulation of cartilage development; P:proteolysis; P:skeletal system development;|Q99423 Q9UL38,Bone morphogenetic protein 1,Mammalian tolloid protein;Procollagen C-proteinase;, PF01400;PF00431;PF07645;, GO:0005576;GO:0005615;GO:0005794;GO:0031982;GO:0005509;GO:0005125;GO:0008083;GO:0042802;GO:0004222;GO:0008237;GO:0008233;GO:0008270;GO:0001502;GO:0030154;GO:0030199;GO:0022617;GO:0034380;GO:0007275;GO:0001503;GO:0061036;GO:0006508;GO:0001501;, C:extracellular region; C:extracellular space; C:Golgi apparatus; C:vesicle;, F:calcium ion binding; F:cytokine activity; F:growth factor activity; F:identical protein binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:high-density lipoprotein particle assembly; P:multicellular organism development; P:ossification; P:positive regulation of cartilage development; P:proteolysis; P:skeletal system development;|O43897 B2RMU2 Q96AN3 Q9NQS4,Tolloid-like protein 1,, PF01400;PF00431;PF07645;, GO:0005576;GO:0005509;GO:0004222;GO:0008270;GO:0030154;GO:0030199;GO:0022617;GO:0001501;, C:extracellular region;, F:calcium ion binding; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:skeletal system development;|Q99423 Q9UL38,Bone morphogenetic protein 1,Mammalian tolloid protein;Procollagen C-proteinase;, PF01400;PF00431;PF07645;, GO:0005576;GO:0005615;GO:0005794;GO:0031982;GO:0005509;GO:0005125;GO:0008083;GO:0042802;GO:0004222;GO:0008237;GO:0008233;GO:0008270;GO:0001502;GO:0030154;GO:0030199;GO:0022617;GO:0034380;GO:0007275;GO:0001503;GO:0061036;GO:0006508;GO:0001501;, C:extracellular region; C:extracellular space; C:Golgi apparatus; C:vesicle;, F:calcium ion binding; F:cytokine activity; F:growth factor activity; F:identical protein binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:high-density lipoprotein particle assembly; P:multicellular organism development; P:ossification; P:positive regulation of cartilage development; P:proteolysis; P:skeletal system development;|Q99423 Q9UL38,Bone morphogenetic protein 1,Mammalian tolloid protein;Procollagen C-proteinase;, PF01400;PF00431;PF07645;, GO:0005576;GO:0005615;GO:0005794;GO:0031982;GO:0005509;GO:0005125;GO:0008083;GO:0042802;GO:0004222;GO:0008237;GO:0008233;GO:0008270;GO:0001502;GO:0030154;GO:0030199;GO:0022617;GO:0034380;GO:0007275;GO:0001503;GO:0061036;GO:0006508;GO:0001501;, C:extracellular region; C:extracellular space; C:Golgi apparatus; C:vesicle;, F:calcium ion binding; F:cytokine activity; F:growth factor activity; F:identical protein binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:high-density lipoprotein particle assembly; P:multicellular organism development; P:ossification; P:positive regulation of cartilage development; P:proteolysis; P:skeletal system development;|Q99423 Q9UL38,Bone morphogenetic protein 1,Mammalian tolloid protein;Procollagen C-proteinase;, PF01400;PF00431;PF07645;, GO:0005576;GO:0005615;GO:0005794;GO:0031982;GO:0005509;GO:0005125;GO:0008083;GO:0042802;GO:0004222;GO:0008237;GO:0008233;GO:0008270;GO:0001502;GO:0030154;GO:0030199;GO:0022617;GO:0034380;GO:0007275;GO:0001503;GO:0061036;GO:0006508;GO:0001501;, C:extracellular region; C:extracellular space; C:Golgi apparatus; C:vesicle;, F:calcium ion binding; F:cytokine activity; F:growth factor activity; F:identical protein binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:high-density lipoprotein particle assembly; P:multicellular organism development; P:ossification; P:positive regulation of cartilage development; P:proteolysis; P:skeletal system development;|Q99423 Q9UL38,Bone morphogenetic protein 1,Mammalian tolloid protein;Procollagen C-proteinase;, PF01400;PF00431;PF07645;, GO:0005576;GO:0005615;GO:0005794;GO:0031982;GO:0005509;GO:0005125;GO:0008083;GO:0042802;GO:0004222;GO:0008237;GO:0008233;GO:0008270;GO:0001502;GO:0030154;GO:0030199;GO:0022617;GO:0034380;GO:0007275;GO:0001503;GO:0061036;GO:0006508;GO:0001501;, C:extracellular region; C:extracellular space; C:Golgi apparatus; C:vesicle;, F:calcium ion binding; F:cytokine activity; F:growth factor activity; F:identical protein binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:high-density lipoprotein particle assembly; P:multicellular organism development; P:ossification; P:positive regulation of cartilage development; P:proteolysis; P:skeletal system development;|Q99423 Q9UL38,Bone morphogenetic protein 1,Mammalian tolloid protein;Procollagen C-proteinase;, PF01400;PF00431;PF07645;, GO:0005576;GO:0005615;GO:0005794;GO:0031982;GO:0005509;GO:0005125;GO:0008083;GO:0042802;GO:0004222;GO:0008237;GO:0008233;GO:0008270;GO:0001502;GO:0030154;GO:0030199;GO:0022617;GO:0034380;GO:0007275;GO:0001503;GO:0061036;GO:0006508;GO:0001501;, C:extracellular region; C:extracellular space; C:Golgi apparatus; C:vesicle;, F:calcium ion binding; F:cytokine activity; F:growth factor activity; F:identical protein binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:collagen fibril organization; P:extracellular matrix disassembly; P:high-density lipoprotein particle assembly; P:multicellular organism development; P:ossification; P:positive regulation of cartilage development; P:proteolysis; P:skeletal system development; scaffold28 indexed_genome mRNA 39200470 39203803 . - . ID=transcript_6373;P11686 A6XNE4 B2RE00 E9PGX3 P11687 Q12793 Q7Z5D0,Pulmonary surfactant-associated protein C,Pulmonary surfactant-associated proteolipid SPL(Val);SP5;, PF04089;PF08999;, GO:0097208;GO:0045334;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0097486;GO:0042802;GO:0044267;GO:0007585;, C:alveolar lamellar body; C:clathrin-coated endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body; C:multivesicular body lumen;, F:identical protein binding;, P:cellular protein metabolic process; P:respiratory gaseous exchange by respiratory system;|P11686 A6XNE4 B2RE00 E9PGX3 P11687 Q12793 Q7Z5D0,Pulmonary surfactant-associated protein C,Pulmonary surfactant-associated proteolipid SPL(Val);SP5;, PF04089;PF08999;, GO:0097208;GO:0045334;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0097486;GO:0042802;GO:0044267;GO:0007585;, C:alveolar lamellar body; C:clathrin-coated endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body; C:multivesicular body lumen;, F:identical protein binding;, P:cellular protein metabolic process; P:respiratory gaseous exchange by respiratory system;|P11686 A6XNE4 B2RE00 E9PGX3 P11687 Q12793 Q7Z5D0,Pulmonary surfactant-associated protein C,Pulmonary surfactant-associated proteolipid SPL(Val);SP5;, PF04089;PF08999;, GO:0097208;GO:0045334;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0097486;GO:0042802;GO:0044267;GO:0007585;, C:alveolar lamellar body; C:clathrin-coated endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body; C:multivesicular body lumen;, F:identical protein binding;, P:cellular protein metabolic process; P:respiratory gaseous exchange by respiratory system;|P11686 A6XNE4 B2RE00 E9PGX3 P11687 Q12793 Q7Z5D0,Pulmonary surfactant-associated protein C,Pulmonary surfactant-associated proteolipid SPL(Val);SP5;, PF04089;PF08999;, GO:0097208;GO:0045334;GO:0005789;GO:0005576;GO:0005615;GO:0042599;GO:0097486;GO:0042802;GO:0044267;GO:0007585;, C:alveolar lamellar body; C:clathrin-coated endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lamellar body; C:multivesicular body lumen;, F:identical protein binding;, P:cellular protein metabolic process; P:respiratory gaseous exchange by respiratory system; scaffold28 indexed_genome mRNA 39209779 39218789 . + . ID=transcript_6374;Q8N145 A5PLP2 Q86TL4 Q8N296,Leucine-rich repeat LGI family member 3,LGI1-like protein 4;Leucine-rich glioma-inactivated protein 3;, PF03736;PF13855;, GO:0005576;GO:0043005;GO:0008021;GO:0003824;GO:0006887;GO:0017157;, C:extracellular region; C:neuron projection; C:synaptic vesicle;, F:catalytic activity;, P:exocytosis; P:regulation of exocytosis;|Q8N145 A5PLP2 Q86TL4 Q8N296,Leucine-rich repeat LGI family member 3,LGI1-like protein 4;Leucine-rich glioma-inactivated protein 3;, PF03736;PF13855;, GO:0005576;GO:0043005;GO:0008021;GO:0003824;GO:0006887;GO:0017157;, C:extracellular region; C:neuron projection; C:synaptic vesicle;, F:catalytic activity;, P:exocytosis; P:regulation of exocytosis;|Q8N145 A5PLP2 Q86TL4 Q8N296,Leucine-rich repeat LGI family member 3,LGI1-like protein 4;Leucine-rich glioma-inactivated protein 3;, PF03736;PF13855;, GO:0005576;GO:0043005;GO:0008021;GO:0003824;GO:0006887;GO:0017157;, C:extracellular region; C:neuron projection; C:synaptic vesicle;, F:catalytic activity;, P:exocytosis; P:regulation of exocytosis;|Q8N145 A5PLP2 Q86TL4 Q8N296,Leucine-rich repeat LGI family member 3,LGI1-like protein 4;Leucine-rich glioma-inactivated protein 3;, PF03736;PF13855;, GO:0005576;GO:0043005;GO:0008021;GO:0003824;GO:0006887;GO:0017157;, C:extracellular region; C:neuron projection; C:synaptic vesicle;, F:catalytic activity;, P:exocytosis; P:regulation of exocytosis; scaffold28 indexed_genome mRNA 39222277 39226234 . + . ID=transcript_6375;Q9H6H4 D3DSQ9 Q86VL1 Q9H6I5 Q9HBP4,Receptor expression-enhancing protein 4,, PF03134;, GO:0005881;GO:0005783;GO:0005789;GO:0071782;GO:0016021;GO:0016020;GO:0008017;GO:0051301;GO:0071786;GO:0007084;GO:0006998;, C:cytoplasmic microtubule; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of membrane; C:membrane;, F:microtubule binding;, P:cell division; P:endoplasmic reticulum tubular network organization; P:mitotic nuclear envelope reassembly; P:nuclear envelope organization;|Q9H6H4 D3DSQ9 Q86VL1 Q9H6I5 Q9HBP4,Receptor expression-enhancing protein 4,, PF03134;, GO:0005881;GO:0005783;GO:0005789;GO:0071782;GO:0016021;GO:0016020;GO:0008017;GO:0051301;GO:0071786;GO:0007084;GO:0006998;, C:cytoplasmic microtubule; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of membrane; C:membrane;, F:microtubule binding;, P:cell division; P:endoplasmic reticulum tubular network organization; P:mitotic nuclear envelope reassembly; P:nuclear envelope organization;|Q9H6H4 D3DSQ9 Q86VL1 Q9H6I5 Q9HBP4,Receptor expression-enhancing protein 4,, PF03134;, GO:0005881;GO:0005783;GO:0005789;GO:0071782;GO:0016021;GO:0016020;GO:0008017;GO:0051301;GO:0071786;GO:0007084;GO:0006998;, C:cytoplasmic microtubule; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of membrane; C:membrane;, F:microtubule binding;, P:cell division; P:endoplasmic reticulum tubular network organization; P:mitotic nuclear envelope reassembly; P:nuclear envelope organization; scaffold28 indexed_genome mRNA 39232706 39249681 . + . ID=transcript_6376;O43593 Q6GS30 Q96H33 Q9NPE1,Lysine-specific demethylase hairless,[histone H3]-dimethyl-L-lysine(9) demethylase hairless {ECO:0000305};, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0032454;GO:0046872;GO:0016491;GO:0003712;GO:0033169;GO:0006357;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:oxidoreductase activity; F:transcription coregulator activity;, P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II;|O43593 Q6GS30 Q96H33 Q9NPE1,Lysine-specific demethylase hairless,[histone H3]-dimethyl-L-lysine(9) demethylase hairless {ECO:0000305};, PF02373;, GO:0000785;GO:0000118;GO:0005654;GO:0031490;GO:0032454;GO:0046872;GO:0016491;GO:0003712;GO:0033169;GO:0006357;, C:chromatin; C:histone deacetylase complex; C:nucleoplasm;, F:chromatin DNA binding; F:histone demethylase activity (H3-K9 specific); F:metal ion binding; F:oxidoreductase activity; F:transcription coregulator activity;, P:histone H3-K9 demethylation; P:regulation of transcription by RNA polymerase II; scaffold28 indexed_genome mRNA 39254948 39258859 . + . ID=transcript_6377;Q6ZVK8 Q8IZ75 Q9H687,8-oxo-dGDP phosphatase NUDT18,2-hydroxy-dADP phosphatase;7,8-dihydro-8-oxoguanine phosphatase;MutT homolog 3;Nucleoside diphosphate-linked moiety X motif 18;, PF00293;, GO:0005829;GO:0044717;GO:0044715;GO:0044716;GO:0000287;GO:0046057;GO:0046067;GO:0046712;GO:0034656;, C:cytosol;, F:8-hydroxy-dADP phosphatase activity; F:8-oxo-dGDP phosphatase activity; F:8-oxo-GDP phosphatase activity; F:magnesium ion binding;, P:dADP catabolic process; P:dGDP catabolic process; P:GDP catabolic process; P:nucleobase-containing small molecule catabolic process;|Q6ZVK8 Q8IZ75 Q9H687,8-oxo-dGDP phosphatase NUDT18,2-hydroxy-dADP phosphatase;7,8-dihydro-8-oxoguanine phosphatase;MutT homolog 3;Nucleoside diphosphate-linked moiety X motif 18;, PF00293;, GO:0005829;GO:0044717;GO:0044715;GO:0044716;GO:0000287;GO:0046057;GO:0046067;GO:0046712;GO:0034656;, C:cytosol;, F:8-hydroxy-dADP phosphatase activity; F:8-oxo-dGDP phosphatase activity; F:8-oxo-GDP phosphatase activity; F:magnesium ion binding;, P:dADP catabolic process; P:dGDP catabolic process; P:GDP catabolic process; P:nucleobase-containing small molecule catabolic process; scaffold28 indexed_genome mRNA 39259398 39267105 . - . ID=transcript_6378;Q86V87 B2RDQ5 B3KNX1 Q2M211 Q71JB5 Q7L3J6 Q969T0 Q9H6W4,Protein FAM160B2,Retinoic acid-induced protein 16;, PF10257;|Q86V87 B2RDQ5 B3KNX1 Q2M211 Q71JB5 Q7L3J6 Q969T0 Q9H6W4,Protein FAM160B2,Retinoic acid-induced protein 16;, PF10257;|Q86V87 B2RDQ5 B3KNX1 Q2M211 Q71JB5 Q7L3J6 Q969T0 Q9H6W4,Protein FAM160B2,Retinoic acid-induced protein 16;, PF10257;|Q86V87 B2RDQ5 B3KNX1 Q2M211 Q71JB5 Q7L3J6 Q969T0 Q9H6W4,Protein FAM160B2,Retinoic acid-induced protein 16;, PF10257;|Q86V87 B2RDQ5 B3KNX1 Q2M211 Q71JB5 Q7L3J6 Q969T0 Q9H6W4,Protein FAM160B2,Retinoic acid-induced protein 16;, PF10257;|Q86V87 B2RDQ5 B3KNX1 Q2M211 Q71JB5 Q7L3J6 Q969T0 Q9H6W4,Protein FAM160B2,Retinoic acid-induced protein 16;, PF10257; scaffold28 indexed_genome mRNA 39269876 39270868 . - . ID=transcript_6379;Q86V87 B2RDQ5 B3KNX1 Q2M211 Q71JB5 Q7L3J6 Q969T0 Q9H6W4,Protein FAM160B2,Retinoic acid-induced protein 16;, PF10257; scaffold28 indexed_genome mRNA 39286376 39297366 . - . ID=transcript_6380;Q08495 A8K0T5 B3KP70 B3KRH3 B4DI75 E9PEJ0 Q13215 Q9BRE3,Dematin,Dematin actin-binding protein;Erythrocyte membrane protein band 4.9;, PF16182;PF02209;, GO:0015629;GO:0005884;GO:0031253;GO:0030863;GO:0031410;GO:0005829;GO:0012505;GO:0048471;GO:0005886;GO:0031095;GO:0014069;GO:0014731;GO:0003779;GO:0051015;GO:0043621;GO:0005102;GO:0030507;GO:0030036;GO:0051017;GO:0051693;GO:0090527;GO:0035585;GO:0035584;GO:0071277;GO:0071320;GO:0007010;GO:0048821;GO:0030032;GO:0010812;GO:0051895;GO:0033137;GO:0010801;GO:0050732;GO:0090315;GO:1900025;GO:0030194;GO:0010763;GO:2001046;GO:1901731;GO:1900026;GO:0090303;GO:0070560;GO:0065003;GO:0032956;GO:0008360;GO:0051489;GO:0010591;GO:0055085;, C:actin cytoskeleton; C:actin filament; C:cell projection membrane; C:cortical cytoskeleton; C:cytoplasmic vesicle; C:cytosol; C:endomembrane system; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense tubular network membrane; C:postsynaptic density; C:spectrin-associated cytoskeleton;, F:actin binding; F:actin filament binding; F:protein self-association; F:signaling receptor binding; F:spectrin binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:actin filament capping; P:actin filament reorganization; P:calcium-mediated signaling using extracellular calcium source; P:calcium-mediated signaling using intracellular calcium source; P:cellular response to calcium ion; P:cellular response to cAMP; P:cytoskeleton organization; P:erythrocyte development; P:lamellipodium assembly; P:negative regulation of cell-substrate adhesion; P:negative regulation of focal adhesion assembly; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein targeting to membrane; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of blood coagulation; P:positive regulation of fibroblast migration; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of platelet aggregation; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of wound healing; P:protein secretion by platelet; P:protein-containing complex assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of filopodium assembly; P:regulation of lamellipodium assembly; P:transmembrane transport;|Q08495 A8K0T5 B3KP70 B3KRH3 B4DI75 E9PEJ0 Q13215 Q9BRE3,Dematin,Dematin actin-binding protein;Erythrocyte membrane protein band 4.9;, PF16182;PF02209;, GO:0015629;GO:0005884;GO:0031253;GO:0030863;GO:0031410;GO:0005829;GO:0012505;GO:0048471;GO:0005886;GO:0031095;GO:0014069;GO:0014731;GO:0003779;GO:0051015;GO:0043621;GO:0005102;GO:0030507;GO:0030036;GO:0051017;GO:0051693;GO:0090527;GO:0035585;GO:0035584;GO:0071277;GO:0071320;GO:0007010;GO:0048821;GO:0030032;GO:0010812;GO:0051895;GO:0033137;GO:0010801;GO:0050732;GO:0090315;GO:1900025;GO:0030194;GO:0010763;GO:2001046;GO:1901731;GO:1900026;GO:0090303;GO:0070560;GO:0065003;GO:0032956;GO:0008360;GO:0051489;GO:0010591;GO:0055085;, C:actin cytoskeleton; C:actin filament; C:cell projection membrane; C:cortical cytoskeleton; C:cytoplasmic vesicle; C:cytosol; C:endomembrane system; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense tubular network membrane; C:postsynaptic density; C:spectrin-associated cytoskeleton;, F:actin binding; F:actin filament binding; F:protein self-association; F:signaling receptor binding; F:spectrin binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:actin filament capping; P:actin filament reorganization; P:calcium-mediated signaling using extracellular calcium source; P:calcium-mediated signaling using intracellular calcium source; P:cellular response to calcium ion; P:cellular response to cAMP; P:cytoskeleton organization; P:erythrocyte development; P:lamellipodium assembly; P:negative regulation of cell-substrate adhesion; P:negative regulation of focal adhesion assembly; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein targeting to membrane; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of blood coagulation; P:positive regulation of fibroblast migration; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of platelet aggregation; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of wound healing; P:protein secretion by platelet; P:protein-containing complex assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of filopodium assembly; P:regulation of lamellipodium assembly; P:transmembrane transport;|Q08495 A8K0T5 B3KP70 B3KRH3 B4DI75 E9PEJ0 Q13215 Q9BRE3,Dematin,Dematin actin-binding protein;Erythrocyte membrane protein band 4.9;, PF16182;PF02209;, GO:0015629;GO:0005884;GO:0031253;GO:0030863;GO:0031410;GO:0005829;GO:0012505;GO:0048471;GO:0005886;GO:0031095;GO:0014069;GO:0014731;GO:0003779;GO:0051015;GO:0043621;GO:0005102;GO:0030507;GO:0030036;GO:0051017;GO:0051693;GO:0090527;GO:0035585;GO:0035584;GO:0071277;GO:0071320;GO:0007010;GO:0048821;GO:0030032;GO:0010812;GO:0051895;GO:0033137;GO:0010801;GO:0050732;GO:0090315;GO:1900025;GO:0030194;GO:0010763;GO:2001046;GO:1901731;GO:1900026;GO:0090303;GO:0070560;GO:0065003;GO:0032956;GO:0008360;GO:0051489;GO:0010591;GO:0055085;, C:actin cytoskeleton; C:actin filament; C:cell projection membrane; C:cortical cytoskeleton; C:cytoplasmic vesicle; C:cytosol; C:endomembrane system; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense tubular network membrane; C:postsynaptic density; C:spectrin-associated cytoskeleton;, F:actin binding; F:actin filament binding; F:protein self-association; F:signaling receptor binding; F:spectrin binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:actin filament capping; P:actin filament reorganization; P:calcium-mediated signaling using extracellular calcium source; P:calcium-mediated signaling using intracellular calcium source; P:cellular response to calcium ion; P:cellular response to cAMP; P:cytoskeleton organization; P:erythrocyte development; P:lamellipodium assembly; P:negative regulation of cell-substrate adhesion; P:negative regulation of focal adhesion assembly; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein targeting to membrane; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of blood coagulation; P:positive regulation of fibroblast migration; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of platelet aggregation; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of wound healing; P:protein secretion by platelet; P:protein-containing complex assembly; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of filopodium assembly; P:regulation of lamellipodium assembly; P:transmembrane transport; scaffold28 indexed_genome mRNA 39348902 39371087 . - . ID=transcript_6381;Q9UIA9 O94846 Q6PJK9 Q8NEK7,Exportin-7,Ran-binding protein 16;, PF03810;, GO:0005737;GO:0005643;GO:0005634;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus;|Q9UIA9 O94846 Q6PJK9 Q8NEK7,Exportin-7,Ran-binding protein 16;, PF03810;, GO:0005737;GO:0005643;GO:0005634;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus;|Q9UIA9 O94846 Q6PJK9 Q8NEK7,Exportin-7,Ran-binding protein 16;, PF03810;, GO:0005737;GO:0005643;GO:0005634;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; scaffold28 indexed_genome mRNA 39459481 39464258 . + . ID=transcript_6382;O60496 Q8N5A4,Docking protein 2,Downstream of tyrosine kinase 2;p56(dok-2);, PF02174;, GO:0005829;GO:0005068;GO:0007411;GO:0007166;GO:0050900;GO:0007265;GO:0007165;GO:0016032;, C:cytosol;, F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:axon guidance; P:cell surface receptor signaling pathway; P:leukocyte migration; P:Ras protein signal transduction; P:signal transduction; P:viral process; scaffold29 indexed_genome mRNA 35897 51687 . - . ID=transcript_6383;Q9H446 A8K3W2 A8MT24 Q9Y313 Q9Y6B3,RWD domain-containing protein 1,DRG family-regulatory protein 2;, PF16543;PF05773;, GO:0005844;GO:0002181;, C:polysome;, , P:cytoplasmic translation; scaffold29 indexed_genome mRNA 63315 64776 . - . ID=transcript_6384;Q5JW98 B0QZ25 B0QZ27 B4DTQ0 Q96MK0,Calcium homeostasis modulator protein 4,Protein FAM26D;, PF14798;, GO:0005887;GO:0005261;, C:integral component of plasma membrane;, F:cation channel activity; scaffold29 indexed_genome mRNA 68548 69394 . + . ID=transcript_6385;Q5JW98 B0QZ25 B0QZ27 B4DTQ0 Q96MK0,Calcium homeostasis modulator protein 4,Protein FAM26D;, PF14798;, GO:0005887;GO:0005261;, C:integral component of plasma membrane;, F:cation channel activity; scaffold29 indexed_genome mRNA 75568 114561 . + . ID=transcript_6386;Q5T215 Q5T213 Q5T214,Trafficking protein particle complex subunit 3-like protein,BET3-like protein;, PF04051;, GO:0033106;GO:0005829;GO:0005783;GO:0030008;GO:0006888;GO:0006891;, C:cis-Golgi network membrane; C:cytosol; C:endoplasmic reticulum; C:TRAPP complex;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport;|Q8N5C1 B2RDJ9 B3KSR3,Calcium homeostasis modulator protein 5,Protein FAM26E;, PF14798;, GO:0005887;GO:0005261;, C:integral component of plasma membrane;, F:cation channel activity; scaffold29 indexed_genome mRNA 116363 117900 . - . ID=transcript_6387;Q8N5C1 B2RDJ9 B3KSR3,Calcium homeostasis modulator protein 5,Protein FAM26E;, PF14798;, GO:0005887;GO:0005261;, C:integral component of plasma membrane;, F:cation channel activity; scaffold29 indexed_genome mRNA 134517 136634 . - . ID=transcript_6388;Q5R3K3 B9EJB0 Q5R3K4,Calcium homeostasis modulator protein 6,Protein FAM26F;, PF14798;, GO:0005887;GO:0005261;, C:integral component of plasma membrane;, F:cation channel activity; scaffold29 indexed_genome mRNA 161279 206609 . - . ID=transcript_6389;Q9UL01 Q5R3K6,Dermatan-sulfate epimerase,Chondroitin-glucuronate 5-epimerase;Squamous cell carcinoma antigen recognized by T-cells 2;, PF16332;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0047757;GO:0030206;GO:0030204;GO:0030208;GO:0030205;GO:0015012;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:chondroitin-glucuronate 5-epimerase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate metabolic process; P:dermatan sulfate biosynthetic process; P:dermatan sulfate metabolic process; P:heparan sulfate proteoglycan biosynthetic process; scaffold29 indexed_genome mRNA 313661 318597 . + . ID=transcript_6390;Q9H0U9 O75885 Q5TFE6,Testis-specific Y-encoded-like protein 1,, PF00956;, GO:0000785;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0042393;GO:0006334;, C:chromatin; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:histone binding;, P:nucleosome assembly; scaffold29 indexed_genome mRNA 331816 336066 . - . ID=transcript_6391;Q9UJ04 B4DYQ2 O94828 Q96GW8,Testis-specific Y-encoded-like protein 4,, PF00956;, GO:0000785;GO:0005634;GO:0003682;GO:0042393;GO:0006334;, C:chromatin; C:nucleus;, F:chromatin binding; F:histone binding;, P:nucleosome assembly; scaffold29 indexed_genome mRNA 352122 462286 . - . ID=transcript_6392;Q5TFE4 B2RND9 B3KR35 Q6XYD5,5'-nucleotidase domain-containing protein 1,, PF05761;, GO:0008253;GO:0046872;, , F:5'-nucleotidase activity; F:metal ion binding;|Q5TFE4 B2RND9 B3KR35 Q6XYD5,5'-nucleotidase domain-containing protein 1,, PF05761;, GO:0008253;GO:0046872;, , F:5'-nucleotidase activity; F:metal ion binding;|Q5TFE4 B2RND9 B3KR35 Q6XYD5,5'-nucleotidase domain-containing protein 1,, PF05761;, GO:0008253;GO:0046872;, , F:5'-nucleotidase activity; F:metal ion binding; scaffold29 indexed_genome mRNA 573101 589811 . + . ID=transcript_6393;P42685 B4DY49 Q13128 Q9NTR5,Tyrosine-protein kinase FRK,FYN-related kinase;Nuclear tyrosine protein kinase RAK;Protein-tyrosine kinase 5;, PF07714;PF00017;PF00018;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0031234;GO:0005622;GO:0005654;GO:0005634;GO:0035580;GO:0005524;GO:0004715;GO:0004713;GO:0005102;GO:0004714;GO:0030154;GO:0045087;GO:0008285;GO:0000122;GO:0043312;GO:0006468;GO:0007169;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:extrinsic component of cytoplasmic side of plasma membrane; C:intracellular anatomical structure; C:nucleoplasm; C:nucleus; C:specific granule lumen;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:innate immune response; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:neutrophil degranulation; P:protein phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold29 indexed_genome mRNA 2147758 2149328 . - . ID=transcript_6394;Q8IZT8 A8K1J2 Q52LI2 Q8N285,Heparan sulfate glucosamine 3-O-sulfotransferase 5,Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 5;, PF00685;, GO:0000139;GO:0016021;GO:0050656;GO:0008467;GO:0006024;GO:0015015;GO:0050819;GO:0006477;GO:0046596;, C:Golgi membrane; C:integral component of membrane;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity;, P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; P:negative regulation of coagulation; P:protein sulfation; P:regulation of viral entry into host cell; scaffold29 indexed_genome mRNA 2221866 2254768 . + . ID=transcript_6395;Q92769 B3KRS5 B4DL58 E1P561 Q5SRI8 Q5SZ86 Q8NEH4,Histone deacetylase 2 {ECO:0000305},, PF00850;, GO:0000785;GO:0005737;GO:0035098;GO:0000118;GO:0005654;GO:0005634;GO:0016581;GO:0032991;GO:0016580;GO:0003682;GO:0019213;GO:0019899;GO:0031072;GO:0004407;GO:0042826;GO:0032041;GO:0051059;GO:1990841;GO:0033558;GO:0003723;GO:0001103;GO:0043565;GO:0008134;GO:0043044;GO:0048149;GO:0007596;GO:0003300;GO:1903351;GO:0034605;GO:0070301;GO:0071300;GO:0071560;GO:0006338;GO:0032922;GO:0016358;GO:0042733;GO:0009913;GO:0061029;GO:0061198;GO:0060789;GO:0070829;GO:0016575;GO:0070932;GO:0070933;GO:0043066;GO:0061000;GO:0043392;GO:0043433;GO:0045347;GO:0010977;GO:2000757;GO:0000122;GO:0045892;GO:0042475;GO:0008284;GO:0032967;GO:0010718;GO:0032732;GO:1902437;GO:0048714;GO:0045862;GO:2000273;GO:0045944;GO:0045893;GO:0032760;GO:0042531;GO:1901796;GO:0001975;GO:0031000;GO:0042220;GO:0042493;GO:0055093;GO:0032496;GO:0035094;, C:chromatin; C:cytoplasm; C:ESC/E(Z) complex; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:NuRD complex; C:protein-containing complex; C:Sin3 complex;, F:chromatin binding; F:deacetylase activity; F:enzyme binding; F:heat shock protein binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:RNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:behavioral response to ethanol; P:blood coagulation; P:cardiac muscle hypertrophy; P:cellular response to dopamine; P:cellular response to heat; P:cellular response to hydrogen peroxide; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:chromatin remodeling; P:circadian regulation of gene expression; P:dendrite development; P:embryonic digit morphogenesis; P:epidermal cell differentiation; P:eyelid development in camera-type eye; P:fungiform papilla formation; P:hair follicle placode formation; P:heterochromatin maintenance; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation of apoptotic process; P:negative regulation of dendritic spine development; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of MHC class II biosynthetic process; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of interleukin-1 production; P:positive regulation of male mating behavior; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of proteolysis; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of signal transduction by p53 class mediator; P:response to amphetamine; P:response to caffeine; P:response to cocaine; P:response to drug; P:response to hyperoxia; P:response to lipopolysaccharide; P:response to nicotine;|Q13547 Q92534,Histone deacetylase 1 {ECO:0000305},, PF00850;, GO:0000785;GO:0005737;GO:0005829;GO:0000792;GO:0000118;GO:0043025;GO:0005654;GO:0005634;GO:0016581;GO:0032991;GO:0016580;GO:0033613;GO:0001046;GO:0019213;GO:0070888;GO:0019899;GO:0004407;GO:0042826;GO:0035851;GO:0032041;GO:0051059;GO:0002039;GO:1990841;GO:0033558;GO:0047485;GO:0070491;GO:0000978;GO:0000979;GO:0001103;GO:0001085;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0007596;GO:0006325;GO:0006338;GO:0032922;GO:0006346;GO:0042733;GO:0007492;GO:0009913;GO:0061029;GO:0061198;GO:0060789;GO:0021766;GO:0016575;GO:0070932;GO:0070933;GO:0043922;GO:0060766;GO:0043066;GO:0090090;GO:0010629;GO:0043124;GO:2001243;GO:0000122;GO:0045892;GO:0030182;GO:0042475;GO:0008284;GO:0048714;GO:2000273;GO:0045944;GO:0045893;GO:0006476;GO:1900221;GO:0052548;GO:0045652;GO:1901796;GO:0006357;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:heterochromatin; C:histone deacetylase complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:NuRD complex; C:protein-containing complex; C:Sin3 complex;, F:activating transcription factor binding; F:core promoter sequence-specific DNA binding; F:deacetylase activity; F:E-box binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:Krueppel-associated box domain binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:protein N-terminus binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:blood coagulation; P:chromatin organization; P:chromatin remodeling; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:embryonic digit morphogenesis; P:endoderm development; P:epidermal cell differentiation; P:eyelid development in camera-type eye; P:fungiform papilla formation; P:hair follicle placode formation; P:hippocampus development; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation by host of viral transcription; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deacetylation; P:regulation of amyloid-beta clearance; P:regulation of endopeptidase activity; P:regulation of megakaryocyte differentiation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q92769 B3KRS5 B4DL58 E1P561 Q5SRI8 Q5SZ86 Q8NEH4,Histone deacetylase 2 {ECO:0000305},, PF00850;, GO:0000785;GO:0005737;GO:0035098;GO:0000118;GO:0005654;GO:0005634;GO:0016581;GO:0032991;GO:0016580;GO:0003682;GO:0019213;GO:0019899;GO:0031072;GO:0004407;GO:0042826;GO:0032041;GO:0051059;GO:1990841;GO:0033558;GO:0003723;GO:0001103;GO:0043565;GO:0008134;GO:0043044;GO:0048149;GO:0007596;GO:0003300;GO:1903351;GO:0034605;GO:0070301;GO:0071300;GO:0071560;GO:0006338;GO:0032922;GO:0016358;GO:0042733;GO:0009913;GO:0061029;GO:0061198;GO:0060789;GO:0070829;GO:0016575;GO:0070932;GO:0070933;GO:0043066;GO:0061000;GO:0043392;GO:0043433;GO:0045347;GO:0010977;GO:2000757;GO:0000122;GO:0045892;GO:0042475;GO:0008284;GO:0032967;GO:0010718;GO:0032732;GO:1902437;GO:0048714;GO:0045862;GO:2000273;GO:0045944;GO:0045893;GO:0032760;GO:0042531;GO:1901796;GO:0001975;GO:0031000;GO:0042220;GO:0042493;GO:0055093;GO:0032496;GO:0035094;, C:chromatin; C:cytoplasm; C:ESC/E(Z) complex; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:NuRD complex; C:protein-containing complex; C:Sin3 complex;, F:chromatin binding; F:deacetylase activity; F:enzyme binding; F:heat shock protein binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:RNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:behavioral response to ethanol; P:blood coagulation; P:cardiac muscle hypertrophy; P:cellular response to dopamine; P:cellular response to heat; P:cellular response to hydrogen peroxide; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:chromatin remodeling; P:circadian regulation of gene expression; P:dendrite development; P:embryonic digit morphogenesis; P:epidermal cell differentiation; P:eyelid development in camera-type eye; P:fungiform papilla formation; P:hair follicle placode formation; P:heterochromatin maintenance; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation of apoptotic process; P:negative regulation of dendritic spine development; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of MHC class II biosynthetic process; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of interleukin-1 production; P:positive regulation of male mating behavior; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of proteolysis; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of signal transduction by p53 class mediator; P:response to amphetamine; P:response to caffeine; P:response to cocaine; P:response to drug; P:response to hyperoxia; P:response to lipopolysaccharide; P:response to nicotine;|P46778 Q16699,60S ribosomal protein L21,Large ribosomal subunit protein eL21 {ECO:0000303|PubMed:24524803};, PF01157;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q92769 B3KRS5 B4DL58 E1P561 Q5SRI8 Q5SZ86 Q8NEH4,Histone deacetylase 2 {ECO:0000305},, PF00850;, GO:0000785;GO:0005737;GO:0035098;GO:0000118;GO:0005654;GO:0005634;GO:0016581;GO:0032991;GO:0016580;GO:0003682;GO:0019213;GO:0019899;GO:0031072;GO:0004407;GO:0042826;GO:0032041;GO:0051059;GO:1990841;GO:0033558;GO:0003723;GO:0001103;GO:0043565;GO:0008134;GO:0043044;GO:0048149;GO:0007596;GO:0003300;GO:1903351;GO:0034605;GO:0070301;GO:0071300;GO:0071560;GO:0006338;GO:0032922;GO:0016358;GO:0042733;GO:0009913;GO:0061029;GO:0061198;GO:0060789;GO:0070829;GO:0016575;GO:0070932;GO:0070933;GO:0043066;GO:0061000;GO:0043392;GO:0043433;GO:0045347;GO:0010977;GO:2000757;GO:0000122;GO:0045892;GO:0042475;GO:0008284;GO:0032967;GO:0010718;GO:0032732;GO:1902437;GO:0048714;GO:0045862;GO:2000273;GO:0045944;GO:0045893;GO:0032760;GO:0042531;GO:1901796;GO:0001975;GO:0031000;GO:0042220;GO:0042493;GO:0055093;GO:0032496;GO:0035094;, C:chromatin; C:cytoplasm; C:ESC/E(Z) complex; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:NuRD complex; C:protein-containing complex; C:Sin3 complex;, F:chromatin binding; F:deacetylase activity; F:enzyme binding; F:heat shock protein binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:RNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:behavioral response to ethanol; P:blood coagulation; P:cardiac muscle hypertrophy; P:cellular response to dopamine; P:cellular response to heat; P:cellular response to hydrogen peroxide; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:chromatin remodeling; P:circadian regulation of gene expression; P:dendrite development; P:embryonic digit morphogenesis; P:epidermal cell differentiation; P:eyelid development in camera-type eye; P:fungiform papilla formation; P:hair follicle placode formation; P:heterochromatin maintenance; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation of apoptotic process; P:negative regulation of dendritic spine development; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of MHC class II biosynthetic process; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of interleukin-1 production; P:positive regulation of male mating behavior; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of proteolysis; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of signal transduction by p53 class mediator; P:response to amphetamine; P:response to caffeine; P:response to cocaine; P:response to drug; P:response to hyperoxia; P:response to lipopolysaccharide; P:response to nicotine; scaffold29 indexed_genome mRNA 2325189 2325842 . + . ID=transcript_6396;P29966 E1P560 Q2LA83 Q5TDB7,Myristoylated alanine-rich C-kinase substrate,Protein kinase C substrate, 80 kDa protein, light chain;, PF02063;, GO:0015629;GO:0032432;GO:0005938;GO:0005813;GO:0005737;GO:0070062;GO:0005925;GO:0042585;GO:0005886;GO:0051015;GO:0005516;GO:0042802;GO:0005080;GO:0051764;GO:0051017;GO:0007015;GO:0007417;, C:actin cytoskeleton; C:actin filament bundle; C:cell cortex; C:centrosome; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:germinal vesicle; C:plasma membrane;, F:actin filament binding; F:calmodulin binding; F:identical protein binding; F:protein kinase C binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:actin filament organization; P:central nervous system development; scaffold29 indexed_genome mRNA 2358601 2359464 . + . ID=transcript_6397;P15954 Q6NR81,Cytochrome c oxidase subunit 7C, mitochondrial,Cytochrome c oxidase polypeptide VIIc;, PF02935;, GO:0016021;GO:0005743;GO:0005751;GO:0005739;GO:0004129;GO:0006091;GO:0006123;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV; C:mitochondrion;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen; scaffold29 indexed_genome mRNA 3855047 3995134 . + . ID=transcript_6398;Q16363 Q14731 Q14735 Q15335 Q4LE44 Q5SZG8 Q9BTB8 Q9UE18 Q9UJN9,Laminin subunit alpha-4,Laminin-14 subunit alpha;Laminin-8 subunit alpha;Laminin-9 subunit alpha;, PF00053;PF02210;PF06008;PF06009;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005201;GO:0005102;GO:0007155;GO:0030198;GO:0120163;GO:0030155;GO:0030334;GO:0045995;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:extracellular matrix structural constituent; F:signaling receptor binding;, P:cell adhesion; P:extracellular matrix organization; P:negative regulation of cold-induced thermogenesis; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development;|Q16363 Q14731 Q14735 Q15335 Q4LE44 Q5SZG8 Q9BTB8 Q9UE18 Q9UJN9,Laminin subunit alpha-4,Laminin-14 subunit alpha;Laminin-8 subunit alpha;Laminin-9 subunit alpha;, PF00053;PF02210;PF06008;PF06009;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005201;GO:0005102;GO:0007155;GO:0030198;GO:0120163;GO:0030155;GO:0030334;GO:0045995;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:extracellular matrix structural constituent; F:signaling receptor binding;, P:cell adhesion; P:extracellular matrix organization; P:negative regulation of cold-induced thermogenesis; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development;|Q16363 Q14731 Q14735 Q15335 Q4LE44 Q5SZG8 Q9BTB8 Q9UE18 Q9UJN9,Laminin subunit alpha-4,Laminin-14 subunit alpha;Laminin-8 subunit alpha;Laminin-9 subunit alpha;, PF00053;PF02210;PF06008;PF06009;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005201;GO:0005102;GO:0007155;GO:0030198;GO:0120163;GO:0030155;GO:0030334;GO:0045995;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:extracellular matrix structural constituent; F:signaling receptor binding;, P:cell adhesion; P:extracellular matrix organization; P:negative regulation of cold-induced thermogenesis; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development;|Q16363 Q14731 Q14735 Q15335 Q4LE44 Q5SZG8 Q9BTB8 Q9UE18 Q9UJN9,Laminin subunit alpha-4,Laminin-14 subunit alpha;Laminin-8 subunit alpha;Laminin-9 subunit alpha;, PF00053;PF02210;PF06008;PF06009;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005201;GO:0005102;GO:0007155;GO:0030198;GO:0120163;GO:0030155;GO:0030334;GO:0045995;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:extracellular matrix structural constituent; F:signaling receptor binding;, P:cell adhesion; P:extracellular matrix organization; P:negative regulation of cold-induced thermogenesis; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; scaffold29 indexed_genome mRNA 3995361 4008832 . - . ID=transcript_6399;Q4G0N7 B8ZZ33,Protein FAM229B,, PF14982; scaffold29 indexed_genome mRNA 4008909 4037171 . + . ID=transcript_6400;Q9UJT0 Q5H8W8 Q8NEG3,Tubulin epsilon chain,Epsilon-tubulin;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0000242;GO:0005525;GO:0003924;GO:0005200;GO:0007098;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:pericentriolar material;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:centrosome cycle; P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q9UJT0 Q5H8W8 Q8NEG3,Tubulin epsilon chain,Epsilon-tubulin;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0000242;GO:0005525;GO:0003924;GO:0005200;GO:0007098;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:pericentriolar material;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:centrosome cycle; P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q9UJT0 Q5H8W8 Q8NEG3,Tubulin epsilon chain,Epsilon-tubulin;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0000242;GO:0005525;GO:0003924;GO:0005200;GO:0007098;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:pericentriolar material;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:centrosome cycle; P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q9UJT0 Q5H8W8 Q8NEG3,Tubulin epsilon chain,Epsilon-tubulin;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0000242;GO:0005525;GO:0003924;GO:0005200;GO:0007098;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:pericentriolar material;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:centrosome cycle; P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q9UJT0 Q5H8W8 Q8NEG3,Tubulin epsilon chain,Epsilon-tubulin;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0000242;GO:0005525;GO:0003924;GO:0005200;GO:0007098;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:pericentriolar material;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:centrosome cycle; P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q9UJT0 Q5H8W8 Q8NEG3,Tubulin epsilon chain,Epsilon-tubulin;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0000242;GO:0005525;GO:0003924;GO:0005200;GO:0007098;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:pericentriolar material;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:centrosome cycle; P:microtubule cytoskeleton organization; P:mitotic cell cycle; scaffold29 indexed_genome mRNA 4227174 4453937 . + . ID=transcript_6401;P06241 B5BU57 E1P557 H0UI48 Q16248 Q5R3A6 Q5R3A7 Q8N5D7,Tyrosine-protein kinase Fyn,Proto-oncogene Syn;Proto-oncogene c-Fyn;Src-like kinase;p59-Fyn;, PF07714;PF00017;PF00018;, GO:0005884;GO:0044297;GO:0005829;GO:0030425;GO:0005768;GO:0031234;GO:0097386;GO:0098978;GO:0045121;GO:0005739;GO:0005634;GO:0097038;GO:0048471;GO:0005886;GO:0014069;GO:0099092;GO:0098685;GO:0043014;GO:0005524;GO:0042609;GO:0042610;GO:0097718;GO:0019899;GO:0046875;GO:0070851;GO:0042802;GO:0044325;GO:0046872;GO:0004715;GO:0051428;GO:0043548;GO:0004713;GO:0005102;GO:0042608;GO:0048156;GO:0050321;GO:0004714;GO:0031802;GO:0050798;GO:0002250;GO:0007411;GO:0007596;GO:0006816;GO:0030154;GO:1904646;GO:1905430;GO:1905232;GO:0071375;GO:0036120;GO:0071560;GO:0019221;GO:0048813;GO:0097062;GO:0050966;GO:0048013;GO:0038096;GO:0007631;GO:0030900;GO:0003015;GO:0045087;GO:0035556;GO:0007612;GO:0050900;GO:0000165;GO:0050804;GO:1902951;GO:2001240;GO:0010629;GO:0010730;GO:0002862;GO:0043524;GO:1903202;GO:0042177;GO:0031397;GO:0001764;GO:0018108;GO:0030168;GO:2001056;GO:0043123;GO:1901216;GO:0010976;GO:1903997;GO:0014068;GO:0051897;GO:1905477;GO:1900182;GO:0090314;GO:0042531;GO:0046777;GO:0006468;GO:1905664;GO:0008360;GO:0050690;GO:1900449;GO:0050730;GO:1904645;GO:0042493;GO:0045471;GO:0042542;GO:0000304;GO:0002223;GO:0031295;GO:0050852;GO:0007169;GO:0048010;, C:actin filament; C:cell body; C:cytosol; C:dendrite; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:glial cell projection; C:glutamatergic synapse; C:membrane raft; C:mitochondrion; C:nucleus; C:perinuclear endoplasmic reticulum; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic density, intracellular component; C:Schaffer collateral - CA1 synapse;, F:alpha-tubulin binding; F:ATP binding; F:CD4 receptor binding; F:CD8 receptor binding; F:disordered domain specific binding; F:enzyme binding; F:ephrin receptor binding; F:growth factor receptor binding; F:identical protein binding; F:ion channel binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:peptide hormone receptor binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:T cell receptor binding; F:tau protein binding; F:tau-protein kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:type 5 metabotropic glutamate receptor binding;, P:activated T cell proliferation; P:adaptive immune response; P:axon guidance; P:blood coagulation; P:calcium ion transport; P:cell differentiation; P:cellular response to amyloid-beta; P:cellular response to glycine; P:cellular response to L-glutamate; P:cellular response to peptide hormone stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:cytokine-mediated signaling pathway; P:dendrite morphogenesis; P:dendritic spine maintenance; P:detection of mechanical stimulus involved in sensory perception of pain; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:feeding behavior; P:forebrain development; P:heart process; P:innate immune response; P:intracellular signal transduction; P:learning; P:leukocyte migration; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:negative regulation of dendritic spine maintenance; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide biosynthetic process; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of protein catabolic process; P:negative regulation of protein ubiquitination; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron death; P:positive regulation of neuron projection development; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to membrane; P:positive regulation of protein localization to nucleus; P:positive regulation of protein targeting to membrane; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion import across plasma membrane; P:regulation of cell shape; P:regulation of defense response to virus by virus; P:regulation of glutamate receptor signaling pathway; P:regulation of peptidyl-tyrosine phosphorylation; P:response to amyloid-beta; P:response to drug; P:response to ethanol; P:response to hydrogen peroxide; P:response to singlet oxygen; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P07947 A6NLB3 D3DUH1,Tyrosine-protein kinase Yes,Proto-oncogene c-Yes;p61-Yes;, PF07714;PF00017;PF00018;, GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0005794;GO:0005815;GO:0005886;GO:0005524;GO:0019899;GO:0044325;GO:0004715;GO:0001784;GO:0004713;GO:0005102;GO:0004714;GO:0030154;GO:0006464;GO:0048013;GO:0038096;GO:0045087;GO:0050900;GO:0002862;GO:0043114;GO:0031295;GO:0007169;, C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:microtubule organizing center; C:plasma membrane;, F:ATP binding; F:enzyme binding; F:ion channel binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:cellular protein modification process; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:innate immune response; P:leukocyte migration; P:negative regulation of inflammatory response to antigenic stimulus; P:regulation of vascular permeability; P:T cell costimulation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P06241 B5BU57 E1P557 H0UI48 Q16248 Q5R3A6 Q5R3A7 Q8N5D7,Tyrosine-protein kinase Fyn,Proto-oncogene Syn;Proto-oncogene c-Fyn;Src-like kinase;p59-Fyn;, PF07714;PF00017;PF00018;, GO:0005884;GO:0044297;GO:0005829;GO:0030425;GO:0005768;GO:0031234;GO:0097386;GO:0098978;GO:0045121;GO:0005739;GO:0005634;GO:0097038;GO:0048471;GO:0005886;GO:0014069;GO:0099092;GO:0098685;GO:0043014;GO:0005524;GO:0042609;GO:0042610;GO:0097718;GO:0019899;GO:0046875;GO:0070851;GO:0042802;GO:0044325;GO:0046872;GO:0004715;GO:0051428;GO:0043548;GO:0004713;GO:0005102;GO:0042608;GO:0048156;GO:0050321;GO:0004714;GO:0031802;GO:0050798;GO:0002250;GO:0007411;GO:0007596;GO:0006816;GO:0030154;GO:1904646;GO:1905430;GO:1905232;GO:0071375;GO:0036120;GO:0071560;GO:0019221;GO:0048813;GO:0097062;GO:0050966;GO:0048013;GO:0038096;GO:0007631;GO:0030900;GO:0003015;GO:0045087;GO:0035556;GO:0007612;GO:0050900;GO:0000165;GO:0050804;GO:1902951;GO:2001240;GO:0010629;GO:0010730;GO:0002862;GO:0043524;GO:1903202;GO:0042177;GO:0031397;GO:0001764;GO:0018108;GO:0030168;GO:2001056;GO:0043123;GO:1901216;GO:0010976;GO:1903997;GO:0014068;GO:0051897;GO:1905477;GO:1900182;GO:0090314;GO:0042531;GO:0046777;GO:0006468;GO:1905664;GO:0008360;GO:0050690;GO:1900449;GO:0050730;GO:1904645;GO:0042493;GO:0045471;GO:0042542;GO:0000304;GO:0002223;GO:0031295;GO:0050852;GO:0007169;GO:0048010;, C:actin filament; C:cell body; C:cytosol; C:dendrite; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:glial cell projection; C:glutamatergic synapse; C:membrane raft; C:mitochondrion; C:nucleus; C:perinuclear endoplasmic reticulum; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic density, intracellular component; C:Schaffer collateral - CA1 synapse;, F:alpha-tubulin binding; F:ATP binding; F:CD4 receptor binding; F:CD8 receptor binding; F:disordered domain specific binding; F:enzyme binding; F:ephrin receptor binding; F:growth factor receptor binding; F:identical protein binding; F:ion channel binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:peptide hormone receptor binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:T cell receptor binding; F:tau protein binding; F:tau-protein kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:type 5 metabotropic glutamate receptor binding;, P:activated T cell proliferation; P:adaptive immune response; P:axon guidance; P:blood coagulation; P:calcium ion transport; P:cell differentiation; P:cellular response to amyloid-beta; P:cellular response to glycine; P:cellular response to L-glutamate; P:cellular response to peptide hormone stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:cytokine-mediated signaling pathway; P:dendrite morphogenesis; P:dendritic spine maintenance; P:detection of mechanical stimulus involved in sensory perception of pain; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:feeding behavior; P:forebrain development; P:heart process; P:innate immune response; P:intracellular signal transduction; P:learning; P:leukocyte migration; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:negative regulation of dendritic spine maintenance; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide biosynthetic process; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of protein catabolic process; P:negative regulation of protein ubiquitination; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron death; P:positive regulation of neuron projection development; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to membrane; P:positive regulation of protein localization to nucleus; P:positive regulation of protein targeting to membrane; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion import across plasma membrane; P:regulation of cell shape; P:regulation of defense response to virus by virus; P:regulation of glutamate receptor signaling pathway; P:regulation of peptidyl-tyrosine phosphorylation; P:response to amyloid-beta; P:response to drug; P:response to ethanol; P:response to hydrogen peroxide; P:response to singlet oxygen; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P06241 B5BU57 E1P557 H0UI48 Q16248 Q5R3A6 Q5R3A7 Q8N5D7,Tyrosine-protein kinase Fyn,Proto-oncogene Syn;Proto-oncogene c-Fyn;Src-like kinase;p59-Fyn;, PF07714;PF00017;PF00018;, GO:0005884;GO:0044297;GO:0005829;GO:0030425;GO:0005768;GO:0031234;GO:0097386;GO:0098978;GO:0045121;GO:0005739;GO:0005634;GO:0097038;GO:0048471;GO:0005886;GO:0014069;GO:0099092;GO:0098685;GO:0043014;GO:0005524;GO:0042609;GO:0042610;GO:0097718;GO:0019899;GO:0046875;GO:0070851;GO:0042802;GO:0044325;GO:0046872;GO:0004715;GO:0051428;GO:0043548;GO:0004713;GO:0005102;GO:0042608;GO:0048156;GO:0050321;GO:0004714;GO:0031802;GO:0050798;GO:0002250;GO:0007411;GO:0007596;GO:0006816;GO:0030154;GO:1904646;GO:1905430;GO:1905232;GO:0071375;GO:0036120;GO:0071560;GO:0019221;GO:0048813;GO:0097062;GO:0050966;GO:0048013;GO:0038096;GO:0007631;GO:0030900;GO:0003015;GO:0045087;GO:0035556;GO:0007612;GO:0050900;GO:0000165;GO:0050804;GO:1902951;GO:2001240;GO:0010629;GO:0010730;GO:0002862;GO:0043524;GO:1903202;GO:0042177;GO:0031397;GO:0001764;GO:0018108;GO:0030168;GO:2001056;GO:0043123;GO:1901216;GO:0010976;GO:1903997;GO:0014068;GO:0051897;GO:1905477;GO:1900182;GO:0090314;GO:0042531;GO:0046777;GO:0006468;GO:1905664;GO:0008360;GO:0050690;GO:1900449;GO:0050730;GO:1904645;GO:0042493;GO:0045471;GO:0042542;GO:0000304;GO:0002223;GO:0031295;GO:0050852;GO:0007169;GO:0048010;, C:actin filament; C:cell body; C:cytosol; C:dendrite; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:glial cell projection; C:glutamatergic synapse; C:membrane raft; C:mitochondrion; C:nucleus; C:perinuclear endoplasmic reticulum; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic density, intracellular component; C:Schaffer collateral - CA1 synapse;, F:alpha-tubulin binding; F:ATP binding; F:CD4 receptor binding; F:CD8 receptor binding; F:disordered domain specific binding; F:enzyme binding; F:ephrin receptor binding; F:growth factor receptor binding; F:identical protein binding; F:ion channel binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:peptide hormone receptor binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:T cell receptor binding; F:tau protein binding; F:tau-protein kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:type 5 metabotropic glutamate receptor binding;, P:activated T cell proliferation; P:adaptive immune response; P:axon guidance; P:blood coagulation; P:calcium ion transport; P:cell differentiation; P:cellular response to amyloid-beta; P:cellular response to glycine; P:cellular response to L-glutamate; P:cellular response to peptide hormone stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:cytokine-mediated signaling pathway; P:dendrite morphogenesis; P:dendritic spine maintenance; P:detection of mechanical stimulus involved in sensory perception of pain; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:feeding behavior; P:forebrain development; P:heart process; P:innate immune response; P:intracellular signal transduction; P:learning; P:leukocyte migration; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:negative regulation of dendritic spine maintenance; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide biosynthetic process; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of protein catabolic process; P:negative regulation of protein ubiquitination; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron death; P:positive regulation of neuron projection development; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to membrane; P:positive regulation of protein localization to nucleus; P:positive regulation of protein targeting to membrane; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion import across plasma membrane; P:regulation of cell shape; P:regulation of defense response to virus by virus; P:regulation of glutamate receptor signaling pathway; P:regulation of peptidyl-tyrosine phosphorylation; P:response to amyloid-beta; P:response to drug; P:response to ethanol; P:response to hydrogen peroxide; P:response to singlet oxygen; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P06241 B5BU57 E1P557 H0UI48 Q16248 Q5R3A6 Q5R3A7 Q8N5D7,Tyrosine-protein kinase Fyn,Proto-oncogene Syn;Proto-oncogene c-Fyn;Src-like kinase;p59-Fyn;, PF07714;PF00017;PF00018;, GO:0005884;GO:0044297;GO:0005829;GO:0030425;GO:0005768;GO:0031234;GO:0097386;GO:0098978;GO:0045121;GO:0005739;GO:0005634;GO:0097038;GO:0048471;GO:0005886;GO:0014069;GO:0099092;GO:0098685;GO:0043014;GO:0005524;GO:0042609;GO:0042610;GO:0097718;GO:0019899;GO:0046875;GO:0070851;GO:0042802;GO:0044325;GO:0046872;GO:0004715;GO:0051428;GO:0043548;GO:0004713;GO:0005102;GO:0042608;GO:0048156;GO:0050321;GO:0004714;GO:0031802;GO:0050798;GO:0002250;GO:0007411;GO:0007596;GO:0006816;GO:0030154;GO:1904646;GO:1905430;GO:1905232;GO:0071375;GO:0036120;GO:0071560;GO:0019221;GO:0048813;GO:0097062;GO:0050966;GO:0048013;GO:0038096;GO:0007631;GO:0030900;GO:0003015;GO:0045087;GO:0035556;GO:0007612;GO:0050900;GO:0000165;GO:0050804;GO:1902951;GO:2001240;GO:0010629;GO:0010730;GO:0002862;GO:0043524;GO:1903202;GO:0042177;GO:0031397;GO:0001764;GO:0018108;GO:0030168;GO:2001056;GO:0043123;GO:1901216;GO:0010976;GO:1903997;GO:0014068;GO:0051897;GO:1905477;GO:1900182;GO:0090314;GO:0042531;GO:0046777;GO:0006468;GO:1905664;GO:0008360;GO:0050690;GO:1900449;GO:0050730;GO:1904645;GO:0042493;GO:0045471;GO:0042542;GO:0000304;GO:0002223;GO:0031295;GO:0050852;GO:0007169;GO:0048010;, C:actin filament; C:cell body; C:cytosol; C:dendrite; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:glial cell projection; C:glutamatergic synapse; C:membrane raft; C:mitochondrion; C:nucleus; C:perinuclear endoplasmic reticulum; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic density, intracellular component; C:Schaffer collateral - CA1 synapse;, F:alpha-tubulin binding; F:ATP binding; F:CD4 receptor binding; F:CD8 receptor binding; F:disordered domain specific binding; F:enzyme binding; F:ephrin receptor binding; F:growth factor receptor binding; F:identical protein binding; F:ion channel binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:peptide hormone receptor binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:T cell receptor binding; F:tau protein binding; F:tau-protein kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:type 5 metabotropic glutamate receptor binding;, P:activated T cell proliferation; P:adaptive immune response; P:axon guidance; P:blood coagulation; P:calcium ion transport; P:cell differentiation; P:cellular response to amyloid-beta; P:cellular response to glycine; P:cellular response to L-glutamate; P:cellular response to peptide hormone stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:cytokine-mediated signaling pathway; P:dendrite morphogenesis; P:dendritic spine maintenance; P:detection of mechanical stimulus involved in sensory perception of pain; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:feeding behavior; P:forebrain development; P:heart process; P:innate immune response; P:intracellular signal transduction; P:learning; P:leukocyte migration; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:negative regulation of dendritic spine maintenance; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide biosynthetic process; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of protein catabolic process; P:negative regulation of protein ubiquitination; P:neuron migration; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron death; P:positive regulation of neuron projection development; P:positive regulation of non-membrane spanning protein tyrosine kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to membrane; P:positive regulation of protein localization to nucleus; P:positive regulation of protein targeting to membrane; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion import across plasma membrane; P:regulation of cell shape; P:regulation of defense response to virus by virus; P:regulation of glutamate receptor signaling pathway; P:regulation of peptidyl-tyrosine phosphorylation; P:response to amyloid-beta; P:response to drug; P:response to ethanol; P:response to hydrogen peroxide; P:response to singlet oxygen; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold29 indexed_genome mRNA 4498761 4541847 . + . ID=transcript_6402;Q9NS14 Q9UG72,E3 ubiquitin ligase TRAF3IP2 {ECO:0000303|PubMed:19825828},Adapter protein CIKS;Connection to IKK and SAPK/JNK;E3 ubiquitin-protein ligase CIKS;Nuclear factor NF-kappa-B activator 1;TRAF3-interacting protein 2;, PF08357;, GO:0005102;GO:0061630;GO:0001783;GO:0006959;GO:0006954;GO:0097400;GO:0035556;GO:0002230;GO:0043123;GO:0070534;, , F:signaling receptor binding; F:ubiquitin protein ligase activity;, P:B cell apoptotic process; P:humoral immune response; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:intracellular signal transduction; P:positive regulation of defense response to virus by host; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein K63-linked ubiquitination;|Q9NS14 Q9UG72,E3 ubiquitin ligase TRAF3IP2 {ECO:0000303|PubMed:19825828},Adapter protein CIKS;Connection to IKK and SAPK/JNK;E3 ubiquitin-protein ligase CIKS;Nuclear factor NF-kappa-B activator 1;TRAF3-interacting protein 2;, PF08357;, GO:0005102;GO:0061630;GO:0001783;GO:0006959;GO:0006954;GO:0097400;GO:0035556;GO:0002230;GO:0043123;GO:0070534;, , F:signaling receptor binding; F:ubiquitin protein ligase activity;, P:B cell apoptotic process; P:humoral immune response; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:intracellular signal transduction; P:positive regulation of defense response to virus by host; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein K63-linked ubiquitination;|Q9NS14 Q9UG72,E3 ubiquitin ligase TRAF3IP2 {ECO:0000303|PubMed:19825828},Adapter protein CIKS;Connection to IKK and SAPK/JNK;E3 ubiquitin-protein ligase CIKS;Nuclear factor NF-kappa-B activator 1;TRAF3-interacting protein 2;, PF08357;, GO:0005102;GO:0061630;GO:0001783;GO:0006959;GO:0006954;GO:0097400;GO:0035556;GO:0002230;GO:0043123;GO:0070534;, , F:signaling receptor binding; F:ubiquitin protein ligase activity;, P:B cell apoptotic process; P:humoral immune response; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:intracellular signal transduction; P:positive regulation of defense response to virus by host; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein K63-linked ubiquitination;|Q9NS14 Q9UG72,E3 ubiquitin ligase TRAF3IP2 {ECO:0000303|PubMed:19825828},Adapter protein CIKS;Connection to IKK and SAPK/JNK;E3 ubiquitin-protein ligase CIKS;Nuclear factor NF-kappa-B activator 1;TRAF3-interacting protein 2;, PF08357;, GO:0005102;GO:0061630;GO:0001783;GO:0006959;GO:0006954;GO:0097400;GO:0035556;GO:0002230;GO:0043123;GO:0070534;, , F:signaling receptor binding; F:ubiquitin protein ligase activity;, P:B cell apoptotic process; P:humoral immune response; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:intracellular signal transduction; P:positive regulation of defense response to virus by host; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein K63-linked ubiquitination;|Q9NS14 Q9UG72,E3 ubiquitin ligase TRAF3IP2 {ECO:0000303|PubMed:19825828},Adapter protein CIKS;Connection to IKK and SAPK/JNK;E3 ubiquitin-protein ligase CIKS;Nuclear factor NF-kappa-B activator 1;TRAF3-interacting protein 2;, PF08357;, GO:0005102;GO:0061630;GO:0001783;GO:0006959;GO:0006954;GO:0097400;GO:0035556;GO:0002230;GO:0043123;GO:0070534;, , F:signaling receptor binding; F:ubiquitin protein ligase activity;, P:B cell apoptotic process; P:humoral immune response; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:intracellular signal transduction; P:positive regulation of defense response to virus by host; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein K63-linked ubiquitination;|Q9NS14 Q9UG72,E3 ubiquitin ligase TRAF3IP2 {ECO:0000303|PubMed:19825828},Adapter protein CIKS;Connection to IKK and SAPK/JNK;E3 ubiquitin-protein ligase CIKS;Nuclear factor NF-kappa-B activator 1;TRAF3-interacting protein 2;, PF08357;, GO:0005102;GO:0061630;GO:0001783;GO:0006959;GO:0006954;GO:0097400;GO:0035556;GO:0002230;GO:0043123;GO:0070534;, , F:signaling receptor binding; F:ubiquitin protein ligase activity;, P:B cell apoptotic process; P:humoral immune response; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:intracellular signal transduction; P:positive regulation of defense response to virus by host; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein K63-linked ubiquitination; scaffold29 indexed_genome mRNA 4624070 4625408 . - . ID=transcript_6403;Q96FH9 Q9H012 Q9H0D0 Q9H988 Q9HC49 Q9NVG4,Cytoskeleton-associated protein 2,CTCL tumor antigen se20-10;Tumor- and microtubule-associated protein;, PF15297;, GO:0005813;GO:0005829;GO:0005874;GO:0015630;GO:0000922;GO:0006915;GO:0000281;GO:0045944;, C:centrosome; C:cytosol; C:microtubule; C:microtubule cytoskeleton; C:spindle pole;, , P:apoptotic process; P:mitotic cytokinesis; P:positive regulation of transcription by RNA polymerase II; scaffold29 indexed_genome mRNA 4664619 4779982 . + . ID=transcript_6404;O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis;|O60673 O43214 Q5TC33,DNA polymerase zeta catalytic subunit,Protein reversionless 3-like;, PF00136;PF03104;PF15735;PF14260;, GO:0005730;GO:0005654;GO:0005634;GO:0016035;GO:0051539;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006261;GO:0000724;GO:0042276;GO:0090305;, C:nucleolus; C:nucleoplasm; C:nucleus; C:zeta DNA polymerase complex;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-prone translesion synthesis; P:nucleic acid phosphodiester bond hydrolysis; scaffold29 indexed_genome mRNA 4806086 4812887 . - . ID=transcript_6405;Q5TF39 A8K9M0 Q8IYB6 Q96PW9 Q9P0D6,Sodium-dependent glucose transporter 1 {ECO:0000250|UniProtKB:Q80T22},Major facilitator superfamily domain-containing protein 4B {ECO:0000312|HGNC:HGNC:21053};, PF07690;, GO:0016324;GO:0016021;GO:0005355;GO:0015293;GO:0006814;, C:apical plasma membrane; C:integral component of membrane;, F:glucose transmembrane transporter activity; F:symporter activity;, P:sodium ion transport; scaffold29 indexed_genome mRNA 4829416 4836093 . - . ID=transcript_6406;Q8TF71 B3KWY0 Q6ZMG0 Q8WVI5,Monocarboxylate transporter 10,Aromatic amino acid transporter 1;Solute carrier family 16 member 10;T-type amino acid transporter 1;, PF07690;, GO:0016323;GO:0030054;GO:0016021;GO:0005887;GO:0043231;GO:0005886;GO:0015173;GO:0015349;GO:0006865;GO:0015801;GO:0006590;GO:0070327;GO:0070460;, C:basolateral plasma membrane; C:cell junction; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:aromatic amino acid transmembrane transporter activity; F:thyroid hormone transmembrane transporter activity;, P:amino acid transport; P:aromatic amino acid transport; P:thyroid hormone generation; P:thyroid hormone transport; P:thyroid-stimulating hormone secretion; scaffold29 indexed_genome mRNA 4842985 4843706 . + . ID=transcript_6407;Q8TF71 B3KWY0 Q6ZMG0 Q8WVI5,Monocarboxylate transporter 10,Aromatic amino acid transporter 1;Solute carrier family 16 member 10;T-type amino acid transporter 1;, PF07690;, GO:0016323;GO:0030054;GO:0016021;GO:0005887;GO:0043231;GO:0005886;GO:0015173;GO:0015349;GO:0006865;GO:0015801;GO:0006590;GO:0070327;GO:0070460;, C:basolateral plasma membrane; C:cell junction; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:aromatic amino acid transmembrane transporter activity; F:thyroid hormone transmembrane transporter activity;, P:amino acid transport; P:aromatic amino acid transport; P:thyroid hormone generation; P:thyroid hormone transport; P:thyroid-stimulating hormone secretion; scaffold29 indexed_genome mRNA 4989433 5021248 . - . ID=transcript_6408;Q9H7B2 Q5VXN1 Q8N4A1,Ribosome production factor 2 homolog,Brix domain-containing protein 1;Ribosome biogenesis protein RPF2 homolog;, PF04427;, GO:0005694;GO:0005730;GO:0005654;GO:0008097;GO:0003723;GO:0019843;GO:0000463;GO:1902570;GO:1901796;GO:0000027;GO:0042273;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:5S rRNA binding; F:RNA binding; F:rRNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:protein localization to nucleolus; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosomal large subunit biogenesis;|Q9H7B2 Q5VXN1 Q8N4A1,Ribosome production factor 2 homolog,Brix domain-containing protein 1;Ribosome biogenesis protein RPF2 homolog;, PF04427;, GO:0005694;GO:0005730;GO:0005654;GO:0008097;GO:0003723;GO:0019843;GO:0000463;GO:1902570;GO:1901796;GO:0000027;GO:0042273;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:5S rRNA binding; F:RNA binding; F:rRNA binding;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:protein localization to nucleolus; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosomal large subunit biogenesis; scaffold29 indexed_genome mRNA 5028020 5039367 . - . ID=transcript_6409;Q969F1 Q5VXN2,General transcription factor 3C polypeptide 6,Transcription factor IIIC 35 kDa subunit;Transcription factor IIIC subunit 6;, PF10419;, GO:0016604;GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0006383;GO:0042797;, C:nuclear body; C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III; scaffold29 indexed_genome mRNA 5077494 5090396 . - . ID=transcript_6410;P17707 E1P5F7 Q5VXN4 Q5VXN6 Q9BWK4,S-adenosylmethionine decarboxylase proenzyme,, PF01536;, GO:0005829;GO:0004014;GO:0042802;GO:0019810;GO:0006595;GO:0006557;GO:0008295;GO:0006597;, C:cytosol;, F:adenosylmethionine decarboxylase activity; F:identical protein binding; F:putrescine binding;, P:polyamine metabolic process; P:S-adenosylmethioninamine biosynthetic process; P:spermidine biosynthetic process; P:spermine biosynthetic process;|P17707 E1P5F7 Q5VXN4 Q5VXN6 Q9BWK4,S-adenosylmethionine decarboxylase proenzyme,, PF01536;, GO:0005829;GO:0004014;GO:0042802;GO:0019810;GO:0006595;GO:0006557;GO:0008295;GO:0006597;, C:cytosol;, F:adenosylmethionine decarboxylase activity; F:identical protein binding; F:putrescine binding;, P:polyamine metabolic process; P:S-adenosylmethioninamine biosynthetic process; P:spermidine biosynthetic process; P:spermine biosynthetic process;|P17707 E1P5F7 Q5VXN4 Q5VXN6 Q9BWK4,S-adenosylmethionine decarboxylase proenzyme,, PF01536;, GO:0005829;GO:0004014;GO:0042802;GO:0019810;GO:0006595;GO:0006557;GO:0008295;GO:0006597;, C:cytosol;, F:adenosylmethionine decarboxylase activity; F:identical protein binding; F:putrescine binding;, P:polyamine metabolic process; P:S-adenosylmethioninamine biosynthetic process; P:spermidine biosynthetic process; P:spermine biosynthetic process; scaffold29 indexed_genome mRNA 5243689 5347481 . + . ID=transcript_6411;Q5JXM2 Q6ZSU5,Methyltransferase-like protein 24,, PF13383;, GO:0005576;GO:0008168;GO:0032259;, C:extracellular region;, F:methyltransferase activity;, P:methylation;|Q5JXM2 Q6ZSU5,Methyltransferase-like protein 24,, PF13383;, GO:0005576;GO:0008168;GO:0032259;, C:extracellular region;, F:methyltransferase activity;, P:methylation;|O60508 B2RBC5 O75471 Q5SRN0 Q9UPG1,Pre-mRNA-processing factor 17,Cell division cycle 40 homolog;EH-binding protein 3;PRP17 homolog;, PF00400;, GO:0071013;GO:0016607;GO:0005654;GO:0071007;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus;|O60508 B2RBC5 O75471 Q5SRN0 Q9UPG1,Pre-mRNA-processing factor 17,Cell division cycle 40 homolog;EH-binding protein 3;PRP17 homolog;, PF00400;, GO:0071013;GO:0016607;GO:0005654;GO:0071007;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus;|O60508 B2RBC5 O75471 Q5SRN0 Q9UPG1,Pre-mRNA-processing factor 17,Cell division cycle 40 homolog;EH-binding protein 3;PRP17 homolog;, PF00400;, GO:0071013;GO:0016607;GO:0005654;GO:0071007;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus;|O60508 B2RBC5 O75471 Q5SRN0 Q9UPG1,Pre-mRNA-processing factor 17,Cell division cycle 40 homolog;EH-binding protein 3;PRP17 homolog;, PF00400;, GO:0071013;GO:0016607;GO:0005654;GO:0071007;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus;|O60508 B2RBC5 O75471 Q5SRN0 Q9UPG1,Pre-mRNA-processing factor 17,Cell division cycle 40 homolog;EH-binding protein 3;PRP17 homolog;, PF00400;, GO:0071013;GO:0016607;GO:0005654;GO:0071007;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; scaffold29 indexed_genome mRNA 5645114 5812684 . - . ID=transcript_6412;Q92562 Q53H49 Q5TCS6,Polyphosphoinositide phosphatase,Phosphatidylinositol 3,5-bisphosphate 5-phosphatase;SAC domain-containing protein 3;, PF02383;, GO:0031901;GO:0010008;GO:0000139;GO:0043231;GO:0031902;GO:0005811;GO:0043813;GO:0006661;GO:0046856;, C:early endosome membrane; C:endosome membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lipid droplet;, F:phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; scaffold29 indexed_genome mRNA 5931041 5933213 . + . ID=transcript_6413;Q8WW00 Q96NF4,Adenylate kinase 9,Adenylate kinase domain-containing protein 1;Adenylate kinase domain-containing protein 2;, , GO:0005737;GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0005634;GO:0004017;GO:0005524;GO:0004550;GO:0050145;GO:0006756;GO:0006757;GO:0061508;GO:0061566;GO:0006174;GO:0061565;GO:0061570;GO:0061567;GO:0006186;GO:0061568;GO:0015949;GO:0061571;GO:0061569;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:adenylate kinase activity; F:ATP binding; F:nucleoside diphosphate kinase activity; F:nucleoside monophosphate kinase activity;, P:AMP phosphorylation; P:ATP generation from ADP; P:CDP phosphorylation; P:CMP phosphorylation; P:dADP phosphorylation; P:dAMP phosphorylation; P:dCDP phosphorylation; P:dCMP phosphorylation; P:dGDP phosphorylation; P:GDP phosphorylation; P:nucleobase-containing small molecule interconversion; P:TDP phosphorylation; P:UDP phosphorylation; scaffold29 indexed_genome mRNA 5939459 5949664 . + . ID=transcript_6414;O43167 Q17RC6 Q5TED5 Q8N455,Zinc finger and BTB domain-containing protein 24,Zinc finger protein 450;, PF00651;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0002244;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:hematopoietic progenitor cell differentiation; P:regulation of transcription by RNA polymerase II;|O43167 Q17RC6 Q5TED5 Q8N455,Zinc finger and BTB domain-containing protein 24,Zinc finger protein 450;, PF00651;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0002244;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:hematopoietic progenitor cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold29 indexed_genome mRNA 5956885 5968293 . + . ID=transcript_6415;Q9UFF7,[F-actin]-monooxygenase MICAL1 {ECO:0000305},Molecule interacting with CasL protein 1;NEDD9-interacting protein with calponin homology and LIM domains;, PF00307;PF12130;PF01494;PF00412;, GO:0015629;GO:0005737;GO:0005829;GO:1990026;GO:0045171;GO:0005882;GO:0030496;GO:0005886;GO:0003779;GO:0051015;GO:0071949;GO:0046872;GO:0016174;GO:0016709;GO:0019901;GO:0017124;GO:0031267;GO:0051017;GO:0030042;GO:0007596;GO:0007010;GO:0043154;GO:0001933;GO:1903305;GO:0007165;GO:0019417;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:hippocampal mossy fiber expansion; C:intercellular bridge; C:intermediate filament; C:midbody; C:plasma membrane;, F:actin binding; F:actin filament binding; F:FAD binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:actin filament bundle assembly; P:actin filament depolymerization; P:blood coagulation; P:cytoskeleton organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of protein phosphorylation; P:regulation of regulated secretory pathway; P:signal transduction; P:sulfur oxidation;|Q9UFF7,[F-actin]-monooxygenase MICAL1 {ECO:0000305},Molecule interacting with CasL protein 1;NEDD9-interacting protein with calponin homology and LIM domains;, PF00307;PF12130;PF01494;PF00412;, GO:0015629;GO:0005737;GO:0005829;GO:1990026;GO:0045171;GO:0005882;GO:0030496;GO:0005886;GO:0003779;GO:0051015;GO:0071949;GO:0046872;GO:0016174;GO:0016709;GO:0019901;GO:0017124;GO:0031267;GO:0051017;GO:0030042;GO:0007596;GO:0007010;GO:0043154;GO:0001933;GO:1903305;GO:0007165;GO:0019417;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:hippocampal mossy fiber expansion; C:intercellular bridge; C:intermediate filament; C:midbody; C:plasma membrane;, F:actin binding; F:actin filament binding; F:FAD binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:actin filament bundle assembly; P:actin filament depolymerization; P:blood coagulation; P:cytoskeleton organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of protein phosphorylation; P:regulation of regulated secretory pathway; P:signal transduction; P:sulfur oxidation;|Q9UFF7,[F-actin]-monooxygenase MICAL1 {ECO:0000305},Molecule interacting with CasL protein 1;NEDD9-interacting protein with calponin homology and LIM domains;, PF00307;PF12130;PF01494;PF00412;, GO:0015629;GO:0005737;GO:0005829;GO:1990026;GO:0045171;GO:0005882;GO:0030496;GO:0005886;GO:0003779;GO:0051015;GO:0071949;GO:0046872;GO:0016174;GO:0016709;GO:0019901;GO:0017124;GO:0031267;GO:0051017;GO:0030042;GO:0007596;GO:0007010;GO:0043154;GO:0001933;GO:1903305;GO:0007165;GO:0019417;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:hippocampal mossy fiber expansion; C:intercellular bridge; C:intermediate filament; C:midbody; C:plasma membrane;, F:actin binding; F:actin filament binding; F:FAD binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:actin filament bundle assembly; P:actin filament depolymerization; P:blood coagulation; P:cytoskeleton organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of protein phosphorylation; P:regulation of regulated secretory pathway; P:signal transduction; P:sulfur oxidation;|Q9UFF7,[F-actin]-monooxygenase MICAL1 {ECO:0000305},Molecule interacting with CasL protein 1;NEDD9-interacting protein with calponin homology and LIM domains;, PF00307;PF12130;PF01494;PF00412;, GO:0015629;GO:0005737;GO:0005829;GO:1990026;GO:0045171;GO:0005882;GO:0030496;GO:0005886;GO:0003779;GO:0051015;GO:0071949;GO:0046872;GO:0016174;GO:0016709;GO:0019901;GO:0017124;GO:0031267;GO:0051017;GO:0030042;GO:0007596;GO:0007010;GO:0043154;GO:0001933;GO:1903305;GO:0007165;GO:0019417;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:hippocampal mossy fiber expansion; C:intercellular bridge; C:intermediate filament; C:midbody; C:plasma membrane;, F:actin binding; F:actin filament binding; F:FAD binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:actin filament bundle assembly; P:actin filament depolymerization; P:blood coagulation; P:cytoskeleton organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of protein phosphorylation; P:regulation of regulated secretory pathway; P:signal transduction; P:sulfur oxidation;|Q9UFF7,[F-actin]-monooxygenase MICAL1 {ECO:0000305},Molecule interacting with CasL protein 1;NEDD9-interacting protein with calponin homology and LIM domains;, PF00307;PF12130;PF01494;PF00412;, GO:0015629;GO:0005737;GO:0005829;GO:1990026;GO:0045171;GO:0005882;GO:0030496;GO:0005886;GO:0003779;GO:0051015;GO:0071949;GO:0046872;GO:0016174;GO:0016709;GO:0019901;GO:0017124;GO:0031267;GO:0051017;GO:0030042;GO:0007596;GO:0007010;GO:0043154;GO:0001933;GO:1903305;GO:0007165;GO:0019417;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:hippocampal mossy fiber expansion; C:intercellular bridge; C:intermediate filament; C:midbody; C:plasma membrane;, F:actin binding; F:actin filament binding; F:FAD binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:actin filament bundle assembly; P:actin filament depolymerization; P:blood coagulation; P:cytoskeleton organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of protein phosphorylation; P:regulation of regulated secretory pathway; P:signal transduction; P:sulfur oxidation; scaffold29 indexed_genome mRNA 5968634 6008252 . - . ID=transcript_6416;O60906 Q5TED1 Q9BWR3,Sphingomyelin phosphodiesterase 2 {ECO:0000305},Lyso-platelet-activating factor-phospholipase C;Neutral sphingomyelinase;, PF03372;, GO:0005901;GO:0071944;GO:0005783;GO:0005887;GO:0016020;GO:0005886;GO:0046872;GO:0004620;GO:0004767;GO:0046513;GO:0006687;GO:0035556;GO:2000304;GO:0009612;GO:0030149;GO:0006685;GO:0006684;, C:caveola; C:cell periphery; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:metal ion binding; F:phospholipase activity; F:sphingomyelin phosphodiesterase activity;, P:ceramide biosynthetic process; P:glycosphingolipid metabolic process; P:intracellular signal transduction; P:positive regulation of ceramide biosynthetic process; P:response to mechanical stimulus; P:sphingolipid catabolic process; P:sphingomyelin catabolic process; P:sphingomyelin metabolic process;|O60906 Q5TED1 Q9BWR3,Sphingomyelin phosphodiesterase 2 {ECO:0000305},Lyso-platelet-activating factor-phospholipase C;Neutral sphingomyelinase;, PF03372;, GO:0005901;GO:0071944;GO:0005783;GO:0005887;GO:0016020;GO:0005886;GO:0046872;GO:0004620;GO:0004767;GO:0046513;GO:0006687;GO:0035556;GO:2000304;GO:0009612;GO:0030149;GO:0006685;GO:0006684;, C:caveola; C:cell periphery; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:metal ion binding; F:phospholipase activity; F:sphingomyelin phosphodiesterase activity;, P:ceramide biosynthetic process; P:glycosphingolipid metabolic process; P:intracellular signal transduction; P:positive regulation of ceramide biosynthetic process; P:response to mechanical stimulus; P:sphingolipid catabolic process; P:sphingomyelin catabolic process; P:sphingomyelin metabolic process;|O60906 Q5TED1 Q9BWR3,Sphingomyelin phosphodiesterase 2 {ECO:0000305},Lyso-platelet-activating factor-phospholipase C;Neutral sphingomyelinase;, PF03372;, GO:0005901;GO:0071944;GO:0005783;GO:0005887;GO:0016020;GO:0005886;GO:0046872;GO:0004620;GO:0004767;GO:0046513;GO:0006687;GO:0035556;GO:2000304;GO:0009612;GO:0030149;GO:0006685;GO:0006684;, C:caveola; C:cell periphery; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:metal ion binding; F:phospholipase activity; F:sphingomyelin phosphodiesterase activity;, P:ceramide biosynthetic process; P:glycosphingolipid metabolic process; P:intracellular signal transduction; P:positive regulation of ceramide biosynthetic process; P:response to mechanical stimulus; P:sphingolipid catabolic process; P:sphingomyelin catabolic process; P:sphingomyelin metabolic process;|O60906 Q5TED1 Q9BWR3,Sphingomyelin phosphodiesterase 2 {ECO:0000305},Lyso-platelet-activating factor-phospholipase C;Neutral sphingomyelinase;, PF03372;, GO:0005901;GO:0071944;GO:0005783;GO:0005887;GO:0016020;GO:0005886;GO:0046872;GO:0004620;GO:0004767;GO:0046513;GO:0006687;GO:0035556;GO:2000304;GO:0009612;GO:0030149;GO:0006685;GO:0006684;, C:caveola; C:cell periphery; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:metal ion binding; F:phospholipase activity; F:sphingomyelin phosphodiesterase activity;, P:ceramide biosynthetic process; P:glycosphingolipid metabolic process; P:intracellular signal transduction; P:positive regulation of ceramide biosynthetic process; P:response to mechanical stimulus; P:sphingolipid catabolic process; P:sphingomyelin catabolic process; P:sphingomyelin metabolic process;|Q8IXY8 A9NIU0 A9NIU9 E7EX15,Probable inactive peptidyl-prolyl cis-trans isomerase-like 6 {ECO:0000305|PubMed:20676357},Cyclophilin-like protein PPIL6 {ECO:0000312|EMBL:ABC88651.1};Rotamase PPIL6;, PF00160;, GO:0005737;GO:0006457;GO:0000413;, C:cytoplasm;, , P:protein folding; P:protein peptidyl-prolyl isomerization; scaffold29 indexed_genome mRNA 6016673 6029693 . + . ID=transcript_6417;Q04900 B4DQ85 E1P5E7 E1P5E8 E1P5E9 O95413 Q5JSU6 Q9BPV0 Q9NR26,Sialomucin core protein 24,Endolyn;Multi-glycosylated core protein 24;, PF05283;, GO:0031410;GO:0005768;GO:0010008;GO:0005576;GO:0005887;GO:0005765;GO:0005764;GO:0005886;GO:0007155;GO:0030097;GO:0007157;GO:0006955;GO:0007275;GO:0007517;GO:0007162;GO:0008285;GO:0007165;, C:cytoplasmic vesicle; C:endosome; C:endosome membrane; C:extracellular region; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane;, , P:cell adhesion; P:hemopoiesis; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:immune response; P:multicellular organism development; P:muscle organ development; P:negative regulation of cell adhesion; P:negative regulation of cell population proliferation; P:signal transduction; scaffold29 indexed_genome mRNA 6223025 6249647 . - . ID=transcript_6418;Q8IYX8 G5E992,Centrosomal protein CEP57L1,Centrosomal protein 57kDa-like protein 1;Centrosomal protein of 57 kDa-related protein;Cep57-related protein;, PF14073;PF06657;, GO:0005813;GO:0005737;GO:0005874;GO:0043015;GO:0042802;GO:0008017;, C:centrosome; C:cytoplasm; C:microtubule;, F:gamma-tubulin binding; F:identical protein binding; F:microtubule binding; scaffold29 indexed_genome mRNA 6314005 6426807 . - . ID=transcript_6419;Q9Y6P5 Q2M2B7 Q5T316 Q9NV00 Q9UPD5 Q9Y6P6,Sestrin-1 {ECO:0000305},p53-regulated protein PA26 {ECO:0000303|PubMed:9926927};, PF04636;, GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0070728;GO:0016684;GO:0051920;GO:0098869;GO:0034198;GO:0042149;GO:0071233;GO:1990253;GO:1904262;GO:0016239;GO:0072593;GO:1901031;, C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:negative regulation of TORC1 signaling; P:positive regulation of macroautophagy; P:reactive oxygen species metabolic process; P:regulation of response to reactive oxygen species;|Q9Y6P5 Q2M2B7 Q5T316 Q9NV00 Q9UPD5 Q9Y6P6,Sestrin-1 {ECO:0000305},p53-regulated protein PA26 {ECO:0000303|PubMed:9926927};, PF04636;, GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0070728;GO:0016684;GO:0051920;GO:0098869;GO:0034198;GO:0042149;GO:0071233;GO:1990253;GO:1904262;GO:0016239;GO:0072593;GO:1901031;, C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:negative regulation of TORC1 signaling; P:positive regulation of macroautophagy; P:reactive oxygen species metabolic process; P:regulation of response to reactive oxygen species;|Q9Y6P5 Q2M2B7 Q5T316 Q9NV00 Q9UPD5 Q9Y6P6,Sestrin-1 {ECO:0000305},p53-regulated protein PA26 {ECO:0000303|PubMed:9926927};, PF04636;, GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0070728;GO:0016684;GO:0051920;GO:0098869;GO:0034198;GO:0042149;GO:0071233;GO:1990253;GO:1904262;GO:0016239;GO:0072593;GO:1901031;, C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:negative regulation of TORC1 signaling; P:positive regulation of macroautophagy; P:reactive oxygen species metabolic process; P:regulation of response to reactive oxygen species;|Q9Y6P5 Q2M2B7 Q5T316 Q9NV00 Q9UPD5 Q9Y6P6,Sestrin-1 {ECO:0000305},p53-regulated protein PA26 {ECO:0000303|PubMed:9926927};, PF04636;, GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0070728;GO:0016684;GO:0051920;GO:0098869;GO:0034198;GO:0042149;GO:0071233;GO:1990253;GO:1904262;GO:0016239;GO:0072593;GO:1901031;, C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:negative regulation of TORC1 signaling; P:positive regulation of macroautophagy; P:reactive oxygen species metabolic process; P:regulation of response to reactive oxygen species;|Q9Y6P5 Q2M2B7 Q5T316 Q9NV00 Q9UPD5 Q9Y6P6,Sestrin-1 {ECO:0000305},p53-regulated protein PA26 {ECO:0000303|PubMed:9926927};, PF04636;, GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0070728;GO:0016684;GO:0051920;GO:0098869;GO:0034198;GO:0042149;GO:0071233;GO:1990253;GO:1904262;GO:0016239;GO:0072593;GO:1901031;, C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:negative regulation of TORC1 signaling; P:positive regulation of macroautophagy; P:reactive oxygen species metabolic process; P:regulation of response to reactive oxygen species;|Q9Y6P5 Q2M2B7 Q5T316 Q9NV00 Q9UPD5 Q9Y6P6,Sestrin-1 {ECO:0000305},p53-regulated protein PA26 {ECO:0000303|PubMed:9926927};, PF04636;, GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0070728;GO:0016684;GO:0051920;GO:0098869;GO:0034198;GO:0042149;GO:0071233;GO:1990253;GO:1904262;GO:0016239;GO:0072593;GO:1901031;, C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:peroxiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:negative regulation of TORC1 signaling; P:positive regulation of macroautophagy; P:reactive oxygen species metabolic process; P:regulation of response to reactive oxygen species; scaffold29 indexed_genome mRNA 6439330 6562531 . - . ID=transcript_6420;Q8NEN0 A8K8Y4 B4DGF5 G5E993 Q5VVY8 Q9H0K9,Armadillo repeat-containing protein 2 {ECO:0000305},, , GO:0044782;GO:0007288;, , , P:cilium organization; P:sperm axoneme assembly;|Q8NEN0 A8K8Y4 B4DGF5 G5E993 Q5VVY8 Q9H0K9,Armadillo repeat-containing protein 2 {ECO:0000305},, , GO:0044782;GO:0007288;, , , P:cilium organization; P:sperm axoneme assembly; scaffold29 indexed_genome mRNA 6734394 6754476 . - . ID=transcript_6421;O43524 B4DVZ6 E1P5E6 O15171 Q5T2I7 Q9BZ04,Forkhead box protein O3 {ECO:0000305},AF6q21 protein {ECO:0000303|PubMed:9345057};Forkhead in rhabdomyosarcoma-like 1 {ECO:0000303|PubMed:9479491};, PF00250;PF16676;PF16675;, GO:0000785;GO:0005737;GO:0005829;GO:0005759;GO:0005741;GO:0005654;GO:0005634;GO:0032991;GO:0008013;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0034246;GO:0019901;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0006915;GO:0042149;GO:0034599;GO:0019221;GO:0006390;GO:0030336;GO:0000122;GO:0043065;GO:0010508;GO:0045648;GO:0014737;GO:0043525;GO:1902895;GO:0045944;GO:0045893;GO:0006357;GO:0006417;GO:0070542;GO:0042594;GO:0033209;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrial outer membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:beta-catenin binding; F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:mitochondrial transcription factor activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cellular response to glucose starvation; P:cellular response to oxidative stress; P:cytokine-mediated signaling pathway; P:mitochondrial transcription; P:negative regulation of cell migration; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of erythrocyte differentiation; P:positive regulation of muscle atrophy; P:positive regulation of neuron apoptotic process; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:response to fatty acid; P:response to starvation; P:tumor necrosis factor-mediated signaling pathway; scaffold29 indexed_genome mRNA 6892541 7081829 . - . ID=transcript_6422;Q8WV93 Q8N6A3,AFG1-like ATPase {ECO:0000312|HGNC:HGNC:16411},Lactation elevated protein 1 {ECO:0000303|PubMed:12079282};Protein AFG1 homolog;, PF03969;, GO:0005737;GO:0031966;GO:0005739;GO:0005524;GO:0016887;GO:0006123;GO:0035694;GO:0007005;, C:cytoplasm; C:mitochondrial membrane; C:mitochondrion;, F:ATP binding; F:ATPase activity;, P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial protein catabolic process; P:mitochondrion organization;|Q8WV93 Q8N6A3,AFG1-like ATPase {ECO:0000312|HGNC:HGNC:16411},Lactation elevated protein 1 {ECO:0000303|PubMed:12079282};Protein AFG1 homolog;, PF03969;, GO:0005737;GO:0031966;GO:0005739;GO:0005524;GO:0016887;GO:0006123;GO:0035694;GO:0007005;, C:cytoplasm; C:mitochondrial membrane; C:mitochondrion;, F:ATP binding; F:ATPase activity;, P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial protein catabolic process; P:mitochondrion organization;|Q8WV93 Q8N6A3,AFG1-like ATPase {ECO:0000312|HGNC:HGNC:16411},Lactation elevated protein 1 {ECO:0000303|PubMed:12079282};Protein AFG1 homolog;, PF03969;, GO:0005737;GO:0031966;GO:0005739;GO:0005524;GO:0016887;GO:0006123;GO:0035694;GO:0007005;, C:cytoplasm; C:mitochondrial membrane; C:mitochondrion;, F:ATP binding; F:ATPase activity;, P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial protein catabolic process; P:mitochondrion organization; scaffold29 indexed_genome mRNA 7099701 7148460 . + . ID=transcript_6423;Q96AP9 Q9C0J5 Q9NU45,Sorting nexin-3,Protein SDP3;, PF00787;, GO:0030136;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0032009;GO:0010008;GO:0070062;GO:0080025;GO:0032266;GO:0070273;GO:0010314;GO:0019903;GO:1905394;GO:0032456;GO:0070676;GO:0034499;GO:0010324;GO:2000642;GO:0050765;GO:0042177;GO:0051224;GO:0046597;GO:0010976;GO:0016579;GO:0022615;GO:0015031;GO:0030111;GO:0009617;GO:0016055;, C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:early phagosome; C:endosome membrane; C:extracellular exosome;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein phosphatase binding; F:retromer complex binding;, P:endocytic recycling; P:intralumenal vesicle formation; P:late endosome to Golgi transport; P:membrane invagination; P:negative regulation of early endosome to late endosome transport; P:negative regulation of phagocytosis; P:negative regulation of protein catabolic process; P:negative regulation of protein transport; P:negative regulation of viral entry into host cell; P:positive regulation of neuron projection development; P:protein deubiquitination; P:protein to membrane docking; P:protein transport; P:regulation of Wnt signaling pathway; P:response to bacterium; P:Wnt signaling pathway;|Q96AP9 Q9C0J5 Q9NU45,Sorting nexin-3,Protein SDP3;, PF00787;, GO:0030136;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0032009;GO:0010008;GO:0070062;GO:0080025;GO:0032266;GO:0070273;GO:0010314;GO:0019903;GO:1905394;GO:0032456;GO:0070676;GO:0034499;GO:0010324;GO:2000642;GO:0050765;GO:0042177;GO:0051224;GO:0046597;GO:0010976;GO:0016579;GO:0022615;GO:0015031;GO:0030111;GO:0009617;GO:0016055;, C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:early phagosome; C:endosome membrane; C:extracellular exosome;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein phosphatase binding; F:retromer complex binding;, P:endocytic recycling; P:intralumenal vesicle formation; P:late endosome to Golgi transport; P:membrane invagination; P:negative regulation of early endosome to late endosome transport; P:negative regulation of phagocytosis; P:negative regulation of protein catabolic process; P:negative regulation of protein transport; P:negative regulation of viral entry into host cell; P:positive regulation of neuron projection development; P:protein deubiquitination; P:protein to membrane docking; P:protein transport; P:regulation of Wnt signaling pathway; P:response to bacterium; P:Wnt signaling pathway; scaffold29 indexed_genome mRNA 7165601 7182110 . - . ID=transcript_6424;Q9Y466 Q6ZMP8,Nuclear receptor subfamily 2 group E member 1,Nuclear receptor TLX;Protein tailless homolog;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0001228;GO:0000981;GO:0001227;GO:0042826;GO:0004879;GO:0000978;GO:1990837;GO:0003707;GO:0008270;GO:0002118;GO:0021764;GO:0048856;GO:0021960;GO:0001662;GO:0030154;GO:0045165;GO:0021895;GO:0021542;GO:0030198;GO:0021872;GO:0021819;GO:0060291;GO:0043066;GO:0048712;GO:2000178;GO:0045665;GO:0000122;GO:0007399;GO:0021772;GO:0045766;GO:0045787;GO:2000179;GO:2000648;GO:0090049;GO:0048814;GO:0060164;GO:0006357;GO:0060041;GO:0035176;GO:0035019;GO:0006367;GO:0007601;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:aggressive behavior; P:amygdala development; P:anatomical structure development; P:anterior commissure morphogenesis; P:behavioral fear response; P:cell differentiation; P:cell fate commitment; P:cerebral cortex neuron differentiation; P:dentate gyrus development; P:extracellular matrix organization; P:forebrain generation of neurons; P:layer formation in cerebral cortex; P:long-term synaptic potentiation; P:negative regulation of apoptotic process; P:negative regulation of astrocyte differentiation; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neuron differentiation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:olfactory bulb development; P:positive regulation of angiogenesis; P:positive regulation of cell cycle; P:positive regulation of neural precursor cell proliferation; P:positive regulation of stem cell proliferation; P:regulation of cell migration involved in sprouting angiogenesis; P:regulation of dendrite morphogenesis; P:regulation of timing of neuron differentiation; P:regulation of transcription by RNA polymerase II; P:retina development in camera-type eye; P:social behavior; P:somatic stem cell population maintenance; P:transcription initiation from RNA polymerase II promoter; P:visual perception; scaffold29 indexed_genome mRNA 7289021 7329364 . + . ID=transcript_6425;Q86WC4 E1P5E3 Q5R391 Q6PCA7 Q7RTW6 Q8NC29 Q8TC82 Q9Y2S9,Osteopetrosis-associated transmembrane protein 1,Chloride channel 7 beta subunit;, PF09777;, GO:0005829;GO:0016021;GO:0005765;GO:0034220;GO:0030316;, C:cytosol; C:integral component of membrane; C:lysosomal membrane;, , P:ion transmembrane transport; P:osteoclast differentiation; scaffold29 indexed_genome mRNA 7411225 7466998 . + . ID=transcript_6426;Q9UGP8 O95380 Q5THN4 Q86VS9 Q8IWL0 Q9NTE0,Translocation protein SEC63 homolog,, PF00226;PF02889;, GO:0005783;GO:0016021;GO:0016020;GO:0031207;GO:0008320;GO:0003723;GO:0038023;GO:0001889;GO:0010259;GO:0006807;GO:0006620;GO:0031204;GO:0006612;GO:0006614;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:Sec62/Sec63 complex;, F:protein transmembrane transporter activity; F:RNA binding; F:signaling receptor activity;, P:liver development; P:multicellular organism aging; P:nitrogen compound metabolic process; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UGP8 O95380 Q5THN4 Q86VS9 Q8IWL0 Q9NTE0,Translocation protein SEC63 homolog,, PF00226;PF02889;, GO:0005783;GO:0016021;GO:0016020;GO:0031207;GO:0008320;GO:0003723;GO:0038023;GO:0001889;GO:0010259;GO:0006807;GO:0006620;GO:0031204;GO:0006612;GO:0006614;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:Sec62/Sec63 complex;, F:protein transmembrane transporter activity; F:RNA binding; F:signaling receptor activity;, P:liver development; P:multicellular organism aging; P:nitrogen compound metabolic process; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UGP8 O95380 Q5THN4 Q86VS9 Q8IWL0 Q9NTE0,Translocation protein SEC63 homolog,, PF00226;PF02889;, GO:0005783;GO:0016021;GO:0016020;GO:0031207;GO:0008320;GO:0003723;GO:0038023;GO:0001889;GO:0010259;GO:0006807;GO:0006620;GO:0031204;GO:0006612;GO:0006614;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:Sec62/Sec63 complex;, F:protein transmembrane transporter activity; F:RNA binding; F:signaling receptor activity;, P:liver development; P:multicellular organism aging; P:nitrogen compound metabolic process; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UGP8 O95380 Q5THN4 Q86VS9 Q8IWL0 Q9NTE0,Translocation protein SEC63 homolog,, PF00226;PF02889;, GO:0005783;GO:0016021;GO:0016020;GO:0031207;GO:0008320;GO:0003723;GO:0038023;GO:0001889;GO:0010259;GO:0006807;GO:0006620;GO:0031204;GO:0006612;GO:0006614;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:Sec62/Sec63 complex;, F:protein transmembrane transporter activity; F:RNA binding; F:signaling receptor activity;, P:liver development; P:multicellular organism aging; P:nitrogen compound metabolic process; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UGP8 O95380 Q5THN4 Q86VS9 Q8IWL0 Q9NTE0,Translocation protein SEC63 homolog,, PF00226;PF02889;, GO:0005783;GO:0016021;GO:0016020;GO:0031207;GO:0008320;GO:0003723;GO:0038023;GO:0001889;GO:0010259;GO:0006807;GO:0006620;GO:0031204;GO:0006612;GO:0006614;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:Sec62/Sec63 complex;, F:protein transmembrane transporter activity; F:RNA binding; F:signaling receptor activity;, P:liver development; P:multicellular organism aging; P:nitrogen compound metabolic process; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UGP8 O95380 Q5THN4 Q86VS9 Q8IWL0 Q9NTE0,Translocation protein SEC63 homolog,, PF00226;PF02889;, GO:0005783;GO:0016021;GO:0016020;GO:0031207;GO:0008320;GO:0003723;GO:0038023;GO:0001889;GO:0010259;GO:0006807;GO:0006620;GO:0031204;GO:0006612;GO:0006614;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:Sec62/Sec63 complex;, F:protein transmembrane transporter activity; F:RNA binding; F:signaling receptor activity;, P:liver development; P:multicellular organism aging; P:nitrogen compound metabolic process; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane; scaffold29 indexed_genome mRNA 7650503 7806159 . - . ID=transcript_6427;A7XYQ1 B0QZ12 Q5BJD4 Q8N2B2,Sine oculis-binding protein homolog,Jackson circler protein 1;, PF15279;, GO:0005634;GO:0046872;GO:0032184;GO:0090102;GO:0050890;GO:0042472;GO:0007626;GO:0007605;, C:nucleus;, F:metal ion binding; F:SUMO polymer binding;, P:cochlea development; P:cognition; P:inner ear morphogenesis; P:locomotory behavior; P:sensory perception of sound;|A7XYQ1 B0QZ12 Q5BJD4 Q8N2B2,Sine oculis-binding protein homolog,Jackson circler protein 1;, PF15279;, GO:0005634;GO:0046872;GO:0032184;GO:0090102;GO:0050890;GO:0042472;GO:0007626;GO:0007605;, C:nucleus;, F:metal ion binding; F:SUMO polymer binding;, P:cochlea development; P:cognition; P:inner ear morphogenesis; P:locomotory behavior; P:sensory perception of sound;|A7XYQ1 B0QZ12 Q5BJD4 Q8N2B2,Sine oculis-binding protein homolog,Jackson circler protein 1;, PF15279;, GO:0005634;GO:0046872;GO:0032184;GO:0090102;GO:0050890;GO:0042472;GO:0007626;GO:0007605;, C:nucleus;, F:metal ion binding; F:SUMO polymer binding;, P:cochlea development; P:cognition; P:inner ear morphogenesis; P:locomotory behavior; P:sensory perception of sound; scaffold29 indexed_genome mRNA 7856684 8111435 . + . ID=transcript_6428;Q86YH6 Q33DR4 Q4G158 Q5VU38 Q5VU39 Q9NR58,All trans-polyprenyl-diphosphate synthase PDSS2 {ECO:0000305},All-trans-decaprenyl-diphosphate synthase subunit 2;Candidate tumor suppressor protein;Decaprenyl pyrophosphate synthase subunit 2;Decaprenyl-diphosphate synthase subunit 2 {ECO:0000312|HGNC:HGNC:23041};Solanesyl-diphosphate synthase subunit 2 {ECO:0000250|UniProtKB:Q33DR3};, PF00348;, GO:0005829;GO:0005759;GO:1990234;GO:0097269;GO:0004659;GO:0046982;GO:0000010;GO:0050347;GO:0021549;GO:0008299;GO:0050878;GO:0006744;, C:cytosol; C:mitochondrial matrix; C:transferase complex;, F:all-trans-decaprenyl-diphosphate synthase activity; F:prenyltransferase activity; F:protein heterodimerization activity; F:trans-hexaprenyltranstransferase activity; F:trans-octaprenyltranstransferase activity;, P:cerebellum development; P:isoprenoid biosynthetic process; P:regulation of body fluid levels; P:ubiquinone biosynthetic process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold29 indexed_genome mRNA 8171388 8172574 . + . ID=transcript_6429;Q5T5X7 A2RRH2 Q9HCL9,BEN domain-containing protein 3,, PF10523;, GO:0000792;GO:0005730;GO:0005654;GO:0000182;GO:0006306;GO:0098532;GO:0080182;GO:0036124;GO:0043967;GO:0034773;GO:0000122;GO:1903580;GO:0051260;GO:0000183;, C:heterochromatin; C:nucleolus; C:nucleoplasm;, F:rDNA binding;, P:DNA methylation; P:histone H3-K27 trimethylation; P:histone H3-K4 trimethylation; P:histone H3-K9 trimethylation; P:histone H4 acetylation; P:histone H4-K20 trimethylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of ATP metabolic process; P:protein homooligomerization; P:rDNA heterochromatin assembly; scaffold29 indexed_genome mRNA 8173688 8174310 . + . ID=transcript_6430;Q5T5X7 A2RRH2 Q9HCL9,BEN domain-containing protein 3,, PF10523;, GO:0000792;GO:0005730;GO:0005654;GO:0000182;GO:0006306;GO:0098532;GO:0080182;GO:0036124;GO:0043967;GO:0034773;GO:0000122;GO:1903580;GO:0051260;GO:0000183;, C:heterochromatin; C:nucleolus; C:nucleoplasm;, F:rDNA binding;, P:DNA methylation; P:histone H3-K27 trimethylation; P:histone H3-K4 trimethylation; P:histone H3-K9 trimethylation; P:histone H4 acetylation; P:histone H4-K20 trimethylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of ATP metabolic process; P:protein homooligomerization; P:rDNA heterochromatin assembly; scaffold29 indexed_genome mRNA 8187292 8197288 . - . ID=transcript_6431;Q9P0P8 B3KRG9,Mitochondrial transcription rescue factor 1 {ECO:0000303|PubMed:31226201},, , GO:0005759;GO:0005739;GO:0003723;GO:1903108;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding;, P:regulation of mitochondrial transcription;|Q9P0P8 B3KRG9,Mitochondrial transcription rescue factor 1 {ECO:0000303|PubMed:31226201},, , GO:0005759;GO:0005739;GO:0003723;GO:1903108;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding;, P:regulation of mitochondrial transcription;|Q9P0P8 B3KRG9,Mitochondrial transcription rescue factor 1 {ECO:0000303|PubMed:31226201},, , GO:0005759;GO:0005739;GO:0003723;GO:1903108;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding;, P:regulation of mitochondrial transcription; scaffold29 indexed_genome mRNA 8244554 8247547 . + . ID=transcript_6432;P25063 A0A087WYI6 B6EC88 Q16257 Q53XS0 R4I4T5,Signal transducer CD24,Small cell lung carcinoma cluster 4 antigen;, PF14984;, GO:0031362;GO:0009986;GO:0016020;GO:0045121;GO:0019901;GO:0030296;GO:0032597;GO:0001775;GO:0016477;GO:0098609;GO:0032600;GO:0042632;GO:0072139;GO:0072112;GO:0002768;GO:0097193;GO:0032913;GO:0042104;GO:0007204;GO:0043406;GO:2000768;GO:0001959;GO:0030856;GO:0043408;GO:0042325;GO:0045730;GO:0043627;GO:0001666;GO:0002237;GO:0031295;GO:0016055;, C:anchored component of external side of plasma membrane; C:cell surface; C:membrane; C:membrane raft;, F:protein kinase binding; F:protein tyrosine kinase activator activity;, P:B cell receptor transport into membrane raft; P:cell activation; P:cell migration; P:cell-cell adhesion; P:chemokine receptor transport out of membrane raft; P:cholesterol homeostasis; P:glomerular parietal epithelial cell differentiation; P:glomerular visceral epithelial cell differentiation; P:immune response-regulating cell surface receptor signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of transforming growth factor beta3 production; P:positive regulation of activated T cell proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of MAP kinase activity; P:positive regulation of nephron tubule epithelial cell differentiation; P:regulation of cytokine-mediated signaling pathway; P:regulation of epithelial cell differentiation; P:regulation of MAPK cascade; P:regulation of phosphorylation; P:respiratory burst; P:response to estrogen; P:response to hypoxia; P:response to molecule of bacterial origin; P:T cell costimulation; P:Wnt signaling pathway;|P25063 A0A087WYI6 B6EC88 Q16257 Q53XS0 R4I4T5,Signal transducer CD24,Small cell lung carcinoma cluster 4 antigen;, PF14984;, GO:0031362;GO:0009986;GO:0016020;GO:0045121;GO:0019901;GO:0030296;GO:0032597;GO:0001775;GO:0016477;GO:0098609;GO:0032600;GO:0042632;GO:0072139;GO:0072112;GO:0002768;GO:0097193;GO:0032913;GO:0042104;GO:0007204;GO:0043406;GO:2000768;GO:0001959;GO:0030856;GO:0043408;GO:0042325;GO:0045730;GO:0043627;GO:0001666;GO:0002237;GO:0031295;GO:0016055;, C:anchored component of external side of plasma membrane; C:cell surface; C:membrane; C:membrane raft;, F:protein kinase binding; F:protein tyrosine kinase activator activity;, P:B cell receptor transport into membrane raft; P:cell activation; P:cell migration; P:cell-cell adhesion; P:chemokine receptor transport out of membrane raft; P:cholesterol homeostasis; P:glomerular parietal epithelial cell differentiation; P:glomerular visceral epithelial cell differentiation; P:immune response-regulating cell surface receptor signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of transforming growth factor beta3 production; P:positive regulation of activated T cell proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of MAP kinase activity; P:positive regulation of nephron tubule epithelial cell differentiation; P:regulation of cytokine-mediated signaling pathway; P:regulation of epithelial cell differentiation; P:regulation of MAPK cascade; P:regulation of phosphorylation; P:respiratory burst; P:response to estrogen; P:response to hypoxia; P:response to molecule of bacterial origin; P:T cell costimulation; P:Wnt signaling pathway; scaffold29 indexed_genome mRNA 8494177 8523395 . - . ID=transcript_6433;Q9H0R6 Q5VWJ4 Q9HA60 Q9NV19,Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03150},Glutaminyl-tRNA synthase-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03150};, PF01425;, GO:0030956;GO:0005739;GO:0005524;GO:0050567;GO:0016787;GO:0070681;GO:0032543;GO:0031647;, C:glutamyl-tRNA(Gln) amidotransferase complex; C:mitochondrion;, F:ATP binding; F:glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity; F:hydrolase activity;, P:glutaminyl-tRNAGln biosynthesis via transamidation; P:mitochondrial translation; P:regulation of protein stability; scaffold29 indexed_genome mRNA 8531059 8582265 . + . ID=transcript_6434;Q8WWV3 Q8N9B3 Q8WZ66 Q9BRA4,Reticulon-4-interacting protein 1, mitochondrial,NOGO-interacting mitochondrial protein;, PF08240;, GO:0005741;GO:0005739;GO:0016491;GO:0008270;GO:0007399;GO:0050773;, C:mitochondrial outer membrane; C:mitochondrion;, F:oxidoreductase activity; F:zinc ion binding;, P:nervous system development; P:regulation of dendrite development; scaffold29 indexed_genome mRNA 8583207 8590281 . - . ID=transcript_6435;Q9Y4K1 B4DU04 O00296 Q5VWJ2,Beta/gamma crystallin domain-containing protein 1 {ECO:0000312|HGNC:HGNC:356},Absent in melanoma 1 protein {ECO:0000303|PubMed:9096375};, PF00030;PF00652;, GO:0030246;, , F:carbohydrate binding;|Q9Y4K1 B4DU04 O00296 Q5VWJ2,Beta/gamma crystallin domain-containing protein 1 {ECO:0000312|HGNC:HGNC:356},Absent in melanoma 1 protein {ECO:0000303|PubMed:9096375};, PF00030;PF00652;, GO:0030246;, , F:carbohydrate binding;|Q9Y4K1 B4DU04 O00296 Q5VWJ2,Beta/gamma crystallin domain-containing protein 1 {ECO:0000312|HGNC:HGNC:356},Absent in melanoma 1 protein {ECO:0000303|PubMed:9096375};, PF00030;PF00652;, GO:0030246;, , F:carbohydrate binding; scaffold29 indexed_genome mRNA 8591179 8636909 . + . ID=transcript_6436;Q9Y4K1 B4DU04 O00296 Q5VWJ2,Beta/gamma crystallin domain-containing protein 1 {ECO:0000312|HGNC:HGNC:356},Absent in melanoma 1 protein {ECO:0000303|PubMed:9096375};, PF00030;PF00652;, GO:0030246;, , F:carbohydrate binding;|Q9Y4K1 B4DU04 O00296 Q5VWJ2,Beta/gamma crystallin domain-containing protein 1 {ECO:0000312|HGNC:HGNC:356},Absent in melanoma 1 protein {ECO:0000303|PubMed:9096375};, PF00030;PF00652;, GO:0030246;, , F:carbohydrate binding;|Q9Y4K1 B4DU04 O00296 Q5VWJ2,Beta/gamma crystallin domain-containing protein 1 {ECO:0000312|HGNC:HGNC:356},Absent in melanoma 1 protein {ECO:0000303|PubMed:9096375};, PF00030;PF00652;, GO:0030246;, , F:carbohydrate binding;|Q9Y4K1 B4DU04 O00296 Q5VWJ2,Beta/gamma crystallin domain-containing protein 1 {ECO:0000312|HGNC:HGNC:356},Absent in melanoma 1 protein {ECO:0000303|PubMed:9096375};, PF00030;PF00652;, GO:0030246;, , F:carbohydrate binding;|Q9Y4K1 B4DU04 O00296 Q5VWJ2,Beta/gamma crystallin domain-containing protein 1 {ECO:0000312|HGNC:HGNC:356},Absent in melanoma 1 protein {ECO:0000303|PubMed:9096375};, PF00030;PF00652;, GO:0030246;, , F:carbohydrate binding; scaffold29 indexed_genome mRNA 8836378 8951387 . + . ID=transcript_6437;Q9H1Y0 O60875 Q5JVR2 Q68DI4 Q9H2B8 Q9HCZ7,Autophagy protein 5,APG5-like;Apoptosis-specific protein;, PF04106;, GO:0034274;GO:0005776;GO:0005930;GO:0005737;GO:0005829;GO:0016020;GO:0044233;GO:0030670;GO:0034045;GO:0035973;GO:0019883;GO:0006915;GO:0000045;GO:0006914;GO:0000422;GO:0044804;GO:0001974;GO:0006501;GO:0006995;GO:0071500;GO:0060047;GO:0016236;GO:0043066;GO:0060548;GO:2000619;GO:0050765;GO:0031397;GO:2000378;GO:0039689;GO:0045060;GO:0048840;GO:0075044;GO:0070257;GO:0043687;GO:0061739;GO:1902017;GO:0002718;GO:0051279;GO:0042493;GO:0009620;GO:0042311;GO:0055015;, C:Atg12-Atg5-Atg16 complex; C:autophagosome; C:axoneme; C:cytoplasm; C:cytosol; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:phagocytic vesicle membrane; C:phagophore assembly site membrane;, , P:aggrephagy; P:antigen processing and presentation of endogenous antigen; P:apoptotic process; P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of nucleus; P:blood vessel remodeling; P:C-terminal protein lipidation; P:cellular response to nitrogen starvation; P:cellular response to nitrosative stress; P:heart contraction; P:macroautophagy; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of phagocytosis; P:negative regulation of protein ubiquitination; P:negative regulation of reactive oxygen species metabolic process; P:negative stranded viral RNA replication; P:negative thymic T cell selection; P:otolith development; P:positive regulation by symbiont of host autophagy; P:positive regulation of mucus secretion; P:post-translational protein modification; P:protein lipidation involved in autophagosome assembly; P:regulation of cilium assembly; P:regulation of cytokine production involved in immune response; P:regulation of release of sequestered calcium ion into cytosol; P:response to drug; P:response to fungus; P:vasodilation; P:ventricular cardiac muscle cell development; scaffold29 indexed_genome mRNA 9023698 9043456 . + . ID=transcript_6438;O75626 B2REA6 E1P5E0 Q86WM7,PR domain zinc finger protein 1,BLIMP-1;Beta-interferon gene positive regulatory domain I-binding factor;PR domain-containing protein 1;Positive regulatory domain I-binding factor 1;, PF00856;PF00096;, GO:0005737;GO:0005654;GO:0005634;GO:0003700;GO:0001227;GO:0042826;GO:0046872;GO:0008168;GO:1990841;GO:0000978;GO:1990837;GO:0002250;GO:0045165;GO:0045087;GO:0032259;GO:0000122;GO:0033082;GO:0010468;GO:0032823;GO:0051136;GO:1901796;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:metal ion binding; F:methyltransferase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adaptive immune response; P:cell fate commitment; P:innate immune response; P:methylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of extrathymic T cell differentiation; P:regulation of gene expression; P:regulation of natural killer cell differentiation; P:regulation of NK T cell differentiation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|O75626 B2REA6 E1P5E0 Q86WM7,PR domain zinc finger protein 1,BLIMP-1;Beta-interferon gene positive regulatory domain I-binding factor;PR domain-containing protein 1;Positive regulatory domain I-binding factor 1;, PF00856;PF00096;, GO:0005737;GO:0005654;GO:0005634;GO:0003700;GO:0001227;GO:0042826;GO:0046872;GO:0008168;GO:1990841;GO:0000978;GO:1990837;GO:0002250;GO:0045165;GO:0045087;GO:0032259;GO:0000122;GO:0033082;GO:0010468;GO:0032823;GO:0051136;GO:1901796;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:metal ion binding; F:methyltransferase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adaptive immune response; P:cell fate commitment; P:innate immune response; P:methylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of extrathymic T cell differentiation; P:regulation of gene expression; P:regulation of natural killer cell differentiation; P:regulation of NK T cell differentiation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|O75626 B2REA6 E1P5E0 Q86WM7,PR domain zinc finger protein 1,BLIMP-1;Beta-interferon gene positive regulatory domain I-binding factor;PR domain-containing protein 1;Positive regulatory domain I-binding factor 1;, PF00856;PF00096;, GO:0005737;GO:0005654;GO:0005634;GO:0003700;GO:0001227;GO:0042826;GO:0046872;GO:0008168;GO:1990841;GO:0000978;GO:1990837;GO:0002250;GO:0045165;GO:0045087;GO:0032259;GO:0000122;GO:0033082;GO:0010468;GO:0032823;GO:0051136;GO:1901796;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:metal ion binding; F:methyltransferase activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adaptive immune response; P:cell fate commitment; P:innate immune response; P:methylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of extrathymic T cell differentiation; P:regulation of gene expression; P:regulation of natural killer cell differentiation; P:regulation of NK T cell differentiation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; scaffold29 indexed_genome mRNA 9723825 9861507 . + . ID=transcript_6439;P48147 Q8N6D4,Prolyl endopeptidase,Post-proline cleaving enzyme;, PF00326;PF02897;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0004175;GO:0070012;GO:0004252;GO:0008236;GO:0006508;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:endopeptidase activity; F:oligopeptidase activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:proteolysis;|P48147 Q8N6D4,Prolyl endopeptidase,Post-proline cleaving enzyme;, PF00326;PF02897;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0004175;GO:0070012;GO:0004252;GO:0008236;GO:0006508;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:endopeptidase activity; F:oligopeptidase activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:proteolysis;|P48147 Q8N6D4,Prolyl endopeptidase,Post-proline cleaving enzyme;, PF00326;PF02897;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0004175;GO:0070012;GO:0004252;GO:0008236;GO:0006508;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:endopeptidase activity; F:oligopeptidase activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:proteolysis;|P48147 Q8N6D4,Prolyl endopeptidase,Post-proline cleaving enzyme;, PF00326;PF02897;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0004175;GO:0070012;GO:0004252;GO:0008236;GO:0006508;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:endopeptidase activity; F:oligopeptidase activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:proteolysis; scaffold29 indexed_genome mRNA 10005061 10009156 . + . ID=transcript_6440;Q9HBV1 B2RA98 Q5T3Y8 Q8TBW6,Popeye domain-containing protein 3,, PF04831;, GO:0016021;GO:0042383;GO:0030552;GO:0007507;GO:0042391;GO:0007519;GO:0051146;, C:integral component of membrane; C:sarcolemma;, F:cAMP binding;, P:heart development; P:regulation of membrane potential; P:skeletal muscle tissue development; P:striated muscle cell differentiation;|Q9HBV1 B2RA98 Q5T3Y8 Q8TBW6,Popeye domain-containing protein 3,, PF04831;, GO:0016021;GO:0042383;GO:0030552;GO:0007507;GO:0042391;GO:0007519;GO:0051146;, C:integral component of membrane; C:sarcolemma;, F:cAMP binding;, P:heart development; P:regulation of membrane potential; P:skeletal muscle tissue development; P:striated muscle cell differentiation;|Q9HBV1 B2RA98 Q5T3Y8 Q8TBW6,Popeye domain-containing protein 3,, PF04831;, GO:0016021;GO:0042383;GO:0030552;GO:0007507;GO:0042391;GO:0007519;GO:0051146;, C:integral component of membrane; C:sarcolemma;, F:cAMP binding;, P:heart development; P:regulation of membrane potential; P:skeletal muscle tissue development; P:striated muscle cell differentiation; scaffold29 indexed_genome mRNA 10027938 10070521 . + . ID=transcript_6441;Q8NE79 A8K1R4 E1P5D8 Q5T550 Q5T551 Q8IWC6 Q9HBV0 Q9UNG6,Blood vessel epicardial substance {ECO:0000312|HGNC:HGNC:1152},Popeye domain-containing protein 1;, PF04831;, GO:0005923;GO:0005901;GO:0030054;GO:0031253;GO:0016021;GO:0016328;GO:0005886;GO:0042383;GO:0030552;GO:0005198;GO:0060973;GO:0090136;GO:0007507;GO:0002244;GO:0007517;GO:0040017;GO:0001921;GO:0008360;GO:2001135;GO:0043087;GO:0002027;GO:0042391;GO:0002931;GO:0060931;GO:0007519;GO:0051146;GO:0034446;GO:0048278;GO:0016192;, C:bicellular tight junction; C:caveola; C:cell junction; C:cell projection membrane; C:integral component of membrane; C:lateral plasma membrane; C:plasma membrane; C:sarcolemma;, F:cAMP binding; F:structural molecule activity;, P:cell migration involved in heart development; P:epithelial cell-cell adhesion; P:heart development; P:hematopoietic progenitor cell differentiation; P:muscle organ development; P:positive regulation of locomotion; P:positive regulation of receptor recycling; P:regulation of cell shape; P:regulation of endocytic recycling; P:regulation of GTPase activity; P:regulation of heart rate; P:regulation of membrane potential; P:response to ischemia; P:sinoatrial node cell development; P:skeletal muscle tissue development; P:striated muscle cell differentiation; P:substrate adhesion-dependent cell spreading; P:vesicle docking; P:vesicle-mediated transport; scaffold29 indexed_genome mRNA 10282986 10412472 . + . ID=transcript_6442;Q8ND12 Q9P2M6,E3 ubiquitin-protein ligase HACE1,HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1;HECT-type E3 ubiquitin transferase HACE1;, PF12796;PF00632;, GO:0005737;GO:0005783;GO:0032580;GO:0000139;GO:0016604;GO:0005634;GO:0031267;GO:0061630;GO:0004842;GO:0007049;GO:0007030;GO:0061025;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0016601;GO:0030334;GO:0006511;, C:cytoplasm; C:endoplasmic reticulum; C:Golgi cisterna membrane; C:Golgi membrane; C:nuclear body; C:nucleus;, F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell cycle; P:Golgi organization; P:membrane fusion; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:Rac protein signal transduction; P:regulation of cell migration; P:ubiquitin-dependent protein catabolic process;|Q8ND12 Q9P2M6,E3 ubiquitin-protein ligase HACE1,HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1;HECT-type E3 ubiquitin transferase HACE1;, PF12796;PF00632;, GO:0005737;GO:0005783;GO:0032580;GO:0000139;GO:0016604;GO:0005634;GO:0031267;GO:0061630;GO:0004842;GO:0007049;GO:0007030;GO:0061025;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0016601;GO:0030334;GO:0006511;, C:cytoplasm; C:endoplasmic reticulum; C:Golgi cisterna membrane; C:Golgi membrane; C:nuclear body; C:nucleus;, F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell cycle; P:Golgi organization; P:membrane fusion; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:Rac protein signal transduction; P:regulation of cell migration; P:ubiquitin-dependent protein catabolic process;|Q8ND12 Q9P2M6,E3 ubiquitin-protein ligase HACE1,HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1;HECT-type E3 ubiquitin transferase HACE1;, PF12796;PF00632;, GO:0005737;GO:0005783;GO:0032580;GO:0000139;GO:0016604;GO:0005634;GO:0031267;GO:0061630;GO:0004842;GO:0007049;GO:0007030;GO:0061025;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0016601;GO:0030334;GO:0006511;, C:cytoplasm; C:endoplasmic reticulum; C:Golgi cisterna membrane; C:Golgi membrane; C:nuclear body; C:nucleus;, F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell cycle; P:Golgi organization; P:membrane fusion; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:Rac protein signal transduction; P:regulation of cell migration; P:ubiquitin-dependent protein catabolic process;|Q8ND12 Q9P2M6,E3 ubiquitin-protein ligase HACE1,HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1;HECT-type E3 ubiquitin transferase HACE1;, PF12796;PF00632;, GO:0005737;GO:0005783;GO:0032580;GO:0000139;GO:0016604;GO:0005634;GO:0031267;GO:0061630;GO:0004842;GO:0007049;GO:0007030;GO:0061025;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0016601;GO:0030334;GO:0006511;, C:cytoplasm; C:endoplasmic reticulum; C:Golgi cisterna membrane; C:Golgi membrane; C:nuclear body; C:nucleus;, F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell cycle; P:Golgi organization; P:membrane fusion; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:Rac protein signal transduction; P:regulation of cell migration; P:ubiquitin-dependent protein catabolic process;|Q8ND12 Q9P2M6,E3 ubiquitin-protein ligase HACE1,HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1;HECT-type E3 ubiquitin transferase HACE1;, PF12796;PF00632;, GO:0005737;GO:0005783;GO:0032580;GO:0000139;GO:0016604;GO:0005634;GO:0031267;GO:0061630;GO:0004842;GO:0007049;GO:0007030;GO:0061025;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0016601;GO:0030334;GO:0006511;, C:cytoplasm; C:endoplasmic reticulum; C:Golgi cisterna membrane; C:Golgi membrane; C:nuclear body; C:nucleus;, F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell cycle; P:Golgi organization; P:membrane fusion; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:Rac protein signal transduction; P:regulation of cell migration; P:ubiquitin-dependent protein catabolic process;|Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response;|Q8ND12 Q9P2M6,E3 ubiquitin-protein ligase HACE1,HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1;HECT-type E3 ubiquitin transferase HACE1;, PF12796;PF00632;, GO:0005737;GO:0005783;GO:0032580;GO:0000139;GO:0016604;GO:0005634;GO:0031267;GO:0061630;GO:0004842;GO:0007049;GO:0007030;GO:0061025;GO:0045732;GO:0043161;GO:0070936;GO:0000209;GO:0016567;GO:0016601;GO:0030334;GO:0006511;, C:cytoplasm; C:endoplasmic reticulum; C:Golgi cisterna membrane; C:Golgi membrane; C:nuclear body; C:nucleus;, F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell cycle; P:Golgi organization; P:membrane fusion; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:Rac protein signal transduction; P:regulation of cell migration; P:ubiquitin-dependent protein catabolic process; scaffold29 indexed_genome mRNA 12730221 12737833 . + . ID=transcript_6443;Q96KS6 Q96KS7 Q96KS8,Glutamate receptor ionotropic, kainate 2,Excitatory amino acid receptor 4;Glutamate receptor 6;, PF01094;PF00060;PF10613;, GO:0032839;GO:0098978;GO:0098686;GO:0005887;GO:0032983;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0042734;GO:0043195;GO:0005234;GO:0008066;GO:0042802;GO:0015277;GO:0015276;GO:0099507;GO:0030165;GO:0038023;GO:1904315;GO:0031624;GO:0031625;GO:0001662;GO:0006874;GO:0007268;GO:0120169;GO:0007215;GO:0060080;GO:0050804;GO:0043524;GO:0051967;GO:0051402;GO:0019228;GO:0043525;GO:0050806;GO:0043113;GO:0046328;GO:0048169;GO:0048172;GO:0035249;, C:dendrite cytoplasm; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:kainate selective glutamate receptor complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:presynaptic membrane; C:terminal bouton;, F:extracellularly glutamate-gated ion channel activity; F:glutamate receptor activity; F:identical protein binding; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:ligand-gated ion channel activity involved in regulation of presynaptic membrane potential; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding;, P:behavioral fear response; P:cellular calcium ion homeostasis; P:chemical synaptic transmission; P:detection of cold stimulus involved in thermoception; P:glutamate receptor signaling pathway; P:inhibitory postsynaptic potential; P:modulation of chemical synaptic transmission; P:negative regulation of neuron apoptotic process; P:negative regulation of synaptic transmission, glutamatergic; P:neuron apoptotic process; P:neuronal action potential; P:positive regulation of neuron apoptotic process; P:positive regulation of synaptic transmission; P:receptor clustering; P:regulation of JNK cascade; P:regulation of long-term neuronal synaptic plasticity; P:regulation of short-term neuronal synaptic plasticity; P:synaptic transmission, glutamatergic;|Q96KS6 Q96KS7 Q96KS8,Glutamate receptor ionotropic, kainate 2,Excitatory amino acid receptor 4;Glutamate receptor 6;, PF01094;PF00060;PF10613;, GO:0032839;GO:0098978;GO:0098686;GO:0005887;GO:0032983;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0042734;GO:0043195;GO:0005234;GO:0008066;GO:0042802;GO:0015277;GO:0015276;GO:0099507;GO:0030165;GO:0038023;GO:1904315;GO:0031624;GO:0031625;GO:0001662;GO:0006874;GO:0007268;GO:0120169;GO:0007215;GO:0060080;GO:0050804;GO:0043524;GO:0051967;GO:0051402;GO:0019228;GO:0043525;GO:0050806;GO:0043113;GO:0046328;GO:0048169;GO:0048172;GO:0035249;, C:dendrite cytoplasm; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:kainate selective glutamate receptor complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:presynaptic membrane; C:terminal bouton;, F:extracellularly glutamate-gated ion channel activity; F:glutamate receptor activity; F:identical protein binding; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:ligand-gated ion channel activity involved in regulation of presynaptic membrane potential; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding;, P:behavioral fear response; P:cellular calcium ion homeostasis; P:chemical synaptic transmission; P:detection of cold stimulus involved in thermoception; P:glutamate receptor signaling pathway; P:inhibitory postsynaptic potential; P:modulation of chemical synaptic transmission; P:negative regulation of neuron apoptotic process; P:negative regulation of synaptic transmission, glutamatergic; P:neuron apoptotic process; P:neuronal action potential; P:positive regulation of neuron apoptotic process; P:positive regulation of synaptic transmission; P:receptor clustering; P:regulation of JNK cascade; P:regulation of long-term neuronal synaptic plasticity; P:regulation of short-term neuronal synaptic plasticity; P:synaptic transmission, glutamatergic; scaffold29 indexed_genome mRNA 12771609 12774262 . + . ID=transcript_6444;Q96KS6 Q96KS7 Q96KS8,Glutamate receptor ionotropic, kainate 2,Excitatory amino acid receptor 4;Glutamate receptor 6;, PF01094;PF00060;PF10613;, GO:0032839;GO:0098978;GO:0098686;GO:0005887;GO:0032983;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0042734;GO:0043195;GO:0005234;GO:0008066;GO:0042802;GO:0015277;GO:0015276;GO:0099507;GO:0030165;GO:0038023;GO:1904315;GO:0031624;GO:0031625;GO:0001662;GO:0006874;GO:0007268;GO:0120169;GO:0007215;GO:0060080;GO:0050804;GO:0043524;GO:0051967;GO:0051402;GO:0019228;GO:0043525;GO:0050806;GO:0043113;GO:0046328;GO:0048169;GO:0048172;GO:0035249;, C:dendrite cytoplasm; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:kainate selective glutamate receptor complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:presynaptic membrane; C:terminal bouton;, F:extracellularly glutamate-gated ion channel activity; F:glutamate receptor activity; F:identical protein binding; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:ligand-gated ion channel activity involved in regulation of presynaptic membrane potential; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding;, P:behavioral fear response; P:cellular calcium ion homeostasis; P:chemical synaptic transmission; P:detection of cold stimulus involved in thermoception; P:glutamate receptor signaling pathway; P:inhibitory postsynaptic potential; P:modulation of chemical synaptic transmission; P:negative regulation of neuron apoptotic process; P:negative regulation of synaptic transmission, glutamatergic; P:neuron apoptotic process; P:neuronal action potential; P:positive regulation of neuron apoptotic process; P:positive regulation of synaptic transmission; P:receptor clustering; P:regulation of JNK cascade; P:regulation of long-term neuronal synaptic plasticity; P:regulation of short-term neuronal synaptic plasticity; P:synaptic transmission, glutamatergic; scaffold29 indexed_genome mRNA 12869318 13465616 . - . ID=transcript_6445;Q96KS6 Q96KS7 Q96KS8,Glutamate receptor ionotropic, kainate 2,Excitatory amino acid receptor 4;Glutamate receptor 6;, PF01094;PF00060;PF10613;, GO:0032839;GO:0098978;GO:0098686;GO:0005887;GO:0032983;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0042734;GO:0043195;GO:0005234;GO:0008066;GO:0042802;GO:0015277;GO:0015276;GO:0099507;GO:0030165;GO:0038023;GO:1904315;GO:0031624;GO:0031625;GO:0001662;GO:0006874;GO:0007268;GO:0120169;GO:0007215;GO:0060080;GO:0050804;GO:0043524;GO:0051967;GO:0051402;GO:0019228;GO:0043525;GO:0050806;GO:0043113;GO:0046328;GO:0048169;GO:0048172;GO:0035249;, C:dendrite cytoplasm; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:kainate selective glutamate receptor complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:presynaptic membrane; C:terminal bouton;, F:extracellularly glutamate-gated ion channel activity; F:glutamate receptor activity; F:identical protein binding; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:ligand-gated ion channel activity involved in regulation of presynaptic membrane potential; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding;, P:behavioral fear response; P:cellular calcium ion homeostasis; P:chemical synaptic transmission; P:detection of cold stimulus involved in thermoception; P:glutamate receptor signaling pathway; P:inhibitory postsynaptic potential; P:modulation of chemical synaptic transmission; P:negative regulation of neuron apoptotic process; P:negative regulation of synaptic transmission, glutamatergic; P:neuron apoptotic process; P:neuronal action potential; P:positive regulation of neuron apoptotic process; P:positive regulation of synaptic transmission; P:receptor clustering; P:regulation of JNK cascade; P:regulation of long-term neuronal synaptic plasticity; P:regulation of short-term neuronal synaptic plasticity; P:synaptic transmission, glutamatergic;|Q96KS6 Q96KS7 Q96KS8,Glutamate receptor ionotropic, kainate 2,Excitatory amino acid receptor 4;Glutamate receptor 6;, PF01094;PF00060;PF10613;, GO:0032839;GO:0098978;GO:0098686;GO:0005887;GO:0032983;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0042734;GO:0043195;GO:0005234;GO:0008066;GO:0042802;GO:0015277;GO:0015276;GO:0099507;GO:0030165;GO:0038023;GO:1904315;GO:0031624;GO:0031625;GO:0001662;GO:0006874;GO:0007268;GO:0120169;GO:0007215;GO:0060080;GO:0050804;GO:0043524;GO:0051967;GO:0051402;GO:0019228;GO:0043525;GO:0050806;GO:0043113;GO:0046328;GO:0048169;GO:0048172;GO:0035249;, C:dendrite cytoplasm; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:kainate selective glutamate receptor complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:presynaptic membrane; C:terminal bouton;, F:extracellularly glutamate-gated ion channel activity; F:glutamate receptor activity; F:identical protein binding; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:ligand-gated ion channel activity involved in regulation of presynaptic membrane potential; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding;, P:behavioral fear response; P:cellular calcium ion homeostasis; P:chemical synaptic transmission; P:detection of cold stimulus involved in thermoception; P:glutamate receptor signaling pathway; P:inhibitory postsynaptic potential; P:modulation of chemical synaptic transmission; P:negative regulation of neuron apoptotic process; P:negative regulation of synaptic transmission, glutamatergic; P:neuron apoptotic process; P:neuronal action potential; P:positive regulation of neuron apoptotic process; P:positive regulation of synaptic transmission; P:receptor clustering; P:regulation of JNK cascade; P:regulation of long-term neuronal synaptic plasticity; P:regulation of short-term neuronal synaptic plasticity; P:synaptic transmission, glutamatergic;|Q96KS6 Q96KS7 Q96KS8,Glutamate receptor ionotropic, kainate 2,Excitatory amino acid receptor 4;Glutamate receptor 6;, PF01094;PF00060;PF10613;, GO:0032839;GO:0098978;GO:0098686;GO:0005887;GO:0032983;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0042734;GO:0043195;GO:0005234;GO:0008066;GO:0042802;GO:0015277;GO:0015276;GO:0099507;GO:0030165;GO:0038023;GO:1904315;GO:0031624;GO:0031625;GO:0001662;GO:0006874;GO:0007268;GO:0120169;GO:0007215;GO:0060080;GO:0050804;GO:0043524;GO:0051967;GO:0051402;GO:0019228;GO:0043525;GO:0050806;GO:0043113;GO:0046328;GO:0048169;GO:0048172;GO:0035249;, C:dendrite cytoplasm; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:kainate selective glutamate receptor complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:presynaptic membrane; C:terminal bouton;, F:extracellularly glutamate-gated ion channel activity; F:glutamate receptor activity; F:identical protein binding; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:ligand-gated ion channel activity involved in regulation of presynaptic membrane potential; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding;, P:behavioral fear response; P:cellular calcium ion homeostasis; P:chemical synaptic transmission; P:detection of cold stimulus involved in thermoception; P:glutamate receptor signaling pathway; P:inhibitory postsynaptic potential; P:modulation of chemical synaptic transmission; P:negative regulation of neuron apoptotic process; P:negative regulation of synaptic transmission, glutamatergic; P:neuron apoptotic process; P:neuronal action potential; P:positive regulation of neuron apoptotic process; P:positive regulation of synaptic transmission; P:receptor clustering; P:regulation of JNK cascade; P:regulation of long-term neuronal synaptic plasticity; P:regulation of short-term neuronal synaptic plasticity; P:synaptic transmission, glutamatergic; scaffold29 indexed_genome mRNA 13869615 13896240 . + . ID=transcript_6446;Q8N3C0 E7EW23 O43738 Q4G1A0 Q5VTN2 Q9H1I9 Q9H5A2 Q9NTR0,Activating signal cointegrator 1 complex subunit 3,ASC-1 complex subunit p200 {ECO:0000303|PubMed:12077347};Helicase, ATP binding 1;Trip4 complex subunit p200 {ECO:0000303|PubMed:12077347};, PF00270;PF00271;PF02889;, GO:0099053;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0043138;GO:0005524;GO:0003723;GO:0008283;GO:0006307;GO:0032508;, C:activating signal cointegrator 1 complex; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:3'-5' DNA helicase activity; F:ATP binding; F:RNA binding;, P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA duplex unwinding; scaffold29 indexed_genome mRNA 13906751 14188320 . + . ID=transcript_6447;Q8N3C0 E7EW23 O43738 Q4G1A0 Q5VTN2 Q9H1I9 Q9H5A2 Q9NTR0,Activating signal cointegrator 1 complex subunit 3,ASC-1 complex subunit p200 {ECO:0000303|PubMed:12077347};Helicase, ATP binding 1;Trip4 complex subunit p200 {ECO:0000303|PubMed:12077347};, PF00270;PF00271;PF02889;, GO:0099053;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0043138;GO:0005524;GO:0003723;GO:0008283;GO:0006307;GO:0032508;, C:activating signal cointegrator 1 complex; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:3'-5' DNA helicase activity; F:ATP binding; F:RNA binding;, P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA duplex unwinding;|Q8N3C0 E7EW23 O43738 Q4G1A0 Q5VTN2 Q9H1I9 Q9H5A2 Q9NTR0,Activating signal cointegrator 1 complex subunit 3,ASC-1 complex subunit p200 {ECO:0000303|PubMed:12077347};Helicase, ATP binding 1;Trip4 complex subunit p200 {ECO:0000303|PubMed:12077347};, PF00270;PF00271;PF02889;, GO:0099053;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0043138;GO:0005524;GO:0003723;GO:0008283;GO:0006307;GO:0032508;, C:activating signal cointegrator 1 complex; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:3'-5' DNA helicase activity; F:ATP binding; F:RNA binding;, P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA duplex unwinding;|Q8N3C0 E7EW23 O43738 Q4G1A0 Q5VTN2 Q9H1I9 Q9H5A2 Q9NTR0,Activating signal cointegrator 1 complex subunit 3,ASC-1 complex subunit p200 {ECO:0000303|PubMed:12077347};Helicase, ATP binding 1;Trip4 complex subunit p200 {ECO:0000303|PubMed:12077347};, PF00270;PF00271;PF02889;, GO:0099053;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0043138;GO:0005524;GO:0003723;GO:0008283;GO:0006307;GO:0032508;, C:activating signal cointegrator 1 complex; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:3'-5' DNA helicase activity; F:ATP binding; F:RNA binding;, P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA duplex unwinding; scaffold29 indexed_genome mRNA 14306959 14308260 . - . ID=transcript_6448;P81133 Q5TDP7,Single-minded homolog 1,Class E basic helix-loop-helix protein 14;, PF00010;PF00989;PF08447;PF06621;, GO:0000785;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0046982;GO:0000977;GO:0030154;GO:0007399;GO:0006357;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; scaffold29 indexed_genome mRNA 14958095 15056906 . + . ID=transcript_6449;P24863 B4DPZ1 Q9H543,Cyclin-C,SRB11 homolog;, PF00134;, GO:0016592;GO:0005654;GO:0005634;GO:0016538;GO:0042802;GO:0045944;GO:0006357;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:identical protein binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|P24863 B4DPZ1 Q9H543,Cyclin-C,SRB11 homolog;, PF00134;, GO:0016592;GO:0005654;GO:0005634;GO:0016538;GO:0042802;GO:0045944;GO:0006357;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:identical protein binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|P24863 B4DPZ1 Q9H543,Cyclin-C,SRB11 homolog;, PF00134;, GO:0016592;GO:0005654;GO:0005634;GO:0016538;GO:0042802;GO:0045944;GO:0006357;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:identical protein binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|P24863 B4DPZ1 Q9H543,Cyclin-C,SRB11 homolog;, PF00134;, GO:0016592;GO:0005654;GO:0005634;GO:0016538;GO:0042802;GO:0045944;GO:0006357;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:identical protein binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|Q70EL2 B2RXG0 Q5T062 Q86T44 Q86TC0 Q9BRU1,Ubiquitin carboxyl-terminal hydrolase 45,Deubiquitinating enzyme 45;Ubiquitin thioesterase 45;Ubiquitin-specific-processing protease 45;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0001917;GO:0008234;GO:0004843;GO:0008270;GO:0016477;GO:0006281;GO:0070911;GO:0003407;GO:0045494;GO:0016579;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:photoreceptor inner segment;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell migration; P:DNA repair; P:global genome nucleotide-excision repair; P:neural retina development; P:photoreceptor cell maintenance; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|H0UI37,Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3,Rhodanese domain-containing protein 3;, PF00581;|Q70EL2 B2RXG0 Q5T062 Q86T44 Q86TC0 Q9BRU1,Ubiquitin carboxyl-terminal hydrolase 45,Deubiquitinating enzyme 45;Ubiquitin thioesterase 45;Ubiquitin-specific-processing protease 45;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0001917;GO:0008234;GO:0004843;GO:0008270;GO:0016477;GO:0006281;GO:0070911;GO:0003407;GO:0045494;GO:0016579;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:photoreceptor inner segment;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell migration; P:DNA repair; P:global genome nucleotide-excision repair; P:neural retina development; P:photoreceptor cell maintenance; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70EL2 B2RXG0 Q5T062 Q86T44 Q86TC0 Q9BRU1,Ubiquitin carboxyl-terminal hydrolase 45,Deubiquitinating enzyme 45;Ubiquitin thioesterase 45;Ubiquitin-specific-processing protease 45;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0001917;GO:0008234;GO:0004843;GO:0008270;GO:0016477;GO:0006281;GO:0070911;GO:0003407;GO:0045494;GO:0016579;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:photoreceptor inner segment;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell migration; P:DNA repair; P:global genome nucleotide-excision repair; P:neural retina development; P:photoreceptor cell maintenance; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70EL2 B2RXG0 Q5T062 Q86T44 Q86TC0 Q9BRU1,Ubiquitin carboxyl-terminal hydrolase 45,Deubiquitinating enzyme 45;Ubiquitin thioesterase 45;Ubiquitin-specific-processing protease 45;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0001917;GO:0008234;GO:0004843;GO:0008270;GO:0016477;GO:0006281;GO:0070911;GO:0003407;GO:0045494;GO:0016579;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:photoreceptor inner segment;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell migration; P:DNA repair; P:global genome nucleotide-excision repair; P:neural retina development; P:photoreceptor cell maintenance; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70EL2 B2RXG0 Q5T062 Q86T44 Q86TC0 Q9BRU1,Ubiquitin carboxyl-terminal hydrolase 45,Deubiquitinating enzyme 45;Ubiquitin thioesterase 45;Ubiquitin-specific-processing protease 45;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0001917;GO:0008234;GO:0004843;GO:0008270;GO:0016477;GO:0006281;GO:0070911;GO:0003407;GO:0045494;GO:0016579;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:photoreceptor inner segment;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell migration; P:DNA repair; P:global genome nucleotide-excision repair; P:neural retina development; P:photoreceptor cell maintenance; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70EL2 B2RXG0 Q5T062 Q86T44 Q86TC0 Q9BRU1,Ubiquitin carboxyl-terminal hydrolase 45,Deubiquitinating enzyme 45;Ubiquitin thioesterase 45;Ubiquitin-specific-processing protease 45;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0001917;GO:0008234;GO:0004843;GO:0008270;GO:0016477;GO:0006281;GO:0070911;GO:0003407;GO:0045494;GO:0016579;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:photoreceptor inner segment;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell migration; P:DNA repair; P:global genome nucleotide-excision repair; P:neural retina development; P:photoreceptor cell maintenance; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold29 indexed_genome mRNA 15069837 15092699 . + . ID=transcript_6450;Q7Z640 Q8N2L1 Q8TF00 Q96K10 Q96SI3 Q96SM5 Q9P076 Q9P0C0 Q9Y4N3,Arginine/serine-rich protein PNISR,PNN-interacting serine/arginine-rich protein;SR-related protein;SR-rich protein;Serine/arginine-rich-splicing regulatory protein 130;Splicing factor, arginine/serine-rich 130;Splicing factor, arginine/serine-rich 18;, PF15996;, GO:0005829;GO:0016607;GO:0005654;GO:0005886;GO:0048786;GO:0003723;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:plasma membrane; C:presynaptic active zone;, F:RNA binding;|Q7Z640 Q8N2L1 Q8TF00 Q96K10 Q96SI3 Q96SM5 Q9P076 Q9P0C0 Q9Y4N3,Arginine/serine-rich protein PNISR,PNN-interacting serine/arginine-rich protein;SR-related protein;SR-rich protein;Serine/arginine-rich-splicing regulatory protein 130;Splicing factor, arginine/serine-rich 130;Splicing factor, arginine/serine-rich 18;, PF15996;, GO:0005829;GO:0016607;GO:0005654;GO:0005886;GO:0048786;GO:0003723;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:plasma membrane; C:presynaptic active zone;, F:RNA binding;|Q7Z640 Q8N2L1 Q8TF00 Q96K10 Q96SI3 Q96SM5 Q9P076 Q9P0C0 Q9Y4N3,Arginine/serine-rich protein PNISR,PNN-interacting serine/arginine-rich protein;SR-related protein;SR-rich protein;Serine/arginine-rich-splicing regulatory protein 130;Splicing factor, arginine/serine-rich 130;Splicing factor, arginine/serine-rich 18;, PF15996;, GO:0005829;GO:0016607;GO:0005654;GO:0005886;GO:0048786;GO:0003723;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:plasma membrane; C:presynaptic active zone;, F:RNA binding; scaffold29 indexed_genome mRNA 15092748 15112631 . + . ID=transcript_6451;Q9NZJ6 B3KPX0 Q5T061 Q6P4F0 Q8IXG6 Q96BG1 Q9H0N1,Ubiquinone biosynthesis O-methyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03190},3-demethylubiquinol 3-O-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03190};Polyprenyldihydroxybenzoate methyltransferase {ECO:0000255|HAMAP-Rule:MF_03190};, , GO:0031314;GO:0005759;GO:0005739;GO:0008425;GO:0044596;GO:0008689;GO:0044595;GO:0004395;GO:0008171;GO:0006071;GO:0032259;GO:0010795;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; F:3-demethylubiquinol-10 3-O-methyltransferase activity; F:3-demethylubiquinone-9 3-O-methyltransferase activity; F:decaprenyldihydroxybenzoate methyltransferase activity; F:hexaprenyldihydroxybenzoate methyltransferase activity; F:O-methyltransferase activity;, P:glycerol metabolic process; P:methylation; P:regulation of ubiquinone biosynthetic process; P:ubiquinone biosynthetic process; scaffold29 indexed_genome mRNA 15112634 15116205 . + . ID=transcript_6452;Q9NZJ6 B3KPX0 Q5T061 Q6P4F0 Q8IXG6 Q96BG1 Q9H0N1,Ubiquinone biosynthesis O-methyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03190},3-demethylubiquinol 3-O-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03190};Polyprenyldihydroxybenzoate methyltransferase {ECO:0000255|HAMAP-Rule:MF_03190};, , GO:0031314;GO:0005759;GO:0005739;GO:0008425;GO:0044596;GO:0008689;GO:0044595;GO:0004395;GO:0008171;GO:0006071;GO:0032259;GO:0010795;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; F:3-demethylubiquinol-10 3-O-methyltransferase activity; F:3-demethylubiquinone-9 3-O-methyltransferase activity; F:decaprenyldihydroxybenzoate methyltransferase activity; F:hexaprenyldihydroxybenzoate methyltransferase activity; F:O-methyltransferase activity;, P:glycerol metabolic process; P:methylation; P:regulation of ubiquinone biosynthetic process; P:ubiquinone biosynthetic process;|Q9NZJ6 B3KPX0 Q5T061 Q6P4F0 Q8IXG6 Q96BG1 Q9H0N1,Ubiquinone biosynthesis O-methyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03190},3-demethylubiquinol 3-O-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03190};Polyprenyldihydroxybenzoate methyltransferase {ECO:0000255|HAMAP-Rule:MF_03190};, , GO:0031314;GO:0005759;GO:0005739;GO:0008425;GO:0044596;GO:0008689;GO:0044595;GO:0004395;GO:0008171;GO:0006071;GO:0032259;GO:0010795;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; F:3-demethylubiquinol-10 3-O-methyltransferase activity; F:3-demethylubiquinone-9 3-O-methyltransferase activity; F:decaprenyldihydroxybenzoate methyltransferase activity; F:hexaprenyldihydroxybenzoate methyltransferase activity; F:O-methyltransferase activity;, P:glycerol metabolic process; P:methylation; P:regulation of ubiquinone biosynthetic process; P:ubiquinone biosynthetic process;|Q9NZJ6 B3KPX0 Q5T061 Q6P4F0 Q8IXG6 Q96BG1 Q9H0N1,Ubiquinone biosynthesis O-methyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03190},3-demethylubiquinol 3-O-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03190};Polyprenyldihydroxybenzoate methyltransferase {ECO:0000255|HAMAP-Rule:MF_03190};, , GO:0031314;GO:0005759;GO:0005739;GO:0008425;GO:0044596;GO:0008689;GO:0044595;GO:0004395;GO:0008171;GO:0006071;GO:0032259;GO:0010795;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; F:3-demethylubiquinol-10 3-O-methyltransferase activity; F:3-demethylubiquinone-9 3-O-methyltransferase activity; F:decaprenyldihydroxybenzoate methyltransferase activity; F:hexaprenyldihydroxybenzoate methyltransferase activity; F:O-methyltransferase activity;, P:glycerol metabolic process; P:methylation; P:regulation of ubiquinone biosynthetic process; P:ubiquinone biosynthetic process; scaffold29 indexed_genome mRNA 15138157 15200433 . + . ID=transcript_6453;Q5TGI0 B3KU39 Q96F61 Q96LU3 Q9BR58 Q9BSS2,Failed axon connections homolog,, PF17171;PF17172;, GO:0005737;GO:0016021;, C:cytoplasm; C:integral component of membrane; scaffold29 indexed_genome mRNA 16510302 16512863 . + . ID=transcript_6454;Q6ZRQ5 D6R9Y8 D6RBQ4 E1P529 Q5THT2 Q68CQ6 Q68D32,Protein MMS22-like,Methyl methanesulfonate-sensitivity protein 22-like;, PF14911;PF14910;, GO:0005829;GO:0043596;GO:0005654;GO:0000724;GO:0031297;, C:cytosol; C:nuclear replication fork; C:nucleoplasm;, , P:double-strand break repair via homologous recombination; P:replication fork processing; scaffold29 indexed_genome mRNA 16516112 16520243 . + . ID=transcript_6455;Q96NJ5 B7Z346 B7Z4E2 E1P528 Q5THT0 Q96PY7,Kelch-like protein 32,BTB and kelch domain-containing protein 5;, PF07707;PF00651;PF01344; scaffold29 indexed_genome mRNA 16531000 16723727 . - . ID=transcript_6456;Q96NJ5 B7Z346 B7Z4E2 E1P528 Q5THT0 Q96PY7,Kelch-like protein 32,BTB and kelch domain-containing protein 5;, PF07707;PF00651;PF01344; scaffold29 indexed_genome mRNA 16763475 16774190 . + . ID=transcript_6457;Q9P032 B2R4J5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4,Hormone-regulated proliferation-associated protein of 20 kDa;, PF06784;, GO:0005743;GO:0031966;GO:0005739;GO:0005516;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion;, F:calmodulin binding;, P:mitochondrial respiratory chain complex I assembly; scaffold29 indexed_genome mRNA 16832502 16894192 . + . ID=transcript_6458;Q9BZJ6 Q9UJH3,Probable G-protein coupled receptor 63,PSP24-2;PSP24-beta;, PF00001;, GO:0005829;GO:0016021;GO:0005654;GO:0005886;GO:0043235;GO:0004930;GO:0007186;, C:cytosol; C:integral component of membrane; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; scaffold29 indexed_genome mRNA 17046177 17063577 . - . ID=transcript_6459;Q5TD97 B2RBD1 E1P526 Q5TD98 Q8WW21 Q9NQU2,Four and a half LIM domains protein 5,Activator of cAMP-responsive element modulator in testis;, PF00412;, GO:0005634;GO:0030018;GO:0046872;GO:0003713;GO:0003712;GO:0045944;, C:nucleus; C:Z disc;, F:metal ion binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:positive regulation of transcription by RNA polymerase II; scaffold29 indexed_genome mRNA 17107902 17170985 . - . ID=transcript_6460;O94874 A0PJ53 B4DJ57 C0H5X5 Q8N765 Q9NTQ0,E3 UFM1-protein ligase 1 {ECO:0000305},E3 UFM1-protein transferase 1 {ECO:0000305};Multiple alpha-helix protein located at ER {ECO:0000303|PubMed:20531390};Novel LZAP-binding protein {ECO:0000303|PubMed:20164180};Regulator of C53/LZAP and DDRGK1 {ECO:0000303|PubMed:20228063};, PF09743;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0016020;GO:0043005;GO:0005634;GO:0032991;GO:0035861;GO:0019901;GO:0061666;GO:0071568;GO:0006974;GO:0006281;GO:0030218;GO:0060218;GO:0016570;GO:0043066;GO:1903895;GO:0032088;GO:0031397;GO:0001649;GO:0010508;GO:0008284;GO:0060252;GO:1990592;GO:0071569;GO:0043122;GO:0050727;GO:0033146;GO:0032434;GO:0032880;GO:0034976;GO:1902065;GO:0061709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:neuron projection; C:nucleus; C:protein-containing complex; C:site of double-strand break;, F:protein kinase binding; F:UFM1 ligase activity; F:UFM1 transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:erythrocyte differentiation; P:hematopoietic stem cell differentiation; P:histone modification; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:positive regulation of autophagy; P:positive regulation of cell population proliferation; P:positive regulation of glial cell proliferation; P:protein K69-linked ufmylation; P:protein ufmylation; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of inflammatory response; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of protein localization; P:response to endoplasmic reticulum stress; P:response to L-glutamate; P:reticulophagy;|O94874 A0PJ53 B4DJ57 C0H5X5 Q8N765 Q9NTQ0,E3 UFM1-protein ligase 1 {ECO:0000305},E3 UFM1-protein transferase 1 {ECO:0000305};Multiple alpha-helix protein located at ER {ECO:0000303|PubMed:20531390};Novel LZAP-binding protein {ECO:0000303|PubMed:20164180};Regulator of C53/LZAP and DDRGK1 {ECO:0000303|PubMed:20228063};, PF09743;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0016020;GO:0043005;GO:0005634;GO:0032991;GO:0035861;GO:0019901;GO:0061666;GO:0071568;GO:0006974;GO:0006281;GO:0030218;GO:0060218;GO:0016570;GO:0043066;GO:1903895;GO:0032088;GO:0031397;GO:0001649;GO:0010508;GO:0008284;GO:0060252;GO:1990592;GO:0071569;GO:0043122;GO:0050727;GO:0033146;GO:0032434;GO:0032880;GO:0034976;GO:1902065;GO:0061709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:neuron projection; C:nucleus; C:protein-containing complex; C:site of double-strand break;, F:protein kinase binding; F:UFM1 ligase activity; F:UFM1 transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:erythrocyte differentiation; P:hematopoietic stem cell differentiation; P:histone modification; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:positive regulation of autophagy; P:positive regulation of cell population proliferation; P:positive regulation of glial cell proliferation; P:protein K69-linked ufmylation; P:protein ufmylation; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of inflammatory response; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of protein localization; P:response to endoplasmic reticulum stress; P:response to L-glutamate; P:reticulophagy;|O94874 A0PJ53 B4DJ57 C0H5X5 Q8N765 Q9NTQ0,E3 UFM1-protein ligase 1 {ECO:0000305},E3 UFM1-protein transferase 1 {ECO:0000305};Multiple alpha-helix protein located at ER {ECO:0000303|PubMed:20531390};Novel LZAP-binding protein {ECO:0000303|PubMed:20164180};Regulator of C53/LZAP and DDRGK1 {ECO:0000303|PubMed:20228063};, PF09743;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0016020;GO:0043005;GO:0005634;GO:0032991;GO:0035861;GO:0019901;GO:0061666;GO:0071568;GO:0006974;GO:0006281;GO:0030218;GO:0060218;GO:0016570;GO:0043066;GO:1903895;GO:0032088;GO:0031397;GO:0001649;GO:0010508;GO:0008284;GO:0060252;GO:1990592;GO:0071569;GO:0043122;GO:0050727;GO:0033146;GO:0032434;GO:0032880;GO:0034976;GO:1902065;GO:0061709;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:neuron projection; C:nucleus; C:protein-containing complex; C:site of double-strand break;, F:protein kinase binding; F:UFM1 ligase activity; F:UFM1 transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:erythrocyte differentiation; P:hematopoietic stem cell differentiation; P:histone modification; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein ubiquitination; P:osteoblast differentiation; P:positive regulation of autophagy; P:positive regulation of cell population proliferation; P:positive regulation of glial cell proliferation; P:protein K69-linked ufmylation; P:protein ufmylation; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of inflammatory response; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of protein localization; P:response to endoplasmic reticulum stress; P:response to L-glutamate; P:reticulophagy; scaffold29 indexed_genome mRNA 17433748 17443128 . - . ID=transcript_6461;Q9Y231 Q5T0W4,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 {ECO:0000305},Fucosyltransferase 9 {ECO:0000303|PubMed:23000574};Fucosyltransferase IX {ECO:0000303|PubMed:10386598};Galactoside 3-L-fucosyltransferase;, PF17039;PF00852;, GO:0005794;GO:0000139;GO:0016021;GO:0005802;GO:0032588;GO:0017083;GO:0046920;GO:0008417;GO:0005975;GO:0033692;GO:0036065;GO:0042355;GO:0030182;GO:0009312;GO:0010976;GO:0006486;GO:1903037;GO:1903236;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity; F:alpha-(1->3)-fucosyltransferase activity; F:fucosyltransferase activity;, P:carbohydrate metabolic process; P:cellular polysaccharide biosynthetic process; P:fucosylation; P:L-fucose catabolic process; P:neuron differentiation; P:oligosaccharide biosynthetic process; P:positive regulation of neuron projection development; P:protein glycosylation; P:regulation of leukocyte cell-cell adhesion; P:regulation of leukocyte tethering or rolling; scaffold29 indexed_genome mRNA 20154694 20223716 . + . ID=transcript_6462;Q15375 A0AUX7 B2R8W1 B7ZLJ9 B7ZLK0 Q59G40 Q5VTU0 Q8N368 Q9H124,Ephrin type-A receptor 7,EPH homology kinase 3;EPH-like kinase 11;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0030425;GO:0098978;GO:0098686;GO:0005887;GO:0099061;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0043235;GO:0098685;GO:0005524;GO:0008046;GO:0045499;GO:0046875;GO:0005004;GO:0019838;GO:0004713;GO:0004714;GO:0005005;GO:0006915;GO:0007411;GO:0007420;GO:0048755;GO:0048013;GO:0007275;GO:0050919;GO:0048671;GO:0051964;GO:0072178;GO:0016310;GO:0033674;GO:0043525;GO:0001934;GO:0022407;GO:0043281;GO:0070372;GO:0050730;GO:0099175;GO:0031952;GO:0031290;GO:0007169;, C:dendrite; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:axon guidance receptor activity; F:chemorepellent activity; F:ephrin receptor binding; F:GPI-linked ephrin receptor activity; F:growth factor binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:apoptotic process; P:axon guidance; P:brain development; P:branching morphogenesis of a nerve; P:ephrin receptor signaling pathway; P:multicellular organism development; P:negative chemotaxis; P:negative regulation of collateral sprouting; P:negative regulation of synapse assembly; P:nephric duct morphogenesis; P:phosphorylation; P:positive regulation of kinase activity; P:positive regulation of neuron apoptotic process; P:positive regulation of protein phosphorylation; P:regulation of cell-cell adhesion; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of ERK1 and ERK2 cascade; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of postsynapse organization; P:regulation of protein autophosphorylation; P:retinal ganglion cell axon guidance; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold29 indexed_genome mRNA 20317068 20329761 . + . ID=transcript_6463;Q15375 A0AUX7 B2R8W1 B7ZLJ9 B7ZLK0 Q59G40 Q5VTU0 Q8N368 Q9H124,Ephrin type-A receptor 7,EPH homology kinase 3;EPH-like kinase 11;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0030425;GO:0098978;GO:0098686;GO:0005887;GO:0099061;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0043235;GO:0098685;GO:0005524;GO:0008046;GO:0045499;GO:0046875;GO:0005004;GO:0019838;GO:0004713;GO:0004714;GO:0005005;GO:0006915;GO:0007411;GO:0007420;GO:0048755;GO:0048013;GO:0007275;GO:0050919;GO:0048671;GO:0051964;GO:0072178;GO:0016310;GO:0033674;GO:0043525;GO:0001934;GO:0022407;GO:0043281;GO:0070372;GO:0050730;GO:0099175;GO:0031952;GO:0031290;GO:0007169;, C:dendrite; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:axon guidance receptor activity; F:chemorepellent activity; F:ephrin receptor binding; F:GPI-linked ephrin receptor activity; F:growth factor binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:apoptotic process; P:axon guidance; P:brain development; P:branching morphogenesis of a nerve; P:ephrin receptor signaling pathway; P:multicellular organism development; P:negative chemotaxis; P:negative regulation of collateral sprouting; P:negative regulation of synapse assembly; P:nephric duct morphogenesis; P:phosphorylation; P:positive regulation of kinase activity; P:positive regulation of neuron apoptotic process; P:positive regulation of protein phosphorylation; P:regulation of cell-cell adhesion; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of ERK1 and ERK2 cascade; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of postsynapse organization; P:regulation of protein autophosphorylation; P:retinal ganglion cell axon guidance; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold29 indexed_genome mRNA 20329994 20351177 . + . ID=transcript_6464;Q15375 A0AUX7 B2R8W1 B7ZLJ9 B7ZLK0 Q59G40 Q5VTU0 Q8N368 Q9H124,Ephrin type-A receptor 7,EPH homology kinase 3;EPH-like kinase 11;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0030425;GO:0098978;GO:0098686;GO:0005887;GO:0099061;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0043235;GO:0098685;GO:0005524;GO:0008046;GO:0045499;GO:0046875;GO:0005004;GO:0019838;GO:0004713;GO:0004714;GO:0005005;GO:0006915;GO:0007411;GO:0007420;GO:0048755;GO:0048013;GO:0007275;GO:0050919;GO:0048671;GO:0051964;GO:0072178;GO:0016310;GO:0033674;GO:0043525;GO:0001934;GO:0022407;GO:0043281;GO:0070372;GO:0050730;GO:0099175;GO:0031952;GO:0031290;GO:0007169;, C:dendrite; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:axon guidance receptor activity; F:chemorepellent activity; F:ephrin receptor binding; F:GPI-linked ephrin receptor activity; F:growth factor binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:apoptotic process; P:axon guidance; P:brain development; P:branching morphogenesis of a nerve; P:ephrin receptor signaling pathway; P:multicellular organism development; P:negative chemotaxis; P:negative regulation of collateral sprouting; P:negative regulation of synapse assembly; P:nephric duct morphogenesis; P:phosphorylation; P:positive regulation of kinase activity; P:positive regulation of neuron apoptotic process; P:positive regulation of protein phosphorylation; P:regulation of cell-cell adhesion; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of ERK1 and ERK2 cascade; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of postsynapse organization; P:regulation of protein autophosphorylation; P:retinal ganglion cell axon guidance; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q15375 A0AUX7 B2R8W1 B7ZLJ9 B7ZLK0 Q59G40 Q5VTU0 Q8N368 Q9H124,Ephrin type-A receptor 7,EPH homology kinase 3;EPH-like kinase 11;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0030425;GO:0098978;GO:0098686;GO:0005887;GO:0099061;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0043235;GO:0098685;GO:0005524;GO:0008046;GO:0045499;GO:0046875;GO:0005004;GO:0019838;GO:0004713;GO:0004714;GO:0005005;GO:0006915;GO:0007411;GO:0007420;GO:0048755;GO:0048013;GO:0007275;GO:0050919;GO:0048671;GO:0051964;GO:0072178;GO:0016310;GO:0033674;GO:0043525;GO:0001934;GO:0022407;GO:0043281;GO:0070372;GO:0050730;GO:0099175;GO:0031952;GO:0031290;GO:0007169;, C:dendrite; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:axon guidance receptor activity; F:chemorepellent activity; F:ephrin receptor binding; F:GPI-linked ephrin receptor activity; F:growth factor binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:apoptotic process; P:axon guidance; P:brain development; P:branching morphogenesis of a nerve; P:ephrin receptor signaling pathway; P:multicellular organism development; P:negative chemotaxis; P:negative regulation of collateral sprouting; P:negative regulation of synapse assembly; P:nephric duct morphogenesis; P:phosphorylation; P:positive regulation of kinase activity; P:positive regulation of neuron apoptotic process; P:positive regulation of protein phosphorylation; P:regulation of cell-cell adhesion; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of ERK1 and ERK2 cascade; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of postsynapse organization; P:regulation of protein autophosphorylation; P:retinal ganglion cell axon guidance; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q15375 A0AUX7 B2R8W1 B7ZLJ9 B7ZLK0 Q59G40 Q5VTU0 Q8N368 Q9H124,Ephrin type-A receptor 7,EPH homology kinase 3;EPH-like kinase 11;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0030425;GO:0098978;GO:0098686;GO:0005887;GO:0099061;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0043235;GO:0098685;GO:0005524;GO:0008046;GO:0045499;GO:0046875;GO:0005004;GO:0019838;GO:0004713;GO:0004714;GO:0005005;GO:0006915;GO:0007411;GO:0007420;GO:0048755;GO:0048013;GO:0007275;GO:0050919;GO:0048671;GO:0051964;GO:0072178;GO:0016310;GO:0033674;GO:0043525;GO:0001934;GO:0022407;GO:0043281;GO:0070372;GO:0050730;GO:0099175;GO:0031952;GO:0031290;GO:0007169;, C:dendrite; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:axon guidance receptor activity; F:chemorepellent activity; F:ephrin receptor binding; F:GPI-linked ephrin receptor activity; F:growth factor binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:apoptotic process; P:axon guidance; P:brain development; P:branching morphogenesis of a nerve; P:ephrin receptor signaling pathway; P:multicellular organism development; P:negative chemotaxis; P:negative regulation of collateral sprouting; P:negative regulation of synapse assembly; P:nephric duct morphogenesis; P:phosphorylation; P:positive regulation of kinase activity; P:positive regulation of neuron apoptotic process; P:positive regulation of protein phosphorylation; P:regulation of cell-cell adhesion; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of ERK1 and ERK2 cascade; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of postsynapse organization; P:regulation of protein autophosphorylation; P:retinal ganglion cell axon guidance; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold29 indexed_genome mRNA 22805591 22867981 . + . ID=transcript_6465;Q9NZ70,Mitogen-activated protein kinase kinase kinase 7,Transforming growth factor-beta-activated kinase 1;, PF07714;, GO:0005671;GO:0005829;GO:0010008;GO:0005634;GO:0005886;GO:0005524;GO:0042802;GO:0000287;GO:0004709;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0030971;GO:0097110;GO:0000187;GO:0000186;GO:0007250;GO:0043276;GO:0002753;GO:0038095;GO:0043966;GO:0007249;GO:0007252;GO:0070498;GO:0007254;GO:0002755;GO:0070423;GO:0043123;GO:0032743;GO:0043507;GO:0016239;GO:0051092;GO:0002726;GO:0016579;GO:0002223;GO:0051403;GO:0050852;GO:0007179;GO:0016032;GO:0007223;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytosol; C:endosome membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:MAP kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:receptor tyrosine kinase binding; F:scaffold protein binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:activation of NF-kappaB-inducing kinase activity; P:anoikis; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:histone H3 acetylation; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:MyD88-dependent toll-like receptor signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-2 production; P:positive regulation of JUN kinase activity; P:positive regulation of macroautophagy; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T cell cytokine production; P:protein deubiquitination; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q9NZ70,Mitogen-activated protein kinase kinase kinase 7,Transforming growth factor-beta-activated kinase 1;, PF07714;, GO:0005671;GO:0005829;GO:0010008;GO:0005634;GO:0005886;GO:0005524;GO:0042802;GO:0000287;GO:0004709;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0030971;GO:0097110;GO:0000187;GO:0000186;GO:0007250;GO:0043276;GO:0002753;GO:0038095;GO:0043966;GO:0007249;GO:0007252;GO:0070498;GO:0007254;GO:0002755;GO:0070423;GO:0043123;GO:0032743;GO:0043507;GO:0016239;GO:0051092;GO:0002726;GO:0016579;GO:0002223;GO:0051403;GO:0050852;GO:0007179;GO:0016032;GO:0007223;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:cytosol; C:endosome membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:MAP kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:receptor tyrosine kinase binding; F:scaffold protein binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:activation of NF-kappaB-inducing kinase activity; P:anoikis; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:histone H3 acetylation; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:MyD88-dependent toll-like receptor signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-2 production; P:positive regulation of JUN kinase activity; P:positive regulation of macroautophagy; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T cell cytokine production; P:protein deubiquitination; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway; P:viral process; P:Wnt signaling pathway, calcium modulating pathway; scaffold29 indexed_genome mRNA 23428234 23440350 . + . ID=transcript_6466;Q9BYV9 E1P518 Q59H70 Q5T793 Q9NTS5,Transcription regulator protein BACH2,BTB and CNC homolog 2;, PF00651;PF03131;, GO:0000785;GO:0005829;GO:0005654;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0051170;GO:0090721;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:import into nucleus; P:primary adaptive immune response involving T cells and B cells; P:regulation of transcription by RNA polymerase II; scaffold29 indexed_genome mRNA 23447011 23447628 . + . ID=transcript_6467;Q9BYV9 E1P518 Q59H70 Q5T793 Q9NTS5,Transcription regulator protein BACH2,BTB and CNC homolog 2;, PF00651;PF03131;, GO:0000785;GO:0005829;GO:0005654;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0051170;GO:0090721;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:import into nucleus; P:primary adaptive immune response involving T cells and B cells; P:regulation of transcription by RNA polymerase II; scaffold29 indexed_genome mRNA 23455314 23465448 . - . ID=transcript_6468;Q969M2,Gap junction alpha-10 protein,Connexin-62;, PF00029;, GO:0005922;GO:0016021;GO:0005886;GO:0005243;GO:0007267;GO:0050908;GO:0007276;GO:0007416;, C:connexin complex; C:integral component of membrane; C:plasma membrane;, F:gap junction channel activity;, P:cell-cell signaling; P:detection of light stimulus involved in visual perception; P:gamete generation; P:synapse assembly;|Q969M2,Gap junction alpha-10 protein,Connexin-62;, PF00029;, GO:0005922;GO:0016021;GO:0005886;GO:0005243;GO:0007267;GO:0050908;GO:0007276;GO:0007416;, C:connexin complex; C:integral component of membrane; C:plasma membrane;, F:gap junction channel activity;, P:cell-cell signaling; P:detection of light stimulus involved in visual perception; P:gamete generation; P:synapse assembly;|Q969M2,Gap junction alpha-10 protein,Connexin-62;, PF00029;, GO:0005922;GO:0016021;GO:0005886;GO:0005243;GO:0007267;GO:0050908;GO:0007276;GO:0007416;, C:connexin complex; C:integral component of membrane; C:plasma membrane;, F:gap junction channel activity;, P:cell-cell signaling; P:detection of light stimulus involved in visual perception; P:gamete generation; P:synapse assembly; scaffold29 indexed_genome mRNA 23471854 23492093 . - . ID=transcript_6469;Q9Y563,CASP8-associated protein 2,FLICE-associated huge protein;, , GO:0005737;GO:0005739;GO:0005654;GO:0005634;GO:0016605;GO:0008656;GO:0005123;GO:0016505;GO:0032184;GO:0003714;GO:0006919;GO:0097190;GO:0007049;GO:0071260;GO:0008625;GO:0036337;GO:0007165;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:nucleus; C:PML body;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:death receptor binding; F:peptidase activator activity involved in apoptotic process; F:SUMO polymer binding; F:transcription corepressor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic signaling pathway; P:cell cycle; P:cellular response to mechanical stimulus; P:extrinsic apoptotic signaling pathway via death domain receptors; P:Fas signaling pathway; P:signal transduction;|Q9Y563,CASP8-associated protein 2,FLICE-associated huge protein;, , GO:0005737;GO:0005739;GO:0005654;GO:0005634;GO:0016605;GO:0008656;GO:0005123;GO:0016505;GO:0032184;GO:0003714;GO:0006919;GO:0097190;GO:0007049;GO:0071260;GO:0008625;GO:0036337;GO:0007165;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:nucleus; C:PML body;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:death receptor binding; F:peptidase activator activity involved in apoptotic process; F:SUMO polymer binding; F:transcription corepressor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic signaling pathway; P:cell cycle; P:cellular response to mechanical stimulus; P:extrinsic apoptotic signaling pathway via death domain receptors; P:Fas signaling pathway; P:signal transduction;|Q9Y563,CASP8-associated protein 2,FLICE-associated huge protein;, , GO:0005737;GO:0005739;GO:0005654;GO:0005634;GO:0016605;GO:0008656;GO:0005123;GO:0016505;GO:0032184;GO:0003714;GO:0006919;GO:0097190;GO:0007049;GO:0071260;GO:0008625;GO:0036337;GO:0007165;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:nucleus; C:PML body;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:death receptor binding; F:peptidase activator activity involved in apoptotic process; F:SUMO polymer binding; F:transcription corepressor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic signaling pathway; P:cell cycle; P:cellular response to mechanical stimulus; P:extrinsic apoptotic signaling pathway via death domain receptors; P:Fas signaling pathway; P:signal transduction; scaffold29 indexed_genome mRNA 23509538 23526327 . + . ID=transcript_6470;Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing; scaffold29 indexed_genome mRNA 23529484 23654751 . + . ID=transcript_6471;Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing;|Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing;|Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing;|Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing;|Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing;|Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing;|Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing;|Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing;|Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing;|Q9NU22 O15019 Q5T794,Midasin,Dynein-related AAA-ATPase MDN1;MIDAS-containing protein;, PF07728;PF17865;PF17867;, GO:0005829;GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0005524;GO:0016887;GO:0051082;GO:0065003;GO:0000027;GO:0006364;, C:cytosol; C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ATP binding; F:ATPase activity; F:unfolded protein binding;, P:protein-containing complex assembly; P:ribosomal large subunit assembly; P:rRNA processing; scaffold29 indexed_genome mRNA 23657429 23667330 . + . ID=transcript_6472;Q9NU23 B2R4U2 E1P517,LYR motif-containing protein 2,, PF05347; scaffold29 indexed_genome mRNA 23669155 23684394 . - . ID=transcript_6473;Q9Y2G4 B3KUC3 Q5JUJ4 Q5JUJ5 Q8IUQ8 Q9NU24 Q9UFQ9,Ankyrin repeat domain-containing protein 6,Diversin;, PF00023;PF12796;, GO:0005737;GO:0043231;GO:0005634;GO:0090090;GO:0046330;GO:2000096;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus;, , P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of JNK cascade; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; scaffold29 indexed_genome mRNA 23684444 23743759 . - . ID=transcript_6474;Q9Y2G4 B3KUC3 Q5JUJ4 Q5JUJ5 Q8IUQ8 Q9NU24 Q9UFQ9,Ankyrin repeat domain-containing protein 6,Diversin;, PF00023;PF12796;, GO:0005737;GO:0043231;GO:0005634;GO:0090090;GO:0046330;GO:2000096;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus;, , P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of JNK cascade; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; scaffold29 indexed_genome mRNA 23859727 23860528 . + . ID=transcript_6475;Q9UF10,Ubiquitin-conjugating enzyme E2 J1,E2 ubiquitin-conjugating enzyme J1;Non-canonical ubiquitin-conjugating enzyme 1;Yeast ubiquitin-conjugating enzyme UBC6 homolog E;, PF00179;, GO:0005789;GO:0016021;GO:0005634;GO:0005524;GO:0061631;GO:0031625;GO:1904153;GO:0018279;GO:0000209;GO:0032680;GO:0007286;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding;, P:negative regulation of retrograde protein transport, ER to cytosol; P:protein N-linked glycosylation via asparagine; P:protein polyubiquitination; P:regulation of tumor necrosis factor production; P:spermatid development; P:ubiquitin-dependent ERAD pathway; scaffold29 indexed_genome mRNA 23861814 23870966 . + . ID=transcript_6476;Q9UF10,Ubiquitin-conjugating enzyme E2 J1,E2 ubiquitin-conjugating enzyme J1;Non-canonical ubiquitin-conjugating enzyme 1;Yeast ubiquitin-conjugating enzyme UBC6 homolog E;, PF00179;, GO:0005789;GO:0016021;GO:0005634;GO:0005524;GO:0061631;GO:0031625;GO:1904153;GO:0018279;GO:0000209;GO:0032680;GO:0007286;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding;, P:negative regulation of retrograde protein transport, ER to cytosol; P:protein N-linked glycosylation via asparagine; P:protein polyubiquitination; P:regulation of tumor necrosis factor production; P:spermatid development; P:ubiquitin-dependent ERAD pathway; scaffold29 indexed_genome mRNA 23916639 23917548 . - . ID=transcript_6477;P28476 A2BDE4 Q9H153,Gamma-aminobutyric acid receptor subunit rho-2,GABA(A) receptor subunit rho-2;GABA(C) receptor;, PF02931;PF02932;, GO:0034707;GO:1902711;GO:0098982;GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0005254;GO:0004890;GO:0030594;GO:0019904;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0007165;GO:0007601;, C:chloride channel complex; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:chloride channel activity; F:GABA-A receptor activity; F:neurotransmitter receptor activity; F:protein domain specific binding; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:signal transduction; P:visual perception; scaffold29 indexed_genome mRNA 23984381 23999439 . - . ID=transcript_6478;Q8IYS1 B4DYJ2 Q5T7J9 Q6MZV2 Q86XD9,Peptidase M20 domain-containing protein 2,Aminoacylase-1-like protein 2;, PF07687;PF01546;, GO:0005654;GO:0016805;GO:0042802;GO:0006508;GO:0032268;, C:nucleoplasm;, F:dipeptidase activity; F:identical protein binding;, P:proteolysis; P:regulation of cellular protein metabolic process;|Q8IYS1 B4DYJ2 Q5T7J9 Q6MZV2 Q86XD9,Peptidase M20 domain-containing protein 2,Aminoacylase-1-like protein 2;, PF07687;PF01546;, GO:0005654;GO:0016805;GO:0042802;GO:0006508;GO:0032268;, C:nucleoplasm;, F:dipeptidase activity; F:identical protein binding;, P:proteolysis; P:regulation of cellular protein metabolic process;|Q8IYS1 B4DYJ2 Q5T7J9 Q6MZV2 Q86XD9,Peptidase M20 domain-containing protein 2,Aminoacylase-1-like protein 2;, PF07687;PF01546;, GO:0005654;GO:0016805;GO:0042802;GO:0006508;GO:0032268;, C:nucleoplasm;, F:dipeptidase activity; F:identical protein binding;, P:proteolysis; P:regulation of cellular protein metabolic process;|Q8IYS1 B4DYJ2 Q5T7J9 Q6MZV2 Q86XD9,Peptidase M20 domain-containing protein 2,Aminoacylase-1-like protein 2;, PF07687;PF01546;, GO:0005654;GO:0016805;GO:0042802;GO:0006508;GO:0032268;, C:nucleoplasm;, F:dipeptidase activity; F:identical protein binding;, P:proteolysis; P:regulation of cellular protein metabolic process;|Q8IYS1 B4DYJ2 Q5T7J9 Q6MZV2 Q86XD9,Peptidase M20 domain-containing protein 2,Aminoacylase-1-like protein 2;, PF07687;PF01546;, GO:0005654;GO:0016805;GO:0042802;GO:0006508;GO:0032268;, C:nucleoplasm;, F:dipeptidase activity; F:identical protein binding;, P:proteolysis; P:regulation of cellular protein metabolic process;|Q8IYS1 B4DYJ2 Q5T7J9 Q6MZV2 Q86XD9,Peptidase M20 domain-containing protein 2,Aminoacylase-1-like protein 2;, PF07687;PF01546;, GO:0005654;GO:0016805;GO:0042802;GO:0006508;GO:0032268;, C:nucleoplasm;, F:dipeptidase activity; F:identical protein binding;, P:proteolysis; P:regulation of cellular protein metabolic process; scaffold29 indexed_genome mRNA 24025554 24041859 . + . ID=transcript_6479;Q8WXF0 B2RA22 Q5T7K0 Q8WW25,Serine/arginine-rich splicing factor 12,35 kDa SR repressor protein;Splicing factor, arginine/serine-rich 13B;Splicing factor, arginine/serine-rich 19;, PF00076;, GO:0005737;GO:0016607;GO:0005654;GO:0003723;GO:0050733;GO:0051082;GO:0000395;GO:0000398;GO:0048025;GO:0000381;GO:0000244;, C:cytoplasm; C:nuclear speck; C:nucleoplasm;, F:RNA binding; F:RS domain binding; F:unfolded protein binding;, P:mRNA 5'-splice site recognition; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:spliceosomal tri-snRNP complex assembly;|Q8WXF0 B2RA22 Q5T7K0 Q8WW25,Serine/arginine-rich splicing factor 12,35 kDa SR repressor protein;Splicing factor, arginine/serine-rich 13B;Splicing factor, arginine/serine-rich 19;, PF00076;, GO:0005737;GO:0016607;GO:0005654;GO:0003723;GO:0050733;GO:0051082;GO:0000395;GO:0000398;GO:0048025;GO:0000381;GO:0000244;, C:cytoplasm; C:nuclear speck; C:nucleoplasm;, F:RNA binding; F:RS domain binding; F:unfolded protein binding;, P:mRNA 5'-splice site recognition; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:spliceosomal tri-snRNP complex assembly;|Q8WXF0 B2RA22 Q5T7K0 Q8WW25,Serine/arginine-rich splicing factor 12,35 kDa SR repressor protein;Splicing factor, arginine/serine-rich 13B;Splicing factor, arginine/serine-rich 19;, PF00076;, GO:0005737;GO:0016607;GO:0005654;GO:0003723;GO:0050733;GO:0051082;GO:0000395;GO:0000398;GO:0048025;GO:0000381;GO:0000244;, C:cytoplasm; C:nuclear speck; C:nucleoplasm;, F:RNA binding; F:RS domain binding; F:unfolded protein binding;, P:mRNA 5'-splice site recognition; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:spliceosomal tri-snRNP complex assembly; scaffold29 indexed_genome mRNA 24045728 24065392 . - . ID=transcript_6480;Q12796 B2R6Q0 E1P515 Q5T7J6 Q7Z5N0,Proline-rich nuclear receptor coactivator 1,Proline-rich protein 2;Protein B4-2;, , GO:0005634;, C:nucleus;|Q12796 B2R6Q0 E1P515 Q5T7J6 Q7Z5N0,Proline-rich nuclear receptor coactivator 1,Proline-rich protein 2;Protein B4-2;, , GO:0005634;, C:nucleus; scaffold29 indexed_genome mRNA 24139871 24355269 . + . ID=transcript_6481;O60942 E1P513 E1P514 O43483 O60257 O60351 Q5TCW8 Q8WUM8,mRNA-capping enzyme,HCAP1;HCE;, PF03919;PF01331;, GO:0005654;GO:0005634;GO:0005525;GO:0004484;GO:0004651;GO:0004725;GO:0008192;GO:0050355;GO:0006370;GO:0006396;GO:0006366;GO:0016032;, C:nucleoplasm; C:nucleus;, F:GTP binding; F:mRNA guanylyltransferase activity; F:polynucleotide 5'-phosphatase activity; F:protein tyrosine phosphatase activity; F:RNA guanylyltransferase activity; F:triphosphatase activity;, P:7-methylguanosine mRNA capping; P:RNA processing; P:transcription by RNA polymerase II; P:viral process; scaffold29 indexed_genome mRNA 24779598 24790908 . + . ID=transcript_6482;Q9UNN0,Cannabinoid receptor 1,CANN6;, PF00001;, GO:0015629;GO:0005737;GO:0098982;GO:0098978;GO:0030426;GO:0032592;GO:0005887;GO:0099056;GO:0045121;GO:0005741;GO:0005886;GO:0004949;GO:0008144;GO:0004930;GO:0042802;GO:0099635;GO:0007189;GO:0007188;GO:0007568;GO:0007413;GO:0038171;GO:0007186;GO:0007187;GO:0042593;GO:0060135;GO:0007613;GO:0045759;GO:0045776;GO:0033602;GO:0031999;GO:0033004;GO:0051001;GO:0014063;GO:0002866;GO:0043065;GO:0045777;GO:0031622;GO:0010976;GO:0060259;GO:0050796;GO:0019222;GO:0060405;GO:0032228;GO:0051966;GO:0042220;GO:0045471;GO:0032496;GO:0043278;GO:0035094;GO:0007584;GO:0098921;GO:0019233;GO:0007283;GO:0099553;, C:actin cytoskeleton; C:cytoplasm; C:GABA-ergic synapse; C:glutamatergic synapse; C:growth cone; C:integral component of mitochondrial membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:membrane raft; C:mitochondrial outer membrane; C:plasma membrane;, F:cannabinoid receptor activity; F:drug binding; F:G protein-coupled receptor activity; F:identical protein binding; F:voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:axonal fasciculation; P:cannabinoid signaling pathway; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:glucose homeostasis; P:maternal process involved in female pregnancy; P:memory; P:negative regulation of action potential; P:negative regulation of blood pressure; P:negative regulation of dopamine secretion; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of mast cell activation; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of serotonin secretion; P:positive regulation of acute inflammatory response to antigenic stimulus; P:positive regulation of apoptotic process; P:positive regulation of blood pressure; P:positive regulation of fever generation; P:positive regulation of neuron projection development; P:regulation of feeding behavior; P:regulation of insulin secretion; P:regulation of metabolic process; P:regulation of penile erection; P:regulation of synaptic transmission, GABAergic; P:regulation of synaptic transmission, glutamatergic; P:response to cocaine; P:response to ethanol; P:response to lipopolysaccharide; P:response to morphine; P:response to nicotine; P:response to nutrient; P:retrograde trans-synaptic signaling by endocannabinoid; P:sensory perception of pain; P:spermatogenesis; P:trans-synaptic signaling by endocannabinoid, modulating synaptic transmission;|Q9UNN0,Cannabinoid receptor 1,CANN6;, PF00001;, GO:0015629;GO:0005737;GO:0098982;GO:0098978;GO:0030426;GO:0032592;GO:0005887;GO:0099056;GO:0045121;GO:0005741;GO:0005886;GO:0004949;GO:0008144;GO:0004930;GO:0042802;GO:0099635;GO:0007189;GO:0007188;GO:0007568;GO:0007413;GO:0038171;GO:0007186;GO:0007187;GO:0042593;GO:0060135;GO:0007613;GO:0045759;GO:0045776;GO:0033602;GO:0031999;GO:0033004;GO:0051001;GO:0014063;GO:0002866;GO:0043065;GO:0045777;GO:0031622;GO:0010976;GO:0060259;GO:0050796;GO:0019222;GO:0060405;GO:0032228;GO:0051966;GO:0042220;GO:0045471;GO:0032496;GO:0043278;GO:0035094;GO:0007584;GO:0098921;GO:0019233;GO:0007283;GO:0099553;, C:actin cytoskeleton; C:cytoplasm; C:GABA-ergic synapse; C:glutamatergic synapse; C:growth cone; C:integral component of mitochondrial membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:membrane raft; C:mitochondrial outer membrane; C:plasma membrane;, F:cannabinoid receptor activity; F:drug binding; F:G protein-coupled receptor activity; F:identical protein binding; F:voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:axonal fasciculation; P:cannabinoid signaling pathway; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:glucose homeostasis; P:maternal process involved in female pregnancy; P:memory; P:negative regulation of action potential; P:negative regulation of blood pressure; P:negative regulation of dopamine secretion; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of mast cell activation; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of serotonin secretion; P:positive regulation of acute inflammatory response to antigenic stimulus; P:positive regulation of apoptotic process; P:positive regulation of blood pressure; P:positive regulation of fever generation; P:positive regulation of neuron projection development; P:regulation of feeding behavior; P:regulation of insulin secretion; P:regulation of metabolic process; P:regulation of penile erection; P:regulation of synaptic transmission, GABAergic; P:regulation of synaptic transmission, glutamatergic; P:response to cocaine; P:response to ethanol; P:response to lipopolysaccharide; P:response to morphine; P:response to nicotine; P:response to nutrient; P:retrograde trans-synaptic signaling by endocannabinoid; P:sensory perception of pain; P:spermatogenesis; P:trans-synaptic signaling by endocannabinoid, modulating synaptic transmission; scaffold29 indexed_genome mRNA 25230202 25231901 . - . ID=transcript_6483;Q53H80 Q9BQB1,Akirin-2,, , GO:0000785;GO:0005654;GO:0005634;GO:0017053;GO:0019899;GO:0042802;GO:0003712;GO:0009792;GO:0045087;GO:0000122;GO:0008284;GO:0010950;GO:0045089;GO:0032755;GO:0045944;GO:0032496;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:enzyme binding; F:identical protein binding; F:transcription coregulator activity;, P:embryo development ending in birth or egg hatching; P:innate immune response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of endopeptidase activity; P:positive regulation of innate immune response; P:positive regulation of interleukin-6 production; P:positive regulation of transcription by RNA polymerase II; P:response to lipopolysaccharide; scaffold29 indexed_genome mRNA 25232482 25233872 . + . ID=transcript_6484;Q53H80 Q9BQB1,Akirin-2,, , GO:0000785;GO:0005654;GO:0005634;GO:0017053;GO:0019899;GO:0042802;GO:0003712;GO:0009792;GO:0045087;GO:0000122;GO:0008284;GO:0010950;GO:0045089;GO:0032755;GO:0045944;GO:0032496;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:enzyme binding; F:identical protein binding; F:transcription coregulator activity;, P:embryo development ending in birth or egg hatching; P:innate immune response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of endopeptidase activity; P:positive regulation of innate immune response; P:positive regulation of interleukin-6 production; P:positive regulation of transcription by RNA polymerase II; P:response to lipopolysaccharide; scaffold29 indexed_genome mRNA 25236024 25271637 . + . ID=transcript_6485;Q9UNT6,Origin recognition complex subunit 3,Origin recognition complex subunit Latheo;, PF07034;PF18137;, GO:0000785;GO:0000781;GO:0031261;GO:0016604;GO:0005664;GO:0005656;GO:0005654;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0061351;GO:0036388;GO:0006267;GO:0006275;, C:chromatin; C:chromosome, telomeric region; C:DNA replication preinitiation complex; C:nuclear body; C:nuclear origin of replication recognition complex; C:nuclear pre-replicative complex; C:nucleoplasm; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:neural precursor cell proliferation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; P:regulation of DNA replication;|Q9UNT6,Origin recognition complex subunit 3,Origin recognition complex subunit Latheo;, PF07034;PF18137;, GO:0000785;GO:0000781;GO:0031261;GO:0016604;GO:0005664;GO:0005656;GO:0005654;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0061351;GO:0036388;GO:0006267;GO:0006275;, C:chromatin; C:chromosome, telomeric region; C:DNA replication preinitiation complex; C:nuclear body; C:nuclear origin of replication recognition complex; C:nuclear pre-replicative complex; C:nucleoplasm; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:neural precursor cell proliferation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; P:regulation of DNA replication;|Q9UNT6,Origin recognition complex subunit 3,Origin recognition complex subunit Latheo;, PF07034;PF18137;, GO:0000785;GO:0000781;GO:0031261;GO:0016604;GO:0005664;GO:0005656;GO:0005654;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0061351;GO:0036388;GO:0006267;GO:0006275;, C:chromatin; C:chromosome, telomeric region; C:DNA replication preinitiation complex; C:nuclear body; C:nuclear origin of replication recognition complex; C:nuclear pre-replicative complex; C:nucleoplasm; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:neural precursor cell proliferation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; P:regulation of DNA replication;|Q9UNT6,Origin recognition complex subunit 3,Origin recognition complex subunit Latheo;, PF07034;PF18137;, GO:0000785;GO:0000781;GO:0031261;GO:0016604;GO:0005664;GO:0005656;GO:0005654;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0061351;GO:0036388;GO:0006267;GO:0006275;, C:chromatin; C:chromosome, telomeric region; C:DNA replication preinitiation complex; C:nuclear body; C:nuclear origin of replication recognition complex; C:nuclear pre-replicative complex; C:nucleoplasm; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:neural precursor cell proliferation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; P:regulation of DNA replication;|Q9UNT6,Origin recognition complex subunit 3,Origin recognition complex subunit Latheo;, PF07034;PF18137;, GO:0000785;GO:0000781;GO:0031261;GO:0016604;GO:0005664;GO:0005656;GO:0005654;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0061351;GO:0036388;GO:0006267;GO:0006275;, C:chromatin; C:chromosome, telomeric region; C:DNA replication preinitiation complex; C:nuclear body; C:nuclear origin of replication recognition complex; C:nuclear pre-replicative complex; C:nucleoplasm; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:neural precursor cell proliferation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; P:regulation of DNA replication;|Q9UNT6,Origin recognition complex subunit 3,Origin recognition complex subunit Latheo;, PF07034;PF18137;, GO:0000785;GO:0000781;GO:0031261;GO:0016604;GO:0005664;GO:0005656;GO:0005654;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0061351;GO:0036388;GO:0006267;GO:0006275;, C:chromatin; C:chromosome, telomeric region; C:DNA replication preinitiation complex; C:nuclear body; C:nuclear origin of replication recognition complex; C:nuclear pre-replicative complex; C:nucleoplasm; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:neural precursor cell proliferation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; P:regulation of DNA replication; scaffold29 indexed_genome mRNA 25285710 25305901 . - . ID=transcript_6486;Q9UNT6,Origin recognition complex subunit 3,Origin recognition complex subunit Latheo;, PF07034;PF18137;, GO:0000785;GO:0000781;GO:0031261;GO:0016604;GO:0005664;GO:0005656;GO:0005654;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0061351;GO:0036388;GO:0006267;GO:0006275;, C:chromatin; C:chromosome, telomeric region; C:DNA replication preinitiation complex; C:nuclear body; C:nuclear origin of replication recognition complex; C:nuclear pre-replicative complex; C:nucleoplasm; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:neural precursor cell proliferation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; P:regulation of DNA replication; scaffold29 indexed_genome mRNA 25306029 25328182 . + . ID=transcript_6487;Q5T160 B2RDT7 Q96FU5 Q9H8K8,Probable arginine--tRNA ligase, mitochondrial,Arginyl-tRNA synthetase;, PF05746;PF00750;, GO:0005759;GO:0005739;GO:0004814;GO:0005524;GO:0003723;GO:0006420;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:arginine-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:arginyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation; scaffold29 indexed_genome mRNA 25329955 25393688 . + . ID=transcript_6488;Q5T160 B2RDT7 Q96FU5 Q9H8K8,Probable arginine--tRNA ligase, mitochondrial,Arginyl-tRNA synthetase;, PF05746;PF00750;, GO:0005759;GO:0005739;GO:0004814;GO:0005524;GO:0003723;GO:0006420;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:arginine-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:arginyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|Q5T160 B2RDT7 Q96FU5 Q9H8K8,Probable arginine--tRNA ligase, mitochondrial,Arginyl-tRNA synthetase;, PF05746;PF00750;, GO:0005759;GO:0005739;GO:0004814;GO:0005524;GO:0003723;GO:0006420;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:arginine-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:arginyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|Q5T160 B2RDT7 Q96FU5 Q9H8K8,Probable arginine--tRNA ligase, mitochondrial,Arginyl-tRNA synthetase;, PF05746;PF00750;, GO:0005759;GO:0005739;GO:0004814;GO:0005524;GO:0003723;GO:0006420;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:arginine-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:arginyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|Q5T160 B2RDT7 Q96FU5 Q9H8K8,Probable arginine--tRNA ligase, mitochondrial,Arginyl-tRNA synthetase;, PF05746;PF00750;, GO:0005759;GO:0005739;GO:0004814;GO:0005524;GO:0003723;GO:0006420;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:arginine-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:arginyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|Q5T160 B2RDT7 Q96FU5 Q9H8K8,Probable arginine--tRNA ligase, mitochondrial,Arginyl-tRNA synthetase;, PF05746;PF00750;, GO:0005759;GO:0005739;GO:0004814;GO:0005524;GO:0003723;GO:0006420;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:arginine-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:arginyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|Q5T160 B2RDT7 Q96FU5 Q9H8K8,Probable arginine--tRNA ligase, mitochondrial,Arginyl-tRNA synthetase;, PF05746;PF00750;, GO:0005759;GO:0005739;GO:0004814;GO:0005524;GO:0003723;GO:0006420;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:arginine-tRNA ligase activity; F:ATP binding; F:RNA binding;, P:arginyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|P78382 Q5W1L8,CMP-sialic acid transporter,Solute carrier family 35 member A1;, PF04142;, GO:0005794;GO:0000139;GO:0030173;GO:0016021;GO:0005887;GO:0015297;GO:0005456;GO:0005459;GO:0005975;GO:0008643;GO:0006464;GO:0015782;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:antiporter activity; F:CMP-N-acetylneuraminate transmembrane transporter activity; F:UDP-galactose transmembrane transporter activity;, P:carbohydrate metabolic process; P:carbohydrate transport; P:cellular protein modification process; P:CMP-N-acetylneuraminate transmembrane transport;|P78382 Q5W1L8,CMP-sialic acid transporter,Solute carrier family 35 member A1;, PF04142;, GO:0005794;GO:0000139;GO:0030173;GO:0016021;GO:0005887;GO:0015297;GO:0005456;GO:0005459;GO:0005975;GO:0008643;GO:0006464;GO:0015782;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:antiporter activity; F:CMP-N-acetylneuraminate transmembrane transporter activity; F:UDP-galactose transmembrane transporter activity;, P:carbohydrate metabolic process; P:carbohydrate transport; P:cellular protein modification process; P:CMP-N-acetylneuraminate transmembrane transport;|P78382 Q5W1L8,CMP-sialic acid transporter,Solute carrier family 35 member A1;, PF04142;, GO:0005794;GO:0000139;GO:0030173;GO:0016021;GO:0005887;GO:0015297;GO:0005456;GO:0005459;GO:0005975;GO:0008643;GO:0006464;GO:0015782;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:antiporter activity; F:CMP-N-acetylneuraminate transmembrane transporter activity; F:UDP-galactose transmembrane transporter activity;, P:carbohydrate metabolic process; P:carbohydrate transport; P:cellular protein modification process; P:CMP-N-acetylneuraminate transmembrane transport;|P78382 Q5W1L8,CMP-sialic acid transporter,Solute carrier family 35 member A1;, PF04142;, GO:0005794;GO:0000139;GO:0030173;GO:0016021;GO:0005887;GO:0015297;GO:0005456;GO:0005459;GO:0005975;GO:0008643;GO:0006464;GO:0015782;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:antiporter activity; F:CMP-N-acetylneuraminate transmembrane transporter activity; F:UDP-galactose transmembrane transporter activity;, P:carbohydrate metabolic process; P:carbohydrate transport; P:cellular protein modification process; P:CMP-N-acetylneuraminate transmembrane transport;|P78382 Q5W1L8,CMP-sialic acid transporter,Solute carrier family 35 member A1;, PF04142;, GO:0005794;GO:0000139;GO:0030173;GO:0016021;GO:0005887;GO:0015297;GO:0005456;GO:0005459;GO:0005975;GO:0008643;GO:0006464;GO:0015782;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:antiporter activity; F:CMP-N-acetylneuraminate transmembrane transporter activity; F:UDP-galactose transmembrane transporter activity;, P:carbohydrate metabolic process; P:carbohydrate transport; P:cellular protein modification process; P:CMP-N-acetylneuraminate transmembrane transport;|P78382 Q5W1L8,CMP-sialic acid transporter,Solute carrier family 35 member A1;, PF04142;, GO:0005794;GO:0000139;GO:0030173;GO:0016021;GO:0005887;GO:0015297;GO:0005456;GO:0005459;GO:0005975;GO:0008643;GO:0006464;GO:0015782;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:antiporter activity; F:CMP-N-acetylneuraminate transmembrane transporter activity; F:UDP-galactose transmembrane transporter activity;, P:carbohydrate metabolic process; P:carbohydrate transport; P:cellular protein modification process; P:CMP-N-acetylneuraminate transmembrane transport;|P78382 Q5W1L8,CMP-sialic acid transporter,Solute carrier family 35 member A1;, PF04142;, GO:0005794;GO:0000139;GO:0030173;GO:0016021;GO:0005887;GO:0015297;GO:0005456;GO:0005459;GO:0005975;GO:0008643;GO:0006464;GO:0015782;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:antiporter activity; F:CMP-N-acetylneuraminate transmembrane transporter activity; F:UDP-galactose transmembrane transporter activity;, P:carbohydrate metabolic process; P:carbohydrate transport; P:cellular protein modification process; P:CMP-N-acetylneuraminate transmembrane transport; scaffold29 indexed_genome mRNA 25421824 25427155 . - . ID=transcript_6489;Q8IYR0 A8K969 E1P507 Q8N9U4,Cilia- and flagella-associated protein 206 {ECO:0000305},, PF12018;, GO:0005930;GO:0036064;GO:0031514;GO:0001534;GO:0035082;GO:0003341;GO:0003356;GO:1901317;GO:0007288;, C:axoneme; C:ciliary basal body; C:motile cilium; C:radial spoke;, , P:axoneme assembly; P:cilium movement; P:regulation of cilium beat frequency; P:regulation of flagellated sperm motility; P:sperm axoneme assembly; scaffold29 indexed_genome mRNA 25432882 25443789 . - . ID=transcript_6490;Q8IYR0 A8K969 E1P507 Q8N9U4,Cilia- and flagella-associated protein 206 {ECO:0000305},, PF12018;, GO:0005930;GO:0036064;GO:0031514;GO:0001534;GO:0035082;GO:0003341;GO:0003356;GO:1901317;GO:0007288;, C:axoneme; C:ciliary basal body; C:motile cilium; C:radial spoke;, , P:axoneme assembly; P:cilium movement; P:regulation of cilium beat frequency; P:regulation of flagellated sperm motility; P:sperm axoneme assembly; scaffold29 indexed_genome mRNA 25557589 25651131 . - . ID=transcript_6491;O60281 Q5W0B2 Q7Z3L7 Q9H8G3 Q9H8J4,Zinc finger protein 292,, PF00096;, GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0046872;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of transcription by RNA polymerase II;|O60281 Q5W0B2 Q7Z3L7 Q9H8G3 Q9H8J4,Zinc finger protein 292,, PF00096;, GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0046872;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of transcription by RNA polymerase II;|O60281 Q5W0B2 Q7Z3L7 Q9H8G3 Q9H8J4,Zinc finger protein 292,, PF00096;, GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0046872;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of transcription by RNA polymerase II; scaffold29 indexed_genome mRNA 26635557 26662876 . + . ID=transcript_6492;Q96LC2 Q9Y583,Heterogeneous nuclear ribonucleoprotein Q,Glycine- and tyrosine-rich RNA-binding protein;NS1-associated protein 1;Synaptotagmin-binding, cytoplasmic RNA-interacting protein;, PF18360;PF00076;, GO:0071013;GO:0070937;GO:0005783;GO:0097452;GO:0071204;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0048027;GO:0003729;GO:0003723;GO:0071346;GO:0070934;GO:0000398;GO:0017148;GO:0001649;GO:0006396;GO:0008380;GO:0016032;, C:catalytic step 2 spliceosome; C:CRD-mediated mRNA stability complex; C:endoplasmic reticulum; C:GAIT complex; C:histone pre-mRNA 3'end processing complex; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 5'-UTR binding; F:mRNA binding; F:RNA binding;, P:cellular response to interferon-gamma; P:CRD-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:negative regulation of translation; P:osteoblast differentiation; P:RNA processing; P:RNA splicing; P:viral process;|Q96LC2 Q9Y583,Heterogeneous nuclear ribonucleoprotein Q,Glycine- and tyrosine-rich RNA-binding protein;NS1-associated protein 1;Synaptotagmin-binding, cytoplasmic RNA-interacting protein;, PF18360;PF00076;, GO:0071013;GO:0070937;GO:0005783;GO:0097452;GO:0071204;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0048027;GO:0003729;GO:0003723;GO:0071346;GO:0070934;GO:0000398;GO:0017148;GO:0001649;GO:0006396;GO:0008380;GO:0016032;, C:catalytic step 2 spliceosome; C:CRD-mediated mRNA stability complex; C:endoplasmic reticulum; C:GAIT complex; C:histone pre-mRNA 3'end processing complex; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 5'-UTR binding; F:mRNA binding; F:RNA binding;, P:cellular response to interferon-gamma; P:CRD-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:negative regulation of translation; P:osteoblast differentiation; P:RNA processing; P:RNA splicing; P:viral process; scaffold29 indexed_genome mRNA 26674335 26719466 . + . ID=transcript_6493;Q9Y5W7 B4DI55 Q4VBR3 Q5TCF9 Q5TCG0 Q6NUI7 Q6PI37 Q9BSD1,Sorting nexin-14,, PF08628;PF00787;PF02194;PF00615;, GO:0005829;GO:0030425;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0080025;GO:0097352;GO:0015031;, C:cytosol; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:phosphatidylinositol-3,5-bisphosphate binding;, P:autophagosome maturation; P:protein transport;|Q9Y5W7 B4DI55 Q4VBR3 Q5TCF9 Q5TCG0 Q6NUI7 Q6PI37 Q9BSD1,Sorting nexin-14,, PF08628;PF00787;PF02194;PF00615;, GO:0005829;GO:0030425;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0080025;GO:0097352;GO:0015031;, C:cytosol; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:phosphatidylinositol-3,5-bisphosphate binding;, P:autophagosome maturation; P:protein transport;|Q9Y5W7 B4DI55 Q4VBR3 Q5TCF9 Q5TCG0 Q6NUI7 Q6PI37 Q9BSD1,Sorting nexin-14,, PF08628;PF00787;PF02194;PF00615;, GO:0005829;GO:0030425;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0080025;GO:0097352;GO:0015031;, C:cytosol; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:phosphatidylinositol-3,5-bisphosphate binding;, P:autophagosome maturation; P:protein transport;|Q9Y5W7 B4DI55 Q4VBR3 Q5TCF9 Q5TCG0 Q6NUI7 Q6PI37 Q9BSD1,Sorting nexin-14,, PF08628;PF00787;PF02194;PF00615;, GO:0005829;GO:0030425;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0080025;GO:0097352;GO:0015031;, C:cytosol; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:phosphatidylinositol-3,5-bisphosphate binding;, P:autophagosome maturation; P:protein transport; scaffold29 indexed_genome mRNA 26719791 26746625 . + . ID=transcript_6494;Q9Y5W7 B4DI55 Q4VBR3 Q5TCF9 Q5TCG0 Q6NUI7 Q6PI37 Q9BSD1,Sorting nexin-14,, PF08628;PF00787;PF02194;PF00615;, GO:0005829;GO:0030425;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0080025;GO:0097352;GO:0015031;, C:cytosol; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:phosphatidylinositol-3,5-bisphosphate binding;, P:autophagosome maturation; P:protein transport;|Q9Y5W7 B4DI55 Q4VBR3 Q5TCF9 Q5TCG0 Q6NUI7 Q6PI37 Q9BSD1,Sorting nexin-14,, PF08628;PF00787;PF02194;PF00615;, GO:0005829;GO:0030425;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0080025;GO:0097352;GO:0015031;, C:cytosol; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:phosphatidylinositol-3,5-bisphosphate binding;, P:autophagosome maturation; P:protein transport;|Q9Y5W7 B4DI55 Q4VBR3 Q5TCF9 Q5TCG0 Q6NUI7 Q6PI37 Q9BSD1,Sorting nexin-14,, PF08628;PF00787;PF02194;PF00615;, GO:0005829;GO:0030425;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0080025;GO:0097352;GO:0015031;, C:cytosol; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:phosphatidylinositol-3,5-bisphosphate binding;, P:autophagosome maturation; P:protein transport; scaffold29 indexed_genome mRNA 26751531 26759439 . - . ID=transcript_6495;P21589 B3KQI8 O75520 Q5W116,5'-nucleotidase,Ecto-5'-nucleotidase;, PF02872;PF00149;, GO:0031225;GO:0009986;GO:0005829;GO:0009897;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0008253;GO:0046872;GO:0000166;GO:0046086;GO:0046032;GO:0006196;GO:0006259;GO:0007159;GO:0019674;GO:0050728;GO:0006195;GO:0035590;GO:0046135;, C:anchored component of membrane; C:cell surface; C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine biosynthetic process; P:ADP catabolic process; P:AMP catabolic process; P:DNA metabolic process; P:leukocyte cell-cell adhesion; P:NAD metabolic process; P:negative regulation of inflammatory response; P:purine nucleotide catabolic process; P:purinergic nucleotide receptor signaling pathway; P:pyrimidine nucleoside catabolic process;|P21589 B3KQI8 O75520 Q5W116,5'-nucleotidase,Ecto-5'-nucleotidase;, PF02872;PF00149;, GO:0031225;GO:0009986;GO:0005829;GO:0009897;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0008253;GO:0046872;GO:0000166;GO:0046086;GO:0046032;GO:0006196;GO:0006259;GO:0007159;GO:0019674;GO:0050728;GO:0006195;GO:0035590;GO:0046135;, C:anchored component of membrane; C:cell surface; C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine biosynthetic process; P:ADP catabolic process; P:AMP catabolic process; P:DNA metabolic process; P:leukocyte cell-cell adhesion; P:NAD metabolic process; P:negative regulation of inflammatory response; P:purine nucleotide catabolic process; P:purinergic nucleotide receptor signaling pathway; P:pyrimidine nucleoside catabolic process; scaffold29 indexed_genome mRNA 26759626 26816359 . - . ID=transcript_6496;P21589 B3KQI8 O75520 Q5W116,5'-nucleotidase,Ecto-5'-nucleotidase;, PF02872;PF00149;, GO:0031225;GO:0009986;GO:0005829;GO:0009897;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0008253;GO:0046872;GO:0000166;GO:0046086;GO:0046032;GO:0006196;GO:0006259;GO:0007159;GO:0019674;GO:0050728;GO:0006195;GO:0035590;GO:0046135;, C:anchored component of membrane; C:cell surface; C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine biosynthetic process; P:ADP catabolic process; P:AMP catabolic process; P:DNA metabolic process; P:leukocyte cell-cell adhesion; P:NAD metabolic process; P:negative regulation of inflammatory response; P:purine nucleotide catabolic process; P:purinergic nucleotide receptor signaling pathway; P:pyrimidine nucleoside catabolic process;|P21589 B3KQI8 O75520 Q5W116,5'-nucleotidase,Ecto-5'-nucleotidase;, PF02872;PF00149;, GO:0031225;GO:0009986;GO:0005829;GO:0009897;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0008253;GO:0046872;GO:0000166;GO:0046086;GO:0046032;GO:0006196;GO:0006259;GO:0007159;GO:0019674;GO:0050728;GO:0006195;GO:0035590;GO:0046135;, C:anchored component of membrane; C:cell surface; C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;, P:adenosine biosynthetic process; P:ADP catabolic process; P:AMP catabolic process; P:DNA metabolic process; P:leukocyte cell-cell adhesion; P:NAD metabolic process; P:negative regulation of inflammatory response; P:purine nucleotide catabolic process; P:purinergic nucleotide receptor signaling pathway; P:pyrimidine nucleoside catabolic process; scaffold30 indexed_genome mRNA 1 11747 . + . ID=transcript_6497;Q86UU0 A1A4C1 Q67FY1 Q6ZWJ0 Q6ZWK2,B-cell CLL/lymphoma 9-like protein,Protein BCL9-2;, PF11502;, GO:1990907;GO:0005730;GO:0005654;GO:0005634;GO:0008013;GO:0003713;GO:1904837;GO:0060070;GO:0030512;GO:0010718;GO:0045944;GO:0022604;GO:0035914;GO:0035019;, C:beta-catenin-TCF complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:canonical Wnt signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell morphogenesis; P:skeletal muscle cell differentiation; P:somatic stem cell population maintenance;|Q86UU0 A1A4C1 Q67FY1 Q6ZWJ0 Q6ZWK2,B-cell CLL/lymphoma 9-like protein,Protein BCL9-2;, PF11502;, GO:1990907;GO:0005730;GO:0005654;GO:0005634;GO:0008013;GO:0003713;GO:1904837;GO:0060070;GO:0030512;GO:0010718;GO:0045944;GO:0022604;GO:0035914;GO:0035019;, C:beta-catenin-TCF complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:canonical Wnt signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell morphogenesis; P:skeletal muscle cell differentiation; P:somatic stem cell population maintenance;|Q86UU0 A1A4C1 Q67FY1 Q6ZWJ0 Q6ZWK2,B-cell CLL/lymphoma 9-like protein,Protein BCL9-2;, PF11502;, GO:1990907;GO:0005730;GO:0005654;GO:0005634;GO:0008013;GO:0003713;GO:1904837;GO:0060070;GO:0030512;GO:0010718;GO:0045944;GO:0022604;GO:0035914;GO:0035019;, C:beta-catenin-TCF complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:canonical Wnt signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell morphogenesis; P:skeletal muscle cell differentiation; P:somatic stem cell population maintenance; scaffold30 indexed_genome mRNA 105654 148225 . + . ID=transcript_6498;P26196 Q5D048,Probable ATP-dependent RNA helicase DDX6 {ECO:0000305},ATP-dependent RNA helicase p54;DEAD box protein 6;Oncogene RCK;, PF00270;PF00271;, GO:0005912;GO:0033391;GO:0061830;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0000792;GO:0016020;GO:0005739;GO:0005730;GO:0005634;GO:0001520;GO:0000932;GO:0048471;GO:0016442;GO:0097227;GO:0005524;GO:0045296;GO:0004386;GO:0003729;GO:0019904;GO:0003723;GO:0003724;GO:0043928;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0048515;GO:0019827;GO:0034063;GO:0019074;, C:adherens junction; C:chromatoid body; C:concave side of sperm head; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:heterochromatin; C:membrane; C:mitochondrion; C:nucleolus; C:nucleus; C:outer dense fiber; C:P-body; C:perinuclear region of cytoplasm; C:RISC complex; C:sperm annulus;, F:ATP binding; F:cadherin binding; F:helicase activity; F:mRNA binding; F:protein domain specific binding; F:RNA binding; F:RNA helicase activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:spermatid differentiation; P:stem cell population maintenance; P:stress granule assembly; P:viral RNA genome packaging;|P26196 Q5D048,Probable ATP-dependent RNA helicase DDX6 {ECO:0000305},ATP-dependent RNA helicase p54;DEAD box protein 6;Oncogene RCK;, PF00270;PF00271;, GO:0005912;GO:0033391;GO:0061830;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0000792;GO:0016020;GO:0005739;GO:0005730;GO:0005634;GO:0001520;GO:0000932;GO:0048471;GO:0016442;GO:0097227;GO:0005524;GO:0045296;GO:0004386;GO:0003729;GO:0019904;GO:0003723;GO:0003724;GO:0043928;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0048515;GO:0019827;GO:0034063;GO:0019074;, C:adherens junction; C:chromatoid body; C:concave side of sperm head; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:heterochromatin; C:membrane; C:mitochondrion; C:nucleolus; C:nucleus; C:outer dense fiber; C:P-body; C:perinuclear region of cytoplasm; C:RISC complex; C:sperm annulus;, F:ATP binding; F:cadherin binding; F:helicase activity; F:mRNA binding; F:protein domain specific binding; F:RNA binding; F:RNA helicase activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:spermatid differentiation; P:stem cell population maintenance; P:stress granule assembly; P:viral RNA genome packaging;|P26196 Q5D048,Probable ATP-dependent RNA helicase DDX6 {ECO:0000305},ATP-dependent RNA helicase p54;DEAD box protein 6;Oncogene RCK;, PF00270;PF00271;, GO:0005912;GO:0033391;GO:0061830;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0000792;GO:0016020;GO:0005739;GO:0005730;GO:0005634;GO:0001520;GO:0000932;GO:0048471;GO:0016442;GO:0097227;GO:0005524;GO:0045296;GO:0004386;GO:0003729;GO:0019904;GO:0003723;GO:0003724;GO:0043928;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0048515;GO:0019827;GO:0034063;GO:0019074;, C:adherens junction; C:chromatoid body; C:concave side of sperm head; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:heterochromatin; C:membrane; C:mitochondrion; C:nucleolus; C:nucleus; C:outer dense fiber; C:P-body; C:perinuclear region of cytoplasm; C:RISC complex; C:sperm annulus;, F:ATP binding; F:cadherin binding; F:helicase activity; F:mRNA binding; F:protein domain specific binding; F:RNA binding; F:RNA helicase activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:spermatid differentiation; P:stem cell population maintenance; P:stress granule assembly; P:viral RNA genome packaging;|P26196 Q5D048,Probable ATP-dependent RNA helicase DDX6 {ECO:0000305},ATP-dependent RNA helicase p54;DEAD box protein 6;Oncogene RCK;, PF00270;PF00271;, GO:0005912;GO:0033391;GO:0061830;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0000792;GO:0016020;GO:0005739;GO:0005730;GO:0005634;GO:0001520;GO:0000932;GO:0048471;GO:0016442;GO:0097227;GO:0005524;GO:0045296;GO:0004386;GO:0003729;GO:0019904;GO:0003723;GO:0003724;GO:0043928;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0048515;GO:0019827;GO:0034063;GO:0019074;, C:adherens junction; C:chromatoid body; C:concave side of sperm head; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:heterochromatin; C:membrane; C:mitochondrion; C:nucleolus; C:nucleus; C:outer dense fiber; C:P-body; C:perinuclear region of cytoplasm; C:RISC complex; C:sperm annulus;, F:ATP binding; F:cadherin binding; F:helicase activity; F:mRNA binding; F:protein domain specific binding; F:RNA binding; F:RNA helicase activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:spermatid differentiation; P:stem cell population maintenance; P:stress granule assembly; P:viral RNA genome packaging;|P26196 Q5D048,Probable ATP-dependent RNA helicase DDX6 {ECO:0000305},ATP-dependent RNA helicase p54;DEAD box protein 6;Oncogene RCK;, PF00270;PF00271;, GO:0005912;GO:0033391;GO:0061830;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0000792;GO:0016020;GO:0005739;GO:0005730;GO:0005634;GO:0001520;GO:0000932;GO:0048471;GO:0016442;GO:0097227;GO:0005524;GO:0045296;GO:0004386;GO:0003729;GO:0019904;GO:0003723;GO:0003724;GO:0043928;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0048515;GO:0019827;GO:0034063;GO:0019074;, C:adherens junction; C:chromatoid body; C:concave side of sperm head; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:heterochromatin; C:membrane; C:mitochondrion; C:nucleolus; C:nucleus; C:outer dense fiber; C:P-body; C:perinuclear region of cytoplasm; C:RISC complex; C:sperm annulus;, F:ATP binding; F:cadherin binding; F:helicase activity; F:mRNA binding; F:protein domain specific binding; F:RNA binding; F:RNA helicase activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:spermatid differentiation; P:stem cell population maintenance; P:stress granule assembly; P:viral RNA genome packaging; scaffold30 indexed_genome mRNA 196206 247118 . - . ID=transcript_6499;Q86UU1 B0YJ63 B0YJ64 O75133 Q4KMF8 Q8TEQ2,Pleckstrin homology-like domain family B member 1,Protein LL5-alpha;, PF00169;, GO:0045180;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex;, , P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86UU1 B0YJ63 B0YJ64 O75133 Q4KMF8 Q8TEQ2,Pleckstrin homology-like domain family B member 1,Protein LL5-alpha;, PF00169;, GO:0045180;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex;, , P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86UU1 B0YJ63 B0YJ64 O75133 Q4KMF8 Q8TEQ2,Pleckstrin homology-like domain family B member 1,Protein LL5-alpha;, PF00169;, GO:0045180;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex;, , P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86UU1 B0YJ63 B0YJ64 O75133 Q4KMF8 Q8TEQ2,Pleckstrin homology-like domain family B member 1,Protein LL5-alpha;, PF00169;, GO:0045180;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex;, , P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86UU1 B0YJ63 B0YJ64 O75133 Q4KMF8 Q8TEQ2,Pleckstrin homology-like domain family B member 1,Protein LL5-alpha;, PF00169;, GO:0045180;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex;, , P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86UU1 B0YJ63 B0YJ64 O75133 Q4KMF8 Q8TEQ2,Pleckstrin homology-like domain family B member 1,Protein LL5-alpha;, PF00169;, GO:0045180;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex;, , P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization;|Q86UU1 B0YJ63 B0YJ64 O75133 Q4KMF8 Q8TEQ2,Pleckstrin homology-like domain family B member 1,Protein LL5-alpha;, PF00169;, GO:0045180;GO:1904261;GO:0010717;GO:0010470;GO:0070507;, C:basal cortex;, , P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule cytoskeleton organization; scaffold30 indexed_genome mRNA 257095 276665 . - . ID=transcript_6500;P48444 B4E1X2 E9PEU4 Q52M80,Coatomer subunit delta,Archain;Delta-coat protein;, PF00928;PF01217;, GO:0030126;GO:0005829;GO:0005789;GO:0000139;GO:0016020;GO:0030133;GO:0003723;GO:0006888;GO:0051645;GO:0006886;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:membrane; C:transport vesicle;, F:RNA binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi localization; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold30 indexed_genome mRNA 303628 310980 . + . ID=transcript_6501;Q9NQC8 A8K0F6 Q9H6V5,Intraflagellar transport protein 46 homolog,, PF12317;, GO:0005813;GO:0097542;GO:0005929;GO:0005737;GO:0030992;GO:0031514;GO:0008022;GO:0060271;GO:0042073;GO:0035735;GO:0050821;, C:centrosome; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle B; C:motile cilium;, F:protein C-terminus binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:protein stabilization;|Q9NQC8 A8K0F6 Q9H6V5,Intraflagellar transport protein 46 homolog,, PF12317;, GO:0005813;GO:0097542;GO:0005929;GO:0005737;GO:0030992;GO:0031514;GO:0008022;GO:0060271;GO:0042073;GO:0035735;GO:0050821;, C:centrosome; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle B; C:motile cilium;, F:protein C-terminus binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:protein stabilization;|Q9NQC8 A8K0F6 Q9H6V5,Intraflagellar transport protein 46 homolog,, PF12317;, GO:0005813;GO:0097542;GO:0005929;GO:0005737;GO:0030992;GO:0031514;GO:0008022;GO:0060271;GO:0042073;GO:0035735;GO:0050821;, C:centrosome; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle B; C:motile cilium;, F:protein C-terminus binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:protein stabilization; scaffold30 indexed_genome mRNA 312016 322129 . - . ID=transcript_6502;Q96KA6 Q96MW9,Transmembrane protein 25,, PF08205;, GO:0005576;GO:0016021;GO:0005770;GO:0005764;GO:0005886;GO:0090394;GO:0031647;, C:extracellular region; C:integral component of membrane; C:late endosome; C:lysosome; C:plasma membrane;, , P:negative regulation of excitatory postsynaptic potential; P:regulation of protein stability;|Q96KA6 Q96MW9,Transmembrane protein 25,, PF08205;, GO:0005576;GO:0016021;GO:0005770;GO:0005764;GO:0005886;GO:0090394;GO:0031647;, C:extracellular region; C:integral component of membrane; C:late endosome; C:lysosome; C:plasma membrane;, , P:negative regulation of excitatory postsynaptic potential; P:regulation of protein stability;|A6NLP5 B7ZW72 B9EJD8,Tetratricopeptide repeat protein 36,HSP70-binding protein 21;, , GO:0021954;GO:0060271;GO:0007613;GO:0010801;GO:0032435;GO:0032091;GO:1902915;GO:0006570;GO:0008542;, , , P:central nervous system neuron development; P:cilium assembly; P:memory; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein binding; P:negative regulation of protein polyubiquitination; P:tyrosine metabolic process; P:visual learning; scaffold30 indexed_genome mRNA 324974 329160 . + . ID=transcript_6503;Q9UD94 Q9UMA3,Histone-lysine N-methyltransferase 2A,ALL-1 {ECO:0000303|PubMed:12453419};CXXC-type zinc finger protein 7;Myeloid/lymphoid or mixed-lineage leukemia;Myeloid/lymphoid or mixed-lineage leukemia protein 1;Trithorax-like protein;Zinc finger protein HRX;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0005829;GO:0035097;GO:0071339;GO:0005654;GO:0005634;GO:0042800;GO:0042802;GO:0070577;GO:0003680;GO:0042803;GO:0045322;GO:0008270;GO:0006915;GO:0032922;GO:0035162;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0043984;GO:1905642;GO:0051571;GO:0045944;GO:0045893;GO:0032411;GO:0065003;GO:1902036;GO:0071440;GO:2000615;GO:0045652;, C:cytosol; C:histone methyltransferase complex; C:MLL1 complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:identical protein binding; F:lysine-acetylated histone binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein homodimerization activity; F:unmethylated CpG binding; F:zinc ion binding;, P:apoptotic process; P:circadian regulation of gene expression; P:embryonic hemopoiesis; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:negative regulation of DNA methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transporter activity; P:protein-containing complex assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone H3-K14 acetylation; P:regulation of histone H3-K9 acetylation; P:regulation of megakaryocyte differentiation;|Q9UD94 Q9UMA3,Histone-lysine N-methyltransferase 2A,ALL-1 {ECO:0000303|PubMed:12453419};CXXC-type zinc finger protein 7;Myeloid/lymphoid or mixed-lineage leukemia;Myeloid/lymphoid or mixed-lineage leukemia protein 1;Trithorax-like protein;Zinc finger protein HRX;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0005829;GO:0035097;GO:0071339;GO:0005654;GO:0005634;GO:0042800;GO:0042802;GO:0070577;GO:0003680;GO:0042803;GO:0045322;GO:0008270;GO:0006915;GO:0032922;GO:0035162;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0043984;GO:1905642;GO:0051571;GO:0045944;GO:0045893;GO:0032411;GO:0065003;GO:1902036;GO:0071440;GO:2000615;GO:0045652;, C:cytosol; C:histone methyltransferase complex; C:MLL1 complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:identical protein binding; F:lysine-acetylated histone binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein homodimerization activity; F:unmethylated CpG binding; F:zinc ion binding;, P:apoptotic process; P:circadian regulation of gene expression; P:embryonic hemopoiesis; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:negative regulation of DNA methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transporter activity; P:protein-containing complex assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone H3-K14 acetylation; P:regulation of histone H3-K9 acetylation; P:regulation of megakaryocyte differentiation;|Q9UD94 Q9UMA3,Histone-lysine N-methyltransferase 2A,ALL-1 {ECO:0000303|PubMed:12453419};CXXC-type zinc finger protein 7;Myeloid/lymphoid or mixed-lineage leukemia;Myeloid/lymphoid or mixed-lineage leukemia protein 1;Trithorax-like protein;Zinc finger protein HRX;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0005829;GO:0035097;GO:0071339;GO:0005654;GO:0005634;GO:0042800;GO:0042802;GO:0070577;GO:0003680;GO:0042803;GO:0045322;GO:0008270;GO:0006915;GO:0032922;GO:0035162;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0043984;GO:1905642;GO:0051571;GO:0045944;GO:0045893;GO:0032411;GO:0065003;GO:1902036;GO:0071440;GO:2000615;GO:0045652;, C:cytosol; C:histone methyltransferase complex; C:MLL1 complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:identical protein binding; F:lysine-acetylated histone binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein homodimerization activity; F:unmethylated CpG binding; F:zinc ion binding;, P:apoptotic process; P:circadian regulation of gene expression; P:embryonic hemopoiesis; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:negative regulation of DNA methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transporter activity; P:protein-containing complex assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone H3-K14 acetylation; P:regulation of histone H3-K9 acetylation; P:regulation of megakaryocyte differentiation; scaffold30 indexed_genome mRNA 329172 402721 . - . ID=transcript_6504;Q9UD94 Q9UMA3,Histone-lysine N-methyltransferase 2A,ALL-1 {ECO:0000303|PubMed:12453419};CXXC-type zinc finger protein 7;Myeloid/lymphoid or mixed-lineage leukemia;Myeloid/lymphoid or mixed-lineage leukemia protein 1;Trithorax-like protein;Zinc finger protein HRX;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0005829;GO:0035097;GO:0071339;GO:0005654;GO:0005634;GO:0042800;GO:0042802;GO:0070577;GO:0003680;GO:0042803;GO:0045322;GO:0008270;GO:0006915;GO:0032922;GO:0035162;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0043984;GO:1905642;GO:0051571;GO:0045944;GO:0045893;GO:0032411;GO:0065003;GO:1902036;GO:0071440;GO:2000615;GO:0045652;, C:cytosol; C:histone methyltransferase complex; C:MLL1 complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:identical protein binding; F:lysine-acetylated histone binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein homodimerization activity; F:unmethylated CpG binding; F:zinc ion binding;, P:apoptotic process; P:circadian regulation of gene expression; P:embryonic hemopoiesis; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:negative regulation of DNA methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transporter activity; P:protein-containing complex assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone H3-K14 acetylation; P:regulation of histone H3-K9 acetylation; P:regulation of megakaryocyte differentiation;|Q9UD94 Q9UMA3,Histone-lysine N-methyltransferase 2A,ALL-1 {ECO:0000303|PubMed:12453419};CXXC-type zinc finger protein 7;Myeloid/lymphoid or mixed-lineage leukemia;Myeloid/lymphoid or mixed-lineage leukemia protein 1;Trithorax-like protein;Zinc finger protein HRX;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0005829;GO:0035097;GO:0071339;GO:0005654;GO:0005634;GO:0042800;GO:0042802;GO:0070577;GO:0003680;GO:0042803;GO:0045322;GO:0008270;GO:0006915;GO:0032922;GO:0035162;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0043984;GO:1905642;GO:0051571;GO:0045944;GO:0045893;GO:0032411;GO:0065003;GO:1902036;GO:0071440;GO:2000615;GO:0045652;, C:cytosol; C:histone methyltransferase complex; C:MLL1 complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:identical protein binding; F:lysine-acetylated histone binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein homodimerization activity; F:unmethylated CpG binding; F:zinc ion binding;, P:apoptotic process; P:circadian regulation of gene expression; P:embryonic hemopoiesis; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:negative regulation of DNA methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transporter activity; P:protein-containing complex assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone H3-K14 acetylation; P:regulation of histone H3-K9 acetylation; P:regulation of megakaryocyte differentiation;|Q9UD94 Q9UMA3,Histone-lysine N-methyltransferase 2A,ALL-1 {ECO:0000303|PubMed:12453419};CXXC-type zinc finger protein 7;Myeloid/lymphoid or mixed-lineage leukemia;Myeloid/lymphoid or mixed-lineage leukemia protein 1;Trithorax-like protein;Zinc finger protein HRX;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0005829;GO:0035097;GO:0071339;GO:0005654;GO:0005634;GO:0042800;GO:0042802;GO:0070577;GO:0003680;GO:0042803;GO:0045322;GO:0008270;GO:0006915;GO:0032922;GO:0035162;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0043984;GO:1905642;GO:0051571;GO:0045944;GO:0045893;GO:0032411;GO:0065003;GO:1902036;GO:0071440;GO:2000615;GO:0045652;, C:cytosol; C:histone methyltransferase complex; C:MLL1 complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:identical protein binding; F:lysine-acetylated histone binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein homodimerization activity; F:unmethylated CpG binding; F:zinc ion binding;, P:apoptotic process; P:circadian regulation of gene expression; P:embryonic hemopoiesis; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:negative regulation of DNA methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transporter activity; P:protein-containing complex assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone H3-K14 acetylation; P:regulation of histone H3-K9 acetylation; P:regulation of megakaryocyte differentiation;|Q9UD94 Q9UMA3,Histone-lysine N-methyltransferase 2A,ALL-1 {ECO:0000303|PubMed:12453419};CXXC-type zinc finger protein 7;Myeloid/lymphoid or mixed-lineage leukemia;Myeloid/lymphoid or mixed-lineage leukemia protein 1;Trithorax-like protein;Zinc finger protein HRX;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0005829;GO:0035097;GO:0071339;GO:0005654;GO:0005634;GO:0042800;GO:0042802;GO:0070577;GO:0003680;GO:0042803;GO:0045322;GO:0008270;GO:0006915;GO:0032922;GO:0035162;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0043984;GO:1905642;GO:0051571;GO:0045944;GO:0045893;GO:0032411;GO:0065003;GO:1902036;GO:0071440;GO:2000615;GO:0045652;, C:cytosol; C:histone methyltransferase complex; C:MLL1 complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:identical protein binding; F:lysine-acetylated histone binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein homodimerization activity; F:unmethylated CpG binding; F:zinc ion binding;, P:apoptotic process; P:circadian regulation of gene expression; P:embryonic hemopoiesis; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:negative regulation of DNA methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transporter activity; P:protein-containing complex assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone H3-K14 acetylation; P:regulation of histone H3-K9 acetylation; P:regulation of megakaryocyte differentiation; scaffold30 indexed_genome mRNA 432437 442720 . - . ID=transcript_6505;O75964 A8K0K3 Q96BV6 Q9UBZ7,ATP synthase subunit g, mitochondrial {ECO:0000305},ATP synthase membrane subunit g {ECO:0000305};, PF04718;, GO:0005743;GO:0005753;GO:0000276;GO:0005739;GO:0015078;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion;, F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport;|O75964 A8K0K3 Q96BV6 Q9UBZ7,ATP synthase subunit g, mitochondrial {ECO:0000305},ATP synthase membrane subunit g {ECO:0000305};, PF04718;, GO:0005743;GO:0005753;GO:0000276;GO:0005739;GO:0015078;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion;, F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport;|O75964 A8K0K3 Q96BV6 Q9UBZ7,ATP synthase subunit g, mitochondrial {ECO:0000305},ATP synthase membrane subunit g {ECO:0000305};, PF04718;, GO:0005743;GO:0005753;GO:0000276;GO:0005739;GO:0015078;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion;, F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport;|O75964 A8K0K3 Q96BV6 Q9UBZ7,ATP synthase subunit g, mitochondrial {ECO:0000305},ATP synthase membrane subunit g {ECO:0000305};, PF04718;, GO:0005743;GO:0005753;GO:0000276;GO:0005739;GO:0015078;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion;, F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; scaffold30 indexed_genome mRNA 444732 476021 . - . ID=transcript_6506;Q14139 B0YJB6 Q2M1H0 Q6P5T4 Q7Z639,Ubiquitin conjugation factor E4 A {ECO:0000305},RING-type E3 ubiquitin transferase E4 A;, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0034450;GO:0000209;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q14139 B0YJB6 Q2M1H0 Q6P5T4 Q7Z639,Ubiquitin conjugation factor E4 A {ECO:0000305},RING-type E3 ubiquitin transferase E4 A;, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0034450;GO:0000209;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q14139 B0YJB6 Q2M1H0 Q6P5T4 Q7Z639,Ubiquitin conjugation factor E4 A {ECO:0000305},RING-type E3 ubiquitin transferase E4 A;, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0034450;GO:0000209;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q14139 B0YJB6 Q2M1H0 Q6P5T4 Q7Z639,Ubiquitin conjugation factor E4 A {ECO:0000305},RING-type E3 ubiquitin transferase E4 A;, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0034450;GO:0000209;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q14139 B0YJB6 Q2M1H0 Q6P5T4 Q7Z639,Ubiquitin conjugation factor E4 A {ECO:0000305},RING-type E3 ubiquitin transferase E4 A;, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0034450;GO:0000209;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q14139 B0YJB6 Q2M1H0 Q6P5T4 Q7Z639,Ubiquitin conjugation factor E4 A {ECO:0000305},RING-type E3 ubiquitin transferase E4 A;, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0034450;GO:0000209;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q14139 B0YJB6 Q2M1H0 Q6P5T4 Q7Z639,Ubiquitin conjugation factor E4 A {ECO:0000305},RING-type E3 ubiquitin transferase E4 A;, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0034450;GO:0000209;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold30 indexed_genome mRNA 487044 499030 . - . ID=transcript_6507;P09693 Q2HIZ6,T-cell surface glycoprotein CD3 gamma chain,T-cell receptor T3 gamma chain;, PF16680;PF02189;, GO:0042105;GO:0030669;GO:0005829;GO:0009897;GO:0005887;GO:0005886;GO:0042101;GO:0042802;GO:0046982;GO:0030159;GO:0042608;GO:0004888;GO:0002250;GO:0007166;GO:0007163;GO:0038096;GO:0061024;GO:0002862;GO:0018149;GO:0045059;GO:0015031;GO:0065003;GO:0050776;GO:0070228;GO:0042110;GO:0050852;, C:alpha-beta T cell receptor complex; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane; C:T cell receptor complex;, F:identical protein binding; F:protein heterodimerization activity; F:signaling receptor complex adaptor activity; F:T cell receptor binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:cell surface receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:negative regulation of inflammatory response to antigenic stimulus; P:peptide cross-linking; P:positive thymic T cell selection; P:protein transport; P:protein-containing complex assembly; P:regulation of immune response; P:regulation of lymphocyte apoptotic process; P:T cell activation; P:T cell receptor signaling pathway; scaffold30 indexed_genome mRNA 500855 505864 . + . ID=transcript_6508;P04234 A8MVP6,T-cell surface glycoprotein CD3 delta chain,T-cell receptor T3 delta chain;, PF16680;PF02189;, GO:0042105;GO:0030669;GO:0005737;GO:0009897;GO:0016021;GO:0005886;GO:0042101;GO:0042802;GO:0046982;GO:0004888;GO:0002250;GO:0007166;GO:0061024;GO:0045059;GO:0050776;GO:0050852;, C:alpha-beta T cell receptor complex; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane; C:T cell receptor complex;, F:identical protein binding; F:protein heterodimerization activity; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:cell surface receptor signaling pathway; P:membrane organization; P:positive thymic T cell selection; P:regulation of immune response; P:T cell receptor signaling pathway; scaffold30 indexed_genome mRNA 510388 520861 . + . ID=transcript_6509;P07766 A8K997,T-cell surface glycoprotein CD3 epsilon chain,T-cell surface antigen T3/Leu-4 epsilon chain;, PF02189;, GO:0042105;GO:0044297;GO:0005911;GO:0043197;GO:0005783;GO:0009897;GO:0001772;GO:0005887;GO:0005886;GO:0042101;GO:0042802;GO:0046982;GO:0019901;GO:0017124;GO:0030159;GO:0042608;GO:0004888;GO:0002250;GO:0097190;GO:0007166;GO:0021549;GO:0016358;GO:0007186;GO:0010629;GO:0045879;GO:0045060;GO:0046641;GO:0050850;GO:0033634;GO:0001954;GO:0010628;GO:0032729;GO:0032743;GO:0032753;GO:0050731;GO:0002669;GO:0042102;GO:0045059;GO:0065003;GO:0042981;GO:0050776;GO:0007584;GO:0007172;GO:0042110;GO:0031295;GO:0050852;GO:0007169;, C:alpha-beta T cell receptor complex; C:cell body; C:cell-cell junction; C:dendritic spine; C:endoplasmic reticulum; C:external side of plasma membrane; C:immunological synapse; C:integral component of plasma membrane; C:plasma membrane; C:T cell receptor complex;, F:identical protein binding; F:protein heterodimerization activity; F:protein kinase binding; F:SH3 domain binding; F:signaling receptor complex adaptor activity; F:T cell receptor binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:apoptotic signaling pathway; P:cell surface receptor signaling pathway; P:cerebellum development; P:dendrite development; P:G protein-coupled receptor signaling pathway; P:negative regulation of gene expression; P:negative regulation of smoothened signaling pathway; P:negative thymic T cell selection; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of calcium-mediated signaling; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of cell-matrix adhesion; P:positive regulation of gene expression; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-4 production; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of T cell anergy; P:positive regulation of T cell proliferation; P:positive thymic T cell selection; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of immune response; P:response to nutrient; P:signal complex assembly; P:T cell activation; P:T cell costimulation; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P07766 A8K997,T-cell surface glycoprotein CD3 epsilon chain,T-cell surface antigen T3/Leu-4 epsilon chain;, PF02189;, GO:0042105;GO:0044297;GO:0005911;GO:0043197;GO:0005783;GO:0009897;GO:0001772;GO:0005887;GO:0005886;GO:0042101;GO:0042802;GO:0046982;GO:0019901;GO:0017124;GO:0030159;GO:0042608;GO:0004888;GO:0002250;GO:0097190;GO:0007166;GO:0021549;GO:0016358;GO:0007186;GO:0010629;GO:0045879;GO:0045060;GO:0046641;GO:0050850;GO:0033634;GO:0001954;GO:0010628;GO:0032729;GO:0032743;GO:0032753;GO:0050731;GO:0002669;GO:0042102;GO:0045059;GO:0065003;GO:0042981;GO:0050776;GO:0007584;GO:0007172;GO:0042110;GO:0031295;GO:0050852;GO:0007169;, C:alpha-beta T cell receptor complex; C:cell body; C:cell-cell junction; C:dendritic spine; C:endoplasmic reticulum; C:external side of plasma membrane; C:immunological synapse; C:integral component of plasma membrane; C:plasma membrane; C:T cell receptor complex;, F:identical protein binding; F:protein heterodimerization activity; F:protein kinase binding; F:SH3 domain binding; F:signaling receptor complex adaptor activity; F:T cell receptor binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:apoptotic signaling pathway; P:cell surface receptor signaling pathway; P:cerebellum development; P:dendrite development; P:G protein-coupled receptor signaling pathway; P:negative regulation of gene expression; P:negative regulation of smoothened signaling pathway; P:negative thymic T cell selection; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of calcium-mediated signaling; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of cell-matrix adhesion; P:positive regulation of gene expression; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-4 production; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of T cell anergy; P:positive regulation of T cell proliferation; P:positive thymic T cell selection; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of immune response; P:response to nutrient; P:signal complex assembly; P:T cell activation; P:T cell costimulation; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold30 indexed_genome mRNA 550860 551382 . - . ID=transcript_6510;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold30 indexed_genome mRNA 551711 552621 . + . ID=transcript_6511;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold30 indexed_genome mRNA 568190 579649 . + . ID=transcript_6512;O60487 A8K2R1,Myelin protein zero-like protein 2,Epithelial V-like antigen 1;, PF07686;, GO:0005856;GO:0016021;GO:0009653;GO:0007156;, C:cytoskeleton; C:integral component of membrane;, , P:anatomical structure morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold30 indexed_genome mRNA 579712 603605 . + . ID=transcript_6513;Q6UWV2 A8K025 B4DLD5 B4E2I8,Myelin protein zero-like protein 3,, PF07686;, GO:0016021;GO:0007155;GO:0030198;GO:0042633;, C:integral component of membrane;, , P:cell adhesion; P:extracellular matrix organization; P:hair cycle; scaffold30 indexed_genome mRNA 607204 638142 . + . ID=transcript_6514;Q86YT9 B0YIV1 B0YIV2 Q496M1 Q5DTC6 Q7Z499 Q8N9I7 Q8NF70,Junctional adhesion molecule-like {ECO:0000312|HGNC:HGNC:19084},Adhesion molecule interacting with CXADR antigen 1;Dendritic cell-specific protein CREA7-1;, PF07686;, GO:0005923;GO:0016021;GO:0005654;GO:0005886;GO:0050839;GO:0005178;GO:0042803;GO:0046629;GO:0007157;GO:0050900;GO:0035696;GO:0030593;GO:0072672;GO:0060054;GO:0050776;, C:bicellular tight junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:integrin binding; F:protein homodimerization activity;, P:gamma-delta T cell activation; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:leukocyte migration; P:monocyte extravasation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:positive regulation of epithelial cell proliferation involved in wound healing; P:regulation of immune response;|Q86YT9 B0YIV1 B0YIV2 Q496M1 Q5DTC6 Q7Z499 Q8N9I7 Q8NF70,Junctional adhesion molecule-like {ECO:0000312|HGNC:HGNC:19084},Adhesion molecule interacting with CXADR antigen 1;Dendritic cell-specific protein CREA7-1;, PF07686;, GO:0005923;GO:0016021;GO:0005654;GO:0005886;GO:0050839;GO:0005178;GO:0042803;GO:0046629;GO:0007157;GO:0050900;GO:0035696;GO:0030593;GO:0072672;GO:0060054;GO:0050776;, C:bicellular tight junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:integrin binding; F:protein homodimerization activity;, P:gamma-delta T cell activation; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:leukocyte migration; P:monocyte extravasation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:positive regulation of epithelial cell proliferation involved in wound healing; P:regulation of immune response;|Q86YT9 B0YIV1 B0YIV2 Q496M1 Q5DTC6 Q7Z499 Q8N9I7 Q8NF70,Junctional adhesion molecule-like {ECO:0000312|HGNC:HGNC:19084},Adhesion molecule interacting with CXADR antigen 1;Dendritic cell-specific protein CREA7-1;, PF07686;, GO:0005923;GO:0016021;GO:0005654;GO:0005886;GO:0050839;GO:0005178;GO:0042803;GO:0046629;GO:0007157;GO:0050900;GO:0035696;GO:0030593;GO:0072672;GO:0060054;GO:0050776;, C:bicellular tight junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:integrin binding; F:protein homodimerization activity;, P:gamma-delta T cell activation; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:leukocyte migration; P:monocyte extravasation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:positive regulation of epithelial cell proliferation involved in wound healing; P:regulation of immune response;|Q86YT9 B0YIV1 B0YIV2 Q496M1 Q5DTC6 Q7Z499 Q8N9I7 Q8NF70,Junctional adhesion molecule-like {ECO:0000312|HGNC:HGNC:19084},Adhesion molecule interacting with CXADR antigen 1;Dendritic cell-specific protein CREA7-1;, PF07686;, GO:0005923;GO:0016021;GO:0005654;GO:0005886;GO:0050839;GO:0005178;GO:0042803;GO:0046629;GO:0007157;GO:0050900;GO:0035696;GO:0030593;GO:0072672;GO:0060054;GO:0050776;, C:bicellular tight junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:integrin binding; F:protein homodimerization activity;, P:gamma-delta T cell activation; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:leukocyte migration; P:monocyte extravasation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:positive regulation of epithelial cell proliferation involved in wound healing; P:regulation of immune response;|Q86YT9 B0YIV1 B0YIV2 Q496M1 Q5DTC6 Q7Z499 Q8N9I7 Q8NF70,Junctional adhesion molecule-like {ECO:0000312|HGNC:HGNC:19084},Adhesion molecule interacting with CXADR antigen 1;Dendritic cell-specific protein CREA7-1;, PF07686;, GO:0005923;GO:0016021;GO:0005654;GO:0005886;GO:0050839;GO:0005178;GO:0042803;GO:0046629;GO:0007157;GO:0050900;GO:0035696;GO:0030593;GO:0072672;GO:0060054;GO:0050776;, C:bicellular tight junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:integrin binding; F:protein homodimerization activity;, P:gamma-delta T cell activation; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:leukocyte migration; P:monocyte extravasation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:positive regulation of epithelial cell proliferation involved in wound healing; P:regulation of immune response;|Q86YT9 B0YIV1 B0YIV2 Q496M1 Q5DTC6 Q7Z499 Q8N9I7 Q8NF70,Junctional adhesion molecule-like {ECO:0000312|HGNC:HGNC:19084},Adhesion molecule interacting with CXADR antigen 1;Dendritic cell-specific protein CREA7-1;, PF07686;, GO:0005923;GO:0016021;GO:0005654;GO:0005886;GO:0050839;GO:0005178;GO:0042803;GO:0046629;GO:0007157;GO:0050900;GO:0035696;GO:0030593;GO:0072672;GO:0060054;GO:0050776;, C:bicellular tight junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:integrin binding; F:protein homodimerization activity;, P:gamma-delta T cell activation; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:leukocyte migration; P:monocyte extravasation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:positive regulation of epithelial cell proliferation involved in wound healing; P:regulation of immune response; scaffold30 indexed_genome mRNA 657837 666110 . + . ID=transcript_6515;O60939 O75302 Q9UNN3,Sodium channel subunit beta-2,, PF07686;, GO:0045202;GO:0001518;GO:0017080;GO:0005244;GO:0086006;GO:0086002;GO:0060048;GO:0007268;GO:0086012;GO:0007399;GO:0060371;GO:0086091;GO:2000649;GO:0046684;GO:0035725;, C:synapse; C:voltage-gated sodium channel complex;, F:sodium channel regulator activity; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential;, P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:chemical synaptic transmission; P:membrane depolarization during cardiac muscle cell action potential; P:nervous system development; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:response to pyrethroid; P:sodium ion transmembrane transport; scaffold30 indexed_genome mRNA 676296 697208 . + . ID=transcript_6516;Q8IWT1 E9PPT5 Q6PIG5,Sodium channel subunit beta-4,, PF07686;, GO:0014704;GO:0031226;GO:0001518;GO:0044325;GO:0017080;GO:0005244;GO:0005248;GO:0086006;GO:0086016;GO:0086002;GO:0060048;GO:0086012;GO:0010765;GO:0086091;GO:2000649;GO:0060307;GO:0035725;GO:0006814;, C:intercalated disc; C:intrinsic component of plasma membrane; C:voltage-gated sodium channel complex;, F:ion channel binding; F:sodium channel regulator activity; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential;, P:AV node cell action potential; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of sodium ion transport; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold30 indexed_genome mRNA 836086 850257 . - . ID=transcript_6517;Q13651 A8K6I0 B0YJ27,Interleukin-10 receptor subunit alpha,CDw210a;Interleukin-10 receptor subunit 1;, PF01108;, GO:0005829;GO:0016021;GO:0005886;GO:0004896;GO:0019969;GO:0004920;GO:0038023;GO:0019221;GO:0010507;GO:0046427;GO:0050807;GO:0032496;GO:0070086;, C:cytosol; C:integral component of membrane; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-10 binding; F:interleukin-10 receptor activity; F:signaling receptor activity;, P:cytokine-mediated signaling pathway; P:negative regulation of autophagy; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of synapse organization; P:response to lipopolysaccharide; P:ubiquitin-dependent endocytosis;|Q13651 A8K6I0 B0YJ27,Interleukin-10 receptor subunit alpha,CDw210a;Interleukin-10 receptor subunit 1;, PF01108;, GO:0005829;GO:0016021;GO:0005886;GO:0004896;GO:0019969;GO:0004920;GO:0038023;GO:0019221;GO:0010507;GO:0046427;GO:0050807;GO:0032496;GO:0070086;, C:cytosol; C:integral component of membrane; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-10 binding; F:interleukin-10 receptor activity; F:signaling receptor activity;, P:cytokine-mediated signaling pathway; P:negative regulation of autophagy; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of synapse organization; P:response to lipopolysaccharide; P:ubiquitin-dependent endocytosis; scaffold30 indexed_genome mRNA 969484 1004814 . + . ID=transcript_6518;Q9H0Q3 A8K0R4 J3QLD2 Q6FIG9 Q6UW52,FXYD domain-containing ion transport regulator 6,Phosphohippolin;, PF02038;, GO:0016021;GO:0005886;GO:0099106;GO:0017080;GO:0034220;GO:1903779;GO:2000649;, C:integral component of membrane; C:plasma membrane;, F:ion channel regulator activity; F:sodium channel regulator activity;, P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of sodium ion transmembrane transporter activity;|Q9H0Q3 A8K0R4 J3QLD2 Q6FIG9 Q6UW52,FXYD domain-containing ion transport regulator 6,Phosphohippolin;, PF02038;, GO:0016021;GO:0005886;GO:0099106;GO:0017080;GO:0034220;GO:1903779;GO:2000649;, C:integral component of membrane; C:plasma membrane;, F:ion channel regulator activity; F:sodium channel regulator activity;, P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; scaffold30 indexed_genome mRNA 1017352 1022411 . + . ID=transcript_6519;P54710 Q15332 Q53YC1 Q9GZP3 Q9GZQ7,Sodium/potassium-transporting ATPase subunit gamma,FXYD domain-containing ion transport regulator 2;Sodium pump gamma chain;, PF02038;, GO:0070062;GO:0005886;GO:0005890;GO:0001671;GO:0099106;GO:0030674;GO:0017080;GO:0034220;GO:1903408;GO:1990573;GO:1903779;GO:2000649;GO:0036376;GO:0055085;, C:extracellular exosome; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex;, F:ATPase activator activity; F:ion channel regulator activity; F:protein-macromolecule adaptor activity; F:sodium channel regulator activity;, P:ion transmembrane transport; P:positive regulation of sodium:potassium-exchanging ATPase activity; P:potassium ion import across plasma membrane; P:regulation of cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:sodium ion export across plasma membrane; P:transmembrane transport; scaffold30 indexed_genome mRNA 1057492 1305573 . + . ID=transcript_6520;Q8TD84 G3V1B5 Q76MU9 Q8IZY3 Q8IZY4 Q8WXU7 Q9ULT7,Down syndrome cell adhesion molecule-like protein 1,Down syndrome cell adhesion molecule 2;, PF00041;PF07679;, GO:0030424;GO:0009986;GO:0005615;GO:0016021;GO:0005886;GO:0045202;GO:0098632;GO:0042803;GO:0007411;GO:0007409;GO:0007420;GO:0001709;GO:0007417;GO:0070593;GO:0009953;GO:0048704;GO:0007156;, C:axon; C:cell surface; C:extracellular space; C:integral component of membrane; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:protein homodimerization activity;, P:axon guidance; P:axonogenesis; P:brain development; P:cell fate determination; P:central nervous system development; P:dendrite self-avoidance; P:dorsal/ventral pattern formation; P:embryonic skeletal system morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules;|P60174 B7Z5D8 D3DUS9 P00938 Q6FHP9 Q6IS07 Q8WWD0 Q96AG5,Triosephosphate isomerase {ECO:0000305|PubMed:18562316},Methylglyoxal synthase {ECO:0000250|UniProtKB:P00939};Triose-phosphate isomerase;, PF00121;, GO:0005829;GO:0070062;GO:0005615;GO:0005634;GO:0008929;GO:0042803;GO:0004807;GO:0031625;GO:0061621;GO:0006094;GO:0046166;GO:0019563;GO:0006096;GO:0019242;GO:0007275;, C:cytosol; C:extracellular exosome; C:extracellular space; C:nucleus;, F:methylglyoxal synthase activity; F:protein homodimerization activity; F:triose-phosphate isomerase activity; F:ubiquitin protein ligase binding;, P:canonical glycolysis; P:gluconeogenesis; P:glyceraldehyde-3-phosphate biosynthetic process; P:glycerol catabolic process; P:glycolytic process; P:methylglyoxal biosynthetic process; P:multicellular organism development; scaffold30 indexed_genome mRNA 1359179 1373340 . + . ID=transcript_6521;Q8TD84 G3V1B5 Q76MU9 Q8IZY3 Q8IZY4 Q8WXU7 Q9ULT7,Down syndrome cell adhesion molecule-like protein 1,Down syndrome cell adhesion molecule 2;, PF00041;PF07679;, GO:0030424;GO:0009986;GO:0005615;GO:0016021;GO:0005886;GO:0045202;GO:0098632;GO:0042803;GO:0007411;GO:0007409;GO:0007420;GO:0001709;GO:0007417;GO:0070593;GO:0009953;GO:0048704;GO:0007156;, C:axon; C:cell surface; C:extracellular space; C:integral component of membrane; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:protein homodimerization activity;, P:axon guidance; P:axonogenesis; P:brain development; P:cell fate determination; P:central nervous system development; P:dendrite self-avoidance; P:dorsal/ventral pattern formation; P:embryonic skeletal system morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold30 indexed_genome mRNA 1373414 1387276 . + . ID=transcript_6522;Q8TD84 G3V1B5 Q76MU9 Q8IZY3 Q8IZY4 Q8WXU7 Q9ULT7,Down syndrome cell adhesion molecule-like protein 1,Down syndrome cell adhesion molecule 2;, PF00041;PF07679;, GO:0030424;GO:0009986;GO:0005615;GO:0016021;GO:0005886;GO:0045202;GO:0098632;GO:0042803;GO:0007411;GO:0007409;GO:0007420;GO:0001709;GO:0007417;GO:0070593;GO:0009953;GO:0048704;GO:0007156;, C:axon; C:cell surface; C:extracellular space; C:integral component of membrane; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:protein homodimerization activity;, P:axon guidance; P:axonogenesis; P:brain development; P:cell fate determination; P:central nervous system development; P:dendrite self-avoidance; P:dorsal/ventral pattern formation; P:embryonic skeletal system morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold30 indexed_genome mRNA 1389274 1395901 . + . ID=transcript_6523;Q8TD84 G3V1B5 Q76MU9 Q8IZY3 Q8IZY4 Q8WXU7 Q9ULT7,Down syndrome cell adhesion molecule-like protein 1,Down syndrome cell adhesion molecule 2;, PF00041;PF07679;, GO:0030424;GO:0009986;GO:0005615;GO:0016021;GO:0005886;GO:0045202;GO:0098632;GO:0042803;GO:0007411;GO:0007409;GO:0007420;GO:0001709;GO:0007417;GO:0070593;GO:0009953;GO:0048704;GO:0007156;, C:axon; C:cell surface; C:extracellular space; C:integral component of membrane; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:protein homodimerization activity;, P:axon guidance; P:axonogenesis; P:brain development; P:cell fate determination; P:central nervous system development; P:dendrite self-avoidance; P:dorsal/ventral pattern formation; P:embryonic skeletal system morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q8TD84 G3V1B5 Q76MU9 Q8IZY3 Q8IZY4 Q8WXU7 Q9ULT7,Down syndrome cell adhesion molecule-like protein 1,Down syndrome cell adhesion molecule 2;, PF00041;PF07679;, GO:0030424;GO:0009986;GO:0005615;GO:0016021;GO:0005886;GO:0045202;GO:0098632;GO:0042803;GO:0007411;GO:0007409;GO:0007420;GO:0001709;GO:0007417;GO:0070593;GO:0009953;GO:0048704;GO:0007156;, C:axon; C:cell surface; C:extracellular space; C:integral component of membrane; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:protein homodimerization activity;, P:axon guidance; P:axonogenesis; P:brain development; P:cell fate determination; P:central nervous system development; P:dendrite self-avoidance; P:dorsal/ventral pattern formation; P:embryonic skeletal system morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold30 indexed_genome mRNA 1421062 1428865 . - . ID=transcript_6524;Q9UPV0 Q6PKH9 Q7Z2X9 Q9NVS0 Q9UFJ6,Centrosomal protein of 164 kDa,, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005615;GO:0005654;GO:0051301;GO:0097711;GO:0060271;GO:0006281;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:extracellular space; C:nucleoplasm;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:DNA repair; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|Q9UPV0 Q6PKH9 Q7Z2X9 Q9NVS0 Q9UFJ6,Centrosomal protein of 164 kDa,, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005615;GO:0005654;GO:0051301;GO:0097711;GO:0060271;GO:0006281;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:extracellular space; C:nucleoplasm;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:DNA repair; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|Q9UPV0 Q6PKH9 Q7Z2X9 Q9NVS0 Q9UFJ6,Centrosomal protein of 164 kDa,, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005615;GO:0005654;GO:0051301;GO:0097711;GO:0060271;GO:0006281;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:extracellular space; C:nucleoplasm;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:DNA repair; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|Q9UPV0 Q6PKH9 Q7Z2X9 Q9NVS0 Q9UFJ6,Centrosomal protein of 164 kDa,, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005615;GO:0005654;GO:0051301;GO:0097711;GO:0060271;GO:0006281;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:extracellular space; C:nucleoplasm;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:DNA repair; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; scaffold30 indexed_genome mRNA 1430673 1491310 . - . ID=transcript_6525;Q9UPV0 Q6PKH9 Q7Z2X9 Q9NVS0 Q9UFJ6,Centrosomal protein of 164 kDa,, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005615;GO:0005654;GO:0051301;GO:0097711;GO:0060271;GO:0006281;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:extracellular space; C:nucleoplasm;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:DNA repair; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|Q9UPV0 Q6PKH9 Q7Z2X9 Q9NVS0 Q9UFJ6,Centrosomal protein of 164 kDa,, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005615;GO:0005654;GO:0051301;GO:0097711;GO:0060271;GO:0006281;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:extracellular space; C:nucleoplasm;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:DNA repair; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|Q9UPV0 Q6PKH9 Q7Z2X9 Q9NVS0 Q9UFJ6,Centrosomal protein of 164 kDa,, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005615;GO:0005654;GO:0051301;GO:0097711;GO:0060271;GO:0006281;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:extracellular space; C:nucleoplasm;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:DNA repair; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|Q9UPV0 Q6PKH9 Q7Z2X9 Q9NVS0 Q9UFJ6,Centrosomal protein of 164 kDa,, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005615;GO:0005654;GO:0051301;GO:0097711;GO:0060271;GO:0006281;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:extracellular space; C:nucleoplasm;, , P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:DNA repair; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; scaffold30 indexed_genome mRNA 1498170 1563470 . + . ID=transcript_6526;Q9ULS1,Beta-secretase 1 {ECO:0000305},Aspartyl protease 2 {ECO:0000303|PubMed:10656250};Beta-site amyloid precursor protein cleaving enzyme 1;Memapsin-2 {ECO:0000303|PubMed:10677483, ECO:0000303|PubMed:14567678};Membrane-associated aspartic protease 2;, PF00026;, GO:0030424;GO:0009986;GO:0030659;GO:0030425;GO:0005769;GO:0005788;GO:0005768;GO:0010008;GO:0005794;GO:0070931;GO:0098686;GO:0016021;GO:0005887;GO:0005770;GO:0005764;GO:0016020;GO:0045121;GO:0005771;GO:0043025;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0001540;GO:0004190;GO:0004175;GO:0019899;GO:0008233;GO:1990000;GO:0042987;GO:0034205;GO:0050435;GO:1904646;GO:0071280;GO:0071287;GO:0050966;GO:0006509;GO:0043525;GO:0060134;GO:0016485;GO:0006508;GO:2000300;GO:0010288;GO:0009314;, C:axon; C:cell surface; C:cytoplasmic vesicle membrane; C:dendrite; C:early endosome; C:endoplasmic reticulum lumen; C:endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi-associated vesicle lumen; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:membrane; C:membrane raft; C:multivesicular body; C:neuronal cell body; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, F:amyloid-beta binding; F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:enzyme binding; F:peptidase activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:cellular response to amyloid-beta; P:cellular response to copper ion; P:cellular response to manganese ion; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane protein ectodomain proteolysis; P:positive regulation of neuron apoptotic process; P:prepulse inhibition; P:protein processing; P:proteolysis; P:regulation of synaptic vesicle exocytosis; P:response to lead ion; P:response to radiation;|Q9ULS1,Beta-secretase 1 {ECO:0000305},Aspartyl protease 2 {ECO:0000303|PubMed:10656250};Beta-site amyloid precursor protein cleaving enzyme 1;Memapsin-2 {ECO:0000303|PubMed:10677483, ECO:0000303|PubMed:14567678};Membrane-associated aspartic protease 2;, PF00026;, GO:0030424;GO:0009986;GO:0030659;GO:0030425;GO:0005769;GO:0005788;GO:0005768;GO:0010008;GO:0005794;GO:0070931;GO:0098686;GO:0016021;GO:0005887;GO:0005770;GO:0005764;GO:0016020;GO:0045121;GO:0005771;GO:0043025;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0001540;GO:0004190;GO:0004175;GO:0019899;GO:0008233;GO:1990000;GO:0042987;GO:0034205;GO:0050435;GO:1904646;GO:0071280;GO:0071287;GO:0050966;GO:0006509;GO:0043525;GO:0060134;GO:0016485;GO:0006508;GO:2000300;GO:0010288;GO:0009314;, C:axon; C:cell surface; C:cytoplasmic vesicle membrane; C:dendrite; C:early endosome; C:endoplasmic reticulum lumen; C:endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi-associated vesicle lumen; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:membrane; C:membrane raft; C:multivesicular body; C:neuronal cell body; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, F:amyloid-beta binding; F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:enzyme binding; F:peptidase activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:cellular response to amyloid-beta; P:cellular response to copper ion; P:cellular response to manganese ion; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane protein ectodomain proteolysis; P:positive regulation of neuron apoptotic process; P:prepulse inhibition; P:protein processing; P:proteolysis; P:regulation of synaptic vesicle exocytosis; P:response to lead ion; P:response to radiation;|Q9ULS1,Beta-secretase 1 {ECO:0000305},Aspartyl protease 2 {ECO:0000303|PubMed:10656250};Beta-site amyloid precursor protein cleaving enzyme 1;Memapsin-2 {ECO:0000303|PubMed:10677483, ECO:0000303|PubMed:14567678};Membrane-associated aspartic protease 2;, PF00026;, GO:0030424;GO:0009986;GO:0030659;GO:0030425;GO:0005769;GO:0005788;GO:0005768;GO:0010008;GO:0005794;GO:0070931;GO:0098686;GO:0016021;GO:0005887;GO:0005770;GO:0005764;GO:0016020;GO:0045121;GO:0005771;GO:0043025;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0001540;GO:0004190;GO:0004175;GO:0019899;GO:0008233;GO:1990000;GO:0042987;GO:0034205;GO:0050435;GO:1904646;GO:0071280;GO:0071287;GO:0050966;GO:0006509;GO:0043525;GO:0060134;GO:0016485;GO:0006508;GO:2000300;GO:0010288;GO:0009314;, C:axon; C:cell surface; C:cytoplasmic vesicle membrane; C:dendrite; C:early endosome; C:endoplasmic reticulum lumen; C:endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi-associated vesicle lumen; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:membrane; C:membrane raft; C:multivesicular body; C:neuronal cell body; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, F:amyloid-beta binding; F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:enzyme binding; F:peptidase activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:cellular response to amyloid-beta; P:cellular response to copper ion; P:cellular response to manganese ion; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane protein ectodomain proteolysis; P:positive regulation of neuron apoptotic process; P:prepulse inhibition; P:protein processing; P:proteolysis; P:regulation of synaptic vesicle exocytosis; P:response to lead ion; P:response to radiation;|Q9ULS1,Beta-secretase 1 {ECO:0000305},Aspartyl protease 2 {ECO:0000303|PubMed:10656250};Beta-site amyloid precursor protein cleaving enzyme 1;Memapsin-2 {ECO:0000303|PubMed:10677483, ECO:0000303|PubMed:14567678};Membrane-associated aspartic protease 2;, PF00026;, GO:0030424;GO:0009986;GO:0030659;GO:0030425;GO:0005769;GO:0005788;GO:0005768;GO:0010008;GO:0005794;GO:0070931;GO:0098686;GO:0016021;GO:0005887;GO:0005770;GO:0005764;GO:0016020;GO:0045121;GO:0005771;GO:0043025;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0001540;GO:0004190;GO:0004175;GO:0019899;GO:0008233;GO:1990000;GO:0042987;GO:0034205;GO:0050435;GO:1904646;GO:0071280;GO:0071287;GO:0050966;GO:0006509;GO:0043525;GO:0060134;GO:0016485;GO:0006508;GO:2000300;GO:0010288;GO:0009314;, C:axon; C:cell surface; C:cytoplasmic vesicle membrane; C:dendrite; C:early endosome; C:endoplasmic reticulum lumen; C:endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi-associated vesicle lumen; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:membrane; C:membrane raft; C:multivesicular body; C:neuronal cell body; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, F:amyloid-beta binding; F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:enzyme binding; F:peptidase activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:cellular response to amyloid-beta; P:cellular response to copper ion; P:cellular response to manganese ion; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane protein ectodomain proteolysis; P:positive regulation of neuron apoptotic process; P:prepulse inhibition; P:protein processing; P:proteolysis; P:regulation of synaptic vesicle exocytosis; P:response to lead ion; P:response to radiation;|Q9ULS1,Beta-secretase 1 {ECO:0000305},Aspartyl protease 2 {ECO:0000303|PubMed:10656250};Beta-site amyloid precursor protein cleaving enzyme 1;Memapsin-2 {ECO:0000303|PubMed:10677483, ECO:0000303|PubMed:14567678};Membrane-associated aspartic protease 2;, PF00026;, GO:0030424;GO:0009986;GO:0030659;GO:0030425;GO:0005769;GO:0005788;GO:0005768;GO:0010008;GO:0005794;GO:0070931;GO:0098686;GO:0016021;GO:0005887;GO:0005770;GO:0005764;GO:0016020;GO:0045121;GO:0005771;GO:0043025;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0001540;GO:0004190;GO:0004175;GO:0019899;GO:0008233;GO:1990000;GO:0042987;GO:0034205;GO:0050435;GO:1904646;GO:0071280;GO:0071287;GO:0050966;GO:0006509;GO:0043525;GO:0060134;GO:0016485;GO:0006508;GO:2000300;GO:0010288;GO:0009314;, C:axon; C:cell surface; C:cytoplasmic vesicle membrane; C:dendrite; C:early endosome; C:endoplasmic reticulum lumen; C:endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi-associated vesicle lumen; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:membrane; C:membrane raft; C:multivesicular body; C:neuronal cell body; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, F:amyloid-beta binding; F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:enzyme binding; F:peptidase activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:cellular response to amyloid-beta; P:cellular response to copper ion; P:cellular response to manganese ion; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane protein ectodomain proteolysis; P:positive regulation of neuron apoptotic process; P:prepulse inhibition; P:protein processing; P:proteolysis; P:regulation of synaptic vesicle exocytosis; P:response to lead ion; P:response to radiation;|Q9ULS1,Beta-secretase 1 {ECO:0000305},Aspartyl protease 2 {ECO:0000303|PubMed:10656250};Beta-site amyloid precursor protein cleaving enzyme 1;Memapsin-2 {ECO:0000303|PubMed:10677483, ECO:0000303|PubMed:14567678};Membrane-associated aspartic protease 2;, PF00026;, GO:0030424;GO:0009986;GO:0030659;GO:0030425;GO:0005769;GO:0005788;GO:0005768;GO:0010008;GO:0005794;GO:0070931;GO:0098686;GO:0016021;GO:0005887;GO:0005770;GO:0005764;GO:0016020;GO:0045121;GO:0005771;GO:0043025;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0001540;GO:0004190;GO:0004175;GO:0019899;GO:0008233;GO:1990000;GO:0042987;GO:0034205;GO:0050435;GO:1904646;GO:0071280;GO:0071287;GO:0050966;GO:0006509;GO:0043525;GO:0060134;GO:0016485;GO:0006508;GO:2000300;GO:0010288;GO:0009314;, C:axon; C:cell surface; C:cytoplasmic vesicle membrane; C:dendrite; C:early endosome; C:endoplasmic reticulum lumen; C:endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi-associated vesicle lumen; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:membrane; C:membrane raft; C:multivesicular body; C:neuronal cell body; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network;, F:amyloid-beta binding; F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:enzyme binding; F:peptidase activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:cellular response to amyloid-beta; P:cellular response to copper ion; P:cellular response to manganese ion; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane protein ectodomain proteolysis; P:positive regulation of neuron apoptotic process; P:prepulse inhibition; P:protein processing; P:proteolysis; P:regulation of synaptic vesicle exocytosis; P:response to lead ion; P:response to radiation;|Q8ND24 B2RUW0 B4DTD1,RING finger protein 214,, , GO:0046872;GO:0004842;, , F:metal ion binding; F:ubiquitin-protein transferase activity;|Q8ND24 B2RUW0 B4DTD1,RING finger protein 214,, , GO:0046872;GO:0004842;, , F:metal ion binding; F:ubiquitin-protein transferase activity;|Q8ND24 B2RUW0 B4DTD1,RING finger protein 214,, , GO:0046872;GO:0004842;, , F:metal ion binding; F:ubiquitin-protein transferase activity;|Q8ND24 B2RUW0 B4DTD1,RING finger protein 214,, , GO:0046872;GO:0004842;, , F:metal ion binding; F:ubiquitin-protein transferase activity;|Q8ND24 B2RUW0 B4DTD1,RING finger protein 214,, , GO:0046872;GO:0004842;, , F:metal ion binding; F:ubiquitin-protein transferase activity; scaffold30 indexed_genome mRNA 1586931 1596026 . + . ID=transcript_6527;Q16549 B0YJ60 Q3C1X1 Q53GM4 Q96FK8 Q9UL57,Proprotein convertase subtilisin/kexin type 7,Lymphoma proprotein convertase;Prohormone convertase 7;Proprotein convertase 7;Proprotein convertase 8;Subtilisin/kexin-like protease PC7;, PF01483;PF00082;PF16470;, GO:0030173;GO:0016020;GO:0005802;GO:0008233;GO:0004252;GO:0016486;GO:0016485;, C:integral component of Golgi membrane; C:membrane; C:trans-Golgi network;, F:peptidase activity; F:serine-type endopeptidase activity;, P:peptide hormone processing; P:protein processing;|Q16549 B0YJ60 Q3C1X1 Q53GM4 Q96FK8 Q9UL57,Proprotein convertase subtilisin/kexin type 7,Lymphoma proprotein convertase;Prohormone convertase 7;Proprotein convertase 7;Proprotein convertase 8;Subtilisin/kexin-like protease PC7;, PF01483;PF00082;PF16470;, GO:0030173;GO:0016020;GO:0005802;GO:0008233;GO:0004252;GO:0016486;GO:0016485;, C:integral component of Golgi membrane; C:membrane; C:trans-Golgi network;, F:peptidase activity; F:serine-type endopeptidase activity;, P:peptide hormone processing; P:protein processing;|Q16549 B0YJ60 Q3C1X1 Q53GM4 Q96FK8 Q9UL57,Proprotein convertase subtilisin/kexin type 7,Lymphoma proprotein convertase;Prohormone convertase 7;Proprotein convertase 7;Proprotein convertase 8;Subtilisin/kexin-like protease PC7;, PF01483;PF00082;PF16470;, GO:0030173;GO:0016020;GO:0005802;GO:0008233;GO:0004252;GO:0016486;GO:0016485;, C:integral component of Golgi membrane; C:membrane; C:trans-Golgi network;, F:peptidase activity; F:serine-type endopeptidase activity;, P:peptide hormone processing; P:protein processing; scaffold30 indexed_genome mRNA 1596260 1599929 . - . ID=transcript_6528;Q01995 O15542,Transgelin,22 kDa actin-binding protein;Protein WS3-10;Smooth muscle protein 22-alpha;, PF00402;PF00307;, GO:0005737;GO:0051015;GO:0030855;GO:0007517;, C:cytoplasm;, F:actin filament binding;, P:epithelial cell differentiation; P:muscle organ development;|Q01995 O15542,Transgelin,22 kDa actin-binding protein;Protein WS3-10;Smooth muscle protein 22-alpha;, PF00402;PF00307;, GO:0005737;GO:0051015;GO:0030855;GO:0007517;, C:cytoplasm;, F:actin filament binding;, P:epithelial cell differentiation; P:muscle organ development; scaffold30 indexed_genome mRNA 1603482 1620082 . - . ID=transcript_6529;Q8NBJ9 Q8NBY7 Q9Y357,SID1 transmembrane family member 2,, PF13965;, GO:0016021;GO:0005765;GO:0005764;GO:0005886;GO:0035650;GO:0035612;GO:0003677;GO:0003725;GO:0051032;GO:0051033;GO:0006401;GO:0050658;, C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:DNA binding; F:double-stranded RNA binding; F:nucleic acid transmembrane transporter activity; F:RNA transmembrane transporter activity;, P:RNA catabolic process; P:RNA transport;|Q9NXL6 Q17RR4,SID1 transmembrane family member 1,, PF13965;, GO:0016021;GO:0005764;GO:0005886;GO:0015485;GO:0003725;GO:0051033;GO:0050658;, C:integral component of membrane; C:lysosome; C:plasma membrane;, F:cholesterol binding; F:double-stranded RNA binding; F:RNA transmembrane transporter activity;, P:RNA transport;|Q8NBJ9 Q8NBY7 Q9Y357,SID1 transmembrane family member 2,, PF13965;, GO:0016021;GO:0005765;GO:0005764;GO:0005886;GO:0035650;GO:0035612;GO:0003677;GO:0003725;GO:0051032;GO:0051033;GO:0006401;GO:0050658;, C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:DNA binding; F:double-stranded RNA binding; F:nucleic acid transmembrane transporter activity; F:RNA transmembrane transporter activity;, P:RNA catabolic process; P:RNA transport;|Q8NBJ9 Q8NBY7 Q9Y357,SID1 transmembrane family member 2,, PF13965;, GO:0016021;GO:0005765;GO:0005764;GO:0005886;GO:0035650;GO:0035612;GO:0003677;GO:0003725;GO:0051032;GO:0051033;GO:0006401;GO:0050658;, C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:DNA binding; F:double-stranded RNA binding; F:nucleic acid transmembrane transporter activity; F:RNA transmembrane transporter activity;, P:RNA catabolic process; P:RNA transport;|Q8NBJ9 Q8NBY7 Q9Y357,SID1 transmembrane family member 2,, PF13965;, GO:0016021;GO:0005765;GO:0005764;GO:0005886;GO:0035650;GO:0035612;GO:0003677;GO:0003725;GO:0051032;GO:0051033;GO:0006401;GO:0050658;, C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane;, F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:DNA binding; F:double-stranded RNA binding; F:nucleic acid transmembrane transporter activity; F:RNA transmembrane transporter activity;, P:RNA catabolic process; P:RNA transport; scaffold30 indexed_genome mRNA 1632570 1659147 . - . ID=transcript_6530;P68402 A8DPS5 A8DPS6 A8DPS7 E9PEJ5 E9PLP3 O00687 Q29459 Q6IBR6,Platelet-activating factor acetylhydrolase IB subunit alpha2 {ECO:0000305},PAF acetylhydrolase 30 kDa subunit;PAF-AH subunit beta;, PF13472;, GO:0008247;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0001650;GO:1904813;GO:0005730;GO:0005886;GO:0034774;GO:0003847;GO:0047179;GO:0046982;GO:0042803;GO:0044877;GO:0007420;GO:0016042;GO:0006629;GO:0043312;GO:0016239;GO:0007283;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:fibrillar center; C:ficolin-1-rich granule lumen; C:nucleolus; C:plasma membrane; C:secretory granule lumen;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:platelet-activating factor acetyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding;, P:brain development; P:lipid catabolic process; P:lipid metabolic process; P:neutrophil degranulation; P:positive regulation of macroautophagy; P:spermatogenesis;|P68402 A8DPS5 A8DPS6 A8DPS7 E9PEJ5 E9PLP3 O00687 Q29459 Q6IBR6,Platelet-activating factor acetylhydrolase IB subunit alpha2 {ECO:0000305},PAF acetylhydrolase 30 kDa subunit;PAF-AH subunit beta;, PF13472;, GO:0008247;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0001650;GO:1904813;GO:0005730;GO:0005886;GO:0034774;GO:0003847;GO:0047179;GO:0046982;GO:0042803;GO:0044877;GO:0007420;GO:0016042;GO:0006629;GO:0043312;GO:0016239;GO:0007283;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:fibrillar center; C:ficolin-1-rich granule lumen; C:nucleolus; C:plasma membrane; C:secretory granule lumen;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:platelet-activating factor acetyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding;, P:brain development; P:lipid catabolic process; P:lipid metabolic process; P:neutrophil degranulation; P:positive regulation of macroautophagy; P:spermatogenesis;|P68402 A8DPS5 A8DPS6 A8DPS7 E9PEJ5 E9PLP3 O00687 Q29459 Q6IBR6,Platelet-activating factor acetylhydrolase IB subunit alpha2 {ECO:0000305},PAF acetylhydrolase 30 kDa subunit;PAF-AH subunit beta;, PF13472;, GO:0008247;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0001650;GO:1904813;GO:0005730;GO:0005886;GO:0034774;GO:0003847;GO:0047179;GO:0046982;GO:0042803;GO:0044877;GO:0007420;GO:0016042;GO:0006629;GO:0043312;GO:0016239;GO:0007283;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:fibrillar center; C:ficolin-1-rich granule lumen; C:nucleolus; C:plasma membrane; C:secretory granule lumen;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:platelet-activating factor acetyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding;, P:brain development; P:lipid catabolic process; P:lipid metabolic process; P:neutrophil degranulation; P:positive regulation of macroautophagy; P:spermatogenesis;|P68402 A8DPS5 A8DPS6 A8DPS7 E9PEJ5 E9PLP3 O00687 Q29459 Q6IBR6,Platelet-activating factor acetylhydrolase IB subunit alpha2 {ECO:0000305},PAF acetylhydrolase 30 kDa subunit;PAF-AH subunit beta;, PF13472;, GO:0008247;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0001650;GO:1904813;GO:0005730;GO:0005886;GO:0034774;GO:0003847;GO:0047179;GO:0046982;GO:0042803;GO:0044877;GO:0007420;GO:0016042;GO:0006629;GO:0043312;GO:0016239;GO:0007283;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:fibrillar center; C:ficolin-1-rich granule lumen; C:nucleolus; C:plasma membrane; C:secretory granule lumen;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:platelet-activating factor acetyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding;, P:brain development; P:lipid catabolic process; P:lipid metabolic process; P:neutrophil degranulation; P:positive regulation of macroautophagy; P:spermatogenesis; scaffold30 indexed_genome mRNA 1731879 1971269 . + . ID=transcript_6531;Q9Y2K2 A1A5A8 H0Y494 J3KPC8 Q59FY2 Q5M9N1 Q6P3R6 Q8IYM8 Q9HA50,Serine/threonine-protein kinase SIK3 {ECO:0000305},Salt-inducible kinase 3;Serine/threonine-protein kinase QSK;, PF00069;, GO:0005737;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0050321;GO:0035556;GO:0000226;GO:1904263;GO:1904515;GO:0006468;, C:cytoplasm;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein phosphorylation; scaffold30 indexed_genome mRNA 1971298 1990190 . + . ID=transcript_6532;Q9Y2K2 A1A5A8 H0Y494 J3KPC8 Q59FY2 Q5M9N1 Q6P3R6 Q8IYM8 Q9HA50,Serine/threonine-protein kinase SIK3 {ECO:0000305},Salt-inducible kinase 3;Serine/threonine-protein kinase QSK;, PF00069;, GO:0005737;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0050321;GO:0035556;GO:0000226;GO:1904263;GO:1904515;GO:0006468;, C:cytoplasm;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein phosphorylation;|Q9Y2K2 A1A5A8 H0Y494 J3KPC8 Q59FY2 Q5M9N1 Q6P3R6 Q8IYM8 Q9HA50,Serine/threonine-protein kinase SIK3 {ECO:0000305},Salt-inducible kinase 3;Serine/threonine-protein kinase QSK;, PF00069;, GO:0005737;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0050321;GO:0035556;GO:0000226;GO:1904263;GO:1904515;GO:0006468;, C:cytoplasm;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein phosphorylation;|Q9Y2K2 A1A5A8 H0Y494 J3KPC8 Q59FY2 Q5M9N1 Q6P3R6 Q8IYM8 Q9HA50,Serine/threonine-protein kinase SIK3 {ECO:0000305},Salt-inducible kinase 3;Serine/threonine-protein kinase QSK;, PF00069;, GO:0005737;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0050321;GO:0035556;GO:0000226;GO:1904263;GO:1904515;GO:0006468;, C:cytoplasm;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein phosphorylation;|Q9Y2K2 A1A5A8 H0Y494 J3KPC8 Q59FY2 Q5M9N1 Q6P3R6 Q8IYM8 Q9HA50,Serine/threonine-protein kinase SIK3 {ECO:0000305},Salt-inducible kinase 3;Serine/threonine-protein kinase QSK;, PF00069;, GO:0005737;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0050321;GO:0035556;GO:0000226;GO:1904263;GO:1904515;GO:0006468;, C:cytoplasm;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein phosphorylation;|Q9Y2K2 A1A5A8 H0Y494 J3KPC8 Q59FY2 Q5M9N1 Q6P3R6 Q8IYM8 Q9HA50,Serine/threonine-protein kinase SIK3 {ECO:0000305},Salt-inducible kinase 3;Serine/threonine-protein kinase QSK;, PF00069;, GO:0005737;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0050321;GO:0035556;GO:0000226;GO:1904263;GO:1904515;GO:0006468;, C:cytoplasm;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein phosphorylation; scaffold30 indexed_genome mRNA 2020296 2020935 . - . ID=transcript_6533;P06727 A8MSL6 Q14CW8 Q6Q787,Apolipoprotein A-IV,Apolipoprotein A4;, PF01442;, GO:0072562;GO:0042627;GO:0062023;GO:0005829;GO:0005769;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0034361;GO:0016209;GO:0015485;GO:0120020;GO:0005507;GO:0042802;GO:0008289;GO:0005319;GO:0031210;GO:0060228;GO:0005543;GO:0042803;GO:1990000;GO:0006695;GO:0033344;GO:0042632;GO:0008203;GO:0034378;GO:0034371;GO:0034380;GO:0034375;GO:0042744;GO:0002227;GO:0007159;GO:0016042;GO:0055088;GO:0006869;GO:0042157;GO:0034445;GO:0046470;GO:0033700;GO:0010873;GO:0045723;GO:0046889;GO:0051006;GO:0010898;GO:0065005;GO:0032374;GO:0030300;GO:0019430;GO:0006982;GO:0035634;GO:0001523;GO:0043691;GO:0070328;GO:0034372;, C:blood microparticle; C:chylomicron; C:collagen-containing extracellular matrix; C:cytosol; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:very-low-density lipoprotein particle;, F:antioxidant activity; F:cholesterol binding; F:cholesterol transfer activity; F:copper ion binding; F:identical protein binding; F:lipid binding; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine-sterol O-acyltransferase activator activity; F:phospholipid binding; F:protein homodimerization activity;, P:amyloid fibril formation; P:cholesterol biosynthetic process; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:chylomicron assembly; P:chylomicron remodeling; P:high-density lipoprotein particle assembly; P:high-density lipoprotein particle remodeling; P:hydrogen peroxide catabolic process; P:innate immune response in mucosa; P:leukocyte cell-cell adhesion; P:lipid catabolic process; P:lipid homeostasis; P:lipid transport; P:lipoprotein metabolic process; P:negative regulation of plasma lipoprotein oxidation; P:phosphatidylcholine metabolic process; P:phospholipid efflux; P:positive regulation of cholesterol esterification; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of lipoprotein lipase activity; P:positive regulation of triglyceride catabolic process; P:protein-lipid complex assembly; P:regulation of cholesterol transport; P:regulation of intestinal cholesterol absorption; P:removal of superoxide radicals; P:response to lipid hydroperoxide; P:response to stilbenoid; P:retinoid metabolic process; P:reverse cholesterol transport; P:triglyceride homeostasis; P:very-low-density lipoprotein particle remodeling; scaffold30 indexed_genome mRNA 2049857 2053201 . + . ID=transcript_6534;Q6Q788 B0YIV9 Q3MIK6 Q6UWK9 Q9UBJ3,Apolipoprotein A-V,Apolipoprotein A5;Regeneration-associated protein 3;, PF01442;, GO:0042627;GO:0005769;GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0034364;GO:0005770;GO:0034361;GO:0015485;GO:0008047;GO:0019899;GO:0008201;GO:0060229;GO:0035473;GO:0008289;GO:0060230;GO:0070325;GO:0050750;GO:0031210;GO:0060228;GO:0005543;GO:0055090;GO:0044267;GO:0006695;GO:0033344;GO:0042632;GO:0034380;GO:0006869;GO:0042157;GO:0046470;GO:0033700;GO:0010873;GO:0045723;GO:0046889;GO:0050996;GO:0051006;GO:0048260;GO:0010898;GO:0010902;GO:0043687;GO:0030300;GO:0019222;GO:0042246;GO:0019433;GO:0070328;GO:0006641;GO:0034372;, C:chylomicron; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:high-density lipoprotein particle; C:late endosome; C:very-low-density lipoprotein particle;, F:cholesterol binding; F:enzyme activator activity; F:enzyme binding; F:heparin binding; F:lipase activator activity; F:lipase binding; F:lipid binding; F:lipoprotein lipase activator activity; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylcholine binding; F:phosphatidylcholine-sterol O-acyltransferase activator activity; F:phospholipid binding;, P:acylglycerol homeostasis; P:cellular protein metabolic process; P:cholesterol biosynthetic process; P:cholesterol efflux; P:cholesterol homeostasis; P:high-density lipoprotein particle assembly; P:lipid transport; P:lipoprotein metabolic process; P:phosphatidylcholine metabolic process; P:phospholipid efflux; P:positive regulation of cholesterol esterification; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of lipid catabolic process; P:positive regulation of lipoprotein lipase activity; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of triglyceride catabolic process; P:positive regulation of very-low-density lipoprotein particle remodeling; P:post-translational protein modification; P:regulation of intestinal cholesterol absorption; P:regulation of metabolic process; P:tissue regeneration; P:triglyceride catabolic process; P:triglyceride homeostasis; P:triglyceride metabolic process; P:very-low-density lipoprotein particle remodeling;|Q6Q788 B0YIV9 Q3MIK6 Q6UWK9 Q9UBJ3,Apolipoprotein A-V,Apolipoprotein A5;Regeneration-associated protein 3;, PF01442;, GO:0042627;GO:0005769;GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0034364;GO:0005770;GO:0034361;GO:0015485;GO:0008047;GO:0019899;GO:0008201;GO:0060229;GO:0035473;GO:0008289;GO:0060230;GO:0070325;GO:0050750;GO:0031210;GO:0060228;GO:0005543;GO:0055090;GO:0044267;GO:0006695;GO:0033344;GO:0042632;GO:0034380;GO:0006869;GO:0042157;GO:0046470;GO:0033700;GO:0010873;GO:0045723;GO:0046889;GO:0050996;GO:0051006;GO:0048260;GO:0010898;GO:0010902;GO:0043687;GO:0030300;GO:0019222;GO:0042246;GO:0019433;GO:0070328;GO:0006641;GO:0034372;, C:chylomicron; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:high-density lipoprotein particle; C:late endosome; C:very-low-density lipoprotein particle;, F:cholesterol binding; F:enzyme activator activity; F:enzyme binding; F:heparin binding; F:lipase activator activity; F:lipase binding; F:lipid binding; F:lipoprotein lipase activator activity; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylcholine binding; F:phosphatidylcholine-sterol O-acyltransferase activator activity; F:phospholipid binding;, P:acylglycerol homeostasis; P:cellular protein metabolic process; P:cholesterol biosynthetic process; P:cholesterol efflux; P:cholesterol homeostasis; P:high-density lipoprotein particle assembly; P:lipid transport; P:lipoprotein metabolic process; P:phosphatidylcholine metabolic process; P:phospholipid efflux; P:positive regulation of cholesterol esterification; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of lipid catabolic process; P:positive regulation of lipoprotein lipase activity; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of triglyceride catabolic process; P:positive regulation of very-low-density lipoprotein particle remodeling; P:post-translational protein modification; P:regulation of intestinal cholesterol absorption; P:regulation of metabolic process; P:tissue regeneration; P:triglyceride catabolic process; P:triglyceride homeostasis; P:triglyceride metabolic process; P:very-low-density lipoprotein particle remodeling; scaffold30 indexed_genome mRNA 2054632 2063949 . + . ID=transcript_6535;O75312 Q2TAA0,Zinc finger protein ZPR1,Zinc finger protein 259;, PF03367;, GO:0030424;GO:0015030;GO:0005737;GO:0097504;GO:0030426;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0030971;GO:0031369;GO:0008270;GO:1902742;GO:0061564;GO:0030576;GO:0008283;GO:0071364;GO:0042023;GO:0001833;GO:0000226;GO:0006397;GO:2000672;GO:0010628;GO:0045927;GO:0042307;GO:0033120;GO:0071931;GO:1990261;GO:0031641;GO:0008380;GO:0007165;GO:0021510;GO:0001834;, C:axon; C:Cajal body; C:cytoplasm; C:Gemini of coiled bodies; C:growth cone; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm;, F:receptor tyrosine kinase binding; F:translation initiation factor binding; F:zinc ion binding;, P:apoptotic process involved in development; P:axon development; P:Cajal body organization; P:cell population proliferation; P:cellular response to epidermal growth factor stimulus; P:DNA endoreduplication; P:inner cell mass cell proliferation; P:microtubule cytoskeleton organization; P:mRNA processing; P:negative regulation of motor neuron apoptotic process; P:positive regulation of gene expression; P:positive regulation of growth; P:positive regulation of protein import into nucleus; P:positive regulation of RNA splicing; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:pre-mRNA catabolic process; P:regulation of myelination; P:RNA splicing; P:signal transduction; P:spinal cord development; P:trophectodermal cell proliferation;|O75312 Q2TAA0,Zinc finger protein ZPR1,Zinc finger protein 259;, PF03367;, GO:0030424;GO:0015030;GO:0005737;GO:0097504;GO:0030426;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0030971;GO:0031369;GO:0008270;GO:1902742;GO:0061564;GO:0030576;GO:0008283;GO:0071364;GO:0042023;GO:0001833;GO:0000226;GO:0006397;GO:2000672;GO:0010628;GO:0045927;GO:0042307;GO:0033120;GO:0071931;GO:1990261;GO:0031641;GO:0008380;GO:0007165;GO:0021510;GO:0001834;, C:axon; C:Cajal body; C:cytoplasm; C:Gemini of coiled bodies; C:growth cone; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm;, F:receptor tyrosine kinase binding; F:translation initiation factor binding; F:zinc ion binding;, P:apoptotic process involved in development; P:axon development; P:Cajal body organization; P:cell population proliferation; P:cellular response to epidermal growth factor stimulus; P:DNA endoreduplication; P:inner cell mass cell proliferation; P:microtubule cytoskeleton organization; P:mRNA processing; P:negative regulation of motor neuron apoptotic process; P:positive regulation of gene expression; P:positive regulation of growth; P:positive regulation of protein import into nucleus; P:positive regulation of RNA splicing; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:pre-mRNA catabolic process; P:regulation of myelination; P:RNA splicing; P:signal transduction; P:spinal cord development; P:trophectodermal cell proliferation;|O75312 Q2TAA0,Zinc finger protein ZPR1,Zinc finger protein 259;, PF03367;, GO:0030424;GO:0015030;GO:0005737;GO:0097504;GO:0030426;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0030971;GO:0031369;GO:0008270;GO:1902742;GO:0061564;GO:0030576;GO:0008283;GO:0071364;GO:0042023;GO:0001833;GO:0000226;GO:0006397;GO:2000672;GO:0010628;GO:0045927;GO:0042307;GO:0033120;GO:0071931;GO:1990261;GO:0031641;GO:0008380;GO:0007165;GO:0021510;GO:0001834;, C:axon; C:Cajal body; C:cytoplasm; C:Gemini of coiled bodies; C:growth cone; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm;, F:receptor tyrosine kinase binding; F:translation initiation factor binding; F:zinc ion binding;, P:apoptotic process involved in development; P:axon development; P:Cajal body organization; P:cell population proliferation; P:cellular response to epidermal growth factor stimulus; P:DNA endoreduplication; P:inner cell mass cell proliferation; P:microtubule cytoskeleton organization; P:mRNA processing; P:negative regulation of motor neuron apoptotic process; P:positive regulation of gene expression; P:positive regulation of growth; P:positive regulation of protein import into nucleus; P:positive regulation of RNA splicing; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:pre-mRNA catabolic process; P:regulation of myelination; P:RNA splicing; P:signal transduction; P:spinal cord development; P:trophectodermal cell proliferation;|O75312 Q2TAA0,Zinc finger protein ZPR1,Zinc finger protein 259;, PF03367;, GO:0030424;GO:0015030;GO:0005737;GO:0097504;GO:0030426;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0030971;GO:0031369;GO:0008270;GO:1902742;GO:0061564;GO:0030576;GO:0008283;GO:0071364;GO:0042023;GO:0001833;GO:0000226;GO:0006397;GO:2000672;GO:0010628;GO:0045927;GO:0042307;GO:0033120;GO:0071931;GO:1990261;GO:0031641;GO:0008380;GO:0007165;GO:0021510;GO:0001834;, C:axon; C:Cajal body; C:cytoplasm; C:Gemini of coiled bodies; C:growth cone; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm;, F:receptor tyrosine kinase binding; F:translation initiation factor binding; F:zinc ion binding;, P:apoptotic process involved in development; P:axon development; P:Cajal body organization; P:cell population proliferation; P:cellular response to epidermal growth factor stimulus; P:DNA endoreduplication; P:inner cell mass cell proliferation; P:microtubule cytoskeleton organization; P:mRNA processing; P:negative regulation of motor neuron apoptotic process; P:positive regulation of gene expression; P:positive regulation of growth; P:positive regulation of protein import into nucleus; P:positive regulation of RNA splicing; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:pre-mRNA catabolic process; P:regulation of myelination; P:RNA splicing; P:signal transduction; P:spinal cord development; P:trophectodermal cell proliferation;|O75312 Q2TAA0,Zinc finger protein ZPR1,Zinc finger protein 259;, PF03367;, GO:0030424;GO:0015030;GO:0005737;GO:0097504;GO:0030426;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0030971;GO:0031369;GO:0008270;GO:1902742;GO:0061564;GO:0030576;GO:0008283;GO:0071364;GO:0042023;GO:0001833;GO:0000226;GO:0006397;GO:2000672;GO:0010628;GO:0045927;GO:0042307;GO:0033120;GO:0071931;GO:1990261;GO:0031641;GO:0008380;GO:0007165;GO:0021510;GO:0001834;, C:axon; C:Cajal body; C:cytoplasm; C:Gemini of coiled bodies; C:growth cone; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm;, F:receptor tyrosine kinase binding; F:translation initiation factor binding; F:zinc ion binding;, P:apoptotic process involved in development; P:axon development; P:Cajal body organization; P:cell population proliferation; P:cellular response to epidermal growth factor stimulus; P:DNA endoreduplication; P:inner cell mass cell proliferation; P:microtubule cytoskeleton organization; P:mRNA processing; P:negative regulation of motor neuron apoptotic process; P:positive regulation of gene expression; P:positive regulation of growth; P:positive regulation of protein import into nucleus; P:positive regulation of RNA splicing; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:pre-mRNA catabolic process; P:regulation of myelination; P:RNA splicing; P:signal transduction; P:spinal cord development; P:trophectodermal cell proliferation;|O75312 Q2TAA0,Zinc finger protein ZPR1,Zinc finger protein 259;, PF03367;, GO:0030424;GO:0015030;GO:0005737;GO:0097504;GO:0030426;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0030971;GO:0031369;GO:0008270;GO:1902742;GO:0061564;GO:0030576;GO:0008283;GO:0071364;GO:0042023;GO:0001833;GO:0000226;GO:0006397;GO:2000672;GO:0010628;GO:0045927;GO:0042307;GO:0033120;GO:0071931;GO:1990261;GO:0031641;GO:0008380;GO:0007165;GO:0021510;GO:0001834;, C:axon; C:Cajal body; C:cytoplasm; C:Gemini of coiled bodies; C:growth cone; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm;, F:receptor tyrosine kinase binding; F:translation initiation factor binding; F:zinc ion binding;, P:apoptotic process involved in development; P:axon development; P:Cajal body organization; P:cell population proliferation; P:cellular response to epidermal growth factor stimulus; P:DNA endoreduplication; P:inner cell mass cell proliferation; P:microtubule cytoskeleton organization; P:mRNA processing; P:negative regulation of motor neuron apoptotic process; P:positive regulation of gene expression; P:positive regulation of growth; P:positive regulation of protein import into nucleus; P:positive regulation of RNA splicing; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:pre-mRNA catabolic process; P:regulation of myelination; P:RNA splicing; P:signal transduction; P:spinal cord development; P:trophectodermal cell proliferation;|O75312 Q2TAA0,Zinc finger protein ZPR1,Zinc finger protein 259;, PF03367;, GO:0030424;GO:0015030;GO:0005737;GO:0097504;GO:0030426;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0030971;GO:0031369;GO:0008270;GO:1902742;GO:0061564;GO:0030576;GO:0008283;GO:0071364;GO:0042023;GO:0001833;GO:0000226;GO:0006397;GO:2000672;GO:0010628;GO:0045927;GO:0042307;GO:0033120;GO:0071931;GO:1990261;GO:0031641;GO:0008380;GO:0007165;GO:0021510;GO:0001834;, C:axon; C:Cajal body; C:cytoplasm; C:Gemini of coiled bodies; C:growth cone; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm;, F:receptor tyrosine kinase binding; F:translation initiation factor binding; F:zinc ion binding;, P:apoptotic process involved in development; P:axon development; P:Cajal body organization; P:cell population proliferation; P:cellular response to epidermal growth factor stimulus; P:DNA endoreduplication; P:inner cell mass cell proliferation; P:microtubule cytoskeleton organization; P:mRNA processing; P:negative regulation of motor neuron apoptotic process; P:positive regulation of gene expression; P:positive regulation of growth; P:positive regulation of protein import into nucleus; P:positive regulation of RNA splicing; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:pre-mRNA catabolic process; P:regulation of myelination; P:RNA splicing; P:signal transduction; P:spinal cord development; P:trophectodermal cell proliferation; scaffold30 indexed_genome mRNA 2072964 2089724 . + . ID=transcript_6536;Q9BRD0 A8K0S0 Q96LS7,BUD13 homolog,, PF09736;, GO:0005654;GO:0005634;GO:0070274;GO:0071005;GO:0005684;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus; C:RES complex; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q9BRD0 A8K0S0 Q96LS7,BUD13 homolog,, PF09736;, GO:0005654;GO:0005634;GO:0070274;GO:0071005;GO:0005684;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus; C:RES complex; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; scaffold30 indexed_genome mRNA 3654854 3720364 . + . ID=transcript_6537;X5D2C8,Cell adhesion molecule 1,Immunoglobulin superfamily member 4;Nectin-like protein 2;Spermatogenic immunoglobulin superfamily;Synaptic cell adhesion molecule;Tumor suppressor in lung cancer 1;, PF08205;PF07686;, GO:0016323;GO:0005911;GO:0016021;GO:0005886;GO:0045202;GO:0030165;GO:0042803;GO:0005102;GO:0034332;GO:0006915;GO:0030154;GO:0008037;GO:0051606;GO:0007157;GO:0007156;GO:0002376;GO:0007275;GO:0001819;GO:0045954;GO:0007283;GO:0042271;GO:0016032;, C:basolateral plasma membrane; C:cell-cell junction; C:integral component of membrane; C:plasma membrane; C:synapse;, F:PDZ domain binding; F:protein homodimerization activity; F:signaling receptor binding;, P:adherens junction organization; P:apoptotic process; P:cell differentiation; P:cell recognition; P:detection of stimulus; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:immune system process; P:multicellular organism development; P:positive regulation of cytokine production; P:positive regulation of natural killer cell mediated cytotoxicity; P:spermatogenesis; P:susceptibility to natural killer cell mediated cytotoxicity; P:viral process;|X5D2C8,Cell adhesion molecule 1,Immunoglobulin superfamily member 4;Nectin-like protein 2;Spermatogenic immunoglobulin superfamily;Synaptic cell adhesion molecule;Tumor suppressor in lung cancer 1;, PF08205;PF07686;, GO:0016323;GO:0005911;GO:0016021;GO:0005886;GO:0045202;GO:0030165;GO:0042803;GO:0005102;GO:0034332;GO:0006915;GO:0030154;GO:0008037;GO:0051606;GO:0007157;GO:0007156;GO:0002376;GO:0007275;GO:0001819;GO:0045954;GO:0007283;GO:0042271;GO:0016032;, C:basolateral plasma membrane; C:cell-cell junction; C:integral component of membrane; C:plasma membrane; C:synapse;, F:PDZ domain binding; F:protein homodimerization activity; F:signaling receptor binding;, P:adherens junction organization; P:apoptotic process; P:cell differentiation; P:cell recognition; P:detection of stimulus; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:immune system process; P:multicellular organism development; P:positive regulation of cytokine production; P:positive regulation of natural killer cell mediated cytotoxicity; P:spermatogenesis; P:susceptibility to natural killer cell mediated cytotoxicity; P:viral process;|X5D2C8,Cell adhesion molecule 1,Immunoglobulin superfamily member 4;Nectin-like protein 2;Spermatogenic immunoglobulin superfamily;Synaptic cell adhesion molecule;Tumor suppressor in lung cancer 1;, PF08205;PF07686;, GO:0016323;GO:0005911;GO:0016021;GO:0005886;GO:0045202;GO:0030165;GO:0042803;GO:0005102;GO:0034332;GO:0006915;GO:0030154;GO:0008037;GO:0051606;GO:0007157;GO:0007156;GO:0002376;GO:0007275;GO:0001819;GO:0045954;GO:0007283;GO:0042271;GO:0016032;, C:basolateral plasma membrane; C:cell-cell junction; C:integral component of membrane; C:plasma membrane; C:synapse;, F:PDZ domain binding; F:protein homodimerization activity; F:signaling receptor binding;, P:adherens junction organization; P:apoptotic process; P:cell differentiation; P:cell recognition; P:detection of stimulus; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:immune system process; P:multicellular organism development; P:positive regulation of cytokine production; P:positive regulation of natural killer cell mediated cytotoxicity; P:spermatogenesis; P:susceptibility to natural killer cell mediated cytotoxicity; P:viral process;|X5D2C8,Cell adhesion molecule 1,Immunoglobulin superfamily member 4;Nectin-like protein 2;Spermatogenic immunoglobulin superfamily;Synaptic cell adhesion molecule;Tumor suppressor in lung cancer 1;, PF08205;PF07686;, GO:0016323;GO:0005911;GO:0016021;GO:0005886;GO:0045202;GO:0030165;GO:0042803;GO:0005102;GO:0034332;GO:0006915;GO:0030154;GO:0008037;GO:0051606;GO:0007157;GO:0007156;GO:0002376;GO:0007275;GO:0001819;GO:0045954;GO:0007283;GO:0042271;GO:0016032;, C:basolateral plasma membrane; C:cell-cell junction; C:integral component of membrane; C:plasma membrane; C:synapse;, F:PDZ domain binding; F:protein homodimerization activity; F:signaling receptor binding;, P:adherens junction organization; P:apoptotic process; P:cell differentiation; P:cell recognition; P:detection of stimulus; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:immune system process; P:multicellular organism development; P:positive regulation of cytokine production; P:positive regulation of natural killer cell mediated cytotoxicity; P:spermatogenesis; P:susceptibility to natural killer cell mediated cytotoxicity; P:viral process; scaffold30 indexed_genome mRNA 4291781 4292628 . + . ID=transcript_6538;Q6UWF7 Q6QDB4 Q9NXP5,NXPE family member 4,Protein FAM55D;, PF06312;, GO:0070062;, C:extracellular exosome; scaffold30 indexed_genome mRNA 4292668 4298748 . + . ID=transcript_6539;Q6UWF7 Q6QDB4 Q9NXP5,NXPE family member 4,Protein FAM55D;, PF06312;, GO:0070062;, C:extracellular exosome; scaffold30 indexed_genome mRNA 4411925 4422754 . - . ID=transcript_6540;Q9Y3B8 B2R532 Q32Q18 Q53FT1 Q6FIC6 Q9UFY7,Oligoribonuclease, mitochondrial,RNA exonuclease 2 homolog;Small fragment nuclease;, PF00929;, GO:0005925;GO:0005758;GO:0005759;GO:0005739;GO:0005730;GO:0005634;GO:0008408;GO:0000175;GO:0003676;GO:0006139;GO:0009117;, C:focal adhesion; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleolus; C:nucleus;, F:3'-5' exonuclease activity; F:3'-5'-exoribonuclease activity; F:nucleic acid binding;, P:nucleobase-containing compound metabolic process; P:nucleotide metabolic process;|Q9Y3B8 B2R532 Q32Q18 Q53FT1 Q6FIC6 Q9UFY7,Oligoribonuclease, mitochondrial,RNA exonuclease 2 homolog;Small fragment nuclease;, PF00929;, GO:0005925;GO:0005758;GO:0005759;GO:0005739;GO:0005730;GO:0005634;GO:0008408;GO:0000175;GO:0003676;GO:0006139;GO:0009117;, C:focal adhesion; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleolus; C:nucleus;, F:3'-5' exonuclease activity; F:3'-5'-exoribonuclease activity; F:nucleic acid binding;, P:nucleobase-containing compound metabolic process; P:nucleotide metabolic process;|Q9Y3B8 B2R532 Q32Q18 Q53FT1 Q6FIC6 Q9UFY7,Oligoribonuclease, mitochondrial,RNA exonuclease 2 homolog;Small fragment nuclease;, PF00929;, GO:0005925;GO:0005758;GO:0005759;GO:0005739;GO:0005730;GO:0005634;GO:0008408;GO:0000175;GO:0003676;GO:0006139;GO:0009117;, C:focal adhesion; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleolus; C:nucleus;, F:3'-5' exonuclease activity; F:3'-5'-exoribonuclease activity; F:nucleic acid binding;, P:nucleobase-containing compound metabolic process; P:nucleotide metabolic process;|Q9Y3B8 B2R532 Q32Q18 Q53FT1 Q6FIC6 Q9UFY7,Oligoribonuclease, mitochondrial,RNA exonuclease 2 homolog;Small fragment nuclease;, PF00929;, GO:0005925;GO:0005758;GO:0005759;GO:0005739;GO:0005730;GO:0005634;GO:0008408;GO:0000175;GO:0003676;GO:0006139;GO:0009117;, C:focal adhesion; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleolus; C:nucleus;, F:3'-5' exonuclease activity; F:3'-5'-exoribonuclease activity; F:nucleic acid binding;, P:nucleobase-containing compound metabolic process; P:nucleotide metabolic process; scaffold30 indexed_genome mRNA 4456654 4463901 . - . ID=transcript_6541;Q9Y580 B2R6K8 Q9NUT4,RNA-binding protein 7 {ECO:0000305},RNA-binding motif protein 7 {ECO:0000312|HGNC:HGNC:9904};, PF00076;, GO:0005654;GO:0005634;GO:0071889;GO:0097157;GO:0003723;GO:0003727;GO:0017069;GO:0051321;GO:0000381;GO:0016076;, C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:pre-mRNA intronic binding; F:RNA binding; F:single-stranded RNA binding; F:snRNA binding;, P:meiotic cell cycle; P:regulation of alternative mRNA splicing, via spliceosome; P:snRNA catabolic process;|Q9Y580 B2R6K8 Q9NUT4,RNA-binding protein 7 {ECO:0000305},RNA-binding motif protein 7 {ECO:0000312|HGNC:HGNC:9904};, PF00076;, GO:0005654;GO:0005634;GO:0071889;GO:0097157;GO:0003723;GO:0003727;GO:0017069;GO:0051321;GO:0000381;GO:0016076;, C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:pre-mRNA intronic binding; F:RNA binding; F:single-stranded RNA binding; F:snRNA binding;, P:meiotic cell cycle; P:regulation of alternative mRNA splicing, via spliceosome; P:snRNA catabolic process; scaffold30 indexed_genome mRNA 4463961 4465618 . + . ID=transcript_6542;Q6IPW1 Q6IAD3 Q9NXX1,Uncharacterized protein C11orf71,, PF15747;, GO:0016604;GO:0005654;, C:nuclear body; C:nucleoplasm; scaffold30 indexed_genome mRNA 4598214 4789067 . - . ID=transcript_6543;Q05516 Q8TAL4,Zinc finger and BTB domain-containing protein 16,Promyelocytic leukemia zinc finger protein;Zinc finger protein 145;Zinc finger protein PLZF;, PF00651;PF00096;, GO:0005829;GO:0016604;GO:0016607;GO:0005634;GO:0005886;GO:0016605;GO:0032991;GO:0017053;GO:0003677;GO:0001228;GO:0001227;GO:0042802;GO:0046872;GO:0008022;GO:0019904;GO:0042803;GO:0000978;GO:0009952;GO:0006915;GO:0051216;GO:0007417;GO:0042733;GO:0035116;GO:0009880;GO:0035136;GO:0030097;GO:0048133;GO:0001823;GO:0030099;GO:0008285;GO:0045638;GO:0000122;GO:0045892;GO:0043065;GO:0061036;GO:0032332;GO:0045600;GO:0051138;GO:0045778;GO:0045893;GO:0043687;GO:0034504;GO:0016567;GO:0006357;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleus; C:plasma membrane; C:PML body; C:protein-containing complex; C:transcription repressor complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anterior/posterior pattern specification; P:apoptotic process; P:cartilage development; P:central nervous system development; P:embryonic digit morphogenesis; P:embryonic hindlimb morphogenesis; P:embryonic pattern specification; P:forelimb morphogenesis; P:hemopoiesis; P:male germ-line stem cell asymmetric division; P:mesonephros development; P:myeloid cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of cartilage development; P:positive regulation of chondrocyte differentiation; P:positive regulation of fat cell differentiation; P:positive regulation of NK T cell differentiation; P:positive regulation of ossification; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:protein localization to nucleus; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II;|Q05516 Q8TAL4,Zinc finger and BTB domain-containing protein 16,Promyelocytic leukemia zinc finger protein;Zinc finger protein 145;Zinc finger protein PLZF;, PF00651;PF00096;, GO:0005829;GO:0016604;GO:0016607;GO:0005634;GO:0005886;GO:0016605;GO:0032991;GO:0017053;GO:0003677;GO:0001228;GO:0001227;GO:0042802;GO:0046872;GO:0008022;GO:0019904;GO:0042803;GO:0000978;GO:0009952;GO:0006915;GO:0051216;GO:0007417;GO:0042733;GO:0035116;GO:0009880;GO:0035136;GO:0030097;GO:0048133;GO:0001823;GO:0030099;GO:0008285;GO:0045638;GO:0000122;GO:0045892;GO:0043065;GO:0061036;GO:0032332;GO:0045600;GO:0051138;GO:0045778;GO:0045893;GO:0043687;GO:0034504;GO:0016567;GO:0006357;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleus; C:plasma membrane; C:PML body; C:protein-containing complex; C:transcription repressor complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anterior/posterior pattern specification; P:apoptotic process; P:cartilage development; P:central nervous system development; P:embryonic digit morphogenesis; P:embryonic hindlimb morphogenesis; P:embryonic pattern specification; P:forelimb morphogenesis; P:hemopoiesis; P:male germ-line stem cell asymmetric division; P:mesonephros development; P:myeloid cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of cartilage development; P:positive regulation of chondrocyte differentiation; P:positive regulation of fat cell differentiation; P:positive regulation of NK T cell differentiation; P:positive regulation of ossification; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:protein localization to nucleus; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; scaffold30 indexed_genome mRNA 4859723 4869832 . - . ID=transcript_6544;P46098 B4DSY6 G5E986 O60854 Q7KZM7 Q99918 Q9BSZ9,5-hydroxytryptamine receptor 3A,5-hydroxytryptamine receptor 3;Serotonin receptor 3A;Serotonin-gated ion channel receptor;, PF02931;PF02932;, GO:0030424;GO:0032154;GO:0005737;GO:0098978;GO:0005887;GO:0099055;GO:0099056;GO:0043005;GO:0043025;GO:0005886;GO:1904602;GO:0045202;GO:0030594;GO:0051378;GO:0022850;GO:0004888;GO:0071363;GO:0007268;GO:0034220;GO:0050877;GO:0032414;GO:0042391;GO:0042220;GO:0045471;GO:0007165;, C:axon; C:cleavage furrow; C:cytoplasm; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:serotonin-activated cation-selective channel complex; C:synapse;, F:neurotransmitter receptor activity; F:serotonin binding; F:serotonin-gated cation-selective channel activity; F:transmembrane signaling receptor activity;, P:cellular response to growth factor stimulus; P:chemical synaptic transmission; P:ion transmembrane transport; P:nervous system process; P:positive regulation of ion transmembrane transporter activity; P:regulation of membrane potential; P:response to cocaine; P:response to ethanol; P:signal transduction; scaffold30 indexed_genome mRNA 5003983 5051298 . + . ID=transcript_6545;Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process;|Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process;|Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process;|Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process;|Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process;|Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process;|Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process;|Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process;|Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process;|Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process;|Q96RU2 B0YJC0 B0YJC1 Q6NZX9 Q9P213,Ubiquitin carboxyl-terminal hydrolase 28,Deubiquitinating enzyme 28;Ubiquitin thioesterase 28;Ubiquitin-specific-processing protease 28;, PF00443;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0004197;GO:0004843;GO:0008283;GO:0006974;GO:0034644;GO:0000077;GO:0006281;GO:0042771;GO:0016579;GO:0007265;GO:0031647;GO:0010212;GO:0006511;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA damage checkpoint; P:DNA repair; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of protein stability; P:response to ionizing radiation; P:ubiquitin-dependent protein catabolic process; scaffold30 indexed_genome mRNA 5067110 5101515 . + . ID=transcript_6546;O43264 A1A528,Centromere/kinetochore protein zw10 homolog,, PF06248;, GO:0000777;GO:0005829;GO:0070939;GO:0005783;GO:0005789;GO:0000776;GO:0005828;GO:0005811;GO:0016020;GO:0005634;GO:1990423;GO:0000922;GO:0019237;GO:0051301;GO:0006888;GO:0000132;GO:0007030;GO:0051321;GO:0007080;GO:0000070;GO:0007094;GO:0007052;GO:0034501;GO:0015031;GO:0065003;GO:0007096;GO:0006890;GO:0072413;, C:condensed chromosome kinetochore; C:cytosol; C:Dsl1/NZR complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:kinetochore; C:kinetochore microtubule; C:lipid droplet; C:membrane; C:nucleus; C:RZZ complex; C:spindle pole;, F:centromeric DNA binding;, P:cell division; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of mitotic spindle orientation; P:Golgi organization; P:meiotic cell cycle; P:mitotic metaphase plate congression; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to kinetochore; P:protein transport; P:protein-containing complex assembly; P:regulation of exit from mitosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:signal transduction involved in mitotic cell cycle checkpoint;|O43264 A1A528,Centromere/kinetochore protein zw10 homolog,, PF06248;, GO:0000777;GO:0005829;GO:0070939;GO:0005783;GO:0005789;GO:0000776;GO:0005828;GO:0005811;GO:0016020;GO:0005634;GO:1990423;GO:0000922;GO:0019237;GO:0051301;GO:0006888;GO:0000132;GO:0007030;GO:0051321;GO:0007080;GO:0000070;GO:0007094;GO:0007052;GO:0034501;GO:0015031;GO:0065003;GO:0007096;GO:0006890;GO:0072413;, C:condensed chromosome kinetochore; C:cytosol; C:Dsl1/NZR complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:kinetochore; C:kinetochore microtubule; C:lipid droplet; C:membrane; C:nucleus; C:RZZ complex; C:spindle pole;, F:centromeric DNA binding;, P:cell division; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of mitotic spindle orientation; P:Golgi organization; P:meiotic cell cycle; P:mitotic metaphase plate congression; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to kinetochore; P:protein transport; P:protein-containing complex assembly; P:regulation of exit from mitosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:signal transduction involved in mitotic cell cycle checkpoint;|O43264 A1A528,Centromere/kinetochore protein zw10 homolog,, PF06248;, GO:0000777;GO:0005829;GO:0070939;GO:0005783;GO:0005789;GO:0000776;GO:0005828;GO:0005811;GO:0016020;GO:0005634;GO:1990423;GO:0000922;GO:0019237;GO:0051301;GO:0006888;GO:0000132;GO:0007030;GO:0051321;GO:0007080;GO:0000070;GO:0007094;GO:0007052;GO:0034501;GO:0015031;GO:0065003;GO:0007096;GO:0006890;GO:0072413;, C:condensed chromosome kinetochore; C:cytosol; C:Dsl1/NZR complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:kinetochore; C:kinetochore microtubule; C:lipid droplet; C:membrane; C:nucleus; C:RZZ complex; C:spindle pole;, F:centromeric DNA binding;, P:cell division; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of mitotic spindle orientation; P:Golgi organization; P:meiotic cell cycle; P:mitotic metaphase plate congression; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to kinetochore; P:protein transport; P:protein-containing complex assembly; P:regulation of exit from mitosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:signal transduction involved in mitotic cell cycle checkpoint;|O43264 A1A528,Centromere/kinetochore protein zw10 homolog,, PF06248;, GO:0000777;GO:0005829;GO:0070939;GO:0005783;GO:0005789;GO:0000776;GO:0005828;GO:0005811;GO:0016020;GO:0005634;GO:1990423;GO:0000922;GO:0019237;GO:0051301;GO:0006888;GO:0000132;GO:0007030;GO:0051321;GO:0007080;GO:0000070;GO:0007094;GO:0007052;GO:0034501;GO:0015031;GO:0065003;GO:0007096;GO:0006890;GO:0072413;, C:condensed chromosome kinetochore; C:cytosol; C:Dsl1/NZR complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:kinetochore; C:kinetochore microtubule; C:lipid droplet; C:membrane; C:nucleus; C:RZZ complex; C:spindle pole;, F:centromeric DNA binding;, P:cell division; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of mitotic spindle orientation; P:Golgi organization; P:meiotic cell cycle; P:mitotic metaphase plate congression; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to kinetochore; P:protein transport; P:protein-containing complex assembly; P:regulation of exit from mitosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:signal transduction involved in mitotic cell cycle checkpoint; scaffold30 indexed_genome mRNA 5469558 5484261 . - . ID=transcript_6547;Q9H892 Q8N5H9 Q9NWY3,Tetratricopeptide repeat protein 12,, PF00515;PF13181;, GO:0005813;GO:0005737;GO:0070286;GO:0007288;, C:centrosome; C:cytoplasm;, , P:axonemal dynein complex assembly; P:sperm axoneme assembly;|Q9H892 Q8N5H9 Q9NWY3,Tetratricopeptide repeat protein 12,, PF00515;PF13181;, GO:0005813;GO:0005737;GO:0070286;GO:0007288;, C:centrosome; C:cytoplasm;, , P:axonemal dynein complex assembly; P:sperm axoneme assembly; scaffold30 indexed_genome mRNA 5484279 5507478 . - . ID=transcript_6548;Q9H892 Q8N5H9 Q9NWY3,Tetratricopeptide repeat protein 12,, PF00515;PF13181;, GO:0005813;GO:0005737;GO:0070286;GO:0007288;, C:centrosome; C:cytoplasm;, , P:axonemal dynein complex assembly; P:sperm axoneme assembly; scaffold30 indexed_genome mRNA 5553624 5555739 . + . ID=transcript_6549;Q86X47 Q96CJ3,Neural cell adhesion molecule 1,, PF00041;PF07679;, GO:0031225;GO:0009986;GO:0062023;GO:0005829;GO:0009897;GO:0005576;GO:0000139;GO:0016021;GO:0016020;GO:0043005;GO:0005886;GO:0042802;GO:0001618;GO:0007411;GO:0007155;GO:0071679;GO:0060333;GO:0000165;GO:2001260;, C:anchored component of membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytosol; C:external side of plasma membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:membrane; C:neuron projection; C:plasma membrane;, F:identical protein binding; F:virus receptor activity;, P:axon guidance; P:cell adhesion; P:commissural neuron axon guidance; P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:regulation of semaphorin-plexin signaling pathway; scaffold30 indexed_genome mRNA 5557765 5562972 . - . ID=transcript_6550;Q86X47 Q96CJ3,Neural cell adhesion molecule 1,, PF00041;PF07679;, GO:0031225;GO:0009986;GO:0062023;GO:0005829;GO:0009897;GO:0005576;GO:0000139;GO:0016021;GO:0016020;GO:0043005;GO:0005886;GO:0042802;GO:0001618;GO:0007411;GO:0007155;GO:0071679;GO:0060333;GO:0000165;GO:2001260;, C:anchored component of membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytosol; C:external side of plasma membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:membrane; C:neuron projection; C:plasma membrane;, F:identical protein binding; F:virus receptor activity;, P:axon guidance; P:cell adhesion; P:commissural neuron axon guidance; P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:regulation of semaphorin-plexin signaling pathway; scaffold30 indexed_genome mRNA 5564832 5899742 . - . ID=transcript_6551;Q86X47 Q96CJ3,Neural cell adhesion molecule 1,, PF00041;PF07679;, GO:0031225;GO:0009986;GO:0062023;GO:0005829;GO:0009897;GO:0005576;GO:0000139;GO:0016021;GO:0016020;GO:0043005;GO:0005886;GO:0042802;GO:0001618;GO:0007411;GO:0007155;GO:0071679;GO:0060333;GO:0000165;GO:2001260;, C:anchored component of membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytosol; C:external side of plasma membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:membrane; C:neuron projection; C:plasma membrane;, F:identical protein binding; F:virus receptor activity;, P:axon guidance; P:cell adhesion; P:commissural neuron axon guidance; P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:regulation of semaphorin-plexin signaling pathway;|Q86X47 Q96CJ3,Neural cell adhesion molecule 1,, PF00041;PF07679;, GO:0031225;GO:0009986;GO:0062023;GO:0005829;GO:0009897;GO:0005576;GO:0000139;GO:0016021;GO:0016020;GO:0043005;GO:0005886;GO:0042802;GO:0001618;GO:0007411;GO:0007155;GO:0071679;GO:0060333;GO:0000165;GO:2001260;, C:anchored component of membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytosol; C:external side of plasma membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:membrane; C:neuron projection; C:plasma membrane;, F:identical protein binding; F:virus receptor activity;, P:axon guidance; P:cell adhesion; P:commissural neuron axon guidance; P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:regulation of semaphorin-plexin signaling pathway;|Q86X47 Q96CJ3,Neural cell adhesion molecule 1,, PF00041;PF07679;, GO:0031225;GO:0009986;GO:0062023;GO:0005829;GO:0009897;GO:0005576;GO:0000139;GO:0016021;GO:0016020;GO:0043005;GO:0005886;GO:0042802;GO:0001618;GO:0007411;GO:0007155;GO:0071679;GO:0060333;GO:0000165;GO:2001260;, C:anchored component of membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytosol; C:external side of plasma membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:membrane; C:neuron projection; C:plasma membrane;, F:identical protein binding; F:virus receptor activity;, P:axon guidance; P:cell adhesion; P:commissural neuron axon guidance; P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:regulation of semaphorin-plexin signaling pathway;|Q86X47 Q96CJ3,Neural cell adhesion molecule 1,, PF00041;PF07679;, GO:0031225;GO:0009986;GO:0062023;GO:0005829;GO:0009897;GO:0005576;GO:0000139;GO:0016021;GO:0016020;GO:0043005;GO:0005886;GO:0042802;GO:0001618;GO:0007411;GO:0007155;GO:0071679;GO:0060333;GO:0000165;GO:2001260;, C:anchored component of membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytosol; C:external side of plasma membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:membrane; C:neuron projection; C:plasma membrane;, F:identical protein binding; F:virus receptor activity;, P:axon guidance; P:cell adhesion; P:commissural neuron axon guidance; P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:regulation of semaphorin-plexin signaling pathway;|Q86X47 Q96CJ3,Neural cell adhesion molecule 1,, PF00041;PF07679;, GO:0031225;GO:0009986;GO:0062023;GO:0005829;GO:0009897;GO:0005576;GO:0000139;GO:0016021;GO:0016020;GO:0043005;GO:0005886;GO:0042802;GO:0001618;GO:0007411;GO:0007155;GO:0071679;GO:0060333;GO:0000165;GO:2001260;, C:anchored component of membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytosol; C:external side of plasma membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:membrane; C:neuron projection; C:plasma membrane;, F:identical protein binding; F:virus receptor activity;, P:axon guidance; P:cell adhesion; P:commissural neuron axon guidance; P:interferon-gamma-mediated signaling pathway; P:MAPK cascade; P:regulation of semaphorin-plexin signaling pathway; scaffold30 indexed_genome mRNA 6693571 6694113 . + . ID=transcript_6552;Q6UQ28 Q6UQ24 Q6UQ25 Q6UQ27,Placenta-expressed transcript 1 protein,, , GO:0031225;GO:0016324;GO:0009897;GO:0005576;GO:0005886;GO:0030154;GO:0001953;GO:0030335;GO:0035313;, C:anchored component of membrane; C:apical plasma membrane; C:external side of plasma membrane; C:extracellular region; C:plasma membrane;, , P:cell differentiation; P:negative regulation of cell-matrix adhesion; P:positive regulation of cell migration; P:wound healing, spreading of epidermal cells; scaffold30 indexed_genome mRNA 6695356 6734606 . - . ID=transcript_6553;Q03393 B0YJ87 Q8WVG8,6-pyruvoyl tetrahydrobiopterin synthase,, PF01242;, GO:0005737;GO:0005829;GO:0005739;GO:0003874;GO:0042802;GO:0046872;GO:0006520;GO:0007417;GO:0006729;GO:0046146;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:6-pyruvoyltetrahydropterin synthase activity; F:identical protein binding; F:metal ion binding;, P:cellular amino acid metabolic process; P:central nervous system development; P:tetrahydrobiopterin biosynthetic process; P:tetrahydrobiopterin metabolic process;|P63128 Q9UKH4,Endogenous retrovirus group K member 9 Pol protein,HERV-K(C6) Gag-Pol protein;HERV-K109 Gag-Pol protein;HERV-K_6q14.1 provirus ancestral Gag-Pol polyprotein;, PF00692;PF01585;PF02337;PF00607;PF00077;PF00078;PF00098;, GO:0005886;GO:0004190;GO:0003887;GO:0003723;GO:0003964;GO:0004523;GO:0005198;GO:0008270;GO:0016032;, C:plasma membrane;, F:aspartic-type endopeptidase activity; F:DNA-directed DNA polymerase activity; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:structural molecule activity; F:zinc ion binding;, P:viral process;|P63132,Endogenous retrovirus group K member 113 Pol protein,HERV-K113 Pol protein;HERV-K_19p13.11 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination;|Q03393 B0YJ87 Q8WVG8,6-pyruvoyl tetrahydrobiopterin synthase,, PF01242;, GO:0005737;GO:0005829;GO:0005739;GO:0003874;GO:0042802;GO:0046872;GO:0006520;GO:0007417;GO:0006729;GO:0046146;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:6-pyruvoyltetrahydropterin synthase activity; F:identical protein binding; F:metal ion binding;, P:cellular amino acid metabolic process; P:central nervous system development; P:tetrahydrobiopterin biosynthetic process; P:tetrahydrobiopterin metabolic process;|Q03393 B0YJ87 Q8WVG8,6-pyruvoyl tetrahydrobiopterin synthase,, PF01242;, GO:0005737;GO:0005829;GO:0005739;GO:0003874;GO:0042802;GO:0046872;GO:0006520;GO:0007417;GO:0006729;GO:0046146;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:6-pyruvoyltetrahydropterin synthase activity; F:identical protein binding; F:metal ion binding;, P:cellular amino acid metabolic process; P:central nervous system development; P:tetrahydrobiopterin biosynthetic process; P:tetrahydrobiopterin metabolic process; scaffold30 indexed_genome mRNA 6738006 6811030 . - . ID=transcript_6554;Q9BYV7 B0YIX5 B4DNC3 E9PBI8 E9PJJ1 Q8IUS0 Q96JC8 Q96JY5,Beta,beta-carotene 9',10'-oxygenase,B-diox-II;Beta-carotene dioxygenase 2;, PF03055;, GO:0005759;GO:0005739;GO:0102076;GO:0003834;GO:0010436;GO:0046872;GO:0016702;GO:0016121;GO:0016119;GO:0016116;GO:0051881;GO:2000377;GO:0042574;GO:0042573;GO:0001523;GO:0016122;, C:mitochondrial matrix; C:mitochondrion;, F:beta,beta-carotene-9',10'-cleaving oxygenase activity; F:beta-carotene 15,15'-monooxygenase activity; F:carotenoid dioxygenase activity; F:metal ion binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;, P:carotene catabolic process; P:carotene metabolic process; P:carotenoid metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of reactive oxygen species metabolic process; P:retinal metabolic process; P:retinoic acid metabolic process; P:retinoid metabolic process; P:xanthophyll metabolic process;|Q9BYV7 B0YIX5 B4DNC3 E9PBI8 E9PJJ1 Q8IUS0 Q96JC8 Q96JY5,Beta,beta-carotene 9',10'-oxygenase,B-diox-II;Beta-carotene dioxygenase 2;, PF03055;, GO:0005759;GO:0005739;GO:0102076;GO:0003834;GO:0010436;GO:0046872;GO:0016702;GO:0016121;GO:0016119;GO:0016116;GO:0051881;GO:2000377;GO:0042574;GO:0042573;GO:0001523;GO:0016122;, C:mitochondrial matrix; C:mitochondrion;, F:beta,beta-carotene-9',10'-cleaving oxygenase activity; F:beta-carotene 15,15'-monooxygenase activity; F:carotenoid dioxygenase activity; F:metal ion binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;, P:carotene catabolic process; P:carotene metabolic process; P:carotenoid metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of reactive oxygen species metabolic process; P:retinal metabolic process; P:retinoic acid metabolic process; P:retinoid metabolic process; P:xanthophyll metabolic process;|Q9BYV7 B0YIX5 B4DNC3 E9PBI8 E9PJJ1 Q8IUS0 Q96JC8 Q96JY5,Beta,beta-carotene 9',10'-oxygenase,B-diox-II;Beta-carotene dioxygenase 2;, PF03055;, GO:0005759;GO:0005739;GO:0102076;GO:0003834;GO:0010436;GO:0046872;GO:0016702;GO:0016121;GO:0016119;GO:0016116;GO:0051881;GO:2000377;GO:0042574;GO:0042573;GO:0001523;GO:0016122;, C:mitochondrial matrix; C:mitochondrion;, F:beta,beta-carotene-9',10'-cleaving oxygenase activity; F:beta-carotene 15,15'-monooxygenase activity; F:carotenoid dioxygenase activity; F:metal ion binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;, P:carotene catabolic process; P:carotene metabolic process; P:carotenoid metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of reactive oxygen species metabolic process; P:retinal metabolic process; P:retinoic acid metabolic process; P:retinoid metabolic process; P:xanthophyll metabolic process; scaffold30 indexed_genome mRNA 6815151 6819282 . - . ID=transcript_6555;Q9BXU0 A6NDL9 B0YIX3,Testis-expressed protein 12,, PF15219;, GO:0000801;GO:0005694;GO:0000711;GO:0007130;, C:central element; C:chromosome;, , P:meiotic DNA repair synthesis; P:synaptonemal complex assembly; scaffold30 indexed_genome mRNA 6822450 6851081 . + . ID=transcript_6556;Q14116 O75599 Q6FGY3 Q6WWJ7,Interleukin-18 {ECO:0000303|PubMed:14528293, ECO:0000303|PubMed:25261253, ECO:0000303|PubMed:25500532},Iboctadekin;Interferon gamma-inducing factor {ECO:0000303|PubMed:14528293, ECO:0000303|PubMed:25500532};Interleukin-1 gamma;, PF00340;, GO:0005829;GO:0005576;GO:0005615;GO:0005125;GO:0045515;GO:0032148;GO:0001525;GO:0008283;GO:0007267;GO:0071407;GO:0042632;GO:0019221;GO:0006954;GO:0035655;GO:0031663;GO:0000165;GO:0030101;GO:0042267;GO:0045662;GO:0042119;GO:0042104;GO:0032722;GO:0120162;GO:0032725;GO:0050729;GO:0032729;GO:0032736;GO:0032740;GO:0010744;GO:0032819;GO:0150078;GO:0051092;GO:1901224;GO:0051142;GO:0014068;GO:0051897;GO:0048661;GO:2000556;GO:0045630;GO:0034105;GO:0045944;GO:0042531;GO:0035590;GO:0030155;GO:0030431;GO:0042088;GO:0070328;GO:0042092;, C:cytosol; C:extracellular region; C:extracellular space;, F:cytokine activity; F:interleukin-18 receptor binding;, P:activation of protein kinase B activity; P:angiogenesis; P:cell population proliferation; P:cell-cell signaling; P:cellular response to organic cyclic compound; P:cholesterol homeostasis; P:cytokine-mediated signaling pathway; P:inflammatory response; P:interleukin-18-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:MAPK cascade; P:natural killer cell activation; P:natural killer cell mediated cytotoxicity; P:negative regulation of myoblast differentiation; P:neutrophil activation; P:positive regulation of activated T cell proliferation; P:positive regulation of chemokine production; P:positive regulation of cold-induced thermogenesis; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-17 production; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of natural killer cell proliferation; P:positive regulation of neuroinflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of NK T cell proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T-helper 1 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:positive regulation of tissue remodeling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:purinergic nucleotide receptor signaling pathway; P:regulation of cell adhesion; P:sleep; P:T-helper 1 type immune response; P:triglyceride homeostasis; P:type 2 immune response;|Q14116 O75599 Q6FGY3 Q6WWJ7,Interleukin-18 {ECO:0000303|PubMed:14528293, ECO:0000303|PubMed:25261253, ECO:0000303|PubMed:25500532},Iboctadekin;Interferon gamma-inducing factor {ECO:0000303|PubMed:14528293, ECO:0000303|PubMed:25500532};Interleukin-1 gamma;, PF00340;, GO:0005829;GO:0005576;GO:0005615;GO:0005125;GO:0045515;GO:0032148;GO:0001525;GO:0008283;GO:0007267;GO:0071407;GO:0042632;GO:0019221;GO:0006954;GO:0035655;GO:0031663;GO:0000165;GO:0030101;GO:0042267;GO:0045662;GO:0042119;GO:0042104;GO:0032722;GO:0120162;GO:0032725;GO:0050729;GO:0032729;GO:0032736;GO:0032740;GO:0010744;GO:0032819;GO:0150078;GO:0051092;GO:1901224;GO:0051142;GO:0014068;GO:0051897;GO:0048661;GO:2000556;GO:0045630;GO:0034105;GO:0045944;GO:0042531;GO:0035590;GO:0030155;GO:0030431;GO:0042088;GO:0070328;GO:0042092;, C:cytosol; C:extracellular region; C:extracellular space;, F:cytokine activity; F:interleukin-18 receptor binding;, P:activation of protein kinase B activity; P:angiogenesis; P:cell population proliferation; P:cell-cell signaling; P:cellular response to organic cyclic compound; P:cholesterol homeostasis; P:cytokine-mediated signaling pathway; P:inflammatory response; P:interleukin-18-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:MAPK cascade; P:natural killer cell activation; P:natural killer cell mediated cytotoxicity; P:negative regulation of myoblast differentiation; P:neutrophil activation; P:positive regulation of activated T cell proliferation; P:positive regulation of chemokine production; P:positive regulation of cold-induced thermogenesis; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-17 production; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of natural killer cell proliferation; P:positive regulation of neuroinflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of NK T cell proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T-helper 1 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:positive regulation of tissue remodeling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:purinergic nucleotide receptor signaling pathway; P:regulation of cell adhesion; P:sleep; P:T-helper 1 type immune response; P:triglyceride homeostasis; P:type 2 immune response;|Q14116 O75599 Q6FGY3 Q6WWJ7,Interleukin-18 {ECO:0000303|PubMed:14528293, ECO:0000303|PubMed:25261253, ECO:0000303|PubMed:25500532},Iboctadekin;Interferon gamma-inducing factor {ECO:0000303|PubMed:14528293, ECO:0000303|PubMed:25500532};Interleukin-1 gamma;, PF00340;, GO:0005829;GO:0005576;GO:0005615;GO:0005125;GO:0045515;GO:0032148;GO:0001525;GO:0008283;GO:0007267;GO:0071407;GO:0042632;GO:0019221;GO:0006954;GO:0035655;GO:0031663;GO:0000165;GO:0030101;GO:0042267;GO:0045662;GO:0042119;GO:0042104;GO:0032722;GO:0120162;GO:0032725;GO:0050729;GO:0032729;GO:0032736;GO:0032740;GO:0010744;GO:0032819;GO:0150078;GO:0051092;GO:1901224;GO:0051142;GO:0014068;GO:0051897;GO:0048661;GO:2000556;GO:0045630;GO:0034105;GO:0045944;GO:0042531;GO:0035590;GO:0030155;GO:0030431;GO:0042088;GO:0070328;GO:0042092;, C:cytosol; C:extracellular region; C:extracellular space;, F:cytokine activity; F:interleukin-18 receptor binding;, P:activation of protein kinase B activity; P:angiogenesis; P:cell population proliferation; P:cell-cell signaling; P:cellular response to organic cyclic compound; P:cholesterol homeostasis; P:cytokine-mediated signaling pathway; P:inflammatory response; P:interleukin-18-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:MAPK cascade; P:natural killer cell activation; P:natural killer cell mediated cytotoxicity; P:negative regulation of myoblast differentiation; P:neutrophil activation; P:positive regulation of activated T cell proliferation; P:positive regulation of chemokine production; P:positive regulation of cold-induced thermogenesis; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-17 production; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of natural killer cell proliferation; P:positive regulation of neuroinflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of NK T cell proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T-helper 1 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:positive regulation of tissue remodeling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:purinergic nucleotide receptor signaling pathway; P:regulation of cell adhesion; P:sleep; P:T-helper 1 type immune response; P:triglyceride homeostasis; P:type 2 immune response; scaffold30 indexed_genome mRNA 6911385 6914299 . + . ID=transcript_6557;O14521 A6ND90 B3KQQ8 E9PIC0 E9PIG3 E9PQI9 Q53XW5 Q6IRW2,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial,CII-4;QPs3;Succinate dehydrogenase complex subunit D;Succinate-ubiquinone oxidoreductase cytochrome b small subunit;Succinate-ubiquinone reductase membrane anchor subunit;, , GO:0016021;GO:0005740;GO:0005743;GO:0005749;GO:0005739;GO:0009055;GO:0020037;GO:0046872;GO:0000104;GO:0048039;GO:0006121;GO:0006099;, C:integral component of membrane; C:mitochondrial envelope; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion;, F:electron transfer activity; F:heme binding; F:metal ion binding; F:succinate dehydrogenase activity; F:ubiquinone binding;, P:mitochondrial electron transport, succinate to ubiquinone; P:tricarboxylic acid cycle;|O14521 A6ND90 B3KQQ8 E9PIC0 E9PIG3 E9PQI9 Q53XW5 Q6IRW2,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial,CII-4;QPs3;Succinate dehydrogenase complex subunit D;Succinate-ubiquinone oxidoreductase cytochrome b small subunit;Succinate-ubiquinone reductase membrane anchor subunit;, , GO:0016021;GO:0005740;GO:0005743;GO:0005749;GO:0005739;GO:0009055;GO:0020037;GO:0046872;GO:0000104;GO:0048039;GO:0006121;GO:0006099;, C:integral component of membrane; C:mitochondrial envelope; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion;, F:electron transfer activity; F:heme binding; F:metal ion binding; F:succinate dehydrogenase activity; F:ubiquinone binding;, P:mitochondrial electron transport, succinate to ubiquinone; P:tricarboxylic acid cycle; scaffold30 indexed_genome mRNA 6914332 6915009 . - . ID=transcript_6558;O14521 A6ND90 B3KQQ8 E9PIC0 E9PIG3 E9PQI9 Q53XW5 Q6IRW2,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial,CII-4;QPs3;Succinate dehydrogenase complex subunit D;Succinate-ubiquinone oxidoreductase cytochrome b small subunit;Succinate-ubiquinone reductase membrane anchor subunit;, , GO:0016021;GO:0005740;GO:0005743;GO:0005749;GO:0005739;GO:0009055;GO:0020037;GO:0046872;GO:0000104;GO:0048039;GO:0006121;GO:0006099;, C:integral component of membrane; C:mitochondrial envelope; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion;, F:electron transfer activity; F:heme binding; F:metal ion binding; F:succinate dehydrogenase activity; F:ubiquinone binding;, P:mitochondrial electron transport, succinate to ubiquinone; P:tricarboxylic acid cycle; scaffold30 indexed_genome mRNA 6920823 6921949 . - . ID=transcript_6559;Q9Y5J9 B0YJA5 Q3KQS9 Q9UN04,Mitochondrial import inner membrane translocase subunit Tim8 B,DDP-like protein;Deafness dystonia protein 2;, PF02953;, GO:0005615;GO:0005743;GO:0042719;GO:0140318;GO:0008270;GO:0072321;GO:0045039;GO:0006626;GO:0007605;, C:extracellular space; C:mitochondrial inner membrane; C:mitochondrial intermembrane space protein transporter complex;, F:protein transporter activity; F:zinc ion binding;, P:chaperone-mediated protein transport; P:protein insertion into mitochondrial inner membrane; P:protein targeting to mitochondrion; P:sensory perception of sound; scaffold30 indexed_genome mRNA 6921957 6932924 . - . ID=transcript_6560;Q6ZUT1 Q5RL41 Q6IN53 Q7Z357 Q8N2T3,Uncharacterized protein NKAPD1,NKAP domain containing protein 1 {ECO:0000312|HGNC:HGNC:25569};, , GO:0042802;, , F:identical protein binding; scaffold30 indexed_genome mRNA 6932984 6939590 . + . ID=transcript_6561;Q8WWB5 B4DU48 E9PD82,PIH1 domain-containing protein 2,, PF08190;PF18201;, GO:0005737;GO:0097255;GO:1990904;GO:0031267;GO:0000492;GO:0006364;, C:cytoplasm; C:R2TP complex; C:ribonucleoprotein complex;, F:small GTPase binding;, P:box C/D snoRNP assembly; P:rRNA processing; scaffold30 indexed_genome mRNA 6940511 6973609 . - . ID=transcript_6562;P10515 Q16783 Q53EP3,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial,70 kDa mitochondrial autoantigen of primary biliary cirrhosis;Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex;M2 antigen complex 70 kDa subunit;Pyruvate dehydrogenase complex component E2;, PF00198;PF00364;PF02817;, GO:0043231;GO:0005759;GO:0005967;GO:0005739;GO:0045254;GO:0004742;GO:0042802;GO:0006086;GO:0006006;GO:0006090;GO:0030431;GO:0006099;, C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:pyruvate dehydrogenase complex;, F:dihydrolipoyllysine-residue acetyltransferase activity; F:identical protein binding;, P:acetyl-CoA biosynthetic process from pyruvate; P:glucose metabolic process; P:pyruvate metabolic process; P:sleep; P:tricarboxylic acid cycle;|P10515 Q16783 Q53EP3,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial,70 kDa mitochondrial autoantigen of primary biliary cirrhosis;Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex;M2 antigen complex 70 kDa subunit;Pyruvate dehydrogenase complex component E2;, PF00198;PF00364;PF02817;, GO:0043231;GO:0005759;GO:0005967;GO:0005739;GO:0045254;GO:0004742;GO:0042802;GO:0006086;GO:0006006;GO:0006090;GO:0030431;GO:0006099;, C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:pyruvate dehydrogenase complex;, F:dihydrolipoyllysine-residue acetyltransferase activity; F:identical protein binding;, P:acetyl-CoA biosynthetic process from pyruvate; P:glucose metabolic process; P:pyruvate metabolic process; P:sleep; P:tricarboxylic acid cycle;|P10515 Q16783 Q53EP3,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial,70 kDa mitochondrial autoantigen of primary biliary cirrhosis;Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex;M2 antigen complex 70 kDa subunit;Pyruvate dehydrogenase complex component E2;, PF00198;PF00364;PF02817;, GO:0043231;GO:0005759;GO:0005967;GO:0005739;GO:0045254;GO:0004742;GO:0042802;GO:0006086;GO:0006006;GO:0006090;GO:0030431;GO:0006099;, C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:pyruvate dehydrogenase complex;, F:dihydrolipoyllysine-residue acetyltransferase activity; F:identical protein binding;, P:acetyl-CoA biosynthetic process from pyruvate; P:glucose metabolic process; P:pyruvate metabolic process; P:sleep; P:tricarboxylic acid cycle; scaffold30 indexed_genome mRNA 6975644 7043568 . - . ID=transcript_6563;Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization;|Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization;|Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization;|Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization;|Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization;|Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization;|Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization;|Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization;|Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization;|Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization;|Q155Q3 A1A5D8 E9PRV4 Q6P2J8 Q6PIK4 Q86SR7 Q8IVY4 Q96N69 Q9C0C8,Dixin,Coiled-coil protein DIX1;DIX domain-containing protein 1;, PF00307;PF00778;, GO:0005856;GO:0005829;GO:0005925;GO:0003779;GO:0043015;GO:0019904;GO:0060070;GO:0021799;GO:0021869;GO:0045665;GO:0030177;GO:0032956;GO:0070507;, C:cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:gamma-tubulin binding; F:protein domain specific binding;, P:canonical Wnt signaling pathway; P:cerebral cortex radially oriented cell migration; P:forebrain ventricular zone progenitor cell division; P:negative regulation of neuron differentiation; P:positive regulation of Wnt signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of microtubule cytoskeleton organization; scaffold30 indexed_genome mRNA 7052102 7058898 . - . ID=transcript_6564;Q96A22,Uncharacterized protein C11orf52,, PF15147;, GO:0070062;, C:extracellular exosome; scaffold30 indexed_genome mRNA 7060972 7062585 . - . ID=transcript_6565;Q16082 Q6I9U7,Heat shock protein beta-2,DMPK-binding protein;, PF00525;PF00011;, GO:0005737;GO:0005829;GO:0005634;GO:0008047;GO:0005212;GO:0006986;, C:cytoplasm; C:cytosol; C:nucleus;, F:enzyme activator activity; F:structural constituent of eye lens;, P:response to unfolded protein; scaffold30 indexed_genome mRNA 7072921 7077988 . - . ID=transcript_6566;P02511 B0YIX0 O43416 Q9UC37 Q9UC38 Q9UC39 Q9UC40 Q9UC41,Alpha-crystallin B chain,Alpha(B)-crystallin;Heat shock protein beta-5;Renal carcinoma antigen NY-REN-27;Rosenthal fiber component;, PF00525;PF00011;, GO:0032432;GO:0030424;GO:0097512;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0005794;GO:0031430;GO:0015630;GO:0005739;GO:0005654;GO:0005634;GO:0043204;GO:0014069;GO:0032991;GO:0097060;GO:0030018;GO:0001540;GO:0042802;GO:0046872;GO:0008017;GO:0042803;GO:0044877;GO:0005212;GO:0005198;GO:0051082;GO:0060561;GO:0071480;GO:0002088;GO:0031109;GO:0010259;GO:0006936;GO:0007517;GO:1905907;GO:0043066;GO:0030308;GO:0043154;GO:0032387;GO:0031333;GO:2000378;GO:0045892;GO:0006457;GO:0050821;GO:0010941;GO:1900034;GO:0032355;GO:0042542;GO:0001666;GO:0051403;GO:0007021;, C:actin filament bundle; C:axon; C:cardiac myofibril; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:Golgi apparatus; C:M band; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perikaryon; C:postsynaptic density; C:protein-containing complex; C:synaptic membrane; C:Z disc;, F:amyloid-beta binding; F:identical protein binding; F:metal ion binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:structural constituent of eye lens; F:structural molecule activity; F:unfolded protein binding;, P:apoptotic process involved in morphogenesis; P:cellular response to gamma radiation; P:lens development in camera-type eye; P:microtubule polymerization or depolymerization; P:multicellular organism aging; P:muscle contraction; P:muscle organ development; P:negative regulation of amyloid fibril formation; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of intracellular transport; P:negative regulation of protein-containing complex assembly; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of transcription, DNA-templated; P:protein folding; P:protein stabilization; P:regulation of cell death; P:regulation of cellular response to heat; P:response to estradiol; P:response to hydrogen peroxide; P:response to hypoxia; P:stress-activated MAPK cascade; P:tubulin complex assembly;|P02511 B0YIX0 O43416 Q9UC37 Q9UC38 Q9UC39 Q9UC40 Q9UC41,Alpha-crystallin B chain,Alpha(B)-crystallin;Heat shock protein beta-5;Renal carcinoma antigen NY-REN-27;Rosenthal fiber component;, PF00525;PF00011;, GO:0032432;GO:0030424;GO:0097512;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0005794;GO:0031430;GO:0015630;GO:0005739;GO:0005654;GO:0005634;GO:0043204;GO:0014069;GO:0032991;GO:0097060;GO:0030018;GO:0001540;GO:0042802;GO:0046872;GO:0008017;GO:0042803;GO:0044877;GO:0005212;GO:0005198;GO:0051082;GO:0060561;GO:0071480;GO:0002088;GO:0031109;GO:0010259;GO:0006936;GO:0007517;GO:1905907;GO:0043066;GO:0030308;GO:0043154;GO:0032387;GO:0031333;GO:2000378;GO:0045892;GO:0006457;GO:0050821;GO:0010941;GO:1900034;GO:0032355;GO:0042542;GO:0001666;GO:0051403;GO:0007021;, C:actin filament bundle; C:axon; C:cardiac myofibril; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:Golgi apparatus; C:M band; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perikaryon; C:postsynaptic density; C:protein-containing complex; C:synaptic membrane; C:Z disc;, F:amyloid-beta binding; F:identical protein binding; F:metal ion binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:structural constituent of eye lens; F:structural molecule activity; F:unfolded protein binding;, P:apoptotic process involved in morphogenesis; P:cellular response to gamma radiation; P:lens development in camera-type eye; P:microtubule polymerization or depolymerization; P:multicellular organism aging; P:muscle contraction; P:muscle organ development; P:negative regulation of amyloid fibril formation; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of intracellular transport; P:negative regulation of protein-containing complex assembly; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of transcription, DNA-templated; P:protein folding; P:protein stabilization; P:regulation of cell death; P:regulation of cellular response to heat; P:response to estradiol; P:response to hydrogen peroxide; P:response to hypoxia; P:stress-activated MAPK cascade; P:tubulin complex assembly;|P02511 B0YIX0 O43416 Q9UC37 Q9UC38 Q9UC39 Q9UC40 Q9UC41,Alpha-crystallin B chain,Alpha(B)-crystallin;Heat shock protein beta-5;Renal carcinoma antigen NY-REN-27;Rosenthal fiber component;, PF00525;PF00011;, GO:0032432;GO:0030424;GO:0097512;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0005794;GO:0031430;GO:0015630;GO:0005739;GO:0005654;GO:0005634;GO:0043204;GO:0014069;GO:0032991;GO:0097060;GO:0030018;GO:0001540;GO:0042802;GO:0046872;GO:0008017;GO:0042803;GO:0044877;GO:0005212;GO:0005198;GO:0051082;GO:0060561;GO:0071480;GO:0002088;GO:0031109;GO:0010259;GO:0006936;GO:0007517;GO:1905907;GO:0043066;GO:0030308;GO:0043154;GO:0032387;GO:0031333;GO:2000378;GO:0045892;GO:0006457;GO:0050821;GO:0010941;GO:1900034;GO:0032355;GO:0042542;GO:0001666;GO:0051403;GO:0007021;, C:actin filament bundle; C:axon; C:cardiac myofibril; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:Golgi apparatus; C:M band; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perikaryon; C:postsynaptic density; C:protein-containing complex; C:synaptic membrane; C:Z disc;, F:amyloid-beta binding; F:identical protein binding; F:metal ion binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:structural constituent of eye lens; F:structural molecule activity; F:unfolded protein binding;, P:apoptotic process involved in morphogenesis; P:cellular response to gamma radiation; P:lens development in camera-type eye; P:microtubule polymerization or depolymerization; P:multicellular organism aging; P:muscle contraction; P:muscle organ development; P:negative regulation of amyloid fibril formation; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of intracellular transport; P:negative regulation of protein-containing complex assembly; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of transcription, DNA-templated; P:protein folding; P:protein stabilization; P:regulation of cell death; P:regulation of cellular response to heat; P:response to estradiol; P:response to hydrogen peroxide; P:response to hypoxia; P:stress-activated MAPK cascade; P:tubulin complex assembly; scaffold30 indexed_genome mRNA 7091160 7096615 . + . ID=transcript_6567;Q9BRP7 A0PJW7 B4DUU2,Ferredoxin-fold anticodon-binding domain-containing protein 1,, PF10354;PF03147;, GO:0005737;GO:0070042;GO:0070475;, C:cytoplasm;, F:rRNA (uridine-N3-)-methyltransferase activity;, P:rRNA base methylation; scaffold30 indexed_genome mRNA 7099435 7205240 . + . ID=transcript_6568;Q9H6U8 Q6ZMD5 Q7Z4R4 Q96GS7 Q96PB9 Q9H068,Alpha-1,2-mannosyltransferase ALG9 {ECO:0000305},Asparagine-linked glycosylation protein 9 homolog {ECO:0000312|HGNC:HGNC:15672};Disrupted in bipolar disorder protein 1 {ECO:0000303|PubMed:12030331};Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase {ECO:0000305};Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase {ECO:0000305};, PF03901;, GO:0005789;GO:0016021;GO:0016020;GO:0000026;GO:0052926;GO:0052918;GO:0000030;GO:0006488;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:alpha-1,2-mannosyltransferase activity; F:dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity; F:dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity; F:mannosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein N-linked glycosylation;|Q9H6U8 Q6ZMD5 Q7Z4R4 Q96GS7 Q96PB9 Q9H068,Alpha-1,2-mannosyltransferase ALG9 {ECO:0000305},Asparagine-linked glycosylation protein 9 homolog {ECO:0000312|HGNC:HGNC:15672};Disrupted in bipolar disorder protein 1 {ECO:0000303|PubMed:12030331};Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase {ECO:0000305};Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase {ECO:0000305};, PF03901;, GO:0005789;GO:0016021;GO:0016020;GO:0000026;GO:0052926;GO:0052918;GO:0000030;GO:0006488;GO:0006487;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:alpha-1,2-mannosyltransferase activity; F:dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity; F:dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity; F:mannosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein N-linked glycosylation; scaffold30 indexed_genome mRNA 7227312 7254369 . + . ID=transcript_6569;P30154 A8MY67 B0YJ69 B4DGQ6 B4DK91 B4DWW5 F8W8G1 O75620 Q8NHV8,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,PP2A subunit A isoform PR65-beta;PP2A subunit A isoform R1-beta;, PF02985;, GO:0005737;GO:0070062;GO:0045121;GO:0000159;GO:0008287;GO:0019888;GO:0060561;GO:2001241;GO:0006470;, C:cytoplasm; C:extracellular exosome; C:membrane raft; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:apoptotic process involved in morphogenesis; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein dephosphorylation;|P30153 Q13773 Q6ICQ3 Q96DH3,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,Medium tumor antigen-associated 61 kDa protein;PP2A subunit A isoform PR65-alpha;PP2A subunit A isoform R1-alpha;, PF02985;, GO:0000775;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0016328;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0000159;GO:0008287;GO:1990405;GO:0046982;GO:0019888;GO:0006915;GO:0006672;GO:0007059;GO:0097711;GO:0000086;GO:0000188;GO:0007084;GO:0030308;GO:0042532;GO:0000184;GO:0006470;GO:0065003;GO:0030155;GO:0045595;GO:0006275;GO:0010389;GO:0040008;GO:0006355;GO:0030111;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:lateral plasma membrane; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein antigen binding; F:protein heterodimerization activity; F:protein phosphatase regulator activity;, P:apoptotic process; P:ceramide metabolic process; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:inactivation of MAPK activity; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein dephosphorylation; P:protein-containing complex assembly; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of growth; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling;|P30154 A8MY67 B0YJ69 B4DGQ6 B4DK91 B4DWW5 F8W8G1 O75620 Q8NHV8,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,PP2A subunit A isoform PR65-beta;PP2A subunit A isoform R1-beta;, PF02985;, GO:0005737;GO:0070062;GO:0045121;GO:0000159;GO:0008287;GO:0019888;GO:0060561;GO:2001241;GO:0006470;, C:cytoplasm; C:extracellular exosome; C:membrane raft; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:apoptotic process involved in morphogenesis; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein dephosphorylation;|P30154 A8MY67 B0YJ69 B4DGQ6 B4DK91 B4DWW5 F8W8G1 O75620 Q8NHV8,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,PP2A subunit A isoform PR65-beta;PP2A subunit A isoform R1-beta;, PF02985;, GO:0005737;GO:0070062;GO:0045121;GO:0000159;GO:0008287;GO:0019888;GO:0060561;GO:2001241;GO:0006470;, C:cytoplasm; C:extracellular exosome; C:membrane raft; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:apoptotic process involved in morphogenesis; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein dephosphorylation;|P30154 A8MY67 B0YJ69 B4DGQ6 B4DK91 B4DWW5 F8W8G1 O75620 Q8NHV8,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,PP2A subunit A isoform PR65-beta;PP2A subunit A isoform R1-beta;, PF02985;, GO:0005737;GO:0070062;GO:0045121;GO:0000159;GO:0008287;GO:0019888;GO:0060561;GO:2001241;GO:0006470;, C:cytoplasm; C:extracellular exosome; C:membrane raft; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:apoptotic process involved in morphogenesis; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein dephosphorylation;|P30154 A8MY67 B0YJ69 B4DGQ6 B4DK91 B4DWW5 F8W8G1 O75620 Q8NHV8,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,PP2A subunit A isoform PR65-beta;PP2A subunit A isoform R1-beta;, PF02985;, GO:0005737;GO:0070062;GO:0045121;GO:0000159;GO:0008287;GO:0019888;GO:0060561;GO:2001241;GO:0006470;, C:cytoplasm; C:extracellular exosome; C:membrane raft; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:apoptotic process involved in morphogenesis; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein dephosphorylation;|P30154 A8MY67 B0YJ69 B4DGQ6 B4DK91 B4DWW5 F8W8G1 O75620 Q8NHV8,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,PP2A subunit A isoform PR65-beta;PP2A subunit A isoform R1-beta;, PF02985;, GO:0005737;GO:0070062;GO:0045121;GO:0000159;GO:0008287;GO:0019888;GO:0060561;GO:2001241;GO:0006470;, C:cytoplasm; C:extracellular exosome; C:membrane raft; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:apoptotic process involved in morphogenesis; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein dephosphorylation;|P30154 A8MY67 B0YJ69 B4DGQ6 B4DK91 B4DWW5 F8W8G1 O75620 Q8NHV8,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,PP2A subunit A isoform PR65-beta;PP2A subunit A isoform R1-beta;, PF02985;, GO:0005737;GO:0070062;GO:0045121;GO:0000159;GO:0008287;GO:0019888;GO:0060561;GO:2001241;GO:0006470;, C:cytoplasm; C:extracellular exosome; C:membrane raft; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:apoptotic process involved in morphogenesis; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein dephosphorylation;|P30154 A8MY67 B0YJ69 B4DGQ6 B4DK91 B4DWW5 F8W8G1 O75620 Q8NHV8,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,PP2A subunit A isoform PR65-beta;PP2A subunit A isoform R1-beta;, PF02985;, GO:0005737;GO:0070062;GO:0045121;GO:0000159;GO:0008287;GO:0019888;GO:0060561;GO:2001241;GO:0006470;, C:cytoplasm; C:extracellular exosome; C:membrane raft; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:apoptotic process involved in morphogenesis; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein dephosphorylation; scaffold30 indexed_genome mRNA 7262634 7382983 . - . ID=transcript_6570;Q9H0K1 A8K5B8 B0YJ94 O94878 Q17RV0 Q6AZE2 Q76N03 Q8NCV7 Q96CZ8,Serine/threonine-protein kinase SIK2,Qin-induced kinase;Salt-inducible kinase 2;Serine/threonine-protein kinase SNF1-like kinase 2;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0042149;GO:0035556;GO:0046777;GO:0006468;GO:0046626;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to glucose starvation; P:intracellular signal transduction; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of insulin receptor signaling pathway;|Q9H0K1 A8K5B8 B0YJ94 O94878 Q17RV0 Q6AZE2 Q76N03 Q8NCV7 Q96CZ8,Serine/threonine-protein kinase SIK2,Qin-induced kinase;Salt-inducible kinase 2;Serine/threonine-protein kinase SNF1-like kinase 2;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0042149;GO:0035556;GO:0046777;GO:0006468;GO:0046626;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to glucose starvation; P:intracellular signal transduction; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of insulin receptor signaling pathway;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold30 indexed_genome mRNA 7462792 7463418 . - . ID=transcript_6571;Q6UX15 A6NJB0 B4DJU0 Q8TAY8 Q96NC5 Q96NF3,Layilin,, PF00059;, GO:0009986;GO:0005925;GO:0016021;GO:0001726;GO:0030246;GO:0005540;, C:cell surface; C:focal adhesion; C:integral component of membrane; C:ruffle;, F:carbohydrate binding; F:hyaluronic acid binding; scaffold30 indexed_genome mRNA 7493858 7525371 . - . ID=transcript_6572;Q6PI97 E9PAN0 Q6ZRL3,Cilia- and flagella-associated protein HOATZ {ECO:0000312|HGNC:HGNC:25061},, PF17664;, GO:0005929;GO:0005737;GO:0035082;GO:0060271;GO:0030317;GO:0007283;, C:cilium; C:cytoplasm;, , P:axoneme assembly; P:cilium assembly; P:flagellated sperm motility; P:spermatogenesis; scaffold30 indexed_genome mRNA 7687703 7691779 . + . ID=transcript_6573;Q16633 B2R8Z9 Q14983,POU domain class 2-associating factor 1 {ECO:0000305},B-cell-specific coactivator OBF-1;BOB-1 {ECO:0000303|PubMed:7779176};OCA-B;OCT-binding factor 1;, PF09310;, GO:0090575;GO:0003677;GO:0003713;GO:0003712;GO:0098586;GO:0002314;GO:0006959;GO:0032755;GO:0045944;, C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:cellular response to virus; P:germinal center B cell differentiation; P:humoral immune response; P:positive regulation of interleukin-6 production; P:positive regulation of transcription by RNA polymerase II; scaffold30 indexed_genome mRNA 7740296 7748573 . - . ID=transcript_6574;A8K830 E9PMJ8 Q2TBJ3 V5LD62 V5LDI3 V5LDV1 V5LE09 V5LEU3,Colorectal cancer-associated protein 2,Cancer susceptibility candidate protein 13;, , GO:0005737;, C:cytoplasm; scaffold30 indexed_genome mRNA 8637180 8649983 . + . ID=transcript_6575;Q9P2F6 A8K8C5 B0YIW7 B0YIW8 Q6RJU1 Q6RJU2 Q6RJU3 Q6RJU5 Q8IXS1,Rho GTPase-activating protein 20,Rho-type GTPase-activating protein 20;, PF00788;PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9P2F6 A8K8C5 B0YIW7 B0YIW8 Q6RJU1 Q6RJU2 Q6RJU3 Q6RJU5 Q8IXS1,Rho GTPase-activating protein 20,Rho-type GTPase-activating protein 20;, PF00788;PF00620;, GO:0005829;GO:0005096;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold30 indexed_genome mRNA 8740936 8785759 . - . ID=transcript_6576;P10109 B0YJ14 Q53YD6,Adrenodoxin, mitochondrial,Adrenal ferredoxin;Ferredoxin-1;Hepatoredoxin;, PF00111;, GO:0005759;GO:0005739;GO:0051537;GO:0009055;GO:0005506;GO:0006700;GO:0071320;GO:1904322;GO:0008203;GO:0006124;GO:0042446;GO:0016125;, C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:iron ion binding;, P:C21-steroid hormone biosynthetic process; P:cellular response to cAMP; P:cellular response to forskolin; P:cholesterol metabolic process; P:ferredoxin metabolic process; P:hormone biosynthetic process; P:sterol metabolic process;|P10109 B0YJ14 Q53YD6,Adrenodoxin, mitochondrial,Adrenal ferredoxin;Ferredoxin-1;Hepatoredoxin;, PF00111;, GO:0005759;GO:0005739;GO:0051537;GO:0009055;GO:0005506;GO:0006700;GO:0071320;GO:1904322;GO:0008203;GO:0006124;GO:0042446;GO:0016125;, C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:iron ion binding;, P:C21-steroid hormone biosynthetic process; P:cellular response to cAMP; P:cellular response to forskolin; P:cholesterol metabolic process; P:ferredoxin metabolic process; P:hormone biosynthetic process; P:sterol metabolic process; scaffold30 indexed_genome mRNA 8892102 8958730 . + . ID=transcript_6577;P35241 A7YIJ8 A7YIK0 A7YIK3 B7Z9U6 F5H1A7 Q86Y61,Radixin,, PF00769;PF09380;PF00373;PF09379;, GO:0005912;GO:0016324;GO:0071944;GO:0051286;GO:0032154;GO:0030864;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0030027;GO:0005902;GO:0030496;GO:0005886;GO:0030315;GO:0003779;GO:0051117;GO:0045296;GO:0051018;GO:0003723;GO:0045176;GO:0051016;GO:0036120;GO:0097067;GO:0061028;GO:0045184;GO:1903392;GO:0045792;GO:0034260;GO:0034111;GO:0030335;GO:1903364;GO:2000643;GO:1900087;GO:0010628;GO:1902966;GO:0010737;GO:0072659;GO:0032231;GO:0008360;GO:0008361;GO:0043087;GO:1902115;GO:0032487;GO:1900027;, C:adherens junction; C:apical plasma membrane; C:cell periphery; C:cell tip; C:cleavage furrow; C:cortical actin cytoskeleton; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:lamellipodium; C:microvillus; C:midbody; C:plasma membrane; C:T-tubule;, F:actin binding; F:ATPase binding; F:cadherin binding; F:protein kinase A binding; F:RNA binding;, P:apical protein localization; P:barbed-end actin filament capping; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to thyroid hormone stimulus; P:establishment of endothelial barrier; P:establishment of protein localization; P:negative regulation of adherens junction organization; P:negative regulation of cell size; P:negative regulation of GTPase activity; P:negative regulation of homotypic cell-cell adhesion; P:positive regulation of cell migration; P:positive regulation of cellular protein catabolic process; P:positive regulation of early endosome to late endosome transport; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of protein localization to early endosome; P:protein kinase A signaling; P:protein localization to plasma membrane; P:regulation of actin filament bundle assembly; P:regulation of cell shape; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of organelle assembly; P:regulation of Rap protein signal transduction; P:regulation of ruffle assembly;|P35241 A7YIJ8 A7YIK0 A7YIK3 B7Z9U6 F5H1A7 Q86Y61,Radixin,, PF00769;PF09380;PF00373;PF09379;, GO:0005912;GO:0016324;GO:0071944;GO:0051286;GO:0032154;GO:0030864;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0030027;GO:0005902;GO:0030496;GO:0005886;GO:0030315;GO:0003779;GO:0051117;GO:0045296;GO:0051018;GO:0003723;GO:0045176;GO:0051016;GO:0036120;GO:0097067;GO:0061028;GO:0045184;GO:1903392;GO:0045792;GO:0034260;GO:0034111;GO:0030335;GO:1903364;GO:2000643;GO:1900087;GO:0010628;GO:1902966;GO:0010737;GO:0072659;GO:0032231;GO:0008360;GO:0008361;GO:0043087;GO:1902115;GO:0032487;GO:1900027;, C:adherens junction; C:apical plasma membrane; C:cell periphery; C:cell tip; C:cleavage furrow; C:cortical actin cytoskeleton; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:lamellipodium; C:microvillus; C:midbody; C:plasma membrane; C:T-tubule;, F:actin binding; F:ATPase binding; F:cadherin binding; F:protein kinase A binding; F:RNA binding;, P:apical protein localization; P:barbed-end actin filament capping; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to thyroid hormone stimulus; P:establishment of endothelial barrier; P:establishment of protein localization; P:negative regulation of adherens junction organization; P:negative regulation of cell size; P:negative regulation of GTPase activity; P:negative regulation of homotypic cell-cell adhesion; P:positive regulation of cell migration; P:positive regulation of cellular protein catabolic process; P:positive regulation of early endosome to late endosome transport; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of protein localization to early endosome; P:protein kinase A signaling; P:protein localization to plasma membrane; P:regulation of actin filament bundle assembly; P:regulation of cell shape; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of organelle assembly; P:regulation of Rap protein signal transduction; P:regulation of ruffle assembly; scaffold30 indexed_genome mRNA 8987537 9022503 . - . ID=transcript_6578;Q9C0D7 B4DI65 B4DR47,Probable ribonuclease ZC3H12C,MCP-induced protein 3;Zinc finger CCCH domain-containing protein 12C;, PF18561;PF11977;PF18039;, GO:0036464;GO:0005634;GO:0004521;GO:0046872;GO:0003729;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:nucleus;, F:endoribonuclease activity; F:metal ion binding; F:mRNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold30 indexed_genome mRNA 10502237 10792638 . - . ID=transcript_6579;Q13206 B2RCQ3 Q5BJD8,Probable ATP-dependent RNA helicase DDX10,DEAD box protein 10;, PF00270;PF13959;PF00271;, GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0097065;GO:0006364;, C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:anterior head development; P:rRNA processing; scaffold30 indexed_genome mRNA 10913804 10945168 . + . ID=transcript_6580;Q8NEV8 Q2KHM1 Q9Y4D6,Exophilin-5,Synaptotagmin-like protein homolog lacking C2 domains b;, , GO:0005768;GO:0031267;GO:0006886;GO:0003334;GO:0071985;GO:0045921;GO:0050714;, C:endosome;, F:small GTPase binding;, P:intracellular protein transport; P:keratinocyte development; P:multivesicular body sorting pathway; P:positive regulation of exocytosis; P:positive regulation of protein secretion;|Q8NEV8 Q2KHM1 Q9Y4D6,Exophilin-5,Synaptotagmin-like protein homolog lacking C2 domains b;, , GO:0005768;GO:0031267;GO:0006886;GO:0003334;GO:0071985;GO:0045921;GO:0050714;, C:endosome;, F:small GTPase binding;, P:intracellular protein transport; P:keratinocyte development; P:multivesicular body sorting pathway; P:positive regulation of exocytosis; P:positive regulation of protein secretion;|Q8NEV8 Q2KHM1 Q9Y4D6,Exophilin-5,Synaptotagmin-like protein homolog lacking C2 domains b;, , GO:0005768;GO:0031267;GO:0006886;GO:0003334;GO:0071985;GO:0045921;GO:0050714;, C:endosome;, F:small GTPase binding;, P:intracellular protein transport; P:keratinocyte development; P:multivesicular body sorting pathway; P:positive regulation of exocytosis; P:positive regulation of protein secretion;|Q8NEV8 Q2KHM1 Q9Y4D6,Exophilin-5,Synaptotagmin-like protein homolog lacking C2 domains b;, , GO:0005768;GO:0031267;GO:0006886;GO:0003334;GO:0071985;GO:0045921;GO:0050714;, C:endosome;, F:small GTPase binding;, P:intracellular protein transport; P:keratinocyte development; P:multivesicular body sorting pathway; P:positive regulation of exocytosis; P:positive regulation of protein secretion; scaffold30 indexed_genome mRNA 10948389 10989985 . + . ID=transcript_6581;Q7Z4H8 Q6UWW2 Q6ZUM9 Q8N7L8 Q8NE24,Protein O-glucosyltransferase 3 {ECO:0000305|PubMed:30127001},KDEL motif-containing protein 2 {ECO:0000312|HGNC:HGNC:28496};Protein O-xylosyltransferase POGLUT3 {ECO:0000305|PubMed:30127001};, PF00630;PF05686;, GO:0012505;GO:0005788;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0018242;, C:endomembrane system; C:endoplasmic reticulum lumen;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:protein O-linked glycosylation via serine;|Q7Z4H8 Q6UWW2 Q6ZUM9 Q8N7L8 Q8NE24,Protein O-glucosyltransferase 3 {ECO:0000305|PubMed:30127001},KDEL motif-containing protein 2 {ECO:0000312|HGNC:HGNC:28496};Protein O-xylosyltransferase POGLUT3 {ECO:0000305|PubMed:30127001};, PF00630;PF05686;, GO:0012505;GO:0005788;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0018242;, C:endomembrane system; C:endoplasmic reticulum lumen;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:protein O-linked glycosylation via serine; scaffold30 indexed_genome mRNA 11095864 11262861 . - . ID=transcript_6582;Q13315 B2RNX5 O15429 Q12758 Q16551 Q93007 Q9NP02 Q9UCX7,Serine-protein kinase ATM,Ataxia telangiectasia mutated;, PF02259;PF02260;PF00454;PF11640;, GO:0005737;GO:0031410;GO:0005829;GO:1990391;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005782;GO:0005819;GO:0016303;GO:0005524;GO:0003677;GO:0004677;GO:0042802;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007420;GO:0007050;GO:0006974;GO:0071480;GO:0071500;GO:0071300;GO:0071481;GO:0008340;GO:0000077;GO:0006975;GO:0006977;GO:0000729;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097695;GO:0097694;GO:0007143;GO:0007507;GO:0071044;GO:0016572;GO:0008630;GO:0042159;GO:0007140;GO:0045141;GO:0007094;GO:0035264;GO:0030889;GO:1904354;GO:1904262;GO:0051402;GO:0048599;GO:0001541;GO:0036289;GO:0018105;GO:0000425;GO:0043065;GO:0045785;GO:0030335;GO:1903626;GO:0043517;GO:0010628;GO:0033129;GO:0043525;GO:1904884;GO:0032212;GO:1904358;GO:0045944;GO:0009791;GO:0002331;GO:0046777;GO:0006468;GO:0007131;GO:0042981;GO:0010506;GO:1905843;GO:1900034;GO:1903978;GO:1901796;GO:0032210;GO:0090399;GO:0001666;GO:0010212;GO:0007165;GO:0072434;GO:0001756;GO:0000723;GO:0048538;GO:0033151;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:DNA repair complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:peroxisomal matrix; C:spindle;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:DNA binding; F:DNA-dependent protein kinase activity; F:identical protein binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:brain development; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to nitrosative stress; P:cellular response to retinoic acid; P:cellular response to X-ray; P:determination of adult lifespan; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:female meiotic nuclear division; P:heart development; P:histone mRNA catabolic process; P:histone phosphorylation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lipoprotein catabolic process; P:male meiotic nuclear division; P:meiotic telomere clustering; P:mitotic spindle assembly checkpoint; P:multicellular organism growth; P:negative regulation of B cell proliferation; P:negative regulation of telomere capping; P:negative regulation of TORC1 signaling; P:neuron apoptotic process; P:oocyte development; P:ovarian follicle development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of DNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of gene expression; P:positive regulation of histone phosphorylation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:pre-B cell allelic exclusion; P:protein autophosphorylation; P:protein phosphorylation; P:reciprocal meiotic recombination; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cellular response to gamma radiation; P:regulation of cellular response to heat; P:regulation of microglial cell activation; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere maintenance via telomerase; P:replicative senescence; P:response to hypoxia; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in mitotic G2 DNA damage checkpoint; P:somitogenesis; P:telomere maintenance; P:thymus development; P:V(D)J recombination;|Q13315 B2RNX5 O15429 Q12758 Q16551 Q93007 Q9NP02 Q9UCX7,Serine-protein kinase ATM,Ataxia telangiectasia mutated;, PF02259;PF02260;PF00454;PF11640;, GO:0005737;GO:0031410;GO:0005829;GO:1990391;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005782;GO:0005819;GO:0016303;GO:0005524;GO:0003677;GO:0004677;GO:0042802;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007420;GO:0007050;GO:0006974;GO:0071480;GO:0071500;GO:0071300;GO:0071481;GO:0008340;GO:0000077;GO:0006975;GO:0006977;GO:0000729;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097695;GO:0097694;GO:0007143;GO:0007507;GO:0071044;GO:0016572;GO:0008630;GO:0042159;GO:0007140;GO:0045141;GO:0007094;GO:0035264;GO:0030889;GO:1904354;GO:1904262;GO:0051402;GO:0048599;GO:0001541;GO:0036289;GO:0018105;GO:0000425;GO:0043065;GO:0045785;GO:0030335;GO:1903626;GO:0043517;GO:0010628;GO:0033129;GO:0043525;GO:1904884;GO:0032212;GO:1904358;GO:0045944;GO:0009791;GO:0002331;GO:0046777;GO:0006468;GO:0007131;GO:0042981;GO:0010506;GO:1905843;GO:1900034;GO:1903978;GO:1901796;GO:0032210;GO:0090399;GO:0001666;GO:0010212;GO:0007165;GO:0072434;GO:0001756;GO:0000723;GO:0048538;GO:0033151;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:DNA repair complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:peroxisomal matrix; C:spindle;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:DNA binding; F:DNA-dependent protein kinase activity; F:identical protein binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:brain development; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to nitrosative stress; P:cellular response to retinoic acid; P:cellular response to X-ray; P:determination of adult lifespan; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:female meiotic nuclear division; P:heart development; P:histone mRNA catabolic process; P:histone phosphorylation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lipoprotein catabolic process; P:male meiotic nuclear division; P:meiotic telomere clustering; P:mitotic spindle assembly checkpoint; P:multicellular organism growth; P:negative regulation of B cell proliferation; P:negative regulation of telomere capping; P:negative regulation of TORC1 signaling; P:neuron apoptotic process; P:oocyte development; P:ovarian follicle development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of DNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of gene expression; P:positive regulation of histone phosphorylation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:pre-B cell allelic exclusion; P:protein autophosphorylation; P:protein phosphorylation; P:reciprocal meiotic recombination; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cellular response to gamma radiation; P:regulation of cellular response to heat; P:regulation of microglial cell activation; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere maintenance via telomerase; P:replicative senescence; P:response to hypoxia; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in mitotic G2 DNA damage checkpoint; P:somitogenesis; P:telomere maintenance; P:thymus development; P:V(D)J recombination;|Q13315 B2RNX5 O15429 Q12758 Q16551 Q93007 Q9NP02 Q9UCX7,Serine-protein kinase ATM,Ataxia telangiectasia mutated;, PF02259;PF02260;PF00454;PF11640;, GO:0005737;GO:0031410;GO:0005829;GO:1990391;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005782;GO:0005819;GO:0016303;GO:0005524;GO:0003677;GO:0004677;GO:0042802;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007420;GO:0007050;GO:0006974;GO:0071480;GO:0071500;GO:0071300;GO:0071481;GO:0008340;GO:0000077;GO:0006975;GO:0006977;GO:0000729;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097695;GO:0097694;GO:0007143;GO:0007507;GO:0071044;GO:0016572;GO:0008630;GO:0042159;GO:0007140;GO:0045141;GO:0007094;GO:0035264;GO:0030889;GO:1904354;GO:1904262;GO:0051402;GO:0048599;GO:0001541;GO:0036289;GO:0018105;GO:0000425;GO:0043065;GO:0045785;GO:0030335;GO:1903626;GO:0043517;GO:0010628;GO:0033129;GO:0043525;GO:1904884;GO:0032212;GO:1904358;GO:0045944;GO:0009791;GO:0002331;GO:0046777;GO:0006468;GO:0007131;GO:0042981;GO:0010506;GO:1905843;GO:1900034;GO:1903978;GO:1901796;GO:0032210;GO:0090399;GO:0001666;GO:0010212;GO:0007165;GO:0072434;GO:0001756;GO:0000723;GO:0048538;GO:0033151;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:DNA repair complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:peroxisomal matrix; C:spindle;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:DNA binding; F:DNA-dependent protein kinase activity; F:identical protein binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:brain development; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to nitrosative stress; P:cellular response to retinoic acid; P:cellular response to X-ray; P:determination of adult lifespan; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:female meiotic nuclear division; P:heart development; P:histone mRNA catabolic process; P:histone phosphorylation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lipoprotein catabolic process; P:male meiotic nuclear division; P:meiotic telomere clustering; P:mitotic spindle assembly checkpoint; P:multicellular organism growth; P:negative regulation of B cell proliferation; P:negative regulation of telomere capping; P:negative regulation of TORC1 signaling; P:neuron apoptotic process; P:oocyte development; P:ovarian follicle development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of DNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of gene expression; P:positive regulation of histone phosphorylation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:pre-B cell allelic exclusion; P:protein autophosphorylation; P:protein phosphorylation; P:reciprocal meiotic recombination; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cellular response to gamma radiation; P:regulation of cellular response to heat; P:regulation of microglial cell activation; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere maintenance via telomerase; P:replicative senescence; P:response to hypoxia; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in mitotic G2 DNA damage checkpoint; P:somitogenesis; P:telomere maintenance; P:thymus development; P:V(D)J recombination;|Q13315 B2RNX5 O15429 Q12758 Q16551 Q93007 Q9NP02 Q9UCX7,Serine-protein kinase ATM,Ataxia telangiectasia mutated;, PF02259;PF02260;PF00454;PF11640;, GO:0005737;GO:0031410;GO:0005829;GO:1990391;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005782;GO:0005819;GO:0016303;GO:0005524;GO:0003677;GO:0004677;GO:0042802;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007420;GO:0007050;GO:0006974;GO:0071480;GO:0071500;GO:0071300;GO:0071481;GO:0008340;GO:0000077;GO:0006975;GO:0006977;GO:0000729;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097695;GO:0097694;GO:0007143;GO:0007507;GO:0071044;GO:0016572;GO:0008630;GO:0042159;GO:0007140;GO:0045141;GO:0007094;GO:0035264;GO:0030889;GO:1904354;GO:1904262;GO:0051402;GO:0048599;GO:0001541;GO:0036289;GO:0018105;GO:0000425;GO:0043065;GO:0045785;GO:0030335;GO:1903626;GO:0043517;GO:0010628;GO:0033129;GO:0043525;GO:1904884;GO:0032212;GO:1904358;GO:0045944;GO:0009791;GO:0002331;GO:0046777;GO:0006468;GO:0007131;GO:0042981;GO:0010506;GO:1905843;GO:1900034;GO:1903978;GO:1901796;GO:0032210;GO:0090399;GO:0001666;GO:0010212;GO:0007165;GO:0072434;GO:0001756;GO:0000723;GO:0048538;GO:0033151;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:DNA repair complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:peroxisomal matrix; C:spindle;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:DNA binding; F:DNA-dependent protein kinase activity; F:identical protein binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:brain development; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to nitrosative stress; P:cellular response to retinoic acid; P:cellular response to X-ray; P:determination of adult lifespan; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:female meiotic nuclear division; P:heart development; P:histone mRNA catabolic process; P:histone phosphorylation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lipoprotein catabolic process; P:male meiotic nuclear division; P:meiotic telomere clustering; P:mitotic spindle assembly checkpoint; P:multicellular organism growth; P:negative regulation of B cell proliferation; P:negative regulation of telomere capping; P:negative regulation of TORC1 signaling; P:neuron apoptotic process; P:oocyte development; P:ovarian follicle development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of DNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of gene expression; P:positive regulation of histone phosphorylation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:pre-B cell allelic exclusion; P:protein autophosphorylation; P:protein phosphorylation; P:reciprocal meiotic recombination; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cellular response to gamma radiation; P:regulation of cellular response to heat; P:regulation of microglial cell activation; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere maintenance via telomerase; P:replicative senescence; P:response to hypoxia; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in mitotic G2 DNA damage checkpoint; P:somitogenesis; P:telomere maintenance; P:thymus development; P:V(D)J recombination;|Q13315 B2RNX5 O15429 Q12758 Q16551 Q93007 Q9NP02 Q9UCX7,Serine-protein kinase ATM,Ataxia telangiectasia mutated;, PF02259;PF02260;PF00454;PF11640;, GO:0005737;GO:0031410;GO:0005829;GO:1990391;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005782;GO:0005819;GO:0016303;GO:0005524;GO:0003677;GO:0004677;GO:0042802;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007420;GO:0007050;GO:0006974;GO:0071480;GO:0071500;GO:0071300;GO:0071481;GO:0008340;GO:0000077;GO:0006975;GO:0006977;GO:0000729;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097695;GO:0097694;GO:0007143;GO:0007507;GO:0071044;GO:0016572;GO:0008630;GO:0042159;GO:0007140;GO:0045141;GO:0007094;GO:0035264;GO:0030889;GO:1904354;GO:1904262;GO:0051402;GO:0048599;GO:0001541;GO:0036289;GO:0018105;GO:0000425;GO:0043065;GO:0045785;GO:0030335;GO:1903626;GO:0043517;GO:0010628;GO:0033129;GO:0043525;GO:1904884;GO:0032212;GO:1904358;GO:0045944;GO:0009791;GO:0002331;GO:0046777;GO:0006468;GO:0007131;GO:0042981;GO:0010506;GO:1905843;GO:1900034;GO:1903978;GO:1901796;GO:0032210;GO:0090399;GO:0001666;GO:0010212;GO:0007165;GO:0072434;GO:0001756;GO:0000723;GO:0048538;GO:0033151;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:DNA repair complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:peroxisomal matrix; C:spindle;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:DNA binding; F:DNA-dependent protein kinase activity; F:identical protein binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:brain development; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to nitrosative stress; P:cellular response to retinoic acid; P:cellular response to X-ray; P:determination of adult lifespan; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:female meiotic nuclear division; P:heart development; P:histone mRNA catabolic process; P:histone phosphorylation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lipoprotein catabolic process; P:male meiotic nuclear division; P:meiotic telomere clustering; P:mitotic spindle assembly checkpoint; P:multicellular organism growth; P:negative regulation of B cell proliferation; P:negative regulation of telomere capping; P:negative regulation of TORC1 signaling; P:neuron apoptotic process; P:oocyte development; P:ovarian follicle development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of DNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of gene expression; P:positive regulation of histone phosphorylation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:pre-B cell allelic exclusion; P:protein autophosphorylation; P:protein phosphorylation; P:reciprocal meiotic recombination; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cellular response to gamma radiation; P:regulation of cellular response to heat; P:regulation of microglial cell activation; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere maintenance via telomerase; P:replicative senescence; P:response to hypoxia; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in mitotic G2 DNA damage checkpoint; P:somitogenesis; P:telomere maintenance; P:thymus development; P:V(D)J recombination;|Q13315 B2RNX5 O15429 Q12758 Q16551 Q93007 Q9NP02 Q9UCX7,Serine-protein kinase ATM,Ataxia telangiectasia mutated;, PF02259;PF02260;PF00454;PF11640;, GO:0005737;GO:0031410;GO:0005829;GO:1990391;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005782;GO:0005819;GO:0016303;GO:0005524;GO:0003677;GO:0004677;GO:0042802;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007420;GO:0007050;GO:0006974;GO:0071480;GO:0071500;GO:0071300;GO:0071481;GO:0008340;GO:0000077;GO:0006975;GO:0006977;GO:0000729;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097695;GO:0097694;GO:0007143;GO:0007507;GO:0071044;GO:0016572;GO:0008630;GO:0042159;GO:0007140;GO:0045141;GO:0007094;GO:0035264;GO:0030889;GO:1904354;GO:1904262;GO:0051402;GO:0048599;GO:0001541;GO:0036289;GO:0018105;GO:0000425;GO:0043065;GO:0045785;GO:0030335;GO:1903626;GO:0043517;GO:0010628;GO:0033129;GO:0043525;GO:1904884;GO:0032212;GO:1904358;GO:0045944;GO:0009791;GO:0002331;GO:0046777;GO:0006468;GO:0007131;GO:0042981;GO:0010506;GO:1905843;GO:1900034;GO:1903978;GO:1901796;GO:0032210;GO:0090399;GO:0001666;GO:0010212;GO:0007165;GO:0072434;GO:0001756;GO:0000723;GO:0048538;GO:0033151;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:DNA repair complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:peroxisomal matrix; C:spindle;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:DNA binding; F:DNA-dependent protein kinase activity; F:identical protein binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:brain development; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to nitrosative stress; P:cellular response to retinoic acid; P:cellular response to X-ray; P:determination of adult lifespan; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:female meiotic nuclear division; P:heart development; P:histone mRNA catabolic process; P:histone phosphorylation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lipoprotein catabolic process; P:male meiotic nuclear division; P:meiotic telomere clustering; P:mitotic spindle assembly checkpoint; P:multicellular organism growth; P:negative regulation of B cell proliferation; P:negative regulation of telomere capping; P:negative regulation of TORC1 signaling; P:neuron apoptotic process; P:oocyte development; P:ovarian follicle development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of DNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of gene expression; P:positive regulation of histone phosphorylation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:pre-B cell allelic exclusion; P:protein autophosphorylation; P:protein phosphorylation; P:reciprocal meiotic recombination; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cellular response to gamma radiation; P:regulation of cellular response to heat; P:regulation of microglial cell activation; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere maintenance via telomerase; P:replicative senescence; P:response to hypoxia; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in mitotic G2 DNA damage checkpoint; P:somitogenesis; P:telomere maintenance; P:thymus development; P:V(D)J recombination;|Q13315 B2RNX5 O15429 Q12758 Q16551 Q93007 Q9NP02 Q9UCX7,Serine-protein kinase ATM,Ataxia telangiectasia mutated;, PF02259;PF02260;PF00454;PF11640;, GO:0005737;GO:0031410;GO:0005829;GO:1990391;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005782;GO:0005819;GO:0016303;GO:0005524;GO:0003677;GO:0004677;GO:0042802;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007420;GO:0007050;GO:0006974;GO:0071480;GO:0071500;GO:0071300;GO:0071481;GO:0008340;GO:0000077;GO:0006975;GO:0006977;GO:0000729;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097695;GO:0097694;GO:0007143;GO:0007507;GO:0071044;GO:0016572;GO:0008630;GO:0042159;GO:0007140;GO:0045141;GO:0007094;GO:0035264;GO:0030889;GO:1904354;GO:1904262;GO:0051402;GO:0048599;GO:0001541;GO:0036289;GO:0018105;GO:0000425;GO:0043065;GO:0045785;GO:0030335;GO:1903626;GO:0043517;GO:0010628;GO:0033129;GO:0043525;GO:1904884;GO:0032212;GO:1904358;GO:0045944;GO:0009791;GO:0002331;GO:0046777;GO:0006468;GO:0007131;GO:0042981;GO:0010506;GO:1905843;GO:1900034;GO:1903978;GO:1901796;GO:0032210;GO:0090399;GO:0001666;GO:0010212;GO:0007165;GO:0072434;GO:0001756;GO:0000723;GO:0048538;GO:0033151;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:DNA repair complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:peroxisomal matrix; C:spindle;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:DNA binding; F:DNA-dependent protein kinase activity; F:identical protein binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:brain development; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to nitrosative stress; P:cellular response to retinoic acid; P:cellular response to X-ray; P:determination of adult lifespan; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:female meiotic nuclear division; P:heart development; P:histone mRNA catabolic process; P:histone phosphorylation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lipoprotein catabolic process; P:male meiotic nuclear division; P:meiotic telomere clustering; P:mitotic spindle assembly checkpoint; P:multicellular organism growth; P:negative regulation of B cell proliferation; P:negative regulation of telomere capping; P:negative regulation of TORC1 signaling; P:neuron apoptotic process; P:oocyte development; P:ovarian follicle development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of DNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of gene expression; P:positive regulation of histone phosphorylation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:pre-B cell allelic exclusion; P:protein autophosphorylation; P:protein phosphorylation; P:reciprocal meiotic recombination; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cellular response to gamma radiation; P:regulation of cellular response to heat; P:regulation of microglial cell activation; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere maintenance via telomerase; P:replicative senescence; P:response to hypoxia; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in mitotic G2 DNA damage checkpoint; P:somitogenesis; P:telomere maintenance; P:thymus development; P:V(D)J recombination;|Q13315 B2RNX5 O15429 Q12758 Q16551 Q93007 Q9NP02 Q9UCX7,Serine-protein kinase ATM,Ataxia telangiectasia mutated;, PF02259;PF02260;PF00454;PF11640;, GO:0005737;GO:0031410;GO:0005829;GO:1990391;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005782;GO:0005819;GO:0016303;GO:0005524;GO:0003677;GO:0004677;GO:0042802;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007420;GO:0007050;GO:0006974;GO:0071480;GO:0071500;GO:0071300;GO:0071481;GO:0008340;GO:0000077;GO:0006975;GO:0006977;GO:0000729;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097695;GO:0097694;GO:0007143;GO:0007507;GO:0071044;GO:0016572;GO:0008630;GO:0042159;GO:0007140;GO:0045141;GO:0007094;GO:0035264;GO:0030889;GO:1904354;GO:1904262;GO:0051402;GO:0048599;GO:0001541;GO:0036289;GO:0018105;GO:0000425;GO:0043065;GO:0045785;GO:0030335;GO:1903626;GO:0043517;GO:0010628;GO:0033129;GO:0043525;GO:1904884;GO:0032212;GO:1904358;GO:0045944;GO:0009791;GO:0002331;GO:0046777;GO:0006468;GO:0007131;GO:0042981;GO:0010506;GO:1905843;GO:1900034;GO:1903978;GO:1901796;GO:0032210;GO:0090399;GO:0001666;GO:0010212;GO:0007165;GO:0072434;GO:0001756;GO:0000723;GO:0048538;GO:0033151;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:DNA repair complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:peroxisomal matrix; C:spindle;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:DNA binding; F:DNA-dependent protein kinase activity; F:identical protein binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:brain development; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to nitrosative stress; P:cellular response to retinoic acid; P:cellular response to X-ray; P:determination of adult lifespan; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:female meiotic nuclear division; P:heart development; P:histone mRNA catabolic process; P:histone phosphorylation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lipoprotein catabolic process; P:male meiotic nuclear division; P:meiotic telomere clustering; P:mitotic spindle assembly checkpoint; P:multicellular organism growth; P:negative regulation of B cell proliferation; P:negative regulation of telomere capping; P:negative regulation of TORC1 signaling; P:neuron apoptotic process; P:oocyte development; P:ovarian follicle development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of DNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of gene expression; P:positive regulation of histone phosphorylation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:pre-B cell allelic exclusion; P:protein autophosphorylation; P:protein phosphorylation; P:reciprocal meiotic recombination; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cellular response to gamma radiation; P:regulation of cellular response to heat; P:regulation of microglial cell activation; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere maintenance via telomerase; P:replicative senescence; P:response to hypoxia; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in mitotic G2 DNA damage checkpoint; P:somitogenesis; P:telomere maintenance; P:thymus development; P:V(D)J recombination;|Q13315 B2RNX5 O15429 Q12758 Q16551 Q93007 Q9NP02 Q9UCX7,Serine-protein kinase ATM,Ataxia telangiectasia mutated;, PF02259;PF02260;PF00454;PF11640;, GO:0005737;GO:0031410;GO:0005829;GO:1990391;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005782;GO:0005819;GO:0016303;GO:0005524;GO:0003677;GO:0004677;GO:0042802;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007420;GO:0007050;GO:0006974;GO:0071480;GO:0071500;GO:0071300;GO:0071481;GO:0008340;GO:0000077;GO:0006975;GO:0006977;GO:0000729;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097695;GO:0097694;GO:0007143;GO:0007507;GO:0071044;GO:0016572;GO:0008630;GO:0042159;GO:0007140;GO:0045141;GO:0007094;GO:0035264;GO:0030889;GO:1904354;GO:1904262;GO:0051402;GO:0048599;GO:0001541;GO:0036289;GO:0018105;GO:0000425;GO:0043065;GO:0045785;GO:0030335;GO:1903626;GO:0043517;GO:0010628;GO:0033129;GO:0043525;GO:1904884;GO:0032212;GO:1904358;GO:0045944;GO:0009791;GO:0002331;GO:0046777;GO:0006468;GO:0007131;GO:0042981;GO:0010506;GO:1905843;GO:1900034;GO:1903978;GO:1901796;GO:0032210;GO:0090399;GO:0001666;GO:0010212;GO:0007165;GO:0072434;GO:0001756;GO:0000723;GO:0048538;GO:0033151;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:DNA repair complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:peroxisomal matrix; C:spindle;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:DNA binding; F:DNA-dependent protein kinase activity; F:identical protein binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:brain development; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to nitrosative stress; P:cellular response to retinoic acid; P:cellular response to X-ray; P:determination of adult lifespan; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:female meiotic nuclear division; P:heart development; P:histone mRNA catabolic process; P:histone phosphorylation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lipoprotein catabolic process; P:male meiotic nuclear division; P:meiotic telomere clustering; P:mitotic spindle assembly checkpoint; P:multicellular organism growth; P:negative regulation of B cell proliferation; P:negative regulation of telomere capping; P:negative regulation of TORC1 signaling; P:neuron apoptotic process; P:oocyte development; P:ovarian follicle development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of DNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of gene expression; P:positive regulation of histone phosphorylation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:pre-B cell allelic exclusion; P:protein autophosphorylation; P:protein phosphorylation; P:reciprocal meiotic recombination; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cellular response to gamma radiation; P:regulation of cellular response to heat; P:regulation of microglial cell activation; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere maintenance via telomerase; P:replicative senescence; P:response to hypoxia; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in mitotic G2 DNA damage checkpoint; P:somitogenesis; P:telomere maintenance; P:thymus development; P:V(D)J recombination;|Q13315 B2RNX5 O15429 Q12758 Q16551 Q93007 Q9NP02 Q9UCX7,Serine-protein kinase ATM,Ataxia telangiectasia mutated;, PF02259;PF02260;PF00454;PF11640;, GO:0005737;GO:0031410;GO:0005829;GO:1990391;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005782;GO:0005819;GO:0016303;GO:0005524;GO:0003677;GO:0004677;GO:0042802;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007420;GO:0007050;GO:0006974;GO:0071480;GO:0071500;GO:0071300;GO:0071481;GO:0008340;GO:0000077;GO:0006975;GO:0006977;GO:0000729;GO:0006260;GO:0006302;GO:0000724;GO:0006303;GO:0097695;GO:0097694;GO:0007143;GO:0007507;GO:0071044;GO:0016572;GO:0008630;GO:0042159;GO:0007140;GO:0045141;GO:0007094;GO:0035264;GO:0030889;GO:1904354;GO:1904262;GO:0051402;GO:0048599;GO:0001541;GO:0036289;GO:0018105;GO:0000425;GO:0043065;GO:0045785;GO:0030335;GO:1903626;GO:0043517;GO:0010628;GO:0033129;GO:0043525;GO:1904884;GO:0032212;GO:1904358;GO:0045944;GO:0009791;GO:0002331;GO:0046777;GO:0006468;GO:0007131;GO:0042981;GO:0010506;GO:1905843;GO:1900034;GO:1903978;GO:1901796;GO:0032210;GO:0090399;GO:0001666;GO:0010212;GO:0007165;GO:0072434;GO:0001756;GO:0000723;GO:0048538;GO:0033151;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:DNA repair complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:peroxisomal matrix; C:spindle;, F:1-phosphatidylinositol-3-kinase activity; F:ATP binding; F:DNA binding; F:DNA-dependent protein kinase activity; F:identical protein binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:brain development; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to nitrosative stress; P:cellular response to retinoic acid; P:cellular response to X-ray; P:determination of adult lifespan; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:establishment of protein-containing complex localization to telomere; P:establishment of RNA localization to telomere; P:female meiotic nuclear division; P:heart development; P:histone mRNA catabolic process; P:histone phosphorylation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lipoprotein catabolic process; P:male meiotic nuclear division; P:meiotic telomere clustering; P:mitotic spindle assembly checkpoint; P:multicellular organism growth; P:negative regulation of B cell proliferation; P:negative regulation of telomere capping; P:negative regulation of TORC1 signaling; P:neuron apoptotic process; P:oocyte development; P:ovarian follicle development; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of DNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of gene expression; P:positive regulation of histone phosphorylation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase catalytic core complex assembly; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:pre-B cell allelic exclusion; P:protein autophosphorylation; P:protein phosphorylation; P:reciprocal meiotic recombination; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cellular response to gamma radiation; P:regulation of cellular response to heat; P:regulation of microglial cell activation; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere maintenance via telomerase; P:replicative senescence; P:response to hypoxia; P:response to ionizing radiation; P:signal transduction; P:signal transduction involved in mitotic G2 DNA damage checkpoint; P:somitogenesis; P:telomere maintenance; P:thymus development; P:V(D)J recombination; scaffold30 indexed_genome mRNA 11263201 11315648 . + . ID=transcript_6583;Q14207 A8K1V5 A8K6M2 Q13632 Q14967 Q16580 Q86W55 Q8IWE9,Protein NPAT,Nuclear protein of the ataxia telangiectasia mutated locus;p220;, PF15712;, GO:0015030;GO:0005737;GO:0097504;GO:0005654;GO:0005634;GO:0008022;GO:0003713;GO:0003712;GO:0003714;GO:0001701;GO:0045944;GO:0045893;GO:0010468;GO:0000083;, C:Cajal body; C:cytoplasm; C:Gemini of coiled bodies; C:nucleoplasm; C:nucleus;, F:protein C-terminus binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity;, P:in utero embryonic development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q14207 A8K1V5 A8K6M2 Q13632 Q14967 Q16580 Q86W55 Q8IWE9,Protein NPAT,Nuclear protein of the ataxia telangiectasia mutated locus;p220;, PF15712;, GO:0015030;GO:0005737;GO:0097504;GO:0005654;GO:0005634;GO:0008022;GO:0003713;GO:0003712;GO:0003714;GO:0001701;GO:0045944;GO:0045893;GO:0010468;GO:0000083;, C:Cajal body; C:cytoplasm; C:Gemini of coiled bodies; C:nucleoplasm; C:nucleus;, F:protein C-terminus binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity;, P:in utero embryonic development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; scaffold30 indexed_genome mRNA 11337752 11351597 . - . ID=transcript_6584;P24752 B2R6H1 G3XAB4 Q96FG8,Acetyl-CoA acetyltransferase, mitochondrial,Acetoacetyl-CoA thiolase;T2;, PF02803;PF00108;, GO:0070062;GO:0005759;GO:0005739;GO:0003985;GO:0016453;GO:0030955;GO:0006085;GO:0046356;GO:0009083;GO:0034435;GO:0015937;GO:0015936;GO:0006635;GO:0006550;GO:0046951;GO:0046952;GO:1902224;GO:1902860;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA C-acetyltransferase activity; F:C-acetyltransferase activity; F:potassium ion binding;, P:acetyl-CoA biosynthetic process; P:acetyl-CoA catabolic process; P:branched-chain amino acid catabolic process; P:cholesterol esterification; P:coenzyme A biosynthetic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:isoleucine catabolic process; P:ketone body biosynthetic process; P:ketone body catabolic process; P:ketone body metabolic process; P:propionyl-CoA biosynthetic process;|P24752 B2R6H1 G3XAB4 Q96FG8,Acetyl-CoA acetyltransferase, mitochondrial,Acetoacetyl-CoA thiolase;T2;, PF02803;PF00108;, GO:0070062;GO:0005759;GO:0005739;GO:0003985;GO:0016453;GO:0030955;GO:0006085;GO:0046356;GO:0009083;GO:0034435;GO:0015937;GO:0015936;GO:0006635;GO:0006550;GO:0046951;GO:0046952;GO:1902224;GO:1902860;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA C-acetyltransferase activity; F:C-acetyltransferase activity; F:potassium ion binding;, P:acetyl-CoA biosynthetic process; P:acetyl-CoA catabolic process; P:branched-chain amino acid catabolic process; P:cholesterol esterification; P:coenzyme A biosynthetic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:isoleucine catabolic process; P:ketone body biosynthetic process; P:ketone body catabolic process; P:ketone body metabolic process; P:propionyl-CoA biosynthetic process;|P24752 B2R6H1 G3XAB4 Q96FG8,Acetyl-CoA acetyltransferase, mitochondrial,Acetoacetyl-CoA thiolase;T2;, PF02803;PF00108;, GO:0070062;GO:0005759;GO:0005739;GO:0003985;GO:0016453;GO:0030955;GO:0006085;GO:0046356;GO:0009083;GO:0034435;GO:0015937;GO:0015936;GO:0006635;GO:0006550;GO:0046951;GO:0046952;GO:1902224;GO:1902860;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA C-acetyltransferase activity; F:C-acetyltransferase activity; F:potassium ion binding;, P:acetyl-CoA biosynthetic process; P:acetyl-CoA catabolic process; P:branched-chain amino acid catabolic process; P:cholesterol esterification; P:coenzyme A biosynthetic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:isoleucine catabolic process; P:ketone body biosynthetic process; P:ketone body catabolic process; P:ketone body metabolic process; P:propionyl-CoA biosynthetic process;|P24752 B2R6H1 G3XAB4 Q96FG8,Acetyl-CoA acetyltransferase, mitochondrial,Acetoacetyl-CoA thiolase;T2;, PF02803;PF00108;, GO:0070062;GO:0005759;GO:0005739;GO:0003985;GO:0016453;GO:0030955;GO:0006085;GO:0046356;GO:0009083;GO:0034435;GO:0015937;GO:0015936;GO:0006635;GO:0006550;GO:0046951;GO:0046952;GO:1902224;GO:1902860;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA C-acetyltransferase activity; F:C-acetyltransferase activity; F:potassium ion binding;, P:acetyl-CoA biosynthetic process; P:acetyl-CoA catabolic process; P:branched-chain amino acid catabolic process; P:cholesterol esterification; P:coenzyme A biosynthetic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:isoleucine catabolic process; P:ketone body biosynthetic process; P:ketone body catabolic process; P:ketone body metabolic process; P:propionyl-CoA biosynthetic process;|P24752 B2R6H1 G3XAB4 Q96FG8,Acetyl-CoA acetyltransferase, mitochondrial,Acetoacetyl-CoA thiolase;T2;, PF02803;PF00108;, GO:0070062;GO:0005759;GO:0005739;GO:0003985;GO:0016453;GO:0030955;GO:0006085;GO:0046356;GO:0009083;GO:0034435;GO:0015937;GO:0015936;GO:0006635;GO:0006550;GO:0046951;GO:0046952;GO:1902224;GO:1902860;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA C-acetyltransferase activity; F:C-acetyltransferase activity; F:potassium ion binding;, P:acetyl-CoA biosynthetic process; P:acetyl-CoA catabolic process; P:branched-chain amino acid catabolic process; P:cholesterol esterification; P:coenzyme A biosynthetic process; P:coenzyme A metabolic process; P:fatty acid beta-oxidation; P:isoleucine catabolic process; P:ketone body biosynthetic process; P:ketone body catabolic process; P:ketone body metabolic process; P:propionyl-CoA biosynthetic process; scaffold30 indexed_genome mRNA 11391756 11519858 . - . ID=transcript_6585;Q93034 A8K960 O14766 Q9BZC6,Cullin-5,Vasopressin-activated calcium-mobilizing receptor 1;, PF00888;PF10557;, GO:0031466;GO:0031461;GO:0005829;GO:0019005;GO:0090734;GO:0005262;GO:0038023;GO:0031625;GO:0004842;GO:0038128;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0031146;GO:0016032;, C:Cul5-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:SCF ubiquitin ligase complex; C:site of DNA damage;, F:calcium channel activity; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:ERBB2 signaling pathway; P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q93034 A8K960 O14766 Q9BZC6,Cullin-5,Vasopressin-activated calcium-mobilizing receptor 1;, PF00888;PF10557;, GO:0031466;GO:0031461;GO:0005829;GO:0019005;GO:0090734;GO:0005262;GO:0038023;GO:0031625;GO:0004842;GO:0038128;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0031146;GO:0016032;, C:Cul5-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:SCF ubiquitin ligase complex; C:site of DNA damage;, F:calcium channel activity; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:ERBB2 signaling pathway; P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q93034 A8K960 O14766 Q9BZC6,Cullin-5,Vasopressin-activated calcium-mobilizing receptor 1;, PF00888;PF10557;, GO:0031466;GO:0031461;GO:0005829;GO:0019005;GO:0090734;GO:0005262;GO:0038023;GO:0031625;GO:0004842;GO:0038128;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0031146;GO:0016032;, C:Cul5-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:SCF ubiquitin ligase complex; C:site of DNA damage;, F:calcium channel activity; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:ERBB2 signaling pathway; P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q93034 A8K960 O14766 Q9BZC6,Cullin-5,Vasopressin-activated calcium-mobilizing receptor 1;, PF00888;PF10557;, GO:0031466;GO:0031461;GO:0005829;GO:0019005;GO:0090734;GO:0005262;GO:0038023;GO:0031625;GO:0004842;GO:0038128;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0031146;GO:0016032;, C:Cul5-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:SCF ubiquitin ligase complex; C:site of DNA damage;, F:calcium channel activity; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:ERBB2 signaling pathway; P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q93034 A8K960 O14766 Q9BZC6,Cullin-5,Vasopressin-activated calcium-mobilizing receptor 1;, PF00888;PF10557;, GO:0031466;GO:0031461;GO:0005829;GO:0019005;GO:0090734;GO:0005262;GO:0038023;GO:0031625;GO:0004842;GO:0038128;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0031146;GO:0016032;, C:Cul5-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:SCF ubiquitin ligase complex; C:site of DNA damage;, F:calcium channel activity; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:ERBB2 signaling pathway; P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q93034 A8K960 O14766 Q9BZC6,Cullin-5,Vasopressin-activated calcium-mobilizing receptor 1;, PF00888;PF10557;, GO:0031466;GO:0031461;GO:0005829;GO:0019005;GO:0090734;GO:0005262;GO:0038023;GO:0031625;GO:0004842;GO:0038128;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0031146;GO:0016032;, C:Cul5-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:SCF ubiquitin ligase complex; C:site of DNA damage;, F:calcium channel activity; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:ERBB2 signaling pathway; P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q93034 A8K960 O14766 Q9BZC6,Cullin-5,Vasopressin-activated calcium-mobilizing receptor 1;, PF00888;PF10557;, GO:0031466;GO:0031461;GO:0005829;GO:0019005;GO:0090734;GO:0005262;GO:0038023;GO:0031625;GO:0004842;GO:0038128;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0031146;GO:0016032;, C:Cul5-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:SCF ubiquitin ligase complex; C:site of DNA damage;, F:calcium channel activity; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:ERBB2 signaling pathway; P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q93034 A8K960 O14766 Q9BZC6,Cullin-5,Vasopressin-activated calcium-mobilizing receptor 1;, PF00888;PF10557;, GO:0031466;GO:0031461;GO:0005829;GO:0019005;GO:0090734;GO:0005262;GO:0038023;GO:0031625;GO:0004842;GO:0038128;GO:0000082;GO:0097193;GO:0043687;GO:0016567;GO:0031146;GO:0016032;, C:Cul5-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:SCF ubiquitin ligase complex; C:site of DNA damage;, F:calcium channel activity; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:ERBB2 signaling pathway; P:G1/S transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway; P:post-translational protein modification; P:protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process; scaffold30 indexed_genome mRNA 11568148 11569758 . + . ID=transcript_6586;Q14964 A8KAA4 Q8N6W2,Ras-related protein Rab-39A,, PF00071;, GO:0005829;GO:0005794;GO:0000139;GO:0005764;GO:0045335;GO:0030670;GO:0005886;GO:0005525;GO:0003924;GO:0006914;GO:0090383;GO:0090385;GO:0015031;GO:0032482;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:lysosome; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:autophagy; P:phagosome acidification; P:phagosome-lysosome fusion; P:protein transport; P:Rab protein signal transduction; scaffold30 indexed_genome mRNA 11659382 11722942 . + . ID=transcript_6587;Q8IXU6 Q14963 Q5JPA8 Q6ZRQ3 Q9H947,Solute carrier family 35 member F2,, PF06027;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q7L5A3 B1AML4 B1AML5 D3DRN5 O60377 Q9BQ60 Q9HAI9 Q9P1Y9,Protein FAM214B,, PF13889;PF13915;, GO:0005634;, C:nucleus;|Q7L5A3 B1AML4 B1AML5 D3DRN5 O60377 Q9BQ60 Q9HAI9 Q9P1Y9,Protein FAM214B,, PF13889;PF13915;, GO:0005634;, C:nucleus; scaffold30 indexed_genome mRNA 11906281 11989352 . - . ID=transcript_6588;Q8N336 B4E167 G5E9S5 Q9NPW3,ELMO domain-containing protein 1,, PF04727;, GO:0005096;, , F:GTPase activator activity;|Q8N336 B4E167 G5E9S5 Q9NPW3,ELMO domain-containing protein 1,, PF04727;, GO:0005096;, , F:GTPase activator activity;|Q8N336 B4E167 G5E9S5 Q9NPW3,ELMO domain-containing protein 1,, PF04727;, GO:0005096;, , F:GTPase activator activity;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q8N336 B4E167 G5E9S5 Q9NPW3,ELMO domain-containing protein 1,, PF04727;, GO:0005096;, , F:GTPase activator activity; scaffold30 indexed_genome mRNA 12035689 12168717 . + . ID=transcript_6589;Q96BT7 B1Q2M0 B4DEF6 Q8N989,Alkylated DNA repair protein alkB homolog 8,Probable alpha-ketoglutarate-dependent dioxygenase ABH8;S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8;tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8;, PF13532;PF09004;PF08241;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016706;GO:0005506;GO:0106335;GO:0016300;GO:0000049;GO:0008270;GO:0006974;GO:0030488;GO:0002098;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:iron ion binding; F:tRNA (carboxymethyluridine(34)-5-O)-methyltransferase activity; F:tRNA (uracil) methyltransferase activity; F:tRNA binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:tRNA methylation; P:tRNA wobble uridine modification; scaffold30 indexed_genome mRNA 12341390 12506267 . - . ID=transcript_6590;P33402 A1L4C4 B7ZLT5,Guanylate cyclase soluble subunit alpha-2,, PF00211;PF07700;PF07701;, GO:0005737;GO:0005525;GO:0004383;GO:0020037;GO:0044877;GO:0035556;GO:0010750;GO:0007165;, C:cytoplasm;, F:GTP binding; F:guanylate cyclase activity; F:heme binding; F:protein-containing complex binding;, P:intracellular signal transduction; P:positive regulation of nitric oxide mediated signal transduction; P:signal transduction;|P33402 A1L4C4 B7ZLT5,Guanylate cyclase soluble subunit alpha-2,, PF00211;PF07700;PF07701;, GO:0005737;GO:0005525;GO:0004383;GO:0020037;GO:0044877;GO:0035556;GO:0010750;GO:0007165;, C:cytoplasm;, F:GTP binding; F:guanylate cyclase activity; F:heme binding; F:protein-containing complex binding;, P:intracellular signal transduction; P:positive regulation of nitric oxide mediated signal transduction; P:signal transduction; scaffold30 indexed_genome mRNA 12761094 12914919 . - . ID=transcript_6591;Q2TBE0 A4FU66 A4FU67 A4FU68 A8KAD6 Q6PHW1 Q96MI1,CWF19-like protein 2,, PF04677;PF04676;, GO:0071014;GO:0000398;, C:post-mRNA release spliceosomal complex;, , P:mRNA splicing, via spliceosome; scaffold30 indexed_genome mRNA 13010477 13011011 . + . ID=transcript_6592;P22083 B2RMS0,Alpha-(1,3)-fucosyltransferase 4,ELAM-1 ligand fucosyltransferase;Fucosyltransferase 4;Fucosyltransferase IV;Galactoside 3-L-fucosyltransferase;, PF17039;PF00852;, GO:0071944;GO:0009986;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0005802;GO:0017083;GO:0046920;GO:0008417;GO:0005975;GO:0036065;GO:0042355;GO:0009312;GO:0009311;GO:1903238;GO:0006486;GO:1903037;, C:cell periphery; C:cell surface; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network;, F:4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity; F:alpha-(1->3)-fucosyltransferase activity; F:fucosyltransferase activity;, P:carbohydrate metabolic process; P:fucosylation; P:L-fucose catabolic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:positive regulation of leukocyte tethering or rolling; P:protein glycosylation; P:regulation of leukocyte cell-cell adhesion; scaffold30 indexed_genome mRNA 13011025 13012702 . - . ID=transcript_6593;P22083 B2RMS0,Alpha-(1,3)-fucosyltransferase 4,ELAM-1 ligand fucosyltransferase;Fucosyltransferase 4;Fucosyltransferase IV;Galactoside 3-L-fucosyltransferase;, PF17039;PF00852;, GO:0071944;GO:0009986;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0005802;GO:0017083;GO:0046920;GO:0008417;GO:0005975;GO:0036065;GO:0042355;GO:0009312;GO:0009311;GO:1903238;GO:0006486;GO:1903037;, C:cell periphery; C:cell surface; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network;, F:4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity; F:alpha-(1->3)-fucosyltransferase activity; F:fucosyltransferase activity;, P:carbohydrate metabolic process; P:fucosylation; P:L-fucose catabolic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:positive regulation of leukocyte tethering or rolling; P:protein glycosylation; P:regulation of leukocyte cell-cell adhesion; scaffold30 indexed_genome mRNA 13342964 13427024 . + . ID=transcript_6594;Q8IY63 Q63HK7 Q8NDN0 Q8TEN8 Q8WXD1 Q96CM5,Angiomotin-like protein 1,, PF12240;, GO:0005923;GO:0031410;GO:0005829;GO:0005886;GO:0042802;GO:0030036;GO:0001525;GO:0003365;GO:0035329;GO:0030334;GO:0016055;, C:bicellular tight junction; C:cytoplasmic vesicle; C:cytosol; C:plasma membrane;, F:identical protein binding;, P:actin cytoskeleton organization; P:angiogenesis; P:establishment of cell polarity involved in ameboidal cell migration; P:hippo signaling; P:regulation of cell migration; P:Wnt signaling pathway; scaffold30 indexed_genome mRNA 13510288 13517641 . - . ID=transcript_6595;Q9P013 B2RC17 Q05BV9 Q05DM1 Q9UI29,Spliceosome-associated protein CWC15 homolog,, PF04889;, GO:0071013;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0003723;GO:0045292;GO:0000398;, C:catalytic step 2 spliceosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome;|Q9P013 B2RC17 Q05BV9 Q05DM1 Q9UI29,Spliceosome-associated protein CWC15 homolog,, PF04889;, GO:0071013;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0003723;GO:0045292;GO:0000398;, C:catalytic step 2 spliceosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome;|Q9P013 B2RC17 Q05BV9 Q05DM1 Q9UI29,Spliceosome-associated protein CWC15 homolog,, PF04889;, GO:0071013;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0003723;GO:0045292;GO:0000398;, C:catalytic step 2 spliceosome; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; scaffold30 indexed_genome mRNA 13634926 13636808 . + . ID=transcript_6596;O94919 A8K6K8 Q6GQY5 Q8TAQ8,Endonuclease domain-containing 1 protein,, PF01223;, GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0004519;GO:0046872;GO:0003676;GO:0002576;, C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane;, F:endonuclease activity; F:metal ion binding; F:nucleic acid binding;, P:platelet degranulation;|O94919 A8K6K8 Q6GQY5 Q8TAQ8,Endonuclease domain-containing 1 protein,, PF01223;, GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0004519;GO:0046872;GO:0003676;GO:0002576;, C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane;, F:endonuclease activity; F:metal ion binding; F:nucleic acid binding;, P:platelet degranulation; scaffold30 indexed_genome mRNA 13696259 13715904 . - . ID=transcript_6597;P58005 B7Z7P9 Q96AD1,Sestrin-3 {ECO:0000305},, PF04636;, GO:0005737;GO:0005634;GO:0031932;GO:0070728;GO:0016684;GO:0034198;GO:0042149;GO:0071233;GO:1990253;GO:0042593;GO:1904262;GO:0016239;GO:0046626;GO:0051896;GO:1901031;GO:0032868;GO:0038203;, C:cytoplasm; C:nucleus; C:TORC2 complex;, F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor;, P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:glucose homeostasis; P:negative regulation of TORC1 signaling; P:positive regulation of macroautophagy; P:regulation of insulin receptor signaling pathway; P:regulation of protein kinase B signaling; P:regulation of response to reactive oxygen species; P:response to insulin; P:TORC2 signaling; scaffold30 indexed_genome mRNA 14414710 14435641 . + . ID=transcript_6598;Q5HYJ3 B2R9C2 Q6PIU3 Q8TC53,Protein FAM76B,, PF16046;, GO:0016607;, C:nuclear speck;|Q5HYJ3 B2R9C2 Q6PIU3 Q8TC53,Protein FAM76B,, PF16046;, GO:0016607;, C:nuclear speck;|Q5HYJ3 B2R9C2 Q6PIU3 Q8TC53,Protein FAM76B,, PF16046;, GO:0016607;, C:nuclear speck;|Q5HYJ3 B2R9C2 Q6PIU3 Q8TC53,Protein FAM76B,, PF16046;, GO:0016607;, C:nuclear speck;|Q5HYJ3 B2R9C2 Q6PIU3 Q8TC53,Protein FAM76B,, PF16046;, GO:0016607;, C:nuclear speck;|Q5HYJ3 B2R9C2 Q6PIU3 Q8TC53,Protein FAM76B,, PF16046;, GO:0016607;, C:nuclear speck; scaffold30 indexed_genome mRNA 14446758 14490092 . + . ID=transcript_6599;Q86XR8 A0PJH1 A8K5D0 B4DDP5 F5H5F7 Q14704 Q5JB46 Q8IXP0 Q9BVF9,Centrosomal protein of 57 kDa,FGF2-interacting protein;Testis-specific protein 57;Translokin;, PF14073;PF06657;, GO:0005813;GO:0005829;GO:0005794;GO:0005874;GO:0005634;GO:0017134;GO:0043015;GO:0008017;GO:0042803;GO:0097711;GO:0008543;GO:0000086;GO:0034453;GO:0051260;GO:0010389;GO:0007286;, C:centrosome; C:cytosol; C:Golgi apparatus; C:microtubule; C:nucleus;, F:fibroblast growth factor binding; F:gamma-tubulin binding; F:microtubule binding; F:protein homodimerization activity;, P:ciliary basal body-plasma membrane docking; P:fibroblast growth factor receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring; P:protein homooligomerization; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q86XR8 A0PJH1 A8K5D0 B4DDP5 F5H5F7 Q14704 Q5JB46 Q8IXP0 Q9BVF9,Centrosomal protein of 57 kDa,FGF2-interacting protein;Testis-specific protein 57;Translokin;, PF14073;PF06657;, GO:0005813;GO:0005829;GO:0005794;GO:0005874;GO:0005634;GO:0017134;GO:0043015;GO:0008017;GO:0042803;GO:0097711;GO:0008543;GO:0000086;GO:0034453;GO:0051260;GO:0010389;GO:0007286;, C:centrosome; C:cytosol; C:Golgi apparatus; C:microtubule; C:nucleus;, F:fibroblast growth factor binding; F:gamma-tubulin binding; F:microtubule binding; F:protein homodimerization activity;, P:ciliary basal body-plasma membrane docking; P:fibroblast growth factor receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring; P:protein homooligomerization; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q86XR8 A0PJH1 A8K5D0 B4DDP5 F5H5F7 Q14704 Q5JB46 Q8IXP0 Q9BVF9,Centrosomal protein of 57 kDa,FGF2-interacting protein;Testis-specific protein 57;Translokin;, PF14073;PF06657;, GO:0005813;GO:0005829;GO:0005794;GO:0005874;GO:0005634;GO:0017134;GO:0043015;GO:0008017;GO:0042803;GO:0097711;GO:0008543;GO:0000086;GO:0034453;GO:0051260;GO:0010389;GO:0007286;, C:centrosome; C:cytosol; C:Golgi apparatus; C:microtubule; C:nucleus;, F:fibroblast growth factor binding; F:gamma-tubulin binding; F:microtubule binding; F:protein homodimerization activity;, P:ciliary basal body-plasma membrane docking; P:fibroblast growth factor receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring; P:protein homooligomerization; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q86XR8 A0PJH1 A8K5D0 B4DDP5 F5H5F7 Q14704 Q5JB46 Q8IXP0 Q9BVF9,Centrosomal protein of 57 kDa,FGF2-interacting protein;Testis-specific protein 57;Translokin;, PF14073;PF06657;, GO:0005813;GO:0005829;GO:0005794;GO:0005874;GO:0005634;GO:0017134;GO:0043015;GO:0008017;GO:0042803;GO:0097711;GO:0008543;GO:0000086;GO:0034453;GO:0051260;GO:0010389;GO:0007286;, C:centrosome; C:cytosol; C:Golgi apparatus; C:microtubule; C:nucleus;, F:fibroblast growth factor binding; F:gamma-tubulin binding; F:microtubule binding; F:protein homodimerization activity;, P:ciliary basal body-plasma membrane docking; P:fibroblast growth factor receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring; P:protein homooligomerization; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q86XR8 A0PJH1 A8K5D0 B4DDP5 F5H5F7 Q14704 Q5JB46 Q8IXP0 Q9BVF9,Centrosomal protein of 57 kDa,FGF2-interacting protein;Testis-specific protein 57;Translokin;, PF14073;PF06657;, GO:0005813;GO:0005829;GO:0005794;GO:0005874;GO:0005634;GO:0017134;GO:0043015;GO:0008017;GO:0042803;GO:0097711;GO:0008543;GO:0000086;GO:0034453;GO:0051260;GO:0010389;GO:0007286;, C:centrosome; C:cytosol; C:Golgi apparatus; C:microtubule; C:nucleus;, F:fibroblast growth factor binding; F:gamma-tubulin binding; F:microtubule binding; F:protein homodimerization activity;, P:ciliary basal body-plasma membrane docking; P:fibroblast growth factor receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring; P:protein homooligomerization; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development;|Q86XR8 A0PJH1 A8K5D0 B4DDP5 F5H5F7 Q14704 Q5JB46 Q8IXP0 Q9BVF9,Centrosomal protein of 57 kDa,FGF2-interacting protein;Testis-specific protein 57;Translokin;, PF14073;PF06657;, GO:0005813;GO:0005829;GO:0005794;GO:0005874;GO:0005634;GO:0017134;GO:0043015;GO:0008017;GO:0042803;GO:0097711;GO:0008543;GO:0000086;GO:0034453;GO:0051260;GO:0010389;GO:0007286;, C:centrosome; C:cytosol; C:Golgi apparatus; C:microtubule; C:nucleus;, F:fibroblast growth factor binding; F:gamma-tubulin binding; F:microtubule binding; F:protein homodimerization activity;, P:ciliary basal body-plasma membrane docking; P:fibroblast growth factor receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring; P:protein homooligomerization; P:regulation of G2/M transition of mitotic cell cycle; P:spermatid development; scaffold30 indexed_genome mRNA 14497216 14532134 . - . ID=transcript_6600;Q13614 A6NN98 Q9UPS9,Myotubularin-related protein 2 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;, PF02893;PF06602;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0043197;GO:0031901;GO:0070062;GO:0043231;GO:0005634;GO:0048471;GO:0014069;GO:0097060;GO:0008021;GO:0005774;GO:0042802;GO:0052629;GO:0004438;GO:0004725;GO:0008138;GO:0097062;GO:0046855;GO:0032288;GO:0045806;GO:0090394;GO:0031642;GO:2000645;GO:0002091;GO:0048666;GO:0006661;GO:0046856;GO:2000643;GO:0006470;GO:0060304;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synaptic membrane; C:synaptic vesicle; C:vacuolar membrane;, F:identical protein binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dendritic spine maintenance; P:inositol phosphate dephosphorylation; P:myelin assembly; P:negative regulation of endocytosis; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of myelination; P:negative regulation of receptor catabolic process; P:negative regulation of receptor internalization; P:neuron development; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of early endosome to late endosome transport; P:protein dephosphorylation; P:regulation of phosphatidylinositol dephosphorylation;|Q13614 A6NN98 Q9UPS9,Myotubularin-related protein 2 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;, PF02893;PF06602;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0043197;GO:0031901;GO:0070062;GO:0043231;GO:0005634;GO:0048471;GO:0014069;GO:0097060;GO:0008021;GO:0005774;GO:0042802;GO:0052629;GO:0004438;GO:0004725;GO:0008138;GO:0097062;GO:0046855;GO:0032288;GO:0045806;GO:0090394;GO:0031642;GO:2000645;GO:0002091;GO:0048666;GO:0006661;GO:0046856;GO:2000643;GO:0006470;GO:0060304;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synaptic membrane; C:synaptic vesicle; C:vacuolar membrane;, F:identical protein binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dendritic spine maintenance; P:inositol phosphate dephosphorylation; P:myelin assembly; P:negative regulation of endocytosis; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of myelination; P:negative regulation of receptor catabolic process; P:negative regulation of receptor internalization; P:neuron development; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of early endosome to late endosome transport; P:protein dephosphorylation; P:regulation of phosphatidylinositol dephosphorylation;|Q13614 A6NN98 Q9UPS9,Myotubularin-related protein 2 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;, PF02893;PF06602;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0043197;GO:0031901;GO:0070062;GO:0043231;GO:0005634;GO:0048471;GO:0014069;GO:0097060;GO:0008021;GO:0005774;GO:0042802;GO:0052629;GO:0004438;GO:0004725;GO:0008138;GO:0097062;GO:0046855;GO:0032288;GO:0045806;GO:0090394;GO:0031642;GO:2000645;GO:0002091;GO:0048666;GO:0006661;GO:0046856;GO:2000643;GO:0006470;GO:0060304;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synaptic membrane; C:synaptic vesicle; C:vacuolar membrane;, F:identical protein binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dendritic spine maintenance; P:inositol phosphate dephosphorylation; P:myelin assembly; P:negative regulation of endocytosis; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of myelination; P:negative regulation of receptor catabolic process; P:negative regulation of receptor internalization; P:neuron development; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of early endosome to late endosome transport; P:protein dephosphorylation; P:regulation of phosphatidylinositol dephosphorylation; scaffold30 indexed_genome mRNA 14536178 14602194 . - . ID=transcript_6601;Q13614 A6NN98 Q9UPS9,Myotubularin-related protein 2 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;, PF02893;PF06602;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0043197;GO:0031901;GO:0070062;GO:0043231;GO:0005634;GO:0048471;GO:0014069;GO:0097060;GO:0008021;GO:0005774;GO:0042802;GO:0052629;GO:0004438;GO:0004725;GO:0008138;GO:0097062;GO:0046855;GO:0032288;GO:0045806;GO:0090394;GO:0031642;GO:2000645;GO:0002091;GO:0048666;GO:0006661;GO:0046856;GO:2000643;GO:0006470;GO:0060304;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synaptic membrane; C:synaptic vesicle; C:vacuolar membrane;, F:identical protein binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dendritic spine maintenance; P:inositol phosphate dephosphorylation; P:myelin assembly; P:negative regulation of endocytosis; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of myelination; P:negative regulation of receptor catabolic process; P:negative regulation of receptor internalization; P:neuron development; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of early endosome to late endosome transport; P:protein dephosphorylation; P:regulation of phosphatidylinositol dephosphorylation; scaffold30 indexed_genome mRNA 14647609 15065798 . - . ID=transcript_6602;Q8IZL2 A7MD26 Q6AI23 Q6Y3A3 Q8IUL3 Q96JK6,Mastermind-like protein 2,, PF09596;, GO:0016607;GO:0005654;GO:0005634;GO:0003713;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0006367;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity;, P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:transcription initiation from RNA polymerase II promoter;|Q8N4S0 B3KPU7 Q8WV71 Q9H2Q5 Q9H5E3,Coiled-coil domain-containing protein 82,, PF13846;PF13926;, GO:0005634;, C:nucleus; scaffold30 indexed_genome mRNA 15074686 15081483 . - . ID=transcript_6603;Q8N4S0 B3KPU7 Q8WV71 Q9H2Q5 Q9H5E3,Coiled-coil domain-containing protein 82,, PF13846;PF13926;, GO:0005634;, C:nucleus;|Q8N4S0 B3KPU7 Q8WV71 Q9H2Q5 Q9H5E3,Coiled-coil domain-containing protein 82,, PF13846;PF13926;, GO:0005634;, C:nucleus;|Q8N4S0 B3KPU7 Q8WV71 Q9H2Q5 Q9H5E3,Coiled-coil domain-containing protein 82,, PF13846;PF13926;, GO:0005634;, C:nucleus; scaffold30 indexed_genome mRNA 15081704 15083989 . + . ID=transcript_6604;Q9Y4A0 A8K3G4 B2RAJ3 Q32MC2,Jerky protein homolog-like,Human homolog of mouse jerky gene protein;, PF04218;PF03184;PF03221;, GO:0005634;GO:0003677;GO:0007417;, C:nucleus;, F:DNA binding;, P:central nervous system development; scaffold30 indexed_genome mRNA 19000485 19210907 . + . ID=transcript_6605;O94779 A1L4P0 B7ZM07 E9PKE8 O94780 Q49AF3,Contactin-5,Neural recognition molecule NB-2;, PF00041;PF07679;PF13895;, GO:0099026;GO:0005576;GO:0098982;GO:0005886;GO:0007155;GO:0099054;GO:0007605;, C:anchored component of presynaptic membrane; C:extracellular region; C:GABA-ergic synapse; C:plasma membrane;, , P:cell adhesion; P:presynapse assembly; P:sensory perception of sound; scaffold30 indexed_genome mRNA 19261260 19396103 . + . ID=transcript_6606;O94779 A1L4P0 B7ZM07 E9PKE8 O94780 Q49AF3,Contactin-5,Neural recognition molecule NB-2;, PF00041;PF07679;PF13895;, GO:0099026;GO:0005576;GO:0098982;GO:0005886;GO:0007155;GO:0099054;GO:0007605;, C:anchored component of presynaptic membrane; C:extracellular region; C:GABA-ergic synapse; C:plasma membrane;, , P:cell adhesion; P:presynapse assembly; P:sensory perception of sound; scaffold30 indexed_genome mRNA 20159047 20293672 . + . ID=transcript_6607;A6NI28 Q96M56,Rho GTPase-activating protein 42 {ECO:0000305},Rho GTPase-activating protein 10-like;Rho-type GTPase-activating protein 42;, PF00169;PF00620;PF14604;, GO:0005096;GO:0090630;GO:0035024;GO:0003085;GO:1904694;GO:0007165;, , F:GTPase activator activity;, P:activation of GTPase activity; P:negative regulation of Rho protein signal transduction; P:negative regulation of systemic arterial blood pressure; P:negative regulation of vascular associated smooth muscle contraction; P:signal transduction;|A6NI28 Q96M56,Rho GTPase-activating protein 42 {ECO:0000305},Rho GTPase-activating protein 10-like;Rho-type GTPase-activating protein 42;, PF00169;PF00620;PF14604;, GO:0005096;GO:0090630;GO:0035024;GO:0003085;GO:1904694;GO:0007165;, , F:GTPase activator activity;, P:activation of GTPase activity; P:negative regulation of Rho protein signal transduction; P:negative regulation of systemic arterial blood pressure; P:negative regulation of vascular associated smooth muscle contraction; P:signal transduction;|A6NI28 Q96M56,Rho GTPase-activating protein 42 {ECO:0000305},Rho GTPase-activating protein 10-like;Rho-type GTPase-activating protein 42;, PF00169;PF00620;PF14604;, GO:0005096;GO:0090630;GO:0035024;GO:0003085;GO:1904694;GO:0007165;, , F:GTPase activator activity;, P:activation of GTPase activity; P:negative regulation of Rho protein signal transduction; P:negative regulation of systemic arterial blood pressure; P:negative regulation of vascular associated smooth muscle contraction; P:signal transduction; scaffold30 indexed_genome mRNA 20338337 20361047 . - . ID=transcript_6608;P06401 A7LQ08 A7X8B0 B4E3T0 Q8TDS3 Q9UPF7,Progesterone receptor,Nuclear receptor subfamily 3 group C member 3;, PF00104;PF02161;PF00105;, GO:0000785;GO:0005829;GO:0005741;GO:0005654;GO:0051117;GO:0003677;GO:0001228;GO:0000981;GO:0019899;GO:0042802;GO:0004879;GO:0000978;GO:0001225;GO:0005102;GO:0005496;GO:0003707;GO:0008270;GO:0007267;GO:0002070;GO:0030518;GO:0048286;GO:0010629;GO:0001542;GO:0038001;GO:0045944;GO:0050847;GO:0050678;GO:0006357;GO:0007165;GO:0060748;GO:0006367;, C:chromatin; C:cytosol; C:mitochondrial outer membrane; C:nucleoplasm;, F:ATPase binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:signaling receptor binding; F:steroid binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:cell-cell signaling; P:epithelial cell maturation; P:intracellular steroid hormone receptor signaling pathway; P:lung alveolus development; P:negative regulation of gene expression; P:ovulation from ovarian follicle; P:paracrine signaling; P:positive regulation of transcription by RNA polymerase II; P:progesterone receptor signaling pathway; P:regulation of epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:tertiary branching involved in mammary gland duct morphogenesis; P:transcription initiation from RNA polymerase II promoter; scaffold30 indexed_genome mRNA 20798222 20818106 . - . ID=transcript_6609;Q9Y210 Q52M59 Q9HCW3 Q9NQA8 Q9NQA9,Short transient receptor potential channel 6,Transient receptor protein 6;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005737;GO:0005887;GO:0016020;GO:0005886;GO:0036057;GO:0003779;GO:0042805;GO:0051117;GO:0005261;GO:0030276;GO:0070679;GO:0042803;GO:0015279;GO:0007568;GO:0070588;GO:0006812;GO:0070301;GO:0071456;GO:0006828;GO:0050774;GO:0030182;GO:0030168;GO:0051928;GO:0007204;GO:0032414;GO:0045666;GO:0010800;GO:0051480;GO:0007338;, C:cation channel complex; C:cytoplasm; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:slit diaphragm;, F:actin binding; F:actinin binding; F:ATPase binding; F:cation channel activity; F:clathrin binding; F:inositol 1,4,5 trisphosphate binding; F:protein homodimerization activity; F:store-operated calcium channel activity;, P:aging; P:calcium ion transmembrane transport; P:cation transport; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:manganese ion transport; P:negative regulation of dendrite morphogenesis; P:neuron differentiation; P:platelet activation; P:positive regulation of calcium ion transport; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ion transmembrane transporter activity; P:positive regulation of neuron differentiation; P:positive regulation of peptidyl-threonine phosphorylation; P:regulation of cytosolic calcium ion concentration; P:single fertilization; scaffold30 indexed_genome mRNA 20850172 20850803 . + . ID=transcript_6610;Q9Y210 Q52M59 Q9HCW3 Q9NQA8 Q9NQA9,Short transient receptor potential channel 6,Transient receptor protein 6;, PF12796;PF00520;PF08344;, GO:0034703;GO:0005737;GO:0005887;GO:0016020;GO:0005886;GO:0036057;GO:0003779;GO:0042805;GO:0051117;GO:0005261;GO:0030276;GO:0070679;GO:0042803;GO:0015279;GO:0007568;GO:0070588;GO:0006812;GO:0070301;GO:0071456;GO:0006828;GO:0050774;GO:0030182;GO:0030168;GO:0051928;GO:0007204;GO:0032414;GO:0045666;GO:0010800;GO:0051480;GO:0007338;, C:cation channel complex; C:cytoplasm; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:slit diaphragm;, F:actin binding; F:actinin binding; F:ATPase binding; F:cation channel activity; F:clathrin binding; F:inositol 1,4,5 trisphosphate binding; F:protein homodimerization activity; F:store-operated calcium channel activity;, P:aging; P:calcium ion transmembrane transport; P:cation transport; P:cellular response to hydrogen peroxide; P:cellular response to hypoxia; P:manganese ion transport; P:negative regulation of dendrite morphogenesis; P:neuron differentiation; P:platelet activation; P:positive regulation of calcium ion transport; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ion transmembrane transporter activity; P:positive regulation of neuron differentiation; P:positive regulation of peptidyl-threonine phosphorylation; P:regulation of cytosolic calcium ion concentration; P:single fertilization; scaffold30 indexed_genome mRNA 21322801 21338881 . - . ID=transcript_6611;Q86XS5 A8K658 Q86VR9,Angiopoietin-related protein 5,Angiopoietin-like protein 5;, PF00147;, GO:0062023;GO:0005615;, C:collagen-containing extracellular matrix; C:extracellular space; scaffold30 indexed_genome mRNA 21409104 21436130 . + . ID=transcript_6612;Q9P2H0 Q4G0U6,Centrosomal protein of 126 kDa {ECO:0000303|PubMed:24867236, ECO:0000312|HGNC:HGNC:29264},, PF15352;, GO:0005813;GO:0097546;GO:0005737;GO:0030496;GO:0060271;GO:0031122;GO:0007052;GO:1905515;, C:centrosome; C:ciliary base; C:cytoplasm; C:midbody;, , P:cilium assembly; P:cytoplasmic microtubule organization; P:mitotic spindle organization; P:non-motile cilium assembly;|Q9P2H0 Q4G0U6,Centrosomal protein of 126 kDa {ECO:0000303|PubMed:24867236, ECO:0000312|HGNC:HGNC:29264},, PF15352;, GO:0005813;GO:0097546;GO:0005737;GO:0030496;GO:0060271;GO:0031122;GO:0007052;GO:1905515;, C:centrosome; C:ciliary base; C:cytoplasm; C:midbody;, , P:cilium assembly; P:cytoplasmic microtubule organization; P:mitotic spindle organization; P:non-motile cilium assembly; scaffold30 indexed_genome mRNA 21523653 21551763 . + . ID=transcript_6613;Q9BRQ4 E9PJU1,Cilia- and flagella-associated protein 300 {ECO:0000305},, PF14926;, GO:0005737;GO:0005856;GO:0031514;, C:cytoplasm; C:cytoskeleton; C:motile cilium; scaffold30 indexed_genome mRNA 21706713 21712773 . + . ID=transcript_6614;K0L195 K0L1G3 Q7Z574 Q8IUY9,Transcriptional coactivator YAP1,Protein yorkie homolog;Yes-associated protein YAP65 homolog;, PF00397;, GO:0005737;GO:0005829;GO:0001674;GO:0016020;GO:0005654;GO:0005634;GO:0140552;GO:0003682;GO:0140297;GO:0070064;GO:0008022;GO:0000978;GO:0003713;GO:0003714;GO:0000976;GO:0060449;GO:0061026;GO:0000902;GO:0008283;GO:0006974;GO:0071480;GO:0071300;GO:0060242;GO:0003143;GO:0003015;GO:0035329;GO:0070102;GO:0060576;GO:0030216;GO:0048368;GO:0060487;GO:1902018;GO:1904036;GO:0030857;GO:2001237;GO:0045599;GO:0010629;GO:2000737;GO:0000122;GO:0007399;GO:0030903;GO:0048339;GO:0090263;GO:0060045;GO:0050679;GO:0010628;GO:0033148;GO:0045747;GO:0045669;GO:1900182;GO:1902459;GO:0045944;GO:0045893;GO:0050847;GO:0065003;GO:1902036;GO:0010837;GO:0072307;GO:0050767;GO:0072091;GO:0032570;GO:0035019;GO:0001894;GO:0006367;GO:0001829;GO:0001570;GO:0042060;, C:cytoplasm; C:cytosol; C:female germ cell nucleus; C:membrane; C:nucleoplasm; C:nucleus; C:TEAD-YAP complex;, F:chromatin binding; F:DNA-binding transcription factor binding; F:proline-rich region binding; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:bud elongation involved in lung branching; P:cardiac muscle tissue regeneration; P:cell morphogenesis; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to retinoic acid; P:contact inhibition; P:embryonic heart tube morphogenesis; P:heart process; P:hippo signaling; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell development; P:keratinocyte differentiation; P:lateral mesoderm development; P:lung epithelial cell differentiation; P:negative regulation of cilium assembly; P:negative regulation of epithelial cell apoptotic process; P:negative regulation of epithelial cell differentiation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:notochord development; P:paraxial mesoderm development; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of gene expression; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of protein localization to nucleus; P:positive regulation of stem cell population maintenance; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:progesterone receptor signaling pathway; P:protein-containing complex assembly; P:regulation of hematopoietic stem cell differentiation; P:regulation of keratinocyte proliferation; P:regulation of metanephric nephron tubule epithelial cell differentiation; P:regulation of neurogenesis; P:regulation of stem cell proliferation; P:response to progesterone; P:somatic stem cell population maintenance; P:tissue homeostasis; P:transcription initiation from RNA polymerase II promoter; P:trophectodermal cell differentiation; P:vasculogenesis; P:wound healing; scaffold30 indexed_genome mRNA 21824220 21827944 . + . ID=transcript_6615;Q3ZCU0 Q8N9C3,Protein GVQW3 {ECO:0000305},GVQW motif-containing protein 3 {ECO:0000305};, PF17906; scaffold30 indexed_genome mRNA 21827953 21843240 . + . ID=transcript_6616;Q13489 Q16628 Q9HC27 Q9UP46,Baculoviral IAP repeat-containing protein 3,Apoptosis inhibitor 2;Cellular inhibitor of apoptosis 2;IAP homolog C;Inhibitor of apoptosis protein 1;RING finger protein 49;RING-type E3 ubiquitin transferase BIRC3 {ECO:0000305};TNFR2-TRAF-signaling complex protein 1;, PF00653;PF00619;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0043027;GO:0046872;GO:0016740;GO:0061630;GO:0004842;GO:0007166;GO:0007249;GO:0002756;GO:0043066;GO:0060546;GO:0038061;GO:0043123;GO:0031398;GO:0016579;GO:0042981;GO:0051726;GO:2000116;GO:0050727;GO:0045088;GO:0060544;GO:0070424;GO:0039535;GO:0034121;GO:0010803;GO:0035666;GO:0033209;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell surface receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of necroptotic process; P:NIK/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein ubiquitination; P:protein deubiquitination; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of cysteine-type endopeptidase activity; P:regulation of inflammatory response; P:regulation of innate immune response; P:regulation of necroptotic process; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:regulation of RIG-I signaling pathway; P:regulation of toll-like receptor signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13489 Q16628 Q9HC27 Q9UP46,Baculoviral IAP repeat-containing protein 3,Apoptosis inhibitor 2;Cellular inhibitor of apoptosis 2;IAP homolog C;Inhibitor of apoptosis protein 1;RING finger protein 49;RING-type E3 ubiquitin transferase BIRC3 {ECO:0000305};TNFR2-TRAF-signaling complex protein 1;, PF00653;PF00619;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0043027;GO:0046872;GO:0016740;GO:0061630;GO:0004842;GO:0007166;GO:0007249;GO:0002756;GO:0043066;GO:0060546;GO:0038061;GO:0043123;GO:0031398;GO:0016579;GO:0042981;GO:0051726;GO:2000116;GO:0050727;GO:0045088;GO:0060544;GO:0070424;GO:0039535;GO:0034121;GO:0010803;GO:0035666;GO:0033209;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell surface receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of necroptotic process; P:NIK/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein ubiquitination; P:protein deubiquitination; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of cysteine-type endopeptidase activity; P:regulation of inflammatory response; P:regulation of innate immune response; P:regulation of necroptotic process; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:regulation of RIG-I signaling pathway; P:regulation of toll-like receptor signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13489 Q16628 Q9HC27 Q9UP46,Baculoviral IAP repeat-containing protein 3,Apoptosis inhibitor 2;Cellular inhibitor of apoptosis 2;IAP homolog C;Inhibitor of apoptosis protein 1;RING finger protein 49;RING-type E3 ubiquitin transferase BIRC3 {ECO:0000305};TNFR2-TRAF-signaling complex protein 1;, PF00653;PF00619;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0043027;GO:0046872;GO:0016740;GO:0061630;GO:0004842;GO:0007166;GO:0007249;GO:0002756;GO:0043066;GO:0060546;GO:0038061;GO:0043123;GO:0031398;GO:0016579;GO:0042981;GO:0051726;GO:2000116;GO:0050727;GO:0045088;GO:0060544;GO:0070424;GO:0039535;GO:0034121;GO:0010803;GO:0035666;GO:0033209;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell surface receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of necroptotic process; P:NIK/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein ubiquitination; P:protein deubiquitination; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of cysteine-type endopeptidase activity; P:regulation of inflammatory response; P:regulation of innate immune response; P:regulation of necroptotic process; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:regulation of RIG-I signaling pathway; P:regulation of toll-like receptor signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; scaffold30 indexed_genome mRNA 21889990 21913738 . + . ID=transcript_6617;Q13490 B4E026 Q16516 Q4TTG0,Baculoviral IAP repeat-containing protein 2,Cellular inhibitor of apoptosis 1;IAP homolog B;Inhibitor of apoptosis protein 2;RING finger protein 48;RING-type E3 ubiquitin transferase BIRC2 {ECO:0000305};TNFR2-TRAF-signaling complex protein 2;, PF00653;PF00619;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0045121;GO:0005634;GO:0001741;GO:0051087;GO:0043027;GO:0098770;GO:0042802;GO:0047485;GO:0044877;GO:0003713;GO:0016740;GO:0043130;GO:0061630;GO:0004842;GO:0008270;GO:0007166;GO:0007249;GO:0002756;GO:0070266;GO:0043066;GO:0060546;GO:1902443;GO:0038061;GO:0001890;GO:0043123;GO:1902524;GO:1902523;GO:1902527;GO:0031398;GO:0043161;GO:0016579;GO:0000209;GO:0042981;GO:0051726;GO:0045595;GO:0042127;GO:2000116;GO:0050727;GO:0045088;GO:0060544;GO:1901222;GO:0070424;GO:2000377;GO:0039535;GO:0034121;GO:0010803;GO:0051591;GO:0045471;GO:0001666;GO:0035666;GO:0033209;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:membrane raft; C:nucleus; C:XY body;, F:chaperone binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:FBXO family protein binding; F:identical protein binding; F:protein N-terminus binding; F:protein-containing complex binding; F:transcription coactivator activity; F:transferase activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:negative regulation of apoptotic process; P:negative regulation of necroptotic process; P:negative regulation of ripoptosome assembly involved in necroptotic process; P:NIK/NF-kappaB signaling; P:placenta development; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein K48-linked ubiquitination; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of protein monoubiquitination; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cysteine-type endopeptidase activity; P:regulation of inflammatory response; P:regulation of innate immune response; P:regulation of necroptotic process; P:regulation of NIK/NF-kappaB signaling; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:regulation of reactive oxygen species metabolic process; P:regulation of RIG-I signaling pathway; P:regulation of toll-like receptor signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to cAMP; P:response to ethanol; P:response to hypoxia; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13490 B4E026 Q16516 Q4TTG0,Baculoviral IAP repeat-containing protein 2,Cellular inhibitor of apoptosis 1;IAP homolog B;Inhibitor of apoptosis protein 2;RING finger protein 48;RING-type E3 ubiquitin transferase BIRC2 {ECO:0000305};TNFR2-TRAF-signaling complex protein 2;, PF00653;PF00619;, GO:0035631;GO:0005737;GO:0009898;GO:0005829;GO:0045121;GO:0005634;GO:0001741;GO:0051087;GO:0043027;GO:0098770;GO:0042802;GO:0047485;GO:0044877;GO:0003713;GO:0016740;GO:0043130;GO:0061630;GO:0004842;GO:0008270;GO:0007166;GO:0007249;GO:0002756;GO:0070266;GO:0043066;GO:0060546;GO:1902443;GO:0038061;GO:0001890;GO:0043123;GO:1902524;GO:1902523;GO:1902527;GO:0031398;GO:0043161;GO:0016579;GO:0000209;GO:0042981;GO:0051726;GO:0045595;GO:0042127;GO:2000116;GO:0050727;GO:0045088;GO:0060544;GO:1901222;GO:0070424;GO:2000377;GO:0039535;GO:0034121;GO:0010803;GO:0051591;GO:0045471;GO:0001666;GO:0035666;GO:0033209;, C:CD40 receptor complex; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:membrane raft; C:nucleus; C:XY body;, F:chaperone binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:FBXO family protein binding; F:identical protein binding; F:protein N-terminus binding; F:protein-containing complex binding; F:transcription coactivator activity; F:transferase activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:negative regulation of apoptotic process; P:negative regulation of necroptotic process; P:negative regulation of ripoptosome assembly involved in necroptotic process; P:NIK/NF-kappaB signaling; P:placenta development; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein K48-linked ubiquitination; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of protein monoubiquitination; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cysteine-type endopeptidase activity; P:regulation of inflammatory response; P:regulation of innate immune response; P:regulation of necroptotic process; P:regulation of NIK/NF-kappaB signaling; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:regulation of reactive oxygen species metabolic process; P:regulation of RIG-I signaling pathway; P:regulation of toll-like receptor signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to cAMP; P:response to ethanol; P:response to hypoxia; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; scaffold30 indexed_genome mRNA 21956535 22019140 . - . ID=transcript_6618;Q8N131 Q8IWS2 Q96QV2,Porimin,Keratinocytes-associated transmembrane protein 3;Pro-oncosis receptor inducing membrane injury;Transmembrane protein 123;, PF05283;, GO:0031410;GO:0009897;GO:0016021;GO:0038023;GO:0070267;, C:cytoplasmic vesicle; C:external side of plasma membrane; C:integral component of membrane;, F:signaling receptor activity;, P:oncosis; scaffold30 indexed_genome mRNA 22089958 22099895 . - . ID=transcript_6619;P09237 Q9BTK9,Matrilysin,Matrin;Matrix metalloproteinase-7;Pump-1 protease;Uterine metalloproteinase;, PF00413;PF01471;, GO:0009986;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0004175;GO:0008201;GO:0004222;GO:0008237;GO:0008270;GO:0007568;GO:0071260;GO:0030574;GO:0044849;GO:0022617;GO:0030198;GO:0060135;GO:0006509;GO:0031293;GO:0030335;GO:0006508;GO:0031667;, C:cell surface; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:endopeptidase activity; F:heparin binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:aging; P:cellular response to mechanical stimulus; P:collagen catabolic process; P:estrous cycle; P:extracellular matrix disassembly; P:extracellular matrix organization; P:maternal process involved in female pregnancy; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:positive regulation of cell migration; P:proteolysis; P:response to nutrient levels; scaffold30 indexed_genome mRNA 22343815 22352391 . - . ID=transcript_6620;P03956 P08156,Interstitial collagenase,Fibroblast collagenase;Matrix metalloproteinase-1;, PF00045;PF00413;PF01471;, GO:0031012;GO:0005576;GO:0004175;GO:0004222;GO:0008233;GO:0004252;GO:0008270;GO:0044267;GO:0071492;GO:0030574;GO:0019221;GO:0022617;GO:0030198;GO:0050900;GO:0031334;GO:0006508;GO:0016032;, C:extracellular matrix; C:extracellular region;, F:endopeptidase activity; F:metalloendopeptidase activity; F:peptidase activity; F:serine-type endopeptidase activity; F:zinc ion binding;, P:cellular protein metabolic process; P:cellular response to UV-A; P:collagen catabolic process; P:cytokine-mediated signaling pathway; P:extracellular matrix disassembly; P:extracellular matrix organization; P:leukocyte migration; P:positive regulation of protein-containing complex assembly; P:proteolysis; P:viral process; scaffold30 indexed_genome mRNA 22456912 22467477 . - . ID=transcript_6621;P39900 B2R9X8 B7ZLF6 Q2M1L9,Macrophage metalloelastase,Macrophage elastase;Matrix metalloproteinase-12;, PF00045;PF00413;PF01471;, GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0005634;GO:0005509;GO:0005518;GO:0001046;GO:0004175;GO:0004222;GO:0043565;GO:0008270;GO:0060435;GO:0098586;GO:0030574;GO:0060309;GO:0022617;GO:0030198;GO:0048286;GO:1904905;GO:0000122;GO:0060339;GO:0060054;GO:0032727;GO:0045944;GO:0060340;GO:0006606;GO:0006508;GO:0050691;GO:1904645;GO:0035313;, C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nucleus;, F:calcium ion binding; F:collagen binding; F:core promoter sequence-specific DNA binding; F:endopeptidase activity; F:metalloendopeptidase activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:bronchiole development; P:cellular response to virus; P:collagen catabolic process; P:elastin catabolic process; P:extracellular matrix disassembly; P:extracellular matrix organization; P:lung alveolus development; P:negative regulation of endothelial cell-matrix adhesion via fibronectin; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of epithelial cell proliferation involved in wound healing; P:positive regulation of interferon-alpha production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon-mediated signaling pathway; P:protein import into nucleus; P:proteolysis; P:regulation of defense response to virus by host; P:response to amyloid-beta; P:wound healing, spreading of epidermal cells;|P39900 B2R9X8 B7ZLF6 Q2M1L9,Macrophage metalloelastase,Macrophage elastase;Matrix metalloproteinase-12;, PF00045;PF00413;PF01471;, GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0005634;GO:0005509;GO:0005518;GO:0001046;GO:0004175;GO:0004222;GO:0043565;GO:0008270;GO:0060435;GO:0098586;GO:0030574;GO:0060309;GO:0022617;GO:0030198;GO:0048286;GO:1904905;GO:0000122;GO:0060339;GO:0060054;GO:0032727;GO:0045944;GO:0060340;GO:0006606;GO:0006508;GO:0050691;GO:1904645;GO:0035313;, C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nucleus;, F:calcium ion binding; F:collagen binding; F:core promoter sequence-specific DNA binding; F:endopeptidase activity; F:metalloendopeptidase activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:bronchiole development; P:cellular response to virus; P:collagen catabolic process; P:elastin catabolic process; P:extracellular matrix disassembly; P:extracellular matrix organization; P:lung alveolus development; P:negative regulation of endothelial cell-matrix adhesion via fibronectin; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of epithelial cell proliferation involved in wound healing; P:positive regulation of interferon-alpha production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon-mediated signaling pathway; P:protein import into nucleus; P:proteolysis; P:regulation of defense response to virus by host; P:response to amyloid-beta; P:wound healing, spreading of epidermal cells;|P39900 B2R9X8 B7ZLF6 Q2M1L9,Macrophage metalloelastase,Macrophage elastase;Matrix metalloproteinase-12;, PF00045;PF00413;PF01471;, GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0005634;GO:0005509;GO:0005518;GO:0001046;GO:0004175;GO:0004222;GO:0043565;GO:0008270;GO:0060435;GO:0098586;GO:0030574;GO:0060309;GO:0022617;GO:0030198;GO:0048286;GO:1904905;GO:0000122;GO:0060339;GO:0060054;GO:0032727;GO:0045944;GO:0060340;GO:0006606;GO:0006508;GO:0050691;GO:1904645;GO:0035313;, C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nucleus;, F:calcium ion binding; F:collagen binding; F:core promoter sequence-specific DNA binding; F:endopeptidase activity; F:metalloendopeptidase activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:bronchiole development; P:cellular response to virus; P:collagen catabolic process; P:elastin catabolic process; P:extracellular matrix disassembly; P:extracellular matrix organization; P:lung alveolus development; P:negative regulation of endothelial cell-matrix adhesion via fibronectin; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of epithelial cell proliferation involved in wound healing; P:positive regulation of interferon-alpha production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon-mediated signaling pathway; P:protein import into nucleus; P:proteolysis; P:regulation of defense response to virus by host; P:response to amyloid-beta; P:wound healing, spreading of epidermal cells; scaffold30 indexed_genome mRNA 22694027 22730047 . - . ID=transcript_6622;Q9BTE7 Q3ZTT2,DCN1-like protein 5 {ECO:0000305},DCUN1 domain-containing protein 5;Defective in cullin neddylation protein 1-like protein 5;Squamous cell carcinoma-related oncogene 5 {ECO:0000303|PubMed:24192928};, PF03556;, GO:0005737;GO:0005634;GO:0005819;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:0006974;GO:2000436;GO:0051443;GO:0045116;GO:0001558;GO:2000434;, C:cytoplasm; C:nucleus; C:spindle; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:cellular response to DNA damage stimulus; P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation; P:regulation of cell growth; P:regulation of protein neddylation;|Q9BTE7 Q3ZTT2,DCN1-like protein 5 {ECO:0000305},DCUN1 domain-containing protein 5;Defective in cullin neddylation protein 1-like protein 5;Squamous cell carcinoma-related oncogene 5 {ECO:0000303|PubMed:24192928};, PF03556;, GO:0005737;GO:0005634;GO:0005819;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:0006974;GO:2000436;GO:0051443;GO:0045116;GO:0001558;GO:2000434;, C:cytoplasm; C:nucleus; C:spindle; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:cellular response to DNA damage stimulus; P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation; P:regulation of cell growth; P:regulation of protein neddylation; scaffold30 indexed_genome mRNA 22749917 22790994 . + . ID=transcript_6623;Q92815 Q9HAE4,Cytoplasmic dynein 2 heavy chain 1,Cytoplasmic dynein 2 heavy chain;Dynein cytoplasmic heavy chain 2;Dynein heavy chain 11;Dynein heavy chain isotype 1B;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF18199;PF03028;PF12777;, GO:0045177;GO:0005930;GO:0097542;GO:0005929;GO:0005868;GO:0030286;GO:0070062;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003774;GO:0060271;GO:0060976;GO:0007368;GO:0009953;GO:0030326;GO:0030900;GO:0007030;GO:0035721;GO:0035735;GO:0001822;GO:0007018;GO:1905515;GO:0045880;GO:0061512;GO:0016485;GO:0021522;, C:apical part of cell; C:axoneme; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:dynein complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:motor activity;, P:cilium assembly; P:coronary vasculature development; P:determination of left/right symmetry; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:forebrain development; P:Golgi organization; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:microtubule-based movement; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:protein localization to cilium; P:protein processing; P:spinal cord motor neuron differentiation;|Q92815 Q9HAE4,Cytoplasmic dynein 2 heavy chain 1,Cytoplasmic dynein 2 heavy chain;Dynein cytoplasmic heavy chain 2;Dynein heavy chain 11;Dynein heavy chain isotype 1B;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF18199;PF03028;PF12777;, GO:0045177;GO:0005930;GO:0097542;GO:0005929;GO:0005868;GO:0030286;GO:0070062;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003774;GO:0060271;GO:0060976;GO:0007368;GO:0009953;GO:0030326;GO:0030900;GO:0007030;GO:0035721;GO:0035735;GO:0001822;GO:0007018;GO:1905515;GO:0045880;GO:0061512;GO:0016485;GO:0021522;, C:apical part of cell; C:axoneme; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:dynein complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:motor activity;, P:cilium assembly; P:coronary vasculature development; P:determination of left/right symmetry; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:forebrain development; P:Golgi organization; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:microtubule-based movement; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:protein localization to cilium; P:protein processing; P:spinal cord motor neuron differentiation;|Q92815 Q9HAE4,Cytoplasmic dynein 2 heavy chain 1,Cytoplasmic dynein 2 heavy chain;Dynein cytoplasmic heavy chain 2;Dynein heavy chain 11;Dynein heavy chain isotype 1B;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF18199;PF03028;PF12777;, GO:0045177;GO:0005930;GO:0097542;GO:0005929;GO:0005868;GO:0030286;GO:0070062;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003774;GO:0060271;GO:0060976;GO:0007368;GO:0009953;GO:0030326;GO:0030900;GO:0007030;GO:0035721;GO:0035735;GO:0001822;GO:0007018;GO:1905515;GO:0045880;GO:0061512;GO:0016485;GO:0021522;, C:apical part of cell; C:axoneme; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:dynein complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:motor activity;, P:cilium assembly; P:coronary vasculature development; P:determination of left/right symmetry; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:forebrain development; P:Golgi organization; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:microtubule-based movement; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:protein localization to cilium; P:protein processing; P:spinal cord motor neuron differentiation; scaffold30 indexed_genome mRNA 22792857 22823060 . + . ID=transcript_6624;Q92815 Q9HAE4,Cytoplasmic dynein 2 heavy chain 1,Cytoplasmic dynein 2 heavy chain;Dynein cytoplasmic heavy chain 2;Dynein heavy chain 11;Dynein heavy chain isotype 1B;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF18199;PF03028;PF12777;, GO:0045177;GO:0005930;GO:0097542;GO:0005929;GO:0005868;GO:0030286;GO:0070062;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003774;GO:0060271;GO:0060976;GO:0007368;GO:0009953;GO:0030326;GO:0030900;GO:0007030;GO:0035721;GO:0035735;GO:0001822;GO:0007018;GO:1905515;GO:0045880;GO:0061512;GO:0016485;GO:0021522;, C:apical part of cell; C:axoneme; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:dynein complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:motor activity;, P:cilium assembly; P:coronary vasculature development; P:determination of left/right symmetry; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:forebrain development; P:Golgi organization; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:microtubule-based movement; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:protein localization to cilium; P:protein processing; P:spinal cord motor neuron differentiation; scaffold30 indexed_genome mRNA 22823094 22916899 . + . ID=transcript_6625;Q92815 Q9HAE4,Cytoplasmic dynein 2 heavy chain 1,Cytoplasmic dynein 2 heavy chain;Dynein cytoplasmic heavy chain 2;Dynein heavy chain 11;Dynein heavy chain isotype 1B;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF18199;PF03028;PF12777;, GO:0045177;GO:0005930;GO:0097542;GO:0005929;GO:0005868;GO:0030286;GO:0070062;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003774;GO:0060271;GO:0060976;GO:0007368;GO:0009953;GO:0030326;GO:0030900;GO:0007030;GO:0035721;GO:0035735;GO:0001822;GO:0007018;GO:1905515;GO:0045880;GO:0061512;GO:0016485;GO:0021522;, C:apical part of cell; C:axoneme; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:dynein complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:motor activity;, P:cilium assembly; P:coronary vasculature development; P:determination of left/right symmetry; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:forebrain development; P:Golgi organization; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:microtubule-based movement; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:protein localization to cilium; P:protein processing; P:spinal cord motor neuron differentiation;|Q92815 Q9HAE4,Cytoplasmic dynein 2 heavy chain 1,Cytoplasmic dynein 2 heavy chain;Dynein cytoplasmic heavy chain 2;Dynein heavy chain 11;Dynein heavy chain isotype 1B;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF18199;PF03028;PF12777;, GO:0045177;GO:0005930;GO:0097542;GO:0005929;GO:0005868;GO:0030286;GO:0070062;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003774;GO:0060271;GO:0060976;GO:0007368;GO:0009953;GO:0030326;GO:0030900;GO:0007030;GO:0035721;GO:0035735;GO:0001822;GO:0007018;GO:1905515;GO:0045880;GO:0061512;GO:0016485;GO:0021522;, C:apical part of cell; C:axoneme; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:dynein complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:motor activity;, P:cilium assembly; P:coronary vasculature development; P:determination of left/right symmetry; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:forebrain development; P:Golgi organization; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:microtubule-based movement; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:protein localization to cilium; P:protein processing; P:spinal cord motor neuron differentiation; scaffold30 indexed_genome mRNA 22926771 23012902 . + . ID=transcript_6626;Q92815 Q9HAE4,Cytoplasmic dynein 2 heavy chain 1,Cytoplasmic dynein 2 heavy chain;Dynein cytoplasmic heavy chain 2;Dynein heavy chain 11;Dynein heavy chain isotype 1B;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF18199;PF03028;PF12777;, GO:0045177;GO:0005930;GO:0097542;GO:0005929;GO:0005868;GO:0030286;GO:0070062;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003774;GO:0060271;GO:0060976;GO:0007368;GO:0009953;GO:0030326;GO:0030900;GO:0007030;GO:0035721;GO:0035735;GO:0001822;GO:0007018;GO:1905515;GO:0045880;GO:0061512;GO:0016485;GO:0021522;, C:apical part of cell; C:axoneme; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:dynein complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:motor activity;, P:cilium assembly; P:coronary vasculature development; P:determination of left/right symmetry; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:forebrain development; P:Golgi organization; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:microtubule-based movement; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:protein localization to cilium; P:protein processing; P:spinal cord motor neuron differentiation; scaffold30 indexed_genome mRNA 23014010 23133650 . + . ID=transcript_6627;Q92815 Q9HAE4,Cytoplasmic dynein 2 heavy chain 1,Cytoplasmic dynein 2 heavy chain;Dynein cytoplasmic heavy chain 2;Dynein heavy chain 11;Dynein heavy chain isotype 1B;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF18199;PF03028;PF12777;, GO:0045177;GO:0005930;GO:0097542;GO:0005929;GO:0005868;GO:0030286;GO:0070062;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003774;GO:0060271;GO:0060976;GO:0007368;GO:0009953;GO:0030326;GO:0030900;GO:0007030;GO:0035721;GO:0035735;GO:0001822;GO:0007018;GO:1905515;GO:0045880;GO:0061512;GO:0016485;GO:0021522;, C:apical part of cell; C:axoneme; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:dynein complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:motor activity;, P:cilium assembly; P:coronary vasculature development; P:determination of left/right symmetry; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:forebrain development; P:Golgi organization; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:microtubule-based movement; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:protein localization to cilium; P:protein processing; P:spinal cord motor neuron differentiation;|Q92815 Q9HAE4,Cytoplasmic dynein 2 heavy chain 1,Cytoplasmic dynein 2 heavy chain;Dynein cytoplasmic heavy chain 2;Dynein heavy chain 11;Dynein heavy chain isotype 1B;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF18199;PF03028;PF12777;, GO:0045177;GO:0005930;GO:0097542;GO:0005929;GO:0005868;GO:0030286;GO:0070062;GO:0005794;GO:0005874;GO:0031514;GO:0005886;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003774;GO:0060271;GO:0060976;GO:0007368;GO:0009953;GO:0030326;GO:0030900;GO:0007030;GO:0035721;GO:0035735;GO:0001822;GO:0007018;GO:1905515;GO:0045880;GO:0061512;GO:0016485;GO:0021522;, C:apical part of cell; C:axoneme; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:dynein complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule; C:motile cilium; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:motor activity;, P:cilium assembly; P:coronary vasculature development; P:determination of left/right symmetry; P:dorsal/ventral pattern formation; P:embryonic limb morphogenesis; P:forebrain development; P:Golgi organization; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:microtubule-based movement; P:non-motile cilium assembly; P:positive regulation of smoothened signaling pathway; P:protein localization to cilium; P:protein processing; P:spinal cord motor neuron differentiation; scaffold30 indexed_genome mRNA 23646875 23905287 . - . ID=transcript_6628;Q9GZP0 A8K9T6 Q9BWV5,Platelet-derived growth factor D,Iris-expressed growth factor;Spinal cord-derived growth factor B;, PF00431;PF00341;, GO:0005788;GO:0005576;GO:0005615;GO:0000139;GO:0008083;GO:0070851;GO:0005161;GO:0071230;GO:0070301;GO:0036120;GO:0071560;GO:0007275;GO:0048008;GO:0051781;GO:0030335;GO:0008284;GO:0070374;GO:0048146;GO:0072126;GO:0043406;GO:2000439;GO:0014068;GO:0031954;GO:0071673;GO:0048661;GO:0050730;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi membrane;, F:growth factor activity; F:growth factor receptor binding; F:platelet-derived growth factor receptor binding;, P:cellular response to amino acid stimulus; P:cellular response to hydrogen peroxide; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:multicellular organism development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of glomerular mesangial cell proliferation; P:positive regulation of MAP kinase activity; P:positive regulation of monocyte extravasation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein autophosphorylation; P:positive regulation of smooth muscle cell chemotaxis; P:positive regulation of smooth muscle cell proliferation; P:regulation of peptidyl-tyrosine phosphorylation; scaffold30 indexed_genome mRNA 24878028 24886318 . - . ID=transcript_6629;Q9UG96,Caspase-4 {ECO:0000303|PubMed:15123740},ICE and Ced-3 homolog 2 {ECO:0000303|PubMed:7797510};ICE(rel)-II {ECO:0000303|PubMed:7797592};Mih1 {ECO:0000303|Ref.4};Protease TX {ECO:0000303|PubMed:7743998};, PF00619;, GO:0097169;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005576;GO:0072557;GO:0005739;GO:0072559;GO:0005886;GO:0032991;GO:0050700;GO:0004197;GO:0097199;GO:0006915;GO:1904646;GO:0097194;GO:0006954;GO:0045087;GO:0097193;GO:0070059;GO:1903265;GO:0016540;GO:0006508;GO:0070269;GO:0042981;GO:0050727;, C:AIM2 inflammasome complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:IPAF inflammasome complex; C:mitochondrion; C:NLRP3 inflammasome complex; C:plasma membrane; C:protein-containing complex;, F:CARD domain binding; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway;, P:apoptotic process; P:cellular response to amyloid-beta; P:execution phase of apoptosis; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:protein autoprocessing; P:proteolysis; P:pyroptosis; P:regulation of apoptotic process; P:regulation of inflammatory response;|Q9UG96,Caspase-4 {ECO:0000303|PubMed:15123740},ICE and Ced-3 homolog 2 {ECO:0000303|PubMed:7797510};ICE(rel)-II {ECO:0000303|PubMed:7797592};Mih1 {ECO:0000303|Ref.4};Protease TX {ECO:0000303|PubMed:7743998};, PF00619;, GO:0097169;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005576;GO:0072557;GO:0005739;GO:0072559;GO:0005886;GO:0032991;GO:0050700;GO:0004197;GO:0097199;GO:0006915;GO:1904646;GO:0097194;GO:0006954;GO:0045087;GO:0097193;GO:0070059;GO:1903265;GO:0016540;GO:0006508;GO:0070269;GO:0042981;GO:0050727;, C:AIM2 inflammasome complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:IPAF inflammasome complex; C:mitochondrion; C:NLRP3 inflammasome complex; C:plasma membrane; C:protein-containing complex;, F:CARD domain binding; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway;, P:apoptotic process; P:cellular response to amyloid-beta; P:execution phase of apoptosis; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:protein autoprocessing; P:proteolysis; P:pyroptosis; P:regulation of apoptotic process; P:regulation of inflammatory response;|Q9UG96,Caspase-4 {ECO:0000303|PubMed:15123740},ICE and Ced-3 homolog 2 {ECO:0000303|PubMed:7797510};ICE(rel)-II {ECO:0000303|PubMed:7797592};Mih1 {ECO:0000303|Ref.4};Protease TX {ECO:0000303|PubMed:7743998};, PF00619;, GO:0097169;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005576;GO:0072557;GO:0005739;GO:0072559;GO:0005886;GO:0032991;GO:0050700;GO:0004197;GO:0097199;GO:0006915;GO:1904646;GO:0097194;GO:0006954;GO:0045087;GO:0097193;GO:0070059;GO:1903265;GO:0016540;GO:0006508;GO:0070269;GO:0042981;GO:0050727;, C:AIM2 inflammasome complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:IPAF inflammasome complex; C:mitochondrion; C:NLRP3 inflammasome complex; C:plasma membrane; C:protein-containing complex;, F:CARD domain binding; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway;, P:apoptotic process; P:cellular response to amyloid-beta; P:execution phase of apoptosis; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:protein autoprocessing; P:proteolysis; P:pyroptosis; P:regulation of apoptotic process; P:regulation of inflammatory response;|Q9UG96,Caspase-4 {ECO:0000303|PubMed:15123740},ICE and Ced-3 homolog 2 {ECO:0000303|PubMed:7797510};ICE(rel)-II {ECO:0000303|PubMed:7797592};Mih1 {ECO:0000303|Ref.4};Protease TX {ECO:0000303|PubMed:7743998};, PF00619;, GO:0097169;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005576;GO:0072557;GO:0005739;GO:0072559;GO:0005886;GO:0032991;GO:0050700;GO:0004197;GO:0097199;GO:0006915;GO:1904646;GO:0097194;GO:0006954;GO:0045087;GO:0097193;GO:0070059;GO:1903265;GO:0016540;GO:0006508;GO:0070269;GO:0042981;GO:0050727;, C:AIM2 inflammasome complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:IPAF inflammasome complex; C:mitochondrion; C:NLRP3 inflammasome complex; C:plasma membrane; C:protein-containing complex;, F:CARD domain binding; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway;, P:apoptotic process; P:cellular response to amyloid-beta; P:execution phase of apoptosis; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:protein autoprocessing; P:proteolysis; P:pyroptosis; P:regulation of apoptotic process; P:regulation of inflammatory response;|Q9UG96,Caspase-4 {ECO:0000303|PubMed:15123740},ICE and Ced-3 homolog 2 {ECO:0000303|PubMed:7797510};ICE(rel)-II {ECO:0000303|PubMed:7797592};Mih1 {ECO:0000303|Ref.4};Protease TX {ECO:0000303|PubMed:7743998};, PF00619;, GO:0097169;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005576;GO:0072557;GO:0005739;GO:0072559;GO:0005886;GO:0032991;GO:0050700;GO:0004197;GO:0097199;GO:0006915;GO:1904646;GO:0097194;GO:0006954;GO:0045087;GO:0097193;GO:0070059;GO:1903265;GO:0016540;GO:0006508;GO:0070269;GO:0042981;GO:0050727;, C:AIM2 inflammasome complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:IPAF inflammasome complex; C:mitochondrion; C:NLRP3 inflammasome complex; C:plasma membrane; C:protein-containing complex;, F:CARD domain binding; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway;, P:apoptotic process; P:cellular response to amyloid-beta; P:execution phase of apoptosis; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:protein autoprocessing; P:proteolysis; P:pyroptosis; P:regulation of apoptotic process; P:regulation of inflammatory response; scaffold30 indexed_genome mRNA 24898084 24909663 . - . ID=transcript_6630;P29466 B5MDZ1 Q53EY6 Q6DMQ1 Q6GSS3 Q6PI75 Q9UCN3,Caspase-1,Interleukin-1 beta convertase {ECO:0000303|PubMed:1574116};Interleukin-1 beta-converting enzyme {ECO:0000303|PubMed:11051551, ECO:0000303|PubMed:1574116};p45;, PF00619;, GO:0097169;GO:0005737;GO:0005829;GO:0005576;GO:0072557;GO:0005739;GO:0072558;GO:0072559;GO:0005886;GO:0097179;GO:0032991;GO:0050700;GO:0008656;GO:0004197;GO:0097199;GO:0004175;GO:0042802;GO:0019900;GO:0006915;GO:0071345;GO:0071346;GO:0071222;GO:0071260;GO:0071310;GO:0140447;GO:0019221;GO:0097194;GO:0060081;GO:0051882;GO:0043280;GO:0043123;GO:0032730;GO:0032731;GO:1903265;GO:0097300;GO:0016540;GO:0006508;GO:0035590;GO:0070269;GO:0042981;GO:0010506;GO:0050727;GO:0033198;GO:0001666;GO:0007165;GO:0140448;GO:1901998;, C:AIM2 inflammasome complex; C:cytoplasm; C:cytosol; C:extracellular region; C:IPAF inflammasome complex; C:mitochondrion; C:NLRP1 inflammasome complex; C:NLRP3 inflammasome complex; C:plasma membrane; C:protease inhibitor complex; C:protein-containing complex;, F:CARD domain binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:endopeptidase activity; F:identical protein binding; F:kinase binding;, P:apoptotic process; P:cellular response to cytokine stimulus; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to organic substance; P:cytokine precursor processing; P:cytokine-mediated signaling pathway; P:execution phase of apoptosis; P:membrane hyperpolarization; P:mitochondrial depolarization; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-1 beta production; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:programmed necrotic cell death; P:protein autoprocessing; P:proteolysis; P:purinergic nucleotide receptor signaling pathway; P:pyroptosis; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of inflammatory response; P:response to ATP; P:response to hypoxia; P:signal transduction; P:signaling receptor ligand precursor processing; P:toxin transport;|Q5EG05 Q96RJ9,Caspase recruitment domain-containing protein 16,Caspase recruitment domain-only protein 1;Caspase-1 inhibitor COP;Pseudo interleukin-1 beta converting enzyme;, PF00619;, GO:0097179;GO:0032991;GO:0050700;GO:0089720;GO:0004869;GO:0042802;GO:0019900;GO:0071456;GO:0071222;GO:0071494;GO:0097340;GO:0043154;GO:0032691;GO:0031665;GO:0032091;GO:0010804;GO:0043123;GO:0051092;, C:protease inhibitor complex; C:protein-containing complex;, F:CARD domain binding; F:caspase binding; F:cysteine-type endopeptidase inhibitor activity; F:identical protein binding; F:kinase binding;, P:cellular response to hypoxia; P:cellular response to lipopolysaccharide; P:cellular response to UV-C; P:inhibition of cysteine-type endopeptidase activity; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of interleukin-1 beta production; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of protein binding; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity;|P29466 B5MDZ1 Q53EY6 Q6DMQ1 Q6GSS3 Q6PI75 Q9UCN3,Caspase-1,Interleukin-1 beta convertase {ECO:0000303|PubMed:1574116};Interleukin-1 beta-converting enzyme {ECO:0000303|PubMed:11051551, ECO:0000303|PubMed:1574116};p45;, PF00619;, GO:0097169;GO:0005737;GO:0005829;GO:0005576;GO:0072557;GO:0005739;GO:0072558;GO:0072559;GO:0005886;GO:0097179;GO:0032991;GO:0050700;GO:0008656;GO:0004197;GO:0097199;GO:0004175;GO:0042802;GO:0019900;GO:0006915;GO:0071345;GO:0071346;GO:0071222;GO:0071260;GO:0071310;GO:0140447;GO:0019221;GO:0097194;GO:0060081;GO:0051882;GO:0043280;GO:0043123;GO:0032730;GO:0032731;GO:1903265;GO:0097300;GO:0016540;GO:0006508;GO:0035590;GO:0070269;GO:0042981;GO:0010506;GO:0050727;GO:0033198;GO:0001666;GO:0007165;GO:0140448;GO:1901998;, C:AIM2 inflammasome complex; C:cytoplasm; C:cytosol; C:extracellular region; C:IPAF inflammasome complex; C:mitochondrion; C:NLRP1 inflammasome complex; C:NLRP3 inflammasome complex; C:plasma membrane; C:protease inhibitor complex; C:protein-containing complex;, F:CARD domain binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:endopeptidase activity; F:identical protein binding; F:kinase binding;, P:apoptotic process; P:cellular response to cytokine stimulus; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to organic substance; P:cytokine precursor processing; P:cytokine-mediated signaling pathway; P:execution phase of apoptosis; P:membrane hyperpolarization; P:mitochondrial depolarization; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-1 beta production; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:programmed necrotic cell death; P:protein autoprocessing; P:proteolysis; P:purinergic nucleotide receptor signaling pathway; P:pyroptosis; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of inflammatory response; P:response to ATP; P:response to hypoxia; P:signal transduction; P:signaling receptor ligand precursor processing; P:toxin transport;|P29466 B5MDZ1 Q53EY6 Q6DMQ1 Q6GSS3 Q6PI75 Q9UCN3,Caspase-1,Interleukin-1 beta convertase {ECO:0000303|PubMed:1574116};Interleukin-1 beta-converting enzyme {ECO:0000303|PubMed:11051551, ECO:0000303|PubMed:1574116};p45;, PF00619;, GO:0097169;GO:0005737;GO:0005829;GO:0005576;GO:0072557;GO:0005739;GO:0072558;GO:0072559;GO:0005886;GO:0097179;GO:0032991;GO:0050700;GO:0008656;GO:0004197;GO:0097199;GO:0004175;GO:0042802;GO:0019900;GO:0006915;GO:0071345;GO:0071346;GO:0071222;GO:0071260;GO:0071310;GO:0140447;GO:0019221;GO:0097194;GO:0060081;GO:0051882;GO:0043280;GO:0043123;GO:0032730;GO:0032731;GO:1903265;GO:0097300;GO:0016540;GO:0006508;GO:0035590;GO:0070269;GO:0042981;GO:0010506;GO:0050727;GO:0033198;GO:0001666;GO:0007165;GO:0140448;GO:1901998;, C:AIM2 inflammasome complex; C:cytoplasm; C:cytosol; C:extracellular region; C:IPAF inflammasome complex; C:mitochondrion; C:NLRP1 inflammasome complex; C:NLRP3 inflammasome complex; C:plasma membrane; C:protease inhibitor complex; C:protein-containing complex;, F:CARD domain binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:endopeptidase activity; F:identical protein binding; F:kinase binding;, P:apoptotic process; P:cellular response to cytokine stimulus; P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to organic substance; P:cytokine precursor processing; P:cytokine-mediated signaling pathway; P:execution phase of apoptosis; P:membrane hyperpolarization; P:mitochondrial depolarization; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-1 beta production; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:programmed necrotic cell death; P:protein autoprocessing; P:proteolysis; P:purinergic nucleotide receptor signaling pathway; P:pyroptosis; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of inflammatory response; P:response to ATP; P:response to hypoxia; P:signal transduction; P:signaling receptor ligand precursor processing; P:toxin transport; scaffold30 indexed_genome mRNA 25612884 26194985 . + . ID=transcript_6631;P48058 Q86XE8,Glutamate receptor 4,AMPA-selective glutamate receptor 4;GluR-D;Glutamate receptor ionotropic, AMPA 4;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:1903561;GO:0043025;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:extracellular vesicle; C:neuronal cell body; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P10809 B2R5M6 B7Z712 Q38L19 Q9UCR6,60 kDa heat shock protein, mitochondrial,60 kDa chaperonin;Chaperonin 60;Heat shock protein 60;HuCHA60;Mitochondrial matrix protein P1;P60 lymphocyte protein;, PF00118;, GO:0009986;GO:0005905;GO:0030135;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0005615;GO:0046696;GO:0016020;GO:0005743;GO:0005759;GO:0005739;GO:0005886;GO:0032991;GO:0030141;GO:0034186;GO:0034185;GO:0005524;GO:0016887;GO:0051087;GO:0003688;GO:0003725;GO:0019899;GO:0008035;GO:0016853;GO:0001530;GO:0002039;GO:0003723;GO:0003697;GO:0031625;GO:0051082;GO:0006458;GO:0006919;GO:0008637;GO:0042113;GO:0042100;GO:0051702;GO:0051131;GO:0048291;GO:0034514;GO:0002755;GO:0043066;GO:0043065;GO:0032727;GO:0032729;GO:0032733;GO:0032735;GO:0032755;GO:0043032;GO:0050870;GO:0002842;GO:0006457;GO:0045041;GO:0051604;GO:0042026;GO:0050821;GO:0006357;GO:0009409;GO:0006986;GO:0042110;GO:0016032;, C:cell surface; C:clathrin-coated pit; C:coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:extracellular space; C:lipopolysaccharide receptor complex; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:secretory granule;, F:apolipoprotein A-I binding; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:chaperone binding; F:DNA replication origin binding; F:double-stranded RNA binding; F:enzyme binding; F:high-density lipoprotein particle binding; F:isomerase activity; F:lipopolysaccharide binding; F:p53 binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:'de novo' protein folding; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic mitochondrial changes; P:B cell activation; P:B cell proliferation; P:biological process involved in interaction with symbiont; P:chaperone-mediated protein complex assembly; P:isotype switching to IgG isotypes; P:mitochondrial unfolded protein response; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated immune response to tumor cell; P:protein folding; P:protein import into mitochondrial intermembrane space; P:protein maturation; P:protein refolding; P:protein stabilization; P:regulation of transcription by RNA polymerase II; P:response to cold; P:response to unfolded protein; P:T cell activation; P:viral process;|P10809 B2R5M6 B7Z712 Q38L19 Q9UCR6,60 kDa heat shock protein, mitochondrial,60 kDa chaperonin;Chaperonin 60;Heat shock protein 60;HuCHA60;Mitochondrial matrix protein P1;P60 lymphocyte protein;, PF00118;, GO:0009986;GO:0005905;GO:0030135;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0005615;GO:0046696;GO:0016020;GO:0005743;GO:0005759;GO:0005739;GO:0005886;GO:0032991;GO:0030141;GO:0034186;GO:0034185;GO:0005524;GO:0016887;GO:0051087;GO:0003688;GO:0003725;GO:0019899;GO:0008035;GO:0016853;GO:0001530;GO:0002039;GO:0003723;GO:0003697;GO:0031625;GO:0051082;GO:0006458;GO:0006919;GO:0008637;GO:0042113;GO:0042100;GO:0051702;GO:0051131;GO:0048291;GO:0034514;GO:0002755;GO:0043066;GO:0043065;GO:0032727;GO:0032729;GO:0032733;GO:0032735;GO:0032755;GO:0043032;GO:0050870;GO:0002842;GO:0006457;GO:0045041;GO:0051604;GO:0042026;GO:0050821;GO:0006357;GO:0009409;GO:0006986;GO:0042110;GO:0016032;, C:cell surface; C:clathrin-coated pit; C:coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:extracellular space; C:lipopolysaccharide receptor complex; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:secretory granule;, F:apolipoprotein A-I binding; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:chaperone binding; F:DNA replication origin binding; F:double-stranded RNA binding; F:enzyme binding; F:high-density lipoprotein particle binding; F:isomerase activity; F:lipopolysaccharide binding; F:p53 binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:'de novo' protein folding; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic mitochondrial changes; P:B cell activation; P:B cell proliferation; P:biological process involved in interaction with symbiont; P:chaperone-mediated protein complex assembly; P:isotype switching to IgG isotypes; P:mitochondrial unfolded protein response; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated immune response to tumor cell; P:protein folding; P:protein import into mitochondrial intermembrane space; P:protein maturation; P:protein refolding; P:protein stabilization; P:regulation of transcription by RNA polymerase II; P:response to cold; P:response to unfolded protein; P:T cell activation; P:viral process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|P48058 Q86XE8,Glutamate receptor 4,AMPA-selective glutamate receptor 4;GluR-D;Glutamate receptor ionotropic, AMPA 4;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:1903561;GO:0043025;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:extracellular vesicle; C:neuronal cell body; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P48058 Q86XE8,Glutamate receptor 4,AMPA-selective glutamate receptor 4;GluR-D;Glutamate receptor ionotropic, AMPA 4;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:1903561;GO:0043025;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:extracellular vesicle; C:neuronal cell body; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity; scaffold30 indexed_genome mRNA 26220832 26240538 . + . ID=transcript_6632;P42263 D3DTF1 Q4VXD5 Q4VXD6 Q9HDA0 Q9HDA1 Q9HDA2 Q9P0H1,Glutamate receptor 3,AMPA-selective glutamate receptor 3;GluR-C;GluR-K3;Glutamate receptor ionotropic, AMPA 3;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:0098688;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0015276;GO:0038023;GO:1904315;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P42263 D3DTF1 Q4VXD5 Q4VXD6 Q9HDA0 Q9HDA1 Q9HDA2 Q9P0H1,Glutamate receptor 3,AMPA-selective glutamate receptor 3;GluR-C;GluR-K3;Glutamate receptor ionotropic, AMPA 3;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:0098688;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0015276;GO:0038023;GO:1904315;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P42262 A8MT92 I6L997 Q96FP6,Glutamate receptor 2 {ECO:0000305},AMPA-selective glutamate receptor 2;GluR-B;GluR-K2;Glutamate receptor ionotropic, AMPA 2;, PF01094;PF00060;PF10613;, GO:0032281;GO:0032279;GO:0030425;GO:0043197;GO:0030666;GO:0005789;GO:0060076;GO:0009897;GO:0005887;GO:0043025;GO:0005886;GO:0098794;GO:0014069;GO:0098839;GO:0098843;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0035235;GO:2000310;GO:0007165;GO:0035249;, C:AMPA glutamate receptor complex; C:asymmetric synapse; C:dendrite; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:excitatory synapse; C:external side of plasma membrane; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic endocytic zone;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:ionotropic glutamate receptor signaling pathway; P:regulation of NMDA receptor activity; P:signal transduction; P:synaptic transmission, glutamatergic;|P48058 Q86XE8,Glutamate receptor 4,AMPA-selective glutamate receptor 4;GluR-D;Glutamate receptor ionotropic, AMPA 4;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:1903561;GO:0043025;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:extracellular vesicle; C:neuronal cell body; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P48058 Q86XE8,Glutamate receptor 4,AMPA-selective glutamate receptor 4;GluR-D;Glutamate receptor ionotropic, AMPA 4;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:1903561;GO:0043025;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:extracellular vesicle; C:neuronal cell body; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity; scaffold30 indexed_genome mRNA 26302397 26305012 . - . ID=transcript_6633;Q8NCY6 Q96JK1 Q96JZ3 Q9H2N4,Myb/SANT-like DNA-binding domain-containing protein 4,Myb/SANT-like DNA-binding domain containing 4 with coiled-coils;, PF13873;, GO:0005634;, C:nucleus;|Q8NCY6 Q96JK1 Q96JZ3 Q9H2N4,Myb/SANT-like DNA-binding domain-containing protein 4,Myb/SANT-like DNA-binding domain containing 4 with coiled-coils;, PF13873;, GO:0005634;, C:nucleus; scaffold30 indexed_genome mRNA 26411071 26420313 . - . ID=transcript_6634;Q8NAB2 Q6N066 Q86X38 Q96NK5,Kelch repeat and BTB domain-containing protein 3 {ECO:0000305},BTB and kelch domain-containing protein 3 {ECO:0000312|HGNC:HGNC:22934};, PF07707;PF00651;PF01344;|Q8NAB2 Q6N066 Q86X38 Q96NK5,Kelch repeat and BTB domain-containing protein 3 {ECO:0000305},BTB and kelch domain-containing protein 3 {ECO:0000312|HGNC:HGNC:22934};, PF07707;PF00651;PF01344; scaffold30 indexed_genome mRNA 26474083 26497457 . + . ID=transcript_6635;Q9NRN7 B2R6D1 B4DDW7 Q9C068 Q9P0Q3 Q9UG80 Q9Y389,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase,4'-phosphopantetheinyl transferase;Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase;LYS5 ortholog;, PF01648;, GO:0005829;GO:0070062;GO:0008897;GO:0000287;GO:0019878;GO:0015939;, C:cytosol; C:extracellular exosome;, F:holo-[acyl-carrier-protein] synthase activity; F:magnesium ion binding;, P:lysine biosynthetic process via aminoadipic acid; P:pantothenate metabolic process;|Q9NRN7 B2R6D1 B4DDW7 Q9C068 Q9P0Q3 Q9UG80 Q9Y389,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase,4'-phosphopantetheinyl transferase;Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase;LYS5 ortholog;, PF01648;, GO:0005829;GO:0070062;GO:0008897;GO:0000287;GO:0019878;GO:0015939;, C:cytosol; C:extracellular exosome;, F:holo-[acyl-carrier-protein] synthase activity; F:magnesium ion binding;, P:lysine biosynthetic process via aminoadipic acid; P:pantothenate metabolic process;|Q9NRN7 B2R6D1 B4DDW7 Q9C068 Q9P0Q3 Q9UG80 Q9Y389,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase,4'-phosphopantetheinyl transferase;Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase;LYS5 ortholog;, PF01648;, GO:0005829;GO:0070062;GO:0008897;GO:0000287;GO:0019878;GO:0015939;, C:cytosol; C:extracellular exosome;, F:holo-[acyl-carrier-protein] synthase activity; F:magnesium ion binding;, P:lysine biosynthetic process via aminoadipic acid; P:pantothenate metabolic process;|Q9NRN7 B2R6D1 B4DDW7 Q9C068 Q9P0Q3 Q9UG80 Q9Y389,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase,4'-phosphopantetheinyl transferase;Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase;LYS5 ortholog;, PF01648;, GO:0005829;GO:0070062;GO:0008897;GO:0000287;GO:0019878;GO:0015939;, C:cytosol; C:extracellular exosome;, F:holo-[acyl-carrier-protein] synthase activity; F:magnesium ion binding;, P:lysine biosynthetic process via aminoadipic acid; P:pantothenate metabolic process; scaffold30 indexed_genome mRNA 26533257 26537875 . - . ID=transcript_6636;Q8WVL7 Q8NDF2 Q96JE5 Q9NXK7,Ankyrin repeat domain-containing protein 49,Fetal globin-inducing factor;, PF12796;, GO:0005634;GO:0030154;GO:0045893;GO:0007283;, C:nucleus;, , P:cell differentiation; P:positive regulation of transcription, DNA-templated; P:spermatogenesis;|Q8WVL7 Q8NDF2 Q96JE5 Q9NXK7,Ankyrin repeat domain-containing protein 49,Fetal globin-inducing factor;, PF12796;, GO:0005634;GO:0030154;GO:0045893;GO:0007283;, C:nucleus;, , P:cell differentiation; P:positive regulation of transcription, DNA-templated; P:spermatogenesis;|Q8WVL7 Q8NDF2 Q96JE5 Q9NXK7,Ankyrin repeat domain-containing protein 49,Fetal globin-inducing factor;, PF12796;, GO:0005634;GO:0030154;GO:0045893;GO:0007283;, C:nucleus;, , P:cell differentiation; P:positive regulation of transcription, DNA-templated; P:spermatogenesis; scaffold31 indexed_genome mRNA 28559 29988 . - . ID=transcript_6637;Q7Z6J2 Q6PIF8 Q7Z741,Protein TAMALIN {ECO:0000305},General receptor for phosphoinositides 1-associated scaffold protein {ECO:0000305};, PF00595;, GO:0098978;GO:0048471;GO:0005886;GO:0014069;GO:0045211;GO:0098685;GO:0042802;GO:0030165;GO:0008104;GO:0099152;GO:0007165;, C:glutamatergic synapse; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:identical protein binding; F:PDZ domain binding;, P:protein localization; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:signal transduction; scaffold31 indexed_genome mRNA 30092 30779 . - . ID=transcript_6638;Q7Z6J2 Q6PIF8 Q7Z741,Protein TAMALIN {ECO:0000305},General receptor for phosphoinositides 1-associated scaffold protein {ECO:0000305};, PF00595;, GO:0098978;GO:0048471;GO:0005886;GO:0014069;GO:0045211;GO:0098685;GO:0042802;GO:0030165;GO:0008104;GO:0099152;GO:0007165;, C:glutamatergic synapse; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:identical protein binding; F:PDZ domain binding;, P:protein localization; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:signal transduction; scaffold31 indexed_genome mRNA 33010 34035 . - . ID=transcript_6639;Q7Z6J2 Q6PIF8 Q7Z741,Protein TAMALIN {ECO:0000305},General receptor for phosphoinositides 1-associated scaffold protein {ECO:0000305};, PF00595;, GO:0098978;GO:0048471;GO:0005886;GO:0014069;GO:0045211;GO:0098685;GO:0042802;GO:0030165;GO:0008104;GO:0099152;GO:0007165;, C:glutamatergic synapse; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:identical protein binding; F:PDZ domain binding;, P:protein localization; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:signal transduction; scaffold31 indexed_genome mRNA 44069 58978 . - . ID=transcript_6640;P36896 B7Z5L8 B7Z5W5 Q15479 Q15480 Q15481 Q15482,Activin receptor type-1B,Activin receptor type IB;Activin receptor-like kinase 4;Serine/threonine-protein kinase receptor R2;, PF01064;PF00069;PF08515;, GO:0048179;GO:0009986;GO:0005829;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0016361;GO:0005524;GO:0034711;GO:0046872;GO:0004674;GO:0046332;GO:0004675;GO:0031625;GO:0032924;GO:0071363;GO:0007417;GO:0046545;GO:0097191;GO:0000082;GO:0001942;GO:0001701;GO:0030308;GO:0010629;GO:0007399;GO:0038092;GO:0018107;GO:0032927;GO:0045648;GO:0010862;GO:0045944;GO:1901165;GO:0046777;GO:0006468;GO:0006355;GO:0007165;GO:0007178;, C:activin receptor complex; C:cell surface; C:cytosol; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:activin receptor activity, type I; F:ATP binding; F:inhibin binding; F:metal ion binding; F:protein serine/threonine kinase activity; F:SMAD binding; F:transmembrane receptor protein serine/threonine kinase activity; F:ubiquitin protein ligase binding;, P:activin receptor signaling pathway; P:cellular response to growth factor stimulus; P:central nervous system development; P:development of primary female sexual characteristics; P:extrinsic apoptotic signaling pathway; P:G1/S transition of mitotic cell cycle; P:hair follicle development; P:in utero embryonic development; P:negative regulation of cell growth; P:negative regulation of gene expression; P:nervous system development; P:nodal signaling pathway; P:peptidyl-threonine phosphorylation; P:positive regulation of activin receptor signaling pathway; P:positive regulation of erythrocyte differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of trophoblast cell migration; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of transcription, DNA-templated; P:signal transduction; P:transmembrane receptor protein serine/threonine kinase signaling pathway; scaffold31 indexed_genome mRNA 112357 128092 . - . ID=transcript_6641;P37023 A6NGA8,Serine/threonine-protein kinase receptor R3,Activin receptor-like kinase 1;TGF-B superfamily receptor type I;, PF07714;PF08515;, GO:0070724;GO:0009986;GO:0005887;GO:0005886;GO:0043235;GO:0048185;GO:0016361;GO:0005524;GO:0098821;GO:0046872;GO:0019901;GO:0004674;GO:0046332;GO:0050431;GO:0005025;GO:0005024;GO:0004675;GO:0001525;GO:0060840;GO:0008015;GO:0002043;GO:0001955;GO:0001974;GO:0030509;GO:0071773;GO:0071363;GO:0071560;GO:0035912;GO:0009953;GO:0003203;GO:0061154;GO:0007507;GO:0001946;GO:0060836;GO:0043537;GO:0007162;GO:0030308;GO:0030336;GO:0008285;GO:2000279;GO:0010596;GO:0051895;GO:0010629;GO:0030513;GO:0032332;GO:0010862;GO:0045944;GO:0045893;GO:0006468;GO:0008217;GO:0043535;GO:0006275;GO:0001936;GO:0006355;GO:0061298;GO:0007165;GO:0007179;GO:0060841;GO:0035313;, C:BMP receptor complex; C:cell surface; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:activin binding; F:activin receptor activity, type I; F:ATP binding; F:BMP receptor activity; F:metal ion binding; F:protein kinase binding; F:protein serine/threonine kinase activity; F:SMAD binding; F:transforming growth factor beta binding; F:transforming growth factor beta receptor activity, type I; F:transforming growth factor beta-activated receptor activity; F:transmembrane receptor protein serine/threonine kinase activity;, P:angiogenesis; P:artery development; P:blood circulation; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:blood vessel maturation; P:blood vessel remodeling; P:BMP signaling pathway; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:dorsal aorta morphogenesis; P:dorsal/ventral pattern formation; P:endocardial cushion morphogenesis; P:endothelial tube morphogenesis; P:heart development; P:lymphangiogenesis; P:lymphatic endothelial cell differentiation; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell adhesion; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of DNA biosynthetic process; P:negative regulation of endothelial cell migration; P:negative regulation of focal adhesion assembly; P:negative regulation of gene expression; P:positive regulation of BMP signaling pathway; P:positive regulation of chondrocyte differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of blood pressure; P:regulation of blood vessel endothelial cell migration; P:regulation of DNA replication; P:regulation of endothelial cell proliferation; P:regulation of transcription, DNA-templated; P:retina vasculature development in camera-type eye; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; P:venous blood vessel development; P:wound healing, spreading of epidermal cells; scaffold31 indexed_genome mRNA 217187 341124 . - . ID=transcript_6642;Q9UQD0 B9VWG8 O95788 Q9NYX2 Q9UPB2,Sodium channel protein type 8 subunit alpha,Sodium channel protein type VIII subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.6;, PF00520;PF00612;PF06512;PF11933;, GO:0030424;GO:0043194;GO:0030054;GO:0031410;GO:0016021;GO:0033268;GO:0005886;GO:0001518;GO:0030018;GO:0005524;GO:0005244;GO:0005248;GO:0086010;GO:0042552;GO:0007399;GO:0019228;GO:0007422;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:axon initial segment; C:cell junction; C:cytoplasmic vesicle; C:integral component of membrane; C:node of Ranvier; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:ATP binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:membrane depolarization during action potential; P:myelination; P:nervous system development; P:neuronal action potential; P:peripheral nervous system development; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|Q9UQD0 B9VWG8 O95788 Q9NYX2 Q9UPB2,Sodium channel protein type 8 subunit alpha,Sodium channel protein type VIII subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.6;, PF00520;PF00612;PF06512;PF11933;, GO:0030424;GO:0043194;GO:0030054;GO:0031410;GO:0016021;GO:0033268;GO:0005886;GO:0001518;GO:0030018;GO:0005524;GO:0005244;GO:0005248;GO:0086010;GO:0042552;GO:0007399;GO:0019228;GO:0007422;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:axon initial segment; C:cell junction; C:cytoplasmic vesicle; C:integral component of membrane; C:node of Ranvier; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:ATP binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:membrane depolarization during action potential; P:myelination; P:nervous system development; P:neuronal action potential; P:peripheral nervous system development; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport;|Q9UQD0 B9VWG8 O95788 Q9NYX2 Q9UPB2,Sodium channel protein type 8 subunit alpha,Sodium channel protein type VIII subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.6;, PF00520;PF00612;PF06512;PF11933;, GO:0030424;GO:0043194;GO:0030054;GO:0031410;GO:0016021;GO:0033268;GO:0005886;GO:0001518;GO:0030018;GO:0005524;GO:0005244;GO:0005248;GO:0086010;GO:0042552;GO:0007399;GO:0019228;GO:0007422;GO:0034765;GO:0035725;GO:0006814;, C:axon; C:axon initial segment; C:cell junction; C:cytoplasmic vesicle; C:integral component of membrane; C:node of Ranvier; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:ATP binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:membrane depolarization during action potential; P:myelination; P:nervous system development; P:neuronal action potential; P:peripheral nervous system development; P:regulation of ion transmembrane transport; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold31 indexed_genome mRNA 465994 540596 . - . ID=transcript_6643;Q8N3U2 Q8TC60 Q9UKX8,Electroneutral sodium bicarbonate exchanger 1,Electroneutral Na(+)-driven Cl-HCO3 exchanger;Solute carrier family 4 member 8;k-NBC3;, PF07565;PF00955;, GO:0032279;GO:0043679;GO:0030425;GO:0097386;GO:0098978;GO:0097457;GO:0016021;GO:0016020;GO:0043005;GO:0032809;GO:0005886;GO:0098793;GO:0042734;GO:0032280;GO:0008021;GO:0043195;GO:0015301;GO:0015106;GO:0015108;GO:0005452;GO:0015081;GO:0008510;GO:0022857;GO:0015701;GO:1902476;GO:0050801;GO:0050804;GO:2000302;GO:0051453;GO:0042391;GO:0035725;GO:0055085;GO:0150104;, C:asymmetric synapse; C:axon terminus; C:dendrite; C:glial cell projection; C:glutamatergic synapse; C:hippocampal mossy fiber; C:integral component of membrane; C:membrane; C:neuron projection; C:neuronal cell body membrane; C:plasma membrane; C:presynapse; C:presynaptic membrane; C:symmetric synapse; C:synaptic vesicle; C:terminal bouton;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:inorganic anion exchanger activity; F:sodium ion transmembrane transporter activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:chloride transmembrane transport; P:ion homeostasis; P:modulation of chemical synaptic transmission; P:positive regulation of synaptic vesicle exocytosis; P:regulation of intracellular pH; P:regulation of membrane potential; P:sodium ion transmembrane transport; P:transmembrane transport; P:transport across blood-brain barrier;|Q8N3U2 Q8TC60 Q9UKX8,Electroneutral sodium bicarbonate exchanger 1,Electroneutral Na(+)-driven Cl-HCO3 exchanger;Solute carrier family 4 member 8;k-NBC3;, PF07565;PF00955;, GO:0032279;GO:0043679;GO:0030425;GO:0097386;GO:0098978;GO:0097457;GO:0016021;GO:0016020;GO:0043005;GO:0032809;GO:0005886;GO:0098793;GO:0042734;GO:0032280;GO:0008021;GO:0043195;GO:0015301;GO:0015106;GO:0015108;GO:0005452;GO:0015081;GO:0008510;GO:0022857;GO:0015701;GO:1902476;GO:0050801;GO:0050804;GO:2000302;GO:0051453;GO:0042391;GO:0035725;GO:0055085;GO:0150104;, C:asymmetric synapse; C:axon terminus; C:dendrite; C:glial cell projection; C:glutamatergic synapse; C:hippocampal mossy fiber; C:integral component of membrane; C:membrane; C:neuron projection; C:neuronal cell body membrane; C:plasma membrane; C:presynapse; C:presynaptic membrane; C:symmetric synapse; C:synaptic vesicle; C:terminal bouton;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:inorganic anion exchanger activity; F:sodium ion transmembrane transporter activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:chloride transmembrane transport; P:ion homeostasis; P:modulation of chemical synaptic transmission; P:positive regulation of synaptic vesicle exocytosis; P:regulation of intracellular pH; P:regulation of membrane potential; P:sodium ion transmembrane transport; P:transmembrane transport; P:transport across blood-brain barrier; scaffold31 indexed_genome mRNA 573828 609294 . + . ID=transcript_6644;Q8NCL4 Q8IYH4 Q9H6G2 Q9UIV5,Polypeptide N-acetylgalactosaminyltransferase 6,Polypeptide GalNAc transferase 6;Protein-UDP acetylgalactosaminyltransferase 6;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0048471;GO:0030246;GO:0046872;GO:0004653;GO:0016266;GO:0006493;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation; scaffold31 indexed_genome mRNA 610446 619641 . + . ID=transcript_6645;Q9UNI1 Q5MLF0 Q6DJT0 Q6ISM6,Chymotrypsin-like elastase family member 1,Elastase-1;Pancreatic elastase 1;, PF00089;, GO:0005615;GO:0046872;GO:0004252;GO:0060309;GO:0031017;GO:0006954;GO:0035264;GO:0000122;GO:0061113;GO:0045766;GO:0045944;GO:0009791;GO:0006508;GO:0045595;GO:0042127;GO:0048771;GO:0016055;, C:extracellular space;, F:metal ion binding; F:serine-type endopeptidase activity;, P:elastin catabolic process; P:exocrine pancreas development; P:inflammatory response; P:multicellular organism growth; P:negative regulation of transcription by RNA polymerase II; P:pancreas morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:proteolysis; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:tissue remodeling; P:Wnt signaling pathway; scaffold31 indexed_genome mRNA 620666 629402 . + . ID=transcript_6646;Q9UNI1 Q5MLF0 Q6DJT0 Q6ISM6,Chymotrypsin-like elastase family member 1,Elastase-1;Pancreatic elastase 1;, PF00089;, GO:0005615;GO:0046872;GO:0004252;GO:0060309;GO:0031017;GO:0006954;GO:0035264;GO:0000122;GO:0061113;GO:0045766;GO:0045944;GO:0009791;GO:0006508;GO:0045595;GO:0042127;GO:0048771;GO:0016055;, C:extracellular space;, F:metal ion binding; F:serine-type endopeptidase activity;, P:elastin catabolic process; P:exocrine pancreas development; P:inflammatory response; P:multicellular organism growth; P:negative regulation of transcription by RNA polymerase II; P:pancreas morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:proteolysis; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:tissue remodeling; P:Wnt signaling pathway; scaffold31 indexed_genome mRNA 652588 669472 . + . ID=transcript_6647;Q9UBW5 B7Z6F3 F5H0W4 Q86VV0 Q9NWK4 Q9UKN4,Bridging integrator 2,Breast cancer-associated protein 1;, PF03114;, GO:0005938;GO:0030054;GO:0042995;GO:0005576;GO:1904813;GO:0001891;GO:0005886;GO:0002102;GO:0034774;GO:0005543;GO:0060326;GO:0043312;GO:0006911;GO:0097320;GO:0071800;, C:cell cortex; C:cell junction; C:cell projection; C:extracellular region; C:ficolin-1-rich granule lumen; C:phagocytic cup; C:plasma membrane; C:podosome; C:secretory granule lumen;, F:phospholipid binding;, P:cell chemotaxis; P:neutrophil degranulation; P:phagocytosis, engulfment; P:plasma membrane tubulation; P:podosome assembly;|Q9UBW5 B7Z6F3 F5H0W4 Q86VV0 Q9NWK4 Q9UKN4,Bridging integrator 2,Breast cancer-associated protein 1;, PF03114;, GO:0005938;GO:0030054;GO:0042995;GO:0005576;GO:1904813;GO:0001891;GO:0005886;GO:0002102;GO:0034774;GO:0005543;GO:0060326;GO:0043312;GO:0006911;GO:0097320;GO:0071800;, C:cell cortex; C:cell junction; C:cell projection; C:extracellular region; C:ficolin-1-rich granule lumen; C:phagocytic cup; C:plasma membrane; C:podosome; C:secretory granule lumen;, F:phospholipid binding;, P:cell chemotaxis; P:neutrophil degranulation; P:phagocytosis, engulfment; P:plasma membrane tubulation; P:podosome assembly;|Q9UBW5 B7Z6F3 F5H0W4 Q86VV0 Q9NWK4 Q9UKN4,Bridging integrator 2,Breast cancer-associated protein 1;, PF03114;, GO:0005938;GO:0030054;GO:0042995;GO:0005576;GO:1904813;GO:0001891;GO:0005886;GO:0002102;GO:0034774;GO:0005543;GO:0060326;GO:0043312;GO:0006911;GO:0097320;GO:0071800;, C:cell cortex; C:cell junction; C:cell projection; C:extracellular region; C:ficolin-1-rich granule lumen; C:phagocytic cup; C:plasma membrane; C:podosome; C:secretory granule lumen;, F:phospholipid binding;, P:cell chemotaxis; P:neutrophil degranulation; P:phagocytosis, engulfment; P:plasma membrane tubulation; P:podosome assembly; scaffold31 indexed_genome mRNA 676378 680220 . - . ID=transcript_6648;Q0VAQ4 A6NIL5,Small cell adhesion glycoprotein,Small transmembrane and glycosylated protein;, , GO:0030054;GO:0030659;GO:0016021;GO:0005654;GO:0005886;, C:cell junction; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:nucleoplasm; C:plasma membrane; scaffold31 indexed_genome mRNA 698141 719117 . + . ID=transcript_6649;Q86XK3 A8K569 B2RTV8 Q5JT39 Q5JT40 Q8WW47,Swi5-dependent recombination DNA repair protein 1 homolog,Meiosis protein 5 homolog;, PF10376;, GO:0005634;GO:0032798;GO:0030374;GO:0071391;GO:0000724;GO:0045893;, C:nucleus; C:Swi5-Sfr1 complex;, F:nuclear receptor coactivator activity;, P:cellular response to estrogen stimulus; P:double-strand break repair via homologous recombination; P:positive regulation of transcription, DNA-templated;|Q14863 Q15944 Q6DK47 Q7Z7P6,POU domain, class 6, transcription factor 1,Brain-specific homeobox/POU domain protein 5;mPOU homeobox protein;, PF00046;PF00157;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0043565;GO:1990837;GO:0007420;GO:0007507;GO:0007517;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:heart development; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14863 Q15944 Q6DK47 Q7Z7P6,POU domain, class 6, transcription factor 1,Brain-specific homeobox/POU domain protein 5;mPOU homeobox protein;, PF00046;PF00157;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0043565;GO:1990837;GO:0007420;GO:0007507;GO:0007517;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:heart development; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14863 Q15944 Q6DK47 Q7Z7P6,POU domain, class 6, transcription factor 1,Brain-specific homeobox/POU domain protein 5;mPOU homeobox protein;, PF00046;PF00157;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0043565;GO:1990837;GO:0007420;GO:0007507;GO:0007517;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:heart development; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14863 Q15944 Q6DK47 Q7Z7P6,POU domain, class 6, transcription factor 1,Brain-specific homeobox/POU domain protein 5;mPOU homeobox protein;, PF00046;PF00157;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0043565;GO:1990837;GO:0007420;GO:0007507;GO:0007517;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:heart development; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14863 Q15944 Q6DK47 Q7Z7P6,POU domain, class 6, transcription factor 1,Brain-specific homeobox/POU domain protein 5;mPOU homeobox protein;, PF00046;PF00157;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0043565;GO:1990837;GO:0007420;GO:0007507;GO:0007517;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:heart development; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14863 Q15944 Q6DK47 Q7Z7P6,POU domain, class 6, transcription factor 1,Brain-specific homeobox/POU domain protein 5;mPOU homeobox protein;, PF00046;PF00157;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0043565;GO:1990837;GO:0007420;GO:0007507;GO:0007517;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:heart development; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold31 indexed_genome mRNA 727054 776921 . + . ID=transcript_6650;Q12800 A8K5E9 Q12801 Q9UD75 Q9UD77,Alpha-globin transcription factor CP2,SAA3 enhancer factor;Transcription factor LSF;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0008022;GO:0000978;GO:1990837;GO:0008134;GO:0042789;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:mRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q12800 A8K5E9 Q12801 Q9UD75 Q9UD77,Alpha-globin transcription factor CP2,SAA3 enhancer factor;Transcription factor LSF;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0008022;GO:0000978;GO:1990837;GO:0008134;GO:0042789;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:mRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q12800 A8K5E9 Q12801 Q9UD75 Q9UD77,Alpha-globin transcription factor CP2,SAA3 enhancer factor;Transcription factor LSF;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0008022;GO:0000978;GO:1990837;GO:0008134;GO:0042789;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:mRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q12800 A8K5E9 Q12801 Q9UD75 Q9UD77,Alpha-globin transcription factor CP2,SAA3 enhancer factor;Transcription factor LSF;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0008022;GO:0000978;GO:1990837;GO:0008134;GO:0042789;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:mRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q12800 A8K5E9 Q12801 Q9UD75 Q9UD77,Alpha-globin transcription factor CP2,SAA3 enhancer factor;Transcription factor LSF;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0008022;GO:0000978;GO:1990837;GO:0008134;GO:0042789;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:mRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q12800 A8K5E9 Q12801 Q9UD75 Q9UD77,Alpha-globin transcription factor CP2,SAA3 enhancer factor;Transcription factor LSF;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0008022;GO:0000978;GO:1990837;GO:0008134;GO:0042789;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:mRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q12800 A8K5E9 Q12801 Q9UD75 Q9UD77,Alpha-globin transcription factor CP2,SAA3 enhancer factor;Transcription factor LSF;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0008022;GO:0000978;GO:1990837;GO:0008134;GO:0042789;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:mRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q12800 A8K5E9 Q12801 Q9UD75 Q9UD77,Alpha-globin transcription factor CP2,SAA3 enhancer factor;Transcription factor LSF;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0008022;GO:0000978;GO:1990837;GO:0008134;GO:0042789;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:mRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold31 indexed_genome mRNA 786034 807563 . + . ID=transcript_6651;Q9H175,Cysteine/serine-rich nuclear protein 2,Protein FAM130A1;TGF-beta-induced apoptosis protein 12;, PF16019;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0019902;GO:0043565;GO:0006915;GO:0010923;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:phosphatase binding; F:sequence-specific DNA binding;, P:apoptotic process; P:negative regulation of phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9H175,Cysteine/serine-rich nuclear protein 2,Protein FAM130A1;TGF-beta-induced apoptosis protein 12;, PF16019;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0019902;GO:0043565;GO:0006915;GO:0010923;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:phosphatase binding; F:sequence-specific DNA binding;, P:apoptotic process; P:negative regulation of phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9H175,Cysteine/serine-rich nuclear protein 2,Protein FAM130A1;TGF-beta-induced apoptosis protein 12;, PF16019;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0019902;GO:0043565;GO:0006915;GO:0010923;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:phosphatase binding; F:sequence-specific DNA binding;, P:apoptotic process; P:negative regulation of phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BY59 Q9Y3X3,LETM1 domain-containing protein 1,Cervical cancer 1 proto-oncogene protein p40;Cervical cancer proto-oncogene 2 protein;HCCR-1;HCRR-2;, PF07766;, GO:0016021;GO:0005743;GO:0005741;GO:0005739;GO:0005730;GO:0005654;GO:0043022;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ribosome binding;|Q9BY59 Q9Y3X3,LETM1 domain-containing protein 1,Cervical cancer 1 proto-oncogene protein p40;Cervical cancer proto-oncogene 2 protein;HCCR-1;HCRR-2;, PF07766;, GO:0016021;GO:0005743;GO:0005741;GO:0005739;GO:0005730;GO:0005654;GO:0043022;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ribosome binding;|Q9BY59 Q9Y3X3,LETM1 domain-containing protein 1,Cervical cancer 1 proto-oncogene protein p40;Cervical cancer proto-oncogene 2 protein;HCCR-1;HCRR-2;, PF07766;, GO:0016021;GO:0005743;GO:0005741;GO:0005739;GO:0005730;GO:0005654;GO:0043022;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ribosome binding;|Q9BY59 Q9Y3X3,LETM1 domain-containing protein 1,Cervical cancer 1 proto-oncogene protein p40;Cervical cancer proto-oncogene 2 protein;HCCR-1;HCRR-2;, PF07766;, GO:0016021;GO:0005743;GO:0005741;GO:0005739;GO:0005730;GO:0005654;GO:0043022;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ribosome binding;|Q9BY59 Q9Y3X3,LETM1 domain-containing protein 1,Cervical cancer 1 proto-oncogene protein p40;Cervical cancer proto-oncogene 2 protein;HCCR-1;HCRR-2;, PF07766;, GO:0016021;GO:0005743;GO:0005741;GO:0005739;GO:0005730;GO:0005654;GO:0043022;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ribosome binding;|Q9BY59 Q9Y3X3,LETM1 domain-containing protein 1,Cervical cancer 1 proto-oncogene protein p40;Cervical cancer proto-oncogene 2 protein;HCCR-1;HCRR-2;, PF07766;, GO:0016021;GO:0005743;GO:0005741;GO:0005739;GO:0005730;GO:0005654;GO:0043022;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ribosome binding;|Q9BY59 Q9Y3X3,LETM1 domain-containing protein 1,Cervical cancer 1 proto-oncogene protein p40;Cervical cancer proto-oncogene 2 protein;HCCR-1;HCRR-2;, PF07766;, GO:0016021;GO:0005743;GO:0005741;GO:0005739;GO:0005730;GO:0005654;GO:0043022;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ribosome binding; scaffold31 indexed_genome mRNA 834699 860592 . + . ID=transcript_6652;Q96J35,Natural resistance-associated macrophage protein 2,Divalent cation transporter 1;Divalent metal transporter 1;Solute carrier family 11 member 2;, PF01566;, GO:0045177;GO:0016324;GO:0045178;GO:0031526;GO:0009986;GO:0005737;GO:0031410;GO:0005769;GO:1903561;GO:0005887;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0070826;GO:0048471;GO:0005886;GO:0055037;GO:0005802;GO:0005773;GO:0046870;GO:0015086;GO:0015087;GO:0005375;GO:0015093;GO:0022890;GO:0005381;GO:0015094;GO:0005384;GO:0015099;GO:1905394;GO:0015295;GO:0046915;GO:0015100;GO:0005385;GO:0006919;GO:0098656;GO:0070574;GO:0070588;GO:0006879;GO:0034599;GO:0006824;GO:0006825;GO:0048813;GO:0003032;GO:0048821;GO:0006783;GO:0033212;GO:0034755;GO:0006826;GO:0015692;GO:0007611;GO:0006828;GO:0060586;GO:0015675;GO:0001666;GO:0010039;GO:0015676;GO:0071577;, C:apical part of cell; C:apical plasma membrane; C:basal part of cell; C:brush border membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:early endosome; C:extracellular vesicle; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:paraferritin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:trans-Golgi network; C:vacuole;, F:cadmium ion binding; F:cadmium ion transmembrane transporter activity; F:cobalt ion transmembrane transporter activity; F:copper ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:inorganic cation transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:lead ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:nickel cation transmembrane transporter activity; F:retromer complex binding; F:solute:proton symporter activity; F:transition metal ion transmembrane transporter activity; F:vanadium ion transmembrane transporter activity; F:zinc ion transmembrane transporter activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:anion transmembrane transport; P:cadmium ion transmembrane transport; P:calcium ion transmembrane transport; P:cellular iron ion homeostasis; P:cellular response to oxidative stress; P:cobalt ion transport; P:copper ion transport; P:dendrite morphogenesis; P:detection of oxygen; P:erythrocyte development; P:heme biosynthetic process; P:iron import into cell; P:iron ion transmembrane transport; P:iron ion transport; P:lead ion transport; P:learning or memory; P:manganese ion transport; P:multicellular organismal iron ion homeostasis; P:nickel cation transport; P:response to hypoxia; P:response to iron ion; P:vanadium ion transport; P:zinc ion transmembrane transport;|Q96J35,Natural resistance-associated macrophage protein 2,Divalent cation transporter 1;Divalent metal transporter 1;Solute carrier family 11 member 2;, PF01566;, GO:0045177;GO:0016324;GO:0045178;GO:0031526;GO:0009986;GO:0005737;GO:0031410;GO:0005769;GO:1903561;GO:0005887;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0070826;GO:0048471;GO:0005886;GO:0055037;GO:0005802;GO:0005773;GO:0046870;GO:0015086;GO:0015087;GO:0005375;GO:0015093;GO:0022890;GO:0005381;GO:0015094;GO:0005384;GO:0015099;GO:1905394;GO:0015295;GO:0046915;GO:0015100;GO:0005385;GO:0006919;GO:0098656;GO:0070574;GO:0070588;GO:0006879;GO:0034599;GO:0006824;GO:0006825;GO:0048813;GO:0003032;GO:0048821;GO:0006783;GO:0033212;GO:0034755;GO:0006826;GO:0015692;GO:0007611;GO:0006828;GO:0060586;GO:0015675;GO:0001666;GO:0010039;GO:0015676;GO:0071577;, C:apical part of cell; C:apical plasma membrane; C:basal part of cell; C:brush border membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:early endosome; C:extracellular vesicle; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:paraferritin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:trans-Golgi network; C:vacuole;, F:cadmium ion binding; F:cadmium ion transmembrane transporter activity; F:cobalt ion transmembrane transporter activity; F:copper ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:inorganic cation transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:lead ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:nickel cation transmembrane transporter activity; F:retromer complex binding; F:solute:proton symporter activity; F:transition metal ion transmembrane transporter activity; F:vanadium ion transmembrane transporter activity; F:zinc ion transmembrane transporter activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:anion transmembrane transport; P:cadmium ion transmembrane transport; P:calcium ion transmembrane transport; P:cellular iron ion homeostasis; P:cellular response to oxidative stress; P:cobalt ion transport; P:copper ion transport; P:dendrite morphogenesis; P:detection of oxygen; P:erythrocyte development; P:heme biosynthetic process; P:iron import into cell; P:iron ion transmembrane transport; P:iron ion transport; P:lead ion transport; P:learning or memory; P:manganese ion transport; P:multicellular organismal iron ion homeostasis; P:nickel cation transport; P:response to hypoxia; P:response to iron ion; P:vanadium ion transport; P:zinc ion transmembrane transport;|Q96J35,Natural resistance-associated macrophage protein 2,Divalent cation transporter 1;Divalent metal transporter 1;Solute carrier family 11 member 2;, PF01566;, GO:0045177;GO:0016324;GO:0045178;GO:0031526;GO:0009986;GO:0005737;GO:0031410;GO:0005769;GO:1903561;GO:0005887;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0070826;GO:0048471;GO:0005886;GO:0055037;GO:0005802;GO:0005773;GO:0046870;GO:0015086;GO:0015087;GO:0005375;GO:0015093;GO:0022890;GO:0005381;GO:0015094;GO:0005384;GO:0015099;GO:1905394;GO:0015295;GO:0046915;GO:0015100;GO:0005385;GO:0006919;GO:0098656;GO:0070574;GO:0070588;GO:0006879;GO:0034599;GO:0006824;GO:0006825;GO:0048813;GO:0003032;GO:0048821;GO:0006783;GO:0033212;GO:0034755;GO:0006826;GO:0015692;GO:0007611;GO:0006828;GO:0060586;GO:0015675;GO:0001666;GO:0010039;GO:0015676;GO:0071577;, C:apical part of cell; C:apical plasma membrane; C:basal part of cell; C:brush border membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:early endosome; C:extracellular vesicle; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:paraferritin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:trans-Golgi network; C:vacuole;, F:cadmium ion binding; F:cadmium ion transmembrane transporter activity; F:cobalt ion transmembrane transporter activity; F:copper ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:inorganic cation transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:lead ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:nickel cation transmembrane transporter activity; F:retromer complex binding; F:solute:proton symporter activity; F:transition metal ion transmembrane transporter activity; F:vanadium ion transmembrane transporter activity; F:zinc ion transmembrane transporter activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:anion transmembrane transport; P:cadmium ion transmembrane transport; P:calcium ion transmembrane transport; P:cellular iron ion homeostasis; P:cellular response to oxidative stress; P:cobalt ion transport; P:copper ion transport; P:dendrite morphogenesis; P:detection of oxygen; P:erythrocyte development; P:heme biosynthetic process; P:iron import into cell; P:iron ion transmembrane transport; P:iron ion transport; P:lead ion transport; P:learning or memory; P:manganese ion transport; P:multicellular organismal iron ion homeostasis; P:nickel cation transport; P:response to hypoxia; P:response to iron ion; P:vanadium ion transport; P:zinc ion transmembrane transport;|Q96J35,Natural resistance-associated macrophage protein 2,Divalent cation transporter 1;Divalent metal transporter 1;Solute carrier family 11 member 2;, PF01566;, GO:0045177;GO:0016324;GO:0045178;GO:0031526;GO:0009986;GO:0005737;GO:0031410;GO:0005769;GO:1903561;GO:0005887;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0070826;GO:0048471;GO:0005886;GO:0055037;GO:0005802;GO:0005773;GO:0046870;GO:0015086;GO:0015087;GO:0005375;GO:0015093;GO:0022890;GO:0005381;GO:0015094;GO:0005384;GO:0015099;GO:1905394;GO:0015295;GO:0046915;GO:0015100;GO:0005385;GO:0006919;GO:0098656;GO:0070574;GO:0070588;GO:0006879;GO:0034599;GO:0006824;GO:0006825;GO:0048813;GO:0003032;GO:0048821;GO:0006783;GO:0033212;GO:0034755;GO:0006826;GO:0015692;GO:0007611;GO:0006828;GO:0060586;GO:0015675;GO:0001666;GO:0010039;GO:0015676;GO:0071577;, C:apical part of cell; C:apical plasma membrane; C:basal part of cell; C:brush border membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:early endosome; C:extracellular vesicle; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:paraferritin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:trans-Golgi network; C:vacuole;, F:cadmium ion binding; F:cadmium ion transmembrane transporter activity; F:cobalt ion transmembrane transporter activity; F:copper ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:inorganic cation transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:lead ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:nickel cation transmembrane transporter activity; F:retromer complex binding; F:solute:proton symporter activity; F:transition metal ion transmembrane transporter activity; F:vanadium ion transmembrane transporter activity; F:zinc ion transmembrane transporter activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:anion transmembrane transport; P:cadmium ion transmembrane transport; P:calcium ion transmembrane transport; P:cellular iron ion homeostasis; P:cellular response to oxidative stress; P:cobalt ion transport; P:copper ion transport; P:dendrite morphogenesis; P:detection of oxygen; P:erythrocyte development; P:heme biosynthetic process; P:iron import into cell; P:iron ion transmembrane transport; P:iron ion transport; P:lead ion transport; P:learning or memory; P:manganese ion transport; P:multicellular organismal iron ion homeostasis; P:nickel cation transport; P:response to hypoxia; P:response to iron ion; P:vanadium ion transport; P:zinc ion transmembrane transport; scaffold31 indexed_genome mRNA 864151 867193 . - . ID=transcript_6653;Q96J35,Natural resistance-associated macrophage protein 2,Divalent cation transporter 1;Divalent metal transporter 1;Solute carrier family 11 member 2;, PF01566;, GO:0045177;GO:0016324;GO:0045178;GO:0031526;GO:0009986;GO:0005737;GO:0031410;GO:0005769;GO:1903561;GO:0005887;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0070826;GO:0048471;GO:0005886;GO:0055037;GO:0005802;GO:0005773;GO:0046870;GO:0015086;GO:0015087;GO:0005375;GO:0015093;GO:0022890;GO:0005381;GO:0015094;GO:0005384;GO:0015099;GO:1905394;GO:0015295;GO:0046915;GO:0015100;GO:0005385;GO:0006919;GO:0098656;GO:0070574;GO:0070588;GO:0006879;GO:0034599;GO:0006824;GO:0006825;GO:0048813;GO:0003032;GO:0048821;GO:0006783;GO:0033212;GO:0034755;GO:0006826;GO:0015692;GO:0007611;GO:0006828;GO:0060586;GO:0015675;GO:0001666;GO:0010039;GO:0015676;GO:0071577;, C:apical part of cell; C:apical plasma membrane; C:basal part of cell; C:brush border membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:early endosome; C:extracellular vesicle; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:paraferritin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:trans-Golgi network; C:vacuole;, F:cadmium ion binding; F:cadmium ion transmembrane transporter activity; F:cobalt ion transmembrane transporter activity; F:copper ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:inorganic cation transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:lead ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:nickel cation transmembrane transporter activity; F:retromer complex binding; F:solute:proton symporter activity; F:transition metal ion transmembrane transporter activity; F:vanadium ion transmembrane transporter activity; F:zinc ion transmembrane transporter activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:anion transmembrane transport; P:cadmium ion transmembrane transport; P:calcium ion transmembrane transport; P:cellular iron ion homeostasis; P:cellular response to oxidative stress; P:cobalt ion transport; P:copper ion transport; P:dendrite morphogenesis; P:detection of oxygen; P:erythrocyte development; P:heme biosynthetic process; P:iron import into cell; P:iron ion transmembrane transport; P:iron ion transport; P:lead ion transport; P:learning or memory; P:manganese ion transport; P:multicellular organismal iron ion homeostasis; P:nickel cation transport; P:response to hypoxia; P:response to iron ion; P:vanadium ion transport; P:zinc ion transmembrane transport; scaffold31 indexed_genome mRNA 1039540 1050560 . - . ID=transcript_6654;Q9H8H3 Q9H7R3 Q9UHZ7 Q9Y422,Methyltransferase-like protein 7A,Protein AAM-B;, PF08241;, GO:0005783;GO:0005576;GO:0005811;GO:0016020;GO:1904724;GO:0008168;GO:0032259;GO:0043312;, C:endoplasmic reticulum; C:extracellular region; C:lipid droplet; C:membrane; C:tertiary granule lumen;, F:methyltransferase activity;, P:methylation; P:neutrophil degranulation; scaffold31 indexed_genome mRNA 1146468 1209452 . - . ID=transcript_6655;P18846 B4DRF9 P25168 Q9H4A8,Cyclic AMP-dependent transcription factor ATF-1,Activating transcription factor 1;Protein TREB36;, PF00170;PF02173;, GO:1990590;GO:1990589;GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0046982;GO:0044877;GO:0000978;GO:0000977;GO:0034622;GO:0045740;GO:0010976;GO:0045944;GO:0006357;GO:0032025;GO:0014070;, C:ATF1-ATF4 transcription factor complex; C:ATF4-CREB1 transcription factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein heterodimerization activity; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cellular protein-containing complex assembly; P:positive regulation of DNA replication; P:positive regulation of neuron projection development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to cobalt ion; P:response to organic cyclic compound;|P18846 B4DRF9 P25168 Q9H4A8,Cyclic AMP-dependent transcription factor ATF-1,Activating transcription factor 1;Protein TREB36;, PF00170;PF02173;, GO:1990590;GO:1990589;GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0046982;GO:0044877;GO:0000978;GO:0000977;GO:0034622;GO:0045740;GO:0010976;GO:0045944;GO:0006357;GO:0032025;GO:0014070;, C:ATF1-ATF4 transcription factor complex; C:ATF4-CREB1 transcription factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein heterodimerization activity; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cellular protein-containing complex assembly; P:positive regulation of DNA replication; P:positive regulation of neuron projection development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to cobalt ion; P:response to organic cyclic compound; scaffold31 indexed_genome mRNA 1220022 1334485 . - . ID=transcript_6656;Q9P265 Q6B011 Q8N1L5 Q8NB38,Disco-interacting protein 2 homolog B,, PF00501;PF06464;, GO:0030424;GO:0005737;GO:0030425;GO:0070062;GO:0016020;GO:0005634;GO:0043204;GO:0043014;GO:0030517;GO:2000758;, C:axon; C:cytoplasm; C:dendrite; C:extracellular exosome; C:membrane; C:nucleus; C:perikaryon;, F:alpha-tubulin binding;, P:negative regulation of axon extension; P:positive regulation of peptidyl-lysine acetylation;|Q9P265 Q6B011 Q8N1L5 Q8NB38,Disco-interacting protein 2 homolog B,, PF00501;PF06464;, GO:0030424;GO:0005737;GO:0030425;GO:0070062;GO:0016020;GO:0005634;GO:0043204;GO:0043014;GO:0030517;GO:2000758;, C:axon; C:cytoplasm; C:dendrite; C:extracellular exosome; C:membrane; C:nucleus; C:perikaryon;, F:alpha-tubulin binding;, P:negative regulation of axon extension; P:positive regulation of peptidyl-lysine acetylation; scaffold31 indexed_genome mRNA 1489863 1523977 . - . ID=transcript_6657;Q71RC2 A8K6T1 E9PDG5 G3XAA8 G5E976 Q5CZ97 Q6ZV14 Q96NF9,La-related protein 4,La ribonucleoprotein domain family member 4;, PF05383;, GO:0010494;GO:0005829;GO:0016020;GO:0003730;GO:0008143;GO:0003723;GO:0007010;GO:0045727;GO:0010608;GO:0022604;GO:0006412;, C:cytoplasmic stress granule; C:cytosol; C:membrane;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:RNA binding;, P:cytoskeleton organization; P:positive regulation of translation; P:posttranscriptional regulation of gene expression; P:regulation of cell morphogenesis; P:translation; scaffold31 indexed_genome mRNA 1649753 1718926 . + . ID=transcript_6658;Q9NXU6 Q9P0H8 Q9UHB5,LIM domain and actin-binding protein 1,Epithelial protein lost in neoplasm;, PF00412;, GO:0015629;GO:0031526;GO:0032154;GO:0005829;GO:0005925;GO:0005886;GO:0001726;GO:0001725;GO:0051015;GO:0003785;GO:0045296;GO:0046872;GO:0051017;GO:0016477;GO:0042632;GO:0008203;GO:0030299;GO:0030835;GO:0031529;, C:actin cytoskeleton; C:brush border membrane; C:cleavage furrow; C:cytosol; C:focal adhesion; C:plasma membrane; C:ruffle; C:stress fiber;, F:actin filament binding; F:actin monomer binding; F:cadherin binding; F:metal ion binding;, P:actin filament bundle assembly; P:cell migration; P:cholesterol homeostasis; P:cholesterol metabolic process; P:intestinal cholesterol absorption; P:negative regulation of actin filament depolymerization; P:ruffle organization; scaffold31 indexed_genome mRNA 1721474 1740404 . + . ID=transcript_6659;Q9NXU6 Q9P0H8 Q9UHB5,LIM domain and actin-binding protein 1,Epithelial protein lost in neoplasm;, PF00412;, GO:0015629;GO:0031526;GO:0032154;GO:0005829;GO:0005925;GO:0005886;GO:0001726;GO:0001725;GO:0051015;GO:0003785;GO:0045296;GO:0046872;GO:0051017;GO:0016477;GO:0042632;GO:0008203;GO:0030299;GO:0030835;GO:0031529;, C:actin cytoskeleton; C:brush border membrane; C:cleavage furrow; C:cytosol; C:focal adhesion; C:plasma membrane; C:ruffle; C:stress fiber;, F:actin filament binding; F:actin monomer binding; F:cadherin binding; F:metal ion binding;, P:actin filament bundle assembly; P:cell migration; P:cholesterol homeostasis; P:cholesterol metabolic process; P:intestinal cholesterol absorption; P:negative regulation of actin filament depolymerization; P:ruffle organization;|Q9NXU6 Q9P0H8 Q9UHB5,LIM domain and actin-binding protein 1,Epithelial protein lost in neoplasm;, PF00412;, GO:0015629;GO:0031526;GO:0032154;GO:0005829;GO:0005925;GO:0005886;GO:0001726;GO:0001725;GO:0051015;GO:0003785;GO:0045296;GO:0046872;GO:0051017;GO:0016477;GO:0042632;GO:0008203;GO:0030299;GO:0030835;GO:0031529;, C:actin cytoskeleton; C:brush border membrane; C:cleavage furrow; C:cytosol; C:focal adhesion; C:plasma membrane; C:ruffle; C:stress fiber;, F:actin filament binding; F:actin monomer binding; F:cadherin binding; F:metal ion binding;, P:actin filament bundle assembly; P:cell migration; P:cholesterol homeostasis; P:cholesterol metabolic process; P:intestinal cholesterol absorption; P:negative regulation of actin filament depolymerization; P:ruffle organization;|Q9NXU6 Q9P0H8 Q9UHB5,LIM domain and actin-binding protein 1,Epithelial protein lost in neoplasm;, PF00412;, GO:0015629;GO:0031526;GO:0032154;GO:0005829;GO:0005925;GO:0005886;GO:0001726;GO:0001725;GO:0051015;GO:0003785;GO:0045296;GO:0046872;GO:0051017;GO:0016477;GO:0042632;GO:0008203;GO:0030299;GO:0030835;GO:0031529;, C:actin cytoskeleton; C:brush border membrane; C:cleavage furrow; C:cytosol; C:focal adhesion; C:plasma membrane; C:ruffle; C:stress fiber;, F:actin filament binding; F:actin monomer binding; F:cadherin binding; F:metal ion binding;, P:actin filament bundle assembly; P:cell migration; P:cholesterol homeostasis; P:cholesterol metabolic process; P:intestinal cholesterol absorption; P:negative regulation of actin filament depolymerization; P:ruffle organization; scaffold31 indexed_genome mRNA 1745658 1775013 . + . ID=transcript_6660;Q8N5B7 B4DV54,Ceramide synthase 5 {ECO:0000305},LAG1 longevity assurance homolog 5 {ECO:0000250|UniProtKB:Q9D6K9};Sphingosine N-acyltransferase CERS5 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process;|Q8N5B7 B4DV54,Ceramide synthase 5 {ECO:0000305},LAG1 longevity assurance homolog 5 {ECO:0000250|UniProtKB:Q9D6K9};Sphingosine N-acyltransferase CERS5 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process;|Q8N5B7 B4DV54,Ceramide synthase 5 {ECO:0000305},LAG1 longevity assurance homolog 5 {ECO:0000250|UniProtKB:Q9D6K9};Sphingosine N-acyltransferase CERS5 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process;|Q8N5B7 B4DV54,Ceramide synthase 5 {ECO:0000305},LAG1 longevity assurance homolog 5 {ECO:0000250|UniProtKB:Q9D6K9};Sphingosine N-acyltransferase CERS5 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process;|Q8N5B7 B4DV54,Ceramide synthase 5 {ECO:0000305},LAG1 longevity assurance homolog 5 {ECO:0000250|UniProtKB:Q9D6K9};Sphingosine N-acyltransferase CERS5 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process;|Q8N5B7 B4DV54,Ceramide synthase 5 {ECO:0000305},LAG1 longevity assurance homolog 5 {ECO:0000250|UniProtKB:Q9D6K9};Sphingosine N-acyltransferase CERS5 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process; scaffold31 indexed_genome mRNA 1785471 1814143 . + . ID=transcript_6661;Q96I36 B2R5G6,Cytochrome c oxidase assembly protein COX14,, PF14880;, GO:0016021;GO:0031966;GO:0005739;GO:0033617;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;, , P:mitochondrial cytochrome c oxidase assembly;|Q96I36 B2R5G6,Cytochrome c oxidase assembly protein COX14,, PF14880;, GO:0016021;GO:0031966;GO:0005739;GO:0033617;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;, , P:mitochondrial cytochrome c oxidase assembly;|Q96I36 B2R5G6,Cytochrome c oxidase assembly protein COX14,, PF14880;, GO:0016021;GO:0031966;GO:0005739;GO:0033617;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;, , P:mitochondrial cytochrome c oxidase assembly;|P21695 F8W1L5 Q8N1B0,Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic {ECO:0000305},, PF07479;PF01210;, GO:0005829;GO:0070062;GO:0009331;GO:0004368;GO:0004367;GO:0051287;GO:0042803;GO:0071320;GO:0071356;GO:0006094;GO:0046168;GO:0006072;GO:0006127;GO:0006116;GO:0006654;GO:0045821;, C:cytosol; C:extracellular exosome; C:glycerol-3-phosphate dehydrogenase complex;, F:glycerol-3-phosphate dehydrogenase (quinone) activity; F:glycerol-3-phosphate dehydrogenase [NAD+] activity; F:NAD binding; F:protein homodimerization activity;, P:cellular response to cAMP; P:cellular response to tumor necrosis factor; P:gluconeogenesis; P:glycerol-3-phosphate catabolic process; P:glycerol-3-phosphate metabolic process; P:glycerophosphate shuttle; P:NADH oxidation; P:phosphatidic acid biosynthetic process; P:positive regulation of glycolytic process;|P21695 F8W1L5 Q8N1B0,Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic {ECO:0000305},, PF07479;PF01210;, GO:0005829;GO:0070062;GO:0009331;GO:0004368;GO:0004367;GO:0051287;GO:0042803;GO:0071320;GO:0071356;GO:0006094;GO:0046168;GO:0006072;GO:0006127;GO:0006116;GO:0006654;GO:0045821;, C:cytosol; C:extracellular exosome; C:glycerol-3-phosphate dehydrogenase complex;, F:glycerol-3-phosphate dehydrogenase (quinone) activity; F:glycerol-3-phosphate dehydrogenase [NAD+] activity; F:NAD binding; F:protein homodimerization activity;, P:cellular response to cAMP; P:cellular response to tumor necrosis factor; P:gluconeogenesis; P:glycerol-3-phosphate catabolic process; P:glycerol-3-phosphate metabolic process; P:glycerophosphate shuttle; P:NADH oxidation; P:phosphatidic acid biosynthetic process; P:positive regulation of glycolytic process;|P21695 F8W1L5 Q8N1B0,Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic {ECO:0000305},, PF07479;PF01210;, GO:0005829;GO:0070062;GO:0009331;GO:0004368;GO:0004367;GO:0051287;GO:0042803;GO:0071320;GO:0071356;GO:0006094;GO:0046168;GO:0006072;GO:0006127;GO:0006116;GO:0006654;GO:0045821;, C:cytosol; C:extracellular exosome; C:glycerol-3-phosphate dehydrogenase complex;, F:glycerol-3-phosphate dehydrogenase (quinone) activity; F:glycerol-3-phosphate dehydrogenase [NAD+] activity; F:NAD binding; F:protein homodimerization activity;, P:cellular response to cAMP; P:cellular response to tumor necrosis factor; P:gluconeogenesis; P:glycerol-3-phosphate catabolic process; P:glycerol-3-phosphate metabolic process; P:glycerophosphate shuttle; P:NADH oxidation; P:phosphatidic acid biosynthetic process; P:positive regulation of glycolytic process;|P21695 F8W1L5 Q8N1B0,Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic {ECO:0000305},, PF07479;PF01210;, GO:0005829;GO:0070062;GO:0009331;GO:0004368;GO:0004367;GO:0051287;GO:0042803;GO:0071320;GO:0071356;GO:0006094;GO:0046168;GO:0006072;GO:0006127;GO:0006116;GO:0006654;GO:0045821;, C:cytosol; C:extracellular exosome; C:glycerol-3-phosphate dehydrogenase complex;, F:glycerol-3-phosphate dehydrogenase (quinone) activity; F:glycerol-3-phosphate dehydrogenase [NAD+] activity; F:NAD binding; F:protein homodimerization activity;, P:cellular response to cAMP; P:cellular response to tumor necrosis factor; P:gluconeogenesis; P:glycerol-3-phosphate catabolic process; P:glycerol-3-phosphate metabolic process; P:glycerophosphate shuttle; P:NADH oxidation; P:phosphatidic acid biosynthetic process; P:positive regulation of glycolytic process;|Q96GM5 A6NN27 Q92924 Q9Y635,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1,60 kDa BRG-1/Brm-associated factor subunit A;BRG1-associated factor 60A;SWI/SNF complex 60 kDa subunit;, PF02201;, GO:0043231;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003682;GO:0060090;GO:0005102;GO:0003713;GO:0071398;GO:0006338;GO:0048096;GO:0007399;GO:0006337;GO:0045944;GO:0006357;, C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:molecular adaptor activity; F:signaling receptor binding; F:transcription coactivator activity;, P:cellular response to fatty acid; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96GM5 A6NN27 Q92924 Q9Y635,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1,60 kDa BRG-1/Brm-associated factor subunit A;BRG1-associated factor 60A;SWI/SNF complex 60 kDa subunit;, PF02201;, GO:0043231;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003682;GO:0060090;GO:0005102;GO:0003713;GO:0071398;GO:0006338;GO:0048096;GO:0007399;GO:0006337;GO:0045944;GO:0006357;, C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:molecular adaptor activity; F:signaling receptor binding; F:transcription coactivator activity;, P:cellular response to fatty acid; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96GM5 A6NN27 Q92924 Q9Y635,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1,60 kDa BRG-1/Brm-associated factor subunit A;BRG1-associated factor 60A;SWI/SNF complex 60 kDa subunit;, PF02201;, GO:0043231;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003682;GO:0060090;GO:0005102;GO:0003713;GO:0071398;GO:0006338;GO:0048096;GO:0007399;GO:0006337;GO:0045944;GO:0006357;, C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:molecular adaptor activity; F:signaling receptor binding; F:transcription coactivator activity;, P:cellular response to fatty acid; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96GM5 A6NN27 Q92924 Q9Y635,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1,60 kDa BRG-1/Brm-associated factor subunit A;BRG1-associated factor 60A;SWI/SNF complex 60 kDa subunit;, PF02201;, GO:0043231;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003682;GO:0060090;GO:0005102;GO:0003713;GO:0071398;GO:0006338;GO:0048096;GO:0007399;GO:0006337;GO:0045944;GO:0006357;, C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:molecular adaptor activity; F:signaling receptor binding; F:transcription coactivator activity;, P:cellular response to fatty acid; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96GM5 A6NN27 Q92924 Q9Y635,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1,60 kDa BRG-1/Brm-associated factor subunit A;BRG1-associated factor 60A;SWI/SNF complex 60 kDa subunit;, PF02201;, GO:0043231;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003682;GO:0060090;GO:0005102;GO:0003713;GO:0071398;GO:0006338;GO:0048096;GO:0007399;GO:0006337;GO:0045944;GO:0006357;, C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:molecular adaptor activity; F:signaling receptor binding; F:transcription coactivator activity;, P:cellular response to fatty acid; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96GM5 A6NN27 Q92924 Q9Y635,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1,60 kDa BRG-1/Brm-associated factor subunit A;BRG1-associated factor 60A;SWI/SNF complex 60 kDa subunit;, PF02201;, GO:0043231;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003682;GO:0060090;GO:0005102;GO:0003713;GO:0071398;GO:0006338;GO:0048096;GO:0007399;GO:0006337;GO:0045944;GO:0006357;, C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:molecular adaptor activity; F:signaling receptor binding; F:transcription coactivator activity;, P:cellular response to fatty acid; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold31 indexed_genome mRNA 1814979 1820331 . - . ID=transcript_6662;P78348 A3KN86 E5KBL7 P78349 Q96CV2,Acid-sensing ion channel 1 {ECO:0000303|PubMed:10798398},Amiloride-sensitive cation channel 2, neuronal;Brain sodium channel 2 {ECO:0000303|PubMed:9037075};, PF00858;, GO:0009986;GO:0005794;GO:0005887;GO:0005886;GO:0045202;GO:0044736;GO:0022839;GO:0015280;GO:0008306;GO:0001662;GO:0070588;GO:0071467;GO:0034220;GO:0007613;GO:0046929;GO:0070207;GO:0042391;GO:0010447;GO:0001975;GO:0009268;GO:0050915;GO:0007165;GO:0035725;GO:0006814;, C:cell surface; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:acid-sensing ion channel activity; F:ion gated channel activity; F:ligand-gated sodium channel activity;, P:associative learning; P:behavioral fear response; P:calcium ion transmembrane transport; P:cellular response to pH; P:ion transmembrane transport; P:memory; P:negative regulation of neurotransmitter secretion; P:protein homotrimerization; P:regulation of membrane potential; P:response to acidic pH; P:response to amphetamine; P:response to pH; P:sensory perception of sour taste; P:signal transduction; P:sodium ion transmembrane transport; P:sodium ion transport;|P78348 A3KN86 E5KBL7 P78349 Q96CV2,Acid-sensing ion channel 1 {ECO:0000303|PubMed:10798398},Amiloride-sensitive cation channel 2, neuronal;Brain sodium channel 2 {ECO:0000303|PubMed:9037075};, PF00858;, GO:0009986;GO:0005794;GO:0005887;GO:0005886;GO:0045202;GO:0044736;GO:0022839;GO:0015280;GO:0008306;GO:0001662;GO:0070588;GO:0071467;GO:0034220;GO:0007613;GO:0046929;GO:0070207;GO:0042391;GO:0010447;GO:0001975;GO:0009268;GO:0050915;GO:0007165;GO:0035725;GO:0006814;, C:cell surface; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:acid-sensing ion channel activity; F:ion gated channel activity; F:ligand-gated sodium channel activity;, P:associative learning; P:behavioral fear response; P:calcium ion transmembrane transport; P:cellular response to pH; P:ion transmembrane transport; P:memory; P:negative regulation of neurotransmitter secretion; P:protein homotrimerization; P:regulation of membrane potential; P:response to acidic pH; P:response to amphetamine; P:response to pH; P:sensory perception of sour taste; P:signal transduction; P:sodium ion transmembrane transport; P:sodium ion transport;|P78348 A3KN86 E5KBL7 P78349 Q96CV2,Acid-sensing ion channel 1 {ECO:0000303|PubMed:10798398},Amiloride-sensitive cation channel 2, neuronal;Brain sodium channel 2 {ECO:0000303|PubMed:9037075};, PF00858;, GO:0009986;GO:0005794;GO:0005887;GO:0005886;GO:0045202;GO:0044736;GO:0022839;GO:0015280;GO:0008306;GO:0001662;GO:0070588;GO:0071467;GO:0034220;GO:0007613;GO:0046929;GO:0070207;GO:0042391;GO:0010447;GO:0001975;GO:0009268;GO:0050915;GO:0007165;GO:0035725;GO:0006814;, C:cell surface; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:acid-sensing ion channel activity; F:ion gated channel activity; F:ligand-gated sodium channel activity;, P:associative learning; P:behavioral fear response; P:calcium ion transmembrane transport; P:cellular response to pH; P:ion transmembrane transport; P:memory; P:negative regulation of neurotransmitter secretion; P:protein homotrimerization; P:regulation of membrane potential; P:response to acidic pH; P:response to amphetamine; P:response to pH; P:sensory perception of sour taste; P:signal transduction; P:sodium ion transmembrane transport; P:sodium ion transport;|P78348 A3KN86 E5KBL7 P78349 Q96CV2,Acid-sensing ion channel 1 {ECO:0000303|PubMed:10798398},Amiloride-sensitive cation channel 2, neuronal;Brain sodium channel 2 {ECO:0000303|PubMed:9037075};, PF00858;, GO:0009986;GO:0005794;GO:0005887;GO:0005886;GO:0045202;GO:0044736;GO:0022839;GO:0015280;GO:0008306;GO:0001662;GO:0070588;GO:0071467;GO:0034220;GO:0007613;GO:0046929;GO:0070207;GO:0042391;GO:0010447;GO:0001975;GO:0009268;GO:0050915;GO:0007165;GO:0035725;GO:0006814;, C:cell surface; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:acid-sensing ion channel activity; F:ion gated channel activity; F:ligand-gated sodium channel activity;, P:associative learning; P:behavioral fear response; P:calcium ion transmembrane transport; P:cellular response to pH; P:ion transmembrane transport; P:memory; P:negative regulation of neurotransmitter secretion; P:protein homotrimerization; P:regulation of membrane potential; P:response to acidic pH; P:response to amphetamine; P:response to pH; P:sensory perception of sour taste; P:signal transduction; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold31 indexed_genome mRNA 1866009 1890703 . + . ID=transcript_6663;Q9H0H5 Q6PJ26 Q9NWN2 Q9P250 Q9P2W2,Rac GTPase-activating protein 1,Male germ cell RacGap;Protein CYK4 homolog;, PF00130;PF00620;, GO:0001669;GO:0097149;GO:0032154;GO:0005829;GO:0070062;GO:0031234;GO:0090543;GO:0005874;GO:0030496;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0051233;GO:0043014;GO:0048487;GO:0043015;GO:0005096;GO:0046872;GO:0008017;GO:0005547;GO:0019901;GO:0000915;GO:0019886;GO:0035556;GO:0007018;GO:0000281;GO:0051256;GO:0007405;GO:0032467;GO:0051988;GO:0045995;GO:0051056;GO:0006890;GO:0007283;GO:0008272;, C:acrosomal vesicle; C:centralspindlin complex; C:cleavage furrow; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Flemming body; C:microtubule; C:midbody; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle; C:spindle midzone;, F:alpha-tubulin binding; F:beta-tubulin binding; F:gamma-tubulin binding; F:GTPase activator activity; F:metal ion binding; F:microtubule binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein kinase binding;, P:actomyosin contractile ring assembly; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intracellular signal transduction; P:microtubule-based movement; P:mitotic cytokinesis; P:mitotic spindle midzone assembly; P:neuroblast proliferation; P:positive regulation of cytokinesis; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of embryonic development; P:regulation of small GTPase mediated signal transduction; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:spermatogenesis; P:sulfate transport;|Q9H0H5 Q6PJ26 Q9NWN2 Q9P250 Q9P2W2,Rac GTPase-activating protein 1,Male germ cell RacGap;Protein CYK4 homolog;, PF00130;PF00620;, GO:0001669;GO:0097149;GO:0032154;GO:0005829;GO:0070062;GO:0031234;GO:0090543;GO:0005874;GO:0030496;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0051233;GO:0043014;GO:0048487;GO:0043015;GO:0005096;GO:0046872;GO:0008017;GO:0005547;GO:0019901;GO:0000915;GO:0019886;GO:0035556;GO:0007018;GO:0000281;GO:0051256;GO:0007405;GO:0032467;GO:0051988;GO:0045995;GO:0051056;GO:0006890;GO:0007283;GO:0008272;, C:acrosomal vesicle; C:centralspindlin complex; C:cleavage furrow; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Flemming body; C:microtubule; C:midbody; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle; C:spindle midzone;, F:alpha-tubulin binding; F:beta-tubulin binding; F:gamma-tubulin binding; F:GTPase activator activity; F:metal ion binding; F:microtubule binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein kinase binding;, P:actomyosin contractile ring assembly; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intracellular signal transduction; P:microtubule-based movement; P:mitotic cytokinesis; P:mitotic spindle midzone assembly; P:neuroblast proliferation; P:positive regulation of cytokinesis; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of embryonic development; P:regulation of small GTPase mediated signal transduction; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:spermatogenesis; P:sulfate transport; scaffold31 indexed_genome mRNA 1988622 2023003 . + . ID=transcript_6664;Q9BWQ8 A8K1W6 B3KR08 Q9UJY9 Q9Y2F7,Protein lifeguard 2,Fas apoptotic inhibitory molecule 2;Neural membrane protein 35;Transmembrane BAX inhibitor motif-containing protein 2;, PF01027;, GO:0005783;GO:0005794;GO:0016021;GO:0045121;GO:0045211;GO:0006915;GO:0021681;GO:0021702;GO:0021680;GO:0021549;GO:0043066;GO:1902042;GO:0043524;GO:0043523;GO:0002931;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:membrane raft; C:postsynaptic membrane;, , P:apoptotic process; P:cerebellar granular layer development; P:cerebellar Purkinje cell differentiation; P:cerebellar Purkinje cell layer development; P:cerebellum development; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of neuron apoptotic process; P:regulation of neuron apoptotic process; P:response to ischemia;|Q9BWQ8 A8K1W6 B3KR08 Q9UJY9 Q9Y2F7,Protein lifeguard 2,Fas apoptotic inhibitory molecule 2;Neural membrane protein 35;Transmembrane BAX inhibitor motif-containing protein 2;, PF01027;, GO:0005783;GO:0005794;GO:0016021;GO:0045121;GO:0045211;GO:0006915;GO:0021681;GO:0021702;GO:0021680;GO:0021549;GO:0043066;GO:1902042;GO:0043524;GO:0043523;GO:0002931;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:membrane raft; C:postsynaptic membrane;, , P:apoptotic process; P:cerebellar granular layer development; P:cerebellar Purkinje cell differentiation; P:cerebellar Purkinje cell layer development; P:cerebellum development; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of neuron apoptotic process; P:regulation of neuron apoptotic process; P:response to ischemia; scaffold31 indexed_genome mRNA 2041138 2048001 . + . ID=transcript_6665;Q7Z5W3 A8K829,RNA 5'-monophosphate methyltransferase {ECO:0000305},BCDIN3 domain-containing protein;, PF06859;, GO:0005737;GO:0005829;GO:0005654;GO:0008171;GO:0008173;GO:0008175;GO:0061715;GO:0010586;GO:2000632;GO:0001510;GO:0030488;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:O-methyltransferase activity; F:RNA methyltransferase activity; F:tRNA methyltransferase activity;, P:miRNA 2'-O-methylation; P:miRNA metabolic process; P:negative regulation of pre-miRNA processing; P:RNA methylation; P:tRNA methylation; scaffold31 indexed_genome mRNA 2053828 2056646 . + . ID=transcript_6666;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold31 indexed_genome mRNA 2056663 2059440 . - . ID=transcript_6667;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold31 indexed_genome mRNA 2079611 2092456 . + . ID=transcript_6668;Q9HCH0 Q2TB26 Q71RH1 Q8N4W1 Q96HX2,Nck-associated protein 5-like,Centrosomal protein of 169 kDa {ECO:0000303|PubMed:26485573};, PF15246;, GO:0005813;GO:0005737;GO:0035371;GO:0001578;GO:0007019;, C:centrosome; C:cytoplasm; C:microtubule plus-end;, , P:microtubule bundle formation; P:microtubule depolymerization;|Q9HCH0 Q2TB26 Q71RH1 Q8N4W1 Q96HX2,Nck-associated protein 5-like,Centrosomal protein of 169 kDa {ECO:0000303|PubMed:26485573};, PF15246;, GO:0005813;GO:0005737;GO:0035371;GO:0001578;GO:0007019;, C:centrosome; C:cytoplasm; C:microtubule plus-end;, , P:microtubule bundle formation; P:microtubule depolymerization; scaffold31 indexed_genome mRNA 2112632 2127537 . - . ID=transcript_6669;P55061 B2R5M4 F8W034 O14938 Q643A7 Q96J50,Bax inhibitor 1,Testis-enhanced gene transcript protein;Transmembrane BAX inhibitor motif-containing protein 6;, PF01027;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0005887;GO:0016020;GO:0031966;GO:0005634;GO:0060698;GO:0019899;GO:0031625;GO:0006914;GO:0034620;GO:0032469;GO:0070059;GO:0043066;GO:2001234;GO:0010523;GO:1902236;GO:0060702;GO:1903298;GO:0002638;GO:0032091;GO:0033119;GO:1990441;GO:1902065;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial membrane; C:nucleus;, F:endoribonuclease inhibitor activity; F:enzyme binding; F:ubiquitin protein ligase binding;, P:autophagy; P:cellular response to unfolded protein; P:endoplasmic reticulum calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of calcium ion transport into cytosol; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of endoribonuclease activity; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of immunoglobulin production; P:negative regulation of protein binding; P:negative regulation of RNA splicing; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:response to L-glutamate;|P55061 B2R5M4 F8W034 O14938 Q643A7 Q96J50,Bax inhibitor 1,Testis-enhanced gene transcript protein;Transmembrane BAX inhibitor motif-containing protein 6;, PF01027;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0005887;GO:0016020;GO:0031966;GO:0005634;GO:0060698;GO:0019899;GO:0031625;GO:0006914;GO:0034620;GO:0032469;GO:0070059;GO:0043066;GO:2001234;GO:0010523;GO:1902236;GO:0060702;GO:1903298;GO:0002638;GO:0032091;GO:0033119;GO:1990441;GO:1902065;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial membrane; C:nucleus;, F:endoribonuclease inhibitor activity; F:enzyme binding; F:ubiquitin protein ligase binding;, P:autophagy; P:cellular response to unfolded protein; P:endoplasmic reticulum calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of calcium ion transport into cytosol; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of endoribonuclease activity; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of immunoglobulin production; P:negative regulation of protein binding; P:negative regulation of RNA splicing; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:response to L-glutamate;|P55061 B2R5M4 F8W034 O14938 Q643A7 Q96J50,Bax inhibitor 1,Testis-enhanced gene transcript protein;Transmembrane BAX inhibitor motif-containing protein 6;, PF01027;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0005887;GO:0016020;GO:0031966;GO:0005634;GO:0060698;GO:0019899;GO:0031625;GO:0006914;GO:0034620;GO:0032469;GO:0070059;GO:0043066;GO:2001234;GO:0010523;GO:1902236;GO:0060702;GO:1903298;GO:0002638;GO:0032091;GO:0033119;GO:1990441;GO:1902065;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial membrane; C:nucleus;, F:endoribonuclease inhibitor activity; F:enzyme binding; F:ubiquitin protein ligase binding;, P:autophagy; P:cellular response to unfolded protein; P:endoplasmic reticulum calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of calcium ion transport into cytosol; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of endoribonuclease activity; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of immunoglobulin production; P:negative regulation of protein binding; P:negative regulation of RNA splicing; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:response to L-glutamate;|P55061 B2R5M4 F8W034 O14938 Q643A7 Q96J50,Bax inhibitor 1,Testis-enhanced gene transcript protein;Transmembrane BAX inhibitor motif-containing protein 6;, PF01027;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0005887;GO:0016020;GO:0031966;GO:0005634;GO:0060698;GO:0019899;GO:0031625;GO:0006914;GO:0034620;GO:0032469;GO:0070059;GO:0043066;GO:2001234;GO:0010523;GO:1902236;GO:0060702;GO:1903298;GO:0002638;GO:0032091;GO:0033119;GO:1990441;GO:1902065;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:mitochondrial membrane; C:nucleus;, F:endoribonuclease inhibitor activity; F:enzyme binding; F:ubiquitin protein ligase binding;, P:autophagy; P:cellular response to unfolded protein; P:endoplasmic reticulum calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of calcium ion transport into cytosol; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of endoribonuclease activity; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of immunoglobulin production; P:negative regulation of protein binding; P:negative regulation of RNA splicing; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:response to L-glutamate; scaffold31 indexed_genome mRNA 2149644 2201038 . + . ID=transcript_6670;Q8IVF7 B0JZA7 Q6ZRJ1,Formin-like protein 3,Formin homology 2 domain-containing protein 3;WW domain-binding protein 3;, PF06367;PF06371;PF02181;, GO:0005737;GO:0005829;GO:0005794;GO:0043231;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0001525;GO:0016477;GO:0030866;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:angiogenesis; P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell shape;|Q8IVF7 B0JZA7 Q6ZRJ1,Formin-like protein 3,Formin homology 2 domain-containing protein 3;WW domain-binding protein 3;, PF06367;PF06371;PF02181;, GO:0005737;GO:0005829;GO:0005794;GO:0043231;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0001525;GO:0016477;GO:0030866;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:angiogenesis; P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell shape;|Q8IVF7 B0JZA7 Q6ZRJ1,Formin-like protein 3,Formin homology 2 domain-containing protein 3;WW domain-binding protein 3;, PF06367;PF06371;PF02181;, GO:0005737;GO:0005829;GO:0005794;GO:0043231;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0001525;GO:0016477;GO:0030866;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:angiogenesis; P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell shape;|Q8IVF7 B0JZA7 Q6ZRJ1,Formin-like protein 3,Formin homology 2 domain-containing protein 3;WW domain-binding protein 3;, PF06367;PF06371;PF02181;, GO:0005737;GO:0005829;GO:0005794;GO:0043231;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0001525;GO:0016477;GO:0030866;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:angiogenesis; P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell shape;|Q8IVF7 B0JZA7 Q6ZRJ1,Formin-like protein 3,Formin homology 2 domain-containing protein 3;WW domain-binding protein 3;, PF06367;PF06371;PF02181;, GO:0005737;GO:0005829;GO:0005794;GO:0043231;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0001525;GO:0016477;GO:0030866;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:angiogenesis; P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell shape;|Q8IVF7 B0JZA7 Q6ZRJ1,Formin-like protein 3,Formin homology 2 domain-containing protein 3;WW domain-binding protein 3;, PF06367;PF06371;PF02181;, GO:0005737;GO:0005829;GO:0005794;GO:0043231;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0001525;GO:0016477;GO:0030866;GO:0007010;GO:0008360;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:angiogenesis; P:cell migration; P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:regulation of cell shape; scaffold31 indexed_genome mRNA 2201528 2215573 . - . ID=transcript_6671;Q6NWY9 O75401 Q6PI09 Q6ZWB3 Q8NCZ1 Q9H5G4 Q9NT95,Pre-mRNA-processing factor 40 homolog B,Huntingtin yeast partner C;Huntingtin-interacting protein C;, PF01846;PF00397;, GO:0016607;GO:0005685;GO:0071004;GO:0003723;GO:0045292;GO:0000398;, C:nuclear speck; C:U1 snRNP; C:U2-type prespliceosome;, F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome;|Q6NWY9 O75401 Q6PI09 Q6ZWB3 Q8NCZ1 Q9H5G4 Q9NT95,Pre-mRNA-processing factor 40 homolog B,Huntingtin yeast partner C;Huntingtin-interacting protein C;, PF01846;PF00397;, GO:0016607;GO:0005685;GO:0071004;GO:0003723;GO:0045292;GO:0000398;, C:nuclear speck; C:U1 snRNP; C:U2-type prespliceosome;, F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome;|Q6NWY9 O75401 Q6PI09 Q6ZWB3 Q8NCZ1 Q9H5G4 Q9NT95,Pre-mRNA-processing factor 40 homolog B,Huntingtin yeast partner C;Huntingtin-interacting protein C;, PF01846;PF00397;, GO:0016607;GO:0005685;GO:0071004;GO:0003723;GO:0045292;GO:0000398;, C:nuclear speck; C:U1 snRNP; C:U2-type prespliceosome;, F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome;|Q6NWY9 O75401 Q6PI09 Q6ZWB3 Q8NCZ1 Q9H5G4 Q9NT95,Pre-mRNA-processing factor 40 homolog B,Huntingtin yeast partner C;Huntingtin-interacting protein C;, PF01846;PF00397;, GO:0016607;GO:0005685;GO:0071004;GO:0003723;GO:0045292;GO:0000398;, C:nuclear speck; C:U1 snRNP; C:U2-type prespliceosome;, F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome;|Q6NWY9 O75401 Q6PI09 Q6ZWB3 Q8NCZ1 Q9H5G4 Q9NT95,Pre-mRNA-processing factor 40 homolog B,Huntingtin yeast partner C;Huntingtin-interacting protein C;, PF01846;PF00397;, GO:0016607;GO:0005685;GO:0071004;GO:0003723;GO:0045292;GO:0000398;, C:nuclear speck; C:U1 snRNP; C:U2-type prespliceosome;, F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; scaffold31 indexed_genome mRNA 2268563 2295729 . + . ID=transcript_6672;Q96EZ8 O14742 O75497 Q6VN53 Q7Z372,Microspherule protein 1,58 kDa microspherule protein;Cell cycle-regulated factor p78;INO80 complex subunit J;MCRS2;, PF00498;PF13325;, GO:0005737;GO:0030425;GO:0005783;GO:0000123;GO:0031011;GO:0071339;GO:0044545;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0005844;GO:0002151;GO:0034046;GO:0008266;GO:0010521;GO:0006464;GO:0006310;GO:0006281;GO:0043984;GO:0043981;GO:0043982;GO:0051974;GO:1904357;GO:1904751;GO:0045944;GO:0016579;GO:0016032;, C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:histone acetyltransferase complex; C:Ino80 complex; C:MLL1 complex; C:NSL complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:polysome;, F:G-quadruplex RNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:telomerase inhibitor activity;, P:cellular protein modification process; P:DNA recombination; P:DNA repair; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of protein localization to nucleolus; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:viral process;|Q96EZ8 O14742 O75497 Q6VN53 Q7Z372,Microspherule protein 1,58 kDa microspherule protein;Cell cycle-regulated factor p78;INO80 complex subunit J;MCRS2;, PF00498;PF13325;, GO:0005737;GO:0030425;GO:0005783;GO:0000123;GO:0031011;GO:0071339;GO:0044545;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0005844;GO:0002151;GO:0034046;GO:0008266;GO:0010521;GO:0006464;GO:0006310;GO:0006281;GO:0043984;GO:0043981;GO:0043982;GO:0051974;GO:1904357;GO:1904751;GO:0045944;GO:0016579;GO:0016032;, C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:histone acetyltransferase complex; C:Ino80 complex; C:MLL1 complex; C:NSL complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:polysome;, F:G-quadruplex RNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:telomerase inhibitor activity;, P:cellular protein modification process; P:DNA recombination; P:DNA repair; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of protein localization to nucleolus; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:viral process;|Q96EZ8 O14742 O75497 Q6VN53 Q7Z372,Microspherule protein 1,58 kDa microspherule protein;Cell cycle-regulated factor p78;INO80 complex subunit J;MCRS2;, PF00498;PF13325;, GO:0005737;GO:0030425;GO:0005783;GO:0000123;GO:0031011;GO:0071339;GO:0044545;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0005844;GO:0002151;GO:0034046;GO:0008266;GO:0010521;GO:0006464;GO:0006310;GO:0006281;GO:0043984;GO:0043981;GO:0043982;GO:0051974;GO:1904357;GO:1904751;GO:0045944;GO:0016579;GO:0016032;, C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:histone acetyltransferase complex; C:Ino80 complex; C:MLL1 complex; C:NSL complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:polysome;, F:G-quadruplex RNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:telomerase inhibitor activity;, P:cellular protein modification process; P:DNA recombination; P:DNA repair; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of protein localization to nucleolus; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:viral process;|Q9ULD8 Q9UQ06,Potassium voltage-gated channel subfamily H member 3,Brain-specific eag-like channel 1;Ether-a-go-go-like potassium channel 2;Voltage-gated potassium channel subunit Kv12.2;, PF00027;PF00520;PF13426;, GO:0016021;GO:0005887;GO:0005886;GO:0005249;GO:0071805;GO:0006813;GO:0034765;GO:0042391;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential;|Q9ULD8 Q9UQ06,Potassium voltage-gated channel subfamily H member 3,Brain-specific eag-like channel 1;Ether-a-go-go-like potassium channel 2;Voltage-gated potassium channel subunit Kv12.2;, PF00027;PF00520;PF13426;, GO:0016021;GO:0005887;GO:0005886;GO:0005249;GO:0071805;GO:0006813;GO:0034765;GO:0042391;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; scaffold31 indexed_genome mRNA 2295767 2298641 . - . ID=transcript_6673;Q9ULD8 Q9UQ06,Potassium voltage-gated channel subfamily H member 3,Brain-specific eag-like channel 1;Ether-a-go-go-like potassium channel 2;Voltage-gated potassium channel subunit Kv12.2;, PF00027;PF00520;PF13426;, GO:0016021;GO:0005887;GO:0005886;GO:0005249;GO:0071805;GO:0006813;GO:0034765;GO:0042391;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; scaffold31 indexed_genome mRNA 2420956 2422628 . + . ID=transcript_6674;Q92820,Gamma-glutamyl hydrolase,Conjugase;GH;Gamma-Glu-X carboxypeptidase;, PF07722;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0042470;GO:0005634;GO:0035580;GO:1904724;GO:0005773;GO:0008238;GO:0034722;GO:0008242;GO:0043312;GO:0042493;GO:0045471;GO:0032868;GO:0010043;GO:0046900;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:melanosome; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:vacuole;, F:exopeptidase activity; F:gamma-glutamyl-peptidase activity; F:omega peptidase activity;, P:neutrophil degranulation; P:response to drug; P:response to ethanol; P:response to insulin; P:response to zinc ion; P:tetrahydrofolylpolyglutamate metabolic process; scaffold31 indexed_genome mRNA 2422803 2426403 . - . ID=transcript_6675;Q92820,Gamma-glutamyl hydrolase,Conjugase;GH;Gamma-Glu-X carboxypeptidase;, PF07722;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0042470;GO:0005634;GO:0035580;GO:1904724;GO:0005773;GO:0008238;GO:0034722;GO:0008242;GO:0043312;GO:0042493;GO:0045471;GO:0032868;GO:0010043;GO:0046900;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:melanosome; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:vacuole;, F:exopeptidase activity; F:gamma-glutamyl-peptidase activity; F:omega peptidase activity;, P:neutrophil degranulation; P:response to drug; P:response to ethanol; P:response to insulin; P:response to zinc ion; P:tetrahydrofolylpolyglutamate metabolic process;|Q8N4W6 B3KP54,DnaJ homolog subfamily C member 22,, PF00226;PF05154;, GO:0016021;, C:integral component of membrane; scaffold31 indexed_genome mRNA 2442822 2443547 . - . ID=transcript_6676;Q12815 F8VSF9 Q6PJU7 Q8N5B2,Tastin,Trophinin-assisting protein;Trophinin-associated protein;, , GO:0005737;GO:0007155;, C:cytoplasm;, , P:cell adhesion; scaffold31 indexed_genome mRNA 2470647 2473874 . - . ID=transcript_6677;P41219 Q8N577,Peripherin,Neurofilament 4;, PF00038;PF04732;, GO:0030424;GO:0005737;GO:0070062;GO:0005882;GO:0016020;GO:0043204;GO:0045098;GO:0005198;GO:0045104;, C:axon; C:cytoplasm; C:extracellular exosome; C:intermediate filament; C:membrane; C:perikaryon; C:type III intermediate filament;, F:structural molecule activity;, P:intermediate filament cytoskeleton organization; scaffold31 indexed_genome mRNA 2473886 2475466 . - . ID=transcript_6678;P41219 Q8N577,Peripherin,Neurofilament 4;, PF00038;PF04732;, GO:0030424;GO:0005737;GO:0070062;GO:0005882;GO:0016020;GO:0043204;GO:0045098;GO:0005198;GO:0045104;, C:axon; C:cytoplasm; C:extracellular exosome; C:intermediate filament; C:membrane; C:perikaryon; C:type III intermediate filament;, F:structural molecule activity;, P:intermediate filament cytoskeleton organization; scaffold31 indexed_genome mRNA 2550041 2587696 . - . ID=transcript_6679;Q6PEY2,Tubulin alpha-3E chain,Alpha-tubulin 3E;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0015630;GO:0005634;GO:0005525;GO:0003924;GO:0005200;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:nucleus;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:microtubule cytoskeleton organization; P:mitotic cell cycle; scaffold31 indexed_genome mRNA 2588439 2588954 . - . ID=transcript_6680;Q71U36 A8K0B8 G3V1U9 P04687 P05209,Tubulin alpha-1A chain,Alpha-tubulin 3;Tubulin B-alpha-1;Tubulin alpha-3 chain;, PF00091;PF03953;, GO:0005737;GO:0005881;GO:0036464;GO:0005829;GO:0070062;GO:0045121;GO:0005874;GO:0015630;GO:0043209;GO:0031594;GO:0005634;GO:0055037;GO:0005525;GO:0003924;GO:0042802;GO:0019904;GO:0005200;GO:0005198;GO:0051301;GO:0097711;GO:0030705;GO:0000086;GO:0000226;GO:0007017;GO:0000278;GO:0010389;GO:0050807;, C:cytoplasm; C:cytoplasmic microtubule; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:membrane raft; C:microtubule; C:microtubule cytoskeleton; C:myelin sheath; C:neuromuscular junction; C:nucleus; C:recycling endosome;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:protein domain specific binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cell division; P:ciliary basal body-plasma membrane docking; P:cytoskeleton-dependent intracellular transport; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:microtubule-based process; P:mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of synapse organization; scaffold31 indexed_genome mRNA 2626460 2626975 . - . ID=transcript_6681;P68363 P04687 P05209 Q27I68 Q8WU19,Tubulin alpha-1B chain,Alpha-tubulin ubiquitous;Tubulin K-alpha-1;Tubulin alpha-ubiquitous chain;, PF00091;PF03953;, GO:0005737;GO:0005881;GO:0045121;GO:0005874;GO:0015630;GO:0003725;GO:0005525;GO:0003924;GO:0005200;GO:0005198;GO:0031625;GO:0051301;GO:0071353;GO:0030705;GO:0000226;GO:0007017;GO:0000278;, C:cytoplasm; C:cytoplasmic microtubule; C:membrane raft; C:microtubule; C:microtubule cytoskeleton;, F:double-stranded RNA binding; F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:cell division; P:cellular response to interleukin-4; P:cytoskeleton-dependent intracellular transport; P:microtubule cytoskeleton organization; P:microtubule-based process; P:mitotic cell cycle; scaffold31 indexed_genome mRNA 2627222 2629069 . - . ID=transcript_6682;P68363 P04687 P05209 Q27I68 Q8WU19,Tubulin alpha-1B chain,Alpha-tubulin ubiquitous;Tubulin K-alpha-1;Tubulin alpha-ubiquitous chain;, PF00091;PF03953;, GO:0005737;GO:0005881;GO:0045121;GO:0005874;GO:0015630;GO:0003725;GO:0005525;GO:0003924;GO:0005200;GO:0005198;GO:0031625;GO:0051301;GO:0071353;GO:0030705;GO:0000226;GO:0007017;GO:0000278;, C:cytoplasm; C:cytoplasmic microtubule; C:membrane raft; C:microtubule; C:microtubule cytoskeleton;, F:double-stranded RNA binding; F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; F:structural molecule activity; F:ubiquitin protein ligase binding;, P:cell division; P:cellular response to interleukin-4; P:cytoskeleton-dependent intracellular transport; P:microtubule cytoskeleton organization; P:microtubule-based process; P:mitotic cell cycle; scaffold31 indexed_genome mRNA 2645214 2657695 . + . ID=transcript_6683;Q6UX01 Q969J4 Q96BY8 Q96HN8 Q9NT09 Q9NVE1 Q9NVU9 Q9ULP6,Protein LMBR1L,Limb region 1 protein homolog-like;Lipocalin-1-interacting membrane receptor {ECO:0000303|PubMed:11287427, ECO:0000303|PubMed:23964685};, PF04791;, GO:0005789;GO:0005887;GO:0005886;GO:0004888;GO:0060218;GO:0090090;GO:0006898;GO:0007165;GO:0070231;GO:0030217;GO:0042098;GO:0016055;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:plasma membrane;, F:transmembrane signaling receptor activity;, P:hematopoietic stem cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:receptor-mediated endocytosis; P:signal transduction; P:T cell apoptotic process; P:T cell differentiation; P:T cell proliferation; P:Wnt signaling pathway;|Q6UX01 Q969J4 Q96BY8 Q96HN8 Q9NT09 Q9NVE1 Q9NVU9 Q9ULP6,Protein LMBR1L,Limb region 1 protein homolog-like;Lipocalin-1-interacting membrane receptor {ECO:0000303|PubMed:11287427, ECO:0000303|PubMed:23964685};, PF04791;, GO:0005789;GO:0005887;GO:0005886;GO:0004888;GO:0060218;GO:0090090;GO:0006898;GO:0007165;GO:0070231;GO:0030217;GO:0042098;GO:0016055;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:plasma membrane;, F:transmembrane signaling receptor activity;, P:hematopoietic stem cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:receptor-mediated endocytosis; P:signal transduction; P:T cell apoptotic process; P:T cell differentiation; P:T cell proliferation; P:Wnt signaling pathway;|Q6UX01 Q969J4 Q96BY8 Q96HN8 Q9NT09 Q9NVE1 Q9NVU9 Q9ULP6,Protein LMBR1L,Limb region 1 protein homolog-like;Lipocalin-1-interacting membrane receptor {ECO:0000303|PubMed:11287427, ECO:0000303|PubMed:23964685};, PF04791;, GO:0005789;GO:0005887;GO:0005886;GO:0004888;GO:0060218;GO:0090090;GO:0006898;GO:0007165;GO:0070231;GO:0030217;GO:0042098;GO:0016055;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:plasma membrane;, F:transmembrane signaling receptor activity;, P:hematopoietic stem cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:receptor-mediated endocytosis; P:signal transduction; P:T cell apoptotic process; P:T cell differentiation; P:T cell proliferation; P:Wnt signaling pathway; scaffold31 indexed_genome mRNA 2686091 2687899 . + . ID=transcript_6684;Q8TAI7 Q56VH8,GTPase RhebL1,Ras homolog enriched in brain like-1 c;Ras homolog enriched in brain-like protein 1;Rheb2;, PF00071;, GO:0005737;GO:0012505;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0046872;GO:0051092;GO:0007264;GO:0031929;, C:cytoplasm; C:endomembrane system; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:positive regulation of NF-kappaB transcription factor activity; P:small GTPase mediated signal transduction; P:TOR signaling; scaffold31 indexed_genome mRNA 2692092 2729370 . + . ID=transcript_6685;O14686 O14687,Histone-lysine N-methyltransferase 2D,ALL1-related protein;Myeloid/lymphoid or mixed-lineage leukemia protein 2;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042800;GO:0046872;GO:0003713;GO:0000976;GO:1904837;GO:0006342;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0001555;GO:0048477;GO:0008284;GO:0033148;GO:0045944;GO:0045652;GO:0006355;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:chromatin silencing; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:oocyte growth; P:oogenesis; P:positive regulation of cell population proliferation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation; P:regulation of transcription, DNA-templated; P:response to estrogen;|O14686 O14687,Histone-lysine N-methyltransferase 2D,ALL1-related protein;Myeloid/lymphoid or mixed-lineage leukemia protein 2;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042800;GO:0046872;GO:0003713;GO:0000976;GO:1904837;GO:0006342;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0001555;GO:0048477;GO:0008284;GO:0033148;GO:0045944;GO:0045652;GO:0006355;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:chromatin silencing; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:oocyte growth; P:oogenesis; P:positive regulation of cell population proliferation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation; P:regulation of transcription, DNA-templated; P:response to estrogen;|O14686 O14687,Histone-lysine N-methyltransferase 2D,ALL1-related protein;Myeloid/lymphoid or mixed-lineage leukemia protein 2;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042800;GO:0046872;GO:0003713;GO:0000976;GO:1904837;GO:0006342;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0001555;GO:0048477;GO:0008284;GO:0033148;GO:0045944;GO:0045652;GO:0006355;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:chromatin silencing; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:oocyte growth; P:oogenesis; P:positive regulation of cell population proliferation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation; P:regulation of transcription, DNA-templated; P:response to estrogen;|O14686 O14687,Histone-lysine N-methyltransferase 2D,ALL1-related protein;Myeloid/lymphoid or mixed-lineage leukemia protein 2;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042800;GO:0046872;GO:0003713;GO:0000976;GO:1904837;GO:0006342;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0001555;GO:0048477;GO:0008284;GO:0033148;GO:0045944;GO:0045652;GO:0006355;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:chromatin silencing; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:oocyte growth; P:oogenesis; P:positive regulation of cell population proliferation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation; P:regulation of transcription, DNA-templated; P:response to estrogen;|O14686 O14687,Histone-lysine N-methyltransferase 2D,ALL1-related protein;Myeloid/lymphoid or mixed-lineage leukemia protein 2;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042800;GO:0046872;GO:0003713;GO:0000976;GO:1904837;GO:0006342;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0001555;GO:0048477;GO:0008284;GO:0033148;GO:0045944;GO:0045652;GO:0006355;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:chromatin silencing; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:oocyte growth; P:oogenesis; P:positive regulation of cell population proliferation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation; P:regulation of transcription, DNA-templated; P:response to estrogen;|O14686 O14687,Histone-lysine N-methyltransferase 2D,ALL1-related protein;Myeloid/lymphoid or mixed-lineage leukemia protein 2;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042800;GO:0046872;GO:0003713;GO:0000976;GO:1904837;GO:0006342;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0001555;GO:0048477;GO:0008284;GO:0033148;GO:0045944;GO:0045652;GO:0006355;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:chromatin silencing; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:oocyte growth; P:oogenesis; P:positive regulation of cell population proliferation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation; P:regulation of transcription, DNA-templated; P:response to estrogen;|O14686 O14687,Histone-lysine N-methyltransferase 2D,ALL1-related protein;Myeloid/lymphoid or mixed-lineage leukemia protein 2;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042800;GO:0046872;GO:0003713;GO:0000976;GO:1904837;GO:0006342;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0001555;GO:0048477;GO:0008284;GO:0033148;GO:0045944;GO:0045652;GO:0006355;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:chromatin silencing; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:oocyte growth; P:oogenesis; P:positive regulation of cell population proliferation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation; P:regulation of transcription, DNA-templated; P:response to estrogen;|O14686 O14687,Histone-lysine N-methyltransferase 2D,ALL1-related protein;Myeloid/lymphoid or mixed-lineage leukemia protein 2;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042800;GO:0046872;GO:0003713;GO:0000976;GO:1904837;GO:0006342;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0001555;GO:0048477;GO:0008284;GO:0033148;GO:0045944;GO:0045652;GO:0006355;GO:0043627;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:chromatin silencing; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:oocyte growth; P:oogenesis; P:positive regulation of cell population proliferation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation; P:regulation of transcription, DNA-templated; P:response to estrogen; scaffold31 indexed_genome mRNA 2731183 2744981 . + . ID=transcript_6686;P54619 B4DDT7 Q8N7V9,5'-AMP-activated protein kinase subunit gamma-1,, PF00571;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0031588;GO:0005634;GO:0043531;GO:0016208;GO:0005524;GO:0004691;GO:0008603;GO:0004672;GO:0019901;GO:0019887;GO:0007050;GO:0042149;GO:0006633;GO:0051170;GO:0016236;GO:0010628;GO:0045860;GO:0006468;GO:0050790;GO:0006110;GO:0016241;GO:1901796;GO:0007165;GO:0007283;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:ADP binding; F:AMP binding; F:ATP binding; F:cAMP-dependent protein kinase activity; F:cAMP-dependent protein kinase regulator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase regulator activity;, P:cell cycle arrest; P:cellular response to glucose starvation; P:fatty acid biosynthetic process; P:import into nucleus; P:macroautophagy; P:positive regulation of gene expression; P:positive regulation of protein kinase activity; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of glycolytic process; P:regulation of macroautophagy; P:regulation of signal transduction by p53 class mediator; P:signal transduction; P:spermatogenesis;|P54619 B4DDT7 Q8N7V9,5'-AMP-activated protein kinase subunit gamma-1,, PF00571;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0031588;GO:0005634;GO:0043531;GO:0016208;GO:0005524;GO:0004691;GO:0008603;GO:0004672;GO:0019901;GO:0019887;GO:0007050;GO:0042149;GO:0006633;GO:0051170;GO:0016236;GO:0010628;GO:0045860;GO:0006468;GO:0050790;GO:0006110;GO:0016241;GO:1901796;GO:0007165;GO:0007283;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:ADP binding; F:AMP binding; F:ATP binding; F:cAMP-dependent protein kinase activity; F:cAMP-dependent protein kinase regulator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase regulator activity;, P:cell cycle arrest; P:cellular response to glucose starvation; P:fatty acid biosynthetic process; P:import into nucleus; P:macroautophagy; P:positive regulation of gene expression; P:positive regulation of protein kinase activity; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of glycolytic process; P:regulation of macroautophagy; P:regulation of signal transduction by p53 class mediator; P:signal transduction; P:spermatogenesis; scaffold31 indexed_genome mRNA 2794824 2800059 . + . ID=transcript_6687;P61204 A8K6G8 B7ZB63 P16587,ADP-ribosylation factor 3,, PF00025;, GO:0070062;GO:0000139;GO:0048471;GO:0005886;GO:0005525;GO:0003924;GO:0006886;GO:0006661;GO:0006890;GO:0016192;, C:extracellular exosome; C:Golgi membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:phosphatidylinositol biosynthetic process; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport; scaffold31 indexed_genome mRNA 2806248 2810792 . + . ID=transcript_6688;Q9NYL4 B4DWB7,Peptidyl-prolyl cis-trans isomerase FKBP11,19 kDa FK506-binding protein;FK506-binding protein 11;Rotamase;, PF00254;, GO:0016021;GO:0016020;GO:0003755;, C:integral component of membrane; C:membrane;, F:peptidyl-prolyl cis-trans isomerase activity;|Q9NYL4 B4DWB7,Peptidyl-prolyl cis-trans isomerase FKBP11,19 kDa FK506-binding protein;FK506-binding protein 11;Rotamase;, PF00254;, GO:0016021;GO:0016020;GO:0003755;, C:integral component of membrane; C:membrane;, F:peptidyl-prolyl cis-trans isomerase activity; scaffold31 indexed_genome mRNA 2811420 2820091 . - . ID=transcript_6689;Q8IXS2 A6NJG5 B2RBE2 Q8N7G4 Q8NA91 Q96JA0,Dynein regulatory complex subunit 2 {ECO:0000303|PubMed:24094744},Coiled-coil domain-containing protein 65;Testis development protein NYD-SP28;, PF14772;, GO:0005858;GO:0005930;GO:0036064;GO:0031514;GO:0070286;GO:0060271;GO:0060285;GO:0003352;, C:axonemal dynein complex; C:axoneme; C:ciliary basal body; C:motile cilium;, , P:axonemal dynein complex assembly; P:cilium assembly; P:cilium-dependent cell motility; P:regulation of cilium movement;|Q8IXS2 A6NJG5 B2RBE2 Q8N7G4 Q8NA91 Q96JA0,Dynein regulatory complex subunit 2 {ECO:0000303|PubMed:24094744},Coiled-coil domain-containing protein 65;Testis development protein NYD-SP28;, PF14772;, GO:0005858;GO:0005930;GO:0036064;GO:0031514;GO:0070286;GO:0060271;GO:0060285;GO:0003352;, C:axonemal dynein complex; C:axoneme; C:ciliary basal body; C:motile cilium;, , P:axonemal dynein complex assembly; P:cilium assembly; P:cilium-dependent cell motility; P:regulation of cilium movement; scaffold31 indexed_genome mRNA 2846487 2853475 . - . ID=transcript_6690;Q92730 A8K9P7,Rho-related GTP-binding protein Rho6,Rho family GTPase 1;Rnd1;, PF00071;, GO:0015629;GO:0005912;GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0005102;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0007162;GO:0016322;GO:0032956;GO:0008360;GO:0007264;, C:actin cytoskeleton; C:adherens junction; C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding; F:signaling receptor binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:negative regulation of cell adhesion; P:neuron remodeling; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:small GTPase mediated signal transduction; scaffold31 indexed_genome mRNA 2858528 2873100 . + . ID=transcript_6691;Q9BUQ8 B2R600 B4DH15 O43188,Probable ATP-dependent RNA helicase DDX23,100 kDa U5 snRNP-specific protein;DEAD box protein 23;PRP28 homolog;U5-100kD;, PF00270;PF00271;, GO:0071013;GO:0000785;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0046540;GO:0005682;GO:0005524;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0062176;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:chromatin; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:R-loop disassembly; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q9BUQ8 B2R600 B4DH15 O43188,Probable ATP-dependent RNA helicase DDX23,100 kDa U5 snRNP-specific protein;DEAD box protein 23;PRP28 homolog;U5-100kD;, PF00270;PF00271;, GO:0071013;GO:0000785;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0046540;GO:0005682;GO:0005524;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0062176;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:chromatin; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:R-loop disassembly; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q9BUQ8 B2R600 B4DH15 O43188,Probable ATP-dependent RNA helicase DDX23,100 kDa U5 snRNP-specific protein;DEAD box protein 23;PRP28 homolog;U5-100kD;, PF00270;PF00271;, GO:0071013;GO:0000785;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0046540;GO:0005682;GO:0005524;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0062176;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:chromatin; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:R-loop disassembly; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q9BUQ8 B2R600 B4DH15 O43188,Probable ATP-dependent RNA helicase DDX23,100 kDa U5 snRNP-specific protein;DEAD box protein 23;PRP28 homolog;U5-100kD;, PF00270;PF00271;, GO:0071013;GO:0000785;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0046540;GO:0005682;GO:0005524;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0062176;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:chromatin; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:R-loop disassembly; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q9BUQ8 B2R600 B4DH15 O43188,Probable ATP-dependent RNA helicase DDX23,100 kDa U5 snRNP-specific protein;DEAD box protein 23;PRP28 homolog;U5-100kD;, PF00270;PF00271;, GO:0071013;GO:0000785;GO:0070062;GO:0005730;GO:0005654;GO:0005634;GO:0046540;GO:0005682;GO:0005524;GO:0003723;GO:0003724;GO:0000354;GO:0000398;GO:0062176;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:chromatin; C:extracellular exosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:cis assembly of pre-catalytic spliceosome; P:mRNA splicing, via spliceosome; P:R-loop disassembly; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold31 indexed_genome mRNA 2873913 2883109 . - . ID=transcript_6692;P54284 A8K0Z4 B7Z4Q1 B7Z973 B7ZAK8 F5GZW7 F5H2P6 F8VSG3 Q13913,Voltage-dependent L-type calcium channel subunit beta-3,Calcium channel voltage-dependent subunit beta 3;, PF00625;PF12052;, GO:0016324;GO:0005829;GO:1990454;GO:0016020;GO:0045202;GO:0005891;GO:0005246;GO:0008331;GO:0019901;GO:0005245;GO:0061577;GO:0006816;GO:0060402;GO:0090650;GO:0007268;GO:0050966;GO:0051899;GO:1905788;GO:1901386;GO:0007528;GO:2000463;GO:1901843;GO:0090314;GO:0072659;GO:1902630;GO:0098903;GO:1901385;GO:0050852;, C:apical plasma membrane; C:cytosol; C:L-type voltage-gated calcium channel complex; C:membrane; C:synapse; C:voltage-gated calcium channel complex;, F:calcium channel regulator activity; F:high voltage-gated calcium channel activity; F:protein kinase binding; F:voltage-gated calcium channel activity;, P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:cellular response to oxygen-glucose deprivation; P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization; P:negative regulation of detection of mechanical stimulus involved in sensory perception of touch; P:negative regulation of voltage-gated calcium channel activity; P:neuromuscular junction development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of high voltage-gated calcium channel activity; P:positive regulation of protein targeting to membrane; P:protein localization to plasma membrane; P:regulation of membrane hyperpolarization; P:regulation of membrane repolarization during action potential; P:regulation of voltage-gated calcium channel activity; P:T cell receptor signaling pathway;|P54284 A8K0Z4 B7Z4Q1 B7Z973 B7ZAK8 F5GZW7 F5H2P6 F8VSG3 Q13913,Voltage-dependent L-type calcium channel subunit beta-3,Calcium channel voltage-dependent subunit beta 3;, PF00625;PF12052;, GO:0016324;GO:0005829;GO:1990454;GO:0016020;GO:0045202;GO:0005891;GO:0005246;GO:0008331;GO:0019901;GO:0005245;GO:0061577;GO:0006816;GO:0060402;GO:0090650;GO:0007268;GO:0050966;GO:0051899;GO:1905788;GO:1901386;GO:0007528;GO:2000463;GO:1901843;GO:0090314;GO:0072659;GO:1902630;GO:0098903;GO:1901385;GO:0050852;, C:apical plasma membrane; C:cytosol; C:L-type voltage-gated calcium channel complex; C:membrane; C:synapse; C:voltage-gated calcium channel complex;, F:calcium channel regulator activity; F:high voltage-gated calcium channel activity; F:protein kinase binding; F:voltage-gated calcium channel activity;, P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:cellular response to oxygen-glucose deprivation; P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization; P:negative regulation of detection of mechanical stimulus involved in sensory perception of touch; P:negative regulation of voltage-gated calcium channel activity; P:neuromuscular junction development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of high voltage-gated calcium channel activity; P:positive regulation of protein targeting to membrane; P:protein localization to plasma membrane; P:regulation of membrane hyperpolarization; P:regulation of membrane repolarization during action potential; P:regulation of voltage-gated calcium channel activity; P:T cell receptor signaling pathway;|P54284 A8K0Z4 B7Z4Q1 B7Z973 B7ZAK8 F5GZW7 F5H2P6 F8VSG3 Q13913,Voltage-dependent L-type calcium channel subunit beta-3,Calcium channel voltage-dependent subunit beta 3;, PF00625;PF12052;, GO:0016324;GO:0005829;GO:1990454;GO:0016020;GO:0045202;GO:0005891;GO:0005246;GO:0008331;GO:0019901;GO:0005245;GO:0061577;GO:0006816;GO:0060402;GO:0090650;GO:0007268;GO:0050966;GO:0051899;GO:1905788;GO:1901386;GO:0007528;GO:2000463;GO:1901843;GO:0090314;GO:0072659;GO:1902630;GO:0098903;GO:1901385;GO:0050852;, C:apical plasma membrane; C:cytosol; C:L-type voltage-gated calcium channel complex; C:membrane; C:synapse; C:voltage-gated calcium channel complex;, F:calcium channel regulator activity; F:high voltage-gated calcium channel activity; F:protein kinase binding; F:voltage-gated calcium channel activity;, P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:cellular response to oxygen-glucose deprivation; P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization; P:negative regulation of detection of mechanical stimulus involved in sensory perception of touch; P:negative regulation of voltage-gated calcium channel activity; P:neuromuscular junction development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of high voltage-gated calcium channel activity; P:positive regulation of protein targeting to membrane; P:protein localization to plasma membrane; P:regulation of membrane hyperpolarization; P:regulation of membrane repolarization during action potential; P:regulation of voltage-gated calcium channel activity; P:T cell receptor signaling pathway;|P54284 A8K0Z4 B7Z4Q1 B7Z973 B7ZAK8 F5GZW7 F5H2P6 F8VSG3 Q13913,Voltage-dependent L-type calcium channel subunit beta-3,Calcium channel voltage-dependent subunit beta 3;, PF00625;PF12052;, GO:0016324;GO:0005829;GO:1990454;GO:0016020;GO:0045202;GO:0005891;GO:0005246;GO:0008331;GO:0019901;GO:0005245;GO:0061577;GO:0006816;GO:0060402;GO:0090650;GO:0007268;GO:0050966;GO:0051899;GO:1905788;GO:1901386;GO:0007528;GO:2000463;GO:1901843;GO:0090314;GO:0072659;GO:1902630;GO:0098903;GO:1901385;GO:0050852;, C:apical plasma membrane; C:cytosol; C:L-type voltage-gated calcium channel complex; C:membrane; C:synapse; C:voltage-gated calcium channel complex;, F:calcium channel regulator activity; F:high voltage-gated calcium channel activity; F:protein kinase binding; F:voltage-gated calcium channel activity;, P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:cellular response to oxygen-glucose deprivation; P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception of pain; P:membrane depolarization; P:negative regulation of detection of mechanical stimulus involved in sensory perception of touch; P:negative regulation of voltage-gated calcium channel activity; P:neuromuscular junction development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of high voltage-gated calcium channel activity; P:positive regulation of protein targeting to membrane; P:protein localization to plasma membrane; P:regulation of membrane hyperpolarization; P:regulation of membrane repolarization during action potential; P:regulation of voltage-gated calcium channel activity; P:T cell receptor signaling pathway; scaffold31 indexed_genome mRNA 2922129 2936752 . + . ID=transcript_6693;O43306 Q9NR75 Q9UDB0,Adenylate cyclase type 6,ATP pyrophosphate-lyase 6;Adenylate cyclase type VI;Adenylyl cyclase 6 {ECO:0000303|PubMed:17916776};Ca(2+)-inhibitable adenylyl cyclase;, PF16214;PF06327;PF00211;, GO:0005929;GO:0005887;GO:0031226;GO:0016020;GO:0005886;GO:0032420;GO:0004016;GO:0005524;GO:0046872;GO:0019901;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0097746;GO:0006171;GO:0071870;GO:1904322;GO:0071377;GO:0071380;GO:1904117;GO:0007212;GO:0007186;GO:0002862;GO:0010977;GO:0035811;GO:0003091;, C:cilium; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane; C:stereocilium;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:blood vessel diameter maintenance; P:cAMP biosynthetic process; P:cellular response to catecholamine stimulus; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to vasopressin; P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron projection development; P:negative regulation of urine volume; P:renal water homeostasis;|O43306 Q9NR75 Q9UDB0,Adenylate cyclase type 6,ATP pyrophosphate-lyase 6;Adenylate cyclase type VI;Adenylyl cyclase 6 {ECO:0000303|PubMed:17916776};Ca(2+)-inhibitable adenylyl cyclase;, PF16214;PF06327;PF00211;, GO:0005929;GO:0005887;GO:0031226;GO:0016020;GO:0005886;GO:0032420;GO:0004016;GO:0005524;GO:0046872;GO:0019901;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0097746;GO:0006171;GO:0071870;GO:1904322;GO:0071377;GO:0071380;GO:1904117;GO:0007212;GO:0007186;GO:0002862;GO:0010977;GO:0035811;GO:0003091;, C:cilium; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane; C:stereocilium;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:blood vessel diameter maintenance; P:cAMP biosynthetic process; P:cellular response to catecholamine stimulus; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to vasopressin; P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron projection development; P:negative regulation of urine volume; P:renal water homeostasis;|O43306 Q9NR75 Q9UDB0,Adenylate cyclase type 6,ATP pyrophosphate-lyase 6;Adenylate cyclase type VI;Adenylyl cyclase 6 {ECO:0000303|PubMed:17916776};Ca(2+)-inhibitable adenylyl cyclase;, PF16214;PF06327;PF00211;, GO:0005929;GO:0005887;GO:0031226;GO:0016020;GO:0005886;GO:0032420;GO:0004016;GO:0005524;GO:0046872;GO:0019901;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0097746;GO:0006171;GO:0071870;GO:1904322;GO:0071377;GO:0071380;GO:1904117;GO:0007212;GO:0007186;GO:0002862;GO:0010977;GO:0035811;GO:0003091;, C:cilium; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane; C:stereocilium;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:blood vessel diameter maintenance; P:cAMP biosynthetic process; P:cellular response to catecholamine stimulus; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to vasopressin; P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron projection development; P:negative regulation of urine volume; P:renal water homeostasis; scaffold31 indexed_genome mRNA 2986030 2990491 . + . ID=transcript_6694;O60563 A9XU13 E7EX76 O60581,Cyclin-T1,, PF00134;, GO:0008024;GO:0005829;GO:0005654;GO:0005634;GO:0070691;GO:0097322;GO:0003682;GO:0061575;GO:0016538;GO:0003677;GO:0019901;GO:0070063;GO:0008134;GO:0000976;GO:0007049;GO:0051301;GO:1900364;GO:0043923;GO:0032786;GO:0045944;GO:0050434;GO:0006468;GO:0000079;GO:0006357;GO:0042795;GO:0006366;GO:0006368;GO:0016032;, C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:nucleoplasm; C:nucleus; C:P-TEFb complex;, F:7SK snRNA binding; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:DNA binding; F:protein kinase binding; F:RNA polymerase binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:cell division; P:negative regulation of mRNA polyadenylation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:protein phosphorylation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process; scaffold31 indexed_genome mRNA 3003908 3022212 . + . ID=transcript_6695;O60563 A9XU13 E7EX76 O60581,Cyclin-T1,, PF00134;, GO:0008024;GO:0005829;GO:0005654;GO:0005634;GO:0070691;GO:0097322;GO:0003682;GO:0061575;GO:0016538;GO:0003677;GO:0019901;GO:0070063;GO:0008134;GO:0000976;GO:0007049;GO:0051301;GO:1900364;GO:0043923;GO:0032786;GO:0045944;GO:0050434;GO:0006468;GO:0000079;GO:0006357;GO:0042795;GO:0006366;GO:0006368;GO:0016032;, C:cyclin/CDK positive transcription elongation factor complex; C:cytosol; C:nucleoplasm; C:nucleus; C:P-TEFb complex;, F:7SK snRNA binding; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:DNA binding; F:protein kinase binding; F:RNA polymerase binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell cycle; P:cell division; P:negative regulation of mRNA polyadenylation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:protein phosphorylation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process; scaffold31 indexed_genome mRNA 3031483 3048870 . + . ID=transcript_6696;Q9H9L4 Q8N3B5 Q96CV0 Q9NX51,KAT8 regulatory NSL complex subunit 2,NSL complex protein NSL2;Non-specific lethal 2 homolog;, PF13891;, GO:0015629;GO:0005829;GO:0000123;GO:0044545;GO:0005654;GO:0005886;GO:0043984;GO:0043981;GO:0043982;, C:actin cytoskeleton; C:cytosol; C:histone acetyltransferase complex; C:NSL complex; C:nucleoplasm; C:plasma membrane;, , P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9H9L4 Q8N3B5 Q96CV0 Q9NX51,KAT8 regulatory NSL complex subunit 2,NSL complex protein NSL2;Non-specific lethal 2 homolog;, PF13891;, GO:0015629;GO:0005829;GO:0000123;GO:0044545;GO:0005654;GO:0005886;GO:0043984;GO:0043981;GO:0043982;, C:actin cytoskeleton; C:cytosol; C:histone acetyltransferase complex; C:NSL complex; C:nucleoplasm; C:plasma membrane;, , P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9H9L4 Q8N3B5 Q96CV0 Q9NX51,KAT8 regulatory NSL complex subunit 2,NSL complex protein NSL2;Non-specific lethal 2 homolog;, PF13891;, GO:0015629;GO:0005829;GO:0000123;GO:0044545;GO:0005654;GO:0005886;GO:0043984;GO:0043981;GO:0043982;, C:actin cytoskeleton; C:cytosol; C:histone acetyltransferase complex; C:NSL complex; C:nucleoplasm; C:plasma membrane;, , P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9H9L4 Q8N3B5 Q96CV0 Q9NX51,KAT8 regulatory NSL complex subunit 2,NSL complex protein NSL2;Non-specific lethal 2 homolog;, PF13891;, GO:0015629;GO:0005829;GO:0000123;GO:0044545;GO:0005654;GO:0005886;GO:0043984;GO:0043981;GO:0043982;, C:actin cytoskeleton; C:cytosol; C:histone acetyltransferase complex; C:NSL complex; C:nucleoplasm; C:plasma membrane;, , P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9H9L4 Q8N3B5 Q96CV0 Q9NX51,KAT8 regulatory NSL complex subunit 2,NSL complex protein NSL2;Non-specific lethal 2 homolog;, PF13891;, GO:0015629;GO:0005829;GO:0000123;GO:0044545;GO:0005654;GO:0005886;GO:0043984;GO:0043981;GO:0043982;, C:actin cytoskeleton; C:cytosol; C:histone acetyltransferase complex; C:NSL complex; C:nucleoplasm; C:plasma membrane;, , P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9H9L4 Q8N3B5 Q96CV0 Q9NX51,KAT8 regulatory NSL complex subunit 2,NSL complex protein NSL2;Non-specific lethal 2 homolog;, PF13891;, GO:0015629;GO:0005829;GO:0000123;GO:0044545;GO:0005654;GO:0005886;GO:0043984;GO:0043981;GO:0043982;, C:actin cytoskeleton; C:cytosol; C:histone acetyltransferase complex; C:NSL complex; C:nucleoplasm; C:plasma membrane;, , P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; scaffold31 indexed_genome mRNA 3829926 3840345 . + . ID=transcript_6697;Q96N77 B3KS43 B4DNU5 Q8TCQ7 Q8WVE1,Zinc finger protein 641,, PF01352;PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold31 indexed_genome mRNA 3985896 3987361 . + . ID=transcript_6698;Q52MB2 Q96MK5 Q96N39,Coiled-coil domain-containing protein 184,, PF15726;, GO:0005737;, C:cytoplasm; scaffold31 indexed_genome mRNA 4015552 4047942 . + . ID=transcript_6699;Q9H765 A8K1P2 Q547Q2,Ankyrin repeat and SOCS box protein 8,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q9H765 A8K1P2 Q547Q2,Ankyrin repeat and SOCS box protein 8,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|P08237 J3KNX3 Q16814 Q16815 Q6ZTT1,ATP-dependent 6-phosphofructokinase, muscle type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type A;Phosphofructo-1-kinase isozyme A;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0016324;GO:0005829;GO:0016020;GO:0005634;GO:0003872;GO:0016208;GO:0005524;GO:0070061;GO:0070095;GO:0042802;GO:0019900;GO:0046872;GO:0048029;GO:0008022;GO:0061621;GO:0030388;GO:0006002;GO:0006096;GO:0061615;GO:0046716;GO:0045944;, C:6-phosphofructokinase complex; C:apical plasma membrane; C:cytosol; C:membrane; C:nucleus;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose binding; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding; F:metal ion binding; F:monosaccharide binding; F:protein C-terminus binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:glycolytic process; P:glycolytic process through fructose-6-phosphate; P:muscle cell cellular homeostasis; P:positive regulation of transcription by RNA polymerase II;|P08237 J3KNX3 Q16814 Q16815 Q6ZTT1,ATP-dependent 6-phosphofructokinase, muscle type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type A;Phosphofructo-1-kinase isozyme A;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0016324;GO:0005829;GO:0016020;GO:0005634;GO:0003872;GO:0016208;GO:0005524;GO:0070061;GO:0070095;GO:0042802;GO:0019900;GO:0046872;GO:0048029;GO:0008022;GO:0061621;GO:0030388;GO:0006002;GO:0006096;GO:0061615;GO:0046716;GO:0045944;, C:6-phosphofructokinase complex; C:apical plasma membrane; C:cytosol; C:membrane; C:nucleus;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose binding; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding; F:metal ion binding; F:monosaccharide binding; F:protein C-terminus binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:glycolytic process; P:glycolytic process through fructose-6-phosphate; P:muscle cell cellular homeostasis; P:positive regulation of transcription by RNA polymerase II;|P08237 J3KNX3 Q16814 Q16815 Q6ZTT1,ATP-dependent 6-phosphofructokinase, muscle type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type A;Phosphofructo-1-kinase isozyme A;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0016324;GO:0005829;GO:0016020;GO:0005634;GO:0003872;GO:0016208;GO:0005524;GO:0070061;GO:0070095;GO:0042802;GO:0019900;GO:0046872;GO:0048029;GO:0008022;GO:0061621;GO:0030388;GO:0006002;GO:0006096;GO:0061615;GO:0046716;GO:0045944;, C:6-phosphofructokinase complex; C:apical plasma membrane; C:cytosol; C:membrane; C:nucleus;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose binding; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding; F:metal ion binding; F:monosaccharide binding; F:protein C-terminus binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:glycolytic process; P:glycolytic process through fructose-6-phosphate; P:muscle cell cellular homeostasis; P:positive regulation of transcription by RNA polymerase II;|P08237 J3KNX3 Q16814 Q16815 Q6ZTT1,ATP-dependent 6-phosphofructokinase, muscle type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type A;Phosphofructo-1-kinase isozyme A;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0016324;GO:0005829;GO:0016020;GO:0005634;GO:0003872;GO:0016208;GO:0005524;GO:0070061;GO:0070095;GO:0042802;GO:0019900;GO:0046872;GO:0048029;GO:0008022;GO:0061621;GO:0030388;GO:0006002;GO:0006096;GO:0061615;GO:0046716;GO:0045944;, C:6-phosphofructokinase complex; C:apical plasma membrane; C:cytosol; C:membrane; C:nucleus;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose binding; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding; F:metal ion binding; F:monosaccharide binding; F:protein C-terminus binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:glycolytic process; P:glycolytic process through fructose-6-phosphate; P:muscle cell cellular homeostasis; P:positive regulation of transcription by RNA polymerase II;|P08237 J3KNX3 Q16814 Q16815 Q6ZTT1,ATP-dependent 6-phosphofructokinase, muscle type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type A;Phosphofructo-1-kinase isozyme A;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0016324;GO:0005829;GO:0016020;GO:0005634;GO:0003872;GO:0016208;GO:0005524;GO:0070061;GO:0070095;GO:0042802;GO:0019900;GO:0046872;GO:0048029;GO:0008022;GO:0061621;GO:0030388;GO:0006002;GO:0006096;GO:0061615;GO:0046716;GO:0045944;, C:6-phosphofructokinase complex; C:apical plasma membrane; C:cytosol; C:membrane; C:nucleus;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose binding; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding; F:metal ion binding; F:monosaccharide binding; F:protein C-terminus binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:glycolytic process; P:glycolytic process through fructose-6-phosphate; P:muscle cell cellular homeostasis; P:positive regulation of transcription by RNA polymerase II;|P08237 J3KNX3 Q16814 Q16815 Q6ZTT1,ATP-dependent 6-phosphofructokinase, muscle type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type A;Phosphofructo-1-kinase isozyme A;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0016324;GO:0005829;GO:0016020;GO:0005634;GO:0003872;GO:0016208;GO:0005524;GO:0070061;GO:0070095;GO:0042802;GO:0019900;GO:0046872;GO:0048029;GO:0008022;GO:0061621;GO:0030388;GO:0006002;GO:0006096;GO:0061615;GO:0046716;GO:0045944;, C:6-phosphofructokinase complex; C:apical plasma membrane; C:cytosol; C:membrane; C:nucleus;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose binding; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding; F:metal ion binding; F:monosaccharide binding; F:protein C-terminus binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:glycolytic process; P:glycolytic process through fructose-6-phosphate; P:muscle cell cellular homeostasis; P:positive regulation of transcription by RNA polymerase II;|P08237 J3KNX3 Q16814 Q16815 Q6ZTT1,ATP-dependent 6-phosphofructokinase, muscle type {ECO:0000255|HAMAP-Rule:MF_03184},6-phosphofructokinase type A;Phosphofructo-1-kinase isozyme A;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};, PF00365;, GO:0005945;GO:0016324;GO:0005829;GO:0016020;GO:0005634;GO:0003872;GO:0016208;GO:0005524;GO:0070061;GO:0070095;GO:0042802;GO:0019900;GO:0046872;GO:0048029;GO:0008022;GO:0061621;GO:0030388;GO:0006002;GO:0006096;GO:0061615;GO:0046716;GO:0045944;, C:6-phosphofructokinase complex; C:apical plasma membrane; C:cytosol; C:membrane; C:nucleus;, F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose binding; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding; F:metal ion binding; F:monosaccharide binding; F:protein C-terminus binding;, P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process; P:glycolytic process; P:glycolytic process through fructose-6-phosphate; P:muscle cell cellular homeostasis; P:positive regulation of transcription by RNA polymerase II; scaffold31 indexed_genome mRNA 4067984 4093994 . + . ID=transcript_6700;Q9P0U3 A8K7P5 Q86XC8,Sentrin-specific protease 1,Sentrin/SUMO-specific protease SENP1;, PF02902;, GO:0005737;GO:0005925;GO:0031965;GO:0005654;GO:0005634;GO:0004175;GO:0070140;GO:0006919;GO:0097190;GO:0045944;GO:0016926;GO:0006508;, C:cytoplasm; C:focal adhesion; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:endopeptidase activity; F:SUMO-specific isopeptidase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:protein desumoylation; P:proteolysis; scaffold31 indexed_genome mRNA 4097560 4116424 . + . ID=transcript_6701;Q9P0U3 A8K7P5 Q86XC8,Sentrin-specific protease 1,Sentrin/SUMO-specific protease SENP1;, PF02902;, GO:0005737;GO:0005925;GO:0031965;GO:0005654;GO:0005634;GO:0004175;GO:0070140;GO:0006919;GO:0097190;GO:0045944;GO:0016926;GO:0006508;, C:cytoplasm; C:focal adhesion; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:endopeptidase activity; F:SUMO-specific isopeptidase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:protein desumoylation; P:proteolysis; scaffold31 indexed_genome mRNA 4188443 4188999 . - . ID=transcript_6702;Q9UE38 Q9UE39 Q9UE40 Q9UE41 Q9UE42 Q9UE43,Collagen alpha-1(II) chain {ECO:0000305},Alpha-1 type II collagen {ECO:0000305};, PF01410;PF01391;PF00093;, GO:0005604;GO:0005581;GO:0005585;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0042802;GO:0046872;GO:0042289;GO:0048407;GO:0043394;GO:0097065;GO:0001502;GO:0051216;GO:0060351;GO:0071773;GO:0007417;GO:0002062;GO:0030199;GO:0060272;GO:0001958;GO:0030198;GO:0003007;GO:0042472;GO:0060174;GO:2001240;GO:0030903;GO:0071599;GO:0006029;GO:0010468;GO:0050776;GO:0060021;GO:0007605;GO:0001501;GO:0001894;GO:0007601;, C:basement membrane; C:collagen trimer; C:collagen type II trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:identical protein binding; F:metal ion binding; F:MHC class II protein binding; F:platelet-derived growth factor binding; F:proteoglycan binding;, P:anterior head development; P:cartilage condensation; P:cartilage development; P:cartilage development involved in endochondral bone morphogenesis; P:cellular response to BMP stimulus; P:central nervous system development; P:chondrocyte differentiation; P:collagen fibril organization; P:embryonic skeletal joint morphogenesis; P:endochondral ossification; P:extracellular matrix organization; P:heart morphogenesis; P:inner ear morphogenesis; P:limb bud formation; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:notochord development; P:otic vesicle development; P:proteoglycan metabolic process; P:regulation of gene expression; P:regulation of immune response; P:roof of mouth development; P:sensory perception of sound; P:skeletal system development; P:tissue homeostasis; P:visual perception; scaffold31 indexed_genome mRNA 4193463 4198916 . + . ID=transcript_6703;Q9BVX2 B2R998 B7Z5M4 Q3B761,Transmembrane protein 106C,Endoplasmic reticulum membrane protein overexpressed in cancer;, PF07092;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane;|Q9BVX2 B2R998 B7Z5M4 Q3B761,Transmembrane protein 106C,Endoplasmic reticulum membrane protein overexpressed in cancer;, PF07092;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane;|Q9BVX2 B2R998 B7Z5M4 Q3B761,Transmembrane protein 106C,Endoplasmic reticulum membrane protein overexpressed in cancer;, PF07092;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane; scaffold31 indexed_genome mRNA 4291473 4311036 . + . ID=transcript_6704;P11473 B2R5Q1 G3V1V9 Q5PSV3,Vitamin D3 receptor,1,25-dihydroxyvitamin D3 receptor;Nuclear receptor subfamily 1 group I member 1;, PF00104;PF00105;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0043235;GO:0090575;GO:1902098;GO:0003677;GO:0000981;GO:1902121;GO:0038186;GO:0004879;GO:0046965;GO:0000978;GO:0008270;GO:0038183;GO:0030154;GO:0000902;GO:0046697;GO:0007275;GO:0008285;GO:0010629;GO:0010839;GO:0000122;GO:0045892;GO:0010628;GO:0045618;GO:0045944;GO:0010980;GO:0060558;GO:0006367;GO:0042359;GO:0070561;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:calcitriol binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:lithocholic acid binding; F:lithocholic acid receptor activity; F:nuclear receptor activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:bile acid signaling pathway; P:cell differentiation; P:cell morphogenesis; P:decidualization; P:multicellular organism development; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of gene expression; P:positive regulation of keratinocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vitamin D 24-hydroxylase activity; P:regulation of calcidiol 1-monooxygenase activity; P:transcription initiation from RNA polymerase II promoter; P:vitamin D metabolic process; P:vitamin D receptor signaling pathway; scaffold31 indexed_genome mRNA 4353706 4354219 . - . ID=transcript_6705;Q9BR73 Q9H7L0 Q9NW41 Q9NWA9 Q9NYK9 Q9UFU7,Histone deacetylase 7,Histone deacetylase 7A;, PF00850;, GO:0005737;GO:0005829;GO:0000118;GO:0005654;GO:0005634;GO:0071889;GO:0033613;GO:0046872;GO:0032041;GO:0033558;GO:0019901;GO:0005080;GO:0070491;GO:0032703;GO:1901223;GO:0045668;GO:0090050;GO:0006476;GO:0006367;, C:cytoplasm; C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:activating transcription factor binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase binding; F:protein kinase C binding; F:repressing transcription factor binding;, P:negative regulation of interleukin-2 production; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of osteoblast differentiation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:protein deacetylation; P:transcription initiation from RNA polymerase II promoter; scaffold31 indexed_genome mRNA 4355670 4376441 . + . ID=transcript_6706;Q9BR73 Q9H7L0 Q9NW41 Q9NWA9 Q9NYK9 Q9UFU7,Histone deacetylase 7,Histone deacetylase 7A;, PF00850;, GO:0005737;GO:0005829;GO:0000118;GO:0005654;GO:0005634;GO:0071889;GO:0033613;GO:0046872;GO:0032041;GO:0033558;GO:0019901;GO:0005080;GO:0070491;GO:0032703;GO:1901223;GO:0045668;GO:0090050;GO:0006476;GO:0006367;, C:cytoplasm; C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:activating transcription factor binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase binding; F:protein kinase C binding; F:repressing transcription factor binding;, P:negative regulation of interleukin-2 production; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of osteoblast differentiation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:protein deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q9BR73 Q9H7L0 Q9NW41 Q9NWA9 Q9NYK9 Q9UFU7,Histone deacetylase 7,Histone deacetylase 7A;, PF00850;, GO:0005737;GO:0005829;GO:0000118;GO:0005654;GO:0005634;GO:0071889;GO:0033613;GO:0046872;GO:0032041;GO:0033558;GO:0019901;GO:0005080;GO:0070491;GO:0032703;GO:1901223;GO:0045668;GO:0090050;GO:0006476;GO:0006367;, C:cytoplasm; C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:activating transcription factor binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase binding; F:protein kinase C binding; F:repressing transcription factor binding;, P:negative regulation of interleukin-2 production; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of osteoblast differentiation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:protein deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q9BR73 Q9H7L0 Q9NW41 Q9NWA9 Q9NYK9 Q9UFU7,Histone deacetylase 7,Histone deacetylase 7A;, PF00850;, GO:0005737;GO:0005829;GO:0000118;GO:0005654;GO:0005634;GO:0071889;GO:0033613;GO:0046872;GO:0032041;GO:0033558;GO:0019901;GO:0005080;GO:0070491;GO:0032703;GO:1901223;GO:0045668;GO:0090050;GO:0006476;GO:0006367;, C:cytoplasm; C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:activating transcription factor binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase binding; F:protein kinase C binding; F:repressing transcription factor binding;, P:negative regulation of interleukin-2 production; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of osteoblast differentiation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:protein deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q9BR73 Q9H7L0 Q9NW41 Q9NWA9 Q9NYK9 Q9UFU7,Histone deacetylase 7,Histone deacetylase 7A;, PF00850;, GO:0005737;GO:0005829;GO:0000118;GO:0005654;GO:0005634;GO:0071889;GO:0033613;GO:0046872;GO:0032041;GO:0033558;GO:0019901;GO:0005080;GO:0070491;GO:0032703;GO:1901223;GO:0045668;GO:0090050;GO:0006476;GO:0006367;, C:cytoplasm; C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:activating transcription factor binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase binding; F:protein kinase C binding; F:repressing transcription factor binding;, P:negative regulation of interleukin-2 production; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of osteoblast differentiation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:protein deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q9BR73 Q9H7L0 Q9NW41 Q9NWA9 Q9NYK9 Q9UFU7,Histone deacetylase 7,Histone deacetylase 7A;, PF00850;, GO:0005737;GO:0005829;GO:0000118;GO:0005654;GO:0005634;GO:0071889;GO:0033613;GO:0046872;GO:0032041;GO:0033558;GO:0019901;GO:0005080;GO:0070491;GO:0032703;GO:1901223;GO:0045668;GO:0090050;GO:0006476;GO:0006367;, C:cytoplasm; C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:activating transcription factor binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase binding; F:protein kinase C binding; F:repressing transcription factor binding;, P:negative regulation of interleukin-2 production; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of osteoblast differentiation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:protein deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q9BR73 Q9H7L0 Q9NW41 Q9NWA9 Q9NYK9 Q9UFU7,Histone deacetylase 7,Histone deacetylase 7A;, PF00850;, GO:0005737;GO:0005829;GO:0000118;GO:0005654;GO:0005634;GO:0071889;GO:0033613;GO:0046872;GO:0032041;GO:0033558;GO:0019901;GO:0005080;GO:0070491;GO:0032703;GO:1901223;GO:0045668;GO:0090050;GO:0006476;GO:0006367;, C:cytoplasm; C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:activating transcription factor binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase binding; F:protein kinase C binding; F:repressing transcription factor binding;, P:negative regulation of interleukin-2 production; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of osteoblast differentiation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:protein deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q6P1K1 Q9BUB3 Q9NX17,Heme transporter HRG1,Heme-responsive gene 1 protein homolog;Solute carrier family 48 member 1;, PF16954;, GO:0010008;GO:0016021;GO:0005765;GO:0005886;GO:0020037;GO:0015232;GO:0015886;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane;, F:heme binding; F:heme transmembrane transporter activity;, P:heme transport;|Q6P1K1 Q9BUB3 Q9NX17,Heme transporter HRG1,Heme-responsive gene 1 protein homolog;Solute carrier family 48 member 1;, PF16954;, GO:0010008;GO:0016021;GO:0005765;GO:0005886;GO:0020037;GO:0015232;GO:0015886;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane;, F:heme binding; F:heme transmembrane transporter activity;, P:heme transport; scaffold31 indexed_genome mRNA 4394286 4407869 . + . ID=transcript_6707;O95398 A8K2G5 E7EQC8 O95634 Q8WVN0,Rap guanine nucleotide exchange factor 3,Exchange factor directly activated by cAMP 1;Exchange protein directly activated by cAMP 1;Rap1 guanine-nucleotide-exchange factor directly activated by cAMP;cAMP-regulated guanine nucleotide exchange factor I;, PF00027;PF00610;PF00617;PF00618;, GO:0012505;GO:0070062;GO:0030175;GO:0030027;GO:0016020;GO:0005902;GO:0005886;GO:0030552;GO:0005085;GO:0019904;GO:0002250;GO:0001525;GO:0019933;GO:0071320;GO:0061028;GO:0034242;GO:0045766;GO:0043547;GO:0033138;GO:1901985;GO:0046827;GO:0051496;GO:0060143;GO:0032486;GO:2000249;GO:0050796;GO:0007165;, C:endomembrane system; C:extracellular exosome; C:filopodium; C:lamellipodium; C:membrane; C:microvillus; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:adaptive immune response; P:angiogenesis; P:cAMP-mediated signaling; P:cellular response to cAMP; P:establishment of endothelial barrier; P:negative regulation of syncytium formation by plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of GTPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of syncytium formation by plasma membrane fusion; P:Rap protein signal transduction; P:regulation of actin cytoskeleton reorganization; P:regulation of insulin secretion; P:signal transduction;|O95398 A8K2G5 E7EQC8 O95634 Q8WVN0,Rap guanine nucleotide exchange factor 3,Exchange factor directly activated by cAMP 1;Exchange protein directly activated by cAMP 1;Rap1 guanine-nucleotide-exchange factor directly activated by cAMP;cAMP-regulated guanine nucleotide exchange factor I;, PF00027;PF00610;PF00617;PF00618;, GO:0012505;GO:0070062;GO:0030175;GO:0030027;GO:0016020;GO:0005902;GO:0005886;GO:0030552;GO:0005085;GO:0019904;GO:0002250;GO:0001525;GO:0019933;GO:0071320;GO:0061028;GO:0034242;GO:0045766;GO:0043547;GO:0033138;GO:1901985;GO:0046827;GO:0051496;GO:0060143;GO:0032486;GO:2000249;GO:0050796;GO:0007165;, C:endomembrane system; C:extracellular exosome; C:filopodium; C:lamellipodium; C:membrane; C:microvillus; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:adaptive immune response; P:angiogenesis; P:cAMP-mediated signaling; P:cellular response to cAMP; P:establishment of endothelial barrier; P:negative regulation of syncytium formation by plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of GTPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of syncytium formation by plasma membrane fusion; P:Rap protein signal transduction; P:regulation of actin cytoskeleton reorganization; P:regulation of insulin secretion; P:signal transduction;|O95398 A8K2G5 E7EQC8 O95634 Q8WVN0,Rap guanine nucleotide exchange factor 3,Exchange factor directly activated by cAMP 1;Exchange protein directly activated by cAMP 1;Rap1 guanine-nucleotide-exchange factor directly activated by cAMP;cAMP-regulated guanine nucleotide exchange factor I;, PF00027;PF00610;PF00617;PF00618;, GO:0012505;GO:0070062;GO:0030175;GO:0030027;GO:0016020;GO:0005902;GO:0005886;GO:0030552;GO:0005085;GO:0019904;GO:0002250;GO:0001525;GO:0019933;GO:0071320;GO:0061028;GO:0034242;GO:0045766;GO:0043547;GO:0033138;GO:1901985;GO:0046827;GO:0051496;GO:0060143;GO:0032486;GO:2000249;GO:0050796;GO:0007165;, C:endomembrane system; C:extracellular exosome; C:filopodium; C:lamellipodium; C:membrane; C:microvillus; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:adaptive immune response; P:angiogenesis; P:cAMP-mediated signaling; P:cellular response to cAMP; P:establishment of endothelial barrier; P:negative regulation of syncytium formation by plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of GTPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of syncytium formation by plasma membrane fusion; P:Rap protein signal transduction; P:regulation of actin cytoskeleton reorganization; P:regulation of insulin secretion; P:signal transduction;|O95398 A8K2G5 E7EQC8 O95634 Q8WVN0,Rap guanine nucleotide exchange factor 3,Exchange factor directly activated by cAMP 1;Exchange protein directly activated by cAMP 1;Rap1 guanine-nucleotide-exchange factor directly activated by cAMP;cAMP-regulated guanine nucleotide exchange factor I;, PF00027;PF00610;PF00617;PF00618;, GO:0012505;GO:0070062;GO:0030175;GO:0030027;GO:0016020;GO:0005902;GO:0005886;GO:0030552;GO:0005085;GO:0019904;GO:0002250;GO:0001525;GO:0019933;GO:0071320;GO:0061028;GO:0034242;GO:0045766;GO:0043547;GO:0033138;GO:1901985;GO:0046827;GO:0051496;GO:0060143;GO:0032486;GO:2000249;GO:0050796;GO:0007165;, C:endomembrane system; C:extracellular exosome; C:filopodium; C:lamellipodium; C:membrane; C:microvillus; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:adaptive immune response; P:angiogenesis; P:cAMP-mediated signaling; P:cellular response to cAMP; P:establishment of endothelial barrier; P:negative regulation of syncytium formation by plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of GTPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of syncytium formation by plasma membrane fusion; P:Rap protein signal transduction; P:regulation of actin cytoskeleton reorganization; P:regulation of insulin secretion; P:signal transduction;|O95398 A8K2G5 E7EQC8 O95634 Q8WVN0,Rap guanine nucleotide exchange factor 3,Exchange factor directly activated by cAMP 1;Exchange protein directly activated by cAMP 1;Rap1 guanine-nucleotide-exchange factor directly activated by cAMP;cAMP-regulated guanine nucleotide exchange factor I;, PF00027;PF00610;PF00617;PF00618;, GO:0012505;GO:0070062;GO:0030175;GO:0030027;GO:0016020;GO:0005902;GO:0005886;GO:0030552;GO:0005085;GO:0019904;GO:0002250;GO:0001525;GO:0019933;GO:0071320;GO:0061028;GO:0034242;GO:0045766;GO:0043547;GO:0033138;GO:1901985;GO:0046827;GO:0051496;GO:0060143;GO:0032486;GO:2000249;GO:0050796;GO:0007165;, C:endomembrane system; C:extracellular exosome; C:filopodium; C:lamellipodium; C:membrane; C:microvillus; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:adaptive immune response; P:angiogenesis; P:cAMP-mediated signaling; P:cellular response to cAMP; P:establishment of endothelial barrier; P:negative regulation of syncytium formation by plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of GTPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of syncytium formation by plasma membrane fusion; P:Rap protein signal transduction; P:regulation of actin cytoskeleton reorganization; P:regulation of insulin secretion; P:signal transduction;|O95398 A8K2G5 E7EQC8 O95634 Q8WVN0,Rap guanine nucleotide exchange factor 3,Exchange factor directly activated by cAMP 1;Exchange protein directly activated by cAMP 1;Rap1 guanine-nucleotide-exchange factor directly activated by cAMP;cAMP-regulated guanine nucleotide exchange factor I;, PF00027;PF00610;PF00617;PF00618;, GO:0012505;GO:0070062;GO:0030175;GO:0030027;GO:0016020;GO:0005902;GO:0005886;GO:0030552;GO:0005085;GO:0019904;GO:0002250;GO:0001525;GO:0019933;GO:0071320;GO:0061028;GO:0034242;GO:0045766;GO:0043547;GO:0033138;GO:1901985;GO:0046827;GO:0051496;GO:0060143;GO:0032486;GO:2000249;GO:0050796;GO:0007165;, C:endomembrane system; C:extracellular exosome; C:filopodium; C:lamellipodium; C:membrane; C:microvillus; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:adaptive immune response; P:angiogenesis; P:cAMP-mediated signaling; P:cellular response to cAMP; P:establishment of endothelial barrier; P:negative regulation of syncytium formation by plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of GTPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of syncytium formation by plasma membrane fusion; P:Rap protein signal transduction; P:regulation of actin cytoskeleton reorganization; P:regulation of insulin secretion; P:signal transduction; scaffold31 indexed_genome mRNA 4408513 4419512 . + . ID=transcript_6708;O95398 A8K2G5 E7EQC8 O95634 Q8WVN0,Rap guanine nucleotide exchange factor 3,Exchange factor directly activated by cAMP 1;Exchange protein directly activated by cAMP 1;Rap1 guanine-nucleotide-exchange factor directly activated by cAMP;cAMP-regulated guanine nucleotide exchange factor I;, PF00027;PF00610;PF00617;PF00618;, GO:0012505;GO:0070062;GO:0030175;GO:0030027;GO:0016020;GO:0005902;GO:0005886;GO:0030552;GO:0005085;GO:0019904;GO:0002250;GO:0001525;GO:0019933;GO:0071320;GO:0061028;GO:0034242;GO:0045766;GO:0043547;GO:0033138;GO:1901985;GO:0046827;GO:0051496;GO:0060143;GO:0032486;GO:2000249;GO:0050796;GO:0007165;, C:endomembrane system; C:extracellular exosome; C:filopodium; C:lamellipodium; C:membrane; C:microvillus; C:plasma membrane;, F:cAMP binding; F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:adaptive immune response; P:angiogenesis; P:cAMP-mediated signaling; P:cellular response to cAMP; P:establishment of endothelial barrier; P:negative regulation of syncytium formation by plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of GTPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of syncytium formation by plasma membrane fusion; P:Rap protein signal transduction; P:regulation of actin cytoskeleton reorganization; P:regulation of insulin secretion; P:signal transduction; scaffold31 indexed_genome mRNA 4458813 4494992 . + . ID=transcript_6709;Q9H6T3 B4DRW9 Q6PHR5,RNA polymerase II-associated protein 3,, PF13877;PF00515;PF13176;PF13181;, GO:0005829;GO:0097255;, C:cytosol; C:R2TP complex; scaffold31 indexed_genome mRNA 4846538 4884502 . + . ID=transcript_6710;Q96HM7 Q96B20,PC-esterase domain-containing protein 1B {ECO:0000305},Protein FAM113B;|Q96HM7 Q96B20,PC-esterase domain-containing protein 1B {ECO:0000305},Protein FAM113B; scaffold31 indexed_genome mRNA 5253190 5286829 . + . ID=transcript_6711;Q969I6 A8K553,Sodium-coupled neutral amino acid transporter 4,Amino acid transporter A3;Na(+)-coupled neutral amino acid transporter 4;Solute carrier family 38 member 4;System A amino acid transporter 3;System N amino acid transporter 3;, PF01490;, GO:0005887;GO:0005886;GO:0015171;GO:0015293;GO:0003333;GO:0006865;GO:0006814;, C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:symporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:sodium ion transport;|Q969I6 A8K553,Sodium-coupled neutral amino acid transporter 4,Amino acid transporter A3;Na(+)-coupled neutral amino acid transporter 4;Solute carrier family 38 member 4;System A amino acid transporter 3;System N amino acid transporter 3;, PF01490;, GO:0005887;GO:0005886;GO:0015171;GO:0015293;GO:0003333;GO:0006865;GO:0006814;, C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:symporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:sodium ion transport;|Q969I6 A8K553,Sodium-coupled neutral amino acid transporter 4,Amino acid transporter A3;Na(+)-coupled neutral amino acid transporter 4;Solute carrier family 38 member 4;System A amino acid transporter 3;System N amino acid transporter 3;, PF01490;, GO:0005887;GO:0005886;GO:0015171;GO:0015293;GO:0003333;GO:0006865;GO:0006814;, C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:symporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:sodium ion transport; scaffold31 indexed_genome mRNA 5618534 5633129 . + . ID=transcript_6712;Q96QD8 Q6IA88 Q6ZMG2 Q9HAV3 Q9NVA8 Q9P2G5,Sodium-coupled neutral amino acid transporter 2,Amino acid transporter A2;Protein 40-9-1;Solute carrier family 38 member 2;System A amino acid transporter 2;System A transporter 1;System N amino acid transporter 2;, PF01490;, GO:0030424;GO:0005903;GO:0005737;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0042383;GO:0015171;GO:0015186;GO:0015194;GO:0005295;GO:0032328;GO:0003333;GO:0006865;GO:0034198;GO:1903841;GO:0071260;GO:0021987;GO:0007565;GO:0006868;GO:0031460;GO:0015825;GO:0006836;GO:0015804;GO:0010628;GO:0033120;GO:0080135;GO:0150104;, C:axon; C:brush border; C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:sarcolemma;, F:amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:neutral amino acid:sodium symporter activity;, P:alanine transport; P:amino acid transmembrane transport; P:amino acid transport; P:cellular response to amino acid starvation; P:cellular response to arsenite(3-); P:cellular response to mechanical stimulus; P:cerebral cortex development; P:female pregnancy; P:glutamine transport; P:glycine betaine transport; P:L-serine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:positive regulation of gene expression; P:positive regulation of RNA splicing; P:regulation of cellular response to stress; P:transport across blood-brain barrier;|Q96QD8 Q6IA88 Q6ZMG2 Q9HAV3 Q9NVA8 Q9P2G5,Sodium-coupled neutral amino acid transporter 2,Amino acid transporter A2;Protein 40-9-1;Solute carrier family 38 member 2;System A amino acid transporter 2;System A transporter 1;System N amino acid transporter 2;, PF01490;, GO:0030424;GO:0005903;GO:0005737;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0042383;GO:0015171;GO:0015186;GO:0015194;GO:0005295;GO:0032328;GO:0003333;GO:0006865;GO:0034198;GO:1903841;GO:0071260;GO:0021987;GO:0007565;GO:0006868;GO:0031460;GO:0015825;GO:0006836;GO:0015804;GO:0010628;GO:0033120;GO:0080135;GO:0150104;, C:axon; C:brush border; C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:sarcolemma;, F:amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:neutral amino acid:sodium symporter activity;, P:alanine transport; P:amino acid transmembrane transport; P:amino acid transport; P:cellular response to amino acid starvation; P:cellular response to arsenite(3-); P:cellular response to mechanical stimulus; P:cerebral cortex development; P:female pregnancy; P:glutamine transport; P:glycine betaine transport; P:L-serine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:positive regulation of gene expression; P:positive regulation of RNA splicing; P:regulation of cellular response to stress; P:transport across blood-brain barrier;|Q96QD8 Q6IA88 Q6ZMG2 Q9HAV3 Q9NVA8 Q9P2G5,Sodium-coupled neutral amino acid transporter 2,Amino acid transporter A2;Protein 40-9-1;Solute carrier family 38 member 2;System A amino acid transporter 2;System A transporter 1;System N amino acid transporter 2;, PF01490;, GO:0030424;GO:0005903;GO:0005737;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0042383;GO:0015171;GO:0015186;GO:0015194;GO:0005295;GO:0032328;GO:0003333;GO:0006865;GO:0034198;GO:1903841;GO:0071260;GO:0021987;GO:0007565;GO:0006868;GO:0031460;GO:0015825;GO:0006836;GO:0015804;GO:0010628;GO:0033120;GO:0080135;GO:0150104;, C:axon; C:brush border; C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:sarcolemma;, F:amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:neutral amino acid:sodium symporter activity;, P:alanine transport; P:amino acid transmembrane transport; P:amino acid transport; P:cellular response to amino acid starvation; P:cellular response to arsenite(3-); P:cellular response to mechanical stimulus; P:cerebral cortex development; P:female pregnancy; P:glutamine transport; P:glycine betaine transport; P:L-serine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:positive regulation of gene expression; P:positive regulation of RNA splicing; P:regulation of cellular response to stress; P:transport across blood-brain barrier;|Q96QD8 Q6IA88 Q6ZMG2 Q9HAV3 Q9NVA8 Q9P2G5,Sodium-coupled neutral amino acid transporter 2,Amino acid transporter A2;Protein 40-9-1;Solute carrier family 38 member 2;System A amino acid transporter 2;System A transporter 1;System N amino acid transporter 2;, PF01490;, GO:0030424;GO:0005903;GO:0005737;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0042383;GO:0015171;GO:0015186;GO:0015194;GO:0005295;GO:0032328;GO:0003333;GO:0006865;GO:0034198;GO:1903841;GO:0071260;GO:0021987;GO:0007565;GO:0006868;GO:0031460;GO:0015825;GO:0006836;GO:0015804;GO:0010628;GO:0033120;GO:0080135;GO:0150104;, C:axon; C:brush border; C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:sarcolemma;, F:amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:neutral amino acid:sodium symporter activity;, P:alanine transport; P:amino acid transmembrane transport; P:amino acid transport; P:cellular response to amino acid starvation; P:cellular response to arsenite(3-); P:cellular response to mechanical stimulus; P:cerebral cortex development; P:female pregnancy; P:glutamine transport; P:glycine betaine transport; P:L-serine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:positive regulation of gene expression; P:positive regulation of RNA splicing; P:regulation of cellular response to stress; P:transport across blood-brain barrier;|Q96QD8 Q6IA88 Q6ZMG2 Q9HAV3 Q9NVA8 Q9P2G5,Sodium-coupled neutral amino acid transporter 2,Amino acid transporter A2;Protein 40-9-1;Solute carrier family 38 member 2;System A amino acid transporter 2;System A transporter 1;System N amino acid transporter 2;, PF01490;, GO:0030424;GO:0005903;GO:0005737;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0042383;GO:0015171;GO:0015186;GO:0015194;GO:0005295;GO:0032328;GO:0003333;GO:0006865;GO:0034198;GO:1903841;GO:0071260;GO:0021987;GO:0007565;GO:0006868;GO:0031460;GO:0015825;GO:0006836;GO:0015804;GO:0010628;GO:0033120;GO:0080135;GO:0150104;, C:axon; C:brush border; C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:sarcolemma;, F:amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:neutral amino acid:sodium symporter activity;, P:alanine transport; P:amino acid transmembrane transport; P:amino acid transport; P:cellular response to amino acid starvation; P:cellular response to arsenite(3-); P:cellular response to mechanical stimulus; P:cerebral cortex development; P:female pregnancy; P:glutamine transport; P:glycine betaine transport; P:L-serine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:positive regulation of gene expression; P:positive regulation of RNA splicing; P:regulation of cellular response to stress; P:transport across blood-brain barrier;|Q96QD8 Q6IA88 Q6ZMG2 Q9HAV3 Q9NVA8 Q9P2G5,Sodium-coupled neutral amino acid transporter 2,Amino acid transporter A2;Protein 40-9-1;Solute carrier family 38 member 2;System A amino acid transporter 2;System A transporter 1;System N amino acid transporter 2;, PF01490;, GO:0030424;GO:0005903;GO:0005737;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0042383;GO:0015171;GO:0015186;GO:0015194;GO:0005295;GO:0032328;GO:0003333;GO:0006865;GO:0034198;GO:1903841;GO:0071260;GO:0021987;GO:0007565;GO:0006868;GO:0031460;GO:0015825;GO:0006836;GO:0015804;GO:0010628;GO:0033120;GO:0080135;GO:0150104;, C:axon; C:brush border; C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:sarcolemma;, F:amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:neutral amino acid:sodium symporter activity;, P:alanine transport; P:amino acid transmembrane transport; P:amino acid transport; P:cellular response to amino acid starvation; P:cellular response to arsenite(3-); P:cellular response to mechanical stimulus; P:cerebral cortex development; P:female pregnancy; P:glutamine transport; P:glycine betaine transport; P:L-serine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:positive regulation of gene expression; P:positive regulation of RNA splicing; P:regulation of cellular response to stress; P:transport across blood-brain barrier;|Q96QD8 Q6IA88 Q6ZMG2 Q9HAV3 Q9NVA8 Q9P2G5,Sodium-coupled neutral amino acid transporter 2,Amino acid transporter A2;Protein 40-9-1;Solute carrier family 38 member 2;System A amino acid transporter 2;System A transporter 1;System N amino acid transporter 2;, PF01490;, GO:0030424;GO:0005903;GO:0005737;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0042383;GO:0015171;GO:0015186;GO:0015194;GO:0005295;GO:0032328;GO:0003333;GO:0006865;GO:0034198;GO:1903841;GO:0071260;GO:0021987;GO:0007565;GO:0006868;GO:0031460;GO:0015825;GO:0006836;GO:0015804;GO:0010628;GO:0033120;GO:0080135;GO:0150104;, C:axon; C:brush border; C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:sarcolemma;, F:amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:neutral amino acid:sodium symporter activity;, P:alanine transport; P:amino acid transmembrane transport; P:amino acid transport; P:cellular response to amino acid starvation; P:cellular response to arsenite(3-); P:cellular response to mechanical stimulus; P:cerebral cortex development; P:female pregnancy; P:glutamine transport; P:glycine betaine transport; P:L-serine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:positive regulation of gene expression; P:positive regulation of RNA splicing; P:regulation of cellular response to stress; P:transport across blood-brain barrier;|Q96QD8 Q6IA88 Q6ZMG2 Q9HAV3 Q9NVA8 Q9P2G5,Sodium-coupled neutral amino acid transporter 2,Amino acid transporter A2;Protein 40-9-1;Solute carrier family 38 member 2;System A amino acid transporter 2;System A transporter 1;System N amino acid transporter 2;, PF01490;, GO:0030424;GO:0005903;GO:0005737;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0042383;GO:0015171;GO:0015186;GO:0015194;GO:0005295;GO:0032328;GO:0003333;GO:0006865;GO:0034198;GO:1903841;GO:0071260;GO:0021987;GO:0007565;GO:0006868;GO:0031460;GO:0015825;GO:0006836;GO:0015804;GO:0010628;GO:0033120;GO:0080135;GO:0150104;, C:axon; C:brush border; C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane; C:sarcolemma;, F:amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:neutral amino acid:sodium symporter activity;, P:alanine transport; P:amino acid transmembrane transport; P:amino acid transport; P:cellular response to amino acid starvation; P:cellular response to arsenite(3-); P:cellular response to mechanical stimulus; P:cerebral cortex development; P:female pregnancy; P:glutamine transport; P:glycine betaine transport; P:L-serine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:positive regulation of gene expression; P:positive regulation of RNA splicing; P:regulation of cellular response to stress; P:transport across blood-brain barrier; scaffold31 indexed_genome mRNA 5676574 5740752 . + . ID=transcript_6713;Q9H2H9 Q8NC61 Q8NCF8 Q96JX2 Q9H2Q2,Sodium-coupled neutral amino acid transporter 1,Amino acid transporter A1;N-system amino acid transporter 2;Solute carrier family 38 member 1;System A amino acid transporter 1;System N amino acid transporter 1;, PF01490;, GO:0016323;GO:0098591;GO:0070062;GO:0016021;GO:0005887;GO:0043025;GO:0005886;GO:0015171;GO:0005283;GO:0015179;GO:0015186;GO:0015175;GO:0005295;GO:0003333;GO:0006865;GO:0006868;GO:1902475;GO:0001504;GO:0015804;GO:0150104;, C:basolateral plasma membrane; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:amino acid:sodium symporter activity; F:L-amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:neutral amino acid:sodium symporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:glutamine transport; P:L-alpha-amino acid transmembrane transport; P:neurotransmitter uptake; P:neutral amino acid transport; P:transport across blood-brain barrier;|Q9H2H9 Q8NC61 Q8NCF8 Q96JX2 Q9H2Q2,Sodium-coupled neutral amino acid transporter 1,Amino acid transporter A1;N-system amino acid transporter 2;Solute carrier family 38 member 1;System A amino acid transporter 1;System N amino acid transporter 1;, PF01490;, GO:0016323;GO:0098591;GO:0070062;GO:0016021;GO:0005887;GO:0043025;GO:0005886;GO:0015171;GO:0005283;GO:0015179;GO:0015186;GO:0015175;GO:0005295;GO:0003333;GO:0006865;GO:0006868;GO:1902475;GO:0001504;GO:0015804;GO:0150104;, C:basolateral plasma membrane; C:external side of apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:amino acid:sodium symporter activity; F:L-amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:neutral amino acid:sodium symporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:glutamine transport; P:L-alpha-amino acid transmembrane transport; P:neurotransmitter uptake; P:neutral amino acid transport; P:transport across blood-brain barrier; scaffold31 indexed_genome mRNA 6031015 6040390 . - . ID=transcript_6714;Q99590 A6NEU9 A6NLW5 Q8IW59,Protein SCAF11,CTD-associated SR protein 11;Renal carcinoma antigen NY-REN-40;SC35-interacting protein 1;SR-related and CTD-associated factor 11;SRSF2-interacting protein;Serine/arginine-rich splicing factor 2-interacting protein;Splicing factor, arginine/serine-rich 2-interacting protein;Splicing regulatory protein 129;, PF13639;, GO:0016604;GO:0005730;GO:0005654;GO:0046872;GO:0003723;GO:0006397;GO:0008380;GO:0000375;GO:0000245;, C:nuclear body; C:nucleolus; C:nucleoplasm;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly;|Q99590 A6NEU9 A6NLW5 Q8IW59,Protein SCAF11,CTD-associated SR protein 11;Renal carcinoma antigen NY-REN-40;SC35-interacting protein 1;SR-related and CTD-associated factor 11;SRSF2-interacting protein;Serine/arginine-rich splicing factor 2-interacting protein;Splicing factor, arginine/serine-rich 2-interacting protein;Splicing regulatory protein 129;, PF13639;, GO:0016604;GO:0005730;GO:0005654;GO:0046872;GO:0003723;GO:0006397;GO:0008380;GO:0000375;GO:0000245;, C:nuclear body; C:nucleolus; C:nucleoplasm;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly;|Q99590 A6NEU9 A6NLW5 Q8IW59,Protein SCAF11,CTD-associated SR protein 11;Renal carcinoma antigen NY-REN-40;SC35-interacting protein 1;SR-related and CTD-associated factor 11;SRSF2-interacting protein;Serine/arginine-rich splicing factor 2-interacting protein;Splicing factor, arginine/serine-rich 2-interacting protein;Splicing regulatory protein 129;, PF13639;, GO:0016604;GO:0005730;GO:0005654;GO:0046872;GO:0003723;GO:0006397;GO:0008380;GO:0000375;GO:0000245;, C:nuclear body; C:nucleolus; C:nucleoplasm;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; scaffold31 indexed_genome mRNA 6042303 6117392 . - . ID=transcript_6715;Q68CP9 Q15KG9 Q5EB51 Q645I3 Q6ZRY5 Q7Z3I5 Q86T28 Q96SJ6 Q9HCL5,AT-rich interactive domain-containing protein 2 {ECO:0000305},BRG1-associated factor 200 {ECO:0000305};Zinc finger protein with activation potential {ECO:0000305};Zipzap/p200 {ECO:0000303|PubMed:16782067};, PF01388;PF02257;, GO:0005654;GO:0005886;GO:0003677;GO:0046872;GO:0060038;GO:0060982;GO:0048568;GO:0003007;GO:0042592;GO:0030336;GO:0008285;GO:0006337;GO:1905168;GO:0006355;, C:nucleoplasm; C:plasma membrane;, F:DNA binding; F:metal ion binding;, P:cardiac muscle cell proliferation; P:coronary artery morphogenesis; P:embryonic organ development; P:heart morphogenesis; P:homeostatic process; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:nucleosome disassembly; P:positive regulation of double-strand break repair via homologous recombination; P:regulation of transcription, DNA-templated;|Q68CP9 Q15KG9 Q5EB51 Q645I3 Q6ZRY5 Q7Z3I5 Q86T28 Q96SJ6 Q9HCL5,AT-rich interactive domain-containing protein 2 {ECO:0000305},BRG1-associated factor 200 {ECO:0000305};Zinc finger protein with activation potential {ECO:0000305};Zipzap/p200 {ECO:0000303|PubMed:16782067};, PF01388;PF02257;, GO:0005654;GO:0005886;GO:0003677;GO:0046872;GO:0060038;GO:0060982;GO:0048568;GO:0003007;GO:0042592;GO:0030336;GO:0008285;GO:0006337;GO:1905168;GO:0006355;, C:nucleoplasm; C:plasma membrane;, F:DNA binding; F:metal ion binding;, P:cardiac muscle cell proliferation; P:coronary artery morphogenesis; P:embryonic organ development; P:heart morphogenesis; P:homeostatic process; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:nucleosome disassembly; P:positive regulation of double-strand break repair via homologous recombination; P:regulation of transcription, DNA-templated;|Q68CP9 Q15KG9 Q5EB51 Q645I3 Q6ZRY5 Q7Z3I5 Q86T28 Q96SJ6 Q9HCL5,AT-rich interactive domain-containing protein 2 {ECO:0000305},BRG1-associated factor 200 {ECO:0000305};Zinc finger protein with activation potential {ECO:0000305};Zipzap/p200 {ECO:0000303|PubMed:16782067};, PF01388;PF02257;, GO:0005654;GO:0005886;GO:0003677;GO:0046872;GO:0060038;GO:0060982;GO:0048568;GO:0003007;GO:0042592;GO:0030336;GO:0008285;GO:0006337;GO:1905168;GO:0006355;, C:nucleoplasm; C:plasma membrane;, F:DNA binding; F:metal ion binding;, P:cardiac muscle cell proliferation; P:coronary artery morphogenesis; P:embryonic organ development; P:heart morphogenesis; P:homeostatic process; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:nucleosome disassembly; P:positive regulation of double-strand break repair via homologous recombination; P:regulation of transcription, DNA-templated; scaffold31 indexed_genome mRNA 6250947 6252436 . - . ID=transcript_6716;Q8IZ13 D3DQJ9 Q9H5S8 Q9UH87,Protein ZBED8,Transposon-derived Buster3 transposase-like protein;Zinc finger BED domain-containing protein 8;, PF14291;, GO:0005654;, C:nucleoplasm; scaffold31 indexed_genome mRNA 6277327 6278143 . + . ID=transcript_6717;Q9P2N5 Q8IYW9,RNA-binding protein 27,RNA-binding motif protein 27;, PF01480;PF00076;PF00642;, GO:0005737;GO:0016607;GO:0005634;GO:0046872;GO:0003723;GO:0006397;, C:cytoplasm; C:nuclear speck; C:nucleus;, F:metal ion binding; F:RNA binding;, P:mRNA processing; scaffold31 indexed_genome mRNA 6535886 6610422 . - . ID=transcript_6718;Q4KMQ2 A6NNM6 B9EGG0 E7ENK4 E9PB30 E9PCT2 Q8N3Q2,Anoctamin-6,Small-conductance calcium-activated nonselective cation channel;Transmembrane protein 16F;, PF16178;PF04547;, GO:0009986;GO:0034707;GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0035579;GO:0070821;GO:0005227;GO:0005254;GO:0005229;GO:0046872;GO:0017128;GO:0046983;GO:0005247;GO:0005244;GO:0002543;GO:0032060;GO:0007596;GO:0061590;GO:0061589;GO:0070588;GO:0006812;GO:1902476;GO:0006821;GO:0002407;GO:0034220;GO:0045794;GO:0043312;GO:0097045;GO:0017121;GO:0046931;GO:0043065;GO:0030501;GO:2000353;GO:0034767;GO:0090026;GO:0060100;GO:1903766;GO:0035590;GO:0035725;GO:0055085;, C:cell surface; C:chloride channel complex; C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium activated cation channel activity; F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:metal ion binding; F:phospholipid scramblase activity; F:protein dimerization activity; F:voltage-gated chloride channel activity; F:voltage-gated ion channel activity;, P:activation of blood coagulation via clotting cascade; P:bleb assembly; P:blood coagulation; P:calcium activated phosphatidylcholine scrambling; P:calcium activated phosphatidylserine scrambling; P:calcium ion transmembrane transport; P:cation transport; P:chloride transmembrane transport; P:chloride transport; P:dendritic cell chemotaxis; P:ion transmembrane transport; P:negative regulation of cell volume; P:neutrophil degranulation; P:phosphatidylserine exposure on blood platelet; P:plasma membrane phospholipid scrambling; P:pore complex assembly; P:positive regulation of apoptotic process; P:positive regulation of bone mineralization; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of ion transmembrane transport; P:positive regulation of monocyte chemotaxis; P:positive regulation of phagocytosis, engulfment; P:positive regulation of potassium ion export across plasma membrane; P:purinergic nucleotide receptor signaling pathway; P:sodium ion transmembrane transport; P:transmembrane transport;|Q4KMQ2 A6NNM6 B9EGG0 E7ENK4 E9PB30 E9PCT2 Q8N3Q2,Anoctamin-6,Small-conductance calcium-activated nonselective cation channel;Transmembrane protein 16F;, PF16178;PF04547;, GO:0009986;GO:0034707;GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0035579;GO:0070821;GO:0005227;GO:0005254;GO:0005229;GO:0046872;GO:0017128;GO:0046983;GO:0005247;GO:0005244;GO:0002543;GO:0032060;GO:0007596;GO:0061590;GO:0061589;GO:0070588;GO:0006812;GO:1902476;GO:0006821;GO:0002407;GO:0034220;GO:0045794;GO:0043312;GO:0097045;GO:0017121;GO:0046931;GO:0043065;GO:0030501;GO:2000353;GO:0034767;GO:0090026;GO:0060100;GO:1903766;GO:0035590;GO:0035725;GO:0055085;, C:cell surface; C:chloride channel complex; C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calcium activated cation channel activity; F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:metal ion binding; F:phospholipid scramblase activity; F:protein dimerization activity; F:voltage-gated chloride channel activity; F:voltage-gated ion channel activity;, P:activation of blood coagulation via clotting cascade; P:bleb assembly; P:blood coagulation; P:calcium activated phosphatidylcholine scrambling; P:calcium activated phosphatidylserine scrambling; P:calcium ion transmembrane transport; P:cation transport; P:chloride transmembrane transport; P:chloride transport; P:dendritic cell chemotaxis; P:ion transmembrane transport; P:negative regulation of cell volume; P:neutrophil degranulation; P:phosphatidylserine exposure on blood platelet; P:plasma membrane phospholipid scrambling; P:pore complex assembly; P:positive regulation of apoptotic process; P:positive regulation of bone mineralization; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of ion transmembrane transport; P:positive regulation of monocyte chemotaxis; P:positive regulation of phagocytosis, engulfment; P:positive regulation of potassium ion export across plasma membrane; P:purinergic nucleotide receptor signaling pathway; P:sodium ion transmembrane transport; P:transmembrane transport; scaffold31 indexed_genome mRNA 6918650 6954995 . + . ID=transcript_6719;Q6ZNG2,Homeobox protein DBX2,Developing brain homeobox protein 2;, PF00046;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0006357;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific;, P:regulation of transcription by RNA polymerase II;|Q6ZNG2,Homeobox protein DBX2,Developing brain homeobox protein 2;, PF00046;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0006357;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific;, P:regulation of transcription by RNA polymerase II; scaffold31 indexed_genome mRNA 7091336 7354688 . + . ID=transcript_6720;Q99435 B7Z2U7 B7Z5Q4 B7Z9J5 B7Z9U3 Q96JS2,Protein kinase C-binding protein NELL2,NEL-like protein 2;Nel-related protein 2;, PF07645;PF02210;PF00093;, GO:0005737;GO:0005576;GO:0005509;GO:0008201;GO:0005080;GO:0070050;, C:cytoplasm; C:extracellular region;, F:calcium ion binding; F:heparin binding; F:protein kinase C binding;, P:neuron cellular homeostasis; scaffold31 indexed_genome mRNA 7433831 7451746 . + . ID=transcript_6721;Q99435 B7Z2U7 B7Z5Q4 B7Z9J5 B7Z9U3 Q96JS2,Protein kinase C-binding protein NELL2,NEL-like protein 2;Nel-related protein 2;, PF07645;PF02210;PF00093;, GO:0005737;GO:0005576;GO:0005509;GO:0008201;GO:0005080;GO:0070050;, C:cytoplasm; C:extracellular region;, F:calcium ion binding; F:heparin binding; F:protein kinase C binding;, P:neuron cellular homeostasis;|Q99435 B7Z2U7 B7Z5Q4 B7Z9J5 B7Z9U3 Q96JS2,Protein kinase C-binding protein NELL2,NEL-like protein 2;Nel-related protein 2;, PF07645;PF02210;PF00093;, GO:0005737;GO:0005576;GO:0005509;GO:0008201;GO:0005080;GO:0070050;, C:cytoplasm; C:extracellular region;, F:calcium ion binding; F:heparin binding; F:protein kinase C binding;, P:neuron cellular homeostasis; scaffold31 indexed_genome mRNA 7584148 8123115 . + . ID=transcript_6722;Q9H0C3,Transmembrane protein 117,, PF15113;, GO:0005783;GO:0016021;GO:0005886;GO:0070059;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, , P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;|Q9H0C3,Transmembrane protein 117,, PF15113;, GO:0005783;GO:0016021;GO:0005886;GO:0070059;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, , P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;|Q9H0C3,Transmembrane protein 117,, PF15113;, GO:0005783;GO:0016021;GO:0005886;GO:0070059;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, , P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;|Q9H0C3,Transmembrane protein 117,, PF15113;, GO:0005783;GO:0016021;GO:0005886;GO:0070059;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, , P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; scaffold31 indexed_genome mRNA 8168116 8179206 . + . ID=transcript_6723;Q86XL6 Q8TCD3,Twinfilin-1,Protein A6;Protein tyrosine kinase 9;, PF00241;, GO:0015629;GO:0005884;GO:0005911;GO:0005737;GO:0005829;GO:0030175;GO:0005925;GO:0030016;GO:0005730;GO:0048471;GO:0003779;GO:0051015;GO:0003785;GO:0005524;GO:0045296;GO:0005546;GO:0030042;GO:0051016;GO:0030837;GO:0018108;GO:0010976;GO:0043538;GO:0010591;GO:0042989;, C:actin cytoskeleton; C:actin filament; C:cell-cell junction; C:cytoplasm; C:cytosol; C:filopodium; C:focal adhesion; C:myofibril; C:nucleolus; C:perinuclear region of cytoplasm;, F:actin binding; F:actin filament binding; F:actin monomer binding; F:ATP binding; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament depolymerization; P:barbed-end actin filament capping; P:negative regulation of actin filament polymerization; P:peptidyl-tyrosine phosphorylation; P:positive regulation of neuron projection development; P:regulation of actin phosphorylation; P:regulation of lamellipodium assembly; P:sequestering of actin monomers;|Q86XL6 Q8TCD3,Twinfilin-1,Protein A6;Protein tyrosine kinase 9;, PF00241;, GO:0015629;GO:0005884;GO:0005911;GO:0005737;GO:0005829;GO:0030175;GO:0005925;GO:0030016;GO:0005730;GO:0048471;GO:0003779;GO:0051015;GO:0003785;GO:0005524;GO:0045296;GO:0005546;GO:0030042;GO:0051016;GO:0030837;GO:0018108;GO:0010976;GO:0043538;GO:0010591;GO:0042989;, C:actin cytoskeleton; C:actin filament; C:cell-cell junction; C:cytoplasm; C:cytosol; C:filopodium; C:focal adhesion; C:myofibril; C:nucleolus; C:perinuclear region of cytoplasm;, F:actin binding; F:actin filament binding; F:actin monomer binding; F:ATP binding; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament depolymerization; P:barbed-end actin filament capping; P:negative regulation of actin filament polymerization; P:peptidyl-tyrosine phosphorylation; P:positive regulation of neuron projection development; P:regulation of actin phosphorylation; P:regulation of lamellipodium assembly; P:sequestering of actin monomers;|Q86XL6 Q8TCD3,Twinfilin-1,Protein A6;Protein tyrosine kinase 9;, PF00241;, GO:0015629;GO:0005884;GO:0005911;GO:0005737;GO:0005829;GO:0030175;GO:0005925;GO:0030016;GO:0005730;GO:0048471;GO:0003779;GO:0051015;GO:0003785;GO:0005524;GO:0045296;GO:0005546;GO:0030042;GO:0051016;GO:0030837;GO:0018108;GO:0010976;GO:0043538;GO:0010591;GO:0042989;, C:actin cytoskeleton; C:actin filament; C:cell-cell junction; C:cytoplasm; C:cytosol; C:filopodium; C:focal adhesion; C:myofibril; C:nucleolus; C:perinuclear region of cytoplasm;, F:actin binding; F:actin filament binding; F:actin monomer binding; F:ATP binding; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament depolymerization; P:barbed-end actin filament capping; P:negative regulation of actin filament polymerization; P:peptidyl-tyrosine phosphorylation; P:positive regulation of neuron projection development; P:regulation of actin phosphorylation; P:regulation of lamellipodium assembly; P:sequestering of actin monomers; scaffold31 indexed_genome mRNA 8194730 8220413 . - . ID=transcript_6724;Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589,Interleukin-1 receptor-associated kinase 4,Renal carcinoma antigen NY-REN-64;, PF07714;, GO:0005737;GO:0005829;GO:0010008;GO:0005615;GO:0005634;GO:0005886;GO:0005524;GO:0005149;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0019221;GO:0045087;GO:0070498;GO:0035556;GO:0007254;GO:0002755;GO:0002446;GO:1990266;GO:0043123;GO:0048661;GO:0034162;GO:0002224;, C:cytoplasm; C:cytosol; C:endosome membrane; C:extracellular space; C:nucleus; C:plasma membrane;, F:ATP binding; F:interleukin-1 receptor binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytokine-mediated signaling pathway; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:MyD88-dependent toll-like receptor signaling pathway; P:neutrophil mediated immunity; P:neutrophil migration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of smooth muscle cell proliferation; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; scaffold31 indexed_genome mRNA 8222453 8242781 . + . ID=transcript_6725;Q9H0K6 B3KUJ1 Q05CU0 Q6AHZ3 Q6NUP2,Pseudouridylate synthase 7 homolog-like protein,, PF01142;, GO:0005634;GO:0009982;GO:0003723;GO:0001522;, C:nucleus;, F:pseudouridine synthase activity; F:RNA binding;, P:pseudouridine synthesis;|Q9H0K6 B3KUJ1 Q05CU0 Q6AHZ3 Q6NUP2,Pseudouridylate synthase 7 homolog-like protein,, PF01142;, GO:0005634;GO:0009982;GO:0003723;GO:0001522;, C:nucleus;, F:pseudouridine synthase activity; F:RNA binding;, P:pseudouridine synthesis; scaffold31 indexed_genome mRNA 8479515 8483808 . + . ID=transcript_6726;Q9P2N4 A1L4L0 B7ZVX9 B9ZVN0 Q9NR29,A disintegrin and metalloproteinase with thrombospondin motifs 9,, PF17771;PF05986;PF08685;PF01562;PF01421;PF00090;, GO:0005783;GO:0031012;GO:0005576;GO:0043231;GO:0004222;GO:0008237;GO:0008270;GO:0035909;GO:0090673;GO:0030198;GO:0006516;GO:0003179;GO:0007275;GO:0010596;GO:1903671;GO:0015031;GO:0006508;GO:0003229;GO:0016192;, C:endoplasmic reticulum; C:extracellular matrix; C:extracellular region; C:intracellular membrane-bounded organelle;, F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:aorta morphogenesis; P:endothelial cell-matrix adhesion; P:extracellular matrix organization; P:glycoprotein catabolic process; P:heart valve morphogenesis; P:multicellular organism development; P:negative regulation of endothelial cell migration; P:negative regulation of sprouting angiogenesis; P:protein transport; P:proteolysis; P:ventricular cardiac muscle tissue development; P:vesicle-mediated transport; scaffold31 indexed_genome mRNA 8495198 8514763 . + . ID=transcript_6727;Q9P2N4 A1L4L0 B7ZVX9 B9ZVN0 Q9NR29,A disintegrin and metalloproteinase with thrombospondin motifs 9,, PF17771;PF05986;PF08685;PF01562;PF01421;PF00090;, GO:0005783;GO:0031012;GO:0005576;GO:0043231;GO:0004222;GO:0008237;GO:0008270;GO:0035909;GO:0090673;GO:0030198;GO:0006516;GO:0003179;GO:0007275;GO:0010596;GO:1903671;GO:0015031;GO:0006508;GO:0003229;GO:0016192;, C:endoplasmic reticulum; C:extracellular matrix; C:extracellular region; C:intracellular membrane-bounded organelle;, F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:aorta morphogenesis; P:endothelial cell-matrix adhesion; P:extracellular matrix organization; P:glycoprotein catabolic process; P:heart valve morphogenesis; P:multicellular organism development; P:negative regulation of endothelial cell migration; P:negative regulation of sprouting angiogenesis; P:protein transport; P:proteolysis; P:ventricular cardiac muscle tissue development; P:vesicle-mediated transport;|P59510 A6NNC9 J3QT00,A disintegrin and metalloproteinase with thrombospondin motifs 20,, PF17771;PF05986;PF08685;PF01562;PF01421;PF00090;, GO:0031012;GO:0005615;GO:0004222;GO:0008270;GO:0030198;GO:0043066;GO:0045636;GO:0009967;, C:extracellular matrix; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:extracellular matrix organization; P:negative regulation of apoptotic process; P:positive regulation of melanocyte differentiation; P:positive regulation of signal transduction; scaffold31 indexed_genome mRNA 8516485 8519424 . + . ID=transcript_6728;P59510 A6NNC9 J3QT00,A disintegrin and metalloproteinase with thrombospondin motifs 20,, PF17771;PF05986;PF08685;PF01562;PF01421;PF00090;, GO:0031012;GO:0005615;GO:0004222;GO:0008270;GO:0030198;GO:0043066;GO:0045636;GO:0009967;, C:extracellular matrix; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:extracellular matrix organization; P:negative regulation of apoptotic process; P:positive regulation of melanocyte differentiation; P:positive regulation of signal transduction; scaffold31 indexed_genome mRNA 8547695 8599746 . + . ID=transcript_6729;P59510 A6NNC9 J3QT00,A disintegrin and metalloproteinase with thrombospondin motifs 20,, PF17771;PF05986;PF08685;PF01562;PF01421;PF00090;, GO:0031012;GO:0005615;GO:0004222;GO:0008270;GO:0030198;GO:0043066;GO:0045636;GO:0009967;, C:extracellular matrix; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:extracellular matrix organization; P:negative regulation of apoptotic process; P:positive regulation of melanocyte differentiation; P:positive regulation of signal transduction; scaffold31 indexed_genome mRNA 9571210 9587153 . + . ID=transcript_6730;Q96MT3 Q14C83 Q71QF8 Q96N00,Prickle-like protein 1,REST/NRSF-interacting LIM domain protein 1;, PF00412;PF06297;, GO:0005829;GO:0031965;GO:0005634;GO:0008270;GO:0035904;GO:0060976;GO:0090090;GO:2000691;GO:0045892;GO:0001843;GO:0032436;GO:0031398;GO:0006606;GO:0060071;, C:cytosol; C:nuclear membrane; C:nucleus;, F:zinc ion binding;, P:aorta development; P:coronary vasculature development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cardiac muscle cell myoblast differentiation; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein import into nucleus; P:Wnt signaling pathway, planar cell polarity pathway;|Q96MT3 Q14C83 Q71QF8 Q96N00,Prickle-like protein 1,REST/NRSF-interacting LIM domain protein 1;, PF00412;PF06297;, GO:0005829;GO:0031965;GO:0005634;GO:0008270;GO:0035904;GO:0060976;GO:0090090;GO:2000691;GO:0045892;GO:0001843;GO:0032436;GO:0031398;GO:0006606;GO:0060071;, C:cytosol; C:nuclear membrane; C:nucleus;, F:zinc ion binding;, P:aorta development; P:coronary vasculature development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cardiac muscle cell myoblast differentiation; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein import into nucleus; P:Wnt signaling pathway, planar cell polarity pathway;|Q96MT3 Q14C83 Q71QF8 Q96N00,Prickle-like protein 1,REST/NRSF-interacting LIM domain protein 1;, PF00412;PF06297;, GO:0005829;GO:0031965;GO:0005634;GO:0008270;GO:0035904;GO:0060976;GO:0090090;GO:2000691;GO:0045892;GO:0001843;GO:0032436;GO:0031398;GO:0006606;GO:0060071;, C:cytosol; C:nuclear membrane; C:nucleus;, F:zinc ion binding;, P:aorta development; P:coronary vasculature development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cardiac muscle cell myoblast differentiation; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein import into nucleus; P:Wnt signaling pathway, planar cell polarity pathway; scaffold31 indexed_genome mRNA 9593874 9745451 . - . ID=transcript_6731;Q8NEY8 E9PAX8 Q86YT2 Q8IXN3 Q8TB09 Q96NB9 Q9NXL4 Q9P0P6 Q9P0R9,Periphilin-1 {ECO:0000303|PubMed:12853457},CDC7 expression repressor {ECO:0000303|PubMed:15474462};Gastric cancer antigen Ga50 {ECO:0000303|PubMed:12087473};, , GO:0005694;GO:0005829;GO:0005794;GO:0005654;GO:0003723;GO:0031424;GO:0045814;GO:0045892;GO:0090309;GO:0097355;, C:chromosome; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RNA binding;, P:keratinization; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin;|O95219 B3KMH0 B4DQV4 D3DNA3,Sorting nexin-4,, PF00787;, GO:0005737;GO:0005868;GO:0031901;GO:0016020;GO:0005886;GO:0032991;GO:0031201;GO:0005154;GO:0005158;GO:1990460;GO:0035091;GO:1990459;GO:0032456;GO:1903595;GO:0015031;, C:cytoplasm; C:cytoplasmic dynein complex; C:early endosome membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:SNARE complex;, F:epidermal growth factor receptor binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:transferrin receptor binding;, P:endocytic recycling; P:positive regulation of histamine secretion by mast cell; P:protein transport;|Q8NEY8 E9PAX8 Q86YT2 Q8IXN3 Q8TB09 Q96NB9 Q9NXL4 Q9P0P6 Q9P0R9,Periphilin-1 {ECO:0000303|PubMed:12853457},CDC7 expression repressor {ECO:0000303|PubMed:15474462};Gastric cancer antigen Ga50 {ECO:0000303|PubMed:12087473};, , GO:0005694;GO:0005829;GO:0005794;GO:0005654;GO:0003723;GO:0031424;GO:0045814;GO:0045892;GO:0090309;GO:0097355;, C:chromosome; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RNA binding;, P:keratinization; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin;|Q8NEY8 E9PAX8 Q86YT2 Q8IXN3 Q8TB09 Q96NB9 Q9NXL4 Q9P0P6 Q9P0R9,Periphilin-1 {ECO:0000303|PubMed:12853457},CDC7 expression repressor {ECO:0000303|PubMed:15474462};Gastric cancer antigen Ga50 {ECO:0000303|PubMed:12087473};, , GO:0005694;GO:0005829;GO:0005794;GO:0005654;GO:0003723;GO:0031424;GO:0045814;GO:0045892;GO:0090309;GO:0097355;, C:chromosome; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RNA binding;, P:keratinization; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:protein localization to heterochromatin; scaffold31 indexed_genome mRNA 9746322 9765326 . + . ID=transcript_6732;Q8TBF4 Q6PJX0 Q96TA6,Zinc finger CCHC-type and RNA-binding motif-containing protein 1,U11/U12 small nuclear ribonucleoprotein 31 kDa protein;, PF00076;PF00098;, GO:0005829;GO:0005654;GO:0005689;GO:0003723;GO:0008270;GO:0000398;GO:0008380;, C:cytosol; C:nucleoplasm; C:U12-type spliceosomal complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:RNA splicing;|Q8TBF4 Q6PJX0 Q96TA6,Zinc finger CCHC-type and RNA-binding motif-containing protein 1,U11/U12 small nuclear ribonucleoprotein 31 kDa protein;, PF00076;PF00098;, GO:0005829;GO:0005654;GO:0005689;GO:0003723;GO:0008270;GO:0000398;GO:0008380;, C:cytosol; C:nucleoplasm; C:U12-type spliceosomal complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:RNA splicing;|Q8TBF4 Q6PJX0 Q96TA6,Zinc finger CCHC-type and RNA-binding motif-containing protein 1,U11/U12 small nuclear ribonucleoprotein 31 kDa protein;, PF00076;PF00098;, GO:0005829;GO:0005654;GO:0005689;GO:0003723;GO:0008270;GO:0000398;GO:0008380;, C:cytosol; C:nucleoplasm; C:U12-type spliceosomal complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:RNA splicing;|Q8TBF4 Q6PJX0 Q96TA6,Zinc finger CCHC-type and RNA-binding motif-containing protein 1,U11/U12 small nuclear ribonucleoprotein 31 kDa protein;, PF00076;PF00098;, GO:0005829;GO:0005654;GO:0005689;GO:0003723;GO:0008270;GO:0000398;GO:0008380;, C:cytosol; C:nucleoplasm; C:U12-type spliceosomal complex;, F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; scaffold31 indexed_genome mRNA 9913560 9916667 . + . ID=transcript_6733;Q8IY57 A8K5P0 B4DFU3 G3V465 Q99710,YY1-associated factor 2,, PF17219;PF00641;, GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003713;GO:0003712;GO:0003714;GO:0070317;GO:0045892;GO:0045893;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity;, P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold31 indexed_genome mRNA 9947236 9977091 . + . ID=transcript_6734;Q4G148 B3KWJ2 Q8IXV1 Q96BH4,Glucoside xylosyltransferase 1,Glycosyltransferase 8 domain-containing protein 3;, PF01501;, GO:0016021;GO:0140563;GO:0035252;GO:0016266;, C:integral component of membrane;, F:UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity; F:UDP-xylosyltransferase activity;, P:O-glycan processing; scaffold31 indexed_genome mRNA 10552745 10554144 . + . ID=transcript_6735;Q6ZMN7 Q52LY3 Q52LY4 Q6N052 Q8IUU1 Q9NTP7,PDZ domain-containing RING finger protein 4,Ligand of Numb protein X 4;SEMACAP3-like protein;, PF00595;, GO:0046872;, , F:metal ion binding; scaffold31 indexed_genome mRNA 10554265 10555440 . - . ID=transcript_6736;Q6ZMN7 Q52LY3 Q52LY4 Q6N052 Q8IUU1 Q9NTP7,PDZ domain-containing RING finger protein 4,Ligand of Numb protein X 4;SEMACAP3-like protein;, PF00595;, GO:0046872;, , F:metal ion binding; scaffold31 indexed_genome mRNA 11075429 11325238 . - . ID=transcript_6737;Q12860 A8K0H9 A8K0Y3 Q12861 Q14030 Q7M4P0 Q8N466,Contactin-1,Glycoprotein gp135;Neural cell surface protein F3;, PF00041;PF07679;, GO:0099025;GO:0099026;GO:0070062;GO:0016020;GO:0045121;GO:0030246;GO:0007155;GO:0021549;GO:0031175;GO:0007219;GO:0010628;GO:0010976;GO:0050731;GO:0010765;, C:anchored component of postsynaptic membrane; C:anchored component of presynaptic membrane; C:extracellular exosome; C:membrane; C:membrane raft;, F:carbohydrate binding;, P:cell adhesion; P:cerebellum development; P:neuron projection development; P:Notch signaling pathway; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sodium ion transport;|Q12860 A8K0H9 A8K0Y3 Q12861 Q14030 Q7M4P0 Q8N466,Contactin-1,Glycoprotein gp135;Neural cell surface protein F3;, PF00041;PF07679;, GO:0099025;GO:0099026;GO:0070062;GO:0016020;GO:0045121;GO:0030246;GO:0007155;GO:0021549;GO:0031175;GO:0007219;GO:0010628;GO:0010976;GO:0050731;GO:0010765;, C:anchored component of postsynaptic membrane; C:anchored component of presynaptic membrane; C:extracellular exosome; C:membrane; C:membrane raft;, F:carbohydrate binding;, P:cell adhesion; P:cerebellum development; P:neuron projection development; P:Notch signaling pathway; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sodium ion transport;|Q12860 A8K0H9 A8K0Y3 Q12861 Q14030 Q7M4P0 Q8N466,Contactin-1,Glycoprotein gp135;Neural cell surface protein F3;, PF00041;PF07679;, GO:0099025;GO:0099026;GO:0070062;GO:0016020;GO:0045121;GO:0030246;GO:0007155;GO:0021549;GO:0031175;GO:0007219;GO:0010628;GO:0010976;GO:0050731;GO:0010765;, C:anchored component of postsynaptic membrane; C:anchored component of presynaptic membrane; C:extracellular exosome; C:membrane; C:membrane raft;, F:carbohydrate binding;, P:cell adhesion; P:cerebellum development; P:neuron projection development; P:Notch signaling pathway; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sodium ion transport;|Q12860 A8K0H9 A8K0Y3 Q12861 Q14030 Q7M4P0 Q8N466,Contactin-1,Glycoprotein gp135;Neural cell surface protein F3;, PF00041;PF07679;, GO:0099025;GO:0099026;GO:0070062;GO:0016020;GO:0045121;GO:0030246;GO:0007155;GO:0021549;GO:0031175;GO:0007219;GO:0010628;GO:0010976;GO:0050731;GO:0010765;, C:anchored component of postsynaptic membrane; C:anchored component of presynaptic membrane; C:extracellular exosome; C:membrane; C:membrane raft;, F:carbohydrate binding;, P:cell adhesion; P:cerebellum development; P:neuron projection development; P:Notch signaling pathway; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sodium ion transport;|Q12860 A8K0H9 A8K0Y3 Q12861 Q14030 Q7M4P0 Q8N466,Contactin-1,Glycoprotein gp135;Neural cell surface protein F3;, PF00041;PF07679;, GO:0099025;GO:0099026;GO:0070062;GO:0016020;GO:0045121;GO:0030246;GO:0007155;GO:0021549;GO:0031175;GO:0007219;GO:0010628;GO:0010976;GO:0050731;GO:0010765;, C:anchored component of postsynaptic membrane; C:anchored component of presynaptic membrane; C:extracellular exosome; C:membrane; C:membrane raft;, F:carbohydrate binding;, P:cell adhesion; P:cerebellum development; P:neuron projection development; P:Notch signaling pathway; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sodium ion transport;|Q12860 A8K0H9 A8K0Y3 Q12861 Q14030 Q7M4P0 Q8N466,Contactin-1,Glycoprotein gp135;Neural cell surface protein F3;, PF00041;PF07679;, GO:0099025;GO:0099026;GO:0070062;GO:0016020;GO:0045121;GO:0030246;GO:0007155;GO:0021549;GO:0031175;GO:0007219;GO:0010628;GO:0010976;GO:0050731;GO:0010765;, C:anchored component of postsynaptic membrane; C:anchored component of presynaptic membrane; C:extracellular exosome; C:membrane; C:membrane raft;, F:carbohydrate binding;, P:cell adhesion; P:cerebellum development; P:neuron projection development; P:Notch signaling pathway; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sodium ion transport;|Q12860 A8K0H9 A8K0Y3 Q12861 Q14030 Q7M4P0 Q8N466,Contactin-1,Glycoprotein gp135;Neural cell surface protein F3;, PF00041;PF07679;, GO:0099025;GO:0099026;GO:0070062;GO:0016020;GO:0045121;GO:0030246;GO:0007155;GO:0021549;GO:0031175;GO:0007219;GO:0010628;GO:0010976;GO:0050731;GO:0010765;, C:anchored component of postsynaptic membrane; C:anchored component of presynaptic membrane; C:extracellular exosome; C:membrane; C:membrane raft;, F:carbohydrate binding;, P:cell adhesion; P:cerebellum development; P:neuron projection development; P:Notch signaling pathway; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sodium ion transport; scaffold31 indexed_genome mRNA 11754261 11860511 . + . ID=transcript_6738;Q5S007 A6NJU2 Q6ZS50 Q8NCX9,Leucine-rich repeat serine/threonine-protein kinase 2,Dardarin;, PF16095;PF12799;PF13855;PF00069;, GO:0044753;GO:0044754;GO:0030424;GO:0099400;GO:0005737;GO:0032473;GO:0031410;GO:0005829;GO:0030425;GO:0032839;GO:0005783;GO:0070971;GO:0005789;GO:0005768;GO:0070062;GO:0005615;GO:0098978;GO:0005794;GO:0000139;GO:0005798;GO:0030426;GO:0016234;GO:0043231;GO:0005764;GO:0045121;GO:0005902;GO:0005743;GO:0005759;GO:0031966;GO:0005741;GO:0005739;GO:0097487;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0099523;GO:1990904;GO:0030672;GO:0043195;GO:0005802;GO:1990909;GO:0003779;GO:0005524;GO:1904713;GO:0030276;GO:0039706;GO:0005525;GO:0034211;GO:0005096;GO:0003924;GO:0042802;GO:0044325;GO:0016301;GO:0000287;GO:0004708;GO:0008017;GO:0036479;GO:0042803;GO:0051018;GO:0004672;GO:0106310;GO:0004674;GO:0004722;GO:0106311;GO:0030159;GO:0031267;GO:0000149;GO:0017075;GO:0015631;GO:0000187;GO:0000186;GO:0006914;GO:0019722;GO:0060070;GO:0034613;GO:1903351;GO:0071287;GO:0071407;GO:0034599;GO:0009267;GO:0008340;GO:0006897;GO:0007029;GO:0060079;GO:0035640;GO:0007030;GO:0046039;GO:0048312;GO:0035556;GO:0035641;GO:0007040;GO:0000165;GO:0051646;GO:0007005;GO:1902902;GO:1902236;GO:0090394;GO:0034260;GO:1903206;GO:1902823;GO:0016242;GO:1901215;GO:0010977;GO:0032091;GO:0001933;GO:0010955;GO:1903217;GO:1903215;GO:1903125;GO:0007528;GO:0070997;GO:0140058;GO:0048812;GO:0021772;GO:0018105;GO:0018107;GO:0016310;GO:0010508;GO:0090263;GO:0060161;GO:1901727;GO:0043406;GO:1903980;GO:0051770;GO:0043068;GO:0032436;GO:1902499;GO:0032092;GO:0001934;GO:0031398;GO:1900244;GO:0046777;GO:0006606;GO:0070973;GO:0070585;GO:0006468;GO:0072593;GO:0010506;GO:2000172;GO:1905289;GO:0060828;GO:0061001;GO:0060159;GO:0060628;GO:0035564;GO:0040012;GO:0035751;GO:0042391;GO:0051900;GO:0090140;GO:1902692;GO:1901214;GO:0014041;GO:0010738;GO:0031647;GO:1905279;GO:0051966;GO:2000300;GO:1902803;GO:0006979;GO:0007165;GO:0007283;GO:0021756;GO:0022028;GO:1904887;, C:amphisome; C:autolysosome; C:axon; C:caveola neck; C:cytoplasm; C:cytoplasmic side of mitochondrial outer membrane; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:dendrite cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:extracellular space; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:growth cone; C:inclusion body; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane raft; C:microvillus; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:multivesicular body, internal vesicle; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:presynaptic cytosol; C:ribonucleoprotein complex; C:synaptic vesicle membrane; C:terminal bouton; C:trans-Golgi network; C:Wnt signalosome;, F:actin binding; F:ATP binding; F:beta-catenin destruction complex binding; F:clathrin binding; F:co-receptor binding; F:GTP binding; F:GTP-dependent protein kinase activity; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:ion channel binding; F:kinase activity; F:magnesium ion binding; F:MAP kinase kinase activity; F:microtubule binding; F:peroxidase inhibitor activity; F:protein homodimerization activity; F:protein kinase A binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine phosphatase activity; F:protein threonine kinase activity; F:signaling receptor complex adaptor activity; F:small GTPase binding; F:SNARE binding; F:syntaxin-1 binding; F:tubulin binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:autophagy; P:calcium-mediated signaling; P:canonical Wnt signaling pathway; P:cellular protein localization; P:cellular response to dopamine; P:cellular response to manganese ion; P:cellular response to organic cyclic compound; P:cellular response to oxidative stress; P:cellular response to starvation; P:determination of adult lifespan; P:endocytosis; P:endoplasmic reticulum organization; P:excitatory postsynaptic potential; P:exploration behavior; P:Golgi organization; P:GTP metabolic process; P:intracellular distribution of mitochondria; P:intracellular signal transduction; P:locomotory exploration behavior; P:lysosome organization; P:MAPK cascade; P:mitochondrion localization; P:mitochondrion organization; P:negative regulation of autophagosome assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of GTPase activity; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of late endosome to lysosome transport; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of neuron projection development; P:negative regulation of protein binding; P:negative regulation of protein phosphorylation; P:negative regulation of protein processing; P:negative regulation of protein processing involved in protein targeting to mitochondrion; P:negative regulation of protein targeting to mitochondrion; P:negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation; P:neuromuscular junction development; P:neuron death; P:neuron projection arborization; P:neuron projection morphogenesis; P:olfactory bulb development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of autophagy; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of histone deacetylase activity; P:positive regulation of MAP kinase activity; P:positive regulation of microglial cell activation; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of programmed cell death; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein autoubiquitination; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of synaptic vesicle endocytosis; P:protein autophosphorylation; P:protein import into nucleus; P:protein localization to endoplasmic reticulum exit site; P:protein localization to mitochondrion; P:protein phosphorylation; P:reactive oxygen species metabolic process; P:regulation of autophagy; P:regulation of branching morphogenesis of a nerve; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of canonical Wnt signaling pathway; P:regulation of dendritic spine morphogenesis; P:regulation of dopamine receptor signaling pathway; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of kidney size; P:regulation of locomotion; P:regulation of lysosomal lumen pH; P:regulation of membrane potential; P:regulation of mitochondrial depolarization; P:regulation of mitochondrial fission; P:regulation of neuroblast proliferation; P:regulation of neuron death; P:regulation of neuron maturation; P:regulation of protein kinase A signaling; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of synaptic transmission, glutamatergic; P:regulation of synaptic vesicle exocytosis; P:regulation of synaptic vesicle transport; P:response to oxidative stress; P:signal transduction; P:spermatogenesis; P:striatum development; P:tangential migration from the subventricular zone to the olfactory bulb; P:Wnt signalosome assembly;|Q5S007 A6NJU2 Q6ZS50 Q8NCX9,Leucine-rich repeat serine/threonine-protein kinase 2,Dardarin;, PF16095;PF12799;PF13855;PF00069;, GO:0044753;GO:0044754;GO:0030424;GO:0099400;GO:0005737;GO:0032473;GO:0031410;GO:0005829;GO:0030425;GO:0032839;GO:0005783;GO:0070971;GO:0005789;GO:0005768;GO:0070062;GO:0005615;GO:0098978;GO:0005794;GO:0000139;GO:0005798;GO:0030426;GO:0016234;GO:0043231;GO:0005764;GO:0045121;GO:0005902;GO:0005743;GO:0005759;GO:0031966;GO:0005741;GO:0005739;GO:0097487;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0099523;GO:1990904;GO:0030672;GO:0043195;GO:0005802;GO:1990909;GO:0003779;GO:0005524;GO:1904713;GO:0030276;GO:0039706;GO:0005525;GO:0034211;GO:0005096;GO:0003924;GO:0042802;GO:0044325;GO:0016301;GO:0000287;GO:0004708;GO:0008017;GO:0036479;GO:0042803;GO:0051018;GO:0004672;GO:0106310;GO:0004674;GO:0004722;GO:0106311;GO:0030159;GO:0031267;GO:0000149;GO:0017075;GO:0015631;GO:0000187;GO:0000186;GO:0006914;GO:0019722;GO:0060070;GO:0034613;GO:1903351;GO:0071287;GO:0071407;GO:0034599;GO:0009267;GO:0008340;GO:0006897;GO:0007029;GO:0060079;GO:0035640;GO:0007030;GO:0046039;GO:0048312;GO:0035556;GO:0035641;GO:0007040;GO:0000165;GO:0051646;GO:0007005;GO:1902902;GO:1902236;GO:0090394;GO:0034260;GO:1903206;GO:1902823;GO:0016242;GO:1901215;GO:0010977;GO:0032091;GO:0001933;GO:0010955;GO:1903217;GO:1903215;GO:1903125;GO:0007528;GO:0070997;GO:0140058;GO:0048812;GO:0021772;GO:0018105;GO:0018107;GO:0016310;GO:0010508;GO:0090263;GO:0060161;GO:1901727;GO:0043406;GO:1903980;GO:0051770;GO:0043068;GO:0032436;GO:1902499;GO:0032092;GO:0001934;GO:0031398;GO:1900244;GO:0046777;GO:0006606;GO:0070973;GO:0070585;GO:0006468;GO:0072593;GO:0010506;GO:2000172;GO:1905289;GO:0060828;GO:0061001;GO:0060159;GO:0060628;GO:0035564;GO:0040012;GO:0035751;GO:0042391;GO:0051900;GO:0090140;GO:1902692;GO:1901214;GO:0014041;GO:0010738;GO:0031647;GO:1905279;GO:0051966;GO:2000300;GO:1902803;GO:0006979;GO:0007165;GO:0007283;GO:0021756;GO:0022028;GO:1904887;, C:amphisome; C:autolysosome; C:axon; C:caveola neck; C:cytoplasm; C:cytoplasmic side of mitochondrial outer membrane; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:dendrite cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:extracellular space; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:growth cone; C:inclusion body; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane raft; C:microvillus; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:multivesicular body, internal vesicle; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:presynaptic cytosol; C:ribonucleoprotein complex; C:synaptic vesicle membrane; C:terminal bouton; C:trans-Golgi network; C:Wnt signalosome;, F:actin binding; F:ATP binding; F:beta-catenin destruction complex binding; F:clathrin binding; F:co-receptor binding; F:GTP binding; F:GTP-dependent protein kinase activity; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:ion channel binding; F:kinase activity; F:magnesium ion binding; F:MAP kinase kinase activity; F:microtubule binding; F:peroxidase inhibitor activity; F:protein homodimerization activity; F:protein kinase A binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine phosphatase activity; F:protein threonine kinase activity; F:signaling receptor complex adaptor activity; F:small GTPase binding; F:SNARE binding; F:syntaxin-1 binding; F:tubulin binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:autophagy; P:calcium-mediated signaling; P:canonical Wnt signaling pathway; P:cellular protein localization; P:cellular response to dopamine; P:cellular response to manganese ion; P:cellular response to organic cyclic compound; P:cellular response to oxidative stress; P:cellular response to starvation; P:determination of adult lifespan; P:endocytosis; P:endoplasmic reticulum organization; P:excitatory postsynaptic potential; P:exploration behavior; P:Golgi organization; P:GTP metabolic process; P:intracellular distribution of mitochondria; P:intracellular signal transduction; P:locomotory exploration behavior; P:lysosome organization; P:MAPK cascade; P:mitochondrion localization; P:mitochondrion organization; P:negative regulation of autophagosome assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of GTPase activity; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of late endosome to lysosome transport; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of neuron projection development; P:negative regulation of protein binding; P:negative regulation of protein phosphorylation; P:negative regulation of protein processing; P:negative regulation of protein processing involved in protein targeting to mitochondrion; P:negative regulation of protein targeting to mitochondrion; P:negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation; P:neuromuscular junction development; P:neuron death; P:neuron projection arborization; P:neuron projection morphogenesis; P:olfactory bulb development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of autophagy; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of histone deacetylase activity; P:positive regulation of MAP kinase activity; P:positive regulation of microglial cell activation; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of programmed cell death; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein autoubiquitination; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of synaptic vesicle endocytosis; P:protein autophosphorylation; P:protein import into nucleus; P:protein localization to endoplasmic reticulum exit site; P:protein localization to mitochondrion; P:protein phosphorylation; P:reactive oxygen species metabolic process; P:regulation of autophagy; P:regulation of branching morphogenesis of a nerve; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of canonical Wnt signaling pathway; P:regulation of dendritic spine morphogenesis; P:regulation of dopamine receptor signaling pathway; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of kidney size; P:regulation of locomotion; P:regulation of lysosomal lumen pH; P:regulation of membrane potential; P:regulation of mitochondrial depolarization; P:regulation of mitochondrial fission; P:regulation of neuroblast proliferation; P:regulation of neuron death; P:regulation of neuron maturation; P:regulation of protein kinase A signaling; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of synaptic transmission, glutamatergic; P:regulation of synaptic vesicle exocytosis; P:regulation of synaptic vesicle transport; P:response to oxidative stress; P:signal transduction; P:spermatogenesis; P:striatum development; P:tangential migration from the subventricular zone to the olfactory bulb; P:Wnt signalosome assembly;|Q5S007 A6NJU2 Q6ZS50 Q8NCX9,Leucine-rich repeat serine/threonine-protein kinase 2,Dardarin;, PF16095;PF12799;PF13855;PF00069;, GO:0044753;GO:0044754;GO:0030424;GO:0099400;GO:0005737;GO:0032473;GO:0031410;GO:0005829;GO:0030425;GO:0032839;GO:0005783;GO:0070971;GO:0005789;GO:0005768;GO:0070062;GO:0005615;GO:0098978;GO:0005794;GO:0000139;GO:0005798;GO:0030426;GO:0016234;GO:0043231;GO:0005764;GO:0045121;GO:0005902;GO:0005743;GO:0005759;GO:0031966;GO:0005741;GO:0005739;GO:0097487;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0099523;GO:1990904;GO:0030672;GO:0043195;GO:0005802;GO:1990909;GO:0003779;GO:0005524;GO:1904713;GO:0030276;GO:0039706;GO:0005525;GO:0034211;GO:0005096;GO:0003924;GO:0042802;GO:0044325;GO:0016301;GO:0000287;GO:0004708;GO:0008017;GO:0036479;GO:0042803;GO:0051018;GO:0004672;GO:0106310;GO:0004674;GO:0004722;GO:0106311;GO:0030159;GO:0031267;GO:0000149;GO:0017075;GO:0015631;GO:0000187;GO:0000186;GO:0006914;GO:0019722;GO:0060070;GO:0034613;GO:1903351;GO:0071287;GO:0071407;GO:0034599;GO:0009267;GO:0008340;GO:0006897;GO:0007029;GO:0060079;GO:0035640;GO:0007030;GO:0046039;GO:0048312;GO:0035556;GO:0035641;GO:0007040;GO:0000165;GO:0051646;GO:0007005;GO:1902902;GO:1902236;GO:0090394;GO:0034260;GO:1903206;GO:1902823;GO:0016242;GO:1901215;GO:0010977;GO:0032091;GO:0001933;GO:0010955;GO:1903217;GO:1903215;GO:1903125;GO:0007528;GO:0070997;GO:0140058;GO:0048812;GO:0021772;GO:0018105;GO:0018107;GO:0016310;GO:0010508;GO:0090263;GO:0060161;GO:1901727;GO:0043406;GO:1903980;GO:0051770;GO:0043068;GO:0032436;GO:1902499;GO:0032092;GO:0001934;GO:0031398;GO:1900244;GO:0046777;GO:0006606;GO:0070973;GO:0070585;GO:0006468;GO:0072593;GO:0010506;GO:2000172;GO:1905289;GO:0060828;GO:0061001;GO:0060159;GO:0060628;GO:0035564;GO:0040012;GO:0035751;GO:0042391;GO:0051900;GO:0090140;GO:1902692;GO:1901214;GO:0014041;GO:0010738;GO:0031647;GO:1905279;GO:0051966;GO:2000300;GO:1902803;GO:0006979;GO:0007165;GO:0007283;GO:0021756;GO:0022028;GO:1904887;, C:amphisome; C:autolysosome; C:axon; C:caveola neck; C:cytoplasm; C:cytoplasmic side of mitochondrial outer membrane; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:dendrite cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:extracellular space; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:growth cone; C:inclusion body; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane raft; C:microvillus; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:multivesicular body, internal vesicle; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:presynaptic cytosol; C:ribonucleoprotein complex; C:synaptic vesicle membrane; C:terminal bouton; C:trans-Golgi network; C:Wnt signalosome;, F:actin binding; F:ATP binding; F:beta-catenin destruction complex binding; F:clathrin binding; F:co-receptor binding; F:GTP binding; F:GTP-dependent protein kinase activity; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:ion channel binding; F:kinase activity; F:magnesium ion binding; F:MAP kinase kinase activity; F:microtubule binding; F:peroxidase inhibitor activity; F:protein homodimerization activity; F:protein kinase A binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine phosphatase activity; F:protein threonine kinase activity; F:signaling receptor complex adaptor activity; F:small GTPase binding; F:SNARE binding; F:syntaxin-1 binding; F:tubulin binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:autophagy; P:calcium-mediated signaling; P:canonical Wnt signaling pathway; P:cellular protein localization; P:cellular response to dopamine; P:cellular response to manganese ion; P:cellular response to organic cyclic compound; P:cellular response to oxidative stress; P:cellular response to starvation; P:determination of adult lifespan; P:endocytosis; P:endoplasmic reticulum organization; P:excitatory postsynaptic potential; P:exploration behavior; P:Golgi organization; P:GTP metabolic process; P:intracellular distribution of mitochondria; P:intracellular signal transduction; P:locomotory exploration behavior; P:lysosome organization; P:MAPK cascade; P:mitochondrion localization; P:mitochondrion organization; P:negative regulation of autophagosome assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of GTPase activity; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of late endosome to lysosome transport; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of neuron projection development; P:negative regulation of protein binding; P:negative regulation of protein phosphorylation; P:negative regulation of protein processing; P:negative regulation of protein processing involved in protein targeting to mitochondrion; P:negative regulation of protein targeting to mitochondrion; P:negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation; P:neuromuscular junction development; P:neuron death; P:neuron projection arborization; P:neuron projection morphogenesis; P:olfactory bulb development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of autophagy; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of histone deacetylase activity; P:positive regulation of MAP kinase activity; P:positive regulation of microglial cell activation; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of programmed cell death; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein autoubiquitination; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of synaptic vesicle endocytosis; P:protein autophosphorylation; P:protein import into nucleus; P:protein localization to endoplasmic reticulum exit site; P:protein localization to mitochondrion; P:protein phosphorylation; P:reactive oxygen species metabolic process; P:regulation of autophagy; P:regulation of branching morphogenesis of a nerve; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of canonical Wnt signaling pathway; P:regulation of dendritic spine morphogenesis; P:regulation of dopamine receptor signaling pathway; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of kidney size; P:regulation of locomotion; P:regulation of lysosomal lumen pH; P:regulation of membrane potential; P:regulation of mitochondrial depolarization; P:regulation of mitochondrial fission; P:regulation of neuroblast proliferation; P:regulation of neuron death; P:regulation of neuron maturation; P:regulation of protein kinase A signaling; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of synaptic transmission, glutamatergic; P:regulation of synaptic vesicle exocytosis; P:regulation of synaptic vesicle transport; P:response to oxidative stress; P:signal transduction; P:spermatogenesis; P:striatum development; P:tangential migration from the subventricular zone to the olfactory bulb; P:Wnt signalosome assembly;|Q5S007 A6NJU2 Q6ZS50 Q8NCX9,Leucine-rich repeat serine/threonine-protein kinase 2,Dardarin;, PF16095;PF12799;PF13855;PF00069;, GO:0044753;GO:0044754;GO:0030424;GO:0099400;GO:0005737;GO:0032473;GO:0031410;GO:0005829;GO:0030425;GO:0032839;GO:0005783;GO:0070971;GO:0005789;GO:0005768;GO:0070062;GO:0005615;GO:0098978;GO:0005794;GO:0000139;GO:0005798;GO:0030426;GO:0016234;GO:0043231;GO:0005764;GO:0045121;GO:0005902;GO:0005743;GO:0005759;GO:0031966;GO:0005741;GO:0005739;GO:0097487;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0099523;GO:1990904;GO:0030672;GO:0043195;GO:0005802;GO:1990909;GO:0003779;GO:0005524;GO:1904713;GO:0030276;GO:0039706;GO:0005525;GO:0034211;GO:0005096;GO:0003924;GO:0042802;GO:0044325;GO:0016301;GO:0000287;GO:0004708;GO:0008017;GO:0036479;GO:0042803;GO:0051018;GO:0004672;GO:0106310;GO:0004674;GO:0004722;GO:0106311;GO:0030159;GO:0031267;GO:0000149;GO:0017075;GO:0015631;GO:0000187;GO:0000186;GO:0006914;GO:0019722;GO:0060070;GO:0034613;GO:1903351;GO:0071287;GO:0071407;GO:0034599;GO:0009267;GO:0008340;GO:0006897;GO:0007029;GO:0060079;GO:0035640;GO:0007030;GO:0046039;GO:0048312;GO:0035556;GO:0035641;GO:0007040;GO:0000165;GO:0051646;GO:0007005;GO:1902902;GO:1902236;GO:0090394;GO:0034260;GO:1903206;GO:1902823;GO:0016242;GO:1901215;GO:0010977;GO:0032091;GO:0001933;GO:0010955;GO:1903217;GO:1903215;GO:1903125;GO:0007528;GO:0070997;GO:0140058;GO:0048812;GO:0021772;GO:0018105;GO:0018107;GO:0016310;GO:0010508;GO:0090263;GO:0060161;GO:1901727;GO:0043406;GO:1903980;GO:0051770;GO:0043068;GO:0032436;GO:1902499;GO:0032092;GO:0001934;GO:0031398;GO:1900244;GO:0046777;GO:0006606;GO:0070973;GO:0070585;GO:0006468;GO:0072593;GO:0010506;GO:2000172;GO:1905289;GO:0060828;GO:0061001;GO:0060159;GO:0060628;GO:0035564;GO:0040012;GO:0035751;GO:0042391;GO:0051900;GO:0090140;GO:1902692;GO:1901214;GO:0014041;GO:0010738;GO:0031647;GO:1905279;GO:0051966;GO:2000300;GO:1902803;GO:0006979;GO:0007165;GO:0007283;GO:0021756;GO:0022028;GO:1904887;, C:amphisome; C:autolysosome; C:axon; C:caveola neck; C:cytoplasm; C:cytoplasmic side of mitochondrial outer membrane; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:dendrite cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:extracellular space; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:growth cone; C:inclusion body; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane raft; C:microvillus; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:multivesicular body, internal vesicle; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:presynaptic cytosol; C:ribonucleoprotein complex; C:synaptic vesicle membrane; C:terminal bouton; C:trans-Golgi network; C:Wnt signalosome;, F:actin binding; F:ATP binding; F:beta-catenin destruction complex binding; F:clathrin binding; F:co-receptor binding; F:GTP binding; F:GTP-dependent protein kinase activity; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:ion channel binding; F:kinase activity; F:magnesium ion binding; F:MAP kinase kinase activity; F:microtubule binding; F:peroxidase inhibitor activity; F:protein homodimerization activity; F:protein kinase A binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine phosphatase activity; F:protein threonine kinase activity; F:signaling receptor complex adaptor activity; F:small GTPase binding; F:SNARE binding; F:syntaxin-1 binding; F:tubulin binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:autophagy; P:calcium-mediated signaling; P:canonical Wnt signaling pathway; P:cellular protein localization; P:cellular response to dopamine; P:cellular response to manganese ion; P:cellular response to organic cyclic compound; P:cellular response to oxidative stress; P:cellular response to starvation; P:determination of adult lifespan; P:endocytosis; P:endoplasmic reticulum organization; P:excitatory postsynaptic potential; P:exploration behavior; P:Golgi organization; P:GTP metabolic process; P:intracellular distribution of mitochondria; P:intracellular signal transduction; P:locomotory exploration behavior; P:lysosome organization; P:MAPK cascade; P:mitochondrion localization; P:mitochondrion organization; P:negative regulation of autophagosome assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of GTPase activity; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of late endosome to lysosome transport; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of neuron projection development; P:negative regulation of protein binding; P:negative regulation of protein phosphorylation; P:negative regulation of protein processing; P:negative regulation of protein processing involved in protein targeting to mitochondrion; P:negative regulation of protein targeting to mitochondrion; P:negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation; P:neuromuscular junction development; P:neuron death; P:neuron projection arborization; P:neuron projection morphogenesis; P:olfactory bulb development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of autophagy; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of histone deacetylase activity; P:positive regulation of MAP kinase activity; P:positive regulation of microglial cell activation; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of programmed cell death; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein autoubiquitination; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of synaptic vesicle endocytosis; P:protein autophosphorylation; P:protein import into nucleus; P:protein localization to endoplasmic reticulum exit site; P:protein localization to mitochondrion; P:protein phosphorylation; P:reactive oxygen species metabolic process; P:regulation of autophagy; P:regulation of branching morphogenesis of a nerve; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of canonical Wnt signaling pathway; P:regulation of dendritic spine morphogenesis; P:regulation of dopamine receptor signaling pathway; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of kidney size; P:regulation of locomotion; P:regulation of lysosomal lumen pH; P:regulation of membrane potential; P:regulation of mitochondrial depolarization; P:regulation of mitochondrial fission; P:regulation of neuroblast proliferation; P:regulation of neuron death; P:regulation of neuron maturation; P:regulation of protein kinase A signaling; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of synaptic transmission, glutamatergic; P:regulation of synaptic vesicle exocytosis; P:regulation of synaptic vesicle transport; P:response to oxidative stress; P:signal transduction; P:spermatogenesis; P:striatum development; P:tangential migration from the subventricular zone to the olfactory bulb; P:Wnt signalosome assembly;|Q5S007 A6NJU2 Q6ZS50 Q8NCX9,Leucine-rich repeat serine/threonine-protein kinase 2,Dardarin;, PF16095;PF12799;PF13855;PF00069;, GO:0044753;GO:0044754;GO:0030424;GO:0099400;GO:0005737;GO:0032473;GO:0031410;GO:0005829;GO:0030425;GO:0032839;GO:0005783;GO:0070971;GO:0005789;GO:0005768;GO:0070062;GO:0005615;GO:0098978;GO:0005794;GO:0000139;GO:0005798;GO:0030426;GO:0016234;GO:0043231;GO:0005764;GO:0045121;GO:0005902;GO:0005743;GO:0005759;GO:0031966;GO:0005741;GO:0005739;GO:0097487;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0099523;GO:1990904;GO:0030672;GO:0043195;GO:0005802;GO:1990909;GO:0003779;GO:0005524;GO:1904713;GO:0030276;GO:0039706;GO:0005525;GO:0034211;GO:0005096;GO:0003924;GO:0042802;GO:0044325;GO:0016301;GO:0000287;GO:0004708;GO:0008017;GO:0036479;GO:0042803;GO:0051018;GO:0004672;GO:0106310;GO:0004674;GO:0004722;GO:0106311;GO:0030159;GO:0031267;GO:0000149;GO:0017075;GO:0015631;GO:0000187;GO:0000186;GO:0006914;GO:0019722;GO:0060070;GO:0034613;GO:1903351;GO:0071287;GO:0071407;GO:0034599;GO:0009267;GO:0008340;GO:0006897;GO:0007029;GO:0060079;GO:0035640;GO:0007030;GO:0046039;GO:0048312;GO:0035556;GO:0035641;GO:0007040;GO:0000165;GO:0051646;GO:0007005;GO:1902902;GO:1902236;GO:0090394;GO:0034260;GO:1903206;GO:1902823;GO:0016242;GO:1901215;GO:0010977;GO:0032091;GO:0001933;GO:0010955;GO:1903217;GO:1903215;GO:1903125;GO:0007528;GO:0070997;GO:0140058;GO:0048812;GO:0021772;GO:0018105;GO:0018107;GO:0016310;GO:0010508;GO:0090263;GO:0060161;GO:1901727;GO:0043406;GO:1903980;GO:0051770;GO:0043068;GO:0032436;GO:1902499;GO:0032092;GO:0001934;GO:0031398;GO:1900244;GO:0046777;GO:0006606;GO:0070973;GO:0070585;GO:0006468;GO:0072593;GO:0010506;GO:2000172;GO:1905289;GO:0060828;GO:0061001;GO:0060159;GO:0060628;GO:0035564;GO:0040012;GO:0035751;GO:0042391;GO:0051900;GO:0090140;GO:1902692;GO:1901214;GO:0014041;GO:0010738;GO:0031647;GO:1905279;GO:0051966;GO:2000300;GO:1902803;GO:0006979;GO:0007165;GO:0007283;GO:0021756;GO:0022028;GO:1904887;, C:amphisome; C:autolysosome; C:axon; C:caveola neck; C:cytoplasm; C:cytoplasmic side of mitochondrial outer membrane; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:dendrite cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:extracellular space; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:growth cone; C:inclusion body; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane raft; C:microvillus; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:multivesicular body, internal vesicle; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:presynaptic cytosol; C:ribonucleoprotein complex; C:synaptic vesicle membrane; C:terminal bouton; C:trans-Golgi network; C:Wnt signalosome;, F:actin binding; F:ATP binding; F:beta-catenin destruction complex binding; F:clathrin binding; F:co-receptor binding; F:GTP binding; F:GTP-dependent protein kinase activity; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:ion channel binding; F:kinase activity; F:magnesium ion binding; F:MAP kinase kinase activity; F:microtubule binding; F:peroxidase inhibitor activity; F:protein homodimerization activity; F:protein kinase A binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine phosphatase activity; F:protein threonine kinase activity; F:signaling receptor complex adaptor activity; F:small GTPase binding; F:SNARE binding; F:syntaxin-1 binding; F:tubulin binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:autophagy; P:calcium-mediated signaling; P:canonical Wnt signaling pathway; P:cellular protein localization; P:cellular response to dopamine; P:cellular response to manganese ion; P:cellular response to organic cyclic compound; P:cellular response to oxidative stress; P:cellular response to starvation; P:determination of adult lifespan; P:endocytosis; P:endoplasmic reticulum organization; P:excitatory postsynaptic potential; P:exploration behavior; P:Golgi organization; P:GTP metabolic process; P:intracellular distribution of mitochondria; P:intracellular signal transduction; P:locomotory exploration behavior; P:lysosome organization; P:MAPK cascade; P:mitochondrion localization; P:mitochondrion organization; P:negative regulation of autophagosome assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of GTPase activity; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of late endosome to lysosome transport; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of neuron projection development; P:negative regulation of protein binding; P:negative regulation of protein phosphorylation; P:negative regulation of protein processing; P:negative regulation of protein processing involved in protein targeting to mitochondrion; P:negative regulation of protein targeting to mitochondrion; P:negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation; P:neuromuscular junction development; P:neuron death; P:neuron projection arborization; P:neuron projection morphogenesis; P:olfactory bulb development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of autophagy; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of histone deacetylase activity; P:positive regulation of MAP kinase activity; P:positive regulation of microglial cell activation; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of programmed cell death; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein autoubiquitination; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of synaptic vesicle endocytosis; P:protein autophosphorylation; P:protein import into nucleus; P:protein localization to endoplasmic reticulum exit site; P:protein localization to mitochondrion; P:protein phosphorylation; P:reactive oxygen species metabolic process; P:regulation of autophagy; P:regulation of branching morphogenesis of a nerve; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of canonical Wnt signaling pathway; P:regulation of dendritic spine morphogenesis; P:regulation of dopamine receptor signaling pathway; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of kidney size; P:regulation of locomotion; P:regulation of lysosomal lumen pH; P:regulation of membrane potential; P:regulation of mitochondrial depolarization; P:regulation of mitochondrial fission; P:regulation of neuroblast proliferation; P:regulation of neuron death; P:regulation of neuron maturation; P:regulation of protein kinase A signaling; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of synaptic transmission, glutamatergic; P:regulation of synaptic vesicle exocytosis; P:regulation of synaptic vesicle transport; P:response to oxidative stress; P:signal transduction; P:spermatogenesis; P:striatum development; P:tangential migration from the subventricular zone to the olfactory bulb; P:Wnt signalosome assembly; scaffold31 indexed_genome mRNA 11865821 11950810 . - . ID=transcript_6739;Q5S007 A6NJU2 Q6ZS50 Q8NCX9,Leucine-rich repeat serine/threonine-protein kinase 2,Dardarin;, PF16095;PF12799;PF13855;PF00069;, GO:0044753;GO:0044754;GO:0030424;GO:0099400;GO:0005737;GO:0032473;GO:0031410;GO:0005829;GO:0030425;GO:0032839;GO:0005783;GO:0070971;GO:0005789;GO:0005768;GO:0070062;GO:0005615;GO:0098978;GO:0005794;GO:0000139;GO:0005798;GO:0030426;GO:0016234;GO:0043231;GO:0005764;GO:0045121;GO:0005902;GO:0005743;GO:0005759;GO:0031966;GO:0005741;GO:0005739;GO:0097487;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0099523;GO:1990904;GO:0030672;GO:0043195;GO:0005802;GO:1990909;GO:0003779;GO:0005524;GO:1904713;GO:0030276;GO:0039706;GO:0005525;GO:0034211;GO:0005096;GO:0003924;GO:0042802;GO:0044325;GO:0016301;GO:0000287;GO:0004708;GO:0008017;GO:0036479;GO:0042803;GO:0051018;GO:0004672;GO:0106310;GO:0004674;GO:0004722;GO:0106311;GO:0030159;GO:0031267;GO:0000149;GO:0017075;GO:0015631;GO:0000187;GO:0000186;GO:0006914;GO:0019722;GO:0060070;GO:0034613;GO:1903351;GO:0071287;GO:0071407;GO:0034599;GO:0009267;GO:0008340;GO:0006897;GO:0007029;GO:0060079;GO:0035640;GO:0007030;GO:0046039;GO:0048312;GO:0035556;GO:0035641;GO:0007040;GO:0000165;GO:0051646;GO:0007005;GO:1902902;GO:1902236;GO:0090394;GO:0034260;GO:1903206;GO:1902823;GO:0016242;GO:1901215;GO:0010977;GO:0032091;GO:0001933;GO:0010955;GO:1903217;GO:1903215;GO:1903125;GO:0007528;GO:0070997;GO:0140058;GO:0048812;GO:0021772;GO:0018105;GO:0018107;GO:0016310;GO:0010508;GO:0090263;GO:0060161;GO:1901727;GO:0043406;GO:1903980;GO:0051770;GO:0043068;GO:0032436;GO:1902499;GO:0032092;GO:0001934;GO:0031398;GO:1900244;GO:0046777;GO:0006606;GO:0070973;GO:0070585;GO:0006468;GO:0072593;GO:0010506;GO:2000172;GO:1905289;GO:0060828;GO:0061001;GO:0060159;GO:0060628;GO:0035564;GO:0040012;GO:0035751;GO:0042391;GO:0051900;GO:0090140;GO:1902692;GO:1901214;GO:0014041;GO:0010738;GO:0031647;GO:1905279;GO:0051966;GO:2000300;GO:1902803;GO:0006979;GO:0007165;GO:0007283;GO:0021756;GO:0022028;GO:1904887;, C:amphisome; C:autolysosome; C:axon; C:caveola neck; C:cytoplasm; C:cytoplasmic side of mitochondrial outer membrane; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:dendrite cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:extracellular space; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:growth cone; C:inclusion body; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane raft; C:microvillus; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:multivesicular body, internal vesicle; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:presynaptic cytosol; C:ribonucleoprotein complex; C:synaptic vesicle membrane; C:terminal bouton; C:trans-Golgi network; C:Wnt signalosome;, F:actin binding; F:ATP binding; F:beta-catenin destruction complex binding; F:clathrin binding; F:co-receptor binding; F:GTP binding; F:GTP-dependent protein kinase activity; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:ion channel binding; F:kinase activity; F:magnesium ion binding; F:MAP kinase kinase activity; F:microtubule binding; F:peroxidase inhibitor activity; F:protein homodimerization activity; F:protein kinase A binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine phosphatase activity; F:protein threonine kinase activity; F:signaling receptor complex adaptor activity; F:small GTPase binding; F:SNARE binding; F:syntaxin-1 binding; F:tubulin binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:autophagy; P:calcium-mediated signaling; P:canonical Wnt signaling pathway; P:cellular protein localization; P:cellular response to dopamine; P:cellular response to manganese ion; P:cellular response to organic cyclic compound; P:cellular response to oxidative stress; P:cellular response to starvation; P:determination of adult lifespan; P:endocytosis; P:endoplasmic reticulum organization; P:excitatory postsynaptic potential; P:exploration behavior; P:Golgi organization; P:GTP metabolic process; P:intracellular distribution of mitochondria; P:intracellular signal transduction; P:locomotory exploration behavior; P:lysosome organization; P:MAPK cascade; P:mitochondrion localization; P:mitochondrion organization; P:negative regulation of autophagosome assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of GTPase activity; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of late endosome to lysosome transport; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of neuron projection development; P:negative regulation of protein binding; P:negative regulation of protein phosphorylation; P:negative regulation of protein processing; P:negative regulation of protein processing involved in protein targeting to mitochondrion; P:negative regulation of protein targeting to mitochondrion; P:negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation; P:neuromuscular junction development; P:neuron death; P:neuron projection arborization; P:neuron projection morphogenesis; P:olfactory bulb development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of autophagy; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of histone deacetylase activity; P:positive regulation of MAP kinase activity; P:positive regulation of microglial cell activation; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of programmed cell death; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein autoubiquitination; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of synaptic vesicle endocytosis; P:protein autophosphorylation; P:protein import into nucleus; P:protein localization to endoplasmic reticulum exit site; P:protein localization to mitochondrion; P:protein phosphorylation; P:reactive oxygen species metabolic process; P:regulation of autophagy; P:regulation of branching morphogenesis of a nerve; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of canonical Wnt signaling pathway; P:regulation of dendritic spine morphogenesis; P:regulation of dopamine receptor signaling pathway; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of kidney size; P:regulation of locomotion; P:regulation of lysosomal lumen pH; P:regulation of membrane potential; P:regulation of mitochondrial depolarization; P:regulation of mitochondrial fission; P:regulation of neuroblast proliferation; P:regulation of neuron death; P:regulation of neuron maturation; P:regulation of protein kinase A signaling; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of synaptic transmission, glutamatergic; P:regulation of synaptic vesicle exocytosis; P:regulation of synaptic vesicle transport; P:response to oxidative stress; P:signal transduction; P:spermatogenesis; P:striatum development; P:tangential migration from the subventricular zone to the olfactory bulb; P:Wnt signalosome assembly; scaffold31 indexed_genome mRNA 12103942 12315844 . + . ID=transcript_6740;Q96QE2 Q17S07,Proton myo-inositol cotransporter {ECO:0000305},H(+)-myo-inositol symporter {ECO:0000303|PubMed:11500374};Solute carrier family 2 member 13;, PF00083;, GO:0097450;GO:0044297;GO:0071944;GO:0042995;GO:0005737;GO:0030426;GO:0005887;GO:0043231;GO:0016020;GO:0031090;GO:0005886;GO:0051117;GO:0005365;GO:0005366;GO:0002020;GO:0015798;GO:1902004;GO:0150104;, C:astrocyte end-foot; C:cell body; C:cell periphery; C:cell projection; C:cytoplasm; C:growth cone; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:plasma membrane;, F:ATPase binding; F:myo-inositol transmembrane transporter activity; F:myo-inositol:proton symporter activity; F:protease binding;, P:myo-inositol transport; P:positive regulation of amyloid-beta formation; P:transport across blood-brain barrier; scaffold31 indexed_genome mRNA 12419666 12561857 . + . ID=transcript_6741;Q96QE2 Q17S07,Proton myo-inositol cotransporter {ECO:0000305},H(+)-myo-inositol symporter {ECO:0000303|PubMed:11500374};Solute carrier family 2 member 13;, PF00083;, GO:0097450;GO:0044297;GO:0071944;GO:0042995;GO:0005737;GO:0030426;GO:0005887;GO:0043231;GO:0016020;GO:0031090;GO:0005886;GO:0051117;GO:0005365;GO:0005366;GO:0002020;GO:0015798;GO:1902004;GO:0150104;, C:astrocyte end-foot; C:cell body; C:cell periphery; C:cell projection; C:cytoplasm; C:growth cone; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:plasma membrane;, F:ATPase binding; F:myo-inositol transmembrane transporter activity; F:myo-inositol:proton symporter activity; F:protease binding;, P:myo-inositol transport; P:positive regulation of amyloid-beta formation; P:transport across blood-brain barrier; scaffold31 indexed_genome mRNA 12696495 12783017 . + . ID=transcript_6742;Q9UBJ2 B2RAM3 Q13210 Q2M3H9,ATP-binding cassette sub-family D member 2,Adrenoleukodystrophy-like 1;Adrenoleukodystrophy-related protein;, PF06472;PF00005;, GO:0005829;GO:0016021;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:0042803;GO:0006635;GO:0006869;GO:0015910;GO:0043217;GO:1900016;GO:1903427;GO:1990535;GO:0007031;GO:0032000;GO:2001280;GO:0045046;GO:0042760;GO:0000038;, C:cytosol; C:integral component of membrane; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:protein homodimerization activity;, P:fatty acid beta-oxidation; P:lipid transport; P:long-chain fatty acid import into peroxisome; P:myelin maintenance; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of reactive oxygen species biosynthetic process; P:neuron projection maintenance; P:peroxisome organization; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of unsaturated fatty acid biosynthetic process; P:protein import into peroxisome membrane; P:very long-chain fatty acid catabolic process; P:very long-chain fatty acid metabolic process; scaffold31 indexed_genome mRNA 12877304 12906583 . + . ID=transcript_6743;Q9CWI7 Q9CZA2 Q9UDJ5 Q9UEU9,GTP-binding nuclear protein Ran,Androgen receptor-associated protein 24 {ECO:0000303|PubMed:10400640};GTPase Ran;Ras-like protein TC4 {ECO:0000303|PubMed:2108320, ECO:0000303|PubMed:8276887, ECO:0000303|PubMed:8421051};Ras-related nuclear protein;, PF00071;, GO:0005814;GO:0005737;GO:0005829;GO:0070062;GO:0043657;GO:0042470;GO:0016020;GO:0030496;GO:0005635;GO:0005643;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0055037;GO:0042565;GO:0045296;GO:0003682;GO:0019003;GO:0005525;GO:0003924;GO:0000287;GO:0046982;GO:0003723;GO:0051301;GO:0006259;GO:0046039;GO:0075733;GO:0010586;GO:0000278;GO:0007084;GO:0000070;GO:0007052;GO:0032092;GO:0042307;GO:0035281;GO:0006611;GO:0006606;GO:1902570;GO:0045540;GO:0000055;GO:0000056;GO:0000054;GO:0061015;GO:0006409;GO:0016032;, C:centriole; C:cytoplasm; C:cytosol; C:extracellular exosome; C:host cell; C:melanosome; C:membrane; C:midbody; C:nuclear envelope; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:recycling endosome; C:RNA nuclear export complex;, F:cadherin binding; F:chromatin binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:magnesium ion binding; F:protein heterodimerization activity; F:RNA binding;, P:cell division; P:DNA metabolic process; P:GTP metabolic process; P:intracellular transport of virus; P:miRNA metabolic process; P:mitotic cell cycle; P:mitotic nuclear envelope reassembly; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:pre-miRNA export from nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein localization to nucleolus; P:regulation of cholesterol biosynthetic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:snRNA import into nucleus; P:tRNA export from nucleus; P:viral process; scaffold31 indexed_genome mRNA 12907224 13085028 . + . ID=transcript_6744;Q86WZ5 Q8IVZ8 Q9C0F5 Q9NXU4 Q9Y590,Kinesin-like protein KIF21A,Kinesin-like protein KIF2;Renal carcinoma antigen NY-REN-62;, PF00225;PF00400;, GO:0005829;GO:0005871;GO:0005874;GO:0005886;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytosol; C:kinesin complex; C:microtubule; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement;|Q86WZ5 Q8IVZ8 Q9C0F5 Q9NXU4 Q9Y590,Kinesin-like protein KIF21A,Kinesin-like protein KIF2;Renal carcinoma antigen NY-REN-62;, PF00225;PF00400;, GO:0005829;GO:0005871;GO:0005874;GO:0005886;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytosol; C:kinesin complex; C:microtubule; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement;|Q86WZ5 Q8IVZ8 Q9C0F5 Q9NXU4 Q9Y590,Kinesin-like protein KIF21A,Kinesin-like protein KIF2;Renal carcinoma antigen NY-REN-62;, PF00225;PF00400;, GO:0005829;GO:0005871;GO:0005874;GO:0005886;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytosol; C:kinesin complex; C:microtubule; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement;|Q86WZ5 Q8IVZ8 Q9C0F5 Q9NXU4 Q9Y590,Kinesin-like protein KIF21A,Kinesin-like protein KIF2;Renal carcinoma antigen NY-REN-62;, PF00225;PF00400;, GO:0005829;GO:0005871;GO:0005874;GO:0005886;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytosol; C:kinesin complex; C:microtubule; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement;|Q86WZ5 Q8IVZ8 Q9C0F5 Q9NXU4 Q9Y590,Kinesin-like protein KIF21A,Kinesin-like protein KIF2;Renal carcinoma antigen NY-REN-62;, PF00225;PF00400;, GO:0005829;GO:0005871;GO:0005874;GO:0005886;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytosol; C:kinesin complex; C:microtubule; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement;|Q86WZ5 Q8IVZ8 Q9C0F5 Q9NXU4 Q9Y590,Kinesin-like protein KIF21A,Kinesin-like protein KIF2;Renal carcinoma antigen NY-REN-62;, PF00225;PF00400;, GO:0005829;GO:0005871;GO:0005874;GO:0005886;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytosol; C:kinesin complex; C:microtubule; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement;|Q86WZ5 Q8IVZ8 Q9C0F5 Q9NXU4 Q9Y590,Kinesin-like protein KIF21A,Kinesin-like protein KIF2;Renal carcinoma antigen NY-REN-62;, PF00225;PF00400;, GO:0005829;GO:0005871;GO:0005874;GO:0005886;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytosol; C:kinesin complex; C:microtubule; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement;|Q86WZ5 Q8IVZ8 Q9C0F5 Q9NXU4 Q9Y590,Kinesin-like protein KIF21A,Kinesin-like protein KIF2;Renal carcinoma antigen NY-REN-62;, PF00225;PF00400;, GO:0005829;GO:0005871;GO:0005874;GO:0005886;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytosol; C:kinesin complex; C:microtubule; C:plasma membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; scaffold31 indexed_genome mRNA 13237760 13479346 . + . ID=transcript_6745;Q86YQ8 Q2TB41 Q86VY2,Copine-8 {ECO:0000305},Copine VIII {ECO:0000312|HGNC:HGNC:23498};, PF00168;PF07002;, GO:0070062;GO:0005886;GO:0005544;GO:0046872;GO:0071277;, C:extracellular exosome; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cellular response to calcium ion; scaffold31 indexed_genome mRNA 13486052 13490872 . + . ID=transcript_6746;Q86YQ8 Q2TB41 Q86VY2,Copine-8 {ECO:0000305},Copine VIII {ECO:0000312|HGNC:HGNC:23498};, PF00168;PF07002;, GO:0070062;GO:0005886;GO:0005544;GO:0046872;GO:0071277;, C:extracellular exosome; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cellular response to calcium ion;|Q86YQ8 Q2TB41 Q86VY2,Copine-8 {ECO:0000305},Copine VIII {ECO:0000312|HGNC:HGNC:23498};, PF00168;PF07002;, GO:0070062;GO:0005886;GO:0005544;GO:0046872;GO:0071277;, C:extracellular exosome; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cellular response to calcium ion; scaffold31 indexed_genome mRNA 13587231 13856784 . + . ID=transcript_6747;Q15256 B2R5Z7 B7Z3J1 F5GXR7 O00342 Q92682 Q9UE65,Receptor-type tyrosine-protein phosphatase R,Ch-1PTPase;NC-PTPCOM1;Protein-tyrosine phosphatase PCPTP1;, PF00102;, GO:0030054;GO:0005829;GO:0005615;GO:0016021;GO:0048471;GO:0005886;GO:0019901;GO:0004725;GO:0005001;GO:0038128;GO:0001701;GO:0010633;GO:0070373;GO:0006470;, C:cell junction; C:cytosol; C:extracellular space; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:ERBB2 signaling pathway; P:in utero embryonic development; P:negative regulation of epithelial cell migration; P:negative regulation of ERK1 and ERK2 cascade; P:protein dephosphorylation;|Q15256 B2R5Z7 B7Z3J1 F5GXR7 O00342 Q92682 Q9UE65,Receptor-type tyrosine-protein phosphatase R,Ch-1PTPase;NC-PTPCOM1;Protein-tyrosine phosphatase PCPTP1;, PF00102;, GO:0030054;GO:0005829;GO:0005615;GO:0016021;GO:0048471;GO:0005886;GO:0019901;GO:0004725;GO:0005001;GO:0038128;GO:0001701;GO:0010633;GO:0070373;GO:0006470;, C:cell junction; C:cytosol; C:extracellular space; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:ERBB2 signaling pathway; P:in utero embryonic development; P:negative regulation of epithelial cell migration; P:negative regulation of ERK1 and ERK2 cascade; P:protein dephosphorylation;|Q15256 B2R5Z7 B7Z3J1 F5GXR7 O00342 Q92682 Q9UE65,Receptor-type tyrosine-protein phosphatase R,Ch-1PTPase;NC-PTPCOM1;Protein-tyrosine phosphatase PCPTP1;, PF00102;, GO:0030054;GO:0005829;GO:0005615;GO:0016021;GO:0048471;GO:0005886;GO:0019901;GO:0004725;GO:0005001;GO:0038128;GO:0001701;GO:0010633;GO:0070373;GO:0006470;, C:cell junction; C:cytosol; C:extracellular space; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:ERBB2 signaling pathway; P:in utero embryonic development; P:negative regulation of epithelial cell migration; P:negative regulation of ERK1 and ERK2 cascade; P:protein dephosphorylation;|Q15256 B2R5Z7 B7Z3J1 F5GXR7 O00342 Q92682 Q9UE65,Receptor-type tyrosine-protein phosphatase R,Ch-1PTPase;NC-PTPCOM1;Protein-tyrosine phosphatase PCPTP1;, PF00102;, GO:0030054;GO:0005829;GO:0005615;GO:0016021;GO:0048471;GO:0005886;GO:0019901;GO:0004725;GO:0005001;GO:0038128;GO:0001701;GO:0010633;GO:0070373;GO:0006470;, C:cell junction; C:cytosol; C:extracellular space; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:ERBB2 signaling pathway; P:in utero embryonic development; P:negative regulation of epithelial cell migration; P:negative regulation of ERK1 and ERK2 cascade; P:protein dephosphorylation;|Q15256 B2R5Z7 B7Z3J1 F5GXR7 O00342 Q92682 Q9UE65,Receptor-type tyrosine-protein phosphatase R,Ch-1PTPase;NC-PTPCOM1;Protein-tyrosine phosphatase PCPTP1;, PF00102;, GO:0030054;GO:0005829;GO:0005615;GO:0016021;GO:0048471;GO:0005886;GO:0019901;GO:0004725;GO:0005001;GO:0038128;GO:0001701;GO:0010633;GO:0070373;GO:0006470;, C:cell junction; C:cytosol; C:extracellular space; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:ERBB2 signaling pathway; P:in utero embryonic development; P:negative regulation of epithelial cell migration; P:negative regulation of ERK1 and ERK2 cascade; P:protein dephosphorylation;|Q15256 B2R5Z7 B7Z3J1 F5GXR7 O00342 Q92682 Q9UE65,Receptor-type tyrosine-protein phosphatase R,Ch-1PTPase;NC-PTPCOM1;Protein-tyrosine phosphatase PCPTP1;, PF00102;, GO:0030054;GO:0005829;GO:0005615;GO:0016021;GO:0048471;GO:0005886;GO:0019901;GO:0004725;GO:0005001;GO:0038128;GO:0001701;GO:0010633;GO:0070373;GO:0006470;, C:cell junction; C:cytosol; C:extracellular space; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:ERBB2 signaling pathway; P:in utero embryonic development; P:negative regulation of epithelial cell migration; P:negative regulation of ERK1 and ERK2 cascade; P:protein dephosphorylation;|Q15256 B2R5Z7 B7Z3J1 F5GXR7 O00342 Q92682 Q9UE65,Receptor-type tyrosine-protein phosphatase R,Ch-1PTPase;NC-PTPCOM1;Protein-tyrosine phosphatase PCPTP1;, PF00102;, GO:0030054;GO:0005829;GO:0005615;GO:0016021;GO:0048471;GO:0005886;GO:0019901;GO:0004725;GO:0005001;GO:0038128;GO:0001701;GO:0010633;GO:0070373;GO:0006470;, C:cell junction; C:cytosol; C:extracellular space; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:ERBB2 signaling pathway; P:in utero embryonic development; P:negative regulation of epithelial cell migration; P:negative regulation of ERK1 and ERK2 cascade; P:protein dephosphorylation; scaffold31 indexed_genome mRNA 13889328 13978855 . + . ID=transcript_6748;P23467 B7ZKS8 B7ZKT0 C9JX87 F5H3G6 Q14D85 Q3MIV7,Receptor-type tyrosine-protein phosphatase beta,Vascular endothelial protein tyrosine phosphatase;, PF00041;PF18861;PF00102;, GO:0005887;GO:0005886;GO:0043235;GO:0035579;GO:0070821;GO:0045296;GO:0005001;GO:0001525;GO:0016311;GO:0043312;GO:1990264;GO:0006796;GO:0006470;, C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:specific granule membrane; C:tertiary granule membrane;, F:cadherin binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:angiogenesis; P:dephosphorylation; P:neutrophil degranulation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:phosphate-containing compound metabolic process; P:protein dephosphorylation;|P23467 B7ZKS8 B7ZKT0 C9JX87 F5H3G6 Q14D85 Q3MIV7,Receptor-type tyrosine-protein phosphatase beta,Vascular endothelial protein tyrosine phosphatase;, PF00041;PF18861;PF00102;, GO:0005887;GO:0005886;GO:0043235;GO:0035579;GO:0070821;GO:0045296;GO:0005001;GO:0001525;GO:0016311;GO:0043312;GO:1990264;GO:0006796;GO:0006470;, C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:specific granule membrane; C:tertiary granule membrane;, F:cadherin binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:angiogenesis; P:dephosphorylation; P:neutrophil degranulation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:phosphate-containing compound metabolic process; P:protein dephosphorylation; scaffold31 indexed_genome mRNA 14004593 14078452 . - . ID=transcript_6749;Q86W47 Q8IVR3 Q9NPA4 Q9P0G5,Calcium-activated potassium channel subunit beta-4,BK channel subunit beta-4;Calcium-activated potassium channel, subfamily M subunit beta-4;Charybdotoxin receptor subunit beta-4;K(VCA)beta-4;Maxi K channel subunit beta-4;Slo-beta-4;, PF03185;, GO:0005887;GO:0005886;GO:0045202;GO:0008076;GO:0015269;GO:0015459;GO:0001508;GO:0007268;GO:0005513;GO:0019228;GO:1901381;GO:0006813;GO:0046928;GO:0019229;, C:integral component of plasma membrane; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:calcium-activated potassium channel activity; F:potassium channel regulator activity;, P:action potential; P:chemical synaptic transmission; P:detection of calcium ion; P:neuronal action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transport; P:regulation of neurotransmitter secretion; P:regulation of vasoconstriction; scaffold31 indexed_genome mRNA 14096190 14216662 . - . ID=transcript_6750;Q9NZN8 Q9H3E0 Q9NSX5 Q9NWR6 Q9P028,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2;, PF04153;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0001226;GO:0003712;GO:0006977;GO:0031047;GO:0033147;GO:0000122;GO:0000289;GO:0010606;GO:2000036;GO:0006357;GO:0006417;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane;, F:RNA polymerase II transcription corepressor binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|Q9NZN8 Q9H3E0 Q9NSX5 Q9NWR6 Q9P028,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2;, PF04153;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0001226;GO:0003712;GO:0006977;GO:0031047;GO:0033147;GO:0000122;GO:0000289;GO:0010606;GO:2000036;GO:0006357;GO:0006417;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane;, F:RNA polymerase II transcription corepressor binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|Q9NZN8 Q9H3E0 Q9NSX5 Q9NWR6 Q9P028,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2;, PF04153;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0001226;GO:0003712;GO:0006977;GO:0031047;GO:0033147;GO:0000122;GO:0000289;GO:0010606;GO:2000036;GO:0006357;GO:0006417;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane;, F:RNA polymerase II transcription corepressor binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|Q9NZN8 Q9H3E0 Q9NSX5 Q9NWR6 Q9P028,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2;, PF04153;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0001226;GO:0003712;GO:0006977;GO:0031047;GO:0033147;GO:0000122;GO:0000289;GO:0010606;GO:2000036;GO:0006357;GO:0006417;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane;, F:RNA polymerase II transcription corepressor binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|Q9NZN8 Q9H3E0 Q9NSX5 Q9NWR6 Q9P028,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2;, PF04153;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0001226;GO:0003712;GO:0006977;GO:0031047;GO:0033147;GO:0000122;GO:0000289;GO:0010606;GO:2000036;GO:0006357;GO:0006417;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane;, F:RNA polymerase II transcription corepressor binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|Q9NZN8 Q9H3E0 Q9NSX5 Q9NWR6 Q9P028,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2;, PF04153;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0001226;GO:0003712;GO:0006977;GO:0031047;GO:0033147;GO:0000122;GO:0000289;GO:0010606;GO:2000036;GO:0006357;GO:0006417;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane;, F:RNA polymerase II transcription corepressor binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|Q9NZN8 Q9H3E0 Q9NSX5 Q9NWR6 Q9P028,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2;, PF04153;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0001226;GO:0003712;GO:0006977;GO:0031047;GO:0033147;GO:0000122;GO:0000289;GO:0010606;GO:2000036;GO:0006357;GO:0006417;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane;, F:RNA polymerase II transcription corepressor binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|Q9NZN8 Q9H3E0 Q9NSX5 Q9NWR6 Q9P028,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2;, PF04153;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0001226;GO:0003712;GO:0006977;GO:0031047;GO:0033147;GO:0000122;GO:0000289;GO:0010606;GO:2000036;GO:0006357;GO:0006417;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane;, F:RNA polymerase II transcription corepressor binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|Q9NZN8 Q9H3E0 Q9NSX5 Q9NWR6 Q9P028,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2;, PF04153;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0001226;GO:0003712;GO:0006977;GO:0031047;GO:0033147;GO:0000122;GO:0000289;GO:0010606;GO:2000036;GO:0006357;GO:0006417;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane;, F:RNA polymerase II transcription corepressor binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation;|Q9NZN8 Q9H3E0 Q9NSX5 Q9NWR6 Q9P028,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2;, PF04153;, GO:0030014;GO:0030015;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0001226;GO:0003712;GO:0006977;GO:0031047;GO:0033147;GO:0000122;GO:0000289;GO:0010606;GO:2000036;GO:0006357;GO:0006417;GO:0090503;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane;, F:RNA polymerase II transcription corepressor binding; F:transcription coregulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of translation; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:trophectodermal cell differentiation; scaffold31 indexed_genome mRNA 14578179 14612084 . - . ID=transcript_6751;Q9H673,Rab-3A-interacting protein,Rabin-3;SSX2-interacting protein;, PF06428;, GO:0005813;GO:0036064;GO:0005829;GO:0070319;GO:0030027;GO:0005815;GO:0005634;GO:0005085;GO:0042802;GO:0097711;GO:0060271;GO:0006887;GO:0006893;GO:0033365;GO:0006612;, C:centrosome; C:ciliary basal body; C:cytosol; C:Golgi to plasma membrane transport vesicle; C:lamellipodium; C:microtubule organizing center; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein localization to organelle; P:protein targeting to membrane;|Q9H673,Rab-3A-interacting protein,Rabin-3;SSX2-interacting protein;, PF06428;, GO:0005813;GO:0036064;GO:0005829;GO:0070319;GO:0030027;GO:0005815;GO:0005634;GO:0005085;GO:0042802;GO:0097711;GO:0060271;GO:0006887;GO:0006893;GO:0033365;GO:0006612;, C:centrosome; C:ciliary basal body; C:cytosol; C:Golgi to plasma membrane transport vesicle; C:lamellipodium; C:microtubule organizing center; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein localization to organelle; P:protein targeting to membrane;|Q9H673,Rab-3A-interacting protein,Rabin-3;SSX2-interacting protein;, PF06428;, GO:0005813;GO:0036064;GO:0005829;GO:0070319;GO:0030027;GO:0005815;GO:0005634;GO:0005085;GO:0042802;GO:0097711;GO:0060271;GO:0006887;GO:0006893;GO:0033365;GO:0006612;, C:centrosome; C:ciliary basal body; C:cytosol; C:Golgi to plasma membrane transport vesicle; C:lamellipodium; C:microtubule organizing center; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein localization to organelle; P:protein targeting to membrane;|Q9H673,Rab-3A-interacting protein,Rabin-3;SSX2-interacting protein;, PF06428;, GO:0005813;GO:0036064;GO:0005829;GO:0070319;GO:0030027;GO:0005815;GO:0005634;GO:0005085;GO:0042802;GO:0097711;GO:0060271;GO:0006887;GO:0006893;GO:0033365;GO:0006612;, C:centrosome; C:ciliary basal body; C:cytosol; C:Golgi to plasma membrane transport vesicle; C:lamellipodium; C:microtubule organizing center; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein localization to organelle; P:protein targeting to membrane;|Q9H673,Rab-3A-interacting protein,Rabin-3;SSX2-interacting protein;, PF06428;, GO:0005813;GO:0036064;GO:0005829;GO:0070319;GO:0030027;GO:0005815;GO:0005634;GO:0005085;GO:0042802;GO:0097711;GO:0060271;GO:0006887;GO:0006893;GO:0033365;GO:0006612;, C:centrosome; C:ciliary basal body; C:cytosol; C:Golgi to plasma membrane transport vesicle; C:lamellipodium; C:microtubule organizing center; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein localization to organelle; P:protein targeting to membrane;|Q9H673,Rab-3A-interacting protein,Rabin-3;SSX2-interacting protein;, PF06428;, GO:0005813;GO:0036064;GO:0005829;GO:0070319;GO:0030027;GO:0005815;GO:0005634;GO:0005085;GO:0042802;GO:0097711;GO:0060271;GO:0006887;GO:0006893;GO:0033365;GO:0006612;, C:centrosome; C:ciliary basal body; C:cytosol; C:Golgi to plasma membrane transport vesicle; C:lamellipodium; C:microtubule organizing center; C:nucleus;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein localization to organelle; P:protein targeting to membrane; scaffold31 indexed_genome mRNA 14720321 14720960 . + . ID=transcript_6752;Q8N1M1 B5MDI8 F8VVZ2 Q53YQ7 Q8N356 Q8NFT9 Q9BR80,Bestrophin-3,Vitelliform macular dystrophy 2-like protein 3;, PF01062;, GO:0034707;GO:0005886;GO:0005254;GO:0043271;, C:chloride channel complex; C:plasma membrane;, F:chloride channel activity;, P:negative regulation of ion transport; scaffold31 indexed_genome mRNA 14761346 14782762 . - . ID=transcript_6753;P78371 A8K402 B5BTY7 B7Z243 B7Z7K4 B7ZAT2 Q14D36 Q6IAT3,T-complex protein 1 subunit beta,CCT-beta;, PF00118;, GO:0035578;GO:0044297;GO:0005832;GO:0005829;GO:0070062;GO:0005576;GO:0005874;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0031625;GO:0051082;GO:0007339;GO:0051086;GO:0051131;GO:0043312;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:azurophil granule lumen; C:cell body; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:extracellular region; C:microtubule; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:chaperone mediated protein folding independent of cofactor; P:chaperone-mediated protein complex assembly; P:neutrophil degranulation; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport;|P78371 A8K402 B5BTY7 B7Z243 B7Z7K4 B7ZAT2 Q14D36 Q6IAT3,T-complex protein 1 subunit beta,CCT-beta;, PF00118;, GO:0035578;GO:0044297;GO:0005832;GO:0005829;GO:0070062;GO:0005576;GO:0005874;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0031625;GO:0051082;GO:0007339;GO:0051086;GO:0051131;GO:0043312;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:azurophil granule lumen; C:cell body; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:extracellular region; C:microtubule; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:chaperone mediated protein folding independent of cofactor; P:chaperone-mediated protein complex assembly; P:neutrophil degranulation; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport;|P78371 A8K402 B5BTY7 B7Z243 B7Z7K4 B7ZAT2 Q14D36 Q6IAT3,T-complex protein 1 subunit beta,CCT-beta;, PF00118;, GO:0035578;GO:0044297;GO:0005832;GO:0005829;GO:0070062;GO:0005576;GO:0005874;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0031625;GO:0051082;GO:0007339;GO:0051086;GO:0051131;GO:0043312;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:azurophil granule lumen; C:cell body; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:extracellular region; C:microtubule; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:chaperone mediated protein folding independent of cofactor; P:chaperone-mediated protein complex assembly; P:neutrophil degranulation; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport;|P78371 A8K402 B5BTY7 B7Z243 B7Z7K4 B7ZAT2 Q14D36 Q6IAT3,T-complex protein 1 subunit beta,CCT-beta;, PF00118;, GO:0035578;GO:0044297;GO:0005832;GO:0005829;GO:0070062;GO:0005576;GO:0005874;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0031625;GO:0051082;GO:0007339;GO:0051086;GO:0051131;GO:0043312;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:azurophil granule lumen; C:cell body; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:extracellular region; C:microtubule; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:chaperone mediated protein folding independent of cofactor; P:chaperone-mediated protein complex assembly; P:neutrophil degranulation; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport;|P78371 A8K402 B5BTY7 B7Z243 B7Z7K4 B7ZAT2 Q14D36 Q6IAT3,T-complex protein 1 subunit beta,CCT-beta;, PF00118;, GO:0035578;GO:0044297;GO:0005832;GO:0005829;GO:0070062;GO:0005576;GO:0005874;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0031625;GO:0051082;GO:0007339;GO:0051086;GO:0051131;GO:0043312;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:0090666;GO:1901998;, C:azurophil granule lumen; C:cell body; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:extracellular region; C:microtubule; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:chaperone mediated protein folding independent of cofactor; P:chaperone-mediated protein complex assembly; P:neutrophil degranulation; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:scaRNA localization to Cajal body; P:toxin transport; scaffold31 indexed_genome mRNA 14791861 14893162 . - . ID=transcript_6754;Q8WU20 B0LPF2 B2R684 O43558 Q7LDQ6,Fibroblast growth factor receptor substrate 2,FGFR-signaling adaptor SNT;Suc1-associated neurotrophic factor target 1;, PF02174;, GO:0005912;GO:0005829;GO:0012505;GO:0005887;GO:0016020;GO:0005886;GO:0005104;GO:0005168;GO:0019211;GO:0005068;GO:0000187;GO:0000186;GO:0008595;GO:0007411;GO:0008543;GO:0030900;GO:0007186;GO:0001702;GO:0070307;GO:0000165;GO:2000726;GO:0007405;GO:0048011;GO:0046619;GO:0001759;GO:0051897;GO:0060527;GO:0042981;GO:0050678;GO:0070372;GO:0007185;GO:0003281;, C:adherens junction; C:cytosol; C:endomembrane system; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:fibroblast growth factor receptor binding; F:neurotrophin TRKA receptor binding; F:phosphatase activator activity; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:activation of MAPK activity; P:activation of MAPKK activity; P:anterior/posterior axis specification, embryo; P:axon guidance; P:fibroblast growth factor receptor signaling pathway; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:gastrulation with mouth forming second; P:lens fiber cell development; P:MAPK cascade; P:negative regulation of cardiac muscle cell differentiation; P:neuroblast proliferation; P:neurotrophin TRK receptor signaling pathway; P:optic placode formation involved in camera-type eye formation; P:organ induction; P:positive regulation of protein kinase B signaling; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; P:regulation of apoptotic process; P:regulation of epithelial cell proliferation; P:regulation of ERK1 and ERK2 cascade; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; P:ventricular septum development; scaffold31 indexed_genome mRNA 14974094 14976731 . - . ID=transcript_6755;O95619 Q9NQD0,YEATS domain-containing protein 4 {ECO:0000305},Glioma-amplified sequence 41 {ECO:0000303|PubMed:9302258};NuMA-binding protein 1;, PF03366;, GO:0035267;GO:0016363;GO:0031965;GO:0005654;GO:0005634;GO:0070577;GO:0140030;GO:0008022;GO:0005200;GO:0043968;GO:0043967;GO:0000278;GO:0045944;GO:0045893;GO:0040008;, C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:modification-dependent protein binding; F:protein C-terminus binding; F:structural constituent of cytoskeleton;, P:histone H2A acetylation; P:histone H4 acetylation; P:mitotic cell cycle; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of growth; scaffold31 indexed_genome mRNA 14982877 14993727 . - . ID=transcript_6756;O95619 Q9NQD0,YEATS domain-containing protein 4 {ECO:0000305},Glioma-amplified sequence 41 {ECO:0000303|PubMed:9302258};NuMA-binding protein 1;, PF03366;, GO:0035267;GO:0016363;GO:0031965;GO:0005654;GO:0005634;GO:0070577;GO:0140030;GO:0008022;GO:0005200;GO:0043968;GO:0043967;GO:0000278;GO:0045944;GO:0045893;GO:0040008;, C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:modification-dependent protein binding; F:protein C-terminus binding; F:structural constituent of cytoskeleton;, P:histone H2A acetylation; P:histone H4 acetylation; P:mitotic cell cycle; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of growth; scaffold31 indexed_genome mRNA 15043370 15048656 . + . ID=transcript_6757;P61626 P00695 Q13170 Q9UCF8,Lysozyme C,1,4-beta-N-acetylmuramidase C;, PF00062;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:0035580;GO:1904724;GO:0042802;GO:0003796;GO:1990000;GO:0019730;GO:0019835;GO:0042742;GO:0050829;GO:0050830;GO:0006954;GO:0031640;GO:0043312;GO:0001895;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:specific granule lumen; C:tertiary granule lumen;, F:identical protein binding; F:lysozyme activity;, P:amyloid fibril formation; P:antimicrobial humoral response; P:cytolysis; P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:inflammatory response; P:killing of cells of other organism; P:neutrophil degranulation; P:retina homeostasis; scaffold31 indexed_genome mRNA 15226625 15232867 . - . ID=transcript_6758;P61626 P00695 Q13170 Q9UCF8,Lysozyme C,1,4-beta-N-acetylmuramidase C;, PF00062;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:0035580;GO:1904724;GO:0042802;GO:0003796;GO:1990000;GO:0019730;GO:0019835;GO:0042742;GO:0050829;GO:0050830;GO:0006954;GO:0031640;GO:0043312;GO:0001895;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:specific granule lumen; C:tertiary granule lumen;, F:identical protein binding; F:lysozyme activity;, P:amyloid fibril formation; P:antimicrobial humoral response; P:cytolysis; P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:inflammatory response; P:killing of cells of other organism; P:neutrophil degranulation; P:retina homeostasis; scaffold31 indexed_genome mRNA 15277717 15291201 . - . ID=transcript_6759;Q16630 A8K7K9 Q53ES1 Q9BSJ7 Q9BW18,Cleavage and polyadenylation specificity factor subunit 6 {ECO:0000305},Cleavage and polyadenylation specificity factor 68 kDa subunit;Cleavage factor Im complex 68 kDa subunit {ECO:0000303|PubMed:9659921};Pre-mRNA cleavage factor Im 68 kDa subunit;Protein HPBRII-4/7;, PF00076;, GO:0005737;GO:0035061;GO:0016020;GO:0005847;GO:0005849;GO:0016607;GO:0005654;GO:0005634;GO:0042382;GO:0005726;GO:1990904;GO:1990448;GO:0003729;GO:0043023;GO:0003723;GO:1990120;GO:0110104;GO:0006397;GO:0046833;GO:0098789;GO:0051290;GO:0051262;, C:cytoplasm; C:interchromatin granule; C:membrane; C:mRNA cleavage and polyadenylation specificity factor complex; C:mRNA cleavage factor complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:paraspeckles; C:perichromatin fibrils; C:ribonucleoprotein complex;, F:exon-exon junction complex binding; F:mRNA binding; F:ribosomal large subunit binding; F:RNA binding;, P:messenger ribonucleoprotein complex assembly; P:mRNA alternative polyadenylation; P:mRNA processing; P:positive regulation of RNA export from nucleus; P:pre-mRNA cleavage required for polyadenylation; P:protein heterotetramerization; P:protein tetramerization;|Q16630 A8K7K9 Q53ES1 Q9BSJ7 Q9BW18,Cleavage and polyadenylation specificity factor subunit 6 {ECO:0000305},Cleavage and polyadenylation specificity factor 68 kDa subunit;Cleavage factor Im complex 68 kDa subunit {ECO:0000303|PubMed:9659921};Pre-mRNA cleavage factor Im 68 kDa subunit;Protein HPBRII-4/7;, PF00076;, GO:0005737;GO:0035061;GO:0016020;GO:0005847;GO:0005849;GO:0016607;GO:0005654;GO:0005634;GO:0042382;GO:0005726;GO:1990904;GO:1990448;GO:0003729;GO:0043023;GO:0003723;GO:1990120;GO:0110104;GO:0006397;GO:0046833;GO:0098789;GO:0051290;GO:0051262;, C:cytoplasm; C:interchromatin granule; C:membrane; C:mRNA cleavage and polyadenylation specificity factor complex; C:mRNA cleavage factor complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:paraspeckles; C:perichromatin fibrils; C:ribonucleoprotein complex;, F:exon-exon junction complex binding; F:mRNA binding; F:ribosomal large subunit binding; F:RNA binding;, P:messenger ribonucleoprotein complex assembly; P:mRNA alternative polyadenylation; P:mRNA processing; P:positive regulation of RNA export from nucleus; P:pre-mRNA cleavage required for polyadenylation; P:protein heterotetramerization; P:protein tetramerization; scaffold31 indexed_genome mRNA 15595399 15669190 . + . ID=transcript_6760;P14384 B2R800 Q9H2K9,Carboxypeptidase M,, PF00246;, GO:0031225;GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004180;GO:0004181;GO:0008270;GO:0009653;GO:0006518;GO:0016485;, C:anchored component of membrane; C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:carboxypeptidase activity; F:metallocarboxypeptidase activity; F:zinc ion binding;, P:anatomical structure morphogenesis; P:peptide metabolic process; P:protein processing;|P14384 B2R800 Q9H2K9,Carboxypeptidase M,, PF00246;, GO:0031225;GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004180;GO:0004181;GO:0008270;GO:0009653;GO:0006518;GO:0016485;, C:anchored component of membrane; C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:carboxypeptidase activity; F:metallocarboxypeptidase activity; F:zinc ion binding;, P:anatomical structure morphogenesis; P:peptide metabolic process; P:protein processing;|P14384 B2R800 Q9H2K9,Carboxypeptidase M,, PF00246;, GO:0031225;GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004180;GO:0004181;GO:0008270;GO:0009653;GO:0006518;GO:0016485;, C:anchored component of membrane; C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:carboxypeptidase activity; F:metallocarboxypeptidase activity; F:zinc ion binding;, P:anatomical structure morphogenesis; P:peptide metabolic process; P:protein processing;|P14384 B2R800 Q9H2K9,Carboxypeptidase M,, PF00246;, GO:0031225;GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004180;GO:0004181;GO:0008270;GO:0009653;GO:0006518;GO:0016485;, C:anchored component of membrane; C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:carboxypeptidase activity; F:metallocarboxypeptidase activity; F:zinc ion binding;, P:anatomical structure morphogenesis; P:peptide metabolic process; P:protein processing;|P14384 B2R800 Q9H2K9,Carboxypeptidase M,, PF00246;, GO:0031225;GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004180;GO:0004181;GO:0008270;GO:0009653;GO:0006518;GO:0016485;, C:anchored component of membrane; C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:carboxypeptidase activity; F:metallocarboxypeptidase activity; F:zinc ion binding;, P:anatomical structure morphogenesis; P:peptide metabolic process; P:protein processing; scaffold31 indexed_genome mRNA 15687179 15709814 . - . ID=transcript_6761;Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8,E3 ubiquitin-protein ligase Mdm2,Double minute 2 protein;Oncoprotein Mdm2;RING-type E3 ubiquitin transferase Mdm2 {ECO:0000305};p53-binding protein Mdm2;, PF02201;PF00641;, GO:0005737;GO:0005829;GO:0030666;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0008097;GO:0097718;GO:0019899;GO:0042802;GO:0016874;GO:0061663;GO:0002039;GO:0019904;GO:0047485;GO:0043021;GO:0019789;GO:0043130;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:1990000;GO:0006915;GO:0072717;GO:0071480;GO:0071456;GO:0006977;GO:0045184;GO:0071157;GO:0043518;GO:1902254;GO:1901797;GO:0000122;GO:0045892;GO:0008284;GO:0045931;GO:0032436;GO:0045944;GO:0043161;GO:0051865;GO:0031648;GO:0016579;GO:0034504;GO:0000209;GO:0016567;GO:0065003;GO:0051603;GO:0042176;GO:1901796;GO:0006357;GO:0046677;GO:0036369;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:5S rRNA binding; F:disordered domain specific binding; F:enzyme binding; F:identical protein binding; F:ligase activity; F:NEDD8 ligase activity; F:p53 binding; F:protein domain specific binding; F:protein N-terminus binding; F:ribonucleoprotein complex binding; F:SUMO transferase activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:amyloid fibril formation; P:apoptotic process; P:cellular response to actinomycin D; P:cellular response to gamma radiation; P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:establishment of protein localization; P:negative regulation of cell cycle arrest; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of mitotic cell cycle; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein destabilization; P:protein deubiquitination; P:protein localization to nucleus; P:protein polyubiquitination; P:protein ubiquitination; P:protein-containing complex assembly; P:proteolysis involved in cellular protein catabolic process; P:regulation of protein catabolic process; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:response to antibiotic; P:transcription factor catabolic process; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8,E3 ubiquitin-protein ligase Mdm2,Double minute 2 protein;Oncoprotein Mdm2;RING-type E3 ubiquitin transferase Mdm2 {ECO:0000305};p53-binding protein Mdm2;, PF02201;PF00641;, GO:0005737;GO:0005829;GO:0030666;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0008097;GO:0097718;GO:0019899;GO:0042802;GO:0016874;GO:0061663;GO:0002039;GO:0019904;GO:0047485;GO:0043021;GO:0019789;GO:0043130;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:1990000;GO:0006915;GO:0072717;GO:0071480;GO:0071456;GO:0006977;GO:0045184;GO:0071157;GO:0043518;GO:1902254;GO:1901797;GO:0000122;GO:0045892;GO:0008284;GO:0045931;GO:0032436;GO:0045944;GO:0043161;GO:0051865;GO:0031648;GO:0016579;GO:0034504;GO:0000209;GO:0016567;GO:0065003;GO:0051603;GO:0042176;GO:1901796;GO:0006357;GO:0046677;GO:0036369;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:5S rRNA binding; F:disordered domain specific binding; F:enzyme binding; F:identical protein binding; F:ligase activity; F:NEDD8 ligase activity; F:p53 binding; F:protein domain specific binding; F:protein N-terminus binding; F:ribonucleoprotein complex binding; F:SUMO transferase activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:amyloid fibril formation; P:apoptotic process; P:cellular response to actinomycin D; P:cellular response to gamma radiation; P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:establishment of protein localization; P:negative regulation of cell cycle arrest; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of mitotic cell cycle; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein destabilization; P:protein deubiquitination; P:protein localization to nucleus; P:protein polyubiquitination; P:protein ubiquitination; P:protein-containing complex assembly; P:proteolysis involved in cellular protein catabolic process; P:regulation of protein catabolic process; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:response to antibiotic; P:transcription factor catabolic process; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8,E3 ubiquitin-protein ligase Mdm2,Double minute 2 protein;Oncoprotein Mdm2;RING-type E3 ubiquitin transferase Mdm2 {ECO:0000305};p53-binding protein Mdm2;, PF02201;PF00641;, GO:0005737;GO:0005829;GO:0030666;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0008097;GO:0097718;GO:0019899;GO:0042802;GO:0016874;GO:0061663;GO:0002039;GO:0019904;GO:0047485;GO:0043021;GO:0019789;GO:0043130;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:1990000;GO:0006915;GO:0072717;GO:0071480;GO:0071456;GO:0006977;GO:0045184;GO:0071157;GO:0043518;GO:1902254;GO:1901797;GO:0000122;GO:0045892;GO:0008284;GO:0045931;GO:0032436;GO:0045944;GO:0043161;GO:0051865;GO:0031648;GO:0016579;GO:0034504;GO:0000209;GO:0016567;GO:0065003;GO:0051603;GO:0042176;GO:1901796;GO:0006357;GO:0046677;GO:0036369;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:5S rRNA binding; F:disordered domain specific binding; F:enzyme binding; F:identical protein binding; F:ligase activity; F:NEDD8 ligase activity; F:p53 binding; F:protein domain specific binding; F:protein N-terminus binding; F:ribonucleoprotein complex binding; F:SUMO transferase activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:amyloid fibril formation; P:apoptotic process; P:cellular response to actinomycin D; P:cellular response to gamma radiation; P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:establishment of protein localization; P:negative regulation of cell cycle arrest; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of mitotic cell cycle; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein destabilization; P:protein deubiquitination; P:protein localization to nucleus; P:protein polyubiquitination; P:protein ubiquitination; P:protein-containing complex assembly; P:proteolysis involved in cellular protein catabolic process; P:regulation of protein catabolic process; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:response to antibiotic; P:transcription factor catabolic process; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8,E3 ubiquitin-protein ligase Mdm2,Double minute 2 protein;Oncoprotein Mdm2;RING-type E3 ubiquitin transferase Mdm2 {ECO:0000305};p53-binding protein Mdm2;, PF02201;PF00641;, GO:0005737;GO:0005829;GO:0030666;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0008097;GO:0097718;GO:0019899;GO:0042802;GO:0016874;GO:0061663;GO:0002039;GO:0019904;GO:0047485;GO:0043021;GO:0019789;GO:0043130;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:1990000;GO:0006915;GO:0072717;GO:0071480;GO:0071456;GO:0006977;GO:0045184;GO:0071157;GO:0043518;GO:1902254;GO:1901797;GO:0000122;GO:0045892;GO:0008284;GO:0045931;GO:0032436;GO:0045944;GO:0043161;GO:0051865;GO:0031648;GO:0016579;GO:0034504;GO:0000209;GO:0016567;GO:0065003;GO:0051603;GO:0042176;GO:1901796;GO:0006357;GO:0046677;GO:0036369;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:5S rRNA binding; F:disordered domain specific binding; F:enzyme binding; F:identical protein binding; F:ligase activity; F:NEDD8 ligase activity; F:p53 binding; F:protein domain specific binding; F:protein N-terminus binding; F:ribonucleoprotein complex binding; F:SUMO transferase activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:amyloid fibril formation; P:apoptotic process; P:cellular response to actinomycin D; P:cellular response to gamma radiation; P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:establishment of protein localization; P:negative regulation of cell cycle arrest; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of mitotic cell cycle; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein destabilization; P:protein deubiquitination; P:protein localization to nucleus; P:protein polyubiquitination; P:protein ubiquitination; P:protein-containing complex assembly; P:proteolysis involved in cellular protein catabolic process; P:regulation of protein catabolic process; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:response to antibiotic; P:transcription factor catabolic process; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8,E3 ubiquitin-protein ligase Mdm2,Double minute 2 protein;Oncoprotein Mdm2;RING-type E3 ubiquitin transferase Mdm2 {ECO:0000305};p53-binding protein Mdm2;, PF02201;PF00641;, GO:0005737;GO:0005829;GO:0030666;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0008097;GO:0097718;GO:0019899;GO:0042802;GO:0016874;GO:0061663;GO:0002039;GO:0019904;GO:0047485;GO:0043021;GO:0019789;GO:0043130;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:1990000;GO:0006915;GO:0072717;GO:0071480;GO:0071456;GO:0006977;GO:0045184;GO:0071157;GO:0043518;GO:1902254;GO:1901797;GO:0000122;GO:0045892;GO:0008284;GO:0045931;GO:0032436;GO:0045944;GO:0043161;GO:0051865;GO:0031648;GO:0016579;GO:0034504;GO:0000209;GO:0016567;GO:0065003;GO:0051603;GO:0042176;GO:1901796;GO:0006357;GO:0046677;GO:0036369;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:5S rRNA binding; F:disordered domain specific binding; F:enzyme binding; F:identical protein binding; F:ligase activity; F:NEDD8 ligase activity; F:p53 binding; F:protein domain specific binding; F:protein N-terminus binding; F:ribonucleoprotein complex binding; F:SUMO transferase activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:amyloid fibril formation; P:apoptotic process; P:cellular response to actinomycin D; P:cellular response to gamma radiation; P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:establishment of protein localization; P:negative regulation of cell cycle arrest; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of mitotic cell cycle; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein destabilization; P:protein deubiquitination; P:protein localization to nucleus; P:protein polyubiquitination; P:protein ubiquitination; P:protein-containing complex assembly; P:proteolysis involved in cellular protein catabolic process; P:regulation of protein catabolic process; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:response to antibiotic; P:transcription factor catabolic process; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8,E3 ubiquitin-protein ligase Mdm2,Double minute 2 protein;Oncoprotein Mdm2;RING-type E3 ubiquitin transferase Mdm2 {ECO:0000305};p53-binding protein Mdm2;, PF02201;PF00641;, GO:0005737;GO:0005829;GO:0030666;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0008097;GO:0097718;GO:0019899;GO:0042802;GO:0016874;GO:0061663;GO:0002039;GO:0019904;GO:0047485;GO:0043021;GO:0019789;GO:0043130;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:1990000;GO:0006915;GO:0072717;GO:0071480;GO:0071456;GO:0006977;GO:0045184;GO:0071157;GO:0043518;GO:1902254;GO:1901797;GO:0000122;GO:0045892;GO:0008284;GO:0045931;GO:0032436;GO:0045944;GO:0043161;GO:0051865;GO:0031648;GO:0016579;GO:0034504;GO:0000209;GO:0016567;GO:0065003;GO:0051603;GO:0042176;GO:1901796;GO:0006357;GO:0046677;GO:0036369;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:5S rRNA binding; F:disordered domain specific binding; F:enzyme binding; F:identical protein binding; F:ligase activity; F:NEDD8 ligase activity; F:p53 binding; F:protein domain specific binding; F:protein N-terminus binding; F:ribonucleoprotein complex binding; F:SUMO transferase activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:amyloid fibril formation; P:apoptotic process; P:cellular response to actinomycin D; P:cellular response to gamma radiation; P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:establishment of protein localization; P:negative regulation of cell cycle arrest; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of mitotic cell cycle; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein destabilization; P:protein deubiquitination; P:protein localization to nucleus; P:protein polyubiquitination; P:protein ubiquitination; P:protein-containing complex assembly; P:proteolysis involved in cellular protein catabolic process; P:regulation of protein catabolic process; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:response to antibiotic; P:transcription factor catabolic process; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold31 indexed_genome mRNA 15746861 15764138 . - . ID=transcript_6762;Q7Z769 A8K0T0 Q0P5Y5 Q9P0V1,Solute carrier family 35 member E3,Bladder cancer-overexpressed gene 1 protein;, PF03151;, GO:0005794;GO:0016021;GO:0015297;GO:0005338;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity; F:nucleotide-sugar transmembrane transporter activity;|Q7Z769 A8K0T0 Q0P5Y5 Q9P0V1,Solute carrier family 35 member E3,Bladder cancer-overexpressed gene 1 protein;, PF03151;, GO:0005794;GO:0016021;GO:0015297;GO:0005338;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity; F:nucleotide-sugar transmembrane transporter activity;|Q7Z769 A8K0T0 Q0P5Y5 Q9P0V1,Solute carrier family 35 member E3,Bladder cancer-overexpressed gene 1 protein;, PF03151;, GO:0005794;GO:0016021;GO:0015297;GO:0005338;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity; F:nucleotide-sugar transmembrane transporter activity; scaffold31 indexed_genome mRNA 15769168 15819289 . - . ID=transcript_6763;P57740 B4DZ67 Q6PJE1,Nuclear pore complex protein Nup107,107 kDa nucleoporin;Nucleoporin Nup107;, PF04121;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0031080;GO:0017056;GO:0008585;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0051292;GO:0000973;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006355;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:female gonad development; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:nuclear pore complex assembly; P:posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of transcription, DNA-templated; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P57740 B4DZ67 Q6PJE1,Nuclear pore complex protein Nup107,107 kDa nucleoporin;Nucleoporin Nup107;, PF04121;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0031080;GO:0017056;GO:0008585;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0051292;GO:0000973;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006355;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:female gonad development; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:nuclear pore complex assembly; P:posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of transcription, DNA-templated; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P57740 B4DZ67 Q6PJE1,Nuclear pore complex protein Nup107,107 kDa nucleoporin;Nucleoporin Nup107;, PF04121;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0031080;GO:0017056;GO:0008585;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0051292;GO:0000973;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006355;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:female gonad development; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:nuclear pore complex assembly; P:posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of transcription, DNA-templated; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P57740 B4DZ67 Q6PJE1,Nuclear pore complex protein Nup107,107 kDa nucleoporin;Nucleoporin Nup107;, PF04121;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0034399;GO:0005643;GO:0031080;GO:0017056;GO:0008585;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0051292;GO:0000973;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006355;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:female gonad development; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:nuclear pore complex assembly; P:posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of transcription, DNA-templated; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold31 indexed_genome mRNA 15854372 15860943 . - . ID=transcript_6764;A6NIZ1,Ras-related protein Rap-1b-like protein,, PF00071;, GO:0005829;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0071320;GO:2000301;GO:0032486;, C:cytosol; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:cellular response to cAMP; P:negative regulation of synaptic vesicle exocytosis; P:Rap protein signal transduction;|A6NIZ1,Ras-related protein Rap-1b-like protein,, PF00071;, GO:0005829;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0071320;GO:2000301;GO:0032486;, C:cytosol; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:cellular response to cAMP; P:negative regulation of synaptic vesicle exocytosis; P:Rap protein signal transduction;|Q6LES0,Ras-related protein Rap-1b,GTP-binding protein smg p21B;, PF00071;, GO:0035577;GO:0005911;GO:0005829;GO:0070062;GO:0005811;GO:0016020;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0044877;GO:0002250;GO:0008283;GO:0071320;GO:0035690;GO:0097211;GO:0061028;GO:0035722;GO:0045955;GO:2000301;GO:0043312;GO:0070374;GO:0033625;GO:0032486;GO:1901888;GO:2000114;GO:0009743;, C:azurophil granule membrane; C:cell-cell junction; C:cytosol; C:extracellular exosome; C:lipid droplet; C:membrane; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:protein-containing complex binding;, P:adaptive immune response; P:cell population proliferation; P:cellular response to cAMP; P:cellular response to drug; P:cellular response to gonadotropin-releasing hormone; P:establishment of endothelial barrier; P:interleukin-12-mediated signaling pathway; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of synaptic vesicle exocytosis; P:neutrophil degranulation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of integrin activation; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of establishment of cell polarity; P:response to carbohydrate;|A6NIZ1,Ras-related protein Rap-1b-like protein,, PF00071;, GO:0005829;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0071320;GO:2000301;GO:0032486;, C:cytosol; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:cellular response to cAMP; P:negative regulation of synaptic vesicle exocytosis; P:Rap protein signal transduction; scaffold31 indexed_genome mRNA 16138796 16166538 . + . ID=transcript_6765;Q8TC05 B4DM65 E7EPQ3 O43406 Q8WTV9 Q9NR04,Nuclear protein MDM1,, PF15501;, GO:0005814;GO:0005813;GO:0005829;GO:0005874;GO:0005634;GO:0008017;GO:0046600;GO:0045494;GO:0060041;, C:centriole; C:centrosome; C:cytosol; C:microtubule; C:nucleus;, F:microtubule binding;, P:negative regulation of centriole replication; P:photoreceptor cell maintenance; P:retina development in camera-type eye;|Q8TC05 B4DM65 E7EPQ3 O43406 Q8WTV9 Q9NR04,Nuclear protein MDM1,, PF15501;, GO:0005814;GO:0005813;GO:0005829;GO:0005874;GO:0005634;GO:0008017;GO:0046600;GO:0045494;GO:0060041;, C:centriole; C:centrosome; C:cytosol; C:microtubule; C:nucleus;, F:microtubule binding;, P:negative regulation of centriole replication; P:photoreceptor cell maintenance; P:retina development in camera-type eye;|Q8TC05 B4DM65 E7EPQ3 O43406 Q8WTV9 Q9NR04,Nuclear protein MDM1,, PF15501;, GO:0005814;GO:0005813;GO:0005829;GO:0005874;GO:0005634;GO:0008017;GO:0046600;GO:0045494;GO:0060041;, C:centriole; C:centrosome; C:cytosol; C:microtubule; C:nucleus;, F:microtubule binding;, P:negative regulation of centriole replication; P:photoreceptor cell maintenance; P:retina development in camera-type eye; scaffold31 indexed_genome mRNA 16230257 16244710 . + . ID=transcript_6766;Q9NPH9,Interleukin-26,Protein AK155;, PF00726;, GO:0005829;GO:0005576;GO:0005615;GO:0005125;GO:0007267;GO:0019221;GO:0050680;GO:0001819;GO:0070374;GO:0051897;GO:0046427;GO:0032874;GO:0045944;, C:cytosol; C:extracellular region; C:extracellular space;, F:cytokine activity;, P:cell-cell signaling; P:cytokine-mediated signaling pathway; P:negative regulation of epithelial cell proliferation; P:positive regulation of cytokine production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of stress-activated MAPK cascade; P:positive regulation of transcription by RNA polymerase II; scaffold31 indexed_genome mRNA 16754524 16770135 . - . ID=transcript_6767;Q92630 B2R9V9 Q9BRB5,Dual specificity tyrosine-phosphorylation-regulated kinase 2,, PF00069;, GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0000151;GO:0005524;GO:0000287;GO:0030145;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004713;GO:0004714;GO:0006974;GO:0042771;GO:0070885;GO:0018105;GO:0018107;GO:0045725;GO:0006468;GO:1901796;GO:0007224;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ubiquitin ligase complex;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cellular response to DNA damage stimulus; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of calcineurin-NFAT signaling cascade; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of glycogen biosynthetic process; P:protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:smoothened signaling pathway; scaffold31 indexed_genome mRNA 17105761 17144394 . - . ID=transcript_6768;Q9P0H7 Q9UF85,Cullin-associated NEDD8-dissociated protein 1,Cullin-associated and neddylation-dissociated protein 1;TBP-interacting protein of 120 kDa A;p120 CAND1;, PF08623;, GO:0031461;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005794;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0000151;GO:0017025;GO:0030154;GO:0006879;GO:0043086;GO:0043312;GO:0045899;GO:0043687;GO:0016567;GO:0010265;, C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:ubiquitin ligase complex;, F:TBP-class protein binding;, P:cell differentiation; P:cellular iron ion homeostasis; P:negative regulation of catalytic activity; P:neutrophil degranulation; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:protein ubiquitination; P:SCF complex assembly; scaffold31 indexed_genome mRNA 17881884 17945146 . + . ID=transcript_6769;Q9Y3R0 C9JT59 Q1RLM0,Glutamate receptor-interacting protein 1,, PF00595;PF17820;, GO:0031410;GO:0005829;GO:0030425;GO:0005789;GO:0098978;GO:0045121;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0008013;GO:0035259;GO:0008022;GO:0030159;GO:0016358;GO:0035556;GO:0098887;GO:0150012;GO:0099003;, C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:membrane raft; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:beta-catenin binding; F:glucocorticoid receptor binding; F:protein C-terminus binding; F:signaling receptor complex adaptor activity;, P:dendrite development; P:intracellular signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:positive regulation of neuron projection arborization; P:vesicle-mediated transport in synapse; scaffold31 indexed_genome mRNA 17976549 18046737 . + . ID=transcript_6770;Q9Y3R0 C9JT59 Q1RLM0,Glutamate receptor-interacting protein 1,, PF00595;PF17820;, GO:0031410;GO:0005829;GO:0030425;GO:0005789;GO:0098978;GO:0045121;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0008013;GO:0035259;GO:0008022;GO:0030159;GO:0016358;GO:0035556;GO:0098887;GO:0150012;GO:0099003;, C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:membrane raft; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:beta-catenin binding; F:glucocorticoid receptor binding; F:protein C-terminus binding; F:signaling receptor complex adaptor activity;, P:dendrite development; P:intracellular signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:positive regulation of neuron projection arborization; P:vesicle-mediated transport in synapse;|Q9Y3R0 C9JT59 Q1RLM0,Glutamate receptor-interacting protein 1,, PF00595;PF17820;, GO:0031410;GO:0005829;GO:0030425;GO:0005789;GO:0098978;GO:0045121;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0008013;GO:0035259;GO:0008022;GO:0030159;GO:0016358;GO:0035556;GO:0098887;GO:0150012;GO:0099003;, C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:membrane raft; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:beta-catenin binding; F:glucocorticoid receptor binding; F:protein C-terminus binding; F:signaling receptor complex adaptor activity;, P:dendrite development; P:intracellular signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:positive regulation of neuron projection arborization; P:vesicle-mediated transport in synapse; scaffold31 indexed_genome mRNA 18052079 18085451 . - . ID=transcript_6771;Q8NG08 A8K4C9 Q4G0T2 Q9H7L5,DNA helicase B {ECO:0000305},, PF13538;, GO:0005737;GO:0005730;GO:0005634;GO:0035861;GO:0043139;GO:0005524;GO:0044877;GO:0003723;GO:0017116;GO:0006974;GO:0006281;GO:0006260;GO:0006269;GO:0000462;GO:2000042;GO:1903775;, C:cytoplasm; C:nucleolus; C:nucleus; C:site of double-strand break;, F:5'-3' DNA helicase activity; F:ATP binding; F:protein-containing complex binding; F:RNA binding; F:single-stranded DNA helicase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:DNA replication; P:DNA replication, synthesis of RNA primer; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:negative regulation of double-strand break repair via homologous recombination; P:regulation of DNA double-strand break processing; scaffold31 indexed_genome mRNA 18139667 18200863 . - . ID=transcript_6772;Q9Y616 B4DQ57,Interleukin-1 receptor-associated kinase 3,IL-1 receptor-associated kinase M;, PF00531;PF00069;, GO:0005737;GO:0005634;GO:0005886;GO:0005524;GO:0000287;GO:0046982;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0019221;GO:0070498;GO:0035556;GO:0002755;GO:0001960;GO:0045824;GO:0032695;GO:0032715;GO:0010936;GO:0043407;GO:0032088;GO:0042177;GO:0043242;GO:0034122;GO:0032720;GO:0010933;GO:0051092;GO:0046777;GO:0006468;GO:0043244;GO:0043330;GO:0070555;GO:0032496;GO:0032494;GO:0009615;, C:cytoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytokine-mediated signaling pathway; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of innate immune response; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-6 production; P:negative regulation of macrophage cytokine production; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein catabolic process; P:negative regulation of protein-containing complex disassembly; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:positive regulation of macrophage tolerance induction; P:positive regulation of NF-kappaB transcription factor activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of protein-containing complex disassembly; P:response to exogenous dsRNA; P:response to interleukin-1; P:response to lipopolysaccharide; P:response to peptidoglycan; P:response to virus;|Q9Y616 B4DQ57,Interleukin-1 receptor-associated kinase 3,IL-1 receptor-associated kinase M;, PF00531;PF00069;, GO:0005737;GO:0005634;GO:0005886;GO:0005524;GO:0000287;GO:0046982;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0019221;GO:0070498;GO:0035556;GO:0002755;GO:0001960;GO:0045824;GO:0032695;GO:0032715;GO:0010936;GO:0043407;GO:0032088;GO:0042177;GO:0043242;GO:0034122;GO:0032720;GO:0010933;GO:0051092;GO:0046777;GO:0006468;GO:0043244;GO:0043330;GO:0070555;GO:0032496;GO:0032494;GO:0009615;, C:cytoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytokine-mediated signaling pathway; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of innate immune response; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-6 production; P:negative regulation of macrophage cytokine production; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein catabolic process; P:negative regulation of protein-containing complex disassembly; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:positive regulation of macrophage tolerance induction; P:positive regulation of NF-kappaB transcription factor activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of protein-containing complex disassembly; P:response to exogenous dsRNA; P:response to interleukin-1; P:response to lipopolysaccharide; P:response to peptidoglycan; P:response to virus; scaffold31 indexed_genome mRNA 18213574 18240105 . + . ID=transcript_6773;Q9HC24 Q542Z6 Q9UHY5 Q9Y3C2,Protein lifeguard 4,Golgi anti-apoptotic protein;Protein S1R;Transmembrane BAX inhibitor motif-containing protein 4;Z-protein;, PF01027;, GO:0000139;GO:0005795;GO:0016021;GO:0006915;GO:0043066;GO:0050848;, C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, , P:apoptotic process; P:negative regulation of apoptotic process; P:regulation of calcium-mediated signaling;|Q9HC24 Q542Z6 Q9UHY5 Q9Y3C2,Protein lifeguard 4,Golgi anti-apoptotic protein;Protein S1R;Transmembrane BAX inhibitor motif-containing protein 4;Z-protein;, PF01027;, GO:0000139;GO:0005795;GO:0016021;GO:0006915;GO:0043066;GO:0050848;, C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, , P:apoptotic process; P:negative regulation of apoptotic process; P:regulation of calcium-mediated signaling;|Q9HC24 Q542Z6 Q9UHY5 Q9Y3C2,Protein lifeguard 4,Golgi anti-apoptotic protein;Protein S1R;Transmembrane BAX inhibitor motif-containing protein 4;Z-protein;, PF01027;, GO:0000139;GO:0005795;GO:0016021;GO:0006915;GO:0043066;GO:0050848;, C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, , P:apoptotic process; P:negative regulation of apoptotic process; P:regulation of calcium-mediated signaling;|Q9HC24 Q542Z6 Q9UHY5 Q9Y3C2,Protein lifeguard 4,Golgi anti-apoptotic protein;Protein S1R;Transmembrane BAX inhibitor motif-containing protein 4;Z-protein;, PF01027;, GO:0000139;GO:0005795;GO:0016021;GO:0006915;GO:0043066;GO:0050848;, C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, , P:apoptotic process; P:negative regulation of apoptotic process; P:regulation of calcium-mediated signaling;|Q9BRT6 Q3B766,Protein LLP homolog,Protein LAPS18-like;, PF10169;, GO:0005694;GO:0005730;GO:0001099;GO:0003723;GO:0097484;GO:0060999;, C:chromosome; C:nucleolus;, F:basal RNA polymerase II transcription machinery binding; F:RNA binding;, P:dendrite extension; P:positive regulation of dendritic spine development; scaffold31 indexed_genome mRNA 18866760 18983818 . - . ID=transcript_6774;Q8IXL7 B4DR19 B7ZAQ0 Q6UXS2,Methionine-R-sulfoxide reductase B3,, PF01641;, GO:0005737;GO:0005829;GO:0005783;GO:0005739;GO:0033745;GO:0033743;GO:0008270;GO:0030091;GO:0006979;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:mitochondrion;, F:L-methionine-(R)-S-oxide reductase activity; F:peptide-methionine (R)-S-oxide reductase activity; F:zinc ion binding;, P:protein repair; P:response to oxidative stress; scaffold31 indexed_genome mRNA 19061845 19072020 . - . ID=transcript_6775;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|P62837 D3DQC9 P51669 Q3MN78 Q96RP6,Ubiquitin-conjugating enzyme E2 D2,(E3-independent) E2 ubiquitin-conjugating enzyme D2;E2 ubiquitin-conjugating enzyme D2;Ubiquitin carrier protein D2;Ubiquitin-conjugating enzyme E2(17)KB 2;Ubiquitin-conjugating enzyme E2-17 kDa 2;Ubiquitin-protein ligase D2;p53-regulated ubiquitin-conjugating enzyme 1;, PF00179;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0000151;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006464;GO:0002756;GO:0051865;GO:0070936;GO:0008104;GO:0000209;GO:0016567;GO:0035666;GO:0006511;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:MyD88-independent toll-like receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold31 indexed_genome mRNA 19073877 19143269 . - . ID=transcript_6776;Q9Y2U8 Q9NT47 Q9NYA5,Inner nuclear membrane protein Man1,LEM domain-containing protein 3;, PF03020;PF09402;, GO:0016021;GO:0005639;GO:0016020;GO:0005637;GO:0031965;GO:0031490;GO:0032926;GO:0030514;GO:0030512;GO:0006998;GO:1902531;, C:integral component of membrane; C:integral component of nuclear inner membrane; C:membrane; C:nuclear inner membrane; C:nuclear membrane;, F:chromatin DNA binding;, P:negative regulation of activin receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:nuclear envelope organization; P:regulation of intracellular signal transduction;|Q9Y2U8 Q9NT47 Q9NYA5,Inner nuclear membrane protein Man1,LEM domain-containing protein 3;, PF03020;PF09402;, GO:0016021;GO:0005639;GO:0016020;GO:0005637;GO:0031965;GO:0031490;GO:0032926;GO:0030514;GO:0030512;GO:0006998;GO:1902531;, C:integral component of membrane; C:integral component of nuclear inner membrane; C:membrane; C:nuclear inner membrane; C:nuclear membrane;, F:chromatin DNA binding;, P:negative regulation of activin receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:nuclear envelope organization; P:regulation of intracellular signal transduction;|Q9Y2U8 Q9NT47 Q9NYA5,Inner nuclear membrane protein Man1,LEM domain-containing protein 3;, PF03020;PF09402;, GO:0016021;GO:0005639;GO:0016020;GO:0005637;GO:0031965;GO:0031490;GO:0032926;GO:0030514;GO:0030512;GO:0006998;GO:1902531;, C:integral component of membrane; C:integral component of nuclear inner membrane; C:membrane; C:nuclear inner membrane; C:nuclear membrane;, F:chromatin DNA binding;, P:negative regulation of activin receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:nuclear envelope organization; P:regulation of intracellular signal transduction; scaffold31 indexed_genome mRNA 19214969 19297140 . + . ID=transcript_6777;Q9Y5W5 Q6UXI1 Q8WVG4,Wnt inhibitory factor 1,, PF12661;PF02019;, GO:0009986;GO:0005576;GO:0005102;GO:0017147;GO:0048856;GO:0007275;GO:0030178;GO:0045600;GO:0007165;GO:0016055;, C:cell surface; C:extracellular region;, F:signaling receptor binding; F:Wnt-protein binding;, P:anatomical structure development; P:multicellular organism development; P:negative regulation of Wnt signaling pathway; P:positive regulation of fat cell differentiation; P:signal transduction; P:Wnt signaling pathway;|Q9Y5W5 Q6UXI1 Q8WVG4,Wnt inhibitory factor 1,, PF12661;PF02019;, GO:0009986;GO:0005576;GO:0005102;GO:0017147;GO:0048856;GO:0007275;GO:0030178;GO:0045600;GO:0007165;GO:0016055;, C:cell surface; C:extracellular region;, F:signaling receptor binding; F:Wnt-protein binding;, P:anatomical structure development; P:multicellular organism development; P:negative regulation of Wnt signaling pathway; P:positive regulation of fat cell differentiation; P:signal transduction; P:Wnt signaling pathway;|Q9Y5W5 Q6UXI1 Q8WVG4,Wnt inhibitory factor 1,, PF12661;PF02019;, GO:0009986;GO:0005576;GO:0005102;GO:0017147;GO:0048856;GO:0007275;GO:0030178;GO:0045600;GO:0007165;GO:0016055;, C:cell surface; C:extracellular region;, F:signaling receptor binding; F:Wnt-protein binding;, P:anatomical structure development; P:multicellular organism development; P:negative regulation of Wnt signaling pathway; P:positive regulation of fat cell differentiation; P:signal transduction; P:Wnt signaling pathway; scaffold31 indexed_genome mRNA 19461150 19505748 . - . ID=transcript_6778;Q9Y2I9 B3KP01 B9A6M9 E7EMW4 F5GYJ9,TBC1 domain family member 30,, PF15733;PF00566;, GO:0036064;GO:0005929;GO:0005829;GO:0005886;GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:1902018;GO:0043547;, C:ciliary basal body; C:cilium; C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:negative regulation of cilium assembly; P:positive regulation of GTPase activity; scaffold31 indexed_genome mRNA 19562501 19609912 . + . ID=transcript_6779;P15586 B4DYH8 Q53F05,N-acetylglucosamine-6-sulfatase,Glucosamine-6-sulfatase;, PF00884;, GO:0035578;GO:0070062;GO:0005576;GO:1904813;GO:0043202;GO:0005539;GO:0046872;GO:0008449;GO:0008484;GO:0006027;GO:0042340;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:lysosomal lumen;, F:glycosaminoglycan binding; F:metal ion binding; F:N-acetylglucosamine-6-sulfatase activity; F:sulfuric ester hydrolase activity;, P:glycosaminoglycan catabolic process; P:keratan sulfate catabolic process; P:neutrophil degranulation;|P15586 B4DYH8 Q53F05,N-acetylglucosamine-6-sulfatase,Glucosamine-6-sulfatase;, PF00884;, GO:0035578;GO:0070062;GO:0005576;GO:1904813;GO:0043202;GO:0005539;GO:0046872;GO:0008449;GO:0008484;GO:0006027;GO:0042340;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:lysosomal lumen;, F:glycosaminoglycan binding; F:metal ion binding; F:N-acetylglucosamine-6-sulfatase activity; F:sulfuric ester hydrolase activity;, P:glycosaminoglycan catabolic process; P:keratan sulfate catabolic process; P:neutrophil degranulation;|P15586 B4DYH8 Q53F05,N-acetylglucosamine-6-sulfatase,Glucosamine-6-sulfatase;, PF00884;, GO:0035578;GO:0070062;GO:0005576;GO:1904813;GO:0043202;GO:0005539;GO:0046872;GO:0008449;GO:0008484;GO:0006027;GO:0042340;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:lysosomal lumen;, F:glycosaminoglycan binding; F:metal ion binding; F:N-acetylglucosamine-6-sulfatase activity; F:sulfuric ester hydrolase activity;, P:glycosaminoglycan catabolic process; P:keratan sulfate catabolic process; P:neutrophil degranulation; scaffold31 indexed_genome mRNA 19619951 19695720 . - . ID=transcript_6780;Q86WH2 Q86WH1,Ras association domain-containing protein 3,, PF16517;PF00788;, GO:0005737;GO:0005829;GO:0005874;GO:0005886;GO:0042802;GO:0042981;GO:0007165;, C:cytoplasm; C:cytosol; C:microtubule; C:plasma membrane;, F:identical protein binding;, P:regulation of apoptotic process; P:signal transduction; scaffold31 indexed_genome mRNA 19784700 19828955 . - . ID=transcript_6781;Q9UHD2 A8K4S4 Q8IYV3 Q9NUJ5,Serine/threonine-protein kinase TBK1 {ECO:0000305},NF-kappa-B-activating kinase {ECO:0000303|PubMed:10783893};T2K;TANK-binding kinase 1 {ECO:0000303|PubMed:10581243};, PF00069;PF18394;PF18396;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005524;GO:0042802;GO:0003676;GO:0051219;GO:0004672;GO:0019903;GO:0106310;GO:0004674;GO:0106311;GO:0002218;GO:0071345;GO:0050830;GO:0051607;GO:0044565;GO:0007249;GO:0006954;GO:0045087;GO:0032480;GO:0018105;GO:0018107;GO:0043123;GO:0032727;GO:0032728;GO:0016239;GO:0033138;GO:0045944;GO:0032481;GO:0060340;GO:1904417;GO:0006468;GO:1901214;GO:0032479;GO:0009615;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:nucleic acid binding; F:phosphoprotein binding; F:protein kinase activity; F:protein phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of innate immune response; P:cellular response to cytokine stimulus; P:defense response to Gram-positive bacterium; P:defense response to virus; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:negative regulation of type I interferon production; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of macroautophagy; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:positive regulation of xenophagy; P:protein phosphorylation; P:regulation of neuron death; P:regulation of type I interferon production; P:response to virus; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9UHD2 A8K4S4 Q8IYV3 Q9NUJ5,Serine/threonine-protein kinase TBK1 {ECO:0000305},NF-kappa-B-activating kinase {ECO:0000303|PubMed:10783893};T2K;TANK-binding kinase 1 {ECO:0000303|PubMed:10581243};, PF00069;PF18394;PF18396;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005524;GO:0042802;GO:0003676;GO:0051219;GO:0004672;GO:0019903;GO:0106310;GO:0004674;GO:0106311;GO:0002218;GO:0071345;GO:0050830;GO:0051607;GO:0044565;GO:0007249;GO:0006954;GO:0045087;GO:0032480;GO:0018105;GO:0018107;GO:0043123;GO:0032727;GO:0032728;GO:0016239;GO:0033138;GO:0045944;GO:0032481;GO:0060340;GO:1904417;GO:0006468;GO:1901214;GO:0032479;GO:0009615;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:nucleic acid binding; F:phosphoprotein binding; F:protein kinase activity; F:protein phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of innate immune response; P:cellular response to cytokine stimulus; P:defense response to Gram-positive bacterium; P:defense response to virus; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:negative regulation of type I interferon production; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of macroautophagy; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:positive regulation of xenophagy; P:protein phosphorylation; P:regulation of neuron death; P:regulation of type I interferon production; P:response to virus; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|Q9UHD2 A8K4S4 Q8IYV3 Q9NUJ5,Serine/threonine-protein kinase TBK1 {ECO:0000305},NF-kappa-B-activating kinase {ECO:0000303|PubMed:10783893};T2K;TANK-binding kinase 1 {ECO:0000303|PubMed:10581243};, PF00069;PF18394;PF18396;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005524;GO:0042802;GO:0003676;GO:0051219;GO:0004672;GO:0019903;GO:0106310;GO:0004674;GO:0106311;GO:0002218;GO:0071345;GO:0050830;GO:0051607;GO:0044565;GO:0007249;GO:0006954;GO:0045087;GO:0032480;GO:0018105;GO:0018107;GO:0043123;GO:0032727;GO:0032728;GO:0016239;GO:0033138;GO:0045944;GO:0032481;GO:0060340;GO:1904417;GO:0006468;GO:1901214;GO:0032479;GO:0009615;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:nucleic acid binding; F:phosphoprotein binding; F:protein kinase activity; F:protein phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of innate immune response; P:cellular response to cytokine stimulus; P:defense response to Gram-positive bacterium; P:defense response to virus; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:negative regulation of type I interferon production; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of macroautophagy; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:positive regulation of xenophagy; P:protein phosphorylation; P:regulation of neuron death; P:regulation of type I interferon production; P:response to virus; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|Q9UHD2 A8K4S4 Q8IYV3 Q9NUJ5,Serine/threonine-protein kinase TBK1 {ECO:0000305},NF-kappa-B-activating kinase {ECO:0000303|PubMed:10783893};T2K;TANK-binding kinase 1 {ECO:0000303|PubMed:10581243};, PF00069;PF18394;PF18396;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005524;GO:0042802;GO:0003676;GO:0051219;GO:0004672;GO:0019903;GO:0106310;GO:0004674;GO:0106311;GO:0002218;GO:0071345;GO:0050830;GO:0051607;GO:0044565;GO:0007249;GO:0006954;GO:0045087;GO:0032480;GO:0018105;GO:0018107;GO:0043123;GO:0032727;GO:0032728;GO:0016239;GO:0033138;GO:0045944;GO:0032481;GO:0060340;GO:1904417;GO:0006468;GO:1901214;GO:0032479;GO:0009615;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:nucleic acid binding; F:phosphoprotein binding; F:protein kinase activity; F:protein phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of innate immune response; P:cellular response to cytokine stimulus; P:defense response to Gram-positive bacterium; P:defense response to virus; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:negative regulation of type I interferon production; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of macroautophagy; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:positive regulation of xenophagy; P:protein phosphorylation; P:regulation of neuron death; P:regulation of type I interferon production; P:response to virus; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|Q9UHD2 A8K4S4 Q8IYV3 Q9NUJ5,Serine/threonine-protein kinase TBK1 {ECO:0000305},NF-kappa-B-activating kinase {ECO:0000303|PubMed:10783893};T2K;TANK-binding kinase 1 {ECO:0000303|PubMed:10581243};, PF00069;PF18394;PF18396;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005524;GO:0042802;GO:0003676;GO:0051219;GO:0004672;GO:0019903;GO:0106310;GO:0004674;GO:0106311;GO:0002218;GO:0071345;GO:0050830;GO:0051607;GO:0044565;GO:0007249;GO:0006954;GO:0045087;GO:0032480;GO:0018105;GO:0018107;GO:0043123;GO:0032727;GO:0032728;GO:0016239;GO:0033138;GO:0045944;GO:0032481;GO:0060340;GO:1904417;GO:0006468;GO:1901214;GO:0032479;GO:0009615;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:nucleic acid binding; F:phosphoprotein binding; F:protein kinase activity; F:protein phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of innate immune response; P:cellular response to cytokine stimulus; P:defense response to Gram-positive bacterium; P:defense response to virus; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:negative regulation of type I interferon production; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of macroautophagy; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:positive regulation of xenophagy; P:protein phosphorylation; P:regulation of neuron death; P:regulation of type I interferon production; P:response to virus; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|Q9UHD2 A8K4S4 Q8IYV3 Q9NUJ5,Serine/threonine-protein kinase TBK1 {ECO:0000305},NF-kappa-B-activating kinase {ECO:0000303|PubMed:10783893};T2K;TANK-binding kinase 1 {ECO:0000303|PubMed:10581243};, PF00069;PF18394;PF18396;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005524;GO:0042802;GO:0003676;GO:0051219;GO:0004672;GO:0019903;GO:0106310;GO:0004674;GO:0106311;GO:0002218;GO:0071345;GO:0050830;GO:0051607;GO:0044565;GO:0007249;GO:0006954;GO:0045087;GO:0032480;GO:0018105;GO:0018107;GO:0043123;GO:0032727;GO:0032728;GO:0016239;GO:0033138;GO:0045944;GO:0032481;GO:0060340;GO:1904417;GO:0006468;GO:1901214;GO:0032479;GO:0009615;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:nucleic acid binding; F:phosphoprotein binding; F:protein kinase activity; F:protein phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of innate immune response; P:cellular response to cytokine stimulus; P:defense response to Gram-positive bacterium; P:defense response to virus; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:negative regulation of type I interferon production; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of macroautophagy; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:positive regulation of xenophagy; P:protein phosphorylation; P:regulation of neuron death; P:regulation of type I interferon production; P:response to virus; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process; scaffold31 indexed_genome mRNA 19836064 19872312 . - . ID=transcript_6782;O43592 A6NLH1 O43784 Q8WUG2 Q9BVS7,Exportin-T,Exportin(tRNA);tRNA exportin;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0016363;GO:0005654;GO:0031267;GO:0000049;GO:0006409;GO:0071528;, C:cytoplasm; C:cytosol; C:nuclear matrix; C:nucleoplasm;, F:small GTPase binding; F:tRNA binding;, P:tRNA export from nucleus; P:tRNA re-export from nucleus;|O43592 A6NLH1 O43784 Q8WUG2 Q9BVS7,Exportin-T,Exportin(tRNA);tRNA exportin;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0016363;GO:0005654;GO:0031267;GO:0000049;GO:0006409;GO:0071528;, C:cytoplasm; C:cytosol; C:nuclear matrix; C:nucleoplasm;, F:small GTPase binding; F:tRNA binding;, P:tRNA export from nucleus; P:tRNA re-export from nucleus;|O43592 A6NLH1 O43784 Q8WUG2 Q9BVS7,Exportin-T,Exportin(tRNA);tRNA exportin;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0016363;GO:0005654;GO:0031267;GO:0000049;GO:0006409;GO:0071528;, C:cytoplasm; C:cytosol; C:nuclear matrix; C:nucleoplasm;, F:small GTPase binding; F:tRNA binding;, P:tRNA export from nucleus; P:tRNA re-export from nucleus;|O43592 A6NLH1 O43784 Q8WUG2 Q9BVS7,Exportin-T,Exportin(tRNA);tRNA exportin;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0016363;GO:0005654;GO:0031267;GO:0000049;GO:0006409;GO:0071528;, C:cytoplasm; C:cytosol; C:nuclear matrix; C:nucleoplasm;, F:small GTPase binding; F:tRNA binding;, P:tRNA export from nucleus; P:tRNA re-export from nucleus; scaffold31 indexed_genome mRNA 19881832 19910304 . + . ID=transcript_6783;Q8IXR9,Uncharacterized protein C12orf56,, PF15087; scaffold31 indexed_genome mRNA 19927875 19956335 . + . ID=transcript_6784;Q8IXR9,Uncharacterized protein C12orf56,, PF15087; scaffold31 indexed_genome mRNA 19994123 20007052 . - . ID=transcript_6785;Q96MD2 C9JX54 Q8IYA0,KICSTOR complex protein C12orf66 {ECO:0000305|PubMed:28199306},, PF09404;, GO:0045171;GO:0140007;GO:0005765;GO:0005764;GO:0034198;GO:0042149;GO:1904262;GO:0061462;, C:intercellular bridge; C:KICSTOR complex; C:lysosomal membrane; C:lysosome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:negative regulation of TORC1 signaling; P:protein localization to lysosome; scaffold31 indexed_genome mRNA 20070274 20360000 . - . ID=transcript_6786;Q7Z6B7 Q9H8A3 Q9P2P2,SLIT-ROBO Rho GTPase-activating protein 1,Rho GTPase-activating protein 13;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0005096;GO:0030336;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol;, F:GTPase activator activity;, P:negative regulation of cell migration; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q7Z6B7 Q9H8A3 Q9P2P2,SLIT-ROBO Rho GTPase-activating protein 1,Rho GTPase-activating protein 13;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0005096;GO:0030336;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol;, F:GTPase activator activity;, P:negative regulation of cell migration; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q7Z6B7 Q9H8A3 Q9P2P2,SLIT-ROBO Rho GTPase-activating protein 1,Rho GTPase-activating protein 13;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0005096;GO:0030336;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol;, F:GTPase activator activity;, P:negative regulation of cell migration; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold31 indexed_genome mRNA 20388478 20398839 . - . ID=transcript_6787;Q9Y2B1 A8K017 Q6PKD6,Ribitol-5-phosphate xylosyltransferase 1 {ECO:0000305},Transmembrane protein 5 {ECO:0000305};UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase {ECO:0000303|PubMed:27733679};, , GO:0005794;GO:0000139;GO:0005887;GO:0005654;GO:0120053;GO:0035269;, C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:nucleoplasm;, F:ribitol beta-1,4-xylosyltransferase activity;, P:protein O-linked mannosylation;|Q9Y2B1 A8K017 Q6PKD6,Ribitol-5-phosphate xylosyltransferase 1 {ECO:0000305},Transmembrane protein 5 {ECO:0000305};UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase {ECO:0000303|PubMed:27733679};, , GO:0005794;GO:0000139;GO:0005887;GO:0005654;GO:0120053;GO:0035269;, C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:nucleoplasm;, F:ribitol beta-1,4-xylosyltransferase activity;, P:protein O-linked mannosylation;|Q9Y2B1 A8K017 Q6PKD6,Ribitol-5-phosphate xylosyltransferase 1 {ECO:0000305},Transmembrane protein 5 {ECO:0000305};UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase {ECO:0000303|PubMed:27733679};, , GO:0005794;GO:0000139;GO:0005887;GO:0005654;GO:0120053;GO:0035269;, C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:nucleoplasm;, F:ribitol beta-1,4-xylosyltransferase activity;, P:protein O-linked mannosylation; scaffold31 indexed_genome mRNA 20785529 20786196 . + . ID=transcript_6788;P37288,Vasopressin V1a receptor,AVPR V1a;Antidiuretic hormone receptor 1a;Vascular/hepatic-type arginine vasopressin receptor;, PF00001;PF08983;, GO:0030139;GO:0005768;GO:0005887;GO:0005886;GO:0004930;GO:0042277;GO:0017046;GO:0005080;GO:0031894;GO:0005000;GO:0007202;GO:0008015;GO:0019722;GO:0042631;GO:0007186;GO:0006091;GO:0007625;GO:0002125;GO:0042711;GO:0014902;GO:0007621;GO:0051970;GO:0043084;GO:0030307;GO:0008284;GO:0032849;GO:0007204;GO:0014049;GO:0010460;GO:0031394;GO:0035815;GO:0003084;GO:0045907;GO:0001992;GO:0051412;GO:0035176;GO:0042713;GO:0021537;GO:0150104;, C:endocytic vesicle; C:endosome; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:peptide binding; F:peptide hormone binding; F:protein kinase C binding; F:V1A vasopressin receptor binding; F:vasopressin receptor activity;, P:activation of phospholipase C activity; P:blood circulation; P:calcium-mediated signaling; P:cellular response to water deprivation; P:G protein-coupled receptor signaling pathway; P:generation of precursor metabolites and energy; P:grooming behavior; P:maternal aggressive behavior; P:maternal behavior; P:myotube differentiation; P:negative regulation of female receptivity; P:negative regulation of transmission of nerve impulse; P:penile erection; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of cellular pH reduction; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of glutamate secretion; P:positive regulation of heart rate; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of renal sodium excretion; P:positive regulation of systemic arterial blood pressure; P:positive regulation of vasoconstriction; P:regulation of systemic arterial blood pressure by vasopressin; P:response to corticosterone; P:social behavior; P:sperm ejaculation; P:telencephalon development; P:transport across blood-brain barrier; scaffold31 indexed_genome mRNA 20786209 20788673 . + . ID=transcript_6789;P37288,Vasopressin V1a receptor,AVPR V1a;Antidiuretic hormone receptor 1a;Vascular/hepatic-type arginine vasopressin receptor;, PF00001;PF08983;, GO:0030139;GO:0005768;GO:0005887;GO:0005886;GO:0004930;GO:0042277;GO:0017046;GO:0005080;GO:0031894;GO:0005000;GO:0007202;GO:0008015;GO:0019722;GO:0042631;GO:0007186;GO:0006091;GO:0007625;GO:0002125;GO:0042711;GO:0014902;GO:0007621;GO:0051970;GO:0043084;GO:0030307;GO:0008284;GO:0032849;GO:0007204;GO:0014049;GO:0010460;GO:0031394;GO:0035815;GO:0003084;GO:0045907;GO:0001992;GO:0051412;GO:0035176;GO:0042713;GO:0021537;GO:0150104;, C:endocytic vesicle; C:endosome; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:peptide binding; F:peptide hormone binding; F:protein kinase C binding; F:V1A vasopressin receptor binding; F:vasopressin receptor activity;, P:activation of phospholipase C activity; P:blood circulation; P:calcium-mediated signaling; P:cellular response to water deprivation; P:G protein-coupled receptor signaling pathway; P:generation of precursor metabolites and energy; P:grooming behavior; P:maternal aggressive behavior; P:maternal behavior; P:myotube differentiation; P:negative regulation of female receptivity; P:negative regulation of transmission of nerve impulse; P:penile erection; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of cellular pH reduction; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of glutamate secretion; P:positive regulation of heart rate; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of renal sodium excretion; P:positive regulation of systemic arterial blood pressure; P:positive regulation of vasoconstriction; P:regulation of systemic arterial blood pressure by vasopressin; P:response to corticosterone; P:social behavior; P:sperm ejaculation; P:telencephalon development; P:transport across blood-brain barrier; scaffold31 indexed_genome mRNA 21021418 21313728 . + . ID=transcript_6790;Q9ULR3 B1Q2A9 B2RXG4 Q6PI86,Protein phosphatase 1H,, PF00481;, GO:0005737;GO:0098978;GO:0005654;GO:0005634;GO:0042802;GO:0004724;GO:0004721;GO:0106306;GO:0106307;GO:0006470;, C:cytoplasm; C:glutamatergic synapse; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:magnesium-dependent protein serine/threonine phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation; scaffold31 indexed_genome mRNA 21316168 21316709 . + . ID=transcript_6791;P24941 A8K7C6 O75100,Cyclin-dependent kinase 2,Cell division protein kinase 2;p33 protein kinase;, PF00069;, GO:0015030;GO:0005813;GO:0097123;GO:0097124;GO:0097134;GO:0097135;GO:0000307;GO:0005737;GO:0005829;GO:0005768;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0097472;GO:0004693;GO:0046872;GO:0019904;GO:0106310;GO:0004674;GO:0106311;GO:0031145;GO:0051301;GO:0071732;GO:0007099;GO:0051298;GO:0006281;GO:0006260;GO:0006270;GO:0000082;GO:0000086;GO:0030851;GO:0016572;GO:0051321;GO:0031571;GO:0018105;GO:0008284;GO:0006468;GO:0007265;GO:0010389;GO:0010468;GO:0060968;GO:1901796;GO:0007165;GO:0007004;, C:Cajal body; C:centrosome; C:cyclin A1-CDK2 complex; C:cyclin A2-CDK2 complex; C:cyclin E1-CDK2 complex; C:cyclin E2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:endosome; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein kinase activity; F:cyclin-dependent protein serine/threonine kinase activity; F:metal ion binding; F:protein domain specific binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:cellular response to nitric oxide; P:centriole replication; P:centrosome duplication; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:granulocyte differentiation; P:histone phosphorylation; P:meiotic cell cycle; P:mitotic G1 DNA damage checkpoint; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:Ras protein signal transduction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gene expression; P:regulation of gene silencing; P:regulation of signal transduction by p53 class mediator; P:signal transduction; P:telomere maintenance via telomerase; scaffold31 indexed_genome mRNA 21374691 21487056 . - . ID=transcript_6792;Q8NHE2 Q9UPW1,Protein MON2 homolog,Protein SF21;, PF16213;PF09324;PF16206;PF12783;, GO:0005829;GO:0031901;GO:0070062;GO:0006895;GO:0015031;, C:cytosol; C:early endosome membrane; C:extracellular exosome;, , P:Golgi to endosome transport; P:protein transport;|Q8NHE2 Q9UPW1,Protein MON2 homolog,Protein SF21;, PF16213;PF09324;PF16206;PF12783;, GO:0005829;GO:0031901;GO:0070062;GO:0006895;GO:0015031;, C:cytosol; C:early endosome membrane; C:extracellular exosome;, , P:Golgi to endosome transport; P:protein transport;|Q8NHE2 Q9UPW1,Protein MON2 homolog,Protein SF21;, PF16213;PF09324;PF16206;PF12783;, GO:0005829;GO:0031901;GO:0070062;GO:0006895;GO:0015031;, C:cytosol; C:early endosome membrane; C:extracellular exosome;, , P:Golgi to endosome transport; P:protein transport;|Q8NHE2 Q9UPW1,Protein MON2 homolog,Protein SF21;, PF16213;PF09324;PF16206;PF12783;, GO:0005829;GO:0031901;GO:0070062;GO:0006895;GO:0015031;, C:cytosol; C:early endosome membrane; C:extracellular exosome;, , P:Golgi to endosome transport; P:protein transport;|Q8NHE2 Q9UPW1,Protein MON2 homolog,Protein SF21;, PF16213;PF09324;PF16206;PF12783;, GO:0005829;GO:0031901;GO:0070062;GO:0006895;GO:0015031;, C:cytosol; C:early endosome membrane; C:extracellular exosome;, , P:Golgi to endosome transport; P:protein transport;|Q8NHE2 Q9UPW1,Protein MON2 homolog,Protein SF21;, PF16213;PF09324;PF16206;PF12783;, GO:0005829;GO:0031901;GO:0070062;GO:0006895;GO:0015031;, C:cytosol; C:early endosome membrane; C:extracellular exosome;, , P:Golgi to endosome transport; P:protein transport; scaffold31 indexed_genome mRNA 21521901 21648933 . - . ID=transcript_6793;Q9Y4E8 Q08AL5 Q9H8G9 Q9HCA6 Q9UNP0 Q9Y5B5,Ubiquitin carboxyl-terminal hydrolase 15,Deubiquitinating enzyme 15;Ubiquitin thioesterase 15;Ubiquitin-specific-processing protease 15;Unph-2;Unph4;, PF06337;PF14836;PF00443;PF14533;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0005886;GO:0004197;GO:0042802;GO:1990380;GO:0046332;GO:0004843;GO:0005160;GO:0061649;GO:0030509;GO:0035616;GO:0035520;GO:0060389;GO:1900246;GO:0016579;GO:0007179;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:plasma membrane;, F:cysteine-type endopeptidase activity; F:identical protein binding; F:Lys48-specific deubiquitinase activity; F:SMAD binding; F:thiol-dependent ubiquitin-specific protease activity; F:transforming growth factor beta receptor binding; F:ubiquitin modification-dependent histone binding;, P:BMP signaling pathway; P:histone H2B conserved C-terminal lysine deubiquitination; P:monoubiquitinated protein deubiquitination; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of RIG-I signaling pathway; P:protein deubiquitination; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9Y4E8 Q08AL5 Q9H8G9 Q9HCA6 Q9UNP0 Q9Y5B5,Ubiquitin carboxyl-terminal hydrolase 15,Deubiquitinating enzyme 15;Ubiquitin thioesterase 15;Ubiquitin-specific-processing protease 15;Unph-2;Unph4;, PF06337;PF14836;PF00443;PF14533;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0005886;GO:0004197;GO:0042802;GO:1990380;GO:0046332;GO:0004843;GO:0005160;GO:0061649;GO:0030509;GO:0035616;GO:0035520;GO:0060389;GO:1900246;GO:0016579;GO:0007179;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:plasma membrane;, F:cysteine-type endopeptidase activity; F:identical protein binding; F:Lys48-specific deubiquitinase activity; F:SMAD binding; F:thiol-dependent ubiquitin-specific protease activity; F:transforming growth factor beta receptor binding; F:ubiquitin modification-dependent histone binding;, P:BMP signaling pathway; P:histone H2B conserved C-terminal lysine deubiquitination; P:monoubiquitinated protein deubiquitination; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of RIG-I signaling pathway; P:protein deubiquitination; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9Y4E8 Q08AL5 Q9H8G9 Q9HCA6 Q9UNP0 Q9Y5B5,Ubiquitin carboxyl-terminal hydrolase 15,Deubiquitinating enzyme 15;Ubiquitin thioesterase 15;Ubiquitin-specific-processing protease 15;Unph-2;Unph4;, PF06337;PF14836;PF00443;PF14533;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0005886;GO:0004197;GO:0042802;GO:1990380;GO:0046332;GO:0004843;GO:0005160;GO:0061649;GO:0030509;GO:0035616;GO:0035520;GO:0060389;GO:1900246;GO:0016579;GO:0007179;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:plasma membrane;, F:cysteine-type endopeptidase activity; F:identical protein binding; F:Lys48-specific deubiquitinase activity; F:SMAD binding; F:thiol-dependent ubiquitin-specific protease activity; F:transforming growth factor beta receptor binding; F:ubiquitin modification-dependent histone binding;, P:BMP signaling pathway; P:histone H2B conserved C-terminal lysine deubiquitination; P:monoubiquitinated protein deubiquitination; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of RIG-I signaling pathway; P:protein deubiquitination; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9Y4E8 Q08AL5 Q9H8G9 Q9HCA6 Q9UNP0 Q9Y5B5,Ubiquitin carboxyl-terminal hydrolase 15,Deubiquitinating enzyme 15;Ubiquitin thioesterase 15;Ubiquitin-specific-processing protease 15;Unph-2;Unph4;, PF06337;PF14836;PF00443;PF14533;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0005886;GO:0004197;GO:0042802;GO:1990380;GO:0046332;GO:0004843;GO:0005160;GO:0061649;GO:0030509;GO:0035616;GO:0035520;GO:0060389;GO:1900246;GO:0016579;GO:0007179;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:plasma membrane;, F:cysteine-type endopeptidase activity; F:identical protein binding; F:Lys48-specific deubiquitinase activity; F:SMAD binding; F:thiol-dependent ubiquitin-specific protease activity; F:transforming growth factor beta receptor binding; F:ubiquitin modification-dependent histone binding;, P:BMP signaling pathway; P:histone H2B conserved C-terminal lysine deubiquitination; P:monoubiquitinated protein deubiquitination; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of RIG-I signaling pathway; P:protein deubiquitination; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9Y4E8 Q08AL5 Q9H8G9 Q9HCA6 Q9UNP0 Q9Y5B5,Ubiquitin carboxyl-terminal hydrolase 15,Deubiquitinating enzyme 15;Ubiquitin thioesterase 15;Ubiquitin-specific-processing protease 15;Unph-2;Unph4;, PF06337;PF14836;PF00443;PF14533;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0005886;GO:0004197;GO:0042802;GO:1990380;GO:0046332;GO:0004843;GO:0005160;GO:0061649;GO:0030509;GO:0035616;GO:0035520;GO:0060389;GO:1900246;GO:0016579;GO:0007179;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:plasma membrane;, F:cysteine-type endopeptidase activity; F:identical protein binding; F:Lys48-specific deubiquitinase activity; F:SMAD binding; F:thiol-dependent ubiquitin-specific protease activity; F:transforming growth factor beta receptor binding; F:ubiquitin modification-dependent histone binding;, P:BMP signaling pathway; P:histone H2B conserved C-terminal lysine deubiquitination; P:monoubiquitinated protein deubiquitination; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of RIG-I signaling pathway; P:protein deubiquitination; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9Y4E8 Q08AL5 Q9H8G9 Q9HCA6 Q9UNP0 Q9Y5B5,Ubiquitin carboxyl-terminal hydrolase 15,Deubiquitinating enzyme 15;Ubiquitin thioesterase 15;Ubiquitin-specific-processing protease 15;Unph-2;Unph4;, PF06337;PF14836;PF00443;PF14533;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0005886;GO:0004197;GO:0042802;GO:1990380;GO:0046332;GO:0004843;GO:0005160;GO:0061649;GO:0030509;GO:0035616;GO:0035520;GO:0060389;GO:1900246;GO:0016579;GO:0007179;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:plasma membrane;, F:cysteine-type endopeptidase activity; F:identical protein binding; F:Lys48-specific deubiquitinase activity; F:SMAD binding; F:thiol-dependent ubiquitin-specific protease activity; F:transforming growth factor beta receptor binding; F:ubiquitin modification-dependent histone binding;, P:BMP signaling pathway; P:histone H2B conserved C-terminal lysine deubiquitination; P:monoubiquitinated protein deubiquitination; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of RIG-I signaling pathway; P:protein deubiquitination; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9Y4E8 Q08AL5 Q9H8G9 Q9HCA6 Q9UNP0 Q9Y5B5,Ubiquitin carboxyl-terminal hydrolase 15,Deubiquitinating enzyme 15;Ubiquitin thioesterase 15;Ubiquitin-specific-processing protease 15;Unph-2;Unph4;, PF06337;PF14836;PF00443;PF14533;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0005886;GO:0004197;GO:0042802;GO:1990380;GO:0046332;GO:0004843;GO:0005160;GO:0061649;GO:0030509;GO:0035616;GO:0035520;GO:0060389;GO:1900246;GO:0016579;GO:0007179;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:plasma membrane;, F:cysteine-type endopeptidase activity; F:identical protein binding; F:Lys48-specific deubiquitinase activity; F:SMAD binding; F:thiol-dependent ubiquitin-specific protease activity; F:transforming growth factor beta receptor binding; F:ubiquitin modification-dependent histone binding;, P:BMP signaling pathway; P:histone H2B conserved C-terminal lysine deubiquitination; P:monoubiquitinated protein deubiquitination; P:pathway-restricted SMAD protein phosphorylation; P:positive regulation of RIG-I signaling pathway; P:protein deubiquitination; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold31 indexed_genome mRNA 23770115 23783338 . - . ID=transcript_6794;O60669 Q8NEM3 Q9UPB3,Monocarboxylate transporter 2,Solute carrier family 16 member 7;, PF07690;, GO:0016021;GO:0005887;GO:0005654;GO:0005886;GO:0015129;GO:0008028;GO:0005477;GO:0050833;GO:0015293;GO:0035873;GO:0015718;GO:1901475;GO:0150104;, C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:lactate transmembrane transporter activity; F:monocarboxylic acid transmembrane transporter activity; F:pyruvate secondary active transmembrane transporter activity; F:pyruvate transmembrane transporter activity; F:symporter activity;, P:lactate transmembrane transport; P:monocarboxylic acid transport; P:pyruvate transmembrane transport; P:transport across blood-brain barrier; scaffold31 indexed_genome mRNA 24593791 24642688 . + . ID=transcript_6795;Q6UXM1 Q6UXL7 Q8NC72,Leucine-rich repeats and immunoglobulin-like domains protein 3,, PF07679;PF13855;, GO:0030659;GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0032474;, C:cytoplasmic vesicle membrane; C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:otolith morphogenesis;|Q6UXM1 Q6UXL7 Q8NC72,Leucine-rich repeats and immunoglobulin-like domains protein 3,, PF07679;PF13855;, GO:0030659;GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0032474;, C:cytoplasmic vesicle membrane; C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:otolith morphogenesis; scaffold31 indexed_genome mRNA 24642692 24644783 . - . ID=transcript_6796;Q6UXM1 Q6UXL7 Q8NC72,Leucine-rich repeats and immunoglobulin-like domains protein 3,, PF07679;PF13855;, GO:0030659;GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0032474;, C:cytoplasmic vesicle membrane; C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:otolith morphogenesis;|Q6UXM1 Q6UXL7 Q8NC72,Leucine-rich repeats and immunoglobulin-like domains protein 3,, PF07679;PF13855;, GO:0030659;GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0032474;, C:cytoplasmic vesicle membrane; C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:otolith morphogenesis; scaffold31 indexed_genome mRNA 25501844 25519436 . - . ID=transcript_6797;Q9Y6H3 Q1RLM4 Q96E81,Mitochondrial inner membrane protease ATP23 homolog,Ku70-binding protein 3;XRCC6-binding protein 1;, PF09768;, GO:0030054;GO:0005829;GO:0005958;GO:0031314;GO:0043231;GO:0005886;GO:0004677;GO:0046872;GO:0004222;GO:0006303;GO:0034982;GO:0033615;, C:cell junction; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:extrinsic component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:DNA-dependent protein kinase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:double-strand break repair via nonhomologous end joining; P:mitochondrial protein processing; P:mitochondrial proton-transporting ATP synthase complex assembly;|Q9Y6H3 Q1RLM4 Q96E81,Mitochondrial inner membrane protease ATP23 homolog,Ku70-binding protein 3;XRCC6-binding protein 1;, PF09768;, GO:0030054;GO:0005829;GO:0005958;GO:0031314;GO:0043231;GO:0005886;GO:0004677;GO:0046872;GO:0004222;GO:0006303;GO:0034982;GO:0033615;, C:cell junction; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:extrinsic component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:DNA-dependent protein kinase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:double-strand break repair via nonhomologous end joining; P:mitochondrial protein processing; P:mitochondrial proton-transporting ATP synthase complex assembly;|Q9Y6H3 Q1RLM4 Q96E81,Mitochondrial inner membrane protease ATP23 homolog,Ku70-binding protein 3;XRCC6-binding protein 1;, PF09768;, GO:0030054;GO:0005829;GO:0005958;GO:0031314;GO:0043231;GO:0005886;GO:0004677;GO:0046872;GO:0004222;GO:0006303;GO:0034982;GO:0033615;, C:cell junction; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:extrinsic component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:DNA-dependent protein kinase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:double-strand break repair via nonhomologous end joining; P:mitochondrial protein processing; P:mitochondrial proton-transporting ATP synthase complex assembly;|Q9Y6H3 Q1RLM4 Q96E81,Mitochondrial inner membrane protease ATP23 homolog,Ku70-binding protein 3;XRCC6-binding protein 1;, PF09768;, GO:0030054;GO:0005829;GO:0005958;GO:0031314;GO:0043231;GO:0005886;GO:0004677;GO:0046872;GO:0004222;GO:0006303;GO:0034982;GO:0033615;, C:cell junction; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:extrinsic component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:DNA-dependent protein kinase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:double-strand break repair via nonhomologous end joining; P:mitochondrial protein processing; P:mitochondrial proton-transporting ATP synthase complex assembly; scaffold31 indexed_genome mRNA 25617723 25640510 . + . ID=transcript_6798;O14595 A8K5H4 Q53ZR2 Q6NZY3 Q9UEX1,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2,Nuclear LIM interactor-interacting factor 2;Protein OS-4;Small C-terminal domain phosphatase 2;Small CTD phosphatase 2;, PF03031;, GO:0005654;GO:0046872;GO:0004721;GO:0106306;GO:0106307;GO:0008420;GO:0036498;GO:2000134;GO:0001933;GO:0006470;, C:nucleoplasm;, F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:IRE1-mediated unfolded protein response; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein phosphorylation; P:protein dephosphorylation;|O14595 A8K5H4 Q53ZR2 Q6NZY3 Q9UEX1,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2,Nuclear LIM interactor-interacting factor 2;Protein OS-4;Small C-terminal domain phosphatase 2;Small CTD phosphatase 2;, PF03031;, GO:0005654;GO:0046872;GO:0004721;GO:0106306;GO:0106307;GO:0008420;GO:0036498;GO:2000134;GO:0001933;GO:0006470;, C:nucleoplasm;, F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:IRE1-mediated unfolded protein response; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein phosphorylation; P:protein dephosphorylation;|O14595 A8K5H4 Q53ZR2 Q6NZY3 Q9UEX1,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2,Nuclear LIM interactor-interacting factor 2;Protein OS-4;Small C-terminal domain phosphatase 2;Small CTD phosphatase 2;, PF03031;, GO:0005654;GO:0046872;GO:0004721;GO:0106306;GO:0106307;GO:0008420;GO:0036498;GO:2000134;GO:0001933;GO:0006470;, C:nucleoplasm;, F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:IRE1-mediated unfolded protein response; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein phosphorylation; P:protein dephosphorylation; scaffold31 indexed_genome mRNA 25644418 25645402 . + . ID=transcript_6799;O75366 B2RAU7 Q2NKM9,Advillin {ECO:0000305},p92;, PF00626;PF02209;, GO:0015629;GO:0005884;GO:0030424;GO:0042995;GO:0005737;GO:0005925;GO:0030027;GO:0043005;GO:0003779;GO:0051015;GO:0071933;GO:0005546;GO:0007015;GO:0051014;GO:0008154;GO:0051016;GO:0060271;GO:0007399;GO:0010592;GO:0010976;GO:1900480;, C:actin cytoskeleton; C:actin filament; C:axon; C:cell projection; C:cytoplasm; C:focal adhesion; C:lamellipodium; C:neuron projection;, F:actin binding; F:actin filament binding; F:Arp2/3 complex binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament organization; P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cilium assembly; P:nervous system development; P:positive regulation of lamellipodium assembly; P:positive regulation of neuron projection development; P:regulation of diacylglycerol biosynthetic process; scaffold31 indexed_genome mRNA 25646289 25650500 . + . ID=transcript_6800;O75366 B2RAU7 Q2NKM9,Advillin {ECO:0000305},p92;, PF00626;PF02209;, GO:0015629;GO:0005884;GO:0030424;GO:0042995;GO:0005737;GO:0005925;GO:0030027;GO:0043005;GO:0003779;GO:0051015;GO:0071933;GO:0005546;GO:0007015;GO:0051014;GO:0008154;GO:0051016;GO:0060271;GO:0007399;GO:0010592;GO:0010976;GO:1900480;, C:actin cytoskeleton; C:actin filament; C:axon; C:cell projection; C:cytoplasm; C:focal adhesion; C:lamellipodium; C:neuron projection;, F:actin binding; F:actin filament binding; F:Arp2/3 complex binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament organization; P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cilium assembly; P:nervous system development; P:positive regulation of lamellipodium assembly; P:positive regulation of neuron projection development; P:regulation of diacylglycerol biosynthetic process;|O75366 B2RAU7 Q2NKM9,Advillin {ECO:0000305},p92;, PF00626;PF02209;, GO:0015629;GO:0005884;GO:0030424;GO:0042995;GO:0005737;GO:0005925;GO:0030027;GO:0043005;GO:0003779;GO:0051015;GO:0071933;GO:0005546;GO:0007015;GO:0051014;GO:0008154;GO:0051016;GO:0060271;GO:0007399;GO:0010592;GO:0010976;GO:1900480;, C:actin cytoskeleton; C:actin filament; C:axon; C:cell projection; C:cytoplasm; C:focal adhesion; C:lamellipodium; C:neuron projection;, F:actin binding; F:actin filament binding; F:Arp2/3 complex binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament organization; P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cilium assembly; P:nervous system development; P:positive regulation of lamellipodium assembly; P:positive regulation of neuron projection development; P:regulation of diacylglycerol biosynthetic process; scaffold31 indexed_genome mRNA 25651233 25660159 . + . ID=transcript_6801;O75366 B2RAU7 Q2NKM9,Advillin {ECO:0000305},p92;, PF00626;PF02209;, GO:0015629;GO:0005884;GO:0030424;GO:0042995;GO:0005737;GO:0005925;GO:0030027;GO:0043005;GO:0003779;GO:0051015;GO:0071933;GO:0005546;GO:0007015;GO:0051014;GO:0008154;GO:0051016;GO:0060271;GO:0007399;GO:0010592;GO:0010976;GO:1900480;, C:actin cytoskeleton; C:actin filament; C:axon; C:cell projection; C:cytoplasm; C:focal adhesion; C:lamellipodium; C:neuron projection;, F:actin binding; F:actin filament binding; F:Arp2/3 complex binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament organization; P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cilium assembly; P:nervous system development; P:positive regulation of lamellipodium assembly; P:positive regulation of neuron projection development; P:regulation of diacylglycerol biosynthetic process;|O75366 B2RAU7 Q2NKM9,Advillin {ECO:0000305},p92;, PF00626;PF02209;, GO:0015629;GO:0005884;GO:0030424;GO:0042995;GO:0005737;GO:0005925;GO:0030027;GO:0043005;GO:0003779;GO:0051015;GO:0071933;GO:0005546;GO:0007015;GO:0051014;GO:0008154;GO:0051016;GO:0060271;GO:0007399;GO:0010592;GO:0010976;GO:1900480;, C:actin cytoskeleton; C:actin filament; C:axon; C:cell projection; C:cytoplasm; C:focal adhesion; C:lamellipodium; C:neuron projection;, F:actin binding; F:actin filament binding; F:Arp2/3 complex binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament organization; P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cilium assembly; P:nervous system development; P:positive regulation of lamellipodium assembly; P:positive regulation of neuron projection development; P:regulation of diacylglycerol biosynthetic process;|O75366 B2RAU7 Q2NKM9,Advillin {ECO:0000305},p92;, PF00626;PF02209;, GO:0015629;GO:0005884;GO:0030424;GO:0042995;GO:0005737;GO:0005925;GO:0030027;GO:0043005;GO:0003779;GO:0051015;GO:0071933;GO:0005546;GO:0007015;GO:0051014;GO:0008154;GO:0051016;GO:0060271;GO:0007399;GO:0010592;GO:0010976;GO:1900480;, C:actin cytoskeleton; C:actin filament; C:axon; C:cell projection; C:cytoplasm; C:focal adhesion; C:lamellipodium; C:neuron projection;, F:actin binding; F:actin filament binding; F:Arp2/3 complex binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament organization; P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cilium assembly; P:nervous system development; P:positive regulation of lamellipodium assembly; P:positive regulation of neuron projection development; P:regulation of diacylglycerol biosynthetic process; scaffold31 indexed_genome mRNA 25661118 25669236 . - . ID=transcript_6802;P43897 B4E391 F5H2T7 Q561V7 Q8TBC2 Q9UQK0,Elongation factor Ts, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03135},, PF00889;, GO:0005759;GO:0005739;GO:0005654;GO:0003723;GO:0003746;GO:0070125;GO:0032784;GO:0070129;GO:0006414;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:RNA binding; F:translation elongation factor activity;, P:mitochondrial translational elongation; P:regulation of DNA-templated transcription, elongation; P:regulation of mitochondrial translation; P:translational elongation;|P43897 B4E391 F5H2T7 Q561V7 Q8TBC2 Q9UQK0,Elongation factor Ts, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03135},, PF00889;, GO:0005759;GO:0005739;GO:0005654;GO:0003723;GO:0003746;GO:0070125;GO:0032784;GO:0070129;GO:0006414;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:RNA binding; F:translation elongation factor activity;, P:mitochondrial translational elongation; P:regulation of DNA-templated transcription, elongation; P:regulation of mitochondrial translation; P:translational elongation; scaffold31 indexed_genome mRNA 25669248 25672078 . - . ID=transcript_6803;Q96AZ1 Q9H749 Q9Y3W2,EEF1A lysine methyltransferase 3 {ECO:0000312|HGNC:HGNC:24936},Hepatocellular carcinoma-associated antigen 557a;Methyltransferase-like protein 21B;Protein-lysine methyltransferase METTL21B;, PF10294;, GO:0005813;GO:0005694;GO:0005737;GO:0005829;GO:0005654;GO:0032991;GO:0031072;GO:0008168;GO:0016279;GO:0018022;, C:centrosome; C:chromosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:protein-containing complex;, F:heat shock protein binding; F:methyltransferase activity; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine methylation; scaffold31 indexed_genome mRNA 25677300 25681688 . + . ID=transcript_6804;Q9UBP6 B2RBX1 H7BXF2 Q14105 Q53FS9,tRNA (guanine-N(7)-)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03055},Methyltransferase-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03055};mRNA (guanine-N(7)-)-methyltransferase {ECO:0000305};miRNA (guanine-N(7)-)-methyltransferase {ECO:0000305};tRNA (guanine(46)-N(7))-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03055};tRNA(m7G46)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03055};, PF02390;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0043527;GO:0008176;GO:0000049;GO:0036265;GO:0030488;GO:0006400;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:tRNA methyltransferase complex;, F:tRNA (guanine-N7-)-methyltransferase activity; F:tRNA binding;, P:RNA (guanine-N7)-methylation; P:tRNA methylation; P:tRNA modification;|Q9UBP6 B2RBX1 H7BXF2 Q14105 Q53FS9,tRNA (guanine-N(7)-)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03055},Methyltransferase-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03055};mRNA (guanine-N(7)-)-methyltransferase {ECO:0000305};miRNA (guanine-N(7)-)-methyltransferase {ECO:0000305};tRNA (guanine(46)-N(7))-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03055};tRNA(m7G46)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03055};, PF02390;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0043527;GO:0008176;GO:0000049;GO:0036265;GO:0030488;GO:0006400;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:tRNA methyltransferase complex;, F:tRNA (guanine-N7-)-methyltransferase activity; F:tRNA binding;, P:RNA (guanine-N7)-methylation; P:tRNA methylation; P:tRNA modification;|Q9UBP6 B2RBX1 H7BXF2 Q14105 Q53FS9,tRNA (guanine-N(7)-)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03055},Methyltransferase-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03055};mRNA (guanine-N(7)-)-methyltransferase {ECO:0000305};miRNA (guanine-N(7)-)-methyltransferase {ECO:0000305};tRNA (guanine(46)-N(7))-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03055};tRNA(m7G46)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03055};, PF02390;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0043527;GO:0008176;GO:0000049;GO:0036265;GO:0030488;GO:0006400;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:tRNA methyltransferase complex;, F:tRNA (guanine-N7-)-methyltransferase activity; F:tRNA binding;, P:RNA (guanine-N7)-methylation; P:tRNA methylation; P:tRNA modification; scaffold31 indexed_genome mRNA 25682339 25683152 . - . ID=transcript_6805;O15528 B2RC61 Q548T3,25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial,25-OHD-1 alpha-hydroxylase;25-hydroxyvitamin D(3) 1-alpha-hydroxylase;Calcidiol 1-monooxygenase;Cytochrome P450 subfamily XXVIIB polypeptide 1;Cytochrome P450C1 alpha;Cytochrome P450VD1-alpha;Cytochrome p450 27B1;, PF00067;, GO:0005737;GO:0005741;GO:0005739;GO:0004498;GO:0020037;GO:0005506;GO:0062185;GO:0030282;GO:0036378;GO:0055074;GO:0006816;GO:0046697;GO:0070314;GO:0010956;GO:0030308;GO:0008285;GO:0045618;GO:0010980;GO:0070564;GO:0030500;GO:0043627;GO:0034341;GO:0032496;GO:0033280;GO:0042369;GO:0042359;GO:0006766;, C:cytoplasm; C:mitochondrial outer membrane; C:mitochondrion;, F:calcidiol 1-monooxygenase activity; F:heme binding; F:iron ion binding; F:secalciferol 1-monooxygenase activity;, P:bone mineralization; P:calcitriol biosynthetic process from calciol; P:calcium ion homeostasis; P:calcium ion transport; P:decidualization; P:G1 to G0 transition; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:positive regulation of keratinocyte differentiation; P:positive regulation of vitamin D 24-hydroxylase activity; P:positive regulation of vitamin D receptor signaling pathway; P:regulation of bone mineralization; P:response to estrogen; P:response to interferon-gamma; P:response to lipopolysaccharide; P:response to vitamin D; P:vitamin D catabolic process; P:vitamin D metabolic process; P:vitamin metabolic process; scaffold31 indexed_genome mRNA 25683364 25683987 . + . ID=transcript_6806;O15528 B2RC61 Q548T3,25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial,25-OHD-1 alpha-hydroxylase;25-hydroxyvitamin D(3) 1-alpha-hydroxylase;Calcidiol 1-monooxygenase;Cytochrome P450 subfamily XXVIIB polypeptide 1;Cytochrome P450C1 alpha;Cytochrome P450VD1-alpha;Cytochrome p450 27B1;, PF00067;, GO:0005737;GO:0005741;GO:0005739;GO:0004498;GO:0020037;GO:0005506;GO:0062185;GO:0030282;GO:0036378;GO:0055074;GO:0006816;GO:0046697;GO:0070314;GO:0010956;GO:0030308;GO:0008285;GO:0045618;GO:0010980;GO:0070564;GO:0030500;GO:0043627;GO:0034341;GO:0032496;GO:0033280;GO:0042369;GO:0042359;GO:0006766;, C:cytoplasm; C:mitochondrial outer membrane; C:mitochondrion;, F:calcidiol 1-monooxygenase activity; F:heme binding; F:iron ion binding; F:secalciferol 1-monooxygenase activity;, P:bone mineralization; P:calcitriol biosynthetic process from calciol; P:calcium ion homeostasis; P:calcium ion transport; P:decidualization; P:G1 to G0 transition; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:positive regulation of keratinocyte differentiation; P:positive regulation of vitamin D 24-hydroxylase activity; P:positive regulation of vitamin D receptor signaling pathway; P:regulation of bone mineralization; P:response to estrogen; P:response to interferon-gamma; P:response to lipopolysaccharide; P:response to vitamin D; P:vitamin D catabolic process; P:vitamin D metabolic process; P:vitamin metabolic process; scaffold31 indexed_genome mRNA 25685448 25687015 . + . ID=transcript_6807;O15528 B2RC61 Q548T3,25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial,25-OHD-1 alpha-hydroxylase;25-hydroxyvitamin D(3) 1-alpha-hydroxylase;Calcidiol 1-monooxygenase;Cytochrome P450 subfamily XXVIIB polypeptide 1;Cytochrome P450C1 alpha;Cytochrome P450VD1-alpha;Cytochrome p450 27B1;, PF00067;, GO:0005737;GO:0005741;GO:0005739;GO:0004498;GO:0020037;GO:0005506;GO:0062185;GO:0030282;GO:0036378;GO:0055074;GO:0006816;GO:0046697;GO:0070314;GO:0010956;GO:0030308;GO:0008285;GO:0045618;GO:0010980;GO:0070564;GO:0030500;GO:0043627;GO:0034341;GO:0032496;GO:0033280;GO:0042369;GO:0042359;GO:0006766;, C:cytoplasm; C:mitochondrial outer membrane; C:mitochondrion;, F:calcidiol 1-monooxygenase activity; F:heme binding; F:iron ion binding; F:secalciferol 1-monooxygenase activity;, P:bone mineralization; P:calcitriol biosynthetic process from calciol; P:calcium ion homeostasis; P:calcium ion transport; P:decidualization; P:G1 to G0 transition; P:negative regulation of calcidiol 1-monooxygenase activity; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:positive regulation of keratinocyte differentiation; P:positive regulation of vitamin D 24-hydroxylase activity; P:positive regulation of vitamin D receptor signaling pathway; P:regulation of bone mineralization; P:response to estrogen; P:response to interferon-gamma; P:response to lipopolysaccharide; P:response to vitamin D; P:vitamin D catabolic process; P:vitamin D metabolic process; P:vitamin metabolic process; scaffold31 indexed_genome mRNA 25696507 25699805 . + . ID=transcript_6808;P11802 B2R9A0 B4DNF9 O00576 Q6FG61,Cyclin-dependent kinase 4,Cell division protein kinase 4;PSK-J3;, PF00069;, GO:0005923;GO:0000785;GO:0097129;GO:0000307;GO:0005829;GO:0016592;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005667;GO:0005524;GO:0030332;GO:0004693;GO:0106310;GO:0106311;GO:0044877;GO:0008353;GO:0060612;GO:0031100;GO:0051301;GO:0032869;GO:0071353;GO:1904637;GO:0071222;GO:1904628;GO:0007623;GO:0000082;GO:0030851;GO:0002088;GO:0071157;GO:2000134;GO:0043065;GO:0045787;GO:0008284;GO:0045793;GO:0048146;GO:0010971;GO:0045727;GO:0006468;GO:0051726;GO:0000079;GO:0010468;GO:0046626;GO:0046890;GO:0050994;GO:0040014;GO:0060260;GO:0042493;GO:0055093;GO:0010288;GO:0033574;GO:0009636;GO:0007165;, C:bicellular tight junction; C:chromatin; C:cyclin D2-CDK4 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytosol; C:mediator complex; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:transcription regulator complex;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:adipose tissue development; P:animal organ regeneration; P:cell division; P:cellular response to insulin stimulus; P:cellular response to interleukin-4; P:cellular response to ionomycin; P:cellular response to lipopolysaccharide; P:cellular response to phorbol 13-acetate 12-myristate; P:circadian rhythm; P:G1/S transition of mitotic cell cycle; P:granulocyte differentiation; P:lens development in camera-type eye; P:negative regulation of cell cycle arrest; P:negative regulation of G1/S transition of mitotic cell cycle; P:positive regulation of apoptotic process; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of cell size; P:positive regulation of fibroblast proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of translation; P:protein phosphorylation; P:regulation of cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of gene expression; P:regulation of insulin receptor signaling pathway; P:regulation of lipid biosynthetic process; P:regulation of lipid catabolic process; P:regulation of multicellular organism growth; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to drug; P:response to hyperoxia; P:response to lead ion; P:response to testosterone; P:response to toxic substance; P:signal transduction;|P11802 B2R9A0 B4DNF9 O00576 Q6FG61,Cyclin-dependent kinase 4,Cell division protein kinase 4;PSK-J3;, PF00069;, GO:0005923;GO:0000785;GO:0097129;GO:0000307;GO:0005829;GO:0016592;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005667;GO:0005524;GO:0030332;GO:0004693;GO:0106310;GO:0106311;GO:0044877;GO:0008353;GO:0060612;GO:0031100;GO:0051301;GO:0032869;GO:0071353;GO:1904637;GO:0071222;GO:1904628;GO:0007623;GO:0000082;GO:0030851;GO:0002088;GO:0071157;GO:2000134;GO:0043065;GO:0045787;GO:0008284;GO:0045793;GO:0048146;GO:0010971;GO:0045727;GO:0006468;GO:0051726;GO:0000079;GO:0010468;GO:0046626;GO:0046890;GO:0050994;GO:0040014;GO:0060260;GO:0042493;GO:0055093;GO:0010288;GO:0033574;GO:0009636;GO:0007165;, C:bicellular tight junction; C:chromatin; C:cyclin D2-CDK4 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytosol; C:mediator complex; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:transcription regulator complex;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:adipose tissue development; P:animal organ regeneration; P:cell division; P:cellular response to insulin stimulus; P:cellular response to interleukin-4; P:cellular response to ionomycin; P:cellular response to lipopolysaccharide; P:cellular response to phorbol 13-acetate 12-myristate; P:circadian rhythm; P:G1/S transition of mitotic cell cycle; P:granulocyte differentiation; P:lens development in camera-type eye; P:negative regulation of cell cycle arrest; P:negative regulation of G1/S transition of mitotic cell cycle; P:positive regulation of apoptotic process; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of cell size; P:positive regulation of fibroblast proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of translation; P:protein phosphorylation; P:regulation of cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of gene expression; P:regulation of insulin receptor signaling pathway; P:regulation of lipid biosynthetic process; P:regulation of lipid catabolic process; P:regulation of multicellular organism growth; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to drug; P:response to hyperoxia; P:response to lead ion; P:response to testosterone; P:response to toxic substance; P:signal transduction; scaffold31 indexed_genome mRNA 25699830 25703343 . - . ID=transcript_6809;Q12999 O00577 Q53X76,Tetraspanin-31,Sarcoma-amplified sequence;, PF00335;, GO:0005887;GO:0016020;GO:0008284;, C:integral component of plasma membrane; C:membrane;, , P:positive regulation of cell population proliferation;|Q12999 O00577 Q53X76,Tetraspanin-31,Sarcoma-amplified sequence;, PF00335;, GO:0005887;GO:0016020;GO:0008284;, C:integral component of plasma membrane; C:membrane;, , P:positive regulation of cell population proliferation;|Q12999 O00577 Q53X76,Tetraspanin-31,Sarcoma-amplified sequence;, PF00335;, GO:0005887;GO:0016020;GO:0008284;, C:integral component of plasma membrane; C:membrane;, , P:positive regulation of cell population proliferation; scaffold31 indexed_genome mRNA 25708138 25721056 . + . ID=transcript_6810;Q99490 A8K9F7 O00578 Q548E0 Q8IWU3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2,Centaurin-gamma-1;GTP-binding and GTPase-activating protein 2;Phosphatidylinositol 3-kinase enhancer;, PF12796;PF01412;PF00071;, GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0090543;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0035014;GO:0030295;GO:0019901;GO:0030036;GO:0016197;GO:0043524;GO:0042177;GO:0061903;GO:0045860;GO:0015031;, C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:Flemming body; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:phosphatidylinositol 3-kinase regulator activity; F:protein kinase activator activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:endosomal transport; P:negative regulation of neuron apoptotic process; P:negative regulation of protein catabolic process; P:positive regulation of 1-phosphatidylinositol-3-kinase activity; P:positive regulation of protein kinase activity; P:protein transport;|Q99490 A8K9F7 O00578 Q548E0 Q8IWU3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2,Centaurin-gamma-1;GTP-binding and GTPase-activating protein 2;Phosphatidylinositol 3-kinase enhancer;, PF12796;PF01412;PF00071;, GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0090543;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0035014;GO:0030295;GO:0019901;GO:0030036;GO:0016197;GO:0043524;GO:0042177;GO:0061903;GO:0045860;GO:0015031;, C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:Flemming body; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:phosphatidylinositol 3-kinase regulator activity; F:protein kinase activator activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:endosomal transport; P:negative regulation of neuron apoptotic process; P:negative regulation of protein catabolic process; P:positive regulation of 1-phosphatidylinositol-3-kinase activity; P:positive regulation of protein kinase activity; P:protein transport;|Q99490 A8K9F7 O00578 Q548E0 Q8IWU3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2,Centaurin-gamma-1;GTP-binding and GTPase-activating protein 2;Phosphatidylinositol 3-kinase enhancer;, PF12796;PF01412;PF00071;, GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0090543;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0035014;GO:0030295;GO:0019901;GO:0030036;GO:0016197;GO:0043524;GO:0042177;GO:0061903;GO:0045860;GO:0015031;, C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:Flemming body; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:phosphatidylinositol 3-kinase regulator activity; F:protein kinase activator activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:endosomal transport; P:negative regulation of neuron apoptotic process; P:negative regulation of protein catabolic process; P:positive regulation of 1-phosphatidylinositol-3-kinase activity; P:positive regulation of protein kinase activity; P:protein transport;|Q99490 A8K9F7 O00578 Q548E0 Q8IWU3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2,Centaurin-gamma-1;GTP-binding and GTPase-activating protein 2;Phosphatidylinositol 3-kinase enhancer;, PF12796;PF01412;PF00071;, GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0090543;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0035014;GO:0030295;GO:0019901;GO:0030036;GO:0016197;GO:0043524;GO:0042177;GO:0061903;GO:0045860;GO:0015031;, C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:Flemming body; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:phosphatidylinositol 3-kinase regulator activity; F:protein kinase activator activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:endosomal transport; P:negative regulation of neuron apoptotic process; P:negative regulation of protein catabolic process; P:positive regulation of 1-phosphatidylinositol-3-kinase activity; P:positive regulation of protein kinase activity; P:protein transport;|Q99490 A8K9F7 O00578 Q548E0 Q8IWU3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2,Centaurin-gamma-1;GTP-binding and GTPase-activating protein 2;Phosphatidylinositol 3-kinase enhancer;, PF12796;PF01412;PF00071;, GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0090543;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0035014;GO:0030295;GO:0019901;GO:0030036;GO:0016197;GO:0043524;GO:0042177;GO:0061903;GO:0045860;GO:0015031;, C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:Flemming body; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:phosphatidylinositol 3-kinase regulator activity; F:protein kinase activator activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:endosomal transport; P:negative regulation of neuron apoptotic process; P:negative regulation of protein catabolic process; P:positive regulation of 1-phosphatidylinositol-3-kinase activity; P:positive regulation of protein kinase activity; P:protein transport; scaffold31 indexed_genome mRNA 25744695 25745316 . - . ID=transcript_6811;E7EW91 F8VUH2 G3XA88 O00579 Q6IBL2 Q8IZ58 Q9BW99,Protein OS-9,Amplified in osteosarcoma 9;, PF07915;, GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0000836;GO:0030246;GO:0002020;GO:1904380;GO:1904153;GO:0006621;GO:0006605;GO:0016567;GO:0034976;GO:0030970;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex;, F:carbohydrate binding; F:protease binding;, P:endoplasmic reticulum mannose trimming; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein retention in ER lumen; P:protein targeting; P:protein ubiquitination; P:response to endoplasmic reticulum stress; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold31 indexed_genome mRNA 25791285 25796165 . + . ID=transcript_6812;Q00973 B4DE26 Q8N636,Beta-1,4 N-acetylgalactosaminyltransferase 1 {ECO:0000305},(N-acetylneuraminyl)-galactosylglucosylceramide;GM2/GD2 synthase;GalNAc-T;, PF00535;, GO:0005794;GO:0000139;GO:0030173;GO:0016020;GO:0005886;GO:0003947;GO:0008376;GO:0005975;GO:0001574;GO:0006687;GO:0030259;GO:0019915;GO:0007283;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:plasma membrane;, F:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity; F:acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:ganglioside biosynthetic process; P:glycosphingolipid metabolic process; P:lipid glycosylation; P:lipid storage; P:spermatogenesis;|Q00973 B4DE26 Q8N636,Beta-1,4 N-acetylgalactosaminyltransferase 1 {ECO:0000305},(N-acetylneuraminyl)-galactosylglucosylceramide;GM2/GD2 synthase;GalNAc-T;, PF00535;, GO:0005794;GO:0000139;GO:0030173;GO:0016020;GO:0005886;GO:0003947;GO:0008376;GO:0005975;GO:0001574;GO:0006687;GO:0030259;GO:0019915;GO:0007283;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:plasma membrane;, F:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity; F:acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:ganglioside biosynthetic process; P:glycosphingolipid metabolic process; P:lipid glycosylation; P:lipid storage; P:spermatogenesis;|Q00973 B4DE26 Q8N636,Beta-1,4 N-acetylgalactosaminyltransferase 1 {ECO:0000305},(N-acetylneuraminyl)-galactosylglucosylceramide;GM2/GD2 synthase;GalNAc-T;, PF00535;, GO:0005794;GO:0000139;GO:0030173;GO:0016020;GO:0005886;GO:0003947;GO:0008376;GO:0005975;GO:0001574;GO:0006687;GO:0030259;GO:0019915;GO:0007283;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:plasma membrane;, F:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity; F:acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:ganglioside biosynthetic process; P:glycosphingolipid metabolic process; P:lipid glycosylation; P:lipid storage; P:spermatogenesis;|Q00973 B4DE26 Q8N636,Beta-1,4 N-acetylgalactosaminyltransferase 1 {ECO:0000305},(N-acetylneuraminyl)-galactosylglucosylceramide;GM2/GD2 synthase;GalNAc-T;, PF00535;, GO:0005794;GO:0000139;GO:0030173;GO:0016020;GO:0005886;GO:0003947;GO:0008376;GO:0005975;GO:0001574;GO:0006687;GO:0030259;GO:0019915;GO:0007283;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:plasma membrane;, F:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity; F:acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:ganglioside biosynthetic process; P:glycosphingolipid metabolic process; P:lipid glycosylation; P:lipid storage; P:spermatogenesis;|Q00973 B4DE26 Q8N636,Beta-1,4 N-acetylgalactosaminyltransferase 1 {ECO:0000305},(N-acetylneuraminyl)-galactosylglucosylceramide;GM2/GD2 synthase;GalNAc-T;, PF00535;, GO:0005794;GO:0000139;GO:0030173;GO:0016020;GO:0005886;GO:0003947;GO:0008376;GO:0005975;GO:0001574;GO:0006687;GO:0030259;GO:0019915;GO:0007283;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:plasma membrane;, F:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity; F:acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:ganglioside biosynthetic process; P:glycosphingolipid metabolic process; P:lipid glycosylation; P:lipid storage; P:spermatogenesis; scaffold31 indexed_genome mRNA 25796175 25804934 . + . ID=transcript_6813;Q8NG04 A6NMJ2 B6ZDQ3 Q6ZWI7,Solute carrier family 26 member 10,, PF01740;PF00916;, GO:0016323;GO:0005887;GO:0015301;GO:0015106;GO:0015108;GO:0019531;GO:0008271;GO:0015116;, C:basolateral plasma membrane; C:integral component of plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;|P62244 P39027 P39031 Q3MHD9 Q8C023 Q9BV24,40S ribosomal protein S15a,Small ribosomal subunit protein uS8 {ECO:0000303|PubMed:24524803};, PF00410;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0003723;GO:0003735;GO:0000184;GO:0045787;GO:0008284;GO:0009615;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:response to virus; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q8NG04 A6NMJ2 B6ZDQ3 Q6ZWI7,Solute carrier family 26 member 10,, PF01740;PF00916;, GO:0016323;GO:0005887;GO:0015301;GO:0015106;GO:0015108;GO:0019531;GO:0008271;GO:0015116;, C:basolateral plasma membrane; C:integral component of plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;|Q8NG04 A6NMJ2 B6ZDQ3 Q6ZWI7,Solute carrier family 26 member 10,, PF01740;PF00916;, GO:0016323;GO:0005887;GO:0015301;GO:0015106;GO:0015108;GO:0019531;GO:0008271;GO:0015116;, C:basolateral plasma membrane; C:integral component of plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;|Q8NG04 A6NMJ2 B6ZDQ3 Q6ZWI7,Solute carrier family 26 member 10,, PF01740;PF00916;, GO:0016323;GO:0005887;GO:0015301;GO:0015106;GO:0015108;GO:0019531;GO:0008271;GO:0015116;, C:basolateral plasma membrane; C:integral component of plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;|Q8NG04 A6NMJ2 B6ZDQ3 Q6ZWI7,Solute carrier family 26 member 10,, PF01740;PF00916;, GO:0016323;GO:0005887;GO:0015301;GO:0015106;GO:0015108;GO:0019531;GO:0008271;GO:0015116;, C:basolateral plasma membrane; C:integral component of plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity; scaffold31 indexed_genome mRNA 25805830 25812768 . - . ID=transcript_6814;Q86VW2 A6NJH5 A9CQZ6 F8W7Z4 Q8WV84 Q96E63,Rho guanine nucleotide exchange factor 25,Guanine nucleotide exchange factor GEFT;Rac/Cdc42/Rho exchange factor GEFT;RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT;p63RhoGEF;, PF00621;, GO:0005829;GO:0030016;GO:0005886;GO:0030017;GO:0005085;GO:0007186;GO:0035023;, C:cytosol; C:myofibril; C:plasma membrane; C:sarcomere;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:regulation of Rho protein signal transduction;|O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|Q86VW2 A6NJH5 A9CQZ6 F8W7Z4 Q8WV84 Q96E63,Rho guanine nucleotide exchange factor 25,Guanine nucleotide exchange factor GEFT;Rac/Cdc42/Rho exchange factor GEFT;RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT;p63RhoGEF;, PF00621;, GO:0005829;GO:0030016;GO:0005886;GO:0030017;GO:0005085;GO:0007186;GO:0035023;, C:cytosol; C:myofibril; C:plasma membrane; C:sarcomere;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:regulation of Rho protein signal transduction;|Q86VW2 A6NJH5 A9CQZ6 F8W7Z4 Q8WV84 Q96E63,Rho guanine nucleotide exchange factor 25,Guanine nucleotide exchange factor GEFT;Rac/Cdc42/Rho exchange factor GEFT;RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT;p63RhoGEF;, PF00621;, GO:0005829;GO:0030016;GO:0005886;GO:0030017;GO:0005085;GO:0007186;GO:0035023;, C:cytosol; C:myofibril; C:plasma membrane; C:sarcomere;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:regulation of Rho protein signal transduction;|Q86VW2 A6NJH5 A9CQZ6 F8W7Z4 Q8WV84 Q96E63,Rho guanine nucleotide exchange factor 25,Guanine nucleotide exchange factor GEFT;Rac/Cdc42/Rho exchange factor GEFT;RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT;p63RhoGEF;, PF00621;, GO:0005829;GO:0030016;GO:0005886;GO:0030017;GO:0005085;GO:0007186;GO:0035023;, C:cytosol; C:myofibril; C:plasma membrane; C:sarcomere;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:regulation of Rho protein signal transduction; scaffold31 indexed_genome mRNA 25814334 25817917 . - . ID=transcript_6815;Q8N9I9 Q53ZZ2 Q8NAU6 Q8NDS8,Probable E3 ubiquitin-protein ligase DTX3,Protein deltex-3;RING finger protein 154;RING-type E3 ubiquitin transferase DTX3 {ECO:0000305};, PF18102;, GO:0005737;GO:0005654;GO:0046872;GO:0061630;GO:0007219;GO:0016567;, C:cytoplasm; C:nucleoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:Notch signaling pathway; P:protein ubiquitination;|Q8N9I9 Q53ZZ2 Q8NAU6 Q8NDS8,Probable E3 ubiquitin-protein ligase DTX3,Protein deltex-3;RING finger protein 154;RING-type E3 ubiquitin transferase DTX3 {ECO:0000305};, PF18102;, GO:0005737;GO:0005654;GO:0046872;GO:0061630;GO:0007219;GO:0016567;, C:cytoplasm; C:nucleoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:Notch signaling pathway; P:protein ubiquitination; scaffold31 indexed_genome mRNA 25820612 25823069 . + . ID=transcript_6816;Q8TBX8 B2RDL3 B4DM11 B4DY44 Q9H6N2,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma {ECO:0000305},Phosphatidylinositol 5-phosphate 4-kinase type II gamma;, PF01504;, GO:0005776;GO:0005829;GO:0005783;GO:0070062;GO:0043229;GO:0005654;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0042802;GO:1902635;GO:0090217;GO:0046627;GO:0006661;GO:2000786;GO:0010506;GO:0014066;, C:autophagosome; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular organelle; C:nucleoplasm; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:identical protein binding;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling;|Q8TBX8 B2RDL3 B4DM11 B4DY44 Q9H6N2,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma {ECO:0000305},Phosphatidylinositol 5-phosphate 4-kinase type II gamma;, PF01504;, GO:0005776;GO:0005829;GO:0005783;GO:0070062;GO:0043229;GO:0005654;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0042802;GO:1902635;GO:0090217;GO:0046627;GO:0006661;GO:2000786;GO:0010506;GO:0014066;, C:autophagosome; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular organelle; C:nucleoplasm; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:identical protein binding;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling; scaffold31 indexed_genome mRNA 25844421 25845171 . - . ID=transcript_6817;Q96DN6 Q8N3M0 Q8NA81 Q96Q00,Methyl-CpG-binding domain protein 6,Methyl-CpG-binding protein MBD6;, , GO:0010369;GO:0005694;GO:0001650;GO:0005654;GO:0005634;GO:0003682;GO:0016579;, C:chromocenter; C:chromosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:protein deubiquitination; scaffold31 indexed_genome mRNA 25868751 25881964 . + . ID=transcript_6818;Q13561 B2RBK5 Q86YN2 Q9BW17,Dynactin subunit 2,50 kDa dynein-associated polypeptide;Dynactin complex 50 kDa subunit;p50 dynamitin;, PF04912;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0030286;GO:0070062;GO:0030426;GO:0000776;GO:0016020;GO:0005874;GO:0031982;GO:0042802;GO:0019901;GO:0030507;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0032402;GO:0007080;GO:0007052;GO:0071539;GO:0010389;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:dynein complex; C:extracellular exosome; C:growth cone; C:kinetochore; C:membrane; C:microtubule; C:vesicle;, F:identical protein binding; F:protein kinase binding; F:spectrin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q13561 B2RBK5 Q86YN2 Q9BW17,Dynactin subunit 2,50 kDa dynein-associated polypeptide;Dynactin complex 50 kDa subunit;p50 dynamitin;, PF04912;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0030286;GO:0070062;GO:0030426;GO:0000776;GO:0016020;GO:0005874;GO:0031982;GO:0042802;GO:0019901;GO:0030507;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0032402;GO:0007080;GO:0007052;GO:0071539;GO:0010389;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:dynein complex; C:extracellular exosome; C:growth cone; C:kinetochore; C:membrane; C:microtubule; C:vesicle;, F:identical protein binding; F:protein kinase binding; F:spectrin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q13561 B2RBK5 Q86YN2 Q9BW17,Dynactin subunit 2,50 kDa dynein-associated polypeptide;Dynactin complex 50 kDa subunit;p50 dynamitin;, PF04912;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0030286;GO:0070062;GO:0030426;GO:0000776;GO:0016020;GO:0005874;GO:0031982;GO:0042802;GO:0019901;GO:0030507;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0032402;GO:0007080;GO:0007052;GO:0071539;GO:0010389;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:dynein complex; C:extracellular exosome; C:growth cone; C:kinetochore; C:membrane; C:microtubule; C:vesicle;, F:identical protein binding; F:protein kinase binding; F:spectrin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q13561 B2RBK5 Q86YN2 Q9BW17,Dynactin subunit 2,50 kDa dynein-associated polypeptide;Dynactin complex 50 kDa subunit;p50 dynamitin;, PF04912;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0030286;GO:0070062;GO:0030426;GO:0000776;GO:0016020;GO:0005874;GO:0031982;GO:0042802;GO:0019901;GO:0030507;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0032402;GO:0007080;GO:0007052;GO:0071539;GO:0010389;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:dynein complex; C:extracellular exosome; C:growth cone; C:kinetochore; C:membrane; C:microtubule; C:vesicle;, F:identical protein binding; F:protein kinase binding; F:spectrin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q13561 B2RBK5 Q86YN2 Q9BW17,Dynactin subunit 2,50 kDa dynein-associated polypeptide;Dynactin complex 50 kDa subunit;p50 dynamitin;, PF04912;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0030286;GO:0070062;GO:0030426;GO:0000776;GO:0016020;GO:0005874;GO:0031982;GO:0042802;GO:0019901;GO:0030507;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0032402;GO:0007080;GO:0007052;GO:0071539;GO:0010389;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:dynein complex; C:extracellular exosome; C:growth cone; C:kinetochore; C:membrane; C:microtubule; C:vesicle;, F:identical protein binding; F:protein kinase binding; F:spectrin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; scaffold31 indexed_genome mRNA 25882416 25884093 . - . ID=transcript_6819;Q96DN6 Q8N3M0 Q8NA81 Q96Q00,Methyl-CpG-binding domain protein 6,Methyl-CpG-binding protein MBD6;, , GO:0010369;GO:0005694;GO:0001650;GO:0005654;GO:0005634;GO:0003682;GO:0016579;, C:chromocenter; C:chromosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:protein deubiquitination;|Q96DN6 Q8N3M0 Q8NA81 Q96Q00,Methyl-CpG-binding domain protein 6,Methyl-CpG-binding protein MBD6;, , GO:0010369;GO:0005694;GO:0001650;GO:0005654;GO:0005634;GO:0003682;GO:0016579;, C:chromocenter; C:chromosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:protein deubiquitination; scaffold31 indexed_genome mRNA 25884210 25887570 . - . ID=transcript_6820;Q96DN6 Q8N3M0 Q8NA81 Q96Q00,Methyl-CpG-binding domain protein 6,Methyl-CpG-binding protein MBD6;, , GO:0010369;GO:0005694;GO:0001650;GO:0005654;GO:0005634;GO:0003682;GO:0016579;, C:chromocenter; C:chromosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:protein deubiquitination; scaffold32 indexed_genome mRNA 132271 145020 . + . ID=transcript_6821;O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40,Glutaminase kidney isoform, mitochondrial,K-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005829;GO:0005759;GO:0005739;GO:0045202;GO:0004359;GO:0007268;GO:0006537;GO:0090461;GO:0006543;GO:0009064;GO:0006836;GO:0051289;GO:0002087;GO:0001967;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:synapse;, F:glutaminase activity;, P:chemical synaptic transmission; P:glutamate biosynthetic process; P:glutamate homeostasis; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:protein homotetramerization; P:regulation of respiratory gaseous exchange by nervous system process; P:suckling behavior;|O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40,Glutaminase kidney isoform, mitochondrial,K-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005829;GO:0005759;GO:0005739;GO:0045202;GO:0004359;GO:0007268;GO:0006537;GO:0090461;GO:0006543;GO:0009064;GO:0006836;GO:0051289;GO:0002087;GO:0001967;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:synapse;, F:glutaminase activity;, P:chemical synaptic transmission; P:glutamate biosynthetic process; P:glutamate homeostasis; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:protein homotetramerization; P:regulation of respiratory gaseous exchange by nervous system process; P:suckling behavior; scaffold32 indexed_genome mRNA 145570 166665 . + . ID=transcript_6822;O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40,Glutaminase kidney isoform, mitochondrial,K-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005829;GO:0005759;GO:0005739;GO:0045202;GO:0004359;GO:0007268;GO:0006537;GO:0090461;GO:0006543;GO:0009064;GO:0006836;GO:0051289;GO:0002087;GO:0001967;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:synapse;, F:glutaminase activity;, P:chemical synaptic transmission; P:glutamate biosynthetic process; P:glutamate homeostasis; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:protein homotetramerization; P:regulation of respiratory gaseous exchange by nervous system process; P:suckling behavior;|O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40,Glutaminase kidney isoform, mitochondrial,K-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005829;GO:0005759;GO:0005739;GO:0045202;GO:0004359;GO:0007268;GO:0006537;GO:0090461;GO:0006543;GO:0009064;GO:0006836;GO:0051289;GO:0002087;GO:0001967;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:synapse;, F:glutaminase activity;, P:chemical synaptic transmission; P:glutamate biosynthetic process; P:glutamate homeostasis; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:protein homotetramerization; P:regulation of respiratory gaseous exchange by nervous system process; P:suckling behavior;|O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40,Glutaminase kidney isoform, mitochondrial,K-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005829;GO:0005759;GO:0005739;GO:0045202;GO:0004359;GO:0007268;GO:0006537;GO:0090461;GO:0006543;GO:0009064;GO:0006836;GO:0051289;GO:0002087;GO:0001967;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:synapse;, F:glutaminase activity;, P:chemical synaptic transmission; P:glutamate biosynthetic process; P:glutamate homeostasis; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:protein homotetramerization; P:regulation of respiratory gaseous exchange by nervous system process; P:suckling behavior; scaffold32 indexed_genome mRNA 168530 171836 . + . ID=transcript_6823;O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40,Glutaminase kidney isoform, mitochondrial,K-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005829;GO:0005759;GO:0005739;GO:0045202;GO:0004359;GO:0007268;GO:0006537;GO:0090461;GO:0006543;GO:0009064;GO:0006836;GO:0051289;GO:0002087;GO:0001967;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:synapse;, F:glutaminase activity;, P:chemical synaptic transmission; P:glutamate biosynthetic process; P:glutamate homeostasis; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:protein homotetramerization; P:regulation of respiratory gaseous exchange by nervous system process; P:suckling behavior; scaffold32 indexed_genome mRNA 178018 182949 . + . ID=transcript_6824;O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40,Glutaminase kidney isoform, mitochondrial,K-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005829;GO:0005759;GO:0005739;GO:0045202;GO:0004359;GO:0007268;GO:0006537;GO:0090461;GO:0006543;GO:0009064;GO:0006836;GO:0051289;GO:0002087;GO:0001967;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:synapse;, F:glutaminase activity;, P:chemical synaptic transmission; P:glutamate biosynthetic process; P:glutamate homeostasis; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:protein homotetramerization; P:regulation of respiratory gaseous exchange by nervous system process; P:suckling behavior; scaffold32 indexed_genome mRNA 212535 215611 . + . ID=transcript_6825;O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40,Glutaminase kidney isoform, mitochondrial,K-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005829;GO:0005759;GO:0005739;GO:0045202;GO:0004359;GO:0007268;GO:0006537;GO:0090461;GO:0006543;GO:0009064;GO:0006836;GO:0051289;GO:0002087;GO:0001967;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:synapse;, F:glutaminase activity;, P:chemical synaptic transmission; P:glutamate biosynthetic process; P:glutamate homeostasis; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:protein homotetramerization; P:regulation of respiratory gaseous exchange by nervous system process; P:suckling behavior; scaffold32 indexed_genome mRNA 221811 259969 . - . ID=transcript_6826;P42224 A8K989 B2RCA0 D2KFR8 D3DPI7 Q53S88 Q53XW4 Q68D00 Q9UDL5,Signal transducer and activator of transcription 1-alpha/beta,Transcription factor ISGF-3 components p91/p84;, PF00017;PF12162;PF01017;PF02864;PF02865;, GO:0030424;GO:0000785;GO:0005737;GO:0005829;GO:0030425;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0045296;GO:0003700;GO:0000981;GO:0003690;GO:0019899;GO:0035035;GO:0042393;GO:0042802;GO:0035257;GO:1990841;GO:0042803;GO:0070491;GO:0000978;GO:0000979;GO:0005164;GO:0044389;GO:0008015;GO:0035458;GO:0071346;GO:0019221;GO:0006952;GO:0051607;GO:0060333;GO:0038114;GO:0070106;GO:0070757;GO:0070102;GO:0038113;GO:0010742;GO:0072162;GO:0072136;GO:0046725;GO:0016525;GO:0001937;GO:0043124;GO:0003340;GO:0072308;GO:0000122;GO:0002230;GO:0045648;GO:0032727;GO:0002053;GO:0048661;GO:0045944;GO:0007221;GO:0045893;GO:0007259;GO:0042981;GO:0042127;GO:0060334;GO:0006355;GO:0061326;GO:0051591;GO:0034097;GO:0035456;GO:0043434;GO:0033209;GO:0060337;GO:0016032;, C:axon; C:chromatin; C:cytoplasm; C:cytosol; C:dendrite; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:cadherin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:enzyme binding; F:histone acetyltransferase binding; F:histone binding; F:identical protein binding; F:nuclear hormone receptor binding; F:promoter-specific chromatin binding; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:tumor necrosis factor receptor binding; F:ubiquitin-like protein ligase binding;, P:blood circulation; P:cellular response to interferon-beta; P:cellular response to interferon-gamma; P:cytokine-mediated signaling pathway; P:defense response; P:defense response to virus; P:interferon-gamma-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:macrophage derived foam cell differentiation; P:metanephric mesenchymal cell differentiation; P:metanephric mesenchymal cell proliferation involved in metanephros development; P:negative regulation by virus of viral protein levels in host cell; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; P:negative regulation of metanephric nephron tubule epithelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of defense response to virus by host; P:positive regulation of erythrocyte differentiation; P:positive regulation of interferon-alpha production; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:receptor signaling pathway via JAK-STAT; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of transcription, DNA-templated; P:renal tubule development; P:response to cAMP; P:response to cytokine; P:response to interferon-beta; P:response to peptide hormone; P:tumor necrosis factor-mediated signaling pathway; P:type I interferon signaling pathway; P:viral process;|P42224 A8K989 B2RCA0 D2KFR8 D3DPI7 Q53S88 Q53XW4 Q68D00 Q9UDL5,Signal transducer and activator of transcription 1-alpha/beta,Transcription factor ISGF-3 components p91/p84;, PF00017;PF12162;PF01017;PF02864;PF02865;, GO:0030424;GO:0000785;GO:0005737;GO:0005829;GO:0030425;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0045296;GO:0003700;GO:0000981;GO:0003690;GO:0019899;GO:0035035;GO:0042393;GO:0042802;GO:0035257;GO:1990841;GO:0042803;GO:0070491;GO:0000978;GO:0000979;GO:0005164;GO:0044389;GO:0008015;GO:0035458;GO:0071346;GO:0019221;GO:0006952;GO:0051607;GO:0060333;GO:0038114;GO:0070106;GO:0070757;GO:0070102;GO:0038113;GO:0010742;GO:0072162;GO:0072136;GO:0046725;GO:0016525;GO:0001937;GO:0043124;GO:0003340;GO:0072308;GO:0000122;GO:0002230;GO:0045648;GO:0032727;GO:0002053;GO:0048661;GO:0045944;GO:0007221;GO:0045893;GO:0007259;GO:0042981;GO:0042127;GO:0060334;GO:0006355;GO:0061326;GO:0051591;GO:0034097;GO:0035456;GO:0043434;GO:0033209;GO:0060337;GO:0016032;, C:axon; C:chromatin; C:cytoplasm; C:cytosol; C:dendrite; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:cadherin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:enzyme binding; F:histone acetyltransferase binding; F:histone binding; F:identical protein binding; F:nuclear hormone receptor binding; F:promoter-specific chromatin binding; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:tumor necrosis factor receptor binding; F:ubiquitin-like protein ligase binding;, P:blood circulation; P:cellular response to interferon-beta; P:cellular response to interferon-gamma; P:cytokine-mediated signaling pathway; P:defense response; P:defense response to virus; P:interferon-gamma-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:macrophage derived foam cell differentiation; P:metanephric mesenchymal cell differentiation; P:metanephric mesenchymal cell proliferation involved in metanephros development; P:negative regulation by virus of viral protein levels in host cell; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; P:negative regulation of metanephric nephron tubule epithelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of defense response to virus by host; P:positive regulation of erythrocyte differentiation; P:positive regulation of interferon-alpha production; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:receptor signaling pathway via JAK-STAT; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of transcription, DNA-templated; P:renal tubule development; P:response to cAMP; P:response to cytokine; P:response to interferon-beta; P:response to peptide hormone; P:tumor necrosis factor-mediated signaling pathway; P:type I interferon signaling pathway; P:viral process; scaffold32 indexed_genome mRNA 269863 275984 . + . ID=transcript_6827;Q14765 Q96NZ6,Signal transducer and activator of transcription 4,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0003700;GO:0000981;GO:0042802;GO:0000978;GO:0019221;GO:0006952;GO:0035722;GO:0038114;GO:0038155;GO:0070757;GO:0045944;GO:0007259;GO:0042127;GO:0006357;GO:0043434;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:interleukin-12-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; scaffold32 indexed_genome mRNA 275987 369626 . - . ID=transcript_6828;Q14765 Q96NZ6,Signal transducer and activator of transcription 4,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0003700;GO:0000981;GO:0042802;GO:0000978;GO:0019221;GO:0006952;GO:0035722;GO:0038114;GO:0038155;GO:0070757;GO:0045944;GO:0007259;GO:0042127;GO:0006357;GO:0043434;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:interleukin-12-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; scaffold32 indexed_genome mRNA 494040 682164 . + . ID=transcript_6829;O43795 O43794 Q7Z6L5,Unconventional myosin-Ib,MYH-1c;Myosin I alpha;, PF00612;PF00063;PF06017;, GO:0015629;GO:0005884;GO:0045177;GO:0005903;GO:0071944;GO:0005737;GO:0005769;GO:0010008;GO:0070062;GO:0030175;GO:0005902;GO:0016459;GO:0048471;GO:0005886;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0045296;GO:0005516;GO:0000146;GO:0005547;GO:0005546;GO:0051017;GO:0007015;GO:0030048;GO:0006892;GO:0030050;, C:actin cytoskeleton; C:actin filament; C:apical part of cell; C:brush border; C:cell periphery; C:cytoplasm; C:early endosome; C:endosome membrane; C:extracellular exosome; C:filopodium; C:microvillus; C:myosin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:cadherin binding; F:calmodulin binding; F:microfilament motor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament bundle assembly; P:actin filament organization; P:actin filament-based movement; P:post-Golgi vesicle-mediated transport; P:vesicle transport along actin filament;|O43795 O43794 Q7Z6L5,Unconventional myosin-Ib,MYH-1c;Myosin I alpha;, PF00612;PF00063;PF06017;, GO:0015629;GO:0005884;GO:0045177;GO:0005903;GO:0071944;GO:0005737;GO:0005769;GO:0010008;GO:0070062;GO:0030175;GO:0005902;GO:0016459;GO:0048471;GO:0005886;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0045296;GO:0005516;GO:0000146;GO:0005547;GO:0005546;GO:0051017;GO:0007015;GO:0030048;GO:0006892;GO:0030050;, C:actin cytoskeleton; C:actin filament; C:apical part of cell; C:brush border; C:cell periphery; C:cytoplasm; C:early endosome; C:endosome membrane; C:extracellular exosome; C:filopodium; C:microvillus; C:myosin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:cadherin binding; F:calmodulin binding; F:microfilament motor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament bundle assembly; P:actin filament organization; P:actin filament-based movement; P:post-Golgi vesicle-mediated transport; P:vesicle transport along actin filament;|O43795 O43794 Q7Z6L5,Unconventional myosin-Ib,MYH-1c;Myosin I alpha;, PF00612;PF00063;PF06017;, GO:0015629;GO:0005884;GO:0045177;GO:0005903;GO:0071944;GO:0005737;GO:0005769;GO:0010008;GO:0070062;GO:0030175;GO:0005902;GO:0016459;GO:0048471;GO:0005886;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0045296;GO:0005516;GO:0000146;GO:0005547;GO:0005546;GO:0051017;GO:0007015;GO:0030048;GO:0006892;GO:0030050;, C:actin cytoskeleton; C:actin filament; C:apical part of cell; C:brush border; C:cell periphery; C:cytoplasm; C:early endosome; C:endosome membrane; C:extracellular exosome; C:filopodium; C:microvillus; C:myosin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:cadherin binding; F:calmodulin binding; F:microfilament motor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament bundle assembly; P:actin filament organization; P:actin filament-based movement; P:post-Golgi vesicle-mediated transport; P:vesicle transport along actin filament;|O43795 O43794 Q7Z6L5,Unconventional myosin-Ib,MYH-1c;Myosin I alpha;, PF00612;PF00063;PF06017;, GO:0015629;GO:0005884;GO:0045177;GO:0005903;GO:0071944;GO:0005737;GO:0005769;GO:0010008;GO:0070062;GO:0030175;GO:0005902;GO:0016459;GO:0048471;GO:0005886;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0045296;GO:0005516;GO:0000146;GO:0005547;GO:0005546;GO:0051017;GO:0007015;GO:0030048;GO:0006892;GO:0030050;, C:actin cytoskeleton; C:actin filament; C:apical part of cell; C:brush border; C:cell periphery; C:cytoplasm; C:early endosome; C:endosome membrane; C:extracellular exosome; C:filopodium; C:microvillus; C:myosin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:cadherin binding; F:calmodulin binding; F:microfilament motor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament bundle assembly; P:actin filament organization; P:actin filament-based movement; P:post-Golgi vesicle-mediated transport; P:vesicle transport along actin filament;|O43795 O43794 Q7Z6L5,Unconventional myosin-Ib,MYH-1c;Myosin I alpha;, PF00612;PF00063;PF06017;, GO:0015629;GO:0005884;GO:0045177;GO:0005903;GO:0071944;GO:0005737;GO:0005769;GO:0010008;GO:0070062;GO:0030175;GO:0005902;GO:0016459;GO:0048471;GO:0005886;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0045296;GO:0005516;GO:0000146;GO:0005547;GO:0005546;GO:0051017;GO:0007015;GO:0030048;GO:0006892;GO:0030050;, C:actin cytoskeleton; C:actin filament; C:apical part of cell; C:brush border; C:cell periphery; C:cytoplasm; C:early endosome; C:endosome membrane; C:extracellular exosome; C:filopodium; C:microvillus; C:myosin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:cadherin binding; F:calmodulin binding; F:microfilament motor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament bundle assembly; P:actin filament organization; P:actin filament-based movement; P:post-Golgi vesicle-mediated transport; P:vesicle transport along actin filament; scaffold32 indexed_genome mRNA 954337 962711 . - . ID=transcript_6830;Q96AH0 Q658Y8 Q9H5X6,SOSS complex subunit B2,Nucleic acid-binding protein 1;Oligonucleotide/oligosaccharide-binding fold-containing protein 2A;Sensor of single-strand DNA complex subunit B2;Sensor of ssDNA subunit B2;Single-stranded DNA-binding protein 2;, , GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0003677;GO:0003723;GO:0003697;GO:0006974;GO:0006281;GO:0000724;GO:0044818;GO:0010212;GO:0042795;, C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, F:DNA binding; F:RNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:double-strand break repair via homologous recombination; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA transcription by RNA polymerase II;|Q96AH0 Q658Y8 Q9H5X6,SOSS complex subunit B2,Nucleic acid-binding protein 1;Oligonucleotide/oligosaccharide-binding fold-containing protein 2A;Sensor of single-strand DNA complex subunit B2;Sensor of ssDNA subunit B2;Single-stranded DNA-binding protein 2;, , GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0003677;GO:0003723;GO:0003697;GO:0006974;GO:0006281;GO:0000724;GO:0044818;GO:0010212;GO:0042795;, C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, F:DNA binding; F:RNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:double-strand break repair via homologous recombination; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA transcription by RNA polymerase II;|Q96AH0 Q658Y8 Q9H5X6,SOSS complex subunit B2,Nucleic acid-binding protein 1;Oligonucleotide/oligosaccharide-binding fold-containing protein 2A;Sensor of single-strand DNA complex subunit B2;Sensor of ssDNA subunit B2;Single-stranded DNA-binding protein 2;, , GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0003677;GO:0003723;GO:0003697;GO:0006974;GO:0006281;GO:0000724;GO:0044818;GO:0010212;GO:0042795;, C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, F:DNA binding; F:RNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:double-strand break repair via homologous recombination; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA transcription by RNA polymerase II;|Q96AH0 Q658Y8 Q9H5X6,SOSS complex subunit B2,Nucleic acid-binding protein 1;Oligonucleotide/oligosaccharide-binding fold-containing protein 2A;Sensor of single-strand DNA complex subunit B2;Sensor of ssDNA subunit B2;Single-stranded DNA-binding protein 2;, , GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0003677;GO:0003723;GO:0003697;GO:0006974;GO:0006281;GO:0000724;GO:0044818;GO:0010212;GO:0042795;, C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, F:DNA binding; F:RNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:double-strand break repair via homologous recombination; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA transcription by RNA polymerase II;|Q96AH0 Q658Y8 Q9H5X6,SOSS complex subunit B2,Nucleic acid-binding protein 1;Oligonucleotide/oligosaccharide-binding fold-containing protein 2A;Sensor of single-strand DNA complex subunit B2;Sensor of ssDNA subunit B2;Single-stranded DNA-binding protein 2;, , GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0003677;GO:0003723;GO:0003697;GO:0006974;GO:0006281;GO:0000724;GO:0044818;GO:0010212;GO:0042795;, C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, F:DNA binding; F:RNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:double-strand break repair via homologous recombination; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA transcription by RNA polymerase II; scaffold32 indexed_genome mRNA 1125416 1140682 . - . ID=transcript_6831;O95810,Caveolae-associated protein 2 {ECO:0000312|HGNC:HGNC:10690},Cavin-2;PS-p68;Phosphatidylserine-binding protein;Serum deprivation-response protein;, PF15237;, GO:0005901;GO:0005737;GO:0005829;GO:0045121;GO:0005654;GO:0005886;GO:0001786;GO:0005543;GO:0005080;GO:0097320;, C:caveola; C:cytoplasm; C:cytosol; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:phosphatidylserine binding; F:phospholipid binding; F:protein kinase C binding;, P:plasma membrane tubulation; scaffold32 indexed_genome mRNA 1255729 1526503 . - . ID=transcript_6832;Q9UK65,Tomoregulin-2,Hyperplastic polyposis protein 1;Transmembrane protein with EGF-like and two follistatin-like domains;, PF07648;, GO:0005604;GO:0005576;GO:0016021;GO:0005886;GO:0009887;GO:0016477;GO:0030336;GO:0045720;GO:0051497;GO:0034446;GO:0009888;GO:0044319;, C:basement membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane;, , P:animal organ morphogenesis; P:cell migration; P:negative regulation of cell migration; P:negative regulation of integrin biosynthetic process; P:negative regulation of stress fiber assembly; P:substrate adhesion-dependent cell spreading; P:tissue development; P:wound healing, spreading of cells; scaffold32 indexed_genome mRNA 4622000 4660878 . + . ID=transcript_6833;Q9ULF5 A8K5C6 B4DGU0 Q3MJA4 Q68CR5 Q6DKH6 Q9Y3Z1,Zinc transporter ZIP10,Solute carrier family 39 member 10;Zrt- and Irt-like protein 10;, PF02535;, GO:0005887;GO:0005385;GO:0006882;GO:0002903;GO:0030890;GO:0050861;GO:1903615;GO:0071578;, C:integral component of plasma membrane;, F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:negative regulation of B cell apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of protein tyrosine phosphatase activity; P:zinc ion import across plasma membrane;|Q9ULF5 A8K5C6 B4DGU0 Q3MJA4 Q68CR5 Q6DKH6 Q9Y3Z1,Zinc transporter ZIP10,Solute carrier family 39 member 10;Zrt- and Irt-like protein 10;, PF02535;, GO:0005887;GO:0005385;GO:0006882;GO:0002903;GO:0030890;GO:0050861;GO:1903615;GO:0071578;, C:integral component of plasma membrane;, F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:negative regulation of B cell apoptotic process; P:positive regulation of B cell proliferation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of protein tyrosine phosphatase activity; P:zinc ion import across plasma membrane; scaffold32 indexed_genome mRNA 4662895 4749042 . - . ID=transcript_6834;Q8N1Z2 Q9UMS3 Q9Y2F3,Dynein heavy chain 7, axonemal,Axonemal beta dynein heavy chain 7;Ciliary dynein heavy chain 7;Dynein heavy chain-like protein 2;hDHC2;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005929;GO:0005829;GO:0030286;GO:0036156;GO:0005874;GO:0005524;GO:0008569;GO:0005509;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0036159;GO:0007018;, C:axonemal dynein complex; C:cilium; C:cytosol; C:dynein complex; C:inner dynein arm; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:calcium ion binding; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:inner dynein arm assembly; P:microtubule-based movement; scaffold32 indexed_genome mRNA 4953377 4983411 . - . ID=transcript_6835;O94768,Serine/threonine-protein kinase 17B,DAP kinase-related apoptosis-inducing protein kinase 2;, PF00069;, GO:0015629;GO:0005793;GO:0005634;GO:0005886;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0035556;GO:0043065;GO:2000271;GO:0046777;GO:0006468;, C:actin cytoskeleton; C:endoplasmic reticulum-Golgi intermediate compartment; C:nucleus; C:plasma membrane;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of fibroblast apoptotic process; P:protein autophosphorylation; P:protein phosphorylation;|O94768,Serine/threonine-protein kinase 17B,DAP kinase-related apoptosis-inducing protein kinase 2;, PF00069;, GO:0015629;GO:0005793;GO:0005634;GO:0005886;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0035556;GO:0043065;GO:2000271;GO:0046777;GO:0006468;, C:actin cytoskeleton; C:endoplasmic reticulum-Golgi intermediate compartment; C:nucleus; C:plasma membrane;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of fibroblast apoptotic process; P:protein autophosphorylation; P:protein phosphorylation; scaffold32 indexed_genome mRNA 5006098 5144441 . - . ID=transcript_6836;Q9P2P5 B8ZZB4 Q17RT5 Q68DF8 Q9NPS9,E3 ubiquitin-protein ligase HECW2,HECT, C2 and WW domain-containing protein 2;HECT-type E3 ubiquitin transferase HECW2;NEDD4-like E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF18436;PF16562;PF00397;, GO:0005737;GO:0072686;GO:0061630;GO:2000650;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0048814;GO:0030071;, C:cytoplasm; C:mitotic spindle;, F:ubiquitin protein ligase activity;, P:negative regulation of sodium ion transmembrane transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of mitotic metaphase/anaphase transition;|Q9P2P5 B8ZZB4 Q17RT5 Q68DF8 Q9NPS9,E3 ubiquitin-protein ligase HECW2,HECT, C2 and WW domain-containing protein 2;HECT-type E3 ubiquitin transferase HECW2;NEDD4-like E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF18436;PF16562;PF00397;, GO:0005737;GO:0072686;GO:0061630;GO:2000650;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0048814;GO:0030071;, C:cytoplasm; C:mitotic spindle;, F:ubiquitin protein ligase activity;, P:negative regulation of sodium ion transmembrane transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of mitotic metaphase/anaphase transition;|Q9P2P5 B8ZZB4 Q17RT5 Q68DF8 Q9NPS9,E3 ubiquitin-protein ligase HECW2,HECT, C2 and WW domain-containing protein 2;HECT-type E3 ubiquitin transferase HECW2;NEDD4-like E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF18436;PF16562;PF00397;, GO:0005737;GO:0072686;GO:0061630;GO:2000650;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0048814;GO:0030071;, C:cytoplasm; C:mitotic spindle;, F:ubiquitin protein ligase activity;, P:negative regulation of sodium ion transmembrane transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of mitotic metaphase/anaphase transition;|Q9P2P5 B8ZZB4 Q17RT5 Q68DF8 Q9NPS9,E3 ubiquitin-protein ligase HECW2,HECT, C2 and WW domain-containing protein 2;HECT-type E3 ubiquitin transferase HECW2;NEDD4-like E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF18436;PF16562;PF00397;, GO:0005737;GO:0072686;GO:0061630;GO:2000650;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0048814;GO:0030071;, C:cytoplasm; C:mitotic spindle;, F:ubiquitin protein ligase activity;, P:negative regulation of sodium ion transmembrane transporter activity; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of dendrite morphogenesis; P:regulation of mitotic metaphase/anaphase transition; scaffold32 indexed_genome mRNA 5484696 5520455 . + . ID=transcript_6837;Q8NCX0 Q6P5U6 Q6P663 Q8N8V5,Coiled-coil domain-containing protein 150 scaffold32 indexed_genome mRNA 5537062 5576608 . + . ID=transcript_6838;Q8NCX0 Q6P5U6 Q6P663 Q8N8V5,Coiled-coil domain-containing protein 150|Q8NCX0 Q6P5U6 Q6P663 Q8N8V5,Coiled-coil domain-containing protein 150 scaffold32 indexed_genome mRNA 5576610 5581194 . + . ID=transcript_6839;Q8NCX0 Q6P5U6 Q6P663 Q8N8V5,Coiled-coil domain-containing protein 150 scaffold32 indexed_genome mRNA 5611296 5635660 . - . ID=transcript_6840;Q9Y5Q9 Q4ZG48 Q86XJ8 Q8WX84 Q96B44 Q9H5I8 Q9NT97,General transcription factor 3C polypeptide 3,Transcription factor IIIC 102 kDa subunit;Transcription factor IIIC subunit gamma;, PF13181;, GO:0031965;GO:0005730;GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0006383;GO:0042797;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III;|Q9Y5Q9 Q4ZG48 Q86XJ8 Q8WX84 Q96B44 Q9H5I8 Q9NT97,General transcription factor 3C polypeptide 3,Transcription factor IIIC 102 kDa subunit;Transcription factor IIIC subunit gamma;, PF13181;, GO:0031965;GO:0005730;GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0006383;GO:0042797;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III;|Q9Y5Q9 Q4ZG48 Q86XJ8 Q8WX84 Q96B44 Q9H5I8 Q9NT97,General transcription factor 3C polypeptide 3,Transcription factor IIIC 102 kDa subunit;Transcription factor IIIC subunit gamma;, PF13181;, GO:0031965;GO:0005730;GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0006383;GO:0042797;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III; scaffold32 indexed_genome mRNA 5635686 5639619 . - . ID=transcript_6841;Q9Y5Q9 Q4ZG48 Q86XJ8 Q8WX84 Q96B44 Q9H5I8 Q9NT97,General transcription factor 3C polypeptide 3,Transcription factor IIIC 102 kDa subunit;Transcription factor IIIC subunit gamma;, PF13181;, GO:0031965;GO:0005730;GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0006383;GO:0042797;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III; scaffold32 indexed_genome mRNA 5668749 5679845 . - . ID=transcript_6842;Q75T13 Q4G0R8 Q4ZG47 Q53SM0 Q6AW92 Q6UWV4 Q9HA24,GPI inositol-deacylase,Post-GPI attachment to proteins factor 1;, PF07819;, GO:0005783;GO:0005789;GO:0016021;GO:0050185;GO:0009948;GO:0016255;GO:0009880;GO:0006888;GO:0021871;GO:0006505;GO:1902953;GO:0015031;GO:0007605;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:phosphatidylinositol deacylase activity;, P:anterior/posterior axis specification; P:attachment of GPI anchor to protein; P:embryonic pattern specification; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:forebrain regionalization; P:GPI anchor metabolic process; P:positive regulation of ER to Golgi vesicle-mediated transport; P:protein transport; P:sensory perception of sound;|Q75T13 Q4G0R8 Q4ZG47 Q53SM0 Q6AW92 Q6UWV4 Q9HA24,GPI inositol-deacylase,Post-GPI attachment to proteins factor 1;, PF07819;, GO:0005783;GO:0005789;GO:0016021;GO:0050185;GO:0009948;GO:0016255;GO:0009880;GO:0006888;GO:0021871;GO:0006505;GO:1902953;GO:0015031;GO:0007605;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:phosphatidylinositol deacylase activity;, P:anterior/posterior axis specification; P:attachment of GPI anchor to protein; P:embryonic pattern specification; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:forebrain regionalization; P:GPI anchor metabolic process; P:positive regulation of ER to Golgi vesicle-mediated transport; P:protein transport; P:sensory perception of sound; scaffold32 indexed_genome mRNA 5686309 5745789 . - . ID=transcript_6843;Q75T13 Q4G0R8 Q4ZG47 Q53SM0 Q6AW92 Q6UWV4 Q9HA24,GPI inositol-deacylase,Post-GPI attachment to proteins factor 1;, PF07819;, GO:0005783;GO:0005789;GO:0016021;GO:0050185;GO:0009948;GO:0016255;GO:0009880;GO:0006888;GO:0021871;GO:0006505;GO:1902953;GO:0015031;GO:0007605;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:phosphatidylinositol deacylase activity;, P:anterior/posterior axis specification; P:attachment of GPI anchor to protein; P:embryonic pattern specification; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:forebrain regionalization; P:GPI anchor metabolic process; P:positive regulation of ER to Golgi vesicle-mediated transport; P:protein transport; P:sensory perception of sound;|Q75T13 Q4G0R8 Q4ZG47 Q53SM0 Q6AW92 Q6UWV4 Q9HA24,GPI inositol-deacylase,Post-GPI attachment to proteins factor 1;, PF07819;, GO:0005783;GO:0005789;GO:0016021;GO:0050185;GO:0009948;GO:0016255;GO:0009880;GO:0006888;GO:0021871;GO:0006505;GO:1902953;GO:0015031;GO:0007605;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:phosphatidylinositol deacylase activity;, P:anterior/posterior axis specification; P:attachment of GPI anchor to protein; P:embryonic pattern specification; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:forebrain regionalization; P:GPI anchor metabolic process; P:positive regulation of ER to Golgi vesicle-mediated transport; P:protein transport; P:sensory perception of sound;|Q75T13 Q4G0R8 Q4ZG47 Q53SM0 Q6AW92 Q6UWV4 Q9HA24,GPI inositol-deacylase,Post-GPI attachment to proteins factor 1;, PF07819;, GO:0005783;GO:0005789;GO:0016021;GO:0050185;GO:0009948;GO:0016255;GO:0009880;GO:0006888;GO:0021871;GO:0006505;GO:1902953;GO:0015031;GO:0007605;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:phosphatidylinositol deacylase activity;, P:anterior/posterior axis specification; P:attachment of GPI anchor to protein; P:embryonic pattern specification; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:forebrain regionalization; P:GPI anchor metabolic process; P:positive regulation of ER to Golgi vesicle-mediated transport; P:protein transport; P:sensory perception of sound; scaffold32 indexed_genome mRNA 5801565 5806183 . + . ID=transcript_6844;O15084 B4DES5 Q1WWL4 Q29RW6 Q3B857 Q6ULS0 Q6ZT57,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A,Ankyrin repeat domain-containing protein 28;Phosphatase interactor targeting protein hnRNP K;, PF00023;PF12796;, GO:0005829;GO:0005654;GO:0048208;GO:0007004;, C:cytosol; C:nucleoplasm;, , P:COPII vesicle coating; P:telomere maintenance via telomerase; scaffold32 indexed_genome mRNA 5806204 5896706 . - . ID=transcript_6845;Q8N8A2 Q53SL9 Q6P480 Q86VL5 Q8IZ72 Q9UFA4,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B,Ankyrin repeat domain-containing protein 44;, PF12796;|Q8N8A2 Q53SL9 Q6P480 Q86VL5 Q8IZ72 Q9UFA4,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B,Ankyrin repeat domain-containing protein 44;, PF12796;|Q8N8A2 Q53SL9 Q6P480 Q86VL5 Q8IZ72 Q9UFA4,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B,Ankyrin repeat domain-containing protein 44;, PF12796; scaffold32 indexed_genome mRNA 6176234 6194008 . - . ID=transcript_6846;O75533 E9PCH3,Splicing factor 3B subunit 1,Pre-mRNA-splicing factor SF3b 155 kDa subunit;Spliceosome-associated protein 155;, PF08920;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0034693;GO:0005689;GO:0005686;GO:0071005;GO:0071004;GO:0003729;GO:0003723;GO:1990935;GO:0000398;GO:0045815;GO:0008380;GO:0000375;GO:0000245;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U11/U12 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome;, F:mRNA binding; F:RNA binding; F:splicing factor binding;, P:mRNA splicing, via spliceosome; P:positive regulation of gene expression, epigenetic; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly;|O75533 E9PCH3,Splicing factor 3B subunit 1,Pre-mRNA-splicing factor SF3b 155 kDa subunit;Spliceosome-associated protein 155;, PF08920;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0034693;GO:0005689;GO:0005686;GO:0071005;GO:0071004;GO:0003729;GO:0003723;GO:1990935;GO:0000398;GO:0045815;GO:0008380;GO:0000375;GO:0000245;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U11/U12 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome;, F:mRNA binding; F:RNA binding; F:splicing factor binding;, P:mRNA splicing, via spliceosome; P:positive regulation of gene expression, epigenetic; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly;|O75533 E9PCH3,Splicing factor 3B subunit 1,Pre-mRNA-splicing factor SF3b 155 kDa subunit;Spliceosome-associated protein 155;, PF08920;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0034693;GO:0005689;GO:0005686;GO:0071005;GO:0071004;GO:0003729;GO:0003723;GO:1990935;GO:0000398;GO:0045815;GO:0008380;GO:0000375;GO:0000245;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U11/U12 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome;, F:mRNA binding; F:RNA binding; F:splicing factor binding;, P:mRNA splicing, via spliceosome; P:positive regulation of gene expression, epigenetic; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly;|O75533 E9PCH3,Splicing factor 3B subunit 1,Pre-mRNA-splicing factor SF3b 155 kDa subunit;Spliceosome-associated protein 155;, PF08920;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0034693;GO:0005689;GO:0005686;GO:0071005;GO:0071004;GO:0003729;GO:0003723;GO:1990935;GO:0000398;GO:0045815;GO:0008380;GO:0000375;GO:0000245;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U11/U12 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome;, F:mRNA binding; F:RNA binding; F:splicing factor binding;, P:mRNA splicing, via spliceosome; P:positive regulation of gene expression, epigenetic; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly;|O75533 E9PCH3,Splicing factor 3B subunit 1,Pre-mRNA-splicing factor SF3b 155 kDa subunit;Spliceosome-associated protein 155;, PF08920;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0034693;GO:0005689;GO:0005686;GO:0071005;GO:0071004;GO:0003729;GO:0003723;GO:1990935;GO:0000398;GO:0045815;GO:0008380;GO:0000375;GO:0000245;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U11/U12 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome;, F:mRNA binding; F:RNA binding; F:splicing factor binding;, P:mRNA splicing, via spliceosome; P:positive regulation of gene expression, epigenetic; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; scaffold32 indexed_genome mRNA 6196119 6237067 . - . ID=transcript_6847;O75533 E9PCH3,Splicing factor 3B subunit 1,Pre-mRNA-splicing factor SF3b 155 kDa subunit;Spliceosome-associated protein 155;, PF08920;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0034693;GO:0005689;GO:0005686;GO:0071005;GO:0071004;GO:0003729;GO:0003723;GO:1990935;GO:0000398;GO:0045815;GO:0008380;GO:0000375;GO:0000245;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U11/U12 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome;, F:mRNA binding; F:RNA binding; F:splicing factor binding;, P:mRNA splicing, via spliceosome; P:positive regulation of gene expression, epigenetic; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly;|Q9UF10,Ubiquitin-conjugating enzyme E2 J1,E2 ubiquitin-conjugating enzyme J1;Non-canonical ubiquitin-conjugating enzyme 1;Yeast ubiquitin-conjugating enzyme UBC6 homolog E;, PF00179;, GO:0005789;GO:0016021;GO:0005634;GO:0005524;GO:0061631;GO:0031625;GO:1904153;GO:0018279;GO:0000209;GO:0032680;GO:0007286;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding;, P:negative regulation of retrograde protein transport, ER to cytosol; P:protein N-linked glycosylation via asparagine; P:protein polyubiquitination; P:regulation of tumor necrosis factor production; P:spermatid development; P:ubiquitin-dependent ERAD pathway;|Q9UF10,Ubiquitin-conjugating enzyme E2 J1,E2 ubiquitin-conjugating enzyme J1;Non-canonical ubiquitin-conjugating enzyme 1;Yeast ubiquitin-conjugating enzyme UBC6 homolog E;, PF00179;, GO:0005789;GO:0016021;GO:0005634;GO:0005524;GO:0061631;GO:0031625;GO:1904153;GO:0018279;GO:0000209;GO:0032680;GO:0007286;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding;, P:negative regulation of retrograde protein transport, ER to cytosol; P:protein N-linked glycosylation via asparagine; P:protein polyubiquitination; P:regulation of tumor necrosis factor production; P:spermatid development; P:ubiquitin-dependent ERAD pathway; scaffold32 indexed_genome mRNA 6240904 6254595 . + . ID=transcript_6848;Q9H8M1 B7Z1Y4,Coenzyme Q-binding protein COQ10 homolog B, mitochondrial,, PF03364;, GO:0005743;GO:0005739;GO:0048039;GO:0045333;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:ubiquinone binding;, P:cellular respiration; P:ubiquinone biosynthetic process;|Q9H8M1 B7Z1Y4,Coenzyme Q-binding protein COQ10 homolog B, mitochondrial,, PF03364;, GO:0005743;GO:0005739;GO:0048039;GO:0045333;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:ubiquinone binding;, P:cellular respiration; P:ubiquinone biosynthetic process;|Q9H8M1 B7Z1Y4,Coenzyme Q-binding protein COQ10 homolog B, mitochondrial,, PF03364;, GO:0005743;GO:0005739;GO:0048039;GO:0045333;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:ubiquinone binding;, P:cellular respiration; P:ubiquinone biosynthetic process; scaffold32 indexed_genome mRNA 6261731 6269135 . - . ID=transcript_6849;P10809 B2R5M6 B7Z712 Q38L19 Q9UCR6,60 kDa heat shock protein, mitochondrial,60 kDa chaperonin;Chaperonin 60;Heat shock protein 60;HuCHA60;Mitochondrial matrix protein P1;P60 lymphocyte protein;, PF00118;, GO:0009986;GO:0005905;GO:0030135;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0005615;GO:0046696;GO:0016020;GO:0005743;GO:0005759;GO:0005739;GO:0005886;GO:0032991;GO:0030141;GO:0034186;GO:0034185;GO:0005524;GO:0016887;GO:0051087;GO:0003688;GO:0003725;GO:0019899;GO:0008035;GO:0016853;GO:0001530;GO:0002039;GO:0003723;GO:0003697;GO:0031625;GO:0051082;GO:0006458;GO:0006919;GO:0008637;GO:0042113;GO:0042100;GO:0051702;GO:0051131;GO:0048291;GO:0034514;GO:0002755;GO:0043066;GO:0043065;GO:0032727;GO:0032729;GO:0032733;GO:0032735;GO:0032755;GO:0043032;GO:0050870;GO:0002842;GO:0006457;GO:0045041;GO:0051604;GO:0042026;GO:0050821;GO:0006357;GO:0009409;GO:0006986;GO:0042110;GO:0016032;, C:cell surface; C:clathrin-coated pit; C:coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:extracellular space; C:lipopolysaccharide receptor complex; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:secretory granule;, F:apolipoprotein A-I binding; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:chaperone binding; F:DNA replication origin binding; F:double-stranded RNA binding; F:enzyme binding; F:high-density lipoprotein particle binding; F:isomerase activity; F:lipopolysaccharide binding; F:p53 binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:'de novo' protein folding; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic mitochondrial changes; P:B cell activation; P:B cell proliferation; P:biological process involved in interaction with symbiont; P:chaperone-mediated protein complex assembly; P:isotype switching to IgG isotypes; P:mitochondrial unfolded protein response; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated immune response to tumor cell; P:protein folding; P:protein import into mitochondrial intermembrane space; P:protein maturation; P:protein refolding; P:protein stabilization; P:regulation of transcription by RNA polymerase II; P:response to cold; P:response to unfolded protein; P:T cell activation; P:viral process;|P10809 B2R5M6 B7Z712 Q38L19 Q9UCR6,60 kDa heat shock protein, mitochondrial,60 kDa chaperonin;Chaperonin 60;Heat shock protein 60;HuCHA60;Mitochondrial matrix protein P1;P60 lymphocyte protein;, PF00118;, GO:0009986;GO:0005905;GO:0030135;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0005615;GO:0046696;GO:0016020;GO:0005743;GO:0005759;GO:0005739;GO:0005886;GO:0032991;GO:0030141;GO:0034186;GO:0034185;GO:0005524;GO:0016887;GO:0051087;GO:0003688;GO:0003725;GO:0019899;GO:0008035;GO:0016853;GO:0001530;GO:0002039;GO:0003723;GO:0003697;GO:0031625;GO:0051082;GO:0006458;GO:0006919;GO:0008637;GO:0042113;GO:0042100;GO:0051702;GO:0051131;GO:0048291;GO:0034514;GO:0002755;GO:0043066;GO:0043065;GO:0032727;GO:0032729;GO:0032733;GO:0032735;GO:0032755;GO:0043032;GO:0050870;GO:0002842;GO:0006457;GO:0045041;GO:0051604;GO:0042026;GO:0050821;GO:0006357;GO:0009409;GO:0006986;GO:0042110;GO:0016032;, C:cell surface; C:clathrin-coated pit; C:coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:extracellular space; C:lipopolysaccharide receptor complex; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:secretory granule;, F:apolipoprotein A-I binding; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:chaperone binding; F:DNA replication origin binding; F:double-stranded RNA binding; F:enzyme binding; F:high-density lipoprotein particle binding; F:isomerase activity; F:lipopolysaccharide binding; F:p53 binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:'de novo' protein folding; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic mitochondrial changes; P:B cell activation; P:B cell proliferation; P:biological process involved in interaction with symbiont; P:chaperone-mediated protein complex assembly; P:isotype switching to IgG isotypes; P:mitochondrial unfolded protein response; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated immune response to tumor cell; P:protein folding; P:protein import into mitochondrial intermembrane space; P:protein maturation; P:protein refolding; P:protein stabilization; P:regulation of transcription by RNA polymerase II; P:response to cold; P:response to unfolded protein; P:T cell activation; P:viral process;|P10809 B2R5M6 B7Z712 Q38L19 Q9UCR6,60 kDa heat shock protein, mitochondrial,60 kDa chaperonin;Chaperonin 60;Heat shock protein 60;HuCHA60;Mitochondrial matrix protein P1;P60 lymphocyte protein;, PF00118;, GO:0009986;GO:0005905;GO:0030135;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0005615;GO:0046696;GO:0016020;GO:0005743;GO:0005759;GO:0005739;GO:0005886;GO:0032991;GO:0030141;GO:0034186;GO:0034185;GO:0005524;GO:0016887;GO:0051087;GO:0003688;GO:0003725;GO:0019899;GO:0008035;GO:0016853;GO:0001530;GO:0002039;GO:0003723;GO:0003697;GO:0031625;GO:0051082;GO:0006458;GO:0006919;GO:0008637;GO:0042113;GO:0042100;GO:0051702;GO:0051131;GO:0048291;GO:0034514;GO:0002755;GO:0043066;GO:0043065;GO:0032727;GO:0032729;GO:0032733;GO:0032735;GO:0032755;GO:0043032;GO:0050870;GO:0002842;GO:0006457;GO:0045041;GO:0051604;GO:0042026;GO:0050821;GO:0006357;GO:0009409;GO:0006986;GO:0042110;GO:0016032;, C:cell surface; C:clathrin-coated pit; C:coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:extracellular space; C:lipopolysaccharide receptor complex; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:secretory granule;, F:apolipoprotein A-I binding; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:chaperone binding; F:DNA replication origin binding; F:double-stranded RNA binding; F:enzyme binding; F:high-density lipoprotein particle binding; F:isomerase activity; F:lipopolysaccharide binding; F:p53 binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:'de novo' protein folding; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic mitochondrial changes; P:B cell activation; P:B cell proliferation; P:biological process involved in interaction with symbiont; P:chaperone-mediated protein complex assembly; P:isotype switching to IgG isotypes; P:mitochondrial unfolded protein response; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated immune response to tumor cell; P:protein folding; P:protein import into mitochondrial intermembrane space; P:protein maturation; P:protein refolding; P:protein stabilization; P:regulation of transcription by RNA polymerase II; P:response to cold; P:response to unfolded protein; P:T cell activation; P:viral process; scaffold32 indexed_genome mRNA 6270272 6271283 . + . ID=transcript_6850;P10809 B2R5M6 B7Z712 Q38L19 Q9UCR6,60 kDa heat shock protein, mitochondrial,60 kDa chaperonin;Chaperonin 60;Heat shock protein 60;HuCHA60;Mitochondrial matrix protein P1;P60 lymphocyte protein;, PF00118;, GO:0009986;GO:0005905;GO:0030135;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0005615;GO:0046696;GO:0016020;GO:0005743;GO:0005759;GO:0005739;GO:0005886;GO:0032991;GO:0030141;GO:0034186;GO:0034185;GO:0005524;GO:0016887;GO:0051087;GO:0003688;GO:0003725;GO:0019899;GO:0008035;GO:0016853;GO:0001530;GO:0002039;GO:0003723;GO:0003697;GO:0031625;GO:0051082;GO:0006458;GO:0006919;GO:0008637;GO:0042113;GO:0042100;GO:0051702;GO:0051131;GO:0048291;GO:0034514;GO:0002755;GO:0043066;GO:0043065;GO:0032727;GO:0032729;GO:0032733;GO:0032735;GO:0032755;GO:0043032;GO:0050870;GO:0002842;GO:0006457;GO:0045041;GO:0051604;GO:0042026;GO:0050821;GO:0006357;GO:0009409;GO:0006986;GO:0042110;GO:0016032;, C:cell surface; C:clathrin-coated pit; C:coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:extracellular space; C:lipopolysaccharide receptor complex; C:membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:secretory granule;, F:apolipoprotein A-I binding; F:apolipoprotein binding; F:ATP binding; F:ATPase activity; F:chaperone binding; F:DNA replication origin binding; F:double-stranded RNA binding; F:enzyme binding; F:high-density lipoprotein particle binding; F:isomerase activity; F:lipopolysaccharide binding; F:p53 binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:'de novo' protein folding; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic mitochondrial changes; P:B cell activation; P:B cell proliferation; P:biological process involved in interaction with symbiont; P:chaperone-mediated protein complex assembly; P:isotype switching to IgG isotypes; P:mitochondrial unfolded protein response; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of macrophage activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated immune response to tumor cell; P:protein folding; P:protein import into mitochondrial intermembrane space; P:protein maturation; P:protein refolding; P:protein stabilization; P:regulation of transcription by RNA polymerase II; P:response to cold; P:response to unfolded protein; P:T cell activation; P:viral process; scaffold32 indexed_genome mRNA 6285549 6314454 . + . ID=transcript_6851;Q9Y3A3 B4DML0 Q53SE0 Q7Z4Y6 Q9H2P3 Q9H5J1 Q9Y4T8,MOB-like protein phocein,2C4D;Class II mMOB1;Mob1 homolog 3;Mps one binder kinase activator-like 3;Preimplantation protein 3;, PF03637;, GO:0005737;GO:0005794;GO:0032580;GO:0048471;GO:0046872;, C:cytoplasm; C:Golgi apparatus; C:Golgi cisterna membrane; C:perinuclear region of cytoplasm;, F:metal ion binding;|P62244 P39027 P39031 Q3MHD9 Q8C023 Q9BV24,40S ribosomal protein S15a,Small ribosomal subunit protein uS8 {ECO:0000303|PubMed:24524803};, PF00410;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0003723;GO:0003735;GO:0000184;GO:0045787;GO:0008284;GO:0009615;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:response to virus; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q9Y3A3 B4DML0 Q53SE0 Q7Z4Y6 Q9H2P3 Q9H5J1 Q9Y4T8,MOB-like protein phocein,2C4D;Class II mMOB1;Mob1 homolog 3;Mps one binder kinase activator-like 3;Preimplantation protein 3;, PF03637;, GO:0005737;GO:0005794;GO:0032580;GO:0048471;GO:0046872;, C:cytoplasm; C:Golgi apparatus; C:Golgi cisterna membrane; C:perinuclear region of cytoplasm;, F:metal ion binding; scaffold32 indexed_genome mRNA 6325494 6391545 . - . ID=transcript_6852;Q52LD8 Q14DH4 Q2TA69 Q53QE0 Q53SE1 Q96NM3,Raftlin-2,Raft-linking protein 2;, PF15250;, GO:0005886;GO:0033227;GO:0043330;, C:plasma membrane;, , P:dsRNA transport; P:response to exogenous dsRNA;|Q52LD8 Q14DH4 Q2TA69 Q53QE0 Q53SE1 Q96NM3,Raftlin-2,Raft-linking protein 2;, PF15250;, GO:0005886;GO:0033227;GO:0043330;, C:plasma membrane;, , P:dsRNA transport; P:response to exogenous dsRNA; scaffold32 indexed_genome mRNA 6402352 6405169 . + . ID=transcript_6853;Q96GW9 A0AVC3 Q76E79 Q8IW62 Q8N7N4,Methionine--tRNA ligase, mitochondrial,Methionyl-tRNA synthetase 2;Mitochondrial methionyl-tRNA synthetase;, PF09334;, GO:0005759;GO:0005524;GO:0004825;GO:0006431;GO:0006418;, C:mitochondrial matrix;, F:ATP binding; F:methionine-tRNA ligase activity;, P:methionyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; scaffold32 indexed_genome mRNA 6438701 6459563 . - . ID=transcript_6854;Q8N9W6 B4DZA4 Q0JW32 Q53T62 Q969U3,Protein boule-like,, PF00076;, GO:0005737;GO:0005829;GO:0001650;GO:0090543;GO:0005886;GO:0003730;GO:0008494;GO:0070935;GO:0030154;GO:0051321;GO:0007275;GO:0045948;GO:0007283;, C:cytoplasm; C:cytosol; C:fibrillar center; C:Flemming body; C:plasma membrane;, F:mRNA 3'-UTR binding; F:translation activator activity;, P:3'-UTR-mediated mRNA stabilization; P:cell differentiation; P:meiotic cell cycle; P:multicellular organism development; P:positive regulation of translational initiation; P:spermatogenesis; scaffold32 indexed_genome mRNA 6515878 6878508 . + . ID=transcript_6855;Q15111 Q3MJ90 Q53SD3 Q7Z3S3,Inactive phospholipase C-like protein 1,Phospholipase C-deleted in lung carcinoma;Phospholipase C-related but catalytically inactive protein;, PF00168;PF09279;PF16457;PF00388;PF00387;, GO:0005737;GO:0005886;GO:0050811;GO:0070679;GO:0004435;GO:0004629;GO:0007214;GO:0035556;GO:0006629;GO:0120163;GO:0048015;GO:1900122;GO:0033135;GO:0032228;, C:cytoplasm; C:plasma membrane;, F:GABA receptor binding; F:inositol 1,4,5 trisphosphate binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:gamma-aminobutyric acid signaling pathway; P:intracellular signal transduction; P:lipid metabolic process; P:negative regulation of cold-induced thermogenesis; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor binding; P:regulation of peptidyl-serine phosphorylation; P:regulation of synaptic transmission, GABAergic;|Q15111 Q3MJ90 Q53SD3 Q7Z3S3,Inactive phospholipase C-like protein 1,Phospholipase C-deleted in lung carcinoma;Phospholipase C-related but catalytically inactive protein;, PF00168;PF09279;PF16457;PF00388;PF00387;, GO:0005737;GO:0005886;GO:0050811;GO:0070679;GO:0004435;GO:0004629;GO:0007214;GO:0035556;GO:0006629;GO:0120163;GO:0048015;GO:1900122;GO:0033135;GO:0032228;, C:cytoplasm; C:plasma membrane;, F:GABA receptor binding; F:inositol 1,4,5 trisphosphate binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:gamma-aminobutyric acid signaling pathway; P:intracellular signal transduction; P:lipid metabolic process; P:negative regulation of cold-induced thermogenesis; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor binding; P:regulation of peptidyl-serine phosphorylation; P:regulation of synaptic transmission, GABAergic; scaffold32 indexed_genome mRNA 8469312 8512674 . - . ID=transcript_6856;E5RQL4,Formiminotransferase N-terminal subdomain-containing protein,Formiminotransferase-cyclodeaminase N-terminal-like protein;, PF07837;, GO:0005542;GO:0016740;, , F:folic acid binding; F:transferase activity; scaffold32 indexed_genome mRNA 8563147 8585963 . + . ID=transcript_6857;Q8N8R5 Q8NE30,UPF0565 protein C2orf69,, PF10561;, GO:0005576;, C:extracellular region;|Q8N8R5 Q8NE30,UPF0565 protein C2orf69,, PF10561;, GO:0005576;, C:extracellular region;|Q8N8R5 Q8NE30,UPF0565 protein C2orf69,, PF10561;, GO:0005576;, C:extracellular region;|A2RUC4 B2RNE3 Q8N1R2,tRNA wybutosine-synthesizing protein 5,tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase;, PF13621;, GO:0005737;GO:0016706;GO:0005506;GO:0042803;GO:0000049;GO:0102524;GO:0006400;GO:0031591;, C:cytoplasm;, F:2-oxoglutarate-dependent dioxygenase activity; F:iron ion binding; F:protein homodimerization activity; F:tRNA binding; F:tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity;, P:tRNA modification; P:wybutosine biosynthetic process; scaffold32 indexed_genome mRNA 8595434 8603168 . - . ID=transcript_6858;A2RUC4 B2RNE3 Q8N1R2,tRNA wybutosine-synthesizing protein 5,tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase;, PF13621;, GO:0005737;GO:0016706;GO:0005506;GO:0042803;GO:0000049;GO:0102524;GO:0006400;GO:0031591;, C:cytoplasm;, F:2-oxoglutarate-dependent dioxygenase activity; F:iron ion binding; F:protein homodimerization activity; F:tRNA binding; F:tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity;, P:tRNA modification; P:wybutosine biosynthetic process; scaffold32 indexed_genome mRNA 8603516 8630828 . + . ID=transcript_6859;Q8WWC4 Q658V9 Q9H671,m-AAA protease-interacting protein 1, mitochondrial {ECO:0000303|PubMed:27642048},Matrix AAA peptidase-interacting protein 1 {ECO:0000312|HGNC:HGNC:26198};, , GO:0005743;GO:0005759;GO:0043022;GO:0036444;GO:0007007;GO:0051560;GO:0006851;GO:0032979;GO:0051204;, C:mitochondrial inner membrane; C:mitochondrial matrix;, F:ribosome binding;, P:calcium import into the mitochondrion; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:protein insertion into mitochondrial inner membrane from matrix; P:protein insertion into mitochondrial membrane;|Q8WWC4 Q658V9 Q9H671,m-AAA protease-interacting protein 1, mitochondrial {ECO:0000303|PubMed:27642048},Matrix AAA peptidase-interacting protein 1 {ECO:0000312|HGNC:HGNC:26198};, , GO:0005743;GO:0005759;GO:0043022;GO:0036444;GO:0007007;GO:0051560;GO:0006851;GO:0032979;GO:0051204;, C:mitochondrial inner membrane; C:mitochondrial matrix;, F:ribosome binding;, P:calcium import into the mitochondrion; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:protein insertion into mitochondrial inner membrane from matrix; P:protein insertion into mitochondrial membrane;|Q8WWC4 Q658V9 Q9H671,m-AAA protease-interacting protein 1, mitochondrial {ECO:0000303|PubMed:27642048},Matrix AAA peptidase-interacting protein 1 {ECO:0000312|HGNC:HGNC:26198};, , GO:0005743;GO:0005759;GO:0043022;GO:0036444;GO:0007007;GO:0051560;GO:0006851;GO:0032979;GO:0051204;, C:mitochondrial inner membrane; C:mitochondrial matrix;, F:ribosome binding;, P:calcium import into the mitochondrion; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:protein insertion into mitochondrial inner membrane from matrix; P:protein insertion into mitochondrial membrane;|Q8WWC4 Q658V9 Q9H671,m-AAA protease-interacting protein 1, mitochondrial {ECO:0000303|PubMed:27642048},Matrix AAA peptidase-interacting protein 1 {ECO:0000312|HGNC:HGNC:26198};, , GO:0005743;GO:0005759;GO:0043022;GO:0036444;GO:0007007;GO:0051560;GO:0006851;GO:0032979;GO:0051204;, C:mitochondrial inner membrane; C:mitochondrial matrix;, F:ribosome binding;, P:calcium import into the mitochondrion; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:protein insertion into mitochondrial inner membrane from matrix; P:protein insertion into mitochondrial membrane;|Q8WWC4 Q658V9 Q9H671,m-AAA protease-interacting protein 1, mitochondrial {ECO:0000303|PubMed:27642048},Matrix AAA peptidase-interacting protein 1 {ECO:0000312|HGNC:HGNC:26198};, , GO:0005743;GO:0005759;GO:0043022;GO:0036444;GO:0007007;GO:0051560;GO:0006851;GO:0032979;GO:0051204;, C:mitochondrial inner membrane; C:mitochondrial matrix;, F:ribosome binding;, P:calcium import into the mitochondrion; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:protein insertion into mitochondrial inner membrane from matrix; P:protein insertion into mitochondrial membrane;|Q8WWC4 Q658V9 Q9H671,m-AAA protease-interacting protein 1, mitochondrial {ECO:0000303|PubMed:27642048},Matrix AAA peptidase-interacting protein 1 {ECO:0000312|HGNC:HGNC:26198};, , GO:0005743;GO:0005759;GO:0043022;GO:0036444;GO:0007007;GO:0051560;GO:0006851;GO:0032979;GO:0051204;, C:mitochondrial inner membrane; C:mitochondrial matrix;, F:ribosome binding;, P:calcium import into the mitochondrion; P:inner mitochondrial membrane organization; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:protein insertion into mitochondrial inner membrane from matrix; P:protein insertion into mitochondrial membrane; scaffold32 indexed_genome mRNA 8975941 9072343 . + . ID=transcript_6860;Q9NUQ6 A8K381 B4DRE6 B4DT67 B7WNZ7 Q53T22 Q8WV53 Q8WYG1 Q9NTW4,SPATS2-like protein,DNA polymerase-transactivated protein 6;Stress granule and nucleolar protein;, PF07139;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0032991;GO:0003723;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:protein-containing complex;, F:RNA binding; scaffold32 indexed_genome mRNA 9080040 9102043 . - . ID=transcript_6861;Q6PI47 Q53T21 Q6NW26 Q6PCD8 Q8N9B7 Q96N73,BTB/POZ domain-containing protein KCTD18,, PF02214;, GO:0051260;, , , P:protein homooligomerization; scaffold32 indexed_genome mRNA 9121160 9146334 . + . ID=transcript_6862;Q562F6 Q53RR9 Q53T20 Q86XY4 Q8IWK2 Q8IZK1 Q8N1Q5 Q96LQ3,Shugoshin 2 {ECO:0000312|HGNC:HGNC:30812},Shugoshin-2;Shugoshin-like 2;Tripin;, , GO:0000775;GO:0000777;GO:0005829;GO:0000776;GO:0030892;GO:0016604;GO:0005654;GO:0051301;GO:0045143;GO:0051177;GO:0051754;GO:0000070;GO:0007052;, C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:mitotic cohesin complex; C:nuclear body; C:nucleoplasm;, , P:cell division; P:homologous chromosome segregation; P:meiotic sister chromatid cohesion; P:meiotic sister chromatid cohesion, centromeric; P:mitotic sister chromatid segregation; P:mitotic spindle organization; scaffold32 indexed_genome mRNA 9151122 9222701 . + . ID=transcript_6863;Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process; scaffold32 indexed_genome mRNA 9319141 9401528 . + . ID=transcript_6864;Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process; scaffold32 indexed_genome mRNA 9413107 9492356 . + . ID=transcript_6865;Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|P47989 Q16681 Q16712 Q4PJ16,Xanthine dehydrogenase/oxidase,, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0005615;GO:0005777;GO:0016529;GO:0051537;GO:0009055;GO:0071949;GO:0050660;GO:0070674;GO:0070675;GO:0005506;GO:0043546;GO:0042803;GO:0004854;GO:0004855;GO:0006919;GO:0002250;GO:0006154;GO:0006196;GO:0046055;GO:0046038;GO:0006204;GO:0006148;GO:0016226;GO:0007595;GO:0045602;GO:0001937;GO:0010629;GO:0051898;GO:0001933;GO:1900747;GO:2001213;GO:1900745;GO:2000379;GO:0006195;GO:0009115;, C:cytosol; C:extracellular space; C:peroxisome; C:sarcoplasmic reticulum;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:hypoxanthine dehydrogenase activity; F:hypoxanthine oxidase activity; F:iron ion binding; F:molybdopterin cofactor binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity; F:xanthine oxidase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:adaptive immune response; P:adenosine catabolic process; P:AMP catabolic process; P:dGMP catabolic process; P:GMP catabolic process; P:IMP catabolic process; P:inosine catabolic process; P:iron-sulfur cluster assembly; P:lactation; P:negative regulation of endothelial cell differentiation; P:negative regulation of endothelial cell proliferation; P:negative regulation of gene expression; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of vascular endothelial growth factor signaling pathway; P:negative regulation of vasculogenesis; P:positive regulation of p38MAPK cascade; P:positive regulation of reactive oxygen species metabolic process; P:purine nucleotide catabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process;|Q06278 O14765 Q53RR8 Q53TV3 Q9BYF0 Q9UPG6,Aldehyde oxidase {ECO:0000312|HGNC:HGNC:553},Aldehyde oxidase 1;Azaheterocycle hydroxylase {ECO:0000305|PubMed:7786031, ECO:0000305|PubMed:9224775};, PF01315;PF02738;PF03450;PF00941;PF00111;PF01799;, GO:0005829;GO:0070062;GO:0051537;GO:0004031;GO:0009055;GO:0071949;GO:0050660;GO:0102797;GO:0102798;GO:0042802;GO:0005506;GO:0043546;GO:0051287;GO:0042803;GO:0004854;GO:0017144;GO:0042816;GO:0009115;, C:cytosol; C:extracellular exosome;, F:2 iron, 2 sulfur cluster binding; F:aldehyde oxidase activity; F:electron transfer activity; F:FAD binding; F:flavin adenine dinucleotide binding; F:geranial:oxygen oxidoreductase activity; F:heptaldehyde:oxygen oxidoreductase activity; F:identical protein binding; F:iron ion binding; F:molybdopterin cofactor binding; F:NAD binding; F:protein homodimerization activity; F:xanthine dehydrogenase activity;, P:drug metabolic process; P:vitamin B6 metabolic process; P:xanthine catabolic process; scaffold32 indexed_genome mRNA 9523519 9526813 . + . ID=transcript_6866;Q7L1Q6 B4DLZ8 B4DWF7 Q14281 Q15394 Q9BUY0,Basic leucine zipper and W2 domain-containing protein 1,Protein Orf;, PF02020;, GO:0005737;GO:0016020;GO:0045296;GO:0003723;, C:cytoplasm; C:membrane;, F:cadherin binding; F:RNA binding; scaffold32 indexed_genome mRNA 9526970 9527889 . - . ID=transcript_6867;Q7L1Q6 B4DLZ8 B4DWF7 Q14281 Q15394 Q9BUY0,Basic leucine zipper and W2 domain-containing protein 1,Protein Orf;, PF02020;, GO:0005737;GO:0016020;GO:0045296;GO:0003723;, C:cytoplasm; C:membrane;, F:cadherin binding; F:RNA binding; scaffold32 indexed_genome mRNA 9554387 9578898 . - . ID=transcript_6868;P49759 B4DFW7 Q0P694 Q8N5V8,Dual specificity protein kinase CLK1,CDC-like kinase 1;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004715;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0018105;GO:0018107;GO:0046777;GO:0043484;, C:cytoplasm; C:nucleus;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:regulation of RNA splicing;|P49759 B4DFW7 Q0P694 Q8N5V8,Dual specificity protein kinase CLK1,CDC-like kinase 1;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004715;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0018105;GO:0018107;GO:0046777;GO:0043484;, C:cytoplasm; C:nucleus;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:regulation of RNA splicing;|P49759 B4DFW7 Q0P694 Q8N5V8,Dual specificity protein kinase CLK1,CDC-like kinase 1;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004715;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0018105;GO:0018107;GO:0046777;GO:0043484;, C:cytoplasm; C:nucleus;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:regulation of RNA splicing;|P49759 B4DFW7 Q0P694 Q8N5V8,Dual specificity protein kinase CLK1,CDC-like kinase 1;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004715;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0018105;GO:0018107;GO:0046777;GO:0043484;, C:cytoplasm; C:nucleus;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:regulation of RNA splicing;|Q9H2H8 Q86WF9 Q96IA9 Q9BXZ1,Peptidyl-prolyl cis-trans isomerase-like 3,Cyclophilin J;Cyclophilin-like protein PPIL3;Rotamase PPIL3;, PF00160;, GO:0071013;GO:0003755;GO:0000398;GO:0006457;GO:0000413;, C:catalytic step 2 spliceosome;, F:peptidyl-prolyl cis-trans isomerase activity;, P:mRNA splicing, via spliceosome; P:protein folding; P:protein peptidyl-prolyl isomerization;|Q9H2H8 Q86WF9 Q96IA9 Q9BXZ1,Peptidyl-prolyl cis-trans isomerase-like 3,Cyclophilin J;Cyclophilin-like protein PPIL3;Rotamase PPIL3;, PF00160;, GO:0071013;GO:0003755;GO:0000398;GO:0006457;GO:0000413;, C:catalytic step 2 spliceosome;, F:peptidyl-prolyl cis-trans isomerase activity;, P:mRNA splicing, via spliceosome; P:protein folding; P:protein peptidyl-prolyl isomerization; scaffold32 indexed_genome mRNA 9584031 9599601 . + . ID=transcript_6869;Q9GZT8 Q53TX4 Q6X735 Q9H2D2 Q9HC18,NIF3-like protein 1 {ECO:0000305|PubMed:11124544},Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein {ECO:0000303|PubMed:11161814};, PF01784;, GO:0005737;GO:0005739;GO:0005634;GO:0042802;GO:0008134;GO:1903507;GO:0030182;GO:0045893;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:identical protein binding; F:transcription factor binding;, P:negative regulation of nucleic acid-templated transcription; P:neuron differentiation; P:positive regulation of transcription, DNA-templated;|Q9GZT8 Q53TX4 Q6X735 Q9H2D2 Q9HC18,NIF3-like protein 1 {ECO:0000305|PubMed:11124544},Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein {ECO:0000303|PubMed:11161814};, PF01784;, GO:0005737;GO:0005739;GO:0005634;GO:0042802;GO:0008134;GO:1903507;GO:0030182;GO:0045893;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:identical protein binding; F:transcription factor binding;, P:negative regulation of nucleic acid-templated transcription; P:neuron differentiation; P:positive regulation of transcription, DNA-templated;|Q9GZT8 Q53TX4 Q6X735 Q9H2D2 Q9HC18,NIF3-like protein 1 {ECO:0000305|PubMed:11124544},Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein {ECO:0000303|PubMed:11161814};, PF01784;, GO:0005737;GO:0005739;GO:0005634;GO:0042802;GO:0008134;GO:1903507;GO:0030182;GO:0045893;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:identical protein binding; F:transcription factor binding;, P:negative regulation of nucleic acid-templated transcription; P:neuron differentiation; P:positive regulation of transcription, DNA-templated;|Q9GZT8 Q53TX4 Q6X735 Q9H2D2 Q9HC18,NIF3-like protein 1 {ECO:0000305|PubMed:11124544},Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein {ECO:0000303|PubMed:11161814};, PF01784;, GO:0005737;GO:0005739;GO:0005634;GO:0042802;GO:0008134;GO:1903507;GO:0030182;GO:0045893;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:identical protein binding; F:transcription factor binding;, P:negative regulation of nucleic acid-templated transcription; P:neuron differentiation; P:positive regulation of transcription, DNA-templated; scaffold32 indexed_genome mRNA 9601516 9639273 . - . ID=transcript_6870;Q13416 Q13204 Q53TX5,Origin recognition complex subunit 2,, PF04084;, GO:0005813;GO:0000781;GO:0000939;GO:0000792;GO:0016020;GO:0005664;GO:0005654;GO:0005634;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0000122;GO:0036388;, C:centrosome; C:chromosome, telomeric region; C:condensed chromosome inner kinetochore; C:heterochromatin; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly;|Q13416 Q13204 Q53TX5,Origin recognition complex subunit 2,, PF04084;, GO:0005813;GO:0000781;GO:0000939;GO:0000792;GO:0016020;GO:0005664;GO:0005654;GO:0005634;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0000122;GO:0036388;, C:centrosome; C:chromosome, telomeric region; C:condensed chromosome inner kinetochore; C:heterochromatin; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly;|Q13416 Q13204 Q53TX5,Origin recognition complex subunit 2,, PF04084;, GO:0005813;GO:0000781;GO:0000939;GO:0000792;GO:0016020;GO:0005664;GO:0005654;GO:0005634;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0000122;GO:0036388;, C:centrosome; C:chromosome, telomeric region; C:condensed chromosome inner kinetochore; C:heterochromatin; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly;|Q13416 Q13204 Q53TX5,Origin recognition complex subunit 2,, PF04084;, GO:0005813;GO:0000781;GO:0000939;GO:0000792;GO:0016020;GO:0005664;GO:0005654;GO:0005634;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0000122;GO:0036388;, C:centrosome; C:chromosome, telomeric region; C:condensed chromosome inner kinetochore; C:heterochromatin; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly;|Q13416 Q13204 Q53TX5,Origin recognition complex subunit 2,, PF04084;, GO:0005813;GO:0000781;GO:0000939;GO:0000792;GO:0016020;GO:0005664;GO:0005654;GO:0005634;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0000122;GO:0036388;, C:centrosome; C:chromosome, telomeric region; C:condensed chromosome inner kinetochore; C:heterochromatin; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly;|Q13416 Q13204 Q53TX5,Origin recognition complex subunit 2,, PF04084;, GO:0005813;GO:0000781;GO:0000939;GO:0000792;GO:0016020;GO:0005664;GO:0005654;GO:0005634;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0000122;GO:0036388;, C:centrosome; C:chromosome, telomeric region; C:condensed chromosome inner kinetochore; C:heterochromatin; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly;|Q13416 Q13204 Q53TX5,Origin recognition complex subunit 2,, PF04084;, GO:0005813;GO:0000781;GO:0000939;GO:0000792;GO:0016020;GO:0005664;GO:0005654;GO:0005634;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0000122;GO:0036388;, C:centrosome; C:chromosome, telomeric region; C:condensed chromosome inner kinetochore; C:heterochromatin; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly;|Q01344 B3IU77 B4E2G0 Q14633 Q15469 Q6ISX9,Interleukin-5 receptor subunit alpha,CDw125;, PF09240;, GO:0009897;GO:0005615;GO:0016021;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0004914;GO:0019221;GO:0002437;GO:0000165;GO:0070665;GO:0032674;GO:0007165;, C:external side of plasma membrane; C:extracellular space; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-5 receptor activity;, P:cytokine-mediated signaling pathway; P:inflammatory response to antigenic stimulus; P:MAPK cascade; P:positive regulation of leukocyte proliferation; P:regulation of interleukin-5 production; P:signal transduction;|Q13416 Q13204 Q53TX5,Origin recognition complex subunit 2,, PF04084;, GO:0005813;GO:0000781;GO:0000939;GO:0000792;GO:0016020;GO:0005664;GO:0005654;GO:0005634;GO:0000808;GO:0003688;GO:0006260;GO:0006270;GO:0000122;GO:0036388;, C:centrosome; C:chromosome, telomeric region; C:condensed chromosome inner kinetochore; C:heterochromatin; C:membrane; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus; C:origin recognition complex;, F:DNA replication origin binding;, P:DNA replication; P:DNA replication initiation; P:negative regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly; scaffold32 indexed_genome mRNA 9652572 9708618 . - . ID=transcript_6871;Q8IXS8 B2RCG7 Q4ZG87 Q53TX6,Protein FAM126B,, PF09790;, GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q8IXS8 B2RCG7 Q4ZG87 Q53TX6,Protein FAM126B,, PF09790;, GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q9BYI3 A0A024RA06 A4D145 B8ZZJ1 Q6N010 Q75MR4 Q7LDZ4 Q96MX1 Q96NQ6,Hyccin {ECO:0000303|PubMed:16951682},Down-regulated by CTNNB1 protein A {ECO:0000303|PubMed:10910037};Protein FAM126A {ECO:0000305};, PF09790;, GO:0005829;GO:0005886;GO:0042552;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:myelination; P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q969G3 B3KMC1 B4DFR4 C0IMW4 C0IMW5 C0IMW7 H7C3F6 O43539,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,BRG1-associated factor 57;, PF00505;, GO:0000785;GO:0071565;GO:0071564;GO:0000228;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003682;GO:0003677;GO:0008080;GO:0016922;GO:0047485;GO:0003723;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0022008;GO:0006337;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:DNA binding; F:N-acetyltransferase activity; F:nuclear receptor binding; F:protein N-terminus binding; F:RNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:neurogenesis; P:nucleosome disassembly; P:regulation of transcription by RNA polymerase II; scaffold32 indexed_genome mRNA 9708638 9719999 . + . ID=transcript_6872;O43676 Q6IB80,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3,Complex I-B12;NADH-ubiquinone oxidoreductase B12 subunit;, PF08122;, GO:0016021;GO:0005743;GO:0005747;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O43676 Q6IB80,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3,Complex I-B12;NADH-ubiquinone oxidoreductase B12 subunit;, PF08122;, GO:0016021;GO:0005743;GO:0005747;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O43676 Q6IB80,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3,Complex I-B12;NADH-ubiquinone oxidoreductase B12 subunit;, PF08122;, GO:0016021;GO:0005743;GO:0005747;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold32 indexed_genome mRNA 9721010 9721775 . + . ID=transcript_6873;P09651 A8K4Z8 Q3MIB7 Q6PJZ7,Heterogeneous nuclear ribonucleoprotein A1,Helix-destabilizing protein;Single-strand RNA-binding protein;hnRNP core protein A1;, PF11627;PF00076;, GO:0071013;GO:0005737;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0005681;GO:0098505;GO:0042802;GO:0035198;GO:0036002;GO:0019904;GO:0003723;GO:0003697;GO:0003727;GO:0061752;GO:0042149;GO:1903936;GO:0008543;GO:0051170;GO:0000398;GO:0051028;GO:0032211;GO:0051168;GO:0032212;GO:0000381;GO:0006405;GO:0016070;GO:0016032;, C:catalytic step 2 spliceosome; C:cytoplasm; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal complex;, F:G-rich strand telomeric DNA binding; F:identical protein binding; F:miRNA binding; F:pre-mRNA binding; F:protein domain specific binding; F:RNA binding; F:single-stranded DNA binding; F:single-stranded RNA binding; F:telomeric repeat-containing RNA binding;, P:cellular response to glucose starvation; P:cellular response to sodium arsenite; P:fibroblast growth factor receptor signaling pathway; P:import into nucleus; P:mRNA splicing, via spliceosome; P:mRNA transport; P:negative regulation of telomere maintenance via telomerase; P:nuclear export; P:positive regulation of telomere maintenance via telomerase; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA metabolic process; P:viral process; scaffold32 indexed_genome mRNA 9767148 9799225 . + . ID=transcript_6874;Q9UEW1,CASP8 and FADD-like apoptosis regulator,Caspase homolog;Caspase-eight-related protein;Caspase-like apoptosis regulatory protein;Cellular FLICE-like inhibitory protein;FADD-like antiapoptotic molecule 1;Inhibitor of FLICE;MACH-related inducer of toxicity;Usurpin;, PF01335;, GO:0031265;GO:0005737;GO:0005829;GO:0031264;GO:0045121;GO:0097342;GO:0097153;GO:0097199;GO:0097200;GO:0005123;GO:0008047;GO:0002020;GO:0044877;GO:0006919;GO:0006915;GO:0071549;GO:0071364;GO:0071392;GO:0071456;GO:0032869;GO:0071732;GO:0043066;GO:0010667;GO:1903845;GO:2001237;GO:1902042;GO:1903944;GO:1901740;GO:1903427;GO:0070374;GO:1903055;GO:0072126;GO:2000347;GO:0043123;GO:0010976;GO:0051092;GO:1902041;GO:0060544;GO:0014842;GO:0010803;GO:0033574;GO:0014732;GO:0007519;GO:0043403;GO:0014866;GO:0016032;GO:0042060;, C:CD95 death-inducing signaling complex; C:cytoplasm; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:ripoptosome;, F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:death receptor binding; F:enzyme activator activity; F:protease binding; F:protein-containing complex binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to dexamethasone stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to nitric oxide; P:negative regulation of apoptotic process; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cellular response to transforming growth factor beta stimulus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of hepatocyte apoptotic process; P:negative regulation of myoblast fusion; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extracellular matrix organization; P:positive regulation of glomerular mesangial cell proliferation; P:positive regulation of hepatocyte proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to testosterone; P:skeletal muscle atrophy; P:skeletal muscle tissue development; P:skeletal muscle tissue regeneration; P:skeletal myofibril assembly; P:viral process; P:wound healing;|Q9UEW1,CASP8 and FADD-like apoptosis regulator,Caspase homolog;Caspase-eight-related protein;Caspase-like apoptosis regulatory protein;Cellular FLICE-like inhibitory protein;FADD-like antiapoptotic molecule 1;Inhibitor of FLICE;MACH-related inducer of toxicity;Usurpin;, PF01335;, GO:0031265;GO:0005737;GO:0005829;GO:0031264;GO:0045121;GO:0097342;GO:0097153;GO:0097199;GO:0097200;GO:0005123;GO:0008047;GO:0002020;GO:0044877;GO:0006919;GO:0006915;GO:0071549;GO:0071364;GO:0071392;GO:0071456;GO:0032869;GO:0071732;GO:0043066;GO:0010667;GO:1903845;GO:2001237;GO:1902042;GO:1903944;GO:1901740;GO:1903427;GO:0070374;GO:1903055;GO:0072126;GO:2000347;GO:0043123;GO:0010976;GO:0051092;GO:1902041;GO:0060544;GO:0014842;GO:0010803;GO:0033574;GO:0014732;GO:0007519;GO:0043403;GO:0014866;GO:0016032;GO:0042060;, C:CD95 death-inducing signaling complex; C:cytoplasm; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:ripoptosome;, F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:death receptor binding; F:enzyme activator activity; F:protease binding; F:protein-containing complex binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to dexamethasone stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to nitric oxide; P:negative regulation of apoptotic process; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cellular response to transforming growth factor beta stimulus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of hepatocyte apoptotic process; P:negative regulation of myoblast fusion; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extracellular matrix organization; P:positive regulation of glomerular mesangial cell proliferation; P:positive regulation of hepatocyte proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to testosterone; P:skeletal muscle atrophy; P:skeletal muscle tissue development; P:skeletal muscle tissue regeneration; P:skeletal myofibril assembly; P:viral process; P:wound healing;|Q9UEW1,CASP8 and FADD-like apoptosis regulator,Caspase homolog;Caspase-eight-related protein;Caspase-like apoptosis regulatory protein;Cellular FLICE-like inhibitory protein;FADD-like antiapoptotic molecule 1;Inhibitor of FLICE;MACH-related inducer of toxicity;Usurpin;, PF01335;, GO:0031265;GO:0005737;GO:0005829;GO:0031264;GO:0045121;GO:0097342;GO:0097153;GO:0097199;GO:0097200;GO:0005123;GO:0008047;GO:0002020;GO:0044877;GO:0006919;GO:0006915;GO:0071549;GO:0071364;GO:0071392;GO:0071456;GO:0032869;GO:0071732;GO:0043066;GO:0010667;GO:1903845;GO:2001237;GO:1902042;GO:1903944;GO:1901740;GO:1903427;GO:0070374;GO:1903055;GO:0072126;GO:2000347;GO:0043123;GO:0010976;GO:0051092;GO:1902041;GO:0060544;GO:0014842;GO:0010803;GO:0033574;GO:0014732;GO:0007519;GO:0043403;GO:0014866;GO:0016032;GO:0042060;, C:CD95 death-inducing signaling complex; C:cytoplasm; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:ripoptosome;, F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:death receptor binding; F:enzyme activator activity; F:protease binding; F:protein-containing complex binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to dexamethasone stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to nitric oxide; P:negative regulation of apoptotic process; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cellular response to transforming growth factor beta stimulus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of hepatocyte apoptotic process; P:negative regulation of myoblast fusion; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extracellular matrix organization; P:positive regulation of glomerular mesangial cell proliferation; P:positive regulation of hepatocyte proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to testosterone; P:skeletal muscle atrophy; P:skeletal muscle tissue development; P:skeletal muscle tissue regeneration; P:skeletal myofibril assembly; P:viral process; P:wound healing;|Q9UEW1,CASP8 and FADD-like apoptosis regulator,Caspase homolog;Caspase-eight-related protein;Caspase-like apoptosis regulatory protein;Cellular FLICE-like inhibitory protein;FADD-like antiapoptotic molecule 1;Inhibitor of FLICE;MACH-related inducer of toxicity;Usurpin;, PF01335;, GO:0031265;GO:0005737;GO:0005829;GO:0031264;GO:0045121;GO:0097342;GO:0097153;GO:0097199;GO:0097200;GO:0005123;GO:0008047;GO:0002020;GO:0044877;GO:0006919;GO:0006915;GO:0071549;GO:0071364;GO:0071392;GO:0071456;GO:0032869;GO:0071732;GO:0043066;GO:0010667;GO:1903845;GO:2001237;GO:1902042;GO:1903944;GO:1901740;GO:1903427;GO:0070374;GO:1903055;GO:0072126;GO:2000347;GO:0043123;GO:0010976;GO:0051092;GO:1902041;GO:0060544;GO:0014842;GO:0010803;GO:0033574;GO:0014732;GO:0007519;GO:0043403;GO:0014866;GO:0016032;GO:0042060;, C:CD95 death-inducing signaling complex; C:cytoplasm; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:ripoptosome;, F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:death receptor binding; F:enzyme activator activity; F:protease binding; F:protein-containing complex binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to dexamethasone stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to nitric oxide; P:negative regulation of apoptotic process; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cellular response to transforming growth factor beta stimulus; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of hepatocyte apoptotic process; P:negative regulation of myoblast fusion; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extracellular matrix organization; P:positive regulation of glomerular mesangial cell proliferation; P:positive regulation of hepatocyte proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to testosterone; P:skeletal muscle atrophy; P:skeletal muscle tissue development; P:skeletal muscle tissue regeneration; P:skeletal myofibril assembly; P:viral process; P:wound healing; scaffold32 indexed_genome mRNA 9904189 9927329 . + . ID=transcript_6875;Q9UQ81,Caspase-8 {ECO:0000303|PubMed:12010809},Apoptotic cysteine protease;Apoptotic protease Mch-5 {ECO:0000303|PubMed:8962078};CAP4;FADD-homologous ICE/ced-3-like protease {ECO:0000303|PubMed:8681377};FADD-like ICE {ECO:0000303|PubMed:8681377};ICE-like apoptotic protease 5;MORT1-associated ced-3 homolog {ECO:0000303|PubMed:8681376};, PF01335;, GO:0031265;GO:0044297;GO:0005737;GO:0005856;GO:0005829;GO:0031264;GO:0045121;GO:0005741;GO:0005739;GO:0043005;GO:0005654;GO:0032991;GO:0097342;GO:0004197;GO:0097153;GO:0097199;GO:0097200;GO:0008234;GO:0035877;GO:0005123;GO:0042802;GO:0008233;GO:0044877;GO:0097110;GO:0005164;GO:0031625;GO:0097202;GO:0006919;GO:0097296;GO:0001525;GO:0006915;GO:0097190;GO:0042113;GO:0007166;GO:0071260;GO:0071407;GO:0071550;GO:0097194;GO:0097191;GO:0008625;GO:0007507;GO:0030225;GO:0019054;GO:0030101;GO:1902042;GO:0043124;GO:0060546;GO:0070423;GO:0043065;GO:0043123;GO:0032731;GO:0045651;GO:1901216;GO:1900740;GO:0045862;GO:0006508;GO:0051603;GO:0070269;GO:0001817;GO:1902041;GO:0045088;GO:0060544;GO:0010803;GO:0046677;GO:0032025;GO:0009409;GO:0032355;GO:0045471;GO:0032496;GO:0034612;GO:0097264;GO:0039650;GO:0060715;GO:0042110;GO:0034138;GO:0036462;GO:0035666;, C:CD95 death-inducing signaling complex; C:cell body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:protein-containing complex; C:ripoptosome;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:cysteine-type peptidase activity; F:death effector domain binding; F:death receptor binding; F:identical protein binding; F:peptidase activity; F:protein-containing complex binding; F:scaffold protein binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:angiogenesis; P:apoptotic process; P:apoptotic signaling pathway; P:B cell activation; P:cell surface receptor signaling pathway; P:cellular response to mechanical stimulus; P:cellular response to organic cyclic compound; P:death-inducing signaling complex assembly; P:execution phase of apoptosis; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:heart development; P:macrophage differentiation; P:modulation by virus of host cellular process; P:natural killer cell activation; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of macrophage differentiation; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of proteolysis; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:pyroptosis; P:regulation of cytokine production; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of innate immune response; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to antibiotic; P:response to cobalt ion; P:response to cold; P:response to estradiol; P:response to ethanol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:self proteolysis; P:suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process; P:syncytiotrophoblast cell differentiation involved in labyrinthine layer development; P:T cell activation; P:toll-like receptor 3 signaling pathway; P:TRAIL-activated apoptotic signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway;|Q9UQ81,Caspase-8 {ECO:0000303|PubMed:12010809},Apoptotic cysteine protease;Apoptotic protease Mch-5 {ECO:0000303|PubMed:8962078};CAP4;FADD-homologous ICE/ced-3-like protease {ECO:0000303|PubMed:8681377};FADD-like ICE {ECO:0000303|PubMed:8681377};ICE-like apoptotic protease 5;MORT1-associated ced-3 homolog {ECO:0000303|PubMed:8681376};, PF01335;, GO:0031265;GO:0044297;GO:0005737;GO:0005856;GO:0005829;GO:0031264;GO:0045121;GO:0005741;GO:0005739;GO:0043005;GO:0005654;GO:0032991;GO:0097342;GO:0004197;GO:0097153;GO:0097199;GO:0097200;GO:0008234;GO:0035877;GO:0005123;GO:0042802;GO:0008233;GO:0044877;GO:0097110;GO:0005164;GO:0031625;GO:0097202;GO:0006919;GO:0097296;GO:0001525;GO:0006915;GO:0097190;GO:0042113;GO:0007166;GO:0071260;GO:0071407;GO:0071550;GO:0097194;GO:0097191;GO:0008625;GO:0007507;GO:0030225;GO:0019054;GO:0030101;GO:1902042;GO:0043124;GO:0060546;GO:0070423;GO:0043065;GO:0043123;GO:0032731;GO:0045651;GO:1901216;GO:1900740;GO:0045862;GO:0006508;GO:0051603;GO:0070269;GO:0001817;GO:1902041;GO:0045088;GO:0060544;GO:0010803;GO:0046677;GO:0032025;GO:0009409;GO:0032355;GO:0045471;GO:0032496;GO:0034612;GO:0097264;GO:0039650;GO:0060715;GO:0042110;GO:0034138;GO:0036462;GO:0035666;, C:CD95 death-inducing signaling complex; C:cell body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:protein-containing complex; C:ripoptosome;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:cysteine-type peptidase activity; F:death effector domain binding; F:death receptor binding; F:identical protein binding; F:peptidase activity; F:protein-containing complex binding; F:scaffold protein binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:angiogenesis; P:apoptotic process; P:apoptotic signaling pathway; P:B cell activation; P:cell surface receptor signaling pathway; P:cellular response to mechanical stimulus; P:cellular response to organic cyclic compound; P:death-inducing signaling complex assembly; P:execution phase of apoptosis; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:heart development; P:macrophage differentiation; P:modulation by virus of host cellular process; P:natural killer cell activation; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of macrophage differentiation; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of proteolysis; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:pyroptosis; P:regulation of cytokine production; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of innate immune response; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to antibiotic; P:response to cobalt ion; P:response to cold; P:response to estradiol; P:response to ethanol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:self proteolysis; P:suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process; P:syncytiotrophoblast cell differentiation involved in labyrinthine layer development; P:T cell activation; P:toll-like receptor 3 signaling pathway; P:TRAIL-activated apoptotic signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; scaffold32 indexed_genome mRNA 9985343 10050765 . - . ID=transcript_6876;O60296 E7EV21 Q8WVH7 Q96NS2 Q9C0K5 Q9C0K6,Trafficking kinesin-binding protein 2,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 3 protein;, PF04849;PF12448;, GO:1904115;GO:0044295;GO:0005737;GO:0031410;GO:0030425;GO:0032839;GO:0005769;GO:0005739;GO:0043025;GO:0005634;GO:0005886;GO:0019899;GO:0050811;GO:0019894;GO:0017022;GO:0005102;GO:0030911;GO:0098957;GO:0098972;GO:0048813;GO:0008333;GO:0048311;GO:0050771;GO:0022008;GO:0006493;GO:0006605;GO:0006357;GO:0047496;, C:axon cytoplasm; C:axonal growth cone; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:dendrite cytoplasm; C:early endosome; C:mitochondrion; C:neuronal cell body; C:nucleus; C:plasma membrane;, F:enzyme binding; F:GABA receptor binding; F:kinesin binding; F:myosin binding; F:signaling receptor binding; F:TPR domain binding;, P:anterograde axonal transport of mitochondrion; P:anterograde dendritic transport of mitochondrion; P:dendrite morphogenesis; P:endosome to lysosome transport; P:mitochondrion distribution; P:negative regulation of axonogenesis; P:neurogenesis; P:protein O-linked glycosylation; P:protein targeting; P:regulation of transcription by RNA polymerase II; P:vesicle transport along microtubule; scaffold32 indexed_genome mRNA 10050890 10075099 . + . ID=transcript_6877;Q9C0K7 Q5BKY7 Q9P1L0,STE20-related kinase adapter protein beta,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein;CALS-21;ILP-interacting protein;Pseudokinase ALS2CR2;, PF00069;, GO:0016235;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0032147;GO:0007050;GO:0000902;GO:0007254;GO:2001240;GO:0006611;GO:0006468;, C:aggresome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding;, P:activation of protein kinase activity; P:cell cycle arrest; P:cell morphogenesis; P:JNK cascade; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein export from nucleus; P:protein phosphorylation;|Q9C0K7 Q5BKY7 Q9P1L0,STE20-related kinase adapter protein beta,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein;CALS-21;ILP-interacting protein;Pseudokinase ALS2CR2;, PF00069;, GO:0016235;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0032147;GO:0007050;GO:0000902;GO:0007254;GO:2001240;GO:0006611;GO:0006468;, C:aggresome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding;, P:activation of protein kinase activity; P:cell cycle arrest; P:cell morphogenesis; P:JNK cascade; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein export from nucleus; P:protein phosphorylation;|Q9C0K7 Q5BKY7 Q9P1L0,STE20-related kinase adapter protein beta,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein;CALS-21;ILP-interacting protein;Pseudokinase ALS2CR2;, PF00069;, GO:0016235;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0032147;GO:0007050;GO:0000902;GO:0007254;GO:2001240;GO:0006611;GO:0006468;, C:aggresome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding;, P:activation of protein kinase activity; P:cell cycle arrest; P:cell morphogenesis; P:JNK cascade; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein export from nucleus; P:protein phosphorylation;|Q9C0K7 Q5BKY7 Q9P1L0,STE20-related kinase adapter protein beta,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein;CALS-21;ILP-interacting protein;Pseudokinase ALS2CR2;, PF00069;, GO:0016235;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0032147;GO:0007050;GO:0000902;GO:0007254;GO:2001240;GO:0006611;GO:0006468;, C:aggresome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding;, P:activation of protein kinase activity; P:cell cycle arrest; P:cell morphogenesis; P:JNK cascade; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein export from nucleus; P:protein phosphorylation;|Q9C0K7 Q5BKY7 Q9P1L0,STE20-related kinase adapter protein beta,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein;CALS-21;ILP-interacting protein;Pseudokinase ALS2CR2;, PF00069;, GO:0016235;GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0032147;GO:0007050;GO:0000902;GO:0007254;GO:2001240;GO:0006611;GO:0006468;, C:aggresome; C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding;, P:activation of protein kinase activity; P:cell cycle arrest; P:cell morphogenesis; P:JNK cascade; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein export from nucleus; P:protein phosphorylation; scaffold32 indexed_genome mRNA 10144193 10198208 . - . ID=transcript_6878;Q53TS8 C9IZH7 E9PGG4 Q8NCN6 Q96LN4,C2 calcium-dependent domain-containing protein 6,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein;, PF15729; scaffold32 indexed_genome mRNA 10213388 10236573 . - . ID=transcript_6879;Q7Z3B6 Q8IZ18 Q8NBF8 Q96CY1,Transmembrane protein 237,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein;, PF15383;, GO:0035869;GO:0120199;GO:0016021;GO:0016020;GO:0032391;GO:0120200;GO:0060271;GO:0030111;, C:ciliary transition zone; C:cone photoreceptor outer segment; C:integral component of membrane; C:membrane; C:photoreceptor connecting cilium; C:rod photoreceptor outer segment;, , P:cilium assembly; P:regulation of Wnt signaling pathway; scaffold32 indexed_genome mRNA 10290386 10300586 . - . ID=transcript_6880;Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size;|Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size;|Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size;|Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size;|Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size;|Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size;|Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size; scaffold32 indexed_genome mRNA 10300953 10329762 . - . ID=transcript_6881;Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size;|Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size;|Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size;|Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size;|Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size; scaffold32 indexed_genome mRNA 10329817 10332517 . + . ID=transcript_6882;Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size; scaffold32 indexed_genome mRNA 10333301 10348042 . - . ID=transcript_6883;Q96Q42 Q53TT1 Q53TV2 Q8N1E0 Q96PC4 Q96Q41 Q9H973 Q9HCK9,Alsin,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein;Amyotrophic lateral sclerosis 2 protein;, PF02493;PF00415;PF00621;PF02204;, GO:0005813;GO:0005829;GO:0030425;GO:0005769;GO:0030426;GO:0030027;GO:0005634;GO:0032991;GO:0001726;GO:0031982;GO:0005096;GO:0005085;GO:0042802;GO:0042803;GO:0043539;GO:0031267;GO:0007032;GO:0007041;GO:0048812;GO:0043547;GO:0045860;GO:0035022;GO:0051260;GO:0051036;, C:centrosome; C:cytosol; C:dendrite; C:early endosome; C:growth cone; C:lamellipodium; C:nucleus; C:protein-containing complex; C:ruffle; C:vesicle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:protein homodimerization activity; F:protein serine/threonine kinase activator activity; F:small GTPase binding;, P:endosome organization; P:lysosomal transport; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:positive regulation of protein kinase activity; P:positive regulation of Rac protein signal transduction; P:protein homooligomerization; P:regulation of endosome size; scaffold32 indexed_genome mRNA 10658434 10660452 . + . ID=transcript_6884;Q0VF49 Q8IVF9,Uncharacterized protein KIAA2012 {ECO:0000305},, PF15709; scaffold32 indexed_genome mRNA 10660459 10692123 . + . ID=transcript_6885;Q0VF49 Q8IVF9,Uncharacterized protein KIAA2012 {ECO:0000305},, PF15709; scaffold32 indexed_genome mRNA 10771143 10774954 . + . ID=transcript_6886;Q0VF49 Q8IVF9,Uncharacterized protein KIAA2012 {ECO:0000305},, PF15709; scaffold32 indexed_genome mRNA 10777254 10785655 . + . ID=transcript_6887;P63165 A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068,Small ubiquitin-related modifier 1,GAP-modifying protein 1;SMT3 homolog 3;Sentrin;Ubiquitin-homology domain protein PIC1;Ubiquitin-like protein SMT3C;Ubiquitin-like protein UBL1;, PF11976;, GO:0005829;GO:0016604;GO:0005635;GO:0031965;GO:0005643;GO:0016607;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0019899;GO:0015459;GO:0031386;GO:0003723;GO:0044388;GO:0008134;GO:0031625;GO:0044389;GO:1990381;GO:0071276;GO:0034605;GO:0006281;GO:0006302;GO:0006303;GO:0007084;GO:0045759;GO:1902260;GO:0043392;GO:0043433;GO:0000122;GO:0045892;GO:0032436;GO:0031334;GO:0050821;GO:0016925;GO:0060334;GO:0032880;GO:0060021;GO:0019082;, C:cytosol; C:nuclear body; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear speck; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body;, F:enzyme binding; F:potassium channel regulator activity; F:protein tag; F:RNA binding; F:small protein activating enzyme binding; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding; F:ubiquitin-specific protease binding;, P:cellular response to cadmium ion; P:cellular response to heat; P:DNA repair; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:mitotic nuclear envelope reassembly; P:negative regulation of action potential; P:negative regulation of delayed rectifier potassium channel activity; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein-containing complex assembly; P:protein stabilization; P:protein sumoylation; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of protein localization; P:roof of mouth development; P:viral protein processing; scaffold32 indexed_genome mRNA 10785675 10805229 . - . ID=transcript_6888;P63165 A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068,Small ubiquitin-related modifier 1,GAP-modifying protein 1;SMT3 homolog 3;Sentrin;Ubiquitin-homology domain protein PIC1;Ubiquitin-like protein SMT3C;Ubiquitin-like protein UBL1;, PF11976;, GO:0005829;GO:0016604;GO:0005635;GO:0031965;GO:0005643;GO:0016607;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0019899;GO:0015459;GO:0031386;GO:0003723;GO:0044388;GO:0008134;GO:0031625;GO:0044389;GO:1990381;GO:0071276;GO:0034605;GO:0006281;GO:0006302;GO:0006303;GO:0007084;GO:0045759;GO:1902260;GO:0043392;GO:0043433;GO:0000122;GO:0045892;GO:0032436;GO:0031334;GO:0050821;GO:0016925;GO:0060334;GO:0032880;GO:0060021;GO:0019082;, C:cytosol; C:nuclear body; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear speck; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body;, F:enzyme binding; F:potassium channel regulator activity; F:protein tag; F:RNA binding; F:small protein activating enzyme binding; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding; F:ubiquitin-specific protease binding;, P:cellular response to cadmium ion; P:cellular response to heat; P:DNA repair; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:mitotic nuclear envelope reassembly; P:negative regulation of action potential; P:negative regulation of delayed rectifier potassium channel activity; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein-containing complex assembly; P:protein stabilization; P:protein sumoylation; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of protein localization; P:roof of mouth development; P:viral protein processing;|P63165 A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068,Small ubiquitin-related modifier 1,GAP-modifying protein 1;SMT3 homolog 3;Sentrin;Ubiquitin-homology domain protein PIC1;Ubiquitin-like protein SMT3C;Ubiquitin-like protein UBL1;, PF11976;, GO:0005829;GO:0016604;GO:0005635;GO:0031965;GO:0005643;GO:0016607;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0019899;GO:0015459;GO:0031386;GO:0003723;GO:0044388;GO:0008134;GO:0031625;GO:0044389;GO:1990381;GO:0071276;GO:0034605;GO:0006281;GO:0006302;GO:0006303;GO:0007084;GO:0045759;GO:1902260;GO:0043392;GO:0043433;GO:0000122;GO:0045892;GO:0032436;GO:0031334;GO:0050821;GO:0016925;GO:0060334;GO:0032880;GO:0060021;GO:0019082;, C:cytosol; C:nuclear body; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear speck; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body;, F:enzyme binding; F:potassium channel regulator activity; F:protein tag; F:RNA binding; F:small protein activating enzyme binding; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding; F:ubiquitin-specific protease binding;, P:cellular response to cadmium ion; P:cellular response to heat; P:DNA repair; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:mitotic nuclear envelope reassembly; P:negative regulation of action potential; P:negative regulation of delayed rectifier potassium channel activity; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein-containing complex assembly; P:protein stabilization; P:protein sumoylation; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of protein localization; P:roof of mouth development; P:viral protein processing; scaffold32 indexed_genome mRNA 10833061 10856913 . + . ID=transcript_6889;Q9Y2X3 Q53SA4 Q6PK08 Q9P036 Q9UFN3,Nucleolar protein 58,Nucleolar protein 5;, PF01798;PF08156;, GO:0031428;GO:0015030;GO:0005829;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0070761;GO:0032040;GO:0005732;GO:0051117;GO:0003723;GO:0030515;GO:0001094;GO:0006364;GO:0048254;, C:box C/D RNP complex; C:Cajal body; C:cytosol; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:pre-snoRNP complex; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:ATPase binding; F:RNA binding; F:snoRNA binding; F:TFIID-class transcription factor complex binding;, P:rRNA processing; P:snoRNA localization;|Q9Y2X3 Q53SA4 Q6PK08 Q9P036 Q9UFN3,Nucleolar protein 58,Nucleolar protein 5;, PF01798;PF08156;, GO:0031428;GO:0015030;GO:0005829;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0070761;GO:0032040;GO:0005732;GO:0051117;GO:0003723;GO:0030515;GO:0001094;GO:0006364;GO:0048254;, C:box C/D RNP complex; C:Cajal body; C:cytosol; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:pre-snoRNP complex; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:ATPase binding; F:RNA binding; F:snoRNA binding; F:TFIID-class transcription factor complex binding;, P:rRNA processing; P:snoRNA localization;|Q9Y2X3 Q53SA4 Q6PK08 Q9P036 Q9UFN3,Nucleolar protein 58,Nucleolar protein 5;, PF01798;PF08156;, GO:0031428;GO:0015030;GO:0005829;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0070761;GO:0032040;GO:0005732;GO:0051117;GO:0003723;GO:0030515;GO:0001094;GO:0006364;GO:0048254;, C:box C/D RNP complex; C:Cajal body; C:cytosol; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:pre-snoRNP complex; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:ATPase binding; F:RNA binding; F:snoRNA binding; F:TFIID-class transcription factor complex binding;, P:rRNA processing; P:snoRNA localization;|Q9Y2X3 Q53SA4 Q6PK08 Q9P036 Q9UFN3,Nucleolar protein 58,Nucleolar protein 5;, PF01798;PF08156;, GO:0031428;GO:0015030;GO:0005829;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0070761;GO:0032040;GO:0005732;GO:0051117;GO:0003723;GO:0030515;GO:0001094;GO:0006364;GO:0048254;, C:box C/D RNP complex; C:Cajal body; C:cytosol; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:pre-snoRNP complex; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:ATPase binding; F:RNA binding; F:snoRNA binding; F:TFIID-class transcription factor complex binding;, P:rRNA processing; P:snoRNA localization;|Q9Y2X3 Q53SA4 Q6PK08 Q9P036 Q9UFN3,Nucleolar protein 58,Nucleolar protein 5;, PF01798;PF08156;, GO:0031428;GO:0015030;GO:0005829;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0070761;GO:0032040;GO:0005732;GO:0051117;GO:0003723;GO:0030515;GO:0001094;GO:0006364;GO:0048254;, C:box C/D RNP complex; C:Cajal body; C:cytosol; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:pre-snoRNP complex; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:ATPase binding; F:RNA binding; F:snoRNA binding; F:TFIID-class transcription factor complex binding;, P:rRNA processing; P:snoRNA localization; scaffold32 indexed_genome mRNA 10925910 11073956 . + . ID=transcript_6890;Q13873 Q13161 Q16569 Q4ZG08 Q53SA5 Q585T8,Bone morphogenetic protein receptor type-2,Bone morphogenetic protein receptor type II;, PF01064;PF00069;, GO:0005912;GO:0016324;GO:0009925;GO:0005901;GO:0009986;GO:0005737;GO:0030425;GO:0005615;GO:0005887;GO:0043025;GO:0005654;GO:0005886;GO:0014069;GO:0043235;GO:0044214;GO:0005524;GO:0036122;GO:0098821;GO:0045296;GO:0019838;GO:0046872;GO:0004674;GO:1990782;GO:0005024;GO:0032924;GO:0009952;GO:0003176;GO:0060840;GO:0060413;GO:0001568;GO:0001974;GO:0030509;GO:0007420;GO:0071773;GO:0071363;GO:0009267;GO:0002063;GO:0003197;GO:0060350;GO:0072577;GO:0001935;GO:0060173;GO:0048286;GO:0001946;GO:0060836;GO:0001893;GO:0001707;GO:0003183;GO:0030514;GO:0030308;GO:0003252;GO:1902731;GO:2000279;GO:0003085;GO:0045906;GO:0003151;GO:0003148;GO:0061626;GO:0048842;GO:0030513;GO:0030501;GO:0061036;GO:0010595;GO:0001938;GO:0010634;GO:0045778;GO:0045669;GO:0010862;GO:0045944;GO:0006468;GO:0030166;GO:0003177;GO:0042127;GO:0014916;GO:0061298;GO:1905314;GO:0007178;GO:0003186;GO:0060841;GO:0060412;, C:adherens junction; C:apical plasma membrane; C:basal plasma membrane; C:caveola; C:cell surface; C:cytoplasm; C:dendrite; C:extracellular space; C:integral component of plasma membrane; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:receptor complex; C:spanning component of plasma membrane;, F:ATP binding; F:BMP binding; F:BMP receptor activity; F:cadherin binding; F:growth factor binding; F:metal ion binding; F:protein serine/threonine kinase activity; F:protein tyrosine kinase binding; F:transforming growth factor beta-activated receptor activity;, P:activin receptor signaling pathway; P:anterior/posterior pattern specification; P:aortic valve development; P:artery development; P:atrial septum morphogenesis; P:blood vessel development; P:blood vessel remodeling; P:BMP signaling pathway; P:brain development; P:cellular response to BMP stimulus; P:cellular response to growth factor stimulus; P:cellular response to starvation; P:chondrocyte development; P:endocardial cushion development; P:endochondral bone morphogenesis; P:endothelial cell apoptotic process; P:endothelial cell proliferation; P:limb development; P:lung alveolus development; P:lymphangiogenesis; P:lymphatic endothelial cell differentiation; P:maternal placenta development; P:mesoderm formation; P:mitral valve morphogenesis; P:negative regulation of BMP signaling pathway; P:negative regulation of cell growth; P:negative regulation of cell proliferation involved in heart valve morphogenesis; P:negative regulation of chondrocyte proliferation; P:negative regulation of DNA biosynthetic process; P:negative regulation of systemic arterial blood pressure; P:negative regulation of vasoconstriction; P:outflow tract morphogenesis; P:outflow tract septum morphogenesis; P:pharyngeal arch artery morphogenesis; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of cartilage development; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of ossification; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:proteoglycan biosynthetic process; P:pulmonary valve development; P:regulation of cell population proliferation; P:regulation of lung blood pressure; P:retina vasculature development in camera-type eye; P:semi-lunar valve development; P:transmembrane receptor protein serine/threonine kinase signaling pathway; P:tricuspid valve morphogenesis; P:venous blood vessel development; P:ventricular septum morphogenesis; scaffold32 indexed_genome mRNA 11117314 11191146 . + . ID=transcript_6891;Q6P1L5 Q53QZ5 Q585T9 Q8N8W1 Q96Q34,Protein FAM117B,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein;, PF15388;|Q6P1L5 Q53QZ5 Q585T9 Q8N8W1 Q96Q34,Protein FAM117B,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein;, PF15388; scaffold32 indexed_genome mRNA 11195404 11234486 . - . ID=transcript_6892;Q8NDH6 B3KRW6 Q53P45 Q53QZ4 Q53T97 Q96N47 Q96Q32 Q9BVQ2,Islet cell autoantigen 1-like protein,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 14 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein;, PF06456;PF04629;, GO:0005794;GO:0019904;GO:0051049;, C:Golgi apparatus;, F:protein domain specific binding;, P:regulation of transport;|Q8NDH6 B3KRW6 Q53P45 Q53QZ4 Q53T97 Q96N47 Q96Q32 Q9BVQ2,Islet cell autoantigen 1-like protein,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 14 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein;, PF06456;PF04629;, GO:0005794;GO:0019904;GO:0051049;, C:Golgi apparatus;, F:protein domain specific binding;, P:regulation of transport;|Q8NDH6 B3KRW6 Q53P45 Q53QZ4 Q53T97 Q96N47 Q96Q32 Q9BVQ2,Islet cell autoantigen 1-like protein,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 14 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein;, PF06456;PF04629;, GO:0005794;GO:0019904;GO:0051049;, C:Golgi apparatus;, F:protein domain specific binding;, P:regulation of transport;|Q8NDH6 B3KRW6 Q53P45 Q53QZ4 Q53T97 Q96N47 Q96Q32 Q9BVQ2,Islet cell autoantigen 1-like protein,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 14 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein;, PF06456;PF04629;, GO:0005794;GO:0019904;GO:0051049;, C:Golgi apparatus;, F:protein domain specific binding;, P:regulation of transport;|Q8NDH6 B3KRW6 Q53P45 Q53QZ4 Q53T97 Q96N47 Q96Q32 Q9BVQ2,Islet cell autoantigen 1-like protein,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 14 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein;, PF06456;PF04629;, GO:0005794;GO:0019904;GO:0051049;, C:Golgi apparatus;, F:protein domain specific binding;, P:regulation of transport; scaffold32 indexed_genome mRNA 11260789 11271640 . - . ID=transcript_6893;Q9GZL7 B3KPA9 Q96HU0 Q9NV80 Q9NYI8,Ribosome biogenesis protein WDR12 {ECO:0000255|HAMAP-Rule:MF_03029},WD repeat-containing protein 12 {ECO:0000255|HAMAP-Rule:MF_03029};, PF08154;PF00400;, GO:0005730;GO:0005654;GO:0070545;GO:0030687;GO:0043021;GO:0000466;GO:0000463;GO:0007219;GO:0051726;GO:0042273;GO:0006364;, C:nucleolus; C:nucleoplasm; C:PeBoW complex; C:preribosome, large subunit precursor;, F:ribonucleoprotein complex binding;, P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:Notch signaling pathway; P:regulation of cell cycle; P:ribosomal large subunit biogenesis; P:rRNA processing;|Q9GZL7 B3KPA9 Q96HU0 Q9NV80 Q9NYI8,Ribosome biogenesis protein WDR12 {ECO:0000255|HAMAP-Rule:MF_03029},WD repeat-containing protein 12 {ECO:0000255|HAMAP-Rule:MF_03029};, PF08154;PF00400;, GO:0005730;GO:0005654;GO:0070545;GO:0030687;GO:0043021;GO:0000466;GO:0000463;GO:0007219;GO:0051726;GO:0042273;GO:0006364;, C:nucleolus; C:nucleoplasm; C:PeBoW complex; C:preribosome, large subunit precursor;, F:ribonucleoprotein complex binding;, P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:Notch signaling pathway; P:regulation of cell cycle; P:ribosomal large subunit biogenesis; P:rRNA processing; scaffold32 indexed_genome mRNA 11275636 11276854 . - . ID=transcript_6894;Q9GZL7 B3KPA9 Q96HU0 Q9NV80 Q9NYI8,Ribosome biogenesis protein WDR12 {ECO:0000255|HAMAP-Rule:MF_03029},WD repeat-containing protein 12 {ECO:0000255|HAMAP-Rule:MF_03029};, PF08154;PF00400;, GO:0005730;GO:0005654;GO:0070545;GO:0030687;GO:0043021;GO:0000466;GO:0000463;GO:0007219;GO:0051726;GO:0042273;GO:0006364;, C:nucleolus; C:nucleoplasm; C:PeBoW complex; C:preribosome, large subunit precursor;, F:ribonucleoprotein complex binding;, P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:Notch signaling pathway; P:regulation of cell cycle; P:ribosomal large subunit biogenesis; P:rRNA processing; scaffold32 indexed_genome mRNA 11290054 11342377 . + . ID=transcript_6895;Q8N187 B4E1W7 G3V1K7 Q8ND29 Q8WXC0 Q96J78 Q96Q38 Q96Q39 Q9H712,Calcium-responsive transcription factor,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein;Calcium-response factor;Testis development protein NYD-SP24;, PF15299;, GO:0001652;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0071277;GO:0035865;GO:0061400;GO:0051090;GO:0006357;, C:granular component; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to calcium ion; P:cellular response to potassium ion; P:positive regulation of transcription from RNA polymerase II promoter in response to calcium ion; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription by RNA polymerase II;|Q8N187 B4E1W7 G3V1K7 Q8ND29 Q8WXC0 Q96J78 Q96Q38 Q96Q39 Q9H712,Calcium-responsive transcription factor,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein;Calcium-response factor;Testis development protein NYD-SP24;, PF15299;, GO:0001652;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0071277;GO:0035865;GO:0061400;GO:0051090;GO:0006357;, C:granular component; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to calcium ion; P:cellular response to potassium ion; P:positive regulation of transcription from RNA polymerase II promoter in response to calcium ion; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription by RNA polymerase II;|Q8N187 B4E1W7 G3V1K7 Q8ND29 Q8WXC0 Q96J78 Q96Q38 Q96Q39 Q9H712,Calcium-responsive transcription factor,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein;Calcium-response factor;Testis development protein NYD-SP24;, PF15299;, GO:0001652;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0071277;GO:0035865;GO:0061400;GO:0051090;GO:0006357;, C:granular component; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to calcium ion; P:cellular response to potassium ion; P:positive regulation of transcription from RNA polymerase II promoter in response to calcium ion; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription by RNA polymerase II; scaffold32 indexed_genome mRNA 11404206 11539753 . + . ID=transcript_6896;Q6ZS30 A6NHD5 Q6Y876 Q6ZP36 Q6ZQY5 Q8N8R4 Q96Q30 Q96Q31,Neurobeachin-like protein 1,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein;, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0019901;GO:0008104;, C:cytosol; C:membrane;, F:protein kinase binding;, P:protein localization;|Q6ZS30 A6NHD5 Q6Y876 Q6ZP36 Q6ZQY5 Q8N8R4 Q96Q30 Q96Q31,Neurobeachin-like protein 1,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein;, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0019901;GO:0008104;, C:cytosol; C:membrane;, F:protein kinase binding;, P:protein localization;|Q6ZS30 A6NHD5 Q6Y876 Q6ZP36 Q6ZQY5 Q8N8R4 Q96Q30 Q96Q31,Neurobeachin-like protein 1,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein;, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0019901;GO:0008104;, C:cytosol; C:membrane;, F:protein kinase binding;, P:protein localization;|Q6ZS30 A6NHD5 Q6Y876 Q6ZP36 Q6ZQY5 Q8N8R4 Q96Q30 Q96Q31,Neurobeachin-like protein 1,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein;, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0019901;GO:0008104;, C:cytosol; C:membrane;, F:protein kinase binding;, P:protein localization;|Q6ZS30 A6NHD5 Q6Y876 Q6ZP36 Q6ZQY5 Q8N8R4 Q96Q30 Q96Q31,Neurobeachin-like protein 1,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein;, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0019901;GO:0008104;, C:cytosol; C:membrane;, F:protein kinase binding;, P:protein localization;|Q6ZS30 A6NHD5 Q6Y876 Q6ZP36 Q6ZQY5 Q8N8R4 Q96Q30 Q96Q31,Neurobeachin-like protein 1,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein;, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0019901;GO:0008104;, C:cytosol; C:membrane;, F:protein kinase binding;, P:protein localization;|Q6ZS30 A6NHD5 Q6Y876 Q6ZP36 Q6ZQY5 Q8N8R4 Q96Q30 Q96Q31,Neurobeachin-like protein 1,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein;, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0019901;GO:0008104;, C:cytosol; C:membrane;, F:protein kinase binding;, P:protein localization; scaffold32 indexed_genome mRNA 11556603 11579794 . + . ID=transcript_6897;Q6UW02 Q4ZG61 Q8N4Q8 Q8WWA9 Q9HC04,Cytochrome P450 20A1,, PF00067;, GO:0016021;GO:0016020;GO:0020037;GO:0005506;GO:0004497;GO:0016705;, C:integral component of membrane; C:membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;|Q6UW02 Q4ZG61 Q8N4Q8 Q8WWA9 Q9HC04,Cytochrome P450 20A1,, PF00067;, GO:0016021;GO:0016020;GO:0020037;GO:0005506;GO:0004497;GO:0016705;, C:integral component of membrane; C:membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; scaffold32 indexed_genome mRNA 11595668 11654263 . + . ID=transcript_6898;Q9NYB9 B4DSN1 Q13147 Q13249 Q13801 Q9BV70,Abl interactor 2 {ECO:0000303|Ref.16},Abelson interactor 2 {ECO:0000303|Ref.16};Abl-binding protein 3;Arg-binding protein 1 {ECO:0000303|PubMed:8649853};, PF07815;PF00018;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0032433;GO:0030027;GO:0005634;GO:0031209;GO:0008093;GO:0042802;GO:0019900;GO:0070064;GO:0017124;GO:0035591;GO:0031625;GO:0008154;GO:0016477;GO:0007010;GO:0070309;GO:0007399;GO:0018108;GO:2000601;GO:0010592;GO:0016601;GO:0061001;GO:0016032;GO:0045186;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:filopodium tip; C:lamellipodium; C:nucleus; C:SCAR complex;, F:cytoskeletal anchor activity; F:identical protein binding; F:kinase binding; F:proline-rich region binding; F:SH3 domain binding; F:signaling adaptor activity; F:ubiquitin protein ligase binding;, P:actin polymerization or depolymerization; P:cell migration; P:cytoskeleton organization; P:lens fiber cell morphogenesis; P:nervous system development; P:peptidyl-tyrosine phosphorylation; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:Rac protein signal transduction; P:regulation of dendritic spine morphogenesis; P:viral process; P:zonula adherens assembly; scaffold32 indexed_genome mRNA 11665072 11674375 . + . ID=transcript_6899;Q9NYB9 B4DSN1 Q13147 Q13249 Q13801 Q9BV70,Abl interactor 2 {ECO:0000303|Ref.16},Abelson interactor 2 {ECO:0000303|Ref.16};Abl-binding protein 3;Arg-binding protein 1 {ECO:0000303|PubMed:8649853};, PF07815;PF00018;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0032433;GO:0030027;GO:0005634;GO:0031209;GO:0008093;GO:0042802;GO:0019900;GO:0070064;GO:0017124;GO:0035591;GO:0031625;GO:0008154;GO:0016477;GO:0007010;GO:0070309;GO:0007399;GO:0018108;GO:2000601;GO:0010592;GO:0016601;GO:0061001;GO:0016032;GO:0045186;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:filopodium tip; C:lamellipodium; C:nucleus; C:SCAR complex;, F:cytoskeletal anchor activity; F:identical protein binding; F:kinase binding; F:proline-rich region binding; F:SH3 domain binding; F:signaling adaptor activity; F:ubiquitin protein ligase binding;, P:actin polymerization or depolymerization; P:cell migration; P:cytoskeleton organization; P:lens fiber cell morphogenesis; P:nervous system development; P:peptidyl-tyrosine phosphorylation; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:Rac protein signal transduction; P:regulation of dendritic spine morphogenesis; P:viral process; P:zonula adherens assembly;|Q9NYB9 B4DSN1 Q13147 Q13249 Q13801 Q9BV70,Abl interactor 2 {ECO:0000303|Ref.16},Abelson interactor 2 {ECO:0000303|Ref.16};Abl-binding protein 3;Arg-binding protein 1 {ECO:0000303|PubMed:8649853};, PF07815;PF00018;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0032433;GO:0030027;GO:0005634;GO:0031209;GO:0008093;GO:0042802;GO:0019900;GO:0070064;GO:0017124;GO:0035591;GO:0031625;GO:0008154;GO:0016477;GO:0007010;GO:0070309;GO:0007399;GO:0018108;GO:2000601;GO:0010592;GO:0016601;GO:0061001;GO:0016032;GO:0045186;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:filopodium tip; C:lamellipodium; C:nucleus; C:SCAR complex;, F:cytoskeletal anchor activity; F:identical protein binding; F:kinase binding; F:proline-rich region binding; F:SH3 domain binding; F:signaling adaptor activity; F:ubiquitin protein ligase binding;, P:actin polymerization or depolymerization; P:cell migration; P:cytoskeleton organization; P:lens fiber cell morphogenesis; P:nervous system development; P:peptidyl-tyrosine phosphorylation; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:Rac protein signal transduction; P:regulation of dendritic spine morphogenesis; P:viral process; P:zonula adherens assembly; scaffold32 indexed_genome mRNA 11703201 11706724 . + . ID=transcript_6900;Q70E73 Q96Q37 Q9C0I2,Ras-associated and pleckstrin homology domains-containing protein 1,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein;Lamellipodin;Proline-rich EVH1 ligand 2;Protein RMO1;, PF00169;PF00788;, GO:0005856;GO:0005829;GO:0030175;GO:0030027;GO:0016604;GO:0005886;GO:0007165;, C:cytoskeleton; C:cytosol; C:filopodium; C:lamellipodium; C:nuclear body; C:plasma membrane;, , P:signal transduction; scaffold32 indexed_genome mRNA 11707715 11763565 . - . ID=transcript_6901;Q70E73 Q96Q37 Q9C0I2,Ras-associated and pleckstrin homology domains-containing protein 1,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein;Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein;Lamellipodin;Proline-rich EVH1 ligand 2;Protein RMO1;, PF00169;PF00788;, GO:0005856;GO:0005829;GO:0030175;GO:0030027;GO:0016604;GO:0005886;GO:0007165;, C:cytoskeleton; C:cytosol; C:filopodium; C:lamellipodium; C:nuclear body; C:plasma membrane;, , P:signal transduction; scaffold32 indexed_genome mRNA 11978879 11986091 . + . ID=transcript_6902;Q9BYV0,T-cell-specific surface glycoprotein CD28,TP44;, PF15910;, GO:0009986;GO:0005829;GO:0009897;GO:0001772;GO:0005887;GO:0005886;GO:0098636;GO:0015026;GO:0042802;GO:0002020;GO:0019901;GO:0097190;GO:0007166;GO:0006959;GO:0043066;GO:0010629;GO:0045060;GO:0046641;GO:0001819;GO:0010628;GO:0002863;GO:0032733;GO:0032743;GO:0032753;GO:0048304;GO:0045840;GO:0014068;GO:0051897;GO:0042102;GO:0045944;GO:0045727;GO:0045070;GO:0050690;GO:0045589;GO:0045066;GO:0042110;GO:0031295;GO:0050852;, C:cell surface; C:cytosol; C:external side of plasma membrane; C:immunological synapse; C:integral component of plasma membrane; C:plasma membrane; C:protein complex involved in cell adhesion;, F:coreceptor activity; F:identical protein binding; F:protease binding; F:protein kinase binding;, P:apoptotic signaling pathway; P:cell surface receptor signaling pathway; P:humoral immune response; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative thymic T cell selection; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of cytokine production; P:positive regulation of gene expression; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-4 production; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of mitotic nuclear division; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of viral genome replication; P:regulation of defense response to virus by virus; P:regulation of regulatory T cell differentiation; P:regulatory T cell differentiation; P:T cell activation; P:T cell costimulation; P:T cell receptor signaling pathway; scaffold32 indexed_genome mRNA 12178916 12201893 . + . ID=transcript_6903;Q9Y6W8 Q8N6W8,Inducible T-cell costimulator,Activation-inducible lymphocyte immunomediatory molecule;, PF15910;, GO:0005576;GO:0016021;GO:0005886;GO:0098609;GO:0006955;GO:0051897;GO:0031295;GO:0002517;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, , P:cell-cell adhesion; P:immune response; P:positive regulation of protein kinase B signaling; P:T cell costimulation; P:T cell tolerance induction; scaffold32 indexed_genome mRNA 13518847 13934005 . + . ID=transcript_6904;Q8TEW8 E9PE87 Q8IUC7 Q8IUC9 Q96DK9 Q96N09 Q96NX6 Q96NX7 Q96Q29,Partitioning defective 3 homolog B,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein;PAR3-beta;Partitioning defective 3-like protein;, PF12053;PF00595;, GO:0005912;GO:0043296;GO:0016324;GO:0005923;GO:0005938;GO:0030054;GO:0012505;GO:0032991;GO:0035091;GO:0007155;GO:0007049;GO:0051301;GO:0030010;GO:0051660;GO:0045197;GO:0000226;GO:0008104;, C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:bicellular tight junction; C:cell cortex; C:cell junction; C:endomembrane system; C:protein-containing complex;, F:phosphatidylinositol binding;, P:cell adhesion; P:cell cycle; P:cell division; P:establishment of cell polarity; P:establishment of centrosome localization; P:establishment or maintenance of epithelial cell apical/basal polarity; P:microtubule cytoskeleton organization; P:protein localization; scaffold32 indexed_genome mRNA 13999309 14119494 . + . ID=transcript_6905;Q7LBX6 Q7LBX7 Q9H2D4 Q9H2D5 Q9H2E2 Q9H2E3 Q9H2E4 X5D2Q8,Neuropilin-2,Vascular endothelial cell growth factor 165 receptor 2;, PF00431;PF11980;PF00754;PF00629;, GO:0030424;GO:0005576;GO:0098978;GO:0016021;GO:0099055;GO:0016020;GO:0005886;GO:0002116;GO:0019955;GO:0019838;GO:0008201;GO:0042802;GO:0046872;GO:0017154;GO:0038023;GO:0005021;GO:0001525;GO:0048846;GO:0007411;GO:0007155;GO:1990830;GO:1904835;GO:0021612;GO:1903375;GO:0021828;GO:0050919;GO:0021675;GO:1901166;GO:0003148;GO:0010595;GO:0001938;GO:0099175;GO:1902285;GO:0097374;GO:0061549;GO:0097490;GO:0097491;GO:0061551;GO:0048010;GO:0036486;GO:0021649;GO:0016032;, C:axon; C:extracellular region; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:cytokine binding; F:growth factor binding; F:heparin binding; F:identical protein binding; F:metal ion binding; F:semaphorin receptor activity; F:signaling receptor activity; F:vascular endothelial growth factor-activated receptor activity;, P:angiogenesis; P:axon extension involved in axon guidance; P:axon guidance; P:cell adhesion; P:cellular response to leukemia inhibitory factor; P:dorsal root ganglion morphogenesis; P:facial nerve structural organization; P:facioacoustic ganglion development; P:gonadotrophin-releasing hormone neuronal migration to the hypothalamus; P:negative chemotaxis; P:nerve development; P:neural crest cell migration involved in autonomic nervous system development; P:outflow tract septum morphogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:regulation of postsynapse organization; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; P:sensory neuron axon guidance; P:sympathetic ganglion development; P:sympathetic neuron projection extension; P:sympathetic neuron projection guidance; P:trigeminal ganglion development; P:vascular endothelial growth factor receptor signaling pathway; P:ventral trunk neural crest cell migration; P:vestibulocochlear nerve structural organization; P:viral process;|Q7LBX6 Q7LBX7 Q9H2D4 Q9H2D5 Q9H2E2 Q9H2E3 Q9H2E4 X5D2Q8,Neuropilin-2,Vascular endothelial cell growth factor 165 receptor 2;, PF00431;PF11980;PF00754;PF00629;, GO:0030424;GO:0005576;GO:0098978;GO:0016021;GO:0099055;GO:0016020;GO:0005886;GO:0002116;GO:0019955;GO:0019838;GO:0008201;GO:0042802;GO:0046872;GO:0017154;GO:0038023;GO:0005021;GO:0001525;GO:0048846;GO:0007411;GO:0007155;GO:1990830;GO:1904835;GO:0021612;GO:1903375;GO:0021828;GO:0050919;GO:0021675;GO:1901166;GO:0003148;GO:0010595;GO:0001938;GO:0099175;GO:1902285;GO:0097374;GO:0061549;GO:0097490;GO:0097491;GO:0061551;GO:0048010;GO:0036486;GO:0021649;GO:0016032;, C:axon; C:extracellular region; C:glutamatergic synapse; C:integral component of membrane; C:integral component of postsynaptic membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:cytokine binding; F:growth factor binding; F:heparin binding; F:identical protein binding; F:metal ion binding; F:semaphorin receptor activity; F:signaling receptor activity; F:vascular endothelial growth factor-activated receptor activity;, P:angiogenesis; P:axon extension involved in axon guidance; P:axon guidance; P:cell adhesion; P:cellular response to leukemia inhibitory factor; P:dorsal root ganglion morphogenesis; P:facial nerve structural organization; P:facioacoustic ganglion development; P:gonadotrophin-releasing hormone neuronal migration to the hypothalamus; P:negative chemotaxis; P:nerve development; P:neural crest cell migration involved in autonomic nervous system development; P:outflow tract septum morphogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:regulation of postsynapse organization; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; P:sensory neuron axon guidance; P:sympathetic ganglion development; P:sympathetic neuron projection extension; P:sympathetic neuron projection guidance; P:trigeminal ganglion development; P:vascular endothelial growth factor receptor signaling pathway; P:ventral trunk neural crest cell migration; P:vestibulocochlear nerve structural organization; P:viral process; scaffold32 indexed_genome mRNA 14322489 14354080 . - . ID=transcript_6906;Q53TQ3 B3KU68 B9EG77 Q6PJC6 Q6PJU1 Q6PKA1 Q9NXD5,INO80 complex subunit D {ECO:0000305},, PF13891;, GO:0005654;GO:0005634;GO:0006310;GO:0006281;GO:0016579;, C:nucleoplasm; C:nucleus;, , P:DNA recombination; P:DNA repair; P:protein deubiquitination; scaffold32 indexed_genome mRNA 14354093 14359945 . - . ID=transcript_6907;Q53TQ3 B3KU68 B9EG77 Q6PJC6 Q6PJU1 Q6PKA1 Q9NXD5,INO80 complex subunit D {ECO:0000305},, PF13891;, GO:0005654;GO:0005634;GO:0006310;GO:0006281;GO:0016579;, C:nucleoplasm; C:nucleus;, , P:DNA recombination; P:DNA repair; P:protein deubiquitination; scaffold32 indexed_genome mRNA 14416873 14448606 . - . ID=transcript_6908;P28331 B4DIN9 B4DJA0 B4DPG1 B4DUC1 E7ENF3 Q53TR8 Q8N1C4 Q8TCC9,NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial,Complex I-75kD;, PF00384;PF10588;PF09326;, GO:0005758;GO:0005759;GO:0005747;GO:0005739;GO:0051537;GO:0051539;GO:0009055;GO:0046872;GO:0008137;GO:0008637;GO:0046034;GO:0045333;GO:0006120;GO:0032981;GO:0072593;GO:0051881;, C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:apoptotic mitochondrial changes; P:ATP metabolic process; P:cellular respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:reactive oxygen species metabolic process; P:regulation of mitochondrial membrane potential;|P28331 B4DIN9 B4DJA0 B4DPG1 B4DUC1 E7ENF3 Q53TR8 Q8N1C4 Q8TCC9,NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial,Complex I-75kD;, PF00384;PF10588;PF09326;, GO:0005758;GO:0005759;GO:0005747;GO:0005739;GO:0051537;GO:0051539;GO:0009055;GO:0046872;GO:0008137;GO:0008637;GO:0046034;GO:0045333;GO:0006120;GO:0032981;GO:0072593;GO:0051881;, C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:apoptotic mitochondrial changes; P:ATP metabolic process; P:cellular respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:reactive oxygen species metabolic process; P:regulation of mitochondrial membrane potential;|P28331 B4DIN9 B4DJA0 B4DPG1 B4DUC1 E7ENF3 Q53TR8 Q8N1C4 Q8TCC9,NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial,Complex I-75kD;, PF00384;PF10588;PF09326;, GO:0005758;GO:0005759;GO:0005747;GO:0005739;GO:0051537;GO:0051539;GO:0009055;GO:0046872;GO:0008137;GO:0008637;GO:0046034;GO:0045333;GO:0006120;GO:0032981;GO:0072593;GO:0051881;, C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:apoptotic mitochondrial changes; P:ATP metabolic process; P:cellular respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:reactive oxygen species metabolic process; P:regulation of mitochondrial membrane potential;|P28331 B4DIN9 B4DJA0 B4DPG1 B4DUC1 E7ENF3 Q53TR8 Q8N1C4 Q8TCC9,NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial,Complex I-75kD;, PF00384;PF10588;PF09326;, GO:0005758;GO:0005759;GO:0005747;GO:0005739;GO:0051537;GO:0051539;GO:0009055;GO:0046872;GO:0008137;GO:0008637;GO:0046034;GO:0045333;GO:0006120;GO:0032981;GO:0072593;GO:0051881;, C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:apoptotic mitochondrial changes; P:ATP metabolic process; P:cellular respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:reactive oxygen species metabolic process; P:regulation of mitochondrial membrane potential;|P28331 B4DIN9 B4DJA0 B4DPG1 B4DUC1 E7ENF3 Q53TR8 Q8N1C4 Q8TCC9,NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial,Complex I-75kD;, PF00384;PF10588;PF09326;, GO:0005758;GO:0005759;GO:0005747;GO:0005739;GO:0051537;GO:0051539;GO:0009055;GO:0046872;GO:0008137;GO:0008637;GO:0046034;GO:0045333;GO:0006120;GO:0032981;GO:0072593;GO:0051881;, C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:apoptotic mitochondrial changes; P:ATP metabolic process; P:cellular respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:reactive oxygen species metabolic process; P:regulation of mitochondrial membrane potential; scaffold32 indexed_genome mRNA 14448811 14456483 . + . ID=transcript_6909;P24534 A8K795 Q6IBH9,Elongation factor 1-beta,, PF10587;PF00736;, GO:0005737;GO:0005829;GO:0005853;GO:0005085;GO:0003746;GO:0006414;, C:cytoplasm; C:cytosol; C:eukaryotic translation elongation factor 1 complex;, F:guanyl-nucleotide exchange factor activity; F:translation elongation factor activity;, P:translational elongation;|P24534 A8K795 Q6IBH9,Elongation factor 1-beta,, PF10587;PF00736;, GO:0005737;GO:0005829;GO:0005853;GO:0005085;GO:0003746;GO:0006414;, C:cytoplasm; C:cytosol; C:eukaryotic translation elongation factor 1 complex;, F:guanyl-nucleotide exchange factor activity; F:translation elongation factor activity;, P:translational elongation;|P24534 A8K795 Q6IBH9,Elongation factor 1-beta,, PF10587;PF00736;, GO:0005737;GO:0005829;GO:0005853;GO:0005085;GO:0003746;GO:0006414;, C:cytoplasm; C:cytosol; C:eukaryotic translation elongation factor 1 complex;, F:guanyl-nucleotide exchange factor activity; F:translation elongation factor activity;, P:translational elongation; scaffold32 indexed_genome mRNA 14462189 14517931 . - . ID=transcript_6910;P46091 A5JUU6 A8K4L1 Q53TR9 Q6NVX4,G-protein coupled receptor 1,, PF00001;, GO:0005887;GO:0043231;GO:0043005;GO:0005654;GO:0005886;GO:0004930;GO:0042923;GO:0042277;GO:0007186;GO:0007218;, C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:neuron projection; C:nucleoplasm; C:plasma membrane;, F:G protein-coupled receptor activity; F:neuropeptide binding; F:peptide binding;, P:G protein-coupled receptor signaling pathway; P:neuropeptide signaling pathway; scaffold32 indexed_genome mRNA 14784888 14858123 . + . ID=transcript_6911;O75077 A2RU59,Disintegrin and metalloproteinase domain-containing protein 23,Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3;, PF08516;PF00200;PF01562;PF01421;, GO:0005576;GO:0098978;GO:0005887;GO:0099056;GO:0005886;GO:0005178;GO:0004222;GO:0008237;GO:0007155;GO:1990830;GO:0007417;, C:extracellular region; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cell adhesion; P:cellular response to leukemia inhibitory factor; P:central nervous system development;|O75077 A2RU59,Disintegrin and metalloproteinase domain-containing protein 23,Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3;, PF08516;PF00200;PF01562;PF01421;, GO:0005576;GO:0098978;GO:0005887;GO:0099056;GO:0005886;GO:0005178;GO:0004222;GO:0008237;GO:0007155;GO:1990830;GO:0007417;, C:extracellular region; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cell adhesion; P:cellular response to leukemia inhibitory factor; P:central nervous system development;|O75077 A2RU59,Disintegrin and metalloproteinase domain-containing protein 23,Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3;, PF08516;PF00200;PF01562;PF01421;, GO:0005576;GO:0098978;GO:0005887;GO:0099056;GO:0005886;GO:0005178;GO:0004222;GO:0008237;GO:0007155;GO:1990830;GO:0007417;, C:extracellular region; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cell adhesion; P:cellular response to leukemia inhibitory factor; P:central nervous system development;|O75077 A2RU59,Disintegrin and metalloproteinase domain-containing protein 23,Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3;, PF08516;PF00200;PF01562;PF01421;, GO:0005576;GO:0098978;GO:0005887;GO:0099056;GO:0005886;GO:0005178;GO:0004222;GO:0008237;GO:0007155;GO:1990830;GO:0007417;, C:extracellular region; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cell adhesion; P:cellular response to leukemia inhibitory factor; P:central nervous system development; scaffold32 indexed_genome mRNA 14991039 15014729 . - . ID=transcript_6912;Q5I0G3 A8K8M1 Q53TK9 Q8IV51,Putative malate dehydrogenase 1B,, , GO:0030060;GO:0005975;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, , F:L-malate dehydrogenase activity;, P:carbohydrate metabolic process; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|Q5I0G3 A8K8M1 Q53TK9 Q8IV51,Putative malate dehydrogenase 1B,, , GO:0030060;GO:0005975;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, , F:L-malate dehydrogenase activity;, P:carbohydrate metabolic process; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|Q5I0G3 A8K8M1 Q53TK9 Q8IV51,Putative malate dehydrogenase 1B,, , GO:0030060;GO:0005975;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, , F:L-malate dehydrogenase activity;, P:carbohydrate metabolic process; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle; scaffold32 indexed_genome mRNA 15018217 15025251 . + . ID=transcript_6913;Q9NYY8 Q9NVX6 Q9Y2H7,FAST kinase domain-containing protein 2, mitochondrial,, PF06743;PF08368;PF08373;, GO:0042645;GO:0005739;GO:0035770;GO:0003723;GO:0019843;GO:0006915;GO:1902775;GO:0032543;GO:0070131;GO:0044528;GO:0006396;, C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:RNA binding; F:rRNA binding;, P:apoptotic process; P:mitochondrial large ribosomal subunit assembly; P:mitochondrial translation; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability; P:RNA processing;|Q9NYY8 Q9NVX6 Q9Y2H7,FAST kinase domain-containing protein 2, mitochondrial,, PF06743;PF08368;PF08373;, GO:0042645;GO:0005739;GO:0035770;GO:0003723;GO:0019843;GO:0006915;GO:1902775;GO:0032543;GO:0070131;GO:0044528;GO:0006396;, C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:RNA binding; F:rRNA binding;, P:apoptotic process; P:mitochondrial large ribosomal subunit assembly; P:mitochondrial translation; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability; P:RNA processing; scaffold32 indexed_genome mRNA 15026372 15038145 . + . ID=transcript_6914;Q9NYY8 Q9NVX6 Q9Y2H7,FAST kinase domain-containing protein 2, mitochondrial,, PF06743;PF08368;PF08373;, GO:0042645;GO:0005739;GO:0035770;GO:0003723;GO:0019843;GO:0006915;GO:1902775;GO:0032543;GO:0070131;GO:0044528;GO:0006396;, C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:RNA binding; F:rRNA binding;, P:apoptotic process; P:mitochondrial large ribosomal subunit assembly; P:mitochondrial translation; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability; P:RNA processing;|Q9NYY8 Q9NVX6 Q9Y2H7,FAST kinase domain-containing protein 2, mitochondrial,, PF06743;PF08368;PF08373;, GO:0042645;GO:0005739;GO:0035770;GO:0003723;GO:0019843;GO:0006915;GO:1902775;GO:0032543;GO:0070131;GO:0044528;GO:0006396;, C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:RNA binding; F:rRNA binding;, P:apoptotic process; P:mitochondrial large ribosomal subunit assembly; P:mitochondrial translation; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability; P:RNA processing;|Q9NYY8 Q9NVX6 Q9Y2H7,FAST kinase domain-containing protein 2, mitochondrial,, PF06743;PF08368;PF08373;, GO:0042645;GO:0005739;GO:0035770;GO:0003723;GO:0019843;GO:0006915;GO:1902775;GO:0032543;GO:0070131;GO:0044528;GO:0006396;, C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:RNA binding; F:rRNA binding;, P:apoptotic process; P:mitochondrial large ribosomal subunit assembly; P:mitochondrial translation; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability; P:RNA processing;|Q9NYY8 Q9NVX6 Q9Y2H7,FAST kinase domain-containing protein 2, mitochondrial,, PF06743;PF08368;PF08373;, GO:0042645;GO:0005739;GO:0035770;GO:0003723;GO:0019843;GO:0006915;GO:1902775;GO:0032543;GO:0070131;GO:0044528;GO:0006396;, C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:RNA binding; F:rRNA binding;, P:apoptotic process; P:mitochondrial large ribosomal subunit assembly; P:mitochondrial translation; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability; P:RNA processing;|Q9NYY8 Q9NVX6 Q9Y2H7,FAST kinase domain-containing protein 2, mitochondrial,, PF06743;PF08368;PF08373;, GO:0042645;GO:0005739;GO:0035770;GO:0003723;GO:0019843;GO:0006915;GO:1902775;GO:0032543;GO:0070131;GO:0044528;GO:0006396;, C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:RNA binding; F:rRNA binding;, P:apoptotic process; P:mitochondrial large ribosomal subunit assembly; P:mitochondrial translation; P:positive regulation of mitochondrial translation; P:regulation of mitochondrial mRNA stability; P:RNA processing; scaffold32 indexed_genome mRNA 15305056 15363296 . - . ID=transcript_6915;O75840 B2RB03 B7Z4F7 C9JF04 E7EWH1 L0R4P2 Q7Z3H8 Q96E51,Krueppel-like factor 7,Ubiquitous krueppel-like factor {ECO:0000303|PubMed:9774444};, PF00096;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0008270;GO:0007411;GO:0007409;GO:0048813;GO:0042593;GO:1904178;GO:0061179;GO:0000122;GO:0045944;GO:0045604;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:axon guidance; P:axonogenesis; P:dendrite morphogenesis; P:glucose homeostasis; P:negative regulation of adipose tissue development; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of epidermal cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold32 indexed_genome mRNA 15815530 15821540 . - . ID=transcript_6916;P16220 P21934 Q6V963 Q9UMA7,Cyclic AMP-responsive element-binding protein 1,, PF00170;PF02173;, GO:1990589;GO:0030424;GO:0000785;GO:0000791;GO:0005759;GO:0005654;GO:0005634;GO:0005667;GO:1990763;GO:0035497;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0035035;GO:0030544;GO:0042802;GO:0001102;GO:0000978;GO:0001225;GO:1990837;GO:0007568;GO:0007409;GO:0071398;GO:0035729;GO:1990314;GO:1990830;GO:1990090;GO:0036120;GO:0071300;GO:0071294;GO:0034670;GO:0007623;GO:0007595;GO:0060430;GO:0007613;GO:0002862;GO:1901215;GO:0010944;GO:0021983;GO:0043065;GO:0055025;GO:0045600;GO:0046887;GO:0046889;GO:1900273;GO:0040018;GO:0045672;GO:0045899;GO:0045944;GO:0045893;GO:0032916;GO:0006468;GO:0050821;GO:0008361;GO:0042752;GO:0048145;GO:0060251;GO:0006357;GO:0014823;GO:0042493;GO:0033762;GO:0001666;GO:1902065;GO:0035094;GO:0010033;GO:0033363;GO:0007165;GO:0006366;GO:0007179;GO:0060509;GO:0016032;GO:0008542;, C:ATF4-CREB1 transcription factor complex; C:axon; C:chromatin; C:euchromatin; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:arrestin family protein binding; F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone acetyltransferase binding; F:Hsp70 protein binding; F:identical protein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:sequence-specific double-stranded DNA binding;, P:aging; P:axonogenesis; P:cellular response to fatty acid; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to nerve growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to retinoic acid; P:cellular response to zinc ion; P:chemotaxis to arachidonic acid; P:circadian rhythm; P:lactation; P:lung saccule development; P:memory; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron death; P:negative regulation of transcription by competitive promoter binding; P:pituitary gland development; P:positive regulation of apoptotic process; P:positive regulation of cardiac muscle tissue development; P:positive regulation of fat cell differentiation; P:positive regulation of hormone secretion; P:positive regulation of lipid biosynthetic process; P:positive regulation of long-term synaptic potentiation; P:positive regulation of multicellular organism growth; P:positive regulation of osteoclast differentiation; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta3 production; P:protein phosphorylation; P:protein stabilization; P:regulation of cell size; P:regulation of circadian rhythm; P:regulation of fibroblast proliferation; P:regulation of glial cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to drug; P:response to glucagon; P:response to hypoxia; P:response to L-glutamate; P:response to nicotine; P:response to organic substance; P:secretory granule organization; P:signal transduction; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; P:type I pneumocyte differentiation; P:viral process; P:visual learning; scaffold32 indexed_genome mRNA 15823892 15867869 . + . ID=transcript_6917;P16220 P21934 Q6V963 Q9UMA7,Cyclic AMP-responsive element-binding protein 1,, PF00170;PF02173;, GO:1990589;GO:0030424;GO:0000785;GO:0000791;GO:0005759;GO:0005654;GO:0005634;GO:0005667;GO:1990763;GO:0035497;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0035035;GO:0030544;GO:0042802;GO:0001102;GO:0000978;GO:0001225;GO:1990837;GO:0007568;GO:0007409;GO:0071398;GO:0035729;GO:1990314;GO:1990830;GO:1990090;GO:0036120;GO:0071300;GO:0071294;GO:0034670;GO:0007623;GO:0007595;GO:0060430;GO:0007613;GO:0002862;GO:1901215;GO:0010944;GO:0021983;GO:0043065;GO:0055025;GO:0045600;GO:0046887;GO:0046889;GO:1900273;GO:0040018;GO:0045672;GO:0045899;GO:0045944;GO:0045893;GO:0032916;GO:0006468;GO:0050821;GO:0008361;GO:0042752;GO:0048145;GO:0060251;GO:0006357;GO:0014823;GO:0042493;GO:0033762;GO:0001666;GO:1902065;GO:0035094;GO:0010033;GO:0033363;GO:0007165;GO:0006366;GO:0007179;GO:0060509;GO:0016032;GO:0008542;, C:ATF4-CREB1 transcription factor complex; C:axon; C:chromatin; C:euchromatin; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:arrestin family protein binding; F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone acetyltransferase binding; F:Hsp70 protein binding; F:identical protein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:sequence-specific double-stranded DNA binding;, P:aging; P:axonogenesis; P:cellular response to fatty acid; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to nerve growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to retinoic acid; P:cellular response to zinc ion; P:chemotaxis to arachidonic acid; P:circadian rhythm; P:lactation; P:lung saccule development; P:memory; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron death; P:negative regulation of transcription by competitive promoter binding; P:pituitary gland development; P:positive regulation of apoptotic process; P:positive regulation of cardiac muscle tissue development; P:positive regulation of fat cell differentiation; P:positive regulation of hormone secretion; P:positive regulation of lipid biosynthetic process; P:positive regulation of long-term synaptic potentiation; P:positive regulation of multicellular organism growth; P:positive regulation of osteoclast differentiation; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta3 production; P:protein phosphorylation; P:protein stabilization; P:regulation of cell size; P:regulation of circadian rhythm; P:regulation of fibroblast proliferation; P:regulation of glial cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to drug; P:response to glucagon; P:response to hypoxia; P:response to L-glutamate; P:response to nicotine; P:response to organic substance; P:secretory granule organization; P:signal transduction; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; P:type I pneumocyte differentiation; P:viral process; P:visual learning;|P16220 P21934 Q6V963 Q9UMA7,Cyclic AMP-responsive element-binding protein 1,, PF00170;PF02173;, GO:1990589;GO:0030424;GO:0000785;GO:0000791;GO:0005759;GO:0005654;GO:0005634;GO:0005667;GO:1990763;GO:0035497;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0035035;GO:0030544;GO:0042802;GO:0001102;GO:0000978;GO:0001225;GO:1990837;GO:0007568;GO:0007409;GO:0071398;GO:0035729;GO:1990314;GO:1990830;GO:1990090;GO:0036120;GO:0071300;GO:0071294;GO:0034670;GO:0007623;GO:0007595;GO:0060430;GO:0007613;GO:0002862;GO:1901215;GO:0010944;GO:0021983;GO:0043065;GO:0055025;GO:0045600;GO:0046887;GO:0046889;GO:1900273;GO:0040018;GO:0045672;GO:0045899;GO:0045944;GO:0045893;GO:0032916;GO:0006468;GO:0050821;GO:0008361;GO:0042752;GO:0048145;GO:0060251;GO:0006357;GO:0014823;GO:0042493;GO:0033762;GO:0001666;GO:1902065;GO:0035094;GO:0010033;GO:0033363;GO:0007165;GO:0006366;GO:0007179;GO:0060509;GO:0016032;GO:0008542;, C:ATF4-CREB1 transcription factor complex; C:axon; C:chromatin; C:euchromatin; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:arrestin family protein binding; F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone acetyltransferase binding; F:Hsp70 protein binding; F:identical protein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:sequence-specific double-stranded DNA binding;, P:aging; P:axonogenesis; P:cellular response to fatty acid; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to nerve growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to retinoic acid; P:cellular response to zinc ion; P:chemotaxis to arachidonic acid; P:circadian rhythm; P:lactation; P:lung saccule development; P:memory; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron death; P:negative regulation of transcription by competitive promoter binding; P:pituitary gland development; P:positive regulation of apoptotic process; P:positive regulation of cardiac muscle tissue development; P:positive regulation of fat cell differentiation; P:positive regulation of hormone secretion; P:positive regulation of lipid biosynthetic process; P:positive regulation of long-term synaptic potentiation; P:positive regulation of multicellular organism growth; P:positive regulation of osteoclast differentiation; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta3 production; P:protein phosphorylation; P:protein stabilization; P:regulation of cell size; P:regulation of circadian rhythm; P:regulation of fibroblast proliferation; P:regulation of glial cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to drug; P:response to glucagon; P:response to hypoxia; P:response to L-glutamate; P:response to nicotine; P:response to organic substance; P:secretory granule organization; P:signal transduction; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; P:type I pneumocyte differentiation; P:viral process; P:visual learning;|P16220 P21934 Q6V963 Q9UMA7,Cyclic AMP-responsive element-binding protein 1,, PF00170;PF02173;, GO:1990589;GO:0030424;GO:0000785;GO:0000791;GO:0005759;GO:0005654;GO:0005634;GO:0005667;GO:1990763;GO:0035497;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0035035;GO:0030544;GO:0042802;GO:0001102;GO:0000978;GO:0001225;GO:1990837;GO:0007568;GO:0007409;GO:0071398;GO:0035729;GO:1990314;GO:1990830;GO:1990090;GO:0036120;GO:0071300;GO:0071294;GO:0034670;GO:0007623;GO:0007595;GO:0060430;GO:0007613;GO:0002862;GO:1901215;GO:0010944;GO:0021983;GO:0043065;GO:0055025;GO:0045600;GO:0046887;GO:0046889;GO:1900273;GO:0040018;GO:0045672;GO:0045899;GO:0045944;GO:0045893;GO:0032916;GO:0006468;GO:0050821;GO:0008361;GO:0042752;GO:0048145;GO:0060251;GO:0006357;GO:0014823;GO:0042493;GO:0033762;GO:0001666;GO:1902065;GO:0035094;GO:0010033;GO:0033363;GO:0007165;GO:0006366;GO:0007179;GO:0060509;GO:0016032;GO:0008542;, C:ATF4-CREB1 transcription factor complex; C:axon; C:chromatin; C:euchromatin; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:arrestin family protein binding; F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone acetyltransferase binding; F:Hsp70 protein binding; F:identical protein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:sequence-specific double-stranded DNA binding;, P:aging; P:axonogenesis; P:cellular response to fatty acid; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:cellular response to nerve growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to retinoic acid; P:cellular response to zinc ion; P:chemotaxis to arachidonic acid; P:circadian rhythm; P:lactation; P:lung saccule development; P:memory; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron death; P:negative regulation of transcription by competitive promoter binding; P:pituitary gland development; P:positive regulation of apoptotic process; P:positive regulation of cardiac muscle tissue development; P:positive regulation of fat cell differentiation; P:positive regulation of hormone secretion; P:positive regulation of lipid biosynthetic process; P:positive regulation of long-term synaptic potentiation; P:positive regulation of multicellular organism growth; P:positive regulation of osteoclast differentiation; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta3 production; P:protein phosphorylation; P:protein stabilization; P:regulation of cell size; P:regulation of circadian rhythm; P:regulation of fibroblast proliferation; P:regulation of glial cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to drug; P:response to glucagon; P:response to hypoxia; P:response to L-glutamate; P:response to nicotine; P:response to organic substance; P:secretory granule organization; P:signal transduction; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; P:type I pneumocyte differentiation; P:viral process; P:visual learning;|Q8WXB1 Q53RV0 Q8N1Z9 Q96GH6,Protein N-lysine methyltransferase METTL21A,HSPA lysine methyltransferase;HSPA-KMT;Hepatocellular carcinoma-associated antigen 557b;Methyltransferase-like protein 21A;, PF10294;, GO:0005737;GO:0005829;GO:0005654;GO:0032991;GO:0051117;GO:0031072;GO:0030544;GO:0008276;GO:0016279;GO:0018022;GO:0006479;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:protein-containing complex;, F:ATPase binding; F:heat shock protein binding; F:Hsp70 protein binding; F:protein methyltransferase activity; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine methylation; P:protein methylation;|Q8WXB1 Q53RV0 Q8N1Z9 Q96GH6,Protein N-lysine methyltransferase METTL21A,HSPA lysine methyltransferase;HSPA-KMT;Hepatocellular carcinoma-associated antigen 557b;Methyltransferase-like protein 21A;, PF10294;, GO:0005737;GO:0005829;GO:0005654;GO:0032991;GO:0051117;GO:0031072;GO:0030544;GO:0008276;GO:0016279;GO:0018022;GO:0006479;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:protein-containing complex;, F:ATPase binding; F:heat shock protein binding; F:Hsp70 protein binding; F:protein methyltransferase activity; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine methylation; P:protein methylation; scaffold32 indexed_genome mRNA 15879001 15890152 . + . ID=transcript_6918;Q96G01 A8K2C3 F8W113 O43892 O43893,Protein bicaudal D homolog 1,, PF09730;, GO:0005813;GO:0031410;GO:0005856;GO:0005829;GO:0005794;GO:0016020;GO:0048471;GO:0099503;GO:0005802;GO:0008093;GO:0034452;GO:0070840;GO:0045505;GO:0019901;GO:0031871;GO:0031267;GO:0005200;GO:0009653;GO:0008298;GO:0072393;GO:0072385;GO:1900275;GO:1900737;GO:1904781;GO:0048260;GO:0033365;GO:0070507;GO:1900276;GO:0006396;GO:0034063;GO:0016032;, C:centrosome; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:secretory vesicle; C:trans-Golgi network;, F:cytoskeletal anchor activity; F:dynactin binding; F:dynein complex binding; F:dynein intermediate chain binding; F:protein kinase binding; F:proteinase activated receptor binding; F:small GTPase binding; F:structural constituent of cytoskeleton;, P:anatomical structure morphogenesis; P:intracellular mRNA localization; P:microtubule anchoring at microtubule organizing center; P:minus-end-directed organelle transport along microtubule; P:negative regulation of phospholipase C activity; P:negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of protein localization to centrosome; P:positive regulation of receptor-mediated endocytosis; P:protein localization to organelle; P:regulation of microtubule cytoskeleton organization; P:regulation of proteinase activated receptor activity; P:RNA processing; P:stress granule assembly; P:viral process; scaffold32 indexed_genome mRNA 15953405 15993068 . + . ID=transcript_6919;Q8N7R7 Q6NX60,Cyclin-Y-like protein 1,, PF00134;, GO:0005737;GO:0005886;GO:0016538;GO:0019901;GO:0030317;GO:0045737;GO:0007283;, C:cytoplasm; C:plasma membrane;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:flagellated sperm motility; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis;|Q8N7R7 Q6NX60,Cyclin-Y-like protein 1,, PF00134;, GO:0005737;GO:0005886;GO:0016538;GO:0019901;GO:0030317;GO:0045737;GO:0007283;, C:cytoplasm; C:plasma membrane;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:flagellated sperm motility; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis;|Q8N7R7 Q6NX60,Cyclin-Y-like protein 1,, PF00134;, GO:0005737;GO:0005886;GO:0016538;GO:0019901;GO:0030317;GO:0045737;GO:0007283;, C:cytoplasm; C:plasma membrane;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:flagellated sperm motility; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis; scaffold32 indexed_genome mRNA 15994396 15997104 . + . ID=transcript_6920;Q8N7R7 Q6NX60,Cyclin-Y-like protein 1,, PF00134;, GO:0005737;GO:0005886;GO:0016538;GO:0019901;GO:0030317;GO:0045737;GO:0007283;, C:cytoplasm; C:plasma membrane;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:flagellated sperm motility; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis;|Q8N7R7 Q6NX60,Cyclin-Y-like protein 1,, PF00134;, GO:0005737;GO:0005886;GO:0016538;GO:0019901;GO:0030317;GO:0045737;GO:0007283;, C:cytoplasm; C:plasma membrane;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:flagellated sperm motility; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:spermatogenesis; scaffold32 indexed_genome mRNA 16074563 16075483 . - . ID=transcript_6921;Q6ZWE6 B9EKV2 Q8WW68,Pleckstrin homology domain-containing family M member 3,Differentiation associated protein {ECO:0000250|UniProtKB:Q8BM47};, PF00169;PF13901;, GO:0005737;GO:0005794;GO:0005886;GO:0046872;GO:0045445;, C:cytoplasm; C:Golgi apparatus; C:plasma membrane;, F:metal ion binding;, P:myoblast differentiation; scaffold32 indexed_genome mRNA 16183080 16247219 . - . ID=transcript_6922;Q6ZWE6 B9EKV2 Q8WW68,Pleckstrin homology domain-containing family M member 3,Differentiation associated protein {ECO:0000250|UniProtKB:Q8BM47};, PF00169;PF13901;, GO:0005737;GO:0005794;GO:0005886;GO:0046872;GO:0045445;, C:cytoplasm; C:Golgi apparatus; C:plasma membrane;, F:metal ion binding;, P:myoblast differentiation; scaffold32 indexed_genome mRNA 16399012 16422577 . - . ID=transcript_6923;Q0P641 A6NKZ3,Uncharacterized protein C2orf80,, PF17718; scaffold32 indexed_genome mRNA 16462984 16483450 . - . ID=transcript_6924;O75874 Q567U4 Q6FHQ6 Q7Z3V0 Q93090 Q9NTJ9 Q9UKW8,Isocitrate dehydrogenase [NADP] cytoplasmic,Cytosolic NADP-isocitrate dehydrogenase;IDP;NADP(+)-specific ICDH;Oxalosuccinate decarboxylase;, PF00180;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005739;GO:0005782;GO:0005777;GO:0034774;GO:1904724;GO:0045296;GO:0042802;GO:0004450;GO:0000287;GO:0051287;GO:0050661;GO:0042803;GO:0006103;GO:0008585;GO:0006749;GO:0006097;GO:0006102;GO:0006739;GO:0006740;GO:0043312;GO:0008104;GO:0071071;GO:0060696;GO:0006979;GO:0048545;GO:0006099;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:mitochondrion; C:peroxisomal matrix; C:peroxisome; C:secretory granule lumen; C:tertiary granule lumen;, F:cadherin binding; F:identical protein binding; F:isocitrate dehydrogenase (NADP+) activity; F:magnesium ion binding; F:NAD binding; F:NADP binding; F:protein homodimerization activity;, P:2-oxoglutarate metabolic process; P:female gonad development; P:glutathione metabolic process; P:glyoxylate cycle; P:isocitrate metabolic process; P:NADP metabolic process; P:NADPH regeneration; P:neutrophil degranulation; P:protein localization; P:regulation of phospholipid biosynthetic process; P:regulation of phospholipid catabolic process; P:response to oxidative stress; P:response to steroid hormone; P:tricarboxylic acid cycle;|O75874 Q567U4 Q6FHQ6 Q7Z3V0 Q93090 Q9NTJ9 Q9UKW8,Isocitrate dehydrogenase [NADP] cytoplasmic,Cytosolic NADP-isocitrate dehydrogenase;IDP;NADP(+)-specific ICDH;Oxalosuccinate decarboxylase;, PF00180;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005739;GO:0005782;GO:0005777;GO:0034774;GO:1904724;GO:0045296;GO:0042802;GO:0004450;GO:0000287;GO:0051287;GO:0050661;GO:0042803;GO:0006103;GO:0008585;GO:0006749;GO:0006097;GO:0006102;GO:0006739;GO:0006740;GO:0043312;GO:0008104;GO:0071071;GO:0060696;GO:0006979;GO:0048545;GO:0006099;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:mitochondrion; C:peroxisomal matrix; C:peroxisome; C:secretory granule lumen; C:tertiary granule lumen;, F:cadherin binding; F:identical protein binding; F:isocitrate dehydrogenase (NADP+) activity; F:magnesium ion binding; F:NAD binding; F:NADP binding; F:protein homodimerization activity;, P:2-oxoglutarate metabolic process; P:female gonad development; P:glutathione metabolic process; P:glyoxylate cycle; P:isocitrate metabolic process; P:NADP metabolic process; P:NADPH regeneration; P:neutrophil degranulation; P:protein localization; P:regulation of phospholipid biosynthetic process; P:regulation of phospholipid catabolic process; P:response to oxidative stress; P:response to steroid hormone; P:tricarboxylic acid cycle; scaffold32 indexed_genome mRNA 16510802 16586200 . + . ID=transcript_6925;Q9Y2I7 Q08AR7 Q08AR8 Q53ST3 Q53T36 Q8N5H0 Q8NB67,1-phosphatidylinositol 3-phosphate 5-kinase {ECO:0000305},FYVE finger-containing phosphoinositide kinase;PIKfyve;Phosphatidylinositol 3-phosphate 5-kinase type III;Serine-protein kinase PIKFYVE;, PF00118;PF00610;PF01363;PF01504;, GO:0005911;GO:0005829;GO:0031901;GO:0010008;GO:0000139;GO:0043231;GO:0031902;GO:0045121;GO:0048471;GO:0030670;GO:0000285;GO:0016308;GO:0052810;GO:0005524;GO:0016887;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:1903100;GO:0019886;GO:0035556;GO:0032438;GO:0032288;GO:0030593;GO:0036289;GO:0090382;GO:0090385;GO:1904562;GO:0006661;GO:0036092;GO:0034504;GO:0006612;GO:0019065;GO:2000785;GO:1903426;GO:0042147;, C:cell-cell junction; C:cytosol; C:early endosome membrane; C:endosome membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane;, F:1-phosphatidylinositol-3-phosphate 5-kinase activity; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-kinase activity; F:ATP binding; F:ATPase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intracellular signal transduction; P:melanosome organization; P:myelin assembly; P:neutrophil chemotaxis; P:peptidyl-serine autophosphorylation; P:phagosome maturation; P:phagosome-lysosome fusion; P:phosphatidylinositol 5-phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol-3-phosphate biosynthetic process; P:protein localization to nucleus; P:protein targeting to membrane; P:receptor-mediated endocytosis of virus by host cell; P:regulation of autophagosome assembly; P:regulation of reactive oxygen species biosynthetic process; P:retrograde transport, endosome to Golgi;|Q9Y2I7 Q08AR7 Q08AR8 Q53ST3 Q53T36 Q8N5H0 Q8NB67,1-phosphatidylinositol 3-phosphate 5-kinase {ECO:0000305},FYVE finger-containing phosphoinositide kinase;PIKfyve;Phosphatidylinositol 3-phosphate 5-kinase type III;Serine-protein kinase PIKFYVE;, PF00118;PF00610;PF01363;PF01504;, GO:0005911;GO:0005829;GO:0031901;GO:0010008;GO:0000139;GO:0043231;GO:0031902;GO:0045121;GO:0048471;GO:0030670;GO:0000285;GO:0016308;GO:0052810;GO:0005524;GO:0016887;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:1903100;GO:0019886;GO:0035556;GO:0032438;GO:0032288;GO:0030593;GO:0036289;GO:0090382;GO:0090385;GO:1904562;GO:0006661;GO:0036092;GO:0034504;GO:0006612;GO:0019065;GO:2000785;GO:1903426;GO:0042147;, C:cell-cell junction; C:cytosol; C:early endosome membrane; C:endosome membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane;, F:1-phosphatidylinositol-3-phosphate 5-kinase activity; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-kinase activity; F:ATP binding; F:ATPase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intracellular signal transduction; P:melanosome organization; P:myelin assembly; P:neutrophil chemotaxis; P:peptidyl-serine autophosphorylation; P:phagosome maturation; P:phagosome-lysosome fusion; P:phosphatidylinositol 5-phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol-3-phosphate biosynthetic process; P:protein localization to nucleus; P:protein targeting to membrane; P:receptor-mediated endocytosis of virus by host cell; P:regulation of autophagosome assembly; P:regulation of reactive oxygen species biosynthetic process; P:retrograde transport, endosome to Golgi;|Q9Y2I7 Q08AR7 Q08AR8 Q53ST3 Q53T36 Q8N5H0 Q8NB67,1-phosphatidylinositol 3-phosphate 5-kinase {ECO:0000305},FYVE finger-containing phosphoinositide kinase;PIKfyve;Phosphatidylinositol 3-phosphate 5-kinase type III;Serine-protein kinase PIKFYVE;, PF00118;PF00610;PF01363;PF01504;, GO:0005911;GO:0005829;GO:0031901;GO:0010008;GO:0000139;GO:0043231;GO:0031902;GO:0045121;GO:0048471;GO:0030670;GO:0000285;GO:0016308;GO:0052810;GO:0005524;GO:0016887;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:1903100;GO:0019886;GO:0035556;GO:0032438;GO:0032288;GO:0030593;GO:0036289;GO:0090382;GO:0090385;GO:1904562;GO:0006661;GO:0036092;GO:0034504;GO:0006612;GO:0019065;GO:2000785;GO:1903426;GO:0042147;, C:cell-cell junction; C:cytosol; C:early endosome membrane; C:endosome membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane;, F:1-phosphatidylinositol-3-phosphate 5-kinase activity; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-kinase activity; F:ATP binding; F:ATPase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intracellular signal transduction; P:melanosome organization; P:myelin assembly; P:neutrophil chemotaxis; P:peptidyl-serine autophosphorylation; P:phagosome maturation; P:phagosome-lysosome fusion; P:phosphatidylinositol 5-phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol-3-phosphate biosynthetic process; P:protein localization to nucleus; P:protein targeting to membrane; P:receptor-mediated endocytosis of virus by host cell; P:regulation of autophagosome assembly; P:regulation of reactive oxygen species biosynthetic process; P:retrograde transport, endosome to Golgi; scaffold32 indexed_genome mRNA 16595629 16597807 . - . ID=transcript_6926;Q8N5Y2 A6NCU2 A6NHW8 A8K165 B4DUV8 B7Z227 Q9UG70 Q9Y5Z8,Male-specific lethal 3 homolog,Male-specific lethal-3 homolog 1;Male-specific lethal-3 protein-like 1;, PF05712;PF11717;, GO:0000123;GO:0072487;GO:0035267;GO:0005654;GO:0005634;GO:0003677;GO:0046972;GO:0035064;GO:0006342;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0043984;GO:0006355;, C:histone acetyltransferase complex; C:MSL complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone acetyltransferase activity (H4-K16 specific); F:methylated histone binding;, P:chromatin silencing; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:histone H4-K16 acetylation; P:regulation of transcription, DNA-templated; scaffold32 indexed_genome mRNA 17422428 17498597 . + . ID=transcript_6927;P11137 Q17S04 Q8IUX2 Q99975 Q99976,Microtubule-associated protein 2,, PF08377;PF00418;, GO:0150014;GO:0043203;GO:0043194;GO:0097441;GO:0005737;GO:0005829;GO:0030425;GO:0032839;GO:0044307;GO:1902737;GO:0044294;GO:0043198;GO:0150002;GO:0005874;GO:0005875;GO:0043005;GO:0043025;GO:0150001;GO:1990635;GO:1990769;GO:0005516;GO:0002162;GO:0008017;GO:0005198;GO:0048156;GO:0021954;GO:0016358;GO:0048813;GO:0001578;GO:0000226;GO:0030517;GO:1904527;GO:2000575;GO:0031115;GO:0031175;GO:1901953;GO:1903744;GO:1903827;GO:0031113;GO:1902513;, C:apical distal dendrite; C:axon hillock; C:axon initial segment; C:basal dendrite; C:cytoplasm; C:cytosol; C:dendrite; C:dendrite cytoplasm; C:dendritic branch; C:dendritic filopodium; C:dendritic growth cone; C:dendritic shaft; C:distal dendrite; C:microtubule; C:microtubule associated complex; C:neuron projection; C:neuronal cell body; C:primary dendrite; C:proximal dendrite; C:proximal neuron projection;, F:calmodulin binding; F:dystroglycan binding; F:microtubule binding; F:structural molecule activity; F:tau protein binding;, P:central nervous system neuron development; P:dendrite development; P:dendrite morphogenesis; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of axon extension; P:negative regulation of microtubule binding; P:negative regulation of microtubule motor activity; P:negative regulation of microtubule polymerization; P:neuron projection development; P:positive regulation of anterograde dense core granule transport; P:positive regulation of anterograde synaptic vesicle transport; P:regulation of cellular protein localization; P:regulation of microtubule polymerization; P:regulation of organelle transport along microtubule;|P11137 Q17S04 Q8IUX2 Q99975 Q99976,Microtubule-associated protein 2,, PF08377;PF00418;, GO:0150014;GO:0043203;GO:0043194;GO:0097441;GO:0005737;GO:0005829;GO:0030425;GO:0032839;GO:0044307;GO:1902737;GO:0044294;GO:0043198;GO:0150002;GO:0005874;GO:0005875;GO:0043005;GO:0043025;GO:0150001;GO:1990635;GO:1990769;GO:0005516;GO:0002162;GO:0008017;GO:0005198;GO:0048156;GO:0021954;GO:0016358;GO:0048813;GO:0001578;GO:0000226;GO:0030517;GO:1904527;GO:2000575;GO:0031115;GO:0031175;GO:1901953;GO:1903744;GO:1903827;GO:0031113;GO:1902513;, C:apical distal dendrite; C:axon hillock; C:axon initial segment; C:basal dendrite; C:cytoplasm; C:cytosol; C:dendrite; C:dendrite cytoplasm; C:dendritic branch; C:dendritic filopodium; C:dendritic growth cone; C:dendritic shaft; C:distal dendrite; C:microtubule; C:microtubule associated complex; C:neuron projection; C:neuronal cell body; C:primary dendrite; C:proximal dendrite; C:proximal neuron projection;, F:calmodulin binding; F:dystroglycan binding; F:microtubule binding; F:structural molecule activity; F:tau protein binding;, P:central nervous system neuron development; P:dendrite development; P:dendrite morphogenesis; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of axon extension; P:negative regulation of microtubule binding; P:negative regulation of microtubule motor activity; P:negative regulation of microtubule polymerization; P:neuron projection development; P:positive regulation of anterograde dense core granule transport; P:positive regulation of anterograde synaptic vesicle transport; P:regulation of cellular protein localization; P:regulation of microtubule polymerization; P:regulation of organelle transport along microtubule;|Q5XWF0 Q6QT54 Q9UDJ3 Q9UMH0 Q9UQ96,Microtubule-associated protein tau {ECO:0000305},Neurofibrillary tangle protein;Paired helical filament-tau;, PF00418;, GO:0030673;GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0036464;GO:0005829;GO:0030425;GO:0043197;GO:0005576;GO:0097386;GO:0030426;GO:0044304;GO:0045121;GO:0005874;GO:0015630;GO:0005739;GO:0097418;GO:0043005;GO:0043025;GO:0034399;GO:0016607;GO:0005634;GO:0005886;GO:0036477;GO:0045298;GO:0003779;GO:0034185;GO:0051087;GO:0003677;GO:0003690;GO:0034452;GO:0019899;GO:0099077;GO:0051879;GO:0042802;GO:0071813;GO:0008017;GO:0099609;GO:0003680;GO:0035091;GO:1902936;GO:0019901;GO:0051721;GO:0030674;GO:0003723;GO:0043565;GO:0017124;GO:0003697;GO:0006919;GO:1990000;GO:0048143;GO:0061564;GO:0098930;GO:0019896;GO:0007267;GO:1990416;GO:0034605;GO:1990090;GO:0034614;GO:0021954;GO:0031122;GO:0048699;GO:0006475;GO:0048312;GO:0007611;GO:0007613;GO:0001774;GO:0000226;GO:0046785;GO:1903748;GO:0010629;GO:0033673;GO:0090258;GO:0010917;GO:1904428;GO:1902988;GO:0031175;GO:0072386;GO:0045773;GO:1903829;GO:1905689;GO:0031116;GO:1901216;GO:1902474;GO:0032930;GO:0051260;GO:0051258;GO:0010506;GO:0050848;GO:1900034;GO:0033044;GO:1900452;GO:0070507;GO:0031113;GO:0031110;GO:0090140;GO:2001020;GO:0048167;GO:0010288;GO:0016072;GO:0034063;GO:0097435;GO:0007416;GO:0050808;, C:axolemma; C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendrite; C:dendritic spine; C:extracellular region; C:glial cell projection; C:growth cone; C:main axon; C:membrane raft; C:microtubule; C:microtubule cytoskeleton; C:mitochondrion; C:neurofibrillary tangle; C:neuron projection; C:neuronal cell body; C:nuclear periphery; C:nuclear speck; C:nucleus; C:plasma membrane; C:somatodendritic compartment; C:tubulin complex;, F:actin binding; F:apolipoprotein binding; F:chaperone binding; F:DNA binding; F:double-stranded DNA binding; F:dynactin binding; F:enzyme binding; F:histone-dependent DNA binding; F:Hsp90 protein binding; F:identical protein binding; F:lipoprotein particle binding; F:microtubule binding; F:microtubule lateral binding; F:minor groove of adenine-thymine-rich DNA binding; F:phosphatidylinositol binding; F:phosphatidylinositol bisphosphate binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:sequence-specific DNA binding; F:SH3 domain binding; F:single-stranded DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:amyloid fibril formation; P:astrocyte activation; P:axon development; P:axonal transport; P:axonal transport of mitochondrion; P:cell-cell signaling; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to heat; P:cellular response to nerve growth factor stimulus; P:cellular response to reactive oxygen species; P:central nervous system neuron development; P:cytoplasmic microtubule organization; P:generation of neurons; P:internal protein amino acid acetylation; P:intracellular distribution of mitochondria; P:learning or memory; P:memory; P:microglial cell activation; P:microtubule cytoskeleton organization; P:microtubule polymerization; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of gene expression; P:negative regulation of kinase activity; P:negative regulation of mitochondrial fission; P:negative regulation of mitochondrial membrane potential; P:negative regulation of tubulin deacetylation; P:neurofibrillary tangle assembly; P:neuron projection development; P:plus-end-directed organelle transport along microtubule; P:positive regulation of axon extension; P:positive regulation of cellular protein localization; P:positive regulation of diacylglycerol kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of neuron death; P:positive regulation of protein localization to synapse; P:positive regulation of superoxide anion generation; P:protein homooligomerization; P:protein polymerization; P:regulation of autophagy; P:regulation of calcium-mediated signaling; P:regulation of cellular response to heat; P:regulation of chromosome organization; P:regulation of long-term synaptic depression; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of mitochondrial fission; P:regulation of response to DNA damage stimulus; P:regulation of synaptic plasticity; P:response to lead ion; P:rRNA metabolic process; P:stress granule assembly; P:supramolecular fiber organization; P:synapse assembly; P:synapse organization;|P11137 Q17S04 Q8IUX2 Q99975 Q99976,Microtubule-associated protein 2,, PF08377;PF00418;, GO:0150014;GO:0043203;GO:0043194;GO:0097441;GO:0005737;GO:0005829;GO:0030425;GO:0032839;GO:0044307;GO:1902737;GO:0044294;GO:0043198;GO:0150002;GO:0005874;GO:0005875;GO:0043005;GO:0043025;GO:0150001;GO:1990635;GO:1990769;GO:0005516;GO:0002162;GO:0008017;GO:0005198;GO:0048156;GO:0021954;GO:0016358;GO:0048813;GO:0001578;GO:0000226;GO:0030517;GO:1904527;GO:2000575;GO:0031115;GO:0031175;GO:1901953;GO:1903744;GO:1903827;GO:0031113;GO:1902513;, C:apical distal dendrite; C:axon hillock; C:axon initial segment; C:basal dendrite; C:cytoplasm; C:cytosol; C:dendrite; C:dendrite cytoplasm; C:dendritic branch; C:dendritic filopodium; C:dendritic growth cone; C:dendritic shaft; C:distal dendrite; C:microtubule; C:microtubule associated complex; C:neuron projection; C:neuronal cell body; C:primary dendrite; C:proximal dendrite; C:proximal neuron projection;, F:calmodulin binding; F:dystroglycan binding; F:microtubule binding; F:structural molecule activity; F:tau protein binding;, P:central nervous system neuron development; P:dendrite development; P:dendrite morphogenesis; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of axon extension; P:negative regulation of microtubule binding; P:negative regulation of microtubule motor activity; P:negative regulation of microtubule polymerization; P:neuron projection development; P:positive regulation of anterograde dense core granule transport; P:positive regulation of anterograde synaptic vesicle transport; P:regulation of cellular protein localization; P:regulation of microtubule polymerization; P:regulation of organelle transport along microtubule;|P11137 Q17S04 Q8IUX2 Q99975 Q99976,Microtubule-associated protein 2,, PF08377;PF00418;, GO:0150014;GO:0043203;GO:0043194;GO:0097441;GO:0005737;GO:0005829;GO:0030425;GO:0032839;GO:0044307;GO:1902737;GO:0044294;GO:0043198;GO:0150002;GO:0005874;GO:0005875;GO:0043005;GO:0043025;GO:0150001;GO:1990635;GO:1990769;GO:0005516;GO:0002162;GO:0008017;GO:0005198;GO:0048156;GO:0021954;GO:0016358;GO:0048813;GO:0001578;GO:0000226;GO:0030517;GO:1904527;GO:2000575;GO:0031115;GO:0031175;GO:1901953;GO:1903744;GO:1903827;GO:0031113;GO:1902513;, C:apical distal dendrite; C:axon hillock; C:axon initial segment; C:basal dendrite; C:cytoplasm; C:cytosol; C:dendrite; C:dendrite cytoplasm; C:dendritic branch; C:dendritic filopodium; C:dendritic growth cone; C:dendritic shaft; C:distal dendrite; C:microtubule; C:microtubule associated complex; C:neuron projection; C:neuronal cell body; C:primary dendrite; C:proximal dendrite; C:proximal neuron projection;, F:calmodulin binding; F:dystroglycan binding; F:microtubule binding; F:structural molecule activity; F:tau protein binding;, P:central nervous system neuron development; P:dendrite development; P:dendrite morphogenesis; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of axon extension; P:negative regulation of microtubule binding; P:negative regulation of microtubule motor activity; P:negative regulation of microtubule polymerization; P:neuron projection development; P:positive regulation of anterograde dense core granule transport; P:positive regulation of anterograde synaptic vesicle transport; P:regulation of cellular protein localization; P:regulation of microtubule polymerization; P:regulation of organelle transport along microtubule; scaffold32 indexed_genome mRNA 17529527 17550240 . + . ID=transcript_6928;Q8N2C7 B2RN50 B4DQY9 B4DZB3 C4IXS8 C9J1U3 Q96JI4 Q96SS0,Protein unc-80 homolog,, PF15778;, GO:0030424;GO:0034703;GO:0005886;GO:0005261;GO:0055080;GO:0034220;, C:axon; C:cation channel complex; C:plasma membrane;, F:cation channel activity;, P:cation homeostasis; P:ion transmembrane transport; scaffold32 indexed_genome mRNA 17568098 17575540 . + . ID=transcript_6929;Q8N2C7 B2RN50 B4DQY9 B4DZB3 C4IXS8 C9J1U3 Q96JI4 Q96SS0,Protein unc-80 homolog,, PF15778;, GO:0030424;GO:0034703;GO:0005886;GO:0005261;GO:0055080;GO:0034220;, C:axon; C:cation channel complex; C:plasma membrane;, F:cation channel activity;, P:cation homeostasis; P:ion transmembrane transport; scaffold32 indexed_genome mRNA 17586397 17725037 . + . ID=transcript_6930;Q8N2C7 B2RN50 B4DQY9 B4DZB3 C4IXS8 C9J1U3 Q96JI4 Q96SS0,Protein unc-80 homolog,, PF15778;, GO:0030424;GO:0034703;GO:0005886;GO:0005261;GO:0055080;GO:0034220;, C:axon; C:cation channel complex; C:plasma membrane;, F:cation channel activity;, P:cation homeostasis; P:ion transmembrane transport;|Q8N2C7 B2RN50 B4DQY9 B4DZB3 C4IXS8 C9J1U3 Q96JI4 Q96SS0,Protein unc-80 homolog,, PF15778;, GO:0030424;GO:0034703;GO:0005886;GO:0005261;GO:0055080;GO:0034220;, C:axon; C:cation channel complex; C:plasma membrane;, F:cation channel activity;, P:cation homeostasis; P:ion transmembrane transport;|Q8N2C7 B2RN50 B4DQY9 B4DZB3 C4IXS8 C9J1U3 Q96JI4 Q96SS0,Protein unc-80 homolog,, PF15778;, GO:0030424;GO:0034703;GO:0005886;GO:0005261;GO:0055080;GO:0034220;, C:axon; C:cation channel complex; C:plasma membrane;, F:cation channel activity;, P:cation homeostasis; P:ion transmembrane transport;|Q8N2C7 B2RN50 B4DQY9 B4DZB3 C4IXS8 C9J1U3 Q96JI4 Q96SS0,Protein unc-80 homolog,, PF15778;, GO:0030424;GO:0034703;GO:0005886;GO:0005261;GO:0055080;GO:0034220;, C:axon; C:cation channel complex; C:plasma membrane;, F:cation channel activity;, P:cation homeostasis; P:ion transmembrane transport; scaffold32 indexed_genome mRNA 17728577 17752569 . + . ID=transcript_6931;Q8N2C7 B2RN50 B4DQY9 B4DZB3 C4IXS8 C9J1U3 Q96JI4 Q96SS0,Protein unc-80 homolog,, PF15778;, GO:0030424;GO:0034703;GO:0005886;GO:0005261;GO:0055080;GO:0034220;, C:axon; C:cation channel complex; C:plasma membrane;, F:cation channel activity;, P:cation homeostasis; P:ion transmembrane transport;|Q8N2C7 B2RN50 B4DQY9 B4DZB3 C4IXS8 C9J1U3 Q96JI4 Q96SS0,Protein unc-80 homolog,, PF15778;, GO:0030424;GO:0034703;GO:0005886;GO:0005261;GO:0055080;GO:0034220;, C:axon; C:cation channel complex; C:plasma membrane;, F:cation channel activity;, P:cation homeostasis; P:ion transmembrane transport;|Q8N2C7 B2RN50 B4DQY9 B4DZB3 C4IXS8 C9J1U3 Q96JI4 Q96SS0,Protein unc-80 homolog,, PF15778;, GO:0030424;GO:0034703;GO:0005886;GO:0005261;GO:0055080;GO:0034220;, C:axon; C:cation channel complex; C:plasma membrane;, F:cation channel activity;, P:cation homeostasis; P:ion transmembrane transport; scaffold32 indexed_genome mRNA 17753568 17783016 . + . ID=transcript_6932;Q96AT9 A8K4S0 B4E016 C9JPQ7 O43767 Q53TV9 Q8N215 Q96N34 Q9BSB5,Ribulose-phosphate 3-epimerase,Ribulose-5-phosphate-3-epimerase;, PF00834;, GO:0005829;GO:0070062;GO:0042802;GO:0046872;GO:0042803;GO:0004750;GO:0005975;GO:0044262;GO:0019323;GO:0006098;GO:0009052;, C:cytosol; C:extracellular exosome;, F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:ribulose-phosphate 3-epimerase activity;, P:carbohydrate metabolic process; P:cellular carbohydrate metabolic process; P:pentose catabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch;|Q2QD12,Ribulose-phosphate 3-epimerase-like protein 1,Ribulose-5-phosphate-3-epimerase-like protein 1;, PF00834;, GO:0005829;GO:0046872;GO:0004750;GO:0044262;GO:0019323;GO:0006098;GO:0009052;, C:cytosol;, F:metal ion binding; F:ribulose-phosphate 3-epimerase activity;, P:cellular carbohydrate metabolic process; P:pentose catabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch;|Q96AT9 A8K4S0 B4E016 C9JPQ7 O43767 Q53TV9 Q8N215 Q96N34 Q9BSB5,Ribulose-phosphate 3-epimerase,Ribulose-5-phosphate-3-epimerase;, PF00834;, GO:0005829;GO:0070062;GO:0042802;GO:0046872;GO:0042803;GO:0004750;GO:0005975;GO:0044262;GO:0019323;GO:0006098;GO:0009052;, C:cytosol; C:extracellular exosome;, F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:ribulose-phosphate 3-epimerase activity;, P:carbohydrate metabolic process; P:cellular carbohydrate metabolic process; P:pentose catabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch;|A0AUZ9 B7ZLN1 I6L9A8 Q53TV8 Q53TW3 Q6IS05 Q8TCI1 Q96MI0 Q9UFC3,KAT8 regulatory NSL complex subunit 1-like protein,MSL1v2;, PF15275;, GO:0044545;GO:0035035;, C:NSL complex;, F:histone acetyltransferase binding;|A0AUZ9 B7ZLN1 I6L9A8 Q53TV8 Q53TW3 Q6IS05 Q8TCI1 Q96MI0 Q9UFC3,KAT8 regulatory NSL complex subunit 1-like protein,MSL1v2;, PF15275;, GO:0044545;GO:0035035;, C:NSL complex;, F:histone acetyltransferase binding; scaffold32 indexed_genome mRNA 17792739 17879614 . - . ID=transcript_6933;A0AUZ9 B7ZLN1 I6L9A8 Q53TV8 Q53TW3 Q6IS05 Q8TCI1 Q96MI0 Q9UFC3,KAT8 regulatory NSL complex subunit 1-like protein,MSL1v2;, PF15275;, GO:0044545;GO:0035035;, C:NSL complex;, F:histone acetyltransferase binding; scaffold32 indexed_genome mRNA 17908803 17953631 . - . ID=transcript_6934;P28330 B2R8T3 Q8IUN8,Long-chain specific acyl-CoA dehydrogenase, mitochondrial,, PF00441;PF02770;PF02771;, GO:0005759;GO:0031966;GO:0005739;GO:0003995;GO:0000062;GO:0050660;GO:0042802;GO:0004466;GO:0016401;GO:0042413;GO:0019254;GO:0044242;GO:0006635;GO:0033539;GO:0042758;GO:0045717;GO:0046322;GO:0120162;GO:0090181;GO:0001659;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion;, F:acyl-CoA dehydrogenase activity; F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:identical protein binding; F:long-chain-acyl-CoA dehydrogenase activity; F:palmitoyl-CoA oxidase activity;, P:carnitine catabolic process; P:carnitine metabolic process, CoA-linked; P:cellular lipid catabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:long-chain fatty acid catabolic process; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of fatty acid oxidation; P:positive regulation of cold-induced thermogenesis; P:regulation of cholesterol metabolic process; P:temperature homeostasis;|P28330 B2R8T3 Q8IUN8,Long-chain specific acyl-CoA dehydrogenase, mitochondrial,, PF00441;PF02770;PF02771;, GO:0005759;GO:0031966;GO:0005739;GO:0003995;GO:0000062;GO:0050660;GO:0042802;GO:0004466;GO:0016401;GO:0042413;GO:0019254;GO:0044242;GO:0006635;GO:0033539;GO:0042758;GO:0045717;GO:0046322;GO:0120162;GO:0090181;GO:0001659;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion;, F:acyl-CoA dehydrogenase activity; F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:identical protein binding; F:long-chain-acyl-CoA dehydrogenase activity; F:palmitoyl-CoA oxidase activity;, P:carnitine catabolic process; P:carnitine metabolic process, CoA-linked; P:cellular lipid catabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:long-chain fatty acid catabolic process; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of fatty acid oxidation; P:positive regulation of cold-induced thermogenesis; P:regulation of cholesterol metabolic process; P:temperature homeostasis;|P28330 B2R8T3 Q8IUN8,Long-chain specific acyl-CoA dehydrogenase, mitochondrial,, PF00441;PF02770;PF02771;, GO:0005759;GO:0031966;GO:0005739;GO:0003995;GO:0000062;GO:0050660;GO:0042802;GO:0004466;GO:0016401;GO:0042413;GO:0019254;GO:0044242;GO:0006635;GO:0033539;GO:0042758;GO:0045717;GO:0046322;GO:0120162;GO:0090181;GO:0001659;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion;, F:acyl-CoA dehydrogenase activity; F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:identical protein binding; F:long-chain-acyl-CoA dehydrogenase activity; F:palmitoyl-CoA oxidase activity;, P:carnitine catabolic process; P:carnitine metabolic process, CoA-linked; P:cellular lipid catabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:long-chain fatty acid catabolic process; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of fatty acid oxidation; P:positive regulation of cold-induced thermogenesis; P:regulation of cholesterol metabolic process; P:temperature homeostasis; scaffold32 indexed_genome mRNA 18117116 18164468 . - . ID=transcript_6935;O43813,Glutathione S-transferase LANCL1 {ECO:0000250|UniProtKB:O89112},40 kDa erythrocyte membrane protein;LanC-like protein 1 {ECO:0000303|PubMed:11474189};, PF05147;, GO:0005737;GO:0005887;GO:0005886;GO:0004930;GO:0043295;GO:0004364;GO:0050750;GO:0017124;GO:0008270;GO:0005975;GO:0007186;GO:0043523;GO:1903203;, C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:glutathione binding; F:glutathione transferase activity; F:low-density lipoprotein particle receptor binding; F:SH3 domain binding; F:zinc ion binding;, P:carbohydrate metabolic process; P:G protein-coupled receptor signaling pathway; P:regulation of neuron apoptotic process; P:regulation of oxidative stress-induced neuron death;|O43813,Glutathione S-transferase LANCL1 {ECO:0000250|UniProtKB:O89112},40 kDa erythrocyte membrane protein;LanC-like protein 1 {ECO:0000303|PubMed:11474189};, PF05147;, GO:0005737;GO:0005887;GO:0005886;GO:0004930;GO:0043295;GO:0004364;GO:0050750;GO:0017124;GO:0008270;GO:0005975;GO:0007186;GO:0043523;GO:1903203;, C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:glutathione binding; F:glutathione transferase activity; F:low-density lipoprotein particle receptor binding; F:SH3 domain binding; F:zinc ion binding;, P:carbohydrate metabolic process; P:G protein-coupled receptor signaling pathway; P:regulation of neuron apoptotic process; P:regulation of oxidative stress-induced neuron death;|O43813,Glutathione S-transferase LANCL1 {ECO:0000250|UniProtKB:O89112},40 kDa erythrocyte membrane protein;LanC-like protein 1 {ECO:0000303|PubMed:11474189};, PF05147;, GO:0005737;GO:0005887;GO:0005886;GO:0004930;GO:0043295;GO:0004364;GO:0050750;GO:0017124;GO:0008270;GO:0005975;GO:0007186;GO:0043523;GO:1903203;, C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:glutathione binding; F:glutathione transferase activity; F:low-density lipoprotein particle receptor binding; F:SH3 domain binding; F:zinc ion binding;, P:carbohydrate metabolic process; P:G protein-coupled receptor signaling pathway; P:regulation of neuron apoptotic process; P:regulation of oxidative stress-induced neuron death;|O43813,Glutathione S-transferase LANCL1 {ECO:0000250|UniProtKB:O89112},40 kDa erythrocyte membrane protein;LanC-like protein 1 {ECO:0000303|PubMed:11474189};, PF05147;, GO:0005737;GO:0005887;GO:0005886;GO:0004930;GO:0043295;GO:0004364;GO:0050750;GO:0017124;GO:0008270;GO:0005975;GO:0007186;GO:0043523;GO:1903203;, C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:glutathione binding; F:glutathione transferase activity; F:low-density lipoprotein particle receptor binding; F:SH3 domain binding; F:zinc ion binding;, P:carbohydrate metabolic process; P:G protein-coupled receptor signaling pathway; P:regulation of neuron apoptotic process; P:regulation of oxidative stress-induced neuron death;|O43813,Glutathione S-transferase LANCL1 {ECO:0000250|UniProtKB:O89112},40 kDa erythrocyte membrane protein;LanC-like protein 1 {ECO:0000303|PubMed:11474189};, PF05147;, GO:0005737;GO:0005887;GO:0005886;GO:0004930;GO:0043295;GO:0004364;GO:0050750;GO:0017124;GO:0008270;GO:0005975;GO:0007186;GO:0043523;GO:1903203;, C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:glutathione binding; F:glutathione transferase activity; F:low-density lipoprotein particle receptor binding; F:SH3 domain binding; F:zinc ion binding;, P:carbohydrate metabolic process; P:G protein-coupled receptor signaling pathway; P:regulation of neuron apoptotic process; P:regulation of oxidative stress-induced neuron death; scaffold32 indexed_genome mRNA 18279662 18395776 . + . ID=transcript_6936;P31327 B7Z818 J3KQL0 O43774 Q53TL5 Q59HF8 Q7Z5I5,Carbamoyl-phosphate synthase [ammonia], mitochondrial,Carbamoyl-phosphate synthetase I;, PF02786;PF02787;PF00988;PF00117;PF02142;, GO:0005737;GO:0005743;GO:0005759;GO:0042645;GO:0005730;GO:0032991;GO:0005524;GO:0005509;GO:0004087;GO:0004088;GO:0004175;GO:0016595;GO:0072341;GO:0005543;GO:0044877;GO:0006207;GO:0055081;GO:0070409;GO:0071242;GO:0071320;GO:0044344;GO:0071377;GO:0071400;GO:0019240;GO:0006541;GO:0070365;GO:0050667;GO:0007494;GO:0046209;GO:0006807;GO:0014075;GO:0043200;GO:0071548;GO:0042493;GO:0032094;GO:0060416;GO:0032496;GO:0042594;GO:0009636;GO:0010043;GO:0019433;GO:0000050;GO:0042311;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:nucleolus; C:protein-containing complex;, F:ATP binding; F:calcium ion binding; F:carbamoyl-phosphate synthase (ammonia) activity; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:endopeptidase activity; F:glutamate binding; F:modified amino acid binding; F:phospholipid binding; F:protein-containing complex binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:anion homeostasis; P:carbamoyl phosphate biosynthetic process; P:cellular response to ammonium ion; P:cellular response to cAMP; P:cellular response to fibroblast growth factor stimulus; P:cellular response to glucagon stimulus; P:cellular response to oleic acid; P:citrulline biosynthetic process; P:glutamine metabolic process; P:hepatocyte differentiation; P:homocysteine metabolic process; P:midgut development; P:nitric oxide metabolic process; P:nitrogen compound metabolic process; P:response to amine; P:response to amino acid; P:response to dexamethasone; P:response to drug; P:response to food; P:response to growth hormone; P:response to lipopolysaccharide; P:response to starvation; P:response to toxic substance; P:response to zinc ion; P:triglyceride catabolic process; P:urea cycle; P:vasodilation;|P31327 B7Z818 J3KQL0 O43774 Q53TL5 Q59HF8 Q7Z5I5,Carbamoyl-phosphate synthase [ammonia], mitochondrial,Carbamoyl-phosphate synthetase I;, PF02786;PF02787;PF00988;PF00117;PF02142;, GO:0005737;GO:0005743;GO:0005759;GO:0042645;GO:0005730;GO:0032991;GO:0005524;GO:0005509;GO:0004087;GO:0004088;GO:0004175;GO:0016595;GO:0072341;GO:0005543;GO:0044877;GO:0006207;GO:0055081;GO:0070409;GO:0071242;GO:0071320;GO:0044344;GO:0071377;GO:0071400;GO:0019240;GO:0006541;GO:0070365;GO:0050667;GO:0007494;GO:0046209;GO:0006807;GO:0014075;GO:0043200;GO:0071548;GO:0042493;GO:0032094;GO:0060416;GO:0032496;GO:0042594;GO:0009636;GO:0010043;GO:0019433;GO:0000050;GO:0042311;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:nucleolus; C:protein-containing complex;, F:ATP binding; F:calcium ion binding; F:carbamoyl-phosphate synthase (ammonia) activity; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:endopeptidase activity; F:glutamate binding; F:modified amino acid binding; F:phospholipid binding; F:protein-containing complex binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:anion homeostasis; P:carbamoyl phosphate biosynthetic process; P:cellular response to ammonium ion; P:cellular response to cAMP; P:cellular response to fibroblast growth factor stimulus; P:cellular response to glucagon stimulus; P:cellular response to oleic acid; P:citrulline biosynthetic process; P:glutamine metabolic process; P:hepatocyte differentiation; P:homocysteine metabolic process; P:midgut development; P:nitric oxide metabolic process; P:nitrogen compound metabolic process; P:response to amine; P:response to amino acid; P:response to dexamethasone; P:response to drug; P:response to food; P:response to growth hormone; P:response to lipopolysaccharide; P:response to starvation; P:response to toxic substance; P:response to zinc ion; P:triglyceride catabolic process; P:urea cycle; P:vasodilation;|P31327 B7Z818 J3KQL0 O43774 Q53TL5 Q59HF8 Q7Z5I5,Carbamoyl-phosphate synthase [ammonia], mitochondrial,Carbamoyl-phosphate synthetase I;, PF02786;PF02787;PF00988;PF00117;PF02142;, GO:0005737;GO:0005743;GO:0005759;GO:0042645;GO:0005730;GO:0032991;GO:0005524;GO:0005509;GO:0004087;GO:0004088;GO:0004175;GO:0016595;GO:0072341;GO:0005543;GO:0044877;GO:0006207;GO:0055081;GO:0070409;GO:0071242;GO:0071320;GO:0044344;GO:0071377;GO:0071400;GO:0019240;GO:0006541;GO:0070365;GO:0050667;GO:0007494;GO:0046209;GO:0006807;GO:0014075;GO:0043200;GO:0071548;GO:0042493;GO:0032094;GO:0060416;GO:0032496;GO:0042594;GO:0009636;GO:0010043;GO:0019433;GO:0000050;GO:0042311;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:nucleolus; C:protein-containing complex;, F:ATP binding; F:calcium ion binding; F:carbamoyl-phosphate synthase (ammonia) activity; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:endopeptidase activity; F:glutamate binding; F:modified amino acid binding; F:phospholipid binding; F:protein-containing complex binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:anion homeostasis; P:carbamoyl phosphate biosynthetic process; P:cellular response to ammonium ion; P:cellular response to cAMP; P:cellular response to fibroblast growth factor stimulus; P:cellular response to glucagon stimulus; P:cellular response to oleic acid; P:citrulline biosynthetic process; P:glutamine metabolic process; P:hepatocyte differentiation; P:homocysteine metabolic process; P:midgut development; P:nitric oxide metabolic process; P:nitrogen compound metabolic process; P:response to amine; P:response to amino acid; P:response to dexamethasone; P:response to drug; P:response to food; P:response to growth hormone; P:response to lipopolysaccharide; P:response to starvation; P:response to toxic substance; P:response to zinc ion; P:triglyceride catabolic process; P:urea cycle; P:vasodilation;|P31327 B7Z818 J3KQL0 O43774 Q53TL5 Q59HF8 Q7Z5I5,Carbamoyl-phosphate synthase [ammonia], mitochondrial,Carbamoyl-phosphate synthetase I;, PF02786;PF02787;PF00988;PF00117;PF02142;, GO:0005737;GO:0005743;GO:0005759;GO:0042645;GO:0005730;GO:0032991;GO:0005524;GO:0005509;GO:0004087;GO:0004088;GO:0004175;GO:0016595;GO:0072341;GO:0005543;GO:0044877;GO:0006207;GO:0055081;GO:0070409;GO:0071242;GO:0071320;GO:0044344;GO:0071377;GO:0071400;GO:0019240;GO:0006541;GO:0070365;GO:0050667;GO:0007494;GO:0046209;GO:0006807;GO:0014075;GO:0043200;GO:0071548;GO:0042493;GO:0032094;GO:0060416;GO:0032496;GO:0042594;GO:0009636;GO:0010043;GO:0019433;GO:0000050;GO:0042311;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:nucleolus; C:protein-containing complex;, F:ATP binding; F:calcium ion binding; F:carbamoyl-phosphate synthase (ammonia) activity; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; F:endopeptidase activity; F:glutamate binding; F:modified amino acid binding; F:phospholipid binding; F:protein-containing complex binding;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:anion homeostasis; P:carbamoyl phosphate biosynthetic process; P:cellular response to ammonium ion; P:cellular response to cAMP; P:cellular response to fibroblast growth factor stimulus; P:cellular response to glucagon stimulus; P:cellular response to oleic acid; P:citrulline biosynthetic process; P:glutamine metabolic process; P:hepatocyte differentiation; P:homocysteine metabolic process; P:midgut development; P:nitric oxide metabolic process; P:nitrogen compound metabolic process; P:response to amine; P:response to amino acid; P:response to dexamethasone; P:response to drug; P:response to food; P:response to growth hormone; P:response to lipopolysaccharide; P:response to starvation; P:response to toxic substance; P:response to zinc ion; P:triglyceride catabolic process; P:urea cycle; P:vasodilation; scaffold32 indexed_genome mRNA 19131059 19135742 . - . ID=transcript_6937;Q15303 B7ZLD7 B7ZLE2 B7ZLE3 Q2M1W1 Q59EW4,Receptor tyrosine-protein kinase erbB-4,Proto-oncogene-like protein c-ErbB-4;Tyrosine kinase-type cell surface receptor HER4;p180erbB4;, PF00757;PF14843;PF07714;PF01030;, GO:0009925;GO:0016323;GO:0005829;GO:0005576;GO:0098982;GO:0098978;GO:0005887;GO:0099061;GO:0099056;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0045211;GO:0043235;GO:0005524;GO:0005154;GO:0042803;GO:0004713;GO:0000976;GO:0004714;GO:0061026;GO:0045165;GO:0016477;GO:0071364;GO:0021551;GO:0009880;GO:0038128;GO:0007507;GO:0007595;GO:0060749;GO:0060644;GO:0000165;GO:0043653;GO:0007275;GO:0043066;GO:0008285;GO:2001223;GO:0007399;GO:0001755;GO:0021889;GO:0018108;GO:0060045;GO:0008284;GO:0070374;GO:0033674;GO:0043552;GO:0014068;GO:0051897;GO:2000010;GO:0001934;GO:0046427;GO:0045893;GO:0042531;GO:0046777;GO:0030334;GO:2000145;GO:0007165;GO:0007416;GO:0007169;, C:basal plasma membrane; C:basolateral plasma membrane; C:cytosol; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:receptor complex;, F:ATP binding; F:epidermal growth factor receptor binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:transcription regulatory region sequence-specific DNA binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cardiac muscle tissue regeneration; P:cell fate commitment; P:cell migration; P:cellular response to epidermal growth factor stimulus; P:central nervous system morphogenesis; P:embryonic pattern specification; P:ERBB2 signaling pathway; P:heart development; P:lactation; P:mammary gland alveolus development; P:mammary gland epithelial cell differentiation; P:MAPK cascade; P:mitochondrial fragmentation involved in apoptotic process; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of neuron migration; P:nervous system development; P:neural crest cell migration; P:olfactory bulb interneuron differentiation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to cell surface; P:positive regulation of protein phosphorylation; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of transcription, DNA-templated; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:regulation of cell migration; P:regulation of cell motility; P:signal transduction; P:synapse assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold32 indexed_genome mRNA 19170365 19442076 . - . ID=transcript_6938;Q15303 B7ZLD7 B7ZLE2 B7ZLE3 Q2M1W1 Q59EW4,Receptor tyrosine-protein kinase erbB-4,Proto-oncogene-like protein c-ErbB-4;Tyrosine kinase-type cell surface receptor HER4;p180erbB4;, PF00757;PF14843;PF07714;PF01030;, GO:0009925;GO:0016323;GO:0005829;GO:0005576;GO:0098982;GO:0098978;GO:0005887;GO:0099061;GO:0099056;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0045211;GO:0043235;GO:0005524;GO:0005154;GO:0042803;GO:0004713;GO:0000976;GO:0004714;GO:0061026;GO:0045165;GO:0016477;GO:0071364;GO:0021551;GO:0009880;GO:0038128;GO:0007507;GO:0007595;GO:0060749;GO:0060644;GO:0000165;GO:0043653;GO:0007275;GO:0043066;GO:0008285;GO:2001223;GO:0007399;GO:0001755;GO:0021889;GO:0018108;GO:0060045;GO:0008284;GO:0070374;GO:0033674;GO:0043552;GO:0014068;GO:0051897;GO:2000010;GO:0001934;GO:0046427;GO:0045893;GO:0042531;GO:0046777;GO:0030334;GO:2000145;GO:0007165;GO:0007416;GO:0007169;, C:basal plasma membrane; C:basolateral plasma membrane; C:cytosol; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:receptor complex;, F:ATP binding; F:epidermal growth factor receptor binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:transcription regulatory region sequence-specific DNA binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cardiac muscle tissue regeneration; P:cell fate commitment; P:cell migration; P:cellular response to epidermal growth factor stimulus; P:central nervous system morphogenesis; P:embryonic pattern specification; P:ERBB2 signaling pathway; P:heart development; P:lactation; P:mammary gland alveolus development; P:mammary gland epithelial cell differentiation; P:MAPK cascade; P:mitochondrial fragmentation involved in apoptotic process; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of neuron migration; P:nervous system development; P:neural crest cell migration; P:olfactory bulb interneuron differentiation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to cell surface; P:positive regulation of protein phosphorylation; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of transcription, DNA-templated; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:regulation of cell migration; P:regulation of cell motility; P:signal transduction; P:synapse assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold32 indexed_genome mRNA 19447925 20340048 . - . ID=transcript_6939;Q15303 B7ZLD7 B7ZLE2 B7ZLE3 Q2M1W1 Q59EW4,Receptor tyrosine-protein kinase erbB-4,Proto-oncogene-like protein c-ErbB-4;Tyrosine kinase-type cell surface receptor HER4;p180erbB4;, PF00757;PF14843;PF07714;PF01030;, GO:0009925;GO:0016323;GO:0005829;GO:0005576;GO:0098982;GO:0098978;GO:0005887;GO:0099061;GO:0099056;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0045211;GO:0043235;GO:0005524;GO:0005154;GO:0042803;GO:0004713;GO:0000976;GO:0004714;GO:0061026;GO:0045165;GO:0016477;GO:0071364;GO:0021551;GO:0009880;GO:0038128;GO:0007507;GO:0007595;GO:0060749;GO:0060644;GO:0000165;GO:0043653;GO:0007275;GO:0043066;GO:0008285;GO:2001223;GO:0007399;GO:0001755;GO:0021889;GO:0018108;GO:0060045;GO:0008284;GO:0070374;GO:0033674;GO:0043552;GO:0014068;GO:0051897;GO:2000010;GO:0001934;GO:0046427;GO:0045893;GO:0042531;GO:0046777;GO:0030334;GO:2000145;GO:0007165;GO:0007416;GO:0007169;, C:basal plasma membrane; C:basolateral plasma membrane; C:cytosol; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:receptor complex;, F:ATP binding; F:epidermal growth factor receptor binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:transcription regulatory region sequence-specific DNA binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cardiac muscle tissue regeneration; P:cell fate commitment; P:cell migration; P:cellular response to epidermal growth factor stimulus; P:central nervous system morphogenesis; P:embryonic pattern specification; P:ERBB2 signaling pathway; P:heart development; P:lactation; P:mammary gland alveolus development; P:mammary gland epithelial cell differentiation; P:MAPK cascade; P:mitochondrial fragmentation involved in apoptotic process; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of neuron migration; P:nervous system development; P:neural crest cell migration; P:olfactory bulb interneuron differentiation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to cell surface; P:positive regulation of protein phosphorylation; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of transcription, DNA-templated; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:regulation of cell migration; P:regulation of cell motility; P:signal transduction; P:synapse assembly; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold32 indexed_genome mRNA 20874255 20981914 . - . ID=transcript_6940;Q9UKS7 Q53YJ5 Q6PQC5 Q6PQC6 Q6PQC7 Q6PQC8 Q6PQD0 Q6PQD1 Q8N6S1,Zinc finger protein Helios,Ikaros family zinc finger protein 2;, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold32 indexed_genome mRNA 21142463 21197353 . + . ID=transcript_6941;Q8N0X2 Q498B7 Q658W1 Q68DB3 Q6I9Z6 Q8N9C7 Q9H601,Sperm-associated antigen 16 protein,Pf20 protein homolog;, PF00400;, GO:1990716;GO:0005930;GO:0005576;GO:0036126;GO:0035082;GO:0090660;GO:0060271;GO:0120197;GO:0007288;, C:axonemal central apparatus; C:axoneme; C:extracellular region; C:sperm flagellum;, , P:axoneme assembly; P:cerebrospinal fluid circulation; P:cilium assembly; P:mucociliary clearance; P:sperm axoneme assembly; scaffold32 indexed_genome mRNA 22397222 22398391 . + . ID=transcript_6942;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold32 indexed_genome mRNA 22399483 22450002 . - . ID=transcript_6943;Q99728 F6MDH7 F6MDH8 F6MDH9 O43574 Q53SS5,BRCA1-associated RING domain protein 1,RING-type E3 ubiquitin transferase BARD1 {ECO:0000305};, PF12796;PF14835;, GO:0070531;GO:0031436;GO:0005737;GO:0036464;GO:0016607;GO:0005654;GO:0005634;GO:0000151;GO:0019900;GO:0046872;GO:0046982;GO:0042803;GO:0003723;GO:0004842;GO:0007050;GO:0006974;GO:0000729;GO:0006260;GO:0006302;GO:0006303;GO:0043066;GO:0031441;GO:0046826;GO:0043065;GO:0045732;GO:0016579;GO:0085020;GO:0016567;GO:0042325;GO:1901796;GO:0001894;, C:BRCA1-A complex; C:BRCA1-BARD1 complex; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:kinase binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:ubiquitin-protein transferase activity;, P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of apoptotic process; P:negative regulation of mRNA 3'-end processing; P:negative regulation of protein export from nucleus; P:positive regulation of apoptotic process; P:positive regulation of protein catabolic process; P:protein deubiquitination; P:protein K6-linked ubiquitination; P:protein ubiquitination; P:regulation of phosphorylation; P:regulation of signal transduction by p53 class mediator; P:tissue homeostasis; scaffold32 indexed_genome mRNA 22905376 22928000 . + . ID=transcript_6944;P31939 A8K202 E9PBU3 Q13856 Q53S28,Bifunctional purine biosynthesis protein ATIC,AICAR transformylase/inosine monophosphate cyclohydrolase;, PF01808;PF02142;, GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0045296;GO:0003937;GO:0004643;GO:0042803;GO:0006189;GO:0031100;GO:0003360;GO:0098761;GO:0021549;GO:0021987;GO:0046452;GO:0006139;GO:0009116;GO:0009168;GO:0010035;GO:0046654;, C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane;, F:cadherin binding; F:IMP cyclohydrolase activity; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity; F:protein homodimerization activity;, P:'de novo' IMP biosynthetic process; P:animal organ regeneration; P:brainstem development; P:cellular response to interleukin-7; P:cerebellum development; P:cerebral cortex development; P:dihydrofolate metabolic process; P:nucleobase-containing compound metabolic process; P:nucleoside metabolic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:tetrahydrofolate biosynthetic process;|P31939 A8K202 E9PBU3 Q13856 Q53S28,Bifunctional purine biosynthesis protein ATIC,AICAR transformylase/inosine monophosphate cyclohydrolase;, PF01808;PF02142;, GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0045296;GO:0003937;GO:0004643;GO:0042803;GO:0006189;GO:0031100;GO:0003360;GO:0098761;GO:0021549;GO:0021987;GO:0046452;GO:0006139;GO:0009116;GO:0009168;GO:0010035;GO:0046654;, C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane;, F:cadherin binding; F:IMP cyclohydrolase activity; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity; F:protein homodimerization activity;, P:'de novo' IMP biosynthetic process; P:animal organ regeneration; P:brainstem development; P:cellular response to interleukin-7; P:cerebellum development; P:cerebral cortex development; P:dihydrofolate metabolic process; P:nucleobase-containing compound metabolic process; P:nucleoside metabolic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to inorganic substance; P:tetrahydrofolate biosynthetic process; scaffold32 indexed_genome mRNA 22935704 23004885 . - . ID=transcript_6945;Q96KP8 Q96KP9 Q9H1B8 Q9HAP3 Q9UMK2,Fibronectin {ECO:0000305},Cold-insoluble globulin;, PF00039;PF00040;PF00041;, GO:0016324;GO:0005604;GO:0072562;GO:0062023;GO:0005788;GO:0005793;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031093;GO:0051087;GO:0005518;GO:0097718;GO:0019899;GO:0005201;GO:0008201;GO:0042802;GO:0005178;GO:0016504;GO:0002020;GO:0008022;GO:0043394;GO:0005102;GO:0006953;GO:0001525;GO:0051702;GO:0072378;GO:0007161;GO:0007155;GO:0007160;GO:0007044;GO:0044267;GO:0019221;GO:0035987;GO:0030198;GO:0007507;GO:0033622;GO:0007229;GO:0050900;GO:0071635;GO:0007399;GO:1901166;GO:0018149;GO:0070527;GO:0002576;GO:0045773;GO:0008284;GO:0048146;GO:0010628;GO:0014068;GO:1904237;GO:0043687;GO:0008360;GO:0070372;GO:0001932;GO:0009611;GO:0034446;, C:apical plasma membrane; C:basement membrane; C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule lumen;, F:chaperone binding; F:collagen binding; F:disordered domain specific binding; F:enzyme binding; F:extracellular matrix structural constituent; F:heparin binding; F:identical protein binding; F:integrin binding; F:peptidase activator activity; F:protease binding; F:protein C-terminus binding; F:proteoglycan binding; F:signaling receptor binding;, P:acute-phase response; P:angiogenesis; P:biological process involved in interaction with symbiont; P:blood coagulation, fibrin clot formation; P:calcium-independent cell-matrix adhesion; P:cell adhesion; P:cell-matrix adhesion; P:cell-substrate junction assembly; P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:endodermal cell differentiation; P:extracellular matrix organization; P:heart development; P:integrin activation; P:integrin-mediated signaling pathway; P:leukocyte migration; P:negative regulation of transforming growth factor beta production; P:nervous system development; P:neural crest cell migration involved in autonomic nervous system development; P:peptide cross-linking; P:platelet aggregation; P:platelet degranulation; P:positive regulation of axon extension; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; P:post-translational protein modification; P:regulation of cell shape; P:regulation of ERK1 and ERK2 cascade; P:regulation of protein phosphorylation; P:response to wounding; P:substrate adhesion-dependent cell spreading;|Q96KP8 Q96KP9 Q9H1B8 Q9HAP3 Q9UMK2,Fibronectin {ECO:0000305},Cold-insoluble globulin;, PF00039;PF00040;PF00041;, GO:0016324;GO:0005604;GO:0072562;GO:0062023;GO:0005788;GO:0005793;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031093;GO:0051087;GO:0005518;GO:0097718;GO:0019899;GO:0005201;GO:0008201;GO:0042802;GO:0005178;GO:0016504;GO:0002020;GO:0008022;GO:0043394;GO:0005102;GO:0006953;GO:0001525;GO:0051702;GO:0072378;GO:0007161;GO:0007155;GO:0007160;GO:0007044;GO:0044267;GO:0019221;GO:0035987;GO:0030198;GO:0007507;GO:0033622;GO:0007229;GO:0050900;GO:0071635;GO:0007399;GO:1901166;GO:0018149;GO:0070527;GO:0002576;GO:0045773;GO:0008284;GO:0048146;GO:0010628;GO:0014068;GO:1904237;GO:0043687;GO:0008360;GO:0070372;GO:0001932;GO:0009611;GO:0034446;, C:apical plasma membrane; C:basement membrane; C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule lumen;, F:chaperone binding; F:collagen binding; F:disordered domain specific binding; F:enzyme binding; F:extracellular matrix structural constituent; F:heparin binding; F:identical protein binding; F:integrin binding; F:peptidase activator activity; F:protease binding; F:protein C-terminus binding; F:proteoglycan binding; F:signaling receptor binding;, P:acute-phase response; P:angiogenesis; P:biological process involved in interaction with symbiont; P:blood coagulation, fibrin clot formation; P:calcium-independent cell-matrix adhesion; P:cell adhesion; P:cell-matrix adhesion; P:cell-substrate junction assembly; P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:endodermal cell differentiation; P:extracellular matrix organization; P:heart development; P:integrin activation; P:integrin-mediated signaling pathway; P:leukocyte migration; P:negative regulation of transforming growth factor beta production; P:nervous system development; P:neural crest cell migration involved in autonomic nervous system development; P:peptide cross-linking; P:platelet aggregation; P:platelet degranulation; P:positive regulation of axon extension; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; P:post-translational protein modification; P:regulation of cell shape; P:regulation of ERK1 and ERK2 cascade; P:regulation of protein phosphorylation; P:response to wounding; P:substrate adhesion-dependent cell spreading;|Q96KP8 Q96KP9 Q9H1B8 Q9HAP3 Q9UMK2,Fibronectin {ECO:0000305},Cold-insoluble globulin;, PF00039;PF00040;PF00041;, GO:0016324;GO:0005604;GO:0072562;GO:0062023;GO:0005788;GO:0005793;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031093;GO:0051087;GO:0005518;GO:0097718;GO:0019899;GO:0005201;GO:0008201;GO:0042802;GO:0005178;GO:0016504;GO:0002020;GO:0008022;GO:0043394;GO:0005102;GO:0006953;GO:0001525;GO:0051702;GO:0072378;GO:0007161;GO:0007155;GO:0007160;GO:0007044;GO:0044267;GO:0019221;GO:0035987;GO:0030198;GO:0007507;GO:0033622;GO:0007229;GO:0050900;GO:0071635;GO:0007399;GO:1901166;GO:0018149;GO:0070527;GO:0002576;GO:0045773;GO:0008284;GO:0048146;GO:0010628;GO:0014068;GO:1904237;GO:0043687;GO:0008360;GO:0070372;GO:0001932;GO:0009611;GO:0034446;, C:apical plasma membrane; C:basement membrane; C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule lumen;, F:chaperone binding; F:collagen binding; F:disordered domain specific binding; F:enzyme binding; F:extracellular matrix structural constituent; F:heparin binding; F:identical protein binding; F:integrin binding; F:peptidase activator activity; F:protease binding; F:protein C-terminus binding; F:proteoglycan binding; F:signaling receptor binding;, P:acute-phase response; P:angiogenesis; P:biological process involved in interaction with symbiont; P:blood coagulation, fibrin clot formation; P:calcium-independent cell-matrix adhesion; P:cell adhesion; P:cell-matrix adhesion; P:cell-substrate junction assembly; P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:endodermal cell differentiation; P:extracellular matrix organization; P:heart development; P:integrin activation; P:integrin-mediated signaling pathway; P:leukocyte migration; P:negative regulation of transforming growth factor beta production; P:nervous system development; P:neural crest cell migration involved in autonomic nervous system development; P:peptide cross-linking; P:platelet aggregation; P:platelet degranulation; P:positive regulation of axon extension; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; P:post-translational protein modification; P:regulation of cell shape; P:regulation of ERK1 and ERK2 cascade; P:regulation of protein phosphorylation; P:response to wounding; P:substrate adhesion-dependent cell spreading;|Q96KP8 Q96KP9 Q9H1B8 Q9HAP3 Q9UMK2,Fibronectin {ECO:0000305},Cold-insoluble globulin;, PF00039;PF00040;PF00041;, GO:0016324;GO:0005604;GO:0072562;GO:0062023;GO:0005788;GO:0005793;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031093;GO:0051087;GO:0005518;GO:0097718;GO:0019899;GO:0005201;GO:0008201;GO:0042802;GO:0005178;GO:0016504;GO:0002020;GO:0008022;GO:0043394;GO:0005102;GO:0006953;GO:0001525;GO:0051702;GO:0072378;GO:0007161;GO:0007155;GO:0007160;GO:0007044;GO:0044267;GO:0019221;GO:0035987;GO:0030198;GO:0007507;GO:0033622;GO:0007229;GO:0050900;GO:0071635;GO:0007399;GO:1901166;GO:0018149;GO:0070527;GO:0002576;GO:0045773;GO:0008284;GO:0048146;GO:0010628;GO:0014068;GO:1904237;GO:0043687;GO:0008360;GO:0070372;GO:0001932;GO:0009611;GO:0034446;, C:apical plasma membrane; C:basement membrane; C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule lumen;, F:chaperone binding; F:collagen binding; F:disordered domain specific binding; F:enzyme binding; F:extracellular matrix structural constituent; F:heparin binding; F:identical protein binding; F:integrin binding; F:peptidase activator activity; F:protease binding; F:protein C-terminus binding; F:proteoglycan binding; F:signaling receptor binding;, P:acute-phase response; P:angiogenesis; P:biological process involved in interaction with symbiont; P:blood coagulation, fibrin clot formation; P:calcium-independent cell-matrix adhesion; P:cell adhesion; P:cell-matrix adhesion; P:cell-substrate junction assembly; P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:endodermal cell differentiation; P:extracellular matrix organization; P:heart development; P:integrin activation; P:integrin-mediated signaling pathway; P:leukocyte migration; P:negative regulation of transforming growth factor beta production; P:nervous system development; P:neural crest cell migration involved in autonomic nervous system development; P:peptide cross-linking; P:platelet aggregation; P:platelet degranulation; P:positive regulation of axon extension; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; P:post-translational protein modification; P:regulation of cell shape; P:regulation of ERK1 and ERK2 cascade; P:regulation of protein phosphorylation; P:response to wounding; P:substrate adhesion-dependent cell spreading;|Q96KP8 Q96KP9 Q9H1B8 Q9HAP3 Q9UMK2,Fibronectin {ECO:0000305},Cold-insoluble globulin;, PF00039;PF00040;PF00041;, GO:0016324;GO:0005604;GO:0072562;GO:0062023;GO:0005788;GO:0005793;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031093;GO:0051087;GO:0005518;GO:0097718;GO:0019899;GO:0005201;GO:0008201;GO:0042802;GO:0005178;GO:0016504;GO:0002020;GO:0008022;GO:0043394;GO:0005102;GO:0006953;GO:0001525;GO:0051702;GO:0072378;GO:0007161;GO:0007155;GO:0007160;GO:0007044;GO:0044267;GO:0019221;GO:0035987;GO:0030198;GO:0007507;GO:0033622;GO:0007229;GO:0050900;GO:0071635;GO:0007399;GO:1901166;GO:0018149;GO:0070527;GO:0002576;GO:0045773;GO:0008284;GO:0048146;GO:0010628;GO:0014068;GO:1904237;GO:0043687;GO:0008360;GO:0070372;GO:0001932;GO:0009611;GO:0034446;, C:apical plasma membrane; C:basement membrane; C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule lumen;, F:chaperone binding; F:collagen binding; F:disordered domain specific binding; F:enzyme binding; F:extracellular matrix structural constituent; F:heparin binding; F:identical protein binding; F:integrin binding; F:peptidase activator activity; F:protease binding; F:protein C-terminus binding; F:proteoglycan binding; F:signaling receptor binding;, P:acute-phase response; P:angiogenesis; P:biological process involved in interaction with symbiont; P:blood coagulation, fibrin clot formation; P:calcium-independent cell-matrix adhesion; P:cell adhesion; P:cell-matrix adhesion; P:cell-substrate junction assembly; P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:endodermal cell differentiation; P:extracellular matrix organization; P:heart development; P:integrin activation; P:integrin-mediated signaling pathway; P:leukocyte migration; P:negative regulation of transforming growth factor beta production; P:nervous system development; P:neural crest cell migration involved in autonomic nervous system development; P:peptide cross-linking; P:platelet aggregation; P:platelet degranulation; P:positive regulation of axon extension; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; P:post-translational protein modification; P:regulation of cell shape; P:regulation of ERK1 and ERK2 cascade; P:regulation of protein phosphorylation; P:response to wounding; P:substrate adhesion-dependent cell spreading;|Q96KP8 Q96KP9 Q9H1B8 Q9HAP3 Q9UMK2,Fibronectin {ECO:0000305},Cold-insoluble globulin;, PF00039;PF00040;PF00041;, GO:0016324;GO:0005604;GO:0072562;GO:0062023;GO:0005788;GO:0005793;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031093;GO:0051087;GO:0005518;GO:0097718;GO:0019899;GO:0005201;GO:0008201;GO:0042802;GO:0005178;GO:0016504;GO:0002020;GO:0008022;GO:0043394;GO:0005102;GO:0006953;GO:0001525;GO:0051702;GO:0072378;GO:0007161;GO:0007155;GO:0007160;GO:0007044;GO:0044267;GO:0019221;GO:0035987;GO:0030198;GO:0007507;GO:0033622;GO:0007229;GO:0050900;GO:0071635;GO:0007399;GO:1901166;GO:0018149;GO:0070527;GO:0002576;GO:0045773;GO:0008284;GO:0048146;GO:0010628;GO:0014068;GO:1904237;GO:0043687;GO:0008360;GO:0070372;GO:0001932;GO:0009611;GO:0034446;, C:apical plasma membrane; C:basement membrane; C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule lumen;, F:chaperone binding; F:collagen binding; F:disordered domain specific binding; F:enzyme binding; F:extracellular matrix structural constituent; F:heparin binding; F:identical protein binding; F:integrin binding; F:peptidase activator activity; F:protease binding; F:protein C-terminus binding; F:proteoglycan binding; F:signaling receptor binding;, P:acute-phase response; P:angiogenesis; P:biological process involved in interaction with symbiont; P:blood coagulation, fibrin clot formation; P:calcium-independent cell-matrix adhesion; P:cell adhesion; P:cell-matrix adhesion; P:cell-substrate junction assembly; P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:endodermal cell differentiation; P:extracellular matrix organization; P:heart development; P:integrin activation; P:integrin-mediated signaling pathway; P:leukocyte migration; P:negative regulation of transforming growth factor beta production; P:nervous system development; P:neural crest cell migration involved in autonomic nervous system development; P:peptide cross-linking; P:platelet aggregation; P:platelet degranulation; P:positive regulation of axon extension; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; P:post-translational protein modification; P:regulation of cell shape; P:regulation of ERK1 and ERK2 cascade; P:regulation of protein phosphorylation; P:response to wounding; P:substrate adhesion-dependent cell spreading; scaffold32 indexed_genome mRNA 23514079 23517472 . - . ID=transcript_6946;Q8N565 Q53R89 Q53TC1 Q5XKB6 Q9NWC9 Q9P1S1,Melanoregulin,Dilute suppressor protein homolog;, PF15812;, GO:0016324;GO:0030659;GO:0031300;GO:0031902;GO:0005765;GO:0042470;GO:0033162;GO:0032991;GO:0035091;GO:0030318;GO:0032400;GO:0032402;GO:0072385;GO:0090382;, C:apical plasma membrane; C:cytoplasmic vesicle membrane; C:intrinsic component of organelle membrane; C:late endosome membrane; C:lysosomal membrane; C:melanosome; C:melanosome membrane; C:protein-containing complex;, F:phosphatidylinositol binding;, P:melanocyte differentiation; P:melanosome localization; P:melanosome transport; P:minus-end-directed organelle transport along microtubule; P:phagosome maturation; scaffold32 indexed_genome mRNA 23517771 23518644 . - . ID=transcript_6947;Q8N565 Q53R89 Q53TC1 Q5XKB6 Q9NWC9 Q9P1S1,Melanoregulin,Dilute suppressor protein homolog;, PF15812;, GO:0016324;GO:0030659;GO:0031300;GO:0031902;GO:0005765;GO:0042470;GO:0033162;GO:0032991;GO:0035091;GO:0030318;GO:0032400;GO:0032402;GO:0072385;GO:0090382;, C:apical plasma membrane; C:cytoplasmic vesicle membrane; C:intrinsic component of organelle membrane; C:late endosome membrane; C:lysosomal membrane; C:melanosome; C:melanosome membrane; C:protein-containing complex;, F:phosphatidylinositol binding;, P:melanocyte differentiation; P:melanosome localization; P:melanosome transport; P:minus-end-directed organelle transport along microtubule; P:phagosome maturation; scaffold32 indexed_genome mRNA 23608404 23658608 . - . ID=transcript_6948;Q9BY49 B2RE42 Q53TC4 Q6IAK9 Q9NRD4 Q9NY60 Q9P1A4,Peroxisomal trans-2-enoyl-CoA reductase {ECO:0000305},2,4-dienoyl-CoA reductase-related protein;HPDHase;Short chain dehydrogenase/reductase family 29C member 1;pVI-ARL;, , GO:0005829;GO:0005739;GO:0005778;GO:0005777;GO:0005102;GO:0019166;GO:0001561;GO:0006633;GO:0033306;GO:0008104;, C:cytosol; C:mitochondrion; C:peroxisomal membrane; C:peroxisome;, F:signaling receptor binding; F:trans-2-enoyl-CoA reductase (NADPH) activity;, P:fatty acid alpha-oxidation; P:fatty acid biosynthetic process; P:phytol metabolic process; P:protein localization;|Q9BY49 B2RE42 Q53TC4 Q6IAK9 Q9NRD4 Q9NY60 Q9P1A4,Peroxisomal trans-2-enoyl-CoA reductase {ECO:0000305},2,4-dienoyl-CoA reductase-related protein;HPDHase;Short chain dehydrogenase/reductase family 29C member 1;pVI-ARL;, , GO:0005829;GO:0005739;GO:0005778;GO:0005777;GO:0005102;GO:0019166;GO:0001561;GO:0006633;GO:0033306;GO:0008104;, C:cytosol; C:mitochondrion; C:peroxisomal membrane; C:peroxisome;, F:signaling receptor binding; F:trans-2-enoyl-CoA reductase (NADPH) activity;, P:fatty acid alpha-oxidation; P:fatty acid biosynthetic process; P:phytol metabolic process; P:protein localization;|Q9BY49 B2RE42 Q53TC4 Q6IAK9 Q9NRD4 Q9NY60 Q9P1A4,Peroxisomal trans-2-enoyl-CoA reductase {ECO:0000305},2,4-dienoyl-CoA reductase-related protein;HPDHase;Short chain dehydrogenase/reductase family 29C member 1;pVI-ARL;, , GO:0005829;GO:0005739;GO:0005778;GO:0005777;GO:0005102;GO:0019166;GO:0001561;GO:0006633;GO:0033306;GO:0008104;, C:cytosol; C:mitochondrion; C:peroxisomal membrane; C:peroxisome;, F:signaling receptor binding; F:trans-2-enoyl-CoA reductase (NADPH) activity;, P:fatty acid alpha-oxidation; P:fatty acid biosynthetic process; P:phytol metabolic process; P:protein localization; scaffold32 indexed_genome mRNA 23665770 23668680 . + . ID=transcript_6949;Q96HH4 B2R8W6,Transmembrane protein 169,, PF15052;, GO:0016021;, C:integral component of membrane; scaffold32 indexed_genome mRNA 23676164 23757385 . + . ID=transcript_6950;P13010 A8K3X5 Q0Z7V0 Q4VBQ5 Q53HH7 Q7M4N0 Q9UCQ0 Q9UCQ1,X-ray repair cross-complementing protein 5,86 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 2;ATP-dependent DNA helicase II 80 kDa subunit;CTC box-binding factor 85 kDa subunit;DNA repair protein XRCC5;Ku80;Ku86;Lupus Ku autoantigen protein p86;Nuclear factor IV;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining);, PF02735;PF03730;PF03731;PF08785;, GO:0000781;GO:0005829;GO:0005576;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032993;GO:1990904;GO:0034774;GO:0090734;GO:0032040;GO:0005524;GO:0003684;GO:0003677;GO:0045027;GO:0003678;GO:0008094;GO:0003690;GO:0008047;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0034511;GO:0031625;GO:0002218;GO:0007420;GO:0008283;GO:0071475;GO:0006974;GO:0071398;GO:0071480;GO:1990830;GO:0071481;GO:0006310;GO:0006302;GO:0006303;GO:0075713;GO:0060218;GO:0045087;GO:1904430;GO:0045892;GO:0043312;GO:0043085;GO:0050769;GO:0045860;GO:0051973;GO:0032212;GO:0032481;GO:0070198;GO:0048660;GO:0032204;GO:0042493;GO:0034462;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:secretory granule lumen; C:site of DNA damage; C:small-subunit processome;, F:ATP binding; F:damaged DNA binding; F:DNA binding; F:DNA end binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:U3 snoRNA binding; F:ubiquitin protein ligase binding;, P:activation of innate immune response; P:brain development; P:cell population proliferation; P:cellular hyperosmotic salinity response; P:cellular response to DNA damage stimulus; P:cellular response to fatty acid; P:cellular response to gamma radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to X-ray; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:hematopoietic stem cell differentiation; P:innate immune response; P:negative regulation of t-circle formation; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of catalytic activity; P:positive regulation of neurogenesis; P:positive regulation of protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of type I interferon production; P:protein localization to chromosome, telomeric region; P:regulation of smooth muscle cell proliferation; P:regulation of telomere maintenance; P:response to drug; P:small-subunit processome assembly; P:telomere maintenance;|P13010 A8K3X5 Q0Z7V0 Q4VBQ5 Q53HH7 Q7M4N0 Q9UCQ0 Q9UCQ1,X-ray repair cross-complementing protein 5,86 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 2;ATP-dependent DNA helicase II 80 kDa subunit;CTC box-binding factor 85 kDa subunit;DNA repair protein XRCC5;Ku80;Ku86;Lupus Ku autoantigen protein p86;Nuclear factor IV;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining);, PF02735;PF03730;PF03731;PF08785;, GO:0000781;GO:0005829;GO:0005576;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032993;GO:1990904;GO:0034774;GO:0090734;GO:0032040;GO:0005524;GO:0003684;GO:0003677;GO:0045027;GO:0003678;GO:0008094;GO:0003690;GO:0008047;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0034511;GO:0031625;GO:0002218;GO:0007420;GO:0008283;GO:0071475;GO:0006974;GO:0071398;GO:0071480;GO:1990830;GO:0071481;GO:0006310;GO:0006302;GO:0006303;GO:0075713;GO:0060218;GO:0045087;GO:1904430;GO:0045892;GO:0043312;GO:0043085;GO:0050769;GO:0045860;GO:0051973;GO:0032212;GO:0032481;GO:0070198;GO:0048660;GO:0032204;GO:0042493;GO:0034462;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:secretory granule lumen; C:site of DNA damage; C:small-subunit processome;, F:ATP binding; F:damaged DNA binding; F:DNA binding; F:DNA end binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:U3 snoRNA binding; F:ubiquitin protein ligase binding;, P:activation of innate immune response; P:brain development; P:cell population proliferation; P:cellular hyperosmotic salinity response; P:cellular response to DNA damage stimulus; P:cellular response to fatty acid; P:cellular response to gamma radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to X-ray; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:hematopoietic stem cell differentiation; P:innate immune response; P:negative regulation of t-circle formation; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of catalytic activity; P:positive regulation of neurogenesis; P:positive regulation of protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of type I interferon production; P:protein localization to chromosome, telomeric region; P:regulation of smooth muscle cell proliferation; P:regulation of telomere maintenance; P:response to drug; P:small-subunit processome assembly; P:telomere maintenance;|P13010 A8K3X5 Q0Z7V0 Q4VBQ5 Q53HH7 Q7M4N0 Q9UCQ0 Q9UCQ1,X-ray repair cross-complementing protein 5,86 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 2;ATP-dependent DNA helicase II 80 kDa subunit;CTC box-binding factor 85 kDa subunit;DNA repair protein XRCC5;Ku80;Ku86;Lupus Ku autoantigen protein p86;Nuclear factor IV;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining);, PF02735;PF03730;PF03731;PF08785;, GO:0000781;GO:0005829;GO:0005576;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032993;GO:1990904;GO:0034774;GO:0090734;GO:0032040;GO:0005524;GO:0003684;GO:0003677;GO:0045027;GO:0003678;GO:0008094;GO:0003690;GO:0008047;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0034511;GO:0031625;GO:0002218;GO:0007420;GO:0008283;GO:0071475;GO:0006974;GO:0071398;GO:0071480;GO:1990830;GO:0071481;GO:0006310;GO:0006302;GO:0006303;GO:0075713;GO:0060218;GO:0045087;GO:1904430;GO:0045892;GO:0043312;GO:0043085;GO:0050769;GO:0045860;GO:0051973;GO:0032212;GO:0032481;GO:0070198;GO:0048660;GO:0032204;GO:0042493;GO:0034462;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:secretory granule lumen; C:site of DNA damage; C:small-subunit processome;, F:ATP binding; F:damaged DNA binding; F:DNA binding; F:DNA end binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:U3 snoRNA binding; F:ubiquitin protein ligase binding;, P:activation of innate immune response; P:brain development; P:cell population proliferation; P:cellular hyperosmotic salinity response; P:cellular response to DNA damage stimulus; P:cellular response to fatty acid; P:cellular response to gamma radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to X-ray; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:hematopoietic stem cell differentiation; P:innate immune response; P:negative regulation of t-circle formation; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of catalytic activity; P:positive regulation of neurogenesis; P:positive regulation of protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of type I interferon production; P:protein localization to chromosome, telomeric region; P:regulation of smooth muscle cell proliferation; P:regulation of telomere maintenance; P:response to drug; P:small-subunit processome assembly; P:telomere maintenance;|P13010 A8K3X5 Q0Z7V0 Q4VBQ5 Q53HH7 Q7M4N0 Q9UCQ0 Q9UCQ1,X-ray repair cross-complementing protein 5,86 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 2;ATP-dependent DNA helicase II 80 kDa subunit;CTC box-binding factor 85 kDa subunit;DNA repair protein XRCC5;Ku80;Ku86;Lupus Ku autoantigen protein p86;Nuclear factor IV;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining);, PF02735;PF03730;PF03731;PF08785;, GO:0000781;GO:0005829;GO:0005576;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032993;GO:1990904;GO:0034774;GO:0090734;GO:0032040;GO:0005524;GO:0003684;GO:0003677;GO:0045027;GO:0003678;GO:0008094;GO:0003690;GO:0008047;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0034511;GO:0031625;GO:0002218;GO:0007420;GO:0008283;GO:0071475;GO:0006974;GO:0071398;GO:0071480;GO:1990830;GO:0071481;GO:0006310;GO:0006302;GO:0006303;GO:0075713;GO:0060218;GO:0045087;GO:1904430;GO:0045892;GO:0043312;GO:0043085;GO:0050769;GO:0045860;GO:0051973;GO:0032212;GO:0032481;GO:0070198;GO:0048660;GO:0032204;GO:0042493;GO:0034462;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:secretory granule lumen; C:site of DNA damage; C:small-subunit processome;, F:ATP binding; F:damaged DNA binding; F:DNA binding; F:DNA end binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:U3 snoRNA binding; F:ubiquitin protein ligase binding;, P:activation of innate immune response; P:brain development; P:cell population proliferation; P:cellular hyperosmotic salinity response; P:cellular response to DNA damage stimulus; P:cellular response to fatty acid; P:cellular response to gamma radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to X-ray; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:hematopoietic stem cell differentiation; P:innate immune response; P:negative regulation of t-circle formation; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of catalytic activity; P:positive regulation of neurogenesis; P:positive regulation of protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of type I interferon production; P:protein localization to chromosome, telomeric region; P:regulation of smooth muscle cell proliferation; P:regulation of telomere maintenance; P:response to drug; P:small-subunit processome assembly; P:telomere maintenance;|P13010 A8K3X5 Q0Z7V0 Q4VBQ5 Q53HH7 Q7M4N0 Q9UCQ0 Q9UCQ1,X-ray repair cross-complementing protein 5,86 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 2;ATP-dependent DNA helicase II 80 kDa subunit;CTC box-binding factor 85 kDa subunit;DNA repair protein XRCC5;Ku80;Ku86;Lupus Ku autoantigen protein p86;Nuclear factor IV;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining);, PF02735;PF03730;PF03731;PF08785;, GO:0000781;GO:0005829;GO:0005576;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032993;GO:1990904;GO:0034774;GO:0090734;GO:0032040;GO:0005524;GO:0003684;GO:0003677;GO:0045027;GO:0003678;GO:0008094;GO:0003690;GO:0008047;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0034511;GO:0031625;GO:0002218;GO:0007420;GO:0008283;GO:0071475;GO:0006974;GO:0071398;GO:0071480;GO:1990830;GO:0071481;GO:0006310;GO:0006302;GO:0006303;GO:0075713;GO:0060218;GO:0045087;GO:1904430;GO:0045892;GO:0043312;GO:0043085;GO:0050769;GO:0045860;GO:0051973;GO:0032212;GO:0032481;GO:0070198;GO:0048660;GO:0032204;GO:0042493;GO:0034462;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:secretory granule lumen; C:site of DNA damage; C:small-subunit processome;, F:ATP binding; F:damaged DNA binding; F:DNA binding; F:DNA end binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:U3 snoRNA binding; F:ubiquitin protein ligase binding;, P:activation of innate immune response; P:brain development; P:cell population proliferation; P:cellular hyperosmotic salinity response; P:cellular response to DNA damage stimulus; P:cellular response to fatty acid; P:cellular response to gamma radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to X-ray; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:hematopoietic stem cell differentiation; P:innate immune response; P:negative regulation of t-circle formation; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of catalytic activity; P:positive regulation of neurogenesis; P:positive regulation of protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of type I interferon production; P:protein localization to chromosome, telomeric region; P:regulation of smooth muscle cell proliferation; P:regulation of telomere maintenance; P:response to drug; P:small-subunit processome assembly; P:telomere maintenance;|P13010 A8K3X5 Q0Z7V0 Q4VBQ5 Q53HH7 Q7M4N0 Q9UCQ0 Q9UCQ1,X-ray repair cross-complementing protein 5,86 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 2;ATP-dependent DNA helicase II 80 kDa subunit;CTC box-binding factor 85 kDa subunit;DNA repair protein XRCC5;Ku80;Ku86;Lupus Ku autoantigen protein p86;Nuclear factor IV;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining);, PF02735;PF03730;PF03731;PF08785;, GO:0000781;GO:0005829;GO:0005576;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032993;GO:1990904;GO:0034774;GO:0090734;GO:0032040;GO:0005524;GO:0003684;GO:0003677;GO:0045027;GO:0003678;GO:0008094;GO:0003690;GO:0008047;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0034511;GO:0031625;GO:0002218;GO:0007420;GO:0008283;GO:0071475;GO:0006974;GO:0071398;GO:0071480;GO:1990830;GO:0071481;GO:0006310;GO:0006302;GO:0006303;GO:0075713;GO:0060218;GO:0045087;GO:1904430;GO:0045892;GO:0043312;GO:0043085;GO:0050769;GO:0045860;GO:0051973;GO:0032212;GO:0032481;GO:0070198;GO:0048660;GO:0032204;GO:0042493;GO:0034462;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:secretory granule lumen; C:site of DNA damage; C:small-subunit processome;, F:ATP binding; F:damaged DNA binding; F:DNA binding; F:DNA end binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:U3 snoRNA binding; F:ubiquitin protein ligase binding;, P:activation of innate immune response; P:brain development; P:cell population proliferation; P:cellular hyperosmotic salinity response; P:cellular response to DNA damage stimulus; P:cellular response to fatty acid; P:cellular response to gamma radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to X-ray; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:hematopoietic stem cell differentiation; P:innate immune response; P:negative regulation of t-circle formation; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of catalytic activity; P:positive regulation of neurogenesis; P:positive regulation of protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of type I interferon production; P:protein localization to chromosome, telomeric region; P:regulation of smooth muscle cell proliferation; P:regulation of telomere maintenance; P:response to drug; P:small-subunit processome assembly; P:telomere maintenance;|P13010 A8K3X5 Q0Z7V0 Q4VBQ5 Q53HH7 Q7M4N0 Q9UCQ0 Q9UCQ1,X-ray repair cross-complementing protein 5,86 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 2;ATP-dependent DNA helicase II 80 kDa subunit;CTC box-binding factor 85 kDa subunit;DNA repair protein XRCC5;Ku80;Ku86;Lupus Ku autoantigen protein p86;Nuclear factor IV;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining);, PF02735;PF03730;PF03731;PF08785;, GO:0000781;GO:0005829;GO:0005576;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032993;GO:1990904;GO:0034774;GO:0090734;GO:0032040;GO:0005524;GO:0003684;GO:0003677;GO:0045027;GO:0003678;GO:0008094;GO:0003690;GO:0008047;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0034511;GO:0031625;GO:0002218;GO:0007420;GO:0008283;GO:0071475;GO:0006974;GO:0071398;GO:0071480;GO:1990830;GO:0071481;GO:0006310;GO:0006302;GO:0006303;GO:0075713;GO:0060218;GO:0045087;GO:1904430;GO:0045892;GO:0043312;GO:0043085;GO:0050769;GO:0045860;GO:0051973;GO:0032212;GO:0032481;GO:0070198;GO:0048660;GO:0032204;GO:0042493;GO:0034462;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:secretory granule lumen; C:site of DNA damage; C:small-subunit processome;, F:ATP binding; F:damaged DNA binding; F:DNA binding; F:DNA end binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:U3 snoRNA binding; F:ubiquitin protein ligase binding;, P:activation of innate immune response; P:brain development; P:cell population proliferation; P:cellular hyperosmotic salinity response; P:cellular response to DNA damage stimulus; P:cellular response to fatty acid; P:cellular response to gamma radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to X-ray; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:hematopoietic stem cell differentiation; P:innate immune response; P:negative regulation of t-circle formation; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of catalytic activity; P:positive regulation of neurogenesis; P:positive regulation of protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of type I interferon production; P:protein localization to chromosome, telomeric region; P:regulation of smooth muscle cell proliferation; P:regulation of telomere maintenance; P:response to drug; P:small-subunit processome assembly; P:telomere maintenance;|P13010 A8K3X5 Q0Z7V0 Q4VBQ5 Q53HH7 Q7M4N0 Q9UCQ0 Q9UCQ1,X-ray repair cross-complementing protein 5,86 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 2;ATP-dependent DNA helicase II 80 kDa subunit;CTC box-binding factor 85 kDa subunit;DNA repair protein XRCC5;Ku80;Ku86;Lupus Ku autoantigen protein p86;Nuclear factor IV;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining);, PF02735;PF03730;PF03731;PF08785;, GO:0000781;GO:0005829;GO:0005576;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032993;GO:1990904;GO:0034774;GO:0090734;GO:0032040;GO:0005524;GO:0003684;GO:0003677;GO:0045027;GO:0003678;GO:0008094;GO:0003690;GO:0008047;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0034511;GO:0031625;GO:0002218;GO:0007420;GO:0008283;GO:0071475;GO:0006974;GO:0071398;GO:0071480;GO:1990830;GO:0071481;GO:0006310;GO:0006302;GO:0006303;GO:0075713;GO:0060218;GO:0045087;GO:1904430;GO:0045892;GO:0043312;GO:0043085;GO:0050769;GO:0045860;GO:0051973;GO:0032212;GO:0032481;GO:0070198;GO:0048660;GO:0032204;GO:0042493;GO:0034462;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:secretory granule lumen; C:site of DNA damage; C:small-subunit processome;, F:ATP binding; F:damaged DNA binding; F:DNA binding; F:DNA end binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:U3 snoRNA binding; F:ubiquitin protein ligase binding;, P:activation of innate immune response; P:brain development; P:cell population proliferation; P:cellular hyperosmotic salinity response; P:cellular response to DNA damage stimulus; P:cellular response to fatty acid; P:cellular response to gamma radiation; P:cellular response to leukemia inhibitory factor; P:cellular response to X-ray; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:hematopoietic stem cell differentiation; P:innate immune response; P:negative regulation of t-circle formation; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of catalytic activity; P:positive regulation of neurogenesis; P:positive regulation of protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of type I interferon production; P:protein localization to chromosome, telomeric region; P:regulation of smooth muscle cell proliferation; P:regulation of telomere maintenance; P:response to drug; P:small-subunit processome assembly; P:telomere maintenance; scaffold32 indexed_genome mRNA 23799307 23819125 . - . ID=transcript_6951;Q9P2E8 Q4KMN7 Q86WR8,E3 ubiquitin-protein ligase MARCHF4,Membrane-associated RING finger protein 4;Membrane-associated RING-CH protein IV;RING finger protein 174;RING-type E3 ubiquitin transferase MARCHF4 {ECO:0000305};, PF12906;, GO:0000139;GO:0005795;GO:0016021;GO:0005802;GO:0004842;GO:0008270;, C:Golgi membrane; C:Golgi stack; C:integral component of membrane; C:trans-Golgi network;, F:ubiquitin-protein transferase activity; F:zinc ion binding; scaffold32 indexed_genome mRNA 23964263 24014784 . + . ID=transcript_6952;Q9NZC9 A6NEH0 Q53R00 Q96AY1 Q9NXQ5 Q9UFH3 Q9UI93,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1,HepA-related protein;Sucrose nonfermenting protein 2-like 1;, PF07443;PF00271;PF00176;, GO:0043596;GO:0005654;GO:0005634;GO:0035861;GO:0036310;GO:0005524;GO:0008094;GO:0004386;GO:0070615;GO:0006974;GO:0006259;GO:0006281;GO:0006303;GO:0006357;GO:0031297;GO:0048478;GO:0090656;, C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:annealing helicase activity; F:ATP binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA metabolic process; P:DNA repair; P:double-strand break repair via nonhomologous end joining; P:regulation of transcription by RNA polymerase II; P:replication fork processing; P:replication fork protection; P:t-circle formation;|Q9NZC9 A6NEH0 Q53R00 Q96AY1 Q9NXQ5 Q9UFH3 Q9UI93,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1,HepA-related protein;Sucrose nonfermenting protein 2-like 1;, PF07443;PF00271;PF00176;, GO:0043596;GO:0005654;GO:0005634;GO:0035861;GO:0036310;GO:0005524;GO:0008094;GO:0004386;GO:0070615;GO:0006974;GO:0006259;GO:0006281;GO:0006303;GO:0006357;GO:0031297;GO:0048478;GO:0090656;, C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:annealing helicase activity; F:ATP binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA metabolic process; P:DNA repair; P:double-strand break repair via nonhomologous end joining; P:regulation of transcription by RNA polymerase II; P:replication fork processing; P:replication fork protection; P:t-circle formation;|Q9NZC9 A6NEH0 Q53R00 Q96AY1 Q9NXQ5 Q9UFH3 Q9UI93,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1,HepA-related protein;Sucrose nonfermenting protein 2-like 1;, PF07443;PF00271;PF00176;, GO:0043596;GO:0005654;GO:0005634;GO:0035861;GO:0036310;GO:0005524;GO:0008094;GO:0004386;GO:0070615;GO:0006974;GO:0006259;GO:0006281;GO:0006303;GO:0006357;GO:0031297;GO:0048478;GO:0090656;, C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:annealing helicase activity; F:ATP binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA metabolic process; P:DNA repair; P:double-strand break repair via nonhomologous end joining; P:regulation of transcription by RNA polymerase II; P:replication fork processing; P:replication fork protection; P:t-circle formation;|Q9NZC9 A6NEH0 Q53R00 Q96AY1 Q9NXQ5 Q9UFH3 Q9UI93,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1,HepA-related protein;Sucrose nonfermenting protein 2-like 1;, PF07443;PF00271;PF00176;, GO:0043596;GO:0005654;GO:0005634;GO:0035861;GO:0036310;GO:0005524;GO:0008094;GO:0004386;GO:0070615;GO:0006974;GO:0006259;GO:0006281;GO:0006303;GO:0006357;GO:0031297;GO:0048478;GO:0090656;, C:nuclear replication fork; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:annealing helicase activity; F:ATP binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA metabolic process; P:DNA repair; P:double-strand break repair via nonhomologous end joining; P:regulation of transcription by RNA polymerase II; P:replication fork processing; P:replication fork protection; P:t-circle formation; scaffold32 indexed_genome mRNA 24027223 24034976 . + . ID=transcript_6953;P61513 P12751 Q6FGF5,60S ribosomal protein L37a,Large ribosomal subunit protein eL43 {ECO:0000303|PubMed:24524803};, PF01780;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0005634;GO:0046872;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:nucleus;, F:metal ion binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P61513 P12751 Q6FGF5,60S ribosomal protein L37a,Large ribosomal subunit protein eL43 {ECO:0000303|PubMed:24524803};, PF01780;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0005634;GO:0046872;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:nucleus;, F:metal ion binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold32 indexed_genome mRNA 24190282 24191058 . + . ID=transcript_6954;P18065 Q14619 Q9UCL3,Insulin-like growth factor-binding protein 2,, PF00219;PF00086;, GO:0016324;GO:0031410;GO:0070062;GO:0005576;GO:0005615;GO:0031994;GO:0031995;GO:0005102;GO:0007568;GO:0044267;GO:0032870;GO:0007565;GO:0090090;GO:0042104;GO:0040008;GO:0043567;GO:0042493;GO:0032355;GO:0043627;GO:0051384;GO:0010226;GO:0009612;GO:0007584;GO:0032526;GO:0007165;, C:apical plasma membrane; C:cytoplasmic vesicle; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:signaling receptor binding;, P:aging; P:cellular protein metabolic process; P:cellular response to hormone stimulus; P:female pregnancy; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of activated T cell proliferation; P:regulation of growth; P:regulation of insulin-like growth factor receptor signaling pathway; P:response to drug; P:response to estradiol; P:response to estrogen; P:response to glucocorticoid; P:response to lithium ion; P:response to mechanical stimulus; P:response to nutrient; P:response to retinoic acid; P:signal transduction; scaffold32 indexed_genome mRNA 24192537 24194668 . - . ID=transcript_6955;P18065 Q14619 Q9UCL3,Insulin-like growth factor-binding protein 2,, PF00219;PF00086;, GO:0016324;GO:0031410;GO:0070062;GO:0005576;GO:0005615;GO:0031994;GO:0031995;GO:0005102;GO:0007568;GO:0044267;GO:0032870;GO:0007565;GO:0090090;GO:0042104;GO:0040008;GO:0043567;GO:0042493;GO:0032355;GO:0043627;GO:0051384;GO:0010226;GO:0009612;GO:0007584;GO:0032526;GO:0007165;, C:apical plasma membrane; C:cytoplasmic vesicle; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:signaling receptor binding;, P:aging; P:cellular protein metabolic process; P:cellular response to hormone stimulus; P:female pregnancy; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of activated T cell proliferation; P:regulation of growth; P:regulation of insulin-like growth factor receptor signaling pathway; P:response to drug; P:response to estradiol; P:response to estrogen; P:response to glucocorticoid; P:response to lithium ion; P:response to mechanical stimulus; P:response to nutrient; P:response to retinoic acid; P:signal transduction; scaffold32 indexed_genome mRNA 24202121 24224497 . - . ID=transcript_6956;P24593 Q5U0A3,Insulin-like growth factor-binding protein 5,, PF00219;PF00086;, GO:0005788;GO:0005576;GO:0005615;GO:0016942;GO:0042567;GO:0001968;GO:0031994;GO:0031995;GO:0007568;GO:0044267;GO:0071320;GO:0071407;GO:0007565;GO:0042593;GO:0031069;GO:0035556;GO:0048286;GO:0060056;GO:0030336;GO:0045926;GO:0043569;GO:1901862;GO:0045668;GO:1904205;GO:0014912;GO:0048662;GO:0017148;GO:0001649;GO:0043568;GO:0051897;GO:1904754;GO:1904707;GO:0043687;GO:0001558;GO:0043567;GO:0060416;GO:0007165;GO:0051146;GO:0044342;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:insulin-like growth factor binding protein complex; C:insulin-like growth factor ternary complex;, F:fibronectin binding; F:insulin-like growth factor I binding; F:insulin-like growth factor II binding;, P:aging; P:cellular protein metabolic process; P:cellular response to cAMP; P:cellular response to organic cyclic compound; P:female pregnancy; P:glucose homeostasis; P:hair follicle morphogenesis; P:intracellular signal transduction; P:lung alveolus development; P:mammary gland involution; P:negative regulation of cell migration; P:negative regulation of growth; P:negative regulation of insulin-like growth factor receptor signaling pathway; P:negative regulation of muscle tissue development; P:negative regulation of osteoblast differentiation; P:negative regulation of skeletal muscle hypertrophy; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of translation; P:osteoblast differentiation; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of protein kinase B signaling; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:post-translational protein modification; P:regulation of cell growth; P:regulation of insulin-like growth factor receptor signaling pathway; P:response to growth hormone; P:signal transduction; P:striated muscle cell differentiation; P:type B pancreatic cell proliferation; scaffold32 indexed_genome mRNA 25359329 25382218 . - . ID=transcript_6957;Q9HBL0 Q4ZG71 Q6IPI5,Tensin-1,, PF08416;PF10409;PF00017;, GO:0009986;GO:0005737;GO:0005856;GO:0005925;GO:0003779;GO:0003723;, C:cell surface; C:cytoplasm; C:cytoskeleton; C:focal adhesion;, F:actin binding; F:RNA binding;|Q9HBL0 Q4ZG71 Q6IPI5,Tensin-1,, PF08416;PF10409;PF00017;, GO:0009986;GO:0005737;GO:0005856;GO:0005925;GO:0003779;GO:0003723;, C:cell surface; C:cytoplasm; C:cytoskeleton; C:focal adhesion;, F:actin binding; F:RNA binding;|Q9HBL0 Q4ZG71 Q6IPI5,Tensin-1,, PF08416;PF10409;PF00017;, GO:0009986;GO:0005737;GO:0005856;GO:0005925;GO:0003779;GO:0003723;, C:cell surface; C:cytoplasm; C:cytoskeleton; C:focal adhesion;, F:actin binding; F:RNA binding;|Q9HBL0 Q4ZG71 Q6IPI5,Tensin-1,, PF08416;PF10409;PF00017;, GO:0009986;GO:0005737;GO:0005856;GO:0005925;GO:0003779;GO:0003723;, C:cell surface; C:cytoplasm; C:cytoskeleton; C:focal adhesion;, F:actin binding; F:RNA binding;|Q9HBL0 Q4ZG71 Q6IPI5,Tensin-1,, PF08416;PF10409;PF00017;, GO:0009986;GO:0005737;GO:0005856;GO:0005925;GO:0003779;GO:0003723;, C:cell surface; C:cytoplasm; C:cytoskeleton; C:focal adhesion;, F:actin binding; F:RNA binding; scaffold32 indexed_genome mRNA 25387898 25464283 . - . ID=transcript_6958;Q9HBL0 Q4ZG71 Q6IPI5,Tensin-1,, PF08416;PF10409;PF00017;, GO:0009986;GO:0005737;GO:0005856;GO:0005925;GO:0003779;GO:0003723;, C:cell surface; C:cytoplasm; C:cytoskeleton; C:focal adhesion;, F:actin binding; F:RNA binding;|Q9HBL0 Q4ZG71 Q6IPI5,Tensin-1,, PF08416;PF10409;PF00017;, GO:0009986;GO:0005737;GO:0005856;GO:0005925;GO:0003779;GO:0003723;, C:cell surface; C:cytoplasm; C:cytoskeleton; C:focal adhesion;, F:actin binding; F:RNA binding; scaffold32 indexed_genome mRNA 25608668 25614950 . + . ID=transcript_6959;Q6ZNE9 Q6ZR96,RUN and FYVE domain-containing protein 4,, PF02759;, GO:0005776;GO:0031410;GO:0046872;GO:0032266;GO:0000045;GO:0071353;GO:0016239;, C:autophagosome; C:cytoplasmic vesicle;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:cellular response to interleukin-4; P:positive regulation of macroautophagy;|Q6ZNE9 Q6ZR96,RUN and FYVE domain-containing protein 4,, PF02759;, GO:0005776;GO:0031410;GO:0046872;GO:0032266;GO:0000045;GO:0071353;GO:0016239;, C:autophagosome; C:cytoplasmic vesicle;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:cellular response to interleukin-4; P:positive regulation of macroautophagy; scaffold32 indexed_genome mRNA 25615371 25628618 . + . ID=transcript_6960;Q6ZNE9 Q6ZR96,RUN and FYVE domain-containing protein 4,, PF02759;, GO:0005776;GO:0031410;GO:0046872;GO:0032266;GO:0000045;GO:0071353;GO:0016239;, C:autophagosome; C:cytoplasmic vesicle;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:cellular response to interleukin-4; P:positive regulation of macroautophagy; scaffold32 indexed_genome mRNA 25708621 25709719 . + . ID=transcript_6961;O15144 Q92801 Q9P1D4,Actin-related protein 2/3 complex subunit 2,Arp2/3 complex 34 kDa subunit;, PF04045;, GO:0015629;GO:0005885;GO:0005829;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0030027;GO:0036195;GO:0043005;GO:0005654;GO:0005634;GO:0035861;GO:0003779;GO:0005200;GO:0030041;GO:0070358;GO:0034314;GO:0048013;GO:0038096;GO:0061024;GO:0010592;GO:1900026;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:lamellipodium; C:muscle cell projection membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin filament polymerization; P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of substrate adhesion-dependent cell spreading; scaffold32 indexed_genome mRNA 25717146 25719582 . + . ID=transcript_6962;O15144 Q92801 Q9P1D4,Actin-related protein 2/3 complex subunit 2,Arp2/3 complex 34 kDa subunit;, PF04045;, GO:0015629;GO:0005885;GO:0005829;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0030027;GO:0036195;GO:0043005;GO:0005654;GO:0005634;GO:0035861;GO:0003779;GO:0005200;GO:0030041;GO:0070358;GO:0034314;GO:0048013;GO:0038096;GO:0061024;GO:0010592;GO:1900026;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:lamellipodium; C:muscle cell projection membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin filament polymerization; P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of substrate adhesion-dependent cell spreading; scaffold32 indexed_genome mRNA 25722146 25725096 . + . ID=transcript_6963;O15144 Q92801 Q9P1D4,Actin-related protein 2/3 complex subunit 2,Arp2/3 complex 34 kDa subunit;, PF04045;, GO:0015629;GO:0005885;GO:0005829;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0030027;GO:0036195;GO:0043005;GO:0005654;GO:0005634;GO:0035861;GO:0003779;GO:0005200;GO:0030041;GO:0070358;GO:0034314;GO:0048013;GO:0038096;GO:0061024;GO:0010592;GO:1900026;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:lamellipodium; C:muscle cell projection membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin filament polymerization; P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of substrate adhesion-dependent cell spreading; scaffold32 indexed_genome mRNA 25725108 25736531 . + . ID=transcript_6964;O15144 Q92801 Q9P1D4,Actin-related protein 2/3 complex subunit 2,Arp2/3 complex 34 kDa subunit;, PF04045;, GO:0015629;GO:0005885;GO:0005829;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0030027;GO:0036195;GO:0043005;GO:0005654;GO:0005634;GO:0035861;GO:0003779;GO:0005200;GO:0030041;GO:0070358;GO:0034314;GO:0048013;GO:0038096;GO:0061024;GO:0010592;GO:1900026;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:lamellipodium; C:muscle cell projection membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin filament polymerization; P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of substrate adhesion-dependent cell spreading;|O15144 Q92801 Q9P1D4,Actin-related protein 2/3 complex subunit 2,Arp2/3 complex 34 kDa subunit;, PF04045;, GO:0015629;GO:0005885;GO:0005829;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0030027;GO:0036195;GO:0043005;GO:0005654;GO:0005634;GO:0035861;GO:0003779;GO:0005200;GO:0030041;GO:0070358;GO:0034314;GO:0048013;GO:0038096;GO:0061024;GO:0010592;GO:1900026;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:lamellipodium; C:muscle cell projection membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin filament polymerization; P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of substrate adhesion-dependent cell spreading;|O15144 Q92801 Q9P1D4,Actin-related protein 2/3 complex subunit 2,Arp2/3 complex 34 kDa subunit;, PF04045;, GO:0015629;GO:0005885;GO:0005829;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0030027;GO:0036195;GO:0043005;GO:0005654;GO:0005634;GO:0035861;GO:0003779;GO:0005200;GO:0030041;GO:0070358;GO:0034314;GO:0048013;GO:0038096;GO:0061024;GO:0010592;GO:1900026;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:lamellipodium; C:muscle cell projection membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin filament polymerization; P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of substrate adhesion-dependent cell spreading;|O15144 Q92801 Q9P1D4,Actin-related protein 2/3 complex subunit 2,Arp2/3 complex 34 kDa subunit;, PF04045;, GO:0015629;GO:0005885;GO:0005829;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0030027;GO:0036195;GO:0043005;GO:0005654;GO:0005634;GO:0035861;GO:0003779;GO:0005200;GO:0030041;GO:0070358;GO:0034314;GO:0048013;GO:0038096;GO:0061024;GO:0010592;GO:1900026;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:lamellipodium; C:muscle cell projection membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin filament polymerization; P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of substrate adhesion-dependent cell spreading; scaffold32 indexed_genome mRNA 25741799 25745099 . + . ID=transcript_6965;Q8TDU6 B3KV35,G-protein coupled bile acid receptor 1,G-protein coupled receptor GPCR19;Membrane-type receptor for bile acids;hBG37;, PF00001;, GO:0005737;GO:0016021;GO:0005886;GO:0043235;GO:0038181;GO:0038182;GO:0038184;GO:1903413;GO:0007186;GO:0002862;GO:1904056;GO:0070374;GO:2000810;, C:cytoplasm; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:bile acid receptor activity; F:G protein-coupled bile acid receptor activity;, P:cell surface bile acid receptor signaling pathway; P:cellular response to bile acid; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of cholangiocyte proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:regulation of bicellular tight junction assembly; scaffold32 indexed_genome mRNA 25745461 25750409 . - . ID=transcript_6966;Q13685 Q8WUJ9 Q96H92,Angio-associated migratory cell protein,, PF00400;, GO:0009986;GO:0005829;GO:0045171;GO:0015630;GO:0005886;GO:0008201;GO:0001525;GO:0030154;GO:0007173;GO:0070423;GO:0010595;GO:0014909;GO:0048010;, C:cell surface; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:plasma membrane;, F:heparin binding;, P:angiogenesis; P:cell differentiation; P:epidermal growth factor receptor signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of endothelial cell migration; P:smooth muscle cell migration; P:vascular endothelial growth factor receptor signaling pathway;|Q13685 Q8WUJ9 Q96H92,Angio-associated migratory cell protein,, PF00400;, GO:0009986;GO:0005829;GO:0045171;GO:0015630;GO:0005886;GO:0008201;GO:0001525;GO:0030154;GO:0007173;GO:0070423;GO:0010595;GO:0014909;GO:0048010;, C:cell surface; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:plasma membrane;, F:heparin binding;, P:angiogenesis; P:cell differentiation; P:epidermal growth factor receptor signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of endothelial cell migration; P:smooth muscle cell migration; P:vascular endothelial growth factor receptor signaling pathway;|Q13685 Q8WUJ9 Q96H92,Angio-associated migratory cell protein,, PF00400;, GO:0009986;GO:0005829;GO:0045171;GO:0015630;GO:0005886;GO:0008201;GO:0001525;GO:0030154;GO:0007173;GO:0070423;GO:0010595;GO:0014909;GO:0048010;, C:cell surface; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:plasma membrane;, F:heparin binding;, P:angiogenesis; P:cell differentiation; P:epidermal growth factor receptor signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of endothelial cell migration; P:smooth muscle cell migration; P:vascular endothelial growth factor receptor signaling pathway;|Q13685 Q8WUJ9 Q96H92,Angio-associated migratory cell protein,, PF00400;, GO:0009986;GO:0005829;GO:0045171;GO:0015630;GO:0005886;GO:0008201;GO:0001525;GO:0030154;GO:0007173;GO:0070423;GO:0010595;GO:0014909;GO:0048010;, C:cell surface; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:plasma membrane;, F:heparin binding;, P:angiogenesis; P:cell differentiation; P:epidermal growth factor receptor signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of endothelial cell migration; P:smooth muscle cell migration; P:vascular endothelial growth factor receptor signaling pathway; scaffold32 indexed_genome mRNA 25750844 25753346 . + . ID=transcript_6967;Q8N490 A8K1F2 Q96A48 Q9BU26 Q9NSX4 Q9ULN6 Q9Y4T1,Probable hydrolase PNKD,Myofibrillogenesis regulator 1;Paroxysmal nonkinesiogenic dyskinesia protein;Trans-activated by hepatitis C virus core protein 2;, PF16123;PF00753;, GO:0016020;GO:0005739;GO:0005634;GO:0004416;GO:0046872;GO:0019243;GO:0046929;GO:0050884;GO:0042053;GO:0032225;, C:membrane; C:mitochondrion; C:nucleus;, F:hydroxyacylglutathione hydrolase activity; F:metal ion binding;, P:methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione; P:negative regulation of neurotransmitter secretion; P:neuromuscular process controlling posture; P:regulation of dopamine metabolic process; P:regulation of synaptic transmission, dopaminergic; scaffold32 indexed_genome mRNA 25753875 25762570 . - . ID=transcript_6968;Q969X1 B3KQY6 Q8N1R3 Q8TAM3 Q96K13,Protein lifeguard 3,Protein RECS1 homolog;Transmembrane BAX inhibitor motif-containing protein 1;, PF01027;, GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0005123;GO:0043086;GO:1902042;GO:1902045;GO:1903077;GO:0043312;GO:2000504;, C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane;, F:death receptor binding;, P:negative regulation of catalytic activity; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of Fas signaling pathway; P:negative regulation of protein localization to plasma membrane; P:neutrophil degranulation; P:positive regulation of blood vessel remodeling;|Q969X1 B3KQY6 Q8N1R3 Q8TAM3 Q96K13,Protein lifeguard 3,Protein RECS1 homolog;Transmembrane BAX inhibitor motif-containing protein 1;, PF01027;, GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0005123;GO:0043086;GO:1902042;GO:1902045;GO:1903077;GO:0043312;GO:2000504;, C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane;, F:death receptor binding;, P:negative regulation of catalytic activity; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of Fas signaling pathway; P:negative regulation of protein localization to plasma membrane; P:neutrophil degranulation; P:positive regulation of blood vessel remodeling;|Q969X1 B3KQY6 Q8N1R3 Q8TAM3 Q96K13,Protein lifeguard 3,Protein RECS1 homolog;Transmembrane BAX inhibitor motif-containing protein 1;, PF01027;, GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0005123;GO:0043086;GO:1902042;GO:1902045;GO:1903077;GO:0043312;GO:2000504;, C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane;, F:death receptor binding;, P:negative regulation of catalytic activity; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of Fas signaling pathway; P:negative regulation of protein localization to plasma membrane; P:neutrophil degranulation; P:positive regulation of blood vessel remodeling;|Q969X1 B3KQY6 Q8N1R3 Q8TAM3 Q96K13,Protein lifeguard 3,Protein RECS1 homolog;Transmembrane BAX inhibitor motif-containing protein 1;, PF01027;, GO:0010008;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0035579;GO:0005123;GO:0043086;GO:1902042;GO:1902045;GO:1903077;GO:0043312;GO:2000504;, C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane; C:specific granule membrane;, F:death receptor binding;, P:negative regulation of catalytic activity; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of Fas signaling pathway; P:negative regulation of protein localization to plasma membrane; P:neutrophil degranulation; P:positive regulation of blood vessel remodeling; scaffold32 indexed_genome mRNA 25802161 25824388 . + . ID=transcript_6969;Q8N490 A8K1F2 Q96A48 Q9BU26 Q9NSX4 Q9ULN6 Q9Y4T1,Probable hydrolase PNKD,Myofibrillogenesis regulator 1;Paroxysmal nonkinesiogenic dyskinesia protein;Trans-activated by hepatitis C virus core protein 2;, PF16123;PF00753;, GO:0016020;GO:0005739;GO:0005634;GO:0004416;GO:0046872;GO:0019243;GO:0046929;GO:0050884;GO:0042053;GO:0032225;, C:membrane; C:mitochondrion; C:nucleus;, F:hydroxyacylglutathione hydrolase activity; F:metal ion binding;, P:methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione; P:negative regulation of neurotransmitter secretion; P:neuromuscular process controlling posture; P:regulation of dopamine metabolic process; P:regulation of synaptic transmission, dopaminergic;|Q8N490 A8K1F2 Q96A48 Q9BU26 Q9NSX4 Q9ULN6 Q9Y4T1,Probable hydrolase PNKD,Myofibrillogenesis regulator 1;Paroxysmal nonkinesiogenic dyskinesia protein;Trans-activated by hepatitis C virus core protein 2;, PF16123;PF00753;, GO:0016020;GO:0005739;GO:0005634;GO:0004416;GO:0046872;GO:0019243;GO:0046929;GO:0050884;GO:0042053;GO:0032225;, C:membrane; C:mitochondrion; C:nucleus;, F:hydroxyacylglutathione hydrolase activity; F:metal ion binding;, P:methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione; P:negative regulation of neurotransmitter secretion; P:neuromuscular process controlling posture; P:regulation of dopamine metabolic process; P:regulation of synaptic transmission, dopaminergic;|Q8N490 A8K1F2 Q96A48 Q9BU26 Q9NSX4 Q9ULN6 Q9Y4T1,Probable hydrolase PNKD,Myofibrillogenesis regulator 1;Paroxysmal nonkinesiogenic dyskinesia protein;Trans-activated by hepatitis C virus core protein 2;, PF16123;PF00753;, GO:0016020;GO:0005739;GO:0005634;GO:0004416;GO:0046872;GO:0019243;GO:0046929;GO:0050884;GO:0042053;GO:0032225;, C:membrane; C:mitochondrion; C:nucleus;, F:hydroxyacylglutathione hydrolase activity; F:metal ion binding;, P:methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione; P:negative regulation of neurotransmitter secretion; P:neuromuscular process controlling posture; P:regulation of dopamine metabolic process; P:regulation of synaptic transmission, dopaminergic;|Q8N490 A8K1F2 Q96A48 Q9BU26 Q9NSX4 Q9ULN6 Q9Y4T1,Probable hydrolase PNKD,Myofibrillogenesis regulator 1;Paroxysmal nonkinesiogenic dyskinesia protein;Trans-activated by hepatitis C virus core protein 2;, PF16123;PF00753;, GO:0016020;GO:0005739;GO:0005634;GO:0004416;GO:0046872;GO:0019243;GO:0046929;GO:0050884;GO:0042053;GO:0032225;, C:membrane; C:mitochondrion; C:nucleus;, F:hydroxyacylglutathione hydrolase activity; F:metal ion binding;, P:methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione; P:negative regulation of neurotransmitter secretion; P:neuromuscular process controlling posture; P:regulation of dopamine metabolic process; P:regulation of synaptic transmission, dopaminergic; scaffold32 indexed_genome mRNA 25830147 25834792 . + . ID=transcript_6970;Q7Z7H3,Ciliogenesis-associated TTC17-interacting protein,, , GO:0015629;GO:0005737;GO:0005634;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:nucleus; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization; scaffold32 indexed_genome mRNA 25835547 25836209 . + . ID=transcript_6971;Q7Z7H3,Ciliogenesis-associated TTC17-interacting protein,, , GO:0015629;GO:0005737;GO:0005634;GO:0005886;GO:0030041;GO:0044782;, C:actin cytoskeleton; C:cytoplasm; C:nucleus; C:plasma membrane;, , P:actin filament polymerization; P:cilium organization; scaffold32 indexed_genome mRNA 25843786 25848436 . + . ID=transcript_6972;P49279 C0H5Y3,Natural resistance-associated macrophage protein 1,Solute carrier family 11 member 1;, PF01566;, GO:0101003;GO:0005887;GO:0005770;GO:0031902;GO:0005764;GO:0030670;GO:0005886;GO:0070821;GO:0015086;GO:0005381;GO:0005384;GO:0051139;GO:0042803;GO:0046915;GO:0032147;GO:0048002;GO:0019730;GO:0070574;GO:0045454;GO:0006876;GO:0006879;GO:0042742;GO:0050829;GO:0042832;GO:0006954;GO:0055072;GO:0006826;GO:1902023;GO:0042116;GO:0006828;GO:0070839;GO:0045342;GO:0048255;GO:0060586;GO:0001818;GO:0043312;GO:0015707;GO:0006909;GO:0001819;GO:0002606;GO:0010628;GO:0032729;GO:0050766;GO:0002827;GO:0045944;GO:0045730;GO:0009617;GO:0034341;GO:0032496;GO:0002309;GO:0007035;GO:0042060;, C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosome; C:phagocytic vesicle membrane; C:plasma membrane; C:tertiary granule membrane;, F:cadmium ion transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:metal ion:proton antiporter activity; F:protein homodimerization activity; F:transition metal ion transmembrane transporter activity;, P:activation of protein kinase activity; P:antigen processing and presentation of peptide antigen; P:antimicrobial humoral response; P:cadmium ion transmembrane transport; P:cell redox homeostasis; P:cellular cadmium ion homeostasis; P:cellular iron ion homeostasis; P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:defense response to protozoan; P:inflammatory response; P:iron ion homeostasis; P:iron ion transport; P:L-arginine transport; P:macrophage activation; P:manganese ion transport; P:metal ion export; P:MHC class II biosynthetic process; P:mRNA stabilization; P:multicellular organismal iron ion homeostasis; P:negative regulation of cytokine production; P:neutrophil degranulation; P:nitrite transport; P:phagocytosis; P:positive regulation of cytokine production; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of gene expression; P:positive regulation of interferon-gamma production; P:positive regulation of phagocytosis; P:positive regulation of T-helper 1 type immune response; P:positive regulation of transcription by RNA polymerase II; P:respiratory burst; P:response to bacterium; P:response to interferon-gamma; P:response to lipopolysaccharide; P:T cell proliferation involved in immune response; P:vacuolar acidification; P:wound healing;|P49279 C0H5Y3,Natural resistance-associated macrophage protein 1,Solute carrier family 11 member 1;, PF01566;, GO:0101003;GO:0005887;GO:0005770;GO:0031902;GO:0005764;GO:0030670;GO:0005886;GO:0070821;GO:0015086;GO:0005381;GO:0005384;GO:0051139;GO:0042803;GO:0046915;GO:0032147;GO:0048002;GO:0019730;GO:0070574;GO:0045454;GO:0006876;GO:0006879;GO:0042742;GO:0050829;GO:0042832;GO:0006954;GO:0055072;GO:0006826;GO:1902023;GO:0042116;GO:0006828;GO:0070839;GO:0045342;GO:0048255;GO:0060586;GO:0001818;GO:0043312;GO:0015707;GO:0006909;GO:0001819;GO:0002606;GO:0010628;GO:0032729;GO:0050766;GO:0002827;GO:0045944;GO:0045730;GO:0009617;GO:0034341;GO:0032496;GO:0002309;GO:0007035;GO:0042060;, C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosome; C:phagocytic vesicle membrane; C:plasma membrane; C:tertiary granule membrane;, F:cadmium ion transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:metal ion:proton antiporter activity; F:protein homodimerization activity; F:transition metal ion transmembrane transporter activity;, P:activation of protein kinase activity; P:antigen processing and presentation of peptide antigen; P:antimicrobial humoral response; P:cadmium ion transmembrane transport; P:cell redox homeostasis; P:cellular cadmium ion homeostasis; P:cellular iron ion homeostasis; P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:defense response to protozoan; P:inflammatory response; P:iron ion homeostasis; P:iron ion transport; P:L-arginine transport; P:macrophage activation; P:manganese ion transport; P:metal ion export; P:MHC class II biosynthetic process; P:mRNA stabilization; P:multicellular organismal iron ion homeostasis; P:negative regulation of cytokine production; P:neutrophil degranulation; P:nitrite transport; P:phagocytosis; P:positive regulation of cytokine production; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of gene expression; P:positive regulation of interferon-gamma production; P:positive regulation of phagocytosis; P:positive regulation of T-helper 1 type immune response; P:positive regulation of transcription by RNA polymerase II; P:respiratory burst; P:response to bacterium; P:response to interferon-gamma; P:response to lipopolysaccharide; P:T cell proliferation involved in immune response; P:vacuolar acidification; P:wound healing; scaffold32 indexed_genome mRNA 25849651 25850405 . - . ID=transcript_6973;P49279 C0H5Y3,Natural resistance-associated macrophage protein 1,Solute carrier family 11 member 1;, PF01566;, GO:0101003;GO:0005887;GO:0005770;GO:0031902;GO:0005764;GO:0030670;GO:0005886;GO:0070821;GO:0015086;GO:0005381;GO:0005384;GO:0051139;GO:0042803;GO:0046915;GO:0032147;GO:0048002;GO:0019730;GO:0070574;GO:0045454;GO:0006876;GO:0006879;GO:0042742;GO:0050829;GO:0042832;GO:0006954;GO:0055072;GO:0006826;GO:1902023;GO:0042116;GO:0006828;GO:0070839;GO:0045342;GO:0048255;GO:0060586;GO:0001818;GO:0043312;GO:0015707;GO:0006909;GO:0001819;GO:0002606;GO:0010628;GO:0032729;GO:0050766;GO:0002827;GO:0045944;GO:0045730;GO:0009617;GO:0034341;GO:0032496;GO:0002309;GO:0007035;GO:0042060;, C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosome; C:phagocytic vesicle membrane; C:plasma membrane; C:tertiary granule membrane;, F:cadmium ion transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:metal ion:proton antiporter activity; F:protein homodimerization activity; F:transition metal ion transmembrane transporter activity;, P:activation of protein kinase activity; P:antigen processing and presentation of peptide antigen; P:antimicrobial humoral response; P:cadmium ion transmembrane transport; P:cell redox homeostasis; P:cellular cadmium ion homeostasis; P:cellular iron ion homeostasis; P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:defense response to protozoan; P:inflammatory response; P:iron ion homeostasis; P:iron ion transport; P:L-arginine transport; P:macrophage activation; P:manganese ion transport; P:metal ion export; P:MHC class II biosynthetic process; P:mRNA stabilization; P:multicellular organismal iron ion homeostasis; P:negative regulation of cytokine production; P:neutrophil degranulation; P:nitrite transport; P:phagocytosis; P:positive regulation of cytokine production; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of gene expression; P:positive regulation of interferon-gamma production; P:positive regulation of phagocytosis; P:positive regulation of T-helper 1 type immune response; P:positive regulation of transcription by RNA polymerase II; P:respiratory burst; P:response to bacterium; P:response to interferon-gamma; P:response to lipopolysaccharide; P:T cell proliferation involved in immune response; P:vacuolar acidification; P:wound healing; scaffold32 indexed_genome mRNA 25850438 25855067 . - . ID=transcript_6974;P49279 C0H5Y3,Natural resistance-associated macrophage protein 1,Solute carrier family 11 member 1;, PF01566;, GO:0101003;GO:0005887;GO:0005770;GO:0031902;GO:0005764;GO:0030670;GO:0005886;GO:0070821;GO:0015086;GO:0005381;GO:0005384;GO:0051139;GO:0042803;GO:0046915;GO:0032147;GO:0048002;GO:0019730;GO:0070574;GO:0045454;GO:0006876;GO:0006879;GO:0042742;GO:0050829;GO:0042832;GO:0006954;GO:0055072;GO:0006826;GO:1902023;GO:0042116;GO:0006828;GO:0070839;GO:0045342;GO:0048255;GO:0060586;GO:0001818;GO:0043312;GO:0015707;GO:0006909;GO:0001819;GO:0002606;GO:0010628;GO:0032729;GO:0050766;GO:0002827;GO:0045944;GO:0045730;GO:0009617;GO:0034341;GO:0032496;GO:0002309;GO:0007035;GO:0042060;, C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosome; C:phagocytic vesicle membrane; C:plasma membrane; C:tertiary granule membrane;, F:cadmium ion transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:metal ion:proton antiporter activity; F:protein homodimerization activity; F:transition metal ion transmembrane transporter activity;, P:activation of protein kinase activity; P:antigen processing and presentation of peptide antigen; P:antimicrobial humoral response; P:cadmium ion transmembrane transport; P:cell redox homeostasis; P:cellular cadmium ion homeostasis; P:cellular iron ion homeostasis; P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:defense response to protozoan; P:inflammatory response; P:iron ion homeostasis; P:iron ion transport; P:L-arginine transport; P:macrophage activation; P:manganese ion transport; P:metal ion export; P:MHC class II biosynthetic process; P:mRNA stabilization; P:multicellular organismal iron ion homeostasis; P:negative regulation of cytokine production; P:neutrophil degranulation; P:nitrite transport; P:phagocytosis; P:positive regulation of cytokine production; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of gene expression; P:positive regulation of interferon-gamma production; P:positive regulation of phagocytosis; P:positive regulation of T-helper 1 type immune response; P:positive regulation of transcription by RNA polymerase II; P:respiratory burst; P:response to bacterium; P:response to interferon-gamma; P:response to lipopolysaccharide; P:T cell proliferation involved in immune response; P:vacuolar acidification; P:wound healing;|P49279 C0H5Y3,Natural resistance-associated macrophage protein 1,Solute carrier family 11 member 1;, PF01566;, GO:0101003;GO:0005887;GO:0005770;GO:0031902;GO:0005764;GO:0030670;GO:0005886;GO:0070821;GO:0015086;GO:0005381;GO:0005384;GO:0051139;GO:0042803;GO:0046915;GO:0032147;GO:0048002;GO:0019730;GO:0070574;GO:0045454;GO:0006876;GO:0006879;GO:0042742;GO:0050829;GO:0042832;GO:0006954;GO:0055072;GO:0006826;GO:1902023;GO:0042116;GO:0006828;GO:0070839;GO:0045342;GO:0048255;GO:0060586;GO:0001818;GO:0043312;GO:0015707;GO:0006909;GO:0001819;GO:0002606;GO:0010628;GO:0032729;GO:0050766;GO:0002827;GO:0045944;GO:0045730;GO:0009617;GO:0034341;GO:0032496;GO:0002309;GO:0007035;GO:0042060;, C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosome; C:phagocytic vesicle membrane; C:plasma membrane; C:tertiary granule membrane;, F:cadmium ion transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:metal ion:proton antiporter activity; F:protein homodimerization activity; F:transition metal ion transmembrane transporter activity;, P:activation of protein kinase activity; P:antigen processing and presentation of peptide antigen; P:antimicrobial humoral response; P:cadmium ion transmembrane transport; P:cell redox homeostasis; P:cellular cadmium ion homeostasis; P:cellular iron ion homeostasis; P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:defense response to protozoan; P:inflammatory response; P:iron ion homeostasis; P:iron ion transport; P:L-arginine transport; P:macrophage activation; P:manganese ion transport; P:metal ion export; P:MHC class II biosynthetic process; P:mRNA stabilization; P:multicellular organismal iron ion homeostasis; P:negative regulation of cytokine production; P:neutrophil degranulation; P:nitrite transport; P:phagocytosis; P:positive regulation of cytokine production; P:positive regulation of dendritic cell antigen processing and presentation; P:positive regulation of gene expression; P:positive regulation of interferon-gamma production; P:positive regulation of phagocytosis; P:positive regulation of T-helper 1 type immune response; P:positive regulation of transcription by RNA polymerase II; P:respiratory burst; P:response to bacterium; P:response to interferon-gamma; P:response to lipopolysaccharide; P:T cell proliferation involved in immune response; P:vacuolar acidification; P:wound healing; scaffold33 indexed_genome mRNA 41081 48977 . + . ID=transcript_6975;Q07002 Q5VXQ2 Q6V3A2 Q6V3A3 Q96F90,Cyclin-dependent kinase 18,Cell division protein kinase 18;PCTAIRE-motif protein kinase 3;Serine/threonine-protein kinase PCTAIRE-3;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0006468;GO:0000083;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q07002 Q5VXQ2 Q6V3A2 Q6V3A3 Q96F90,Cyclin-dependent kinase 18,Cell division protein kinase 18;PCTAIRE-motif protein kinase 3;Serine/threonine-protein kinase PCTAIRE-3;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0006468;GO:0000083;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q07002 Q5VXQ2 Q6V3A2 Q6V3A3 Q96F90,Cyclin-dependent kinase 18,Cell division protein kinase 18;PCTAIRE-motif protein kinase 3;Serine/threonine-protein kinase PCTAIRE-3;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0006468;GO:0000083;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q07002 Q5VXQ2 Q6V3A2 Q6V3A3 Q96F90,Cyclin-dependent kinase 18,Cell division protein kinase 18;PCTAIRE-motif protein kinase 3;Serine/threonine-protein kinase PCTAIRE-3;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0006468;GO:0000083;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|Q07002 Q5VXQ2 Q6V3A2 Q6V3A3 Q96F90,Cyclin-dependent kinase 18,Cell division protein kinase 18;PCTAIRE-motif protein kinase 3;Serine/threonine-protein kinase PCTAIRE-3;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0006468;GO:0000083;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; scaffold33 indexed_genome mRNA 105161 116531 . + . ID=transcript_6976;Q8N468 B7Z8X3 Q6UY25 Q8NAY0 Q8TCP4,Major facilitator superfamily domain-containing protein 4A,Major facilitator superfamily domain-containing protein 4;, PF07690;, GO:0016021;GO:0005355;, C:integral component of membrane;, F:glucose transmembrane transporter activity; scaffold33 indexed_genome mRNA 116556 129899 . + . ID=transcript_6977;Q8N468 B7Z8X3 Q6UY25 Q8NAY0 Q8TCP4,Major facilitator superfamily domain-containing protein 4A,Major facilitator superfamily domain-containing protein 4;, PF07690;, GO:0016021;GO:0005355;, C:integral component of membrane;, F:glucose transmembrane transporter activity;|Q8N468 B7Z8X3 Q6UY25 Q8NAY0 Q8TCP4,Major facilitator superfamily domain-containing protein 4A,Major facilitator superfamily domain-containing protein 4;, PF07690;, GO:0016021;GO:0005355;, C:integral component of membrane;, F:glucose transmembrane transporter activity;|Q8N468 B7Z8X3 Q6UY25 Q8NAY0 Q8TCP4,Major facilitator superfamily domain-containing protein 4A,Major facilitator superfamily domain-containing protein 4;, PF07690;, GO:0016021;GO:0005355;, C:integral component of membrane;, F:glucose transmembrane transporter activity;|Q8N468 B7Z8X3 Q6UY25 Q8NAY0 Q8TCP4,Major facilitator superfamily domain-containing protein 4A,Major facilitator superfamily domain-containing protein 4;, PF07690;, GO:0016021;GO:0005355;, C:integral component of membrane;, F:glucose transmembrane transporter activity;|Q8N468 B7Z8X3 Q6UY25 Q8NAY0 Q8TCP4,Major facilitator superfamily domain-containing protein 4A,Major facilitator superfamily domain-containing protein 4;, PF07690;, GO:0016021;GO:0005355;, C:integral component of membrane;, F:glucose transmembrane transporter activity;|Q8N468 B7Z8X3 Q6UY25 Q8NAY0 Q8TCP4,Major facilitator superfamily domain-containing protein 4A,Major facilitator superfamily domain-containing protein 4;, PF07690;, GO:0016021;GO:0005355;, C:integral component of membrane;, F:glucose transmembrane transporter activity; scaffold33 indexed_genome mRNA 143757 156622 . - . ID=transcript_6978;P28324 P28323 Q6GSJ2,ETS domain-containing protein Elk-4,Serum response factor accessory protein 1;, PF00178;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0070932;GO:0000122;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:histone H3 deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P28324 P28323 Q6GSJ2,ETS domain-containing protein Elk-4,Serum response factor accessory protein 1;, PF00178;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0070932;GO:0000122;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:histone H3 deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P28324 P28323 Q6GSJ2,ETS domain-containing protein Elk-4,Serum response factor accessory protein 1;, PF00178;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0070932;GO:0000122;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:histone H3 deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P28324 P28323 Q6GSJ2,ETS domain-containing protein Elk-4,Serum response factor accessory protein 1;, PF00178;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0070932;GO:0000122;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:histone H3 deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold33 indexed_genome mRNA 173274 191654 . - . ID=transcript_6979;Q96JT2 A8K2U9,Solute carrier family 45 member 3,Prostate cancer-associated protein 6;Prostein;, PF07690;, GO:0016021;GO:0016020;GO:0005886;GO:0008506;GO:0008645;GO:0045723;GO:0010907;GO:0048713;GO:0015770;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:sucrose:proton symporter activity;, P:hexose transmembrane transport; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glucose metabolic process; P:regulation of oligodendrocyte differentiation; P:sucrose transport; scaffold33 indexed_genome mRNA 225015 227587 . - . ID=transcript_6980;Q9H1E3 Q54AC0 Q5PXE7 Q9H1D6 Q9H723,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 {ECO:0000303|PubMed:11298763},P1;, , GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0003697;GO:0003713;GO:0008134;GO:0001678;GO:0071481;GO:0006325;GO:0000724;GO:0035822;GO:0036297;GO:1990968;GO:1990969;GO:0044829;GO:0043923;GO:0046628;GO:0045944;GO:0006275;GO:0060382;GO:0046626;GO:0006357;GO:0019046;GO:0031297;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:single-stranded DNA binding; F:transcription coactivator activity; F:transcription factor binding;, P:cellular glucose homeostasis; P:cellular response to X-ray; P:chromatin organization; P:double-strand break repair via homologous recombination; P:gene conversion; P:interstrand cross-link repair; P:modulation by host of RNA binding by virus; P:modulation by host of viral RNA-binding transcription factor activity; P:positive regulation by host of viral genome replication; P:positive regulation by host of viral transcription; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA replication; P:regulation of DNA strand elongation; P:regulation of insulin receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:release from viral latency; P:replication fork processing; scaffold33 indexed_genome mRNA 282676 287870 . - . ID=transcript_6981;O14966 B4E1K3 C9JE77,Ras-related protein Rab-7L1,Rab-7-like protein 1;Ras-related protein Rab-29;, PF00071;, GO:0005801;GO:0005737;GO:0005856;GO:0005829;GO:0005769;GO:0012505;GO:0070062;GO:0005794;GO:0043231;GO:0097708;GO:0042470;GO:0005739;GO:0048471;GO:0005886;GO:0055037;GO:0020003;GO:0005802;GO:0005773;GO:0070840;GO:0019003;GO:0005525;GO:0003924;GO:0019894;GO:0031267;GO:0030154;GO:0007030;GO:0006886;GO:0032438;GO:0007005;GO:0010977;GO:0090316;GO:0001921;GO:0050862;GO:1903441;GO:0072657;GO:1901214;GO:1905279;GO:0009617;GO:0042147;GO:0007416;GO:0042110;GO:1901998;GO:0039694;, C:cis-Golgi network; C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome; C:endomembrane system; C:extracellular exosome; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:intracellular vesicle; C:melanosome; C:mitochondrion; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:symbiont-containing vacuole; C:trans-Golgi network; C:vacuole;, F:dynein complex binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:kinesin binding; F:small GTPase binding;, P:cell differentiation; P:Golgi organization; P:intracellular protein transport; P:melanosome organization; P:mitochondrion organization; P:negative regulation of neuron projection development; P:positive regulation of intracellular protein transport; P:positive regulation of receptor recycling; P:positive regulation of T cell receptor signaling pathway; P:protein localization to ciliary membrane; P:protein localization to membrane; P:regulation of neuron death; P:regulation of retrograde transport, endosome to Golgi; P:response to bacterium; P:retrograde transport, endosome to Golgi; P:synapse assembly; P:T cell activation; P:toxin transport; P:viral RNA genome replication; scaffold33 indexed_genome mRNA 303353 325928 . - . ID=transcript_6982;Q8IVJ1 Q63HJ4 Q658Z5 Q659A4 Q6MZK2,Solute carrier family 41 member 1,, PF01769;, GO:0016323;GO:0016021;GO:0005886;GO:0032991;GO:0022890;GO:0015095;GO:0061768;GO:0022857;GO:0010961;GO:0071286;GO:1903830;GO:0015693;GO:0030001;, C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:inorganic cation transmembrane transporter activity; F:magnesium ion transmembrane transporter activity; F:magnesium:sodium antiporter activity; F:transmembrane transporter activity;, P:cellular magnesium ion homeostasis; P:cellular response to magnesium ion; P:magnesium ion transmembrane transport; P:magnesium ion transport; P:metal ion transport;|Q8IVJ1 Q63HJ4 Q658Z5 Q659A4 Q6MZK2,Solute carrier family 41 member 1,, PF01769;, GO:0016323;GO:0016021;GO:0005886;GO:0032991;GO:0022890;GO:0015095;GO:0061768;GO:0022857;GO:0010961;GO:0071286;GO:1903830;GO:0015693;GO:0030001;, C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:inorganic cation transmembrane transporter activity; F:magnesium ion transmembrane transporter activity; F:magnesium:sodium antiporter activity; F:transmembrane transporter activity;, P:cellular magnesium ion homeostasis; P:cellular response to magnesium ion; P:magnesium ion transmembrane transport; P:magnesium ion transport; P:metal ion transport;|Q8IVJ1 Q63HJ4 Q658Z5 Q659A4 Q6MZK2,Solute carrier family 41 member 1,, PF01769;, GO:0016323;GO:0016021;GO:0005886;GO:0032991;GO:0022890;GO:0015095;GO:0061768;GO:0022857;GO:0010961;GO:0071286;GO:1903830;GO:0015693;GO:0030001;, C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:inorganic cation transmembrane transporter activity; F:magnesium ion transmembrane transporter activity; F:magnesium:sodium antiporter activity; F:transmembrane transporter activity;, P:cellular magnesium ion homeostasis; P:cellular response to magnesium ion; P:magnesium ion transmembrane transport; P:magnesium ion transport; P:metal ion transport;|Q8IVJ1 Q63HJ4 Q658Z5 Q659A4 Q6MZK2,Solute carrier family 41 member 1,, PF01769;, GO:0016323;GO:0016021;GO:0005886;GO:0032991;GO:0022890;GO:0015095;GO:0061768;GO:0022857;GO:0010961;GO:0071286;GO:1903830;GO:0015693;GO:0030001;, C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:inorganic cation transmembrane transporter activity; F:magnesium ion transmembrane transporter activity; F:magnesium:sodium antiporter activity; F:transmembrane transporter activity;, P:cellular magnesium ion homeostasis; P:cellular response to magnesium ion; P:magnesium ion transmembrane transport; P:magnesium ion transport; P:metal ion transport;|Q8IVJ1 Q63HJ4 Q658Z5 Q659A4 Q6MZK2,Solute carrier family 41 member 1,, PF01769;, GO:0016323;GO:0016021;GO:0005886;GO:0032991;GO:0022890;GO:0015095;GO:0061768;GO:0022857;GO:0010961;GO:0071286;GO:1903830;GO:0015693;GO:0030001;, C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:inorganic cation transmembrane transporter activity; F:magnesium ion transmembrane transporter activity; F:magnesium:sodium antiporter activity; F:transmembrane transporter activity;, P:cellular magnesium ion homeostasis; P:cellular response to magnesium ion; P:magnesium ion transmembrane transport; P:magnesium ion transport; P:metal ion transport;|Q8IVJ1 Q63HJ4 Q658Z5 Q659A4 Q6MZK2,Solute carrier family 41 member 1,, PF01769;, GO:0016323;GO:0016021;GO:0005886;GO:0032991;GO:0022890;GO:0015095;GO:0061768;GO:0022857;GO:0010961;GO:0071286;GO:1903830;GO:0015693;GO:0030001;, C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:inorganic cation transmembrane transporter activity; F:magnesium ion transmembrane transporter activity; F:magnesium:sodium antiporter activity; F:transmembrane transporter activity;, P:cellular magnesium ion homeostasis; P:cellular response to magnesium ion; P:magnesium ion transmembrane transport; P:magnesium ion transport; P:metal ion transport; scaffold33 indexed_genome mRNA 368702 390012 . - . ID=transcript_6983;Q6GTS8 Q6P4E3 Q96DM4,N-fatty-acyl-amino acid synthase/hydrolase PM20D1 {ECO:0000305|PubMed:27374330},Peptidase M20 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26518};, PF07687;PF01546;, GO:0070062;GO:0005576;GO:0004046;GO:0016811;GO:0016829;GO:0046872;GO:0008233;GO:1990845;GO:0043604;GO:0043605;GO:0006520;GO:0044255;GO:0097009;GO:0006631;GO:1901215;GO:0006807;GO:2000275;, C:extracellular exosome; C:extracellular region;, F:aminoacylase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:lyase activity; F:metal ion binding; F:peptidase activity;, P:adaptive thermogenesis; P:amide biosynthetic process; P:cellular amide catabolic process; P:cellular amino acid metabolic process; P:cellular lipid metabolic process; P:energy homeostasis; P:fatty acid metabolic process; P:negative regulation of neuron death; P:nitrogen compound metabolic process; P:regulation of oxidative phosphorylation uncoupler activity;|Q6GTS8 Q6P4E3 Q96DM4,N-fatty-acyl-amino acid synthase/hydrolase PM20D1 {ECO:0000305|PubMed:27374330},Peptidase M20 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26518};, PF07687;PF01546;, GO:0070062;GO:0005576;GO:0004046;GO:0016811;GO:0016829;GO:0046872;GO:0008233;GO:1990845;GO:0043604;GO:0043605;GO:0006520;GO:0044255;GO:0097009;GO:0006631;GO:1901215;GO:0006807;GO:2000275;, C:extracellular exosome; C:extracellular region;, F:aminoacylase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:lyase activity; F:metal ion binding; F:peptidase activity;, P:adaptive thermogenesis; P:amide biosynthetic process; P:cellular amide catabolic process; P:cellular amino acid metabolic process; P:cellular lipid metabolic process; P:energy homeostasis; P:fatty acid metabolic process; P:negative regulation of neuron death; P:nitrogen compound metabolic process; P:regulation of oxidative phosphorylation uncoupler activity;|Q6GTS8 Q6P4E3 Q96DM4,N-fatty-acyl-amino acid synthase/hydrolase PM20D1 {ECO:0000305|PubMed:27374330},Peptidase M20 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26518};, PF07687;PF01546;, GO:0070062;GO:0005576;GO:0004046;GO:0016811;GO:0016829;GO:0046872;GO:0008233;GO:1990845;GO:0043604;GO:0043605;GO:0006520;GO:0044255;GO:0097009;GO:0006631;GO:1901215;GO:0006807;GO:2000275;, C:extracellular exosome; C:extracellular region;, F:aminoacylase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:lyase activity; F:metal ion binding; F:peptidase activity;, P:adaptive thermogenesis; P:amide biosynthetic process; P:cellular amide catabolic process; P:cellular amino acid metabolic process; P:cellular lipid metabolic process; P:energy homeostasis; P:fatty acid metabolic process; P:negative regulation of neuron death; P:nitrogen compound metabolic process; P:regulation of oxidative phosphorylation uncoupler activity;|Q6GTS8 Q6P4E3 Q96DM4,N-fatty-acyl-amino acid synthase/hydrolase PM20D1 {ECO:0000305|PubMed:27374330},Peptidase M20 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26518};, PF07687;PF01546;, GO:0070062;GO:0005576;GO:0004046;GO:0016811;GO:0016829;GO:0046872;GO:0008233;GO:1990845;GO:0043604;GO:0043605;GO:0006520;GO:0044255;GO:0097009;GO:0006631;GO:1901215;GO:0006807;GO:2000275;, C:extracellular exosome; C:extracellular region;, F:aminoacylase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:lyase activity; F:metal ion binding; F:peptidase activity;, P:adaptive thermogenesis; P:amide biosynthetic process; P:cellular amide catabolic process; P:cellular amino acid metabolic process; P:cellular lipid metabolic process; P:energy homeostasis; P:fatty acid metabolic process; P:negative regulation of neuron death; P:nitrogen compound metabolic process; P:regulation of oxidative phosphorylation uncoupler activity; scaffold33 indexed_genome mRNA 404564 412277 . - . ID=transcript_6984;Q7LBE3 A7E2V6 B1AVM8 B1AVM9 B7ZKK2 Q96PK9 Q96RN0,Solute carrier family 26 member 9,Anion transporter/exchanger protein 9;, PF01740;PF00916;, GO:0016324;GO:0009986;GO:0070062;GO:0005887;GO:0005886;GO:0015301;GO:0051117;GO:0015106;GO:0005254;GO:0015108;GO:0019531;GO:0008271;GO:0015116;GO:0006820;GO:0015701;GO:0006821;GO:0006811;GO:0010628;, C:apical plasma membrane; C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:ATPase binding; F:bicarbonate transmembrane transporter activity; F:chloride channel activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:anion transport; P:bicarbonate transport; P:chloride transport; P:ion transport; P:positive regulation of gene expression; scaffold33 indexed_genome mRNA 412447 422701 . - . ID=transcript_6985;Q7LBE3 A7E2V6 B1AVM8 B1AVM9 B7ZKK2 Q96PK9 Q96RN0,Solute carrier family 26 member 9,Anion transporter/exchanger protein 9;, PF01740;PF00916;, GO:0016324;GO:0009986;GO:0070062;GO:0005887;GO:0005886;GO:0015301;GO:0051117;GO:0015106;GO:0005254;GO:0015108;GO:0019531;GO:0008271;GO:0015116;GO:0006820;GO:0015701;GO:0006821;GO:0006811;GO:0010628;, C:apical plasma membrane; C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:ATPase binding; F:bicarbonate transmembrane transporter activity; F:chloride channel activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:anion transport; P:bicarbonate transport; P:chloride transport; P:ion transport; P:positive regulation of gene expression; scaffold33 indexed_genome mRNA 487796 514671 . - . ID=transcript_6986;Q96AH8,Ras-related protein Rab-7b,, PF00071;, GO:0005794;GO:0005770;GO:0031902;GO:0005764;GO:0045335;GO:0030670;GO:0005802;GO:0005525;GO:0003924;GO:0071346;GO:0008333;GO:0034499;GO:0034144;GO:0034164;GO:0090385;GO:0032755;GO:0045654;GO:0051092;GO:0015031;, C:Golgi apparatus; C:late endosome; C:late endosome membrane; C:lysosome; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:trans-Golgi network;, F:GTP binding; F:GTPase activity;, P:cellular response to interferon-gamma; P:endosome to lysosome transport; P:late endosome to Golgi transport; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of toll-like receptor 9 signaling pathway; P:phagosome-lysosome fusion; P:positive regulation of interleukin-6 production; P:positive regulation of megakaryocyte differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:protein transport;|Q96AH8,Ras-related protein Rab-7b,, PF00071;, GO:0005794;GO:0005770;GO:0031902;GO:0005764;GO:0045335;GO:0030670;GO:0005802;GO:0005525;GO:0003924;GO:0071346;GO:0008333;GO:0034499;GO:0034144;GO:0034164;GO:0090385;GO:0032755;GO:0045654;GO:0051092;GO:0015031;, C:Golgi apparatus; C:late endosome; C:late endosome membrane; C:lysosome; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:trans-Golgi network;, F:GTP binding; F:GTPase activity;, P:cellular response to interferon-gamma; P:endosome to lysosome transport; P:late endosome to Golgi transport; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of toll-like receptor 9 signaling pathway; P:phagosome-lysosome fusion; P:positive regulation of interleukin-6 production; P:positive regulation of megakaryocyte differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:protein transport; scaffold33 indexed_genome mRNA 581558 604938 . + . ID=transcript_6987;Q6ZWK4,Regulator of hemoglobinization and erythroid cell expansion protein {ECO:0000312|HGNC:HGNC:25341},Regulator of human erythroid cell expansion protein {ECO:0000303|PubMed:25092874};, PF15763;, GO:0016021;GO:0005886;GO:0005128;GO:0036018;GO:0043249;GO:0038162;GO:0045648;, C:integral component of membrane; C:plasma membrane;, F:erythropoietin receptor binding;, P:cellular response to erythropoietin; P:erythrocyte maturation; P:erythropoietin-mediated signaling pathway; P:positive regulation of erythrocyte differentiation; scaffold33 indexed_genome mRNA 712214 952654 . - . ID=transcript_6988;Q5TYM5 B2RV15 Q5TYM4,Protein FAM72A,Latent membrane protein 1-induced protein;, PF14976;, GO:0005829;GO:0043231;GO:0016020;GO:0005739;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion;|Q5TYM5 B2RV15 Q5TYM4,Protein FAM72A,Latent membrane protein 1-induced protein;, PF14976;, GO:0005829;GO:0043231;GO:0016020;GO:0005739;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion;|Q5TYM5 B2RV15 Q5TYM4,Protein FAM72A,Latent membrane protein 1-induced protein;, PF14976;, GO:0005829;GO:0043231;GO:0016020;GO:0005739;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion;|O75044 A2RUF3,SLIT-ROBO Rho GTPase-activating protein 2,Formin-binding protein 2;Rho GTPase-activating protein 34;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0044327;GO:0030027;GO:0005654;GO:0045335;GO:0005886;GO:0014069;GO:0045211;GO:0005096;GO:0042802;GO:0042803;GO:0031267;GO:0051014;GO:0060996;GO:0021816;GO:0046847;GO:0003363;GO:0030336;GO:2001223;GO:0048812;GO:0043547;GO:0051056;GO:0007165;GO:0034446;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:lamellipodium; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:GTPase activator activity; F:identical protein binding; F:protein homodimerization activity; F:small GTPase binding;, P:actin filament severing; P:dendritic spine development; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; P:filopodium assembly; P:lamellipodium assembly involved in ameboidal cell migration; P:negative regulation of cell migration; P:negative regulation of neuron migration; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:substrate adhesion-dependent cell spreading;|H0Y354,Protein FAM72C,, PF14976;, GO:0005829;GO:0043231;GO:0016020;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane;|O75044 A2RUF3,SLIT-ROBO Rho GTPase-activating protein 2,Formin-binding protein 2;Rho GTPase-activating protein 34;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0044327;GO:0030027;GO:0005654;GO:0045335;GO:0005886;GO:0014069;GO:0045211;GO:0005096;GO:0042802;GO:0042803;GO:0031267;GO:0051014;GO:0060996;GO:0021816;GO:0046847;GO:0003363;GO:0030336;GO:2001223;GO:0048812;GO:0043547;GO:0051056;GO:0007165;GO:0034446;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:lamellipodium; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:GTPase activator activity; F:identical protein binding; F:protein homodimerization activity; F:small GTPase binding;, P:actin filament severing; P:dendritic spine development; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; P:filopodium assembly; P:lamellipodium assembly involved in ameboidal cell migration; P:negative regulation of cell migration; P:negative regulation of neuron migration; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:substrate adhesion-dependent cell spreading;|O75044 A2RUF3,SLIT-ROBO Rho GTPase-activating protein 2,Formin-binding protein 2;Rho GTPase-activating protein 34;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0044327;GO:0030027;GO:0005654;GO:0045335;GO:0005886;GO:0014069;GO:0045211;GO:0005096;GO:0042802;GO:0042803;GO:0031267;GO:0051014;GO:0060996;GO:0021816;GO:0046847;GO:0003363;GO:0030336;GO:2001223;GO:0048812;GO:0043547;GO:0051056;GO:0007165;GO:0034446;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:lamellipodium; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:GTPase activator activity; F:identical protein binding; F:protein homodimerization activity; F:small GTPase binding;, P:actin filament severing; P:dendritic spine development; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; P:filopodium assembly; P:lamellipodium assembly involved in ameboidal cell migration; P:negative regulation of cell migration; P:negative regulation of neuron migration; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:substrate adhesion-dependent cell spreading;|O75044 A2RUF3,SLIT-ROBO Rho GTPase-activating protein 2,Formin-binding protein 2;Rho GTPase-activating protein 34;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0044327;GO:0030027;GO:0005654;GO:0045335;GO:0005886;GO:0014069;GO:0045211;GO:0005096;GO:0042802;GO:0042803;GO:0031267;GO:0051014;GO:0060996;GO:0021816;GO:0046847;GO:0003363;GO:0030336;GO:2001223;GO:0048812;GO:0043547;GO:0051056;GO:0007165;GO:0034446;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:lamellipodium; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:GTPase activator activity; F:identical protein binding; F:protein homodimerization activity; F:small GTPase binding;, P:actin filament severing; P:dendritic spine development; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; P:filopodium assembly; P:lamellipodium assembly involved in ameboidal cell migration; P:negative regulation of cell migration; P:negative regulation of neuron migration; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:substrate adhesion-dependent cell spreading; scaffold33 indexed_genome mRNA 960837 980239 . - . ID=transcript_6989;O75044 A2RUF3,SLIT-ROBO Rho GTPase-activating protein 2,Formin-binding protein 2;Rho GTPase-activating protein 34;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0044327;GO:0030027;GO:0005654;GO:0045335;GO:0005886;GO:0014069;GO:0045211;GO:0005096;GO:0042802;GO:0042803;GO:0031267;GO:0051014;GO:0060996;GO:0021816;GO:0046847;GO:0003363;GO:0030336;GO:2001223;GO:0048812;GO:0043547;GO:0051056;GO:0007165;GO:0034446;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:lamellipodium; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:GTPase activator activity; F:identical protein binding; F:protein homodimerization activity; F:small GTPase binding;, P:actin filament severing; P:dendritic spine development; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; P:filopodium assembly; P:lamellipodium assembly involved in ameboidal cell migration; P:negative regulation of cell migration; P:negative regulation of neuron migration; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:substrate adhesion-dependent cell spreading;|O75044 A2RUF3,SLIT-ROBO Rho GTPase-activating protein 2,Formin-binding protein 2;Rho GTPase-activating protein 34;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0044327;GO:0030027;GO:0005654;GO:0045335;GO:0005886;GO:0014069;GO:0045211;GO:0005096;GO:0042802;GO:0042803;GO:0031267;GO:0051014;GO:0060996;GO:0021816;GO:0046847;GO:0003363;GO:0030336;GO:2001223;GO:0048812;GO:0043547;GO:0051056;GO:0007165;GO:0034446;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:lamellipodium; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:GTPase activator activity; F:identical protein binding; F:protein homodimerization activity; F:small GTPase binding;, P:actin filament severing; P:dendritic spine development; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; P:filopodium assembly; P:lamellipodium assembly involved in ameboidal cell migration; P:negative regulation of cell migration; P:negative regulation of neuron migration; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:substrate adhesion-dependent cell spreading;|O75044 A2RUF3,SLIT-ROBO Rho GTPase-activating protein 2,Formin-binding protein 2;Rho GTPase-activating protein 34;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0044327;GO:0030027;GO:0005654;GO:0045335;GO:0005886;GO:0014069;GO:0045211;GO:0005096;GO:0042802;GO:0042803;GO:0031267;GO:0051014;GO:0060996;GO:0021816;GO:0046847;GO:0003363;GO:0030336;GO:2001223;GO:0048812;GO:0043547;GO:0051056;GO:0007165;GO:0034446;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:lamellipodium; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:GTPase activator activity; F:identical protein binding; F:protein homodimerization activity; F:small GTPase binding;, P:actin filament severing; P:dendritic spine development; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; P:filopodium assembly; P:lamellipodium assembly involved in ameboidal cell migration; P:negative regulation of cell migration; P:negative regulation of neuron migration; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:substrate adhesion-dependent cell spreading;|O75044 A2RUF3,SLIT-ROBO Rho GTPase-activating protein 2,Formin-binding protein 2;Rho GTPase-activating protein 34;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0044327;GO:0030027;GO:0005654;GO:0045335;GO:0005886;GO:0014069;GO:0045211;GO:0005096;GO:0042802;GO:0042803;GO:0031267;GO:0051014;GO:0060996;GO:0021816;GO:0046847;GO:0003363;GO:0030336;GO:2001223;GO:0048812;GO:0043547;GO:0051056;GO:0007165;GO:0034446;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:lamellipodium; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:GTPase activator activity; F:identical protein binding; F:protein homodimerization activity; F:small GTPase binding;, P:actin filament severing; P:dendritic spine development; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; P:filopodium assembly; P:lamellipodium assembly involved in ameboidal cell migration; P:negative regulation of cell migration; P:negative regulation of neuron migration; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:substrate adhesion-dependent cell spreading;|O75044 A2RUF3,SLIT-ROBO Rho GTPase-activating protein 2,Formin-binding protein 2;Rho GTPase-activating protein 34;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0044327;GO:0030027;GO:0005654;GO:0045335;GO:0005886;GO:0014069;GO:0045211;GO:0005096;GO:0042802;GO:0042803;GO:0031267;GO:0051014;GO:0060996;GO:0021816;GO:0046847;GO:0003363;GO:0030336;GO:2001223;GO:0048812;GO:0043547;GO:0051056;GO:0007165;GO:0034446;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:lamellipodium; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:GTPase activator activity; F:identical protein binding; F:protein homodimerization activity; F:small GTPase binding;, P:actin filament severing; P:dendritic spine development; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; P:filopodium assembly; P:lamellipodium assembly involved in ameboidal cell migration; P:negative regulation of cell migration; P:negative regulation of neuron migration; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:substrate adhesion-dependent cell spreading;|O75044 A2RUF3,SLIT-ROBO Rho GTPase-activating protein 2,Formin-binding protein 2;Rho GTPase-activating protein 34;, PF00611;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0044327;GO:0030027;GO:0005654;GO:0045335;GO:0005886;GO:0014069;GO:0045211;GO:0005096;GO:0042802;GO:0042803;GO:0031267;GO:0051014;GO:0060996;GO:0021816;GO:0046847;GO:0003363;GO:0030336;GO:2001223;GO:0048812;GO:0043547;GO:0051056;GO:0007165;GO:0034446;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:lamellipodium; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:GTPase activator activity; F:identical protein binding; F:protein homodimerization activity; F:small GTPase binding;, P:actin filament severing; P:dendritic spine development; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; P:filopodium assembly; P:lamellipodium assembly involved in ameboidal cell migration; P:negative regulation of cell migration; P:negative regulation of neuron migration; P:neuron projection morphogenesis; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:substrate adhesion-dependent cell spreading; scaffold33 indexed_genome mRNA 985434 1009693 . + . ID=transcript_6990;Q14164 D3DT78 Q3B754 Q3KR43 Q5JTS6,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Inducible I kappa-B kinase;, PF00069;PF18394;PF18396;, GO:0005737;GO:0005829;GO:0031966;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0042802;GO:0008384;GO:0036435;GO:0004704;GO:0019903;GO:0004674;GO:0031625;GO:0098586;GO:0006955;GO:0008630;GO:0032480;GO:0018105;GO:0043123;GO:0010884;GO:0060340;GO:0006468;GO:0035456;GO:0034340;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrial membrane; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:K48-linked polyubiquitin modification-dependent protein binding; F:NF-kappaB-inducing kinase activity; F:protein phosphatase binding; F:protein serine/threonine kinase activity; F:ubiquitin protein ligase binding;, P:cellular response to virus; P:immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of type I interferon production; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of lipid storage; P:positive regulation of type I interferon-mediated signaling pathway; P:protein phosphorylation; P:response to interferon-beta; P:response to type I interferon; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|Q14164 D3DT78 Q3B754 Q3KR43 Q5JTS6,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Inducible I kappa-B kinase;, PF00069;PF18394;PF18396;, GO:0005737;GO:0005829;GO:0031966;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0042802;GO:0008384;GO:0036435;GO:0004704;GO:0019903;GO:0004674;GO:0031625;GO:0098586;GO:0006955;GO:0008630;GO:0032480;GO:0018105;GO:0043123;GO:0010884;GO:0060340;GO:0006468;GO:0035456;GO:0034340;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrial membrane; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:K48-linked polyubiquitin modification-dependent protein binding; F:NF-kappaB-inducing kinase activity; F:protein phosphatase binding; F:protein serine/threonine kinase activity; F:ubiquitin protein ligase binding;, P:cellular response to virus; P:immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of type I interferon production; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of lipid storage; P:positive regulation of type I interferon-mediated signaling pathway; P:protein phosphorylation; P:response to interferon-beta; P:response to type I interferon; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|Q14164 D3DT78 Q3B754 Q3KR43 Q5JTS6,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Inducible I kappa-B kinase;, PF00069;PF18394;PF18396;, GO:0005737;GO:0005829;GO:0031966;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0042802;GO:0008384;GO:0036435;GO:0004704;GO:0019903;GO:0004674;GO:0031625;GO:0098586;GO:0006955;GO:0008630;GO:0032480;GO:0018105;GO:0043123;GO:0010884;GO:0060340;GO:0006468;GO:0035456;GO:0034340;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrial membrane; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:K48-linked polyubiquitin modification-dependent protein binding; F:NF-kappaB-inducing kinase activity; F:protein phosphatase binding; F:protein serine/threonine kinase activity; F:ubiquitin protein ligase binding;, P:cellular response to virus; P:immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of type I interferon production; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of lipid storage; P:positive regulation of type I interferon-mediated signaling pathway; P:protein phosphorylation; P:response to interferon-beta; P:response to type I interferon; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|Q14164 D3DT78 Q3B754 Q3KR43 Q5JTS6,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Inducible I kappa-B kinase;, PF00069;PF18394;PF18396;, GO:0005737;GO:0005829;GO:0031966;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0042802;GO:0008384;GO:0036435;GO:0004704;GO:0019903;GO:0004674;GO:0031625;GO:0098586;GO:0006955;GO:0008630;GO:0032480;GO:0018105;GO:0043123;GO:0010884;GO:0060340;GO:0006468;GO:0035456;GO:0034340;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:mitochondrial membrane; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:identical protein binding; F:IkappaB kinase activity; F:K48-linked polyubiquitin modification-dependent protein binding; F:NF-kappaB-inducing kinase activity; F:protein phosphatase binding; F:protein serine/threonine kinase activity; F:ubiquitin protein ligase binding;, P:cellular response to virus; P:immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of type I interferon production; P:peptidyl-serine phosphorylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of lipid storage; P:positive regulation of type I interferon-mediated signaling pathway; P:protein phosphorylation; P:response to interferon-beta; P:response to type I interferon; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process; scaffold33 indexed_genome mRNA 1061340 1092535 . + . ID=transcript_6991;Q8WWW0 A8K1E6 Q5SY32 Q8WWV9 Q8WXF4 Q9BT99,Ras association domain-containing protein 5,New ras effector 1;Regulator for cell adhesion and polarization enriched in lymphoid tissues;, PF00130;PF16517;PF00788;, GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0046872;GO:0031267;GO:0006915;GO:0035556;GO:0008285;GO:0031398;GO:0042981;GO:1900180;GO:0007165;, C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:metal ion binding; F:small GTPase binding;, P:apoptotic process; P:intracellular signal transduction; P:negative regulation of cell population proliferation; P:positive regulation of protein ubiquitination; P:regulation of apoptotic process; P:regulation of protein localization to nucleus; P:signal transduction;|Q8WWW0 A8K1E6 Q5SY32 Q8WWV9 Q8WXF4 Q9BT99,Ras association domain-containing protein 5,New ras effector 1;Regulator for cell adhesion and polarization enriched in lymphoid tissues;, PF00130;PF16517;PF00788;, GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0046872;GO:0031267;GO:0006915;GO:0035556;GO:0008285;GO:0031398;GO:0042981;GO:1900180;GO:0007165;, C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:metal ion binding; F:small GTPase binding;, P:apoptotic process; P:intracellular signal transduction; P:negative regulation of cell population proliferation; P:positive regulation of protein ubiquitination; P:regulation of apoptotic process; P:regulation of protein localization to nucleus; P:signal transduction; scaffold33 indexed_genome mRNA 1095013 1111362 . - . ID=transcript_6992;P41214 Q5SY40 Q8IXV3 Q96DG3 Q96TG7 Q9NR27 Q9NSN0 Q9NV18 Q9NZ21,Eukaryotic translation initiation factor 2D,Hepatocellular carcinoma-associated antigen 56;Ligatin;, PF17832;PF01253;, GO:0005737;GO:0005829;GO:0016604;GO:0038023;GO:0003743;GO:0001731;GO:0006886;GO:0075522;GO:0032790;, C:cytoplasm; C:cytosol; C:nuclear body;, F:signaling receptor activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:intracellular protein transport; P:IRES-dependent viral translational initiation; P:ribosome disassembly;|P41214 Q5SY40 Q8IXV3 Q96DG3 Q96TG7 Q9NR27 Q9NSN0 Q9NV18 Q9NZ21,Eukaryotic translation initiation factor 2D,Hepatocellular carcinoma-associated antigen 56;Ligatin;, PF17832;PF01253;, GO:0005737;GO:0005829;GO:0016604;GO:0038023;GO:0003743;GO:0001731;GO:0006886;GO:0075522;GO:0032790;, C:cytoplasm; C:cytosol; C:nuclear body;, F:signaling receptor activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:intracellular protein transport; P:IRES-dependent viral translational initiation; P:ribosome disassembly;|P41214 Q5SY40 Q8IXV3 Q96DG3 Q96TG7 Q9NR27 Q9NSN0 Q9NV18 Q9NZ21,Eukaryotic translation initiation factor 2D,Hepatocellular carcinoma-associated antigen 56;Ligatin;, PF17832;PF01253;, GO:0005737;GO:0005829;GO:0016604;GO:0038023;GO:0003743;GO:0001731;GO:0006886;GO:0075522;GO:0032790;, C:cytoplasm; C:cytosol; C:nuclear body;, F:signaling receptor activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:intracellular protein transport; P:IRES-dependent viral translational initiation; P:ribosome disassembly;|P41214 Q5SY40 Q8IXV3 Q96DG3 Q96TG7 Q9NR27 Q9NSN0 Q9NV18 Q9NZ21,Eukaryotic translation initiation factor 2D,Hepatocellular carcinoma-associated antigen 56;Ligatin;, PF17832;PF01253;, GO:0005737;GO:0005829;GO:0016604;GO:0038023;GO:0003743;GO:0001731;GO:0006886;GO:0075522;GO:0032790;, C:cytoplasm; C:cytosol; C:nuclear body;, F:signaling receptor activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:intracellular protein transport; P:IRES-dependent viral translational initiation; P:ribosome disassembly;|P41214 Q5SY40 Q8IXV3 Q96DG3 Q96TG7 Q9NR27 Q9NSN0 Q9NV18 Q9NZ21,Eukaryotic translation initiation factor 2D,Hepatocellular carcinoma-associated antigen 56;Ligatin;, PF17832;PF01253;, GO:0005737;GO:0005829;GO:0016604;GO:0038023;GO:0003743;GO:0001731;GO:0006886;GO:0075522;GO:0032790;, C:cytoplasm; C:cytosol; C:nuclear body;, F:signaling receptor activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:intracellular protein transport; P:IRES-dependent viral translational initiation; P:ribosome disassembly;|P41214 Q5SY40 Q8IXV3 Q96DG3 Q96TG7 Q9NR27 Q9NSN0 Q9NV18 Q9NZ21,Eukaryotic translation initiation factor 2D,Hepatocellular carcinoma-associated antigen 56;Ligatin;, PF17832;PF01253;, GO:0005737;GO:0005829;GO:0016604;GO:0038023;GO:0003743;GO:0001731;GO:0006886;GO:0075522;GO:0032790;, C:cytoplasm; C:cytosol; C:nuclear body;, F:signaling receptor activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:intracellular protein transport; P:IRES-dependent viral translational initiation; P:ribosome disassembly; scaffold33 indexed_genome mRNA 1111387 1117442 . - . ID=transcript_6993;P41214 Q5SY40 Q8IXV3 Q96DG3 Q96TG7 Q9NR27 Q9NSN0 Q9NV18 Q9NZ21,Eukaryotic translation initiation factor 2D,Hepatocellular carcinoma-associated antigen 56;Ligatin;, PF17832;PF01253;, GO:0005737;GO:0005829;GO:0016604;GO:0038023;GO:0003743;GO:0001731;GO:0006886;GO:0075522;GO:0032790;, C:cytoplasm; C:cytosol; C:nuclear body;, F:signaling receptor activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:intracellular protein transport; P:IRES-dependent viral translational initiation; P:ribosome disassembly;|P41214 Q5SY40 Q8IXV3 Q96DG3 Q96TG7 Q9NR27 Q9NSN0 Q9NV18 Q9NZ21,Eukaryotic translation initiation factor 2D,Hepatocellular carcinoma-associated antigen 56;Ligatin;, PF17832;PF01253;, GO:0005737;GO:0005829;GO:0016604;GO:0038023;GO:0003743;GO:0001731;GO:0006886;GO:0075522;GO:0032790;, C:cytoplasm; C:cytosol; C:nuclear body;, F:signaling receptor activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:intracellular protein transport; P:IRES-dependent viral translational initiation; P:ribosome disassembly;|P41214 Q5SY40 Q8IXV3 Q96DG3 Q96TG7 Q9NR27 Q9NSN0 Q9NV18 Q9NZ21,Eukaryotic translation initiation factor 2D,Hepatocellular carcinoma-associated antigen 56;Ligatin;, PF17832;PF01253;, GO:0005737;GO:0005829;GO:0016604;GO:0038023;GO:0003743;GO:0001731;GO:0006886;GO:0075522;GO:0032790;, C:cytoplasm; C:cytosol; C:nuclear body;, F:signaling receptor activity; F:translation initiation factor activity;, P:formation of translation preinitiation complex; P:intracellular protein transport; P:IRES-dependent viral translational initiation; P:ribosome disassembly; scaffold33 indexed_genome mRNA 1145008 1154684 . + . ID=transcript_6994;O43781 D3DT79 Q7Z752 Q9HBY6 Q9HBY7,Dual specificity tyrosine-phosphorylation-regulated kinase 3,Regulatory erythroid kinase {ECO:0000303|PubMed:10779429};, PF00069;, GO:0005737;GO:0010494;GO:0005856;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0000242;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0007049;GO:0051301;GO:0030218;GO:0043066;GO:0043518;GO:0035063;GO:1903008;GO:0018105;GO:0018107;GO:1902751;GO:0006468;GO:0080135;GO:1903432;GO:0035617;, C:cytoplasm; C:cytoplasmic stress granule; C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:pericentriolar material;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell cycle; P:cell division; P:erythrocyte differentiation; P:negative regulation of apoptotic process; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:nuclear speck organization; P:organelle disassembly; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of cell cycle G2/M phase transition; P:protein phosphorylation; P:regulation of cellular response to stress; P:regulation of TORC1 signaling; P:stress granule disassembly; scaffold33 indexed_genome mRNA 1231877 1234654 . + . ID=transcript_6995;P49137 Q5SY30 Q5SY41 Q8IYD6,MAP kinase-activated protein kinase 2,, PF00069;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0051019;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0070935;GO:0000187;GO:0006974;GO:0035924;GO:0006954;GO:0048839;GO:0035556;GO:0006691;GO:0044351;GO:0000165;GO:0038066;GO:0018105;GO:0032760;GO:0046777;GO:0006468;GO:1900034;GO:0032675;GO:0043488;GO:0032680;GO:0034097;GO:0032496;GO:0002224;GO:0048010;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:mitogen-activated protein kinase binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:3'-UTR-mediated mRNA stabilization; P:activation of MAPK activity; P:cellular response to DNA damage stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:inflammatory response; P:inner ear development; P:intracellular signal transduction; P:leukotriene metabolic process; P:macropinocytosis; P:MAPK cascade; P:p38MAPK cascade; P:peptidyl-serine phosphorylation; P:positive regulation of tumor necrosis factor production; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cellular response to heat; P:regulation of interleukin-6 production; P:regulation of mRNA stability; P:regulation of tumor necrosis factor production; P:response to cytokine; P:response to lipopolysaccharide; P:toll-like receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P49137 Q5SY30 Q5SY41 Q8IYD6,MAP kinase-activated protein kinase 2,, PF00069;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0051019;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0070935;GO:0000187;GO:0006974;GO:0035924;GO:0006954;GO:0048839;GO:0035556;GO:0006691;GO:0044351;GO:0000165;GO:0038066;GO:0018105;GO:0032760;GO:0046777;GO:0006468;GO:1900034;GO:0032675;GO:0043488;GO:0032680;GO:0034097;GO:0032496;GO:0002224;GO:0048010;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:mitogen-activated protein kinase binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:3'-UTR-mediated mRNA stabilization; P:activation of MAPK activity; P:cellular response to DNA damage stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:inflammatory response; P:inner ear development; P:intracellular signal transduction; P:leukotriene metabolic process; P:macropinocytosis; P:MAPK cascade; P:p38MAPK cascade; P:peptidyl-serine phosphorylation; P:positive regulation of tumor necrosis factor production; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cellular response to heat; P:regulation of interleukin-6 production; P:regulation of mRNA stability; P:regulation of tumor necrosis factor production; P:response to cytokine; P:response to lipopolysaccharide; P:toll-like receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold33 indexed_genome mRNA 1269955 1273541 . - . ID=transcript_6996;P22301,Interleukin-10,Cytokine synthesis inhibitory factor;, PF00726;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005141;GO:0046983;GO:0007568;GO:0030183;GO:0042100;GO:0060670;GO:0071392;GO:0035729;GO:0071222;GO:0019221;GO:0007253;GO:0042742;GO:0042832;GO:0072577;GO:0030097;GO:0035722;GO:0030595;GO:0097421;GO:0043066;GO:0010507;GO:0030889;GO:0008285;GO:0071650;GO:0002875;GO:0060302;GO:0001818;GO:0002719;GO:0034115;GO:1903208;GO:0050728;GO:0002862;GO:0032687;GO:0032689;GO:0032692;GO:0032695;GO:0032701;GO:0032715;GO:0032717;GO:0051045;GO:0045347;GO:0045930;GO:0030886;GO:0043524;GO:0045019;GO:1904057;GO:0042130;GO:0032720;GO:1904706;GO:0002904;GO:0045787;GO:0001819;GO:0051091;GO:0001938;GO:0034116;GO:0002639;GO:0043032;GO:0045348;GO:1900100;GO:1902895;GO:0046427;GO:2000273;GO:1903672;GO:0045893;GO:1904707;GO:0010468;GO:0045191;GO:1903034;GO:0050807;GO:0014823;GO:0034465;GO:0042493;GO:0051384;GO:0014854;GO:0032868;GO:0002237;GO:0042092;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:interleukin-10 receptor binding; F:protein dimerization activity;, P:aging; P:B cell differentiation; P:B cell proliferation; P:branching involved in labyrinthine layer morphogenesis; P:cellular response to estradiol stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to lipopolysaccharide; P:cytokine-mediated signaling pathway; P:cytoplasmic sequestering of NF-kappaB; P:defense response to bacterium; P:defense response to protozoan; P:endothelial cell apoptotic process; P:hemopoiesis; P:interleukin-12-mediated signaling pathway; P:leukocyte chemotaxis; P:liver regeneration; P:negative regulation of apoptotic process; P:negative regulation of autophagy; P:negative regulation of B cell proliferation; P:negative regulation of cell population proliferation; P:negative regulation of chemokine (C-C motif) ligand 5 production; P:negative regulation of chronic inflammatory response to antigenic stimulus; P:negative regulation of cytokine activity; P:negative regulation of cytokine production; P:negative regulation of cytokine production involved in immune response; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of inflammatory response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-6 production; P:negative regulation of interleukin-8 production; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of MHC class II biosynthetic process; P:negative regulation of mitotic cell cycle; P:negative regulation of myeloid dendritic cell activation; P:negative regulation of neuron apoptotic process; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of sensory perception of pain; P:negative regulation of T cell proliferation; P:negative regulation of tumor necrosis factor production; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of B cell apoptotic process; P:positive regulation of cell cycle; P:positive regulation of cytokine production; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell proliferation; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of immunoglobulin production; P:positive regulation of macrophage activation; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of plasma cell differentiation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of signaling receptor activity; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of gene expression; P:regulation of isotype switching; P:regulation of response to wounding; P:regulation of synapse organization; P:response to activity; P:response to carbon monoxide; P:response to drug; P:response to glucocorticoid; P:response to inactivity; P:response to insulin; P:response to molecule of bacterial origin; P:type 2 immune response; scaffold33 indexed_genome mRNA 1477914 1490436 . - . ID=transcript_6997;Q9BW04 C9JV41 Q658X3,Specifically androgen-regulated gene protein,, , GO:0005737;GO:0005829;GO:0070062;GO:0005886;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:plasma membrane; scaffold33 indexed_genome mRNA 1515642 1518603 . - . ID=transcript_6998;Q5VVQ6 B2RNX3 Q5VVQ5 Q6ZRS6 Q86T63 Q9P1L8,Ubiquitin thioesterase OTU1,DUBA-8;HIV-1-induced protease 7;OTU domain-containing protein 2;, PF02338;, GO:0005737;GO:0005829;GO:0008234;GO:1990380;GO:0061578;GO:0046872;GO:0004843;GO:0031625;GO:0101005;GO:0030968;GO:0016236;GO:1904153;GO:0016579;GO:0035871;GO:1990167;GO:0035523;GO:1990168;GO:0071108;GO:0070536;GO:0030433;, C:cytoplasm; C:cytosol;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:endoplasmic reticulum unfolded protein response; P:macroautophagy; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K27-linked deubiquitination; P:protein K29-linked deubiquitination; P:protein K33-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:ubiquitin-dependent ERAD pathway; scaffold33 indexed_genome mRNA 1520389 1546868 . + . ID=transcript_6999;O60825 O60824 Q5VVQ3 Q5VVQ4 Q9H3P1,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2,6PF-2-K/Fru-2,6-P2ase heart-type isozyme;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0019901;GO:0006003;GO:0006000;GO:0006007;GO:0006096;GO:0006089;GO:0033133;GO:0045821;GO:0032024;GO:0009749;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:protein kinase binding;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:glucose catabolic process; P:glycolytic process; P:lactate metabolic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:positive regulation of insulin secretion; P:response to glucose;|O60825 O60824 Q5VVQ3 Q5VVQ4 Q9H3P1,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2,6PF-2-K/Fru-2,6-P2ase heart-type isozyme;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0019901;GO:0006003;GO:0006000;GO:0006007;GO:0006096;GO:0006089;GO:0033133;GO:0045821;GO:0032024;GO:0009749;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:protein kinase binding;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:glucose catabolic process; P:glycolytic process; P:lactate metabolic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:positive regulation of insulin secretion; P:response to glucose;|O60825 O60824 Q5VVQ3 Q5VVQ4 Q9H3P1,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2,6PF-2-K/Fru-2,6-P2ase heart-type isozyme;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0019901;GO:0006003;GO:0006000;GO:0006007;GO:0006096;GO:0006089;GO:0033133;GO:0045821;GO:0032024;GO:0009749;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:protein kinase binding;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:glucose catabolic process; P:glycolytic process; P:lactate metabolic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:positive regulation of insulin secretion; P:response to glucose;|O60825 O60824 Q5VVQ3 Q5VVQ4 Q9H3P1,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2,6PF-2-K/Fru-2,6-P2ase heart-type isozyme;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0019901;GO:0006003;GO:0006000;GO:0006007;GO:0006096;GO:0006089;GO:0033133;GO:0045821;GO:0032024;GO:0009749;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:protein kinase binding;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:glucose catabolic process; P:glycolytic process; P:lactate metabolic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:positive regulation of insulin secretion; P:response to glucose;|O60825 O60824 Q5VVQ3 Q5VVQ4 Q9H3P1,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2,6PF-2-K/Fru-2,6-P2ase heart-type isozyme;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0019901;GO:0006003;GO:0006000;GO:0006007;GO:0006096;GO:0006089;GO:0033133;GO:0045821;GO:0032024;GO:0009749;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:protein kinase binding;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:glucose catabolic process; P:glycolytic process; P:lactate metabolic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:positive regulation of insulin secretion; P:response to glucose;|O60825 O60824 Q5VVQ3 Q5VVQ4 Q9H3P1,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2,6PF-2-K/Fru-2,6-P2ase heart-type isozyme;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0019901;GO:0006003;GO:0006000;GO:0006007;GO:0006096;GO:0006089;GO:0033133;GO:0045821;GO:0032024;GO:0009749;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:protein kinase binding;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:glucose catabolic process; P:glycolytic process; P:lactate metabolic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:positive regulation of insulin secretion; P:response to glucose;|O60825 O60824 Q5VVQ3 Q5VVQ4 Q9H3P1,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2,6PF-2-K/Fru-2,6-P2ase heart-type isozyme;, PF01591;PF00300;, GO:0005829;GO:0005654;GO:0003873;GO:0005524;GO:0004331;GO:0019901;GO:0006003;GO:0006000;GO:0006007;GO:0006096;GO:0006089;GO:0033133;GO:0045821;GO:0032024;GO:0009749;, C:cytosol; C:nucleoplasm;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:protein kinase binding;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:glucose catabolic process; P:glycolytic process; P:lactate metabolic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:positive regulation of insulin secretion; P:response to glucose; scaffold33 indexed_genome mRNA 1561578 1571176 . + . ID=transcript_7000;P20851 A5JYP8 D3DT81 Q5VVR0 Q9BS25,C4b-binding protein beta chain,, PF00084;, GO:0005576;GO:0005615;GO:0005886;GO:0007596;GO:0006958;GO:0045087;GO:0045959;GO:0045732;GO:0030449;GO:1903027;GO:0009609;, C:extracellular region; C:extracellular space; C:plasma membrane;, , P:blood coagulation; P:complement activation, classical pathway; P:innate immune response; P:negative regulation of complement activation, classical pathway; P:positive regulation of protein catabolic process; P:regulation of complement activation; P:regulation of opsonization; P:response to symbiotic bacterium; scaffold33 indexed_genome mRNA 1576918 1611521 . + . ID=transcript_7001;P04003 Q5VVQ8,C4b-binding protein alpha chain,Proline-rich protein;, PF18453;PF00084;, GO:0072562;GO:0005576;GO:0005615;GO:0005886;GO:0003723;GO:0006958;GO:0045087;GO:0045959;GO:0045732;GO:0030449;GO:1903027;GO:0009609;, C:blood microparticle; C:extracellular region; C:extracellular space; C:plasma membrane;, F:RNA binding;, P:complement activation, classical pathway; P:innate immune response; P:negative regulation of complement activation, classical pathway; P:positive regulation of protein catabolic process; P:regulation of complement activation; P:regulation of opsonization; P:response to symbiotic bacterium;|P04003 Q5VVQ8,C4b-binding protein alpha chain,Proline-rich protein;, PF18453;PF00084;, GO:0072562;GO:0005576;GO:0005615;GO:0005886;GO:0003723;GO:0006958;GO:0045087;GO:0045959;GO:0045732;GO:0030449;GO:1903027;GO:0009609;, C:blood microparticle; C:extracellular region; C:extracellular space; C:plasma membrane;, F:RNA binding;, P:complement activation, classical pathway; P:innate immune response; P:negative regulation of complement activation, classical pathway; P:positive regulation of protein catabolic process; P:regulation of complement activation; P:regulation of opsonization; P:response to symbiotic bacterium;|P04003 Q5VVQ8,C4b-binding protein alpha chain,Proline-rich protein;, PF18453;PF00084;, GO:0072562;GO:0005576;GO:0005615;GO:0005886;GO:0003723;GO:0006958;GO:0045087;GO:0045959;GO:0045732;GO:0030449;GO:1903027;GO:0009609;, C:blood microparticle; C:extracellular region; C:extracellular space; C:plasma membrane;, F:RNA binding;, P:complement activation, classical pathway; P:innate immune response; P:negative regulation of complement activation, classical pathway; P:positive regulation of protein catabolic process; P:regulation of complement activation; P:regulation of opsonization; P:response to symbiotic bacterium; scaffold33 indexed_genome mRNA 1766369 1774585 . + . ID=transcript_7002;P04003 Q5VVQ8,C4b-binding protein alpha chain,Proline-rich protein;, PF18453;PF00084;, GO:0072562;GO:0005576;GO:0005615;GO:0005886;GO:0003723;GO:0006958;GO:0045087;GO:0045959;GO:0045732;GO:0030449;GO:1903027;GO:0009609;, C:blood microparticle; C:extracellular region; C:extracellular space; C:plasma membrane;, F:RNA binding;, P:complement activation, classical pathway; P:innate immune response; P:negative regulation of complement activation, classical pathway; P:positive regulation of protein catabolic process; P:regulation of complement activation; P:regulation of opsonization; P:response to symbiotic bacterium; scaffold33 indexed_genome mRNA 1876005 1904350 . + . ID=transcript_7003;Q14UF4 Q14UF5 Q14UF6,Complement decay-accelerating factor,, PF00084;, GO:0031225;GO:0009986;GO:0033116;GO:0070062;GO:0005576;GO:0101003;GO:0000139;GO:0045121;GO:0005886;GO:0030667;GO:0030133;GO:0008289;GO:0001618;GO:0006958;GO:0006888;GO:0045087;GO:0045916;GO:0043312;GO:2000516;GO:2000563;GO:0007204;GO:0002726;GO:0030449;GO:1903659;GO:0031664;GO:0045730;, C:anchored component of membrane; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule membrane; C:Golgi membrane; C:membrane raft; C:plasma membrane; C:secretory granule membrane; C:transport vesicle;, F:lipid binding; F:virus receptor activity;, P:complement activation, classical pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:negative regulation of complement activation; P:neutrophil degranulation; P:positive regulation of CD4-positive, alpha-beta T cell activation; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of T cell cytokine production; P:regulation of complement activation; P:regulation of complement-dependent cytotoxicity; P:regulation of lipopolysaccharide-mediated signaling pathway; P:respiratory burst;|Q14UF4 Q14UF5 Q14UF6,Complement decay-accelerating factor,, PF00084;, GO:0031225;GO:0009986;GO:0033116;GO:0070062;GO:0005576;GO:0101003;GO:0000139;GO:0045121;GO:0005886;GO:0030667;GO:0030133;GO:0008289;GO:0001618;GO:0006958;GO:0006888;GO:0045087;GO:0045916;GO:0043312;GO:2000516;GO:2000563;GO:0007204;GO:0002726;GO:0030449;GO:1903659;GO:0031664;GO:0045730;, C:anchored component of membrane; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule membrane; C:Golgi membrane; C:membrane raft; C:plasma membrane; C:secretory granule membrane; C:transport vesicle;, F:lipid binding; F:virus receptor activity;, P:complement activation, classical pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:innate immune response; P:negative regulation of complement activation; P:neutrophil degranulation; P:positive regulation of CD4-positive, alpha-beta T cell activation; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of T cell cytokine production; P:regulation of complement activation; P:regulation of complement-dependent cytotoxicity; P:regulation of lipopolysaccharide-mediated signaling pathway; P:respiratory burst; scaffold33 indexed_genome mRNA 2007843 2053172 . + . ID=transcript_7004;P20023 C9JHD2 Q13866 Q14212 Q53EL2 Q5BKT9 Q5SR46 Q5SR48,Complement receptor type 2,Complement C3d receptor;Epstein-Barr virus receptor;, PF00084;, GO:0070062;GO:0016021;GO:0005886;GO:0043235;GO:0001848;GO:0004875;GO:0003677;GO:0042803;GO:0004888;GO:0001618;GO:0030183;GO:0042100;GO:0006957;GO:0006958;GO:0006955;GO:0030449;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:complement binding; F:complement receptor activity; F:DNA binding; F:protein homodimerization activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:B cell differentiation; P:B cell proliferation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:immune response; P:regulation of complement activation; scaffold33 indexed_genome mRNA 2305359 2343712 . - . ID=transcript_7005;P08603 A5PL14 P78435 Q14570 Q2TAZ5 Q38G77 Q5TFM3 Q8N708 Q9NU86,Complement factor H,H factor 1;, PF00084;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0043395;GO:0008201;GO:0042802;GO:0006956;GO:0006957;GO:0030449;GO:1903659;GO:0016032;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:heparan sulfate proteoglycan binding; F:heparin binding; F:identical protein binding;, P:complement activation; P:complement activation, alternative pathway; P:regulation of complement activation; P:regulation of complement-dependent cytotoxicity; P:viral process; scaffold33 indexed_genome mRNA 2394098 2493978 . - . ID=transcript_7006;P08603 A5PL14 P78435 Q14570 Q2TAZ5 Q38G77 Q5TFM3 Q8N708 Q9NU86,Complement factor H,H factor 1;, PF00084;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0043395;GO:0008201;GO:0042802;GO:0006956;GO:0006957;GO:0030449;GO:1903659;GO:0016032;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:heparan sulfate proteoglycan binding; F:heparin binding; F:identical protein binding;, P:complement activation; P:complement activation, alternative pathway; P:regulation of complement activation; P:regulation of complement-dependent cytotoxicity; P:viral process;|P36980 Q14310 Q5T9T1,Complement factor H-related protein 2,DDESK59;H factor-like 3;H factor-like protein 2;, PF00084;, GO:0005576;GO:0032991;GO:0042802;GO:0051838;GO:0032091;GO:0030449;, C:extracellular region; C:protein-containing complex;, F:identical protein binding;, P:cytolysis by host of symbiont cells; P:negative regulation of protein binding; P:regulation of complement activation;|P08603 A5PL14 P78435 Q14570 Q2TAZ5 Q38G77 Q5TFM3 Q8N708 Q9NU86,Complement factor H,H factor 1;, PF00084;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0043395;GO:0008201;GO:0042802;GO:0006956;GO:0006957;GO:0030449;GO:1903659;GO:0016032;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:heparan sulfate proteoglycan binding; F:heparin binding; F:identical protein binding;, P:complement activation; P:complement activation, alternative pathway; P:regulation of complement activation; P:regulation of complement-dependent cytotoxicity; P:viral process; scaffold33 indexed_genome mRNA 2725529 2778640 . + . ID=transcript_7007;Q6UVM3 Q3SY59 Q5VTN1 Q6ZMT3,Potassium channel subfamily T member 2,Sequence like an intermediate conductance potassium channel subunit;Sodium and chloride-activated ATP-sensitive potassium channel Slo2.1;, PF03493;PF07885;, GO:0016021;GO:0005886;GO:0005524;GO:0070089;GO:0005228;GO:0015271;GO:0097623;, C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:chloride-activated potassium channel activity; F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity;, P:potassium ion export across plasma membrane; scaffold33 indexed_genome mRNA 2932655 2959928 . + . ID=transcript_7008;Q6UVM3 Q3SY59 Q5VTN1 Q6ZMT3,Potassium channel subfamily T member 2,Sequence like an intermediate conductance potassium channel subunit;Sodium and chloride-activated ATP-sensitive potassium channel Slo2.1;, PF03493;PF07885;, GO:0016021;GO:0005886;GO:0005524;GO:0070089;GO:0005228;GO:0015271;GO:0097623;, C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:chloride-activated potassium channel activity; F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity;, P:potassium ion export across plasma membrane; scaffold33 indexed_genome mRNA 3616101 3624687 . - . ID=transcript_7009;P19075 B2R7T7 Q9BS78,Tetraspanin-8,Transmembrane 4 superfamily member 3;Tumor-associated antigen CO-029;, PF00335;, GO:0009986;GO:0070062;GO:0005887;GO:0005178;GO:0030195;GO:0010468;GO:0007283;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane;, F:integrin binding;, P:negative regulation of blood coagulation; P:regulation of gene expression; P:spermatogenesis; scaffold33 indexed_genome mRNA 3898849 4024547 . - . ID=transcript_7010;O75473 D8MCT0 Q4VAM0 Q4VAM2 Q9UP75,Leucine-rich repeat-containing G-protein coupled receptor 5,G-protein coupled receptor 49;G-protein coupled receptor 67;G-protein coupled receptor HG38;, PF00560;PF13855;PF01462;, GO:0005794;GO:0005887;GO:0005654;GO:0005886;GO:0032588;GO:0008528;GO:0004930;GO:0016500;GO:0004888;GO:0007190;GO:0007189;GO:2001013;GO:0007186;GO:0001942;GO:0009755;GO:0048839;GO:0009994;GO:0090263;GO:0042127;, C:Golgi apparatus; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network membrane;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:protein-hormone receptor activity; F:transmembrane signaling receptor activity;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:G protein-coupled receptor signaling pathway; P:hair follicle development; P:hormone-mediated signaling pathway; P:inner ear development; P:oocyte differentiation; P:positive regulation of canonical Wnt signaling pathway; P:regulation of cell population proliferation;|O75473 D8MCT0 Q4VAM0 Q4VAM2 Q9UP75,Leucine-rich repeat-containing G-protein coupled receptor 5,G-protein coupled receptor 49;G-protein coupled receptor 67;G-protein coupled receptor HG38;, PF00560;PF13855;PF01462;, GO:0005794;GO:0005887;GO:0005654;GO:0005886;GO:0032588;GO:0008528;GO:0004930;GO:0016500;GO:0004888;GO:0007190;GO:0007189;GO:2001013;GO:0007186;GO:0001942;GO:0009755;GO:0048839;GO:0009994;GO:0090263;GO:0042127;, C:Golgi apparatus; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network membrane;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:protein-hormone receptor activity; F:transmembrane signaling receptor activity;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:G protein-coupled receptor signaling pathway; P:hair follicle development; P:hormone-mediated signaling pathway; P:inner ear development; P:oocyte differentiation; P:positive regulation of canonical Wnt signaling pathway; P:regulation of cell population proliferation;|O75473 D8MCT0 Q4VAM0 Q4VAM2 Q9UP75,Leucine-rich repeat-containing G-protein coupled receptor 5,G-protein coupled receptor 49;G-protein coupled receptor 67;G-protein coupled receptor HG38;, PF00560;PF13855;PF01462;, GO:0005794;GO:0005887;GO:0005654;GO:0005886;GO:0032588;GO:0008528;GO:0004930;GO:0016500;GO:0004888;GO:0007190;GO:0007189;GO:2001013;GO:0007186;GO:0001942;GO:0009755;GO:0048839;GO:0009994;GO:0090263;GO:0042127;, C:Golgi apparatus; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network membrane;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:protein-hormone receptor activity; F:transmembrane signaling receptor activity;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:G protein-coupled receptor signaling pathway; P:hair follicle development; P:hormone-mediated signaling pathway; P:inner ear development; P:oocyte differentiation; P:positive regulation of canonical Wnt signaling pathway; P:regulation of cell population proliferation; scaffold33 indexed_genome mRNA 4048224 4079203 . + . ID=transcript_7011;O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing;|O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing;|O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing;|O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing;|O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing;|O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing;|O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing;|O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing;|O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing;|O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing;|O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing; scaffold33 indexed_genome mRNA 4080670 4099662 . - . ID=transcript_7012;O60293 Q6GMU1 Q6P2S9 Q6ZV36 Q96BE7,Zinc finger C3H1 domain-containing protein,Coiled-coil domain-containing protein 131;Proline/serine-rich coiled-coil protein 2;, PF10650;, GO:0000178;GO:0005615;GO:0005634;GO:0046872;GO:0006396;, C:exosome (RNase complex); C:extracellular space; C:nucleus;, F:metal ion binding;, P:RNA processing; scaffold33 indexed_genome mRNA 4100123 4108249 . + . ID=transcript_7013;Q9H0W7 B2R8P3,THAP domain-containing protein 2,, PF05485;, GO:0005730;GO:0005634;GO:0003677;GO:0046872;, C:nucleolus; C:nucleus;, F:DNA binding; F:metal ion binding;|Q9H0W7 B2R8P3,THAP domain-containing protein 2,, PF05485;, GO:0005730;GO:0005634;GO:0003677;GO:0046872;, C:nucleolus; C:nucleus;, F:DNA binding; F:metal ion binding; scaffold33 indexed_genome mRNA 4110531 4116686 . - . ID=transcript_7014;Q9H0W7 B2R8P3,THAP domain-containing protein 2,, PF05485;, GO:0005730;GO:0005634;GO:0003677;GO:0046872;, C:nucleolus; C:nucleus;, F:DNA binding; F:metal ion binding; scaffold33 indexed_genome mRNA 4121096 4152442 . + . ID=transcript_7015;Q96HH6 B2RDL2 Q53FY3 Q9NV41,Transmembrane protein 19,, PF01940;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q96HH6 B2RDL2 Q53FY3 Q9NV41,Transmembrane protein 19,, PF01940;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane; scaffold33 indexed_genome mRNA 4197975 4216607 . + . ID=transcript_7016;Q9UL25 Q14466 Q569H3,Ras-related protein Rab-21,, PF00071;, GO:1904115;GO:0032154;GO:0098559;GO:0009898;GO:0030659;GO:0005829;GO:0005769;GO:0031901;GO:0012505;GO:0005789;GO:0005768;GO:0070062;GO:0005925;GO:0032580;GO:0045202;GO:0005802;GO:0012506;GO:0019003;GO:0005525;GO:0003924;GO:0008089;GO:0006886;GO:0050775;GO:2000643;GO:0048260;GO:0050821;GO:0032482;GO:0030516;GO:0017157;, C:axon cytoplasm; C:cleavage furrow; C:cytoplasmic side of early endosome membrane; C:cytoplasmic side of plasma membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:early endosome membrane; C:endomembrane system; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:Golgi cisterna membrane; C:synapse; C:trans-Golgi network; C:vesicle membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:anterograde axonal transport; P:intracellular protein transport; P:positive regulation of dendrite morphogenesis; P:positive regulation of early endosome to late endosome transport; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:Rab protein signal transduction; P:regulation of axon extension; P:regulation of exocytosis;|Q9UL25 Q14466 Q569H3,Ras-related protein Rab-21,, PF00071;, GO:1904115;GO:0032154;GO:0098559;GO:0009898;GO:0030659;GO:0005829;GO:0005769;GO:0031901;GO:0012505;GO:0005789;GO:0005768;GO:0070062;GO:0005925;GO:0032580;GO:0045202;GO:0005802;GO:0012506;GO:0019003;GO:0005525;GO:0003924;GO:0008089;GO:0006886;GO:0050775;GO:2000643;GO:0048260;GO:0050821;GO:0032482;GO:0030516;GO:0017157;, C:axon cytoplasm; C:cleavage furrow; C:cytoplasmic side of early endosome membrane; C:cytoplasmic side of plasma membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:early endosome membrane; C:endomembrane system; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:Golgi cisterna membrane; C:synapse; C:trans-Golgi network; C:vesicle membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:anterograde axonal transport; P:intracellular protein transport; P:positive regulation of dendrite morphogenesis; P:positive regulation of early endosome to late endosome transport; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:Rab protein signal transduction; P:regulation of axon extension; P:regulation of exocytosis;|Q9UL25 Q14466 Q569H3,Ras-related protein Rab-21,, PF00071;, GO:1904115;GO:0032154;GO:0098559;GO:0009898;GO:0030659;GO:0005829;GO:0005769;GO:0031901;GO:0012505;GO:0005789;GO:0005768;GO:0070062;GO:0005925;GO:0032580;GO:0045202;GO:0005802;GO:0012506;GO:0019003;GO:0005525;GO:0003924;GO:0008089;GO:0006886;GO:0050775;GO:2000643;GO:0048260;GO:0050821;GO:0032482;GO:0030516;GO:0017157;, C:axon cytoplasm; C:cleavage furrow; C:cytoplasmic side of early endosome membrane; C:cytoplasmic side of plasma membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:early endosome membrane; C:endomembrane system; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:Golgi cisterna membrane; C:synapse; C:trans-Golgi network; C:vesicle membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:anterograde axonal transport; P:intracellular protein transport; P:positive regulation of dendrite morphogenesis; P:positive regulation of early endosome to late endosome transport; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:Rab protein signal transduction; P:regulation of axon extension; P:regulation of exocytosis;|Q9UL25 Q14466 Q569H3,Ras-related protein Rab-21,, PF00071;, GO:1904115;GO:0032154;GO:0098559;GO:0009898;GO:0030659;GO:0005829;GO:0005769;GO:0031901;GO:0012505;GO:0005789;GO:0005768;GO:0070062;GO:0005925;GO:0032580;GO:0045202;GO:0005802;GO:0012506;GO:0019003;GO:0005525;GO:0003924;GO:0008089;GO:0006886;GO:0050775;GO:2000643;GO:0048260;GO:0050821;GO:0032482;GO:0030516;GO:0017157;, C:axon cytoplasm; C:cleavage furrow; C:cytoplasmic side of early endosome membrane; C:cytoplasmic side of plasma membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:early endosome membrane; C:endomembrane system; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:Golgi cisterna membrane; C:synapse; C:trans-Golgi network; C:vesicle membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:anterograde axonal transport; P:intracellular protein transport; P:positive regulation of dendrite morphogenesis; P:positive regulation of early endosome to late endosome transport; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:Rab protein signal transduction; P:regulation of axon extension; P:regulation of exocytosis; scaffold33 indexed_genome mRNA 4259948 4331857 . + . ID=transcript_7017;Q8TC07 B4DMT9 B9A6L6 J3KNI9 Q9HA83,TBC1 domain family member 15,GTPase-activating protein RAB7;, PF12068;PF00566;, GO:0005737;GO:0005576;GO:0005096;GO:0090630;GO:0006886;GO:0043087;, C:cytoplasm; C:extracellular region;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of GTPase activity;|Q8TC07 B4DMT9 B9A6L6 J3KNI9 Q9HA83,TBC1 domain family member 15,GTPase-activating protein RAB7;, PF12068;PF00566;, GO:0005737;GO:0005576;GO:0005096;GO:0090630;GO:0006886;GO:0043087;, C:cytoplasm; C:extracellular region;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of GTPase activity;|Q8TC07 B4DMT9 B9A6L6 J3KNI9 Q9HA83,TBC1 domain family member 15,GTPase-activating protein RAB7;, PF12068;PF00566;, GO:0005737;GO:0005576;GO:0005096;GO:0090630;GO:0006886;GO:0043087;, C:cytoplasm; C:extracellular region;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of GTPase activity;|Q8TC07 B4DMT9 B9A6L6 J3KNI9 Q9HA83,TBC1 domain family member 15,GTPase-activating protein RAB7;, PF12068;PF00566;, GO:0005737;GO:0005576;GO:0005096;GO:0090630;GO:0006886;GO:0043087;, C:cytoplasm; C:extracellular region;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of GTPase activity; scaffold33 indexed_genome mRNA 4710972 4724882 . + . ID=transcript_7018;Q9UKU6 A5PL19 Q6UWJ4,Thyrotropin-releasing hormone-degrading ectoenzyme,Pyroglutamyl-peptidase II;TRH-specific aminopeptidase;Thyroliberinase;, PF11838;PF01433;, GO:0005737;GO:0070062;GO:0005887;GO:0005886;GO:0004177;GO:0070006;GO:0042277;GO:0008270;GO:0007267;GO:0043171;GO:0006508;GO:0008217;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:peptide binding; F:zinc ion binding;, P:cell-cell signaling; P:peptide catabolic process; P:proteolysis; P:regulation of blood pressure; P:signal transduction; scaffold33 indexed_genome mRNA 4775392 5042702 . + . ID=transcript_7019;Q9UKU6 A5PL19 Q6UWJ4,Thyrotropin-releasing hormone-degrading ectoenzyme,Pyroglutamyl-peptidase II;TRH-specific aminopeptidase;Thyroliberinase;, PF11838;PF01433;, GO:0005737;GO:0070062;GO:0005887;GO:0005886;GO:0004177;GO:0070006;GO:0042277;GO:0008270;GO:0007267;GO:0043171;GO:0006508;GO:0008217;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:peptide binding; F:zinc ion binding;, P:cell-cell signaling; P:peptide catabolic process; P:proteolysis; P:regulation of blood pressure; P:signal transduction; scaffold33 indexed_genome mRNA 6660315 6664045 . - . ID=transcript_7020;Q96GX2,Ataxin-7-like protein 3B,, , GO:0005737;GO:0010468;, C:cytoplasm;, , P:regulation of gene expression; scaffold33 indexed_genome mRNA 7042903 7261706 . - . ID=transcript_7021;Q96PR1 B7Z231 F5H030 J3KPP5 Q4LE77 Q86W09 Q8N1V9 Q96PR0,Potassium voltage-gated channel subfamily C member 2 {ECO:0000312|HGNC:HGNC:6234},Shaw-like potassium channel {ECO:0000250|UniProtKB:P22462};Voltage-gated potassium channel Kv3.2 {ECO:0000250|UniProtKB:P22462};, PF02214;PF00520;, GO:0016324;GO:0030673;GO:0030424;GO:0016323;GO:0030425;GO:0032590;GO:0016021;GO:0005887;GO:0016020;GO:0032809;GO:0043204;GO:0005886;GO:0045211;GO:0042734;GO:0045202;GO:0043195;GO:0031982;GO:0008076;GO:0005251;GO:0044325;GO:0099508;GO:0005249;GO:0001508;GO:0071242;GO:0071732;GO:0097237;GO:0021759;GO:0038060;GO:1903818;GO:0071805;GO:0051291;GO:0051260;GO:0050796;GO:0014075;GO:0045471;GO:0009642;GO:0032026;GO:1990089;GO:0014070;, C:apical plasma membrane; C:axolemma; C:axon; C:basolateral plasma membrane; C:dendrite; C:dendrite membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:neuronal cell body membrane; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:synapse; C:terminal bouton; C:vesicle; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:ion channel binding; F:voltage-gated ion channel activity involved in regulation of presynaptic membrane potential; F:voltage-gated potassium channel activity;, P:action potential; P:cellular response to ammonium ion; P:cellular response to nitric oxide; P:cellular response to toxic substance; P:globus pallidus development; P:nitric oxide-cGMP-mediated signaling pathway; P:positive regulation of voltage-gated potassium channel activity; P:potassium ion transmembrane transport; P:protein heterooligomerization; P:protein homooligomerization; P:regulation of insulin secretion; P:response to amine; P:response to ethanol; P:response to light intensity; P:response to magnesium ion; P:response to nerve growth factor; P:response to organic cyclic compound;|Q96PR1 B7Z231 F5H030 J3KPP5 Q4LE77 Q86W09 Q8N1V9 Q96PR0,Potassium voltage-gated channel subfamily C member 2 {ECO:0000312|HGNC:HGNC:6234},Shaw-like potassium channel {ECO:0000250|UniProtKB:P22462};Voltage-gated potassium channel Kv3.2 {ECO:0000250|UniProtKB:P22462};, PF02214;PF00520;, GO:0016324;GO:0030673;GO:0030424;GO:0016323;GO:0030425;GO:0032590;GO:0016021;GO:0005887;GO:0016020;GO:0032809;GO:0043204;GO:0005886;GO:0045211;GO:0042734;GO:0045202;GO:0043195;GO:0031982;GO:0008076;GO:0005251;GO:0044325;GO:0099508;GO:0005249;GO:0001508;GO:0071242;GO:0071732;GO:0097237;GO:0021759;GO:0038060;GO:1903818;GO:0071805;GO:0051291;GO:0051260;GO:0050796;GO:0014075;GO:0045471;GO:0009642;GO:0032026;GO:1990089;GO:0014070;, C:apical plasma membrane; C:axolemma; C:axon; C:basolateral plasma membrane; C:dendrite; C:dendrite membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:neuronal cell body membrane; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:synapse; C:terminal bouton; C:vesicle; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:ion channel binding; F:voltage-gated ion channel activity involved in regulation of presynaptic membrane potential; F:voltage-gated potassium channel activity;, P:action potential; P:cellular response to ammonium ion; P:cellular response to nitric oxide; P:cellular response to toxic substance; P:globus pallidus development; P:nitric oxide-cGMP-mediated signaling pathway; P:positive regulation of voltage-gated potassium channel activity; P:potassium ion transmembrane transport; P:protein heterooligomerization; P:protein homooligomerization; P:regulation of insulin secretion; P:response to amine; P:response to ethanol; P:response to light intensity; P:response to magnesium ion; P:response to nerve growth factor; P:response to organic cyclic compound; scaffold33 indexed_genome mRNA 7332219 7365277 . - . ID=transcript_7022;Q9BXY5 Q6PH84 Q8N242 Q8NAY5,Calcyphosin-2,Calcyphosine-2;, , GO:0005509;, , F:calcium ion binding; scaffold33 indexed_genome mRNA 7549956 7552864 . - . ID=transcript_7023;Q13601 A0FIK6 A0JLP0 B2R989 E7EUQ0 Q8NEA8 Q8TC37 Q96AT5,KRR1 small subunit processome component homolog,HIV-1 Rev-binding protein 2;KRR-R motif-containing protein 1;Rev-interacting protein 1;, PF17903;, GO:0005694;GO:0005737;GO:0045171;GO:0016020;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:chromosome; C:cytoplasm; C:intercellular bridge; C:membrane; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing;|Q13601 A0FIK6 A0JLP0 B2R989 E7EUQ0 Q8NEA8 Q8TC37 Q96AT5,KRR1 small subunit processome component homolog,HIV-1 Rev-binding protein 2;KRR-R motif-containing protein 1;Rev-interacting protein 1;, PF17903;, GO:0005694;GO:0005737;GO:0045171;GO:0016020;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:chromosome; C:cytoplasm; C:intercellular bridge; C:membrane; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing; scaffold33 indexed_genome mRNA 7554792 7557455 . - . ID=transcript_7024;Q13601 A0FIK6 A0JLP0 B2R989 E7EUQ0 Q8NEA8 Q8TC37 Q96AT5,KRR1 small subunit processome component homolog,HIV-1 Rev-binding protein 2;KRR-R motif-containing protein 1;Rev-interacting protein 1;, PF17903;, GO:0005694;GO:0005737;GO:0045171;GO:0016020;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:chromosome; C:cytoplasm; C:intercellular bridge; C:membrane; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing; scaffold33 indexed_genome mRNA 7558241 7559562 . + . ID=transcript_7025;Q13601 A0FIK6 A0JLP0 B2R989 E7EUQ0 Q8NEA8 Q8TC37 Q96AT5,KRR1 small subunit processome component homolog,HIV-1 Rev-binding protein 2;KRR-R motif-containing protein 1;Rev-interacting protein 1;, PF17903;, GO:0005694;GO:0005737;GO:0045171;GO:0016020;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:chromosome; C:cytoplasm; C:intercellular bridge; C:membrane; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing; scaffold33 indexed_genome mRNA 8052289 8054147 . - . ID=transcript_7026;Q8WV24 A1A4G9 Q15184 Q2TAN2 Q9NZ17,Pleckstrin homology-like domain family A member 1,Apoptosis-associated nuclear protein;Proline- and glutamine-rich protein;Proline- and histidine-rich protein;T-cell death-associated gene 51 protein;, , GO:0031410;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:1901981;GO:0006915;GO:0045210;GO:0000086;GO:0043065;, C:cytoplasmic vesicle; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:phosphatidylinositol phosphate binding;, P:apoptotic process; P:FasL biosynthetic process; P:G2/M transition of mitotic cell cycle; P:positive regulation of apoptotic process; scaffold33 indexed_genome mRNA 8069627 8092590 . - . ID=transcript_7027;P55209 B3KNT8 B3KV44,Nucleosome assembly protein 1-like 1,NAP-1-related protein;, PF00956;, GO:0000785;GO:0005737;GO:0042470;GO:0016020;GO:0005634;GO:0003682;GO:0042393;GO:0003723;GO:0006260;GO:0006334;GO:0008284;GO:2000179;GO:0050769;, C:chromatin; C:cytoplasm; C:melanosome; C:membrane; C:nucleus;, F:chromatin binding; F:histone binding; F:RNA binding;, P:DNA replication; P:nucleosome assembly; P:positive regulation of cell population proliferation; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neurogenesis;|P55209 B3KNT8 B3KV44,Nucleosome assembly protein 1-like 1,NAP-1-related protein;, PF00956;, GO:0000785;GO:0005737;GO:0042470;GO:0016020;GO:0005634;GO:0003682;GO:0042393;GO:0003723;GO:0006260;GO:0006334;GO:0008284;GO:2000179;GO:0050769;, C:chromatin; C:cytoplasm; C:melanosome; C:membrane; C:nucleus;, F:chromatin binding; F:histone binding; F:RNA binding;, P:DNA replication; P:nucleosome assembly; P:positive regulation of cell population proliferation; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neurogenesis;|P55209 B3KNT8 B3KV44,Nucleosome assembly protein 1-like 1,NAP-1-related protein;, PF00956;, GO:0000785;GO:0005737;GO:0042470;GO:0016020;GO:0005634;GO:0003682;GO:0042393;GO:0003723;GO:0006260;GO:0006334;GO:0008284;GO:2000179;GO:0050769;, C:chromatin; C:cytoplasm; C:melanosome; C:membrane; C:nucleus;, F:chromatin binding; F:histone binding; F:RNA binding;, P:DNA replication; P:nucleosome assembly; P:positive regulation of cell population proliferation; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neurogenesis;|Q5VTE0,Putative elongation factor 1-alpha-like 3,Eukaryotic elongation factor 1 A-like 3;Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5;, PF00009;PF03144;PF03143;, GO:0005737;GO:0070062;GO:0005615;GO:0005634;GO:0005525;GO:0003924;GO:0003746;GO:0006412;GO:0006414;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleus;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:translation; P:translational elongation; scaffold33 indexed_genome mRNA 8094639 8096147 . - . ID=transcript_7028;P68104 P04719 P04720 Q6IQ15,Elongation factor 1-alpha 1,Elongation factor Tu;Eukaryotic elongation factor 1 A-1;Leukocyte receptor cluster member 7;, PF00009;PF03144;PF03143;, GO:0030864;GO:0005737;GO:0098574;GO:0005829;GO:0005853;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0016020;GO:0005730;GO:0005634;GO:0005886;GO:0032587;GO:0034774;GO:0005516;GO:0005525;GO:0003924;GO:0019900;GO:0019901;GO:0003723;GO:0003746;GO:0000049;GO:0071364;GO:0043312;GO:1904714;GO:1900022;GO:0006412;GO:0006414;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of lysosomal membrane; C:cytosol; C:eukaryotic translation elongation factor 1 complex; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:membrane; C:nucleolus; C:nucleus; C:plasma membrane; C:ruffle membrane; C:secretory granule lumen;, F:calmodulin binding; F:GTP binding; F:GTPase activity; F:kinase binding; F:protein kinase binding; F:RNA binding; F:translation elongation factor activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:neutrophil degranulation; P:regulation of chaperone-mediated autophagy; P:regulation of D-erythro-sphingosine kinase activity; P:translation; P:translational elongation; scaffold33 indexed_genome mRNA 8305692 8309932 . - . ID=transcript_7029;Q8TAM1 Q96CW2 Q9H5D2,Bardet-Biedl syndrome 10 protein,, PF00118;, GO:0005929;GO:0005524;GO:0016887;GO:0001103;GO:0051131;GO:1905515;GO:0045494;GO:0043254;GO:0050896;GO:0007601;, C:cilium;, F:ATP binding; F:ATPase activity; F:RNA polymerase II repressing transcription factor binding;, P:chaperone-mediated protein complex assembly; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:regulation of protein-containing complex assembly; P:response to stimulus; P:visual perception; scaffold33 indexed_genome mRNA 8315107 8476999 . - . ID=transcript_7030;Q9BZF1 A8K1T2 E9PE66 E9PE68 Q52LQ3 Q68D75 Q8WXP8 Q9P277,Oxysterol-binding protein-related protein 8,, PF01237;PF00169;, GO:0032541;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0031965;GO:0015485;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0032148;GO:0045444;GO:0030336;GO:0010891;GO:0036150;GO:0015914;GO:0046326;GO:0046628;GO:0051897;GO:0090204;, C:cortical endoplasmic reticulum; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear membrane;, F:cholesterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:activation of protein kinase B activity; P:fat cell differentiation; P:negative regulation of cell migration; P:negative regulation of sequestering of triglyceride; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; P:positive regulation of glucose import; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein kinase B signaling; P:protein localization to nuclear pore;|Q9BZF1 A8K1T2 E9PE66 E9PE68 Q52LQ3 Q68D75 Q8WXP8 Q9P277,Oxysterol-binding protein-related protein 8,, PF01237;PF00169;, GO:0032541;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0031965;GO:0015485;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0032148;GO:0045444;GO:0030336;GO:0010891;GO:0036150;GO:0015914;GO:0046326;GO:0046628;GO:0051897;GO:0090204;, C:cortical endoplasmic reticulum; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear membrane;, F:cholesterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:activation of protein kinase B activity; P:fat cell differentiation; P:negative regulation of cell migration; P:negative regulation of sequestering of triglyceride; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; P:positive regulation of glucose import; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein kinase B signaling; P:protein localization to nuclear pore;|Q9BZF1 A8K1T2 E9PE66 E9PE68 Q52LQ3 Q68D75 Q8WXP8 Q9P277,Oxysterol-binding protein-related protein 8,, PF01237;PF00169;, GO:0032541;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0031965;GO:0015485;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0032148;GO:0045444;GO:0030336;GO:0010891;GO:0036150;GO:0015914;GO:0046326;GO:0046628;GO:0051897;GO:0090204;, C:cortical endoplasmic reticulum; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear membrane;, F:cholesterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:activation of protein kinase B activity; P:fat cell differentiation; P:negative regulation of cell migration; P:negative regulation of sequestering of triglyceride; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; P:positive regulation of glucose import; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein kinase B signaling; P:protein localization to nuclear pore;|Q9BZF1 A8K1T2 E9PE66 E9PE68 Q52LQ3 Q68D75 Q8WXP8 Q9P277,Oxysterol-binding protein-related protein 8,, PF01237;PF00169;, GO:0032541;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0031965;GO:0015485;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0032148;GO:0045444;GO:0030336;GO:0010891;GO:0036150;GO:0015914;GO:0046326;GO:0046628;GO:0051897;GO:0090204;, C:cortical endoplasmic reticulum; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear membrane;, F:cholesterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:activation of protein kinase B activity; P:fat cell differentiation; P:negative regulation of cell migration; P:negative regulation of sequestering of triglyceride; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; P:positive regulation of glucose import; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein kinase B signaling; P:protein localization to nuclear pore;|P46778 Q16699,60S ribosomal protein L21,Large ribosomal subunit protein eL21 {ECO:0000303|PubMed:24524803};, PF01157;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold33 indexed_genome mRNA 8674720 8746549 . + . ID=transcript_7031;Q8IUH5 B4DR39 O75407 Q7Z2I0 Q86W89 Q86YK0 Q9P088 Q9UPZ8,Palmitoyltransferase ZDHHC17 {ECO:0000305},Acyltransferase ZDHHC17 {ECO:0000250|UniProtKB:Q80TN5};DHHC domain-containing cysteine-rich protein 17 {ECO:0000305|PubMed:28757145};Huntingtin yeast partner H {ECO:0000303|PubMed:9700202};Huntingtin-interacting protein 14 {ECO:0000303|PubMed:15489887};Huntingtin-interacting protein 3 {ECO:0000312|EMBL:BAC22089.1};Huntingtin-interacting protein H {ECO:0000303|PubMed:9700202};Putative MAPK-activating protein PM11 {ECO:0000305|PubMed:12761501};Putative NF-kappa-B-activating protein 205 {ECO:0000305|PubMed:12761501};Zinc finger DHHC domain-containing protein 17 {ECO:0000312|HGNC:HGNC:18412};, PF12796;PF01529;, GO:0016235;GO:0042995;GO:0030659;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0043231;GO:0042734;GO:0042802;GO:0015095;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0005102;GO:0007409;GO:0042953;GO:0018230;GO:0043123;GO:0018345;GO:0070372;GO:0051386;, C:aggresome; C:cell projection; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:presynaptic membrane;, F:identical protein binding; F:magnesium ion transmembrane transporter activity; F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:signaling receptor binding;, P:axonogenesis; P:lipoprotein transport; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein palmitoylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of neurotrophin TRK receptor signaling pathway;|Q8IUH5 B4DR39 O75407 Q7Z2I0 Q86W89 Q86YK0 Q9P088 Q9UPZ8,Palmitoyltransferase ZDHHC17 {ECO:0000305},Acyltransferase ZDHHC17 {ECO:0000250|UniProtKB:Q80TN5};DHHC domain-containing cysteine-rich protein 17 {ECO:0000305|PubMed:28757145};Huntingtin yeast partner H {ECO:0000303|PubMed:9700202};Huntingtin-interacting protein 14 {ECO:0000303|PubMed:15489887};Huntingtin-interacting protein 3 {ECO:0000312|EMBL:BAC22089.1};Huntingtin-interacting protein H {ECO:0000303|PubMed:9700202};Putative MAPK-activating protein PM11 {ECO:0000305|PubMed:12761501};Putative NF-kappa-B-activating protein 205 {ECO:0000305|PubMed:12761501};Zinc finger DHHC domain-containing protein 17 {ECO:0000312|HGNC:HGNC:18412};, PF12796;PF01529;, GO:0016235;GO:0042995;GO:0030659;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0043231;GO:0042734;GO:0042802;GO:0015095;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0005102;GO:0007409;GO:0042953;GO:0018230;GO:0043123;GO:0018345;GO:0070372;GO:0051386;, C:aggresome; C:cell projection; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:presynaptic membrane;, F:identical protein binding; F:magnesium ion transmembrane transporter activity; F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:signaling receptor binding;, P:axonogenesis; P:lipoprotein transport; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein palmitoylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of neurotrophin TRK receptor signaling pathway;|Q8IUH5 B4DR39 O75407 Q7Z2I0 Q86W89 Q86YK0 Q9P088 Q9UPZ8,Palmitoyltransferase ZDHHC17 {ECO:0000305},Acyltransferase ZDHHC17 {ECO:0000250|UniProtKB:Q80TN5};DHHC domain-containing cysteine-rich protein 17 {ECO:0000305|PubMed:28757145};Huntingtin yeast partner H {ECO:0000303|PubMed:9700202};Huntingtin-interacting protein 14 {ECO:0000303|PubMed:15489887};Huntingtin-interacting protein 3 {ECO:0000312|EMBL:BAC22089.1};Huntingtin-interacting protein H {ECO:0000303|PubMed:9700202};Putative MAPK-activating protein PM11 {ECO:0000305|PubMed:12761501};Putative NF-kappa-B-activating protein 205 {ECO:0000305|PubMed:12761501};Zinc finger DHHC domain-containing protein 17 {ECO:0000312|HGNC:HGNC:18412};, PF12796;PF01529;, GO:0016235;GO:0042995;GO:0030659;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0043231;GO:0042734;GO:0042802;GO:0015095;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0005102;GO:0007409;GO:0042953;GO:0018230;GO:0043123;GO:0018345;GO:0070372;GO:0051386;, C:aggresome; C:cell projection; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:presynaptic membrane;, F:identical protein binding; F:magnesium ion transmembrane transporter activity; F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:signaling receptor binding;, P:axonogenesis; P:lipoprotein transport; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein palmitoylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of neurotrophin TRK receptor signaling pathway;|Q8IUH5 B4DR39 O75407 Q7Z2I0 Q86W89 Q86YK0 Q9P088 Q9UPZ8,Palmitoyltransferase ZDHHC17 {ECO:0000305},Acyltransferase ZDHHC17 {ECO:0000250|UniProtKB:Q80TN5};DHHC domain-containing cysteine-rich protein 17 {ECO:0000305|PubMed:28757145};Huntingtin yeast partner H {ECO:0000303|PubMed:9700202};Huntingtin-interacting protein 14 {ECO:0000303|PubMed:15489887};Huntingtin-interacting protein 3 {ECO:0000312|EMBL:BAC22089.1};Huntingtin-interacting protein H {ECO:0000303|PubMed:9700202};Putative MAPK-activating protein PM11 {ECO:0000305|PubMed:12761501};Putative NF-kappa-B-activating protein 205 {ECO:0000305|PubMed:12761501};Zinc finger DHHC domain-containing protein 17 {ECO:0000312|HGNC:HGNC:18412};, PF12796;PF01529;, GO:0016235;GO:0042995;GO:0030659;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0043231;GO:0042734;GO:0042802;GO:0015095;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0005102;GO:0007409;GO:0042953;GO:0018230;GO:0043123;GO:0018345;GO:0070372;GO:0051386;, C:aggresome; C:cell projection; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:presynaptic membrane;, F:identical protein binding; F:magnesium ion transmembrane transporter activity; F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:signaling receptor binding;, P:axonogenesis; P:lipoprotein transport; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein palmitoylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of neurotrophin TRK receptor signaling pathway;|Q8IUH5 B4DR39 O75407 Q7Z2I0 Q86W89 Q86YK0 Q9P088 Q9UPZ8,Palmitoyltransferase ZDHHC17 {ECO:0000305},Acyltransferase ZDHHC17 {ECO:0000250|UniProtKB:Q80TN5};DHHC domain-containing cysteine-rich protein 17 {ECO:0000305|PubMed:28757145};Huntingtin yeast partner H {ECO:0000303|PubMed:9700202};Huntingtin-interacting protein 14 {ECO:0000303|PubMed:15489887};Huntingtin-interacting protein 3 {ECO:0000312|EMBL:BAC22089.1};Huntingtin-interacting protein H {ECO:0000303|PubMed:9700202};Putative MAPK-activating protein PM11 {ECO:0000305|PubMed:12761501};Putative NF-kappa-B-activating protein 205 {ECO:0000305|PubMed:12761501};Zinc finger DHHC domain-containing protein 17 {ECO:0000312|HGNC:HGNC:18412};, PF12796;PF01529;, GO:0016235;GO:0042995;GO:0030659;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0043231;GO:0042734;GO:0042802;GO:0015095;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0005102;GO:0007409;GO:0042953;GO:0018230;GO:0043123;GO:0018345;GO:0070372;GO:0051386;, C:aggresome; C:cell projection; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:presynaptic membrane;, F:identical protein binding; F:magnesium ion transmembrane transporter activity; F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:signaling receptor binding;, P:axonogenesis; P:lipoprotein transport; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein palmitoylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of neurotrophin TRK receptor signaling pathway;|Q8IUH5 B4DR39 O75407 Q7Z2I0 Q86W89 Q86YK0 Q9P088 Q9UPZ8,Palmitoyltransferase ZDHHC17 {ECO:0000305},Acyltransferase ZDHHC17 {ECO:0000250|UniProtKB:Q80TN5};DHHC domain-containing cysteine-rich protein 17 {ECO:0000305|PubMed:28757145};Huntingtin yeast partner H {ECO:0000303|PubMed:9700202};Huntingtin-interacting protein 14 {ECO:0000303|PubMed:15489887};Huntingtin-interacting protein 3 {ECO:0000312|EMBL:BAC22089.1};Huntingtin-interacting protein H {ECO:0000303|PubMed:9700202};Putative MAPK-activating protein PM11 {ECO:0000305|PubMed:12761501};Putative NF-kappa-B-activating protein 205 {ECO:0000305|PubMed:12761501};Zinc finger DHHC domain-containing protein 17 {ECO:0000312|HGNC:HGNC:18412};, PF12796;PF01529;, GO:0016235;GO:0042995;GO:0030659;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0043231;GO:0042734;GO:0042802;GO:0015095;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0005102;GO:0007409;GO:0042953;GO:0018230;GO:0043123;GO:0018345;GO:0070372;GO:0051386;, C:aggresome; C:cell projection; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:presynaptic membrane;, F:identical protein binding; F:magnesium ion transmembrane transporter activity; F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:signaling receptor binding;, P:axonogenesis; P:lipoprotein transport; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein palmitoylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of neurotrophin TRK receptor signaling pathway;|Q8IUH5 B4DR39 O75407 Q7Z2I0 Q86W89 Q86YK0 Q9P088 Q9UPZ8,Palmitoyltransferase ZDHHC17 {ECO:0000305},Acyltransferase ZDHHC17 {ECO:0000250|UniProtKB:Q80TN5};DHHC domain-containing cysteine-rich protein 17 {ECO:0000305|PubMed:28757145};Huntingtin yeast partner H {ECO:0000303|PubMed:9700202};Huntingtin-interacting protein 14 {ECO:0000303|PubMed:15489887};Huntingtin-interacting protein 3 {ECO:0000312|EMBL:BAC22089.1};Huntingtin-interacting protein H {ECO:0000303|PubMed:9700202};Putative MAPK-activating protein PM11 {ECO:0000305|PubMed:12761501};Putative NF-kappa-B-activating protein 205 {ECO:0000305|PubMed:12761501};Zinc finger DHHC domain-containing protein 17 {ECO:0000312|HGNC:HGNC:18412};, PF12796;PF01529;, GO:0016235;GO:0042995;GO:0030659;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0043231;GO:0042734;GO:0042802;GO:0015095;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0005102;GO:0007409;GO:0042953;GO:0018230;GO:0043123;GO:0018345;GO:0070372;GO:0051386;, C:aggresome; C:cell projection; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:presynaptic membrane;, F:identical protein binding; F:magnesium ion transmembrane transporter activity; F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:signaling receptor binding;, P:axonogenesis; P:lipoprotein transport; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein palmitoylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of neurotrophin TRK receptor signaling pathway; scaffold33 indexed_genome mRNA 8751605 8772110 . - . ID=transcript_7032;Q16527 Q93030,Cysteine and glycine-rich protein 2,Cysteine-rich protein 2;LIM domain only protein 5;Smooth muscle cell LIM protein;, PF00412;, GO:0005737;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0046872;GO:0008307;GO:0030036;GO:0030154;GO:0007275;GO:0060537;GO:0045214;, C:cytoplasm; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:metal ion binding; F:structural constituent of muscle;, P:actin cytoskeleton organization; P:cell differentiation; P:multicellular organism development; P:muscle tissue development; P:sarcomere organization;|Q16527 Q93030,Cysteine and glycine-rich protein 2,Cysteine-rich protein 2;LIM domain only protein 5;Smooth muscle cell LIM protein;, PF00412;, GO:0005737;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0046872;GO:0008307;GO:0030036;GO:0030154;GO:0007275;GO:0060537;GO:0045214;, C:cytoplasm; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:metal ion binding; F:structural constituent of muscle;, P:actin cytoskeleton organization; P:cell differentiation; P:multicellular organism development; P:muscle tissue development; P:sarcomere organization;|Q16527 Q93030,Cysteine and glycine-rich protein 2,Cysteine-rich protein 2;LIM domain only protein 5;Smooth muscle cell LIM protein;, PF00412;, GO:0005737;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0046872;GO:0008307;GO:0030036;GO:0030154;GO:0007275;GO:0060537;GO:0045214;, C:cytoplasm; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:metal ion binding; F:structural constituent of muscle;, P:actin cytoskeleton organization; P:cell differentiation; P:multicellular organism development; P:muscle tissue development; P:sarcomere organization;|Q16527 Q93030,Cysteine and glycine-rich protein 2,Cysteine-rich protein 2;LIM domain only protein 5;Smooth muscle cell LIM protein;, PF00412;, GO:0005737;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0046872;GO:0008307;GO:0030036;GO:0030154;GO:0007275;GO:0060537;GO:0045214;, C:cytoplasm; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:metal ion binding; F:structural constituent of muscle;, P:actin cytoskeleton organization; P:cell differentiation; P:multicellular organism development; P:muscle tissue development; P:sarcomere organization; scaffold33 indexed_genome mRNA 9866391 9930536 . + . ID=transcript_7033;Q8IVL0 Q8NFW7 Q9Y2E7,Neuron navigator 3,Pore membrane and/or filament-interacting-like protein 1;Steerin-3;Unc-53 homolog 3;, PF00004;PF00307;, GO:0005640;GO:0005524;GO:0016887;GO:0008017;GO:0030336;GO:0032703;GO:0007026;GO:0007399;GO:0022008;GO:0031116;, C:nuclear outer membrane;, F:ATP binding; F:ATPase activity; F:microtubule binding;, P:negative regulation of cell migration; P:negative regulation of interleukin-2 production; P:negative regulation of microtubule depolymerization; P:nervous system development; P:neurogenesis; P:positive regulation of microtubule polymerization;|Q8IVL0 Q8NFW7 Q9Y2E7,Neuron navigator 3,Pore membrane and/or filament-interacting-like protein 1;Steerin-3;Unc-53 homolog 3;, PF00004;PF00307;, GO:0005640;GO:0005524;GO:0016887;GO:0008017;GO:0030336;GO:0032703;GO:0007026;GO:0007399;GO:0022008;GO:0031116;, C:nuclear outer membrane;, F:ATP binding; F:ATPase activity; F:microtubule binding;, P:negative regulation of cell migration; P:negative regulation of interleukin-2 production; P:negative regulation of microtubule depolymerization; P:nervous system development; P:neurogenesis; P:positive regulation of microtubule polymerization; scaffold33 indexed_genome mRNA 9974134 10042935 . + . ID=transcript_7034;Q8IVL0 Q8NFW7 Q9Y2E7,Neuron navigator 3,Pore membrane and/or filament-interacting-like protein 1;Steerin-3;Unc-53 homolog 3;, PF00004;PF00307;, GO:0005640;GO:0005524;GO:0016887;GO:0008017;GO:0030336;GO:0032703;GO:0007026;GO:0007399;GO:0022008;GO:0031116;, C:nuclear outer membrane;, F:ATP binding; F:ATPase activity; F:microtubule binding;, P:negative regulation of cell migration; P:negative regulation of interleukin-2 production; P:negative regulation of microtubule depolymerization; P:nervous system development; P:neurogenesis; P:positive regulation of microtubule polymerization; scaffold33 indexed_genome mRNA 10048888 10123173 . + . ID=transcript_7035;Q8IVL0 Q8NFW7 Q9Y2E7,Neuron navigator 3,Pore membrane and/or filament-interacting-like protein 1;Steerin-3;Unc-53 homolog 3;, PF00004;PF00307;, GO:0005640;GO:0005524;GO:0016887;GO:0008017;GO:0030336;GO:0032703;GO:0007026;GO:0007399;GO:0022008;GO:0031116;, C:nuclear outer membrane;, F:ATP binding; F:ATPase activity; F:microtubule binding;, P:negative regulation of cell migration; P:negative regulation of interleukin-2 production; P:negative regulation of microtubule depolymerization; P:nervous system development; P:neurogenesis; P:positive regulation of microtubule polymerization; scaffold33 indexed_genome mRNA 11187191 11409858 . + . ID=transcript_7036;P21579 Q6AI31,Synaptotagmin-1,Synaptotagmin I;p65;, PF00168;, GO:0030424;GO:0042584;GO:0030669;GO:0060201;GO:0061202;GO:0060203;GO:0070083;GO:0005737;GO:0031045;GO:0060076;GO:0070382;GO:0098978;GO:0005794;GO:0098686;GO:0030285;GO:0043005;GO:0044306;GO:0005886;GO:0042734;GO:0008021;GO:0030672;GO:0005509;GO:0061891;GO:0005544;GO:0048306;GO:0005516;GO:0030276;GO:0042802;GO:0050750;GO:0005546;GO:0001786;GO:0008022;GO:0046982;GO:0000149;GO:0019905;GO:0017075;GO:0030348;GO:0007420;GO:0048791;GO:0099502;GO:0017156;GO:0030154;GO:0071277;GO:0007268;GO:0005513;GO:0098746;GO:0061024;GO:0007269;GO:0006836;GO:1903235;GO:1903861;GO:0033603;GO:0050806;GO:0051291;GO:0017158;GO:0014059;GO:0017157;GO:1903305;GO:0051966;GO:0061669;GO:0048488;GO:0071911;GO:0048278;GO:0016192;, C:axon; C:chromaffin granule membrane; C:clathrin-coated endocytic vesicle membrane; C:clathrin-sculpted acetylcholine transport vesicle membrane; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:clathrin-sculpted glutamate transport vesicle membrane; C:clathrin-sculpted monoamine transport vesicle membrane; C:cytoplasm; C:dense core granule; C:excitatory synapse; C:exocytic vesicle; C:glutamatergic synapse; C:Golgi apparatus; C:hippocampal mossy fiber to CA3 synapse; C:integral component of synaptic vesicle membrane; C:neuron projection; C:neuron projection terminus; C:plasma membrane; C:presynaptic membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium ion sensor activity; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:calmodulin binding; F:clathrin binding; F:identical protein binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:SNARE binding; F:syntaxin binding; F:syntaxin-1 binding; F:syntaxin-3 binding;, P:brain development; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-dependent activation of synaptic vesicle fusion; P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:chemical synaptic transmission; P:detection of calcium ion; P:fast, calcium ion-dependent exocytosis of neurotransmitter; P:membrane organization; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of calcium ion-dependent exocytosis of neurotransmitter; P:positive regulation of dendrite extension; P:positive regulation of dopamine secretion; P:positive regulation of synaptic transmission; P:protein heterooligomerization; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of exocytosis; P:regulation of regulated secretory pathway; P:regulation of synaptic transmission, glutamatergic; P:spontaneous neurotransmitter secretion; P:synaptic vesicle endocytosis; P:synchronous neurotransmitter secretion; P:vesicle docking; P:vesicle-mediated transport; scaffold33 indexed_genome mRNA 11409876 11415783 . + . ID=transcript_7037;P21579 Q6AI31,Synaptotagmin-1,Synaptotagmin I;p65;, PF00168;, GO:0030424;GO:0042584;GO:0030669;GO:0060201;GO:0061202;GO:0060203;GO:0070083;GO:0005737;GO:0031045;GO:0060076;GO:0070382;GO:0098978;GO:0005794;GO:0098686;GO:0030285;GO:0043005;GO:0044306;GO:0005886;GO:0042734;GO:0008021;GO:0030672;GO:0005509;GO:0061891;GO:0005544;GO:0048306;GO:0005516;GO:0030276;GO:0042802;GO:0050750;GO:0005546;GO:0001786;GO:0008022;GO:0046982;GO:0000149;GO:0019905;GO:0017075;GO:0030348;GO:0007420;GO:0048791;GO:0099502;GO:0017156;GO:0030154;GO:0071277;GO:0007268;GO:0005513;GO:0098746;GO:0061024;GO:0007269;GO:0006836;GO:1903235;GO:1903861;GO:0033603;GO:0050806;GO:0051291;GO:0017158;GO:0014059;GO:0017157;GO:1903305;GO:0051966;GO:0061669;GO:0048488;GO:0071911;GO:0048278;GO:0016192;, C:axon; C:chromaffin granule membrane; C:clathrin-coated endocytic vesicle membrane; C:clathrin-sculpted acetylcholine transport vesicle membrane; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:clathrin-sculpted glutamate transport vesicle membrane; C:clathrin-sculpted monoamine transport vesicle membrane; C:cytoplasm; C:dense core granule; C:excitatory synapse; C:exocytic vesicle; C:glutamatergic synapse; C:Golgi apparatus; C:hippocampal mossy fiber to CA3 synapse; C:integral component of synaptic vesicle membrane; C:neuron projection; C:neuron projection terminus; C:plasma membrane; C:presynaptic membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium ion sensor activity; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:calmodulin binding; F:clathrin binding; F:identical protein binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:SNARE binding; F:syntaxin binding; F:syntaxin-1 binding; F:syntaxin-3 binding;, P:brain development; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-dependent activation of synaptic vesicle fusion; P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:chemical synaptic transmission; P:detection of calcium ion; P:fast, calcium ion-dependent exocytosis of neurotransmitter; P:membrane organization; P:neurotransmitter secretion; P:neurotransmitter transport; P:positive regulation of calcium ion-dependent exocytosis of neurotransmitter; P:positive regulation of dendrite extension; P:positive regulation of dopamine secretion; P:positive regulation of synaptic transmission; P:protein heterooligomerization; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of exocytosis; P:regulation of regulated secretory pathway; P:regulation of synaptic transmission, glutamatergic; P:spontaneous neurotransmitter secretion; P:synaptic vesicle endocytosis; P:synchronous neurotransmitter secretion; P:vesicle docking; P:vesicle-mediated transport; scaffold33 indexed_genome mRNA 11487854 11605848 . - . ID=transcript_7038;Q96IZ0 O75796 Q6FHY9 Q8N700,PRKC apoptosis WT1 regulator protein,Prostate apoptosis response 4 protein;, , GO:0015629;GO:0000785;GO:0005737;GO:0005634;GO:0005886;GO:0003779;GO:0019899;GO:0043522;GO:0003714;GO:0051017;GO:0006915;GO:0097190;GO:0030889;GO:0048147;GO:0042130;GO:0050860;GO:0000122;GO:0042986;GO:0043065;GO:2000774;GO:0010628;GO:1901300;, C:actin cytoskeleton; C:chromatin; C:cytoplasm; C:nucleus; C:plasma membrane;, F:actin binding; F:enzyme binding; F:leucine zipper domain binding; F:transcription corepressor activity;, P:actin filament bundle assembly; P:apoptotic process; P:apoptotic signaling pathway; P:negative regulation of B cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of T cell proliferation; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of cellular senescence; P:positive regulation of gene expression; P:positive regulation of hydrogen peroxide-mediated programmed cell death; scaffold33 indexed_genome mRNA 11657486 11660576 . - . ID=transcript_7039;O14974 B4DZ09 F8VWB4 Q2NKL4 Q569H0 Q86WU3 Q8NFR6 Q9BYH0,Protein phosphatase 1 regulatory subunit 12A,Myosin phosphatase-targeting subunit 1;Protein phosphatase myosin-binding subunit;, PF12796;PF15898;, GO:0031672;GO:0015629;GO:0005813;GO:0043292;GO:0005737;GO:0005829;GO:0005925;GO:0000776;GO:0005730;GO:0005654;GO:0005886;GO:0072357;GO:0030018;GO:0071889;GO:0004857;GO:0019208;GO:0019901;GO:0035690;GO:0007098;GO:0000086;GO:0000278;GO:0043086;GO:0035508;GO:0045944;GO:0006470;GO:0030155;GO:0035507;GO:0046822;GO:0007165;, C:A band; C:actin cytoskeleton; C:centrosome; C:contractile fiber; C:cytoplasm; C:cytosol; C:focal adhesion; C:kinetochore; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:PTW/PP1 phosphatase complex; C:Z disc;, F:14-3-3 protein binding; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:cellular response to drug; P:centrosome cycle; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of catalytic activity; P:positive regulation of myosin-light-chain-phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of myosin-light-chain-phosphatase activity; P:regulation of nucleocytoplasmic transport; P:signal transduction; scaffold33 indexed_genome mRNA 11662724 11815917 . - . ID=transcript_7040;O14974 B4DZ09 F8VWB4 Q2NKL4 Q569H0 Q86WU3 Q8NFR6 Q9BYH0,Protein phosphatase 1 regulatory subunit 12A,Myosin phosphatase-targeting subunit 1;Protein phosphatase myosin-binding subunit;, PF12796;PF15898;, GO:0031672;GO:0015629;GO:0005813;GO:0043292;GO:0005737;GO:0005829;GO:0005925;GO:0000776;GO:0005730;GO:0005654;GO:0005886;GO:0072357;GO:0030018;GO:0071889;GO:0004857;GO:0019208;GO:0019901;GO:0035690;GO:0007098;GO:0000086;GO:0000278;GO:0043086;GO:0035508;GO:0045944;GO:0006470;GO:0030155;GO:0035507;GO:0046822;GO:0007165;, C:A band; C:actin cytoskeleton; C:centrosome; C:contractile fiber; C:cytoplasm; C:cytosol; C:focal adhesion; C:kinetochore; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:PTW/PP1 phosphatase complex; C:Z disc;, F:14-3-3 protein binding; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:cellular response to drug; P:centrosome cycle; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of catalytic activity; P:positive regulation of myosin-light-chain-phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of myosin-light-chain-phosphatase activity; P:regulation of nucleocytoplasmic transport; P:signal transduction;|O14974 B4DZ09 F8VWB4 Q2NKL4 Q569H0 Q86WU3 Q8NFR6 Q9BYH0,Protein phosphatase 1 regulatory subunit 12A,Myosin phosphatase-targeting subunit 1;Protein phosphatase myosin-binding subunit;, PF12796;PF15898;, GO:0031672;GO:0015629;GO:0005813;GO:0043292;GO:0005737;GO:0005829;GO:0005925;GO:0000776;GO:0005730;GO:0005654;GO:0005886;GO:0072357;GO:0030018;GO:0071889;GO:0004857;GO:0019208;GO:0019901;GO:0035690;GO:0007098;GO:0000086;GO:0000278;GO:0043086;GO:0035508;GO:0045944;GO:0006470;GO:0030155;GO:0035507;GO:0046822;GO:0007165;, C:A band; C:actin cytoskeleton; C:centrosome; C:contractile fiber; C:cytoplasm; C:cytosol; C:focal adhesion; C:kinetochore; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:PTW/PP1 phosphatase complex; C:Z disc;, F:14-3-3 protein binding; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:cellular response to drug; P:centrosome cycle; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of catalytic activity; P:positive regulation of myosin-light-chain-phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of myosin-light-chain-phosphatase activity; P:regulation of nucleocytoplasmic transport; P:signal transduction;|O14974 B4DZ09 F8VWB4 Q2NKL4 Q569H0 Q86WU3 Q8NFR6 Q9BYH0,Protein phosphatase 1 regulatory subunit 12A,Myosin phosphatase-targeting subunit 1;Protein phosphatase myosin-binding subunit;, PF12796;PF15898;, GO:0031672;GO:0015629;GO:0005813;GO:0043292;GO:0005737;GO:0005829;GO:0005925;GO:0000776;GO:0005730;GO:0005654;GO:0005886;GO:0072357;GO:0030018;GO:0071889;GO:0004857;GO:0019208;GO:0019901;GO:0035690;GO:0007098;GO:0000086;GO:0000278;GO:0043086;GO:0035508;GO:0045944;GO:0006470;GO:0030155;GO:0035507;GO:0046822;GO:0007165;, C:A band; C:actin cytoskeleton; C:centrosome; C:contractile fiber; C:cytoplasm; C:cytosol; C:focal adhesion; C:kinetochore; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:PTW/PP1 phosphatase complex; C:Z disc;, F:14-3-3 protein binding; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:cellular response to drug; P:centrosome cycle; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of catalytic activity; P:positive regulation of myosin-light-chain-phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of myosin-light-chain-phosphatase activity; P:regulation of nucleocytoplasmic transport; P:signal transduction;|O14974 B4DZ09 F8VWB4 Q2NKL4 Q569H0 Q86WU3 Q8NFR6 Q9BYH0,Protein phosphatase 1 regulatory subunit 12A,Myosin phosphatase-targeting subunit 1;Protein phosphatase myosin-binding subunit;, PF12796;PF15898;, GO:0031672;GO:0015629;GO:0005813;GO:0043292;GO:0005737;GO:0005829;GO:0005925;GO:0000776;GO:0005730;GO:0005654;GO:0005886;GO:0072357;GO:0030018;GO:0071889;GO:0004857;GO:0019208;GO:0019901;GO:0035690;GO:0007098;GO:0000086;GO:0000278;GO:0043086;GO:0035508;GO:0045944;GO:0006470;GO:0030155;GO:0035507;GO:0046822;GO:0007165;, C:A band; C:actin cytoskeleton; C:centrosome; C:contractile fiber; C:cytoplasm; C:cytosol; C:focal adhesion; C:kinetochore; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:PTW/PP1 phosphatase complex; C:Z disc;, F:14-3-3 protein binding; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:cellular response to drug; P:centrosome cycle; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of catalytic activity; P:positive regulation of myosin-light-chain-phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of myosin-light-chain-phosphatase activity; P:regulation of nucleocytoplasmic transport; P:signal transduction;|O14974 B4DZ09 F8VWB4 Q2NKL4 Q569H0 Q86WU3 Q8NFR6 Q9BYH0,Protein phosphatase 1 regulatory subunit 12A,Myosin phosphatase-targeting subunit 1;Protein phosphatase myosin-binding subunit;, PF12796;PF15898;, GO:0031672;GO:0015629;GO:0005813;GO:0043292;GO:0005737;GO:0005829;GO:0005925;GO:0000776;GO:0005730;GO:0005654;GO:0005886;GO:0072357;GO:0030018;GO:0071889;GO:0004857;GO:0019208;GO:0019901;GO:0035690;GO:0007098;GO:0000086;GO:0000278;GO:0043086;GO:0035508;GO:0045944;GO:0006470;GO:0030155;GO:0035507;GO:0046822;GO:0007165;, C:A band; C:actin cytoskeleton; C:centrosome; C:contractile fiber; C:cytoplasm; C:cytosol; C:focal adhesion; C:kinetochore; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:PTW/PP1 phosphatase complex; C:Z disc;, F:14-3-3 protein binding; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:cellular response to drug; P:centrosome cycle; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of catalytic activity; P:positive regulation of myosin-light-chain-phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of myosin-light-chain-phosphatase activity; P:regulation of nucleocytoplasmic transport; P:signal transduction;|O14974 B4DZ09 F8VWB4 Q2NKL4 Q569H0 Q86WU3 Q8NFR6 Q9BYH0,Protein phosphatase 1 regulatory subunit 12A,Myosin phosphatase-targeting subunit 1;Protein phosphatase myosin-binding subunit;, PF12796;PF15898;, GO:0031672;GO:0015629;GO:0005813;GO:0043292;GO:0005737;GO:0005829;GO:0005925;GO:0000776;GO:0005730;GO:0005654;GO:0005886;GO:0072357;GO:0030018;GO:0071889;GO:0004857;GO:0019208;GO:0019901;GO:0035690;GO:0007098;GO:0000086;GO:0000278;GO:0043086;GO:0035508;GO:0045944;GO:0006470;GO:0030155;GO:0035507;GO:0046822;GO:0007165;, C:A band; C:actin cytoskeleton; C:centrosome; C:contractile fiber; C:cytoplasm; C:cytosol; C:focal adhesion; C:kinetochore; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:PTW/PP1 phosphatase complex; C:Z disc;, F:14-3-3 protein binding; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:cellular response to drug; P:centrosome cycle; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of catalytic activity; P:positive regulation of myosin-light-chain-phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of myosin-light-chain-phosphatase activity; P:regulation of nucleocytoplasmic transport; P:signal transduction;|O14974 B4DZ09 F8VWB4 Q2NKL4 Q569H0 Q86WU3 Q8NFR6 Q9BYH0,Protein phosphatase 1 regulatory subunit 12A,Myosin phosphatase-targeting subunit 1;Protein phosphatase myosin-binding subunit;, PF12796;PF15898;, GO:0031672;GO:0015629;GO:0005813;GO:0043292;GO:0005737;GO:0005829;GO:0005925;GO:0000776;GO:0005730;GO:0005654;GO:0005886;GO:0072357;GO:0030018;GO:0071889;GO:0004857;GO:0019208;GO:0019901;GO:0035690;GO:0007098;GO:0000086;GO:0000278;GO:0043086;GO:0035508;GO:0045944;GO:0006470;GO:0030155;GO:0035507;GO:0046822;GO:0007165;, C:A band; C:actin cytoskeleton; C:centrosome; C:contractile fiber; C:cytoplasm; C:cytosol; C:focal adhesion; C:kinetochore; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:PTW/PP1 phosphatase complex; C:Z disc;, F:14-3-3 protein binding; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:cellular response to drug; P:centrosome cycle; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of catalytic activity; P:positive regulation of myosin-light-chain-phosphatase activity; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of cell adhesion; P:regulation of myosin-light-chain-phosphatase activity; P:regulation of nucleocytoplasmic transport; P:signal transduction; scaffold33 indexed_genome mRNA 12214110 12239232 . + . ID=transcript_7041;Q3ZCN5 F8W0C3 Q495U8 Q8N8G5 Q8NC28,Otogelin-like protein,, PF05270;PF08742;PF01826;PF00094;, GO:0031012;GO:0005615;GO:0046556;GO:0046373;GO:0007605;, C:extracellular matrix; C:extracellular space;, F:alpha-L-arabinofuranosidase activity;, P:L-arabinose metabolic process; P:sensory perception of sound;|Q3ZCN5 F8W0C3 Q495U8 Q8N8G5 Q8NC28,Otogelin-like protein,, PF05270;PF08742;PF01826;PF00094;, GO:0031012;GO:0005615;GO:0046556;GO:0046373;GO:0007605;, C:extracellular matrix; C:extracellular space;, F:alpha-L-arabinofuranosidase activity;, P:L-arabinose metabolic process; P:sensory perception of sound; scaffold33 indexed_genome mRNA 12245383 12259399 . + . ID=transcript_7042;Q3ZCN5 F8W0C3 Q495U8 Q8N8G5 Q8NC28,Otogelin-like protein,, PF05270;PF08742;PF01826;PF00094;, GO:0031012;GO:0005615;GO:0046556;GO:0046373;GO:0007605;, C:extracellular matrix; C:extracellular space;, F:alpha-L-arabinofuranosidase activity;, P:L-arabinose metabolic process; P:sensory perception of sound; scaffold33 indexed_genome mRNA 12499071 12505304 . + . ID=transcript_7043;Q9UMZ3,Phosphatidylinositol phosphatase PTPRQ,Receptor-type tyrosine-protein phosphatase Q;, PF00041;PF18861;PF00102;, GO:0016021;GO:0043235;GO:0004725;GO:1990264;GO:0045598;, C:integral component of membrane; C:receptor complex;, F:protein tyrosine phosphatase activity;, P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:regulation of fat cell differentiation; scaffold33 indexed_genome mRNA 12540305 12571437 . + . ID=transcript_7044;Q9UMZ3,Phosphatidylinositol phosphatase PTPRQ,Receptor-type tyrosine-protein phosphatase Q;, PF00041;PF18861;PF00102;, GO:0016021;GO:0043235;GO:0004725;GO:1990264;GO:0045598;, C:integral component of membrane; C:receptor complex;, F:protein tyrosine phosphatase activity;, P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:regulation of fat cell differentiation; scaffold33 indexed_genome mRNA 12594815 12595994 . + . ID=transcript_7045;P23409 B2R898 Q53X80 Q6FHI9,Myogenic factor 6,Class C basic helix-loop-helix protein 4;Muscle-specific regulatory factor 4;, PF01586;PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0090575;GO:0001228;GO:0003700;GO:0000981;GO:0046983;GO:0000978;GO:1990837;GO:0042693;GO:0060415;GO:0045892;GO:0051149;GO:0045663;GO:0048743;GO:0045944;GO:0006357;GO:0035914;GO:0007519;GO:0043403;GO:0001756;, C:chromatin; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:muscle cell fate commitment; P:muscle tissue morphogenesis; P:negative regulation of transcription, DNA-templated; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of skeletal muscle fiber development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; P:skeletal muscle tissue development; P:skeletal muscle tissue regeneration; P:somitogenesis; scaffold33 indexed_genome mRNA 12665787 12720404 . - . ID=transcript_7046;O14910 A4FTY3 Q147W1 Q6LES3 Q7LDS4,Protein lin-7 homolog A,Mammalian lin-seven protein 1;Tax interaction protein 33;Vertebrate lin-7 homolog 1;, PF02828;PF00595;, GO:0016323;GO:0005923;GO:0005911;GO:0070062;GO:0097025;GO:0005886;GO:0098839;GO:0098793;GO:0045202;GO:0097016;GO:0006887;GO:0048839;GO:0045199;GO:0007269;GO:0006836;GO:1903361;GO:0015031;GO:0065003;GO:0048489;, C:basolateral plasma membrane; C:bicellular tight junction; C:cell-cell junction; C:extracellular exosome; C:MPP7-DLG1-LIN7 complex; C:plasma membrane; C:postsynaptic density membrane; C:presynapse; C:synapse;, F:L27 domain binding;, P:exocytosis; P:inner ear development; P:maintenance of epithelial cell apical/basal polarity; P:neurotransmitter secretion; P:neurotransmitter transport; P:protein localization to basolateral plasma membrane; P:protein transport; P:protein-containing complex assembly; P:synaptic vesicle transport; scaffold33 indexed_genome mRNA 12967169 13104371 . + . ID=transcript_7047;Q9H6R3 Q8NC66,Acyl-CoA synthetase short-chain family member 3, mitochondrial,Acetate--CoA ligase 3;Acyl-CoA synthetase short-chain family member 3;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0043231;GO:0005759;GO:0005739;GO:0003987;GO:0005524;GO:0047760;GO:0050218;GO:0046951;, C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:acetate-CoA ligase activity; F:ATP binding; F:butyrate-CoA ligase activity; F:propionate-CoA ligase activity;, P:ketone body biosynthetic process;|Q9H6R3 Q8NC66,Acyl-CoA synthetase short-chain family member 3, mitochondrial,Acetate--CoA ligase 3;Acyl-CoA synthetase short-chain family member 3;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0043231;GO:0005759;GO:0005739;GO:0003987;GO:0005524;GO:0047760;GO:0050218;GO:0046951;, C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:acetate-CoA ligase activity; F:ATP binding; F:butyrate-CoA ligase activity; F:propionate-CoA ligase activity;, P:ketone body biosynthetic process; scaffold33 indexed_genome mRNA 13127543 13134750 . - . ID=transcript_7048;F8VP68 Q2M3G8,Liprin-alpha-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2;, PF00536;PF07647;, GO:0030424;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0048786;GO:0099181;GO:0007160;GO:0099519;GO:0006836;GO:0060998;GO:0061001;GO:2000300;GO:0050808;, C:axon; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:presynaptic active zone;, F:structural constituent of presynapse;, P:cell-matrix adhesion; P:dense core granule cytoskeletal transport; P:neurotransmitter transport; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:regulation of synaptic vesicle exocytosis; P:synapse organization;|F8VP68 Q2M3G8,Liprin-alpha-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2;, PF00536;PF07647;, GO:0030424;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0048786;GO:0099181;GO:0007160;GO:0099519;GO:0006836;GO:0060998;GO:0061001;GO:2000300;GO:0050808;, C:axon; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:presynaptic active zone;, F:structural constituent of presynapse;, P:cell-matrix adhesion; P:dense core granule cytoskeletal transport; P:neurotransmitter transport; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:regulation of synaptic vesicle exocytosis; P:synapse organization;|F8VP68 Q2M3G8,Liprin-alpha-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2;, PF00536;PF07647;, GO:0030424;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0048786;GO:0099181;GO:0007160;GO:0099519;GO:0006836;GO:0060998;GO:0061001;GO:2000300;GO:0050808;, C:axon; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:presynaptic active zone;, F:structural constituent of presynapse;, P:cell-matrix adhesion; P:dense core granule cytoskeletal transport; P:neurotransmitter transport; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:regulation of synaptic vesicle exocytosis; P:synapse organization; scaffold33 indexed_genome mRNA 13145693 13146925 . - . ID=transcript_7049;F8VP68 Q2M3G8,Liprin-alpha-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2;, PF00536;PF07647;, GO:0030424;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0048786;GO:0099181;GO:0007160;GO:0099519;GO:0006836;GO:0060998;GO:0061001;GO:2000300;GO:0050808;, C:axon; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:presynaptic active zone;, F:structural constituent of presynapse;, P:cell-matrix adhesion; P:dense core granule cytoskeletal transport; P:neurotransmitter transport; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:regulation of synaptic vesicle exocytosis; P:synapse organization; scaffold33 indexed_genome mRNA 13147487 13149910 . + . ID=transcript_7050;F8VP68 Q2M3G8,Liprin-alpha-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2;, PF00536;PF07647;, GO:0030424;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0048786;GO:0099181;GO:0007160;GO:0099519;GO:0006836;GO:0060998;GO:0061001;GO:2000300;GO:0050808;, C:axon; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:presynaptic active zone;, F:structural constituent of presynapse;, P:cell-matrix adhesion; P:dense core granule cytoskeletal transport; P:neurotransmitter transport; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:regulation of synaptic vesicle exocytosis; P:synapse organization; scaffold33 indexed_genome mRNA 13158745 13619521 . - . ID=transcript_7051;F8VP68 Q2M3G8,Liprin-alpha-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2;, PF00536;PF07647;, GO:0030424;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0048786;GO:0099181;GO:0007160;GO:0099519;GO:0006836;GO:0060998;GO:0061001;GO:2000300;GO:0050808;, C:axon; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:presynaptic active zone;, F:structural constituent of presynapse;, P:cell-matrix adhesion; P:dense core granule cytoskeletal transport; P:neurotransmitter transport; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:regulation of synaptic vesicle exocytosis; P:synapse organization; scaffold33 indexed_genome mRNA 14118280 14231107 . + . ID=transcript_7052;Q8N6Q8 Q9H5Y3,Methyltransferase-like protein 25,, PF13679;, GO:0008168;GO:0032259;, , F:methyltransferase activity;, P:methylation; scaffold33 indexed_genome mRNA 14427251 14817312 . + . ID=transcript_7053;Q8N394 B2RCU7 Q8N2K8,Protein O-mannosyl-transferase TMTC2 {ECO:0000305},Transmembrane and TPR repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:25440};, PF08409;PF00515;PF13181;, GO:0005783;GO:0005789;GO:0016021;GO:0004169;GO:0000030;GO:0055074;GO:0035269;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity;, P:calcium ion homeostasis; P:protein O-linked mannosylation; scaffold33 indexed_genome mRNA 16508227 16508994 . + . ID=transcript_7054;Q9H2J7 A8K592 B7Z2P7 E7ESJ5 Q9H9F5,Sodium-dependent neutral amino acid transporter B(0)AT2,Sodium- and chloride-dependent neurotransmitter transporter NTT73;Sodium-coupled branched-chain amino-acid transporter 1;Solute carrier family 6 member 15;Transporter v7-3;, PF00209;, GO:0016021;GO:0005887;GO:0005886;GO:0005326;GO:0005298;GO:0006865;GO:0015820;GO:0006836;GO:0015804;GO:0015824;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:neurotransmitter transmembrane transporter activity; F:proline:sodium symporter activity;, P:amino acid transport; P:leucine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:proline transport; P:sodium ion transmembrane transport; scaffold33 indexed_genome mRNA 16514134 16556574 . - . ID=transcript_7055;Q9H2J7 A8K592 B7Z2P7 E7ESJ5 Q9H9F5,Sodium-dependent neutral amino acid transporter B(0)AT2,Sodium- and chloride-dependent neurotransmitter transporter NTT73;Sodium-coupled branched-chain amino-acid transporter 1;Solute carrier family 6 member 15;Transporter v7-3;, PF00209;, GO:0016021;GO:0005887;GO:0005886;GO:0005326;GO:0005298;GO:0006865;GO:0015820;GO:0006836;GO:0015804;GO:0015824;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:neurotransmitter transmembrane transporter activity; F:proline:sodium symporter activity;, P:amino acid transport; P:leucine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:proline transport; P:sodium ion transmembrane transport;|Q9H2J7 A8K592 B7Z2P7 E7ESJ5 Q9H9F5,Sodium-dependent neutral amino acid transporter B(0)AT2,Sodium- and chloride-dependent neurotransmitter transporter NTT73;Sodium-coupled branched-chain amino-acid transporter 1;Solute carrier family 6 member 15;Transporter v7-3;, PF00209;, GO:0016021;GO:0005887;GO:0005886;GO:0005326;GO:0005298;GO:0006865;GO:0015820;GO:0006836;GO:0015804;GO:0015824;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:neurotransmitter transmembrane transporter activity; F:proline:sodium symporter activity;, P:amino acid transport; P:leucine transport; P:neurotransmitter transport; P:neutral amino acid transport; P:proline transport; P:sodium ion transmembrane transport; scaffold33 indexed_genome mRNA 16632477 16659546 . - . ID=transcript_7056;P0C672,Tetraspanin-19 {ECO:0000305},, PF00335;, GO:0005887;, C:integral component of plasma membrane; scaffold33 indexed_genome mRNA 16659651 16746774 . + . ID=transcript_7057;Q96JM4 Q567P4 Q9BS17 Q9HA36,Leucine-rich repeat and IQ domain-containing protein 1,, PF00612;PF13855; scaffold33 indexed_genome mRNA 17388534 17390196 . - . ID=transcript_7058;O75901 B3KMQ4 Q8N5U8,Ras association domain-containing protein 9,PAM COOH-terminal interactor protein 1;Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor;, , GO:0005829;GO:0005768;GO:0070062;GO:0055037;GO:0012510;GO:0016197;GO:0046907;GO:0006605;GO:0007165;, C:cytosol; C:endosome; C:extracellular exosome; C:recycling endosome; C:trans-Golgi network transport vesicle membrane;, , P:endosomal transport; P:intracellular transport; P:protein targeting; P:signal transduction;|O75901 B3KMQ4 Q8N5U8,Ras association domain-containing protein 9,PAM COOH-terminal interactor protein 1;Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor;, , GO:0005829;GO:0005768;GO:0070062;GO:0055037;GO:0012510;GO:0016197;GO:0046907;GO:0006605;GO:0007165;, C:cytosol; C:endosome; C:extracellular exosome; C:recycling endosome; C:trans-Golgi network transport vesicle membrane;, , P:endosomal transport; P:intracellular transport; P:protein targeting; P:signal transduction; scaffold33 indexed_genome mRNA 17451602 17454914 . + . ID=transcript_7059;P30990,Neurotensin/neuromedin N,, PF07421;, GO:0043679;GO:0005576;GO:0043231;GO:0030133;GO:0005184;GO:0071855;GO:0048018;GO:0061844;GO:0007186;GO:0031640;GO:0007218;GO:0007165;, C:axon terminus; C:extracellular region; C:intracellular membrane-bounded organelle; C:transport vesicle;, F:neuropeptide hormone activity; F:neuropeptide receptor binding; F:receptor ligand activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:G protein-coupled receptor signaling pathway; P:killing of cells of other organism; P:neuropeptide signaling pathway; P:signal transduction; scaffold33 indexed_genome mRNA 19411416 19431486 . + . ID=transcript_7060;Q8N999 Q569K5 Q6AWA8 Q6PEK5 Q8IYQ5 Q9NT75,Uncharacterized protein C12orf29,, PF17720;, GO:0002244;, , , P:hematopoietic progenitor cell differentiation;|Q8N999 Q569K5 Q6AWA8 Q6PEK5 Q8IYQ5 Q9NT75,Uncharacterized protein C12orf29,, PF17720;, GO:0002244;, , , P:hematopoietic progenitor cell differentiation;|Q8N999 Q569K5 Q6AWA8 Q6PEK5 Q8IYQ5 Q9NT75,Uncharacterized protein C12orf29,, PF17720;, GO:0002244;, , , P:hematopoietic progenitor cell differentiation;|O15078 Q1PSK5 Q66GS8 Q9H2G6 Q9H6Q7 Q9H8I0,Centrosomal protein of 290 kDa,Bardet-Biedl syndrome 14 protein;Cancer/testis antigen 87;Nephrocystin-6;Tumor antigen se2-2;, PF16574;, GO:0034451;GO:0005814;GO:0005813;GO:0035869;GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0036038;GO:0005634;GO:0032391;GO:0032991;GO:0035580;GO:0042802;GO:0097711;GO:0060271;GO:0042462;GO:0000086;GO:0030902;GO:0043312;GO:0030916;GO:0090316;GO:0045893;GO:0048793;GO:0015031;GO:0070201;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:extracellular region; C:membrane; C:MKS complex; C:nucleus; C:photoreceptor connecting cilium; C:protein-containing complex; C:specific granule lumen;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:eye photoreceptor cell development; P:G2/M transition of mitotic cell cycle; P:hindbrain development; P:neutrophil degranulation; P:otic vesicle formation; P:positive regulation of intracellular protein transport; P:positive regulation of transcription, DNA-templated; P:pronephros development; P:protein transport; P:regulation of establishment of protein localization; P:regulation of G2/M transition of mitotic cell cycle;|O15078 Q1PSK5 Q66GS8 Q9H2G6 Q9H6Q7 Q9H8I0,Centrosomal protein of 290 kDa,Bardet-Biedl syndrome 14 protein;Cancer/testis antigen 87;Nephrocystin-6;Tumor antigen se2-2;, PF16574;, GO:0034451;GO:0005814;GO:0005813;GO:0035869;GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0036038;GO:0005634;GO:0032391;GO:0032991;GO:0035580;GO:0042802;GO:0097711;GO:0060271;GO:0042462;GO:0000086;GO:0030902;GO:0043312;GO:0030916;GO:0090316;GO:0045893;GO:0048793;GO:0015031;GO:0070201;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:extracellular region; C:membrane; C:MKS complex; C:nucleus; C:photoreceptor connecting cilium; C:protein-containing complex; C:specific granule lumen;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:eye photoreceptor cell development; P:G2/M transition of mitotic cell cycle; P:hindbrain development; P:neutrophil degranulation; P:otic vesicle formation; P:positive regulation of intracellular protein transport; P:positive regulation of transcription, DNA-templated; P:pronephros development; P:protein transport; P:regulation of establishment of protein localization; P:regulation of G2/M transition of mitotic cell cycle; scaffold33 indexed_genome mRNA 19433362 19510453 . + . ID=transcript_7061;O15078 Q1PSK5 Q66GS8 Q9H2G6 Q9H6Q7 Q9H8I0,Centrosomal protein of 290 kDa,Bardet-Biedl syndrome 14 protein;Cancer/testis antigen 87;Nephrocystin-6;Tumor antigen se2-2;, PF16574;, GO:0034451;GO:0005814;GO:0005813;GO:0035869;GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0036038;GO:0005634;GO:0032391;GO:0032991;GO:0035580;GO:0042802;GO:0097711;GO:0060271;GO:0042462;GO:0000086;GO:0030902;GO:0043312;GO:0030916;GO:0090316;GO:0045893;GO:0048793;GO:0015031;GO:0070201;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:extracellular region; C:membrane; C:MKS complex; C:nucleus; C:photoreceptor connecting cilium; C:protein-containing complex; C:specific granule lumen;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:eye photoreceptor cell development; P:G2/M transition of mitotic cell cycle; P:hindbrain development; P:neutrophil degranulation; P:otic vesicle formation; P:positive regulation of intracellular protein transport; P:positive regulation of transcription, DNA-templated; P:pronephros development; P:protein transport; P:regulation of establishment of protein localization; P:regulation of G2/M transition of mitotic cell cycle;|O15078 Q1PSK5 Q66GS8 Q9H2G6 Q9H6Q7 Q9H8I0,Centrosomal protein of 290 kDa,Bardet-Biedl syndrome 14 protein;Cancer/testis antigen 87;Nephrocystin-6;Tumor antigen se2-2;, PF16574;, GO:0034451;GO:0005814;GO:0005813;GO:0035869;GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0036038;GO:0005634;GO:0032391;GO:0032991;GO:0035580;GO:0042802;GO:0097711;GO:0060271;GO:0042462;GO:0000086;GO:0030902;GO:0043312;GO:0030916;GO:0090316;GO:0045893;GO:0048793;GO:0015031;GO:0070201;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:extracellular region; C:membrane; C:MKS complex; C:nucleus; C:photoreceptor connecting cilium; C:protein-containing complex; C:specific granule lumen;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:eye photoreceptor cell development; P:G2/M transition of mitotic cell cycle; P:hindbrain development; P:neutrophil degranulation; P:otic vesicle formation; P:positive regulation of intracellular protein transport; P:positive regulation of transcription, DNA-templated; P:pronephros development; P:protein transport; P:regulation of establishment of protein localization; P:regulation of G2/M transition of mitotic cell cycle;|O15078 Q1PSK5 Q66GS8 Q9H2G6 Q9H6Q7 Q9H8I0,Centrosomal protein of 290 kDa,Bardet-Biedl syndrome 14 protein;Cancer/testis antigen 87;Nephrocystin-6;Tumor antigen se2-2;, PF16574;, GO:0034451;GO:0005814;GO:0005813;GO:0035869;GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0036038;GO:0005634;GO:0032391;GO:0032991;GO:0035580;GO:0042802;GO:0097711;GO:0060271;GO:0042462;GO:0000086;GO:0030902;GO:0043312;GO:0030916;GO:0090316;GO:0045893;GO:0048793;GO:0015031;GO:0070201;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:extracellular region; C:membrane; C:MKS complex; C:nucleus; C:photoreceptor connecting cilium; C:protein-containing complex; C:specific granule lumen;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:eye photoreceptor cell development; P:G2/M transition of mitotic cell cycle; P:hindbrain development; P:neutrophil degranulation; P:otic vesicle formation; P:positive regulation of intracellular protein transport; P:positive regulation of transcription, DNA-templated; P:pronephros development; P:protein transport; P:regulation of establishment of protein localization; P:regulation of G2/M transition of mitotic cell cycle;|O15078 Q1PSK5 Q66GS8 Q9H2G6 Q9H6Q7 Q9H8I0,Centrosomal protein of 290 kDa,Bardet-Biedl syndrome 14 protein;Cancer/testis antigen 87;Nephrocystin-6;Tumor antigen se2-2;, PF16574;, GO:0034451;GO:0005814;GO:0005813;GO:0035869;GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0036038;GO:0005634;GO:0032391;GO:0032991;GO:0035580;GO:0042802;GO:0097711;GO:0060271;GO:0042462;GO:0000086;GO:0030902;GO:0043312;GO:0030916;GO:0090316;GO:0045893;GO:0048793;GO:0015031;GO:0070201;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:extracellular region; C:membrane; C:MKS complex; C:nucleus; C:photoreceptor connecting cilium; C:protein-containing complex; C:specific granule lumen;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:eye photoreceptor cell development; P:G2/M transition of mitotic cell cycle; P:hindbrain development; P:neutrophil degranulation; P:otic vesicle formation; P:positive regulation of intracellular protein transport; P:positive regulation of transcription, DNA-templated; P:pronephros development; P:protein transport; P:regulation of establishment of protein localization; P:regulation of G2/M transition of mitotic cell cycle;|O15078 Q1PSK5 Q66GS8 Q9H2G6 Q9H6Q7 Q9H8I0,Centrosomal protein of 290 kDa,Bardet-Biedl syndrome 14 protein;Cancer/testis antigen 87;Nephrocystin-6;Tumor antigen se2-2;, PF16574;, GO:0034451;GO:0005814;GO:0005813;GO:0035869;GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0036038;GO:0005634;GO:0032391;GO:0032991;GO:0035580;GO:0042802;GO:0097711;GO:0060271;GO:0042462;GO:0000086;GO:0030902;GO:0043312;GO:0030916;GO:0090316;GO:0045893;GO:0048793;GO:0015031;GO:0070201;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:extracellular region; C:membrane; C:MKS complex; C:nucleus; C:photoreceptor connecting cilium; C:protein-containing complex; C:specific granule lumen;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:eye photoreceptor cell development; P:G2/M transition of mitotic cell cycle; P:hindbrain development; P:neutrophil degranulation; P:otic vesicle formation; P:positive regulation of intracellular protein transport; P:positive regulation of transcription, DNA-templated; P:pronephros development; P:protein transport; P:regulation of establishment of protein localization; P:regulation of G2/M transition of mitotic cell cycle;|O15078 Q1PSK5 Q66GS8 Q9H2G6 Q9H6Q7 Q9H8I0,Centrosomal protein of 290 kDa,Bardet-Biedl syndrome 14 protein;Cancer/testis antigen 87;Nephrocystin-6;Tumor antigen se2-2;, PF16574;, GO:0034451;GO:0005814;GO:0005813;GO:0035869;GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0036038;GO:0005634;GO:0032391;GO:0032991;GO:0035580;GO:0042802;GO:0097711;GO:0060271;GO:0042462;GO:0000086;GO:0030902;GO:0043312;GO:0030916;GO:0090316;GO:0045893;GO:0048793;GO:0015031;GO:0070201;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:extracellular region; C:membrane; C:MKS complex; C:nucleus; C:photoreceptor connecting cilium; C:protein-containing complex; C:specific granule lumen;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:eye photoreceptor cell development; P:G2/M transition of mitotic cell cycle; P:hindbrain development; P:neutrophil degranulation; P:otic vesicle formation; P:positive regulation of intracellular protein transport; P:positive regulation of transcription, DNA-templated; P:pronephros development; P:protein transport; P:regulation of establishment of protein localization; P:regulation of G2/M transition of mitotic cell cycle; scaffold33 indexed_genome mRNA 19510644 19529628 . + . ID=transcript_7062;Q6ZXV5 Q5CZ86 Q5H9T6 Q68DQ6 Q68DX0 Q7Z332 Q8NC50,Protein O-mannosyl-transferase TMTC3 {ECO:0000305},Protein SMILE {ECO:0000303|PubMed:17974005};Transmembrane and TPR repeat-containing protein 3 {ECO:0000312|HGNC:HGNC:26899};, PF08409;PF13174;PF13181;, GO:0005783;GO:0016021;GO:0004169;GO:0000030;GO:1901800;GO:0035269;GO:0034976;, C:endoplasmic reticulum; C:integral component of membrane;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity;, P:positive regulation of proteasomal protein catabolic process; P:protein O-linked mannosylation; P:response to endoplasmic reticulum stress; scaffold33 indexed_genome mRNA 19529717 19570461 . + . ID=transcript_7063;Q6ZXV5 Q5CZ86 Q5H9T6 Q68DQ6 Q68DX0 Q7Z332 Q8NC50,Protein O-mannosyl-transferase TMTC3 {ECO:0000305},Protein SMILE {ECO:0000303|PubMed:17974005};Transmembrane and TPR repeat-containing protein 3 {ECO:0000312|HGNC:HGNC:26899};, PF08409;PF13174;PF13181;, GO:0005783;GO:0016021;GO:0004169;GO:0000030;GO:1901800;GO:0035269;GO:0034976;, C:endoplasmic reticulum; C:integral component of membrane;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity;, P:positive regulation of proteasomal protein catabolic process; P:protein O-linked mannosylation; P:response to endoplasmic reticulum stress;|Q6ZXV5 Q5CZ86 Q5H9T6 Q68DQ6 Q68DX0 Q7Z332 Q8NC50,Protein O-mannosyl-transferase TMTC3 {ECO:0000305},Protein SMILE {ECO:0000303|PubMed:17974005};Transmembrane and TPR repeat-containing protein 3 {ECO:0000312|HGNC:HGNC:26899};, PF08409;PF13174;PF13181;, GO:0005783;GO:0016021;GO:0004169;GO:0000030;GO:1901800;GO:0035269;GO:0034976;, C:endoplasmic reticulum; C:integral component of membrane;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity;, P:positive regulation of proteasomal protein catabolic process; P:protein O-linked mannosylation; P:response to endoplasmic reticulum stress; scaffold33 indexed_genome mRNA 19825301 19922071 . - . ID=transcript_7064;P21583 A0AV09 A8K2Q4 B7ZLM4 Q16487 Q68DZ2 Q7M4N8 Q9UQK7,Kit ligand,Mast cell growth factor;Stem cell factor;c-Kit ligand;, PF02404;, GO:0005737;GO:0005856;GO:0005576;GO:0005615;GO:0030175;GO:0016021;GO:0030027;GO:0005886;GO:0005125;GO:0008083;GO:0005173;GO:0007155;GO:0035234;GO:0035162;GO:0097192;GO:0008584;GO:0000165;GO:0033026;GO:0001755;GO:0001541;GO:0008284;GO:1901534;GO:1902035;GO:0002687;GO:0043406;GO:0070668;GO:0045636;GO:0002763;GO:0050731;GO:0051897;GO:0046579;, C:cytoplasm; C:cytoskeleton; C:extracellular region; C:extracellular space; C:filopodium; C:integral component of membrane; C:lamellipodium; C:plasma membrane;, F:cytokine activity; F:growth factor activity; F:stem cell factor receptor binding;, P:cell adhesion; P:ectopic germ cell programmed cell death; P:embryonic hemopoiesis; P:extrinsic apoptotic signaling pathway in absence of ligand; P:male gonad development; P:MAPK cascade; P:negative regulation of mast cell apoptotic process; P:neural crest cell migration; P:ovarian follicle development; P:positive regulation of cell population proliferation; P:positive regulation of hematopoietic progenitor cell differentiation; P:positive regulation of hematopoietic stem cell proliferation; P:positive regulation of leukocyte migration; P:positive regulation of MAP kinase activity; P:positive regulation of mast cell proliferation; P:positive regulation of melanocyte differentiation; P:positive regulation of myeloid leukocyte differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of Ras protein signal transduction; scaffold33 indexed_genome mRNA 20689037 20693710 . + . ID=transcript_7065;Q16828 O75109 Q53Y75 Q9BSH6,Dual specificity protein phosphatase 6,Dual specificity protein phosphatase PYST1;Mitogen-activated protein kinase phosphatase 3;, PF00581;, GO:0005737;GO:0005829;GO:0005654;GO:0017017;GO:0051019;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0000187;GO:0030154;GO:0000188;GO:0000165;GO:0070373;GO:0035970;GO:0035335;GO:0043065;GO:0006470;GO:0060420;GO:0042493;GO:0070848;GO:0051409;GO:0014070;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:activation of MAPK activity; P:cell differentiation; P:inactivation of MAPK activity; P:MAPK cascade; P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of apoptotic process; P:protein dephosphorylation; P:regulation of heart growth; P:response to drug; P:response to growth factor; P:response to nitrosative stress; P:response to organic cyclic compound;|Q16828 O75109 Q53Y75 Q9BSH6,Dual specificity protein phosphatase 6,Dual specificity protein phosphatase PYST1;Mitogen-activated protein kinase phosphatase 3;, PF00581;, GO:0005737;GO:0005829;GO:0005654;GO:0017017;GO:0051019;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0000187;GO:0030154;GO:0000188;GO:0000165;GO:0070373;GO:0035970;GO:0035335;GO:0043065;GO:0006470;GO:0060420;GO:0042493;GO:0070848;GO:0051409;GO:0014070;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:activation of MAPK activity; P:cell differentiation; P:inactivation of MAPK activity; P:MAPK cascade; P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of apoptotic process; P:protein dephosphorylation; P:regulation of heart growth; P:response to drug; P:response to growth factor; P:response to nitrosative stress; P:response to organic cyclic compound;|Q16828 O75109 Q53Y75 Q9BSH6,Dual specificity protein phosphatase 6,Dual specificity protein phosphatase PYST1;Mitogen-activated protein kinase phosphatase 3;, PF00581;, GO:0005737;GO:0005829;GO:0005654;GO:0017017;GO:0051019;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0000187;GO:0030154;GO:0000188;GO:0000165;GO:0070373;GO:0035970;GO:0035335;GO:0043065;GO:0006470;GO:0060420;GO:0042493;GO:0070848;GO:0051409;GO:0014070;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:activation of MAPK activity; P:cell differentiation; P:inactivation of MAPK activity; P:MAPK cascade; P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of apoptotic process; P:protein dephosphorylation; P:regulation of heart growth; P:response to drug; P:response to growth factor; P:response to nitrosative stress; P:response to organic cyclic compound; scaffold33 indexed_genome mRNA 20765392 20861738 . - . ID=transcript_7066;Q8TC44 G3V1X0,POC1 centriolar protein homolog B {ECO:0000305},Pix1;Proteome of centriole protein 1B;WD repeat-containing protein 51B;, PF00400;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0000922;GO:0008283;GO:0007099;GO:0060271;GO:0001895;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:spindle pole;, , P:cell population proliferation; P:centriole replication; P:cilium assembly; P:retina homeostasis;|Q8TC44 G3V1X0,POC1 centriolar protein homolog B {ECO:0000305},Pix1;Proteome of centriole protein 1B;WD repeat-containing protein 51B;, PF00400;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0000922;GO:0008283;GO:0007099;GO:0060271;GO:0001895;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:spindle pole;, , P:cell population proliferation; P:centriole replication; P:cilium assembly; P:retina homeostasis;|Q8TC44 G3V1X0,POC1 centriolar protein homolog B {ECO:0000305},Pix1;Proteome of centriole protein 1B;WD repeat-containing protein 51B;, PF00400;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0000922;GO:0008283;GO:0007099;GO:0060271;GO:0001895;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:spindle pole;, , P:cell population proliferation; P:centriole replication; P:cilium assembly; P:retina homeostasis;|Q8N4A0 B2R775 B4DMX6 O00208,Polypeptide N-acetylgalactosaminyltransferase 4,Polypeptide GalNAc transferase 4;Protein-UDP acetylgalactosaminyltransferase 4;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4;, PF00535;PF00652;, GO:0070062;GO:0000139;GO:0016021;GO:0048471;GO:0030246;GO:0030145;GO:0004653;GO:0016266;GO:0018242;GO:0018243;, C:extracellular exosome; C:Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine; scaffold33 indexed_genome mRNA 20931548 20942245 . + . ID=transcript_7067;P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold; scaffold33 indexed_genome mRNA 20942339 20972373 . - . ID=transcript_7068;P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold;|P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold;|P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold;|P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold;|P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold;|Q16720 B7WNR8 B7WNY5 Q12995 Q16858,Plasma membrane calcium-transporting ATPase 3,Plasma membrane calcium ATPase isoform 3;Plasma membrane calcium pump isoform 3;, PF12424;PF00689;PF00690;, GO:1903561;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098793;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:1990034;GO:0006874;GO:0034220;GO:1903779;GO:0051480;, C:extracellular vesicle; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration;|P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold;|P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold;|P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold; scaffold33 indexed_genome mRNA 20973144 20995479 . - . ID=transcript_7069;P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold;|P20020 Q12992 Q12993 Q13819 Q13820 Q13821 Q16504 Q93082,Plasma membrane calcium-transporting ATPase 1 {ECO:0000305},Plasma membrane calcium ATPase isoform 1 {ECO:0000303|PubMed:8396145};Plasma membrane calcium pump isoform 1;, PF12424;PF00689;PF00690;, GO:0016324;GO:0016323;GO:0009898;GO:0032591;GO:0070062;GO:0098982;GO:0098978;GO:0001772;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0032809;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0007568;GO:0007420;GO:1990034;GO:0006874;GO:0071386;GO:0071305;GO:0034220;GO:0001818;GO:0051481;GO:0003407;GO:0030501;GO:0051928;GO:0008217;GO:1903779;GO:1900076;GO:0051480;GO:0003056;GO:0009409;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic side of plasma membrane; C:dendritic spine membrane; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:aging; P:brain development; P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:cellular response to corticosterone stimulus; P:cellular response to vitamin D; P:ion transmembrane transport; P:negative regulation of cytokine production; P:negative regulation of cytosolic calcium ion concentration; P:neural retina development; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cellular response to insulin stimulus; P:regulation of cytosolic calcium ion concentration; P:regulation of vascular associated smooth muscle contraction; P:response to cold; scaffold33 indexed_genome mRNA 22219071 22231724 . - . ID=transcript_7070;Q99645 A8K3M7 Q8NEJ5,Epiphycan,Dermatan sulfate proteoglycan 3;Proteoglycan-Lb;Small chondroitin/dermatan sulfate proteoglycan;, PF13855;, GO:0031012;GO:0005576;GO:0005539;GO:0061975;GO:0060348;GO:0007565;GO:0007605;, C:extracellular matrix; C:extracellular region;, F:glycosaminoglycan binding;, P:articular cartilage development; P:bone development; P:female pregnancy; P:sensory perception of sound; scaffold33 indexed_genome mRNA 22301086 22308741 . - . ID=transcript_7071;O60938,Keratocan,Keratan sulfate proteoglycan keratocan;, PF13516;PF13855;, GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0043202;GO:0061303;GO:0018146;GO:0042340;GO:0050896;GO:0007601;, C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:lysosomal lumen;, , P:cornea development in camera-type eye; P:keratan sulfate biosynthetic process; P:keratan sulfate catabolic process; P:response to stimulus; P:visual perception; scaffold33 indexed_genome mRNA 22341020 22348264 . - . ID=transcript_7072;P51884 B2R6R5 Q96QM7,Lumican,Keratan sulfate proteoglycan lumican;, PF13516;PF13855;PF01462;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005583;GO:0005796;GO:0043202;GO:0005518;GO:0005201;GO:0030021;GO:0051216;GO:0030199;GO:0030198;GO:0018146;GO:0042340;GO:0045944;GO:0032914;GO:0070848;GO:0014070;GO:0007601;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrillar collagen trimer; C:Golgi lumen; C:lysosomal lumen;, F:collagen binding; F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring compression resistance;, P:cartilage development; P:collagen fibril organization; P:extracellular matrix organization; P:keratan sulfate biosynthetic process; P:keratan sulfate catabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta1 production; P:response to growth factor; P:response to organic cyclic compound; P:visual perception; scaffold33 indexed_genome mRNA 22384107 22420455 . - . ID=transcript_7073;P07585 Q9P0Z0 Q9P0Z1 Q9Y5N8 Q9Y5N9,Decorin,Bone proteoglycan II;PG-S2;PG40;, PF13855;PF01462;, GO:0005589;GO:0062023;GO:0005576;GO:0005615;GO:0005796;GO:0043202;GO:0005518;GO:0050840;GO:0030021;GO:0005539;GO:0047485;GO:0003723;GO:0007568;GO:0009887;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0001822;GO:0016525;GO:0010596;GO:1900747;GO:0019800;GO:0001890;GO:0010508;GO:0016239;GO:0051901;GO:0090141;GO:0014068;GO:0045944;GO:0032496;GO:0009612;GO:0007519;GO:0042060;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:lysosomal lumen;, F:collagen binding; F:extracellular matrix binding; F:extracellular matrix structural constituent conferring compression resistance; F:glycosaminoglycan binding; F:protein N-terminus binding; F:RNA binding;, P:aging; P:animal organ morphogenesis; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:kidney development; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell migration; P:negative regulation of vascular endothelial growth factor signaling pathway; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; P:placenta development; P:positive regulation of autophagy; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial depolarization; P:positive regulation of mitochondrial fission; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of transcription by RNA polymerase II; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:skeletal muscle tissue development; P:wound healing;|P07585 Q9P0Z0 Q9P0Z1 Q9Y5N8 Q9Y5N9,Decorin,Bone proteoglycan II;PG-S2;PG40;, PF13855;PF01462;, GO:0005589;GO:0062023;GO:0005576;GO:0005615;GO:0005796;GO:0043202;GO:0005518;GO:0050840;GO:0030021;GO:0005539;GO:0047485;GO:0003723;GO:0007568;GO:0009887;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0001822;GO:0016525;GO:0010596;GO:1900747;GO:0019800;GO:0001890;GO:0010508;GO:0016239;GO:0051901;GO:0090141;GO:0014068;GO:0045944;GO:0032496;GO:0009612;GO:0007519;GO:0042060;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:lysosomal lumen;, F:collagen binding; F:extracellular matrix binding; F:extracellular matrix structural constituent conferring compression resistance; F:glycosaminoglycan binding; F:protein N-terminus binding; F:RNA binding;, P:aging; P:animal organ morphogenesis; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:kidney development; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell migration; P:negative regulation of vascular endothelial growth factor signaling pathway; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; P:placenta development; P:positive regulation of autophagy; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial depolarization; P:positive regulation of mitochondrial fission; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of transcription by RNA polymerase II; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:skeletal muscle tissue development; P:wound healing;|P07585 Q9P0Z0 Q9P0Z1 Q9Y5N8 Q9Y5N9,Decorin,Bone proteoglycan II;PG-S2;PG40;, PF13855;PF01462;, GO:0005589;GO:0062023;GO:0005576;GO:0005615;GO:0005796;GO:0043202;GO:0005518;GO:0050840;GO:0030021;GO:0005539;GO:0047485;GO:0003723;GO:0007568;GO:0009887;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0001822;GO:0016525;GO:0010596;GO:1900747;GO:0019800;GO:0001890;GO:0010508;GO:0016239;GO:0051901;GO:0090141;GO:0014068;GO:0045944;GO:0032496;GO:0009612;GO:0007519;GO:0042060;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:lysosomal lumen;, F:collagen binding; F:extracellular matrix binding; F:extracellular matrix structural constituent conferring compression resistance; F:glycosaminoglycan binding; F:protein N-terminus binding; F:RNA binding;, P:aging; P:animal organ morphogenesis; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:kidney development; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell migration; P:negative regulation of vascular endothelial growth factor signaling pathway; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; P:placenta development; P:positive regulation of autophagy; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial depolarization; P:positive regulation of mitochondrial fission; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of transcription by RNA polymerase II; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:skeletal muscle tissue development; P:wound healing;|P07585 Q9P0Z0 Q9P0Z1 Q9Y5N8 Q9Y5N9,Decorin,Bone proteoglycan II;PG-S2;PG40;, PF13855;PF01462;, GO:0005589;GO:0062023;GO:0005576;GO:0005615;GO:0005796;GO:0043202;GO:0005518;GO:0050840;GO:0030021;GO:0005539;GO:0047485;GO:0003723;GO:0007568;GO:0009887;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0001822;GO:0016525;GO:0010596;GO:1900747;GO:0019800;GO:0001890;GO:0010508;GO:0016239;GO:0051901;GO:0090141;GO:0014068;GO:0045944;GO:0032496;GO:0009612;GO:0007519;GO:0042060;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:lysosomal lumen;, F:collagen binding; F:extracellular matrix binding; F:extracellular matrix structural constituent conferring compression resistance; F:glycosaminoglycan binding; F:protein N-terminus binding; F:RNA binding;, P:aging; P:animal organ morphogenesis; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:kidney development; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell migration; P:negative regulation of vascular endothelial growth factor signaling pathway; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; P:placenta development; P:positive regulation of autophagy; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial depolarization; P:positive regulation of mitochondrial fission; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of transcription by RNA polymerase II; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:skeletal muscle tissue development; P:wound healing; scaffold33 indexed_genome mRNA 23923763 24010113 . - . ID=transcript_7074;Q15075 Q14221,Early endosome antigen 1,Endosome-associated protein p162;Zinc finger FYVE domain-containing protein 2;, PF01363;, GO:0044308;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0070062;GO:0019897;GO:0016020;GO:0055037;GO:0005969;GO:0005545;GO:0005516;GO:0030742;GO:0042803;GO:0008270;GO:0045022;GO:0006897;GO:0016189;GO:0006906;GO:0039694;, C:axonal spine; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:extrinsic component of plasma membrane; C:membrane; C:recycling endosome; C:serine-pyruvate aminotransferase complex;, F:1-phosphatidylinositol binding; F:calmodulin binding; F:GTP-dependent protein binding; F:protein homodimerization activity; F:zinc ion binding;, P:early endosome to late endosome transport; P:endocytosis; P:synaptic vesicle to endosome fusion; P:vesicle fusion; P:viral RNA genome replication;|Q15075 Q14221,Early endosome antigen 1,Endosome-associated protein p162;Zinc finger FYVE domain-containing protein 2;, PF01363;, GO:0044308;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0070062;GO:0019897;GO:0016020;GO:0055037;GO:0005969;GO:0005545;GO:0005516;GO:0030742;GO:0042803;GO:0008270;GO:0045022;GO:0006897;GO:0016189;GO:0006906;GO:0039694;, C:axonal spine; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:extrinsic component of plasma membrane; C:membrane; C:recycling endosome; C:serine-pyruvate aminotransferase complex;, F:1-phosphatidylinositol binding; F:calmodulin binding; F:GTP-dependent protein binding; F:protein homodimerization activity; F:zinc ion binding;, P:early endosome to late endosome transport; P:endocytosis; P:synaptic vesicle to endosome fusion; P:vesicle fusion; P:viral RNA genome replication;|Q15075 Q14221,Early endosome antigen 1,Endosome-associated protein p162;Zinc finger FYVE domain-containing protein 2;, PF01363;, GO:0044308;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0070062;GO:0019897;GO:0016020;GO:0055037;GO:0005969;GO:0005545;GO:0005516;GO:0030742;GO:0042803;GO:0008270;GO:0045022;GO:0006897;GO:0016189;GO:0006906;GO:0039694;, C:axonal spine; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:extrinsic component of plasma membrane; C:membrane; C:recycling endosome; C:serine-pyruvate aminotransferase complex;, F:1-phosphatidylinositol binding; F:calmodulin binding; F:GTP-dependent protein binding; F:protein homodimerization activity; F:zinc ion binding;, P:early endosome to late endosome transport; P:endocytosis; P:synaptic vesicle to endosome fusion; P:vesicle fusion; P:viral RNA genome replication;|Q15075 Q14221,Early endosome antigen 1,Endosome-associated protein p162;Zinc finger FYVE domain-containing protein 2;, PF01363;, GO:0044308;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0070062;GO:0019897;GO:0016020;GO:0055037;GO:0005969;GO:0005545;GO:0005516;GO:0030742;GO:0042803;GO:0008270;GO:0045022;GO:0006897;GO:0016189;GO:0006906;GO:0039694;, C:axonal spine; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:extrinsic component of plasma membrane; C:membrane; C:recycling endosome; C:serine-pyruvate aminotransferase complex;, F:1-phosphatidylinositol binding; F:calmodulin binding; F:GTP-dependent protein binding; F:protein homodimerization activity; F:zinc ion binding;, P:early endosome to late endosome transport; P:endocytosis; P:synaptic vesicle to endosome fusion; P:vesicle fusion; P:viral RNA genome replication;|Q15075 Q14221,Early endosome antigen 1,Endosome-associated protein p162;Zinc finger FYVE domain-containing protein 2;, PF01363;, GO:0044308;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0070062;GO:0019897;GO:0016020;GO:0055037;GO:0005969;GO:0005545;GO:0005516;GO:0030742;GO:0042803;GO:0008270;GO:0045022;GO:0006897;GO:0016189;GO:0006906;GO:0039694;, C:axonal spine; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:extracellular exosome; C:extrinsic component of plasma membrane; C:membrane; C:recycling endosome; C:serine-pyruvate aminotransferase complex;, F:1-phosphatidylinositol binding; F:calmodulin binding; F:GTP-dependent protein binding; F:protein homodimerization activity; F:zinc ion binding;, P:early endosome to late endosome transport; P:endocytosis; P:synaptic vesicle to endosome fusion; P:vesicle fusion; P:viral RNA genome replication; scaffold33 indexed_genome mRNA 24454411 24459679 . - . ID=transcript_7075;P61088 Q16781 Q53Y81,Ubiquitin-conjugating enzyme E2 N,Bendless-like ubiquitin-conjugating enzyme;E2 ubiquitin-conjugating enzyme N;Ubc13;UbcH13;Ubiquitin carrier protein N;Ubiquitin-protein ligase N;, PF00179;, GO:0005737;GO:0005829;GO:0070062;GO:0001650;GO:0005654;GO:0005634;GO:0032991;GO:0031372;GO:0035370;GO:0000151;GO:0005524;GO:0003723;GO:0043130;GO:0061631;GO:0031625;GO:0004842;GO:0000187;GO:0035973;GO:0000729;GO:0006302;GO:0000724;GO:0006303;GO:0016574;GO:0070498;GO:0007254;GO:0070423;GO:0045739;GO:0031058;GO:0043123;GO:0051092;GO:0051443;GO:0006301;GO:0070534;GO:0000209;GO:0016567;GO:0006282;GO:0033182;GO:0050852;GO:0006511;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:fibrillar center; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:UBC13-MMS2 complex; C:UBC13-UEV1A complex; C:ubiquitin ligase complex;, F:ATP binding; F:RNA binding; F:ubiquitin binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:activation of MAPK activity; P:aggrephagy; P:DNA double-strand break processing; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:histone ubiquitination; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of DNA repair; P:positive regulation of histone modification; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of ubiquitin-protein transferase activity; P:postreplication repair; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of DNA repair; P:regulation of histone ubiquitination; P:T cell receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|P61088 Q16781 Q53Y81,Ubiquitin-conjugating enzyme E2 N,Bendless-like ubiquitin-conjugating enzyme;E2 ubiquitin-conjugating enzyme N;Ubc13;UbcH13;Ubiquitin carrier protein N;Ubiquitin-protein ligase N;, PF00179;, GO:0005737;GO:0005829;GO:0070062;GO:0001650;GO:0005654;GO:0005634;GO:0032991;GO:0031372;GO:0035370;GO:0000151;GO:0005524;GO:0003723;GO:0043130;GO:0061631;GO:0031625;GO:0004842;GO:0000187;GO:0035973;GO:0000729;GO:0006302;GO:0000724;GO:0006303;GO:0016574;GO:0070498;GO:0007254;GO:0070423;GO:0045739;GO:0031058;GO:0043123;GO:0051092;GO:0051443;GO:0006301;GO:0070534;GO:0000209;GO:0016567;GO:0006282;GO:0033182;GO:0050852;GO:0006511;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:fibrillar center; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:UBC13-MMS2 complex; C:UBC13-UEV1A complex; C:ubiquitin ligase complex;, F:ATP binding; F:RNA binding; F:ubiquitin binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:activation of MAPK activity; P:aggrephagy; P:DNA double-strand break processing; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:histone ubiquitination; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of DNA repair; P:positive regulation of histone modification; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of ubiquitin-protein transferase activity; P:postreplication repair; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of DNA repair; P:regulation of histone ubiquitination; P:T cell receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold33 indexed_genome mRNA 24511579 24543314 . + . ID=transcript_7076;Q9Y6G3 Q6FID1 Q96Q48 Q9P0S1,39S ribosomal protein L42, mitochondrial {ECO:0000303|PubMed:11551941},39S ribosomal protein L31, mitochondrial {ECO:0000250|UniProtKB:P0C2B9};Mitochondrial large ribosomal subunit protein mL42 {ECO:0000303|PubMed:25278503};, PF10210;, GO:0005743;GO:0005762;GO:0005763;GO:0005739;GO:0005886;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:plasma membrane;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold33 indexed_genome mRNA 24595888 24600437 . + . ID=transcript_7077;O14508 A8K3D1 O14542 O95102 Q9UKS5,Suppressor of cytokine signaling 2,Cytokine-inducible SH2 protein 2;STAT-induced STAT inhibitor 2;, PF00017;PF07525;, GO:0005737;GO:0005829;GO:0005942;GO:0046935;GO:0005131;GO:0005159;GO:0008269;GO:0032870;GO:0019221;GO:0060396;GO:0038111;GO:0035556;GO:0007595;GO:0060749;GO:0043066;GO:0040015;GO:0046426;GO:0046854;GO:0045666;GO:0043687;GO:0016567;GO:0007259;GO:0001558;GO:0009966;GO:0032355;, C:cytoplasm; C:cytosol; C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase regulator activity; F:growth hormone receptor binding; F:insulin-like growth factor receptor binding; F:JAK pathway signal transduction adaptor activity;, P:cellular response to hormone stimulus; P:cytokine-mediated signaling pathway; P:growth hormone receptor signaling pathway; P:interleukin-7-mediated signaling pathway; P:intracellular signal transduction; P:lactation; P:mammary gland alveolus development; P:negative regulation of apoptotic process; P:negative regulation of multicellular organism growth; P:negative regulation of receptor signaling pathway via JAK-STAT; P:phosphatidylinositol phosphorylation; P:positive regulation of neuron differentiation; P:post-translational protein modification; P:protein ubiquitination; P:receptor signaling pathway via JAK-STAT; P:regulation of cell growth; P:regulation of signal transduction; P:response to estradiol; scaffold33 indexed_genome mRNA 24690550 24737104 . + . ID=transcript_7078;P78560 B7Z2Q5,Death domain-containing protein CRADD,Caspase and RIP adapter with death domain;RIP-associated protein with a death domain;, PF00619;PF00531;, GO:0005737;GO:0005829;GO:0005634;GO:0070513;GO:0002020;GO:0030674;GO:0006919;GO:0097190;GO:0071260;GO:0006977;GO:0008625;GO:0043065;GO:2001235;GO:0042981;, C:cytoplasm; C:cytosol; C:nucleus;, F:death domain binding; F:protease binding; F:protein-macromolecule adaptor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic signaling pathway; P:cellular response to mechanical stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:regulation of apoptotic process; scaffold33 indexed_genome mRNA 24777092 24876906 . - . ID=transcript_7079;P78560 B7Z2Q5,Death domain-containing protein CRADD,Caspase and RIP adapter with death domain;RIP-associated protein with a death domain;, PF00619;PF00531;, GO:0005737;GO:0005829;GO:0005634;GO:0070513;GO:0002020;GO:0030674;GO:0006919;GO:0097190;GO:0071260;GO:0006977;GO:0008625;GO:0043065;GO:2001235;GO:0042981;, C:cytoplasm; C:cytosol; C:nucleus;, F:death domain binding; F:protease binding; F:protein-macromolecule adaptor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic signaling pathway; P:cellular response to mechanical stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:regulation of apoptotic process; scaffold33 indexed_genome mRNA 25126255 25277869 . + . ID=transcript_7080;O60486 Q59H25,Plexin-C1,Virus-encoded semaphorin protein receptor;, PF08337;PF01437;PF01833;, GO:0005887;GO:0016020;GO:0005886;GO:0002116;GO:0017154;GO:0005102;GO:0007155;GO:0007162;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:1902287;, C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:signaling receptor binding;, P:cell adhesion; P:negative regulation of cell adhesion; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway involved in axon guidance;|O60486 Q59H25,Plexin-C1,Virus-encoded semaphorin protein receptor;, PF08337;PF01437;PF01833;, GO:0005887;GO:0016020;GO:0005886;GO:0002116;GO:0017154;GO:0005102;GO:0007155;GO:0007162;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:1902287;, C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:signaling receptor binding;, P:cell adhesion; P:negative regulation of cell adhesion; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway involved in axon guidance;|O60486 Q59H25,Plexin-C1,Virus-encoded semaphorin protein receptor;, PF08337;PF01437;PF01833;, GO:0005887;GO:0016020;GO:0005886;GO:0002116;GO:0017154;GO:0005102;GO:0007155;GO:0007162;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:1902287;, C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:signaling receptor binding;, P:cell adhesion; P:negative regulation of cell adhesion; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway involved in axon guidance;|O60486 Q59H25,Plexin-C1,Virus-encoded semaphorin protein receptor;, PF08337;PF01437;PF01833;, GO:0005887;GO:0016020;GO:0005886;GO:0002116;GO:0017154;GO:0005102;GO:0007155;GO:0007162;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:1902287;, C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:signaling receptor binding;, P:cell adhesion; P:negative regulation of cell adhesion; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway involved in axon guidance;|O60486 Q59H25,Plexin-C1,Virus-encoded semaphorin protein receptor;, PF08337;PF01437;PF01833;, GO:0005887;GO:0016020;GO:0005886;GO:0002116;GO:0017154;GO:0005102;GO:0007155;GO:0007162;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:1902287;, C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:signaling receptor binding;, P:cell adhesion; P:negative regulation of cell adhesion; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway involved in axon guidance;|O60486 Q59H25,Plexin-C1,Virus-encoded semaphorin protein receptor;, PF08337;PF01437;PF01833;, GO:0005887;GO:0016020;GO:0005886;GO:0002116;GO:0017154;GO:0005102;GO:0007155;GO:0007162;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:1902287;, C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:signaling receptor binding;, P:cell adhesion; P:negative regulation of cell adhesion; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway involved in axon guidance;|O60486 Q59H25,Plexin-C1,Virus-encoded semaphorin protein receptor;, PF08337;PF01437;PF01833;, GO:0005887;GO:0016020;GO:0005886;GO:0002116;GO:0017154;GO:0005102;GO:0007155;GO:0007162;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:1902287;, C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:signaling receptor binding;, P:cell adhesion; P:negative regulation of cell adhesion; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway involved in axon guidance; scaffold33 indexed_genome mRNA 25278387 25414851 . - . ID=transcript_7081;Q9Y592 A4FVB1 Q08AP1,Centrosomal protein of 83 kDa,Coiled-coil domain-containing protein 41;Renal carcinoma antigen NY-REN-58;, , GO:0005814;GO:0097539;GO:0005829;GO:0005794;GO:0042802;GO:0097711;GO:0060271;GO:0051660;GO:0071539;GO:0048278;, C:centriole; C:ciliary transition fiber; C:cytosol; C:Golgi apparatus;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of centrosome localization; P:protein localization to centrosome; P:vesicle docking;|Q9Y592 A4FVB1 Q08AP1,Centrosomal protein of 83 kDa,Coiled-coil domain-containing protein 41;Renal carcinoma antigen NY-REN-58;, , GO:0005814;GO:0097539;GO:0005829;GO:0005794;GO:0042802;GO:0097711;GO:0060271;GO:0051660;GO:0071539;GO:0048278;, C:centriole; C:ciliary transition fiber; C:cytosol; C:Golgi apparatus;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of centrosome localization; P:protein localization to centrosome; P:vesicle docking;|Q9Y592 A4FVB1 Q08AP1,Centrosomal protein of 83 kDa,Coiled-coil domain-containing protein 41;Renal carcinoma antigen NY-REN-58;, , GO:0005814;GO:0097539;GO:0005829;GO:0005794;GO:0042802;GO:0097711;GO:0060271;GO:0051660;GO:0071539;GO:0048278;, C:centriole; C:ciliary transition fiber; C:cytosol; C:Golgi apparatus;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of centrosome localization; P:protein localization to centrosome; P:vesicle docking;|Q9Y592 A4FVB1 Q08AP1,Centrosomal protein of 83 kDa,Coiled-coil domain-containing protein 41;Renal carcinoma antigen NY-REN-58;, , GO:0005814;GO:0097539;GO:0005829;GO:0005794;GO:0042802;GO:0097711;GO:0060271;GO:0051660;GO:0071539;GO:0048278;, C:centriole; C:ciliary transition fiber; C:cytosol; C:Golgi apparatus;, F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of centrosome localization; P:protein localization to centrosome; P:vesicle docking; scaffold33 indexed_genome mRNA 25511998 25580685 . - . ID=transcript_7082;Q9ULS5 Q8IWB2,Transmembrane and coiled-coil domain protein 3 {ECO:0000303|PubMed:24454821},, PF10267;, GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0071889;GO:0042802;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:14-3-3 protein binding; F:identical protein binding; scaffold34 indexed_genome mRNA 157826 188854 . + . ID=transcript_7083;Q9NNW4 Q9UCJ4,Membrane cofactor protein,TLX;Trophoblast leukocyte common antigen;, PF00084;, GO:0009986;GO:0070062;GO:0005925;GO:0002079;GO:0005887;GO:0005886;GO:0045296;GO:0038023;GO:0001618;GO:0002250;GO:0006958;GO:0045087;GO:0010629;GO:0010628;GO:0032733;GO:0043382;GO:0045591;GO:0042102;GO:0071636;GO:0030449;GO:0008593;GO:0035581;GO:0007338;GO:0002456;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:inner acrosomal membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cadherin binding; F:signaling receptor activity; F:virus receptor activity;, P:adaptive immune response; P:complement activation, classical pathway; P:innate immune response; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of interleukin-10 production; P:positive regulation of memory T cell differentiation; P:positive regulation of regulatory T cell differentiation; P:positive regulation of T cell proliferation; P:positive regulation of transforming growth factor beta production; P:regulation of complement activation; P:regulation of Notch signaling pathway; P:sequestering of extracellular ligand from receptor; P:single fertilization; P:T cell mediated immunity; scaffold34 indexed_genome mRNA 363811 399453 . - . ID=transcript_7084;O75051 A2RTX9 B2RMX7 Q6UX61 Q96GN9 Q9BRL1 Q9UIW1,Plexin-A2,Semaphorin receptor OCT;, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005887;GO:0005886;GO:0002116;GO:0042802;GO:0017154;GO:0051642;GO:0021935;GO:0060174;GO:0007162;GO:0021915;GO:0060037;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0001756;, C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:identical protein binding; F:semaphorin receptor activity;, P:centrosome localization; P:cerebellar granule cell precursor tangential migration; P:limb bud formation; P:negative regulation of cell adhesion; P:neural tube development; P:pharyngeal system development; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:somitogenesis; scaffold34 indexed_genome mRNA 1862479 1876069 . + . ID=transcript_7085;Q96NX5 Q86UH5 Q9Y3J7,Calcium/calmodulin-dependent protein kinase type 1G,CaM kinase I gamma;CaMK-like CREB kinase III;, PF00069;, GO:0005954;GO:0000139;GO:0043005;GO:0005886;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0018105;, C:calcium- and calmodulin-dependent protein kinase complex; C:Golgi membrane; C:neuron projection; C:plasma membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:peptidyl-serine phosphorylation; scaffold34 indexed_genome mRNA 1878425 1881709 . + . ID=transcript_7086;Q96NX5 Q86UH5 Q9Y3J7,Calcium/calmodulin-dependent protein kinase type 1G,CaM kinase I gamma;CaMK-like CREB kinase III;, PF00069;, GO:0005954;GO:0000139;GO:0043005;GO:0005886;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0018105;, C:calcium- and calmodulin-dependent protein kinase complex; C:Golgi membrane; C:neuron projection; C:plasma membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:peptidyl-serine phosphorylation; scaffold34 indexed_genome mRNA 1881713 1884330 . + . ID=transcript_7087;Q96NX5 Q86UH5 Q9Y3J7,Calcium/calmodulin-dependent protein kinase type 1G,CaM kinase I gamma;CaMK-like CREB kinase III;, PF00069;, GO:0005954;GO:0000139;GO:0043005;GO:0005886;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0018105;, C:calcium- and calmodulin-dependent protein kinase complex; C:Golgi membrane; C:neuron projection; C:plasma membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:peptidyl-serine phosphorylation; scaffold34 indexed_genome mRNA 1887812 1888430 . + . ID=transcript_7088;Q13751 D3DT88 O14947 Q14733 Q9UJK4 Q9UJL1,Laminin subunit beta-3,Epiligrin subunit bata;Kalinin B1 chain;Kalinin subunit beta;Laminin B1k chain;Laminin-5 subunit beta;Nicein subunit beta;, PF00053;PF00055;, GO:0062023;GO:0005576;GO:0043256;GO:0005201;GO:0044877;GO:0005198;GO:0009887;GO:0070831;GO:0016477;GO:0030199;GO:0035987;GO:0008544;GO:0030198;GO:0031581;GO:0034446;GO:0009888;, C:collagen-containing extracellular matrix; C:extracellular region; C:laminin complex;, F:extracellular matrix structural constituent; F:protein-containing complex binding; F:structural molecule activity;, P:animal organ morphogenesis; P:basement membrane assembly; P:cell migration; P:collagen fibril organization; P:endodermal cell differentiation; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:substrate adhesion-dependent cell spreading; P:tissue development; scaffold34 indexed_genome mRNA 1889113 1936050 . - . ID=transcript_7089;Q13751 D3DT88 O14947 Q14733 Q9UJK4 Q9UJL1,Laminin subunit beta-3,Epiligrin subunit bata;Kalinin B1 chain;Kalinin subunit beta;Laminin B1k chain;Laminin-5 subunit beta;Nicein subunit beta;, PF00053;PF00055;, GO:0062023;GO:0005576;GO:0043256;GO:0005201;GO:0044877;GO:0005198;GO:0009887;GO:0070831;GO:0016477;GO:0030199;GO:0035987;GO:0008544;GO:0030198;GO:0031581;GO:0034446;GO:0009888;, C:collagen-containing extracellular matrix; C:extracellular region; C:laminin complex;, F:extracellular matrix structural constituent; F:protein-containing complex binding; F:structural molecule activity;, P:animal organ morphogenesis; P:basement membrane assembly; P:cell migration; P:collagen fibril organization; P:endodermal cell differentiation; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:substrate adhesion-dependent cell spreading; P:tissue development;|Q13751 D3DT88 O14947 Q14733 Q9UJK4 Q9UJL1,Laminin subunit beta-3,Epiligrin subunit bata;Kalinin B1 chain;Kalinin subunit beta;Laminin B1k chain;Laminin-5 subunit beta;Nicein subunit beta;, PF00053;PF00055;, GO:0062023;GO:0005576;GO:0043256;GO:0005201;GO:0044877;GO:0005198;GO:0009887;GO:0070831;GO:0016477;GO:0030199;GO:0035987;GO:0008544;GO:0030198;GO:0031581;GO:0034446;GO:0009888;, C:collagen-containing extracellular matrix; C:extracellular region; C:laminin complex;, F:extracellular matrix structural constituent; F:protein-containing complex binding; F:structural molecule activity;, P:animal organ morphogenesis; P:basement membrane assembly; P:cell migration; P:collagen fibril organization; P:endodermal cell differentiation; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:substrate adhesion-dependent cell spreading; P:tissue development;|Q13751 D3DT88 O14947 Q14733 Q9UJK4 Q9UJL1,Laminin subunit beta-3,Epiligrin subunit bata;Kalinin B1 chain;Kalinin subunit beta;Laminin B1k chain;Laminin-5 subunit beta;Nicein subunit beta;, PF00053;PF00055;, GO:0062023;GO:0005576;GO:0043256;GO:0005201;GO:0044877;GO:0005198;GO:0009887;GO:0070831;GO:0016477;GO:0030199;GO:0035987;GO:0008544;GO:0030198;GO:0031581;GO:0034446;GO:0009888;, C:collagen-containing extracellular matrix; C:extracellular region; C:laminin complex;, F:extracellular matrix structural constituent; F:protein-containing complex binding; F:structural molecule activity;, P:animal organ morphogenesis; P:basement membrane assembly; P:cell migration; P:collagen fibril organization; P:endodermal cell differentiation; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:substrate adhesion-dependent cell spreading; P:tissue development;|Q13751 D3DT88 O14947 Q14733 Q9UJK4 Q9UJL1,Laminin subunit beta-3,Epiligrin subunit bata;Kalinin B1 chain;Kalinin subunit beta;Laminin B1k chain;Laminin-5 subunit beta;Nicein subunit beta;, PF00053;PF00055;, GO:0062023;GO:0005576;GO:0043256;GO:0005201;GO:0044877;GO:0005198;GO:0009887;GO:0070831;GO:0016477;GO:0030199;GO:0035987;GO:0008544;GO:0030198;GO:0031581;GO:0034446;GO:0009888;, C:collagen-containing extracellular matrix; C:extracellular region; C:laminin complex;, F:extracellular matrix structural constituent; F:protein-containing complex binding; F:structural molecule activity;, P:animal organ morphogenesis; P:basement membrane assembly; P:cell migration; P:collagen fibril organization; P:endodermal cell differentiation; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:substrate adhesion-dependent cell spreading; P:tissue development; scaffold34 indexed_genome mRNA 1957640 1958300 . + . ID=transcript_7090;P27469 Q6FGC8,G0/G1 switch protein 2,G0/G1 switch regulatory protein 2;Putative lymphocyte G0/G1 switch gene;, PF15103;, GO:0005811;GO:0005739;GO:0097191;GO:0120162;GO:2001238;GO:0019222;, C:lipid droplet; C:mitochondrion;, , P:extrinsic apoptotic signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of extrinsic apoptotic signaling pathway; P:regulation of metabolic process; scaffold34 indexed_genome mRNA 1987976 2027676 . + . ID=transcript_7091;P28845 B2R9Z1 D3DT89,Corticosteroid 11-beta-dehydrogenase isozyme 1 {ECO:0000305},11-beta-hydroxysteroid dehydrogenase 1;Short chain dehydrogenase/reductase family 26C member 1;, PF00106;, GO:0005789;GO:0030176;GO:0016020;GO:0070524;GO:0003845;GO:0050661;GO:0042803;GO:0005496;GO:0006704;GO:0030324;GO:0006706;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:11-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity; F:NADP binding; F:protein homodimerization activity; F:steroid binding;, P:glucocorticoid biosynthetic process; P:lung development; P:steroid catabolic process;|P28845 B2R9Z1 D3DT89,Corticosteroid 11-beta-dehydrogenase isozyme 1 {ECO:0000305},11-beta-hydroxysteroid dehydrogenase 1;Short chain dehydrogenase/reductase family 26C member 1;, PF00106;, GO:0005789;GO:0030176;GO:0016020;GO:0070524;GO:0003845;GO:0050661;GO:0042803;GO:0005496;GO:0006704;GO:0030324;GO:0006706;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:11-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity; F:NADP binding; F:protein homodimerization activity; F:steroid binding;, P:glucocorticoid biosynthetic process; P:lung development; P:steroid catabolic process;|P28845 B2R9Z1 D3DT89,Corticosteroid 11-beta-dehydrogenase isozyme 1 {ECO:0000305},11-beta-hydroxysteroid dehydrogenase 1;Short chain dehydrogenase/reductase family 26C member 1;, PF00106;, GO:0005789;GO:0030176;GO:0016020;GO:0070524;GO:0003845;GO:0050661;GO:0042803;GO:0005496;GO:0006704;GO:0030324;GO:0006706;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:11-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity; F:NADP binding; F:protein homodimerization activity; F:steroid binding;, P:glucocorticoid biosynthetic process; P:lung development; P:steroid catabolic process; scaffold34 indexed_genome mRNA 2042318 2067982 . + . ID=transcript_7092;Q9Y228 A1L464 A6NIU9 Q2YDB5 Q4VY06 Q7Z706,TRAF3-interacting JNK-activating modulator,TRAF3-interacting protein 3;, , GO:0000139;GO:0016021;GO:0005765;GO:0005741;GO:0005886;, C:Golgi membrane; C:integral component of membrane; C:lysosomal membrane; C:mitochondrial outer membrane; C:plasma membrane;|Q9Y228 A1L464 A6NIU9 Q2YDB5 Q4VY06 Q7Z706,TRAF3-interacting JNK-activating modulator,TRAF3-interacting protein 3;, , GO:0000139;GO:0016021;GO:0005765;GO:0005741;GO:0005886;, C:Golgi membrane; C:integral component of membrane; C:lysosomal membrane; C:mitochondrial outer membrane; C:plasma membrane; scaffold34 indexed_genome mRNA 2071093 2087860 . + . ID=transcript_7093;O14896 B4DLE2 D3DT90 F5GWX8 G0ZTL0,Interferon regulatory factor 6,, PF00605;PF10401;, GO:0030054;GO:0000785;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0007050;GO:0048468;GO:1904888;GO:0002376;GO:0060333;GO:0030216;GO:0043616;GO:0060173;GO:0060644;GO:0008285;GO:0045944;GO:0045893;GO:0006357;GO:0060021;GO:0060337;, C:cell junction; C:chromatin; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell cycle arrest; P:cell development; P:cranial skeletal system development; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:keratinocyte differentiation; P:keratinocyte proliferation; P:limb development; P:mammary gland epithelial cell differentiation; P:negative regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; P:type I interferon signaling pathway;|O14896 B4DLE2 D3DT90 F5GWX8 G0ZTL0,Interferon regulatory factor 6,, PF00605;PF10401;, GO:0030054;GO:0000785;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0007050;GO:0048468;GO:1904888;GO:0002376;GO:0060333;GO:0030216;GO:0043616;GO:0060173;GO:0060644;GO:0008285;GO:0045944;GO:0045893;GO:0006357;GO:0060021;GO:0060337;, C:cell junction; C:chromatin; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell cycle arrest; P:cell development; P:cranial skeletal system development; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:keratinocyte differentiation; P:keratinocyte proliferation; P:limb development; P:mammary gland epithelial cell differentiation; P:negative regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; P:type I interferon signaling pathway; scaffold34 indexed_genome mRNA 2112609 2139937 . + . ID=transcript_7094;Q68CQ4 O75992 Q4VY00 Q63HL9,Digestive organ expansion factor homolog,, PF06862;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0019843;GO:0034511;GO:0000462;GO:0007275;GO:0040019;GO:0030163;GO:0031648;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding; F:rRNA binding; F:U3 snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:multicellular organism development; P:positive regulation of embryonic development; P:protein catabolic process; P:protein destabilization; P:rRNA processing;|Q68CQ4 O75992 Q4VY00 Q63HL9,Digestive organ expansion factor homolog,, PF06862;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0019843;GO:0034511;GO:0000462;GO:0007275;GO:0040019;GO:0030163;GO:0031648;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding; F:rRNA binding; F:U3 snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:multicellular organism development; P:positive regulation of embryonic development; P:protein catabolic process; P:protein destabilization; P:rRNA processing;|Q68CQ4 O75992 Q4VY00 Q63HL9,Digestive organ expansion factor homolog,, PF06862;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0019843;GO:0034511;GO:0000462;GO:0007275;GO:0040019;GO:0030163;GO:0031648;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding; F:rRNA binding; F:U3 snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:multicellular organism development; P:positive regulation of embryonic development; P:protein catabolic process; P:protein destabilization; P:rRNA processing; scaffold34 indexed_genome mRNA 2289502 2294172 . + . ID=transcript_7095;Q707N7,Synaptotagmin-14,Synaptotagmin XIV;, PF00168;, GO:0016021;, C:integral component of membrane; scaffold34 indexed_genome mRNA 2366219 2372400 . + . ID=transcript_7096;Q9NUC0 B2RD32,SERTA domain-containing protein 4,, PF06031;, GO:0005634;, C:nucleus; scaffold34 indexed_genome mRNA 2751189 2810616 . + . ID=transcript_7097;Q5CZ95 Q5TGI2 Q9NVH9 Q9Y3N8,Protein-cysteine N-palmitoyltransferase HHAT,Hedgehog acyltransferase;Melanoma antigen recognized by T-cells 2;Skinny hedgehog protein 1;, PF03062;, GO:0005783;GO:0005789;GO:0016021;GO:0005525;GO:0016409;GO:0016746;GO:0007275;GO:0018345;GO:0007224;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:GTP binding; F:palmitoyltransferase activity; F:transferase activity, transferring acyl groups;, P:multicellular organism development; P:protein palmitoylation; P:smoothened signaling pathway; scaffold34 indexed_genome mRNA 2816365 2942693 . - . ID=transcript_7098;O95259 B1AQ26 O76035 Q14CL3,Potassium voltage-gated channel subfamily H member 1,Ether-a-go-go potassium channel 1 {ECO:0000303|PubMed:27325704};Voltage-gated potassium channel subunit Kv10.1;, PF00027;PF00520;PF13426;, GO:0030424;GO:0030425;GO:0031901;GO:0005887;GO:0043231;GO:0005637;GO:0043204;GO:0005886;GO:0098839;GO:0042734;GO:0008076;GO:0005516;GO:0005251;GO:1902936;GO:0005249;GO:0071277;GO:0007520;GO:0048015;GO:0071805;GO:0006813;GO:0042127;GO:0034765;GO:0042391;, C:axon; C:dendrite; C:early endosome membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nuclear inner membrane; C:perikaryon; C:plasma membrane; C:postsynaptic density membrane; C:presynaptic membrane; C:voltage-gated potassium channel complex;, F:calmodulin binding; F:delayed rectifier potassium channel activity; F:phosphatidylinositol bisphosphate binding; F:voltage-gated potassium channel activity;, P:cellular response to calcium ion; P:myoblast fusion; P:phosphatidylinositol-mediated signaling; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of cell population proliferation; P:regulation of ion transmembrane transport; P:regulation of membrane potential; scaffold34 indexed_genome mRNA 3051544 3130120 . - . ID=transcript_7099;O95259 B1AQ26 O76035 Q14CL3,Potassium voltage-gated channel subfamily H member 1,Ether-a-go-go potassium channel 1 {ECO:0000303|PubMed:27325704};Voltage-gated potassium channel subunit Kv10.1;, PF00027;PF00520;PF13426;, GO:0030424;GO:0030425;GO:0031901;GO:0005887;GO:0043231;GO:0005637;GO:0043204;GO:0005886;GO:0098839;GO:0042734;GO:0008076;GO:0005516;GO:0005251;GO:1902936;GO:0005249;GO:0071277;GO:0007520;GO:0048015;GO:0071805;GO:0006813;GO:0042127;GO:0034765;GO:0042391;, C:axon; C:dendrite; C:early endosome membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nuclear inner membrane; C:perikaryon; C:plasma membrane; C:postsynaptic density membrane; C:presynaptic membrane; C:voltage-gated potassium channel complex;, F:calmodulin binding; F:delayed rectifier potassium channel activity; F:phosphatidylinositol bisphosphate binding; F:voltage-gated potassium channel activity;, P:cellular response to calcium ion; P:myoblast fusion; P:phosphatidylinositol-mediated signaling; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of cell population proliferation; P:regulation of ion transmembrane transport; P:regulation of membrane potential; scaffold34 indexed_genome mRNA 3317039 3386988 . - . ID=transcript_7100;Q9P2K3 B3KYA2 B4DYY7 Q5VT47 Q7L9I5 Q8N5U3 Q9NV83,REST corepressor 3,, PF01448;PF00249;, GO:0005829;GO:0000118;GO:0005654;GO:0005667;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9P2K3 B3KYA2 B4DYY7 Q5VT47 Q7L9I5 Q8N5U3 Q9NV83,REST corepressor 3,, PF01448;PF00249;, GO:0005829;GO:0000118;GO:0005654;GO:0005667;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9P2K3 B3KYA2 B4DYY7 Q5VT47 Q7L9I5 Q8N5U3 Q9NV83,REST corepressor 3,, PF01448;PF00249;, GO:0005829;GO:0000118;GO:0005654;GO:0005667;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9P2K3 B3KYA2 B4DYY7 Q5VT47 Q7L9I5 Q8N5U3 Q9NV83,REST corepressor 3,, PF01448;PF00249;, GO:0005829;GO:0000118;GO:0005654;GO:0005667;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9P2K3 B3KYA2 B4DYY7 Q5VT47 Q7L9I5 Q8N5U3 Q9NV83,REST corepressor 3,, PF01448;PF00249;, GO:0005829;GO:0000118;GO:0005654;GO:0005667;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9P2K3 B3KYA2 B4DYY7 Q5VT47 Q7L9I5 Q8N5U3 Q9NV83,REST corepressor 3,, PF01448;PF00249;, GO:0005829;GO:0000118;GO:0005654;GO:0005667;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9P2K3 B3KYA2 B4DYY7 Q5VT47 Q7L9I5 Q8N5U3 Q9NV83,REST corepressor 3,, PF01448;PF00249;, GO:0005829;GO:0000118;GO:0005654;GO:0005667;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:cytosol; C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold34 indexed_genome mRNA 3432210 3441602 . + . ID=transcript_7101;O00463 B4DIS9 B4E0A2 Q6FHY1,TNF receptor-associated factor 5,RING finger protein 84;, PF00097;PF02176;, GO:0035631;GO:0005813;GO:0009898;GO:0005829;GO:0042802;GO:0031996;GO:0005164;GO:0031625;GO:0004842;GO:0008270;GO:0006915;GO:0008284;GO:0051091;GO:0043123;GO:0046330;GO:0051092;GO:0070534;GO:0042981;GO:0043122;GO:0007165;GO:0033209;, C:CD40 receptor complex; C:centrosome; C:cytoplasmic side of plasma membrane; C:cytosol;, F:identical protein binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:regulation of apoptotic process; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; scaffold34 indexed_genome mRNA 3441606 3445872 . + . ID=transcript_7102;O00463 B4DIS9 B4E0A2 Q6FHY1,TNF receptor-associated factor 5,RING finger protein 84;, PF00097;PF02176;, GO:0035631;GO:0005813;GO:0009898;GO:0005829;GO:0042802;GO:0031996;GO:0005164;GO:0031625;GO:0004842;GO:0008270;GO:0006915;GO:0008284;GO:0051091;GO:0043123;GO:0046330;GO:0051092;GO:0070534;GO:0042981;GO:0043122;GO:0007165;GO:0033209;, C:CD40 receptor complex; C:centrosome; C:cytoplasmic side of plasma membrane; C:cytosol;, F:identical protein binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:regulation of apoptotic process; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; scaffold34 indexed_genome mRNA 3726206 3737078 . + . ID=transcript_7103;Q92604 Q53YL2,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 {ECO:0000305},Acyl-CoA:monoacylglycerol acyltransferase LPGAT1 {ECO:0000250|UniProtKB:Q91YX5};, PF16076;PF01553;, GO:0005737;GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003846;GO:0071617;GO:0016746;GO:0036148;GO:0036149;GO:0008654;GO:0045723;GO:0019432;, C:cytoplasm; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:2-acylglycerol O-acyltransferase activity; F:lysophospholipid acyltransferase activity; F:transferase activity, transferring acyl groups;, P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of fatty acid biosynthetic process; P:triglyceride biosynthetic process;|Q92604 Q53YL2,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 {ECO:0000305},Acyl-CoA:monoacylglycerol acyltransferase LPGAT1 {ECO:0000250|UniProtKB:Q91YX5};, PF16076;PF01553;, GO:0005737;GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003846;GO:0071617;GO:0016746;GO:0036148;GO:0036149;GO:0008654;GO:0045723;GO:0019432;, C:cytoplasm; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:2-acylglycerol O-acyltransferase activity; F:lysophospholipid acyltransferase activity; F:transferase activity, transferring acyl groups;, P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of fatty acid biosynthetic process; P:triglyceride biosynthetic process;|Q92604 Q53YL2,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 {ECO:0000305},Acyl-CoA:monoacylglycerol acyltransferase LPGAT1 {ECO:0000250|UniProtKB:Q91YX5};, PF16076;PF01553;, GO:0005737;GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003846;GO:0071617;GO:0016746;GO:0036148;GO:0036149;GO:0008654;GO:0045723;GO:0019432;, C:cytoplasm; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:2-acylglycerol O-acyltransferase activity; F:lysophospholipid acyltransferase activity; F:transferase activity, transferring acyl groups;, P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of fatty acid biosynthetic process; P:triglyceride biosynthetic process; scaffold34 indexed_genome mRNA 3740660 3759324 . - . ID=transcript_7104;Q92604 Q53YL2,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 {ECO:0000305},Acyl-CoA:monoacylglycerol acyltransferase LPGAT1 {ECO:0000250|UniProtKB:Q91YX5};, PF16076;PF01553;, GO:0005737;GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003846;GO:0071617;GO:0016746;GO:0036148;GO:0036149;GO:0008654;GO:0045723;GO:0019432;, C:cytoplasm; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:2-acylglycerol O-acyltransferase activity; F:lysophospholipid acyltransferase activity; F:transferase activity, transferring acyl groups;, P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of fatty acid biosynthetic process; P:triglyceride biosynthetic process;|Q92604 Q53YL2,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 {ECO:0000305},Acyl-CoA:monoacylglycerol acyltransferase LPGAT1 {ECO:0000250|UniProtKB:Q91YX5};, PF16076;PF01553;, GO:0005737;GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003846;GO:0071617;GO:0016746;GO:0036148;GO:0036149;GO:0008654;GO:0045723;GO:0019432;, C:cytoplasm; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:2-acylglycerol O-acyltransferase activity; F:lysophospholipid acyltransferase activity; F:transferase activity, transferring acyl groups;, P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of fatty acid biosynthetic process; P:triglyceride biosynthetic process; scaffold34 indexed_genome mRNA 3759572 3761889 . + . ID=transcript_7105;Q92604 Q53YL2,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 {ECO:0000305},Acyl-CoA:monoacylglycerol acyltransferase LPGAT1 {ECO:0000250|UniProtKB:Q91YX5};, PF16076;PF01553;, GO:0005737;GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003846;GO:0071617;GO:0016746;GO:0036148;GO:0036149;GO:0008654;GO:0045723;GO:0019432;, C:cytoplasm; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:2-acylglycerol O-acyltransferase activity; F:lysophospholipid acyltransferase activity; F:transferase activity, transferring acyl groups;, P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of fatty acid biosynthetic process; P:triglyceride biosynthetic process; scaffold34 indexed_genome mRNA 3897418 3985407 . - . ID=transcript_7106;Q9UFM3,Integrator complex subunit 7,, , GO:0005694;GO:0005737;GO:0032039;GO:0016604;GO:0005654;GO:0005634;GO:0071479;GO:0000077;GO:0034472;GO:0016180;GO:0042795;, C:chromosome; C:cytoplasm; C:integrator complex; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9UFM3,Integrator complex subunit 7,, , GO:0005694;GO:0005737;GO:0032039;GO:0016604;GO:0005654;GO:0005634;GO:0071479;GO:0000077;GO:0034472;GO:0016180;GO:0042795;, C:chromosome; C:cytoplasm; C:integrator complex; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9UFM3,Integrator complex subunit 7,, , GO:0005694;GO:0005737;GO:0032039;GO:0016604;GO:0005654;GO:0005634;GO:0071479;GO:0000077;GO:0034472;GO:0016180;GO:0042795;, C:chromosome; C:cytoplasm; C:integrator complex; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9UFM3,Integrator complex subunit 7,, , GO:0005694;GO:0005737;GO:0032039;GO:0016604;GO:0005654;GO:0005634;GO:0071479;GO:0000077;GO:0034472;GO:0016180;GO:0042795;, C:chromosome; C:cytoplasm; C:integrator complex; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9UFM3,Integrator complex subunit 7,, , GO:0005694;GO:0005737;GO:0032039;GO:0016604;GO:0005654;GO:0005634;GO:0071479;GO:0000077;GO:0034472;GO:0016180;GO:0042795;, C:chromosome; C:cytoplasm; C:integrator complex; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9UFM3,Integrator complex subunit 7,, , GO:0005694;GO:0005737;GO:0032039;GO:0016604;GO:0005654;GO:0005634;GO:0071479;GO:0000077;GO:0034472;GO:0016180;GO:0042795;, C:chromosome; C:cytoplasm; C:integrator complex; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold34 indexed_genome mRNA 4029435 4032268 . + . ID=transcript_7107;Q9NZJ0 A8K8H8 D3DT98 Q5VT77 Q96SN0 Q9NW03 Q9NW34 Q9NWM5,Denticleless protein homolog,DDB1- and CUL4-associated factor 2;Lethal(2) denticleless protein homolog;Retinoic acid-regulated nuclear matrix-associated protein;, PF00400;, GO:0005813;GO:0005694;GO:0080008;GO:0031464;GO:0031465;GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0006974;GO:0042769;GO:0006260;GO:0010971;GO:0045732;GO:0043687;GO:0006513;GO:0000209;GO:0051726;GO:0009411;GO:0048511;GO:0072425;GO:0019985;GO:0006511;, C:centrosome; C:chromosome; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA replication; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of protein catabolic process; P:post-translational protein modification; P:protein monoubiquitination; P:protein polyubiquitination; P:regulation of cell cycle; P:response to UV; P:rhythmic process; P:signal transduction involved in G2 DNA damage checkpoint; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process; scaffold34 indexed_genome mRNA 4225407 4299438 . - . ID=transcript_7108;Q15172 B2R6D2 B7Z7L2 D3DT99 Q2NL72 Q5VVB2 Q8TBI9,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,PP2A B subunit isoform B'-alpha;PP2A B subunit isoform B56-alpha;PP2A B subunit isoform PR61-alpha;PP2A B subunit isoform R5-alpha;, PF01603;, GO:0005813;GO:0000775;GO:0005737;GO:0005829;GO:0031430;GO:0016020;GO:0005634;GO:0000159;GO:0030018;GO:0019900;GO:0004721;GO:0072542;GO:0019888;GO:0090219;GO:1903077;GO:0035307;GO:0006470;GO:0031952;GO:0007165;, C:centrosome; C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:M band; C:membrane; C:nucleus; C:protein phosphatase type 2A complex; C:Z disc;, F:kinase binding; F:phosphoprotein phosphatase activity; F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:negative regulation of lipid kinase activity; P:negative regulation of protein localization to plasma membrane; P:positive regulation of protein dephosphorylation; P:protein dephosphorylation; P:regulation of protein autophosphorylation; P:signal transduction;|Q15172 B2R6D2 B7Z7L2 D3DT99 Q2NL72 Q5VVB2 Q8TBI9,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,PP2A B subunit isoform B'-alpha;PP2A B subunit isoform B56-alpha;PP2A B subunit isoform PR61-alpha;PP2A B subunit isoform R5-alpha;, PF01603;, GO:0005813;GO:0000775;GO:0005737;GO:0005829;GO:0031430;GO:0016020;GO:0005634;GO:0000159;GO:0030018;GO:0019900;GO:0004721;GO:0072542;GO:0019888;GO:0090219;GO:1903077;GO:0035307;GO:0006470;GO:0031952;GO:0007165;, C:centrosome; C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:M band; C:membrane; C:nucleus; C:protein phosphatase type 2A complex; C:Z disc;, F:kinase binding; F:phosphoprotein phosphatase activity; F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:negative regulation of lipid kinase activity; P:negative regulation of protein localization to plasma membrane; P:positive regulation of protein dephosphorylation; P:protein dephosphorylation; P:regulation of protein autophosphorylation; P:signal transduction;|Q15172 B2R6D2 B7Z7L2 D3DT99 Q2NL72 Q5VVB2 Q8TBI9,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,PP2A B subunit isoform B'-alpha;PP2A B subunit isoform B56-alpha;PP2A B subunit isoform PR61-alpha;PP2A B subunit isoform R5-alpha;, PF01603;, GO:0005813;GO:0000775;GO:0005737;GO:0005829;GO:0031430;GO:0016020;GO:0005634;GO:0000159;GO:0030018;GO:0019900;GO:0004721;GO:0072542;GO:0019888;GO:0090219;GO:1903077;GO:0035307;GO:0006470;GO:0031952;GO:0007165;, C:centrosome; C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:M band; C:membrane; C:nucleus; C:protein phosphatase type 2A complex; C:Z disc;, F:kinase binding; F:phosphoprotein phosphatase activity; F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:negative regulation of lipid kinase activity; P:negative regulation of protein localization to plasma membrane; P:positive regulation of protein dephosphorylation; P:protein dephosphorylation; P:regulation of protein autophosphorylation; P:signal transduction;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q15172 B2R6D2 B7Z7L2 D3DT99 Q2NL72 Q5VVB2 Q8TBI9,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,PP2A B subunit isoform B'-alpha;PP2A B subunit isoform B56-alpha;PP2A B subunit isoform PR61-alpha;PP2A B subunit isoform R5-alpha;, PF01603;, GO:0005813;GO:0000775;GO:0005737;GO:0005829;GO:0031430;GO:0016020;GO:0005634;GO:0000159;GO:0030018;GO:0019900;GO:0004721;GO:0072542;GO:0019888;GO:0090219;GO:1903077;GO:0035307;GO:0006470;GO:0031952;GO:0007165;, C:centrosome; C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:M band; C:membrane; C:nucleus; C:protein phosphatase type 2A complex; C:Z disc;, F:kinase binding; F:phosphoprotein phosphatase activity; F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:negative regulation of lipid kinase activity; P:negative regulation of protein localization to plasma membrane; P:positive regulation of protein dephosphorylation; P:protein dephosphorylation; P:regulation of protein autophosphorylation; P:signal transduction;|Q15172 B2R6D2 B7Z7L2 D3DT99 Q2NL72 Q5VVB2 Q8TBI9,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,PP2A B subunit isoform B'-alpha;PP2A B subunit isoform B56-alpha;PP2A B subunit isoform PR61-alpha;PP2A B subunit isoform R5-alpha;, PF01603;, GO:0005813;GO:0000775;GO:0005737;GO:0005829;GO:0031430;GO:0016020;GO:0005634;GO:0000159;GO:0030018;GO:0019900;GO:0004721;GO:0072542;GO:0019888;GO:0090219;GO:1903077;GO:0035307;GO:0006470;GO:0031952;GO:0007165;, C:centrosome; C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:M band; C:membrane; C:nucleus; C:protein phosphatase type 2A complex; C:Z disc;, F:kinase binding; F:phosphoprotein phosphatase activity; F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:negative regulation of lipid kinase activity; P:negative regulation of protein localization to plasma membrane; P:positive regulation of protein dephosphorylation; P:protein dephosphorylation; P:regulation of protein autophosphorylation; P:signal transduction;|Q9H813 B7Z4D6 Q6IA87 Q9NV85,Proton-activated chloride channel {ECO:0000303|PubMed:31023925},Acid-sensitive outwardly-rectifying anion channel {ECO:0000303|PubMed:31318332};Proton-activated outwardly rectifying anion channel {ECO:0000303|PubMed:31318332};Transmembrane protein 206 {ECO:0000305};, PF15122;, GO:0009986;GO:0034707;GO:0005887;GO:0061797;GO:0006821;, C:cell surface; C:chloride channel complex; C:integral component of plasma membrane;, F:pH-gated chloride channel activity;, P:chloride transport;|Q9H813 B7Z4D6 Q6IA87 Q9NV85,Proton-activated chloride channel {ECO:0000303|PubMed:31023925},Acid-sensitive outwardly-rectifying anion channel {ECO:0000303|PubMed:31318332};Proton-activated outwardly rectifying anion channel {ECO:0000303|PubMed:31318332};Transmembrane protein 206 {ECO:0000305};, PF15122;, GO:0009986;GO:0034707;GO:0005887;GO:0061797;GO:0006821;, C:cell surface; C:chloride channel complex; C:integral component of plasma membrane;, F:pH-gated chloride channel activity;, P:chloride transport;|Q9H813 B7Z4D6 Q6IA87 Q9NV85,Proton-activated chloride channel {ECO:0000303|PubMed:31023925},Acid-sensitive outwardly-rectifying anion channel {ECO:0000303|PubMed:31318332};Proton-activated outwardly rectifying anion channel {ECO:0000303|PubMed:31318332};Transmembrane protein 206 {ECO:0000305};, PF15122;, GO:0009986;GO:0034707;GO:0005887;GO:0061797;GO:0006821;, C:cell surface; C:chloride channel complex; C:integral component of plasma membrane;, F:pH-gated chloride channel activity;, P:chloride transport; scaffold34 indexed_genome mRNA 4504166 4510498 . + . ID=transcript_7109;P18847 Q5VTZ2 Q6ICQ9 Q7Z566 Q8WYM6,Cyclic AMP-dependent transcription factor ATF-3,Activating transcription factor 3;, PF00170;, GO:1990622;GO:0000785;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0042802;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0034198;GO:0030968;GO:0006094;GO:0070373;GO:0000122;GO:0008284;GO:1903984;GO:0045944;GO:1990440;GO:0010999;GO:0006357;GO:0061394;GO:0035914;, C:CHOP-ATF3 complex; C:chromatin; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to amino acid starvation; P:endoplasmic reticulum unfolded protein response; P:gluconeogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of eIF2 alpha phosphorylation by heme; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance; P:skeletal muscle cell differentiation;|P18847 Q5VTZ2 Q6ICQ9 Q7Z566 Q8WYM6,Cyclic AMP-dependent transcription factor ATF-3,Activating transcription factor 3;, PF00170;, GO:1990622;GO:0000785;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0042802;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0034198;GO:0030968;GO:0006094;GO:0070373;GO:0000122;GO:0008284;GO:1903984;GO:0045944;GO:1990440;GO:0010999;GO:0006357;GO:0061394;GO:0035914;, C:CHOP-ATF3 complex; C:chromatin; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to amino acid starvation; P:endoplasmic reticulum unfolded protein response; P:gluconeogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of eIF2 alpha phosphorylation by heme; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance; P:skeletal muscle cell differentiation; scaffold34 indexed_genome mRNA 4575650 4589192 . - . ID=transcript_7110;Q9NR55,Basic leucine zipper transcriptional factor ATF-like 3,21 kDa small nuclear factor isolated from T-cells;Jun dimerization protein p21SNFT;, PF00170;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0097028;GO:0043011;GO:0000122;GO:0006357;GO:0009615;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:dendritic cell differentiation; P:myeloid dendritic cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to virus; scaffold34 indexed_genome mRNA 4625739 4648119 . - . ID=transcript_7111;Q96IY1 E7ETD5 Q5SY75 Q9H2M5 Q9NRN8 Q9Y415,Kinetochore-associated protein NSL1 homolog,, PF08641;, GO:0000777;GO:0005829;GO:0000444;GO:0016607;GO:0051301;GO:0000070;GO:0007052;, C:condensed chromosome kinetochore; C:cytosol; C:MIS12/MIND type complex; C:nuclear speck;, , P:cell division; P:mitotic sister chromatid segregation; P:mitotic spindle organization;|Q96IY1 E7ETD5 Q5SY75 Q9H2M5 Q9NRN8 Q9Y415,Kinetochore-associated protein NSL1 homolog,, PF08641;, GO:0000777;GO:0005829;GO:0000444;GO:0016607;GO:0051301;GO:0000070;GO:0007052;, C:condensed chromosome kinetochore; C:cytosol; C:MIS12/MIND type complex; C:nuclear speck;, , P:cell division; P:mitotic sister chromatid segregation; P:mitotic spindle organization; scaffold34 indexed_genome mRNA 4667546 4675519 . + . ID=transcript_7112;Q17R31 A6NGS3 B7Z1C1 B7Z978 B7ZLQ6 E9PJE5 E9PNH3 G3V151 Q4G0L1,Putative deoxyribonuclease TATDN3,, PF01026;, GO:0005634;GO:0046872;GO:0004518;, C:nucleus;, F:metal ion binding; F:nuclease activity;|Q17R31 A6NGS3 B7Z1C1 B7Z978 B7ZLQ6 E9PJE5 E9PNH3 G3V151 Q4G0L1,Putative deoxyribonuclease TATDN3,, PF01026;, GO:0005634;GO:0046872;GO:0004518;, C:nucleus;, F:metal ion binding; F:nuclease activity; scaffold34 indexed_genome mRNA 4676294 4679340 . + . ID=transcript_7113;Q17R31 A6NGS3 B7Z1C1 B7Z978 B7ZLQ6 E9PJE5 E9PNH3 G3V151 Q4G0L1,Putative deoxyribonuclease TATDN3,, PF01026;, GO:0005634;GO:0046872;GO:0004518;, C:nucleus;, F:metal ion binding; F:nuclease activity;|Q17R31 A6NGS3 B7Z1C1 B7Z978 B7ZLQ6 E9PJE5 E9PNH3 G3V151 Q4G0L1,Putative deoxyribonuclease TATDN3,, PF01026;, GO:0005634;GO:0046872;GO:0004518;, C:nucleus;, F:metal ion binding; F:nuclease activity; scaffold34 indexed_genome mRNA 4728793 4758092 . + . ID=transcript_7114;Q9Y5Y0 Q1HE16 Q86XY9 Q9NVR9,Feline leukemia virus subgroup C receptor-related protein 1,, PF07690;, GO:0016021;GO:0005743;GO:0005739;GO:0005886;GO:0020037;GO:0015232;GO:0001568;GO:0006879;GO:0042733;GO:0048704;GO:0030218;GO:0043249;GO:0060323;GO:0006783;GO:0097037;GO:0015886;GO:0001701;GO:0006839;GO:0035264;GO:0046620;GO:0048536;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:plasma membrane;, F:heme binding; F:heme transmembrane transporter activity;, P:blood vessel development; P:cellular iron ion homeostasis; P:embryonic digit morphogenesis; P:embryonic skeletal system morphogenesis; P:erythrocyte differentiation; P:erythrocyte maturation; P:head morphogenesis; P:heme biosynthetic process; P:heme export; P:heme transport; P:in utero embryonic development; P:mitochondrial transport; P:multicellular organism growth; P:regulation of organ growth; P:spleen development;|Q9Y5Y0 Q1HE16 Q86XY9 Q9NVR9,Feline leukemia virus subgroup C receptor-related protein 1,, PF07690;, GO:0016021;GO:0005743;GO:0005739;GO:0005886;GO:0020037;GO:0015232;GO:0001568;GO:0006879;GO:0042733;GO:0048704;GO:0030218;GO:0043249;GO:0060323;GO:0006783;GO:0097037;GO:0015886;GO:0001701;GO:0006839;GO:0035264;GO:0046620;GO:0048536;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:plasma membrane;, F:heme binding; F:heme transmembrane transporter activity;, P:blood vessel development; P:cellular iron ion homeostasis; P:embryonic digit morphogenesis; P:embryonic skeletal system morphogenesis; P:erythrocyte differentiation; P:erythrocyte maturation; P:head morphogenesis; P:heme biosynthetic process; P:heme export; P:heme transport; P:in utero embryonic development; P:mitochondrial transport; P:multicellular organism growth; P:regulation of organ growth; P:spleen development;|Q9Y5Y0 Q1HE16 Q86XY9 Q9NVR9,Feline leukemia virus subgroup C receptor-related protein 1,, PF07690;, GO:0016021;GO:0005743;GO:0005739;GO:0005886;GO:0020037;GO:0015232;GO:0001568;GO:0006879;GO:0042733;GO:0048704;GO:0030218;GO:0043249;GO:0060323;GO:0006783;GO:0097037;GO:0015886;GO:0001701;GO:0006839;GO:0035264;GO:0046620;GO:0048536;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:plasma membrane;, F:heme binding; F:heme transmembrane transporter activity;, P:blood vessel development; P:cellular iron ion homeostasis; P:embryonic digit morphogenesis; P:embryonic skeletal system morphogenesis; P:erythrocyte differentiation; P:erythrocyte maturation; P:head morphogenesis; P:heme biosynthetic process; P:heme export; P:heme transport; P:in utero embryonic development; P:mitochondrial transport; P:multicellular organism growth; P:regulation of organ growth; P:spleen development;|Q9Y5Y0 Q1HE16 Q86XY9 Q9NVR9,Feline leukemia virus subgroup C receptor-related protein 1,, PF07690;, GO:0016021;GO:0005743;GO:0005739;GO:0005886;GO:0020037;GO:0015232;GO:0001568;GO:0006879;GO:0042733;GO:0048704;GO:0030218;GO:0043249;GO:0060323;GO:0006783;GO:0097037;GO:0015886;GO:0001701;GO:0006839;GO:0035264;GO:0046620;GO:0048536;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:plasma membrane;, F:heme binding; F:heme transmembrane transporter activity;, P:blood vessel development; P:cellular iron ion homeostasis; P:embryonic digit morphogenesis; P:embryonic skeletal system morphogenesis; P:erythrocyte differentiation; P:erythrocyte maturation; P:head morphogenesis; P:heme biosynthetic process; P:heme export; P:heme transport; P:in utero embryonic development; P:mitochondrial transport; P:multicellular organism growth; P:regulation of organ growth; P:spleen development; scaffold34 indexed_genome mRNA 4809131 4835331 . + . ID=transcript_7115;Q86V25 B4DYZ5 Q2VT46 Q5VTE7 Q5VTE9 Q7Z6E3 Q8IZ24 Q9H9W5,Tubulinyl-Tyr carboxypeptidase 2 {ECO:0000305},Vasohibin-2 {ECO:0000303|PubMed:16528006};Vasohibin-like protein;, PF14822;, GO:0005737;GO:0005856;GO:0005576;GO:0003779;GO:0004181;GO:0008017;GO:0061564;GO:0140253;GO:0060716;GO:0045766;GO:0001938;GO:0006508;GO:0045765;GO:0000768;, C:cytoplasm; C:cytoskeleton; C:extracellular region;, F:actin binding; F:metallocarboxypeptidase activity; F:microtubule binding;, P:axon development; P:cell-cell fusion; P:labyrinthine layer blood vessel development; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:proteolysis; P:regulation of angiogenesis; P:syncytium formation by plasma membrane fusion;|Q86V25 B4DYZ5 Q2VT46 Q5VTE7 Q5VTE9 Q7Z6E3 Q8IZ24 Q9H9W5,Tubulinyl-Tyr carboxypeptidase 2 {ECO:0000305},Vasohibin-2 {ECO:0000303|PubMed:16528006};Vasohibin-like protein;, PF14822;, GO:0005737;GO:0005856;GO:0005576;GO:0003779;GO:0004181;GO:0008017;GO:0061564;GO:0140253;GO:0060716;GO:0045766;GO:0001938;GO:0006508;GO:0045765;GO:0000768;, C:cytoplasm; C:cytoskeleton; C:extracellular region;, F:actin binding; F:metallocarboxypeptidase activity; F:microtubule binding;, P:axon development; P:cell-cell fusion; P:labyrinthine layer blood vessel development; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:proteolysis; P:regulation of angiogenesis; P:syncytium formation by plasma membrane fusion;|Q86V25 B4DYZ5 Q2VT46 Q5VTE7 Q5VTE9 Q7Z6E3 Q8IZ24 Q9H9W5,Tubulinyl-Tyr carboxypeptidase 2 {ECO:0000305},Vasohibin-2 {ECO:0000303|PubMed:16528006};Vasohibin-like protein;, PF14822;, GO:0005737;GO:0005856;GO:0005576;GO:0003779;GO:0004181;GO:0008017;GO:0061564;GO:0140253;GO:0060716;GO:0045766;GO:0001938;GO:0006508;GO:0045765;GO:0000768;, C:cytoplasm; C:cytoskeleton; C:extracellular region;, F:actin binding; F:metallocarboxypeptidase activity; F:microtubule binding;, P:axon development; P:cell-cell fusion; P:labyrinthine layer blood vessel development; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:proteolysis; P:regulation of angiogenesis; P:syncytium formation by plasma membrane fusion; scaffold34 indexed_genome mRNA 4835351 4855504 . - . ID=transcript_7116;Q5VTE6 B7Z2U4 D3DTA3 Q86X13 Q8NHH3,Protein angel homolog 2,, PF03372;, GO:0015030;GO:0005737;GO:0000175;GO:0003730;GO:0070935;GO:0045930;, C:Cajal body; C:cytoplasm;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR binding;, P:3'-UTR-mediated mRNA stabilization; P:negative regulation of mitotic cell cycle;|Q5VTE6 B7Z2U4 D3DTA3 Q86X13 Q8NHH3,Protein angel homolog 2,, PF03372;, GO:0015030;GO:0005737;GO:0000175;GO:0003730;GO:0070935;GO:0045930;, C:Cajal body; C:cytoplasm;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR binding;, P:3'-UTR-mediated mRNA stabilization; P:negative regulation of mitotic cell cycle;|Q5VTE6 B7Z2U4 D3DTA3 Q86X13 Q8NHH3,Protein angel homolog 2,, PF03372;, GO:0015030;GO:0005737;GO:0000175;GO:0003730;GO:0070935;GO:0045930;, C:Cajal body; C:cytoplasm;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR binding;, P:3'-UTR-mediated mRNA stabilization; P:negative regulation of mitotic cell cycle;|Q5VTE6 B7Z2U4 D3DTA3 Q86X13 Q8NHH3,Protein angel homolog 2,, PF03372;, GO:0015030;GO:0005737;GO:0000175;GO:0003730;GO:0070935;GO:0045930;, C:Cajal body; C:cytoplasm;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR binding;, P:3'-UTR-mediated mRNA stabilization; P:negative regulation of mitotic cell cycle;|Q5VTE6 B7Z2U4 D3DTA3 Q86X13 Q8NHH3,Protein angel homolog 2,, PF03372;, GO:0015030;GO:0005737;GO:0000175;GO:0003730;GO:0070935;GO:0045930;, C:Cajal body; C:cytoplasm;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR binding;, P:3'-UTR-mediated mRNA stabilization; P:negative regulation of mitotic cell cycle;|Q5VTE6 B7Z2U4 D3DTA3 Q86X13 Q8NHH3,Protein angel homolog 2,, PF03372;, GO:0015030;GO:0005737;GO:0000175;GO:0003730;GO:0070935;GO:0045930;, C:Cajal body; C:cytoplasm;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR binding;, P:3'-UTR-mediated mRNA stabilization; P:negative regulation of mitotic cell cycle;|Q5VTE6 B7Z2U4 D3DTA3 Q86X13 Q8NHH3,Protein angel homolog 2,, PF03372;, GO:0015030;GO:0005737;GO:0000175;GO:0003730;GO:0070935;GO:0045930;, C:Cajal body; C:cytoplasm;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR binding;, P:3'-UTR-mediated mRNA stabilization; P:negative regulation of mitotic cell cycle; scaffold34 indexed_genome mRNA 4879464 5081513 . + . ID=transcript_7117;Q96S38 B1APS8 B3KVM4 D3DTA4 Q8TDD3 Q9NSF4 Q9UL66,Ribosomal protein S6 kinase delta-1,52 kDa ribosomal protein S6 kinase;Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein;SPHK1-binding protein;, PF04212;PF00069;PF00787;, GO:0005769;GO:0005768;GO:0005764;GO:0016020;GO:0005524;GO:0035091;GO:0106310;GO:0004674;GO:0106311;GO:0007165;, C:early endosome; C:endosome; C:lysosome; C:membrane;, F:ATP binding; F:phosphatidylinositol binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:signal transduction;|Q96S38 B1APS8 B3KVM4 D3DTA4 Q8TDD3 Q9NSF4 Q9UL66,Ribosomal protein S6 kinase delta-1,52 kDa ribosomal protein S6 kinase;Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein;SPHK1-binding protein;, PF04212;PF00069;PF00787;, GO:0005769;GO:0005768;GO:0005764;GO:0016020;GO:0005524;GO:0035091;GO:0106310;GO:0004674;GO:0106311;GO:0007165;, C:early endosome; C:endosome; C:lysosome; C:membrane;, F:ATP binding; F:phosphatidylinositol binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:signal transduction;|Q96S38 B1APS8 B3KVM4 D3DTA4 Q8TDD3 Q9NSF4 Q9UL66,Ribosomal protein S6 kinase delta-1,52 kDa ribosomal protein S6 kinase;Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein;SPHK1-binding protein;, PF04212;PF00069;PF00787;, GO:0005769;GO:0005768;GO:0005764;GO:0016020;GO:0005524;GO:0035091;GO:0106310;GO:0004674;GO:0106311;GO:0007165;, C:early endosome; C:endosome; C:lysosome; C:membrane;, F:ATP binding; F:phosphatidylinositol binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:signal transduction; scaffold34 indexed_genome mRNA 5640964 5641869 . - . ID=transcript_7118;Q9Y3E7 A8K3W0 B4DG34 B8ZZM0 B8ZZX5 Q3ZTS9 Q53S71 Q53SU5 Q9NZ51,Charged multivesicular body protein 3,Chromatin-modifying protein 3;Neuroendocrine differentiation factor;Vacuolar protein sorting-associated protein 24;, PF03357;, GO:0031410;GO:0005829;GO:0000815;GO:0070062;GO:0005770;GO:0031902;GO:0005771;GO:0005886;GO:0042802;GO:0031210;GO:1990381;GO:0006915;GO:0097352;GO:0016197;GO:0032509;GO:0045324;GO:0016236;GO:0061952;GO:0007084;GO:0036258;GO:0071985;GO:0061763;GO:1902187;GO:1902188;GO:0051258;GO:0015031;GO:0010824;GO:2000641;GO:0050792;GO:0039702;GO:0019058;, C:cytoplasmic vesicle; C:cytosol; C:ESCRT III complex; C:extracellular exosome; C:late endosome; C:late endosome membrane; C:multivesicular body; C:plasma membrane;, F:identical protein binding; F:phosphatidylcholine binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:autophagosome maturation; P:endosomal transport; P:endosome transport via multivesicular body sorting pathway; P:late endosome to vacuole transport; P:macroautophagy; P:midbody abscission; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:multivesicular body-lysosome fusion; P:negative regulation of viral release from host cell; P:positive regulation of viral release from host cell; P:protein polymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of early endosome to late endosome transport; P:regulation of viral process; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold34 indexed_genome mRNA 5787771 5839003 . + . ID=transcript_7119;Q92786 A6NK29 A8K2B1 Q5SW76 Q8TB91,Prospero homeobox protein 1,Homeobox prospero-like protein PROX1;, PF05044;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0050692;GO:0003700;GO:0000981;GO:0001227;GO:0050693;GO:0016922;GO:0000978;GO:1990837;GO:0000976;GO:0090425;GO:0060414;GO:0055009;GO:0007420;GO:0061114;GO:0001709;GO:0021707;GO:0007623;GO:0021542;GO:0021516;GO:0060059;GO:0060214;GO:0002194;GO:0070365;GO:0072574;GO:0001822;GO:0002088;GO:0070309;GO:0001889;GO:0030324;GO:0001946;GO:0060836;GO:0060838;GO:0070858;GO:0008285;GO:0043433;GO:0000122;GO:0045892;GO:0045071;GO:0021915;GO:0097150;GO:0030910;GO:0046619;GO:0043049;GO:0031016;GO:0045787;GO:1901978;GO:0008284;GO:0045737;GO:0010595;GO:0001938;GO:2000979;GO:0060421;GO:2000179;GO:0060298;GO:0045944;GO:0042752;GO:0010468;GO:0006357;GO:0031667;GO:0060042;GO:0030240;GO:0048845;GO:0055010;GO:0055005;GO:0060412;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA binding domain binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:LBD domain binding; F:nuclear receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:acinar cell differentiation; P:aorta smooth muscle tissue morphogenesis; P:atrial cardiac muscle tissue morphogenesis; P:brain development; P:branching involved in pancreas morphogenesis; P:cell fate determination; P:cerebellar granule cell differentiation; P:circadian rhythm; P:dentate gyrus development; P:dorsal spinal cord development; P:embryonic retina morphogenesis in camera-type eye; P:endocardium formation; P:hepatocyte cell migration; P:hepatocyte differentiation; P:hepatocyte proliferation; P:kidney development; P:lens development in camera-type eye; P:lens fiber cell morphogenesis; P:liver development; P:lung development; P:lymphangiogenesis; P:lymphatic endothelial cell differentiation; P:lymphatic endothelial cell fate commitment; P:negative regulation of bile acid biosynthetic process; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral genome replication; P:neural tube development; P:neuronal stem cell population maintenance; P:olfactory placode formation; P:optic placode formation involved in camera-type eye formation; P:otic placode formation; P:pancreas development; P:positive regulation of cell cycle; P:positive regulation of cell cycle checkpoint; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of forebrain neuron differentiation; P:positive regulation of heart growth; P:positive regulation of neural precursor cell proliferation; P:positive regulation of sarcomere organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:response to nutrient levels; P:retina morphogenesis in camera-type eye; P:skeletal muscle thin filament assembly; P:venous blood vessel morphogenesis; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular cardiac myofibril assembly; P:ventricular septum morphogenesis;|Q92786 A6NK29 A8K2B1 Q5SW76 Q8TB91,Prospero homeobox protein 1,Homeobox prospero-like protein PROX1;, PF05044;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0050692;GO:0003700;GO:0000981;GO:0001227;GO:0050693;GO:0016922;GO:0000978;GO:1990837;GO:0000976;GO:0090425;GO:0060414;GO:0055009;GO:0007420;GO:0061114;GO:0001709;GO:0021707;GO:0007623;GO:0021542;GO:0021516;GO:0060059;GO:0060214;GO:0002194;GO:0070365;GO:0072574;GO:0001822;GO:0002088;GO:0070309;GO:0001889;GO:0030324;GO:0001946;GO:0060836;GO:0060838;GO:0070858;GO:0008285;GO:0043433;GO:0000122;GO:0045892;GO:0045071;GO:0021915;GO:0097150;GO:0030910;GO:0046619;GO:0043049;GO:0031016;GO:0045787;GO:1901978;GO:0008284;GO:0045737;GO:0010595;GO:0001938;GO:2000979;GO:0060421;GO:2000179;GO:0060298;GO:0045944;GO:0042752;GO:0010468;GO:0006357;GO:0031667;GO:0060042;GO:0030240;GO:0048845;GO:0055010;GO:0055005;GO:0060412;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA binding domain binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:LBD domain binding; F:nuclear receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:acinar cell differentiation; P:aorta smooth muscle tissue morphogenesis; P:atrial cardiac muscle tissue morphogenesis; P:brain development; P:branching involved in pancreas morphogenesis; P:cell fate determination; P:cerebellar granule cell differentiation; P:circadian rhythm; P:dentate gyrus development; P:dorsal spinal cord development; P:embryonic retina morphogenesis in camera-type eye; P:endocardium formation; P:hepatocyte cell migration; P:hepatocyte differentiation; P:hepatocyte proliferation; P:kidney development; P:lens development in camera-type eye; P:lens fiber cell morphogenesis; P:liver development; P:lung development; P:lymphangiogenesis; P:lymphatic endothelial cell differentiation; P:lymphatic endothelial cell fate commitment; P:negative regulation of bile acid biosynthetic process; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral genome replication; P:neural tube development; P:neuronal stem cell population maintenance; P:olfactory placode formation; P:optic placode formation involved in camera-type eye formation; P:otic placode formation; P:pancreas development; P:positive regulation of cell cycle; P:positive regulation of cell cycle checkpoint; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of forebrain neuron differentiation; P:positive regulation of heart growth; P:positive regulation of neural precursor cell proliferation; P:positive regulation of sarcomere organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:response to nutrient levels; P:retina morphogenesis in camera-type eye; P:skeletal muscle thin filament assembly; P:venous blood vessel morphogenesis; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular cardiac myofibril assembly; P:ventricular septum morphogenesis;|Q92786 A6NK29 A8K2B1 Q5SW76 Q8TB91,Prospero homeobox protein 1,Homeobox prospero-like protein PROX1;, PF05044;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0050692;GO:0003700;GO:0000981;GO:0001227;GO:0050693;GO:0016922;GO:0000978;GO:1990837;GO:0000976;GO:0090425;GO:0060414;GO:0055009;GO:0007420;GO:0061114;GO:0001709;GO:0021707;GO:0007623;GO:0021542;GO:0021516;GO:0060059;GO:0060214;GO:0002194;GO:0070365;GO:0072574;GO:0001822;GO:0002088;GO:0070309;GO:0001889;GO:0030324;GO:0001946;GO:0060836;GO:0060838;GO:0070858;GO:0008285;GO:0043433;GO:0000122;GO:0045892;GO:0045071;GO:0021915;GO:0097150;GO:0030910;GO:0046619;GO:0043049;GO:0031016;GO:0045787;GO:1901978;GO:0008284;GO:0045737;GO:0010595;GO:0001938;GO:2000979;GO:0060421;GO:2000179;GO:0060298;GO:0045944;GO:0042752;GO:0010468;GO:0006357;GO:0031667;GO:0060042;GO:0030240;GO:0048845;GO:0055010;GO:0055005;GO:0060412;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA binding domain binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:LBD domain binding; F:nuclear receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:acinar cell differentiation; P:aorta smooth muscle tissue morphogenesis; P:atrial cardiac muscle tissue morphogenesis; P:brain development; P:branching involved in pancreas morphogenesis; P:cell fate determination; P:cerebellar granule cell differentiation; P:circadian rhythm; P:dentate gyrus development; P:dorsal spinal cord development; P:embryonic retina morphogenesis in camera-type eye; P:endocardium formation; P:hepatocyte cell migration; P:hepatocyte differentiation; P:hepatocyte proliferation; P:kidney development; P:lens development in camera-type eye; P:lens fiber cell morphogenesis; P:liver development; P:lung development; P:lymphangiogenesis; P:lymphatic endothelial cell differentiation; P:lymphatic endothelial cell fate commitment; P:negative regulation of bile acid biosynthetic process; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral genome replication; P:neural tube development; P:neuronal stem cell population maintenance; P:olfactory placode formation; P:optic placode formation involved in camera-type eye formation; P:otic placode formation; P:pancreas development; P:positive regulation of cell cycle; P:positive regulation of cell cycle checkpoint; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of forebrain neuron differentiation; P:positive regulation of heart growth; P:positive regulation of neural precursor cell proliferation; P:positive regulation of sarcomere organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:response to nutrient levels; P:retina morphogenesis in camera-type eye; P:skeletal muscle thin filament assembly; P:venous blood vessel morphogenesis; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular cardiac myofibril assembly; P:ventricular septum morphogenesis;|Q92786 A6NK29 A8K2B1 Q5SW76 Q8TB91,Prospero homeobox protein 1,Homeobox prospero-like protein PROX1;, PF05044;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0050692;GO:0003700;GO:0000981;GO:0001227;GO:0050693;GO:0016922;GO:0000978;GO:1990837;GO:0000976;GO:0090425;GO:0060414;GO:0055009;GO:0007420;GO:0061114;GO:0001709;GO:0021707;GO:0007623;GO:0021542;GO:0021516;GO:0060059;GO:0060214;GO:0002194;GO:0070365;GO:0072574;GO:0001822;GO:0002088;GO:0070309;GO:0001889;GO:0030324;GO:0001946;GO:0060836;GO:0060838;GO:0070858;GO:0008285;GO:0043433;GO:0000122;GO:0045892;GO:0045071;GO:0021915;GO:0097150;GO:0030910;GO:0046619;GO:0043049;GO:0031016;GO:0045787;GO:1901978;GO:0008284;GO:0045737;GO:0010595;GO:0001938;GO:2000979;GO:0060421;GO:2000179;GO:0060298;GO:0045944;GO:0042752;GO:0010468;GO:0006357;GO:0031667;GO:0060042;GO:0030240;GO:0048845;GO:0055010;GO:0055005;GO:0060412;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA binding domain binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:LBD domain binding; F:nuclear receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:acinar cell differentiation; P:aorta smooth muscle tissue morphogenesis; P:atrial cardiac muscle tissue morphogenesis; P:brain development; P:branching involved in pancreas morphogenesis; P:cell fate determination; P:cerebellar granule cell differentiation; P:circadian rhythm; P:dentate gyrus development; P:dorsal spinal cord development; P:embryonic retina morphogenesis in camera-type eye; P:endocardium formation; P:hepatocyte cell migration; P:hepatocyte differentiation; P:hepatocyte proliferation; P:kidney development; P:lens development in camera-type eye; P:lens fiber cell morphogenesis; P:liver development; P:lung development; P:lymphangiogenesis; P:lymphatic endothelial cell differentiation; P:lymphatic endothelial cell fate commitment; P:negative regulation of bile acid biosynthetic process; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral genome replication; P:neural tube development; P:neuronal stem cell population maintenance; P:olfactory placode formation; P:optic placode formation involved in camera-type eye formation; P:otic placode formation; P:pancreas development; P:positive regulation of cell cycle; P:positive regulation of cell cycle checkpoint; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of forebrain neuron differentiation; P:positive regulation of heart growth; P:positive regulation of neural precursor cell proliferation; P:positive regulation of sarcomere organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:response to nutrient levels; P:retina morphogenesis in camera-type eye; P:skeletal muscle thin filament assembly; P:venous blood vessel morphogenesis; P:ventricular cardiac muscle tissue morphogenesis; P:ventricular cardiac myofibril assembly; P:ventricular septum morphogenesis; scaffold34 indexed_genome mRNA 6115160 6122338 . + . ID=transcript_7120;Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4,N-lysine methyltransferase SMYD2,HSKM-B;Histone methyltransferase SMYD2;Lysine N-methyltransferase 3C;SET and MYND domain-containing protein 2;, PF00856;PF01753;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0002039;GO:0016279;GO:0000993;GO:0007507;GO:0034968;GO:0008285;GO:0000122;GO:0018027;GO:0018026;GO:0043516;GO:1901796;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II complex binding;, P:heart development; P:histone lysine methylation; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of signal transduction by p53 class mediator; scaffold34 indexed_genome mRNA 6127407 6128889 . + . ID=transcript_7121;Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4,N-lysine methyltransferase SMYD2,HSKM-B;Histone methyltransferase SMYD2;Lysine N-methyltransferase 3C;SET and MYND domain-containing protein 2;, PF00856;PF01753;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0002039;GO:0016279;GO:0000993;GO:0007507;GO:0034968;GO:0008285;GO:0000122;GO:0018027;GO:0018026;GO:0043516;GO:1901796;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II complex binding;, P:heart development; P:histone lysine methylation; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of signal transduction by p53 class mediator; scaffold34 indexed_genome mRNA 6132778 6135222 . + . ID=transcript_7122;Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4,N-lysine methyltransferase SMYD2,HSKM-B;Histone methyltransferase SMYD2;Lysine N-methyltransferase 3C;SET and MYND domain-containing protein 2;, PF00856;PF01753;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046975;GO:0018024;GO:0046872;GO:0002039;GO:0016279;GO:0000993;GO:0007507;GO:0034968;GO:0008285;GO:0000122;GO:0018027;GO:0018026;GO:0043516;GO:1901796;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II complex binding;, P:heart development; P:histone lysine methylation; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of signal transduction by p53 class mediator; scaffold34 indexed_genome mRNA 6139076 6322141 . - . ID=transcript_7123;Q15678 Q5VSI0,Tyrosine-protein phosphatase non-receptor type 14,Protein-tyrosine phosphatase pez;, PF09380;PF00373;PF09379;PF00102;, GO:0005737;GO:0005856;GO:0005654;GO:0005634;GO:0004725;GO:0030971;GO:0003712;GO:0071345;GO:0001946;GO:0008285;GO:0006470;GO:0046825;, C:cytoplasm; C:cytoskeleton; C:nucleoplasm; C:nucleus;, F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:transcription coregulator activity;, P:cellular response to cytokine stimulus; P:lymphangiogenesis; P:negative regulation of cell population proliferation; P:protein dephosphorylation; P:regulation of protein export from nucleus;|Q15678 Q5VSI0,Tyrosine-protein phosphatase non-receptor type 14,Protein-tyrosine phosphatase pez;, PF09380;PF00373;PF09379;PF00102;, GO:0005737;GO:0005856;GO:0005654;GO:0005634;GO:0004725;GO:0030971;GO:0003712;GO:0071345;GO:0001946;GO:0008285;GO:0006470;GO:0046825;, C:cytoplasm; C:cytoskeleton; C:nucleoplasm; C:nucleus;, F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:transcription coregulator activity;, P:cellular response to cytokine stimulus; P:lymphangiogenesis; P:negative regulation of cell population proliferation; P:protein dephosphorylation; P:regulation of protein export from nucleus; scaffold34 indexed_genome mRNA 6406739 6422126 . + . ID=transcript_7124;P49454 Q13171 Q13246 Q5VVM7,Centromere protein F,AH antigen;Kinetochore protein CENPF;Mitosin;, PF10490;PF10473;PF10481;, GO:0005930;GO:0005813;GO:0000775;GO:0036064;GO:0097539;GO:0000940;GO:0005737;GO:0005829;GO:0000776;GO:0030496;GO:0005635;GO:0016363;GO:0005654;GO:0005634;GO:0048471;GO:0045120;GO:0005819;GO:0000922;GO:0003682;GO:0070840;GO:0008017;GO:0008022;GO:0042803;GO:0008134;GO:0030154;GO:0051301;GO:0007059;GO:0071897;GO:0001822;GO:0051382;GO:0051310;GO:0000278;GO:0007094;GO:0007052;GO:0007517;GO:0045892;GO:0015031;GO:0051726;GO:0010389;GO:0016202;GO:0042493;GO:0021591;, C:axoneme; C:centrosome; C:chromosome, centromeric region; C:ciliary basal body; C:ciliary transition fiber; C:condensed chromosome outer kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:midbody; C:nuclear envelope; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:pronucleus; C:spindle; C:spindle pole;, F:chromatin binding; F:dynein complex binding; F:microtubule binding; F:protein C-terminus binding; F:protein homodimerization activity; F:transcription factor binding;, P:cell differentiation; P:cell division; P:chromosome segregation; P:DNA biosynthetic process; P:kidney development; P:kinetochore assembly; P:metaphase plate congression; P:mitotic cell cycle; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:muscle organ development; P:negative regulation of transcription, DNA-templated; P:protein transport; P:regulation of cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of striated muscle tissue development; P:response to drug; P:ventricular system development;|P49454 Q13171 Q13246 Q5VVM7,Centromere protein F,AH antigen;Kinetochore protein CENPF;Mitosin;, PF10490;PF10473;PF10481;, GO:0005930;GO:0005813;GO:0000775;GO:0036064;GO:0097539;GO:0000940;GO:0005737;GO:0005829;GO:0000776;GO:0030496;GO:0005635;GO:0016363;GO:0005654;GO:0005634;GO:0048471;GO:0045120;GO:0005819;GO:0000922;GO:0003682;GO:0070840;GO:0008017;GO:0008022;GO:0042803;GO:0008134;GO:0030154;GO:0051301;GO:0007059;GO:0071897;GO:0001822;GO:0051382;GO:0051310;GO:0000278;GO:0007094;GO:0007052;GO:0007517;GO:0045892;GO:0015031;GO:0051726;GO:0010389;GO:0016202;GO:0042493;GO:0021591;, C:axoneme; C:centrosome; C:chromosome, centromeric region; C:ciliary basal body; C:ciliary transition fiber; C:condensed chromosome outer kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:midbody; C:nuclear envelope; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:pronucleus; C:spindle; C:spindle pole;, F:chromatin binding; F:dynein complex binding; F:microtubule binding; F:protein C-terminus binding; F:protein homodimerization activity; F:transcription factor binding;, P:cell differentiation; P:cell division; P:chromosome segregation; P:DNA biosynthetic process; P:kidney development; P:kinetochore assembly; P:metaphase plate congression; P:mitotic cell cycle; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:muscle organ development; P:negative regulation of transcription, DNA-templated; P:protein transport; P:regulation of cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of striated muscle tissue development; P:response to drug; P:ventricular system development; scaffold34 indexed_genome mRNA 6822908 6942536 . + . ID=transcript_7125;Q9UNE3,Potassium channel subfamily K member 2,Outward rectifying potassium channel protein TREK-1;TREK-1 K(+) channel subunit;Two pore domain potassium channel TREK-1;Two pore potassium channel TPKC1;, PF07885;, GO:0016324;GO:0097449;GO:0044305;GO:0009986;GO:0005783;GO:0005789;GO:0005887;GO:0043025;GO:0005634;GO:0005886;GO:0008076;GO:0015271;GO:0019870;GO:0022841;GO:0003231;GO:0071456;GO:0090102;GO:0007186;GO:0007613;GO:0060044;GO:2000279;GO:0010942;GO:1900039;GO:0071805;GO:0048678;GO:0009612;GO:0030322;, C:apical plasma membrane; C:astrocyte projection; C:calyx of Held; C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:voltage-gated potassium channel complex;, F:outward rectifier potassium channel activity; F:potassium channel inhibitor activity; F:potassium ion leak channel activity;, P:cardiac ventricle development; P:cellular response to hypoxia; P:cochlea development; P:G protein-coupled receptor signaling pathway; P:memory; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of DNA biosynthetic process; P:positive regulation of cell death; P:positive regulation of cellular response to hypoxia; P:potassium ion transmembrane transport; P:response to axon injury; P:response to mechanical stimulus; P:stabilization of membrane potential; scaffold34 indexed_genome mRNA 7209204 7295070 . + . ID=transcript_7126;P47712 B1AKG4 Q29R80,Cytosolic phospholipase A2,Phospholipase A2 group IVA;, PF00168;PF01735;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0005743;GO:0005635;GO:0005634;GO:0005509;GO:0047498;GO:0005544;GO:0047499;GO:1902387;GO:0004622;GO:0008374;GO:0102545;GO:0032266;GO:0070273;GO:0010314;GO:0004623;GO:0102567;GO:0102568;GO:0019369;GO:0050482;GO:0035965;GO:0071236;GO:0006071;GO:0046475;GO:0006690;GO:0019370;GO:0006640;GO:0006654;GO:0036151;GO:0034638;GO:0036152;GO:0036148;GO:0034478;GO:0036149;GO:0036150;GO:0006644;GO:0006663;GO:0043032;GO:0010572;GO:0032308;GO:0002827;GO:0001516;GO:0042127;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:nuclear envelope; C:nucleus;, F:calcium ion binding; F:calcium-dependent phospholipase A2 activity; F:calcium-dependent phospholipid binding; F:calcium-independent phospholipase A2 activity; F:ceramide 1-phosphate binding; F:lysophospholipase activity; F:O-acyltransferase activity; F:phosphatidyl phospholipase B activity; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:arachidonic acid metabolic process; P:arachidonic acid secretion; P:cardiolipin acyl-chain remodeling; P:cellular response to antibiotic; P:glycerol metabolic process; P:glycerophospholipid catabolic process; P:icosanoid metabolic process; P:leukotriene biosynthetic process; P:monoacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylglycerol catabolic process; P:phosphatidylinositol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process; P:platelet activating factor biosynthetic process; P:positive regulation of macrophage activation; P:positive regulation of platelet activation; P:positive regulation of prostaglandin secretion; P:positive regulation of T-helper 1 type immune response; P:prostaglandin biosynthetic process; P:regulation of cell population proliferation;|P47712 B1AKG4 Q29R80,Cytosolic phospholipase A2,Phospholipase A2 group IVA;, PF00168;PF01735;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0005743;GO:0005635;GO:0005634;GO:0005509;GO:0047498;GO:0005544;GO:0047499;GO:1902387;GO:0004622;GO:0008374;GO:0102545;GO:0032266;GO:0070273;GO:0010314;GO:0004623;GO:0102567;GO:0102568;GO:0019369;GO:0050482;GO:0035965;GO:0071236;GO:0006071;GO:0046475;GO:0006690;GO:0019370;GO:0006640;GO:0006654;GO:0036151;GO:0034638;GO:0036152;GO:0036148;GO:0034478;GO:0036149;GO:0036150;GO:0006644;GO:0006663;GO:0043032;GO:0010572;GO:0032308;GO:0002827;GO:0001516;GO:0042127;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:nuclear envelope; C:nucleus;, F:calcium ion binding; F:calcium-dependent phospholipase A2 activity; F:calcium-dependent phospholipid binding; F:calcium-independent phospholipase A2 activity; F:ceramide 1-phosphate binding; F:lysophospholipase activity; F:O-acyltransferase activity; F:phosphatidyl phospholipase B activity; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:arachidonic acid metabolic process; P:arachidonic acid secretion; P:cardiolipin acyl-chain remodeling; P:cellular response to antibiotic; P:glycerol metabolic process; P:glycerophospholipid catabolic process; P:icosanoid metabolic process; P:leukotriene biosynthetic process; P:monoacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylglycerol catabolic process; P:phosphatidylinositol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process; P:platelet activating factor biosynthetic process; P:positive regulation of macrophage activation; P:positive regulation of platelet activation; P:positive regulation of prostaglandin secretion; P:positive regulation of T-helper 1 type immune response; P:prostaglandin biosynthetic process; P:regulation of cell population proliferation;|P47712 B1AKG4 Q29R80,Cytosolic phospholipase A2,Phospholipase A2 group IVA;, PF00168;PF01735;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0005743;GO:0005635;GO:0005634;GO:0005509;GO:0047498;GO:0005544;GO:0047499;GO:1902387;GO:0004622;GO:0008374;GO:0102545;GO:0032266;GO:0070273;GO:0010314;GO:0004623;GO:0102567;GO:0102568;GO:0019369;GO:0050482;GO:0035965;GO:0071236;GO:0006071;GO:0046475;GO:0006690;GO:0019370;GO:0006640;GO:0006654;GO:0036151;GO:0034638;GO:0036152;GO:0036148;GO:0034478;GO:0036149;GO:0036150;GO:0006644;GO:0006663;GO:0043032;GO:0010572;GO:0032308;GO:0002827;GO:0001516;GO:0042127;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:nuclear envelope; C:nucleus;, F:calcium ion binding; F:calcium-dependent phospholipase A2 activity; F:calcium-dependent phospholipid binding; F:calcium-independent phospholipase A2 activity; F:ceramide 1-phosphate binding; F:lysophospholipase activity; F:O-acyltransferase activity; F:phosphatidyl phospholipase B activity; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:arachidonic acid metabolic process; P:arachidonic acid secretion; P:cardiolipin acyl-chain remodeling; P:cellular response to antibiotic; P:glycerol metabolic process; P:glycerophospholipid catabolic process; P:icosanoid metabolic process; P:leukotriene biosynthetic process; P:monoacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylglycerol catabolic process; P:phosphatidylinositol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process; P:platelet activating factor biosynthetic process; P:positive regulation of macrophage activation; P:positive regulation of platelet activation; P:positive regulation of prostaglandin secretion; P:positive regulation of T-helper 1 type immune response; P:prostaglandin biosynthetic process; P:regulation of cell population proliferation; scaffold34 indexed_genome mRNA 7532745 7539589 . + . ID=transcript_7127;P35354 A8K802 Q16876,Prostaglandin G/H synthase 2 {ECO:0000305},Cyclooxygenase-2 {ECO:0000303|PubMed:17113084};PHS II;Prostaglandin H2 synthase 2;Prostaglandin-endoperoxide synthase 2;, PF03098;PF00008;, GO:0005737;GO:0005783;GO:0005788;GO:0005789;GO:0043005;GO:0005637;GO:0005640;GO:0051213;GO:0019899;GO:0020037;GO:0046872;GO:0004601;GO:0004666;GO:0071456;GO:0019371;GO:0019221;GO:0006954;GO:0019372;GO:0042759;GO:0034356;GO:0090336;GO:0090050;GO:0031622;GO:0090271;GO:0045429;GO:0090362;GO:0031394;GO:0071636;GO:0010575;GO:0001516;GO:0008217;GO:0050727;GO:0150077;GO:0006979;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:neuron projection; C:nuclear inner membrane; C:nuclear outer membrane;, F:dioxygenase activity; F:enzyme binding; F:heme binding; F:metal ion binding; F:peroxidase activity; F:prostaglandin-endoperoxide synthase activity;, P:cellular response to hypoxia; P:cyclooxygenase pathway; P:cytokine-mediated signaling pathway; P:inflammatory response; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:positive regulation of brown fat cell differentiation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of fever generation; P:positive regulation of fibroblast growth factor production; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of platelet-derived growth factor production; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of transforming growth factor beta production; P:positive regulation of vascular endothelial growth factor production; P:prostaglandin biosynthetic process; P:regulation of blood pressure; P:regulation of inflammatory response; P:regulation of neuroinflammatory response; P:response to oxidative stress;|P35354 A8K802 Q16876,Prostaglandin G/H synthase 2 {ECO:0000305},Cyclooxygenase-2 {ECO:0000303|PubMed:17113084};PHS II;Prostaglandin H2 synthase 2;Prostaglandin-endoperoxide synthase 2;, PF03098;PF00008;, GO:0005737;GO:0005783;GO:0005788;GO:0005789;GO:0043005;GO:0005637;GO:0005640;GO:0051213;GO:0019899;GO:0020037;GO:0046872;GO:0004601;GO:0004666;GO:0071456;GO:0019371;GO:0019221;GO:0006954;GO:0019372;GO:0042759;GO:0034356;GO:0090336;GO:0090050;GO:0031622;GO:0090271;GO:0045429;GO:0090362;GO:0031394;GO:0071636;GO:0010575;GO:0001516;GO:0008217;GO:0050727;GO:0150077;GO:0006979;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:neuron projection; C:nuclear inner membrane; C:nuclear outer membrane;, F:dioxygenase activity; F:enzyme binding; F:heme binding; F:metal ion binding; F:peroxidase activity; F:prostaglandin-endoperoxide synthase activity;, P:cellular response to hypoxia; P:cyclooxygenase pathway; P:cytokine-mediated signaling pathway; P:inflammatory response; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:positive regulation of brown fat cell differentiation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of fever generation; P:positive regulation of fibroblast growth factor production; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of platelet-derived growth factor production; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of transforming growth factor beta production; P:positive regulation of vascular endothelial growth factor production; P:prostaglandin biosynthetic process; P:regulation of blood pressure; P:regulation of inflammatory response; P:regulation of neuroinflammatory response; P:response to oxidative stress;|P35354 A8K802 Q16876,Prostaglandin G/H synthase 2 {ECO:0000305},Cyclooxygenase-2 {ECO:0000303|PubMed:17113084};PHS II;Prostaglandin H2 synthase 2;Prostaglandin-endoperoxide synthase 2;, PF03098;PF00008;, GO:0005737;GO:0005783;GO:0005788;GO:0005789;GO:0043005;GO:0005637;GO:0005640;GO:0051213;GO:0019899;GO:0020037;GO:0046872;GO:0004601;GO:0004666;GO:0071456;GO:0019371;GO:0019221;GO:0006954;GO:0019372;GO:0042759;GO:0034356;GO:0090336;GO:0090050;GO:0031622;GO:0090271;GO:0045429;GO:0090362;GO:0031394;GO:0071636;GO:0010575;GO:0001516;GO:0008217;GO:0050727;GO:0150077;GO:0006979;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:neuron projection; C:nuclear inner membrane; C:nuclear outer membrane;, F:dioxygenase activity; F:enzyme binding; F:heme binding; F:metal ion binding; F:peroxidase activity; F:prostaglandin-endoperoxide synthase activity;, P:cellular response to hypoxia; P:cyclooxygenase pathway; P:cytokine-mediated signaling pathway; P:inflammatory response; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:positive regulation of brown fat cell differentiation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of fever generation; P:positive regulation of fibroblast growth factor production; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of platelet-derived growth factor production; P:positive regulation of prostaglandin biosynthetic process; P:positive regulation of transforming growth factor beta production; P:positive regulation of vascular endothelial growth factor production; P:prostaglandin biosynthetic process; P:regulation of blood pressure; P:regulation of inflammatory response; P:regulation of neuroinflammatory response; P:response to oxidative stress; scaffold34 indexed_genome mRNA 7790414 7829668 . - . ID=transcript_7128;Q5SWX8 B4DNY0 E9PFR7 Q19CC6 Q8WYB6 Q9BTS2 Q9H6A6 Q9NX06,Protein odr-4 homolog,LAG1-interacting protein;Transactivated by transforming growth factor beta protein 1;, PF14778;, GO:0016021;GO:0008104;, C:integral component of membrane;, , P:protein localization;|Q5SWX8 B4DNY0 E9PFR7 Q19CC6 Q8WYB6 Q9BTS2 Q9H6A6 Q9NX06,Protein odr-4 homolog,LAG1-interacting protein;Transactivated by transforming growth factor beta protein 1;, PF14778;, GO:0016021;GO:0008104;, C:integral component of membrane;, , P:protein localization;|Q5SWX8 B4DNY0 E9PFR7 Q19CC6 Q8WYB6 Q9BTS2 Q9H6A6 Q9NX06,Protein odr-4 homolog,LAG1-interacting protein;Transactivated by transforming growth factor beta protein 1;, PF14778;, GO:0016021;GO:0008104;, C:integral component of membrane;, , P:protein localization; scaffold34 indexed_genome mRNA 7830292 7889243 . + . ID=transcript_7129;P12270 Q15624 Q15655 Q5SWY0 Q99968,Nucleoprotein TPR,Megator;NPC-associated intranuclear protein;Translocated promoter region protein;, PF07926;, GO:0005737;GO:0005868;GO:0019898;GO:0043657;GO:0000776;GO:0072686;GO:0005635;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0005654;GO:0005634;GO:0003682;GO:0070840;GO:0031072;GO:0051019;GO:0003729;GO:0042803;GO:0003723;GO:0017056;GO:0015631;GO:0051301;GO:0034605;GO:0035457;GO:0075733;GO:0007094;GO:0006406;GO:0031990;GO:0046832;GO:0000122;GO:0045947;GO:0006999;GO:0031453;GO:0090316;GO:0090267;GO:0046827;GO:0042307;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0010965;GO:1901673;GO:0032880;GO:0070849;GO:0006405;GO:0006404;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasm; C:cytoplasmic dynein complex; C:extrinsic component of membrane; C:host cell; C:kinetochore; C:mitotic spindle; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:dynein complex binding; F:heat shock protein binding; F:mitogen-activated protein kinase binding; F:mRNA binding; F:protein homodimerization activity; F:RNA binding; F:structural constituent of nuclear pore; F:tubulin binding;, P:cell division; P:cellular response to heat; P:cellular response to interferon-alpha; P:intracellular transport of virus; P:mitotic spindle assembly checkpoint; P:mRNA export from nucleus; P:mRNA export from nucleus in response to heat stress; P:negative regulation of RNA export from nucleus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translational initiation; P:nuclear pore organization; P:positive regulation of heterochromatin assembly; P:positive regulation of intracellular protein transport; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:positive regulation of protein export from nucleus; P:positive regulation of protein import into nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mitotic sister chromatid separation; P:regulation of mitotic spindle assembly; P:regulation of protein localization; P:response to epidermal growth factor; P:RNA export from nucleus; P:RNA import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P12270 Q15624 Q15655 Q5SWY0 Q99968,Nucleoprotein TPR,Megator;NPC-associated intranuclear protein;Translocated promoter region protein;, PF07926;, GO:0005737;GO:0005868;GO:0019898;GO:0043657;GO:0000776;GO:0072686;GO:0005635;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0005654;GO:0005634;GO:0003682;GO:0070840;GO:0031072;GO:0051019;GO:0003729;GO:0042803;GO:0003723;GO:0017056;GO:0015631;GO:0051301;GO:0034605;GO:0035457;GO:0075733;GO:0007094;GO:0006406;GO:0031990;GO:0046832;GO:0000122;GO:0045947;GO:0006999;GO:0031453;GO:0090316;GO:0090267;GO:0046827;GO:0042307;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0010965;GO:1901673;GO:0032880;GO:0070849;GO:0006405;GO:0006404;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasm; C:cytoplasmic dynein complex; C:extrinsic component of membrane; C:host cell; C:kinetochore; C:mitotic spindle; C:nuclear envelope; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:dynein complex binding; F:heat shock protein binding; F:mitogen-activated protein kinase binding; F:mRNA binding; F:protein homodimerization activity; F:RNA binding; F:structural constituent of nuclear pore; F:tubulin binding;, P:cell division; P:cellular response to heat; P:cellular response to interferon-alpha; P:intracellular transport of virus; P:mitotic spindle assembly checkpoint; P:mRNA export from nucleus; P:mRNA export from nucleus in response to heat stress; P:negative regulation of RNA export from nucleus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translational initiation; P:nuclear pore organization; P:positive regulation of heterochromatin assembly; P:positive regulation of intracellular protein transport; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:positive regulation of protein export from nucleus; P:positive regulation of protein import into nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mitotic sister chromatid separation; P:regulation of mitotic spindle assembly; P:regulation of protein localization; P:response to epidermal growth factor; P:RNA export from nucleus; P:RNA import into nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold34 indexed_genome mRNA 7889262 7894453 . - . ID=transcript_7130;Q92954 Q6DNC4 Q6DNC5 Q6ZMZ5 Q9BX49,Proteoglycan 4,Lubricin;Megakaryocyte-stimulating factor;Superficial zone proteoglycan;, PF00045;PF01033;, GO:0062023;GO:0005576;GO:0030247;GO:0005044;GO:0006955;, C:collagen-containing extracellular matrix; C:extracellular region;, F:polysaccharide binding; F:scavenger receptor activity;, P:immune response;|Q92954 Q6DNC4 Q6DNC5 Q6ZMZ5 Q9BX49,Proteoglycan 4,Lubricin;Megakaryocyte-stimulating factor;Superficial zone proteoglycan;, PF00045;PF01033;, GO:0062023;GO:0005576;GO:0030247;GO:0005044;GO:0006955;, C:collagen-containing extracellular matrix; C:extracellular region;, F:polysaccharide binding; F:scavenger receptor activity;, P:immune response;|Q92954 Q6DNC4 Q6DNC5 Q6ZMZ5 Q9BX49,Proteoglycan 4,Lubricin;Megakaryocyte-stimulating factor;Superficial zone proteoglycan;, PF00045;PF01033;, GO:0062023;GO:0005576;GO:0030247;GO:0005044;GO:0006955;, C:collagen-containing extracellular matrix; C:extracellular region;, F:polysaccharide binding; F:scavenger receptor activity;, P:immune response;|Q92954 Q6DNC4 Q6DNC5 Q6ZMZ5 Q9BX49,Proteoglycan 4,Lubricin;Megakaryocyte-stimulating factor;Superficial zone proteoglycan;, PF00045;PF01033;, GO:0062023;GO:0005576;GO:0030247;GO:0005044;GO:0006955;, C:collagen-containing extracellular matrix; C:extracellular region;, F:polysaccharide binding; F:scavenger receptor activity;, P:immune response; scaffold34 indexed_genome mRNA 7896058 7905947 . - . ID=transcript_7131;Q92954 Q6DNC4 Q6DNC5 Q6ZMZ5 Q9BX49,Proteoglycan 4,Lubricin;Megakaryocyte-stimulating factor;Superficial zone proteoglycan;, PF00045;PF01033;, GO:0062023;GO:0005576;GO:0030247;GO:0005044;GO:0006955;, C:collagen-containing extracellular matrix; C:extracellular region;, F:polysaccharide binding; F:scavenger receptor activity;, P:immune response; scaffold34 indexed_genome mRNA 8029221 8114475 . - . ID=transcript_7132;Q96RW7 A6NGE3 Q5TYR7 Q96DN3 Q96DN8 Q96SC3,Hemicentin-1,Fibulin-6;, PF12662;PF07645;PF07474;PF07679;PF00090;, GO:0005912;GO:0005604;GO:0005938;GO:0032154;GO:0062023;GO:0070062;GO:0005509;GO:0005201;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;GO:0007601;, C:adherens junction; C:basement membrane; C:cell cortex; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular exosome;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium; P:visual perception;|Q96RW7 A6NGE3 Q5TYR7 Q96DN3 Q96DN8 Q96SC3,Hemicentin-1,Fibulin-6;, PF12662;PF07645;PF07474;PF07679;PF00090;, GO:0005912;GO:0005604;GO:0005938;GO:0032154;GO:0062023;GO:0070062;GO:0005509;GO:0005201;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;GO:0007601;, C:adherens junction; C:basement membrane; C:cell cortex; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular exosome;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium; P:visual perception;|Q96RW7 A6NGE3 Q5TYR7 Q96DN3 Q96DN8 Q96SC3,Hemicentin-1,Fibulin-6;, PF12662;PF07645;PF07474;PF07679;PF00090;, GO:0005912;GO:0005604;GO:0005938;GO:0032154;GO:0062023;GO:0070062;GO:0005509;GO:0005201;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;GO:0007601;, C:adherens junction; C:basement membrane; C:cell cortex; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular exosome;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium; P:visual perception;|Q96RW7 A6NGE3 Q5TYR7 Q96DN3 Q96DN8 Q96SC3,Hemicentin-1,Fibulin-6;, PF12662;PF07645;PF07474;PF07679;PF00090;, GO:0005912;GO:0005604;GO:0005938;GO:0032154;GO:0062023;GO:0070062;GO:0005509;GO:0005201;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;GO:0007601;, C:adherens junction; C:basement membrane; C:cell cortex; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular exosome;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium; P:visual perception;|Q96RW7 A6NGE3 Q5TYR7 Q96DN3 Q96DN8 Q96SC3,Hemicentin-1,Fibulin-6;, PF12662;PF07645;PF07474;PF07679;PF00090;, GO:0005912;GO:0005604;GO:0005938;GO:0032154;GO:0062023;GO:0070062;GO:0005509;GO:0005201;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;GO:0007601;, C:adherens junction; C:basement membrane; C:cell cortex; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular exosome;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium; P:visual perception; scaffold34 indexed_genome mRNA 8114723 8139625 . - . ID=transcript_7133;Q96RW7 A6NGE3 Q5TYR7 Q96DN3 Q96DN8 Q96SC3,Hemicentin-1,Fibulin-6;, PF12662;PF07645;PF07474;PF07679;PF00090;, GO:0005912;GO:0005604;GO:0005938;GO:0032154;GO:0062023;GO:0070062;GO:0005509;GO:0005201;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;GO:0007601;, C:adherens junction; C:basement membrane; C:cell cortex; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular exosome;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium; P:visual perception; scaffold34 indexed_genome mRNA 8236508 8248599 . - . ID=transcript_7134;Q96RW7 A6NGE3 Q5TYR7 Q96DN3 Q96DN8 Q96SC3,Hemicentin-1,Fibulin-6;, PF12662;PF07645;PF07474;PF07679;PF00090;, GO:0005912;GO:0005604;GO:0005938;GO:0032154;GO:0062023;GO:0070062;GO:0005509;GO:0005201;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;GO:0007601;, C:adherens junction; C:basement membrane; C:cell cortex; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular exosome;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium; P:visual perception; scaffold34 indexed_genome mRNA 8347448 8541576 . - . ID=transcript_7135;Q96RW7 A6NGE3 Q5TYR7 Q96DN3 Q96DN8 Q96SC3,Hemicentin-1,Fibulin-6;, PF12662;PF07645;PF07474;PF07679;PF00090;, GO:0005912;GO:0005604;GO:0005938;GO:0032154;GO:0062023;GO:0070062;GO:0005509;GO:0005201;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;GO:0007601;, C:adherens junction; C:basement membrane; C:cell cortex; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular exosome;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium; P:visual perception; scaffold34 indexed_genome mRNA 8940549 8964134 . + . ID=transcript_7136;Q9Y6Y0 A8K8R6 Q1G4T6 Q1G4T7 Q5TF75 Q6NW38 Q7LCG2 Q9NZX0 Q9Y480,Influenza virus NS1A-binding protein,Aryl hydrocarbon receptor-associated protein 3 {ECO:0000303|PubMed:16582008};Kelch-like protein 39 {ECO:0000303|PubMed:25619834};, PF07707;PF00651;PF01344;, GO:0005856;GO:0005829;GO:0005654;GO:0005681;GO:0005667;GO:2001243;GO:0031397;GO:0009615;GO:0008380;GO:0006383;GO:0016032;, C:cytoskeleton; C:cytosol; C:nucleoplasm; C:spliceosomal complex; C:transcription regulator complex;, , P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein ubiquitination; P:response to virus; P:RNA splicing; P:transcription by RNA polymerase III; P:viral process;|Q9Y6Y0 A8K8R6 Q1G4T6 Q1G4T7 Q5TF75 Q6NW38 Q7LCG2 Q9NZX0 Q9Y480,Influenza virus NS1A-binding protein,Aryl hydrocarbon receptor-associated protein 3 {ECO:0000303|PubMed:16582008};Kelch-like protein 39 {ECO:0000303|PubMed:25619834};, PF07707;PF00651;PF01344;, GO:0005856;GO:0005829;GO:0005654;GO:0005681;GO:0005667;GO:2001243;GO:0031397;GO:0009615;GO:0008380;GO:0006383;GO:0016032;, C:cytoskeleton; C:cytosol; C:nucleoplasm; C:spliceosomal complex; C:transcription regulator complex;, , P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein ubiquitination; P:response to virus; P:RNA splicing; P:transcription by RNA polymerase III; P:viral process;|Q9Y6Y0 A8K8R6 Q1G4T6 Q1G4T7 Q5TF75 Q6NW38 Q7LCG2 Q9NZX0 Q9Y480,Influenza virus NS1A-binding protein,Aryl hydrocarbon receptor-associated protein 3 {ECO:0000303|PubMed:16582008};Kelch-like protein 39 {ECO:0000303|PubMed:25619834};, PF07707;PF00651;PF01344;, GO:0005856;GO:0005829;GO:0005654;GO:0005681;GO:0005667;GO:2001243;GO:0031397;GO:0009615;GO:0008380;GO:0006383;GO:0016032;, C:cytoskeleton; C:cytosol; C:nucleoplasm; C:spliceosomal complex; C:transcription regulator complex;, , P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein ubiquitination; P:response to virus; P:RNA splicing; P:transcription by RNA polymerase III; P:viral process;|Q9Y6Y0 A8K8R6 Q1G4T6 Q1G4T7 Q5TF75 Q6NW38 Q7LCG2 Q9NZX0 Q9Y480,Influenza virus NS1A-binding protein,Aryl hydrocarbon receptor-associated protein 3 {ECO:0000303|PubMed:16582008};Kelch-like protein 39 {ECO:0000303|PubMed:25619834};, PF07707;PF00651;PF01344;, GO:0005856;GO:0005829;GO:0005654;GO:0005681;GO:0005667;GO:2001243;GO:0031397;GO:0009615;GO:0008380;GO:0006383;GO:0016032;, C:cytoskeleton; C:cytosol; C:nucleoplasm; C:spliceosomal complex; C:transcription regulator complex;, , P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein ubiquitination; P:response to virus; P:RNA splicing; P:transcription by RNA polymerase III; P:viral process; scaffold34 indexed_genome mRNA 8965588 9060616 . - . ID=transcript_7137;Q5T5J6 Q8NEK9 Q9BZQ7 Q9NXQ0,Transcriptional protein SWT1,, PF13638;, GO:0005634;, C:nucleus;|Q5T5J6 Q8NEK9 Q9BZQ7 Q9NXQ0,Transcriptional protein SWT1,, PF13638;, GO:0005634;, C:nucleus;|Q5T5J6 Q8NEK9 Q9BZQ7 Q9NXQ0,Transcriptional protein SWT1,, PF13638;, GO:0005634;, C:nucleus;|Q5T5J6 Q8NEK9 Q9BZQ7 Q9NXQ0,Transcriptional protein SWT1,, PF13638;, GO:0005634;, C:nucleus; scaffold34 indexed_genome mRNA 9060916 9095177 . + . ID=transcript_7138;Q7Z2T5 Q5TEN0 Q6ZMX0 Q8IWH5 Q8NC68 Q9BZQ1,TRMT1-like protein,, PF02005;, GO:0005634;GO:0046872;GO:0003723;GO:0004809;GO:0000049;GO:0007610;GO:0002940;, C:nucleus;, F:metal ion binding; F:RNA binding; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;, P:behavior; P:tRNA N2-guanine methylation;|Q7Z2T5 Q5TEN0 Q6ZMX0 Q8IWH5 Q8NC68 Q9BZQ1,TRMT1-like protein,, PF02005;, GO:0005634;GO:0046872;GO:0003723;GO:0004809;GO:0000049;GO:0007610;GO:0002940;, C:nucleus;, F:metal ion binding; F:RNA binding; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;, P:behavior; P:tRNA N2-guanine methylation;|Q7Z2T5 Q5TEN0 Q6ZMX0 Q8IWH5 Q8NC68 Q9BZQ1,TRMT1-like protein,, PF02005;, GO:0005634;GO:0046872;GO:0003723;GO:0004809;GO:0000049;GO:0007610;GO:0002940;, C:nucleus;, F:metal ion binding; F:RNA binding; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;, P:behavior; P:tRNA N2-guanine methylation; scaffold34 indexed_genome mRNA 9100064 9109579 . - . ID=transcript_7139;Q99496 B2RBS7 B3KRH1 Q5TEN1 Q5TEN2,E3 ubiquitin-protein ligase RING2,Huntingtin-interacting protein 2-interacting protein 3;Protein DinG;RING finger protein 1B;RING finger protein 2;RING finger protein BAP-1;RING-type E3 ubiquitin transferase RING2 {ECO:0000305};, PF16207;, GO:0000791;GO:0071339;GO:0016604;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0001739;GO:0000151;GO:0003682;GO:0071535;GO:0061630;GO:0008270;GO:0009948;GO:0001702;GO:0010467;GO:0007281;GO:0035518;GO:0036353;GO:0000278;GO:0043433;GO:0070317;GO:0000122;, C:euchromatin; C:MLL1 complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:sex chromatin; C:ubiquitin ligase complex;, F:chromatin binding; F:RING-like zinc finger domain binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:anterior/posterior axis specification; P:gastrulation with mouth forming second; P:gene expression; P:germ cell development; P:histone H2A monoubiquitination; P:histone H2A-K119 monoubiquitination; P:mitotic cell cycle; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; scaffold34 indexed_genome mRNA 9202920 9373783 . + . ID=transcript_7140;Q9BZQ8 Q2TTR2 Q5TEM8 Q8TEI5 Q9H593 Q9H9Y8 Q9HCB9,Protein Niban 1 {ECO:0000305},Cell growth-inhibiting gene 39 protein;Protein FAM129A;, , GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0001933;GO:0001934;GO:0045727;GO:0034976;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane;, , P:negative regulation of protein phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of translation; P:response to endoplasmic reticulum stress;|Q9BZQ8 Q2TTR2 Q5TEM8 Q8TEI5 Q9H593 Q9H9Y8 Q9HCB9,Protein Niban 1 {ECO:0000305},Cell growth-inhibiting gene 39 protein;Protein FAM129A;, , GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0001933;GO:0001934;GO:0045727;GO:0034976;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane;, , P:negative regulation of protein phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of translation; P:response to endoplasmic reticulum stress; scaffold34 indexed_genome mRNA 9409164 9471568 . + . ID=transcript_7141;Q9BZQ6 B2RCH6 B7ZLZ2 Q0VGM5 Q5TEZ0 Q7L2Y5 Q9HCW1 Q9UFV7,ER degradation-enhancing alpha-mannosidase-like protein 3,Alpha-1,2-mannosidase EDEM3;, PF01532;PF02225;, GO:0005788;GO:0044322;GO:0016020;GO:0005509;GO:0004571;GO:0005975;GO:1904382;GO:0006486;GO:0006986;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:mannose trimming involved in glycoprotein ERAD pathway; P:protein glycosylation; P:response to unfolded protein; scaffold34 indexed_genome mRNA 9477249 9480472 . - . ID=transcript_7142;Q9BZQ6 B2RCH6 B7ZLZ2 Q0VGM5 Q5TEZ0 Q7L2Y5 Q9HCW1 Q9UFV7,ER degradation-enhancing alpha-mannosidase-like protein 3,Alpha-1,2-mannosidase EDEM3;, PF01532;PF02225;, GO:0005788;GO:0044322;GO:0016020;GO:0005509;GO:0004571;GO:0005975;GO:1904382;GO:0006486;GO:0006986;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:mannose trimming involved in glycoprotein ERAD pathway; P:protein glycosylation; P:response to unfolded protein;|Q9BZQ6 B2RCH6 B7ZLZ2 Q0VGM5 Q5TEZ0 Q7L2Y5 Q9HCW1 Q9UFV7,ER degradation-enhancing alpha-mannosidase-like protein 3,Alpha-1,2-mannosidase EDEM3;, PF01532;PF02225;, GO:0005788;GO:0044322;GO:0016020;GO:0005509;GO:0004571;GO:0005975;GO:1904382;GO:0006486;GO:0006986;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:mannose trimming involved in glycoprotein ERAD pathway; P:protein glycosylation; P:response to unfolded protein; scaffold34 indexed_genome mRNA 10047116 10074572 . - . ID=transcript_7143;Q8WW01 B4DKP0 Q9BZQ5,tRNA-splicing endonuclease subunit Sen15,SEN15 homolog;tRNA-intron endonuclease Sen15;, PF09631;, GO:0005730;GO:0005654;GO:0004518;GO:0003676;GO:0006397;GO:0006388;, C:nucleolus; C:nucleoplasm;, F:nuclease activity; F:nucleic acid binding;, P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q8WW01 B4DKP0 Q9BZQ5,tRNA-splicing endonuclease subunit Sen15,SEN15 homolog;tRNA-intron endonuclease Sen15;, PF09631;, GO:0005730;GO:0005654;GO:0004518;GO:0003676;GO:0006397;GO:0006388;, C:nucleolus; C:nucleoplasm;, F:nuclease activity; F:nucleic acid binding;, P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q8WW01 B4DKP0 Q9BZQ5,tRNA-splicing endonuclease subunit Sen15,SEN15 homolog;tRNA-intron endonuclease Sen15;, PF09631;, GO:0005730;GO:0005654;GO:0004518;GO:0003676;GO:0006397;GO:0006388;, C:nucleolus; C:nucleoplasm;, F:nuclease activity; F:nucleic acid binding;, P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q8WW01 B4DKP0 Q9BZQ5,tRNA-splicing endonuclease subunit Sen15,SEN15 homolog;tRNA-intron endonuclease Sen15;, PF09631;, GO:0005730;GO:0005654;GO:0004518;GO:0003676;GO:0006397;GO:0006388;, C:nucleolus; C:nucleoplasm;, F:nuclease activity; F:nucleic acid binding;, P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold34 indexed_genome mRNA 10083205 10195772 . + . ID=transcript_7144;Q8IYK4 O60327 Q9BZR0,Procollagen galactosyltransferase 2,Collagen beta(1-O)galactosyltransferase 2;Glycosyltransferase 25 family member 2;Hydroxylysine galactosyltransferase 2;, PF01755;, GO:0005788;GO:0050211;GO:0030199;, C:endoplasmic reticulum lumen;, F:procollagen galactosyltransferase activity;, P:collagen fibril organization; scaffold34 indexed_genome mRNA 10204629 10334225 . - . ID=transcript_7145;Q9NZL6 Q5SXQ2 Q5SXQ6 Q9HBY3 Q9HBY4 Q9NZL5 Q9UG43 Q9Y2G6,Ral guanine nucleotide dissociation stimulator-like 1,, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0000165;GO:0019222;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:regulation of metabolic process; P:small GTPase mediated signal transduction; scaffold34 indexed_genome mRNA 10482464 10488504 . + . ID=transcript_7146;O15511 A6NEC4 Q6PG42,Actin-related protein 2/3 complex subunit 5,Arp2/3 complex 16 kDa subunit;, PF04699;, GO:0015629;GO:0005885;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0030426;GO:0030027;GO:0005634;GO:0034774;GO:0035861;GO:0003779;GO:0005200;GO:0030036;GO:0051639;GO:0034314;GO:0016477;GO:0048013;GO:0038096;GO:0097581;GO:0030011;GO:0061024;GO:0061842;GO:0043312;GO:0021769;GO:0014909;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:growth cone; C:lamellipodium; C:nucleus; C:secretory granule lumen; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actin filament network formation; P:Arp2/3 complex-mediated actin nucleation; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium organization; P:maintenance of cell polarity; P:membrane organization; P:microtubule organizing center localization; P:neutrophil degranulation; P:orbitofrontal cortex development; P:smooth muscle cell migration;|O15511 A6NEC4 Q6PG42,Actin-related protein 2/3 complex subunit 5,Arp2/3 complex 16 kDa subunit;, PF04699;, GO:0015629;GO:0005885;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0030426;GO:0030027;GO:0005634;GO:0034774;GO:0035861;GO:0003779;GO:0005200;GO:0030036;GO:0051639;GO:0034314;GO:0016477;GO:0048013;GO:0038096;GO:0097581;GO:0030011;GO:0061024;GO:0061842;GO:0043312;GO:0021769;GO:0014909;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:growth cone; C:lamellipodium; C:nucleus; C:secretory granule lumen; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actin filament network formation; P:Arp2/3 complex-mediated actin nucleation; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium organization; P:maintenance of cell polarity; P:membrane organization; P:microtubule organizing center localization; P:neutrophil degranulation; P:orbitofrontal cortex development; P:smooth muscle cell migration;|O15511 A6NEC4 Q6PG42,Actin-related protein 2/3 complex subunit 5,Arp2/3 complex 16 kDa subunit;, PF04699;, GO:0015629;GO:0005885;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0030426;GO:0030027;GO:0005634;GO:0034774;GO:0035861;GO:0003779;GO:0005200;GO:0030036;GO:0051639;GO:0034314;GO:0016477;GO:0048013;GO:0038096;GO:0097581;GO:0030011;GO:0061024;GO:0061842;GO:0043312;GO:0021769;GO:0014909;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:growth cone; C:lamellipodium; C:nucleus; C:secretory granule lumen; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actin filament network formation; P:Arp2/3 complex-mediated actin nucleation; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium organization; P:maintenance of cell polarity; P:membrane organization; P:microtubule organizing center localization; P:neutrophil degranulation; P:orbitofrontal cortex development; P:smooth muscle cell migration; scaffold34 indexed_genome mRNA 10523816 10556558 . + . ID=transcript_7147;P19878 B2R6Q1 B4DKQ7 B4DQA7 E9PHJ2 E9PHX3 Q2PP06 Q8NFC7 Q9BV51,Neutrophil cytosol factor 2,67 kDa neutrophil oxidase factor;NADPH oxidase activator 2;Neutrophil NADPH oxidase factor 2;p67-phox;, PF00564;PF00018;PF13181;, GO:0001669;GO:0005829;GO:0016020;GO:0043020;GO:0032010;GO:0009055;GO:0008022;GO:0031267;GO:0016175;GO:0016176;GO:0002479;GO:0045454;GO:0006968;GO:0034599;GO:0045087;GO:0006909;GO:0045730;GO:0042554;GO:0006801;GO:0048010;, C:acrosomal vesicle; C:cytosol; C:membrane; C:NADPH oxidase complex; C:phagolysosome;, F:electron transfer activity; F:protein C-terminus binding; F:small GTPase binding; F:superoxide-generating NAD(P)H oxidase activity; F:superoxide-generating NADPH oxidase activator activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell redox homeostasis; P:cellular defense response; P:cellular response to oxidative stress; P:innate immune response; P:phagocytosis; P:respiratory burst; P:superoxide anion generation; P:superoxide metabolic process; P:vascular endothelial growth factor receptor signaling pathway; scaffold34 indexed_genome mRNA 10557036 10562761 . - . ID=transcript_7148;Q92540 B4DRB2 E9PCI0 E9PEH2 Q5T1Q0 Q6PIE0 Q7Z7H9 Q8IXC1 Q8IXC2,Protein SMG7,EST1-like protein C;SMG-7 homolog;, PF10374;PF10373;, GO:0005737;GO:0005829;GO:0045111;GO:0005634;GO:0005697;GO:0051721;GO:0070034;GO:0042162;GO:0006406;GO:0000184;GO:0035303;, C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:nucleus; C:telomerase holoenzyme complex;, F:protein phosphatase 2A binding; F:telomerase RNA binding; F:telomeric DNA binding;, P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of dephosphorylation;|Q92540 B4DRB2 E9PCI0 E9PEH2 Q5T1Q0 Q6PIE0 Q7Z7H9 Q8IXC1 Q8IXC2,Protein SMG7,EST1-like protein C;SMG-7 homolog;, PF10374;PF10373;, GO:0005737;GO:0005829;GO:0045111;GO:0005634;GO:0005697;GO:0051721;GO:0070034;GO:0042162;GO:0006406;GO:0000184;GO:0035303;, C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:nucleus; C:telomerase holoenzyme complex;, F:protein phosphatase 2A binding; F:telomerase RNA binding; F:telomeric DNA binding;, P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of dephosphorylation; scaffold34 indexed_genome mRNA 10565035 10638935 . - . ID=transcript_7149;Q92540 B4DRB2 E9PCI0 E9PEH2 Q5T1Q0 Q6PIE0 Q7Z7H9 Q8IXC1 Q8IXC2,Protein SMG7,EST1-like protein C;SMG-7 homolog;, PF10374;PF10373;, GO:0005737;GO:0005829;GO:0045111;GO:0005634;GO:0005697;GO:0051721;GO:0070034;GO:0042162;GO:0006406;GO:0000184;GO:0035303;, C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:nucleus; C:telomerase holoenzyme complex;, F:protein phosphatase 2A binding; F:telomerase RNA binding; F:telomeric DNA binding;, P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of dephosphorylation; scaffold34 indexed_genome mRNA 10683497 10838355 . + . ID=transcript_7150;Q9BZQ4 O75067 Q5T1Q3 Q8WU99 Q96QW1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 {ECO:0000305},Nicotinamide mononucleotide adenylyltransferase 2;Nicotinate-nucleotide adenylyltransferase 2;, PF01467;, GO:0030424;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0005770;GO:0045202;GO:0005802;GO:0005524;GO:0000309;GO:0004515;GO:0009435;GO:0019674;GO:0009165;, C:axon; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:late endosome; C:synapse; C:trans-Golgi network;, F:ATP binding; F:nicotinamide-nucleotide adenylyltransferase activity; F:nicotinate-nucleotide adenylyltransferase activity;, P:NAD biosynthetic process; P:NAD metabolic process; P:nucleotide biosynthetic process; scaffold34 indexed_genome mRNA 10848013 10917440 . - . ID=transcript_7151;Q13753 Q02536 Q02537 Q13752 Q14941 Q14DF7 Q2M1N2 Q5VYE8,Laminin subunit gamma-2,Cell-scattering factor 140 kDa subunit;Epiligrin subunit gamma;Kalinin subunit gamma;Kalinin/nicein/epiligrin 100 kDa subunit;Ladsin 140 kDa subunit;Laminin B2t chain;Laminin-5 subunit gamma;Large adhesive scatter factor 140 kDa subunit;Nicein subunit gamma;, PF00052;PF00053;, GO:0005604;GO:0005938;GO:0062023;GO:0005576;GO:0005615;GO:0005607;GO:0016020;GO:0048471;GO:0008201;GO:0005102;GO:0009887;GO:0007155;GO:0030199;GO:0016358;GO:0008544;GO:0030198;GO:0031581;GO:0008045;GO:0030335;GO:0008284;GO:0009888;, C:basement membrane; C:cell cortex; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:laminin-2 complex; C:membrane; C:perinuclear region of cytoplasm;, F:heparin binding; F:signaling receptor binding;, P:animal organ morphogenesis; P:cell adhesion; P:collagen fibril organization; P:dendrite development; P:epidermis development; P:extracellular matrix organization; P:hemidesmosome assembly; P:motor neuron axon guidance; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:tissue development; scaffold34 indexed_genome mRNA 10956071 10993757 . - . ID=transcript_7152;P11047 Q5VYE7,Laminin subunit gamma-1,Laminin B2 chain;Laminin-1 subunit gamma;Laminin-10 subunit gamma;Laminin-11 subunit gamma;Laminin-2 subunit gamma;Laminin-3 subunit gamma;Laminin-4 subunit gamma;Laminin-6 subunit gamma;Laminin-7 subunit gamma;Laminin-8 subunit gamma;Laminin-9 subunit gamma;S-laminin subunit gamma;, PF00052;PF00053;PF00055;, GO:0005604;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005606;GO:0043259;GO:0043260;GO:0005201;GO:0009887;GO:0007155;GO:0016477;GO:0044267;GO:0007492;GO:0022617;GO:0030198;GO:0031581;GO:0035633;GO:0050679;GO:0043687;GO:0065003;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin-1 complex; C:laminin-10 complex; C:laminin-11 complex;, F:extracellular matrix structural constituent;, P:animal organ morphogenesis; P:cell adhesion; P:cell migration; P:cellular protein metabolic process; P:endoderm development; P:extracellular matrix disassembly; P:extracellular matrix organization; P:hemidesmosome assembly; P:maintenance of blood-brain barrier; P:positive regulation of epithelial cell proliferation; P:post-translational protein modification; P:protein-containing complex assembly; P:substrate adhesion-dependent cell spreading; P:tissue development; scaffold34 indexed_genome mRNA 11177437 11223081 . - . ID=transcript_7153;Q08211 B2RNV4 Q05CI5 Q12803 Q32Q22 Q5VY62 Q6PD69 Q99556,ATP-dependent RNA helicase A {ECO:0000305},DEAH box protein 9;DExH-box helicase 9 {ECO:0000312|HGNC:HGNC:2750};Leukophysin {ECO:0000303|PubMed:8690889};Nuclear DNA helicase II {ECO:0000303|PubMed:1537828, ECO:0000303|PubMed:8344961, ECO:0000303|PubMed:9111062};RNA helicase A {ECO:0000303|PubMed:9111062};, PF00270;PF00035;PF04408;PF00271;PF07717;, GO:0015629;GO:0005813;GO:0070937;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0016604;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0042788;GO:0005844;GO:0032991;GO:1990904;GO:0016442;GO:0070578;GO:0043138;GO:0033679;GO:0034458;GO:0005524;GO:0016887;GO:0031490;GO:0003677;GO:0003678;GO:0003688;GO:0003690;GO:0003725;GO:0061676;GO:0046872;GO:0003729;GO:0017111;GO:0047429;GO:1905538;GO:1990841;GO:0001069;GO:1905172;GO:0003723;GO:0003724;GO:0070063;GO:0000978;GO:0000993;GO:0001085;GO:0035613;GO:1990825;GO:1990518;GO:0003697;GO:0003727;GO:0035197;GO:0003713;GO:0003712;GO:0045142;GO:0000380;GO:0034622;GO:0071360;GO:0071356;GO:0070934;GO:0032508;GO:0006260;GO:0006353;GO:0039695;GO:0044806;GO:0006954;GO:0045087;GO:0000398;GO:0051028;GO:0001649;GO:2000767;GO:0045739;GO:0045740;GO:2000373;GO:0048146;GO:2000637;GO:0050729;GO:0045089;GO:0032727;GO:0032728;GO:0032741;GO:0032755;GO:0051092;GO:1905698;GO:0060760;GO:0046833;GO:0045944;GO:0032760;GO:0032481;GO:0050434;GO:1904973;GO:1903608;GO:0070269;GO:2000765;GO:0050691;GO:0050684;GO:0006357;GO:0048511;GO:0010501;GO:0070922;GO:0030423;, C:actin cytoskeleton; C:centrosome; C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nuclear body; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:polysomal ribosome; C:polysome; C:protein-containing complex; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity; F:3'-5' RNA helicase activity; F:ATP binding; F:ATPase activity; F:chromatin DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:double-stranded DNA binding; F:double-stranded RNA binding; F:importin-alpha family protein binding; F:metal ion binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:polysome binding; F:promoter-specific chromatin binding; F:regulatory region RNA binding; F:RISC complex binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II transcription factor binding; F:RNA stem-loop binding; F:sequence-specific mRNA binding; F:single-stranded 3'-5' DNA helicase activity; F:single-stranded DNA binding; F:single-stranded RNA binding; F:siRNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:triplex DNA binding;, P:alternative mRNA splicing, via spliceosome; P:cellular protein-containing complex assembly; P:cellular response to exogenous dsRNA; P:cellular response to tumor necrosis factor; P:CRD-mediated mRNA stabilization; P:DNA duplex unwinding; P:DNA replication; P:DNA-templated transcription, termination; P:DNA-templated viral transcription; P:G-quadruplex DNA unwinding; P:inflammatory response; P:innate immune response; P:mRNA splicing, via spliceosome; P:mRNA transport; P:osteoblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of fibroblast proliferation; P:positive regulation of gene silencing by miRNA; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-18 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of polysome binding; P:positive regulation of response to cytokine stimulus; P:positive regulation of RNA export from nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:positive regulation of viral translation; P:protein localization to cytoplasmic stress granule; P:pyroptosis; P:regulation of cytoplasmic translation; P:regulation of defense response to virus by host; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:RNA secondary structure unwinding; P:small RNA loading onto RISC; P:targeting of mRNA for destruction involved in RNA interference;|Q08211 B2RNV4 Q05CI5 Q12803 Q32Q22 Q5VY62 Q6PD69 Q99556,ATP-dependent RNA helicase A {ECO:0000305},DEAH box protein 9;DExH-box helicase 9 {ECO:0000312|HGNC:HGNC:2750};Leukophysin {ECO:0000303|PubMed:8690889};Nuclear DNA helicase II {ECO:0000303|PubMed:1537828, ECO:0000303|PubMed:8344961, ECO:0000303|PubMed:9111062};RNA helicase A {ECO:0000303|PubMed:9111062};, PF00270;PF00035;PF04408;PF00271;PF07717;, GO:0015629;GO:0005813;GO:0070937;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0016604;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0042788;GO:0005844;GO:0032991;GO:1990904;GO:0016442;GO:0070578;GO:0043138;GO:0033679;GO:0034458;GO:0005524;GO:0016887;GO:0031490;GO:0003677;GO:0003678;GO:0003688;GO:0003690;GO:0003725;GO:0061676;GO:0046872;GO:0003729;GO:0017111;GO:0047429;GO:1905538;GO:1990841;GO:0001069;GO:1905172;GO:0003723;GO:0003724;GO:0070063;GO:0000978;GO:0000993;GO:0001085;GO:0035613;GO:1990825;GO:1990518;GO:0003697;GO:0003727;GO:0035197;GO:0003713;GO:0003712;GO:0045142;GO:0000380;GO:0034622;GO:0071360;GO:0071356;GO:0070934;GO:0032508;GO:0006260;GO:0006353;GO:0039695;GO:0044806;GO:0006954;GO:0045087;GO:0000398;GO:0051028;GO:0001649;GO:2000767;GO:0045739;GO:0045740;GO:2000373;GO:0048146;GO:2000637;GO:0050729;GO:0045089;GO:0032727;GO:0032728;GO:0032741;GO:0032755;GO:0051092;GO:1905698;GO:0060760;GO:0046833;GO:0045944;GO:0032760;GO:0032481;GO:0050434;GO:1904973;GO:1903608;GO:0070269;GO:2000765;GO:0050691;GO:0050684;GO:0006357;GO:0048511;GO:0010501;GO:0070922;GO:0030423;, C:actin cytoskeleton; C:centrosome; C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nuclear body; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:polysomal ribosome; C:polysome; C:protein-containing complex; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity; F:3'-5' RNA helicase activity; F:ATP binding; F:ATPase activity; F:chromatin DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:double-stranded DNA binding; F:double-stranded RNA binding; F:importin-alpha family protein binding; F:metal ion binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:polysome binding; F:promoter-specific chromatin binding; F:regulatory region RNA binding; F:RISC complex binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II transcription factor binding; F:RNA stem-loop binding; F:sequence-specific mRNA binding; F:single-stranded 3'-5' DNA helicase activity; F:single-stranded DNA binding; F:single-stranded RNA binding; F:siRNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:triplex DNA binding;, P:alternative mRNA splicing, via spliceosome; P:cellular protein-containing complex assembly; P:cellular response to exogenous dsRNA; P:cellular response to tumor necrosis factor; P:CRD-mediated mRNA stabilization; P:DNA duplex unwinding; P:DNA replication; P:DNA-templated transcription, termination; P:DNA-templated viral transcription; P:G-quadruplex DNA unwinding; P:inflammatory response; P:innate immune response; P:mRNA splicing, via spliceosome; P:mRNA transport; P:osteoblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of fibroblast proliferation; P:positive regulation of gene silencing by miRNA; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-18 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of polysome binding; P:positive regulation of response to cytokine stimulus; P:positive regulation of RNA export from nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:positive regulation of viral translation; P:protein localization to cytoplasmic stress granule; P:pyroptosis; P:regulation of cytoplasmic translation; P:regulation of defense response to virus by host; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:RNA secondary structure unwinding; P:small RNA loading onto RISC; P:targeting of mRNA for destruction involved in RNA interference;|Q08211 B2RNV4 Q05CI5 Q12803 Q32Q22 Q5VY62 Q6PD69 Q99556,ATP-dependent RNA helicase A {ECO:0000305},DEAH box protein 9;DExH-box helicase 9 {ECO:0000312|HGNC:HGNC:2750};Leukophysin {ECO:0000303|PubMed:8690889};Nuclear DNA helicase II {ECO:0000303|PubMed:1537828, ECO:0000303|PubMed:8344961, ECO:0000303|PubMed:9111062};RNA helicase A {ECO:0000303|PubMed:9111062};, PF00270;PF00035;PF04408;PF00271;PF07717;, GO:0015629;GO:0005813;GO:0070937;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0016604;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0042788;GO:0005844;GO:0032991;GO:1990904;GO:0016442;GO:0070578;GO:0043138;GO:0033679;GO:0034458;GO:0005524;GO:0016887;GO:0031490;GO:0003677;GO:0003678;GO:0003688;GO:0003690;GO:0003725;GO:0061676;GO:0046872;GO:0003729;GO:0017111;GO:0047429;GO:1905538;GO:1990841;GO:0001069;GO:1905172;GO:0003723;GO:0003724;GO:0070063;GO:0000978;GO:0000993;GO:0001085;GO:0035613;GO:1990825;GO:1990518;GO:0003697;GO:0003727;GO:0035197;GO:0003713;GO:0003712;GO:0045142;GO:0000380;GO:0034622;GO:0071360;GO:0071356;GO:0070934;GO:0032508;GO:0006260;GO:0006353;GO:0039695;GO:0044806;GO:0006954;GO:0045087;GO:0000398;GO:0051028;GO:0001649;GO:2000767;GO:0045739;GO:0045740;GO:2000373;GO:0048146;GO:2000637;GO:0050729;GO:0045089;GO:0032727;GO:0032728;GO:0032741;GO:0032755;GO:0051092;GO:1905698;GO:0060760;GO:0046833;GO:0045944;GO:0032760;GO:0032481;GO:0050434;GO:1904973;GO:1903608;GO:0070269;GO:2000765;GO:0050691;GO:0050684;GO:0006357;GO:0048511;GO:0010501;GO:0070922;GO:0030423;, C:actin cytoskeleton; C:centrosome; C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nuclear body; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:polysomal ribosome; C:polysome; C:protein-containing complex; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity; F:3'-5' RNA helicase activity; F:ATP binding; F:ATPase activity; F:chromatin DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:double-stranded DNA binding; F:double-stranded RNA binding; F:importin-alpha family protein binding; F:metal ion binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:polysome binding; F:promoter-specific chromatin binding; F:regulatory region RNA binding; F:RISC complex binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II transcription factor binding; F:RNA stem-loop binding; F:sequence-specific mRNA binding; F:single-stranded 3'-5' DNA helicase activity; F:single-stranded DNA binding; F:single-stranded RNA binding; F:siRNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:triplex DNA binding;, P:alternative mRNA splicing, via spliceosome; P:cellular protein-containing complex assembly; P:cellular response to exogenous dsRNA; P:cellular response to tumor necrosis factor; P:CRD-mediated mRNA stabilization; P:DNA duplex unwinding; P:DNA replication; P:DNA-templated transcription, termination; P:DNA-templated viral transcription; P:G-quadruplex DNA unwinding; P:inflammatory response; P:innate immune response; P:mRNA splicing, via spliceosome; P:mRNA transport; P:osteoblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of fibroblast proliferation; P:positive regulation of gene silencing by miRNA; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-18 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of polysome binding; P:positive regulation of response to cytokine stimulus; P:positive regulation of RNA export from nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:positive regulation of viral translation; P:protein localization to cytoplasmic stress granule; P:pyroptosis; P:regulation of cytoplasmic translation; P:regulation of defense response to virus by host; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:RNA secondary structure unwinding; P:small RNA loading onto RISC; P:targeting of mRNA for destruction involved in RNA interference;|Q08211 B2RNV4 Q05CI5 Q12803 Q32Q22 Q5VY62 Q6PD69 Q99556,ATP-dependent RNA helicase A {ECO:0000305},DEAH box protein 9;DExH-box helicase 9 {ECO:0000312|HGNC:HGNC:2750};Leukophysin {ECO:0000303|PubMed:8690889};Nuclear DNA helicase II {ECO:0000303|PubMed:1537828, ECO:0000303|PubMed:8344961, ECO:0000303|PubMed:9111062};RNA helicase A {ECO:0000303|PubMed:9111062};, PF00270;PF00035;PF04408;PF00271;PF07717;, GO:0015629;GO:0005813;GO:0070937;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0016604;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0042788;GO:0005844;GO:0032991;GO:1990904;GO:0016442;GO:0070578;GO:0043138;GO:0033679;GO:0034458;GO:0005524;GO:0016887;GO:0031490;GO:0003677;GO:0003678;GO:0003688;GO:0003690;GO:0003725;GO:0061676;GO:0046872;GO:0003729;GO:0017111;GO:0047429;GO:1905538;GO:1990841;GO:0001069;GO:1905172;GO:0003723;GO:0003724;GO:0070063;GO:0000978;GO:0000993;GO:0001085;GO:0035613;GO:1990825;GO:1990518;GO:0003697;GO:0003727;GO:0035197;GO:0003713;GO:0003712;GO:0045142;GO:0000380;GO:0034622;GO:0071360;GO:0071356;GO:0070934;GO:0032508;GO:0006260;GO:0006353;GO:0039695;GO:0044806;GO:0006954;GO:0045087;GO:0000398;GO:0051028;GO:0001649;GO:2000767;GO:0045739;GO:0045740;GO:2000373;GO:0048146;GO:2000637;GO:0050729;GO:0045089;GO:0032727;GO:0032728;GO:0032741;GO:0032755;GO:0051092;GO:1905698;GO:0060760;GO:0046833;GO:0045944;GO:0032760;GO:0032481;GO:0050434;GO:1904973;GO:1903608;GO:0070269;GO:2000765;GO:0050691;GO:0050684;GO:0006357;GO:0048511;GO:0010501;GO:0070922;GO:0030423;, C:actin cytoskeleton; C:centrosome; C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nuclear body; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:polysomal ribosome; C:polysome; C:protein-containing complex; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity; F:3'-5' RNA helicase activity; F:ATP binding; F:ATPase activity; F:chromatin DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:double-stranded DNA binding; F:double-stranded RNA binding; F:importin-alpha family protein binding; F:metal ion binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:polysome binding; F:promoter-specific chromatin binding; F:regulatory region RNA binding; F:RISC complex binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II transcription factor binding; F:RNA stem-loop binding; F:sequence-specific mRNA binding; F:single-stranded 3'-5' DNA helicase activity; F:single-stranded DNA binding; F:single-stranded RNA binding; F:siRNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:triplex DNA binding;, P:alternative mRNA splicing, via spliceosome; P:cellular protein-containing complex assembly; P:cellular response to exogenous dsRNA; P:cellular response to tumor necrosis factor; P:CRD-mediated mRNA stabilization; P:DNA duplex unwinding; P:DNA replication; P:DNA-templated transcription, termination; P:DNA-templated viral transcription; P:G-quadruplex DNA unwinding; P:inflammatory response; P:innate immune response; P:mRNA splicing, via spliceosome; P:mRNA transport; P:osteoblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of fibroblast proliferation; P:positive regulation of gene silencing by miRNA; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-18 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of polysome binding; P:positive regulation of response to cytokine stimulus; P:positive regulation of RNA export from nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:positive regulation of viral translation; P:protein localization to cytoplasmic stress granule; P:pyroptosis; P:regulation of cytoplasmic translation; P:regulation of defense response to virus by host; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:RNA secondary structure unwinding; P:small RNA loading onto RISC; P:targeting of mRNA for destruction involved in RNA interference;|Q08211 B2RNV4 Q05CI5 Q12803 Q32Q22 Q5VY62 Q6PD69 Q99556,ATP-dependent RNA helicase A {ECO:0000305},DEAH box protein 9;DExH-box helicase 9 {ECO:0000312|HGNC:HGNC:2750};Leukophysin {ECO:0000303|PubMed:8690889};Nuclear DNA helicase II {ECO:0000303|PubMed:1537828, ECO:0000303|PubMed:8344961, ECO:0000303|PubMed:9111062};RNA helicase A {ECO:0000303|PubMed:9111062};, PF00270;PF00035;PF04408;PF00271;PF07717;, GO:0015629;GO:0005813;GO:0070937;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0016604;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0042788;GO:0005844;GO:0032991;GO:1990904;GO:0016442;GO:0070578;GO:0043138;GO:0033679;GO:0034458;GO:0005524;GO:0016887;GO:0031490;GO:0003677;GO:0003678;GO:0003688;GO:0003690;GO:0003725;GO:0061676;GO:0046872;GO:0003729;GO:0017111;GO:0047429;GO:1905538;GO:1990841;GO:0001069;GO:1905172;GO:0003723;GO:0003724;GO:0070063;GO:0000978;GO:0000993;GO:0001085;GO:0035613;GO:1990825;GO:1990518;GO:0003697;GO:0003727;GO:0035197;GO:0003713;GO:0003712;GO:0045142;GO:0000380;GO:0034622;GO:0071360;GO:0071356;GO:0070934;GO:0032508;GO:0006260;GO:0006353;GO:0039695;GO:0044806;GO:0006954;GO:0045087;GO:0000398;GO:0051028;GO:0001649;GO:2000767;GO:0045739;GO:0045740;GO:2000373;GO:0048146;GO:2000637;GO:0050729;GO:0045089;GO:0032727;GO:0032728;GO:0032741;GO:0032755;GO:0051092;GO:1905698;GO:0060760;GO:0046833;GO:0045944;GO:0032760;GO:0032481;GO:0050434;GO:1904973;GO:1903608;GO:0070269;GO:2000765;GO:0050691;GO:0050684;GO:0006357;GO:0048511;GO:0010501;GO:0070922;GO:0030423;, C:actin cytoskeleton; C:centrosome; C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nuclear body; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:polysomal ribosome; C:polysome; C:protein-containing complex; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity; F:3'-5' RNA helicase activity; F:ATP binding; F:ATPase activity; F:chromatin DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:double-stranded DNA binding; F:double-stranded RNA binding; F:importin-alpha family protein binding; F:metal ion binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:polysome binding; F:promoter-specific chromatin binding; F:regulatory region RNA binding; F:RISC complex binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II transcription factor binding; F:RNA stem-loop binding; F:sequence-specific mRNA binding; F:single-stranded 3'-5' DNA helicase activity; F:single-stranded DNA binding; F:single-stranded RNA binding; F:siRNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:triplex DNA binding;, P:alternative mRNA splicing, via spliceosome; P:cellular protein-containing complex assembly; P:cellular response to exogenous dsRNA; P:cellular response to tumor necrosis factor; P:CRD-mediated mRNA stabilization; P:DNA duplex unwinding; P:DNA replication; P:DNA-templated transcription, termination; P:DNA-templated viral transcription; P:G-quadruplex DNA unwinding; P:inflammatory response; P:innate immune response; P:mRNA splicing, via spliceosome; P:mRNA transport; P:osteoblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of fibroblast proliferation; P:positive regulation of gene silencing by miRNA; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-18 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of polysome binding; P:positive regulation of response to cytokine stimulus; P:positive regulation of RNA export from nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:positive regulation of viral translation; P:protein localization to cytoplasmic stress granule; P:pyroptosis; P:regulation of cytoplasmic translation; P:regulation of defense response to virus by host; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:RNA secondary structure unwinding; P:small RNA loading onto RISC; P:targeting of mRNA for destruction involved in RNA interference;|Q08211 B2RNV4 Q05CI5 Q12803 Q32Q22 Q5VY62 Q6PD69 Q99556,ATP-dependent RNA helicase A {ECO:0000305},DEAH box protein 9;DExH-box helicase 9 {ECO:0000312|HGNC:HGNC:2750};Leukophysin {ECO:0000303|PubMed:8690889};Nuclear DNA helicase II {ECO:0000303|PubMed:1537828, ECO:0000303|PubMed:8344961, ECO:0000303|PubMed:9111062};RNA helicase A {ECO:0000303|PubMed:9111062};, PF00270;PF00035;PF04408;PF00271;PF07717;, GO:0015629;GO:0005813;GO:0070937;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0016604;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0042788;GO:0005844;GO:0032991;GO:1990904;GO:0016442;GO:0070578;GO:0043138;GO:0033679;GO:0034458;GO:0005524;GO:0016887;GO:0031490;GO:0003677;GO:0003678;GO:0003688;GO:0003690;GO:0003725;GO:0061676;GO:0046872;GO:0003729;GO:0017111;GO:0047429;GO:1905538;GO:1990841;GO:0001069;GO:1905172;GO:0003723;GO:0003724;GO:0070063;GO:0000978;GO:0000993;GO:0001085;GO:0035613;GO:1990825;GO:1990518;GO:0003697;GO:0003727;GO:0035197;GO:0003713;GO:0003712;GO:0045142;GO:0000380;GO:0034622;GO:0071360;GO:0071356;GO:0070934;GO:0032508;GO:0006260;GO:0006353;GO:0039695;GO:0044806;GO:0006954;GO:0045087;GO:0000398;GO:0051028;GO:0001649;GO:2000767;GO:0045739;GO:0045740;GO:2000373;GO:0048146;GO:2000637;GO:0050729;GO:0045089;GO:0032727;GO:0032728;GO:0032741;GO:0032755;GO:0051092;GO:1905698;GO:0060760;GO:0046833;GO:0045944;GO:0032760;GO:0032481;GO:0050434;GO:1904973;GO:1903608;GO:0070269;GO:2000765;GO:0050691;GO:0050684;GO:0006357;GO:0048511;GO:0010501;GO:0070922;GO:0030423;, C:actin cytoskeleton; C:centrosome; C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nuclear body; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:polysomal ribosome; C:polysome; C:protein-containing complex; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity; F:3'-5' RNA helicase activity; F:ATP binding; F:ATPase activity; F:chromatin DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:double-stranded DNA binding; F:double-stranded RNA binding; F:importin-alpha family protein binding; F:metal ion binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:polysome binding; F:promoter-specific chromatin binding; F:regulatory region RNA binding; F:RISC complex binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II transcription factor binding; F:RNA stem-loop binding; F:sequence-specific mRNA binding; F:single-stranded 3'-5' DNA helicase activity; F:single-stranded DNA binding; F:single-stranded RNA binding; F:siRNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:triplex DNA binding;, P:alternative mRNA splicing, via spliceosome; P:cellular protein-containing complex assembly; P:cellular response to exogenous dsRNA; P:cellular response to tumor necrosis factor; P:CRD-mediated mRNA stabilization; P:DNA duplex unwinding; P:DNA replication; P:DNA-templated transcription, termination; P:DNA-templated viral transcription; P:G-quadruplex DNA unwinding; P:inflammatory response; P:innate immune response; P:mRNA splicing, via spliceosome; P:mRNA transport; P:osteoblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of fibroblast proliferation; P:positive regulation of gene silencing by miRNA; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-18 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of polysome binding; P:positive regulation of response to cytokine stimulus; P:positive regulation of RNA export from nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:positive regulation of viral translation; P:protein localization to cytoplasmic stress granule; P:pyroptosis; P:regulation of cytoplasmic translation; P:regulation of defense response to virus by host; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:RNA secondary structure unwinding; P:small RNA loading onto RISC; P:targeting of mRNA for destruction involved in RNA interference;|Q08211 B2RNV4 Q05CI5 Q12803 Q32Q22 Q5VY62 Q6PD69 Q99556,ATP-dependent RNA helicase A {ECO:0000305},DEAH box protein 9;DExH-box helicase 9 {ECO:0000312|HGNC:HGNC:2750};Leukophysin {ECO:0000303|PubMed:8690889};Nuclear DNA helicase II {ECO:0000303|PubMed:1537828, ECO:0000303|PubMed:8344961, ECO:0000303|PubMed:9111062};RNA helicase A {ECO:0000303|PubMed:9111062};, PF00270;PF00035;PF04408;PF00271;PF07717;, GO:0015629;GO:0005813;GO:0070937;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0016604;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0042788;GO:0005844;GO:0032991;GO:1990904;GO:0016442;GO:0070578;GO:0043138;GO:0033679;GO:0034458;GO:0005524;GO:0016887;GO:0031490;GO:0003677;GO:0003678;GO:0003688;GO:0003690;GO:0003725;GO:0061676;GO:0046872;GO:0003729;GO:0017111;GO:0047429;GO:1905538;GO:1990841;GO:0001069;GO:1905172;GO:0003723;GO:0003724;GO:0070063;GO:0000978;GO:0000993;GO:0001085;GO:0035613;GO:1990825;GO:1990518;GO:0003697;GO:0003727;GO:0035197;GO:0003713;GO:0003712;GO:0045142;GO:0000380;GO:0034622;GO:0071360;GO:0071356;GO:0070934;GO:0032508;GO:0006260;GO:0006353;GO:0039695;GO:0044806;GO:0006954;GO:0045087;GO:0000398;GO:0051028;GO:0001649;GO:2000767;GO:0045739;GO:0045740;GO:2000373;GO:0048146;GO:2000637;GO:0050729;GO:0045089;GO:0032727;GO:0032728;GO:0032741;GO:0032755;GO:0051092;GO:1905698;GO:0060760;GO:0046833;GO:0045944;GO:0032760;GO:0032481;GO:0050434;GO:1904973;GO:1903608;GO:0070269;GO:2000765;GO:0050691;GO:0050684;GO:0006357;GO:0048511;GO:0010501;GO:0070922;GO:0030423;, C:actin cytoskeleton; C:centrosome; C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nuclear body; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:polysomal ribosome; C:polysome; C:protein-containing complex; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity; F:3'-5' RNA helicase activity; F:ATP binding; F:ATPase activity; F:chromatin DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:double-stranded DNA binding; F:double-stranded RNA binding; F:importin-alpha family protein binding; F:metal ion binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:polysome binding; F:promoter-specific chromatin binding; F:regulatory region RNA binding; F:RISC complex binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II transcription factor binding; F:RNA stem-loop binding; F:sequence-specific mRNA binding; F:single-stranded 3'-5' DNA helicase activity; F:single-stranded DNA binding; F:single-stranded RNA binding; F:siRNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:triplex DNA binding;, P:alternative mRNA splicing, via spliceosome; P:cellular protein-containing complex assembly; P:cellular response to exogenous dsRNA; P:cellular response to tumor necrosis factor; P:CRD-mediated mRNA stabilization; P:DNA duplex unwinding; P:DNA replication; P:DNA-templated transcription, termination; P:DNA-templated viral transcription; P:G-quadruplex DNA unwinding; P:inflammatory response; P:innate immune response; P:mRNA splicing, via spliceosome; P:mRNA transport; P:osteoblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of fibroblast proliferation; P:positive regulation of gene silencing by miRNA; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-18 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of polysome binding; P:positive regulation of response to cytokine stimulus; P:positive regulation of RNA export from nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:positive regulation of viral translation; P:protein localization to cytoplasmic stress granule; P:pyroptosis; P:regulation of cytoplasmic translation; P:regulation of defense response to virus by host; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:RNA secondary structure unwinding; P:small RNA loading onto RISC; P:targeting of mRNA for destruction involved in RNA interference;|Q08211 B2RNV4 Q05CI5 Q12803 Q32Q22 Q5VY62 Q6PD69 Q99556,ATP-dependent RNA helicase A {ECO:0000305},DEAH box protein 9;DExH-box helicase 9 {ECO:0000312|HGNC:HGNC:2750};Leukophysin {ECO:0000303|PubMed:8690889};Nuclear DNA helicase II {ECO:0000303|PubMed:1537828, ECO:0000303|PubMed:8344961, ECO:0000303|PubMed:9111062};RNA helicase A {ECO:0000303|PubMed:9111062};, PF00270;PF00035;PF04408;PF00271;PF07717;, GO:0015629;GO:0005813;GO:0070937;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0016604;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0042788;GO:0005844;GO:0032991;GO:1990904;GO:0016442;GO:0070578;GO:0043138;GO:0033679;GO:0034458;GO:0005524;GO:0016887;GO:0031490;GO:0003677;GO:0003678;GO:0003688;GO:0003690;GO:0003725;GO:0061676;GO:0046872;GO:0003729;GO:0017111;GO:0047429;GO:1905538;GO:1990841;GO:0001069;GO:1905172;GO:0003723;GO:0003724;GO:0070063;GO:0000978;GO:0000993;GO:0001085;GO:0035613;GO:1990825;GO:1990518;GO:0003697;GO:0003727;GO:0035197;GO:0003713;GO:0003712;GO:0045142;GO:0000380;GO:0034622;GO:0071360;GO:0071356;GO:0070934;GO:0032508;GO:0006260;GO:0006353;GO:0039695;GO:0044806;GO:0006954;GO:0045087;GO:0000398;GO:0051028;GO:0001649;GO:2000767;GO:0045739;GO:0045740;GO:2000373;GO:0048146;GO:2000637;GO:0050729;GO:0045089;GO:0032727;GO:0032728;GO:0032741;GO:0032755;GO:0051092;GO:1905698;GO:0060760;GO:0046833;GO:0045944;GO:0032760;GO:0032481;GO:0050434;GO:1904973;GO:1903608;GO:0070269;GO:2000765;GO:0050691;GO:0050684;GO:0006357;GO:0048511;GO:0010501;GO:0070922;GO:0030423;, C:actin cytoskeleton; C:centrosome; C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nuclear body; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:polysomal ribosome; C:polysome; C:protein-containing complex; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity; F:3'-5' RNA helicase activity; F:ATP binding; F:ATPase activity; F:chromatin DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:double-stranded DNA binding; F:double-stranded RNA binding; F:importin-alpha family protein binding; F:metal ion binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:polysome binding; F:promoter-specific chromatin binding; F:regulatory region RNA binding; F:RISC complex binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II transcription factor binding; F:RNA stem-loop binding; F:sequence-specific mRNA binding; F:single-stranded 3'-5' DNA helicase activity; F:single-stranded DNA binding; F:single-stranded RNA binding; F:siRNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:triplex DNA binding;, P:alternative mRNA splicing, via spliceosome; P:cellular protein-containing complex assembly; P:cellular response to exogenous dsRNA; P:cellular response to tumor necrosis factor; P:CRD-mediated mRNA stabilization; P:DNA duplex unwinding; P:DNA replication; P:DNA-templated transcription, termination; P:DNA-templated viral transcription; P:G-quadruplex DNA unwinding; P:inflammatory response; P:innate immune response; P:mRNA splicing, via spliceosome; P:mRNA transport; P:osteoblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of fibroblast proliferation; P:positive regulation of gene silencing by miRNA; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-18 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of polysome binding; P:positive regulation of response to cytokine stimulus; P:positive regulation of RNA export from nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:positive regulation of viral translation; P:protein localization to cytoplasmic stress granule; P:pyroptosis; P:regulation of cytoplasmic translation; P:regulation of defense response to virus by host; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:RNA secondary structure unwinding; P:small RNA loading onto RISC; P:targeting of mRNA for destruction involved in RNA interference;|Q08211 B2RNV4 Q05CI5 Q12803 Q32Q22 Q5VY62 Q6PD69 Q99556,ATP-dependent RNA helicase A {ECO:0000305},DEAH box protein 9;DExH-box helicase 9 {ECO:0000312|HGNC:HGNC:2750};Leukophysin {ECO:0000303|PubMed:8690889};Nuclear DNA helicase II {ECO:0000303|PubMed:1537828, ECO:0000303|PubMed:8344961, ECO:0000303|PubMed:9111062};RNA helicase A {ECO:0000303|PubMed:9111062};, PF00270;PF00035;PF04408;PF00271;PF07717;, GO:0015629;GO:0005813;GO:0070937;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0016604;GO:0097165;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0042788;GO:0005844;GO:0032991;GO:1990904;GO:0016442;GO:0070578;GO:0043138;GO:0033679;GO:0034458;GO:0005524;GO:0016887;GO:0031490;GO:0003677;GO:0003678;GO:0003688;GO:0003690;GO:0003725;GO:0061676;GO:0046872;GO:0003729;GO:0017111;GO:0047429;GO:1905538;GO:1990841;GO:0001069;GO:1905172;GO:0003723;GO:0003724;GO:0070063;GO:0000978;GO:0000993;GO:0001085;GO:0035613;GO:1990825;GO:1990518;GO:0003697;GO:0003727;GO:0035197;GO:0003713;GO:0003712;GO:0045142;GO:0000380;GO:0034622;GO:0071360;GO:0071356;GO:0070934;GO:0032508;GO:0006260;GO:0006353;GO:0039695;GO:0044806;GO:0006954;GO:0045087;GO:0000398;GO:0051028;GO:0001649;GO:2000767;GO:0045739;GO:0045740;GO:2000373;GO:0048146;GO:2000637;GO:0050729;GO:0045089;GO:0032727;GO:0032728;GO:0032741;GO:0032755;GO:0051092;GO:1905698;GO:0060760;GO:0046833;GO:0045944;GO:0032760;GO:0032481;GO:0050434;GO:1904973;GO:1903608;GO:0070269;GO:2000765;GO:0050691;GO:0050684;GO:0006357;GO:0048511;GO:0010501;GO:0070922;GO:0030423;, C:actin cytoskeleton; C:centrosome; C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nuclear body; C:nuclear stress granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:polysomal ribosome; C:polysome; C:protein-containing complex; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:3'-5' DNA helicase activity; F:3'-5' DNA/RNA helicase activity; F:3'-5' RNA helicase activity; F:ATP binding; F:ATPase activity; F:chromatin DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:double-stranded DNA binding; F:double-stranded RNA binding; F:importin-alpha family protein binding; F:metal ion binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:polysome binding; F:promoter-specific chromatin binding; F:regulatory region RNA binding; F:RISC complex binding; F:RNA binding; F:RNA helicase activity; F:RNA polymerase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II transcription factor binding; F:RNA stem-loop binding; F:sequence-specific mRNA binding; F:single-stranded 3'-5' DNA helicase activity; F:single-stranded DNA binding; F:single-stranded RNA binding; F:siRNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:triplex DNA binding;, P:alternative mRNA splicing, via spliceosome; P:cellular protein-containing complex assembly; P:cellular response to exogenous dsRNA; P:cellular response to tumor necrosis factor; P:CRD-mediated mRNA stabilization; P:DNA duplex unwinding; P:DNA replication; P:DNA-templated transcription, termination; P:DNA-templated viral transcription; P:G-quadruplex DNA unwinding; P:inflammatory response; P:innate immune response; P:mRNA splicing, via spliceosome; P:mRNA transport; P:osteoblast differentiation; P:positive regulation of cytoplasmic translation; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of fibroblast proliferation; P:positive regulation of gene silencing by miRNA; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-18 production; P:positive regulation of interleukin-6 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of polysome binding; P:positive regulation of response to cytokine stimulus; P:positive regulation of RNA export from nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:positive regulation of viral translation; P:protein localization to cytoplasmic stress granule; P:pyroptosis; P:regulation of cytoplasmic translation; P:regulation of defense response to virus by host; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:RNA secondary structure unwinding; P:small RNA loading onto RISC; P:targeting of mRNA for destruction involved in RNA interference; scaffold34 indexed_genome mRNA 11231556 11271838 . - . ID=transcript_7154;Q9BXD5 B2R839 Q4G0Q8 Q4G0Z2 Q64L88 Q6PEL0,N-acetylneuraminate lyase,N-acetylneuraminate pyruvate-lyase;N-acetylneuraminic acid aldolase;Sialate lyase;Sialate-pyruvate lyase;Sialic acid aldolase;Sialic acid lyase;, PF00701;, GO:0005829;GO:0042802;GO:0008747;GO:0005975;GO:0019262;, C:cytosol;, F:identical protein binding; F:N-acetylneuraminate lyase activity;, P:carbohydrate metabolic process; P:N-acetylneuraminate catabolic process; scaffold34 indexed_genome mRNA 11322013 11406868 . + . ID=transcript_7155;P57771 B4DGL9 Q3SYD2,Regulator of G-protein signaling 8,, PF00615;, GO:0030425;GO:0031234;GO:0032809;GO:0005634;GO:0043204;GO:0005886;GO:0045202;GO:0005096;GO:0007213;GO:0007186;GO:0009968;GO:0043547;GO:0060159;, C:dendrite; C:extrinsic component of cytoplasmic side of plasma membrane; C:neuronal cell body membrane; C:nucleus; C:perikaryon; C:plasma membrane; C:synapse;, F:GTPase activator activity;, P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of dopamine receptor signaling pathway; scaffold34 indexed_genome mRNA 11407379 11412681 . + . ID=transcript_7156;P57771 B4DGL9 Q3SYD2,Regulator of G-protein signaling 8,, PF00615;, GO:0030425;GO:0031234;GO:0032809;GO:0005634;GO:0043204;GO:0005886;GO:0045202;GO:0005096;GO:0007213;GO:0007186;GO:0009968;GO:0043547;GO:0060159;, C:dendrite; C:extrinsic component of cytoplasmic side of plasma membrane; C:neuronal cell body membrane; C:nucleus; C:perikaryon; C:plasma membrane; C:synapse;, F:GTPase activator activity;, P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of dopamine receptor signaling pathway; scaffold34 indexed_genome mRNA 11455960 11461576 . + . ID=transcript_7157;O15492 B2R4M4 Q5VYN9 Q99701,Regulator of G-protein signaling 16,A28-RGS14P;Retinal-specific RGS;Retinally abundant regulator of G-protein signaling;, PF00615;, GO:0005737;GO:0031224;GO:0005886;GO:0005516;GO:0005096;GO:0007186;GO:0009968;GO:0043547;GO:0008277;GO:0007601;, C:cytoplasm; C:intrinsic component of membrane; C:plasma membrane;, F:calmodulin binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of G protein-coupled receptor signaling pathway; P:visual perception;|O15492 B2R4M4 Q5VYN9 Q99701,Regulator of G-protein signaling 16,A28-RGS14P;Retinal-specific RGS;Retinally abundant regulator of G-protein signaling;, PF00615;, GO:0005737;GO:0031224;GO:0005886;GO:0005516;GO:0005096;GO:0007186;GO:0009968;GO:0043547;GO:0008277;GO:0007601;, C:cytoplasm; C:intrinsic component of membrane; C:plasma membrane;, F:calmodulin binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of G protein-coupled receptor signaling pathway; P:visual perception; scaffold34 indexed_genome mRNA 11471466 11493896 . + . ID=transcript_7158;Q05823 Q5W0L2 Q6AI46,2-5A-dependent ribonuclease,Ribonuclease 4;Ribonuclease L;, PF12796;PF00069;PF06479;, GO:0005829;GO:0005759;GO:0016363;GO:0005524;GO:0004521;GO:0042802;GO:0046872;GO:0004672;GO:0004540;GO:0043021;GO:0003723;GO:0019843;GO:0051607;GO:0045444;GO:0006397;GO:0045071;GO:0046326;GO:0045944;GO:0006468;GO:0043488;GO:0060338;GO:0006396;GO:0006364;GO:0060337;, C:cytosol; C:mitochondrial matrix; C:nuclear matrix;, F:ATP binding; F:endoribonuclease activity; F:identical protein binding; F:metal ion binding; F:protein kinase activity; F:ribonuclease activity; F:ribonucleoprotein complex binding; F:RNA binding; F:rRNA binding;, P:defense response to virus; P:fat cell differentiation; P:mRNA processing; P:negative regulation of viral genome replication; P:positive regulation of glucose import; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of mRNA stability; P:regulation of type I interferon-mediated signaling pathway; P:RNA processing; P:rRNA processing; P:type I interferon signaling pathway; scaffold34 indexed_genome mRNA 11622688 11630934 . + . ID=transcript_7159;P15104 Q499Y9 Q5T9Z1 Q7Z3W4 Q8IZ17,Glutamine synthetase {ECO:0000303|PubMed:2888076, ECO:0000303|PubMed:30158707},Glutamate--ammonia ligase {ECO:0000305};Palmitoyltransferase GLUL {ECO:0000305};, PF00120;PF03951;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004356;GO:0042802;GO:0046872;GO:0019706;GO:0001525;GO:0008283;GO:0006538;GO:0006542;GO:0009064;GO:0001504;GO:0018345;GO:0010594;GO:1904749;GO:1903670;GO:0042254;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:glutamate-ammonia ligase activity; F:identical protein binding; F:metal ion binding; F:protein-cysteine S-palmitoyltransferase activity;, P:angiogenesis; P:cell population proliferation; P:glutamate catabolic process; P:glutamine biosynthetic process; P:glutamine family amino acid metabolic process; P:neurotransmitter uptake; P:protein palmitoylation; P:regulation of endothelial cell migration; P:regulation of protein localization to nucleolus; P:regulation of sprouting angiogenesis; P:ribosome biogenesis;|P15104 Q499Y9 Q5T9Z1 Q7Z3W4 Q8IZ17,Glutamine synthetase {ECO:0000303|PubMed:2888076, ECO:0000303|PubMed:30158707},Glutamate--ammonia ligase {ECO:0000305};Palmitoyltransferase GLUL {ECO:0000305};, PF00120;PF03951;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004356;GO:0042802;GO:0046872;GO:0019706;GO:0001525;GO:0008283;GO:0006538;GO:0006542;GO:0009064;GO:0001504;GO:0018345;GO:0010594;GO:1904749;GO:1903670;GO:0042254;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:glutamate-ammonia ligase activity; F:identical protein binding; F:metal ion binding; F:protein-cysteine S-palmitoyltransferase activity;, P:angiogenesis; P:cell population proliferation; P:glutamate catabolic process; P:glutamine biosynthetic process; P:glutamine family amino acid metabolic process; P:neurotransmitter uptake; P:protein palmitoylation; P:regulation of endothelial cell migration; P:regulation of protein localization to nucleolus; P:regulation of sprouting angiogenesis; P:ribosome biogenesis;|P15104 Q499Y9 Q5T9Z1 Q7Z3W4 Q8IZ17,Glutamine synthetase {ECO:0000303|PubMed:2888076, ECO:0000303|PubMed:30158707},Glutamate--ammonia ligase {ECO:0000305};Palmitoyltransferase GLUL {ECO:0000305};, PF00120;PF03951;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004356;GO:0042802;GO:0046872;GO:0019706;GO:0001525;GO:0008283;GO:0006538;GO:0006542;GO:0009064;GO:0001504;GO:0018345;GO:0010594;GO:1904749;GO:1903670;GO:0042254;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:glutamate-ammonia ligase activity; F:identical protein binding; F:metal ion binding; F:protein-cysteine S-palmitoyltransferase activity;, P:angiogenesis; P:cell population proliferation; P:glutamate catabolic process; P:glutamine biosynthetic process; P:glutamine family amino acid metabolic process; P:neurotransmitter uptake; P:protein palmitoylation; P:regulation of endothelial cell migration; P:regulation of protein localization to nucleolus; P:regulation of sprouting angiogenesis; P:ribosome biogenesis;|P15104 Q499Y9 Q5T9Z1 Q7Z3W4 Q8IZ17,Glutamine synthetase {ECO:0000303|PubMed:2888076, ECO:0000303|PubMed:30158707},Glutamate--ammonia ligase {ECO:0000305};Palmitoyltransferase GLUL {ECO:0000305};, PF00120;PF03951;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004356;GO:0042802;GO:0046872;GO:0019706;GO:0001525;GO:0008283;GO:0006538;GO:0006542;GO:0009064;GO:0001504;GO:0018345;GO:0010594;GO:1904749;GO:1903670;GO:0042254;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:glutamate-ammonia ligase activity; F:identical protein binding; F:metal ion binding; F:protein-cysteine S-palmitoyltransferase activity;, P:angiogenesis; P:cell population proliferation; P:glutamate catabolic process; P:glutamine biosynthetic process; P:glutamine family amino acid metabolic process; P:neurotransmitter uptake; P:protein palmitoylation; P:regulation of endothelial cell migration; P:regulation of protein localization to nucleolus; P:regulation of sprouting angiogenesis; P:ribosome biogenesis;|P15104 Q499Y9 Q5T9Z1 Q7Z3W4 Q8IZ17,Glutamine synthetase {ECO:0000303|PubMed:2888076, ECO:0000303|PubMed:30158707},Glutamate--ammonia ligase {ECO:0000305};Palmitoyltransferase GLUL {ECO:0000305};, PF00120;PF03951;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004356;GO:0042802;GO:0046872;GO:0019706;GO:0001525;GO:0008283;GO:0006538;GO:0006542;GO:0009064;GO:0001504;GO:0018345;GO:0010594;GO:1904749;GO:1903670;GO:0042254;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:glutamate-ammonia ligase activity; F:identical protein binding; F:metal ion binding; F:protein-cysteine S-palmitoyltransferase activity;, P:angiogenesis; P:cell population proliferation; P:glutamate catabolic process; P:glutamine biosynthetic process; P:glutamine family amino acid metabolic process; P:neurotransmitter uptake; P:protein palmitoylation; P:regulation of endothelial cell migration; P:regulation of protein localization to nucleolus; P:regulation of sprouting angiogenesis; P:ribosome biogenesis;|P15104 Q499Y9 Q5T9Z1 Q7Z3W4 Q8IZ17,Glutamine synthetase {ECO:0000303|PubMed:2888076, ECO:0000303|PubMed:30158707},Glutamate--ammonia ligase {ECO:0000305};Palmitoyltransferase GLUL {ECO:0000305};, PF00120;PF03951;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004356;GO:0042802;GO:0046872;GO:0019706;GO:0001525;GO:0008283;GO:0006538;GO:0006542;GO:0009064;GO:0001504;GO:0018345;GO:0010594;GO:1904749;GO:1903670;GO:0042254;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:glutamate-ammonia ligase activity; F:identical protein binding; F:metal ion binding; F:protein-cysteine S-palmitoyltransferase activity;, P:angiogenesis; P:cell population proliferation; P:glutamate catabolic process; P:glutamine biosynthetic process; P:glutamine family amino acid metabolic process; P:neurotransmitter uptake; P:protein palmitoylation; P:regulation of endothelial cell migration; P:regulation of protein localization to nucleolus; P:regulation of sprouting angiogenesis; P:ribosome biogenesis; scaffold34 indexed_genome mRNA 12133992 12201165 . - . ID=transcript_7160;Q15878 B1AM12 B1AM13 B1AM14 Q14580 Q14581,Voltage-dependent R-type calcium channel subunit alpha-1E,Brain calcium channel II;Calcium channel, L type, alpha-1 polypeptide, isoform 6;Voltage-gated calcium channel subunit alpha Cav2.3;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0005509;GO:0005245;GO:0022843;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050796;GO:0034765;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:calcium ion binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:regulation of insulin secretion; P:regulation of ion transmembrane transport;|Q15878 B1AM12 B1AM13 B1AM14 Q14580 Q14581,Voltage-dependent R-type calcium channel subunit alpha-1E,Brain calcium channel II;Calcium channel, L type, alpha-1 polypeptide, isoform 6;Voltage-gated calcium channel subunit alpha Cav2.3;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0005509;GO:0005245;GO:0022843;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050796;GO:0034765;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:calcium ion binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:regulation of insulin secretion; P:regulation of ion transmembrane transport;|Q15878 B1AM12 B1AM13 B1AM14 Q14580 Q14581,Voltage-dependent R-type calcium channel subunit alpha-1E,Brain calcium channel II;Calcium channel, L type, alpha-1 polypeptide, isoform 6;Voltage-gated calcium channel subunit alpha Cav2.3;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0005509;GO:0005245;GO:0022843;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050796;GO:0034765;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:calcium ion binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; scaffold34 indexed_genome mRNA 12201181 12435017 . - . ID=transcript_7161;Q15878 B1AM12 B1AM13 B1AM14 Q14580 Q14581,Voltage-dependent R-type calcium channel subunit alpha-1E,Brain calcium channel II;Calcium channel, L type, alpha-1 polypeptide, isoform 6;Voltage-gated calcium channel subunit alpha Cav2.3;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0005509;GO:0005245;GO:0022843;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050796;GO:0034765;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:calcium ion binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; scaffold34 indexed_genome mRNA 12892094 12900356 . - . ID=transcript_7162;Q9TQB3 Q9TQB9 Q9TQK3,Major histocompatibility complex class I-related gene protein,Class I histocompatibility antigen-like protein;, PF07654;PF00129;, GO:0031901;GO:0005783;GO:0005789;GO:0009897;GO:0005615;GO:0000139;GO:0016021;GO:0031902;GO:0042612;GO:0005886;GO:0030881;GO:0032393;GO:0042608;GO:0019884;GO:0002474;GO:0050829;GO:0050830;GO:0006955;GO:0045087;GO:0002854;GO:0033077;, C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi membrane; C:integral component of membrane; C:late endosome membrane; C:MHC class I protein complex; C:plasma membrane;, F:beta-2-microglobulin binding; F:MHC class I receptor activity; F:T cell receptor binding;, P:antigen processing and presentation of exogenous antigen; P:antigen processing and presentation of peptide antigen via MHC class I; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:immune response; P:innate immune response; P:positive regulation of T cell mediated cytotoxicity directed against tumor cell target; P:T cell differentiation in thymus; scaffold34 indexed_genome mRNA 12922403 12963912 . + . ID=transcript_7163;O43752 B2R652 B4DR17 Q5VY08 Q6FH83,Syntaxin-6,, PF05739;PF09177;, GO:0030136;GO:0005829;GO:0005769;GO:0012505;GO:0005794;GO:0000139;GO:0016021;GO:0030285;GO:0005654;GO:0048471;GO:0045335;GO:0005886;GO:0031201;GO:0005802;GO:0032588;GO:0005484;GO:0000149;GO:0019905;GO:0032456;GO:0007032;GO:0090161;GO:0048193;GO:0006886;GO:1903827;GO:0032880;GO:0042147;GO:0016189;GO:0048278;GO:0006906;, C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:endomembrane system; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:plasma membrane; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:endocytic recycling; P:endosome organization; P:Golgi ribbon formation; P:Golgi vesicle transport; P:intracellular protein transport; P:regulation of cellular protein localization; P:regulation of protein localization; P:retrograde transport, endosome to Golgi; P:synaptic vesicle to endosome fusion; P:vesicle docking; P:vesicle fusion; scaffold34 indexed_genome mRNA 12982389 13030359 . - . ID=transcript_7164;Q5VZ46 Q5VZ45 Q9HCF8,Uncharacterized protein KIAA1614,, PF15737;, GO:0016324;GO:0005938;GO:0005634;GO:0005080;GO:0007098;GO:0007163;GO:0060341;, C:apical plasma membrane; C:cell cortex; C:nucleus;, F:protein kinase C binding;, P:centrosome cycle; P:establishment or maintenance of cell polarity; P:regulation of cellular localization;|Q5VZ46 Q5VZ45 Q9HCF8,Uncharacterized protein KIAA1614,, PF15737;, GO:0016324;GO:0005938;GO:0005634;GO:0005080;GO:0007098;GO:0007163;GO:0060341;, C:apical plasma membrane; C:cell cortex; C:nucleus;, F:protein kinase C binding;, P:centrosome cycle; P:establishment or maintenance of cell polarity; P:regulation of cellular localization; scaffold34 indexed_genome mRNA 13053431 13247891 . - . ID=transcript_7165;Q9UBH6 O95719 Q7L8K9 Q8IW20 Q9NT19 Q9UFB9,Xenotropic and polytropic retrovirus receptor 1,Protein SYG1 homolog;Xenotropic and polytropic murine leukemia virus receptor X3;, PF03124;PF03105;, GO:0005737;GO:0005794;GO:0016021;GO:0031226;GO:0005886;GO:0015562;GO:0004930;GO:0000822;GO:0015114;GO:0038023;GO:0004888;GO:0001618;GO:0030643;GO:0016036;GO:0007186;GO:0035435;GO:0006817;GO:0009615;, C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:efflux transmembrane transporter activity; F:G protein-coupled receptor activity; F:inositol hexakisphosphate binding; F:phosphate ion transmembrane transporter activity; F:signaling receptor activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:cellular phosphate ion homeostasis; P:cellular response to phosphate starvation; P:G protein-coupled receptor signaling pathway; P:phosphate ion transmembrane transport; P:phosphate ion transport; P:response to virus;|Q9UBH6 O95719 Q7L8K9 Q8IW20 Q9NT19 Q9UFB9,Xenotropic and polytropic retrovirus receptor 1,Protein SYG1 homolog;Xenotropic and polytropic murine leukemia virus receptor X3;, PF03124;PF03105;, GO:0005737;GO:0005794;GO:0016021;GO:0031226;GO:0005886;GO:0015562;GO:0004930;GO:0000822;GO:0015114;GO:0038023;GO:0004888;GO:0001618;GO:0030643;GO:0016036;GO:0007186;GO:0035435;GO:0006817;GO:0009615;, C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:efflux transmembrane transporter activity; F:G protein-coupled receptor activity; F:inositol hexakisphosphate binding; F:phosphate ion transmembrane transporter activity; F:signaling receptor activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:cellular phosphate ion homeostasis; P:cellular response to phosphate starvation; P:G protein-coupled receptor signaling pathway; P:phosphate ion transmembrane transport; P:phosphate ion transport; P:response to virus; scaffold34 indexed_genome mRNA 13370155 13536594 . + . ID=transcript_7166;Q9BR61,Acyl-CoA-binding domain-containing protein 6,, PF00887;PF12796;, GO:0005829;GO:0000062;GO:0008289;GO:0006637;, C:cytosol;, F:fatty-acyl-CoA binding; F:lipid binding;, P:acyl-CoA metabolic process; scaffold34 indexed_genome mRNA 13651149 13691437 . - . ID=transcript_7167;O00391 Q59G29 Q5T2X0 Q8TDL6 Q8WVP4,Sulfhydryl oxidase 1,Quiescin Q6 {ECO:0000303|PubMed:10708601, ECO:0000303|PubMed:9878249};, PF04777;PF18371;PF18108;PF00085;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0030173;GO:0045171;GO:0043231;GO:0031093;GO:0035580;GO:1904724;GO:0071949;GO:0016971;GO:0003756;GO:0044267;GO:0085029;GO:0016242;GO:0043312;GO:0002576;GO:0043687;GO:0006457;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:platelet alpha granule lumen; C:specific granule lumen; C:tertiary granule lumen;, F:FAD binding; F:flavin-linked sulfhydryl oxidase activity; F:protein disulfide isomerase activity;, P:cellular protein metabolic process; P:extracellular matrix assembly; P:negative regulation of macroautophagy; P:neutrophil degranulation; P:platelet degranulation; P:post-translational protein modification; P:protein folding;|O00391 Q59G29 Q5T2X0 Q8TDL6 Q8WVP4,Sulfhydryl oxidase 1,Quiescin Q6 {ECO:0000303|PubMed:10708601, ECO:0000303|PubMed:9878249};, PF04777;PF18371;PF18108;PF00085;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0030173;GO:0045171;GO:0043231;GO:0031093;GO:0035580;GO:1904724;GO:0071949;GO:0016971;GO:0003756;GO:0044267;GO:0085029;GO:0016242;GO:0043312;GO:0002576;GO:0043687;GO:0006457;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:platelet alpha granule lumen; C:specific granule lumen; C:tertiary granule lumen;, F:FAD binding; F:flavin-linked sulfhydryl oxidase activity; F:protein disulfide isomerase activity;, P:cellular protein metabolic process; P:extracellular matrix assembly; P:negative regulation of macroautophagy; P:neutrophil degranulation; P:platelet degranulation; P:post-translational protein modification; P:protein folding; scaffold34 indexed_genome mRNA 13721639 13773078 . - . ID=transcript_7168;Q5VT06 O75068 Q8TDK3 Q8WY20,Centrosome-associated protein 350 {ECO:0000305},Centrosome-associated protein of 350 kDa {ECO:0000303|Ref.1};, PF01302;PF14309;, GO:0042995;GO:0005814;GO:0005813;GO:0005737;GO:0016020;GO:0005634;GO:0005819;GO:0008017;GO:0034453;GO:1905515;GO:0071539;, C:cell projection; C:centriole; C:centrosome; C:cytoplasm; C:membrane; C:nucleus; C:spindle;, F:microtubule binding;, P:microtubule anchoring; P:non-motile cilium assembly; P:protein localization to centrosome;|Q5VT06 O75068 Q8TDK3 Q8WY20,Centrosome-associated protein 350 {ECO:0000305},Centrosome-associated protein of 350 kDa {ECO:0000303|Ref.1};, PF01302;PF14309;, GO:0042995;GO:0005814;GO:0005813;GO:0005737;GO:0016020;GO:0005634;GO:0005819;GO:0008017;GO:0034453;GO:1905515;GO:0071539;, C:cell projection; C:centriole; C:centrosome; C:cytoplasm; C:membrane; C:nucleus; C:spindle;, F:microtubule binding;, P:microtubule anchoring; P:non-motile cilium assembly; P:protein localization to centrosome;|Q5VT06 O75068 Q8TDK3 Q8WY20,Centrosome-associated protein 350 {ECO:0000305},Centrosome-associated protein of 350 kDa {ECO:0000303|Ref.1};, PF01302;PF14309;, GO:0042995;GO:0005814;GO:0005813;GO:0005737;GO:0016020;GO:0005634;GO:0005819;GO:0008017;GO:0034453;GO:1905515;GO:0071539;, C:cell projection; C:centriole; C:centrosome; C:cytoplasm; C:membrane; C:nucleus; C:spindle;, F:microtubule binding;, P:microtubule anchoring; P:non-motile cilium assembly; P:protein localization to centrosome; scaffold34 indexed_genome mRNA 13908715 13949900 . - . ID=transcript_7169;Q5JTV8 A8K630 B0QZ57 Q5JTV6 Q8IZ65 Q9H8Y6 Q9HAJ1 Q9NV52 Q9Y3X5,Torsin-1A-interacting protein 1,Lamin-associated protein 1B;, PF05609;, GO:0016021;GO:0005637;GO:0031965;GO:0005634;GO:0001671;GO:0051117;GO:0008092;GO:0032781;GO:0034504;, C:integral component of membrane; C:nuclear inner membrane; C:nuclear membrane; C:nucleus;, F:ATPase activator activity; F:ATPase binding; F:cytoskeletal protein binding;, P:positive regulation of ATPase activity; P:protein localization to nucleus;|Q5JTV8 A8K630 B0QZ57 Q5JTV6 Q8IZ65 Q9H8Y6 Q9HAJ1 Q9NV52 Q9Y3X5,Torsin-1A-interacting protein 1,Lamin-associated protein 1B;, PF05609;, GO:0016021;GO:0005637;GO:0031965;GO:0005634;GO:0001671;GO:0051117;GO:0008092;GO:0032781;GO:0034504;, C:integral component of membrane; C:nuclear inner membrane; C:nuclear membrane; C:nucleus;, F:ATPase activator activity; F:ATPase binding; F:cytoskeletal protein binding;, P:positive regulation of ATPase activity; P:protein localization to nucleus; scaffold34 indexed_genome mRNA 13955475 13994491 . + . ID=transcript_7170;Q8NFQ8,Torsin-1A-interacting protein 2,Lumenal domain-like LAP1;, PF05609;, GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0001671;GO:0051117;GO:0007029;GO:0032781;GO:0090435;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, F:ATPase activator activity; F:ATPase binding;, P:endoplasmic reticulum organization; P:positive regulation of ATPase activity; P:protein localization to nuclear envelope;|Q9H496 Q05BU2,Torsin-1A-interacting protein 2, isoform IFRG15,15 kDa interferon-responsive protein; scaffold34 indexed_genome mRNA 14361736 14422390 . - . ID=transcript_7171;P35610 A6NC40 A8K3P4 A9Z1V7 B4DU95 Q5T0X4 Q8N1E4,Sterol O-acyltransferase 1 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase 1 {ECO:0000303|PubMed:11294643, ECO:0000303|PubMed:32433613, ECO:0000303|PubMed:32433614, ECO:0000303|PubMed:9020103};Cholesterol acyltransferase 1;, PF03062;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0015485;GO:0034736;GO:0000062;GO:0042802;GO:0008374;GO:0004772;GO:0033344;GO:0034435;GO:0042632;GO:0008203;GO:0010878;GO:0034383;GO:0010742;GO:0042986;GO:0034379;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:cholesterol binding; F:cholesterol O-acyltransferase activity; F:fatty-acyl-CoA binding; F:identical protein binding; F:O-acyltransferase activity; F:sterol O-acyltransferase activity;, P:cholesterol efflux; P:cholesterol esterification; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol storage; P:low-density lipoprotein particle clearance; P:macrophage derived foam cell differentiation; P:positive regulation of amyloid precursor protein biosynthetic process; P:very-low-density lipoprotein particle assembly;|P35610 A6NC40 A8K3P4 A9Z1V7 B4DU95 Q5T0X4 Q8N1E4,Sterol O-acyltransferase 1 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase 1 {ECO:0000303|PubMed:11294643, ECO:0000303|PubMed:32433613, ECO:0000303|PubMed:32433614, ECO:0000303|PubMed:9020103};Cholesterol acyltransferase 1;, PF03062;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0015485;GO:0034736;GO:0000062;GO:0042802;GO:0008374;GO:0004772;GO:0033344;GO:0034435;GO:0042632;GO:0008203;GO:0010878;GO:0034383;GO:0010742;GO:0042986;GO:0034379;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:cholesterol binding; F:cholesterol O-acyltransferase activity; F:fatty-acyl-CoA binding; F:identical protein binding; F:O-acyltransferase activity; F:sterol O-acyltransferase activity;, P:cholesterol efflux; P:cholesterol esterification; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol storage; P:low-density lipoprotein particle clearance; P:macrophage derived foam cell differentiation; P:positive regulation of amyloid precursor protein biosynthetic process; P:very-low-density lipoprotein particle assembly; scaffold34 indexed_genome mRNA 14569500 14576171 . + . ID=transcript_7172;Q7Z301,Tyrosine-protein kinase ABL2,Abelson murine leukemia viral oncogene homolog 2;Abelson tyrosine-protein kinase 2;Abelson-related gene protein;Tyrosine-protein kinase ARG;, PF08919;PF07714;PF00017;PF00018;, GO:0015629;GO:0005829;GO:0051015;GO:0003785;GO:0005524;GO:0000287;GO:0030145;GO:0004715;GO:0001784;GO:0004672;GO:0004713;GO:0004714;GO:0007155;GO:0006464;GO:0071300;GO:0019221;GO:0035640;GO:0035024;GO:0018108;GO:0007204;GO:0010976;GO:0051353;GO:0010863;GO:2000249;GO:0010506;GO:0030155;GO:2000145;GO:0030100;GO:0007165;, C:actin cytoskeleton; C:cytosol;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell adhesion; P:cellular protein modification process; P:cellular response to retinoic acid; P:cytokine-mediated signaling pathway; P:exploration behavior; P:negative regulation of Rho protein signal transduction; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of neuron projection development; P:positive regulation of oxidoreductase activity; P:positive regulation of phospholipase C activity; P:regulation of actin cytoskeleton reorganization; P:regulation of autophagy; P:regulation of cell adhesion; P:regulation of cell motility; P:regulation of endocytosis; P:signal transduction; scaffold34 indexed_genome mRNA 14576200 14582595 . + . ID=transcript_7173;Q7Z301,Tyrosine-protein kinase ABL2,Abelson murine leukemia viral oncogene homolog 2;Abelson tyrosine-protein kinase 2;Abelson-related gene protein;Tyrosine-protein kinase ARG;, PF08919;PF07714;PF00017;PF00018;, GO:0015629;GO:0005829;GO:0051015;GO:0003785;GO:0005524;GO:0000287;GO:0030145;GO:0004715;GO:0001784;GO:0004672;GO:0004713;GO:0004714;GO:0007155;GO:0006464;GO:0071300;GO:0019221;GO:0035640;GO:0035024;GO:0018108;GO:0007204;GO:0010976;GO:0051353;GO:0010863;GO:2000249;GO:0010506;GO:0030155;GO:2000145;GO:0030100;GO:0007165;, C:actin cytoskeleton; C:cytosol;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell adhesion; P:cellular protein modification process; P:cellular response to retinoic acid; P:cytokine-mediated signaling pathway; P:exploration behavior; P:negative regulation of Rho protein signal transduction; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of neuron projection development; P:positive regulation of oxidoreductase activity; P:positive regulation of phospholipase C activity; P:regulation of actin cytoskeleton reorganization; P:regulation of autophagy; P:regulation of cell adhesion; P:regulation of cell motility; P:regulation of endocytosis; P:signal transduction;|Q7Z301,Tyrosine-protein kinase ABL2,Abelson murine leukemia viral oncogene homolog 2;Abelson tyrosine-protein kinase 2;Abelson-related gene protein;Tyrosine-protein kinase ARG;, PF08919;PF07714;PF00017;PF00018;, GO:0015629;GO:0005829;GO:0051015;GO:0003785;GO:0005524;GO:0000287;GO:0030145;GO:0004715;GO:0001784;GO:0004672;GO:0004713;GO:0004714;GO:0007155;GO:0006464;GO:0071300;GO:0019221;GO:0035640;GO:0035024;GO:0018108;GO:0007204;GO:0010976;GO:0051353;GO:0010863;GO:2000249;GO:0010506;GO:0030155;GO:2000145;GO:0030100;GO:0007165;, C:actin cytoskeleton; C:cytosol;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell adhesion; P:cellular protein modification process; P:cellular response to retinoic acid; P:cytokine-mediated signaling pathway; P:exploration behavior; P:negative regulation of Rho protein signal transduction; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of neuron projection development; P:positive regulation of oxidoreductase activity; P:positive regulation of phospholipase C activity; P:regulation of actin cytoskeleton reorganization; P:regulation of autophagy; P:regulation of cell adhesion; P:regulation of cell motility; P:regulation of endocytosis; P:signal transduction; scaffold34 indexed_genome mRNA 14582758 14588926 . + . ID=transcript_7174;Q7Z301,Tyrosine-protein kinase ABL2,Abelson murine leukemia viral oncogene homolog 2;Abelson tyrosine-protein kinase 2;Abelson-related gene protein;Tyrosine-protein kinase ARG;, PF08919;PF07714;PF00017;PF00018;, GO:0015629;GO:0005829;GO:0051015;GO:0003785;GO:0005524;GO:0000287;GO:0030145;GO:0004715;GO:0001784;GO:0004672;GO:0004713;GO:0004714;GO:0007155;GO:0006464;GO:0071300;GO:0019221;GO:0035640;GO:0035024;GO:0018108;GO:0007204;GO:0010976;GO:0051353;GO:0010863;GO:2000249;GO:0010506;GO:0030155;GO:2000145;GO:0030100;GO:0007165;, C:actin cytoskeleton; C:cytosol;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell adhesion; P:cellular protein modification process; P:cellular response to retinoic acid; P:cytokine-mediated signaling pathway; P:exploration behavior; P:negative regulation of Rho protein signal transduction; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of neuron projection development; P:positive regulation of oxidoreductase activity; P:positive regulation of phospholipase C activity; P:regulation of actin cytoskeleton reorganization; P:regulation of autophagy; P:regulation of cell adhesion; P:regulation of cell motility; P:regulation of endocytosis; P:signal transduction; scaffold34 indexed_genome mRNA 14592633 14620906 . - . ID=transcript_7175;Q9H497 B4DSY0 B7ZB65 Q5M7Y7 Q8WVA7 Q8WWM2 Q9H495 Q9H6E7,Torsin-3A,ATP-dependent interferon-responsive protein;Torsin family 3 member A;, PF06309;, GO:0005783;GO:0005788;GO:0070062;GO:0005635;GO:0005524;GO:0016887;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:nuclear envelope;, F:ATP binding; F:ATPase activity;|Q9H497 B4DSY0 B7ZB65 Q5M7Y7 Q8WVA7 Q8WWM2 Q9H495 Q9H6E7,Torsin-3A,ATP-dependent interferon-responsive protein;Torsin family 3 member A;, PF06309;, GO:0005783;GO:0005788;GO:0070062;GO:0005635;GO:0005524;GO:0016887;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:nuclear envelope;, F:ATP binding; F:ATPase activity; scaffold34 indexed_genome mRNA 14622601 14662926 . - . ID=transcript_7176;O75063 Q5W0C3 Q5W0C4,Glycosaminoglycan xylosylkinase,Xylose kinase;, PF06702;, GO:0005794;GO:0000139;GO:0016021;GO:0005654;GO:0005524;GO:0016301;GO:0046872;GO:0016773;GO:0030166;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleoplasm;, F:ATP binding; F:kinase activity; F:metal ion binding; F:phosphotransferase activity, alcohol group as acceptor;, P:proteoglycan biosynthetic process; scaffold34 indexed_genome mRNA 14760505 14773917 . - . ID=transcript_7177;Q86X27 B7Z7B1 Q5T5Z1 Q5VZ67 Q9NW78,Ras-specific guanine nucleotide-releasing factor RalGPS2,Ral GEF with PH domain and SH3-binding motif 2;RalA exchange factor RalGPS2;, PF00169;PF00617;, GO:0005737;GO:0005886;GO:0005085;GO:0032485;GO:0007264;, C:cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Ral protein signal transduction; P:small GTPase mediated signal transduction; scaffold34 indexed_genome mRNA 14774876 14868329 . - . ID=transcript_7178;Q86X27 B7Z7B1 Q5T5Z1 Q5VZ67 Q9NW78,Ras-specific guanine nucleotide-releasing factor RalGPS2,Ral GEF with PH domain and SH3-binding motif 2;RalA exchange factor RalGPS2;, PF00169;PF00617;, GO:0005737;GO:0005886;GO:0005085;GO:0032485;GO:0007264;, C:cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Ral protein signal transduction; P:small GTPase mediated signal transduction;|Q86X27 B7Z7B1 Q5T5Z1 Q5VZ67 Q9NW78,Ras-specific guanine nucleotide-releasing factor RalGPS2,Ral GEF with PH domain and SH3-binding motif 2;RalA exchange factor RalGPS2;, PF00169;PF00617;, GO:0005737;GO:0005886;GO:0005085;GO:0032485;GO:0007264;, C:cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Ral protein signal transduction; P:small GTPase mediated signal transduction;|O95841 Q5T5Z5,Angiopoietin-related protein 1,Angiopoietin-3;Angiopoietin-like protein 1;, PF00147;, GO:0062023;GO:0070062;GO:0005615;GO:0005102;GO:0001525;GO:0007169;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space;, F:signaling receptor binding;, P:angiogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold34 indexed_genome mRNA 15008027 15009749 . + . ID=transcript_7179;Q3ZCU0 Q8N9C3,Protein GVQW3 {ECO:0000305},GVQW motif-containing protein 3 {ECO:0000305};, PF17906; scaffold34 indexed_genome mRNA 15088896 15094577 . - . ID=transcript_7180;Q5T0J7 Q5T0J8 Q5T0J9 Q8IYU6 Q8N7Z1 Q8NA15 Q9H0Q7,Testis-expressed protein 35,, PF15079;, GO:0015630;GO:0005634;, C:microtubule cytoskeleton; C:nucleus; scaffold34 indexed_genome mRNA 15127725 15129850 . + . ID=transcript_7181;Q6ZU45 A0A1B0GWE9,Putative C-type lectin domain family 20 member A,, PF00059;, GO:0030246;, , F:carbohydrate binding; scaffold34 indexed_genome mRNA 15137267 15233877 . - . ID=transcript_7182;Q9UJF2 F8W755 O95174 Q2TB22 Q5TFU9,Ras GTPase-activating protein nGAP,RAS protein activator-like 2;, PF00168;PF12004;PF00616;, GO:0005829;GO:0005096;GO:0000165;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:MAPK cascade; P:signal transduction; scaffold34 indexed_genome mRNA 15651329 15697419 . + . ID=transcript_7183;Q96JE7 A3EYF1 Q5HYF6 Q8N7D6 Q96GX6,Protein transport protein Sec16B,Leucine zipper transcription regulator 2;Regucalcin gene promoter region-related protein p117;SEC16 homolog B;, PF12932;PF12931;, GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000139;GO:0043231;GO:0006914;GO:0048208;GO:0007029;GO:0006888;GO:0007030;GO:0016559;GO:0007031;GO:0010628;GO:0070863;GO:0070973;GO:0015031;, C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle;, , P:autophagy; P:COPII vesicle coating; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:peroxisome fission; P:peroxisome organization; P:positive regulation of gene expression; P:positive regulation of protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein transport; scaffold34 indexed_genome mRNA 16459233 16482635 . - . ID=transcript_7184;Q9C0B6 O95560 Q6ZWC1 Q7LCZ9 Q8N360,BMP/retinoic acid-inducible neural-specific protein 2,DBCCR1-like protein 2;, PF19052;PF01823;, GO:0030425;GO:0005783;GO:0005576;GO:0043025;GO:0007050;GO:0071300;GO:0045930;GO:0045666;, C:dendrite; C:endoplasmic reticulum; C:extracellular region; C:neuronal cell body;, , P:cell cycle arrest; P:cellular response to retinoic acid; P:negative regulation of mitotic cell cycle; P:positive regulation of neuron differentiation; scaffold34 indexed_genome mRNA 16759910 16948631 . + . ID=transcript_7185;O14525 A5PL12 B4DHI9 E9PFR8 O60799 Q5W0V7 Q5W0V8,Astrotactin-1,, PF18411;, GO:0030136;GO:0005768;GO:0009897;GO:0016021;GO:0043204;GO:0007626;GO:0007158;GO:0001764;, C:clathrin-coated vesicle; C:endosome; C:external side of plasma membrane; C:integral component of membrane; C:perikaryon;, , P:locomotory behavior; P:neuron cell-cell adhesion; P:neuron migration; scaffold34 indexed_genome mRNA 17536123 17744288 . + . ID=transcript_7186;Q8NHY2 E9PKI0 Q504W6 Q6H103 Q9H6L7 X5D9B4,E3 ubiquitin-protein ligase COP1 {ECO:0000305},Constitutive photomorphogenesis protein 1 homolog {ECO:0000303|PubMed:12466024};RING finger and WD repeat domain protein 2 {ECO:0000305};RING finger protein 200;RING-type E3 ubiquitin transferase RFWD2 {ECO:0000305};, PF00400;, GO:0031464;GO:0005829;GO:0000139;GO:0016607;GO:0005654;GO:0046872;GO:0061630;GO:0032436;GO:0043687;GO:0043161;GO:0010212;, C:Cul4A-RING E3 ubiquitin ligase complex; C:cytosol; C:Golgi membrane; C:nuclear speck; C:nucleoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:response to ionizing radiation; scaffold34 indexed_genome mRNA 17914077 18298684 . + . ID=transcript_7187;Q92752 C9J563 Q15568 Q5R3G0,Tenascin-R,Janusin;Restrictin;, PF07974;PF18720;PF00147;PF00041;, GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0098978;GO:0045121;GO:0072534;GO:0098685;GO:0005102;GO:0008306;GO:0007411;GO:0007155;GO:0030198;GO:0035641;GO:0060291;GO:0048692;GO:0022408;GO:0050805;GO:0050885;GO:0007158;GO:0051968;GO:0051971;GO:0050808;GO:0022029;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:membrane raft; C:perineuronal net; C:Schaffer collateral - CA1 synapse;, F:signaling receptor binding;, P:associative learning; P:axon guidance; P:cell adhesion; P:extracellular matrix organization; P:locomotory exploration behavior; P:long-term synaptic potentiation; P:negative regulation of axon extension involved in regeneration; P:negative regulation of cell-cell adhesion; P:negative regulation of synaptic transmission; P:neuromuscular process controlling balance; P:neuron cell-cell adhesion; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of transmission of nerve impulse; P:synapse organization; P:telencephalon cell migration; scaffold34 indexed_genome mRNA 18306786 18364108 . + . ID=transcript_7188;Q92752 C9J563 Q15568 Q5R3G0,Tenascin-R,Janusin;Restrictin;, PF07974;PF18720;PF00147;PF00041;, GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0098978;GO:0045121;GO:0072534;GO:0098685;GO:0005102;GO:0008306;GO:0007411;GO:0007155;GO:0030198;GO:0035641;GO:0060291;GO:0048692;GO:0022408;GO:0050805;GO:0050885;GO:0007158;GO:0051968;GO:0051971;GO:0050808;GO:0022029;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:membrane raft; C:perineuronal net; C:Schaffer collateral - CA1 synapse;, F:signaling receptor binding;, P:associative learning; P:axon guidance; P:cell adhesion; P:extracellular matrix organization; P:locomotory exploration behavior; P:long-term synaptic potentiation; P:negative regulation of axon extension involved in regeneration; P:negative regulation of cell-cell adhesion; P:negative regulation of synaptic transmission; P:neuromuscular process controlling balance; P:neuron cell-cell adhesion; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of transmission of nerve impulse; P:synapse organization; P:telencephalon cell migration; scaffold34 indexed_genome mRNA 18373692 18378180 . + . ID=transcript_7189;Q92752 C9J563 Q15568 Q5R3G0,Tenascin-R,Janusin;Restrictin;, PF07974;PF18720;PF00147;PF00041;, GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0098978;GO:0045121;GO:0072534;GO:0098685;GO:0005102;GO:0008306;GO:0007411;GO:0007155;GO:0030198;GO:0035641;GO:0060291;GO:0048692;GO:0022408;GO:0050805;GO:0050885;GO:0007158;GO:0051968;GO:0051971;GO:0050808;GO:0022029;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:membrane raft; C:perineuronal net; C:Schaffer collateral - CA1 synapse;, F:signaling receptor binding;, P:associative learning; P:axon guidance; P:cell adhesion; P:extracellular matrix organization; P:locomotory exploration behavior; P:long-term synaptic potentiation; P:negative regulation of axon extension involved in regeneration; P:negative regulation of cell-cell adhesion; P:negative regulation of synaptic transmission; P:neuromuscular process controlling balance; P:neuron cell-cell adhesion; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of transmission of nerve impulse; P:synapse organization; P:telencephalon cell migration; scaffold34 indexed_genome mRNA 18475436 18514950 . + . ID=transcript_7190;Q15053 A8K9H6 J3QR46 Q2NKQ0,Uncharacterized protein KIAA0040,, , GO:0016021;, C:integral component of membrane; scaffold34 indexed_genome mRNA 18658634 18667336 . + . ID=transcript_7191;Q9HB71 B2ZWH2 B3KSF1 O60666 Q5R370 Q5R371,Calcyclin-binding protein,S100A6-binding protein;Siah-interacting protein;, PF04969;PF05002;PF09032;, GO:0030877;GO:0044297;GO:0005829;GO:0070062;GO:0043005;GO:0005641;GO:0005654;GO:0005634;GO:0019005;GO:0019904;GO:0042803;GO:0044548;GO:0015631;GO:0031625;GO:0007568;GO:0055007;GO:0071277;GO:1990830;GO:0007507;GO:0060548;GO:0045740;GO:0060416;, C:beta-catenin destruction complex; C:cell body; C:cytosol; C:extracellular exosome; C:neuron projection; C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:protein domain specific binding; F:protein homodimerization activity; F:S100 protein binding; F:tubulin binding; F:ubiquitin protein ligase binding;, P:aging; P:cardiac muscle cell differentiation; P:cellular response to calcium ion; P:cellular response to leukemia inhibitory factor; P:heart development; P:negative regulation of cell death; P:positive regulation of DNA replication; P:response to growth hormone;|Q9HB71 B2ZWH2 B3KSF1 O60666 Q5R370 Q5R371,Calcyclin-binding protein,S100A6-binding protein;Siah-interacting protein;, PF04969;PF05002;PF09032;, GO:0030877;GO:0044297;GO:0005829;GO:0070062;GO:0043005;GO:0005641;GO:0005654;GO:0005634;GO:0019005;GO:0019904;GO:0042803;GO:0044548;GO:0015631;GO:0031625;GO:0007568;GO:0055007;GO:0071277;GO:1990830;GO:0007507;GO:0060548;GO:0045740;GO:0060416;, C:beta-catenin destruction complex; C:cell body; C:cytosol; C:extracellular exosome; C:neuron projection; C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:protein domain specific binding; F:protein homodimerization activity; F:S100 protein binding; F:tubulin binding; F:ubiquitin protein ligase binding;, P:aging; P:cardiac muscle cell differentiation; P:cellular response to calcium ion; P:cellular response to leukemia inhibitory factor; P:heart development; P:negative regulation of cell death; P:positive regulation of DNA replication; P:response to growth hormone;|Q9HB71 B2ZWH2 B3KSF1 O60666 Q5R370 Q5R371,Calcyclin-binding protein,S100A6-binding protein;Siah-interacting protein;, PF04969;PF05002;PF09032;, GO:0030877;GO:0044297;GO:0005829;GO:0070062;GO:0043005;GO:0005641;GO:0005654;GO:0005634;GO:0019005;GO:0019904;GO:0042803;GO:0044548;GO:0015631;GO:0031625;GO:0007568;GO:0055007;GO:0071277;GO:1990830;GO:0007507;GO:0060548;GO:0045740;GO:0060416;, C:beta-catenin destruction complex; C:cell body; C:cytosol; C:extracellular exosome; C:neuron projection; C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:protein domain specific binding; F:protein homodimerization activity; F:S100 protein binding; F:tubulin binding; F:ubiquitin protein ligase binding;, P:aging; P:cardiac muscle cell differentiation; P:cellular response to calcium ion; P:cellular response to leukemia inhibitory factor; P:heart development; P:negative regulation of cell death; P:positive regulation of DNA replication; P:response to growth hormone;|Q9HB71 B2ZWH2 B3KSF1 O60666 Q5R370 Q5R371,Calcyclin-binding protein,S100A6-binding protein;Siah-interacting protein;, PF04969;PF05002;PF09032;, GO:0030877;GO:0044297;GO:0005829;GO:0070062;GO:0043005;GO:0005641;GO:0005654;GO:0005634;GO:0019005;GO:0019904;GO:0042803;GO:0044548;GO:0015631;GO:0031625;GO:0007568;GO:0055007;GO:0071277;GO:1990830;GO:0007507;GO:0060548;GO:0045740;GO:0060416;, C:beta-catenin destruction complex; C:cell body; C:cytosol; C:extracellular exosome; C:neuron projection; C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:protein domain specific binding; F:protein homodimerization activity; F:S100 protein binding; F:tubulin binding; F:ubiquitin protein ligase binding;, P:aging; P:cardiac muscle cell differentiation; P:cellular response to calcium ion; P:cellular response to leukemia inhibitory factor; P:heart development; P:negative regulation of cell death; P:positive regulation of DNA replication; P:response to growth hormone; scaffold34 indexed_genome mRNA 18701723 18707711 . - . ID=transcript_7192;B7ZAP0 B7ZAA4,Rab GTPase-activating protein 1-like, isoform 10 scaffold34 indexed_genome mRNA 18710484 18712418 . - . ID=transcript_7193;Q9UQP5 Q9Y6Y5 Q9Y6Y6,Rab GTPase-activating protein 1-like,, PF12473;PF00566;, GO:0005769;GO:0005794;GO:0005634;GO:0005096;GO:0031267;GO:0090630;GO:0006897;GO:0006886;GO:0032880;, C:early endosome; C:Golgi apparatus; C:nucleus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:endocytosis; P:intracellular protein transport; P:regulation of protein localization; scaffold34 indexed_genome mRNA 18912919 19278145 . - . ID=transcript_7194;Q9UQP5 Q9Y6Y5 Q9Y6Y6,Rab GTPase-activating protein 1-like,, PF12473;PF00566;, GO:0005769;GO:0005794;GO:0005634;GO:0005096;GO:0031267;GO:0090630;GO:0006897;GO:0006886;GO:0032880;, C:early endosome; C:Golgi apparatus; C:nucleus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:endocytosis; P:intracellular protein transport; P:regulation of protein localization; scaffold34 indexed_genome mRNA 19493104 19532500 . + . ID=transcript_7195;Q5TC82 B3KVK1 Q5W180 Q5W181 Q8IVE6 Q8N9V1,Roquin-1 {ECO:0000305},RING finger and C3H zinc finger protein 1;RING finger and CCCH-type zinc finger domain-containing protein 1;RING finger protein 198;, PF18386;PF00642;PF13445;, GO:0010494;GO:0000932;GO:0003725;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:0035613;GO:0061630;GO:0004842;GO:0008270;GO:0061158;GO:0001782;GO:0071347;GO:0048535;GO:0046007;GO:0030889;GO:0002635;GO:2000320;GO:0045623;GO:0000956;GO:0000288;GO:0033962;GO:0061014;GO:1901224;GO:0010608;GO:0000209;GO:0002634;GO:2000628;GO:0043488;GO:0050856;GO:0048536;GO:0043029;GO:0042098;GO:0050852;GO:0061470;GO:0006511;, C:cytoplasmic stress granule; C:P-body;, F:double-stranded RNA binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding; F:RNA stem-loop binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:B cell homeostasis; P:cellular response to interleukin-1; P:lymph node development; P:negative regulation of activated T cell proliferation; P:negative regulation of B cell proliferation; P:negative regulation of germinal center formation; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of T-helper cell differentiation; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:P-body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of NIK/NF-kappaB signaling; P:posttranscriptional regulation of gene expression; P:protein polyubiquitination; P:regulation of germinal center formation; P:regulation of miRNA metabolic process; P:regulation of mRNA stability; P:regulation of T cell receptor signaling pathway; P:spleen development; P:T cell homeostasis; P:T cell proliferation; P:T cell receptor signaling pathway; P:T follicular helper cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q5TC82 B3KVK1 Q5W180 Q5W181 Q8IVE6 Q8N9V1,Roquin-1 {ECO:0000305},RING finger and C3H zinc finger protein 1;RING finger and CCCH-type zinc finger domain-containing protein 1;RING finger protein 198;, PF18386;PF00642;PF13445;, GO:0010494;GO:0000932;GO:0003725;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:0035613;GO:0061630;GO:0004842;GO:0008270;GO:0061158;GO:0001782;GO:0071347;GO:0048535;GO:0046007;GO:0030889;GO:0002635;GO:2000320;GO:0045623;GO:0000956;GO:0000288;GO:0033962;GO:0061014;GO:1901224;GO:0010608;GO:0000209;GO:0002634;GO:2000628;GO:0043488;GO:0050856;GO:0048536;GO:0043029;GO:0042098;GO:0050852;GO:0061470;GO:0006511;, C:cytoplasmic stress granule; C:P-body;, F:double-stranded RNA binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding; F:RNA stem-loop binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:B cell homeostasis; P:cellular response to interleukin-1; P:lymph node development; P:negative regulation of activated T cell proliferation; P:negative regulation of B cell proliferation; P:negative regulation of germinal center formation; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of T-helper cell differentiation; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:P-body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of NIK/NF-kappaB signaling; P:posttranscriptional regulation of gene expression; P:protein polyubiquitination; P:regulation of germinal center formation; P:regulation of miRNA metabolic process; P:regulation of mRNA stability; P:regulation of T cell receptor signaling pathway; P:spleen development; P:T cell homeostasis; P:T cell proliferation; P:T cell receptor signaling pathway; P:T follicular helper cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q5TC82 B3KVK1 Q5W180 Q5W181 Q8IVE6 Q8N9V1,Roquin-1 {ECO:0000305},RING finger and C3H zinc finger protein 1;RING finger and CCCH-type zinc finger domain-containing protein 1;RING finger protein 198;, PF18386;PF00642;PF13445;, GO:0010494;GO:0000932;GO:0003725;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:0035613;GO:0061630;GO:0004842;GO:0008270;GO:0061158;GO:0001782;GO:0071347;GO:0048535;GO:0046007;GO:0030889;GO:0002635;GO:2000320;GO:0045623;GO:0000956;GO:0000288;GO:0033962;GO:0061014;GO:1901224;GO:0010608;GO:0000209;GO:0002634;GO:2000628;GO:0043488;GO:0050856;GO:0048536;GO:0043029;GO:0042098;GO:0050852;GO:0061470;GO:0006511;, C:cytoplasmic stress granule; C:P-body;, F:double-stranded RNA binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding; F:RNA stem-loop binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:B cell homeostasis; P:cellular response to interleukin-1; P:lymph node development; P:negative regulation of activated T cell proliferation; P:negative regulation of B cell proliferation; P:negative regulation of germinal center formation; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of T-helper cell differentiation; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:P-body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of NIK/NF-kappaB signaling; P:posttranscriptional regulation of gene expression; P:protein polyubiquitination; P:regulation of germinal center formation; P:regulation of miRNA metabolic process; P:regulation of mRNA stability; P:regulation of T cell receptor signaling pathway; P:spleen development; P:T cell homeostasis; P:T cell proliferation; P:T cell receptor signaling pathway; P:T follicular helper cell differentiation; P:ubiquitin-dependent protein catabolic process;|Q5TC82 B3KVK1 Q5W180 Q5W181 Q8IVE6 Q8N9V1,Roquin-1 {ECO:0000305},RING finger and C3H zinc finger protein 1;RING finger and CCCH-type zinc finger domain-containing protein 1;RING finger protein 198;, PF18386;PF00642;PF13445;, GO:0010494;GO:0000932;GO:0003725;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:0035613;GO:0061630;GO:0004842;GO:0008270;GO:0061158;GO:0001782;GO:0071347;GO:0048535;GO:0046007;GO:0030889;GO:0002635;GO:2000320;GO:0045623;GO:0000956;GO:0000288;GO:0033962;GO:0061014;GO:1901224;GO:0010608;GO:0000209;GO:0002634;GO:2000628;GO:0043488;GO:0050856;GO:0048536;GO:0043029;GO:0042098;GO:0050852;GO:0061470;GO:0006511;, C:cytoplasmic stress granule; C:P-body;, F:double-stranded RNA binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding; F:RNA stem-loop binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:B cell homeostasis; P:cellular response to interleukin-1; P:lymph node development; P:negative regulation of activated T cell proliferation; P:negative regulation of B cell proliferation; P:negative regulation of germinal center formation; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of T-helper cell differentiation; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:P-body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of NIK/NF-kappaB signaling; P:posttranscriptional regulation of gene expression; P:protein polyubiquitination; P:regulation of germinal center formation; P:regulation of miRNA metabolic process; P:regulation of mRNA stability; P:regulation of T cell receptor signaling pathway; P:spleen development; P:T cell homeostasis; P:T cell proliferation; P:T cell receptor signaling pathway; P:T follicular helper cell differentiation; P:ubiquitin-dependent protein catabolic process; scaffold34 indexed_genome mRNA 19547269 19558952 . + . ID=transcript_7196;P01008 B2R6P0 P78439 P78447 Q13815 Q5TC78 Q7KZ43 Q7KZ97 Q9UC78,Antithrombin-III,Serpin C1;, PF00079;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0008201;GO:0042802;GO:0002020;GO:0004867;GO:0002438;GO:0007596;GO:0044267;GO:0007595;GO:0010951;GO:0043687;GO:2000266;GO:0007584;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:heparin binding; F:identical protein binding; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:acute inflammatory response to antigenic stimulus; P:blood coagulation; P:cellular protein metabolic process; P:lactation; P:negative regulation of endopeptidase activity; P:post-translational protein modification; P:regulation of blood coagulation, intrinsic pathway; P:response to nutrient;|P01008 B2R6P0 P78439 P78447 Q13815 Q5TC78 Q7KZ43 Q7KZ97 Q9UC78,Antithrombin-III,Serpin C1;, PF00079;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0008201;GO:0042802;GO:0002020;GO:0004867;GO:0002438;GO:0007596;GO:0044267;GO:0007595;GO:0010951;GO:0043687;GO:2000266;GO:0007584;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:heparin binding; F:identical protein binding; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:acute inflammatory response to antigenic stimulus; P:blood coagulation; P:cellular protein metabolic process; P:lactation; P:negative regulation of endopeptidase activity; P:post-translational protein modification; P:regulation of blood coagulation, intrinsic pathway; P:response to nutrient;|P01008 B2R6P0 P78439 P78447 Q13815 Q5TC78 Q7KZ43 Q7KZ97 Q9UC78,Antithrombin-III,Serpin C1;, PF00079;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0008201;GO:0042802;GO:0002020;GO:0004867;GO:0002438;GO:0007596;GO:0044267;GO:0007595;GO:0010951;GO:0043687;GO:2000266;GO:0007584;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:heparin binding; F:identical protein binding; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:acute inflammatory response to antigenic stimulus; P:blood coagulation; P:cellular protein metabolic process; P:lactation; P:negative regulation of endopeptidase activity; P:post-translational protein modification; P:regulation of blood coagulation, intrinsic pathway; P:response to nutrient; scaffold34 indexed_genome mRNA 19584414 19586052 . - . ID=transcript_7197;Q5TC79 Q5TC80 Q96M87 Q9BQ88,Zinc finger and BTB domain-containing protein 37,, PF00651;PF00096;, GO:0000785;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold34 indexed_genome mRNA 19593268 19619079 . - . ID=transcript_7198;Q6PI48,Aspartate--tRNA ligase, mitochondrial,Aspartyl-tRNA synthetase;, PF02938;PF00152;PF01336;, GO:0005759;GO:0005739;GO:0005654;GO:0004815;GO:0050560;GO:0005524;GO:0042803;GO:0000049;GO:0070145;GO:0043039;GO:0006418;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:aspartate-tRNA ligase activity; F:aspartate-tRNA(Asn) ligase activity; F:ATP binding; F:protein homodimerization activity; F:tRNA binding;, P:mitochondrial asparaginyl-tRNA aminoacylation; P:tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|Q6PI48,Aspartate--tRNA ligase, mitochondrial,Aspartyl-tRNA synthetase;, PF02938;PF00152;PF01336;, GO:0005759;GO:0005739;GO:0005654;GO:0004815;GO:0050560;GO:0005524;GO:0042803;GO:0000049;GO:0070145;GO:0043039;GO:0006418;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:aspartate-tRNA ligase activity; F:aspartate-tRNA(Asn) ligase activity; F:ATP binding; F:protein homodimerization activity; F:tRNA binding;, P:mitochondrial asparaginyl-tRNA aminoacylation; P:tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|Q6PI48,Aspartate--tRNA ligase, mitochondrial,Aspartyl-tRNA synthetase;, PF02938;PF00152;PF01336;, GO:0005759;GO:0005739;GO:0005654;GO:0004815;GO:0050560;GO:0005524;GO:0042803;GO:0000049;GO:0070145;GO:0043039;GO:0006418;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:aspartate-tRNA ligase activity; F:aspartate-tRNA(Asn) ligase activity; F:ATP binding; F:protein homodimerization activity; F:tRNA binding;, P:mitochondrial asparaginyl-tRNA aminoacylation; P:tRNA aminoacylation; P:tRNA aminoacylation for protein translation; scaffold34 indexed_genome mRNA 19619368 19637100 . + . ID=transcript_7199;Q8N0S6 Q5TEL5 Q96ND4,Centromere protein L,Interphase centromere complex protein 33;, PF13092;, GO:0000775;GO:0005829;GO:0005654;GO:0034080;GO:0007052;, C:chromosome, centromeric region; C:cytosol; C:nucleoplasm;, , P:CENP-A containing nucleosome assembly; P:mitotic spindle organization; scaffold34 indexed_genome mRNA 19648716 19652220 . - . ID=transcript_7200;Q9Y2M5 B3KMA0 B4DUR0 Q5TZF2 Q5ZF45 Q9H457,Kelch-like protein 20,Kelch-like ECT2-interacting protein;Kelch-like protein X;, PF07707;PF00651;PF01344;, GO:0015629;GO:0030424;GO:0031463;GO:0005737;GO:0005829;GO:0030425;GO:0005794;GO:0048471;GO:0016605;GO:0005802;GO:0003779;GO:0019964;GO:0004842;GO:0007010;GO:0006895;GO:0043066;GO:0043687;GO:0043161;GO:1990390;GO:0015031;GO:0016567;GO:0035455;, C:actin cytoskeleton; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:dendrite; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:PML body; C:trans-Golgi network;, F:actin binding; F:interferon-gamma binding; F:ubiquitin-protein transferase activity;, P:cytoskeleton organization; P:Golgi to endosome transport; P:negative regulation of apoptotic process; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K33-linked ubiquitination; P:protein transport; P:protein ubiquitination; P:response to interferon-alpha;|Q9Y2M5 B3KMA0 B4DUR0 Q5TZF2 Q5ZF45 Q9H457,Kelch-like protein 20,Kelch-like ECT2-interacting protein;Kelch-like protein X;, PF07707;PF00651;PF01344;, GO:0015629;GO:0030424;GO:0031463;GO:0005737;GO:0005829;GO:0030425;GO:0005794;GO:0048471;GO:0016605;GO:0005802;GO:0003779;GO:0019964;GO:0004842;GO:0007010;GO:0006895;GO:0043066;GO:0043687;GO:0043161;GO:1990390;GO:0015031;GO:0016567;GO:0035455;, C:actin cytoskeleton; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:dendrite; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:PML body; C:trans-Golgi network;, F:actin binding; F:interferon-gamma binding; F:ubiquitin-protein transferase activity;, P:cytoskeleton organization; P:Golgi to endosome transport; P:negative regulation of apoptotic process; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K33-linked ubiquitination; P:protein transport; P:protein ubiquitination; P:response to interferon-alpha; scaffold34 indexed_genome mRNA 19652395 19655397 . + . ID=transcript_7201;Q9Y2M5 B3KMA0 B4DUR0 Q5TZF2 Q5ZF45 Q9H457,Kelch-like protein 20,Kelch-like ECT2-interacting protein;Kelch-like protein X;, PF07707;PF00651;PF01344;, GO:0015629;GO:0030424;GO:0031463;GO:0005737;GO:0005829;GO:0030425;GO:0005794;GO:0048471;GO:0016605;GO:0005802;GO:0003779;GO:0019964;GO:0004842;GO:0007010;GO:0006895;GO:0043066;GO:0043687;GO:0043161;GO:1990390;GO:0015031;GO:0016567;GO:0035455;, C:actin cytoskeleton; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:dendrite; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:PML body; C:trans-Golgi network;, F:actin binding; F:interferon-gamma binding; F:ubiquitin-protein transferase activity;, P:cytoskeleton organization; P:Golgi to endosome transport; P:negative regulation of apoptotic process; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K33-linked ubiquitination; P:protein transport; P:protein ubiquitination; P:response to interferon-alpha; scaffold34 indexed_genome mRNA 19655401 19656026 . + . ID=transcript_7202;Q9Y2M5 B3KMA0 B4DUR0 Q5TZF2 Q5ZF45 Q9H457,Kelch-like protein 20,Kelch-like ECT2-interacting protein;Kelch-like protein X;, PF07707;PF00651;PF01344;, GO:0015629;GO:0030424;GO:0031463;GO:0005737;GO:0005829;GO:0030425;GO:0005794;GO:0048471;GO:0016605;GO:0005802;GO:0003779;GO:0019964;GO:0004842;GO:0007010;GO:0006895;GO:0043066;GO:0043687;GO:0043161;GO:1990390;GO:0015031;GO:0016567;GO:0035455;, C:actin cytoskeleton; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:dendrite; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:PML body; C:trans-Golgi network;, F:actin binding; F:interferon-gamma binding; F:ubiquitin-protein transferase activity;, P:cytoskeleton organization; P:Golgi to endosome transport; P:negative regulation of apoptotic process; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K33-linked ubiquitination; P:protein transport; P:protein ubiquitination; P:response to interferon-alpha; scaffold34 indexed_genome mRNA 19656078 19719246 . - . ID=transcript_7203;Q9Y2M5 B3KMA0 B4DUR0 Q5TZF2 Q5ZF45 Q9H457,Kelch-like protein 20,Kelch-like ECT2-interacting protein;Kelch-like protein X;, PF07707;PF00651;PF01344;, GO:0015629;GO:0030424;GO:0031463;GO:0005737;GO:0005829;GO:0030425;GO:0005794;GO:0048471;GO:0016605;GO:0005802;GO:0003779;GO:0019964;GO:0004842;GO:0007010;GO:0006895;GO:0043066;GO:0043687;GO:0043161;GO:1990390;GO:0015031;GO:0016567;GO:0035455;, C:actin cytoskeleton; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:dendrite; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:PML body; C:trans-Golgi network;, F:actin binding; F:interferon-gamma binding; F:ubiquitin-protein transferase activity;, P:cytoskeleton organization; P:Golgi to endosome transport; P:negative regulation of apoptotic process; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K33-linked ubiquitination; P:protein transport; P:protein ubiquitination; P:response to interferon-alpha;|Q9Y2M5 B3KMA0 B4DUR0 Q5TZF2 Q5ZF45 Q9H457,Kelch-like protein 20,Kelch-like ECT2-interacting protein;Kelch-like protein X;, PF07707;PF00651;PF01344;, GO:0015629;GO:0030424;GO:0031463;GO:0005737;GO:0005829;GO:0030425;GO:0005794;GO:0048471;GO:0016605;GO:0005802;GO:0003779;GO:0019964;GO:0004842;GO:0007010;GO:0006895;GO:0043066;GO:0043687;GO:0043161;GO:1990390;GO:0015031;GO:0016567;GO:0035455;, C:actin cytoskeleton; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:dendrite; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:PML body; C:trans-Golgi network;, F:actin binding; F:interferon-gamma binding; F:ubiquitin-protein transferase activity;, P:cytoskeleton organization; P:Golgi to endosome transport; P:negative regulation of apoptotic process; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K33-linked ubiquitination; P:protein transport; P:protein ubiquitination; P:response to interferon-alpha;|Q9Y2M5 B3KMA0 B4DUR0 Q5TZF2 Q5ZF45 Q9H457,Kelch-like protein 20,Kelch-like ECT2-interacting protein;Kelch-like protein X;, PF07707;PF00651;PF01344;, GO:0015629;GO:0030424;GO:0031463;GO:0005737;GO:0005829;GO:0030425;GO:0005794;GO:0048471;GO:0016605;GO:0005802;GO:0003779;GO:0019964;GO:0004842;GO:0007010;GO:0006895;GO:0043066;GO:0043687;GO:0043161;GO:1990390;GO:0015031;GO:0016567;GO:0035455;, C:actin cytoskeleton; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:dendrite; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:PML body; C:trans-Golgi network;, F:actin binding; F:interferon-gamma binding; F:ubiquitin-protein transferase activity;, P:cytoskeleton organization; P:Golgi to endosome transport; P:negative regulation of apoptotic process; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K33-linked ubiquitination; P:protein transport; P:protein ubiquitination; P:response to interferon-alpha;|Q9Y2M5 B3KMA0 B4DUR0 Q5TZF2 Q5ZF45 Q9H457,Kelch-like protein 20,Kelch-like ECT2-interacting protein;Kelch-like protein X;, PF07707;PF00651;PF01344;, GO:0015629;GO:0030424;GO:0031463;GO:0005737;GO:0005829;GO:0030425;GO:0005794;GO:0048471;GO:0016605;GO:0005802;GO:0003779;GO:0019964;GO:0004842;GO:0007010;GO:0006895;GO:0043066;GO:0043687;GO:0043161;GO:1990390;GO:0015031;GO:0016567;GO:0035455;, C:actin cytoskeleton; C:axon; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:dendrite; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:PML body; C:trans-Golgi network;, F:actin binding; F:interferon-gamma binding; F:ubiquitin-protein transferase activity;, P:cytoskeleton organization; P:Golgi to endosome transport; P:negative regulation of apoptotic process; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K33-linked ubiquitination; P:protein transport; P:protein ubiquitination; P:response to interferon-alpha; scaffold34 indexed_genome mRNA 19719334 19766802 . + . ID=transcript_7204;Q5TZF3 A1A4G2 Q6ZST1,Ankyrin repeat domain-containing protein 45 {ECO:0000305},, PF12796;|Q5TZF3 A1A4G2 Q6ZST1,Ankyrin repeat domain-containing protein 45 {ECO:0000305},, PF12796;|P62910 B2R4Q3 P02433,60S ribosomal protein L32,Large ribosomal subunit protein eL32 {ECO:0000303|PubMed:24524803};, PF01655;, GO:0005829;GO:0022625;GO:0016020;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:membrane; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold34 indexed_genome mRNA 19850341 19861008 . + . ID=transcript_7205;Q5TAH2 Q86UF3,Sodium/hydrogen exchanger 11,Na(+)/H(+) exchanger 11;Solute carrier family 9 member 11;Solute carrier family 9 member C2;, PF00027;PF00999;, GO:0016021;GO:0005886;GO:0015386;GO:0015385;GO:0071805;GO:0051453;GO:0098719;, C:integral component of membrane; C:plasma membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane; scaffold34 indexed_genome mRNA 19867930 19869902 . + . ID=transcript_7206;P30041 A8JZY7 P32077 Q5TAH4 Q5ZEZ8,Peroxiredoxin-6,1-Cys peroxiredoxin;24 kDa protein;Acidic calcium-independent phospholipase A2;Antioxidant protein 2;Glutathione-dependent peroxiredoxin {ECO:0000305};Liver 2D page spot 40;Lysophosphatidylcholine acyltransferase 5 {ECO:0000303|PubMed:26830860};Non-selenium glutathione peroxidase;Red blood cells page spot 12;, PF10417;PF00578;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005739;GO:0005634;GO:0048471;GO:0047184;GO:0045296;GO:0047499;GO:0004602;GO:0042802;GO:0051920;GO:0004623;GO:0102567;GO:0102568;GO:0031625;GO:0045454;GO:0098869;GO:0034599;GO:0046475;GO:0042744;GO:0043312;GO:0048026;GO:0006979;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:cadherin binding; F:calcium-independent phospholipase A2 activity; F:glutathione peroxidase activity; F:identical protein binding; F:peroxiredoxin activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:ubiquitin protein ligase binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:cellular response to oxidative stress; P:glycerophospholipid catabolic process; P:hydrogen peroxide catabolic process; P:neutrophil degranulation; P:positive regulation of mRNA splicing, via spliceosome; P:response to oxidative stress; scaffold34 indexed_genome mRNA 19870699 19871288 . + . ID=transcript_7207;P30041 A8JZY7 P32077 Q5TAH4 Q5ZEZ8,Peroxiredoxin-6,1-Cys peroxiredoxin;24 kDa protein;Acidic calcium-independent phospholipase A2;Antioxidant protein 2;Glutathione-dependent peroxiredoxin {ECO:0000305};Liver 2D page spot 40;Lysophosphatidylcholine acyltransferase 5 {ECO:0000303|PubMed:26830860};Non-selenium glutathione peroxidase;Red blood cells page spot 12;, PF10417;PF00578;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005739;GO:0005634;GO:0048471;GO:0047184;GO:0045296;GO:0047499;GO:0004602;GO:0042802;GO:0051920;GO:0004623;GO:0102567;GO:0102568;GO:0031625;GO:0045454;GO:0098869;GO:0034599;GO:0046475;GO:0042744;GO:0043312;GO:0048026;GO:0006979;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:cadherin binding; F:calcium-independent phospholipase A2 activity; F:glutathione peroxidase activity; F:identical protein binding; F:peroxiredoxin activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:ubiquitin protein ligase binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:cellular response to oxidative stress; P:glycerophospholipid catabolic process; P:hydrogen peroxide catabolic process; P:neutrophil degranulation; P:positive regulation of mRNA splicing, via spliceosome; P:response to oxidative stress; scaffold34 indexed_genome mRNA 19871376 19871894 . - . ID=transcript_7208;P30041 A8JZY7 P32077 Q5TAH4 Q5ZEZ8,Peroxiredoxin-6,1-Cys peroxiredoxin;24 kDa protein;Acidic calcium-independent phospholipase A2;Antioxidant protein 2;Glutathione-dependent peroxiredoxin {ECO:0000305};Liver 2D page spot 40;Lysophosphatidylcholine acyltransferase 5 {ECO:0000303|PubMed:26830860};Non-selenium glutathione peroxidase;Red blood cells page spot 12;, PF10417;PF00578;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005739;GO:0005634;GO:0048471;GO:0047184;GO:0045296;GO:0047499;GO:0004602;GO:0042802;GO:0051920;GO:0004623;GO:0102567;GO:0102568;GO:0031625;GO:0045454;GO:0098869;GO:0034599;GO:0046475;GO:0042744;GO:0043312;GO:0048026;GO:0006979;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:cadherin binding; F:calcium-independent phospholipase A2 activity; F:glutathione peroxidase activity; F:identical protein binding; F:peroxiredoxin activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:ubiquitin protein ligase binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:cellular response to oxidative stress; P:glycerophospholipid catabolic process; P:hydrogen peroxide catabolic process; P:neutrophil degranulation; P:positive regulation of mRNA splicing, via spliceosome; P:response to oxidative stress; scaffold34 indexed_genome mRNA 19873393 19874374 . - . ID=transcript_7209;P30041 A8JZY7 P32077 Q5TAH4 Q5ZEZ8,Peroxiredoxin-6,1-Cys peroxiredoxin;24 kDa protein;Acidic calcium-independent phospholipase A2;Antioxidant protein 2;Glutathione-dependent peroxiredoxin {ECO:0000305};Liver 2D page spot 40;Lysophosphatidylcholine acyltransferase 5 {ECO:0000303|PubMed:26830860};Non-selenium glutathione peroxidase;Red blood cells page spot 12;, PF10417;PF00578;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005739;GO:0005634;GO:0048471;GO:0047184;GO:0045296;GO:0047499;GO:0004602;GO:0042802;GO:0051920;GO:0004623;GO:0102567;GO:0102568;GO:0031625;GO:0045454;GO:0098869;GO:0034599;GO:0046475;GO:0042744;GO:0043312;GO:0048026;GO:0006979;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:cadherin binding; F:calcium-independent phospholipase A2 activity; F:glutathione peroxidase activity; F:identical protein binding; F:peroxiredoxin activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:ubiquitin protein ligase binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:cellular response to oxidative stress; P:glycerophospholipid catabolic process; P:hydrogen peroxide catabolic process; P:neutrophil degranulation; P:positive regulation of mRNA splicing, via spliceosome; P:response to oxidative stress;|P30041 A8JZY7 P32077 Q5TAH4 Q5ZEZ8,Peroxiredoxin-6,1-Cys peroxiredoxin;24 kDa protein;Acidic calcium-independent phospholipase A2;Antioxidant protein 2;Glutathione-dependent peroxiredoxin {ECO:0000305};Liver 2D page spot 40;Lysophosphatidylcholine acyltransferase 5 {ECO:0000303|PubMed:26830860};Non-selenium glutathione peroxidase;Red blood cells page spot 12;, PF10417;PF00578;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005739;GO:0005634;GO:0048471;GO:0047184;GO:0045296;GO:0047499;GO:0004602;GO:0042802;GO:0051920;GO:0004623;GO:0102567;GO:0102568;GO:0031625;GO:0045454;GO:0098869;GO:0034599;GO:0046475;GO:0042744;GO:0043312;GO:0048026;GO:0006979;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:cadherin binding; F:calcium-independent phospholipase A2 activity; F:glutathione peroxidase activity; F:identical protein binding; F:peroxiredoxin activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:ubiquitin protein ligase binding;, P:cell redox homeostasis; P:cellular oxidant detoxification; P:cellular response to oxidative stress; P:glycerophospholipid catabolic process; P:hydrogen peroxide catabolic process; P:neutrophil degranulation; P:positive regulation of mRNA splicing, via spliceosome; P:response to oxidative stress; scaffold34 indexed_genome mRNA 19968427 19969119 . - . ID=transcript_7210;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold34 indexed_genome mRNA 19981667 19982316 . + . ID=transcript_7211;Q5VUY0 B3KXR9 Q5VUY1,Arylacetamide deacetylase-like 3,, PF07859;, GO:0016021;GO:0052689;GO:0016787;, C:integral component of membrane;, F:carboxylic ester hydrolase activity; F:hydrolase activity; scaffold34 indexed_genome mRNA 20661378 20697895 . + . ID=transcript_7212;Q8NBR3,Podoplanin {ECO:0000303|Ref.9},Aggrus {ECO:0000303|Ref.3};Glycoprotein 36;PA2.26 antigen {ECO:0000303|PubMed:15515019};T1-alpha {ECO:0000250|UniProtKB:Q64294};, , GO:0016324;GO:0016323;GO:0030054;GO:0042995;GO:0031410;GO:0005829;GO:0030175;GO:0031527;GO:0005887;GO:0030027;GO:0031258;GO:0061851;GO:0016020;GO:0045121;GO:0031528;GO:0005739;GO:0005886;GO:0001726;GO:0032587;GO:0097197;GO:0051087;GO:0019956;GO:0005102;GO:0070252;GO:0003333;GO:0000902;GO:0098609;GO:0015884;GO:0030324;GO:0048535;GO:0001946;GO:0060838;GO:0043066;GO:0008285;GO:0030168;GO:0030335;GO:0051272;GO:0010718;GO:0090091;GO:1901731;GO:0008360;GO:2000392;GO:1904328;GO:1900024;GO:0055093;GO:0007266;GO:0035239;GO:0006833;GO:0044319;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cell projection; C:cytoplasmic vesicle; C:cytosol; C:filopodium; C:filopodium membrane; C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:leading edge of lamellipodium; C:membrane; C:membrane raft; C:microvillus membrane; C:mitochondrion; C:plasma membrane; C:ruffle; C:ruffle membrane; C:tetraspanin-enriched microdomain;, F:chaperone binding; F:chemokine binding; F:signaling receptor binding;, P:actin-mediated cell contraction; P:amino acid transmembrane transport; P:cell morphogenesis; P:cell-cell adhesion; P:folic acid transport; P:lung development; P:lymph node development; P:lymphangiogenesis; P:lymphatic endothelial cell fate commitment; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:platelet activation; P:positive regulation of cell migration; P:positive regulation of cellular component movement; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of extracellular matrix disassembly; P:positive regulation of platelet aggregation; P:regulation of cell shape; P:regulation of lamellipodium morphogenesis; P:regulation of myofibroblast contraction; P:regulation of substrate adhesion-dependent cell spreading; P:response to hyperoxia; P:Rho protein signal transduction; P:tube morphogenesis; P:water transport; P:wound healing, spreading of cells; scaffold34 indexed_genome mRNA 20824812 20917873 . + . ID=transcript_7213;Q13029 B1AJZ4 B5MC68 Q13149 Q14550 Q5THJ1 Q5VUL9,PR domain zinc finger protein 2,GATA-3-binding protein G3B;Lysine N-methyltransferase 8;MTB-ZF;MTE-binding protein;PR domain-containing protein 2;Retinoblastoma protein-interacting zinc finger protein;Zinc finger protein RIZ;, PF00856;PF00096;, GO:0005794;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0042054;GO:0000977;GO:0043565;GO:0008270;GO:0008340;GO:0000122;GO:0045944;GO:0010468;GO:0006357;GO:0006355;, C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone methyltransferase activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:zinc ion binding;, P:determination of adult lifespan; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q13029 B1AJZ4 B5MC68 Q13149 Q14550 Q5THJ1 Q5VUL9,PR domain zinc finger protein 2,GATA-3-binding protein G3B;Lysine N-methyltransferase 8;MTB-ZF;MTE-binding protein;PR domain-containing protein 2;Retinoblastoma protein-interacting zinc finger protein;Zinc finger protein RIZ;, PF00856;PF00096;, GO:0005794;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0042054;GO:0000977;GO:0043565;GO:0008270;GO:0008340;GO:0000122;GO:0045944;GO:0010468;GO:0006357;GO:0006355;, C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone methyltransferase activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:zinc ion binding;, P:determination of adult lifespan; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold34 indexed_genome mRNA 21797704 22274211 . + . ID=transcript_7214;Q8N409 Q9UIL2 Q9UPX4,Kazrin,, PF00536;PF07647;, GO:0001533;GO:0005856;GO:0005829;GO:0030057;GO:0016607;GO:0005654;GO:0070268;, C:cornified envelope; C:cytoskeleton; C:cytosol; C:desmosome; C:nuclear speck; C:nucleoplasm;, , P:cornification;|Q8N409 Q9UIL2 Q9UPX4,Kazrin,, PF00536;PF07647;, GO:0001533;GO:0005856;GO:0005829;GO:0030057;GO:0016607;GO:0005654;GO:0070268;, C:cornified envelope; C:cytoskeleton; C:cytosol; C:desmosome; C:nuclear speck; C:nucleoplasm;, , P:cornification; scaffold34 indexed_genome mRNA 22296029 22326266 . + . ID=transcript_7215;Q8N409 Q9UIL2 Q9UPX4,Kazrin,, PF00536;PF07647;, GO:0001533;GO:0005856;GO:0005829;GO:0030057;GO:0016607;GO:0005654;GO:0070268;, C:cornified envelope; C:cytoskeleton; C:cytosol; C:desmosome; C:nuclear speck; C:nucleoplasm;, , P:cornification; scaffold34 indexed_genome mRNA 22373010 22428282 . + . ID=transcript_7216;Q9NW97 A8K819,Transmembrane protein 51,, , GO:0016021;, C:integral component of membrane; scaffold34 indexed_genome mRNA 22451886 22521064 . + . ID=transcript_7217;B1AJZ9 Q0P6F5 Q8N8D3 Q8N9T6 Q8NA05,Forkhead-associated domain-containing protein 1,, PF00498; scaffold34 indexed_genome mRNA 22533157 22547311 . + . ID=transcript_7218;B1AJZ9 Q0P6F5 Q8N8D3 Q8N9T6 Q8NA05,Forkhead-associated domain-containing protein 1,, PF00498; scaffold34 indexed_genome mRNA 22591747 22599737 . + . ID=transcript_7219;B1AJZ9 Q0P6F5 Q8N8D3 Q8N9T6 Q8NA05,Forkhead-associated domain-containing protein 1,, PF00498; scaffold34 indexed_genome mRNA 22599793 22614496 . + . ID=transcript_7220;B1AJZ9 Q0P6F5 Q8N8D3 Q8N9T6 Q8NA05,Forkhead-associated domain-containing protein 1,, PF00498; scaffold34 indexed_genome mRNA 22630712 22648359 . + . ID=transcript_7221;Q96C19 Q5JYW9,EF-hand domain-containing protein D2,Swiprosin-1;, PF13499;, GO:0045121;GO:0045296;GO:0005509;, C:membrane raft;, F:cadherin binding; F:calcium ion binding;|Q96C19 Q5JYW9,EF-hand domain-containing protein D2,Swiprosin-1;, PF13499;, GO:0045121;GO:0045296;GO:0005509;, C:membrane raft;, F:cadherin binding; F:calcium ion binding; scaffold34 indexed_genome mRNA 22684514 22714224 . - . ID=transcript_7222;Q9UIJ8,Caspase-9,Apoptotic protease Mch-6;Apoptotic protease-activating factor 3;ICE-like apoptotic protease 6;, PF00619;, GO:0043293;GO:0005737;GO:0005829;GO:0032991;GO:0004197;GO:0097153;GO:0097199;GO:0097200;GO:0008047;GO:0042802;GO:0008233;GO:0019901;GO:0017124;GO:0006919;GO:0008635;GO:0006915;GO:0006974;GO:0034644;GO:0097192;GO:0008630;GO:0030220;GO:0043065;GO:2001020;GO:0042770;, C:apoptosome; C:cytoplasm; C:cytosol; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:enzyme activator activity; F:identical protein binding; F:peptidase activity; F:protein kinase binding; F:SH3 domain binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:platelet formation; P:positive regulation of apoptotic process; P:regulation of response to DNA damage stimulus; P:signal transduction in response to DNA damage;|Q9UIJ8,Caspase-9,Apoptotic protease Mch-6;Apoptotic protease-activating factor 3;ICE-like apoptotic protease 6;, PF00619;, GO:0043293;GO:0005737;GO:0005829;GO:0032991;GO:0004197;GO:0097153;GO:0097199;GO:0097200;GO:0008047;GO:0042802;GO:0008233;GO:0019901;GO:0017124;GO:0006919;GO:0008635;GO:0006915;GO:0006974;GO:0034644;GO:0097192;GO:0008630;GO:0030220;GO:0043065;GO:2001020;GO:0042770;, C:apoptosome; C:cytoplasm; C:cytosol; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:enzyme activator activity; F:identical protein binding; F:peptidase activity; F:protein kinase binding; F:SH3 domain binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:platelet formation; P:positive regulation of apoptotic process; P:regulation of response to DNA damage stimulus; P:signal transduction in response to DNA damage; scaffold34 indexed_genome mRNA 22718611 22764977 . - . ID=transcript_7223;Q9Y2G8 Q68D57 Q86X32 Q8N5P4,DnaJ homolog subfamily C member 16,, PF00226;PF00085;, GO:0016021;, C:integral component of membrane;|Q9Y2G8 Q68D57 Q86X32 Q8N5P4,DnaJ homolog subfamily C member 16,, PF00226;PF00085;, GO:0016021;, C:integral component of membrane;|Q9BSE5 Q5TDH1 Q9H5J3,Agmatinase, mitochondrial,Agmatine ureohydrolase;, PF00491;, GO:0005739;GO:0008783;GO:0046872;GO:0097055;GO:0033389;GO:0008295;, C:mitochondrion;, F:agmatinase activity; F:metal ion binding;, P:agmatine biosynthetic process; P:putrescine biosynthetic process from arginine, using agmatinase; P:spermidine biosynthetic process;|Q9BSE5 Q5TDH1 Q9H5J3,Agmatinase, mitochondrial,Agmatine ureohydrolase;, PF00491;, GO:0005739;GO:0008783;GO:0046872;GO:0097055;GO:0033389;GO:0008295;, C:mitochondrion;, F:agmatinase activity; F:metal ion binding;, P:agmatine biosynthetic process; P:putrescine biosynthetic process from arginine, using agmatinase; P:spermidine biosynthetic process;|Q9BSE5 Q5TDH1 Q9H5J3,Agmatinase, mitochondrial,Agmatine ureohydrolase;, PF00491;, GO:0005739;GO:0008783;GO:0046872;GO:0097055;GO:0033389;GO:0008295;, C:mitochondrion;, F:agmatinase activity; F:metal ion binding;, P:agmatine biosynthetic process; P:putrescine biosynthetic process from arginine, using agmatinase; P:spermidine biosynthetic process; scaffold34 indexed_genome mRNA 22804128 22833655 . + . ID=transcript_7224;Q5TDH0 A8KAE1 Q7RTZ0 Q9BRT1,Protein DDI1 homolog 2 {ECO:0000305},, PF09668;PF00240;, GO:0005694;GO:0005829;GO:0005654;GO:0004190;GO:0042802;GO:0043130;GO:0072711;GO:0010498;GO:0016485;GO:0097752;GO:0031647;, C:chromosome; C:cytosol; C:nucleoplasm;, F:aspartic-type endopeptidase activity; F:identical protein binding; F:ubiquitin binding;, P:cellular response to hydroxyurea; P:proteasomal protein catabolic process; P:protein processing; P:regulation of DNA stability; P:regulation of protein stability;|Q5TDH0 A8KAE1 Q7RTZ0 Q9BRT1,Protein DDI1 homolog 2 {ECO:0000305},, PF09668;PF00240;, GO:0005694;GO:0005829;GO:0005654;GO:0004190;GO:0042802;GO:0043130;GO:0072711;GO:0010498;GO:0016485;GO:0097752;GO:0031647;, C:chromosome; C:cytosol; C:nucleoplasm;, F:aspartic-type endopeptidase activity; F:identical protein binding; F:ubiquitin binding;, P:cellular response to hydroxyurea; P:proteasomal protein catabolic process; P:protein processing; P:regulation of DNA stability; P:regulation of protein stability;|Q92681 B2RBP5,Regulatory solute carrier protein family 1 member 1,Transporter regulator RS1;, , GO:0030054;GO:0005794;GO:0005654;GO:0005886;GO:0019871;GO:0045920;GO:0010829;GO:0042997;GO:0032243;GO:1903077;GO:0051051;GO:0006355;, C:cell junction; C:Golgi apparatus; C:nucleoplasm; C:plasma membrane;, F:sodium channel inhibitor activity;, P:negative regulation of exocytosis; P:negative regulation of glucose transmembrane transport; P:negative regulation of Golgi to plasma membrane protein transport; P:negative regulation of nucleoside transport; P:negative regulation of protein localization to plasma membrane; P:negative regulation of transport; P:regulation of transcription, DNA-templated;|Q92681 B2RBP5,Regulatory solute carrier protein family 1 member 1,Transporter regulator RS1;, , GO:0030054;GO:0005794;GO:0005654;GO:0005886;GO:0019871;GO:0045920;GO:0010829;GO:0042997;GO:0032243;GO:1903077;GO:0051051;GO:0006355;, C:cell junction; C:Golgi apparatus; C:nucleoplasm; C:plasma membrane;, F:sodium channel inhibitor activity;, P:negative regulation of exocytosis; P:negative regulation of glucose transmembrane transport; P:negative regulation of Golgi to plasma membrane protein transport; P:negative regulation of nucleoside transport; P:negative regulation of protein localization to plasma membrane; P:negative regulation of transport; P:regulation of transcription, DNA-templated; scaffold34 indexed_genome mRNA 22846987 22892728 . + . ID=transcript_7225;Q8IWE5 O94928 Q5VT65 Q6NUH9 Q7L8G1 Q8IVT7 Q8N2T4 Q96AY0 Q9NTF7,Pleckstrin homology domain-containing family M member 2,Salmonella-induced filaments A and kinesin-interacting protein;, PF00169;PF02759;, GO:0010008;GO:0019894;GO:0007030;GO:0032418;GO:1903527;GO:0032880;, C:endosome membrane;, F:kinesin binding;, P:Golgi organization; P:lysosome localization; P:positive regulation of membrane tubulation; P:regulation of protein localization;|Q8IWE5 O94928 Q5VT65 Q6NUH9 Q7L8G1 Q8IVT7 Q8N2T4 Q96AY0 Q9NTF7,Pleckstrin homology domain-containing family M member 2,Salmonella-induced filaments A and kinesin-interacting protein;, PF00169;PF02759;, GO:0010008;GO:0019894;GO:0007030;GO:0032418;GO:1903527;GO:0032880;, C:endosome membrane;, F:kinesin binding;, P:Golgi organization; P:lysosome localization; P:positive regulation of membrane tubulation; P:regulation of protein localization;|Q8IWE5 O94928 Q5VT65 Q6NUH9 Q7L8G1 Q8IVT7 Q8N2T4 Q96AY0 Q9NTF7,Pleckstrin homology domain-containing family M member 2,Salmonella-induced filaments A and kinesin-interacting protein;, PF00169;PF02759;, GO:0010008;GO:0019894;GO:0007030;GO:0032418;GO:1903527;GO:0032880;, C:endosome membrane;, F:kinesin binding;, P:Golgi organization; P:lysosome localization; P:positive regulation of membrane tubulation; P:regulation of protein localization;|Q8IWE5 O94928 Q5VT65 Q6NUH9 Q7L8G1 Q8IVT7 Q8N2T4 Q96AY0 Q9NTF7,Pleckstrin homology domain-containing family M member 2,Salmonella-induced filaments A and kinesin-interacting protein;, PF00169;PF02759;, GO:0010008;GO:0019894;GO:0007030;GO:0032418;GO:1903527;GO:0032880;, C:endosome membrane;, F:kinesin binding;, P:Golgi organization; P:lysosome localization; P:positive regulation of membrane tubulation; P:regulation of protein localization;|Q8IWE5 O94928 Q5VT65 Q6NUH9 Q7L8G1 Q8IVT7 Q8N2T4 Q96AY0 Q9NTF7,Pleckstrin homology domain-containing family M member 2,Salmonella-induced filaments A and kinesin-interacting protein;, PF00169;PF02759;, GO:0010008;GO:0019894;GO:0007030;GO:0032418;GO:1903527;GO:0032880;, C:endosome membrane;, F:kinesin binding;, P:Golgi organization; P:lysosome localization; P:positive regulation of membrane tubulation; P:regulation of protein localization;|Q8IWE5 O94928 Q5VT65 Q6NUH9 Q7L8G1 Q8IVT7 Q8N2T4 Q96AY0 Q9NTF7,Pleckstrin homology domain-containing family M member 2,Salmonella-induced filaments A and kinesin-interacting protein;, PF00169;PF02759;, GO:0010008;GO:0019894;GO:0007030;GO:0032418;GO:1903527;GO:0032880;, C:endosome membrane;, F:kinesin binding;, P:Golgi organization; P:lysosome localization; P:positive regulation of membrane tubulation; P:regulation of protein localization;|Q6PIV7 Q68DV0,Solute carrier family 25 member 34,, PF00153;, GO:0016021;GO:0005743;GO:0001835;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:blastocyst hatching;|Q6PIV7 Q68DV0,Solute carrier family 25 member 34,, PF00153;, GO:0016021;GO:0005743;GO:0001835;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:blastocyst hatching; scaffold34 indexed_genome mRNA 22893171 22897319 . + . ID=transcript_7226;A0PJX8 B2RP27 Q5VVD4,Transmembrane protein 82,, PF15816;, GO:0016021;, C:integral component of membrane; scaffold34 indexed_genome mRNA 22916589 22937222 . + . ID=transcript_7227;Q8WUP2 B3KNY0 Q5VVE0 Q5VVE1 Q8IX23 Q96T00 Q9UFD6,Filamin-binding LIM protein 1,Migfilin;Mitogen-inducible 2-interacting protein;, PF00412;, GO:0030054;GO:0071944;GO:0005737;GO:0005829;GO:0001650;GO:0005925;GO:0001725;GO:0031005;GO:0046872;GO:0034329;GO:0098609;GO:0008360;GO:0033623;, C:cell junction; C:cell periphery; C:cytoplasm; C:cytosol; C:fibrillar center; C:focal adhesion; C:stress fiber;, F:filamin binding; F:metal ion binding;, P:cell junction assembly; P:cell-cell adhesion; P:regulation of cell shape; P:regulation of integrin activation;|Q8WUP2 B3KNY0 Q5VVE0 Q5VVE1 Q8IX23 Q96T00 Q9UFD6,Filamin-binding LIM protein 1,Migfilin;Mitogen-inducible 2-interacting protein;, PF00412;, GO:0030054;GO:0071944;GO:0005737;GO:0005829;GO:0001650;GO:0005925;GO:0001725;GO:0031005;GO:0046872;GO:0034329;GO:0098609;GO:0008360;GO:0033623;, C:cell junction; C:cell periphery; C:cytoplasm; C:cytosol; C:fibrillar center; C:focal adhesion; C:stress fiber;, F:filamin binding; F:metal ion binding;, P:cell junction assembly; P:cell-cell adhesion; P:regulation of cell shape; P:regulation of integrin activation; scaffold34 indexed_genome mRNA 22983342 23073148 . + . ID=transcript_7228;Q96T58 Q9H9A8 Q9NWH5 Q9UQ01 Q9Y556,Msx2-interacting protein,SMART/HDAC1-associated repressor protein;SPEN homolog;, PF00076;PF07744;, GO:0070062;GO:0005654;GO:0005634;GO:0017053;GO:0003677;GO:0003676;GO:0003723;GO:0001085;GO:0003714;GO:0000398;GO:0000122;GO:0045892;GO:0007219;GO:0050769;GO:0016032;, C:extracellular exosome; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:DNA binding; F:nucleic acid binding; F:RNA binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:positive regulation of neurogenesis; P:viral process;|Q96T58 Q9H9A8 Q9NWH5 Q9UQ01 Q9Y556,Msx2-interacting protein,SMART/HDAC1-associated repressor protein;SPEN homolog;, PF00076;PF07744;, GO:0070062;GO:0005654;GO:0005634;GO:0017053;GO:0003677;GO:0003676;GO:0003723;GO:0001085;GO:0003714;GO:0000398;GO:0000122;GO:0045892;GO:0007219;GO:0050769;GO:0016032;, C:extracellular exosome; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:DNA binding; F:nucleic acid binding; F:RNA binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:positive regulation of neurogenesis; P:viral process;|Q96T58 Q9H9A8 Q9NWH5 Q9UQ01 Q9Y556,Msx2-interacting protein,SMART/HDAC1-associated repressor protein;SPEN homolog;, PF00076;PF07744;, GO:0070062;GO:0005654;GO:0005634;GO:0017053;GO:0003677;GO:0003676;GO:0003723;GO:0001085;GO:0003714;GO:0000398;GO:0000122;GO:0045892;GO:0007219;GO:0050769;GO:0016032;, C:extracellular exosome; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:DNA binding; F:nucleic acid binding; F:RNA binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:positive regulation of neurogenesis; P:viral process; scaffold34 indexed_genome mRNA 23073176 23103492 . - . ID=transcript_7229;Q13105 A0AV07 B4DXB4 B7ZLQ9 F5H411 Q15932 Q5JYB2 Q9NUC9,Zinc finger and BTB domain-containing protein 17,Myc-interacting zinc finger protein 1;Zinc finger protein 151;Zinc finger protein 60;, PF00651;PF00096;, GO:0005654;GO:0032991;GO:0032993;GO:0001046;GO:0001228;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0001223;GO:0008134;GO:0007398;GO:0001702;GO:0036498;GO:0045786;GO:0008285;GO:0071158;GO:0045944;GO:0006357;, C:nucleoplasm; C:protein-containing complex; C:protein-DNA complex;, F:core promoter sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator binding; F:transcription factor binding;, P:ectoderm development; P:gastrulation with mouth forming second; P:IRE1-mediated unfolded protein response; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:positive regulation of cell cycle arrest; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q13105 A0AV07 B4DXB4 B7ZLQ9 F5H411 Q15932 Q5JYB2 Q9NUC9,Zinc finger and BTB domain-containing protein 17,Myc-interacting zinc finger protein 1;Zinc finger protein 151;Zinc finger protein 60;, PF00651;PF00096;, GO:0005654;GO:0032991;GO:0032993;GO:0001046;GO:0001228;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0001223;GO:0008134;GO:0007398;GO:0001702;GO:0036498;GO:0045786;GO:0008285;GO:0071158;GO:0045944;GO:0006357;, C:nucleoplasm; C:protein-containing complex; C:protein-DNA complex;, F:core promoter sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator binding; F:transcription factor binding;, P:ectoderm development; P:gastrulation with mouth forming second; P:IRE1-mediated unfolded protein response; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:positive regulation of cell cycle arrest; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold34 indexed_genome mRNA 23163036 23194714 . + . ID=transcript_7230;O75513 Q9UET1,Deformed epidermal autoregulatory factor 1 homolog,Nuclear DEAF-1-related transcriptional regulator;Suppressin;Zinc finger MYND domain-containing protein 5;, PF01342;PF01753;, GO:0000785;GO:0005737;GO:0005576;GO:0001650;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0009653;GO:0048706;GO:0007281;GO:0000122;GO:0045892;GO:0001843;GO:0045893;GO:0033599;GO:0006357;GO:0006366;, C:chromatin; C:cytoplasm; C:extracellular region; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:embryonic skeletal system development; P:germ cell development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q8TB59,Sterile alpha motif domain-containing protein 11,, PF07647;, GO:0005634;GO:0003682;GO:0042393;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding;, P:negative regulation of transcription, DNA-templated;|Q8TB59,Sterile alpha motif domain-containing protein 11,, PF07647;, GO:0005634;GO:0003682;GO:0042393;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding;, P:negative regulation of transcription, DNA-templated;|Q8TB59,Sterile alpha motif domain-containing protein 11,, PF07647;, GO:0005634;GO:0003682;GO:0042393;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding;, P:negative regulation of transcription, DNA-templated;|Q8TB59,Sterile alpha motif domain-containing protein 11,, PF07647;, GO:0005634;GO:0003682;GO:0042393;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding;, P:negative regulation of transcription, DNA-templated;|Q9Y3T9 Q5SVA3 Q9BTN6,Nucleolar complex protein 2 homolog,NOC2-like protein;Novel INHAT repressor;, PF03715;, GO:0005694;GO:0005829;GO:0030690;GO:0030691;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0070491;GO:0003723;GO:0003714;GO:0006915;GO:0034644;GO:0031497;GO:0002903;GO:0035067;GO:2001243;GO:0000122;GO:1901796;GO:0042273;, C:chromosome; C:cytosol; C:Noc1p-Noc2p complex; C:Noc2p-Noc3p complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:repressing transcription factor binding; F:RNA binding; F:transcription corepressor activity;, P:apoptotic process; P:cellular response to UV; P:chromatin assembly; P:negative regulation of B cell apoptotic process; P:negative regulation of histone acetylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis;|Q9Y3T9 Q5SVA3 Q9BTN6,Nucleolar complex protein 2 homolog,NOC2-like protein;Novel INHAT repressor;, PF03715;, GO:0005694;GO:0005829;GO:0030690;GO:0030691;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0070491;GO:0003723;GO:0003714;GO:0006915;GO:0034644;GO:0031497;GO:0002903;GO:0035067;GO:2001243;GO:0000122;GO:1901796;GO:0042273;, C:chromosome; C:cytosol; C:Noc1p-Noc2p complex; C:Noc2p-Noc3p complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:repressing transcription factor binding; F:RNA binding; F:transcription corepressor activity;, P:apoptotic process; P:cellular response to UV; P:chromatin assembly; P:negative regulation of B cell apoptotic process; P:negative regulation of histone acetylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis;|Q9Y3T9 Q5SVA3 Q9BTN6,Nucleolar complex protein 2 homolog,NOC2-like protein;Novel INHAT repressor;, PF03715;, GO:0005694;GO:0005829;GO:0030690;GO:0030691;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0070491;GO:0003723;GO:0003714;GO:0006915;GO:0034644;GO:0031497;GO:0002903;GO:0035067;GO:2001243;GO:0000122;GO:1901796;GO:0042273;, C:chromosome; C:cytosol; C:Noc1p-Noc2p complex; C:Noc2p-Noc3p complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:repressing transcription factor binding; F:RNA binding; F:transcription corepressor activity;, P:apoptotic process; P:cellular response to UV; P:chromatin assembly; P:negative regulation of B cell apoptotic process; P:negative regulation of histone acetylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis;|Q9Y3T9 Q5SVA3 Q9BTN6,Nucleolar complex protein 2 homolog,NOC2-like protein;Novel INHAT repressor;, PF03715;, GO:0005694;GO:0005829;GO:0030690;GO:0030691;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0070491;GO:0003723;GO:0003714;GO:0006915;GO:0034644;GO:0031497;GO:0002903;GO:0035067;GO:2001243;GO:0000122;GO:1901796;GO:0042273;, C:chromosome; C:cytosol; C:Noc1p-Noc2p complex; C:Noc2p-Noc3p complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:repressing transcription factor binding; F:RNA binding; F:transcription corepressor activity;, P:apoptotic process; P:cellular response to UV; P:chromatin assembly; P:negative regulation of B cell apoptotic process; P:negative regulation of histone acetylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis;|Q9Y3T9 Q5SVA3 Q9BTN6,Nucleolar complex protein 2 homolog,NOC2-like protein;Novel INHAT repressor;, PF03715;, GO:0005694;GO:0005829;GO:0030690;GO:0030691;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0070491;GO:0003723;GO:0003714;GO:0006915;GO:0034644;GO:0031497;GO:0002903;GO:0035067;GO:2001243;GO:0000122;GO:1901796;GO:0042273;, C:chromosome; C:cytosol; C:Noc1p-Noc2p complex; C:Noc2p-Noc3p complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:repressing transcription factor binding; F:RNA binding; F:transcription corepressor activity;, P:apoptotic process; P:cellular response to UV; P:chromatin assembly; P:negative regulation of B cell apoptotic process; P:negative regulation of histone acetylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis;|Q9Y3T9 Q5SVA3 Q9BTN6,Nucleolar complex protein 2 homolog,NOC2-like protein;Novel INHAT repressor;, PF03715;, GO:0005694;GO:0005829;GO:0030690;GO:0030691;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0070491;GO:0003723;GO:0003714;GO:0006915;GO:0034644;GO:0031497;GO:0002903;GO:0035067;GO:2001243;GO:0000122;GO:1901796;GO:0042273;, C:chromosome; C:cytosol; C:Noc1p-Noc2p complex; C:Noc2p-Noc3p complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:repressing transcription factor binding; F:RNA binding; F:transcription corepressor activity;, P:apoptotic process; P:cellular response to UV; P:chromatin assembly; P:negative regulation of B cell apoptotic process; P:negative regulation of histone acetylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis;|Q9Y3T9 Q5SVA3 Q9BTN6,Nucleolar complex protein 2 homolog,NOC2-like protein;Novel INHAT repressor;, PF03715;, GO:0005694;GO:0005829;GO:0030690;GO:0030691;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0070491;GO:0003723;GO:0003714;GO:0006915;GO:0034644;GO:0031497;GO:0002903;GO:0035067;GO:2001243;GO:0000122;GO:1901796;GO:0042273;, C:chromosome; C:cytosol; C:Noc1p-Noc2p complex; C:Noc2p-Noc3p complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:repressing transcription factor binding; F:RNA binding; F:transcription corepressor activity;, P:apoptotic process; P:cellular response to UV; P:chromatin assembly; P:negative regulation of B cell apoptotic process; P:negative regulation of histone acetylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis;|Q9Y3T9 Q5SVA3 Q9BTN6,Nucleolar complex protein 2 homolog,NOC2-like protein;Novel INHAT repressor;, PF03715;, GO:0005694;GO:0005829;GO:0030690;GO:0030691;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0070491;GO:0003723;GO:0003714;GO:0006915;GO:0034644;GO:0031497;GO:0002903;GO:0035067;GO:2001243;GO:0000122;GO:1901796;GO:0042273;, C:chromosome; C:cytosol; C:Noc1p-Noc2p complex; C:Noc2p-Noc3p complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:repressing transcription factor binding; F:RNA binding; F:transcription corepressor activity;, P:apoptotic process; P:cellular response to UV; P:chromatin assembly; P:negative regulation of B cell apoptotic process; P:negative regulation of histone acetylation; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis; scaffold34 indexed_genome mRNA 23200954 23220363 . + . ID=transcript_7231;Q6TDP4 Q5SV94,Kelch-like protein 17,Actinfilin;, PF07707;PF00651;PF01344;, GO:0015629;GO:0032839;GO:0005615;GO:0043025;GO:0014069;GO:0051015;GO:0060090;GO:0031208;GO:0030036;GO:0007420;GO:0016567;, C:actin cytoskeleton; C:dendrite cytoplasm; C:extracellular space; C:neuronal cell body; C:postsynaptic density;, F:actin filament binding; F:molecular adaptor activity; F:POZ domain binding;, P:actin cytoskeleton organization; P:brain development; P:protein ubiquitination;|Q6TDP4 Q5SV94,Kelch-like protein 17,Actinfilin;, PF07707;PF00651;PF01344;, GO:0015629;GO:0032839;GO:0005615;GO:0043025;GO:0014069;GO:0051015;GO:0060090;GO:0031208;GO:0030036;GO:0007420;GO:0016567;, C:actin cytoskeleton; C:dendrite cytoplasm; C:extracellular space; C:neuronal cell body; C:postsynaptic density;, F:actin filament binding; F:molecular adaptor activity; F:POZ domain binding;, P:actin cytoskeleton organization; P:brain development; P:protein ubiquitination;|Q494U1 Q494U2 Q5SV98 Q9H0M7,Pleckstrin homology domain-containing family N member 1,Cardiolipin and phosphatidic acid-binding protein {ECO:0000303|PubMed:18191643, ECO:0000303|PubMed:29180010};, , GO:0005856;GO:0031966;GO:0005739;GO:0005886;GO:1901612;GO:0070300;GO:1901981;GO:0001786;GO:0061158;GO:0043065;GO:0001666;, C:cytoskeleton; C:mitochondrial membrane; C:mitochondrion; C:plasma membrane;, F:cardiolipin binding; F:phosphatidic acid binding; F:phosphatidylinositol phosphate binding; F:phosphatidylserine binding;, P:3'-UTR-mediated mRNA destabilization; P:positive regulation of apoptotic process; P:response to hypoxia;|Q5SV97 Q6ZVZ7 Q9BRF2 S5G239,PGC-1 and ERR-induced regulator in muscle protein 1,PPARGC1 and ESRR-induced regulator in muscle 1;Peroxisome proliferator-activated receptor gamma coactivator 1 and estrogen-related receptor-induced regulator in muscle 1;, , GO:0005737;GO:0005634;GO:0006355;GO:0014850;, C:cytoplasm; C:nucleus;, , P:regulation of transcription, DNA-templated; P:response to muscle activity; scaffold34 indexed_genome mRNA 23226043 23226851 . - . ID=transcript_7232;Q96M89 Q05DF1 Q4ZG07 Q53TE1 Q6ZUY5 Q86VL7,Coiled-coil domain-containing protein 138 scaffold34 indexed_genome mRNA 23232778 23237165 . - . ID=transcript_7233;Q9HCC6 Q5SVA5,Transcription factor HES-4,Class B basic helix-loop-helix protein 42;Hairy and enhancer of split 4;bHLH factor Hes4;, PF07527;PF00010;, GO:0000785;GO:0005634;GO:0000981;GO:0046983;GO:0000978;GO:0008134;GO:0009952;GO:0030154;GO:0007399;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; scaffold34 indexed_genome mRNA 23248349 23249432 . + . ID=transcript_7234;P05161 Q5SVA4 Q7Z2G2 Q96GF0,Ubiquitin-like protein ISG15,Interferon-induced 15 kDa protein;Interferon-induced 17 kDa protein;Ubiquitin cross-reactive protein;, PF00240;, GO:0005737;GO:0005829;GO:0022627;GO:0005576;GO:0005654;GO:0005634;GO:0005178;GO:0031386;GO:0031625;GO:0042742;GO:0051607;GO:0007229;GO:0032020;GO:0019941;GO:0031397;GO:0032480;GO:0045071;GO:0030501;GO:0045648;GO:0032729;GO:0032733;GO:0032649;GO:0034340;GO:0019985;GO:0060337;GO:0016032;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular region; C:nucleoplasm; C:nucleus;, F:integrin binding; F:protein tag; F:ubiquitin protein ligase binding;, P:defense response to bacterium; P:defense response to virus; P:integrin-mediated signaling pathway; P:ISG15-protein conjugation; P:modification-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:negative regulation of type I interferon production; P:negative regulation of viral genome replication; P:positive regulation of bone mineralization; P:positive regulation of erythrocyte differentiation; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:regulation of interferon-gamma production; P:response to type I interferon; P:translesion synthesis; P:type I interferon signaling pathway; P:viral process; scaffold34 indexed_genome mRNA 23256447 23292646 . + . ID=transcript_7235;O00468 Q5SVA1 Q5SVA2 Q60FE1 Q7KYS8 Q8N4J5 Q96IC1 Q9BTD4,Agrin,, PF00008;PF00050;PF07648;PF00053;PF00054;PF03146;PF01390;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005796;GO:0016021;GO:0043202;GO:0005886;GO:0045202;GO:0005509;GO:0035374;GO:0002162;GO:0043395;GO:0043236;GO:0033691;GO:0005200;GO:0009887;GO:0045162;GO:0030198;GO:0007213;GO:0006024;GO:0006027;GO:0007528;GO:0051491;GO:0043547;GO:0045887;GO:0045944;GO:0043113;GO:0001523;GO:0007165;GO:0050808;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:plasma membrane; C:synapse;, F:calcium ion binding; F:chondroitin sulfate binding; F:dystroglycan binding; F:heparan sulfate proteoglycan binding; F:laminin binding; F:sialic acid binding; F:structural constituent of cytoskeleton;, P:animal organ morphogenesis; P:clustering of voltage-gated sodium channels; P:extracellular matrix organization; P:G protein-coupled acetylcholine receptor signaling pathway; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:neuromuscular junction development; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:positive regulation of synaptic growth at neuromuscular junction; P:positive regulation of transcription by RNA polymerase II; P:receptor clustering; P:retinoid metabolic process; P:signal transduction; P:synapse organization; P:tissue development; scaffold34 indexed_genome mRNA 23301303 23306590 . + . ID=transcript_7236;Q06124 A8K1D9 Q96HD7,Tyrosine-protein phosphatase non-receptor type 11,Protein-tyrosine phosphatase 1D;Protein-tyrosine phosphatase 2C;SH-PTP2;SH-PTP3;, PF00017;PF00102;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0045296;GO:0050839;GO:0031748;GO:0005158;GO:0043560;GO:0004726;GO:0051428;GO:0043274;GO:0004721;GO:0001784;GO:0019904;GO:0019901;GO:1990782;GO:0004725;GO:0030971;GO:0030159;GO:0033277;GO:0000187;GO:0036302;GO:0007411;GO:0060020;GO:0007420;GO:0071345;GO:0071364;GO:0071260;GO:0021697;GO:0019221;GO:0000077;GO:0048013;GO:0007173;GO:0038127;GO:0060325;GO:0008543;GO:0048806;GO:0042593;GO:0007507;GO:0048873;GO:0042445;GO:0009755;GO:0048839;GO:0007229;GO:0070102;GO:0061582;GO:0050900;GO:0035855;GO:0032528;GO:0035264;GO:0048609;GO:0033629;GO:0032331;GO:0051463;GO:0060125;GO:0046676;GO:0048011;GO:0035265;GO:0035335;GO:0030168;GO:0030220;GO:0048008;GO:0070374;GO:0046326;GO:0046887;GO:0046628;GO:0032728;GO:0032755;GO:0045931;GO:0045778;GO:0050731;GO:0051897;GO:0032760;GO:0033628;GO:0046825;GO:0043254;GO:0060338;GO:0031295;GO:0006641;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cadherin binding; F:cell adhesion molecule binding; F:D1 dopamine receptor binding; F:insulin receptor binding; F:insulin receptor substrate binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:peptide hormone receptor binding; F:phospholipase binding; F:phosphoprotein phosphatase activity; F:phosphotyrosine residue binding; F:protein domain specific binding; F:protein kinase binding; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:signaling receptor complex adaptor activity;, P:abortive mitotic cell cycle; P:activation of MAPK activity; P:atrioventricular canal development; P:axon guidance; P:Bergmann glial cell differentiation; P:brain development; P:cellular response to cytokine stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to mechanical stimulus; P:cerebellar cortex formation; P:cytokine-mediated signaling pathway; P:DNA damage checkpoint; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB signaling pathway; P:face morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:genitalia development; P:glucose homeostasis; P:heart development; P:homeostasis of number of cells within a tissue; P:hormone metabolic process; P:hormone-mediated signaling pathway; P:inner ear development; P:integrin-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell migration; P:leukocyte migration; P:megakaryocyte development; P:microvillus organization; P:multicellular organism growth; P:multicellular organismal reproductive process; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of chondrocyte differentiation; P:negative regulation of cortisol secretion; P:negative regulation of growth hormone secretion; P:negative regulation of insulin secretion; P:neurotrophin TRK receptor signaling pathway; P:organ growth; P:peptidyl-tyrosine dephosphorylation; P:platelet activation; P:platelet formation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glucose import; P:positive regulation of hormone secretion; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of mitotic cell cycle; P:positive regulation of ossification; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor production; P:regulation of cell adhesion mediated by integrin; P:regulation of protein export from nucleus; P:regulation of protein-containing complex assembly; P:regulation of type I interferon-mediated signaling pathway; P:T cell costimulation; P:triglyceride metabolic process; scaffold34 indexed_genome mRNA 23307568 23323464 . - . ID=transcript_7237;E7ERA6 B4DKI4,RING finger protein 223,, PF13639;, GO:0016021;GO:0046872;, C:integral component of membrane;, F:metal ion binding;|Q96HA4 B3KQ46 Q5T2W6 Q6UX67 Q6ZR77 Q9NWV0,Uncharacterized protein C1orf159,, PF14946;, GO:0016021;, C:integral component of membrane; scaffold34 indexed_genome mRNA 23417517 23420536 . - . ID=transcript_7238;Q9Y5U5 B1AME1 O95851 Q5U0I4 Q9NYJ9,Tumor necrosis factor receptor superfamily member 18,Activation-inducible TNFR family receptor;Glucocorticoid-induced TNFR-related protein;, , GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0005031;GO:0006915;GO:0043066;GO:0045785;GO:0002687;GO:0042531;GO:0045589;GO:0007165;GO:0033209;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:tumor necrosis factor-activated receptor activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of leukocyte migration; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of regulatory T cell differentiation; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; scaffold34 indexed_genome mRNA 23425289 23427024 . - . ID=transcript_7239;P43489 Q13663 Q2M312 Q5T7M0,Tumor necrosis factor receptor superfamily member 4,ACT35 antigen;OX40L receptor;TAX transcriptionally-activated glycoprotein 1 receptor;, PF00020;, GO:0009986;GO:0009897;GO:0005887;GO:0005886;GO:0005031;GO:0001618;GO:0006955;GO:0006954;GO:0043433;GO:0045892;GO:0030890;GO:0002639;GO:0042098;GO:0033209;, C:cell surface; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:tumor necrosis factor-activated receptor activity; F:virus receptor activity;, P:immune response; P:inflammatory response; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription, DNA-templated; P:positive regulation of B cell proliferation; P:positive regulation of immunoglobulin production; P:T cell proliferation; P:tumor necrosis factor-mediated signaling pathway; scaffold34 indexed_genome mRNA 23430790 23443641 . - . ID=transcript_7240;Q9NZP7 Q9UN53,45 kDa calcium-binding protein,Stromal cell-derived factor 4;, PF13202;PF13499;, GO:0032059;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0005796;GO:0005770;GO:0016020;GO:0005886;GO:0005509;GO:0042802;GO:0017156;GO:0021549;GO:0045444;GO:0045471;GO:0009650;GO:0070625;, C:bleb; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi lumen; C:late endosome; C:membrane; C:plasma membrane;, F:calcium ion binding; F:identical protein binding;, P:calcium-ion regulated exocytosis; P:cerebellum development; P:fat cell differentiation; P:response to ethanol; P:UV protection; P:zymogen granule exocytosis; scaffold34 indexed_genome mRNA 23455395 23457234 . - . ID=transcript_7241;Q5T7M4 Q5EBL5,Adipolin,Adipose-derived insulin-sensitizing factor;C1q and TNF related protein 12 {ECO:0000303|PubMed:22275362};Complement C1q tumor necrosis factor-related protein 12;, , GO:0005576;GO:0005615;GO:0005179;GO:0045721;GO:0050728;GO:0046326;GO:0046628;GO:0035774;GO:0051897;GO:0046324;, C:extracellular region; C:extracellular space;, F:hormone activity;, P:negative regulation of gluconeogenesis; P:negative regulation of inflammatory response; P:positive regulation of glucose import; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of protein kinase B signaling; P:regulation of glucose import; scaffold34 indexed_genome mRNA 23461397 23471874 . - . ID=transcript_7242;Q8N2K1 A8MYC7 Q504T9 Q96N26 Q96T84,Ubiquitin-conjugating enzyme E2 J2,E2 ubiquitin-conjugating enzyme J2;Non-canonical ubiquitin-conjugating enzyme 2;, PF00179;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0005634;GO:0000151;GO:0005524;GO:0061631;GO:0031625;GO:1903955;GO:0045048;GO:0000209;GO:0016567;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding;, P:positive regulation of protein targeting to mitochondrion; P:protein insertion into ER membrane; P:protein polyubiquitination; P:protein ubiquitination; P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q8N2K1 A8MYC7 Q504T9 Q96N26 Q96T84,Ubiquitin-conjugating enzyme E2 J2,E2 ubiquitin-conjugating enzyme J2;Non-canonical ubiquitin-conjugating enzyme 2;, PF00179;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0005634;GO:0000151;GO:0005524;GO:0061631;GO:0031625;GO:1903955;GO:0045048;GO:0000209;GO:0016567;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding;, P:positive regulation of protein targeting to mitochondrion; P:protein insertion into ER membrane; P:protein polyubiquitination; P:protein ubiquitination; P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q8N2K1 A8MYC7 Q504T9 Q96N26 Q96T84,Ubiquitin-conjugating enzyme E2 J2,E2 ubiquitin-conjugating enzyme J2;Non-canonical ubiquitin-conjugating enzyme 2;, PF00179;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0005634;GO:0000151;GO:0005524;GO:0061631;GO:0031625;GO:1903955;GO:0045048;GO:0000209;GO:0016567;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding;, P:positive regulation of protein targeting to mitochondrion; P:protein insertion into ER membrane; P:protein polyubiquitination; P:protein ubiquitination; P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q8N2K1 A8MYC7 Q504T9 Q96N26 Q96T84,Ubiquitin-conjugating enzyme E2 J2,E2 ubiquitin-conjugating enzyme J2;Non-canonical ubiquitin-conjugating enzyme 2;, PF00179;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0005634;GO:0000151;GO:0005524;GO:0061631;GO:0031625;GO:1903955;GO:0045048;GO:0000209;GO:0016567;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding;, P:positive regulation of protein targeting to mitochondrion; P:protein insertion into ER membrane; P:protein polyubiquitination; P:protein ubiquitination; P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q8N2K1 A8MYC7 Q504T9 Q96N26 Q96T84,Ubiquitin-conjugating enzyme E2 J2,E2 ubiquitin-conjugating enzyme J2;Non-canonical ubiquitin-conjugating enzyme 2;, PF00179;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0005634;GO:0000151;GO:0005524;GO:0061631;GO:0031625;GO:1903955;GO:0045048;GO:0000209;GO:0016567;GO:0006986;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding;, P:positive regulation of protein targeting to mitochondrion; P:protein insertion into ER membrane; P:protein polyubiquitination; P:protein ubiquitination; P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway; scaffold34 indexed_genome mRNA 23488552 23507815 . - . ID=transcript_7243;Q96P50 B1AMF5 Q5TA42 Q5TA43 Q86UT3 Q9BSR9 Q9C0E7,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3,Centaurin-beta-5;, PF01412;PF00169;, GO:0030426;GO:0005096;GO:0046872;GO:0001764;GO:0010975;, C:growth cone;, F:GTPase activator activity; F:metal ion binding;, P:neuron migration; P:regulation of neuron projection development;|Q96P50 B1AMF5 Q5TA42 Q5TA43 Q86UT3 Q9BSR9 Q9C0E7,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3,Centaurin-beta-5;, PF01412;PF00169;, GO:0030426;GO:0005096;GO:0046872;GO:0001764;GO:0010975;, C:growth cone;, F:GTPase activator activity; F:metal ion binding;, P:neuron migration; P:regulation of neuron projection development;|Q96P50 B1AMF5 Q5TA42 Q5TA43 Q86UT3 Q9BSR9 Q9C0E7,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3,Centaurin-beta-5;, PF01412;PF00169;, GO:0030426;GO:0005096;GO:0046872;GO:0001764;GO:0010975;, C:growth cone;, F:GTPase activator activity; F:metal ion binding;, P:neuron migration; P:regulation of neuron projection development;|Q96P50 B1AMF5 Q5TA42 Q5TA43 Q86UT3 Q9BSR9 Q9C0E7,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3,Centaurin-beta-5;, PF01412;PF00169;, GO:0030426;GO:0005096;GO:0046872;GO:0001764;GO:0010975;, C:growth cone;, F:GTPase activator activity; F:metal ion binding;, P:neuron migration; P:regulation of neuron projection development;|Q96P50 B1AMF5 Q5TA42 Q5TA43 Q86UT3 Q9BSR9 Q9C0E7,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3,Centaurin-beta-5;, PF01412;PF00169;, GO:0030426;GO:0005096;GO:0046872;GO:0001764;GO:0010975;, C:growth cone;, F:GTPase activator activity; F:metal ion binding;, P:neuron migration; P:regulation of neuron projection development; scaffold34 indexed_genome mRNA 23513750 23526543 . + . ID=transcript_7244;Q8N0Z8 B4DP76 Q5TA41,tRNA pseudouridine synthase-like 1,tRNA pseudouridylate synthase-like 1;tRNA-uridine isomerase-like 1;, PF01416;, GO:0043231;GO:0005739;GO:0009982;GO:0003723;GO:0031119;, C:intracellular membrane-bounded organelle; C:mitochondrion;, F:pseudouridine synthase activity; F:RNA binding;, P:tRNA pseudouridine synthesis;|Q5TA54 Q7L3D7 Q96HY1 Q9BW36 Q9H0F9 Q9H8R5 Q9HAA6 Q9NWX9,Integrator complex subunit 11,Cleavage and polyadenylation-specific factor 3-like protein;Protein related to CPSF subunits of 68 kDa;, PF10996;PF16661;PF07521;, GO:0072562;GO:0005737;GO:0005829;GO:0032039;GO:0005654;GO:0005634;GO:0016787;GO:0016180;GO:0042795;, C:blood microparticle; C:cytoplasm; C:cytosol; C:integrator complex; C:nucleoplasm; C:nucleus;, F:hydrolase activity;, P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q5TA54 Q7L3D7 Q96HY1 Q9BW36 Q9H0F9 Q9H8R5 Q9HAA6 Q9NWX9,Integrator complex subunit 11,Cleavage and polyadenylation-specific factor 3-like protein;Protein related to CPSF subunits of 68 kDa;, PF10996;PF16661;PF07521;, GO:0072562;GO:0005737;GO:0005829;GO:0032039;GO:0005654;GO:0005634;GO:0016787;GO:0016180;GO:0042795;, C:blood microparticle; C:cytoplasm; C:cytosol; C:integrator complex; C:nucleoplasm; C:nucleus;, F:hydrolase activity;, P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q5TA54 Q7L3D7 Q96HY1 Q9BW36 Q9H0F9 Q9H8R5 Q9HAA6 Q9NWX9,Integrator complex subunit 11,Cleavage and polyadenylation-specific factor 3-like protein;Protein related to CPSF subunits of 68 kDa;, PF10996;PF16661;PF07521;, GO:0072562;GO:0005737;GO:0005829;GO:0032039;GO:0005654;GO:0005634;GO:0016787;GO:0016180;GO:0042795;, C:blood microparticle; C:cytoplasm; C:cytosol; C:integrator complex; C:nucleoplasm; C:nucleus;, F:hydrolase activity;, P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold34 indexed_genome mRNA 23533209 23535309 . + . ID=transcript_7245;Q5TA50 Q4G0E6 Q7L5A4,Ceramide-1-phosphate transfer protein {ECO:0000303|PubMed:23863933, ECO:0000305},Glycolipid transfer protein domain-containing protein 1 {ECO:0000305};, PF08718;, GO:0005829;GO:0010008;GO:0005794;GO:0016020;GO:0005640;GO:0005886;GO:1902387;GO:1902388;GO:0005543;GO:1902389;GO:0035627;GO:0006687;GO:0120009;GO:0010507;GO:0032691;GO:1900226;, C:cytosol; C:endosome membrane; C:Golgi apparatus; C:membrane; C:nuclear outer membrane; C:plasma membrane;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:phospholipid binding;, P:ceramide 1-phosphate transport; P:ceramide transport; P:glycosphingolipid metabolic process; P:intermembrane lipid transfer; P:negative regulation of autophagy; P:negative regulation of interleukin-1 beta production; P:negative regulation of NLRP3 inflammasome complex assembly; scaffold34 indexed_genome mRNA 23535995 23537164 . - . ID=transcript_7246;Q7RTX0 Q5TA49 Q8NGW9,Taste receptor type 1 member 3,Sweet taste receptor T1R3;, PF00003;PF01094;PF07562;, GO:0016021;GO:0005887;GO:0005886;GO:1903767;GO:0004930;GO:0008527;GO:0001582;GO:0007186;GO:0050916;GO:0050917;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:sweet taste receptor complex;, F:G protein-coupled receptor activity; F:taste receptor activity;, P:detection of chemical stimulus involved in sensory perception of sweet taste; P:G protein-coupled receptor signaling pathway; P:sensory perception of sweet taste; P:sensory perception of umami taste; scaffold34 indexed_genome mRNA 23538038 23538912 . + . ID=transcript_7247;Q7RTX0 Q5TA49 Q8NGW9,Taste receptor type 1 member 3,Sweet taste receptor T1R3;, PF00003;PF01094;PF07562;, GO:0016021;GO:0005887;GO:0005886;GO:1903767;GO:0004930;GO:0008527;GO:0001582;GO:0007186;GO:0050916;GO:0050917;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:sweet taste receptor complex;, F:G protein-coupled receptor activity; F:taste receptor activity;, P:detection of chemical stimulus involved in sensory perception of sweet taste; P:G protein-coupled receptor signaling pathway; P:sensory perception of sweet taste; P:sensory perception of umami taste; scaffold34 indexed_genome mRNA 23538913 23539607 . + . ID=transcript_7248;Q7RTX0 Q5TA49 Q8NGW9,Taste receptor type 1 member 3,Sweet taste receptor T1R3;, PF00003;PF01094;PF07562;, GO:0016021;GO:0005887;GO:0005886;GO:1903767;GO:0004930;GO:0008527;GO:0001582;GO:0007186;GO:0050916;GO:0050917;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:sweet taste receptor complex;, F:G protein-coupled receptor activity; F:taste receptor activity;, P:detection of chemical stimulus involved in sensory perception of sweet taste; P:G protein-coupled receptor signaling pathway; P:sensory perception of sweet taste; P:sensory perception of umami taste; scaffold34 indexed_genome mRNA 23540083 23545576 . - . ID=transcript_7249;O14640 Q5TA33 Q5TA35,Segment polarity protein dishevelled homolog DVL-1,DSH homolog 1;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0030136;GO:0031410;GO:0005829;GO:0043197;GO:0098978;GO:0030426;GO:0016328;GO:0005874;GO:0043005;GO:0043025;GO:0014069;GO:0098793;GO:0098685;GO:0045202;GO:1990909;GO:0008013;GO:0019899;GO:0005109;GO:0042802;GO:0019901;GO:0048675;GO:0007411;GO:1904886;GO:0060070;GO:0090103;GO:0048668;GO:0022007;GO:0031122;GO:0048813;GO:0060997;GO:0035556;GO:0090090;GO:0032091;GO:0006469;GO:0021915;GO:0007528;GO:0007269;GO:0035567;GO:0090179;GO:2000463;GO:0150012;GO:0010976;GO:0032436;GO:1905386;GO:0001934;GO:0045944;GO:0060134;GO:0099054;GO:0035372;GO:0034504;GO:0050821;GO:0043113;GO:1903827;GO:0001505;GO:2000300;GO:0006355;GO:0071340;GO:0035176;GO:0050808;GO:0060071;, C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:growth cone; C:lateral plasma membrane; C:microtubule; C:neuron projection; C:neuronal cell body; C:postsynaptic density; C:presynapse; C:Schaffer collateral - CA1 synapse; C:synapse; C:Wnt signalosome;, F:beta-catenin binding; F:enzyme binding; F:frizzled binding; F:identical protein binding; F:protein kinase binding;, P:axon extension; P:axon guidance; P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:cochlea morphogenesis; P:collateral sprouting; P:convergent extension involved in neural plate elongation; P:cytoplasmic microtubule organization; P:dendrite morphogenesis; P:dendritic spine morphogenesis; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:neural tube development; P:neuromuscular junction development; P:neurotransmitter secretion; P:non-canonical Wnt signaling pathway; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron projection arborization; P:positive regulation of neuron projection development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to presynapse; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:prepulse inhibition; P:presynapse assembly; P:protein localization to microtubule; P:protein localization to nucleus; P:protein stabilization; P:receptor clustering; P:regulation of cellular protein localization; P:regulation of neurotransmitter levels; P:regulation of synaptic vesicle exocytosis; P:regulation of transcription, DNA-templated; P:skeletal muscle acetylcholine-gated channel clustering; P:social behavior; P:synapse organization; P:Wnt signaling pathway, planar cell polarity pathway;|O14640 Q5TA33 Q5TA35,Segment polarity protein dishevelled homolog DVL-1,DSH homolog 1;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0030136;GO:0031410;GO:0005829;GO:0043197;GO:0098978;GO:0030426;GO:0016328;GO:0005874;GO:0043005;GO:0043025;GO:0014069;GO:0098793;GO:0098685;GO:0045202;GO:1990909;GO:0008013;GO:0019899;GO:0005109;GO:0042802;GO:0019901;GO:0048675;GO:0007411;GO:1904886;GO:0060070;GO:0090103;GO:0048668;GO:0022007;GO:0031122;GO:0048813;GO:0060997;GO:0035556;GO:0090090;GO:0032091;GO:0006469;GO:0021915;GO:0007528;GO:0007269;GO:0035567;GO:0090179;GO:2000463;GO:0150012;GO:0010976;GO:0032436;GO:1905386;GO:0001934;GO:0045944;GO:0060134;GO:0099054;GO:0035372;GO:0034504;GO:0050821;GO:0043113;GO:1903827;GO:0001505;GO:2000300;GO:0006355;GO:0071340;GO:0035176;GO:0050808;GO:0060071;, C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:growth cone; C:lateral plasma membrane; C:microtubule; C:neuron projection; C:neuronal cell body; C:postsynaptic density; C:presynapse; C:Schaffer collateral - CA1 synapse; C:synapse; C:Wnt signalosome;, F:beta-catenin binding; F:enzyme binding; F:frizzled binding; F:identical protein binding; F:protein kinase binding;, P:axon extension; P:axon guidance; P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:cochlea morphogenesis; P:collateral sprouting; P:convergent extension involved in neural plate elongation; P:cytoplasmic microtubule organization; P:dendrite morphogenesis; P:dendritic spine morphogenesis; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:neural tube development; P:neuromuscular junction development; P:neurotransmitter secretion; P:non-canonical Wnt signaling pathway; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron projection arborization; P:positive regulation of neuron projection development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to presynapse; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:prepulse inhibition; P:presynapse assembly; P:protein localization to microtubule; P:protein localization to nucleus; P:protein stabilization; P:receptor clustering; P:regulation of cellular protein localization; P:regulation of neurotransmitter levels; P:regulation of synaptic vesicle exocytosis; P:regulation of transcription, DNA-templated; P:skeletal muscle acetylcholine-gated channel clustering; P:social behavior; P:synapse organization; P:Wnt signaling pathway, planar cell polarity pathway;|O14640 Q5TA33 Q5TA35,Segment polarity protein dishevelled homolog DVL-1,DSH homolog 1;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0030136;GO:0031410;GO:0005829;GO:0043197;GO:0098978;GO:0030426;GO:0016328;GO:0005874;GO:0043005;GO:0043025;GO:0014069;GO:0098793;GO:0098685;GO:0045202;GO:1990909;GO:0008013;GO:0019899;GO:0005109;GO:0042802;GO:0019901;GO:0048675;GO:0007411;GO:1904886;GO:0060070;GO:0090103;GO:0048668;GO:0022007;GO:0031122;GO:0048813;GO:0060997;GO:0035556;GO:0090090;GO:0032091;GO:0006469;GO:0021915;GO:0007528;GO:0007269;GO:0035567;GO:0090179;GO:2000463;GO:0150012;GO:0010976;GO:0032436;GO:1905386;GO:0001934;GO:0045944;GO:0060134;GO:0099054;GO:0035372;GO:0034504;GO:0050821;GO:0043113;GO:1903827;GO:0001505;GO:2000300;GO:0006355;GO:0071340;GO:0035176;GO:0050808;GO:0060071;, C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:growth cone; C:lateral plasma membrane; C:microtubule; C:neuron projection; C:neuronal cell body; C:postsynaptic density; C:presynapse; C:Schaffer collateral - CA1 synapse; C:synapse; C:Wnt signalosome;, F:beta-catenin binding; F:enzyme binding; F:frizzled binding; F:identical protein binding; F:protein kinase binding;, P:axon extension; P:axon guidance; P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:cochlea morphogenesis; P:collateral sprouting; P:convergent extension involved in neural plate elongation; P:cytoplasmic microtubule organization; P:dendrite morphogenesis; P:dendritic spine morphogenesis; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:neural tube development; P:neuromuscular junction development; P:neurotransmitter secretion; P:non-canonical Wnt signaling pathway; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron projection arborization; P:positive regulation of neuron projection development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to presynapse; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:prepulse inhibition; P:presynapse assembly; P:protein localization to microtubule; P:protein localization to nucleus; P:protein stabilization; P:receptor clustering; P:regulation of cellular protein localization; P:regulation of neurotransmitter levels; P:regulation of synaptic vesicle exocytosis; P:regulation of transcription, DNA-templated; P:skeletal muscle acetylcholine-gated channel clustering; P:social behavior; P:synapse organization; P:Wnt signaling pathway, planar cell polarity pathway; scaffold34 indexed_genome mRNA 23545646 23548324 . - . ID=transcript_7250;O14640 Q5TA33 Q5TA35,Segment polarity protein dishevelled homolog DVL-1,DSH homolog 1;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0030136;GO:0031410;GO:0005829;GO:0043197;GO:0098978;GO:0030426;GO:0016328;GO:0005874;GO:0043005;GO:0043025;GO:0014069;GO:0098793;GO:0098685;GO:0045202;GO:1990909;GO:0008013;GO:0019899;GO:0005109;GO:0042802;GO:0019901;GO:0048675;GO:0007411;GO:1904886;GO:0060070;GO:0090103;GO:0048668;GO:0022007;GO:0031122;GO:0048813;GO:0060997;GO:0035556;GO:0090090;GO:0032091;GO:0006469;GO:0021915;GO:0007528;GO:0007269;GO:0035567;GO:0090179;GO:2000463;GO:0150012;GO:0010976;GO:0032436;GO:1905386;GO:0001934;GO:0045944;GO:0060134;GO:0099054;GO:0035372;GO:0034504;GO:0050821;GO:0043113;GO:1903827;GO:0001505;GO:2000300;GO:0006355;GO:0071340;GO:0035176;GO:0050808;GO:0060071;, C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:growth cone; C:lateral plasma membrane; C:microtubule; C:neuron projection; C:neuronal cell body; C:postsynaptic density; C:presynapse; C:Schaffer collateral - CA1 synapse; C:synapse; C:Wnt signalosome;, F:beta-catenin binding; F:enzyme binding; F:frizzled binding; F:identical protein binding; F:protein kinase binding;, P:axon extension; P:axon guidance; P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:cochlea morphogenesis; P:collateral sprouting; P:convergent extension involved in neural plate elongation; P:cytoplasmic microtubule organization; P:dendrite morphogenesis; P:dendritic spine morphogenesis; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:neural tube development; P:neuromuscular junction development; P:neurotransmitter secretion; P:non-canonical Wnt signaling pathway; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron projection arborization; P:positive regulation of neuron projection development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to presynapse; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:prepulse inhibition; P:presynapse assembly; P:protein localization to microtubule; P:protein localization to nucleus; P:protein stabilization; P:receptor clustering; P:regulation of cellular protein localization; P:regulation of neurotransmitter levels; P:regulation of synaptic vesicle exocytosis; P:regulation of transcription, DNA-templated; P:skeletal muscle acetylcholine-gated channel clustering; P:social behavior; P:synapse organization; P:Wnt signaling pathway, planar cell polarity pathway;|Q92997 B4E3E5 D3DNT0 O14642 Q13531 Q8N5E9 Q92607,Segment polarity protein dishevelled homolog DVL-3,DSH homolog 3;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0000785;GO:0005829;GO:0008013;GO:0005109;GO:0002020;GO:0005102;GO:0031267;GO:1904886;GO:0060070;GO:0035556;GO:0090090;GO:0035567;GO:0038031;GO:0090179;GO:0043547;GO:0043507;GO:0150012;GO:0001934;GO:0045944;GO:0045893;GO:0050821;GO:1903827;GO:0042493;GO:0060071;, C:chromatin; C:cytosol;, F:beta-catenin binding; F:frizzled binding; F:protease binding; F:signaling receptor binding; F:small GTPase binding;, P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:intracellular signal transduction; P:negative regulation of canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway; P:non-canonical Wnt signaling pathway via JNK cascade; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of GTPase activity; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection arborization; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of cellular protein localization; P:response to drug; P:Wnt signaling pathway, planar cell polarity pathway; scaffold34 indexed_genome mRNA 23555618 23560736 . - . ID=transcript_7251;Q9BRK3 B3KTR6 B4DE34 Q5TA39 Q96KC3,Matrix remodeling-associated protein 8,Limitrin;, PF07686;, GO:0005923;GO:0009986;GO:0060170;GO:0005788;GO:0070062;GO:0016021;GO:0005634;GO:0007155;GO:0044267;GO:0060857;GO:0043687;GO:0016032;, C:bicellular tight junction; C:cell surface; C:ciliary membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:integral component of membrane; C:nucleus;, , P:cell adhesion; P:cellular protein metabolic process; P:establishment of glial blood-brain barrier; P:post-translational protein modification; P:viral process;|Q9BRK3 B3KTR6 B4DE34 Q5TA39 Q96KC3,Matrix remodeling-associated protein 8,Limitrin;, PF07686;, GO:0005923;GO:0009986;GO:0060170;GO:0005788;GO:0070062;GO:0016021;GO:0005634;GO:0007155;GO:0044267;GO:0060857;GO:0043687;GO:0016032;, C:bicellular tight junction; C:cell surface; C:ciliary membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:integral component of membrane; C:nucleus;, , P:cell adhesion; P:cellular protein metabolic process; P:establishment of glial blood-brain barrier; P:post-translational protein modification; P:viral process;|Q9BRK3 B3KTR6 B4DE34 Q5TA39 Q96KC3,Matrix remodeling-associated protein 8,Limitrin;, PF07686;, GO:0005923;GO:0009986;GO:0060170;GO:0005788;GO:0070062;GO:0016021;GO:0005634;GO:0007155;GO:0044267;GO:0060857;GO:0043687;GO:0016032;, C:bicellular tight junction; C:cell surface; C:ciliary membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:integral component of membrane; C:nucleus;, , P:cell adhesion; P:cellular protein metabolic process; P:establishment of glial blood-brain barrier; P:post-translational protein modification; P:viral process; scaffold34 indexed_genome mRNA 23581170 23585800 . - . ID=transcript_7252;Q9NWT8 Q5TA36 Q8TBD3,Aurora kinase A-interacting protein,28S ribosomal protein S38, mitochondrial;Mitochondrial small ribosomal subunit protein mS38 {ECO:0000303|PubMed:25838379};, PF08213;, GO:0043231;GO:0005743;GO:0005739;GO:0005654;GO:0005634;GO:0005840;GO:0070125;GO:0070126;GO:0006397;GO:0045839;GO:0045862;, C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ribosome;, , P:mitochondrial translational elongation; P:mitochondrial translational termination; P:mRNA processing; P:negative regulation of mitotic nuclear division; P:positive regulation of proteolysis;|Q9NWT8 Q5TA36 Q8TBD3,Aurora kinase A-interacting protein,28S ribosomal protein S38, mitochondrial;Mitochondrial small ribosomal subunit protein mS38 {ECO:0000303|PubMed:25838379};, PF08213;, GO:0043231;GO:0005743;GO:0005739;GO:0005654;GO:0005634;GO:0005840;GO:0070125;GO:0070126;GO:0006397;GO:0045839;GO:0045862;, C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:ribosome;, , P:mitochondrial translational elongation; P:mitochondrial translational termination; P:mRNA processing; P:negative regulation of mitotic nuclear division; P:positive regulation of proteolysis; scaffold34 indexed_genome mRNA 23587343 23595631 . - . ID=transcript_7253;Q5T2N6 Q6IQ12 Q7Z4Z8 Q8N3C9 Q8N3D5 Q8NHE3 Q8TEL0 Q96B00,Cyclin-L2,Paneth cell-enhanced expression protein;, PF02984;PF00134;, GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0016538;GO:0006357;, C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II;|Q5T2N6 Q6IQ12 Q7Z4Z8 Q8N3C9 Q8N3D5 Q8NHE3 Q8TEL0 Q96B00,Cyclin-L2,Paneth cell-enhanced expression protein;, PF02984;PF00134;, GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0016538;GO:0006357;, C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II;|Q5T2N6 Q6IQ12 Q7Z4Z8 Q8N3C9 Q8N3D5 Q8NHE3 Q8TEL0 Q96B00,Cyclin-L2,Paneth cell-enhanced expression protein;, PF02984;PF00134;, GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0016538;GO:0006357;, C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II; scaffold34 indexed_genome mRNA 23595916 23600919 . - . ID=transcript_7254;Q9BYC9 B2RE41 B7Z746,39S ribosomal protein L20, mitochondrial,Mitochondrial large ribosomal subunit protein bL20m {ECO:0000303|PubMed:25278503};, PF00453;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003723;GO:0019843;GO:0003735;GO:0070125;GO:0070126;GO:0000027;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosomal large subunit assembly;|Q9BYC9 B2RE41 B7Z746,39S ribosomal protein L20, mitochondrial,Mitochondrial large ribosomal subunit protein bL20m {ECO:0000303|PubMed:25278503};, PF00453;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003723;GO:0019843;GO:0003735;GO:0070125;GO:0070126;GO:0000027;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosomal large subunit assembly;|Q9BYC9 B2RE41 B7Z746,39S ribosomal protein L20, mitochondrial,Mitochondrial large ribosomal subunit protein bL20m {ECO:0000303|PubMed:25278503};, PF00453;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003723;GO:0019843;GO:0003735;GO:0070125;GO:0070126;GO:0000027;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosomal large subunit assembly; scaffold34 indexed_genome mRNA 23612124 23616610 . + . ID=transcript_7255;A6NKF7,Transmembrane protein 88B,, , GO:0016021;GO:0005886;GO:0030165;, C:integral component of membrane; C:plasma membrane;, F:PDZ domain binding; scaffold34 indexed_genome mRNA 23629447 23634726 . + . ID=transcript_7256;Q6PCB0 A8K692 B3KUA1 E9PB53 Q7L5D7 Q9H6J5,von Willebrand factor A domain-containing protein 1,, PF00041;PF00092;, GO:0005604;GO:0062023;GO:0005788;GO:0070062;GO:0005615;GO:0005614;GO:0042802;GO:0048266;GO:0044267;GO:0030198;GO:0043687;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:interstitial matrix;, F:identical protein binding;, P:behavioral response to pain; P:cellular protein metabolic process; P:extracellular matrix organization; P:post-translational protein modification;|Q6PCB0 A8K692 B3KUA1 E9PB53 Q7L5D7 Q9H6J5,von Willebrand factor A domain-containing protein 1,, PF00041;PF00092;, GO:0005604;GO:0062023;GO:0005788;GO:0070062;GO:0005615;GO:0005614;GO:0042802;GO:0048266;GO:0044267;GO:0030198;GO:0043687;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:interstitial matrix;, F:identical protein binding;, P:behavioral response to pain; P:cellular protein metabolic process; P:extracellular matrix organization; P:post-translational protein modification; scaffold34 indexed_genome mRNA 23641381 23658555 . + . ID=transcript_7257;Q9NVI7 B3KPB3 D2K8Q1 G3V1I6 Q5SV23 Q8N275 Q96A50,ATPase family AAA domain-containing protein 3A {ECO:0000312|HGNC:HGNC:25567},, PF00004;PF12037;, GO:0016021;GO:0005743;GO:0042645;GO:0005739;GO:0005524;GO:0016887;GO:0042802;GO:0008270;GO:0140374;GO:0007005;GO:0043066;GO:0001558;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:zinc ion binding;, P:antiviral innate immune response; P:mitochondrion organization; P:negative regulation of apoptotic process; P:regulation of cell growth;|Q9NVI7 B3KPB3 D2K8Q1 G3V1I6 Q5SV23 Q8N275 Q96A50,ATPase family AAA domain-containing protein 3A {ECO:0000312|HGNC:HGNC:25567},, PF00004;PF12037;, GO:0016021;GO:0005743;GO:0042645;GO:0005739;GO:0005524;GO:0016887;GO:0042802;GO:0008270;GO:0140374;GO:0007005;GO:0043066;GO:0001558;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:zinc ion binding;, P:antiviral innate immune response; P:mitochondrion organization; P:negative regulation of apoptotic process; P:regulation of cell growth;|Q9NVI7 B3KPB3 D2K8Q1 G3V1I6 Q5SV23 Q8N275 Q96A50,ATPase family AAA domain-containing protein 3A {ECO:0000312|HGNC:HGNC:25567},, PF00004;PF12037;, GO:0016021;GO:0005743;GO:0042645;GO:0005739;GO:0005524;GO:0016887;GO:0042802;GO:0008270;GO:0140374;GO:0007005;GO:0043066;GO:0001558;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:zinc ion binding;, P:antiviral innate immune response; P:mitochondrion organization; P:negative regulation of apoptotic process; P:regulation of cell growth;|Q9NVI7 B3KPB3 D2K8Q1 G3V1I6 Q5SV23 Q8N275 Q96A50,ATPase family AAA domain-containing protein 3A {ECO:0000312|HGNC:HGNC:25567},, PF00004;PF12037;, GO:0016021;GO:0005743;GO:0042645;GO:0005739;GO:0005524;GO:0016887;GO:0042802;GO:0008270;GO:0140374;GO:0007005;GO:0043066;GO:0001558;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:zinc ion binding;, P:antiviral innate immune response; P:mitochondrion organization; P:negative regulation of apoptotic process; P:regulation of cell growth;|Q9NVI7 B3KPB3 D2K8Q1 G3V1I6 Q5SV23 Q8N275 Q96A50,ATPase family AAA domain-containing protein 3A {ECO:0000312|HGNC:HGNC:25567},, PF00004;PF12037;, GO:0016021;GO:0005743;GO:0042645;GO:0005739;GO:0005524;GO:0016887;GO:0042802;GO:0008270;GO:0140374;GO:0007005;GO:0043066;GO:0001558;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial nucleoid; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:zinc ion binding;, P:antiviral innate immune response; P:mitochondrion organization; P:negative regulation of apoptotic process; P:regulation of cell growth;|Q5T9A4 A8K3H1 Q6ZRB5 Q9BUK4 Q9ULE7,ATPase family AAA domain-containing protein 3B,AAA-TOB3;, PF00004;PF12037;, GO:0101003;GO:0005743;GO:0005739;GO:0005886;GO:0030667;GO:0005524;GO:0016887;GO:0008270;GO:0007005;GO:0043312;, C:ficolin-1-rich granule membrane; C:mitochondrial inner membrane; C:mitochondrion; C:plasma membrane; C:secretory granule membrane;, F:ATP binding; F:ATPase activity; F:zinc ion binding;, P:mitochondrion organization; P:neutrophil degranulation; scaffold34 indexed_genome mRNA 23665416 23690156 . - . ID=transcript_7258;Q9NP77 Q9BZS6 Q9H933,RNA polymerase II subunit A C-terminal domain phosphatase SSU72,, PF04722;, GO:0005829;GO:0005847;GO:0005654;GO:0106306;GO:0106307;GO:0008420;GO:0070940;GO:0006378;GO:0006369;, C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:mRNA polyadenylation; P:termination of RNA polymerase II transcription;|Q9NP77 Q9BZS6 Q9H933,RNA polymerase II subunit A C-terminal domain phosphatase SSU72,, PF04722;, GO:0005829;GO:0005847;GO:0005654;GO:0106306;GO:0106307;GO:0008420;GO:0070940;GO:0006378;GO:0006369;, C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:mRNA polyadenylation; P:termination of RNA polymerase II transcription;|Q9NP77 Q9BZS6 Q9H933,RNA polymerase II subunit A C-terminal domain phosphatase SSU72,, PF04722;, GO:0005829;GO:0005847;GO:0005654;GO:0106306;GO:0106307;GO:0008420;GO:0070940;GO:0006378;GO:0006369;, C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:mRNA polyadenylation; P:termination of RNA polymerase II transcription;|Q9NP77 Q9BZS6 Q9H933,RNA polymerase II subunit A C-terminal domain phosphatase SSU72,, PF04722;, GO:0005829;GO:0005847;GO:0005654;GO:0106306;GO:0106307;GO:0008420;GO:0070940;GO:0006378;GO:0006369;, C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:mRNA polyadenylation; P:termination of RNA polymerase II transcription;|Q9NP77 Q9BZS6 Q9H933,RNA polymerase II subunit A C-terminal domain phosphatase SSU72,, PF04722;, GO:0005829;GO:0005847;GO:0005654;GO:0106306;GO:0106307;GO:0008420;GO:0070940;GO:0006378;GO:0006369;, C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:mRNA polyadenylation; P:termination of RNA polymerase II transcription; scaffold34 indexed_genome mRNA 23731842 23741503 . + . ID=transcript_7259;Q8NCY1 Q8NG59 Q8NG60 Q8NG61 Q8NI59 Q8WYN1,E3 ubiquitin-protein ligase MIB2,Mind bomb homolog 2;Novel zinc finger protein;Putative NF-kappa-B-activating protein 002N;RING-type E3 ubiquitin transferase MIB2 {ECO:0000305};Skeletrophin;Zinc finger ZZ type with ankyrin repeat domain protein 1;, PF12796;PF06701;PF18346;PF00569;, GO:0005737;GO:0005829;GO:0005769;GO:0000151;GO:0003779;GO:0061630;GO:0004842;GO:0008270;GO:0007219;GO:0043123;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:ubiquitin ligase complex;, F:actin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:Notch signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein polyubiquitination; P:protein ubiquitination;|Q8NCY1 Q8NG59 Q8NG60 Q8NG61 Q8NI59 Q8WYN1,E3 ubiquitin-protein ligase MIB2,Mind bomb homolog 2;Novel zinc finger protein;Putative NF-kappa-B-activating protein 002N;RING-type E3 ubiquitin transferase MIB2 {ECO:0000305};Skeletrophin;Zinc finger ZZ type with ankyrin repeat domain protein 1;, PF12796;PF06701;PF18346;PF00569;, GO:0005737;GO:0005829;GO:0005769;GO:0000151;GO:0003779;GO:0061630;GO:0004842;GO:0008270;GO:0007219;GO:0043123;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:ubiquitin ligase complex;, F:actin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:Notch signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein polyubiquitination; P:protein ubiquitination;|Q8NCY1 Q8NG59 Q8NG60 Q8NG61 Q8NI59 Q8WYN1,E3 ubiquitin-protein ligase MIB2,Mind bomb homolog 2;Novel zinc finger protein;Putative NF-kappa-B-activating protein 002N;RING-type E3 ubiquitin transferase MIB2 {ECO:0000305};Skeletrophin;Zinc finger ZZ type with ankyrin repeat domain protein 1;, PF12796;PF06701;PF18346;PF00569;, GO:0005737;GO:0005829;GO:0005769;GO:0000151;GO:0003779;GO:0061630;GO:0004842;GO:0008270;GO:0007219;GO:0043123;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:ubiquitin ligase complex;, F:actin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:Notch signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein polyubiquitination; P:protein ubiquitination;|Q8NCY1 Q8NG59 Q8NG60 Q8NG61 Q8NI59 Q8WYN1,E3 ubiquitin-protein ligase MIB2,Mind bomb homolog 2;Novel zinc finger protein;Putative NF-kappa-B-activating protein 002N;RING-type E3 ubiquitin transferase MIB2 {ECO:0000305};Skeletrophin;Zinc finger ZZ type with ankyrin repeat domain protein 1;, PF12796;PF06701;PF18346;PF00569;, GO:0005737;GO:0005829;GO:0005769;GO:0000151;GO:0003779;GO:0061630;GO:0004842;GO:0008270;GO:0007219;GO:0043123;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:ubiquitin ligase complex;, F:actin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:Notch signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein polyubiquitination; P:protein ubiquitination;|Q8NCY1 Q8NG59 Q8NG60 Q8NG61 Q8NI59 Q8WYN1,E3 ubiquitin-protein ligase MIB2,Mind bomb homolog 2;Novel zinc finger protein;Putative NF-kappa-B-activating protein 002N;RING-type E3 ubiquitin transferase MIB2 {ECO:0000305};Skeletrophin;Zinc finger ZZ type with ankyrin repeat domain protein 1;, PF12796;PF06701;PF18346;PF00569;, GO:0005737;GO:0005829;GO:0005769;GO:0000151;GO:0003779;GO:0061630;GO:0004842;GO:0008270;GO:0007219;GO:0043123;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:ubiquitin ligase complex;, F:actin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:Notch signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein polyubiquitination; P:protein ubiquitination; scaffold34 indexed_genome mRNA 23746569 23748841 . + . ID=transcript_7260;Q9UBR9 Q9UJK8,Matrix metalloproteinase-23,Femalysin;MIFR-1;Matrix metalloproteinase-21;Matrix metalloproteinase-22;, PF00413;PF01549;, GO:0062023;GO:0005789;GO:0031012;GO:0005615;GO:0016021;GO:0004222;GO:0008237;GO:0008270;GO:0030574;GO:0030198;GO:0006508;GO:0000003;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum membrane; C:extracellular matrix; C:extracellular space; C:integral component of membrane;, F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:proteolysis; P:reproduction; scaffold34 indexed_genome mRNA 23749246 23766117 . - . ID=transcript_7261;Q9UP58 Q9UP59,Cyclin-dependent kinase 11B,Cell division cycle 2-like protein kinase 1;Cell division protein kinase 11B;Galactosyltransferase-associated protein kinase p58/GTA;PITSLRE serine/threonine-protein kinase CDC2L1;p58 CLK-1;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0006915;GO:0000278;GO:0006468;GO:0001558;GO:0007346;GO:0050684;GO:0006355;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:apoptotic process; P:mitotic cell cycle; P:protein phosphorylation; P:regulation of cell growth; P:regulation of mitotic cell cycle; P:regulation of mRNA processing; P:regulation of transcription, DNA-templated;|Q9UP58 Q9UP59,Cyclin-dependent kinase 11B,Cell division cycle 2-like protein kinase 1;Cell division protein kinase 11B;Galactosyltransferase-associated protein kinase p58/GTA;PITSLRE serine/threonine-protein kinase CDC2L1;p58 CLK-1;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0006915;GO:0000278;GO:0006468;GO:0001558;GO:0007346;GO:0050684;GO:0006355;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:apoptotic process; P:mitotic cell cycle; P:protein phosphorylation; P:regulation of cell growth; P:regulation of mitotic cell cycle; P:regulation of mRNA processing; P:regulation of transcription, DNA-templated;|Q9UP58 Q9UP59,Cyclin-dependent kinase 11B,Cell division cycle 2-like protein kinase 1;Cell division protein kinase 11B;Galactosyltransferase-associated protein kinase p58/GTA;PITSLRE serine/threonine-protein kinase CDC2L1;p58 CLK-1;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0006915;GO:0000278;GO:0006468;GO:0001558;GO:0007346;GO:0050684;GO:0006355;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:apoptotic process; P:mitotic cell cycle; P:protein phosphorylation; P:regulation of cell growth; P:regulation of mitotic cell cycle; P:regulation of mRNA processing; P:regulation of transcription, DNA-templated;|Q9UP56 Q9UQ86 Q9UQ87 Q9UQ89,Cyclin-dependent kinase 11A,Cell division cycle 2-like protein kinase 2;Cell division protein kinase 11A;Galactosyltransferase-associated protein kinase p58/GTA;PITSLRE serine/threonine-protein kinase CDC2L2;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0000278;GO:0006468;GO:0001558;GO:0007346;GO:0050684;GO:0006355;, C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:mitotic cell cycle; P:protein phosphorylation; P:regulation of cell growth; P:regulation of mitotic cell cycle; P:regulation of mRNA processing; P:regulation of transcription, DNA-templated; scaffold34 indexed_genome mRNA 23770131 23781382 . - . ID=transcript_7262;P0CK96 B3KWR0 O75035 Q2TAY8 Q569F8 Q5CZA4 Q9Y3J8,Solute carrier family 35 member E2B,, PF03151;, GO:0005794;GO:0016021;GO:0015297;GO:0001835;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity;, P:blastocyst hatching;|P0CK96 B3KWR0 O75035 Q2TAY8 Q569F8 Q5CZA4 Q9Y3J8,Solute carrier family 35 member E2B,, PF03151;, GO:0005794;GO:0016021;GO:0015297;GO:0001835;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity;, P:blastocyst hatching;|P0CK96 B3KWR0 O75035 Q2TAY8 Q569F8 Q5CZA4 Q9Y3J8,Solute carrier family 35 member E2B,, PF03151;, GO:0005794;GO:0016021;GO:0015297;GO:0001835;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity;, P:blastocyst hatching;|P0CK96 B3KWR0 O75035 Q2TAY8 Q569F8 Q5CZA4 Q9Y3J8,Solute carrier family 35 member E2B,, PF03151;, GO:0005794;GO:0016021;GO:0015297;GO:0001835;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity;, P:blastocyst hatching; scaffold34 indexed_genome mRNA 23795390 23816394 . - . ID=transcript_7263;O95544 A6NNN3 A8K296 B7Z434 F5GXR5 Q5QPS4 Q9H2P2 Q9H931,NAD kinase,Poly(P)/ATP NAD kinase;, PF01513;, GO:0005829;GO:0005524;GO:0046872;GO:0003951;GO:0046034;GO:0019674;GO:0006741;GO:0016310;GO:0035774;, C:cytosol;, F:ATP binding; F:metal ion binding; F:NAD+ kinase activity;, P:ATP metabolic process; P:NAD metabolic process; P:NADP biosynthetic process; P:phosphorylation; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O95544 A6NNN3 A8K296 B7Z434 F5GXR5 Q5QPS4 Q9H2P2 Q9H931,NAD kinase,Poly(P)/ATP NAD kinase;, PF01513;, GO:0005829;GO:0005524;GO:0046872;GO:0003951;GO:0046034;GO:0019674;GO:0006741;GO:0016310;GO:0035774;, C:cytosol;, F:ATP binding; F:metal ion binding; F:NAD+ kinase activity;, P:ATP metabolic process; P:NAD metabolic process; P:NADP biosynthetic process; P:phosphorylation; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O95544 A6NNN3 A8K296 B7Z434 F5GXR5 Q5QPS4 Q9H2P2 Q9H931,NAD kinase,Poly(P)/ATP NAD kinase;, PF01513;, GO:0005829;GO:0005524;GO:0046872;GO:0003951;GO:0046034;GO:0019674;GO:0006741;GO:0016310;GO:0035774;, C:cytosol;, F:ATP binding; F:metal ion binding; F:NAD+ kinase activity;, P:ATP metabolic process; P:NAD metabolic process; P:NADP biosynthetic process; P:phosphorylation; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O95544 A6NNN3 A8K296 B7Z434 F5GXR5 Q5QPS4 Q9H2P2 Q9H931,NAD kinase,Poly(P)/ATP NAD kinase;, PF01513;, GO:0005829;GO:0005524;GO:0046872;GO:0003951;GO:0046034;GO:0019674;GO:0006741;GO:0016310;GO:0035774;, C:cytosol;, F:ATP binding; F:metal ion binding; F:NAD+ kinase activity;, P:ATP metabolic process; P:NAD metabolic process; P:NADP biosynthetic process; P:phosphorylation; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O95544 A6NNN3 A8K296 B7Z434 F5GXR5 Q5QPS4 Q9H2P2 Q9H931,NAD kinase,Poly(P)/ATP NAD kinase;, PF01513;, GO:0005829;GO:0005524;GO:0046872;GO:0003951;GO:0046034;GO:0019674;GO:0006741;GO:0016310;GO:0035774;, C:cytosol;, F:ATP binding; F:metal ion binding; F:NAD+ kinase activity;, P:ATP metabolic process; P:NAD metabolic process; P:NADP biosynthetic process; P:phosphorylation; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; scaffold34 indexed_genome mRNA 23819412 23852259 . - . ID=transcript_7264;P62873 B1AJZ7 P04697 P04901 Q1RMY8,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,Transducin beta chain 1;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1903561;GO:0005834;GO:0005765;GO:0016020;GO:0097381;GO:0001917;GO:0042622;GO:0005886;GO:0045202;GO:0047391;GO:0031682;GO:0003924;GO:0051020;GO:0044877;GO:0030507;GO:0007191;GO:0010659;GO:0008283;GO:0071870;GO:0071456;GO:0071380;GO:0007213;GO:0007186;GO:0002862;GO:0007200;GO:0030168;GO:0007204;GO:1901381;GO:0006457;GO:0007265;GO:0060041;GO:0016056;GO:0050909;GO:0007165;GO:0007223;, C:cell body; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular vesicle; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:photoreceptor disc membrane; C:photoreceptor inner segment; C:photoreceptor outer segment membrane; C:plasma membrane; C:synapse;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:protein-containing complex binding; F:spectrin binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:cardiac muscle cell apoptotic process; P:cell population proliferation; P:cellular response to catecholamine stimulus; P:cellular response to hypoxia; P:cellular response to prostaglandin E stimulus; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of potassium ion transmembrane transport; P:protein folding; P:Ras protein signal transduction; P:retina development in camera-type eye; P:rhodopsin mediated signaling pathway; P:sensory perception of taste; P:signal transduction; P:Wnt signaling pathway, calcium modulating pathway;|P62873 B1AJZ7 P04697 P04901 Q1RMY8,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,Transducin beta chain 1;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1903561;GO:0005834;GO:0005765;GO:0016020;GO:0097381;GO:0001917;GO:0042622;GO:0005886;GO:0045202;GO:0047391;GO:0031682;GO:0003924;GO:0051020;GO:0044877;GO:0030507;GO:0007191;GO:0010659;GO:0008283;GO:0071870;GO:0071456;GO:0071380;GO:0007213;GO:0007186;GO:0002862;GO:0007200;GO:0030168;GO:0007204;GO:1901381;GO:0006457;GO:0007265;GO:0060041;GO:0016056;GO:0050909;GO:0007165;GO:0007223;, C:cell body; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular vesicle; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:photoreceptor disc membrane; C:photoreceptor inner segment; C:photoreceptor outer segment membrane; C:plasma membrane; C:synapse;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:protein-containing complex binding; F:spectrin binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:cardiac muscle cell apoptotic process; P:cell population proliferation; P:cellular response to catecholamine stimulus; P:cellular response to hypoxia; P:cellular response to prostaglandin E stimulus; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of potassium ion transmembrane transport; P:protein folding; P:Ras protein signal transduction; P:retina development in camera-type eye; P:rhodopsin mediated signaling pathway; P:sensory perception of taste; P:signal transduction; P:Wnt signaling pathway, calcium modulating pathway;|P62873 B1AJZ7 P04697 P04901 Q1RMY8,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,Transducin beta chain 1;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1903561;GO:0005834;GO:0005765;GO:0016020;GO:0097381;GO:0001917;GO:0042622;GO:0005886;GO:0045202;GO:0047391;GO:0031682;GO:0003924;GO:0051020;GO:0044877;GO:0030507;GO:0007191;GO:0010659;GO:0008283;GO:0071870;GO:0071456;GO:0071380;GO:0007213;GO:0007186;GO:0002862;GO:0007200;GO:0030168;GO:0007204;GO:1901381;GO:0006457;GO:0007265;GO:0060041;GO:0016056;GO:0050909;GO:0007165;GO:0007223;, C:cell body; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular vesicle; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:photoreceptor disc membrane; C:photoreceptor inner segment; C:photoreceptor outer segment membrane; C:plasma membrane; C:synapse;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:protein-containing complex binding; F:spectrin binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:cardiac muscle cell apoptotic process; P:cell population proliferation; P:cellular response to catecholamine stimulus; P:cellular response to hypoxia; P:cellular response to prostaglandin E stimulus; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of potassium ion transmembrane transport; P:protein folding; P:Ras protein signal transduction; P:retina development in camera-type eye; P:rhodopsin mediated signaling pathway; P:sensory perception of taste; P:signal transduction; P:Wnt signaling pathway, calcium modulating pathway;|P62873 B1AJZ7 P04697 P04901 Q1RMY8,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,Transducin beta chain 1;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1903561;GO:0005834;GO:0005765;GO:0016020;GO:0097381;GO:0001917;GO:0042622;GO:0005886;GO:0045202;GO:0047391;GO:0031682;GO:0003924;GO:0051020;GO:0044877;GO:0030507;GO:0007191;GO:0010659;GO:0008283;GO:0071870;GO:0071456;GO:0071380;GO:0007213;GO:0007186;GO:0002862;GO:0007200;GO:0030168;GO:0007204;GO:1901381;GO:0006457;GO:0007265;GO:0060041;GO:0016056;GO:0050909;GO:0007165;GO:0007223;, C:cell body; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular vesicle; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:photoreceptor disc membrane; C:photoreceptor inner segment; C:photoreceptor outer segment membrane; C:plasma membrane; C:synapse;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:protein-containing complex binding; F:spectrin binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:cardiac muscle cell apoptotic process; P:cell population proliferation; P:cellular response to catecholamine stimulus; P:cellular response to hypoxia; P:cellular response to prostaglandin E stimulus; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of potassium ion transmembrane transport; P:protein folding; P:Ras protein signal transduction; P:retina development in camera-type eye; P:rhodopsin mediated signaling pathway; P:sensory perception of taste; P:signal transduction; P:Wnt signaling pathway, calcium modulating pathway;|P62873 B1AJZ7 P04697 P04901 Q1RMY8,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,Transducin beta chain 1;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1903561;GO:0005834;GO:0005765;GO:0016020;GO:0097381;GO:0001917;GO:0042622;GO:0005886;GO:0045202;GO:0047391;GO:0031682;GO:0003924;GO:0051020;GO:0044877;GO:0030507;GO:0007191;GO:0010659;GO:0008283;GO:0071870;GO:0071456;GO:0071380;GO:0007213;GO:0007186;GO:0002862;GO:0007200;GO:0030168;GO:0007204;GO:1901381;GO:0006457;GO:0007265;GO:0060041;GO:0016056;GO:0050909;GO:0007165;GO:0007223;, C:cell body; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular vesicle; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:photoreceptor disc membrane; C:photoreceptor inner segment; C:photoreceptor outer segment membrane; C:plasma membrane; C:synapse;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:protein-containing complex binding; F:spectrin binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:cardiac muscle cell apoptotic process; P:cell population proliferation; P:cellular response to catecholamine stimulus; P:cellular response to hypoxia; P:cellular response to prostaglandin E stimulus; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of potassium ion transmembrane transport; P:protein folding; P:Ras protein signal transduction; P:retina development in camera-type eye; P:rhodopsin mediated signaling pathway; P:sensory perception of taste; P:signal transduction; P:Wnt signaling pathway, calcium modulating pathway;|P62873 B1AJZ7 P04697 P04901 Q1RMY8,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,Transducin beta chain 1;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:1903561;GO:0005834;GO:0005765;GO:0016020;GO:0097381;GO:0001917;GO:0042622;GO:0005886;GO:0045202;GO:0047391;GO:0031682;GO:0003924;GO:0051020;GO:0044877;GO:0030507;GO:0007191;GO:0010659;GO:0008283;GO:0071870;GO:0071456;GO:0071380;GO:0007213;GO:0007186;GO:0002862;GO:0007200;GO:0030168;GO:0007204;GO:1901381;GO:0006457;GO:0007265;GO:0060041;GO:0016056;GO:0050909;GO:0007165;GO:0007223;, C:cell body; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular vesicle; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:photoreceptor disc membrane; C:photoreceptor inner segment; C:photoreceptor outer segment membrane; C:plasma membrane; C:synapse;, F:alkylglycerophosphoethanolamine phosphodiesterase activity; F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:protein-containing complex binding; F:spectrin binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:cardiac muscle cell apoptotic process; P:cell population proliferation; P:cellular response to catecholamine stimulus; P:cellular response to hypoxia; P:cellular response to prostaglandin E stimulus; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of potassium ion transmembrane transport; P:protein folding; P:Ras protein signal transduction; P:retina development in camera-type eye; P:rhodopsin mediated signaling pathway; P:sensory perception of taste; P:signal transduction; P:Wnt signaling pathway, calcium modulating pathway; scaffold34 indexed_genome mRNA 23940756 24002284 . - . ID=transcript_7265;Q9C0B2 A4VCI2 H7C4E1 Q5T2D9 Q5T2E0 Q69YW0 Q6ZSJ4,Cilia- and flagella-associated protein 74 {ECO:0000305},, , GO:0005930;GO:0035082;, C:axoneme;, , P:axoneme assembly;|Q9C0B2 A4VCI2 H7C4E1 Q5T2D9 Q5T2E0 Q69YW0 Q6ZSJ4,Cilia- and flagella-associated protein 74 {ECO:0000305},, , GO:0005930;GO:0035082;, C:axoneme;, , P:axoneme assembly; scaffold34 indexed_genome mRNA 24047453 24059476 . + . ID=transcript_7266;O14764 Q8N4N9,Gamma-aminobutyric acid receptor subunit delta,GABA(A) receptor subunit delta;, PF02931;PF02932;, GO:0034707;GO:1902711;GO:0005887;GO:0043005;GO:0045211;GO:0045202;GO:0005254;GO:0005230;GO:0004890;GO:0030594;GO:0007268;GO:1902476;GO:0034220;GO:0050877;GO:0042391;GO:0007165;, C:chloride channel complex; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:postsynaptic membrane; C:synapse;, F:chloride channel activity; F:extracellular ligand-gated ion channel activity; F:GABA-A receptor activity; F:neurotransmitter receptor activity;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:signal transduction;|O14764 Q8N4N9,Gamma-aminobutyric acid receptor subunit delta,GABA(A) receptor subunit delta;, PF02931;PF02932;, GO:0034707;GO:1902711;GO:0005887;GO:0043005;GO:0045211;GO:0045202;GO:0005254;GO:0005230;GO:0004890;GO:0030594;GO:0007268;GO:1902476;GO:0034220;GO:0050877;GO:0042391;GO:0007165;, C:chloride channel complex; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:postsynaptic membrane; C:synapse;, F:chloride channel activity; F:extracellular ligand-gated ion channel activity; F:GABA-A receptor activity; F:neurotransmitter receptor activity;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:signal transduction; scaffold34 indexed_genome mRNA 24091647 24175656 . + . ID=transcript_7267;Q05513 A8K4N0 A8MU64 B7Z2J7 E9PCW2 Q15207 Q5SYT5 Q969S4,Protein kinase C zeta type,nPKC-zeta;, PF00130;PF00564;PF00069;PF00433;, GO:0045179;GO:0016324;GO:0043203;GO:0005923;GO:0030054;GO:0031252;GO:0005911;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0016020;GO:0045121;GO:0005815;GO:0035748;GO:0005635;GO:0016363;GO:0048471;GO:0005886;GO:0014069;GO:0098685;GO:0001725;GO:0031982;GO:0071889;GO:0005524;GO:0004698;GO:0043560;GO:0046872;GO:0043274;GO:0015459;GO:0004672;GO:0019901;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031584;GO:0032148;GO:0016477;GO:0032869;GO:0030010;GO:0006954;GO:0035556;GO:0007616;GO:0060291;GO:0051899;GO:0060081;GO:0000226;GO:0043066;GO:0051346;GO:0046627;GO:0050732;GO:0031333;GO:1990138;GO:0018105;GO:0008284;GO:0001954;GO:0070374;GO:2000463;GO:0046628;GO:0032733;GO:0032736;GO:0032753;GO:0032754;GO:0051092;GO:0051222;GO:2000553;GO:0045630;GO:0070528;GO:0072659;GO:0006468;GO:0098696;GO:0007165;GO:0007179;GO:0047496;, C:apical cortex; C:apical plasma membrane; C:axon hillock; C:bicellular tight junction; C:cell junction; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:membrane raft; C:microtubule organizing center; C:myelin sheath abaxonal region; C:nuclear envelope; C:nuclear matrix; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:Schaffer collateral - CA1 synapse; C:stress fiber; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:insulin receptor substrate binding; F:metal ion binding; F:phospholipase binding; F:potassium channel regulator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of phospholipase D activity; P:activation of protein kinase B activity; P:cell migration; P:cellular response to insulin stimulus; P:establishment of cell polarity; P:inflammatory response; P:intracellular signal transduction; P:long-term memory; P:long-term synaptic potentiation; P:membrane depolarization; P:membrane hyperpolarization; P:microtubule cytoskeleton organization; P:negative regulation of apoptotic process; P:negative regulation of hydrolase activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein-containing complex assembly; P:neuron projection extension; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein transport; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:protein kinase C signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vesicle transport along microtubule;|Q05513 A8K4N0 A8MU64 B7Z2J7 E9PCW2 Q15207 Q5SYT5 Q969S4,Protein kinase C zeta type,nPKC-zeta;, PF00130;PF00564;PF00069;PF00433;, GO:0045179;GO:0016324;GO:0043203;GO:0005923;GO:0030054;GO:0031252;GO:0005911;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0016020;GO:0045121;GO:0005815;GO:0035748;GO:0005635;GO:0016363;GO:0048471;GO:0005886;GO:0014069;GO:0098685;GO:0001725;GO:0031982;GO:0071889;GO:0005524;GO:0004698;GO:0043560;GO:0046872;GO:0043274;GO:0015459;GO:0004672;GO:0019901;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031584;GO:0032148;GO:0016477;GO:0032869;GO:0030010;GO:0006954;GO:0035556;GO:0007616;GO:0060291;GO:0051899;GO:0060081;GO:0000226;GO:0043066;GO:0051346;GO:0046627;GO:0050732;GO:0031333;GO:1990138;GO:0018105;GO:0008284;GO:0001954;GO:0070374;GO:2000463;GO:0046628;GO:0032733;GO:0032736;GO:0032753;GO:0032754;GO:0051092;GO:0051222;GO:2000553;GO:0045630;GO:0070528;GO:0072659;GO:0006468;GO:0098696;GO:0007165;GO:0007179;GO:0047496;, C:apical cortex; C:apical plasma membrane; C:axon hillock; C:bicellular tight junction; C:cell junction; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:membrane raft; C:microtubule organizing center; C:myelin sheath abaxonal region; C:nuclear envelope; C:nuclear matrix; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:Schaffer collateral - CA1 synapse; C:stress fiber; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:insulin receptor substrate binding; F:metal ion binding; F:phospholipase binding; F:potassium channel regulator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of phospholipase D activity; P:activation of protein kinase B activity; P:cell migration; P:cellular response to insulin stimulus; P:establishment of cell polarity; P:inflammatory response; P:intracellular signal transduction; P:long-term memory; P:long-term synaptic potentiation; P:membrane depolarization; P:membrane hyperpolarization; P:microtubule cytoskeleton organization; P:negative regulation of apoptotic process; P:negative regulation of hydrolase activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein-containing complex assembly; P:neuron projection extension; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein transport; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:protein kinase C signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vesicle transport along microtubule;|Q05513 A8K4N0 A8MU64 B7Z2J7 E9PCW2 Q15207 Q5SYT5 Q969S4,Protein kinase C zeta type,nPKC-zeta;, PF00130;PF00564;PF00069;PF00433;, GO:0045179;GO:0016324;GO:0043203;GO:0005923;GO:0030054;GO:0031252;GO:0005911;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0016020;GO:0045121;GO:0005815;GO:0035748;GO:0005635;GO:0016363;GO:0048471;GO:0005886;GO:0014069;GO:0098685;GO:0001725;GO:0031982;GO:0071889;GO:0005524;GO:0004698;GO:0043560;GO:0046872;GO:0043274;GO:0015459;GO:0004672;GO:0019901;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031584;GO:0032148;GO:0016477;GO:0032869;GO:0030010;GO:0006954;GO:0035556;GO:0007616;GO:0060291;GO:0051899;GO:0060081;GO:0000226;GO:0043066;GO:0051346;GO:0046627;GO:0050732;GO:0031333;GO:1990138;GO:0018105;GO:0008284;GO:0001954;GO:0070374;GO:2000463;GO:0046628;GO:0032733;GO:0032736;GO:0032753;GO:0032754;GO:0051092;GO:0051222;GO:2000553;GO:0045630;GO:0070528;GO:0072659;GO:0006468;GO:0098696;GO:0007165;GO:0007179;GO:0047496;, C:apical cortex; C:apical plasma membrane; C:axon hillock; C:bicellular tight junction; C:cell junction; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:membrane raft; C:microtubule organizing center; C:myelin sheath abaxonal region; C:nuclear envelope; C:nuclear matrix; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:Schaffer collateral - CA1 synapse; C:stress fiber; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:insulin receptor substrate binding; F:metal ion binding; F:phospholipase binding; F:potassium channel regulator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of phospholipase D activity; P:activation of protein kinase B activity; P:cell migration; P:cellular response to insulin stimulus; P:establishment of cell polarity; P:inflammatory response; P:intracellular signal transduction; P:long-term memory; P:long-term synaptic potentiation; P:membrane depolarization; P:membrane hyperpolarization; P:microtubule cytoskeleton organization; P:negative regulation of apoptotic process; P:negative regulation of hydrolase activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein-containing complex assembly; P:neuron projection extension; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein transport; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:protein kinase C signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vesicle transport along microtubule;|Q05513 A8K4N0 A8MU64 B7Z2J7 E9PCW2 Q15207 Q5SYT5 Q969S4,Protein kinase C zeta type,nPKC-zeta;, PF00130;PF00564;PF00069;PF00433;, GO:0045179;GO:0016324;GO:0043203;GO:0005923;GO:0030054;GO:0031252;GO:0005911;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0016020;GO:0045121;GO:0005815;GO:0035748;GO:0005635;GO:0016363;GO:0048471;GO:0005886;GO:0014069;GO:0098685;GO:0001725;GO:0031982;GO:0071889;GO:0005524;GO:0004698;GO:0043560;GO:0046872;GO:0043274;GO:0015459;GO:0004672;GO:0019901;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031584;GO:0032148;GO:0016477;GO:0032869;GO:0030010;GO:0006954;GO:0035556;GO:0007616;GO:0060291;GO:0051899;GO:0060081;GO:0000226;GO:0043066;GO:0051346;GO:0046627;GO:0050732;GO:0031333;GO:1990138;GO:0018105;GO:0008284;GO:0001954;GO:0070374;GO:2000463;GO:0046628;GO:0032733;GO:0032736;GO:0032753;GO:0032754;GO:0051092;GO:0051222;GO:2000553;GO:0045630;GO:0070528;GO:0072659;GO:0006468;GO:0098696;GO:0007165;GO:0007179;GO:0047496;, C:apical cortex; C:apical plasma membrane; C:axon hillock; C:bicellular tight junction; C:cell junction; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:membrane raft; C:microtubule organizing center; C:myelin sheath abaxonal region; C:nuclear envelope; C:nuclear matrix; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:Schaffer collateral - CA1 synapse; C:stress fiber; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:insulin receptor substrate binding; F:metal ion binding; F:phospholipase binding; F:potassium channel regulator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of phospholipase D activity; P:activation of protein kinase B activity; P:cell migration; P:cellular response to insulin stimulus; P:establishment of cell polarity; P:inflammatory response; P:intracellular signal transduction; P:long-term memory; P:long-term synaptic potentiation; P:membrane depolarization; P:membrane hyperpolarization; P:microtubule cytoskeleton organization; P:negative regulation of apoptotic process; P:negative regulation of hydrolase activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein-containing complex assembly; P:neuron projection extension; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein transport; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:protein kinase C signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vesicle transport along microtubule;|Q05513 A8K4N0 A8MU64 B7Z2J7 E9PCW2 Q15207 Q5SYT5 Q969S4,Protein kinase C zeta type,nPKC-zeta;, PF00130;PF00564;PF00069;PF00433;, GO:0045179;GO:0016324;GO:0043203;GO:0005923;GO:0030054;GO:0031252;GO:0005911;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0016020;GO:0045121;GO:0005815;GO:0035748;GO:0005635;GO:0016363;GO:0048471;GO:0005886;GO:0014069;GO:0098685;GO:0001725;GO:0031982;GO:0071889;GO:0005524;GO:0004698;GO:0043560;GO:0046872;GO:0043274;GO:0015459;GO:0004672;GO:0019901;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031584;GO:0032148;GO:0016477;GO:0032869;GO:0030010;GO:0006954;GO:0035556;GO:0007616;GO:0060291;GO:0051899;GO:0060081;GO:0000226;GO:0043066;GO:0051346;GO:0046627;GO:0050732;GO:0031333;GO:1990138;GO:0018105;GO:0008284;GO:0001954;GO:0070374;GO:2000463;GO:0046628;GO:0032733;GO:0032736;GO:0032753;GO:0032754;GO:0051092;GO:0051222;GO:2000553;GO:0045630;GO:0070528;GO:0072659;GO:0006468;GO:0098696;GO:0007165;GO:0007179;GO:0047496;, C:apical cortex; C:apical plasma membrane; C:axon hillock; C:bicellular tight junction; C:cell junction; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:membrane raft; C:microtubule organizing center; C:myelin sheath abaxonal region; C:nuclear envelope; C:nuclear matrix; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:Schaffer collateral - CA1 synapse; C:stress fiber; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:insulin receptor substrate binding; F:metal ion binding; F:phospholipase binding; F:potassium channel regulator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of phospholipase D activity; P:activation of protein kinase B activity; P:cell migration; P:cellular response to insulin stimulus; P:establishment of cell polarity; P:inflammatory response; P:intracellular signal transduction; P:long-term memory; P:long-term synaptic potentiation; P:membrane depolarization; P:membrane hyperpolarization; P:microtubule cytoskeleton organization; P:negative regulation of apoptotic process; P:negative regulation of hydrolase activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein-containing complex assembly; P:neuron projection extension; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein transport; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:protein kinase C signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vesicle transport along microtubule;|Q05513 A8K4N0 A8MU64 B7Z2J7 E9PCW2 Q15207 Q5SYT5 Q969S4,Protein kinase C zeta type,nPKC-zeta;, PF00130;PF00564;PF00069;PF00433;, GO:0045179;GO:0016324;GO:0043203;GO:0005923;GO:0030054;GO:0031252;GO:0005911;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0016020;GO:0045121;GO:0005815;GO:0035748;GO:0005635;GO:0016363;GO:0048471;GO:0005886;GO:0014069;GO:0098685;GO:0001725;GO:0031982;GO:0071889;GO:0005524;GO:0004698;GO:0043560;GO:0046872;GO:0043274;GO:0015459;GO:0004672;GO:0019901;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031584;GO:0032148;GO:0016477;GO:0032869;GO:0030010;GO:0006954;GO:0035556;GO:0007616;GO:0060291;GO:0051899;GO:0060081;GO:0000226;GO:0043066;GO:0051346;GO:0046627;GO:0050732;GO:0031333;GO:1990138;GO:0018105;GO:0008284;GO:0001954;GO:0070374;GO:2000463;GO:0046628;GO:0032733;GO:0032736;GO:0032753;GO:0032754;GO:0051092;GO:0051222;GO:2000553;GO:0045630;GO:0070528;GO:0072659;GO:0006468;GO:0098696;GO:0007165;GO:0007179;GO:0047496;, C:apical cortex; C:apical plasma membrane; C:axon hillock; C:bicellular tight junction; C:cell junction; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:membrane raft; C:microtubule organizing center; C:myelin sheath abaxonal region; C:nuclear envelope; C:nuclear matrix; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:Schaffer collateral - CA1 synapse; C:stress fiber; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:insulin receptor substrate binding; F:metal ion binding; F:phospholipase binding; F:potassium channel regulator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of phospholipase D activity; P:activation of protein kinase B activity; P:cell migration; P:cellular response to insulin stimulus; P:establishment of cell polarity; P:inflammatory response; P:intracellular signal transduction; P:long-term memory; P:long-term synaptic potentiation; P:membrane depolarization; P:membrane hyperpolarization; P:microtubule cytoskeleton organization; P:negative regulation of apoptotic process; P:negative regulation of hydrolase activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein-containing complex assembly; P:neuron projection extension; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein transport; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:protein kinase C signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vesicle transport along microtubule;|Q05513 A8K4N0 A8MU64 B7Z2J7 E9PCW2 Q15207 Q5SYT5 Q969S4,Protein kinase C zeta type,nPKC-zeta;, PF00130;PF00564;PF00069;PF00433;, GO:0045179;GO:0016324;GO:0043203;GO:0005923;GO:0030054;GO:0031252;GO:0005911;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0016020;GO:0045121;GO:0005815;GO:0035748;GO:0005635;GO:0016363;GO:0048471;GO:0005886;GO:0014069;GO:0098685;GO:0001725;GO:0031982;GO:0071889;GO:0005524;GO:0004698;GO:0043560;GO:0046872;GO:0043274;GO:0015459;GO:0004672;GO:0019901;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031584;GO:0032148;GO:0016477;GO:0032869;GO:0030010;GO:0006954;GO:0035556;GO:0007616;GO:0060291;GO:0051899;GO:0060081;GO:0000226;GO:0043066;GO:0051346;GO:0046627;GO:0050732;GO:0031333;GO:1990138;GO:0018105;GO:0008284;GO:0001954;GO:0070374;GO:2000463;GO:0046628;GO:0032733;GO:0032736;GO:0032753;GO:0032754;GO:0051092;GO:0051222;GO:2000553;GO:0045630;GO:0070528;GO:0072659;GO:0006468;GO:0098696;GO:0007165;GO:0007179;GO:0047496;, C:apical cortex; C:apical plasma membrane; C:axon hillock; C:bicellular tight junction; C:cell junction; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:membrane raft; C:microtubule organizing center; C:myelin sheath abaxonal region; C:nuclear envelope; C:nuclear matrix; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:Schaffer collateral - CA1 synapse; C:stress fiber; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:insulin receptor substrate binding; F:metal ion binding; F:phospholipase binding; F:potassium channel regulator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of phospholipase D activity; P:activation of protein kinase B activity; P:cell migration; P:cellular response to insulin stimulus; P:establishment of cell polarity; P:inflammatory response; P:intracellular signal transduction; P:long-term memory; P:long-term synaptic potentiation; P:membrane depolarization; P:membrane hyperpolarization; P:microtubule cytoskeleton organization; P:negative regulation of apoptotic process; P:negative regulation of hydrolase activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein-containing complex assembly; P:neuron projection extension; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein transport; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of T-helper 2 cell differentiation; P:protein kinase C signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; P:vesicle transport along microtubule;|Q6NZ36 A6PW39 A6PW40 A6PW41 A8MQT6 F2Z2L4 Q6ZT64 Q71M24 Q96ND7,Fanconi anemia core complex-associated protein 20 {ECO:0000312|HGNC:HGNC:26428},FANCA-associated protein of 20 kDa {ECO:0000303|PubMed:22343915};Fanconi anemia-associated protein of 20 kDa {ECO:0000303|PubMed:22343915};, PF15751;PF15750;, GO:0030054;GO:0005694;GO:0043240;GO:0016604;GO:0005654;GO:0070530;GO:0046872;GO:0031593;GO:0043130;GO:0140036;GO:0006974;GO:0036297;GO:0019985;, C:cell junction; C:chromosome; C:Fanconi anaemia nuclear complex; C:nuclear body; C:nucleoplasm;, F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:ubiquitin binding; F:ubiquitin-dependent protein binding;, P:cellular response to DNA damage stimulus; P:interstrand cross-link repair; P:translesion synthesis; scaffold34 indexed_genome mRNA 24258507 24259055 . - . ID=transcript_7268;P12755 Q5SYT7,Ski oncogene,Proto-oncogene c-Ski;, PF08782;PF02437;, GO:0005813;GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0005667;GO:0017053;GO:0000981;GO:0001227;GO:0046811;GO:0042802;GO:0019904;GO:0019901;GO:0070491;GO:0000978;GO:0046332;GO:0031625;GO:0008270;GO:0009948;GO:0060349;GO:0043010;GO:0048593;GO:0048870;GO:0030326;GO:0060325;GO:0002089;GO:0022011;GO:0014902;GO:0032926;GO:0030514;GO:0008285;GO:0048147;GO:0045668;GO:0010626;GO:0000122;GO:0030512;GO:0001843;GO:0043585;GO:0021772;GO:0043388;GO:0045944;GO:0030177;GO:0060041;GO:0060021;GO:0048741;GO:0060395;GO:0035019;GO:0006351;GO:0007179;, C:centrosome; C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex; C:transcription regulator complex; C:transcription repressor complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase inhibitor activity; F:identical protein binding; F:protein domain specific binding; F:protein kinase binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:SMAD binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:anterior/posterior axis specification; P:bone morphogenesis; P:camera-type eye development; P:camera-type eye morphogenesis; P:cell motility; P:embryonic limb morphogenesis; P:face morphogenesis; P:lens morphogenesis in camera-type eye; P:myelination in peripheral nervous system; P:myotube differentiation; P:negative regulation of activin receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of osteoblast differentiation; P:negative regulation of Schwann cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neural tube closure; P:nose morphogenesis; P:olfactory bulb development; P:positive regulation of DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway; P:retina development in camera-type eye; P:roof of mouth development; P:skeletal muscle fiber development; P:SMAD protein signal transduction; P:somatic stem cell population maintenance; P:transcription, DNA-templated; P:transforming growth factor beta receptor signaling pathway; scaffold35 indexed_genome mRNA 761487 844984 . - . ID=transcript_7269;O75581 Q17RZ2,Low-density lipoprotein receptor-related protein 6,, PF00057;PF00058;, GO:0009986;GO:0031410;GO:0031901;GO:0005783;GO:0005576;GO:0016021;GO:0045121;GO:0043025;GO:0005886;GO:0045202;GO:1990909;GO:1990851;GO:0034185;GO:0015026;GO:1904928;GO:0071936;GO:0005109;GO:0042802;GO:0019210;GO:0005041;GO:0042803;GO:0005102;GO:0019534;GO:0042813;GO:0017147;GO:0090245;GO:1904886;GO:0060349;GO:0046849;GO:0060444;GO:0060070;GO:0044335;GO:0044340;GO:0098609;GO:0071397;GO:0021587;GO:0021987;GO:0007268;GO:0060026;GO:0071542;GO:0048596;GO:0030326;GO:0009880;GO:0060059;GO:0035261;GO:0060325;GO:0030901;GO:1904948;GO:0030917;GO:0090090;GO:0006469;GO:0001933;GO:0071901;GO:0034392;GO:0014033;GO:0014029;GO:0001843;GO:0042475;GO:0003344;GO:0045787;GO:0007204;GO:0051091;GO:0045944;GO:0045893;GO:0090009;GO:0072659;GO:0090118;GO:0030278;GO:0043434;GO:0060021;GO:0021794;GO:0060535;GO:0016055;GO:1904953;GO:0090244;, C:cell surface; C:cytoplasmic vesicle; C:early endosome membrane; C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:membrane raft; C:neuronal cell body; C:plasma membrane; C:synapse; C:Wnt signalosome; C:Wnt-Frizzled-LRP5/6 complex;, F:apolipoprotein binding; F:coreceptor activity; F:coreceptor activity involved in canonical Wnt signaling pathway; F:coreceptor activity involved in Wnt signaling pathway; F:frizzled binding; F:identical protein binding; F:kinase inhibitor activity; F:low-density lipoprotein particle receptor activity; F:protein homodimerization activity; F:signaling receptor binding; F:toxin transmembrane transporter activity; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:axis elongation involved in somitogenesis; P:beta-catenin destruction complex disassembly; P:bone morphogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in neural crest cell differentiation; P:canonical Wnt signaling pathway involved in regulation of cell proliferation; P:cell-cell adhesion; P:cellular response to cholesterol; P:cerebellum morphogenesis; P:cerebral cortex development; P:chemical synaptic transmission; P:convergent extension; P:dopaminergic neuron differentiation; P:embryonic camera-type eye morphogenesis; P:embryonic limb morphogenesis; P:embryonic pattern specification; P:embryonic retina morphogenesis in camera-type eye; P:external genitalia morphogenesis; P:face morphogenesis; P:midbrain development; P:midbrain dopaminergic neuron differentiation; P:midbrain-hindbrain boundary development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of smooth muscle cell apoptotic process; P:neural crest cell differentiation; P:neural crest formation; P:neural tube closure; P:odontogenesis of dentin-containing tooth; P:pericardium morphogenesis; P:positive regulation of cell cycle; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:primitive streak formation; P:protein localization to plasma membrane; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of ossification; P:response to peptide hormone; P:roof of mouth development; P:thalamus development; P:trachea cartilage morphogenesis; P:Wnt signaling pathway; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:Wnt signaling pathway involved in somitogenesis; scaffold35 indexed_genome mRNA 980569 1003931 . - . ID=transcript_7270;Q9H8J5 Q8NEC1 Q9NW60,MANSC domain-containing protein 1,Loss of heterozygosity 12 chromosomal region 3 protein;, PF07502;, GO:0016021;, C:integral component of membrane; scaffold35 indexed_genome mRNA 1012607 1109060 . + . ID=transcript_7271;Q969J3 Q96QS5,BLOC-1-related complex subunit 5 {ECO:0000305},Loss of heterozygosity 12 chromosomal region 1 {ECO:0000312|HGNC:HGNC:17950};Myristoylated lysosomal protein {ECO:0000303|PubMed:25898167};, PF10158;, GO:0099078;GO:0098574;GO:0043231;GO:0031224;GO:0005886;GO:0030672;GO:0032418;GO:0072384;GO:1903744;, C:BORC complex; C:cytoplasmic side of lysosomal membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of membrane; C:plasma membrane; C:synaptic vesicle membrane;, , P:lysosome localization; P:organelle transport along microtubule; P:positive regulation of anterograde synaptic vesicle transport;|Q969J3 Q96QS5,BLOC-1-related complex subunit 5 {ECO:0000305},Loss of heterozygosity 12 chromosomal region 1 {ECO:0000312|HGNC:HGNC:17950};Myristoylated lysosomal protein {ECO:0000303|PubMed:25898167};, PF10158;, GO:0099078;GO:0098574;GO:0043231;GO:0031224;GO:0005886;GO:0030672;GO:0032418;GO:0072384;GO:1903744;, C:BORC complex; C:cytoplasmic side of lysosomal membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of membrane; C:plasma membrane; C:synaptic vesicle membrane;, , P:lysosome localization; P:organelle transport along microtubule; P:positive regulation of anterograde synaptic vesicle transport; scaffold35 indexed_genome mRNA 1243515 1273488 . + . ID=transcript_7272;O60519 B5BUM5,cAMP-responsive element-binding protein-like 2,, PF07716;, GO:0000785;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0007049;GO:0030154;GO:0045600;GO:0046326;GO:0046889;GO:0033138;GO:0045893;GO:0050821;GO:0006355;GO:0007165;GO:0006351;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific;, P:cell cycle; P:cell differentiation; P:positive regulation of fat cell differentiation; P:positive regulation of glucose import; P:positive regulation of lipid biosynthetic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of transcription, DNA-templated; P:signal transduction; P:transcription, DNA-templated;|O60519 B5BUM5,cAMP-responsive element-binding protein-like 2,, PF07716;, GO:0000785;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0007049;GO:0030154;GO:0045600;GO:0046326;GO:0046889;GO:0033138;GO:0045893;GO:0050821;GO:0006355;GO:0007165;GO:0006351;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific;, P:cell cycle; P:cell differentiation; P:positive regulation of fat cell differentiation; P:positive regulation of glucose import; P:positive regulation of lipid biosynthetic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of transcription, DNA-templated; P:signal transduction; P:transcription, DNA-templated; scaffold35 indexed_genome mRNA 1282005 1284298 . - . ID=transcript_7273;Q15760,Probable G-protein coupled receptor 19,GPR-NGA;, PF00001;, GO:0005929;GO:0005887;GO:0004930;GO:0007186;, C:cilium; C:integral component of plasma membrane;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; scaffold35 indexed_genome mRNA 1339851 1342822 . + . ID=transcript_7274;P46527 Q16307 Q5U0H2 Q9BUS6,Cyclin-dependent kinase inhibitor 1B,Cyclin-dependent kinase inhibitor p27 {ECO:0000303|PubMed:28666995};p27Kip1 {ECO:0000303|PubMed:8033212};, PF02234;, GO:0031464;GO:0005737;GO:0005829;GO:0005768;GO:0043231;GO:0005654;GO:0005634;GO:0051087;GO:0030332;GO:0004861;GO:0019901;GO:0004860;GO:0019903;GO:0044877;GO:0048102;GO:0007050;GO:0071285;GO:0019221;GO:0006977;GO:0000082;GO:0007507;GO:0071850;GO:1905179;GO:0045786;GO:0030308;GO:0008285;GO:1904030;GO:0045736;GO:0033673;GO:0045930;GO:0042326;GO:0045892;GO:1904706;GO:0045787;GO:0010942;GO:0045732;GO:1902806;GO:0000079;, C:Cul4A-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:chaperone binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein phosphatase binding; F:protein-containing complex binding;, P:autophagic cell death; P:cell cycle arrest; P:cellular response to lithium ion; P:cytokine-mediated signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:heart development; P:mitotic cell cycle arrest; P:negative regulation of cardiac muscle tissue regeneration; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein kinase activity; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of kinase activity; P:negative regulation of mitotic cell cycle; P:negative regulation of phosphorylation; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of cell cycle; P:positive regulation of cell death; P:positive regulation of protein catabolic process; P:regulation of cell cycle G1/S phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|P46527 Q16307 Q5U0H2 Q9BUS6,Cyclin-dependent kinase inhibitor 1B,Cyclin-dependent kinase inhibitor p27 {ECO:0000303|PubMed:28666995};p27Kip1 {ECO:0000303|PubMed:8033212};, PF02234;, GO:0031464;GO:0005737;GO:0005829;GO:0005768;GO:0043231;GO:0005654;GO:0005634;GO:0051087;GO:0030332;GO:0004861;GO:0019901;GO:0004860;GO:0019903;GO:0044877;GO:0048102;GO:0007050;GO:0071285;GO:0019221;GO:0006977;GO:0000082;GO:0007507;GO:0071850;GO:1905179;GO:0045786;GO:0030308;GO:0008285;GO:1904030;GO:0045736;GO:0033673;GO:0045930;GO:0042326;GO:0045892;GO:1904706;GO:0045787;GO:0010942;GO:0045732;GO:1902806;GO:0000079;, C:Cul4A-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:chaperone binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein phosphatase binding; F:protein-containing complex binding;, P:autophagic cell death; P:cell cycle arrest; P:cellular response to lithium ion; P:cytokine-mediated signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:heart development; P:mitotic cell cycle arrest; P:negative regulation of cardiac muscle tissue regeneration; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein kinase activity; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of kinase activity; P:negative regulation of mitotic cell cycle; P:negative regulation of phosphorylation; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of cell cycle; P:positive regulation of cell death; P:positive regulation of protein catabolic process; P:regulation of cell cycle G1/S phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold35 indexed_genome mRNA 1398062 1402663 . - . ID=transcript_7275;Q96LR9 Q8IVR2 Q9H0I5,Apolipoprotein L domain-containing protein 1,Vascular early response gene protein;, PF05461;, GO:0005576;GO:0016021;GO:0005886;GO:0008289;GO:0001525;GO:0030154;GO:0042118;GO:0006869;GO:0042157;GO:0045601;GO:0001666;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:lipid binding;, P:angiogenesis; P:cell differentiation; P:endothelial cell activation; P:lipid transport; P:lipoprotein metabolic process; P:regulation of endothelial cell differentiation; P:response to hypoxia; scaffold35 indexed_genome mRNA 1419139 1432758 . + . ID=transcript_7276;Q9H0S4 B3KXP4 G5E955 Q96GM0 Q96NV8 Q9UI98,Probable ATP-dependent RNA helicase DDX47,DEAD box protein 47;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0008625;GO:0006397;GO:0008380;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:extrinsic apoptotic signaling pathway via death domain receptors; P:mRNA processing; P:RNA splicing; P:rRNA processing;|Q9H0S4 B3KXP4 G5E955 Q96GM0 Q96NV8 Q9UI98,Probable ATP-dependent RNA helicase DDX47,DEAD box protein 47;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0008625;GO:0006397;GO:0008380;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:extrinsic apoptotic signaling pathway via death domain receptors; P:mRNA processing; P:RNA splicing; P:rRNA processing;|Q9H0S4 B3KXP4 G5E955 Q96GM0 Q96NV8 Q9UI98,Probable ATP-dependent RNA helicase DDX47,DEAD box protein 47;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0008625;GO:0006397;GO:0008380;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:extrinsic apoptotic signaling pathway via death domain receptors; P:mRNA processing; P:RNA splicing; P:rRNA processing;|Q9H0S4 B3KXP4 G5E955 Q96GM0 Q96NV8 Q9UI98,Probable ATP-dependent RNA helicase DDX47,DEAD box protein 47;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0008625;GO:0006397;GO:0008380;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:extrinsic apoptotic signaling pathway via death domain receptors; P:mRNA processing; P:RNA splicing; P:rRNA processing; scaffold35 indexed_genome mRNA 1467803 1487560 . + . ID=transcript_7277;Q8NFJ5 B3KV45 O95357,Retinoic acid-induced protein 3,G-protein coupled receptor family C group 5 member A;Phorbol ester induced gene 1 {ECO:0000303|PubMed:8832110};Retinoic acid-induced gene 1 protein;, PF00003;, GO:0030659;GO:0070062;GO:0005887;GO:0043231;GO:0005730;GO:0005886;GO:0043235;GO:0031982;GO:0045296;GO:0004930;GO:0030295;GO:0007175;GO:0007165;, C:cytoplasmic vesicle membrane; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:receptor complex; C:vesicle;, F:cadherin binding; F:G protein-coupled receptor activity; F:protein kinase activator activity;, P:negative regulation of epidermal growth factor-activated receptor activity; P:signal transduction; scaffold35 indexed_genome mRNA 1618344 1647383 . + . ID=transcript_7278;A2RU67 Q49AF2 Q5CZ81 Q6ZUV7 Q9P261,Protein FAM234B,, , GO:0005856;GO:0016021;GO:0150051;, C:cytoskeleton; C:integral component of membrane; C:postsynaptic Golgi apparatus;|A2RU67 Q49AF2 Q5CZ81 Q6ZUV7 Q9P261,Protein FAM234B,, , GO:0005856;GO:0016021;GO:0150051;, C:cytoskeleton; C:integral component of membrane; C:postsynaptic Golgi apparatus; scaffold35 indexed_genome mRNA 2935155 2982174 . + . ID=transcript_7279;Q6VMQ6 F5GX74 G3V1U0 Q4G0T9 Q6P3T3 Q86XW5 Q9NVJ9 Q9NWC2 Q9Y4X8,Activating transcription factor 7-interacting protein 1 {ECO:0000305},ATF-interacting protein;ATF7-interacting protein;ATFa-associated modulator;MBD1-containing chromatin-associated factor 1;P621;, PF16788;PF16794;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016887;GO:0003714;GO:0006306;GO:0000122;GO:0045892;GO:0090309;GO:0045893;GO:0050821;GO:0031647;GO:0045898;GO:0016032;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:ATPase activity; F:transcription corepressor activity;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of protein stability; P:regulation of RNA polymerase II transcription preinitiation complex assembly; P:viral process;|Q6VMQ6 F5GX74 G3V1U0 Q4G0T9 Q6P3T3 Q86XW5 Q9NVJ9 Q9NWC2 Q9Y4X8,Activating transcription factor 7-interacting protein 1 {ECO:0000305},ATF-interacting protein;ATF7-interacting protein;ATFa-associated modulator;MBD1-containing chromatin-associated factor 1;P621;, PF16788;PF16794;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016887;GO:0003714;GO:0006306;GO:0000122;GO:0045892;GO:0090309;GO:0045893;GO:0050821;GO:0031647;GO:0045898;GO:0016032;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:ATPase activity; F:transcription corepressor activity;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of protein stability; P:regulation of RNA polymerase II transcription preinitiation complex assembly; P:viral process; scaffold35 indexed_genome mRNA 2983776 2994434 . + . ID=transcript_7280;Q6VMQ6 F5GX74 G3V1U0 Q4G0T9 Q6P3T3 Q86XW5 Q9NVJ9 Q9NWC2 Q9Y4X8,Activating transcription factor 7-interacting protein 1 {ECO:0000305},ATF-interacting protein;ATF7-interacting protein;ATFa-associated modulator;MBD1-containing chromatin-associated factor 1;P621;, PF16788;PF16794;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016887;GO:0003714;GO:0006306;GO:0000122;GO:0045892;GO:0090309;GO:0045893;GO:0050821;GO:0031647;GO:0045898;GO:0016032;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:ATPase activity; F:transcription corepressor activity;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of protein stability; P:regulation of RNA polymerase II transcription preinitiation complex assembly; P:viral process;|Q6VMQ6 F5GX74 G3V1U0 Q4G0T9 Q6P3T3 Q86XW5 Q9NVJ9 Q9NWC2 Q9Y4X8,Activating transcription factor 7-interacting protein 1 {ECO:0000305},ATF-interacting protein;ATF7-interacting protein;ATFa-associated modulator;MBD1-containing chromatin-associated factor 1;P621;, PF16788;PF16794;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016887;GO:0003714;GO:0006306;GO:0000122;GO:0045892;GO:0090309;GO:0045893;GO:0050821;GO:0031647;GO:0045898;GO:0016032;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:ATPase activity; F:transcription corepressor activity;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of protein stability; P:regulation of RNA polymerase II transcription preinitiation complex assembly; P:viral process;|Q6VMQ6 F5GX74 G3V1U0 Q4G0T9 Q6P3T3 Q86XW5 Q9NVJ9 Q9NWC2 Q9Y4X8,Activating transcription factor 7-interacting protein 1 {ECO:0000305},ATF-interacting protein;ATF7-interacting protein;ATFa-associated modulator;MBD1-containing chromatin-associated factor 1;P621;, PF16788;PF16794;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016887;GO:0003714;GO:0006306;GO:0000122;GO:0045892;GO:0090309;GO:0045893;GO:0050821;GO:0031647;GO:0045898;GO:0016032;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:ATPase activity; F:transcription corepressor activity;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of transcription, DNA-templated; P:protein stabilization; P:regulation of protein stability; P:regulation of RNA polymerase II transcription preinitiation complex assembly; P:viral process; scaffold35 indexed_genome mRNA 2994470 3082030 . - . ID=transcript_7281;Q6P4A8 A8K4E9 Q9BVV3 Q9H625,Phospholipase B-like 1,LAMA-like protein 1;Lamina ancestor homolog 1;Phospholipase B domain-containing protein 1;, PF04916;, GO:0005829;GO:0005576;GO:0005615;GO:0005764;GO:0004620;GO:0036151;GO:0036152;GO:0036149;GO:0009395;GO:0006644;, C:cytosol; C:extracellular region; C:extracellular space; C:lysosome;, F:phospholipase activity;, P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phospholipid catabolic process; P:phospholipid metabolic process; scaffold35 indexed_genome mRNA 3134187 3197621 . - . ID=transcript_7282;P25092 B2RMY6,Heat-stable enterotoxin receptor,Guanylyl cyclase C;Intestinal guanylate cyclase;, PF00211;PF07714;, GO:0005789;GO:0016021;GO:0005886;GO:0005524;GO:0005525;GO:0004383;GO:0016941;GO:0017046;GO:0001653;GO:0004672;GO:0015643;GO:0006182;GO:0007586;GO:0035556;GO:0007168;GO:0042127;GO:0009636;GO:0007165;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:guanylate cyclase activity; F:natriuretic peptide receptor activity; F:peptide hormone binding; F:peptide receptor activity; F:protein kinase activity; F:toxic substance binding;, P:cGMP biosynthetic process; P:digestion; P:intracellular signal transduction; P:receptor guanylyl cyclase signaling pathway; P:regulation of cell population proliferation; P:response to toxic substance; P:signal transduction;|P25092 B2RMY6,Heat-stable enterotoxin receptor,Guanylyl cyclase C;Intestinal guanylate cyclase;, PF00211;PF07714;, GO:0005789;GO:0016021;GO:0005886;GO:0005524;GO:0005525;GO:0004383;GO:0016941;GO:0017046;GO:0001653;GO:0004672;GO:0015643;GO:0006182;GO:0007586;GO:0035556;GO:0007168;GO:0042127;GO:0009636;GO:0007165;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:guanylate cyclase activity; F:natriuretic peptide receptor activity; F:peptide hormone binding; F:peptide receptor activity; F:protein kinase activity; F:toxic substance binding;, P:cGMP biosynthetic process; P:digestion; P:intracellular signal transduction; P:receptor guanylyl cyclase signaling pathway; P:regulation of cell population proliferation; P:response to toxic substance; P:signal transduction; scaffold35 indexed_genome mRNA 3233948 3234806 . + . ID=transcript_7283;Q9BTM1 Q9NV63,Histone H2A.J,, PF00125;PF16211;, GO:0070062;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006342;, C:extracellular exosome; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:chromatin silencing; scaffold35 indexed_genome mRNA 3249171 3264577 . - . ID=transcript_7284;Q9Y2W2 Q96AY8,WW domain-binding protein 11,Npw38-binding protein;SH3 domain-binding protein SNP70;Splicing factor that interacts with PQBP-1 and PP1;, PF09429;, GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0003697;GO:0050699;GO:0045292;GO:0000398;GO:0006364;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding; F:single-stranded DNA binding; F:WW domain binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:rRNA processing;|Q9Y2W2 Q96AY8,WW domain-binding protein 11,Npw38-binding protein;SH3 domain-binding protein SNP70;Splicing factor that interacts with PQBP-1 and PP1;, PF09429;, GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0003697;GO:0050699;GO:0045292;GO:0000398;GO:0006364;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding; F:single-stranded DNA binding; F:WW domain binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:rRNA processing;|Q9Y2W2 Q96AY8,WW domain-binding protein 11,Npw38-binding protein;SH3 domain-binding protein SNP70;Splicing factor that interacts with PQBP-1 and PP1;, PF09429;, GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0003697;GO:0050699;GO:0045292;GO:0000398;GO:0006364;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding; F:single-stranded DNA binding; F:WW domain binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:rRNA processing; scaffold35 indexed_genome mRNA 3266520 3267716 . + . ID=transcript_7285;A2RU48 Q8NAI5,Single-pass membrane and coiled-coil domain-containing protein 3,, PF15047;, GO:0016021;, C:integral component of membrane; scaffold35 indexed_genome mRNA 3284795 3298973 . - . ID=transcript_7286;Q93070 Q9BZ50 Q9BZ51 Q9HB06,Ecto-ADP-ribosyltransferase 4,ADP-ribosyltransferase C2 and C3 toxin-like 4;Dombrock blood group carrier molecule;Mono(ADP-ribosyl)transferase 4;NAD(P)(+)--arginine ADP-ribosyltransferase 4;, PF01129;, GO:0031225;GO:0005576;GO:0016020;GO:0005886;GO:0003956;GO:0003950;GO:0106274;GO:0106275;GO:0006525;GO:0018120;GO:0006471;, C:anchored component of membrane; C:extracellular region; C:membrane; C:plasma membrane;, F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:NAD+-protein-arginine ADP-ribosyltransferase activity; F:NADP+-protein-arginine ADP-ribosyltransferase activity;, P:arginine metabolic process; P:peptidyl-arginine ADP-ribosylation; P:protein ADP-ribosylation; scaffold35 indexed_genome mRNA 3337083 3342366 . - . ID=transcript_7287;P08493 A0M8W5 B2R519 J3KMX7 Q2TU41 Q567P9 Q6ICN5,Matrix Gla protein,Cell growth-inhibiting gene 36 protein;, , GO:0062023;GO:0070062;GO:0031012;GO:0005509;GO:0005201;GO:0008147;GO:0001502;GO:0030154;GO:0001503;GO:0030500;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix;, F:calcium ion binding; F:extracellular matrix structural constituent; F:structural constituent of bone;, P:cartilage condensation; P:cell differentiation; P:ossification; P:regulation of bone mineralization;|P08493 A0M8W5 B2R519 J3KMX7 Q2TU41 Q567P9 Q6ICN5,Matrix Gla protein,Cell growth-inhibiting gene 36 protein;, , GO:0062023;GO:0070062;GO:0031012;GO:0005509;GO:0005201;GO:0008147;GO:0001502;GO:0030154;GO:0001503;GO:0030500;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix;, F:calcium ion binding; F:extracellular matrix structural constituent; F:structural constituent of bone;, P:cartilage condensation; P:cell differentiation; P:ossification; P:regulation of bone mineralization; scaffold35 indexed_genome mRNA 3541361 3667253 . - . ID=transcript_7288;Q96A58 B2R9R0 B4DI02,Ras-related and estrogen-regulated growth inhibitor,, PF00071;, GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0005886;GO:0030331;GO:0019003;GO:0005525;GO:0003924;GO:0030308;GO:0008285;GO:0007265;GO:0009725;GO:0007264;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:estrogen receptor binding; F:GDP binding; F:GTP binding; F:GTPase activity;, P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:Ras protein signal transduction; P:response to hormone; P:small GTPase mediated signal transduction; scaffold35 indexed_genome mRNA 3933437 3978643 . + . ID=transcript_7289;Q16827 A0AV39 Q13101 Q8IYG3 Q9UBF0 Q9UBT5,Receptor-type tyrosine-protein phosphatase O,Glomerular epithelial protein 1;Protein tyrosine phosphatase U2;, PF00041;PF00102;, GO:0016324;GO:0030424;GO:0043197;GO:0070062;GO:0098982;GO:0098978;GO:0030426;GO:0016021;GO:0005887;GO:0030027;GO:0016328;GO:0043005;GO:0005886;GO:0045296;GO:0016791;GO:0042803;GO:0004725;GO:0005001;GO:0017147;GO:0007411;GO:0000902;GO:0072112;GO:0032835;GO:0030032;GO:0002548;GO:0090090;GO:0010812;GO:0003105;GO:0010977;GO:0090260;GO:0035335;GO:1990264;GO:0006470;GO:0003093;GO:0036060;, C:apical plasma membrane; C:axon; C:dendritic spine; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:lamellipodium; C:lateral plasma membrane; C:neuron projection; C:plasma membrane;, F:cadherin binding; F:phosphatase activity; F:protein homodimerization activity; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity; F:Wnt-protein binding;, P:axon guidance; P:cell morphogenesis; P:glomerular visceral epithelial cell differentiation; P:glomerulus development; P:lamellipodium assembly; P:monocyte chemotaxis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell-substrate adhesion; P:negative regulation of glomerular filtration; P:negative regulation of neuron projection development; P:negative regulation of retinal ganglion cell axon guidance; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:protein dephosphorylation; P:regulation of glomerular filtration; P:slit diaphragm assembly; scaffold35 indexed_genome mRNA 4028817 4107665 . + . ID=transcript_7290;Q9Y315 Q53HN9 Q6PHW2,Deoxyribose-phosphate aldolase,2-deoxy-D-ribose 5-phosphate aldolase;Phosphodeoxyriboaldolase;, PF01791;, GO:0005829;GO:0005576;GO:1904813;GO:0005654;GO:0034774;GO:0004139;GO:0016052;GO:0046121;GO:0009264;GO:0046386;GO:0043312;GO:0006098;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:secretory granule lumen;, F:deoxyribose-phosphate aldolase activity;, P:carbohydrate catabolic process; P:deoxyribonucleoside catabolic process; P:deoxyribonucleotide catabolic process; P:deoxyribose phosphate catabolic process; P:neutrophil degranulation; P:pentose-phosphate shunt; scaffold35 indexed_genome mRNA 4430105 4445722 . + . ID=transcript_7291;P10620 A8K533 G5EA53,Microsomal glutathione S-transferase 1,Microsomal GST-I;, PF01124;, GO:0045177;GO:0035577;GO:0005783;GO:0005789;GO:0016021;GO:0005741;GO:0005739;GO:0005634;GO:0005778;GO:0005886;GO:0043295;GO:0004602;GO:0004364;GO:0042802;GO:0046222;GO:0071449;GO:1901687;GO:0034635;GO:0033327;GO:0043312;GO:0042493;GO:0032496;GO:0010243;, C:apical part of cell; C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane; C:plasma membrane;, F:glutathione binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:identical protein binding;, P:aflatoxin metabolic process; P:cellular response to lipid hydroperoxide; P:glutathione derivative biosynthetic process; P:glutathione transport; P:Leydig cell differentiation; P:neutrophil degranulation; P:response to drug; P:response to lipopolysaccharide; P:response to organonitrogen compound; scaffold35 indexed_genome mRNA 4447730 4453565 . + . ID=transcript_7292;P10620 A8K533 G5EA53,Microsomal glutathione S-transferase 1,Microsomal GST-I;, PF01124;, GO:0045177;GO:0035577;GO:0005783;GO:0005789;GO:0016021;GO:0005741;GO:0005739;GO:0005634;GO:0005778;GO:0005886;GO:0043295;GO:0004602;GO:0004364;GO:0042802;GO:0046222;GO:0071449;GO:1901687;GO:0034635;GO:0033327;GO:0043312;GO:0042493;GO:0032496;GO:0010243;, C:apical part of cell; C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane; C:plasma membrane;, F:glutathione binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:identical protein binding;, P:aflatoxin metabolic process; P:cellular response to lipid hydroperoxide; P:glutathione derivative biosynthetic process; P:glutathione transport; P:Leydig cell differentiation; P:neutrophil degranulation; P:response to drug; P:response to lipopolysaccharide; P:response to organonitrogen compound; scaffold35 indexed_genome mRNA 4600026 4661465 . + . ID=transcript_7293;Q8TAP4 B4DG90 B4DH35 Q58A66 Q58A67 Q8N974 Q9UDD5,LIM domain only protein 3,Neuronal-specific transcription factor DAT1;Rhombotin-3;, PF00412;, GO:0005737;GO:0046872;GO:0070373;GO:0045600;GO:2000324;GO:0035360;, C:cytoplasm;, F:metal ion binding;, P:negative regulation of ERK1 and ERK2 cascade; P:positive regulation of fat cell differentiation; P:positive regulation of glucocorticoid receptor signaling pathway; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; scaffold35 indexed_genome mRNA 5837726 5864813 . - . ID=transcript_7294;Q9H628,Ras-related and estrogen-regulated growth inhibitor-like protein,RERG/Ras-like protein;, PF00071;, GO:0016020;GO:0005525;GO:0003924;GO:0007165;, C:membrane;, F:GTP binding; F:GTPase activity;, P:signal transduction; scaffold35 indexed_genome mRNA 5995398 6398853 . + . ID=transcript_7295;O75747 A1L3U0,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma,Phosphoinositide 3-kinase-C2-gamma;, PF00168;PF00454;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0016020;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0035091;GO:0052742;GO:0016307;GO:0016477;GO:0006935;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0039694;, C:cytoplasm; C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity; F:phosphatidylinositol phosphate kinase activity;, P:cell migration; P:chemotaxis; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:viral RNA genome replication; scaffold35 indexed_genome mRNA 7026208 7128529 . + . ID=transcript_7296;Q9BVR4 Q9C0H7 Q9H924 Q9NVK8,Pleckstrin homology domain-containing family A member 5,Phosphoinositol 3-phosphate-binding protein 2;, PF00169;PF00397;, GO:0005829;GO:0098978;GO:0016020;GO:0005654;GO:0014069;GO:0080025;GO:0032266;GO:0070273;GO:0010314;GO:0061458;, C:cytosol; C:glutamatergic synapse; C:membrane; C:nucleoplasm; C:postsynaptic density;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:reproductive system development;|Q9BVR4 Q9C0H7 Q9H924 Q9NVK8,Pleckstrin homology domain-containing family A member 5,Phosphoinositol 3-phosphate-binding protein 2;, PF00169;PF00397;, GO:0005829;GO:0098978;GO:0016020;GO:0005654;GO:0014069;GO:0080025;GO:0032266;GO:0070273;GO:0010314;GO:0061458;, C:cytosol; C:glutamatergic synapse; C:membrane; C:nucleoplasm; C:postsynaptic density;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:reproductive system development;|Q9BVR4 Q9C0H7 Q9H924 Q9NVK8,Pleckstrin homology domain-containing family A member 5,Phosphoinositol 3-phosphate-binding protein 2;, PF00169;PF00397;, GO:0005829;GO:0098978;GO:0016020;GO:0005654;GO:0014069;GO:0080025;GO:0032266;GO:0070273;GO:0010314;GO:0061458;, C:cytosol; C:glutamatergic synapse; C:membrane; C:nucleoplasm; C:postsynaptic density;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:reproductive system development; scaffold35 indexed_genome mRNA 7203983 7267757 . + . ID=transcript_7297;Q6ZN18 Q59FS5 Q6ZN62 Q96BG3,Zinc finger protein AEBP2,Adipocyte enhancer-binding protein 2;, , GO:0000785;GO:0035098;GO:0005654;GO:0003677;GO:0001227;GO:0046872;GO:0006325;GO:0045814;GO:0006357;, C:chromatin; C:ESC/E(Z) complex; C:nucleoplasm;, F:DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding;, P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:regulation of transcription by RNA polymerase II;|Q6ZN18 Q59FS5 Q6ZN62 Q96BG3,Zinc finger protein AEBP2,Adipocyte enhancer-binding protein 2;, , GO:0000785;GO:0035098;GO:0005654;GO:0003677;GO:0001227;GO:0046872;GO:0006325;GO:0045814;GO:0006357;, C:chromatin; C:ESC/E(Z) complex; C:nucleoplasm;, F:DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding;, P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:regulation of transcription by RNA polymerase II; scaffold35 indexed_genome mRNA 8180617 8530976 . + . ID=transcript_7298;Q14432 O60865 Q13348 Q17RD1,cGMP-inhibited 3',5'-cyclic phosphodiesterase A,Cyclic GMP-inhibited phosphodiesterase A;, PF00233;, GO:0005829;GO:0016021;GO:0004115;GO:0004114;GO:0004119;GO:0046872;GO:0019933;GO:0071321;GO:0071560;GO:0019934;GO:0007186;GO:0006629;GO:0043066;GO:0043951;GO:0043116;GO:0001556;GO:0060282;GO:0043117;GO:0040020;GO:0042493;GO:0007165;, C:cytosol; C:integral component of membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP-mediated signaling; P:cellular response to cGMP; P:cellular response to transforming growth factor beta stimulus; P:cGMP-mediated signaling; P:G protein-coupled receptor signaling pathway; P:lipid metabolic process; P:negative regulation of apoptotic process; P:negative regulation of cAMP-mediated signaling; P:negative regulation of vascular permeability; P:oocyte maturation; P:positive regulation of oocyte development; P:positive regulation of vascular permeability; P:regulation of meiotic nuclear division; P:response to drug; P:signal transduction;|Q96QE2 Q17S07,Proton myo-inositol cotransporter {ECO:0000305},H(+)-myo-inositol symporter {ECO:0000303|PubMed:11500374};Solute carrier family 2 member 13;, PF00083;, GO:0097450;GO:0044297;GO:0071944;GO:0042995;GO:0005737;GO:0030426;GO:0005887;GO:0043231;GO:0016020;GO:0031090;GO:0005886;GO:0051117;GO:0005365;GO:0005366;GO:0002020;GO:0015798;GO:1902004;GO:0150104;, C:astrocyte end-foot; C:cell body; C:cell periphery; C:cell projection; C:cytoplasm; C:growth cone; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:plasma membrane;, F:ATPase binding; F:myo-inositol transmembrane transporter activity; F:myo-inositol:proton symporter activity; F:protease binding;, P:myo-inositol transport; P:positive regulation of amyloid-beta formation; P:transport across blood-brain barrier; scaffold35 indexed_genome mRNA 8560379 8636680 . + . ID=transcript_7299;Q9NYB5 B7Z251 B7Z3Q3 B7Z8P1 F5GZD6 Q5JPA4,Solute carrier organic anion transporter family member 1C1,Organic anion transporter F;Organic anion transporter polypeptide-related protein 5;Organic anion-transporting polypeptide 14;Solute carrier family 21 member 14;Thyroxine transporter;, PF07648;PF03137;, GO:0016323;GO:0005887;GO:0005886;GO:0015125;GO:0015347;GO:0015349;GO:0015721;GO:2000611;GO:0043252;GO:0070327;GO:0055085;GO:0150104;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity; F:thyroid hormone transmembrane transporter activity;, P:bile acid and bile salt transport; P:positive regulation of thyroid hormone generation; P:sodium-independent organic anion transport; P:thyroid hormone transport; P:transmembrane transport; P:transport across blood-brain barrier; scaffold35 indexed_genome mRNA 8679004 8744442 . + . ID=transcript_7300;Q9NPD5 E7EMT8 Q5JAR4,Solute carrier organic anion transporter family member 1B3,Liver-specific organic anion transporter 2;Organic anion transporter 8;Organic anion-transporting polypeptide 8;Solute carrier family 21 member 8;, PF07648;PF03137;, GO:0016323;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport;|Q9NPD5 E7EMT8 Q5JAR4,Solute carrier organic anion transporter family member 1B3,Liver-specific organic anion transporter 2;Organic anion transporter 8;Organic anion-transporting polypeptide 8;Solute carrier family 21 member 8;, PF07648;PF03137;, GO:0016323;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport;|Q9Y6L6 B2R7G2 Q29R64 Q9NQ37 Q9UBF3 Q9UH89,Solute carrier organic anion transporter family member 1B1,Liver-specific organic anion transporter 1;OATP-C;Sodium-independent organic anion-transporting polypeptide 2;Solute carrier family 21 member 6;, PF07648;PF03137;, GO:0016323;GO:0005887;GO:0016020;GO:0005886;GO:0015125;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport;|Q9NPD5 E7EMT8 Q5JAR4,Solute carrier organic anion transporter family member 1B3,Liver-specific organic anion transporter 2;Organic anion transporter 8;Organic anion-transporting polypeptide 8;Solute carrier family 21 member 8;, PF07648;PF03137;, GO:0016323;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport; scaffold35 indexed_genome mRNA 8760499 8778443 . - . ID=transcript_7301;P46721 Q9UGP7 Q9UL38,Solute carrier organic anion transporter family member 1A2,OATP-A;Organic anion-transporting polypeptide 1;Sodium-independent organic anion transporter;Solute carrier family 21 member 3;, PF07648;PF03137;, GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0015711;GO:0043252;, C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:organic anion transport; P:sodium-independent organic anion transport; scaffold35 indexed_genome mRNA 8779471 8805527 . - . ID=transcript_7302;P46721 Q9UGP7 Q9UL38,Solute carrier organic anion transporter family member 1A2,OATP-A;Organic anion-transporting polypeptide 1;Sodium-independent organic anion transporter;Solute carrier family 21 member 3;, PF07648;PF03137;, GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0015711;GO:0043252;, C:integral component of plasma membrane; C:plasma membrane;, F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;, P:bile acid and bile salt transport; P:organic anion transport; P:sodium-independent organic anion transport; scaffold35 indexed_genome mRNA 8888149 8950736 . + . ID=transcript_7303;Q8WU10 A6NKI6 B3KWN8 Q9H6P1,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1,, PF07992;PF18267;, GO:0005634;GO:0030017;GO:0016491;GO:0034599;, C:nucleus; C:sarcomere;, F:oxidoreductase activity;, P:cellular response to oxidative stress;|P46063 A8K6G2,ATP-dependent DNA helicase Q1,DNA helicase, RecQ-like type 1;DNA-dependent ATPase Q1;RecQ protein-like 1;, PF00270;PF00271;PF16124;, GO:0005694;GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0043138;GO:0036310;GO:0005524;GO:0003677;GO:0003678;GO:0009378;GO:0032508;GO:0006310;GO:0006281;GO:0000733;GO:0006268;GO:0000724;, C:chromosome; C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:3'-5' DNA helicase activity; F:annealing helicase activity; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:four-way junction helicase activity;, P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA strand renaturation; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination;|Q8WU10 A6NKI6 B3KWN8 Q9H6P1,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1,, PF07992;PF18267;, GO:0005634;GO:0030017;GO:0016491;GO:0034599;, C:nucleus; C:sarcomere;, F:oxidoreductase activity;, P:cellular response to oxidative stress;|Q8WU10 A6NKI6 B3KWN8 Q9H6P1,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1,, PF07992;PF18267;, GO:0005634;GO:0030017;GO:0016491;GO:0034599;, C:nucleus; C:sarcomere;, F:oxidoreductase activity;, P:cellular response to oxidative stress; scaffold35 indexed_genome mRNA 8955663 8961727 . + . ID=transcript_7304;Q9Y3E0 B2R4R4 Q54A40 Q6I9W6 Q9P1R9,Vesicle transport protein GOT1B,Germ cell tumor 2;Golgi transport 1 homolog B;Putative NF-kappa-B-activating protein 470;hGOT1a;, PF04178;, GO:0005783;GO:0000139;GO:0016021;GO:0016020;GO:0032991;GO:0043123;GO:0015031;GO:0016192;, C:endoplasmic reticulum; C:Golgi membrane; C:integral component of membrane; C:membrane; C:protein-containing complex;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein transport; P:vesicle-mediated transport;|Q9Y3E0 B2R4R4 Q54A40 Q6I9W6 Q9P1R9,Vesicle transport protein GOT1B,Germ cell tumor 2;Golgi transport 1 homolog B;Putative NF-kappa-B-activating protein 470;hGOT1a;, PF04178;, GO:0005783;GO:0000139;GO:0016021;GO:0016020;GO:0032991;GO:0043123;GO:0015031;GO:0016192;, C:endoplasmic reticulum; C:Golgi membrane; C:integral component of membrane; C:membrane; C:protein-containing complex;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein transport; P:vesicle-mediated transport; scaffold35 indexed_genome mRNA 8971994 8984053 . + . ID=transcript_7305;Q9BT56 B3KND6,Spexin,NPQ;Neuropeptide Q;Spexin hormone;, PF15171;, GO:0005737;GO:0031045;GO:0005615;GO:0030133;GO:0005184;GO:0031765;GO:0031766;GO:0044539;GO:0032099;GO:0010459;GO:0035814;GO:1904306;GO:0003084;GO:0045944;GO:0051930;, C:cytoplasm; C:dense core granule; C:extracellular space; C:transport vesicle;, F:neuropeptide hormone activity; F:type 2 galanin receptor binding; F:type 3 galanin receptor binding;, P:long-chain fatty acid import into cell; P:negative regulation of appetite; P:negative regulation of heart rate; P:negative regulation of renal sodium excretion; P:positive regulation of gastro-intestinal system smooth muscle contraction; P:positive regulation of systemic arterial blood pressure; P:positive regulation of transcription by RNA polymerase II; P:regulation of sensory perception of pain; scaffold35 indexed_genome mRNA 8990226 8991199 . - . ID=transcript_7306;P54840 A0AVD8,Glycogen [starch] synthase, liver,, PF05693;, GO:0005938;GO:0030864;GO:0005737;GO:0005856;GO:0005829;GO:0043265;GO:0004373;GO:0006091;GO:0005978;GO:0009749;, C:cell cortex; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:ectoplasm;, F:glycogen (starch) synthase activity;, P:generation of precursor metabolites and energy; P:glycogen biosynthetic process; P:response to glucose; scaffold35 indexed_genome mRNA 8993922 9049505 . - . ID=transcript_7307;P54840 A0AVD8,Glycogen [starch] synthase, liver,, PF05693;, GO:0005938;GO:0030864;GO:0005737;GO:0005856;GO:0005829;GO:0043265;GO:0004373;GO:0006091;GO:0005978;GO:0009749;, C:cell cortex; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:ectoplasm;, F:glycogen (starch) synthase activity;, P:generation of precursor metabolites and energy; P:glycogen biosynthetic process; P:response to glucose; scaffold35 indexed_genome mRNA 9081808 9084942 . + . ID=transcript_7308;P07195,L-lactate dehydrogenase B chain,LDH heart subunit;Renal carcinoma antigen NY-REN-46;, PF02866;PF00056;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0042802;GO:0004459;GO:0005975;GO:0006090;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft;, F:identical protein binding; F:L-lactate dehydrogenase activity;, P:carbohydrate metabolic process; P:pyruvate metabolic process;|P07195,L-lactate dehydrogenase B chain,LDH heart subunit;Renal carcinoma antigen NY-REN-46;, PF02866;PF00056;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0042802;GO:0004459;GO:0005975;GO:0006090;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft;, F:identical protein binding; F:L-lactate dehydrogenase activity;, P:carbohydrate metabolic process; P:pyruvate metabolic process;|P07195,L-lactate dehydrogenase B chain,LDH heart subunit;Renal carcinoma antigen NY-REN-46;, PF02866;PF00056;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0042802;GO:0004459;GO:0005975;GO:0006090;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft;, F:identical protein binding; F:L-lactate dehydrogenase activity;, P:carbohydrate metabolic process; P:pyruvate metabolic process; scaffold35 indexed_genome mRNA 9086180 9087598 . + . ID=transcript_7309;P07195,L-lactate dehydrogenase B chain,LDH heart subunit;Renal carcinoma antigen NY-REN-46;, PF02866;PF00056;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0042802;GO:0004459;GO:0005975;GO:0006090;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft;, F:identical protein binding; F:L-lactate dehydrogenase activity;, P:carbohydrate metabolic process; P:pyruvate metabolic process; scaffold35 indexed_genome mRNA 9088094 9092289 . + . ID=transcript_7310;P07195,L-lactate dehydrogenase B chain,LDH heart subunit;Renal carcinoma antigen NY-REN-46;, PF02866;PF00056;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0042802;GO:0004459;GO:0005975;GO:0006090;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft;, F:identical protein binding; F:L-lactate dehydrogenase activity;, P:carbohydrate metabolic process; P:pyruvate metabolic process;|P07195,L-lactate dehydrogenase B chain,LDH heart subunit;Renal carcinoma antigen NY-REN-46;, PF02866;PF00056;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0042802;GO:0004459;GO:0005975;GO:0006090;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft;, F:identical protein binding; F:L-lactate dehydrogenase activity;, P:carbohydrate metabolic process; P:pyruvate metabolic process; scaffold35 indexed_genome mRNA 9194583 9201961 . - . ID=transcript_7311;Q15842 O00657,ATP-sensitive inward rectifier potassium channel 8,Inward rectifier K(+) channel Kir6.1;Potassium channel, inwardly rectifying subfamily J member 8;uKATP-1;, PF01007;PF17655;, GO:0008282;GO:0005739;GO:0030016;GO:0005886;GO:0031004;GO:0042383;GO:0008076;GO:0005524;GO:0015272;GO:0019829;GO:0005242;GO:0017098;GO:1902282;GO:0051607;GO:0007507;GO:0098662;GO:0001822;GO:0098915;GO:1990573;GO:0071805;GO:0006813;GO:0034765;GO:0043330;GO:0032496;GO:0150104;, C:inward rectifying potassium channel; C:mitochondrion; C:myofibril; C:plasma membrane; C:potassium ion-transporting ATPase complex; C:sarcolemma; C:voltage-gated potassium channel complex;, F:ATP binding; F:ATP-activated inward rectifier potassium channel activity; F:ATPase-coupled cation transmembrane transporter activity; F:inward rectifier potassium channel activity; F:sulfonylurea receptor binding; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:defense response to virus; P:heart development; P:inorganic cation transmembrane transport; P:kidney development; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:response to exogenous dsRNA; P:response to lipopolysaccharide; P:transport across blood-brain barrier;|Q15842 O00657,ATP-sensitive inward rectifier potassium channel 8,Inward rectifier K(+) channel Kir6.1;Potassium channel, inwardly rectifying subfamily J member 8;uKATP-1;, PF01007;PF17655;, GO:0008282;GO:0005739;GO:0030016;GO:0005886;GO:0031004;GO:0042383;GO:0008076;GO:0005524;GO:0015272;GO:0019829;GO:0005242;GO:0017098;GO:1902282;GO:0051607;GO:0007507;GO:0098662;GO:0001822;GO:0098915;GO:1990573;GO:0071805;GO:0006813;GO:0034765;GO:0043330;GO:0032496;GO:0150104;, C:inward rectifying potassium channel; C:mitochondrion; C:myofibril; C:plasma membrane; C:potassium ion-transporting ATPase complex; C:sarcolemma; C:voltage-gated potassium channel complex;, F:ATP binding; F:ATP-activated inward rectifier potassium channel activity; F:ATPase-coupled cation transmembrane transporter activity; F:inward rectifier potassium channel activity; F:sulfonylurea receptor binding; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:defense response to virus; P:heart development; P:inorganic cation transmembrane transport; P:kidney development; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:response to exogenous dsRNA; P:response to lipopolysaccharide; P:transport across blood-brain barrier;|Q15842 O00657,ATP-sensitive inward rectifier potassium channel 8,Inward rectifier K(+) channel Kir6.1;Potassium channel, inwardly rectifying subfamily J member 8;uKATP-1;, PF01007;PF17655;, GO:0008282;GO:0005739;GO:0030016;GO:0005886;GO:0031004;GO:0042383;GO:0008076;GO:0005524;GO:0015272;GO:0019829;GO:0005242;GO:0017098;GO:1902282;GO:0051607;GO:0007507;GO:0098662;GO:0001822;GO:0098915;GO:1990573;GO:0071805;GO:0006813;GO:0034765;GO:0043330;GO:0032496;GO:0150104;, C:inward rectifying potassium channel; C:mitochondrion; C:myofibril; C:plasma membrane; C:potassium ion-transporting ATPase complex; C:sarcolemma; C:voltage-gated potassium channel complex;, F:ATP binding; F:ATP-activated inward rectifier potassium channel activity; F:ATPase-coupled cation transmembrane transporter activity; F:inward rectifier potassium channel activity; F:sulfonylurea receptor binding; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:defense response to virus; P:heart development; P:inorganic cation transmembrane transport; P:kidney development; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:response to exogenous dsRNA; P:response to lipopolysaccharide; P:transport across blood-brain barrier; scaffold35 indexed_genome mRNA 9218848 9367634 . - . ID=transcript_7312;Q09428 A6NMX8 E3UYX6 O75948 Q16583,ATP-binding cassette sub-family C member 8,Sulfonylurea receptor 1;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0008281;GO:0098662;GO:0071805;GO:0006813;GO:0050796;GO:0055085;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:sulfonylurea receptor activity;, P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of insulin secretion; P:transmembrane transport;|O60706 O60707,ATP-binding cassette sub-family C member 9,Sulfonylurea receptor 2;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0030017;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0015459;GO:0008281;GO:0061337;GO:0098655;GO:0051607;GO:0098662;GO:1990573;GO:0071805;GO:1903779;GO:0033198;GO:0055085;GO:0150104;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex; C:sarcomere;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:potassium channel regulator activity; F:sulfonylurea receptor activity;, P:cardiac conduction; P:cation transmembrane transport; P:defense response to virus; P:inorganic cation transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of cardiac conduction; P:response to ATP; P:transmembrane transport; P:transport across blood-brain barrier;|O60706 O60707,ATP-binding cassette sub-family C member 9,Sulfonylurea receptor 2;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0030017;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0015459;GO:0008281;GO:0061337;GO:0098655;GO:0051607;GO:0098662;GO:1990573;GO:0071805;GO:1903779;GO:0033198;GO:0055085;GO:0150104;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex; C:sarcomere;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:potassium channel regulator activity; F:sulfonylurea receptor activity;, P:cardiac conduction; P:cation transmembrane transport; P:defense response to virus; P:inorganic cation transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of cardiac conduction; P:response to ATP; P:transmembrane transport; P:transport across blood-brain barrier;|O60706 O60707,ATP-binding cassette sub-family C member 9,Sulfonylurea receptor 2;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0030017;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0015459;GO:0008281;GO:0061337;GO:0098655;GO:0051607;GO:0098662;GO:1990573;GO:0071805;GO:1903779;GO:0033198;GO:0055085;GO:0150104;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex; C:sarcomere;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:potassium channel regulator activity; F:sulfonylurea receptor activity;, P:cardiac conduction; P:cation transmembrane transport; P:defense response to virus; P:inorganic cation transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of cardiac conduction; P:response to ATP; P:transmembrane transport; P:transport across blood-brain barrier; scaffold35 indexed_genome mRNA 9454259 9470191 . + . ID=transcript_7313;Q8NFW8 Q96AX5 Q9NQZ0,N-acylneuraminate cytidylyltransferase,CMP-N-acetylneuraminic acid synthase;, PF02348;, GO:0016020;GO:0005654;GO:0005634;GO:0008781;GO:0006054;, C:membrane; C:nucleoplasm; C:nucleus;, F:N-acylneuraminate cytidylyltransferase activity;, P:N-acetylneuraminate metabolic process;|Q8NFW8 Q96AX5 Q9NQZ0,N-acylneuraminate cytidylyltransferase,CMP-N-acetylneuraminic acid synthase;, PF02348;, GO:0016020;GO:0005654;GO:0005634;GO:0008781;GO:0006054;, C:membrane; C:nucleoplasm; C:nucleus;, F:N-acylneuraminate cytidylyltransferase activity;, P:N-acetylneuraminate metabolic process;|Q8NFW8 Q96AX5 Q9NQZ0,N-acylneuraminate cytidylyltransferase,CMP-N-acetylneuraminic acid synthase;, PF02348;, GO:0016020;GO:0005654;GO:0005634;GO:0008781;GO:0006054;, C:membrane; C:nucleoplasm; C:nucleus;, F:N-acylneuraminate cytidylyltransferase activity;, P:N-acetylneuraminate metabolic process;|Q8NFW8 Q96AX5 Q9NQZ0,N-acylneuraminate cytidylyltransferase,CMP-N-acetylneuraminic acid synthase;, PF02348;, GO:0016020;GO:0005654;GO:0005634;GO:0008781;GO:0006054;, C:membrane; C:nucleoplasm; C:nucleus;, F:N-acylneuraminate cytidylyltransferase activity;, P:N-acetylneuraminate metabolic process;|Q8NFW8 Q96AX5 Q9NQZ0,N-acylneuraminate cytidylyltransferase,CMP-N-acetylneuraminic acid synthase;, PF02348;, GO:0016020;GO:0005654;GO:0005634;GO:0008781;GO:0006054;, C:membrane; C:nucleoplasm; C:nucleus;, F:N-acylneuraminate cytidylyltransferase activity;, P:N-acetylneuraminate metabolic process; scaffold35 indexed_genome mRNA 9569141 9721884 . - . ID=transcript_7314;Q92185 A8K4H6 Q17RL0 Q6PZN5 Q93064,Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase,Alpha-2,8-sialyltransferase 8A;Ganglioside GD3 synthase;Ganglioside GT3 synthase;Sialyltransferase 8A;Sialyltransferase St8Sia I;, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0008373;GO:0005975;GO:0034605;GO:0006688;GO:0006491;GO:0009311;GO:0008284;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:sialyltransferase activity;, P:carbohydrate metabolic process; P:cellular response to heat; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:positive regulation of cell population proliferation; P:protein glycosylation;|Q92185 A8K4H6 Q17RL0 Q6PZN5 Q93064,Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase,Alpha-2,8-sialyltransferase 8A;Ganglioside GD3 synthase;Ganglioside GT3 synthase;Sialyltransferase 8A;Sialyltransferase St8Sia I;, PF00777;, GO:0000139;GO:0016021;GO:0003828;GO:0008373;GO:0005975;GO:0034605;GO:0006688;GO:0006491;GO:0009311;GO:0008284;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:sialyltransferase activity;, P:carbohydrate metabolic process; P:cellular response to heat; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:positive regulation of cell population proliferation; P:protein glycosylation; scaffold35 indexed_genome mRNA 9805958 9905688 . + . ID=transcript_7315;Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane;|Q86SU3,C2 domain-containing protein 5,C2 domain-containing phosphoprotein of 138 kDa;, PF00168;, GO:0005938;GO:0034451;GO:0030659;GO:0005829;GO:0005886;GO:0032587;GO:0005509;GO:0005544;GO:0032869;GO:0038028;GO:0065002;GO:0010828;GO:0090314;GO:0031340;GO:0072659;, C:cell cortex; C:centriolar satellite; C:cytoplasmic vesicle membrane; C:cytosol; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:cellular response to insulin stimulus; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:intracellular protein transmembrane transport; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane; scaffold35 indexed_genome mRNA 9975541 10009547 . + . ID=transcript_7316;Q9HBU6 G5E969,Ethanolamine kinase 1 {ECO:0000305},, , GO:0005829;GO:0016020;GO:0005524;GO:0004305;GO:0006646;, C:cytosol; C:membrane;, F:ATP binding; F:ethanolamine kinase activity;, P:phosphatidylethanolamine biosynthetic process; scaffold35 indexed_genome mRNA 10014958 10031417 . + . ID=transcript_7317;Q9HBU6 G5E969,Ethanolamine kinase 1 {ECO:0000305},, , GO:0005829;GO:0016020;GO:0005524;GO:0004305;GO:0006646;, C:cytosol; C:membrane;, F:ATP binding; F:ethanolamine kinase activity;, P:phosphatidylethanolamine biosynthetic process; scaffold35 indexed_genome mRNA 10876881 10922738 . - . ID=transcript_7318;Q8N7E0 Q8TEA4,Transcription factor SOX-5 {ECO:0000305},, PF00505;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0055059;GO:0001502;GO:0051216;GO:0045165;GO:0071560;GO:0002062;GO:0061036;GO:0032332;GO:2000741;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:asymmetric neuroblast division; P:cartilage condensation; P:cartilage development; P:cell fate commitment; P:cellular response to transforming growth factor beta stimulus; P:chondrocyte differentiation; P:positive regulation of cartilage development; P:positive regulation of chondrocyte differentiation; P:positive regulation of mesenchymal stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold35 indexed_genome mRNA 11096075 11311683 . - . ID=transcript_7319;Q8N7E0 Q8TEA4,Transcription factor SOX-5 {ECO:0000305},, PF00505;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0055059;GO:0001502;GO:0051216;GO:0045165;GO:0071560;GO:0002062;GO:0061036;GO:0032332;GO:2000741;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:asymmetric neuroblast division; P:cartilage condensation; P:cartilage development; P:cell fate commitment; P:cellular response to transforming growth factor beta stimulus; P:chondrocyte differentiation; P:positive regulation of cartilage development; P:positive regulation of chondrocyte differentiation; P:positive regulation of mesenchymal stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold35 indexed_genome mRNA 12209470 12272833 . - . ID=transcript_7320;P54687 B3KY27 B7Z2M5 B7Z5L0 F5H5E4 Q68DQ7 Q96MY9,Branched-chain-amino-acid aminotransferase, cytosolic,Protein ECA39;, PF01063;, GO:0005829;GO:0005739;GO:0004084;GO:0042802;GO:0052656;GO:0052654;GO:0050048;GO:0052655;GO:0009082;GO:0009083;GO:0000082;GO:0009098;GO:0009099;, C:cytosol; C:mitochondrion;, F:branched-chain-amino-acid transaminase activity; F:identical protein binding; F:L-isoleucine transaminase activity; F:L-leucine transaminase activity; F:L-leucine:2-oxoglutarate aminotransferase activity; F:L-valine transaminase activity;, P:branched-chain amino acid biosynthetic process; P:branched-chain amino acid catabolic process; P:G1/S transition of mitotic cell cycle; P:leucine biosynthetic process; P:valine biosynthetic process; scaffold35 indexed_genome mRNA 12448048 12564878 . + . ID=transcript_7321;Q12912 A0AVM2 B4E077 Q8N301,Inositol 1,4,5-triphosphate receptor associated 2 {ECO:0000305},Lymphoid-restricted membrane protein;Protein Jaw1;, PF05781;, GO:0035577;GO:0005694;GO:0005789;GO:0016021;GO:0005887;GO:0016020;GO:0005815;GO:0005635;GO:0005886;GO:0000922;GO:0008017;GO:0043312;GO:0006997;GO:0007338;GO:0006906;GO:0006903;, C:azurophil granule membrane; C:chromosome; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:microtubule organizing center; C:nuclear envelope; C:plasma membrane; C:spindle pole;, F:microtubule binding;, P:neutrophil degranulation; P:nucleus organization; P:single fertilization; P:vesicle fusion; P:vesicle targeting;|Q12912 A0AVM2 B4E077 Q8N301,Inositol 1,4,5-triphosphate receptor associated 2 {ECO:0000305},Lymphoid-restricted membrane protein;Protein Jaw1;, PF05781;, GO:0035577;GO:0005694;GO:0005789;GO:0016021;GO:0005887;GO:0016020;GO:0005815;GO:0005635;GO:0005886;GO:0000922;GO:0008017;GO:0043312;GO:0006997;GO:0007338;GO:0006906;GO:0006903;, C:azurophil granule membrane; C:chromosome; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:microtubule organizing center; C:nuclear envelope; C:plasma membrane; C:spindle pole;, F:microtubule binding;, P:neutrophil degranulation; P:nucleus organization; P:single fertilization; P:vesicle fusion; P:vesicle targeting;|Q12912 A0AVM2 B4E077 Q8N301,Inositol 1,4,5-triphosphate receptor associated 2 {ECO:0000305},Lymphoid-restricted membrane protein;Protein Jaw1;, PF05781;, GO:0035577;GO:0005694;GO:0005789;GO:0016021;GO:0005887;GO:0016020;GO:0005815;GO:0005635;GO:0005886;GO:0000922;GO:0008017;GO:0043312;GO:0006997;GO:0007338;GO:0006906;GO:0006903;, C:azurophil granule membrane; C:chromosome; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:microtubule organizing center; C:nuclear envelope; C:plasma membrane; C:spindle pole;, F:microtubule binding;, P:neutrophil degranulation; P:nucleus organization; P:single fertilization; P:vesicle fusion; P:vesicle targeting;|Q6TDU7 B4DNP2 F5H6T6 Q17RL2 Q4G171 Q5U5K5 Q9NV50,Dynein intermediate chain CFAP94, axonemal {ECO:0000305},Cancer susceptibility candidate gene 1 protein;Cilia and flagella associated protein 94 {ECO:0000312|HGNC:HGNC:29599};Lung adenoma susceptibility 1-like protein;Protein phosphatase 1 regulatory subunit 54;, PF15927;, GO:0005858;GO:0005929;GO:0048487;GO:0008017;, C:axonemal dynein complex; C:cilium;, F:beta-tubulin binding; F:microtubule binding;|Q6TDU7 B4DNP2 F5H6T6 Q17RL2 Q4G171 Q5U5K5 Q9NV50,Dynein intermediate chain CFAP94, axonemal {ECO:0000305},Cancer susceptibility candidate gene 1 protein;Cilia and flagella associated protein 94 {ECO:0000312|HGNC:HGNC:29599};Lung adenoma susceptibility 1-like protein;Protein phosphatase 1 regulatory subunit 54;, PF15927;, GO:0005858;GO:0005929;GO:0048487;GO:0008017;, C:axonemal dynein complex; C:cilium;, F:beta-tubulin binding; F:microtubule binding;|Q6TDU7 B4DNP2 F5H6T6 Q17RL2 Q4G171 Q5U5K5 Q9NV50,Dynein intermediate chain CFAP94, axonemal {ECO:0000305},Cancer susceptibility candidate gene 1 protein;Cilia and flagella associated protein 94 {ECO:0000312|HGNC:HGNC:29599};Lung adenoma susceptibility 1-like protein;Protein phosphatase 1 regulatory subunit 54;, PF15927;, GO:0005858;GO:0005929;GO:0048487;GO:0008017;, C:axonemal dynein complex; C:cilium;, F:beta-tubulin binding; F:microtubule binding; scaffold35 indexed_genome mRNA 12576699 12583195 . + . ID=transcript_7322;Q6IPR1 J3KPI7,Electron transfer flavoprotein regulatory factor 1 {ECO:0000312|HGNC:HGNC:27052},LYR motif-containing protein 5 {ECO:0000312|HGNC:HGNC:27052};, PF05347;, GO:0005739;GO:0022904;, C:mitochondrion;, , P:respiratory electron transport chain; scaffold35 indexed_genome mRNA 12589165 12593306 . - . ID=transcript_7323;P01116 A8K8Z5 B0LPF9 P01118 Q96D10,GTPase KRas,K-Ras 2;Ki-Ras;c-K-ras;c-Ki-ras;, PF00071;, GO:0005737;GO:0005829;GO:0005789;GO:0031234;GO:0005925;GO:0000139;GO:0016020;GO:0045121;GO:0005741;GO:0005886;GO:0019003;GO:0019002;GO:0005525;GO:0003924;GO:0042802;GO:0030275;GO:0044877;GO:0030036;GO:0019221;GO:0038002;GO:0060441;GO:0007565;GO:0021897;GO:0048873;GO:0001889;GO:0000165;GO:0045596;GO:0043524;GO:0008284;GO:2000774;GO:0010628;GO:0043406;GO:0051092;GO:0051000;GO:0001934;GO:0035022;GO:0007265;GO:0048169;GO:0031647;GO:0032228;GO:0051384;GO:0035900;GO:0051385;GO:0002223;GO:0051146;GO:0008542;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi membrane; C:membrane; C:membrane raft; C:mitochondrial outer membrane; C:plasma membrane;, F:GDP binding; F:GMP binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:LRR domain binding; F:protein-containing complex binding;, P:actin cytoskeleton organization; P:cytokine-mediated signaling pathway; P:endocrine signaling; P:epithelial tube branching involved in lung morphogenesis; P:female pregnancy; P:forebrain astrocyte development; P:homeostasis of number of cells within a tissue; P:liver development; P:MAPK cascade; P:negative regulation of cell differentiation; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of cellular senescence; P:positive regulation of gene expression; P:positive regulation of MAP kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of protein phosphorylation; P:positive regulation of Rac protein signal transduction; P:Ras protein signal transduction; P:regulation of long-term neuronal synaptic plasticity; P:regulation of protein stability; P:regulation of synaptic transmission, GABAergic; P:response to glucocorticoid; P:response to isolation stress; P:response to mineralocorticoid; P:stimulatory C-type lectin receptor signaling pathway; P:striated muscle cell differentiation; P:visual learning; scaffold35 indexed_genome mRNA 12599745 12600407 . + . ID=transcript_7324;P01116 A8K8Z5 B0LPF9 P01118 Q96D10,GTPase KRas,K-Ras 2;Ki-Ras;c-K-ras;c-Ki-ras;, PF00071;, GO:0005737;GO:0005829;GO:0005789;GO:0031234;GO:0005925;GO:0000139;GO:0016020;GO:0045121;GO:0005741;GO:0005886;GO:0019003;GO:0019002;GO:0005525;GO:0003924;GO:0042802;GO:0030275;GO:0044877;GO:0030036;GO:0019221;GO:0038002;GO:0060441;GO:0007565;GO:0021897;GO:0048873;GO:0001889;GO:0000165;GO:0045596;GO:0043524;GO:0008284;GO:2000774;GO:0010628;GO:0043406;GO:0051092;GO:0051000;GO:0001934;GO:0035022;GO:0007265;GO:0048169;GO:0031647;GO:0032228;GO:0051384;GO:0035900;GO:0051385;GO:0002223;GO:0051146;GO:0008542;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi membrane; C:membrane; C:membrane raft; C:mitochondrial outer membrane; C:plasma membrane;, F:GDP binding; F:GMP binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:LRR domain binding; F:protein-containing complex binding;, P:actin cytoskeleton organization; P:cytokine-mediated signaling pathway; P:endocrine signaling; P:epithelial tube branching involved in lung morphogenesis; P:female pregnancy; P:forebrain astrocyte development; P:homeostasis of number of cells within a tissue; P:liver development; P:MAPK cascade; P:negative regulation of cell differentiation; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of cellular senescence; P:positive regulation of gene expression; P:positive regulation of MAP kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of protein phosphorylation; P:positive regulation of Rac protein signal transduction; P:Ras protein signal transduction; P:regulation of long-term neuronal synaptic plasticity; P:regulation of protein stability; P:regulation of synaptic transmission, GABAergic; P:response to glucocorticoid; P:response to isolation stress; P:response to mineralocorticoid; P:stimulatory C-type lectin receptor signaling pathway; P:striated muscle cell differentiation; P:visual learning; scaffold35 indexed_genome mRNA 12601077 12601600 . - . ID=transcript_7325;P01116 A8K8Z5 B0LPF9 P01118 Q96D10,GTPase KRas,K-Ras 2;Ki-Ras;c-K-ras;c-Ki-ras;, PF00071;, GO:0005737;GO:0005829;GO:0005789;GO:0031234;GO:0005925;GO:0000139;GO:0016020;GO:0045121;GO:0005741;GO:0005886;GO:0019003;GO:0019002;GO:0005525;GO:0003924;GO:0042802;GO:0030275;GO:0044877;GO:0030036;GO:0019221;GO:0038002;GO:0060441;GO:0007565;GO:0021897;GO:0048873;GO:0001889;GO:0000165;GO:0045596;GO:0043524;GO:0008284;GO:2000774;GO:0010628;GO:0043406;GO:0051092;GO:0051000;GO:0001934;GO:0035022;GO:0007265;GO:0048169;GO:0031647;GO:0032228;GO:0051384;GO:0035900;GO:0051385;GO:0002223;GO:0051146;GO:0008542;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi membrane; C:membrane; C:membrane raft; C:mitochondrial outer membrane; C:plasma membrane;, F:GDP binding; F:GMP binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:LRR domain binding; F:protein-containing complex binding;, P:actin cytoskeleton organization; P:cytokine-mediated signaling pathway; P:endocrine signaling; P:epithelial tube branching involved in lung morphogenesis; P:female pregnancy; P:forebrain astrocyte development; P:homeostasis of number of cells within a tissue; P:liver development; P:MAPK cascade; P:negative regulation of cell differentiation; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of cellular senescence; P:positive regulation of gene expression; P:positive regulation of MAP kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of protein phosphorylation; P:positive regulation of Rac protein signal transduction; P:Ras protein signal transduction; P:regulation of long-term neuronal synaptic plasticity; P:regulation of protein stability; P:regulation of synaptic transmission, GABAergic; P:response to glucocorticoid; P:response to isolation stress; P:response to mineralocorticoid; P:stimulatory C-type lectin receptor signaling pathway; P:striated muscle cell differentiation; P:visual learning; scaffold35 indexed_genome mRNA 12904199 12932096 . - . ID=transcript_7326;Q8N9Z9 B4DL27 B4DY70 Q8IY38,Lamin tail domain-containing protein 1,Intermediate filament tail domain-containing protein 1;, PF00932;, GO:0005737;GO:0005882;GO:0005635;GO:0008283;, C:cytoplasm; C:intermediate filament; C:nuclear envelope;, , P:cell population proliferation;|Q8N9Z9 B4DL27 B4DY70 Q8IY38,Lamin tail domain-containing protein 1,Intermediate filament tail domain-containing protein 1;, PF00932;, GO:0005737;GO:0005882;GO:0005635;GO:0008283;, C:cytoplasm; C:intermediate filament; C:nuclear envelope;, , P:cell population proliferation; scaffold35 indexed_genome mRNA 13402314 13491220 . + . ID=transcript_7327;Q8NHQ8 A8K1Z0 O95647 Q5SCI2 Q76KB6,Ras association domain-containing protein 8,Carcinoma-associated protein HOJ-1;, PF00788;, GO:0007165;, , , P:signal transduction; scaffold35 indexed_genome mRNA 13540354 13541157 . + . ID=transcript_7328;Q9C0J9 A2I2N8,Class E basic helix-loop-helix protein 41 {ECO:0000305},Class B basic helix-loop-helix protein 3;Differentially expressed in chondrocytes protein 2;Enhancer-of-split and hairy-related protein 1;, PF07527;PF00010;, GO:0000785;GO:0005634;GO:0043425;GO:0000981;GO:0001227;GO:0070888;GO:0042826;GO:0043426;GO:0046982;GO:0042803;GO:0001102;GO:0000978;GO:1990837;GO:0009952;GO:0032922;GO:0010832;GO:0010944;GO:0000122;GO:0045892;GO:0050767;GO:0006357;, C:chromatin; C:nucleus;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:histone deacetylase binding; F:MRF binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:circadian regulation of gene expression; P:negative regulation of myotube differentiation; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; scaffold35 indexed_genome mRNA 13604729 13650251 . + . ID=transcript_7329;Q14714 B3KS67,Sarcospan,K-ras oncogene-associated protein;Kirsten-ras-associated protein;, PF04103;, GO:0016010;GO:0005887;GO:0045211;GO:0042383;GO:0030133;GO:0007155;GO:0006936;, C:dystrophin-associated glycoprotein complex; C:integral component of plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:transport vesicle;, , P:cell adhesion; P:muscle contraction; scaffold35 indexed_genome mRNA 13743915 14085864 . - . ID=transcript_7330;Q14571 O94773,Inositol 1,4,5-trisphosphate receptor type 2,IP3 receptor isoform 2;Type 2 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0005938;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0031095;GO:0043235;GO:0016529;GO:0033017;GO:0030667;GO:0005509;GO:0015085;GO:0070679;GO:0005220;GO:0044325;GO:0035091;GO:0097110;GO:0071320;GO:0071361;GO:0030168;GO:1903779;GO:0050796;GO:0051209;GO:0001666;GO:0007165;, C:cell cortex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane; C:platelet dense tubular network membrane; C:receptor complex; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:secretory granule membrane;, F:calcium ion binding; F:calcium ion transmembrane transporter activity; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:ion channel binding; F:phosphatidylinositol binding; F:scaffold protein binding;, P:cellular response to cAMP; P:cellular response to ethanol; P:platelet activation; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to hypoxia; P:signal transduction; scaffold35 indexed_genome mRNA 14116511 14309394 . - . ID=transcript_7331;Q14571 O94773,Inositol 1,4,5-trisphosphate receptor type 2,IP3 receptor isoform 2;Type 2 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0005938;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0031095;GO:0043235;GO:0016529;GO:0033017;GO:0030667;GO:0005509;GO:0015085;GO:0070679;GO:0005220;GO:0044325;GO:0035091;GO:0097110;GO:0071320;GO:0071361;GO:0030168;GO:1903779;GO:0050796;GO:0051209;GO:0001666;GO:0007165;, C:cell cortex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane; C:platelet dense tubular network membrane; C:receptor complex; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:secretory granule membrane;, F:calcium ion binding; F:calcium ion transmembrane transporter activity; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:ion channel binding; F:phosphatidylinositol binding; F:scaffold protein binding;, P:cellular response to cAMP; P:cellular response to ethanol; P:platelet activation; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to hypoxia; P:signal transduction; scaffold35 indexed_genome mRNA 14392599 14420905 . - . ID=transcript_7332;Q9NVM9 B4DNK1 Q86WE2 Q96HM2 Q9BTX2 Q9NTB6 Q9NVM5,Integrator complex subunit 13 {ECO:0000312|HGNC:HGNC:20174},Cell cycle regulator Mat89Bb homolog;Germ cell tumor 1;Protein asunder homolog;Sarcoma antigen NY-SAR-95;, PF10221;, GO:0005737;GO:0032039;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0051301;GO:0051642;GO:0030317;GO:0007052;GO:0090435;GO:0080154;GO:0007346;GO:0042795;, C:cytoplasm; C:integrator complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell division; P:centrosome localization; P:flagellated sperm motility; P:mitotic spindle organization; P:protein localization to nuclear envelope; P:regulation of fertilization; P:regulation of mitotic cell cycle; P:snRNA transcription by RNA polymerase II;|Q9NVM9 B4DNK1 Q86WE2 Q96HM2 Q9BTX2 Q9NTB6 Q9NVM5,Integrator complex subunit 13 {ECO:0000312|HGNC:HGNC:20174},Cell cycle regulator Mat89Bb homolog;Germ cell tumor 1;Protein asunder homolog;Sarcoma antigen NY-SAR-95;, PF10221;, GO:0005737;GO:0032039;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0051301;GO:0051642;GO:0030317;GO:0007052;GO:0090435;GO:0080154;GO:0007346;GO:0042795;, C:cytoplasm; C:integrator complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell division; P:centrosome localization; P:flagellated sperm motility; P:mitotic spindle organization; P:protein localization to nuclear envelope; P:regulation of fertilization; P:regulation of mitotic cell cycle; P:snRNA transcription by RNA polymerase II;|Q9NVM9 B4DNK1 Q86WE2 Q96HM2 Q9BTX2 Q9NTB6 Q9NVM5,Integrator complex subunit 13 {ECO:0000312|HGNC:HGNC:20174},Cell cycle regulator Mat89Bb homolog;Germ cell tumor 1;Protein asunder homolog;Sarcoma antigen NY-SAR-95;, PF10221;, GO:0005737;GO:0032039;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0051301;GO:0051642;GO:0030317;GO:0007052;GO:0090435;GO:0080154;GO:0007346;GO:0042795;, C:cytoplasm; C:integrator complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell division; P:centrosome localization; P:flagellated sperm motility; P:mitotic spindle organization; P:protein localization to nuclear envelope; P:regulation of fertilization; P:regulation of mitotic cell cycle; P:snRNA transcription by RNA polymerase II;|Q9NVM9 B4DNK1 Q86WE2 Q96HM2 Q9BTX2 Q9NTB6 Q9NVM5,Integrator complex subunit 13 {ECO:0000312|HGNC:HGNC:20174},Cell cycle regulator Mat89Bb homolog;Germ cell tumor 1;Protein asunder homolog;Sarcoma antigen NY-SAR-95;, PF10221;, GO:0005737;GO:0032039;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0051301;GO:0051642;GO:0030317;GO:0007052;GO:0090435;GO:0080154;GO:0007346;GO:0042795;, C:cytoplasm; C:integrator complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell division; P:centrosome localization; P:flagellated sperm motility; P:mitotic spindle organization; P:protein localization to nuclear envelope; P:regulation of fertilization; P:regulation of mitotic cell cycle; P:snRNA transcription by RNA polymerase II;|Q9NVM9 B4DNK1 Q86WE2 Q96HM2 Q9BTX2 Q9NTB6 Q9NVM5,Integrator complex subunit 13 {ECO:0000312|HGNC:HGNC:20174},Cell cycle regulator Mat89Bb homolog;Germ cell tumor 1;Protein asunder homolog;Sarcoma antigen NY-SAR-95;, PF10221;, GO:0005737;GO:0032039;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0051301;GO:0051642;GO:0030317;GO:0007052;GO:0090435;GO:0080154;GO:0007346;GO:0042795;, C:cytoplasm; C:integrator complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell division; P:centrosome localization; P:flagellated sperm motility; P:mitotic spindle organization; P:protein localization to nuclear envelope; P:regulation of fertilization; P:regulation of mitotic cell cycle; P:snRNA transcription by RNA polymerase II;|Q9NVM9 B4DNK1 Q86WE2 Q96HM2 Q9BTX2 Q9NTB6 Q9NVM5,Integrator complex subunit 13 {ECO:0000312|HGNC:HGNC:20174},Cell cycle regulator Mat89Bb homolog;Germ cell tumor 1;Protein asunder homolog;Sarcoma antigen NY-SAR-95;, PF10221;, GO:0005737;GO:0032039;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0051301;GO:0051642;GO:0030317;GO:0007052;GO:0090435;GO:0080154;GO:0007346;GO:0042795;, C:cytoplasm; C:integrator complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell division; P:centrosome localization; P:flagellated sperm motility; P:mitotic spindle organization; P:protein localization to nuclear envelope; P:regulation of fertilization; P:regulation of mitotic cell cycle; P:snRNA transcription by RNA polymerase II;|Q9NVM9 B4DNK1 Q86WE2 Q96HM2 Q9BTX2 Q9NTB6 Q9NVM5,Integrator complex subunit 13 {ECO:0000312|HGNC:HGNC:20174},Cell cycle regulator Mat89Bb homolog;Germ cell tumor 1;Protein asunder homolog;Sarcoma antigen NY-SAR-95;, PF10221;, GO:0005737;GO:0032039;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0051301;GO:0051642;GO:0030317;GO:0007052;GO:0090435;GO:0080154;GO:0007346;GO:0042795;, C:cytoplasm; C:integrator complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell division; P:centrosome localization; P:flagellated sperm motility; P:mitotic spindle organization; P:protein localization to nuclear envelope; P:regulation of fertilization; P:regulation of mitotic cell cycle; P:snRNA transcription by RNA polymerase II; scaffold35 indexed_genome mRNA 14433160 14440115 . + . ID=transcript_7333;Q9NVK5 Q6R955 Q8N5L7 Q9P034 Q9UFK8,FGFR1 oncogene partner 2,, PF05769;, GO:0005829;GO:0042802;GO:0009611;GO:0042060;, C:cytosol;, F:identical protein binding;, P:response to wounding; P:wound healing; scaffold35 indexed_genome mRNA 14454000 14494042 . + . ID=transcript_7334;Q9NS93 B3KMZ3 Q9NUS4,Transmembrane 7 superfamily member 3,Seven span transmembrane protein;, PF13886;, GO:0070062;GO:0016021;GO:0005886;GO:0034620;GO:0043069;GO:0032024;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:cellular response to unfolded protein; P:negative regulation of programmed cell death; P:positive regulation of insulin secretion;|Q9NS93 B3KMZ3 Q9NUS4,Transmembrane 7 superfamily member 3,Seven span transmembrane protein;, PF13886;, GO:0070062;GO:0016021;GO:0005886;GO:0034620;GO:0043069;GO:0032024;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:cellular response to unfolded protein; P:negative regulation of programmed cell death; P:positive regulation of insulin secretion;|Q9NS93 B3KMZ3 Q9NUS4,Transmembrane 7 superfamily member 3,Seven span transmembrane protein;, PF13886;, GO:0070062;GO:0016021;GO:0005886;GO:0034620;GO:0043069;GO:0032024;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:cellular response to unfolded protein; P:negative regulation of programmed cell death; P:positive regulation of insulin secretion;|Q9NS93 B3KMZ3 Q9NUS4,Transmembrane 7 superfamily member 3,Seven span transmembrane protein;, PF13886;, GO:0070062;GO:0016021;GO:0005886;GO:0034620;GO:0043069;GO:0032024;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:cellular response to unfolded protein; P:negative regulation of programmed cell death; P:positive regulation of insulin secretion; scaffold35 indexed_genome mRNA 14512244 14512767 . + . ID=transcript_7335;Q13503 B2R4I3 Q6IB05 Q92811,Mediator of RNA polymerase II transcription subunit 21,Mediator complex subunit 21;RNA polymerase II holoenzyme component SRB7;, PF11221;, GO:0016592;GO:0003899;GO:0003713;GO:0003712;GO:0045944;GO:0006357;, C:mediator complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:transcription coactivator activity; F:transcription coregulator activity;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold35 indexed_genome mRNA 14685850 14712597 . - . ID=transcript_7336;Q9Y2H1 A8K4U0 B4E3J8 Q8TBX7,Serine/threonine-protein kinase 38-like,NDR2 protein kinase;Nuclear Dbf2-related kinase 2;, PF00069;PF00433;, GO:0015629;GO:0005737;GO:0005829;GO:0016020;GO:0003779;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0006468;GO:0051128;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:membrane;, F:actin binding; F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of cellular component organization;|Q9Y2H1 A8K4U0 B4E3J8 Q8TBX7,Serine/threonine-protein kinase 38-like,NDR2 protein kinase;Nuclear Dbf2-related kinase 2;, PF00069;PF00433;, GO:0015629;GO:0005737;GO:0005829;GO:0016020;GO:0003779;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0006468;GO:0051128;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:membrane;, F:actin binding; F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of cellular component organization;|Q9Y2H1 A8K4U0 B4E3J8 Q8TBX7,Serine/threonine-protein kinase 38-like,NDR2 protein kinase;Nuclear Dbf2-related kinase 2;, PF00069;PF00433;, GO:0015629;GO:0005737;GO:0005829;GO:0016020;GO:0003779;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0006468;GO:0051128;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:membrane;, F:actin binding; F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of cellular component organization; scaffold35 indexed_genome mRNA 14950831 15147319 . + . ID=transcript_7337;Q86W92 O75336 Q86X70 Q9NY03 Q9ULJ0,Liprin-beta-1,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1;hSGT2;, PF00536;PF07647;, GO:0005829;GO:0005925;GO:0005886;GO:0048786;GO:0045296;GO:0007155;GO:0007528;GO:0050808;, C:cytosol; C:focal adhesion; C:plasma membrane; C:presynaptic active zone;, F:cadherin binding;, P:cell adhesion; P:neuromuscular junction development; P:synapse organization;|Q86W92 O75336 Q86X70 Q9NY03 Q9ULJ0,Liprin-beta-1,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1;hSGT2;, PF00536;PF07647;, GO:0005829;GO:0005925;GO:0005886;GO:0048786;GO:0045296;GO:0007155;GO:0007528;GO:0050808;, C:cytosol; C:focal adhesion; C:plasma membrane; C:presynaptic active zone;, F:cadherin binding;, P:cell adhesion; P:neuromuscular junction development; P:synapse organization;|Q86W92 O75336 Q86X70 Q9NY03 Q9ULJ0,Liprin-beta-1,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1;hSGT2;, PF00536;PF07647;, GO:0005829;GO:0005925;GO:0005886;GO:0048786;GO:0045296;GO:0007155;GO:0007528;GO:0050808;, C:cytosol; C:focal adhesion; C:plasma membrane; C:presynaptic active zone;, F:cadherin binding;, P:cell adhesion; P:neuromuscular junction development; P:synapse organization;|Q86W92 O75336 Q86X70 Q9NY03 Q9ULJ0,Liprin-beta-1,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1;hSGT2;, PF00536;PF07647;, GO:0005829;GO:0005925;GO:0005886;GO:0048786;GO:0045296;GO:0007155;GO:0007528;GO:0050808;, C:cytosol; C:focal adhesion; C:plasma membrane; C:presynaptic active zone;, F:cadherin binding;, P:cell adhesion; P:neuromuscular junction development; P:synapse organization;|Q86W92 O75336 Q86X70 Q9NY03 Q9ULJ0,Liprin-beta-1,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1;hSGT2;, PF00536;PF07647;, GO:0005829;GO:0005925;GO:0005886;GO:0048786;GO:0045296;GO:0007155;GO:0007528;GO:0050808;, C:cytosol; C:focal adhesion; C:plasma membrane; C:presynaptic active zone;, F:cadherin binding;, P:cell adhesion; P:neuromuscular junction development; P:synapse organization; scaffold35 indexed_genome mRNA 15157496 15202493 . + . ID=transcript_7338;P82673 Q32LZ1 Q6P4C6 Q7L1M6 Q8NBP4 Q96AI0 Q9H044 Q9HC14 Q9P1R5,28S ribosomal protein S35, mitochondrial,28S ribosomal protein S28, mitochondrial;Mitochondrial small ribosomal subunit protein mS35 {ECO:0000303|PubMed:25838379};, PF10213;, GO:0005743;GO:0005763;GO:0003723;GO:0003735;GO:0042769;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:DNA damage response, detection of DNA damage; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold35 indexed_genome mRNA 15206857 15211925 . - . ID=transcript_7339;A6NHS7,MANSC domain-containing protein 4,, PF07502;, GO:0016021;, C:integral component of membrane; scaffold35 indexed_genome mRNA 15226333 15229285 . + . ID=transcript_7340;Q9P2K6 Q2VPK1 Q8N334,Kelch-like protein 42,Cullin-3-binding protein 9;Kelch domain-containing protein 5;, PF07707;PF01344;, GO:0031463;GO:0005829;GO:0005819;GO:0007049;GO:0051301;GO:0043687;GO:0043161;GO:0000209;GO:0032886;, C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:spindle;, , P:cell cycle; P:cell division; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of microtubule-based process; scaffold35 indexed_genome mRNA 15793450 16079282 . + . ID=transcript_7341;Q7Z6B0 B3KSA3 C9JR07 Q68D43 Q6IA78 Q8NEN7 Q9NUW9,Coiled-coil domain-containing protein 91,GGA-binding partner;p56 accessory protein;, , GO:0005829;GO:0005794;GO:0016020;GO:0005654;GO:0005802;GO:0042802;GO:0090160;GO:0015031;, C:cytosol; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:trans-Golgi network;, F:identical protein binding;, P:Golgi to lysosome transport; P:protein transport;|Q7Z6B0 B3KSA3 C9JR07 Q68D43 Q6IA78 Q8NEN7 Q9NUW9,Coiled-coil domain-containing protein 91,GGA-binding partner;p56 accessory protein;, , GO:0005829;GO:0005794;GO:0016020;GO:0005654;GO:0005802;GO:0042802;GO:0090160;GO:0015031;, C:cytosol; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:trans-Golgi network;, F:identical protein binding;, P:Golgi to lysosome transport; P:protein transport; scaffold35 indexed_genome mRNA 16922351 16957988 . + . ID=transcript_7342;Q96K12 F8VV73 Q9H0D5 Q9NVW8,Fatty acyl-CoA reductase 2 {ECO:0000305|PubMed:15220348},Male sterility domain-containing protein 1 {ECO:0000312|HGNC:HGNC:25531};, PF07993;PF03015;, GO:0005779;GO:0043231;GO:0005778;GO:0005777;GO:0102965;GO:0080019;GO:0006629;GO:0035336;GO:0010025;, C:integral component of peroxisomal membrane; C:intracellular membrane-bounded organelle; C:peroxisomal membrane; C:peroxisome;, F:alcohol-forming fatty acyl-CoA reductase activity; F:fatty-acyl-CoA reductase (alcohol-forming) activity;, P:lipid metabolic process; P:long-chain fatty-acyl-CoA metabolic process; P:wax biosynthetic process;|Q96K12 F8VV73 Q9H0D5 Q9NVW8,Fatty acyl-CoA reductase 2 {ECO:0000305|PubMed:15220348},Male sterility domain-containing protein 1 {ECO:0000312|HGNC:HGNC:25531};, PF07993;PF03015;, GO:0005779;GO:0043231;GO:0005778;GO:0005777;GO:0102965;GO:0080019;GO:0006629;GO:0035336;GO:0010025;, C:integral component of peroxisomal membrane; C:intracellular membrane-bounded organelle; C:peroxisomal membrane; C:peroxisome;, F:alcohol-forming fatty acyl-CoA reductase activity; F:fatty-acyl-CoA reductase (alcohol-forming) activity;, P:lipid metabolic process; P:long-chain fatty-acyl-CoA metabolic process; P:wax biosynthetic process; scaffold35 indexed_genome mRNA 16959887 17002892 . - . ID=transcript_7343;Q96RQ1 A6NHH6 Q53GY2 Q8N2Q9 Q9BVV9 Q9NZA3,Endoplasmic reticulum-Golgi intermediate compartment protein 2,, PF07970;PF13850;, GO:0030134;GO:0005737;GO:0005783;GO:0005789;GO:0033116;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0005730;GO:0005634;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleus;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q96RQ1 A6NHH6 Q53GY2 Q8N2Q9 Q9BVV9 Q9NZA3,Endoplasmic reticulum-Golgi intermediate compartment protein 2,, PF07970;PF13850;, GO:0030134;GO:0005737;GO:0005783;GO:0005789;GO:0033116;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0005730;GO:0005634;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleus;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q96RQ1 A6NHH6 Q53GY2 Q8N2Q9 Q9BVV9 Q9NZA3,Endoplasmic reticulum-Golgi intermediate compartment protein 2,, PF07970;PF13850;, GO:0030134;GO:0005737;GO:0005783;GO:0005789;GO:0033116;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0005730;GO:0005634;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleus;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q96RQ1 A6NHH6 Q53GY2 Q8N2Q9 Q9BVV9 Q9NZA3,Endoplasmic reticulum-Golgi intermediate compartment protein 2,, PF07970;PF13850;, GO:0030134;GO:0005737;GO:0005783;GO:0005789;GO:0033116;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0005730;GO:0005634;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleus;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold35 indexed_genome mRNA 17119834 17387142 . - . ID=transcript_7344;Q8IUR5 D0EP37 F5H8B5 Q6PIU4 Q6ZSM5 Q96N52 Q9BXM2,Protein O-mannosyl-transferase TMTC1 {ECO:0000305},Transmembrane and TPR repeat-containing protein 1 {ECO:0000312|HGNC:HGNC:24099};, PF08409;PF07719;PF13181;, GO:0005783;GO:0016021;GO:0004169;GO:0000030;GO:0035269;GO:0006396;, C:endoplasmic reticulum; C:integral component of membrane;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity;, P:protein O-linked mannosylation; P:RNA processing;|Q8IUR5 D0EP37 F5H8B5 Q6PIU4 Q6ZSM5 Q96N52 Q9BXM2,Protein O-mannosyl-transferase TMTC1 {ECO:0000305},Transmembrane and TPR repeat-containing protein 1 {ECO:0000312|HGNC:HGNC:24099};, PF08409;PF07719;PF13181;, GO:0005783;GO:0016021;GO:0004169;GO:0000030;GO:0035269;GO:0006396;, C:endoplasmic reticulum; C:integral component of membrane;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity;, P:protein O-linked mannosylation; P:RNA processing; scaffold35 indexed_genome mRNA 18198433 18204874 . - . ID=transcript_7345;O15397 B7Z7M3,Importin-8,Ran-binding protein 8;, PF08506;PF03810;, GO:0005829;GO:0005635;GO:0005654;GO:0031267;GO:0006606;GO:0060964;GO:0007165;, C:cytosol; C:nuclear envelope; C:nucleoplasm;, F:small GTPase binding;, P:protein import into nucleus; P:regulation of gene silencing by miRNA; P:signal transduction;|O15397 B7Z7M3,Importin-8,Ran-binding protein 8;, PF08506;PF03810;, GO:0005829;GO:0005635;GO:0005654;GO:0031267;GO:0006606;GO:0060964;GO:0007165;, C:cytosol; C:nuclear envelope; C:nucleoplasm;, F:small GTPase binding;, P:protein import into nucleus; P:regulation of gene silencing by miRNA; P:signal transduction; scaffold35 indexed_genome mRNA 18207939 18237189 . - . ID=transcript_7346;O15397 B7Z7M3,Importin-8,Ran-binding protein 8;, PF08506;PF03810;, GO:0005829;GO:0005635;GO:0005654;GO:0031267;GO:0006606;GO:0060964;GO:0007165;, C:cytosol; C:nuclear envelope; C:nucleoplasm;, F:small GTPase binding;, P:protein import into nucleus; P:regulation of gene silencing by miRNA; P:signal transduction;|O15397 B7Z7M3,Importin-8,Ran-binding protein 8;, PF08506;PF03810;, GO:0005829;GO:0005635;GO:0005654;GO:0031267;GO:0006606;GO:0060964;GO:0007165;, C:cytosol; C:nuclear envelope; C:nucleoplasm;, F:small GTPase binding;, P:protein import into nucleus; P:regulation of gene silencing by miRNA; P:signal transduction;|O15397 B7Z7M3,Importin-8,Ran-binding protein 8;, PF08506;PF03810;, GO:0005829;GO:0005635;GO:0005654;GO:0031267;GO:0006606;GO:0060964;GO:0007165;, C:cytosol; C:nuclear envelope; C:nucleoplasm;, F:small GTPase binding;, P:protein import into nucleus; P:regulation of gene silencing by miRNA; P:signal transduction; scaffold35 indexed_genome mRNA 18241360 18271550 . - . ID=transcript_7347;O15397 B7Z7M3,Importin-8,Ran-binding protein 8;, PF08506;PF03810;, GO:0005829;GO:0005635;GO:0005654;GO:0031267;GO:0006606;GO:0060964;GO:0007165;, C:cytosol; C:nuclear envelope; C:nucleoplasm;, F:small GTPase binding;, P:protein import into nucleus; P:regulation of gene silencing by miRNA; P:signal transduction; scaffold35 indexed_genome mRNA 18285326 18291127 . - . ID=transcript_7348;Q9H667 Q9HAL4,Caprin-2,C1q domain-containing protein 1;Cytoplasmic activation/proliferation-associated protein 2;Gastric cancer multidrug resistance-associated protein;Protein EEG-1;RNA granule protein 140;, PF00386;PF12287;PF18293;, GO:0005813;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005886;GO:0043235;GO:0046872;GO:0003723;GO:0005102;GO:0030308;GO:0017148;GO:0090263;GO:0050775;GO:0061003;GO:0033138;GO:0032092;GO:0045944;, C:centrosome; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:metal ion binding; F:RNA binding; F:signaling receptor binding;, P:negative regulation of cell growth; P:negative regulation of translation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; scaffold35 indexed_genome mRNA 18291168 18333445 . - . ID=transcript_7349;Q9H667 Q9HAL4,Caprin-2,C1q domain-containing protein 1;Cytoplasmic activation/proliferation-associated protein 2;Gastric cancer multidrug resistance-associated protein;Protein EEG-1;RNA granule protein 140;, PF00386;PF12287;PF18293;, GO:0005813;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005886;GO:0043235;GO:0046872;GO:0003723;GO:0005102;GO:0030308;GO:0017148;GO:0090263;GO:0050775;GO:0061003;GO:0033138;GO:0032092;GO:0045944;, C:centrosome; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:metal ion binding; F:RNA binding; F:signaling receptor binding;, P:negative regulation of cell growth; P:negative regulation of translation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II;|Q9H667 Q9HAL4,Caprin-2,C1q domain-containing protein 1;Cytoplasmic activation/proliferation-associated protein 2;Gastric cancer multidrug resistance-associated protein;Protein EEG-1;RNA granule protein 140;, PF00386;PF12287;PF18293;, GO:0005813;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005886;GO:0043235;GO:0046872;GO:0003723;GO:0005102;GO:0030308;GO:0017148;GO:0090263;GO:0050775;GO:0061003;GO:0033138;GO:0032092;GO:0045944;, C:centrosome; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:metal ion binding; F:RNA binding; F:signaling receptor binding;, P:negative regulation of cell growth; P:negative regulation of translation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II;|Q9H667 Q9HAL4,Caprin-2,C1q domain-containing protein 1;Cytoplasmic activation/proliferation-associated protein 2;Gastric cancer multidrug resistance-associated protein;Protein EEG-1;RNA granule protein 140;, PF00386;PF12287;PF18293;, GO:0005813;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005886;GO:0043235;GO:0046872;GO:0003723;GO:0005102;GO:0030308;GO:0017148;GO:0090263;GO:0050775;GO:0061003;GO:0033138;GO:0032092;GO:0045944;, C:centrosome; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:metal ion binding; F:RNA binding; F:signaling receptor binding;, P:negative regulation of cell growth; P:negative regulation of translation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II;|Q9H667 Q9HAL4,Caprin-2,C1q domain-containing protein 1;Cytoplasmic activation/proliferation-associated protein 2;Gastric cancer multidrug resistance-associated protein;Protein EEG-1;RNA granule protein 140;, PF00386;PF12287;PF18293;, GO:0005813;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005886;GO:0043235;GO:0046872;GO:0003723;GO:0005102;GO:0030308;GO:0017148;GO:0090263;GO:0050775;GO:0061003;GO:0033138;GO:0032092;GO:0045944;, C:centrosome; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:metal ion binding; F:RNA binding; F:signaling receptor binding;, P:negative regulation of cell growth; P:negative regulation of translation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II;|Q9H667 Q9HAL4,Caprin-2,C1q domain-containing protein 1;Cytoplasmic activation/proliferation-associated protein 2;Gastric cancer multidrug resistance-associated protein;Protein EEG-1;RNA granule protein 140;, PF00386;PF12287;PF18293;, GO:0005813;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005886;GO:0043235;GO:0046872;GO:0003723;GO:0005102;GO:0030308;GO:0017148;GO:0090263;GO:0050775;GO:0061003;GO:0033138;GO:0032092;GO:0045944;, C:centrosome; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:metal ion binding; F:RNA binding; F:signaling receptor binding;, P:negative regulation of cell growth; P:negative regulation of translation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II;|Q9H667 Q9HAL4,Caprin-2,C1q domain-containing protein 1;Cytoplasmic activation/proliferation-associated protein 2;Gastric cancer multidrug resistance-associated protein;Protein EEG-1;RNA granule protein 140;, PF00386;PF12287;PF18293;, GO:0005813;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005886;GO:0043235;GO:0046872;GO:0003723;GO:0005102;GO:0030308;GO:0017148;GO:0090263;GO:0050775;GO:0061003;GO:0033138;GO:0032092;GO:0045944;, C:centrosome; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:metal ion binding; F:RNA binding; F:signaling receptor binding;, P:negative regulation of cell growth; P:negative regulation of translation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of dendrite morphogenesis; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; scaffold35 indexed_genome mRNA 18513207 18627941 . + . ID=transcript_7350;Q6ZUT9 B5ME75 Q59FW8 Q68CZ7 Q6NUJ0 Q7Z3F9 Q8N973 Q8WUC8,DENN domain-containing protein 5B,Rab6IP1-like protein;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0016021;GO:0005085;, C:cytosol; C:integral component of membrane;, F:guanyl-nucleotide exchange factor activity;|Q6ZUT9 B5ME75 Q59FW8 Q68CZ7 Q6NUJ0 Q7Z3F9 Q8N973 Q8WUC8,DENN domain-containing protein 5B,Rab6IP1-like protein;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0016021;GO:0005085;, C:cytosol; C:integral component of membrane;, F:guanyl-nucleotide exchange factor activity;|Q6ZUT9 B5ME75 Q59FW8 Q68CZ7 Q6NUJ0 Q7Z3F9 Q8N973 Q8WUC8,DENN domain-containing protein 5B,Rab6IP1-like protein;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0016021;GO:0005085;, C:cytosol; C:integral component of membrane;, F:guanyl-nucleotide exchange factor activity;|Q6ZUT9 B5ME75 Q59FW8 Q68CZ7 Q6NUJ0 Q7Z3F9 Q8N973 Q8WUC8,DENN domain-containing protein 5B,Rab6IP1-like protein;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0016021;GO:0005085;, C:cytosol; C:integral component of membrane;, F:guanyl-nucleotide exchange factor activity;|Q6ZUT9 B5ME75 Q59FW8 Q68CZ7 Q6NUJ0 Q7Z3F9 Q8N973 Q8WUC8,DENN domain-containing protein 5B,Rab6IP1-like protein;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0016021;GO:0005085;, C:cytosol; C:integral component of membrane;, F:guanyl-nucleotide exchange factor activity;|Q6ZUT9 B5ME75 Q59FW8 Q68CZ7 Q6NUJ0 Q7Z3F9 Q8N973 Q8WUC8,DENN domain-containing protein 5B,Rab6IP1-like protein;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0016021;GO:0005085;, C:cytosol; C:integral component of membrane;, F:guanyl-nucleotide exchange factor activity; scaffold35 indexed_genome mRNA 18727091 18727593 . - . ID=transcript_7351;O95243 B4DZN2 D3DNC3 D3DNC4 E9PEE4 Q2MD36 Q7Z4T3 Q96F09,Methyl-CpG-binding domain protein 4,Methyl-CpG-binding endonuclease 1;Methyl-CpG-binding protein MBD4;Mismatch-specific DNA N-glycosylase;, PF01429;, GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0004520;GO:0008263;GO:0003696;GO:0006287;GO:0045008;GO:0006281;GO:0032355;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:endodeoxyribonuclease activity; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; F:satellite DNA binding;, P:base-excision repair, gap-filling; P:depyrimidination; P:DNA repair; P:response to estradiol; scaffold35 indexed_genome mRNA 18738268 18740480 . + . ID=transcript_7352;Q6ZUT9 B5ME75 Q59FW8 Q68CZ7 Q6NUJ0 Q7Z3F9 Q8N973 Q8WUC8,DENN domain-containing protein 5B,Rab6IP1-like protein;, PF03455;PF02141;PF01477;PF02759;PF03456;, GO:0005829;GO:0016021;GO:0005085;, C:cytosol; C:integral component of membrane;, F:guanyl-nucleotide exchange factor activity; scaffold35 indexed_genome mRNA 18823427 18836602 . - . ID=transcript_7353;Q8IXQ9 D3DUW3,Electron transfer flavoprotein beta subunit lysine methyltransferase {ECO:0000303|PubMed:25416781},ETFB lysine methyltransferase {ECO:0000303|PubMed:25416781};Protein N-lysine methyltransferase METTL20;, , GO:0005737;GO:0005759;GO:0032991;GO:0031072;GO:0016279;GO:1904733;GO:1904736;GO:0018022;GO:0018023;GO:0006479;, C:cytoplasm; C:mitochondrial matrix; C:protein-containing complex;, F:heat shock protein binding; F:protein-lysine N-methyltransferase activity;, P:negative regulation of electron transfer activity; P:negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:peptidyl-lysine methylation; P:peptidyl-lysine trimethylation; P:protein methylation;|Q8IXQ9 D3DUW3,Electron transfer flavoprotein beta subunit lysine methyltransferase {ECO:0000303|PubMed:25416781},ETFB lysine methyltransferase {ECO:0000303|PubMed:25416781};Protein N-lysine methyltransferase METTL20;, , GO:0005737;GO:0005759;GO:0032991;GO:0031072;GO:0016279;GO:1904733;GO:1904736;GO:0018022;GO:0018023;GO:0006479;, C:cytoplasm; C:mitochondrial matrix; C:protein-containing complex;, F:heat shock protein binding; F:protein-lysine N-methyltransferase activity;, P:negative regulation of electron transfer activity; P:negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:peptidyl-lysine methylation; P:peptidyl-lysine trimethylation; P:protein methylation; scaffold35 indexed_genome mRNA 18845002 18920500 . - . ID=transcript_7354;Q8IY45 B7Z7J3 Q6NVU4 Q86X98,Protein AMN1 homolog,, PF13516;, GO:0019005;GO:0031146;, C:SCF ubiquitin ligase complex;, , P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold35 indexed_genome mRNA 19160083 19185608 . + . ID=transcript_7355;Q9HCM1 B2RTU5 Q4KN17 Q9NVL6 Q9NWP9,Retroelement silencing factor 1 {ECO:0000305},, PF15395;, GO:0005634;GO:0042393;GO:0045869;GO:0090309;, C:nucleus;, F:histone binding;, P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; scaffold35 indexed_genome mRNA 19370750 19578138 . + . ID=transcript_7356;Q96G01 A8K2C3 F8W113 O43892 O43893,Protein bicaudal D homolog 1,, PF09730;, GO:0005813;GO:0031410;GO:0005856;GO:0005829;GO:0005794;GO:0016020;GO:0048471;GO:0099503;GO:0005802;GO:0008093;GO:0034452;GO:0070840;GO:0045505;GO:0019901;GO:0031871;GO:0031267;GO:0005200;GO:0009653;GO:0008298;GO:0072393;GO:0072385;GO:1900275;GO:1900737;GO:1904781;GO:0048260;GO:0033365;GO:0070507;GO:1900276;GO:0006396;GO:0034063;GO:0016032;, C:centrosome; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:secretory vesicle; C:trans-Golgi network;, F:cytoskeletal anchor activity; F:dynactin binding; F:dynein complex binding; F:dynein intermediate chain binding; F:protein kinase binding; F:proteinase activated receptor binding; F:small GTPase binding; F:structural constituent of cytoskeleton;, P:anatomical structure morphogenesis; P:intracellular mRNA localization; P:microtubule anchoring at microtubule organizing center; P:minus-end-directed organelle transport along microtubule; P:negative regulation of phospholipase C activity; P:negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of protein localization to centrosome; P:positive regulation of receptor-mediated endocytosis; P:protein localization to organelle; P:regulation of microtubule cytoskeleton organization; P:regulation of proteinase activated receptor activity; P:RNA processing; P:stress granule assembly; P:viral process; scaffold35 indexed_genome mRNA 19601295 19615688 . + . ID=transcript_7357;Q96G01 A8K2C3 F8W113 O43892 O43893,Protein bicaudal D homolog 1,, PF09730;, GO:0005813;GO:0031410;GO:0005856;GO:0005829;GO:0005794;GO:0016020;GO:0048471;GO:0099503;GO:0005802;GO:0008093;GO:0034452;GO:0070840;GO:0045505;GO:0019901;GO:0031871;GO:0031267;GO:0005200;GO:0009653;GO:0008298;GO:0072393;GO:0072385;GO:1900275;GO:1900737;GO:1904781;GO:0048260;GO:0033365;GO:0070507;GO:1900276;GO:0006396;GO:0034063;GO:0016032;, C:centrosome; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:secretory vesicle; C:trans-Golgi network;, F:cytoskeletal anchor activity; F:dynactin binding; F:dynein complex binding; F:dynein intermediate chain binding; F:protein kinase binding; F:proteinase activated receptor binding; F:small GTPase binding; F:structural constituent of cytoskeleton;, P:anatomical structure morphogenesis; P:intracellular mRNA localization; P:microtubule anchoring at microtubule organizing center; P:minus-end-directed organelle transport along microtubule; P:negative regulation of phospholipase C activity; P:negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of protein localization to centrosome; P:positive regulation of receptor-mediated endocytosis; P:protein localization to organelle; P:regulation of microtubule cytoskeleton organization; P:regulation of proteinase activated receptor activity; P:RNA processing; P:stress granule assembly; P:viral process;|Q96G01 A8K2C3 F8W113 O43892 O43893,Protein bicaudal D homolog 1,, PF09730;, GO:0005813;GO:0031410;GO:0005856;GO:0005829;GO:0005794;GO:0016020;GO:0048471;GO:0099503;GO:0005802;GO:0008093;GO:0034452;GO:0070840;GO:0045505;GO:0019901;GO:0031871;GO:0031267;GO:0005200;GO:0009653;GO:0008298;GO:0072393;GO:0072385;GO:1900275;GO:1900737;GO:1904781;GO:0048260;GO:0033365;GO:0070507;GO:1900276;GO:0006396;GO:0034063;GO:0016032;, C:centrosome; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:secretory vesicle; C:trans-Golgi network;, F:cytoskeletal anchor activity; F:dynactin binding; F:dynein complex binding; F:dynein intermediate chain binding; F:protein kinase binding; F:proteinase activated receptor binding; F:small GTPase binding; F:structural constituent of cytoskeleton;, P:anatomical structure morphogenesis; P:intracellular mRNA localization; P:microtubule anchoring at microtubule organizing center; P:minus-end-directed organelle transport along microtubule; P:negative regulation of phospholipase C activity; P:negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of protein localization to centrosome; P:positive regulation of receptor-mediated endocytosis; P:protein localization to organelle; P:regulation of microtubule cytoskeleton organization; P:regulation of proteinase activated receptor activity; P:RNA processing; P:stress granule assembly; P:viral process; scaffold35 indexed_genome mRNA 19637531 19874209 . + . ID=transcript_7358;Q96M96 Q6ULS2 Q8TCP6,FYVE, RhoGEF and PH domain-containing protein 4,Actin filament-binding protein frabin;FGD1-related F-actin-binding protein;Zinc finger FYVE domain-containing protein 6;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0030175;GO:0005794;GO:0030027;GO:0001726;GO:0003779;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:filopodium; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:actin binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold35 indexed_genome mRNA 19910409 20004238 . + . ID=transcript_7359;Q7L6B3 Q8TBT7 Q9BWM1 Q9Y5J2,Dynamin-1-like protein,Dnm1p/Vps1p-like protein;Dynamin family member proline-rich carboxyl-terminal domain less;Dynamin-like protein;Dynamin-like protein 4;Dynamin-like protein IV;Dynamin-related protein 1;, PF01031;PF00350;PF02212;, GO:0005903;GO:0005905;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005874;GO:0031966;GO:0005741;GO:0005739;GO:0048471;GO:0005777;GO:0098835;GO:0032991;GO:0030672;GO:0051433;GO:0030276;GO:0005525;GO:0030742;GO:0005096;GO:0003924;GO:0042802;GO:0008289;GO:0008017;GO:0042803;GO:0044877;GO:0031267;GO:0031625;GO:0006816;GO:0090650;GO:1904579;GO:0003374;GO:0097194;GO:0060047;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0090149;GO:0070584;GO:0007005;GO:0070266;GO:0010637;GO:0016559;GO:0043065;GO:0061003;GO:2001244;GO:0090141;GO:0090023;GO:0050714;GO:0090200;GO:1900244;GO:2000302;GO:0051259;GO:0070585;GO:0065003;GO:1903578;GO:1903146;GO:0010468;GO:0010821;GO:1900063;GO:1904666;GO:0001836;GO:1905395;GO:1990910;GO:0048511;GO:0048488;GO:0036466;, C:brush border; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:peroxisome; C:presynaptic endocytic zone membrane; C:protein-containing complex; C:synaptic vesicle membrane;, F:BH2 domain binding; F:clathrin binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:lipid binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:calcium ion transport; P:cellular response to oxygen-glucose deprivation; P:cellular response to thapsigargin; P:dynamin family protein polymerization involved in mitochondrial fission; P:execution phase of apoptosis; P:heart contraction; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial membrane fission; P:mitochondrion morphogenesis; P:mitochondrion organization; P:necroptotic process; P:negative regulation of mitochondrial fusion; P:peroxisome fission; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein secretion; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:protein complex oligomerization; P:protein localization to mitochondrion; P:protein-containing complex assembly; P:regulation of ATP metabolic process; P:regulation of autophagy of mitochondrion; P:regulation of gene expression; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:regulation of ubiquitin protein ligase activity; P:release of cytochrome c from mitochondria; P:response to flavonoid; P:response to hypobaric hypoxia; P:rhythmic process; P:synaptic vesicle endocytosis; P:synaptic vesicle recycling via endosome;|P84077 P10947 P32889,ADP-ribosylation factor 1,, PF00025;, GO:0031252;GO:0030137;GO:0005829;GO:0070062;GO:0005925;GO:0098978;GO:0000139;GO:0005770;GO:0043005;GO:0048471;GO:0005778;GO:0005886;GO:0014069;GO:0032991;GO:0030017;GO:0005802;GO:0019003;GO:0005525;GO:0000287;GO:1990583;GO:0019904;GO:0003723;GO:0007015;GO:0019886;GO:0006878;GO:0098586;GO:0097061;GO:0055108;GO:0035722;GO:0006886;GO:0060292;GO:0097212;GO:1990386;GO:0006661;GO:0045956;GO:0060999;GO:0045807;GO:1902953;GO:1902824;GO:0050714;GO:1902307;GO:0006892;GO:0098974;GO:0034315;GO:0050690;GO:1903725;GO:0002090;GO:0070142;GO:0034379;GO:0016192;, C:cell leading edge; C:COPI-coated vesicle; C:cytosol; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:Golgi membrane; C:late endosome; C:neuron projection; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcomere; C:trans-Golgi network;, F:GDP binding; F:GTP binding; F:magnesium ion binding; F:phospholipase D activator activity; F:protein domain specific binding; F:RNA binding;, P:actin filament organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular copper ion homeostasis; P:cellular response to virus; P:dendritic spine organization; P:Golgi to transport vesicle transport; P:interleukin-12-mediated signaling pathway; P:intracellular protein transport; P:long-term synaptic depression; P:lysosomal membrane organization; P:mitotic cleavage furrow ingression; P:phosphatidylinositol biosynthetic process; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of dendritic spine development; P:positive regulation of endocytosis; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of late endosome to lysosome transport; P:positive regulation of protein secretion; P:positive regulation of sodium ion transmembrane transport; P:post-Golgi vesicle-mediated transport; P:postsynaptic actin cytoskeleton organization; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of defense response to virus by virus; P:regulation of phospholipid metabolic process; P:regulation of receptor internalization; P:synaptic vesicle budding; P:very-low-density lipoprotein particle assembly; P:vesicle-mediated transport;|Q7L6B3 Q8TBT7 Q9BWM1 Q9Y5J2,Dynamin-1-like protein,Dnm1p/Vps1p-like protein;Dynamin family member proline-rich carboxyl-terminal domain less;Dynamin-like protein;Dynamin-like protein 4;Dynamin-like protein IV;Dynamin-related protein 1;, PF01031;PF00350;PF02212;, GO:0005903;GO:0005905;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005874;GO:0031966;GO:0005741;GO:0005739;GO:0048471;GO:0005777;GO:0098835;GO:0032991;GO:0030672;GO:0051433;GO:0030276;GO:0005525;GO:0030742;GO:0005096;GO:0003924;GO:0042802;GO:0008289;GO:0008017;GO:0042803;GO:0044877;GO:0031267;GO:0031625;GO:0006816;GO:0090650;GO:1904579;GO:0003374;GO:0097194;GO:0060047;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0090149;GO:0070584;GO:0007005;GO:0070266;GO:0010637;GO:0016559;GO:0043065;GO:0061003;GO:2001244;GO:0090141;GO:0090023;GO:0050714;GO:0090200;GO:1900244;GO:2000302;GO:0051259;GO:0070585;GO:0065003;GO:1903578;GO:1903146;GO:0010468;GO:0010821;GO:1900063;GO:1904666;GO:0001836;GO:1905395;GO:1990910;GO:0048511;GO:0048488;GO:0036466;, C:brush border; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:peroxisome; C:presynaptic endocytic zone membrane; C:protein-containing complex; C:synaptic vesicle membrane;, F:BH2 domain binding; F:clathrin binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:lipid binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:calcium ion transport; P:cellular response to oxygen-glucose deprivation; P:cellular response to thapsigargin; P:dynamin family protein polymerization involved in mitochondrial fission; P:execution phase of apoptosis; P:heart contraction; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial membrane fission; P:mitochondrion morphogenesis; P:mitochondrion organization; P:necroptotic process; P:negative regulation of mitochondrial fusion; P:peroxisome fission; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein secretion; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:protein complex oligomerization; P:protein localization to mitochondrion; P:protein-containing complex assembly; P:regulation of ATP metabolic process; P:regulation of autophagy of mitochondrion; P:regulation of gene expression; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:regulation of ubiquitin protein ligase activity; P:release of cytochrome c from mitochondria; P:response to flavonoid; P:response to hypobaric hypoxia; P:rhythmic process; P:synaptic vesicle endocytosis; P:synaptic vesicle recycling via endosome;|Q7L6B3 Q8TBT7 Q9BWM1 Q9Y5J2,Dynamin-1-like protein,Dnm1p/Vps1p-like protein;Dynamin family member proline-rich carboxyl-terminal domain less;Dynamin-like protein;Dynamin-like protein 4;Dynamin-like protein IV;Dynamin-related protein 1;, PF01031;PF00350;PF02212;, GO:0005903;GO:0005905;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005874;GO:0031966;GO:0005741;GO:0005739;GO:0048471;GO:0005777;GO:0098835;GO:0032991;GO:0030672;GO:0051433;GO:0030276;GO:0005525;GO:0030742;GO:0005096;GO:0003924;GO:0042802;GO:0008289;GO:0008017;GO:0042803;GO:0044877;GO:0031267;GO:0031625;GO:0006816;GO:0090650;GO:1904579;GO:0003374;GO:0097194;GO:0060047;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0090149;GO:0070584;GO:0007005;GO:0070266;GO:0010637;GO:0016559;GO:0043065;GO:0061003;GO:2001244;GO:0090141;GO:0090023;GO:0050714;GO:0090200;GO:1900244;GO:2000302;GO:0051259;GO:0070585;GO:0065003;GO:1903578;GO:1903146;GO:0010468;GO:0010821;GO:1900063;GO:1904666;GO:0001836;GO:1905395;GO:1990910;GO:0048511;GO:0048488;GO:0036466;, C:brush border; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:peroxisome; C:presynaptic endocytic zone membrane; C:protein-containing complex; C:synaptic vesicle membrane;, F:BH2 domain binding; F:clathrin binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:lipid binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:calcium ion transport; P:cellular response to oxygen-glucose deprivation; P:cellular response to thapsigargin; P:dynamin family protein polymerization involved in mitochondrial fission; P:execution phase of apoptosis; P:heart contraction; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial membrane fission; P:mitochondrion morphogenesis; P:mitochondrion organization; P:necroptotic process; P:negative regulation of mitochondrial fusion; P:peroxisome fission; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein secretion; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:protein complex oligomerization; P:protein localization to mitochondrion; P:protein-containing complex assembly; P:regulation of ATP metabolic process; P:regulation of autophagy of mitochondrion; P:regulation of gene expression; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:regulation of ubiquitin protein ligase activity; P:release of cytochrome c from mitochondria; P:response to flavonoid; P:response to hypobaric hypoxia; P:rhythmic process; P:synaptic vesicle endocytosis; P:synaptic vesicle recycling via endosome;|Q7L6B3 Q8TBT7 Q9BWM1 Q9Y5J2,Dynamin-1-like protein,Dnm1p/Vps1p-like protein;Dynamin family member proline-rich carboxyl-terminal domain less;Dynamin-like protein;Dynamin-like protein 4;Dynamin-like protein IV;Dynamin-related protein 1;, PF01031;PF00350;PF02212;, GO:0005903;GO:0005905;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005874;GO:0031966;GO:0005741;GO:0005739;GO:0048471;GO:0005777;GO:0098835;GO:0032991;GO:0030672;GO:0051433;GO:0030276;GO:0005525;GO:0030742;GO:0005096;GO:0003924;GO:0042802;GO:0008289;GO:0008017;GO:0042803;GO:0044877;GO:0031267;GO:0031625;GO:0006816;GO:0090650;GO:1904579;GO:0003374;GO:0097194;GO:0060047;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0090149;GO:0070584;GO:0007005;GO:0070266;GO:0010637;GO:0016559;GO:0043065;GO:0061003;GO:2001244;GO:0090141;GO:0090023;GO:0050714;GO:0090200;GO:1900244;GO:2000302;GO:0051259;GO:0070585;GO:0065003;GO:1903578;GO:1903146;GO:0010468;GO:0010821;GO:1900063;GO:1904666;GO:0001836;GO:1905395;GO:1990910;GO:0048511;GO:0048488;GO:0036466;, C:brush border; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:peroxisome; C:presynaptic endocytic zone membrane; C:protein-containing complex; C:synaptic vesicle membrane;, F:BH2 domain binding; F:clathrin binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:lipid binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:calcium ion transport; P:cellular response to oxygen-glucose deprivation; P:cellular response to thapsigargin; P:dynamin family protein polymerization involved in mitochondrial fission; P:execution phase of apoptosis; P:heart contraction; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial membrane fission; P:mitochondrion morphogenesis; P:mitochondrion organization; P:necroptotic process; P:negative regulation of mitochondrial fusion; P:peroxisome fission; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein secretion; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:protein complex oligomerization; P:protein localization to mitochondrion; P:protein-containing complex assembly; P:regulation of ATP metabolic process; P:regulation of autophagy of mitochondrion; P:regulation of gene expression; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:regulation of ubiquitin protein ligase activity; P:release of cytochrome c from mitochondria; P:response to flavonoid; P:response to hypobaric hypoxia; P:rhythmic process; P:synaptic vesicle endocytosis; P:synaptic vesicle recycling via endosome;|Q7L6B3 Q8TBT7 Q9BWM1 Q9Y5J2,Dynamin-1-like protein,Dnm1p/Vps1p-like protein;Dynamin family member proline-rich carboxyl-terminal domain less;Dynamin-like protein;Dynamin-like protein 4;Dynamin-like protein IV;Dynamin-related protein 1;, PF01031;PF00350;PF02212;, GO:0005903;GO:0005905;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005874;GO:0031966;GO:0005741;GO:0005739;GO:0048471;GO:0005777;GO:0098835;GO:0032991;GO:0030672;GO:0051433;GO:0030276;GO:0005525;GO:0030742;GO:0005096;GO:0003924;GO:0042802;GO:0008289;GO:0008017;GO:0042803;GO:0044877;GO:0031267;GO:0031625;GO:0006816;GO:0090650;GO:1904579;GO:0003374;GO:0097194;GO:0060047;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0090149;GO:0070584;GO:0007005;GO:0070266;GO:0010637;GO:0016559;GO:0043065;GO:0061003;GO:2001244;GO:0090141;GO:0090023;GO:0050714;GO:0090200;GO:1900244;GO:2000302;GO:0051259;GO:0070585;GO:0065003;GO:1903578;GO:1903146;GO:0010468;GO:0010821;GO:1900063;GO:1904666;GO:0001836;GO:1905395;GO:1990910;GO:0048511;GO:0048488;GO:0036466;, C:brush border; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:peroxisome; C:presynaptic endocytic zone membrane; C:protein-containing complex; C:synaptic vesicle membrane;, F:BH2 domain binding; F:clathrin binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:lipid binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:calcium ion transport; P:cellular response to oxygen-glucose deprivation; P:cellular response to thapsigargin; P:dynamin family protein polymerization involved in mitochondrial fission; P:execution phase of apoptosis; P:heart contraction; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial membrane fission; P:mitochondrion morphogenesis; P:mitochondrion organization; P:necroptotic process; P:negative regulation of mitochondrial fusion; P:peroxisome fission; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein secretion; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:protein complex oligomerization; P:protein localization to mitochondrion; P:protein-containing complex assembly; P:regulation of ATP metabolic process; P:regulation of autophagy of mitochondrion; P:regulation of gene expression; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:regulation of ubiquitin protein ligase activity; P:release of cytochrome c from mitochondria; P:response to flavonoid; P:response to hypobaric hypoxia; P:rhythmic process; P:synaptic vesicle endocytosis; P:synaptic vesicle recycling via endosome;|Q7L6B3 Q8TBT7 Q9BWM1 Q9Y5J2,Dynamin-1-like protein,Dnm1p/Vps1p-like protein;Dynamin family member proline-rich carboxyl-terminal domain less;Dynamin-like protein;Dynamin-like protein 4;Dynamin-like protein IV;Dynamin-related protein 1;, PF01031;PF00350;PF02212;, GO:0005903;GO:0005905;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005874;GO:0031966;GO:0005741;GO:0005739;GO:0048471;GO:0005777;GO:0098835;GO:0032991;GO:0030672;GO:0051433;GO:0030276;GO:0005525;GO:0030742;GO:0005096;GO:0003924;GO:0042802;GO:0008289;GO:0008017;GO:0042803;GO:0044877;GO:0031267;GO:0031625;GO:0006816;GO:0090650;GO:1904579;GO:0003374;GO:0097194;GO:0060047;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0090149;GO:0070584;GO:0007005;GO:0070266;GO:0010637;GO:0016559;GO:0043065;GO:0061003;GO:2001244;GO:0090141;GO:0090023;GO:0050714;GO:0090200;GO:1900244;GO:2000302;GO:0051259;GO:0070585;GO:0065003;GO:1903578;GO:1903146;GO:0010468;GO:0010821;GO:1900063;GO:1904666;GO:0001836;GO:1905395;GO:1990910;GO:0048511;GO:0048488;GO:0036466;, C:brush border; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:peroxisome; C:presynaptic endocytic zone membrane; C:protein-containing complex; C:synaptic vesicle membrane;, F:BH2 domain binding; F:clathrin binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:lipid binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:calcium ion transport; P:cellular response to oxygen-glucose deprivation; P:cellular response to thapsigargin; P:dynamin family protein polymerization involved in mitochondrial fission; P:execution phase of apoptosis; P:heart contraction; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial membrane fission; P:mitochondrion morphogenesis; P:mitochondrion organization; P:necroptotic process; P:negative regulation of mitochondrial fusion; P:peroxisome fission; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein secretion; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:protein complex oligomerization; P:protein localization to mitochondrion; P:protein-containing complex assembly; P:regulation of ATP metabolic process; P:regulation of autophagy of mitochondrion; P:regulation of gene expression; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:regulation of ubiquitin protein ligase activity; P:release of cytochrome c from mitochondria; P:response to flavonoid; P:response to hypobaric hypoxia; P:rhythmic process; P:synaptic vesicle endocytosis; P:synaptic vesicle recycling via endosome;|Q7L6B3 Q8TBT7 Q9BWM1 Q9Y5J2,Dynamin-1-like protein,Dnm1p/Vps1p-like protein;Dynamin family member proline-rich carboxyl-terminal domain less;Dynamin-like protein;Dynamin-like protein 4;Dynamin-like protein IV;Dynamin-related protein 1;, PF01031;PF00350;PF02212;, GO:0005903;GO:0005905;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005874;GO:0031966;GO:0005741;GO:0005739;GO:0048471;GO:0005777;GO:0098835;GO:0032991;GO:0030672;GO:0051433;GO:0030276;GO:0005525;GO:0030742;GO:0005096;GO:0003924;GO:0042802;GO:0008289;GO:0008017;GO:0042803;GO:0044877;GO:0031267;GO:0031625;GO:0006816;GO:0090650;GO:1904579;GO:0003374;GO:0097194;GO:0060047;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0090149;GO:0070584;GO:0007005;GO:0070266;GO:0010637;GO:0016559;GO:0043065;GO:0061003;GO:2001244;GO:0090141;GO:0090023;GO:0050714;GO:0090200;GO:1900244;GO:2000302;GO:0051259;GO:0070585;GO:0065003;GO:1903578;GO:1903146;GO:0010468;GO:0010821;GO:1900063;GO:1904666;GO:0001836;GO:1905395;GO:1990910;GO:0048511;GO:0048488;GO:0036466;, C:brush border; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:peroxisome; C:presynaptic endocytic zone membrane; C:protein-containing complex; C:synaptic vesicle membrane;, F:BH2 domain binding; F:clathrin binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:lipid binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:calcium ion transport; P:cellular response to oxygen-glucose deprivation; P:cellular response to thapsigargin; P:dynamin family protein polymerization involved in mitochondrial fission; P:execution phase of apoptosis; P:heart contraction; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial membrane fission; P:mitochondrion morphogenesis; P:mitochondrion organization; P:necroptotic process; P:negative regulation of mitochondrial fusion; P:peroxisome fission; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein secretion; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:protein complex oligomerization; P:protein localization to mitochondrion; P:protein-containing complex assembly; P:regulation of ATP metabolic process; P:regulation of autophagy of mitochondrion; P:regulation of gene expression; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:regulation of ubiquitin protein ligase activity; P:release of cytochrome c from mitochondria; P:response to flavonoid; P:response to hypobaric hypoxia; P:rhythmic process; P:synaptic vesicle endocytosis; P:synaptic vesicle recycling via endosome;|Q7L6B3 Q8TBT7 Q9BWM1 Q9Y5J2,Dynamin-1-like protein,Dnm1p/Vps1p-like protein;Dynamin family member proline-rich carboxyl-terminal domain less;Dynamin-like protein;Dynamin-like protein 4;Dynamin-like protein IV;Dynamin-related protein 1;, PF01031;PF00350;PF02212;, GO:0005903;GO:0005905;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005874;GO:0031966;GO:0005741;GO:0005739;GO:0048471;GO:0005777;GO:0098835;GO:0032991;GO:0030672;GO:0051433;GO:0030276;GO:0005525;GO:0030742;GO:0005096;GO:0003924;GO:0042802;GO:0008289;GO:0008017;GO:0042803;GO:0044877;GO:0031267;GO:0031625;GO:0006816;GO:0090650;GO:1904579;GO:0003374;GO:0097194;GO:0060047;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0090149;GO:0070584;GO:0007005;GO:0070266;GO:0010637;GO:0016559;GO:0043065;GO:0061003;GO:2001244;GO:0090141;GO:0090023;GO:0050714;GO:0090200;GO:1900244;GO:2000302;GO:0051259;GO:0070585;GO:0065003;GO:1903578;GO:1903146;GO:0010468;GO:0010821;GO:1900063;GO:1904666;GO:0001836;GO:1905395;GO:1990910;GO:0048511;GO:0048488;GO:0036466;, C:brush border; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:peroxisome; C:presynaptic endocytic zone membrane; C:protein-containing complex; C:synaptic vesicle membrane;, F:BH2 domain binding; F:clathrin binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:lipid binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:calcium ion transport; P:cellular response to oxygen-glucose deprivation; P:cellular response to thapsigargin; P:dynamin family protein polymerization involved in mitochondrial fission; P:execution phase of apoptosis; P:heart contraction; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial membrane fission; P:mitochondrion morphogenesis; P:mitochondrion organization; P:necroptotic process; P:negative regulation of mitochondrial fusion; P:peroxisome fission; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein secretion; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:protein complex oligomerization; P:protein localization to mitochondrion; P:protein-containing complex assembly; P:regulation of ATP metabolic process; P:regulation of autophagy of mitochondrion; P:regulation of gene expression; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:regulation of ubiquitin protein ligase activity; P:release of cytochrome c from mitochondria; P:response to flavonoid; P:response to hypobaric hypoxia; P:rhythmic process; P:synaptic vesicle endocytosis; P:synaptic vesicle recycling via endosome;|Q7L6B3 Q8TBT7 Q9BWM1 Q9Y5J2,Dynamin-1-like protein,Dnm1p/Vps1p-like protein;Dynamin family member proline-rich carboxyl-terminal domain less;Dynamin-like protein;Dynamin-like protein 4;Dynamin-like protein IV;Dynamin-related protein 1;, PF01031;PF00350;PF02212;, GO:0005903;GO:0005905;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005874;GO:0031966;GO:0005741;GO:0005739;GO:0048471;GO:0005777;GO:0098835;GO:0032991;GO:0030672;GO:0051433;GO:0030276;GO:0005525;GO:0030742;GO:0005096;GO:0003924;GO:0042802;GO:0008289;GO:0008017;GO:0042803;GO:0044877;GO:0031267;GO:0031625;GO:0006816;GO:0090650;GO:1904579;GO:0003374;GO:0097194;GO:0060047;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0090149;GO:0070584;GO:0007005;GO:0070266;GO:0010637;GO:0016559;GO:0043065;GO:0061003;GO:2001244;GO:0090141;GO:0090023;GO:0050714;GO:0090200;GO:1900244;GO:2000302;GO:0051259;GO:0070585;GO:0065003;GO:1903578;GO:1903146;GO:0010468;GO:0010821;GO:1900063;GO:1904666;GO:0001836;GO:1905395;GO:1990910;GO:0048511;GO:0048488;GO:0036466;, C:brush border; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:peroxisome; C:presynaptic endocytic zone membrane; C:protein-containing complex; C:synaptic vesicle membrane;, F:BH2 domain binding; F:clathrin binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:lipid binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:calcium ion transport; P:cellular response to oxygen-glucose deprivation; P:cellular response to thapsigargin; P:dynamin family protein polymerization involved in mitochondrial fission; P:execution phase of apoptosis; P:heart contraction; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial membrane fission; P:mitochondrion morphogenesis; P:mitochondrion organization; P:necroptotic process; P:negative regulation of mitochondrial fusion; P:peroxisome fission; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein secretion; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:protein complex oligomerization; P:protein localization to mitochondrion; P:protein-containing complex assembly; P:regulation of ATP metabolic process; P:regulation of autophagy of mitochondrion; P:regulation of gene expression; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:regulation of ubiquitin protein ligase activity; P:release of cytochrome c from mitochondria; P:response to flavonoid; P:response to hypobaric hypoxia; P:rhythmic process; P:synaptic vesicle endocytosis; P:synaptic vesicle recycling via endosome;|Q7L6B3 Q8TBT7 Q9BWM1 Q9Y5J2,Dynamin-1-like protein,Dnm1p/Vps1p-like protein;Dynamin family member proline-rich carboxyl-terminal domain less;Dynamin-like protein;Dynamin-like protein 4;Dynamin-like protein IV;Dynamin-related protein 1;, PF01031;PF00350;PF02212;, GO:0005903;GO:0005905;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005874;GO:0031966;GO:0005741;GO:0005739;GO:0048471;GO:0005777;GO:0098835;GO:0032991;GO:0030672;GO:0051433;GO:0030276;GO:0005525;GO:0030742;GO:0005096;GO:0003924;GO:0042802;GO:0008289;GO:0008017;GO:0042803;GO:0044877;GO:0031267;GO:0031625;GO:0006816;GO:0090650;GO:1904579;GO:0003374;GO:0097194;GO:0060047;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0090149;GO:0070584;GO:0007005;GO:0070266;GO:0010637;GO:0016559;GO:0043065;GO:0061003;GO:2001244;GO:0090141;GO:0090023;GO:0050714;GO:0090200;GO:1900244;GO:2000302;GO:0051259;GO:0070585;GO:0065003;GO:1903578;GO:1903146;GO:0010468;GO:0010821;GO:1900063;GO:1904666;GO:0001836;GO:1905395;GO:1990910;GO:0048511;GO:0048488;GO:0036466;, C:brush border; C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:peroxisome; C:presynaptic endocytic zone membrane; C:protein-containing complex; C:synaptic vesicle membrane;, F:BH2 domain binding; F:clathrin binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activator activity; F:GTPase activity; F:identical protein binding; F:lipid binding; F:microtubule binding; F:protein homodimerization activity; F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:calcium ion transport; P:cellular response to oxygen-glucose deprivation; P:cellular response to thapsigargin; P:dynamin family protein polymerization involved in mitochondrial fission; P:execution phase of apoptosis; P:heart contraction; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial membrane fission; P:mitochondrion morphogenesis; P:mitochondrion organization; P:necroptotic process; P:negative regulation of mitochondrial fusion; P:peroxisome fission; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial fission; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein secretion; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic vesicle endocytosis; P:positive regulation of synaptic vesicle exocytosis; P:protein complex oligomerization; P:protein localization to mitochondrion; P:protein-containing complex assembly; P:regulation of ATP metabolic process; P:regulation of autophagy of mitochondrion; P:regulation of gene expression; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:regulation of ubiquitin protein ligase activity; P:release of cytochrome c from mitochondria; P:response to flavonoid; P:response to hypobaric hypoxia; P:rhythmic process; P:synaptic vesicle endocytosis; P:synaptic vesicle recycling via endosome;|Q9Y2Z4 D3DUW8 Q9H817,Tyrosine--tRNA ligase, mitochondrial,Tyrosyl-tRNA synthetase;, PF00579;, GO:0005829;GO:0005759;GO:0005739;GO:0016604;GO:0005524;GO:0042803;GO:0003723;GO:0000049;GO:0072545;GO:0004831;GO:0070184;GO:0006412;GO:0043039;GO:0006418;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nuclear body;, F:ATP binding; F:protein homodimerization activity; F:RNA binding; F:tRNA binding; F:tyrosine binding; F:tyrosine-tRNA ligase activity;, P:mitochondrial tyrosyl-tRNA aminoacylation; P:translation; P:tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|Q9Y2Z4 D3DUW8 Q9H817,Tyrosine--tRNA ligase, mitochondrial,Tyrosyl-tRNA synthetase;, PF00579;, GO:0005829;GO:0005759;GO:0005739;GO:0016604;GO:0005524;GO:0042803;GO:0003723;GO:0000049;GO:0072545;GO:0004831;GO:0070184;GO:0006412;GO:0043039;GO:0006418;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nuclear body;, F:ATP binding; F:protein homodimerization activity; F:RNA binding; F:tRNA binding; F:tyrosine binding; F:tyrosine-tRNA ligase activity;, P:mitochondrial tyrosyl-tRNA aminoacylation; P:translation; P:tRNA aminoacylation; P:tRNA aminoacylation for protein translation; scaffold35 indexed_genome mRNA 20027614 20122865 . - . ID=transcript_7360;Q99959 A0AV37 B8QFA1 B8QGS6 B8QGS7 D3DUW9 Q4VC01 Q99960,Plakophilin-2,, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0030057;GO:0016021;GO:0014704;GO:0005882;GO:0005654;GO:0005634;GO:0005886;GO:0045294;GO:0045296;GO:0086083;GO:0019215;GO:0044325;GO:0060090;GO:0005080;GO:0017080;GO:0086073;GO:0086002;GO:0086064;GO:0098609;GO:0007043;GO:0086019;GO:0070268;GO:0002159;GO:0002934;GO:0007507;GO:0045110;GO:0031424;GO:0048496;GO:0010765;GO:0072659;GO:0086091;GO:0098911;GO:0086005;GO:0055010;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:desmosome; C:integral component of membrane; C:intercalated disc; C:intermediate filament; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:alpha-catenin binding; F:cadherin binding; F:cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication; F:intermediate filament binding; F:ion channel binding; F:molecular adaptor activity; F:protein kinase C binding; F:sodium channel regulator activity;, P:bundle of His cell-Purkinje myocyte adhesion involved in cell communication; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling involved in cardiac conduction; P:cornification; P:desmosome assembly; P:desmosome organization; P:heart development; P:intermediate filament bundle assembly; P:keratinization; P:maintenance of animal organ identity; P:positive regulation of sodium ion transport; P:protein localization to plasma membrane; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell action potential; P:ventricular cardiac muscle cell action potential; P:ventricular cardiac muscle tissue morphogenesis;|Q99959 A0AV37 B8QFA1 B8QGS6 B8QGS7 D3DUW9 Q4VC01 Q99960,Plakophilin-2,, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0030057;GO:0016021;GO:0014704;GO:0005882;GO:0005654;GO:0005634;GO:0005886;GO:0045294;GO:0045296;GO:0086083;GO:0019215;GO:0044325;GO:0060090;GO:0005080;GO:0017080;GO:0086073;GO:0086002;GO:0086064;GO:0098609;GO:0007043;GO:0086019;GO:0070268;GO:0002159;GO:0002934;GO:0007507;GO:0045110;GO:0031424;GO:0048496;GO:0010765;GO:0072659;GO:0086091;GO:0098911;GO:0086005;GO:0055010;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:desmosome; C:integral component of membrane; C:intercalated disc; C:intermediate filament; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:alpha-catenin binding; F:cadherin binding; F:cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication; F:intermediate filament binding; F:ion channel binding; F:molecular adaptor activity; F:protein kinase C binding; F:sodium channel regulator activity;, P:bundle of His cell-Purkinje myocyte adhesion involved in cell communication; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling involved in cardiac conduction; P:cornification; P:desmosome assembly; P:desmosome organization; P:heart development; P:intermediate filament bundle assembly; P:keratinization; P:maintenance of animal organ identity; P:positive regulation of sodium ion transport; P:protein localization to plasma membrane; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell action potential; P:ventricular cardiac muscle cell action potential; P:ventricular cardiac muscle tissue morphogenesis;|Q8N5S3 A0AV79 A0AV81 Q8N7V4,Uncharacterized protein C2orf73,, PF15667; scaffold35 indexed_genome mRNA 20979192 20988427 . + . ID=transcript_7361;Q5BKT4 Q6NS98 Q96DU0 Q96SM6,Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase,Alpha-1,2-glucosyltransferase ALG10-A;Alpha-2-glucosyltransferase ALG10-A;Asparagine-linked glycosylation protein 10 homolog A;, PF04922;, GO:0005783;GO:0005789;GO:0016021;GO:0106073;GO:0006488;GO:0006487;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein N-linked glycosylation;|Q5BKT4 Q6NS98 Q96DU0 Q96SM6,Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase,Alpha-1,2-glucosyltransferase ALG10-A;Alpha-2-glucosyltransferase ALG10-A;Asparagine-linked glycosylation protein 10 homolog A;, PF04922;, GO:0005783;GO:0005789;GO:0016021;GO:0106073;GO:0006488;GO:0006487;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein N-linked glycosylation;|Q5BKT4 Q6NS98 Q96DU0 Q96SM6,Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase,Alpha-1,2-glucosyltransferase ALG10-A;Alpha-2-glucosyltransferase ALG10-A;Asparagine-linked glycosylation protein 10 homolog A;, PF04922;, GO:0005783;GO:0005789;GO:0016021;GO:0106073;GO:0006488;GO:0006487;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein N-linked glycosylation;|Q5I7T1 B2RPF4,Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase {ECO:0000250|UniProtKB:P50076},Alpha-1,2-glucosyltransferase ALG10-A;Alpha-2-glucosyltransferase ALG10-B;Asparagine-linked glycosylation protein 10 homolog B;Potassium channel regulator 1;, PF04922;, GO:0005783;GO:0016021;GO:0005886;GO:0106073;GO:0016740;GO:0006488;GO:1901980;GO:0060050;GO:0006486;GO:0006487;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, F:dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity; F:transferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:positive regulation of inward rectifier potassium channel activity; P:positive regulation of protein glycosylation; P:protein glycosylation; P:protein N-linked glycosylation; scaffold35 indexed_genome mRNA 21056913 21076689 . - . ID=transcript_7362;Q9UMW8 Q53Y90 Q6IAD9 Q9NY71,Ubl carboxyl-terminal hydrolase 18,43 kDa ISG15-specific protease;ISG15-specific-processing protease;Ubl thioesterase 18;, PF00443;, GO:0005829;GO:0043231;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0050727;GO:0060338;GO:0006511;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of inflammatory response; P:regulation of type I interferon-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold35 indexed_genome mRNA 21142434 21166470 . + . ID=transcript_7363;Q9BWT7 Q14CQ8 Q5TFG6 Q8NC81 Q9UGR5 Q9UGR6 Q9Y3H0,Caspase recruitment domain-containing protein 10,CARD-containing MAGUK protein 3;, PF00619;, GO:0032449;GO:0005737;GO:0050700;GO:0030159;GO:0007250;GO:0090051;GO:1900182;GO:0065003;GO:0042981;, C:CBM complex; C:cytoplasm;, F:CARD domain binding; F:signaling receptor complex adaptor activity;, P:activation of NF-kappaB-inducing kinase activity; P:negative regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of protein localization to nucleus; P:protein-containing complex assembly; P:regulation of apoptotic process;|Q9BWT7 Q14CQ8 Q5TFG6 Q8NC81 Q9UGR5 Q9UGR6 Q9Y3H0,Caspase recruitment domain-containing protein 10,CARD-containing MAGUK protein 3;, PF00619;, GO:0032449;GO:0005737;GO:0050700;GO:0030159;GO:0007250;GO:0090051;GO:1900182;GO:0065003;GO:0042981;, C:CBM complex; C:cytoplasm;, F:CARD domain binding; F:signaling receptor complex adaptor activity;, P:activation of NF-kappaB-inducing kinase activity; P:negative regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of protein localization to nucleus; P:protein-containing complex assembly; P:regulation of apoptotic process;|Q9BWT7 Q14CQ8 Q5TFG6 Q8NC81 Q9UGR5 Q9UGR6 Q9Y3H0,Caspase recruitment domain-containing protein 10,CARD-containing MAGUK protein 3;, PF00619;, GO:0032449;GO:0005737;GO:0050700;GO:0030159;GO:0007250;GO:0090051;GO:1900182;GO:0065003;GO:0042981;, C:CBM complex; C:cytoplasm;, F:CARD domain binding; F:signaling receptor complex adaptor activity;, P:activation of NF-kappaB-inducing kinase activity; P:negative regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of protein localization to nucleus; P:protein-containing complex assembly; P:regulation of apoptotic process;|Q9BWT7 Q14CQ8 Q5TFG6 Q8NC81 Q9UGR5 Q9UGR6 Q9Y3H0,Caspase recruitment domain-containing protein 10,CARD-containing MAGUK protein 3;, PF00619;, GO:0032449;GO:0005737;GO:0050700;GO:0030159;GO:0007250;GO:0090051;GO:1900182;GO:0065003;GO:0042981;, C:CBM complex; C:cytoplasm;, F:CARD domain binding; F:signaling receptor complex adaptor activity;, P:activation of NF-kappaB-inducing kinase activity; P:negative regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of protein localization to nucleus; P:protein-containing complex assembly; P:regulation of apoptotic process;|Q9BWT7 Q14CQ8 Q5TFG6 Q8NC81 Q9UGR5 Q9UGR6 Q9Y3H0,Caspase recruitment domain-containing protein 10,CARD-containing MAGUK protein 3;, PF00619;, GO:0032449;GO:0005737;GO:0050700;GO:0030159;GO:0007250;GO:0090051;GO:1900182;GO:0065003;GO:0042981;, C:CBM complex; C:cytoplasm;, F:CARD domain binding; F:signaling receptor complex adaptor activity;, P:activation of NF-kappaB-inducing kinase activity; P:negative regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of protein localization to nucleus; P:protein-containing complex assembly; P:regulation of apoptotic process; scaffold35 indexed_genome mRNA 21176250 21190924 . + . ID=transcript_7364;O00587 B4DLT6 O43730 Q504S9,Beta-1,3-N-acetylglucosaminyltransferase manic fringe,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase;, PF02434;, GO:0005615;GO:0030173;GO:0008375;GO:0046872;GO:0033829;GO:0001825;GO:0002315;GO:0007389;GO:0045747;GO:0032092;GO:0008593;, C:extracellular space; C:integral component of Golgi membrane;, F:acetylglucosaminyltransferase activity; F:metal ion binding; F:O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity;, P:blastocyst formation; P:marginal zone B cell differentiation; P:pattern specification process; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:regulation of Notch signaling pathway; scaffold35 indexed_genome mRNA 21335387 21367256 . - . ID=transcript_7365;Q9UIA0 Q5R3F9 Q9UGT6,Cytohesin-4,PH, SEC7 and coiled-coil domain-containing protein 4;, PF00169;PF01369;, GO:0034451;GO:0005829;GO:0000139;GO:0045171;GO:0005886;GO:0005085;GO:0008289;GO:0032012;, C:centriolar satellite; C:cytosol; C:Golgi membrane; C:intercellular bridge; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:regulation of ARF protein signal transduction; scaffold35 indexed_genome mRNA 21397359 21415319 . + . ID=transcript_7366;P15153 Q9UDJ4,Ras-related C3 botulinum toxin substrate 2,GX;Small G protein;p21-Rac2;, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0043231;GO:0030027;GO:0005635;GO:0030670;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0019887;GO:0007015;GO:0045453;GO:0030031;GO:0045454;GO:0030865;GO:0043652;GO:0007163;GO:0007186;GO:0071593;GO:0008045;GO:0008284;GO:0010592;GO:0090023;GO:0051897;GO:1903955;GO:0016601;GO:0032956;GO:0008360;GO:0010810;GO:0010310;GO:0060753;GO:0043304;GO:1902622;GO:0060263;GO:0051056;GO:0042129;GO:0007165;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:intracellular membrane-bounded organelle; C:lamellipodium; C:nuclear envelope; C:phagocytic vesicle membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding; F:protein kinase regulator activity;, P:actin filament organization; P:bone resorption; P:cell projection assembly; P:cell redox homeostasis; P:cortical cytoskeleton organization; P:engulfment of apoptotic cell; P:establishment or maintenance of cell polarity; P:G protein-coupled receptor signaling pathway; P:lymphocyte aggregation; P:motor neuron axon guidance; P:positive regulation of cell population proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein kinase B signaling; P:positive regulation of protein targeting to mitochondrion; P:Rac protein signal transduction; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of cell-substrate adhesion; P:regulation of hydrogen peroxide metabolic process; P:regulation of mast cell chemotaxis; P:regulation of mast cell degranulation; P:regulation of neutrophil migration; P:regulation of respiratory burst; P:regulation of small GTPase mediated signal transduction; P:regulation of T cell proliferation; P:signal transduction; scaffold35 indexed_genome mRNA 21427633 21436677 . + . ID=transcript_7367;P32745 A8K550 Q53ZR7,Somatostatin receptor type 3,SSR-28;, PF00001;, GO:0060170;GO:0005929;GO:0005737;GO:0005887;GO:0043005;GO:0097730;GO:0005886;GO:0004930;GO:0042923;GO:0042277;GO:0005102;GO:0004994;GO:0007267;GO:0071392;GO:0071385;GO:0021549;GO:0060271;GO:0030900;GO:0007186;GO:0007187;GO:0008628;GO:0008285;GO:0007218;GO:0042594;GO:0007283;, C:ciliary membrane; C:cilium; C:cytoplasm; C:integral component of plasma membrane; C:neuron projection; C:non-motile cilium; C:plasma membrane;, F:G protein-coupled receptor activity; F:neuropeptide binding; F:peptide binding; F:signaling receptor binding; F:somatostatin receptor activity;, P:cell-cell signaling; P:cellular response to estradiol stimulus; P:cellular response to glucocorticoid stimulus; P:cerebellum development; P:cilium assembly; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:hormone-mediated apoptotic signaling pathway; P:negative regulation of cell population proliferation; P:neuropeptide signaling pathway; P:response to starvation; P:spermatogenesis; scaffold35 indexed_genome mRNA 21448848 21451812 . + . ID=transcript_7368;Q9BXI9 Q5H9G8 Q6ZRM7,Complement C1q tumor necrosis factor-related protein 6,, PF00386;PF01391;, GO:0005581;GO:0005615;GO:0042802;, C:collagen trimer; C:extracellular space;, F:identical protein binding; scaffold35 indexed_genome mRNA 21492460 21495420 . + . ID=transcript_7369;P14784 B2R765,Interleukin-2 receptor subunit beta,High affinity IL-2 receptor subunit beta;Interleukin-15 receptor subunit beta {ECO:0000312|HGNC:HGNC:6009};p70-75;, PF18707;, GO:0009986;GO:0005829;GO:0005768;GO:0009897;GO:0005887;GO:0005893;GO:0016020;GO:0005886;GO:0042010;GO:0019976;GO:0004911;GO:0019221;GO:0035723;GO:0038110;GO:0000165;GO:0043066;GO:0050766;GO:0065003;GO:0007165;GO:0016032;, C:cell surface; C:cytosol; C:endosome; C:external side of plasma membrane; C:integral component of plasma membrane; C:interleukin-2 receptor complex; C:membrane; C:plasma membrane;, F:interleukin-15 receptor activity; F:interleukin-2 binding; F:interleukin-2 receptor activity;, P:cytokine-mediated signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:MAPK cascade; P:negative regulation of apoptotic process; P:positive regulation of phagocytosis; P:protein-containing complex assembly; P:signal transduction; P:viral process; scaffold35 indexed_genome mRNA 21516941 21555966 . + . ID=transcript_7370;Q8IU80 B0QYB4 B0QYB7 B0QYB8 Q5TI06 Q6ICC2 Q6UXD8 Q8IUE2 Q8IXV8,Transmembrane protease serine 6,Matriptase-2;, PF00057;PF01390;PF00089;, GO:0005615;GO:0016021;GO:0005886;GO:0004252;GO:0006879;GO:0030574;GO:0022617;GO:0055072;GO:0033619;GO:0030514;GO:0000122;GO:0045892;GO:0045944;GO:0097264;, C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:serine-type endopeptidase activity;, P:cellular iron ion homeostasis; P:collagen catabolic process; P:extracellular matrix disassembly; P:iron ion homeostasis; P:membrane protein proteolysis; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:self proteolysis;|Q8IU80 B0QYB4 B0QYB7 B0QYB8 Q5TI06 Q6ICC2 Q6UXD8 Q8IUE2 Q8IXV8,Transmembrane protease serine 6,Matriptase-2;, PF00057;PF01390;PF00089;, GO:0005615;GO:0016021;GO:0005886;GO:0004252;GO:0006879;GO:0030574;GO:0022617;GO:0055072;GO:0033619;GO:0030514;GO:0000122;GO:0045892;GO:0045944;GO:0097264;, C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:serine-type endopeptidase activity;, P:cellular iron ion homeostasis; P:collagen catabolic process; P:extracellular matrix disassembly; P:iron ion homeostasis; P:membrane protein proteolysis; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:self proteolysis;|Q8IU80 B0QYB4 B0QYB7 B0QYB8 Q5TI06 Q6ICC2 Q6UXD8 Q8IUE2 Q8IXV8,Transmembrane protease serine 6,Matriptase-2;, PF00057;PF01390;PF00089;, GO:0005615;GO:0016021;GO:0005886;GO:0004252;GO:0006879;GO:0030574;GO:0022617;GO:0055072;GO:0033619;GO:0030514;GO:0000122;GO:0045892;GO:0045944;GO:0097264;, C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:serine-type endopeptidase activity;, P:cellular iron ion homeostasis; P:collagen catabolic process; P:extracellular matrix disassembly; P:iron ion homeostasis; P:membrane protein proteolysis; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:self proteolysis; scaffold35 indexed_genome mRNA 21559044 21569805 . - . ID=transcript_7371;Q8N5Z5 B0QYA9 B0QYB0 O95517,BTB/POZ domain-containing protein KCTD17,, PF02214;, GO:0031463;GO:0005737;GO:0005783;GO:0097602;GO:0042802;GO:0030030;GO:0032469;GO:0045724;GO:0043161;GO:0051260;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:endoplasmic reticulum;, F:cullin family protein binding; F:identical protein binding;, P:cell projection organization; P:endoplasmic reticulum calcium ion homeostasis; P:positive regulation of cilium assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; scaffold35 indexed_genome mRNA 21584169 21589892 . + . ID=transcript_7372;P25325 A8MZ34 B3KP52 J3KPV7 O75750 Q6FHN9,3-mercaptopyruvate sulfurtransferase,, PF00581;, GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0043005;GO:0045202;GO:0016784;GO:0042802;GO:0004792;GO:0009440;GO:0070814;GO:0001822;GO:0001889;GO:0009636;GO:0021510;GO:0000098;GO:0019346;, C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:neuron projection; C:synapse;, F:3-mercaptopyruvate sulfurtransferase activity; F:identical protein binding; F:thiosulfate sulfurtransferase activity;, P:cyanate catabolic process; P:hydrogen sulfide biosynthetic process; P:kidney development; P:liver development; P:response to toxic substance; P:spinal cord development; P:sulfur amino acid catabolic process; P:transsulfuration;|P25325 A8MZ34 B3KP52 J3KPV7 O75750 Q6FHN9,3-mercaptopyruvate sulfurtransferase,, PF00581;, GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0043005;GO:0045202;GO:0016784;GO:0042802;GO:0004792;GO:0009440;GO:0070814;GO:0001822;GO:0001889;GO:0009636;GO:0021510;GO:0000098;GO:0019346;, C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:neuron projection; C:synapse;, F:3-mercaptopyruvate sulfurtransferase activity; F:identical protein binding; F:thiosulfate sulfurtransferase activity;, P:cyanate catabolic process; P:hydrogen sulfide biosynthetic process; P:kidney development; P:liver development; P:response to toxic substance; P:spinal cord development; P:sulfur amino acid catabolic process; P:transsulfuration;|P25325 A8MZ34 B3KP52 J3KPV7 O75750 Q6FHN9,3-mercaptopyruvate sulfurtransferase,, PF00581;, GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0043005;GO:0045202;GO:0016784;GO:0042802;GO:0004792;GO:0009440;GO:0070814;GO:0001822;GO:0001889;GO:0009636;GO:0021510;GO:0000098;GO:0019346;, C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:neuron projection; C:synapse;, F:3-mercaptopyruvate sulfurtransferase activity; F:identical protein binding; F:thiosulfate sulfurtransferase activity;, P:cyanate catabolic process; P:hydrogen sulfide biosynthetic process; P:kidney development; P:liver development; P:response to toxic substance; P:spinal cord development; P:sulfur amino acid catabolic process; P:transsulfuration; scaffold35 indexed_genome mRNA 21611272 21614456 . + . ID=transcript_7373;Q16762 B3KRM1 Q6IB06,Thiosulfate sulfurtransferase,Rhodanese;, PF00581;, GO:0005615;GO:0005759;GO:0005739;GO:0008097;GO:0004792;GO:0009440;GO:0030855;GO:0035928;GO:0051029;GO:0000098;GO:0019346;, C:extracellular space; C:mitochondrial matrix; C:mitochondrion;, F:5S rRNA binding; F:thiosulfate sulfurtransferase activity;, P:cyanate catabolic process; P:epithelial cell differentiation; P:rRNA import into mitochondrion; P:rRNA transport; P:sulfur amino acid catabolic process; P:transsulfuration; scaffold35 indexed_genome mRNA 21616088 21618418 . - . ID=transcript_7374;Q16762 B3KRM1 Q6IB06,Thiosulfate sulfurtransferase,Rhodanese;, PF00581;, GO:0005615;GO:0005759;GO:0005739;GO:0008097;GO:0004792;GO:0009440;GO:0030855;GO:0035928;GO:0051029;GO:0000098;GO:0019346;, C:extracellular space; C:mitochondrial matrix; C:mitochondrion;, F:5S rRNA binding; F:thiosulfate sulfurtransferase activity;, P:cyanate catabolic process; P:epithelial cell differentiation; P:rRNA import into mitochondrion; P:rRNA transport; P:sulfur amino acid catabolic process; P:transsulfuration; scaffold35 indexed_genome mRNA 21673626 21689256 . - . ID=transcript_7375;P32927 Q5JZI1 Q6ICE0,Cytokine receptor common subunit beta,CDw131;GM-CSF/IL-3/IL-5 receptor common beta subunit;, PF09294;, GO:0030526;GO:0005887;GO:0005886;GO:0004896;GO:0038023;GO:0044267;GO:0036016;GO:0019221;GO:0038156;GO:0038043;GO:0000165;GO:0007585;GO:0032496;GO:0007165;, C:granulocyte macrophage colony-stimulating factor receptor complex; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine receptor activity; F:signaling receptor activity;, P:cellular protein metabolic process; P:cellular response to interleukin-3; P:cytokine-mediated signaling pathway; P:interleukin-3-mediated signaling pathway; P:interleukin-5-mediated signaling pathway; P:MAPK cascade; P:respiratory gaseous exchange by respiratory system; P:response to lipopolysaccharide; P:signal transduction; scaffold35 indexed_genome mRNA 21756455 21774852 . - . ID=transcript_7376;Q15080 A8K4F9 O60808 Q86U56 Q9BU98 Q9NP45,Neutrophil cytosol factor 4,Neutrophil NADPH oxidase factor 4;SH3 and PX domain-containing protein 4;p40-phox;, PF00564;PF00787;PF00018;, GO:0005737;GO:0005829;GO:0010008;GO:0016020;GO:0043020;GO:0032010;GO:0060090;GO:0032266;GO:0016175;GO:0016176;GO:0002479;GO:0045454;GO:0034599;GO:0006909;GO:0045730;GO:0042554;GO:0006801;GO:0048010;, C:cytoplasm; C:cytosol; C:endosome membrane; C:membrane; C:NADPH oxidase complex; C:phagolysosome;, F:molecular adaptor activity; F:phosphatidylinositol-3-phosphate binding; F:superoxide-generating NAD(P)H oxidase activity; F:superoxide-generating NADPH oxidase activator activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell redox homeostasis; P:cellular response to oxidative stress; P:phagocytosis; P:respiratory burst; P:superoxide anion generation; P:superoxide metabolic process; P:vascular endothelial growth factor receptor signaling pathway;|Q15080 A8K4F9 O60808 Q86U56 Q9BU98 Q9NP45,Neutrophil cytosol factor 4,Neutrophil NADPH oxidase factor 4;SH3 and PX domain-containing protein 4;p40-phox;, PF00564;PF00787;PF00018;, GO:0005737;GO:0005829;GO:0010008;GO:0016020;GO:0043020;GO:0032010;GO:0060090;GO:0032266;GO:0016175;GO:0016176;GO:0002479;GO:0045454;GO:0034599;GO:0006909;GO:0045730;GO:0042554;GO:0006801;GO:0048010;, C:cytoplasm; C:cytosol; C:endosome membrane; C:membrane; C:NADPH oxidase complex; C:phagolysosome;, F:molecular adaptor activity; F:phosphatidylinositol-3-phosphate binding; F:superoxide-generating NAD(P)H oxidase activity; F:superoxide-generating NADPH oxidase activator activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell redox homeostasis; P:cellular response to oxidative stress; P:phagocytosis; P:respiratory burst; P:superoxide anion generation; P:superoxide metabolic process; P:vascular endothelial growth factor receptor signaling pathway; scaffold35 indexed_genome mRNA 21836426 21850407 . + . ID=transcript_7377;P20472 B2R4H7 P78378 Q4VB78 Q5R3Q9,Parvalbumin alpha,, PF13499;, GO:0030424;GO:0032437;GO:0005737;GO:0043025;GO:0005634;GO:0032991;GO:0032420;GO:0005509;GO:0042802;GO:0044877;GO:0090102;, C:axon; C:cuticular plate; C:cytoplasm; C:neuronal cell body; C:nucleus; C:protein-containing complex; C:stereocilium;, F:calcium ion binding; F:identical protein binding; F:protein-containing complex binding;, P:cochlea development; scaffold35 indexed_genome mRNA 21880329 21880830 . - . ID=transcript_7378;Q9BW83 O60897,Intraflagellar transport protein 27 homolog,Putative GTP-binding protein RAY-like;Rab-like protein 4;, PF00071;, GO:0005813;GO:0097542;GO:0005929;GO:0005737;GO:0005794;GO:0000139;GO:0030992;GO:0031514;GO:0036126;GO:0097225;GO:0097228;GO:0005525;GO:0003924;GO:0090102;GO:0060122;GO:0006886;GO:0042073;GO:0035735;GO:0001822;GO:0007224;GO:0007283;, C:centrosome; C:ciliary tip; C:cilium; C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:intraciliary transport particle B; C:motile cilium; C:sperm flagellum; C:sperm midpiece; C:sperm principal piece;, F:GTP binding; F:GTPase activity;, P:cochlea development; P:inner ear receptor cell stereocilium organization; P:intracellular protein transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:smoothened signaling pathway; P:spermatogenesis; scaffold35 indexed_genome mRNA 21886751 21888393 . - . ID=transcript_7379;Q9BW83 O60897,Intraflagellar transport protein 27 homolog,Putative GTP-binding protein RAY-like;Rab-like protein 4;, PF00071;, GO:0005813;GO:0097542;GO:0005929;GO:0005737;GO:0005794;GO:0000139;GO:0030992;GO:0031514;GO:0036126;GO:0097225;GO:0097228;GO:0005525;GO:0003924;GO:0090102;GO:0060122;GO:0006886;GO:0042073;GO:0035735;GO:0001822;GO:0007224;GO:0007283;, C:centrosome; C:ciliary tip; C:cilium; C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:intraciliary transport particle B; C:motile cilium; C:sperm flagellum; C:sperm midpiece; C:sperm principal piece;, F:GTP binding; F:GTPase activity;, P:cochlea development; P:inner ear receptor cell stereocilium organization; P:intracellular protein transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:smoothened signaling pathway; P:spermatogenesis; scaffold35 indexed_genome mRNA 21932875 22031498 . + . ID=transcript_7380;Q9Y698 Q2M1M1 Q5TGT3 Q9UGZ7,Voltage-dependent calcium channel gamma-2 subunit,Neuronal voltage-gated calcium channel gamma-2 subunit;Transmembrane AMPAR regulatory protein gamma-2;, PF00822;, GO:0032281;GO:0009986;GO:0044300;GO:0005829;GO:0030666;GO:0098978;GO:0098686;GO:0099061;GO:0005886;GO:0098839;GO:0098685;GO:0036477;GO:0005891;GO:0016247;GO:0035255;GO:0005245;GO:0060082;GO:0051899;GO:0060081;GO:0007528;GO:0099590;GO:0098943;GO:2000969;GO:1904510;GO:0051968;GO:0098970;GO:0006612;GO:2000311;GO:0051592;GO:0019226;, C:AMPA glutamate receptor complex; C:cell surface; C:cerebellar mossy fiber; C:cytosol; C:endocytic vesicle membrane; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of postsynaptic density membrane; C:plasma membrane; C:postsynaptic density membrane; C:Schaffer collateral - CA1 synapse; C:somatodendritic compartment; C:voltage-gated calcium channel complex;, F:channel regulator activity; F:ionotropic glutamate receptor binding; F:voltage-gated calcium channel activity;, P:eye blink reflex; P:membrane depolarization; P:membrane hyperpolarization; P:neuromuscular junction development; P:neurotransmitter receptor internalization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of AMPA receptor activity; P:positive regulation of protein localization to basolateral plasma membrane; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic neurotransmitter receptor diffusion trapping; P:protein targeting to membrane; P:regulation of AMPA receptor activity; P:response to calcium ion; P:transmission of nerve impulse; scaffold35 indexed_genome mRNA 22047484 22049598 . + . ID=transcript_7381;Q9Y698 Q2M1M1 Q5TGT3 Q9UGZ7,Voltage-dependent calcium channel gamma-2 subunit,Neuronal voltage-gated calcium channel gamma-2 subunit;Transmembrane AMPAR regulatory protein gamma-2;, PF00822;, GO:0032281;GO:0009986;GO:0044300;GO:0005829;GO:0030666;GO:0098978;GO:0098686;GO:0099061;GO:0005886;GO:0098839;GO:0098685;GO:0036477;GO:0005891;GO:0016247;GO:0035255;GO:0005245;GO:0060082;GO:0051899;GO:0060081;GO:0007528;GO:0099590;GO:0098943;GO:2000969;GO:1904510;GO:0051968;GO:0098970;GO:0006612;GO:2000311;GO:0051592;GO:0019226;, C:AMPA glutamate receptor complex; C:cell surface; C:cerebellar mossy fiber; C:cytosol; C:endocytic vesicle membrane; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of postsynaptic density membrane; C:plasma membrane; C:postsynaptic density membrane; C:Schaffer collateral - CA1 synapse; C:somatodendritic compartment; C:voltage-gated calcium channel complex;, F:channel regulator activity; F:ionotropic glutamate receptor binding; F:voltage-gated calcium channel activity;, P:eye blink reflex; P:membrane depolarization; P:membrane hyperpolarization; P:neuromuscular junction development; P:neurotransmitter receptor internalization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of AMPA receptor activity; P:positive regulation of protein localization to basolateral plasma membrane; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic neurotransmitter receptor diffusion trapping; P:protein targeting to membrane; P:regulation of AMPA receptor activity; P:response to calcium ion; P:transmission of nerve impulse;|Q9Y698 Q2M1M1 Q5TGT3 Q9UGZ7,Voltage-dependent calcium channel gamma-2 subunit,Neuronal voltage-gated calcium channel gamma-2 subunit;Transmembrane AMPAR regulatory protein gamma-2;, PF00822;, GO:0032281;GO:0009986;GO:0044300;GO:0005829;GO:0030666;GO:0098978;GO:0098686;GO:0099061;GO:0005886;GO:0098839;GO:0098685;GO:0036477;GO:0005891;GO:0016247;GO:0035255;GO:0005245;GO:0060082;GO:0051899;GO:0060081;GO:0007528;GO:0099590;GO:0098943;GO:2000969;GO:1904510;GO:0051968;GO:0098970;GO:0006612;GO:2000311;GO:0051592;GO:0019226;, C:AMPA glutamate receptor complex; C:cell surface; C:cerebellar mossy fiber; C:cytosol; C:endocytic vesicle membrane; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of postsynaptic density membrane; C:plasma membrane; C:postsynaptic density membrane; C:Schaffer collateral - CA1 synapse; C:somatodendritic compartment; C:voltage-gated calcium channel complex;, F:channel regulator activity; F:ionotropic glutamate receptor binding; F:voltage-gated calcium channel activity;, P:eye blink reflex; P:membrane depolarization; P:membrane hyperpolarization; P:neuromuscular junction development; P:neurotransmitter receptor internalization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of AMPA receptor activity; P:positive regulation of protein localization to basolateral plasma membrane; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic neurotransmitter receptor diffusion trapping; P:protein targeting to membrane; P:regulation of AMPA receptor activity; P:response to calcium ion; P:transmission of nerve impulse; scaffold35 indexed_genome mRNA 22081939 22082527 . - . ID=transcript_7382;O15371 A8MWD3 B2R7D4 B4DTF8 B4DVY1 Q3MJD9 Q5M9Q6,Eukaryotic translation initiation factor 3 subunit D {ECO:0000255|HAMAP-Rule:MF_03003},Eukaryotic translation initiation factor 3 subunit 7 {ECO:0000255|HAMAP-Rule:MF_03003};eIF-3-zeta {ECO:0000255|HAMAP-Rule:MF_03003};eIF3 p66;, PF05091;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0016020;GO:0098808;GO:0003723;GO:0003743;GO:0002191;GO:0001732;GO:0075522;GO:1902416;GO:0045727;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane;, F:mRNA cap binding; F:RNA binding; F:translation initiation factor activity;, P:cap-dependent translational initiation; P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:positive regulation of mRNA binding; P:positive regulation of translation; P:translational initiation; P:viral translational termination-reinitiation; scaffold35 indexed_genome mRNA 22083259 22092273 . + . ID=transcript_7383;O15371 A8MWD3 B2R7D4 B4DTF8 B4DVY1 Q3MJD9 Q5M9Q6,Eukaryotic translation initiation factor 3 subunit D {ECO:0000255|HAMAP-Rule:MF_03003},Eukaryotic translation initiation factor 3 subunit 7 {ECO:0000255|HAMAP-Rule:MF_03003};eIF-3-zeta {ECO:0000255|HAMAP-Rule:MF_03003};eIF3 p66;, PF05091;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0016020;GO:0098808;GO:0003723;GO:0003743;GO:0002191;GO:0001732;GO:0075522;GO:1902416;GO:0045727;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane;, F:mRNA cap binding; F:RNA binding; F:translation initiation factor activity;, P:cap-dependent translational initiation; P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:positive regulation of mRNA binding; P:positive regulation of translation; P:translational initiation; P:viral translational termination-reinitiation;|O15371 A8MWD3 B2R7D4 B4DTF8 B4DVY1 Q3MJD9 Q5M9Q6,Eukaryotic translation initiation factor 3 subunit D {ECO:0000255|HAMAP-Rule:MF_03003},Eukaryotic translation initiation factor 3 subunit 7 {ECO:0000255|HAMAP-Rule:MF_03003};eIF-3-zeta {ECO:0000255|HAMAP-Rule:MF_03003};eIF3 p66;, PF05091;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0016020;GO:0098808;GO:0003723;GO:0003743;GO:0002191;GO:0001732;GO:0075522;GO:1902416;GO:0045727;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane;, F:mRNA cap binding; F:RNA binding; F:translation initiation factor activity;, P:cap-dependent translational initiation; P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:positive regulation of mRNA binding; P:positive regulation of translation; P:translational initiation; P:viral translational termination-reinitiation;|O15371 A8MWD3 B2R7D4 B4DTF8 B4DVY1 Q3MJD9 Q5M9Q6,Eukaryotic translation initiation factor 3 subunit D {ECO:0000255|HAMAP-Rule:MF_03003},Eukaryotic translation initiation factor 3 subunit 7 {ECO:0000255|HAMAP-Rule:MF_03003};eIF-3-zeta {ECO:0000255|HAMAP-Rule:MF_03003};eIF3 p66;, PF05091;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0016020;GO:0098808;GO:0003723;GO:0003743;GO:0002191;GO:0001732;GO:0075522;GO:1902416;GO:0045727;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane;, F:mRNA cap binding; F:RNA binding; F:translation initiation factor activity;, P:cap-dependent translational initiation; P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:positive regulation of mRNA binding; P:positive regulation of translation; P:translational initiation; P:viral translational termination-reinitiation; scaffold35 indexed_genome mRNA 22103192 22109630 . + . ID=transcript_7384;Q8IWF2 B2RDI4 Q8N378 Q96BD1 Q9H5L5 Q9H6M8,FAD-dependent oxidoreductase domain-containing protein 2,Endoplasmic reticulum flavoprotein associated with degradation;, , GO:0005788;GO:0050660;GO:0016491;GO:0030433;, C:endoplasmic reticulum lumen;, F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:ubiquitin-dependent ERAD pathway;|Q8IWF2 B2RDI4 Q8N378 Q96BD1 Q9H5L5 Q9H6M8,FAD-dependent oxidoreductase domain-containing protein 2,Endoplasmic reticulum flavoprotein associated with degradation;, , GO:0005788;GO:0050660;GO:0016491;GO:0030433;, C:endoplasmic reticulum lumen;, F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:ubiquitin-dependent ERAD pathway; scaffold35 indexed_genome mRNA 22115303 22118869 . + . ID=transcript_7385;Q8IWF2 B2RDI4 Q8N378 Q96BD1 Q9H5L5 Q9H6M8,FAD-dependent oxidoreductase domain-containing protein 2,Endoplasmic reticulum flavoprotein associated with degradation;, , GO:0005788;GO:0050660;GO:0016491;GO:0030433;, C:endoplasmic reticulum lumen;, F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:ubiquitin-dependent ERAD pathway; scaffold35 indexed_genome mRNA 22128170 22138475 . + . ID=transcript_7386;Q99757 Q5JZA0 Q6FH60 Q9UH29,Thioredoxin, mitochondrial,Thioredoxin-2;, PF00085;, GO:0030425;GO:0005759;GO:0005739;GO:0043025;GO:0005730;GO:0033743;GO:0008113;GO:0015035;GO:0044877;GO:0045454;GO:0031669;GO:0006662;GO:0048678;GO:0042493;GO:0009749;GO:0009725;GO:0001666;GO:0014070;GO:0006979;GO:0000098;, C:dendrite; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleolus;, F:peptide-methionine (R)-S-oxide reductase activity; F:peptide-methionine (S)-S-oxide reductase activity; F:protein disulfide oxidoreductase activity; F:protein-containing complex binding;, P:cell redox homeostasis; P:cellular response to nutrient levels; P:glycerol ether metabolic process; P:response to axon injury; P:response to drug; P:response to glucose; P:response to hormone; P:response to hypoxia; P:response to organic cyclic compound; P:response to oxidative stress; P:sulfur amino acid catabolic process;|Q99757 Q5JZA0 Q6FH60 Q9UH29,Thioredoxin, mitochondrial,Thioredoxin-2;, PF00085;, GO:0030425;GO:0005759;GO:0005739;GO:0043025;GO:0005730;GO:0033743;GO:0008113;GO:0015035;GO:0044877;GO:0045454;GO:0031669;GO:0006662;GO:0048678;GO:0042493;GO:0009749;GO:0009725;GO:0001666;GO:0014070;GO:0006979;GO:0000098;, C:dendrite; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleolus;, F:peptide-methionine (R)-S-oxide reductase activity; F:peptide-methionine (S)-S-oxide reductase activity; F:protein disulfide oxidoreductase activity; F:protein-containing complex binding;, P:cell redox homeostasis; P:cellular response to nutrient levels; P:glycerol ether metabolic process; P:response to axon injury; P:response to drug; P:response to glucose; P:response to hormone; P:response to hypoxia; P:response to organic cyclic compound; P:response to oxidative stress; P:sulfur amino acid catabolic process;|Q99757 Q5JZA0 Q6FH60 Q9UH29,Thioredoxin, mitochondrial,Thioredoxin-2;, PF00085;, GO:0030425;GO:0005759;GO:0005739;GO:0043025;GO:0005730;GO:0033743;GO:0008113;GO:0015035;GO:0044877;GO:0045454;GO:0031669;GO:0006662;GO:0048678;GO:0042493;GO:0009749;GO:0009725;GO:0001666;GO:0014070;GO:0006979;GO:0000098;, C:dendrite; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleolus;, F:peptide-methionine (R)-S-oxide reductase activity; F:peptide-methionine (S)-S-oxide reductase activity; F:protein disulfide oxidoreductase activity; F:protein-containing complex binding;, P:cell redox homeostasis; P:cellular response to nutrient levels; P:glycerol ether metabolic process; P:response to axon injury; P:response to drug; P:response to glucose; P:response to hormone; P:response to hypoxia; P:response to organic cyclic compound; P:response to oxidative stress; P:sulfur amino acid catabolic process; scaffold35 indexed_genome mRNA 22150751 22155101 . - . ID=transcript_7387;Q969W0 B2RD54 D3DS93 Q8WTZ7,Serine palmitoyltransferase small subunit A {ECO:0000305},Small subunit of serine palmitoyltransferase A;, PF11779;, GO:0005783;GO:0005789;GO:0016021;GO:0017059;GO:0004758;GO:0046513;GO:0008104;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:serine C-palmitoyltransferase complex;, F:serine C-palmitoyltransferase activity;, P:ceramide biosynthetic process; P:protein localization; P:sphingolipid biosynthetic process; scaffold35 indexed_genome mRNA 22214704 22299749 . + . ID=transcript_7388;P35579 A8K6E4 O60805 Q60FE2 Q86T83,Myosin-9,Cellular myosin heavy chain, type A;Myosin heavy chain 9;Myosin heavy chain, non-muscle IIa;Non-muscle myosin heavy chain A;Non-muscle myosin heavy chain IIa;, PF00063;PF02736;PF01576;, GO:0015629;GO:0042641;GO:0005826;GO:0005912;GO:0005903;GO:0031252;GO:0032154;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0005925;GO:0001772;GO:0016020;GO:0016460;GO:0097513;GO:0031594;GO:0005634;GO:0005886;GO:0032991;GO:0001726;GO:0005819;GO:0001725;GO:0001931;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0045296;GO:0005516;GO:0042802;GO:0005178;GO:0000146;GO:0003774;GO:0019904;GO:0042803;GO:0043495;GO:0003723;GO:0031532;GO:0030048;GO:0031032;GO:0001525;GO:0043534;GO:0032506;GO:0051295;GO:0001768;GO:0001701;GO:0007229;GO:0050900;GO:0032418;GO:0000212;GO:0006509;GO:0030224;GO:0007520;GO:1903919;GO:0002862;GO:0006911;GO:0001778;GO:0070527;GO:0030220;GO:1903923;GO:0015031;GO:0045055;GO:0008360;GO:1905684;GO:0032796;, C:actin cytoskeleton; C:actomyosin; C:actomyosin contractile ring; C:adherens junction; C:brush border; C:cell leading edge; C:cleavage furrow; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:membrane; C:myosin II complex; C:myosin II filament; C:neuromuscular junction; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle; C:spindle; C:stress fiber; C:uropod;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:cadherin binding; F:calmodulin binding; F:identical protein binding; F:integrin binding; F:microfilament motor activity; F:motor activity; F:protein domain specific binding; F:protein homodimerization activity; F:protein-membrane adaptor activity; F:RNA binding;, P:actin cytoskeleton reorganization; P:actin filament-based movement; P:actomyosin structure organization; P:angiogenesis; P:blood vessel endothelial cell migration; P:cytokinetic process; P:establishment of meiotic spindle localization; P:establishment of T cell polarity; P:in utero embryonic development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lysosome localization; P:meiotic spindle organization; P:membrane protein ectodomain proteolysis; P:monocyte differentiation; P:myoblast fusion; P:negative regulation of actin filament severing; P:negative regulation of inflammatory response to antigenic stimulus; P:phagocytosis, engulfment; P:plasma membrane repair; P:platelet aggregation; P:platelet formation; P:positive regulation of protein processing in phagocytic vesicle; P:protein transport; P:regulated exocytosis; P:regulation of cell shape; P:regulation of plasma membrane repair; P:uropod organization;|P35579 A8K6E4 O60805 Q60FE2 Q86T83,Myosin-9,Cellular myosin heavy chain, type A;Myosin heavy chain 9;Myosin heavy chain, non-muscle IIa;Non-muscle myosin heavy chain A;Non-muscle myosin heavy chain IIa;, PF00063;PF02736;PF01576;, GO:0015629;GO:0042641;GO:0005826;GO:0005912;GO:0005903;GO:0031252;GO:0032154;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0005925;GO:0001772;GO:0016020;GO:0016460;GO:0097513;GO:0031594;GO:0005634;GO:0005886;GO:0032991;GO:0001726;GO:0005819;GO:0001725;GO:0001931;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0045296;GO:0005516;GO:0042802;GO:0005178;GO:0000146;GO:0003774;GO:0019904;GO:0042803;GO:0043495;GO:0003723;GO:0031532;GO:0030048;GO:0031032;GO:0001525;GO:0043534;GO:0032506;GO:0051295;GO:0001768;GO:0001701;GO:0007229;GO:0050900;GO:0032418;GO:0000212;GO:0006509;GO:0030224;GO:0007520;GO:1903919;GO:0002862;GO:0006911;GO:0001778;GO:0070527;GO:0030220;GO:1903923;GO:0015031;GO:0045055;GO:0008360;GO:1905684;GO:0032796;, C:actin cytoskeleton; C:actomyosin; C:actomyosin contractile ring; C:adherens junction; C:brush border; C:cell leading edge; C:cleavage furrow; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:membrane; C:myosin II complex; C:myosin II filament; C:neuromuscular junction; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle; C:spindle; C:stress fiber; C:uropod;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:cadherin binding; F:calmodulin binding; F:identical protein binding; F:integrin binding; F:microfilament motor activity; F:motor activity; F:protein domain specific binding; F:protein homodimerization activity; F:protein-membrane adaptor activity; F:RNA binding;, P:actin cytoskeleton reorganization; P:actin filament-based movement; P:actomyosin structure organization; P:angiogenesis; P:blood vessel endothelial cell migration; P:cytokinetic process; P:establishment of meiotic spindle localization; P:establishment of T cell polarity; P:in utero embryonic development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lysosome localization; P:meiotic spindle organization; P:membrane protein ectodomain proteolysis; P:monocyte differentiation; P:myoblast fusion; P:negative regulation of actin filament severing; P:negative regulation of inflammatory response to antigenic stimulus; P:phagocytosis, engulfment; P:plasma membrane repair; P:platelet aggregation; P:platelet formation; P:positive regulation of protein processing in phagocytic vesicle; P:protein transport; P:regulated exocytosis; P:regulation of cell shape; P:regulation of plasma membrane repair; P:uropod organization;|P35579 A8K6E4 O60805 Q60FE2 Q86T83,Myosin-9,Cellular myosin heavy chain, type A;Myosin heavy chain 9;Myosin heavy chain, non-muscle IIa;Non-muscle myosin heavy chain A;Non-muscle myosin heavy chain IIa;, PF00063;PF02736;PF01576;, GO:0015629;GO:0042641;GO:0005826;GO:0005912;GO:0005903;GO:0031252;GO:0032154;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0005925;GO:0001772;GO:0016020;GO:0016460;GO:0097513;GO:0031594;GO:0005634;GO:0005886;GO:0032991;GO:0001726;GO:0005819;GO:0001725;GO:0001931;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0045296;GO:0005516;GO:0042802;GO:0005178;GO:0000146;GO:0003774;GO:0019904;GO:0042803;GO:0043495;GO:0003723;GO:0031532;GO:0030048;GO:0031032;GO:0001525;GO:0043534;GO:0032506;GO:0051295;GO:0001768;GO:0001701;GO:0007229;GO:0050900;GO:0032418;GO:0000212;GO:0006509;GO:0030224;GO:0007520;GO:1903919;GO:0002862;GO:0006911;GO:0001778;GO:0070527;GO:0030220;GO:1903923;GO:0015031;GO:0045055;GO:0008360;GO:1905684;GO:0032796;, C:actin cytoskeleton; C:actomyosin; C:actomyosin contractile ring; C:adherens junction; C:brush border; C:cell leading edge; C:cleavage furrow; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:membrane; C:myosin II complex; C:myosin II filament; C:neuromuscular junction; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle; C:spindle; C:stress fiber; C:uropod;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:cadherin binding; F:calmodulin binding; F:identical protein binding; F:integrin binding; F:microfilament motor activity; F:motor activity; F:protein domain specific binding; F:protein homodimerization activity; F:protein-membrane adaptor activity; F:RNA binding;, P:actin cytoskeleton reorganization; P:actin filament-based movement; P:actomyosin structure organization; P:angiogenesis; P:blood vessel endothelial cell migration; P:cytokinetic process; P:establishment of meiotic spindle localization; P:establishment of T cell polarity; P:in utero embryonic development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lysosome localization; P:meiotic spindle organization; P:membrane protein ectodomain proteolysis; P:monocyte differentiation; P:myoblast fusion; P:negative regulation of actin filament severing; P:negative regulation of inflammatory response to antigenic stimulus; P:phagocytosis, engulfment; P:plasma membrane repair; P:platelet aggregation; P:platelet formation; P:positive regulation of protein processing in phagocytic vesicle; P:protein transport; P:regulated exocytosis; P:regulation of cell shape; P:regulation of plasma membrane repair; P:uropod organization;|P35579 A8K6E4 O60805 Q60FE2 Q86T83,Myosin-9,Cellular myosin heavy chain, type A;Myosin heavy chain 9;Myosin heavy chain, non-muscle IIa;Non-muscle myosin heavy chain A;Non-muscle myosin heavy chain IIa;, PF00063;PF02736;PF01576;, GO:0015629;GO:0042641;GO:0005826;GO:0005912;GO:0005903;GO:0031252;GO:0032154;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0005925;GO:0001772;GO:0016020;GO:0016460;GO:0097513;GO:0031594;GO:0005634;GO:0005886;GO:0032991;GO:0001726;GO:0005819;GO:0001725;GO:0001931;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0045296;GO:0005516;GO:0042802;GO:0005178;GO:0000146;GO:0003774;GO:0019904;GO:0042803;GO:0043495;GO:0003723;GO:0031532;GO:0030048;GO:0031032;GO:0001525;GO:0043534;GO:0032506;GO:0051295;GO:0001768;GO:0001701;GO:0007229;GO:0050900;GO:0032418;GO:0000212;GO:0006509;GO:0030224;GO:0007520;GO:1903919;GO:0002862;GO:0006911;GO:0001778;GO:0070527;GO:0030220;GO:1903923;GO:0015031;GO:0045055;GO:0008360;GO:1905684;GO:0032796;, C:actin cytoskeleton; C:actomyosin; C:actomyosin contractile ring; C:adherens junction; C:brush border; C:cell leading edge; C:cleavage furrow; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:membrane; C:myosin II complex; C:myosin II filament; C:neuromuscular junction; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle; C:spindle; C:stress fiber; C:uropod;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:cadherin binding; F:calmodulin binding; F:identical protein binding; F:integrin binding; F:microfilament motor activity; F:motor activity; F:protein domain specific binding; F:protein homodimerization activity; F:protein-membrane adaptor activity; F:RNA binding;, P:actin cytoskeleton reorganization; P:actin filament-based movement; P:actomyosin structure organization; P:angiogenesis; P:blood vessel endothelial cell migration; P:cytokinetic process; P:establishment of meiotic spindle localization; P:establishment of T cell polarity; P:in utero embryonic development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lysosome localization; P:meiotic spindle organization; P:membrane protein ectodomain proteolysis; P:monocyte differentiation; P:myoblast fusion; P:negative regulation of actin filament severing; P:negative regulation of inflammatory response to antigenic stimulus; P:phagocytosis, engulfment; P:plasma membrane repair; P:platelet aggregation; P:platelet formation; P:positive regulation of protein processing in phagocytic vesicle; P:protein transport; P:regulated exocytosis; P:regulation of cell shape; P:regulation of plasma membrane repair; P:uropod organization; scaffold36 indexed_genome mRNA 192090 221070 . - . ID=transcript_7389;Q9H999 D3DQL1 Q53FJ9 Q7RTX4,Pantothenate kinase 3,Pantothenic acid kinase 3;, PF03630;, GO:0005829;GO:0005634;GO:1905502;GO:0005524;GO:0004594;GO:0042803;GO:0019842;GO:0015937;GO:0016310;, C:cytosol; C:nucleus;, F:acetyl-CoA binding; F:ATP binding; F:pantothenate kinase activity; F:protein homodimerization activity; F:vitamin binding;, P:coenzyme A biosynthetic process; P:phosphorylation;|Q9H999 D3DQL1 Q53FJ9 Q7RTX4,Pantothenate kinase 3,Pantothenic acid kinase 3;, PF03630;, GO:0005829;GO:0005634;GO:1905502;GO:0005524;GO:0004594;GO:0042803;GO:0019842;GO:0015937;GO:0016310;, C:cytosol; C:nucleus;, F:acetyl-CoA binding; F:ATP binding; F:pantothenate kinase activity; F:protein homodimerization activity; F:vitamin binding;, P:coenzyme A biosynthetic process; P:phosphorylation;|Q9H999 D3DQL1 Q53FJ9 Q7RTX4,Pantothenate kinase 3,Pantothenic acid kinase 3;, PF03630;, GO:0005829;GO:0005634;GO:1905502;GO:0005524;GO:0004594;GO:0042803;GO:0019842;GO:0015937;GO:0016310;, C:cytosol; C:nucleus;, F:acetyl-CoA binding; F:ATP binding; F:pantothenate kinase activity; F:protein homodimerization activity; F:vitamin binding;, P:coenzyme A biosynthetic process; P:phosphorylation; scaffold36 indexed_genome mRNA 344738 1066653 . - . ID=transcript_7390;O75094 A6H8U9 J3KNP3 O95804 Q9UFH5,Slit homolog 3 protein,Multiple epidermal growth factor-like domains protein 5;, PF00008;PF12661;PF02210;PF13855;PF01463;PF01462;, GO:0005615;GO:0005739;GO:0005509;GO:0008201;GO:0048495;GO:0003180;GO:0061364;GO:0003181;GO:0048846;GO:0007411;GO:0032870;GO:0050919;GO:0030308;GO:0008285;GO:0070100;GO:0010629;GO:0051414;GO:0035385;GO:0060412;, C:extracellular space; C:mitochondrion;, F:calcium ion binding; F:heparin binding; F:Roundabout binding;, P:aortic valve morphogenesis; P:apoptotic process involved in luteolysis; P:atrioventricular valve morphogenesis; P:axon extension involved in axon guidance; P:axon guidance; P:cellular response to hormone stimulus; P:negative chemotaxis; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of gene expression; P:response to cortisol; P:Roundabout signaling pathway; P:ventricular septum morphogenesis; scaffold36 indexed_genome mRNA 1385756 1416671 . + . ID=transcript_7391;Q96EA4 B4E393 C9JS47 Q8TEC8 Q9HD44 Q9NX97,Protein Spindly {ECO:0000255|HAMAP-Rule:MF_03041},Arsenite-related gene 1 protein;Coiled-coil domain-containing protein 99 {ECO:0000255|HAMAP-Rule:MF_03041};Rhabdomyosarcoma antigen MU-RMS-40.4A;Spindle apparatus coiled-coil domain-containing protein 1 {ECO:0000255|HAMAP-Rule:MF_03041};, , GO:0000940;GO:0005829;GO:0005815;GO:0005634;GO:0000922;GO:0019899;GO:0043515;GO:0051301;GO:0016477;GO:0000132;GO:0007080;GO:0007094;GO:0007052;GO:0034501;, C:condensed chromosome outer kinetochore; C:cytosol; C:microtubule organizing center; C:nucleus; C:spindle pole;, F:enzyme binding; F:kinetochore binding;, P:cell division; P:cell migration; P:establishment of mitotic spindle orientation; P:mitotic metaphase plate congression; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to kinetochore;|Q96EA4 B4E393 C9JS47 Q8TEC8 Q9HD44 Q9NX97,Protein Spindly {ECO:0000255|HAMAP-Rule:MF_03041},Arsenite-related gene 1 protein;Coiled-coil domain-containing protein 99 {ECO:0000255|HAMAP-Rule:MF_03041};Rhabdomyosarcoma antigen MU-RMS-40.4A;Spindle apparatus coiled-coil domain-containing protein 1 {ECO:0000255|HAMAP-Rule:MF_03041};, , GO:0000940;GO:0005829;GO:0005815;GO:0005634;GO:0000922;GO:0019899;GO:0043515;GO:0051301;GO:0016477;GO:0000132;GO:0007080;GO:0007094;GO:0007052;GO:0034501;, C:condensed chromosome outer kinetochore; C:cytosol; C:microtubule organizing center; C:nucleus; C:spindle pole;, F:enzyme binding; F:kinetochore binding;, P:cell division; P:cell migration; P:establishment of mitotic spindle orientation; P:mitotic metaphase plate congression; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to kinetochore; scaffold36 indexed_genome mRNA 1671778 1701875 . - . ID=transcript_7392;A6NMK8,Protein INSYN2B {ECO:0000305},Inhibitory synaptic factor family member 2B {ECO:0000312|HGNC:HGNC:37271};, PF15265; scaffold36 indexed_genome mRNA 1891875 1896400 . + . ID=transcript_7393;Q92608 Q2M3I0 Q96AK7,Dedicator of cytokinesis protein 2,, PF06920;PF14429;PF16172;PF07653;, GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0035580;GO:0005096;GO:0005085;GO:0042608;GO:0030036;GO:0046633;GO:0006935;GO:0001768;GO:0001771;GO:0044351;GO:0001766;GO:0002277;GO:0045060;GO:0043312;GO:0050766;GO:0045059;GO:0050690;GO:0007264;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:specific granule lumen;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:T cell receptor binding;, P:actin cytoskeleton organization; P:alpha-beta T cell proliferation; P:chemotaxis; P:establishment of T cell polarity; P:immunological synapse formation; P:macropinocytosis; P:membrane raft polarization; P:myeloid dendritic cell activation involved in immune response; P:negative thymic T cell selection; P:neutrophil degranulation; P:positive regulation of phagocytosis; P:positive thymic T cell selection; P:regulation of defense response to virus by virus; P:small GTPase mediated signal transduction;|Q92608 Q2M3I0 Q96AK7,Dedicator of cytokinesis protein 2,, PF06920;PF14429;PF16172;PF07653;, GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0035580;GO:0005096;GO:0005085;GO:0042608;GO:0030036;GO:0046633;GO:0006935;GO:0001768;GO:0001771;GO:0044351;GO:0001766;GO:0002277;GO:0045060;GO:0043312;GO:0050766;GO:0045059;GO:0050690;GO:0007264;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:specific granule lumen;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:T cell receptor binding;, P:actin cytoskeleton organization; P:alpha-beta T cell proliferation; P:chemotaxis; P:establishment of T cell polarity; P:immunological synapse formation; P:macropinocytosis; P:membrane raft polarization; P:myeloid dendritic cell activation involved in immune response; P:negative thymic T cell selection; P:neutrophil degranulation; P:positive regulation of phagocytosis; P:positive thymic T cell selection; P:regulation of defense response to virus by virus; P:small GTPase mediated signal transduction; scaffold36 indexed_genome mRNA 2028895 2051682 . - . ID=transcript_7394;Q13094 A8KA25 Q53XV4,Lymphocyte cytosolic protein 2,SH2 domain-containing leukocyte protein of 76 kDa;SLP-76 tyrosine phosphoprotein;, PF07647;PF00017;, GO:0005911;GO:0005829;GO:0044853;GO:0036398;GO:0038095;GO:0006955;GO:0035556;GO:0045576;GO:0030168;GO:0045860;GO:0050852;GO:0007169;, C:cell-cell junction; C:cytosol; C:plasma membrane raft; C:TCR signalosome;, , P:Fc-epsilon receptor signaling pathway; P:immune response; P:intracellular signal transduction; P:mast cell activation; P:platelet activation; P:positive regulation of protein kinase activity; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q13094 A8KA25 Q53XV4,Lymphocyte cytosolic protein 2,SH2 domain-containing leukocyte protein of 76 kDa;SLP-76 tyrosine phosphoprotein;, PF07647;PF00017;, GO:0005911;GO:0005829;GO:0044853;GO:0036398;GO:0038095;GO:0006955;GO:0035556;GO:0045576;GO:0030168;GO:0045860;GO:0050852;GO:0007169;, C:cell-cell junction; C:cytosol; C:plasma membrane raft; C:TCR signalosome;, , P:Fc-epsilon receptor signaling pathway; P:immune response; P:intracellular signal transduction; P:mast cell activation; P:platelet activation; P:positive regulation of protein kinase activity; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold36 indexed_genome mRNA 2052639 2078343 . - . ID=transcript_7395;Q13094 A8KA25 Q53XV4,Lymphocyte cytosolic protein 2,SH2 domain-containing leukocyte protein of 76 kDa;SLP-76 tyrosine phosphoprotein;, PF07647;PF00017;, GO:0005911;GO:0005829;GO:0044853;GO:0036398;GO:0038095;GO:0006955;GO:0035556;GO:0045576;GO:0030168;GO:0045860;GO:0050852;GO:0007169;, C:cell-cell junction; C:cytosol; C:plasma membrane raft; C:TCR signalosome;, , P:Fc-epsilon receptor signaling pathway; P:immune response; P:intracellular signal transduction; P:mast cell activation; P:platelet activation; P:positive regulation of protein kinase activity; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold36 indexed_genome mRNA 2160121 2170834 . - . ID=transcript_7396;Q16558 O00707 O00708 P78475 Q53YR0 Q8TAX3 Q93005,Calcium-activated potassium channel subunit beta-1,BK channel subunit beta-1;Calcium-activated potassium channel, subfamily M subunit beta-1;Charybdotoxin receptor subunit beta-1;K(VCA)beta-1;Maxi K channel subunit beta-1;Slo-beta-1;, PF03185;, GO:0005886;GO:0045202;GO:0008076;GO:0015269;GO:0015459;GO:0007568;GO:1903413;GO:0071361;GO:0071456;GO:0007268;GO:0005513;GO:1901381;GO:0006813;, C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:calcium-activated potassium channel activity; F:potassium channel regulator activity;, P:aging; P:cellular response to bile acid; P:cellular response to ethanol; P:cellular response to hypoxia; P:chemical synaptic transmission; P:detection of calcium ion; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transport; scaffold36 indexed_genome mRNA 2516773 2535931 . + . ID=transcript_7397;Q9NZI2 A0A0C4DFQ7 B7Z7B4 Q3YAD0 Q3YAD1 Q3YAD2 Q3YAD3 Q5U822,Kv channel-interacting protein 1,A-type potassium channel modulatory protein 1;Potassium channel-interacting protein 1;Vesicle APC-binding protein;, PF13499;PF13833;, GO:0005737;GO:0030425;GO:0031234;GO:0005886;GO:0008076;GO:0005509;GO:0005267;GO:0015459;GO:0005244;GO:0061337;GO:1901379;, C:cytoplasm; C:dendrite; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calcium ion binding; F:potassium channel activity; F:potassium channel regulator activity; F:voltage-gated ion channel activity;, P:cardiac conduction; P:regulation of potassium ion transmembrane transport; scaffold36 indexed_genome mRNA 2571985 2599365 . + . ID=transcript_7398;O00591 A8KA36 D3DQL2 Q32MJ1,Gamma-aminobutyric acid receptor subunit pi,GABA(A) receptor subunit pi;, PF02931;PF02932;, GO:0034707;GO:1902711;GO:0005887;GO:0043005;GO:0045211;GO:0045202;GO:0005254;GO:0005230;GO:0004890;GO:0030594;GO:0007268;GO:1902476;GO:0034220;GO:0050877;GO:0042391;GO:0007165;, C:chloride channel complex; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:postsynaptic membrane; C:synapse;, F:chloride channel activity; F:extracellular ligand-gated ion channel activity; F:GABA-A receptor activity; F:neurotransmitter receptor activity;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:signal transduction; scaffold36 indexed_genome mRNA 3252071 3381961 . - . ID=transcript_7399;Q9UKB1 B2RC98 Q9P2S8 Q9P2S9 Q9Y4C6,F-box/WD repeat-containing protein 11,F-box and WD repeats protein beta-TrCP2;F-box/WD repeat-containing protein 1B;Homologous to Slimb protein;, PF12125;PF12937;PF00400;, GO:1904115;GO:0005813;GO:0005881;GO:0005829;GO:0000776;GO:0005875;GO:0043005;GO:0043025;GO:0005635;GO:0005634;GO:0019005;GO:0000151;GO:0070840;GO:0051010;GO:0046983;GO:0004842;GO:0048854;GO:0000132;GO:0038095;GO:0000086;GO:0007281;GO:0070498;GO:0031023;GO:0045892;GO:0038061;GO:0007097;GO:0042753;GO:0045862;GO:0045893;GO:0043687;GO:0043161;GO:0006470;GO:0031648;GO:0000209;GO:0016567;GO:2000574;GO:0008090;GO:0048511;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0047496;GO:0016032;GO:0016055;, C:axon cytoplasm; C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:kinetochore; C:microtubule associated complex; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nucleus; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:dynein complex binding; F:microtubule plus-end binding; F:protein dimerization activity; F:ubiquitin-protein transferase activity;, P:brain morphogenesis; P:establishment of mitotic spindle orientation; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:germ cell development; P:interleukin-1-mediated signaling pathway; P:microtubule organizing center organization; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:nuclear migration; P:positive regulation of circadian rhythm; P:positive regulation of proteolysis; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of microtubule motor activity; P:retrograde axonal transport; P:rhythmic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:vesicle transport along microtubule; P:viral process; P:Wnt signaling pathway; scaffold36 indexed_genome mRNA 3418811 3540340 . - . ID=transcript_7400;O94804 A6ND35 B2R8F5 B3KMY1 Q6NSK0 Q9UIW4,Serine/threonine-protein kinase 10,Lymphocyte-oriented kinase;, PF00069;PF12474;, GO:0070062;GO:0005886;GO:0035579;GO:0005524;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0071593;GO:0043312;GO:0046777;GO:0006468;GO:2000401;, C:extracellular exosome; C:plasma membrane; C:specific granule membrane;, F:ATP binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:lymphocyte aggregation; P:neutrophil degranulation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of lymphocyte migration;|O94804 A6ND35 B2R8F5 B3KMY1 Q6NSK0 Q9UIW4,Serine/threonine-protein kinase 10,Lymphocyte-oriented kinase;, PF00069;PF12474;, GO:0070062;GO:0005886;GO:0035579;GO:0005524;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0071593;GO:0043312;GO:0046777;GO:0006468;GO:2000401;, C:extracellular exosome; C:plasma membrane; C:specific granule membrane;, F:ATP binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:lymphocyte aggregation; P:neutrophil degranulation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of lymphocyte migration;|O94804 A6ND35 B2R8F5 B3KMY1 Q6NSK0 Q9UIW4,Serine/threonine-protein kinase 10,Lymphocyte-oriented kinase;, PF00069;PF12474;, GO:0070062;GO:0005886;GO:0035579;GO:0005524;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0071593;GO:0043312;GO:0046777;GO:0006468;GO:2000401;, C:extracellular exosome; C:plasma membrane; C:specific granule membrane;, F:ATP binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:lymphocyte aggregation; P:neutrophil degranulation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of lymphocyte migration;|O94804 A6ND35 B2R8F5 B3KMY1 Q6NSK0 Q9UIW4,Serine/threonine-protein kinase 10,Lymphocyte-oriented kinase;, PF00069;PF12474;, GO:0070062;GO:0005886;GO:0035579;GO:0005524;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0071593;GO:0043312;GO:0046777;GO:0006468;GO:2000401;, C:extracellular exosome; C:plasma membrane; C:specific granule membrane;, F:ATP binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:lymphocyte aggregation; P:neutrophil degranulation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of lymphocyte migration;|O94804 A6ND35 B2R8F5 B3KMY1 Q6NSK0 Q9UIW4,Serine/threonine-protein kinase 10,Lymphocyte-oriented kinase;, PF00069;PF12474;, GO:0070062;GO:0005886;GO:0035579;GO:0005524;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0071593;GO:0043312;GO:0046777;GO:0006468;GO:2000401;, C:extracellular exosome; C:plasma membrane; C:specific granule membrane;, F:ATP binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:lymphocyte aggregation; P:neutrophil degranulation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of lymphocyte migration;|O94804 A6ND35 B2R8F5 B3KMY1 Q6NSK0 Q9UIW4,Serine/threonine-protein kinase 10,Lymphocyte-oriented kinase;, PF00069;PF12474;, GO:0070062;GO:0005886;GO:0035579;GO:0005524;GO:0042802;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0071593;GO:0043312;GO:0046777;GO:0006468;GO:2000401;, C:extracellular exosome; C:plasma membrane; C:specific granule membrane;, F:ATP binding; F:identical protein binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:lymphocyte aggregation; P:neutrophil degranulation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of lymphocyte migration; scaffold36 indexed_genome mRNA 3554750 3556100 . - . ID=transcript_7401;A8MZ26,EF-hand calcium-binding domain-containing protein 9 {ECO:0000305},, , GO:0005737;GO:0097228;GO:0005509;GO:0061891;GO:0030317;GO:0048240;GO:0007283;, C:cytoplasm; C:sperm principal piece;, F:calcium ion binding; F:calcium ion sensor activity;, P:flagellated sperm motility; P:sperm capacitation; P:spermatogenesis; scaffold36 indexed_genome mRNA 3557455 3559027 . + . ID=transcript_7402;A8MZ26,EF-hand calcium-binding domain-containing protein 9 {ECO:0000305},, , GO:0005737;GO:0097228;GO:0005509;GO:0061891;GO:0030317;GO:0048240;GO:0007283;, C:cytoplasm; C:sperm principal piece;, F:calcium ion binding; F:calcium ion sensor activity;, P:flagellated sperm motility; P:sperm capacitation; P:spermatogenesis; scaffold36 indexed_genome mRNA 3559259 3559853 . - . ID=transcript_7403;A8MZ26,EF-hand calcium-binding domain-containing protein 9 {ECO:0000305},, , GO:0005737;GO:0097228;GO:0005509;GO:0061891;GO:0030317;GO:0048240;GO:0007283;, C:cytoplasm; C:sperm principal piece;, F:calcium ion binding; F:calcium ion sensor activity;, P:flagellated sperm motility; P:sperm capacitation; P:spermatogenesis; scaffold36 indexed_genome mRNA 3564842 3623568 . - . ID=transcript_7404;Q8WUN7 Q8TDQ3,Ubiquitin domain-containing protein 2,Dendritic cell-derived ubiquitin-like protein;Ubiquitin-like protein SB72;, PF16455;PF00240;, GO:0005737;, C:cytoplasm; scaffold36 indexed_genome mRNA 3664327 3688047 . - . ID=transcript_7405;A1X283 B6F0V2 Q9P2Q1,SH3 and PX domain-containing protein 2B,Adapter protein HOFI;Factor for adipocyte differentiation 49;Tyrosine kinase substrate with four SH3 domains;, PF00787;PF00018;PF07653;, GO:0030054;GO:0042995;GO:0005737;GO:0002102;GO:0060090;GO:0080025;GO:0032266;GO:0010314;GO:0042169;GO:0016176;GO:0060612;GO:0060348;GO:0030154;GO:0022617;GO:0001654;GO:0007507;GO:0071800;GO:0072657;GO:0001501;GO:0006801;, C:cell junction; C:cell projection; C:cytoplasm; C:podosome;, F:molecular adaptor activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:SH2 domain binding; F:superoxide-generating NADPH oxidase activator activity;, P:adipose tissue development; P:bone development; P:cell differentiation; P:extracellular matrix disassembly; P:eye development; P:heart development; P:podosome assembly; P:protein localization to membrane; P:skeletal system development; P:superoxide metabolic process; scaffold36 indexed_genome mRNA 3690544 3779595 . - . ID=transcript_7406;A1X283 B6F0V2 Q9P2Q1,SH3 and PX domain-containing protein 2B,Adapter protein HOFI;Factor for adipocyte differentiation 49;Tyrosine kinase substrate with four SH3 domains;, PF00787;PF00018;PF07653;, GO:0030054;GO:0042995;GO:0005737;GO:0002102;GO:0060090;GO:0080025;GO:0032266;GO:0010314;GO:0042169;GO:0016176;GO:0060612;GO:0060348;GO:0030154;GO:0022617;GO:0001654;GO:0007507;GO:0071800;GO:0072657;GO:0001501;GO:0006801;, C:cell junction; C:cell projection; C:cytoplasm; C:podosome;, F:molecular adaptor activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:SH2 domain binding; F:superoxide-generating NADPH oxidase activator activity;, P:adipose tissue development; P:bone development; P:cell differentiation; P:extracellular matrix disassembly; P:eye development; P:heart development; P:podosome assembly; P:protein localization to membrane; P:skeletal system development; P:superoxide metabolic process;|A1X283 B6F0V2 Q9P2Q1,SH3 and PX domain-containing protein 2B,Adapter protein HOFI;Factor for adipocyte differentiation 49;Tyrosine kinase substrate with four SH3 domains;, PF00787;PF00018;PF07653;, GO:0030054;GO:0042995;GO:0005737;GO:0002102;GO:0060090;GO:0080025;GO:0032266;GO:0010314;GO:0042169;GO:0016176;GO:0060612;GO:0060348;GO:0030154;GO:0022617;GO:0001654;GO:0007507;GO:0071800;GO:0072657;GO:0001501;GO:0006801;, C:cell junction; C:cell projection; C:cytoplasm; C:podosome;, F:molecular adaptor activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:SH2 domain binding; F:superoxide-generating NADPH oxidase activator activity;, P:adipose tissue development; P:bone development; P:cell differentiation; P:extracellular matrix disassembly; P:eye development; P:heart development; P:podosome assembly; P:protein localization to membrane; P:skeletal system development; P:superoxide metabolic process; scaffold36 indexed_genome mRNA 3970889 4011241 . + . ID=transcript_7407;A8MQ27 C9DQJ5 C9DQJ6 C9DQJ7,E3 ubiquitin-protein ligase NEURL1B,Neuralized-2;Neuralized-like protein 1B;Neuralized-like protein 3;RING-type E3 ubiquitin transferase NEURL1B {ECO:0000305};, PF07177;, GO:0015629;GO:0005829;GO:0005769;GO:0046872;GO:0061630;GO:0007219;GO:0070086;, C:actin cytoskeleton; C:cytosol; C:early endosome;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:Notch signaling pathway; P:ubiquitin-dependent endocytosis; scaffold36 indexed_genome mRNA 4208858 4210689 . - . ID=transcript_7408;Q969X5 Q9H0L0 Q9H2J2 Q9ULN9,Endoplasmic reticulum-Golgi intermediate compartment protein 1,ER-Golgi intermediate compartment 32 kDa protein;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0005793;GO:0033116;GO:0030176;GO:0030173;GO:0043231;GO:0016020;GO:0005654;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold36 indexed_genome mRNA 4215768 4226788 . + . ID=transcript_7409;Q969X5 Q9H0L0 Q9H2J2 Q9ULN9,Endoplasmic reticulum-Golgi intermediate compartment protein 1,ER-Golgi intermediate compartment 32 kDa protein;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0005793;GO:0033116;GO:0030176;GO:0030173;GO:0043231;GO:0016020;GO:0005654;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold36 indexed_genome mRNA 4228320 4273289 . + . ID=transcript_7410;Q969X5 Q9H0L0 Q9H2J2 Q9ULN9,Endoplasmic reticulum-Golgi intermediate compartment protein 1,ER-Golgi intermediate compartment 32 kDa protein;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0005793;GO:0033116;GO:0030176;GO:0030173;GO:0043231;GO:0016020;GO:0005654;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q969X5 Q9H0L0 Q9H2J2 Q9ULN9,Endoplasmic reticulum-Golgi intermediate compartment protein 1,ER-Golgi intermediate compartment 32 kDa protein;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0005793;GO:0033116;GO:0030176;GO:0030173;GO:0043231;GO:0016020;GO:0005654;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q969X5 Q9H0L0 Q9H2J2 Q9ULN9,Endoplasmic reticulum-Golgi intermediate compartment protein 1,ER-Golgi intermediate compartment 32 kDa protein;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0005793;GO:0033116;GO:0030176;GO:0030173;GO:0043231;GO:0016020;GO:0005654;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q969X5 Q9H0L0 Q9H2J2 Q9ULN9,Endoplasmic reticulum-Golgi intermediate compartment protein 1,ER-Golgi intermediate compartment 32 kDa protein;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0005793;GO:0033116;GO:0030176;GO:0030173;GO:0043231;GO:0016020;GO:0005654;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q969X5 Q9H0L0 Q9H2J2 Q9ULN9,Endoplasmic reticulum-Golgi intermediate compartment protein 1,ER-Golgi intermediate compartment 32 kDa protein;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0005793;GO:0033116;GO:0030176;GO:0030173;GO:0043231;GO:0016020;GO:0005654;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold36 indexed_genome mRNA 4280063 4287491 . + . ID=transcript_7411;Q9UNX3 B3KY82 D3DQM0,60S ribosomal protein L26-like 1,Large ribosomal subunit protein uL24-like 1;, PF00467;PF16906;, GO:0022625;GO:0070062;GO:0003723;GO:0003735;GO:0002181;GO:0042273;, C:cytosolic large ribosomal subunit; C:extracellular exosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:ribosomal large subunit biogenesis;|Q9UNX3 B3KY82 D3DQM0,60S ribosomal protein L26-like 1,Large ribosomal subunit protein uL24-like 1;, PF00467;PF16906;, GO:0022625;GO:0070062;GO:0003723;GO:0003735;GO:0002181;GO:0042273;, C:cytosolic large ribosomal subunit; C:extracellular exosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:ribosomal large subunit biogenesis; scaffold36 indexed_genome mRNA 4294764 4320361 . + . ID=transcript_7412;O15342 B2R557 D3DQM1 Q6IBE8,V-type proton ATPase subunit e 1,V-ATPase 9.2 kDa membrane accessory protein;V-ATPase M9.2 subunit;Vacuolar proton pump subunit e 1;, PF05493;, GO:0010008;GO:0016021;GO:0005765;GO:0030670;GO:0033179;GO:0042625;GO:0016787;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0055085;GO:0007035;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:phagocytic vesicle membrane; C:proton-transporting V-type ATPase, V0 domain;, F:ATPase-coupled ion transmembrane transporter activity; F:hydrolase activity; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:transmembrane transport; P:vacuolar acidification;|O15342 B2R557 D3DQM1 Q6IBE8,V-type proton ATPase subunit e 1,V-ATPase 9.2 kDa membrane accessory protein;V-ATPase M9.2 subunit;Vacuolar proton pump subunit e 1;, PF05493;, GO:0010008;GO:0016021;GO:0005765;GO:0030670;GO:0033179;GO:0042625;GO:0016787;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0055085;GO:0007035;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:phagocytic vesicle membrane; C:proton-transporting V-type ATPase, V0 domain;, F:ATPase-coupled ion transmembrane transporter activity; F:hydrolase activity; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:transmembrane transport; P:vacuolar acidification; scaffold36 indexed_genome mRNA 4359489 4392787 . + . ID=transcript_7413;Q8IUR6 B3DFH2 B3KW49 D3DQM2 F5GXN3 Q5HYG4 Q5HYK0 Q86YR3 Q8IZG1,CREB3 regulatory factor,Luman recruitment factor;, , GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000977;GO:0030968;GO:1900102;GO:0000122;GO:0032388;GO:0045732;GO:0051222;GO:0045944;GO:0006357;GO:0034976;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:endoplasmic reticulum unfolded protein response; P:negative regulation of endoplasmic reticulum unfolded protein response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of intracellular transport; P:positive regulation of protein catabolic process; P:positive regulation of protein transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to endoplasmic reticulum stress; scaffold36 indexed_genome mRNA 4400625 4412815 . + . ID=transcript_7414;Q96FG4,Vesicle transport protein SEC20,BCL2/adenovirus E1B 19 kDa protein-interacting protein 1;Transformation-related gene 8 protein;, PF03908;, GO:0030137;GO:0005737;GO:0005783;GO:0005789;GO:0030176;GO:0043231;GO:0031966;GO:0005635;GO:0031201;GO:0005484;GO:0006915;GO:0016320;GO:0007029;GO:0097194;GO:0043066;GO:0014823;GO:0090649;GO:0042594;GO:0006890;GO:0016032;, C:COPI-coated vesicle; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:mitochondrial membrane; C:nuclear envelope; C:SNARE complex;, F:SNAP receptor activity;, P:apoptotic process; P:endoplasmic reticulum membrane fusion; P:endoplasmic reticulum organization; P:execution phase of apoptosis; P:negative regulation of apoptotic process; P:response to activity; P:response to oxygen-glucose deprivation; P:response to starvation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process; scaffold36 indexed_genome mRNA 4560856 4572681 . - . ID=transcript_7415;O76061,Stanniocalcin-2,Stanniocalcin-related protein;, PF03298;, GO:0005783;GO:0005788;GO:0005615;GO:0048471;GO:0019899;GO:0020037;GO:0005179;GO:0042803;GO:0006874;GO:0044267;GO:0071456;GO:0046697;GO:0007566;GO:0010629;GO:0043687;GO:0046885;GO:0043434;GO:0033280;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:perinuclear region of cytoplasm;, F:enzyme binding; F:heme binding; F:hormone activity; F:protein homodimerization activity;, P:cellular calcium ion homeostasis; P:cellular protein metabolic process; P:cellular response to hypoxia; P:decidualization; P:embryo implantation; P:negative regulation of gene expression; P:post-translational protein modification; P:regulation of hormone biosynthetic process; P:response to peptide hormone; P:response to vitamin D; scaffold36 indexed_genome mRNA 4877007 4883514 . - . ID=transcript_7416;Q96IK1 B4DXH8 Q9BTW1,Biorientation of chromosomes in cell division protein 1,Biorientation defective protein 1;Protein FAM44B;, , GO:0005813;GO:0000940;GO:0005737;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0051301;GO:0007080;GO:1990758;GO:0071962;GO:0032515;GO:0071459;, C:centrosome; C:condensed chromosome outer kinetochore; C:cytoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cell division; P:mitotic metaphase plate congression; P:mitotic sister chromatid biorientation; P:mitotic sister chromatid cohesion, centromeric; P:negative regulation of phosphoprotein phosphatase activity; P:protein localization to chromosome, centromeric region;|Q96IK1 B4DXH8 Q9BTW1,Biorientation of chromosomes in cell division protein 1,Biorientation defective protein 1;Protein FAM44B;, , GO:0005813;GO:0000940;GO:0005737;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0051301;GO:0007080;GO:1990758;GO:0071962;GO:0032515;GO:0071459;, C:centrosome; C:condensed chromosome outer kinetochore; C:cytoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cell division; P:mitotic metaphase plate congression; P:mitotic sister chromatid biorientation; P:mitotic sister chromatid cohesion, centromeric; P:negative regulation of phosphoprotein phosphatase activity; P:protein localization to chromosome, centromeric region;|Q96IK1 B4DXH8 Q9BTW1,Biorientation of chromosomes in cell division protein 1,Biorientation defective protein 1;Protein FAM44B;, , GO:0005813;GO:0000940;GO:0005737;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0051301;GO:0007080;GO:1990758;GO:0071962;GO:0032515;GO:0071459;, C:centrosome; C:condensed chromosome outer kinetochore; C:cytoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cell division; P:mitotic metaphase plate congression; P:mitotic sister chromatid biorientation; P:mitotic sister chromatid cohesion, centromeric; P:negative regulation of phosphoprotein phosphatase activity; P:protein localization to chromosome, centromeric region;|Q96IK1 B4DXH8 Q9BTW1,Biorientation of chromosomes in cell division protein 1,Biorientation defective protein 1;Protein FAM44B;, , GO:0005813;GO:0000940;GO:0005737;GO:0005876;GO:0000922;GO:0051721;GO:0004864;GO:0051301;GO:0007080;GO:1990758;GO:0071962;GO:0032515;GO:0071459;, C:centrosome; C:condensed chromosome outer kinetochore; C:cytoplasm; C:spindle microtubule; C:spindle pole;, F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity;, P:cell division; P:mitotic metaphase plate congression; P:mitotic sister chromatid biorientation; P:mitotic sister chromatid cohesion, centromeric; P:negative regulation of phosphoprotein phosphatase activity; P:protein localization to chromosome, centromeric region; scaffold36 indexed_genome mRNA 5158632 5160767 . + . ID=transcript_7417;Q17RY0 B7ZLQ7 Q7Z310 Q8N405 Q9C0J0,Cytoplasmic polyadenylation element-binding protein 4,, PF16366;PF16367;, GO:0005737;GO:0030425;GO:0043197;GO:0005783;GO:0030426;GO:1990124;GO:0043005;GO:0005634;GO:0048471;GO:0014069;GO:0045202;GO:0046872;GO:0003730;GO:0043022;GO:0003723;GO:0008135;GO:0000900;GO:0071230;GO:0036294;GO:0042149;GO:0035235;GO:2000766;GO:0043524;GO:0002931;, C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum; C:growth cone; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:ionotropic glutamate receptor signaling pathway; P:negative regulation of cytoplasmic translation; P:negative regulation of neuron apoptotic process; P:response to ischemia; scaffold36 indexed_genome mRNA 5198113 5199636 . - . ID=transcript_7418;Q17RY0 B7ZLQ7 Q7Z310 Q8N405 Q9C0J0,Cytoplasmic polyadenylation element-binding protein 4,, PF16366;PF16367;, GO:0005737;GO:0030425;GO:0043197;GO:0005783;GO:0030426;GO:1990124;GO:0043005;GO:0005634;GO:0048471;GO:0014069;GO:0045202;GO:0046872;GO:0003730;GO:0043022;GO:0003723;GO:0008135;GO:0000900;GO:0071230;GO:0036294;GO:0042149;GO:0035235;GO:2000766;GO:0043524;GO:0002931;, C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum; C:growth cone; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:ionotropic glutamate receptor signaling pathway; P:negative regulation of cytoplasmic translation; P:negative regulation of neuron apoptotic process; P:response to ischemia; scaffold36 indexed_genome mRNA 5209278 5226684 . + . ID=transcript_7419;Q17RY0 B7ZLQ7 Q7Z310 Q8N405 Q9C0J0,Cytoplasmic polyadenylation element-binding protein 4,, PF16366;PF16367;, GO:0005737;GO:0030425;GO:0043197;GO:0005783;GO:0030426;GO:1990124;GO:0043005;GO:0005634;GO:0048471;GO:0014069;GO:0045202;GO:0046872;GO:0003730;GO:0043022;GO:0003723;GO:0008135;GO:0000900;GO:0071230;GO:0036294;GO:0042149;GO:0035235;GO:2000766;GO:0043524;GO:0002931;, C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum; C:growth cone; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:ionotropic glutamate receptor signaling pathway; P:negative regulation of cytoplasmic translation; P:negative regulation of neuron apoptotic process; P:response to ischemia;|Q17RY0 B7ZLQ7 Q7Z310 Q8N405 Q9C0J0,Cytoplasmic polyadenylation element-binding protein 4,, PF16366;PF16367;, GO:0005737;GO:0030425;GO:0043197;GO:0005783;GO:0030426;GO:1990124;GO:0043005;GO:0005634;GO:0048471;GO:0014069;GO:0045202;GO:0046872;GO:0003730;GO:0043022;GO:0003723;GO:0008135;GO:0000900;GO:0071230;GO:0036294;GO:0042149;GO:0035235;GO:2000766;GO:0043524;GO:0002931;, C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum; C:growth cone; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:ionotropic glutamate receptor signaling pathway; P:negative regulation of cytoplasmic translation; P:negative regulation of neuron apoptotic process; P:response to ischemia;|Q17RY0 B7ZLQ7 Q7Z310 Q8N405 Q9C0J0,Cytoplasmic polyadenylation element-binding protein 4,, PF16366;PF16367;, GO:0005737;GO:0030425;GO:0043197;GO:0005783;GO:0030426;GO:1990124;GO:0043005;GO:0005634;GO:0048471;GO:0014069;GO:0045202;GO:0046872;GO:0003730;GO:0043022;GO:0003723;GO:0008135;GO:0000900;GO:0071230;GO:0036294;GO:0042149;GO:0035235;GO:2000766;GO:0043524;GO:0002931;, C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum; C:growth cone; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:ionotropic glutamate receptor signaling pathway; P:negative regulation of cytoplasmic translation; P:negative regulation of neuron apoptotic process; P:response to ischemia; scaffold36 indexed_genome mRNA 5290651 5353722 . + . ID=transcript_7420;Q9Y328 B2R5Y0 D3DQN0 Q9UHX8,Neuronal vesicle trafficking-associated protein 2 {ECO:0000312|HGNC:HGNC:24955},Neuron-specific protein family member 2 {ECO:0000312|HGNC:HGNC:24955};Protein p19;, PF06387;, GO:0030659;GO:0030425;GO:0005769;GO:0031901;GO:0005768;GO:0005794;GO:1990674;GO:0016021;GO:0005770;GO:0043202;GO:0032585;GO:0032588;GO:0032051;GO:0048268;GO:0007212;GO:0016197;, C:cytoplasmic vesicle membrane; C:dendrite; C:early endosome; C:early endosome membrane; C:endosome; C:Golgi apparatus; C:Golgi cis cisterna membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:multivesicular body membrane; C:trans-Golgi network membrane;, F:clathrin light chain binding;, P:clathrin coat assembly; P:dopamine receptor signaling pathway; P:endosomal transport; scaffold36 indexed_genome mRNA 5965557 5971579 . + . ID=transcript_7421;P35548 D3DQN1 Q53XM4 Q9UD60,Homeobox protein MSX-2,Homeobox protein Hox-8;, PF00046;, GO:0000785;GO:0005829;GO:0016607;GO:0005634;GO:0000981;GO:0000977;GO:0043565;GO:1990837;GO:0000976;GO:0060363;GO:0048598;GO:0000122;GO:2000678;GO:0045892;GO:0001649;GO:0006357;, C:chromatin; C:cytosol; C:nuclear speck; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cranial suture morphogenesis; P:embryonic morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:osteoblast differentiation; P:regulation of transcription by RNA polymerase II; scaffold36 indexed_genome mRNA 6197426 6290502 . + . ID=transcript_7422;Q9Y6X4 A8K1T9 Q6MZT0 Q9H989,Soluble lamin-associated protein of 75 kDa,Protein FAM169A;, , GO:0005637;, C:nuclear inner membrane;|Q9Y6X4 A8K1T9 Q6MZT0 Q9H989,Soluble lamin-associated protein of 75 kDa,Protein FAM169A;, , GO:0005637;, C:nuclear inner membrane;|O95478,Ribosome biogenesis protein NSA2 homolog,Hairy cell leukemia protein 1;TGF-beta-inducible nuclear protein 1;, PF01201;, GO:0005730;GO:0030687;GO:0003723;GO:0000460;GO:0000470;, C:nucleolus; C:preribosome, large subunit precursor;, F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA;|Q969S9 A0AR28 Q8N6D8 Q8WYI0 Q9H6Z1,Ribosome-releasing factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059},Elongation factor G 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059};Elongation factor G2;, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0032543;GO:0070126;GO:0032790;GO:0006414;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity;, P:mitochondrial translation; P:mitochondrial translational termination; P:ribosome disassembly; P:translational elongation;|Q969S9 A0AR28 Q8N6D8 Q8WYI0 Q9H6Z1,Ribosome-releasing factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059},Elongation factor G 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059};Elongation factor G2;, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0032543;GO:0070126;GO:0032790;GO:0006414;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity;, P:mitochondrial translation; P:mitochondrial translational termination; P:ribosome disassembly; P:translational elongation;|Q969S9 A0AR28 Q8N6D8 Q8WYI0 Q9H6Z1,Ribosome-releasing factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059},Elongation factor G 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059};Elongation factor G2;, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0032543;GO:0070126;GO:0032790;GO:0006414;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity;, P:mitochondrial translation; P:mitochondrial translational termination; P:ribosome disassembly; P:translational elongation;|Q969S9 A0AR28 Q8N6D8 Q8WYI0 Q9H6Z1,Ribosome-releasing factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059},Elongation factor G 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059};Elongation factor G2;, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0032543;GO:0070126;GO:0032790;GO:0006414;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity;, P:mitochondrial translation; P:mitochondrial translational termination; P:ribosome disassembly; P:translational elongation;|Q969S9 A0AR28 Q8N6D8 Q8WYI0 Q9H6Z1,Ribosome-releasing factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059},Elongation factor G 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059};Elongation factor G2;, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0032543;GO:0070126;GO:0032790;GO:0006414;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity;, P:mitochondrial translation; P:mitochondrial translational termination; P:ribosome disassembly; P:translational elongation;|Q969S9 A0AR28 Q8N6D8 Q8WYI0 Q9H6Z1,Ribosome-releasing factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059},Elongation factor G 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059};Elongation factor G2;, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0032543;GO:0070126;GO:0032790;GO:0006414;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity;, P:mitochondrial translation; P:mitochondrial translational termination; P:ribosome disassembly; P:translational elongation;|Q969S9 A0AR28 Q8N6D8 Q8WYI0 Q9H6Z1,Ribosome-releasing factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059},Elongation factor G 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059};Elongation factor G2;, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0032543;GO:0070126;GO:0032790;GO:0006414;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity;, P:mitochondrial translation; P:mitochondrial translational termination; P:ribosome disassembly; P:translational elongation;|Q969S9 A0AR28 Q8N6D8 Q8WYI0 Q9H6Z1,Ribosome-releasing factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059},Elongation factor G 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059};Elongation factor G2;, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0032543;GO:0070126;GO:0032790;GO:0006414;, C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity;, P:mitochondrial translation; P:mitochondrial translational termination; P:ribosome disassembly; P:translational elongation; scaffold36 indexed_genome mRNA 6339067 6344721 . + . ID=transcript_7423;O14682 B4DHJ1 E9PFU0 O75464 Q9UPG9,Ectoderm-neural cortex protein 1,Kelch-like protein 37;Nuclear matrix protein NRP/B;p53-induced gene 10 protein;, PF07707;PF00651;PF01344;, GO:0031463;GO:0005737;GO:0005856;GO:0043025;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0003779;GO:0007275;GO:0017148;GO:0007399;GO:0010976;GO:0010499;GO:0016567;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytoskeleton; C:neuronal cell body; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, F:actin binding;, P:multicellular organism development; P:negative regulation of translation; P:nervous system development; P:positive regulation of neuron projection development; P:proteasomal ubiquitin-independent protein catabolic process; P:protein ubiquitination; scaffold36 indexed_genome mRNA 6344738 6349396 . + . ID=transcript_7424;O14682 B4DHJ1 E9PFU0 O75464 Q9UPG9,Ectoderm-neural cortex protein 1,Kelch-like protein 37;Nuclear matrix protein NRP/B;p53-induced gene 10 protein;, PF07707;PF00651;PF01344;, GO:0031463;GO:0005737;GO:0005856;GO:0043025;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0003779;GO:0007275;GO:0017148;GO:0007399;GO:0010976;GO:0010499;GO:0016567;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytoskeleton; C:neuronal cell body; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, F:actin binding;, P:multicellular organism development; P:negative regulation of translation; P:nervous system development; P:positive regulation of neuron projection development; P:proteasomal ubiquitin-independent protein catabolic process; P:protein ubiquitination; scaffold36 indexed_genome mRNA 7046534 7120396 . - . ID=transcript_7425;Q9H6W0,Rho guanine nucleotide exchange factor 28,190 kDa guanine nucleotide exchange factor;Rho guanine nucleotide exchange factor;, PF00130;PF17838;PF00621;, GO:0005829;GO:0005886;GO:0005085;GO:0046872;GO:0003723;GO:0030154;GO:0000902;GO:0048013;GO:0035556;GO:0035023;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:cell morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:regulation of Rho protein signal transduction;|Q9H6W0,Rho guanine nucleotide exchange factor 28,190 kDa guanine nucleotide exchange factor;Rho guanine nucleotide exchange factor;, PF00130;PF17838;PF00621;, GO:0005829;GO:0005886;GO:0005085;GO:0046872;GO:0003723;GO:0030154;GO:0000902;GO:0048013;GO:0035556;GO:0035023;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:cell morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:regulation of Rho protein signal transduction;|Q9H6W0,Rho guanine nucleotide exchange factor 28,190 kDa guanine nucleotide exchange factor;Rho guanine nucleotide exchange factor;, PF00130;PF17838;PF00621;, GO:0005829;GO:0005886;GO:0005085;GO:0046872;GO:0003723;GO:0030154;GO:0000902;GO:0048013;GO:0035556;GO:0035023;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:cell morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:regulation of Rho protein signal transduction;|Q9H6W0,Rho guanine nucleotide exchange factor 28,190 kDa guanine nucleotide exchange factor;Rho guanine nucleotide exchange factor;, PF00130;PF17838;PF00621;, GO:0005829;GO:0005886;GO:0005085;GO:0046872;GO:0003723;GO:0030154;GO:0000902;GO:0048013;GO:0035556;GO:0035023;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:cell morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:regulation of Rho protein signal transduction; scaffold36 indexed_genome mRNA 7120397 7131351 . - . ID=transcript_7426;Q9H6W0,Rho guanine nucleotide exchange factor 28,190 kDa guanine nucleotide exchange factor;Rho guanine nucleotide exchange factor;, PF00130;PF17838;PF00621;, GO:0005829;GO:0005886;GO:0005085;GO:0046872;GO:0003723;GO:0030154;GO:0000902;GO:0048013;GO:0035556;GO:0035023;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:cell morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:regulation of Rho protein signal transduction; scaffold36 indexed_genome mRNA 7136016 7235003 . - . ID=transcript_7427;Q9H6W0,Rho guanine nucleotide exchange factor 28,190 kDa guanine nucleotide exchange factor;Rho guanine nucleotide exchange factor;, PF00130;PF17838;PF00621;, GO:0005829;GO:0005886;GO:0005085;GO:0046872;GO:0003723;GO:0030154;GO:0000902;GO:0048013;GO:0035556;GO:0035023;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:cell morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:regulation of Rho protein signal transduction; scaffold36 indexed_genome mRNA 7394492 7412622 . - . ID=transcript_7428;Q8TED0 B4DU75 B4DXK8 Q6IA60 Q96E08 Q9H9F8,U3 small nucleolar RNA-associated protein 15 homolog,, PF09384;PF00400;, GO:0005737;GO:0005783;GO:0001650;GO:0005730;GO:0005654;GO:0003723;GO:2000234;GO:0045943;GO:0006364;, C:cytoplasm; C:endoplasmic reticulum; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q8TED0 B4DU75 B4DXK8 Q6IA60 Q96E08 Q9H9F8,U3 small nucleolar RNA-associated protein 15 homolog,, PF09384;PF00400;, GO:0005737;GO:0005783;GO:0001650;GO:0005730;GO:0005654;GO:0003723;GO:2000234;GO:0045943;GO:0006364;, C:cytoplasm; C:endoplasmic reticulum; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q8TED0 B4DU75 B4DXK8 Q6IA60 Q96E08 Q9H9F8,U3 small nucleolar RNA-associated protein 15 homolog,, PF09384;PF00400;, GO:0005737;GO:0005783;GO:0001650;GO:0005730;GO:0005654;GO:0003723;GO:2000234;GO:0045943;GO:0006364;, C:cytoplasm; C:endoplasmic reticulum; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q8TED0 B4DU75 B4DXK8 Q6IA60 Q96E08 Q9H9F8,U3 small nucleolar RNA-associated protein 15 homolog,, PF09384;PF00400;, GO:0005737;GO:0005783;GO:0001650;GO:0005730;GO:0005654;GO:0003723;GO:2000234;GO:0045943;GO:0006364;, C:cytoplasm; C:endoplasmic reticulum; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing; scaffold36 indexed_genome mRNA 7412672 7422711 . + . ID=transcript_7429;Q9H9E1,Ankyrin repeat family A protein 2,RFXANK-like protein 2;, PF00023;PF12796;, GO:0005856;GO:0005829;GO:0016020;GO:0005634;GO:0032991;GO:0042826;GO:0050750;GO:0019901;GO:0031625;GO:0010468;GO:0043254;, C:cytoskeleton; C:cytosol; C:membrane; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:low-density lipoprotein particle receptor binding; F:protein kinase binding; F:ubiquitin protein ligase binding;, P:regulation of gene expression; P:regulation of protein-containing complex assembly;|Q9H9E1,Ankyrin repeat family A protein 2,RFXANK-like protein 2;, PF00023;PF12796;, GO:0005856;GO:0005829;GO:0016020;GO:0005634;GO:0032991;GO:0042826;GO:0050750;GO:0019901;GO:0031625;GO:0010468;GO:0043254;, C:cytoskeleton; C:cytosol; C:membrane; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:low-density lipoprotein particle receptor binding; F:protein kinase binding; F:ubiquitin protein ligase binding;, P:regulation of gene expression; P:regulation of protein-containing complex assembly;|Q9H9E1,Ankyrin repeat family A protein 2,RFXANK-like protein 2;, PF00023;PF12796;, GO:0005856;GO:0005829;GO:0016020;GO:0005634;GO:0032991;GO:0042826;GO:0050750;GO:0019901;GO:0031625;GO:0010468;GO:0043254;, C:cytoskeleton; C:cytosol; C:membrane; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:low-density lipoprotein particle receptor binding; F:protein kinase binding; F:ubiquitin protein ligase binding;, P:regulation of gene expression; P:regulation of protein-containing complex assembly; scaffold36 indexed_genome mRNA 7458496 7465453 . - . ID=transcript_7430;P20290 A8K510 Q13893 Q76M56,Transcription factor BTF3,Nascent polypeptide-associated complex subunit beta;RNA polymerase B transcription factor 3;, PF01849;, GO:0005829;GO:0005854;GO:0005634;GO:0042788;GO:0003723;GO:0001701;GO:0015031;GO:0006366;, C:cytosol; C:nascent polypeptide-associated complex; C:nucleus; C:polysomal ribosome;, F:RNA binding;, P:in utero embryonic development; P:protein transport; P:transcription by RNA polymerase II; scaffold36 indexed_genome mRNA 7875167 8011512 . - . ID=transcript_7431;Q0JRZ9 A8K6W7 B2RNQ9 B4DHK0 E9PG79 Q0JTJ3 Q96CF5,F-BAR domain only protein 2,, PF00611;PF10291;, GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0098835;GO:0042802;GO:0035091;GO:0005546;GO:0001786;GO:0048268;GO:0072583;GO:0010324;GO:0061024;GO:0072659;GO:0048488;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane; C:presynaptic endocytic zone membrane;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:protein localization to plasma membrane; P:synaptic vesicle endocytosis;|Q0JRZ9 A8K6W7 B2RNQ9 B4DHK0 E9PG79 Q0JTJ3 Q96CF5,F-BAR domain only protein 2,, PF00611;PF10291;, GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0098835;GO:0042802;GO:0035091;GO:0005546;GO:0001786;GO:0048268;GO:0072583;GO:0010324;GO:0061024;GO:0072659;GO:0048488;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane; C:presynaptic endocytic zone membrane;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:protein localization to plasma membrane; P:synaptic vesicle endocytosis;|Q0JRZ9 A8K6W7 B2RNQ9 B4DHK0 E9PG79 Q0JTJ3 Q96CF5,F-BAR domain only protein 2,, PF00611;PF10291;, GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0098835;GO:0042802;GO:0035091;GO:0005546;GO:0001786;GO:0048268;GO:0072583;GO:0010324;GO:0061024;GO:0072659;GO:0048488;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane; C:presynaptic endocytic zone membrane;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:protein localization to plasma membrane; P:synaptic vesicle endocytosis;|Q0JRZ9 A8K6W7 B2RNQ9 B4DHK0 E9PG79 Q0JTJ3 Q96CF5,F-BAR domain only protein 2,, PF00611;PF10291;, GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0098835;GO:0042802;GO:0035091;GO:0005546;GO:0001786;GO:0048268;GO:0072583;GO:0010324;GO:0061024;GO:0072659;GO:0048488;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane; C:presynaptic endocytic zone membrane;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:protein localization to plasma membrane; P:synaptic vesicle endocytosis;|Q0JRZ9 A8K6W7 B2RNQ9 B4DHK0 E9PG79 Q0JTJ3 Q96CF5,F-BAR domain only protein 2,, PF00611;PF10291;, GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0098835;GO:0042802;GO:0035091;GO:0005546;GO:0001786;GO:0048268;GO:0072583;GO:0010324;GO:0061024;GO:0072659;GO:0048488;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane; C:presynaptic endocytic zone membrane;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:protein localization to plasma membrane; P:synaptic vesicle endocytosis;|Q0JRZ9 A8K6W7 B2RNQ9 B4DHK0 E9PG79 Q0JTJ3 Q96CF5,F-BAR domain only protein 2,, PF00611;PF10291;, GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0098835;GO:0042802;GO:0035091;GO:0005546;GO:0001786;GO:0048268;GO:0072583;GO:0010324;GO:0061024;GO:0072659;GO:0048488;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane; C:presynaptic endocytic zone membrane;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:protein localization to plasma membrane; P:synaptic vesicle endocytosis;|Q0JRZ9 A8K6W7 B2RNQ9 B4DHK0 E9PG79 Q0JTJ3 Q96CF5,F-BAR domain only protein 2,, PF00611;PF10291;, GO:0005905;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0098835;GO:0042802;GO:0035091;GO:0005546;GO:0001786;GO:0048268;GO:0072583;GO:0010324;GO:0061024;GO:0072659;GO:0048488;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane; C:presynaptic endocytic zone membrane;, F:identical protein binding; F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane invagination; P:membrane organization; P:protein localization to plasma membrane; P:synaptic vesicle endocytosis; scaffold36 indexed_genome mRNA 8058077 8148217 . - . ID=transcript_7432;Q92973 B4DVC6 Q92957 Q92975,Transportin-1,Importin beta-2;Karyopherin beta-2;M9 region interaction protein;, PF03810;, GO:0005929;GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0061608;GO:0008139;GO:0003723;GO:0031267;GO:0035735;GO:0006606;GO:0043488;GO:0016032;, C:cilium; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:RNA binding; F:small GTPase binding;, P:intraciliary transport involved in cilium assembly; P:protein import into nucleus; P:regulation of mRNA stability; P:viral process;|Q92973 B4DVC6 Q92957 Q92975,Transportin-1,Importin beta-2;Karyopherin beta-2;M9 region interaction protein;, PF03810;, GO:0005929;GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0061608;GO:0008139;GO:0003723;GO:0031267;GO:0035735;GO:0006606;GO:0043488;GO:0016032;, C:cilium; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:RNA binding; F:small GTPase binding;, P:intraciliary transport involved in cilium assembly; P:protein import into nucleus; P:regulation of mRNA stability; P:viral process;|O14787 O14655 Q6IN77,Transportin-2,Karyopherin beta-2b;, PF03810;, GO:0005737;GO:0005634;GO:0061608;GO:0008139;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:protein import into nucleus; scaffold36 indexed_genome mRNA 8478409 8497168 . + . ID=transcript_7433;Q8N895 Q5HYI9 Q7RTV4,Zinc finger protein 366 {ECO:0000303|PubMed:12234665},Dendritic cell-specific transcript protein {ECO:0000303|PubMed:16393996};, PF00096;, GO:0005634;GO:0003700;GO:0030331;GO:0046872;GO:0000978;GO:0003714;GO:0033147;GO:0000122;GO:0006357;GO:0043627;, C:nucleus;, F:DNA-binding transcription factor activity; F:estrogen receptor binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor activity;, P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to estrogen; scaffold36 indexed_genome mRNA 8581836 8592796 . - . ID=transcript_7434;Q8WV60 B7Z5D0 B7Z8L7 E9PFV7 Q6IA65 Q9H9R0,Pentatricopeptide repeat-containing protein 2, mitochondrial,, PF10037;, GO:0005739;GO:0003723;GO:0001822;GO:0001889;GO:0007005;GO:0006397;GO:0007275;GO:0048747;GO:0010468;GO:0050684;GO:0055010;, C:mitochondrion;, F:RNA binding;, P:kidney development; P:liver development; P:mitochondrion organization; P:mRNA processing; P:multicellular organism development; P:muscle fiber development; P:regulation of gene expression; P:regulation of mRNA processing; P:ventricular cardiac muscle tissue morphogenesis;|Q8WV60 B7Z5D0 B7Z8L7 E9PFV7 Q6IA65 Q9H9R0,Pentatricopeptide repeat-containing protein 2, mitochondrial,, PF10037;, GO:0005739;GO:0003723;GO:0001822;GO:0001889;GO:0007005;GO:0006397;GO:0007275;GO:0048747;GO:0010468;GO:0050684;GO:0055010;, C:mitochondrion;, F:RNA binding;, P:kidney development; P:liver development; P:mitochondrion organization; P:mRNA processing; P:multicellular organism development; P:muscle fiber development; P:regulation of gene expression; P:regulation of mRNA processing; P:ventricular cardiac muscle tissue morphogenesis; scaffold36 indexed_genome mRNA 8596190 8611329 . - . ID=transcript_7435;Q8WV60 B7Z5D0 B7Z8L7 E9PFV7 Q6IA65 Q9H9R0,Pentatricopeptide repeat-containing protein 2, mitochondrial,, PF10037;, GO:0005739;GO:0003723;GO:0001822;GO:0001889;GO:0007005;GO:0006397;GO:0007275;GO:0048747;GO:0010468;GO:0050684;GO:0055010;, C:mitochondrion;, F:RNA binding;, P:kidney development; P:liver development; P:mitochondrion organization; P:mRNA processing; P:multicellular organism development; P:muscle fiber development; P:regulation of gene expression; P:regulation of mRNA processing; P:ventricular cardiac muscle tissue morphogenesis;|Q8WV60 B7Z5D0 B7Z8L7 E9PFV7 Q6IA65 Q9H9R0,Pentatricopeptide repeat-containing protein 2, mitochondrial,, PF10037;, GO:0005739;GO:0003723;GO:0001822;GO:0001889;GO:0007005;GO:0006397;GO:0007275;GO:0048747;GO:0010468;GO:0050684;GO:0055010;, C:mitochondrion;, F:RNA binding;, P:kidney development; P:liver development; P:mitochondrion organization; P:mRNA processing; P:multicellular organism development; P:muscle fiber development; P:regulation of gene expression; P:regulation of mRNA processing; P:ventricular cardiac muscle tissue morphogenesis; scaffold36 indexed_genome mRNA 8611582 8708666 . + . ID=transcript_7436;Q92552 B4DRT2 Q6P1S1,28S ribosomal protein S27, mitochondrial {ECO:0000305},Mitochondrial ribosomal protein S27 {ECO:0000312|HGNC:HGNC:14512};Mitochondrial small ribosomal subunit protein mS27 {ECO:0000303|PubMed:25838379};, PF10037;, GO:0005737;GO:0005743;GO:0005763;GO:0005739;GO:0005730;GO:0097177;GO:0019843;GO:0000049;GO:0008283;GO:0070125;GO:0070126;GO:0070131;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleolus;, F:mitochondrial ribosome binding; F:rRNA binding; F:tRNA binding;, P:cell population proliferation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:positive regulation of mitochondrial translation;|Q92552 B4DRT2 Q6P1S1,28S ribosomal protein S27, mitochondrial {ECO:0000305},Mitochondrial ribosomal protein S27 {ECO:0000312|HGNC:HGNC:14512};Mitochondrial small ribosomal subunit protein mS27 {ECO:0000303|PubMed:25838379};, PF10037;, GO:0005737;GO:0005743;GO:0005763;GO:0005739;GO:0005730;GO:0097177;GO:0019843;GO:0000049;GO:0008283;GO:0070125;GO:0070126;GO:0070131;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleolus;, F:mitochondrial ribosome binding; F:rRNA binding; F:tRNA binding;, P:cell population proliferation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:positive regulation of mitochondrial translation; scaffold36 indexed_genome mRNA 8709210 8711386 . + . ID=transcript_7437;Q92552 B4DRT2 Q6P1S1,28S ribosomal protein S27, mitochondrial {ECO:0000305},Mitochondrial ribosomal protein S27 {ECO:0000312|HGNC:HGNC:14512};Mitochondrial small ribosomal subunit protein mS27 {ECO:0000303|PubMed:25838379};, PF10037;, GO:0005737;GO:0005743;GO:0005763;GO:0005739;GO:0005730;GO:0097177;GO:0019843;GO:0000049;GO:0008283;GO:0070125;GO:0070126;GO:0070131;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleolus;, F:mitochondrial ribosome binding; F:rRNA binding; F:tRNA binding;, P:cell population proliferation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:positive regulation of mitochondrial translation; scaffold36 indexed_genome mRNA 8724989 8815231 . - . ID=transcript_7438;P46821 A2BDK5,Microtubule-associated protein 1B,, PF00414;, GO:0097440;GO:0030424;GO:0097441;GO:0005829;GO:0030425;GO:0043197;GO:0030426;GO:0097457;GO:0005874;GO:0005875;GO:0043025;GO:0043204;GO:0048471;GO:0001750;GO:0005886;GO:0014069;GO:0036477;GO:0045202;GO:0043196;GO:0003779;GO:0008017;GO:0005543;GO:0044877;GO:0005198;GO:0048675;GO:0007409;GO:0009987;GO:0071363;GO:0071375;GO:0016358;GO:0021700;GO:0061162;GO:0051915;GO:0001578;GO:0000226;GO:0047497;GO:0032387;GO:0007026;GO:0001764;GO:0014012;GO:0045773;GO:0031116;GO:0045666;GO:0031114;GO:0009743;GO:0042493;GO:0032355;GO:0010035;GO:0017085;GO:0009612;GO:0033189;GO:0007416;, C:apical dendrite; C:axon; C:basal dendrite; C:cytosol; C:dendrite; C:dendritic spine; C:growth cone; C:hippocampal mossy fiber; C:microtubule; C:microtubule associated complex; C:neuronal cell body; C:perikaryon; C:perinuclear region of cytoplasm; C:photoreceptor outer segment; C:plasma membrane; C:postsynaptic density; C:somatodendritic compartment; C:synapse; C:varicosity;, F:actin binding; F:microtubule binding; F:phospholipid binding; F:protein-containing complex binding; F:structural molecule activity;, P:axon extension; P:axonogenesis; P:cellular process; P:cellular response to growth factor stimulus; P:cellular response to peptide hormone stimulus; P:dendrite development; P:developmental maturation; P:establishment of monopolar cell polarity; P:induction of synaptic plasticity by chemical substance; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:mitochondrion transport along microtubule; P:negative regulation of intracellular transport; P:negative regulation of microtubule depolymerization; P:neuron migration; P:peripheral nervous system axon regeneration; P:positive regulation of axon extension; P:positive regulation of microtubule polymerization; P:positive regulation of neuron differentiation; P:regulation of microtubule depolymerization; P:response to carbohydrate; P:response to drug; P:response to estradiol; P:response to inorganic substance; P:response to insecticide; P:response to mechanical stimulus; P:response to vitamin A; P:synapse assembly; scaffold36 indexed_genome mRNA 9229243 9304968 . - . ID=transcript_7439;Q9HCC0 A6NIY9 Q96C27 Q9Y4L7,Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial,3-methylcrotonyl-CoA carboxylase 2;3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit;3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta;, PF01039;, GO:0002169;GO:0005829;GO:1905202;GO:0005759;GO:0005739;GO:0005524;GO:0004485;GO:0006768;GO:0009083;GO:0015936;GO:0006552;, C:3-methylcrotonyl-CoA carboxylase complex, mitochondrial; C:cytosol; C:methylcrotonoyl-CoA carboxylase complex; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:methylcrotonoyl-CoA carboxylase activity;, P:biotin metabolic process; P:branched-chain amino acid catabolic process; P:coenzyme A metabolic process; P:leucine catabolic process; scaffold36 indexed_genome mRNA 9313192 9314714 . - . ID=transcript_7440;Q9H1A1 Q9HAW1 Q9HAW2 Q9HCY0 Q9ULH9,Transcription factor TFIIIB component B'' homolog,Transcription factor IIIB 150;Transcription factor-like nuclear regulator;, PF15963;, GO:0005654;GO:0000126;GO:0001156;GO:0070898;, C:nucleoplasm; C:transcription factor TFIIIB complex;, F:TFIIIC-class transcription factor complex binding;, P:RNA polymerase III preinitiation complex assembly; scaffold36 indexed_genome mRNA 9317541 9343775 . - . ID=transcript_7441;Q9H1A1 Q9HAW1 Q9HAW2 Q9HCY0 Q9ULH9,Transcription factor TFIIIB component B'' homolog,Transcription factor IIIB 150;Transcription factor-like nuclear regulator;, PF15963;, GO:0005654;GO:0000126;GO:0001156;GO:0070898;, C:nucleoplasm; C:transcription factor TFIIIB complex;, F:TFIIIC-class transcription factor complex binding;, P:RNA polymerase III preinitiation complex assembly; scaffold36 indexed_genome mRNA 9352870 9390048 . - . ID=transcript_7442;Q9H1A1 Q9HAW1 Q9HAW2 Q9HCY0 Q9ULH9,Transcription factor TFIIIB component B'' homolog,Transcription factor IIIB 150;Transcription factor-like nuclear regulator;, PF15963;, GO:0005654;GO:0000126;GO:0001156;GO:0070898;, C:nucleoplasm; C:transcription factor TFIIIB complex;, F:TFIIIC-class transcription factor complex binding;, P:RNA polymerase III preinitiation complex assembly; scaffold36 indexed_genome mRNA 9399346 9403166 . + . ID=transcript_7443;P84101 A6NL45 B5MCG1 B9A026 O75918 O88891 Q9BZH7,Small EDRK-rich factor 2,Gastric cancer-related protein VRG107;Protein 4F5-related;, PF04419;, GO:0005829;GO:0005634;GO:0031648;, C:cytosol; C:nucleus;, , P:protein destabilization; scaffold36 indexed_genome mRNA 9431830 9437560 . + . ID=transcript_7444;Q16637 A8K0V4 Q13119 Q549U5 Q96J51,Survival motor neuron protein,Component of gems 1;Gemin-1;, PF06003;, GO:0030424;GO:0015030;GO:0005737;GO:0036464;GO:0005829;GO:0097504;GO:0043005;GO:0016604;GO:0005654;GO:0005634;GO:0043204;GO:0032797;GO:0034719;GO:0030018;GO:0042802;GO:0003723;GO:0006353;GO:0051170;GO:0007399;GO:0000245;GO:0000387;, C:axon; C:Cajal body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:Gemini of coiled bodies; C:neuron projection; C:nuclear body; C:nucleoplasm; C:nucleus; C:perikaryon; C:SMN complex; C:SMN-Sm protein complex; C:Z disc;, F:identical protein binding; F:RNA binding;, P:DNA-templated transcription, termination; P:import into nucleus; P:nervous system development; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly; scaffold36 indexed_genome mRNA 9445637 9451736 . - . ID=transcript_7445;Q13075 B9EG72 E9PHD1 O75857 Q13730 Q59GI6 Q8TDZ4 Q99796,Baculoviral IAP repeat-containing protein 1,Neuronal apoptosis inhibitory protein;, PF00653;PF05729;PF17889;PF17779;, GO:0016323;GO:0005737;GO:0072557;GO:0005524;GO:0043027;GO:0046872;GO:0042742;GO:0016045;GO:0006954;GO:0045087;GO:0043066;GO:0043154;GO:0043524;GO:0007399;GO:0070269;, C:basolateral plasma membrane; C:cytoplasm; C:IPAF inflammasome complex;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:metal ion binding;, P:defense response to bacterium; P:detection of bacterium; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of neuron apoptotic process; P:nervous system development; P:pyroptosis; scaffold36 indexed_genome mRNA 9453624 9460565 . - . ID=transcript_7446;Q13075 B9EG72 E9PHD1 O75857 Q13730 Q59GI6 Q8TDZ4 Q99796,Baculoviral IAP repeat-containing protein 1,Neuronal apoptosis inhibitory protein;, PF00653;PF05729;PF17889;PF17779;, GO:0016323;GO:0005737;GO:0072557;GO:0005524;GO:0043027;GO:0046872;GO:0042742;GO:0016045;GO:0006954;GO:0045087;GO:0043066;GO:0043154;GO:0043524;GO:0007399;GO:0070269;, C:basolateral plasma membrane; C:cytoplasm; C:IPAF inflammasome complex;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:metal ion binding;, P:defense response to bacterium; P:detection of bacterium; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of neuron apoptotic process; P:nervous system development; P:pyroptosis; scaffold36 indexed_genome mRNA 9460570 9462083 . - . ID=transcript_7447;Q13075 B9EG72 E9PHD1 O75857 Q13730 Q59GI6 Q8TDZ4 Q99796,Baculoviral IAP repeat-containing protein 1,Neuronal apoptosis inhibitory protein;, PF00653;PF05729;PF17889;PF17779;, GO:0016323;GO:0005737;GO:0072557;GO:0005524;GO:0043027;GO:0046872;GO:0042742;GO:0016045;GO:0006954;GO:0045087;GO:0043066;GO:0043154;GO:0043524;GO:0007399;GO:0070269;, C:basolateral plasma membrane; C:cytoplasm; C:IPAF inflammasome complex;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:metal ion binding;, P:defense response to bacterium; P:detection of bacterium; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of neuron apoptotic process; P:nervous system development; P:pyroptosis;|Q13075 B9EG72 E9PHD1 O75857 Q13730 Q59GI6 Q8TDZ4 Q99796,Baculoviral IAP repeat-containing protein 1,Neuronal apoptosis inhibitory protein;, PF00653;PF05729;PF17889;PF17779;, GO:0016323;GO:0005737;GO:0072557;GO:0005524;GO:0043027;GO:0046872;GO:0042742;GO:0016045;GO:0006954;GO:0045087;GO:0043066;GO:0043154;GO:0043524;GO:0007399;GO:0070269;, C:basolateral plasma membrane; C:cytoplasm; C:IPAF inflammasome complex;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:metal ion binding;, P:defense response to bacterium; P:detection of bacterium; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of neuron apoptotic process; P:nervous system development; P:pyroptosis; scaffold36 indexed_genome mRNA 9481390 9482032 . + . ID=transcript_7448;Q13075 B9EG72 E9PHD1 O75857 Q13730 Q59GI6 Q8TDZ4 Q99796,Baculoviral IAP repeat-containing protein 1,Neuronal apoptosis inhibitory protein;, PF00653;PF05729;PF17889;PF17779;, GO:0016323;GO:0005737;GO:0072557;GO:0005524;GO:0043027;GO:0046872;GO:0042742;GO:0016045;GO:0006954;GO:0045087;GO:0043066;GO:0043154;GO:0043524;GO:0007399;GO:0070269;, C:basolateral plasma membrane; C:cytoplasm; C:IPAF inflammasome complex;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:metal ion binding;, P:defense response to bacterium; P:detection of bacterium; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of neuron apoptotic process; P:nervous system development; P:pyroptosis; scaffold36 indexed_genome mRNA 9483793 9484973 . + . ID=transcript_7449;Q13075 B9EG72 E9PHD1 O75857 Q13730 Q59GI6 Q8TDZ4 Q99796,Baculoviral IAP repeat-containing protein 1,Neuronal apoptosis inhibitory protein;, PF00653;PF05729;PF17889;PF17779;, GO:0016323;GO:0005737;GO:0072557;GO:0005524;GO:0043027;GO:0046872;GO:0042742;GO:0016045;GO:0006954;GO:0045087;GO:0043066;GO:0043154;GO:0043524;GO:0007399;GO:0070269;, C:basolateral plasma membrane; C:cytoplasm; C:IPAF inflammasome complex;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:metal ion binding;, P:defense response to bacterium; P:detection of bacterium; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of neuron apoptotic process; P:nervous system development; P:pyroptosis; scaffold36 indexed_genome mRNA 9488123 9493973 . + . ID=transcript_7450;Q96C11 B1AK92 B1AK93 B1AK94 B2RDR8 D3DQ56 Q9HA63 Q9NV20,FGGY carbohydrate kinase domain-containing protein,, PF02782;PF00370;, GO:0019150;GO:0046835;GO:0070050;GO:0019321;, , F:D-ribulokinase activity;, P:carbohydrate phosphorylation; P:neuron cellular homeostasis; P:pentose metabolic process; scaffold36 indexed_genome mRNA 9502058 9524283 . - . ID=transcript_7451;Q13888 Q15570 Q15571 Q9BS41,General transcription factor IIH subunit 2,Basic transcription factor 2 44 kDa subunit;General transcription factor IIH polypeptide 2;TFIIH basal transcription factor complex p44 subunit {ECO:0000303|PubMed:11319235, ECO:0000303|PubMed:8194529};, PF07975;PF04056;, GO:0000438;GO:0016607;GO:0005654;GO:0005634;GO:0005669;GO:0000439;GO:0005675;GO:0047485;GO:0016251;GO:0008270;GO:0006370;GO:0002031;GO:0070911;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:1905776;GO:0006357;GO:0009411;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;GO:0016032;, C:core TFIIH complex portion of holo TFIIH complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, F:protein N-terminus binding; F:RNA polymerase II general transcription initiation factor activity; F:zinc ion binding;, P:7-methylguanosine mRNA capping; P:G protein-coupled receptor internalization; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of DNA helicase activity; P:regulation of transcription by RNA polymerase II; P:response to UV; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q13888 Q15570 Q15571 Q9BS41,General transcription factor IIH subunit 2,Basic transcription factor 2 44 kDa subunit;General transcription factor IIH polypeptide 2;TFIIH basal transcription factor complex p44 subunit {ECO:0000303|PubMed:11319235, ECO:0000303|PubMed:8194529};, PF07975;PF04056;, GO:0000438;GO:0016607;GO:0005654;GO:0005634;GO:0005669;GO:0000439;GO:0005675;GO:0047485;GO:0016251;GO:0008270;GO:0006370;GO:0002031;GO:0070911;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:1905776;GO:0006357;GO:0009411;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;GO:0016032;, C:core TFIIH complex portion of holo TFIIH complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, F:protein N-terminus binding; F:RNA polymerase II general transcription initiation factor activity; F:zinc ion binding;, P:7-methylguanosine mRNA capping; P:G protein-coupled receptor internalization; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of DNA helicase activity; P:regulation of transcription by RNA polymerase II; P:response to UV; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; P:viral process; scaffold36 indexed_genome mRNA 9532260 9579522 . - . ID=transcript_7452;Q16625 B5BU70 D2DU64 D2DU65 D2IGC0 D2IGC1 E2CYV9 Q5U1V4 Q8N6K1,Occludin,, PF01284;PF07303;, GO:0016324;GO:0016327;GO:0005923;GO:0030054;GO:0031252;GO:0005911;GO:0031410;GO:0030139;GO:0016021;GO:0016328;GO:0005765;GO:0005886;GO:0032991;GO:0070160;GO:0019904;GO:0070830;GO:0045216;GO:0071356;GO:0035633;GO:0010629;GO:0001933;GO:1905605;GO:0010628;GO:0046326;GO:0010592;GO:0031116;GO:0090303;GO:1902463;GO:0065003;GO:2000810;GO:0010827;GO:0070673;, C:apical plasma membrane; C:apicolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell leading edge; C:cell-cell junction; C:cytoplasmic vesicle; C:endocytic vesicle; C:integral component of membrane; C:lateral plasma membrane; C:lysosomal membrane; C:plasma membrane; C:protein-containing complex; C:tight junction;, F:protein domain specific binding;, P:bicellular tight junction assembly; P:cell-cell junction organization; P:cellular response to tumor necrosis factor; P:maintenance of blood-brain barrier; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:positive regulation of blood-brain barrier permeability; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of lamellipodium assembly; P:positive regulation of microtubule polymerization; P:positive regulation of wound healing; P:protein localization to cell leading edge; P:protein-containing complex assembly; P:regulation of bicellular tight junction assembly; P:regulation of glucose transmembrane transport; P:response to interleukin-18;|Q16625 B5BU70 D2DU64 D2DU65 D2IGC0 D2IGC1 E2CYV9 Q5U1V4 Q8N6K1,Occludin,, PF01284;PF07303;, GO:0016324;GO:0016327;GO:0005923;GO:0030054;GO:0031252;GO:0005911;GO:0031410;GO:0030139;GO:0016021;GO:0016328;GO:0005765;GO:0005886;GO:0032991;GO:0070160;GO:0019904;GO:0070830;GO:0045216;GO:0071356;GO:0035633;GO:0010629;GO:0001933;GO:1905605;GO:0010628;GO:0046326;GO:0010592;GO:0031116;GO:0090303;GO:1902463;GO:0065003;GO:2000810;GO:0010827;GO:0070673;, C:apical plasma membrane; C:apicolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell leading edge; C:cell-cell junction; C:cytoplasmic vesicle; C:endocytic vesicle; C:integral component of membrane; C:lateral plasma membrane; C:lysosomal membrane; C:plasma membrane; C:protein-containing complex; C:tight junction;, F:protein domain specific binding;, P:bicellular tight junction assembly; P:cell-cell junction organization; P:cellular response to tumor necrosis factor; P:maintenance of blood-brain barrier; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:positive regulation of blood-brain barrier permeability; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of lamellipodium assembly; P:positive regulation of microtubule polymerization; P:positive regulation of wound healing; P:protein localization to cell leading edge; P:protein-containing complex assembly; P:regulation of bicellular tight junction assembly; P:regulation of glucose transmembrane transport; P:response to interleukin-18; scaffold36 indexed_genome mRNA 9617619 9634879 . - . ID=transcript_7453;Q8N4S9 A1BQX0 A1BQX1 A8KA97 Q96NM9,MARVEL domain-containing protein 2,Tricellulin {ECO:0000303|PubMed:16365161};, PF01284;PF07303;, GO:0016324;GO:0016323;GO:0005923;GO:0030054;GO:0005737;GO:0031410;GO:0016021;GO:0033010;GO:0043220;GO:0061689;GO:0070830;GO:0045216;GO:0061028;GO:0007605;, C:apical plasma membrane; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cytoplasm; C:cytoplasmic vesicle; C:integral component of membrane; C:paranodal junction; C:Schmidt-Lanterman incisure; C:tricellular tight junction;, , P:bicellular tight junction assembly; P:cell-cell junction organization; P:establishment of endothelial barrier; P:sensory perception of sound; scaffold36 indexed_genome mRNA 9644153 9649558 . + . ID=transcript_7454;O75943 A8K8X2 D3DWA5 O75714 Q7Z3S4 Q9UNK7 Q9UNR7 Q9UNR8 Q9UPF5,Cell cycle checkpoint protein RAD17,RF-C/activator 1 homolog;, , GO:0005730;GO:0005654;GO:0005634;GO:0031389;GO:0005524;GO:0003682;GO:0003689;GO:0006974;GO:0000077;GO:0006281;GO:0006260;GO:0000076;GO:0031573;GO:0033314;GO:0008156;GO:0042325;GO:1901796;, C:nucleolus; C:nucleoplasm; C:nucleus; C:Rad17 RFC-like complex;, F:ATP binding; F:chromatin binding; F:DNA clamp loader activity;, P:cellular response to DNA damage stimulus; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:intra-S DNA damage checkpoint; P:mitotic DNA replication checkpoint; P:negative regulation of DNA replication; P:regulation of phosphorylation; P:regulation of signal transduction by p53 class mediator; scaffold36 indexed_genome mRNA 9664781 9665521 . + . ID=transcript_7455;O75943 A8K8X2 D3DWA5 O75714 Q7Z3S4 Q9UNK7 Q9UNR7 Q9UNR8 Q9UPF5,Cell cycle checkpoint protein RAD17,RF-C/activator 1 homolog;, , GO:0005730;GO:0005654;GO:0005634;GO:0031389;GO:0005524;GO:0003682;GO:0003689;GO:0006974;GO:0000077;GO:0006281;GO:0006260;GO:0000076;GO:0031573;GO:0033314;GO:0008156;GO:0042325;GO:1901796;, C:nucleolus; C:nucleoplasm; C:nucleus; C:Rad17 RFC-like complex;, F:ATP binding; F:chromatin binding; F:DNA clamp loader activity;, P:cellular response to DNA damage stimulus; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:intra-S DNA damage checkpoint; P:mitotic DNA replication checkpoint; P:negative regulation of DNA replication; P:regulation of phosphorylation; P:regulation of signal transduction by p53 class mediator; scaffold36 indexed_genome mRNA 9673742 9689036 . - . ID=transcript_7456;O75943 A8K8X2 D3DWA5 O75714 Q7Z3S4 Q9UNK7 Q9UNR7 Q9UNR8 Q9UPF5,Cell cycle checkpoint protein RAD17,RF-C/activator 1 homolog;, , GO:0005730;GO:0005654;GO:0005634;GO:0031389;GO:0005524;GO:0003682;GO:0003689;GO:0006974;GO:0000077;GO:0006281;GO:0006260;GO:0000076;GO:0031573;GO:0033314;GO:0008156;GO:0042325;GO:1901796;, C:nucleolus; C:nucleoplasm; C:nucleus; C:Rad17 RFC-like complex;, F:ATP binding; F:chromatin binding; F:DNA clamp loader activity;, P:cellular response to DNA damage stimulus; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:intra-S DNA damage checkpoint; P:mitotic DNA replication checkpoint; P:negative regulation of DNA replication; P:regulation of phosphorylation; P:regulation of signal transduction by p53 class mediator;|Q9Y3D8 A8MSZ6 Q5F2S9,Adenylate kinase isoenzyme 6 {ECO:0000255|HAMAP-Rule:MF_03173},Adrenal gland protein AD-004;Coilin-interacting nuclear ATPase protein {ECO:0000255|HAMAP-Rule:MF_03173};Dual activity adenylate kinase/ATPase {ECO:0000255|HAMAP-Rule:MF_03173};, , GO:0015030;GO:0005813;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0004017;GO:0005524;GO:0016887;GO:0015949;, C:Cajal body; C:centrosome; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:adenylate kinase activity; F:ATP binding; F:ATPase activity;, P:nucleobase-containing small molecule interconversion;|Q16594 D3DWA3 Q5U0D1 Q9BTS1,Transcription initiation factor TFIID subunit 9,RNA polymerase II TBP-associated factor subunit G;STAF31/32;Transcription initiation factor TFIID 31 kDa subunit;Transcription initiation factor TFIID 32 kDa subunit;, PF02291;, GO:0071339;GO:0005654;GO:0005634;GO:0000125;GO:0070761;GO:0000124;GO:0030914;GO:0005669;GO:0033276;GO:0033613;GO:0051117;GO:0070742;GO:0003677;GO:0002039;GO:0046982;GO:0016251;GO:0003713;GO:0000976;GO:0000492;GO:0006974;GO:0043966;GO:0043066;GO:1902166;GO:0032435;GO:0060760;GO:0045944;GO:0050821;GO:1901796;GO:0070555;GO:0042795;GO:0006366;GO:0006367;, C:MLL1 complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:pre-snoRNP complex; C:SAGA complex; C:STAGA complex; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:activating transcription factor binding; F:ATPase binding; F:C2H2 zinc finger domain binding; F:DNA binding; F:p53 binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:box C/D snoRNP assembly; P:cellular response to DNA damage stimulus; P:histone H3 acetylation; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of response to cytokine stimulus; P:positive regulation of transcription by RNA polymerase II; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:response to interleukin-1; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q9Y3D8 A8MSZ6 Q5F2S9,Adenylate kinase isoenzyme 6 {ECO:0000255|HAMAP-Rule:MF_03173},Adrenal gland protein AD-004;Coilin-interacting nuclear ATPase protein {ECO:0000255|HAMAP-Rule:MF_03173};Dual activity adenylate kinase/ATPase {ECO:0000255|HAMAP-Rule:MF_03173};, , GO:0015030;GO:0005813;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0004017;GO:0005524;GO:0016887;GO:0015949;, C:Cajal body; C:centrosome; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:adenylate kinase activity; F:ATP binding; F:ATPase activity;, P:nucleobase-containing small molecule interconversion;|P61599 A6NHA3 B2R4G4 Q5TFT7 Q9D7H8 Q9H0Y4 Q9NQH6 Q9Y6D2,N-alpha-acetyltransferase 20,Methionine N-acetyltransferase;N-acetyltransferase 5;N-terminal acetyltransferase B complex catalytic subunit NAA20;N-terminal acetyltransferase B complex catalytic subunit NAT5;NatB catalytic subunit;, PF00583;, GO:0005737;GO:0005829;GO:0031416;GO:0005634;GO:0004596;GO:0017196;, C:cytoplasm; C:cytosol; C:NatB complex; C:nucleus;, F:peptide alpha-N-acetyltransferase activity;, P:N-terminal peptidyl-methionine acetylation; scaffold36 indexed_genome mRNA 9691394 9692078 . - . ID=transcript_7457;Q9Y3D8 A8MSZ6 Q5F2S9,Adenylate kinase isoenzyme 6 {ECO:0000255|HAMAP-Rule:MF_03173},Adrenal gland protein AD-004;Coilin-interacting nuclear ATPase protein {ECO:0000255|HAMAP-Rule:MF_03173};Dual activity adenylate kinase/ATPase {ECO:0000255|HAMAP-Rule:MF_03173};, , GO:0015030;GO:0005813;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0004017;GO:0005524;GO:0016887;GO:0015949;, C:Cajal body; C:centrosome; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:adenylate kinase activity; F:ATP binding; F:ATPase activity;, P:nucleobase-containing small molecule interconversion; scaffold36 indexed_genome mRNA 9711307 9718770 . - . ID=transcript_7458;P50613 Q9BS60 Q9UE19,Cyclin-dependent kinase 7,39 kDa protein kinase;CDK-activating kinase 1;Cell division protein kinase 7;Serine/threonine-protein kinase 1;TFIIH basal transcription factor complex kinase subunit;, PF00069;, GO:0070516;GO:0019907;GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0000439;GO:0005675;GO:0070985;GO:0005524;GO:0004693;GO:0008094;GO:0008022;GO:0004672;GO:0106310;GO:0106311;GO:0008353;GO:0006370;GO:0007050;GO:0051301;GO:0000082;GO:0000086;GO:0006294;GO:0070816;GO:0045944;GO:0006468;GO:0050821;GO:0000079;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:CAK-ERCC2 complex; C:cyclin-dependent protein kinase activating kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex; C:transcription factor TFIIK complex;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:DNA-dependent ATPase activity; F:protein C-terminus binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:7-methylguanosine mRNA capping; P:cell cycle arrest; P:cell division; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:nucleotide-excision repair, preincision complex assembly; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; scaffold36 indexed_genome mRNA 9724438 9734221 . - . ID=transcript_7459;P82909 Q9H2H4,28S ribosomal protein S36, mitochondrial,Alpha-ketoglutarate dehydrogenase component 4;, , GO:0005743;GO:0009353;GO:0005763;GO:0005739;GO:0003735;GO:0006103;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial oxoglutarate dehydrogenase complex; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:2-oxoglutarate metabolic process; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold36 indexed_genome mRNA 9742123 9759844 . - . ID=transcript_7460;Q9H3R5 A8K3Y1,Centromere protein H,Interphase centromere complex protein 35;, PF05837;, GO:0005694;GO:0000777;GO:0005829;GO:0000776;GO:0005730;GO:0005654;GO:0005634;GO:0043515;GO:0034080;GO:0007059;GO:0051382;GO:0051383;GO:0007052;, C:chromosome; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus;, F:kinetochore binding;, P:CENP-A containing nucleosome assembly; P:chromosome segregation; P:kinetochore assembly; P:kinetochore organization; P:mitotic spindle organization;|Q9H3R5 A8K3Y1,Centromere protein H,Interphase centromere complex protein 35;, PF05837;, GO:0005694;GO:0000777;GO:0005829;GO:0000776;GO:0005730;GO:0005654;GO:0005634;GO:0043515;GO:0034080;GO:0007059;GO:0051382;GO:0051383;GO:0007052;, C:chromosome; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus;, F:kinetochore binding;, P:CENP-A containing nucleosome assembly; P:chromosome segregation; P:kinetochore assembly; P:kinetochore organization; P:mitotic spindle organization; scaffold36 indexed_genome mRNA 9767320 9776559 . - . ID=transcript_7461;P14635 A8K066 Q5TZP9,G2/mitotic-specific cyclin-B1,, PF02984;PF00134;, GO:0005813;GO:0000942;GO:0097125;GO:0000307;GO:0005737;GO:0005829;GO:0016020;GO:0005759;GO:0005654;GO:0005634;GO:0000922;GO:0061575;GO:0016538;GO:0005113;GO:0019901;GO:0044389;GO:0031145;GO:0051301;GO:0071398;GO:0071456;GO:0071283;GO:0071407;GO:0048565;GO:0006977;GO:0000086;GO:2000775;GO:0001701;GO:0044772;GO:0007076;GO:0007080;GO:0007077;GO:0007084;GO:0007052;GO:0010629;GO:0001933;GO:0001556;GO:0051987;GO:0060045;GO:0048146;GO:0010971;GO:0033129;GO:1905448;GO:0045931;GO:0031442;GO:0065003;GO:0051726;GO:0060623;GO:0000079;GO:1901990;GO:0090266;GO:0060260;GO:0046680;GO:0042493;GO:0009612;GO:0007283;GO:0042246;GO:0055015;, C:centrosome; C:condensed nuclear chromosome outer kinetochore; C:cyclin B1-CDK1 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:membrane; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:spindle pole;, F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:patched binding; F:protein kinase binding; F:ubiquitin-like protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:cellular response to fatty acid; P:cellular response to hypoxia; P:cellular response to iron(III) ion; P:cellular response to organic cyclic compound; P:digestive tract development; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G2/M transition of mitotic cell cycle; P:histone H3-S10 phosphorylation involved in chromosome condensation; P:in utero embryonic development; P:mitotic cell cycle phase transition; P:mitotic chromosome condensation; P:mitotic metaphase plate congression; P:mitotic nuclear envelope disassembly; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:oocyte maturation; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of histone phosphorylation; P:positive regulation of mitochondrial ATP synthesis coupled electron transport; P:positive regulation of mitotic cell cycle; P:positive regulation of mRNA 3'-end processing; P:protein-containing complex assembly; P:regulation of cell cycle; P:regulation of chromosome condensation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to DDT; P:response to drug; P:response to mechanical stimulus; P:spermatogenesis; P:tissue regeneration; P:ventricular cardiac muscle cell development; scaffold36 indexed_genome mRNA 9791214 9823592 . - . ID=transcript_7462;Q8TAD4 B7ZM89 Q6UX54 Q7L4M4 Q8TDG3 Q9BVY8 Q9H9H1,Zinc transporter 5,Solute carrier family 30 member 5;ZnT-like transporter 1;, PF01545;, GO:0016324;GO:0005794;GO:0005887;GO:0016020;GO:0005730;GO:0005654;GO:0030141;GO:0030667;GO:0008270;GO:0005385;GO:0006882;GO:0006824;GO:0010155;GO:0010043;GO:0071577;GO:0006829;, C:apical plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:nucleolus; C:nucleoplasm; C:secretory granule; C:secretory granule membrane;, F:zinc ion binding; F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:cobalt ion transport; P:regulation of proton transport; P:response to zinc ion; P:zinc ion transmembrane transport; P:zinc ion transport;|Q8TAD4 B7ZM89 Q6UX54 Q7L4M4 Q8TDG3 Q9BVY8 Q9H9H1,Zinc transporter 5,Solute carrier family 30 member 5;ZnT-like transporter 1;, PF01545;, GO:0016324;GO:0005794;GO:0005887;GO:0016020;GO:0005730;GO:0005654;GO:0030141;GO:0030667;GO:0008270;GO:0005385;GO:0006882;GO:0006824;GO:0010155;GO:0010043;GO:0071577;GO:0006829;, C:apical plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:nucleolus; C:nucleoplasm; C:secretory granule; C:secretory granule membrane;, F:zinc ion binding; F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:cobalt ion transport; P:regulation of proton transport; P:response to zinc ion; P:zinc ion transmembrane transport; P:zinc ion transport;|Q8TAD4 B7ZM89 Q6UX54 Q7L4M4 Q8TDG3 Q9BVY8 Q9H9H1,Zinc transporter 5,Solute carrier family 30 member 5;ZnT-like transporter 1;, PF01545;, GO:0016324;GO:0005794;GO:0005887;GO:0016020;GO:0005730;GO:0005654;GO:0030141;GO:0030667;GO:0008270;GO:0005385;GO:0006882;GO:0006824;GO:0010155;GO:0010043;GO:0071577;GO:0006829;, C:apical plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:nucleolus; C:nucleoplasm; C:secretory granule; C:secretory granule membrane;, F:zinc ion binding; F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:cobalt ion transport; P:regulation of proton transport; P:response to zinc ion; P:zinc ion transmembrane transport; P:zinc ion transport;|Q8TAD4 B7ZM89 Q6UX54 Q7L4M4 Q8TDG3 Q9BVY8 Q9H9H1,Zinc transporter 5,Solute carrier family 30 member 5;ZnT-like transporter 1;, PF01545;, GO:0016324;GO:0005794;GO:0005887;GO:0016020;GO:0005730;GO:0005654;GO:0030141;GO:0030667;GO:0008270;GO:0005385;GO:0006882;GO:0006824;GO:0010155;GO:0010043;GO:0071577;GO:0006829;, C:apical plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:nucleolus; C:nucleoplasm; C:secretory granule; C:secretory granule membrane;, F:zinc ion binding; F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:cobalt ion transport; P:regulation of proton transport; P:response to zinc ion; P:zinc ion transmembrane transport; P:zinc ion transport; scaffold36 indexed_genome mRNA 10625485 10630067 . - . ID=transcript_7463;P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5,Phosphatidylinositol 3-kinase regulatory subunit alpha,Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha;, PF16454;PF00620;PF00017;, GO:0005911;GO:0005801;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:1990578;GO:0048471;GO:0005942;GO:0005943;GO:0005886;GO:0046935;GO:0043125;GO:0043559;GO:0005158;GO:0043560;GO:0005159;GO:0005168;GO:0043548;GO:0035014;GO:0036312;GO:0001784;GO:0046982;GO:0019903;GO:0008134;GO:0005068;GO:0007411;GO:0030183;GO:0001678;GO:0032869;GO:0034644;GO:0019221;GO:0007173;GO:0038128;GO:0008625;GO:0038095;GO:0038096;GO:0007186;GO:0060396;GO:0008286;GO:0048009;GO:0008630;GO:0050900;GO:0000165;GO:0043066;GO:0001953;GO:0045671;GO:0051497;GO:0014065;GO:0006661;GO:0046854;GO:0048015;GO:0030168;GO:0030335;GO:1900103;GO:0051491;GO:0120183;GO:0046326;GO:0010592;GO:0014068;GO:0042307;GO:0051897;GO:1903078;GO:0033120;GO:0045944;GO:0032760;GO:0006606;GO:0006468;GO:0050821;GO:0046626;GO:0043551;GO:0034976;GO:0034446;GO:0031295;GO:0050852;GO:0048010;GO:0016032;, C:cell-cell junction; C:cis-Golgi network; C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:perinuclear endoplasmic reticulum membrane; C:perinuclear region of cytoplasm; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IA; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:ErbB-3 class receptor binding; F:insulin binding; F:insulin receptor binding; F:insulin receptor substrate binding; F:insulin-like growth factor receptor binding; F:neurotrophin TRKA receptor binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylinositol 3-kinase regulator activity; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:phosphotyrosine residue binding; F:protein heterodimerization activity; F:protein phosphatase binding; F:transcription factor binding; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:axon guidance; P:B cell differentiation; P:cellular glucose homeostasis; P:cellular response to insulin stimulus; P:cellular response to UV; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:growth hormone receptor signaling pathway; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:leukocyte migration; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell-matrix adhesion; P:negative regulation of osteoclast differentiation; P:negative regulation of stress fiber assembly; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:platelet activation; P:positive regulation of cell migration; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of filopodium assembly; P:positive regulation of focal adhesion disassembly; P:positive regulation of glucose import; P:positive regulation of lamellipodium assembly; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of RNA splicing; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:protein import into nucleus; P:protein phosphorylation; P:protein stabilization; P:regulation of insulin receptor signaling pathway; P:regulation of phosphatidylinositol 3-kinase activity; P:response to endoplasmic reticulum stress; P:substrate adhesion-dependent cell spreading; P:T cell costimulation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; scaffold36 indexed_genome mRNA 10630293 10707500 . - . ID=transcript_7464;P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5,Phosphatidylinositol 3-kinase regulatory subunit alpha,Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha;, PF16454;PF00620;PF00017;, GO:0005911;GO:0005801;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:1990578;GO:0048471;GO:0005942;GO:0005943;GO:0005886;GO:0046935;GO:0043125;GO:0043559;GO:0005158;GO:0043560;GO:0005159;GO:0005168;GO:0043548;GO:0035014;GO:0036312;GO:0001784;GO:0046982;GO:0019903;GO:0008134;GO:0005068;GO:0007411;GO:0030183;GO:0001678;GO:0032869;GO:0034644;GO:0019221;GO:0007173;GO:0038128;GO:0008625;GO:0038095;GO:0038096;GO:0007186;GO:0060396;GO:0008286;GO:0048009;GO:0008630;GO:0050900;GO:0000165;GO:0043066;GO:0001953;GO:0045671;GO:0051497;GO:0014065;GO:0006661;GO:0046854;GO:0048015;GO:0030168;GO:0030335;GO:1900103;GO:0051491;GO:0120183;GO:0046326;GO:0010592;GO:0014068;GO:0042307;GO:0051897;GO:1903078;GO:0033120;GO:0045944;GO:0032760;GO:0006606;GO:0006468;GO:0050821;GO:0046626;GO:0043551;GO:0034976;GO:0034446;GO:0031295;GO:0050852;GO:0048010;GO:0016032;, C:cell-cell junction; C:cis-Golgi network; C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:perinuclear endoplasmic reticulum membrane; C:perinuclear region of cytoplasm; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IA; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:ErbB-3 class receptor binding; F:insulin binding; F:insulin receptor binding; F:insulin receptor substrate binding; F:insulin-like growth factor receptor binding; F:neurotrophin TRKA receptor binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylinositol 3-kinase regulator activity; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:phosphotyrosine residue binding; F:protein heterodimerization activity; F:protein phosphatase binding; F:transcription factor binding; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:axon guidance; P:B cell differentiation; P:cellular glucose homeostasis; P:cellular response to insulin stimulus; P:cellular response to UV; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:growth hormone receptor signaling pathway; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:leukocyte migration; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell-matrix adhesion; P:negative regulation of osteoclast differentiation; P:negative regulation of stress fiber assembly; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:platelet activation; P:positive regulation of cell migration; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of filopodium assembly; P:positive regulation of focal adhesion disassembly; P:positive regulation of glucose import; P:positive regulation of lamellipodium assembly; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of RNA splicing; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:protein import into nucleus; P:protein phosphorylation; P:protein stabilization; P:regulation of insulin receptor signaling pathway; P:regulation of phosphatidylinositol 3-kinase activity; P:response to endoplasmic reticulum stress; P:substrate adhesion-dependent cell spreading; P:T cell costimulation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; scaffold36 indexed_genome mRNA 11648858 11649497 . + . ID=transcript_7465;Q99467 B2R7Z7 Q32MM5,CD180 antigen,Lymphocyte antigen 64;Radioprotective 105 kDa protein;, PF00560;PF18831;PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0002322;GO:0071222;GO:0006954;GO:0045087;GO:0031666;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:B cell proliferation involved in immune response; P:cellular response to lipopolysaccharide; P:inflammatory response; P:innate immune response; P:positive regulation of lipopolysaccharide-mediated signaling pathway; scaffold36 indexed_genome mRNA 11649648 11650577 . + . ID=transcript_7466;Q99467 B2R7Z7 Q32MM5,CD180 antigen,Lymphocyte antigen 64;Radioprotective 105 kDa protein;, PF00560;PF18831;PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0002322;GO:0071222;GO:0006954;GO:0045087;GO:0031666;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:B cell proliferation involved in immune response; P:cellular response to lipopolysaccharide; P:inflammatory response; P:innate immune response; P:positive regulation of lipopolysaccharide-mediated signaling pathway; scaffold36 indexed_genome mRNA 11661195 11666454 . + . ID=transcript_7467;O15021 A6NL49 B5ME48 E7EWQ5 J3QT34 Q05EE6 Q6ZN07 Q8N4X4 Q96LY3,Microtubule-associated serine/threonine-protein kinase 4 {ECO:0000305},, PF08926;PF17820;PF00069;, GO:0005737;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;, C:cytoplasm;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; scaffold36 indexed_genome mRNA 11669092 11729019 . - . ID=transcript_7468;O15021 A6NL49 B5ME48 E7EWQ5 J3QT34 Q05EE6 Q6ZN07 Q8N4X4 Q96LY3,Microtubule-associated serine/threonine-protein kinase 4 {ECO:0000305},, PF08926;PF17820;PF00069;, GO:0005737;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;, C:cytoplasm;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; scaffold36 indexed_genome mRNA 12635700 12659539 . - . ID=transcript_7469;Q8WXA9 A4FTW3 Q2M1J0 Q86X37,Splicing regulatory glutamine/lysine-rich protein 1,Serine/arginine-rich-splicing regulatory protein 86;Splicing factor, arginine/serine-rich 12;Splicing regulatory protein 508;, PF00076;, GO:0016607;GO:0005654;GO:0005681;GO:0003723;GO:0006397;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:RNA splicing;|Q8WXA9 A4FTW3 Q2M1J0 Q86X37,Splicing regulatory glutamine/lysine-rich protein 1,Serine/arginine-rich-splicing regulatory protein 86;Splicing factor, arginine/serine-rich 12;Splicing regulatory protein 508;, PF00076;, GO:0016607;GO:0005654;GO:0005681;GO:0003723;GO:0006397;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:RNA splicing; scaffold36 indexed_genome mRNA 12659852 12682695 . - . ID=transcript_7470;Q05519 Q5T758 Q8IWE6,Serine/arginine-rich splicing factor 11,Arginine-rich 54 kDa nuclear protein;Splicing factor, arginine/serine-rich 11;, PF00076;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0006405;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing;|Q05519 Q5T758 Q8IWE6,Serine/arginine-rich splicing factor 11,Arginine-rich 54 kDa nuclear protein;Splicing factor, arginine/serine-rich 11;, PF00076;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0006405;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing;|Q05519 Q5T758 Q8IWE6,Serine/arginine-rich splicing factor 11,Arginine-rich 54 kDa nuclear protein;Splicing factor, arginine/serine-rich 11;, PF00076;, GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0006405;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; scaffold36 indexed_genome mRNA 12920164 12923507 . + . ID=transcript_7471;Q9BYT8 Q9ULJ4,Neurolysin, mitochondrial,Angiotensin-binding protein;Microsomal endopeptidase;Mitochondrial oligopeptidase M;Neurotensin endopeptidase;, PF01432;, GO:0005576;GO:0005758;GO:0005886;GO:0046872;GO:0004222;GO:0042277;GO:0007186;GO:0006518;GO:0006508;GO:0006111;GO:1902809;, C:extracellular region; C:mitochondrial intermembrane space; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:peptide binding;, P:G protein-coupled receptor signaling pathway; P:peptide metabolic process; P:proteolysis; P:regulation of gluconeogenesis; P:regulation of skeletal muscle fiber differentiation;|Q9BYT8 Q9ULJ4,Neurolysin, mitochondrial,Angiotensin-binding protein;Microsomal endopeptidase;Mitochondrial oligopeptidase M;Neurotensin endopeptidase;, PF01432;, GO:0005576;GO:0005758;GO:0005886;GO:0046872;GO:0004222;GO:0042277;GO:0007186;GO:0006518;GO:0006508;GO:0006111;GO:1902809;, C:extracellular region; C:mitochondrial intermembrane space; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:peptide binding;, P:G protein-coupled receptor signaling pathway; P:peptide metabolic process; P:proteolysis; P:regulation of gluconeogenesis; P:regulation of skeletal muscle fiber differentiation; scaffold36 indexed_genome mRNA 12971319 13016048 . + . ID=transcript_7472;Q96EQ0,Small glutamine-rich tetratricopeptide repeat-containing protein beta,Beta-SGT;Small glutamine-rich protein with tetratricopeptide repeats 2;, PF16546;PF00515;, GO:0016020;GO:0072380;GO:0060090;GO:1903646;GO:0006620;GO:0030433;, C:membrane; C:TRC complex;, F:molecular adaptor activity;, P:positive regulation of chaperone-mediated protein folding; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:ubiquitin-dependent ERAD pathway; scaffold36 indexed_genome mRNA 13019872 13029002 . - . ID=transcript_7473;A5PLN9 Q17RZ9 Q49A23 Q4JHG0 Q6MZG4 Q8TCM2 Q9H8I3,Trafficking protein particle complex subunit 13,, PF06159;, GO:0005829;GO:1990072;, C:cytosol; C:TRAPPIII protein complex;|A5PLN9 Q17RZ9 Q49A23 Q4JHG0 Q6MZG4 Q8TCM2 Q9H8I3,Trafficking protein particle complex subunit 13,, PF06159;, GO:0005829;GO:1990072;, C:cytosol; C:TRAPPIII protein complex;|A5PLN9 Q17RZ9 Q49A23 Q4JHG0 Q6MZG4 Q8TCM2 Q9H8I3,Trafficking protein particle complex subunit 13,, PF06159;, GO:0005829;GO:1990072;, C:cytosol; C:TRAPPIII protein complex;|A5PLN9 Q17RZ9 Q49A23 Q4JHG0 Q6MZG4 Q8TCM2 Q9H8I3,Trafficking protein particle complex subunit 13,, PF06159;, GO:0005829;GO:1990072;, C:cytosol; C:TRAPPIII protein complex; scaffold36 indexed_genome mRNA 13033509 13052370 . - . ID=transcript_7474;A5PLN9 Q17RZ9 Q49A23 Q4JHG0 Q6MZG4 Q8TCM2 Q9H8I3,Trafficking protein particle complex subunit 13,, PF06159;, GO:0005829;GO:1990072;, C:cytosol; C:TRAPPIII protein complex;|A5PLN9 Q17RZ9 Q49A23 Q4JHG0 Q6MZG4 Q8TCM2 Q9H8I3,Trafficking protein particle complex subunit 13,, PF06159;, GO:0005829;GO:1990072;, C:cytosol; C:TRAPPIII protein complex;|Q6ZNX1,Shieldin complex subunit 3 {ECO:0000312|HGNC:HGNC:53826},REV7-interacting novel NHEJ regulator 1 {ECO:0000303|PubMed:29656893};Shield complex subunit 3;, , GO:0005694;GO:0035861;GO:0006281;GO:2000042;GO:2001034;GO:0045830;, C:chromosome; C:site of double-strand break;, , P:DNA repair; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching; scaffold36 indexed_genome mRNA 13052751 13115272 . + . ID=transcript_7475;P36406 Q9BZY4 Q9BZY5,E3 ubiquitin-protein ligase TRIM23,ADP-ribosylation factor domain-containing protein 1;GTP-binding protein ARD-1;RING finger protein 46;RING-type E3 ubiquitin transferase TRIM23 {ECO:0000305};Tripartite motif-containing protein 23;, PF00025;PF00643;PF14634;, GO:0000139;GO:0005765;GO:0005634;GO:0005886;GO:0008047;GO:0019003;GO:0005525;GO:0003924;GO:0042802;GO:0004842;GO:0008270;GO:0045087;GO:0006886;GO:0016567;GO:0016192;GO:0016032;, C:Golgi membrane; C:lysosomal membrane; C:nucleus; C:plasma membrane;, F:enzyme activator activity; F:GDP binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:intracellular protein transport; P:protein ubiquitination; P:vesicle-mediated transport; P:viral process;|P36406 Q9BZY4 Q9BZY5,E3 ubiquitin-protein ligase TRIM23,ADP-ribosylation factor domain-containing protein 1;GTP-binding protein ARD-1;RING finger protein 46;RING-type E3 ubiquitin transferase TRIM23 {ECO:0000305};Tripartite motif-containing protein 23;, PF00025;PF00643;PF14634;, GO:0000139;GO:0005765;GO:0005634;GO:0005886;GO:0008047;GO:0019003;GO:0005525;GO:0003924;GO:0042802;GO:0004842;GO:0008270;GO:0045087;GO:0006886;GO:0016567;GO:0016192;GO:0016032;, C:Golgi membrane; C:lysosomal membrane; C:nucleus; C:plasma membrane;, F:enzyme activator activity; F:GDP binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:intracellular protein transport; P:protein ubiquitination; P:vesicle-mediated transport; P:viral process;|P36406 Q9BZY4 Q9BZY5,E3 ubiquitin-protein ligase TRIM23,ADP-ribosylation factor domain-containing protein 1;GTP-binding protein ARD-1;RING finger protein 46;RING-type E3 ubiquitin transferase TRIM23 {ECO:0000305};Tripartite motif-containing protein 23;, PF00025;PF00643;PF14634;, GO:0000139;GO:0005765;GO:0005634;GO:0005886;GO:0008047;GO:0019003;GO:0005525;GO:0003924;GO:0042802;GO:0004842;GO:0008270;GO:0045087;GO:0006886;GO:0016567;GO:0016192;GO:0016032;, C:Golgi membrane; C:lysosomal membrane; C:nucleus; C:plasma membrane;, F:enzyme activator activity; F:GDP binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:intracellular protein transport; P:protein ubiquitination; P:vesicle-mediated transport; P:viral process;|P36406 Q9BZY4 Q9BZY5,E3 ubiquitin-protein ligase TRIM23,ADP-ribosylation factor domain-containing protein 1;GTP-binding protein ARD-1;RING finger protein 46;RING-type E3 ubiquitin transferase TRIM23 {ECO:0000305};Tripartite motif-containing protein 23;, PF00025;PF00643;PF14634;, GO:0000139;GO:0005765;GO:0005634;GO:0005886;GO:0008047;GO:0019003;GO:0005525;GO:0003924;GO:0042802;GO:0004842;GO:0008270;GO:0045087;GO:0006886;GO:0016567;GO:0016192;GO:0016032;, C:Golgi membrane; C:lysosomal membrane; C:nucleus; C:plasma membrane;, F:enzyme activator activity; F:GDP binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:intracellular protein transport; P:protein ubiquitination; P:vesicle-mediated transport; P:viral process;|P36406 Q9BZY4 Q9BZY5,E3 ubiquitin-protein ligase TRIM23,ADP-ribosylation factor domain-containing protein 1;GTP-binding protein ARD-1;RING finger protein 46;RING-type E3 ubiquitin transferase TRIM23 {ECO:0000305};Tripartite motif-containing protein 23;, PF00025;PF00643;PF14634;, GO:0000139;GO:0005765;GO:0005634;GO:0005886;GO:0008047;GO:0019003;GO:0005525;GO:0003924;GO:0042802;GO:0004842;GO:0008270;GO:0045087;GO:0006886;GO:0016567;GO:0016192;GO:0016032;, C:Golgi membrane; C:lysosomal membrane; C:nucleus; C:plasma membrane;, F:enzyme activator activity; F:GDP binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:intracellular protein transport; P:protein ubiquitination; P:vesicle-mediated transport; P:viral process;|P36406 Q9BZY4 Q9BZY5,E3 ubiquitin-protein ligase TRIM23,ADP-ribosylation factor domain-containing protein 1;GTP-binding protein ARD-1;RING finger protein 46;RING-type E3 ubiquitin transferase TRIM23 {ECO:0000305};Tripartite motif-containing protein 23;, PF00025;PF00643;PF14634;, GO:0000139;GO:0005765;GO:0005634;GO:0005886;GO:0008047;GO:0019003;GO:0005525;GO:0003924;GO:0042802;GO:0004842;GO:0008270;GO:0045087;GO:0006886;GO:0016567;GO:0016192;GO:0016032;, C:Golgi membrane; C:lysosomal membrane; C:nucleus; C:plasma membrane;, F:enzyme activator activity; F:GDP binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:intracellular protein transport; P:protein ubiquitination; P:vesicle-mediated transport; P:viral process;|Q96BP3 B4DWR9 Q15002 Q7KZ89,Peptidylprolyl isomerase domain and WD repeat-containing protein 1 {ECO:0000305},Spliceosome-associated cyclophilin {ECO:0000305|PubMed:11991638};, PF00160;PF00400;, GO:0071013;GO:0016604;GO:0005654;GO:0016018;GO:0003755;GO:0000398;GO:0000413;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:mRNA splicing, via spliceosome; P:protein peptidyl-prolyl isomerization;|Q96BP3 B4DWR9 Q15002 Q7KZ89,Peptidylprolyl isomerase domain and WD repeat-containing protein 1 {ECO:0000305},Spliceosome-associated cyclophilin {ECO:0000305|PubMed:11991638};, PF00160;PF00400;, GO:0071013;GO:0016604;GO:0005654;GO:0016018;GO:0003755;GO:0000398;GO:0000413;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:mRNA splicing, via spliceosome; P:protein peptidyl-prolyl isomerization;|Q96BP3 B4DWR9 Q15002 Q7KZ89,Peptidylprolyl isomerase domain and WD repeat-containing protein 1 {ECO:0000305},Spliceosome-associated cyclophilin {ECO:0000305|PubMed:11991638};, PF00160;PF00400;, GO:0071013;GO:0016604;GO:0005654;GO:0016018;GO:0003755;GO:0000398;GO:0000413;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:mRNA splicing, via spliceosome; P:protein peptidyl-prolyl isomerization;|Q96BP3 B4DWR9 Q15002 Q7KZ89,Peptidylprolyl isomerase domain and WD repeat-containing protein 1 {ECO:0000305},Spliceosome-associated cyclophilin {ECO:0000305|PubMed:11991638};, PF00160;PF00400;, GO:0071013;GO:0016604;GO:0005654;GO:0016018;GO:0003755;GO:0000398;GO:0000413;, C:catalytic step 2 spliceosome; C:nuclear body; C:nucleoplasm;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:mRNA splicing, via spliceosome; P:protein peptidyl-prolyl isomerization; scaffold36 indexed_genome mRNA 13115383 13147036 . + . ID=transcript_7476;Q9BS16 Q9H4L0,Centromere protein K,Interphase centromere complex protein 37;Protein AF-5alpha;p33;, PF11802;, GO:0000941;GO:0005829;GO:0005654;GO:0034080;GO:0051382;GO:0000070;GO:0007052;, C:condensed nuclear chromosome inner kinetochore; C:cytosol; C:nucleoplasm;, , P:CENP-A containing nucleosome assembly; P:kinetochore assembly; P:mitotic sister chromatid segregation; P:mitotic spindle organization;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold36 indexed_genome mRNA 13167291 13274684 . + . ID=transcript_7477;Q9UKP5 Q59EX6 Q5IR87 Q5IR88 Q5IR89 Q68DL1,A disintegrin and metalloproteinase with thrombospondin motifs 6,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0035904;GO:0003279;GO:0060976;GO:0030198;GO:0001822;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:aorta development; P:cardiac septum development; P:coronary vasculature development; P:extracellular matrix organization; P:kidney development; scaffold36 indexed_genome mRNA 13305498 13385311 . + . ID=transcript_7478;Q9UKP5 Q59EX6 Q5IR87 Q5IR88 Q5IR89 Q68DL1,A disintegrin and metalloproteinase with thrombospondin motifs 6,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0035904;GO:0003279;GO:0060976;GO:0030198;GO:0001822;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:aorta development; P:cardiac septum development; P:coronary vasculature development; P:extracellular matrix organization; P:kidney development; scaffold36 indexed_genome mRNA 13404408 13440709 . + . ID=transcript_7479;Q9UKP5 Q59EX6 Q5IR87 Q5IR88 Q5IR89 Q68DL1,A disintegrin and metalloproteinase with thrombospondin motifs 6,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0035904;GO:0003279;GO:0060976;GO:0030198;GO:0001822;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:aorta development; P:cardiac septum development; P:coronary vasculature development; P:extracellular matrix organization; P:kidney development;|Q9UKP5 Q59EX6 Q5IR87 Q5IR88 Q5IR89 Q68DL1,A disintegrin and metalloproteinase with thrombospondin motifs 6,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0035904;GO:0003279;GO:0060976;GO:0030198;GO:0001822;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:aorta development; P:cardiac septum development; P:coronary vasculature development; P:extracellular matrix organization; P:kidney development; scaffold36 indexed_genome mRNA 13563943 13788453 . - . ID=transcript_7480;Q6UX04 O60529 O60530 Q96EM3,Spliceosome-associated protein CWC27 homolog {ECO:0000305},Antigen NY-CO-10 {ECO:0000303|PubMed:9610721};Probable inactive peptidyl-prolyl cis-trans isomerase CWC27 homolog {ECO:0000305|PubMed:20676357};Serologically defined colon cancer antigen 10;, PF00160;, GO:0071013;GO:0005654;GO:0071005;GO:0000398;GO:0006457;GO:0000413;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:U2-type precatalytic spliceosome;, , P:mRNA splicing, via spliceosome; P:protein folding; P:protein peptidyl-prolyl isomerization; scaffold36 indexed_genome mRNA 13822792 13824400 . - . ID=transcript_7481;A6NKW6,Protein shisa-like-2B {ECO:0000312|HGNC:HGNC:34236},, , GO:0016021;, C:integral component of membrane; scaffold36 indexed_genome mRNA 13914950 14019543 . - . ID=transcript_7482;Q6MZT1 B7Z3X1,Regulator of G-protein signaling 7-binding protein,R7 family-binding protein;, , GO:0099031;GO:0099026;GO:0005737;GO:0098978;GO:0005634;GO:0007186;GO:0009968;GO:0060078;, C:anchored component of postsynaptic density membrane; C:anchored component of presynaptic membrane; C:cytoplasm; C:glutamatergic synapse; C:nucleus;, , P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of postsynaptic membrane potential; scaffold36 indexed_genome mRNA 14146228 14390234 . - . ID=transcript_7483;Q86T96 Q0JSU3 Q495A8 Q8NBD1,E3 ubiquitin-protein ligase RNF180,RING finger protein 180;RING-type E3 ubiquitin transferase RNF180 {ECO:0000305};, , GO:0016021;GO:0031227;GO:0005635;GO:0046872;GO:0031624;GO:0061630;GO:0030534;GO:0042415;GO:0032436;GO:0031398;GO:0000209;GO:0050790;GO:0042428;, C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane; C:nuclear envelope;, F:metal ion binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:adult behavior; P:norepinephrine metabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein polyubiquitination; P:regulation of catalytic activity; P:serotonin metabolic process; scaffold36 indexed_genome mRNA 15761190 15761720 . - . ID=transcript_7484;Q9UI26 A6NGJ5 B4DZ73 D3DW98 Q8N5R2 Q9NSJ6 Q9NVB1,Importin-11,Ran-binding protein 11;, PF03810;, GO:0005829;GO:0005635;GO:0005654;GO:0061608;GO:0031267;GO:0006606;GO:0006610;, C:cytosol; C:nuclear envelope; C:nucleoplasm;, F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus; P:ribosomal protein import into nucleus; scaffold36 indexed_genome mRNA 15795063 15922446 . - . ID=transcript_7485;Q9UI26 A6NGJ5 B4DZ73 D3DW98 Q8N5R2 Q9NSJ6 Q9NVB1,Importin-11,Ran-binding protein 11;, PF03810;, GO:0005829;GO:0005635;GO:0005654;GO:0061608;GO:0031267;GO:0006606;GO:0006610;, C:cytosol; C:nuclear envelope; C:nucleoplasm;, F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus; P:ribosomal protein import into nucleus;|Q7Z2Q7 Q6ZWI5,Leucine-rich repeat-containing protein 70,Synleurin;, PF13855;, GO:0005887;GO:0060760;, C:integral component of plasma membrane;, , P:positive regulation of response to cytokine stimulus; scaffold36 indexed_genome mRNA 15932646 15974994 . + . ID=transcript_7486;Q9UNQ2 O76025 Q9BU77 Q9UES1,Probable dimethyladenosine transferase,DIM1 dimethyladenosine transferase 1 homolog;DIM1 dimethyladenosine transferase 1-like;Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase;Probable 18S rRNA dimethylase;Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase;, PF00398;, GO:0005829;GO:0005759;GO:0005730;GO:0005654;GO:0052909;GO:0003723;GO:0000179;GO:2000234;GO:0031167;, C:cytosol; C:mitochondrial matrix; C:nucleolus; C:nucleoplasm;, F:18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity;, P:positive regulation of rRNA processing; P:rRNA methylation;|Q9UNQ2 O76025 Q9BU77 Q9UES1,Probable dimethyladenosine transferase,DIM1 dimethyladenosine transferase 1 homolog;DIM1 dimethyladenosine transferase 1-like;Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase;Probable 18S rRNA dimethylase;Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase;, PF00398;, GO:0005829;GO:0005759;GO:0005730;GO:0005654;GO:0052909;GO:0003723;GO:0000179;GO:2000234;GO:0031167;, C:cytosol; C:mitochondrial matrix; C:nucleolus; C:nucleoplasm;, F:18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity;, P:positive regulation of rRNA processing; P:rRNA methylation;|Q9UNQ2 O76025 Q9BU77 Q9UES1,Probable dimethyladenosine transferase,DIM1 dimethyladenosine transferase 1 homolog;DIM1 dimethyladenosine transferase 1-like;Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase;Probable 18S rRNA dimethylase;Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase;, PF00398;, GO:0005829;GO:0005759;GO:0005730;GO:0005654;GO:0052909;GO:0003723;GO:0000179;GO:2000234;GO:0031167;, C:cytosol; C:mitochondrial matrix; C:nucleolus; C:nucleoplasm;, F:18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity;, P:positive regulation of rRNA processing; P:rRNA methylation;|Q9UNQ2 O76025 Q9BU77 Q9UES1,Probable dimethyladenosine transferase,DIM1 dimethyladenosine transferase 1 homolog;DIM1 dimethyladenosine transferase 1-like;Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase;Probable 18S rRNA dimethylase;Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase;, PF00398;, GO:0005829;GO:0005759;GO:0005730;GO:0005654;GO:0052909;GO:0003723;GO:0000179;GO:2000234;GO:0031167;, C:cytosol; C:mitochondrial matrix; C:nucleolus; C:nucleoplasm;, F:18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity;, P:positive regulation of rRNA processing; P:rRNA methylation;|Q9UNQ2 O76025 Q9BU77 Q9UES1,Probable dimethyladenosine transferase,DIM1 dimethyladenosine transferase 1 homolog;DIM1 dimethyladenosine transferase 1-like;Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase;Probable 18S rRNA dimethylase;Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase;, PF00398;, GO:0005829;GO:0005759;GO:0005730;GO:0005654;GO:0052909;GO:0003723;GO:0000179;GO:2000234;GO:0031167;, C:cytosol; C:mitochondrial matrix; C:nucleolus; C:nucleoplasm;, F:18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity;, P:positive regulation of rRNA processing; P:rRNA methylation;|Q9UNQ2 O76025 Q9BU77 Q9UES1,Probable dimethyladenosine transferase,DIM1 dimethyladenosine transferase 1 homolog;DIM1 dimethyladenosine transferase 1-like;Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase;Probable 18S rRNA dimethylase;Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase;, PF00398;, GO:0005829;GO:0005759;GO:0005730;GO:0005654;GO:0052909;GO:0003723;GO:0000179;GO:2000234;GO:0031167;, C:cytosol; C:mitochondrial matrix; C:nucleolus; C:nucleoplasm;, F:18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity;, P:positive regulation of rRNA processing; P:rRNA methylation;|O00139 A5YM42 A5YM54 B4DY54 D3DW97 E9PB70 Q7Z5I3 Q8N5Q7,Kinesin-like protein KIF2A,Kinesin-2;, PF00225;, GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0016604;GO:0005730;GO:0005654;GO:0005819;GO:0000922;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0030154;GO:0051301;GO:0000226;GO:0007019;GO:0007018;GO:0090307;GO:0007052;GO:0007399;GO:0030334;GO:0006890;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:nuclear body; C:nucleolus; C:nucleoplasm; C:spindle; C:spindle pole;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell differentiation; P:cell division; P:microtubule cytoskeleton organization; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic spindle assembly; P:mitotic spindle organization; P:nervous system development; P:regulation of cell migration; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O00139 A5YM42 A5YM54 B4DY54 D3DW97 E9PB70 Q7Z5I3 Q8N5Q7,Kinesin-like protein KIF2A,Kinesin-2;, PF00225;, GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0016604;GO:0005730;GO:0005654;GO:0005819;GO:0000922;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0030154;GO:0051301;GO:0000226;GO:0007019;GO:0007018;GO:0090307;GO:0007052;GO:0007399;GO:0030334;GO:0006890;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:nuclear body; C:nucleolus; C:nucleoplasm; C:spindle; C:spindle pole;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell differentiation; P:cell division; P:microtubule cytoskeleton organization; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic spindle assembly; P:mitotic spindle organization; P:nervous system development; P:regulation of cell migration; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O00139 A5YM42 A5YM54 B4DY54 D3DW97 E9PB70 Q7Z5I3 Q8N5Q7,Kinesin-like protein KIF2A,Kinesin-2;, PF00225;, GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0016604;GO:0005730;GO:0005654;GO:0005819;GO:0000922;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0030154;GO:0051301;GO:0000226;GO:0007019;GO:0007018;GO:0090307;GO:0007052;GO:0007399;GO:0030334;GO:0006890;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:nuclear body; C:nucleolus; C:nucleoplasm; C:spindle; C:spindle pole;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell differentiation; P:cell division; P:microtubule cytoskeleton organization; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic spindle assembly; P:mitotic spindle organization; P:nervous system development; P:regulation of cell migration; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O00139 A5YM42 A5YM54 B4DY54 D3DW97 E9PB70 Q7Z5I3 Q8N5Q7,Kinesin-like protein KIF2A,Kinesin-2;, PF00225;, GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0016604;GO:0005730;GO:0005654;GO:0005819;GO:0000922;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0030154;GO:0051301;GO:0000226;GO:0007019;GO:0007018;GO:0090307;GO:0007052;GO:0007399;GO:0030334;GO:0006890;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:nuclear body; C:nucleolus; C:nucleoplasm; C:spindle; C:spindle pole;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell differentiation; P:cell division; P:microtubule cytoskeleton organization; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic spindle assembly; P:mitotic spindle organization; P:nervous system development; P:regulation of cell migration; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O00139 A5YM42 A5YM54 B4DY54 D3DW97 E9PB70 Q7Z5I3 Q8N5Q7,Kinesin-like protein KIF2A,Kinesin-2;, PF00225;, GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0016604;GO:0005730;GO:0005654;GO:0005819;GO:0000922;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0030154;GO:0051301;GO:0000226;GO:0007019;GO:0007018;GO:0090307;GO:0007052;GO:0007399;GO:0030334;GO:0006890;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:nuclear body; C:nucleolus; C:nucleoplasm; C:spindle; C:spindle pole;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell differentiation; P:cell division; P:microtubule cytoskeleton organization; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic spindle assembly; P:mitotic spindle organization; P:nervous system development; P:regulation of cell migration; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O00139 A5YM42 A5YM54 B4DY54 D3DW97 E9PB70 Q7Z5I3 Q8N5Q7,Kinesin-like protein KIF2A,Kinesin-2;, PF00225;, GO:0120103;GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0016604;GO:0005730;GO:0005654;GO:0005819;GO:0000922;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0030154;GO:0051301;GO:0000226;GO:0007019;GO:0007018;GO:0090307;GO:0007052;GO:0007399;GO:0030334;GO:0006890;, C:centriolar subdistal appendage; C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:nuclear body; C:nucleolus; C:nucleoplasm; C:spindle; C:spindle pole;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell differentiation; P:cell division; P:microtubule cytoskeleton organization; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic spindle assembly; P:mitotic spindle organization; P:nervous system development; P:regulation of cell migration; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold36 indexed_genome mRNA 16736895 16820442 . - . ID=transcript_7487;Q9HCJ5,Zinc finger SWIM domain-containing protein 6,, , GO:0031462;GO:0008270;GO:1902667;GO:0021773;, C:Cul2-RING ubiquitin ligase complex;, F:zinc ion binding;, P:regulation of axon guidance; P:striatal medium spiny neuron differentiation;|Q9HCJ5,Zinc finger SWIM domain-containing protein 6,, , GO:0031462;GO:0008270;GO:1902667;GO:0021773;, C:Cul2-RING ubiquitin ligase complex;, F:zinc ion binding;, P:regulation of axon guidance; P:striatal medium spiny neuron differentiation;|Q9HCJ5,Zinc finger SWIM domain-containing protein 6,, , GO:0031462;GO:0008270;GO:1902667;GO:0021773;, C:Cul2-RING ubiquitin ligase complex;, F:zinc ion binding;, P:regulation of axon guidance; P:striatal medium spiny neuron differentiation; scaffold36 indexed_genome mRNA 17114646 17116962 . - . ID=transcript_7488;Q8N183 A8K5I1,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2,B17.2-like;Mimitin {ECO:0000303|PubMed:15774466};Myc-induced mitochondrial protein {ECO:0000303|PubMed:15774466};NDUFA12-like protein;, PF05071;, GO:0005743;GO:0005739;GO:0044877;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrion;, F:protein-containing complex binding;, P:mitochondrial respiratory chain complex I assembly; scaffold36 indexed_genome mRNA 17274219 17331458 . + . ID=transcript_7489;Q13216 B2RB64 Q6FHX5 Q96GB9,DNA excision repair protein ERCC-8,Cockayne syndrome WD repeat protein CSA;, PF00400;, GO:0080008;GO:0031464;GO:0005737;GO:0016363;GO:0005654;GO:0000109;GO:0005634;GO:0043204;GO:0032991;GO:0044877;GO:0006974;GO:0032508;GO:0097680;GO:0006289;GO:0045739;GO:0043687;GO:0043161;GO:0051865;GO:0000209;GO:0010996;GO:0014070;GO:0006979;GO:0009411;GO:0010165;GO:0000012;GO:0006283;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleus; C:perikaryon; C:protein-containing complex;, F:protein-containing complex binding;, P:cellular response to DNA damage stimulus; P:DNA duplex unwinding; P:double-strand break repair via classical nonhomologous end joining; P:nucleotide-excision repair; P:positive regulation of DNA repair; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein polyubiquitination; P:response to auditory stimulus; P:response to organic cyclic compound; P:response to oxidative stress; P:response to UV; P:response to X-ray; P:single strand break repair; P:transcription-coupled nucleotide-excision repair; scaffold36 indexed_genome mRNA 17358827 17435639 . + . ID=transcript_7490;A1L3X0 Q589T3 Q9H5D0 Q9NT66,Elongation of very long chain fatty acids protein 7 {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000305},3-keto acyl-CoA synthase ELOVL7 {ECO:0000255|HAMAP-Rule:MF_03207};ELOVL fatty acid elongase 7 {ECO:0000255|HAMAP-Rule:MF_03207};Very long chain 3-ketoacyl-CoA synthase 7 {ECO:0000255|HAMAP-Rule:MF_03207};Very long chain 3-oxoacyl-CoA synthase 7 {ECO:0000255|HAMAP-Rule:MF_03207};, PF01151;, GO:0005783;GO:0005789;GO:0030176;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0034625;GO:0034626;GO:0019367;GO:0035338;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|A1L3X0 Q589T3 Q9H5D0 Q9NT66,Elongation of very long chain fatty acids protein 7 {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000305},3-keto acyl-CoA synthase ELOVL7 {ECO:0000255|HAMAP-Rule:MF_03207};ELOVL fatty acid elongase 7 {ECO:0000255|HAMAP-Rule:MF_03207};Very long chain 3-ketoacyl-CoA synthase 7 {ECO:0000255|HAMAP-Rule:MF_03207};Very long chain 3-oxoacyl-CoA synthase 7 {ECO:0000255|HAMAP-Rule:MF_03207};, PF01151;, GO:0005783;GO:0005789;GO:0030176;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0034625;GO:0034626;GO:0019367;GO:0035338;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold36 indexed_genome mRNA 18148986 19559651 . + . ID=transcript_7491;Q8IVD3 Q96HL4 Q9HCX7,cAMP-specific 3',5'-cyclic phosphodiesterase 4D,DPDE3;PDE43;, PF18100;PF00233;, GO:0016324;GO:0034704;GO:0005829;GO:0016020;GO:0005815;GO:0005634;GO:0048471;GO:0005886;GO:0005891;GO:0004115;GO:0004114;GO:0051117;GO:0031698;GO:0030552;GO:0019899;GO:1901363;GO:0044325;GO:0046872;GO:0097110;GO:0086024;GO:0071875;GO:0006198;GO:0019933;GO:0071320;GO:0071872;GO:0061028;GO:0007186;GO:0043951;GO:0045822;GO:0033137;GO:1901898;GO:0032729;GO:0032743;GO:0032754;GO:0086004;GO:1901844;GO:0002027;GO:0010880;GO:0060314;GO:0010469;GO:0007165;GO:0050852;, C:apical plasma membrane; C:calcium channel complex; C:cytosol; C:membrane; C:microtubule organizing center; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:voltage-gated calcium channel complex;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:ATPase binding; F:beta-2 adrenergic receptor binding; F:cAMP binding; F:enzyme binding; F:heterocyclic compound binding; F:ion channel binding; F:metal ion binding; F:scaffold protein binding;, P:adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate; P:adrenergic receptor signaling pathway; P:cAMP catabolic process; P:cAMP-mediated signaling; P:cellular response to cAMP; P:cellular response to epinephrine stimulus; P:establishment of endothelial barrier; P:G protein-coupled receptor signaling pathway; P:negative regulation of cAMP-mediated signaling; P:negative regulation of heart contraction; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of relaxation of cardiac muscle; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-5 production; P:regulation of cardiac muscle cell contraction; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of heart rate; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of signaling receptor activity; P:signal transduction; P:T cell receptor signaling pathway;|Q9H4J3 Q9H4J4 Q9UKL1 Q9UM48 Q9UM49 Q9UM50,Ubiquitin-conjugating enzyme E2 variant 1,CROC-1;TRAF6-regulated IKK activator 1 beta Uev1A;, PF00179;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0035370;GO:0031371;GO:0000151;GO:0000187;GO:0035973;GO:0030154;GO:0070498;GO:0007254;GO:0070423;GO:0043123;GO:0051092;GO:0045893;GO:0006301;GO:0070534;GO:0000209;GO:0006282;GO:0006355;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:UBC13-UEV1A complex; C:ubiquitin conjugating enzyme complex; C:ubiquitin ligase complex;, , P:activation of MAPK activity; P:aggrephagy; P:cell differentiation; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription, DNA-templated; P:postreplication repair; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of DNA repair; P:regulation of transcription, DNA-templated;|Q96E17,Ras-related protein Rab-3C,, PF00071;, GO:0098993;GO:0005829;GO:0005768;GO:0048471;GO:0005886;GO:0008021;GO:0031982;GO:0005525;GO:0030742;GO:0003924;GO:0031489;GO:0019882;GO:0072659;GO:0009306;GO:0017157;GO:0006904;, C:anchored component of synaptic vesicle membrane; C:cytosol; C:endosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:synaptic vesicle; C:vesicle;, F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity; F:myosin V binding;, P:antigen processing and presentation; P:protein localization to plasma membrane; P:protein secretion; P:regulation of exocytosis; P:vesicle docking involved in exocytosis; scaffold36 indexed_genome mRNA 19672710 19677046 . - . ID=transcript_7492;Q8N292,Protein GAPT,Growth factor receptor-bound protein 2-binding adapter protein, transmembrane;, PF11770;, GO:0005794;GO:0016021;GO:0043231;GO:0005886;GO:0001782;GO:0002322;, C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, , P:B cell homeostasis; P:B cell proliferation involved in immune response; scaffold36 indexed_genome mRNA 19707468 19713526 . + . ID=transcript_7493;Q9NYY3 O60679 Q96CV7 Q9UE61,Serine/threonine-protein kinase PLK2,Polo-like kinase 2;Serine/threonine-protein kinase SNK;Serum-inducible kinase;, PF00069;PF00659;, GO:0005814;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0030425;GO:0005634;GO:0000922;GO:0005524;GO:0043008;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0006977;GO:0000082;GO:0060292;GO:0060291;GO:0007613;GO:0000278;GO:0007093;GO:0007052;GO:0016525;GO:0043066;GO:0071866;GO:2000773;GO:0061000;GO:0002862;GO:0018105;GO:0010508;GO:0090050;GO:0043123;GO:0032436;GO:0032092;GO:0045732;GO:0006468;GO:0032486;GO:0007265;GO:0046599;GO:0032465;GO:0048167;, C:centriole; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:dendrite; C:nucleus; C:spindle pole;, F:ATP binding; F:ATP-dependent protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:long-term synaptic depression; P:long-term synaptic potentiation; P:memory; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle organization; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic process in bone marrow cell; P:negative regulation of cellular senescence; P:negative regulation of dendritic spine development; P:negative regulation of inflammatory response to antigenic stimulus; P:peptidyl-serine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:protein phosphorylation; P:Rap protein signal transduction; P:Ras protein signal transduction; P:regulation of centriole replication; P:regulation of cytokinesis; P:regulation of synaptic plasticity;|Q9NYY3 O60679 Q96CV7 Q9UE61,Serine/threonine-protein kinase PLK2,Polo-like kinase 2;Serine/threonine-protein kinase SNK;Serum-inducible kinase;, PF00069;PF00659;, GO:0005814;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0030425;GO:0005634;GO:0000922;GO:0005524;GO:0043008;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0006977;GO:0000082;GO:0060292;GO:0060291;GO:0007613;GO:0000278;GO:0007093;GO:0007052;GO:0016525;GO:0043066;GO:0071866;GO:2000773;GO:0061000;GO:0002862;GO:0018105;GO:0010508;GO:0090050;GO:0043123;GO:0032436;GO:0032092;GO:0045732;GO:0006468;GO:0032486;GO:0007265;GO:0046599;GO:0032465;GO:0048167;, C:centriole; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:dendrite; C:nucleus; C:spindle pole;, F:ATP binding; F:ATP-dependent protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:long-term synaptic depression; P:long-term synaptic potentiation; P:memory; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle organization; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic process in bone marrow cell; P:negative regulation of cellular senescence; P:negative regulation of dendritic spine development; P:negative regulation of inflammatory response to antigenic stimulus; P:peptidyl-serine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:protein phosphorylation; P:Rap protein signal transduction; P:Ras protein signal transduction; P:regulation of centriole replication; P:regulation of cytokinesis; P:regulation of synaptic plasticity;|Q9NYY3 O60679 Q96CV7 Q9UE61,Serine/threonine-protein kinase PLK2,Polo-like kinase 2;Serine/threonine-protein kinase SNK;Serum-inducible kinase;, PF00069;PF00659;, GO:0005814;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0030425;GO:0005634;GO:0000922;GO:0005524;GO:0043008;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0006977;GO:0000082;GO:0060292;GO:0060291;GO:0007613;GO:0000278;GO:0007093;GO:0007052;GO:0016525;GO:0043066;GO:0071866;GO:2000773;GO:0061000;GO:0002862;GO:0018105;GO:0010508;GO:0090050;GO:0043123;GO:0032436;GO:0032092;GO:0045732;GO:0006468;GO:0032486;GO:0007265;GO:0046599;GO:0032465;GO:0048167;, C:centriole; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:dendrite; C:nucleus; C:spindle pole;, F:ATP binding; F:ATP-dependent protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:long-term synaptic depression; P:long-term synaptic potentiation; P:memory; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle organization; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic process in bone marrow cell; P:negative regulation of cellular senescence; P:negative regulation of dendritic spine development; P:negative regulation of inflammatory response to antigenic stimulus; P:peptidyl-serine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:protein phosphorylation; P:Rap protein signal transduction; P:Ras protein signal transduction; P:regulation of centriole replication; P:regulation of cytokinesis; P:regulation of synaptic plasticity;|Q9NYY3 O60679 Q96CV7 Q9UE61,Serine/threonine-protein kinase PLK2,Polo-like kinase 2;Serine/threonine-protein kinase SNK;Serum-inducible kinase;, PF00069;PF00659;, GO:0005814;GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0030425;GO:0005634;GO:0000922;GO:0005524;GO:0043008;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0006977;GO:0000082;GO:0060292;GO:0060291;GO:0007613;GO:0000278;GO:0007093;GO:0007052;GO:0016525;GO:0043066;GO:0071866;GO:2000773;GO:0061000;GO:0002862;GO:0018105;GO:0010508;GO:0090050;GO:0043123;GO:0032436;GO:0032092;GO:0045732;GO:0006468;GO:0032486;GO:0007265;GO:0046599;GO:0032465;GO:0048167;, C:centriole; C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:dendrite; C:nucleus; C:spindle pole;, F:ATP binding; F:ATP-dependent protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:long-term synaptic depression; P:long-term synaptic potentiation; P:memory; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle organization; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of apoptotic process in bone marrow cell; P:negative regulation of cellular senescence; P:negative regulation of dendritic spine development; P:negative regulation of inflammatory response to antigenic stimulus; P:peptidyl-serine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:protein phosphorylation; P:Rap protein signal transduction; P:Ras protein signal transduction; P:regulation of centriole replication; P:regulation of cytokinesis; P:regulation of synaptic plasticity; scaffold36 indexed_genome mRNA 20813273 20827034 . - . ID=transcript_7494;Q86WP2 A6NKW3 Q6NSH6 Q9H0D4 Q9H785 Q9NSN4,Vasculin,GC-rich promoter-binding protein 1;Vascular wall-linked protein;, PF15337;, GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0003677;GO:0003723;GO:0045893;GO:0006355;GO:0006351;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:DNA binding; F:RNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q86WP2 A6NKW3 Q6NSH6 Q9H0D4 Q9H785 Q9NSN4,Vasculin,GC-rich promoter-binding protein 1;Vascular wall-linked protein;, PF15337;, GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0003677;GO:0003723;GO:0045893;GO:0006355;GO:0006351;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:DNA binding; F:RNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q86WP2 A6NKW3 Q6NSH6 Q9H0D4 Q9H785 Q9NSN4,Vasculin,GC-rich promoter-binding protein 1;Vascular wall-linked protein;, PF15337;, GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0003677;GO:0003723;GO:0045893;GO:0006355;GO:0006351;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:DNA binding; F:RNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold36 indexed_genome mRNA 20827036 20888454 . - . ID=transcript_7495;Q86WP2 A6NKW3 Q6NSH6 Q9H0D4 Q9H785 Q9NSN4,Vasculin,GC-rich promoter-binding protein 1;Vascular wall-linked protein;, PF15337;, GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0003677;GO:0003723;GO:0045893;GO:0006355;GO:0006351;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:DNA binding; F:RNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q86WP2 A6NKW3 Q6NSH6 Q9H0D4 Q9H785 Q9NSN4,Vasculin,GC-rich promoter-binding protein 1;Vascular wall-linked protein;, PF15337;, GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0003677;GO:0003723;GO:0045893;GO:0006355;GO:0006351;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:DNA binding; F:RNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold36 indexed_genome mRNA 21071880 21099380 . + . ID=transcript_7496;Q7Z3K6 B4DRI9 B8ZZQ0 Q5CZI0 Q68CS3 Q6MZS7 Q86YG8 Q8NA13,Mesoderm induction early response protein 3,, PF01448;PF00249;, GO:0005654;GO:0005634;GO:0032991;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;, C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II;|Q7Z3K6 B4DRI9 B8ZZQ0 Q5CZI0 Q68CS3 Q6MZS7 Q86YG8 Q8NA13,Mesoderm induction early response protein 3,, PF01448;PF00249;, GO:0005654;GO:0005634;GO:0032991;GO:0042826;GO:0001103;GO:0003714;GO:0016575;GO:0000122;, C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; scaffold36 indexed_genome mRNA 21104866 21131096 . - . ID=transcript_7497;Q8NE22 F5H713,SET domain-containing protein 9,, , GO:0005654;GO:0008168;GO:0032259;GO:1901796;, C:nucleoplasm;, F:methyltransferase activity;, P:methylation; P:regulation of signal transduction by p53 class mediator; scaffold36 indexed_genome mRNA 21133059 21162571 . - . ID=transcript_7498;Q13233,Mitogen-activated protein kinase kinase kinase 1,MAPK/ERK kinase kinase 1;, PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:0071260;GO:0038095;GO:0002755;GO:0006468;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:cellular response to mechanical stimulus; P:Fc-epsilon receptor signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:protein phosphorylation;|Q13233,Mitogen-activated protein kinase kinase kinase 1,MAPK/ERK kinase kinase 1;, PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:0071260;GO:0038095;GO:0002755;GO:0006468;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:cellular response to mechanical stimulus; P:Fc-epsilon receptor signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:protein phosphorylation;|Q13233,Mitogen-activated protein kinase kinase kinase 1,MAPK/ERK kinase kinase 1;, PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:0071260;GO:0038095;GO:0002755;GO:0006468;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:cellular response to mechanical stimulus; P:Fc-epsilon receptor signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:protein phosphorylation;|Q13233,Mitogen-activated protein kinase kinase kinase 1,MAPK/ERK kinase kinase 1;, PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:0071260;GO:0038095;GO:0002755;GO:0006468;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:cellular response to mechanical stimulus; P:Fc-epsilon receptor signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:protein phosphorylation;|Q13233,Mitogen-activated protein kinase kinase kinase 1,MAPK/ERK kinase kinase 1;, PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:0071260;GO:0038095;GO:0002755;GO:0006468;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:cellular response to mechanical stimulus; P:Fc-epsilon receptor signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:protein phosphorylation; scaffold36 indexed_genome mRNA 21872451 21873190 . + . ID=transcript_7499;Q3KP44 B3KVT8 Q3KP45 Q9HAD3,Ankyrin repeat domain-containing protein 55,, PF12796; scaffold36 indexed_genome mRNA 21961804 22024016 . + . ID=transcript_7500;P40189 A0N0L4 Q5FC04 Q9UQ41,Interleukin-6 receptor subunit beta {ECO:0000305},CDw130;Interleukin-6 signal transducer;Membrane glycoprotein 130;Oncostatin-M receptor subunit alpha;, PF00041;PF09240;PF06328;, GO:0070110;GO:0030425;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005896;GO:0016020;GO:0043025;GO:0005900;GO:0005886;GO:0043235;GO:0004897;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0042802;GO:0019970;GO:0004921;GO:0045509;GO:0070120;GO:0019221;GO:0005977;GO:0070106;GO:0070757;GO:0070102;GO:0060576;GO:0048861;GO:0043066;GO:0070104;GO:0038165;GO:0002675;GO:0002821;GO:0048711;GO:0010613;GO:0008284;GO:0045747;GO:0045669;GO:0042102;GO:0042531;GO:0010575;GO:0034097;GO:0016032;, C:ciliary neurotrophic factor receptor complex; C:dendrite; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:interleukin-6 receptor complex; C:membrane; C:neuronal cell body; C:oncostatin-M receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor activity; F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:identical protein binding; F:interleukin-11 binding; F:interleukin-11 receptor activity; F:interleukin-27 receptor activity;, P:ciliary neurotrophic factor-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:glycogen metabolic process; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell development; P:leukemia inhibitory factor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of interleukin-6-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of acute inflammatory response; P:positive regulation of adaptive immune response; P:positive regulation of astrocyte differentiation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell population proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of T cell proliferation; P:positive regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of vascular endothelial growth factor production; P:response to cytokine; P:viral process;|P40189 A0N0L4 Q5FC04 Q9UQ41,Interleukin-6 receptor subunit beta {ECO:0000305},CDw130;Interleukin-6 signal transducer;Membrane glycoprotein 130;Oncostatin-M receptor subunit alpha;, PF00041;PF09240;PF06328;, GO:0070110;GO:0030425;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005896;GO:0016020;GO:0043025;GO:0005900;GO:0005886;GO:0043235;GO:0004897;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0042802;GO:0019970;GO:0004921;GO:0045509;GO:0070120;GO:0019221;GO:0005977;GO:0070106;GO:0070757;GO:0070102;GO:0060576;GO:0048861;GO:0043066;GO:0070104;GO:0038165;GO:0002675;GO:0002821;GO:0048711;GO:0010613;GO:0008284;GO:0045747;GO:0045669;GO:0042102;GO:0042531;GO:0010575;GO:0034097;GO:0016032;, C:ciliary neurotrophic factor receptor complex; C:dendrite; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:interleukin-6 receptor complex; C:membrane; C:neuronal cell body; C:oncostatin-M receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor activity; F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:identical protein binding; F:interleukin-11 binding; F:interleukin-11 receptor activity; F:interleukin-27 receptor activity;, P:ciliary neurotrophic factor-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:glycogen metabolic process; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell development; P:leukemia inhibitory factor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of interleukin-6-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of acute inflammatory response; P:positive regulation of adaptive immune response; P:positive regulation of astrocyte differentiation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell population proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of T cell proliferation; P:positive regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of vascular endothelial growth factor production; P:response to cytokine; P:viral process;|P40189 A0N0L4 Q5FC04 Q9UQ41,Interleukin-6 receptor subunit beta {ECO:0000305},CDw130;Interleukin-6 signal transducer;Membrane glycoprotein 130;Oncostatin-M receptor subunit alpha;, PF00041;PF09240;PF06328;, GO:0070110;GO:0030425;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005896;GO:0016020;GO:0043025;GO:0005900;GO:0005886;GO:0043235;GO:0004897;GO:0005127;GO:0019955;GO:0004896;GO:0019838;GO:0042802;GO:0019970;GO:0004921;GO:0045509;GO:0070120;GO:0019221;GO:0005977;GO:0070106;GO:0070757;GO:0070102;GO:0060576;GO:0048861;GO:0043066;GO:0070104;GO:0038165;GO:0002675;GO:0002821;GO:0048711;GO:0010613;GO:0008284;GO:0045747;GO:0045669;GO:0042102;GO:0042531;GO:0010575;GO:0034097;GO:0016032;, C:ciliary neurotrophic factor receptor complex; C:dendrite; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:interleukin-6 receptor complex; C:membrane; C:neuronal cell body; C:oncostatin-M receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor activity; F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:growth factor binding; F:identical protein binding; F:interleukin-11 binding; F:interleukin-11 receptor activity; F:interleukin-27 receptor activity;, P:ciliary neurotrophic factor-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:glycogen metabolic process; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell development; P:leukemia inhibitory factor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of interleukin-6-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of acute inflammatory response; P:positive regulation of adaptive immune response; P:positive regulation of astrocyte differentiation; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell population proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of T cell proliferation; P:positive regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of vascular endothelial growth factor production; P:response to cytokine; P:viral process; scaffold36 indexed_genome mRNA 22059143 22063542 . - . ID=transcript_7501;Q8NI17 A6NIF8 Q2TBA1 Q6EBC3 Q6EBC4 Q6EBC5 Q6EBC6 Q6UWL8 Q8WYJ0,Interleukin-31 receptor subunit alpha,Cytokine receptor-like 3;GLM-R;Gp130-like monocyte receptor;ZcytoR17;, PF00041;PF09240;, GO:0030424;GO:0009897;GO:0016021;GO:0005886;GO:0042734;GO:0043235;GO:0019955;GO:0004896;GO:0051916;GO:0019901;GO:0003713;GO:0002438;GO:0019221;GO:0006952;GO:0098542;GO:0002067;GO:0042592;GO:0030225;GO:0000165;GO:0030224;GO:0043066;GO:0043031;GO:0008284;GO:0045893;GO:0042531;GO:0007259;GO:0007169;, C:axon; C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane; C:presynaptic membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:granulocyte colony-stimulating factor binding; F:protein kinase binding; F:transcription coactivator activity;, P:acute inflammatory response to antigenic stimulus; P:cytokine-mediated signaling pathway; P:defense response; P:defense response to other organism; P:glandular epithelial cell differentiation; P:homeostatic process; P:macrophage differentiation; P:MAPK cascade; P:monocyte differentiation; P:negative regulation of apoptotic process; P:negative regulation of macrophage activation; P:positive regulation of cell population proliferation; P:positive regulation of transcription, DNA-templated; P:positive regulation of tyrosine phosphorylation of STAT protein; P:receptor signaling pathway via JAK-STAT; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold36 indexed_genome mRNA 22243512 22246515 . + . ID=transcript_7502;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold37 indexed_genome mRNA 5049 7545 . + . ID=transcript_7503;Q9BUX1 Q0VIA0,Glutathione-specific gamma-glutamylcyclotransferase 1 {ECO:0000303|PubMed:27913623},Blocks Notch protein {ECO:0000303|PubMed:22445366};Cation transport regulator-like protein 1 {ECO:0000303|PubMed:19109178};, PF04752;, GO:0005737;GO:0005829;GO:0005802;GO:0003839;GO:0061928;GO:0005112;GO:0006750;GO:0006751;GO:0070059;GO:0045746;GO:0010955;GO:0022008;GO:0007219;GO:0006986;, C:cytoplasm; C:cytosol; C:trans-Golgi network;, F:gamma-glutamylcyclotransferase activity; F:glutathione specific gamma-glutamylcyclotransferase activity; F:Notch binding;, P:glutathione biosynthetic process; P:glutathione catabolic process; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of Notch signaling pathway; P:negative regulation of protein processing; P:neurogenesis; P:Notch signaling pathway; P:response to unfolded protein; scaffold37 indexed_genome mRNA 25390 28510 . + . ID=transcript_7504;Q9ULG1 A6H8X4 Q9NTG6,Chromatin-remodeling ATPase INO80 {ECO:0000305},DNA helicase-related INO80 complex homolog 1 {ECO:0000305};DNA helicase-related protein INO80 {ECO:0000305};INO80 complex subunit A;, PF13892;PF00271;PF00176;, GO:0005829;GO:0031011;GO:0005874;GO:0016604;GO:0005654;GO:0005634;GO:0005819;GO:0003779;GO:0043014;GO:0005524;GO:0016887;GO:0003677;GO:0008094;GO:0042393;GO:0070615;GO:0043044;GO:0051301;GO:0071479;GO:0034644;GO:0006338;GO:0032508;GO:0006281;GO:0006302;GO:0000724;GO:0000070;GO:0042766;GO:0030307;GO:0010571;GO:0045944;GO:0016579;GO:2000045;GO:0043618;GO:0051225;GO:0006351;GO:0070914;, C:cytosol; C:Ino80 complex; C:microtubule; C:nuclear body; C:nucleoplasm; C:nucleus; C:spindle;, F:actin binding; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA-dependent ATPase activity; F:histone binding; F:nucleosome-dependent ATPase activity;, P:ATP-dependent chromatin remodeling; P:cell division; P:cellular response to ionizing radiation; P:cellular response to UV; P:chromatin remodeling; P:DNA duplex unwinding; P:DNA repair; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:mitotic sister chromatid segregation; P:nucleosome mobilization; P:positive regulation of cell growth; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of transcription from RNA polymerase II promoter in response to stress; P:spindle assembly; P:transcription, DNA-templated; P:UV-damage excision repair;|Q9ULG1 A6H8X4 Q9NTG6,Chromatin-remodeling ATPase INO80 {ECO:0000305},DNA helicase-related INO80 complex homolog 1 {ECO:0000305};DNA helicase-related protein INO80 {ECO:0000305};INO80 complex subunit A;, PF13892;PF00271;PF00176;, GO:0005829;GO:0031011;GO:0005874;GO:0016604;GO:0005654;GO:0005634;GO:0005819;GO:0003779;GO:0043014;GO:0005524;GO:0016887;GO:0003677;GO:0008094;GO:0042393;GO:0070615;GO:0043044;GO:0051301;GO:0071479;GO:0034644;GO:0006338;GO:0032508;GO:0006281;GO:0006302;GO:0000724;GO:0000070;GO:0042766;GO:0030307;GO:0010571;GO:0045944;GO:0016579;GO:2000045;GO:0043618;GO:0051225;GO:0006351;GO:0070914;, C:cytosol; C:Ino80 complex; C:microtubule; C:nuclear body; C:nucleoplasm; C:nucleus; C:spindle;, F:actin binding; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA-dependent ATPase activity; F:histone binding; F:nucleosome-dependent ATPase activity;, P:ATP-dependent chromatin remodeling; P:cell division; P:cellular response to ionizing radiation; P:cellular response to UV; P:chromatin remodeling; P:DNA duplex unwinding; P:DNA repair; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:mitotic sister chromatid segregation; P:nucleosome mobilization; P:positive regulation of cell growth; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of transcription from RNA polymerase II promoter in response to stress; P:spindle assembly; P:transcription, DNA-templated; P:UV-damage excision repair; scaffold37 indexed_genome mRNA 28945 116783 . - . ID=transcript_7505;Q9ULG1 A6H8X4 Q9NTG6,Chromatin-remodeling ATPase INO80 {ECO:0000305},DNA helicase-related INO80 complex homolog 1 {ECO:0000305};DNA helicase-related protein INO80 {ECO:0000305};INO80 complex subunit A;, PF13892;PF00271;PF00176;, GO:0005829;GO:0031011;GO:0005874;GO:0016604;GO:0005654;GO:0005634;GO:0005819;GO:0003779;GO:0043014;GO:0005524;GO:0016887;GO:0003677;GO:0008094;GO:0042393;GO:0070615;GO:0043044;GO:0051301;GO:0071479;GO:0034644;GO:0006338;GO:0032508;GO:0006281;GO:0006302;GO:0000724;GO:0000070;GO:0042766;GO:0030307;GO:0010571;GO:0045944;GO:0016579;GO:2000045;GO:0043618;GO:0051225;GO:0006351;GO:0070914;, C:cytosol; C:Ino80 complex; C:microtubule; C:nuclear body; C:nucleoplasm; C:nucleus; C:spindle;, F:actin binding; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA-dependent ATPase activity; F:histone binding; F:nucleosome-dependent ATPase activity;, P:ATP-dependent chromatin remodeling; P:cell division; P:cellular response to ionizing radiation; P:cellular response to UV; P:chromatin remodeling; P:DNA duplex unwinding; P:DNA repair; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:mitotic sister chromatid segregation; P:nucleosome mobilization; P:positive regulation of cell growth; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of transcription from RNA polymerase II promoter in response to stress; P:spindle assembly; P:transcription, DNA-templated; P:UV-damage excision repair;|Q9ULG1 A6H8X4 Q9NTG6,Chromatin-remodeling ATPase INO80 {ECO:0000305},DNA helicase-related INO80 complex homolog 1 {ECO:0000305};DNA helicase-related protein INO80 {ECO:0000305};INO80 complex subunit A;, PF13892;PF00271;PF00176;, GO:0005829;GO:0031011;GO:0005874;GO:0016604;GO:0005654;GO:0005634;GO:0005819;GO:0003779;GO:0043014;GO:0005524;GO:0016887;GO:0003677;GO:0008094;GO:0042393;GO:0070615;GO:0043044;GO:0051301;GO:0071479;GO:0034644;GO:0006338;GO:0032508;GO:0006281;GO:0006302;GO:0000724;GO:0000070;GO:0042766;GO:0030307;GO:0010571;GO:0045944;GO:0016579;GO:2000045;GO:0043618;GO:0051225;GO:0006351;GO:0070914;, C:cytosol; C:Ino80 complex; C:microtubule; C:nuclear body; C:nucleoplasm; C:nucleus; C:spindle;, F:actin binding; F:alpha-tubulin binding; F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA-dependent ATPase activity; F:histone binding; F:nucleosome-dependent ATPase activity;, P:ATP-dependent chromatin remodeling; P:cell division; P:cellular response to ionizing radiation; P:cellular response to UV; P:chromatin remodeling; P:DNA duplex unwinding; P:DNA repair; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:mitotic sister chromatid segregation; P:nucleosome mobilization; P:positive regulation of cell growth; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of transcription from RNA polymerase II promoter in response to stress; P:spindle assembly; P:transcription, DNA-templated; P:UV-damage excision repair; scaffold37 indexed_genome mRNA 191311 232364 . - . ID=transcript_7506;Q8NHP7 A8K909 B7Z839 Q6ZW94,piRNA biogenesis protein EXD1 {ECO:0000305},Exonuclease 3'-5' domain-containing protein 1 {ECO:0000312|HGNC:HGNC:28507};Exonuclease 3'-5' domain-like-containing protein 1 {ECO:0000312|HGNC:HGNC:28507};Inactive exonuclease EXD1 {ECO:0000305};, PF01612;, GO:0043186;GO:1990923;GO:0042803;GO:0003723;GO:0031047;GO:0051321;GO:0090305;GO:0034587;, C:P granule; C:PET complex;, F:protein homodimerization activity; F:RNA binding;, P:gene silencing by RNA; P:meiotic cell cycle; P:nucleic acid phosphodiester bond hydrolysis; P:piRNA metabolic process;|Q8NHP7 A8K909 B7Z839 Q6ZW94,piRNA biogenesis protein EXD1 {ECO:0000305},Exonuclease 3'-5' domain-containing protein 1 {ECO:0000312|HGNC:HGNC:28507};Exonuclease 3'-5' domain-like-containing protein 1 {ECO:0000312|HGNC:HGNC:28507};Inactive exonuclease EXD1 {ECO:0000305};, PF01612;, GO:0043186;GO:1990923;GO:0042803;GO:0003723;GO:0031047;GO:0051321;GO:0090305;GO:0034587;, C:P granule; C:PET complex;, F:protein homodimerization activity; F:RNA binding;, P:gene silencing by RNA; P:meiotic cell cycle; P:nucleic acid phosphodiester bond hydrolysis; P:piRNA metabolic process;|Q8NHP7 A8K909 B7Z839 Q6ZW94,piRNA biogenesis protein EXD1 {ECO:0000305},Exonuclease 3'-5' domain-containing protein 1 {ECO:0000312|HGNC:HGNC:28507};Exonuclease 3'-5' domain-like-containing protein 1 {ECO:0000312|HGNC:HGNC:28507};Inactive exonuclease EXD1 {ECO:0000305};, PF01612;, GO:0043186;GO:1990923;GO:0042803;GO:0003723;GO:0031047;GO:0051321;GO:0090305;GO:0034587;, C:P granule; C:PET complex;, F:protein homodimerization activity; F:RNA binding;, P:gene silencing by RNA; P:meiotic cell cycle; P:nucleic acid phosphodiester bond hydrolysis; P:piRNA metabolic process;|Q8NHP7 A8K909 B7Z839 Q6ZW94,piRNA biogenesis protein EXD1 {ECO:0000305},Exonuclease 3'-5' domain-containing protein 1 {ECO:0000312|HGNC:HGNC:28507};Exonuclease 3'-5' domain-like-containing protein 1 {ECO:0000312|HGNC:HGNC:28507};Inactive exonuclease EXD1 {ECO:0000305};, PF01612;, GO:0043186;GO:1990923;GO:0042803;GO:0003723;GO:0031047;GO:0051321;GO:0090305;GO:0034587;, C:P granule; C:PET complex;, F:protein homodimerization activity; F:RNA binding;, P:gene silencing by RNA; P:meiotic cell cycle; P:nucleic acid phosphodiester bond hydrolysis; P:piRNA metabolic process; scaffold37 indexed_genome mRNA 239794 275513 . + . ID=transcript_7507;Q99653 B2R6H9 Q6FHZ9,Calcineurin B homologous protein 1,Calcineurin B-like protein;Calcium-binding protein CHP;Calcium-binding protein p22;EF-hand calcium-binding domain-containing protein p22;, PF13499;, GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0070062;GO:0005925;GO:0000139;GO:0015630;GO:0005634;GO:0005886;GO:0030133;GO:0005509;GO:0048306;GO:0019900;GO:0008017;GO:0015459;GO:0004860;GO:0071468;GO:0031122;GO:0030214;GO:0022406;GO:0061025;GO:0061024;GO:0001578;GO:0070885;GO:0032088;GO:0010923;GO:0031953;GO:0042308;GO:0006469;GO:0001933;GO:0031397;GO:0071073;GO:0060050;GO:0090314;GO:0051222;GO:0032417;GO:0006813;GO:0051259;GO:0006611;GO:0050821;GO:0051453;GO:1901214;GO:0007264;GO:0006906;GO:0006903;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:microtubule cytoskeleton; C:nucleus; C:plasma membrane; C:transport vesicle;, F:calcium ion binding; F:calcium-dependent protein binding; F:kinase binding; F:microtubule binding; F:potassium channel regulator activity; F:protein kinase inhibitor activity;, P:cellular response to acidic pH; P:cytoplasmic microtubule organization; P:hyaluronan catabolic process; P:membrane docking; P:membrane fusion; P:membrane organization; P:microtubule bundle formation; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatase activity; P:negative regulation of protein autophosphorylation; P:negative regulation of protein import into nucleus; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:positive regulation of phospholipid biosynthetic process; P:positive regulation of protein glycosylation; P:positive regulation of protein targeting to membrane; P:positive regulation of protein transport; P:positive regulation of sodium:proton antiporter activity; P:potassium ion transport; P:protein complex oligomerization; P:protein export from nucleus; P:protein stabilization; P:regulation of intracellular pH; P:regulation of neuron death; P:small GTPase mediated signal transduction; P:vesicle fusion; P:vesicle targeting;|Q99653 B2R6H9 Q6FHZ9,Calcineurin B homologous protein 1,Calcineurin B-like protein;Calcium-binding protein CHP;Calcium-binding protein p22;EF-hand calcium-binding domain-containing protein p22;, PF13499;, GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0070062;GO:0005925;GO:0000139;GO:0015630;GO:0005634;GO:0005886;GO:0030133;GO:0005509;GO:0048306;GO:0019900;GO:0008017;GO:0015459;GO:0004860;GO:0071468;GO:0031122;GO:0030214;GO:0022406;GO:0061025;GO:0061024;GO:0001578;GO:0070885;GO:0032088;GO:0010923;GO:0031953;GO:0042308;GO:0006469;GO:0001933;GO:0031397;GO:0071073;GO:0060050;GO:0090314;GO:0051222;GO:0032417;GO:0006813;GO:0051259;GO:0006611;GO:0050821;GO:0051453;GO:1901214;GO:0007264;GO:0006906;GO:0006903;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:microtubule cytoskeleton; C:nucleus; C:plasma membrane; C:transport vesicle;, F:calcium ion binding; F:calcium-dependent protein binding; F:kinase binding; F:microtubule binding; F:potassium channel regulator activity; F:protein kinase inhibitor activity;, P:cellular response to acidic pH; P:cytoplasmic microtubule organization; P:hyaluronan catabolic process; P:membrane docking; P:membrane fusion; P:membrane organization; P:microtubule bundle formation; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatase activity; P:negative regulation of protein autophosphorylation; P:negative regulation of protein import into nucleus; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:positive regulation of phospholipid biosynthetic process; P:positive regulation of protein glycosylation; P:positive regulation of protein targeting to membrane; P:positive regulation of protein transport; P:positive regulation of sodium:proton antiporter activity; P:potassium ion transport; P:protein complex oligomerization; P:protein export from nucleus; P:protein stabilization; P:regulation of intracellular pH; P:regulation of neuron death; P:small GTPase mediated signal transduction; P:vesicle fusion; P:vesicle targeting;|Q99653 B2R6H9 Q6FHZ9,Calcineurin B homologous protein 1,Calcineurin B-like protein;Calcium-binding protein CHP;Calcium-binding protein p22;EF-hand calcium-binding domain-containing protein p22;, PF13499;, GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0070062;GO:0005925;GO:0000139;GO:0015630;GO:0005634;GO:0005886;GO:0030133;GO:0005509;GO:0048306;GO:0019900;GO:0008017;GO:0015459;GO:0004860;GO:0071468;GO:0031122;GO:0030214;GO:0022406;GO:0061025;GO:0061024;GO:0001578;GO:0070885;GO:0032088;GO:0010923;GO:0031953;GO:0042308;GO:0006469;GO:0001933;GO:0031397;GO:0071073;GO:0060050;GO:0090314;GO:0051222;GO:0032417;GO:0006813;GO:0051259;GO:0006611;GO:0050821;GO:0051453;GO:1901214;GO:0007264;GO:0006906;GO:0006903;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:microtubule cytoskeleton; C:nucleus; C:plasma membrane; C:transport vesicle;, F:calcium ion binding; F:calcium-dependent protein binding; F:kinase binding; F:microtubule binding; F:potassium channel regulator activity; F:protein kinase inhibitor activity;, P:cellular response to acidic pH; P:cytoplasmic microtubule organization; P:hyaluronan catabolic process; P:membrane docking; P:membrane fusion; P:membrane organization; P:microtubule bundle formation; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatase activity; P:negative regulation of protein autophosphorylation; P:negative regulation of protein import into nucleus; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:positive regulation of phospholipid biosynthetic process; P:positive regulation of protein glycosylation; P:positive regulation of protein targeting to membrane; P:positive regulation of protein transport; P:positive regulation of sodium:proton antiporter activity; P:potassium ion transport; P:protein complex oligomerization; P:protein export from nucleus; P:protein stabilization; P:regulation of intracellular pH; P:regulation of neuron death; P:small GTPase mediated signal transduction; P:vesicle fusion; P:vesicle targeting;|Q99653 B2R6H9 Q6FHZ9,Calcineurin B homologous protein 1,Calcineurin B-like protein;Calcium-binding protein CHP;Calcium-binding protein p22;EF-hand calcium-binding domain-containing protein p22;, PF13499;, GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0070062;GO:0005925;GO:0000139;GO:0015630;GO:0005634;GO:0005886;GO:0030133;GO:0005509;GO:0048306;GO:0019900;GO:0008017;GO:0015459;GO:0004860;GO:0071468;GO:0031122;GO:0030214;GO:0022406;GO:0061025;GO:0061024;GO:0001578;GO:0070885;GO:0032088;GO:0010923;GO:0031953;GO:0042308;GO:0006469;GO:0001933;GO:0031397;GO:0071073;GO:0060050;GO:0090314;GO:0051222;GO:0032417;GO:0006813;GO:0051259;GO:0006611;GO:0050821;GO:0051453;GO:1901214;GO:0007264;GO:0006906;GO:0006903;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:microtubule cytoskeleton; C:nucleus; C:plasma membrane; C:transport vesicle;, F:calcium ion binding; F:calcium-dependent protein binding; F:kinase binding; F:microtubule binding; F:potassium channel regulator activity; F:protein kinase inhibitor activity;, P:cellular response to acidic pH; P:cytoplasmic microtubule organization; P:hyaluronan catabolic process; P:membrane docking; P:membrane fusion; P:membrane organization; P:microtubule bundle formation; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatase activity; P:negative regulation of protein autophosphorylation; P:negative regulation of protein import into nucleus; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:positive regulation of phospholipid biosynthetic process; P:positive regulation of protein glycosylation; P:positive regulation of protein targeting to membrane; P:positive regulation of protein transport; P:positive regulation of sodium:proton antiporter activity; P:potassium ion transport; P:protein complex oligomerization; P:protein export from nucleus; P:protein stabilization; P:regulation of intracellular pH; P:regulation of neuron death; P:small GTPase mediated signal transduction; P:vesicle fusion; P:vesicle targeting; scaffold37 indexed_genome mRNA 298054 300774 . - . ID=transcript_7508;O43482 Q96BX7,Protein Mis18-beta,Cancer/testis antigen 86;Opa-interacting protein 5 {ECO:0000303|PubMed:9466265};, PF03226;, GO:0015030;GO:0000785;GO:0010369;GO:0000775;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0042802;GO:0046872;GO:0007154;GO:0007049;GO:0051301;GO:0034080;GO:0007059;, C:Cajal body; C:chromatin; C:chromocenter; C:chromosome, centromeric region; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:metal ion binding;, P:cell communication; P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; P:chromosome segregation; scaffold37 indexed_genome mRNA 315768 338142 . + . ID=transcript_7509;Q9NZ85 Q9UI70,Nucleolar and spindle-associated protein 1,, PF16006;, GO:0005694;GO:0005737;GO:0005874;GO:0072686;GO:0005730;GO:0003677;GO:0008017;GO:0003723;GO:0040001;GO:0007076;GO:0000281;GO:0000070;GO:0045840;, C:chromosome; C:cytoplasm; C:microtubule; C:mitotic spindle; C:nucleolus;, F:DNA binding; F:microtubule binding; F:RNA binding;, P:establishment of mitotic spindle localization; P:mitotic chromosome condensation; P:mitotic cytokinesis; P:mitotic sister chromatid segregation; P:positive regulation of mitotic nuclear division;|Q9NZ85 Q9UI70,Nucleolar and spindle-associated protein 1,, PF16006;, GO:0005694;GO:0005737;GO:0005874;GO:0072686;GO:0005730;GO:0003677;GO:0008017;GO:0003723;GO:0040001;GO:0007076;GO:0000281;GO:0000070;GO:0045840;, C:chromosome; C:cytoplasm; C:microtubule; C:mitotic spindle; C:nucleolus;, F:DNA binding; F:microtubule binding; F:RNA binding;, P:establishment of mitotic spindle localization; P:mitotic chromosome condensation; P:mitotic cytokinesis; P:mitotic sister chromatid segregation; P:positive regulation of mitotic nuclear division;|Q9NZ85 Q9UI70,Nucleolar and spindle-associated protein 1,, PF16006;, GO:0005694;GO:0005737;GO:0005874;GO:0072686;GO:0005730;GO:0003677;GO:0008017;GO:0003723;GO:0040001;GO:0007076;GO:0000281;GO:0000070;GO:0045840;, C:chromosome; C:cytoplasm; C:microtubule; C:mitotic spindle; C:nucleolus;, F:DNA binding; F:microtubule binding; F:RNA binding;, P:establishment of mitotic spindle localization; P:mitotic chromosome condensation; P:mitotic cytokinesis; P:mitotic sister chromatid segregation; P:positive regulation of mitotic nuclear division; scaffold37 indexed_genome mRNA 338240 356237 . - . ID=transcript_7510;Q9Y375 Q9BVZ5,Complex I intermediate-associated protein 30, mitochondrial,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 1;, PF08547;, GO:0005829;GO:0005743;GO:0005759;GO:0005747;GO:0005739;GO:0051082;GO:0051131;GO:0006120;GO:0032981;GO:0010257;GO:0065003;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:unfolded protein binding;, P:chaperone-mediated protein complex assembly; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:NADH dehydrogenase complex assembly; P:protein-containing complex assembly; scaffold37 indexed_genome mRNA 386296 433677 . + . ID=transcript_7511;Q92541 Q96BX6,RNA polymerase-associated protein RTF1 homolog,, PF03126;, GO:0016593;GO:0005730;GO:0005654;GO:0003723;GO:1990269;GO:0003697;GO:0001832;GO:0001711;GO:0080182;GO:0000122;GO:0051571;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:single-stranded DNA binding;, P:blastocyst growth; P:endodermal cell fate commitment; P:histone H3-K4 trimethylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H3-K4 methylation; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q92541 Q96BX6,RNA polymerase-associated protein RTF1 homolog,, PF03126;, GO:0016593;GO:0005730;GO:0005654;GO:0003723;GO:1990269;GO:0003697;GO:0001832;GO:0001711;GO:0080182;GO:0000122;GO:0051571;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:single-stranded DNA binding;, P:blastocyst growth; P:endodermal cell fate commitment; P:histone H3-K4 trimethylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H3-K4 methylation; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q92541 Q96BX6,RNA polymerase-associated protein RTF1 homolog,, PF03126;, GO:0016593;GO:0005730;GO:0005654;GO:0003723;GO:1990269;GO:0003697;GO:0001832;GO:0001711;GO:0080182;GO:0000122;GO:0051571;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:single-stranded DNA binding;, P:blastocyst growth; P:endodermal cell fate commitment; P:histone H3-K4 trimethylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H3-K4 methylation; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q92541 Q96BX6,RNA polymerase-associated protein RTF1 homolog,, PF03126;, GO:0016593;GO:0005730;GO:0005654;GO:0003723;GO:1990269;GO:0003697;GO:0001832;GO:0001711;GO:0080182;GO:0000122;GO:0051571;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:single-stranded DNA binding;, P:blastocyst growth; P:endodermal cell fate commitment; P:histone H3-K4 trimethylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H3-K4 methylation; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway; scaffold37 indexed_genome mRNA 464734 480848 . - . ID=transcript_7512;Q9BWH6 Q9H9I2 Q9NSQ5 Q9P2E4 Q9UFS7,RNA polymerase II-associated protein 1,, PF08620;PF08621;, GO:0005634;GO:0003677;GO:0003899;GO:0006366;, C:nucleus;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:transcription by RNA polymerase II;|Q9BWH6 Q9H9I2 Q9NSQ5 Q9P2E4 Q9UFS7,RNA polymerase II-associated protein 1,, PF08620;PF08621;, GO:0005634;GO:0003677;GO:0003899;GO:0006366;, C:nucleus;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:transcription by RNA polymerase II;|Q9BWH6 Q9H9I2 Q9NSQ5 Q9P2E4 Q9UFS7,RNA polymerase II-associated protein 1,, PF08620;PF08621;, GO:0005634;GO:0003677;GO:0003899;GO:0006366;, C:nucleus;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:transcription by RNA polymerase II;|Q9BWH6 Q9H9I2 Q9NSQ5 Q9P2E4 Q9UFS7,RNA polymerase II-associated protein 1,, PF08620;PF08621;, GO:0005634;GO:0003677;GO:0003899;GO:0006366;, C:nucleus;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:transcription by RNA polymerase II;|Q9BWH6 Q9H9I2 Q9NSQ5 Q9P2E4 Q9UFS7,RNA polymerase II-associated protein 1,, PF08620;PF08621;, GO:0005634;GO:0003677;GO:0003899;GO:0006366;, C:nucleus;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:transcription by RNA polymerase II;|Q9BWH6 Q9H9I2 Q9NSQ5 Q9P2E4 Q9UFS7,RNA polymerase II-associated protein 1,, PF08620;PF08621;, GO:0005634;GO:0003677;GO:0003899;GO:0006366;, C:nucleus;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 489262 500009 . + . ID=transcript_7513;Q06418 O14953 Q86VR3,Tyrosine-protein kinase receptor TYRO3,Tyrosine-protein kinase BYK;Tyrosine-protein kinase DTK;Tyrosine-protein kinase RSE;Tyrosine-protein kinase SKY;Tyrosine-protein kinase TIF;, PF00041;PF07679;PF07714;, GO:0009986;GO:0005789;GO:0005887;GO:0005635;GO:0005634;GO:0043235;GO:0005524;GO:0043548;GO:0004713;GO:0004714;GO:0001618;GO:0043277;GO:0007155;GO:0016477;GO:0021885;GO:0007275;GO:0001779;GO:0050728;GO:0045824;GO:0051250;GO:0043524;GO:0034122;GO:0007399;GO:0070050;GO:0007218;GO:0042698;GO:0006909;GO:0014065;GO:0030168;GO:0070527;GO:0033674;GO:1903902;GO:0046777;GO:0043491;GO:0032940;GO:0007165;GO:0007283;GO:0034446;GO:0007169;GO:0060068;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope; C:nucleus; C:receptor complex;, F:ATP binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:virus receptor activity;, P:apoptotic cell clearance; P:cell adhesion; P:cell migration; P:forebrain cell migration; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of lymphocyte activation; P:negative regulation of neuron apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:nervous system development; P:neuron cellular homeostasis; P:neuropeptide signaling pathway; P:ovulation cycle; P:phagocytosis; P:phosphatidylinositol 3-kinase signaling; P:platelet activation; P:platelet aggregation; P:positive regulation of kinase activity; P:positive regulation of viral life cycle; P:protein autophosphorylation; P:protein kinase B signaling; P:secretion by cell; P:signal transduction; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development;|Q06418 O14953 Q86VR3,Tyrosine-protein kinase receptor TYRO3,Tyrosine-protein kinase BYK;Tyrosine-protein kinase DTK;Tyrosine-protein kinase RSE;Tyrosine-protein kinase SKY;Tyrosine-protein kinase TIF;, PF00041;PF07679;PF07714;, GO:0009986;GO:0005789;GO:0005887;GO:0005635;GO:0005634;GO:0043235;GO:0005524;GO:0043548;GO:0004713;GO:0004714;GO:0001618;GO:0043277;GO:0007155;GO:0016477;GO:0021885;GO:0007275;GO:0001779;GO:0050728;GO:0045824;GO:0051250;GO:0043524;GO:0034122;GO:0007399;GO:0070050;GO:0007218;GO:0042698;GO:0006909;GO:0014065;GO:0030168;GO:0070527;GO:0033674;GO:1903902;GO:0046777;GO:0043491;GO:0032940;GO:0007165;GO:0007283;GO:0034446;GO:0007169;GO:0060068;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope; C:nucleus; C:receptor complex;, F:ATP binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:virus receptor activity;, P:apoptotic cell clearance; P:cell adhesion; P:cell migration; P:forebrain cell migration; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of lymphocyte activation; P:negative regulation of neuron apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:nervous system development; P:neuron cellular homeostasis; P:neuropeptide signaling pathway; P:ovulation cycle; P:phagocytosis; P:phosphatidylinositol 3-kinase signaling; P:platelet activation; P:platelet aggregation; P:positive regulation of kinase activity; P:positive regulation of viral life cycle; P:protein autophosphorylation; P:protein kinase B signaling; P:secretion by cell; P:signal transduction; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development; scaffold37 indexed_genome mRNA 500018 510540 . + . ID=transcript_7514;Q06418 O14953 Q86VR3,Tyrosine-protein kinase receptor TYRO3,Tyrosine-protein kinase BYK;Tyrosine-protein kinase DTK;Tyrosine-protein kinase RSE;Tyrosine-protein kinase SKY;Tyrosine-protein kinase TIF;, PF00041;PF07679;PF07714;, GO:0009986;GO:0005789;GO:0005887;GO:0005635;GO:0005634;GO:0043235;GO:0005524;GO:0043548;GO:0004713;GO:0004714;GO:0001618;GO:0043277;GO:0007155;GO:0016477;GO:0021885;GO:0007275;GO:0001779;GO:0050728;GO:0045824;GO:0051250;GO:0043524;GO:0034122;GO:0007399;GO:0070050;GO:0007218;GO:0042698;GO:0006909;GO:0014065;GO:0030168;GO:0070527;GO:0033674;GO:1903902;GO:0046777;GO:0043491;GO:0032940;GO:0007165;GO:0007283;GO:0034446;GO:0007169;GO:0060068;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope; C:nucleus; C:receptor complex;, F:ATP binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:virus receptor activity;, P:apoptotic cell clearance; P:cell adhesion; P:cell migration; P:forebrain cell migration; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of lymphocyte activation; P:negative regulation of neuron apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:nervous system development; P:neuron cellular homeostasis; P:neuropeptide signaling pathway; P:ovulation cycle; P:phagocytosis; P:phosphatidylinositol 3-kinase signaling; P:platelet activation; P:platelet aggregation; P:positive regulation of kinase activity; P:positive regulation of viral life cycle; P:protein autophosphorylation; P:protein kinase B signaling; P:secretion by cell; P:signal transduction; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development;|Q06418 O14953 Q86VR3,Tyrosine-protein kinase receptor TYRO3,Tyrosine-protein kinase BYK;Tyrosine-protein kinase DTK;Tyrosine-protein kinase RSE;Tyrosine-protein kinase SKY;Tyrosine-protein kinase TIF;, PF00041;PF07679;PF07714;, GO:0009986;GO:0005789;GO:0005887;GO:0005635;GO:0005634;GO:0043235;GO:0005524;GO:0043548;GO:0004713;GO:0004714;GO:0001618;GO:0043277;GO:0007155;GO:0016477;GO:0021885;GO:0007275;GO:0001779;GO:0050728;GO:0045824;GO:0051250;GO:0043524;GO:0034122;GO:0007399;GO:0070050;GO:0007218;GO:0042698;GO:0006909;GO:0014065;GO:0030168;GO:0070527;GO:0033674;GO:1903902;GO:0046777;GO:0043491;GO:0032940;GO:0007165;GO:0007283;GO:0034446;GO:0007169;GO:0060068;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope; C:nucleus; C:receptor complex;, F:ATP binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:virus receptor activity;, P:apoptotic cell clearance; P:cell adhesion; P:cell migration; P:forebrain cell migration; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of lymphocyte activation; P:negative regulation of neuron apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:nervous system development; P:neuron cellular homeostasis; P:neuropeptide signaling pathway; P:ovulation cycle; P:phagocytosis; P:phosphatidylinositol 3-kinase signaling; P:platelet activation; P:platelet aggregation; P:positive regulation of kinase activity; P:positive regulation of viral life cycle; P:protein autophosphorylation; P:protein kinase B signaling; P:secretion by cell; P:signal transduction; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development;|Q06418 O14953 Q86VR3,Tyrosine-protein kinase receptor TYRO3,Tyrosine-protein kinase BYK;Tyrosine-protein kinase DTK;Tyrosine-protein kinase RSE;Tyrosine-protein kinase SKY;Tyrosine-protein kinase TIF;, PF00041;PF07679;PF07714;, GO:0009986;GO:0005789;GO:0005887;GO:0005635;GO:0005634;GO:0043235;GO:0005524;GO:0043548;GO:0004713;GO:0004714;GO:0001618;GO:0043277;GO:0007155;GO:0016477;GO:0021885;GO:0007275;GO:0001779;GO:0050728;GO:0045824;GO:0051250;GO:0043524;GO:0034122;GO:0007399;GO:0070050;GO:0007218;GO:0042698;GO:0006909;GO:0014065;GO:0030168;GO:0070527;GO:0033674;GO:1903902;GO:0046777;GO:0043491;GO:0032940;GO:0007165;GO:0007283;GO:0034446;GO:0007169;GO:0060068;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope; C:nucleus; C:receptor complex;, F:ATP binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:virus receptor activity;, P:apoptotic cell clearance; P:cell adhesion; P:cell migration; P:forebrain cell migration; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of lymphocyte activation; P:negative regulation of neuron apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:nervous system development; P:neuron cellular homeostasis; P:neuropeptide signaling pathway; P:ovulation cycle; P:phagocytosis; P:phosphatidylinositol 3-kinase signaling; P:platelet activation; P:platelet aggregation; P:positive regulation of kinase activity; P:positive regulation of viral life cycle; P:protein autophosphorylation; P:protein kinase B signaling; P:secretion by cell; P:signal transduction; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development;|Q06418 O14953 Q86VR3,Tyrosine-protein kinase receptor TYRO3,Tyrosine-protein kinase BYK;Tyrosine-protein kinase DTK;Tyrosine-protein kinase RSE;Tyrosine-protein kinase SKY;Tyrosine-protein kinase TIF;, PF00041;PF07679;PF07714;, GO:0009986;GO:0005789;GO:0005887;GO:0005635;GO:0005634;GO:0043235;GO:0005524;GO:0043548;GO:0004713;GO:0004714;GO:0001618;GO:0043277;GO:0007155;GO:0016477;GO:0021885;GO:0007275;GO:0001779;GO:0050728;GO:0045824;GO:0051250;GO:0043524;GO:0034122;GO:0007399;GO:0070050;GO:0007218;GO:0042698;GO:0006909;GO:0014065;GO:0030168;GO:0070527;GO:0033674;GO:1903902;GO:0046777;GO:0043491;GO:0032940;GO:0007165;GO:0007283;GO:0034446;GO:0007169;GO:0060068;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope; C:nucleus; C:receptor complex;, F:ATP binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:virus receptor activity;, P:apoptotic cell clearance; P:cell adhesion; P:cell migration; P:forebrain cell migration; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of lymphocyte activation; P:negative regulation of neuron apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:nervous system development; P:neuron cellular homeostasis; P:neuropeptide signaling pathway; P:ovulation cycle; P:phagocytosis; P:phosphatidylinositol 3-kinase signaling; P:platelet activation; P:platelet aggregation; P:positive regulation of kinase activity; P:positive regulation of viral life cycle; P:protein autophosphorylation; P:protein kinase B signaling; P:secretion by cell; P:signal transduction; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development;|Q06418 O14953 Q86VR3,Tyrosine-protein kinase receptor TYRO3,Tyrosine-protein kinase BYK;Tyrosine-protein kinase DTK;Tyrosine-protein kinase RSE;Tyrosine-protein kinase SKY;Tyrosine-protein kinase TIF;, PF00041;PF07679;PF07714;, GO:0009986;GO:0005789;GO:0005887;GO:0005635;GO:0005634;GO:0043235;GO:0005524;GO:0043548;GO:0004713;GO:0004714;GO:0001618;GO:0043277;GO:0007155;GO:0016477;GO:0021885;GO:0007275;GO:0001779;GO:0050728;GO:0045824;GO:0051250;GO:0043524;GO:0034122;GO:0007399;GO:0070050;GO:0007218;GO:0042698;GO:0006909;GO:0014065;GO:0030168;GO:0070527;GO:0033674;GO:1903902;GO:0046777;GO:0043491;GO:0032940;GO:0007165;GO:0007283;GO:0034446;GO:0007169;GO:0060068;, C:cell surface; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope; C:nucleus; C:receptor complex;, F:ATP binding; F:phosphatidylinositol 3-kinase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:virus receptor activity;, P:apoptotic cell clearance; P:cell adhesion; P:cell migration; P:forebrain cell migration; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of lymphocyte activation; P:negative regulation of neuron apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:nervous system development; P:neuron cellular homeostasis; P:neuropeptide signaling pathway; P:ovulation cycle; P:phagocytosis; P:phosphatidylinositol 3-kinase signaling; P:platelet activation; P:platelet aggregation; P:positive regulation of kinase activity; P:positive regulation of viral life cycle; P:protein autophosphorylation; P:protein kinase B signaling; P:secretion by cell; P:signal transduction; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development; scaffold37 indexed_genome mRNA 595136 641828 . + . ID=transcript_7515;Q8IWI9 B9EGR5 E7ENI0 F5H7K2 Q9H8R3 Q9H9N7 Q9UG69 Q9Y4E9,MAX gene-associated protein,MAX dimerization protein 5;, PF16059;PF00010;PF00907;, GO:0000785;GO:0071339;GO:0005654;GO:0000981;GO:0046983;GO:0000978;GO:0001708;GO:0070317;GO:0006357;, C:chromatin; C:MLL1 complex; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell fate specification; P:negative regulation of G0 to G1 transition; P:regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 657915 690070 . + . ID=transcript_7516;Q8IWI9 B9EGR5 E7ENI0 F5H7K2 Q9H8R3 Q9H9N7 Q9UG69 Q9Y4E9,MAX gene-associated protein,MAX dimerization protein 5;, PF16059;PF00010;PF00907;, GO:0000785;GO:0071339;GO:0005654;GO:0000981;GO:0046983;GO:0000978;GO:0001708;GO:0070317;GO:0006357;, C:chromatin; C:MLL1 complex; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell fate specification; P:negative regulation of G0 to G1 transition; P:regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 692258 744847 . + . ID=transcript_7517;O60336 A6NM93 A8K8P9 Q14CB5 Q14CD8 Q49AJ8 Q5W9G9,Mitogen-activated protein kinase-binding protein 1,JNK-binding protein 1;, PF00400;, GO:0005737;GO:0097431;GO:0005730;GO:0005654;GO:1900425;GO:0043124;GO:0032717;, C:cytoplasm; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm;, , P:negative regulation of defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production;|O60336 A6NM93 A8K8P9 Q14CB5 Q14CD8 Q49AJ8 Q5W9G9,Mitogen-activated protein kinase-binding protein 1,JNK-binding protein 1;, PF00400;, GO:0005737;GO:0097431;GO:0005730;GO:0005654;GO:1900425;GO:0043124;GO:0032717;, C:cytoplasm; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm;, , P:negative regulation of defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production;|O60336 A6NM93 A8K8P9 Q14CB5 Q14CD8 Q49AJ8 Q5W9G9,Mitogen-activated protein kinase-binding protein 1,JNK-binding protein 1;, PF00400;, GO:0005737;GO:0097431;GO:0005730;GO:0005654;GO:1900425;GO:0043124;GO:0032717;, C:cytoplasm; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm;, , P:negative regulation of defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production;|O60336 A6NM93 A8K8P9 Q14CB5 Q14CD8 Q49AJ8 Q5W9G9,Mitogen-activated protein kinase-binding protein 1,JNK-binding protein 1;, PF00400;, GO:0005737;GO:0097431;GO:0005730;GO:0005654;GO:1900425;GO:0043124;GO:0032717;, C:cytoplasm; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm;, , P:negative regulation of defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production;|O60336 A6NM93 A8K8P9 Q14CB5 Q14CD8 Q49AJ8 Q5W9G9,Mitogen-activated protein kinase-binding protein 1,JNK-binding protein 1;, PF00400;, GO:0005737;GO:0097431;GO:0005730;GO:0005654;GO:1900425;GO:0043124;GO:0032717;, C:cytoplasm; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm;, , P:negative regulation of defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production;|O60336 A6NM93 A8K8P9 Q14CB5 Q14CD8 Q49AJ8 Q5W9G9,Mitogen-activated protein kinase-binding protein 1,JNK-binding protein 1;, PF00400;, GO:0005737;GO:0097431;GO:0005730;GO:0005654;GO:1900425;GO:0043124;GO:0032717;, C:cytoplasm; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm;, , P:negative regulation of defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production;|O60336 A6NM93 A8K8P9 Q14CB5 Q14CD8 Q49AJ8 Q5W9G9,Mitogen-activated protein kinase-binding protein 1,JNK-binding protein 1;, PF00400;, GO:0005737;GO:0097431;GO:0005730;GO:0005654;GO:1900425;GO:0043124;GO:0032717;, C:cytoplasm; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm;, , P:negative regulation of defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production;|O60336 A6NM93 A8K8P9 Q14CB5 Q14CD8 Q49AJ8 Q5W9G9,Mitogen-activated protein kinase-binding protein 1,JNK-binding protein 1;, PF00400;, GO:0005737;GO:0097431;GO:0005730;GO:0005654;GO:1900425;GO:0043124;GO:0032717;, C:cytoplasm; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm;, , P:negative regulation of defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production;|O60336 A6NM93 A8K8P9 Q14CB5 Q14CD8 Q49AJ8 Q5W9G9,Mitogen-activated protein kinase-binding protein 1,JNK-binding protein 1;, PF00400;, GO:0005737;GO:0097431;GO:0005730;GO:0005654;GO:1900425;GO:0043124;GO:0032717;, C:cytoplasm; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm;, , P:negative regulation of defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production;|O60336 A6NM93 A8K8P9 Q14CB5 Q14CD8 Q49AJ8 Q5W9G9,Mitogen-activated protein kinase-binding protein 1,JNK-binding protein 1;, PF00400;, GO:0005737;GO:0097431;GO:0005730;GO:0005654;GO:1900425;GO:0043124;GO:0032717;, C:cytoplasm; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm;, , P:negative regulation of defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production; scaffold37 indexed_genome mRNA 745063 763887 . + . ID=transcript_7518;P0C869 B4DRT9 O95712 Q19KD5 Q19KD6 Q59GF9 Q8TB10 Q9UKV7,Cytosolic phospholipase A2 beta {ECO:0000303|PubMed:16617059},Lysophospholipase A1 group IVB {ECO:0000305|PubMed:16617059};Phospholipase A2 group IVB;, PF00168;PF18695;PF01735;, GO:0005829;GO:0031901;GO:0005576;GO:0005743;GO:0005509;GO:0047498;GO:0005544;GO:0004622;GO:0102545;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0019369;GO:0019722;GO:0046475;GO:0006954;GO:0036498;GO:0007567;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036150;GO:0006644;, C:cytosol; C:early endosome membrane; C:extracellular region; C:mitochondrial inner membrane;, F:calcium ion binding; F:calcium-dependent phospholipase A2 activity; F:calcium-dependent phospholipid binding; F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:arachidonic acid metabolic process; P:calcium-mediated signaling; P:glycerophospholipid catabolic process; P:inflammatory response; P:IRE1-mediated unfolded protein response; P:parturition; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process;|P0C869 B4DRT9 O95712 Q19KD5 Q19KD6 Q59GF9 Q8TB10 Q9UKV7,Cytosolic phospholipase A2 beta {ECO:0000303|PubMed:16617059},Lysophospholipase A1 group IVB {ECO:0000305|PubMed:16617059};Phospholipase A2 group IVB;, PF00168;PF18695;PF01735;, GO:0005829;GO:0031901;GO:0005576;GO:0005743;GO:0005509;GO:0047498;GO:0005544;GO:0004622;GO:0102545;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0019369;GO:0019722;GO:0046475;GO:0006954;GO:0036498;GO:0007567;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036150;GO:0006644;, C:cytosol; C:early endosome membrane; C:extracellular region; C:mitochondrial inner membrane;, F:calcium ion binding; F:calcium-dependent phospholipase A2 activity; F:calcium-dependent phospholipid binding; F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:arachidonic acid metabolic process; P:calcium-mediated signaling; P:glycerophospholipid catabolic process; P:inflammatory response; P:IRE1-mediated unfolded protein response; P:parturition; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process; scaffold37 indexed_genome mRNA 766875 769454 . - . ID=transcript_7519;Q9NRC6,Spectrin beta chain, non-erythrocytic 5,Beta-V spectrin;, PF00307;PF00435;, GO:0045179;GO:0005737;GO:0005829;GO:0016020;GO:0005875;GO:0032391;GO:0097381;GO:0008091;GO:0003779;GO:0051015;GO:0034452;GO:0045505;GO:0042802;GO:0019894;GO:0032029;GO:0002046;GO:0008022;GO:0043621;GO:0030507;GO:0030036;GO:0051693;GO:0007411;GO:0006888;GO:0007030;GO:0007041;GO:0000165;, C:apical cortex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule associated complex; C:photoreceptor connecting cilium; C:photoreceptor disc membrane; C:spectrin;, F:actin binding; F:actin filament binding; F:dynactin binding; F:dynein intermediate chain binding; F:identical protein binding; F:kinesin binding; F:myosin tail binding; F:opsin binding; F:protein C-terminus binding; F:protein self-association; F:spectrin binding;, P:actin cytoskeleton organization; P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:lysosomal transport; P:MAPK cascade; scaffold37 indexed_genome mRNA 770746 774516 . - . ID=transcript_7520;Q9NRC6,Spectrin beta chain, non-erythrocytic 5,Beta-V spectrin;, PF00307;PF00435;, GO:0045179;GO:0005737;GO:0005829;GO:0016020;GO:0005875;GO:0032391;GO:0097381;GO:0008091;GO:0003779;GO:0051015;GO:0034452;GO:0045505;GO:0042802;GO:0019894;GO:0032029;GO:0002046;GO:0008022;GO:0043621;GO:0030507;GO:0030036;GO:0051693;GO:0007411;GO:0006888;GO:0007030;GO:0007041;GO:0000165;, C:apical cortex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule associated complex; C:photoreceptor connecting cilium; C:photoreceptor disc membrane; C:spectrin;, F:actin binding; F:actin filament binding; F:dynactin binding; F:dynein intermediate chain binding; F:identical protein binding; F:kinesin binding; F:myosin tail binding; F:opsin binding; F:protein C-terminus binding; F:protein self-association; F:spectrin binding;, P:actin cytoskeleton organization; P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:lysosomal transport; P:MAPK cascade; scaffold37 indexed_genome mRNA 818138 901187 . - . ID=transcript_7521;Q9H223 Q9HAR1 Q9NZN2,EH domain-containing protein 4 {ECO:0000305},Hepatocellular carcinoma-associated protein 10/11 {ECO:0000303|PubMed:12097419};PAST homolog 4 {ECO:0000305};, PF18150;PF00350;PF12763;PF16880;, GO:0005769;GO:0031901;GO:0030139;GO:0005783;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0055038;GO:0005524;GO:0045296;GO:0005509;GO:0005525;GO:0003676;GO:0071363;GO:0060271;GO:0032456;GO:0006897;GO:0016197;GO:0006907;GO:0050731;GO:0051260;GO:0072659;GO:0030100;, C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome membrane;, F:ATP binding; F:cadherin binding; F:calcium ion binding; F:GTP binding; F:nucleic acid binding;, P:cellular response to growth factor stimulus; P:cilium assembly; P:endocytic recycling; P:endocytosis; P:endosomal transport; P:pinocytosis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein homooligomerization; P:protein localization to plasma membrane; P:regulation of endocytosis; scaffold37 indexed_genome mRNA 1068816 1114396 . - . ID=transcript_7522;Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane;|Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane;|Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane;|Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane;|Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane;|Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane;|Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane;|Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane;|Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane;|Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane;|Q96JC1 O94869 Q71SQ6 Q7Z3V3 Q96B93 Q96RM0,Vam6/Vps39-like protein {ECO:0000305},TRAP1-like protein;, PF00780;PF10366;PF10367;, GO:0030123;GO:0005737;GO:0030897;GO:0005770;GO:0031902;GO:1902501;GO:0005765;GO:0016020;GO:0061909;GO:0006914;GO:0034058;GO:0008333;GO:0006886;GO:1902774;GO:1990126;, C:AP-3 adaptor complex; C:cytoplasm; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal HOPS complex; C:lysosomal membrane; C:membrane;, , P:autophagosome-lysosome fusion; P:autophagy; P:endosomal vesicle fusion; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:retrograde transport, endosome to plasma membrane; scaffold37 indexed_genome mRNA 1117243 1217809 . + . ID=transcript_7523;Q8NBN3 Q6NT77 Q8NCA4 Q9BS46 Q9P103 Q9Y3Y7,Transmembrane protein 87A {ECO:0000305},, PF06814;, GO:0005829;GO:0005794;GO:0032580;GO:0016021;GO:0016020;GO:0042147;, C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:membrane;, , P:retrograde transport, endosome to Golgi;|Q6P5R6 Q32Q77,60S ribosomal protein L22-like 1,Large ribosomal subunit protein eL22-like 1;, PF01776;, GO:0005840;GO:0003723;GO:0003735;GO:0002181;, C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation;|Q8NBN3 Q6NT77 Q8NCA4 Q9BS46 Q9P103 Q9Y3Y7,Transmembrane protein 87A {ECO:0000305},, PF06814;, GO:0005829;GO:0005794;GO:0032580;GO:0016021;GO:0016020;GO:0042147;, C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:membrane;, , P:retrograde transport, endosome to Golgi;|Q8TET4 Q52LQ4 Q8IWZ0 Q8IZM4 Q8IZM5,Neutral alpha-glucosidase C,, PF13802;PF01055;, GO:0004558;GO:0090599;GO:0030246;GO:0004553;GO:0032450;GO:0006491;, , F:alpha-1,4-glucosidase activity; F:alpha-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:N-glycan processing;|Q8TET4 Q52LQ4 Q8IWZ0 Q8IZM4 Q8IZM5,Neutral alpha-glucosidase C,, PF13802;PF01055;, GO:0004558;GO:0090599;GO:0030246;GO:0004553;GO:0032450;GO:0006491;, , F:alpha-1,4-glucosidase activity; F:alpha-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:N-glycan processing;|Q8TET4 Q52LQ4 Q8IWZ0 Q8IZM4 Q8IZM5,Neutral alpha-glucosidase C,, PF13802;PF01055;, GO:0004558;GO:0090599;GO:0030246;GO:0004553;GO:0032450;GO:0006491;, , F:alpha-1,4-glucosidase activity; F:alpha-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:N-glycan processing;|Q8TET4 Q52LQ4 Q8IWZ0 Q8IZM4 Q8IZM5,Neutral alpha-glucosidase C,, PF13802;PF01055;, GO:0004558;GO:0090599;GO:0030246;GO:0004553;GO:0032450;GO:0006491;, , F:alpha-1,4-glucosidase activity; F:alpha-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:N-glycan processing;|Q8TET4 Q52LQ4 Q8IWZ0 Q8IZM4 Q8IZM5,Neutral alpha-glucosidase C,, PF13802;PF01055;, GO:0004558;GO:0090599;GO:0030246;GO:0004553;GO:0032450;GO:0006491;, , F:alpha-1,4-glucosidase activity; F:alpha-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:N-glycan processing; scaffold37 indexed_genome mRNA 1217816 1224040 . + . ID=transcript_7524;Q8TET4 Q52LQ4 Q8IWZ0 Q8IZM4 Q8IZM5,Neutral alpha-glucosidase C,, PF13802;PF01055;, GO:0004558;GO:0090599;GO:0030246;GO:0004553;GO:0032450;GO:0006491;, , F:alpha-1,4-glucosidase activity; F:alpha-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:N-glycan processing; scaffold37 indexed_genome mRNA 1232858 1314235 . + . ID=transcript_7525;P20807 A6H8K6 Q7L4R0 Q9BQC8 Q9BTU4 Q9Y5S6 Q9Y5S7,Calpain-3,Calcium-activated neutral proteinase 3;Calpain L3;Calpain p94;Muscle-specific calcium-activated neutral protease 3;New calpain 1;, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0005622;GO:0030016;GO:0005634;GO:0005886;GO:0032991;GO:0030315;GO:0030018;GO:0005509;GO:0004198;GO:0003824;GO:0008234;GO:0042802;GO:0055103;GO:0060090;GO:0008233;GO:0031402;GO:0008307;GO:0031432;GO:0006915;GO:1990092;GO:0071277;GO:0071472;GO:0070315;GO:0046716;GO:0007517;GO:0061061;GO:0030239;GO:0043066;GO:0033234;GO:0045892;GO:0051092;GO:0045862;GO:0051281;GO:0014718;GO:0045893;GO:0030163;GO:0031648;GO:0072657;GO:0065003;GO:0006508;GO:0050790;GO:0043122;GO:0045661;GO:0051592;GO:0014850;GO:0045214;GO:0097264;, C:cytoplasm; C:cytosol; C:intracellular anatomical structure; C:myofibril; C:nucleus; C:plasma membrane; C:protein-containing complex; C:T-tubule; C:Z disc;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:catalytic activity; F:cysteine-type peptidase activity; F:identical protein binding; F:ligase regulator activity; F:molecular adaptor activity; F:peptidase activity; F:sodium ion binding; F:structural constituent of muscle; F:titin binding;, P:apoptotic process; P:calcium-dependent self proteolysis; P:cellular response to calcium ion; P:cellular response to salt stress; P:G1 to G0 transition involved in cell differentiation; P:muscle cell cellular homeostasis; P:muscle organ development; P:muscle structure development; P:myofibril assembly; P:negative regulation of apoptotic process; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of proteolysis; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of satellite cell activation involved in skeletal muscle regeneration; P:positive regulation of transcription, DNA-templated; P:protein catabolic process; P:protein destabilization; P:protein localization to membrane; P:protein-containing complex assembly; P:proteolysis; P:regulation of catalytic activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of myoblast differentiation; P:response to calcium ion; P:response to muscle activity; P:sarcomere organization; P:self proteolysis;|P20807 A6H8K6 Q7L4R0 Q9BQC8 Q9BTU4 Q9Y5S6 Q9Y5S7,Calpain-3,Calcium-activated neutral proteinase 3;Calpain L3;Calpain p94;Muscle-specific calcium-activated neutral protease 3;New calpain 1;, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0005622;GO:0030016;GO:0005634;GO:0005886;GO:0032991;GO:0030315;GO:0030018;GO:0005509;GO:0004198;GO:0003824;GO:0008234;GO:0042802;GO:0055103;GO:0060090;GO:0008233;GO:0031402;GO:0008307;GO:0031432;GO:0006915;GO:1990092;GO:0071277;GO:0071472;GO:0070315;GO:0046716;GO:0007517;GO:0061061;GO:0030239;GO:0043066;GO:0033234;GO:0045892;GO:0051092;GO:0045862;GO:0051281;GO:0014718;GO:0045893;GO:0030163;GO:0031648;GO:0072657;GO:0065003;GO:0006508;GO:0050790;GO:0043122;GO:0045661;GO:0051592;GO:0014850;GO:0045214;GO:0097264;, C:cytoplasm; C:cytosol; C:intracellular anatomical structure; C:myofibril; C:nucleus; C:plasma membrane; C:protein-containing complex; C:T-tubule; C:Z disc;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:catalytic activity; F:cysteine-type peptidase activity; F:identical protein binding; F:ligase regulator activity; F:molecular adaptor activity; F:peptidase activity; F:sodium ion binding; F:structural constituent of muscle; F:titin binding;, P:apoptotic process; P:calcium-dependent self proteolysis; P:cellular response to calcium ion; P:cellular response to salt stress; P:G1 to G0 transition involved in cell differentiation; P:muscle cell cellular homeostasis; P:muscle organ development; P:muscle structure development; P:myofibril assembly; P:negative regulation of apoptotic process; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of proteolysis; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of satellite cell activation involved in skeletal muscle regeneration; P:positive regulation of transcription, DNA-templated; P:protein catabolic process; P:protein destabilization; P:protein localization to membrane; P:protein-containing complex assembly; P:proteolysis; P:regulation of catalytic activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of myoblast differentiation; P:response to calcium ion; P:response to muscle activity; P:sarcomere organization; P:self proteolysis;|P20807 A6H8K6 Q7L4R0 Q9BQC8 Q9BTU4 Q9Y5S6 Q9Y5S7,Calpain-3,Calcium-activated neutral proteinase 3;Calpain L3;Calpain p94;Muscle-specific calcium-activated neutral protease 3;New calpain 1;, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0005622;GO:0030016;GO:0005634;GO:0005886;GO:0032991;GO:0030315;GO:0030018;GO:0005509;GO:0004198;GO:0003824;GO:0008234;GO:0042802;GO:0055103;GO:0060090;GO:0008233;GO:0031402;GO:0008307;GO:0031432;GO:0006915;GO:1990092;GO:0071277;GO:0071472;GO:0070315;GO:0046716;GO:0007517;GO:0061061;GO:0030239;GO:0043066;GO:0033234;GO:0045892;GO:0051092;GO:0045862;GO:0051281;GO:0014718;GO:0045893;GO:0030163;GO:0031648;GO:0072657;GO:0065003;GO:0006508;GO:0050790;GO:0043122;GO:0045661;GO:0051592;GO:0014850;GO:0045214;GO:0097264;, C:cytoplasm; C:cytosol; C:intracellular anatomical structure; C:myofibril; C:nucleus; C:plasma membrane; C:protein-containing complex; C:T-tubule; C:Z disc;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:catalytic activity; F:cysteine-type peptidase activity; F:identical protein binding; F:ligase regulator activity; F:molecular adaptor activity; F:peptidase activity; F:sodium ion binding; F:structural constituent of muscle; F:titin binding;, P:apoptotic process; P:calcium-dependent self proteolysis; P:cellular response to calcium ion; P:cellular response to salt stress; P:G1 to G0 transition involved in cell differentiation; P:muscle cell cellular homeostasis; P:muscle organ development; P:muscle structure development; P:myofibril assembly; P:negative regulation of apoptotic process; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of proteolysis; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of satellite cell activation involved in skeletal muscle regeneration; P:positive regulation of transcription, DNA-templated; P:protein catabolic process; P:protein destabilization; P:protein localization to membrane; P:protein-containing complex assembly; P:proteolysis; P:regulation of catalytic activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of myoblast differentiation; P:response to calcium ion; P:response to muscle activity; P:sarcomere organization; P:self proteolysis;|P20807 A6H8K6 Q7L4R0 Q9BQC8 Q9BTU4 Q9Y5S6 Q9Y5S7,Calpain-3,Calcium-activated neutral proteinase 3;Calpain L3;Calpain p94;Muscle-specific calcium-activated neutral protease 3;New calpain 1;, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0005622;GO:0030016;GO:0005634;GO:0005886;GO:0032991;GO:0030315;GO:0030018;GO:0005509;GO:0004198;GO:0003824;GO:0008234;GO:0042802;GO:0055103;GO:0060090;GO:0008233;GO:0031402;GO:0008307;GO:0031432;GO:0006915;GO:1990092;GO:0071277;GO:0071472;GO:0070315;GO:0046716;GO:0007517;GO:0061061;GO:0030239;GO:0043066;GO:0033234;GO:0045892;GO:0051092;GO:0045862;GO:0051281;GO:0014718;GO:0045893;GO:0030163;GO:0031648;GO:0072657;GO:0065003;GO:0006508;GO:0050790;GO:0043122;GO:0045661;GO:0051592;GO:0014850;GO:0045214;GO:0097264;, C:cytoplasm; C:cytosol; C:intracellular anatomical structure; C:myofibril; C:nucleus; C:plasma membrane; C:protein-containing complex; C:T-tubule; C:Z disc;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:catalytic activity; F:cysteine-type peptidase activity; F:identical protein binding; F:ligase regulator activity; F:molecular adaptor activity; F:peptidase activity; F:sodium ion binding; F:structural constituent of muscle; F:titin binding;, P:apoptotic process; P:calcium-dependent self proteolysis; P:cellular response to calcium ion; P:cellular response to salt stress; P:G1 to G0 transition involved in cell differentiation; P:muscle cell cellular homeostasis; P:muscle organ development; P:muscle structure development; P:myofibril assembly; P:negative regulation of apoptotic process; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of proteolysis; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of satellite cell activation involved in skeletal muscle regeneration; P:positive regulation of transcription, DNA-templated; P:protein catabolic process; P:protein destabilization; P:protein localization to membrane; P:protein-containing complex assembly; P:proteolysis; P:regulation of catalytic activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of myoblast differentiation; P:response to calcium ion; P:response to muscle activity; P:sarcomere organization; P:self proteolysis;|P20807 A6H8K6 Q7L4R0 Q9BQC8 Q9BTU4 Q9Y5S6 Q9Y5S7,Calpain-3,Calcium-activated neutral proteinase 3;Calpain L3;Calpain p94;Muscle-specific calcium-activated neutral protease 3;New calpain 1;, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0005622;GO:0030016;GO:0005634;GO:0005886;GO:0032991;GO:0030315;GO:0030018;GO:0005509;GO:0004198;GO:0003824;GO:0008234;GO:0042802;GO:0055103;GO:0060090;GO:0008233;GO:0031402;GO:0008307;GO:0031432;GO:0006915;GO:1990092;GO:0071277;GO:0071472;GO:0070315;GO:0046716;GO:0007517;GO:0061061;GO:0030239;GO:0043066;GO:0033234;GO:0045892;GO:0051092;GO:0045862;GO:0051281;GO:0014718;GO:0045893;GO:0030163;GO:0031648;GO:0072657;GO:0065003;GO:0006508;GO:0050790;GO:0043122;GO:0045661;GO:0051592;GO:0014850;GO:0045214;GO:0097264;, C:cytoplasm; C:cytosol; C:intracellular anatomical structure; C:myofibril; C:nucleus; C:plasma membrane; C:protein-containing complex; C:T-tubule; C:Z disc;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:catalytic activity; F:cysteine-type peptidase activity; F:identical protein binding; F:ligase regulator activity; F:molecular adaptor activity; F:peptidase activity; F:sodium ion binding; F:structural constituent of muscle; F:titin binding;, P:apoptotic process; P:calcium-dependent self proteolysis; P:cellular response to calcium ion; P:cellular response to salt stress; P:G1 to G0 transition involved in cell differentiation; P:muscle cell cellular homeostasis; P:muscle organ development; P:muscle structure development; P:myofibril assembly; P:negative regulation of apoptotic process; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of proteolysis; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of satellite cell activation involved in skeletal muscle regeneration; P:positive regulation of transcription, DNA-templated; P:protein catabolic process; P:protein destabilization; P:protein localization to membrane; P:protein-containing complex assembly; P:proteolysis; P:regulation of catalytic activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of myoblast differentiation; P:response to calcium ion; P:response to muscle activity; P:sarcomere organization; P:self proteolysis;|P20807 A6H8K6 Q7L4R0 Q9BQC8 Q9BTU4 Q9Y5S6 Q9Y5S7,Calpain-3,Calcium-activated neutral proteinase 3;Calpain L3;Calpain p94;Muscle-specific calcium-activated neutral protease 3;New calpain 1;, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0005622;GO:0030016;GO:0005634;GO:0005886;GO:0032991;GO:0030315;GO:0030018;GO:0005509;GO:0004198;GO:0003824;GO:0008234;GO:0042802;GO:0055103;GO:0060090;GO:0008233;GO:0031402;GO:0008307;GO:0031432;GO:0006915;GO:1990092;GO:0071277;GO:0071472;GO:0070315;GO:0046716;GO:0007517;GO:0061061;GO:0030239;GO:0043066;GO:0033234;GO:0045892;GO:0051092;GO:0045862;GO:0051281;GO:0014718;GO:0045893;GO:0030163;GO:0031648;GO:0072657;GO:0065003;GO:0006508;GO:0050790;GO:0043122;GO:0045661;GO:0051592;GO:0014850;GO:0045214;GO:0097264;, C:cytoplasm; C:cytosol; C:intracellular anatomical structure; C:myofibril; C:nucleus; C:plasma membrane; C:protein-containing complex; C:T-tubule; C:Z disc;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:catalytic activity; F:cysteine-type peptidase activity; F:identical protein binding; F:ligase regulator activity; F:molecular adaptor activity; F:peptidase activity; F:sodium ion binding; F:structural constituent of muscle; F:titin binding;, P:apoptotic process; P:calcium-dependent self proteolysis; P:cellular response to calcium ion; P:cellular response to salt stress; P:G1 to G0 transition involved in cell differentiation; P:muscle cell cellular homeostasis; P:muscle organ development; P:muscle structure development; P:myofibril assembly; P:negative regulation of apoptotic process; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of proteolysis; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of satellite cell activation involved in skeletal muscle regeneration; P:positive regulation of transcription, DNA-templated; P:protein catabolic process; P:protein destabilization; P:protein localization to membrane; P:protein-containing complex assembly; P:proteolysis; P:regulation of catalytic activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of myoblast differentiation; P:response to calcium ion; P:response to muscle activity; P:sarcomere organization; P:self proteolysis;|Q86TA9 Q96M37 Q9H7B8,Zinc finger protein 106,Zinc finger protein 474;, PF00400;, GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0046872;GO:0003723;GO:0017124;GO:0008286;, C:cytosol; C:membrane; C:nuclear speck; C:nucleolus;, F:metal ion binding; F:RNA binding; F:SH3 domain binding;, P:insulin receptor signaling pathway;|Q86TA9 Q96M37 Q9H7B8,Zinc finger protein 106,Zinc finger protein 474;, PF00400;, GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0046872;GO:0003723;GO:0017124;GO:0008286;, C:cytosol; C:membrane; C:nuclear speck; C:nucleolus;, F:metal ion binding; F:RNA binding; F:SH3 domain binding;, P:insulin receptor signaling pathway;|Q86TA9 Q96M37 Q9H7B8,Zinc finger protein 106,Zinc finger protein 474;, PF00400;, GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0046872;GO:0003723;GO:0017124;GO:0008286;, C:cytosol; C:membrane; C:nuclear speck; C:nucleolus;, F:metal ion binding; F:RNA binding; F:SH3 domain binding;, P:insulin receptor signaling pathway;|Q86TA9 Q96M37 Q9H7B8,Zinc finger protein 106,Zinc finger protein 474;, PF00400;, GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0046872;GO:0003723;GO:0017124;GO:0008286;, C:cytosol; C:membrane; C:nuclear speck; C:nucleolus;, F:metal ion binding; F:RNA binding; F:SH3 domain binding;, P:insulin receptor signaling pathway;|Q86TA9 Q96M37 Q9H7B8,Zinc finger protein 106,Zinc finger protein 474;, PF00400;, GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0046872;GO:0003723;GO:0017124;GO:0008286;, C:cytosol; C:membrane; C:nuclear speck; C:nucleolus;, F:metal ion binding; F:RNA binding; F:SH3 domain binding;, P:insulin receptor signaling pathway; scaffold37 indexed_genome mRNA 1375230 1376022 . + . ID=transcript_7526;O00161 O00162 Q13602 Q6IAE3,Synaptosomal-associated protein 23,Vesicle-membrane fusion protein SNAP-23;, PF00835;, GO:0005912;GO:0042582;GO:0005737;GO:0070062;GO:0005925;GO:0005739;GO:0043005;GO:0005654;GO:0030670;GO:0005886;GO:0098793;GO:0031201;GO:0042581;GO:0035579;GO:0070821;GO:0005484;GO:0019905;GO:0002479;GO:0006887;GO:0002553;GO:0061025;GO:0043312;GO:0006892;GO:0015031;GO:0031629;GO:0016082;GO:0006906;GO:0006903;, C:adherens junction; C:azurophil granule; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:presynapse; C:SNARE complex; C:specific granule; C:specific granule membrane; C:tertiary granule membrane;, F:SNAP receptor activity; F:syntaxin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:exocytosis; P:histamine secretion by mast cell; P:membrane fusion; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; P:protein transport; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle priming; P:vesicle fusion; P:vesicle targeting; scaffold37 indexed_genome mRNA 1386869 1397220 . - . ID=transcript_7527;Q8N9N7 Q7Z2Z6 Q8N1T6,Leucine-rich repeat-containing protein 57,, PF00560;PF13855;, GO:0070062;GO:0016020;, C:extracellular exosome; C:membrane;|Q8N9N7 Q7Z2Z6 Q8N1T6,Leucine-rich repeat-containing protein 57,, PF00560;PF13855;, GO:0070062;GO:0016020;, C:extracellular exosome; C:membrane;|Q9NVX0 C9JH36 Q9H9B3,HAUS augmin-like complex subunit 2,Centrosomal protein of 27 kDa;, PF15003;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold37 indexed_genome mRNA 1397274 1404923 . + . ID=transcript_7528;Q9GZZ1 D3DN74 Q68DQ1,N-alpha-acetyltransferase 50 {ECO:0000305},N-acetyltransferase 13;N-acetyltransferase 5 {ECO:0000303|PubMed:16507339};N-acetyltransferase san homolog {ECO:0000303|PubMed:16507339};N-epsilon-acetyltransferase 50 {ECO:0000305};NatE catalytic subunit;, PF00583;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0010485;GO:0008080;GO:0004596;GO:0052858;GO:0034087;GO:0016573;GO:0007064;GO:0071962;GO:0006474;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus;, F:H4 histone acetyltransferase activity; F:N-acetyltransferase activity; F:peptide alpha-N-acetyltransferase activity; F:peptidyl-lysine acetyltransferase activity;, P:establishment of mitotic sister chromatid cohesion; P:histone acetylation; P:mitotic sister chromatid cohesion; P:mitotic sister chromatid cohesion, centromeric; P:N-terminal protein amino acid acetylation; scaffold37 indexed_genome mRNA 1463945 1494669 . + . ID=transcript_7529;Q9P2P6 Q68DG2 Q6AI01 Q6ZWK0 Q9UF70,StAR-related lipid transfer protein 9,START domain-containing protein 9;, PF00498;PF00225;PF01852;, GO:0005814;GO:0005737;GO:0005634;GO:0005524;GO:1990939;GO:0008289;GO:0008017;GO:0003777;GO:0007018;GO:0051225;, C:centriole; C:cytoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:lipid binding; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:spindle assembly;|Q9P2P6 Q68DG2 Q6AI01 Q6ZWK0 Q9UF70,StAR-related lipid transfer protein 9,START domain-containing protein 9;, PF00498;PF00225;PF01852;, GO:0005814;GO:0005737;GO:0005634;GO:0005524;GO:1990939;GO:0008289;GO:0008017;GO:0003777;GO:0007018;GO:0051225;, C:centriole; C:cytoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:lipid binding; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:spindle assembly;|Q9P2P6 Q68DG2 Q6AI01 Q6ZWK0 Q9UF70,StAR-related lipid transfer protein 9,START domain-containing protein 9;, PF00498;PF00225;PF01852;, GO:0005814;GO:0005737;GO:0005634;GO:0005524;GO:1990939;GO:0008289;GO:0008017;GO:0003777;GO:0007018;GO:0051225;, C:centriole; C:cytoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:lipid binding; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:spindle assembly; scaffold37 indexed_genome mRNA 1495436 1530435 . + . ID=transcript_7530;Q9P2P6 Q68DG2 Q6AI01 Q6ZWK0 Q9UF70,StAR-related lipid transfer protein 9,START domain-containing protein 9;, PF00498;PF00225;PF01852;, GO:0005814;GO:0005737;GO:0005634;GO:0005524;GO:1990939;GO:0008289;GO:0008017;GO:0003777;GO:0007018;GO:0051225;, C:centriole; C:cytoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:lipid binding; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:spindle assembly;|Q9P2P6 Q68DG2 Q6AI01 Q6ZWK0 Q9UF70,StAR-related lipid transfer protein 9,START domain-containing protein 9;, PF00498;PF00225;PF01852;, GO:0005814;GO:0005737;GO:0005634;GO:0005524;GO:1990939;GO:0008289;GO:0008017;GO:0003777;GO:0007018;GO:0051225;, C:centriole; C:cytoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:lipid binding; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:spindle assembly;|Q9P2P6 Q68DG2 Q6AI01 Q6ZWK0 Q9UF70,StAR-related lipid transfer protein 9,START domain-containing protein 9;, PF00498;PF00225;PF01852;, GO:0005814;GO:0005737;GO:0005634;GO:0005524;GO:1990939;GO:0008289;GO:0008017;GO:0003777;GO:0007018;GO:0051225;, C:centriole; C:cytoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:lipid binding; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:spindle assembly;|Q9P2P6 Q68DG2 Q6AI01 Q6ZWK0 Q9UF70,StAR-related lipid transfer protein 9,START domain-containing protein 9;, PF00498;PF00225;PF01852;, GO:0005814;GO:0005737;GO:0005634;GO:0005524;GO:1990939;GO:0008289;GO:0008017;GO:0003777;GO:0007018;GO:0051225;, C:centriole; C:cytoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:lipid binding; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:spindle assembly;|Q9P2P6 Q68DG2 Q6AI01 Q6ZWK0 Q9UF70,StAR-related lipid transfer protein 9,START domain-containing protein 9;, PF00498;PF00225;PF01852;, GO:0005814;GO:0005737;GO:0005634;GO:0005524;GO:1990939;GO:0008289;GO:0008017;GO:0003777;GO:0007018;GO:0051225;, C:centriole; C:cytoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:lipid binding; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:spindle assembly; scaffold37 indexed_genome mRNA 1530936 1543318 . - . ID=transcript_7531;Q8IWY9 Q6NYD0 Q7Z7L5 Q969N3,Codanin-1,, PF15296;, GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0005634;GO:0005886;GO:0031497;GO:0006325;GO:0008156;GO:0008104;, C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:nucleus; C:plasma membrane;, , P:chromatin assembly; P:chromatin organization; P:negative regulation of DNA replication; P:protein localization;|Q8IWY9 Q6NYD0 Q7Z7L5 Q969N3,Codanin-1,, PF15296;, GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0005634;GO:0005886;GO:0031497;GO:0006325;GO:0008156;GO:0008104;, C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:nucleus; C:plasma membrane;, , P:chromatin assembly; P:chromatin organization; P:negative regulation of DNA replication; P:protein localization;|Q8IWY9 Q6NYD0 Q7Z7L5 Q969N3,Codanin-1,, PF15296;, GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0005634;GO:0005886;GO:0031497;GO:0006325;GO:0008156;GO:0008104;, C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:nucleus; C:plasma membrane;, , P:chromatin assembly; P:chromatin organization; P:negative regulation of DNA replication; P:protein localization;|Q8IWY9 Q6NYD0 Q7Z7L5 Q969N3,Codanin-1,, PF15296;, GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0005634;GO:0005886;GO:0031497;GO:0006325;GO:0008156;GO:0008104;, C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:nucleus; C:plasma membrane;, , P:chromatin assembly; P:chromatin organization; P:negative regulation of DNA replication; P:protein localization;|Q8IWY9 Q6NYD0 Q7Z7L5 Q969N3,Codanin-1,, PF15296;, GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0005634;GO:0005886;GO:0031497;GO:0006325;GO:0008156;GO:0008104;, C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:nucleus; C:plasma membrane;, , P:chromatin assembly; P:chromatin organization; P:negative regulation of DNA replication; P:protein localization;|Q8IWY9 Q6NYD0 Q7Z7L5 Q969N3,Codanin-1,, PF15296;, GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0005634;GO:0005886;GO:0031497;GO:0006325;GO:0008156;GO:0008104;, C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:nucleus; C:plasma membrane;, , P:chromatin assembly; P:chromatin organization; P:negative regulation of DNA replication; P:protein localization;|Q8IWY9 Q6NYD0 Q7Z7L5 Q969N3,Codanin-1,, PF15296;, GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0005634;GO:0005886;GO:0031497;GO:0006325;GO:0008156;GO:0008104;, C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:nucleus; C:plasma membrane;, , P:chromatin assembly; P:chromatin organization; P:negative regulation of DNA replication; P:protein localization;|Q8IWY9 Q6NYD0 Q7Z7L5 Q969N3,Codanin-1,, PF15296;, GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0005634;GO:0005886;GO:0031497;GO:0006325;GO:0008156;GO:0008104;, C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:nucleus; C:plasma membrane;, , P:chromatin assembly; P:chromatin organization; P:negative regulation of DNA replication; P:protein localization;|Q8IWY9 Q6NYD0 Q7Z7L5 Q969N3,Codanin-1,, PF15296;, GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0005634;GO:0005886;GO:0031497;GO:0006325;GO:0008156;GO:0008104;, C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:nucleus; C:plasma membrane;, , P:chromatin assembly; P:chromatin organization; P:negative regulation of DNA replication; P:protein localization; scaffold37 indexed_genome mRNA 1557287 1600386 . - . ID=transcript_7532;Q6IQ55 O94932 Q6ZN52 Q8IVV1,Tau-tubulin kinase 2,, PF00069;, GO:0005814;GO:0036064;GO:0035869;GO:0005737;GO:0005829;GO:0005615;GO:0005634;GO:0005524;GO:0019894;GO:0051010;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0021681;GO:0021935;GO:0021549;GO:0097711;GO:0060271;GO:0000226;GO:1904527;GO:0007026;GO:1902817;GO:0018105;GO:0030334;GO:0007224;, C:centriole; C:ciliary basal body; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:extracellular space; C:nucleus;, F:ATP binding; F:kinesin binding; F:microtubule plus-end binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:cerebellar granular layer development; P:cerebellar granule cell precursor tangential migration; P:cerebellum development; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:microtubule cytoskeleton organization; P:negative regulation of microtubule binding; P:negative regulation of microtubule depolymerization; P:negative regulation of protein localization to microtubule; P:peptidyl-serine phosphorylation; P:regulation of cell migration; P:smoothened signaling pathway; scaffold37 indexed_genome mRNA 1602090 1679746 . - . ID=transcript_7533;Q6IQ55 O94932 Q6ZN52 Q8IVV1,Tau-tubulin kinase 2,, PF00069;, GO:0005814;GO:0036064;GO:0035869;GO:0005737;GO:0005829;GO:0005615;GO:0005634;GO:0005524;GO:0019894;GO:0051010;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0021681;GO:0021935;GO:0021549;GO:0097711;GO:0060271;GO:0000226;GO:1904527;GO:0007026;GO:1902817;GO:0018105;GO:0030334;GO:0007224;, C:centriole; C:ciliary basal body; C:ciliary transition zone; C:cytoplasm; C:cytosol; C:extracellular space; C:nucleus;, F:ATP binding; F:kinesin binding; F:microtubule plus-end binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:cerebellar granular layer development; P:cerebellar granule cell precursor tangential migration; P:cerebellum development; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:microtubule cytoskeleton organization; P:negative regulation of microtubule binding; P:negative regulation of microtubule depolymerization; P:negative regulation of protein localization to microtubule; P:peptidyl-serine phosphorylation; P:regulation of cell migration; P:smoothened signaling pathway; scaffold37 indexed_genome mRNA 1693122 1721254 . - . ID=transcript_7534;Q8IWV7 O60708 O75492 Q14D45 Q68DN9 Q8IWY6 Q96JY4,E3 ubiquitin-protein ligase UBR1,N-recognin-1;RING-type E3 ubiquitin transferase UBR1;Ubiquitin-protein ligase E3-alpha-1;Ubiquitin-protein ligase E3-alpha-I;, PF02617;PF18995;PF02207;, GO:0005737;GO:0005829;GO:0000502;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0032007;GO:0016567;GO:0071596;, C:cytoplasm; C:cytosol; C:proteasome complex; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:negative regulation of TOR signaling; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV7 O60708 O75492 Q14D45 Q68DN9 Q8IWY6 Q96JY4,E3 ubiquitin-protein ligase UBR1,N-recognin-1;RING-type E3 ubiquitin transferase UBR1;Ubiquitin-protein ligase E3-alpha-1;Ubiquitin-protein ligase E3-alpha-I;, PF02617;PF18995;PF02207;, GO:0005737;GO:0005829;GO:0000502;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0032007;GO:0016567;GO:0071596;, C:cytoplasm; C:cytosol; C:proteasome complex; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:negative regulation of TOR signaling; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV7 O60708 O75492 Q14D45 Q68DN9 Q8IWY6 Q96JY4,E3 ubiquitin-protein ligase UBR1,N-recognin-1;RING-type E3 ubiquitin transferase UBR1;Ubiquitin-protein ligase E3-alpha-1;Ubiquitin-protein ligase E3-alpha-I;, PF02617;PF18995;PF02207;, GO:0005737;GO:0005829;GO:0000502;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0032007;GO:0016567;GO:0071596;, C:cytoplasm; C:cytosol; C:proteasome complex; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:negative regulation of TOR signaling; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|O43447 A6NNE7,Peptidyl-prolyl cis-trans isomerase H,Rotamase H;Small nuclear ribonucleoprotein particle-specific cyclophilin H;U-snRNP-associated cyclophilin SnuCyp-20;, PF00160;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005681;GO:0071001;GO:0046540;GO:0016018;GO:0003755;GO:0043021;GO:0000398;GO:0045070;GO:0006457;GO:0000413;GO:0065003;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:spliceosomal complex; C:U4/U6 snRNP; C:U4/U6 x U5 tri-snRNP complex;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:ribonucleoprotein complex binding;, P:mRNA splicing, via spliceosome; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein-containing complex assembly; scaffold37 indexed_genome mRNA 1736640 1737535 . + . ID=transcript_7535;Q8IWV7 O60708 O75492 Q14D45 Q68DN9 Q8IWY6 Q96JY4,E3 ubiquitin-protein ligase UBR1,N-recognin-1;RING-type E3 ubiquitin transferase UBR1;Ubiquitin-protein ligase E3-alpha-1;Ubiquitin-protein ligase E3-alpha-I;, PF02617;PF18995;PF02207;, GO:0005737;GO:0005829;GO:0000502;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0032007;GO:0016567;GO:0071596;, C:cytoplasm; C:cytosol; C:proteasome complex; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:negative regulation of TOR signaling; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; scaffold37 indexed_genome mRNA 1740190 1840780 . + . ID=transcript_7536;Q8IWV7 O60708 O75492 Q14D45 Q68DN9 Q8IWY6 Q96JY4,E3 ubiquitin-protein ligase UBR1,N-recognin-1;RING-type E3 ubiquitin transferase UBR1;Ubiquitin-protein ligase E3-alpha-1;Ubiquitin-protein ligase E3-alpha-I;, PF02617;PF18995;PF02207;, GO:0005737;GO:0005829;GO:0000502;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0032007;GO:0016567;GO:0071596;, C:cytoplasm; C:cytosol; C:proteasome complex; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:negative regulation of TOR signaling; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV7 O60708 O75492 Q14D45 Q68DN9 Q8IWY6 Q96JY4,E3 ubiquitin-protein ligase UBR1,N-recognin-1;RING-type E3 ubiquitin transferase UBR1;Ubiquitin-protein ligase E3-alpha-1;Ubiquitin-protein ligase E3-alpha-I;, PF02617;PF18995;PF02207;, GO:0005737;GO:0005829;GO:0000502;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0032007;GO:0016567;GO:0071596;, C:cytoplasm; C:cytosol; C:proteasome complex; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:negative regulation of TOR signaling; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV7 O60708 O75492 Q14D45 Q68DN9 Q8IWY6 Q96JY4,E3 ubiquitin-protein ligase UBR1,N-recognin-1;RING-type E3 ubiquitin transferase UBR1;Ubiquitin-protein ligase E3-alpha-1;Ubiquitin-protein ligase E3-alpha-I;, PF02617;PF18995;PF02207;, GO:0005737;GO:0005829;GO:0000502;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0032007;GO:0016567;GO:0071596;, C:cytoplasm; C:cytosol; C:proteasome complex; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:negative regulation of TOR signaling; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; scaffold37 indexed_genome mRNA 1863768 1881247 . + . ID=transcript_7537;Q0P6H9 Q6I9Y5 Q9H5J6,Transmembrane protein 62,, PF00149;, GO:0016021;GO:0016787;, C:integral component of membrane;, F:hydrolase activity; scaffold37 indexed_genome mRNA 1885091 1899784 . + . ID=transcript_7538;Q0P6H9 Q6I9Y5 Q9H5J6,Transmembrane protein 62,, PF00149;, GO:0016021;GO:0016787;, C:integral component of membrane;, F:hydrolase activity;|Q0P6H9 Q6I9Y5 Q9H5J6,Transmembrane protein 62,, PF00149;, GO:0016021;GO:0016787;, C:integral component of membrane;, F:hydrolase activity;|Q0P6H9 Q6I9Y5 Q9H5J6,Transmembrane protein 62,, PF00149;, GO:0016021;GO:0016787;, C:integral component of membrane;, F:hydrolase activity;|Q0P6H9 Q6I9Y5 Q9H5J6,Transmembrane protein 62,, PF00149;, GO:0016021;GO:0016787;, C:integral component of membrane;, F:hydrolase activity; scaffold37 indexed_genome mRNA 1899885 1910086 . - . ID=transcript_7539;Q9UHX9,Cyclin-D1-binding protein 1,Grap2 and cyclin-D-interacting protein;Human homolog of Maid;, , GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051726;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:regulation of cell cycle;|Q9UHX9,Cyclin-D1-binding protein 1,Grap2 and cyclin-D-interacting protein;Human homolog of Maid;, , GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051726;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:regulation of cell cycle;|Q9UHX9,Cyclin-D1-binding protein 1,Grap2 and cyclin-D-interacting protein;Human homolog of Maid;, , GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051726;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:regulation of cell cycle;|Q9UHX9,Cyclin-D1-binding protein 1,Grap2 and cyclin-D-interacting protein;Human homolog of Maid;, , GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051726;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:regulation of cell cycle; scaffold37 indexed_genome mRNA 3256496 3657769 . - . ID=transcript_7540;Q7Z553 F6W3S7 J3KPX6,MAM domain-containing glycosylphosphatidylinositol anchor protein 2,MAM domain-containing protein 1;, PF07679;PF00629;, GO:0031225;GO:0005576;GO:0005886;GO:0021522;, C:anchored component of membrane; C:extracellular region; C:plasma membrane;, , P:spinal cord motor neuron differentiation; scaffold37 indexed_genome mRNA 5890575 5894227 . - . ID=transcript_7541;P62273 A8MZ73 P30054,40S ribosomal protein S29,Small ribosomal subunit protein uS14 {ECO:0000303|PubMed:24524803};, PF00253;, GO:0098556;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0005654;GO:0042788;GO:0015935;GO:0003735;GO:0008270;GO:0002181;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic side of rough endoplasmic reticulum membrane; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:nucleoplasm; C:polysomal ribosome; C:small ribosomal subunit;, F:structural constituent of ribosome; F:zinc ion binding;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold37 indexed_genome mRNA 5907958 5913459 . + . ID=transcript_7542;Q96L50 A5D6X3 B4DDE0 Q52M24 Q86SZ1 Q8N6H9,Leucine-rich repeat protein 1,4-1BB-mediated-signaling molecule;4-1BBlrr;LRR-repeat protein 1;Peptidylprolyl isomerase-like 5;, PF12799;, GO:0005829;GO:0043687;GO:0016567;, C:cytosol;, , P:post-translational protein modification; P:protein ubiquitination; scaffold37 indexed_genome mRNA 5921451 5960936 . - . ID=transcript_7543;Q9NVR5 B9WS54 C0JAP7 Q86TR1 Q86TY8 Q969Z5,Protein kintoun {ECO:0000255|HAMAP-Rule:MF_03069},Dynein assembly factor 2, axonemal {ECO:0000255|HAMAP-Rule:MF_03069};, PF08190;PF18201;, GO:0005737;GO:0005829;GO:0005576;GO:0070286;GO:0060285;GO:0003351;GO:0061966;GO:0001701;GO:0036159;GO:0036158;GO:0032526;, C:cytoplasm; C:cytosol; C:extracellular region;, , P:axonemal dynein complex assembly; P:cilium-dependent cell motility; P:epithelial cilium movement involved in extracellular fluid movement; P:establishment of left/right asymmetry; P:in utero embryonic development; P:inner dynein arm assembly; P:outer dynein arm assembly; P:response to retinoic acid;|Q9NVR5 B9WS54 C0JAP7 Q86TR1 Q86TY8 Q969Z5,Protein kintoun {ECO:0000255|HAMAP-Rule:MF_03069},Dynein assembly factor 2, axonemal {ECO:0000255|HAMAP-Rule:MF_03069};, PF08190;PF18201;, GO:0005737;GO:0005829;GO:0005576;GO:0070286;GO:0060285;GO:0003351;GO:0061966;GO:0001701;GO:0036159;GO:0036158;GO:0032526;, C:cytoplasm; C:cytosol; C:extracellular region;, , P:axonemal dynein complex assembly; P:cilium-dependent cell motility; P:epithelial cilium movement involved in extracellular fluid movement; P:establishment of left/right asymmetry; P:in utero embryonic development; P:inner dynein arm assembly; P:outer dynein arm assembly; P:response to retinoic acid;|P56282 A0AV55 A4FU92 A4LBB7 A6NH58 B4DDE6 O43560,DNA polymerase epsilon subunit 2,DNA polymerase II subunit 2;DNA polymerase epsilon subunit B;, PF04042;PF12213;, GO:0008622;GO:0043231;GO:0016604;GO:0005654;GO:0003677;GO:0003887;GO:0006281;GO:0006260;GO:0006270;GO:0006261;GO:0042276;, C:epsilon DNA polymerase complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm;, F:DNA binding; F:DNA-directed DNA polymerase activity;, P:DNA repair; P:DNA replication; P:DNA replication initiation; P:DNA-dependent DNA replication; P:error-prone translesion synthesis;|P56282 A0AV55 A4FU92 A4LBB7 A6NH58 B4DDE6 O43560,DNA polymerase epsilon subunit 2,DNA polymerase II subunit 2;DNA polymerase epsilon subunit B;, PF04042;PF12213;, GO:0008622;GO:0043231;GO:0016604;GO:0005654;GO:0003677;GO:0003887;GO:0006281;GO:0006260;GO:0006270;GO:0006261;GO:0042276;, C:epsilon DNA polymerase complex; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm;, F:DNA binding; F:DNA-directed DNA polymerase activity;, P:DNA repair; P:DNA replication; P:DNA replication initiation; P:DNA-dependent DNA replication; P:error-prone translesion synthesis; scaffold37 indexed_genome mRNA 5979611 6008989 . + . ID=transcript_7544;Q8N7A1 B3KXD9 Q8WYI1,Kelch domain-containing protein 1,, , GO:0005829;, C:cytosol;|Q8N7A1 B3KXD9 Q8WYI1,Kelch domain-containing protein 1,, , GO:0005829;, C:cytosol;|Q8N7A1 B3KXD9 Q8WYI1,Kelch domain-containing protein 1,, , GO:0005829;, C:cytosol;|Q8N7A1 B3KXD9 Q8WYI1,Kelch domain-containing protein 1,, , GO:0005829;, C:cytosol; scaffold37 indexed_genome mRNA 6009414 6076514 . + . ID=transcript_7545;Q9Y2U9 B3KPF9 Q6IAF0 Q86TY9,Kelch domain-containing protein 2,Hepatocellular carcinoma-associated antigen 33;Host cell factor homolog LCP;Host cell factor-like protein 1;, , GO:0016604;GO:0031965;GO:0005654;, C:nuclear body; C:nuclear membrane; C:nucleoplasm;|Q9Y2U9 B3KPF9 Q6IAF0 Q86TY9,Kelch domain-containing protein 2,Hepatocellular carcinoma-associated antigen 33;Host cell factor homolog LCP;Host cell factor-like protein 1;, , GO:0016604;GO:0031965;GO:0005654;, C:nuclear body; C:nuclear membrane; C:nucleoplasm;|Q9Y2U9 B3KPF9 Q6IAF0 Q86TY9,Kelch domain-containing protein 2,Hepatocellular carcinoma-associated antigen 33;Host cell factor homolog LCP;Host cell factor-like protein 1;, , GO:0016604;GO:0031965;GO:0005654;, C:nuclear body; C:nuclear membrane; C:nucleoplasm;|Q9Y2U9 B3KPF9 Q6IAF0 Q86TY9,Kelch domain-containing protein 2,Hepatocellular carcinoma-associated antigen 33;Host cell factor homolog LCP;Host cell factor-like protein 1;, , GO:0016604;GO:0031965;GO:0005654;, C:nuclear body; C:nuclear membrane; C:nucleoplasm;|Q9Y2U9 B3KPF9 Q6IAF0 Q86TY9,Kelch domain-containing protein 2,Hepatocellular carcinoma-associated antigen 33;Host cell factor homolog LCP;Host cell factor-like protein 1;, , GO:0016604;GO:0031965;GO:0005654;, C:nuclear body; C:nuclear membrane; C:nucleoplasm;|Q9Y2U9 B3KPF9 Q6IAF0 Q86TY9,Kelch domain-containing protein 2,Hepatocellular carcinoma-associated antigen 33;Host cell factor homolog LCP;Host cell factor-like protein 1;, , GO:0016604;GO:0031965;GO:0005654;, C:nuclear body; C:nuclear membrane; C:nucleoplasm;|O60524 A0JLQ3 B3KSK1 B4DDL3 B4DHA9 B4E3F3 Q32Q66 Q8WW70 Q9NWG1,Nuclear export mediator factor NEMF,Antigen NY-CO-1;Serologically defined colon cancer antigen 1;, PF11923;PF05670;, GO:0005634;GO:1990112;GO:0043023;GO:0000049;GO:0051168;GO:0072344;GO:1990116;, C:nucleus; C:RQC complex;, F:ribosomal large subunit binding; F:tRNA binding;, P:nuclear export; P:rescue of stalled ribosome; P:ribosome-associated ubiquitin-dependent protein catabolic process;|O60524 A0JLQ3 B3KSK1 B4DDL3 B4DHA9 B4E3F3 Q32Q66 Q8WW70 Q9NWG1,Nuclear export mediator factor NEMF,Antigen NY-CO-1;Serologically defined colon cancer antigen 1;, PF11923;PF05670;, GO:0005634;GO:1990112;GO:0043023;GO:0000049;GO:0051168;GO:0072344;GO:1990116;, C:nucleus; C:RQC complex;, F:ribosomal large subunit binding; F:tRNA binding;, P:nuclear export; P:rescue of stalled ribosome; P:ribosome-associated ubiquitin-dependent protein catabolic process;|O60524 A0JLQ3 B3KSK1 B4DDL3 B4DHA9 B4E3F3 Q32Q66 Q8WW70 Q9NWG1,Nuclear export mediator factor NEMF,Antigen NY-CO-1;Serologically defined colon cancer antigen 1;, PF11923;PF05670;, GO:0005634;GO:1990112;GO:0043023;GO:0000049;GO:0051168;GO:0072344;GO:1990116;, C:nucleus; C:RQC complex;, F:ribosomal large subunit binding; F:tRNA binding;, P:nuclear export; P:rescue of stalled ribosome; P:ribosome-associated ubiquitin-dependent protein catabolic process;|O60524 A0JLQ3 B3KSK1 B4DDL3 B4DHA9 B4E3F3 Q32Q66 Q8WW70 Q9NWG1,Nuclear export mediator factor NEMF,Antigen NY-CO-1;Serologically defined colon cancer antigen 1;, PF11923;PF05670;, GO:0005634;GO:1990112;GO:0043023;GO:0000049;GO:0051168;GO:0072344;GO:1990116;, C:nucleus; C:RQC complex;, F:ribosomal large subunit binding; F:tRNA binding;, P:nuclear export; P:rescue of stalled ribosome; P:ribosome-associated ubiquitin-dependent protein catabolic process;|O60524 A0JLQ3 B3KSK1 B4DDL3 B4DHA9 B4E3F3 Q32Q66 Q8WW70 Q9NWG1,Nuclear export mediator factor NEMF,Antigen NY-CO-1;Serologically defined colon cancer antigen 1;, PF11923;PF05670;, GO:0005634;GO:1990112;GO:0043023;GO:0000049;GO:0051168;GO:0072344;GO:1990116;, C:nucleus; C:RQC complex;, F:ribosomal large subunit binding; F:tRNA binding;, P:nuclear export; P:rescue of stalled ribosome; P:ribosome-associated ubiquitin-dependent protein catabolic process;|O60524 A0JLQ3 B3KSK1 B4DDL3 B4DHA9 B4E3F3 Q32Q66 Q8WW70 Q9NWG1,Nuclear export mediator factor NEMF,Antigen NY-CO-1;Serologically defined colon cancer antigen 1;, PF11923;PF05670;, GO:0005634;GO:1990112;GO:0043023;GO:0000049;GO:0051168;GO:0072344;GO:1990116;, C:nucleus; C:RQC complex;, F:ribosomal large subunit binding; F:tRNA binding;, P:nuclear export; P:rescue of stalled ribosome; P:ribosome-associated ubiquitin-dependent protein catabolic process; scaffold37 indexed_genome mRNA 6289257 6301279 . - . ID=transcript_7546;Q9H867 B7ZLA3 B7ZLA4 Q2M2X3 Q86T12,Protein-lysine methyltransferase METTL21D,Methyltransferase-like protein 21D;VCP lysine methyltransferase;Valosin-containing protein lysine methyltransferase;, PF10294;, GO:0005737;GO:0005829;GO:0032991;GO:0051117;GO:0016279;GO:0032780;GO:0018022;GO:0018023;GO:0006479;, C:cytoplasm; C:cytosol; C:protein-containing complex;, F:ATPase binding; F:protein-lysine N-methyltransferase activity;, P:negative regulation of ATPase activity; P:peptidyl-lysine methylation; P:peptidyl-lysine trimethylation; P:protein methylation;|Q9H867 B7ZLA3 B7ZLA4 Q2M2X3 Q86T12,Protein-lysine methyltransferase METTL21D,Methyltransferase-like protein 21D;VCP lysine methyltransferase;Valosin-containing protein lysine methyltransferase;, PF10294;, GO:0005737;GO:0005829;GO:0032991;GO:0051117;GO:0016279;GO:0032780;GO:0018022;GO:0018023;GO:0006479;, C:cytoplasm; C:cytosol; C:protein-containing complex;, F:ATPase binding; F:protein-lysine N-methyltransferase activity;, P:negative regulation of ATPase activity; P:peptidyl-lysine methylation; P:peptidyl-lysine trimethylation; P:protein methylation; scaffold37 indexed_genome mRNA 6301932 6380225 . - . ID=transcript_7547;Q07890 B7ZKT6 D3DSB4 Q15503 Q17RN1,Son of sevenless homolog 2,, PF00125;PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0003677;GO:0005085;GO:0046982;GO:0001782;GO:0007186;GO:0043065;GO:0051057;GO:2000973;GO:0051056;GO:0033081;GO:0042129;GO:0007264;, C:cytosol;, F:DNA binding; F:guanyl-nucleotide exchange factor activity; F:protein heterodimerization activity;, P:B cell homeostasis; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of small GTPase mediated signal transduction; P:regulation of pro-B cell differentiation; P:regulation of small GTPase mediated signal transduction; P:regulation of T cell differentiation in thymus; P:regulation of T cell proliferation; P:small GTPase mediated signal transduction; scaffold37 indexed_genome mRNA 6413798 6464573 . - . ID=transcript_7548;Q9H9P8 Q9BRR1,L-2-hydroxyglutarate dehydrogenase, mitochondrial,Duranin;, PF01266;, GO:0016021;GO:0031305;GO:0005743;GO:0005739;GO:0003973;GO:0047545;GO:0006103;GO:0044267;, C:integral component of membrane; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:(S)-2-hydroxy-acid oxidase activity; F:2-hydroxyglutarate dehydrogenase activity;, P:2-oxoglutarate metabolic process; P:cellular protein metabolic process;|Q9H9P8 Q9BRR1,L-2-hydroxyglutarate dehydrogenase, mitochondrial,Duranin;, PF01266;, GO:0016021;GO:0031305;GO:0005743;GO:0005739;GO:0003973;GO:0047545;GO:0006103;GO:0044267;, C:integral component of membrane; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:(S)-2-hydroxy-acid oxidase activity; F:2-hydroxyglutarate dehydrogenase activity;, P:2-oxoglutarate metabolic process; P:cellular protein metabolic process;|Q9H9P8 Q9BRR1,L-2-hydroxyglutarate dehydrogenase, mitochondrial,Duranin;, PF01266;, GO:0016021;GO:0031305;GO:0005743;GO:0005739;GO:0003973;GO:0047545;GO:0006103;GO:0044267;, C:integral component of membrane; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:(S)-2-hydroxy-acid oxidase activity; F:2-hydroxyglutarate dehydrogenase activity;, P:2-oxoglutarate metabolic process; P:cellular protein metabolic process;|Q9H9P8 Q9BRR1,L-2-hydroxyglutarate dehydrogenase, mitochondrial,Duranin;, PF01266;, GO:0016021;GO:0031305;GO:0005743;GO:0005739;GO:0003973;GO:0047545;GO:0006103;GO:0044267;, C:integral component of membrane; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:(S)-2-hydroxy-acid oxidase activity; F:2-hydroxyglutarate dehydrogenase activity;, P:2-oxoglutarate metabolic process; P:cellular protein metabolic process;|Q9H9P8 Q9BRR1,L-2-hydroxyglutarate dehydrogenase, mitochondrial,Duranin;, PF01266;, GO:0016021;GO:0031305;GO:0005743;GO:0005739;GO:0003973;GO:0047545;GO:0006103;GO:0044267;, C:integral component of membrane; C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:(S)-2-hydroxy-acid oxidase activity; F:2-hydroxyglutarate dehydrogenase activity;, P:2-oxoglutarate metabolic process; P:cellular protein metabolic process; scaffold37 indexed_genome mRNA 6471028 6477950 . + . ID=transcript_7549;Q99766 A8K1U3 D9N156 Q8WWX3 Q96F77,ATP synthase subunit s, mitochondrial {ECO:0000305},ATP synthase-coupling factor B;Distal membrane arm assembly complex 2-like protein {ECO:0000312|HGNC:HGNC:18799};Mitochondrial ATP synthase regulatory component factor B;, , GO:0005737;GO:0005743;GO:0045263;GO:0046872;GO:0015078;GO:0006754;GO:0042407;GO:0042776;GO:1902600;, C:cytoplasm; C:mitochondrial inner membrane; C:proton-transporting ATP synthase complex, coupling factor F(o);, F:metal ion binding; F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:proton transmembrane transport;|Q99766 A8K1U3 D9N156 Q8WWX3 Q96F77,ATP synthase subunit s, mitochondrial {ECO:0000305},ATP synthase-coupling factor B;Distal membrane arm assembly complex 2-like protein {ECO:0000312|HGNC:HGNC:18799};Mitochondrial ATP synthase regulatory component factor B;, , GO:0005737;GO:0005743;GO:0045263;GO:0046872;GO:0015078;GO:0006754;GO:0042407;GO:0042776;GO:1902600;, C:cytoplasm; C:mitochondrial inner membrane; C:proton-transporting ATP synthase complex, coupling factor F(o);, F:metal ion binding; F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:proton transmembrane transport; scaffold37 indexed_genome mRNA 6478069 6480364 . - . ID=transcript_7550;Q00532 J3KMW1 Q2M3A4 Q6QUA0 Q8WXQ5,Cyclin-dependent kinase-like 1 {ECO:0000305},Protein kinase p42 KKIALRE;Serine/threonine-protein kinase KKIALRE {ECO:0000303|Ref.2};, PF00069;, GO:0035869;GO:0005737;GO:0070062;GO:0043231;GO:0005654;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0007507;GO:0006468;GO:1902017;, C:ciliary transition zone; C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:heart development; P:protein phosphorylation; P:regulation of cilium assembly; scaffold37 indexed_genome mRNA 6525169 6525731 . - . ID=transcript_7551;Q00532 J3KMW1 Q2M3A4 Q6QUA0 Q8WXQ5,Cyclin-dependent kinase-like 1 {ECO:0000305},Protein kinase p42 KKIALRE;Serine/threonine-protein kinase KKIALRE {ECO:0000303|Ref.2};, PF00069;, GO:0035869;GO:0005737;GO:0070062;GO:0043231;GO:0005654;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0007507;GO:0006468;GO:1902017;, C:ciliary transition zone; C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:heart development; P:protein phosphorylation; P:regulation of cilium assembly; scaffold37 indexed_genome mRNA 6556573 6784320 . - . ID=transcript_7552;Q9Y4K4 A0A0A0MQR1 Q8IYF6,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase homologous to SPS1/STE20;MAPK/ERK kinase kinase kinase 5;, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0035556;GO:0006468;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:intracellular signal transduction; P:protein phosphorylation;|Q9Y4K4 A0A0A0MQR1 Q8IYF6,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase homologous to SPS1/STE20;MAPK/ERK kinase kinase kinase 5;, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0035556;GO:0006468;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:intracellular signal transduction; P:protein phosphorylation;|Q9Y4K4 A0A0A0MQR1 Q8IYF6,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase homologous to SPS1/STE20;MAPK/ERK kinase kinase kinase 5;, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0035556;GO:0006468;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:intracellular signal transduction; P:protein phosphorylation;|Q9Y4K4 A0A0A0MQR1 Q8IYF6,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase homologous to SPS1/STE20;MAPK/ERK kinase kinase kinase 5;, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0035556;GO:0006468;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:intracellular signal transduction; P:protein phosphorylation;|Q9Y4K4 A0A0A0MQR1 Q8IYF6,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase homologous to SPS1/STE20;MAPK/ERK kinase kinase kinase 5;, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0035556;GO:0006468;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:intracellular signal transduction; P:protein phosphorylation;|Q9Y4K4 A0A0A0MQR1 Q8IYF6,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase homologous to SPS1/STE20;MAPK/ERK kinase kinase kinase 5;, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0035556;GO:0006468;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:intracellular signal transduction; P:protein phosphorylation;|Q9Y4K4 A0A0A0MQR1 Q8IYF6,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase homologous to SPS1/STE20;MAPK/ERK kinase kinase kinase 5;, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0035556;GO:0006468;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:intracellular signal transduction; P:protein phosphorylation;|Q02878 Q2M3Q3 Q8WW97,60S ribosomal protein L6,Large ribosomal subunit protein eL6 {ECO:0000303|PubMed:24524803};Neoplasm-related protein C140;Tax-responsive enhancer element-binding protein 107;, PF01159;PF03868;, GO:0036464;GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0014069;GO:0005791;GO:0045296;GO:0003677;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006355;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome; C:postsynaptic density; C:rough endoplasmic reticulum;, F:cadherin binding; F:DNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of transcription, DNA-templated; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q02878 Q2M3Q3 Q8WW97,60S ribosomal protein L6,Large ribosomal subunit protein eL6 {ECO:0000303|PubMed:24524803};Neoplasm-related protein C140;Tax-responsive enhancer element-binding protein 107;, PF01159;PF03868;, GO:0036464;GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0014069;GO:0005791;GO:0045296;GO:0003677;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006355;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome; C:postsynaptic density; C:rough endoplasmic reticulum;, F:cadherin binding; F:DNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of transcription, DNA-templated; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q9Y4K4 A0A0A0MQR1 Q8IYF6,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase homologous to SPS1/STE20;MAPK/ERK kinase kinase kinase 5;, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0035556;GO:0006468;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:intracellular signal transduction; P:protein phosphorylation;|Q8WXF7 A6NND5 A8K2C0 G5E9T1 O95890 Q69YH7 Q96FK0,Atlastin-1,Brain-specific GTP-binding protein;GTP-binding protein 3;Guanine nucleotide-binding protein 3;Spastic paraplegia 3 protein A;, PF02263;, GO:0030424;GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0005794;GO:0000137;GO:0000139;GO:0016021;GO:0005525;GO:0003924;GO:0042802;GO:0007409;GO:0007029;GO:1990809;GO:0051260;, C:axon; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi membrane; C:integral component of membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:axonogenesis; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:protein homooligomerization;|Q9Y4K4 A0A0A0MQR1 Q8IYF6,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase homologous to SPS1/STE20;MAPK/ERK kinase kinase kinase 5;, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0035556;GO:0006468;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:intracellular signal transduction; P:protein phosphorylation;|Q8WXF7 A6NND5 A8K2C0 G5E9T1 O95890 Q69YH7 Q96FK0,Atlastin-1,Brain-specific GTP-binding protein;GTP-binding protein 3;Guanine nucleotide-binding protein 3;Spastic paraplegia 3 protein A;, PF02263;, GO:0030424;GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0005794;GO:0000137;GO:0000139;GO:0016021;GO:0005525;GO:0003924;GO:0042802;GO:0007409;GO:0007029;GO:1990809;GO:0051260;, C:axon; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi membrane; C:integral component of membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:axonogenesis; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:protein homooligomerization;|Q8WXF7 A6NND5 A8K2C0 G5E9T1 O95890 Q69YH7 Q96FK0,Atlastin-1,Brain-specific GTP-binding protein;GTP-binding protein 3;Guanine nucleotide-binding protein 3;Spastic paraplegia 3 protein A;, PF02263;, GO:0030424;GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0005794;GO:0000137;GO:0000139;GO:0016021;GO:0005525;GO:0003924;GO:0042802;GO:0007409;GO:0007029;GO:1990809;GO:0051260;, C:axon; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi membrane; C:integral component of membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:axonogenesis; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:protein homooligomerization;|Q8WXF7 A6NND5 A8K2C0 G5E9T1 O95890 Q69YH7 Q96FK0,Atlastin-1,Brain-specific GTP-binding protein;GTP-binding protein 3;Guanine nucleotide-binding protein 3;Spastic paraplegia 3 protein A;, PF02263;, GO:0030424;GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0005794;GO:0000137;GO:0000139;GO:0016021;GO:0005525;GO:0003924;GO:0042802;GO:0007409;GO:0007029;GO:1990809;GO:0051260;, C:axon; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi membrane; C:integral component of membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:axonogenesis; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:protein homooligomerization;|Q8WXF7 A6NND5 A8K2C0 G5E9T1 O95890 Q69YH7 Q96FK0,Atlastin-1,Brain-specific GTP-binding protein;GTP-binding protein 3;Guanine nucleotide-binding protein 3;Spastic paraplegia 3 protein A;, PF02263;, GO:0030424;GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0005794;GO:0000137;GO:0000139;GO:0016021;GO:0005525;GO:0003924;GO:0042802;GO:0007409;GO:0007029;GO:1990809;GO:0051260;, C:axon; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:Golgi membrane; C:integral component of membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:axonogenesis; P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:protein homooligomerization;|Q9H4B6 A8K4B8 D3DSB6 Q6IA58 Q9H949 Q9HAK9,Protein salvador homolog 1,45 kDa WW domain protein;, PF00397;, GO:0005911;GO:0005737;GO:0005829;GO:0030425;GO:0005634;GO:0005886;GO:0031697;GO:0042802;GO:0030159;GO:0046332;GO:0070699;GO:0006915;GO:0001942;GO:0035329;GO:0060575;GO:0030216;GO:0060487;GO:0060044;GO:0050680;GO:0043065;GO:0051091;GO:0045600;GO:0050821;GO:0043113;GO:2000036;GO:0007165;GO:0060412;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:dendrite; C:nucleus; C:plasma membrane;, F:beta-1 adrenergic receptor binding; F:identical protein binding; F:signaling receptor complex adaptor activity; F:SMAD binding; F:type II activin receptor binding;, P:apoptotic process; P:hair follicle development; P:hippo signaling; P:intestinal epithelial cell differentiation; P:keratinocyte differentiation; P:lung epithelial cell differentiation; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of epithelial cell proliferation; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of fat cell differentiation; P:protein stabilization; P:receptor clustering; P:regulation of stem cell population maintenance; P:signal transduction; P:ventricular septum morphogenesis; scaffold37 indexed_genome mRNA 6817968 6915828 . - . ID=transcript_7553;Q9C012 Q9C013 Q9C014 Q9H5I6 Q9HAT7 Q9HBY5 Q9HCK7 Q9UH61,Ninein,Glycogen synthase kinase 3 beta-interacting protein;, , GO:0045177;GO:0044295;GO:0120103;GO:0005814;GO:0005813;GO:0097539;GO:0005881;GO:0030425;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0000242;GO:0005886;GO:0000922;GO:0005509;GO:0005525;GO:0019900;GO:0051011;GO:0010457;GO:0051642;GO:0090222;GO:0048668;GO:0021540;GO:0021957;GO:0034454;GO:0050772;GO:0031116;GO:0008104;, C:apical part of cell; C:axonal growth cone; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary transition fiber; C:cytoplasmic microtubule; C:dendrite; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:pericentriolar material; C:plasma membrane; C:spindle pole;, F:calcium ion binding; F:GTP binding; F:kinase binding; F:microtubule minus-end binding;, P:centriole-centriole cohesion; P:centrosome localization; P:centrosome-templated microtubule nucleation; P:collateral sprouting; P:corpus callosum morphogenesis; P:corticospinal tract morphogenesis; P:microtubule anchoring at centrosome; P:positive regulation of axonogenesis; P:positive regulation of microtubule polymerization; P:protein localization;|Q9C012 Q9C013 Q9C014 Q9H5I6 Q9HAT7 Q9HBY5 Q9HCK7 Q9UH61,Ninein,Glycogen synthase kinase 3 beta-interacting protein;, , GO:0045177;GO:0044295;GO:0120103;GO:0005814;GO:0005813;GO:0097539;GO:0005881;GO:0030425;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0000242;GO:0005886;GO:0000922;GO:0005509;GO:0005525;GO:0019900;GO:0051011;GO:0010457;GO:0051642;GO:0090222;GO:0048668;GO:0021540;GO:0021957;GO:0034454;GO:0050772;GO:0031116;GO:0008104;, C:apical part of cell; C:axonal growth cone; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary transition fiber; C:cytoplasmic microtubule; C:dendrite; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:pericentriolar material; C:plasma membrane; C:spindle pole;, F:calcium ion binding; F:GTP binding; F:kinase binding; F:microtubule minus-end binding;, P:centriole-centriole cohesion; P:centrosome localization; P:centrosome-templated microtubule nucleation; P:collateral sprouting; P:corpus callosum morphogenesis; P:corticospinal tract morphogenesis; P:microtubule anchoring at centrosome; P:positive regulation of axonogenesis; P:positive regulation of microtubule polymerization; P:protein localization;|Q9C012 Q9C013 Q9C014 Q9H5I6 Q9HAT7 Q9HBY5 Q9HCK7 Q9UH61,Ninein,Glycogen synthase kinase 3 beta-interacting protein;, , GO:0045177;GO:0044295;GO:0120103;GO:0005814;GO:0005813;GO:0097539;GO:0005881;GO:0030425;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0000242;GO:0005886;GO:0000922;GO:0005509;GO:0005525;GO:0019900;GO:0051011;GO:0010457;GO:0051642;GO:0090222;GO:0048668;GO:0021540;GO:0021957;GO:0034454;GO:0050772;GO:0031116;GO:0008104;, C:apical part of cell; C:axonal growth cone; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary transition fiber; C:cytoplasmic microtubule; C:dendrite; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:pericentriolar material; C:plasma membrane; C:spindle pole;, F:calcium ion binding; F:GTP binding; F:kinase binding; F:microtubule minus-end binding;, P:centriole-centriole cohesion; P:centrosome localization; P:centrosome-templated microtubule nucleation; P:collateral sprouting; P:corpus callosum morphogenesis; P:corticospinal tract morphogenesis; P:microtubule anchoring at centrosome; P:positive regulation of axonogenesis; P:positive regulation of microtubule polymerization; P:protein localization;|Q9C012 Q9C013 Q9C014 Q9H5I6 Q9HAT7 Q9HBY5 Q9HCK7 Q9UH61,Ninein,Glycogen synthase kinase 3 beta-interacting protein;, , GO:0045177;GO:0044295;GO:0120103;GO:0005814;GO:0005813;GO:0097539;GO:0005881;GO:0030425;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0000242;GO:0005886;GO:0000922;GO:0005509;GO:0005525;GO:0019900;GO:0051011;GO:0010457;GO:0051642;GO:0090222;GO:0048668;GO:0021540;GO:0021957;GO:0034454;GO:0050772;GO:0031116;GO:0008104;, C:apical part of cell; C:axonal growth cone; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary transition fiber; C:cytoplasmic microtubule; C:dendrite; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:pericentriolar material; C:plasma membrane; C:spindle pole;, F:calcium ion binding; F:GTP binding; F:kinase binding; F:microtubule minus-end binding;, P:centriole-centriole cohesion; P:centrosome localization; P:centrosome-templated microtubule nucleation; P:collateral sprouting; P:corpus callosum morphogenesis; P:corticospinal tract morphogenesis; P:microtubule anchoring at centrosome; P:positive regulation of axonogenesis; P:positive regulation of microtubule polymerization; P:protein localization;|Q9C012 Q9C013 Q9C014 Q9H5I6 Q9HAT7 Q9HBY5 Q9HCK7 Q9UH61,Ninein,Glycogen synthase kinase 3 beta-interacting protein;, , GO:0045177;GO:0044295;GO:0120103;GO:0005814;GO:0005813;GO:0097539;GO:0005881;GO:0030425;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0000242;GO:0005886;GO:0000922;GO:0005509;GO:0005525;GO:0019900;GO:0051011;GO:0010457;GO:0051642;GO:0090222;GO:0048668;GO:0021540;GO:0021957;GO:0034454;GO:0050772;GO:0031116;GO:0008104;, C:apical part of cell; C:axonal growth cone; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary transition fiber; C:cytoplasmic microtubule; C:dendrite; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:pericentriolar material; C:plasma membrane; C:spindle pole;, F:calcium ion binding; F:GTP binding; F:kinase binding; F:microtubule minus-end binding;, P:centriole-centriole cohesion; P:centrosome localization; P:centrosome-templated microtubule nucleation; P:collateral sprouting; P:corpus callosum morphogenesis; P:corticospinal tract morphogenesis; P:microtubule anchoring at centrosome; P:positive regulation of axonogenesis; P:positive regulation of microtubule polymerization; P:protein localization;|Q9C012 Q9C013 Q9C014 Q9H5I6 Q9HAT7 Q9HBY5 Q9HCK7 Q9UH61,Ninein,Glycogen synthase kinase 3 beta-interacting protein;, , GO:0045177;GO:0044295;GO:0120103;GO:0005814;GO:0005813;GO:0097539;GO:0005881;GO:0030425;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0000242;GO:0005886;GO:0000922;GO:0005509;GO:0005525;GO:0019900;GO:0051011;GO:0010457;GO:0051642;GO:0090222;GO:0048668;GO:0021540;GO:0021957;GO:0034454;GO:0050772;GO:0031116;GO:0008104;, C:apical part of cell; C:axonal growth cone; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary transition fiber; C:cytoplasmic microtubule; C:dendrite; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:pericentriolar material; C:plasma membrane; C:spindle pole;, F:calcium ion binding; F:GTP binding; F:kinase binding; F:microtubule minus-end binding;, P:centriole-centriole cohesion; P:centrosome localization; P:centrosome-templated microtubule nucleation; P:collateral sprouting; P:corpus callosum morphogenesis; P:corticospinal tract morphogenesis; P:microtubule anchoring at centrosome; P:positive regulation of axonogenesis; P:positive regulation of microtubule polymerization; P:protein localization;|Q9C012 Q9C013 Q9C014 Q9H5I6 Q9HAT7 Q9HBY5 Q9HCK7 Q9UH61,Ninein,Glycogen synthase kinase 3 beta-interacting protein;, , GO:0045177;GO:0044295;GO:0120103;GO:0005814;GO:0005813;GO:0097539;GO:0005881;GO:0030425;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0000242;GO:0005886;GO:0000922;GO:0005509;GO:0005525;GO:0019900;GO:0051011;GO:0010457;GO:0051642;GO:0090222;GO:0048668;GO:0021540;GO:0021957;GO:0034454;GO:0050772;GO:0031116;GO:0008104;, C:apical part of cell; C:axonal growth cone; C:centriolar subdistal appendage; C:centriole; C:centrosome; C:ciliary transition fiber; C:cytoplasmic microtubule; C:dendrite; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:pericentriolar material; C:plasma membrane; C:spindle pole;, F:calcium ion binding; F:GTP binding; F:kinase binding; F:microtubule minus-end binding;, P:centriole-centriole cohesion; P:centrosome localization; P:centrosome-templated microtubule nucleation; P:collateral sprouting; P:corpus callosum morphogenesis; P:corticospinal tract morphogenesis; P:microtubule anchoring at centrosome; P:positive regulation of axonogenesis; P:positive regulation of microtubule polymerization; P:protein localization; scaffold37 indexed_genome mRNA 6957099 7026571 . + . ID=transcript_7554;Q7Z5M8 Q3KNR9 Q3KNS0 Q7Z5M6 Q7Z5M7 Q8N4D2,Protein ABHD12B {ECO:0000305},Abhydrolase domain-containing protein 12B {ECO:0000312|HGNC:HGNC:19837};Alpha/beta hydrolase domain-containing protein 12B {ECO:0000305};, PF12146;, GO:0005789;GO:0016020;GO:0047372;GO:0004622;GO:0008474;GO:0052651;GO:0006660;, C:endoplasmic reticulum membrane; C:membrane;, F:acylglycerol lipase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity;, P:monoacylglycerol catabolic process; P:phosphatidylserine catabolic process;|Q96G82,Glycogen phosphorylase, liver form,, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0034774;GO:0016208;GO:0005524;GO:0032052;GO:0008144;GO:0005536;GO:0008184;GO:0042802;GO:0102250;GO:0002060;GO:0030170;GO:0102499;GO:0019842;GO:0006015;GO:0042593;GO:0005980;GO:0005977;GO:0070266;GO:0043312;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen;, F:AMP binding; F:ATP binding; F:bile acid binding; F:drug binding; F:glucose binding; F:glycogen phosphorylase activity; F:identical protein binding; F:linear malto-oligosaccharide phosphorylase activity; F:purine nucleobase binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity; F:vitamin binding;, P:5-phosphoribose 1-diphosphate biosynthetic process; P:glucose homeostasis; P:glycogen catabolic process; P:glycogen metabolic process; P:necroptotic process; P:neutrophil degranulation; P:response to bacterium;|Q96G82,Glycogen phosphorylase, liver form,, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0034774;GO:0016208;GO:0005524;GO:0032052;GO:0008144;GO:0005536;GO:0008184;GO:0042802;GO:0102250;GO:0002060;GO:0030170;GO:0102499;GO:0019842;GO:0006015;GO:0042593;GO:0005980;GO:0005977;GO:0070266;GO:0043312;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen;, F:AMP binding; F:ATP binding; F:bile acid binding; F:drug binding; F:glucose binding; F:glycogen phosphorylase activity; F:identical protein binding; F:linear malto-oligosaccharide phosphorylase activity; F:purine nucleobase binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity; F:vitamin binding;, P:5-phosphoribose 1-diphosphate biosynthetic process; P:glucose homeostasis; P:glycogen catabolic process; P:glycogen metabolic process; P:necroptotic process; P:neutrophil degranulation; P:response to bacterium;|Q96G82,Glycogen phosphorylase, liver form,, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0034774;GO:0016208;GO:0005524;GO:0032052;GO:0008144;GO:0005536;GO:0008184;GO:0042802;GO:0102250;GO:0002060;GO:0030170;GO:0102499;GO:0019842;GO:0006015;GO:0042593;GO:0005980;GO:0005977;GO:0070266;GO:0043312;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen;, F:AMP binding; F:ATP binding; F:bile acid binding; F:drug binding; F:glucose binding; F:glycogen phosphorylase activity; F:identical protein binding; F:linear malto-oligosaccharide phosphorylase activity; F:purine nucleobase binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity; F:vitamin binding;, P:5-phosphoribose 1-diphosphate biosynthetic process; P:glucose homeostasis; P:glycogen catabolic process; P:glycogen metabolic process; P:necroptotic process; P:neutrophil degranulation; P:response to bacterium; scaffold37 indexed_genome mRNA 7051683 7064412 . - . ID=transcript_7555;Q9C026 D3DSB7 D3DSB8 Q92557 Q96D24 Q96NI4 Q9C025 Q9C027,E3 ubiquitin-protein ligase TRIM9,RING finger protein 91;RING-type E3 ubiquitin transferase TRIM9 {ECO:0000305};Tripartite motif-containing protein 9;, PF00041;PF00622;PF00643;, GO:0005737;GO:0005856;GO:0030425;GO:0099523;GO:0008021;GO:0019904;GO:0042803;GO:0000149;GO:0061630;GO:0008270;GO:0045955;GO:0035544;GO:0043161;GO:0016079;, C:cytoplasm; C:cytoskeleton; C:dendrite; C:presynaptic cytosol; C:synaptic vesicle;, F:protein domain specific binding; F:protein homodimerization activity; F:SNARE binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of SNARE complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:synaptic vesicle exocytosis;|Q9C026 D3DSB7 D3DSB8 Q92557 Q96D24 Q96NI4 Q9C025 Q9C027,E3 ubiquitin-protein ligase TRIM9,RING finger protein 91;RING-type E3 ubiquitin transferase TRIM9 {ECO:0000305};Tripartite motif-containing protein 9;, PF00041;PF00622;PF00643;, GO:0005737;GO:0005856;GO:0030425;GO:0099523;GO:0008021;GO:0019904;GO:0042803;GO:0000149;GO:0061630;GO:0008270;GO:0045955;GO:0035544;GO:0043161;GO:0016079;, C:cytoplasm; C:cytoskeleton; C:dendrite; C:presynaptic cytosol; C:synaptic vesicle;, F:protein domain specific binding; F:protein homodimerization activity; F:SNARE binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of SNARE complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:synaptic vesicle exocytosis;|Q9C026 D3DSB7 D3DSB8 Q92557 Q96D24 Q96NI4 Q9C025 Q9C027,E3 ubiquitin-protein ligase TRIM9,RING finger protein 91;RING-type E3 ubiquitin transferase TRIM9 {ECO:0000305};Tripartite motif-containing protein 9;, PF00041;PF00622;PF00643;, GO:0005737;GO:0005856;GO:0030425;GO:0099523;GO:0008021;GO:0019904;GO:0042803;GO:0000149;GO:0061630;GO:0008270;GO:0045955;GO:0035544;GO:0043161;GO:0016079;, C:cytoplasm; C:cytoskeleton; C:dendrite; C:presynaptic cytosol; C:synaptic vesicle;, F:protein domain specific binding; F:protein homodimerization activity; F:SNARE binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of SNARE complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:synaptic vesicle exocytosis;|Q9C026 D3DSB7 D3DSB8 Q92557 Q96D24 Q96NI4 Q9C025 Q9C027,E3 ubiquitin-protein ligase TRIM9,RING finger protein 91;RING-type E3 ubiquitin transferase TRIM9 {ECO:0000305};Tripartite motif-containing protein 9;, PF00041;PF00622;PF00643;, GO:0005737;GO:0005856;GO:0030425;GO:0099523;GO:0008021;GO:0019904;GO:0042803;GO:0000149;GO:0061630;GO:0008270;GO:0045955;GO:0035544;GO:0043161;GO:0016079;, C:cytoplasm; C:cytoskeleton; C:dendrite; C:presynaptic cytosol; C:synaptic vesicle;, F:protein domain specific binding; F:protein homodimerization activity; F:SNARE binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of SNARE complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:synaptic vesicle exocytosis; scaffold37 indexed_genome mRNA 7073745 7167710 . - . ID=transcript_7556;Q9C026 D3DSB7 D3DSB8 Q92557 Q96D24 Q96NI4 Q9C025 Q9C027,E3 ubiquitin-protein ligase TRIM9,RING finger protein 91;RING-type E3 ubiquitin transferase TRIM9 {ECO:0000305};Tripartite motif-containing protein 9;, PF00041;PF00622;PF00643;, GO:0005737;GO:0005856;GO:0030425;GO:0099523;GO:0008021;GO:0019904;GO:0042803;GO:0000149;GO:0061630;GO:0008270;GO:0045955;GO:0035544;GO:0043161;GO:0016079;, C:cytoplasm; C:cytoskeleton; C:dendrite; C:presynaptic cytosol; C:synaptic vesicle;, F:protein domain specific binding; F:protein homodimerization activity; F:SNARE binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of SNARE complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:synaptic vesicle exocytosis;|Q9C026 D3DSB7 D3DSB8 Q92557 Q96D24 Q96NI4 Q9C025 Q9C027,E3 ubiquitin-protein ligase TRIM9,RING finger protein 91;RING-type E3 ubiquitin transferase TRIM9 {ECO:0000305};Tripartite motif-containing protein 9;, PF00041;PF00622;PF00643;, GO:0005737;GO:0005856;GO:0030425;GO:0099523;GO:0008021;GO:0019904;GO:0042803;GO:0000149;GO:0061630;GO:0008270;GO:0045955;GO:0035544;GO:0043161;GO:0016079;, C:cytoplasm; C:cytoskeleton; C:dendrite; C:presynaptic cytosol; C:synaptic vesicle;, F:protein domain specific binding; F:protein homodimerization activity; F:SNARE binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of SNARE complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:synaptic vesicle exocytosis; scaffold37 indexed_genome mRNA 7262788 7274338 . + . ID=transcript_7557;Q9H3N1 B2R7A4 Q8N487 Q8NBN5 Q9Y4T6,Thioredoxin-related transmembrane protein 1,Thioredoxin domain-containing protein 1;Transmembrane Trx-related protein;, PF00085;, GO:0005789;GO:0016021;GO:0015036;GO:0034976;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:disulfide oxidoreductase activity;, P:response to endoplasmic reticulum stress;|Q9H3N1 B2R7A4 Q8N487 Q8NBN5 Q9Y4T6,Thioredoxin-related transmembrane protein 1,Thioredoxin domain-containing protein 1;Transmembrane Trx-related protein;, PF00085;, GO:0005789;GO:0016021;GO:0015036;GO:0034976;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:disulfide oxidoreductase activity;, P:response to endoplasmic reticulum stress;|Q9H3N1 B2R7A4 Q8N487 Q8NBN5 Q9Y4T6,Thioredoxin-related transmembrane protein 1,Thioredoxin domain-containing protein 1;Transmembrane Trx-related protein;, PF00085;, GO:0005789;GO:0016021;GO:0015036;GO:0034976;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:disulfide oxidoreductase activity;, P:response to endoplasmic reticulum stress;|Q9H3N1 B2R7A4 Q8N487 Q8NBN5 Q9Y4T6,Thioredoxin-related transmembrane protein 1,Thioredoxin domain-containing protein 1;Transmembrane Trx-related protein;, PF00085;, GO:0005789;GO:0016021;GO:0015036;GO:0034976;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:disulfide oxidoreductase activity;, P:response to endoplasmic reticulum stress; scaffold37 indexed_genome mRNA 7274904 7277358 . + . ID=transcript_7558;Q9H3N1 B2R7A4 Q8N487 Q8NBN5 Q9Y4T6,Thioredoxin-related transmembrane protein 1,Thioredoxin domain-containing protein 1;Transmembrane Trx-related protein;, PF00085;, GO:0005789;GO:0016021;GO:0015036;GO:0034976;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:disulfide oxidoreductase activity;, P:response to endoplasmic reticulum stress; scaffold37 indexed_genome mRNA 7688081 7764699 . + . ID=transcript_7559;Q96NE9 D3DSB9 Q5HYF2 Q8N2X1 Q8WUH7,FERM domain-containing protein 6,Willin;, PF09380;PF00373;PF09379;, GO:0005737;GO:0005856;GO:0005886;GO:0031032;, C:cytoplasm; C:cytoskeleton; C:plasma membrane;, , P:actomyosin structure organization;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q96NE9 D3DSB9 Q5HYF2 Q8N2X1 Q8WUH7,FERM domain-containing protein 6,Willin;, PF09380;PF00373;PF09379;, GO:0005737;GO:0005856;GO:0005886;GO:0031032;, C:cytoplasm; C:cytoskeleton; C:plasma membrane;, , P:actomyosin structure organization; scaffold37 indexed_genome mRNA 7984883 7988738 . + . ID=transcript_7560;P59768 Q5JPE2 Q6P9A9,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2,G gamma-I;, PF00631;, GO:0070062;GO:0031680;GO:0005834;GO:0016020;GO:0005886;GO:0031681;GO:0007191;GO:0071870;GO:0071380;GO:0007186;GO:0002862;GO:0030168;GO:1901381;GO:0006457;GO:0007223;, C:extracellular exosome; C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:membrane; C:plasma membrane;, F:G-protein beta-subunit binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:cellular response to catecholamine stimulus; P:cellular response to prostaglandin E stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:platelet activation; P:positive regulation of potassium ion transmembrane transport; P:protein folding; P:Wnt signaling pathway, calcium modulating pathway;|P59768 Q5JPE2 Q6P9A9,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2,G gamma-I;, PF00631;, GO:0070062;GO:0031680;GO:0005834;GO:0016020;GO:0005886;GO:0031681;GO:0007191;GO:0071870;GO:0071380;GO:0007186;GO:0002862;GO:0030168;GO:1901381;GO:0006457;GO:0007223;, C:extracellular exosome; C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:membrane; C:plasma membrane;, F:G-protein beta-subunit binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:cellular response to catecholamine stimulus; P:cellular response to prostaglandin E stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:platelet activation; P:positive regulation of potassium ion transmembrane transport; P:protein folding; P:Wnt signaling pathway, calcium modulating pathway; scaffold37 indexed_genome mRNA 8018253 8032776 . + . ID=transcript_7561;Q9Y224,RNA transcription, translation and transport factor protein {ECO:0000312|HGNC:HGNC:23169},CLE7 homolog;, PF10036;, GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0005634;GO:0048471;GO:0072669;GO:0042802;GO:0003723;GO:0000993;GO:0006469;GO:0045944;GO:0050658;GO:0006388;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:tRNA-splicing ligase complex;, F:identical protein binding; F:RNA binding; F:RNA polymerase II complex binding;, P:negative regulation of protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:RNA transport; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:viral process;|Q9Y224,RNA transcription, translation and transport factor protein {ECO:0000312|HGNC:HGNC:23169},CLE7 homolog;, PF10036;, GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0005634;GO:0048471;GO:0072669;GO:0042802;GO:0003723;GO:0000993;GO:0006469;GO:0045944;GO:0050658;GO:0006388;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:tRNA-splicing ligase complex;, F:identical protein binding; F:RNA binding; F:RNA polymerase II complex binding;, P:negative regulation of protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:RNA transport; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:viral process; scaffold37 indexed_genome mRNA 8033081 8042140 . - . ID=transcript_7562;Q14112 A8K6I7 B4DU19 O43710,Nidogen-2,Osteonidogen;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0071711;GO:0007155;GO:0007160;GO:0030198;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent;, P:basement membrane organization; P:cell adhesion; P:cell-matrix adhesion; P:extracellular matrix organization;|Q14112 A8K6I7 B4DU19 O43710,Nidogen-2,Osteonidogen;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0071711;GO:0007155;GO:0007160;GO:0030198;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent;, P:basement membrane organization; P:cell adhesion; P:cell-matrix adhesion; P:extracellular matrix organization;|Q14112 A8K6I7 B4DU19 O43710,Nidogen-2,Osteonidogen;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0071711;GO:0007155;GO:0007160;GO:0030198;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent;, P:basement membrane organization; P:cell adhesion; P:cell-matrix adhesion; P:extracellular matrix organization;|Q14112 A8K6I7 B4DU19 O43710,Nidogen-2,Osteonidogen;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0071711;GO:0007155;GO:0007160;GO:0030198;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent;, P:basement membrane organization; P:cell adhesion; P:cell-matrix adhesion; P:extracellular matrix organization;|Q14112 A8K6I7 B4DU19 O43710,Nidogen-2,Osteonidogen;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0071711;GO:0007155;GO:0007160;GO:0030198;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent;, P:basement membrane organization; P:cell adhesion; P:cell-matrix adhesion; P:extracellular matrix organization;|Q14112 A8K6I7 B4DU19 O43710,Nidogen-2,Osteonidogen;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0071711;GO:0007155;GO:0007160;GO:0030198;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent;, P:basement membrane organization; P:cell adhesion; P:cell-matrix adhesion; P:extracellular matrix organization; scaffold37 indexed_genome mRNA 8298645 8306271 . + . ID=transcript_7563;Q13258 G3V5L3 Q13250 Q13251 Q1ZZ52,Prostaglandin D2 receptor,Prostanoid DP receptor;, PF00001;, GO:0016021;GO:0005886;GO:0004956;GO:0007186;GO:0006954;GO:0043303;GO:0002862;GO:0007204;, C:integral component of membrane; C:plasma membrane;, F:prostaglandin D receptor activity;, P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:mast cell degranulation; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of cytosolic calcium ion concentration; scaffold37 indexed_genome mRNA 8370633 8393110 . - . ID=transcript_7564;Q8TD55 Q7L4H4 Q8WYS8,Pleckstrin homology domain-containing family O member 2,Pleckstrin homology domain-containing family Q member 1;, PF00169;, GO:0005576;GO:1904813;GO:0071888;GO:0043312;, C:extracellular region; C:ficolin-1-rich granule lumen;, , P:macrophage apoptotic process; P:neutrophil degranulation;|Q8TD55 Q7L4H4 Q8WYS8,Pleckstrin homology domain-containing family O member 2,Pleckstrin homology domain-containing family Q member 1;, PF00169;, GO:0005576;GO:1904813;GO:0071888;GO:0043312;, C:extracellular region; C:ficolin-1-rich granule lumen;, , P:macrophage apoptotic process; P:neutrophil degranulation; scaffold37 indexed_genome mRNA 8404911 8409525 . - . ID=transcript_7565;Q9H611 B2RPL7 Q1W5B6 Q330H5 Q33E24,ATP-dependent DNA helicase PIF1 {ECO:0000255|HAMAP-Rule:MF_03176},DNA repair and recombination helicase PIF1 {ECO:0000255|HAMAP-Rule:MF_03176};PIF1/RRM3 DNA helicase-like protein;, PF02689;PF05970;, GO:0000781;GO:0005739;GO:0005654;GO:0005657;GO:0043139;GO:0033678;GO:0005524;GO:0051880;GO:0000287;GO:0017116;GO:0010521;GO:0042162;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0000002;GO:0051974;GO:0032211;GO:0032204;GO:0007004;, C:chromosome, telomeric region; C:mitochondrion; C:nucleoplasm; C:replication fork;, F:5'-3' DNA helicase activity; F:5'-3' DNA/RNA helicase activity; F:ATP binding; F:G-quadruplex DNA binding; F:magnesium ion binding; F:single-stranded DNA helicase activity; F:telomerase inhibitor activity; F:telomeric DNA binding;, P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:mitochondrial genome maintenance; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:regulation of telomere maintenance; P:telomere maintenance via telomerase;|Q9H611 B2RPL7 Q1W5B6 Q330H5 Q33E24,ATP-dependent DNA helicase PIF1 {ECO:0000255|HAMAP-Rule:MF_03176},DNA repair and recombination helicase PIF1 {ECO:0000255|HAMAP-Rule:MF_03176};PIF1/RRM3 DNA helicase-like protein;, PF02689;PF05970;, GO:0000781;GO:0005739;GO:0005654;GO:0005657;GO:0043139;GO:0033678;GO:0005524;GO:0051880;GO:0000287;GO:0017116;GO:0010521;GO:0042162;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0000002;GO:0051974;GO:0032211;GO:0032204;GO:0007004;, C:chromosome, telomeric region; C:mitochondrion; C:nucleoplasm; C:replication fork;, F:5'-3' DNA helicase activity; F:5'-3' DNA/RNA helicase activity; F:ATP binding; F:G-quadruplex DNA binding; F:magnesium ion binding; F:single-stranded DNA helicase activity; F:telomerase inhibitor activity; F:telomeric DNA binding;, P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:mitochondrial genome maintenance; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:regulation of telomere maintenance; P:telomere maintenance via telomerase; scaffold37 indexed_genome mRNA 8410133 8410721 . - . ID=transcript_7566;Q9H611 B2RPL7 Q1W5B6 Q330H5 Q33E24,ATP-dependent DNA helicase PIF1 {ECO:0000255|HAMAP-Rule:MF_03176},DNA repair and recombination helicase PIF1 {ECO:0000255|HAMAP-Rule:MF_03176};PIF1/RRM3 DNA helicase-like protein;, PF02689;PF05970;, GO:0000781;GO:0005739;GO:0005654;GO:0005657;GO:0043139;GO:0033678;GO:0005524;GO:0051880;GO:0000287;GO:0017116;GO:0010521;GO:0042162;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0000002;GO:0051974;GO:0032211;GO:0032204;GO:0007004;, C:chromosome, telomeric region; C:mitochondrion; C:nucleoplasm; C:replication fork;, F:5'-3' DNA helicase activity; F:5'-3' DNA/RNA helicase activity; F:ATP binding; F:G-quadruplex DNA binding; F:magnesium ion binding; F:single-stranded DNA helicase activity; F:telomerase inhibitor activity; F:telomeric DNA binding;, P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:mitochondrial genome maintenance; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:regulation of telomere maintenance; P:telomere maintenance via telomerase; scaffold37 indexed_genome mRNA 8412103 8413594 . + . ID=transcript_7567;Q9H611 B2RPL7 Q1W5B6 Q330H5 Q33E24,ATP-dependent DNA helicase PIF1 {ECO:0000255|HAMAP-Rule:MF_03176},DNA repair and recombination helicase PIF1 {ECO:0000255|HAMAP-Rule:MF_03176};PIF1/RRM3 DNA helicase-like protein;, PF02689;PF05970;, GO:0000781;GO:0005739;GO:0005654;GO:0005657;GO:0043139;GO:0033678;GO:0005524;GO:0051880;GO:0000287;GO:0017116;GO:0010521;GO:0042162;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0000002;GO:0051974;GO:0032211;GO:0032204;GO:0007004;, C:chromosome, telomeric region; C:mitochondrion; C:nucleoplasm; C:replication fork;, F:5'-3' DNA helicase activity; F:5'-3' DNA/RNA helicase activity; F:ATP binding; F:G-quadruplex DNA binding; F:magnesium ion binding; F:single-stranded DNA helicase activity; F:telomerase inhibitor activity; F:telomeric DNA binding;, P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:mitochondrial genome maintenance; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:regulation of telomere maintenance; P:telomere maintenance via telomerase;|Q9H611 B2RPL7 Q1W5B6 Q330H5 Q33E24,ATP-dependent DNA helicase PIF1 {ECO:0000255|HAMAP-Rule:MF_03176},DNA repair and recombination helicase PIF1 {ECO:0000255|HAMAP-Rule:MF_03176};PIF1/RRM3 DNA helicase-like protein;, PF02689;PF05970;, GO:0000781;GO:0005739;GO:0005654;GO:0005657;GO:0043139;GO:0033678;GO:0005524;GO:0051880;GO:0000287;GO:0017116;GO:0010521;GO:0042162;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0000002;GO:0051974;GO:0032211;GO:0032204;GO:0007004;, C:chromosome, telomeric region; C:mitochondrion; C:nucleoplasm; C:replication fork;, F:5'-3' DNA helicase activity; F:5'-3' DNA/RNA helicase activity; F:ATP binding; F:G-quadruplex DNA binding; F:magnesium ion binding; F:single-stranded DNA helicase activity; F:telomerase inhibitor activity; F:telomeric DNA binding;, P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:mitochondrial genome maintenance; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:regulation of telomere maintenance; P:telomere maintenance via telomerase; scaffold37 indexed_genome mRNA 8476903 8478094 . + . ID=transcript_7568;Q6ZRY4 A2RRG0,RNA-binding protein with multiple splicing 2,RNA binding protein, mRNA processing factor 2;, PF00076;, GO:0005737;GO:0042802;GO:0003729;GO:0042803;GO:0048557;GO:0030514;GO:0051151;GO:0048661;, C:cytoplasm;, F:identical protein binding; F:mRNA binding; F:protein homodimerization activity;, P:embryonic digestive tract morphogenesis; P:negative regulation of BMP signaling pathway; P:negative regulation of smooth muscle cell differentiation; P:positive regulation of smooth muscle cell proliferation; scaffold37 indexed_genome mRNA 8503837 8517215 . + . ID=transcript_7569;O95190,Ornithine decarboxylase antizyme 2,, PF02100;, GO:0005737;GO:0005829;GO:0005634;GO:0008073;GO:1902268;GO:0006596;GO:0006595;GO:0090316;GO:0045732;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase inhibitor activity;, P:negative regulation of polyamine transmembrane transport; P:polyamine biosynthetic process; P:polyamine metabolic process; P:positive regulation of intracellular protein transport; P:positive regulation of protein catabolic process; P:regulation of cellular amino acid metabolic process;|O95190,Ornithine decarboxylase antizyme 2,, PF02100;, GO:0005737;GO:0005829;GO:0005634;GO:0008073;GO:1902268;GO:0006596;GO:0006595;GO:0090316;GO:0045732;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase inhibitor activity;, P:negative regulation of polyamine transmembrane transport; P:polyamine biosynthetic process; P:polyamine metabolic process; P:positive regulation of intracellular protein transport; P:positive regulation of protein catabolic process; P:regulation of cellular amino acid metabolic process;|O95190,Ornithine decarboxylase antizyme 2,, PF02100;, GO:0005737;GO:0005829;GO:0005634;GO:0008073;GO:1902268;GO:0006596;GO:0006595;GO:0090316;GO:0045732;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase inhibitor activity;, P:negative regulation of polyamine transmembrane transport; P:polyamine biosynthetic process; P:polyamine metabolic process; P:positive regulation of intracellular protein transport; P:positive regulation of protein catabolic process; P:regulation of cellular amino acid metabolic process; scaffold37 indexed_genome mRNA 8517943 8710209 . - . ID=transcript_7570;O15014 Q0D2I2,Zinc finger protein 609 {ECO:0000312|HGNC:HGNC:29003},, , GO:0005654;GO:0005634;GO:0046872;GO:1990841;GO:0007517;GO:2001224;GO:0045944;GO:2000291;GO:0006357;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:promoter-specific chromatin binding;, P:muscle organ development; P:positive regulation of neuron migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of myoblast proliferation; P:regulation of transcription by RNA polymerase II;|O15014 Q0D2I2,Zinc finger protein 609 {ECO:0000312|HGNC:HGNC:29003},, , GO:0005654;GO:0005634;GO:0046872;GO:1990841;GO:0007517;GO:2001224;GO:0045944;GO:2000291;GO:0006357;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:promoter-specific chromatin binding;, P:muscle organ development; P:positive regulation of neuron migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of myoblast proliferation; P:regulation of transcription by RNA polymerase II;|O15014 Q0D2I2,Zinc finger protein 609 {ECO:0000312|HGNC:HGNC:29003},, , GO:0005654;GO:0005634;GO:0046872;GO:1990841;GO:0007517;GO:2001224;GO:0045944;GO:2000291;GO:0006357;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:promoter-specific chromatin binding;, P:muscle organ development; P:positive regulation of neuron migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of myoblast proliferation; P:regulation of transcription by RNA polymerase II;|O15014 Q0D2I2,Zinc finger protein 609 {ECO:0000312|HGNC:HGNC:29003},, , GO:0005654;GO:0005634;GO:0046872;GO:1990841;GO:0007517;GO:2001224;GO:0045944;GO:2000291;GO:0006357;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:promoter-specific chromatin binding;, P:muscle organ development; P:positive regulation of neuron migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of myoblast proliferation; P:regulation of transcription by RNA polymerase II;|O15014 Q0D2I2,Zinc finger protein 609 {ECO:0000312|HGNC:HGNC:29003},, , GO:0005654;GO:0005634;GO:0046872;GO:1990841;GO:0007517;GO:2001224;GO:0045944;GO:2000291;GO:0006357;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:promoter-specific chromatin binding;, P:muscle organ development; P:positive regulation of neuron migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of myoblast proliferation; P:regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 8725590 8776552 . - . ID=transcript_7571;Q15650 B2RAS0 Q96ED7 Q9UKH0,Activating signal cointegrator 1 {ECO:0000303|PubMed:10454579},Thyroid receptor-interacting protein 4 {ECO:0000303|PubMed:7776974};, PF04266;PF06221;, GO:0099053;GO:0005737;GO:0005829;GO:0005815;GO:0031594;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0030331;GO:0035035;GO:0016922;GO:0002020;GO:0019901;GO:0003713;GO:0044389;GO:0008270;GO:0030520;GO:0045893;GO:0045661;GO:0006355;GO:1901998;, C:activating signal cointegrator 1 complex; C:cytoplasm; C:cytosol; C:microtubule organizing center; C:neuromuscular junction; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:estrogen receptor binding; F:histone acetyltransferase binding; F:nuclear receptor binding; F:protease binding; F:protein kinase binding; F:transcription coactivator activity; F:ubiquitin-like protein ligase binding; F:zinc ion binding;, P:intracellular estrogen receptor signaling pathway; P:positive regulation of transcription, DNA-templated; P:regulation of myoblast differentiation; P:regulation of transcription, DNA-templated; P:toxin transport; scaffold37 indexed_genome mRNA 8795276 8918425 . + . ID=transcript_7572;Q9HCP0 Q5JPH1 Q96AE9 Q9HCP1,Casein kinase I isoform gamma-1,, PF12605;PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006897;GO:0018105;GO:0090263;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:endocytosis; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold37 indexed_genome mRNA 8954350 8960332 . + . ID=transcript_7573;P23284 A8K534 Q6IBH5 Q9BVK5,Peptidyl-prolyl cis-trans isomerase B,CYP-S1;Cyclophilin B;Rotamase B;S-cyclophilin;, PF00160;, GO:0005737;GO:0005783;GO:0005788;GO:0070062;GO:0005925;GO:0043231;GO:0042470;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0016018;GO:0003755;GO:0003723;GO:0070063;GO:0051082;GO:0060348;GO:0061077;GO:0030199;GO:0030593;GO:0044829;GO:0044794;GO:0040018;GO:0006457;GO:0000413;GO:0050821;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:focal adhesion; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding; F:RNA polymerase binding; F:unfolded protein binding;, P:bone development; P:chaperone-mediated protein folding; P:collagen fibril organization; P:neutrophil chemotaxis; P:positive regulation by host of viral genome replication; P:positive regulation by host of viral process; P:positive regulation of multicellular organism growth; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein stabilization;|P23284 A8K534 Q6IBH5 Q9BVK5,Peptidyl-prolyl cis-trans isomerase B,CYP-S1;Cyclophilin B;Rotamase B;S-cyclophilin;, PF00160;, GO:0005737;GO:0005783;GO:0005788;GO:0070062;GO:0005925;GO:0043231;GO:0042470;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0016018;GO:0003755;GO:0003723;GO:0070063;GO:0051082;GO:0060348;GO:0061077;GO:0030199;GO:0030593;GO:0044829;GO:0044794;GO:0040018;GO:0006457;GO:0000413;GO:0050821;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:focal adhesion; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding; F:RNA polymerase binding; F:unfolded protein binding;, P:bone development; P:chaperone-mediated protein folding; P:collagen fibril organization; P:neutrophil chemotaxis; P:positive regulation by host of viral genome replication; P:positive regulation by host of viral process; P:positive regulation of multicellular organism growth; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein stabilization; scaffold37 indexed_genome mRNA 8960833 8964315 . - . ID=transcript_7574;Q96L94 Q8WUS9 Q9H844,Sorting nexin-22,, PF00787;, GO:0030659;GO:1901981;GO:0015031;, C:cytoplasmic vesicle membrane;, F:phosphatidylinositol phosphate binding;, P:protein transport; scaffold37 indexed_genome mRNA 8971103 9009704 . - . ID=transcript_7575;Q13596 A6NM19 A8K6T7 H0Y2M5 O60750 O60751 Q6ZRJ8,Sorting nexin-1,, PF00787;PF03700;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0005794;GO:0043231;GO:0030027;GO:0005764;GO:0016020;GO:0032991;GO:0030904;GO:0030905;GO:0031982;GO:0045296;GO:0005154;GO:0042802;GO:0005158;GO:1990460;GO:0035091;GO:0046982;GO:0042803;GO:1990459;GO:0034498;GO:0006886;GO:0072673;GO:0045732;GO:0031623;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lamellipodium; C:lysosome; C:membrane; C:protein-containing complex; C:retromer complex; C:retromer, tubulation complex; C:vesicle;, F:cadherin binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferrin receptor binding;, P:early endosome to Golgi transport; P:intracellular protein transport; P:lamellipodium morphogenesis; P:positive regulation of protein catabolic process; P:receptor internalization; P:retrograde transport, endosome to Golgi;|Q13596 A6NM19 A8K6T7 H0Y2M5 O60750 O60751 Q6ZRJ8,Sorting nexin-1,, PF00787;PF03700;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0005794;GO:0043231;GO:0030027;GO:0005764;GO:0016020;GO:0032991;GO:0030904;GO:0030905;GO:0031982;GO:0045296;GO:0005154;GO:0042802;GO:0005158;GO:1990460;GO:0035091;GO:0046982;GO:0042803;GO:1990459;GO:0034498;GO:0006886;GO:0072673;GO:0045732;GO:0031623;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lamellipodium; C:lysosome; C:membrane; C:protein-containing complex; C:retromer complex; C:retromer, tubulation complex; C:vesicle;, F:cadherin binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferrin receptor binding;, P:early endosome to Golgi transport; P:intracellular protein transport; P:lamellipodium morphogenesis; P:positive regulation of protein catabolic process; P:receptor internalization; P:retrograde transport, endosome to Golgi;|Q13596 A6NM19 A8K6T7 H0Y2M5 O60750 O60751 Q6ZRJ8,Sorting nexin-1,, PF00787;PF03700;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0005794;GO:0043231;GO:0030027;GO:0005764;GO:0016020;GO:0032991;GO:0030904;GO:0030905;GO:0031982;GO:0045296;GO:0005154;GO:0042802;GO:0005158;GO:1990460;GO:0035091;GO:0046982;GO:0042803;GO:1990459;GO:0034498;GO:0006886;GO:0072673;GO:0045732;GO:0031623;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lamellipodium; C:lysosome; C:membrane; C:protein-containing complex; C:retromer complex; C:retromer, tubulation complex; C:vesicle;, F:cadherin binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferrin receptor binding;, P:early endosome to Golgi transport; P:intracellular protein transport; P:lamellipodium morphogenesis; P:positive regulation of protein catabolic process; P:receptor internalization; P:retrograde transport, endosome to Golgi;|Q13596 A6NM19 A8K6T7 H0Y2M5 O60750 O60751 Q6ZRJ8,Sorting nexin-1,, PF00787;PF03700;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0005794;GO:0043231;GO:0030027;GO:0005764;GO:0016020;GO:0032991;GO:0030904;GO:0030905;GO:0031982;GO:0045296;GO:0005154;GO:0042802;GO:0005158;GO:1990460;GO:0035091;GO:0046982;GO:0042803;GO:1990459;GO:0034498;GO:0006886;GO:0072673;GO:0045732;GO:0031623;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lamellipodium; C:lysosome; C:membrane; C:protein-containing complex; C:retromer complex; C:retromer, tubulation complex; C:vesicle;, F:cadherin binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferrin receptor binding;, P:early endosome to Golgi transport; P:intracellular protein transport; P:lamellipodium morphogenesis; P:positive regulation of protein catabolic process; P:receptor internalization; P:retrograde transport, endosome to Golgi;|Q13596 A6NM19 A8K6T7 H0Y2M5 O60750 O60751 Q6ZRJ8,Sorting nexin-1,, PF00787;PF03700;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0005794;GO:0043231;GO:0030027;GO:0005764;GO:0016020;GO:0032991;GO:0030904;GO:0030905;GO:0031982;GO:0045296;GO:0005154;GO:0042802;GO:0005158;GO:1990460;GO:0035091;GO:0046982;GO:0042803;GO:1990459;GO:0034498;GO:0006886;GO:0072673;GO:0045732;GO:0031623;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lamellipodium; C:lysosome; C:membrane; C:protein-containing complex; C:retromer complex; C:retromer, tubulation complex; C:vesicle;, F:cadherin binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferrin receptor binding;, P:early endosome to Golgi transport; P:intracellular protein transport; P:lamellipodium morphogenesis; P:positive regulation of protein catabolic process; P:receptor internalization; P:retrograde transport, endosome to Golgi;|Q13596 A6NM19 A8K6T7 H0Y2M5 O60750 O60751 Q6ZRJ8,Sorting nexin-1,, PF00787;PF03700;PF09325;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0005794;GO:0043231;GO:0030027;GO:0005764;GO:0016020;GO:0032991;GO:0030904;GO:0030905;GO:0031982;GO:0045296;GO:0005154;GO:0042802;GO:0005158;GO:1990460;GO:0035091;GO:0046982;GO:0042803;GO:1990459;GO:0034498;GO:0006886;GO:0072673;GO:0045732;GO:0031623;GO:0042147;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lamellipodium; C:lysosome; C:membrane; C:protein-containing complex; C:retromer complex; C:retromer, tubulation complex; C:vesicle;, F:cadherin binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:transferrin receptor binding;, P:early endosome to Golgi transport; P:intracellular protein transport; P:lamellipodium morphogenesis; P:positive regulation of protein catabolic process; P:receptor internalization; P:retrograde transport, endosome to Golgi; scaffold37 indexed_genome mRNA 9012607 9028583 . + . ID=transcript_7576;Q9H5X1 A6NKS1 B2R5F8 B7Z8Z5,Cytosolic iron-sulfur assembly component 2A {ECO:0000305},MIP18 family protein FAM96A;, PF01883;, GO:0097361;GO:0005829;GO:0005654;GO:0046872;GO:0007059;GO:0016226;GO:0106035;GO:0097428;, C:CIA complex; C:cytosol; C:nucleoplasm;, F:metal ion binding;, P:chromosome segregation; P:iron-sulfur cluster assembly; P:protein maturation by [4Fe-4S] cluster transfer; P:protein maturation by iron-sulfur cluster transfer; scaffold37 indexed_genome mRNA 9066599 9194831 . + . ID=transcript_7577;Q9UIK4 E9JGM7 O75892 Q24JS1,Death-associated protein kinase 2,DAP-kinase-related protein 1;, PF00069;, GO:0034423;GO:0005737;GO:0031410;GO:0005794;GO:0043231;GO:0005634;GO:0005524;GO:0005516;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0043276;GO:0006915;GO:0035556;GO:0043065;GO:2000424;GO:0090023;GO:0046777;GO:0006468;GO:0042981;GO:0010506;GO:2001242;, C:autophagosome lumen; C:cytoplasm; C:cytoplasmic vesicle; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleus;, F:ATP binding; F:calmodulin binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:anoikis; P:apoptotic process; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of eosinophil chemotaxis; P:positive regulation of neutrophil chemotaxis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of intrinsic apoptotic signaling pathway;|O43293 A0AVN4 B3KQE2 Q05JY4,Death-associated protein kinase 3,DAP-like kinase;MYPT1 kinase;Zipper-interacting protein kinase;, PF00069;, GO:0005884;GO:0005737;GO:0045121;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0008140;GO:0042802;GO:0043522;GO:0008022;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0006915;GO:0097190;GO:0071346;GO:0006325;GO:0035556;GO:0017148;GO:0030182;GO:0043065;GO:0090263;GO:0030335;GO:2001241;GO:0046777;GO:0006468;GO:2000249;GO:0042981;GO:0010506;GO:2000145;GO:0008360;GO:0051893;GO:0007346;GO:0007088;GO:0043519;GO:0006940;GO:0006355;, C:actin filament; C:cytoplasm; C:membrane raft; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:cAMP response element binding protein binding; F:identical protein binding; F:leucine zipper domain binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to interferon-gamma; P:chromatin organization; P:intracellular signal transduction; P:negative regulation of translation; P:neuron differentiation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell migration; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cell motility; P:regulation of cell shape; P:regulation of focal adhesion assembly; P:regulation of mitotic cell cycle; P:regulation of mitotic nuclear division; P:regulation of myosin II filament organization; P:regulation of smooth muscle contraction; P:regulation of transcription, DNA-templated;|Q9UIK4 E9JGM7 O75892 Q24JS1,Death-associated protein kinase 2,DAP-kinase-related protein 1;, PF00069;, GO:0034423;GO:0005737;GO:0031410;GO:0005794;GO:0043231;GO:0005634;GO:0005524;GO:0005516;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0043276;GO:0006915;GO:0035556;GO:0043065;GO:2000424;GO:0090023;GO:0046777;GO:0006468;GO:0042981;GO:0010506;GO:2001242;, C:autophagosome lumen; C:cytoplasm; C:cytoplasmic vesicle; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleus;, F:ATP binding; F:calmodulin binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:anoikis; P:apoptotic process; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of eosinophil chemotaxis; P:positive regulation of neutrophil chemotaxis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of intrinsic apoptotic signaling pathway; scaffold37 indexed_genome mRNA 9294870 9505017 . + . ID=transcript_7578;Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q92667 A8K8Q1 D3DTZ0 Q13320 Q9BW14,A-kinase anchor protein 1, mitochondrial,A-kinase anchor protein 149 kDa;Dual specificity A-kinase-anchoring protein 1;Protein kinase A-anchoring protein 1;Spermatid A-kinase anchor protein 84;, PF00013;PF00567;, GO:0005829;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0034237;GO:0003723;GO:0140374;GO:0006915;GO:0007596;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein kinase A regulatory subunit binding; F:RNA binding;, P:antiviral innate immune response; P:apoptotic process; P:blood coagulation;|Q92667 A8K8Q1 D3DTZ0 Q13320 Q9BW14,A-kinase anchor protein 1, mitochondrial,A-kinase anchor protein 149 kDa;Dual specificity A-kinase-anchoring protein 1;Protein kinase A-anchoring protein 1;Spermatid A-kinase anchor protein 84;, PF00013;PF00567;, GO:0005829;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0034237;GO:0003723;GO:0140374;GO:0006915;GO:0007596;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein kinase A regulatory subunit binding; F:RNA binding;, P:antiviral innate immune response; P:apoptotic process; P:blood coagulation;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;|Q15751 Q8IW65,Probable E3 ubiquitin-protein ligase HERC1,HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;, PF00632;PF00415;PF00622;PF00400;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;, P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development; scaffold37 indexed_genome mRNA 9522071 9629621 . - . ID=transcript_7579;Q9Y6I4 B4DVU5 F5H1A6 Q8WVD0,Ubiquitin carboxyl-terminal hydrolase 3,Deubiquitinating enzyme 3;Ubiquitin thioesterase 3;Ubiquitin-specific-processing protease 3;, PF00443;PF02148;, GO:0000785;GO:0005737;GO:0036464;GO:0090543;GO:0005654;GO:0005634;GO:0008234;GO:0042393;GO:1990841;GO:0000978;GO:0004843;GO:0008270;GO:0006281;GO:0016578;GO:0000278;GO:0000122;GO:0016579;GO:0031647;GO:0006511;, C:chromatin; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:Flemming body; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity; F:histone binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:DNA repair; P:histone deubiquitination; P:mitotic cell cycle; P:negative regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y6I4 B4DVU5 F5H1A6 Q8WVD0,Ubiquitin carboxyl-terminal hydrolase 3,Deubiquitinating enzyme 3;Ubiquitin thioesterase 3;Ubiquitin-specific-processing protease 3;, PF00443;PF02148;, GO:0000785;GO:0005737;GO:0036464;GO:0090543;GO:0005654;GO:0005634;GO:0008234;GO:0042393;GO:1990841;GO:0000978;GO:0004843;GO:0008270;GO:0006281;GO:0016578;GO:0000278;GO:0000122;GO:0016579;GO:0031647;GO:0006511;, C:chromatin; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:Flemming body; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity; F:histone binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:DNA repair; P:histone deubiquitination; P:mitotic cell cycle; P:negative regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y6I4 B4DVU5 F5H1A6 Q8WVD0,Ubiquitin carboxyl-terminal hydrolase 3,Deubiquitinating enzyme 3;Ubiquitin thioesterase 3;Ubiquitin-specific-processing protease 3;, PF00443;PF02148;, GO:0000785;GO:0005737;GO:0036464;GO:0090543;GO:0005654;GO:0005634;GO:0008234;GO:0042393;GO:1990841;GO:0000978;GO:0004843;GO:0008270;GO:0006281;GO:0016578;GO:0000278;GO:0000122;GO:0016579;GO:0031647;GO:0006511;, C:chromatin; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:Flemming body; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity; F:histone binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:DNA repair; P:histone deubiquitination; P:mitotic cell cycle; P:negative regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y6I4 B4DVU5 F5H1A6 Q8WVD0,Ubiquitin carboxyl-terminal hydrolase 3,Deubiquitinating enzyme 3;Ubiquitin thioesterase 3;Ubiquitin-specific-processing protease 3;, PF00443;PF02148;, GO:0000785;GO:0005737;GO:0036464;GO:0090543;GO:0005654;GO:0005634;GO:0008234;GO:0042393;GO:1990841;GO:0000978;GO:0004843;GO:0008270;GO:0006281;GO:0016578;GO:0000278;GO:0000122;GO:0016579;GO:0031647;GO:0006511;, C:chromatin; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:Flemming body; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity; F:histone binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:DNA repair; P:histone deubiquitination; P:mitotic cell cycle; P:negative regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y6I4 B4DVU5 F5H1A6 Q8WVD0,Ubiquitin carboxyl-terminal hydrolase 3,Deubiquitinating enzyme 3;Ubiquitin thioesterase 3;Ubiquitin-specific-processing protease 3;, PF00443;PF02148;, GO:0000785;GO:0005737;GO:0036464;GO:0090543;GO:0005654;GO:0005634;GO:0008234;GO:0042393;GO:1990841;GO:0000978;GO:0004843;GO:0008270;GO:0006281;GO:0016578;GO:0000278;GO:0000122;GO:0016579;GO:0031647;GO:0006511;, C:chromatin; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:Flemming body; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity; F:histone binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:DNA repair; P:histone deubiquitination; P:mitotic cell cycle; P:negative regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9Y6I4 B4DVU5 F5H1A6 Q8WVD0,Ubiquitin carboxyl-terminal hydrolase 3,Deubiquitinating enzyme 3;Ubiquitin thioesterase 3;Ubiquitin-specific-processing protease 3;, PF00443;PF02148;, GO:0000785;GO:0005737;GO:0036464;GO:0090543;GO:0005654;GO:0005634;GO:0008234;GO:0042393;GO:1990841;GO:0000978;GO:0004843;GO:0008270;GO:0006281;GO:0016578;GO:0000278;GO:0000122;GO:0016579;GO:0031647;GO:0006511;, C:chromatin; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:Flemming body; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity; F:histone binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:DNA repair; P:histone deubiquitination; P:mitotic cell cycle; P:negative regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process; scaffold37 indexed_genome mRNA 9812894 9813435 . + . ID=transcript_7580;O43570 B2RE24 Q53YE5 Q9BWG2,Carbonic anhydrase 12,Carbonate dehydratase XII;Carbonic anhydrase XII;Tumor antigen HOM-RCC-3.1.3;, PF00194;, GO:0016021;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0055064;GO:0006730;, C:integral component of membrane; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:chloride ion homeostasis; P:one-carbon metabolic process; scaffold37 indexed_genome mRNA 9825932 9826549 . + . ID=transcript_7581;O43570 B2RE24 Q53YE5 Q9BWG2,Carbonic anhydrase 12,Carbonate dehydratase XII;Carbonic anhydrase XII;Tumor antigen HOM-RCC-3.1.3;, PF00194;, GO:0016021;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0055064;GO:0006730;, C:integral component of membrane; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:chloride ion homeostasis; P:one-carbon metabolic process; scaffold37 indexed_genome mRNA 9842882 9880485 . - . ID=transcript_7582;Q8WW43 A8K589 Q564N3 Q6UWQ1 Q9H0S0,Gamma-secretase subunit APH-1B,Aph-1beta;Presenilin-stabilization factor-like;, PF06105;, GO:0005783;GO:0010008;GO:0070765;GO:0016021;GO:0005887;GO:0005886;GO:0030133;GO:0061133;GO:0004175;GO:0008233;GO:0030674;GO:1990000;GO:0042987;GO:0034205;GO:0048013;GO:0007626;GO:0031293;GO:0007220;GO:0035333;GO:0007219;GO:0043065;GO:0010950;GO:0016485;, C:endoplasmic reticulum; C:endosome membrane; C:gamma-secretase complex; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:transport vesicle;, F:endopeptidase activator activity; F:endopeptidase activity; F:peptidase activity; F:protein-macromolecule adaptor activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:ephrin receptor signaling pathway; P:locomotory behavior; P:membrane protein intracellular domain proteolysis; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:Notch signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of endopeptidase activity; P:protein processing;|Q8WW43 A8K589 Q564N3 Q6UWQ1 Q9H0S0,Gamma-secretase subunit APH-1B,Aph-1beta;Presenilin-stabilization factor-like;, PF06105;, GO:0005783;GO:0010008;GO:0070765;GO:0016021;GO:0005887;GO:0005886;GO:0030133;GO:0061133;GO:0004175;GO:0008233;GO:0030674;GO:1990000;GO:0042987;GO:0034205;GO:0048013;GO:0007626;GO:0031293;GO:0007220;GO:0035333;GO:0007219;GO:0043065;GO:0010950;GO:0016485;, C:endoplasmic reticulum; C:endosome membrane; C:gamma-secretase complex; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:transport vesicle;, F:endopeptidase activator activity; F:endopeptidase activity; F:peptidase activity; F:protein-macromolecule adaptor activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:ephrin receptor signaling pathway; P:locomotory behavior; P:membrane protein intracellular domain proteolysis; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:Notch signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of endopeptidase activity; P:protein processing;|Q8WW43 A8K589 Q564N3 Q6UWQ1 Q9H0S0,Gamma-secretase subunit APH-1B,Aph-1beta;Presenilin-stabilization factor-like;, PF06105;, GO:0005783;GO:0010008;GO:0070765;GO:0016021;GO:0005887;GO:0005886;GO:0030133;GO:0061133;GO:0004175;GO:0008233;GO:0030674;GO:1990000;GO:0042987;GO:0034205;GO:0048013;GO:0007626;GO:0031293;GO:0007220;GO:0035333;GO:0007219;GO:0043065;GO:0010950;GO:0016485;, C:endoplasmic reticulum; C:endosome membrane; C:gamma-secretase complex; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:transport vesicle;, F:endopeptidase activator activity; F:endopeptidase activity; F:peptidase activity; F:protein-macromolecule adaptor activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:ephrin receptor signaling pathway; P:locomotory behavior; P:membrane protein intracellular domain proteolysis; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:Notch signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of endopeptidase activity; P:protein processing; scaffold37 indexed_genome mRNA 9894011 9963277 . - . ID=transcript_7583;Q92930 Q5JPC4 Q9P293,Ras-related protein Rab-8B,, PF00071;, GO:0051286;GO:0005768;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0048471;GO:0005778;GO:0045335;GO:0030670;GO:0005886;GO:0055038;GO:0008021;GO:0030140;GO:0019003;GO:0005525;GO:0003924;GO:0005102;GO:0030911;GO:0019882;GO:0150115;GO:0032869;GO:0048210;GO:0031346;GO:0051461;GO:0045046;GO:0072659;GO:0009306;GO:0017157;GO:0006904;, C:cell tip; C:endosome; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome membrane; C:synaptic vesicle; C:trans-Golgi network transport vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity; F:signaling receptor binding; F:TPR domain binding;, P:antigen processing and presentation; P:cell-substrate junction organization; P:cellular response to insulin stimulus; P:Golgi vesicle fusion to target membrane; P:positive regulation of cell projection organization; P:positive regulation of corticotropin secretion; P:protein import into peroxisome membrane; P:protein localization to plasma membrane; P:protein secretion; P:regulation of exocytosis; P:vesicle docking involved in exocytosis;|Q92930 Q5JPC4 Q9P293,Ras-related protein Rab-8B,, PF00071;, GO:0051286;GO:0005768;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0048471;GO:0005778;GO:0045335;GO:0030670;GO:0005886;GO:0055038;GO:0008021;GO:0030140;GO:0019003;GO:0005525;GO:0003924;GO:0005102;GO:0030911;GO:0019882;GO:0150115;GO:0032869;GO:0048210;GO:0031346;GO:0051461;GO:0045046;GO:0072659;GO:0009306;GO:0017157;GO:0006904;, C:cell tip; C:endosome; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome membrane; C:synaptic vesicle; C:trans-Golgi network transport vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity; F:signaling receptor binding; F:TPR domain binding;, P:antigen processing and presentation; P:cell-substrate junction organization; P:cellular response to insulin stimulus; P:Golgi vesicle fusion to target membrane; P:positive regulation of cell projection organization; P:positive regulation of corticotropin secretion; P:protein import into peroxisome membrane; P:protein localization to plasma membrane; P:protein secretion; P:regulation of exocytosis; P:vesicle docking involved in exocytosis; scaffold37 indexed_genome mRNA 9999355 10002976 . + . ID=transcript_7584;Q71UM5 Q9BTJ1,40S ribosomal protein S27-like,Small ribosomal subunit protein eS27-like;, PF01667;, GO:0022627;GO:0005634;GO:0008656;GO:0046872;GO:0003723;GO:0003735;GO:0008494;GO:0006919;GO:0006978;GO:0042771;GO:0031571;GO:0045727;GO:0000028;GO:0006412;, C:cytosolic small ribosomal subunit; C:nucleus;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:metal ion binding; F:RNA binding; F:structural constituent of ribosome; F:translation activator activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic G1 DNA damage checkpoint; P:positive regulation of translation; P:ribosomal small subunit assembly; P:translation;|Q71UM5 Q9BTJ1,40S ribosomal protein S27-like,Small ribosomal subunit protein eS27-like;, PF01667;, GO:0022627;GO:0005634;GO:0008656;GO:0046872;GO:0003723;GO:0003735;GO:0008494;GO:0006919;GO:0006978;GO:0042771;GO:0031571;GO:0045727;GO:0000028;GO:0006412;, C:cytosolic small ribosomal subunit; C:nucleus;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:metal ion binding; F:RNA binding; F:structural constituent of ribosome; F:translation activator activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic G1 DNA damage checkpoint; P:positive regulation of translation; P:ribosomal small subunit assembly; P:translation;|Q71UM5 Q9BTJ1,40S ribosomal protein S27-like,Small ribosomal subunit protein eS27-like;, PF01667;, GO:0022627;GO:0005634;GO:0008656;GO:0046872;GO:0003723;GO:0003735;GO:0008494;GO:0006919;GO:0006978;GO:0042771;GO:0031571;GO:0045727;GO:0000028;GO:0006412;, C:cytosolic small ribosomal subunit; C:nucleus;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:metal ion binding; F:RNA binding; F:structural constituent of ribosome; F:translation activator activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic G1 DNA damage checkpoint; P:positive regulation of translation; P:ribosomal small subunit assembly; P:translation; scaffold37 indexed_genome mRNA 10015013 10030980 . - . ID=transcript_7585;P83111 P83096,Serine beta-lactamase-like protein LACTB, mitochondrial {ECO:0000305},, PF00144;, GO:0005829;GO:0005739;GO:0042802;GO:0008233;GO:0006629;GO:0006508;GO:0019216;, C:cytosol; C:mitochondrion;, F:identical protein binding; F:peptidase activity;, P:lipid metabolic process; P:proteolysis; P:regulation of lipid metabolic process; scaffold37 indexed_genome mRNA 10095100 10127972 . - . ID=transcript_7586;Q9UCS4,Tropomyosin alpha-4 chain,TM30p1;Tropomyosin-4;, PF00261;, GO:0005884;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005862;GO:0001725;GO:0051015;GO:0005509;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0001649;, C:actin filament; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:muscle thin filament tropomyosin; C:stress fiber;, F:actin filament binding; F:calcium ion binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:osteoblast differentiation;|Q7Z6L8 Q86W64 Q96IK2 Q9UCI1 Q9UCI2 Q9UCY9 Q9Y427,Tropomyosin alpha-1 chain,Alpha-tropomyosin;Tropomyosin-1;, PF00261;, GO:0015629;GO:0005884;GO:0032059;GO:0005856;GO:0005829;GO:0005862;GO:0032587;GO:0030017;GO:0001725;GO:0003779;GO:0051015;GO:0008092;GO:0042802;GO:0046982;GO:0042803;GO:0005200;GO:0008307;GO:0007015;GO:0060048;GO:0034614;GO:0007010;GO:0006936;GO:0030049;GO:0030336;GO:1904753;GO:1904706;GO:0032781;GO:0045785;GO:0003065;GO:0051496;GO:0008360;GO:0008016;GO:0006937;GO:0031529;GO:0045214;GO:0055010;GO:0042060;, C:actin cytoskeleton; C:actin filament; C:bleb; C:cytoskeleton; C:cytosol; C:muscle thin filament tropomyosin; C:ruffle membrane; C:sarcomere; C:stress fiber;, F:actin binding; F:actin filament binding; F:cytoskeletal protein binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cardiac muscle contraction; P:cellular response to reactive oxygen species; P:cytoskeleton organization; P:muscle contraction; P:muscle filament sliding; P:negative regulation of cell migration; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of ATPase activity; P:positive regulation of cell adhesion; P:positive regulation of heart rate by epinephrine; P:positive regulation of stress fiber assembly; P:regulation of cell shape; P:regulation of heart contraction; P:regulation of muscle contraction; P:ruffle organization; P:sarcomere organization; P:ventricular cardiac muscle tissue morphogenesis; P:wound healing;|Q7Z6L8 Q86W64 Q96IK2 Q9UCI1 Q9UCI2 Q9UCY9 Q9Y427,Tropomyosin alpha-1 chain,Alpha-tropomyosin;Tropomyosin-1;, PF00261;, GO:0015629;GO:0005884;GO:0032059;GO:0005856;GO:0005829;GO:0005862;GO:0032587;GO:0030017;GO:0001725;GO:0003779;GO:0051015;GO:0008092;GO:0042802;GO:0046982;GO:0042803;GO:0005200;GO:0008307;GO:0007015;GO:0060048;GO:0034614;GO:0007010;GO:0006936;GO:0030049;GO:0030336;GO:1904753;GO:1904706;GO:0032781;GO:0045785;GO:0003065;GO:0051496;GO:0008360;GO:0008016;GO:0006937;GO:0031529;GO:0045214;GO:0055010;GO:0042060;, C:actin cytoskeleton; C:actin filament; C:bleb; C:cytoskeleton; C:cytosol; C:muscle thin filament tropomyosin; C:ruffle membrane; C:sarcomere; C:stress fiber;, F:actin binding; F:actin filament binding; F:cytoskeletal protein binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cardiac muscle contraction; P:cellular response to reactive oxygen species; P:cytoskeleton organization; P:muscle contraction; P:muscle filament sliding; P:negative regulation of cell migration; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of ATPase activity; P:positive regulation of cell adhesion; P:positive regulation of heart rate by epinephrine; P:positive regulation of stress fiber assembly; P:regulation of cell shape; P:regulation of heart contraction; P:regulation of muscle contraction; P:ruffle organization; P:sarcomere organization; P:ventricular cardiac muscle tissue morphogenesis; P:wound healing;|Q7Z6L8 Q86W64 Q96IK2 Q9UCI1 Q9UCI2 Q9UCY9 Q9Y427,Tropomyosin alpha-1 chain,Alpha-tropomyosin;Tropomyosin-1;, PF00261;, GO:0015629;GO:0005884;GO:0032059;GO:0005856;GO:0005829;GO:0005862;GO:0032587;GO:0030017;GO:0001725;GO:0003779;GO:0051015;GO:0008092;GO:0042802;GO:0046982;GO:0042803;GO:0005200;GO:0008307;GO:0007015;GO:0060048;GO:0034614;GO:0007010;GO:0006936;GO:0030049;GO:0030336;GO:1904753;GO:1904706;GO:0032781;GO:0045785;GO:0003065;GO:0051496;GO:0008360;GO:0008016;GO:0006937;GO:0031529;GO:0045214;GO:0055010;GO:0042060;, C:actin cytoskeleton; C:actin filament; C:bleb; C:cytoskeleton; C:cytosol; C:muscle thin filament tropomyosin; C:ruffle membrane; C:sarcomere; C:stress fiber;, F:actin binding; F:actin filament binding; F:cytoskeletal protein binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cardiac muscle contraction; P:cellular response to reactive oxygen species; P:cytoskeleton organization; P:muscle contraction; P:muscle filament sliding; P:negative regulation of cell migration; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of ATPase activity; P:positive regulation of cell adhesion; P:positive regulation of heart rate by epinephrine; P:positive regulation of stress fiber assembly; P:regulation of cell shape; P:regulation of heart contraction; P:regulation of muscle contraction; P:ruffle organization; P:sarcomere organization; P:ventricular cardiac muscle tissue morphogenesis; P:wound healing; scaffold37 indexed_genome mRNA 10343532 10350069 . - . ID=transcript_7587;Q9Y4G6 A6NLB8,Talin-2,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0015629;GO:0005737;GO:0005925;GO:0005886;GO:0001726;GO:0045202;GO:0003779;GO:0051015;GO:0005178;GO:0005200;GO:0005198;GO:0007155;GO:0098609;GO:0007043;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:plasma membrane; C:ruffle; C:synapse;, F:actin binding; F:actin filament binding; F:integrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cell adhesion; P:cell-cell adhesion; P:cell-cell junction assembly; scaffold37 indexed_genome mRNA 10350578 10488890 . - . ID=transcript_7588;Q9Y4G6 A6NLB8,Talin-2,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0015629;GO:0005737;GO:0005925;GO:0005886;GO:0001726;GO:0045202;GO:0003779;GO:0051015;GO:0005178;GO:0005200;GO:0005198;GO:0007155;GO:0098609;GO:0007043;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:plasma membrane; C:ruffle; C:synapse;, F:actin binding; F:actin filament binding; F:integrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cell adhesion; P:cell-cell adhesion; P:cell-cell junction assembly;|Q9Y4G6 A6NLB8,Talin-2,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0015629;GO:0005737;GO:0005925;GO:0005886;GO:0001726;GO:0045202;GO:0003779;GO:0051015;GO:0005178;GO:0005200;GO:0005198;GO:0007155;GO:0098609;GO:0007043;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:plasma membrane; C:ruffle; C:synapse;, F:actin binding; F:actin filament binding; F:integrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cell adhesion; P:cell-cell adhesion; P:cell-cell junction assembly;|Q9Y4G6 A6NLB8,Talin-2,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0015629;GO:0005737;GO:0005925;GO:0005886;GO:0001726;GO:0045202;GO:0003779;GO:0051015;GO:0005178;GO:0005200;GO:0005198;GO:0007155;GO:0098609;GO:0007043;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:plasma membrane; C:ruffle; C:synapse;, F:actin binding; F:actin filament binding; F:integrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cell adhesion; P:cell-cell adhesion; P:cell-cell junction assembly; scaffold37 indexed_genome mRNA 10491600 10549639 . - . ID=transcript_7589;Q9Y4G6 A6NLB8,Talin-2,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0015629;GO:0005737;GO:0005925;GO:0005886;GO:0001726;GO:0045202;GO:0003779;GO:0051015;GO:0005178;GO:0005200;GO:0005198;GO:0007155;GO:0098609;GO:0007043;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:plasma membrane; C:ruffle; C:synapse;, F:actin binding; F:actin filament binding; F:integrin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cell adhesion; P:cell-cell adhesion; P:cell-cell junction assembly; scaffold37 indexed_genome mRNA 11090922 11092516 . - . ID=transcript_7590;Q8NCU7,C2 calcium-dependent domain-containing protein 4A,Nuclear-localized factor 1;Protein FAM148A;, , GO:0005634;GO:0002675;GO:0030155;GO:0002528;, C:nucleus;, , P:positive regulation of acute inflammatory response; P:regulation of cell adhesion; P:regulation of vascular permeability involved in acute inflammatory response; scaffold37 indexed_genome mRNA 11105134 11264718 . + . ID=transcript_7591;Q709C8 Q6ISR4 Q702P2 Q702P3 Q709C9 Q9NXN8 Q9P2C6,Vacuolar protein sorting-associated protein 13C,, PF09333;PF12624;PF06650;PF16908;PF16909;PF16910;, GO:0005737;GO:0005829;GO:0032127;GO:0070062;GO:0019898;GO:0005741;GO:0006895;GO:0007005;GO:1905090;GO:0045053;GO:0006623;GO:0032868;, C:cytoplasm; C:cytosol; C:dense core granule membrane; C:extracellular exosome; C:extrinsic component of membrane; C:mitochondrial outer membrane;, , P:Golgi to endosome transport; P:mitochondrion organization; P:negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; P:response to insulin; scaffold37 indexed_genome mRNA 11267136 11274903 . + . ID=transcript_7592;Q709C8 Q6ISR4 Q702P2 Q702P3 Q709C9 Q9NXN8 Q9P2C6,Vacuolar protein sorting-associated protein 13C,, PF09333;PF12624;PF06650;PF16908;PF16909;PF16910;, GO:0005737;GO:0005829;GO:0032127;GO:0070062;GO:0019898;GO:0005741;GO:0006895;GO:0007005;GO:1905090;GO:0045053;GO:0006623;GO:0032868;, C:cytoplasm; C:cytosol; C:dense core granule membrane; C:extracellular exosome; C:extrinsic component of membrane; C:mitochondrial outer membrane;, , P:Golgi to endosome transport; P:mitochondrion organization; P:negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; P:response to insulin;|Q709C8 Q6ISR4 Q702P2 Q702P3 Q709C9 Q9NXN8 Q9P2C6,Vacuolar protein sorting-associated protein 13C,, PF09333;PF12624;PF06650;PF16908;PF16909;PF16910;, GO:0005737;GO:0005829;GO:0032127;GO:0070062;GO:0019898;GO:0005741;GO:0006895;GO:0007005;GO:1905090;GO:0045053;GO:0006623;GO:0032868;, C:cytoplasm; C:cytosol; C:dense core granule membrane; C:extracellular exosome; C:extrinsic component of membrane; C:mitochondrial outer membrane;, , P:Golgi to endosome transport; P:mitochondrion organization; P:negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; P:response to insulin;|Q709C8 Q6ISR4 Q702P2 Q702P3 Q709C9 Q9NXN8 Q9P2C6,Vacuolar protein sorting-associated protein 13C,, PF09333;PF12624;PF06650;PF16908;PF16909;PF16910;, GO:0005737;GO:0005829;GO:0032127;GO:0070062;GO:0019898;GO:0005741;GO:0006895;GO:0007005;GO:1905090;GO:0045053;GO:0006623;GO:0032868;, C:cytoplasm; C:cytosol; C:dense core granule membrane; C:extracellular exosome; C:extrinsic component of membrane; C:mitochondrial outer membrane;, , P:Golgi to endosome transport; P:mitochondrion organization; P:negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; P:response to insulin; scaffold37 indexed_genome mRNA 11910358 12690203 . + . ID=transcript_7593;P35398 P35397 P35399 P45445 Q495X4 Q96H83,Nuclear receptor ROR-alpha,Nuclear receptor RZR-alpha;Nuclear receptor subfamily 1 group F member 1;RAR-related orphan receptor A;Retinoid-related orphan receptor-alpha;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005634;GO:0008013;GO:0003677;GO:0003700;GO:0000981;GO:0098531;GO:0004879;GO:0008142;GO:0000978;GO:0000977;GO:0043565;GO:0001223;GO:0001222;GO:0008134;GO:0008270;GO:0001525;GO:0071456;GO:0071347;GO:0036315;GO:0071356;GO:0021930;GO:0021702;GO:0046068;GO:0042632;GO:0032922;GO:0019221;GO:0030522;GO:0042692;GO:0045599;GO:0043124;GO:0050728;GO:0006809;GO:0042753;GO:0045944;GO:0045893;GO:0010575;GO:0010906;GO:0043030;GO:0008589;GO:0019218;GO:0006357;GO:0006355;GO:0072539;GO:0006367;GO:0070328;GO:0006805;, C:chromatin; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:ligand-activated transcription factor activity; F:nuclear receptor activity; F:oxysterol binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:transcription corepressor binding; F:transcription factor binding; F:zinc ion binding;, P:angiogenesis; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to sterol; P:cellular response to tumor necrosis factor; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell differentiation; P:cGMP metabolic process; P:cholesterol homeostasis; P:circadian regulation of gene expression; P:cytokine-mediated signaling pathway; P:intracellular receptor signaling pathway; P:muscle cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:nitric oxide biosynthetic process; P:positive regulation of circadian rhythm; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:regulation of glucose metabolic process; P:regulation of macrophage activation; P:regulation of smoothened signaling pathway; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:T-helper 17 cell differentiation; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis; P:xenobiotic metabolic process;|P35398 P35397 P35399 P45445 Q495X4 Q96H83,Nuclear receptor ROR-alpha,Nuclear receptor RZR-alpha;Nuclear receptor subfamily 1 group F member 1;RAR-related orphan receptor A;Retinoid-related orphan receptor-alpha;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005634;GO:0008013;GO:0003677;GO:0003700;GO:0000981;GO:0098531;GO:0004879;GO:0008142;GO:0000978;GO:0000977;GO:0043565;GO:0001223;GO:0001222;GO:0008134;GO:0008270;GO:0001525;GO:0071456;GO:0071347;GO:0036315;GO:0071356;GO:0021930;GO:0021702;GO:0046068;GO:0042632;GO:0032922;GO:0019221;GO:0030522;GO:0042692;GO:0045599;GO:0043124;GO:0050728;GO:0006809;GO:0042753;GO:0045944;GO:0045893;GO:0010575;GO:0010906;GO:0043030;GO:0008589;GO:0019218;GO:0006357;GO:0006355;GO:0072539;GO:0006367;GO:0070328;GO:0006805;, C:chromatin; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:ligand-activated transcription factor activity; F:nuclear receptor activity; F:oxysterol binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator binding; F:transcription corepressor binding; F:transcription factor binding; F:zinc ion binding;, P:angiogenesis; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to sterol; P:cellular response to tumor necrosis factor; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell differentiation; P:cGMP metabolic process; P:cholesterol homeostasis; P:circadian regulation of gene expression; P:cytokine-mediated signaling pathway; P:intracellular receptor signaling pathway; P:muscle cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:nitric oxide biosynthetic process; P:positive regulation of circadian rhythm; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:regulation of glucose metabolic process; P:regulation of macrophage activation; P:regulation of smoothened signaling pathway; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:T-helper 17 cell differentiation; P:transcription initiation from RNA polymerase II promoter; P:triglyceride homeostasis; P:xenobiotic metabolic process; scaffold37 indexed_genome mRNA 12703231 12763855 . + . ID=transcript_7594;Q71H65 Q96CY5 Q9HAA2,Little elongation complex subunit 2,Interactor of little elongator complex ELL subunit 2;NMDA receptor-regulated protein 2;, PF10505;, GO:0015030;GO:0005829;GO:0035363;GO:0016604;GO:0005654;GO:0008023;GO:0035327;GO:0045945;GO:0042795;GO:0042796;, C:Cajal body; C:cytosol; C:histone locus body; C:nuclear body; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, , P:positive regulation of transcription by RNA polymerase III; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III;|Q71H65 Q96CY5 Q9HAA2,Little elongation complex subunit 2,Interactor of little elongator complex ELL subunit 2;NMDA receptor-regulated protein 2;, PF10505;, GO:0015030;GO:0005829;GO:0035363;GO:0016604;GO:0005654;GO:0008023;GO:0035327;GO:0045945;GO:0042795;GO:0042796;, C:Cajal body; C:cytosol; C:histone locus body; C:nuclear body; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, , P:positive regulation of transcription by RNA polymerase III; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; scaffold37 indexed_genome mRNA 12801599 12834952 . + . ID=transcript_7595;P07355 Q567R4 Q6N0B3 Q8TBV2 Q96DD5 Q9UDH8,Annexin A2,Annexin II;Annexin-2;Calpactin I heavy chain;Calpactin-1 heavy chain;Chromobindin-8;Lipocortin II;Placental anticoagulant protein IV;Protein I;p36;, PF00191;, GO:0005912;GO:1990665;GO:0035578;GO:0005604;GO:0016323;GO:0009986;GO:0062023;GO:0005737;GO:0005768;GO:0070062;GO:0005576;GO:0005615;GO:0031902;GO:0005811;GO:0005765;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:1990667;GO:0005886;GO:0031982;GO:0098641;GO:0005262;GO:0005509;GO:0005544;GO:0048306;GO:0008092;GO:0042802;GO:0005546;GO:0001786;GO:0019834;GO:0002020;GO:0003723;GO:0044548;GO:0004867;GO:0046790;GO:0001525;GO:0052362;GO:0035722;GO:0001765;GO:0052405;GO:0044147;GO:0032804;GO:0043312;GO:0036035;GO:1905581;GO:1905597;GO:1905599;GO:0001921;GO:1905602;GO:0044090;GO:0031340;GO:0006900;GO:0016032;, C:adherens junction; C:AnxA2-p11 complex; C:azurophil granule lumen; C:basement membrane; C:basolateral plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:late endosome membrane; C:lipid droplet; C:lysosomal membrane; C:melanosome; C:membrane; C:midbody; C:nucleus; C:PCSK9-AnxA2 complex; C:plasma membrane; C:vesicle;, F:cadherin binding involved in cell-cell adhesion; F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:cytoskeletal protein binding; F:identical protein binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:phospholipase A2 inhibitor activity; F:protease binding; F:RNA binding; F:S100 protein binding; F:serine-type endopeptidase inhibitor activity; F:virion binding;, P:angiogenesis; P:catabolism by host of symbiont protein; P:interleukin-12-mediated signaling pathway; P:membrane raft assembly; P:negative regulation by host of symbiont molecular function; P:negative regulation of development of symbiont involved in interaction with host; P:negative regulation of low-density lipoprotein particle receptor catabolic process; P:neutrophil degranulation; P:osteoclast development; P:positive regulation of low-density lipoprotein particle clearance; P:positive regulation of low-density lipoprotein particle receptor binding; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of receptor recycling; P:positive regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of vacuole organization; P:positive regulation of vesicle fusion; P:vesicle budding from membrane; P:viral process;|P07355 Q567R4 Q6N0B3 Q8TBV2 Q96DD5 Q9UDH8,Annexin A2,Annexin II;Annexin-2;Calpactin I heavy chain;Calpactin-1 heavy chain;Chromobindin-8;Lipocortin II;Placental anticoagulant protein IV;Protein I;p36;, PF00191;, GO:0005912;GO:1990665;GO:0035578;GO:0005604;GO:0016323;GO:0009986;GO:0062023;GO:0005737;GO:0005768;GO:0070062;GO:0005576;GO:0005615;GO:0031902;GO:0005811;GO:0005765;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:1990667;GO:0005886;GO:0031982;GO:0098641;GO:0005262;GO:0005509;GO:0005544;GO:0048306;GO:0008092;GO:0042802;GO:0005546;GO:0001786;GO:0019834;GO:0002020;GO:0003723;GO:0044548;GO:0004867;GO:0046790;GO:0001525;GO:0052362;GO:0035722;GO:0001765;GO:0052405;GO:0044147;GO:0032804;GO:0043312;GO:0036035;GO:1905581;GO:1905597;GO:1905599;GO:0001921;GO:1905602;GO:0044090;GO:0031340;GO:0006900;GO:0016032;, C:adherens junction; C:AnxA2-p11 complex; C:azurophil granule lumen; C:basement membrane; C:basolateral plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:late endosome membrane; C:lipid droplet; C:lysosomal membrane; C:melanosome; C:membrane; C:midbody; C:nucleus; C:PCSK9-AnxA2 complex; C:plasma membrane; C:vesicle;, F:cadherin binding involved in cell-cell adhesion; F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calcium-dependent protein binding; F:cytoskeletal protein binding; F:identical protein binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:phospholipase A2 inhibitor activity; F:protease binding; F:RNA binding; F:S100 protein binding; F:serine-type endopeptidase inhibitor activity; F:virion binding;, P:angiogenesis; P:catabolism by host of symbiont protein; P:interleukin-12-mediated signaling pathway; P:membrane raft assembly; P:negative regulation by host of symbiont molecular function; P:negative regulation of development of symbiont involved in interaction with host; P:negative regulation of low-density lipoprotein particle receptor catabolic process; P:neutrophil degranulation; P:osteoclast development; P:positive regulation of low-density lipoprotein particle clearance; P:positive regulation of low-density lipoprotein particle receptor binding; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of receptor recycling; P:positive regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of vacuole organization; P:positive regulation of vesicle fusion; P:vesicle budding from membrane; P:viral process;|A6NMY6,Putative annexin A2-like protein,Annexin A2 pseudogene 2;Lipocortin II pseudogene;, PF00191;, GO:0005604;GO:0005737;GO:0070062;GO:0005615;GO:0042470;GO:0005634;GO:0005886;GO:0031982;GO:0005262;GO:0005509;GO:0005544;GO:0008092;GO:0005546;GO:0001786;GO:0019834;GO:0002020;GO:0046790;, C:basement membrane; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:melanosome; C:nucleus; C:plasma membrane; C:vesicle;, F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:cytoskeletal protein binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:phospholipase A2 inhibitor activity; F:protease binding; F:virion binding; scaffold37 indexed_genome mRNA 13540643 13556797 . + . ID=transcript_7596;Q12982 B4DS94,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,, PF12496;PF13716;, GO:0005737;GO:0005829;GO:0043231;GO:0005635;GO:0048471;GO:0005509;GO:0004309;GO:0005096;GO:0006915;GO:0043066;GO:0006798;GO:0051149;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear envelope; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:exopolyphosphatase activity; F:GTPase activator activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:polyphosphate catabolic process; P:positive regulation of muscle cell differentiation;|Q12982 B4DS94,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,, PF12496;PF13716;, GO:0005737;GO:0005829;GO:0043231;GO:0005635;GO:0048471;GO:0005509;GO:0004309;GO:0005096;GO:0006915;GO:0043066;GO:0006798;GO:0051149;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear envelope; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:exopolyphosphatase activity; F:GTPase activator activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:polyphosphate catabolic process; P:positive regulation of muscle cell differentiation;|Q12982 B4DS94,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,, PF12496;PF13716;, GO:0005737;GO:0005829;GO:0043231;GO:0005635;GO:0048471;GO:0005509;GO:0004309;GO:0005096;GO:0006915;GO:0043066;GO:0006798;GO:0051149;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear envelope; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:exopolyphosphatase activity; F:GTPase activator activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:polyphosphate catabolic process; P:positive regulation of muscle cell differentiation; scaffold37 indexed_genome mRNA 13560212 13595268 . + . ID=transcript_7597;P52657 A8MYQ7 Q6FGB5,Transcription initiation factor IIA subunit 2,General transcription factor IIA subunit 2;TFIIA p12 subunit;Transcription initiation factor IIA gamma chain;, PF02751;PF02268;, GO:0030054;GO:0005654;GO:0005672;GO:0005669;GO:0046982;GO:0042803;GO:0016251;GO:0001103;GO:0017025;GO:0008134;GO:0045944;GO:0051123;GO:0042795;GO:0006366;GO:0006367;GO:0016032;, C:cell junction; C:nucleoplasm; C:transcription factor TFIIA complex; C:transcription factor TFIID complex;, F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II repressing transcription factor binding; F:TBP-class protein binding; F:transcription factor binding;, P:positive regulation of transcription by RNA polymerase II; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:viral process;|P52657 A8MYQ7 Q6FGB5,Transcription initiation factor IIA subunit 2,General transcription factor IIA subunit 2;TFIIA p12 subunit;Transcription initiation factor IIA gamma chain;, PF02751;PF02268;, GO:0030054;GO:0005654;GO:0005672;GO:0005669;GO:0046982;GO:0042803;GO:0016251;GO:0001103;GO:0017025;GO:0008134;GO:0045944;GO:0051123;GO:0042795;GO:0006366;GO:0006367;GO:0016032;, C:cell junction; C:nucleoplasm; C:transcription factor TFIIA complex; C:transcription factor TFIID complex;, F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II repressing transcription factor binding; F:TBP-class protein binding; F:transcription factor binding;, P:positive regulation of transcription by RNA polymerase II; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:viral process;|P52657 A8MYQ7 Q6FGB5,Transcription initiation factor IIA subunit 2,General transcription factor IIA subunit 2;TFIIA p12 subunit;Transcription initiation factor IIA gamma chain;, PF02751;PF02268;, GO:0030054;GO:0005654;GO:0005672;GO:0005669;GO:0046982;GO:0042803;GO:0016251;GO:0001103;GO:0017025;GO:0008134;GO:0045944;GO:0051123;GO:0042795;GO:0006366;GO:0006367;GO:0016032;, C:cell junction; C:nucleoplasm; C:transcription factor TFIIA complex; C:transcription factor TFIID complex;, F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II repressing transcription factor binding; F:TBP-class protein binding; F:transcription factor binding;, P:positive regulation of transcription by RNA polymerase II; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:viral process; scaffold37 indexed_genome mRNA 13754149 13812153 . - . ID=transcript_7598;Q8TBF8,Protein FAM81A scaffold37 indexed_genome mRNA 13897934 14121652 . + . ID=transcript_7599;Q12965 Q14778,Unconventional myosin-Ie,Myosin-Ic;Unconventional myosin 1E;, PF00063;PF06017;PF00018;, GO:0015629;GO:0005912;GO:0005903;GO:0030136;GO:0005737;GO:0005856;GO:0070062;GO:0005902;GO:0016459;GO:0005886;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0003774;GO:0035091;GO:0007015;GO:0030048;GO:0006897;GO:0032836;GO:0003094;GO:0072015;GO:0001701;GO:0006807;GO:0048008;GO:0035166;GO:0001570;GO:0030050;, C:actin cytoskeleton; C:adherens junction; C:brush border; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:microvillus; C:myosin complex; C:plasma membrane; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:motor activity; F:phosphatidylinositol binding;, P:actin filament organization; P:actin filament-based movement; P:endocytosis; P:glomerular basement membrane development; P:glomerular filtration; P:glomerular visceral epithelial cell development; P:in utero embryonic development; P:nitrogen compound metabolic process; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic hemopoiesis; P:vasculogenesis; P:vesicle transport along actin filament;|Q12965 Q14778,Unconventional myosin-Ie,Myosin-Ic;Unconventional myosin 1E;, PF00063;PF06017;PF00018;, GO:0015629;GO:0005912;GO:0005903;GO:0030136;GO:0005737;GO:0005856;GO:0070062;GO:0005902;GO:0016459;GO:0005886;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0003774;GO:0035091;GO:0007015;GO:0030048;GO:0006897;GO:0032836;GO:0003094;GO:0072015;GO:0001701;GO:0006807;GO:0048008;GO:0035166;GO:0001570;GO:0030050;, C:actin cytoskeleton; C:adherens junction; C:brush border; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:microvillus; C:myosin complex; C:plasma membrane; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:motor activity; F:phosphatidylinositol binding;, P:actin filament organization; P:actin filament-based movement; P:endocytosis; P:glomerular basement membrane development; P:glomerular filtration; P:glomerular visceral epithelial cell development; P:in utero embryonic development; P:nitrogen compound metabolic process; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic hemopoiesis; P:vasculogenesis; P:vesicle transport along actin filament; scaffold37 indexed_genome mRNA 14129338 14139295 . - . ID=transcript_7600;O95067 B3KM93 Q6FI99,G2/mitotic-specific cyclin-B2,, PF02984;PF00134;, GO:0005813;GO:0000307;GO:0005737;GO:0005829;GO:0016020;GO:0015630;GO:0005634;GO:0045296;GO:0016538;GO:0051301;GO:0000086;GO:0008315;GO:0001701;GO:0044772;GO:0007077;GO:0007084;GO:0051726;GO:0000079;GO:0040008;GO:0007057;GO:0043029;GO:0048538;, C:centrosome; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:membrane; C:microtubule cytoskeleton; C:nucleus;, F:cadherin binding; F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:G2/M transition of mitotic cell cycle; P:G2/MI transition of meiotic cell cycle; P:in utero embryonic development; P:mitotic cell cycle phase transition; P:mitotic nuclear envelope disassembly; P:mitotic nuclear envelope reassembly; P:regulation of cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of growth; P:spindle assembly involved in female meiosis I; P:T cell homeostasis; P:thymus development; scaffold37 indexed_genome mRNA 14170055 14173525 . - . ID=transcript_7601;Q9NSR1,E3 ubiquitin-protein ligase Arkadia {ECO:0000305|PubMed:14657019},RING finger protein 111 {ECO:0000312|HGNC:HGNC:17384};RING-type E3 ubiquitin transferase Arkadia {ECO:0000305};, PF15303;PF13639;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0046872;GO:0046332;GO:0032184;GO:0061630;GO:0070911;GO:0007389;GO:0031398;GO:0045944;GO:0045893;GO:0030511;GO:0000209;GO:0016567;GO:0006511;GO:0030579;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:metal ion binding; F:SMAD binding; F:SUMO polymer binding; F:ubiquitin protein ligase activity;, P:global genome nucleotide-excision repair; P:pattern specification process; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; scaffold37 indexed_genome mRNA 14179797 14251421 . - . ID=transcript_7602;Q9NSR1,E3 ubiquitin-protein ligase Arkadia {ECO:0000305|PubMed:14657019},RING finger protein 111 {ECO:0000312|HGNC:HGNC:17384};RING-type E3 ubiquitin transferase Arkadia {ECO:0000305};, PF15303;PF13639;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0046872;GO:0046332;GO:0032184;GO:0061630;GO:0070911;GO:0007389;GO:0031398;GO:0045944;GO:0045893;GO:0030511;GO:0000209;GO:0016567;GO:0006511;GO:0030579;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:metal ion binding; F:SMAD binding; F:SUMO polymer binding; F:ubiquitin protein ligase activity;, P:global genome nucleotide-excision repair; P:pattern specification process; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process;|Q9NSR1,E3 ubiquitin-protein ligase Arkadia {ECO:0000305|PubMed:14657019},RING finger protein 111 {ECO:0000312|HGNC:HGNC:17384};RING-type E3 ubiquitin transferase Arkadia {ECO:0000305};, PF15303;PF13639;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0046872;GO:0046332;GO:0032184;GO:0061630;GO:0070911;GO:0007389;GO:0031398;GO:0045944;GO:0045893;GO:0030511;GO:0000209;GO:0016567;GO:0006511;GO:0030579;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:metal ion binding; F:SMAD binding; F:SUMO polymer binding; F:ubiquitin protein ligase activity;, P:global genome nucleotide-excision repair; P:pattern specification process; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; scaffold37 indexed_genome mRNA 14276197 14309084 . + . ID=transcript_7603;Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 14314385 14315330 . + . ID=transcript_7604;Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 14317224 14326749 . + . ID=transcript_7605;Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q9H8U9,SAFB-like transcription modulator,Modulator of estrogen-induced transcription;, PF00076;PF02037;, GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0043565;GO:0006915;GO:0050684;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:sequence-specific DNA binding;, P:apoptotic process; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 14334433 14338713 . - . ID=transcript_7606;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold37 indexed_genome mRNA 14340235 14340895 . - . ID=transcript_7607;Q6R2W3 Q2NKL9 Q5SRJ3 Q8TCN2 Q96MV9 Q96PW3,SCAN domain-containing protein 3,Transposon-derived Buster4 transposase-like protein;Zinc finger BED domain-containing protein 9;, PF02023;, GO:0005737;GO:0005634;GO:0003676;GO:0015074;GO:0045787;GO:0050679;, C:cytoplasm; C:nucleus;, F:nucleic acid binding;, P:DNA integration; P:positive regulation of cell cycle; P:positive regulation of epithelial cell proliferation; scaffold37 indexed_genome mRNA 14343347 14418176 . - . ID=transcript_7608;Q8NBR6 B2RTT8 Q9ULQ6,Ubiquitin carboxyl-terminal hydrolase MINDY-2 {ECO:0000303|PubMed:27292798},Deubiquitinating enzyme MINDY-2 {ECO:0000303|PubMed:27292798};Protein FAM63B;, PF04424;, GO:0071944;GO:0005829;GO:0005654;GO:0016807;GO:0071795;GO:0036435;GO:0071796;GO:0070530;GO:1990380;GO:0004843;GO:0071108;, C:cell periphery; C:cytosol; C:nucleoplasm;, F:cysteine-type carboxypeptidase activity; F:K11-linked polyubiquitin modification-dependent protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:K6-linked polyubiquitin modification-dependent protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein K48-linked deubiquitination;|Q8NBR6 B2RTT8 Q9ULQ6,Ubiquitin carboxyl-terminal hydrolase MINDY-2 {ECO:0000303|PubMed:27292798},Deubiquitinating enzyme MINDY-2 {ECO:0000303|PubMed:27292798};Protein FAM63B;, PF04424;, GO:0071944;GO:0005829;GO:0005654;GO:0016807;GO:0071795;GO:0036435;GO:0071796;GO:0070530;GO:1990380;GO:0004843;GO:0071108;, C:cell periphery; C:cytosol; C:nucleoplasm;, F:cysteine-type carboxypeptidase activity; F:K11-linked polyubiquitin modification-dependent protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:K6-linked polyubiquitin modification-dependent protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein K48-linked deubiquitination;|Q8NBR6 B2RTT8 Q9ULQ6,Ubiquitin carboxyl-terminal hydrolase MINDY-2 {ECO:0000303|PubMed:27292798},Deubiquitinating enzyme MINDY-2 {ECO:0000303|PubMed:27292798};Protein FAM63B;, PF04424;, GO:0071944;GO:0005829;GO:0005654;GO:0016807;GO:0071795;GO:0036435;GO:0071796;GO:0070530;GO:1990380;GO:0004843;GO:0071108;, C:cell periphery; C:cytosol; C:nucleoplasm;, F:cysteine-type carboxypeptidase activity; F:K11-linked polyubiquitin modification-dependent protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:K6-linked polyubiquitin modification-dependent protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein K48-linked deubiquitination; scaffold37 indexed_genome mRNA 14418189 14418920 . - . ID=transcript_7609;Q8NBR6 B2RTT8 Q9ULQ6,Ubiquitin carboxyl-terminal hydrolase MINDY-2 {ECO:0000303|PubMed:27292798},Deubiquitinating enzyme MINDY-2 {ECO:0000303|PubMed:27292798};Protein FAM63B;, PF04424;, GO:0071944;GO:0005829;GO:0005654;GO:0016807;GO:0071795;GO:0036435;GO:0071796;GO:0070530;GO:1990380;GO:0004843;GO:0071108;, C:cell periphery; C:cytosol; C:nucleoplasm;, F:cysteine-type carboxypeptidase activity; F:K11-linked polyubiquitin modification-dependent protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:K6-linked polyubiquitin modification-dependent protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein K48-linked deubiquitination; scaffold37 indexed_genome mRNA 14501743 14577687 . + . ID=transcript_7610;O14672 B4DU28 Q10742 Q92650,Disintegrin and metalloproteinase domain-containing protein 10,CDw156;Kuzbanian protein homolog;Mammalian disintegrin-metalloprotease;, PF00200;PF01562;, GO:0005912;GO:0030424;GO:0009986;GO:0030136;GO:0005737;GO:0043197;GO:0005788;GO:0070062;GO:0005925;GO:0098978;GO:0005794;GO:0000139;GO:0005798;GO:0016021;GO:0043231;GO:0016020;GO:0043025;GO:0005634;GO:0097038;GO:0005886;GO:0046930;GO:0014069;GO:0045211;GO:0035579;GO:0097060;GO:0008021;GO:0070821;GO:0097197;GO:0005802;GO:0004175;GO:0005178;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0042803;GO:0019901;GO:0017124;GO:0005102;GO:0034332;GO:1990000;GO:0042987;GO:0034205;GO:0007267;GO:0044267;GO:0090102;GO:0051089;GO:0022617;GO:0001701;GO:0007229;GO:0006509;GO:0042117;GO:0043066;GO:0007162;GO:0071157;GO:0010629;GO:0043312;GO:0035333;GO:0007219;GO:0046931;GO:0043065;GO:0030307;GO:0030335;GO:0008284;GO:0010820;GO:0043687;GO:0099173;GO:0006468;GO:0016485;GO:0061001;GO:0098696;GO:0008593;GO:1901342;GO:0097327;GO:0034612;GO:0007283;GO:1901998;, C:adherens junction; C:axon; C:cell surface; C:clathrin-coated vesicle; C:cytoplasm; C:dendritic spine; C:endoplasmic reticulum lumen; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:neuronal cell body; C:nucleus; C:perinuclear endoplasmic reticulum; C:plasma membrane; C:pore complex; C:postsynaptic density; C:postsynaptic membrane; C:specific granule membrane; C:synaptic membrane; C:synaptic vesicle; C:tertiary granule membrane; C:tetraspanin-enriched microdomain; C:trans-Golgi network;, F:endopeptidase activity; F:integrin binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:protein homodimerization activity; F:protein kinase binding; F:SH3 domain binding; F:signaling receptor binding;, P:adherens junction organization; P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid-beta formation; P:cell-cell signaling; P:cellular protein metabolic process; P:cochlea development; P:constitutive protein ectodomain proteolysis; P:extracellular matrix disassembly; P:in utero embryonic development; P:integrin-mediated signaling pathway; P:membrane protein ectodomain proteolysis; P:monocyte activation; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell cycle arrest; P:negative regulation of gene expression; P:neutrophil degranulation; P:Notch receptor processing, ligand-dependent; P:Notch signaling pathway; P:pore complex assembly; P:positive regulation of apoptotic process; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of T cell chemotaxis; P:post-translational protein modification; P:postsynapse organization; P:protein phosphorylation; P:protein processing; P:regulation of dendritic spine morphogenesis; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:regulation of Notch signaling pathway; P:regulation of vasculature development; P:response to antineoplastic agent; P:response to tumor necrosis factor; P:spermatogenesis; P:toxin transport; scaffold37 indexed_genome mRNA 14595076 14625192 . - . ID=transcript_7611;P11150 A2RUB4 A8K9B6 O43571 P78529 Q99465,Hepatic triacylglycerol lipase,Lipase member C;Lysophospholipase;Phospholipase A1;, PF00151;PF01477;, GO:0005788;GO:0005576;GO:0005615;GO:0034364;GO:0052740;GO:0034185;GO:0008201;GO:0016298;GO:0004465;GO:0030169;GO:0004622;GO:0102545;GO:0052739;GO:0008970;GO:0004620;GO:0004806;GO:0042632;GO:0034382;GO:0006633;GO:0034375;GO:0034373;GO:0016042;GO:0034374;GO:0034638;GO:0051004;GO:0043691;GO:0019433;GO:0070328;GO:0034372;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:apolipoprotein binding; F:heparin binding; F:lipase activity; F:lipoprotein lipase activity; F:low-density lipoprotein particle binding; F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase activity; F:triglyceride lipase activity;, P:cholesterol homeostasis; P:chylomicron remnant clearance; P:fatty acid biosynthetic process; P:high-density lipoprotein particle remodeling; P:intermediate-density lipoprotein particle remodeling; P:lipid catabolic process; P:low-density lipoprotein particle remodeling; P:phosphatidylcholine catabolic process; P:regulation of lipoprotein lipase activity; P:reverse cholesterol transport; P:triglyceride catabolic process; P:triglyceride homeostasis; P:very-low-density lipoprotein particle remodeling;|P11150 A2RUB4 A8K9B6 O43571 P78529 Q99465,Hepatic triacylglycerol lipase,Lipase member C;Lysophospholipase;Phospholipase A1;, PF00151;PF01477;, GO:0005788;GO:0005576;GO:0005615;GO:0034364;GO:0052740;GO:0034185;GO:0008201;GO:0016298;GO:0004465;GO:0030169;GO:0004622;GO:0102545;GO:0052739;GO:0008970;GO:0004620;GO:0004806;GO:0042632;GO:0034382;GO:0006633;GO:0034375;GO:0034373;GO:0016042;GO:0034374;GO:0034638;GO:0051004;GO:0043691;GO:0019433;GO:0070328;GO:0034372;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:apolipoprotein binding; F:heparin binding; F:lipase activity; F:lipoprotein lipase activity; F:low-density lipoprotein particle binding; F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase activity; F:triglyceride lipase activity;, P:cholesterol homeostasis; P:chylomicron remnant clearance; P:fatty acid biosynthetic process; P:high-density lipoprotein particle remodeling; P:intermediate-density lipoprotein particle remodeling; P:lipid catabolic process; P:low-density lipoprotein particle remodeling; P:phosphatidylcholine catabolic process; P:regulation of lipoprotein lipase activity; P:reverse cholesterol transport; P:triglyceride catabolic process; P:triglyceride homeostasis; P:very-low-density lipoprotein particle remodeling;|P11150 A2RUB4 A8K9B6 O43571 P78529 Q99465,Hepatic triacylglycerol lipase,Lipase member C;Lysophospholipase;Phospholipase A1;, PF00151;PF01477;, GO:0005788;GO:0005576;GO:0005615;GO:0034364;GO:0052740;GO:0034185;GO:0008201;GO:0016298;GO:0004465;GO:0030169;GO:0004622;GO:0102545;GO:0052739;GO:0008970;GO:0004620;GO:0004806;GO:0042632;GO:0034382;GO:0006633;GO:0034375;GO:0034373;GO:0016042;GO:0034374;GO:0034638;GO:0051004;GO:0043691;GO:0019433;GO:0070328;GO:0034372;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:apolipoprotein binding; F:heparin binding; F:lipase activity; F:lipoprotein lipase activity; F:low-density lipoprotein particle binding; F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase activity; F:triglyceride lipase activity;, P:cholesterol homeostasis; P:chylomicron remnant clearance; P:fatty acid biosynthetic process; P:high-density lipoprotein particle remodeling; P:intermediate-density lipoprotein particle remodeling; P:lipid catabolic process; P:low-density lipoprotein particle remodeling; P:phosphatidylcholine catabolic process; P:regulation of lipoprotein lipase activity; P:reverse cholesterol transport; P:triglyceride catabolic process; P:triglyceride homeostasis; P:very-low-density lipoprotein particle remodeling; scaffold37 indexed_genome mRNA 14713150 14714154 . - . ID=transcript_7612;Q9Y3D5,28S ribosomal protein S18c, mitochondrial,28S ribosomal protein S18-1, mitochondrial;Mitochondrial small ribosomal subunit protein bS18c {ECO:0000303|PubMed:25838379};Mitochondrial small ribosomal subunit protein bS18m {ECO:0000303|PubMed:25838379};, PF01084;, GO:0005743;GO:0005763;GO:0070181;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit;, F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold37 indexed_genome mRNA 14978945 14981451 . - . ID=transcript_7613;O43315 Q9NP32,Aquaporin-9,Aquaglyceroporin-9;Small solute channel 1;, PF00230;, GO:0016323;GO:0016021;GO:0005887;GO:0043231;GO:0005886;GO:0005275;GO:0046943;GO:0015254;GO:0015166;GO:0005345;GO:0005350;GO:0015265;GO:0015204;GO:0015250;GO:0005372;GO:0015837;GO:0015722;GO:0046942;GO:0071320;GO:0007588;GO:0015793;GO:0015791;GO:0006863;GO:0015855;GO:0046689;GO:0010033;GO:0006970;GO:0071918;GO:0030104;GO:0006833;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:amine transmembrane transporter activity; F:carboxylic acid transmembrane transporter activity; F:glycerol channel activity; F:polyol transmembrane transporter activity; F:purine nucleobase transmembrane transporter activity; F:pyrimidine nucleobase transmembrane transporter activity; F:urea channel activity; F:urea transmembrane transporter activity; F:water channel activity; F:water transmembrane transporter activity;, P:amine transport; P:canalicular bile acid transport; P:carboxylic acid transport; P:cellular response to cAMP; P:excretion; P:glycerol transport; P:polyol transport; P:purine nucleobase transport; P:pyrimidine nucleobase transport; P:response to mercury ion; P:response to organic substance; P:response to osmotic stress; P:urea transmembrane transport; P:water homeostasis; P:water transport; scaffold37 indexed_genome mRNA 14984285 15021895 . - . ID=transcript_7614;O43315 Q9NP32,Aquaporin-9,Aquaglyceroporin-9;Small solute channel 1;, PF00230;, GO:0016323;GO:0016021;GO:0005887;GO:0043231;GO:0005886;GO:0005275;GO:0046943;GO:0015254;GO:0015166;GO:0005345;GO:0005350;GO:0015265;GO:0015204;GO:0015250;GO:0005372;GO:0015837;GO:0015722;GO:0046942;GO:0071320;GO:0007588;GO:0015793;GO:0015791;GO:0006863;GO:0015855;GO:0046689;GO:0010033;GO:0006970;GO:0071918;GO:0030104;GO:0006833;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:amine transmembrane transporter activity; F:carboxylic acid transmembrane transporter activity; F:glycerol channel activity; F:polyol transmembrane transporter activity; F:purine nucleobase transmembrane transporter activity; F:pyrimidine nucleobase transmembrane transporter activity; F:urea channel activity; F:urea transmembrane transporter activity; F:water channel activity; F:water transmembrane transporter activity;, P:amine transport; P:canalicular bile acid transport; P:carboxylic acid transport; P:cellular response to cAMP; P:excretion; P:glycerol transport; P:polyol transport; P:purine nucleobase transport; P:pyrimidine nucleobase transport; P:response to mercury ion; P:response to organic substance; P:response to osmotic stress; P:urea transmembrane transport; P:water homeostasis; P:water transport; scaffold37 indexed_genome mRNA 15091516 15194325 . + . ID=transcript_7615;O94788 B3KY52 B4DZR2 F5H2Y9 H0YM00 Q2PJS6 Q8NHQ4 Q9UBR8 Q9UFY0,Retinal dehydrogenase 2,Aldehyde dehydrogenase family 1 member A2;Retinaldehyde-specific dehydrogenase type 2;, PF00171;, GO:0005737;GO:0005829;GO:0048471;GO:0004028;GO:0004029;GO:0016918;GO:0001758;GO:0042904;GO:0001568;GO:0048738;GO:0071300;GO:0009855;GO:0031076;GO:0048566;GO:0035115;GO:0060324;GO:0003007;GO:0030902;GO:0001822;GO:0001889;GO:0030324;GO:0007494;GO:0016331;GO:0008285;GO:0014032;GO:0021915;GO:0030182;GO:0031016;GO:0021983;GO:0043065;GO:0008284;GO:0010628;GO:0051289;GO:0009954;GO:0001936;GO:0034097;GO:0032355;GO:0033189;GO:0042574;GO:0002138;GO:0042573;GO:0090242;GO:0042572;GO:0035799;GO:0006776;, C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:3-chloroallyl aldehyde dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:retinal binding; F:retinal dehydrogenase activity;, P:9-cis-retinoic acid biosynthetic process; P:blood vessel development; P:cardiac muscle tissue development; P:cellular response to retinoic acid; P:determination of bilateral symmetry; P:embryonic camera-type eye development; P:embryonic digestive tract development; P:embryonic forelimb morphogenesis; P:face development; P:heart morphogenesis; P:hindbrain development; P:kidney development; P:liver development; P:lung development; P:midgut development; P:morphogenesis of embryonic epithelium; P:negative regulation of cell population proliferation; P:neural crest cell development; P:neural tube development; P:neuron differentiation; P:pancreas development; P:pituitary gland development; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:protein homotetramerization; P:proximal/distal pattern formation; P:regulation of endothelial cell proliferation; P:response to cytokine; P:response to estradiol; P:response to vitamin A; P:retinal metabolic process; P:retinoic acid biosynthetic process; P:retinoic acid metabolic process; P:retinoic acid receptor signaling pathway involved in somitogenesis; P:retinol metabolic process; P:ureter maturation; P:vitamin A metabolic process; scaffold37 indexed_genome mRNA 15424310 15431245 . - . ID=transcript_7616;Q96NF5 Q9Y3V6,DNA-directed RNA polymerase II subunit GRINL1A,DNA-directed RNA polymerase II subunit M;Glutamate receptor-like protein 1A;, PF15328;, GO:0043025;GO:0005635;GO:0005665;GO:0016591;GO:0003899;GO:0035556;GO:0051685;, C:neuronal cell body; C:nuclear envelope; C:RNA polymerase II, core complex; C:RNA polymerase II, holoenzyme;, F:DNA-directed 5'-3' RNA polymerase activity;, P:intracellular signal transduction; P:maintenance of ER location; scaffold37 indexed_genome mRNA 15449257 15565018 . - . ID=transcript_7617;Q96JB7 Q96NF5,Myocardial zonula adherens protein,GRINL1A upstream protein;, , GO:0030054;GO:0005856;GO:0031234;GO:0031674;GO:0030018;GO:0035556;, C:cell junction; C:cytoskeleton; C:extrinsic component of cytoplasmic side of plasma membrane; C:I band; C:Z disc;, , P:intracellular signal transduction;|Q96JB7 Q96NF5,Myocardial zonula adherens protein,GRINL1A upstream protein;, , GO:0030054;GO:0005856;GO:0031234;GO:0031674;GO:0030018;GO:0035556;, C:cell junction; C:cytoskeleton; C:extrinsic component of cytoplasmic side of plasma membrane; C:I band; C:Z disc;, , P:intracellular signal transduction;|Q96JB7 Q96NF5,Myocardial zonula adherens protein,GRINL1A upstream protein;, , GO:0030054;GO:0005856;GO:0031234;GO:0031674;GO:0030018;GO:0035556;, C:cell junction; C:cytoskeleton; C:extrinsic component of cytoplasmic side of plasma membrane; C:I band; C:Z disc;, , P:intracellular signal transduction; scaffold37 indexed_genome mRNA 15607142 15717328 . - . ID=transcript_7618;Q0VF96 Q05BZ4 Q52LR0 Q695C7 Q7Z2L3 Q96JV2 Q96MN6 Q9C0B4,Cingulin-like protein 1,Junction-associated coiled-coil protein;Paracingulin;, PF01576;, GO:0005923;GO:0016459;GO:0032991;GO:0007015;GO:0051058;GO:0051497;GO:0150105;, C:bicellular tight junction; C:myosin complex; C:protein-containing complex;, , P:actin filament organization; P:negative regulation of small GTPase mediated signal transduction; P:negative regulation of stress fiber assembly; P:protein localization to cell-cell junction;|Q0VF96 Q05BZ4 Q52LR0 Q695C7 Q7Z2L3 Q96JV2 Q96MN6 Q9C0B4,Cingulin-like protein 1,Junction-associated coiled-coil protein;Paracingulin;, PF01576;, GO:0005923;GO:0016459;GO:0032991;GO:0007015;GO:0051058;GO:0051497;GO:0150105;, C:bicellular tight junction; C:myosin complex; C:protein-containing complex;, , P:actin filament organization; P:negative regulation of small GTPase mediated signal transduction; P:negative regulation of stress fiber assembly; P:protein localization to cell-cell junction; scaffold37 indexed_genome mRNA 15858329 16249452 . - . ID=transcript_7619;Q99081 B4E1W1 Q7Z3D9 Q86TC1 Q86VM2,Transcription factor 12,Class B basic helix-loop-helix protein 20;DNA-binding protein HTF4;E-box-binding protein;Transcription factor HTF-4;, PF00010;, GO:0000785;GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0090575;GO:0005667;GO:0043425;GO:0035497;GO:0000987;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0071837;GO:0046982;GO:0000978;GO:1990837;GO:0046332;GO:0008134;GO:0030154;GO:0006955;GO:0007517;GO:0007399;GO:0045666;GO:0045944;GO:1902036;GO:0006357;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cAMP response element binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:HMG box domain binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SMAD binding; F:transcription factor binding;, P:cell differentiation; P:immune response; P:muscle organ development; P:nervous system development; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II;|Q99081 B4E1W1 Q7Z3D9 Q86TC1 Q86VM2,Transcription factor 12,Class B basic helix-loop-helix protein 20;DNA-binding protein HTF4;E-box-binding protein;Transcription factor HTF-4;, PF00010;, GO:0000785;GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0090575;GO:0005667;GO:0043425;GO:0035497;GO:0000987;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0071837;GO:0046982;GO:0000978;GO:1990837;GO:0046332;GO:0008134;GO:0030154;GO:0006955;GO:0007517;GO:0007399;GO:0045666;GO:0045944;GO:1902036;GO:0006357;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:bHLH transcription factor binding; F:cAMP response element binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:HMG box domain binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SMAD binding; F:transcription factor binding;, P:cell differentiation; P:immune response; P:muscle organ development; P:nervous system development; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 16253295 16254262 . + . ID=transcript_7620;Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold37 indexed_genome mRNA 16495770 16556040 . + . ID=transcript_7621;Q9NXS0,Zinc finger protein 280D,Suppressor of hairy wing homolog 4;Zinc finger protein 634;, PF13836;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q9NXS0,Zinc finger protein 280D,Suppressor of hairy wing homolog 4;Zinc finger protein 634;, PF13836;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q9NXS0,Zinc finger protein 280D,Suppressor of hairy wing homolog 4;Zinc finger protein 634;, PF13836;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q9NXS0,Zinc finger protein 280D,Suppressor of hairy wing homolog 4;Zinc finger protein 634;, PF13836;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold37 indexed_genome mRNA 16566710 16591042 . + . ID=transcript_7622;Q9NXS0,Zinc finger protein 280D,Suppressor of hairy wing homolog 4;Zinc finger protein 634;, PF13836;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold37 indexed_genome mRNA 16696799 16915490 . + . ID=transcript_7623;Q8NEH6 Q8IYT6 Q9NUP4,Meiosis-specific nuclear structural protein 1,, PF13868;, GO:0005930;GO:0005882;GO:0031514;GO:0005635;GO:0036126;GO:0042802;GO:0044782;GO:0070986;GO:0051321;GO:0045724;GO:0007283;, C:axoneme; C:intermediate filament; C:motile cilium; C:nuclear envelope; C:sperm flagellum;, F:identical protein binding;, P:cilium organization; P:left/right axis specification; P:meiotic cell cycle; P:positive regulation of cilium assembly; P:spermatogenesis;|Q8NEH6 Q8IYT6 Q9NUP4,Meiosis-specific nuclear structural protein 1,, PF13868;, GO:0005930;GO:0005882;GO:0031514;GO:0005635;GO:0036126;GO:0042802;GO:0044782;GO:0070986;GO:0051321;GO:0045724;GO:0007283;, C:axoneme; C:intermediate filament; C:motile cilium; C:nuclear envelope; C:sperm flagellum;, F:identical protein binding;, P:cilium organization; P:left/right axis specification; P:meiotic cell cycle; P:positive regulation of cilium assembly; P:spermatogenesis;|Q8N6V9 B4DH73,Testis-expressed protein 9|Q8N6V9 B4DH73,Testis-expressed protein 9 scaffold37 indexed_genome mRNA 16984070 17119962 . + . ID=transcript_7624;Q2KHR2 Q6ZRR1 Q6ZTY6 Q8N3J0 Q9H7A9 Q9H956,DNA-binding protein RFX7,Regulatory factor X 7;Regulatory factor X domain-containing protein 2;, PF02257;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|P83881 P09896 P10661 Q08ES5 Q5J9I6,60S ribosomal protein L36a,60S ribosomal protein L44;Cell growth-inhibiting gene 15 protein;Cell migration-inducing gene 6 protein;Large ribosomal subunit protein eL42 {ECO:0000303|PubMed:24524803};, PF00935;, GO:0005829;GO:0022625;GO:0005783;GO:0005886;GO:0042788;GO:0005840;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:plasma membrane; C:polysomal ribosome; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P83881 P09896 P10661 Q08ES5 Q5J9I6,60S ribosomal protein L36a,60S ribosomal protein L44;Cell growth-inhibiting gene 15 protein;Cell migration-inducing gene 6 protein;Large ribosomal subunit protein eL42 {ECO:0000303|PubMed:24524803};, PF00935;, GO:0005829;GO:0022625;GO:0005783;GO:0005886;GO:0042788;GO:0005840;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:plasma membrane; C:polysomal ribosome; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q2KHR2 Q6ZRR1 Q6ZTY6 Q8N3J0 Q9H7A9 Q9H956,DNA-binding protein RFX7,Regulatory factor X 7;Regulatory factor X domain-containing protein 2;, PF02257;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|Q2KHR2 Q6ZRR1 Q6ZTY6 Q8N3J0 Q9H7A9 Q9H956,DNA-binding protein RFX7,Regulatory factor X 7;Regulatory factor X domain-containing protein 2;, PF02257;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 17554228 17563376 . + . ID=transcript_7625;Q9Y3Y4 A7Y2D6,Pygopus homolog 1,, PF00628;, GO:0005654;GO:0046872;GO:0035064;GO:1904837;GO:0060070;GO:0002244;GO:0001822;GO:0045944;GO:0034504;GO:0007289;, C:nucleoplasm;, F:metal ion binding; F:methylated histone binding;, P:beta-catenin-TCF complex assembly; P:canonical Wnt signaling pathway; P:hematopoietic progenitor cell differentiation; P:kidney development; P:positive regulation of transcription by RNA polymerase II; P:protein localization to nucleus; P:spermatid nucleus differentiation; scaffold37 indexed_genome mRNA 17572311 17632577 . + . ID=transcript_7626;Q8WXU2 Q6P5Y9 Q8N1S6,Dynein assembly factor 4, axonemal {ECO:0000312|HGNC:HGNC:21493},Dyslexia susceptibility 1 candidate gene 1 protein;, PF04969;, GO:0005813;GO:0005737;GO:0005829;GO:0005576;GO:0097730;GO:0005634;GO:0005886;GO:0030331;GO:0003341;GO:0007368;GO:0003351;GO:0007507;GO:0036159;GO:0001764;GO:0036158;GO:0033146;GO:0061136;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular region; C:non-motile cilium; C:nucleus; C:plasma membrane;, F:estrogen receptor binding;, P:cilium movement; P:determination of left/right symmetry; P:epithelial cilium movement involved in extracellular fluid movement; P:heart development; P:inner dynein arm assembly; P:neuron migration; P:outer dynein arm assembly; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of proteasomal protein catabolic process; scaffold37 indexed_genome mRNA 17641588 17642582 . - . ID=transcript_7627;H3BRN8,Uncharacterized protein C15orf65,, PF14892; scaffold37 indexed_genome mRNA 17650379 17674363 . + . ID=transcript_7628;Q9ULG6 A0PJH3 A8K9T0 O14712 Q05DG4 Q5U5S7 Q8IYV8 Q9BY53 Q9HA17,Cell cycle progression protein 1,Cell cycle progression restoration protein 8;, , GO:0016021;GO:0016020;GO:0007049;GO:0045787;GO:0008284;GO:0045944;GO:2001106;, C:integral component of membrane; C:membrane;, , P:cell cycle; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of Rho guanyl-nucleotide exchange factor activity;|Q9ULG6 A0PJH3 A8K9T0 O14712 Q05DG4 Q5U5S7 Q8IYV8 Q9BY53 Q9HA17,Cell cycle progression protein 1,Cell cycle progression restoration protein 8;, , GO:0016021;GO:0016020;GO:0007049;GO:0045787;GO:0008284;GO:0045944;GO:2001106;, C:integral component of membrane; C:membrane;, , P:cell cycle; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of Rho guanyl-nucleotide exchange factor activity;|Q9ULG6 A0PJH3 A8K9T0 O14712 Q05DG4 Q5U5S7 Q8IYV8 Q9BY53 Q9HA17,Cell cycle progression protein 1,Cell cycle progression restoration protein 8;, , GO:0016021;GO:0016020;GO:0007049;GO:0045787;GO:0008284;GO:0045944;GO:2001106;, C:integral component of membrane; C:membrane;, , P:cell cycle; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of Rho guanyl-nucleotide exchange factor activity; scaffold37 indexed_genome mRNA 17676516 17678277 . + . ID=transcript_7629;Q9ULG6 A0PJH3 A8K9T0 O14712 Q05DG4 Q5U5S7 Q8IYV8 Q9BY53 Q9HA17,Cell cycle progression protein 1,Cell cycle progression restoration protein 8;, , GO:0016021;GO:0016020;GO:0007049;GO:0045787;GO:0008284;GO:0045944;GO:2001106;, C:integral component of membrane; C:membrane;, , P:cell cycle; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of Rho guanyl-nucleotide exchange factor activity;|Q9ULG6 A0PJH3 A8K9T0 O14712 Q05DG4 Q5U5S7 Q8IYV8 Q9BY53 Q9HA17,Cell cycle progression protein 1,Cell cycle progression restoration protein 8;, , GO:0016021;GO:0016020;GO:0007049;GO:0045787;GO:0008284;GO:0045944;GO:2001106;, C:integral component of membrane; C:membrane;, , P:cell cycle; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of Rho guanyl-nucleotide exchange factor activity; scaffold37 indexed_genome mRNA 17678284 17718816 . - . ID=transcript_7630;Q9ULG6 A0PJH3 A8K9T0 O14712 Q05DG4 Q5U5S7 Q8IYV8 Q9BY53 Q9HA17,Cell cycle progression protein 1,Cell cycle progression restoration protein 8;, , GO:0016021;GO:0016020;GO:0007049;GO:0045787;GO:0008284;GO:0045944;GO:2001106;, C:integral component of membrane; C:membrane;, , P:cell cycle; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of Rho guanyl-nucleotide exchange factor activity;|Q9ULG6 A0PJH3 A8K9T0 O14712 Q05DG4 Q5U5S7 Q8IYV8 Q9BY53 Q9HA17,Cell cycle progression protein 1,Cell cycle progression restoration protein 8;, , GO:0016021;GO:0016020;GO:0007049;GO:0045787;GO:0008284;GO:0045944;GO:2001106;, C:integral component of membrane; C:membrane;, , P:cell cycle; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of Rho guanyl-nucleotide exchange factor activity;|Q92521 Q53FF9 Q8WVN7,GPI mannosyltransferase 3 {ECO:0000305},GPI mannosyltransferase III;Phosphatidylinositol-glycan biosynthesis class B protein;, PF03901;, GO:0005789;GO:0016021;GO:0000026;GO:0004376;GO:0000030;GO:0006506;GO:0097502;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,2-mannosyltransferase activity; F:glycolipid mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:mannosylation; P:preassembly of GPI anchor in ER membrane;|Q92521 Q53FF9 Q8WVN7,GPI mannosyltransferase 3 {ECO:0000305},GPI mannosyltransferase III;Phosphatidylinositol-glycan biosynthesis class B protein;, PF03901;, GO:0005789;GO:0016021;GO:0000026;GO:0004376;GO:0000030;GO:0006506;GO:0097502;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,2-mannosyltransferase activity; F:glycolipid mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:mannosylation; P:preassembly of GPI anchor in ER membrane;|Q92521 Q53FF9 Q8WVN7,GPI mannosyltransferase 3 {ECO:0000305},GPI mannosyltransferase III;Phosphatidylinositol-glycan biosynthesis class B protein;, PF03901;, GO:0005789;GO:0016021;GO:0000026;GO:0004376;GO:0000030;GO:0006506;GO:0097502;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,2-mannosyltransferase activity; F:glycolipid mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:mannosylation; P:preassembly of GPI anchor in ER membrane;|Q92521 Q53FF9 Q8WVN7,GPI mannosyltransferase 3 {ECO:0000305},GPI mannosyltransferase III;Phosphatidylinositol-glycan biosynthesis class B protein;, PF03901;, GO:0005789;GO:0016021;GO:0000026;GO:0004376;GO:0000030;GO:0006506;GO:0097502;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,2-mannosyltransferase activity; F:glycolipid mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:mannosylation; P:preassembly of GPI anchor in ER membrane;|Q92521 Q53FF9 Q8WVN7,GPI mannosyltransferase 3 {ECO:0000305},GPI mannosyltransferase III;Phosphatidylinositol-glycan biosynthesis class B protein;, PF03901;, GO:0005789;GO:0016021;GO:0000026;GO:0004376;GO:0000030;GO:0006506;GO:0097502;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,2-mannosyltransferase activity; F:glycolipid mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:mannosylation; P:preassembly of GPI anchor in ER membrane; scaffold37 indexed_genome mRNA 17728212 17799279 . + . ID=transcript_7631;P51159 O00195 Q6FI40 Q9UIR9 Q9Y5U3,Ras-related protein Rab-27A,GTP-binding protein Ram;, PF00071;, GO:0016324;GO:0005829;GO:0030425;GO:0070382;GO:0070062;GO:0005576;GO:0005794;GO:0005770;GO:0005764;GO:0042470;GO:0033162;GO:0032585;GO:0001750;GO:0030141;GO:0030667;GO:0035580;GO:0033093;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019904;GO:0019882;GO:0007596;GO:0097278;GO:0043316;GO:0006887;GO:1990182;GO:0030318;GO:0032400;GO:0032402;GO:0036257;GO:0071985;GO:0043320;GO:0043312;GO:1903435;GO:0045921;GO:0010628;GO:0050766;GO:1903428;GO:1903307;GO:0006605;GO:0048489;, C:apical plasma membrane; C:cytosol; C:dendrite; C:exocytic vesicle; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:late endosome; C:lysosome; C:melanosome; C:melanosome membrane; C:multivesicular body membrane; C:photoreceptor outer segment; C:secretory granule; C:secretory granule membrane; C:specific granule lumen; C:Weibel-Palade body;, F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding; F:protein domain specific binding;, P:antigen processing and presentation; P:blood coagulation; P:complement-dependent cytotoxicity; P:cytotoxic T cell degranulation; P:exocytosis; P:exosomal secretion; P:melanocyte differentiation; P:melanosome localization; P:melanosome transport; P:multivesicular body organization; P:multivesicular body sorting pathway; P:natural killer cell degranulation; P:neutrophil degranulation; P:positive regulation of constitutive secretory pathway; P:positive regulation of exocytosis; P:positive regulation of gene expression; P:positive regulation of phagocytosis; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of regulated secretory pathway; P:protein targeting; P:synaptic vesicle transport;|P51159 O00195 Q6FI40 Q9UIR9 Q9Y5U3,Ras-related protein Rab-27A,GTP-binding protein Ram;, PF00071;, GO:0016324;GO:0005829;GO:0030425;GO:0070382;GO:0070062;GO:0005576;GO:0005794;GO:0005770;GO:0005764;GO:0042470;GO:0033162;GO:0032585;GO:0001750;GO:0030141;GO:0030667;GO:0035580;GO:0033093;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019904;GO:0019882;GO:0007596;GO:0097278;GO:0043316;GO:0006887;GO:1990182;GO:0030318;GO:0032400;GO:0032402;GO:0036257;GO:0071985;GO:0043320;GO:0043312;GO:1903435;GO:0045921;GO:0010628;GO:0050766;GO:1903428;GO:1903307;GO:0006605;GO:0048489;, C:apical plasma membrane; C:cytosol; C:dendrite; C:exocytic vesicle; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:late endosome; C:lysosome; C:melanosome; C:melanosome membrane; C:multivesicular body membrane; C:photoreceptor outer segment; C:secretory granule; C:secretory granule membrane; C:specific granule lumen; C:Weibel-Palade body;, F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding; F:protein domain specific binding;, P:antigen processing and presentation; P:blood coagulation; P:complement-dependent cytotoxicity; P:cytotoxic T cell degranulation; P:exocytosis; P:exosomal secretion; P:melanocyte differentiation; P:melanosome localization; P:melanosome transport; P:multivesicular body organization; P:multivesicular body sorting pathway; P:natural killer cell degranulation; P:neutrophil degranulation; P:positive regulation of constitutive secretory pathway; P:positive regulation of exocytosis; P:positive regulation of gene expression; P:positive regulation of phagocytosis; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of regulated secretory pathway; P:protein targeting; P:synaptic vesicle transport; scaffold37 indexed_genome mRNA 17809091 17810587 . - . ID=transcript_7632;P51159 O00195 Q6FI40 Q9UIR9 Q9Y5U3,Ras-related protein Rab-27A,GTP-binding protein Ram;, PF00071;, GO:0016324;GO:0005829;GO:0030425;GO:0070382;GO:0070062;GO:0005576;GO:0005794;GO:0005770;GO:0005764;GO:0042470;GO:0033162;GO:0032585;GO:0001750;GO:0030141;GO:0030667;GO:0035580;GO:0033093;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019904;GO:0019882;GO:0007596;GO:0097278;GO:0043316;GO:0006887;GO:1990182;GO:0030318;GO:0032400;GO:0032402;GO:0036257;GO:0071985;GO:0043320;GO:0043312;GO:1903435;GO:0045921;GO:0010628;GO:0050766;GO:1903428;GO:1903307;GO:0006605;GO:0048489;, C:apical plasma membrane; C:cytosol; C:dendrite; C:exocytic vesicle; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:late endosome; C:lysosome; C:melanosome; C:melanosome membrane; C:multivesicular body membrane; C:photoreceptor outer segment; C:secretory granule; C:secretory granule membrane; C:specific granule lumen; C:Weibel-Palade body;, F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding; F:protein domain specific binding;, P:antigen processing and presentation; P:blood coagulation; P:complement-dependent cytotoxicity; P:cytotoxic T cell degranulation; P:exocytosis; P:exosomal secretion; P:melanocyte differentiation; P:melanosome localization; P:melanosome transport; P:multivesicular body organization; P:multivesicular body sorting pathway; P:natural killer cell degranulation; P:neutrophil degranulation; P:positive regulation of constitutive secretory pathway; P:positive regulation of exocytosis; P:positive regulation of gene expression; P:positive regulation of phagocytosis; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of regulated secretory pathway; P:protein targeting; P:synaptic vesicle transport; scaffold37 indexed_genome mRNA 17817214 17830662 . + . ID=transcript_7633;Q9UHA3 B2RD72 Q561V8 Q8N6S8 Q96B04 Q96C76 Q96HJ1,Probable ribosome biogenesis protein RLP24,Ribosomal L24 domain-containing protein 1;Ribosomal protein L24-like;, PF01246;, GO:0022625;GO:0005730;GO:0005654;GO:0003723;GO:0003735;GO:1902626;GO:0000027;GO:0006412;, C:cytosolic large ribosomal subunit; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:assembly of large subunit precursor of preribosome; P:ribosomal large subunit assembly; P:translation;|Q9UHA3 B2RD72 Q561V8 Q8N6S8 Q96B04 Q96C76 Q96HJ1,Probable ribosome biogenesis protein RLP24,Ribosomal L24 domain-containing protein 1;Ribosomal protein L24-like;, PF01246;, GO:0022625;GO:0005730;GO:0005654;GO:0003723;GO:0003735;GO:1902626;GO:0000027;GO:0006412;, C:cytosolic large ribosomal subunit; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:assembly of large subunit precursor of preribosome; P:ribosomal large subunit assembly; P:translation;|Q9UHA3 B2RD72 Q561V8 Q8N6S8 Q96B04 Q96C76 Q96HJ1,Probable ribosome biogenesis protein RLP24,Ribosomal L24 domain-containing protein 1;Ribosomal protein L24-like;, PF01246;, GO:0022625;GO:0005730;GO:0005654;GO:0003723;GO:0003735;GO:1902626;GO:0000027;GO:0006412;, C:cytosolic large ribosomal subunit; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:assembly of large subunit precursor of preribosome; P:ribosomal large subunit assembly; P:translation; scaffold37 indexed_genome mRNA 18306954 18951930 . - . ID=transcript_7634;Q8NB66 Q0P613 Q8ND48 Q96NP3,Protein unc-13 homolog C,Munc13-3;, PF00130;PF00168;PF06292;PF10540;, GO:0044305;GO:0031594;GO:0098688;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0005543;GO:0017075;GO:0007268;GO:0061789;GO:0035556;GO:0031914;GO:0007528;GO:0099525;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:calyx of Held; C:neuromuscular junction; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:phospholipid binding; F:syntaxin-1 binding;, P:chemical synaptic transmission; P:dense core granule priming; P:intracellular signal transduction; P:negative regulation of synaptic plasticity; P:neuromuscular junction development; P:presynaptic dense core vesicle exocytosis; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|Q8NB66 Q0P613 Q8ND48 Q96NP3,Protein unc-13 homolog C,Munc13-3;, PF00130;PF00168;PF06292;PF10540;, GO:0044305;GO:0031594;GO:0098688;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0005543;GO:0017075;GO:0007268;GO:0061789;GO:0035556;GO:0031914;GO:0007528;GO:0099525;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:calyx of Held; C:neuromuscular junction; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:phospholipid binding; F:syntaxin-1 binding;, P:chemical synaptic transmission; P:dense core granule priming; P:intracellular signal transduction; P:negative regulation of synaptic plasticity; P:neuromuscular junction development; P:presynaptic dense core vesicle exocytosis; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|Q8NB66 Q0P613 Q8ND48 Q96NP3,Protein unc-13 homolog C,Munc13-3;, PF00130;PF00168;PF06292;PF10540;, GO:0044305;GO:0031594;GO:0098688;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0005543;GO:0017075;GO:0007268;GO:0061789;GO:0035556;GO:0031914;GO:0007528;GO:0099525;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:calyx of Held; C:neuromuscular junction; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:phospholipid binding; F:syntaxin-1 binding;, P:chemical synaptic transmission; P:dense core granule priming; P:intracellular signal transduction; P:negative regulation of synaptic plasticity; P:neuromuscular junction development; P:presynaptic dense core vesicle exocytosis; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming; scaffold37 indexed_genome mRNA 20147929 20148438 . + . ID=transcript_7635;Q9UBC0 B2RTV4 Q99744 Q9UMR6,Hepatocyte nuclear factor 6,One cut domain family member 1;One cut homeobox 1;, PF02376;PF00046;, GO:0000785;GO:0005634;GO:0003682;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0009653;GO:0030183;GO:0045165;GO:0060271;GO:0031018;GO:0007492;GO:0002064;GO:0006006;GO:0001889;GO:0030512;GO:0007219;GO:0030335;GO:0045944;GO:0001952;GO:0006357;GO:0006355;GO:0048536;, C:chromatin; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure morphogenesis; P:B cell differentiation; P:cell fate commitment; P:cilium assembly; P:endocrine pancreas development; P:endoderm development; P:epithelial cell development; P:glucose metabolic process; P:liver development; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:Notch signaling pathway; P:positive regulation of cell migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell-matrix adhesion; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spleen development; scaffold37 indexed_genome mRNA 20148448 20182287 . - . ID=transcript_7636;Q9UBC0 B2RTV4 Q99744 Q9UMR6,Hepatocyte nuclear factor 6,One cut domain family member 1;One cut homeobox 1;, PF02376;PF00046;, GO:0000785;GO:0005634;GO:0003682;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0009653;GO:0030183;GO:0045165;GO:0060271;GO:0031018;GO:0007492;GO:0002064;GO:0006006;GO:0001889;GO:0030512;GO:0007219;GO:0030335;GO:0045944;GO:0001952;GO:0006357;GO:0006355;GO:0048536;, C:chromatin; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure morphogenesis; P:B cell differentiation; P:cell fate commitment; P:cilium assembly; P:endocrine pancreas development; P:endoderm development; P:epithelial cell development; P:glucose metabolic process; P:liver development; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:Notch signaling pathway; P:positive regulation of cell migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell-matrix adhesion; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spleen development; scaffold37 indexed_genome mRNA 20278561 20337725 . + . ID=transcript_7637;Q9NV24 Q9P2H7,Protein FAM214A,, PF13889;PF13915;|Q9NV24 Q9P2H7,Protein FAM214A,, PF13889;PF13915;|Q9NV24 Q9P2H7,Protein FAM214A,, PF13889;PF13915;|Q9NV24 Q9P2H7,Protein FAM214A,, PF13889;PF13915;|Q9NV24 Q9P2H7,Protein FAM214A,, PF13889;PF13915;|Q9NV24 Q9P2H7,Protein FAM214A,, PF13889;PF13915; scaffold37 indexed_genome mRNA 20359729 20371461 . + . ID=transcript_7638;P56211 B2R497 Q6IAM2 Q86TA6 Q9UD70,cAMP-regulated phosphoprotein 19,, PF04667;, GO:0005737;GO:0005654;GO:0019212;GO:0015459;GO:0051721;GO:0004864;GO:0019888;GO:0005102;GO:0051301;GO:0000086;GO:0000278;GO:0035308;GO:0045722;GO:0046326;, C:cytoplasm; C:nucleoplasm;, F:phosphatase inhibitor activity; F:potassium channel regulator activity; F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity; F:signaling receptor binding;, P:cell division; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of protein dephosphorylation; P:positive regulation of gluconeogenesis; P:positive regulation of glucose import;|P56211 B2R497 Q6IAM2 Q86TA6 Q9UD70,cAMP-regulated phosphoprotein 19,, PF04667;, GO:0005737;GO:0005654;GO:0019212;GO:0015459;GO:0051721;GO:0004864;GO:0019888;GO:0005102;GO:0051301;GO:0000086;GO:0000278;GO:0035308;GO:0045722;GO:0046326;, C:cytoplasm; C:nucleoplasm;, F:phosphatase inhibitor activity; F:potassium channel regulator activity; F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity; F:signaling receptor binding;, P:cell division; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of protein dephosphorylation; P:positive regulation of gluconeogenesis; P:positive regulation of glucose import; scaffold37 indexed_genome mRNA 20455060 20583565 . + . ID=transcript_7639;Q9Y4I1 A8MZC5 O60653 Q07902 Q16249 Q9UE30 Q9UE31,Unconventional myosin-Va,Dilute myosin heavy chain, non-muscle;Myosin heavy chain 12;Myosin-12;Myoxin;, PF01843;PF00612;PF00063;, GO:0015629;GO:0005737;GO:0005829;GO:0070062;GO:0032433;GO:0030426;GO:0032593;GO:0042470;GO:0016020;GO:0016459;GO:0043005;GO:0001726;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0003723;GO:0031267;GO:0007015;GO:0030048;GO:0032869;GO:0032402;GO:0006892;GO:0072659;GO:0015031;GO:0030050;GO:0016192;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:filopodium tip; C:growth cone; C:insulin-responsive compartment; C:melanosome; C:membrane; C:myosin complex; C:neuron projection; C:ruffle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:RNA binding; F:small GTPase binding;, P:actin filament organization; P:actin filament-based movement; P:cellular response to insulin stimulus; P:melanosome transport; P:post-Golgi vesicle-mediated transport; P:protein localization to plasma membrane; P:protein transport; P:vesicle transport along actin filament; P:vesicle-mediated transport; scaffold37 indexed_genome mRNA 20590811 20631486 . + . ID=transcript_7640;Q9NQX4 Q6P1W8,Unconventional myosin-Vc,, PF01843;PF00612;PF00063;, GO:0015629;GO:0005737;GO:0070062;GO:0016459;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:vesicle transport along actin filament; scaffold37 indexed_genome mRNA 20631496 20647153 . + . ID=transcript_7641;Q9NQX4 Q6P1W8,Unconventional myosin-Vc,, PF01843;PF00612;PF00063;, GO:0015629;GO:0005737;GO:0070062;GO:0016459;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:vesicle transport along actin filament;|Q92954 Q6DNC4 Q6DNC5 Q6ZMZ5 Q9BX49,Proteoglycan 4,Lubricin;Megakaryocyte-stimulating factor;Superficial zone proteoglycan;, PF00045;PF01033;, GO:0062023;GO:0005576;GO:0030247;GO:0005044;GO:0006955;, C:collagen-containing extracellular matrix; C:extracellular region;, F:polysaccharide binding; F:scavenger receptor activity;, P:immune response; scaffold37 indexed_genome mRNA 20647191 20704126 . + . ID=transcript_7642;Q9NQX4 Q6P1W8,Unconventional myosin-Vc,, PF01843;PF00612;PF00063;, GO:0015629;GO:0005737;GO:0070062;GO:0016459;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:vesicle transport along actin filament; scaffold37 indexed_genome mRNA 20728451 20738589 . + . ID=transcript_7643;O14775 B2RBR5 Q9HAU9 Q9UFT3,Guanine nucleotide-binding protein subunit beta-5,Gbeta5;Transducin beta chain 5;, PF00400;, GO:0005737;GO:0005829;GO:1902773;GO:0005834;GO:0005634;GO:0098793;GO:0051087;GO:0031682;GO:0005096;GO:0003924;GO:0007212;GO:0007186;GO:1901386;GO:0043547;GO:0006457;GO:0007165;, C:cytoplasm; C:cytosol; C:GTPase activator complex; C:heterotrimeric G-protein complex; C:nucleus; C:presynapse;, F:chaperone binding; F:G-protein gamma-subunit binding; F:GTPase activator activity; F:GTPase activity;, P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of voltage-gated calcium channel activity; P:positive regulation of GTPase activity; P:protein folding; P:signal transduction;|O14775 B2RBR5 Q9HAU9 Q9UFT3,Guanine nucleotide-binding protein subunit beta-5,Gbeta5;Transducin beta chain 5;, PF00400;, GO:0005737;GO:0005829;GO:1902773;GO:0005834;GO:0005634;GO:0098793;GO:0051087;GO:0031682;GO:0005096;GO:0003924;GO:0007212;GO:0007186;GO:1901386;GO:0043547;GO:0006457;GO:0007165;, C:cytoplasm; C:cytosol; C:GTPase activator complex; C:heterotrimeric G-protein complex; C:nucleus; C:presynapse;, F:chaperone binding; F:G-protein gamma-subunit binding; F:GTPase activator activity; F:GTPase activity;, P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of voltage-gated calcium channel activity; P:positive regulation of GTPase activity; P:protein folding; P:signal transduction; scaffold37 indexed_genome mRNA 20738612 20750248 . + . ID=transcript_7644;O14775 B2RBR5 Q9HAU9 Q9UFT3,Guanine nucleotide-binding protein subunit beta-5,Gbeta5;Transducin beta chain 5;, PF00400;, GO:0005737;GO:0005829;GO:1902773;GO:0005834;GO:0005634;GO:0098793;GO:0051087;GO:0031682;GO:0005096;GO:0003924;GO:0007212;GO:0007186;GO:1901386;GO:0043547;GO:0006457;GO:0007165;, C:cytoplasm; C:cytosol; C:GTPase activator complex; C:heterotrimeric G-protein complex; C:nucleus; C:presynapse;, F:chaperone binding; F:G-protein gamma-subunit binding; F:GTPase activator activity; F:GTPase activity;, P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of voltage-gated calcium channel activity; P:positive regulation of GTPase activity; P:protein folding; P:signal transduction;|O14775 B2RBR5 Q9HAU9 Q9UFT3,Guanine nucleotide-binding protein subunit beta-5,Gbeta5;Transducin beta chain 5;, PF00400;, GO:0005737;GO:0005829;GO:1902773;GO:0005834;GO:0005634;GO:0098793;GO:0051087;GO:0031682;GO:0005096;GO:0003924;GO:0007212;GO:0007186;GO:1901386;GO:0043547;GO:0006457;GO:0007165;, C:cytoplasm; C:cytosol; C:GTPase activator complex; C:heterotrimeric G-protein complex; C:nucleus; C:presynapse;, F:chaperone binding; F:G-protein gamma-subunit binding; F:GTPase activator activity; F:GTPase activity;, P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of voltage-gated calcium channel activity; P:positive regulation of GTPase activity; P:protein folding; P:signal transduction;|O14775 B2RBR5 Q9HAU9 Q9UFT3,Guanine nucleotide-binding protein subunit beta-5,Gbeta5;Transducin beta chain 5;, PF00400;, GO:0005737;GO:0005829;GO:1902773;GO:0005834;GO:0005634;GO:0098793;GO:0051087;GO:0031682;GO:0005096;GO:0003924;GO:0007212;GO:0007186;GO:1901386;GO:0043547;GO:0006457;GO:0007165;, C:cytoplasm; C:cytosol; C:GTPase activator complex; C:heterotrimeric G-protein complex; C:nucleus; C:presynapse;, F:chaperone binding; F:G-protein gamma-subunit binding; F:GTPase activator activity; F:GTPase activity;, P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of voltage-gated calcium channel activity; P:positive regulation of GTPase activity; P:protein folding; P:signal transduction;|O14775 B2RBR5 Q9HAU9 Q9UFT3,Guanine nucleotide-binding protein subunit beta-5,Gbeta5;Transducin beta chain 5;, PF00400;, GO:0005737;GO:0005829;GO:1902773;GO:0005834;GO:0005634;GO:0098793;GO:0051087;GO:0031682;GO:0005096;GO:0003924;GO:0007212;GO:0007186;GO:1901386;GO:0043547;GO:0006457;GO:0007165;, C:cytoplasm; C:cytosol; C:GTPase activator complex; C:heterotrimeric G-protein complex; C:nucleus; C:presynapse;, F:chaperone binding; F:G-protein gamma-subunit binding; F:GTPase activator activity; F:GTPase activity;, P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of voltage-gated calcium channel activity; P:positive regulation of GTPase activity; P:protein folding; P:signal transduction;|O14775 B2RBR5 Q9HAU9 Q9UFT3,Guanine nucleotide-binding protein subunit beta-5,Gbeta5;Transducin beta chain 5;, PF00400;, GO:0005737;GO:0005829;GO:1902773;GO:0005834;GO:0005634;GO:0098793;GO:0051087;GO:0031682;GO:0005096;GO:0003924;GO:0007212;GO:0007186;GO:1901386;GO:0043547;GO:0006457;GO:0007165;, C:cytoplasm; C:cytosol; C:GTPase activator complex; C:heterotrimeric G-protein complex; C:nucleus; C:presynapse;, F:chaperone binding; F:G-protein gamma-subunit binding; F:GTPase activator activity; F:GTPase activity;, P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of voltage-gated calcium channel activity; P:positive regulation of GTPase activity; P:protein folding; P:signal transduction; scaffold37 indexed_genome mRNA 20753003 20762448 . + . ID=transcript_7645;Q9HD36 Q3SX80 Q52LQ9 Q8TCS9,Bcl-2-like protein 10,Anti-apoptotic protein NrH;Apoptosis regulator Bcl-B;, PF00452;, GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0044233;GO:0005741;GO:0005739;GO:0031965;GO:0089720;GO:0046982;GO:0042803;GO:0006919;GO:0006915;GO:0097192;GO:0007292;GO:0008630;GO:0043066;GO:2001243;GO:0007283;, C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear membrane;, F:caspase binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:extrinsic apoptotic signaling pathway in absence of ligand; P:female gamete generation; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway; P:spermatogenesis; scaffold37 indexed_genome mRNA 20863898 20865363 . + . ID=transcript_7646;Q16659 B2R945 B5BU65 Q68DH4 Q8IYN8,Mitogen-activated protein kinase 6,Extracellular signal-regulated kinase 3;MAP kinase isoform p97;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0035556;GO:0006468;GO:0010468;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:intracellular signal transduction; P:protein phosphorylation; P:regulation of gene expression; P:signal transduction; scaffold37 indexed_genome mRNA 20865365 20875579 . - . ID=transcript_7647;Q16659 B2R945 B5BU65 Q68DH4 Q8IYN8,Mitogen-activated protein kinase 6,Extracellular signal-regulated kinase 3;MAP kinase isoform p97;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0035556;GO:0006468;GO:0010468;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:intracellular signal transduction; P:protein phosphorylation; P:regulation of gene expression; P:signal transduction; scaffold37 indexed_genome mRNA 20937335 20970434 . + . ID=transcript_7648;Q8WVC0 Q96N99,RNA polymerase-associated protein LEO1,Replicative senescence down-regulated leo1-like protein;, PF04004;, GO:0016593;GO:0005813;GO:0001650;GO:0005654;GO:0005634;GO:1990269;GO:1904837;GO:0001711;GO:0033523;GO:0010390;GO:0006378;GO:0045638;GO:0031442;GO:0032968;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:centrosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:RNA polymerase II C-terminal domain phosphoserine binding;, P:beta-catenin-TCF complex assembly; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone monoubiquitination; P:mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of mRNA 3'-end processing; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q8WVC0 Q96N99,RNA polymerase-associated protein LEO1,Replicative senescence down-regulated leo1-like protein;, PF04004;, GO:0016593;GO:0005813;GO:0001650;GO:0005654;GO:0005634;GO:1990269;GO:1904837;GO:0001711;GO:0033523;GO:0010390;GO:0006378;GO:0045638;GO:0031442;GO:0032968;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:centrosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:RNA polymerase II C-terminal domain phosphoserine binding;, P:beta-catenin-TCF complex assembly; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone monoubiquitination; P:mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of mRNA 3'-end processing; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q8WVC0 Q96N99,RNA polymerase-associated protein LEO1,Replicative senescence down-regulated leo1-like protein;, PF04004;, GO:0016593;GO:0005813;GO:0001650;GO:0005654;GO:0005634;GO:1990269;GO:1904837;GO:0001711;GO:0033523;GO:0010390;GO:0006378;GO:0045638;GO:0031442;GO:0032968;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:centrosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:RNA polymerase II C-terminal domain phosphoserine binding;, P:beta-catenin-TCF complex assembly; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone monoubiquitination; P:mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of mRNA 3'-end processing; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway; scaffold37 indexed_genome mRNA 20974991 20976980 . + . ID=transcript_7649;Q8WVC0 Q96N99,RNA polymerase-associated protein LEO1,Replicative senescence down-regulated leo1-like protein;, PF04004;, GO:0016593;GO:0005813;GO:0001650;GO:0005654;GO:0005634;GO:1990269;GO:1904837;GO:0001711;GO:0033523;GO:0010390;GO:0006378;GO:0045638;GO:0031442;GO:0032968;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:centrosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:RNA polymerase II C-terminal domain phosphoserine binding;, P:beta-catenin-TCF complex assembly; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone monoubiquitination; P:mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of mRNA 3'-end processing; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q8WVC0 Q96N99,RNA polymerase-associated protein LEO1,Replicative senescence down-regulated leo1-like protein;, PF04004;, GO:0016593;GO:0005813;GO:0001650;GO:0005654;GO:0005634;GO:1990269;GO:1904837;GO:0001711;GO:0033523;GO:0010390;GO:0006378;GO:0045638;GO:0031442;GO:0032968;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:centrosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:RNA polymerase II C-terminal domain phosphoserine binding;, P:beta-catenin-TCF complex assembly; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone monoubiquitination; P:mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of mRNA 3'-end processing; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway; scaffold37 indexed_genome mRNA 20977613 21003073 . - . ID=transcript_7650;Q9NYL9 B2R6G7 Q9NT43 Q9NZR0,Tropomodulin-3,Ubiquitous tropomodulin;, PF03250;, GO:0005912;GO:0005856;GO:0030016;GO:0005865;GO:0003779;GO:0098641;GO:0005523;GO:0007015;GO:0048821;GO:0006936;GO:0030239;GO:0051694;GO:1901992;, C:adherens junction; C:cytoskeleton; C:myofibril; C:striated muscle thin filament;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:tropomyosin binding;, P:actin filament organization; P:erythrocyte development; P:muscle contraction; P:myofibril assembly; P:pointed-end actin filament capping; P:positive regulation of mitotic cell cycle phase transition; scaffold37 indexed_genome mRNA 21004694 21071373 . - . ID=transcript_7651;Q9NYL9 B2R6G7 Q9NT43 Q9NZR0,Tropomodulin-3,Ubiquitous tropomodulin;, PF03250;, GO:0005912;GO:0005856;GO:0030016;GO:0005865;GO:0003779;GO:0098641;GO:0005523;GO:0007015;GO:0048821;GO:0006936;GO:0030239;GO:0051694;GO:1901992;, C:adherens junction; C:cytoskeleton; C:myofibril; C:striated muscle thin filament;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:tropomyosin binding;, P:actin filament organization; P:erythrocyte development; P:muscle contraction; P:myofibril assembly; P:pointed-end actin filament capping; P:positive regulation of mitotic cell cycle phase transition;|Q9NX37 Q9P033 Q9ULX0,Inorganic pyrophosphatase 2, mitochondrial,Pyrophosphatase SID6-306;Pyrophosphate phospho-hydrolase 2;, PF00719;, GO:0005829;GO:0005759;GO:0004427;GO:0000287;GO:0004722;GO:0071344;GO:0006796;GO:0051881;GO:0006418;, C:cytosol; C:mitochondrial matrix;, F:inorganic diphosphatase activity; F:magnesium ion binding; F:protein serine/threonine phosphatase activity;, P:diphosphate metabolic process; P:phosphate-containing compound metabolic process; P:regulation of mitochondrial membrane potential; P:tRNA aminoacylation for protein translation;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold37 indexed_genome mRNA 21084296 21119596 . - . ID=transcript_7652;Q9NZR1 B4DEW6,Tropomodulin-2,Neuronal tropomodulin;, PF03250;, GO:0005856;GO:0030426;GO:0030016;GO:0005865;GO:0045202;GO:0003779;GO:0005523;GO:0007015;GO:0007611;GO:0006936;GO:0030239;GO:0007399;GO:0007270;GO:0051694;GO:0045745;, C:cytoskeleton; C:growth cone; C:myofibril; C:striated muscle thin filament; C:synapse;, F:actin binding; F:tropomyosin binding;, P:actin filament organization; P:learning or memory; P:muscle contraction; P:myofibril assembly; P:nervous system development; P:neuron-neuron synaptic transmission; P:pointed-end actin filament capping; P:positive regulation of G protein-coupled receptor signaling pathway;|Q9NZR1 B4DEW6,Tropomodulin-2,Neuronal tropomodulin;, PF03250;, GO:0005856;GO:0030426;GO:0030016;GO:0005865;GO:0045202;GO:0003779;GO:0005523;GO:0007015;GO:0007611;GO:0006936;GO:0030239;GO:0007399;GO:0007270;GO:0051694;GO:0045745;, C:cytoskeleton; C:growth cone; C:myofibril; C:striated muscle thin filament; C:synapse;, F:actin binding; F:tropomyosin binding;, P:actin filament organization; P:learning or memory; P:muscle contraction; P:myofibril assembly; P:nervous system development; P:neuron-neuron synaptic transmission; P:pointed-end actin filament capping; P:positive regulation of G protein-coupled receptor signaling pathway; scaffold37 indexed_genome mRNA 21169358 21172345 . + . ID=transcript_7653;Q8IV50 Q5CZ88 Q8WTV3,LysM and putative peptidoglycan-binding domain-containing protein 2,, PF01476; scaffold37 indexed_genome mRNA 21172397 21175947 . + . ID=transcript_7654;Q8IV50 Q5CZ88 Q8WTV3,LysM and putative peptidoglycan-binding domain-containing protein 2,, PF01476;|Q8IV50 Q5CZ88 Q8WTV3,LysM and putative peptidoglycan-binding domain-containing protein 2,, PF01476; scaffold37 indexed_genome mRNA 21178013 21216866 . - . ID=transcript_7655;Q8WXD2 A8K2B0 B3KQP6 B4DK99 F5H3R8 Q96C83 Q96GE8 Q9Y6G7,Secretogranin-3,Secretogranin III;, PF15467;, GO:0005788;GO:0005576;GO:0034774;GO:0030667;GO:0030658;GO:0003723;GO:0044267;GO:0002576;GO:0043687;GO:0033366;, C:endoplasmic reticulum lumen; C:extracellular region; C:secretory granule lumen; C:secretory granule membrane; C:transport vesicle membrane;, F:RNA binding;, P:cellular protein metabolic process; P:platelet degranulation; P:post-translational protein modification; P:protein localization to secretory granule;|Q8WXD2 A8K2B0 B3KQP6 B4DK99 F5H3R8 Q96C83 Q96GE8 Q9Y6G7,Secretogranin-3,Secretogranin III;, PF15467;, GO:0005788;GO:0005576;GO:0034774;GO:0030667;GO:0030658;GO:0003723;GO:0044267;GO:0002576;GO:0043687;GO:0033366;, C:endoplasmic reticulum lumen; C:extracellular region; C:secretory granule lumen; C:secretory granule membrane; C:transport vesicle membrane;, F:RNA binding;, P:cellular protein metabolic process; P:platelet degranulation; P:post-translational protein modification; P:protein localization to secretory granule;|Q8WXD2 A8K2B0 B3KQP6 B4DK99 F5H3R8 Q96C83 Q96GE8 Q9Y6G7,Secretogranin-3,Secretogranin III;, PF15467;, GO:0005788;GO:0005576;GO:0034774;GO:0030667;GO:0030658;GO:0003723;GO:0044267;GO:0002576;GO:0043687;GO:0033366;, C:endoplasmic reticulum lumen; C:extracellular region; C:secretory granule lumen; C:secretory granule membrane; C:transport vesicle membrane;, F:RNA binding;, P:cellular protein metabolic process; P:platelet degranulation; P:post-translational protein modification; P:protein localization to secretory granule;|Q8WXD2 A8K2B0 B3KQP6 B4DK99 F5H3R8 Q96C83 Q96GE8 Q9Y6G7,Secretogranin-3,Secretogranin III;, PF15467;, GO:0005788;GO:0005576;GO:0034774;GO:0030667;GO:0030658;GO:0003723;GO:0044267;GO:0002576;GO:0043687;GO:0033366;, C:endoplasmic reticulum lumen; C:extracellular region; C:secretory granule lumen; C:secretory granule membrane; C:transport vesicle membrane;, F:RNA binding;, P:cellular protein metabolic process; P:platelet degranulation; P:post-translational protein modification; P:protein localization to secretory granule;|Q8WXD2 A8K2B0 B3KQP6 B4DK99 F5H3R8 Q96C83 Q96GE8 Q9Y6G7,Secretogranin-3,Secretogranin III;, PF15467;, GO:0005788;GO:0005576;GO:0034774;GO:0030667;GO:0030658;GO:0003723;GO:0044267;GO:0002576;GO:0043687;GO:0033366;, C:endoplasmic reticulum lumen; C:extracellular region; C:secretory granule lumen; C:secretory granule membrane; C:transport vesicle membrane;, F:RNA binding;, P:cellular protein metabolic process; P:platelet degranulation; P:post-translational protein modification; P:protein localization to secretory granule;|Q8WXD2 A8K2B0 B3KQP6 B4DK99 F5H3R8 Q96C83 Q96GE8 Q9Y6G7,Secretogranin-3,Secretogranin III;, PF15467;, GO:0005788;GO:0005576;GO:0034774;GO:0030667;GO:0030658;GO:0003723;GO:0044267;GO:0002576;GO:0043687;GO:0033366;, C:endoplasmic reticulum lumen; C:extracellular region; C:secretory granule lumen; C:secretory granule membrane; C:transport vesicle membrane;, F:RNA binding;, P:cellular protein metabolic process; P:platelet degranulation; P:post-translational protein modification; P:protein localization to secretory granule;|Q8WXD2 A8K2B0 B3KQP6 B4DK99 F5H3R8 Q96C83 Q96GE8 Q9Y6G7,Secretogranin-3,Secretogranin III;, PF15467;, GO:0005788;GO:0005576;GO:0034774;GO:0030667;GO:0030658;GO:0003723;GO:0044267;GO:0002576;GO:0043687;GO:0033366;, C:endoplasmic reticulum lumen; C:extracellular region; C:secretory granule lumen; C:secretory granule membrane; C:transport vesicle membrane;, F:RNA binding;, P:cellular protein metabolic process; P:platelet degranulation; P:post-translational protein modification; P:protein localization to secretory granule; scaffold37 indexed_genome mRNA 21268501 21444667 . + . ID=transcript_7656;Q8TDJ6 B2RTR3 B7ZMH3 F5GWF1 O94938,DmX-like protein 2,Rabconnectin-3;, PF12234;PF00400;, GO:0005615;GO:0098992;GO:0043291;GO:0008021;GO:0030672;GO:0031267;GO:0007035;, C:extracellular space; C:neuronal dense core vesicle; C:RAVE complex; C:synaptic vesicle; C:synaptic vesicle membrane;, F:small GTPase binding;, P:vacuolar acidification;|Q8TDJ6 B2RTR3 B7ZMH3 F5GWF1 O94938,DmX-like protein 2,Rabconnectin-3;, PF12234;PF00400;, GO:0005615;GO:0098992;GO:0043291;GO:0008021;GO:0030672;GO:0031267;GO:0007035;, C:extracellular space; C:neuronal dense core vesicle; C:RAVE complex; C:synaptic vesicle; C:synaptic vesicle membrane;, F:small GTPase binding;, P:vacuolar acidification;|Q8TDJ6 B2RTR3 B7ZMH3 F5GWF1 O94938,DmX-like protein 2,Rabconnectin-3;, PF12234;PF00400;, GO:0005615;GO:0098992;GO:0043291;GO:0008021;GO:0030672;GO:0031267;GO:0007035;, C:extracellular space; C:neuronal dense core vesicle; C:RAVE complex; C:synaptic vesicle; C:synaptic vesicle membrane;, F:small GTPase binding;, P:vacuolar acidification;|Q8TDJ6 B2RTR3 B7ZMH3 F5GWF1 O94938,DmX-like protein 2,Rabconnectin-3;, PF12234;PF00400;, GO:0005615;GO:0098992;GO:0043291;GO:0008021;GO:0030672;GO:0031267;GO:0007035;, C:extracellular space; C:neuronal dense core vesicle; C:RAVE complex; C:synaptic vesicle; C:synaptic vesicle membrane;, F:small GTPase binding;, P:vacuolar acidification;|Q8TDJ6 B2RTR3 B7ZMH3 F5GWF1 O94938,DmX-like protein 2,Rabconnectin-3;, PF12234;PF00400;, GO:0005615;GO:0098992;GO:0043291;GO:0008021;GO:0030672;GO:0031267;GO:0007035;, C:extracellular space; C:neuronal dense core vesicle; C:RAVE complex; C:synaptic vesicle; C:synaptic vesicle membrane;, F:small GTPase binding;, P:vacuolar acidification;|Q8TDJ6 B2RTR3 B7ZMH3 F5GWF1 O94938,DmX-like protein 2,Rabconnectin-3;, PF12234;PF00400;, GO:0005615;GO:0098992;GO:0043291;GO:0008021;GO:0030672;GO:0031267;GO:0007035;, C:extracellular space; C:neuronal dense core vesicle; C:RAVE complex; C:synaptic vesicle; C:synaptic vesicle membrane;, F:small GTPase binding;, P:vacuolar acidification;|Q8TDJ6 B2RTR3 B7ZMH3 F5GWF1 O94938,DmX-like protein 2,Rabconnectin-3;, PF12234;PF00400;, GO:0005615;GO:0098992;GO:0043291;GO:0008021;GO:0030672;GO:0031267;GO:0007035;, C:extracellular space; C:neuronal dense core vesicle; C:RAVE complex; C:synaptic vesicle; C:synaptic vesicle membrane;, F:small GTPase binding;, P:vacuolar acidification;|Q8TDJ6 B2RTR3 B7ZMH3 F5GWF1 O94938,DmX-like protein 2,Rabconnectin-3;, PF12234;PF00400;, GO:0005615;GO:0098992;GO:0043291;GO:0008021;GO:0030672;GO:0031267;GO:0007035;, C:extracellular space; C:neuronal dense core vesicle; C:RAVE complex; C:synaptic vesicle; C:synaptic vesicle membrane;, F:small GTPase binding;, P:vacuolar acidification;|Q8TDJ6 B2RTR3 B7ZMH3 F5GWF1 O94938,DmX-like protein 2,Rabconnectin-3;, PF12234;PF00400;, GO:0005615;GO:0098992;GO:0043291;GO:0008021;GO:0030672;GO:0031267;GO:0007035;, C:extracellular space; C:neuronal dense core vesicle; C:RAVE complex; C:synaptic vesicle; C:synaptic vesicle membrane;, F:small GTPase binding;, P:vacuolar acidification;|Q8TDJ6 B2RTR3 B7ZMH3 F5GWF1 O94938,DmX-like protein 2,Rabconnectin-3;, PF12234;PF00400;, GO:0005615;GO:0098992;GO:0043291;GO:0008021;GO:0030672;GO:0031267;GO:0007035;, C:extracellular space; C:neuronal dense core vesicle; C:RAVE complex; C:synaptic vesicle; C:synaptic vesicle membrane;, F:small GTPase binding;, P:vacuolar acidification; scaffold37 indexed_genome mRNA 21476290 21476852 . + . ID=transcript_7657;Q96DJ0,TAR DNA-binding protein 43,, PF00076;PF18694;, GO:0010494;GO:0035061;GO:0016607;GO:0005654;GO:0005634;GO:0005726;GO:0003690;GO:0042802;GO:0003730;GO:0097157;GO:0003723;GO:0000978;GO:0061158;GO:0070935;GO:0006397;GO:0043922;GO:0010629;GO:0001933;GO:0071765;GO:0032024;GO:0042307;GO:0042981;GO:0051726;GO:0042752;GO:0010468;GO:0031647;GO:0034976;GO:0048511;GO:0008380;, C:cytoplasmic stress granule; C:interchromatin granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perichromatin fibrils;, F:double-stranded DNA binding; F:identical protein binding; F:mRNA 3'-UTR binding; F:pre-mRNA intronic binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:3'-UTR-mediated mRNA stabilization; P:mRNA processing; P:negative regulation by host of viral transcription; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:nuclear inner membrane organization; P:positive regulation of insulin secretion; P:positive regulation of protein import into nucleus; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:rhythmic process; P:RNA splicing; scaffold37 indexed_genome mRNA 21483171 21491556 . - . ID=transcript_7658;Q6ZMI3 Q6UXZ7 Q7Z359,Gliomedin,, PF01391;PF02191;, GO:0030424;GO:0009986;GO:0005581;GO:0005615;GO:0016021;GO:0005886;GO:0086080;GO:0045162;GO:0032528;, C:axon; C:cell surface; C:collagen trimer; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:protein binding involved in heterotypic cell-cell adhesion;, P:clustering of voltage-gated sodium channels; P:microvillus organization; scaffold37 indexed_genome mRNA 21496300 21521139 . - . ID=transcript_7659;Q6ZMI3 Q6UXZ7 Q7Z359,Gliomedin,, PF01391;PF02191;, GO:0030424;GO:0009986;GO:0005581;GO:0005615;GO:0016021;GO:0005886;GO:0086080;GO:0045162;GO:0032528;, C:axon; C:cell surface; C:collagen trimer; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:protein binding involved in heterotypic cell-cell adhesion;, P:clustering of voltage-gated sodium channels; P:microvillus organization; scaffold37 indexed_genome mRNA 21945605 21988850 . + . ID=transcript_7660;Q5GJ75 Q6ZWD1,Tumor necrosis factor alpha-induced protein 8-like protein 3,, PF05527;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0035091;GO:0008526;GO:0048017;GO:0006644;GO:0015914;GO:0070374;GO:0043552;GO:0051897;GO:0042981;GO:0019216;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:inositol lipid-mediated signaling; P:phospholipid metabolic process; P:phospholipid transport; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase B signaling; P:regulation of apoptotic process; P:regulation of lipid metabolic process; scaffold37 indexed_genome mRNA 22016987 22113344 . - . ID=transcript_7661;Q9UPM8 A0AVD6 A1L4A9 A6NNX7 H0YKX4 Q68D31 Q9Y588,AP-4 complex subunit epsilon-1 {ECO:0000305},AP-4 adaptor complex subunit epsilon;Adaptor-related protein complex 4 subunit epsilon-1;Epsilon subunit of AP-4;Epsilon-adaptin;, PF01602;PF14807;, GO:0030124;GO:0031904;GO:0032588;GO:0140312;GO:0006892;GO:0008104;GO:0006605;GO:0006898;, C:AP-4 adaptor complex; C:endosome lumen; C:trans-Golgi network membrane;, F:cargo adaptor activity;, P:post-Golgi vesicle-mediated transport; P:protein localization; P:protein targeting; P:receptor-mediated endocytosis;|Q9UPM8 A0AVD6 A1L4A9 A6NNX7 H0YKX4 Q68D31 Q9Y588,AP-4 complex subunit epsilon-1 {ECO:0000305},AP-4 adaptor complex subunit epsilon;Adaptor-related protein complex 4 subunit epsilon-1;Epsilon subunit of AP-4;Epsilon-adaptin;, PF01602;PF14807;, GO:0030124;GO:0031904;GO:0032588;GO:0140312;GO:0006892;GO:0008104;GO:0006605;GO:0006898;, C:AP-4 adaptor complex; C:endosome lumen; C:trans-Golgi network membrane;, F:cargo adaptor activity;, P:post-Golgi vesicle-mediated transport; P:protein localization; P:protein targeting; P:receptor-mediated endocytosis;|Q9UPM8 A0AVD6 A1L4A9 A6NNX7 H0YKX4 Q68D31 Q9Y588,AP-4 complex subunit epsilon-1 {ECO:0000305},AP-4 adaptor complex subunit epsilon;Adaptor-related protein complex 4 subunit epsilon-1;Epsilon subunit of AP-4;Epsilon-adaptin;, PF01602;PF14807;, GO:0030124;GO:0031904;GO:0032588;GO:0140312;GO:0006892;GO:0008104;GO:0006605;GO:0006898;, C:AP-4 adaptor complex; C:endosome lumen; C:trans-Golgi network membrane;, F:cargo adaptor activity;, P:post-Golgi vesicle-mediated transport; P:protein localization; P:protein targeting; P:receptor-mediated endocytosis;|Q9UPM8 A0AVD6 A1L4A9 A6NNX7 H0YKX4 Q68D31 Q9Y588,AP-4 complex subunit epsilon-1 {ECO:0000305},AP-4 adaptor complex subunit epsilon;Adaptor-related protein complex 4 subunit epsilon-1;Epsilon subunit of AP-4;Epsilon-adaptin;, PF01602;PF14807;, GO:0030124;GO:0031904;GO:0032588;GO:0140312;GO:0006892;GO:0008104;GO:0006605;GO:0006898;, C:AP-4 adaptor complex; C:endosome lumen; C:trans-Golgi network membrane;, F:cargo adaptor activity;, P:post-Golgi vesicle-mediated transport; P:protein localization; P:protein targeting; P:receptor-mediated endocytosis; scaffold37 indexed_genome mRNA 22133848 22462432 . - . ID=transcript_7662;P40818 B4DKA8 Q2TB31 Q7Z3U2 Q86VA0 Q8IWI7,Ubiquitin carboxyl-terminal hydrolase 8 {ECO:0000305},Deubiquitinating enzyme 8;Ubiquitin isopeptidase Y;Ubiquitin thioesterase 8;Ubiquitin-specific-processing protease 8;, PF00581;PF00443;PF08969;, GO:0005737;GO:0005829;GO:0043197;GO:0005769;GO:0031313;GO:0019897;GO:0098978;GO:0030496;GO:0005634;GO:0014069;GO:0045296;GO:0004197;GO:0017124;GO:0004843;GO:0071549;GO:1990090;GO:0007032;GO:0000281;GO:0090263;GO:0016579;GO:0071108;GO:0070536;GO:0007265;GO:0099576;GO:0032880;GO:0031647;GO:0006511;, C:cytoplasm; C:cytosol; C:dendritic spine; C:early endosome; C:extrinsic component of endosome membrane; C:extrinsic component of plasma membrane; C:glutamatergic synapse; C:midbody; C:nucleus; C:postsynaptic density;, F:cadherin binding; F:cysteine-type endopeptidase activity; F:SH3 domain binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular response to dexamethasone stimulus; P:cellular response to nerve growth factor stimulus; P:endosome organization; P:mitotic cytokinesis; P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:Ras protein signal transduction; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:regulation of protein localization; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q8TCT8 B2RDS0 Q8TAW1 Q96SZ8,Signal peptide peptidase-like 2A {ECO:0000303|PubMed:15385547, ECO:0000312|HGNC:HGNC:30227},Intramembrane protease 3 {ECO:0000303|PubMed:12139484};Presenilin-like protein 2;, PF02225;PF04258;, GO:0070062;GO:0030660;GO:0071458;GO:0071556;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0016020;GO:0005886;GO:0042500;GO:0042803;GO:0006509;GO:0031293;GO:0033619;GO:0050776;GO:0010803;, C:extracellular exosome; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:membrane protein proteolysis; P:regulation of immune response; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8TCT8 B2RDS0 Q8TAW1 Q96SZ8,Signal peptide peptidase-like 2A {ECO:0000303|PubMed:15385547, ECO:0000312|HGNC:HGNC:30227},Intramembrane protease 3 {ECO:0000303|PubMed:12139484};Presenilin-like protein 2;, PF02225;PF04258;, GO:0070062;GO:0030660;GO:0071458;GO:0071556;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0016020;GO:0005886;GO:0042500;GO:0042803;GO:0006509;GO:0031293;GO:0033619;GO:0050776;GO:0010803;, C:extracellular exosome; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:membrane protein proteolysis; P:regulation of immune response; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8TCT8 B2RDS0 Q8TAW1 Q96SZ8,Signal peptide peptidase-like 2A {ECO:0000303|PubMed:15385547, ECO:0000312|HGNC:HGNC:30227},Intramembrane protease 3 {ECO:0000303|PubMed:12139484};Presenilin-like protein 2;, PF02225;PF04258;, GO:0070062;GO:0030660;GO:0071458;GO:0071556;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0016020;GO:0005886;GO:0042500;GO:0042803;GO:0006509;GO:0031293;GO:0033619;GO:0050776;GO:0010803;, C:extracellular exosome; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:membrane protein proteolysis; P:regulation of immune response; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8TCT8 B2RDS0 Q8TAW1 Q96SZ8,Signal peptide peptidase-like 2A {ECO:0000303|PubMed:15385547, ECO:0000312|HGNC:HGNC:30227},Intramembrane protease 3 {ECO:0000303|PubMed:12139484};Presenilin-like protein 2;, PF02225;PF04258;, GO:0070062;GO:0030660;GO:0071458;GO:0071556;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0016020;GO:0005886;GO:0042500;GO:0042803;GO:0006509;GO:0031293;GO:0033619;GO:0050776;GO:0010803;, C:extracellular exosome; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:membrane protein proteolysis; P:regulation of immune response; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q96QT4 Q6ZMF5 Q86VJ4 Q8NBW2 Q9BXB2 Q9NXQ2,Transient receptor potential cation channel subfamily M member 7,Channel-kinase 1;Long transient receptor potential channel 7;, PF02816;PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0001726;GO:0003779;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0017022;GO:0106310;GO:0106311;GO:0031032;GO:0070588;GO:0006816;GO:0016340;GO:0098655;GO:0010961;GO:0072507;GO:0030001;GO:0070266;GO:0046777;GO:0051262;, C:integral component of plasma membrane; C:plasma membrane; C:ruffle;, F:actin binding; F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:myosin binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actomyosin structure organization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-matrix adhesion; P:cation transmembrane transport; P:cellular magnesium ion homeostasis; P:divalent inorganic cation homeostasis; P:metal ion transport; P:necroptotic process; P:protein autophosphorylation; P:protein tetramerization;|Q96QT4 Q6ZMF5 Q86VJ4 Q8NBW2 Q9BXB2 Q9NXQ2,Transient receptor potential cation channel subfamily M member 7,Channel-kinase 1;Long transient receptor potential channel 7;, PF02816;PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0001726;GO:0003779;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0017022;GO:0106310;GO:0106311;GO:0031032;GO:0070588;GO:0006816;GO:0016340;GO:0098655;GO:0010961;GO:0072507;GO:0030001;GO:0070266;GO:0046777;GO:0051262;, C:integral component of plasma membrane; C:plasma membrane; C:ruffle;, F:actin binding; F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:myosin binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actomyosin structure organization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-matrix adhesion; P:cation transmembrane transport; P:cellular magnesium ion homeostasis; P:divalent inorganic cation homeostasis; P:metal ion transport; P:necroptotic process; P:protein autophosphorylation; P:protein tetramerization;|Q96QT4 Q6ZMF5 Q86VJ4 Q8NBW2 Q9BXB2 Q9NXQ2,Transient receptor potential cation channel subfamily M member 7,Channel-kinase 1;Long transient receptor potential channel 7;, PF02816;PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0001726;GO:0003779;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0017022;GO:0106310;GO:0106311;GO:0031032;GO:0070588;GO:0006816;GO:0016340;GO:0098655;GO:0010961;GO:0072507;GO:0030001;GO:0070266;GO:0046777;GO:0051262;, C:integral component of plasma membrane; C:plasma membrane; C:ruffle;, F:actin binding; F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:myosin binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actomyosin structure organization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-matrix adhesion; P:cation transmembrane transport; P:cellular magnesium ion homeostasis; P:divalent inorganic cation homeostasis; P:metal ion transport; P:necroptotic process; P:protein autophosphorylation; P:protein tetramerization;|Q96QT4 Q6ZMF5 Q86VJ4 Q8NBW2 Q9BXB2 Q9NXQ2,Transient receptor potential cation channel subfamily M member 7,Channel-kinase 1;Long transient receptor potential channel 7;, PF02816;PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0001726;GO:0003779;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0017022;GO:0106310;GO:0106311;GO:0031032;GO:0070588;GO:0006816;GO:0016340;GO:0098655;GO:0010961;GO:0072507;GO:0030001;GO:0070266;GO:0046777;GO:0051262;, C:integral component of plasma membrane; C:plasma membrane; C:ruffle;, F:actin binding; F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:myosin binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actomyosin structure organization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-matrix adhesion; P:cation transmembrane transport; P:cellular magnesium ion homeostasis; P:divalent inorganic cation homeostasis; P:metal ion transport; P:necroptotic process; P:protein autophosphorylation; P:protein tetramerization;|Q96QT4 Q6ZMF5 Q86VJ4 Q8NBW2 Q9BXB2 Q9NXQ2,Transient receptor potential cation channel subfamily M member 7,Channel-kinase 1;Long transient receptor potential channel 7;, PF02816;PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0001726;GO:0003779;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0017022;GO:0106310;GO:0106311;GO:0031032;GO:0070588;GO:0006816;GO:0016340;GO:0098655;GO:0010961;GO:0072507;GO:0030001;GO:0070266;GO:0046777;GO:0051262;, C:integral component of plasma membrane; C:plasma membrane; C:ruffle;, F:actin binding; F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:myosin binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actomyosin structure organization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-matrix adhesion; P:cation transmembrane transport; P:cellular magnesium ion homeostasis; P:divalent inorganic cation homeostasis; P:metal ion transport; P:necroptotic process; P:protein autophosphorylation; P:protein tetramerization;|Q96QT4 Q6ZMF5 Q86VJ4 Q8NBW2 Q9BXB2 Q9NXQ2,Transient receptor potential cation channel subfamily M member 7,Channel-kinase 1;Long transient receptor potential channel 7;, PF02816;PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0001726;GO:0003779;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0017022;GO:0106310;GO:0106311;GO:0031032;GO:0070588;GO:0006816;GO:0016340;GO:0098655;GO:0010961;GO:0072507;GO:0030001;GO:0070266;GO:0046777;GO:0051262;, C:integral component of plasma membrane; C:plasma membrane; C:ruffle;, F:actin binding; F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:myosin binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actomyosin structure organization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-matrix adhesion; P:cation transmembrane transport; P:cellular magnesium ion homeostasis; P:divalent inorganic cation homeostasis; P:metal ion transport; P:necroptotic process; P:protein autophosphorylation; P:protein tetramerization;|Q96QT4 Q6ZMF5 Q86VJ4 Q8NBW2 Q9BXB2 Q9NXQ2,Transient receptor potential cation channel subfamily M member 7,Channel-kinase 1;Long transient receptor potential channel 7;, PF02816;PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0001726;GO:0003779;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0017022;GO:0106310;GO:0106311;GO:0031032;GO:0070588;GO:0006816;GO:0016340;GO:0098655;GO:0010961;GO:0072507;GO:0030001;GO:0070266;GO:0046777;GO:0051262;, C:integral component of plasma membrane; C:plasma membrane; C:ruffle;, F:actin binding; F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:myosin binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actomyosin structure organization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-matrix adhesion; P:cation transmembrane transport; P:cellular magnesium ion homeostasis; P:divalent inorganic cation homeostasis; P:metal ion transport; P:necroptotic process; P:protein autophosphorylation; P:protein tetramerization;|Q96QT4 Q6ZMF5 Q86VJ4 Q8NBW2 Q9BXB2 Q9NXQ2,Transient receptor potential cation channel subfamily M member 7,Channel-kinase 1;Long transient receptor potential channel 7;, PF02816;PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0001726;GO:0003779;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0017022;GO:0106310;GO:0106311;GO:0031032;GO:0070588;GO:0006816;GO:0016340;GO:0098655;GO:0010961;GO:0072507;GO:0030001;GO:0070266;GO:0046777;GO:0051262;, C:integral component of plasma membrane; C:plasma membrane; C:ruffle;, F:actin binding; F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:myosin binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actomyosin structure organization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-matrix adhesion; P:cation transmembrane transport; P:cellular magnesium ion homeostasis; P:divalent inorganic cation homeostasis; P:metal ion transport; P:necroptotic process; P:protein autophosphorylation; P:protein tetramerization;|Q96QT4 Q6ZMF5 Q86VJ4 Q8NBW2 Q9BXB2 Q9NXQ2,Transient receptor potential cation channel subfamily M member 7,Channel-kinase 1;Long transient receptor potential channel 7;, PF02816;PF00520;PF18139;PF16519;, GO:0005887;GO:0005886;GO:0001726;GO:0003779;GO:0005524;GO:0005262;GO:0005261;GO:0046872;GO:0017022;GO:0106310;GO:0106311;GO:0031032;GO:0070588;GO:0006816;GO:0016340;GO:0098655;GO:0010961;GO:0072507;GO:0030001;GO:0070266;GO:0046777;GO:0051262;, C:integral component of plasma membrane; C:plasma membrane; C:ruffle;, F:actin binding; F:ATP binding; F:calcium channel activity; F:cation channel activity; F:metal ion binding; F:myosin binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:actomyosin structure organization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-matrix adhesion; P:cation transmembrane transport; P:cellular magnesium ion homeostasis; P:divalent inorganic cation homeostasis; P:metal ion transport; P:necroptotic process; P:protein autophosphorylation; P:protein tetramerization;|Q70EL4 A6NDT9 B7ZLT9 B7ZVX5 Q8N2C5 Q96DQ6,Ubiquitin carboxyl-terminal hydrolase 43,Deubiquitinating enzyme 43;Ubiquitin thioesterase 43;Ubiquitin-specific-processing protease 43;, PF00443;, GO:0005654;GO:0008234;GO:0004843;GO:0016579;GO:0019985;GO:0006511;, C:nucleoplasm;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process;|P40818 B4DKA8 Q2TB31 Q7Z3U2 Q86VA0 Q8IWI7,Ubiquitin carboxyl-terminal hydrolase 8 {ECO:0000305},Deubiquitinating enzyme 8;Ubiquitin isopeptidase Y;Ubiquitin thioesterase 8;Ubiquitin-specific-processing protease 8;, PF00581;PF00443;PF08969;, GO:0005737;GO:0005829;GO:0043197;GO:0005769;GO:0031313;GO:0019897;GO:0098978;GO:0030496;GO:0005634;GO:0014069;GO:0045296;GO:0004197;GO:0017124;GO:0004843;GO:0071549;GO:1990090;GO:0007032;GO:0000281;GO:0090263;GO:0016579;GO:0071108;GO:0070536;GO:0007265;GO:0099576;GO:0032880;GO:0031647;GO:0006511;, C:cytoplasm; C:cytosol; C:dendritic spine; C:early endosome; C:extrinsic component of endosome membrane; C:extrinsic component of plasma membrane; C:glutamatergic synapse; C:midbody; C:nucleus; C:postsynaptic density;, F:cadherin binding; F:cysteine-type endopeptidase activity; F:SH3 domain binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular response to dexamethasone stimulus; P:cellular response to nerve growth factor stimulus; P:endosome organization; P:mitotic cytokinesis; P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:Ras protein signal transduction; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:regulation of protein localization; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|P40818 B4DKA8 Q2TB31 Q7Z3U2 Q86VA0 Q8IWI7,Ubiquitin carboxyl-terminal hydrolase 8 {ECO:0000305},Deubiquitinating enzyme 8;Ubiquitin isopeptidase Y;Ubiquitin thioesterase 8;Ubiquitin-specific-processing protease 8;, PF00581;PF00443;PF08969;, GO:0005737;GO:0005829;GO:0043197;GO:0005769;GO:0031313;GO:0019897;GO:0098978;GO:0030496;GO:0005634;GO:0014069;GO:0045296;GO:0004197;GO:0017124;GO:0004843;GO:0071549;GO:1990090;GO:0007032;GO:0000281;GO:0090263;GO:0016579;GO:0071108;GO:0070536;GO:0007265;GO:0099576;GO:0032880;GO:0031647;GO:0006511;, C:cytoplasm; C:cytosol; C:dendritic spine; C:early endosome; C:extrinsic component of endosome membrane; C:extrinsic component of plasma membrane; C:glutamatergic synapse; C:midbody; C:nucleus; C:postsynaptic density;, F:cadherin binding; F:cysteine-type endopeptidase activity; F:SH3 domain binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular response to dexamethasone stimulus; P:cellular response to nerve growth factor stimulus; P:endosome organization; P:mitotic cytokinesis; P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:Ras protein signal transduction; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:regulation of protein localization; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|P40818 B4DKA8 Q2TB31 Q7Z3U2 Q86VA0 Q8IWI7,Ubiquitin carboxyl-terminal hydrolase 8 {ECO:0000305},Deubiquitinating enzyme 8;Ubiquitin isopeptidase Y;Ubiquitin thioesterase 8;Ubiquitin-specific-processing protease 8;, PF00581;PF00443;PF08969;, GO:0005737;GO:0005829;GO:0043197;GO:0005769;GO:0031313;GO:0019897;GO:0098978;GO:0030496;GO:0005634;GO:0014069;GO:0045296;GO:0004197;GO:0017124;GO:0004843;GO:0071549;GO:1990090;GO:0007032;GO:0000281;GO:0090263;GO:0016579;GO:0071108;GO:0070536;GO:0007265;GO:0099576;GO:0032880;GO:0031647;GO:0006511;, C:cytoplasm; C:cytosol; C:dendritic spine; C:early endosome; C:extrinsic component of endosome membrane; C:extrinsic component of plasma membrane; C:glutamatergic synapse; C:midbody; C:nucleus; C:postsynaptic density;, F:cadherin binding; F:cysteine-type endopeptidase activity; F:SH3 domain binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular response to dexamethasone stimulus; P:cellular response to nerve growth factor stimulus; P:endosome organization; P:mitotic cytokinesis; P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:Ras protein signal transduction; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:regulation of protein localization; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|P40818 B4DKA8 Q2TB31 Q7Z3U2 Q86VA0 Q8IWI7,Ubiquitin carboxyl-terminal hydrolase 8 {ECO:0000305},Deubiquitinating enzyme 8;Ubiquitin isopeptidase Y;Ubiquitin thioesterase 8;Ubiquitin-specific-processing protease 8;, PF00581;PF00443;PF08969;, GO:0005737;GO:0005829;GO:0043197;GO:0005769;GO:0031313;GO:0019897;GO:0098978;GO:0030496;GO:0005634;GO:0014069;GO:0045296;GO:0004197;GO:0017124;GO:0004843;GO:0071549;GO:1990090;GO:0007032;GO:0000281;GO:0090263;GO:0016579;GO:0071108;GO:0070536;GO:0007265;GO:0099576;GO:0032880;GO:0031647;GO:0006511;, C:cytoplasm; C:cytosol; C:dendritic spine; C:early endosome; C:extrinsic component of endosome membrane; C:extrinsic component of plasma membrane; C:glutamatergic synapse; C:midbody; C:nucleus; C:postsynaptic density;, F:cadherin binding; F:cysteine-type endopeptidase activity; F:SH3 domain binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular response to dexamethasone stimulus; P:cellular response to nerve growth factor stimulus; P:endosome organization; P:mitotic cytokinesis; P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:Ras protein signal transduction; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:regulation of protein localization; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|P40818 B4DKA8 Q2TB31 Q7Z3U2 Q86VA0 Q8IWI7,Ubiquitin carboxyl-terminal hydrolase 8 {ECO:0000305},Deubiquitinating enzyme 8;Ubiquitin isopeptidase Y;Ubiquitin thioesterase 8;Ubiquitin-specific-processing protease 8;, PF00581;PF00443;PF08969;, GO:0005737;GO:0005829;GO:0043197;GO:0005769;GO:0031313;GO:0019897;GO:0098978;GO:0030496;GO:0005634;GO:0014069;GO:0045296;GO:0004197;GO:0017124;GO:0004843;GO:0071549;GO:1990090;GO:0007032;GO:0000281;GO:0090263;GO:0016579;GO:0071108;GO:0070536;GO:0007265;GO:0099576;GO:0032880;GO:0031647;GO:0006511;, C:cytoplasm; C:cytosol; C:dendritic spine; C:early endosome; C:extrinsic component of endosome membrane; C:extrinsic component of plasma membrane; C:glutamatergic synapse; C:midbody; C:nucleus; C:postsynaptic density;, F:cadherin binding; F:cysteine-type endopeptidase activity; F:SH3 domain binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular response to dexamethasone stimulus; P:cellular response to nerve growth factor stimulus; P:endosome organization; P:mitotic cytokinesis; P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:Ras protein signal transduction; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:regulation of protein localization; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|P40818 B4DKA8 Q2TB31 Q7Z3U2 Q86VA0 Q8IWI7,Ubiquitin carboxyl-terminal hydrolase 8 {ECO:0000305},Deubiquitinating enzyme 8;Ubiquitin isopeptidase Y;Ubiquitin thioesterase 8;Ubiquitin-specific-processing protease 8;, PF00581;PF00443;PF08969;, GO:0005737;GO:0005829;GO:0043197;GO:0005769;GO:0031313;GO:0019897;GO:0098978;GO:0030496;GO:0005634;GO:0014069;GO:0045296;GO:0004197;GO:0017124;GO:0004843;GO:0071549;GO:1990090;GO:0007032;GO:0000281;GO:0090263;GO:0016579;GO:0071108;GO:0070536;GO:0007265;GO:0099576;GO:0032880;GO:0031647;GO:0006511;, C:cytoplasm; C:cytosol; C:dendritic spine; C:early endosome; C:extrinsic component of endosome membrane; C:extrinsic component of plasma membrane; C:glutamatergic synapse; C:midbody; C:nucleus; C:postsynaptic density;, F:cadherin binding; F:cysteine-type endopeptidase activity; F:SH3 domain binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular response to dexamethasone stimulus; P:cellular response to nerve growth factor stimulus; P:endosome organization; P:mitotic cytokinesis; P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:Ras protein signal transduction; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:regulation of protein localization; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|P40818 B4DKA8 Q2TB31 Q7Z3U2 Q86VA0 Q8IWI7,Ubiquitin carboxyl-terminal hydrolase 8 {ECO:0000305},Deubiquitinating enzyme 8;Ubiquitin isopeptidase Y;Ubiquitin thioesterase 8;Ubiquitin-specific-processing protease 8;, PF00581;PF00443;PF08969;, GO:0005737;GO:0005829;GO:0043197;GO:0005769;GO:0031313;GO:0019897;GO:0098978;GO:0030496;GO:0005634;GO:0014069;GO:0045296;GO:0004197;GO:0017124;GO:0004843;GO:0071549;GO:1990090;GO:0007032;GO:0000281;GO:0090263;GO:0016579;GO:0071108;GO:0070536;GO:0007265;GO:0099576;GO:0032880;GO:0031647;GO:0006511;, C:cytoplasm; C:cytosol; C:dendritic spine; C:early endosome; C:extrinsic component of endosome membrane; C:extrinsic component of plasma membrane; C:glutamatergic synapse; C:midbody; C:nucleus; C:postsynaptic density;, F:cadherin binding; F:cysteine-type endopeptidase activity; F:SH3 domain binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cellular response to dexamethasone stimulus; P:cellular response to nerve growth factor stimulus; P:endosome organization; P:mitotic cytokinesis; P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:Ras protein signal transduction; P:regulation of protein catabolic process at postsynapse, modulating synaptic transmission; P:regulation of protein localization; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process; scaffold37 indexed_genome mRNA 22504126 22563616 . + . ID=transcript_7663;Q06547 A8IE52 Q06545 Q12940 Q12941 Q12942 Q8IYD0,GA-binding protein subunit beta-1,GABP subunit beta-2;Nuclear respiratory factor 2;Transcription factor E4TF1-47 {ECO:0000303|PubMed:8441384};Transcription factor E4TF1-53 {ECO:0000303|PubMed:8441384};, PF12796;, GO:0036464;GO:0005654;GO:0005634;GO:0000976;GO:0007005;GO:0045944;, C:cytoplasmic ribonucleoprotein granule; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:mitochondrion organization; P:positive regulation of transcription by RNA polymerase II;|Q06547 A8IE52 Q06545 Q12940 Q12941 Q12942 Q8IYD0,GA-binding protein subunit beta-1,GABP subunit beta-2;Nuclear respiratory factor 2;Transcription factor E4TF1-47 {ECO:0000303|PubMed:8441384};Transcription factor E4TF1-53 {ECO:0000303|PubMed:8441384};, PF12796;, GO:0036464;GO:0005654;GO:0005634;GO:0000976;GO:0007005;GO:0045944;, C:cytoplasmic ribonucleoprotein granule; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:mitochondrion organization; P:positive regulation of transcription by RNA polymerase II;|Q96B49 B2DG15 Q9UH52,Mitochondrial import receptor subunit TOM6 homolog,Overexpressed breast tumor protein;Translocase of outer membrane 6 kDa subunit homolog;, PF15184;, GO:0005741;GO:0005742;GO:0005739;GO:0016236;GO:0015031;, C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, , P:macroautophagy; P:protein transport;|Q06547 A8IE52 Q06545 Q12940 Q12941 Q12942 Q8IYD0,GA-binding protein subunit beta-1,GABP subunit beta-2;Nuclear respiratory factor 2;Transcription factor E4TF1-47 {ECO:0000303|PubMed:8441384};Transcription factor E4TF1-53 {ECO:0000303|PubMed:8441384};, PF12796;, GO:0036464;GO:0005654;GO:0005634;GO:0000976;GO:0007005;GO:0045944;, C:cytoplasmic ribonucleoprotein granule; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:mitochondrion organization; P:positive regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 22568191 22580138 . + . ID=transcript_7664;Q06547 A8IE52 Q06545 Q12940 Q12941 Q12942 Q8IYD0,GA-binding protein subunit beta-1,GABP subunit beta-2;Nuclear respiratory factor 2;Transcription factor E4TF1-47 {ECO:0000303|PubMed:8441384};Transcription factor E4TF1-53 {ECO:0000303|PubMed:8441384};, PF12796;, GO:0036464;GO:0005654;GO:0005634;GO:0000976;GO:0007005;GO:0045944;, C:cytoplasmic ribonucleoprotein granule; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:mitochondrion organization; P:positive regulation of transcription by RNA polymerase II;|Q06547 A8IE52 Q06545 Q12940 Q12941 Q12942 Q8IYD0,GA-binding protein subunit beta-1,GABP subunit beta-2;Nuclear respiratory factor 2;Transcription factor E4TF1-47 {ECO:0000303|PubMed:8441384};Transcription factor E4TF1-53 {ECO:0000303|PubMed:8441384};, PF12796;, GO:0036464;GO:0005654;GO:0005634;GO:0000976;GO:0007005;GO:0045944;, C:cytoplasmic ribonucleoprotein granule; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:mitochondrion organization; P:positive regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 22593484 22618053 . + . ID=transcript_7665;P19113 A1L4G0 B7ZM01,Histidine decarboxylase,, PF00282;, GO:0005737;GO:0005829;GO:0016831;GO:0004398;GO:0030170;GO:0042423;GO:0001694;GO:0006548;GO:0006547;, C:cytoplasm; C:cytosol;, F:carboxy-lyase activity; F:histidine decarboxylase activity; F:pyridoxal phosphate binding;, P:catecholamine biosynthetic process; P:histamine biosynthetic process; P:histidine catabolic process; P:histidine metabolic process;|P19113 A1L4G0 B7ZM01,Histidine decarboxylase,, PF00282;, GO:0005737;GO:0005829;GO:0016831;GO:0004398;GO:0030170;GO:0042423;GO:0001694;GO:0006548;GO:0006547;, C:cytoplasm; C:cytosol;, F:carboxy-lyase activity; F:histidine decarboxylase activity; F:pyridoxal phosphate binding;, P:catecholamine biosynthetic process; P:histamine biosynthetic process; P:histidine catabolic process; P:histidine metabolic process;|P19113 A1L4G0 B7ZM01,Histidine decarboxylase,, PF00282;, GO:0005737;GO:0005829;GO:0016831;GO:0004398;GO:0030170;GO:0042423;GO:0001694;GO:0006548;GO:0006547;, C:cytoplasm; C:cytosol;, F:carboxy-lyase activity; F:histidine decarboxylase activity; F:pyridoxal phosphate binding;, P:catecholamine biosynthetic process; P:histamine biosynthetic process; P:histidine catabolic process; P:histidine metabolic process;|P19113 A1L4G0 B7ZM01,Histidine decarboxylase,, PF00282;, GO:0005737;GO:0005829;GO:0016831;GO:0004398;GO:0030170;GO:0042423;GO:0001694;GO:0006548;GO:0006547;, C:cytoplasm; C:cytosol;, F:carboxy-lyase activity; F:histidine decarboxylase activity; F:pyridoxal phosphate binding;, P:catecholamine biosynthetic process; P:histamine biosynthetic process; P:histidine catabolic process; P:histidine metabolic process;|P19113 A1L4G0 B7ZM01,Histidine decarboxylase,, PF00282;, GO:0005737;GO:0005829;GO:0016831;GO:0004398;GO:0030170;GO:0042423;GO:0001694;GO:0006548;GO:0006547;, C:cytoplasm; C:cytosol;, F:carboxy-lyase activity; F:histidine decarboxylase activity; F:pyridoxal phosphate binding;, P:catecholamine biosynthetic process; P:histamine biosynthetic process; P:histidine catabolic process; P:histidine metabolic process;|P19113 A1L4G0 B7ZM01,Histidine decarboxylase,, PF00282;, GO:0005737;GO:0005829;GO:0016831;GO:0004398;GO:0030170;GO:0042423;GO:0001694;GO:0006548;GO:0006547;, C:cytoplasm; C:cytosol;, F:carboxy-lyase activity; F:histidine decarboxylase activity; F:pyridoxal phosphate binding;, P:catecholamine biosynthetic process; P:histamine biosynthetic process; P:histidine catabolic process; P:histidine metabolic process;|P19113 A1L4G0 B7ZM01,Histidine decarboxylase,, PF00282;, GO:0005737;GO:0005829;GO:0016831;GO:0004398;GO:0030170;GO:0042423;GO:0001694;GO:0006548;GO:0006547;, C:cytoplasm; C:cytosol;, F:carboxy-lyase activity; F:histidine decarboxylase activity; F:pyridoxal phosphate binding;, P:catecholamine biosynthetic process; P:histamine biosynthetic process; P:histidine catabolic process; P:histidine metabolic process; scaffold37 indexed_genome mRNA 22623829 22673600 . - . ID=transcript_7666;O14975 A8K2J7 Q53FY6 Q6PF09,Very long-chain acyl-CoA synthetase {ECO:0000303|PubMed:10198260, ECO:0000303|PubMed:10749848, ECO:0000303|PubMed:11980911},Arachidonate--CoA ligase;Fatty acid transport protein 2 {ECO:0000303|PubMed:20530735};Fatty-acid-coenzyme A ligase, very long-chain 1;Long-chain-fatty-acid--CoA ligase;Phytanate--CoA ligase;Solute carrier family 27 member 2;THCA-CoA ligase;Very long-chain-fatty-acid-CoA ligase;, PF00501;PF13193;, GO:0005829;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0030176;GO:0005779;GO:0005778;GO:0005886;GO:0035579;GO:0047676;GO:0005524;GO:0047747;GO:0019899;GO:0015245;GO:0005324;GO:0004467;GO:0050197;GO:0070251;GO:0031957;GO:0006699;GO:0001561;GO:0006635;GO:0044539;GO:0001676;GO:0097089;GO:0043312;GO:0008104;GO:0042760;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of endoplasmic reticulum membrane; C:integral component of peroxisomal membrane; C:peroxisomal membrane; C:plasma membrane; C:specific granule membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:cholate-CoA ligase activity; F:enzyme binding; F:fatty acid transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:bile acid biosynthetic process; P:fatty acid alpha-oxidation; P:fatty acid beta-oxidation; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:methyl-branched fatty acid metabolic process; P:neutrophil degranulation; P:protein localization; P:very long-chain fatty acid catabolic process;|O14975 A8K2J7 Q53FY6 Q6PF09,Very long-chain acyl-CoA synthetase {ECO:0000303|PubMed:10198260, ECO:0000303|PubMed:10749848, ECO:0000303|PubMed:11980911},Arachidonate--CoA ligase;Fatty acid transport protein 2 {ECO:0000303|PubMed:20530735};Fatty-acid-coenzyme A ligase, very long-chain 1;Long-chain-fatty-acid--CoA ligase;Phytanate--CoA ligase;Solute carrier family 27 member 2;THCA-CoA ligase;Very long-chain-fatty-acid-CoA ligase;, PF00501;PF13193;, GO:0005829;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0030176;GO:0005779;GO:0005778;GO:0005886;GO:0035579;GO:0047676;GO:0005524;GO:0047747;GO:0019899;GO:0015245;GO:0005324;GO:0004467;GO:0050197;GO:0070251;GO:0031957;GO:0006699;GO:0001561;GO:0006635;GO:0044539;GO:0001676;GO:0097089;GO:0043312;GO:0008104;GO:0042760;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of endoplasmic reticulum membrane; C:integral component of peroxisomal membrane; C:peroxisomal membrane; C:plasma membrane; C:specific granule membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:cholate-CoA ligase activity; F:enzyme binding; F:fatty acid transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:phytanate-CoA ligase activity; F:pristanate-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:bile acid biosynthetic process; P:fatty acid alpha-oxidation; P:fatty acid beta-oxidation; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:methyl-branched fatty acid metabolic process; P:neutrophil degranulation; P:protein localization; P:very long-chain fatty acid catabolic process; scaffold37 indexed_genome mRNA 22896797 22913771 . + . ID=transcript_7667;Q8TF62 Q9H727,Probable phospholipid-transporting ATPase IM,ATPase class I type 8B member 4;P4-ATPase flippase complex alpha subunit ATP8B4;, PF16212;PF16209;, GO:0005794;GO:0016021;GO:0005886;GO:0035579;GO:0070821;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0007030;GO:0043312;GO:0045332;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:Golgi organization; P:neutrophil degranulation; P:phospholipid translocation; scaffold37 indexed_genome mRNA 22913813 22979310 . + . ID=transcript_7668;Q8TF62 Q9H727,Probable phospholipid-transporting ATPase IM,ATPase class I type 8B member 4;P4-ATPase flippase complex alpha subunit ATP8B4;, PF16212;PF16209;, GO:0005794;GO:0016021;GO:0005886;GO:0035579;GO:0070821;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0007030;GO:0043312;GO:0045332;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:Golgi organization; P:neutrophil degranulation; P:phospholipid translocation; scaffold37 indexed_genome mRNA 22979436 22993448 . + . ID=transcript_7669;Q8TF62 Q9H727,Probable phospholipid-transporting ATPase IM,ATPase class I type 8B member 4;P4-ATPase flippase complex alpha subunit ATP8B4;, PF16212;PF16209;, GO:0005794;GO:0016021;GO:0005886;GO:0035579;GO:0070821;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0007030;GO:0043312;GO:0045332;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding;, P:Golgi organization; P:neutrophil degranulation; P:phospholipid translocation; scaffold37 indexed_genome mRNA 23249352 23264472 . - . ID=transcript_7670;Q8N5C7 Q567Q3 Q8WVG9 Q9NRU6,tRNA-uridine aminocarboxypropyltransferase 1 {ECO:0000305},DTW domain-containing protein 1 {ECO:0000305};, PF03942;, GO:0005634;GO:0016432;GO:0006400;, C:nucleus;, F:tRNA-uridine aminocarboxypropyltransferase activity;, P:tRNA modification;|Q8N5C7 Q567Q3 Q8WVG9 Q9NRU6,tRNA-uridine aminocarboxypropyltransferase 1 {ECO:0000305},DTW domain-containing protein 1 {ECO:0000305};, PF03942;, GO:0005634;GO:0016432;GO:0006400;, C:nucleus;, F:tRNA-uridine aminocarboxypropyltransferase activity;, P:tRNA modification; scaffold37 indexed_genome mRNA 23267357 23303188 . + . ID=transcript_7671;Q96M60 Q86WS2,Protein FAM227B,, PF14922; scaffold37 indexed_genome mRNA 23344325 23406851 . - . ID=transcript_7672;P21781 H0YNY5 Q6FGV5 Q96FG5,Fibroblast growth factor 7,Heparin-binding growth factor 7;Keratinocyte growth factor;, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005794;GO:0042056;GO:0005104;GO:0008083;GO:0008201;GO:0005111;GO:0031532;GO:0009887;GO:0060445;GO:0030154;GO:0008544;GO:0008543;GO:0031069;GO:0030324;GO:0000165;GO:0010463;GO:0050918;GO:0051781;GO:0008284;GO:0050679;GO:0060501;GO:0010628;GO:0051549;GO:0010838;GO:0050731;GO:0051897;GO:0001934;GO:0045893;GO:0034394;GO:0060665;GO:0030334;GO:0009611;GO:0061033;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space; C:Golgi apparatus;, F:chemoattractant activity; F:fibroblast growth factor receptor binding; F:growth factor activity; F:heparin binding; F:type 2 fibroblast growth factor receptor binding;, P:actin cytoskeleton reorganization; P:animal organ morphogenesis; P:branching involved in salivary gland morphogenesis; P:cell differentiation; P:epidermis development; P:fibroblast growth factor receptor signaling pathway; P:hair follicle morphogenesis; P:lung development; P:MAPK cascade; P:mesenchymal cell proliferation; P:positive chemotaxis; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; P:positive regulation of gene expression; P:positive regulation of keratinocyte migration; P:positive regulation of keratinocyte proliferation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein localization to cell surface; P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling; P:regulation of cell migration; P:response to wounding; P:secretion by lung epithelial cell involved in lung growth; P:signal transduction; scaffold37 indexed_genome mRNA 23480311 23626505 . - . ID=transcript_7673;Q01415 Q7Z4Q4,N-acetylgalactosamine kinase,GalNAc kinase;Galactokinase 2;, PF10509;PF08544;PF00288;, GO:0005829;GO:0005524;GO:0004335;GO:0033858;GO:0005975;GO:0006012;, C:cytosol;, F:ATP binding; F:galactokinase activity; F:N-acetylgalactosamine kinase activity;, P:carbohydrate metabolic process; P:galactose metabolic process; scaffold37 indexed_genome mRNA 23633908 23654870 . + . ID=transcript_7674;P61201 O88950 Q15647 Q6FGP4 Q9BY54 Q9R249 Q9UNI2 Q9UNQ5,COP9 signalosome complex subunit 2,Alien homolog;JAB1-containing signalosome subunit 2;Thyroid receptor-interacting protein 15;, PF01399;, GO:0008180;GO:0005737;GO:0005829;GO:0005654;GO:0003714;GO:0001833;GO:1903507;GO:0000122;GO:0045892;GO:0030182;GO:0000715;GO:0043687;GO:0000338;GO:0006468;GO:0007165;GO:0035914;GO:0006366;GO:0006283;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:transcription corepressor activity;, P:inner cell mass cell proliferation; P:negative regulation of nucleic acid-templated transcription; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:protein phosphorylation; P:signal transduction; P:skeletal muscle cell differentiation; P:transcription by RNA polymerase II; P:transcription-coupled nucleotide-excision repair;|P61201 O88950 Q15647 Q6FGP4 Q9BY54 Q9R249 Q9UNI2 Q9UNQ5,COP9 signalosome complex subunit 2,Alien homolog;JAB1-containing signalosome subunit 2;Thyroid receptor-interacting protein 15;, PF01399;, GO:0008180;GO:0005737;GO:0005829;GO:0005654;GO:0003714;GO:0001833;GO:1903507;GO:0000122;GO:0045892;GO:0030182;GO:0000715;GO:0043687;GO:0000338;GO:0006468;GO:0007165;GO:0035914;GO:0006366;GO:0006283;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:transcription corepressor activity;, P:inner cell mass cell proliferation; P:negative regulation of nucleic acid-templated transcription; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:protein phosphorylation; P:signal transduction; P:skeletal muscle cell differentiation; P:transcription by RNA polymerase II; P:transcription-coupled nucleotide-excision repair; scaffold37 indexed_genome mRNA 23731191 23785379 . + . ID=transcript_7675;Q93073 Q8N767,Selenocysteine insertion sequence-binding protein 2-like,, PF01248;, GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:0001514;, C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:selenocysteine incorporation;|Q93073 Q8N767,Selenocysteine insertion sequence-binding protein 2-like,, PF01248;, GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:0001514;, C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:selenocysteine incorporation;|Q93073 Q8N767,Selenocysteine insertion sequence-binding protein 2-like,, PF01248;, GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:0001514;, C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:selenocysteine incorporation;|Q93073 Q8N767,Selenocysteine insertion sequence-binding protein 2-like,, PF01248;, GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:0001514;, C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding;, P:selenocysteine incorporation; scaffold37 indexed_genome mRNA 23820653 23942532 . + . ID=transcript_7676;Q6S5L8 Q6UXQ3 Q8IYW3,SHC-transforming protein 4,Rai-like protein;SHC-transforming protein D;Src homology 2 domain-containing-transforming protein C4;, PF00640;PF00017;, GO:0005886;GO:0045211;GO:0019904;GO:0019901;GO:0030971;GO:0006915;GO:0035556;GO:0008284;GO:0010468;GO:0048863;GO:0007169;, C:plasma membrane; C:postsynaptic membrane;, F:protein domain specific binding; F:protein kinase binding; F:receptor tyrosine kinase binding;, P:apoptotic process; P:intracellular signal transduction; P:positive regulation of cell population proliferation; P:regulation of gene expression; P:stem cell differentiation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q9Y6B2 B2RD11 Q8N7I4 Q9BZT9,EP300-interacting inhibitor of differentiation 1,21 kDa pRb-associated protein;CREBBP/EP300 inhibitory protein 1;E1A-like inhibitor of differentiation 1;, , GO:0036464;GO:0005654;GO:0005634;GO:0035035;GO:0035034;GO:0003714;GO:0007049;GO:0030154;GO:0000122;GO:0045892;GO:0045595;, C:cytoplasmic ribonucleoprotein granule; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding; F:histone acetyltransferase regulator activity; F:transcription corepressor activity;, P:cell cycle; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of cell differentiation;|Q6S5L8 Q6UXQ3 Q8IYW3,SHC-transforming protein 4,Rai-like protein;SHC-transforming protein D;Src homology 2 domain-containing-transforming protein C4;, PF00640;PF00017;, GO:0005886;GO:0045211;GO:0019904;GO:0019901;GO:0030971;GO:0006915;GO:0035556;GO:0008284;GO:0010468;GO:0048863;GO:0007169;, C:plasma membrane; C:postsynaptic membrane;, F:protein domain specific binding; F:protein kinase binding; F:receptor tyrosine kinase binding;, P:apoptotic process; P:intracellular signal transduction; P:positive regulation of cell population proliferation; P:regulation of gene expression; P:stem cell differentiation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q6S5L8 Q6UXQ3 Q8IYW3,SHC-transforming protein 4,Rai-like protein;SHC-transforming protein D;Src homology 2 domain-containing-transforming protein C4;, PF00640;PF00017;, GO:0005886;GO:0045211;GO:0019904;GO:0019901;GO:0030971;GO:0006915;GO:0035556;GO:0008284;GO:0010468;GO:0048863;GO:0007169;, C:plasma membrane; C:postsynaptic membrane;, F:protein domain specific binding; F:protein kinase binding; F:receptor tyrosine kinase binding;, P:apoptotic process; P:intracellular signal transduction; P:positive regulation of cell population proliferation; P:regulation of gene expression; P:stem cell differentiation; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold37 indexed_genome mRNA 23967525 23973053 . + . ID=transcript_7677;O94986 E7ER66 Q17RV1 Q6NTA0,Centrosomal protein of 152 kDa {ECO:0000305},, , GO:0005814;GO:0005813;GO:0005829;GO:0098536;GO:0005654;GO:0000242;GO:0019901;GO:0007099;GO:0051298;GO:0097711;GO:0098535;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:cytosol; C:deuterosome; C:nucleoplasm; C:pericentriolar material;, F:protein kinase binding;, P:centriole replication; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; scaffold37 indexed_genome mRNA 23977009 23985207 . + . ID=transcript_7678;O94986 E7ER66 Q17RV1 Q6NTA0,Centrosomal protein of 152 kDa {ECO:0000305},, , GO:0005814;GO:0005813;GO:0005829;GO:0098536;GO:0005654;GO:0000242;GO:0019901;GO:0007099;GO:0051298;GO:0097711;GO:0098535;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:cytosol; C:deuterosome; C:nucleoplasm; C:pericentriolar material;, F:protein kinase binding;, P:centriole replication; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; scaffold37 indexed_genome mRNA 24000167 24016968 . + . ID=transcript_7679;O94986 E7ER66 Q17RV1 Q6NTA0,Centrosomal protein of 152 kDa {ECO:0000305},, , GO:0005814;GO:0005813;GO:0005829;GO:0098536;GO:0005654;GO:0000242;GO:0019901;GO:0007099;GO:0051298;GO:0097711;GO:0098535;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:cytosol; C:deuterosome; C:nucleoplasm; C:pericentriolar material;, F:protein kinase binding;, P:centriole replication; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; scaffold37 indexed_genome mRNA 24016972 24046554 . + . ID=transcript_7680;O94986 E7ER66 Q17RV1 Q6NTA0,Centrosomal protein of 152 kDa {ECO:0000305},, , GO:0005814;GO:0005813;GO:0005829;GO:0098536;GO:0005654;GO:0000242;GO:0019901;GO:0007099;GO:0051298;GO:0097711;GO:0098535;GO:0000086;GO:0010389;, C:centriole; C:centrosome; C:cytosol; C:deuterosome; C:nucleoplasm; C:pericentriolar material;, F:protein kinase binding;, P:centriole replication; P:centrosome duplication; P:ciliary basal body-plasma membrane docking; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; scaffold37 indexed_genome mRNA 24156540 24207635 . + . ID=transcript_7681;P35555 B2RUU0 D2JYH6 Q15972 Q75N87,Fibrillin-1 {ECO:0000303|PubMed:15221638},, PF12662;PF07645;PF18193;PF00683;, GO:0005604;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0001527;GO:0005509;GO:0030023;GO:0005201;GO:0008201;GO:0005179;GO:0042802;GO:0005178;GO:0044877;GO:0034199;GO:0009653;GO:0043010;GO:0033627;GO:0044267;GO:1990314;GO:0071560;GO:0048048;GO:0030198;GO:0042593;GO:0006006;GO:0007507;GO:0001656;GO:2001205;GO:0045671;GO:0048050;GO:0043687;GO:0010737;GO:0035582;GO:0035583;GO:0001501;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:microfibril;, F:calcium ion binding; F:extracellular matrix constituent conferring elasticity; F:extracellular matrix structural constituent; F:heparin binding; F:hormone activity; F:identical protein binding; F:integrin binding; F:protein-containing complex binding;, P:activation of protein kinase A activity; P:anatomical structure morphogenesis; P:camera-type eye development; P:cell adhesion mediated by integrin; P:cellular protein metabolic process; P:cellular response to insulin-like growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:embryonic eye morphogenesis; P:extracellular matrix organization; P:glucose homeostasis; P:glucose metabolic process; P:heart development; P:metanephros development; P:negative regulation of osteoclast development; P:negative regulation of osteoclast differentiation; P:post-embryonic eye morphogenesis; P:post-translational protein modification; P:protein kinase A signaling; P:sequestering of BMP in extracellular matrix; P:sequestering of TGFbeta in extracellular matrix; P:skeletal system development; scaffold37 indexed_genome mRNA 24299494 24305900 . + . ID=transcript_7682;P35555 B2RUU0 D2JYH6 Q15972 Q75N87,Fibrillin-1 {ECO:0000303|PubMed:15221638},, PF12662;PF07645;PF18193;PF00683;, GO:0005604;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0001527;GO:0005509;GO:0030023;GO:0005201;GO:0008201;GO:0005179;GO:0042802;GO:0005178;GO:0044877;GO:0034199;GO:0009653;GO:0043010;GO:0033627;GO:0044267;GO:1990314;GO:0071560;GO:0048048;GO:0030198;GO:0042593;GO:0006006;GO:0007507;GO:0001656;GO:2001205;GO:0045671;GO:0048050;GO:0043687;GO:0010737;GO:0035582;GO:0035583;GO:0001501;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:microfibril;, F:calcium ion binding; F:extracellular matrix constituent conferring elasticity; F:extracellular matrix structural constituent; F:heparin binding; F:hormone activity; F:identical protein binding; F:integrin binding; F:protein-containing complex binding;, P:activation of protein kinase A activity; P:anatomical structure morphogenesis; P:camera-type eye development; P:cell adhesion mediated by integrin; P:cellular protein metabolic process; P:cellular response to insulin-like growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:embryonic eye morphogenesis; P:extracellular matrix organization; P:glucose homeostasis; P:glucose metabolic process; P:heart development; P:metanephros development; P:negative regulation of osteoclast development; P:negative regulation of osteoclast differentiation; P:post-embryonic eye morphogenesis; P:post-translational protein modification; P:protein kinase A signaling; P:sequestering of BMP in extracellular matrix; P:sequestering of TGFbeta in extracellular matrix; P:skeletal system development; scaffold37 indexed_genome mRNA 24314393 24323713 . + . ID=transcript_7683;P35555 B2RUU0 D2JYH6 Q15972 Q75N87,Fibrillin-1 {ECO:0000303|PubMed:15221638},, PF12662;PF07645;PF18193;PF00683;, GO:0005604;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0001527;GO:0005509;GO:0030023;GO:0005201;GO:0008201;GO:0005179;GO:0042802;GO:0005178;GO:0044877;GO:0034199;GO:0009653;GO:0043010;GO:0033627;GO:0044267;GO:1990314;GO:0071560;GO:0048048;GO:0030198;GO:0042593;GO:0006006;GO:0007507;GO:0001656;GO:2001205;GO:0045671;GO:0048050;GO:0043687;GO:0010737;GO:0035582;GO:0035583;GO:0001501;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:microfibril;, F:calcium ion binding; F:extracellular matrix constituent conferring elasticity; F:extracellular matrix structural constituent; F:heparin binding; F:hormone activity; F:identical protein binding; F:integrin binding; F:protein-containing complex binding;, P:activation of protein kinase A activity; P:anatomical structure morphogenesis; P:camera-type eye development; P:cell adhesion mediated by integrin; P:cellular protein metabolic process; P:cellular response to insulin-like growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:embryonic eye morphogenesis; P:extracellular matrix organization; P:glucose homeostasis; P:glucose metabolic process; P:heart development; P:metanephros development; P:negative regulation of osteoclast development; P:negative regulation of osteoclast differentiation; P:post-embryonic eye morphogenesis; P:post-translational protein modification; P:protein kinase A signaling; P:sequestering of BMP in extracellular matrix; P:sequestering of TGFbeta in extracellular matrix; P:skeletal system development; scaffold37 indexed_genome mRNA 24323726 24415226 . + . ID=transcript_7684;P35555 B2RUU0 D2JYH6 Q15972 Q75N87,Fibrillin-1 {ECO:0000303|PubMed:15221638},, PF12662;PF07645;PF18193;PF00683;, GO:0005604;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0001527;GO:0005509;GO:0030023;GO:0005201;GO:0008201;GO:0005179;GO:0042802;GO:0005178;GO:0044877;GO:0034199;GO:0009653;GO:0043010;GO:0033627;GO:0044267;GO:1990314;GO:0071560;GO:0048048;GO:0030198;GO:0042593;GO:0006006;GO:0007507;GO:0001656;GO:2001205;GO:0045671;GO:0048050;GO:0043687;GO:0010737;GO:0035582;GO:0035583;GO:0001501;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:microfibril;, F:calcium ion binding; F:extracellular matrix constituent conferring elasticity; F:extracellular matrix structural constituent; F:heparin binding; F:hormone activity; F:identical protein binding; F:integrin binding; F:protein-containing complex binding;, P:activation of protein kinase A activity; P:anatomical structure morphogenesis; P:camera-type eye development; P:cell adhesion mediated by integrin; P:cellular protein metabolic process; P:cellular response to insulin-like growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:embryonic eye morphogenesis; P:extracellular matrix organization; P:glucose homeostasis; P:glucose metabolic process; P:heart development; P:metanephros development; P:negative regulation of osteoclast development; P:negative regulation of osteoclast differentiation; P:post-embryonic eye morphogenesis; P:post-translational protein modification; P:protein kinase A signaling; P:sequestering of BMP in extracellular matrix; P:sequestering of TGFbeta in extracellular matrix; P:skeletal system development; scaffold37 indexed_genome mRNA 24548586 24559841 . - . ID=transcript_7685;P33316 A8K650 B4DPR5 O14785 Q16708 Q16860 Q6FHN1 Q6NSA3 Q96Q81,Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial {ECO:0000303|PubMed:8631816},dUTP pyrophosphatase;, PF00692;, GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0004170;GO:0042802;GO:0000287;GO:0042975;GO:0032556;GO:0030547;GO:0003723;GO:0006260;GO:0006226;GO:0046081;GO:0001889;GO:0006139;GO:0015949;GO:0043254;GO:0014070;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:dUTP diphosphatase activity; F:identical protein binding; F:magnesium ion binding; F:peroxisome proliferator activated receptor binding; F:pyrimidine deoxyribonucleotide binding; F:receptor inhibitor activity; F:RNA binding;, P:DNA replication; P:dUMP biosynthetic process; P:dUTP catabolic process; P:liver development; P:nucleobase-containing compound metabolic process; P:nucleobase-containing small molecule interconversion; P:regulation of protein-containing complex assembly; P:response to organic cyclic compound;|P33316 A8K650 B4DPR5 O14785 Q16708 Q16860 Q6FHN1 Q6NSA3 Q96Q81,Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial {ECO:0000303|PubMed:8631816},dUTP pyrophosphatase;, PF00692;, GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0004170;GO:0042802;GO:0000287;GO:0042975;GO:0032556;GO:0030547;GO:0003723;GO:0006260;GO:0006226;GO:0046081;GO:0001889;GO:0006139;GO:0015949;GO:0043254;GO:0014070;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:dUTP diphosphatase activity; F:identical protein binding; F:magnesium ion binding; F:peroxisome proliferator activated receptor binding; F:pyrimidine deoxyribonucleotide binding; F:receptor inhibitor activity; F:RNA binding;, P:DNA replication; P:dUMP biosynthetic process; P:dUTP catabolic process; P:liver development; P:nucleobase-containing compound metabolic process; P:nucleobase-containing small molecule interconversion; P:regulation of protein-containing complex assembly; P:response to organic cyclic compound;|P33316 A8K650 B4DPR5 O14785 Q16708 Q16860 Q6FHN1 Q6NSA3 Q96Q81,Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial {ECO:0000303|PubMed:8631816},dUTP pyrophosphatase;, PF00692;, GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0004170;GO:0042802;GO:0000287;GO:0042975;GO:0032556;GO:0030547;GO:0003723;GO:0006260;GO:0006226;GO:0046081;GO:0001889;GO:0006139;GO:0015949;GO:0043254;GO:0014070;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:dUTP diphosphatase activity; F:identical protein binding; F:magnesium ion binding; F:peroxisome proliferator activated receptor binding; F:pyrimidine deoxyribonucleotide binding; F:receptor inhibitor activity; F:RNA binding;, P:DNA replication; P:dUMP biosynthetic process; P:dUTP catabolic process; P:liver development; P:nucleobase-containing compound metabolic process; P:nucleobase-containing small molecule interconversion; P:regulation of protein-containing complex assembly; P:response to organic cyclic compound;|P33316 A8K650 B4DPR5 O14785 Q16708 Q16860 Q6FHN1 Q6NSA3 Q96Q81,Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial {ECO:0000303|PubMed:8631816},dUTP pyrophosphatase;, PF00692;, GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0004170;GO:0042802;GO:0000287;GO:0042975;GO:0032556;GO:0030547;GO:0003723;GO:0006260;GO:0006226;GO:0046081;GO:0001889;GO:0006139;GO:0015949;GO:0043254;GO:0014070;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:dUTP diphosphatase activity; F:identical protein binding; F:magnesium ion binding; F:peroxisome proliferator activated receptor binding; F:pyrimidine deoxyribonucleotide binding; F:receptor inhibitor activity; F:RNA binding;, P:DNA replication; P:dUMP biosynthetic process; P:dUTP catabolic process; P:liver development; P:nucleobase-containing compound metabolic process; P:nucleobase-containing small molecule interconversion; P:regulation of protein-containing complex assembly; P:response to organic cyclic compound; scaffold37 indexed_genome mRNA 24656995 24658317 . + . ID=transcript_7686;P55017 A8MSJ2 C9JNN9,Solute carrier family 12 member 3,Na-Cl cotransporter;Na-Cl symporter;Thiazide-sensitive sodium-chloride cotransporter;, PF00324;PF08403;PF03522;, GO:0016324;GO:0005829;GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0015379;GO:0015081;GO:0015378;GO:0008511;GO:0006884;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;GO:0055078;GO:0035725;GO:0006814;, C:apical plasma membrane; C:cytosol; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:potassium:chloride symporter activity; F:sodium ion transmembrane transporter activity; F:sodium:chloride symporter activity; F:sodium:potassium:chloride symporter activity;, P:cell volume homeostasis; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:sodium ion homeostasis; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold37 indexed_genome mRNA 24681167 24687259 . - . ID=transcript_7687;P0C2S0,Cortexin-2,, PF11057;, GO:0016021;, C:integral component of membrane; scaffold37 indexed_genome mRNA 24703855 24745691 . + . ID=transcript_7688;Q9P2K5 A7MCZ9 C9J921 C9K0J4 Q6NUM5 Q7L388 Q7Z4B7 Q9H922 Q9NUQ1,Myelin expression factor 2,MST156;, PF00076;, GO:0005737;GO:0005634;GO:0071014;GO:1990904;GO:0003729;GO:0003723;GO:0003697;GO:0014902;GO:0030182;GO:2000815;GO:0006357;, C:cytoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:myotube differentiation; P:neuron differentiation; P:regulation of mRNA stability involved in response to oxidative stress; P:regulation of transcription by RNA polymerase II;|Q9P2K5 A7MCZ9 C9J921 C9K0J4 Q6NUM5 Q7L388 Q7Z4B7 Q9H922 Q9NUQ1,Myelin expression factor 2,MST156;, PF00076;, GO:0005737;GO:0005634;GO:0071014;GO:1990904;GO:0003729;GO:0003723;GO:0003697;GO:0014902;GO:0030182;GO:2000815;GO:0006357;, C:cytoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:myotube differentiation; P:neuron differentiation; P:regulation of mRNA stability involved in response to oxidative stress; P:regulation of transcription by RNA polymerase II;|Q9P2K5 A7MCZ9 C9J921 C9K0J4 Q6NUM5 Q7L388 Q7Z4B7 Q9H922 Q9NUQ1,Myelin expression factor 2,MST156;, PF00076;, GO:0005737;GO:0005634;GO:0071014;GO:1990904;GO:0003729;GO:0003723;GO:0003697;GO:0014902;GO:0030182;GO:2000815;GO:0006357;, C:cytoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:myotube differentiation; P:neuron differentiation; P:regulation of mRNA stability involved in response to oxidative stress; P:regulation of transcription by RNA polymerase II;|Q9P2K5 A7MCZ9 C9J921 C9K0J4 Q6NUM5 Q7L388 Q7Z4B7 Q9H922 Q9NUQ1,Myelin expression factor 2,MST156;, PF00076;, GO:0005737;GO:0005634;GO:0071014;GO:1990904;GO:0003729;GO:0003723;GO:0003697;GO:0014902;GO:0030182;GO:2000815;GO:0006357;, C:cytoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:myotube differentiation; P:neuron differentiation; P:regulation of mRNA stability involved in response to oxidative stress; P:regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 25111256 25167087 . - . ID=transcript_7689;Q9P249,Semaphorin-6D,, PF01437;PF01403;, GO:0009986;GO:0005737;GO:0005615;GO:0005794;GO:0005887;GO:0005886;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0030517;GO:0048843;GO:0014912;GO:0001755;GO:0030335;GO:0014911;GO:0071526;GO:0021591;, C:cell surface; C:cytoplasm; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of smooth muscle cell migration; P:neural crest cell migration; P:positive regulation of cell migration; P:positive regulation of smooth muscle cell migration; P:semaphorin-plexin signaling pathway; P:ventricular system development;|Q9P249,Semaphorin-6D,, PF01437;PF01403;, GO:0009986;GO:0005737;GO:0005615;GO:0005794;GO:0005887;GO:0005886;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0030517;GO:0048843;GO:0014912;GO:0001755;GO:0030335;GO:0014911;GO:0071526;GO:0021591;, C:cell surface; C:cytoplasm; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of smooth muscle cell migration; P:neural crest cell migration; P:positive regulation of cell migration; P:positive regulation of smooth muscle cell migration; P:semaphorin-plexin signaling pathway; P:ventricular system development;|Q9P249,Semaphorin-6D,, PF01437;PF01403;, GO:0009986;GO:0005737;GO:0005615;GO:0005794;GO:0005887;GO:0005886;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0030517;GO:0048843;GO:0014912;GO:0001755;GO:0030335;GO:0014911;GO:0071526;GO:0021591;, C:cell surface; C:cytoplasm; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of smooth muscle cell migration; P:neural crest cell migration; P:positive regulation of cell migration; P:positive regulation of smooth muscle cell migration; P:semaphorin-plexin signaling pathway; P:ventricular system development;|Q9P249,Semaphorin-6D,, PF01437;PF01403;, GO:0009986;GO:0005737;GO:0005615;GO:0005794;GO:0005887;GO:0005886;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0030517;GO:0048843;GO:0014912;GO:0001755;GO:0030335;GO:0014911;GO:0071526;GO:0021591;, C:cell surface; C:cytoplasm; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of smooth muscle cell migration; P:neural crest cell migration; P:positive regulation of cell migration; P:positive regulation of smooth muscle cell migration; P:semaphorin-plexin signaling pathway; P:ventricular system development; scaffold37 indexed_genome mRNA 27162035 27209713 . - . ID=transcript_7690;Q9Y6N5 Q9UQM8,Sulfide:quinone oxidoreductase, mitochondrial {ECO:0000305},Sulfide dehydrogenase-like;Sulfide quinone oxidoreductase {ECO:0000312|HGNC:HGNC:20390};, PF07992;, GO:0005743;GO:0005739;GO:0071949;GO:0048038;GO:0070224;GO:0070813;GO:0070221;, C:mitochondrial inner membrane; C:mitochondrion;, F:FAD binding; F:quinone binding; F:sulfide:quinone oxidoreductase activity;, P:hydrogen sulfide metabolic process; P:sulfide oxidation, using sulfide:quinone oxidoreductase; scaffold37 indexed_genome mRNA 27227409 27243239 . - . ID=transcript_7691;Q9UL45,Biogenesis of lysosome-related organelles complex 1 subunit 6,Pallid protein homolog;Pallidin;Syntaxin 13-interacting protein;, PF14712;, GO:1904115;GO:0031083;GO:0005737;GO:0005829;GO:0019898;GO:0098793;GO:0030133;GO:0051015;GO:0042802;GO:0042803;GO:0019905;GO:0008089;GO:0048490;GO:0035646;GO:0046907;GO:0032438;GO:0032402;GO:0031175;GO:0050942;GO:0006892;GO:0016081;, C:axon cytoplasm; C:BLOC-1 complex; C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:presynapse; C:transport vesicle;, F:actin filament binding; F:identical protein binding; F:protein homodimerization activity; F:syntaxin binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endosome to melanosome transport; P:intracellular transport; P:melanosome organization; P:melanosome transport; P:neuron projection development; P:positive regulation of pigment cell differentiation; P:post-Golgi vesicle-mediated transport; P:synaptic vesicle docking;|Q9UL45,Biogenesis of lysosome-related organelles complex 1 subunit 6,Pallid protein homolog;Pallidin;Syntaxin 13-interacting protein;, PF14712;, GO:1904115;GO:0031083;GO:0005737;GO:0005829;GO:0019898;GO:0098793;GO:0030133;GO:0051015;GO:0042802;GO:0042803;GO:0019905;GO:0008089;GO:0048490;GO:0035646;GO:0046907;GO:0032438;GO:0032402;GO:0031175;GO:0050942;GO:0006892;GO:0016081;, C:axon cytoplasm; C:BLOC-1 complex; C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:presynapse; C:transport vesicle;, F:actin filament binding; F:identical protein binding; F:protein homodimerization activity; F:syntaxin binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endosome to melanosome transport; P:intracellular transport; P:melanosome organization; P:melanosome transport; P:neuron projection development; P:positive regulation of pigment cell differentiation; P:post-Golgi vesicle-mediated transport; P:synaptic vesicle docking; scaffold37 indexed_genome mRNA 27292295 27318532 . + . ID=transcript_7692;O14863 Q8TC39,Zinc transporter 4,Solute carrier family 30 member 4;, PF01545;, GO:0005737;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005886;GO:0005385;GO:0061088;GO:0009636;GO:0010043;GO:0055069;GO:0071577;, C:cytoplasm; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:zinc ion transmembrane transporter activity;, P:regulation of sequestering of zinc ion; P:response to toxic substance; P:response to zinc ion; P:zinc ion homeostasis; P:zinc ion transmembrane transport;|O14863 Q8TC39,Zinc transporter 4,Solute carrier family 30 member 4;, PF01545;, GO:0005737;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005886;GO:0005385;GO:0061088;GO:0009636;GO:0010043;GO:0055069;GO:0071577;, C:cytoplasm; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:zinc ion transmembrane transporter activity;, P:regulation of sequestering of zinc ion; P:response to toxic substance; P:response to zinc ion; P:zinc ion homeostasis; P:zinc ion transmembrane transport;|O14863 Q8TC39,Zinc transporter 4,Solute carrier family 30 member 4;, PF01545;, GO:0005737;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005886;GO:0005385;GO:0061088;GO:0009636;GO:0010043;GO:0055069;GO:0071577;, C:cytoplasm; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:zinc ion transmembrane transporter activity;, P:regulation of sequestering of zinc ion; P:response to toxic substance; P:response to zinc ion; P:zinc ion homeostasis; P:zinc ion transmembrane transport; scaffold37 indexed_genome mRNA 27318572 27324960 . - . ID=transcript_7693;O14863 Q8TC39,Zinc transporter 4,Solute carrier family 30 member 4;, PF01545;, GO:0005737;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005886;GO:0005385;GO:0061088;GO:0009636;GO:0010043;GO:0055069;GO:0071577;, C:cytoplasm; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane;, F:zinc ion transmembrane transporter activity;, P:regulation of sequestering of zinc ion; P:response to toxic substance; P:response to zinc ion; P:zinc ion homeostasis; P:zinc ion transmembrane transport; scaffold37 indexed_genome mRNA 27356606 27360766 . - . ID=transcript_7694;Q9C002,Normal mucosa of esophagus-specific gene 1 protein,Protein FOAP-11;, PF06522;, GO:0005751;GO:0005634;GO:0022900;GO:1902600;, C:mitochondrial respiratory chain complex IV; C:nucleus;, , P:electron transport chain; P:proton transmembrane transport; scaffold37 indexed_genome mRNA 27369264 27373515 . - . ID=transcript_7695;Q9BVQ7 C9JHR5 Q9H8W7 Q9HA41,Spermatogenesis-associated protein 5-like protein 1,, PF00004;PF17862;, GO:0005737;GO:0005819;GO:0005524;GO:0016887;, C:cytoplasm; C:spindle;, F:ATP binding; F:ATPase activity; scaffold37 indexed_genome mRNA 27373823 27385723 . + . ID=transcript_7696;Q9BVQ7 C9JHR5 Q9H8W7 Q9HA41,Spermatogenesis-associated protein 5-like protein 1,, PF00004;PF17862;, GO:0005737;GO:0005819;GO:0005524;GO:0016887;, C:cytoplasm; C:spindle;, F:ATP binding; F:ATPase activity;|Q9BVQ7 C9JHR5 Q9H8W7 Q9HA41,Spermatogenesis-associated protein 5-like protein 1,, PF00004;PF17862;, GO:0005737;GO:0005819;GO:0005524;GO:0016887;, C:cytoplasm; C:spindle;, F:ATP binding; F:ATPase activity;|Q9BVQ7 C9JHR5 Q9H8W7 Q9HA41,Spermatogenesis-associated protein 5-like protein 1,, PF00004;PF17862;, GO:0005737;GO:0005819;GO:0005524;GO:0016887;, C:cytoplasm; C:spindle;, F:ATP binding; F:ATPase activity; scaffold37 indexed_genome mRNA 27422017 27422634 . - . ID=transcript_7697;P50440 B4DH99 B4DPI3 Q53EQ4,Glycine amidinotransferase, mitochondrial,L-arginine:glycine amidinotransferase;Transamidinase;, , GO:0070062;GO:0005743;GO:0005758;GO:0005739;GO:0015067;GO:0015068;GO:0006601;GO:0006600;GO:0007611;GO:0007275;GO:0014889;GO:0120162;, C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:amidinotransferase activity; F:glycine amidinotransferase activity;, P:creatine biosynthetic process; P:creatine metabolic process; P:learning or memory; P:multicellular organism development; P:muscle atrophy; P:positive regulation of cold-induced thermogenesis; scaffold37 indexed_genome mRNA 27422674 27437857 . + . ID=transcript_7698;P50440 B4DH99 B4DPI3 Q53EQ4,Glycine amidinotransferase, mitochondrial,L-arginine:glycine amidinotransferase;Transamidinase;, , GO:0070062;GO:0005743;GO:0005758;GO:0005739;GO:0015067;GO:0015068;GO:0006601;GO:0006600;GO:0007611;GO:0007275;GO:0014889;GO:0120162;, C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:amidinotransferase activity; F:glycine amidinotransferase activity;, P:creatine biosynthetic process; P:creatine metabolic process; P:learning or memory; P:multicellular organism development; P:muscle atrophy; P:positive regulation of cold-induced thermogenesis;|P50440 B4DH99 B4DPI3 Q53EQ4,Glycine amidinotransferase, mitochondrial,L-arginine:glycine amidinotransferase;Transamidinase;, , GO:0070062;GO:0005743;GO:0005758;GO:0005739;GO:0015067;GO:0015068;GO:0006601;GO:0006600;GO:0007611;GO:0007275;GO:0014889;GO:0120162;, C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:amidinotransferase activity; F:glycine amidinotransferase activity;, P:creatine biosynthetic process; P:creatine metabolic process; P:learning or memory; P:multicellular organism development; P:muscle atrophy; P:positive regulation of cold-induced thermogenesis;|P50440 B4DH99 B4DPI3 Q53EQ4,Glycine amidinotransferase, mitochondrial,L-arginine:glycine amidinotransferase;Transamidinase;, , GO:0070062;GO:0005743;GO:0005758;GO:0005739;GO:0015067;GO:0015068;GO:0006601;GO:0006600;GO:0007611;GO:0007275;GO:0014889;GO:0120162;, C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:amidinotransferase activity; F:glycine amidinotransferase activity;, P:creatine biosynthetic process; P:creatine metabolic process; P:learning or memory; P:multicellular organism development; P:muscle atrophy; P:positive regulation of cold-induced thermogenesis;|P50440 B4DH99 B4DPI3 Q53EQ4,Glycine amidinotransferase, mitochondrial,L-arginine:glycine amidinotransferase;Transamidinase;, , GO:0070062;GO:0005743;GO:0005758;GO:0005739;GO:0015067;GO:0015068;GO:0006601;GO:0006600;GO:0007611;GO:0007275;GO:0014889;GO:0120162;, C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:amidinotransferase activity; F:glycine amidinotransferase activity;, P:creatine biosynthetic process; P:creatine metabolic process; P:learning or memory; P:multicellular organism development; P:muscle atrophy; P:positive regulation of cold-induced thermogenesis;|P50440 B4DH99 B4DPI3 Q53EQ4,Glycine amidinotransferase, mitochondrial,L-arginine:glycine amidinotransferase;Transamidinase;, , GO:0070062;GO:0005743;GO:0005758;GO:0005739;GO:0015067;GO:0015068;GO:0006601;GO:0006600;GO:0007611;GO:0007275;GO:0014889;GO:0120162;, C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:amidinotransferase activity; F:glycine amidinotransferase activity;, P:creatine biosynthetic process; P:creatine metabolic process; P:learning or memory; P:multicellular organism development; P:muscle atrophy; P:positive regulation of cold-induced thermogenesis;|P50440 B4DH99 B4DPI3 Q53EQ4,Glycine amidinotransferase, mitochondrial,L-arginine:glycine amidinotransferase;Transamidinase;, , GO:0070062;GO:0005743;GO:0005758;GO:0005739;GO:0015067;GO:0015068;GO:0006601;GO:0006600;GO:0007611;GO:0007275;GO:0014889;GO:0120162;, C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:amidinotransferase activity; F:glycine amidinotransferase activity;, P:creatine biosynthetic process; P:creatine metabolic process; P:learning or memory; P:multicellular organism development; P:muscle atrophy; P:positive regulation of cold-induced thermogenesis;|P50440 B4DH99 B4DPI3 Q53EQ4,Glycine amidinotransferase, mitochondrial,L-arginine:glycine amidinotransferase;Transamidinase;, , GO:0070062;GO:0005743;GO:0005758;GO:0005739;GO:0015067;GO:0015068;GO:0006601;GO:0006600;GO:0007611;GO:0007275;GO:0014889;GO:0120162;, C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:amidinotransferase activity; F:glycine amidinotransferase activity;, P:creatine biosynthetic process; P:creatine metabolic process; P:learning or memory; P:multicellular organism development; P:muscle atrophy; P:positive regulation of cold-induced thermogenesis;|P50440 B4DH99 B4DPI3 Q53EQ4,Glycine amidinotransferase, mitochondrial,L-arginine:glycine amidinotransferase;Transamidinase;, , GO:0070062;GO:0005743;GO:0005758;GO:0005739;GO:0015067;GO:0015068;GO:0006601;GO:0006600;GO:0007611;GO:0007275;GO:0014889;GO:0120162;, C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:amidinotransferase activity; F:glycine amidinotransferase activity;, P:creatine biosynthetic process; P:creatine metabolic process; P:learning or memory; P:multicellular organism development; P:muscle atrophy; P:positive regulation of cold-induced thermogenesis;|P50440 B4DH99 B4DPI3 Q53EQ4,Glycine amidinotransferase, mitochondrial,L-arginine:glycine amidinotransferase;Transamidinase;, , GO:0070062;GO:0005743;GO:0005758;GO:0005739;GO:0015067;GO:0015068;GO:0006601;GO:0006600;GO:0007611;GO:0007275;GO:0014889;GO:0120162;, C:extracellular exosome; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:amidinotransferase activity; F:glycine amidinotransferase activity;, P:creatine biosynthetic process; P:creatine metabolic process; P:learning or memory; P:multicellular organism development; P:muscle atrophy; P:positive regulation of cold-induced thermogenesis; scaffold37 indexed_genome mRNA 27488371 27504703 . - . ID=transcript_7699;O43868 A8K7F9 O43239 Q52LZ0,Sodium/nucleoside cotransporter 2,Concentrative nucleoside transporter 2;Na(+)/nucleoside cotransporter 2;Sodium-coupled nucleoside transporter 2;Sodium/purine nucleoside co-transporter;Solute carrier family 28 member 2;, PF07670;PF07662;PF01773;, GO:0031526;GO:0030135;GO:0005887;GO:0016020;GO:0005886;GO:0012506;GO:1901474;GO:0005326;GO:0005337;GO:0005415;GO:0005345;GO:0015211;GO:0015389;GO:0015293;GO:0015213;GO:0032238;GO:0045117;GO:0035340;GO:0006836;GO:0006139;GO:1901642;GO:1904823;GO:0015860;GO:0072531;GO:0001895;GO:0150104;GO:0015862;, C:brush border membrane; C:coated vesicle; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle membrane;, F:azole transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:nucleoside:sodium symporter activity; F:purine nucleobase transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:pyrimidine- and adenine-specific:sodium symporter activity; F:symporter activity; F:uridine transmembrane transporter activity;, P:adenosine transport; P:azole transmembrane transport; P:inosine transport; P:neurotransmitter transport; P:nucleobase-containing compound metabolic process; P:nucleoside transmembrane transport; P:purine nucleobase transmembrane transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:retina homeostasis; P:transport across blood-brain barrier; P:uridine transport;|O43868 A8K7F9 O43239 Q52LZ0,Sodium/nucleoside cotransporter 2,Concentrative nucleoside transporter 2;Na(+)/nucleoside cotransporter 2;Sodium-coupled nucleoside transporter 2;Sodium/purine nucleoside co-transporter;Solute carrier family 28 member 2;, PF07670;PF07662;PF01773;, GO:0031526;GO:0030135;GO:0005887;GO:0016020;GO:0005886;GO:0012506;GO:1901474;GO:0005326;GO:0005337;GO:0005415;GO:0005345;GO:0015211;GO:0015389;GO:0015293;GO:0015213;GO:0032238;GO:0045117;GO:0035340;GO:0006836;GO:0006139;GO:1901642;GO:1904823;GO:0015860;GO:0072531;GO:0001895;GO:0150104;GO:0015862;, C:brush border membrane; C:coated vesicle; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle membrane;, F:azole transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:nucleoside:sodium symporter activity; F:purine nucleobase transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:pyrimidine- and adenine-specific:sodium symporter activity; F:symporter activity; F:uridine transmembrane transporter activity;, P:adenosine transport; P:azole transmembrane transport; P:inosine transport; P:neurotransmitter transport; P:nucleobase-containing compound metabolic process; P:nucleoside transmembrane transport; P:purine nucleobase transmembrane transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:retina homeostasis; P:transport across blood-brain barrier; P:uridine transport; scaffold37 indexed_genome mRNA 27505043 27505768 . - . ID=transcript_7700;O43868 A8K7F9 O43239 Q52LZ0,Sodium/nucleoside cotransporter 2,Concentrative nucleoside transporter 2;Na(+)/nucleoside cotransporter 2;Sodium-coupled nucleoside transporter 2;Sodium/purine nucleoside co-transporter;Solute carrier family 28 member 2;, PF07670;PF07662;PF01773;, GO:0031526;GO:0030135;GO:0005887;GO:0016020;GO:0005886;GO:0012506;GO:1901474;GO:0005326;GO:0005337;GO:0005415;GO:0005345;GO:0015211;GO:0015389;GO:0015293;GO:0015213;GO:0032238;GO:0045117;GO:0035340;GO:0006836;GO:0006139;GO:1901642;GO:1904823;GO:0015860;GO:0072531;GO:0001895;GO:0150104;GO:0015862;, C:brush border membrane; C:coated vesicle; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle membrane;, F:azole transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:nucleoside:sodium symporter activity; F:purine nucleobase transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:pyrimidine- and adenine-specific:sodium symporter activity; F:symporter activity; F:uridine transmembrane transporter activity;, P:adenosine transport; P:azole transmembrane transport; P:inosine transport; P:neurotransmitter transport; P:nucleobase-containing compound metabolic process; P:nucleoside transmembrane transport; P:purine nucleobase transmembrane transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:retina homeostasis; P:transport across blood-brain barrier; P:uridine transport; scaffold37 indexed_genome mRNA 27506512 27519228 . - . ID=transcript_7701;O43868 A8K7F9 O43239 Q52LZ0,Sodium/nucleoside cotransporter 2,Concentrative nucleoside transporter 2;Na(+)/nucleoside cotransporter 2;Sodium-coupled nucleoside transporter 2;Sodium/purine nucleoside co-transporter;Solute carrier family 28 member 2;, PF07670;PF07662;PF01773;, GO:0031526;GO:0030135;GO:0005887;GO:0016020;GO:0005886;GO:0012506;GO:1901474;GO:0005326;GO:0005337;GO:0005415;GO:0005345;GO:0015211;GO:0015389;GO:0015293;GO:0015213;GO:0032238;GO:0045117;GO:0035340;GO:0006836;GO:0006139;GO:1901642;GO:1904823;GO:0015860;GO:0072531;GO:0001895;GO:0150104;GO:0015862;, C:brush border membrane; C:coated vesicle; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle membrane;, F:azole transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:nucleoside:sodium symporter activity; F:purine nucleobase transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:pyrimidine- and adenine-specific:sodium symporter activity; F:symporter activity; F:uridine transmembrane transporter activity;, P:adenosine transport; P:azole transmembrane transport; P:inosine transport; P:neurotransmitter transport; P:nucleobase-containing compound metabolic process; P:nucleoside transmembrane transport; P:purine nucleobase transmembrane transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:retina homeostasis; P:transport across blood-brain barrier; P:uridine transport; scaffold37 indexed_genome mRNA 27552984 27567786 . + . ID=transcript_7702;Q7M4L6 Q96IE8,SH2 domain-containing adapter protein F,, PF00017;, GO:0001784;GO:0006915;, , F:phosphotyrosine residue binding;, P:apoptotic process;|Q7M4L6 Q96IE8,SH2 domain-containing adapter protein F,, PF00017;, GO:0001784;GO:0006915;, , F:phosphotyrosine residue binding;, P:apoptotic process;|Q7M4L6 Q96IE8,SH2 domain-containing adapter protein F,, PF00017;, GO:0001784;GO:0006915;, , F:phosphotyrosine residue binding;, P:apoptotic process; scaffold37 indexed_genome mRNA 27567838 27573069 . + . ID=transcript_7703;Q7M4L6 Q96IE8,SH2 domain-containing adapter protein F,, PF00017;, GO:0001784;GO:0006915;, , F:phosphotyrosine residue binding;, P:apoptotic process; scaffold37 indexed_genome mRNA 27584029 27585000 . + . ID=transcript_7704;Q9NRD9 A6NH28 Q14C94 Q6ZMB3 Q6ZR09 Q9NZC1,Dual oxidase 1,Large NOX 1;Long NOX 1;NADPH thyroid oxidase 1;Thyroid oxidase 1;, PF03098;PF00036;PF08022;PF01794;PF08030;, GO:0016324;GO:0031252;GO:0009986;GO:0005783;GO:0043020;GO:0005886;GO:0005509;GO:0020037;GO:0016174;GO:0106293;GO:0050661;GO:0106294;GO:0004601;GO:0016175;GO:0042335;GO:0019221;GO:0006952;GO:0042446;GO:0050665;GO:0042744;GO:2000147;GO:0090303;GO:0051591;GO:0006979;GO:0042554;GO:0006590;, C:apical plasma membrane; C:cell leading edge; C:cell surface; C:endoplasmic reticulum; C:NADPH oxidase complex; C:plasma membrane;, F:calcium ion binding; F:heme binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH oxidase H202-forming activity; F:NADP binding; F:NADPH oxidase H202-forming activity; F:peroxidase activity; F:superoxide-generating NAD(P)H oxidase activity;, P:cuticle development; P:cytokine-mediated signaling pathway; P:defense response; P:hormone biosynthetic process; P:hydrogen peroxide biosynthetic process; P:hydrogen peroxide catabolic process; P:positive regulation of cell motility; P:positive regulation of wound healing; P:response to cAMP; P:response to oxidative stress; P:superoxide anion generation; P:thyroid hormone generation; scaffold37 indexed_genome mRNA 27630420 27633648 . - . ID=transcript_7705;Q1HG44 B2RPI9 H0YNQ6,Dual oxidase maturation factor 2,Dual oxidase activator 2;, PF10204;, GO:0045177;GO:0031252;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0019899;GO:0034613;GO:0042743;GO:2000147;GO:0010729;GO:0008104;GO:0051604;GO:0015031;GO:0050727;GO:2000609;, C:apical part of cell; C:cell leading edge; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:enzyme binding;, P:cellular protein localization; P:hydrogen peroxide metabolic process; P:positive regulation of cell motility; P:positive regulation of hydrogen peroxide biosynthetic process; P:protein localization; P:protein maturation; P:protein transport; P:regulation of inflammatory response; P:regulation of thyroid hormone generation; scaffold37 indexed_genome mRNA 27642005 27652239 . + . ID=transcript_7706;Q9NRD8 A8MQ13 D2XI64 Q9NR02 Q9UHF9,Dual oxidase 2,Large NOX 2;Long NOX 2;NADH/NADPH thyroid oxidase p138-tox;NADPH oxidase/peroxidase DUOX2;NADPH thyroid oxidase 2;Thyroid oxidase 2;p138 thyroid oxidase;, PF03098;PF00036;PF08022;PF01794;PF08030;, GO:0045177;GO:0016324;GO:0030054;GO:0031252;GO:0009986;GO:0005829;GO:0005783;GO:0070062;GO:0043020;GO:0005886;GO:0005509;GO:0020037;GO:0016174;GO:0106293;GO:0106294;GO:0004601;GO:0016175;GO:0042335;GO:0019221;GO:0006952;GO:0042446;GO:0050665;GO:0042744;GO:2000147;GO:0090303;GO:0051591;GO:0006979;GO:0009615;GO:0042554;GO:0006590;, C:apical part of cell; C:apical plasma membrane; C:cell junction; C:cell leading edge; C:cell surface; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:NADPH oxidase complex; C:plasma membrane;, F:calcium ion binding; F:heme binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH oxidase H202-forming activity; F:NADPH oxidase H202-forming activity; F:peroxidase activity; F:superoxide-generating NAD(P)H oxidase activity;, P:cuticle development; P:cytokine-mediated signaling pathway; P:defense response; P:hormone biosynthetic process; P:hydrogen peroxide biosynthetic process; P:hydrogen peroxide catabolic process; P:positive regulation of cell motility; P:positive regulation of wound healing; P:response to cAMP; P:response to oxidative stress; P:response to virus; P:superoxide anion generation; P:thyroid hormone generation;|Q9NRD8 A8MQ13 D2XI64 Q9NR02 Q9UHF9,Dual oxidase 2,Large NOX 2;Long NOX 2;NADH/NADPH thyroid oxidase p138-tox;NADPH oxidase/peroxidase DUOX2;NADPH thyroid oxidase 2;Thyroid oxidase 2;p138 thyroid oxidase;, PF03098;PF00036;PF08022;PF01794;PF08030;, GO:0045177;GO:0016324;GO:0030054;GO:0031252;GO:0009986;GO:0005829;GO:0005783;GO:0070062;GO:0043020;GO:0005886;GO:0005509;GO:0020037;GO:0016174;GO:0106293;GO:0106294;GO:0004601;GO:0016175;GO:0042335;GO:0019221;GO:0006952;GO:0042446;GO:0050665;GO:0042744;GO:2000147;GO:0090303;GO:0051591;GO:0006979;GO:0009615;GO:0042554;GO:0006590;, C:apical part of cell; C:apical plasma membrane; C:cell junction; C:cell leading edge; C:cell surface; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:NADPH oxidase complex; C:plasma membrane;, F:calcium ion binding; F:heme binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH oxidase H202-forming activity; F:NADPH oxidase H202-forming activity; F:peroxidase activity; F:superoxide-generating NAD(P)H oxidase activity;, P:cuticle development; P:cytokine-mediated signaling pathway; P:defense response; P:hormone biosynthetic process; P:hydrogen peroxide biosynthetic process; P:hydrogen peroxide catabolic process; P:positive regulation of cell motility; P:positive regulation of wound healing; P:response to cAMP; P:response to oxidative stress; P:response to virus; P:superoxide anion generation; P:thyroid hormone generation;|Q9NRD8 A8MQ13 D2XI64 Q9NR02 Q9UHF9,Dual oxidase 2,Large NOX 2;Long NOX 2;NADH/NADPH thyroid oxidase p138-tox;NADPH oxidase/peroxidase DUOX2;NADPH thyroid oxidase 2;Thyroid oxidase 2;p138 thyroid oxidase;, PF03098;PF00036;PF08022;PF01794;PF08030;, GO:0045177;GO:0016324;GO:0030054;GO:0031252;GO:0009986;GO:0005829;GO:0005783;GO:0070062;GO:0043020;GO:0005886;GO:0005509;GO:0020037;GO:0016174;GO:0106293;GO:0106294;GO:0004601;GO:0016175;GO:0042335;GO:0019221;GO:0006952;GO:0042446;GO:0050665;GO:0042744;GO:2000147;GO:0090303;GO:0051591;GO:0006979;GO:0009615;GO:0042554;GO:0006590;, C:apical part of cell; C:apical plasma membrane; C:cell junction; C:cell leading edge; C:cell surface; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:NADPH oxidase complex; C:plasma membrane;, F:calcium ion binding; F:heme binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH oxidase H202-forming activity; F:NADPH oxidase H202-forming activity; F:peroxidase activity; F:superoxide-generating NAD(P)H oxidase activity;, P:cuticle development; P:cytokine-mediated signaling pathway; P:defense response; P:hormone biosynthetic process; P:hydrogen peroxide biosynthetic process; P:hydrogen peroxide catabolic process; P:positive regulation of cell motility; P:positive regulation of wound healing; P:response to cAMP; P:response to oxidative stress; P:response to virus; P:superoxide anion generation; P:thyroid hormone generation; scaffold37 indexed_genome mRNA 27664326 27697350 . - . ID=transcript_7707;Q00796 B2R655 B7Z3A6 J3JZZ5 Q16682 Q9UMD6,Sorbitol dehydrogenase {ECO:0000303|PubMed:12962626, ECO:0000303|PubMed:3365415, ECO:0000303|PubMed:8088829},(R,R)-butanediol dehydrogenase {ECO:0000305|PubMed:3365415};L-iditol 2-dehydrogenase;Polyol dehydrogenase {ECO:0000303|PubMed:3365415};Ribitol dehydrogenase {ECO:0000305|PubMed:3365415};Xylitol dehydrogenase {ECO:0000303|PubMed:3365415};, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0031966;GO:0031514;GO:0000721;GO:0030246;GO:0046526;GO:0042802;GO:0003939;GO:0051287;GO:0050255;GO:0008270;GO:0030317;GO:0046370;GO:0006006;GO:0019640;GO:0051160;GO:0051164;GO:0046686;GO:0046688;GO:0042493;GO:0009725;GO:0031667;GO:0006970;GO:0006062;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:mitochondrial membrane; C:motile cilium;, F:(R,R)-butanediol dehydrogenase activity; F:carbohydrate binding; F:D-xylulose reductase activity; F:identical protein binding; F:L-iditol 2-dehydrogenase activity; F:NAD binding; F:ribitol 2-dehydrogenase activity; F:zinc ion binding;, P:flagellated sperm motility; P:fructose biosynthetic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:L-xylitol catabolic process; P:L-xylitol metabolic process; P:response to cadmium ion; P:response to copper ion; P:response to drug; P:response to hormone; P:response to nutrient levels; P:response to osmotic stress; P:sorbitol catabolic process;|Q00796 B2R655 B7Z3A6 J3JZZ5 Q16682 Q9UMD6,Sorbitol dehydrogenase {ECO:0000303|PubMed:12962626, ECO:0000303|PubMed:3365415, ECO:0000303|PubMed:8088829},(R,R)-butanediol dehydrogenase {ECO:0000305|PubMed:3365415};L-iditol 2-dehydrogenase;Polyol dehydrogenase {ECO:0000303|PubMed:3365415};Ribitol dehydrogenase {ECO:0000305|PubMed:3365415};Xylitol dehydrogenase {ECO:0000303|PubMed:3365415};, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0031966;GO:0031514;GO:0000721;GO:0030246;GO:0046526;GO:0042802;GO:0003939;GO:0051287;GO:0050255;GO:0008270;GO:0030317;GO:0046370;GO:0006006;GO:0019640;GO:0051160;GO:0051164;GO:0046686;GO:0046688;GO:0042493;GO:0009725;GO:0031667;GO:0006970;GO:0006062;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:mitochondrial membrane; C:motile cilium;, F:(R,R)-butanediol dehydrogenase activity; F:carbohydrate binding; F:D-xylulose reductase activity; F:identical protein binding; F:L-iditol 2-dehydrogenase activity; F:NAD binding; F:ribitol 2-dehydrogenase activity; F:zinc ion binding;, P:flagellated sperm motility; P:fructose biosynthetic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:L-xylitol catabolic process; P:L-xylitol metabolic process; P:response to cadmium ion; P:response to copper ion; P:response to drug; P:response to hormone; P:response to nutrient levels; P:response to osmotic stress; P:sorbitol catabolic process;|Q00796 B2R655 B7Z3A6 J3JZZ5 Q16682 Q9UMD6,Sorbitol dehydrogenase {ECO:0000303|PubMed:12962626, ECO:0000303|PubMed:3365415, ECO:0000303|PubMed:8088829},(R,R)-butanediol dehydrogenase {ECO:0000305|PubMed:3365415};L-iditol 2-dehydrogenase;Polyol dehydrogenase {ECO:0000303|PubMed:3365415};Ribitol dehydrogenase {ECO:0000305|PubMed:3365415};Xylitol dehydrogenase {ECO:0000303|PubMed:3365415};, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0031966;GO:0031514;GO:0000721;GO:0030246;GO:0046526;GO:0042802;GO:0003939;GO:0051287;GO:0050255;GO:0008270;GO:0030317;GO:0046370;GO:0006006;GO:0019640;GO:0051160;GO:0051164;GO:0046686;GO:0046688;GO:0042493;GO:0009725;GO:0031667;GO:0006970;GO:0006062;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:mitochondrial membrane; C:motile cilium;, F:(R,R)-butanediol dehydrogenase activity; F:carbohydrate binding; F:D-xylulose reductase activity; F:identical protein binding; F:L-iditol 2-dehydrogenase activity; F:NAD binding; F:ribitol 2-dehydrogenase activity; F:zinc ion binding;, P:flagellated sperm motility; P:fructose biosynthetic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:L-xylitol catabolic process; P:L-xylitol metabolic process; P:response to cadmium ion; P:response to copper ion; P:response to drug; P:response to hormone; P:response to nutrient levels; P:response to osmotic stress; P:sorbitol catabolic process;|Q00796 B2R655 B7Z3A6 J3JZZ5 Q16682 Q9UMD6,Sorbitol dehydrogenase {ECO:0000303|PubMed:12962626, ECO:0000303|PubMed:3365415, ECO:0000303|PubMed:8088829},(R,R)-butanediol dehydrogenase {ECO:0000305|PubMed:3365415};L-iditol 2-dehydrogenase;Polyol dehydrogenase {ECO:0000303|PubMed:3365415};Ribitol dehydrogenase {ECO:0000305|PubMed:3365415};Xylitol dehydrogenase {ECO:0000303|PubMed:3365415};, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0031966;GO:0031514;GO:0000721;GO:0030246;GO:0046526;GO:0042802;GO:0003939;GO:0051287;GO:0050255;GO:0008270;GO:0030317;GO:0046370;GO:0006006;GO:0019640;GO:0051160;GO:0051164;GO:0046686;GO:0046688;GO:0042493;GO:0009725;GO:0031667;GO:0006970;GO:0006062;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:mitochondrial membrane; C:motile cilium;, F:(R,R)-butanediol dehydrogenase activity; F:carbohydrate binding; F:D-xylulose reductase activity; F:identical protein binding; F:L-iditol 2-dehydrogenase activity; F:NAD binding; F:ribitol 2-dehydrogenase activity; F:zinc ion binding;, P:flagellated sperm motility; P:fructose biosynthetic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:L-xylitol catabolic process; P:L-xylitol metabolic process; P:response to cadmium ion; P:response to copper ion; P:response to drug; P:response to hormone; P:response to nutrient levels; P:response to osmotic stress; P:sorbitol catabolic process;|Q00796 B2R655 B7Z3A6 J3JZZ5 Q16682 Q9UMD6,Sorbitol dehydrogenase {ECO:0000303|PubMed:12962626, ECO:0000303|PubMed:3365415, ECO:0000303|PubMed:8088829},(R,R)-butanediol dehydrogenase {ECO:0000305|PubMed:3365415};L-iditol 2-dehydrogenase;Polyol dehydrogenase {ECO:0000303|PubMed:3365415};Ribitol dehydrogenase {ECO:0000305|PubMed:3365415};Xylitol dehydrogenase {ECO:0000303|PubMed:3365415};, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0031966;GO:0031514;GO:0000721;GO:0030246;GO:0046526;GO:0042802;GO:0003939;GO:0051287;GO:0050255;GO:0008270;GO:0030317;GO:0046370;GO:0006006;GO:0019640;GO:0051160;GO:0051164;GO:0046686;GO:0046688;GO:0042493;GO:0009725;GO:0031667;GO:0006970;GO:0006062;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:mitochondrial membrane; C:motile cilium;, F:(R,R)-butanediol dehydrogenase activity; F:carbohydrate binding; F:D-xylulose reductase activity; F:identical protein binding; F:L-iditol 2-dehydrogenase activity; F:NAD binding; F:ribitol 2-dehydrogenase activity; F:zinc ion binding;, P:flagellated sperm motility; P:fructose biosynthetic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:L-xylitol catabolic process; P:L-xylitol metabolic process; P:response to cadmium ion; P:response to copper ion; P:response to drug; P:response to hormone; P:response to nutrient levels; P:response to osmotic stress; P:sorbitol catabolic process;|Q00796 B2R655 B7Z3A6 J3JZZ5 Q16682 Q9UMD6,Sorbitol dehydrogenase {ECO:0000303|PubMed:12962626, ECO:0000303|PubMed:3365415, ECO:0000303|PubMed:8088829},(R,R)-butanediol dehydrogenase {ECO:0000305|PubMed:3365415};L-iditol 2-dehydrogenase;Polyol dehydrogenase {ECO:0000303|PubMed:3365415};Ribitol dehydrogenase {ECO:0000305|PubMed:3365415};Xylitol dehydrogenase {ECO:0000303|PubMed:3365415};, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0031966;GO:0031514;GO:0000721;GO:0030246;GO:0046526;GO:0042802;GO:0003939;GO:0051287;GO:0050255;GO:0008270;GO:0030317;GO:0046370;GO:0006006;GO:0019640;GO:0051160;GO:0051164;GO:0046686;GO:0046688;GO:0042493;GO:0009725;GO:0031667;GO:0006970;GO:0006062;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:mitochondrial membrane; C:motile cilium;, F:(R,R)-butanediol dehydrogenase activity; F:carbohydrate binding; F:D-xylulose reductase activity; F:identical protein binding; F:L-iditol 2-dehydrogenase activity; F:NAD binding; F:ribitol 2-dehydrogenase activity; F:zinc ion binding;, P:flagellated sperm motility; P:fructose biosynthetic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:L-xylitol catabolic process; P:L-xylitol metabolic process; P:response to cadmium ion; P:response to copper ion; P:response to drug; P:response to hormone; P:response to nutrient levels; P:response to osmotic stress; P:sorbitol catabolic process;|Q00796 B2R655 B7Z3A6 J3JZZ5 Q16682 Q9UMD6,Sorbitol dehydrogenase {ECO:0000303|PubMed:12962626, ECO:0000303|PubMed:3365415, ECO:0000303|PubMed:8088829},(R,R)-butanediol dehydrogenase {ECO:0000305|PubMed:3365415};L-iditol 2-dehydrogenase;Polyol dehydrogenase {ECO:0000303|PubMed:3365415};Ribitol dehydrogenase {ECO:0000305|PubMed:3365415};Xylitol dehydrogenase {ECO:0000303|PubMed:3365415};, PF08240;PF00107;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0031966;GO:0031514;GO:0000721;GO:0030246;GO:0046526;GO:0042802;GO:0003939;GO:0051287;GO:0050255;GO:0008270;GO:0030317;GO:0046370;GO:0006006;GO:0019640;GO:0051160;GO:0051164;GO:0046686;GO:0046688;GO:0042493;GO:0009725;GO:0031667;GO:0006970;GO:0006062;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:mitochondrial membrane; C:motile cilium;, F:(R,R)-butanediol dehydrogenase activity; F:carbohydrate binding; F:D-xylulose reductase activity; F:identical protein binding; F:L-iditol 2-dehydrogenase activity; F:NAD binding; F:ribitol 2-dehydrogenase activity; F:zinc ion binding;, P:flagellated sperm motility; P:fructose biosynthetic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:L-xylitol catabolic process; P:L-xylitol metabolic process; P:response to cadmium ion; P:response to copper ion; P:response to drug; P:response to hormone; P:response to nutrient levels; P:response to osmotic stress; P:sorbitol catabolic process; scaffold37 indexed_genome mRNA 27744467 27745211 . - . ID=transcript_7708;P10515 Q16783 Q53EP3,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial,70 kDa mitochondrial autoantigen of primary biliary cirrhosis;Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex;M2 antigen complex 70 kDa subunit;Pyruvate dehydrogenase complex component E2;, PF00198;PF00364;PF02817;, GO:0043231;GO:0005759;GO:0005967;GO:0005739;GO:0045254;GO:0004742;GO:0042802;GO:0006086;GO:0006006;GO:0006090;GO:0030431;GO:0006099;, C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:pyruvate dehydrogenase complex;, F:dihydrolipoyllysine-residue acetyltransferase activity; F:identical protein binding;, P:acetyl-CoA biosynthetic process from pyruvate; P:glucose metabolic process; P:pyruvate metabolic process; P:sleep; P:tricarboxylic acid cycle; scaffold37 indexed_genome mRNA 27865729 27937329 . - . ID=transcript_7709;Q96AC1 B5TJY2 Q14840 Q86TY7,Fermitin family homolog 2,Kindlin-2;Mitogen-inducible gene 2 protein;Pleckstrin homology domain-containing family C member 1;, PF00373;PF18124;PF00169;, GO:0005912;GO:0005938;GO:0030054;GO:0009986;GO:0030055;GO:0005737;GO:0005829;GO:0031234;GO:0005925;GO:0031674;GO:0031258;GO:0005654;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0051015;GO:0005178;GO:0005547;GO:0019901;GO:0046332;GO:0034713;GO:0034334;GO:0007155;GO:0034329;GO:0007160;GO:0048041;GO:0033622;GO:0007229;GO:0060173;GO:0060548;GO:0045599;GO:0043116;GO:0030335;GO:0010718;GO:0070374;GO:0051894;GO:0043547;GO:0033625;GO:1902462;GO:0035505;GO:0045669;GO:0051897;GO:1900182;GO:0051496;GO:1900026;GO:1903691;GO:1902414;GO:0072657;GO:0022604;GO:0008360;GO:0034446;GO:0007179;GO:0016055;, C:adherens junction; C:cell cortex; C:cell junction; C:cell surface; C:cell-substrate junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:I band; C:lamellipodium membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:actin filament binding; F:integrin binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein kinase binding; F:SMAD binding; F:type I transforming growth factor beta receptor binding;, P:adherens junction maintenance; P:cell adhesion; P:cell junction assembly; P:cell-matrix adhesion; P:focal adhesion assembly; P:integrin activation; P:integrin-mediated signaling pathway; P:limb development; P:negative regulation of cell death; P:negative regulation of fat cell differentiation; P:negative regulation of vascular permeability; P:positive regulation of cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of GTPase activity; P:positive regulation of integrin activation; P:positive regulation of mesenchymal stem cell proliferation; P:positive regulation of myosin light chain kinase activity; P:positive regulation of osteoblast differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of wound healing, spreading of epidermal cells; P:protein localization to cell junction; P:protein localization to membrane; P:regulation of cell morphogenesis; P:regulation of cell shape; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway;|Q96AC1 B5TJY2 Q14840 Q86TY7,Fermitin family homolog 2,Kindlin-2;Mitogen-inducible gene 2 protein;Pleckstrin homology domain-containing family C member 1;, PF00373;PF18124;PF00169;, GO:0005912;GO:0005938;GO:0030054;GO:0009986;GO:0030055;GO:0005737;GO:0005829;GO:0031234;GO:0005925;GO:0031674;GO:0031258;GO:0005654;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0051015;GO:0005178;GO:0005547;GO:0019901;GO:0046332;GO:0034713;GO:0034334;GO:0007155;GO:0034329;GO:0007160;GO:0048041;GO:0033622;GO:0007229;GO:0060173;GO:0060548;GO:0045599;GO:0043116;GO:0030335;GO:0010718;GO:0070374;GO:0051894;GO:0043547;GO:0033625;GO:1902462;GO:0035505;GO:0045669;GO:0051897;GO:1900182;GO:0051496;GO:1900026;GO:1903691;GO:1902414;GO:0072657;GO:0022604;GO:0008360;GO:0034446;GO:0007179;GO:0016055;, C:adherens junction; C:cell cortex; C:cell junction; C:cell surface; C:cell-substrate junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:I band; C:lamellipodium membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:actin filament binding; F:integrin binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein kinase binding; F:SMAD binding; F:type I transforming growth factor beta receptor binding;, P:adherens junction maintenance; P:cell adhesion; P:cell junction assembly; P:cell-matrix adhesion; P:focal adhesion assembly; P:integrin activation; P:integrin-mediated signaling pathway; P:limb development; P:negative regulation of cell death; P:negative regulation of fat cell differentiation; P:negative regulation of vascular permeability; P:positive regulation of cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of GTPase activity; P:positive regulation of integrin activation; P:positive regulation of mesenchymal stem cell proliferation; P:positive regulation of myosin light chain kinase activity; P:positive regulation of osteoblast differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of wound healing, spreading of epidermal cells; P:protein localization to cell junction; P:protein localization to membrane; P:regulation of cell morphogenesis; P:regulation of cell shape; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway;|Q96AC1 B5TJY2 Q14840 Q86TY7,Fermitin family homolog 2,Kindlin-2;Mitogen-inducible gene 2 protein;Pleckstrin homology domain-containing family C member 1;, PF00373;PF18124;PF00169;, GO:0005912;GO:0005938;GO:0030054;GO:0009986;GO:0030055;GO:0005737;GO:0005829;GO:0031234;GO:0005925;GO:0031674;GO:0031258;GO:0005654;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0051015;GO:0005178;GO:0005547;GO:0019901;GO:0046332;GO:0034713;GO:0034334;GO:0007155;GO:0034329;GO:0007160;GO:0048041;GO:0033622;GO:0007229;GO:0060173;GO:0060548;GO:0045599;GO:0043116;GO:0030335;GO:0010718;GO:0070374;GO:0051894;GO:0043547;GO:0033625;GO:1902462;GO:0035505;GO:0045669;GO:0051897;GO:1900182;GO:0051496;GO:1900026;GO:1903691;GO:1902414;GO:0072657;GO:0022604;GO:0008360;GO:0034446;GO:0007179;GO:0016055;, C:adherens junction; C:cell cortex; C:cell junction; C:cell surface; C:cell-substrate junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:I band; C:lamellipodium membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:actin filament binding; F:integrin binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein kinase binding; F:SMAD binding; F:type I transforming growth factor beta receptor binding;, P:adherens junction maintenance; P:cell adhesion; P:cell junction assembly; P:cell-matrix adhesion; P:focal adhesion assembly; P:integrin activation; P:integrin-mediated signaling pathway; P:limb development; P:negative regulation of cell death; P:negative regulation of fat cell differentiation; P:negative regulation of vascular permeability; P:positive regulation of cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of GTPase activity; P:positive regulation of integrin activation; P:positive regulation of mesenchymal stem cell proliferation; P:positive regulation of myosin light chain kinase activity; P:positive regulation of osteoblast differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of wound healing, spreading of epidermal cells; P:protein localization to cell junction; P:protein localization to membrane; P:regulation of cell morphogenesis; P:regulation of cell shape; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway;|Q96AC1 B5TJY2 Q14840 Q86TY7,Fermitin family homolog 2,Kindlin-2;Mitogen-inducible gene 2 protein;Pleckstrin homology domain-containing family C member 1;, PF00373;PF18124;PF00169;, GO:0005912;GO:0005938;GO:0030054;GO:0009986;GO:0030055;GO:0005737;GO:0005829;GO:0031234;GO:0005925;GO:0031674;GO:0031258;GO:0005654;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0051015;GO:0005178;GO:0005547;GO:0019901;GO:0046332;GO:0034713;GO:0034334;GO:0007155;GO:0034329;GO:0007160;GO:0048041;GO:0033622;GO:0007229;GO:0060173;GO:0060548;GO:0045599;GO:0043116;GO:0030335;GO:0010718;GO:0070374;GO:0051894;GO:0043547;GO:0033625;GO:1902462;GO:0035505;GO:0045669;GO:0051897;GO:1900182;GO:0051496;GO:1900026;GO:1903691;GO:1902414;GO:0072657;GO:0022604;GO:0008360;GO:0034446;GO:0007179;GO:0016055;, C:adherens junction; C:cell cortex; C:cell junction; C:cell surface; C:cell-substrate junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:I band; C:lamellipodium membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:actin filament binding; F:integrin binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein kinase binding; F:SMAD binding; F:type I transforming growth factor beta receptor binding;, P:adherens junction maintenance; P:cell adhesion; P:cell junction assembly; P:cell-matrix adhesion; P:focal adhesion assembly; P:integrin activation; P:integrin-mediated signaling pathway; P:limb development; P:negative regulation of cell death; P:negative regulation of fat cell differentiation; P:negative regulation of vascular permeability; P:positive regulation of cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of GTPase activity; P:positive regulation of integrin activation; P:positive regulation of mesenchymal stem cell proliferation; P:positive regulation of myosin light chain kinase activity; P:positive regulation of osteoblast differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of wound healing, spreading of epidermal cells; P:protein localization to cell junction; P:protein localization to membrane; P:regulation of cell morphogenesis; P:regulation of cell shape; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway;|Q96AC1 B5TJY2 Q14840 Q86TY7,Fermitin family homolog 2,Kindlin-2;Mitogen-inducible gene 2 protein;Pleckstrin homology domain-containing family C member 1;, PF00373;PF18124;PF00169;, GO:0005912;GO:0005938;GO:0030054;GO:0009986;GO:0030055;GO:0005737;GO:0005829;GO:0031234;GO:0005925;GO:0031674;GO:0031258;GO:0005654;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0051015;GO:0005178;GO:0005547;GO:0019901;GO:0046332;GO:0034713;GO:0034334;GO:0007155;GO:0034329;GO:0007160;GO:0048041;GO:0033622;GO:0007229;GO:0060173;GO:0060548;GO:0045599;GO:0043116;GO:0030335;GO:0010718;GO:0070374;GO:0051894;GO:0043547;GO:0033625;GO:1902462;GO:0035505;GO:0045669;GO:0051897;GO:1900182;GO:0051496;GO:1900026;GO:1903691;GO:1902414;GO:0072657;GO:0022604;GO:0008360;GO:0034446;GO:0007179;GO:0016055;, C:adherens junction; C:cell cortex; C:cell junction; C:cell surface; C:cell-substrate junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:I band; C:lamellipodium membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:actin filament binding; F:integrin binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein kinase binding; F:SMAD binding; F:type I transforming growth factor beta receptor binding;, P:adherens junction maintenance; P:cell adhesion; P:cell junction assembly; P:cell-matrix adhesion; P:focal adhesion assembly; P:integrin activation; P:integrin-mediated signaling pathway; P:limb development; P:negative regulation of cell death; P:negative regulation of fat cell differentiation; P:negative regulation of vascular permeability; P:positive regulation of cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of GTPase activity; P:positive regulation of integrin activation; P:positive regulation of mesenchymal stem cell proliferation; P:positive regulation of myosin light chain kinase activity; P:positive regulation of osteoblast differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of wound healing, spreading of epidermal cells; P:protein localization to cell junction; P:protein localization to membrane; P:regulation of cell morphogenesis; P:regulation of cell shape; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway; scaffold37 indexed_genome mRNA 28005026 28013116 . + . ID=transcript_7710;Q8NEL9 G5E9D1 Q8WVH3 Q96LL2 Q9C0F8,Phospholipase DDHD1 {ECO:0000305},DDHD domain-containing protein 1;Phosphatidic acid-preferring phospholipase A1 homolog;, PF02862;, GO:0005737;GO:0005829;GO:0046872;GO:0004620;GO:0016042;GO:0006654;GO:0090141;, C:cytoplasm; C:cytosol;, F:metal ion binding; F:phospholipase activity;, P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; scaffold37 indexed_genome mRNA 28013257 28045711 . - . ID=transcript_7711;Q8NEL9 G5E9D1 Q8WVH3 Q96LL2 Q9C0F8,Phospholipase DDHD1 {ECO:0000305},DDHD domain-containing protein 1;Phosphatidic acid-preferring phospholipase A1 homolog;, PF02862;, GO:0005737;GO:0005829;GO:0046872;GO:0004620;GO:0016042;GO:0006654;GO:0090141;, C:cytoplasm; C:cytosol;, F:metal ion binding; F:phospholipase activity;, P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission;|Q8NEL9 G5E9D1 Q8WVH3 Q96LL2 Q9C0F8,Phospholipase DDHD1 {ECO:0000305},DDHD domain-containing protein 1;Phosphatidic acid-preferring phospholipase A1 homolog;, PF02862;, GO:0005737;GO:0005829;GO:0046872;GO:0004620;GO:0016042;GO:0006654;GO:0090141;, C:cytoplasm; C:cytosol;, F:metal ion binding; F:phospholipase activity;, P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission;|Q8NEL9 G5E9D1 Q8WVH3 Q96LL2 Q9C0F8,Phospholipase DDHD1 {ECO:0000305},DDHD domain-containing protein 1;Phosphatidic acid-preferring phospholipase A1 homolog;, PF02862;, GO:0005737;GO:0005829;GO:0046872;GO:0004620;GO:0016042;GO:0006654;GO:0090141;, C:cytoplasm; C:cytosol;, F:metal ion binding; F:phospholipase activity;, P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:positive regulation of mitochondrial fission; scaffold37 indexed_genome mRNA 28363603 28366616 . - . ID=transcript_7712;P49959 B3KTC7 O43475,Double-strand break repair protein MRE11,Double-strand break repair protein MRE11A;Meiotic recombination 11 homolog 1;Meiotic recombination 11 homolog A;, PF00149;PF04152;, GO:0000781;GO:0005737;GO:0005829;GO:0030870;GO:0005654;GO:0005634;GO:0016605;GO:0005657;GO:0035861;GO:0008408;GO:0008409;GO:0045296;GO:0003690;GO:0004520;GO:0042802;GO:0030145;GO:0004518;GO:0008022;GO:0000014;GO:0008283;GO:0006974;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0110025;GO:0006302;GO:0000724;GO:0006303;GO:0007129;GO:0031573;GO:0042138;GO:0097552;GO:0007095;GO:0043066;GO:0033674;GO:0031954;GO:0032206;GO:0032481;GO:0007131;GO:0000019;GO:1901796;GO:0007062;GO:0000723;GO:0007004;GO:0031860;GO:0016032;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:Mre11 complex; C:nucleoplasm; C:nucleus; C:PML body; C:replication fork; C:site of double-strand break;, F:3'-5' exonuclease activity; F:5'-3' exonuclease activity; F:cadherin binding; F:double-stranded DNA binding; F:endodeoxyribonuclease activity; F:identical protein binding; F:manganese ion binding; F:nuclease activity; F:protein C-terminus binding; F:single-stranded DNA endodeoxyribonuclease activity;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA strand resection involved in replication fork processing; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:homologous chromosome pairing at meiosis; P:intra-S DNA damage checkpoint; P:meiotic DNA double-strand break formation; P:mitochondrial double-strand break repair via homologous recombination; P:mitotic G2 DNA damage checkpoint; P:negative regulation of apoptotic process; P:positive regulation of kinase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of telomere maintenance; P:positive regulation of type I interferon production; P:reciprocal meiotic recombination; P:regulation of mitotic recombination; P:regulation of signal transduction by p53 class mediator; P:sister chromatid cohesion; P:telomere maintenance; P:telomere maintenance via telomerase; P:telomeric 3' overhang formation; P:viral process; scaffold37 indexed_genome mRNA 28785092 28792093 . - . ID=transcript_7713;P12644 Q9UM80,Bone morphogenetic protein 4,Bone morphogenetic protein 2B;, PF00019;PF00688;, GO:0005788;GO:0005576;GO:0005615;GO:0070700;GO:0042056;GO:0039706;GO:0005125;GO:0008083;GO:0008201;GO:0000186;GO:0009948;GO:0003180;GO:0002043;GO:0030509;GO:0061312;GO:0003130;GO:0071893;GO:0061151;GO:0061149;GO:0060442;GO:0001658;GO:0048754;GO:0060433;GO:0060503;GO:0060449;GO:0055007;GO:0003279;GO:0044267;GO:0071773;GO:0002062;GO:0060197;GO:0007182;GO:0060976;GO:0060363;GO:0035993;GO:0021904;GO:0048701;GO:0042733;GO:0035116;GO:0060272;GO:0003197;GO:0001958;GO:0007492;GO:0060502;GO:0060441;GO:0060684;GO:0030218;GO:0007281;GO:0072104;GO:0072015;GO:0002244;GO:0060113;GO:0048392;GO:0001822;GO:0060235;GO:0048286;GO:0060425;GO:0002320;GO:0030225;GO:0060592;GO:0003149;GO:0072161;GO:0072198;GO:0072138;GO:0003337;GO:0007500;GO:0001823;GO:0072205;GO:0030224;GO:0043066;GO:0072097;GO:0090191;GO:0045786;GO:0060548;GO:0008285;GO:2000137;GO:0032331;GO:0050680;GO:2001237;GO:0010629;GO:0072125;GO:0090194;GO:0033088;GO:0043407;GO:0072200;GO:2000007;GO:2000005;GO:0045839;GO:0045662;GO:0042326;GO:1902894;GO:0060686;GO:0045843;GO:0033085;GO:0070244;GO:0000122;GO:0045892;GO:0001843;GO:0048663;GO:0042476;GO:0042475;GO:0001649;GO:0003148;GO:0061626;GO:0021983;GO:0043065;GO:0030513;GO:0030501;GO:0061047;GO:0055020;GO:1905312;GO:0061036;GO:0010942;GO:0008284;GO:1901964;GO:0032967;GO:0045603;GO:0010595;GO:0001938;GO:0045606;GO:0050679;GO:0010718;GO:0070374;GO:0010628;GO:0090184;GO:0045666;GO:0045778;GO:0045669;GO:0010862;GO:1903800;GO:0032092;GO:0001934;GO:0060391;GO:0048661;GO:0045944;GO:0045893;GO:0009791;GO:0043687;GO:0034504;GO:0061155;GO:0003184;GO:0060687;GO:0010453;GO:0042487;GO:0060393;GO:0042306;GO:0051150;GO:0003014;GO:0003139;GO:0060395;GO:0048745;GO:0010159;GO:0072101;GO:0043401;GO:0021537;GO:0021978;GO:0035990;GO:0060438;GO:0060440;GO:0003323;GO:0072192;GO:0072193;GO:0001657;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space;, F:BMP receptor binding; F:chemoattractant activity; F:co-receptor binding; F:cytokine activity; F:growth factor activity; F:heparin binding;, P:activation of MAPKK activity; P:anterior/posterior axis specification; P:aortic valve morphogenesis; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:BMP signaling pathway; P:BMP signaling pathway involved in heart development; P:BMP signaling pathway involved in heart induction; P:BMP signaling pathway involved in nephric duct formation; P:BMP signaling pathway involved in renal system segmentation; P:BMP signaling pathway involved in ureter morphogenesis; P:branching involved in prostate gland morphogenesis; P:branching involved in ureteric bud morphogenesis; P:branching morphogenesis of an epithelial tube; P:bronchus development; P:bud dilation involved in lung branching; P:bud elongation involved in lung branching; P:cardiac muscle cell differentiation; P:cardiac septum development; P:cellular protein metabolic process; P:cellular response to BMP stimulus; P:chondrocyte differentiation; P:cloacal septation; P:common-partner SMAD protein phosphorylation; P:coronary vasculature development; P:cranial suture morphogenesis; P:deltoid tuberosity development; P:dorsal/ventral neural tube patterning; P:embryonic cranial skeleton morphogenesis; P:embryonic digit morphogenesis; P:embryonic hindlimb morphogenesis; P:embryonic skeletal joint morphogenesis; P:endocardial cushion development; P:endochondral ossification; P:endoderm development; P:epithelial cell proliferation involved in lung morphogenesis; P:epithelial tube branching involved in lung morphogenesis; P:epithelial-mesenchymal cell signaling; P:erythrocyte differentiation; P:germ cell development; P:glomerular capillary formation; P:glomerular visceral epithelial cell development; P:hematopoietic progenitor cell differentiation; P:inner ear receptor cell differentiation; P:intermediate mesodermal cell differentiation; P:kidney development; P:lens induction in camera-type eye; P:lung alveolus development; P:lung morphogenesis; P:lymphoid progenitor cell differentiation; P:macrophage differentiation; P:mammary gland formation; P:membranous septum morphogenesis; P:mesenchymal cell differentiation involved in kidney development; P:mesenchymal cell proliferation involved in ureter development; P:mesenchymal cell proliferation involved in ureteric bud development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; P:mesodermal cell fate determination; P:mesonephros development; P:metanephric collecting duct development; P:monocyte differentiation; P:negative regulation of apoptotic process; P:negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway; P:negative regulation of branching involved in ureteric bud morphogenesis; P:negative regulation of cell cycle; P:negative regulation of cell death; P:negative regulation of cell population proliferation; P:negative regulation of cell proliferation involved in heart morphogenesis; P:negative regulation of chondrocyte differentiation; P:negative regulation of epithelial cell proliferation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of gene expression; P:negative regulation of glomerular mesangial cell proliferation; P:negative regulation of glomerulus development; P:negative regulation of immature T cell proliferation in thymus; P:negative regulation of MAP kinase activity; P:negative regulation of mesenchymal cell proliferation involved in ureter development; P:negative regulation of metanephric comma-shaped body morphogenesis; P:negative regulation of metanephric S-shaped body morphogenesis; P:negative regulation of mitotic nuclear division; P:negative regulation of myoblast differentiation; P:negative regulation of phosphorylation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of prostatic bud formation; P:negative regulation of striated muscle tissue development; P:negative regulation of T cell differentiation in thymus; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:neuron fate commitment; P:odontogenesis; P:odontogenesis of dentin-containing tooth; P:osteoblast differentiation; P:outflow tract septum morphogenesis; P:pharyngeal arch artery morphogenesis; P:pituitary gland development; P:positive regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of branching involved in lung morphogenesis; P:positive regulation of cardiac muscle fiber development; P:positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis; P:positive regulation of cartilage development; P:positive regulation of cell death; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation involved in outflow tract morphogenesis; P:positive regulation of collagen biosynthetic process; P:positive regulation of endothelial cell differentiation; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epidermal cell differentiation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of kidney development; P:positive regulation of neuron differentiation; P:positive regulation of ossification; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of SMAD protein signal transduction; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:post-embryonic development; P:post-translational protein modification; P:protein localization to nucleus; P:pulmonary artery endothelial tube morphogenesis; P:pulmonary valve morphogenesis; P:regulation of branching involved in prostate gland morphogenesis; P:regulation of cell fate commitment; P:regulation of odontogenesis of dentin-containing tooth; P:regulation of pathway-restricted SMAD protein phosphorylation; P:regulation of protein import into nucleus; P:regulation of smooth muscle cell differentiation; P:renal system process; P:secondary heart field specification; P:SMAD protein signal transduction; P:smooth muscle tissue development; P:specification of animal organ position; P:specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway; P:steroid hormone mediated signaling pathway; P:telencephalon development; P:telencephalon regionalization; P:tendon cell differentiation; P:trachea development; P:trachea formation; P:type B pancreatic cell development; P:ureter epithelial cell differentiation; P:ureter smooth muscle cell differentiation; P:ureteric bud development; scaffold37 indexed_genome mRNA 29186131 29210011 . - . ID=transcript_7714;O95406 Q3SYM7,Protein cornichon homolog 1,Cornichon family AMPA receptor auxiliary protein 1;Protein cornichon homolog;T-cell growth-associated molecule 77;, PF03311;, GO:0005789;GO:0033116;GO:0012507;GO:0000139;GO:0016021;GO:0048208;GO:0006888;GO:0006955;GO:0007165;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of membrane;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:immune response; P:signal transduction; scaffold37 indexed_genome mRNA 29232756 29245258 . - . ID=transcript_7715;P60983 B2R499 P17774 Q9BS35,Glia maturation factor beta,, PF00241;, GO:0003779;GO:0071933;GO:0008047;GO:0008083;GO:0004860;GO:0071846;GO:0034316;GO:0007399;GO:0006468;, , F:actin binding; F:Arp2/3 complex binding; F:enzyme activator activity; F:growth factor activity; F:protein kinase inhibitor activity;, P:actin filament debranching; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:nervous system development; P:protein phosphorylation;|P60983 B2R499 P17774 Q9BS35,Glia maturation factor beta,, PF00241;, GO:0003779;GO:0071933;GO:0008047;GO:0008083;GO:0004860;GO:0071846;GO:0034316;GO:0007399;GO:0006468;, , F:actin binding; F:Arp2/3 complex binding; F:enzyme activator activity; F:growth factor activity; F:protein kinase inhibitor activity;, P:actin filament debranching; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:nervous system development; P:protein phosphorylation; scaffold37 indexed_genome mRNA 29261589 29279709 . + . ID=transcript_7716;Q99675 Q96BX2,Cell growth regulator with RING finger domain protein 1,Cell growth regulatory gene 19 protein;RING finger protein 197;, , GO:0005783;GO:0043231;GO:0005654;GO:0046872;GO:0007050;GO:0030308;GO:0008285;, C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:metal ion binding;, P:cell cycle arrest; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; scaffold37 indexed_genome mRNA 29284393 29286594 . + . ID=transcript_7717;Q99675 Q96BX2,Cell growth regulator with RING finger domain protein 1,Cell growth regulatory gene 19 protein;RING finger protein 197;, , GO:0005783;GO:0043231;GO:0005654;GO:0046872;GO:0007050;GO:0030308;GO:0008285;, C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:metal ion binding;, P:cell cycle arrest; P:negative regulation of cell growth; P:negative regulation of cell population proliferation;|Q99675 Q96BX2,Cell growth regulator with RING finger domain protein 1,Cell growth regulatory gene 19 protein;RING finger protein 197;, , GO:0005783;GO:0043231;GO:0005654;GO:0046872;GO:0007050;GO:0030308;GO:0008285;, C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:metal ion binding;, P:cell cycle arrest; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; scaffold37 indexed_genome mRNA 29512500 29513524 . + . ID=transcript_7718;Q9UPU9 A8MPZ5 Q0VA96 Q6PEW4,Protein Smaug homolog 1,Sterile alpha motif domain-containing protein 4A;, PF00536;, GO:0030054;GO:0005829;GO:0030425;GO:0001650;GO:0000932;GO:0045202;GO:0003729;GO:0003723;GO:0030371;GO:0017148;GO:0000289;GO:0045727;GO:0043488;, C:cell junction; C:cytosol; C:dendrite; C:fibrillar center; C:P-body; C:synapse;, F:mRNA binding; F:RNA binding; F:translation repressor activity;, P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of translation; P:regulation of mRNA stability; scaffold37 indexed_genome mRNA 29579621 29630665 . - . ID=transcript_7719;P30793 Q6FHY7 Q9Y4I8,GTP cyclohydrolase 1,GTP cyclohydrolase I;, PF01227;, GO:0005737;GO:0031410;GO:0005829;GO:0044306;GO:0031965;GO:0005654;GO:0005634;GO:0032991;GO:0005509;GO:0005525;GO:0003934;GO:0030742;GO:0003924;GO:0042802;GO:0051019;GO:0042803;GO:0044877;GO:0031369;GO:0008270;GO:0035998;GO:0042416;GO:0045776;GO:0050884;GO:0006809;GO:0010460;GO:0051000;GO:0065003;GO:0042559;GO:0008217;GO:0014916;GO:2000121;GO:0034341;GO:0032496;GO:0048265;GO:0034612;GO:0006729;GO:0046146;GO:0046654;GO:0042311;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:neuron projection terminus; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:calcium ion binding; F:GTP binding; F:GTP cyclohydrolase I activity; F:GTP-dependent protein binding; F:GTPase activity; F:identical protein binding; F:mitogen-activated protein kinase binding; F:protein homodimerization activity; F:protein-containing complex binding; F:translation initiation factor binding; F:zinc ion binding;, P:7,8-dihydroneopterin 3'-triphosphate biosynthetic process; P:dopamine biosynthetic process; P:negative regulation of blood pressure; P:neuromuscular process controlling posture; P:nitric oxide biosynthetic process; P:positive regulation of heart rate; P:positive regulation of nitric-oxide synthase activity; P:protein-containing complex assembly; P:pteridine-containing compound biosynthetic process; P:regulation of blood pressure; P:regulation of lung blood pressure; P:regulation of removal of superoxide radicals; P:response to interferon-gamma; P:response to lipopolysaccharide; P:response to pain; P:response to tumor necrosis factor; P:tetrahydrobiopterin biosynthetic process; P:tetrahydrobiopterin metabolic process; P:tetrahydrofolate biosynthetic process; P:vasodilation;|P30793 Q6FHY7 Q9Y4I8,GTP cyclohydrolase 1,GTP cyclohydrolase I;, PF01227;, GO:0005737;GO:0031410;GO:0005829;GO:0044306;GO:0031965;GO:0005654;GO:0005634;GO:0032991;GO:0005509;GO:0005525;GO:0003934;GO:0030742;GO:0003924;GO:0042802;GO:0051019;GO:0042803;GO:0044877;GO:0031369;GO:0008270;GO:0035998;GO:0042416;GO:0045776;GO:0050884;GO:0006809;GO:0010460;GO:0051000;GO:0065003;GO:0042559;GO:0008217;GO:0014916;GO:2000121;GO:0034341;GO:0032496;GO:0048265;GO:0034612;GO:0006729;GO:0046146;GO:0046654;GO:0042311;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:neuron projection terminus; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:calcium ion binding; F:GTP binding; F:GTP cyclohydrolase I activity; F:GTP-dependent protein binding; F:GTPase activity; F:identical protein binding; F:mitogen-activated protein kinase binding; F:protein homodimerization activity; F:protein-containing complex binding; F:translation initiation factor binding; F:zinc ion binding;, P:7,8-dihydroneopterin 3'-triphosphate biosynthetic process; P:dopamine biosynthetic process; P:negative regulation of blood pressure; P:neuromuscular process controlling posture; P:nitric oxide biosynthetic process; P:positive regulation of heart rate; P:positive regulation of nitric-oxide synthase activity; P:protein-containing complex assembly; P:pteridine-containing compound biosynthetic process; P:regulation of blood pressure; P:regulation of lung blood pressure; P:regulation of removal of superoxide radicals; P:response to interferon-gamma; P:response to lipopolysaccharide; P:response to pain; P:response to tumor necrosis factor; P:tetrahydrobiopterin biosynthetic process; P:tetrahydrobiopterin metabolic process; P:tetrahydrofolate biosynthetic process; P:vasodilation;|P30793 Q6FHY7 Q9Y4I8,GTP cyclohydrolase 1,GTP cyclohydrolase I;, PF01227;, GO:0005737;GO:0031410;GO:0005829;GO:0044306;GO:0031965;GO:0005654;GO:0005634;GO:0032991;GO:0005509;GO:0005525;GO:0003934;GO:0030742;GO:0003924;GO:0042802;GO:0051019;GO:0042803;GO:0044877;GO:0031369;GO:0008270;GO:0035998;GO:0042416;GO:0045776;GO:0050884;GO:0006809;GO:0010460;GO:0051000;GO:0065003;GO:0042559;GO:0008217;GO:0014916;GO:2000121;GO:0034341;GO:0032496;GO:0048265;GO:0034612;GO:0006729;GO:0046146;GO:0046654;GO:0042311;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:neuron projection terminus; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:calcium ion binding; F:GTP binding; F:GTP cyclohydrolase I activity; F:GTP-dependent protein binding; F:GTPase activity; F:identical protein binding; F:mitogen-activated protein kinase binding; F:protein homodimerization activity; F:protein-containing complex binding; F:translation initiation factor binding; F:zinc ion binding;, P:7,8-dihydroneopterin 3'-triphosphate biosynthetic process; P:dopamine biosynthetic process; P:negative regulation of blood pressure; P:neuromuscular process controlling posture; P:nitric oxide biosynthetic process; P:positive regulation of heart rate; P:positive regulation of nitric-oxide synthase activity; P:protein-containing complex assembly; P:pteridine-containing compound biosynthetic process; P:regulation of blood pressure; P:regulation of lung blood pressure; P:regulation of removal of superoxide radicals; P:response to interferon-gamma; P:response to lipopolysaccharide; P:response to pain; P:response to tumor necrosis factor; P:tetrahydrobiopterin biosynthetic process; P:tetrahydrobiopterin metabolic process; P:tetrahydrofolate biosynthetic process; P:vasodilation;|P30793 Q6FHY7 Q9Y4I8,GTP cyclohydrolase 1,GTP cyclohydrolase I;, PF01227;, GO:0005737;GO:0031410;GO:0005829;GO:0044306;GO:0031965;GO:0005654;GO:0005634;GO:0032991;GO:0005509;GO:0005525;GO:0003934;GO:0030742;GO:0003924;GO:0042802;GO:0051019;GO:0042803;GO:0044877;GO:0031369;GO:0008270;GO:0035998;GO:0042416;GO:0045776;GO:0050884;GO:0006809;GO:0010460;GO:0051000;GO:0065003;GO:0042559;GO:0008217;GO:0014916;GO:2000121;GO:0034341;GO:0032496;GO:0048265;GO:0034612;GO:0006729;GO:0046146;GO:0046654;GO:0042311;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:neuron projection terminus; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:calcium ion binding; F:GTP binding; F:GTP cyclohydrolase I activity; F:GTP-dependent protein binding; F:GTPase activity; F:identical protein binding; F:mitogen-activated protein kinase binding; F:protein homodimerization activity; F:protein-containing complex binding; F:translation initiation factor binding; F:zinc ion binding;, P:7,8-dihydroneopterin 3'-triphosphate biosynthetic process; P:dopamine biosynthetic process; P:negative regulation of blood pressure; P:neuromuscular process controlling posture; P:nitric oxide biosynthetic process; P:positive regulation of heart rate; P:positive regulation of nitric-oxide synthase activity; P:protein-containing complex assembly; P:pteridine-containing compound biosynthetic process; P:regulation of blood pressure; P:regulation of lung blood pressure; P:regulation of removal of superoxide radicals; P:response to interferon-gamma; P:response to lipopolysaccharide; P:response to pain; P:response to tumor necrosis factor; P:tetrahydrobiopterin biosynthetic process; P:tetrahydrobiopterin metabolic process; P:tetrahydrofolate biosynthetic process; P:vasodilation; scaffold37 indexed_genome mRNA 29678360 29702398 . - . ID=transcript_7720;O75717 C9JW18 F6W0U7,WD repeat and HMG-box DNA-binding protein 1,Acidic nucleoplasmic DNA-binding protein 1;, PF12894;PF12341;PF00400;, GO:0005737;GO:0043596;GO:0005654;GO:0003682;GO:0003677;GO:0006281;GO:0006261;GO:0000278;, C:cytoplasm; C:nuclear replication fork; C:nucleoplasm;, F:chromatin binding; F:DNA binding;, P:DNA repair; P:DNA-dependent DNA replication; P:mitotic cell cycle; scaffold37 indexed_genome mRNA 29702416 29734006 . - . ID=transcript_7721;O75717 C9JW18 F6W0U7,WD repeat and HMG-box DNA-binding protein 1,Acidic nucleoplasmic DNA-binding protein 1;, PF12894;PF12341;PF00400;, GO:0005737;GO:0043596;GO:0005654;GO:0003682;GO:0003677;GO:0006281;GO:0006261;GO:0000278;, C:cytoplasm; C:nuclear replication fork; C:nucleoplasm;, F:chromatin binding; F:DNA binding;, P:DNA repair; P:DNA-dependent DNA replication; P:mitotic cell cycle; scaffold37 indexed_genome mRNA 29734076 29752446 . + . ID=transcript_7722;Q8WXH5,Suppressor of cytokine signaling 4,Suppressor of cytokine signaling 7;, PF00017;PF12610;PF07525;, GO:0005942;GO:0046935;GO:0035556;GO:0007175;GO:0046854;GO:0032436;GO:0016567;GO:0040008;, C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase regulator activity;, P:intracellular signal transduction; P:negative regulation of epidermal growth factor-activated receptor activity; P:phosphatidylinositol phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of growth; scaffold37 indexed_genome mRNA 29754865 29767935 . + . ID=transcript_7723;Q8NDC0 B2RDD8 Q96BG5,MAPK-interacting and spindle-stabilizing protein-like,Mitogen-activated protein kinase 1-interacting protein 1-like;, PF15822;|Q8NDC0 B2RDD8 Q96BG5,MAPK-interacting and spindle-stabilizing protein-like,Mitogen-activated protein kinase 1-interacting protein 1-like;, PF15822; scaffold37 indexed_genome mRNA 29847372 29849824 . + . ID=transcript_7724;P17931 B2RC38 Q16005 Q6IBA7 Q96J47,Galectin-3,35 kDa lectin;Carbohydrate-binding protein 35;Galactose-specific lectin 3;Galactoside-binding protein;IgE-binding protein;L-31;Laminin-binding protein;Lectin L-29;Mac-2 antigen;, PF00337;, GO:0009986;GO:0062023;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0101003;GO:0001772;GO:0016020;GO:0005743;GO:0005634;GO:0044216;GO:0005886;GO:0030667;GO:0005681;GO:0030246;GO:0042056;GO:0019863;GO:0043236;GO:0070492;GO:0019903;GO:0004864;GO:0003723;GO:0061844;GO:0048245;GO:0030855;GO:0045087;GO:0031640;GO:0048246;GO:0002548;GO:0071674;GO:0006397;GO:0045806;GO:2001237;GO:2000521;GO:1903614;GO:2001189;GO:0050860;GO:0030593;GO:0043312;GO:0050918;GO:0090280;GO:0071677;GO:1903078;GO:0031334;GO:1902041;GO:0045637;GO:0070232;GO:0042129;GO:0008380;, C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule membrane; C:immunological synapse; C:membrane; C:mitochondrial inner membrane; C:nucleus; C:other organism cell; C:plasma membrane; C:secretory granule membrane; C:spliceosomal complex;, F:carbohydrate binding; F:chemoattractant activity; F:IgE binding; F:laminin binding; F:oligosaccharide binding; F:protein phosphatase binding; F:protein phosphatase inhibitor activity; F:RNA binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:eosinophil chemotaxis; P:epithelial cell differentiation; P:innate immune response; P:killing of cells of other organism; P:macrophage chemotaxis; P:monocyte chemotaxis; P:mononuclear cell migration; P:mRNA processing; P:negative regulation of endocytosis; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of immunological synapse formation; P:negative regulation of protein tyrosine phosphatase activity; P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:negative regulation of T cell receptor signaling pathway; P:neutrophil chemotaxis; P:neutrophil degranulation; P:positive chemotaxis; P:positive regulation of calcium ion import; P:positive regulation of mononuclear cell migration; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein-containing complex assembly; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of myeloid cell differentiation; P:regulation of T cell apoptotic process; P:regulation of T cell proliferation; P:RNA splicing;|P17931 B2RC38 Q16005 Q6IBA7 Q96J47,Galectin-3,35 kDa lectin;Carbohydrate-binding protein 35;Galactose-specific lectin 3;Galactoside-binding protein;IgE-binding protein;L-31;Laminin-binding protein;Lectin L-29;Mac-2 antigen;, PF00337;, GO:0009986;GO:0062023;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0101003;GO:0001772;GO:0016020;GO:0005743;GO:0005634;GO:0044216;GO:0005886;GO:0030667;GO:0005681;GO:0030246;GO:0042056;GO:0019863;GO:0043236;GO:0070492;GO:0019903;GO:0004864;GO:0003723;GO:0061844;GO:0048245;GO:0030855;GO:0045087;GO:0031640;GO:0048246;GO:0002548;GO:0071674;GO:0006397;GO:0045806;GO:2001237;GO:2000521;GO:1903614;GO:2001189;GO:0050860;GO:0030593;GO:0043312;GO:0050918;GO:0090280;GO:0071677;GO:1903078;GO:0031334;GO:1902041;GO:0045637;GO:0070232;GO:0042129;GO:0008380;, C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule membrane; C:immunological synapse; C:membrane; C:mitochondrial inner membrane; C:nucleus; C:other organism cell; C:plasma membrane; C:secretory granule membrane; C:spliceosomal complex;, F:carbohydrate binding; F:chemoattractant activity; F:IgE binding; F:laminin binding; F:oligosaccharide binding; F:protein phosphatase binding; F:protein phosphatase inhibitor activity; F:RNA binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:eosinophil chemotaxis; P:epithelial cell differentiation; P:innate immune response; P:killing of cells of other organism; P:macrophage chemotaxis; P:monocyte chemotaxis; P:mononuclear cell migration; P:mRNA processing; P:negative regulation of endocytosis; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of immunological synapse formation; P:negative regulation of protein tyrosine phosphatase activity; P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:negative regulation of T cell receptor signaling pathway; P:neutrophil chemotaxis; P:neutrophil degranulation; P:positive chemotaxis; P:positive regulation of calcium ion import; P:positive regulation of mononuclear cell migration; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein-containing complex assembly; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of myeloid cell differentiation; P:regulation of T cell apoptotic process; P:regulation of T cell proliferation; P:RNA splicing;|P17931 B2RC38 Q16005 Q6IBA7 Q96J47,Galectin-3,35 kDa lectin;Carbohydrate-binding protein 35;Galactose-specific lectin 3;Galactoside-binding protein;IgE-binding protein;L-31;Laminin-binding protein;Lectin L-29;Mac-2 antigen;, PF00337;, GO:0009986;GO:0062023;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0101003;GO:0001772;GO:0016020;GO:0005743;GO:0005634;GO:0044216;GO:0005886;GO:0030667;GO:0005681;GO:0030246;GO:0042056;GO:0019863;GO:0043236;GO:0070492;GO:0019903;GO:0004864;GO:0003723;GO:0061844;GO:0048245;GO:0030855;GO:0045087;GO:0031640;GO:0048246;GO:0002548;GO:0071674;GO:0006397;GO:0045806;GO:2001237;GO:2000521;GO:1903614;GO:2001189;GO:0050860;GO:0030593;GO:0043312;GO:0050918;GO:0090280;GO:0071677;GO:1903078;GO:0031334;GO:1902041;GO:0045637;GO:0070232;GO:0042129;GO:0008380;, C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule membrane; C:immunological synapse; C:membrane; C:mitochondrial inner membrane; C:nucleus; C:other organism cell; C:plasma membrane; C:secretory granule membrane; C:spliceosomal complex;, F:carbohydrate binding; F:chemoattractant activity; F:IgE binding; F:laminin binding; F:oligosaccharide binding; F:protein phosphatase binding; F:protein phosphatase inhibitor activity; F:RNA binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:eosinophil chemotaxis; P:epithelial cell differentiation; P:innate immune response; P:killing of cells of other organism; P:macrophage chemotaxis; P:monocyte chemotaxis; P:mononuclear cell migration; P:mRNA processing; P:negative regulation of endocytosis; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of immunological synapse formation; P:negative regulation of protein tyrosine phosphatase activity; P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:negative regulation of T cell receptor signaling pathway; P:neutrophil chemotaxis; P:neutrophil degranulation; P:positive chemotaxis; P:positive regulation of calcium ion import; P:positive regulation of mononuclear cell migration; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein-containing complex assembly; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of myeloid cell differentiation; P:regulation of T cell apoptotic process; P:regulation of T cell proliferation; P:RNA splicing; scaffold37 indexed_genome mRNA 29969935 30045533 . + . ID=transcript_7725;Q9NWN3 Q2VPB5 Q4VBP5 Q86TY4,F-box only protein 34 scaffold37 indexed_genome mRNA 30052278 30092846 . - . ID=transcript_7726;Q6ZNE5 A6NJE4 A8K9U5 B7ZWP5 O94920 Q32MK7 Q32MK8,Beclin 1-associated autophagy-related key regulator {ECO:0000303|PubMed:19050071},Autophagy-related protein 14-like protein {ECO:0000303|PubMed:19270696};, PF10186;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0005789;GO:0097629;GO:0097632;GO:0044233;GO:0045335;GO:0034045;GO:0035032;GO:0051020;GO:0000045;GO:0016240;GO:0042149;GO:0009267;GO:0008333;GO:0016236;GO:0000423;GO:0001933;GO:0043552;GO:0001934;GO:0010608;GO:0061635;GO:0001932;GO:0090207;GO:0098780;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:phagocytic vesicle; C:phagophore assembly site membrane; C:phosphatidylinositol 3-kinase complex, class III;, F:GTPase binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:cellular response to glucose starvation; P:cellular response to starvation; P:endosome to lysosome transport; P:macroautophagy; P:mitophagy; P:negative regulation of protein phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein phosphorylation; P:posttranscriptional regulation of gene expression; P:regulation of protein complex stability; P:regulation of protein phosphorylation; P:regulation of triglyceride metabolic process; P:response to mitochondrial depolarisation;|Q6ZNE5 A6NJE4 A8K9U5 B7ZWP5 O94920 Q32MK7 Q32MK8,Beclin 1-associated autophagy-related key regulator {ECO:0000303|PubMed:19050071},Autophagy-related protein 14-like protein {ECO:0000303|PubMed:19270696};, PF10186;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0005789;GO:0097629;GO:0097632;GO:0044233;GO:0045335;GO:0034045;GO:0035032;GO:0051020;GO:0000045;GO:0016240;GO:0042149;GO:0009267;GO:0008333;GO:0016236;GO:0000423;GO:0001933;GO:0043552;GO:0001934;GO:0010608;GO:0061635;GO:0001932;GO:0090207;GO:0098780;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:phagocytic vesicle; C:phagophore assembly site membrane; C:phosphatidylinositol 3-kinase complex, class III;, F:GTPase binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:cellular response to glucose starvation; P:cellular response to starvation; P:endosome to lysosome transport; P:macroautophagy; P:mitophagy; P:negative regulation of protein phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein phosphorylation; P:posttranscriptional regulation of gene expression; P:regulation of protein complex stability; P:regulation of protein phosphorylation; P:regulation of triglyceride metabolic process; P:response to mitochondrial depolarisation;|Q6ZNE5 A6NJE4 A8K9U5 B7ZWP5 O94920 Q32MK7 Q32MK8,Beclin 1-associated autophagy-related key regulator {ECO:0000303|PubMed:19050071},Autophagy-related protein 14-like protein {ECO:0000303|PubMed:19270696};, PF10186;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0005789;GO:0097629;GO:0097632;GO:0044233;GO:0045335;GO:0034045;GO:0035032;GO:0051020;GO:0000045;GO:0016240;GO:0042149;GO:0009267;GO:0008333;GO:0016236;GO:0000423;GO:0001933;GO:0043552;GO:0001934;GO:0010608;GO:0061635;GO:0001932;GO:0090207;GO:0098780;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:phagocytic vesicle; C:phagophore assembly site membrane; C:phosphatidylinositol 3-kinase complex, class III;, F:GTPase binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:cellular response to glucose starvation; P:cellular response to starvation; P:endosome to lysosome transport; P:macroautophagy; P:mitophagy; P:negative regulation of protein phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein phosphorylation; P:posttranscriptional regulation of gene expression; P:regulation of protein complex stability; P:regulation of protein phosphorylation; P:regulation of triglyceride metabolic process; P:response to mitochondrial depolarisation;|Q6ZNE5 A6NJE4 A8K9U5 B7ZWP5 O94920 Q32MK7 Q32MK8,Beclin 1-associated autophagy-related key regulator {ECO:0000303|PubMed:19050071},Autophagy-related protein 14-like protein {ECO:0000303|PubMed:19270696};, PF10186;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0005789;GO:0097629;GO:0097632;GO:0044233;GO:0045335;GO:0034045;GO:0035032;GO:0051020;GO:0000045;GO:0016240;GO:0042149;GO:0009267;GO:0008333;GO:0016236;GO:0000423;GO:0001933;GO:0043552;GO:0001934;GO:0010608;GO:0061635;GO:0001932;GO:0090207;GO:0098780;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of omegasome membrane; C:extrinsic component of phagophore assembly site membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:phagocytic vesicle; C:phagophore assembly site membrane; C:phosphatidylinositol 3-kinase complex, class III;, F:GTPase binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:cellular response to glucose starvation; P:cellular response to starvation; P:endosome to lysosome transport; P:macroautophagy; P:mitophagy; P:negative regulation of protein phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein phosphorylation; P:posttranscriptional regulation of gene expression; P:regulation of protein complex stability; P:regulation of protein phosphorylation; P:regulation of triglyceride metabolic process; P:response to mitochondrial depolarisation; scaffold37 indexed_genome mRNA 30250745 30326613 . + . ID=transcript_7727;Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport;|Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport;|Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport;|Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport;|Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport;|Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport;|Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport;|Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport;|Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport;|Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport;|Q86UP2 B4DZ88 Q13999 Q14707 Q15387 Q17RZ5 Q5GGW3 Q86W57,Kinectin,CG-1 antigen;Kinesin receptor;, PF05104;, GO:0005783;GO:0005788;GO:0005789;GO:0030176;GO:0016021;GO:0005887;GO:0016020;GO:0045296;GO:0019894;GO:0003723;GO:0044267;GO:0007018;GO:0043687;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:cadherin binding; F:kinesin binding; F:RNA binding;, P:cellular protein metabolic process; P:microtubule-based movement; P:post-translational protein modification; P:protein transport; scaffold37 indexed_genome mRNA 30727515 30912119 . + . ID=transcript_7728;Q9HAT8 B2RDY5,E3 ubiquitin-protein ligase pellino homolog 2,RING-type E3 ubiquitin transferase pellino homolog 2 {ECO:0000305};, PF04710;, GO:0005829;GO:0061630;GO:0070498;GO:0043123;GO:0043410;GO:0001934;GO:0000209;GO:0008592;GO:0008063;, C:cytosol;, F:ubiquitin protein ligase activity;, P:interleukin-1-mediated signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAPK cascade; P:positive regulation of protein phosphorylation; P:protein polyubiquitination; P:regulation of Toll signaling pathway; P:Toll signaling pathway;|Q8N0T1 B2RXE7 E5RFW5,Ribosomal biogenesis factor {ECO:0000305},, PF15679;, GO:0005829;GO:0005730;GO:0005654;GO:0042254;, C:cytosol; C:nucleolus; C:nucleoplasm;, , P:ribosome biogenesis; scaffold37 indexed_genome mRNA 31164499 31233999 . + . ID=transcript_7729;Q9NX78 A8KAN4 B3KPF5 Q0VAA1 Q86XE1,Transmembrane protein 260,, PF11028;, GO:0016021;, C:integral component of membrane;|Q9NX78 A8KAN4 B3KPF5 Q0VAA1 Q86XE1,Transmembrane protein 260,, PF11028;, GO:0016021;, C:integral component of membrane;|Q9NX78 A8KAN4 B3KPF5 Q0VAA1 Q86XE1,Transmembrane protein 260,, PF11028;, GO:0016021;, C:integral component of membrane;|Q9NX78 A8KAN4 B3KPF5 Q0VAA1 Q86XE1,Transmembrane protein 260,, PF11028;, GO:0016021;, C:integral component of membrane; scaffold37 indexed_genome mRNA 31747732 31799718 . - . ID=transcript_7730;O00471 B2R6C5 Q8IW24,Exocyst complex component 5,Exocyst complex component Sec10;, PF07393;, GO:0005737;GO:0005829;GO:0000145;GO:0030496;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0006892;GO:0015031;, C:cytoplasm; C:cytosol; C:exocyst; C:midbody;, F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:post-Golgi vesicle-mediated transport; P:protein transport;|O00471 B2R6C5 Q8IW24,Exocyst complex component 5,Exocyst complex component Sec10;, PF07393;, GO:0005737;GO:0005829;GO:0000145;GO:0030496;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0006892;GO:0015031;, C:cytoplasm; C:cytosol; C:exocyst; C:midbody;, F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:post-Golgi vesicle-mediated transport; P:protein transport;|O00471 B2R6C5 Q8IW24,Exocyst complex component 5,Exocyst complex component Sec10;, PF07393;, GO:0005737;GO:0005829;GO:0000145;GO:0030496;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0006892;GO:0015031;, C:cytoplasm; C:cytosol; C:exocyst; C:midbody;, F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:post-Golgi vesicle-mediated transport; P:protein transport;|O00471 B2R6C5 Q8IW24,Exocyst complex component 5,Exocyst complex component Sec10;, PF07393;, GO:0005737;GO:0005829;GO:0000145;GO:0030496;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0006892;GO:0015031;, C:cytoplasm; C:cytosol; C:exocyst; C:midbody;, F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:post-Golgi vesicle-mediated transport; P:protein transport;|O00471 B2R6C5 Q8IW24,Exocyst complex component 5,Exocyst complex component Sec10;, PF07393;, GO:0005737;GO:0005829;GO:0000145;GO:0030496;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0006892;GO:0015031;, C:cytoplasm; C:cytosol; C:exocyst; C:midbody;, F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:post-Golgi vesicle-mediated transport; P:protein transport;|O00471 B2R6C5 Q8IW24,Exocyst complex component 5,Exocyst complex component Sec10;, PF07393;, GO:0005737;GO:0005829;GO:0000145;GO:0030496;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0006892;GO:0015031;, C:cytoplasm; C:cytosol; C:exocyst; C:midbody;, F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:post-Golgi vesicle-mediated transport; P:protein transport; scaffold37 indexed_genome mRNA 31799757 31823905 . + . ID=transcript_7731;Q9H0R1 O95354 Q6ZMD7 Q96DX3 Q9NVC5,AP-5 complex subunit mu-1,Adaptor-related protein complex 5 subunit mu-1;Mu-2-related death-inducing protein;Putative HIV-1 infection-related protein;, PF00928;, GO:0030119;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0016197;GO:0015031;, C:AP-type membrane coat adaptor complex; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane;, , P:endosomal transport; P:protein transport;|Q9H0R1 O95354 Q6ZMD7 Q96DX3 Q9NVC5,AP-5 complex subunit mu-1,Adaptor-related protein complex 5 subunit mu-1;Mu-2-related death-inducing protein;Putative HIV-1 infection-related protein;, PF00928;, GO:0030119;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0016197;GO:0015031;, C:AP-type membrane coat adaptor complex; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane;, , P:endosomal transport; P:protein transport;|Q9H0R1 O95354 Q6ZMD7 Q96DX3 Q9NVC5,AP-5 complex subunit mu-1,Adaptor-related protein complex 5 subunit mu-1;Mu-2-related death-inducing protein;Putative HIV-1 infection-related protein;, PF00928;, GO:0030119;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0016197;GO:0015031;, C:AP-type membrane coat adaptor complex; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane;, , P:endosomal transport; P:protein transport;|Q9H0R1 O95354 Q6ZMD7 Q96DX3 Q9NVC5,AP-5 complex subunit mu-1,Adaptor-related protein complex 5 subunit mu-1;Mu-2-related death-inducing protein;Putative HIV-1 infection-related protein;, PF00928;, GO:0030119;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0016197;GO:0015031;, C:AP-type membrane coat adaptor complex; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane;, , P:endosomal transport; P:protein transport; scaffold37 indexed_genome mRNA 31894834 31916095 . + . ID=transcript_7732;Q147X3 Q0IIN2,N-alpha-acetyltransferase 30,N-acetyltransferase 12;N-acetyltransferase MAK3 homolog;NatC catalytic subunit;, PF00583;, GO:0005737;GO:0005829;GO:0031417;GO:0005634;GO:0004596;GO:0017196;, C:cytoplasm; C:cytosol; C:NatC complex; C:nucleus;, F:peptide alpha-N-acetyltransferase activity;, P:N-terminal peptidyl-methionine acetylation;|Q147X3 Q0IIN2,N-alpha-acetyltransferase 30,N-acetyltransferase 12;N-acetyltransferase MAK3 homolog;NatC catalytic subunit;, PF00583;, GO:0005737;GO:0005829;GO:0031417;GO:0005634;GO:0004596;GO:0017196;, C:cytoplasm; C:cytosol; C:NatC complex; C:nucleus;, F:peptide alpha-N-acetyltransferase activity;, P:N-terminal peptidyl-methionine acetylation;|Q147X3 Q0IIN2,N-alpha-acetyltransferase 30,N-acetyltransferase 12;N-acetyltransferase MAK3 homolog;NatC catalytic subunit;, PF00583;, GO:0005737;GO:0005829;GO:0031417;GO:0005634;GO:0004596;GO:0017196;, C:cytoplasm; C:cytosol; C:NatC complex; C:nucleus;, F:peptide alpha-N-acetyltransferase activity;, P:N-terminal peptidyl-methionine acetylation; scaffold37 indexed_genome mRNA 31951913 31978453 . - . ID=transcript_7733;Q9NVL8 Q17R99 Q53G04,Uncharacterized protein CCDC198 {ECO:0000305},, PF15398; scaffold37 indexed_genome mRNA 32444399 32578363 . - . ID=transcript_7734;Q86TY3 A8K8Z8 Q6P5Q1 Q86TY1,Armadillo-like helical domain-containing protein 4 {ECO:0000305},, PF15767;, GO:0016021;, C:integral component of membrane; scaffold37 indexed_genome mRNA 32622959 32647919 . + . ID=transcript_7735;Q9NZ32 Q9H9Y5 Q9NWY2,Actin-related protein 10,Actin-related protein 11;, PF00022;, GO:1904115;GO:0035578;GO:0005829;GO:0005869;GO:0005576;GO:1904813;GO:0019886;GO:0006888;GO:0007018;GO:0043312;GO:0098958;, C:axon cytoplasm; C:azurophil granule lumen; C:cytosol; C:dynactin complex; C:extracellular region; C:ficolin-1-rich granule lumen;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule-based movement; P:neutrophil degranulation; P:retrograde axonal transport of mitochondrion;|Q9NZ32 Q9H9Y5 Q9NWY2,Actin-related protein 10,Actin-related protein 11;, PF00022;, GO:1904115;GO:0035578;GO:0005829;GO:0005869;GO:0005576;GO:1904813;GO:0019886;GO:0006888;GO:0007018;GO:0043312;GO:0098958;, C:axon cytoplasm; C:azurophil granule lumen; C:cytosol; C:dynactin complex; C:extracellular region; C:ficolin-1-rich granule lumen;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule-based movement; P:neutrophil degranulation; P:retrograde axonal transport of mitochondrion;|Q9NZ32 Q9H9Y5 Q9NWY2,Actin-related protein 10,Actin-related protein 11;, PF00022;, GO:1904115;GO:0035578;GO:0005829;GO:0005869;GO:0005576;GO:1904813;GO:0019886;GO:0006888;GO:0007018;GO:0043312;GO:0098958;, C:axon cytoplasm; C:azurophil granule lumen; C:cytosol; C:dynactin complex; C:extracellular region; C:ficolin-1-rich granule lumen;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule-based movement; P:neutrophil degranulation; P:retrograde axonal transport of mitochondrion; scaffold37 indexed_genome mRNA 32655248 32695058 . + . ID=transcript_7736;P25788 B2RCK6 Q86U83 Q8N1D8 Q9BS70,Proteasome subunit alpha type-3,Macropain subunit C8;Multicatalytic endopeptidase complex subunit C8;Proteasome component C8;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0045202;GO:0004175;GO:0031625;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:0052548;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:synapse;, F:endopeptidase activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of endopeptidase activity; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P25788 B2RCK6 Q86U83 Q8N1D8 Q9BS70,Proteasome subunit alpha type-3,Macropain subunit C8;Multicatalytic endopeptidase complex subunit C8;Proteasome component C8;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0045202;GO:0004175;GO:0031625;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:0052548;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:synapse;, F:endopeptidase activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of endopeptidase activity; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P25788 B2RCK6 Q86U83 Q8N1D8 Q9BS70,Proteasome subunit alpha type-3,Macropain subunit C8;Multicatalytic endopeptidase complex subunit C8;Proteasome component C8;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0045202;GO:0004175;GO:0031625;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:0052548;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:synapse;, F:endopeptidase activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of endopeptidase activity; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P25788 B2RCK6 Q86U83 Q8N1D8 Q9BS70,Proteasome subunit alpha type-3,Macropain subunit C8;Multicatalytic endopeptidase complex subunit C8;Proteasome component C8;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0045202;GO:0004175;GO:0031625;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:0052548;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:synapse;, F:endopeptidase activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of endopeptidase activity; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P25788 B2RCK6 Q86U83 Q8N1D8 Q9BS70,Proteasome subunit alpha type-3,Macropain subunit C8;Multicatalytic endopeptidase complex subunit C8;Proteasome component C8;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019773;GO:0045202;GO:0004175;GO:0031625;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:0052548;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:synapse;, F:endopeptidase activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of endopeptidase activity; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold37 indexed_genome mRNA 32695355 32734581 . + . ID=transcript_7737;P29374 Q15991 Q15992 Q15993,AT-rich interactive domain-containing protein 4A,Retinoblastoma-binding protein 1;, PF01388;PF08169;PF11717;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0017053;GO:0003677;GO:0000976;GO:0048821;GO:0097368;GO:0080182;GO:0036124;GO:0034773;GO:0045892;GO:0045944;GO:0006349;GO:0006357;GO:0007283;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:transcription repressor complex;, F:DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:erythrocyte development; P:establishment of Sertoli cell barrier; P:histone H3-K4 trimethylation; P:histone H3-K9 trimethylation; P:histone H4-K20 trimethylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression by genetic imprinting; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold37 indexed_genome mRNA 32737682 32747914 . + . ID=transcript_7738;P29374 Q15991 Q15992 Q15993,AT-rich interactive domain-containing protein 4A,Retinoblastoma-binding protein 1;, PF01388;PF08169;PF11717;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0017053;GO:0003677;GO:0000976;GO:0048821;GO:0097368;GO:0080182;GO:0036124;GO:0034773;GO:0045892;GO:0045944;GO:0006349;GO:0006357;GO:0007283;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:transcription repressor complex;, F:DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:erythrocyte development; P:establishment of Sertoli cell barrier; P:histone H3-K4 trimethylation; P:histone H3-K9 trimethylation; P:histone H4-K20 trimethylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression by genetic imprinting; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|P29374 Q15991 Q15992 Q15993,AT-rich interactive domain-containing protein 4A,Retinoblastoma-binding protein 1;, PF01388;PF08169;PF11717;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0017053;GO:0003677;GO:0000976;GO:0048821;GO:0097368;GO:0080182;GO:0036124;GO:0034773;GO:0045892;GO:0045944;GO:0006349;GO:0006357;GO:0007283;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:transcription repressor complex;, F:DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:erythrocyte development; P:establishment of Sertoli cell barrier; P:histone H3-K4 trimethylation; P:histone H3-K9 trimethylation; P:histone H4-K20 trimethylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression by genetic imprinting; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold37 indexed_genome mRNA 32782818 32783932 . + . ID=transcript_7739;Q9Y5J7 B2R584,Mitochondrial import inner membrane translocase subunit Tim9,, PF02953;, GO:0005743;GO:0005758;GO:0042719;GO:0005739;GO:0051087;GO:0042803;GO:0140318;GO:0008270;GO:0072321;GO:0045039;GO:0006626;GO:0007605;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial intermembrane space protein transporter complex; C:mitochondrion;, F:chaperone binding; F:protein homodimerization activity; F:protein transporter activity; F:zinc ion binding;, P:chaperone-mediated protein transport; P:protein insertion into mitochondrial inner membrane; P:protein targeting to mitochondrion; P:sensory perception of sound; scaffold37 indexed_genome mRNA 32797946 32893787 . + . ID=transcript_7740;Q9BVV6 B4DZB6 E7EWM8 J3KQH9 O60328 Q6NYC6 Q6UV20,Protein TALPID3,, PF15324;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0001917;GO:0060271;GO:0070201;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:photoreceptor inner segment;, , P:cilium assembly; P:regulation of establishment of protein localization; P:smoothened signaling pathway;|Q9BVV6 B4DZB6 E7EWM8 J3KQH9 O60328 Q6NYC6 Q6UV20,Protein TALPID3,, PF15324;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0001917;GO:0060271;GO:0070201;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:photoreceptor inner segment;, , P:cilium assembly; P:regulation of establishment of protein localization; P:smoothened signaling pathway;|Q9BVV6 B4DZB6 E7EWM8 J3KQH9 O60328 Q6NYC6 Q6UV20,Protein TALPID3,, PF15324;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0001917;GO:0060271;GO:0070201;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:photoreceptor inner segment;, , P:cilium assembly; P:regulation of establishment of protein localization; P:smoothened signaling pathway; scaffold37 indexed_genome mRNA 32913200 32921490 . + . ID=transcript_7741;Q9BVV6 B4DZB6 E7EWM8 J3KQH9 O60328 Q6NYC6 Q6UV20,Protein TALPID3,, PF15324;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0001917;GO:0060271;GO:0070201;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:photoreceptor inner segment;, , P:cilium assembly; P:regulation of establishment of protein localization; P:smoothened signaling pathway;|Q9BVV6 B4DZB6 E7EWM8 J3KQH9 O60328 Q6NYC6 Q6UV20,Protein TALPID3,, PF15324;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0001917;GO:0060271;GO:0070201;GO:0007224;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:photoreceptor inner segment;, , P:cilium assembly; P:regulation of establishment of protein localization; P:smoothened signaling pathway; scaffold37 indexed_genome mRNA 33257890 33714087 . + . ID=transcript_7742;Q9Y4D1 Q86U34 Q8N1Z8 Q8TB39,Disheveled-associated activator of morphogenesis 1,, PF06367;PF06371;PF02181;, GO:0036064;GO:0005829;GO:0016020;GO:0031514;GO:0005886;GO:0001725;GO:0003779;GO:0042802;GO:0031267;GO:0030036;GO:0060071;, C:ciliary basal body; C:cytosol; C:membrane; C:motile cilium; C:plasma membrane; C:stress fiber;, F:actin binding; F:identical protein binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:Wnt signaling pathway, planar cell polarity pathway;|Q9Y4D1 Q86U34 Q8N1Z8 Q8TB39,Disheveled-associated activator of morphogenesis 1,, PF06367;PF06371;PF02181;, GO:0036064;GO:0005829;GO:0016020;GO:0031514;GO:0005886;GO:0001725;GO:0003779;GO:0042802;GO:0031267;GO:0030036;GO:0060071;, C:ciliary basal body; C:cytosol; C:membrane; C:motile cilium; C:plasma membrane; C:stress fiber;, F:actin binding; F:identical protein binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:Wnt signaling pathway, planar cell polarity pathway;|Q9Y4D1 Q86U34 Q8N1Z8 Q8TB39,Disheveled-associated activator of morphogenesis 1,, PF06367;PF06371;PF02181;, GO:0036064;GO:0005829;GO:0016020;GO:0031514;GO:0005886;GO:0001725;GO:0003779;GO:0042802;GO:0031267;GO:0030036;GO:0060071;, C:ciliary basal body; C:cytosol; C:membrane; C:motile cilium; C:plasma membrane; C:stress fiber;, F:actin binding; F:identical protein binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:Wnt signaling pathway, planar cell polarity pathway; scaffold37 indexed_genome mRNA 33791809 33804183 . - . ID=transcript_7743;Q96EM0 Q96LJ5,Trans-3-hydroxy-L-proline dehydratase {ECO:0000303|PubMed:22528483, ECO:0000303|PubMed:24649405},Trans-L-3-hydroxyproline dehydratase;, PF05544;, GO:0016836;GO:0050346;, , F:hydro-lyase activity; F:trans-L-3-hydroxyproline dehydratase activity; scaffold37 indexed_genome mRNA 33811377 33845084 . + . ID=transcript_7744;Q9P0R3,JNK1/MAPK8-associated membrane protein,JNK1-associated membrane protein;Medulloblastoma antigen MU-MB-50.4;, PF05571;, GO:0005789;GO:0016021;GO:0031625;GO:0006986;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:ubiquitin protein ligase binding;, P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|Q9P0R3,JNK1/MAPK8-associated membrane protein,JNK1-associated membrane protein;Medulloblastoma antigen MU-MB-50.4;, PF05571;, GO:0005789;GO:0016021;GO:0031625;GO:0006986;GO:0030433;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:ubiquitin protein ligase binding;, P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|P0C221 G3V5J7,Coiled-coil domain-containing protein 175|P0C221 G3V5J7,Coiled-coil domain-containing protein 175|P0C221 G3V5J7,Coiled-coil domain-containing protein 175 scaffold37 indexed_genome mRNA 33847182 33852460 . - . ID=transcript_7745;P0C221 G3V5J7,Coiled-coil domain-containing protein 175 scaffold37 indexed_genome mRNA 33852844 33903908 . - . ID=transcript_7746;P0C221 G3V5J7,Coiled-coil domain-containing protein 175|P0C221 G3V5J7,Coiled-coil domain-containing protein 175 scaffold37 indexed_genome mRNA 33904545 34137381 . - . ID=transcript_7747;Q16799 Q16800 Q16801 Q5BKZ4 Q9BQ59,Reticulon-1,Neuroendocrine-specific protein;, PF02453;, GO:0005783;GO:0005789;GO:0000139;GO:0030176;GO:1902430;GO:0030182;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane;, , P:negative regulation of amyloid-beta formation; P:neuron differentiation;|Q16799 Q16800 Q16801 Q5BKZ4 Q9BQ59,Reticulon-1,Neuroendocrine-specific protein;, PF02453;, GO:0005783;GO:0005789;GO:0000139;GO:0030176;GO:1902430;GO:0030182;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane;, , P:negative regulation of amyloid-beta formation; P:neuron differentiation; scaffold37 indexed_genome mRNA 34182353 34257956 . + . ID=transcript_7748;Q6ZRR7,Leucine-rich repeat-containing protein 9,, PF12799;PF13855;|Q6ZRR7,Leucine-rich repeat-containing protein 9,, PF12799;PF13855;|Q6ZRR7,Leucine-rich repeat-containing protein 9,, PF12799;PF13855; scaffold37 indexed_genome mRNA 34259975 34287358 . + . ID=transcript_7749;Q6ZRR7,Leucine-rich repeat-containing protein 9,, PF12799;PF13855; scaffold37 indexed_genome mRNA 34319349 34357012 . + . ID=transcript_7750;Q63HM2 A8MXM2 Q9BQG8 Q9H9F2,Pecanex-like protein 4,Hepatitis C virus F protein-binding protein 2;Pecanex homolog protein 4 {ECO:0000312|HGNC:HGNC:20349};, PF05041;, GO:0016021;, C:integral component of membrane;|Q63HM2 A8MXM2 Q9BQG8 Q9H9F2,Pecanex-like protein 4,Hepatitis C virus F protein-binding protein 2;Pecanex homolog protein 4 {ECO:0000312|HGNC:HGNC:20349};, PF05041;, GO:0016021;, C:integral component of membrane;|Q63HM2 A8MXM2 Q9BQG8 Q9H9F2,Pecanex-like protein 4,Hepatitis C virus F protein-binding protein 2;Pecanex homolog protein 4 {ECO:0000312|HGNC:HGNC:20349};, PF05041;, GO:0016021;, C:integral component of membrane;|Q63HM2 A8MXM2 Q9BQG8 Q9H9F2,Pecanex-like protein 4,Hepatitis C virus F protein-binding protein 2;Pecanex homolog protein 4 {ECO:0000312|HGNC:HGNC:20349};, PF05041;, GO:0016021;, C:integral component of membrane;|Q63HM2 A8MXM2 Q9BQG8 Q9H9F2,Pecanex-like protein 4,Hepatitis C virus F protein-binding protein 2;Pecanex homolog protein 4 {ECO:0000312|HGNC:HGNC:20349};, PF05041;, GO:0016021;, C:integral component of membrane;|Q63HM2 A8MXM2 Q9BQG8 Q9H9F2,Pecanex-like protein 4,Hepatitis C virus F protein-binding protein 2;Pecanex homolog protein 4 {ECO:0000312|HGNC:HGNC:20349};, PF05041;, GO:0016021;, C:integral component of membrane; scaffold37 indexed_genome mRNA 34357469 34385454 . - . ID=transcript_7751;Q9NPJ6 B4DX67 Q53GB4 Q53H68 Q5T912 Q6FHC4 Q6IA79 Q9BS95 Q9NYR5,Mediator of RNA polymerase II transcription subunit 4,Activator-recruited cofactor 36 kDa component;Mediator complex subunit 4;TRAP/SMCC/PC2 subunit p36 subunit;Vitamin D3 receptor-interacting protein complex 36 kDa component;, PF10018;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II;|Q9Y394 B2R896 Q9UKU2,Dehydrogenase/reductase SDR family member 7,Retinal short-chain dehydrogenase/reductase 4;Short chain dehydrogenase/reductase family 34C member 1;, PF00106;, GO:0016020;GO:0016491;, C:membrane;, F:oxidoreductase activity; scaffold37 indexed_genome mRNA 34504775 34524389 . + . ID=transcript_7752;P35813 B5BU11 J3KNM0 O75551,Protein phosphatase 1A,Protein phosphatase 2C isoform alpha;Protein phosphatase IA;, PF00481;PF07830;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0033192;GO:0000287;GO:0030145;GO:0106306;GO:0004722;GO:0106307;GO:0070412;GO:0007050;GO:0071560;GO:0016311;GO:0006499;GO:0030514;GO:0043124;GO:1901223;GO:0010991;GO:0000122;GO:0030512;GO:0035970;GO:0090263;GO:0043123;GO:0046827;GO:0045893;GO:0006470;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calmodulin-dependent protein phosphatase activity; F:magnesium ion binding; F:manganese ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:R-SMAD binding;, P:cell cycle arrest; P:cellular response to transforming growth factor beta stimulus; P:dephosphorylation; P:N-terminal protein myristoylation; P:negative regulation of BMP signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of SMAD protein complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peptidyl-threonine dephosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein export from nucleus; P:positive regulation of transcription, DNA-templated; P:protein dephosphorylation;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|P35813 B5BU11 J3KNM0 O75551,Protein phosphatase 1A,Protein phosphatase 2C isoform alpha;Protein phosphatase IA;, PF00481;PF07830;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0033192;GO:0000287;GO:0030145;GO:0106306;GO:0004722;GO:0106307;GO:0070412;GO:0007050;GO:0071560;GO:0016311;GO:0006499;GO:0030514;GO:0043124;GO:1901223;GO:0010991;GO:0000122;GO:0030512;GO:0035970;GO:0090263;GO:0043123;GO:0046827;GO:0045893;GO:0006470;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calmodulin-dependent protein phosphatase activity; F:magnesium ion binding; F:manganese ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:R-SMAD binding;, P:cell cycle arrest; P:cellular response to transforming growth factor beta stimulus; P:dephosphorylation; P:N-terminal protein myristoylation; P:negative regulation of BMP signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of SMAD protein complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peptidyl-threonine dephosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein export from nucleus; P:positive regulation of transcription, DNA-templated; P:protein dephosphorylation;|P35813 B5BU11 J3KNM0 O75551,Protein phosphatase 1A,Protein phosphatase 2C isoform alpha;Protein phosphatase IA;, PF00481;PF07830;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0033192;GO:0000287;GO:0030145;GO:0106306;GO:0004722;GO:0106307;GO:0070412;GO:0007050;GO:0071560;GO:0016311;GO:0006499;GO:0030514;GO:0043124;GO:1901223;GO:0010991;GO:0000122;GO:0030512;GO:0035970;GO:0090263;GO:0043123;GO:0046827;GO:0045893;GO:0006470;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calmodulin-dependent protein phosphatase activity; F:magnesium ion binding; F:manganese ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:R-SMAD binding;, P:cell cycle arrest; P:cellular response to transforming growth factor beta stimulus; P:dephosphorylation; P:N-terminal protein myristoylation; P:negative regulation of BMP signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of SMAD protein complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peptidyl-threonine dephosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein export from nucleus; P:positive regulation of transcription, DNA-templated; P:protein dephosphorylation;|P35813 B5BU11 J3KNM0 O75551,Protein phosphatase 1A,Protein phosphatase 2C isoform alpha;Protein phosphatase IA;, PF00481;PF07830;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0033192;GO:0000287;GO:0030145;GO:0106306;GO:0004722;GO:0106307;GO:0070412;GO:0007050;GO:0071560;GO:0016311;GO:0006499;GO:0030514;GO:0043124;GO:1901223;GO:0010991;GO:0000122;GO:0030512;GO:0035970;GO:0090263;GO:0043123;GO:0046827;GO:0045893;GO:0006470;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calmodulin-dependent protein phosphatase activity; F:magnesium ion binding; F:manganese ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:R-SMAD binding;, P:cell cycle arrest; P:cellular response to transforming growth factor beta stimulus; P:dephosphorylation; P:N-terminal protein myristoylation; P:negative regulation of BMP signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of SMAD protein complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peptidyl-threonine dephosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein export from nucleus; P:positive regulation of transcription, DNA-templated; P:protein dephosphorylation; scaffold37 indexed_genome mRNA 34805851 34809238 . - . ID=transcript_7753;Q15475 Q53Y16 Q96H64,Homeobox protein SIX1,Sine oculis homeobox homolog 1;, PF00046;PF16878;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0001223;GO:0000976;GO:0035909;GO:0006915;GO:0001658;GO:1905243;GO:0090103;GO:0048701;GO:0048704;GO:0030855;GO:0021610;GO:0061197;GO:0048699;GO:0048839;GO:0042472;GO:0001822;GO:0072172;GO:0072075;GO:0042474;GO:0051451;GO:0061055;GO:0043524;GO:0000122;GO:0048665;GO:0030910;GO:0001759;GO:0071599;GO:0003151;GO:0007389;GO:0060037;GO:0090190;GO:0090336;GO:2000729;GO:0072513;GO:0045944;GO:0045893;GO:0072107;GO:0034504;GO:0072095;GO:0050678;GO:0045664;GO:0032880;GO:2001014;GO:0014857;GO:0014842;GO:0008582;GO:0006357;GO:0006355;GO:0007605;GO:0048741;GO:0007519;GO:0048538;GO:0030878;GO:0061551;GO:0072193;GO:0001657;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription coactivator binding; F:transcription regulatory region sequence-specific DNA binding;, P:aorta morphogenesis; P:apoptotic process; P:branching involved in ureteric bud morphogenesis; P:cellular response to 3,3',5-triiodo-L-thyronine; P:cochlea morphogenesis; P:embryonic cranial skeleton morphogenesis; P:embryonic skeletal system morphogenesis; P:epithelial cell differentiation; P:facial nerve morphogenesis; P:fungiform papilla morphogenesis; P:generation of neurons; P:inner ear development; P:inner ear morphogenesis; P:kidney development; P:mesonephric tubule formation; P:metanephric mesenchyme development; P:middle ear morphogenesis; P:myoblast migration; P:myotome development; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:neuron fate specification; P:olfactory placode formation; P:organ induction; P:otic vesicle development; P:outflow tract morphogenesis; P:pattern specification process; P:pharyngeal system development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:positive regulation of mesenchymal cell proliferation involved in ureter development; P:positive regulation of secondary heart field cardioblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of ureteric bud formation; P:protein localization to nucleus; P:regulation of branch elongation involved in ureteric bud branching; P:regulation of epithelial cell proliferation; P:regulation of neuron differentiation; P:regulation of protein localization; P:regulation of skeletal muscle cell differentiation; P:regulation of skeletal muscle cell proliferation; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of synaptic growth at neuromuscular junction; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:sensory perception of sound; P:skeletal muscle fiber development; P:skeletal muscle tissue development; P:thymus development; P:thyroid gland development; P:trigeminal ganglion development; P:ureter smooth muscle cell differentiation; P:ureteric bud development; scaffold37 indexed_genome mRNA 34864403 34872807 . - . ID=transcript_7754;Q9UIU6 Q4QQH5 Q4V764,Homeobox protein SIX4,Sine oculis homeobox homolog 4;, PF00046;PF16878;, GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0009653;GO:0048701;GO:0061197;GO:0048699;GO:0042472;GO:0008584;GO:0030238;GO:0046661;GO:0072075;GO:0051451;GO:0061055;GO:0043066;GO:0043524;GO:1902725;GO:0045892;GO:0030910;GO:0060037;GO:0090190;GO:0045893;GO:0072107;GO:0034504;GO:0072095;GO:0050678;GO:0032880;GO:0008582;GO:0006357;GO:0045214;GO:0098528;GO:0007519;GO:0048538;GO:0043586;GO:0061551;, C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure morphogenesis; P:embryonic cranial skeleton morphogenesis; P:fungiform papilla morphogenesis; P:generation of neurons; P:inner ear morphogenesis; P:male gonad development; P:male sex determination; P:male sex differentiation; P:metanephric mesenchyme development; P:myoblast migration; P:myotome development; P:negative regulation of apoptotic process; P:negative regulation of neuron apoptotic process; P:negative regulation of satellite cell differentiation; P:negative regulation of transcription, DNA-templated; P:olfactory placode formation; P:pharyngeal system development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of transcription, DNA-templated; P:positive regulation of ureteric bud formation; P:protein localization to nucleus; P:regulation of branch elongation involved in ureteric bud branching; P:regulation of epithelial cell proliferation; P:regulation of protein localization; P:regulation of synaptic growth at neuromuscular junction; P:regulation of transcription by RNA polymerase II; P:sarcomere organization; P:skeletal muscle fiber differentiation; P:skeletal muscle tissue development; P:thymus development; P:tongue development; P:trigeminal ganglion development; scaffold37 indexed_genome mRNA 35097751 35108490 . - . ID=transcript_7755;Q32P41 B2RN19 Q9P2F4,tRNA (guanine(37)-N1)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03152},M1G-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03152};tRNA [GM37] methyltransferase {ECO:0000255|HAMAP-Rule:MF_03152};tRNA methyltransferase 5 homolog {ECO:0000255|HAMAP-Rule:MF_03152};, PF02475;, GO:0005737;GO:0005759;GO:0005634;GO:0052906;GO:0009019;GO:0008175;GO:0070901;GO:0030488;GO:0002939;, C:cytoplasm; C:mitochondrial matrix; C:nucleus;, F:tRNA (guanine(37)-N(1))-methyltransferase activity; F:tRNA (guanine-N1-)-methyltransferase activity; F:tRNA methyltransferase activity;, P:mitochondrial tRNA methylation; P:tRNA methylation; P:tRNA N1-guanine methylation; scaffold37 indexed_genome mRNA 35108597 35176057 . + . ID=transcript_7756;Q8IZM9 C9JWA6 Q86SY5,Probable sodium-coupled neutral amino acid transporter 6,N-system amino acid transporter 1;Na(+)-coupled neutral amino acid transporter 6;Solute carrier family 38 member 6;, PF01490;, GO:0005887;GO:0005886;GO:0015171;GO:0015186;GO:0003333;GO:0006868;GO:0006814;, C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:L-glutamine transmembrane transporter activity;, P:amino acid transmembrane transport; P:glutamine transport; P:sodium ion transport; scaffold37 indexed_genome mRNA 35400569 35634099 . + . ID=transcript_7757;P24723 B4DJN5 Q16246 Q8NE03,Protein kinase C eta type,PKC-L;nPKC-eta;, PF00130;PF00168;PF00069;PF00433;, GO:0005737;GO:0005829;GO:0070062;GO:0005886;GO:0005524;GO:0004698;GO:0019899;GO:0046872;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0034351;GO:0018105;GO:0030168;GO:0050861;GO:0060252;GO:0045618;GO:0010744;GO:0051092;GO:1903078;GO:0006468;GO:2000810;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:plasma membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:enzyme binding; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:negative regulation of glial cell apoptotic process; P:peptidyl-serine phosphorylation; P:platelet activation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of glial cell proliferation; P:positive regulation of keratinocyte differentiation; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein localization to plasma membrane; P:protein phosphorylation; P:regulation of bicellular tight junction assembly; P:signal transduction; scaffold37 indexed_genome mRNA 35797493 35845218 . + . ID=transcript_7758;Q16665 C0LZJ3 Q53XP6 Q96PT9 Q9UPB1,Hypoxia-inducible factor 1-alpha {ECO:0000305},ARNT-interacting protein;Basic-helix-loop-helix-PAS protein MOP1 {ECO:0000303|PubMed:9079689};Class E basic helix-loop-helix protein 78;Member of PAS protein 1 {ECO:0000303|PubMed:9079689};PAS domain-containing protein 8;, PF11413;PF08778;PF00989;PF08447;, GO:1904115;GO:0000785;GO:0005737;GO:0005829;GO:0031514;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0019899;GO:0035035;GO:0042826;GO:0051879;GO:0035257;GO:0002039;GO:0019904;GO:0046982;GO:0019901;GO:0000977;GO:0008134;GO:0031625;GO:0001525;GO:0019896;GO:0001922;GO:0003208;GO:0051216;GO:0006879;GO:0071456;GO:0071347;GO:0098586;GO:0021987;GO:0032963;GO:0002248;GO:0019221;GO:0048546;GO:0071542;GO:0051541;GO:0035162;GO:0001892;GO:0061030;GO:0001837;GO:0042593;GO:0001947;GO:0042541;GO:0097411;GO:0060574;GO:0061072;GO:0006089;GO:0007595;GO:0046716;GO:0030502;GO:0010629;GO:0045926;GO:2001054;GO:1903377;GO:2000378;GO:0070244;GO:0032007;GO:0001755;GO:0021502;GO:0003151;GO:0032364;GO:0045766;GO:1903599;GO:0043536;GO:0032722;GO:0070101;GO:1900017;GO:0001938;GO:0010634;GO:0045648;GO:0010628;GO:0045821;GO:0046886;GO:0035774;GO:0016239;GO:0002052;GO:0051000;GO:1902895;GO:2000273;GO:0045944;GO:0061419;GO:0045893;GO:0010575;GO:0030949;GO:0043687;GO:0016579;GO:0016567;GO:1903715;GO:0010468;GO:0006110;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0006355;GO:0032909;GO:0001666;GO:0010039;GO:0014850;GO:0000302;GO:0061298;GO:0007165;GO:0010573;GO:0008542;, C:axon cytoplasm; C:chromatin; C:cytoplasm; C:cytosol; C:motile cilium; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:Hsp90 protein binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:angiogenesis; P:axonal transport of mitochondrion; P:B-1 B cell homeostasis; P:cardiac ventricle morphogenesis; P:cartilage development; P:cellular iron ion homeostasis; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to virus; P:cerebral cortex development; P:collagen metabolic process; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:digestive tract morphogenesis; P:dopaminergic neuron differentiation; P:elastin metabolic process; P:embryonic hemopoiesis; P:embryonic placenta development; P:epithelial cell differentiation involved in mammary gland alveolus development; P:epithelial to mesenchymal transition; P:glucose homeostasis; P:heart looping; P:hemoglobin biosynthetic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intestinal epithelial cell maturation; P:iris morphogenesis; P:lactate metabolic process; P:lactation; P:muscle cell cellular homeostasis; P:negative regulation of bone mineralization; P:negative regulation of gene expression; P:negative regulation of growth; P:negative regulation of mesenchymal cell apoptotic process; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of TOR signaling; P:neural crest cell migration; P:neural fold elevation formation; P:outflow tract morphogenesis; P:oxygen homeostasis; P:positive regulation of angiogenesis; P:positive regulation of autophagy of mitochondrion; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of chemokine production; P:positive regulation of chemokine-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of hormone biosynthetic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of macroautophagy; P:positive regulation of neuroblast proliferation; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:post-translational protein modification; P:protein deubiquitination; P:protein ubiquitination; P:regulation of aerobic respiration; P:regulation of gene expression; P:regulation of glycolytic process; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to iron ion; P:response to muscle activity; P:response to reactive oxygen species; P:retina vasculature development in camera-type eye; P:signal transduction; P:vascular endothelial growth factor production; P:visual learning;|Q16665 C0LZJ3 Q53XP6 Q96PT9 Q9UPB1,Hypoxia-inducible factor 1-alpha {ECO:0000305},ARNT-interacting protein;Basic-helix-loop-helix-PAS protein MOP1 {ECO:0000303|PubMed:9079689};Class E basic helix-loop-helix protein 78;Member of PAS protein 1 {ECO:0000303|PubMed:9079689};PAS domain-containing protein 8;, PF11413;PF08778;PF00989;PF08447;, GO:1904115;GO:0000785;GO:0005737;GO:0005829;GO:0031514;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0019899;GO:0035035;GO:0042826;GO:0051879;GO:0035257;GO:0002039;GO:0019904;GO:0046982;GO:0019901;GO:0000977;GO:0008134;GO:0031625;GO:0001525;GO:0019896;GO:0001922;GO:0003208;GO:0051216;GO:0006879;GO:0071456;GO:0071347;GO:0098586;GO:0021987;GO:0032963;GO:0002248;GO:0019221;GO:0048546;GO:0071542;GO:0051541;GO:0035162;GO:0001892;GO:0061030;GO:0001837;GO:0042593;GO:0001947;GO:0042541;GO:0097411;GO:0060574;GO:0061072;GO:0006089;GO:0007595;GO:0046716;GO:0030502;GO:0010629;GO:0045926;GO:2001054;GO:1903377;GO:2000378;GO:0070244;GO:0032007;GO:0001755;GO:0021502;GO:0003151;GO:0032364;GO:0045766;GO:1903599;GO:0043536;GO:0032722;GO:0070101;GO:1900017;GO:0001938;GO:0010634;GO:0045648;GO:0010628;GO:0045821;GO:0046886;GO:0035774;GO:0016239;GO:0002052;GO:0051000;GO:1902895;GO:2000273;GO:0045944;GO:0061419;GO:0045893;GO:0010575;GO:0030949;GO:0043687;GO:0016579;GO:0016567;GO:1903715;GO:0010468;GO:0006110;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0006355;GO:0032909;GO:0001666;GO:0010039;GO:0014850;GO:0000302;GO:0061298;GO:0007165;GO:0010573;GO:0008542;, C:axon cytoplasm; C:chromatin; C:cytoplasm; C:cytosol; C:motile cilium; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:Hsp90 protein binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:angiogenesis; P:axonal transport of mitochondrion; P:B-1 B cell homeostasis; P:cardiac ventricle morphogenesis; P:cartilage development; P:cellular iron ion homeostasis; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to virus; P:cerebral cortex development; P:collagen metabolic process; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:digestive tract morphogenesis; P:dopaminergic neuron differentiation; P:elastin metabolic process; P:embryonic hemopoiesis; P:embryonic placenta development; P:epithelial cell differentiation involved in mammary gland alveolus development; P:epithelial to mesenchymal transition; P:glucose homeostasis; P:heart looping; P:hemoglobin biosynthetic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intestinal epithelial cell maturation; P:iris morphogenesis; P:lactate metabolic process; P:lactation; P:muscle cell cellular homeostasis; P:negative regulation of bone mineralization; P:negative regulation of gene expression; P:negative regulation of growth; P:negative regulation of mesenchymal cell apoptotic process; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of TOR signaling; P:neural crest cell migration; P:neural fold elevation formation; P:outflow tract morphogenesis; P:oxygen homeostasis; P:positive regulation of angiogenesis; P:positive regulation of autophagy of mitochondrion; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of chemokine production; P:positive regulation of chemokine-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of hormone biosynthetic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of macroautophagy; P:positive regulation of neuroblast proliferation; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:post-translational protein modification; P:protein deubiquitination; P:protein ubiquitination; P:regulation of aerobic respiration; P:regulation of gene expression; P:regulation of glycolytic process; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to iron ion; P:response to muscle activity; P:response to reactive oxygen species; P:retina vasculature development in camera-type eye; P:signal transduction; P:vascular endothelial growth factor production; P:visual learning;|Q16665 C0LZJ3 Q53XP6 Q96PT9 Q9UPB1,Hypoxia-inducible factor 1-alpha {ECO:0000305},ARNT-interacting protein;Basic-helix-loop-helix-PAS protein MOP1 {ECO:0000303|PubMed:9079689};Class E basic helix-loop-helix protein 78;Member of PAS protein 1 {ECO:0000303|PubMed:9079689};PAS domain-containing protein 8;, PF11413;PF08778;PF00989;PF08447;, GO:1904115;GO:0000785;GO:0005737;GO:0005829;GO:0031514;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0019899;GO:0035035;GO:0042826;GO:0051879;GO:0035257;GO:0002039;GO:0019904;GO:0046982;GO:0019901;GO:0000977;GO:0008134;GO:0031625;GO:0001525;GO:0019896;GO:0001922;GO:0003208;GO:0051216;GO:0006879;GO:0071456;GO:0071347;GO:0098586;GO:0021987;GO:0032963;GO:0002248;GO:0019221;GO:0048546;GO:0071542;GO:0051541;GO:0035162;GO:0001892;GO:0061030;GO:0001837;GO:0042593;GO:0001947;GO:0042541;GO:0097411;GO:0060574;GO:0061072;GO:0006089;GO:0007595;GO:0046716;GO:0030502;GO:0010629;GO:0045926;GO:2001054;GO:1903377;GO:2000378;GO:0070244;GO:0032007;GO:0001755;GO:0021502;GO:0003151;GO:0032364;GO:0045766;GO:1903599;GO:0043536;GO:0032722;GO:0070101;GO:1900017;GO:0001938;GO:0010634;GO:0045648;GO:0010628;GO:0045821;GO:0046886;GO:0035774;GO:0016239;GO:0002052;GO:0051000;GO:1902895;GO:2000273;GO:0045944;GO:0061419;GO:0045893;GO:0010575;GO:0030949;GO:0043687;GO:0016579;GO:0016567;GO:1903715;GO:0010468;GO:0006110;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0006355;GO:0032909;GO:0001666;GO:0010039;GO:0014850;GO:0000302;GO:0061298;GO:0007165;GO:0010573;GO:0008542;, C:axon cytoplasm; C:chromatin; C:cytoplasm; C:cytosol; C:motile cilium; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:Hsp90 protein binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:angiogenesis; P:axonal transport of mitochondrion; P:B-1 B cell homeostasis; P:cardiac ventricle morphogenesis; P:cartilage development; P:cellular iron ion homeostasis; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to virus; P:cerebral cortex development; P:collagen metabolic process; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:digestive tract morphogenesis; P:dopaminergic neuron differentiation; P:elastin metabolic process; P:embryonic hemopoiesis; P:embryonic placenta development; P:epithelial cell differentiation involved in mammary gland alveolus development; P:epithelial to mesenchymal transition; P:glucose homeostasis; P:heart looping; P:hemoglobin biosynthetic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intestinal epithelial cell maturation; P:iris morphogenesis; P:lactate metabolic process; P:lactation; P:muscle cell cellular homeostasis; P:negative regulation of bone mineralization; P:negative regulation of gene expression; P:negative regulation of growth; P:negative regulation of mesenchymal cell apoptotic process; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of TOR signaling; P:neural crest cell migration; P:neural fold elevation formation; P:outflow tract morphogenesis; P:oxygen homeostasis; P:positive regulation of angiogenesis; P:positive regulation of autophagy of mitochondrion; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of chemokine production; P:positive regulation of chemokine-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of hormone biosynthetic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of macroautophagy; P:positive regulation of neuroblast proliferation; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:post-translational protein modification; P:protein deubiquitination; P:protein ubiquitination; P:regulation of aerobic respiration; P:regulation of gene expression; P:regulation of glycolytic process; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to iron ion; P:response to muscle activity; P:response to reactive oxygen species; P:retina vasculature development in camera-type eye; P:signal transduction; P:vascular endothelial growth factor production; P:visual learning;|Q16665 C0LZJ3 Q53XP6 Q96PT9 Q9UPB1,Hypoxia-inducible factor 1-alpha {ECO:0000305},ARNT-interacting protein;Basic-helix-loop-helix-PAS protein MOP1 {ECO:0000303|PubMed:9079689};Class E basic helix-loop-helix protein 78;Member of PAS protein 1 {ECO:0000303|PubMed:9079689};PAS domain-containing protein 8;, PF11413;PF08778;PF00989;PF08447;, GO:1904115;GO:0000785;GO:0005737;GO:0005829;GO:0031514;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0019899;GO:0035035;GO:0042826;GO:0051879;GO:0035257;GO:0002039;GO:0019904;GO:0046982;GO:0019901;GO:0000977;GO:0008134;GO:0031625;GO:0001525;GO:0019896;GO:0001922;GO:0003208;GO:0051216;GO:0006879;GO:0071456;GO:0071347;GO:0098586;GO:0021987;GO:0032963;GO:0002248;GO:0019221;GO:0048546;GO:0071542;GO:0051541;GO:0035162;GO:0001892;GO:0061030;GO:0001837;GO:0042593;GO:0001947;GO:0042541;GO:0097411;GO:0060574;GO:0061072;GO:0006089;GO:0007595;GO:0046716;GO:0030502;GO:0010629;GO:0045926;GO:2001054;GO:1903377;GO:2000378;GO:0070244;GO:0032007;GO:0001755;GO:0021502;GO:0003151;GO:0032364;GO:0045766;GO:1903599;GO:0043536;GO:0032722;GO:0070101;GO:1900017;GO:0001938;GO:0010634;GO:0045648;GO:0010628;GO:0045821;GO:0046886;GO:0035774;GO:0016239;GO:0002052;GO:0051000;GO:1902895;GO:2000273;GO:0045944;GO:0061419;GO:0045893;GO:0010575;GO:0030949;GO:0043687;GO:0016579;GO:0016567;GO:1903715;GO:0010468;GO:0006110;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0006355;GO:0032909;GO:0001666;GO:0010039;GO:0014850;GO:0000302;GO:0061298;GO:0007165;GO:0010573;GO:0008542;, C:axon cytoplasm; C:chromatin; C:cytoplasm; C:cytosol; C:motile cilium; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:Hsp90 protein binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:angiogenesis; P:axonal transport of mitochondrion; P:B-1 B cell homeostasis; P:cardiac ventricle morphogenesis; P:cartilage development; P:cellular iron ion homeostasis; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to virus; P:cerebral cortex development; P:collagen metabolic process; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:digestive tract morphogenesis; P:dopaminergic neuron differentiation; P:elastin metabolic process; P:embryonic hemopoiesis; P:embryonic placenta development; P:epithelial cell differentiation involved in mammary gland alveolus development; P:epithelial to mesenchymal transition; P:glucose homeostasis; P:heart looping; P:hemoglobin biosynthetic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intestinal epithelial cell maturation; P:iris morphogenesis; P:lactate metabolic process; P:lactation; P:muscle cell cellular homeostasis; P:negative regulation of bone mineralization; P:negative regulation of gene expression; P:negative regulation of growth; P:negative regulation of mesenchymal cell apoptotic process; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of TOR signaling; P:neural crest cell migration; P:neural fold elevation formation; P:outflow tract morphogenesis; P:oxygen homeostasis; P:positive regulation of angiogenesis; P:positive regulation of autophagy of mitochondrion; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of chemokine production; P:positive regulation of chemokine-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of hormone biosynthetic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of macroautophagy; P:positive regulation of neuroblast proliferation; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:post-translational protein modification; P:protein deubiquitination; P:protein ubiquitination; P:regulation of aerobic respiration; P:regulation of gene expression; P:regulation of glycolytic process; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to iron ion; P:response to muscle activity; P:response to reactive oxygen species; P:retina vasculature development in camera-type eye; P:signal transduction; P:vascular endothelial growth factor production; P:visual learning;|Q16665 C0LZJ3 Q53XP6 Q96PT9 Q9UPB1,Hypoxia-inducible factor 1-alpha {ECO:0000305},ARNT-interacting protein;Basic-helix-loop-helix-PAS protein MOP1 {ECO:0000303|PubMed:9079689};Class E basic helix-loop-helix protein 78;Member of PAS protein 1 {ECO:0000303|PubMed:9079689};PAS domain-containing protein 8;, PF11413;PF08778;PF00989;PF08447;, GO:1904115;GO:0000785;GO:0005737;GO:0005829;GO:0031514;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0019899;GO:0035035;GO:0042826;GO:0051879;GO:0035257;GO:0002039;GO:0019904;GO:0046982;GO:0019901;GO:0000977;GO:0008134;GO:0031625;GO:0001525;GO:0019896;GO:0001922;GO:0003208;GO:0051216;GO:0006879;GO:0071456;GO:0071347;GO:0098586;GO:0021987;GO:0032963;GO:0002248;GO:0019221;GO:0048546;GO:0071542;GO:0051541;GO:0035162;GO:0001892;GO:0061030;GO:0001837;GO:0042593;GO:0001947;GO:0042541;GO:0097411;GO:0060574;GO:0061072;GO:0006089;GO:0007595;GO:0046716;GO:0030502;GO:0010629;GO:0045926;GO:2001054;GO:1903377;GO:2000378;GO:0070244;GO:0032007;GO:0001755;GO:0021502;GO:0003151;GO:0032364;GO:0045766;GO:1903599;GO:0043536;GO:0032722;GO:0070101;GO:1900017;GO:0001938;GO:0010634;GO:0045648;GO:0010628;GO:0045821;GO:0046886;GO:0035774;GO:0016239;GO:0002052;GO:0051000;GO:1902895;GO:2000273;GO:0045944;GO:0061419;GO:0045893;GO:0010575;GO:0030949;GO:0043687;GO:0016579;GO:0016567;GO:1903715;GO:0010468;GO:0006110;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0006355;GO:0032909;GO:0001666;GO:0010039;GO:0014850;GO:0000302;GO:0061298;GO:0007165;GO:0010573;GO:0008542;, C:axon cytoplasm; C:chromatin; C:cytoplasm; C:cytosol; C:motile cilium; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:Hsp90 protein binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:angiogenesis; P:axonal transport of mitochondrion; P:B-1 B cell homeostasis; P:cardiac ventricle morphogenesis; P:cartilage development; P:cellular iron ion homeostasis; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to virus; P:cerebral cortex development; P:collagen metabolic process; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:digestive tract morphogenesis; P:dopaminergic neuron differentiation; P:elastin metabolic process; P:embryonic hemopoiesis; P:embryonic placenta development; P:epithelial cell differentiation involved in mammary gland alveolus development; P:epithelial to mesenchymal transition; P:glucose homeostasis; P:heart looping; P:hemoglobin biosynthetic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intestinal epithelial cell maturation; P:iris morphogenesis; P:lactate metabolic process; P:lactation; P:muscle cell cellular homeostasis; P:negative regulation of bone mineralization; P:negative regulation of gene expression; P:negative regulation of growth; P:negative regulation of mesenchymal cell apoptotic process; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of TOR signaling; P:neural crest cell migration; P:neural fold elevation formation; P:outflow tract morphogenesis; P:oxygen homeostasis; P:positive regulation of angiogenesis; P:positive regulation of autophagy of mitochondrion; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of chemokine production; P:positive regulation of chemokine-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of hormone biosynthetic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of macroautophagy; P:positive regulation of neuroblast proliferation; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:post-translational protein modification; P:protein deubiquitination; P:protein ubiquitination; P:regulation of aerobic respiration; P:regulation of gene expression; P:regulation of glycolytic process; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to iron ion; P:response to muscle activity; P:response to reactive oxygen species; P:retina vasculature development in camera-type eye; P:signal transduction; P:vascular endothelial growth factor production; P:visual learning;|Q16665 C0LZJ3 Q53XP6 Q96PT9 Q9UPB1,Hypoxia-inducible factor 1-alpha {ECO:0000305},ARNT-interacting protein;Basic-helix-loop-helix-PAS protein MOP1 {ECO:0000303|PubMed:9079689};Class E basic helix-loop-helix protein 78;Member of PAS protein 1 {ECO:0000303|PubMed:9079689};PAS domain-containing protein 8;, PF11413;PF08778;PF00989;PF08447;, GO:1904115;GO:0000785;GO:0005737;GO:0005829;GO:0031514;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0019899;GO:0035035;GO:0042826;GO:0051879;GO:0035257;GO:0002039;GO:0019904;GO:0046982;GO:0019901;GO:0000977;GO:0008134;GO:0031625;GO:0001525;GO:0019896;GO:0001922;GO:0003208;GO:0051216;GO:0006879;GO:0071456;GO:0071347;GO:0098586;GO:0021987;GO:0032963;GO:0002248;GO:0019221;GO:0048546;GO:0071542;GO:0051541;GO:0035162;GO:0001892;GO:0061030;GO:0001837;GO:0042593;GO:0001947;GO:0042541;GO:0097411;GO:0060574;GO:0061072;GO:0006089;GO:0007595;GO:0046716;GO:0030502;GO:0010629;GO:0045926;GO:2001054;GO:1903377;GO:2000378;GO:0070244;GO:0032007;GO:0001755;GO:0021502;GO:0003151;GO:0032364;GO:0045766;GO:1903599;GO:0043536;GO:0032722;GO:0070101;GO:1900017;GO:0001938;GO:0010634;GO:0045648;GO:0010628;GO:0045821;GO:0046886;GO:0035774;GO:0016239;GO:0002052;GO:0051000;GO:1902895;GO:2000273;GO:0045944;GO:0061419;GO:0045893;GO:0010575;GO:0030949;GO:0043687;GO:0016579;GO:0016567;GO:1903715;GO:0010468;GO:0006110;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0006355;GO:0032909;GO:0001666;GO:0010039;GO:0014850;GO:0000302;GO:0061298;GO:0007165;GO:0010573;GO:0008542;, C:axon cytoplasm; C:chromatin; C:cytoplasm; C:cytosol; C:motile cilium; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:Hsp90 protein binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:angiogenesis; P:axonal transport of mitochondrion; P:B-1 B cell homeostasis; P:cardiac ventricle morphogenesis; P:cartilage development; P:cellular iron ion homeostasis; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to virus; P:cerebral cortex development; P:collagen metabolic process; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:digestive tract morphogenesis; P:dopaminergic neuron differentiation; P:elastin metabolic process; P:embryonic hemopoiesis; P:embryonic placenta development; P:epithelial cell differentiation involved in mammary gland alveolus development; P:epithelial to mesenchymal transition; P:glucose homeostasis; P:heart looping; P:hemoglobin biosynthetic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intestinal epithelial cell maturation; P:iris morphogenesis; P:lactate metabolic process; P:lactation; P:muscle cell cellular homeostasis; P:negative regulation of bone mineralization; P:negative regulation of gene expression; P:negative regulation of growth; P:negative regulation of mesenchymal cell apoptotic process; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of TOR signaling; P:neural crest cell migration; P:neural fold elevation formation; P:outflow tract morphogenesis; P:oxygen homeostasis; P:positive regulation of angiogenesis; P:positive regulation of autophagy of mitochondrion; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of chemokine production; P:positive regulation of chemokine-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of hormone biosynthetic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of macroautophagy; P:positive regulation of neuroblast proliferation; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:post-translational protein modification; P:protein deubiquitination; P:protein ubiquitination; P:regulation of aerobic respiration; P:regulation of gene expression; P:regulation of glycolytic process; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to iron ion; P:response to muscle activity; P:response to reactive oxygen species; P:retina vasculature development in camera-type eye; P:signal transduction; P:vascular endothelial growth factor production; P:visual learning;|Q16665 C0LZJ3 Q53XP6 Q96PT9 Q9UPB1,Hypoxia-inducible factor 1-alpha {ECO:0000305},ARNT-interacting protein;Basic-helix-loop-helix-PAS protein MOP1 {ECO:0000303|PubMed:9079689};Class E basic helix-loop-helix protein 78;Member of PAS protein 1 {ECO:0000303|PubMed:9079689};PAS domain-containing protein 8;, PF11413;PF08778;PF00989;PF08447;, GO:1904115;GO:0000785;GO:0005737;GO:0005829;GO:0031514;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0019899;GO:0035035;GO:0042826;GO:0051879;GO:0035257;GO:0002039;GO:0019904;GO:0046982;GO:0019901;GO:0000977;GO:0008134;GO:0031625;GO:0001525;GO:0019896;GO:0001922;GO:0003208;GO:0051216;GO:0006879;GO:0071456;GO:0071347;GO:0098586;GO:0021987;GO:0032963;GO:0002248;GO:0019221;GO:0048546;GO:0071542;GO:0051541;GO:0035162;GO:0001892;GO:0061030;GO:0001837;GO:0042593;GO:0001947;GO:0042541;GO:0097411;GO:0060574;GO:0061072;GO:0006089;GO:0007595;GO:0046716;GO:0030502;GO:0010629;GO:0045926;GO:2001054;GO:1903377;GO:2000378;GO:0070244;GO:0032007;GO:0001755;GO:0021502;GO:0003151;GO:0032364;GO:0045766;GO:1903599;GO:0043536;GO:0032722;GO:0070101;GO:1900017;GO:0001938;GO:0010634;GO:0045648;GO:0010628;GO:0045821;GO:0046886;GO:0035774;GO:0016239;GO:0002052;GO:0051000;GO:1902895;GO:2000273;GO:0045944;GO:0061419;GO:0045893;GO:0010575;GO:0030949;GO:0043687;GO:0016579;GO:0016567;GO:1903715;GO:0010468;GO:0006110;GO:2000434;GO:0006357;GO:0061418;GO:0043619;GO:0006355;GO:0032909;GO:0001666;GO:0010039;GO:0014850;GO:0000302;GO:0061298;GO:0007165;GO:0010573;GO:0008542;, C:axon cytoplasm; C:chromatin; C:cytoplasm; C:cytosol; C:motile cilium; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:Hsp90 protein binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:angiogenesis; P:axonal transport of mitochondrion; P:B-1 B cell homeostasis; P:cardiac ventricle morphogenesis; P:cartilage development; P:cellular iron ion homeostasis; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to virus; P:cerebral cortex development; P:collagen metabolic process; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:digestive tract morphogenesis; P:dopaminergic neuron differentiation; P:elastin metabolic process; P:embryonic hemopoiesis; P:embryonic placenta development; P:epithelial cell differentiation involved in mammary gland alveolus development; P:epithelial to mesenchymal transition; P:glucose homeostasis; P:heart looping; P:hemoglobin biosynthetic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:intestinal epithelial cell maturation; P:iris morphogenesis; P:lactate metabolic process; P:lactation; P:muscle cell cellular homeostasis; P:negative regulation of bone mineralization; P:negative regulation of gene expression; P:negative regulation of growth; P:negative regulation of mesenchymal cell apoptotic process; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of TOR signaling; P:neural crest cell migration; P:neural fold elevation formation; P:outflow tract morphogenesis; P:oxygen homeostasis; P:positive regulation of angiogenesis; P:positive regulation of autophagy of mitochondrion; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of chemokine production; P:positive regulation of chemokine-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of hormone biosynthetic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of macroautophagy; P:positive regulation of neuroblast proliferation; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:post-translational protein modification; P:protein deubiquitination; P:protein ubiquitination; P:regulation of aerobic respiration; P:regulation of gene expression; P:regulation of glycolytic process; P:regulation of protein neddylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta2 production; P:response to hypoxia; P:response to iron ion; P:response to muscle activity; P:response to reactive oxygen species; P:retina vasculature development in camera-type eye; P:signal transduction; P:vascular endothelial growth factor production; P:visual learning; scaffold37 indexed_genome mRNA 35852223 35878576 . + . ID=transcript_7759;Q16533,snRNA-activating protein complex subunit 1,Proximal sequence element-binding transcription factor subunit gamma;Small nuclear RNA-activating complex polypeptide 1;snRNA-activating protein complex 43 kDa subunit;, PF09808;, GO:0005730;GO:0005654;GO:0019185;GO:0016251;GO:0000995;GO:0043565;GO:0042795;GO:0042796;, C:nucleolus; C:nucleoplasm; C:snRNA-activating protein complex;, F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase III general transcription initiation factor activity; F:sequence-specific DNA binding;, P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III;|Q16533,snRNA-activating protein complex subunit 1,Proximal sequence element-binding transcription factor subunit gamma;Small nuclear RNA-activating complex polypeptide 1;snRNA-activating protein complex 43 kDa subunit;, PF09808;, GO:0005730;GO:0005654;GO:0019185;GO:0016251;GO:0000995;GO:0043565;GO:0042795;GO:0042796;, C:nucleolus; C:nucleoplasm; C:snRNA-activating protein complex;, F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase III general transcription initiation factor activity; F:sequence-specific DNA binding;, P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III;|Q16533,snRNA-activating protein complex subunit 1,Proximal sequence element-binding transcription factor subunit gamma;Small nuclear RNA-activating complex polypeptide 1;snRNA-activating protein complex 43 kDa subunit;, PF09808;, GO:0005730;GO:0005654;GO:0019185;GO:0016251;GO:0000995;GO:0043565;GO:0042795;GO:0042796;, C:nucleolus; C:nucleoplasm; C:snRNA-activating protein complex;, F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase III general transcription initiation factor activity; F:sequence-specific DNA binding;, P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; scaffold37 indexed_genome mRNA 36150193 36169808 . + . ID=transcript_7760;Q17RD7 B4DZH2 B7ZL60 C9J8I3 Q707N2 Q7Z441 Q8IUU0 Q9BQR8,Synaptotagmin-16,Chr14Syt;Synaptotagmin 14-like protein;Synaptotagmin XIV-related protein;, PF00168;, GO:0042802;GO:0005543;GO:0006887;, , F:identical protein binding; F:phospholipid binding;, P:exocytosis; scaffold37 indexed_genome mRNA 36191425 36203621 . + . ID=transcript_7761;Q86TS7,Putative UPF0730 protein encoded by LINC00643,Long intergenic non-protein coding RNA 643;, PF15827; scaffold37 indexed_genome mRNA 37315206 37406238 . + . ID=transcript_7762;Q9H4E5 Q96KC1,Rho-related GTP-binding protein RhoJ {ECO:0000305},Ras-like protein family member 7B;Tc10-like GTP-binding protein {ECO:0000303|PubMed:10967094};, PF00071;, GO:0005829;GO:0070062;GO:0005886;GO:0005525;GO:0003924;GO:0030036;GO:0001525;GO:0032488;GO:0016477;GO:0030031;GO:0006897;GO:0090050;GO:0008360;GO:0010594;GO:0051056;GO:1903670;GO:0061299;, C:cytosol; C:extracellular exosome; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:actin cytoskeleton organization; P:angiogenesis; P:Cdc42 protein signal transduction; P:cell migration; P:cell projection assembly; P:endocytosis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:regulation of cell shape; P:regulation of endothelial cell migration; P:regulation of small GTPase mediated signal transduction; P:regulation of sprouting angiogenesis; P:retina vasculature morphogenesis in camera-type eye; scaffold37 indexed_genome mRNA 37488587 37637354 . - . ID=transcript_7763;Q16537 A4FU37 B7ZAW5 B7ZKK8 B7ZKK9 J3KQN6 Q52LW4,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform,PP2A B subunit isoform B'-epsilon;PP2A B subunit isoform B56-epsilon;PP2A B subunit isoform PR61-epsilon;PP2A B subunit isoform R5-epsilon;, PF01603;, GO:0005737;GO:0005829;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0006470;GO:0031952;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:protein dephosphorylation; P:regulation of protein autophosphorylation; P:signal transduction; scaffold37 indexed_genome mRNA 38002661 38008964 . + . ID=transcript_7764;Q8WWW3 Q8WWW4 Q8WWW5 Q8WXH1 Q9NU50 Q9UFQ4 Q9Y2L4 Q9Y4R1,Nesprin-2,KASH domain-containing protein 2;Nuclear envelope spectrin repeat protein 2;Nucleus and actin connecting element protein;Synaptic nuclear envelope protein 2;, PF00307;PF10541;PF00435;, GO:0005737;GO:0070062;GO:0031527;GO:0005925;GO:0016021;GO:0045111;GO:0031258;GO:0034993;GO:0005739;GO:0005635;GO:0031981;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0016529;GO:0033017;GO:0030018;GO:0003779;GO:0051015;GO:0140444;GO:0051642;GO:0007097;GO:0031022;GO:0021817;GO:0030335;GO:1902017;, C:cytoplasm; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of membrane; C:intermediate filament cytoskeleton; C:lamellipodium membrane; C:meiotic nuclear membrane microtubule tethering complex; C:mitochondrion; C:nuclear envelope; C:nuclear lumen; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:Z disc;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:centrosome localization; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; P:regulation of cilium assembly; scaffold37 indexed_genome mRNA 38027239 38027823 . - . ID=transcript_7765;Q8WWW3 Q8WWW4 Q8WWW5 Q8WXH1 Q9NU50 Q9UFQ4 Q9Y2L4 Q9Y4R1,Nesprin-2,KASH domain-containing protein 2;Nuclear envelope spectrin repeat protein 2;Nucleus and actin connecting element protein;Synaptic nuclear envelope protein 2;, PF00307;PF10541;PF00435;, GO:0005737;GO:0070062;GO:0031527;GO:0005925;GO:0016021;GO:0045111;GO:0031258;GO:0034993;GO:0005739;GO:0005635;GO:0031981;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0016529;GO:0033017;GO:0030018;GO:0003779;GO:0051015;GO:0140444;GO:0051642;GO:0007097;GO:0031022;GO:0021817;GO:0030335;GO:1902017;, C:cytoplasm; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of membrane; C:intermediate filament cytoskeleton; C:lamellipodium membrane; C:meiotic nuclear membrane microtubule tethering complex; C:mitochondrion; C:nuclear envelope; C:nuclear lumen; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:Z disc;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:centrosome localization; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; P:regulation of cilium assembly; scaffold37 indexed_genome mRNA 38028366 38028977 . - . ID=transcript_7766;Q8WWW3 Q8WWW4 Q8WWW5 Q8WXH1 Q9NU50 Q9UFQ4 Q9Y2L4 Q9Y4R1,Nesprin-2,KASH domain-containing protein 2;Nuclear envelope spectrin repeat protein 2;Nucleus and actin connecting element protein;Synaptic nuclear envelope protein 2;, PF00307;PF10541;PF00435;, GO:0005737;GO:0070062;GO:0031527;GO:0005925;GO:0016021;GO:0045111;GO:0031258;GO:0034993;GO:0005739;GO:0005635;GO:0031981;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0016529;GO:0033017;GO:0030018;GO:0003779;GO:0051015;GO:0140444;GO:0051642;GO:0007097;GO:0031022;GO:0021817;GO:0030335;GO:1902017;, C:cytoplasm; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of membrane; C:intermediate filament cytoskeleton; C:lamellipodium membrane; C:meiotic nuclear membrane microtubule tethering complex; C:mitochondrion; C:nuclear envelope; C:nuclear lumen; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:Z disc;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:centrosome localization; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; P:regulation of cilium assembly; scaffold37 indexed_genome mRNA 38031177 38069581 . + . ID=transcript_7767;Q8WWW3 Q8WWW4 Q8WWW5 Q8WXH1 Q9NU50 Q9UFQ4 Q9Y2L4 Q9Y4R1,Nesprin-2,KASH domain-containing protein 2;Nuclear envelope spectrin repeat protein 2;Nucleus and actin connecting element protein;Synaptic nuclear envelope protein 2;, PF00307;PF10541;PF00435;, GO:0005737;GO:0070062;GO:0031527;GO:0005925;GO:0016021;GO:0045111;GO:0031258;GO:0034993;GO:0005739;GO:0005635;GO:0031981;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0016529;GO:0033017;GO:0030018;GO:0003779;GO:0051015;GO:0140444;GO:0051642;GO:0007097;GO:0031022;GO:0021817;GO:0030335;GO:1902017;, C:cytoplasm; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of membrane; C:intermediate filament cytoskeleton; C:lamellipodium membrane; C:meiotic nuclear membrane microtubule tethering complex; C:mitochondrion; C:nuclear envelope; C:nuclear lumen; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:Z disc;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:centrosome localization; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; P:regulation of cilium assembly; scaffold37 indexed_genome mRNA 38080219 38139209 . + . ID=transcript_7768;Q8WWW3 Q8WWW4 Q8WWW5 Q8WXH1 Q9NU50 Q9UFQ4 Q9Y2L4 Q9Y4R1,Nesprin-2,KASH domain-containing protein 2;Nuclear envelope spectrin repeat protein 2;Nucleus and actin connecting element protein;Synaptic nuclear envelope protein 2;, PF00307;PF10541;PF00435;, GO:0005737;GO:0070062;GO:0031527;GO:0005925;GO:0016021;GO:0045111;GO:0031258;GO:0034993;GO:0005739;GO:0005635;GO:0031981;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0016529;GO:0033017;GO:0030018;GO:0003779;GO:0051015;GO:0140444;GO:0051642;GO:0007097;GO:0031022;GO:0021817;GO:0030335;GO:1902017;, C:cytoplasm; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of membrane; C:intermediate filament cytoskeleton; C:lamellipodium membrane; C:meiotic nuclear membrane microtubule tethering complex; C:mitochondrion; C:nuclear envelope; C:nuclear lumen; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:Z disc;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:centrosome localization; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; P:regulation of cilium assembly; scaffold37 indexed_genome mRNA 38146460 38175900 . + . ID=transcript_7769;Q8WWW3 Q8WWW4 Q8WWW5 Q8WXH1 Q9NU50 Q9UFQ4 Q9Y2L4 Q9Y4R1,Nesprin-2,KASH domain-containing protein 2;Nuclear envelope spectrin repeat protein 2;Nucleus and actin connecting element protein;Synaptic nuclear envelope protein 2;, PF00307;PF10541;PF00435;, GO:0005737;GO:0070062;GO:0031527;GO:0005925;GO:0016021;GO:0045111;GO:0031258;GO:0034993;GO:0005739;GO:0005635;GO:0031981;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0016529;GO:0033017;GO:0030018;GO:0003779;GO:0051015;GO:0140444;GO:0051642;GO:0007097;GO:0031022;GO:0021817;GO:0030335;GO:1902017;, C:cytoplasm; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of membrane; C:intermediate filament cytoskeleton; C:lamellipodium membrane; C:meiotic nuclear membrane microtubule tethering complex; C:mitochondrion; C:nuclear envelope; C:nuclear lumen; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:Z disc;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:centrosome localization; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; P:regulation of cilium assembly;|Q8WWW3 Q8WWW4 Q8WWW5 Q8WXH1 Q9NU50 Q9UFQ4 Q9Y2L4 Q9Y4R1,Nesprin-2,KASH domain-containing protein 2;Nuclear envelope spectrin repeat protein 2;Nucleus and actin connecting element protein;Synaptic nuclear envelope protein 2;, PF00307;PF10541;PF00435;, GO:0005737;GO:0070062;GO:0031527;GO:0005925;GO:0016021;GO:0045111;GO:0031258;GO:0034993;GO:0005739;GO:0005635;GO:0031981;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0016529;GO:0033017;GO:0030018;GO:0003779;GO:0051015;GO:0140444;GO:0051642;GO:0007097;GO:0031022;GO:0021817;GO:0030335;GO:1902017;, C:cytoplasm; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of membrane; C:intermediate filament cytoskeleton; C:lamellipodium membrane; C:meiotic nuclear membrane microtubule tethering complex; C:mitochondrion; C:nuclear envelope; C:nuclear lumen; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:Z disc;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:centrosome localization; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; P:regulation of cilium assembly;|Q8WWW3 Q8WWW4 Q8WWW5 Q8WXH1 Q9NU50 Q9UFQ4 Q9Y2L4 Q9Y4R1,Nesprin-2,KASH domain-containing protein 2;Nuclear envelope spectrin repeat protein 2;Nucleus and actin connecting element protein;Synaptic nuclear envelope protein 2;, PF00307;PF10541;PF00435;, GO:0005737;GO:0070062;GO:0031527;GO:0005925;GO:0016021;GO:0045111;GO:0031258;GO:0034993;GO:0005739;GO:0005635;GO:0031981;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0016529;GO:0033017;GO:0030018;GO:0003779;GO:0051015;GO:0140444;GO:0051642;GO:0007097;GO:0031022;GO:0021817;GO:0030335;GO:1902017;, C:cytoplasm; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of membrane; C:intermediate filament cytoskeleton; C:lamellipodium membrane; C:meiotic nuclear membrane microtubule tethering complex; C:mitochondrion; C:nuclear envelope; C:nuclear lumen; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:Z disc;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:centrosome localization; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; P:regulation of cilium assembly;|Q8WWW3 Q8WWW4 Q8WWW5 Q8WXH1 Q9NU50 Q9UFQ4 Q9Y2L4 Q9Y4R1,Nesprin-2,KASH domain-containing protein 2;Nuclear envelope spectrin repeat protein 2;Nucleus and actin connecting element protein;Synaptic nuclear envelope protein 2;, PF00307;PF10541;PF00435;, GO:0005737;GO:0070062;GO:0031527;GO:0005925;GO:0016021;GO:0045111;GO:0031258;GO:0034993;GO:0005739;GO:0005635;GO:0031981;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0016529;GO:0033017;GO:0030018;GO:0003779;GO:0051015;GO:0140444;GO:0051642;GO:0007097;GO:0031022;GO:0021817;GO:0030335;GO:1902017;, C:cytoplasm; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of membrane; C:intermediate filament cytoskeleton; C:lamellipodium membrane; C:meiotic nuclear membrane microtubule tethering complex; C:mitochondrion; C:nuclear envelope; C:nuclear lumen; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:Z disc;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:centrosome localization; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; P:regulation of cilium assembly; scaffold37 indexed_genome mRNA 38218655 38227712 . - . ID=transcript_7770;Q0MWT5 Q0MWT6 Q86Z31 Q9UEV6 Q9UHD3 Q9UQK9,Estrogen receptor beta,Nuclear receptor subfamily 3 group A member 2;, PF12497;PF00104;PF00105;, GO:0000785;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0019899;GO:0030284;GO:0034056;GO:0004879;GO:0048019;GO:0000978;GO:0005496;GO:0003707;GO:0008270;GO:0007267;GO:0071392;GO:0030520;GO:0030518;GO:0030308;GO:0000122;GO:0051091;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0007165;GO:0006367;, C:chromatin; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:estrogen receptor activity; F:estrogen response element binding; F:nuclear receptor activity; F:receptor antagonist activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:steroid binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:cell-cell signaling; P:cellular response to estradiol stimulus; P:intracellular estrogen receptor signaling pathway; P:intracellular steroid hormone receptor signaling pathway; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; scaffold37 indexed_genome mRNA 38323434 38379308 . + . ID=transcript_7771;P11586 B2R5Y2 G3V2B8 Q86VC9 Q9BVP5,C-1-tetrahydrofolate synthase, cytoplasmic,, PF01268;PF00763;PF02882;, GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005524;GO:0004329;GO:0004477;GO:0004487;GO:0004488;GO:0004486;GO:0009257;GO:0048702;GO:0048703;GO:0046655;GO:0007507;GO:0000105;GO:0009086;GO:0006555;GO:0001843;GO:0006730;GO:0006164;GO:0009070;GO:0009069;GO:0061053;GO:0035999;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:ATP binding; F:formate-tetrahydrofolate ligase activity; F:methenyltetrahydrofolate cyclohydrolase activity; F:methylenetetrahydrofolate dehydrogenase (NAD+) activity; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; F:methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity;, P:10-formyltetrahydrofolate biosynthetic process; P:embryonic neurocranium morphogenesis; P:embryonic viscerocranium morphogenesis; P:folic acid metabolic process; P:heart development; P:histidine biosynthetic process; P:methionine biosynthetic process; P:methionine metabolic process; P:neural tube closure; P:one-carbon metabolic process; P:purine nucleotide biosynthetic process; P:serine family amino acid biosynthetic process; P:serine family amino acid metabolic process; P:somite development; P:tetrahydrofolate interconversion;|P11586 B2R5Y2 G3V2B8 Q86VC9 Q9BVP5,C-1-tetrahydrofolate synthase, cytoplasmic,, PF01268;PF00763;PF02882;, GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005524;GO:0004329;GO:0004477;GO:0004487;GO:0004488;GO:0004486;GO:0009257;GO:0048702;GO:0048703;GO:0046655;GO:0007507;GO:0000105;GO:0009086;GO:0006555;GO:0001843;GO:0006730;GO:0006164;GO:0009070;GO:0009069;GO:0061053;GO:0035999;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:ATP binding; F:formate-tetrahydrofolate ligase activity; F:methenyltetrahydrofolate cyclohydrolase activity; F:methylenetetrahydrofolate dehydrogenase (NAD+) activity; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; F:methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity;, P:10-formyltetrahydrofolate biosynthetic process; P:embryonic neurocranium morphogenesis; P:embryonic viscerocranium morphogenesis; P:folic acid metabolic process; P:heart development; P:histidine biosynthetic process; P:methionine biosynthetic process; P:methionine metabolic process; P:neural tube closure; P:one-carbon metabolic process; P:purine nucleotide biosynthetic process; P:serine family amino acid biosynthetic process; P:serine family amino acid metabolic process; P:somite development; P:tetrahydrofolate interconversion;|P11586 B2R5Y2 G3V2B8 Q86VC9 Q9BVP5,C-1-tetrahydrofolate synthase, cytoplasmic,, PF01268;PF00763;PF02882;, GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005524;GO:0004329;GO:0004477;GO:0004487;GO:0004488;GO:0004486;GO:0009257;GO:0048702;GO:0048703;GO:0046655;GO:0007507;GO:0000105;GO:0009086;GO:0006555;GO:0001843;GO:0006730;GO:0006164;GO:0009070;GO:0009069;GO:0061053;GO:0035999;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:ATP binding; F:formate-tetrahydrofolate ligase activity; F:methenyltetrahydrofolate cyclohydrolase activity; F:methylenetetrahydrofolate dehydrogenase (NAD+) activity; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; F:methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity;, P:10-formyltetrahydrofolate biosynthetic process; P:embryonic neurocranium morphogenesis; P:embryonic viscerocranium morphogenesis; P:folic acid metabolic process; P:heart development; P:histidine biosynthetic process; P:methionine biosynthetic process; P:methionine metabolic process; P:neural tube closure; P:one-carbon metabolic process; P:purine nucleotide biosynthetic process; P:serine family amino acid biosynthetic process; P:serine family amino acid metabolic process; P:somite development; P:tetrahydrofolate interconversion;|P11586 B2R5Y2 G3V2B8 Q86VC9 Q9BVP5,C-1-tetrahydrofolate synthase, cytoplasmic,, PF01268;PF00763;PF02882;, GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005524;GO:0004329;GO:0004477;GO:0004487;GO:0004488;GO:0004486;GO:0009257;GO:0048702;GO:0048703;GO:0046655;GO:0007507;GO:0000105;GO:0009086;GO:0006555;GO:0001843;GO:0006730;GO:0006164;GO:0009070;GO:0009069;GO:0061053;GO:0035999;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:ATP binding; F:formate-tetrahydrofolate ligase activity; F:methenyltetrahydrofolate cyclohydrolase activity; F:methylenetetrahydrofolate dehydrogenase (NAD+) activity; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; F:methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity;, P:10-formyltetrahydrofolate biosynthetic process; P:embryonic neurocranium morphogenesis; P:embryonic viscerocranium morphogenesis; P:folic acid metabolic process; P:heart development; P:histidine biosynthetic process; P:methionine biosynthetic process; P:methionine metabolic process; P:neural tube closure; P:one-carbon metabolic process; P:purine nucleotide biosynthetic process; P:serine family amino acid biosynthetic process; P:serine family amino acid metabolic process; P:somite development; P:tetrahydrofolate interconversion;|P11586 B2R5Y2 G3V2B8 Q86VC9 Q9BVP5,C-1-tetrahydrofolate synthase, cytoplasmic,, PF01268;PF00763;PF02882;, GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005524;GO:0004329;GO:0004477;GO:0004487;GO:0004488;GO:0004486;GO:0009257;GO:0048702;GO:0048703;GO:0046655;GO:0007507;GO:0000105;GO:0009086;GO:0006555;GO:0001843;GO:0006730;GO:0006164;GO:0009070;GO:0009069;GO:0061053;GO:0035999;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:ATP binding; F:formate-tetrahydrofolate ligase activity; F:methenyltetrahydrofolate cyclohydrolase activity; F:methylenetetrahydrofolate dehydrogenase (NAD+) activity; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; F:methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity;, P:10-formyltetrahydrofolate biosynthetic process; P:embryonic neurocranium morphogenesis; P:embryonic viscerocranium morphogenesis; P:folic acid metabolic process; P:heart development; P:histidine biosynthetic process; P:methionine biosynthetic process; P:methionine metabolic process; P:neural tube closure; P:one-carbon metabolic process; P:purine nucleotide biosynthetic process; P:serine family amino acid biosynthetic process; P:serine family amino acid metabolic process; P:somite development; P:tetrahydrofolate interconversion;|P11586 B2R5Y2 G3V2B8 Q86VC9 Q9BVP5,C-1-tetrahydrofolate synthase, cytoplasmic,, PF01268;PF00763;PF02882;, GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005524;GO:0004329;GO:0004477;GO:0004487;GO:0004488;GO:0004486;GO:0009257;GO:0048702;GO:0048703;GO:0046655;GO:0007507;GO:0000105;GO:0009086;GO:0006555;GO:0001843;GO:0006730;GO:0006164;GO:0009070;GO:0009069;GO:0061053;GO:0035999;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:ATP binding; F:formate-tetrahydrofolate ligase activity; F:methenyltetrahydrofolate cyclohydrolase activity; F:methylenetetrahydrofolate dehydrogenase (NAD+) activity; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; F:methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity;, P:10-formyltetrahydrofolate biosynthetic process; P:embryonic neurocranium morphogenesis; P:embryonic viscerocranium morphogenesis; P:folic acid metabolic process; P:heart development; P:histidine biosynthetic process; P:methionine biosynthetic process; P:methionine metabolic process; P:neural tube closure; P:one-carbon metabolic process; P:purine nucleotide biosynthetic process; P:serine family amino acid biosynthetic process; P:serine family amino acid metabolic process; P:somite development; P:tetrahydrofolate interconversion; scaffold37 indexed_genome mRNA 38386200 38409934 . - . ID=transcript_7772;P24588 A2RRB8,A-kinase anchor protein 5,A-kinase anchor protein 79 kDa;H21;cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein;, PF03832;, GO:0009898;GO:0005829;GO:0032590;GO:0043197;GO:0060076;GO:0045121;GO:0005886;GO:0014069;GO:0098837;GO:0008179;GO:0031698;GO:0005516;GO:0050811;GO:0035254;GO:0060090;GO:0051018;GO:0034237;GO:0030346;GO:0097110;GO:0017124;GO:0007193;GO:0007268;GO:0007194;GO:0045762;GO:1905751;GO:1900273;GO:1903078;GO:0010738;GO:0007165;, C:cytoplasmic side of plasma membrane; C:cytosol; C:dendrite membrane; C:dendritic spine; C:excitatory synapse; C:membrane raft; C:plasma membrane; C:postsynaptic density; C:postsynaptic recycling endosome;, F:adenylate cyclase binding; F:beta-2 adrenergic receptor binding; F:calmodulin binding; F:GABA receptor binding; F:glutamate receptor binding; F:molecular adaptor activity; F:protein kinase A binding; F:protein kinase A regulatory subunit binding; F:protein phosphatase 2B binding; F:scaffold protein binding; F:SH3 domain binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:chemical synaptic transmission; P:negative regulation of adenylate cyclase activity; P:positive regulation of adenylate cyclase activity; P:positive regulation of endosome to plasma membrane protein transport; P:positive regulation of long-term synaptic potentiation; P:positive regulation of protein localization to plasma membrane; P:regulation of protein kinase A signaling; P:signal transduction;|P24278 B3KUX6 Q8IYH9,Zinc finger and BTB domain-containing protein 25,Zinc finger protein 46;Zinc finger protein KUP;, PF00651;PF00096;, GO:0005654;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P24278 B3KUX6 Q8IYH9,Zinc finger and BTB domain-containing protein 25,Zinc finger protein 46;Zinc finger protein KUP;, PF00651;PF00096;, GO:0005654;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P24278 B3KUX6 Q8IYH9,Zinc finger and BTB domain-containing protein 25,Zinc finger protein 46;Zinc finger protein KUP;, PF00651;PF00096;, GO:0005654;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold37 indexed_genome mRNA 38434836 38437449 . + . ID=transcript_7773;Q9Y2K1 A8K6S8 Q86SW8,Zinc finger and BTB domain-containing protein 1,, PF00651;, GO:0005813;GO:0016604;GO:0031965;GO:0005654;GO:0005634;GO:0001227;GO:0070530;GO:0046872;GO:0046982;GO:0042803;GO:0000978;GO:0030183;GO:0006974;GO:0034644;GO:0006338;GO:0006281;GO:0045087;GO:0042789;GO:0000122;GO:0032825;GO:2000176;GO:0045582;GO:0002711;GO:0051260;GO:0006357;GO:0033077;GO:0048538;GO:0019985;, C:centrosome; C:nuclear body; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:B cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:chromatin remodeling; P:DNA repair; P:innate immune response; P:mRNA transcription by RNA polymerase II; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of natural killer cell differentiation; P:positive regulation of pro-T cell differentiation; P:positive regulation of T cell differentiation; P:positive regulation of T cell mediated immunity; P:protein homooligomerization; P:regulation of transcription by RNA polymerase II; P:T cell differentiation in thymus; P:thymus development; P:translesion synthesis; scaffold37 indexed_genome mRNA 38450842 38454138 . + . ID=transcript_7774;P54652 Q15508 Q53XM3 Q9UE78,Heat shock-related 70 kDa protein 2,, PF00012;, GO:0072562;GO:0036128;GO:0009986;GO:0005737;GO:0005829;GO:0070062;GO:0001673;GO:0072687;GO:0016020;GO:0005634;GO:0005886;GO:0000795;GO:0005524;GO:0016887;GO:0051087;GO:0097718;GO:0019899;GO:0051861;GO:0031072;GO:0051787;GO:0044183;GO:0048156;GO:0051082;GO:0034620;GO:0051085;GO:0007141;GO:0007140;GO:0090084;GO:0032781;GO:1901896;GO:0010971;GO:0001934;GO:0042026;GO:0009409;GO:0009408;GO:0006986;GO:0007286;GO:0007283;GO:0070194;GO:0016192;, C:blood microparticle; C:CatSper complex; C:cell surface; C:cytoplasm; C:cytosol; C:extracellular exosome; C:male germ cell nucleus; C:meiotic spindle; C:membrane; C:nucleus; C:plasma membrane; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:chaperone binding; F:disordered domain specific binding; F:enzyme binding; F:glycolipid binding; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:tau protein binding; F:unfolded protein binding;, P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of inclusion body assembly; P:positive regulation of ATPase activity; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of protein phosphorylation; P:protein refolding; P:response to cold; P:response to heat; P:response to unfolded protein; P:spermatid development; P:spermatogenesis; P:synaptonemal complex disassembly; P:vesicle-mediated transport; scaffold37 indexed_genome mRNA 38458624 38483977 . + . ID=transcript_7775;Q96LQ0 Q6NTH6,Protein phosphatase 1 regulatory subunit 36,, PF14895;, GO:0019902;GO:0004864;GO:0010923;, , F:phosphatase binding; F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity; scaffold37 indexed_genome mRNA 38612465 38655189 . + . ID=transcript_7776;Q96EW6 Q9BT82,Pleckstrin homology domain-containing family G member 3,, PF00169;PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity; scaffold37 indexed_genome mRNA 38656958 38694611 . - . ID=transcript_7777;P11277 Q15510 Q15519,Spectrin beta chain, erythrocytic,Beta-I spectrin;, PF00307;PF00435;, GO:0015629;GO:0009986;GO:0005829;GO:0031235;GO:0032991;GO:0008091;GO:0014731;GO:0003779;GO:0051015;GO:0030506;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;, C:actin cytoskeleton; C:cell surface; C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:protein-containing complex; C:spectrin; C:spectrin-associated cytoskeleton;, F:actin binding; F:actin filament binding; F:ankyrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade;|P11277 Q15510 Q15519,Spectrin beta chain, erythrocytic,Beta-I spectrin;, PF00307;PF00435;, GO:0015629;GO:0009986;GO:0005829;GO:0031235;GO:0032991;GO:0008091;GO:0014731;GO:0003779;GO:0051015;GO:0030506;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;, C:actin cytoskeleton; C:cell surface; C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:protein-containing complex; C:spectrin; C:spectrin-associated cytoskeleton;, F:actin binding; F:actin filament binding; F:ankyrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade;|P11277 Q15510 Q15519,Spectrin beta chain, erythrocytic,Beta-I spectrin;, PF00307;PF00435;, GO:0015629;GO:0009986;GO:0005829;GO:0031235;GO:0032991;GO:0008091;GO:0014731;GO:0003779;GO:0051015;GO:0030506;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;, C:actin cytoskeleton; C:cell surface; C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:protein-containing complex; C:spectrin; C:spectrin-associated cytoskeleton;, F:actin binding; F:actin filament binding; F:ankyrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; scaffold37 indexed_genome mRNA 38702523 38725837 . - . ID=transcript_7778;P11277 Q15510 Q15519,Spectrin beta chain, erythrocytic,Beta-I spectrin;, PF00307;PF00435;, GO:0015629;GO:0009986;GO:0005829;GO:0031235;GO:0032991;GO:0008091;GO:0014731;GO:0003779;GO:0051015;GO:0030506;GO:0005200;GO:0051693;GO:0007411;GO:0006888;GO:0000165;, C:actin cytoskeleton; C:cell surface; C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:protein-containing complex; C:spectrin; C:spectrin-associated cytoskeleton;, F:actin binding; F:actin filament binding; F:ankyrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:axon guidance; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; scaffold37 indexed_genome mRNA 38815040 38833001 . + . ID=transcript_7779;Q8WUH1 B3KQ81 G3V1X3 G3V214 Q9H3K7,Protein Churchill,, PF06573;, GO:0008270;GO:0007275;GO:0045893;, , F:zinc ion binding;, P:multicellular organism development; P:positive regulation of transcription, DNA-templated;|Q8WUH1 B3KQ81 G3V1X3 G3V214 Q9H3K7,Protein Churchill,, PF06573;, GO:0008270;GO:0007275;GO:0045893;, , F:zinc ion binding;, P:multicellular organism development; P:positive regulation of transcription, DNA-templated;|Q8WUH1 B3KQ81 G3V1X3 G3V214 Q9H3K7,Protein Churchill,, PF06573;, GO:0008270;GO:0007275;GO:0045893;, , F:zinc ion binding;, P:multicellular organism development; P:positive regulation of transcription, DNA-templated;|Q8WUH1 B3KQ81 G3V1X3 G3V214 Q9H3K7,Protein Churchill,, PF06573;, GO:0008270;GO:0007275;GO:0045893;, , F:zinc ion binding;, P:multicellular organism development; P:positive regulation of transcription, DNA-templated; scaffold37 indexed_genome mRNA 38836045 38850530 . + . ID=transcript_7780;P18283 Q6PJ52 Q8WWI7 Q9NRP9,Glutathione peroxidase 2,Gastrointestinal glutathione peroxidase;Glutathione peroxidase-gastrointestinal;Glutathione peroxidase-related protein 2;, PF00255;, GO:0005737;GO:0005829;GO:0009055;GO:0004602;GO:0004601;GO:0034599;, C:cytoplasm; C:cytosol;, F:electron transfer activity; F:glutathione peroxidase activity; F:peroxidase activity;, P:cellular response to oxidative stress;|P18283 Q6PJ52 Q8WWI7 Q9NRP9,Glutathione peroxidase 2,Gastrointestinal glutathione peroxidase;Glutathione peroxidase-gastrointestinal;Glutathione peroxidase-related protein 2;, PF00255;, GO:0005737;GO:0005829;GO:0009055;GO:0004602;GO:0004601;GO:0034599;, C:cytoplasm; C:cytosol;, F:electron transfer activity; F:glutathione peroxidase activity; F:peroxidase activity;, P:cellular response to oxidative stress;|P59190 G5EMR7 Q86TX7 Q8IW89,Ras-related protein Rab-15,, PF00071;, GO:0005929;GO:0005737;GO:0005768;GO:0010008;GO:0070062;GO:0005794;GO:0032593;GO:0048471;GO:0005886;GO:0055037;GO:0008021;GO:0005525;GO:0003924;GO:0032869;GO:1903307;GO:0072659;GO:0009306;GO:0032482;GO:0017157;GO:0006904;, C:cilium; C:cytoplasm; C:endosome; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:insulin-responsive compartment; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:synaptic vesicle;, F:GTP binding; F:GTPase activity;, P:cellular response to insulin stimulus; P:positive regulation of regulated secretory pathway; P:protein localization to plasma membrane; P:protein secretion; P:Rab protein signal transduction; P:regulation of exocytosis; P:vesicle docking involved in exocytosis;|P59190 G5EMR7 Q86TX7 Q8IW89,Ras-related protein Rab-15,, PF00071;, GO:0005929;GO:0005737;GO:0005768;GO:0010008;GO:0070062;GO:0005794;GO:0032593;GO:0048471;GO:0005886;GO:0055037;GO:0008021;GO:0005525;GO:0003924;GO:0032869;GO:1903307;GO:0072659;GO:0009306;GO:0032482;GO:0017157;GO:0006904;, C:cilium; C:cytoplasm; C:endosome; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:insulin-responsive compartment; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:synaptic vesicle;, F:GTP binding; F:GTPase activity;, P:cellular response to insulin stimulus; P:positive regulation of regulated secretory pathway; P:protein localization to plasma membrane; P:protein secretion; P:Rab protein signal transduction; P:regulation of exocytosis; P:vesicle docking involved in exocytosis; scaffold37 indexed_genome mRNA 38875513 38956022 . + . ID=transcript_7781;P49356 B2RDX6 B4E1A0,Protein farnesyltransferase subunit beta,CAAX farnesyltransferase subunit beta;Ras proteins prenyltransferase subunit beta;, PF00432;, GO:0005829;GO:0005875;GO:0005965;GO:0004660;GO:0008270;GO:0000165;GO:0018343;GO:0018342;GO:0022400;, C:cytosol; C:microtubule associated complex; C:protein farnesyltransferase complex;, F:protein farnesyltransferase activity; F:zinc ion binding;, P:MAPK cascade; P:protein farnesylation; P:protein prenylation; P:regulation of rhodopsin mediated signaling pathway;|P49356 B2RDX6 B4E1A0,Protein farnesyltransferase subunit beta,CAAX farnesyltransferase subunit beta;Ras proteins prenyltransferase subunit beta;, PF00432;, GO:0005829;GO:0005875;GO:0005965;GO:0004660;GO:0008270;GO:0000165;GO:0018343;GO:0018342;GO:0022400;, C:cytosol; C:microtubule associated complex; C:protein farnesyltransferase complex;, F:protein farnesyltransferase activity; F:zinc ion binding;, P:MAPK cascade; P:protein farnesylation; P:protein prenylation; P:regulation of rhodopsin mediated signaling pathway;|P49356 B2RDX6 B4E1A0,Protein farnesyltransferase subunit beta,CAAX farnesyltransferase subunit beta;Ras proteins prenyltransferase subunit beta;, PF00432;, GO:0005829;GO:0005875;GO:0005965;GO:0004660;GO:0008270;GO:0000165;GO:0018343;GO:0018342;GO:0022400;, C:cytosol; C:microtubule associated complex; C:protein farnesyltransferase complex;, F:protein farnesyltransferase activity; F:zinc ion binding;, P:MAPK cascade; P:protein farnesylation; P:protein prenylation; P:regulation of rhodopsin mediated signaling pathway; scaffold37 indexed_genome mRNA 38956070 38961860 . - . ID=transcript_7782;P49356 B2RDX6 B4E1A0,Protein farnesyltransferase subunit beta,CAAX farnesyltransferase subunit beta;Ras proteins prenyltransferase subunit beta;, PF00432;, GO:0005829;GO:0005875;GO:0005965;GO:0004660;GO:0008270;GO:0000165;GO:0018343;GO:0018342;GO:0022400;, C:cytosol; C:microtubule associated complex; C:protein farnesyltransferase complex;, F:protein farnesyltransferase activity; F:zinc ion binding;, P:MAPK cascade; P:protein farnesylation; P:protein prenylation; P:regulation of rhodopsin mediated signaling pathway;|P49356 B2RDX6 B4E1A0,Protein farnesyltransferase subunit beta,CAAX farnesyltransferase subunit beta;Ras proteins prenyltransferase subunit beta;, PF00432;, GO:0005829;GO:0005875;GO:0005965;GO:0004660;GO:0008270;GO:0000165;GO:0018343;GO:0018342;GO:0022400;, C:cytosol; C:microtubule associated complex; C:protein farnesyltransferase complex;, F:protein farnesyltransferase activity; F:zinc ion binding;, P:MAPK cascade; P:protein farnesylation; P:protein prenylation; P:regulation of rhodopsin mediated signaling pathway; scaffold37 indexed_genome mRNA 38974463 38998270 . - . ID=transcript_7783;P61244 A6NH73 A8K265 A8K4G4 A8K824 P25912 P52163 Q14803 Q96CY8,Protein max {ECO:0000305},Class D basic helix-loop-helix protein 4;Myc-associated factor X {ECO:0000312|HGNC:HGNC:6913};, PF00010;, GO:0000785;GO:0005737;GO:0030425;GO:0071339;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0090575;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0042802;GO:0046983;GO:0044877;GO:1990837;GO:0071375;GO:0009267;GO:0000082;GO:0070317;GO:0000122;GO:0051402;GO:0045944;GO:0065003;GO:0006357;GO:0048678;GO:0032868;GO:0060041;, C:chromatin; C:cytoplasm; C:dendrite; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:identical protein binding; F:protein dimerization activity; F:protein-containing complex binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to peptide hormone stimulus; P:cellular response to starvation; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of transcription by RNA polymerase II; P:response to axon injury; P:response to insulin; P:retina development in camera-type eye;|P61244 A6NH73 A8K265 A8K4G4 A8K824 P25912 P52163 Q14803 Q96CY8,Protein max {ECO:0000305},Class D basic helix-loop-helix protein 4;Myc-associated factor X {ECO:0000312|HGNC:HGNC:6913};, PF00010;, GO:0000785;GO:0005737;GO:0030425;GO:0071339;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0090575;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0042802;GO:0046983;GO:0044877;GO:1990837;GO:0071375;GO:0009267;GO:0000082;GO:0070317;GO:0000122;GO:0051402;GO:0045944;GO:0065003;GO:0006357;GO:0048678;GO:0032868;GO:0060041;, C:chromatin; C:cytoplasm; C:dendrite; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:identical protein binding; F:protein dimerization activity; F:protein-containing complex binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to peptide hormone stimulus; P:cellular response to starvation; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of transcription by RNA polymerase II; P:response to axon injury; P:response to insulin; P:retina development in camera-type eye;|P61244 A6NH73 A8K265 A8K4G4 A8K824 P25912 P52163 Q14803 Q96CY8,Protein max {ECO:0000305},Class D basic helix-loop-helix protein 4;Myc-associated factor X {ECO:0000312|HGNC:HGNC:6913};, PF00010;, GO:0000785;GO:0005737;GO:0030425;GO:0071339;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0090575;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0042802;GO:0046983;GO:0044877;GO:1990837;GO:0071375;GO:0009267;GO:0000082;GO:0070317;GO:0000122;GO:0051402;GO:0045944;GO:0065003;GO:0006357;GO:0048678;GO:0032868;GO:0060041;, C:chromatin; C:cytoplasm; C:dendrite; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:identical protein binding; F:protein dimerization activity; F:protein-containing complex binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to peptide hormone stimulus; P:cellular response to starvation; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of transcription by RNA polymerase II; P:response to axon injury; P:response to insulin; P:retina development in camera-type eye;|P61244 A6NH73 A8K265 A8K4G4 A8K824 P25912 P52163 Q14803 Q96CY8,Protein max {ECO:0000305},Class D basic helix-loop-helix protein 4;Myc-associated factor X {ECO:0000312|HGNC:HGNC:6913};, PF00010;, GO:0000785;GO:0005737;GO:0030425;GO:0071339;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0090575;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0042802;GO:0046983;GO:0044877;GO:1990837;GO:0071375;GO:0009267;GO:0000082;GO:0070317;GO:0000122;GO:0051402;GO:0045944;GO:0065003;GO:0006357;GO:0048678;GO:0032868;GO:0060041;, C:chromatin; C:cytoplasm; C:dendrite; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:identical protein binding; F:protein dimerization activity; F:protein-containing complex binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to peptide hormone stimulus; P:cellular response to starvation; P:G1/S transition of mitotic cell cycle; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of transcription by RNA polymerase II; P:response to axon injury; P:response to insulin; P:retina development in camera-type eye; scaffold37 indexed_genome mRNA 39265300 39579417 . + . ID=transcript_7784;Q9BYC5 B4DFS7 G3V5N0 O00235 Q8IUA5 Q9BYC6 Q9P2U5 Q9P2U6,Alpha-(1,6)-fucosyltransferase,Fucosyltransferase 8;GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase;GDP-fucose--glycoprotein fucosyltransferase;Glycoprotein 6-alpha-L-fucosyltransferase;, PF14604;, GO:0070062;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0046921;GO:0008424;GO:0017124;GO:0016477;GO:0046368;GO:0001701;GO:0007229;GO:0042355;GO:0036071;GO:0006491;GO:0009312;GO:0033578;GO:0006487;GO:0018279;GO:0043112;GO:1900407;GO:0010468;GO:0007585;GO:0007179;GO:0019082;, C:extracellular exosome; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:alpha-(1->6)-fucosyltransferase activity; F:glycoprotein 6-alpha-L-fucosyltransferase activity; F:SH3 domain binding;, P:cell migration; P:GDP-L-fucose metabolic process; P:in utero embryonic development; P:integrin-mediated signaling pathway; P:L-fucose catabolic process; P:N-glycan fucosylation; P:N-glycan processing; P:oligosaccharide biosynthetic process; P:protein glycosylation in Golgi; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:receptor metabolic process; P:regulation of cellular response to oxidative stress; P:regulation of gene expression; P:respiratory gaseous exchange by respiratory system; P:transforming growth factor beta receptor signaling pathway; P:viral protein processing; scaffold37 indexed_genome mRNA 40259125 40565218 . + . ID=transcript_7785;Q9NQX3 Q96KU4 Q9H4E9 Q9P2G2,Gephyrin {ECO:0000303|PubMed:10839351},, PF00994;PF03454;PF03453;, GO:0099144;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005886;GO:0014069;GO:0045211;GO:0099572;GO:0099634;GO:0097060;GO:0005524;GO:0042802;GO:0046872;GO:0061598;GO:0043546;GO:0061599;GO:0008940;GO:0007529;GO:0097112;GO:0072579;GO:0006777;GO:0018315;GO:0032324;GO:0098970;GO:0010038;, C:anchored component of synaptic membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization; C:postsynaptic specialization membrane; C:synaptic membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:molybdopterin adenylyltransferase activity; F:molybdopterin cofactor binding; F:molybdopterin molybdotransferase activity; F:nitrate reductase activity;, P:establishment of synaptic specificity at neuromuscular junction; P:gamma-aminobutyric acid receptor clustering; P:glycine receptor clustering; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdenum incorporation into molybdenum-molybdopterin complex; P:molybdopterin cofactor biosynthetic process; P:postsynaptic neurotransmitter receptor diffusion trapping; P:response to metal ion; scaffold37 indexed_genome mRNA 40642167 40793065 . + . ID=transcript_7786;Q9NQX3 Q96KU4 Q9H4E9 Q9P2G2,Gephyrin {ECO:0000303|PubMed:10839351},, PF00994;PF03454;PF03453;, GO:0099144;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005886;GO:0014069;GO:0045211;GO:0099572;GO:0099634;GO:0097060;GO:0005524;GO:0042802;GO:0046872;GO:0061598;GO:0043546;GO:0061599;GO:0008940;GO:0007529;GO:0097112;GO:0072579;GO:0006777;GO:0018315;GO:0032324;GO:0098970;GO:0010038;, C:anchored component of synaptic membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization; C:postsynaptic specialization membrane; C:synaptic membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:molybdopterin adenylyltransferase activity; F:molybdopterin cofactor binding; F:molybdopterin molybdotransferase activity; F:nitrate reductase activity;, P:establishment of synaptic specificity at neuromuscular junction; P:gamma-aminobutyric acid receptor clustering; P:glycine receptor clustering; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdenum incorporation into molybdenum-molybdopterin complex; P:molybdopterin cofactor biosynthetic process; P:postsynaptic neurotransmitter receptor diffusion trapping; P:response to metal ion;|Q9NQX3 Q96KU4 Q9H4E9 Q9P2G2,Gephyrin {ECO:0000303|PubMed:10839351},, PF00994;PF03454;PF03453;, GO:0099144;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005886;GO:0014069;GO:0045211;GO:0099572;GO:0099634;GO:0097060;GO:0005524;GO:0042802;GO:0046872;GO:0061598;GO:0043546;GO:0061599;GO:0008940;GO:0007529;GO:0097112;GO:0072579;GO:0006777;GO:0018315;GO:0032324;GO:0098970;GO:0010038;, C:anchored component of synaptic membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization; C:postsynaptic specialization membrane; C:synaptic membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:molybdopterin adenylyltransferase activity; F:molybdopterin cofactor binding; F:molybdopterin molybdotransferase activity; F:nitrate reductase activity;, P:establishment of synaptic specificity at neuromuscular junction; P:gamma-aminobutyric acid receptor clustering; P:glycine receptor clustering; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdenum incorporation into molybdenum-molybdopterin complex; P:molybdopterin cofactor biosynthetic process; P:postsynaptic neurotransmitter receptor diffusion trapping; P:response to metal ion;|Q9NQX3 Q96KU4 Q9H4E9 Q9P2G2,Gephyrin {ECO:0000303|PubMed:10839351},, PF00994;PF03454;PF03453;, GO:0099144;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005886;GO:0014069;GO:0045211;GO:0099572;GO:0099634;GO:0097060;GO:0005524;GO:0042802;GO:0046872;GO:0061598;GO:0043546;GO:0061599;GO:0008940;GO:0007529;GO:0097112;GO:0072579;GO:0006777;GO:0018315;GO:0032324;GO:0098970;GO:0010038;, C:anchored component of synaptic membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization; C:postsynaptic specialization membrane; C:synaptic membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:molybdopterin adenylyltransferase activity; F:molybdopterin cofactor binding; F:molybdopterin molybdotransferase activity; F:nitrate reductase activity;, P:establishment of synaptic specificity at neuromuscular junction; P:gamma-aminobutyric acid receptor clustering; P:glycine receptor clustering; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdenum incorporation into molybdenum-molybdopterin complex; P:molybdopterin cofactor biosynthetic process; P:postsynaptic neurotransmitter receptor diffusion trapping; P:response to metal ion;|Q9NQX3 Q96KU4 Q9H4E9 Q9P2G2,Gephyrin {ECO:0000303|PubMed:10839351},, PF00994;PF03454;PF03453;, GO:0099144;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005886;GO:0014069;GO:0045211;GO:0099572;GO:0099634;GO:0097060;GO:0005524;GO:0042802;GO:0046872;GO:0061598;GO:0043546;GO:0061599;GO:0008940;GO:0007529;GO:0097112;GO:0072579;GO:0006777;GO:0018315;GO:0032324;GO:0098970;GO:0010038;, C:anchored component of synaptic membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization; C:postsynaptic specialization membrane; C:synaptic membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:molybdopterin adenylyltransferase activity; F:molybdopterin cofactor binding; F:molybdopterin molybdotransferase activity; F:nitrate reductase activity;, P:establishment of synaptic specificity at neuromuscular junction; P:gamma-aminobutyric acid receptor clustering; P:glycine receptor clustering; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdenum incorporation into molybdenum-molybdopterin complex; P:molybdopterin cofactor biosynthetic process; P:postsynaptic neurotransmitter receptor diffusion trapping; P:response to metal ion;|Q9NQX3 Q96KU4 Q9H4E9 Q9P2G2,Gephyrin {ECO:0000303|PubMed:10839351},, PF00994;PF03454;PF03453;, GO:0099144;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005886;GO:0014069;GO:0045211;GO:0099572;GO:0099634;GO:0097060;GO:0005524;GO:0042802;GO:0046872;GO:0061598;GO:0043546;GO:0061599;GO:0008940;GO:0007529;GO:0097112;GO:0072579;GO:0006777;GO:0018315;GO:0032324;GO:0098970;GO:0010038;, C:anchored component of synaptic membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization; C:postsynaptic specialization membrane; C:synaptic membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:molybdopterin adenylyltransferase activity; F:molybdopterin cofactor binding; F:molybdopterin molybdotransferase activity; F:nitrate reductase activity;, P:establishment of synaptic specificity at neuromuscular junction; P:gamma-aminobutyric acid receptor clustering; P:glycine receptor clustering; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdenum incorporation into molybdenum-molybdopterin complex; P:molybdopterin cofactor biosynthetic process; P:postsynaptic neurotransmitter receptor diffusion trapping; P:response to metal ion;|Q9NQX3 Q96KU4 Q9H4E9 Q9P2G2,Gephyrin {ECO:0000303|PubMed:10839351},, PF00994;PF03454;PF03453;, GO:0099144;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005886;GO:0014069;GO:0045211;GO:0099572;GO:0099634;GO:0097060;GO:0005524;GO:0042802;GO:0046872;GO:0061598;GO:0043546;GO:0061599;GO:0008940;GO:0007529;GO:0097112;GO:0072579;GO:0006777;GO:0018315;GO:0032324;GO:0098970;GO:0010038;, C:anchored component of synaptic membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization; C:postsynaptic specialization membrane; C:synaptic membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:molybdopterin adenylyltransferase activity; F:molybdopterin cofactor binding; F:molybdopterin molybdotransferase activity; F:nitrate reductase activity;, P:establishment of synaptic specificity at neuromuscular junction; P:gamma-aminobutyric acid receptor clustering; P:glycine receptor clustering; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdenum incorporation into molybdenum-molybdopterin complex; P:molybdopterin cofactor biosynthetic process; P:postsynaptic neurotransmitter receptor diffusion trapping; P:response to metal ion;|Q9NQX3 Q96KU4 Q9H4E9 Q9P2G2,Gephyrin {ECO:0000303|PubMed:10839351},, PF00994;PF03454;PF03453;, GO:0099144;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005886;GO:0014069;GO:0045211;GO:0099572;GO:0099634;GO:0097060;GO:0005524;GO:0042802;GO:0046872;GO:0061598;GO:0043546;GO:0061599;GO:0008940;GO:0007529;GO:0097112;GO:0072579;GO:0006777;GO:0018315;GO:0032324;GO:0098970;GO:0010038;, C:anchored component of synaptic membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization; C:postsynaptic specialization membrane; C:synaptic membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:molybdopterin adenylyltransferase activity; F:molybdopterin cofactor binding; F:molybdopterin molybdotransferase activity; F:nitrate reductase activity;, P:establishment of synaptic specificity at neuromuscular junction; P:gamma-aminobutyric acid receptor clustering; P:glycine receptor clustering; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdenum incorporation into molybdenum-molybdopterin complex; P:molybdopterin cofactor biosynthetic process; P:postsynaptic neurotransmitter receptor diffusion trapping; P:response to metal ion; scaffold37 indexed_genome mRNA 40882461 40950318 . - . ID=transcript_7787;Q8N3R9 A1L380 Q7Z631 Q86T98 Q8N7I5 Q9H9Q0,MAGUK p55 subfamily member 5,, PF00625;PF02828;PF09060;PF00595;PF07653;, GO:0005912;GO:0016324;GO:0030424;GO:0005923;GO:0005737;GO:0005793;GO:0070062;GO:0005794;GO:0043219;GO:0035749;GO:0043204;GO:0005886;GO:0032991;GO:0043220;GO:0005524;GO:0019904;GO:0070830;GO:0021954;GO:0021987;GO:0010467;GO:0002011;GO:0032288;GO:0032287;GO:0035750;GO:0072659;GO:0017015;, C:adherens junction; C:apical plasma membrane; C:axon; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:lateral loop; C:myelin sheath adaxonal region; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:Schmidt-Lanterman incisure;, F:ATP binding; F:protein domain specific binding;, P:bicellular tight junction assembly; P:central nervous system neuron development; P:cerebral cortex development; P:gene expression; P:morphogenesis of an epithelial sheet; P:myelin assembly; P:peripheral nervous system myelin maintenance; P:protein localization to myelin sheath abaxonal region; P:protein localization to plasma membrane; P:regulation of transforming growth factor beta receptor signaling pathway;|Q8N3R9 A1L380 Q7Z631 Q86T98 Q8N7I5 Q9H9Q0,MAGUK p55 subfamily member 5,, PF00625;PF02828;PF09060;PF00595;PF07653;, GO:0005912;GO:0016324;GO:0030424;GO:0005923;GO:0005737;GO:0005793;GO:0070062;GO:0005794;GO:0043219;GO:0035749;GO:0043204;GO:0005886;GO:0032991;GO:0043220;GO:0005524;GO:0019904;GO:0070830;GO:0021954;GO:0021987;GO:0010467;GO:0002011;GO:0032288;GO:0032287;GO:0035750;GO:0072659;GO:0017015;, C:adherens junction; C:apical plasma membrane; C:axon; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:lateral loop; C:myelin sheath adaxonal region; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:Schmidt-Lanterman incisure;, F:ATP binding; F:protein domain specific binding;, P:bicellular tight junction assembly; P:central nervous system neuron development; P:cerebral cortex development; P:gene expression; P:morphogenesis of an epithelial sheet; P:myelin assembly; P:peripheral nervous system myelin maintenance; P:protein localization to myelin sheath abaxonal region; P:protein localization to plasma membrane; P:regulation of transforming growth factor beta receptor signaling pathway;|Q8N3R9 A1L380 Q7Z631 Q86T98 Q8N7I5 Q9H9Q0,MAGUK p55 subfamily member 5,, PF00625;PF02828;PF09060;PF00595;PF07653;, GO:0005912;GO:0016324;GO:0030424;GO:0005923;GO:0005737;GO:0005793;GO:0070062;GO:0005794;GO:0043219;GO:0035749;GO:0043204;GO:0005886;GO:0032991;GO:0043220;GO:0005524;GO:0019904;GO:0070830;GO:0021954;GO:0021987;GO:0010467;GO:0002011;GO:0032288;GO:0032287;GO:0035750;GO:0072659;GO:0017015;, C:adherens junction; C:apical plasma membrane; C:axon; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:lateral loop; C:myelin sheath adaxonal region; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:Schmidt-Lanterman incisure;, F:ATP binding; F:protein domain specific binding;, P:bicellular tight junction assembly; P:central nervous system neuron development; P:cerebral cortex development; P:gene expression; P:morphogenesis of an epithelial sheet; P:myelin assembly; P:peripheral nervous system myelin maintenance; P:protein localization to myelin sheath abaxonal region; P:protein localization to plasma membrane; P:regulation of transforming growth factor beta receptor signaling pathway;|Q8N3R9 A1L380 Q7Z631 Q86T98 Q8N7I5 Q9H9Q0,MAGUK p55 subfamily member 5,, PF00625;PF02828;PF09060;PF00595;PF07653;, GO:0005912;GO:0016324;GO:0030424;GO:0005923;GO:0005737;GO:0005793;GO:0070062;GO:0005794;GO:0043219;GO:0035749;GO:0043204;GO:0005886;GO:0032991;GO:0043220;GO:0005524;GO:0019904;GO:0070830;GO:0021954;GO:0021987;GO:0010467;GO:0002011;GO:0032288;GO:0032287;GO:0035750;GO:0072659;GO:0017015;, C:adherens junction; C:apical plasma membrane; C:axon; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:lateral loop; C:myelin sheath adaxonal region; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:Schmidt-Lanterman incisure;, F:ATP binding; F:protein domain specific binding;, P:bicellular tight junction assembly; P:central nervous system neuron development; P:cerebral cortex development; P:gene expression; P:morphogenesis of an epithelial sheet; P:myelin assembly; P:peripheral nervous system myelin maintenance; P:protein localization to myelin sheath abaxonal region; P:protein localization to plasma membrane; P:regulation of transforming growth factor beta receptor signaling pathway;|Q8N3R9 A1L380 Q7Z631 Q86T98 Q8N7I5 Q9H9Q0,MAGUK p55 subfamily member 5,, PF00625;PF02828;PF09060;PF00595;PF07653;, GO:0005912;GO:0016324;GO:0030424;GO:0005923;GO:0005737;GO:0005793;GO:0070062;GO:0005794;GO:0043219;GO:0035749;GO:0043204;GO:0005886;GO:0032991;GO:0043220;GO:0005524;GO:0019904;GO:0070830;GO:0021954;GO:0021987;GO:0010467;GO:0002011;GO:0032288;GO:0032287;GO:0035750;GO:0072659;GO:0017015;, C:adherens junction; C:apical plasma membrane; C:axon; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:lateral loop; C:myelin sheath adaxonal region; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:Schmidt-Lanterman incisure;, F:ATP binding; F:protein domain specific binding;, P:bicellular tight junction assembly; P:central nervous system neuron development; P:cerebral cortex development; P:gene expression; P:morphogenesis of an epithelial sheet; P:myelin assembly; P:peripheral nervous system myelin maintenance; P:protein localization to myelin sheath abaxonal region; P:protein localization to plasma membrane; P:regulation of transforming growth factor beta receptor signaling pathway;|Q8N3R9 A1L380 Q7Z631 Q86T98 Q8N7I5 Q9H9Q0,MAGUK p55 subfamily member 5,, PF00625;PF02828;PF09060;PF00595;PF07653;, GO:0005912;GO:0016324;GO:0030424;GO:0005923;GO:0005737;GO:0005793;GO:0070062;GO:0005794;GO:0043219;GO:0035749;GO:0043204;GO:0005886;GO:0032991;GO:0043220;GO:0005524;GO:0019904;GO:0070830;GO:0021954;GO:0021987;GO:0010467;GO:0002011;GO:0032288;GO:0032287;GO:0035750;GO:0072659;GO:0017015;, C:adherens junction; C:apical plasma membrane; C:axon; C:bicellular tight junction; C:cytoplasm; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:lateral loop; C:myelin sheath adaxonal region; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:Schmidt-Lanterman incisure;, F:ATP binding; F:protein domain specific binding;, P:bicellular tight junction assembly; P:central nervous system neuron development; P:cerebral cortex development; P:gene expression; P:morphogenesis of an epithelial sheet; P:myelin assembly; P:peripheral nervous system myelin maintenance; P:protein localization to myelin sheath abaxonal region; P:protein localization to plasma membrane; P:regulation of transforming growth factor beta receptor signaling pathway;|Q9Y5K8 B2RE33 Q9Y688,V-type proton ATPase subunit D,V-ATPase 28 kDa accessory protein;Vacuolar proton pump subunit D;, PF01813;, GO:0005829;GO:0070062;GO:0005765;GO:0016020;GO:0005886;GO:0033176;GO:0035579;GO:0046961;GO:0034198;GO:0060271;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0061512;GO:0016241;GO:0033572;, C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:membrane; C:plasma membrane; C:proton-transporting V-type ATPase complex; C:specific granule membrane;, F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:cilium assembly; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:protein localization to cilium; P:regulation of macroautophagy; P:transferrin transport;|Q9Y5K8 B2RE33 Q9Y688,V-type proton ATPase subunit D,V-ATPase 28 kDa accessory protein;Vacuolar proton pump subunit D;, PF01813;, GO:0005829;GO:0070062;GO:0005765;GO:0016020;GO:0005886;GO:0033176;GO:0035579;GO:0046961;GO:0034198;GO:0060271;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0061512;GO:0016241;GO:0033572;, C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:membrane; C:plasma membrane; C:proton-transporting V-type ATPase complex; C:specific granule membrane;, F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:cilium assembly; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:protein localization to cilium; P:regulation of macroautophagy; P:transferrin transport;|Q9Y5K8 B2RE33 Q9Y688,V-type proton ATPase subunit D,V-ATPase 28 kDa accessory protein;Vacuolar proton pump subunit D;, PF01813;, GO:0005829;GO:0070062;GO:0005765;GO:0016020;GO:0005886;GO:0033176;GO:0035579;GO:0046961;GO:0034198;GO:0060271;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0061512;GO:0016241;GO:0033572;, C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:membrane; C:plasma membrane; C:proton-transporting V-type ATPase complex; C:specific granule membrane;, F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:cilium assembly; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:protein localization to cilium; P:regulation of macroautophagy; P:transferrin transport;|Q9Y5K8 B2RE33 Q9Y688,V-type proton ATPase subunit D,V-ATPase 28 kDa accessory protein;Vacuolar proton pump subunit D;, PF01813;, GO:0005829;GO:0070062;GO:0005765;GO:0016020;GO:0005886;GO:0033176;GO:0035579;GO:0046961;GO:0034198;GO:0060271;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0061512;GO:0016241;GO:0033572;, C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:membrane; C:plasma membrane; C:proton-transporting V-type ATPase complex; C:specific granule membrane;, F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:cilium assembly; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:protein localization to cilium; P:regulation of macroautophagy; P:transferrin transport; scaffold37 indexed_genome mRNA 40950407 40962353 . + . ID=transcript_7788;P05198,Eukaryotic translation initiation factor 2 subunit 1,Eukaryotic translation initiation factor 2 subunit alpha;, PF07541;PF00575;, GO:0010494;GO:0005829;GO:0033290;GO:0005850;GO:0005851;GO:0070062;GO:0097451;GO:0016020;GO:0043614;GO:0005634;GO:0005844;GO:0045202;GO:0044207;GO:0043022;GO:0003723;GO:0003743;GO:0007568;GO:0034198;GO:0034605;GO:0034599;GO:0034644;GO:1905098;GO:0032057;GO:0036499;GO:1901216;GO:2000676;GO:0046777;GO:0034976;GO:1990737;GO:0034063;GO:0006413;GO:0055085;, C:cytoplasmic stress granule; C:cytosol; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 2 complex; C:eukaryotic translation initiation factor 2B complex; C:extracellular exosome; C:glial limiting end-foot; C:membrane; C:multi-eIF complex; C:nucleus; C:polysome; C:synapse; C:translation initiation ternary complex;, F:ribosome binding; F:RNA binding; F:translation initiation factor activity;, P:aging; P:cellular response to amino acid starvation; P:cellular response to heat; P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of translational initiation in response to stress; P:PERK-mediated unfolded protein response; P:positive regulation of neuron death; P:positive regulation of type B pancreatic cell apoptotic process; P:protein autophosphorylation; P:response to endoplasmic reticulum stress; P:response to manganese-induced endoplasmic reticulum stress; P:stress granule assembly; P:translational initiation; P:transmembrane transport; scaffold37 indexed_genome mRNA 40962419 40981452 . + . ID=transcript_7789;P05198,Eukaryotic translation initiation factor 2 subunit 1,Eukaryotic translation initiation factor 2 subunit alpha;, PF07541;PF00575;, GO:0010494;GO:0005829;GO:0033290;GO:0005850;GO:0005851;GO:0070062;GO:0097451;GO:0016020;GO:0043614;GO:0005634;GO:0005844;GO:0045202;GO:0044207;GO:0043022;GO:0003723;GO:0003743;GO:0007568;GO:0034198;GO:0034605;GO:0034599;GO:0034644;GO:1905098;GO:0032057;GO:0036499;GO:1901216;GO:2000676;GO:0046777;GO:0034976;GO:1990737;GO:0034063;GO:0006413;GO:0055085;, C:cytoplasmic stress granule; C:cytosol; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 2 complex; C:eukaryotic translation initiation factor 2B complex; C:extracellular exosome; C:glial limiting end-foot; C:membrane; C:multi-eIF complex; C:nucleus; C:polysome; C:synapse; C:translation initiation ternary complex;, F:ribosome binding; F:RNA binding; F:translation initiation factor activity;, P:aging; P:cellular response to amino acid starvation; P:cellular response to heat; P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of translational initiation in response to stress; P:PERK-mediated unfolded protein response; P:positive regulation of neuron death; P:positive regulation of type B pancreatic cell apoptotic process; P:protein autophosphorylation; P:response to endoplasmic reticulum stress; P:response to manganese-induced endoplasmic reticulum stress; P:stress granule assembly; P:translational initiation; P:transmembrane transport;|Q9NYT0 Q96JT0,Pleckstrin-2,, PF00610;PF00169;, GO:0005737;GO:0005856;GO:0031258;GO:0005886;GO:0043325;GO:0080025;GO:0032266;GO:0031532;GO:0035556;GO:0120034;, C:cytoplasm; C:cytoskeleton; C:lamellipodium membrane; C:plasma membrane;, F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding;, P:actin cytoskeleton reorganization; P:intracellular signal transduction; P:positive regulation of plasma membrane bounded cell projection assembly;|P05198,Eukaryotic translation initiation factor 2 subunit 1,Eukaryotic translation initiation factor 2 subunit alpha;, PF07541;PF00575;, GO:0010494;GO:0005829;GO:0033290;GO:0005850;GO:0005851;GO:0070062;GO:0097451;GO:0016020;GO:0043614;GO:0005634;GO:0005844;GO:0045202;GO:0044207;GO:0043022;GO:0003723;GO:0003743;GO:0007568;GO:0034198;GO:0034605;GO:0034599;GO:0034644;GO:1905098;GO:0032057;GO:0036499;GO:1901216;GO:2000676;GO:0046777;GO:0034976;GO:1990737;GO:0034063;GO:0006413;GO:0055085;, C:cytoplasmic stress granule; C:cytosol; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 2 complex; C:eukaryotic translation initiation factor 2B complex; C:extracellular exosome; C:glial limiting end-foot; C:membrane; C:multi-eIF complex; C:nucleus; C:polysome; C:synapse; C:translation initiation ternary complex;, F:ribosome binding; F:RNA binding; F:translation initiation factor activity;, P:aging; P:cellular response to amino acid starvation; P:cellular response to heat; P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of translational initiation in response to stress; P:PERK-mediated unfolded protein response; P:positive regulation of neuron death; P:positive regulation of type B pancreatic cell apoptotic process; P:protein autophosphorylation; P:response to endoplasmic reticulum stress; P:response to manganese-induced endoplasmic reticulum stress; P:stress granule assembly; P:translational initiation; P:transmembrane transport;|P05198,Eukaryotic translation initiation factor 2 subunit 1,Eukaryotic translation initiation factor 2 subunit alpha;, PF07541;PF00575;, GO:0010494;GO:0005829;GO:0033290;GO:0005850;GO:0005851;GO:0070062;GO:0097451;GO:0016020;GO:0043614;GO:0005634;GO:0005844;GO:0045202;GO:0044207;GO:0043022;GO:0003723;GO:0003743;GO:0007568;GO:0034198;GO:0034605;GO:0034599;GO:0034644;GO:1905098;GO:0032057;GO:0036499;GO:1901216;GO:2000676;GO:0046777;GO:0034976;GO:1990737;GO:0034063;GO:0006413;GO:0055085;, C:cytoplasmic stress granule; C:cytosol; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 2 complex; C:eukaryotic translation initiation factor 2B complex; C:extracellular exosome; C:glial limiting end-foot; C:membrane; C:multi-eIF complex; C:nucleus; C:polysome; C:synapse; C:translation initiation ternary complex;, F:ribosome binding; F:RNA binding; F:translation initiation factor activity;, P:aging; P:cellular response to amino acid starvation; P:cellular response to heat; P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of translational initiation in response to stress; P:PERK-mediated unfolded protein response; P:positive regulation of neuron death; P:positive regulation of type B pancreatic cell apoptotic process; P:protein autophosphorylation; P:response to endoplasmic reticulum stress; P:response to manganese-induced endoplasmic reticulum stress; P:stress granule assembly; P:translational initiation; P:transmembrane transport; scaffold37 indexed_genome mRNA 41048548 41062927 . - . ID=transcript_7790;Q8NBD8,Transmembrane protein 229B,, PF06541;, GO:0016021;GO:0009617;, C:integral component of membrane;, , P:response to bacterium;|Q8NBD8,Transmembrane protein 229B,, PF06541;, GO:0016021;GO:0009617;, C:integral component of membrane;, , P:response to bacterium;|Q8NBD8,Transmembrane protein 229B,, PF06541;, GO:0016021;GO:0009617;, C:integral component of membrane;, , P:response to bacterium; scaffold37 indexed_genome mRNA 41142040 41175505 . + . ID=transcript_7791;Q9ULM0 A6H8X6 Q6PJL4 Q6ZWC7,Pleckstrin homology domain-containing family H member 1,, PF00373;PF00784;PF00169;, GO:0005856;, C:cytoskeleton;|Q9ULM0 A6H8X6 Q6PJL4 Q6ZWC7,Pleckstrin homology domain-containing family H member 1,, PF00373;PF00784;PF00169;, GO:0005856;, C:cytoskeleton;|Q9ULM0 A6H8X6 Q6PJL4 Q6ZWC7,Pleckstrin homology domain-containing family H member 1,, PF00373;PF00784;PF00169;, GO:0005856;, C:cytoskeleton;|Q9ULM0 A6H8X6 Q6PJL4 Q6ZWC7,Pleckstrin homology domain-containing family H member 1,, PF00373;PF00784;PF00169;, GO:0005856;, C:cytoskeleton;|Q9ULM0 A6H8X6 Q6PJL4 Q6ZWC7,Pleckstrin homology domain-containing family H member 1,, PF00373;PF00784;PF00169;, GO:0005856;, C:cytoskeleton;|Q9ULM0 A6H8X6 Q6PJL4 Q6ZWC7,Pleckstrin homology domain-containing family H member 1,, PF00373;PF00784;PF00169;, GO:0005856;, C:cytoskeleton;|Q9ULM0 A6H8X6 Q6PJL4 Q6ZWC7,Pleckstrin homology domain-containing family H member 1,, PF00373;PF00784;PF00169;, GO:0005856;, C:cytoskeleton;|Q8IVE3 Q5JPJ6 Q6P4Q1 Q8N3Q3,Pleckstrin homology domain-containing family H member 2,, PF00373;PF00784;PF00169;, GO:0030864;GO:0005737;GO:0005829;GO:0030027;GO:0016604;GO:0005654;GO:0005886;GO:0003779;GO:0030835;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:lamellipodium; C:nuclear body; C:nucleoplasm; C:plasma membrane;, F:actin binding;, P:negative regulation of actin filament depolymerization;|Q9ULM0 A6H8X6 Q6PJL4 Q6ZWC7,Pleckstrin homology domain-containing family H member 1,, PF00373;PF00784;PF00169;, GO:0005856;, C:cytoskeleton;|Q9ULM0 A6H8X6 Q6PJL4 Q6ZWC7,Pleckstrin homology domain-containing family H member 1,, PF00373;PF00784;PF00169;, GO:0005856;, C:cytoskeleton;|Q14442 B2RAA4,Phosphatidylinositol N-acetylglucosaminyltransferase subunit H {ECO:0000305},Phosphatidylinositol-glycan biosynthesis class H protein;, PF10181;, GO:0005783;GO:0005789;GO:0000506;GO:0003824;GO:0017176;GO:0006464;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex;, F:catalytic activity; F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:cellular protein modification process; P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q14442 B2RAA4,Phosphatidylinositol N-acetylglucosaminyltransferase subunit H {ECO:0000305},Phosphatidylinositol-glycan biosynthesis class H protein;, PF10181;, GO:0005783;GO:0005789;GO:0000506;GO:0003824;GO:0017176;GO:0006464;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex;, F:catalytic activity; F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:cellular protein modification process; P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q14442 B2RAA4,Phosphatidylinositol N-acetylglucosaminyltransferase subunit H {ECO:0000305},Phosphatidylinositol-glycan biosynthesis class H protein;, PF10181;, GO:0005783;GO:0005789;GO:0000506;GO:0003824;GO:0017176;GO:0006464;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex;, F:catalytic activity; F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:cellular protein modification process; P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold37 indexed_genome mRNA 41217909 41245559 . - . ID=transcript_7792;P78540 B2R690 Q6FHY8,Arginase-2, mitochondrial,Arginase II;Kidney-type arginase;Non-hepatic arginase;Type II arginase;, PF00491;, GO:0005737;GO:0005759;GO:0005739;GO:0004053;GO:0030145;GO:0002250;GO:0019547;GO:0045087;GO:1905403;GO:2000562;GO:0071644;GO:0071650;GO:1900425;GO:0032696;GO:0032700;GO:0071641;GO:0032720;GO:0002829;GO:0006809;GO:2000774;GO:0032651;GO:1903426;GO:0006941;GO:0000050;GO:0001657;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:arginase activity; F:manganese ion binding;, P:adaptive immune response; P:arginine catabolic process to ornithine; P:innate immune response; P:negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of chemokine (C-C motif) ligand 4 production; P:negative regulation of chemokine (C-C motif) ligand 5 production; P:negative regulation of defense response to bacterium; P:negative regulation of interleukin-13 production; P:negative regulation of interleukin-17 production; P:negative regulation of macrophage inflammatory protein 1 alpha production; P:negative regulation of tumor necrosis factor production; P:negative regulation of type 2 immune response; P:nitric oxide biosynthetic process; P:positive regulation of cellular senescence; P:regulation of interleukin-1 beta production; P:regulation of reactive oxygen species biosynthetic process; P:striated muscle contraction; P:urea cycle; P:ureteric bud development;|P78540 B2R690 Q6FHY8,Arginase-2, mitochondrial,Arginase II;Kidney-type arginase;Non-hepatic arginase;Type II arginase;, PF00491;, GO:0005737;GO:0005759;GO:0005739;GO:0004053;GO:0030145;GO:0002250;GO:0019547;GO:0045087;GO:1905403;GO:2000562;GO:0071644;GO:0071650;GO:1900425;GO:0032696;GO:0032700;GO:0071641;GO:0032720;GO:0002829;GO:0006809;GO:2000774;GO:0032651;GO:1903426;GO:0006941;GO:0000050;GO:0001657;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:arginase activity; F:manganese ion binding;, P:adaptive immune response; P:arginine catabolic process to ornithine; P:innate immune response; P:negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of chemokine (C-C motif) ligand 4 production; P:negative regulation of chemokine (C-C motif) ligand 5 production; P:negative regulation of defense response to bacterium; P:negative regulation of interleukin-13 production; P:negative regulation of interleukin-17 production; P:negative regulation of macrophage inflammatory protein 1 alpha production; P:negative regulation of tumor necrosis factor production; P:negative regulation of type 2 immune response; P:nitric oxide biosynthetic process; P:positive regulation of cellular senescence; P:regulation of interleukin-1 beta production; P:regulation of reactive oxygen species biosynthetic process; P:striated muscle contraction; P:urea cycle; P:ureteric bud development;|P78540 B2R690 Q6FHY8,Arginase-2, mitochondrial,Arginase II;Kidney-type arginase;Non-hepatic arginase;Type II arginase;, PF00491;, GO:0005737;GO:0005759;GO:0005739;GO:0004053;GO:0030145;GO:0002250;GO:0019547;GO:0045087;GO:1905403;GO:2000562;GO:0071644;GO:0071650;GO:1900425;GO:0032696;GO:0032700;GO:0071641;GO:0032720;GO:0002829;GO:0006809;GO:2000774;GO:0032651;GO:1903426;GO:0006941;GO:0000050;GO:0001657;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:arginase activity; F:manganese ion binding;, P:adaptive immune response; P:arginine catabolic process to ornithine; P:innate immune response; P:negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of chemokine (C-C motif) ligand 4 production; P:negative regulation of chemokine (C-C motif) ligand 5 production; P:negative regulation of defense response to bacterium; P:negative regulation of interleukin-13 production; P:negative regulation of interleukin-17 production; P:negative regulation of macrophage inflammatory protein 1 alpha production; P:negative regulation of tumor necrosis factor production; P:negative regulation of type 2 immune response; P:nitric oxide biosynthetic process; P:positive regulation of cellular senescence; P:regulation of interleukin-1 beta production; P:regulation of reactive oxygen species biosynthetic process; P:striated muscle contraction; P:urea cycle; P:ureteric bud development;|Q9UEU0 O43547 Q96J28,Vesicle transport through interaction with t-SNAREs homolog 1B,Vesicle transport v-SNARE protein Vti1-like 1;Vti1-rp1;, PF05008;, GO:0005829;GO:0031901;GO:0005789;GO:0012507;GO:0005576;GO:0005794;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0043025;GO:0048471;GO:0031093;GO:0055037;GO:0055038;GO:0031201;GO:0008021;GO:0031982;GO:0019869;GO:0005484;GO:0000149;GO:0006888;GO:0006896;GO:0006891;GO:0061025;GO:0002576;GO:0006623;GO:1903076;GO:0042147;GO:0006904;GO:0048280;GO:0016192;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extracellular region; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:recycling endosome; C:recycling endosome membrane; C:SNARE complex; C:synaptic vesicle; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:SNARE binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to vacuole transport; P:intra-Golgi vesicle-mediated transport; P:membrane fusion; P:platelet degranulation; P:protein targeting to vacuole; P:regulation of protein localization to plasma membrane; P:retrograde transport, endosome to Golgi; P:vesicle docking involved in exocytosis; P:vesicle fusion with Golgi apparatus; P:vesicle-mediated transport;|Q9UEU0 O43547 Q96J28,Vesicle transport through interaction with t-SNAREs homolog 1B,Vesicle transport v-SNARE protein Vti1-like 1;Vti1-rp1;, PF05008;, GO:0005829;GO:0031901;GO:0005789;GO:0012507;GO:0005576;GO:0005794;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0043025;GO:0048471;GO:0031093;GO:0055037;GO:0055038;GO:0031201;GO:0008021;GO:0031982;GO:0019869;GO:0005484;GO:0000149;GO:0006888;GO:0006896;GO:0006891;GO:0061025;GO:0002576;GO:0006623;GO:1903076;GO:0042147;GO:0006904;GO:0048280;GO:0016192;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extracellular region; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:recycling endosome; C:recycling endosome membrane; C:SNARE complex; C:synaptic vesicle; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:SNARE binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to vacuole transport; P:intra-Golgi vesicle-mediated transport; P:membrane fusion; P:platelet degranulation; P:protein targeting to vacuole; P:regulation of protein localization to plasma membrane; P:retrograde transport, endosome to Golgi; P:vesicle docking involved in exocytosis; P:vesicle fusion with Golgi apparatus; P:vesicle-mediated transport;|Q9UEU0 O43547 Q96J28,Vesicle transport through interaction with t-SNAREs homolog 1B,Vesicle transport v-SNARE protein Vti1-like 1;Vti1-rp1;, PF05008;, GO:0005829;GO:0031901;GO:0005789;GO:0012507;GO:0005576;GO:0005794;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0043025;GO:0048471;GO:0031093;GO:0055037;GO:0055038;GO:0031201;GO:0008021;GO:0031982;GO:0019869;GO:0005484;GO:0000149;GO:0006888;GO:0006896;GO:0006891;GO:0061025;GO:0002576;GO:0006623;GO:1903076;GO:0042147;GO:0006904;GO:0048280;GO:0016192;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extracellular region; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:recycling endosome; C:recycling endosome membrane; C:SNARE complex; C:synaptic vesicle; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:SNARE binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to vacuole transport; P:intra-Golgi vesicle-mediated transport; P:membrane fusion; P:platelet degranulation; P:protein targeting to vacuole; P:regulation of protein localization to plasma membrane; P:retrograde transport, endosome to Golgi; P:vesicle docking involved in exocytosis; P:vesicle fusion with Golgi apparatus; P:vesicle-mediated transport;|Q9UEU0 O43547 Q96J28,Vesicle transport through interaction with t-SNAREs homolog 1B,Vesicle transport v-SNARE protein Vti1-like 1;Vti1-rp1;, PF05008;, GO:0005829;GO:0031901;GO:0005789;GO:0012507;GO:0005576;GO:0005794;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0043025;GO:0048471;GO:0031093;GO:0055037;GO:0055038;GO:0031201;GO:0008021;GO:0031982;GO:0019869;GO:0005484;GO:0000149;GO:0006888;GO:0006896;GO:0006891;GO:0061025;GO:0002576;GO:0006623;GO:1903076;GO:0042147;GO:0006904;GO:0048280;GO:0016192;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extracellular region; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:recycling endosome; C:recycling endosome membrane; C:SNARE complex; C:synaptic vesicle; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:SNARE binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to vacuole transport; P:intra-Golgi vesicle-mediated transport; P:membrane fusion; P:platelet degranulation; P:protein targeting to vacuole; P:regulation of protein localization to plasma membrane; P:retrograde transport, endosome to Golgi; P:vesicle docking involved in exocytosis; P:vesicle fusion with Golgi apparatus; P:vesicle-mediated transport; scaffold37 indexed_genome mRNA 41248724 41259660 . - . ID=transcript_7793;Q8TC12 A6NDK3 A8K062 B2RB26 B4DDW0 Q0QD40 Q6IAH5 Q9NRW0 Q9Y391,Retinol dehydrogenase 11,Androgen-regulated short-chain dehydrogenase/reductase 1 {ECO:0000303|PubMed:11245473};HCV core-binding protein HCBP12;Prostate short-chain dehydrogenase/reductase 1;Retinal reductase 1 {ECO:0000303|PubMed:12036956};Short chain dehydrogenase/reductase family 7C member 1;, PF00106;, GO:0005789;GO:0016021;GO:0102354;GO:0052650;GO:0004745;GO:0110095;GO:0042574;GO:0001523;GO:0042572;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:11-cis-retinol dehydrogenase activity; F:NADP-retinol dehydrogenase activity; F:retinol dehydrogenase activity;, P:cellular detoxification of aldehyde; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process;|Q8TC12 A6NDK3 A8K062 B2RB26 B4DDW0 Q0QD40 Q6IAH5 Q9NRW0 Q9Y391,Retinol dehydrogenase 11,Androgen-regulated short-chain dehydrogenase/reductase 1 {ECO:0000303|PubMed:11245473};HCV core-binding protein HCBP12;Prostate short-chain dehydrogenase/reductase 1;Retinal reductase 1 {ECO:0000303|PubMed:12036956};Short chain dehydrogenase/reductase family 7C member 1;, PF00106;, GO:0005789;GO:0016021;GO:0102354;GO:0052650;GO:0004745;GO:0110095;GO:0042574;GO:0001523;GO:0042572;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:11-cis-retinol dehydrogenase activity; F:NADP-retinol dehydrogenase activity; F:retinol dehydrogenase activity;, P:cellular detoxification of aldehyde; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process;|Q8TC12 A6NDK3 A8K062 B2RB26 B4DDW0 Q0QD40 Q6IAH5 Q9NRW0 Q9Y391,Retinol dehydrogenase 11,Androgen-regulated short-chain dehydrogenase/reductase 1 {ECO:0000303|PubMed:11245473};HCV core-binding protein HCBP12;Prostate short-chain dehydrogenase/reductase 1;Retinal reductase 1 {ECO:0000303|PubMed:12036956};Short chain dehydrogenase/reductase family 7C member 1;, PF00106;, GO:0005789;GO:0016021;GO:0102354;GO:0052650;GO:0004745;GO:0110095;GO:0042574;GO:0001523;GO:0042572;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:11-cis-retinol dehydrogenase activity; F:NADP-retinol dehydrogenase activity; F:retinol dehydrogenase activity;, P:cellular detoxification of aldehyde; P:retinal metabolic process; P:retinoid metabolic process; P:retinol metabolic process; scaffold37 indexed_genome mRNA 41286135 41290641 . + . ID=transcript_7794;Q96NR8 B2RDA2 Q8TAW6,Retinol dehydrogenase 12,All-trans and 9-cis retinol dehydrogenase;Short chain dehydrogenase/reductase family 7C member 2;, PF00106;, GO:0005789;GO:0001917;GO:0060342;GO:0102354;GO:0052650;GO:0004745;GO:0110095;GO:0045494;GO:0001523;GO:0042572;GO:0007601;, C:endoplasmic reticulum membrane; C:photoreceptor inner segment; C:photoreceptor inner segment membrane;, F:11-cis-retinol dehydrogenase activity; F:NADP-retinol dehydrogenase activity; F:retinol dehydrogenase activity;, P:cellular detoxification of aldehyde; P:photoreceptor cell maintenance; P:retinoid metabolic process; P:retinol metabolic process; P:visual perception; scaffold37 indexed_genome mRNA 41317002 41381946 . - . ID=transcript_7795;Q8N4W7 Q96H43,Zinc finger FYVE domain-containing protein 26,FYVE domain-containing centrosomal protein;Spastizin;, PF01363;, GO:0005813;GO:0005765;GO:0030496;GO:0046872;GO:0032266;GO:0000724;GO:0000281;GO:0032465;, C:centrosome; C:lysosomal membrane; C:midbody;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:double-strand break repair via homologous recombination; P:mitotic cytokinesis; P:regulation of cytokinesis;|Q8N4W7 Q96H43,Zinc finger FYVE domain-containing protein 26,FYVE domain-containing centrosomal protein;Spastizin;, PF01363;, GO:0005813;GO:0005765;GO:0030496;GO:0046872;GO:0032266;GO:0000724;GO:0000281;GO:0032465;, C:centrosome; C:lysosomal membrane; C:midbody;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:double-strand break repair via homologous recombination; P:mitotic cytokinesis; P:regulation of cytokinesis; scaffold37 indexed_genome mRNA 42312552 42315862 . + . ID=transcript_7796;Q07352 Q13851,mRNA decay activator protein ZFP36L1 {ECO:0000305},Butyrate response factor 1 {ECO:0000303|PubMed:10367403, ECO:0000303|PubMed:12198173};EGF-response factor 1 {ECO:0000303|PubMed:8346037};TPA-induced sequence 11b {ECO:0000250|UniProtKB:P23950};Zinc finger protein 36, C3H1 type-like 1 {ECO:0000312|HGNC:HGNC:1107};, PF04553;PF00642;, GO:0005737;GO:0005829;GO:0005634;GO:0000932;GO:1990904;GO:0071889;GO:0003677;GO:0046872;GO:0035925;GO:0003729;GO:0003723;GO:0061158;GO:0006915;GO:0008283;GO:0071320;GO:0071364;GO:0044344;GO:0071385;GO:0071456;GO:0032869;GO:0071375;GO:0097403;GO:0071472;GO:0071560;GO:0071356;GO:0060710;GO:0070371;GO:0007507;GO:0000165;GO:0048382;GO:0006397;GO:0051028;GO:0035264;GO:0045647;GO:1901991;GO:0021915;GO:0000288;GO:0031086;GO:0038066;GO:0014065;GO:0045600;GO:1904582;GO:0045657;GO:1900153;GO:0003342;GO:0043491;GO:0045577;GO:0010468;GO:1902172;GO:0045616;GO:0010837;GO:0031440;GO:0043488;GO:0045661;GO:0072091;GO:0009611;GO:0060712;GO:0033077;GO:0001570;, C:cytoplasm; C:cytosol; C:nucleus; C:P-body; C:ribonucleoprotein complex;, F:14-3-3 protein binding; F:DNA binding; F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:apoptotic process; P:cell population proliferation; P:cellular response to cAMP; P:cellular response to epidermal growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to glucocorticoid stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to peptide hormone stimulus; P:cellular response to raffinose; P:cellular response to salt stress; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:chorio-allantoic fusion; P:ERK1 and ERK2 cascade; P:heart development; P:MAPK cascade; P:mesendoderm development; P:mRNA processing; P:mRNA transport; P:multicellular organism growth; P:negative regulation of erythrocyte differentiation; P:negative regulation of mitotic cell cycle phase transition; P:neural tube development; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:nuclear-transcribed mRNA catabolic process, deadenylation-independent decay; P:p38MAPK cascade; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of fat cell differentiation; P:positive regulation of intracellular mRNA localization; P:positive regulation of monocyte differentiation; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:proepicardium development; P:protein kinase B signaling; P:regulation of B cell differentiation; P:regulation of gene expression; P:regulation of keratinocyte apoptotic process; P:regulation of keratinocyte differentiation; P:regulation of keratinocyte proliferation; P:regulation of mRNA 3'-end processing; P:regulation of mRNA stability; P:regulation of myoblast differentiation; P:regulation of stem cell proliferation; P:response to wounding; P:spongiotrophoblast layer development; P:T cell differentiation in thymus; P:vasculogenesis; scaffold37 indexed_genome mRNA 42379092 42382367 . - . ID=transcript_7797;P12814 B3V8S3 B4DHH3 B7TY16 Q1HE25 Q9BTN1,Alpha-actinin-1,Alpha-actinin cytoskeletal isoform;F-actin cross-linking protein;Non-muscle alpha-actinin-1;, PF00307;PF08726;PF00435;, GO:0005903;GO:0042995;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005916;GO:0005925;GO:0098978;GO:0005886;GO:0031093;GO:0031143;GO:0001726;GO:0001725;GO:0030018;GO:0051015;GO:0005509;GO:0003725;GO:0005178;GO:0044325;GO:0030374;GO:0042803;GO:0099186;GO:0017166;GO:0051017;GO:0051639;GO:0007015;GO:0048041;GO:0051271;GO:0002576;GO:0030220;GO:0036344;GO:0042981;, C:brush border; C:cell projection; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fascia adherens; C:focal adhesion; C:glutamatergic synapse; C:plasma membrane; C:platelet alpha granule lumen; C:pseudopodium; C:ruffle; C:stress fiber; C:Z disc;, F:actin filament binding; F:calcium ion binding; F:double-stranded RNA binding; F:integrin binding; F:ion channel binding; F:nuclear receptor coactivator activity; F:protein homodimerization activity; F:structural constituent of postsynapse; F:vinculin binding;, P:actin filament bundle assembly; P:actin filament network formation; P:actin filament organization; P:focal adhesion assembly; P:negative regulation of cellular component movement; P:platelet degranulation; P:platelet formation; P:platelet morphogenesis; P:regulation of apoptotic process;|P12814 B3V8S3 B4DHH3 B7TY16 Q1HE25 Q9BTN1,Alpha-actinin-1,Alpha-actinin cytoskeletal isoform;F-actin cross-linking protein;Non-muscle alpha-actinin-1;, PF00307;PF08726;PF00435;, GO:0005903;GO:0042995;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005916;GO:0005925;GO:0098978;GO:0005886;GO:0031093;GO:0031143;GO:0001726;GO:0001725;GO:0030018;GO:0051015;GO:0005509;GO:0003725;GO:0005178;GO:0044325;GO:0030374;GO:0042803;GO:0099186;GO:0017166;GO:0051017;GO:0051639;GO:0007015;GO:0048041;GO:0051271;GO:0002576;GO:0030220;GO:0036344;GO:0042981;, C:brush border; C:cell projection; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fascia adherens; C:focal adhesion; C:glutamatergic synapse; C:plasma membrane; C:platelet alpha granule lumen; C:pseudopodium; C:ruffle; C:stress fiber; C:Z disc;, F:actin filament binding; F:calcium ion binding; F:double-stranded RNA binding; F:integrin binding; F:ion channel binding; F:nuclear receptor coactivator activity; F:protein homodimerization activity; F:structural constituent of postsynapse; F:vinculin binding;, P:actin filament bundle assembly; P:actin filament network formation; P:actin filament organization; P:focal adhesion assembly; P:negative regulation of cellular component movement; P:platelet degranulation; P:platelet formation; P:platelet morphogenesis; P:regulation of apoptotic process; scaffold37 indexed_genome mRNA 42382376 42384342 . + . ID=transcript_7798;P12814 B3V8S3 B4DHH3 B7TY16 Q1HE25 Q9BTN1,Alpha-actinin-1,Alpha-actinin cytoskeletal isoform;F-actin cross-linking protein;Non-muscle alpha-actinin-1;, PF00307;PF08726;PF00435;, GO:0005903;GO:0042995;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005916;GO:0005925;GO:0098978;GO:0005886;GO:0031093;GO:0031143;GO:0001726;GO:0001725;GO:0030018;GO:0051015;GO:0005509;GO:0003725;GO:0005178;GO:0044325;GO:0030374;GO:0042803;GO:0099186;GO:0017166;GO:0051017;GO:0051639;GO:0007015;GO:0048041;GO:0051271;GO:0002576;GO:0030220;GO:0036344;GO:0042981;, C:brush border; C:cell projection; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fascia adherens; C:focal adhesion; C:glutamatergic synapse; C:plasma membrane; C:platelet alpha granule lumen; C:pseudopodium; C:ruffle; C:stress fiber; C:Z disc;, F:actin filament binding; F:calcium ion binding; F:double-stranded RNA binding; F:integrin binding; F:ion channel binding; F:nuclear receptor coactivator activity; F:protein homodimerization activity; F:structural constituent of postsynapse; F:vinculin binding;, P:actin filament bundle assembly; P:actin filament network formation; P:actin filament organization; P:focal adhesion assembly; P:negative regulation of cellular component movement; P:platelet degranulation; P:platelet formation; P:platelet morphogenesis; P:regulation of apoptotic process; scaffold37 indexed_genome mRNA 42553265 42621953 . - . ID=transcript_7799;Q96JK2 B2RN31 G3V4J7 O60559 Q8N3V3 Q8N3V5,DDB1- and CUL4-associated factor 5,Breakpoint cluster region protein 2;WD repeat-containing protein 22;, PF00400;, GO:0080008;GO:0005737;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q96JK2 B2RN31 G3V4J7 O60559 Q8N3V3 Q8N3V5,DDB1- and CUL4-associated factor 5,Breakpoint cluster region protein 2;WD repeat-containing protein 22;, PF00400;, GO:0080008;GO:0005737;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination; scaffold37 indexed_genome mRNA 42718251 42748031 . + . ID=transcript_7800;Q9NVH0 B4DIH6 G5E947 Q6AWB6 Q8N3D3,Exonuclease 3'-5' domain-containing protein 2 {ECO:0000303|PubMed:26807646},3'-5' exoribonuclease EXD2 {ECO:0000305};Exonuclease 3'-5' domain-like-containing protein 2 {ECO:0000303|PubMed:26807646};, PF01612;, GO:0005737;GO:0016021;GO:0045111;GO:0005759;GO:0005741;GO:0005739;GO:0005634;GO:0090734;GO:0008408;GO:0008296;GO:0000175;GO:0008852;GO:0000287;GO:0030145;GO:0003676;GO:0042803;GO:0008310;GO:0000729;GO:0006302;GO:0000724;GO:0090305;GO:0031297;, C:cytoplasm; C:integral component of membrane; C:intermediate filament cytoskeleton; C:mitochondrial matrix; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:site of DNA damage;, F:3'-5' exonuclease activity; F:3'-5'-exodeoxyribonuclease activity; F:3'-5'-exoribonuclease activity; F:exodeoxyribonuclease I activity; F:magnesium ion binding; F:manganese ion binding; F:nucleic acid binding; F:protein homodimerization activity; F:single-stranded DNA 3'-5' exodeoxyribonuclease activity;, P:DNA double-strand break processing; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:nucleic acid phosphodiester bond hydrolysis; P:replication fork processing;|Q9NVH0 B4DIH6 G5E947 Q6AWB6 Q8N3D3,Exonuclease 3'-5' domain-containing protein 2 {ECO:0000303|PubMed:26807646},3'-5' exoribonuclease EXD2 {ECO:0000305};Exonuclease 3'-5' domain-like-containing protein 2 {ECO:0000303|PubMed:26807646};, PF01612;, GO:0005737;GO:0016021;GO:0045111;GO:0005759;GO:0005741;GO:0005739;GO:0005634;GO:0090734;GO:0008408;GO:0008296;GO:0000175;GO:0008852;GO:0000287;GO:0030145;GO:0003676;GO:0042803;GO:0008310;GO:0000729;GO:0006302;GO:0000724;GO:0090305;GO:0031297;, C:cytoplasm; C:integral component of membrane; C:intermediate filament cytoskeleton; C:mitochondrial matrix; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:site of DNA damage;, F:3'-5' exonuclease activity; F:3'-5'-exodeoxyribonuclease activity; F:3'-5'-exoribonuclease activity; F:exodeoxyribonuclease I activity; F:magnesium ion binding; F:manganese ion binding; F:nucleic acid binding; F:protein homodimerization activity; F:single-stranded DNA 3'-5' exodeoxyribonuclease activity;, P:DNA double-strand break processing; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:nucleic acid phosphodiester bond hydrolysis; P:replication fork processing; scaffold37 indexed_genome mRNA 42766856 42866106 . + . ID=transcript_7801;Q8N428 Q4KMG3 Q58A55 Q9ULT9,Polypeptide N-acetylgalactosaminyltransferase 16,Polypeptide GalNAc transferase 16;Polypeptide GalNAc transferase-like protein 1;Polypeptide N-acetylgalactosaminyltransferase-like protein 1;Protein-UDP acetylgalactosaminyltransferase-like protein 1;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0018242;GO:0018243;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q8N428 Q4KMG3 Q58A55 Q9ULT9,Polypeptide N-acetylgalactosaminyltransferase 16,Polypeptide GalNAc transferase 16;Polypeptide GalNAc transferase-like protein 1;Polypeptide N-acetylgalactosaminyltransferase-like protein 1;Protein-UDP acetylgalactosaminyltransferase-like protein 1;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0018242;GO:0018243;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q8N428 Q4KMG3 Q58A55 Q9ULT9,Polypeptide N-acetylgalactosaminyltransferase 16,Polypeptide GalNAc transferase 16;Polypeptide GalNAc transferase-like protein 1;Polypeptide N-acetylgalactosaminyltransferase-like protein 1;Protein-UDP acetylgalactosaminyltransferase-like protein 1;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0018242;GO:0018243;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q8N428 Q4KMG3 Q58A55 Q9ULT9,Polypeptide N-acetylgalactosaminyltransferase 16,Polypeptide GalNAc transferase 16;Polypeptide GalNAc transferase-like protein 1;Polypeptide N-acetylgalactosaminyltransferase-like protein 1;Protein-UDP acetylgalactosaminyltransferase-like protein 1;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0018242;GO:0018243;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q8N428 Q4KMG3 Q58A55 Q9ULT9,Polypeptide N-acetylgalactosaminyltransferase 16,Polypeptide GalNAc transferase 16;Polypeptide GalNAc transferase-like protein 1;Polypeptide N-acetylgalactosaminyltransferase-like protein 1;Protein-UDP acetylgalactosaminyltransferase-like protein 1;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0018242;GO:0018243;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q8N428 Q4KMG3 Q58A55 Q9ULT9,Polypeptide N-acetylgalactosaminyltransferase 16,Polypeptide GalNAc transferase 16;Polypeptide GalNAc transferase-like protein 1;Polypeptide N-acetylgalactosaminyltransferase-like protein 1;Protein-UDP acetylgalactosaminyltransferase-like protein 1;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0018242;GO:0018243;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q8N428 Q4KMG3 Q58A55 Q9ULT9,Polypeptide N-acetylgalactosaminyltransferase 16,Polypeptide GalNAc transferase 16;Polypeptide GalNAc transferase-like protein 1;Polypeptide N-acetylgalactosaminyltransferase-like protein 1;Protein-UDP acetylgalactosaminyltransferase-like protein 1;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0018242;GO:0018243;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine; scaffold37 indexed_genome mRNA 42891583 42896789 . - . ID=transcript_7802;P84090 B2R5H2 P70659 Q14259,Enhancer of rudimentary homolog,, PF01133;, GO:0034709;GO:0030496;GO:0005634;GO:0008327;GO:0003723;GO:0007049;GO:0006139;GO:0006213;, C:methylosome; C:midbody; C:nucleus;, F:methyl-CpG binding; F:RNA binding;, P:cell cycle; P:nucleobase-containing compound metabolic process; P:pyrimidine nucleoside metabolic process;|P84090 B2R5H2 P70659 Q14259,Enhancer of rudimentary homolog,, PF01133;, GO:0034709;GO:0030496;GO:0005634;GO:0008327;GO:0003723;GO:0007049;GO:0006139;GO:0006213;, C:methylosome; C:midbody; C:nucleus;, F:methyl-CpG binding; F:RNA binding;, P:cell cycle; P:nucleobase-containing compound metabolic process; P:pyrimidine nucleoside metabolic process; scaffold37 indexed_genome mRNA 42905379 42946612 . + . ID=transcript_7803;Q9NUM3 G3V5J8 Q53HN3 Q5MJQ0 Q6P2Q1 Q86WY2,Zinc transporter ZIP9,Solute carrier family 39 member 9;Zrt- and Irt-like protein 9;, PF02535;, GO:0016021;GO:0046873;GO:0006829;, C:integral component of membrane;, F:metal ion transmembrane transporter activity;, P:zinc ion transport;|Q9NUM3 G3V5J8 Q53HN3 Q5MJQ0 Q6P2Q1 Q86WY2,Zinc transporter ZIP9,Solute carrier family 39 member 9;Zrt- and Irt-like protein 9;, PF02535;, GO:0016021;GO:0046873;GO:0006829;, C:integral component of membrane;, F:metal ion transmembrane transporter activity;, P:zinc ion transport; scaffold37 indexed_genome mRNA 42977822 42988683 . + . ID=transcript_7804;A6NEE1 B9EJC2,Pleckstrin homology domain-containing family D member 1,, PF00169;|A6NEE1 B9EJC2,Pleckstrin homology domain-containing family D member 1,, PF00169; scaffold37 indexed_genome mRNA 42988797 42996838 . + . ID=transcript_7805;A6NEE1 B9EJC2,Pleckstrin homology domain-containing family D member 1,, PF00169; scaffold37 indexed_genome mRNA 43026176 43027636 . - . ID=transcript_7806;Q9NQR7 B2R5G1 Q2M359,Coiled-coil domain-containing protein 177,Myelin proteolipid protein-like protein;, PF15558; scaffold37 indexed_genome mRNA 43068495 43157671 . + . ID=transcript_7807;Q92537,Sushi domain-containing protein 6 {ECO:0000312|HGNC:HGNC:19956},Drug-activated gene overexpressed protein {ECO:0000303|PubMed:24652652};, PF00084;, GO:0016021;GO:0008219;GO:0006974;, C:integral component of membrane;, , P:cell death; P:cellular response to DNA damage stimulus;|Q92537,Sushi domain-containing protein 6 {ECO:0000312|HGNC:HGNC:19956},Drug-activated gene overexpressed protein {ECO:0000303|PubMed:24652652};, PF00084;, GO:0016021;GO:0008219;GO:0006974;, C:integral component of membrane;, , P:cell death; P:cellular response to DNA damage stimulus;|Q92537,Sushi domain-containing protein 6 {ECO:0000312|HGNC:HGNC:19956},Drug-activated gene overexpressed protein {ECO:0000303|PubMed:24652652};, PF00084;, GO:0016021;GO:0008219;GO:0006974;, C:integral component of membrane;, , P:cell death; P:cellular response to DNA damage stimulus;|Q92537,Sushi domain-containing protein 6 {ECO:0000312|HGNC:HGNC:19956},Drug-activated gene overexpressed protein {ECO:0000303|PubMed:24652652};, PF00084;, GO:0016021;GO:0008219;GO:0006974;, C:integral component of membrane;, , P:cell death; P:cellular response to DNA damage stimulus; scaffold37 indexed_genome mRNA 43213014 43219917 . + . ID=transcript_7808;Q13243 O14797 Q16662 Q49AD6 Q6FGE0,Serine/arginine-rich splicing factor 5,Delayed-early protein HRS;Pre-mRNA-splicing factor SRP40;Splicing factor, arginine/serine-rich 5;, PF00076;, GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0003729;GO:0043422;GO:0003723;GO:0032869;GO:0097421;GO:0031124;GO:0006406;GO:0006397;GO:0006376;GO:0000398;GO:0033120;GO:0051726;GO:0006405;, C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:mRNA binding; F:protein kinase B binding; F:RNA binding;, P:cellular response to insulin stimulus; P:liver regeneration; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:positive regulation of RNA splicing; P:regulation of cell cycle; P:RNA export from nucleus;|Q13243 O14797 Q16662 Q49AD6 Q6FGE0,Serine/arginine-rich splicing factor 5,Delayed-early protein HRS;Pre-mRNA-splicing factor SRP40;Splicing factor, arginine/serine-rich 5;, PF00076;, GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0003729;GO:0043422;GO:0003723;GO:0032869;GO:0097421;GO:0031124;GO:0006406;GO:0006397;GO:0006376;GO:0000398;GO:0033120;GO:0051726;GO:0006405;, C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:mRNA binding; F:protein kinase B binding; F:RNA binding;, P:cellular response to insulin stimulus; P:liver regeneration; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:positive regulation of RNA splicing; P:regulation of cell cycle; P:RNA export from nucleus;|Q13243 O14797 Q16662 Q49AD6 Q6FGE0,Serine/arginine-rich splicing factor 5,Delayed-early protein HRS;Pre-mRNA-splicing factor SRP40;Splicing factor, arginine/serine-rich 5;, PF00076;, GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0003729;GO:0043422;GO:0003723;GO:0032869;GO:0097421;GO:0031124;GO:0006406;GO:0006397;GO:0006376;GO:0000398;GO:0033120;GO:0051726;GO:0006405;, C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:mRNA binding; F:protein kinase B binding; F:RNA binding;, P:cellular response to insulin stimulus; P:liver regeneration; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:positive regulation of RNA splicing; P:regulation of cell cycle; P:RNA export from nucleus; scaffold37 indexed_genome mRNA 43219954 43243450 . - . ID=transcript_7809;Q14973 B9EGB6 Q2TU29,Sodium/bile acid cotransporter,Cell growth-inhibiting gene 29 protein;Na(+)/bile acid cotransporter;Na(+)/taurocholate transport protein;Sodium/taurocholate cotransporting polypeptide;Solute carrier family 10 member 1;, PF01758;, GO:0016323;GO:0005887;GO:0005886;GO:0008508;GO:0001618;GO:0015721;GO:0038183;GO:0035690;GO:0120188;GO:0010468;GO:1904486;GO:0045471;GO:0031667;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid:sodium symporter activity; F:virus receptor activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cellular response to drug; P:regulation of bile acid secretion; P:regulation of gene expression; P:response to 17alpha-ethynylestradiol; P:response to ethanol; P:response to nutrient levels;|Q14973 B9EGB6 Q2TU29,Sodium/bile acid cotransporter,Cell growth-inhibiting gene 29 protein;Na(+)/bile acid cotransporter;Na(+)/taurocholate transport protein;Sodium/taurocholate cotransporting polypeptide;Solute carrier family 10 member 1;, PF01758;, GO:0016323;GO:0005887;GO:0005886;GO:0008508;GO:0001618;GO:0015721;GO:0038183;GO:0035690;GO:0120188;GO:0010468;GO:1904486;GO:0045471;GO:0031667;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid:sodium symporter activity; F:virus receptor activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cellular response to drug; P:regulation of bile acid secretion; P:regulation of gene expression; P:response to 17alpha-ethynylestradiol; P:response to ethanol; P:response to nutrient levels;|Q14973 B9EGB6 Q2TU29,Sodium/bile acid cotransporter,Cell growth-inhibiting gene 29 protein;Na(+)/bile acid cotransporter;Na(+)/taurocholate transport protein;Sodium/taurocholate cotransporting polypeptide;Solute carrier family 10 member 1;, PF01758;, GO:0016323;GO:0005887;GO:0005886;GO:0008508;GO:0001618;GO:0015721;GO:0038183;GO:0035690;GO:0120188;GO:0010468;GO:1904486;GO:0045471;GO:0031667;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid:sodium symporter activity; F:virus receptor activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cellular response to drug; P:regulation of bile acid secretion; P:regulation of gene expression; P:response to 17alpha-ethynylestradiol; P:response to ethanol; P:response to nutrient levels;|Q14973 B9EGB6 Q2TU29,Sodium/bile acid cotransporter,Cell growth-inhibiting gene 29 protein;Na(+)/bile acid cotransporter;Na(+)/taurocholate transport protein;Sodium/taurocholate cotransporting polypeptide;Solute carrier family 10 member 1;, PF01758;, GO:0016323;GO:0005887;GO:0005886;GO:0008508;GO:0001618;GO:0015721;GO:0038183;GO:0035690;GO:0120188;GO:0010468;GO:1904486;GO:0045471;GO:0031667;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:bile acid:sodium symporter activity; F:virus receptor activity;, P:bile acid and bile salt transport; P:bile acid signaling pathway; P:cellular response to drug; P:regulation of bile acid secretion; P:regulation of gene expression; P:response to 17alpha-ethynylestradiol; P:response to ethanol; P:response to nutrient levels; scaffold37 indexed_genome mRNA 43244553 43245190 . + . ID=transcript_7810;O76003 B3KMP7 B3KMQ5 D3DRG2 Q5JV01 Q96CE0 Q9P1B0 Q9P1B1,Glutaredoxin-3,PKC-interacting cousin of thioredoxin {ECO:0000303|PubMed:10636891};PKC-theta-interacting protein;Thioredoxin-like protein 2;, PF00462;PF00085;, GO:0005938;GO:0005829;GO:0030425;GO:0005634;GO:0030018;GO:0042802;GO:0051536;GO:0046872;GO:0015035;GO:0005080;GO:0003723;GO:0044571;GO:0006879;GO:0010614;GO:0097428;GO:0002026;, C:cell cortex; C:cytosol; C:dendrite; C:nucleus; C:Z disc;, F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:protein disulfide oxidoreductase activity; F:protein kinase C binding; F:RNA binding;, P:[2Fe-2S] cluster assembly; P:cellular iron ion homeostasis; P:negative regulation of cardiac muscle hypertrophy; P:protein maturation by iron-sulfur cluster transfer; P:regulation of the force of heart contraction; scaffold37 indexed_genome mRNA 43309496 43449340 . + . ID=transcript_7811;Q9H4F8 A8K1S3 B2R7P5 Q96F78,SPARC-related modular calcium-binding protein 1,Secreted modular calcium-binding protein 1;, PF07648;PF10591;PF00086;, GO:0005604;GO:0005615;GO:0005509;GO:0050840;GO:0008201;GO:0030154;GO:0030198;GO:0001654;GO:0060173;GO:0045667;, C:basement membrane; C:extracellular space;, F:calcium ion binding; F:extracellular matrix binding; F:heparin binding;, P:cell differentiation; P:extracellular matrix organization; P:eye development; P:limb development; P:regulation of osteoblast differentiation;|Q9H4F8 A8K1S3 B2R7P5 Q96F78,SPARC-related modular calcium-binding protein 1,Secreted modular calcium-binding protein 1;, PF07648;PF10591;PF00086;, GO:0005604;GO:0005615;GO:0005509;GO:0050840;GO:0008201;GO:0030154;GO:0030198;GO:0001654;GO:0060173;GO:0045667;, C:basement membrane; C:extracellular space;, F:calcium ion binding; F:extracellular matrix binding; F:heparin binding;, P:cell differentiation; P:extracellular matrix organization; P:eye development; P:limb development; P:regulation of osteoblast differentiation;|Q9H4F8 A8K1S3 B2R7P5 Q96F78,SPARC-related modular calcium-binding protein 1,Secreted modular calcium-binding protein 1;, PF07648;PF10591;PF00086;, GO:0005604;GO:0005615;GO:0005509;GO:0050840;GO:0008201;GO:0030154;GO:0030198;GO:0001654;GO:0060173;GO:0045667;, C:basement membrane; C:extracellular space;, F:calcium ion binding; F:extracellular matrix binding; F:heparin binding;, P:cell differentiation; P:extracellular matrix organization; P:eye development; P:limb development; P:regulation of osteoblast differentiation;|Q9H4F8 A8K1S3 B2R7P5 Q96F78,SPARC-related modular calcium-binding protein 1,Secreted modular calcium-binding protein 1;, PF07648;PF10591;PF00086;, GO:0005604;GO:0005615;GO:0005509;GO:0050840;GO:0008201;GO:0030154;GO:0030198;GO:0001654;GO:0060173;GO:0045667;, C:basement membrane; C:extracellular space;, F:calcium ion binding; F:extracellular matrix binding; F:heparin binding;, P:cell differentiation; P:extracellular matrix organization; P:eye development; P:limb development; P:regulation of osteoblast differentiation; scaffold37 indexed_genome mRNA 43472240 43608989 . - . ID=transcript_7812;P57103 Q5K3P6 Q5K3P7 Q8IUE9 Q8IUF0 Q8NFI7 Q96QG1 Q96QG2,Sodium/calcium exchanger 3,Na(+)/Ca(2+)-exchange protein 3;Solute carrier family 8 member 3;, PF03160;PF01699;PF16494;, GO:0030424;GO:0043679;GO:0030425;GO:0043197;GO:0005789;GO:0005887;GO:0099055;GO:0031226;GO:0016020;GO:0005874;GO:0005741;GO:0031594;GO:0043025;GO:0043204;GO:0048471;GO:0005886;GO:0098794;GO:0014069;GO:0042383;GO:0016528;GO:0045202;GO:1905060;GO:0005432;GO:0005516;GO:0015491;GO:0099580;GO:0046872;GO:1990034;GO:0098703;GO:0070588;GO:0007154;GO:0006874;GO:0071320;GO:0071456;GO:0002244;GO:0006811;GO:0007612;GO:0007611;GO:0060291;GO:0007613;GO:0030001;GO:0051560;GO:0006851;GO:0098815;GO:0042552;GO:0071901;GO:0048709;GO:1903779;GO:0014819;GO:0035725;GO:0050808;GO:0021537;, C:axon; C:axon terminus; C:dendrite; C:dendritic spine; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:intrinsic component of plasma membrane; C:membrane; C:microtubule; C:mitochondrial outer membrane; C:neuromuscular junction; C:neuronal cell body; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:sarcolemma; C:sarcoplasm; C:synapse;, F:calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium:sodium antiporter activity; F:calmodulin binding; F:cation:cation antiporter activity; F:ion antiporter activity involved in regulation of postsynaptic membrane potential; F:metal ion binding;, P:calcium ion export across plasma membrane; P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:cell communication; P:cellular calcium ion homeostasis; P:cellular response to cAMP; P:cellular response to hypoxia; P:hematopoietic progenitor cell differentiation; P:ion transport; P:learning; P:learning or memory; P:long-term synaptic potentiation; P:memory; P:metal ion transport; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:modulation of excitatory postsynaptic potential; P:myelination; P:negative regulation of protein serine/threonine kinase activity; P:oligodendrocyte differentiation; P:regulation of cardiac conduction; P:regulation of skeletal muscle contraction; P:sodium ion transmembrane transport; P:synapse organization; P:telencephalon development; scaffold37 indexed_genome mRNA 43684117 43685833 . + . ID=transcript_7813;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold37 indexed_genome mRNA 43740278 43762080 . + . ID=transcript_7814;Q9P0S2 A6NDT5 A8K3X8 B8XYC5,Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial {ECO:0000305},, PF14138;, GO:0031305;GO:0033617;, C:integral component of mitochondrial inner membrane;, , P:mitochondrial cytochrome c oxidase assembly;|Q9P0S2 A6NDT5 A8K3X8 B8XYC5,Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial {ECO:0000305},, PF14138;, GO:0031305;GO:0033617;, C:integral component of mitochondrial inner membrane;, , P:mitochondrial cytochrome c oxidase assembly;|Q8WWW3 Q8WWW4 Q8WWW5 Q8WXH1 Q9NU50 Q9UFQ4 Q9Y2L4 Q9Y4R1,Nesprin-2,KASH domain-containing protein 2;Nuclear envelope spectrin repeat protein 2;Nucleus and actin connecting element protein;Synaptic nuclear envelope protein 2;, PF00307;PF10541;PF00435;, GO:0005737;GO:0070062;GO:0031527;GO:0005925;GO:0016021;GO:0045111;GO:0031258;GO:0034993;GO:0005739;GO:0005635;GO:0031981;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0016529;GO:0033017;GO:0030018;GO:0003779;GO:0051015;GO:0140444;GO:0051642;GO:0007097;GO:0031022;GO:0021817;GO:0030335;GO:1902017;, C:cytoplasm; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of membrane; C:intermediate filament cytoskeleton; C:lamellipodium membrane; C:meiotic nuclear membrane microtubule tethering complex; C:mitochondrion; C:nuclear envelope; C:nuclear lumen; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:Z disc;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity;, P:centrosome localization; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; P:regulation of cilium assembly;|Q9P0S2 A6NDT5 A8K3X8 B8XYC5,Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial {ECO:0000305},, PF14138;, GO:0031305;GO:0033617;, C:integral component of mitochondrial inner membrane;, , P:mitochondrial cytochrome c oxidase assembly; scaffold37 indexed_genome mRNA 43874486 43889212 . - . ID=transcript_7815;O75586 B4DU17 B4E2P0 O15401 Q53FE3 Q53HJ3 Q6FHQ4 Q9BTH1 Q9UHL1,Mediator of RNA polymerase II transcription subunit 6,Activator-recruited cofactor 33 kDa component;Mediator complex subunit 6;Renal carcinoma antigen NY-REN-28;, PF04934;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0003713;GO:0008134;GO:0045944;GO:0006357;GO:0060260;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity; F:transcription factor binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|O75586 B4DU17 B4E2P0 O15401 Q53FE3 Q53HJ3 Q6FHQ4 Q9BTH1 Q9UHL1,Mediator of RNA polymerase II transcription subunit 6,Activator-recruited cofactor 33 kDa component;Mediator complex subunit 6;Renal carcinoma antigen NY-REN-28;, PF04934;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0003713;GO:0008134;GO:0045944;GO:0006357;GO:0060260;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity; F:transcription factor binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|P25787 Q6ICS6 Q9BU45,Proteasome subunit alpha type-2,Macropain subunit C3;Multicatalytic endopeptidase complex subunit C3;Proteasome component C3;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000932;GO:0000502;GO:0005839;GO:0019773;GO:0034774;GO:0004175;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0009615;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex; C:secretory granule lumen;, F:endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to virus; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|O75586 B4DU17 B4E2P0 O15401 Q53FE3 Q53HJ3 Q6FHQ4 Q9BTH1 Q9UHL1,Mediator of RNA polymerase II transcription subunit 6,Activator-recruited cofactor 33 kDa component;Mediator complex subunit 6;Renal carcinoma antigen NY-REN-28;, PF04934;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0003713;GO:0008134;GO:0045944;GO:0006357;GO:0060260;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity; F:transcription factor binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|O75586 B4DU17 B4E2P0 O15401 Q53FE3 Q53HJ3 Q6FHQ4 Q9BTH1 Q9UHL1,Mediator of RNA polymerase II transcription subunit 6,Activator-recruited cofactor 33 kDa component;Mediator complex subunit 6;Renal carcinoma antigen NY-REN-28;, PF04934;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0003713;GO:0008134;GO:0045944;GO:0006357;GO:0060260;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity; F:transcription factor binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; scaffold37 indexed_genome mRNA 43945802 43981772 . + . ID=transcript_7816;Q92623 Q86WT2,Tetratricopeptide repeat protein 9A,, PF07719; scaffold37 indexed_genome mRNA 44031421 44060774 . - . ID=transcript_7817;P80192 A3KN85 Q0D2G7 Q6EH31 Q9H2N5,Mitogen-activated protein kinase kinase kinase 9,Mixed lineage kinase 1;, PF00069;PF14604;, GO:0005524;GO:0004706;GO:0004708;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006915;GO:0043065;GO:0046777;GO:0006468;, , F:ATP binding; F:JUN kinase kinase kinase activity; F:MAP kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:apoptotic process; P:positive regulation of apoptotic process; P:protein autophosphorylation; P:protein phosphorylation;|P80192 A3KN85 Q0D2G7 Q6EH31 Q9H2N5,Mitogen-activated protein kinase kinase kinase 9,Mixed lineage kinase 1;, PF00069;PF14604;, GO:0005524;GO:0004706;GO:0004708;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006915;GO:0043065;GO:0046777;GO:0006468;, , F:ATP binding; F:JUN kinase kinase kinase activity; F:MAP kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:apoptotic process; P:positive regulation of apoptotic process; P:protein autophosphorylation; P:protein phosphorylation;|P80192 A3KN85 Q0D2G7 Q6EH31 Q9H2N5,Mitogen-activated protein kinase kinase kinase 9,Mixed lineage kinase 1;, PF00069;PF14604;, GO:0005524;GO:0004706;GO:0004708;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006915;GO:0043065;GO:0046777;GO:0006468;, , F:ATP binding; F:JUN kinase kinase kinase activity; F:MAP kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:apoptotic process; P:positive regulation of apoptotic process; P:protein autophosphorylation; P:protein phosphorylation;|P80192 A3KN85 Q0D2G7 Q6EH31 Q9H2N5,Mitogen-activated protein kinase kinase kinase 9,Mixed lineage kinase 1;, PF00069;PF14604;, GO:0005524;GO:0004706;GO:0004708;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006915;GO:0043065;GO:0046777;GO:0006468;, , F:ATP binding; F:JUN kinase kinase kinase activity; F:MAP kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:apoptotic process; P:positive regulation of apoptotic process; P:protein autophosphorylation; P:protein phosphorylation; scaffold38 indexed_genome mRNA 39198 65549 . + . ID=transcript_7818;Q9NYH8,DnaJ homolog subfamily A member 3, mitochondrial,DnaJ protein Tid-1;Hepatocellular carcinoma-associated antigen 57;Tumorous imaginal discs protein Tid56 homolog;, PF00226;PF01556;PF00684;, GO:0005737;GO:0005829;GO:0019897;GO:0043231;GO:0005759;GO:0042645;GO:0005739;GO:0031594;GO:0005634;GO:0045211;GO:0005524;GO:0030695;GO:0030544;GO:0106137;GO:0005133;GO:0046872;GO:0051059;GO:0019901;GO:0044877;GO:0008134;GO:0051082;GO:0006919;GO:0006924;GO:0007569;GO:0006264;GO:0007005;GO:0043066;GO:0008285;GO:0043154;GO:0043124;GO:0060336;GO:0032088;GO:0043069;GO:0006469;GO:0000122;GO:0007528;GO:0043065;GO:0031398;GO:0042102;GO:0006457;GO:0050821;GO:0042981;GO:0009408;GO:0034341;GO:0071340;GO:0007264;GO:0033077;, C:cytoplasm; C:cytosol; C:extrinsic component of plasma membrane; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:neuromuscular junction; C:nucleus; C:postsynaptic membrane;, F:ATP binding; F:GTPase regulator activity; F:Hsp70 protein binding; F:IkappaB kinase complex binding; F:interferon-gamma receptor binding; F:metal ion binding; F:NF-kappaB binding; F:protein kinase binding; F:protein-containing complex binding; F:transcription factor binding; F:unfolded protein binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation-induced cell death of T cells; P:cell aging; P:mitochondrial DNA replication; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of programmed cell death; P:negative regulation of protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of protein ubiquitination; P:positive regulation of T cell proliferation; P:protein folding; P:protein stabilization; P:regulation of apoptotic process; P:response to heat; P:response to interferon-gamma; P:skeletal muscle acetylcholine-gated channel clustering; P:small GTPase mediated signal transduction; P:T cell differentiation in thymus;|Q9NYH8,DnaJ homolog subfamily A member 3, mitochondrial,DnaJ protein Tid-1;Hepatocellular carcinoma-associated antigen 57;Tumorous imaginal discs protein Tid56 homolog;, PF00226;PF01556;PF00684;, GO:0005737;GO:0005829;GO:0019897;GO:0043231;GO:0005759;GO:0042645;GO:0005739;GO:0031594;GO:0005634;GO:0045211;GO:0005524;GO:0030695;GO:0030544;GO:0106137;GO:0005133;GO:0046872;GO:0051059;GO:0019901;GO:0044877;GO:0008134;GO:0051082;GO:0006919;GO:0006924;GO:0007569;GO:0006264;GO:0007005;GO:0043066;GO:0008285;GO:0043154;GO:0043124;GO:0060336;GO:0032088;GO:0043069;GO:0006469;GO:0000122;GO:0007528;GO:0043065;GO:0031398;GO:0042102;GO:0006457;GO:0050821;GO:0042981;GO:0009408;GO:0034341;GO:0071340;GO:0007264;GO:0033077;, C:cytoplasm; C:cytosol; C:extrinsic component of plasma membrane; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:neuromuscular junction; C:nucleus; C:postsynaptic membrane;, F:ATP binding; F:GTPase regulator activity; F:Hsp70 protein binding; F:IkappaB kinase complex binding; F:interferon-gamma receptor binding; F:metal ion binding; F:NF-kappaB binding; F:protein kinase binding; F:protein-containing complex binding; F:transcription factor binding; F:unfolded protein binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation-induced cell death of T cells; P:cell aging; P:mitochondrial DNA replication; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of programmed cell death; P:negative regulation of protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of protein ubiquitination; P:positive regulation of T cell proliferation; P:protein folding; P:protein stabilization; P:regulation of apoptotic process; P:response to heat; P:response to interferon-gamma; P:skeletal muscle acetylcholine-gated channel clustering; P:small GTPase mediated signal transduction; P:T cell differentiation in thymus;|Q9NYH8,DnaJ homolog subfamily A member 3, mitochondrial,DnaJ protein Tid-1;Hepatocellular carcinoma-associated antigen 57;Tumorous imaginal discs protein Tid56 homolog;, PF00226;PF01556;PF00684;, GO:0005737;GO:0005829;GO:0019897;GO:0043231;GO:0005759;GO:0042645;GO:0005739;GO:0031594;GO:0005634;GO:0045211;GO:0005524;GO:0030695;GO:0030544;GO:0106137;GO:0005133;GO:0046872;GO:0051059;GO:0019901;GO:0044877;GO:0008134;GO:0051082;GO:0006919;GO:0006924;GO:0007569;GO:0006264;GO:0007005;GO:0043066;GO:0008285;GO:0043154;GO:0043124;GO:0060336;GO:0032088;GO:0043069;GO:0006469;GO:0000122;GO:0007528;GO:0043065;GO:0031398;GO:0042102;GO:0006457;GO:0050821;GO:0042981;GO:0009408;GO:0034341;GO:0071340;GO:0007264;GO:0033077;, C:cytoplasm; C:cytosol; C:extrinsic component of plasma membrane; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:neuromuscular junction; C:nucleus; C:postsynaptic membrane;, F:ATP binding; F:GTPase regulator activity; F:Hsp70 protein binding; F:IkappaB kinase complex binding; F:interferon-gamma receptor binding; F:metal ion binding; F:NF-kappaB binding; F:protein kinase binding; F:protein-containing complex binding; F:transcription factor binding; F:unfolded protein binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation-induced cell death of T cells; P:cell aging; P:mitochondrial DNA replication; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of programmed cell death; P:negative regulation of protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of protein ubiquitination; P:positive regulation of T cell proliferation; P:protein folding; P:protein stabilization; P:regulation of apoptotic process; P:response to heat; P:response to interferon-gamma; P:skeletal muscle acetylcholine-gated channel clustering; P:small GTPase mediated signal transduction; P:T cell differentiation in thymus; scaffold38 indexed_genome mRNA 65650 68851 . - . ID=transcript_7819;Q9NYH8,DnaJ homolog subfamily A member 3, mitochondrial,DnaJ protein Tid-1;Hepatocellular carcinoma-associated antigen 57;Tumorous imaginal discs protein Tid56 homolog;, PF00226;PF01556;PF00684;, GO:0005737;GO:0005829;GO:0019897;GO:0043231;GO:0005759;GO:0042645;GO:0005739;GO:0031594;GO:0005634;GO:0045211;GO:0005524;GO:0030695;GO:0030544;GO:0106137;GO:0005133;GO:0046872;GO:0051059;GO:0019901;GO:0044877;GO:0008134;GO:0051082;GO:0006919;GO:0006924;GO:0007569;GO:0006264;GO:0007005;GO:0043066;GO:0008285;GO:0043154;GO:0043124;GO:0060336;GO:0032088;GO:0043069;GO:0006469;GO:0000122;GO:0007528;GO:0043065;GO:0031398;GO:0042102;GO:0006457;GO:0050821;GO:0042981;GO:0009408;GO:0034341;GO:0071340;GO:0007264;GO:0033077;, C:cytoplasm; C:cytosol; C:extrinsic component of plasma membrane; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:neuromuscular junction; C:nucleus; C:postsynaptic membrane;, F:ATP binding; F:GTPase regulator activity; F:Hsp70 protein binding; F:IkappaB kinase complex binding; F:interferon-gamma receptor binding; F:metal ion binding; F:NF-kappaB binding; F:protein kinase binding; F:protein-containing complex binding; F:transcription factor binding; F:unfolded protein binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation-induced cell death of T cells; P:cell aging; P:mitochondrial DNA replication; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of programmed cell death; P:negative regulation of protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of protein ubiquitination; P:positive regulation of T cell proliferation; P:protein folding; P:protein stabilization; P:regulation of apoptotic process; P:response to heat; P:response to interferon-gamma; P:skeletal muscle acetylcholine-gated channel clustering; P:small GTPase mediated signal transduction; P:T cell differentiation in thymus; scaffold38 indexed_genome mRNA 72264 78335 . - . ID=transcript_7820;Q9HBL8,NmrA-like family domain-containing protein 1,, PF05368;, GO:0005829;GO:0005654;GO:0048471;GO:0042802;GO:0000050;, C:cytosol; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:identical protein binding;, P:urea cycle;|Q9HBL8,NmrA-like family domain-containing protein 1,, PF05368;, GO:0005829;GO:0005654;GO:0048471;GO:0042802;GO:0000050;, C:cytosol; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:identical protein binding;, P:urea cycle; scaffold38 indexed_genome mRNA 108058 171864 . + . ID=transcript_7821;P30519 A8MT35 D3DUD5 I3L430 O60605,Heme oxygenase 2,, PF01126;, GO:0005789;GO:0016020;GO:0005886;GO:0035579;GO:0020037;GO:0004392;GO:0046872;GO:0006879;GO:0042167;GO:0006788;GO:0055072;GO:0043312;GO:0001666;GO:0006979;, C:endoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:specific granule membrane;, F:heme binding; F:heme oxygenase (decyclizing) activity; F:metal ion binding;, P:cellular iron ion homeostasis; P:heme catabolic process; P:heme oxidation; P:iron ion homeostasis; P:neutrophil degranulation; P:response to hypoxia; P:response to oxidative stress;|P30519 A8MT35 D3DUD5 I3L430 O60605,Heme oxygenase 2,, PF01126;, GO:0005789;GO:0016020;GO:0005886;GO:0035579;GO:0020037;GO:0004392;GO:0046872;GO:0006879;GO:0042167;GO:0006788;GO:0055072;GO:0043312;GO:0001666;GO:0006979;, C:endoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:specific granule membrane;, F:heme binding; F:heme oxygenase (decyclizing) activity; F:metal ion binding;, P:cellular iron ion homeostasis; P:heme catabolic process; P:heme oxidation; P:iron ion homeostasis; P:neutrophil degranulation; P:response to hypoxia; P:response to oxidative stress; scaffold38 indexed_genome mRNA 172840 198077 . + . ID=transcript_7822;A6NNT2 C9JH24,Uncharacterized protein C16orf96 {ECO:0000305},, PF16043;|A6NNT2 C9JH24,Uncharacterized protein C16orf96 {ECO:0000305},, PF16043;|A6NNT2 C9JH24,Uncharacterized protein C16orf96 {ECO:0000305},, PF16043; scaffold38 indexed_genome mRNA 203614 208044 . - . ID=transcript_7823;Q8TB05 Q71MF6,UBA-like domain-containing protein 1|Q8TB05 Q71MF6,UBA-like domain-containing protein 1 scaffold38 indexed_genome mRNA 226346 248386 . + . ID=transcript_7824;O60291 A4URL3 A4URL4 Q86W76,E3 ubiquitin-protein ligase MGRN1,Mahogunin RING finger protein 1;RING finger protein 156;RING-type E3 ubiquitin transferase MGRN1 {ECO:0000305};, , GO:0005737;GO:0005829;GO:0005769;GO:0005783;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0004842;GO:0008333;GO:0043951;GO:0045744;GO:0045879;GO:0006513;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:endosome to lysosome transport; P:negative regulation of cAMP-mediated signaling; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of smoothened signaling pathway; P:protein monoubiquitination; P:protein ubiquitination;|O60291 A4URL3 A4URL4 Q86W76,E3 ubiquitin-protein ligase MGRN1,Mahogunin RING finger protein 1;RING finger protein 156;RING-type E3 ubiquitin transferase MGRN1 {ECO:0000305};, , GO:0005737;GO:0005829;GO:0005769;GO:0005783;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0004842;GO:0008333;GO:0043951;GO:0045744;GO:0045879;GO:0006513;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:endosome to lysosome transport; P:negative regulation of cAMP-mediated signaling; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of smoothened signaling pathway; P:protein monoubiquitination; P:protein ubiquitination;|O60291 A4URL3 A4URL4 Q86W76,E3 ubiquitin-protein ligase MGRN1,Mahogunin RING finger protein 1;RING finger protein 156;RING-type E3 ubiquitin transferase MGRN1 {ECO:0000305};, , GO:0005737;GO:0005829;GO:0005769;GO:0005783;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0004842;GO:0008333;GO:0043951;GO:0045744;GO:0045879;GO:0006513;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:endosome to lysosome transport; P:negative regulation of cAMP-mediated signaling; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of smoothened signaling pathway; P:protein monoubiquitination; P:protein ubiquitination;|O60291 A4URL3 A4URL4 Q86W76,E3 ubiquitin-protein ligase MGRN1,Mahogunin RING finger protein 1;RING finger protein 156;RING-type E3 ubiquitin transferase MGRN1 {ECO:0000305};, , GO:0005737;GO:0005829;GO:0005769;GO:0005783;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0004842;GO:0008333;GO:0043951;GO:0045744;GO:0045879;GO:0006513;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:endosome to lysosome transport; P:negative regulation of cAMP-mediated signaling; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of smoothened signaling pathway; P:protein monoubiquitination; P:protein ubiquitination;|O60291 A4URL3 A4URL4 Q86W76,E3 ubiquitin-protein ligase MGRN1,Mahogunin RING finger protein 1;RING finger protein 156;RING-type E3 ubiquitin transferase MGRN1 {ECO:0000305};, , GO:0005737;GO:0005829;GO:0005769;GO:0005783;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0004842;GO:0008333;GO:0043951;GO:0045744;GO:0045879;GO:0006513;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:endosome to lysosome transport; P:negative regulation of cAMP-mediated signaling; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of smoothened signaling pathway; P:protein monoubiquitination; P:protein ubiquitination;|O60291 A4URL3 A4URL4 Q86W76,E3 ubiquitin-protein ligase MGRN1,Mahogunin RING finger protein 1;RING finger protein 156;RING-type E3 ubiquitin transferase MGRN1 {ECO:0000305};, , GO:0005737;GO:0005829;GO:0005769;GO:0005783;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0004842;GO:0008333;GO:0043951;GO:0045744;GO:0045879;GO:0006513;GO:0016567;, C:cytoplasm; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:endosome to lysosome transport; P:negative regulation of cAMP-mediated signaling; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of smoothened signaling pathway; P:protein monoubiquitination; P:protein ubiquitination; scaffold38 indexed_genome mRNA 266498 281806 . + . ID=transcript_7825;Q6ZW76 B4DWU4 D3DUE2 Q8TF25,Ankyrin repeat and SAM domain-containing protein 3,, PF12796;PF00536;, GO:0005929;GO:0005737;, C:cilium; C:cytoplasm;|Q6ZW76 B4DWU4 D3DUE2 Q8TF25,Ankyrin repeat and SAM domain-containing protein 3,, PF12796;PF00536;, GO:0005929;GO:0005737;, C:cilium; C:cytoplasm;|Q6ZW76 B4DWU4 D3DUE2 Q8TF25,Ankyrin repeat and SAM domain-containing protein 3,, PF12796;PF00536;, GO:0005929;GO:0005737;, C:cilium; C:cytoplasm;|Q6ZW76 B4DWU4 D3DUE2 Q8TF25,Ankyrin repeat and SAM domain-containing protein 3,, PF12796;PF00536;, GO:0005929;GO:0005737;, C:cilium; C:cytoplasm;|Q6ZW76 B4DWU4 D3DUE2 Q8TF25,Ankyrin repeat and SAM domain-containing protein 3,, PF12796;PF00536;, GO:0005929;GO:0005737;, C:cilium; C:cytoplasm;|Q6ZW76 B4DWU4 D3DUE2 Q8TF25,Ankyrin repeat and SAM domain-containing protein 3,, PF12796;PF00536;, GO:0005929;GO:0005737;, C:cilium; C:cytoplasm;|Q6ZW76 B4DWU4 D3DUE2 Q8TF25,Ankyrin repeat and SAM domain-containing protein 3,, PF12796;PF00536;, GO:0005929;GO:0005737;, C:cilium; C:cytoplasm;|Q6ZW76 B4DWU4 D3DUE2 Q8TF25,Ankyrin repeat and SAM domain-containing protein 3,, PF12796;PF00536;, GO:0005929;GO:0005737;, C:cilium; C:cytoplasm;|Q6ZW76 B4DWU4 D3DUE2 Q8TF25,Ankyrin repeat and SAM domain-containing protein 3,, PF12796;PF00536;, GO:0005929;GO:0005737;, C:cilium; C:cytoplasm; scaffold38 indexed_genome mRNA 284246 306195 . + . ID=transcript_7826;Q8IYS4 Q8NCV0,Dynein axonemal-associated protein 1 {ECO:0000305|PubMed:33263282},, PF15773;|Q8IYS4 Q8NCV0,Dynein axonemal-associated protein 1 {ECO:0000305|PubMed:33263282},, PF15773;|Q8IYS4 Q8NCV0,Dynein axonemal-associated protein 1 {ECO:0000305|PubMed:33263282},, PF15773;|Q8IYS4 Q8NCV0,Dynein axonemal-associated protein 1 {ECO:0000305|PubMed:33263282},, PF15773; scaffold38 indexed_genome mRNA 307894 311881 . - . ID=transcript_7827;O60304 A8K6X7 B4DNN9 Q0VAL2 Q96CQ8 Q9BTG0,Zinc finger protein 500,Zinc finger protein with KRAB and SCAN domains 18;, PF01352;PF02023;PF00096;, GO:0005829;GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold38 indexed_genome mRNA 312262 317139 . - . ID=transcript_7828;O60304 A8K6X7 B4DNN9 Q0VAL2 Q96CQ8 Q9BTG0,Zinc finger protein 500,Zinc finger protein with KRAB and SCAN domains 18;, PF01352;PF02023;PF00096;, GO:0005829;GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold38 indexed_genome mRNA 348086 349056 . + . ID=transcript_7829;Q9GZN7 Q6IA00,Protein rogdi homolog,, PF10259;, GO:0030424;GO:0030425;GO:0005635;GO:0043204;GO:0043291;GO:0008021;GO:0007420;GO:0030097;GO:0022008;GO:0042475;GO:0008284;, C:axon; C:dendrite; C:nuclear envelope; C:perikaryon; C:RAVE complex; C:synaptic vesicle;, , P:brain development; P:hemopoiesis; P:neurogenesis; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; scaffold38 indexed_genome mRNA 349189 352828 . - . ID=transcript_7830;Q9GZN7 Q6IA00,Protein rogdi homolog,, PF10259;, GO:0030424;GO:0030425;GO:0005635;GO:0043204;GO:0043291;GO:0008021;GO:0007420;GO:0030097;GO:0022008;GO:0042475;GO:0008284;, C:axon; C:dendrite; C:nuclear envelope; C:perikaryon; C:RAVE complex; C:synaptic vesicle;, , P:brain development; P:hemopoiesis; P:neurogenesis; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation;|Q9GZN7 Q6IA00,Protein rogdi homolog,, PF10259;, GO:0030424;GO:0030425;GO:0005635;GO:0043204;GO:0043291;GO:0008021;GO:0007420;GO:0030097;GO:0022008;GO:0042475;GO:0008284;, C:axon; C:dendrite; C:nuclear envelope; C:perikaryon; C:RAVE complex; C:synaptic vesicle;, , P:brain development; P:hemopoiesis; P:neurogenesis; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation;|Q9GZN7 Q6IA00,Protein rogdi homolog,, PF10259;, GO:0030424;GO:0030425;GO:0005635;GO:0043204;GO:0043291;GO:0008021;GO:0007420;GO:0030097;GO:0022008;GO:0042475;GO:0008284;, C:axon; C:dendrite; C:nuclear envelope; C:perikaryon; C:RAVE complex; C:synaptic vesicle;, , P:brain development; P:hemopoiesis; P:neurogenesis; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; scaffold38 indexed_genome mRNA 359062 381238 . - . ID=transcript_7831;Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II;|Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II; scaffold38 indexed_genome mRNA 386767 391180 . - . ID=transcript_7832;Q49A26 B4DL47 C9JJ40 C9JJ60 Q5U632 Q6P1Q2 Q6V3W7 Q9BTI1 Q9BXK2,Putative oxidoreductase GLYR1,3-hydroxyisobutyrate dehydrogenase-like protein;Cytokine-like nuclear factor N-PAC;Glyoxylate reductase 1 homolog;Nuclear protein NP60;Nuclear protein of 60 kDa;Nucleosome-destabilizing factor {ECO:0000303|PubMed:29759984};, PF14833;PF03446;PF00855;, GO:0005829;GO:0005654;GO:0000786;GO:0003682;GO:0003677;GO:0042393;GO:0035064;GO:0051287;GO:0050661;GO:0031491;GO:0016491;GO:0035066;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleosome;, F:chromatin binding; F:DNA binding; F:histone binding; F:methylated histone binding; F:NAD binding; F:NADP binding; F:nucleosome binding; F:oxidoreductase activity;, P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II; scaffold38 indexed_genome mRNA 391329 420566 . + . ID=transcript_7833;Q9NPG3 B7Z6D3 D3DUE8 Q13079 Q9P1P7,Ubinuclein-1,HIRA-binding protein;Protein VT4;Ubiquitously expressed nuclear protein;, PF08729;PF14075;, GO:0005923;GO:0034451;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0006336;GO:0016032;, C:bicellular tight junction; C:centriolar satellite; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding;, P:DNA replication-independent nucleosome assembly; P:viral process;|Q9NPG3 B7Z6D3 D3DUE8 Q13079 Q9P1P7,Ubinuclein-1,HIRA-binding protein;Protein VT4;Ubiquitously expressed nuclear protein;, PF08729;PF14075;, GO:0005923;GO:0034451;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0006336;GO:0016032;, C:bicellular tight junction; C:centriolar satellite; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding;, P:DNA replication-independent nucleosome assembly; P:viral process;|Q9NPG3 B7Z6D3 D3DUE8 Q13079 Q9P1P7,Ubinuclein-1,HIRA-binding protein;Protein VT4;Ubiquitously expressed nuclear protein;, PF08729;PF14075;, GO:0005923;GO:0034451;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0006336;GO:0016032;, C:bicellular tight junction; C:centriolar satellite; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding;, P:DNA replication-independent nucleosome assembly; P:viral process;|Q9NPG3 B7Z6D3 D3DUE8 Q13079 Q9P1P7,Ubinuclein-1,HIRA-binding protein;Protein VT4;Ubiquitously expressed nuclear protein;, PF08729;PF14075;, GO:0005923;GO:0034451;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0006336;GO:0016032;, C:bicellular tight junction; C:centriolar satellite; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding;, P:DNA replication-independent nucleosome assembly; P:viral process;|Q9NPG3 B7Z6D3 D3DUE8 Q13079 Q9P1P7,Ubinuclein-1,HIRA-binding protein;Protein VT4;Ubiquitously expressed nuclear protein;, PF08729;PF14075;, GO:0005923;GO:0034451;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0006336;GO:0016032;, C:bicellular tight junction; C:centriolar satellite; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding;, P:DNA replication-independent nucleosome assembly; P:viral process;|Q9NPG3 B7Z6D3 D3DUE8 Q13079 Q9P1P7,Ubinuclein-1,HIRA-binding protein;Protein VT4;Ubiquitously expressed nuclear protein;, PF08729;PF14075;, GO:0005923;GO:0034451;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0006336;GO:0016032;, C:bicellular tight junction; C:centriolar satellite; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding;, P:DNA replication-independent nucleosome assembly; P:viral process;|Q9NPG3 B7Z6D3 D3DUE8 Q13079 Q9P1P7,Ubinuclein-1,HIRA-binding protein;Protein VT4;Ubiquitously expressed nuclear protein;, PF08729;PF14075;, GO:0005923;GO:0034451;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0006336;GO:0016032;, C:bicellular tight junction; C:centriolar satellite; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding;, P:DNA replication-independent nucleosome assembly; P:viral process;|Q9NPG3 B7Z6D3 D3DUE8 Q13079 Q9P1P7,Ubinuclein-1,HIRA-binding protein;Protein VT4;Ubiquitously expressed nuclear protein;, PF08729;PF14075;, GO:0005923;GO:0034451;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0006336;GO:0016032;, C:bicellular tight junction; C:centriolar satellite; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding;, P:DNA replication-independent nucleosome assembly; P:viral process; scaffold38 indexed_genome mRNA 421937 472629 . - . ID=transcript_7834;O60437 O60314 O60454 Q14C98,Periplakin,190 kDa paraneoplastic pemphigus antigen;195 kDa cornified envelope precursor protein;, PF17902;, GO:0001533;GO:0005737;GO:0005856;GO:0005829;GO:0030057;GO:0070062;GO:0016020;GO:0005886;GO:0045296;GO:0005200;GO:0005198;GO:0002250;GO:0070268;GO:0045104;GO:0009612;GO:0042060;, C:cornified envelope; C:cytoplasm; C:cytoskeleton; C:cytosol; C:desmosome; C:extracellular exosome; C:membrane; C:plasma membrane;, F:cadherin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:adaptive immune response; P:cornification; P:intermediate filament cytoskeleton organization; P:response to mechanical stimulus; P:wound healing;|O60437 O60314 O60454 Q14C98,Periplakin,190 kDa paraneoplastic pemphigus antigen;195 kDa cornified envelope precursor protein;, PF17902;, GO:0001533;GO:0005737;GO:0005856;GO:0005829;GO:0030057;GO:0070062;GO:0016020;GO:0005886;GO:0045296;GO:0005200;GO:0005198;GO:0002250;GO:0070268;GO:0045104;GO:0009612;GO:0042060;, C:cornified envelope; C:cytoplasm; C:cytoskeleton; C:cytosol; C:desmosome; C:extracellular exosome; C:membrane; C:plasma membrane;, F:cadherin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:adaptive immune response; P:cornification; P:intermediate filament cytoskeleton organization; P:response to mechanical stimulus; P:wound healing;|O60437 O60314 O60454 Q14C98,Periplakin,190 kDa paraneoplastic pemphigus antigen;195 kDa cornified envelope precursor protein;, PF17902;, GO:0001533;GO:0005737;GO:0005856;GO:0005829;GO:0030057;GO:0070062;GO:0016020;GO:0005886;GO:0045296;GO:0005200;GO:0005198;GO:0002250;GO:0070268;GO:0045104;GO:0009612;GO:0042060;, C:cornified envelope; C:cytoplasm; C:cytoskeleton; C:cytosol; C:desmosome; C:extracellular exosome; C:membrane; C:plasma membrane;, F:cadherin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:adaptive immune response; P:cornification; P:intermediate filament cytoskeleton organization; P:response to mechanical stimulus; P:wound healing;|O60437 O60314 O60454 Q14C98,Periplakin,190 kDa paraneoplastic pemphigus antigen;195 kDa cornified envelope precursor protein;, PF17902;, GO:0001533;GO:0005737;GO:0005856;GO:0005829;GO:0030057;GO:0070062;GO:0016020;GO:0005886;GO:0045296;GO:0005200;GO:0005198;GO:0002250;GO:0070268;GO:0045104;GO:0009612;GO:0042060;, C:cornified envelope; C:cytoplasm; C:cytoskeleton; C:cytosol; C:desmosome; C:extracellular exosome; C:membrane; C:plasma membrane;, F:cadherin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:adaptive immune response; P:cornification; P:intermediate filament cytoskeleton organization; P:response to mechanical stimulus; P:wound healing;|O60437 O60314 O60454 Q14C98,Periplakin,190 kDa paraneoplastic pemphigus antigen;195 kDa cornified envelope precursor protein;, PF17902;, GO:0001533;GO:0005737;GO:0005856;GO:0005829;GO:0030057;GO:0070062;GO:0016020;GO:0005886;GO:0045296;GO:0005200;GO:0005198;GO:0002250;GO:0070268;GO:0045104;GO:0009612;GO:0042060;, C:cornified envelope; C:cytoplasm; C:cytoskeleton; C:cytosol; C:desmosome; C:extracellular exosome; C:membrane; C:plasma membrane;, F:cadherin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:adaptive immune response; P:cornification; P:intermediate filament cytoskeleton organization; P:response to mechanical stimulus; P:wound healing; scaffold38 indexed_genome mRNA 489974 512700 . - . ID=transcript_7835;O43304,SEC14-like protein 5,, PF00650;PF03765;PF04707; scaffold38 indexed_genome mRNA 519732 526502 . + . ID=transcript_7836;O43304,SEC14-like protein 5,, PF00650;PF03765;PF04707; scaffold38 indexed_genome mRNA 531178 539717 . - . ID=transcript_7837;Q9UK23 B2RAS1 Q96EJ8,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Mannose 6-phosphate-uncovering enzyme;Phosphodiester alpha-GlcNAcase;, PF09992;, GO:0032580;GO:0016021;GO:0003944;GO:0005975;GO:0006464;GO:0007040;GO:0006486;GO:0006622;GO:0033299;, C:Golgi cisterna membrane; C:integral component of membrane;, F:N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:lysosome organization; P:protein glycosylation; P:protein targeting to lysosome; P:secretion of lysosomal enzymes;|Q9UK23 B2RAS1 Q96EJ8,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Mannose 6-phosphate-uncovering enzyme;Phosphodiester alpha-GlcNAcase;, PF09992;, GO:0032580;GO:0016021;GO:0003944;GO:0005975;GO:0006464;GO:0007040;GO:0006486;GO:0006622;GO:0033299;, C:Golgi cisterna membrane; C:integral component of membrane;, F:N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:lysosome organization; P:protein glycosylation; P:protein targeting to lysosome; P:secretion of lysosomal enzymes;|Q9UK23 B2RAS1 Q96EJ8,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Mannose 6-phosphate-uncovering enzyme;Phosphodiester alpha-GlcNAcase;, PF09992;, GO:0032580;GO:0016021;GO:0003944;GO:0005975;GO:0006464;GO:0007040;GO:0006486;GO:0006622;GO:0033299;, C:Golgi cisterna membrane; C:integral component of membrane;, F:N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:lysosome organization; P:protein glycosylation; P:protein targeting to lysosome; P:secretion of lysosomal enzymes; scaffold38 indexed_genome mRNA 540563 555027 . - . ID=transcript_7838;Q6UX73 B4DUM5 Q8N2I3 Q8N4T1,UPF0764 protein C16orf89,, PF15882;, GO:0005829;GO:0070062;GO:0016020;GO:0042803;, C:cytosol; C:extracellular exosome; C:membrane;, F:protein homodimerization activity; scaffold38 indexed_genome mRNA 558680 561729 . + . ID=transcript_7839;Q9BT22 B4DP08 Q6UVZ9 Q8N5Y4 Q9P2Y2,Chitobiosyldiphosphodolichol beta-mannosyltransferase,Asparagine-linked glycosylation protein 1 homolog;Beta-1,4-mannosyltransferase;GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase;GDP-mannose-dolichol diphosphochitobiose mannosyltransferase;Mannosyltransferase-1;, PF00534;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0004578;GO:0000030;GO:0006488;GO:0006486;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:chitobiosyldiphosphodolichol beta-mannosyltransferase activity; F:mannosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein glycosylation; scaffold38 indexed_genome mRNA 568779 569528 . + . ID=transcript_7840;Q6GMV1 D3DNA5,Putative glycosyltransferase ALG1-like,, , GO:0005783;GO:0000030;GO:0006486;, C:endoplasmic reticulum;, F:mannosyltransferase activity;, P:protein glycosylation; scaffold38 indexed_genome mRNA 571839 583093 . - . ID=transcript_7841;Q96G04 D3DUF0 Q96S85,Protein-lysine N-methyltransferase EEF2KMT {ECO:0000305},eEF2-lysine methyltransferase;, PF14904;PF10294;, GO:0005737;GO:0005829;GO:0032991;GO:0016279;GO:0018023;GO:0006479;, C:cytoplasm; C:cytosol; C:protein-containing complex;, F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine trimethylation; P:protein methylation; scaffold38 indexed_genome mRNA 1788458 2927906 . + . ID=transcript_7842;Q9NWB1 Q7Z7I7 Q8TAE3 Q8TAF2 Q8WYB2 Q9NS20,RNA binding protein fox-1 homolog 1,Ataxin-2-binding protein 1;Fox-1 homolog A;Hexaribonucleotide-binding protein 1;, PF12414;PF00076;, GO:0005737;GO:0010494;GO:0097165;GO:0005634;GO:0005802;GO:0003729;GO:0008022;GO:0003723;GO:0006397;GO:0007399;GO:0000381;GO:0008380;GO:0050658;, C:cytoplasm; C:cytoplasmic stress granule; C:nuclear stress granule; C:nucleus; C:trans-Golgi network;, F:mRNA binding; F:protein C-terminus binding; F:RNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:RNA transport;|P30530 Q8N5L2 Q9UD27,Tyrosine-protein kinase receptor UFO,AXL oncogene;, PF00041;PF07714;, GO:0015629;GO:0009986;GO:0070062;GO:0005615;GO:0044228;GO:0005887;GO:0043231;GO:0005886;GO:0043235;GO:0005524;GO:0032036;GO:0043548;GO:0001786;GO:0004713;GO:0004714;GO:0001618;GO:0031100;GO:0001974;GO:0048469;GO:0016477;GO:0031668;GO:0070301;GO:0035457;GO:0071222;GO:0097028;GO:0034101;GO:0021885;GO:0006954;GO:0045087;GO:0007275;GO:0001779;GO:0043066;GO:2000669;GO:0032689;GO:0051250;GO:0043524;GO:0032720;GO:0007399;GO:0001764;GO:0097350;GO:0042698;GO:0006909;GO:0030168;GO:0001961;GO:0033674;GO:0032825;GO:0048549;GO:0051897;GO:1903902;GO:0043491;GO:0032940;GO:0007165;GO:0007283;GO:0034446;GO:0007169;GO:0060068;GO:0048010;GO:0046718;, C:actin cytoskeleton; C:cell surface; C:extracellular exosome; C:extracellular space; C:host cell surface; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:receptor complex;, F:ATP binding; F:myosin heavy chain binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylserine binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:virus receptor activity;, P:animal organ regeneration; P:blood vessel remodeling; P:cell maturation; P:cell migration; P:cellular response to extracellular stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interferon-alpha; P:cellular response to lipopolysaccharide; P:dendritic cell differentiation; P:erythrocyte homeostasis; P:forebrain cell migration; P:inflammatory response; P:innate immune response; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of interferon-gamma production; P:negative regulation of lymphocyte activation; P:negative regulation of neuron apoptotic process; P:negative regulation of tumor necrosis factor production; P:nervous system development; P:neuron migration; P:neutrophil clearance; P:ovulation cycle; P:phagocytosis; P:platelet activation; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of kinase activity; P:positive regulation of natural killer cell differentiation; P:positive regulation of pinocytosis; P:positive regulation of protein kinase B signaling; P:positive regulation of viral life cycle; P:protein kinase B signaling; P:secretion by cell; P:signal transduction; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development; P:vascular endothelial growth factor receptor signaling pathway; P:viral entry into host cell;|A8K979 Q6ZSJ2 Q96FR9 Q9P224 Q9Y6V3,ERI1 exoribonuclease 2,Exonuclease domain-containing protein 1;, PF00929;PF06839;, GO:0000175;GO:0003676;GO:0008270;GO:0000738;GO:0000467;, , F:3'-5'-exoribonuclease activity; F:nucleic acid binding; F:zinc ion binding;, P:DNA catabolic process, exonucleolytic; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q9NWB1 Q7Z7I7 Q8TAE3 Q8TAF2 Q8WYB2 Q9NS20,RNA binding protein fox-1 homolog 1,Ataxin-2-binding protein 1;Fox-1 homolog A;Hexaribonucleotide-binding protein 1;, PF12414;PF00076;, GO:0005737;GO:0010494;GO:0097165;GO:0005634;GO:0005802;GO:0003729;GO:0008022;GO:0003723;GO:0006397;GO:0007399;GO:0000381;GO:0008380;GO:0050658;, C:cytoplasm; C:cytoplasmic stress granule; C:nuclear stress granule; C:nucleus; C:trans-Golgi network;, F:mRNA binding; F:protein C-terminus binding; F:RNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:RNA transport;|Q9NWB1 Q7Z7I7 Q8TAE3 Q8TAF2 Q8WYB2 Q9NS20,RNA binding protein fox-1 homolog 1,Ataxin-2-binding protein 1;Fox-1 homolog A;Hexaribonucleotide-binding protein 1;, PF12414;PF00076;, GO:0005737;GO:0010494;GO:0097165;GO:0005634;GO:0005802;GO:0003729;GO:0008022;GO:0003723;GO:0006397;GO:0007399;GO:0000381;GO:0008380;GO:0050658;, C:cytoplasm; C:cytoplasmic stress granule; C:nuclear stress granule; C:nucleus; C:trans-Golgi network;, F:mRNA binding; F:protein C-terminus binding; F:RNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:RNA transport;|Q9NWB1 Q7Z7I7 Q8TAE3 Q8TAF2 Q8WYB2 Q9NS20,RNA binding protein fox-1 homolog 1,Ataxin-2-binding protein 1;Fox-1 homolog A;Hexaribonucleotide-binding protein 1;, PF12414;PF00076;, GO:0005737;GO:0010494;GO:0097165;GO:0005634;GO:0005802;GO:0003729;GO:0008022;GO:0003723;GO:0006397;GO:0007399;GO:0000381;GO:0008380;GO:0050658;, C:cytoplasm; C:cytoplasmic stress granule; C:nuclear stress granule; C:nucleus; C:trans-Golgi network;, F:mRNA binding; F:protein C-terminus binding; F:RNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:RNA transport;|Q9NWB1 Q7Z7I7 Q8TAE3 Q8TAF2 Q8WYB2 Q9NS20,RNA binding protein fox-1 homolog 1,Ataxin-2-binding protein 1;Fox-1 homolog A;Hexaribonucleotide-binding protein 1;, PF12414;PF00076;, GO:0005737;GO:0010494;GO:0097165;GO:0005634;GO:0005802;GO:0003729;GO:0008022;GO:0003723;GO:0006397;GO:0007399;GO:0000381;GO:0008380;GO:0050658;, C:cytoplasm; C:cytoplasmic stress granule; C:nuclear stress granule; C:nucleus; C:trans-Golgi network;, F:mRNA binding; F:protein C-terminus binding; F:RNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:RNA transport; scaffold38 indexed_genome mRNA 3019387 3022027 . + . ID=transcript_7843;Q9NWB1 Q7Z7I7 Q8TAE3 Q8TAF2 Q8WYB2 Q9NS20,RNA binding protein fox-1 homolog 1,Ataxin-2-binding protein 1;Fox-1 homolog A;Hexaribonucleotide-binding protein 1;, PF12414;PF00076;, GO:0005737;GO:0010494;GO:0097165;GO:0005634;GO:0005802;GO:0003729;GO:0008022;GO:0003723;GO:0006397;GO:0007399;GO:0000381;GO:0008380;GO:0050658;, C:cytoplasm; C:cytoplasmic stress granule; C:nuclear stress granule; C:nucleus; C:trans-Golgi network;, F:mRNA binding; F:protein C-terminus binding; F:RNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:RNA transport;|Q9NWB1 Q7Z7I7 Q8TAE3 Q8TAF2 Q8WYB2 Q9NS20,RNA binding protein fox-1 homolog 1,Ataxin-2-binding protein 1;Fox-1 homolog A;Hexaribonucleotide-binding protein 1;, PF12414;PF00076;, GO:0005737;GO:0010494;GO:0097165;GO:0005634;GO:0005802;GO:0003729;GO:0008022;GO:0003723;GO:0006397;GO:0007399;GO:0000381;GO:0008380;GO:0050658;, C:cytoplasm; C:cytoplasmic stress granule; C:nuclear stress granule; C:nucleus; C:trans-Golgi network;, F:mRNA binding; F:protein C-terminus binding; F:RNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; P:RNA transport; scaffold38 indexed_genome mRNA 3884114 3895193 . + . ID=transcript_7844;Q9BUU2 B2RD29 D3DUF2 Q6XYB4 Q9HA03,Methyltransferase-like protein 22,, PF10294;, GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0031072;GO:0008276;GO:0018022;GO:0006479;, C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:heat shock protein binding; F:protein methyltransferase activity;, P:peptidyl-lysine methylation; P:protein methylation;|Q9BUU2 B2RD29 D3DUF2 Q6XYB4 Q9HA03,Methyltransferase-like protein 22,, PF10294;, GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0031072;GO:0008276;GO:0018022;GO:0006479;, C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:heat shock protein binding; F:protein methyltransferase activity;, P:peptidyl-lysine methylation; P:protein methylation; scaffold38 indexed_genome mRNA 3948700 4008211 . + . ID=transcript_7845;P80404 A8K386 Q16260 Q8N5W2 Q96BG2 Q99800,4-aminobutyrate aminotransferase, mitochondrial,(S)-3-amino-2-methylpropionate transaminase;GABA aminotransferase;Gamma-amino-N-butyrate transaminase;L-AIBAT;, PF00202;, GO:0032144;GO:0005759;GO:0005739;GO:0047298;GO:0034386;GO:0042802;GO:0051536;GO:0046872;GO:0030170;GO:0032145;GO:0048148;GO:0009450;GO:0009448;GO:0042135;, C:4-aminobutyrate transaminase complex; C:mitochondrial matrix; C:mitochondrion;, F:(S)-3-amino-2-methylpropionate transaminase activity; F:4-aminobutyrate:2-oxoglutarate transaminase activity; F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:pyridoxal phosphate binding; F:succinate-semialdehyde dehydrogenase binding;, P:behavioral response to cocaine; P:gamma-aminobutyric acid catabolic process; P:gamma-aminobutyric acid metabolic process; P:neurotransmitter catabolic process;|P80404 A8K386 Q16260 Q8N5W2 Q96BG2 Q99800,4-aminobutyrate aminotransferase, mitochondrial,(S)-3-amino-2-methylpropionate transaminase;GABA aminotransferase;Gamma-amino-N-butyrate transaminase;L-AIBAT;, PF00202;, GO:0032144;GO:0005759;GO:0005739;GO:0047298;GO:0034386;GO:0042802;GO:0051536;GO:0046872;GO:0030170;GO:0032145;GO:0048148;GO:0009450;GO:0009448;GO:0042135;, C:4-aminobutyrate transaminase complex; C:mitochondrial matrix; C:mitochondrion;, F:(S)-3-amino-2-methylpropionate transaminase activity; F:4-aminobutyrate:2-oxoglutarate transaminase activity; F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:pyridoxal phosphate binding; F:succinate-semialdehyde dehydrogenase binding;, P:behavioral response to cocaine; P:gamma-aminobutyric acid catabolic process; P:gamma-aminobutyric acid metabolic process; P:neurotransmitter catabolic process;|P80404 A8K386 Q16260 Q8N5W2 Q96BG2 Q99800,4-aminobutyrate aminotransferase, mitochondrial,(S)-3-amino-2-methylpropionate transaminase;GABA aminotransferase;Gamma-amino-N-butyrate transaminase;L-AIBAT;, PF00202;, GO:0032144;GO:0005759;GO:0005739;GO:0047298;GO:0034386;GO:0042802;GO:0051536;GO:0046872;GO:0030170;GO:0032145;GO:0048148;GO:0009450;GO:0009448;GO:0042135;, C:4-aminobutyrate transaminase complex; C:mitochondrial matrix; C:mitochondrion;, F:(S)-3-amino-2-methylpropionate transaminase activity; F:4-aminobutyrate:2-oxoglutarate transaminase activity; F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:pyridoxal phosphate binding; F:succinate-semialdehyde dehydrogenase binding;, P:behavioral response to cocaine; P:gamma-aminobutyric acid catabolic process; P:gamma-aminobutyric acid metabolic process; P:neurotransmitter catabolic process;|P80404 A8K386 Q16260 Q8N5W2 Q96BG2 Q99800,4-aminobutyrate aminotransferase, mitochondrial,(S)-3-amino-2-methylpropionate transaminase;GABA aminotransferase;Gamma-amino-N-butyrate transaminase;L-AIBAT;, PF00202;, GO:0032144;GO:0005759;GO:0005739;GO:0047298;GO:0034386;GO:0042802;GO:0051536;GO:0046872;GO:0030170;GO:0032145;GO:0048148;GO:0009450;GO:0009448;GO:0042135;, C:4-aminobutyrate transaminase complex; C:mitochondrial matrix; C:mitochondrion;, F:(S)-3-amino-2-methylpropionate transaminase activity; F:4-aminobutyrate:2-oxoglutarate transaminase activity; F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:pyridoxal phosphate binding; F:succinate-semialdehyde dehydrogenase binding;, P:behavioral response to cocaine; P:gamma-aminobutyric acid catabolic process; P:gamma-aminobutyric acid metabolic process; P:neurotransmitter catabolic process;|P80404 A8K386 Q16260 Q8N5W2 Q96BG2 Q99800,4-aminobutyrate aminotransferase, mitochondrial,(S)-3-amino-2-methylpropionate transaminase;GABA aminotransferase;Gamma-amino-N-butyrate transaminase;L-AIBAT;, PF00202;, GO:0032144;GO:0005759;GO:0005739;GO:0047298;GO:0034386;GO:0042802;GO:0051536;GO:0046872;GO:0030170;GO:0032145;GO:0048148;GO:0009450;GO:0009448;GO:0042135;, C:4-aminobutyrate transaminase complex; C:mitochondrial matrix; C:mitochondrion;, F:(S)-3-amino-2-methylpropionate transaminase activity; F:4-aminobutyrate:2-oxoglutarate transaminase activity; F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:pyridoxal phosphate binding; F:succinate-semialdehyde dehydrogenase binding;, P:behavioral response to cocaine; P:gamma-aminobutyric acid catabolic process; P:gamma-aminobutyric acid metabolic process; P:neurotransmitter catabolic process;|P80404 A8K386 Q16260 Q8N5W2 Q96BG2 Q99800,4-aminobutyrate aminotransferase, mitochondrial,(S)-3-amino-2-methylpropionate transaminase;GABA aminotransferase;Gamma-amino-N-butyrate transaminase;L-AIBAT;, PF00202;, GO:0032144;GO:0005759;GO:0005739;GO:0047298;GO:0034386;GO:0042802;GO:0051536;GO:0046872;GO:0030170;GO:0032145;GO:0048148;GO:0009450;GO:0009448;GO:0042135;, C:4-aminobutyrate transaminase complex; C:mitochondrial matrix; C:mitochondrion;, F:(S)-3-amino-2-methylpropionate transaminase activity; F:4-aminobutyrate:2-oxoglutarate transaminase activity; F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:pyridoxal phosphate binding; F:succinate-semialdehyde dehydrogenase binding;, P:behavioral response to cocaine; P:gamma-aminobutyric acid catabolic process; P:gamma-aminobutyric acid metabolic process; P:neurotransmitter catabolic process;|P80404 A8K386 Q16260 Q8N5W2 Q96BG2 Q99800,4-aminobutyrate aminotransferase, mitochondrial,(S)-3-amino-2-methylpropionate transaminase;GABA aminotransferase;Gamma-amino-N-butyrate transaminase;L-AIBAT;, PF00202;, GO:0032144;GO:0005759;GO:0005739;GO:0047298;GO:0034386;GO:0042802;GO:0051536;GO:0046872;GO:0030170;GO:0032145;GO:0048148;GO:0009450;GO:0009448;GO:0042135;, C:4-aminobutyrate transaminase complex; C:mitochondrial matrix; C:mitochondrion;, F:(S)-3-amino-2-methylpropionate transaminase activity; F:4-aminobutyrate:2-oxoglutarate transaminase activity; F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:pyridoxal phosphate binding; F:succinate-semialdehyde dehydrogenase binding;, P:behavioral response to cocaine; P:gamma-aminobutyric acid catabolic process; P:gamma-aminobutyric acid metabolic process; P:neurotransmitter catabolic process;|P80404 A8K386 Q16260 Q8N5W2 Q96BG2 Q99800,4-aminobutyrate aminotransferase, mitochondrial,(S)-3-amino-2-methylpropionate transaminase;GABA aminotransferase;Gamma-amino-N-butyrate transaminase;L-AIBAT;, PF00202;, GO:0032144;GO:0005759;GO:0005739;GO:0047298;GO:0034386;GO:0042802;GO:0051536;GO:0046872;GO:0030170;GO:0032145;GO:0048148;GO:0009450;GO:0009448;GO:0042135;, C:4-aminobutyrate transaminase complex; C:mitochondrial matrix; C:mitochondrion;, F:(S)-3-amino-2-methylpropionate transaminase activity; F:4-aminobutyrate:2-oxoglutarate transaminase activity; F:identical protein binding; F:iron-sulfur cluster binding; F:metal ion binding; F:pyridoxal phosphate binding; F:succinate-semialdehyde dehydrogenase binding;, P:behavioral response to cocaine; P:gamma-aminobutyric acid catabolic process; P:gamma-aminobutyric acid metabolic process; P:neurotransmitter catabolic process; scaffold38 indexed_genome mRNA 4014488 4016762 . + . ID=transcript_7846;Q96B77 B2RAY0 Q9Y4T4,Transmembrane protein 186,, , GO:0016021;GO:0005739;, C:integral component of membrane; C:mitochondrion; scaffold38 indexed_genome mRNA 4017375 4042453 . + . ID=transcript_7847;O15305 A8K672 B7Z6R0 D3DUF3,Phosphomannomutase 2 {ECO:0000303|PubMed:9140401},, PF03332;, GO:0005829;GO:0043025;GO:0005654;GO:0046872;GO:0004615;GO:0009298;GO:0006013;GO:0006486;GO:0006487;, C:cytosol; C:neuronal cell body; C:nucleoplasm;, F:metal ion binding; F:phosphomannomutase activity;, P:GDP-mannose biosynthetic process; P:mannose metabolic process; P:protein glycosylation; P:protein N-linked glycosylation;|O15305 A8K672 B7Z6R0 D3DUF3,Phosphomannomutase 2 {ECO:0000303|PubMed:9140401},, PF03332;, GO:0005829;GO:0043025;GO:0005654;GO:0046872;GO:0004615;GO:0009298;GO:0006013;GO:0006486;GO:0006487;, C:cytosol; C:neuronal cell body; C:nucleoplasm;, F:metal ion binding; F:phosphomannomutase activity;, P:GDP-mannose biosynthetic process; P:mannose metabolic process; P:protein glycosylation; P:protein N-linked glycosylation;|O15305 A8K672 B7Z6R0 D3DUF3,Phosphomannomutase 2 {ECO:0000303|PubMed:9140401},, PF03332;, GO:0005829;GO:0043025;GO:0005654;GO:0046872;GO:0004615;GO:0009298;GO:0006013;GO:0006486;GO:0006487;, C:cytosol; C:neuronal cell body; C:nucleoplasm;, F:metal ion binding; F:phosphomannomutase activity;, P:GDP-mannose biosynthetic process; P:mannose metabolic process; P:protein glycosylation; P:protein N-linked glycosylation; scaffold38 indexed_genome mRNA 4044401 4067038 . - . ID=transcript_7848;Q9Y2V2 B2R4C3 D3DUF5 Q2YDX5 Q9BQ53,Calcium-regulated heat-stable protein 1,Calcium-regulated heat-stable protein of 24 kDa;, PF00313;, GO:0005737;GO:0000177;GO:0005829;GO:0043186;GO:0000932;GO:0003730;GO:0019902;GO:0035556;GO:0043488;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:P granule; C:P-body;, F:mRNA 3'-UTR binding; F:phosphatase binding;, P:intracellular signal transduction; P:regulation of mRNA stability; scaffold38 indexed_genome mRNA 4089687 4118424 . - . ID=transcript_7849;Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q93009 A6NMY8 B7Z815 H0Y3G8,Ubiquitin carboxyl-terminal hydrolase 7,Deubiquitinating enzyme 7;Herpesvirus-associated ubiquitin-specific protease;Ubiquitin thioesterase 7;Ubiquitin-specific-processing protease 7;, PF00917;PF00443;PF14533;PF12436;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0004197;GO:1990380;GO:0002039;GO:0008022;GO:0004843;GO:0008134;GO:0031625;GO:0101005;GO:0035616;GO:0010216;GO:0035520;GO:0007275;GO:0032088;GO:0032435;GO:1901537;GO:0016579;GO:0070536;GO:0050821;GO:0016567;GO:0042752;GO:0051090;GO:0006111;GO:0031647;GO:1905279;GO:1901796;GO:1904353;GO:0048511;GO:0006283;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:cysteine-type endopeptidase activity; F:Lys48-specific deubiquitinase activity; F:p53 binding; F:protein C-terminus binding; F:thiol-dependent ubiquitin-specific protease activity; F:transcription factor binding; F:ubiquitin protein ligase binding; F:ubiquitinyl hydrolase activity;, P:histone H2B conserved C-terminal lysine deubiquitination; P:maintenance of DNA methylation; P:monoubiquitinated protein deubiquitination; P:multicellular organism development; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gluconeogenesis; P:regulation of protein stability; P:regulation of retrograde transport, endosome to Golgi; P:regulation of signal transduction by p53 class mediator; P:regulation of telomere capping; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold38 indexed_genome mRNA 4235998 4250316 . + . ID=transcript_7850;Q14CZ0,UPF0472 protein C16orf72,, PF15251; scaffold38 indexed_genome mRNA 4255863 4261712 . - . ID=transcript_7851;Q14CZ0,UPF0472 protein C16orf72,, PF15251; scaffold38 indexed_genome mRNA 4812068 4818650 . + . ID=transcript_7852;Q12879 O00669 Q17RZ6,Glutamate receptor ionotropic, NMDA 2A,Glutamate [NMDA] receptor subunit epsilon-1;N-methyl D-aspartate receptor subtype 2A;, PF01094;PF00060;PF10613;PF10565;, GO:0009986;GO:0030659;GO:0043197;GO:0005789;GO:0098978;GO:0005887;GO:0099061;GO:0017146;GO:0005886;GO:0014069;GO:0098839;GO:0042734;GO:0097060;GO:0008021;GO:0001540;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:0008270;GO:0097202;GO:0007420;GO:0097553;GO:0007268;GO:0033058;GO:0042417;GO:0098976;GO:0060079;GO:0007215;GO:0007611;GO:0060291;GO:0007613;GO:0042177;GO:0022008;GO:0043065;GO:1903539;GO:2000310;GO:0048167;GO:0001975;GO:0042493;GO:0045471;GO:0009611;GO:0019233;GO:0042428;GO:0030431;GO:0001964;GO:0008542;, C:cell surface; C:cytoplasmic vesicle membrane; C:dendritic spine; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:presynaptic membrane; C:synaptic membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity; P:brain development; P:calcium ion transmembrane import into cytosol; P:chemical synaptic transmission; P:directional locomotion; P:dopamine metabolic process; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:learning or memory; P:long-term synaptic potentiation; P:memory; P:negative regulation of protein catabolic process; P:neurogenesis; P:positive regulation of apoptotic process; P:protein localization to postsynaptic membrane; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to amphetamine; P:response to drug; P:response to ethanol; P:response to wounding; P:sensory perception of pain; P:serotonin metabolic process; P:sleep; P:startle response; P:visual learning; scaffold38 indexed_genome mRNA 4818659 4819422 . - . ID=transcript_7853;Q12879 O00669 Q17RZ6,Glutamate receptor ionotropic, NMDA 2A,Glutamate [NMDA] receptor subunit epsilon-1;N-methyl D-aspartate receptor subtype 2A;, PF01094;PF00060;PF10613;PF10565;, GO:0009986;GO:0030659;GO:0043197;GO:0005789;GO:0098978;GO:0005887;GO:0099061;GO:0017146;GO:0005886;GO:0014069;GO:0098839;GO:0042734;GO:0097060;GO:0008021;GO:0001540;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:0008270;GO:0097202;GO:0007420;GO:0097553;GO:0007268;GO:0033058;GO:0042417;GO:0098976;GO:0060079;GO:0007215;GO:0007611;GO:0060291;GO:0007613;GO:0042177;GO:0022008;GO:0043065;GO:1903539;GO:2000310;GO:0048167;GO:0001975;GO:0042493;GO:0045471;GO:0009611;GO:0019233;GO:0042428;GO:0030431;GO:0001964;GO:0008542;, C:cell surface; C:cytoplasmic vesicle membrane; C:dendritic spine; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:presynaptic membrane; C:synaptic membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity; P:brain development; P:calcium ion transmembrane import into cytosol; P:chemical synaptic transmission; P:directional locomotion; P:dopamine metabolic process; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:learning or memory; P:long-term synaptic potentiation; P:memory; P:negative regulation of protein catabolic process; P:neurogenesis; P:positive regulation of apoptotic process; P:protein localization to postsynaptic membrane; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to amphetamine; P:response to drug; P:response to ethanol; P:response to wounding; P:sensory perception of pain; P:serotonin metabolic process; P:sleep; P:startle response; P:visual learning; scaffold38 indexed_genome mRNA 4819731 4914298 . - . ID=transcript_7854;Q12879 O00669 Q17RZ6,Glutamate receptor ionotropic, NMDA 2A,Glutamate [NMDA] receptor subunit epsilon-1;N-methyl D-aspartate receptor subtype 2A;, PF01094;PF00060;PF10613;PF10565;, GO:0009986;GO:0030659;GO:0043197;GO:0005789;GO:0098978;GO:0005887;GO:0099061;GO:0017146;GO:0005886;GO:0014069;GO:0098839;GO:0042734;GO:0097060;GO:0008021;GO:0001540;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:0008270;GO:0097202;GO:0007420;GO:0097553;GO:0007268;GO:0033058;GO:0042417;GO:0098976;GO:0060079;GO:0007215;GO:0007611;GO:0060291;GO:0007613;GO:0042177;GO:0022008;GO:0043065;GO:1903539;GO:2000310;GO:0048167;GO:0001975;GO:0042493;GO:0045471;GO:0009611;GO:0019233;GO:0042428;GO:0030431;GO:0001964;GO:0008542;, C:cell surface; C:cytoplasmic vesicle membrane; C:dendritic spine; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:presynaptic membrane; C:synaptic membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity; P:brain development; P:calcium ion transmembrane import into cytosol; P:chemical synaptic transmission; P:directional locomotion; P:dopamine metabolic process; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:learning or memory; P:long-term synaptic potentiation; P:memory; P:negative regulation of protein catabolic process; P:neurogenesis; P:positive regulation of apoptotic process; P:protein localization to postsynaptic membrane; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to amphetamine; P:response to drug; P:response to ethanol; P:response to wounding; P:sensory perception of pain; P:serotonin metabolic process; P:sleep; P:startle response; P:visual learning; scaffold38 indexed_genome mRNA 4993206 5241429 . - . ID=transcript_7855;Q12879 O00669 Q17RZ6,Glutamate receptor ionotropic, NMDA 2A,Glutamate [NMDA] receptor subunit epsilon-1;N-methyl D-aspartate receptor subtype 2A;, PF01094;PF00060;PF10613;PF10565;, GO:0009986;GO:0030659;GO:0043197;GO:0005789;GO:0098978;GO:0005887;GO:0099061;GO:0017146;GO:0005886;GO:0014069;GO:0098839;GO:0042734;GO:0097060;GO:0008021;GO:0001540;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:0008270;GO:0097202;GO:0007420;GO:0097553;GO:0007268;GO:0033058;GO:0042417;GO:0098976;GO:0060079;GO:0007215;GO:0007611;GO:0060291;GO:0007613;GO:0042177;GO:0022008;GO:0043065;GO:1903539;GO:2000310;GO:0048167;GO:0001975;GO:0042493;GO:0045471;GO:0009611;GO:0019233;GO:0042428;GO:0030431;GO:0001964;GO:0008542;, C:cell surface; C:cytoplasmic vesicle membrane; C:dendritic spine; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:presynaptic membrane; C:synaptic membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity; P:brain development; P:calcium ion transmembrane import into cytosol; P:chemical synaptic transmission; P:directional locomotion; P:dopamine metabolic process; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:learning or memory; P:long-term synaptic potentiation; P:memory; P:negative regulation of protein catabolic process; P:neurogenesis; P:positive regulation of apoptotic process; P:protein localization to postsynaptic membrane; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to amphetamine; P:response to drug; P:response to ethanol; P:response to wounding; P:sensory perception of pain; P:serotonin metabolic process; P:sleep; P:startle response; P:visual learning; scaffold38 indexed_genome mRNA 5450682 5481794 . + . ID=transcript_7856;Q5U623 B2RNR2 Q53EZ7 Q658U2 Q6IS97 Q8N9X8 Q9H9L6,Activating transcription factor 7-interacting protein 2,MBD1-containing chromatin-associated factor 2;, PF16788;PF16794;, GO:0005634;, C:nucleus; scaffold38 indexed_genome mRNA 5482264 5502443 . + . ID=transcript_7857;Q5U623 B2RNR2 Q53EZ7 Q658U2 Q6IS97 Q8N9X8 Q9H9L6,Activating transcription factor 7-interacting protein 2,MBD1-containing chromatin-associated factor 2;, PF16788;PF16794;, GO:0005634;, C:nucleus; scaffold38 indexed_genome mRNA 5507205 5519472 . + . ID=transcript_7858;Q5U623 B2RNR2 Q53EZ7 Q658U2 Q6IS97 Q8N9X8 Q9H9L6,Activating transcription factor 7-interacting protein 2,MBD1-containing chromatin-associated factor 2;, PF16788;PF16794;, GO:0005634;, C:nucleus; scaffold38 indexed_genome mRNA 5551189 5595683 . - . ID=transcript_7859;P54851 B2R7V6 D3DUF8,Epithelial membrane protein 2,Protein XMP;, PF00822;, GO:0045177;GO:0016324;GO:0009986;GO:0005737;GO:0031410;GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0045121;GO:0005634;GO:0005886;GO:0005178;GO:0019900;GO:0019901;GO:0007015;GO:0070252;GO:0032147;GO:0032060;GO:0043534;GO:0007155;GO:0008219;GO:0016477;GO:0007160;GO:0045022;GO:0007566;GO:0001765;GO:0008284;GO:0001954;GO:2001046;GO:0034394;GO:0072659;GO:0045765;GO:0001952;GO:0010594;GO:0003093;GO:0043549;GO:2001212;GO:0001913;, C:apical part of cell; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane raft; C:nucleus; C:plasma membrane;, F:integrin binding; F:kinase binding; F:protein kinase binding;, P:actin filament organization; P:actin-mediated cell contraction; P:activation of protein kinase activity; P:bleb assembly; P:blood vessel endothelial cell migration; P:cell adhesion; P:cell death; P:cell migration; P:cell-matrix adhesion; P:early endosome to late endosome transport; P:embryo implantation; P:membrane raft assembly; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of integrin-mediated signaling pathway; P:protein localization to cell surface; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of cell-matrix adhesion; P:regulation of endothelial cell migration; P:regulation of glomerular filtration; P:regulation of kinase activity; P:regulation of vasculogenesis; P:T cell mediated cytotoxicity;|P54851 B2R7V6 D3DUF8,Epithelial membrane protein 2,Protein XMP;, PF00822;, GO:0045177;GO:0016324;GO:0009986;GO:0005737;GO:0031410;GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0045121;GO:0005634;GO:0005886;GO:0005178;GO:0019900;GO:0019901;GO:0007015;GO:0070252;GO:0032147;GO:0032060;GO:0043534;GO:0007155;GO:0008219;GO:0016477;GO:0007160;GO:0045022;GO:0007566;GO:0001765;GO:0008284;GO:0001954;GO:2001046;GO:0034394;GO:0072659;GO:0045765;GO:0001952;GO:0010594;GO:0003093;GO:0043549;GO:2001212;GO:0001913;, C:apical part of cell; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane raft; C:nucleus; C:plasma membrane;, F:integrin binding; F:kinase binding; F:protein kinase binding;, P:actin filament organization; P:actin-mediated cell contraction; P:activation of protein kinase activity; P:bleb assembly; P:blood vessel endothelial cell migration; P:cell adhesion; P:cell death; P:cell migration; P:cell-matrix adhesion; P:early endosome to late endosome transport; P:embryo implantation; P:membrane raft assembly; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of integrin-mediated signaling pathway; P:protein localization to cell surface; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of cell-matrix adhesion; P:regulation of endothelial cell migration; P:regulation of glomerular filtration; P:regulation of kinase activity; P:regulation of vasculogenesis; P:T cell mediated cytotoxicity;|P54851 B2R7V6 D3DUF8,Epithelial membrane protein 2,Protein XMP;, PF00822;, GO:0045177;GO:0016324;GO:0009986;GO:0005737;GO:0031410;GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0045121;GO:0005634;GO:0005886;GO:0005178;GO:0019900;GO:0019901;GO:0007015;GO:0070252;GO:0032147;GO:0032060;GO:0043534;GO:0007155;GO:0008219;GO:0016477;GO:0007160;GO:0045022;GO:0007566;GO:0001765;GO:0008284;GO:0001954;GO:2001046;GO:0034394;GO:0072659;GO:0045765;GO:0001952;GO:0010594;GO:0003093;GO:0043549;GO:2001212;GO:0001913;, C:apical part of cell; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane raft; C:nucleus; C:plasma membrane;, F:integrin binding; F:kinase binding; F:protein kinase binding;, P:actin filament organization; P:actin-mediated cell contraction; P:activation of protein kinase activity; P:bleb assembly; P:blood vessel endothelial cell migration; P:cell adhesion; P:cell death; P:cell migration; P:cell-matrix adhesion; P:early endosome to late endosome transport; P:embryo implantation; P:membrane raft assembly; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of integrin-mediated signaling pathway; P:protein localization to cell surface; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of cell-matrix adhesion; P:regulation of endothelial cell migration; P:regulation of glomerular filtration; P:regulation of kinase activity; P:regulation of vasculogenesis; P:T cell mediated cytotoxicity;|P54851 B2R7V6 D3DUF8,Epithelial membrane protein 2,Protein XMP;, PF00822;, GO:0045177;GO:0016324;GO:0009986;GO:0005737;GO:0031410;GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0045121;GO:0005634;GO:0005886;GO:0005178;GO:0019900;GO:0019901;GO:0007015;GO:0070252;GO:0032147;GO:0032060;GO:0043534;GO:0007155;GO:0008219;GO:0016477;GO:0007160;GO:0045022;GO:0007566;GO:0001765;GO:0008284;GO:0001954;GO:2001046;GO:0034394;GO:0072659;GO:0045765;GO:0001952;GO:0010594;GO:0003093;GO:0043549;GO:2001212;GO:0001913;, C:apical part of cell; C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane raft; C:nucleus; C:plasma membrane;, F:integrin binding; F:kinase binding; F:protein kinase binding;, P:actin filament organization; P:actin-mediated cell contraction; P:activation of protein kinase activity; P:bleb assembly; P:blood vessel endothelial cell migration; P:cell adhesion; P:cell death; P:cell migration; P:cell-matrix adhesion; P:early endosome to late endosome transport; P:embryo implantation; P:membrane raft assembly; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of integrin-mediated signaling pathway; P:protein localization to cell surface; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of cell-matrix adhesion; P:regulation of endothelial cell migration; P:regulation of glomerular filtration; P:regulation of kinase activity; P:regulation of vasculogenesis; P:T cell mediated cytotoxicity; scaffold38 indexed_genome mRNA 5720515 5722887 . + . ID=transcript_7860;P53384 Q32M30 Q498A9 Q53FS7,Cytosolic Fe-S cluster assembly factor NUBP1 {ECO:0000255|HAMAP-Rule:MF_03038},Nucleotide-binding protein 1 {ECO:0000255|HAMAP-Rule:MF_03038};, PF10609;, GO:0005814;GO:0005929;GO:0005829;GO:0005634;GO:0005886;GO:0051539;GO:0005524;GO:0016887;GO:0051536;GO:0046872;GO:0000166;GO:0030030;GO:0006879;GO:0051642;GO:0016226;GO:0010826;GO:0072697;GO:0001558;, C:centriole; C:cilium; C:cytosol; C:nucleus; C:plasma membrane;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:nucleotide binding;, P:cell projection organization; P:cellular iron ion homeostasis; P:centrosome localization; P:iron-sulfur cluster assembly; P:negative regulation of centrosome duplication; P:protein localization to cell cortex; P:regulation of cell growth;|P53384 Q32M30 Q498A9 Q53FS7,Cytosolic Fe-S cluster assembly factor NUBP1 {ECO:0000255|HAMAP-Rule:MF_03038},Nucleotide-binding protein 1 {ECO:0000255|HAMAP-Rule:MF_03038};, PF10609;, GO:0005814;GO:0005929;GO:0005829;GO:0005634;GO:0005886;GO:0051539;GO:0005524;GO:0016887;GO:0051536;GO:0046872;GO:0000166;GO:0030030;GO:0006879;GO:0051642;GO:0016226;GO:0010826;GO:0072697;GO:0001558;, C:centriole; C:cilium; C:cytosol; C:nucleus; C:plasma membrane;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:nucleotide binding;, P:cell projection organization; P:cellular iron ion homeostasis; P:centrosome localization; P:iron-sulfur cluster assembly; P:negative regulation of centrosome duplication; P:protein localization to cell cortex; P:regulation of cell growth; scaffold38 indexed_genome mRNA 5722916 5769426 . + . ID=transcript_7861;P53384 Q32M30 Q498A9 Q53FS7,Cytosolic Fe-S cluster assembly factor NUBP1 {ECO:0000255|HAMAP-Rule:MF_03038},Nucleotide-binding protein 1 {ECO:0000255|HAMAP-Rule:MF_03038};, PF10609;, GO:0005814;GO:0005929;GO:0005829;GO:0005634;GO:0005886;GO:0051539;GO:0005524;GO:0016887;GO:0051536;GO:0046872;GO:0000166;GO:0030030;GO:0006879;GO:0051642;GO:0016226;GO:0010826;GO:0072697;GO:0001558;, C:centriole; C:cilium; C:cytosol; C:nucleus; C:plasma membrane;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:nucleotide binding;, P:cell projection organization; P:cellular iron ion homeostasis; P:centrosome localization; P:iron-sulfur cluster assembly; P:negative regulation of centrosome duplication; P:protein localization to cell cortex; P:regulation of cell growth;|P53384 Q32M30 Q498A9 Q53FS7,Cytosolic Fe-S cluster assembly factor NUBP1 {ECO:0000255|HAMAP-Rule:MF_03038},Nucleotide-binding protein 1 {ECO:0000255|HAMAP-Rule:MF_03038};, PF10609;, GO:0005814;GO:0005929;GO:0005829;GO:0005634;GO:0005886;GO:0051539;GO:0005524;GO:0016887;GO:0051536;GO:0046872;GO:0000166;GO:0030030;GO:0006879;GO:0051642;GO:0016226;GO:0010826;GO:0072697;GO:0001558;, C:centriole; C:cilium; C:cytosol; C:nucleus; C:plasma membrane;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:nucleotide binding;, P:cell projection organization; P:cellular iron ion homeostasis; P:centrosome localization; P:iron-sulfur cluster assembly; P:negative regulation of centrosome duplication; P:protein localization to cell cortex; P:regulation of cell growth;|P53384 Q32M30 Q498A9 Q53FS7,Cytosolic Fe-S cluster assembly factor NUBP1 {ECO:0000255|HAMAP-Rule:MF_03038},Nucleotide-binding protein 1 {ECO:0000255|HAMAP-Rule:MF_03038};, PF10609;, GO:0005814;GO:0005929;GO:0005829;GO:0005634;GO:0005886;GO:0051539;GO:0005524;GO:0016887;GO:0051536;GO:0046872;GO:0000166;GO:0030030;GO:0006879;GO:0051642;GO:0016226;GO:0010826;GO:0072697;GO:0001558;, C:centriole; C:cilium; C:cytosol; C:nucleus; C:plasma membrane;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:nucleotide binding;, P:cell projection organization; P:cellular iron ion homeostasis; P:centrosome localization; P:iron-sulfur cluster assembly; P:negative regulation of centrosome duplication; P:protein localization to cell cortex; P:regulation of cell growth;|P53384 Q32M30 Q498A9 Q53FS7,Cytosolic Fe-S cluster assembly factor NUBP1 {ECO:0000255|HAMAP-Rule:MF_03038},Nucleotide-binding protein 1 {ECO:0000255|HAMAP-Rule:MF_03038};, PF10609;, GO:0005814;GO:0005929;GO:0005829;GO:0005634;GO:0005886;GO:0051539;GO:0005524;GO:0016887;GO:0051536;GO:0046872;GO:0000166;GO:0030030;GO:0006879;GO:0051642;GO:0016226;GO:0010826;GO:0072697;GO:0001558;, C:centriole; C:cilium; C:cytosol; C:nucleus; C:plasma membrane;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:nucleotide binding;, P:cell projection organization; P:cellular iron ion homeostasis; P:centrosome localization; P:iron-sulfur cluster assembly; P:negative regulation of centrosome duplication; P:protein localization to cell cortex; P:regulation of cell growth;|A6NH52 B2RUV4 B7ZW18,Golgi apparatus membrane protein TVP23 homolog A,, PF05832;, GO:0030173;GO:0009306;GO:0016192;, C:integral component of Golgi membrane;, , P:protein secretion; P:vesicle-mediated transport;|A6NH52 B2RUV4 B7ZW18,Golgi apparatus membrane protein TVP23 homolog A,, PF05832;, GO:0030173;GO:0009306;GO:0016192;, C:integral component of Golgi membrane;, , P:protein secretion; P:vesicle-mediated transport;|A6NH52 B2RUV4 B7ZW18,Golgi apparatus membrane protein TVP23 homolog A,, PF05832;, GO:0030173;GO:0009306;GO:0016192;, C:integral component of Golgi membrane;, , P:protein secretion; P:vesicle-mediated transport; scaffold38 indexed_genome mRNA 5845343 5872799 . + . ID=transcript_7862;P33076 A0N0N9 D3DUG0 E9PFE0 Q29675 Q8SNB8 Q96KL4,MHC class II transactivator {ECO:0000305},, PF13516;PF05729;, GO:0005829;GO:0005654;GO:0016605;GO:0033613;GO:0005524;GO:0005525;GO:0008022;GO:0106310;GO:0106311;GO:0044877;GO:0003713;GO:0000976;GO:0016746;GO:0006955;GO:0006954;GO:0060333;GO:0032966;GO:0000122;GO:0045892;GO:0046597;GO:0045345;GO:0045348;GO:0045944;GO:0045893;GO:0046677;GO:0034341;, C:cytosol; C:nucleoplasm; C:PML body;, F:activating transcription factor binding; F:ATP binding; F:GTP binding; F:protein C-terminus binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding; F:transferase activity, transferring acyl groups;, P:immune response; P:inflammatory response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of collagen biosynthetic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral entry into host cell; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:response to antibiotic; P:response to interferon-gamma;|P33076 A0N0N9 D3DUG0 E9PFE0 Q29675 Q8SNB8 Q96KL4,MHC class II transactivator {ECO:0000305},, PF13516;PF05729;, GO:0005829;GO:0005654;GO:0016605;GO:0033613;GO:0005524;GO:0005525;GO:0008022;GO:0106310;GO:0106311;GO:0044877;GO:0003713;GO:0000976;GO:0016746;GO:0006955;GO:0006954;GO:0060333;GO:0032966;GO:0000122;GO:0045892;GO:0046597;GO:0045345;GO:0045348;GO:0045944;GO:0045893;GO:0046677;GO:0034341;, C:cytosol; C:nucleoplasm; C:PML body;, F:activating transcription factor binding; F:ATP binding; F:GTP binding; F:protein C-terminus binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding; F:transferase activity, transferring acyl groups;, P:immune response; P:inflammatory response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of collagen biosynthetic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral entry into host cell; P:positive regulation of MHC class I biosynthetic process; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:response to antibiotic; P:response to interferon-gamma; scaffold38 indexed_genome mRNA 5879200 5890367 . - . ID=transcript_7863;O95424 B2RAA7,Dexamethasone-induced protein,Protein MYLE;, PF15198; scaffold38 indexed_genome mRNA 5905045 6117533 . + . ID=transcript_7864;Q2KHT3 O15058 Q6ZTB2,Protein CLEC16A {ECO:0000305},C-type lectin domain family 16 member A {ECO:0000312|HGNC:HGNC:29013};, PF09758;, GO:0005829;GO:0036020;GO:0005794;GO:0016021;GO:0031982;GO:0006914;GO:0009267;GO:0016197;GO:0008333;GO:1901097;GO:1904766;GO:1904263;GO:1901096;, C:cytosol; C:endolysosome membrane; C:Golgi apparatus; C:integral component of membrane; C:vesicle;, , P:autophagy; P:cellular response to starvation; P:endosomal transport; P:endosome to lysosome transport; P:negative regulation of autophagosome maturation; P:negative regulation of macroautophagy by TORC1 signaling; P:positive regulation of TORC1 signaling; P:regulation of autophagosome maturation; scaffold38 indexed_genome mRNA 6120168 6124089 . + . ID=transcript_7865;Q2KHT3 O15058 Q6ZTB2,Protein CLEC16A {ECO:0000305},C-type lectin domain family 16 member A {ECO:0000312|HGNC:HGNC:29013};, PF09758;, GO:0005829;GO:0036020;GO:0005794;GO:0016021;GO:0031982;GO:0006914;GO:0009267;GO:0016197;GO:0008333;GO:1901097;GO:1904766;GO:1904263;GO:1901096;, C:cytosol; C:endolysosome membrane; C:Golgi apparatus; C:integral component of membrane; C:vesicle;, , P:autophagy; P:cellular response to starvation; P:endosomal transport; P:endosome to lysosome transport; P:negative regulation of autophagosome maturation; P:negative regulation of macroautophagy by TORC1 signaling; P:positive regulation of TORC1 signaling; P:regulation of autophagosome maturation; scaffold38 indexed_genome mRNA 6255016 6264878 . + . ID=transcript_7866;Q96E14 B3KVZ6 Q49AE2 Q8TBL0,RecQ-mediated genome instability protein 2,BLM-associated protein of 18 kDa;, PF16100;, GO:0005829;GO:0016607;GO:0005654;GO:0003677;GO:0006281;GO:0006260;GO:0043007;GO:2000042;GO:1901796;GO:0033045;, C:cytosol; C:nuclear speck; C:nucleoplasm;, F:DNA binding;, P:DNA repair; P:DNA replication; P:maintenance of rDNA; P:negative regulation of double-strand break repair via homologous recombination; P:regulation of signal transduction by p53 class mediator; P:regulation of sister chromatid segregation; scaffold38 indexed_genome mRNA 6484231 6520445 . - . ID=transcript_7867;Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6,Lipopolysaccharide-induced tumor necrosis factor-alpha factor {ECO:0000303|PubMed:10200294},Small integral membrane protein of lysosome/late endosome {ECO:0000303|PubMed:11274176};p53-induced gene 7 protein {ECO:0000303|PubMed:11274176};, PF10601;, GO:0098559;GO:0098560;GO:0098574;GO:0009898;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0001228;GO:0000978;GO:0050699;GO:0008270;GO:0007568;GO:0071222;GO:1901223;GO:0043123;GO:0045944;GO:0001817;GO:0006357;, C:cytoplasmic side of early endosome membrane; C:cytoplasmic side of late endosome membrane; C:cytoplasmic side of lysosomal membrane; C:cytoplasmic side of plasma membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:WW domain binding; F:zinc ion binding;, P:aging; P:cellular response to lipopolysaccharide; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of cytokine production; P:regulation of transcription by RNA polymerase II; scaffold38 indexed_genome mRNA 6616756 6680387 . - . ID=transcript_7868;Q6PKC3 O95887 Q6PJA6 Q8N2Q4 Q96K45 Q96K53,Thioredoxin domain-containing protein 11,EF-hand-binding protein 1;, PF00085;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane;|Q6PKC3 O95887 Q6PJA6 Q8N2Q4 Q96K45 Q96K53,Thioredoxin domain-containing protein 11,EF-hand-binding protein 1;, PF00085;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane;|Q6PKC3 O95887 Q6PJA6 Q8N2Q4 Q96K45 Q96K53,Thioredoxin domain-containing protein 11,EF-hand-binding protein 1;, PF00085;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane;|Q6PKC3 O95887 Q6PJA6 Q8N2Q4 Q96K45 Q96K53,Thioredoxin domain-containing protein 11,EF-hand-binding protein 1;, PF00085;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane;|Q6PKC3 O95887 Q6PJA6 Q8N2Q4 Q96K45 Q96K53,Thioredoxin domain-containing protein 11,EF-hand-binding protein 1;, PF00085;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane;|Q6PKC3 O95887 Q6PJA6 Q8N2Q4 Q96K45 Q96K53,Thioredoxin domain-containing protein 11,EF-hand-binding protein 1;, PF00085;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane;|Q6PKC3 O95887 Q6PJA6 Q8N2Q4 Q96K45 Q96K53,Thioredoxin domain-containing protein 11,EF-hand-binding protein 1;, PF00085;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane; scaffold38 indexed_genome mRNA 6692927 6710844 . - . ID=transcript_7869;Q8IWR0 D3DUG5 Q9NPE9,Zinc finger CCCH domain-containing protein 7A,, PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA;|Q8IWR0 D3DUG5 Q9NPE9,Zinc finger CCCH domain-containing protein 7A,, PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA;|Q8IWR0 D3DUG5 Q9NPE9,Zinc finger CCCH domain-containing protein 7A,, PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA;|Q8IWR0 D3DUG5 Q9NPE9,Zinc finger CCCH domain-containing protein 7A,, PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA;|Q8IWR0 D3DUG5 Q9NPE9,Zinc finger CCCH domain-containing protein 7A,, PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA;|Q8IWR0 D3DUG5 Q9NPE9,Zinc finger CCCH domain-containing protein 7A,, PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA;|Q8IWR0 D3DUG5 Q9NPE9,Zinc finger CCCH domain-containing protein 7A,, PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; scaffold38 indexed_genome mRNA 6710922 6719340 . - . ID=transcript_7870;Q8IWR0 D3DUG5 Q9NPE9,Zinc finger CCCH domain-containing protein 7A,, PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; scaffold38 indexed_genome mRNA 6799227 6812593 . - . ID=transcript_7871;O76021 B4DJ58 D3DUG7 Q2M1T7 Q6PL22 Q8IWS7 Q8WUZ1 Q9HDA9 Q9Y3Z9,Ribosomal L1 domain-containing protein 1,CATX-11;Cellular senescence-inhibited gene protein {ECO:0000303|PubMed:18678645};Protein PBK1;, PF00687;, GO:0030686;GO:0005694;GO:0016020;GO:0005730;GO:0045296;GO:0003730;GO:0048027;GO:0003723;GO:0000470;GO:0001649;GO:0042981;GO:2000772;GO:0032880;, C:90S preribosome; C:chromosome; C:membrane; C:nucleolus;, F:cadherin binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:RNA binding;, P:maturation of LSU-rRNA; P:osteoblast differentiation; P:regulation of apoptotic process; P:regulation of cellular senescence; P:regulation of protein localization;|O76021 B4DJ58 D3DUG7 Q2M1T7 Q6PL22 Q8IWS7 Q8WUZ1 Q9HDA9 Q9Y3Z9,Ribosomal L1 domain-containing protein 1,CATX-11;Cellular senescence-inhibited gene protein {ECO:0000303|PubMed:18678645};Protein PBK1;, PF00687;, GO:0030686;GO:0005694;GO:0016020;GO:0005730;GO:0045296;GO:0003730;GO:0048027;GO:0003723;GO:0000470;GO:0001649;GO:0042981;GO:2000772;GO:0032880;, C:90S preribosome; C:chromosome; C:membrane; C:nucleolus;, F:cadherin binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:RNA binding;, P:maturation of LSU-rRNA; P:osteoblast differentiation; P:regulation of apoptotic process; P:regulation of cellular senescence; P:regulation of protein localization;|O76021 B4DJ58 D3DUG7 Q2M1T7 Q6PL22 Q8IWS7 Q8WUZ1 Q9HDA9 Q9Y3Z9,Ribosomal L1 domain-containing protein 1,CATX-11;Cellular senescence-inhibited gene protein {ECO:0000303|PubMed:18678645};Protein PBK1;, PF00687;, GO:0030686;GO:0005694;GO:0016020;GO:0005730;GO:0045296;GO:0003730;GO:0048027;GO:0003723;GO:0000470;GO:0001649;GO:0042981;GO:2000772;GO:0032880;, C:90S preribosome; C:chromosome; C:membrane; C:nucleolus;, F:cadherin binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:RNA binding;, P:maturation of LSU-rRNA; P:osteoblast differentiation; P:regulation of apoptotic process; P:regulation of cellular senescence; P:regulation of protein localization; scaffold38 indexed_genome mRNA 6820649 6862689 . - . ID=transcript_7872;P15170 J3KQG6 Q96GF2,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,G1 to S phase transition protein 1 homolog;, PF00009;PF03144;PF03143;, GO:0005829;GO:0018444;GO:0005525;GO:0003924;GO:0003723;GO:0003747;GO:0002184;GO:0000082;GO:0000184;GO:0006479;GO:0006449;GO:0006412;, C:cytosol; C:translation release factor complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation release factor activity;, P:cytoplasmic translational termination; P:G1/S transition of mitotic cell cycle; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translation;|Q8IYD1 Q9H909 Q9NVY0 Q9NY44,Eukaryotic peptide chain release factor GTP-binding subunit ERF3B,G1 to S phase transition protein 2 homolog;, PF00009;PF03143;PF07145;, GO:0005829;GO:0018444;GO:0005525;GO:0003924;GO:0003723;GO:0003747;GO:0007049;GO:0002184;GO:0000184;GO:0006412;, C:cytosol; C:translation release factor complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation release factor activity;, P:cell cycle; P:cytoplasmic translational termination; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:translation;|P15170 J3KQG6 Q96GF2,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,G1 to S phase transition protein 1 homolog;, PF00009;PF03144;PF03143;, GO:0005829;GO:0018444;GO:0005525;GO:0003924;GO:0003723;GO:0003747;GO:0002184;GO:0000082;GO:0000184;GO:0006479;GO:0006449;GO:0006412;, C:cytosol; C:translation release factor complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation release factor activity;, P:cytoplasmic translational termination; P:G1/S transition of mitotic cell cycle; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translation;|P15170 J3KQG6 Q96GF2,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,G1 to S phase transition protein 1 homolog;, PF00009;PF03144;PF03143;, GO:0005829;GO:0018444;GO:0005525;GO:0003924;GO:0003723;GO:0003747;GO:0002184;GO:0000082;GO:0000184;GO:0006479;GO:0006449;GO:0006412;, C:cytosol; C:translation release factor complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation release factor activity;, P:cytoplasmic translational termination; P:G1/S transition of mitotic cell cycle; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translation;|P15170 J3KQG6 Q96GF2,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,G1 to S phase transition protein 1 homolog;, PF00009;PF03144;PF03143;, GO:0005829;GO:0018444;GO:0005525;GO:0003924;GO:0003723;GO:0003747;GO:0002184;GO:0000082;GO:0000184;GO:0006479;GO:0006449;GO:0006412;, C:cytosol; C:translation release factor complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation release factor activity;, P:cytoplasmic translational termination; P:G1/S transition of mitotic cell cycle; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translation;|P15170 J3KQG6 Q96GF2,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,G1 to S phase transition protein 1 homolog;, PF00009;PF03144;PF03143;, GO:0005829;GO:0018444;GO:0005525;GO:0003924;GO:0003723;GO:0003747;GO:0002184;GO:0000082;GO:0000184;GO:0006479;GO:0006449;GO:0006412;, C:cytosol; C:translation release factor complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation release factor activity;, P:cytoplasmic translational termination; P:G1/S transition of mitotic cell cycle; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein methylation; P:regulation of translational termination; P:translation; scaffold38 indexed_genome mRNA 6940262 6940799 . + . ID=transcript_7873;Q02223 Q2TQ40,Tumor necrosis factor receptor superfamily member 17,B-cell maturation protein;, PF09257;, GO:0012505;GO:0016021;GO:0005886;GO:0038023;GO:0002250;GO:0002260;GO:0007275;GO:0007165;GO:0033209;, C:endomembrane system; C:integral component of membrane; C:plasma membrane;, F:signaling receptor activity;, P:adaptive immune response; P:lymphocyte homeostasis; P:multicellular organism development; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; scaffold38 indexed_genome mRNA 6974059 7526844 . + . ID=transcript_7874;Q8TEQ0 B5MDW2 Q8N2X2 Q9HA26,Sorting nexin-29,RUN domain-containing protein 2A;, PF00787;PF02759;, GO:0035091;, , F:phosphatidylinositol binding; scaffold38 indexed_genome mRNA 7622579 7624785 . + . ID=transcript_7875;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold38 indexed_genome mRNA 7632841 7758903 . - . ID=transcript_7876;Q9BRF8 B4DQ68 Q6MZY9 Q9H9M9 Q9NUT6,Serine/threonine-protein phosphatase CPPED1,Calcineurin-like phosphoesterase domain-containing protein 1;Complete S-transactivated protein 1;, PF00149;, GO:0035578;GO:0005829;GO:0005576;GO:0005886;GO:0046872;GO:0106306;GO:0106307;GO:0043312;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:plasma membrane;, F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:neutrophil degranulation; scaffold38 indexed_genome mRNA 8191764 8192268 . + . ID=transcript_7877;B4DS77 C9J314 C9JCE9,Protein shisa-9,, PF13908;, GO:0032281;GO:0032591;GO:0098978;GO:0099061;GO:0008328;GO:0014069;GO:0045211;GO:0045202;GO:0030165;GO:2000311;GO:0098962;GO:0048172;, C:AMPA glutamate receptor complex; C:dendritic spine membrane; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:ionotropic glutamate receptor complex; C:postsynaptic density; C:postsynaptic membrane; C:synapse;, F:PDZ domain binding;, P:regulation of AMPA receptor activity; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of short-term neuronal synaptic plasticity; scaffold38 indexed_genome mRNA 9024362 9038486 . + . ID=transcript_7878;Q92889 A5PKV6 A8K111 O00140 Q8TD83,DNA repair endonuclease XPF,DNA excision repair protein ERCC-4;DNA repair protein complementing XP-F cells;Xeroderma pigmentosum group F-complementing protein;, PF02732;, GO:0000781;GO:0070522;GO:0005654;GO:0000109;GO:0000110;GO:0005634;GO:0003684;GO:0004520;GO:0042802;GO:1990841;GO:0008022;GO:0047485;GO:0003697;GO:0000014;GO:0001094;GO:0034644;GO:0006281;GO:0000724;GO:0006303;GO:0070911;GO:0036297;GO:1905768;GO:1905765;GO:0051974;GO:0032205;GO:1904357;GO:0006289;GO:1901255;GO:0033683;GO:0006295;GO:0006296;GO:0006293;GO:0010506;GO:0000712;GO:0009411;GO:0000723;GO:0061819;GO:0006283;GO:0009650;, C:chromosome, telomeric region; C:ERCC4-ERCC1 complex; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 1 complex; C:nucleus;, F:damaged DNA binding; F:endodeoxyribonuclease activity; F:identical protein binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein N-terminus binding; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:TFIID-class transcription factor complex binding;, P:cellular response to UV; P:DNA repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:global genome nucleotide-excision repair; P:interstrand cross-link repair; P:negative regulation of double-stranded telomeric DNA binding; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance; P:negative regulation of telomere maintenance via telomere lengthening; P:nucleotide-excision repair; P:nucleotide-excision repair involved in interstrand cross-link repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of autophagy; P:resolution of meiotic recombination intermediates; P:response to UV; P:telomere maintenance; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:UV protection; scaffold38 indexed_genome mRNA 9038508 9044334 . - . ID=transcript_7879;Q92889 A5PKV6 A8K111 O00140 Q8TD83,DNA repair endonuclease XPF,DNA excision repair protein ERCC-4;DNA repair protein complementing XP-F cells;Xeroderma pigmentosum group F-complementing protein;, PF02732;, GO:0000781;GO:0070522;GO:0005654;GO:0000109;GO:0000110;GO:0005634;GO:0003684;GO:0004520;GO:0042802;GO:1990841;GO:0008022;GO:0047485;GO:0003697;GO:0000014;GO:0001094;GO:0034644;GO:0006281;GO:0000724;GO:0006303;GO:0070911;GO:0036297;GO:1905768;GO:1905765;GO:0051974;GO:0032205;GO:1904357;GO:0006289;GO:1901255;GO:0033683;GO:0006295;GO:0006296;GO:0006293;GO:0010506;GO:0000712;GO:0009411;GO:0000723;GO:0061819;GO:0006283;GO:0009650;, C:chromosome, telomeric region; C:ERCC4-ERCC1 complex; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 1 complex; C:nucleus;, F:damaged DNA binding; F:endodeoxyribonuclease activity; F:identical protein binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein N-terminus binding; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:TFIID-class transcription factor complex binding;, P:cellular response to UV; P:DNA repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:global genome nucleotide-excision repair; P:interstrand cross-link repair; P:negative regulation of double-stranded telomeric DNA binding; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance; P:negative regulation of telomere maintenance via telomere lengthening; P:nucleotide-excision repair; P:nucleotide-excision repair involved in interstrand cross-link repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of autophagy; P:resolution of meiotic recombination intermediates; P:response to UV; P:telomere maintenance; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:UV protection; scaffold38 indexed_genome mRNA 9157772 9342587 . + . ID=transcript_7880;Q9ULH7 A6ND53 B4DGT8 Q68CT1 Q6UB16 Q86WW2 Q8N226,Myocardin-related transcription factor B {ECO:0000305},MKL/myocardin-like protein 2;Megakaryoblastic leukemia 2 {ECO:0000303|PubMed:14565952};, PF02755;PF02037;, GO:0005634;GO:0045296;GO:0003713;GO:0007517;GO:0045844;GO:0045944;GO:0051145;, C:nucleus;, F:cadherin binding; F:transcription coactivator activity;, P:muscle organ development; P:positive regulation of striated muscle tissue development; P:positive regulation of transcription by RNA polymerase II; P:smooth muscle cell differentiation;|Q9ULH7 A6ND53 B4DGT8 Q68CT1 Q6UB16 Q86WW2 Q8N226,Myocardin-related transcription factor B {ECO:0000305},MKL/myocardin-like protein 2;Megakaryoblastic leukemia 2 {ECO:0000303|PubMed:14565952};, PF02755;PF02037;, GO:0005634;GO:0045296;GO:0003713;GO:0007517;GO:0045844;GO:0045944;GO:0051145;, C:nucleus;, F:cadherin binding; F:transcription coactivator activity;, P:muscle organ development; P:positive regulation of striated muscle tissue development; P:positive regulation of transcription by RNA polymerase II; P:smooth muscle cell differentiation; scaffold38 indexed_genome mRNA 9342630 9361709 . + . ID=transcript_7881;Q9ULH7 A6ND53 B4DGT8 Q68CT1 Q6UB16 Q86WW2 Q8N226,Myocardin-related transcription factor B {ECO:0000305},MKL/myocardin-like protein 2;Megakaryoblastic leukemia 2 {ECO:0000303|PubMed:14565952};, PF02755;PF02037;, GO:0005634;GO:0045296;GO:0003713;GO:0007517;GO:0045844;GO:0045944;GO:0051145;, C:nucleus;, F:cadherin binding; F:transcription coactivator activity;, P:muscle organ development; P:positive regulation of striated muscle tissue development; P:positive regulation of transcription by RNA polymerase II; P:smooth muscle cell differentiation;|Q9ULH7 A6ND53 B4DGT8 Q68CT1 Q6UB16 Q86WW2 Q8N226,Myocardin-related transcription factor B {ECO:0000305},MKL/myocardin-like protein 2;Megakaryoblastic leukemia 2 {ECO:0000303|PubMed:14565952};, PF02755;PF02037;, GO:0005634;GO:0045296;GO:0003713;GO:0007517;GO:0045844;GO:0045944;GO:0051145;, C:nucleus;, F:cadherin binding; F:transcription coactivator activity;, P:muscle organ development; P:positive regulation of striated muscle tissue development; P:positive regulation of transcription by RNA polymerase II; P:smooth muscle cell differentiation; scaffold38 indexed_genome mRNA 9538725 9715228 . - . ID=transcript_7882;O95453 B2RCB3 B4DDG8 B4DSB0 B4DWR4 B4E1H6,Poly(A)-specific ribonuclease PARN,Deadenylating nuclease;Deadenylation nuclease;Polyadenylate-specific ribonuclease;, PF04857;PF08675;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005634;GO:0000175;GO:0043169;GO:0046872;GO:0003730;GO:0004518;GO:0004535;GO:0019901;GO:0003723;GO:0070034;GO:0000495;GO:0007292;GO:0010587;GO:0110008;GO:0000184;GO:0000289;GO:0071051;GO:0051973;GO:0032212;GO:0043488;GO:1904872;GO:0009451;GO:0090503;GO:0090669;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleus;, F:3'-5'-exoribonuclease activity; F:cation binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:nuclease activity; F:poly(A)-specific ribonuclease activity; F:protein kinase binding; F:RNA binding; F:telomerase RNA binding;, P:box H/ACA RNA 3'-end processing; P:female gamete generation; P:miRNA catabolic process; P:ncRNA deadenylation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:polyadenylation-dependent snoRNA 3'-end processing; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:regulation of mRNA stability; P:regulation of telomerase RNA localization to Cajal body; P:RNA modification; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:telomerase RNA stabilization;|O95453 B2RCB3 B4DDG8 B4DSB0 B4DWR4 B4E1H6,Poly(A)-specific ribonuclease PARN,Deadenylating nuclease;Deadenylation nuclease;Polyadenylate-specific ribonuclease;, PF04857;PF08675;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005634;GO:0000175;GO:0043169;GO:0046872;GO:0003730;GO:0004518;GO:0004535;GO:0019901;GO:0003723;GO:0070034;GO:0000495;GO:0007292;GO:0010587;GO:0110008;GO:0000184;GO:0000289;GO:0071051;GO:0051973;GO:0032212;GO:0043488;GO:1904872;GO:0009451;GO:0090503;GO:0090669;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleus;, F:3'-5'-exoribonuclease activity; F:cation binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:nuclease activity; F:poly(A)-specific ribonuclease activity; F:protein kinase binding; F:RNA binding; F:telomerase RNA binding;, P:box H/ACA RNA 3'-end processing; P:female gamete generation; P:miRNA catabolic process; P:ncRNA deadenylation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:polyadenylation-dependent snoRNA 3'-end processing; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:regulation of mRNA stability; P:regulation of telomerase RNA localization to Cajal body; P:RNA modification; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:telomerase RNA stabilization;|O95453 B2RCB3 B4DDG8 B4DSB0 B4DWR4 B4E1H6,Poly(A)-specific ribonuclease PARN,Deadenylating nuclease;Deadenylation nuclease;Polyadenylate-specific ribonuclease;, PF04857;PF08675;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005634;GO:0000175;GO:0043169;GO:0046872;GO:0003730;GO:0004518;GO:0004535;GO:0019901;GO:0003723;GO:0070034;GO:0000495;GO:0007292;GO:0010587;GO:0110008;GO:0000184;GO:0000289;GO:0071051;GO:0051973;GO:0032212;GO:0043488;GO:1904872;GO:0009451;GO:0090503;GO:0090669;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleus;, F:3'-5'-exoribonuclease activity; F:cation binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:nuclease activity; F:poly(A)-specific ribonuclease activity; F:protein kinase binding; F:RNA binding; F:telomerase RNA binding;, P:box H/ACA RNA 3'-end processing; P:female gamete generation; P:miRNA catabolic process; P:ncRNA deadenylation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:polyadenylation-dependent snoRNA 3'-end processing; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:regulation of mRNA stability; P:regulation of telomerase RNA localization to Cajal body; P:RNA modification; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:telomerase RNA stabilization; scaffold38 indexed_genome mRNA 9720447 9735674 . + . ID=transcript_7883;Q9NZS9 A8K4Z9 B4DUT0 D3DUG8,Bifunctional apoptosis regulator,RING finger protein 47;, PF00536;, GO:0005783;GO:0030176;GO:0005887;GO:0016020;GO:0089720;GO:0046872;GO:0030674;GO:0061630;GO:0006915;GO:0043066;GO:1903895;GO:0043161;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0006511;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:caspase binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:ubiquitin protein ligase activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9NZS9 A8K4Z9 B4DUT0 D3DUG8,Bifunctional apoptosis regulator,RING finger protein 47;, PF00536;, GO:0005783;GO:0030176;GO:0005887;GO:0016020;GO:0089720;GO:0046872;GO:0030674;GO:0061630;GO:0006915;GO:0043066;GO:1903895;GO:0043161;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0006511;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:caspase binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:ubiquitin protein ligase activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold38 indexed_genome mRNA 9743074 9748658 . + . ID=transcript_7884;Q9NZS9 A8K4Z9 B4DUT0 D3DUG8,Bifunctional apoptosis regulator,RING finger protein 47;, PF00536;, GO:0005783;GO:0030176;GO:0005887;GO:0016020;GO:0089720;GO:0046872;GO:0030674;GO:0061630;GO:0006915;GO:0043066;GO:1903895;GO:0043161;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0006511;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:caspase binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:ubiquitin protein ligase activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9NZS9 A8K4Z9 B4DUT0 D3DUG8,Bifunctional apoptosis regulator,RING finger protein 47;, PF00536;, GO:0005783;GO:0030176;GO:0005887;GO:0016020;GO:0089720;GO:0046872;GO:0030674;GO:0061630;GO:0006915;GO:0043066;GO:1903895;GO:0043161;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0006511;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:caspase binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:ubiquitin protein ligase activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9NZS9 A8K4Z9 B4DUT0 D3DUG8,Bifunctional apoptosis regulator,RING finger protein 47;, PF00536;, GO:0005783;GO:0030176;GO:0005887;GO:0016020;GO:0089720;GO:0046872;GO:0030674;GO:0061630;GO:0006915;GO:0043066;GO:1903895;GO:0043161;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0006511;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:caspase binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:ubiquitin protein ligase activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of IRE1-mediated unfolded protein response; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold38 indexed_genome mRNA 9821585 9823113 . + . ID=transcript_7885;C9JI98,Transmembrane protein 238,, PF15125;, GO:0016021;, C:integral component of membrane; scaffold38 indexed_genome mRNA 9844864 9859605 . + . ID=transcript_7886;Q9NYV6 A2RTY9 B4E0J7 B4E3T2 Q3MHU9 Q6IPL4 Q9H4F0,RNA polymerase I-specific transcription initiation factor RRN3,Transcription initiation factor IA;, PF05327;, GO:0005730;GO:0005654;GO:0005634;GO:0001042;GO:0001164;GO:0001181;GO:0010976;GO:0006361;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA polymerase I core binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:RNA polymerase I general transcription initiation factor activity;, P:positive regulation of neuron projection development; P:transcription initiation from RNA polymerase I promoter; scaffold38 indexed_genome mRNA 9859606 9872896 . + . ID=transcript_7887;Q9NYV6 A2RTY9 B4E0J7 B4E3T2 Q3MHU9 Q6IPL4 Q9H4F0,RNA polymerase I-specific transcription initiation factor RRN3,Transcription initiation factor IA;, PF05327;, GO:0005730;GO:0005654;GO:0005634;GO:0001042;GO:0001164;GO:0001181;GO:0010976;GO:0006361;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA polymerase I core binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:RNA polymerase I general transcription initiation factor activity;, P:positive regulation of neuron projection development; P:transcription initiation from RNA polymerase I promoter;|A6NIE6,Putative RRN3-like protein RRN3P2,RNA polymerase I transcription factor homolog pseudogene 2;, PF05327;, GO:0005634;GO:0001042;GO:0001181;GO:0006361;, C:nucleus;, F:RNA polymerase I core binding; F:RNA polymerase I general transcription initiation factor activity;, P:transcription initiation from RNA polymerase I promoter;|Q9NYV6 A2RTY9 B4E0J7 B4E3T2 Q3MHU9 Q6IPL4 Q9H4F0,RNA polymerase I-specific transcription initiation factor RRN3,Transcription initiation factor IA;, PF05327;, GO:0005730;GO:0005654;GO:0005634;GO:0001042;GO:0001164;GO:0001181;GO:0010976;GO:0006361;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA polymerase I core binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:RNA polymerase I general transcription initiation factor activity;, P:positive regulation of neuron projection development; P:transcription initiation from RNA polymerase I promoter;|Q2M238 A8K6T4 B3KWX9 O75704,Putative RRN3-like protein RRN3P1,RNA polymerase I transcription factor homolog pseudogene 1;, PF05327;, GO:0005634;GO:0001042;GO:0001181;GO:0006361;, C:nucleus;, F:RNA polymerase I core binding; F:RNA polymerase I general transcription initiation factor activity;, P:transcription initiation from RNA polymerase I promoter;|Q9NYV6 A2RTY9 B4E0J7 B4E3T2 Q3MHU9 Q6IPL4 Q9H4F0,RNA polymerase I-specific transcription initiation factor RRN3,Transcription initiation factor IA;, PF05327;, GO:0005730;GO:0005654;GO:0005634;GO:0001042;GO:0001164;GO:0001181;GO:0010976;GO:0006361;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA polymerase I core binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:RNA polymerase I general transcription initiation factor activity;, P:positive regulation of neuron projection development; P:transcription initiation from RNA polymerase I promoter;|Q9NYV6 A2RTY9 B4E0J7 B4E3T2 Q3MHU9 Q6IPL4 Q9H4F0,RNA polymerase I-specific transcription initiation factor RRN3,Transcription initiation factor IA;, PF05327;, GO:0005730;GO:0005654;GO:0005634;GO:0001042;GO:0001164;GO:0001181;GO:0010976;GO:0006361;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA polymerase I core binding; F:RNA polymerase I core promoter sequence-specific DNA binding; F:RNA polymerase I general transcription initiation factor activity;, P:positive regulation of neuron projection development; P:transcription initiation from RNA polymerase I promoter; scaffold38 indexed_genome mRNA 9880684 9949165 . + . ID=transcript_7888;Q96AB6 Q7Z4Z0,Protein N-terminal asparagine amidohydrolase,Protein NH2-terminal asparagine amidohydrolase;Protein NH2-terminal asparagine deamidase;, PF14736;, GO:0005737;GO:0005634;GO:0008418;GO:0006511;, C:cytoplasm; C:nucleus;, F:protein-N-terminal asparagine amidohydrolase activity;, P:ubiquitin-dependent protein catabolic process;|Q96AB6 Q7Z4Z0,Protein N-terminal asparagine amidohydrolase,Protein NH2-terminal asparagine amidohydrolase;Protein NH2-terminal asparagine deamidase;, PF14736;, GO:0005737;GO:0005634;GO:0008418;GO:0006511;, C:cytoplasm; C:nucleus;, F:protein-N-terminal asparagine amidohydrolase activity;, P:ubiquitin-dependent protein catabolic process;|Q96AB6 Q7Z4Z0,Protein N-terminal asparagine amidohydrolase,Protein NH2-terminal asparagine amidohydrolase;Protein NH2-terminal asparagine deamidase;, PF14736;, GO:0005737;GO:0005634;GO:0008418;GO:0006511;, C:cytoplasm; C:nucleus;, F:protein-N-terminal asparagine amidohydrolase activity;, P:ubiquitin-dependent protein catabolic process;|Q96AB6 Q7Z4Z0,Protein N-terminal asparagine amidohydrolase,Protein NH2-terminal asparagine amidohydrolase;Protein NH2-terminal asparagine deamidase;, PF14736;, GO:0005737;GO:0005634;GO:0008418;GO:0006511;, C:cytoplasm; C:nucleus;, F:protein-N-terminal asparagine amidohydrolase activity;, P:ubiquitin-dependent protein catabolic process;|Q96AB6 Q7Z4Z0,Protein N-terminal asparagine amidohydrolase,Protein NH2-terminal asparagine amidohydrolase;Protein NH2-terminal asparagine deamidase;, PF14736;, GO:0005737;GO:0005634;GO:0008418;GO:0006511;, C:cytoplasm; C:nucleus;, F:protein-N-terminal asparagine amidohydrolase activity;, P:ubiquitin-dependent protein catabolic process;|Q96AB6 Q7Z4Z0,Protein N-terminal asparagine amidohydrolase,Protein NH2-terminal asparagine amidohydrolase;Protein NH2-terminal asparagine deamidase;, PF14736;, GO:0005737;GO:0005634;GO:0008418;GO:0006511;, C:cytoplasm; C:nucleus;, F:protein-N-terminal asparagine amidohydrolase activity;, P:ubiquitin-dependent protein catabolic process;|Q86YF1 Q8N4Q9 Q8TBS5,Pyridoxal-dependent decarboxylase domain-containing protein 1,, PF00282;, GO:0005783;GO:0005794;GO:0043231;GO:0045296;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0019752;GO:0030149;, C:endoplasmic reticulum; C:Golgi apparatus; C:intracellular membrane-bounded organelle;, F:cadherin binding; F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:carboxylic acid metabolic process; P:sphingolipid catabolic process;|Q6P474 A8K9Z5,Putative pyridoxal-dependent decarboxylase domain-containing protein 2,pyridoxal-dependent decarboxylase domain-containing 2 pseudogene;, PF00282;, GO:0005783;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0019752;GO:0030149;, C:endoplasmic reticulum;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:carboxylic acid metabolic process; P:sphingolipid catabolic process;|Q6P474 A8K9Z5,Putative pyridoxal-dependent decarboxylase domain-containing protein 2,pyridoxal-dependent decarboxylase domain-containing 2 pseudogene;, PF00282;, GO:0005783;GO:0016831;GO:0030170;GO:0008117;GO:0001667;GO:0019752;GO:0030149;, C:endoplasmic reticulum;, F:carboxy-lyase activity; F:pyridoxal phosphate binding; F:sphinganine-1-phosphate aldolase activity;, P:ameboidal-type cell migration; P:carboxylic acid metabolic process; P:sphingolipid catabolic process; scaffold38 indexed_genome mRNA 9978131 9987677 . + . ID=transcript_7889;Q2QL34 B4DDY1 Q6P7T6 Q8N8E9,Mpv17-like protein,M-LP homolog;, PF04117;, GO:0005737;GO:0016021;GO:0043231;GO:0005739;GO:0005778;GO:0005777;GO:0010730;GO:1901029;GO:0072593;, C:cytoplasm; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrion; C:peroxisomal membrane; C:peroxisome;, , P:negative regulation of hydrogen peroxide biosynthetic process; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:reactive oxygen species metabolic process; scaffold38 indexed_genome mRNA 10029315 10172122 . + . ID=transcript_7890;Q96MC5 O00223 O75769 Q8IZ36 Q96H25,bMERB domain-containing protein 1 {ECO:0000305},, PF12130;, GO:0015630;GO:0021822;GO:0007026;, C:microtubule cytoskeleton;, , P:negative regulation of cell motility involved in cerebral cortex radial glia guided migration; P:negative regulation of microtubule depolymerization; scaffold38 indexed_genome mRNA 10188581 10226661 . - . ID=transcript_7891;Q9Y4J9,Meiosis regulator and mRNA stability factor 1 {ECO:0000312|HGNC:HGNC:29562},Limkain-b1 {ECO:0000303|PubMed:15932519};Meiosis arrest female protein 1 {ECO:0000305};, PF11608;PF01936;PF12872;, GO:0005737;GO:0005794;GO:0043231;GO:0016020;GO:0005777;GO:1905762;GO:1903231;GO:0006302;GO:0007143;GO:0010923;GO:0048477;GO:0016441;GO:0010468;, C:cytoplasm; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:peroxisome;, F:CCR4-NOT complex binding; F:mRNA binding involved in posttranscriptional gene silencing;, P:double-strand break repair; P:female meiotic nuclear division; P:negative regulation of phosphatase activity; P:oogenesis; P:posttranscriptional gene silencing; P:regulation of gene expression; scaffold38 indexed_genome mRNA 10247773 10274280 . + . ID=transcript_7892;Q9NXR1 Q49AQ2,Nuclear distribution protein nudE homolog 1,, PF04880;, GO:0005813;GO:0032154;GO:0000777;GO:0005829;GO:0005871;GO:0000776;GO:0016020;GO:0005874;GO:0031616;GO:0042802;GO:0008017;GO:0030154;GO:0051301;GO:0016477;GO:0051298;GO:0051642;GO:0021987;GO:0007059;GO:0097711;GO:0051303;GO:0000132;GO:0000086;GO:0007020;GO:0007100;GO:0007052;GO:0010389;GO:2000574;GO:0047496;, C:centrosome; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytosol; C:kinesin complex; C:kinetochore; C:membrane; C:microtubule; C:spindle pole centrosome;, F:identical protein binding; F:microtubule binding;, P:cell differentiation; P:cell division; P:cell migration; P:centrosome duplication; P:centrosome localization; P:cerebral cortex development; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:establishment of chromosome localization; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:microtubule nucleation; P:mitotic centrosome separation; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule motor activity; P:vesicle transport along microtubule; scaffold38 indexed_genome mRNA 10277220 10280113 . + . ID=transcript_7893;P35749 D2JYH7 O00396 O94944 P78422 Q3MIV8 Q3MNF0 Q3MNF1,Myosin-11,Myosin heavy chain 11;Myosin heavy chain, smooth muscle isoform;SMMHC;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0042470;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0008307;GO:0048739;GO:0048251;GO:0006936;GO:0030241;GO:0006939;, C:cytosol; C:extracellular exosome; C:melanosome; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity; F:structural constituent of muscle;, P:cardiac muscle fiber development; P:elastic fiber assembly; P:muscle contraction; P:skeletal muscle myosin thick filament assembly; P:smooth muscle contraction; scaffold38 indexed_genome mRNA 10281014 10291947 . - . ID=transcript_7894;Q6PK16 Q9BWG0,Myosin-10,Cellular myosin heavy chain, type B;Myosin heavy chain 10;Myosin heavy chain, non-muscle IIb;Non-muscle myosin heavy chain B;Non-muscle myosin heavy chain IIb;, PF00612;PF00063;PF02736;PF01576;, GO:0042641;GO:0005938;GO:0032154;GO:0005737;GO:0005829;GO:0070062;GO:0030027;GO:0030496;GO:0016459;GO:0016460;GO:0097513;GO:0005634;GO:0005844;GO:0001725;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0048027;GO:0035613;GO:0030048;GO:0031032;GO:0007155;GO:0000281;GO:0098885;GO:0050714;GO:0008360;, C:actomyosin; C:cell cortex; C:cleavage furrow; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamellipodium; C:midbody; C:myosin complex; C:myosin II complex; C:myosin II filament; C:nucleus; C:polysome; C:stress fiber;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:mRNA 5'-UTR binding; F:RNA stem-loop binding;, P:actin filament-based movement; P:actomyosin structure organization; P:cell adhesion; P:mitotic cytokinesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of protein secretion; P:regulation of cell shape; scaffold38 indexed_genome mRNA 10292803 10386277 . - . ID=transcript_7895;P35749 D2JYH7 O00396 O94944 P78422 Q3MIV8 Q3MNF0 Q3MNF1,Myosin-11,Myosin heavy chain 11;Myosin heavy chain, smooth muscle isoform;SMMHC;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0042470;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0008307;GO:0048739;GO:0048251;GO:0006936;GO:0030241;GO:0006939;, C:cytosol; C:extracellular exosome; C:melanosome; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity; F:structural constituent of muscle;, P:cardiac muscle fiber development; P:elastic fiber assembly; P:muscle contraction; P:skeletal muscle myosin thick filament assembly; P:smooth muscle contraction;|P35749 D2JYH7 O00396 O94944 P78422 Q3MIV8 Q3MNF0 Q3MNF1,Myosin-11,Myosin heavy chain 11;Myosin heavy chain, smooth muscle isoform;SMMHC;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0042470;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0008307;GO:0048739;GO:0048251;GO:0006936;GO:0030241;GO:0006939;, C:cytosol; C:extracellular exosome; C:melanosome; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity; F:structural constituent of muscle;, P:cardiac muscle fiber development; P:elastic fiber assembly; P:muscle contraction; P:skeletal muscle myosin thick filament assembly; P:smooth muscle contraction;|P35749 D2JYH7 O00396 O94944 P78422 Q3MIV8 Q3MNF0 Q3MNF1,Myosin-11,Myosin heavy chain 11;Myosin heavy chain, smooth muscle isoform;SMMHC;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0042470;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0008307;GO:0048739;GO:0048251;GO:0006936;GO:0030241;GO:0006939;, C:cytosol; C:extracellular exosome; C:melanosome; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity; F:structural constituent of muscle;, P:cardiac muscle fiber development; P:elastic fiber assembly; P:muscle contraction; P:skeletal muscle myosin thick filament assembly; P:smooth muscle contraction;|P35749 D2JYH7 O00396 O94944 P78422 Q3MIV8 Q3MNF0 Q3MNF1,Myosin-11,Myosin heavy chain 11;Myosin heavy chain, smooth muscle isoform;SMMHC;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0042470;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0008307;GO:0048739;GO:0048251;GO:0006936;GO:0030241;GO:0006939;, C:cytosol; C:extracellular exosome; C:melanosome; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity; F:structural constituent of muscle;, P:cardiac muscle fiber development; P:elastic fiber assembly; P:muscle contraction; P:skeletal muscle myosin thick filament assembly; P:smooth muscle contraction; scaffold38 indexed_genome mRNA 10409988 10425336 . - . ID=transcript_7896;Q96NB1 B3KPU9,Centrosomal protein 20 {ECO:0000305},FGFR1OP N-terminal-like protein;FOP-related protein of 20 kDa;LisH domain-containing protein FOPNL;, PF09398;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0031514;GO:0005654;GO:0042802;GO:0060271;GO:0034453;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:motile cilium; C:nucleoplasm;, F:identical protein binding;, P:cilium assembly; P:microtubule anchoring;|Q96NB1 B3KPU9,Centrosomal protein 20 {ECO:0000305},FGFR1OP N-terminal-like protein;FOP-related protein of 20 kDa;LisH domain-containing protein FOPNL;, PF09398;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0031514;GO:0005654;GO:0042802;GO:0060271;GO:0034453;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:motile cilium; C:nucleoplasm;, F:identical protein binding;, P:cilium assembly; P:microtubule anchoring;|Q96NB1 B3KPU9,Centrosomal protein 20 {ECO:0000305},FGFR1OP N-terminal-like protein;FOP-related protein of 20 kDa;LisH domain-containing protein FOPNL;, PF09398;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0031514;GO:0005654;GO:0042802;GO:0060271;GO:0034453;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:motile cilium; C:nucleoplasm;, F:identical protein binding;, P:cilium assembly; P:microtubule anchoring; scaffold38 indexed_genome mRNA 10530904 10623313 . + . ID=transcript_7897;Q9UQA0,Multidrug resistance-associated protein 1 {ECO:0000305},ATP-binding cassette sub-family C member 1;Glutathione-S-conjugate-translocating ATPase ABCC1 {ECO:0000250|UniProtKB:O35379};Leukotriene C(4) transporter;, PF00664;PF00005;, GO:0016324;GO:0009925;GO:0016323;GO:0070062;GO:0005887;GO:0016328;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0034040;GO:0042626;GO:0046943;GO:0015562;GO:0034634;GO:0042910;GO:1905039;GO:0060326;GO:1904646;GO:0009235;GO:0015889;GO:0140115;GO:0034775;GO:0042167;GO:0006691;GO:0071716;GO:0045332;GO:0050729;GO:0042493;GO:0099039;GO:0070633;GO:0055085;GO:0150104;GO:0042908;GO:1990962;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:lateral plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled lipid transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:carboxylic acid transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:carboxylic acid transmembrane transport; P:cell chemotaxis; P:cellular response to amyloid-beta; P:cobalamin metabolic process; P:cobalamin transport; P:export across plasma membrane; P:glutathione transmembrane transport; P:heme catabolic process; P:leukotriene metabolic process; P:leukotriene transport; P:phospholipid translocation; P:positive regulation of inflammatory response; P:response to drug; P:sphingolipid translocation; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport; P:xenobiotic transport across blood-brain barrier;|Q9UQA0,Multidrug resistance-associated protein 1 {ECO:0000305},ATP-binding cassette sub-family C member 1;Glutathione-S-conjugate-translocating ATPase ABCC1 {ECO:0000250|UniProtKB:O35379};Leukotriene C(4) transporter;, PF00664;PF00005;, GO:0016324;GO:0009925;GO:0016323;GO:0070062;GO:0005887;GO:0016328;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0034040;GO:0042626;GO:0046943;GO:0015562;GO:0034634;GO:0042910;GO:1905039;GO:0060326;GO:1904646;GO:0009235;GO:0015889;GO:0140115;GO:0034775;GO:0042167;GO:0006691;GO:0071716;GO:0045332;GO:0050729;GO:0042493;GO:0099039;GO:0070633;GO:0055085;GO:0150104;GO:0042908;GO:1990962;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:lateral plasma membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled lipid transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:carboxylic acid transmembrane transporter activity; F:efflux transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:carboxylic acid transmembrane transport; P:cell chemotaxis; P:cellular response to amyloid-beta; P:cobalamin metabolic process; P:cobalamin transport; P:export across plasma membrane; P:glutathione transmembrane transport; P:heme catabolic process; P:leukotriene metabolic process; P:leukotriene transport; P:phospholipid translocation; P:positive regulation of inflammatory response; P:response to drug; P:sphingolipid translocation; P:transepithelial transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport; P:xenobiotic transport across blood-brain barrier; scaffold38 indexed_genome mRNA 10632757 10706085 . - . ID=transcript_7898;O95255 A2RRN8 A8KIG6 A8Y988 E7ESW8 P78420 Q8TCY8 Q9UMZ7,ATP-binding cassette sub-family C member 6,Anthracycline resistance-associated protein;Multi-specific organic anion transporter E;Multidrug resistance-associated protein 6;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0005789;GO:0016021;GO:0016328;GO:0016020;GO:0005654;GO:0005886;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0030504;GO:0005215;GO:0015867;GO:0030643;GO:0006855;GO:0071716;GO:0042493;GO:0055085;GO:0007601;, C:apical plasma membrane; C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:inorganic diphosphate transmembrane transporter activity; F:transporter activity;, P:ATP transport; P:cellular phosphate ion homeostasis; P:drug transmembrane transport; P:leukotriene transport; P:response to drug; P:transmembrane transport; P:visual perception;|O95255 A2RRN8 A8KIG6 A8Y988 E7ESW8 P78420 Q8TCY8 Q9UMZ7,ATP-binding cassette sub-family C member 6,Anthracycline resistance-associated protein;Multi-specific organic anion transporter E;Multidrug resistance-associated protein 6;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0005789;GO:0016021;GO:0016328;GO:0016020;GO:0005654;GO:0005886;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0030504;GO:0005215;GO:0015867;GO:0030643;GO:0006855;GO:0071716;GO:0042493;GO:0055085;GO:0007601;, C:apical plasma membrane; C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:inorganic diphosphate transmembrane transporter activity; F:transporter activity;, P:ATP transport; P:cellular phosphate ion homeostasis; P:drug transmembrane transport; P:leukotriene transport; P:response to drug; P:transmembrane transport; P:visual perception;|O95255 A2RRN8 A8KIG6 A8Y988 E7ESW8 P78420 Q8TCY8 Q9UMZ7,ATP-binding cassette sub-family C member 6,Anthracycline resistance-associated protein;Multi-specific organic anion transporter E;Multidrug resistance-associated protein 6;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0005789;GO:0016021;GO:0016328;GO:0016020;GO:0005654;GO:0005886;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0030504;GO:0005215;GO:0015867;GO:0030643;GO:0006855;GO:0071716;GO:0042493;GO:0055085;GO:0007601;, C:apical plasma membrane; C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:inorganic diphosphate transmembrane transporter activity; F:transporter activity;, P:ATP transport; P:cellular phosphate ion homeostasis; P:drug transmembrane transport; P:leukotriene transport; P:response to drug; P:transmembrane transport; P:visual perception;|O95255 A2RRN8 A8KIG6 A8Y988 E7ESW8 P78420 Q8TCY8 Q9UMZ7,ATP-binding cassette sub-family C member 6,Anthracycline resistance-associated protein;Multi-specific organic anion transporter E;Multidrug resistance-associated protein 6;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0005789;GO:0016021;GO:0016328;GO:0016020;GO:0005654;GO:0005886;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0030504;GO:0005215;GO:0015867;GO:0030643;GO:0006855;GO:0071716;GO:0042493;GO:0055085;GO:0007601;, C:apical plasma membrane; C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:inorganic diphosphate transmembrane transporter activity; F:transporter activity;, P:ATP transport; P:cellular phosphate ion homeostasis; P:drug transmembrane transport; P:leukotriene transport; P:response to drug; P:transmembrane transport; P:visual perception;|O95255 A2RRN8 A8KIG6 A8Y988 E7ESW8 P78420 Q8TCY8 Q9UMZ7,ATP-binding cassette sub-family C member 6,Anthracycline resistance-associated protein;Multi-specific organic anion transporter E;Multidrug resistance-associated protein 6;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0005789;GO:0016021;GO:0016328;GO:0016020;GO:0005654;GO:0005886;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0030504;GO:0005215;GO:0015867;GO:0030643;GO:0006855;GO:0071716;GO:0042493;GO:0055085;GO:0007601;, C:apical plasma membrane; C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:inorganic diphosphate transmembrane transporter activity; F:transporter activity;, P:ATP transport; P:cellular phosphate ion homeostasis; P:drug transmembrane transport; P:leukotriene transport; P:response to drug; P:transmembrane transport; P:visual perception;|O95255 A2RRN8 A8KIG6 A8Y988 E7ESW8 P78420 Q8TCY8 Q9UMZ7,ATP-binding cassette sub-family C member 6,Anthracycline resistance-associated protein;Multi-specific organic anion transporter E;Multidrug resistance-associated protein 6;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0005789;GO:0016021;GO:0016328;GO:0016020;GO:0005654;GO:0005886;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0030504;GO:0005215;GO:0015867;GO:0030643;GO:0006855;GO:0071716;GO:0042493;GO:0055085;GO:0007601;, C:apical plasma membrane; C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:inorganic diphosphate transmembrane transporter activity; F:transporter activity;, P:ATP transport; P:cellular phosphate ion homeostasis; P:drug transmembrane transport; P:leukotriene transport; P:response to drug; P:transmembrane transport; P:visual perception;|O95255 A2RRN8 A8KIG6 A8Y988 E7ESW8 P78420 Q8TCY8 Q9UMZ7,ATP-binding cassette sub-family C member 6,Anthracycline resistance-associated protein;Multi-specific organic anion transporter E;Multidrug resistance-associated protein 6;, PF00664;PF00005;, GO:0016324;GO:0016323;GO:0005789;GO:0016021;GO:0016328;GO:0016020;GO:0005654;GO:0005886;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0030504;GO:0005215;GO:0015867;GO:0030643;GO:0006855;GO:0071716;GO:0042493;GO:0055085;GO:0007601;, C:apical plasma membrane; C:basolateral plasma membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:inorganic diphosphate transmembrane transporter activity; F:transporter activity;, P:ATP transport; P:cellular phosphate ion homeostasis; P:drug transmembrane transport; P:leukotriene transport; P:response to drug; P:transmembrane transport; P:visual perception; scaffold38 indexed_genome mRNA 10708995 10763522 . + . ID=transcript_7899;P69849,Nodal modulator 3,pM5 protein 3;, PF17802;, GO:0005789;GO:0016021;GO:0030246;GO:1900108;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:carbohydrate binding;, P:negative regulation of nodal signaling pathway;|Q5JPE7 Q4G177,Nodal modulator 2,pM5 protein 2;, PF17802;, GO:0005789;GO:0016021;GO:0032991;GO:0030246;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, F:carbohydrate binding;|Q5JPE7 Q4G177,Nodal modulator 2,pM5 protein 2;, PF17802;, GO:0005789;GO:0016021;GO:0032991;GO:0030246;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, F:carbohydrate binding;|P69849,Nodal modulator 3,pM5 protein 3;, PF17802;, GO:0005789;GO:0016021;GO:0030246;GO:1900108;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:carbohydrate binding;, P:negative regulation of nodal signaling pathway; scaffold38 indexed_genome mRNA 11824172 11892137 . + . ID=transcript_7900;Q86Y38 Q9H1B6,Xylosyltransferase 1,Peptide O-xylosyltransferase 1;Xylosyltransferase I;, PF02485;PF12529;, GO:0005615;GO:0000137;GO:0000139;GO:0016021;GO:0046872;GO:0030158;GO:0030206;GO:0050650;GO:0048706;GO:0006024;GO:0030203;GO:0015012;GO:0043931;GO:0030166;, C:extracellular space; C:Golgi cis cisterna; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:protein xylosyltransferase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:embryonic skeletal system development; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:ossification involved in bone maturation; P:proteoglycan biosynthetic process; scaffold38 indexed_genome mRNA 11927282 11973887 . + . ID=transcript_7901;Q86Y38 Q9H1B6,Xylosyltransferase 1,Peptide O-xylosyltransferase 1;Xylosyltransferase I;, PF02485;PF12529;, GO:0005615;GO:0000137;GO:0000139;GO:0016021;GO:0046872;GO:0030158;GO:0030206;GO:0050650;GO:0048706;GO:0006024;GO:0030203;GO:0015012;GO:0043931;GO:0030166;, C:extracellular space; C:Golgi cis cisterna; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:protein xylosyltransferase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:embryonic skeletal system development; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:ossification involved in bone maturation; P:proteoglycan biosynthetic process; scaffold38 indexed_genome mRNA 11973905 11980244 . - . ID=transcript_7902;Q86Y38 Q9H1B6,Xylosyltransferase 1,Peptide O-xylosyltransferase 1;Xylosyltransferase I;, PF02485;PF12529;, GO:0005615;GO:0000137;GO:0000139;GO:0016021;GO:0046872;GO:0030158;GO:0030206;GO:0050650;GO:0048706;GO:0006024;GO:0030203;GO:0015012;GO:0043931;GO:0030166;, C:extracellular space; C:Golgi cis cisterna; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:protein xylosyltransferase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:embryonic skeletal system development; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:ossification involved in bone maturation; P:proteoglycan biosynthetic process; scaffold38 indexed_genome mRNA 12506295 12512559 . - . ID=transcript_7903;P62244 P39027 P39031 Q3MHD9 Q8C023 Q9BV24,40S ribosomal protein S15a,Small ribosomal subunit protein uS8 {ECO:0000303|PubMed:24524803};, PF00410;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0003723;GO:0003735;GO:0000184;GO:0045787;GO:0008284;GO:0009615;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:response to virus; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62244 P39027 P39031 Q3MHD9 Q8C023 Q9BV24,40S ribosomal protein S15a,Small ribosomal subunit protein uS8 {ECO:0000303|PubMed:24524803};, PF00410;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0003723;GO:0003735;GO:0000184;GO:0045787;GO:0008284;GO:0009615;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:response to virus; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold38 indexed_genome mRNA 12516565 12522997 . - . ID=transcript_7904;Q15041 B7Z6S5 B7Z791 F5GXP4,ADP-ribosylation factor-like protein 6-interacting protein 1,Apoptotic regulator in the membrane of the endoplasmic reticulum {ECO:0000303|PubMed:12754298};, , GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0005784;GO:0042802;GO:0006915;GO:0006613;GO:0071787;GO:1990809;GO:0043066;GO:0043154;GO:0002038;GO:1903371;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:Sec61 translocon complex;, F:identical protein binding;, P:apoptotic process; P:cotranslational protein targeting to membrane; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network membrane organization; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of L-glutamate import across plasma membrane; P:regulation of endoplasmic reticulum tubular network organization;|Q15041 B7Z6S5 B7Z791 F5GXP4,ADP-ribosylation factor-like protein 6-interacting protein 1,Apoptotic regulator in the membrane of the endoplasmic reticulum {ECO:0000303|PubMed:12754298};, , GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0005784;GO:0042802;GO:0006915;GO:0006613;GO:0071787;GO:1990809;GO:0043066;GO:0043154;GO:0002038;GO:1903371;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:Sec61 translocon complex;, F:identical protein binding;, P:apoptotic process; P:cotranslational protein targeting to membrane; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network membrane organization; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of L-glutamate import across plasma membrane; P:regulation of endoplasmic reticulum tubular network organization;|Q15041 B7Z6S5 B7Z791 F5GXP4,ADP-ribosylation factor-like protein 6-interacting protein 1,Apoptotic regulator in the membrane of the endoplasmic reticulum {ECO:0000303|PubMed:12754298};, , GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0005784;GO:0042802;GO:0006915;GO:0006613;GO:0071787;GO:1990809;GO:0043066;GO:0043154;GO:0002038;GO:1903371;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:Sec61 translocon complex;, F:identical protein binding;, P:apoptotic process; P:cotranslational protein targeting to membrane; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network membrane organization; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of L-glutamate import across plasma membrane; P:regulation of endoplasmic reticulum tubular network organization;|Q15041 B7Z6S5 B7Z791 F5GXP4,ADP-ribosylation factor-like protein 6-interacting protein 1,Apoptotic regulator in the membrane of the endoplasmic reticulum {ECO:0000303|PubMed:12754298};, , GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0005784;GO:0042802;GO:0006915;GO:0006613;GO:0071787;GO:1990809;GO:0043066;GO:0043154;GO:0002038;GO:1903371;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:Sec61 translocon complex;, F:identical protein binding;, P:apoptotic process; P:cotranslational protein targeting to membrane; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network membrane organization; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of L-glutamate import across plasma membrane; P:regulation of endoplasmic reticulum tubular network organization;|Q15041 B7Z6S5 B7Z791 F5GXP4,ADP-ribosylation factor-like protein 6-interacting protein 1,Apoptotic regulator in the membrane of the endoplasmic reticulum {ECO:0000303|PubMed:12754298};, , GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0005784;GO:0042802;GO:0006915;GO:0006613;GO:0071787;GO:1990809;GO:0043066;GO:0043154;GO:0002038;GO:1903371;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:Sec61 translocon complex;, F:identical protein binding;, P:apoptotic process; P:cotranslational protein targeting to membrane; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network membrane organization; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of L-glutamate import across plasma membrane; P:regulation of endoplasmic reticulum tubular network organization; scaffold38 indexed_genome mRNA 12526805 12531988 . - . ID=transcript_7905;Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling; scaffold38 indexed_genome mRNA 12531993 12552341 . - . ID=transcript_7906;Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling;|Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling;|Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling;|Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling;|Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling;|Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling;|Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling; scaffold38 indexed_genome mRNA 12779272 12860994 . - . ID=transcript_7907;Q9BSW7 O43330 Q9NZ18,Synaptotagmin-17,Protein B/K;Synaptotagmin XVII;, PF00168;, GO:0070382;GO:0005886;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0000149;GO:0019905;GO:0017156;GO:0030154;GO:0071277;GO:1903861;GO:0017158;GO:0014059;GO:0016192;, C:exocytic vesicle; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:vesicle-mediated transport; scaffold38 indexed_genome mRNA 12919327 12923106 . + . ID=transcript_7908;Q3MIP1,Inositol 1,4,5-trisphosphate receptor-interacting protein-like 2,, PF03281;, GO:0016021;, C:integral component of membrane; scaffold38 indexed_genome mRNA 12966548 12973558 . - . ID=transcript_7909;Q99807 B2RDA9 Q9BTT7 Q9H0T5 Q9UEW5 Q9UNR5,5-demethoxyubiquinone hydroxylase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03194},Timing protein clk-1 homolog {ECO:0000255|HAMAP-Rule:MF_03194};Ubiquinone biosynthesis monooxygenase COQ7 {ECO:0000255|HAMAP-Rule:MF_03194};, PF03232;, GO:0031314;GO:0005743;GO:0005739;GO:0005634;GO:0008682;GO:0003682;GO:0046872;GO:0016709;GO:0008340;GO:0000122;GO:0045944;GO:0010468;GO:2000377;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity; F:chromatin binding; F:metal ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:determination of adult lifespan; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of reactive oxygen species metabolic process; P:ubiquinone biosynthetic process;|Q99807 B2RDA9 Q9BTT7 Q9H0T5 Q9UEW5 Q9UNR5,5-demethoxyubiquinone hydroxylase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03194},Timing protein clk-1 homolog {ECO:0000255|HAMAP-Rule:MF_03194};Ubiquinone biosynthesis monooxygenase COQ7 {ECO:0000255|HAMAP-Rule:MF_03194};, PF03232;, GO:0031314;GO:0005743;GO:0005739;GO:0005634;GO:0008682;GO:0003682;GO:0046872;GO:0016709;GO:0008340;GO:0000122;GO:0045944;GO:0010468;GO:2000377;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity; F:chromatin binding; F:metal ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:determination of adult lifespan; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of reactive oxygen species metabolic process; P:ubiquinone biosynthetic process; scaffold38 indexed_genome mRNA 12984120 13020249 . + . ID=transcript_7910;Q7Z402 E7ERB6 Q5H9Q8 Q7Z5M4 Q86WX0 Q9H766,Transmembrane channel-like protein 7,, PF07810;, GO:0005887;GO:0008381;, C:integral component of plasma membrane;, F:mechanosensitive ion channel activity;|Q7Z402 E7ERB6 Q5H9Q8 Q7Z5M4 Q86WX0 Q9H766,Transmembrane channel-like protein 7,, PF07810;, GO:0005887;GO:0008381;, C:integral component of plasma membrane;, F:mechanosensitive ion channel activity;|Q7Z402 E7ERB6 Q5H9Q8 Q7Z5M4 Q86WX0 Q9H766,Transmembrane channel-like protein 7,, PF07810;, GO:0005887;GO:0008381;, C:integral component of plasma membrane;, F:mechanosensitive ion channel activity;|Q7Z402 E7ERB6 Q5H9Q8 Q7Z5M4 Q86WX0 Q9H766,Transmembrane channel-like protein 7,, PF07810;, GO:0005887;GO:0008381;, C:integral component of plasma membrane;, F:mechanosensitive ion channel activity; scaffold38 indexed_genome mRNA 13145206 13172436 . - . ID=transcript_7911;Q9NZC3 O43334 Q6PKF7 Q7KYR4,Glycerophosphodiester phosphodiesterase 1 {ECO:0000305},Glycerophosphoinositol glycerophosphodiesterase GDE1 {ECO:0000305};Lysophospholipase D GDE1 {ECO:0000305};Membrane-interacting protein of RGS16 {ECO:0000303|PubMed:10760272};RGS16-interacting membrane protein;, PF03009;, GO:0030659;GO:0016021;GO:0005886;GO:0008889;GO:0047395;GO:0004622;GO:0046872;GO:0006580;GO:0046475;GO:0006629;GO:0070291;GO:0006644;, C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:glycerophosphodiester phosphodiesterase activity; F:glycerophosphoinositol glycerophosphodiesterase activity; F:lysophospholipase activity; F:metal ion binding;, P:ethanolamine metabolic process; P:glycerophospholipid catabolic process; P:lipid metabolic process; P:N-acylethanolamine metabolic process; P:phospholipid metabolic process;|Q9NZC3 O43334 Q6PKF7 Q7KYR4,Glycerophosphodiester phosphodiesterase 1 {ECO:0000305},Glycerophosphoinositol glycerophosphodiesterase GDE1 {ECO:0000305};Lysophospholipase D GDE1 {ECO:0000305};Membrane-interacting protein of RGS16 {ECO:0000303|PubMed:10760272};RGS16-interacting membrane protein;, PF03009;, GO:0030659;GO:0016021;GO:0005886;GO:0008889;GO:0047395;GO:0004622;GO:0046872;GO:0006580;GO:0046475;GO:0006629;GO:0070291;GO:0006644;, C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:glycerophosphodiester phosphodiesterase activity; F:glycerophosphoinositol glycerophosphodiesterase activity; F:lysophospholipase activity; F:metal ion binding;, P:ethanolamine metabolic process; P:glycerophospholipid catabolic process; P:lipid metabolic process; P:N-acylethanolamine metabolic process; P:phospholipid metabolic process;|Q9NZC3 O43334 Q6PKF7 Q7KYR4,Glycerophosphodiester phosphodiesterase 1 {ECO:0000305},Glycerophosphoinositol glycerophosphodiesterase GDE1 {ECO:0000305};Lysophospholipase D GDE1 {ECO:0000305};Membrane-interacting protein of RGS16 {ECO:0000303|PubMed:10760272};RGS16-interacting membrane protein;, PF03009;, GO:0030659;GO:0016021;GO:0005886;GO:0008889;GO:0047395;GO:0004622;GO:0046872;GO:0006580;GO:0046475;GO:0006629;GO:0070291;GO:0006644;, C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:glycerophosphodiester phosphodiesterase activity; F:glycerophosphoinositol glycerophosphodiesterase activity; F:lysophospholipase activity; F:metal ion binding;, P:ethanolamine metabolic process; P:glycerophospholipid catabolic process; P:lipid metabolic process; P:N-acylethanolamine metabolic process; P:phospholipid metabolic process;|Q9NZC3 O43334 Q6PKF7 Q7KYR4,Glycerophosphodiester phosphodiesterase 1 {ECO:0000305},Glycerophosphoinositol glycerophosphodiesterase GDE1 {ECO:0000305};Lysophospholipase D GDE1 {ECO:0000305};Membrane-interacting protein of RGS16 {ECO:0000303|PubMed:10760272};RGS16-interacting membrane protein;, PF03009;, GO:0030659;GO:0016021;GO:0005886;GO:0008889;GO:0047395;GO:0004622;GO:0046872;GO:0006580;GO:0046475;GO:0006629;GO:0070291;GO:0006644;, C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:glycerophosphodiester phosphodiesterase activity; F:glycerophosphoinositol glycerophosphodiesterase activity; F:lysophospholipase activity; F:metal ion binding;, P:ethanolamine metabolic process; P:glycerophospholipid catabolic process; P:lipid metabolic process; P:N-acylethanolamine metabolic process; P:phospholipid metabolic process;|Q9NZC3 O43334 Q6PKF7 Q7KYR4,Glycerophosphodiester phosphodiesterase 1 {ECO:0000305},Glycerophosphoinositol glycerophosphodiesterase GDE1 {ECO:0000305};Lysophospholipase D GDE1 {ECO:0000305};Membrane-interacting protein of RGS16 {ECO:0000303|PubMed:10760272};RGS16-interacting membrane protein;, PF03009;, GO:0030659;GO:0016021;GO:0005886;GO:0008889;GO:0047395;GO:0004622;GO:0046872;GO:0006580;GO:0046475;GO:0006629;GO:0070291;GO:0006644;, C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:glycerophosphodiester phosphodiesterase activity; F:glycerophosphoinositol glycerophosphodiesterase activity; F:lysophospholipase activity; F:metal ion binding;, P:ethanolamine metabolic process; P:glycerophospholipid catabolic process; P:lipid metabolic process; P:N-acylethanolamine metabolic process; P:phospholipid metabolic process; scaffold38 indexed_genome mRNA 13176136 13190216 . + . ID=transcript_7912;O43303 B7WP23 O43335 Q68DV9 Q8NE13,Centriolar coiled-coil protein of 110 kDa,Centrosomal protein of 110 kDa;, , GO:0005814;GO:0005813;GO:0005929;GO:0005829;GO:0032991;GO:0007099;GO:0051298;GO:0032053;GO:0097711;GO:0000086;GO:1903723;GO:1902018;GO:0045724;GO:0016579;GO:0032465;GO:0010389;, C:centriole; C:centrosome; C:cilium; C:cytosol; C:protein-containing complex;, , P:centriole replication; P:centrosome duplication; P:ciliary basal body organization; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of centriole elongation; P:negative regulation of cilium assembly; P:positive regulation of cilium assembly; P:protein deubiquitination; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; scaffold38 indexed_genome mRNA 13192174 13197457 . + . ID=transcript_7913;O43303 B7WP23 O43335 Q68DV9 Q8NE13,Centriolar coiled-coil protein of 110 kDa,Centrosomal protein of 110 kDa;, , GO:0005814;GO:0005813;GO:0005929;GO:0005829;GO:0032991;GO:0007099;GO:0051298;GO:0032053;GO:0097711;GO:0000086;GO:1903723;GO:1902018;GO:0045724;GO:0016579;GO:0032465;GO:0010389;, C:centriole; C:centrosome; C:cilium; C:cytosol; C:protein-containing complex;, , P:centriole replication; P:centrosome duplication; P:ciliary basal body organization; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of centriole elongation; P:negative regulation of cilium assembly; P:positive regulation of cilium assembly; P:protein deubiquitination; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle;|O43303 B7WP23 O43335 Q68DV9 Q8NE13,Centriolar coiled-coil protein of 110 kDa,Centrosomal protein of 110 kDa;, , GO:0005814;GO:0005813;GO:0005929;GO:0005829;GO:0032991;GO:0007099;GO:0051298;GO:0032053;GO:0097711;GO:0000086;GO:1903723;GO:1902018;GO:0045724;GO:0016579;GO:0032465;GO:0010389;, C:centriole; C:centrosome; C:cilium; C:cytosol; C:protein-containing complex;, , P:centriole replication; P:centrosome duplication; P:ciliary basal body organization; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of centriole elongation; P:negative regulation of cilium assembly; P:positive regulation of cilium assembly; P:protein deubiquitination; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; scaffold38 indexed_genome mRNA 13258074 13343481 . + . ID=transcript_7914;Q9H7C8,VPS35 endosomal protein-sorting factor-like {ECO:0000305},Esophageal cancer-associated protein;, , GO:0005768;GO:0101003;GO:0016021;GO:0005886;GO:0032456;GO:0006893;GO:0043312;GO:0015031;GO:1990126;, C:endosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:plasma membrane;, , P:endocytic recycling; P:Golgi to plasma membrane transport; P:neutrophil degranulation; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q9H7C8,VPS35 endosomal protein-sorting factor-like {ECO:0000305},Esophageal cancer-associated protein;, , GO:0005768;GO:0101003;GO:0016021;GO:0005886;GO:0032456;GO:0006893;GO:0043312;GO:0015031;GO:1990126;, C:endosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:plasma membrane;, , P:endocytic recycling; P:Golgi to plasma membrane transport; P:neutrophil degranulation; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q9H7C8,VPS35 endosomal protein-sorting factor-like {ECO:0000305},Esophageal cancer-associated protein;, , GO:0005768;GO:0101003;GO:0016021;GO:0005886;GO:0032456;GO:0006893;GO:0043312;GO:0015031;GO:1990126;, C:endosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:plasma membrane;, , P:endocytic recycling; P:Golgi to plasma membrane transport; P:neutrophil degranulation; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q9H7C8,VPS35 endosomal protein-sorting factor-like {ECO:0000305},Esophageal cancer-associated protein;, , GO:0005768;GO:0101003;GO:0016021;GO:0005886;GO:0032456;GO:0006893;GO:0043312;GO:0015031;GO:1990126;, C:endosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:plasma membrane;, , P:endocytic recycling; P:Golgi to plasma membrane transport; P:neutrophil degranulation; P:protein transport; P:retrograde transport, endosome to plasma membrane; scaffold38 indexed_genome mRNA 13344020 13358153 . - . ID=transcript_7915;Q1ED39 O43328 Q5FWF3,Lysine-rich nucleolar protein 1,Protein FAM191A;Testis-specific gene 118 protein;, PF15477;, GO:0005730;GO:0003723;, C:nucleolus;, F:RNA binding; scaffold38 indexed_genome mRNA 13523811 13541004 . - . ID=transcript_7916;Q9NZH0 D2DFB0 O75205 Q8NBZ8,G-protein coupled receptor family C group 5 member B,A-69G12.1;Retinoic acid-induced gene 2 protein;, PF00003;, GO:0009986;GO:0030659;GO:0005829;GO:0070062;GO:0005615;GO:0016021;GO:0043231;GO:0005730;GO:0005654;GO:0005886;GO:0043235;GO:0004930;GO:0001664;GO:0030295;GO:0019901;GO:0090263;GO:0043123;GO:0050729;GO:0060907;GO:0045666;GO:0061098;, C:cell surface; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:G protein-coupled receptor activity; F:G protein-coupled receptor binding; F:protein kinase activator activity; F:protein kinase binding;, P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of macrophage cytokine production; P:positive regulation of neuron differentiation; P:positive regulation of protein tyrosine kinase activity; scaffold38 indexed_genome mRNA 14101389 14130796 . + . ID=transcript_7917;Q6NUN0 Q96AV1 Q96CX8 Q9NWV3,Acyl-coenzyme A synthetase ACSM5, mitochondrial,Acyl-CoA synthetase medium-chain family member 5;, PF00501;PF13193;, GO:0005759;GO:0005524;GO:0047760;GO:0015645;GO:0004321;GO:0005525;GO:0031956;GO:0046872;GO:0006637;GO:0006633;, C:mitochondrial matrix;, F:ATP binding; F:butyrate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:GTP binding; F:medium-chain fatty acid-CoA ligase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:fatty acid biosynthetic process;|Q6NUN0 Q96AV1 Q96CX8 Q9NWV3,Acyl-coenzyme A synthetase ACSM5, mitochondrial,Acyl-CoA synthetase medium-chain family member 5;, PF00501;PF13193;, GO:0005759;GO:0005524;GO:0047760;GO:0015645;GO:0004321;GO:0005525;GO:0031956;GO:0046872;GO:0006637;GO:0006633;, C:mitochondrial matrix;, F:ATP binding; F:butyrate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:GTP binding; F:medium-chain fatty acid-CoA ligase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:fatty acid biosynthetic process; scaffold38 indexed_genome mRNA 14157580 14185721 . + . ID=transcript_7918;Q08AH3 B3KTT9 O75202,Acyl-coenzyme A synthetase ACSM2A, mitochondrial,Acyl-CoA synthetase medium-chain family member 2A;Benzoate--CoA ligase;Butyrate--CoA ligase 2A;Butyryl-coenzyme A synthetase 2A;Middle-chain acyl-CoA synthetase 2A;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0046872;GO:0006637;GO:0006633;GO:0042593;GO:0036112;GO:0070328;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:fatty acid biosynthetic process; P:glucose homeostasis; P:medium-chain fatty-acyl-CoA metabolic process; P:triglyceride homeostasis;|Q08AH3 B3KTT9 O75202,Acyl-coenzyme A synthetase ACSM2A, mitochondrial,Acyl-CoA synthetase medium-chain family member 2A;Benzoate--CoA ligase;Butyrate--CoA ligase 2A;Butyryl-coenzyme A synthetase 2A;Middle-chain acyl-CoA synthetase 2A;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0046872;GO:0006637;GO:0006633;GO:0042593;GO:0036112;GO:0070328;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:fatty acid biosynthetic process; P:glucose homeostasis; P:medium-chain fatty-acyl-CoA metabolic process; P:triglyceride homeostasis;|Q68CK6 Q86YT1,Acyl-coenzyme A synthetase ACSM2B, mitochondrial,Acyl-CoA synthetase medium-chain family member 2B;Benzoate--CoA ligase;Butyrate--CoA ligase 2B;Butyryl-coenzyme A synthetase 2B;Middle-chain acyl-CoA synthetase 2B;Xenobiotic/medium-chain fatty acid-CoA ligase HXM-A {ECO:0000303|PubMed:10434065};, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0046872;GO:0006637;GO:0006633;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:fatty acid biosynthetic process; P:xenobiotic metabolic process;|Q08AH3 B3KTT9 O75202,Acyl-coenzyme A synthetase ACSM2A, mitochondrial,Acyl-CoA synthetase medium-chain family member 2A;Benzoate--CoA ligase;Butyrate--CoA ligase 2A;Butyryl-coenzyme A synthetase 2A;Middle-chain acyl-CoA synthetase 2A;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0046872;GO:0006637;GO:0006633;GO:0042593;GO:0036112;GO:0070328;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:fatty acid biosynthetic process; P:glucose homeostasis; P:medium-chain fatty-acyl-CoA metabolic process; P:triglyceride homeostasis;|Q68CK6 Q86YT1,Acyl-coenzyme A synthetase ACSM2B, mitochondrial,Acyl-CoA synthetase medium-chain family member 2B;Benzoate--CoA ligase;Butyrate--CoA ligase 2B;Butyryl-coenzyme A synthetase 2B;Middle-chain acyl-CoA synthetase 2B;Xenobiotic/medium-chain fatty acid-CoA ligase HXM-A {ECO:0000303|PubMed:10434065};, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0046872;GO:0006637;GO:0006633;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:fatty acid biosynthetic process; P:xenobiotic metabolic process;|Q08AH3 B3KTT9 O75202,Acyl-coenzyme A synthetase ACSM2A, mitochondrial,Acyl-CoA synthetase medium-chain family member 2A;Benzoate--CoA ligase;Butyrate--CoA ligase 2A;Butyryl-coenzyme A synthetase 2A;Middle-chain acyl-CoA synthetase 2A;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0046872;GO:0006637;GO:0006633;GO:0042593;GO:0036112;GO:0070328;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:fatty acid biosynthetic process; P:glucose homeostasis; P:medium-chain fatty-acyl-CoA metabolic process; P:triglyceride homeostasis;|Q08AH3 B3KTT9 O75202,Acyl-coenzyme A synthetase ACSM2A, mitochondrial,Acyl-CoA synthetase medium-chain family member 2A;Benzoate--CoA ligase;Butyrate--CoA ligase 2A;Butyryl-coenzyme A synthetase 2A;Middle-chain acyl-CoA synthetase 2A;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0046872;GO:0006637;GO:0006633;GO:0042593;GO:0036112;GO:0070328;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:fatty acid biosynthetic process; P:glucose homeostasis; P:medium-chain fatty-acyl-CoA metabolic process; P:triglyceride homeostasis;|Q08AH3 B3KTT9 O75202,Acyl-coenzyme A synthetase ACSM2A, mitochondrial,Acyl-CoA synthetase medium-chain family member 2A;Benzoate--CoA ligase;Butyrate--CoA ligase 2A;Butyryl-coenzyme A synthetase 2A;Middle-chain acyl-CoA synthetase 2A;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0046872;GO:0006637;GO:0006633;GO:0042593;GO:0036112;GO:0070328;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:fatty acid biosynthetic process; P:glucose homeostasis; P:medium-chain fatty-acyl-CoA metabolic process; P:triglyceride homeostasis; scaffold38 indexed_genome mRNA 14202857 14244056 . + . ID=transcript_7919;Q08AH1 Q08AH2 Q96A20,Acyl-coenzyme A synthetase ACSM1, mitochondrial,Acyl-CoA synthetase medium-chain family member 1;Benzoate--CoA ligase;Butyrate--CoA ligase 1;Butyryl-coenzyme A synthetase 1;Lipoate-activating enzyme {ECO:0000250|UniProtKB:Q9BEA2};Middle-chain acyl-CoA synthetase 1;Xenobiotic/medium-chain fatty acid-CoA ligase HXM-B {ECO:0000303|PubMed:10434065};, PF00501;PF13193;, GO:0072562;GO:0070062;GO:0005759;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0005525;GO:0004467;GO:0046872;GO:0006637;GO:0018874;GO:0019605;GO:0042632;GO:0015980;GO:0006633;GO:0019395;GO:0006805;, C:blood microparticle; C:extracellular exosome; C:mitochondrial matrix;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:GTP binding; F:long-chain fatty acid-CoA ligase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:benzoate metabolic process; P:butyrate metabolic process; P:cholesterol homeostasis; P:energy derivation by oxidation of organic compounds; P:fatty acid biosynthetic process; P:fatty acid oxidation; P:xenobiotic metabolic process; scaffold38 indexed_genome mRNA 14244549 14264823 . + . ID=transcript_7920;Q08AH1 Q08AH2 Q96A20,Acyl-coenzyme A synthetase ACSM1, mitochondrial,Acyl-CoA synthetase medium-chain family member 1;Benzoate--CoA ligase;Butyrate--CoA ligase 1;Butyryl-coenzyme A synthetase 1;Lipoate-activating enzyme {ECO:0000250|UniProtKB:Q9BEA2};Middle-chain acyl-CoA synthetase 1;Xenobiotic/medium-chain fatty acid-CoA ligase HXM-B {ECO:0000303|PubMed:10434065};, PF00501;PF13193;, GO:0072562;GO:0070062;GO:0005759;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0005525;GO:0004467;GO:0046872;GO:0006637;GO:0018874;GO:0019605;GO:0042632;GO:0015980;GO:0006633;GO:0019395;GO:0006805;, C:blood microparticle; C:extracellular exosome; C:mitochondrial matrix;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:GTP binding; F:long-chain fatty acid-CoA ligase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:benzoate metabolic process; P:butyrate metabolic process; P:cholesterol homeostasis; P:energy derivation by oxidation of organic compounds; P:fatty acid biosynthetic process; P:fatty acid oxidation; P:xenobiotic metabolic process;|Q08AH1 Q08AH2 Q96A20,Acyl-coenzyme A synthetase ACSM1, mitochondrial,Acyl-CoA synthetase medium-chain family member 1;Benzoate--CoA ligase;Butyrate--CoA ligase 1;Butyryl-coenzyme A synthetase 1;Lipoate-activating enzyme {ECO:0000250|UniProtKB:Q9BEA2};Middle-chain acyl-CoA synthetase 1;Xenobiotic/medium-chain fatty acid-CoA ligase HXM-B {ECO:0000303|PubMed:10434065};, PF00501;PF13193;, GO:0072562;GO:0070062;GO:0005759;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0005525;GO:0004467;GO:0046872;GO:0006637;GO:0018874;GO:0019605;GO:0042632;GO:0015980;GO:0006633;GO:0019395;GO:0006805;, C:blood microparticle; C:extracellular exosome; C:mitochondrial matrix;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:GTP binding; F:long-chain fatty acid-CoA ligase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:benzoate metabolic process; P:butyrate metabolic process; P:cholesterol homeostasis; P:energy derivation by oxidation of organic compounds; P:fatty acid biosynthetic process; P:fatty acid oxidation; P:xenobiotic metabolic process;|Q08AH1 Q08AH2 Q96A20,Acyl-coenzyme A synthetase ACSM1, mitochondrial,Acyl-CoA synthetase medium-chain family member 1;Benzoate--CoA ligase;Butyrate--CoA ligase 1;Butyryl-coenzyme A synthetase 1;Lipoate-activating enzyme {ECO:0000250|UniProtKB:Q9BEA2};Middle-chain acyl-CoA synthetase 1;Xenobiotic/medium-chain fatty acid-CoA ligase HXM-B {ECO:0000303|PubMed:10434065};, PF00501;PF13193;, GO:0072562;GO:0070062;GO:0005759;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0005525;GO:0004467;GO:0046872;GO:0006637;GO:0018874;GO:0019605;GO:0042632;GO:0015980;GO:0006633;GO:0019395;GO:0006805;, C:blood microparticle; C:extracellular exosome; C:mitochondrial matrix;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:GTP binding; F:long-chain fatty acid-CoA ligase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:benzoate metabolic process; P:butyrate metabolic process; P:cholesterol homeostasis; P:energy derivation by oxidation of organic compounds; P:fatty acid biosynthetic process; P:fatty acid oxidation; P:xenobiotic metabolic process;|Q08AH1 Q08AH2 Q96A20,Acyl-coenzyme A synthetase ACSM1, mitochondrial,Acyl-CoA synthetase medium-chain family member 1;Benzoate--CoA ligase;Butyrate--CoA ligase 1;Butyryl-coenzyme A synthetase 1;Lipoate-activating enzyme {ECO:0000250|UniProtKB:Q9BEA2};Middle-chain acyl-CoA synthetase 1;Xenobiotic/medium-chain fatty acid-CoA ligase HXM-B {ECO:0000303|PubMed:10434065};, PF00501;PF13193;, GO:0072562;GO:0070062;GO:0005759;GO:0005524;GO:0018858;GO:0047760;GO:0102391;GO:0015645;GO:0004321;GO:0005525;GO:0004467;GO:0046872;GO:0006637;GO:0018874;GO:0019605;GO:0042632;GO:0015980;GO:0006633;GO:0019395;GO:0006805;, C:blood microparticle; C:extracellular exosome; C:mitochondrial matrix;, F:ATP binding; F:benzoate-CoA ligase activity; F:butyrate-CoA ligase activity; F:decanoate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:GTP binding; F:long-chain fatty acid-CoA ligase activity; F:metal ion binding;, P:acyl-CoA metabolic process; P:benzoate metabolic process; P:butyrate metabolic process; P:cholesterol homeostasis; P:energy derivation by oxidation of organic compounds; P:fatty acid biosynthetic process; P:fatty acid oxidation; P:xenobiotic metabolic process; scaffold38 indexed_genome mRNA 14443795 14450884 . - . ID=transcript_7921;Q9NXG2 Q9BWC3,THUMP domain-containing protein 1,, PF02926;, GO:0005654;GO:0003723;GO:0000154;GO:0006400;, C:nucleoplasm;, F:RNA binding;, P:rRNA modification; P:tRNA modification;|Q9NXG2 Q9BWC3,THUMP domain-containing protein 1,, PF02926;, GO:0005654;GO:0003723;GO:0000154;GO:0006400;, C:nucleoplasm;, F:RNA binding;, P:rRNA modification; P:tRNA modification; scaffold38 indexed_genome mRNA 14502876 14624516 . + . ID=transcript_7922;Q53FZ2 O60363 Q13732 Q15425 Q7KYM6 Q9BUA2,Acyl-coenzyme A synthetase ACSM3, mitochondrial,Acyl-CoA synthetase medium-chain family member 3;Butyrate--CoA ligase 3;Butyryl-coenzyme A synthetase 3;Middle-chain acyl-CoA synthetase 3;Propionate--CoA ligase;Protein SA homolog;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0047760;GO:0015645;GO:0004321;GO:0046872;GO:0043759;GO:0050218;GO:0006637;GO:0042632;GO:0006633;GO:0008217;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:butyrate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding; F:methylbutanoate-CoA ligase activity; F:propionate-CoA ligase activity;, P:acyl-CoA metabolic process; P:cholesterol homeostasis; P:fatty acid biosynthetic process; P:regulation of blood pressure;|A8K979 Q6ZSJ2 Q96FR9 Q9P224 Q9Y6V3,ERI1 exoribonuclease 2,Exonuclease domain-containing protein 1;, PF00929;PF06839;, GO:0000175;GO:0003676;GO:0008270;GO:0000738;GO:0000467;, , F:3'-5'-exoribonuclease activity; F:nucleic acid binding; F:zinc ion binding;, P:DNA catabolic process, exonucleolytic; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q53FZ2 O60363 Q13732 Q15425 Q7KYM6 Q9BUA2,Acyl-coenzyme A synthetase ACSM3, mitochondrial,Acyl-CoA synthetase medium-chain family member 3;Butyrate--CoA ligase 3;Butyryl-coenzyme A synthetase 3;Middle-chain acyl-CoA synthetase 3;Propionate--CoA ligase;Protein SA homolog;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0047760;GO:0015645;GO:0004321;GO:0046872;GO:0043759;GO:0050218;GO:0006637;GO:0042632;GO:0006633;GO:0008217;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:butyrate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding; F:methylbutanoate-CoA ligase activity; F:propionate-CoA ligase activity;, P:acyl-CoA metabolic process; P:cholesterol homeostasis; P:fatty acid biosynthetic process; P:regulation of blood pressure;|Q53FZ2 O60363 Q13732 Q15425 Q7KYM6 Q9BUA2,Acyl-coenzyme A synthetase ACSM3, mitochondrial,Acyl-CoA synthetase medium-chain family member 3;Butyrate--CoA ligase 3;Butyryl-coenzyme A synthetase 3;Middle-chain acyl-CoA synthetase 3;Propionate--CoA ligase;Protein SA homolog;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0047760;GO:0015645;GO:0004321;GO:0046872;GO:0043759;GO:0050218;GO:0006637;GO:0042632;GO:0006633;GO:0008217;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:butyrate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding; F:methylbutanoate-CoA ligase activity; F:propionate-CoA ligase activity;, P:acyl-CoA metabolic process; P:cholesterol homeostasis; P:fatty acid biosynthetic process; P:regulation of blood pressure;|Q53FZ2 O60363 Q13732 Q15425 Q7KYM6 Q9BUA2,Acyl-coenzyme A synthetase ACSM3, mitochondrial,Acyl-CoA synthetase medium-chain family member 3;Butyrate--CoA ligase 3;Butyryl-coenzyme A synthetase 3;Middle-chain acyl-CoA synthetase 3;Propionate--CoA ligase;Protein SA homolog;, PF00501;PF13193;, GO:0005759;GO:0005739;GO:0005524;GO:0047760;GO:0015645;GO:0004321;GO:0046872;GO:0043759;GO:0050218;GO:0006637;GO:0042632;GO:0006633;GO:0008217;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:butyrate-CoA ligase activity; F:fatty acid ligase activity; F:fatty-acyl-CoA synthase activity; F:metal ion binding; F:methylbutanoate-CoA ligase activity; F:propionate-CoA ligase activity;, P:acyl-CoA metabolic process; P:cholesterol homeostasis; P:fatty acid biosynthetic process; P:regulation of blood pressure;|A8K979 Q6ZSJ2 Q96FR9 Q9P224 Q9Y6V3,ERI1 exoribonuclease 2,Exonuclease domain-containing protein 1;, PF00929;PF06839;, GO:0000175;GO:0003676;GO:0008270;GO:0000738;GO:0000467;, , F:3'-5'-exoribonuclease activity; F:nucleic acid binding; F:zinc ion binding;, P:DNA catabolic process, exonucleolytic; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|A8K979 Q6ZSJ2 Q96FR9 Q9P224 Q9Y6V3,ERI1 exoribonuclease 2,Exonuclease domain-containing protein 1;, PF00929;PF06839;, GO:0000175;GO:0003676;GO:0008270;GO:0000738;GO:0000467;, , F:3'-5'-exoribonuclease activity; F:nucleic acid binding; F:zinc ion binding;, P:DNA catabolic process, exonucleolytic; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|A8K979 Q6ZSJ2 Q96FR9 Q9P224 Q9Y6V3,ERI1 exoribonuclease 2,Exonuclease domain-containing protein 1;, PF00929;PF06839;, GO:0000175;GO:0003676;GO:0008270;GO:0000738;GO:0000467;, , F:3'-5'-exoribonuclease activity; F:nucleic acid binding; F:zinc ion binding;, P:DNA catabolic process, exonucleolytic; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q96IC2 B2RB19 O60364 Q96MB1 Q9BXH9 Q9H0K2 Q9NSM2,RNA exonuclease 5 {ECO:0000312|HGNC:HGNC:24661},Exonuclease NEF-sp;, PF00929;PF00076;, GO:0070062;GO:0005730;GO:0005634;GO:0004527;GO:0003723;, C:extracellular exosome; C:nucleolus; C:nucleus;, F:exonuclease activity; F:RNA binding;|Q96IC2 B2RB19 O60364 Q96MB1 Q9BXH9 Q9H0K2 Q9NSM2,RNA exonuclease 5 {ECO:0000312|HGNC:HGNC:24661},Exonuclease NEF-sp;, PF00929;PF00076;, GO:0070062;GO:0005730;GO:0005634;GO:0004527;GO:0003723;, C:extracellular exosome; C:nucleolus; C:nucleus;, F:exonuclease activity; F:RNA binding; scaffold38 indexed_genome mRNA 14624838 14625571 . - . ID=transcript_7923;Q96IC2 B2RB19 O60364 Q96MB1 Q9BXH9 Q9H0K2 Q9NSM2,RNA exonuclease 5 {ECO:0000312|HGNC:HGNC:24661},Exonuclease NEF-sp;, PF00929;PF00076;, GO:0070062;GO:0005730;GO:0005634;GO:0004527;GO:0003723;, C:extracellular exosome; C:nucleolus; C:nucleus;, F:exonuclease activity; F:RNA binding; scaffold38 indexed_genome mRNA 14626093 14633092 . + . ID=transcript_7924;Q96IC2 B2RB19 O60364 Q96MB1 Q9BXH9 Q9H0K2 Q9NSM2,RNA exonuclease 5 {ECO:0000312|HGNC:HGNC:24661},Exonuclease NEF-sp;, PF00929;PF00076;, GO:0070062;GO:0005730;GO:0005634;GO:0004527;GO:0003723;, C:extracellular exosome; C:nucleolus; C:nucleus;, F:exonuclease activity; F:RNA binding;|Q96IC2 B2RB19 O60364 Q96MB1 Q9BXH9 Q9H0K2 Q9NSM2,RNA exonuclease 5 {ECO:0000312|HGNC:HGNC:24661},Exonuclease NEF-sp;, PF00929;PF00076;, GO:0070062;GO:0005730;GO:0005634;GO:0004527;GO:0003723;, C:extracellular exosome; C:nucleolus; C:nucleus;, F:exonuclease activity; F:RNA binding; scaffold38 indexed_genome mRNA 14714692 14722967 . - . ID=transcript_7925;O43325 B2R4M5,LYR motif-containing protein 1,, PF05347;, GO:0030496;GO:0005654;, C:midbody; C:nucleoplasm;|O43325 B2R4M5,LYR motif-containing protein 1,, PF05347;, GO:0030496;GO:0005654;, C:midbody; C:nucleoplasm;|O43325 B2R4M5,LYR motif-containing protein 1,, PF05347;, GO:0030496;GO:0005654;, C:midbody; C:nucleoplasm;|O43325 B2R4M5,LYR motif-containing protein 1,, PF05347;, GO:0030496;GO:0005654;, C:midbody; C:nucleoplasm; scaffold38 indexed_genome mRNA 14725537 14727679 . - . ID=transcript_7926;Q8TD57 O00437 O15437 O43326 Q3C0H2 Q8WUP9 Q9UEM3 Q9UEM5 Q9UG35,Dynein heavy chain 3, axonemal,Axonemal beta dynein heavy chain 3;Ciliary dynein heavy chain 3;Dnahc3-b;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement; scaffold38 indexed_genome mRNA 14729113 14792037 . - . ID=transcript_7927;Q8TD57 O00437 O15437 O43326 Q3C0H2 Q8WUP9 Q9UEM3 Q9UEM5 Q9UG35,Dynein heavy chain 3, axonemal,Axonemal beta dynein heavy chain 3;Ciliary dynein heavy chain 3;Dnahc3-b;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement;|Q8TD57 O00437 O15437 O43326 Q3C0H2 Q8WUP9 Q9UEM3 Q9UEM5 Q9UG35,Dynein heavy chain 3, axonemal,Axonemal beta dynein heavy chain 3;Ciliary dynein heavy chain 3;Dnahc3-b;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement;|Q8TD57 O00437 O15437 O43326 Q3C0H2 Q8WUP9 Q9UEM3 Q9UEM5 Q9UG35,Dynein heavy chain 3, axonemal,Axonemal beta dynein heavy chain 3;Ciliary dynein heavy chain 3;Dnahc3-b;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement;|Q8TD57 O00437 O15437 O43326 Q3C0H2 Q8WUP9 Q9UEM3 Q9UEM5 Q9UG35,Dynein heavy chain 3, axonemal,Axonemal beta dynein heavy chain 3;Ciliary dynein heavy chain 3;Dnahc3-b;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement;|Q8TD57 O00437 O15437 O43326 Q3C0H2 Q8WUP9 Q9UEM3 Q9UEM5 Q9UG35,Dynein heavy chain 3, axonemal,Axonemal beta dynein heavy chain 3;Ciliary dynein heavy chain 3;Dnahc3-b;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement;|Q8TD57 O00437 O15437 O43326 Q3C0H2 Q8WUP9 Q9UEM3 Q9UEM5 Q9UG35,Dynein heavy chain 3, axonemal,Axonemal beta dynein heavy chain 3;Ciliary dynein heavy chain 3;Dnahc3-b;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement; scaffold38 indexed_genome mRNA 14796476 14821518 . - . ID=transcript_7928;Q8TD57 O00437 O15437 O43326 Q3C0H2 Q8WUP9 Q9UEM3 Q9UEM5 Q9UG35,Dynein heavy chain 3, axonemal,Axonemal beta dynein heavy chain 3;Ciliary dynein heavy chain 3;Dnahc3-b;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0030286;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:dynein complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement; scaffold38 indexed_genome mRNA 14966218 14976764 . + . ID=transcript_7929;Q96B96 A6NMA9 B4DEC1 O00323,Lipid droplet assembly factor 1 {ECO:0000303|PubMed:31708432},Promethin {ECO:0000303|PubMed:15589683, ECO:0000303|PubMed:30901948};Transmembrane protein 159;, , GO:0005789;GO:0016021;GO:0005811;GO:0140042;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, , P:lipid droplet formation;|Q96B96 A6NMA9 B4DEC1 O00323,Lipid droplet assembly factor 1 {ECO:0000303|PubMed:31708432},Promethin {ECO:0000303|PubMed:15589683, ECO:0000303|PubMed:30901948};Transmembrane protein 159;, , GO:0005789;GO:0016021;GO:0005811;GO:0140042;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, , P:lipid droplet formation; scaffold38 indexed_genome mRNA 15000790 15016369 . - . ID=transcript_7930;Q05996 B2R7J2 Q4VAN9 Q4VAP0 Q4VAP1,Zona pellucida sperm-binding protein 2,Zona pellucida glycoprotein 2;Zona pellucida protein A;, PF00100;, GO:0062023;GO:0035805;GO:0005783;GO:0005576;GO:0016021;GO:0005771;GO:0005886;GO:0032190;GO:0015026;GO:0042802;GO:0035804;GO:0007339;GO:0060468;, C:collagen-containing extracellular matrix; C:egg coat; C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:multivesicular body; C:plasma membrane;, F:acrosin binding; F:coreceptor activity; F:identical protein binding; F:structural constituent of egg coat;, P:binding of sperm to zona pellucida; P:prevention of polyspermy;|Q05996 B2R7J2 Q4VAN9 Q4VAP0 Q4VAP1,Zona pellucida sperm-binding protein 2,Zona pellucida glycoprotein 2;Zona pellucida protein A;, PF00100;, GO:0062023;GO:0035805;GO:0005783;GO:0005576;GO:0016021;GO:0005771;GO:0005886;GO:0032190;GO:0015026;GO:0042802;GO:0035804;GO:0007339;GO:0060468;, C:collagen-containing extracellular matrix; C:egg coat; C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:multivesicular body; C:plasma membrane;, F:acrosin binding; F:coreceptor activity; F:identical protein binding; F:structural constituent of egg coat;, P:binding of sperm to zona pellucida; P:prevention of polyspermy;|Q05996 B2R7J2 Q4VAN9 Q4VAP0 Q4VAP1,Zona pellucida sperm-binding protein 2,Zona pellucida glycoprotein 2;Zona pellucida protein A;, PF00100;, GO:0062023;GO:0035805;GO:0005783;GO:0005576;GO:0016021;GO:0005771;GO:0005886;GO:0032190;GO:0015026;GO:0042802;GO:0035804;GO:0007339;GO:0060468;, C:collagen-containing extracellular matrix; C:egg coat; C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:multivesicular body; C:plasma membrane;, F:acrosin binding; F:coreceptor activity; F:identical protein binding; F:structural constituent of egg coat;, P:binding of sperm to zona pellucida; P:prevention of polyspermy;|Q05996 B2R7J2 Q4VAN9 Q4VAP0 Q4VAP1,Zona pellucida sperm-binding protein 2,Zona pellucida glycoprotein 2;Zona pellucida protein A;, PF00100;, GO:0062023;GO:0035805;GO:0005783;GO:0005576;GO:0016021;GO:0005771;GO:0005886;GO:0032190;GO:0015026;GO:0042802;GO:0035804;GO:0007339;GO:0060468;, C:collagen-containing extracellular matrix; C:egg coat; C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:multivesicular body; C:plasma membrane;, F:acrosin binding; F:coreceptor activity; F:identical protein binding; F:structural constituent of egg coat;, P:binding of sperm to zona pellucida; P:prevention of polyspermy;|Q05996 B2R7J2 Q4VAN9 Q4VAP0 Q4VAP1,Zona pellucida sperm-binding protein 2,Zona pellucida glycoprotein 2;Zona pellucida protein A;, PF00100;, GO:0062023;GO:0035805;GO:0005783;GO:0005576;GO:0016021;GO:0005771;GO:0005886;GO:0032190;GO:0015026;GO:0042802;GO:0035804;GO:0007339;GO:0060468;, C:collagen-containing extracellular matrix; C:egg coat; C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:multivesicular body; C:plasma membrane;, F:acrosin binding; F:coreceptor activity; F:identical protein binding; F:structural constituent of egg coat;, P:binding of sperm to zona pellucida; P:prevention of polyspermy;|Q05996 B2R7J2 Q4VAN9 Q4VAP0 Q4VAP1,Zona pellucida sperm-binding protein 2,Zona pellucida glycoprotein 2;Zona pellucida protein A;, PF00100;, GO:0062023;GO:0035805;GO:0005783;GO:0005576;GO:0016021;GO:0005771;GO:0005886;GO:0032190;GO:0015026;GO:0042802;GO:0035804;GO:0007339;GO:0060468;, C:collagen-containing extracellular matrix; C:egg coat; C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:multivesicular body; C:plasma membrane;, F:acrosin binding; F:coreceptor activity; F:identical protein binding; F:structural constituent of egg coat;, P:binding of sperm to zona pellucida; P:prevention of polyspermy;|Q05996 B2R7J2 Q4VAN9 Q4VAP0 Q4VAP1,Zona pellucida sperm-binding protein 2,Zona pellucida glycoprotein 2;Zona pellucida protein A;, PF00100;, GO:0062023;GO:0035805;GO:0005783;GO:0005576;GO:0016021;GO:0005771;GO:0005886;GO:0032190;GO:0015026;GO:0042802;GO:0035804;GO:0007339;GO:0060468;, C:collagen-containing extracellular matrix; C:egg coat; C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:multivesicular body; C:plasma membrane;, F:acrosin binding; F:coreceptor activity; F:identical protein binding; F:structural constituent of egg coat;, P:binding of sperm to zona pellucida; P:prevention of polyspermy; scaffold38 indexed_genome mRNA 15031364 15048067 . + . ID=transcript_7931;Q8N8V4,Ankyrin repeat and SAM domain-containing protein 4B {ECO:0000305},Harmonin-interacting ankyrin repeat-containing protein {ECO:0000303|PubMed:12588794};, PF12796;PF00536;, GO:0005903;GO:0005789;GO:0005902;GO:0005886;GO:1904970;GO:0030154;GO:0034622;GO:1904106;GO:0034976;, C:brush border; C:endoplasmic reticulum membrane; C:microvillus; C:plasma membrane;, , P:brush border assembly; P:cell differentiation; P:cellular protein-containing complex assembly; P:protein localization to microvillus; P:response to endoplasmic reticulum stress;|Q8N8V4,Ankyrin repeat and SAM domain-containing protein 4B {ECO:0000305},Harmonin-interacting ankyrin repeat-containing protein {ECO:0000303|PubMed:12588794};, PF12796;PF00536;, GO:0005903;GO:0005789;GO:0005902;GO:0005886;GO:1904970;GO:0030154;GO:0034622;GO:1904106;GO:0034976;, C:brush border; C:endoplasmic reticulum membrane; C:microvillus; C:plasma membrane;, , P:brush border assembly; P:cell differentiation; P:cellular protein-containing complex assembly; P:protein localization to microvillus; P:response to endoplasmic reticulum stress; scaffold38 indexed_genome mRNA 15050366 15055458 . - . ID=transcript_7932;Q14894 D5MNX0 Q5HYB7,Ketimine reductase mu-crystallin,NADP-regulated thyroid-hormone-binding protein;, PF02423;, GO:0005737;GO:0005829;GO:0070062;GO:0005782;GO:0042562;GO:0050661;GO:0042803;GO:0047127;GO:0070324;GO:0003714;GO:0006554;GO:0000122;GO:0007605;GO:0042403;GO:0070327;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal matrix;, F:hormone binding; F:NADP binding; F:protein homodimerization activity; F:thiomorpholine-carboxylate dehydrogenase activity; F:thyroid hormone binding; F:transcription corepressor activity;, P:lysine catabolic process; P:negative regulation of transcription by RNA polymerase II; P:sensory perception of sound; P:thyroid hormone metabolic process; P:thyroid hormone transport;|Q14894 D5MNX0 Q5HYB7,Ketimine reductase mu-crystallin,NADP-regulated thyroid-hormone-binding protein;, PF02423;, GO:0005737;GO:0005829;GO:0070062;GO:0005782;GO:0042562;GO:0050661;GO:0042803;GO:0047127;GO:0070324;GO:0003714;GO:0006554;GO:0000122;GO:0007605;GO:0042403;GO:0070327;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal matrix;, F:hormone binding; F:NADP binding; F:protein homodimerization activity; F:thiomorpholine-carboxylate dehydrogenase activity; F:thyroid hormone binding; F:transcription corepressor activity;, P:lysine catabolic process; P:negative regulation of transcription by RNA polymerase II; P:sensory perception of sound; P:thyroid hormone metabolic process; P:thyroid hormone transport; scaffold38 indexed_genome mRNA 15055522 15073985 . - . ID=transcript_7933;Q14894 D5MNX0 Q5HYB7,Ketimine reductase mu-crystallin,NADP-regulated thyroid-hormone-binding protein;, PF02423;, GO:0005737;GO:0005829;GO:0070062;GO:0005782;GO:0042562;GO:0050661;GO:0042803;GO:0047127;GO:0070324;GO:0003714;GO:0006554;GO:0000122;GO:0007605;GO:0042403;GO:0070327;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal matrix;, F:hormone binding; F:NADP binding; F:protein homodimerization activity; F:thiomorpholine-carboxylate dehydrogenase activity; F:thyroid hormone binding; F:transcription corepressor activity;, P:lysine catabolic process; P:negative regulation of transcription by RNA polymerase II; P:sensory perception of sound; P:thyroid hormone metabolic process; P:thyroid hormone transport;|Q14894 D5MNX0 Q5HYB7,Ketimine reductase mu-crystallin,NADP-regulated thyroid-hormone-binding protein;, PF02423;, GO:0005737;GO:0005829;GO:0070062;GO:0005782;GO:0042562;GO:0050661;GO:0042803;GO:0047127;GO:0070324;GO:0003714;GO:0006554;GO:0000122;GO:0007605;GO:0042403;GO:0070327;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal matrix;, F:hormone binding; F:NADP binding; F:protein homodimerization activity; F:thiomorpholine-carboxylate dehydrogenase activity; F:thyroid hormone binding; F:transcription corepressor activity;, P:lysine catabolic process; P:negative regulation of transcription by RNA polymerase II; P:sensory perception of sound; P:thyroid hormone metabolic process; P:thyroid hormone transport;|Q14894 D5MNX0 Q5HYB7,Ketimine reductase mu-crystallin,NADP-regulated thyroid-hormone-binding protein;, PF02423;, GO:0005737;GO:0005829;GO:0070062;GO:0005782;GO:0042562;GO:0050661;GO:0042803;GO:0047127;GO:0070324;GO:0003714;GO:0006554;GO:0000122;GO:0007605;GO:0042403;GO:0070327;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal matrix;, F:hormone binding; F:NADP binding; F:protein homodimerization activity; F:thiomorpholine-carboxylate dehydrogenase activity; F:thyroid hormone binding; F:transcription corepressor activity;, P:lysine catabolic process; P:negative regulation of transcription by RNA polymerase II; P:sensory perception of sound; P:thyroid hormone metabolic process; P:thyroid hormone transport;|Q14894 D5MNX0 Q5HYB7,Ketimine reductase mu-crystallin,NADP-regulated thyroid-hormone-binding protein;, PF02423;, GO:0005737;GO:0005829;GO:0070062;GO:0005782;GO:0042562;GO:0050661;GO:0042803;GO:0047127;GO:0070324;GO:0003714;GO:0006554;GO:0000122;GO:0007605;GO:0042403;GO:0070327;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal matrix;, F:hormone binding; F:NADP binding; F:protein homodimerization activity; F:thiomorpholine-carboxylate dehydrogenase activity; F:thyroid hormone binding; F:transcription corepressor activity;, P:lysine catabolic process; P:negative regulation of transcription by RNA polymerase II; P:sensory perception of sound; P:thyroid hormone metabolic process; P:thyroid hormone transport; scaffold38 indexed_genome mRNA 15414853 15447203 . + . ID=transcript_7934;Q99758 B2RU09 Q54A95 Q6P5P9 Q92473,Phospholipid-transporting ATPase ABCA3 {ECO:0000305},ABC-C transporter;ATP-binding cassette sub-family A member 3 {ECO:0000305};ATP-binding cassette transporter 3;Xenobiotic-transporting ATPase ABCA3 {ECO:0000305};, PF00005;, GO:0097208;GO:0097233;GO:0030659;GO:0005615;GO:0016021;GO:0043231;GO:0042599;GO:0097232;GO:0005770;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0140345;GO:0120019;GO:0044267;GO:0046618;GO:0006855;GO:0006869;GO:0030324;GO:0070925;GO:0046470;GO:0046471;GO:0055091;GO:0015914;GO:0010875;GO:1902995;GO:2001140;GO:0032464;GO:0046890;GO:0150172;GO:0042493;GO:0051384;GO:0043129;GO:0042908;, C:alveolar lamellar body; C:alveolar lamellar body membrane; C:cytoplasmic vesicle membrane; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lamellar body; C:lamellar body membrane; C:late endosome; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity; F:phosphatidylcholine flippase activity; F:phosphatidylcholine transfer activity;, P:cellular protein metabolic process; P:drug export; P:drug transmembrane transport; P:lipid transport; P:lung development; P:organelle assembly; P:phosphatidylcholine metabolic process; P:phosphatidylglycerol metabolic process; P:phospholipid homeostasis; P:phospholipid transport; P:positive regulation of cholesterol efflux; P:positive regulation of phospholipid efflux; P:positive regulation of phospholipid transport; P:positive regulation of protein homooligomerization; P:regulation of lipid biosynthetic process; P:regulation of phosphatidylcholine metabolic process; P:response to drug; P:response to glucocorticoid; P:surfactant homeostasis; P:xenobiotic transport;|Q99758 B2RU09 Q54A95 Q6P5P9 Q92473,Phospholipid-transporting ATPase ABCA3 {ECO:0000305},ABC-C transporter;ATP-binding cassette sub-family A member 3 {ECO:0000305};ATP-binding cassette transporter 3;Xenobiotic-transporting ATPase ABCA3 {ECO:0000305};, PF00005;, GO:0097208;GO:0097233;GO:0030659;GO:0005615;GO:0016021;GO:0043231;GO:0042599;GO:0097232;GO:0005770;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0140345;GO:0120019;GO:0044267;GO:0046618;GO:0006855;GO:0006869;GO:0030324;GO:0070925;GO:0046470;GO:0046471;GO:0055091;GO:0015914;GO:0010875;GO:1902995;GO:2001140;GO:0032464;GO:0046890;GO:0150172;GO:0042493;GO:0051384;GO:0043129;GO:0042908;, C:alveolar lamellar body; C:alveolar lamellar body membrane; C:cytoplasmic vesicle membrane; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lamellar body; C:lamellar body membrane; C:late endosome; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity; F:phosphatidylcholine flippase activity; F:phosphatidylcholine transfer activity;, P:cellular protein metabolic process; P:drug export; P:drug transmembrane transport; P:lipid transport; P:lung development; P:organelle assembly; P:phosphatidylcholine metabolic process; P:phosphatidylglycerol metabolic process; P:phospholipid homeostasis; P:phospholipid transport; P:positive regulation of cholesterol efflux; P:positive regulation of phospholipid efflux; P:positive regulation of phospholipid transport; P:positive regulation of protein homooligomerization; P:regulation of lipid biosynthetic process; P:regulation of phosphatidylcholine metabolic process; P:response to drug; P:response to glucocorticoid; P:surfactant homeostasis; P:xenobiotic transport; scaffold38 indexed_genome mRNA 15622428 15623168 . + . ID=transcript_7935;P22695 B3KSN4 Q9BQ05,Cytochrome b-c1 complex subunit 2, mitochondrial,Complex III subunit 2;Core protein II;Ubiquinol-cytochrome-c reductase complex core protein 2;, PF00675;PF05193;, GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0005654;GO:0046872;GO:0044877;GO:0009060;GO:0006122;GO:0006119;GO:0006508;GO:0042493;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:proteolysis; P:response to drug; scaffold38 indexed_genome mRNA 15623183 15631384 . + . ID=transcript_7936;P22695 B3KSN4 Q9BQ05,Cytochrome b-c1 complex subunit 2, mitochondrial,Complex III subunit 2;Core protein II;Ubiquinol-cytochrome-c reductase complex core protein 2;, PF00675;PF05193;, GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0005654;GO:0046872;GO:0044877;GO:0009060;GO:0006122;GO:0006119;GO:0006508;GO:0042493;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:proteolysis; P:response to drug;|P22695 B3KSN4 Q9BQ05,Cytochrome b-c1 complex subunit 2, mitochondrial,Complex III subunit 2;Core protein II;Ubiquinol-cytochrome-c reductase complex core protein 2;, PF00675;PF05193;, GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0005654;GO:0046872;GO:0044877;GO:0009060;GO:0006122;GO:0006119;GO:0006508;GO:0042493;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:proteolysis; P:response to drug; scaffold38 indexed_genome mRNA 15632765 15635245 . - . ID=transcript_7937;P22695 B3KSN4 Q9BQ05,Cytochrome b-c1 complex subunit 2, mitochondrial,Complex III subunit 2;Core protein II;Ubiquinol-cytochrome-c reductase complex core protein 2;, PF00675;PF05193;, GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0005654;GO:0046872;GO:0044877;GO:0009060;GO:0006122;GO:0006119;GO:0006508;GO:0042493;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:proteolysis; P:response to drug; scaffold38 indexed_genome mRNA 15635310 15635992 . + . ID=transcript_7938;P22695 B3KSN4 Q9BQ05,Cytochrome b-c1 complex subunit 2, mitochondrial,Complex III subunit 2;Core protein II;Ubiquinol-cytochrome-c reductase complex core protein 2;, PF00675;PF05193;, GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0005654;GO:0046872;GO:0044877;GO:0009060;GO:0006122;GO:0006119;GO:0006508;GO:0042493;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:proteolysis; P:response to drug; scaffold38 indexed_genome mRNA 15640596 15648044 . + . ID=transcript_7939;P22695 B3KSN4 Q9BQ05,Cytochrome b-c1 complex subunit 2, mitochondrial,Complex III subunit 2;Core protein II;Ubiquinol-cytochrome-c reductase complex core protein 2;, PF00675;PF05193;, GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0005654;GO:0046872;GO:0044877;GO:0009060;GO:0006122;GO:0006119;GO:0006508;GO:0042493;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:proteolysis; P:response to drug;|P22695 B3KSN4 Q9BQ05,Cytochrome b-c1 complex subunit 2, mitochondrial,Complex III subunit 2;Core protein II;Ubiquinol-cytochrome-c reductase complex core protein 2;, PF00675;PF05193;, GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0005654;GO:0046872;GO:0044877;GO:0009060;GO:0006122;GO:0006119;GO:0006508;GO:0042493;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:proteolysis; P:response to drug;|P22695 B3KSN4 Q9BQ05,Cytochrome b-c1 complex subunit 2, mitochondrial,Complex III subunit 2;Core protein II;Ubiquinol-cytochrome-c reductase complex core protein 2;, PF00675;PF05193;, GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0005654;GO:0046872;GO:0044877;GO:0009060;GO:0006122;GO:0006119;GO:0006508;GO:0042493;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:proteolysis; P:response to drug;|P22695 B3KSN4 Q9BQ05,Cytochrome b-c1 complex subunit 2, mitochondrial,Complex III subunit 2;Core protein II;Ubiquinol-cytochrome-c reductase complex core protein 2;, PF00675;PF05193;, GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0005654;GO:0046872;GO:0044877;GO:0009060;GO:0006122;GO:0006119;GO:0006508;GO:0042493;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion; C:nucleoplasm;, F:metal ion binding; F:protein-containing complex binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:proteolysis; P:response to drug; scaffold38 indexed_genome mRNA 15742241 15748363 . + . ID=transcript_7940;Q8NHV5 H3BNM6,Modulator of smoothened protein {ECO:0000312|HGNC:HGNC:27087},Attenuator of hedgehog {ECO:0000250|UniProtKB:Q8C784};, PF18800;, GO:0060170;GO:0005794;GO:0016021;GO:0005886;GO:0030154;GO:0045879;GO:0045664;GO:0031647;, C:ciliary membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:regulation of neuron differentiation; P:regulation of protein stability;|Q8NHV5 H3BNM6,Modulator of smoothened protein {ECO:0000312|HGNC:HGNC:27087},Attenuator of hedgehog {ECO:0000250|UniProtKB:Q8C784};, PF18800;, GO:0060170;GO:0005794;GO:0016021;GO:0005886;GO:0030154;GO:0045879;GO:0045664;GO:0031647;, C:ciliary membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:regulation of neuron differentiation; P:regulation of protein stability;|Q8NHV5 H3BNM6,Modulator of smoothened protein {ECO:0000312|HGNC:HGNC:27087},Attenuator of hedgehog {ECO:0000250|UniProtKB:Q8C784};, PF18800;, GO:0060170;GO:0005794;GO:0016021;GO:0005886;GO:0030154;GO:0045879;GO:0045664;GO:0031647;, C:ciliary membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:regulation of neuron differentiation; P:regulation of protein stability;|Q8NHV5 H3BNM6,Modulator of smoothened protein {ECO:0000312|HGNC:HGNC:27087},Attenuator of hedgehog {ECO:0000250|UniProtKB:Q8C784};, PF18800;, GO:0060170;GO:0005794;GO:0016021;GO:0005886;GO:0030154;GO:0045879;GO:0045664;GO:0031647;, C:ciliary membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:cell differentiation; P:negative regulation of smoothened signaling pathway; P:regulation of neuron differentiation; P:regulation of protein stability; scaffold38 indexed_genome mRNA 15782541 15790248 . + . ID=transcript_7941;A6NCI4 A4QMU8 A6NNC0 Q6UTX4 Q6ZQZ9 Q8IUY6 Q8N9W1,von Willebrand factor A domain-containing protein 3A,, PF13768;, GO:0005576;, C:extracellular region; scaffold38 indexed_genome mRNA 15794966 15800506 . + . ID=transcript_7942;A6NCI4 A4QMU8 A6NNC0 Q6UTX4 Q6ZQZ9 Q8IUY6 Q8N9W1,von Willebrand factor A domain-containing protein 3A,, PF13768;, GO:0005576;, C:extracellular region; scaffold38 indexed_genome mRNA 15801997 15813922 . + . ID=transcript_7943;A6NCI4 A4QMU8 A6NNC0 Q6UTX4 Q6ZQZ9 Q8IUY6 Q8N9W1,von Willebrand factor A domain-containing protein 3A,, PF13768;, GO:0005576;, C:extracellular region; scaffold38 indexed_genome mRNA 15884980 15936063 . + . ID=transcript_7944;O00418 Q8N588,Eukaryotic elongation factor 2 kinase,Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;, PF02816;PF08238;, GO:0005737;GO:0005829;GO:0043197;GO:0014069;GO:0005524;GO:0005509;GO:0005516;GO:0004686;GO:0004672;GO:0008135;GO:0071454;GO:1990416;GO:0071277;GO:0071320;GO:0032869;GO:0043066;GO:0061003;GO:0045807;GO:0051965;GO:0046777;GO:0031952;GO:0002931;GO:1990637;GO:0006414;, C:cytoplasm; C:cytosol; C:dendritic spine; C:postsynaptic density;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:elongation factor-2 kinase activity; F:protein kinase activity; F:translation factor activity, RNA binding;, P:cellular response to anoxia; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to insulin stimulus; P:negative regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of endocytosis; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of protein autophosphorylation; P:response to ischemia; P:response to prolactin; P:translational elongation;|O00418 Q8N588,Eukaryotic elongation factor 2 kinase,Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;, PF02816;PF08238;, GO:0005737;GO:0005829;GO:0043197;GO:0014069;GO:0005524;GO:0005509;GO:0005516;GO:0004686;GO:0004672;GO:0008135;GO:0071454;GO:1990416;GO:0071277;GO:0071320;GO:0032869;GO:0043066;GO:0061003;GO:0045807;GO:0051965;GO:0046777;GO:0031952;GO:0002931;GO:1990637;GO:0006414;, C:cytoplasm; C:cytosol; C:dendritic spine; C:postsynaptic density;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:elongation factor-2 kinase activity; F:protein kinase activity; F:translation factor activity, RNA binding;, P:cellular response to anoxia; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to insulin stimulus; P:negative regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of endocytosis; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of protein autophosphorylation; P:response to ischemia; P:response to prolactin; P:translational elongation;|O00418 Q8N588,Eukaryotic elongation factor 2 kinase,Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;, PF02816;PF08238;, GO:0005737;GO:0005829;GO:0043197;GO:0014069;GO:0005524;GO:0005509;GO:0005516;GO:0004686;GO:0004672;GO:0008135;GO:0071454;GO:1990416;GO:0071277;GO:0071320;GO:0032869;GO:0043066;GO:0061003;GO:0045807;GO:0051965;GO:0046777;GO:0031952;GO:0002931;GO:1990637;GO:0006414;, C:cytoplasm; C:cytosol; C:dendritic spine; C:postsynaptic density;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:elongation factor-2 kinase activity; F:protein kinase activity; F:translation factor activity, RNA binding;, P:cellular response to anoxia; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to insulin stimulus; P:negative regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of endocytosis; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of protein autophosphorylation; P:response to ischemia; P:response to prolactin; P:translational elongation;|O00418 Q8N588,Eukaryotic elongation factor 2 kinase,Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;, PF02816;PF08238;, GO:0005737;GO:0005829;GO:0043197;GO:0014069;GO:0005524;GO:0005509;GO:0005516;GO:0004686;GO:0004672;GO:0008135;GO:0071454;GO:1990416;GO:0071277;GO:0071320;GO:0032869;GO:0043066;GO:0061003;GO:0045807;GO:0051965;GO:0046777;GO:0031952;GO:0002931;GO:1990637;GO:0006414;, C:cytoplasm; C:cytosol; C:dendritic spine; C:postsynaptic density;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:elongation factor-2 kinase activity; F:protein kinase activity; F:translation factor activity, RNA binding;, P:cellular response to anoxia; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to insulin stimulus; P:negative regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of endocytosis; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of protein autophosphorylation; P:response to ischemia; P:response to prolactin; P:translational elongation;|O00418 Q8N588,Eukaryotic elongation factor 2 kinase,Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;, PF02816;PF08238;, GO:0005737;GO:0005829;GO:0043197;GO:0014069;GO:0005524;GO:0005509;GO:0005516;GO:0004686;GO:0004672;GO:0008135;GO:0071454;GO:1990416;GO:0071277;GO:0071320;GO:0032869;GO:0043066;GO:0061003;GO:0045807;GO:0051965;GO:0046777;GO:0031952;GO:0002931;GO:1990637;GO:0006414;, C:cytoplasm; C:cytosol; C:dendritic spine; C:postsynaptic density;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:elongation factor-2 kinase activity; F:protein kinase activity; F:translation factor activity, RNA binding;, P:cellular response to anoxia; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to insulin stimulus; P:negative regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of endocytosis; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of protein autophosphorylation; P:response to ischemia; P:response to prolactin; P:translational elongation;|O00418 Q8N588,Eukaryotic elongation factor 2 kinase,Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;, PF02816;PF08238;, GO:0005737;GO:0005829;GO:0043197;GO:0014069;GO:0005524;GO:0005509;GO:0005516;GO:0004686;GO:0004672;GO:0008135;GO:0071454;GO:1990416;GO:0071277;GO:0071320;GO:0032869;GO:0043066;GO:0061003;GO:0045807;GO:0051965;GO:0046777;GO:0031952;GO:0002931;GO:1990637;GO:0006414;, C:cytoplasm; C:cytosol; C:dendritic spine; C:postsynaptic density;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:elongation factor-2 kinase activity; F:protein kinase activity; F:translation factor activity, RNA binding;, P:cellular response to anoxia; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to insulin stimulus; P:negative regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of endocytosis; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of protein autophosphorylation; P:response to ischemia; P:response to prolactin; P:translational elongation;|O00418 Q8N588,Eukaryotic elongation factor 2 kinase,Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;, PF02816;PF08238;, GO:0005737;GO:0005829;GO:0043197;GO:0014069;GO:0005524;GO:0005509;GO:0005516;GO:0004686;GO:0004672;GO:0008135;GO:0071454;GO:1990416;GO:0071277;GO:0071320;GO:0032869;GO:0043066;GO:0061003;GO:0045807;GO:0051965;GO:0046777;GO:0031952;GO:0002931;GO:1990637;GO:0006414;, C:cytoplasm; C:cytosol; C:dendritic spine; C:postsynaptic density;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:elongation factor-2 kinase activity; F:protein kinase activity; F:translation factor activity, RNA binding;, P:cellular response to anoxia; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to insulin stimulus; P:negative regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of endocytosis; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of protein autophosphorylation; P:response to ischemia; P:response to prolactin; P:translational elongation;|O00418 Q8N588,Eukaryotic elongation factor 2 kinase,Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;, PF02816;PF08238;, GO:0005737;GO:0005829;GO:0043197;GO:0014069;GO:0005524;GO:0005509;GO:0005516;GO:0004686;GO:0004672;GO:0008135;GO:0071454;GO:1990416;GO:0071277;GO:0071320;GO:0032869;GO:0043066;GO:0061003;GO:0045807;GO:0051965;GO:0046777;GO:0031952;GO:0002931;GO:1990637;GO:0006414;, C:cytoplasm; C:cytosol; C:dendritic spine; C:postsynaptic density;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:elongation factor-2 kinase activity; F:protein kinase activity; F:translation factor activity, RNA binding;, P:cellular response to anoxia; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to calcium ion; P:cellular response to cAMP; P:cellular response to insulin stimulus; P:negative regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of endocytosis; P:positive regulation of synapse assembly; P:protein autophosphorylation; P:regulation of protein autophosphorylation; P:response to ischemia; P:response to prolactin; P:translational elongation; scaffold38 indexed_genome mRNA 15947513 15981714 . + . ID=transcript_7945;Q9NVU0 B4DL24 B4DUP6 H3BT11 Q9BWF7 Q9H8W8 Q9H907 Q9P276,DNA-directed RNA polymerase III subunit RPC5,DNA-directed RNA polymerase III 80 kDa polypeptide;, PF04801;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0051607;GO:0045087;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of type I interferon production; P:transcription, DNA-templated;|Q9NVU0 B4DL24 B4DUP6 H3BT11 Q9BWF7 Q9H8W8 Q9H907 Q9P276,DNA-directed RNA polymerase III subunit RPC5,DNA-directed RNA polymerase III 80 kDa polypeptide;, PF04801;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0051607;GO:0045087;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of type I interferon production; P:transcription, DNA-templated;|Q9NVU0 B4DL24 B4DUP6 H3BT11 Q9BWF7 Q9H8W8 Q9H907 Q9P276,DNA-directed RNA polymerase III subunit RPC5,DNA-directed RNA polymerase III 80 kDa polypeptide;, PF04801;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0051607;GO:0045087;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of type I interferon production; P:transcription, DNA-templated;|Q9NVU0 B4DL24 B4DUP6 H3BT11 Q9BWF7 Q9H8W8 Q9H907 Q9P276,DNA-directed RNA polymerase III subunit RPC5,DNA-directed RNA polymerase III 80 kDa polypeptide;, PF04801;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0051607;GO:0045087;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of type I interferon production; P:transcription, DNA-templated;|Q9NVU0 B4DL24 B4DUP6 H3BT11 Q9BWF7 Q9H8W8 Q9H907 Q9P276,DNA-directed RNA polymerase III subunit RPC5,DNA-directed RNA polymerase III 80 kDa polypeptide;, PF04801;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0051607;GO:0045087;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of type I interferon production; P:transcription, DNA-templated; scaffold38 indexed_genome mRNA 15981782 15988559 . + . ID=transcript_7946;Q9NVU0 B4DL24 B4DUP6 H3BT11 Q9BWF7 Q9H8W8 Q9H907 Q9P276,DNA-directed RNA polymerase III subunit RPC5,DNA-directed RNA polymerase III 80 kDa polypeptide;, PF04801;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0051607;GO:0045087;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of type I interferon production; P:transcription, DNA-templated;|Q9NVU0 B4DL24 B4DUP6 H3BT11 Q9BWF7 Q9H8W8 Q9H907 Q9P276,DNA-directed RNA polymerase III subunit RPC5,DNA-directed RNA polymerase III 80 kDa polypeptide;, PF04801;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0051607;GO:0045087;GO:0032481;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:positive regulation of type I interferon production; P:transcription, DNA-templated; scaffold38 indexed_genome mRNA 15994042 15997227 . - . ID=transcript_7947;Q01850 A8K8A8 Q13977,Cerebellar degeneration-related protein 2,Major Yo paraneoplastic antigen;Paraneoplastic cerebellar degeneration-associated antigen;|Q01850 A8K8A8 Q13977,Cerebellar degeneration-related protein 2,Major Yo paraneoplastic antigen;Paraneoplastic cerebellar degeneration-associated antigen; scaffold38 indexed_genome mRNA 16087918 16140929 . + . ID=transcript_7948;Q9H1A3 Q8NBT8 Q9BWJ7 Q9H1A2 Q9Y390,Methyltransferase-like protein 9,DORA reverse strand protein;DREV1;, PF05219;|Q9H1A3 Q8NBT8 Q9BWJ7 Q9H1A2 Q9Y390,Methyltransferase-like protein 9,DORA reverse strand protein;DREV1;, PF05219;|O95976 Q8WWD8,Immunoglobulin superfamily member 6,Protein DORA;, PF07686;, GO:0005887;GO:0004888;GO:0007166;GO:0006955;, C:integral component of plasma membrane;, F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:immune response;|Q9H1A3 Q8NBT8 Q9BWJ7 Q9H1A2 Q9Y390,Methyltransferase-like protein 9,DORA reverse strand protein;DREV1;, PF05219; scaffold38 indexed_genome mRNA 16708331 16782007 . + . ID=transcript_7949;Q70CQ4 Q6AW97 Q6ZTC0 Q6ZTN2 Q9ULL7,Ubiquitin carboxyl-terminal hydrolase 31,Deubiquitinating enzyme 31;Ubiquitin thioesterase 31;Ubiquitin-specific-processing protease 31;, PF00443;, GO:0005634;GO:0008234;GO:0004843;GO:0016579;GO:0006511;, C:nucleus;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70CQ4 Q6AW97 Q6ZTC0 Q6ZTN2 Q9ULL7,Ubiquitin carboxyl-terminal hydrolase 31,Deubiquitinating enzyme 31;Ubiquitin thioesterase 31;Ubiquitin-specific-processing protease 31;, PF00443;, GO:0005634;GO:0008234;GO:0004843;GO:0016579;GO:0006511;, C:nucleus;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9Y561 A8K137 B4DRQ2,Low-density lipoprotein receptor-related protein 12,Suppressor of tumorigenicity 7 protein;, PF00431;PF00057;, GO:0005905;GO:0016021;GO:0005887;GO:0005041;GO:0006897;GO:0001764;GO:0031175;GO:0040008;GO:0007165;, C:clathrin-coated pit; C:integral component of membrane; C:integral component of plasma membrane;, F:low-density lipoprotein particle receptor activity;, P:endocytosis; P:neuron migration; P:neuron projection development; P:regulation of growth; P:signal transduction;|Q70CQ4 Q6AW97 Q6ZTC0 Q6ZTN2 Q9ULL7,Ubiquitin carboxyl-terminal hydrolase 31,Deubiquitinating enzyme 31;Ubiquitin thioesterase 31;Ubiquitin-specific-processing protease 31;, PF00443;, GO:0005634;GO:0008234;GO:0004843;GO:0016579;GO:0006511;, C:nucleus;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold38 indexed_genome mRNA 16798602 16821204 . + . ID=transcript_7950;P51170 P78437 Q6PCC2 Q93023 Q93024 Q93025 Q93026 Q93027 Q96TD2,Amiloride-sensitive sodium channel subunit gamma,Epithelial Na(+) channel subunit gamma;Gamma-NaCH;Nonvoltage-gated sodium channel 1 subunit gamma;SCNEG;, PF00858;, GO:0016324;GO:0009897;GO:0070062;GO:0005887;GO:0005654;GO:0005886;GO:0098797;GO:0034706;GO:0005216;GO:0015280;GO:0005272;GO:0050699;GO:1904045;GO:0007588;GO:0034220;GO:0050891;GO:0050909;GO:0055078;GO:0035725;GO:0006814;, C:apical plasma membrane; C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:plasma membrane protein complex; C:sodium channel complex;, F:ion channel activity; F:ligand-gated sodium channel activity; F:sodium channel activity; F:WW domain binding;, P:cellular response to aldosterone; P:excretion; P:ion transmembrane transport; P:multicellular organismal water homeostasis; P:sensory perception of taste; P:sodium ion homeostasis; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold38 indexed_genome mRNA 16970202 16996491 . + . ID=transcript_7951;P51168 C5HTZ2 O60891 Q96KG2 Q9UJ32 Q9UMU5,Amiloride-sensitive sodium channel subunit beta,Beta-NaCH;Epithelial Na(+) channel subunit beta;Nonvoltage-gated sodium channel 1 subunit beta;SCNEB;, PF00858;, GO:0016324;GO:0030659;GO:0009897;GO:0070062;GO:0005887;GO:0005886;GO:0098797;GO:0034706;GO:0015280;GO:0050699;GO:0032341;GO:0014824;GO:1904045;GO:0042045;GO:0034101;GO:0007588;GO:0010467;GO:0034220;GO:0002269;GO:0070254;GO:0035264;GO:0050891;GO:0002283;GO:0070944;GO:0055075;GO:0042493;GO:0032094;GO:0050909;GO:0055078;GO:0035725;GO:0006814;GO:0097274;, C:apical plasma membrane; C:cytoplasmic vesicle membrane; C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:plasma membrane protein complex; C:sodium channel complex;, F:ligand-gated sodium channel activity; F:WW domain binding;, P:aldosterone metabolic process; P:artery smooth muscle contraction; P:cellular response to aldosterone; P:epithelial fluid transport; P:erythrocyte homeostasis; P:excretion; P:gene expression; P:ion transmembrane transport; P:leukocyte activation involved in inflammatory response; P:mucus secretion; P:multicellular organism growth; P:multicellular organismal water homeostasis; P:neutrophil activation involved in immune response; P:neutrophil-mediated killing of bacterium; P:potassium ion homeostasis; P:response to drug; P:response to food; P:sensory perception of taste; P:sodium ion homeostasis; P:sodium ion transmembrane transport; P:sodium ion transport; P:urea homeostasis;|P51168 C5HTZ2 O60891 Q96KG2 Q9UJ32 Q9UMU5,Amiloride-sensitive sodium channel subunit beta,Beta-NaCH;Epithelial Na(+) channel subunit beta;Nonvoltage-gated sodium channel 1 subunit beta;SCNEB;, PF00858;, GO:0016324;GO:0030659;GO:0009897;GO:0070062;GO:0005887;GO:0005886;GO:0098797;GO:0034706;GO:0015280;GO:0050699;GO:0032341;GO:0014824;GO:1904045;GO:0042045;GO:0034101;GO:0007588;GO:0010467;GO:0034220;GO:0002269;GO:0070254;GO:0035264;GO:0050891;GO:0002283;GO:0070944;GO:0055075;GO:0042493;GO:0032094;GO:0050909;GO:0055078;GO:0035725;GO:0006814;GO:0097274;, C:apical plasma membrane; C:cytoplasmic vesicle membrane; C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:plasma membrane protein complex; C:sodium channel complex;, F:ligand-gated sodium channel activity; F:WW domain binding;, P:aldosterone metabolic process; P:artery smooth muscle contraction; P:cellular response to aldosterone; P:epithelial fluid transport; P:erythrocyte homeostasis; P:excretion; P:gene expression; P:ion transmembrane transport; P:leukocyte activation involved in inflammatory response; P:mucus secretion; P:multicellular organism growth; P:multicellular organismal water homeostasis; P:neutrophil activation involved in immune response; P:neutrophil-mediated killing of bacterium; P:potassium ion homeostasis; P:response to drug; P:response to food; P:sensory perception of taste; P:sodium ion homeostasis; P:sodium ion transmembrane transport; P:sodium ion transport; P:urea homeostasis; scaffold38 indexed_genome mRNA 17002041 17088084 . - . ID=transcript_7952;P83436 Q6UWU7,Conserved oligomeric Golgi complex subunit 7,Component of oligomeric Golgi complex 7;, PF10191;, GO:0005794;GO:0000139;GO:0017119;GO:0043231;GO:0005730;GO:0032588;GO:0006888;GO:0007030;GO:0006886;GO:0006486;GO:0034067;GO:0033365;GO:0050821;GO:0006890;, C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:protein glycosylation; P:protein localization to Golgi apparatus; P:protein localization to organelle; P:protein stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P83436 Q6UWU7,Conserved oligomeric Golgi complex subunit 7,Component of oligomeric Golgi complex 7;, PF10191;, GO:0005794;GO:0000139;GO:0017119;GO:0043231;GO:0005730;GO:0032588;GO:0006888;GO:0007030;GO:0006886;GO:0006486;GO:0034067;GO:0033365;GO:0050821;GO:0006890;, C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:protein glycosylation; P:protein localization to Golgi apparatus; P:protein localization to organelle; P:protein stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P83436 Q6UWU7,Conserved oligomeric Golgi complex subunit 7,Component of oligomeric Golgi complex 7;, PF10191;, GO:0005794;GO:0000139;GO:0017119;GO:0043231;GO:0005730;GO:0032588;GO:0006888;GO:0007030;GO:0006886;GO:0006486;GO:0034067;GO:0033365;GO:0050821;GO:0006890;, C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:protein glycosylation; P:protein localization to Golgi apparatus; P:protein localization to organelle; P:protein stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold38 indexed_genome mRNA 17099842 17114712 . - . ID=transcript_7953;Q9UJY4 D3DWF0 O14564 Q9NYN2 Q9UPS2,ADP-ribosylation factor-binding protein GGA2,Gamma-adaptin-related protein 2;Golgi-localized, gamma ear-containing, ARF-binding protein 2;VHS domain and ear domain of gamma-adaptin;, PF02883;PF03127;PF18308;PF00790;, GO:0030136;GO:0031901;GO:0010008;GO:0005794;GO:0005802;GO:0031267;GO:1990000;GO:0043001;GO:0006886;GO:0034394;, C:clathrin-coated vesicle; C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:trans-Golgi network;, F:small GTPase binding;, P:amyloid fibril formation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:protein localization to cell surface;|Q9UJY4 D3DWF0 O14564 Q9NYN2 Q9UPS2,ADP-ribosylation factor-binding protein GGA2,Gamma-adaptin-related protein 2;Golgi-localized, gamma ear-containing, ARF-binding protein 2;VHS domain and ear domain of gamma-adaptin;, PF02883;PF03127;PF18308;PF00790;, GO:0030136;GO:0031901;GO:0010008;GO:0005794;GO:0005802;GO:0031267;GO:1990000;GO:0043001;GO:0006886;GO:0034394;, C:clathrin-coated vesicle; C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:trans-Golgi network;, F:small GTPase binding;, P:amyloid fibril formation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:protein localization to cell surface;|Q9UJY4 D3DWF0 O14564 Q9NYN2 Q9UPS2,ADP-ribosylation factor-binding protein GGA2,Gamma-adaptin-related protein 2;Golgi-localized, gamma ear-containing, ARF-binding protein 2;VHS domain and ear domain of gamma-adaptin;, PF02883;PF03127;PF18308;PF00790;, GO:0030136;GO:0031901;GO:0010008;GO:0005794;GO:0005802;GO:0031267;GO:1990000;GO:0043001;GO:0006886;GO:0034394;, C:clathrin-coated vesicle; C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:trans-Golgi network;, F:small GTPase binding;, P:amyloid fibril formation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:protein localization to cell surface;|Q9UJY4 D3DWF0 O14564 Q9NYN2 Q9UPS2,ADP-ribosylation factor-binding protein GGA2,Gamma-adaptin-related protein 2;Golgi-localized, gamma ear-containing, ARF-binding protein 2;VHS domain and ear domain of gamma-adaptin;, PF02883;PF03127;PF18308;PF00790;, GO:0030136;GO:0031901;GO:0010008;GO:0005794;GO:0005802;GO:0031267;GO:1990000;GO:0043001;GO:0006886;GO:0034394;, C:clathrin-coated vesicle; C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:trans-Golgi network;, F:small GTPase binding;, P:amyloid fibril formation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:protein localization to cell surface;|Q9UJY4 D3DWF0 O14564 Q9NYN2 Q9UPS2,ADP-ribosylation factor-binding protein GGA2,Gamma-adaptin-related protein 2;Golgi-localized, gamma ear-containing, ARF-binding protein 2;VHS domain and ear domain of gamma-adaptin;, PF02883;PF03127;PF18308;PF00790;, GO:0030136;GO:0031901;GO:0010008;GO:0005794;GO:0005802;GO:0031267;GO:1990000;GO:0043001;GO:0006886;GO:0034394;, C:clathrin-coated vesicle; C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:trans-Golgi network;, F:small GTPase binding;, P:amyloid fibril formation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:protein localization to cell surface; scaffold38 indexed_genome mRNA 17115145 17118951 . - . ID=transcript_7954;Q9UJY4 D3DWF0 O14564 Q9NYN2 Q9UPS2,ADP-ribosylation factor-binding protein GGA2,Gamma-adaptin-related protein 2;Golgi-localized, gamma ear-containing, ARF-binding protein 2;VHS domain and ear domain of gamma-adaptin;, PF02883;PF03127;PF18308;PF00790;, GO:0030136;GO:0031901;GO:0010008;GO:0005794;GO:0005802;GO:0031267;GO:1990000;GO:0043001;GO:0006886;GO:0034394;, C:clathrin-coated vesicle; C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:trans-Golgi network;, F:small GTPase binding;, P:amyloid fibril formation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:protein localization to cell surface; scaffold38 indexed_genome mRNA 17118957 17120994 . - . ID=transcript_7955;Q9UJY4 D3DWF0 O14564 Q9NYN2 Q9UPS2,ADP-ribosylation factor-binding protein GGA2,Gamma-adaptin-related protein 2;Golgi-localized, gamma ear-containing, ARF-binding protein 2;VHS domain and ear domain of gamma-adaptin;, PF02883;PF03127;PF18308;PF00790;, GO:0030136;GO:0031901;GO:0010008;GO:0005794;GO:0005802;GO:0031267;GO:1990000;GO:0043001;GO:0006886;GO:0034394;, C:clathrin-coated vesicle; C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:trans-Golgi network;, F:small GTPase binding;, P:amyloid fibril formation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:protein localization to cell surface; scaffold38 indexed_genome mRNA 17134447 17169230 . - . ID=transcript_7956;Q5JPH6 B3KTT2 D3DWF1 Q86YH3 Q8TF31,Probable glutamate--tRNA ligase, mitochondrial,Glutamyl-tRNA synthetase;, PF00749;, GO:0005759;GO:0005739;GO:0005524;GO:0004818;GO:0050561;GO:0000049;GO:0008270;GO:0006424;GO:0070127;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:glutamate-tRNA ligase activity; F:glutamate-tRNA(Gln) ligase activity; F:tRNA binding; F:zinc ion binding;, P:glutamyl-tRNA aminoacylation; P:tRNA aminoacylation for mitochondrial protein translation;|Q5JPH6 B3KTT2 D3DWF1 Q86YH3 Q8TF31,Probable glutamate--tRNA ligase, mitochondrial,Glutamyl-tRNA synthetase;, PF00749;, GO:0005759;GO:0005739;GO:0005524;GO:0004818;GO:0050561;GO:0000049;GO:0008270;GO:0006424;GO:0070127;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:glutamate-tRNA ligase activity; F:glutamate-tRNA(Gln) ligase activity; F:tRNA binding; F:zinc ion binding;, P:glutamyl-tRNA aminoacylation; P:tRNA aminoacylation for mitochondrial protein translation; scaffold38 indexed_genome mRNA 17169341 17184728 . + . ID=transcript_7957;O14562 A8MW58 D3DWF2,Ubiquitin domain-containing protein UBFD1,Ubiquitin-binding protein homolog;, PF00240;, GO:0045296;GO:0003723;, , F:cadherin binding; F:RNA binding;|O14562 A8MW58 D3DWF2,Ubiquitin domain-containing protein UBFD1,Ubiquitin-binding protein homolog;, PF00240;, GO:0045296;GO:0003723;, , F:cadherin binding; F:RNA binding;|O14562 A8MW58 D3DWF2,Ubiquitin domain-containing protein UBFD1,Ubiquitin-binding protein homolog;, PF00240;, GO:0045296;GO:0003723;, , F:cadherin binding; F:RNA binding;|O14562 A8MW58 D3DWF2,Ubiquitin domain-containing protein UBFD1,Ubiquitin-binding protein homolog;, PF00240;, GO:0045296;GO:0003723;, , F:cadherin binding; F:RNA binding; scaffold38 indexed_genome mRNA 17191198 17195199 . - . ID=transcript_7958;O14561 B2R4M1 Q9UNV1,Acyl carrier protein, mitochondrial,CI-SDAP;NADH-ubiquinone oxidoreductase 9.6 kDa subunit;, PF00550;, GO:0005743;GO:0005759;GO:0031966;GO:0005747;GO:0005739;GO:0005654;GO:0000035;GO:0000036;GO:0005509;GO:0005504;GO:0006633;GO:0006120;GO:0032981;GO:0009249;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:acyl binding; F:acyl carrier activity; F:calcium ion binding; F:fatty acid binding;, P:fatty acid biosynthetic process; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:protein lipoylation;|O14561 B2R4M1 Q9UNV1,Acyl carrier protein, mitochondrial,CI-SDAP;NADH-ubiquinone oxidoreductase 9.6 kDa subunit;, PF00550;, GO:0005743;GO:0005759;GO:0031966;GO:0005747;GO:0005739;GO:0005654;GO:0000035;GO:0000036;GO:0005509;GO:0005504;GO:0006633;GO:0006120;GO:0032981;GO:0009249;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:acyl binding; F:acyl carrier activity; F:calcium ion binding; F:fatty acid binding;, P:fatty acid biosynthetic process; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:protein lipoylation; scaffold38 indexed_genome mRNA 17206759 17219861 . + . ID=transcript_7959;Q86YC2 A6NIE1 Q8N7Y6 Q8ND31 Q9H6W1,Partner and localizer of BRCA2,, PF16756;, GO:0005654;GO:0032991;GO:0003677;GO:0009887;GO:0000724;GO:0048568;GO:0001833;GO:0007498;GO:0035264;GO:0043066;GO:0036342;GO:0001756;, C:nucleoplasm; C:protein-containing complex;, F:DNA binding;, P:animal organ morphogenesis; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:inner cell mass cell proliferation; P:mesoderm development; P:multicellular organism growth; P:negative regulation of apoptotic process; P:post-anal tail morphogenesis; P:somitogenesis;|Q86YC2 A6NIE1 Q8N7Y6 Q8ND31 Q9H6W1,Partner and localizer of BRCA2,, PF16756;, GO:0005654;GO:0032991;GO:0003677;GO:0009887;GO:0000724;GO:0048568;GO:0001833;GO:0007498;GO:0035264;GO:0043066;GO:0036342;GO:0001756;, C:nucleoplasm; C:protein-containing complex;, F:DNA binding;, P:animal organ morphogenesis; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:inner cell mass cell proliferation; P:mesoderm development; P:multicellular organism growth; P:negative regulation of apoptotic process; P:post-anal tail morphogenesis; P:somitogenesis; scaffold38 indexed_genome mRNA 17220030 17227899 . - . ID=transcript_7960;Q86YC2 A6NIE1 Q8N7Y6 Q8ND31 Q9H6W1,Partner and localizer of BRCA2,, PF16756;, GO:0005654;GO:0032991;GO:0003677;GO:0009887;GO:0000724;GO:0048568;GO:0001833;GO:0007498;GO:0035264;GO:0043066;GO:0036342;GO:0001756;, C:nucleoplasm; C:protein-containing complex;, F:DNA binding;, P:animal organ morphogenesis; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:inner cell mass cell proliferation; P:mesoderm development; P:multicellular organism growth; P:negative regulation of apoptotic process; P:post-anal tail morphogenesis; P:somitogenesis;|Q86YC2 A6NIE1 Q8N7Y6 Q8ND31 Q9H6W1,Partner and localizer of BRCA2,, PF16756;, GO:0005654;GO:0032991;GO:0003677;GO:0009887;GO:0000724;GO:0048568;GO:0001833;GO:0007498;GO:0035264;GO:0043066;GO:0036342;GO:0001756;, C:nucleoplasm; C:protein-containing complex;, F:DNA binding;, P:animal organ morphogenesis; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:inner cell mass cell proliferation; P:mesoderm development; P:multicellular organism growth; P:negative regulation of apoptotic process; P:post-anal tail morphogenesis; P:somitogenesis;|Q86YC2 A6NIE1 Q8N7Y6 Q8ND31 Q9H6W1,Partner and localizer of BRCA2,, PF16756;, GO:0005654;GO:0032991;GO:0003677;GO:0009887;GO:0000724;GO:0048568;GO:0001833;GO:0007498;GO:0035264;GO:0043066;GO:0036342;GO:0001756;, C:nucleoplasm; C:protein-containing complex;, F:DNA binding;, P:animal organ morphogenesis; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:inner cell mass cell proliferation; P:mesoderm development; P:multicellular organism growth; P:negative regulation of apoptotic process; P:post-anal tail morphogenesis; P:somitogenesis; scaffold38 indexed_genome mRNA 17229621 17252717 . + . ID=transcript_7961;Q9BTE1 A8K9X8 H3BN51 H3BQA4,Dynactin subunit 5,Dynactin subunit p25;, PF00132;, GO:0005813;GO:0000777;GO:0005829;GO:0031965;GO:0005654;GO:0019886;GO:0035904;GO:0060976;GO:0006888;GO:0003281;, C:centrosome; C:condensed chromosome kinetochore; C:cytosol; C:nuclear membrane; C:nucleoplasm;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:aorta development; P:coronary vasculature development; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:ventricular septum development; scaffold38 indexed_genome mRNA 17266196 17276118 . + . ID=transcript_7962;P53350 Q15153 Q99746,Serine/threonine-protein kinase PLK1,Polo-like kinase 1;Serine/threonine-protein kinase 13;, PF00069;PF00659;, GO:0034451;GO:0005814;GO:0005813;GO:0000785;GO:0000942;GO:0005737;GO:0005829;GO:0000776;GO:0015630;GO:0030496;GO:0097431;GO:0005654;GO:0005634;GO:0005819;GO:0051233;GO:0000922;GO:0000795;GO:0010997;GO:0005524;GO:0042802;GO:0000287;GO:0008017;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0031145;GO:0007098;GO:0097711;GO:0000132;GO:0045184;GO:0016321;GO:0000086;GO:0045143;GO:0001578;GO:0000278;GO:0007076;GO:0000281;GO:0007077;GO:0000070;GO:0007094;GO:0007052;GO:0043066;GO:0045736;GO:0000122;GO:0051081;GO:0018105;GO:0010800;GO:0032436;GO:1900182;GO:0045862;GO:1904668;GO:0051443;GO:0031648;GO:0071168;GO:0090435;GO:0006468;GO:0016567;GO:0051726;GO:1902749;GO:0032465;GO:0010389;GO:0007346;GO:1901990;GO:0030071;GO:1901673;GO:0043393;GO:1904776;GO:0072425;GO:0007062;GO:0070194;GO:0006511;, C:centriolar satellite; C:centriole; C:centrosome; C:chromatin; C:condensed nuclear chromosome outer kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle pole; C:nucleoplasm; C:nucleus; C:spindle; C:spindle midzone; C:spindle pole; C:synaptonemal complex;, F:anaphase-promoting complex binding; F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:microtubule binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:anaphase-promoting complex-dependent catabolic process; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:establishment of mitotic spindle orientation; P:establishment of protein localization; P:female meiosis chromosome segregation; P:G2/M transition of mitotic cell cycle; P:homologous chromosome segregation; P:microtubule bundle formation; P:mitotic cell cycle; P:mitotic chromosome condensation; P:mitotic cytokinesis; P:mitotic nuclear envelope disassembly; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:negative regulation of apoptotic process; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:nuclear envelope disassembly; P:peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to nucleus; P:positive regulation of proteolysis; P:positive regulation of ubiquitin protein ligase activity; P:positive regulation of ubiquitin-protein transferase activity; P:protein destabilization; P:protein localization to chromatin; P:protein localization to nuclear envelope; P:protein phosphorylation; P:protein ubiquitination; P:regulation of cell cycle; P:regulation of cell cycle G2/M phase transition; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic cell cycle; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic metaphase/anaphase transition; P:regulation of mitotic spindle assembly; P:regulation of protein binding; P:regulation of protein localization to cell cortex; P:signal transduction involved in G2 DNA damage checkpoint; P:sister chromatid cohesion; P:synaptonemal complex disassembly; P:ubiquitin-dependent protein catabolic process; scaffold38 indexed_genome mRNA 17336720 17341103 . + . ID=transcript_7963;O43745 A8K2I8,Calcineurin B homologous protein 2,Hepatocellular carcinoma-associated antigen 520;, PF13202;PF13499;, GO:0005737;GO:0005634;GO:0005886;GO:0005509;GO:0071277;GO:0070886;GO:0008284;GO:0010922;GO:0042307;GO:0045944;GO:0015031;, C:cytoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding;, P:cellular response to calcium ion; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cell population proliferation; P:positive regulation of phosphatase activity; P:positive regulation of protein import into nucleus; P:positive regulation of transcription by RNA polymerase II; P:protein transport; scaffold38 indexed_genome mRNA 17755874 17762134 . + . ID=transcript_7964;Q9UEH8 Q9UJ30 Q9UJ33,Protein kinase C beta type,, PF00130;PF00168;PF00069;PF00433;, GO:0044305;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0099523;GO:0008091;GO:0050681;GO:0005524;GO:0005246;GO:0004698;GO:0003682;GO:0042393;GO:0035403;GO:0030374;GO:0004697;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:0002250;GO:0006915;GO:0042113;GO:0050853;GO:0006816;GO:0006874;GO:0071322;GO:0035408;GO:0035556;GO:0042953;GO:0007077;GO:0010829;GO:0046627;GO:0018105;GO:0030168;GO:0045766;GO:0050861;GO:0043123;GO:0051092;GO:0030949;GO:0099171;GO:0006468;GO:0010827;GO:0045637;GO:2000300;GO:0006357;GO:0007165;, C:calyx of Held; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane; C:presynaptic cytosol; C:spectrin;, F:androgen receptor binding; F:ATP binding; F:calcium channel regulator activity; F:calcium-dependent protein kinase C activity; F:chromatin binding; F:histone binding; F:histone kinase activity (H3-T6 specific); F:nuclear receptor coactivator activity; F:protein kinase C activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:adaptive immune response; P:apoptotic process; P:B cell activation; P:B cell receptor signaling pathway; P:calcium ion transport; P:cellular calcium ion homeostasis; P:cellular response to carbohydrate stimulus; P:histone H3-T6 phosphorylation; P:intracellular signal transduction; P:lipoprotein transport; P:mitotic nuclear envelope disassembly; P:negative regulation of glucose transmembrane transport; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-serine phosphorylation; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:presynaptic modulation of chemical synaptic transmission; P:protein phosphorylation; P:regulation of glucose transmembrane transport; P:regulation of myeloid cell differentiation; P:regulation of synaptic vesicle exocytosis; P:regulation of transcription by RNA polymerase II; P:signal transduction; scaffold38 indexed_genome mRNA 17780299 17782363 . - . ID=transcript_7965;P17252 B5BU22 Q15137 Q32M72 Q96RE4,Protein kinase C alpha type,, PF00130;PF00168;PF00069;PF00433;, GO:0035866;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0031966;GO:0005739;GO:0005654;GO:0048471;GO:0005886;GO:0005524;GO:0004698;GO:0019899;GO:0035403;GO:0005178;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:0001525;GO:0097190;GO:0007411;GO:0007155;GO:0002159;GO:0038128;GO:0035408;GO:0035556;GO:0007077;GO:0034351;GO:0018105;GO:0018107;GO:0030168;GO:0106071;GO:0045766;GO:0043536;GO:0045780;GO:0010613;GO:0045785;GO:0030335;GO:2000707;GO:0010595;GO:0001938;GO:0070374;GO:0031666;GO:0045651;GO:0045931;GO:0006468;GO:0050796;GO:0043488;GO:0090330;GO:0070555;, C:alphav-beta3 integrin-PKCalpha complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrial membrane; C:mitochondrion; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:enzyme binding; F:histone kinase activity (H3-T6 specific); F:integrin binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:angiogenesis; P:apoptotic signaling pathway; P:axon guidance; P:cell adhesion; P:desmosome assembly; P:ERBB2 signaling pathway; P:histone H3-T6 phosphorylation; P:intracellular signal transduction; P:mitotic nuclear envelope disassembly; P:negative regulation of glial cell apoptotic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of bone resorption; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of dense core granule biogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of lipopolysaccharide-mediated signaling pathway; P:positive regulation of macrophage differentiation; P:positive regulation of mitotic cell cycle; P:protein phosphorylation; P:regulation of insulin secretion; P:regulation of mRNA stability; P:regulation of platelet aggregation; P:response to interleukin-1; scaffold38 indexed_genome mRNA 17783855 17788952 . + . ID=transcript_7966;Q9UEH8 Q9UJ30 Q9UJ33,Protein kinase C beta type,, PF00130;PF00168;PF00069;PF00433;, GO:0044305;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0099523;GO:0008091;GO:0050681;GO:0005524;GO:0005246;GO:0004698;GO:0003682;GO:0042393;GO:0035403;GO:0030374;GO:0004697;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0008270;GO:0002250;GO:0006915;GO:0042113;GO:0050853;GO:0006816;GO:0006874;GO:0071322;GO:0035408;GO:0035556;GO:0042953;GO:0007077;GO:0010829;GO:0046627;GO:0018105;GO:0030168;GO:0045766;GO:0050861;GO:0043123;GO:0051092;GO:0030949;GO:0099171;GO:0006468;GO:0010827;GO:0045637;GO:2000300;GO:0006357;GO:0007165;, C:calyx of Held; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane; C:presynaptic cytosol; C:spectrin;, F:androgen receptor binding; F:ATP binding; F:calcium channel regulator activity; F:calcium-dependent protein kinase C activity; F:chromatin binding; F:histone binding; F:histone kinase activity (H3-T6 specific); F:nuclear receptor coactivator activity; F:protein kinase C activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:adaptive immune response; P:apoptotic process; P:B cell activation; P:B cell receptor signaling pathway; P:calcium ion transport; P:cellular calcium ion homeostasis; P:cellular response to carbohydrate stimulus; P:histone H3-T6 phosphorylation; P:intracellular signal transduction; P:lipoprotein transport; P:mitotic nuclear envelope disassembly; P:negative regulation of glucose transmembrane transport; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-serine phosphorylation; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:presynaptic modulation of chemical synaptic transmission; P:protein phosphorylation; P:regulation of glucose transmembrane transport; P:regulation of myeloid cell differentiation; P:regulation of synaptic vesicle exocytosis; P:regulation of transcription by RNA polymerase II; P:signal transduction; scaffold38 indexed_genome mRNA 18069894 18078472 . + . ID=transcript_7967;Q9H3I8 Q9H5M5 Q9NPX4,E3 ubiquitin-protein ligase RBBP6,Proliferation potential-related protein;Protein P2P-R;RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};Retinoblastoma-binding Q protein 1;Retinoblastoma-binding protein 6;p53-associated cellular protein of testis;, PF08783;PF04564;PF13696;, GO:0005694;GO:0005829;GO:0005815;GO:0016607;GO:0005730;GO:0032991;GO:0019901;GO:0003723;GO:0061630;GO:0004842;GO:0008270;GO:0006974;GO:0006260;GO:0048568;GO:0001701;GO:0006397;GO:0035264;GO:0000209;GO:0006275;GO:0061053;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleolus; C:protein-containing complex;, F:protein kinase binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA replication; P:embryonic organ development; P:in utero embryonic development; P:mRNA processing; P:multicellular organism growth; P:protein polyubiquitination; P:regulation of DNA replication; P:somite development; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9H3I8 Q9H5M5 Q9NPX4,E3 ubiquitin-protein ligase RBBP6,Proliferation potential-related protein;Protein P2P-R;RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};Retinoblastoma-binding Q protein 1;Retinoblastoma-binding protein 6;p53-associated cellular protein of testis;, PF08783;PF04564;PF13696;, GO:0005694;GO:0005829;GO:0005815;GO:0016607;GO:0005730;GO:0032991;GO:0019901;GO:0003723;GO:0061630;GO:0004842;GO:0008270;GO:0006974;GO:0006260;GO:0048568;GO:0001701;GO:0006397;GO:0035264;GO:0000209;GO:0006275;GO:0061053;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleolus; C:protein-containing complex;, F:protein kinase binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA replication; P:embryonic organ development; P:in utero embryonic development; P:mRNA processing; P:multicellular organism growth; P:protein polyubiquitination; P:regulation of DNA replication; P:somite development; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9H3I8 Q9H5M5 Q9NPX4,E3 ubiquitin-protein ligase RBBP6,Proliferation potential-related protein;Protein P2P-R;RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};Retinoblastoma-binding Q protein 1;Retinoblastoma-binding protein 6;p53-associated cellular protein of testis;, PF08783;PF04564;PF13696;, GO:0005694;GO:0005829;GO:0005815;GO:0016607;GO:0005730;GO:0032991;GO:0019901;GO:0003723;GO:0061630;GO:0004842;GO:0008270;GO:0006974;GO:0006260;GO:0048568;GO:0001701;GO:0006397;GO:0035264;GO:0000209;GO:0006275;GO:0061053;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleolus; C:protein-containing complex;, F:protein kinase binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA replication; P:embryonic organ development; P:in utero embryonic development; P:mRNA processing; P:multicellular organism growth; P:protein polyubiquitination; P:regulation of DNA replication; P:somite development; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold38 indexed_genome mRNA 18079862 18101614 . + . ID=transcript_7968;Q9H3I8 Q9H5M5 Q9NPX4,E3 ubiquitin-protein ligase RBBP6,Proliferation potential-related protein;Protein P2P-R;RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};Retinoblastoma-binding Q protein 1;Retinoblastoma-binding protein 6;p53-associated cellular protein of testis;, PF08783;PF04564;PF13696;, GO:0005694;GO:0005829;GO:0005815;GO:0016607;GO:0005730;GO:0032991;GO:0019901;GO:0003723;GO:0061630;GO:0004842;GO:0008270;GO:0006974;GO:0006260;GO:0048568;GO:0001701;GO:0006397;GO:0035264;GO:0000209;GO:0006275;GO:0061053;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleolus; C:protein-containing complex;, F:protein kinase binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA replication; P:embryonic organ development; P:in utero embryonic development; P:mRNA processing; P:multicellular organism growth; P:protein polyubiquitination; P:regulation of DNA replication; P:somite development; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9H3I8 Q9H5M5 Q9NPX4,E3 ubiquitin-protein ligase RBBP6,Proliferation potential-related protein;Protein P2P-R;RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};Retinoblastoma-binding Q protein 1;Retinoblastoma-binding protein 6;p53-associated cellular protein of testis;, PF08783;PF04564;PF13696;, GO:0005694;GO:0005829;GO:0005815;GO:0016607;GO:0005730;GO:0032991;GO:0019901;GO:0003723;GO:0061630;GO:0004842;GO:0008270;GO:0006974;GO:0006260;GO:0048568;GO:0001701;GO:0006397;GO:0035264;GO:0000209;GO:0006275;GO:0061053;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleolus; C:protein-containing complex;, F:protein kinase binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA replication; P:embryonic organ development; P:in utero embryonic development; P:mRNA processing; P:multicellular organism growth; P:protein polyubiquitination; P:regulation of DNA replication; P:somite development; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9H3I8 Q9H5M5 Q9NPX4,E3 ubiquitin-protein ligase RBBP6,Proliferation potential-related protein;Protein P2P-R;RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};Retinoblastoma-binding Q protein 1;Retinoblastoma-binding protein 6;p53-associated cellular protein of testis;, PF08783;PF04564;PF13696;, GO:0005694;GO:0005829;GO:0005815;GO:0016607;GO:0005730;GO:0032991;GO:0019901;GO:0003723;GO:0061630;GO:0004842;GO:0008270;GO:0006974;GO:0006260;GO:0048568;GO:0001701;GO:0006397;GO:0035264;GO:0000209;GO:0006275;GO:0061053;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleolus; C:protein-containing complex;, F:protein kinase binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA replication; P:embryonic organ development; P:in utero embryonic development; P:mRNA processing; P:multicellular organism growth; P:protein polyubiquitination; P:regulation of DNA replication; P:somite development; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9H3I8 Q9H5M5 Q9NPX4,E3 ubiquitin-protein ligase RBBP6,Proliferation potential-related protein;Protein P2P-R;RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};Retinoblastoma-binding Q protein 1;Retinoblastoma-binding protein 6;p53-associated cellular protein of testis;, PF08783;PF04564;PF13696;, GO:0005694;GO:0005829;GO:0005815;GO:0016607;GO:0005730;GO:0032991;GO:0019901;GO:0003723;GO:0061630;GO:0004842;GO:0008270;GO:0006974;GO:0006260;GO:0048568;GO:0001701;GO:0006397;GO:0035264;GO:0000209;GO:0006275;GO:0061053;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleolus; C:protein-containing complex;, F:protein kinase binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA replication; P:embryonic organ development; P:in utero embryonic development; P:mRNA processing; P:multicellular organism growth; P:protein polyubiquitination; P:regulation of DNA replication; P:somite development; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9H3I8 Q9H5M5 Q9NPX4,E3 ubiquitin-protein ligase RBBP6,Proliferation potential-related protein;Protein P2P-R;RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};Retinoblastoma-binding Q protein 1;Retinoblastoma-binding protein 6;p53-associated cellular protein of testis;, PF08783;PF04564;PF13696;, GO:0005694;GO:0005829;GO:0005815;GO:0016607;GO:0005730;GO:0032991;GO:0019901;GO:0003723;GO:0061630;GO:0004842;GO:0008270;GO:0006974;GO:0006260;GO:0048568;GO:0001701;GO:0006397;GO:0035264;GO:0000209;GO:0006275;GO:0061053;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleolus; C:protein-containing complex;, F:protein kinase binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA replication; P:embryonic organ development; P:in utero embryonic development; P:mRNA processing; P:multicellular organism growth; P:protein polyubiquitination; P:regulation of DNA replication; P:somite development; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9H3I8 Q9H5M5 Q9NPX4,E3 ubiquitin-protein ligase RBBP6,Proliferation potential-related protein;Protein P2P-R;RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};Retinoblastoma-binding Q protein 1;Retinoblastoma-binding protein 6;p53-associated cellular protein of testis;, PF08783;PF04564;PF13696;, GO:0005694;GO:0005829;GO:0005815;GO:0016607;GO:0005730;GO:0032991;GO:0019901;GO:0003723;GO:0061630;GO:0004842;GO:0008270;GO:0006974;GO:0006260;GO:0048568;GO:0001701;GO:0006397;GO:0035264;GO:0000209;GO:0006275;GO:0061053;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleolus; C:protein-containing complex;, F:protein kinase binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA replication; P:embryonic organ development; P:in utero embryonic development; P:mRNA processing; P:multicellular organism growth; P:protein polyubiquitination; P:regulation of DNA replication; P:somite development; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9H3I8 Q9H5M5 Q9NPX4,E3 ubiquitin-protein ligase RBBP6,Proliferation potential-related protein;Protein P2P-R;RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};Retinoblastoma-binding Q protein 1;Retinoblastoma-binding protein 6;p53-associated cellular protein of testis;, PF08783;PF04564;PF13696;, GO:0005694;GO:0005829;GO:0005815;GO:0016607;GO:0005730;GO:0032991;GO:0019901;GO:0003723;GO:0061630;GO:0004842;GO:0008270;GO:0006974;GO:0006260;GO:0048568;GO:0001701;GO:0006397;GO:0035264;GO:0000209;GO:0006275;GO:0061053;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:microtubule organizing center; C:nuclear speck; C:nucleolus; C:protein-containing complex;, F:protein kinase binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:DNA replication; P:embryonic organ development; P:in utero embryonic development; P:mRNA processing; P:multicellular organism growth; P:protein polyubiquitination; P:regulation of DNA replication; P:somite development; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold38 indexed_genome mRNA 18246858 18342121 . + . ID=transcript_7969;Q9P268,Trinucleotide repeat-containing gene 6A protein,CAG repeat protein 26;EMSY interactor protein;GW182 autoantigen;Glycine-tryptophan protein of 182 kDa;, PF10427;PF12938;PF16608;, GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0000932;GO:0016442;GO:0003723;GO:0009267;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:0060213;GO:0035194;GO:0060964;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:P-body; C:RISC complex;, F:RNA binding;, P:cellular response to starvation; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9P268,Trinucleotide repeat-containing gene 6A protein,CAG repeat protein 26;EMSY interactor protein;GW182 autoantigen;Glycine-tryptophan protein of 182 kDa;, PF10427;PF12938;PF16608;, GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0000932;GO:0016442;GO:0003723;GO:0009267;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:0060213;GO:0035194;GO:0060964;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:P-body; C:RISC complex;, F:RNA binding;, P:cellular response to starvation; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9P268,Trinucleotide repeat-containing gene 6A protein,CAG repeat protein 26;EMSY interactor protein;GW182 autoantigen;Glycine-tryptophan protein of 182 kDa;, PF10427;PF12938;PF16608;, GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0000932;GO:0016442;GO:0003723;GO:0009267;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:0060213;GO:0035194;GO:0060964;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:P-body; C:RISC complex;, F:RNA binding;, P:cellular response to starvation; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9P268,Trinucleotide repeat-containing gene 6A protein,CAG repeat protein 26;EMSY interactor protein;GW182 autoantigen;Glycine-tryptophan protein of 182 kDa;, PF10427;PF12938;PF16608;, GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0000932;GO:0016442;GO:0003723;GO:0009267;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:0060213;GO:0035194;GO:0060964;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:P-body; C:RISC complex;, F:RNA binding;, P:cellular response to starvation; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9P268,Trinucleotide repeat-containing gene 6A protein,CAG repeat protein 26;EMSY interactor protein;GW182 autoantigen;Glycine-tryptophan protein of 182 kDa;, PF10427;PF12938;PF16608;, GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0000932;GO:0016442;GO:0003723;GO:0009267;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:0060213;GO:0035194;GO:0060964;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:P-body; C:RISC complex;, F:RNA binding;, P:cellular response to starvation; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9P268,Trinucleotide repeat-containing gene 6A protein,CAG repeat protein 26;EMSY interactor protein;GW182 autoantigen;Glycine-tryptophan protein of 182 kDa;, PF10427;PF12938;PF16608;, GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0000932;GO:0016442;GO:0003723;GO:0009267;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:0060213;GO:0035194;GO:0060964;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:P-body; C:RISC complex;, F:RNA binding;, P:cellular response to starvation; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9P268,Trinucleotide repeat-containing gene 6A protein,CAG repeat protein 26;EMSY interactor protein;GW182 autoantigen;Glycine-tryptophan protein of 182 kDa;, PF10427;PF12938;PF16608;, GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0000932;GO:0016442;GO:0003723;GO:0009267;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:0060213;GO:0035194;GO:0060964;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:P-body; C:RISC complex;, F:RNA binding;, P:cellular response to starvation; P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway; scaffold38 indexed_genome mRNA 18400983 18426024 . + . ID=transcript_7970;Q8WWX8 B7Z329 Q05BF1 Q6PF02 Q6ZUW3 Q86Y55 Q96PP5,Sodium/myo-inositol cotransporter 2,Sodium-dependent glucose cotransporter;Sodium/glucose cotransporter KST1;Sodium/myo-inositol transporter 2;Solute carrier family 5 member 11;, PF00474;, GO:0016021;GO:0005886;GO:0005412;GO:0006915;GO:0015798;, C:integral component of membrane; C:plasma membrane;, F:glucose:sodium symporter activity;, P:apoptotic process; P:myo-inositol transport;|Q8WWX8 B7Z329 Q05BF1 Q6PF02 Q6ZUW3 Q86Y55 Q96PP5,Sodium/myo-inositol cotransporter 2,Sodium-dependent glucose cotransporter;Sodium/glucose cotransporter KST1;Sodium/myo-inositol transporter 2;Solute carrier family 5 member 11;, PF00474;, GO:0016021;GO:0005886;GO:0005412;GO:0006915;GO:0015798;, C:integral component of membrane; C:plasma membrane;, F:glucose:sodium symporter activity;, P:apoptotic process; P:myo-inositol transport;|Q8WWX8 B7Z329 Q05BF1 Q6PF02 Q6ZUW3 Q86Y55 Q96PP5,Sodium/myo-inositol cotransporter 2,Sodium-dependent glucose cotransporter;Sodium/glucose cotransporter KST1;Sodium/myo-inositol transporter 2;Solute carrier family 5 member 11;, PF00474;, GO:0016021;GO:0005886;GO:0005412;GO:0006915;GO:0015798;, C:integral component of membrane; C:plasma membrane;, F:glucose:sodium symporter activity;, P:apoptotic process; P:myo-inositol transport;|Q8WWX8 B7Z329 Q05BF1 Q6PF02 Q6ZUW3 Q86Y55 Q96PP5,Sodium/myo-inositol cotransporter 2,Sodium-dependent glucose cotransporter;Sodium/glucose cotransporter KST1;Sodium/myo-inositol transporter 2;Solute carrier family 5 member 11;, PF00474;, GO:0016021;GO:0005886;GO:0005412;GO:0006915;GO:0015798;, C:integral component of membrane; C:plasma membrane;, F:glucose:sodium symporter activity;, P:apoptotic process; P:myo-inositol transport;|Q8WWX8 B7Z329 Q05BF1 Q6PF02 Q6ZUW3 Q86Y55 Q96PP5,Sodium/myo-inositol cotransporter 2,Sodium-dependent glucose cotransporter;Sodium/glucose cotransporter KST1;Sodium/myo-inositol transporter 2;Solute carrier family 5 member 11;, PF00474;, GO:0016021;GO:0005886;GO:0005412;GO:0006915;GO:0015798;, C:integral component of membrane; C:plasma membrane;, F:glucose:sodium symporter activity;, P:apoptotic process; P:myo-inositol transport; scaffold38 indexed_genome mRNA 18431893 18485808 . - . ID=transcript_7971;Q9H8U5 Q9NW54,Rho GTPase-activating protein 17,Rho-type GTPase-activating protein 17;RhoGAP interacting with CIP4 homologs protein 1;, PF03114;PF00620;, GO:0005923;GO:0005829;GO:0005654;GO:0005886;GO:0005096;GO:0017124;GO:0007015;GO:0017156;GO:0032956;GO:0035020;GO:0051056;GO:0007165;, C:bicellular tight junction; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:GTPase activator activity; F:SH3 domain binding;, P:actin filament organization; P:calcium-ion regulated exocytosis; P:regulation of actin cytoskeleton organization; P:regulation of Rac protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9H8U5 Q9NW54,Rho GTPase-activating protein 17,Rho-type GTPase-activating protein 17;RhoGAP interacting with CIP4 homologs protein 1;, PF03114;PF00620;, GO:0005923;GO:0005829;GO:0005654;GO:0005886;GO:0005096;GO:0017124;GO:0007015;GO:0017156;GO:0032956;GO:0035020;GO:0051056;GO:0007165;, C:bicellular tight junction; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:GTPase activator activity; F:SH3 domain binding;, P:actin filament organization; P:calcium-ion regulated exocytosis; P:regulation of actin cytoskeleton organization; P:regulation of Rac protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9H8U5 Q9NW54,Rho GTPase-activating protein 17,Rho-type GTPase-activating protein 17;RhoGAP interacting with CIP4 homologs protein 1;, PF03114;PF00620;, GO:0005923;GO:0005829;GO:0005654;GO:0005886;GO:0005096;GO:0017124;GO:0007015;GO:0017156;GO:0032956;GO:0035020;GO:0051056;GO:0007165;, C:bicellular tight junction; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:GTPase activator activity; F:SH3 domain binding;, P:actin filament organization; P:calcium-ion regulated exocytosis; P:regulation of actin cytoskeleton organization; P:regulation of Rac protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold38 indexed_genome mRNA 18547929 18612951 . + . ID=transcript_7972;Q9UIC8 A6NL89 A8K770 Q53FC5 Q96CI5 Q9H6I9 Q9NTG4 Q9Y378,Leucine carboxyl methyltransferase 1,Protein-leucine O-methyltransferase;[Phosphatase 2A protein]-leucine-carboxy methyltransferase 1;, PF04072;, GO:0005829;GO:0005654;GO:0003880;GO:0018423;GO:0008757;GO:0006481;GO:0006464;GO:0000086;GO:0031333;GO:0006479;GO:0042981;GO:0010906;GO:0090266;, C:cytosol; C:nucleoplasm;, F:protein C-terminal carboxyl O-methyltransferase activity; F:protein C-terminal leucine carboxyl O-methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:C-terminal protein methylation; P:cellular protein modification process; P:G2/M transition of mitotic cell cycle; P:negative regulation of protein-containing complex assembly; P:protein methylation; P:regulation of apoptotic process; P:regulation of glucose metabolic process; P:regulation of mitotic cell cycle spindle assembly checkpoint;|Q9UIC8 A6NL89 A8K770 Q53FC5 Q96CI5 Q9H6I9 Q9NTG4 Q9Y378,Leucine carboxyl methyltransferase 1,Protein-leucine O-methyltransferase;[Phosphatase 2A protein]-leucine-carboxy methyltransferase 1;, PF04072;, GO:0005829;GO:0005654;GO:0003880;GO:0018423;GO:0008757;GO:0006481;GO:0006464;GO:0000086;GO:0031333;GO:0006479;GO:0042981;GO:0010906;GO:0090266;, C:cytosol; C:nucleoplasm;, F:protein C-terminal carboxyl O-methyltransferase activity; F:protein C-terminal leucine carboxyl O-methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:C-terminal protein methylation; P:cellular protein modification process; P:G2/M transition of mitotic cell cycle; P:negative regulation of protein-containing complex assembly; P:protein methylation; P:regulation of apoptotic process; P:regulation of glucose metabolic process; P:regulation of mitotic cell cycle spindle assembly checkpoint;|Q9UIC8 A6NL89 A8K770 Q53FC5 Q96CI5 Q9H6I9 Q9NTG4 Q9Y378,Leucine carboxyl methyltransferase 1,Protein-leucine O-methyltransferase;[Phosphatase 2A protein]-leucine-carboxy methyltransferase 1;, PF04072;, GO:0005829;GO:0005654;GO:0003880;GO:0018423;GO:0008757;GO:0006481;GO:0006464;GO:0000086;GO:0031333;GO:0006479;GO:0042981;GO:0010906;GO:0090266;, C:cytosol; C:nucleoplasm;, F:protein C-terminal carboxyl O-methyltransferase activity; F:protein C-terminal leucine carboxyl O-methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:C-terminal protein methylation; P:cellular protein modification process; P:G2/M transition of mitotic cell cycle; P:negative regulation of protein-containing complex assembly; P:protein methylation; P:regulation of apoptotic process; P:regulation of glucose metabolic process; P:regulation of mitotic cell cycle spindle assembly checkpoint;|A8MTT3 A8MUR5,Protein CEBPZOS {ECO:0000305},CEBPZ antisense RNA 1 {ECO:0000312|HGNC:HGNC:49288};CEBPZ opposite strand {ECO:0000312|HGNC:HGNC:49288};, , GO:0016021;GO:0031966;, C:integral component of membrane; C:mitochondrial membrane; scaffold38 indexed_genome mRNA 18643558 18653415 . + . ID=transcript_7973;O94778 Q8IUU3 Q9UIA4,Aquaporin-8,, PF00230;, GO:0045177;GO:0005887;GO:0031966;GO:0005886;GO:0015250;GO:0071320;GO:0006833;, C:apical part of cell; C:integral component of plasma membrane; C:mitochondrial membrane; C:plasma membrane;, F:water channel activity;, P:cellular response to cAMP; P:water transport; scaffold38 indexed_genome mRNA 18664144 18664761 . - . ID=transcript_7974;Q63HK3 A1L3B4 Q6ZN77,Zinc finger protein with KRAB and SCAN domains 2,Zinc finger protein 694;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold38 indexed_genome mRNA 18665306 18666789 . - . ID=transcript_7975;Q63HK3 A1L3B4 Q6ZN77,Zinc finger protein with KRAB and SCAN domains 2,Zinc finger protein 694;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold38 indexed_genome mRNA 18669369 18677121 . - . ID=transcript_7976;Q63HK3 A1L3B4 Q6ZN77,Zinc finger protein with KRAB and SCAN domains 2,Zinc finger protein 694;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold38 indexed_genome mRNA 20521575 20543907 . + . ID=transcript_7977;Q8N371 B4DLU9 Q6VAK5 Q9H8B1,Bifunctional peptidase and arginyl-hydroxylase JMJD5 {ECO:0000305|PubMed:28847961, ECO:0000305|PubMed:29459673, ECO:0000305|PubMed:29563586},JmjC domain-containing protein 5 {ECO:0000303|PubMed:28982940};Jumonji C domain-containing protein 5 {ECO:0000303|PubMed:28982940};L-arginine (3R)-hydroxylase KDM8 {ECO:0000305|PubMed:29563586};, PF13621;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0016706;GO:0004177;GO:0003682;GO:0004175;GO:0051864;GO:0140554;GO:0046872;GO:0035064;GO:0032922;GO:0000086;GO:0070544;GO:0045892;GO:0045893;GO:0031648;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:aminopeptidase activity; F:chromatin binding; F:endopeptidase activity; F:histone demethylase activity (H3-K36 specific); F:L-arginine 3-hydroxylase activity; F:metal ion binding; F:methylated histone binding;, P:circadian regulation of gene expression; P:G2/M transition of mitotic cell cycle; P:histone H3-K36 demethylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:protein destabilization;|Q8N371 B4DLU9 Q6VAK5 Q9H8B1,Bifunctional peptidase and arginyl-hydroxylase JMJD5 {ECO:0000305|PubMed:28847961, ECO:0000305|PubMed:29459673, ECO:0000305|PubMed:29563586},JmjC domain-containing protein 5 {ECO:0000303|PubMed:28982940};Jumonji C domain-containing protein 5 {ECO:0000303|PubMed:28982940};L-arginine (3R)-hydroxylase KDM8 {ECO:0000305|PubMed:29563586};, PF13621;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0016706;GO:0004177;GO:0003682;GO:0004175;GO:0051864;GO:0140554;GO:0046872;GO:0035064;GO:0032922;GO:0000086;GO:0070544;GO:0045892;GO:0045893;GO:0031648;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:aminopeptidase activity; F:chromatin binding; F:endopeptidase activity; F:histone demethylase activity (H3-K36 specific); F:L-arginine 3-hydroxylase activity; F:metal ion binding; F:methylated histone binding;, P:circadian regulation of gene expression; P:G2/M transition of mitotic cell cycle; P:histone H3-K36 demethylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:protein destabilization;|Q8N371 B4DLU9 Q6VAK5 Q9H8B1,Bifunctional peptidase and arginyl-hydroxylase JMJD5 {ECO:0000305|PubMed:28847961, ECO:0000305|PubMed:29459673, ECO:0000305|PubMed:29563586},JmjC domain-containing protein 5 {ECO:0000303|PubMed:28982940};Jumonji C domain-containing protein 5 {ECO:0000303|PubMed:28982940};L-arginine (3R)-hydroxylase KDM8 {ECO:0000305|PubMed:29563586};, PF13621;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0016706;GO:0004177;GO:0003682;GO:0004175;GO:0051864;GO:0140554;GO:0046872;GO:0035064;GO:0032922;GO:0000086;GO:0070544;GO:0045892;GO:0045893;GO:0031648;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:aminopeptidase activity; F:chromatin binding; F:endopeptidase activity; F:histone demethylase activity (H3-K36 specific); F:L-arginine 3-hydroxylase activity; F:metal ion binding; F:methylated histone binding;, P:circadian regulation of gene expression; P:G2/M transition of mitotic cell cycle; P:histone H3-K36 demethylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:protein destabilization; scaffold38 indexed_genome mRNA 20547100 20582319 . + . ID=transcript_7978;Q8WV22 D3DWF6 Q9P045 Q9P049,Non-structural maintenance of chromosomes element 1 homolog,, PF07574;PF08746;, GO:0000781;GO:0043231;GO:0005654;GO:0005634;GO:0030915;GO:0046872;GO:0046983;GO:0061630;GO:0004842;GO:0000724;GO:0035556;GO:2001022;GO:0006301;, C:chromosome, telomeric region; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, F:metal ion binding; F:protein dimerization activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:double-strand break repair via homologous recombination; P:intracellular signal transduction; P:positive regulation of response to DNA damage stimulus; P:postreplication repair;|Q8WV22 D3DWF6 Q9P045 Q9P049,Non-structural maintenance of chromosomes element 1 homolog,, PF07574;PF08746;, GO:0000781;GO:0043231;GO:0005654;GO:0005634;GO:0030915;GO:0046872;GO:0046983;GO:0061630;GO:0004842;GO:0000724;GO:0035556;GO:2001022;GO:0006301;, C:chromosome, telomeric region; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, F:metal ion binding; F:protein dimerization activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:double-strand break repair via homologous recombination; P:intracellular signal transduction; P:positive regulation of response to DNA damage stimulus; P:postreplication repair;|Q8WV22 D3DWF6 Q9P045 Q9P049,Non-structural maintenance of chromosomes element 1 homolog,, PF07574;PF08746;, GO:0000781;GO:0043231;GO:0005654;GO:0005634;GO:0030915;GO:0046872;GO:0046983;GO:0061630;GO:0004842;GO:0000724;GO:0035556;GO:2001022;GO:0006301;, C:chromosome, telomeric region; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, F:metal ion binding; F:protein dimerization activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:double-strand break repair via homologous recombination; P:intracellular signal transduction; P:positive regulation of response to DNA damage stimulus; P:postreplication repair;|Q8WV22 D3DWF6 Q9P045 Q9P049,Non-structural maintenance of chromosomes element 1 homolog,, PF07574;PF08746;, GO:0000781;GO:0043231;GO:0005654;GO:0005634;GO:0030915;GO:0046872;GO:0046983;GO:0061630;GO:0004842;GO:0000724;GO:0035556;GO:2001022;GO:0006301;, C:chromosome, telomeric region; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, F:metal ion binding; F:protein dimerization activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:double-strand break repair via homologous recombination; P:intracellular signal transduction; P:positive regulation of response to DNA damage stimulus; P:postreplication repair;|Q8WV22 D3DWF6 Q9P045 Q9P049,Non-structural maintenance of chromosomes element 1 homolog,, PF07574;PF08746;, GO:0000781;GO:0043231;GO:0005654;GO:0005634;GO:0030915;GO:0046872;GO:0046983;GO:0061630;GO:0004842;GO:0000724;GO:0035556;GO:2001022;GO:0006301;, C:chromosome, telomeric region; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:Smc5-Smc6 complex;, F:metal ion binding; F:protein dimerization activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:double-strand break repair via homologous recombination; P:intracellular signal transduction; P:positive regulation of response to DNA damage stimulus; P:postreplication repair; scaffold38 indexed_genome mRNA 20620784 20671717 . + . ID=transcript_7979;Q9H185 Q9H186 Q9H187 Q9H188,Interleukin-4 receptor subunit alpha,, PF09238;, GO:0034451;GO:0005615;GO:0005887;GO:0005654;GO:0005886;GO:0043235;GO:0004913;GO:0019221;GO:0042832;GO:0006955;GO:0016064;GO:0045626;GO:0030728;GO:0032722;GO:0120162;GO:0002639;GO:0043032;GO:0043306;GO:1901741;GO:0045630;GO:0002532;GO:0042127;GO:0043627;GO:1990834;GO:0007165;, C:centriolar satellite; C:extracellular space; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:interleukin-4 receptor activity;, P:cytokine-mediated signaling pathway; P:defense response to protozoan; P:immune response; P:immunoglobulin mediated immune response; P:negative regulation of T-helper 1 cell differentiation; P:ovulation; P:positive regulation of chemokine production; P:positive regulation of cold-induced thermogenesis; P:positive regulation of immunoglobulin production; P:positive regulation of macrophage activation; P:positive regulation of mast cell degranulation; P:positive regulation of myoblast fusion; P:positive regulation of T-helper 2 cell differentiation; P:production of molecular mediator involved in inflammatory response; P:regulation of cell population proliferation; P:response to estrogen; P:response to odorant; P:signal transduction;|Q9H185 Q9H186 Q9H187 Q9H188,Interleukin-4 receptor subunit alpha,, PF09238;, GO:0034451;GO:0005615;GO:0005887;GO:0005654;GO:0005886;GO:0043235;GO:0004913;GO:0019221;GO:0042832;GO:0006955;GO:0016064;GO:0045626;GO:0030728;GO:0032722;GO:0120162;GO:0002639;GO:0043032;GO:0043306;GO:1901741;GO:0045630;GO:0002532;GO:0042127;GO:0043627;GO:1990834;GO:0007165;, C:centriolar satellite; C:extracellular space; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:interleukin-4 receptor activity;, P:cytokine-mediated signaling pathway; P:defense response to protozoan; P:immune response; P:immunoglobulin mediated immune response; P:negative regulation of T-helper 1 cell differentiation; P:ovulation; P:positive regulation of chemokine production; P:positive regulation of cold-induced thermogenesis; P:positive regulation of immunoglobulin production; P:positive regulation of macrophage activation; P:positive regulation of mast cell degranulation; P:positive regulation of myoblast fusion; P:positive regulation of T-helper 2 cell differentiation; P:production of molecular mediator involved in inflammatory response; P:regulation of cell population proliferation; P:response to estrogen; P:response to odorant; P:signal transduction; scaffold38 indexed_genome mRNA 20735199 20749363 . + . ID=transcript_7980;Q9HBE5 A8K9E8 D3DWF7 Q96HZ1 Q9HB91,Interleukin-21 receptor,Novel interleukin receptor;, , GO:0016021;GO:0005886;GO:0004896;GO:0001532;GO:0004888;GO:0038114;GO:0030101;, C:integral component of membrane; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-21 receptor activity; F:transmembrane signaling receptor activity;, P:interleukin-21-mediated signaling pathway; P:natural killer cell activation;|Q9HBE5 A8K9E8 D3DWF7 Q96HZ1 Q9HB91,Interleukin-21 receptor,Novel interleukin receptor;, , GO:0016021;GO:0005886;GO:0004896;GO:0001532;GO:0004888;GO:0038114;GO:0030101;, C:integral component of membrane; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-21 receptor activity; F:transmembrane signaling receptor activity;, P:interleukin-21-mediated signaling pathway; P:natural killer cell activation;|Q9HBE5 A8K9E8 D3DWF7 Q96HZ1 Q9HB91,Interleukin-21 receptor,Novel interleukin receptor;, , GO:0016021;GO:0005886;GO:0004896;GO:0001532;GO:0004888;GO:0038114;GO:0030101;, C:integral component of membrane; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-21 receptor activity; F:transmembrane signaling receptor activity;, P:interleukin-21-mediated signaling pathway; P:natural killer cell activation; scaffold38 indexed_genome mRNA 20759535 20841705 . + . ID=transcript_7981;Q12789 B2RP21 Q12838 Q6DKN9 Q9Y4W9,General transcription factor 3C polypeptide 1,TF3C-alpha;TFIIIC box B-binding subunit;Transcription factor IIIC 220 kDa subunit;Transcription factor IIIC subunit alpha;, PF04182;, GO:0016020;GO:0005730;GO:0005654;GO:1990904;GO:0000127;GO:0003677;GO:0042791;GO:0009303;GO:0006383;GO:0006384;GO:0009304;GO:0042797;, C:membrane; C:nucleolus; C:nucleoplasm; C:ribonucleoprotein complex; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:rRNA transcription; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription; P:tRNA transcription by RNA polymerase III;|Q12789 B2RP21 Q12838 Q6DKN9 Q9Y4W9,General transcription factor 3C polypeptide 1,TF3C-alpha;TFIIIC box B-binding subunit;Transcription factor IIIC 220 kDa subunit;Transcription factor IIIC subunit alpha;, PF04182;, GO:0016020;GO:0005730;GO:0005654;GO:1990904;GO:0000127;GO:0003677;GO:0042791;GO:0009303;GO:0006383;GO:0006384;GO:0009304;GO:0042797;, C:membrane; C:nucleolus; C:nucleoplasm; C:ribonucleoprotein complex; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:rRNA transcription; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription; P:tRNA transcription by RNA polymerase III;|Q12789 B2RP21 Q12838 Q6DKN9 Q9Y4W9,General transcription factor 3C polypeptide 1,TF3C-alpha;TFIIIC box B-binding subunit;Transcription factor IIIC 220 kDa subunit;Transcription factor IIIC subunit alpha;, PF04182;, GO:0016020;GO:0005730;GO:0005654;GO:1990904;GO:0000127;GO:0003677;GO:0042791;GO:0009303;GO:0006383;GO:0006384;GO:0009304;GO:0042797;, C:membrane; C:nucleolus; C:nucleoplasm; C:ribonucleoprotein complex; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:rRNA transcription; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription; P:tRNA transcription by RNA polymerase III;|Q12789 B2RP21 Q12838 Q6DKN9 Q9Y4W9,General transcription factor 3C polypeptide 1,TF3C-alpha;TFIIIC box B-binding subunit;Transcription factor IIIC 220 kDa subunit;Transcription factor IIIC subunit alpha;, PF04182;, GO:0016020;GO:0005730;GO:0005654;GO:1990904;GO:0000127;GO:0003677;GO:0042791;GO:0009303;GO:0006383;GO:0006384;GO:0009304;GO:0042797;, C:membrane; C:nucleolus; C:nucleoplasm; C:ribonucleoprotein complex; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:rRNA transcription; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription; P:tRNA transcription by RNA polymerase III;|Q12789 B2RP21 Q12838 Q6DKN9 Q9Y4W9,General transcription factor 3C polypeptide 1,TF3C-alpha;TFIIIC box B-binding subunit;Transcription factor IIIC 220 kDa subunit;Transcription factor IIIC subunit alpha;, PF04182;, GO:0016020;GO:0005730;GO:0005654;GO:1990904;GO:0000127;GO:0003677;GO:0042791;GO:0009303;GO:0006383;GO:0006384;GO:0009304;GO:0042797;, C:membrane; C:nucleolus; C:nucleoplasm; C:ribonucleoprotein complex; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:rRNA transcription; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription; P:tRNA transcription by RNA polymerase III;|Q12789 B2RP21 Q12838 Q6DKN9 Q9Y4W9,General transcription factor 3C polypeptide 1,TF3C-alpha;TFIIIC box B-binding subunit;Transcription factor IIIC 220 kDa subunit;Transcription factor IIIC subunit alpha;, PF04182;, GO:0016020;GO:0005730;GO:0005654;GO:1990904;GO:0000127;GO:0003677;GO:0042791;GO:0009303;GO:0006383;GO:0006384;GO:0009304;GO:0042797;, C:membrane; C:nucleolus; C:nucleoplasm; C:ribonucleoprotein complex; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:rRNA transcription; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription; P:tRNA transcription by RNA polymerase III;|Q12789 B2RP21 Q12838 Q6DKN9 Q9Y4W9,General transcription factor 3C polypeptide 1,TF3C-alpha;TFIIIC box B-binding subunit;Transcription factor IIIC 220 kDa subunit;Transcription factor IIIC subunit alpha;, PF04182;, GO:0016020;GO:0005730;GO:0005654;GO:1990904;GO:0000127;GO:0003677;GO:0042791;GO:0009303;GO:0006383;GO:0006384;GO:0009304;GO:0042797;, C:membrane; C:nucleolus; C:nucleoplasm; C:ribonucleoprotein complex; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:rRNA transcription; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription; P:tRNA transcription by RNA polymerase III; scaffold38 indexed_genome mRNA 20911982 21070503 . + . ID=transcript_7982;O60303 A7E2C2,Katanin-interacting protein,, PF14652;, GO:0042995;GO:0005737;GO:0005856;GO:0005615;GO:0090660;, C:cell projection; C:cytoplasm; C:cytoskeleton; C:extracellular space;, , P:cerebrospinal fluid circulation;|O60303 A7E2C2,Katanin-interacting protein,, PF14652;, GO:0042995;GO:0005737;GO:0005856;GO:0005615;GO:0090660;, C:cell projection; C:cytoplasm; C:cytoskeleton; C:extracellular space;, , P:cerebrospinal fluid circulation; scaffold38 indexed_genome mRNA 21373381 21383836 . + . ID=transcript_7983;Q96QU8 A1L3W4 D3DWF9 Q2YDX3 Q53G88 Q68G50 Q76N88 Q96CP8 Q9BT21,Exportin-6,Ran-binding protein 20;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus;|Q96QU8 A1L3W4 D3DWF9 Q2YDX3 Q53G88 Q68G50 Q76N88 Q96CP8 Q9BT21,Exportin-6,Ran-binding protein 20;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus;|Q96QU8 A1L3W4 D3DWF9 Q2YDX3 Q53G88 Q68G50 Q76N88 Q96CP8 Q9BT21,Exportin-6,Ran-binding protein 20;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus;|Q96QU8 A1L3W4 D3DWF9 Q2YDX3 Q53G88 Q68G50 Q76N88 Q96CP8 Q9BT21,Exportin-6,Ran-binding protein 20;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; scaffold38 indexed_genome mRNA 21399475 21423658 . + . ID=transcript_7984;Q96QU8 A1L3W4 D3DWF9 Q2YDX3 Q53G88 Q68G50 Q76N88 Q96CP8 Q9BT21,Exportin-6,Ran-binding protein 20;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus;|Q96QU8 A1L3W4 D3DWF9 Q2YDX3 Q53G88 Q68G50 Q76N88 Q96CP8 Q9BT21,Exportin-6,Ran-binding protein 20;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; scaffold38 indexed_genome mRNA 21424053 21483578 . + . ID=transcript_7985;Q96QU8 A1L3W4 D3DWF9 Q2YDX3 Q53G88 Q68G50 Q76N88 Q96CP8 Q9BT21,Exportin-6,Ran-binding protein 20;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus;|Q96QU8 A1L3W4 D3DWF9 Q2YDX3 Q53G88 Q68G50 Q76N88 Q96CP8 Q9BT21,Exportin-6,Ran-binding protein 20;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus;|Q96QU8 A1L3W4 D3DWF9 Q2YDX3 Q53G88 Q68G50 Q76N88 Q96CP8 Q9BT21,Exportin-6,Ran-binding protein 20;, PF03810;PF08389;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; scaffold38 indexed_genome mRNA 21526489 21584530 . + . ID=transcript_7986;Q52WX2,Serine/threonine-protein kinase SBK1,SH3-binding kinase 1;, PF00069;, GO:0005737;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0018105;GO:0018107;, C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation;|Q52WX2,Serine/threonine-protein kinase SBK1,SH3-binding kinase 1;, PF00069;, GO:0005737;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0018105;GO:0018107;, C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation;|Q52WX2,Serine/threonine-protein kinase SBK1,SH3-binding kinase 1;, PF00069;, GO:0005737;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0018105;GO:0018107;, C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; scaffold38 indexed_genome mRNA 21619383 21634159 . - . ID=transcript_7987;O43561 B7WPI0 C7C5T6 G5E9K3 O43919,Linker for activation of T-cells family member 1,36 kDa phospho-tyrosine adapter protein;p36-38;, PF15234;, GO:0008180;GO:0005794;GO:0001772;GO:0016021;GO:0045121;GO:0005886;GO:0019901;GO:0030159;GO:0002250;GO:0019722;GO:0038095;GO:0006955;GO:0006954;GO:0007229;GO:0035556;GO:0000165;GO:0043303;GO:0045860;GO:0007265;GO:0050863;GO:0042110;GO:0050852;, C:COP9 signalosome; C:Golgi apparatus; C:immunological synapse; C:integral component of membrane; C:membrane raft; C:plasma membrane;, F:protein kinase binding; F:signaling receptor complex adaptor activity;, P:adaptive immune response; P:calcium-mediated signaling; P:Fc-epsilon receptor signaling pathway; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mast cell degranulation; P:positive regulation of protein kinase activity; P:Ras protein signal transduction; P:regulation of T cell activation; P:T cell activation; P:T cell receptor signaling pathway;|O43561 B7WPI0 C7C5T6 G5E9K3 O43919,Linker for activation of T-cells family member 1,36 kDa phospho-tyrosine adapter protein;p36-38;, PF15234;, GO:0008180;GO:0005794;GO:0001772;GO:0016021;GO:0045121;GO:0005886;GO:0019901;GO:0030159;GO:0002250;GO:0019722;GO:0038095;GO:0006955;GO:0006954;GO:0007229;GO:0035556;GO:0000165;GO:0043303;GO:0045860;GO:0007265;GO:0050863;GO:0042110;GO:0050852;, C:COP9 signalosome; C:Golgi apparatus; C:immunological synapse; C:integral component of membrane; C:membrane raft; C:plasma membrane;, F:protein kinase binding; F:signaling receptor complex adaptor activity;, P:adaptive immune response; P:calcium-mediated signaling; P:Fc-epsilon receptor signaling pathway; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mast cell degranulation; P:positive regulation of protein kinase activity; P:Ras protein signal transduction; P:regulation of T cell activation; P:T cell activation; P:T cell receptor signaling pathway;|Q9H2V7 B5MDM9 Q6P182 Q71RB5 Q7L541 Q86VU7 Q8N953 Q8TCS5 Q9BRN5,Protein spinster homolog 1,HSpin1;Spinster-like protein 1;, PF07690;, GO:0016021;GO:0005765;GO:0005743;GO:0022857;GO:0006869;, C:integral component of membrane; C:lysosomal membrane; C:mitochondrial inner membrane;, F:transmembrane transporter activity;, P:lipid transport;|Q9H2V7 B5MDM9 Q6P182 Q71RB5 Q7L541 Q86VU7 Q8N953 Q8TCS5 Q9BRN5,Protein spinster homolog 1,HSpin1;Spinster-like protein 1;, PF07690;, GO:0016021;GO:0005765;GO:0005743;GO:0022857;GO:0006869;, C:integral component of membrane; C:lysosomal membrane; C:mitochondrial inner membrane;, F:transmembrane transporter activity;, P:lipid transport;|Q9H2V7 B5MDM9 Q6P182 Q71RB5 Q7L541 Q86VU7 Q8N953 Q8TCS5 Q9BRN5,Protein spinster homolog 1,HSpin1;Spinster-like protein 1;, PF07690;, GO:0016021;GO:0005765;GO:0005743;GO:0022857;GO:0006869;, C:integral component of membrane; C:lysosomal membrane; C:mitochondrial inner membrane;, F:transmembrane transporter activity;, P:lipid transport;|Q9H2V7 B5MDM9 Q6P182 Q71RB5 Q7L541 Q86VU7 Q8N953 Q8TCS5 Q9BRN5,Protein spinster homolog 1,HSpin1;Spinster-like protein 1;, PF07690;, GO:0016021;GO:0005765;GO:0005743;GO:0022857;GO:0006869;, C:integral component of membrane; C:lysosomal membrane; C:mitochondrial inner membrane;, F:transmembrane transporter activity;, P:lipid transport;|Q9H2V7 B5MDM9 Q6P182 Q71RB5 Q7L541 Q86VU7 Q8N953 Q8TCS5 Q9BRN5,Protein spinster homolog 1,HSpin1;Spinster-like protein 1;, PF07690;, GO:0016021;GO:0005765;GO:0005743;GO:0022857;GO:0006869;, C:integral component of membrane; C:lysosomal membrane; C:mitochondrial inner membrane;, F:transmembrane transporter activity;, P:lipid transport;|Q9H2V7 B5MDM9 Q6P182 Q71RB5 Q7L541 Q86VU7 Q8N953 Q8TCS5 Q9BRN5,Protein spinster homolog 1,HSpin1;Spinster-like protein 1;, PF07690;, GO:0016021;GO:0005765;GO:0005743;GO:0022857;GO:0006869;, C:integral component of membrane; C:lysosomal membrane; C:mitochondrial inner membrane;, F:transmembrane transporter activity;, P:lipid transport; scaffold38 indexed_genome mRNA 21641038 21652088 . - . ID=transcript_7988;Q8NCF5 B7Z4G5 Q66K34 Q6NVK1 Q8NFR2 Q96ST9,NFATC2-interacting protein,45 kDa NF-AT-interacting protein;Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein;, PF11976;, GO:0005737;GO:0005634;GO:0045944;, C:cytoplasm; C:nucleus;, , P:positive regulation of transcription by RNA polymerase II;|Q8NCF5 B7Z4G5 Q66K34 Q6NVK1 Q8NFR2 Q96ST9,NFATC2-interacting protein,45 kDa NF-AT-interacting protein;Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein;, PF11976;, GO:0005737;GO:0005634;GO:0045944;, C:cytoplasm; C:nucleus;, , P:positive regulation of transcription by RNA polymerase II;|Q8NCF5 B7Z4G5 Q66K34 Q6NVK1 Q8NFR2 Q96ST9,NFATC2-interacting protein,45 kDa NF-AT-interacting protein;Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein;, PF11976;, GO:0005737;GO:0005634;GO:0045944;, C:cytoplasm; C:nucleus;, , P:positive regulation of transcription by RNA polymerase II; scaffold38 indexed_genome mRNA 21659982 21662514 . - . ID=transcript_7989;P15391 A0N0P9 F5H635 Q96S68 Q9BRD6,B-lymphocyte antigen CD19,B-lymphocyte surface antigen B4;Differentiation antigen CD19;T-cell surface antigen Leu-12;, , GO:0009897;GO:0070062;GO:0005887;GO:0045121;GO:0005886;GO:0032991;GO:0050851;GO:0002322;GO:0050853;GO:0001923;GO:0016064;GO:0043552;GO:0051897;GO:0051281;GO:0050864;GO:0050855;GO:0030449;GO:0050776;, C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane; C:protein-containing complex;, , P:antigen receptor-mediated signaling pathway; P:B cell proliferation involved in immune response; P:B cell receptor signaling pathway; P:B-1 B cell differentiation; P:immunoglobulin mediated immune response; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of B cell activation; P:regulation of B cell receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; scaffold38 indexed_genome mRNA 21664824 21665501 . - . ID=transcript_7990;P15391 A0N0P9 F5H635 Q96S68 Q9BRD6,B-lymphocyte antigen CD19,B-lymphocyte surface antigen B4;Differentiation antigen CD19;T-cell surface antigen Leu-12;, , GO:0009897;GO:0070062;GO:0005887;GO:0045121;GO:0005886;GO:0032991;GO:0050851;GO:0002322;GO:0050853;GO:0001923;GO:0016064;GO:0043552;GO:0051897;GO:0051281;GO:0050864;GO:0050855;GO:0030449;GO:0050776;, C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane; C:protein-containing complex;, , P:antigen receptor-mediated signaling pathway; P:B cell proliferation involved in immune response; P:B cell receptor signaling pathway; P:B-1 B cell differentiation; P:immunoglobulin mediated immune response; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of release of sequestered calcium ion into cytosol; P:regulation of B cell activation; P:regulation of B cell receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; scaffold38 indexed_genome mRNA 21683344 21683927 . + . ID=transcript_7991;Q9H5N1,Rab GTPase-binding effector protein 2,Rabaptin-5beta;, PF09311;PF03528;, GO:0005813;GO:0036064;GO:0005829;GO:0005769;GO:0043231;GO:0008083;GO:0005096;GO:0030030;GO:0006897;GO:0015031;GO:1902017;, C:centrosome; C:ciliary basal body; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle;, F:growth factor activity; F:GTPase activator activity;, P:cell projection organization; P:endocytosis; P:protein transport; P:regulation of cilium assembly; scaffold38 indexed_genome mRNA 21685280 21705909 . + . ID=transcript_7992;Q9H5N1,Rab GTPase-binding effector protein 2,Rabaptin-5beta;, PF09311;PF03528;, GO:0005813;GO:0036064;GO:0005829;GO:0005769;GO:0043231;GO:0008083;GO:0005096;GO:0030030;GO:0006897;GO:0015031;GO:1902017;, C:centrosome; C:ciliary basal body; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle;, F:growth factor activity; F:GTPase activator activity;, P:cell projection organization; P:endocytosis; P:protein transport; P:regulation of cilium assembly;|Q9H5N1,Rab GTPase-binding effector protein 2,Rabaptin-5beta;, PF09311;PF03528;, GO:0005813;GO:0036064;GO:0005829;GO:0005769;GO:0043231;GO:0008083;GO:0005096;GO:0030030;GO:0006897;GO:0015031;GO:1902017;, C:centrosome; C:ciliary basal body; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle;, F:growth factor activity; F:GTPase activator activity;, P:cell projection organization; P:endocytosis; P:protein transport; P:regulation of cilium assembly;|O14983 A8K5J9 B3KY17 O14984,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 {ECO:0000305},Calcium pump 1;Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0034704;GO:0005789;GO:0005793;GO:0031673;GO:0031674;GO:0016021;GO:0016020;GO:0005739;GO:0048471;GO:0031095;GO:0016529;GO:0033017;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030899;GO:0042803;GO:0008553;GO:0008637;GO:0070509;GO:1990036;GO:0070588;GO:0006816;GO:0006874;GO:0070059;GO:0034220;GO:0051659;GO:0032471;GO:0045988;GO:1901896;GO:1902082;GO:0106134;GO:0032470;GO:0031448;GO:0051561;GO:1903779;GO:0006942;GO:0090076;GO:0034976;, C:calcium channel complex; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:H zone; C:I band; C:integral component of membrane; C:membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:platelet dense tubular network membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-dependent ATPase activity; F:protein homodimerization activity; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:apoptotic mitochondrial changes; P:calcium ion import; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:ion transmembrane transport; P:maintenance of mitochondrion location; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of striated muscle contraction; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of calcium ion import into sarcoplasmic reticulum; P:positive regulation of cardiac muscle cell contraction; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of fast-twitch skeletal muscle fiber contraction; P:positive regulation of mitochondrial calcium ion concentration; P:regulation of cardiac conduction; P:regulation of striated muscle contraction; P:relaxation of skeletal muscle; P:response to endoplasmic reticulum stress;|O14983 A8K5J9 B3KY17 O14984,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 {ECO:0000305},Calcium pump 1;Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0034704;GO:0005789;GO:0005793;GO:0031673;GO:0031674;GO:0016021;GO:0016020;GO:0005739;GO:0048471;GO:0031095;GO:0016529;GO:0033017;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030899;GO:0042803;GO:0008553;GO:0008637;GO:0070509;GO:1990036;GO:0070588;GO:0006816;GO:0006874;GO:0070059;GO:0034220;GO:0051659;GO:0032471;GO:0045988;GO:1901896;GO:1902082;GO:0106134;GO:0032470;GO:0031448;GO:0051561;GO:1903779;GO:0006942;GO:0090076;GO:0034976;, C:calcium channel complex; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:H zone; C:I band; C:integral component of membrane; C:membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:platelet dense tubular network membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-dependent ATPase activity; F:protein homodimerization activity; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:apoptotic mitochondrial changes; P:calcium ion import; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:ion transmembrane transport; P:maintenance of mitochondrion location; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of striated muscle contraction; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of calcium ion import into sarcoplasmic reticulum; P:positive regulation of cardiac muscle cell contraction; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of fast-twitch skeletal muscle fiber contraction; P:positive regulation of mitochondrial calcium ion concentration; P:regulation of cardiac conduction; P:regulation of striated muscle contraction; P:relaxation of skeletal muscle; P:response to endoplasmic reticulum stress;|O14983 A8K5J9 B3KY17 O14984,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 {ECO:0000305},Calcium pump 1;Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0034704;GO:0005789;GO:0005793;GO:0031673;GO:0031674;GO:0016021;GO:0016020;GO:0005739;GO:0048471;GO:0031095;GO:0016529;GO:0033017;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030899;GO:0042803;GO:0008553;GO:0008637;GO:0070509;GO:1990036;GO:0070588;GO:0006816;GO:0006874;GO:0070059;GO:0034220;GO:0051659;GO:0032471;GO:0045988;GO:1901896;GO:1902082;GO:0106134;GO:0032470;GO:0031448;GO:0051561;GO:1903779;GO:0006942;GO:0090076;GO:0034976;, C:calcium channel complex; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:H zone; C:I band; C:integral component of membrane; C:membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:platelet dense tubular network membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-dependent ATPase activity; F:protein homodimerization activity; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:apoptotic mitochondrial changes; P:calcium ion import; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:ion transmembrane transport; P:maintenance of mitochondrion location; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of striated muscle contraction; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of calcium ion import into sarcoplasmic reticulum; P:positive regulation of cardiac muscle cell contraction; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of fast-twitch skeletal muscle fiber contraction; P:positive regulation of mitochondrial calcium ion concentration; P:regulation of cardiac conduction; P:regulation of striated muscle contraction; P:relaxation of skeletal muscle; P:response to endoplasmic reticulum stress;|O14983 A8K5J9 B3KY17 O14984,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 {ECO:0000305},Calcium pump 1;Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0034704;GO:0005789;GO:0005793;GO:0031673;GO:0031674;GO:0016021;GO:0016020;GO:0005739;GO:0048471;GO:0031095;GO:0016529;GO:0033017;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030899;GO:0042803;GO:0008553;GO:0008637;GO:0070509;GO:1990036;GO:0070588;GO:0006816;GO:0006874;GO:0070059;GO:0034220;GO:0051659;GO:0032471;GO:0045988;GO:1901896;GO:1902082;GO:0106134;GO:0032470;GO:0031448;GO:0051561;GO:1903779;GO:0006942;GO:0090076;GO:0034976;, C:calcium channel complex; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:H zone; C:I band; C:integral component of membrane; C:membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:platelet dense tubular network membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-dependent ATPase activity; F:protein homodimerization activity; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:apoptotic mitochondrial changes; P:calcium ion import; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:ion transmembrane transport; P:maintenance of mitochondrion location; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of striated muscle contraction; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of calcium ion import into sarcoplasmic reticulum; P:positive regulation of cardiac muscle cell contraction; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of fast-twitch skeletal muscle fiber contraction; P:positive regulation of mitochondrial calcium ion concentration; P:regulation of cardiac conduction; P:regulation of striated muscle contraction; P:relaxation of skeletal muscle; P:response to endoplasmic reticulum stress;|O14983 A8K5J9 B3KY17 O14984,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 {ECO:0000305},Calcium pump 1;Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0034704;GO:0005789;GO:0005793;GO:0031673;GO:0031674;GO:0016021;GO:0016020;GO:0005739;GO:0048471;GO:0031095;GO:0016529;GO:0033017;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030899;GO:0042803;GO:0008553;GO:0008637;GO:0070509;GO:1990036;GO:0070588;GO:0006816;GO:0006874;GO:0070059;GO:0034220;GO:0051659;GO:0032471;GO:0045988;GO:1901896;GO:1902082;GO:0106134;GO:0032470;GO:0031448;GO:0051561;GO:1903779;GO:0006942;GO:0090076;GO:0034976;, C:calcium channel complex; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:H zone; C:I band; C:integral component of membrane; C:membrane; C:mitochondrion; C:perinuclear region of cytoplasm; C:platelet dense tubular network membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-dependent ATPase activity; F:protein homodimerization activity; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:apoptotic mitochondrial changes; P:calcium ion import; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:ion transmembrane transport; P:maintenance of mitochondrion location; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of striated muscle contraction; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of calcium ion import into sarcoplasmic reticulum; P:positive regulation of cardiac muscle cell contraction; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of fast-twitch skeletal muscle fiber contraction; P:positive regulation of mitochondrial calcium ion concentration; P:regulation of cardiac conduction; P:regulation of striated muscle contraction; P:relaxation of skeletal muscle; P:response to endoplasmic reticulum stress; scaffold38 indexed_genome mRNA 21709936 21718386 . - . ID=transcript_7993;Q9NRF2 A8K2R7 Q96FK3 Q96SX3 Q9NRF1 Q9NRF3 Q9P2P7 Q9Y3Y3,SH2B adapter protein 1,Pro-rich, PH and SH2 domain-containing signaling mediator;SH2 domain-containing protein 1B;, PF00169;PF08916;PF00017;, GO:0005829;GO:0005634;GO:0005886;GO:0005068;GO:0007596;GO:0035556;GO:0030032;GO:0045840;GO:0060391;GO:2000278;, C:cytosol; C:nucleus; C:plasma membrane;, F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:blood coagulation; P:intracellular signal transduction; P:lamellipodium assembly; P:positive regulation of mitotic nuclear division; P:positive regulation of SMAD protein signal transduction; P:regulation of DNA biosynthetic process;|Q9NRF2 A8K2R7 Q96FK3 Q96SX3 Q9NRF1 Q9NRF3 Q9P2P7 Q9Y3Y3,SH2B adapter protein 1,Pro-rich, PH and SH2 domain-containing signaling mediator;SH2 domain-containing protein 1B;, PF00169;PF08916;PF00017;, GO:0005829;GO:0005634;GO:0005886;GO:0005068;GO:0007596;GO:0035556;GO:0030032;GO:0045840;GO:0060391;GO:2000278;, C:cytosol; C:nucleus; C:plasma membrane;, F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:blood coagulation; P:intracellular signal transduction; P:lamellipodium assembly; P:positive regulation of mitotic nuclear division; P:positive regulation of SMAD protein signal transduction; P:regulation of DNA biosynthetic process;|Q9NRF2 A8K2R7 Q96FK3 Q96SX3 Q9NRF1 Q9NRF3 Q9P2P7 Q9Y3Y3,SH2B adapter protein 1,Pro-rich, PH and SH2 domain-containing signaling mediator;SH2 domain-containing protein 1B;, PF00169;PF08916;PF00017;, GO:0005829;GO:0005634;GO:0005886;GO:0005068;GO:0007596;GO:0035556;GO:0030032;GO:0045840;GO:0060391;GO:2000278;, C:cytosol; C:nucleus; C:plasma membrane;, F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:blood coagulation; P:intracellular signal transduction; P:lamellipodium assembly; P:positive regulation of mitotic nuclear division; P:positive regulation of SMAD protein signal transduction; P:regulation of DNA biosynthetic process; scaffold38 indexed_genome mRNA 21727284 21745997 . + . ID=transcript_7994;P49411 O15276,Elongation factor Tu, mitochondrial,P43;, PF00009;PF03144;PF03143;, GO:0070062;GO:0016020;GO:0042645;GO:0005739;GO:0045202;GO:0005525;GO:0003924;GO:0003723;GO:0003746;GO:0070125;GO:0045471;GO:0006414;GO:0016032;, C:extracellular exosome; C:membrane; C:mitochondrial nucleoid; C:mitochondrion; C:synapse;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation elongation factor activity;, P:mitochondrial translational elongation; P:response to ethanol; P:translational elongation; P:viral process;|Q8IU95 Q8WWM3 Q8WWM4 Q8WWM5 Q8WWM6 Q99703,Ataxin-2-like protein,Ataxin-2 domain protein;Ataxin-2-related protein;, PF06741;PF07145;PF14438;, GO:0010494;GO:0005829;GO:0016020;GO:0016607;GO:0045296;GO:0003723;GO:0010603;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nuclear speck;, F:cadherin binding; F:RNA binding;, P:regulation of cytoplasmic mRNA processing body assembly; P:stress granule assembly;|Q8IU95 Q8WWM3 Q8WWM4 Q8WWM5 Q8WWM6 Q99703,Ataxin-2-like protein,Ataxin-2 domain protein;Ataxin-2-related protein;, PF06741;PF07145;PF14438;, GO:0010494;GO:0005829;GO:0016020;GO:0016607;GO:0045296;GO:0003723;GO:0010603;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nuclear speck;, F:cadherin binding; F:RNA binding;, P:regulation of cytoplasmic mRNA processing body assembly; P:stress granule assembly;|Q8IU95 Q8WWM3 Q8WWM4 Q8WWM5 Q8WWM6 Q99703,Ataxin-2-like protein,Ataxin-2 domain protein;Ataxin-2-related protein;, PF06741;PF07145;PF14438;, GO:0010494;GO:0005829;GO:0016020;GO:0016607;GO:0045296;GO:0003723;GO:0010603;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nuclear speck;, F:cadherin binding; F:RNA binding;, P:regulation of cytoplasmic mRNA processing body assembly; P:stress granule assembly;|Q8IU95 Q8WWM3 Q8WWM4 Q8WWM5 Q8WWM6 Q99703,Ataxin-2-like protein,Ataxin-2 domain protein;Ataxin-2-related protein;, PF06741;PF07145;PF14438;, GO:0010494;GO:0005829;GO:0016020;GO:0016607;GO:0045296;GO:0003723;GO:0010603;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nuclear speck;, F:cadherin binding; F:RNA binding;, P:regulation of cytoplasmic mRNA processing body assembly; P:stress granule assembly;|Q8IU95 Q8WWM3 Q8WWM4 Q8WWM5 Q8WWM6 Q99703,Ataxin-2-like protein,Ataxin-2 domain protein;Ataxin-2-related protein;, PF06741;PF07145;PF14438;, GO:0010494;GO:0005829;GO:0016020;GO:0016607;GO:0045296;GO:0003723;GO:0010603;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nuclear speck;, F:cadherin binding; F:RNA binding;, P:regulation of cytoplasmic mRNA processing body assembly; P:stress granule assembly;|Q8IU95 Q8WWM3 Q8WWM4 Q8WWM5 Q8WWM6 Q99703,Ataxin-2-like protein,Ataxin-2 domain protein;Ataxin-2-related protein;, PF06741;PF07145;PF14438;, GO:0010494;GO:0005829;GO:0016020;GO:0016607;GO:0045296;GO:0003723;GO:0010603;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane; C:nuclear speck;, F:cadherin binding; F:RNA binding;, P:regulation of cytoplasmic mRNA processing body assembly; P:stress granule assembly; scaffold38 indexed_genome mRNA 21751083 21820288 . - . ID=transcript_7995;Q9UP13 Q9UP14,Battenin {ECO:0000305},Batten disease protein;Protein CLN3;, PF02487;, GO:0044754;GO:0005776;GO:0005901;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005783;GO:0005794;GO:0000139;GO:0005795;GO:0030176;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0045121;GO:0043005;GO:0005634;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0005773;GO:0051861;GO:0120146;GO:0001508;GO:0042987;GO:0015809;GO:0008306;GO:0097352;GO:0061909;GO:0009992;GO:0046474;GO:0046836;GO:0090160;GO:0035235;GO:0007611;GO:0007042;GO:0035752;GO:1905146;GO:0007040;GO:0061024;GO:0043066;GO:0043086;GO:0043524;GO:0045861;GO:0050885;GO:0042133;GO:0090384;GO:0090385;GO:0044857;GO:2001288;GO:0042998;GO:0048549;GO:0016485;GO:0006898;GO:1900079;GO:1901096;GO:0106049;GO:0051493;GO:0051480;GO:0010762;GO:0051453;GO:1905244;GO:1905162;GO:1903076;GO:0070613;GO:0048172;GO:0032228;GO:0051966;GO:0036359;GO:0047496;, C:autolysosome; C:autophagosome; C:caveola; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane raft; C:neuron projection; C:nucleus; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:glycolipid binding; F:sulfatide binding;, P:action potential; P:amyloid precursor protein catabolic process; P:arginine transport; P:associative learning; P:autophagosome maturation; P:autophagosome-lysosome fusion; P:cellular water homeostasis; P:glycerophospholipid biosynthetic process; P:glycolipid transport; P:Golgi to lysosome transport; P:ionotropic glutamate receptor signaling pathway; P:learning or memory; P:lysosomal lumen acidification; P:lysosomal lumen pH elevation; P:lysosomal protein catabolic process; P:lysosome organization; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteolysis; P:neuromuscular process controlling balance; P:neurotransmitter metabolic process; P:phagosome-lysosome docking; P:phagosome-lysosome fusion; P:plasma membrane raft organization; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of pinocytosis; P:protein processing; P:receptor-mediated endocytosis; P:regulation of arginine biosynthetic process; P:regulation of autophagosome maturation; P:regulation of cellular response to osmotic stress; P:regulation of cytoskeleton organization; P:regulation of cytosolic calcium ion concentration; P:regulation of fibroblast migration; P:regulation of intracellular pH; P:regulation of modification of synaptic structure; P:regulation of phagosome maturation; P:regulation of protein localization to plasma membrane; P:regulation of protein processing; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic transmission, GABAergic; P:regulation of synaptic transmission, glutamatergic; P:renal potassium excretion; P:vesicle transport along microtubule;|Q99613 A8K7Z0 B2RXG3 B4E1D5 H3BRV0 O00215 Q9BW98,Eukaryotic translation initiation factor 3 subunit C {ECO:0000255|HAMAP-Rule:MF_03002},Eukaryotic translation initiation factor 3 subunit 8 {ECO:0000255|HAMAP-Rule:MF_03002};eIF3 p110 {ECO:0000255|HAMAP-Rule:MF_03002};, PF05470;PF01399;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0043022;GO:0003723;GO:0003743;GO:0031369;GO:0001732;GO:1902416;GO:0045727;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex;, F:ribosome binding; F:RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:positive regulation of mRNA binding; P:positive regulation of translation; P:translational initiation;|Q99613 A8K7Z0 B2RXG3 B4E1D5 H3BRV0 O00215 Q9BW98,Eukaryotic translation initiation factor 3 subunit C {ECO:0000255|HAMAP-Rule:MF_03002},Eukaryotic translation initiation factor 3 subunit 8 {ECO:0000255|HAMAP-Rule:MF_03002};eIF3 p110 {ECO:0000255|HAMAP-Rule:MF_03002};, PF05470;PF01399;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0043022;GO:0003723;GO:0003743;GO:0031369;GO:0001732;GO:1902416;GO:0045727;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex;, F:ribosome binding; F:RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:positive regulation of mRNA binding; P:positive regulation of translation; P:translational initiation;|Q9UP13 Q9UP14,Battenin {ECO:0000305},Batten disease protein;Protein CLN3;, PF02487;, GO:0044754;GO:0005776;GO:0005901;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005783;GO:0005794;GO:0000139;GO:0005795;GO:0030176;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0045121;GO:0043005;GO:0005634;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0005773;GO:0051861;GO:0120146;GO:0001508;GO:0042987;GO:0015809;GO:0008306;GO:0097352;GO:0061909;GO:0009992;GO:0046474;GO:0046836;GO:0090160;GO:0035235;GO:0007611;GO:0007042;GO:0035752;GO:1905146;GO:0007040;GO:0061024;GO:0043066;GO:0043086;GO:0043524;GO:0045861;GO:0050885;GO:0042133;GO:0090384;GO:0090385;GO:0044857;GO:2001288;GO:0042998;GO:0048549;GO:0016485;GO:0006898;GO:1900079;GO:1901096;GO:0106049;GO:0051493;GO:0051480;GO:0010762;GO:0051453;GO:1905244;GO:1905162;GO:1903076;GO:0070613;GO:0048172;GO:0032228;GO:0051966;GO:0036359;GO:0047496;, C:autolysosome; C:autophagosome; C:caveola; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane raft; C:neuron projection; C:nucleus; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:glycolipid binding; F:sulfatide binding;, P:action potential; P:amyloid precursor protein catabolic process; P:arginine transport; P:associative learning; P:autophagosome maturation; P:autophagosome-lysosome fusion; P:cellular water homeostasis; P:glycerophospholipid biosynthetic process; P:glycolipid transport; P:Golgi to lysosome transport; P:ionotropic glutamate receptor signaling pathway; P:learning or memory; P:lysosomal lumen acidification; P:lysosomal lumen pH elevation; P:lysosomal protein catabolic process; P:lysosome organization; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteolysis; P:neuromuscular process controlling balance; P:neurotransmitter metabolic process; P:phagosome-lysosome docking; P:phagosome-lysosome fusion; P:plasma membrane raft organization; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of pinocytosis; P:protein processing; P:receptor-mediated endocytosis; P:regulation of arginine biosynthetic process; P:regulation of autophagosome maturation; P:regulation of cellular response to osmotic stress; P:regulation of cytoskeleton organization; P:regulation of cytosolic calcium ion concentration; P:regulation of fibroblast migration; P:regulation of intracellular pH; P:regulation of modification of synaptic structure; P:regulation of phagosome maturation; P:regulation of protein localization to plasma membrane; P:regulation of protein processing; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic transmission, GABAergic; P:regulation of synaptic transmission, glutamatergic; P:renal potassium excretion; P:vesicle transport along microtubule;|Q9UP13 Q9UP14,Battenin {ECO:0000305},Batten disease protein;Protein CLN3;, PF02487;, GO:0044754;GO:0005776;GO:0005901;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005783;GO:0005794;GO:0000139;GO:0005795;GO:0030176;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0045121;GO:0043005;GO:0005634;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0005773;GO:0051861;GO:0120146;GO:0001508;GO:0042987;GO:0015809;GO:0008306;GO:0097352;GO:0061909;GO:0009992;GO:0046474;GO:0046836;GO:0090160;GO:0035235;GO:0007611;GO:0007042;GO:0035752;GO:1905146;GO:0007040;GO:0061024;GO:0043066;GO:0043086;GO:0043524;GO:0045861;GO:0050885;GO:0042133;GO:0090384;GO:0090385;GO:0044857;GO:2001288;GO:0042998;GO:0048549;GO:0016485;GO:0006898;GO:1900079;GO:1901096;GO:0106049;GO:0051493;GO:0051480;GO:0010762;GO:0051453;GO:1905244;GO:1905162;GO:1903076;GO:0070613;GO:0048172;GO:0032228;GO:0051966;GO:0036359;GO:0047496;, C:autolysosome; C:autophagosome; C:caveola; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane raft; C:neuron projection; C:nucleus; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:glycolipid binding; F:sulfatide binding;, P:action potential; P:amyloid precursor protein catabolic process; P:arginine transport; P:associative learning; P:autophagosome maturation; P:autophagosome-lysosome fusion; P:cellular water homeostasis; P:glycerophospholipid biosynthetic process; P:glycolipid transport; P:Golgi to lysosome transport; P:ionotropic glutamate receptor signaling pathway; P:learning or memory; P:lysosomal lumen acidification; P:lysosomal lumen pH elevation; P:lysosomal protein catabolic process; P:lysosome organization; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteolysis; P:neuromuscular process controlling balance; P:neurotransmitter metabolic process; P:phagosome-lysosome docking; P:phagosome-lysosome fusion; P:plasma membrane raft organization; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of pinocytosis; P:protein processing; P:receptor-mediated endocytosis; P:regulation of arginine biosynthetic process; P:regulation of autophagosome maturation; P:regulation of cellular response to osmotic stress; P:regulation of cytoskeleton organization; P:regulation of cytosolic calcium ion concentration; P:regulation of fibroblast migration; P:regulation of intracellular pH; P:regulation of modification of synaptic structure; P:regulation of phagosome maturation; P:regulation of protein localization to plasma membrane; P:regulation of protein processing; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic transmission, GABAergic; P:regulation of synaptic transmission, glutamatergic; P:renal potassium excretion; P:vesicle transport along microtubule;|Q9UP13 Q9UP14,Battenin {ECO:0000305},Batten disease protein;Protein CLN3;, PF02487;, GO:0044754;GO:0005776;GO:0005901;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005783;GO:0005794;GO:0000139;GO:0005795;GO:0030176;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0045121;GO:0043005;GO:0005634;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0005773;GO:0051861;GO:0120146;GO:0001508;GO:0042987;GO:0015809;GO:0008306;GO:0097352;GO:0061909;GO:0009992;GO:0046474;GO:0046836;GO:0090160;GO:0035235;GO:0007611;GO:0007042;GO:0035752;GO:1905146;GO:0007040;GO:0061024;GO:0043066;GO:0043086;GO:0043524;GO:0045861;GO:0050885;GO:0042133;GO:0090384;GO:0090385;GO:0044857;GO:2001288;GO:0042998;GO:0048549;GO:0016485;GO:0006898;GO:1900079;GO:1901096;GO:0106049;GO:0051493;GO:0051480;GO:0010762;GO:0051453;GO:1905244;GO:1905162;GO:1903076;GO:0070613;GO:0048172;GO:0032228;GO:0051966;GO:0036359;GO:0047496;, C:autolysosome; C:autophagosome; C:caveola; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane raft; C:neuron projection; C:nucleus; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:glycolipid binding; F:sulfatide binding;, P:action potential; P:amyloid precursor protein catabolic process; P:arginine transport; P:associative learning; P:autophagosome maturation; P:autophagosome-lysosome fusion; P:cellular water homeostasis; P:glycerophospholipid biosynthetic process; P:glycolipid transport; P:Golgi to lysosome transport; P:ionotropic glutamate receptor signaling pathway; P:learning or memory; P:lysosomal lumen acidification; P:lysosomal lumen pH elevation; P:lysosomal protein catabolic process; P:lysosome organization; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteolysis; P:neuromuscular process controlling balance; P:neurotransmitter metabolic process; P:phagosome-lysosome docking; P:phagosome-lysosome fusion; P:plasma membrane raft organization; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of pinocytosis; P:protein processing; P:receptor-mediated endocytosis; P:regulation of arginine biosynthetic process; P:regulation of autophagosome maturation; P:regulation of cellular response to osmotic stress; P:regulation of cytoskeleton organization; P:regulation of cytosolic calcium ion concentration; P:regulation of fibroblast migration; P:regulation of intracellular pH; P:regulation of modification of synaptic structure; P:regulation of phagosome maturation; P:regulation of protein localization to plasma membrane; P:regulation of protein processing; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic transmission, GABAergic; P:regulation of synaptic transmission, glutamatergic; P:renal potassium excretion; P:vesicle transport along microtubule;|Q9UP13 Q9UP14,Battenin {ECO:0000305},Batten disease protein;Protein CLN3;, PF02487;, GO:0044754;GO:0005776;GO:0005901;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005783;GO:0005794;GO:0000139;GO:0005795;GO:0030176;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0045121;GO:0043005;GO:0005634;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0005773;GO:0051861;GO:0120146;GO:0001508;GO:0042987;GO:0015809;GO:0008306;GO:0097352;GO:0061909;GO:0009992;GO:0046474;GO:0046836;GO:0090160;GO:0035235;GO:0007611;GO:0007042;GO:0035752;GO:1905146;GO:0007040;GO:0061024;GO:0043066;GO:0043086;GO:0043524;GO:0045861;GO:0050885;GO:0042133;GO:0090384;GO:0090385;GO:0044857;GO:2001288;GO:0042998;GO:0048549;GO:0016485;GO:0006898;GO:1900079;GO:1901096;GO:0106049;GO:0051493;GO:0051480;GO:0010762;GO:0051453;GO:1905244;GO:1905162;GO:1903076;GO:0070613;GO:0048172;GO:0032228;GO:0051966;GO:0036359;GO:0047496;, C:autolysosome; C:autophagosome; C:caveola; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane raft; C:neuron projection; C:nucleus; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:glycolipid binding; F:sulfatide binding;, P:action potential; P:amyloid precursor protein catabolic process; P:arginine transport; P:associative learning; P:autophagosome maturation; P:autophagosome-lysosome fusion; P:cellular water homeostasis; P:glycerophospholipid biosynthetic process; P:glycolipid transport; P:Golgi to lysosome transport; P:ionotropic glutamate receptor signaling pathway; P:learning or memory; P:lysosomal lumen acidification; P:lysosomal lumen pH elevation; P:lysosomal protein catabolic process; P:lysosome organization; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteolysis; P:neuromuscular process controlling balance; P:neurotransmitter metabolic process; P:phagosome-lysosome docking; P:phagosome-lysosome fusion; P:plasma membrane raft organization; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of pinocytosis; P:protein processing; P:receptor-mediated endocytosis; P:regulation of arginine biosynthetic process; P:regulation of autophagosome maturation; P:regulation of cellular response to osmotic stress; P:regulation of cytoskeleton organization; P:regulation of cytosolic calcium ion concentration; P:regulation of fibroblast migration; P:regulation of intracellular pH; P:regulation of modification of synaptic structure; P:regulation of phagosome maturation; P:regulation of protein localization to plasma membrane; P:regulation of protein processing; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic transmission, GABAergic; P:regulation of synaptic transmission, glutamatergic; P:renal potassium excretion; P:vesicle transport along microtubule;|Q9UP13 Q9UP14,Battenin {ECO:0000305},Batten disease protein;Protein CLN3;, PF02487;, GO:0044754;GO:0005776;GO:0005901;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005783;GO:0005794;GO:0000139;GO:0005795;GO:0030176;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0045121;GO:0043005;GO:0005634;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0005773;GO:0051861;GO:0120146;GO:0001508;GO:0042987;GO:0015809;GO:0008306;GO:0097352;GO:0061909;GO:0009992;GO:0046474;GO:0046836;GO:0090160;GO:0035235;GO:0007611;GO:0007042;GO:0035752;GO:1905146;GO:0007040;GO:0061024;GO:0043066;GO:0043086;GO:0043524;GO:0045861;GO:0050885;GO:0042133;GO:0090384;GO:0090385;GO:0044857;GO:2001288;GO:0042998;GO:0048549;GO:0016485;GO:0006898;GO:1900079;GO:1901096;GO:0106049;GO:0051493;GO:0051480;GO:0010762;GO:0051453;GO:1905244;GO:1905162;GO:1903076;GO:0070613;GO:0048172;GO:0032228;GO:0051966;GO:0036359;GO:0047496;, C:autolysosome; C:autophagosome; C:caveola; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane raft; C:neuron projection; C:nucleus; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:glycolipid binding; F:sulfatide binding;, P:action potential; P:amyloid precursor protein catabolic process; P:arginine transport; P:associative learning; P:autophagosome maturation; P:autophagosome-lysosome fusion; P:cellular water homeostasis; P:glycerophospholipid biosynthetic process; P:glycolipid transport; P:Golgi to lysosome transport; P:ionotropic glutamate receptor signaling pathway; P:learning or memory; P:lysosomal lumen acidification; P:lysosomal lumen pH elevation; P:lysosomal protein catabolic process; P:lysosome organization; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteolysis; P:neuromuscular process controlling balance; P:neurotransmitter metabolic process; P:phagosome-lysosome docking; P:phagosome-lysosome fusion; P:plasma membrane raft organization; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of pinocytosis; P:protein processing; P:receptor-mediated endocytosis; P:regulation of arginine biosynthetic process; P:regulation of autophagosome maturation; P:regulation of cellular response to osmotic stress; P:regulation of cytoskeleton organization; P:regulation of cytosolic calcium ion concentration; P:regulation of fibroblast migration; P:regulation of intracellular pH; P:regulation of modification of synaptic structure; P:regulation of phagosome maturation; P:regulation of protein localization to plasma membrane; P:regulation of protein processing; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic transmission, GABAergic; P:regulation of synaptic transmission, glutamatergic; P:renal potassium excretion; P:vesicle transport along microtubule;|Q9UP13 Q9UP14,Battenin {ECO:0000305},Batten disease protein;Protein CLN3;, PF02487;, GO:0044754;GO:0005776;GO:0005901;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005783;GO:0005794;GO:0000139;GO:0005795;GO:0030176;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0045121;GO:0043005;GO:0005634;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0005773;GO:0051861;GO:0120146;GO:0001508;GO:0042987;GO:0015809;GO:0008306;GO:0097352;GO:0061909;GO:0009992;GO:0046474;GO:0046836;GO:0090160;GO:0035235;GO:0007611;GO:0007042;GO:0035752;GO:1905146;GO:0007040;GO:0061024;GO:0043066;GO:0043086;GO:0043524;GO:0045861;GO:0050885;GO:0042133;GO:0090384;GO:0090385;GO:0044857;GO:2001288;GO:0042998;GO:0048549;GO:0016485;GO:0006898;GO:1900079;GO:1901096;GO:0106049;GO:0051493;GO:0051480;GO:0010762;GO:0051453;GO:1905244;GO:1905162;GO:1903076;GO:0070613;GO:0048172;GO:0032228;GO:0051966;GO:0036359;GO:0047496;, C:autolysosome; C:autophagosome; C:caveola; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane raft; C:neuron projection; C:nucleus; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:glycolipid binding; F:sulfatide binding;, P:action potential; P:amyloid precursor protein catabolic process; P:arginine transport; P:associative learning; P:autophagosome maturation; P:autophagosome-lysosome fusion; P:cellular water homeostasis; P:glycerophospholipid biosynthetic process; P:glycolipid transport; P:Golgi to lysosome transport; P:ionotropic glutamate receptor signaling pathway; P:learning or memory; P:lysosomal lumen acidification; P:lysosomal lumen pH elevation; P:lysosomal protein catabolic process; P:lysosome organization; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteolysis; P:neuromuscular process controlling balance; P:neurotransmitter metabolic process; P:phagosome-lysosome docking; P:phagosome-lysosome fusion; P:plasma membrane raft organization; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of pinocytosis; P:protein processing; P:receptor-mediated endocytosis; P:regulation of arginine biosynthetic process; P:regulation of autophagosome maturation; P:regulation of cellular response to osmotic stress; P:regulation of cytoskeleton organization; P:regulation of cytosolic calcium ion concentration; P:regulation of fibroblast migration; P:regulation of intracellular pH; P:regulation of modification of synaptic structure; P:regulation of phagosome maturation; P:regulation of protein localization to plasma membrane; P:regulation of protein processing; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic transmission, GABAergic; P:regulation of synaptic transmission, glutamatergic; P:renal potassium excretion; P:vesicle transport along microtubule;|Q9UP13 Q9UP14,Battenin {ECO:0000305},Batten disease protein;Protein CLN3;, PF02487;, GO:0044754;GO:0005776;GO:0005901;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005783;GO:0005794;GO:0000139;GO:0005795;GO:0030176;GO:0016021;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0045121;GO:0043005;GO:0005634;GO:0005886;GO:0055037;GO:0008021;GO:0005802;GO:0005773;GO:0051861;GO:0120146;GO:0001508;GO:0042987;GO:0015809;GO:0008306;GO:0097352;GO:0061909;GO:0009992;GO:0046474;GO:0046836;GO:0090160;GO:0035235;GO:0007611;GO:0007042;GO:0035752;GO:1905146;GO:0007040;GO:0061024;GO:0043066;GO:0043086;GO:0043524;GO:0045861;GO:0050885;GO:0042133;GO:0090384;GO:0090385;GO:0044857;GO:2001288;GO:0042998;GO:0048549;GO:0016485;GO:0006898;GO:1900079;GO:1901096;GO:0106049;GO:0051493;GO:0051480;GO:0010762;GO:0051453;GO:1905244;GO:1905162;GO:1903076;GO:0070613;GO:0048172;GO:0032228;GO:0051966;GO:0036359;GO:0047496;, C:autolysosome; C:autophagosome; C:caveola; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane raft; C:neuron projection; C:nucleus; C:plasma membrane; C:recycling endosome; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:glycolipid binding; F:sulfatide binding;, P:action potential; P:amyloid precursor protein catabolic process; P:arginine transport; P:associative learning; P:autophagosome maturation; P:autophagosome-lysosome fusion; P:cellular water homeostasis; P:glycerophospholipid biosynthetic process; P:glycolipid transport; P:Golgi to lysosome transport; P:ionotropic glutamate receptor signaling pathway; P:learning or memory; P:lysosomal lumen acidification; P:lysosomal lumen pH elevation; P:lysosomal protein catabolic process; P:lysosome organization; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteolysis; P:neuromuscular process controlling balance; P:neurotransmitter metabolic process; P:phagosome-lysosome docking; P:phagosome-lysosome fusion; P:plasma membrane raft organization; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of pinocytosis; P:protein processing; P:receptor-mediated endocytosis; P:regulation of arginine biosynthetic process; P:regulation of autophagosome maturation; P:regulation of cellular response to osmotic stress; P:regulation of cytoskeleton organization; P:regulation of cytosolic calcium ion concentration; P:regulation of fibroblast migration; P:regulation of intracellular pH; P:regulation of modification of synaptic structure; P:regulation of phagosome maturation; P:regulation of protein localization to plasma membrane; P:regulation of protein processing; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic transmission, GABAergic; P:regulation of synaptic transmission, glutamatergic; P:renal potassium excretion; P:vesicle transport along microtubule; scaffold38 indexed_genome mRNA 21820384 21840118 . + . ID=transcript_7996;Q0VD83 H3BU97 Q0VD81 Q8NC15 Q9NPJ9,Apolipoprotein B receptor {ECO:0000305},Apolipoprotein B-100 receptor;Apolipoprotein B-48 receptor;, , GO:0042627;GO:0034362;GO:0016020;GO:0005886;GO:0034361;GO:0030229;GO:0008203;GO:0006869;GO:0006641;GO:0034447;, C:chylomicron; C:low-density lipoprotein particle; C:membrane; C:plasma membrane; C:very-low-density lipoprotein particle;, F:very-low-density lipoprotein particle receptor activity;, P:cholesterol metabolic process; P:lipid transport; P:triglyceride metabolic process; P:very-low-density lipoprotein particle clearance;|Q0VD83 H3BU97 Q0VD81 Q8NC15 Q9NPJ9,Apolipoprotein B receptor {ECO:0000305},Apolipoprotein B-100 receptor;Apolipoprotein B-48 receptor;, , GO:0042627;GO:0034362;GO:0016020;GO:0005886;GO:0034361;GO:0030229;GO:0008203;GO:0006869;GO:0006641;GO:0034447;, C:chylomicron; C:low-density lipoprotein particle; C:membrane; C:plasma membrane; C:very-low-density lipoprotein particle;, F:very-low-density lipoprotein particle receptor activity;, P:cholesterol metabolic process; P:lipid transport; P:triglyceride metabolic process; P:very-low-density lipoprotein particle clearance; scaffold38 indexed_genome mRNA 21846081 21846701 . - . ID=transcript_7997;O60356 B2R5C4 O60357 Q6FGG3,Nuclear protein 1 {ECO:0000305},Candidate of metastasis 1 {ECO:0000303|PubMed:10493524};Protein p8 {ECO:0000303|PubMed:10092851};, PF10195;, GO:0005737;GO:0045171;GO:0005654;GO:0005634;GO:0048471;GO:0032993;GO:0010698;GO:0003682;GO:0003677;GO:0003713;GO:0002526;GO:0042771;GO:0008584;GO:0043066;GO:1902902;GO:0010507;GO:0010667;GO:0045786;GO:0008285;GO:0043433;GO:1904036;GO:0050680;GO:0048147;GO:0045820;GO:0062099;GO:1904691;GO:0045787;GO:2001244;GO:0150078;GO:0043525;GO:1903862;GO:1901800;GO:0031401;GO:0006473;GO:0065003;GO:0010506;GO:2000194;GO:1905897;GO:0009636;GO:0035914;, C:cytoplasm; C:intercellular bridge; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-DNA complex;, F:acetyltransferase activator activity; F:chromatin binding; F:DNA binding; F:transcription coactivator activity;, P:acute inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:male gonad development; P:negative regulation of apoptotic process; P:negative regulation of autophagosome assembly; P:negative regulation of autophagy; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell apoptotic process; P:negative regulation of epithelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of glycolytic process; P:negative regulation of programmed necrotic cell death; P:negative regulation of type B pancreatic cell proliferation; P:positive regulation of cell cycle; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of neuroinflammatory response; P:positive regulation of neuron apoptotic process; P:positive regulation of oxidative phosphorylation; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein modification process; P:protein acetylation; P:protein-containing complex assembly; P:regulation of autophagy; P:regulation of female gonad development; P:regulation of response to endoplasmic reticulum stress; P:response to toxic substance; P:skeletal muscle cell differentiation; scaffold38 indexed_genome mRNA 21855776 21887379 . + . ID=transcript_7998;Q96ES7 Q96MF5,SAGA-associated factor 29 {ECO:0000305},Coiled-coil domain-containing protein 101;SAGA complex-associated factor 29 {ECO:0000312|HGNC:HGNC:25156};, PF07039;, GO:0005671;GO:0000124;GO:0070461;GO:0019899;GO:0035064;GO:0047485;GO:0071169;GO:0016573;GO:0043966;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:SAGA complex; C:SAGA-type complex;, F:enzyme binding; F:methylated histone binding; F:protein N-terminus binding;, P:establishment of protein localization to chromatin; P:histone acetylation; P:histone H3 acetylation;|P50225 Q2NL71 Q86U58 Q92818 Q9BVU6 Q9UGG7,Sulfotransferase 1A1,Aryl sulfotransferase 1 {ECO:0000303|PubMed:8363592};HAST1/HAST2;Phenol sulfotransferase 1;Phenol-sulfating phenol sulfotransferase 1 {ECO:0000303|PubMed:8423770};ST1A3;Thermostable phenol sulfotransferase;, PF00685;, GO:0005737;GO:0005829;GO:0050656;GO:0004062;GO:0047894;GO:0050294;GO:0008146;GO:0050427;GO:0009308;GO:0006584;GO:0008210;GO:0006068;GO:0009812;GO:0051923;GO:0006805;, C:cytoplasm; C:cytosol;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:aryl sulfotransferase activity; F:flavonol 3-sulfotransferase activity; F:steroid sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:amine metabolic process; P:catecholamine metabolic process; P:estrogen metabolic process; P:ethanol catabolic process; P:flavonoid metabolic process; P:sulfation; P:xenobiotic metabolic process;|Q96ES7 Q96MF5,SAGA-associated factor 29 {ECO:0000305},Coiled-coil domain-containing protein 101;SAGA complex-associated factor 29 {ECO:0000312|HGNC:HGNC:25156};, PF07039;, GO:0005671;GO:0000124;GO:0070461;GO:0019899;GO:0035064;GO:0047485;GO:0071169;GO:0016573;GO:0043966;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:SAGA complex; C:SAGA-type complex;, F:enzyme binding; F:methylated histone binding; F:protein N-terminus binding;, P:establishment of protein localization to chromatin; P:histone acetylation; P:histone H3 acetylation;|P50225 Q2NL71 Q86U58 Q92818 Q9BVU6 Q9UGG7,Sulfotransferase 1A1,Aryl sulfotransferase 1 {ECO:0000303|PubMed:8363592};HAST1/HAST2;Phenol sulfotransferase 1;Phenol-sulfating phenol sulfotransferase 1 {ECO:0000303|PubMed:8423770};ST1A3;Thermostable phenol sulfotransferase;, PF00685;, GO:0005737;GO:0005829;GO:0050656;GO:0004062;GO:0047894;GO:0050294;GO:0008146;GO:0050427;GO:0009308;GO:0006584;GO:0008210;GO:0006068;GO:0009812;GO:0051923;GO:0006805;, C:cytoplasm; C:cytosol;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:aryl sulfotransferase activity; F:flavonol 3-sulfotransferase activity; F:steroid sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:amine metabolic process; P:catecholamine metabolic process; P:estrogen metabolic process; P:ethanol catabolic process; P:flavonoid metabolic process; P:sulfation; P:xenobiotic metabolic process;|P50225 Q2NL71 Q86U58 Q92818 Q9BVU6 Q9UGG7,Sulfotransferase 1A1,Aryl sulfotransferase 1 {ECO:0000303|PubMed:8363592};HAST1/HAST2;Phenol sulfotransferase 1;Phenol-sulfating phenol sulfotransferase 1 {ECO:0000303|PubMed:8423770};ST1A3;Thermostable phenol sulfotransferase;, PF00685;, GO:0005737;GO:0005829;GO:0050656;GO:0004062;GO:0047894;GO:0050294;GO:0008146;GO:0050427;GO:0009308;GO:0006584;GO:0008210;GO:0006068;GO:0009812;GO:0051923;GO:0006805;, C:cytoplasm; C:cytosol;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:aryl sulfotransferase activity; F:flavonol 3-sulfotransferase activity; F:steroid sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:amine metabolic process; P:catecholamine metabolic process; P:estrogen metabolic process; P:ethanol catabolic process; P:flavonoid metabolic process; P:sulfation; P:xenobiotic metabolic process;|Q9BQ83 B7ZME1 Q6NTG6,Structure-specific endonuclease subunit SLX1 {ECO:0000255|HAMAP-Rule:MF_03100},GIY-YIG domain-containing protein 1 {ECO:0000255|HAMAP-Rule:MF_03100};, PF01541;, GO:0005654;GO:0033557;GO:0017108;GO:0008821;GO:0046872;GO:0010792;GO:0006281;GO:0000724;GO:0036297;GO:1904357;GO:1904431;GO:0090656;GO:0010833;GO:0061820;, C:nucleoplasm; C:Slx1-Slx4 complex;, F:5'-flap endonuclease activity; F:crossover junction endodeoxyribonuclease activity; F:metal ion binding;, P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of t-circle formation; P:t-circle formation; P:telomere maintenance via telomere lengthening; P:telomeric D-loop disassembly;|Q9BQ83 B7ZME1 Q6NTG6,Structure-specific endonuclease subunit SLX1 {ECO:0000255|HAMAP-Rule:MF_03100},GIY-YIG domain-containing protein 1 {ECO:0000255|HAMAP-Rule:MF_03100};, PF01541;, GO:0005654;GO:0033557;GO:0017108;GO:0008821;GO:0046872;GO:0010792;GO:0006281;GO:0000724;GO:0036297;GO:1904357;GO:1904431;GO:0090656;GO:0010833;GO:0061820;, C:nucleoplasm; C:Slx1-Slx4 complex;, F:5'-flap endonuclease activity; F:crossover junction endodeoxyribonuclease activity; F:metal ion binding;, P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of t-circle formation; P:t-circle formation; P:telomere maintenance via telomere lengthening; P:telomeric D-loop disassembly;|Q9BQ83 B7ZME1 Q6NTG6,Structure-specific endonuclease subunit SLX1 {ECO:0000255|HAMAP-Rule:MF_03100},GIY-YIG domain-containing protein 1 {ECO:0000255|HAMAP-Rule:MF_03100};, PF01541;, GO:0005654;GO:0033557;GO:0017108;GO:0008821;GO:0046872;GO:0010792;GO:0006281;GO:0000724;GO:0036297;GO:1904357;GO:1904431;GO:0090656;GO:0010833;GO:0061820;, C:nucleoplasm; C:Slx1-Slx4 complex;, F:5'-flap endonuclease activity; F:crossover junction endodeoxyribonuclease activity; F:metal ion binding;, P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of t-circle formation; P:t-circle formation; P:telomere maintenance via telomere lengthening; P:telomeric D-loop disassembly; scaffold38 indexed_genome mRNA 21889594 21895160 . - . ID=transcript_7999;P31146 B2RBL1 Q2YD73,Coronin-1A,Coronin-like protein A;Coronin-like protein p57;Tryptophan aspartate-containing coat protein;, PF08953;PF08954;PF00400;, GO:0005884;GO:0030424;GO:0005911;GO:0030864;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0098978;GO:0001772;GO:0030027;GO:0016020;GO:0001891;GO:0045335;GO:0030670;GO:0005886;GO:0032991;GO:0003779;GO:0051015;GO:0003785;GO:0008092;GO:0032036;GO:0043548;GO:0008022;GO:0042803;GO:0003723;GO:0030036;GO:0007015;GO:0006816;GO:0016477;GO:0031589;GO:0071353;GO:0061502;GO:0048873;GO:0045087;GO:0030595;GO:0043320;GO:0051126;GO:0043524;GO:0031339;GO:0038180;GO:0006909;GO:0001845;GO:0050918;GO:0030335;GO:0042102;GO:0032956;GO:0008360;GO:0051279;GO:0043029;GO:0032796;, C:actin filament; C:axon; C:cell-cell junction; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:glutamatergic synapse; C:immunological synapse; C:lamellipodium; C:membrane; C:phagocytic cup; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:protein-containing complex;, F:actin binding; F:actin filament binding; F:actin monomer binding; F:cytoskeletal protein binding; F:myosin heavy chain binding; F:phosphatidylinositol 3-kinase binding; F:protein C-terminus binding; F:protein homodimerization activity; F:RNA binding;, P:actin cytoskeleton organization; P:actin filament organization; P:calcium ion transport; P:cell migration; P:cell-substrate adhesion; P:cellular response to interleukin-4; P:early endosome to recycling endosome transport; P:homeostasis of number of cells within a tissue; P:innate immune response; P:leukocyte chemotaxis; P:natural killer cell degranulation; P:negative regulation of actin nucleation; P:negative regulation of neuron apoptotic process; P:negative regulation of vesicle fusion; P:nerve growth factor signaling pathway; P:phagocytosis; P:phagolysosome assembly; P:positive chemotaxis; P:positive regulation of cell migration; P:positive regulation of T cell proliferation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of release of sequestered calcium ion into cytosol; P:T cell homeostasis; P:uropod organization;|P31146 B2RBL1 Q2YD73,Coronin-1A,Coronin-like protein A;Coronin-like protein p57;Tryptophan aspartate-containing coat protein;, PF08953;PF08954;PF00400;, GO:0005884;GO:0030424;GO:0005911;GO:0030864;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0098978;GO:0001772;GO:0030027;GO:0016020;GO:0001891;GO:0045335;GO:0030670;GO:0005886;GO:0032991;GO:0003779;GO:0051015;GO:0003785;GO:0008092;GO:0032036;GO:0043548;GO:0008022;GO:0042803;GO:0003723;GO:0030036;GO:0007015;GO:0006816;GO:0016477;GO:0031589;GO:0071353;GO:0061502;GO:0048873;GO:0045087;GO:0030595;GO:0043320;GO:0051126;GO:0043524;GO:0031339;GO:0038180;GO:0006909;GO:0001845;GO:0050918;GO:0030335;GO:0042102;GO:0032956;GO:0008360;GO:0051279;GO:0043029;GO:0032796;, C:actin filament; C:axon; C:cell-cell junction; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:glutamatergic synapse; C:immunological synapse; C:lamellipodium; C:membrane; C:phagocytic cup; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:protein-containing complex;, F:actin binding; F:actin filament binding; F:actin monomer binding; F:cytoskeletal protein binding; F:myosin heavy chain binding; F:phosphatidylinositol 3-kinase binding; F:protein C-terminus binding; F:protein homodimerization activity; F:RNA binding;, P:actin cytoskeleton organization; P:actin filament organization; P:calcium ion transport; P:cell migration; P:cell-substrate adhesion; P:cellular response to interleukin-4; P:early endosome to recycling endosome transport; P:homeostasis of number of cells within a tissue; P:innate immune response; P:leukocyte chemotaxis; P:natural killer cell degranulation; P:negative regulation of actin nucleation; P:negative regulation of neuron apoptotic process; P:negative regulation of vesicle fusion; P:nerve growth factor signaling pathway; P:phagocytosis; P:phagolysosome assembly; P:positive chemotaxis; P:positive regulation of cell migration; P:positive regulation of T cell proliferation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of release of sequestered calcium ion into cytosol; P:T cell homeostasis; P:uropod organization;|P31146 B2RBL1 Q2YD73,Coronin-1A,Coronin-like protein A;Coronin-like protein p57;Tryptophan aspartate-containing coat protein;, PF08953;PF08954;PF00400;, GO:0005884;GO:0030424;GO:0005911;GO:0030864;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0098978;GO:0001772;GO:0030027;GO:0016020;GO:0001891;GO:0045335;GO:0030670;GO:0005886;GO:0032991;GO:0003779;GO:0051015;GO:0003785;GO:0008092;GO:0032036;GO:0043548;GO:0008022;GO:0042803;GO:0003723;GO:0030036;GO:0007015;GO:0006816;GO:0016477;GO:0031589;GO:0071353;GO:0061502;GO:0048873;GO:0045087;GO:0030595;GO:0043320;GO:0051126;GO:0043524;GO:0031339;GO:0038180;GO:0006909;GO:0001845;GO:0050918;GO:0030335;GO:0042102;GO:0032956;GO:0008360;GO:0051279;GO:0043029;GO:0032796;, C:actin filament; C:axon; C:cell-cell junction; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:glutamatergic synapse; C:immunological synapse; C:lamellipodium; C:membrane; C:phagocytic cup; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:protein-containing complex;, F:actin binding; F:actin filament binding; F:actin monomer binding; F:cytoskeletal protein binding; F:myosin heavy chain binding; F:phosphatidylinositol 3-kinase binding; F:protein C-terminus binding; F:protein homodimerization activity; F:RNA binding;, P:actin cytoskeleton organization; P:actin filament organization; P:calcium ion transport; P:cell migration; P:cell-substrate adhesion; P:cellular response to interleukin-4; P:early endosome to recycling endosome transport; P:homeostasis of number of cells within a tissue; P:innate immune response; P:leukocyte chemotaxis; P:natural killer cell degranulation; P:negative regulation of actin nucleation; P:negative regulation of neuron apoptotic process; P:negative regulation of vesicle fusion; P:nerve growth factor signaling pathway; P:phagocytosis; P:phagolysosome assembly; P:positive chemotaxis; P:positive regulation of cell migration; P:positive regulation of T cell proliferation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of release of sequestered calcium ion into cytosol; P:T cell homeostasis; P:uropod organization;|P31146 B2RBL1 Q2YD73,Coronin-1A,Coronin-like protein A;Coronin-like protein p57;Tryptophan aspartate-containing coat protein;, PF08953;PF08954;PF00400;, GO:0005884;GO:0030424;GO:0005911;GO:0030864;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0098978;GO:0001772;GO:0030027;GO:0016020;GO:0001891;GO:0045335;GO:0030670;GO:0005886;GO:0032991;GO:0003779;GO:0051015;GO:0003785;GO:0008092;GO:0032036;GO:0043548;GO:0008022;GO:0042803;GO:0003723;GO:0030036;GO:0007015;GO:0006816;GO:0016477;GO:0031589;GO:0071353;GO:0061502;GO:0048873;GO:0045087;GO:0030595;GO:0043320;GO:0051126;GO:0043524;GO:0031339;GO:0038180;GO:0006909;GO:0001845;GO:0050918;GO:0030335;GO:0042102;GO:0032956;GO:0008360;GO:0051279;GO:0043029;GO:0032796;, C:actin filament; C:axon; C:cell-cell junction; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:glutamatergic synapse; C:immunological synapse; C:lamellipodium; C:membrane; C:phagocytic cup; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:protein-containing complex;, F:actin binding; F:actin filament binding; F:actin monomer binding; F:cytoskeletal protein binding; F:myosin heavy chain binding; F:phosphatidylinositol 3-kinase binding; F:protein C-terminus binding; F:protein homodimerization activity; F:RNA binding;, P:actin cytoskeleton organization; P:actin filament organization; P:calcium ion transport; P:cell migration; P:cell-substrate adhesion; P:cellular response to interleukin-4; P:early endosome to recycling endosome transport; P:homeostasis of number of cells within a tissue; P:innate immune response; P:leukocyte chemotaxis; P:natural killer cell degranulation; P:negative regulation of actin nucleation; P:negative regulation of neuron apoptotic process; P:negative regulation of vesicle fusion; P:nerve growth factor signaling pathway; P:phagocytosis; P:phagolysosome assembly; P:positive chemotaxis; P:positive regulation of cell migration; P:positive regulation of T cell proliferation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of release of sequestered calcium ion into cytosol; P:T cell homeostasis; P:uropod organization;|P31146 B2RBL1 Q2YD73,Coronin-1A,Coronin-like protein A;Coronin-like protein p57;Tryptophan aspartate-containing coat protein;, PF08953;PF08954;PF00400;, GO:0005884;GO:0030424;GO:0005911;GO:0030864;GO:0005737;GO:0005829;GO:0005769;GO:0070062;GO:0098978;GO:0001772;GO:0030027;GO:0016020;GO:0001891;GO:0045335;GO:0030670;GO:0005886;GO:0032991;GO:0003779;GO:0051015;GO:0003785;GO:0008092;GO:0032036;GO:0043548;GO:0008022;GO:0042803;GO:0003723;GO:0030036;GO:0007015;GO:0006816;GO:0016477;GO:0031589;GO:0071353;GO:0061502;GO:0048873;GO:0045087;GO:0030595;GO:0043320;GO:0051126;GO:0043524;GO:0031339;GO:0038180;GO:0006909;GO:0001845;GO:0050918;GO:0030335;GO:0042102;GO:0032956;GO:0008360;GO:0051279;GO:0043029;GO:0032796;, C:actin filament; C:axon; C:cell-cell junction; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:early endosome; C:extracellular exosome; C:glutamatergic synapse; C:immunological synapse; C:lamellipodium; C:membrane; C:phagocytic cup; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:protein-containing complex;, F:actin binding; F:actin filament binding; F:actin monomer binding; F:cytoskeletal protein binding; F:myosin heavy chain binding; F:phosphatidylinositol 3-kinase binding; F:protein C-terminus binding; F:protein homodimerization activity; F:RNA binding;, P:actin cytoskeleton organization; P:actin filament organization; P:calcium ion transport; P:cell migration; P:cell-substrate adhesion; P:cellular response to interleukin-4; P:early endosome to recycling endosome transport; P:homeostasis of number of cells within a tissue; P:innate immune response; P:leukocyte chemotaxis; P:natural killer cell degranulation; P:negative regulation of actin nucleation; P:negative regulation of neuron apoptotic process; P:negative regulation of vesicle fusion; P:nerve growth factor signaling pathway; P:phagocytosis; P:phagolysosome assembly; P:positive chemotaxis; P:positive regulation of cell migration; P:positive regulation of T cell proliferation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of release of sequestered calcium ion into cytosol; P:T cell homeostasis; P:uropod organization; scaffold38 indexed_genome mRNA 21943001 21951802 . + . ID=transcript_8000;P27361 A8CZ58 B0LPG3 Q8NHX1,Mitogen-activated protein kinase 3,ERT2;Extracellular signal-regulated kinase 1;Insulin-stimulated MAP2 kinase;MAP kinase isoform p44;Microtubule-associated protein 2 kinase;p44-ERK1;, PF00069;, GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0005769;GO:0005788;GO:0005925;GO:0005794;GO:0005770;GO:0005739;GO:0005635;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0031143;GO:0005524;GO:0042802;GO:0004707;GO:0004708;GO:0019902;GO:0001784;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:0000187;GO:0000186;GO:0007568;GO:0006915;GO:0019369;GO:0007411;GO:0060020;GO:0030509;GO:0061308;GO:0051216;GO:0072584;GO:0007049;GO:0007166;GO:0034198;GO:0071276;GO:1903351;GO:0071260;GO:0034614;GO:0071356;GO:0046697;GO:0006975;GO:0070371;GO:0060324;GO:0038095;GO:0038096;GO:0008543;GO:0070498;GO:0035556;GO:0031663;GO:0060425;GO:0000165;GO:0033668;GO:2000657;GO:0042473;GO:0018105;GO:0038083;GO:0016310;GO:0030168;GO:0031281;GO:0070374;GO:0010628;GO:0035066;GO:0033129;GO:0010759;GO:0120041;GO:0001934;GO:0051973;GO:1904355;GO:0032212;GO:0045944;GO:0045727;GO:1904417;GO:0006468;GO:0065003;GO:0030641;GO:1900034;GO:0051493;GO:0051090;GO:2000641;GO:0010468;GO:0090170;GO:0030278;GO:0014066;GO:0032872;GO:0070849;GO:0043330;GO:0009636;GO:0019233;GO:0051403;GO:0048538;GO:0030878;GO:0060440;GO:0006361;GO:0016032;, C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome; C:endoplasmic reticulum lumen; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:mitochondrion; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:pseudopodium;, F:ATP binding; F:identical protein binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:phosphatase binding; F:phosphotyrosine residue binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:aging; P:apoptotic process; P:arachidonic acid metabolic process; P:axon guidance; P:Bergmann glial cell differentiation; P:BMP signaling pathway; P:cardiac neural crest cell development involved in heart development; P:cartilage development; P:caveolin-mediated endocytosis; P:cell cycle; P:cell surface receptor signaling pathway; P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to dopamine; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:decidualization; P:DNA damage induced protein phosphorylation; P:ERK1 and ERK2 cascade; P:face development; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:lung morphogenesis; P:MAPK cascade; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of apolipoprotein binding; P:outer ear morphogenesis; P:peptidyl-serine phosphorylation; P:peptidyl-tyrosine autophosphorylation; P:phosphorylation; P:platelet activation; P:positive regulation of cyclase activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of protein phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of xenophagy; P:protein phosphorylation; P:protein-containing complex assembly; P:regulation of cellular pH; P:regulation of cellular response to heat; P:regulation of cytoskeleton organization; P:regulation of DNA-binding transcription factor activity; P:regulation of early endosome to late endosome transport; P:regulation of gene expression; P:regulation of Golgi inheritance; P:regulation of ossification; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of stress-activated MAPK cascade; P:response to epidermal growth factor; P:response to exogenous dsRNA; P:response to toxic substance; P:sensory perception of pain; P:stress-activated MAPK cascade; P:thymus development; P:thyroid gland development; P:trachea formation; P:transcription initiation from RNA polymerase I promoter; P:viral process;|P27361 A8CZ58 B0LPG3 Q8NHX1,Mitogen-activated protein kinase 3,ERT2;Extracellular signal-regulated kinase 1;Insulin-stimulated MAP2 kinase;MAP kinase isoform p44;Microtubule-associated protein 2 kinase;p44-ERK1;, PF00069;, GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0005769;GO:0005788;GO:0005925;GO:0005794;GO:0005770;GO:0005739;GO:0005635;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0031143;GO:0005524;GO:0042802;GO:0004707;GO:0004708;GO:0019902;GO:0001784;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:0000187;GO:0000186;GO:0007568;GO:0006915;GO:0019369;GO:0007411;GO:0060020;GO:0030509;GO:0061308;GO:0051216;GO:0072584;GO:0007049;GO:0007166;GO:0034198;GO:0071276;GO:1903351;GO:0071260;GO:0034614;GO:0071356;GO:0046697;GO:0006975;GO:0070371;GO:0060324;GO:0038095;GO:0038096;GO:0008543;GO:0070498;GO:0035556;GO:0031663;GO:0060425;GO:0000165;GO:0033668;GO:2000657;GO:0042473;GO:0018105;GO:0038083;GO:0016310;GO:0030168;GO:0031281;GO:0070374;GO:0010628;GO:0035066;GO:0033129;GO:0010759;GO:0120041;GO:0001934;GO:0051973;GO:1904355;GO:0032212;GO:0045944;GO:0045727;GO:1904417;GO:0006468;GO:0065003;GO:0030641;GO:1900034;GO:0051493;GO:0051090;GO:2000641;GO:0010468;GO:0090170;GO:0030278;GO:0014066;GO:0032872;GO:0070849;GO:0043330;GO:0009636;GO:0019233;GO:0051403;GO:0048538;GO:0030878;GO:0060440;GO:0006361;GO:0016032;, C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome; C:endoplasmic reticulum lumen; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:mitochondrion; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:pseudopodium;, F:ATP binding; F:identical protein binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:phosphatase binding; F:phosphotyrosine residue binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:aging; P:apoptotic process; P:arachidonic acid metabolic process; P:axon guidance; P:Bergmann glial cell differentiation; P:BMP signaling pathway; P:cardiac neural crest cell development involved in heart development; P:cartilage development; P:caveolin-mediated endocytosis; P:cell cycle; P:cell surface receptor signaling pathway; P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to dopamine; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:decidualization; P:DNA damage induced protein phosphorylation; P:ERK1 and ERK2 cascade; P:face development; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:lung morphogenesis; P:MAPK cascade; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of apolipoprotein binding; P:outer ear morphogenesis; P:peptidyl-serine phosphorylation; P:peptidyl-tyrosine autophosphorylation; P:phosphorylation; P:platelet activation; P:positive regulation of cyclase activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of protein phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of xenophagy; P:protein phosphorylation; P:protein-containing complex assembly; P:regulation of cellular pH; P:regulation of cellular response to heat; P:regulation of cytoskeleton organization; P:regulation of DNA-binding transcription factor activity; P:regulation of early endosome to late endosome transport; P:regulation of gene expression; P:regulation of Golgi inheritance; P:regulation of ossification; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of stress-activated MAPK cascade; P:response to epidermal growth factor; P:response to exogenous dsRNA; P:response to toxic substance; P:sensory perception of pain; P:stress-activated MAPK cascade; P:thymus development; P:thyroid gland development; P:trachea formation; P:transcription initiation from RNA polymerase I promoter; P:viral process;|P27361 A8CZ58 B0LPG3 Q8NHX1,Mitogen-activated protein kinase 3,ERT2;Extracellular signal-regulated kinase 1;Insulin-stimulated MAP2 kinase;MAP kinase isoform p44;Microtubule-associated protein 2 kinase;p44-ERK1;, PF00069;, GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0005769;GO:0005788;GO:0005925;GO:0005794;GO:0005770;GO:0005739;GO:0005635;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0031143;GO:0005524;GO:0042802;GO:0004707;GO:0004708;GO:0019902;GO:0001784;GO:0106310;GO:0004674;GO:0106311;GO:0097110;GO:0000187;GO:0000186;GO:0007568;GO:0006915;GO:0019369;GO:0007411;GO:0060020;GO:0030509;GO:0061308;GO:0051216;GO:0072584;GO:0007049;GO:0007166;GO:0034198;GO:0071276;GO:1903351;GO:0071260;GO:0034614;GO:0071356;GO:0046697;GO:0006975;GO:0070371;GO:0060324;GO:0038095;GO:0038096;GO:0008543;GO:0070498;GO:0035556;GO:0031663;GO:0060425;GO:0000165;GO:0033668;GO:2000657;GO:0042473;GO:0018105;GO:0038083;GO:0016310;GO:0030168;GO:0031281;GO:0070374;GO:0010628;GO:0035066;GO:0033129;GO:0010759;GO:0120041;GO:0001934;GO:0051973;GO:1904355;GO:0032212;GO:0045944;GO:0045727;GO:1904417;GO:0006468;GO:0065003;GO:0030641;GO:1900034;GO:0051493;GO:0051090;GO:2000641;GO:0010468;GO:0090170;GO:0030278;GO:0014066;GO:0032872;GO:0070849;GO:0043330;GO:0009636;GO:0019233;GO:0051403;GO:0048538;GO:0030878;GO:0060440;GO:0006361;GO:0016032;, C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome; C:endoplasmic reticulum lumen; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:mitochondrion; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:pseudopodium;, F:ATP binding; F:identical protein binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:phosphatase binding; F:phosphotyrosine residue binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:aging; P:apoptotic process; P:arachidonic acid metabolic process; P:axon guidance; P:Bergmann glial cell differentiation; P:BMP signaling pathway; P:cardiac neural crest cell development involved in heart development; P:cartilage development; P:caveolin-mediated endocytosis; P:cell cycle; P:cell surface receptor signaling pathway; P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to dopamine; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:decidualization; P:DNA damage induced protein phosphorylation; P:ERK1 and ERK2 cascade; P:face development; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:lung morphogenesis; P:MAPK cascade; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of apolipoprotein binding; P:outer ear morphogenesis; P:peptidyl-serine phosphorylation; P:peptidyl-tyrosine autophosphorylation; P:phosphorylation; P:platelet activation; P:positive regulation of cyclase activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of protein phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of xenophagy; P:protein phosphorylation; P:protein-containing complex assembly; P:regulation of cellular pH; P:regulation of cellular response to heat; P:regulation of cytoskeleton organization; P:regulation of DNA-binding transcription factor activity; P:regulation of early endosome to late endosome transport; P:regulation of gene expression; P:regulation of Golgi inheritance; P:regulation of ossification; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of stress-activated MAPK cascade; P:response to epidermal growth factor; P:response to exogenous dsRNA; P:response to toxic substance; P:sensory perception of pain; P:stress-activated MAPK cascade; P:thymus development; P:thyroid gland development; P:trachea formation; P:transcription initiation from RNA polymerase I promoter; P:viral process; scaffold38 indexed_genome mRNA 21951815 21954555 . + . ID=transcript_8001;Q7L5L3 Q9H652,Lysophospholipase D GDPD3 {ECO:0000305},Glycerophosphodiester phosphodiesterase 7 {ECO:0000250|UniProtKB:Q99LY2};Glycerophosphodiester phosphodiesterase domain-containing protein 3;, PF03009;, GO:0005783;GO:0005789;GO:0070062;GO:0016021;GO:0048471;GO:0004622;GO:0046872;GO:0008081;GO:0046475;GO:0070291;GO:0034638;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:lysophospholipase activity; F:metal ion binding; F:phosphoric diester hydrolase activity;, P:glycerophospholipid catabolic process; P:N-acylethanolamine metabolic process; P:phosphatidylcholine catabolic process; scaffold38 indexed_genome mRNA 21966100 21969527 . + . ID=transcript_8002;P61236 Q65Z99 Q86VK6 Q9BSJ4 Q9CQB6,Protein yippee-like 3,, PF03226;, GO:0005730;GO:0046872;GO:2000774;, C:nucleolus;, F:metal ion binding;, P:positive regulation of cellular senescence;|P61236 Q65Z99 Q86VK6 Q9BSJ4 Q9CQB6,Protein yippee-like 3,, PF03226;, GO:0005730;GO:0046872;GO:2000774;, C:nucleolus;, F:metal ion binding;, P:positive regulation of cellular senescence; scaffold38 indexed_genome mRNA 21971696 21973503 . + . ID=transcript_8003;O95947 Q8TAS4 Q9HA44,T-box transcription factor TBX6,, PF00907;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0001102;GO:0000978;GO:0001085;GO:1990837;GO:0009653;GO:0003205;GO:0001708;GO:0007417;GO:0001947;GO:0007498;GO:0001707;GO:0043433;GO:0014043;GO:0010977;GO:0000122;GO:0008284;GO:0045944;GO:0006357;GO:0023019;GO:0032525;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure morphogenesis; P:cardiac chamber development; P:cell fate specification; P:central nervous system development; P:heart looping; P:mesoderm development; P:mesoderm formation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron maturation; P:negative regulation of neuron projection development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:signal transduction involved in regulation of gene expression; P:somite rostral/caudal axis specification;|O95947 Q8TAS4 Q9HA44,T-box transcription factor TBX6,, PF00907;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0001102;GO:0000978;GO:0001085;GO:1990837;GO:0009653;GO:0003205;GO:0001708;GO:0007417;GO:0001947;GO:0007498;GO:0001707;GO:0043433;GO:0014043;GO:0010977;GO:0000122;GO:0008284;GO:0045944;GO:0006357;GO:0023019;GO:0032525;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure morphogenesis; P:cardiac chamber development; P:cell fate specification; P:central nervous system development; P:heart looping; P:mesoderm development; P:mesoderm formation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron maturation; P:negative regulation of neuron projection development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:signal transduction involved in regulation of gene expression; P:somite rostral/caudal axis specification; scaffold38 indexed_genome mRNA 21974841 21975746 . + . ID=transcript_8004;P60510 P33172,Serine/threonine-protein phosphatase 4 catalytic subunit,Protein phosphatase X;, PF00149;, GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0030289;GO:0046872;GO:0004704;GO:0106306;GO:0004722;GO:0106307;GO:0010569;, C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane; C:protein phosphatase 4 complex;, F:metal ion binding; F:NF-kappaB-inducing kinase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:regulation of double-strand break repair via homologous recombination; scaffold38 indexed_genome mRNA 21976211 21980739 . - . ID=transcript_8005;P60510 P33172,Serine/threonine-protein phosphatase 4 catalytic subunit,Protein phosphatase X;, PF00149;, GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0030289;GO:0046872;GO:0004704;GO:0106306;GO:0004722;GO:0106307;GO:0010569;, C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane; C:protein phosphatase 4 complex;, F:metal ion binding; F:NF-kappaB-inducing kinase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:regulation of double-strand break repair via homologous recombination; scaffold38 indexed_genome mRNA 21980766 21982003 . - . ID=transcript_8006;P60510 P33172,Serine/threonine-protein phosphatase 4 catalytic subunit,Protein phosphatase X;, PF00149;, GO:0005829;GO:0005815;GO:0005654;GO:0005886;GO:0030289;GO:0046872;GO:0004704;GO:0106306;GO:0004722;GO:0106307;GO:0010569;, C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:plasma membrane; C:protein phosphatase 4 complex;, F:metal ion binding; F:NF-kappaB-inducing kinase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:regulation of double-strand break repair via homologous recombination; scaffold38 indexed_genome mRNA 21984938 21989819 . - . ID=transcript_8007;P04075 B4DXI7 Q6FH76 Q6FI10 Q96B15 Q9BWD9 Q9UCN2,Fructose-bisphosphate aldolase A,Lung cancer antigen NY-LU-1;Muscle-type aldolase;, PF00274;, GO:0015629;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0031674;GO:0031430;GO:0016020;GO:0005634;GO:0031093;GO:0034774;GO:0061827;GO:1904724;GO:0003779;GO:0045296;GO:0008092;GO:0070061;GO:0004332;GO:0042802;GO:0003723;GO:0015631;GO:0007015;GO:0006754;GO:0007339;GO:0061621;GO:0030388;GO:0006000;GO:0006094;GO:0006096;GO:0046716;GO:0043312;GO:0002576;GO:0051289;GO:0008360;GO:0006941;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:I band; C:M band; C:membrane; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen; C:sperm head; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:cytoskeletal protein binding; F:fructose binding; F:fructose-bisphosphate aldolase activity; F:identical protein binding; F:RNA binding; F:tubulin binding;, P:actin filament organization; P:ATP biosynthetic process; P:binding of sperm to zona pellucida; P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:muscle cell cellular homeostasis; P:neutrophil degranulation; P:platelet degranulation; P:protein homotetramerization; P:regulation of cell shape; P:striated muscle contraction;|P04075 B4DXI7 Q6FH76 Q6FI10 Q96B15 Q9BWD9 Q9UCN2,Fructose-bisphosphate aldolase A,Lung cancer antigen NY-LU-1;Muscle-type aldolase;, PF00274;, GO:0015629;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0031674;GO:0031430;GO:0016020;GO:0005634;GO:0031093;GO:0034774;GO:0061827;GO:1904724;GO:0003779;GO:0045296;GO:0008092;GO:0070061;GO:0004332;GO:0042802;GO:0003723;GO:0015631;GO:0007015;GO:0006754;GO:0007339;GO:0061621;GO:0030388;GO:0006000;GO:0006094;GO:0006096;GO:0046716;GO:0043312;GO:0002576;GO:0051289;GO:0008360;GO:0006941;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:I band; C:M band; C:membrane; C:nucleus; C:platelet alpha granule lumen; C:secretory granule lumen; C:sperm head; C:tertiary granule lumen;, F:actin binding; F:cadherin binding; F:cytoskeletal protein binding; F:fructose binding; F:fructose-bisphosphate aldolase activity; F:identical protein binding; F:RNA binding; F:tubulin binding;, P:actin filament organization; P:ATP biosynthetic process; P:binding of sperm to zona pellucida; P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:muscle cell cellular homeostasis; P:neutrophil degranulation; P:platelet degranulation; P:protein homotetramerization; P:regulation of cell shape; P:striated muscle contraction; scaffold39 indexed_genome mRNA 13839 357292 . + . ID=transcript_8008;O60547 E9PI88 O75357 Q5T954 Q6FH09 Q9UGZ3 Q9UJK9,GDP-mannose 4,6 dehydratase,GDP-D-mannose dehydratase;, PF16363;, GO:0005737;GO:0005829;GO:0070062;GO:0008446;GO:0042802;GO:0070401;GO:0042351;GO:0019673;GO:0007219;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:GDP-mannose 4,6-dehydratase activity; F:identical protein binding; F:NADP+ binding;, P:'de novo' GDP-L-fucose biosynthetic process; P:GDP-mannose metabolic process; P:Notch signaling pathway; scaffold39 indexed_genome mRNA 647408 653717 . - . ID=transcript_8009;Q86YV6 A2RUC0 Q5TAW2,Myosin light chain kinase family member 4,Sugen kinase 85;, PF00069;, GO:0005524;GO:0004687;GO:0106310;GO:0106311;, , F:ATP binding; F:myosin light chain kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; scaffold39 indexed_genome mRNA 723554 726129 . - . ID=transcript_8010;Q96S55 B2RDB0 Q53EP6 Q59ET8 Q5W0E2 Q5W0E4 Q8WV26 Q9H681 Q9NRJ6,ATPase WRNIP1,Werner helicase-interacting protein 1;, PF00004;PF16193;PF12002;PF18279;, GO:0016020;GO:0005634;GO:0048471;GO:0005524;GO:0016887;GO:0003677;GO:0008047;GO:0042802;GO:0046872;GO:0017116;GO:0000731;GO:0006261;GO:0045087;GO:0006282;GO:0030174;, C:membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:DNA binding; F:enzyme activator activity; F:identical protein binding; F:metal ion binding; F:single-stranded DNA helicase activity;, P:DNA synthesis involved in DNA repair; P:DNA-dependent DNA replication; P:innate immune response; P:regulation of DNA repair; P:regulation of DNA-dependent DNA replication initiation;|Q96S55 B2RDB0 Q53EP6 Q59ET8 Q5W0E2 Q5W0E4 Q8WV26 Q9H681 Q9NRJ6,ATPase WRNIP1,Werner helicase-interacting protein 1;, PF00004;PF16193;PF12002;PF18279;, GO:0016020;GO:0005634;GO:0048471;GO:0005524;GO:0016887;GO:0003677;GO:0008047;GO:0042802;GO:0046872;GO:0017116;GO:0000731;GO:0006261;GO:0045087;GO:0006282;GO:0030174;, C:membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:DNA binding; F:enzyme activator activity; F:identical protein binding; F:metal ion binding; F:single-stranded DNA helicase activity;, P:DNA synthesis involved in DNA repair; P:DNA-dependent DNA replication; P:innate immune response; P:regulation of DNA repair; P:regulation of DNA-dependent DNA replication initiation; scaffold39 indexed_genome mRNA 746893 752411 . - . ID=transcript_8011;P30740 A8K5L2 B4DNT0 Q53FB9 Q5W0E1 Q9UDF8,Leukocyte elastase inhibitor,Monocyte/neutrophil elastase inhibitor;Peptidase inhibitor 2;Serpin B1;, PF00079;, GO:0062023;GO:0036464;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0034774;GO:0030414;GO:0004867;GO:0010951;GO:0032691;GO:0043312;GO:0044342;, C:collagen-containing extracellular matrix; C:cytoplasmic ribonucleoprotein granule; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:secretory granule lumen;, F:peptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity; P:negative regulation of interleukin-1 beta production; P:neutrophil degranulation; P:type B pancreatic cell proliferation; scaffold39 indexed_genome mRNA 785135 790257 . + . ID=transcript_8012;P50453 B2RBW3 Q5TD03,Serpin B9,Cytoplasmic antiproteinase 3;Peptidase inhibitor 9;, PF00079;, GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0005794;GO:0016020;GO:0005654;GO:0005634;GO:0043027;GO:0002020;GO:0004867;GO:0071391;GO:0006955;GO:0002448;GO:0033668;GO:0043066;GO:0010951;GO:0010628;GO:0042270;GO:0009617;, C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:cellular response to estrogen stimulus; P:immune response; P:mast cell mediated immunity; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of endopeptidase activity; P:positive regulation of gene expression; P:protection from natural killer cell mediated cytotoxicity; P:response to bacterium;|P50453 B2RBW3 Q5TD03,Serpin B9,Cytoplasmic antiproteinase 3;Peptidase inhibitor 9;, PF00079;, GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0005794;GO:0016020;GO:0005654;GO:0005634;GO:0043027;GO:0002020;GO:0004867;GO:0071391;GO:0006955;GO:0002448;GO:0033668;GO:0043066;GO:0010951;GO:0010628;GO:0042270;GO:0009617;, C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:membrane; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:cellular response to estrogen stimulus; P:immune response; P:mast cell mediated immunity; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of endopeptidase activity; P:positive regulation of gene expression; P:protection from natural killer cell mediated cytotoxicity; P:response to bacterium; scaffold39 indexed_genome mRNA 923102 991948 . + . ID=transcript_8013;P16083 B2R492 Q5TD04,Ribosyldihydronicotinamide dehydrogenase [quinone],NRH dehydrogenase [quinone] 2;NRH:quinone oxidoreductase 2;Quinone reductase 2;, PF02525;, GO:0005829;GO:0070062;GO:0005654;GO:0031404;GO:0001512;GO:0009055;GO:0071949;GO:1904408;GO:0003955;GO:0016491;GO:0016661;GO:0042803;GO:1905594;GO:0008270;GO:0007613;GO:0070374;GO:0043525;GO:2000379;GO:1904707;GO:1901662;GO:0006805;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:chloride ion binding; F:dihydronicotinamide riboside quinone reductase activity; F:electron transfer activity; F:FAD binding; F:melatonin binding; F:NAD(P)H dehydrogenase (quinone) activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on other nitrogenous compounds as donors; F:protein homodimerization activity; F:resveratrol binding; F:zinc ion binding;, P:memory; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of neuron apoptotic process; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of vascular associated smooth muscle cell proliferation; P:quinone catabolic process; P:xenobiotic metabolic process;|Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33,Receptor-interacting serine/threonine-protein kinase 1,Cell death protein RIP {ECO:0000303|PubMed:8612133};Receptor-interacting protein 1 {ECO:0000303|PubMed:16603398};, PF00531;PF07714;PF12721;, GO:0005829;GO:0031264;GO:0010008;GO:0045121;GO:0005739;GO:0005886;GO:0032991;GO:0043235;GO:0097342;GO:0005524;GO:0070513;GO:0005123;GO:0042802;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031625;GO:0006919;GO:0007257;GO:1990000;GO:0006915;GO:0097190;GO:0008219;GO:0044257;GO:0070301;GO:0071356;GO:0071550;GO:0097191;GO:0007249;GO:0006954;GO:0019054;GO:0002756;GO:0070266;GO:0097527;GO:0043066;GO:2001237;GO:1902042;GO:0043124;GO:0060546;GO:0062099;GO:0036289;GO:0043065;GO:2001238;GO:1905206;GO:0043123;GO:0050729;GO:0070105;GO:0032757;GO:0046330;GO:0045651;GO:0060545;GO:0010940;GO:0051092;GO:1903800;GO:0043068;GO:0001934;GO:2000379;GO:0045944;GO:0032760;GO:0097300;GO:0046777;GO:0016579;GO:0070926;GO:1902041;GO:0060544;GO:0010803;GO:0034612;GO:0097343;GO:0070231;GO:0034138;GO:0035666;GO:0033209;, C:cytosol; C:death-inducing signaling complex; C:endosome membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:ripoptosome;, F:ATP binding; F:death domain binding; F:death receptor binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:amyloid fibril formation; P:apoptotic process; P:apoptotic signaling pathway; P:cell death; P:cellular protein catabolic process; P:cellular response to hydrogen peroxide; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:modulation by virus of host cellular process; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of programmed necrotic cell death; P:peptidyl-serine autophosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of hydrogen peroxide-induced cell death; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage differentiation; P:positive regulation of necroptotic process; P:positive regulation of necrotic cell death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed cell death; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:programmed necrotic cell death; P:protein autophosphorylation; P:protein deubiquitination; P:regulation of ATP:ADP antiporter activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to tumor necrosis factor; P:ripoptosome assembly; P:T cell apoptotic process; P:toll-like receptor 3 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33,Receptor-interacting serine/threonine-protein kinase 1,Cell death protein RIP {ECO:0000303|PubMed:8612133};Receptor-interacting protein 1 {ECO:0000303|PubMed:16603398};, PF00531;PF07714;PF12721;, GO:0005829;GO:0031264;GO:0010008;GO:0045121;GO:0005739;GO:0005886;GO:0032991;GO:0043235;GO:0097342;GO:0005524;GO:0070513;GO:0005123;GO:0042802;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031625;GO:0006919;GO:0007257;GO:1990000;GO:0006915;GO:0097190;GO:0008219;GO:0044257;GO:0070301;GO:0071356;GO:0071550;GO:0097191;GO:0007249;GO:0006954;GO:0019054;GO:0002756;GO:0070266;GO:0097527;GO:0043066;GO:2001237;GO:1902042;GO:0043124;GO:0060546;GO:0062099;GO:0036289;GO:0043065;GO:2001238;GO:1905206;GO:0043123;GO:0050729;GO:0070105;GO:0032757;GO:0046330;GO:0045651;GO:0060545;GO:0010940;GO:0051092;GO:1903800;GO:0043068;GO:0001934;GO:2000379;GO:0045944;GO:0032760;GO:0097300;GO:0046777;GO:0016579;GO:0070926;GO:1902041;GO:0060544;GO:0010803;GO:0034612;GO:0097343;GO:0070231;GO:0034138;GO:0035666;GO:0033209;, C:cytosol; C:death-inducing signaling complex; C:endosome membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:ripoptosome;, F:ATP binding; F:death domain binding; F:death receptor binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:amyloid fibril formation; P:apoptotic process; P:apoptotic signaling pathway; P:cell death; P:cellular protein catabolic process; P:cellular response to hydrogen peroxide; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:modulation by virus of host cellular process; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of programmed necrotic cell death; P:peptidyl-serine autophosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of hydrogen peroxide-induced cell death; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage differentiation; P:positive regulation of necroptotic process; P:positive regulation of necrotic cell death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed cell death; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:programmed necrotic cell death; P:protein autophosphorylation; P:protein deubiquitination; P:regulation of ATP:ADP antiporter activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to tumor necrosis factor; P:ripoptosome assembly; P:T cell apoptotic process; P:toll-like receptor 3 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33,Receptor-interacting serine/threonine-protein kinase 1,Cell death protein RIP {ECO:0000303|PubMed:8612133};Receptor-interacting protein 1 {ECO:0000303|PubMed:16603398};, PF00531;PF07714;PF12721;, GO:0005829;GO:0031264;GO:0010008;GO:0045121;GO:0005739;GO:0005886;GO:0032991;GO:0043235;GO:0097342;GO:0005524;GO:0070513;GO:0005123;GO:0042802;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031625;GO:0006919;GO:0007257;GO:1990000;GO:0006915;GO:0097190;GO:0008219;GO:0044257;GO:0070301;GO:0071356;GO:0071550;GO:0097191;GO:0007249;GO:0006954;GO:0019054;GO:0002756;GO:0070266;GO:0097527;GO:0043066;GO:2001237;GO:1902042;GO:0043124;GO:0060546;GO:0062099;GO:0036289;GO:0043065;GO:2001238;GO:1905206;GO:0043123;GO:0050729;GO:0070105;GO:0032757;GO:0046330;GO:0045651;GO:0060545;GO:0010940;GO:0051092;GO:1903800;GO:0043068;GO:0001934;GO:2000379;GO:0045944;GO:0032760;GO:0097300;GO:0046777;GO:0016579;GO:0070926;GO:1902041;GO:0060544;GO:0010803;GO:0034612;GO:0097343;GO:0070231;GO:0034138;GO:0035666;GO:0033209;, C:cytosol; C:death-inducing signaling complex; C:endosome membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:ripoptosome;, F:ATP binding; F:death domain binding; F:death receptor binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:amyloid fibril formation; P:apoptotic process; P:apoptotic signaling pathway; P:cell death; P:cellular protein catabolic process; P:cellular response to hydrogen peroxide; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:modulation by virus of host cellular process; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of programmed necrotic cell death; P:peptidyl-serine autophosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of hydrogen peroxide-induced cell death; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage differentiation; P:positive regulation of necroptotic process; P:positive regulation of necrotic cell death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed cell death; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:programmed necrotic cell death; P:protein autophosphorylation; P:protein deubiquitination; P:regulation of ATP:ADP antiporter activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to tumor necrosis factor; P:ripoptosome assembly; P:T cell apoptotic process; P:toll-like receptor 3 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33,Receptor-interacting serine/threonine-protein kinase 1,Cell death protein RIP {ECO:0000303|PubMed:8612133};Receptor-interacting protein 1 {ECO:0000303|PubMed:16603398};, PF00531;PF07714;PF12721;, GO:0005829;GO:0031264;GO:0010008;GO:0045121;GO:0005739;GO:0005886;GO:0032991;GO:0043235;GO:0097342;GO:0005524;GO:0070513;GO:0005123;GO:0042802;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031625;GO:0006919;GO:0007257;GO:1990000;GO:0006915;GO:0097190;GO:0008219;GO:0044257;GO:0070301;GO:0071356;GO:0071550;GO:0097191;GO:0007249;GO:0006954;GO:0019054;GO:0002756;GO:0070266;GO:0097527;GO:0043066;GO:2001237;GO:1902042;GO:0043124;GO:0060546;GO:0062099;GO:0036289;GO:0043065;GO:2001238;GO:1905206;GO:0043123;GO:0050729;GO:0070105;GO:0032757;GO:0046330;GO:0045651;GO:0060545;GO:0010940;GO:0051092;GO:1903800;GO:0043068;GO:0001934;GO:2000379;GO:0045944;GO:0032760;GO:0097300;GO:0046777;GO:0016579;GO:0070926;GO:1902041;GO:0060544;GO:0010803;GO:0034612;GO:0097343;GO:0070231;GO:0034138;GO:0035666;GO:0033209;, C:cytosol; C:death-inducing signaling complex; C:endosome membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:ripoptosome;, F:ATP binding; F:death domain binding; F:death receptor binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:amyloid fibril formation; P:apoptotic process; P:apoptotic signaling pathway; P:cell death; P:cellular protein catabolic process; P:cellular response to hydrogen peroxide; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:modulation by virus of host cellular process; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of programmed necrotic cell death; P:peptidyl-serine autophosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of hydrogen peroxide-induced cell death; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage differentiation; P:positive regulation of necroptotic process; P:positive regulation of necrotic cell death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed cell death; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:programmed necrotic cell death; P:protein autophosphorylation; P:protein deubiquitination; P:regulation of ATP:ADP antiporter activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to tumor necrosis factor; P:ripoptosome assembly; P:T cell apoptotic process; P:toll-like receptor 3 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33,Receptor-interacting serine/threonine-protein kinase 1,Cell death protein RIP {ECO:0000303|PubMed:8612133};Receptor-interacting protein 1 {ECO:0000303|PubMed:16603398};, PF00531;PF07714;PF12721;, GO:0005829;GO:0031264;GO:0010008;GO:0045121;GO:0005739;GO:0005886;GO:0032991;GO:0043235;GO:0097342;GO:0005524;GO:0070513;GO:0005123;GO:0042802;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031625;GO:0006919;GO:0007257;GO:1990000;GO:0006915;GO:0097190;GO:0008219;GO:0044257;GO:0070301;GO:0071356;GO:0071550;GO:0097191;GO:0007249;GO:0006954;GO:0019054;GO:0002756;GO:0070266;GO:0097527;GO:0043066;GO:2001237;GO:1902042;GO:0043124;GO:0060546;GO:0062099;GO:0036289;GO:0043065;GO:2001238;GO:1905206;GO:0043123;GO:0050729;GO:0070105;GO:0032757;GO:0046330;GO:0045651;GO:0060545;GO:0010940;GO:0051092;GO:1903800;GO:0043068;GO:0001934;GO:2000379;GO:0045944;GO:0032760;GO:0097300;GO:0046777;GO:0016579;GO:0070926;GO:1902041;GO:0060544;GO:0010803;GO:0034612;GO:0097343;GO:0070231;GO:0034138;GO:0035666;GO:0033209;, C:cytosol; C:death-inducing signaling complex; C:endosome membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:ripoptosome;, F:ATP binding; F:death domain binding; F:death receptor binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:amyloid fibril formation; P:apoptotic process; P:apoptotic signaling pathway; P:cell death; P:cellular protein catabolic process; P:cellular response to hydrogen peroxide; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:modulation by virus of host cellular process; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of programmed necrotic cell death; P:peptidyl-serine autophosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of hydrogen peroxide-induced cell death; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage differentiation; P:positive regulation of necroptotic process; P:positive regulation of necrotic cell death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed cell death; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:programmed necrotic cell death; P:protein autophosphorylation; P:protein deubiquitination; P:regulation of ATP:ADP antiporter activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to tumor necrosis factor; P:ripoptosome assembly; P:T cell apoptotic process; P:toll-like receptor 3 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33,Receptor-interacting serine/threonine-protein kinase 1,Cell death protein RIP {ECO:0000303|PubMed:8612133};Receptor-interacting protein 1 {ECO:0000303|PubMed:16603398};, PF00531;PF07714;PF12721;, GO:0005829;GO:0031264;GO:0010008;GO:0045121;GO:0005739;GO:0005886;GO:0032991;GO:0043235;GO:0097342;GO:0005524;GO:0070513;GO:0005123;GO:0042802;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031625;GO:0006919;GO:0007257;GO:1990000;GO:0006915;GO:0097190;GO:0008219;GO:0044257;GO:0070301;GO:0071356;GO:0071550;GO:0097191;GO:0007249;GO:0006954;GO:0019054;GO:0002756;GO:0070266;GO:0097527;GO:0043066;GO:2001237;GO:1902042;GO:0043124;GO:0060546;GO:0062099;GO:0036289;GO:0043065;GO:2001238;GO:1905206;GO:0043123;GO:0050729;GO:0070105;GO:0032757;GO:0046330;GO:0045651;GO:0060545;GO:0010940;GO:0051092;GO:1903800;GO:0043068;GO:0001934;GO:2000379;GO:0045944;GO:0032760;GO:0097300;GO:0046777;GO:0016579;GO:0070926;GO:1902041;GO:0060544;GO:0010803;GO:0034612;GO:0097343;GO:0070231;GO:0034138;GO:0035666;GO:0033209;, C:cytosol; C:death-inducing signaling complex; C:endosome membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:ripoptosome;, F:ATP binding; F:death domain binding; F:death receptor binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:amyloid fibril formation; P:apoptotic process; P:apoptotic signaling pathway; P:cell death; P:cellular protein catabolic process; P:cellular response to hydrogen peroxide; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:modulation by virus of host cellular process; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of programmed necrotic cell death; P:peptidyl-serine autophosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of hydrogen peroxide-induced cell death; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage differentiation; P:positive regulation of necroptotic process; P:positive regulation of necrotic cell death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed cell death; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:programmed necrotic cell death; P:protein autophosphorylation; P:protein deubiquitination; P:regulation of ATP:ADP antiporter activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to tumor necrosis factor; P:ripoptosome assembly; P:T cell apoptotic process; P:toll-like receptor 3 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33,Receptor-interacting serine/threonine-protein kinase 1,Cell death protein RIP {ECO:0000303|PubMed:8612133};Receptor-interacting protein 1 {ECO:0000303|PubMed:16603398};, PF00531;PF07714;PF12721;, GO:0005829;GO:0031264;GO:0010008;GO:0045121;GO:0005739;GO:0005886;GO:0032991;GO:0043235;GO:0097342;GO:0005524;GO:0070513;GO:0005123;GO:0042802;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031625;GO:0006919;GO:0007257;GO:1990000;GO:0006915;GO:0097190;GO:0008219;GO:0044257;GO:0070301;GO:0071356;GO:0071550;GO:0097191;GO:0007249;GO:0006954;GO:0019054;GO:0002756;GO:0070266;GO:0097527;GO:0043066;GO:2001237;GO:1902042;GO:0043124;GO:0060546;GO:0062099;GO:0036289;GO:0043065;GO:2001238;GO:1905206;GO:0043123;GO:0050729;GO:0070105;GO:0032757;GO:0046330;GO:0045651;GO:0060545;GO:0010940;GO:0051092;GO:1903800;GO:0043068;GO:0001934;GO:2000379;GO:0045944;GO:0032760;GO:0097300;GO:0046777;GO:0016579;GO:0070926;GO:1902041;GO:0060544;GO:0010803;GO:0034612;GO:0097343;GO:0070231;GO:0034138;GO:0035666;GO:0033209;, C:cytosol; C:death-inducing signaling complex; C:endosome membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:ripoptosome;, F:ATP binding; F:death domain binding; F:death receptor binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:amyloid fibril formation; P:apoptotic process; P:apoptotic signaling pathway; P:cell death; P:cellular protein catabolic process; P:cellular response to hydrogen peroxide; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:modulation by virus of host cellular process; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of programmed necrotic cell death; P:peptidyl-serine autophosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of hydrogen peroxide-induced cell death; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage differentiation; P:positive regulation of necroptotic process; P:positive regulation of necrotic cell death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed cell death; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:programmed necrotic cell death; P:protein autophosphorylation; P:protein deubiquitination; P:regulation of ATP:ADP antiporter activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to tumor necrosis factor; P:ripoptosome assembly; P:T cell apoptotic process; P:toll-like receptor 3 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33,Receptor-interacting serine/threonine-protein kinase 1,Cell death protein RIP {ECO:0000303|PubMed:8612133};Receptor-interacting protein 1 {ECO:0000303|PubMed:16603398};, PF00531;PF07714;PF12721;, GO:0005829;GO:0031264;GO:0010008;GO:0045121;GO:0005739;GO:0005886;GO:0032991;GO:0043235;GO:0097342;GO:0005524;GO:0070513;GO:0005123;GO:0042802;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031625;GO:0006919;GO:0007257;GO:1990000;GO:0006915;GO:0097190;GO:0008219;GO:0044257;GO:0070301;GO:0071356;GO:0071550;GO:0097191;GO:0007249;GO:0006954;GO:0019054;GO:0002756;GO:0070266;GO:0097527;GO:0043066;GO:2001237;GO:1902042;GO:0043124;GO:0060546;GO:0062099;GO:0036289;GO:0043065;GO:2001238;GO:1905206;GO:0043123;GO:0050729;GO:0070105;GO:0032757;GO:0046330;GO:0045651;GO:0060545;GO:0010940;GO:0051092;GO:1903800;GO:0043068;GO:0001934;GO:2000379;GO:0045944;GO:0032760;GO:0097300;GO:0046777;GO:0016579;GO:0070926;GO:1902041;GO:0060544;GO:0010803;GO:0034612;GO:0097343;GO:0070231;GO:0034138;GO:0035666;GO:0033209;, C:cytosol; C:death-inducing signaling complex; C:endosome membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:ripoptosome;, F:ATP binding; F:death domain binding; F:death receptor binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:amyloid fibril formation; P:apoptotic process; P:apoptotic signaling pathway; P:cell death; P:cellular protein catabolic process; P:cellular response to hydrogen peroxide; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:modulation by virus of host cellular process; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of programmed necrotic cell death; P:peptidyl-serine autophosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of hydrogen peroxide-induced cell death; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage differentiation; P:positive regulation of necroptotic process; P:positive regulation of necrotic cell death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed cell death; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:programmed necrotic cell death; P:protein autophosphorylation; P:protein deubiquitination; P:regulation of ATP:ADP antiporter activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to tumor necrosis factor; P:ripoptosome assembly; P:T cell apoptotic process; P:toll-like receptor 3 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33,Receptor-interacting serine/threonine-protein kinase 1,Cell death protein RIP {ECO:0000303|PubMed:8612133};Receptor-interacting protein 1 {ECO:0000303|PubMed:16603398};, PF00531;PF07714;PF12721;, GO:0005829;GO:0031264;GO:0010008;GO:0045121;GO:0005739;GO:0005886;GO:0032991;GO:0043235;GO:0097342;GO:0005524;GO:0070513;GO:0005123;GO:0042802;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031625;GO:0006919;GO:0007257;GO:1990000;GO:0006915;GO:0097190;GO:0008219;GO:0044257;GO:0070301;GO:0071356;GO:0071550;GO:0097191;GO:0007249;GO:0006954;GO:0019054;GO:0002756;GO:0070266;GO:0097527;GO:0043066;GO:2001237;GO:1902042;GO:0043124;GO:0060546;GO:0062099;GO:0036289;GO:0043065;GO:2001238;GO:1905206;GO:0043123;GO:0050729;GO:0070105;GO:0032757;GO:0046330;GO:0045651;GO:0060545;GO:0010940;GO:0051092;GO:1903800;GO:0043068;GO:0001934;GO:2000379;GO:0045944;GO:0032760;GO:0097300;GO:0046777;GO:0016579;GO:0070926;GO:1902041;GO:0060544;GO:0010803;GO:0034612;GO:0097343;GO:0070231;GO:0034138;GO:0035666;GO:0033209;, C:cytosol; C:death-inducing signaling complex; C:endosome membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:ripoptosome;, F:ATP binding; F:death domain binding; F:death receptor binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:amyloid fibril formation; P:apoptotic process; P:apoptotic signaling pathway; P:cell death; P:cellular protein catabolic process; P:cellular response to hydrogen peroxide; P:cellular response to tumor necrosis factor; P:death-inducing signaling complex assembly; P:extrinsic apoptotic signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:modulation by virus of host cellular process; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of programmed necrotic cell death; P:peptidyl-serine autophosphorylation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of hydrogen peroxide-induced cell death; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of macrophage differentiation; P:positive regulation of necroptotic process; P:positive regulation of necrotic cell death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed cell death; P:positive regulation of protein phosphorylation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:programmed necrotic cell death; P:protein autophosphorylation; P:protein deubiquitination; P:regulation of ATP:ADP antiporter activity; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to tumor necrosis factor; P:ripoptosome assembly; P:T cell apoptotic process; P:toll-like receptor 3 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; scaffold39 indexed_genome mRNA 994211 1014000 . - . ID=transcript_8014;Q86WA6 Q00306 Q13855 Q3KP51,Valacyclovir hydrolase,Biphenyl hydrolase-like protein;Biphenyl hydrolase-related protein;Breast epithelial mucin-associated antigen;, PF00561;, GO:0005741;GO:0005739;GO:0016787;GO:0006520;GO:0009636;GO:0006805;, C:mitochondrial outer membrane; C:mitochondrion;, F:hydrolase activity;, P:cellular amino acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q86WA6 Q00306 Q13855 Q3KP51,Valacyclovir hydrolase,Biphenyl hydrolase-like protein;Biphenyl hydrolase-related protein;Breast epithelial mucin-associated antigen;, PF00561;, GO:0005741;GO:0005739;GO:0016787;GO:0006520;GO:0009636;GO:0006805;, C:mitochondrial outer membrane; C:mitochondrion;, F:hydrolase activity;, P:cellular amino acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q86WA6 Q00306 Q13855 Q3KP51,Valacyclovir hydrolase,Biphenyl hydrolase-like protein;Biphenyl hydrolase-related protein;Breast epithelial mucin-associated antigen;, PF00561;, GO:0005741;GO:0005739;GO:0016787;GO:0006520;GO:0009636;GO:0006805;, C:mitochondrial outer membrane; C:mitochondrion;, F:hydrolase activity;, P:cellular amino acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q86WA6 Q00306 Q13855 Q3KP51,Valacyclovir hydrolase,Biphenyl hydrolase-like protein;Biphenyl hydrolase-related protein;Breast epithelial mucin-associated antigen;, PF00561;, GO:0005741;GO:0005739;GO:0016787;GO:0006520;GO:0009636;GO:0006805;, C:mitochondrial outer membrane; C:mitochondrion;, F:hydrolase activity;, P:cellular amino acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q86WA6 Q00306 Q13855 Q3KP51,Valacyclovir hydrolase,Biphenyl hydrolase-like protein;Biphenyl hydrolase-related protein;Breast epithelial mucin-associated antigen;, PF00561;, GO:0005741;GO:0005739;GO:0016787;GO:0006520;GO:0009636;GO:0006805;, C:mitochondrial outer membrane; C:mitochondrion;, F:hydrolase activity;, P:cellular amino acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q86WA6 Q00306 Q13855 Q3KP51,Valacyclovir hydrolase,Biphenyl hydrolase-like protein;Biphenyl hydrolase-related protein;Breast epithelial mucin-associated antigen;, PF00561;, GO:0005741;GO:0005739;GO:0016787;GO:0006520;GO:0009636;GO:0006805;, C:mitochondrial outer membrane; C:mitochondrion;, F:hydrolase activity;, P:cellular amino acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process; scaffold39 indexed_genome mRNA 1079252 1179421 . - . ID=transcript_8015;A1A5C7 A1A5C8 Q5T8B8 Q6ZMH3 Q8IW73,Solute carrier family 22 member 23,, PF00083;, GO:0016021;GO:0022857;GO:0006811;, C:integral component of membrane;, F:transmembrane transporter activity;, P:ion transport; scaffold39 indexed_genome mRNA 1316866 1321756 . - . ID=transcript_8016;Q5TGL8 A8K0N3 Q6PGP0 Q86XB7,PX domain-containing protein 1,, , GO:0035091;, , F:phosphatidylinositol binding;|Q5TGL8 A8K0N3 Q6PGP0 Q86XB7,PX domain-containing protein 1,, , GO:0035091;, , F:phosphatidylinositol binding; scaffold39 indexed_genome mRNA 1322193 1322839 . - . ID=transcript_8017;Q5TGL8 A8K0N3 Q6PGP0 Q86XB7,PX domain-containing protein 1,, , GO:0035091;, , F:phosphatidylinositol binding; scaffold39 indexed_genome mRNA 1429727 1507886 . + . ID=transcript_8018;Q9UN55,Enoyl-CoA delta isomerase 2 {ECO:0000305},DRS-1;Delta(3),delta(2)-enoyl-CoA isomerase;Diazepam-binding inhibitor-related protein 1;Dodecenoyl-CoA isomerase;Hepatocellular carcinoma-associated antigen 88;Peroxisomal 3,2-trans-enoyl-CoA isomerase;Renal carcinoma antigen NY-REN-1;, PF00887;PF00378;, GO:0005829;GO:0043231;GO:0016020;GO:0005739;GO:0005782;GO:0005777;GO:0004165;GO:0000062;GO:0006635;GO:0033540;GO:0009062;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:dodecenoyl-CoA delta-isomerase activity; F:fatty-acyl-CoA binding;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:protein localization;|Q13523 A8K5C9 Q5D0F6 Q5TAY8 Q8IVC3 Q8TDP2 Q96QT7 Q9UEE6,Serine/threonine-protein kinase PRP4 homolog,PRP4 kinase;PRP4 pre-mRNA-processing factor 4 homolog;, PF00069;, GO:0071013;GO:0005694;GO:0016607;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0003723;GO:0045292;GO:0000398;GO:0006468;GO:0008380;, C:catalytic step 2 spliceosome; C:chromosome; C:nuclear speck; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:protein phosphorylation; P:RNA splicing;|Q13523 A8K5C9 Q5D0F6 Q5TAY8 Q8IVC3 Q8TDP2 Q96QT7 Q9UEE6,Serine/threonine-protein kinase PRP4 homolog,PRP4 kinase;PRP4 pre-mRNA-processing factor 4 homolog;, PF00069;, GO:0071013;GO:0005694;GO:0016607;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0003723;GO:0045292;GO:0000398;GO:0006468;GO:0008380;, C:catalytic step 2 spliceosome; C:chromosome; C:nuclear speck; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:protein phosphorylation; P:RNA splicing;|Q13523 A8K5C9 Q5D0F6 Q5TAY8 Q8IVC3 Q8TDP2 Q96QT7 Q9UEE6,Serine/threonine-protein kinase PRP4 homolog,PRP4 kinase;PRP4 pre-mRNA-processing factor 4 homolog;, PF00069;, GO:0071013;GO:0005694;GO:0016607;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0003723;GO:0045292;GO:0000398;GO:0006468;GO:0008380;, C:catalytic step 2 spliceosome; C:chromosome; C:nuclear speck; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:protein phosphorylation; P:RNA splicing;|Q13523 A8K5C9 Q5D0F6 Q5TAY8 Q8IVC3 Q8TDP2 Q96QT7 Q9UEE6,Serine/threonine-protein kinase PRP4 homolog,PRP4 kinase;PRP4 pre-mRNA-processing factor 4 homolog;, PF00069;, GO:0071013;GO:0005694;GO:0016607;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0003723;GO:0045292;GO:0000398;GO:0006468;GO:0008380;, C:catalytic step 2 spliceosome; C:chromosome; C:nuclear speck; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:protein phosphorylation; P:RNA splicing;|Q13523 A8K5C9 Q5D0F6 Q5TAY8 Q8IVC3 Q8TDP2 Q96QT7 Q9UEE6,Serine/threonine-protein kinase PRP4 homolog,PRP4 kinase;PRP4 pre-mRNA-processing factor 4 homolog;, PF00069;, GO:0071013;GO:0005694;GO:0016607;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0003723;GO:0045292;GO:0000398;GO:0006468;GO:0008380;, C:catalytic step 2 spliceosome; C:chromosome; C:nuclear speck; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:protein phosphorylation; P:RNA splicing;|Q13523 A8K5C9 Q5D0F6 Q5TAY8 Q8IVC3 Q8TDP2 Q96QT7 Q9UEE6,Serine/threonine-protein kinase PRP4 homolog,PRP4 kinase;PRP4 pre-mRNA-processing factor 4 homolog;, PF00069;, GO:0071013;GO:0005694;GO:0016607;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0003723;GO:0045292;GO:0000398;GO:0006468;GO:0008380;, C:catalytic step 2 spliceosome; C:chromosome; C:nuclear speck; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:protein phosphorylation; P:RNA splicing;|Q8IXS0 Q5JYK1,Protein FAM217A,, PF15344;|Q8IXS0 Q5JYK1,Protein FAM217A,, PF15344;|Q8IXS0 Q5JYK1,Protein FAM217A,, PF15344;|Q9UN55,Enoyl-CoA delta isomerase 2 {ECO:0000305},DRS-1;Delta(3),delta(2)-enoyl-CoA isomerase;Diazepam-binding inhibitor-related protein 1;Dodecenoyl-CoA isomerase;Hepatocellular carcinoma-associated antigen 88;Peroxisomal 3,2-trans-enoyl-CoA isomerase;Renal carcinoma antigen NY-REN-1;, PF00887;PF00378;, GO:0005829;GO:0043231;GO:0016020;GO:0005739;GO:0005782;GO:0005777;GO:0004165;GO:0000062;GO:0006635;GO:0033540;GO:0009062;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:dodecenoyl-CoA delta-isomerase activity; F:fatty-acyl-CoA binding;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:protein localization;|Q9UN55,Enoyl-CoA delta isomerase 2 {ECO:0000305},DRS-1;Delta(3),delta(2)-enoyl-CoA isomerase;Diazepam-binding inhibitor-related protein 1;Dodecenoyl-CoA isomerase;Hepatocellular carcinoma-associated antigen 88;Peroxisomal 3,2-trans-enoyl-CoA isomerase;Renal carcinoma antigen NY-REN-1;, PF00887;PF00378;, GO:0005829;GO:0043231;GO:0016020;GO:0005739;GO:0005782;GO:0005777;GO:0004165;GO:0000062;GO:0006635;GO:0033540;GO:0009062;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:dodecenoyl-CoA delta-isomerase activity; F:fatty-acyl-CoA binding;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:protein localization;|Q9UN55,Enoyl-CoA delta isomerase 2 {ECO:0000305},DRS-1;Delta(3),delta(2)-enoyl-CoA isomerase;Diazepam-binding inhibitor-related protein 1;Dodecenoyl-CoA isomerase;Hepatocellular carcinoma-associated antigen 88;Peroxisomal 3,2-trans-enoyl-CoA isomerase;Renal carcinoma antigen NY-REN-1;, PF00887;PF00378;, GO:0005829;GO:0043231;GO:0016020;GO:0005739;GO:0005782;GO:0005777;GO:0004165;GO:0000062;GO:0006635;GO:0033540;GO:0009062;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:dodecenoyl-CoA delta-isomerase activity; F:fatty-acyl-CoA binding;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:protein localization;|Q9UN55,Enoyl-CoA delta isomerase 2 {ECO:0000305},DRS-1;Delta(3),delta(2)-enoyl-CoA isomerase;Diazepam-binding inhibitor-related protein 1;Dodecenoyl-CoA isomerase;Hepatocellular carcinoma-associated antigen 88;Peroxisomal 3,2-trans-enoyl-CoA isomerase;Renal carcinoma antigen NY-REN-1;, PF00887;PF00378;, GO:0005829;GO:0043231;GO:0016020;GO:0005739;GO:0005782;GO:0005777;GO:0004165;GO:0000062;GO:0006635;GO:0033540;GO:0009062;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:dodecenoyl-CoA delta-isomerase activity; F:fatty-acyl-CoA binding;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:protein localization;|Q9UN55,Enoyl-CoA delta isomerase 2 {ECO:0000305},DRS-1;Delta(3),delta(2)-enoyl-CoA isomerase;Diazepam-binding inhibitor-related protein 1;Dodecenoyl-CoA isomerase;Hepatocellular carcinoma-associated antigen 88;Peroxisomal 3,2-trans-enoyl-CoA isomerase;Renal carcinoma antigen NY-REN-1;, PF00887;PF00378;, GO:0005829;GO:0043231;GO:0016020;GO:0005739;GO:0005782;GO:0005777;GO:0004165;GO:0000062;GO:0006635;GO:0033540;GO:0009062;GO:0008104;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:dodecenoyl-CoA delta-isomerase activity; F:fatty-acyl-CoA binding;, P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:protein localization; scaffold39 indexed_genome mRNA 1523737 1524592 . - . ID=transcript_8019;P63128 Q9UKH4,Endogenous retrovirus group K member 9 Pol protein,HERV-K(C6) Gag-Pol protein;HERV-K109 Gag-Pol protein;HERV-K_6q14.1 provirus ancestral Gag-Pol polyprotein;, PF00692;PF01585;PF02337;PF00607;PF00077;PF00078;PF00098;, GO:0005886;GO:0004190;GO:0003887;GO:0003723;GO:0003964;GO:0004523;GO:0005198;GO:0008270;GO:0016032;, C:plasma membrane;, F:aspartic-type endopeptidase activity; F:DNA-directed DNA polymerase activity; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:structural molecule activity; F:zinc ion binding;, P:viral process; scaffold39 indexed_genome mRNA 1919470 1953130 . + . ID=transcript_8020;Q9Y232 A8K6D6 B4DLG4 Q0VDG7 Q32NC5 Q5VX99 Q6P7T5 Q9BWZ2 Q9Y424,Chromodomain Y-like protein {ECO:0000303|PubMed:10192397},Crotonyl-CoA hydratase {ECO:0000303|PubMed:28803779};, PF00385;PF00378;, GO:0005694;GO:0005737;GO:0016607;GO:0005634;GO:0003682;GO:0120092;GO:0042802;GO:0035064;GO:0030674;GO:0003714;GO:0120094;GO:0060816;GO:0007286;GO:0007283;, C:chromosome; C:cytoplasm; C:nuclear speck; C:nucleus;, F:chromatin binding; F:crotonyl-CoA hydratase activity; F:identical protein binding; F:methylated histone binding; F:protein-macromolecule adaptor activity; F:transcription corepressor activity;, P:negative regulation of peptidyl-lysine crotonylation; P:random inactivation of X chromosome; P:spermatid development; P:spermatogenesis;|Q9Y232 A8K6D6 B4DLG4 Q0VDG7 Q32NC5 Q5VX99 Q6P7T5 Q9BWZ2 Q9Y424,Chromodomain Y-like protein {ECO:0000303|PubMed:10192397},Crotonyl-CoA hydratase {ECO:0000303|PubMed:28803779};, PF00385;PF00378;, GO:0005694;GO:0005737;GO:0016607;GO:0005634;GO:0003682;GO:0120092;GO:0042802;GO:0035064;GO:0030674;GO:0003714;GO:0120094;GO:0060816;GO:0007286;GO:0007283;, C:chromosome; C:cytoplasm; C:nuclear speck; C:nucleus;, F:chromatin binding; F:crotonyl-CoA hydratase activity; F:identical protein binding; F:methylated histone binding; F:protein-macromolecule adaptor activity; F:transcription corepressor activity;, P:negative regulation of peptidyl-lysine crotonylation; P:random inactivation of X chromosome; P:spermatid development; P:spermatogenesis;|Q9Y232 A8K6D6 B4DLG4 Q0VDG7 Q32NC5 Q5VX99 Q6P7T5 Q9BWZ2 Q9Y424,Chromodomain Y-like protein {ECO:0000303|PubMed:10192397},Crotonyl-CoA hydratase {ECO:0000303|PubMed:28803779};, PF00385;PF00378;, GO:0005694;GO:0005737;GO:0016607;GO:0005634;GO:0003682;GO:0120092;GO:0042802;GO:0035064;GO:0030674;GO:0003714;GO:0120094;GO:0060816;GO:0007286;GO:0007283;, C:chromosome; C:cytoplasm; C:nuclear speck; C:nucleus;, F:chromatin binding; F:crotonyl-CoA hydratase activity; F:identical protein binding; F:methylated histone binding; F:protein-macromolecule adaptor activity; F:transcription corepressor activity;, P:negative regulation of peptidyl-lysine crotonylation; P:random inactivation of X chromosome; P:spermatid development; P:spermatogenesis; scaffold39 indexed_genome mRNA 1977024 1991144 . - . ID=transcript_8021;O75818 Q5VX97 Q8WVK8,Ribonuclease P protein subunit p40,RNase P subunit 1;, PF08584;, GO:0030681;GO:0005655;GO:0005654;GO:0005634;GO:0000172;GO:0004526;GO:0033204;GO:0000447;GO:1905267;GO:0001682;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleoplasm; C:nucleus; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding;, P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage involved in tRNA processing; P:tRNA 5'-leader removal;|O75818 Q5VX97 Q8WVK8,Ribonuclease P protein subunit p40,RNase P subunit 1;, PF08584;, GO:0030681;GO:0005655;GO:0005654;GO:0005634;GO:0000172;GO:0004526;GO:0033204;GO:0000447;GO:1905267;GO:0001682;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleoplasm; C:nucleus; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding;, P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage involved in tRNA processing; P:tRNA 5'-leader removal;|O75818 Q5VX97 Q8WVK8,Ribonuclease P protein subunit p40,RNase P subunit 1;, PF08584;, GO:0030681;GO:0005655;GO:0005654;GO:0005634;GO:0000172;GO:0004526;GO:0033204;GO:0000447;GO:1905267;GO:0001682;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleoplasm; C:nucleus; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding;, P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage involved in tRNA processing; P:tRNA 5'-leader removal; scaffold39 indexed_genome mRNA 2026223 2026939 . + . ID=transcript_8022;Q9HD34 A8K543 Q5XKP1,LYR motif-containing protein 4,, PF05347;, GO:1990221;GO:0005759;GO:0005739;GO:0016604;GO:0016226;, C:L-cysteine desulfurase complex; C:mitochondrial matrix; C:mitochondrion; C:nuclear body;, , P:iron-sulfur cluster assembly; scaffold39 indexed_genome mRNA 2165195 2400977 . + . ID=transcript_8023;O95363 B2R664 Q53F66 Q5TCS3 Q6FG29 Q9NPY7 Q9P062,Phenylalanine--tRNA ligase, mitochondrial,Phenylalanyl-tRNA synthetase;, PF03147;PF01409;, GO:0005737;GO:0005759;GO:0005739;GO:0005524;GO:0004826;GO:0000049;GO:0006432;GO:0006418;GO:0008033;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:phenylalanine-tRNA ligase activity; F:tRNA binding;, P:phenylalanyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; P:tRNA processing; scaffold39 indexed_genome mRNA 2515982 2523812 . - . ID=transcript_8024;Q9NPD7 B2RA93 Q7Z4Y1,Neuritin,, PF15056;, GO:0031225;GO:0005576;GO:0005886;GO:0045202;GO:0007399;, C:anchored component of membrane; C:extracellular region; C:plasma membrane; C:synapse;, , P:nervous system development;|Q9NPD7 B2RA93 Q7Z4Y1,Neuritin,, PF15056;, GO:0031225;GO:0005576;GO:0005886;GO:0045202;GO:0007399;, C:anchored component of membrane; C:extracellular region; C:plasma membrane; C:synapse;, , P:nervous system development;|Q9NPD7 B2RA93 Q7Z4Y1,Neuritin,, PF15056;, GO:0031225;GO:0005576;GO:0005886;GO:0045202;GO:0007399;, C:anchored component of membrane; C:extracellular region; C:plasma membrane; C:synapse;, , P:nervous system development; scaffold39 indexed_genome mRNA 2589939 2728134 . - . ID=transcript_8025;P00488 Q59HA7 Q8N6X2 Q96P24 Q9BX29,Coagulation factor XIII A chain,Protein-glutamine gamma-glutamyltransferase A chain;Transglutaminase A chain;, PF00927;PF01841;PF00868;, GO:0072562;GO:0062023;GO:0005576;GO:0031093;GO:0046872;GO:0003810;GO:0007596;GO:0072378;GO:0019221;GO:0018149;GO:0002576;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular region; C:platelet alpha granule lumen;, F:metal ion binding; F:protein-glutamine gamma-glutamyltransferase activity;, P:blood coagulation; P:blood coagulation, fibrin clot formation; P:cytokine-mediated signaling pathway; P:peptide cross-linking; P:platelet degranulation; scaffold39 indexed_genome mRNA 2928253 2967094 . + . ID=transcript_8026;O95711 Q9UQC4,Lymphocyte antigen 86,Protein MD-1;, , GO:0005615;GO:0006954;GO:0045087;GO:0031666;, C:extracellular space;, , P:inflammatory response; P:innate immune response; P:positive regulation of lipopolysaccharide-mediated signaling pathway; scaffold39 indexed_genome mRNA 3386917 3430882 . + . ID=transcript_8027;Q6BEP8 Q86SU2 Q9Y474,Ras-responsive element-binding protein 1,Finger protein in nuclear bodies;Raf-responsive zinc finger protein LZ321;Zinc finger motif enhancer-binding protein 1;, PF00096;, GO:0005737;GO:0070062;GO:0001650;GO:0016604;GO:0016607;GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0000977;GO:0007275;GO:0000122;GO:0090336;GO:0010634;GO:2000394;GO:0033601;GO:1900026;GO:0045944;GO:0045893;GO:1903691;GO:0007265;GO:0006357;GO:0006355;GO:0006366;, C:cytoplasm; C:extracellular exosome; C:fibrillar center; C:nuclear body; C:nuclear speck; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of brown fat cell differentiation; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of mammary gland epithelial cell proliferation; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of wound healing, spreading of epidermal cells; P:Ras protein signal transduction; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 3436425 3446701 . + . ID=transcript_8028;Q6BEP8 Q86SU2 Q9Y474,Ras-responsive element-binding protein 1,Finger protein in nuclear bodies;Raf-responsive zinc finger protein LZ321;Zinc finger motif enhancer-binding protein 1;, PF00096;, GO:0005737;GO:0070062;GO:0001650;GO:0016604;GO:0016607;GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0000977;GO:0007275;GO:0000122;GO:0090336;GO:0010634;GO:2000394;GO:0033601;GO:1900026;GO:0045944;GO:0045893;GO:1903691;GO:0007265;GO:0006357;GO:0006355;GO:0006366;, C:cytoplasm; C:extracellular exosome; C:fibrillar center; C:nuclear body; C:nuclear speck; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of brown fat cell differentiation; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of mammary gland epithelial cell proliferation; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of wound healing, spreading of epidermal cells; P:Ras protein signal transduction; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 3478907 3498738 . - . ID=transcript_8029;Q9UN49,Translocon-associated protein subunit alpha,Signal sequence receptor subunit alpha;, PF03896;, GO:0005783;GO:0005789;GO:0016021;GO:0006613;GO:0036498;GO:0008284;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:cotranslational protein targeting to membrane; P:IRE1-mediated unfolded protein response; P:positive regulation of cell population proliferation;|Q9UN49,Translocon-associated protein subunit alpha,Signal sequence receptor subunit alpha;, PF03896;, GO:0005783;GO:0005789;GO:0016021;GO:0006613;GO:0036498;GO:0008284;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:cotranslational protein targeting to membrane; P:IRE1-mediated unfolded protein response; P:positive regulation of cell population proliferation;|Q9UN49,Translocon-associated protein subunit alpha,Signal sequence receptor subunit alpha;, PF03896;, GO:0005783;GO:0005789;GO:0016021;GO:0006613;GO:0036498;GO:0008284;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:cotranslational protein targeting to membrane; P:IRE1-mediated unfolded protein response; P:positive regulation of cell population proliferation; scaffold39 indexed_genome mRNA 3525833 3527788 . - . ID=transcript_8030;Q8TC20 D6RCT9 Q5TAM0 Q86TM4 Q8N7R5,Cancer-associated gene 1 protein,Cancer/testis antigen 3;, PF15066; scaffold39 indexed_genome mRNA 3539110 3543959 . - . ID=transcript_8031;Q8TC20 D6RCT9 Q5TAM0 Q86TM4 Q8N7R5,Cancer-associated gene 1 protein,Cancer/testis antigen 3;, PF15066; scaffold39 indexed_genome mRNA 3544365 3567218 . + . ID=transcript_8032;Q9BRS2 B2RB28 Q8NDC8 Q96NV9,Serine/threonine-protein kinase RIO1,RIO kinase 1;, , GO:0005829;GO:0034708;GO:0005654;GO:0030688;GO:0005524;GO:0016787;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030490;GO:2000234;GO:0042274;, C:cytosol; C:methyltransferase complex; C:nucleoplasm; C:preribosome, small subunit precursor;, F:ATP binding; F:hydrolase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:maturation of SSU-rRNA; P:positive regulation of rRNA processing; P:ribosomal small subunit biogenesis;|Q9BRS2 B2RB28 Q8NDC8 Q96NV9,Serine/threonine-protein kinase RIO1,RIO kinase 1;, , GO:0005829;GO:0034708;GO:0005654;GO:0030688;GO:0005524;GO:0016787;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030490;GO:2000234;GO:0042274;, C:cytosol; C:methyltransferase complex; C:nucleoplasm; C:preribosome, small subunit precursor;, F:ATP binding; F:hydrolase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:maturation of SSU-rRNA; P:positive regulation of rRNA processing; P:ribosomal small subunit biogenesis;|Q9BRS2 B2RB28 Q8NDC8 Q96NV9,Serine/threonine-protein kinase RIO1,RIO kinase 1;, , GO:0005829;GO:0034708;GO:0005654;GO:0030688;GO:0005524;GO:0016787;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030490;GO:2000234;GO:0042274;, C:cytosol; C:methyltransferase complex; C:nucleoplasm; C:preribosome, small subunit precursor;, F:ATP binding; F:hydrolase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:maturation of SSU-rRNA; P:positive regulation of rRNA processing; P:ribosomal small subunit biogenesis; scaffold39 indexed_genome mRNA 3630506 3674681 . + . ID=transcript_8033;P15924 B2RTT2 D7RX09 O75993 Q14189 Q9UHN4,Desmoplakin,250/210 kDa paraneoplastic pemphigus antigen;, PF00681;PF17902;PF18373;, GO:0016323;GO:0001533;GO:0005737;GO:0030057;GO:0070062;GO:0005916;GO:0101003;GO:0014704;GO:0005882;GO:0016020;GO:0005634;GO:0005886;GO:0086083;GO:0005080;GO:0003723;GO:0097110;GO:0005200;GO:0005198;GO:0034332;GO:0086073;GO:0098609;GO:0070268;GO:0002934;GO:0008544;GO:0090136;GO:0045104;GO:0045109;GO:0031424;GO:0030216;GO:0043312;GO:0018149;GO:0150105;GO:0086091;GO:0098911;GO:0043588;GO:0003223;GO:0042060;, C:basolateral plasma membrane; C:cornified envelope; C:cytoplasm; C:desmosome; C:extracellular exosome; C:fascia adherens; C:ficolin-1-rich granule membrane; C:intercalated disc; C:intermediate filament; C:membrane; C:nucleus; C:plasma membrane;, F:cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication; F:protein kinase C binding; F:RNA binding; F:scaffold protein binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:adherens junction organization; P:bundle of His cell-Purkinje myocyte adhesion involved in cell communication; P:cell-cell adhesion; P:cornification; P:desmosome organization; P:epidermis development; P:epithelial cell-cell adhesion; P:intermediate filament cytoskeleton organization; P:intermediate filament organization; P:keratinization; P:keratinocyte differentiation; P:neutrophil degranulation; P:peptide cross-linking; P:protein localization to cell-cell junction; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell action potential; P:skin development; P:ventricular compact myocardium morphogenesis; P:wound healing; scaffold39 indexed_genome mRNA 3678173 3697809 . + . ID=transcript_8034;Q6IEG0 A8K8P4 Q14C91 Q5T339 Q5THM1 Q5THM2 Q96MK1,U11/U12 small nuclear ribonucleoprotein 48 kDa protein,, PF05253;, GO:0005829;GO:0005654;GO:0005689;GO:0046872;GO:0000398;GO:0008380;, C:cytosol; C:nucleoplasm; C:U12-type spliceosomal complex;, F:metal ion binding;, P:mRNA splicing, via spliceosome; P:RNA splicing;|Q6IEG0 A8K8P4 Q14C91 Q5T339 Q5THM1 Q5THM2 Q96MK1,U11/U12 small nuclear ribonucleoprotein 48 kDa protein,, PF05253;, GO:0005829;GO:0005654;GO:0005689;GO:0046872;GO:0000398;GO:0008380;, C:cytosol; C:nucleoplasm; C:U12-type spliceosomal complex;, F:metal ion binding;, P:mRNA splicing, via spliceosome; P:RNA splicing;|Q6IEG0 A8K8P4 Q14C91 Q5T339 Q5THM1 Q5THM2 Q96MK1,U11/U12 small nuclear ribonucleoprotein 48 kDa protein,, PF05253;, GO:0005829;GO:0005654;GO:0005689;GO:0046872;GO:0000398;GO:0008380;, C:cytosol; C:nucleoplasm; C:U12-type spliceosomal complex;, F:metal ion binding;, P:mRNA splicing, via spliceosome; P:RNA splicing;|Q6IEG0 A8K8P4 Q14C91 Q5T339 Q5THM1 Q5THM2 Q96MK1,U11/U12 small nuclear ribonucleoprotein 48 kDa protein,, PF05253;, GO:0005829;GO:0005654;GO:0005689;GO:0046872;GO:0000398;GO:0008380;, C:cytosol; C:nucleoplasm; C:U12-type spliceosomal complex;, F:metal ion binding;, P:mRNA splicing, via spliceosome; P:RNA splicing;|Q6IEG0 A8K8P4 Q14C91 Q5T339 Q5THM1 Q5THM2 Q96MK1,U11/U12 small nuclear ribonucleoprotein 48 kDa protein,, PF05253;, GO:0005829;GO:0005654;GO:0005689;GO:0046872;GO:0000398;GO:0008380;, C:cytosol; C:nucleoplasm; C:U12-type spliceosomal complex;, F:metal ion binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; scaffold39 indexed_genome mRNA 3969886 3991978 . - . ID=transcript_8035;Q8NBS9 B2RDM2 Q5TCQ0 Q8ND33 Q8TCT2 Q9BVH9,Thioredoxin domain-containing protein 5,Endoplasmic reticulum resident protein 46;Thioredoxin-like protein p46;, PF00085;, GO:0035578;GO:0005783;GO:0005788;GO:0070062;GO:0005576;GO:0043202;GO:0003756;GO:0043277;GO:0043066;GO:0043312;GO:0006892;, C:azurophil granule lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:lysosomal lumen;, F:protein disulfide isomerase activity;, P:apoptotic cell clearance; P:negative regulation of apoptotic process; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport;|Q8NBS9 B2RDM2 Q5TCQ0 Q8ND33 Q8TCT2 Q9BVH9,Thioredoxin domain-containing protein 5,Endoplasmic reticulum resident protein 46;Thioredoxin-like protein p46;, PF00085;, GO:0035578;GO:0005783;GO:0005788;GO:0070062;GO:0005576;GO:0043202;GO:0003756;GO:0043277;GO:0043066;GO:0043312;GO:0006892;, C:azurophil granule lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:lysosomal lumen;, F:protein disulfide isomerase activity;, P:apoptotic cell clearance; P:negative regulation of apoptotic process; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; scaffold39 indexed_genome mRNA 4063566 4087651 . - . ID=transcript_8036;Q8TDH9 B4DVM2 Q0VDJ6 Q0VDJ7 Q5THS1 Q68D56 Q8N5F9 Q9NU16,Biogenesis of lysosome-related organelles complex 1 subunit 5,Protein Muted homolog;, PF14942;, GO:1904115;GO:0031083;GO:0030133;GO:0008089;GO:0048490;GO:0035646;GO:0032438;GO:0032402;GO:0031175;GO:0050942;, C:axon cytoplasm; C:BLOC-1 complex; C:transport vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endosome to melanosome transport; P:melanosome organization; P:melanosome transport; P:neuron projection development; P:positive regulation of pigment cell differentiation; scaffold39 indexed_genome mRNA 4097134 4098326 . + . ID=transcript_8037;O43324 C9JLK5 Q5THS2,Eukaryotic translation elongation factor 1 epsilon-1,Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3;Elongation factor p18;Multisynthase complex auxiliary component p18 {ECO:0000303|PubMed:19131329};, PF00043;, GO:0017101;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0008285;GO:0043065;GO:2000774;GO:0043517;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:positive regulation of cellular senescence; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:tRNA aminoacylation for protein translation; scaffold39 indexed_genome mRNA 4099810 4112639 . - . ID=transcript_8038;O43324 C9JLK5 Q5THS2,Eukaryotic translation elongation factor 1 epsilon-1,Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3;Elongation factor p18;Multisynthase complex auxiliary component p18 {ECO:0000303|PubMed:19131329};, PF00043;, GO:0017101;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0008285;GO:0043065;GO:2000774;GO:0043517;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:positive regulation of cellular senescence; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:tRNA aminoacylation for protein translation; scaffold39 indexed_genome mRNA 4291513 4309044 . - . ID=transcript_8039;Q9H1N7 A6NKX9 Q1XH11 Q6MZJ0 Q7Z662 Q9Y308,Adenosine 3'-phospho 5'-phosphosulfate transporter 2,3'-phosphoadenosine 5'-phosphosulfate transporter;PAPS transporter 2;Solute carrier family 35 member B3;, PF08449;, GO:0000139;GO:0030176;GO:0030173;GO:0046964;GO:0022857;GO:0050428;, C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; F:transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;|Q9H1N7 A6NKX9 Q1XH11 Q6MZJ0 Q7Z662 Q9Y308,Adenosine 3'-phospho 5'-phosphosulfate transporter 2,3'-phosphoadenosine 5'-phosphosulfate transporter;PAPS transporter 2;Solute carrier family 35 member B3;, PF08449;, GO:0000139;GO:0030176;GO:0030173;GO:0046964;GO:0022857;GO:0050428;, C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; F:transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;|Q9H1N7 A6NKX9 Q1XH11 Q6MZJ0 Q7Z662 Q9Y308,Adenosine 3'-phospho 5'-phosphosulfate transporter 2,3'-phosphoadenosine 5'-phosphosulfate transporter;PAPS transporter 2;Solute carrier family 35 member B3;, PF08449;, GO:0000139;GO:0030176;GO:0030173;GO:0046964;GO:0022857;GO:0050428;, C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; F:transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;|Q9H1N7 A6NKX9 Q1XH11 Q6MZJ0 Q7Z662 Q9Y308,Adenosine 3'-phospho 5'-phosphosulfate transporter 2,3'-phosphoadenosine 5'-phosphosulfate transporter;PAPS transporter 2;Solute carrier family 35 member B3;, PF08449;, GO:0000139;GO:0030176;GO:0030173;GO:0046964;GO:0022857;GO:0050428;, C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; F:transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;|Q9H1N7 A6NKX9 Q1XH11 Q6MZJ0 Q7Z662 Q9Y308,Adenosine 3'-phospho 5'-phosphosulfate transporter 2,3'-phosphoadenosine 5'-phosphosulfate transporter;PAPS transporter 2;Solute carrier family 35 member B3;, PF08449;, GO:0000139;GO:0030176;GO:0030173;GO:0046964;GO:0022857;GO:0050428;, C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; F:transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;|Q9H1N7 A6NKX9 Q1XH11 Q6MZJ0 Q7Z662 Q9Y308,Adenosine 3'-phospho 5'-phosphosulfate transporter 2,3'-phosphoadenosine 5'-phosphosulfate transporter;PAPS transporter 2;Solute carrier family 35 member B3;, PF08449;, GO:0000139;GO:0030176;GO:0030173;GO:0046964;GO:0022857;GO:0050428;, C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; F:transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;|Q9H1N7 A6NKX9 Q1XH11 Q6MZJ0 Q7Z662 Q9Y308,Adenosine 3'-phospho 5'-phosphosulfate transporter 2,3'-phosphoadenosine 5'-phosphosulfate transporter;PAPS transporter 2;Solute carrier family 35 member B3;, PF08449;, GO:0000139;GO:0030176;GO:0030173;GO:0046964;GO:0022857;GO:0050428;, C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; F:transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;|Q9H1N7 A6NKX9 Q1XH11 Q6MZJ0 Q7Z662 Q9Y308,Adenosine 3'-phospho 5'-phosphosulfate transporter 2,3'-phosphoadenosine 5'-phosphosulfate transporter;PAPS transporter 2;Solute carrier family 35 member B3;, PF08449;, GO:0000139;GO:0030176;GO:0030173;GO:0046964;GO:0022857;GO:0050428;, C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane;, F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; F:transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; scaffold39 indexed_genome mRNA 5775260 5781890 . - . ID=transcript_8040;P05549 Q13777 Q5TAV5 Q8N1C6,Transcription factor AP-2-alpha,AP-2 transcription factor;Activating enhancer-binding protein 2-alpha;Activator protein 2;, PF03299;, GO:0000785;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0000981;GO:0001227;GO:0042802;GO:0140536;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0000976;GO:0048856;GO:0060349;GO:0071281;GO:0048701;GO:0035115;GO:0061029;GO:0042472;GO:0001822;GO:0043066;GO:0008285;GO:2000378;GO:0010944;GO:0000122;GO:0045892;GO:0021623;GO:0003409;GO:0003404;GO:0030501;GO:0010628;GO:0043525;GO:0070172;GO:0045944;GO:0045893;GO:0045595;GO:0042127;GO:0006357;GO:0010842;GO:0060021;GO:0007605;GO:0021559;, C:chromatin; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:nuclear receptor corepressor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure development; P:bone morphogenesis; P:cellular response to iron ion; P:embryonic cranial skeleton morphogenesis; P:embryonic forelimb morphogenesis; P:eyelid development in camera-type eye; P:inner ear morphogenesis; P:kidney development; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:oculomotor nerve formation; P:optic cup structural organization; P:optic vesicle morphogenesis; P:positive regulation of bone mineralization; P:positive regulation of gene expression; P:positive regulation of neuron apoptotic process; P:positive regulation of tooth mineralization; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:retina layer formation; P:roof of mouth development; P:sensory perception of sound; P:trigeminal nerve development; scaffold39 indexed_genome mRNA 5783540 5788780 . - . ID=transcript_8041;P05549 Q13777 Q5TAV5 Q8N1C6,Transcription factor AP-2-alpha,AP-2 transcription factor;Activating enhancer-binding protein 2-alpha;Activator protein 2;, PF03299;, GO:0000785;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0000981;GO:0001227;GO:0042802;GO:0140536;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0000976;GO:0048856;GO:0060349;GO:0071281;GO:0048701;GO:0035115;GO:0061029;GO:0042472;GO:0001822;GO:0043066;GO:0008285;GO:2000378;GO:0010944;GO:0000122;GO:0045892;GO:0021623;GO:0003409;GO:0003404;GO:0030501;GO:0010628;GO:0043525;GO:0070172;GO:0045944;GO:0045893;GO:0045595;GO:0042127;GO:0006357;GO:0010842;GO:0060021;GO:0007605;GO:0021559;, C:chromatin; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:nuclear receptor corepressor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure development; P:bone morphogenesis; P:cellular response to iron ion; P:embryonic cranial skeleton morphogenesis; P:embryonic forelimb morphogenesis; P:eyelid development in camera-type eye; P:inner ear morphogenesis; P:kidney development; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:oculomotor nerve formation; P:optic cup structural organization; P:optic vesicle morphogenesis; P:positive regulation of bone mineralization; P:positive regulation of gene expression; P:positive regulation of neuron apoptotic process; P:positive regulation of tooth mineralization; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:retina layer formation; P:roof of mouth development; P:sensory perception of sound; P:trigeminal nerve development; scaffold39 indexed_genome mRNA 5863357 5951654 . + . ID=transcript_8042;Q8N0V5 Q06430 Q5T4J1 Q5W0E9 Q6T5E5 Q8NFS9,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase {ECO:0000305},I-branching enzyme;IGNT;, PF02485;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0008109;GO:0006024;GO:0036438;GO:0007275;GO:0010812;GO:0030335;GO:0008284;GO:0010718;GO:0070374;GO:0034116;GO:0051897;GO:0010608;GO:0006486;GO:0007179;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity;, P:glycosaminoglycan biosynthetic process; P:maintenance of lens transparency; P:multicellular organism development; P:negative regulation of cell-substrate adhesion; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of protein kinase B signaling; P:posttranscriptional regulation of gene expression; P:protein glycosylation; P:transforming growth factor beta receptor signaling pathway;|Q8N0V5 Q06430 Q5T4J1 Q5W0E9 Q6T5E5 Q8NFS9,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase {ECO:0000305},I-branching enzyme;IGNT;, PF02485;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0008109;GO:0006024;GO:0036438;GO:0007275;GO:0010812;GO:0030335;GO:0008284;GO:0010718;GO:0070374;GO:0034116;GO:0051897;GO:0010608;GO:0006486;GO:0007179;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity;, P:glycosaminoglycan biosynthetic process; P:maintenance of lens transparency; P:multicellular organism development; P:negative regulation of cell-substrate adhesion; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of protein kinase B signaling; P:posttranscriptional regulation of gene expression; P:protein glycosylation; P:transforming growth factor beta receptor signaling pathway; scaffold39 indexed_genome mRNA 5958287 5967836 . - . ID=transcript_8043;Q5T4I8 Q5T4I7 Q96AS6,Putative uncharacterized protein C6orf52,, PF17654; scaffold39 indexed_genome mRNA 5971353 5979994 . + . ID=transcript_8044;Q9NWT1 Q5T4J2 Q96QJ8 Q96T87,p21-activated protein kinase-interacting protein 1,PAK/PLC-interacting protein 1;PAK1-interacting protein 1;WD repeat-containing protein 84;, PF00400;, GO:0005730;GO:0008283;GO:0009968;GO:1901796;GO:0042273;GO:0060021;, C:nucleolus;, , P:cell population proliferation; P:negative regulation of signal transduction; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis; P:roof of mouth development;|Q9NWT1 Q5T4J2 Q96QJ8 Q96T87,p21-activated protein kinase-interacting protein 1,PAK/PLC-interacting protein 1;PAK1-interacting protein 1;WD repeat-containing protein 84;, PF00400;, GO:0005730;GO:0008283;GO:0009968;GO:1901796;GO:0042273;GO:0060021;, C:nucleolus;, , P:cell population proliferation; P:negative regulation of signal transduction; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis; P:roof of mouth development;|Q9NWT1 Q5T4J2 Q96QJ8 Q96T87,p21-activated protein kinase-interacting protein 1,PAK/PLC-interacting protein 1;PAK1-interacting protein 1;WD repeat-containing protein 84;, PF00400;, GO:0005730;GO:0008283;GO:0009968;GO:1901796;GO:0042273;GO:0060021;, C:nucleolus;, , P:cell population proliferation; P:negative regulation of signal transduction; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit biogenesis; P:roof of mouth development; scaffold39 indexed_genome mRNA 5981931 5983303 . + . ID=transcript_8045;Q9P0S9 Q5T4I6,Transmembrane protein 14C,, PF03647;, GO:0016021;GO:0005743;GO:0031966;GO:0030218;GO:0006783;GO:0006839;GO:0070453;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane;, , P:erythrocyte differentiation; P:heme biosynthetic process; P:mitochondrial transport; P:regulation of heme biosynthetic process; scaffold39 indexed_genome mRNA 5984182 5988489 . + . ID=transcript_8046;Q9P0S9 Q5T4I6,Transmembrane protein 14C,, PF03647;, GO:0016021;GO:0005743;GO:0031966;GO:0030218;GO:0006783;GO:0006839;GO:0070453;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane;, , P:erythrocyte differentiation; P:heme biosynthetic process; P:mitochondrial transport; P:regulation of heme biosynthetic process; scaffold39 indexed_genome mRNA 6128785 6154344 . - . ID=transcript_8047;Q9NXB9 Q6P9E1 Q86W94,Elongation of very long chain fatty acids protein 2 {ECO:0000255|HAMAP-Rule:MF_03202, ECO:0000305},3-keto acyl-CoA synthase ELOVL2 {ECO:0000255|HAMAP-Rule:MF_03202};ELOVL fatty acid elongase 2 {ECO:0000255|HAMAP-Rule:MF_03202};Very long chain 3-ketoacyl-CoA synthase 2 {ECO:0000255|HAMAP-Rule:MF_03202};Very long chain 3-oxoacyl-CoA synthase 2 {ECO:0000255|HAMAP-Rule:MF_03202};, PF01151;, GO:0005783;GO:0005789;GO:0030176;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0036109;GO:0034625;GO:0034626;GO:0019367;GO:0043651;GO:0035338;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:alpha-linolenic acid metabolic process; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:linoleic acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9NXB9 Q6P9E1 Q86W94,Elongation of very long chain fatty acids protein 2 {ECO:0000255|HAMAP-Rule:MF_03202, ECO:0000305},3-keto acyl-CoA synthase ELOVL2 {ECO:0000255|HAMAP-Rule:MF_03202};ELOVL fatty acid elongase 2 {ECO:0000255|HAMAP-Rule:MF_03202};Very long chain 3-ketoacyl-CoA synthase 2 {ECO:0000255|HAMAP-Rule:MF_03202};Very long chain 3-oxoacyl-CoA synthase 2 {ECO:0000255|HAMAP-Rule:MF_03202};, PF01151;, GO:0005783;GO:0005789;GO:0030176;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0036109;GO:0034625;GO:0034626;GO:0019367;GO:0043651;GO:0035338;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:alpha-linolenic acid metabolic process; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:linoleic acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold39 indexed_genome mRNA 6213126 6231277 . + . ID=transcript_8048;P0DJ93 G3V581,Small integral membrane protein 13,, PF15938;, GO:0016021;, C:integral component of membrane; scaffold39 indexed_genome mRNA 6261456 6273644 . - . ID=transcript_8049;Q14511 A8K9G7 A8MSJ9 G5E9Y9 Q5T9R4 Q5XKI0,Enhancer of filamentation 1,CRK-associated substrate-related protein;Cas scaffolding protein family member 2;Neural precursor cell expressed developmentally down-regulated protein 9;Renal carcinoma antigen NY-REN-12;p105;, PF12026;PF08824;PF14604;, GO:0005938;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0030027;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0000922;GO:1990782;GO:0051017;GO:0090527;GO:0090630;GO:0007155;GO:0007049;GO:0051301;GO:0016477;GO:0007010;GO:0007229;GO:0030335;GO:0061098;GO:1900026;GO:0040008;GO:0007165;GO:0007169;, C:cell cortex; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle; C:spindle pole;, F:protein tyrosine kinase binding;, P:actin filament bundle assembly; P:actin filament reorganization; P:activation of GTPase activity; P:cell adhesion; P:cell cycle; P:cell division; P:cell migration; P:cytoskeleton organization; P:integrin-mediated signaling pathway; P:positive regulation of cell migration; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of growth; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q14511 A8K9G7 A8MSJ9 G5E9Y9 Q5T9R4 Q5XKI0,Enhancer of filamentation 1,CRK-associated substrate-related protein;Cas scaffolding protein family member 2;Neural precursor cell expressed developmentally down-regulated protein 9;Renal carcinoma antigen NY-REN-12;p105;, PF12026;PF08824;PF14604;, GO:0005938;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0030027;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0000922;GO:1990782;GO:0051017;GO:0090527;GO:0090630;GO:0007155;GO:0007049;GO:0051301;GO:0016477;GO:0007010;GO:0007229;GO:0030335;GO:0061098;GO:1900026;GO:0040008;GO:0007165;GO:0007169;, C:cell cortex; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle; C:spindle pole;, F:protein tyrosine kinase binding;, P:actin filament bundle assembly; P:actin filament reorganization; P:activation of GTPase activity; P:cell adhesion; P:cell cycle; P:cell division; P:cell migration; P:cytoskeleton organization; P:integrin-mediated signaling pathway; P:positive regulation of cell migration; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of growth; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold39 indexed_genome mRNA 6717313 6774074 . - . ID=transcript_8050;Q96IZ2 B2R7T9 B4DV39 Q5THW1,Androgen-dependent TFPI-regulating protein,Fatty acid esters of hydroxy fatty acids hydrolase ADTRP {ECO:0000303|PubMed:27018888};, PF04750;, GO:0005901;GO:0009986;GO:0016021;GO:0016020;GO:0016787;GO:0002042;GO:0140052;GO:0071383;GO:0042758;GO:0030195;GO:0003332;GO:1903038;GO:0002686;GO:2000402;GO:0050709;GO:0010628;GO:0001934;GO:0043491;, C:caveola; C:cell surface; C:integral component of membrane; C:membrane;, F:hydrolase activity;, P:cell migration involved in sprouting angiogenesis; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cellular response to steroid hormone stimulus; P:long-chain fatty acid catabolic process; P:negative regulation of blood coagulation; P:negative regulation of extracellular matrix constituent secretion; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of leukocyte migration; P:negative regulation of lymphocyte migration; P:negative regulation of protein secretion; P:positive regulation of gene expression; P:positive regulation of protein phosphorylation; P:protein kinase B signaling;|Q96IZ2 B2R7T9 B4DV39 Q5THW1,Androgen-dependent TFPI-regulating protein,Fatty acid esters of hydroxy fatty acids hydrolase ADTRP {ECO:0000303|PubMed:27018888};, PF04750;, GO:0005901;GO:0009986;GO:0016021;GO:0016020;GO:0016787;GO:0002042;GO:0140052;GO:0071383;GO:0042758;GO:0030195;GO:0003332;GO:1903038;GO:0002686;GO:2000402;GO:0050709;GO:0010628;GO:0001934;GO:0043491;, C:caveola; C:cell surface; C:integral component of membrane; C:membrane;, F:hydrolase activity;, P:cell migration involved in sprouting angiogenesis; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cellular response to steroid hormone stimulus; P:long-chain fatty acid catabolic process; P:negative regulation of blood coagulation; P:negative regulation of extracellular matrix constituent secretion; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of leukocyte migration; P:negative regulation of lymphocyte migration; P:negative regulation of protein secretion; P:positive regulation of gene expression; P:positive regulation of protein phosphorylation; P:protein kinase B signaling; scaffold39 indexed_genome mRNA 7047857 7081557 . - . ID=transcript_8051;P15822 B2RTU3 Q14122 Q5MPB1 Q5VW60,Zinc finger protein 40,Cirhin interaction protein;Gate keeper of apoptosis-activating protein;Human immunodeficiency virus type I enhancer-binding protein 1;Major histocompatibility complex-binding protein 1;Positive regulatory domain II-binding factor 1;, PF00096;, GO:0005829;GO:0005739;GO:0016604;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0030509;GO:0000122;GO:0045944;GO:0006357;, C:cytosol; C:mitochondrion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P15822 B2RTU3 Q14122 Q5MPB1 Q5VW60,Zinc finger protein 40,Cirhin interaction protein;Gate keeper of apoptosis-activating protein;Human immunodeficiency virus type I enhancer-binding protein 1;Major histocompatibility complex-binding protein 1;Positive regulatory domain II-binding factor 1;, PF00096;, GO:0005829;GO:0005739;GO:0016604;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0030509;GO:0000122;GO:0045944;GO:0006357;, C:cytosol; C:mitochondrion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 7081958 7085591 . + . ID=transcript_8052;P15822 B2RTU3 Q14122 Q5MPB1 Q5VW60,Zinc finger protein 40,Cirhin interaction protein;Gate keeper of apoptosis-activating protein;Human immunodeficiency virus type I enhancer-binding protein 1;Major histocompatibility complex-binding protein 1;Positive regulatory domain II-binding factor 1;, PF00096;, GO:0005829;GO:0005739;GO:0016604;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0030509;GO:0000122;GO:0045944;GO:0006357;, C:cytosol; C:mitochondrion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 7187879 7193929 . + . ID=transcript_8053;P05305 Q96DA1,Endothelin-1,Preproendothelin-1;, PF00322;, GO:0045178;GO:0005737;GO:0005576;GO:0005615;GO:0048237;GO:0030133;GO:0033093;GO:0005125;GO:0031707;GO:0031708;GO:0005179;GO:0007193;GO:0014824;GO:0007589;GO:0001569;GO:0019722;GO:0051216;GO:0007166;GO:0007267;GO:0006874;GO:0071277;GO:0035690;GO:0071398;GO:0071385;GO:0071456;GO:0071346;GO:0071347;GO:0071389;GO:0071375;GO:0071560;GO:0071356;GO:0009953;GO:0086100;GO:0042045;GO:0007186;GO:0007507;GO:0001821;GO:0001701;GO:0048016;GO:0045321;GO:0060137;GO:0051899;GO:0042474;GO:0010259;GO:0030195;GO:0032269;GO:0046888;GO:0051771;GO:0034392;GO:0000122;GO:0014032;GO:0030185;GO:0030072;GO:0014065;GO:0031583;GO:0010613;GO:0061051;GO:0030335;GO:0008284;GO:0045793;GO:0070101;GO:0007204;GO:0051482;GO:0051091;GO:0010595;GO:0010460;GO:0046887;GO:0043507;GO:0043406;GO:0045840;GO:0090023;GO:1901224;GO:0045429;GO:0042482;GO:0032308;GO:0060585;GO:0035815;GO:0060298;GO:2000273;GO:0048661;GO:0045987;GO:0045944;GO:0035810;GO:1904707;GO:0001516;GO:0042313;GO:0007205;GO:0010827;GO:0006885;GO:0051930;GO:0003100;GO:0019229;GO:0007585;GO:0014823;GO:0043200;GO:0071548;GO:0044321;GO:0032496;GO:0035994;GO:0035094;GO:0010193;GO:0034696;GO:1902074;GO:0033574;GO:0043179;GO:0019233;GO:0042554;GO:0042310;GO:0014826;, C:basal part of cell; C:cytoplasm; C:extracellular region; C:extracellular space; C:rough endoplasmic reticulum lumen; C:transport vesicle; C:Weibel-Palade body;, F:cytokine activity; F:endothelin A receptor binding; F:endothelin B receptor binding; F:hormone activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:artery smooth muscle contraction; P:body fluid secretion; P:branching involved in blood vessel morphogenesis; P:calcium-mediated signaling; P:cartilage development; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cellular calcium ion homeostasis; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to fatty acid; P:cellular response to glucocorticoid stimulus; P:cellular response to hypoxia; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to mineralocorticoid stimulus; P:cellular response to peptide hormone stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:dorsal/ventral pattern formation; P:endothelin receptor signaling pathway; P:epithelial fluid transport; P:G protein-coupled receptor signaling pathway; P:heart development; P:histamine secretion; P:in utero embryonic development; P:inositol phosphate-mediated signaling; P:leukocyte activation; P:maternal process involved in parturition; P:membrane depolarization; P:middle ear morphogenesis; P:multicellular organism aging; P:negative regulation of blood coagulation; P:negative regulation of cellular protein metabolic process; P:negative regulation of hormone secretion; P:negative regulation of nitric-oxide synthase biosynthetic process; P:negative regulation of smooth muscle cell apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:neural crest cell development; P:nitric oxide transport; P:peptide hormone secretion; P:phosphatidylinositol 3-kinase signaling; P:phospholipase D-activating G protein-coupled receptor signaling pathway; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell size; P:positive regulation of chemokine-mediated signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell migration; P:positive regulation of heart rate; P:positive regulation of hormone secretion; P:positive regulation of JUN kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of mitotic nuclear division; P:positive regulation of neutrophil chemotaxis; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of odontogenesis; P:positive regulation of prostaglandin secretion; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of renal sodium excretion; P:positive regulation of sarcomere organization; P:positive regulation of signaling receptor activity; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of smooth muscle contraction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of urine volume; P:positive regulation of vascular associated smooth muscle cell proliferation; P:prostaglandin biosynthetic process; P:protein kinase C deactivation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of glucose transmembrane transport; P:regulation of pH; P:regulation of sensory perception of pain; P:regulation of systemic arterial blood pressure by endothelin; P:regulation of vasoconstriction; P:respiratory gaseous exchange by respiratory system; P:response to activity; P:response to amino acid; P:response to dexamethasone; P:response to leptin; P:response to lipopolysaccharide; P:response to muscle stretch; P:response to nicotine; P:response to ozone; P:response to prostaglandin F; P:response to salt; P:response to testosterone; P:rhythmic excitation; P:sensory perception of pain; P:superoxide anion generation; P:vasoconstriction; P:vein smooth muscle contraction; scaffold39 indexed_genome mRNA 7758319 7994258 . + . ID=transcript_8054;Q9C0D0 A8K1V2 Q3MJ93 Q5JSJ2,Phosphatase and actin regulator 1,, PF02755;, GO:0005829;GO:0005634;GO:0045202;GO:0003779;GO:0008157;GO:0004864;GO:0030036;GO:0031532;GO:0031032;GO:0048870;GO:0021987;GO:0140059;GO:2001222;GO:0043149;, C:cytosol; C:nucleus; C:synapse;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell motility; P:cerebral cortex development; P:dendrite arborization; P:regulation of neuron migration; P:stress fiber assembly;|Q9C0D0 A8K1V2 Q3MJ93 Q5JSJ2,Phosphatase and actin regulator 1,, PF02755;, GO:0005829;GO:0005634;GO:0045202;GO:0003779;GO:0008157;GO:0004864;GO:0030036;GO:0031532;GO:0031032;GO:0048870;GO:0021987;GO:0140059;GO:2001222;GO:0043149;, C:cytosol; C:nucleus; C:synapse;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell motility; P:cerebral cortex development; P:dendrite arborization; P:regulation of neuron migration; P:stress fiber assembly;|Q9C0D0 A8K1V2 Q3MJ93 Q5JSJ2,Phosphatase and actin regulator 1,, PF02755;, GO:0005829;GO:0005634;GO:0045202;GO:0003779;GO:0008157;GO:0004864;GO:0030036;GO:0031532;GO:0031032;GO:0048870;GO:0021987;GO:0140059;GO:2001222;GO:0043149;, C:cytosol; C:nucleus; C:synapse;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell motility; P:cerebral cortex development; P:dendrite arborization; P:regulation of neuron migration; P:stress fiber assembly;|Q9C0D0 A8K1V2 Q3MJ93 Q5JSJ2,Phosphatase and actin regulator 1,, PF02755;, GO:0005829;GO:0005634;GO:0045202;GO:0003779;GO:0008157;GO:0004864;GO:0030036;GO:0031532;GO:0031032;GO:0048870;GO:0021987;GO:0140059;GO:2001222;GO:0043149;, C:cytosol; C:nucleus; C:synapse;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell motility; P:cerebral cortex development; P:dendrite arborization; P:regulation of neuron migration; P:stress fiber assembly; scaffold39 indexed_genome mRNA 8032110 8039788 . - . ID=transcript_8055;Q9P0N9 E7EV96 Q2TU37 Q53F44 Q5SZL7 Q86VM8 Q96MB8,TBC1 domain family member 7,Cell migration-inducing protein 23;, PF00566;, GO:0036064;GO:0031410;GO:0005829;GO:0005096;GO:0031267;GO:0090630;GO:1902018;GO:0032007;GO:0043547;GO:0031398;GO:0070848;, C:ciliary basal body; C:cytoplasmic vesicle; C:cytosol;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:negative regulation of cilium assembly; P:negative regulation of TOR signaling; P:positive regulation of GTPase activity; P:positive regulation of protein ubiquitination; P:response to growth factor;|Q9P0N9 E7EV96 Q2TU37 Q53F44 Q5SZL7 Q86VM8 Q96MB8,TBC1 domain family member 7,Cell migration-inducing protein 23;, PF00566;, GO:0036064;GO:0031410;GO:0005829;GO:0005096;GO:0031267;GO:0090630;GO:1902018;GO:0032007;GO:0043547;GO:0031398;GO:0070848;, C:ciliary basal body; C:cytoplasmic vesicle; C:cytosol;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:negative regulation of cilium assembly; P:negative regulation of TOR signaling; P:positive regulation of GTPase activity; P:positive regulation of protein ubiquitination; P:response to growth factor; scaffold39 indexed_genome mRNA 8222009 8255191 . + . ID=transcript_8056;Q9NXA8 B4DFM4 B4DYJ5 F5H5Z9 Q5T294 Q5T295 Q9Y6E6,NAD-dependent protein deacylase sirtuin-5, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03160},Regulatory protein SIR2 homolog 5 {ECO:0000255|HAMAP-Rule:MF_03160};SIR2-like protein 5 {ECO:0000255|HAMAP-Rule:MF_03160};, PF02146;, GO:0005829;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0003950;GO:0070403;GO:0061697;GO:0036054;GO:0036055;GO:0008270;GO:0007005;GO:2000378;GO:0036047;GO:0036049;GO:0006471;GO:0006476;GO:0061698;GO:0036046;GO:0036048;GO:0010566;, C:cytosol; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:protein-glutaryllysine deglutarylase activity; F:protein-malonyllysine demalonylase activity; F:protein-succinyllysine desuccinylase activity; F:zinc ion binding;, P:mitochondrion organization; P:negative regulation of reactive oxygen species metabolic process; P:peptidyl-lysine demalonylation; P:peptidyl-lysine desuccinylation; P:protein ADP-ribosylation; P:protein deacetylation; P:protein deglutarylation; P:protein demalonylation; P:protein desuccinylation; P:regulation of ketone biosynthetic process;|Q9NXA8 B4DFM4 B4DYJ5 F5H5Z9 Q5T294 Q5T295 Q9Y6E6,NAD-dependent protein deacylase sirtuin-5, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03160},Regulatory protein SIR2 homolog 5 {ECO:0000255|HAMAP-Rule:MF_03160};SIR2-like protein 5 {ECO:0000255|HAMAP-Rule:MF_03160};, PF02146;, GO:0005829;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0003950;GO:0070403;GO:0061697;GO:0036054;GO:0036055;GO:0008270;GO:0007005;GO:2000378;GO:0036047;GO:0036049;GO:0006471;GO:0006476;GO:0061698;GO:0036046;GO:0036048;GO:0010566;, C:cytosol; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:protein-glutaryllysine deglutarylase activity; F:protein-malonyllysine demalonylase activity; F:protein-succinyllysine desuccinylase activity; F:zinc ion binding;, P:mitochondrion organization; P:negative regulation of reactive oxygen species metabolic process; P:peptidyl-lysine demalonylation; P:peptidyl-lysine desuccinylation; P:protein ADP-ribosylation; P:protein deacetylation; P:protein deglutarylation; P:protein demalonylation; P:protein desuccinylation; P:regulation of ketone biosynthetic process;|Q96S59 A0PJA2 B2R8E1 O94764 Q6P3T7 Q7LBR2 Q7Z7F9,Ran-binding protein 9,BPM-L;BPM90;Ran-binding protein M;RanBP7;, PF10607;PF08513;PF00622;, GO:0005737;GO:0005829;GO:0005875;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0019899;GO:0031267;GO:0007411;GO:0007166;GO:0007010;GO:0000165;GO:0007020;GO:0070373;GO:1902993;GO:0065003;, C:cytoplasm; C:cytosol; C:microtubule associated complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:enzyme binding; F:small GTPase binding;, P:axon guidance; P:cell surface receptor signaling pathway; P:cytoskeleton organization; P:MAPK cascade; P:microtubule nucleation; P:negative regulation of ERK1 and ERK2 cascade; P:positive regulation of amyloid precursor protein catabolic process; P:protein-containing complex assembly;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold39 indexed_genome mRNA 8255223 8312955 . - . ID=transcript_8057;Q96S59 A0PJA2 B2R8E1 O94764 Q6P3T7 Q7LBR2 Q7Z7F9,Ran-binding protein 9,BPM-L;BPM90;Ran-binding protein M;RanBP7;, PF10607;PF08513;PF00622;, GO:0005737;GO:0005829;GO:0005875;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0019899;GO:0031267;GO:0007411;GO:0007166;GO:0007010;GO:0000165;GO:0007020;GO:0070373;GO:1902993;GO:0065003;, C:cytoplasm; C:cytosol; C:microtubule associated complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:enzyme binding; F:small GTPase binding;, P:axon guidance; P:cell surface receptor signaling pathway; P:cytoskeleton organization; P:MAPK cascade; P:microtubule nucleation; P:negative regulation of ERK1 and ERK2 cascade; P:positive regulation of amyloid precursor protein catabolic process; P:protein-containing complex assembly;|Q96S59 A0PJA2 B2R8E1 O94764 Q6P3T7 Q7LBR2 Q7Z7F9,Ran-binding protein 9,BPM-L;BPM90;Ran-binding protein M;RanBP7;, PF10607;PF08513;PF00622;, GO:0005737;GO:0005829;GO:0005875;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0019899;GO:0031267;GO:0007411;GO:0007166;GO:0007010;GO:0000165;GO:0007020;GO:0070373;GO:1902993;GO:0065003;, C:cytoplasm; C:cytosol; C:microtubule associated complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:enzyme binding; F:small GTPase binding;, P:axon guidance; P:cell surface receptor signaling pathway; P:cytoskeleton organization; P:MAPK cascade; P:microtubule nucleation; P:negative regulation of ERK1 and ERK2 cascade; P:positive regulation of amyloid precursor protein catabolic process; P:protein-containing complex assembly;|Q96S59 A0PJA2 B2R8E1 O94764 Q6P3T7 Q7LBR2 Q7Z7F9,Ran-binding protein 9,BPM-L;BPM90;Ran-binding protein M;RanBP7;, PF10607;PF08513;PF00622;, GO:0005737;GO:0005829;GO:0005875;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0019899;GO:0031267;GO:0007411;GO:0007166;GO:0007010;GO:0000165;GO:0007020;GO:0070373;GO:1902993;GO:0065003;, C:cytoplasm; C:cytosol; C:microtubule associated complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:enzyme binding; F:small GTPase binding;, P:axon guidance; P:cell surface receptor signaling pathway; P:cytoskeleton organization; P:MAPK cascade; P:microtubule nucleation; P:negative regulation of ERK1 and ERK2 cascade; P:positive regulation of amyloid precursor protein catabolic process; P:protein-containing complex assembly;|Q96S59 A0PJA2 B2R8E1 O94764 Q6P3T7 Q7LBR2 Q7Z7F9,Ran-binding protein 9,BPM-L;BPM90;Ran-binding protein M;RanBP7;, PF10607;PF08513;PF00622;, GO:0005737;GO:0005829;GO:0005875;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0019899;GO:0031267;GO:0007411;GO:0007166;GO:0007010;GO:0000165;GO:0007020;GO:0070373;GO:1902993;GO:0065003;, C:cytoplasm; C:cytosol; C:microtubule associated complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:enzyme binding; F:small GTPase binding;, P:axon guidance; P:cell surface receptor signaling pathway; P:cytoskeleton organization; P:MAPK cascade; P:microtubule nucleation; P:negative regulation of ERK1 and ERK2 cascade; P:positive regulation of amyloid precursor protein catabolic process; P:protein-containing complex assembly; scaffold39 indexed_genome mRNA 8382557 8384881 . - . ID=transcript_8058;Q96AQ8 Q96JS7 Q9H7F8,Mitochondrial calcium uniporter regulator 1 {ECO:0000303|PubMed:23178883},Coiled-coil domain-containing protein 90A, mitochondrial {ECO:0000305};, PF07798;, GO:0031305;GO:0005739;GO:0036444;GO:0070509;GO:0006851;GO:0051561;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:calcium import into the mitochondrion; P:calcium ion import; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration;|Q96AQ8 Q96JS7 Q9H7F8,Mitochondrial calcium uniporter regulator 1 {ECO:0000303|PubMed:23178883},Coiled-coil domain-containing protein 90A, mitochondrial {ECO:0000305};, PF07798;, GO:0031305;GO:0005739;GO:0036444;GO:0070509;GO:0006851;GO:0051561;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:calcium import into the mitochondrion; P:calcium ion import; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration; scaffold39 indexed_genome mRNA 8387249 8389644 . - . ID=transcript_8059;Q96AQ8 Q96JS7 Q9H7F8,Mitochondrial calcium uniporter regulator 1 {ECO:0000303|PubMed:23178883},Coiled-coil domain-containing protein 90A, mitochondrial {ECO:0000305};, PF07798;, GO:0031305;GO:0005739;GO:0036444;GO:0070509;GO:0006851;GO:0051561;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:calcium import into the mitochondrion; P:calcium ion import; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration; scaffold39 indexed_genome mRNA 8490588 8492319 . - . ID=transcript_8060;Q8N6D2 B2RDG2 Q8NBG3,E3 ubiquitin-protein ligase RNF182 {ECO:0000303|PubMed:18298843},RING finger protein 182;RING-type E3 ubiquitin transferase RNF182 {ECO:0000305};, PF13639;, GO:0005737;GO:0016021;GO:0046872;GO:0004842;GO:0016567;, C:cytoplasm; C:integral component of membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein ubiquitination; scaffold39 indexed_genome mRNA 8609386 8627841 . + . ID=transcript_8061;Q01151 Q5THX9,CD83 antigen,B-cell activation protein;Cell surface protein HB15;, PF07686;, GO:0009897;GO:0005887;GO:0005886;GO:0006952;GO:0006959;GO:0032713;GO:0043372;GO:0032733;GO:0032743;GO:0014070;GO:0007165;, C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, , P:defense response; P:humoral immune response; P:negative regulation of interleukin-4 production; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-2 production; P:response to organic cyclic compound; P:signal transduction; scaffold39 indexed_genome mRNA 9543078 9770494 . + . ID=transcript_8062;Q92833 A8K9Z6 B7Z5S5 B7Z8L0 Q5U5L5 Q86X63,Protein Jumonji,Jumonji/ARID domain-containing protein 2;, PF01388;PF02373;PF02375;PF02928;, GO:0035098;GO:0035097;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0032452;GO:0008134;GO:1990830;GO:0007417;GO:0006338;GO:0034721;GO:0001889;GO:0060044;GO:0010614;GO:0045814;GO:0031061;GO:0000122;GO:0045892;GO:0051574;GO:0048536;GO:0048863;GO:0048538;, C:ESC/E(Z) complex; C:histone methyltransferase complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone demethylase activity; F:transcription factor binding;, P:cellular response to leukemia inhibitory factor; P:central nervous system development; P:chromatin remodeling; P:histone H3-K4 demethylation, trimethyl-H3-K4-specific; P:liver development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone H3-K9 methylation; P:spleen development; P:stem cell differentiation; P:thymus development;|Q92833 A8K9Z6 B7Z5S5 B7Z8L0 Q5U5L5 Q86X63,Protein Jumonji,Jumonji/ARID domain-containing protein 2;, PF01388;PF02373;PF02375;PF02928;, GO:0035098;GO:0035097;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0032452;GO:0008134;GO:1990830;GO:0007417;GO:0006338;GO:0034721;GO:0001889;GO:0060044;GO:0010614;GO:0045814;GO:0031061;GO:0000122;GO:0045892;GO:0051574;GO:0048536;GO:0048863;GO:0048538;, C:ESC/E(Z) complex; C:histone methyltransferase complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone demethylase activity; F:transcription factor binding;, P:cellular response to leukemia inhibitory factor; P:central nervous system development; P:chromatin remodeling; P:histone H3-K4 demethylation, trimethyl-H3-K4-specific; P:liver development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone H3-K9 methylation; P:spleen development; P:stem cell differentiation; P:thymus development;|Q92833 A8K9Z6 B7Z5S5 B7Z8L0 Q5U5L5 Q86X63,Protein Jumonji,Jumonji/ARID domain-containing protein 2;, PF01388;PF02373;PF02375;PF02928;, GO:0035098;GO:0035097;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0032452;GO:0008134;GO:1990830;GO:0007417;GO:0006338;GO:0034721;GO:0001889;GO:0060044;GO:0010614;GO:0045814;GO:0031061;GO:0000122;GO:0045892;GO:0051574;GO:0048536;GO:0048863;GO:0048538;, C:ESC/E(Z) complex; C:histone methyltransferase complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone demethylase activity; F:transcription factor binding;, P:cellular response to leukemia inhibitory factor; P:central nervous system development; P:chromatin remodeling; P:histone H3-K4 demethylation, trimethyl-H3-K4-specific; P:liver development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone H3-K9 methylation; P:spleen development; P:stem cell differentiation; P:thymus development;|Q92833 A8K9Z6 B7Z5S5 B7Z8L0 Q5U5L5 Q86X63,Protein Jumonji,Jumonji/ARID domain-containing protein 2;, PF01388;PF02373;PF02375;PF02928;, GO:0035098;GO:0035097;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0032452;GO:0008134;GO:1990830;GO:0007417;GO:0006338;GO:0034721;GO:0001889;GO:0060044;GO:0010614;GO:0045814;GO:0031061;GO:0000122;GO:0045892;GO:0051574;GO:0048536;GO:0048863;GO:0048538;, C:ESC/E(Z) complex; C:histone methyltransferase complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone demethylase activity; F:transcription factor binding;, P:cellular response to leukemia inhibitory factor; P:central nervous system development; P:chromatin remodeling; P:histone H3-K4 demethylation, trimethyl-H3-K4-specific; P:liver development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone H3-K9 methylation; P:spleen development; P:stem cell differentiation; P:thymus development;|Q92833 A8K9Z6 B7Z5S5 B7Z8L0 Q5U5L5 Q86X63,Protein Jumonji,Jumonji/ARID domain-containing protein 2;, PF01388;PF02373;PF02375;PF02928;, GO:0035098;GO:0035097;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0032452;GO:0008134;GO:1990830;GO:0007417;GO:0006338;GO:0034721;GO:0001889;GO:0060044;GO:0010614;GO:0045814;GO:0031061;GO:0000122;GO:0045892;GO:0051574;GO:0048536;GO:0048863;GO:0048538;, C:ESC/E(Z) complex; C:histone methyltransferase complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone demethylase activity; F:transcription factor binding;, P:cellular response to leukemia inhibitory factor; P:central nervous system development; P:chromatin remodeling; P:histone H3-K4 demethylation, trimethyl-H3-K4-specific; P:liver development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone H3-K9 methylation; P:spleen development; P:stem cell differentiation; P:thymus development;|Q92833 A8K9Z6 B7Z5S5 B7Z8L0 Q5U5L5 Q86X63,Protein Jumonji,Jumonji/ARID domain-containing protein 2;, PF01388;PF02373;PF02375;PF02928;, GO:0035098;GO:0035097;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0032452;GO:0008134;GO:1990830;GO:0007417;GO:0006338;GO:0034721;GO:0001889;GO:0060044;GO:0010614;GO:0045814;GO:0031061;GO:0000122;GO:0045892;GO:0051574;GO:0048536;GO:0048863;GO:0048538;, C:ESC/E(Z) complex; C:histone methyltransferase complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone demethylase activity; F:transcription factor binding;, P:cellular response to leukemia inhibitory factor; P:central nervous system development; P:chromatin remodeling; P:histone H3-K4 demethylation, trimethyl-H3-K4-specific; P:liver development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone H3-K9 methylation; P:spleen development; P:stem cell differentiation; P:thymus development;|Q92833 A8K9Z6 B7Z5S5 B7Z8L0 Q5U5L5 Q86X63,Protein Jumonji,Jumonji/ARID domain-containing protein 2;, PF01388;PF02373;PF02375;PF02928;, GO:0035098;GO:0035097;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0032452;GO:0008134;GO:1990830;GO:0007417;GO:0006338;GO:0034721;GO:0001889;GO:0060044;GO:0010614;GO:0045814;GO:0031061;GO:0000122;GO:0045892;GO:0051574;GO:0048536;GO:0048863;GO:0048538;, C:ESC/E(Z) complex; C:histone methyltransferase complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone demethylase activity; F:transcription factor binding;, P:cellular response to leukemia inhibitory factor; P:central nervous system development; P:chromatin remodeling; P:histone H3-K4 demethylation, trimethyl-H3-K4-specific; P:liver development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone H3-K9 methylation; P:spleen development; P:stem cell differentiation; P:thymus development;|Q92833 A8K9Z6 B7Z5S5 B7Z8L0 Q5U5L5 Q86X63,Protein Jumonji,Jumonji/ARID domain-containing protein 2;, PF01388;PF02373;PF02375;PF02928;, GO:0035098;GO:0035097;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0032452;GO:0008134;GO:1990830;GO:0007417;GO:0006338;GO:0034721;GO:0001889;GO:0060044;GO:0010614;GO:0045814;GO:0031061;GO:0000122;GO:0045892;GO:0051574;GO:0048536;GO:0048863;GO:0048538;, C:ESC/E(Z) complex; C:histone methyltransferase complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone demethylase activity; F:transcription factor binding;, P:cellular response to leukemia inhibitory factor; P:central nervous system development; P:chromatin remodeling; P:histone H3-K4 demethylation, trimethyl-H3-K4-specific; P:liver development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone H3-K9 methylation; P:spleen development; P:stem cell differentiation; P:thymus development;|Q92833 A8K9Z6 B7Z5S5 B7Z8L0 Q5U5L5 Q86X63,Protein Jumonji,Jumonji/ARID domain-containing protein 2;, PF01388;PF02373;PF02375;PF02928;, GO:0035098;GO:0035097;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0032452;GO:0008134;GO:1990830;GO:0007417;GO:0006338;GO:0034721;GO:0001889;GO:0060044;GO:0010614;GO:0045814;GO:0031061;GO:0000122;GO:0045892;GO:0051574;GO:0048536;GO:0048863;GO:0048538;, C:ESC/E(Z) complex; C:histone methyltransferase complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone demethylase activity; F:transcription factor binding;, P:cellular response to leukemia inhibitory factor; P:central nervous system development; P:chromatin remodeling; P:histone H3-K4 demethylation, trimethyl-H3-K4-specific; P:liver development; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone H3-K9 methylation; P:spleen development; P:stem cell differentiation; P:thymus development; scaffold39 indexed_genome mRNA 9772251 9785027 . - . ID=transcript_8063;Q96EV8 A8K3V3 Q5THY3 Q5THY4 Q96NV2 Q9H0U2 Q9H3J5,Dysbindin,Biogenesis of lysosome-related organelles complex 1 subunit 8;Dysbindin-1;Dystrobrevin-binding protein 1;Hermansky-Pudlak syndrome 7 protein;, PF04440;, GO:0030424;GO:1904115;GO:0031083;GO:0005737;GO:0005829;GO:0043197;GO:0005789;GO:0010008;GO:0098978;GO:0030426;GO:0098686;GO:0033162;GO:0015630;GO:0030496;GO:0043005;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0042383;GO:0016528;GO:0098685;GO:0030672;GO:0031532;GO:0008089;GO:0048490;GO:0007596;GO:0048813;GO:0032438;GO:0032091;GO:0006469;GO:0071901;GO:0031175;GO:0048812;GO:0060155;GO:0010628;GO:0001956;GO:0006892;GO:0060159;GO:0014059;GO:0043506;GO:2000300;, C:axon; C:axon cytoplasm; C:BLOC-1 complex; C:cytoplasm; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:endosome membrane; C:glutamatergic synapse; C:growth cone; C:hippocampal mossy fiber to CA3 synapse; C:melanosome membrane; C:microtubule cytoskeleton; C:midbody; C:neuron projection; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasm; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle membrane;, , P:actin cytoskeleton reorganization; P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:blood coagulation; P:dendrite morphogenesis; P:melanosome organization; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:neuron projection development; P:neuron projection morphogenesis; P:platelet dense granule organization; P:positive regulation of gene expression; P:positive regulation of neurotransmitter secretion; P:post-Golgi vesicle-mediated transport; P:regulation of dopamine receptor signaling pathway; P:regulation of dopamine secretion; P:regulation of JUN kinase activity; P:regulation of synaptic vesicle exocytosis;|Q96EV8 A8K3V3 Q5THY3 Q5THY4 Q96NV2 Q9H0U2 Q9H3J5,Dysbindin,Biogenesis of lysosome-related organelles complex 1 subunit 8;Dysbindin-1;Dystrobrevin-binding protein 1;Hermansky-Pudlak syndrome 7 protein;, PF04440;, GO:0030424;GO:1904115;GO:0031083;GO:0005737;GO:0005829;GO:0043197;GO:0005789;GO:0010008;GO:0098978;GO:0030426;GO:0098686;GO:0033162;GO:0015630;GO:0030496;GO:0043005;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0042383;GO:0016528;GO:0098685;GO:0030672;GO:0031532;GO:0008089;GO:0048490;GO:0007596;GO:0048813;GO:0032438;GO:0032091;GO:0006469;GO:0071901;GO:0031175;GO:0048812;GO:0060155;GO:0010628;GO:0001956;GO:0006892;GO:0060159;GO:0014059;GO:0043506;GO:2000300;, C:axon; C:axon cytoplasm; C:BLOC-1 complex; C:cytoplasm; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:endosome membrane; C:glutamatergic synapse; C:growth cone; C:hippocampal mossy fiber to CA3 synapse; C:melanosome membrane; C:microtubule cytoskeleton; C:midbody; C:neuron projection; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasm; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle membrane;, , P:actin cytoskeleton reorganization; P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:blood coagulation; P:dendrite morphogenesis; P:melanosome organization; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:neuron projection development; P:neuron projection morphogenesis; P:platelet dense granule organization; P:positive regulation of gene expression; P:positive regulation of neurotransmitter secretion; P:post-Golgi vesicle-mediated transport; P:regulation of dopamine receptor signaling pathway; P:regulation of dopamine secretion; P:regulation of JUN kinase activity; P:regulation of synaptic vesicle exocytosis;|Q96EV8 A8K3V3 Q5THY3 Q5THY4 Q96NV2 Q9H0U2 Q9H3J5,Dysbindin,Biogenesis of lysosome-related organelles complex 1 subunit 8;Dysbindin-1;Dystrobrevin-binding protein 1;Hermansky-Pudlak syndrome 7 protein;, PF04440;, GO:0030424;GO:1904115;GO:0031083;GO:0005737;GO:0005829;GO:0043197;GO:0005789;GO:0010008;GO:0098978;GO:0030426;GO:0098686;GO:0033162;GO:0015630;GO:0030496;GO:0043005;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0042383;GO:0016528;GO:0098685;GO:0030672;GO:0031532;GO:0008089;GO:0048490;GO:0007596;GO:0048813;GO:0032438;GO:0032091;GO:0006469;GO:0071901;GO:0031175;GO:0048812;GO:0060155;GO:0010628;GO:0001956;GO:0006892;GO:0060159;GO:0014059;GO:0043506;GO:2000300;, C:axon; C:axon cytoplasm; C:BLOC-1 complex; C:cytoplasm; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:endosome membrane; C:glutamatergic synapse; C:growth cone; C:hippocampal mossy fiber to CA3 synapse; C:melanosome membrane; C:microtubule cytoskeleton; C:midbody; C:neuron projection; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:sarcolemma; C:sarcoplasm; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle membrane;, , P:actin cytoskeleton reorganization; P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:blood coagulation; P:dendrite morphogenesis; P:melanosome organization; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:neuron projection development; P:neuron projection morphogenesis; P:platelet dense granule organization; P:positive regulation of gene expression; P:positive regulation of neurotransmitter secretion; P:post-Golgi vesicle-mediated transport; P:regulation of dopamine receptor signaling pathway; P:regulation of dopamine secretion; P:regulation of JUN kinase activity; P:regulation of synaptic vesicle exocytosis; scaffold39 indexed_genome mRNA 10244724 10263348 . + . ID=transcript_8064;Q8WY64 Q5TIA4 Q9BU73 Q9NRL9 Q9UHE7,E3 ubiquitin-protein ligase MYLIP,Inducible degrader of the LDL-receptor;Myosin regulatory light chain interacting protein;RING-type E3 ubiquitin transferase MYLIP {ECO:0000305};, PF09380;PF00373;PF09379;, GO:0005856;GO:0005829;GO:0005886;GO:0008092;GO:0046872;GO:0061630;GO:0004842;GO:0042632;GO:0030522;GO:0032802;GO:0010989;GO:0010977;GO:0007399;GO:0045732;GO:0031648;GO:0000209;GO:0016567;GO:0032803;GO:0006511;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cytoskeletal protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cholesterol homeostasis; P:intracellular receptor signaling pathway; P:low-density lipoprotein particle receptor catabolic process; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of neuron projection development; P:nervous system development; P:positive regulation of protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of low-density lipoprotein particle receptor catabolic process; P:ubiquitin-dependent protein catabolic process;|Q8WY64 Q5TIA4 Q9BU73 Q9NRL9 Q9UHE7,E3 ubiquitin-protein ligase MYLIP,Inducible degrader of the LDL-receptor;Myosin regulatory light chain interacting protein;RING-type E3 ubiquitin transferase MYLIP {ECO:0000305};, PF09380;PF00373;PF09379;, GO:0005856;GO:0005829;GO:0005886;GO:0008092;GO:0046872;GO:0061630;GO:0004842;GO:0042632;GO:0030522;GO:0032802;GO:0010989;GO:0010977;GO:0007399;GO:0045732;GO:0031648;GO:0000209;GO:0016567;GO:0032803;GO:0006511;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cytoskeletal protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cholesterol homeostasis; P:intracellular receptor signaling pathway; P:low-density lipoprotein particle receptor catabolic process; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of neuron projection development; P:nervous system development; P:positive regulation of protein catabolic process; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of low-density lipoprotein particle receptor catabolic process; P:ubiquitin-dependent protein catabolic process; scaffold39 indexed_genome mRNA 10343981 10409538 . + . ID=transcript_8065;P36959 Q96HQ6,GMP reductase 1 {ECO:0000255|HAMAP-Rule:MF_03195},Guanosine 5'-monophosphate oxidoreductase 1 {ECO:0000255|HAMAP-Rule:MF_03195};, PF00478;, GO:0005829;GO:1902560;GO:0003920;GO:0046872;GO:0006144;GO:0006163;GO:0043101;GO:0009409;, C:cytosol; C:GMP reductase complex;, F:GMP reductase activity; F:metal ion binding;, P:purine nucleobase metabolic process; P:purine nucleotide metabolic process; P:purine-containing compound salvage; P:response to cold;|P36959 Q96HQ6,GMP reductase 1 {ECO:0000255|HAMAP-Rule:MF_03195},Guanosine 5'-monophosphate oxidoreductase 1 {ECO:0000255|HAMAP-Rule:MF_03195};, PF00478;, GO:0005829;GO:1902560;GO:0003920;GO:0046872;GO:0006144;GO:0006163;GO:0043101;GO:0009409;, C:cytosol; C:GMP reductase complex;, F:GMP reductase activity; F:metal ion binding;, P:purine nucleobase metabolic process; P:purine nucleotide metabolic process; P:purine-containing compound salvage; P:response to cold;|P36959 Q96HQ6,GMP reductase 1 {ECO:0000255|HAMAP-Rule:MF_03195},Guanosine 5'-monophosphate oxidoreductase 1 {ECO:0000255|HAMAP-Rule:MF_03195};, PF00478;, GO:0005829;GO:1902560;GO:0003920;GO:0046872;GO:0006144;GO:0006163;GO:0043101;GO:0009409;, C:cytosol; C:GMP reductase complex;, F:GMP reductase activity; F:metal ion binding;, P:purine nucleobase metabolic process; P:purine nucleotide metabolic process; P:purine-containing compound salvage; P:response to cold; scaffold39 indexed_genome mRNA 10418107 10655502 . - . ID=transcript_8066;P54253 Q17S02 Q9UJG2 Q9Y4J1,Ataxin-1,Spinocerebellar ataxia type 1 protein;, PF08517;, GO:0005737;GO:0005829;GO:0042405;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0042802;GO:0034046;GO:0008266;GO:0008022;GO:0043621;GO:0048856;GO:0007420;GO:0007612;GO:0007613;GO:0000122;GO:0045892;GO:0007399;GO:0051168;GO:0006355;GO:0006396;GO:0035176;, C:cytoplasm; C:cytosol; C:nuclear inclusion body; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:identical protein binding; F:poly(G) binding; F:poly(U) RNA binding; F:protein C-terminus binding; F:protein self-association;, P:anatomical structure development; P:brain development; P:learning; P:memory; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nuclear export; P:regulation of transcription, DNA-templated; P:RNA processing; P:social behavior;|P54253 Q17S02 Q9UJG2 Q9Y4J1,Ataxin-1,Spinocerebellar ataxia type 1 protein;, PF08517;, GO:0005737;GO:0005829;GO:0042405;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0042802;GO:0034046;GO:0008266;GO:0008022;GO:0043621;GO:0048856;GO:0007420;GO:0007612;GO:0007613;GO:0000122;GO:0045892;GO:0007399;GO:0051168;GO:0006355;GO:0006396;GO:0035176;, C:cytoplasm; C:cytosol; C:nuclear inclusion body; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:identical protein binding; F:poly(G) binding; F:poly(U) RNA binding; F:protein C-terminus binding; F:protein self-association;, P:anatomical structure development; P:brain development; P:learning; P:memory; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nuclear export; P:regulation of transcription, DNA-templated; P:RNA processing; P:social behavior; scaffold39 indexed_genome mRNA 11139127 11180517 . + . ID=transcript_8067;P40123 B2R5Y3 B7Z1C4 B7Z214 Q6IAY2,Adenylyl cyclase-associated protein 2,, PF08603;PF01213;, GO:0005737;GO:0005886;GO:0014069;GO:0003779;GO:0008179;GO:0042802;GO:0007190;GO:0019933;GO:0000902;GO:0007010;GO:0007163;GO:0045761;GO:0007165;, C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:actin binding; F:adenylate cyclase binding; F:identical protein binding;, P:activation of adenylate cyclase activity; P:cAMP-mediated signaling; P:cell morphogenesis; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:regulation of adenylate cyclase activity; P:signal transduction;|P40123 B2R5Y3 B7Z1C4 B7Z214 Q6IAY2,Adenylyl cyclase-associated protein 2,, PF08603;PF01213;, GO:0005737;GO:0005886;GO:0014069;GO:0003779;GO:0008179;GO:0042802;GO:0007190;GO:0019933;GO:0000902;GO:0007010;GO:0007163;GO:0045761;GO:0007165;, C:cytoplasm; C:plasma membrane; C:postsynaptic density;, F:actin binding; F:adenylate cyclase binding; F:identical protein binding;, P:activation of adenylate cyclase activity; P:cAMP-mediated signaling; P:cell morphogenesis; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:regulation of adenylate cyclase activity; P:signal transduction; scaffold39 indexed_genome mRNA 11211058 11219779 . + . ID=transcript_8068;Q9UBU6 B2R725,Protein FAM8A1,Autosomal highly conserved protein;, PF06271;, GO:0000836;GO:0016021;GO:0030433;, C:Hrd1p ubiquitin ligase complex; C:integral component of membrane;, , P:ubiquitin-dependent ERAD pathway;|Q9UBU6 B2R725,Protein FAM8A1,Autosomal highly conserved protein;, PF06271;, GO:0000836;GO:0016021;GO:0030433;, C:Hrd1p ubiquitin ligase complex; C:integral component of membrane;, , P:ubiquitin-dependent ERAD pathway; scaffold39 indexed_genome mRNA 11221809 11237706 . - . ID=transcript_8069;P49790 B4DIK2 E7EPX5 F6QR24 Q4LE47 Q5T9I7 Q7Z743,Nuclear pore complex protein Nup153,153 kDa nucleoporin;Nucleoporin Nup153;, PF08604;PF10599;PF00641;, GO:0005829;GO:0043657;GO:0016020;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0005730;GO:0005654;GO:0003677;GO:0042802;GO:0046872;GO:0008139;GO:0043495;GO:0017056;GO:0075733;GO:0006406;GO:0046832;GO:0051292;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0046718;GO:0019058;GO:0075732;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:identical protein binding; F:metal ion binding; F:nuclear localization sequence binding; F:protein-membrane adaptor activity; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:negative regulation of RNA export from nucleus; P:nuclear pore complex assembly; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral entry into host cell; P:viral life cycle; P:viral penetration into host nucleus; P:viral process; P:viral transcription;|P49790 B4DIK2 E7EPX5 F6QR24 Q4LE47 Q5T9I7 Q7Z743,Nuclear pore complex protein Nup153,153 kDa nucleoporin;Nucleoporin Nup153;, PF08604;PF10599;PF00641;, GO:0005829;GO:0043657;GO:0016020;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0005730;GO:0005654;GO:0003677;GO:0042802;GO:0046872;GO:0008139;GO:0043495;GO:0017056;GO:0075733;GO:0006406;GO:0046832;GO:0051292;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0046718;GO:0019058;GO:0075732;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:identical protein binding; F:metal ion binding; F:nuclear localization sequence binding; F:protein-membrane adaptor activity; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:negative regulation of RNA export from nucleus; P:nuclear pore complex assembly; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral entry into host cell; P:viral life cycle; P:viral penetration into host nucleus; P:viral process; P:viral transcription; scaffold39 indexed_genome mRNA 11237778 11293661 . - . ID=transcript_8070;P49790 B4DIK2 E7EPX5 F6QR24 Q4LE47 Q5T9I7 Q7Z743,Nuclear pore complex protein Nup153,153 kDa nucleoporin;Nucleoporin Nup153;, PF08604;PF10599;PF00641;, GO:0005829;GO:0043657;GO:0016020;GO:0042405;GO:0031965;GO:0034399;GO:0005643;GO:0044615;GO:0005730;GO:0005654;GO:0003677;GO:0042802;GO:0046872;GO:0008139;GO:0043495;GO:0017056;GO:0075733;GO:0006406;GO:0046832;GO:0051292;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0046718;GO:0019058;GO:0075732;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:membrane; C:nuclear inclusion body; C:nuclear membrane; C:nuclear periphery; C:nuclear pore; C:nuclear pore nuclear basket; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:identical protein binding; F:metal ion binding; F:nuclear localization sequence binding; F:protein-membrane adaptor activity; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:negative regulation of RNA export from nucleus; P:nuclear pore complex assembly; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral entry into host cell; P:viral life cycle; P:viral penetration into host nucleus; P:viral process; P:viral transcription; scaffold39 indexed_genome mRNA 11319417 11515415 . - . ID=transcript_8071;Q9H1H9 A0JP21 A0JP22 F2Z382 Q5THQ2 Q5THQ3 Q9H193 Q9H194 Q9H1H8,Kinesin-like protein KIF13A,Kinesin-like protein RBKIN;, PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0005813;GO:0010008;GO:0005871;GO:0005874;GO:0030496;GO:0032588;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007049;GO:0051301;GO:0008333;GO:0043001;GO:0006886;GO:0032438;GO:0007018;GO:0072383;GO:0032465;GO:0035459;, C:centrosome; C:endosome membrane; C:kinesin complex; C:microtubule; C:midbody; C:trans-Golgi network membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cell cycle; P:cell division; P:endosome to lysosome transport; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:melanosome organization; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:regulation of cytokinesis; P:vesicle cargo loading;|Q9H1H9 A0JP21 A0JP22 F2Z382 Q5THQ2 Q5THQ3 Q9H193 Q9H194 Q9H1H8,Kinesin-like protein KIF13A,Kinesin-like protein RBKIN;, PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0005813;GO:0010008;GO:0005871;GO:0005874;GO:0030496;GO:0032588;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007049;GO:0051301;GO:0008333;GO:0043001;GO:0006886;GO:0032438;GO:0007018;GO:0072383;GO:0032465;GO:0035459;, C:centrosome; C:endosome membrane; C:kinesin complex; C:microtubule; C:midbody; C:trans-Golgi network membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cell cycle; P:cell division; P:endosome to lysosome transport; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:melanosome organization; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:regulation of cytokinesis; P:vesicle cargo loading;|Q9H1H9 A0JP21 A0JP22 F2Z382 Q5THQ2 Q5THQ3 Q9H193 Q9H194 Q9H1H8,Kinesin-like protein KIF13A,Kinesin-like protein RBKIN;, PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0005813;GO:0010008;GO:0005871;GO:0005874;GO:0030496;GO:0032588;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007049;GO:0051301;GO:0008333;GO:0043001;GO:0006886;GO:0032438;GO:0007018;GO:0072383;GO:0032465;GO:0035459;, C:centrosome; C:endosome membrane; C:kinesin complex; C:microtubule; C:midbody; C:trans-Golgi network membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cell cycle; P:cell division; P:endosome to lysosome transport; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:melanosome organization; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:regulation of cytokinesis; P:vesicle cargo loading;|Q9H1H9 A0JP21 A0JP22 F2Z382 Q5THQ2 Q5THQ3 Q9H193 Q9H194 Q9H1H8,Kinesin-like protein KIF13A,Kinesin-like protein RBKIN;, PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0005813;GO:0010008;GO:0005871;GO:0005874;GO:0030496;GO:0032588;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007049;GO:0051301;GO:0008333;GO:0043001;GO:0006886;GO:0032438;GO:0007018;GO:0072383;GO:0032465;GO:0035459;, C:centrosome; C:endosome membrane; C:kinesin complex; C:microtubule; C:midbody; C:trans-Golgi network membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cell cycle; P:cell division; P:endosome to lysosome transport; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:melanosome organization; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:regulation of cytokinesis; P:vesicle cargo loading;|Q9H1H9 A0JP21 A0JP22 F2Z382 Q5THQ2 Q5THQ3 Q9H193 Q9H194 Q9H1H8,Kinesin-like protein KIF13A,Kinesin-like protein RBKIN;, PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0005813;GO:0010008;GO:0005871;GO:0005874;GO:0030496;GO:0032588;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007049;GO:0051301;GO:0008333;GO:0043001;GO:0006886;GO:0032438;GO:0007018;GO:0072383;GO:0032465;GO:0035459;, C:centrosome; C:endosome membrane; C:kinesin complex; C:microtubule; C:midbody; C:trans-Golgi network membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cell cycle; P:cell division; P:endosome to lysosome transport; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:melanosome organization; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:regulation of cytokinesis; P:vesicle cargo loading;|Q9H1H9 A0JP21 A0JP22 F2Z382 Q5THQ2 Q5THQ3 Q9H193 Q9H194 Q9H1H8,Kinesin-like protein KIF13A,Kinesin-like protein RBKIN;, PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0005813;GO:0010008;GO:0005871;GO:0005874;GO:0030496;GO:0032588;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007049;GO:0051301;GO:0008333;GO:0043001;GO:0006886;GO:0032438;GO:0007018;GO:0072383;GO:0032465;GO:0035459;, C:centrosome; C:endosome membrane; C:kinesin complex; C:microtubule; C:midbody; C:trans-Golgi network membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cell cycle; P:cell division; P:endosome to lysosome transport; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:melanosome organization; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:regulation of cytokinesis; P:vesicle cargo loading;|Q9H1H9 A0JP21 A0JP22 F2Z382 Q5THQ2 Q5THQ3 Q9H193 Q9H194 Q9H1H8,Kinesin-like protein KIF13A,Kinesin-like protein RBKIN;, PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0005813;GO:0010008;GO:0005871;GO:0005874;GO:0030496;GO:0032588;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007049;GO:0051301;GO:0008333;GO:0043001;GO:0006886;GO:0032438;GO:0007018;GO:0072383;GO:0032465;GO:0035459;, C:centrosome; C:endosome membrane; C:kinesin complex; C:microtubule; C:midbody; C:trans-Golgi network membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cell cycle; P:cell division; P:endosome to lysosome transport; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:melanosome organization; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:regulation of cytokinesis; P:vesicle cargo loading;|Q9H1H9 A0JP21 A0JP22 F2Z382 Q5THQ2 Q5THQ3 Q9H193 Q9H194 Q9H1H8,Kinesin-like protein KIF13A,Kinesin-like protein RBKIN;, PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0005813;GO:0010008;GO:0005871;GO:0005874;GO:0030496;GO:0032588;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007049;GO:0051301;GO:0008333;GO:0043001;GO:0006886;GO:0032438;GO:0007018;GO:0072383;GO:0032465;GO:0035459;, C:centrosome; C:endosome membrane; C:kinesin complex; C:microtubule; C:midbody; C:trans-Golgi network membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cell cycle; P:cell division; P:endosome to lysosome transport; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:melanosome organization; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:regulation of cytokinesis; P:vesicle cargo loading;|Q9H1H9 A0JP21 A0JP22 F2Z382 Q5THQ2 Q5THQ3 Q9H193 Q9H194 Q9H1H8,Kinesin-like protein KIF13A,Kinesin-like protein RBKIN;, PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0005813;GO:0010008;GO:0005871;GO:0005874;GO:0030496;GO:0032588;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007049;GO:0051301;GO:0008333;GO:0043001;GO:0006886;GO:0032438;GO:0007018;GO:0072383;GO:0032465;GO:0035459;, C:centrosome; C:endosome membrane; C:kinesin complex; C:microtubule; C:midbody; C:trans-Golgi network membrane;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cell cycle; P:cell division; P:endosome to lysosome transport; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:melanosome organization; P:microtubule-based movement; P:plus-end-directed vesicle transport along microtubule; P:regulation of cytokinesis; P:vesicle cargo loading; scaffold39 indexed_genome mRNA 11593227 11615068 . - . ID=transcript_8072;Q5VUK6 Q9UBE6 Q9UBT8 Q9UE62,Thiopurine S-methyltransferase {ECO:0000303|PubMed:18484748},Thiopurine methyltransferase {ECO:0000303|PubMed:657528};, PF05724;, GO:0005829;GO:1904047;GO:0008119;GO:0017144;GO:0032259;GO:0006139;, C:cytosol;, F:S-adenosyl-L-methionine binding; F:thiopurine S-methyltransferase activity;, P:drug metabolic process; P:methylation; P:nucleobase-containing compound metabolic process;|Q5VUK6 Q9UBE6 Q9UBT8 Q9UE62,Thiopurine S-methyltransferase {ECO:0000303|PubMed:18484748},Thiopurine methyltransferase {ECO:0000303|PubMed:657528};, PF05724;, GO:0005829;GO:1904047;GO:0008119;GO:0017144;GO:0032259;GO:0006139;, C:cytosol;, F:S-adenosyl-L-methionine binding; F:thiopurine S-methyltransferase activity;, P:drug metabolic process; P:methylation; P:nucleobase-containing compound metabolic process;|Q5VUK6 Q9UBE6 Q9UBT8 Q9UE62,Thiopurine S-methyltransferase {ECO:0000303|PubMed:18484748},Thiopurine methyltransferase {ECO:0000303|PubMed:657528};, PF05724;, GO:0005829;GO:1904047;GO:0008119;GO:0017144;GO:0032259;GO:0006139;, C:cytosol;, F:S-adenosyl-L-methionine binding; F:thiopurine S-methyltransferase activity;, P:drug metabolic process; P:methylation; P:nucleobase-containing compound metabolic process;|Q5VUK6 Q9UBE6 Q9UBT8 Q9UE62,Thiopurine S-methyltransferase {ECO:0000303|PubMed:18484748},Thiopurine methyltransferase {ECO:0000303|PubMed:657528};, PF05724;, GO:0005829;GO:1904047;GO:0008119;GO:0017144;GO:0032259;GO:0006139;, C:cytosol;, F:S-adenosyl-L-methionine binding; F:thiopurine S-methyltransferase activity;, P:drug metabolic process; P:methylation; P:nucleobase-containing compound metabolic process; scaffold39 indexed_genome mRNA 11623891 11701896 . + . ID=transcript_8073;Q8NB78 A2A2C5 A2A2C6 Q5TGV3 Q6AI15 Q6ZUU4 Q8N258 Q96EL7,Lysine-specific histone demethylase 1B,Flavin-containing amine oxidase domain-containing protein 1;Lysine-specific histone demethylase 2;, PF01593;PF04433;PF07496;, GO:0005654;GO:0000786;GO:0005634;GO:0003682;GO:0071949;GO:0050660;GO:0042393;GO:0034648;GO:0034649;GO:0016491;GO:0008134;GO:0008270;GO:0034720;GO:0030522;GO:0007275;GO:0000122;GO:0045944;GO:0016579;GO:0044030;GO:0006349;, C:nucleoplasm; C:nucleosome; C:nucleus;, F:chromatin binding; F:FAD binding; F:flavin adenine dinucleotide binding; F:histone binding; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-monomethyl-K4 specific); F:oxidoreductase activity; F:transcription factor binding; F:zinc ion binding;, P:histone H3-K4 demethylation; P:intracellular receptor signaling pathway; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of DNA methylation; P:regulation of gene expression by genetic imprinting;|Q8NB78 A2A2C5 A2A2C6 Q5TGV3 Q6AI15 Q6ZUU4 Q8N258 Q96EL7,Lysine-specific histone demethylase 1B,Flavin-containing amine oxidase domain-containing protein 1;Lysine-specific histone demethylase 2;, PF01593;PF04433;PF07496;, GO:0005654;GO:0000786;GO:0005634;GO:0003682;GO:0071949;GO:0050660;GO:0042393;GO:0034648;GO:0034649;GO:0016491;GO:0008134;GO:0008270;GO:0034720;GO:0030522;GO:0007275;GO:0000122;GO:0045944;GO:0016579;GO:0044030;GO:0006349;, C:nucleoplasm; C:nucleosome; C:nucleus;, F:chromatin binding; F:FAD binding; F:flavin adenine dinucleotide binding; F:histone binding; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-monomethyl-K4 specific); F:oxidoreductase activity; F:transcription factor binding; F:zinc ion binding;, P:histone H3-K4 demethylation; P:intracellular receptor signaling pathway; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of DNA methylation; P:regulation of gene expression by genetic imprinting;|P35659 B2R6K6 B4DN37 Q5TGV4 Q5TGV5,Protein DEK,, PF08766;, GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0003723;GO:0006325;GO:0030851;GO:0045815;GO:2000779;GO:0006357;GO:0007165;GO:0006366;GO:0019079;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:RNA binding;, P:chromatin organization; P:granulocyte differentiation; P:positive regulation of gene expression, epigenetic; P:regulation of double-strand break repair; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:transcription by RNA polymerase II; P:viral genome replication;|Q8NB78 A2A2C5 A2A2C6 Q5TGV3 Q6AI15 Q6ZUU4 Q8N258 Q96EL7,Lysine-specific histone demethylase 1B,Flavin-containing amine oxidase domain-containing protein 1;Lysine-specific histone demethylase 2;, PF01593;PF04433;PF07496;, GO:0005654;GO:0000786;GO:0005634;GO:0003682;GO:0071949;GO:0050660;GO:0042393;GO:0034648;GO:0034649;GO:0016491;GO:0008134;GO:0008270;GO:0034720;GO:0030522;GO:0007275;GO:0000122;GO:0045944;GO:0016579;GO:0044030;GO:0006349;, C:nucleoplasm; C:nucleosome; C:nucleus;, F:chromatin binding; F:FAD binding; F:flavin adenine dinucleotide binding; F:histone binding; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-monomethyl-K4 specific); F:oxidoreductase activity; F:transcription factor binding; F:zinc ion binding;, P:histone H3-K4 demethylation; P:intracellular receptor signaling pathway; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of DNA methylation; P:regulation of gene expression by genetic imprinting;|Q8NB78 A2A2C5 A2A2C6 Q5TGV3 Q6AI15 Q6ZUU4 Q8N258 Q96EL7,Lysine-specific histone demethylase 1B,Flavin-containing amine oxidase domain-containing protein 1;Lysine-specific histone demethylase 2;, PF01593;PF04433;PF07496;, GO:0005654;GO:0000786;GO:0005634;GO:0003682;GO:0071949;GO:0050660;GO:0042393;GO:0034648;GO:0034649;GO:0016491;GO:0008134;GO:0008270;GO:0034720;GO:0030522;GO:0007275;GO:0000122;GO:0045944;GO:0016579;GO:0044030;GO:0006349;, C:nucleoplasm; C:nucleosome; C:nucleus;, F:chromatin binding; F:FAD binding; F:flavin adenine dinucleotide binding; F:histone binding; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-monomethyl-K4 specific); F:oxidoreductase activity; F:transcription factor binding; F:zinc ion binding;, P:histone H3-K4 demethylation; P:intracellular receptor signaling pathway; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of DNA methylation; P:regulation of gene expression by genetic imprinting;|P35659 B2R6K6 B4DN37 Q5TGV4 Q5TGV5,Protein DEK,, PF08766;, GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0003723;GO:0006325;GO:0030851;GO:0045815;GO:2000779;GO:0006357;GO:0007165;GO:0006366;GO:0019079;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:RNA binding;, P:chromatin organization; P:granulocyte differentiation; P:positive regulation of gene expression, epigenetic; P:regulation of double-strand break repair; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:transcription by RNA polymerase II; P:viral genome replication;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|P35659 B2R6K6 B4DN37 Q5TGV4 Q5TGV5,Protein DEK,, PF08766;, GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0003723;GO:0006325;GO:0030851;GO:0045815;GO:2000779;GO:0006357;GO:0007165;GO:0006366;GO:0019079;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:RNA binding;, P:chromatin organization; P:granulocyte differentiation; P:positive regulation of gene expression, epigenetic; P:regulation of double-strand break repair; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:transcription by RNA polymerase II; P:viral genome replication; scaffold39 indexed_genome mRNA 11781410 11853673 . + . ID=transcript_8074;Q7Z419 B3KUA8 B4DZI2 Q5TB85 Q6P4Q0 Q8N3R7 Q9BX38,E3 ubiquitin-protein ligase RNF144B,IBR domain-containing protein 2;RING finger protein 144B;p53-inducible RING finger protein;, PF01485;, GO:0005737;GO:0005829;GO:0016021;GO:0031966;GO:0000151;GO:0046872;GO:0031624;GO:0061630;GO:0004842;GO:0006915;GO:0043066;GO:0032436;GO:0000209;GO:0006511;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:mitochondrial membrane; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold39 indexed_genome mRNA 13131534 13180251 . - . ID=transcript_8075;Q6ZNC8 A9EDQ5 B4DL59 B4E3J4 Q86XC2 Q8N9R5,Lysophospholipid acyltransferase 1 {ECO:0000305},1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoethanolamine O-acyltransferase {ECO:0000250|UniProtKB:Q8BH98};1-acylglycerophosphoserine O-acyltransferase MBOAT1 {ECO:0000305};Lysophosphatidylserine acyltransferase;Membrane-bound O-acyltransferase domain-containing protein 1;, PF03062;, GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0016746;GO:0030258;GO:0036152;GO:0036150;GO:0008654;GO:0010975;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:lipid modification; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid biosynthetic process; P:regulation of neuron projection development;|Q6ZNC8 A9EDQ5 B4DL59 B4E3J4 Q86XC2 Q8N9R5,Lysophospholipid acyltransferase 1 {ECO:0000305},1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoethanolamine O-acyltransferase {ECO:0000250|UniProtKB:Q8BH98};1-acylglycerophosphoserine O-acyltransferase MBOAT1 {ECO:0000305};Lysophosphatidylserine acyltransferase;Membrane-bound O-acyltransferase domain-containing protein 1;, PF03062;, GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0016746;GO:0030258;GO:0036152;GO:0036150;GO:0008654;GO:0010975;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:lipid modification; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid biosynthetic process; P:regulation of neuron projection development;|Q6ZNC8 A9EDQ5 B4DL59 B4E3J4 Q86XC2 Q8N9R5,Lysophospholipid acyltransferase 1 {ECO:0000305},1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoethanolamine O-acyltransferase {ECO:0000250|UniProtKB:Q8BH98};1-acylglycerophosphoserine O-acyltransferase MBOAT1 {ECO:0000305};Lysophosphatidylserine acyltransferase;Membrane-bound O-acyltransferase domain-containing protein 1;, PF03062;, GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0016746;GO:0030258;GO:0036152;GO:0036150;GO:0008654;GO:0010975;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:lipid modification; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid biosynthetic process; P:regulation of neuron projection development; scaffold39 indexed_genome mRNA 13479426 13490053 . + . ID=transcript_8076;O00716 Q15000 Q68DT0 Q9BZ44,Transcription factor E2F3,, PF16421;PF02319;, GO:0000785;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0001216;GO:0001228;GO:0003700;GO:0000981;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0000082;GO:0070345;GO:0008284;GO:0045944;GO:1905461;GO:0006606;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:G1/S transition of mitotic cell cycle; P:negative regulation of fat cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:protein import into nucleus; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold39 indexed_genome mRNA 17636531 17649056 . + . ID=transcript_8077;Q8IZ57 B2RAV4 Q8N8R6 Q96P21,Neurensin-1,Neuro-p24;Vesicular membrane protein of 24 kDa;, , GO:0031410;GO:0030426;GO:0016021;GO:0043005;GO:0043025;GO:0030133;GO:0007399;, C:cytoplasmic vesicle; C:growth cone; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:transport vesicle;, , P:nervous system development; scaffold39 indexed_genome mRNA 17838742 17930990 . - . ID=transcript_8078;Q9H167 Q9H4M1 Q9UJC9,Phosphatidylinositol-glycan-specific phospholipase D,Glycoprotein phospholipase D;Glycosyl-phosphatidylinositol-specific phospholipase D;, PF01839;PF00882;, GO:0005737;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0043231;GO:0005765;GO:0004621;GO:0004630;GO:0017080;GO:0006501;GO:0002042;GO:0071277;GO:0071397;GO:0035690;GO:0032869;GO:0071467;GO:0071401;GO:0002062;GO:0002430;GO:0006507;GO:0035701;GO:0097241;GO:0008286;GO:0008285;GO:0010897;GO:0001503;GO:0046470;GO:0010694;GO:0043065;GO:0010595;GO:0010907;GO:0010983;GO:0035774;GO:0051044;GO:0051047;GO:0010867;GO:1900076;GO:0009749;GO:0070633;, C:cytoplasm; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:glycosylphosphatidylinositol phospholipase D activity; F:phospholipase D activity; F:sodium channel regulator activity;, P:C-terminal protein lipidation; P:cell migration involved in sprouting angiogenesis; P:cellular response to calcium ion; P:cellular response to cholesterol; P:cellular response to drug; P:cellular response to insulin stimulus; P:cellular response to pH; P:cellular response to triglyceride; P:chondrocyte differentiation; P:complement receptor mediated signaling pathway; P:GPI anchor release; P:hematopoietic stem cell migration; P:hematopoietic stem cell migration to bone marrow; P:insulin receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of triglyceride catabolic process; P:ossification; P:phosphatidylcholine metabolic process; P:positive regulation of alkaline phosphatase activity; P:positive regulation of apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of glucose metabolic process; P:positive regulation of high-density lipoprotein particle clearance; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of secretion; P:positive regulation of triglyceride biosynthetic process; P:regulation of cellular response to insulin stimulus; P:response to glucose; P:transepithelial transport;|Q9HD23 A8K4U3 B3KNN2 B4DQL2 Q5T3Y1 Q6NTG4 Q96KF8 Q9BVP1,Magnesium transporter MRS2 homolog, mitochondrial,MRS2-like protein;, , GO:0016021;GO:0005743;GO:0005739;GO:0015095;GO:0006089;GO:0015693;GO:0045016;GO:0055085;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:magnesium ion transmembrane transporter activity;, P:lactate metabolic process; P:magnesium ion transport; P:mitochondrial magnesium ion transmembrane transport; P:transmembrane transport;|Q9H167 Q9H4M1 Q9UJC9,Phosphatidylinositol-glycan-specific phospholipase D,Glycoprotein phospholipase D;Glycosyl-phosphatidylinositol-specific phospholipase D;, PF01839;PF00882;, GO:0005737;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0043231;GO:0005765;GO:0004621;GO:0004630;GO:0017080;GO:0006501;GO:0002042;GO:0071277;GO:0071397;GO:0035690;GO:0032869;GO:0071467;GO:0071401;GO:0002062;GO:0002430;GO:0006507;GO:0035701;GO:0097241;GO:0008286;GO:0008285;GO:0010897;GO:0001503;GO:0046470;GO:0010694;GO:0043065;GO:0010595;GO:0010907;GO:0010983;GO:0035774;GO:0051044;GO:0051047;GO:0010867;GO:1900076;GO:0009749;GO:0070633;, C:cytoplasm; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:glycosylphosphatidylinositol phospholipase D activity; F:phospholipase D activity; F:sodium channel regulator activity;, P:C-terminal protein lipidation; P:cell migration involved in sprouting angiogenesis; P:cellular response to calcium ion; P:cellular response to cholesterol; P:cellular response to drug; P:cellular response to insulin stimulus; P:cellular response to pH; P:cellular response to triglyceride; P:chondrocyte differentiation; P:complement receptor mediated signaling pathway; P:GPI anchor release; P:hematopoietic stem cell migration; P:hematopoietic stem cell migration to bone marrow; P:insulin receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of triglyceride catabolic process; P:ossification; P:phosphatidylcholine metabolic process; P:positive regulation of alkaline phosphatase activity; P:positive regulation of apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of glucose metabolic process; P:positive regulation of high-density lipoprotein particle clearance; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of secretion; P:positive regulation of triglyceride biosynthetic process; P:regulation of cellular response to insulin stimulus; P:response to glucose; P:transepithelial transport;|Q9H167 Q9H4M1 Q9UJC9,Phosphatidylinositol-glycan-specific phospholipase D,Glycoprotein phospholipase D;Glycosyl-phosphatidylinositol-specific phospholipase D;, PF01839;PF00882;, GO:0005737;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0043231;GO:0005765;GO:0004621;GO:0004630;GO:0017080;GO:0006501;GO:0002042;GO:0071277;GO:0071397;GO:0035690;GO:0032869;GO:0071467;GO:0071401;GO:0002062;GO:0002430;GO:0006507;GO:0035701;GO:0097241;GO:0008286;GO:0008285;GO:0010897;GO:0001503;GO:0046470;GO:0010694;GO:0043065;GO:0010595;GO:0010907;GO:0010983;GO:0035774;GO:0051044;GO:0051047;GO:0010867;GO:1900076;GO:0009749;GO:0070633;, C:cytoplasm; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:glycosylphosphatidylinositol phospholipase D activity; F:phospholipase D activity; F:sodium channel regulator activity;, P:C-terminal protein lipidation; P:cell migration involved in sprouting angiogenesis; P:cellular response to calcium ion; P:cellular response to cholesterol; P:cellular response to drug; P:cellular response to insulin stimulus; P:cellular response to pH; P:cellular response to triglyceride; P:chondrocyte differentiation; P:complement receptor mediated signaling pathway; P:GPI anchor release; P:hematopoietic stem cell migration; P:hematopoietic stem cell migration to bone marrow; P:insulin receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of triglyceride catabolic process; P:ossification; P:phosphatidylcholine metabolic process; P:positive regulation of alkaline phosphatase activity; P:positive regulation of apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of glucose metabolic process; P:positive regulation of high-density lipoprotein particle clearance; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of secretion; P:positive regulation of triglyceride biosynthetic process; P:regulation of cellular response to insulin stimulus; P:response to glucose; P:transepithelial transport;|Q9H167 Q9H4M1 Q9UJC9,Phosphatidylinositol-glycan-specific phospholipase D,Glycoprotein phospholipase D;Glycosyl-phosphatidylinositol-specific phospholipase D;, PF01839;PF00882;, GO:0005737;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0043231;GO:0005765;GO:0004621;GO:0004630;GO:0017080;GO:0006501;GO:0002042;GO:0071277;GO:0071397;GO:0035690;GO:0032869;GO:0071467;GO:0071401;GO:0002062;GO:0002430;GO:0006507;GO:0035701;GO:0097241;GO:0008286;GO:0008285;GO:0010897;GO:0001503;GO:0046470;GO:0010694;GO:0043065;GO:0010595;GO:0010907;GO:0010983;GO:0035774;GO:0051044;GO:0051047;GO:0010867;GO:1900076;GO:0009749;GO:0070633;, C:cytoplasm; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:glycosylphosphatidylinositol phospholipase D activity; F:phospholipase D activity; F:sodium channel regulator activity;, P:C-terminal protein lipidation; P:cell migration involved in sprouting angiogenesis; P:cellular response to calcium ion; P:cellular response to cholesterol; P:cellular response to drug; P:cellular response to insulin stimulus; P:cellular response to pH; P:cellular response to triglyceride; P:chondrocyte differentiation; P:complement receptor mediated signaling pathway; P:GPI anchor release; P:hematopoietic stem cell migration; P:hematopoietic stem cell migration to bone marrow; P:insulin receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of triglyceride catabolic process; P:ossification; P:phosphatidylcholine metabolic process; P:positive regulation of alkaline phosphatase activity; P:positive regulation of apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of glucose metabolic process; P:positive regulation of high-density lipoprotein particle clearance; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of secretion; P:positive regulation of triglyceride biosynthetic process; P:regulation of cellular response to insulin stimulus; P:response to glucose; P:transepithelial transport; scaffold39 indexed_genome mRNA 17943665 17968992 . + . ID=transcript_8079;P51649 B2RD26 G5E949 Q546H9 Q8N3W6,Succinate-semialdehyde dehydrogenase, mitochondrial,Aldehyde dehydrogenase family 5 member A1;NAD(+)-dependent succinic semialdehyde dehydrogenase;, PF00171;, GO:0005759;GO:0005739;GO:0042802;GO:0004777;GO:0007417;GO:0009450;GO:0006536;GO:0042135;GO:0009791;GO:0006105;, C:mitochondrial matrix; C:mitochondrion;, F:identical protein binding; F:succinate-semialdehyde dehydrogenase (NAD+) activity;, P:central nervous system development; P:gamma-aminobutyric acid catabolic process; P:glutamate metabolic process; P:neurotransmitter catabolic process; P:post-embryonic development; P:succinate metabolic process;|P51649 B2RD26 G5E949 Q546H9 Q8N3W6,Succinate-semialdehyde dehydrogenase, mitochondrial,Aldehyde dehydrogenase family 5 member A1;NAD(+)-dependent succinic semialdehyde dehydrogenase;, PF00171;, GO:0005759;GO:0005739;GO:0042802;GO:0004777;GO:0007417;GO:0009450;GO:0006536;GO:0042135;GO:0009791;GO:0006105;, C:mitochondrial matrix; C:mitochondrion;, F:identical protein binding; F:succinate-semialdehyde dehydrogenase (NAD+) activity;, P:central nervous system development; P:gamma-aminobutyric acid catabolic process; P:glutamate metabolic process; P:neurotransmitter catabolic process; P:post-embryonic development; P:succinate metabolic process;|P51649 B2RD26 G5E949 Q546H9 Q8N3W6,Succinate-semialdehyde dehydrogenase, mitochondrial,Aldehyde dehydrogenase family 5 member A1;NAD(+)-dependent succinic semialdehyde dehydrogenase;, PF00171;, GO:0005759;GO:0005739;GO:0042802;GO:0004777;GO:0007417;GO:0009450;GO:0006536;GO:0042135;GO:0009791;GO:0006105;, C:mitochondrial matrix; C:mitochondrion;, F:identical protein binding; F:succinate-semialdehyde dehydrogenase (NAD+) activity;, P:central nervous system development; P:gamma-aminobutyric acid catabolic process; P:glutamate metabolic process; P:neurotransmitter catabolic process; P:post-embryonic development; P:succinate metabolic process;|P51649 B2RD26 G5E949 Q546H9 Q8N3W6,Succinate-semialdehyde dehydrogenase, mitochondrial,Aldehyde dehydrogenase family 5 member A1;NAD(+)-dependent succinic semialdehyde dehydrogenase;, PF00171;, GO:0005759;GO:0005739;GO:0042802;GO:0004777;GO:0007417;GO:0009450;GO:0006536;GO:0042135;GO:0009791;GO:0006105;, C:mitochondrial matrix; C:mitochondrion;, F:identical protein binding; F:succinate-semialdehyde dehydrogenase (NAD+) activity;, P:central nervous system development; P:gamma-aminobutyric acid catabolic process; P:glutamate metabolic process; P:neurotransmitter catabolic process; P:post-embryonic development; P:succinate metabolic process;|P51649 B2RD26 G5E949 Q546H9 Q8N3W6,Succinate-semialdehyde dehydrogenase, mitochondrial,Aldehyde dehydrogenase family 5 member A1;NAD(+)-dependent succinic semialdehyde dehydrogenase;, PF00171;, GO:0005759;GO:0005739;GO:0042802;GO:0004777;GO:0007417;GO:0009450;GO:0006536;GO:0042135;GO:0009791;GO:0006105;, C:mitochondrial matrix; C:mitochondrion;, F:identical protein binding; F:succinate-semialdehyde dehydrogenase (NAD+) activity;, P:central nervous system development; P:gamma-aminobutyric acid catabolic process; P:glutamate metabolic process; P:neurotransmitter catabolic process; P:post-embryonic development; P:succinate metabolic process; scaffold39 indexed_genome mRNA 17972590 17990304 . - . ID=transcript_8080;Q5VV43 A7MD37 B2RTU7 B4DHA7 B4DK75 B7ZML3 F5H123 Q9UJC8 Q9Y4G7,Dyslexia-associated protein KIAA0319,, PF02010;, GO:0030669;GO:0031410;GO:0005769;GO:0031901;GO:0016021;GO:0043231;GO:0005886;GO:0061024;GO:0033555;GO:0030517;GO:0048692;GO:2000171;GO:0001764;GO:0060391;GO:0010996;, C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:early endosome; C:early endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, , P:membrane organization; P:multicellular organismal response to stress; P:negative regulation of axon extension; P:negative regulation of axon extension involved in regeneration; P:negative regulation of dendrite development; P:neuron migration; P:positive regulation of SMAD protein signal transduction; P:response to auditory stimulus;|Q5VV43 A7MD37 B2RTU7 B4DHA7 B4DK75 B7ZML3 F5H123 Q9UJC8 Q9Y4G7,Dyslexia-associated protein KIAA0319,, PF02010;, GO:0030669;GO:0031410;GO:0005769;GO:0031901;GO:0016021;GO:0043231;GO:0005886;GO:0061024;GO:0033555;GO:0030517;GO:0048692;GO:2000171;GO:0001764;GO:0060391;GO:0010996;, C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:early endosome; C:early endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, , P:membrane organization; P:multicellular organismal response to stress; P:negative regulation of axon extension; P:negative regulation of axon extension involved in regeneration; P:negative regulation of dendrite development; P:neuron migration; P:positive regulation of SMAD protein signal transduction; P:response to auditory stimulus; scaffold39 indexed_genome mRNA 17998892 18048950 . - . ID=transcript_8081;Q5VV43 A7MD37 B2RTU7 B4DHA7 B4DK75 B7ZML3 F5H123 Q9UJC8 Q9Y4G7,Dyslexia-associated protein KIAA0319,, PF02010;, GO:0030669;GO:0031410;GO:0005769;GO:0031901;GO:0016021;GO:0043231;GO:0005886;GO:0061024;GO:0033555;GO:0030517;GO:0048692;GO:2000171;GO:0001764;GO:0060391;GO:0010996;, C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:early endosome; C:early endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, , P:membrane organization; P:multicellular organismal response to stress; P:negative regulation of axon extension; P:negative regulation of axon extension involved in regeneration; P:negative regulation of dendrite development; P:neuron migration; P:positive regulation of SMAD protein signal transduction; P:response to auditory stimulus; scaffold39 indexed_genome mRNA 18050707 18089893 . - . ID=transcript_8082;O95551 B4DKL8 B4DQ95 Q2TBE2 Q5JYM0 Q7Z6U5 Q9NUK5 Q9NYY9,Tyrosyl-DNA phosphodiesterase 2,5'-tyrosyl-DNA phosphodiesterase {ECO:0000303|PubMed:19794497};ETS1-associated protein 2;ETS1-associated protein II;TRAF and TNF receptor-associated protein;Tyrosyl-RNA phosphodiesterase;VPg unlinkase;, PF03372;, GO:0016235;GO:0005737;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0070260;GO:0000287;GO:0030145;GO:0004518;GO:0003697;GO:0003714;GO:0036317;GO:0007166;GO:0006302;GO:0048666;GO:0016032;, C:aggresome; C:cytoplasm; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:5'-tyrosyl-DNA phosphodiesterase activity; F:magnesium ion binding; F:manganese ion binding; F:nuclease activity; F:single-stranded DNA binding; F:transcription corepressor activity; F:tyrosyl-RNA phosphodiesterase activity;, P:cell surface receptor signaling pathway; P:double-strand break repair; P:neuron development; P:viral process;|O95551 B4DKL8 B4DQ95 Q2TBE2 Q5JYM0 Q7Z6U5 Q9NUK5 Q9NYY9,Tyrosyl-DNA phosphodiesterase 2,5'-tyrosyl-DNA phosphodiesterase {ECO:0000303|PubMed:19794497};ETS1-associated protein 2;ETS1-associated protein II;TRAF and TNF receptor-associated protein;Tyrosyl-RNA phosphodiesterase;VPg unlinkase;, PF03372;, GO:0016235;GO:0005737;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0070260;GO:0000287;GO:0030145;GO:0004518;GO:0003697;GO:0003714;GO:0036317;GO:0007166;GO:0006302;GO:0048666;GO:0016032;, C:aggresome; C:cytoplasm; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:5'-tyrosyl-DNA phosphodiesterase activity; F:magnesium ion binding; F:manganese ion binding; F:nuclease activity; F:single-stranded DNA binding; F:transcription corepressor activity; F:tyrosyl-RNA phosphodiesterase activity;, P:cell surface receptor signaling pathway; P:double-strand break repair; P:neuron development; P:viral process;|O95551 B4DKL8 B4DQ95 Q2TBE2 Q5JYM0 Q7Z6U5 Q9NUK5 Q9NYY9,Tyrosyl-DNA phosphodiesterase 2,5'-tyrosyl-DNA phosphodiesterase {ECO:0000303|PubMed:19794497};ETS1-associated protein 2;ETS1-associated protein II;TRAF and TNF receptor-associated protein;Tyrosyl-RNA phosphodiesterase;VPg unlinkase;, PF03372;, GO:0016235;GO:0005737;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0070260;GO:0000287;GO:0030145;GO:0004518;GO:0003697;GO:0003714;GO:0036317;GO:0007166;GO:0006302;GO:0048666;GO:0016032;, C:aggresome; C:cytoplasm; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:5'-tyrosyl-DNA phosphodiesterase activity; F:magnesium ion binding; F:manganese ion binding; F:nuclease activity; F:single-stranded DNA binding; F:transcription corepressor activity; F:tyrosyl-RNA phosphodiesterase activity;, P:cell surface receptor signaling pathway; P:double-strand break repair; P:neuron development; P:viral process;|O95551 B4DKL8 B4DQ95 Q2TBE2 Q5JYM0 Q7Z6U5 Q9NUK5 Q9NYY9,Tyrosyl-DNA phosphodiesterase 2,5'-tyrosyl-DNA phosphodiesterase {ECO:0000303|PubMed:19794497};ETS1-associated protein 2;ETS1-associated protein II;TRAF and TNF receptor-associated protein;Tyrosyl-RNA phosphodiesterase;VPg unlinkase;, PF03372;, GO:0016235;GO:0005737;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0070260;GO:0000287;GO:0030145;GO:0004518;GO:0003697;GO:0003714;GO:0036317;GO:0007166;GO:0006302;GO:0048666;GO:0016032;, C:aggresome; C:cytoplasm; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:5'-tyrosyl-DNA phosphodiesterase activity; F:magnesium ion binding; F:manganese ion binding; F:nuclease activity; F:single-stranded DNA binding; F:transcription corepressor activity; F:tyrosyl-RNA phosphodiesterase activity;, P:cell surface receptor signaling pathway; P:double-strand break repair; P:neuron development; P:viral process;|Q9GZU0 Q3LIB6 Q5JVZ2 Q5JVZ3 Q6IA63 Q9H1Z2,Uncharacterized protein C6orf62,HBV X-transactivated gene 12 protein;HBV XAg-transactivated protein 12;, PF15130;|Q9GZU0 Q3LIB6 Q5JVZ2 Q5JVZ3 Q6IA63 Q9H1Z2,Uncharacterized protein C6orf62,HBV X-transactivated gene 12 protein;HBV XAg-transactivated protein 12;, PF15130;|Q9GZU0 Q3LIB6 Q5JVZ2 Q5JVZ3 Q6IA63 Q9H1Z2,Uncharacterized protein C6orf62,HBV X-transactivated gene 12 protein;HBV XAg-transactivated protein 12;, PF15130; scaffold39 indexed_genome mRNA 18119673 18130068 . + . ID=transcript_8083;O75496 B3KMM8 Q9H1Z1,Geminin,, PF07412;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0042826;GO:0070491;GO:0003714;GO:0009887;GO:0006270;GO:0071163;GO:0045786;GO:0008156;GO:2000104;GO:0045892;GO:0035563;GO:0036388;GO:0006275;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase binding; F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:DNA replication initiation; P:DNA replication preinitiation complex assembly; P:negative regulation of cell cycle; P:negative regulation of DNA replication; P:negative regulation of DNA-dependent DNA replication; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin binding; P:pre-replicative complex assembly; P:regulation of DNA replication;|O75496 B3KMM8 Q9H1Z1,Geminin,, PF07412;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0042826;GO:0070491;GO:0003714;GO:0009887;GO:0006270;GO:0071163;GO:0045786;GO:0008156;GO:2000104;GO:0045892;GO:0035563;GO:0036388;GO:0006275;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase binding; F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:DNA replication initiation; P:DNA replication preinitiation complex assembly; P:negative regulation of cell cycle; P:negative regulation of DNA replication; P:negative regulation of DNA-dependent DNA replication; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin binding; P:pre-replicative complex assembly; P:regulation of DNA replication;|O75496 B3KMM8 Q9H1Z1,Geminin,, PF07412;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0042826;GO:0070491;GO:0003714;GO:0009887;GO:0006270;GO:0071163;GO:0045786;GO:0008156;GO:2000104;GO:0045892;GO:0035563;GO:0036388;GO:0006275;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase binding; F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:DNA replication initiation; P:DNA replication preinitiation complex assembly; P:negative regulation of cell cycle; P:negative regulation of DNA replication; P:negative regulation of DNA-dependent DNA replication; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin binding; P:pre-replicative complex assembly; P:regulation of DNA replication; scaffold39 indexed_genome mRNA 18139042 18220014 . - . ID=transcript_8084;Q9Y4F9 A6NHP2 Q13529 Q5VV37 Q5VV38 Q9BQ28,Rho family-interacting cell polarization regulator 2,, PF15903;, GO:0016324;GO:0005737;GO:0005856;GO:0030175;GO:0032420;GO:0060171;GO:0071889;GO:0042802;GO:0060088;GO:0007155;GO:1990869;GO:0071260;GO:0006935;GO:0045184;GO:0007162;GO:1903904;GO:1905872;GO:2001107;GO:0035024;GO:2000405;GO:0042130;GO:0071158;GO:0051491;GO:0045663;GO:1901741;GO:0090023;GO:2000391;GO:0051260;GO:2000114;GO:1901673;GO:0007605;GO:0048741;, C:apical plasma membrane; C:cytoplasm; C:cytoskeleton; C:filopodium; C:stereocilium; C:stereocilium membrane;, F:14-3-3 protein binding; F:identical protein binding;, P:auditory receptor cell stereocilium organization; P:cell adhesion; P:cellular response to chemokine; P:cellular response to mechanical stimulus; P:chemotaxis; P:establishment of protein localization; P:negative regulation of cell adhesion; P:negative regulation of establishment of T cell polarity; P:negative regulation of protein localization to cell leading edge; P:negative regulation of Rho guanyl-nucleotide exchange factor activity; P:negative regulation of Rho protein signal transduction; P:negative regulation of T cell migration; P:negative regulation of T cell proliferation; P:positive regulation of cell cycle arrest; P:positive regulation of filopodium assembly; P:positive regulation of myoblast differentiation; P:positive regulation of myoblast fusion; P:positive regulation of neutrophil chemotaxis; P:positive regulation of neutrophil extravasation; P:protein homooligomerization; P:regulation of establishment of cell polarity; P:regulation of mitotic spindle assembly; P:sensory perception of sound; P:skeletal muscle fiber development;|Q9Y4F9 A6NHP2 Q13529 Q5VV37 Q5VV38 Q9BQ28,Rho family-interacting cell polarization regulator 2,, PF15903;, GO:0016324;GO:0005737;GO:0005856;GO:0030175;GO:0032420;GO:0060171;GO:0071889;GO:0042802;GO:0060088;GO:0007155;GO:1990869;GO:0071260;GO:0006935;GO:0045184;GO:0007162;GO:1903904;GO:1905872;GO:2001107;GO:0035024;GO:2000405;GO:0042130;GO:0071158;GO:0051491;GO:0045663;GO:1901741;GO:0090023;GO:2000391;GO:0051260;GO:2000114;GO:1901673;GO:0007605;GO:0048741;, C:apical plasma membrane; C:cytoplasm; C:cytoskeleton; C:filopodium; C:stereocilium; C:stereocilium membrane;, F:14-3-3 protein binding; F:identical protein binding;, P:auditory receptor cell stereocilium organization; P:cell adhesion; P:cellular response to chemokine; P:cellular response to mechanical stimulus; P:chemotaxis; P:establishment of protein localization; P:negative regulation of cell adhesion; P:negative regulation of establishment of T cell polarity; P:negative regulation of protein localization to cell leading edge; P:negative regulation of Rho guanyl-nucleotide exchange factor activity; P:negative regulation of Rho protein signal transduction; P:negative regulation of T cell migration; P:negative regulation of T cell proliferation; P:positive regulation of cell cycle arrest; P:positive regulation of filopodium assembly; P:positive regulation of myoblast differentiation; P:positive regulation of myoblast fusion; P:positive regulation of neutrophil chemotaxis; P:positive regulation of neutrophil extravasation; P:protein homooligomerization; P:regulation of establishment of cell polarity; P:regulation of mitotic spindle assembly; P:sensory perception of sound; P:skeletal muscle fiber development;|Q9Y4F9 A6NHP2 Q13529 Q5VV37 Q5VV38 Q9BQ28,Rho family-interacting cell polarization regulator 2,, PF15903;, GO:0016324;GO:0005737;GO:0005856;GO:0030175;GO:0032420;GO:0060171;GO:0071889;GO:0042802;GO:0060088;GO:0007155;GO:1990869;GO:0071260;GO:0006935;GO:0045184;GO:0007162;GO:1903904;GO:1905872;GO:2001107;GO:0035024;GO:2000405;GO:0042130;GO:0071158;GO:0051491;GO:0045663;GO:1901741;GO:0090023;GO:2000391;GO:0051260;GO:2000114;GO:1901673;GO:0007605;GO:0048741;, C:apical plasma membrane; C:cytoplasm; C:cytoskeleton; C:filopodium; C:stereocilium; C:stereocilium membrane;, F:14-3-3 protein binding; F:identical protein binding;, P:auditory receptor cell stereocilium organization; P:cell adhesion; P:cellular response to chemokine; P:cellular response to mechanical stimulus; P:chemotaxis; P:establishment of protein localization; P:negative regulation of cell adhesion; P:negative regulation of establishment of T cell polarity; P:negative regulation of protein localization to cell leading edge; P:negative regulation of Rho guanyl-nucleotide exchange factor activity; P:negative regulation of Rho protein signal transduction; P:negative regulation of T cell migration; P:negative regulation of T cell proliferation; P:positive regulation of cell cycle arrest; P:positive regulation of filopodium assembly; P:positive regulation of myoblast differentiation; P:positive regulation of myoblast fusion; P:positive regulation of neutrophil chemotaxis; P:positive regulation of neutrophil extravasation; P:protein homooligomerization; P:regulation of establishment of cell polarity; P:regulation of mitotic spindle assembly; P:sensory perception of sound; P:skeletal muscle fiber development; scaffold39 indexed_genome mRNA 18378795 18435077 . - . ID=transcript_8085;Q9Y471 C1K3L2 O95250 Q5TD41 Q5TD42 Q5TD43 Q5TD44 Q68DC3 Q9UEE7,Inactive cytidine monophosphate-N-acetylneuraminic acid hydroxylase {ECO:0000305|PubMed:9751737},Cytidine monophosphate-N-acetylneuraminic acid hydroxylase pseudogene;, , GO:0005737;GO:0005856;GO:0016020;GO:0005634;GO:0030111;, C:cytoplasm; C:cytoskeleton; C:membrane; C:nucleus;, , P:regulation of Wnt signaling pathway;|Q9Y471 C1K3L2 O95250 Q5TD41 Q5TD42 Q5TD43 Q5TD44 Q68DC3 Q9UEE7,Inactive cytidine monophosphate-N-acetylneuraminic acid hydroxylase {ECO:0000305|PubMed:9751737},Cytidine monophosphate-N-acetylneuraminic acid hydroxylase pseudogene;, , GO:0005737;GO:0005856;GO:0016020;GO:0005634;GO:0030111;, C:cytoplasm; C:cytoskeleton; C:membrane; C:nucleus;, , P:regulation of Wnt signaling pathway;|Q9Y471 C1K3L2 O95250 Q5TD41 Q5TD42 Q5TD43 Q5TD44 Q68DC3 Q9UEE7,Inactive cytidine monophosphate-N-acetylneuraminic acid hydroxylase {ECO:0000305|PubMed:9751737},Cytidine monophosphate-N-acetylneuraminic acid hydroxylase pseudogene;, , GO:0005737;GO:0005856;GO:0016020;GO:0005634;GO:0030111;, C:cytoplasm; C:cytoskeleton; C:membrane; C:nucleus;, , P:regulation of Wnt signaling pathway; scaffold39 indexed_genome mRNA 18696554 18865877 . + . ID=transcript_8086;Q5VZK9 B8X1J0 Q6ZUH5 Q6ZW07 Q9NXU7,F-actin-uncapping protein LRRC16A {ECO:0000305},CARMIL homolog {ECO:0000250|UniProtKB:Q95VZ3};Capping protein regulator and myosin 1 linker protein 1 {ECO:0000312|HGNC:HGNC:21581};Capping protein, Arp2/3 and myosin-I linker homolog 1 {ECO:0000250|UniProtKB:Q95VZ3};Capping protein, Arp2/3 and myosin-I linker protein 1 {ECO:0000303|PubMed:16054028};Leucine-rich repeat-containing protein 16A {ECO:0000312|HGNC:HGNC:21581};, PF17888;PF16000;PF13516;, GO:0031252;GO:0005829;GO:0070062;GO:0031941;GO:0030027;GO:0044354;GO:0016607;GO:0005654;GO:0005886;GO:0044877;GO:0051639;GO:0007015;GO:0051638;GO:0007596;GO:0016477;GO:0030032;GO:0044351;GO:2000813;GO:0030838;GO:0030335;GO:1902745;GO:0051496;GO:1900026;GO:0031529;GO:0046415;, C:cell leading edge; C:cytosol; C:extracellular exosome; C:filamentous actin; C:lamellipodium; C:macropinosome; C:nuclear speck; C:nucleoplasm; C:plasma membrane;, F:protein-containing complex binding;, P:actin filament network formation; P:actin filament organization; P:barbed-end actin filament uncapping; P:blood coagulation; P:cell migration; P:lamellipodium assembly; P:macropinocytosis; P:negative regulation of barbed-end actin filament capping; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of lamellipodium organization; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:ruffle organization; P:urate metabolic process; scaffold39 indexed_genome mRNA 18869763 18872775 . - . ID=transcript_8087;Q5VZK9 B8X1J0 Q6ZUH5 Q6ZW07 Q9NXU7,F-actin-uncapping protein LRRC16A {ECO:0000305},CARMIL homolog {ECO:0000250|UniProtKB:Q95VZ3};Capping protein regulator and myosin 1 linker protein 1 {ECO:0000312|HGNC:HGNC:21581};Capping protein, Arp2/3 and myosin-I linker homolog 1 {ECO:0000250|UniProtKB:Q95VZ3};Capping protein, Arp2/3 and myosin-I linker protein 1 {ECO:0000303|PubMed:16054028};Leucine-rich repeat-containing protein 16A {ECO:0000312|HGNC:HGNC:21581};, PF17888;PF16000;PF13516;, GO:0031252;GO:0005829;GO:0070062;GO:0031941;GO:0030027;GO:0044354;GO:0016607;GO:0005654;GO:0005886;GO:0044877;GO:0051639;GO:0007015;GO:0051638;GO:0007596;GO:0016477;GO:0030032;GO:0044351;GO:2000813;GO:0030838;GO:0030335;GO:1902745;GO:0051496;GO:1900026;GO:0031529;GO:0046415;, C:cell leading edge; C:cytosol; C:extracellular exosome; C:filamentous actin; C:lamellipodium; C:macropinosome; C:nuclear speck; C:nucleoplasm; C:plasma membrane;, F:protein-containing complex binding;, P:actin filament network formation; P:actin filament organization; P:barbed-end actin filament uncapping; P:blood coagulation; P:cell migration; P:lamellipodium assembly; P:macropinocytosis; P:negative regulation of barbed-end actin filament capping; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of lamellipodium organization; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:ruffle organization; P:urate metabolic process; scaffold39 indexed_genome mRNA 19026863 19045429 . + . ID=transcript_8088;Q9Y2C5 B4DDV9 E7EPE8 E7EU17 Q32MB7 Q32MB8,Probable small intestine urate exporter,Solute carrier family 17 member 4;, PF07690;, GO:0016324;GO:0016021;GO:0005887;GO:0005764;GO:0016020;GO:0015136;GO:0005436;GO:0022857;GO:0006820;GO:0006796;GO:0015739;GO:0006814;, C:apical plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:membrane;, F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:phosphate-containing compound metabolic process; P:sialic acid transport; P:sodium ion transport;|Q9Y2C5 B4DDV9 E7EPE8 E7EU17 Q32MB7 Q32MB8,Probable small intestine urate exporter,Solute carrier family 17 member 4;, PF07690;, GO:0016324;GO:0016021;GO:0005887;GO:0005764;GO:0016020;GO:0015136;GO:0005436;GO:0022857;GO:0006820;GO:0006796;GO:0015739;GO:0006814;, C:apical plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:membrane;, F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:phosphate-containing compound metabolic process; P:sialic acid transport; P:sodium ion transport; scaffold39 indexed_genome mRNA 19053028 19104621 . + . ID=transcript_8089;Q14916 A8K418 O60761 Q13783 Q3MIP5 Q5MJP8 Q5TB83 Q96KL8,Sodium-dependent phosphate transport protein 1,Na(+)/PI cotransporter 1;Na/Pi-4;Renal Na(+)-dependent phosphate cotransporter 1;Renal sodium-dependent phosphate transport protein 1;Sodium/phosphate cotransporter 1;Solute carrier family 17 member 1;, PF07690;, GO:0016324;GO:0016021;GO:0005887;GO:0005764;GO:0016020;GO:0005886;GO:0015114;GO:0015136;GO:0005436;GO:0022857;GO:0006820;GO:0006811;GO:0006817;GO:0015739;GO:0046415;GO:0015747;, C:apical plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:membrane; C:plasma membrane;, F:phosphate ion transmembrane transporter activity; F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:ion transport; P:phosphate ion transport; P:sialic acid transport; P:urate metabolic process; P:urate transport;|Q9Y2C5 B4DDV9 E7EPE8 E7EU17 Q32MB7 Q32MB8,Probable small intestine urate exporter,Solute carrier family 17 member 4;, PF07690;, GO:0016324;GO:0016021;GO:0005887;GO:0005764;GO:0016020;GO:0015136;GO:0005436;GO:0022857;GO:0006820;GO:0006796;GO:0015739;GO:0006814;, C:apical plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:membrane;, F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:phosphate-containing compound metabolic process; P:sialic acid transport; P:sodium ion transport;|Q9Y2C5 B4DDV9 E7EPE8 E7EU17 Q32MB7 Q32MB8,Probable small intestine urate exporter,Solute carrier family 17 member 4;, PF07690;, GO:0016324;GO:0016021;GO:0005887;GO:0005764;GO:0016020;GO:0015136;GO:0005436;GO:0022857;GO:0006820;GO:0006796;GO:0015739;GO:0006814;, C:apical plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:membrane;, F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:phosphate-containing compound metabolic process; P:sialic acid transport; P:sodium ion transport;|Q14916 A8K418 O60761 Q13783 Q3MIP5 Q5MJP8 Q5TB83 Q96KL8,Sodium-dependent phosphate transport protein 1,Na(+)/PI cotransporter 1;Na/Pi-4;Renal Na(+)-dependent phosphate cotransporter 1;Renal sodium-dependent phosphate transport protein 1;Sodium/phosphate cotransporter 1;Solute carrier family 17 member 1;, PF07690;, GO:0016324;GO:0016021;GO:0005887;GO:0005764;GO:0016020;GO:0005886;GO:0015114;GO:0015136;GO:0005436;GO:0022857;GO:0006820;GO:0006811;GO:0006817;GO:0015739;GO:0046415;GO:0015747;, C:apical plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:membrane; C:plasma membrane;, F:phosphate ion transmembrane transporter activity; F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:ion transport; P:phosphate ion transport; P:sialic acid transport; P:urate metabolic process; P:urate transport; scaffold39 indexed_genome mRNA 19120763 19137792 . + . ID=transcript_8090;O00476 B7WNJ5 B7Z511 Q8WWC7 Q9H533,Sodium-dependent phosphate transport protein 4,Na(+)/PI cotransporter 4;Sodium/phosphate cotransporter 4;Solute carrier family 17 member 3;, PF07690;, GO:0016324;GO:0031526;GO:0005737;GO:0005789;GO:0016021;GO:0005887;GO:0005764;GO:0048471;GO:0005886;GO:0015562;GO:0008514;GO:0015136;GO:0005436;GO:0019534;GO:0022857;GO:0015143;GO:0008308;GO:0042910;GO:0006820;GO:0015760;GO:0034220;GO:0015711;GO:0006817;GO:0015739;GO:0006814;GO:0046415;GO:0015747;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:efflux transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:toxin transmembrane transporter activity; F:transmembrane transporter activity; F:urate transmembrane transporter activity; F:voltage-gated anion channel activity; F:xenobiotic transmembrane transporter activity;, P:anion transport; P:glucose-6-phosphate transport; P:ion transmembrane transport; P:organic anion transport; P:phosphate ion transport; P:sialic acid transport; P:sodium ion transport; P:urate metabolic process; P:urate transport; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O00476 B7WNJ5 B7Z511 Q8WWC7 Q9H533,Sodium-dependent phosphate transport protein 4,Na(+)/PI cotransporter 4;Sodium/phosphate cotransporter 4;Solute carrier family 17 member 3;, PF07690;, GO:0016324;GO:0031526;GO:0005737;GO:0005789;GO:0016021;GO:0005887;GO:0005764;GO:0048471;GO:0005886;GO:0015562;GO:0008514;GO:0015136;GO:0005436;GO:0019534;GO:0022857;GO:0015143;GO:0008308;GO:0042910;GO:0006820;GO:0015760;GO:0034220;GO:0015711;GO:0006817;GO:0015739;GO:0006814;GO:0046415;GO:0015747;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:efflux transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:toxin transmembrane transporter activity; F:transmembrane transporter activity; F:urate transmembrane transporter activity; F:voltage-gated anion channel activity; F:xenobiotic transmembrane transporter activity;, P:anion transport; P:glucose-6-phosphate transport; P:ion transmembrane transport; P:organic anion transport; P:phosphate ion transport; P:sialic acid transport; P:sodium ion transport; P:urate metabolic process; P:urate transport; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O00476 B7WNJ5 B7Z511 Q8WWC7 Q9H533,Sodium-dependent phosphate transport protein 4,Na(+)/PI cotransporter 4;Sodium/phosphate cotransporter 4;Solute carrier family 17 member 3;, PF07690;, GO:0016324;GO:0031526;GO:0005737;GO:0005789;GO:0016021;GO:0005887;GO:0005764;GO:0048471;GO:0005886;GO:0015562;GO:0008514;GO:0015136;GO:0005436;GO:0019534;GO:0022857;GO:0015143;GO:0008308;GO:0042910;GO:0006820;GO:0015760;GO:0034220;GO:0015711;GO:0006817;GO:0015739;GO:0006814;GO:0046415;GO:0015747;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:efflux transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:toxin transmembrane transporter activity; F:transmembrane transporter activity; F:urate transmembrane transporter activity; F:voltage-gated anion channel activity; F:xenobiotic transmembrane transporter activity;, P:anion transport; P:glucose-6-phosphate transport; P:ion transmembrane transport; P:organic anion transport; P:phosphate ion transport; P:sialic acid transport; P:sodium ion transport; P:urate metabolic process; P:urate transport; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|O00476 B7WNJ5 B7Z511 Q8WWC7 Q9H533,Sodium-dependent phosphate transport protein 4,Na(+)/PI cotransporter 4;Sodium/phosphate cotransporter 4;Solute carrier family 17 member 3;, PF07690;, GO:0016324;GO:0031526;GO:0005737;GO:0005789;GO:0016021;GO:0005887;GO:0005764;GO:0048471;GO:0005886;GO:0015562;GO:0008514;GO:0015136;GO:0005436;GO:0019534;GO:0022857;GO:0015143;GO:0008308;GO:0042910;GO:0006820;GO:0015760;GO:0034220;GO:0015711;GO:0006817;GO:0015739;GO:0006814;GO:0046415;GO:0015747;GO:1990961;, C:apical plasma membrane; C:brush border membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:efflux transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:toxin transmembrane transporter activity; F:transmembrane transporter activity; F:urate transmembrane transporter activity; F:voltage-gated anion channel activity; F:xenobiotic transmembrane transporter activity;, P:anion transport; P:glucose-6-phosphate transport; P:ion transmembrane transport; P:organic anion transport; P:phosphate ion transport; P:sialic acid transport; P:sodium ion transport; P:urate metabolic process; P:urate transport; P:xenobiotic detoxification by transmembrane export across the plasma membrane; scaffold39 indexed_genome mRNA 19158043 19171136 . - . ID=transcript_8091;O00624 A6NK81 A6NLD6 Q5TB84 Q76P85,Sodium-dependent phosphate transport protein 3,Na(+)/PI cotransporter 3;Sodium/phosphate cotransporter 3;Solute carrier family 17 member 2;, PF07690;, GO:0016021;GO:0005887;GO:0005764;GO:0016020;GO:0015136;GO:0005436;GO:0022857;GO:0006820;GO:0006796;GO:0015739;GO:0006814;, C:integral component of membrane; C:integral component of plasma membrane; C:lysosome; C:membrane;, F:sialic acid transmembrane transporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:phosphate-containing compound metabolic process; P:sialic acid transport; P:sodium ion transport; scaffold39 indexed_genome mRNA 19188559 19203892 . + . ID=transcript_8092;O00635 B2R862,E3 ubiquitin-protein ligase TRIM38,RING finger protein 15;RING-type E3 ubiquitin transferase TRIM38 {ECO:0000305};Tripartite motif-containing protein 38;Zinc finger protein RoRet;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005654;GO:0042803;GO:0019901;GO:0003713;GO:0061630;GO:0008270;GO:0045087;GO:0060333;GO:0010508;GO:0051091;GO:0043123;GO:0051092;GO:0046598;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:protein homodimerization activity; F:protein kinase binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of viral entry into host cell; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell;|O00635 B2R862,E3 ubiquitin-protein ligase TRIM38,RING finger protein 15;RING-type E3 ubiquitin transferase TRIM38 {ECO:0000305};Tripartite motif-containing protein 38;Zinc finger protein RoRet;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005654;GO:0042803;GO:0019901;GO:0003713;GO:0061630;GO:0008270;GO:0045087;GO:0060333;GO:0010508;GO:0051091;GO:0043123;GO:0051092;GO:0046598;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:protein homodimerization activity; F:protein kinase binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of viral entry into host cell; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell; scaffold39 indexed_genome mRNA 19251119 19252824 . - . ID=transcript_8093;P16402 B2R751 Q2M2I2,Histone H1.3,Histone H1c;Histone H1s-2;, PF00538;, GO:0000785;GO:0000791;GO:0000786;GO:0005634;GO:0031490;GO:0003690;GO:0031492;GO:0003723;GO:0030261;GO:0031936;GO:0045910;GO:0006334;GO:0016584;, C:chromatin; C:euchromatin; C:nucleosome; C:nucleus;, F:chromatin DNA binding; F:double-stranded DNA binding; F:nucleosomal DNA binding; F:RNA binding;, P:chromosome condensation; P:negative regulation of chromatin silencing; P:negative regulation of DNA recombination; P:nucleosome assembly; P:nucleosome positioning; scaffold39 indexed_genome mRNA 19264257 19273430 . + . ID=transcript_8094;Q96KU8 Q9HC64 Q9HC68 Q9HC70 Q9HC83,Hereditary hemochromatosis protein,HLA-H;, PF07654;PF00129;, GO:0045177;GO:0045178;GO:0031410;GO:0005769;GO:0009897;GO:0005615;GO:1990712;GO:0005887;GO:0005654;GO:0048471;GO:0005886;GO:0055037;GO:1990357;GO:0030881;GO:0039706;GO:0005102;GO:1990459;GO:0006953;GO:0030509;GO:0006879;GO:0071281;GO:0010106;GO:0007565;GO:0055072;GO:0098711;GO:0097421;GO:1904283;GO:2001186;GO:0032435;GO:1900121;GO:2000272;GO:0002626;GO:0002725;GO:2000059;GO:1904434;GO:0010628;GO:0010862;GO:0090277;GO:0032092;GO:1900122;GO:0048260;GO:2000273;GO:1904437;GO:0065003;GO:0034756;GO:2000008;GO:0010039;GO:1990641;GO:0033572;, C:apical part of cell; C:basal part of cell; C:cytoplasmic vesicle; C:early endosome; C:external side of plasma membrane; C:extracellular space; C:HFE-transferrin receptor complex; C:integral component of plasma membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:terminal web;, F:beta-2-microglobulin binding; F:co-receptor binding; F:signaling receptor binding; F:transferrin receptor binding;, P:acute-phase response; P:BMP signaling pathway; P:cellular iron ion homeostasis; P:cellular response to iron ion; P:cellular response to iron ion starvation; P:female pregnancy; P:iron ion homeostasis; P:iron ion import across plasma membrane; P:liver regeneration; P:negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I; P:negative regulation of CD8-positive, alpha-beta T cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of receptor binding; P:negative regulation of signaling receptor activity; P:negative regulation of T cell antigen processing and presentation; P:negative regulation of T cell cytokine production; P:negative regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ferrous iron binding; P:positive regulation of gene expression; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of peptide hormone secretion; P:positive regulation of protein binding; P:positive regulation of receptor binding; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of signaling receptor activity; P:positive regulation of transferrin receptor binding; P:protein-containing complex assembly; P:regulation of iron ion transport; P:regulation of protein localization to cell surface; P:response to iron ion; P:response to iron ion starvation; P:transferrin transport;|Q96KU8 Q9HC64 Q9HC68 Q9HC70 Q9HC83,Hereditary hemochromatosis protein,HLA-H;, PF07654;PF00129;, GO:0045177;GO:0045178;GO:0031410;GO:0005769;GO:0009897;GO:0005615;GO:1990712;GO:0005887;GO:0005654;GO:0048471;GO:0005886;GO:0055037;GO:1990357;GO:0030881;GO:0039706;GO:0005102;GO:1990459;GO:0006953;GO:0030509;GO:0006879;GO:0071281;GO:0010106;GO:0007565;GO:0055072;GO:0098711;GO:0097421;GO:1904283;GO:2001186;GO:0032435;GO:1900121;GO:2000272;GO:0002626;GO:0002725;GO:2000059;GO:1904434;GO:0010628;GO:0010862;GO:0090277;GO:0032092;GO:1900122;GO:0048260;GO:2000273;GO:1904437;GO:0065003;GO:0034756;GO:2000008;GO:0010039;GO:1990641;GO:0033572;, C:apical part of cell; C:basal part of cell; C:cytoplasmic vesicle; C:early endosome; C:external side of plasma membrane; C:extracellular space; C:HFE-transferrin receptor complex; C:integral component of plasma membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:terminal web;, F:beta-2-microglobulin binding; F:co-receptor binding; F:signaling receptor binding; F:transferrin receptor binding;, P:acute-phase response; P:BMP signaling pathway; P:cellular iron ion homeostasis; P:cellular response to iron ion; P:cellular response to iron ion starvation; P:female pregnancy; P:iron ion homeostasis; P:iron ion import across plasma membrane; P:liver regeneration; P:negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I; P:negative regulation of CD8-positive, alpha-beta T cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of receptor binding; P:negative regulation of signaling receptor activity; P:negative regulation of T cell antigen processing and presentation; P:negative regulation of T cell cytokine production; P:negative regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ferrous iron binding; P:positive regulation of gene expression; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of peptide hormone secretion; P:positive regulation of protein binding; P:positive regulation of receptor binding; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of signaling receptor activity; P:positive regulation of transferrin receptor binding; P:protein-containing complex assembly; P:regulation of iron ion transport; P:regulation of protein localization to cell surface; P:response to iron ion; P:response to iron ion starvation; P:transferrin transport; scaffold39 indexed_genome mRNA 19281685 19283361 . + . ID=transcript_8095;P22492 Q6ISI1 Q8IUE8,Histone H1t,Testicular H1 histone;, PF00538;, GO:0000786;GO:0005634;GO:0003690;GO:0031492;GO:0030154;GO:0030261;GO:0007275;GO:0031936;GO:0045910;GO:0006334;GO:0016584;GO:0007283;, C:nucleosome; C:nucleus;, F:double-stranded DNA binding; F:nucleosomal DNA binding;, P:cell differentiation; P:chromosome condensation; P:multicellular organism development; P:negative regulation of chromatin silencing; P:negative regulation of DNA recombination; P:nucleosome assembly; P:nucleosome positioning; P:spermatogenesis; scaffold39 indexed_genome mRNA 19284172 19298331 . - . ID=transcript_8096;Q99877 B2R5L4 Q494S8 Q96FB7,Histone H2B type 1-N,Histone H2B.d;, PF00125;, GO:0005829;GO:0070062;GO:0005654;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006334;GO:0016567;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:nucleosome assembly; P:protein ubiquitination; scaffold39 indexed_genome mRNA 19370199 19370918 . - . ID=transcript_8097;Q7L7L0 B2R4S4,Histone H2A type 3,, PF00125;PF16211;, GO:0070062;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006342;GO:0006337;GO:0070914;, C:extracellular exosome; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:chromatin silencing; P:nucleosome disassembly; P:UV-damage excision repair; scaffold39 indexed_genome mRNA 19460061 19502150 . + . ID=transcript_8098;Q9NU62,Butyrophilin subfamily 2 member A1,, PF13765;PF00622;PF07686;, GO:0009897;GO:0005887;GO:0005886;GO:0005102;GO:0002250;GO:0006629;GO:0001817;GO:0050852;, C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:signaling receptor binding;, P:adaptive immune response; P:lipid metabolic process; P:regulation of cytokine production; P:T cell receptor signaling pathway;|Q9BU81 Q9NR44,Butyrophilin subfamily 3 member A2,, PF07686;, GO:0009897;GO:0016021;GO:0016020;GO:0005886;GO:0005102;GO:0002250;GO:0032729;GO:0001817;GO:0002456;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:signaling receptor binding;, P:adaptive immune response; P:positive regulation of interferon-gamma production; P:regulation of cytokine production; P:T cell mediated immunity; P:T cell receptor signaling pathway;|Q9BU81 Q9NR44,Butyrophilin subfamily 3 member A2,, PF07686;, GO:0009897;GO:0016021;GO:0016020;GO:0005886;GO:0005102;GO:0002250;GO:0032729;GO:0001817;GO:0002456;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:signaling receptor binding;, P:adaptive immune response; P:positive regulation of interferon-gamma production; P:regulation of cytokine production; P:T cell mediated immunity; P:T cell receptor signaling pathway;|Q53F15 Q99420 Q9HCY1,Butyrophilin subfamily 3 member A1,, PF13765;PF00622;PF07686;, GO:0009897;GO:0016021;GO:0005886;GO:0005102;GO:0050798;GO:0002250;GO:0001819;GO:0032729;GO:0001817;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, F:signaling receptor binding;, P:activated T cell proliferation; P:adaptive immune response; P:positive regulation of cytokine production; P:positive regulation of interferon-gamma production; P:regulation of cytokine production; P:T cell receptor signaling pathway;|O00478 B4DWI7 E9PCP5,Butyrophilin subfamily 3 member A3,, PF13765;PF00622;PF07686;, GO:0009897;GO:0016021;GO:0016020;GO:0005886;GO:0005102;GO:0002250;GO:0001817;GO:0002456;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:signaling receptor binding;, P:adaptive immune response; P:regulation of cytokine production; P:T cell mediated immunity; P:T cell receptor signaling pathway;|O00478 B4DWI7 E9PCP5,Butyrophilin subfamily 3 member A3,, PF13765;PF00622;PF07686;, GO:0009897;GO:0016021;GO:0016020;GO:0005886;GO:0005102;GO:0002250;GO:0001817;GO:0002456;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:signaling receptor binding;, P:adaptive immune response; P:regulation of cytokine production; P:T cell mediated immunity; P:T cell receptor signaling pathway;|Q9NU62,Butyrophilin subfamily 2 member A1,, PF13765;PF00622;PF07686;, GO:0009897;GO:0005887;GO:0005886;GO:0005102;GO:0002250;GO:0006629;GO:0001817;GO:0050852;, C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:signaling receptor binding;, P:adaptive immune response; P:lipid metabolic process; P:regulation of cytokine production; P:T cell receptor signaling pathway;|Q96KV6 A6NEF4,Putative butyrophilin subfamily 2 member A3,, PF13765;PF00622;PF07686;, GO:0009897;GO:0016021;GO:0005102;GO:0001817;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane;, F:signaling receptor binding;, P:regulation of cytokine production; P:T cell receptor signaling pathway; scaffold39 indexed_genome mRNA 19503899 19508262 . + . ID=transcript_8099;Q8WVV5 A6NM84 B4DE97 B4DQ01 E9PH07 O00480,Butyrophilin subfamily 2 member A2,, PF13765;PF00622;PF07686;, GO:0009897;GO:0016021;GO:0005886;GO:0005102;GO:0002250;GO:0046007;GO:0031324;GO:0001818;GO:0001817;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, F:signaling receptor binding;, P:adaptive immune response; P:negative regulation of activated T cell proliferation; P:negative regulation of cellular metabolic process; P:negative regulation of cytokine production; P:regulation of cytokine production; P:T cell receptor signaling pathway; scaffold39 indexed_genome mRNA 19538020 19546207 . + . ID=transcript_8100;Q86SG4 Q495B5 Q86SH8 Q8N8I5,Putative Dresden prostate carcinoma protein 2,High mobility group nucleosome-binding domain-containing protein 2 pseudogene 46;, , GO:0005634;GO:0003682;GO:0006325;, C:nucleus;, F:chromatin binding;, P:chromatin organization; scaffold39 indexed_genome mRNA 19580478 19581333 . + . ID=transcript_8101;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold39 indexed_genome mRNA 19581503 19582082 . + . ID=transcript_8102;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold39 indexed_genome mRNA 19584401 19587910 . + . ID=transcript_8103;Q9ULW3,Activator of basal transcription 1,Basal transcriptional activator;, , GO:0005730;GO:0005634;GO:0003677;GO:0003723;GO:0003713;GO:0000480;GO:0000447;GO:0000472;GO:0034462;GO:0006366;, C:nucleolus; C:nucleus;, F:DNA binding; F:RNA binding; F:transcription coactivator activity;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:small-subunit processome assembly; P:transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 19868271 19872118 . + . ID=transcript_8104;Q9UJN7 B4DH77,Zinc finger protein 391,, PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 19879046 19892186 . - . ID=transcript_8105;Q99676 B2R715 O60792 Q8TBA9,Zinc finger protein 184,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II;|Q99676 B2R715 O60792 Q8TBA9,Zinc finger protein 184,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20092078 20096163 . + . ID=transcript_8106;P62807 P02278 Q3B872 Q4VB69 Q93078 Q93080,Histone H2B type 1-C/E/F/G/I,Histone H2B.1 A;Histone H2B.a;Histone H2B.g;Histone H2B.h;Histone H2B.k;Histone H2B.l;, PF00125;, GO:0005829;GO:0070062;GO:0005615;GO:0005654;GO:0000786;GO:0005634;GO:0003677;GO:0042802;GO:0046982;GO:0019731;GO:0061844;GO:0050830;GO:0002227;GO:0006334;GO:0016567;, C:cytosol; C:extracellular exosome; C:extracellular space; C:nucleoplasm; C:nucleosome; C:nucleus;, F:DNA binding; F:identical protein binding; F:protein heterodimerization activity;, P:antibacterial humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:defense response to Gram-positive bacterium; P:innate immune response in mucosa; P:nucleosome assembly; P:protein ubiquitination; scaffold39 indexed_genome mRNA 20438190 20441599 . + . ID=transcript_8107;P49910,Zinc finger protein 165,Cancer/testis antigen 53;LD65;Zinc finger and SCAN domain-containing protein 7;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20448840 20459942 . + . ID=transcript_8108;Q6ZN57 A5PLN5 B7ZM23 Q9H6Z6,Zinc finger protein 2 homolog,Zinc finger protein 751;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20459984 20463894 . + . ID=transcript_8109;Q9H4T2 Q9H6K2,Zinc finger and SCAN domain-containing protein 16,Zinc finger protein 392;Zinc finger protein 435;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20463960 20469995 . + . ID=transcript_8110;Q9H4T2 Q9H6K2,Zinc finger and SCAN domain-containing protein 16,Zinc finger protein 392;Zinc finger protein 435;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20484947 20495879 . + . ID=transcript_8111;Q15776 A1L3D4 B4DYF1 Q4VAR1 Q4VAR2 Q4VAR3 Q9H4T1,Zinc finger protein with KRAB and SCAN domains 8,LD5-1;Zinc finger protein 192;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20499562 20510613 . + . ID=transcript_8112;Q15776 A1L3D4 B4DYF1 Q4VAR1 Q4VAR2 Q4VAR3 Q9H4T1,Zinc finger protein with KRAB and SCAN domains 8,LD5-1;Zinc finger protein 192;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20553175 20558915 . + . ID=transcript_8113;O15535 B4E1W6 E7EVQ2 Q2TTR1,Zinc finger and SCAN domain-containing protein 9,Cell proliferation-inducing gene 12 protein;PRD51;Zinc finger protein 193;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20567466 20574879 . + . ID=transcript_8114;Q969J2 B2RE32 Q5U7L4,Zinc finger protein with KRAB and SCAN domains 4,P373c6.1;Zinc finger protein 307;Zinc finger protein 427;, PF01352;PF02023;PF00096;, GO:0005654;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q969J2 B2RE32 Q5U7L4,Zinc finger protein with KRAB and SCAN domains 4,P373c6.1;Zinc finger protein 307;Zinc finger protein 427;, PF01352;PF02023;PF00096;, GO:0005654;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q969J2 B2RE32 Q5U7L4,Zinc finger protein with KRAB and SCAN domains 4,P373c6.1;Zinc finger protein 307;Zinc finger protein 427;, PF01352;PF02023;PF00096;, GO:0005654;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9BRR0 B2R8W2 B3KVC0 H7BXX1 Q5VXH3 Q92972 Q9H4T3,Zinc finger protein with KRAB and SCAN domains 3,Zinc finger and SCAN domain-containing protein 13;Zinc finger protein 306;Zinc finger protein 309;Zinc finger protein 47 homolog;, PF01352;PF02023;PF00096;, GO:0005737;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0006914;GO:0007040;GO:0010507;GO:2000773;GO:0000122;GO:0045892;GO:0045893;GO:0006357;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:autophagy; P:lysosome organization; P:negative regulation of autophagy; P:negative regulation of cellular senescence; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20580713 20584659 . + . ID=transcript_8115;Q5M9Q1 Q3MIV1 Q9H4Q7,NKAP-like protein,, PF06047;, GO:0005634;GO:0003682;GO:0030154;GO:0010468;GO:0007283;, C:nucleus;, F:chromatin binding;, P:cell differentiation; P:regulation of gene expression; P:spermatogenesis; scaffold39 indexed_genome mRNA 20601813 20608637 . + . ID=transcript_8116;Q16670 Q5JPG4 Q7Z3Q6 Q96A17,Zinc finger and SCAN domain-containing protein 26,Protein SRE-ZBP;Zinc finger protein 187;, PF02023;PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q16670 Q5JPG4 Q7Z3Q6 Q96A17,Zinc finger and SCAN domain-containing protein 26,Protein SRE-ZBP;Zinc finger protein 187;, PF02023;PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0006357;GO:0006355;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold39 indexed_genome mRNA 20640263 20649770 . - . ID=transcript_8117;Q96LW9 Q6P178 Q8WWS5,Zinc finger and SCAN domain-containing protein 31,Zinc finger protein 323;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20671311 20679895 . - . ID=transcript_8118;O43309 O43724,Zinc finger and SCAN domain-containing protein 12,Zinc finger protein 305;Zinc finger protein 96;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20689705 20696795 . - . ID=transcript_8119;Q3MJ62 Q96KV9,Zinc finger and SCAN domain-containing protein 23,Zinc finger protein 390;Zinc finger protein 453;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 20728209 20732769 . - . ID=transcript_8120;P59796 Q4PJ17,Glutathione peroxidase 6,, PF00255;, GO:0005576;GO:0004602;GO:0004601;GO:0006979;, C:extracellular region;, F:glutathione peroxidase activity; F:peroxidase activity;, P:response to oxidative stress; scaffold39 indexed_genome mRNA 20776237 20780755 . - . ID=transcript_8121;Q6R2W3 Q2NKL9 Q5SRJ3 Q8TCN2 Q96MV9 Q96PW3,SCAN domain-containing protein 3,Transposon-derived Buster4 transposase-like protein;Zinc finger BED domain-containing protein 9;, PF02023;, GO:0005737;GO:0005634;GO:0003676;GO:0015074;GO:0045787;GO:0050679;, C:cytoplasm; C:nucleus;, F:nucleic acid binding;, P:DNA integration; P:positive regulation of cell cycle; P:positive regulation of epithelial cell proliferation; scaffold39 indexed_genome mRNA 20920583 20935184 . - . ID=transcript_8122;P14373 A2BE15 Q5RJA8 Q5ST26 Q6LA73 Q6NXR9 Q9BZY6 Q9UJL3,Zinc finger protein RFP,RING finger protein 76;RING-type E3 ubiquitin transferase TRIM27 {ECO:0000305};Ret finger protein;Tripartite motif-containing protein 27;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0001650;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0042802;GO:0046872;GO:0003676;GO:0042803;GO:0019901;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0034314;GO:0045087;GO:0033668;GO:0002820;GO:0090281;GO:0045814;GO:0032703;GO:0006469;GO:0000122;GO:0032720;GO:0032897;GO:0010508;GO:0051091;GO:0043123;GO:0032729;GO:0051092;GO:0070534;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;GO:0042147;GO:0007283;, C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:fibrillar center; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:identical protein binding; F:metal ion binding; F:nucleic acid binding; F:protein homodimerization activity; F:protein kinase binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:Arp2/3 complex-mediated actin nucleation; P:innate immune response; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of adaptive immune response; P:negative regulation of calcium ion import; P:negative regulation of gene expression, epigenetic; P:negative regulation of interleukin-2 production; P:negative regulation of protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor production; P:negative regulation of viral transcription; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell; P:retrograde transport, endosome to Golgi; P:spermatogenesis;|P14373 A2BE15 Q5RJA8 Q5ST26 Q6LA73 Q6NXR9 Q9BZY6 Q9UJL3,Zinc finger protein RFP,RING finger protein 76;RING-type E3 ubiquitin transferase TRIM27 {ECO:0000305};Ret finger protein;Tripartite motif-containing protein 27;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0001650;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0042802;GO:0046872;GO:0003676;GO:0042803;GO:0019901;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0034314;GO:0045087;GO:0033668;GO:0002820;GO:0090281;GO:0045814;GO:0032703;GO:0006469;GO:0000122;GO:0032720;GO:0032897;GO:0010508;GO:0051091;GO:0043123;GO:0032729;GO:0051092;GO:0070534;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;GO:0042147;GO:0007283;, C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:fibrillar center; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:identical protein binding; F:metal ion binding; F:nucleic acid binding; F:protein homodimerization activity; F:protein kinase binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:Arp2/3 complex-mediated actin nucleation; P:innate immune response; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of adaptive immune response; P:negative regulation of calcium ion import; P:negative regulation of gene expression, epigenetic; P:negative regulation of interleukin-2 production; P:negative regulation of protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor production; P:negative regulation of viral transcription; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell; P:retrograde transport, endosome to Golgi; P:spermatogenesis;|P14373 A2BE15 Q5RJA8 Q5ST26 Q6LA73 Q6NXR9 Q9BZY6 Q9UJL3,Zinc finger protein RFP,RING finger protein 76;RING-type E3 ubiquitin transferase TRIM27 {ECO:0000305};Ret finger protein;Tripartite motif-containing protein 27;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0001650;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0042802;GO:0046872;GO:0003676;GO:0042803;GO:0019901;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0034314;GO:0045087;GO:0033668;GO:0002820;GO:0090281;GO:0045814;GO:0032703;GO:0006469;GO:0000122;GO:0032720;GO:0032897;GO:0010508;GO:0051091;GO:0043123;GO:0032729;GO:0051092;GO:0070534;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;GO:0042147;GO:0007283;, C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:fibrillar center; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:identical protein binding; F:metal ion binding; F:nucleic acid binding; F:protein homodimerization activity; F:protein kinase binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:Arp2/3 complex-mediated actin nucleation; P:innate immune response; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of adaptive immune response; P:negative regulation of calcium ion import; P:negative regulation of gene expression, epigenetic; P:negative regulation of interleukin-2 production; P:negative regulation of protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor production; P:negative regulation of viral transcription; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of NF-kappaB transcription factor activity; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell; P:retrograde transport, endosome to Golgi; P:spermatogenesis; scaffold39 indexed_genome mRNA 20971379 20983520 . - . ID=transcript_8123;Q5JNZ3 A2BFK5 B0S7Y4 Q92971,Zinc finger protein 311,Zinc finger protein zfp-31;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5JNZ3 A2BFK5 B0S7Y4 Q92971,Zinc finger protein 311,Zinc finger protein zfp-31;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5JNZ3 A2BFK5 B0S7Y4 Q92971,Zinc finger protein 311,Zinc finger protein zfp-31;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5JNZ3 A2BFK5 B0S7Y4 Q92971,Zinc finger protein 311,Zinc finger protein zfp-31;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold39 indexed_genome mRNA 21004857 21009630 . + . ID=transcript_8124;Q08AN1 B3KRV1 Q0P658 Q658V7,Zinc finger protein 616,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold40 indexed_genome mRNA 8345 13596 . + . ID=transcript_8125;Q96PV0 A2AB17 A2BEL6 A2BEL7 A8MQC4 Q8TCS2 Q9UGE2,Ras/Rap GTPase-activating protein SynGAP,Neuronal RasGAP;Synaptic Ras GTPase-activating protein 1;, PF00168;PF12004;PF00616;, GO:0005829;GO:0043198;GO:0098978;GO:0005886;GO:0014069;GO:0005096;GO:0017124;GO:0016358;GO:0098880;GO:0000165;GO:0050771;GO:0043524;GO:0046580;GO:0007389;GO:0007265;GO:0043113;GO:0048169;GO:0043408;GO:0050803;GO:0048167;GO:0008542;, C:cytosol; C:dendritic shaft; C:glutamatergic synapse; C:plasma membrane; C:postsynaptic density;, F:GTPase activator activity; F:SH3 domain binding;, P:dendrite development; P:maintenance of postsynaptic specialization structure; P:MAPK cascade; P:negative regulation of axonogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:pattern specification process; P:Ras protein signal transduction; P:receptor clustering; P:regulation of long-term neuronal synaptic plasticity; P:regulation of MAPK cascade; P:regulation of synapse structure or activity; P:regulation of synaptic plasticity; P:visual learning;|Q96PV0 A2AB17 A2BEL6 A2BEL7 A8MQC4 Q8TCS2 Q9UGE2,Ras/Rap GTPase-activating protein SynGAP,Neuronal RasGAP;Synaptic Ras GTPase-activating protein 1;, PF00168;PF12004;PF00616;, GO:0005829;GO:0043198;GO:0098978;GO:0005886;GO:0014069;GO:0005096;GO:0017124;GO:0016358;GO:0098880;GO:0000165;GO:0050771;GO:0043524;GO:0046580;GO:0007389;GO:0007265;GO:0043113;GO:0048169;GO:0043408;GO:0050803;GO:0048167;GO:0008542;, C:cytosol; C:dendritic shaft; C:glutamatergic synapse; C:plasma membrane; C:postsynaptic density;, F:GTPase activator activity; F:SH3 domain binding;, P:dendrite development; P:maintenance of postsynaptic specialization structure; P:MAPK cascade; P:negative regulation of axonogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:pattern specification process; P:Ras protein signal transduction; P:receptor clustering; P:regulation of long-term neuronal synaptic plasticity; P:regulation of MAPK cascade; P:regulation of synapse structure or activity; P:regulation of synaptic plasticity; P:visual learning;|Q96PV0 A2AB17 A2BEL6 A2BEL7 A8MQC4 Q8TCS2 Q9UGE2,Ras/Rap GTPase-activating protein SynGAP,Neuronal RasGAP;Synaptic Ras GTPase-activating protein 1;, PF00168;PF12004;PF00616;, GO:0005829;GO:0043198;GO:0098978;GO:0005886;GO:0014069;GO:0005096;GO:0017124;GO:0016358;GO:0098880;GO:0000165;GO:0050771;GO:0043524;GO:0046580;GO:0007389;GO:0007265;GO:0043113;GO:0048169;GO:0043408;GO:0050803;GO:0048167;GO:0008542;, C:cytosol; C:dendritic shaft; C:glutamatergic synapse; C:plasma membrane; C:postsynaptic density;, F:GTPase activator activity; F:SH3 domain binding;, P:dendrite development; P:maintenance of postsynaptic specialization structure; P:MAPK cascade; P:negative regulation of axonogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:pattern specification process; P:Ras protein signal transduction; P:receptor clustering; P:regulation of long-term neuronal synaptic plasticity; P:regulation of MAPK cascade; P:regulation of synapse structure or activity; P:regulation of synaptic plasticity; P:visual learning; scaffold40 indexed_genome mRNA 13618 20118 . - . ID=transcript_8126;Q96PV0 A2AB17 A2BEL6 A2BEL7 A8MQC4 Q8TCS2 Q9UGE2,Ras/Rap GTPase-activating protein SynGAP,Neuronal RasGAP;Synaptic Ras GTPase-activating protein 1;, PF00168;PF12004;PF00616;, GO:0005829;GO:0043198;GO:0098978;GO:0005886;GO:0014069;GO:0005096;GO:0017124;GO:0016358;GO:0098880;GO:0000165;GO:0050771;GO:0043524;GO:0046580;GO:0007389;GO:0007265;GO:0043113;GO:0048169;GO:0043408;GO:0050803;GO:0048167;GO:0008542;, C:cytosol; C:dendritic shaft; C:glutamatergic synapse; C:plasma membrane; C:postsynaptic density;, F:GTPase activator activity; F:SH3 domain binding;, P:dendrite development; P:maintenance of postsynaptic specialization structure; P:MAPK cascade; P:negative regulation of axonogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:pattern specification process; P:Ras protein signal transduction; P:receptor clustering; P:regulation of long-term neuronal synaptic plasticity; P:regulation of MAPK cascade; P:regulation of synapse structure or activity; P:regulation of synaptic plasticity; P:visual learning; scaffold40 indexed_genome mRNA 22950 25974 . + . ID=transcript_8127;Q96C00 A2AB19,Zinc finger and BTB domain-containing protein 9,, PF00651;, GO:0005634;GO:0042802;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:identical protein binding; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold40 indexed_genome mRNA 103660 110074 . - . ID=transcript_8128;Q16611 C0H5Y7 Q6I9T6 Q92533,Bcl-2 homologous antagonist/killer,Apoptosis regulator BAK;Bcl-2-like protein 7;, PF00452;, GO:0097145;GO:0097136;GO:0005829;GO:0005783;GO:0031307;GO:0005741;GO:0005739;GO:0046930;GO:0051400;GO:0051087;GO:0031072;GO:0042802;GO:0044325;GO:0046872;GO:0046982;GO:0042803;GO:0044877;GO:0097202;GO:0008635;GO:0007568;GO:0031100;GO:0006915;GO:1902262;GO:0097190;GO:0001783;GO:0001782;GO:0002352;GO:0001974;GO:0007420;GO:0008283;GO:0071260;GO:0034620;GO:0034644;GO:0031018;GO:0032469;GO:0010248;GO:0097192;GO:0044346;GO:0008630;GO:0070059;GO:0035108;GO:0008053;GO:0002262;GO:0008285;GO:0032471;GO:0010629;GO:0033137;GO:0043065;GO:0010524;GO:1900103;GO:1903896;GO:1901030;GO:0031334;GO:0045862;GO:0090200;GO:0048597;GO:0051726;GO:0046902;GO:0051881;GO:0001836;GO:0042493;GO:0045471;GO:0009620;GO:0010332;GO:0042542;GO:0010046;GO:0014070;GO:0010225;GO:0070242;GO:0060068;GO:0016032;, C:BAK complex; C:Bcl-2 family protein complex; C:cytosol; C:endoplasmic reticulum; C:integral component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:pore complex;, F:BH domain binding; F:chaperone binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:aging; P:animal organ regeneration; P:apoptotic process; P:apoptotic process involved in blood vessel morphogenesis; P:apoptotic signaling pathway; P:B cell apoptotic process; P:B cell homeostasis; P:B cell negative selection; P:blood vessel remodeling; P:brain development; P:cell population proliferation; P:cellular response to mechanical stimulus; P:cellular response to unfolded protein; P:cellular response to UV; P:endocrine pancreas development; P:endoplasmic reticulum calcium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:extrinsic apoptotic signaling pathway in absence of ligand; P:fibroblast apoptotic process; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:limb morphogenesis; P:mitochondrial fusion; P:myeloid cell homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of gene expression; P:negative regulation of peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of proteolysis; P:positive regulation of release of cytochrome c from mitochondria; P:post-embryonic camera-type eye morphogenesis; P:regulation of cell cycle; P:regulation of mitochondrial membrane permeability; P:regulation of mitochondrial membrane potential; P:release of cytochrome c from mitochondria; P:response to drug; P:response to ethanol; P:response to fungus; P:response to gamma radiation; P:response to hydrogen peroxide; P:response to mycotoxin; P:response to organic cyclic compound; P:response to UV-C; P:thymocyte apoptotic process; P:vagina development; P:viral process;|Q16611 C0H5Y7 Q6I9T6 Q92533,Bcl-2 homologous antagonist/killer,Apoptosis regulator BAK;Bcl-2-like protein 7;, PF00452;, GO:0097145;GO:0097136;GO:0005829;GO:0005783;GO:0031307;GO:0005741;GO:0005739;GO:0046930;GO:0051400;GO:0051087;GO:0031072;GO:0042802;GO:0044325;GO:0046872;GO:0046982;GO:0042803;GO:0044877;GO:0097202;GO:0008635;GO:0007568;GO:0031100;GO:0006915;GO:1902262;GO:0097190;GO:0001783;GO:0001782;GO:0002352;GO:0001974;GO:0007420;GO:0008283;GO:0071260;GO:0034620;GO:0034644;GO:0031018;GO:0032469;GO:0010248;GO:0097192;GO:0044346;GO:0008630;GO:0070059;GO:0035108;GO:0008053;GO:0002262;GO:0008285;GO:0032471;GO:0010629;GO:0033137;GO:0043065;GO:0010524;GO:1900103;GO:1903896;GO:1901030;GO:0031334;GO:0045862;GO:0090200;GO:0048597;GO:0051726;GO:0046902;GO:0051881;GO:0001836;GO:0042493;GO:0045471;GO:0009620;GO:0010332;GO:0042542;GO:0010046;GO:0014070;GO:0010225;GO:0070242;GO:0060068;GO:0016032;, C:BAK complex; C:Bcl-2 family protein complex; C:cytosol; C:endoplasmic reticulum; C:integral component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:pore complex;, F:BH domain binding; F:chaperone binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:aging; P:animal organ regeneration; P:apoptotic process; P:apoptotic process involved in blood vessel morphogenesis; P:apoptotic signaling pathway; P:B cell apoptotic process; P:B cell homeostasis; P:B cell negative selection; P:blood vessel remodeling; P:brain development; P:cell population proliferation; P:cellular response to mechanical stimulus; P:cellular response to unfolded protein; P:cellular response to UV; P:endocrine pancreas development; P:endoplasmic reticulum calcium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:extrinsic apoptotic signaling pathway in absence of ligand; P:fibroblast apoptotic process; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:limb morphogenesis; P:mitochondrial fusion; P:myeloid cell homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of gene expression; P:negative regulation of peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of proteolysis; P:positive regulation of release of cytochrome c from mitochondria; P:post-embryonic camera-type eye morphogenesis; P:regulation of cell cycle; P:regulation of mitochondrial membrane permeability; P:regulation of mitochondrial membrane potential; P:release of cytochrome c from mitochondria; P:response to drug; P:response to ethanol; P:response to fungus; P:response to gamma radiation; P:response to hydrogen peroxide; P:response to mycotoxin; P:response to organic cyclic compound; P:response to UV-C; P:thymocyte apoptotic process; P:vagina development; P:viral process;|Q16611 C0H5Y7 Q6I9T6 Q92533,Bcl-2 homologous antagonist/killer,Apoptosis regulator BAK;Bcl-2-like protein 7;, PF00452;, GO:0097145;GO:0097136;GO:0005829;GO:0005783;GO:0031307;GO:0005741;GO:0005739;GO:0046930;GO:0051400;GO:0051087;GO:0031072;GO:0042802;GO:0044325;GO:0046872;GO:0046982;GO:0042803;GO:0044877;GO:0097202;GO:0008635;GO:0007568;GO:0031100;GO:0006915;GO:1902262;GO:0097190;GO:0001783;GO:0001782;GO:0002352;GO:0001974;GO:0007420;GO:0008283;GO:0071260;GO:0034620;GO:0034644;GO:0031018;GO:0032469;GO:0010248;GO:0097192;GO:0044346;GO:0008630;GO:0070059;GO:0035108;GO:0008053;GO:0002262;GO:0008285;GO:0032471;GO:0010629;GO:0033137;GO:0043065;GO:0010524;GO:1900103;GO:1903896;GO:1901030;GO:0031334;GO:0045862;GO:0090200;GO:0048597;GO:0051726;GO:0046902;GO:0051881;GO:0001836;GO:0042493;GO:0045471;GO:0009620;GO:0010332;GO:0042542;GO:0010046;GO:0014070;GO:0010225;GO:0070242;GO:0060068;GO:0016032;, C:BAK complex; C:Bcl-2 family protein complex; C:cytosol; C:endoplasmic reticulum; C:integral component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:pore complex;, F:BH domain binding; F:chaperone binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:aging; P:animal organ regeneration; P:apoptotic process; P:apoptotic process involved in blood vessel morphogenesis; P:apoptotic signaling pathway; P:B cell apoptotic process; P:B cell homeostasis; P:B cell negative selection; P:blood vessel remodeling; P:brain development; P:cell population proliferation; P:cellular response to mechanical stimulus; P:cellular response to unfolded protein; P:cellular response to UV; P:endocrine pancreas development; P:endoplasmic reticulum calcium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:extrinsic apoptotic signaling pathway in absence of ligand; P:fibroblast apoptotic process; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:limb morphogenesis; P:mitochondrial fusion; P:myeloid cell homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of gene expression; P:negative regulation of peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of proteolysis; P:positive regulation of release of cytochrome c from mitochondria; P:post-embryonic camera-type eye morphogenesis; P:regulation of cell cycle; P:regulation of mitochondrial membrane permeability; P:regulation of mitochondrial membrane potential; P:release of cytochrome c from mitochondria; P:response to drug; P:response to ethanol; P:response to fungus; P:response to gamma radiation; P:response to hydrogen peroxide; P:response to mycotoxin; P:response to organic cyclic compound; P:response to UV-C; P:thymocyte apoptotic process; P:vagina development; P:viral process; scaffold40 indexed_genome mRNA 137928 174554 . + . ID=transcript_8129;Q14573 Q14649 Q5TAQ2,Inositol 1,4,5-trisphosphate receptor type 3,IP3 receptor isoform 3;Type 3 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0045177;GO:0005903;GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0005887;GO:0016020;GO:0043209;GO:0043025;GO:0005640;GO:0005730;GO:0005654;GO:0005886;GO:0031095;GO:0043235;GO:0016529;GO:0030667;GO:0005509;GO:0015278;GO:0043533;GO:0070679;GO:0005220;GO:0000822;GO:0035091;GO:0060402;GO:0007186;GO:0060291;GO:0007613;GO:0030168;GO:0007204;GO:1903779;GO:0050796;GO:0051209;GO:0051592;GO:0050913;GO:0050916;GO:0050917;, C:apical part of cell; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane; C:myelin sheath; C:neuronal cell body; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:platelet dense tubular network membrane; C:receptor complex; C:sarcoplasmic reticulum; C:secretory granule membrane;, F:calcium ion binding; F:calcium-release channel activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:inositol hexakisphosphate binding; F:phosphatidylinositol binding;, P:calcium ion transport into cytosol; P:G protein-coupled receptor signaling pathway; P:long-term synaptic potentiation; P:memory; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to calcium ion; P:sensory perception of bitter taste; P:sensory perception of sweet taste; P:sensory perception of umami taste; scaffold40 indexed_genome mRNA 176825 207513 . + . ID=transcript_8130;Q14573 Q14649 Q5TAQ2,Inositol 1,4,5-trisphosphate receptor type 3,IP3 receptor isoform 3;Type 3 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0045177;GO:0005903;GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0005887;GO:0016020;GO:0043209;GO:0043025;GO:0005640;GO:0005730;GO:0005654;GO:0005886;GO:0031095;GO:0043235;GO:0016529;GO:0030667;GO:0005509;GO:0015278;GO:0043533;GO:0070679;GO:0005220;GO:0000822;GO:0035091;GO:0060402;GO:0007186;GO:0060291;GO:0007613;GO:0030168;GO:0007204;GO:1903779;GO:0050796;GO:0051209;GO:0051592;GO:0050913;GO:0050916;GO:0050917;, C:apical part of cell; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane; C:myelin sheath; C:neuronal cell body; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:platelet dense tubular network membrane; C:receptor complex; C:sarcoplasmic reticulum; C:secretory granule membrane;, F:calcium ion binding; F:calcium-release channel activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:inositol hexakisphosphate binding; F:phosphatidylinositol binding;, P:calcium ion transport into cytosol; P:G protein-coupled receptor signaling pathway; P:long-term synaptic potentiation; P:memory; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to calcium ion; P:sensory perception of bitter taste; P:sensory perception of sweet taste; P:sensory perception of umami taste;|Q14573 Q14649 Q5TAQ2,Inositol 1,4,5-trisphosphate receptor type 3,IP3 receptor isoform 3;Type 3 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0045177;GO:0005903;GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0005887;GO:0016020;GO:0043209;GO:0043025;GO:0005640;GO:0005730;GO:0005654;GO:0005886;GO:0031095;GO:0043235;GO:0016529;GO:0030667;GO:0005509;GO:0015278;GO:0043533;GO:0070679;GO:0005220;GO:0000822;GO:0035091;GO:0060402;GO:0007186;GO:0060291;GO:0007613;GO:0030168;GO:0007204;GO:1903779;GO:0050796;GO:0051209;GO:0051592;GO:0050913;GO:0050916;GO:0050917;, C:apical part of cell; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane; C:myelin sheath; C:neuronal cell body; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:platelet dense tubular network membrane; C:receptor complex; C:sarcoplasmic reticulum; C:secretory granule membrane;, F:calcium ion binding; F:calcium-release channel activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:inositol hexakisphosphate binding; F:phosphatidylinositol binding;, P:calcium ion transport into cytosol; P:G protein-coupled receptor signaling pathway; P:long-term synaptic potentiation; P:memory; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to calcium ion; P:sensory perception of bitter taste; P:sensory perception of sweet taste; P:sensory perception of umami taste;|Q14573 Q14649 Q5TAQ2,Inositol 1,4,5-trisphosphate receptor type 3,IP3 receptor isoform 3;Type 3 inositol 1,4,5-trisphosphate receptor;, PF08709;PF00520;PF02815;PF08454;PF01365;, GO:0045177;GO:0005903;GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0005887;GO:0016020;GO:0043209;GO:0043025;GO:0005640;GO:0005730;GO:0005654;GO:0005886;GO:0031095;GO:0043235;GO:0016529;GO:0030667;GO:0005509;GO:0015278;GO:0043533;GO:0070679;GO:0005220;GO:0000822;GO:0035091;GO:0060402;GO:0007186;GO:0060291;GO:0007613;GO:0030168;GO:0007204;GO:1903779;GO:0050796;GO:0051209;GO:0051592;GO:0050913;GO:0050916;GO:0050917;, C:apical part of cell; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane; C:myelin sheath; C:neuronal cell body; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:plasma membrane; C:platelet dense tubular network membrane; C:receptor complex; C:sarcoplasmic reticulum; C:secretory granule membrane;, F:calcium ion binding; F:calcium-release channel activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:inositol 1,4,5 trisphosphate binding; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; F:inositol hexakisphosphate binding; F:phosphatidylinositol binding;, P:calcium ion transport into cytosol; P:G protein-coupled receptor signaling pathway; P:long-term synaptic potentiation; P:memory; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac conduction; P:regulation of insulin secretion; P:release of sequestered calcium ion into cytosol; P:response to calcium ion; P:sensory perception of bitter taste; P:sensory perception of sweet taste; P:sensory perception of umami taste; scaffold40 indexed_genome mRNA 207657 238983 . - . ID=transcript_8131;Q9BRT2 B2R4I0,Ubiquinol-cytochrome-c reductase complex assembly factor 2,Breast cancer-associated protein SGA-81M;Mitochondrial nucleoid factor 1;Mitochondrial protein M19;, , GO:0005743;GO:0005758;GO:0005759;GO:0042645;GO:0005739;GO:0016604;GO:0034551;GO:1903364;GO:0070131;GO:0050796;GO:0002082;GO:2001014;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nuclear body;, , P:mitochondrial respiratory chain complex III assembly; P:positive regulation of cellular protein catabolic process; P:positive regulation of mitochondrial translation; P:regulation of insulin secretion; P:regulation of oxidative phosphorylation; P:regulation of skeletal muscle cell differentiation;|Q9BRT2 B2R4I0,Ubiquinol-cytochrome-c reductase complex assembly factor 2,Breast cancer-associated protein SGA-81M;Mitochondrial nucleoid factor 1;Mitochondrial protein M19;, , GO:0005743;GO:0005758;GO:0005759;GO:0042645;GO:0005739;GO:0016604;GO:0034551;GO:1903364;GO:0070131;GO:0050796;GO:0002082;GO:2001014;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nuclear body;, , P:mitochondrial respiratory chain complex III assembly; P:positive regulation of cellular protein catabolic process; P:positive regulation of mitochondrial translation; P:regulation of insulin secretion; P:regulation of oxidative phosphorylation; P:regulation of skeletal muscle cell differentiation; scaffold40 indexed_genome mRNA 251523 275422 . - . ID=transcript_8132;Q96PC2 Q96MQ9,Inositol hexakisphosphate kinase 3,Inositol hexaphosphate kinase 3;, PF03770;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0052723;GO:0052724;GO:0000832;GO:0000831;GO:0000828;GO:0000827;GO:0016301;GO:0032958;GO:0043647;GO:0040011;GO:0046488;GO:0046854;GO:0006468;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate 6-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity; F:kinase activity;, P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:locomotion; P:phosphatidylinositol metabolic process; P:phosphatidylinositol phosphorylation; P:protein phosphorylation; scaffold40 indexed_genome mRNA 296533 306380 . - . ID=transcript_8133;Q8NC56 B4DVH5 E7EVT2 Q5T972 Q5T974,LEM domain-containing protein 2,, PF03020;PF09402;, GO:0016021;GO:0005639;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0031490;GO:0060914;GO:0007084;GO:0030514;GO:0043409;GO:0051898;GO:0022008;GO:0006998;GO:0071168;GO:0035914;, C:integral component of membrane; C:integral component of nuclear inner membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane;, F:chromatin DNA binding;, P:heart formation; P:mitotic nuclear envelope reassembly; P:negative regulation of BMP signaling pathway; P:negative regulation of MAPK cascade; P:negative regulation of protein kinase B signaling; P:neurogenesis; P:nuclear envelope organization; P:protein localization to chromatin; P:skeletal muscle cell differentiation;|Q8NC56 B4DVH5 E7EVT2 Q5T972 Q5T974,LEM domain-containing protein 2,, PF03020;PF09402;, GO:0016021;GO:0005639;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0031490;GO:0060914;GO:0007084;GO:0030514;GO:0043409;GO:0051898;GO:0022008;GO:0006998;GO:0071168;GO:0035914;, C:integral component of membrane; C:integral component of nuclear inner membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane;, F:chromatin DNA binding;, P:heart formation; P:mitotic nuclear envelope reassembly; P:negative regulation of BMP signaling pathway; P:negative regulation of MAPK cascade; P:negative regulation of protein kinase B signaling; P:neurogenesis; P:nuclear envelope organization; P:protein localization to chromatin; P:skeletal muscle cell differentiation;|Q8NC56 B4DVH5 E7EVT2 Q5T972 Q5T974,LEM domain-containing protein 2,, PF03020;PF09402;, GO:0016021;GO:0005639;GO:0016020;GO:0005635;GO:0005637;GO:0031965;GO:0031490;GO:0060914;GO:0007084;GO:0030514;GO:0043409;GO:0051898;GO:0022008;GO:0006998;GO:0071168;GO:0035914;, C:integral component of membrane; C:integral component of nuclear inner membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane;, F:chromatin DNA binding;, P:heart formation; P:mitotic nuclear envelope reassembly; P:negative regulation of BMP signaling pathway; P:negative regulation of MAPK cascade; P:negative regulation of protein kinase B signaling; P:neurogenesis; P:nuclear envelope organization; P:protein localization to chromatin; P:skeletal muscle cell differentiation; scaffold40 indexed_genome mRNA 541797 574503 . - . ID=transcript_8134;Q14833 B3KVL9 B7Z1T9 B7Z1U6 F5GXM5 Q5SZ84 Q6ZMQ2,Metabotropic glutamate receptor 4,, PF00003;PF01094;PF07562;, GO:0031410;GO:0005887;GO:0005886;GO:0098793;GO:0001640;GO:0004930;GO:0008066;GO:0000187;GO:0007196;GO:0007268;GO:0007216;GO:0007186;GO:0007269;GO:0043410;GO:0043523;GO:0051966;, C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane; C:presynapse;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled receptor activity; F:glutamate receptor activity;, P:activation of MAPK activity; P:adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neurotransmitter secretion; P:positive regulation of MAPK cascade; P:regulation of neuron apoptotic process; P:regulation of synaptic transmission, glutamatergic;|Q14833 B3KVL9 B7Z1T9 B7Z1U6 F5GXM5 Q5SZ84 Q6ZMQ2,Metabotropic glutamate receptor 4,, PF00003;PF01094;PF07562;, GO:0031410;GO:0005887;GO:0005886;GO:0098793;GO:0001640;GO:0004930;GO:0008066;GO:0000187;GO:0007196;GO:0007268;GO:0007216;GO:0007186;GO:0007269;GO:0043410;GO:0043523;GO:0051966;, C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane; C:presynapse;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled receptor activity; F:glutamate receptor activity;, P:activation of MAPK activity; P:adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neurotransmitter secretion; P:positive regulation of MAPK cascade; P:regulation of neuron apoptotic process; P:regulation of synaptic transmission, glutamatergic;|Q14833 B3KVL9 B7Z1T9 B7Z1U6 F5GXM5 Q5SZ84 Q6ZMQ2,Metabotropic glutamate receptor 4,, PF00003;PF01094;PF07562;, GO:0031410;GO:0005887;GO:0005886;GO:0098793;GO:0001640;GO:0004930;GO:0008066;GO:0000187;GO:0007196;GO:0007268;GO:0007216;GO:0007186;GO:0007269;GO:0043410;GO:0043523;GO:0051966;, C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane; C:presynapse;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled receptor activity; F:glutamate receptor activity;, P:activation of MAPK activity; P:adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neurotransmitter secretion; P:positive regulation of MAPK cascade; P:regulation of neuron apoptotic process; P:regulation of synaptic transmission, glutamatergic;|Q14833 B3KVL9 B7Z1T9 B7Z1U6 F5GXM5 Q5SZ84 Q6ZMQ2,Metabotropic glutamate receptor 4,, PF00003;PF01094;PF07562;, GO:0031410;GO:0005887;GO:0005886;GO:0098793;GO:0001640;GO:0004930;GO:0008066;GO:0000187;GO:0007196;GO:0007268;GO:0007216;GO:0007186;GO:0007269;GO:0043410;GO:0043523;GO:0051966;, C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane; C:presynapse;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled receptor activity; F:glutamate receptor activity;, P:activation of MAPK activity; P:adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neurotransmitter secretion; P:positive regulation of MAPK cascade; P:regulation of neuron apoptotic process; P:regulation of synaptic transmission, glutamatergic; scaffold40 indexed_genome mRNA 574533 642034 . + . ID=transcript_8135;Q14833 B3KVL9 B7Z1T9 B7Z1U6 F5GXM5 Q5SZ84 Q6ZMQ2,Metabotropic glutamate receptor 4,, PF00003;PF01094;PF07562;, GO:0031410;GO:0005887;GO:0005886;GO:0098793;GO:0001640;GO:0004930;GO:0008066;GO:0000187;GO:0007196;GO:0007268;GO:0007216;GO:0007186;GO:0007269;GO:0043410;GO:0043523;GO:0051966;, C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane; C:presynapse;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled receptor activity; F:glutamate receptor activity;, P:activation of MAPK activity; P:adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neurotransmitter secretion; P:positive regulation of MAPK cascade; P:regulation of neuron apoptotic process; P:regulation of synaptic transmission, glutamatergic; scaffold40 indexed_genome mRNA 709182 715693 . + . ID=transcript_8136;P17096 P10910 Q5T6U9 Q9UKB0,High mobility group protein HMG-I/HMG-Y,High mobility group AT-hook protein 1;High mobility group protein R;, , GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0090575;GO:0035985;GO:0005667;GO:0051575;GO:0003682;GO:0000987;GO:0003677;GO:0003906;GO:0019899;GO:0003680;GO:0030374;GO:0042975;GO:0042974;GO:0046965;GO:0030527;GO:0003713;GO:0003712;GO:0008134;GO:0006284;GO:0006268;GO:0075713;GO:0008285;GO:0031936;GO:0045892;GO:0051169;GO:0006337;GO:0090402;GO:2000774;GO:0045944;GO:0045893;GO:0006355;GO:0009615;GO:0035986;, C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex; C:senescence-associated heterochromatin focus; C:transcription regulator complex;, F:5'-deoxyribose-5-phosphate lyase activity; F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:enzyme binding; F:minor groove of adenine-thymine-rich DNA binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:retinoic acid receptor binding; F:retinoid X receptor binding; F:structural constituent of chromatin; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:base-excision repair; P:DNA unwinding involved in DNA replication; P:establishment of integrated proviral latency; P:negative regulation of cell population proliferation; P:negative regulation of chromatin silencing; P:negative regulation of transcription, DNA-templated; P:nuclear transport; P:nucleosome disassembly; P:oncogene-induced cell senescence; P:positive regulation of cellular senescence; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:response to virus; P:senescence-associated heterochromatin focus assembly; scaffold40 indexed_genome mRNA 716966 720197 . - . ID=transcript_8137;Q86T20 A0A1C7CYX6 A8K299,Small integral membrane protein 29 {ECO:0000312|HGNC:HGNC:1340},Protein LBH {ECO:0000303|PubMed:10036196};, , GO:0016021;, C:integral component of membrane;|Q86T20 A0A1C7CYX6 A8K299,Small integral membrane protein 29 {ECO:0000312|HGNC:HGNC:1340},Protein LBH {ECO:0000303|PubMed:10036196};, , GO:0016021;, C:integral component of membrane; scaffold40 indexed_genome mRNA 741853 852060 . - . ID=transcript_8138;O95989 B2R8N4,Diphosphoinositol polyphosphate phosphohydrolase 1 {ECO:0000305},Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 1;Nucleoside diphosphate-linked moiety X motif 3;, PF00293;, GO:0005737;GO:0005829;GO:0005634;GO:0034431;GO:0034432;GO:0008486;GO:0000298;GO:0052842;GO:0052840;GO:0050072;GO:0000287;GO:1901911;GO:0007267;GO:1901909;GO:1901907;GO:0015961;GO:0071544;GO:0071543;GO:0043647;, C:cytoplasm; C:cytosol; C:nucleus;, F:bis(5'-adenosyl)-hexaphosphatase activity; F:bis(5'-adenosyl)-pentaphosphatase activity; F:diphosphoinositol-polyphosphate diphosphatase activity; F:endopolyphosphatase activity; F:inositol diphosphate pentakisphosphate diphosphatase activity; F:inositol diphosphate tetrakisphosphate diphosphatase activity; F:m7G(5')pppN diphosphatase activity; F:magnesium ion binding;, P:adenosine 5'-(hexahydrogen pentaphosphate) catabolic process; P:cell-cell signaling; P:diadenosine hexaphosphate catabolic process; P:diadenosine pentaphosphate catabolic process; P:diadenosine polyphosphate catabolic process; P:diphosphoinositol polyphosphate catabolic process; P:diphosphoinositol polyphosphate metabolic process; P:inositol phosphate metabolic process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold40 indexed_genome mRNA 871910 879018 . + . ID=transcript_8139;P46783 B2R4E3 Q5TZC0,40S ribosomal protein S10,Small ribosomal subunit protein eS10 {ECO:0000303|PubMed:24524803};, PF03501;, GO:0005829;GO:0022627;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005840;GO:0003723;GO:0003735;GO:0000184;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P46783 B2R4E3 Q5TZC0,40S ribosomal protein S10,Small ribosomal subunit protein eS10 {ECO:0000303|PubMed:24524803};, PF03501;, GO:0005829;GO:0022627;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005840;GO:0003723;GO:0003735;GO:0000184;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold40 indexed_genome mRNA 902700 964717 . + . ID=transcript_8140;Q9BY11 Q9P2G8,Protein kinase C and casein kinase substrate in neurons protein 1,Syndapin-1;, PF00611;PF14604;, GO:0043679;GO:0030137;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005768;GO:0048471;GO:0098684;GO:0005886;GO:0098833;GO:0032587;GO:0045202;GO:0008092;GO:0042802;GO:0005543;GO:0007015;GO:0007010;GO:0045806;GO:0048812;GO:0097320;GO:1900006;GO:0072657;GO:0072659;GO:0030100;GO:0048488;, C:axon terminus; C:COPI-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endosome; C:perinuclear region of cytoplasm; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynaptic endocytic zone; C:ruffle membrane; C:synapse;, F:cytoskeletal protein binding; F:identical protein binding; F:phospholipid binding;, P:actin filament organization; P:cytoskeleton organization; P:negative regulation of endocytosis; P:neuron projection morphogenesis; P:plasma membrane tubulation; P:positive regulation of dendrite development; P:protein localization to membrane; P:protein localization to plasma membrane; P:regulation of endocytosis; P:synaptic vesicle endocytosis;|Q9BY11 Q9P2G8,Protein kinase C and casein kinase substrate in neurons protein 1,Syndapin-1;, PF00611;PF14604;, GO:0043679;GO:0030137;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005768;GO:0048471;GO:0098684;GO:0005886;GO:0098833;GO:0032587;GO:0045202;GO:0008092;GO:0042802;GO:0005543;GO:0007015;GO:0007010;GO:0045806;GO:0048812;GO:0097320;GO:1900006;GO:0072657;GO:0072659;GO:0030100;GO:0048488;, C:axon terminus; C:COPI-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endosome; C:perinuclear region of cytoplasm; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynaptic endocytic zone; C:ruffle membrane; C:synapse;, F:cytoskeletal protein binding; F:identical protein binding; F:phospholipid binding;, P:actin filament organization; P:cytoskeleton organization; P:negative regulation of endocytosis; P:neuron projection morphogenesis; P:plasma membrane tubulation; P:positive regulation of dendrite development; P:protein localization to membrane; P:protein localization to plasma membrane; P:regulation of endocytosis; P:synaptic vesicle endocytosis; scaffold40 indexed_genome mRNA 964731 973314 . + . ID=transcript_8141;Q9BY11 Q9P2G8,Protein kinase C and casein kinase substrate in neurons protein 1,Syndapin-1;, PF00611;PF14604;, GO:0043679;GO:0030137;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005768;GO:0048471;GO:0098684;GO:0005886;GO:0098833;GO:0032587;GO:0045202;GO:0008092;GO:0042802;GO:0005543;GO:0007015;GO:0007010;GO:0045806;GO:0048812;GO:0097320;GO:1900006;GO:0072657;GO:0072659;GO:0030100;GO:0048488;, C:axon terminus; C:COPI-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endosome; C:perinuclear region of cytoplasm; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynaptic endocytic zone; C:ruffle membrane; C:synapse;, F:cytoskeletal protein binding; F:identical protein binding; F:phospholipid binding;, P:actin filament organization; P:cytoskeleton organization; P:negative regulation of endocytosis; P:neuron projection morphogenesis; P:plasma membrane tubulation; P:positive regulation of dendrite development; P:protein localization to membrane; P:protein localization to plasma membrane; P:regulation of endocytosis; P:synaptic vesicle endocytosis;|Q9BY11 Q9P2G8,Protein kinase C and casein kinase substrate in neurons protein 1,Syndapin-1;, PF00611;PF14604;, GO:0043679;GO:0030137;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005768;GO:0048471;GO:0098684;GO:0005886;GO:0098833;GO:0032587;GO:0045202;GO:0008092;GO:0042802;GO:0005543;GO:0007015;GO:0007010;GO:0045806;GO:0048812;GO:0097320;GO:1900006;GO:0072657;GO:0072659;GO:0030100;GO:0048488;, C:axon terminus; C:COPI-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endosome; C:perinuclear region of cytoplasm; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynaptic endocytic zone; C:ruffle membrane; C:synapse;, F:cytoskeletal protein binding; F:identical protein binding; F:phospholipid binding;, P:actin filament organization; P:cytoskeleton organization; P:negative regulation of endocytosis; P:neuron projection morphogenesis; P:plasma membrane tubulation; P:positive regulation of dendrite development; P:protein localization to membrane; P:protein localization to plasma membrane; P:regulation of endocytosis; P:synaptic vesicle endocytosis;|Q9BY11 Q9P2G8,Protein kinase C and casein kinase substrate in neurons protein 1,Syndapin-1;, PF00611;PF14604;, GO:0043679;GO:0030137;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005768;GO:0048471;GO:0098684;GO:0005886;GO:0098833;GO:0032587;GO:0045202;GO:0008092;GO:0042802;GO:0005543;GO:0007015;GO:0007010;GO:0045806;GO:0048812;GO:0097320;GO:1900006;GO:0072657;GO:0072659;GO:0030100;GO:0048488;, C:axon terminus; C:COPI-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endosome; C:perinuclear region of cytoplasm; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynaptic endocytic zone; C:ruffle membrane; C:synapse;, F:cytoskeletal protein binding; F:identical protein binding; F:phospholipid binding;, P:actin filament organization; P:cytoskeleton organization; P:negative regulation of endocytosis; P:neuron projection morphogenesis; P:plasma membrane tubulation; P:positive regulation of dendrite development; P:protein localization to membrane; P:protein localization to plasma membrane; P:regulation of endocytosis; P:synaptic vesicle endocytosis;|Q9BY11 Q9P2G8,Protein kinase C and casein kinase substrate in neurons protein 1,Syndapin-1;, PF00611;PF14604;, GO:0043679;GO:0030137;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005768;GO:0048471;GO:0098684;GO:0005886;GO:0098833;GO:0032587;GO:0045202;GO:0008092;GO:0042802;GO:0005543;GO:0007015;GO:0007010;GO:0045806;GO:0048812;GO:0097320;GO:1900006;GO:0072657;GO:0072659;GO:0030100;GO:0048488;, C:axon terminus; C:COPI-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endosome; C:perinuclear region of cytoplasm; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynaptic endocytic zone; C:ruffle membrane; C:synapse;, F:cytoskeletal protein binding; F:identical protein binding; F:phospholipid binding;, P:actin filament organization; P:cytoskeleton organization; P:negative regulation of endocytosis; P:neuron projection morphogenesis; P:plasma membrane tubulation; P:positive regulation of dendrite development; P:protein localization to membrane; P:protein localization to plasma membrane; P:regulation of endocytosis; P:synaptic vesicle endocytosis; scaffold40 indexed_genome mRNA 974417 983053 . + . ID=transcript_8142;O95238 B4DWH8 F5H778,SAM pointed domain-containing Ets transcription factor,Prostate epithelium-specific Ets transcription factor;Prostate-derived Ets factor;, PF00178;PF02198;, GO:0000785;GO:0005634;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0060576;GO:0060480;GO:0007275;GO:0010454;GO:0000122;GO:0043065;GO:0010455;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:intestinal epithelial cell development; P:lung goblet cell differentiation; P:multicellular organism development; P:negative regulation of cell fate commitment; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of cell fate commitment; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O95238 B4DWH8 F5H778,SAM pointed domain-containing Ets transcription factor,Prostate epithelium-specific Ets transcription factor;Prostate-derived Ets factor;, PF00178;PF02198;, GO:0000785;GO:0005634;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0060576;GO:0060480;GO:0007275;GO:0010454;GO:0000122;GO:0043065;GO:0010455;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:intestinal epithelial cell development; P:lung goblet cell differentiation; P:multicellular organism development; P:negative regulation of cell fate commitment; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of cell fate commitment; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O95238 B4DWH8 F5H778,SAM pointed domain-containing Ets transcription factor,Prostate epithelium-specific Ets transcription factor;Prostate-derived Ets factor;, PF00178;PF02198;, GO:0000785;GO:0005634;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0060576;GO:0060480;GO:0007275;GO:0010454;GO:0000122;GO:0043065;GO:0010455;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:intestinal epithelial cell development; P:lung goblet cell differentiation; P:multicellular organism development; P:negative regulation of cell fate commitment; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of cell fate commitment; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O95238 B4DWH8 F5H778,SAM pointed domain-containing Ets transcription factor,Prostate epithelium-specific Ets transcription factor;Prostate-derived Ets factor;, PF00178;PF02198;, GO:0000785;GO:0005634;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0060576;GO:0060480;GO:0007275;GO:0010454;GO:0000122;GO:0043065;GO:0010455;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:intestinal epithelial cell development; P:lung goblet cell differentiation; P:multicellular organism development; P:negative regulation of cell fate commitment; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of cell fate commitment; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold40 indexed_genome mRNA 1018276 1128658 . - . ID=transcript_8143;Q9H6K1 B2R8K7 Q5VV77 Q96MG5 Q9BUR9,Protein ILRUN {ECO:0000305},Inflammation and lipid regulator with UBA-like and NBR1-like domains protein {ECO:0000312|HGNC:HGNC:21215};, PF16158;, GO:0005813;GO:0005737;GO:0005829;GO:0016607;GO:0005634;GO:0000407;GO:0043130;GO:0045087;GO:0016236;GO:0050687;GO:0043392;GO:1900181;GO:0032720;GO:0032480;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleus; C:phagophore assembly site;, F:ubiquitin binding;, P:innate immune response; P:macroautophagy; P:negative regulation of defense response to virus; P:negative regulation of DNA binding; P:negative regulation of protein localization to nucleus; P:negative regulation of tumor necrosis factor production; P:negative regulation of type I interferon production;|Q9H6K1 B2R8K7 Q5VV77 Q96MG5 Q9BUR9,Protein ILRUN {ECO:0000305},Inflammation and lipid regulator with UBA-like and NBR1-like domains protein {ECO:0000312|HGNC:HGNC:21215};, PF16158;, GO:0005813;GO:0005737;GO:0005829;GO:0016607;GO:0005634;GO:0000407;GO:0043130;GO:0045087;GO:0016236;GO:0050687;GO:0043392;GO:1900181;GO:0032720;GO:0032480;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleus; C:phagophore assembly site;, F:ubiquitin binding;, P:innate immune response; P:macroautophagy; P:negative regulation of defense response to virus; P:negative regulation of DNA binding; P:negative regulation of protein localization to nucleus; P:negative regulation of tumor necrosis factor production; P:negative regulation of type I interferon production; scaffold40 indexed_genome mRNA 1184274 1195200 . + . ID=transcript_8144;P09234 Q5TAL3,U1 small nuclear ribonucleoprotein C {ECO:0000255|HAMAP-Rule:MF_03153},, PF06220;, GO:0015030;GO:0000243;GO:0005654;GO:0005685;GO:0071004;GO:0003729;GO:0030627;GO:0042803;GO:0003723;GO:0003727;GO:0008270;GO:0000395;GO:0000398;GO:0000387;, C:Cajal body; C:commitment complex; C:nucleoplasm; C:U1 snRNP; C:U2-type prespliceosome;, F:mRNA binding; F:pre-mRNA 5'-splice site binding; F:protein homodimerization activity; F:RNA binding; F:single-stranded RNA binding; F:zinc ion binding;, P:mRNA 5'-splice site recognition; P:mRNA splicing, via spliceosome; P:spliceosomal snRNP assembly;|P09234 Q5TAL3,U1 small nuclear ribonucleoprotein C {ECO:0000255|HAMAP-Rule:MF_03153},, PF06220;, GO:0015030;GO:0000243;GO:0005654;GO:0005685;GO:0071004;GO:0003729;GO:0030627;GO:0042803;GO:0003723;GO:0003727;GO:0008270;GO:0000395;GO:0000398;GO:0000387;, C:Cajal body; C:commitment complex; C:nucleoplasm; C:U1 snRNP; C:U2-type prespliceosome;, F:mRNA binding; F:pre-mRNA 5'-splice site binding; F:protein homodimerization activity; F:RNA binding; F:single-stranded RNA binding; F:zinc ion binding;, P:mRNA 5'-splice site recognition; P:mRNA splicing, via spliceosome; P:spliceosomal snRNP assembly; scaffold40 indexed_genome mRNA 1214713 1284502 . + . ID=transcript_8145;Q6BDS2 Q9NXE0,UHRF1-binding protein 1,ICBP90-binding protein 1;Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1;, PF12624;, GO:0042826;GO:0042802;, , F:histone deacetylase binding; F:identical protein binding; scaffold40 indexed_genome mRNA 1288263 1293060 . - . ID=transcript_8146;Q15544 B2R8R3 B4DY18 Q9UHS0,Transcription initiation factor TFIID subunit 11,TFIID subunit p30-beta;Transcription initiation factor TFIID 28 kDa subunit;, PF04719;, GO:0005794;GO:0005654;GO:0005669;GO:0046982;GO:0047485;GO:0016251;GO:0017025;GO:0046966;GO:0003713;GO:0008134;GO:0042809;GO:0043923;GO:1901796;GO:0051123;GO:0042795;GO:0006366;GO:0006367;, C:Golgi apparatus; C:nucleoplasm; C:transcription factor TFIID complex;, F:protein heterodimerization activity; F:protein N-terminus binding; F:RNA polymerase II general transcription initiation factor activity; F:TBP-class protein binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription factor binding; F:vitamin D receptor binding;, P:positive regulation by host of viral transcription; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q15544 B2R8R3 B4DY18 Q9UHS0,Transcription initiation factor TFIID subunit 11,TFIID subunit p30-beta;Transcription initiation factor TFIID 28 kDa subunit;, PF04719;, GO:0005794;GO:0005654;GO:0005669;GO:0046982;GO:0047485;GO:0016251;GO:0017025;GO:0046966;GO:0003713;GO:0008134;GO:0042809;GO:0043923;GO:1901796;GO:0051123;GO:0042795;GO:0006366;GO:0006367;, C:Golgi apparatus; C:nucleoplasm; C:transcription factor TFIID complex;, F:protein heterodimerization activity; F:protein N-terminus binding; F:RNA polymerase II general transcription initiation factor activity; F:TBP-class protein binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription factor binding; F:vitamin D receptor binding;, P:positive regulation by host of viral transcription; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold40 indexed_genome mRNA 1300505 1410187 . + . ID=transcript_8147;Q92625 A2RUC1 B4DQW8 Q5JYI9 Q5SYR2 Q86WQ7,Ankyrin repeat and SAM domain-containing protein 1A,Odin;, PF12796;PF00640;PF00536;PF07647;, GO:0005829;GO:0043005;GO:0005654;GO:0046875;GO:0048013;GO:0016322;GO:1901187;GO:0006929;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:neuron remodeling; P:regulation of ephrin receptor signaling pathway; P:substrate-dependent cell migration;|Q92625 A2RUC1 B4DQW8 Q5JYI9 Q5SYR2 Q86WQ7,Ankyrin repeat and SAM domain-containing protein 1A,Odin;, PF12796;PF00640;PF00536;PF07647;, GO:0005829;GO:0043005;GO:0005654;GO:0046875;GO:0048013;GO:0016322;GO:1901187;GO:0006929;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:neuron remodeling; P:regulation of ephrin receptor signaling pathway; P:substrate-dependent cell migration; scaffold40 indexed_genome mRNA 1440201 1473567 . + . ID=transcript_8148;Q92625 A2RUC1 B4DQW8 Q5JYI9 Q5SYR2 Q86WQ7,Ankyrin repeat and SAM domain-containing protein 1A,Odin;, PF12796;PF00640;PF00536;PF07647;, GO:0005829;GO:0043005;GO:0005654;GO:0046875;GO:0048013;GO:0016322;GO:1901187;GO:0006929;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:neuron remodeling; P:regulation of ephrin receptor signaling pathway; P:substrate-dependent cell migration;|Q92625 A2RUC1 B4DQW8 Q5JYI9 Q5SYR2 Q86WQ7,Ankyrin repeat and SAM domain-containing protein 1A,Odin;, PF12796;PF00640;PF00536;PF07647;, GO:0005829;GO:0043005;GO:0005654;GO:0046875;GO:0048013;GO:0016322;GO:1901187;GO:0006929;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:neuron remodeling; P:regulation of ephrin receptor signaling pathway; P:substrate-dependent cell migration;|Q92625 A2RUC1 B4DQW8 Q5JYI9 Q5SYR2 Q86WQ7,Ankyrin repeat and SAM domain-containing protein 1A,Odin;, PF12796;PF00640;PF00536;PF07647;, GO:0005829;GO:0043005;GO:0005654;GO:0046875;GO:0048013;GO:0016322;GO:1901187;GO:0006929;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:neuron remodeling; P:regulation of ephrin receptor signaling pathway; P:substrate-dependent cell migration;|Q92625 A2RUC1 B4DQW8 Q5JYI9 Q5SYR2 Q86WQ7,Ankyrin repeat and SAM domain-containing protein 1A,Odin;, PF12796;PF00640;PF00536;PF07647;, GO:0005829;GO:0043005;GO:0005654;GO:0046875;GO:0048013;GO:0016322;GO:1901187;GO:0006929;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:neuron remodeling; P:regulation of ephrin receptor signaling pathway; P:substrate-dependent cell migration;|F8WC27 Q5XLJ0 Q6IVB5 Q6NUS4 Q7Z6G6 Q7Z6G7 Q8TAP3 Q9NRX7 Q9Y5K9,Ankyrin repeat and sterile alpha motif domain-containing protein 1B,Amyloid-beta protein intracellular domain-associated protein 1;E2A-PBX1-associated protein;, PF12796;PF00640;PF00536;, GO:0015030;GO:0005829;GO:0043197;GO:0043231;GO:0005886;GO:0014069;GO:0046875;GO:0048013;GO:1900383;, C:Cajal body; C:cytosol; C:dendritic spine; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:regulation of synaptic plasticity by receptor localization to synapse;|Q92625 A2RUC1 B4DQW8 Q5JYI9 Q5SYR2 Q86WQ7,Ankyrin repeat and SAM domain-containing protein 1A,Odin;, PF12796;PF00640;PF00536;PF07647;, GO:0005829;GO:0043005;GO:0005654;GO:0046875;GO:0048013;GO:0016322;GO:1901187;GO:0006929;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:neuron remodeling; P:regulation of ephrin receptor signaling pathway; P:substrate-dependent cell migration;|Q92625 A2RUC1 B4DQW8 Q5JYI9 Q5SYR2 Q86WQ7,Ankyrin repeat and SAM domain-containing protein 1A,Odin;, PF12796;PF00640;PF00536;PF07647;, GO:0005829;GO:0043005;GO:0005654;GO:0046875;GO:0048013;GO:0016322;GO:1901187;GO:0006929;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ephrin receptor binding;, P:ephrin receptor signaling pathway; P:neuron remodeling; P:regulation of ephrin receptor signaling pathway; P:substrate-dependent cell migration; scaffold40 indexed_genome mRNA 1484128 1488903 . - . ID=transcript_8149;Q8NF85 Q9NQZ9 Q9NR39,T-complex protein 11 homolog,, PF05794;, GO:0001669;GO:0016021;GO:0036126;GO:0097225;GO:0030154;GO:0007275;GO:0010737;GO:0043949;GO:1902490;GO:0007165;GO:0007283;, C:acrosomal vesicle; C:integral component of membrane; C:sperm flagellum; C:sperm midpiece;, , P:cell differentiation; P:multicellular organism development; P:protein kinase A signaling; P:regulation of cAMP-mediated signaling; P:regulation of sperm capacitation; P:signal transduction; P:spermatogenesis; scaffold40 indexed_genome mRNA 1494247 1570566 . - . ID=transcript_8150;Q8NF85 Q9NQZ9 Q9NR39,T-complex protein 11 homolog,, PF05794;, GO:0001669;GO:0016021;GO:0036126;GO:0097225;GO:0030154;GO:0007275;GO:0010737;GO:0043949;GO:1902490;GO:0007165;GO:0007283;, C:acrosomal vesicle; C:integral component of membrane; C:sperm flagellum; C:sperm midpiece;, , P:cell differentiation; P:multicellular organism development; P:protein kinase A signaling; P:regulation of cAMP-mediated signaling; P:regulation of sperm capacitation; P:signal transduction; P:spermatogenesis;|Q96CT7,Coiled-coil domain-containing protein 124,, PF06244;, GO:0005829;GO:0005815;GO:0030496;GO:0005886;GO:0003723;GO:0007049;GO:0051301;, C:cytosol; C:microtubule organizing center; C:midbody; C:plasma membrane;, F:RNA binding;, P:cell cycle; P:cell division;|Q8NF85 Q9NQZ9 Q9NR39,T-complex protein 11 homolog,, PF05794;, GO:0001669;GO:0016021;GO:0036126;GO:0097225;GO:0030154;GO:0007275;GO:0010737;GO:0043949;GO:1902490;GO:0007165;GO:0007283;, C:acrosomal vesicle; C:integral component of membrane; C:sperm flagellum; C:sperm midpiece;, , P:cell differentiation; P:multicellular organism development; P:protein kinase A signaling; P:regulation of cAMP-mediated signaling; P:regulation of sperm capacitation; P:signal transduction; P:spermatogenesis;|Q8NF85 Q9NQZ9 Q9NR39,T-complex protein 11 homolog,, PF05794;, GO:0001669;GO:0016021;GO:0036126;GO:0097225;GO:0030154;GO:0007275;GO:0010737;GO:0043949;GO:1902490;GO:0007165;GO:0007283;, C:acrosomal vesicle; C:integral component of membrane; C:sperm flagellum; C:sperm midpiece;, , P:cell differentiation; P:multicellular organism development; P:protein kinase A signaling; P:regulation of cAMP-mediated signaling; P:regulation of sperm capacitation; P:signal transduction; P:spermatogenesis; scaffold40 indexed_genome mRNA 1598719 1615216 . + . ID=transcript_8151;Q8IX30 A8K5A3 Q5CZB3 Q86UZ9 Q8NAU9,Signal peptide, CUB and EGF-like domain-containing protein 3,, PF12662;PF00431;PF12947;PF07645;PF07699;, GO:0009986;GO:0005615;GO:0005886;GO:0005509;GO:0042802;GO:0022617;GO:0007165;, C:cell surface; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:identical protein binding;, P:extracellular matrix disassembly; P:signal transduction;|Q8IX30 A8K5A3 Q5CZB3 Q86UZ9 Q8NAU9,Signal peptide, CUB and EGF-like domain-containing protein 3,, PF12662;PF00431;PF12947;PF07645;PF07699;, GO:0009986;GO:0005615;GO:0005886;GO:0005509;GO:0042802;GO:0022617;GO:0007165;, C:cell surface; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:identical protein binding;, P:extracellular matrix disassembly; P:signal transduction; scaffold40 indexed_genome mRNA 1615240 1616105 . - . ID=transcript_8152;Q8IX30 A8K5A3 Q5CZB3 Q86UZ9 Q8NAU9,Signal peptide, CUB and EGF-like domain-containing protein 3,, PF12662;PF00431;PF12947;PF07645;PF07699;, GO:0009986;GO:0005615;GO:0005886;GO:0005509;GO:0042802;GO:0022617;GO:0007165;, C:cell surface; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:identical protein binding;, P:extracellular matrix disassembly; P:signal transduction; scaffold40 indexed_genome mRNA 1626230 1627899 . + . ID=transcript_8153;Q8IX30 A8K5A3 Q5CZB3 Q86UZ9 Q8NAU9,Signal peptide, CUB and EGF-like domain-containing protein 3,, PF12662;PF00431;PF12947;PF07645;PF07699;, GO:0009986;GO:0005615;GO:0005886;GO:0005509;GO:0042802;GO:0022617;GO:0007165;, C:cell surface; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:identical protein binding;, P:extracellular matrix disassembly; P:signal transduction; scaffold40 indexed_genome mRNA 1660566 1661828 . - . ID=transcript_8154;P36508 Q9BQB2,Zinc finger protein 76,Zinc finger protein 523;, PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0045944;GO:0006357;GO:0006359;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III; scaffold40 indexed_genome mRNA 1661937 1671325 . + . ID=transcript_8155;P36508 Q9BQB2,Zinc finger protein 76,Zinc finger protein 523;, PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0045944;GO:0006357;GO:0006359;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III;|P36508 Q9BQB2,Zinc finger protein 76,Zinc finger protein 523;, PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0045944;GO:0006357;GO:0006359;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III;|P36508 Q9BQB2,Zinc finger protein 76,Zinc finger protein 523;, PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0045944;GO:0006357;GO:0006359;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III;|P36508 Q9BQB2,Zinc finger protein 76,Zinc finger protein 523;, PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0045944;GO:0006357;GO:0006359;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III;|P36508 Q9BQB2,Zinc finger protein 76,Zinc finger protein 523;, PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0045944;GO:0006357;GO:0006359;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III;|P36508 Q9BQB2,Zinc finger protein 76,Zinc finger protein 523;, PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0045944;GO:0006357;GO:0006359;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III;|P36508 Q9BQB2,Zinc finger protein 76,Zinc finger protein 523;, PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0045944;GO:0006357;GO:0006359;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III; scaffold40 indexed_genome mRNA 1673065 1695217 . + . ID=transcript_8156;Q9H4E7 Q86VF4,Differentially expressed in FDCP 6 homolog,IRF4-binding protein;, PF00169;, GO:0005737;GO:0005856;GO:0005829;GO:0030175;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:filopodium; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; scaffold40 indexed_genome mRNA 1771849 1786017 . + . ID=transcript_8157;Q03181 A8K6J6 B4E3V3 B6ZGS1 B7Z3W1 E9PE18 Q5D1P0 Q7Z5K0 Q9BUD4,Peroxisome proliferator-activated receptor delta,NUCI;Nuclear hormone receptor 1;Nuclear receptor subfamily 1 group C member 2;Peroxisome proliferator-activated receptor beta;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0008144;GO:0070539;GO:0008289;GO:0051059;GO:0004879;GO:0000978;GO:0001103;GO:1990837;GO:0003707;GO:0001223;GO:0008134;GO:0008270;GO:0060612;GO:0006915;GO:0097190;GO:0008366;GO:0030154;GO:0008283;GO:0031589;GO:0071456;GO:0071222;GO:0008203;GO:0046697;GO:0007566;GO:0006635;GO:0009062;GO:0006631;GO:0015908;GO:0006091;GO:0006006;GO:1904659;GO:0007507;GO:0009755;GO:0051546;GO:0043616;GO:0006629;GO:0043066;GO:0030308;GO:0010887;GO:0032966;GO:0050680;GO:0050728;GO:0045662;GO:1902894;GO:0014912;GO:0048662;GO:0000122;GO:0045892;GO:0008654;GO:0045684;GO:0045600;GO:0045923;GO:0046321;GO:0035774;GO:2000288;GO:0014068;GO:0043415;GO:0045944;GO:0045893;GO:0006029;GO:0019216;GO:0014842;GO:0006357;GO:0014823;GO:0009749;GO:0033993;GO:0033189;GO:0006367;GO:0006776;GO:0042060;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:drug binding; F:linoleic acid binding; F:lipid binding; F:NF-kappaB binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription coactivator binding; F:transcription factor binding; F:zinc ion binding;, P:adipose tissue development; P:apoptotic process; P:apoptotic signaling pathway; P:axon ensheathment; P:cell differentiation; P:cell population proliferation; P:cell-substrate adhesion; P:cellular response to hypoxia; P:cellular response to lipopolysaccharide; P:cholesterol metabolic process; P:decidualization; P:embryo implantation; P:fatty acid beta-oxidation; P:fatty acid catabolic process; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:glucose metabolic process; P:glucose transmembrane transport; P:heart development; P:hormone-mediated signaling pathway; P:keratinocyte migration; P:keratinocyte proliferation; P:lipid metabolic process; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cholesterol storage; P:negative regulation of collagen biosynthetic process; P:negative regulation of epithelial cell proliferation; P:negative regulation of inflammatory response; P:negative regulation of myoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:phospholipid biosynthetic process; P:positive regulation of epidermis development; P:positive regulation of fat cell differentiation; P:positive regulation of fatty acid metabolic process; P:positive regulation of fatty acid oxidation; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of myoblast proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle tissue regeneration; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteoglycan metabolic process; P:regulation of lipid metabolic process; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to glucose; P:response to lipid; P:response to vitamin A; P:transcription initiation from RNA polymerase II promoter; P:vitamin A metabolic process; P:wound healing;|Q03181 A8K6J6 B4E3V3 B6ZGS1 B7Z3W1 E9PE18 Q5D1P0 Q7Z5K0 Q9BUD4,Peroxisome proliferator-activated receptor delta,NUCI;Nuclear hormone receptor 1;Nuclear receptor subfamily 1 group C member 2;Peroxisome proliferator-activated receptor beta;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0008144;GO:0070539;GO:0008289;GO:0051059;GO:0004879;GO:0000978;GO:0001103;GO:1990837;GO:0003707;GO:0001223;GO:0008134;GO:0008270;GO:0060612;GO:0006915;GO:0097190;GO:0008366;GO:0030154;GO:0008283;GO:0031589;GO:0071456;GO:0071222;GO:0008203;GO:0046697;GO:0007566;GO:0006635;GO:0009062;GO:0006631;GO:0015908;GO:0006091;GO:0006006;GO:1904659;GO:0007507;GO:0009755;GO:0051546;GO:0043616;GO:0006629;GO:0043066;GO:0030308;GO:0010887;GO:0032966;GO:0050680;GO:0050728;GO:0045662;GO:1902894;GO:0014912;GO:0048662;GO:0000122;GO:0045892;GO:0008654;GO:0045684;GO:0045600;GO:0045923;GO:0046321;GO:0035774;GO:2000288;GO:0014068;GO:0043415;GO:0045944;GO:0045893;GO:0006029;GO:0019216;GO:0014842;GO:0006357;GO:0014823;GO:0009749;GO:0033993;GO:0033189;GO:0006367;GO:0006776;GO:0042060;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:drug binding; F:linoleic acid binding; F:lipid binding; F:NF-kappaB binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription coactivator binding; F:transcription factor binding; F:zinc ion binding;, P:adipose tissue development; P:apoptotic process; P:apoptotic signaling pathway; P:axon ensheathment; P:cell differentiation; P:cell population proliferation; P:cell-substrate adhesion; P:cellular response to hypoxia; P:cellular response to lipopolysaccharide; P:cholesterol metabolic process; P:decidualization; P:embryo implantation; P:fatty acid beta-oxidation; P:fatty acid catabolic process; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:glucose metabolic process; P:glucose transmembrane transport; P:heart development; P:hormone-mediated signaling pathway; P:keratinocyte migration; P:keratinocyte proliferation; P:lipid metabolic process; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cholesterol storage; P:negative regulation of collagen biosynthetic process; P:negative regulation of epithelial cell proliferation; P:negative regulation of inflammatory response; P:negative regulation of myoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:phospholipid biosynthetic process; P:positive regulation of epidermis development; P:positive regulation of fat cell differentiation; P:positive regulation of fatty acid metabolic process; P:positive regulation of fatty acid oxidation; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of myoblast proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle tissue regeneration; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteoglycan metabolic process; P:regulation of lipid metabolic process; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to glucose; P:response to lipid; P:response to vitamin A; P:transcription initiation from RNA polymerase II promoter; P:vitamin A metabolic process; P:wound healing;|Q03181 A8K6J6 B4E3V3 B6ZGS1 B7Z3W1 E9PE18 Q5D1P0 Q7Z5K0 Q9BUD4,Peroxisome proliferator-activated receptor delta,NUCI;Nuclear hormone receptor 1;Nuclear receptor subfamily 1 group C member 2;Peroxisome proliferator-activated receptor beta;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0008144;GO:0070539;GO:0008289;GO:0051059;GO:0004879;GO:0000978;GO:0001103;GO:1990837;GO:0003707;GO:0001223;GO:0008134;GO:0008270;GO:0060612;GO:0006915;GO:0097190;GO:0008366;GO:0030154;GO:0008283;GO:0031589;GO:0071456;GO:0071222;GO:0008203;GO:0046697;GO:0007566;GO:0006635;GO:0009062;GO:0006631;GO:0015908;GO:0006091;GO:0006006;GO:1904659;GO:0007507;GO:0009755;GO:0051546;GO:0043616;GO:0006629;GO:0043066;GO:0030308;GO:0010887;GO:0032966;GO:0050680;GO:0050728;GO:0045662;GO:1902894;GO:0014912;GO:0048662;GO:0000122;GO:0045892;GO:0008654;GO:0045684;GO:0045600;GO:0045923;GO:0046321;GO:0035774;GO:2000288;GO:0014068;GO:0043415;GO:0045944;GO:0045893;GO:0006029;GO:0019216;GO:0014842;GO:0006357;GO:0014823;GO:0009749;GO:0033993;GO:0033189;GO:0006367;GO:0006776;GO:0042060;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:drug binding; F:linoleic acid binding; F:lipid binding; F:NF-kappaB binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription coactivator binding; F:transcription factor binding; F:zinc ion binding;, P:adipose tissue development; P:apoptotic process; P:apoptotic signaling pathway; P:axon ensheathment; P:cell differentiation; P:cell population proliferation; P:cell-substrate adhesion; P:cellular response to hypoxia; P:cellular response to lipopolysaccharide; P:cholesterol metabolic process; P:decidualization; P:embryo implantation; P:fatty acid beta-oxidation; P:fatty acid catabolic process; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:glucose metabolic process; P:glucose transmembrane transport; P:heart development; P:hormone-mediated signaling pathway; P:keratinocyte migration; P:keratinocyte proliferation; P:lipid metabolic process; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cholesterol storage; P:negative regulation of collagen biosynthetic process; P:negative regulation of epithelial cell proliferation; P:negative regulation of inflammatory response; P:negative regulation of myoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:phospholipid biosynthetic process; P:positive regulation of epidermis development; P:positive regulation of fat cell differentiation; P:positive regulation of fatty acid metabolic process; P:positive regulation of fatty acid oxidation; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of myoblast proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle tissue regeneration; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteoglycan metabolic process; P:regulation of lipid metabolic process; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to glucose; P:response to lipid; P:response to vitamin A; P:transcription initiation from RNA polymerase II promoter; P:vitamin A metabolic process; P:wound healing;|Q03181 A8K6J6 B4E3V3 B6ZGS1 B7Z3W1 E9PE18 Q5D1P0 Q7Z5K0 Q9BUD4,Peroxisome proliferator-activated receptor delta,NUCI;Nuclear hormone receptor 1;Nuclear receptor subfamily 1 group C member 2;Peroxisome proliferator-activated receptor beta;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0008144;GO:0070539;GO:0008289;GO:0051059;GO:0004879;GO:0000978;GO:0001103;GO:1990837;GO:0003707;GO:0001223;GO:0008134;GO:0008270;GO:0060612;GO:0006915;GO:0097190;GO:0008366;GO:0030154;GO:0008283;GO:0031589;GO:0071456;GO:0071222;GO:0008203;GO:0046697;GO:0007566;GO:0006635;GO:0009062;GO:0006631;GO:0015908;GO:0006091;GO:0006006;GO:1904659;GO:0007507;GO:0009755;GO:0051546;GO:0043616;GO:0006629;GO:0043066;GO:0030308;GO:0010887;GO:0032966;GO:0050680;GO:0050728;GO:0045662;GO:1902894;GO:0014912;GO:0048662;GO:0000122;GO:0045892;GO:0008654;GO:0045684;GO:0045600;GO:0045923;GO:0046321;GO:0035774;GO:2000288;GO:0014068;GO:0043415;GO:0045944;GO:0045893;GO:0006029;GO:0019216;GO:0014842;GO:0006357;GO:0014823;GO:0009749;GO:0033993;GO:0033189;GO:0006367;GO:0006776;GO:0042060;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:drug binding; F:linoleic acid binding; F:lipid binding; F:NF-kappaB binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription coactivator binding; F:transcription factor binding; F:zinc ion binding;, P:adipose tissue development; P:apoptotic process; P:apoptotic signaling pathway; P:axon ensheathment; P:cell differentiation; P:cell population proliferation; P:cell-substrate adhesion; P:cellular response to hypoxia; P:cellular response to lipopolysaccharide; P:cholesterol metabolic process; P:decidualization; P:embryo implantation; P:fatty acid beta-oxidation; P:fatty acid catabolic process; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:glucose metabolic process; P:glucose transmembrane transport; P:heart development; P:hormone-mediated signaling pathway; P:keratinocyte migration; P:keratinocyte proliferation; P:lipid metabolic process; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cholesterol storage; P:negative regulation of collagen biosynthetic process; P:negative regulation of epithelial cell proliferation; P:negative regulation of inflammatory response; P:negative regulation of myoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:phospholipid biosynthetic process; P:positive regulation of epidermis development; P:positive regulation of fat cell differentiation; P:positive regulation of fatty acid metabolic process; P:positive regulation of fatty acid oxidation; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of myoblast proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle tissue regeneration; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteoglycan metabolic process; P:regulation of lipid metabolic process; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to glucose; P:response to lipid; P:response to vitamin A; P:transcription initiation from RNA polymerase II promoter; P:vitamin A metabolic process; P:wound healing; scaffold40 indexed_genome mRNA 1807626 1816572 . - . ID=transcript_8158;Q9HB96 A8K907 Q4ZGH2,Fanconi anemia group E protein,, PF11510;, GO:0043240;GO:0005654;GO:0005634;GO:0036297;, C:Fanconi anaemia nuclear complex; C:nucleoplasm; C:nucleus;, , P:interstrand cross-link repair; scaffold40 indexed_genome mRNA 1817220 1819990 . + . ID=transcript_8159;P62906 B2R801 P52859 P53025 Q5TZT6 Q8J013,60S ribosomal protein L10a,CSA-19;Large ribosomal subunit protein uL1 {ECO:0000303|PubMed:24524803};Neural precursor cell expressed developmentally down-regulated protein 6;, PF00687;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000470;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:maturation of LSU-rRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62906 B2R801 P52859 P53025 Q5TZT6 Q8J013,60S ribosomal protein L10a,CSA-19;Large ribosomal subunit protein uL1 {ECO:0000303|PubMed:24524803};Neural precursor cell expressed developmentally down-regulated protein 6;, PF00687;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000470;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:maturation of LSU-rRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62906 B2R801 P52859 P53025 Q5TZT6 Q8J013,60S ribosomal protein L10a,CSA-19;Large ribosomal subunit protein uL1 {ECO:0000303|PubMed:24524803};Neural precursor cell expressed developmentally down-regulated protein 6;, PF00687;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000470;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:maturation of LSU-rRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold40 indexed_genome mRNA 1824012 1837499 . - . ID=transcript_8160;Q99594 O95910 Q5BJG7 Q8N6Y4,Transcriptional enhancer factor TEF-5,DTEF-1;TEA domain family member 3;, PF01285;PF17725;, GO:0000785;GO:0005654;GO:0005667;GO:0003700;GO:0000981;GO:0000978;GO:0001085;GO:0055059;GO:0048568;GO:0007565;GO:0035329;GO:0045944;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:transcription regulator complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding;, P:asymmetric neuroblast division; P:embryonic organ development; P:female pregnancy; P:hippo signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P56134 C9J8H9 F8W7V3 O76079 Q6IBB3 Q96L83 Q9BTI8,ATP synthase subunit f, mitochondrial {ECO:0000305},ATP synthase membrane subunit f {ECO:0000305};, PF10206;, GO:0016021;GO:0005743;GO:0005753;GO:0005739;GO:0031965;GO:0005634;GO:0045263;GO:0006754;GO:0042407;GO:0042776;GO:1902600;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrion; C:nuclear membrane; C:nucleus; C:proton-transporting ATP synthase complex, coupling factor F(o);, , P:ATP biosynthetic process; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:proton transmembrane transport; scaffold40 indexed_genome mRNA 1963587 2000831 . - . ID=transcript_8161;Q13451 F5H7R1 Q59EB8 Q5TGM6,Peptidyl-prolyl cis-trans isomerase FKBP5,51 kDa FK506-binding protein;54 kDa progesterone receptor-associated immunophilin;Androgen-regulated protein 6;FF1 antigen;FK506-binding protein 5;FKBP54;HSP90-binding immunophilin;Rotamase;, PF00254;PF00515;PF13181;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005528;GO:0031072;GO:0003755;GO:0061077;GO:0006457;GO:0000413;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:FK506 binding; F:heat shock protein binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:chaperone-mediated protein folding; P:protein folding; P:protein peptidyl-prolyl isomerization; P:response to bacterium; scaffold40 indexed_genome mRNA 2026502 2073306 . + . ID=transcript_8162;P62750 B2R5B2 P29316 P39024 Q92774,60S ribosomal protein L23a,Large ribosomal subunit protein uL23 {ECO:0000303|PubMed:24524803};, PF00276;PF03939;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005730;GO:0005634;GO:0045296;GO:0003723;GO:0019843;GO:0003735;GO:1904841;GO:0000184;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:nucleolus; C:nucleus;, F:cadherin binding; F:RNA binding; F:rRNA binding; F:structural constituent of ribosome; F:TORC2 complex binding;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold40 indexed_genome mRNA 2123669 2124447 . + . ID=transcript_8163;Q5T9G4 Q8NEB2 Q96LL8,Armadillo repeat-containing protein 12,, PF04826;, GO:0005634;, C:nucleus; scaffold40 indexed_genome mRNA 2124680 2125564 . + . ID=transcript_8164;Q5T9G4 Q8NEB2 Q96LL8,Armadillo repeat-containing protein 12,, PF04826;, GO:0005634;, C:nucleus; scaffold40 indexed_genome mRNA 2187507 2193413 . - . ID=transcript_8165;Q96SB4 B4DS61 Q12890 Q5R364 Q5R365 Q8IY12,SRSF protein kinase 1,SFRS protein kinase 1;Serine/arginine-rich protein-specific kinase 1;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0007059;GO:0045087;GO:0035556;GO:0045071;GO:0045070;GO:0006468;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0035092;GO:0000245;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:chromosome segregation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:sperm chromatin condensation; P:spliceosomal complex assembly; P:viral process; scaffold40 indexed_genome mRNA 2193496 2249157 . - . ID=transcript_8166;Q96SB4 B4DS61 Q12890 Q5R364 Q5R365 Q8IY12,SRSF protein kinase 1,SFRS protein kinase 1;Serine/arginine-rich protein-specific kinase 1;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0007059;GO:0045087;GO:0035556;GO:0045071;GO:0045070;GO:0006468;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0035092;GO:0000245;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:chromosome segregation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:sperm chromatin condensation; P:spliceosomal complex assembly; P:viral process;|Q96SB4 B4DS61 Q12890 Q5R364 Q5R365 Q8IY12,SRSF protein kinase 1,SFRS protein kinase 1;Serine/arginine-rich protein-specific kinase 1;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0007059;GO:0045087;GO:0035556;GO:0045071;GO:0045070;GO:0006468;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0035092;GO:0000245;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:chromosome segregation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:sperm chromatin condensation; P:spliceosomal complex assembly; P:viral process;|Q96SB4 B4DS61 Q12890 Q5R364 Q5R365 Q8IY12,SRSF protein kinase 1,SFRS protein kinase 1;Serine/arginine-rich protein-specific kinase 1;, PF00069;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0007059;GO:0045087;GO:0035556;GO:0045071;GO:0045070;GO:0006468;GO:0010468;GO:0050684;GO:0048024;GO:0008380;GO:0035092;GO:0000245;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:chromosome segregation; P:innate immune response; P:intracellular signal transduction; P:negative regulation of viral genome replication; P:positive regulation of viral genome replication; P:protein phosphorylation; P:regulation of gene expression; P:regulation of mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:sperm chromatin condensation; P:spliceosomal complex assembly; P:viral process; scaffold40 indexed_genome mRNA 2275993 2282342 . - . ID=transcript_8167;Q96RN1 Q5JVR5 Q812C7 Q8TC65 Q96MA0 Q96PK8,Testis anion transporter 1,Anion exchange transporter;Solute carrier family 26 member 8;, PF01740;PF00916;, GO:0005887;GO:0005886;GO:0015301;GO:0015106;GO:0005254;GO:0015108;GO:0019531;GO:0008271;GO:0015116;GO:0006820;GO:0006821;GO:0030317;GO:0051321;GO:0007275;GO:0019532;GO:0048240;GO:0008272;, C:integral component of plasma membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride channel activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:anion transport; P:chloride transport; P:flagellated sperm motility; P:meiotic cell cycle; P:multicellular organism development; P:oxalate transport; P:sperm capacitation; P:sulfate transport; scaffold40 indexed_genome mRNA 2288732 2289453 . - . ID=transcript_8168;Q96RN1 Q5JVR5 Q812C7 Q8TC65 Q96MA0 Q96PK8,Testis anion transporter 1,Anion exchange transporter;Solute carrier family 26 member 8;, PF01740;PF00916;, GO:0005887;GO:0005886;GO:0015301;GO:0015106;GO:0005254;GO:0015108;GO:0019531;GO:0008271;GO:0015116;GO:0006820;GO:0006821;GO:0030317;GO:0051321;GO:0007275;GO:0019532;GO:0048240;GO:0008272;, C:integral component of plasma membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride channel activity; F:chloride transmembrane transporter activity; F:oxalate transmembrane transporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:anion transport; P:chloride transport; P:flagellated sperm motility; P:meiotic cell cycle; P:multicellular organism development; P:oxalate transport; P:sperm capacitation; P:sulfate transport; scaffold40 indexed_genome mRNA 2414215 2439958 . + . ID=transcript_8169;Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0,Mitogen-activated protein kinase 14,Cytokine suppressive anti-inflammatory drug-binding protein;MAP kinase MXI2;MAX-interacting protein 2;Mitogen-activated protein kinase p38 alpha;Stress-activated protein kinase 2a;, PF00069;, GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0098978;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0034774;GO:0000922;GO:0005524;GO:0019899;GO:0004707;GO:0004708;GO:0048273;GO:0051525;GO:0019903;GO:0106310;GO:0106311;GO:0070935;GO:0000187;GO:0001525;GO:0006915;GO:0001502;GO:0000902;GO:0007166;GO:0071479;GO:0071222;GO:0071223;GO:0071356;GO:0035924;GO:0098586;GO:0006935;GO:0002062;GO:0000077;GO:0019395;GO:0006006;GO:0035556;GO:0031663;GO:0090090;GO:0035331;GO:0002862;GO:0043312;GO:0030316;GO:0038066;GO:0018105;GO:0001890;GO:0030168;GO:0090336;GO:0060045;GO:0031281;GO:0045648;GO:0010628;GO:0046326;GO:0032735;GO:0051149;GO:0045663;GO:1901741;GO:0010831;GO:0042307;GO:2000379;GO:0045944;GO:0007265;GO:1900015;GO:0051090;GO:0010468;GO:0030278;GO:1901796;GO:0099179;GO:0006357;GO:0032495;GO:0035994;GO:0007165;GO:0042770;GO:0007519;GO:0090400;GO:0051146;GO:0007178;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:glutamatergic synapse; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:spindle pole;, F:ATP binding; F:enzyme binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase p38 binding; F:NFAT protein binding; F:protein phosphatase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:3'-UTR-mediated mRNA stabilization; P:activation of MAPK activity; P:angiogenesis; P:apoptotic process; P:cartilage condensation; P:cell morphogenesis; P:cell surface receptor signaling pathway; P:cellular response to ionizing radiation; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:cellular response to virus; P:chemotaxis; P:chondrocyte differentiation; P:DNA damage checkpoint; P:fatty acid oxidation; P:glucose metabolic process; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of hippo signaling; P:negative regulation of inflammatory response to antigenic stimulus; P:neutrophil degranulation; P:osteoclast differentiation; P:p38MAPK cascade; P:peptidyl-serine phosphorylation; P:placenta development; P:platelet activation; P:positive regulation of brown fat cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cyclase activity; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of myoblast fusion; P:positive regulation of myotube differentiation; P:positive regulation of protein import into nucleus; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:Ras protein signal transduction; P:regulation of cytokine production involved in inflammatory response; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of ossification; P:regulation of signal transduction by p53 class mediator; P:regulation of synaptic membrane adhesion; P:regulation of transcription by RNA polymerase II; P:response to muramyl dipeptide; P:response to muscle stretch; P:signal transduction; P:signal transduction in response to DNA damage; P:skeletal muscle tissue development; P:stress-induced premature senescence; P:striated muscle cell differentiation; P:transmembrane receptor protein serine/threonine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0,Mitogen-activated protein kinase 14,Cytokine suppressive anti-inflammatory drug-binding protein;MAP kinase MXI2;MAX-interacting protein 2;Mitogen-activated protein kinase p38 alpha;Stress-activated protein kinase 2a;, PF00069;, GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0098978;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0034774;GO:0000922;GO:0005524;GO:0019899;GO:0004707;GO:0004708;GO:0048273;GO:0051525;GO:0019903;GO:0106310;GO:0106311;GO:0070935;GO:0000187;GO:0001525;GO:0006915;GO:0001502;GO:0000902;GO:0007166;GO:0071479;GO:0071222;GO:0071223;GO:0071356;GO:0035924;GO:0098586;GO:0006935;GO:0002062;GO:0000077;GO:0019395;GO:0006006;GO:0035556;GO:0031663;GO:0090090;GO:0035331;GO:0002862;GO:0043312;GO:0030316;GO:0038066;GO:0018105;GO:0001890;GO:0030168;GO:0090336;GO:0060045;GO:0031281;GO:0045648;GO:0010628;GO:0046326;GO:0032735;GO:0051149;GO:0045663;GO:1901741;GO:0010831;GO:0042307;GO:2000379;GO:0045944;GO:0007265;GO:1900015;GO:0051090;GO:0010468;GO:0030278;GO:1901796;GO:0099179;GO:0006357;GO:0032495;GO:0035994;GO:0007165;GO:0042770;GO:0007519;GO:0090400;GO:0051146;GO:0007178;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:glutamatergic synapse; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:spindle pole;, F:ATP binding; F:enzyme binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase p38 binding; F:NFAT protein binding; F:protein phosphatase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:3'-UTR-mediated mRNA stabilization; P:activation of MAPK activity; P:angiogenesis; P:apoptotic process; P:cartilage condensation; P:cell morphogenesis; P:cell surface receptor signaling pathway; P:cellular response to ionizing radiation; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:cellular response to virus; P:chemotaxis; P:chondrocyte differentiation; P:DNA damage checkpoint; P:fatty acid oxidation; P:glucose metabolic process; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of hippo signaling; P:negative regulation of inflammatory response to antigenic stimulus; P:neutrophil degranulation; P:osteoclast differentiation; P:p38MAPK cascade; P:peptidyl-serine phosphorylation; P:placenta development; P:platelet activation; P:positive regulation of brown fat cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cyclase activity; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of myoblast fusion; P:positive regulation of myotube differentiation; P:positive regulation of protein import into nucleus; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:Ras protein signal transduction; P:regulation of cytokine production involved in inflammatory response; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of ossification; P:regulation of signal transduction by p53 class mediator; P:regulation of synaptic membrane adhesion; P:regulation of transcription by RNA polymerase II; P:response to muramyl dipeptide; P:response to muscle stretch; P:signal transduction; P:signal transduction in response to DNA damage; P:skeletal muscle tissue development; P:stress-induced premature senescence; P:striated muscle cell differentiation; P:transmembrane receptor protein serine/threonine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0,Mitogen-activated protein kinase 14,Cytokine suppressive anti-inflammatory drug-binding protein;MAP kinase MXI2;MAX-interacting protein 2;Mitogen-activated protein kinase p38 alpha;Stress-activated protein kinase 2a;, PF00069;, GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0098978;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0034774;GO:0000922;GO:0005524;GO:0019899;GO:0004707;GO:0004708;GO:0048273;GO:0051525;GO:0019903;GO:0106310;GO:0106311;GO:0070935;GO:0000187;GO:0001525;GO:0006915;GO:0001502;GO:0000902;GO:0007166;GO:0071479;GO:0071222;GO:0071223;GO:0071356;GO:0035924;GO:0098586;GO:0006935;GO:0002062;GO:0000077;GO:0019395;GO:0006006;GO:0035556;GO:0031663;GO:0090090;GO:0035331;GO:0002862;GO:0043312;GO:0030316;GO:0038066;GO:0018105;GO:0001890;GO:0030168;GO:0090336;GO:0060045;GO:0031281;GO:0045648;GO:0010628;GO:0046326;GO:0032735;GO:0051149;GO:0045663;GO:1901741;GO:0010831;GO:0042307;GO:2000379;GO:0045944;GO:0007265;GO:1900015;GO:0051090;GO:0010468;GO:0030278;GO:1901796;GO:0099179;GO:0006357;GO:0032495;GO:0035994;GO:0007165;GO:0042770;GO:0007519;GO:0090400;GO:0051146;GO:0007178;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:glutamatergic synapse; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:spindle pole;, F:ATP binding; F:enzyme binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase p38 binding; F:NFAT protein binding; F:protein phosphatase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:3'-UTR-mediated mRNA stabilization; P:activation of MAPK activity; P:angiogenesis; P:apoptotic process; P:cartilage condensation; P:cell morphogenesis; P:cell surface receptor signaling pathway; P:cellular response to ionizing radiation; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:cellular response to virus; P:chemotaxis; P:chondrocyte differentiation; P:DNA damage checkpoint; P:fatty acid oxidation; P:glucose metabolic process; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of hippo signaling; P:negative regulation of inflammatory response to antigenic stimulus; P:neutrophil degranulation; P:osteoclast differentiation; P:p38MAPK cascade; P:peptidyl-serine phosphorylation; P:placenta development; P:platelet activation; P:positive regulation of brown fat cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cyclase activity; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of myoblast fusion; P:positive regulation of myotube differentiation; P:positive regulation of protein import into nucleus; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:Ras protein signal transduction; P:regulation of cytokine production involved in inflammatory response; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of ossification; P:regulation of signal transduction by p53 class mediator; P:regulation of synaptic membrane adhesion; P:regulation of transcription by RNA polymerase II; P:response to muramyl dipeptide; P:response to muscle stretch; P:signal transduction; P:signal transduction in response to DNA damage; P:skeletal muscle tissue development; P:stress-induced premature senescence; P:striated muscle cell differentiation; P:transmembrane receptor protein serine/threonine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0,Mitogen-activated protein kinase 14,Cytokine suppressive anti-inflammatory drug-binding protein;MAP kinase MXI2;MAX-interacting protein 2;Mitogen-activated protein kinase p38 alpha;Stress-activated protein kinase 2a;, PF00069;, GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0098978;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0034774;GO:0000922;GO:0005524;GO:0019899;GO:0004707;GO:0004708;GO:0048273;GO:0051525;GO:0019903;GO:0106310;GO:0106311;GO:0070935;GO:0000187;GO:0001525;GO:0006915;GO:0001502;GO:0000902;GO:0007166;GO:0071479;GO:0071222;GO:0071223;GO:0071356;GO:0035924;GO:0098586;GO:0006935;GO:0002062;GO:0000077;GO:0019395;GO:0006006;GO:0035556;GO:0031663;GO:0090090;GO:0035331;GO:0002862;GO:0043312;GO:0030316;GO:0038066;GO:0018105;GO:0001890;GO:0030168;GO:0090336;GO:0060045;GO:0031281;GO:0045648;GO:0010628;GO:0046326;GO:0032735;GO:0051149;GO:0045663;GO:1901741;GO:0010831;GO:0042307;GO:2000379;GO:0045944;GO:0007265;GO:1900015;GO:0051090;GO:0010468;GO:0030278;GO:1901796;GO:0099179;GO:0006357;GO:0032495;GO:0035994;GO:0007165;GO:0042770;GO:0007519;GO:0090400;GO:0051146;GO:0007178;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:glutamatergic synapse; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:spindle pole;, F:ATP binding; F:enzyme binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase p38 binding; F:NFAT protein binding; F:protein phosphatase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:3'-UTR-mediated mRNA stabilization; P:activation of MAPK activity; P:angiogenesis; P:apoptotic process; P:cartilage condensation; P:cell morphogenesis; P:cell surface receptor signaling pathway; P:cellular response to ionizing radiation; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:cellular response to virus; P:chemotaxis; P:chondrocyte differentiation; P:DNA damage checkpoint; P:fatty acid oxidation; P:glucose metabolic process; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of hippo signaling; P:negative regulation of inflammatory response to antigenic stimulus; P:neutrophil degranulation; P:osteoclast differentiation; P:p38MAPK cascade; P:peptidyl-serine phosphorylation; P:placenta development; P:platelet activation; P:positive regulation of brown fat cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cyclase activity; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of myoblast fusion; P:positive regulation of myotube differentiation; P:positive regulation of protein import into nucleus; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:Ras protein signal transduction; P:regulation of cytokine production involved in inflammatory response; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of ossification; P:regulation of signal transduction by p53 class mediator; P:regulation of synaptic membrane adhesion; P:regulation of transcription by RNA polymerase II; P:response to muramyl dipeptide; P:response to muscle stretch; P:signal transduction; P:signal transduction in response to DNA damage; P:skeletal muscle tissue development; P:stress-induced premature senescence; P:striated muscle cell differentiation; P:transmembrane receptor protein serine/threonine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0,Mitogen-activated protein kinase 14,Cytokine suppressive anti-inflammatory drug-binding protein;MAP kinase MXI2;MAX-interacting protein 2;Mitogen-activated protein kinase p38 alpha;Stress-activated protein kinase 2a;, PF00069;, GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0098978;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0034774;GO:0000922;GO:0005524;GO:0019899;GO:0004707;GO:0004708;GO:0048273;GO:0051525;GO:0019903;GO:0106310;GO:0106311;GO:0070935;GO:0000187;GO:0001525;GO:0006915;GO:0001502;GO:0000902;GO:0007166;GO:0071479;GO:0071222;GO:0071223;GO:0071356;GO:0035924;GO:0098586;GO:0006935;GO:0002062;GO:0000077;GO:0019395;GO:0006006;GO:0035556;GO:0031663;GO:0090090;GO:0035331;GO:0002862;GO:0043312;GO:0030316;GO:0038066;GO:0018105;GO:0001890;GO:0030168;GO:0090336;GO:0060045;GO:0031281;GO:0045648;GO:0010628;GO:0046326;GO:0032735;GO:0051149;GO:0045663;GO:1901741;GO:0010831;GO:0042307;GO:2000379;GO:0045944;GO:0007265;GO:1900015;GO:0051090;GO:0010468;GO:0030278;GO:1901796;GO:0099179;GO:0006357;GO:0032495;GO:0035994;GO:0007165;GO:0042770;GO:0007519;GO:0090400;GO:0051146;GO:0007178;GO:0048010;, C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:glutamatergic synapse; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:secretory granule lumen; C:spindle pole;, F:ATP binding; F:enzyme binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase p38 binding; F:NFAT protein binding; F:protein phosphatase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:3'-UTR-mediated mRNA stabilization; P:activation of MAPK activity; P:angiogenesis; P:apoptotic process; P:cartilage condensation; P:cell morphogenesis; P:cell surface receptor signaling pathway; P:cellular response to ionizing radiation; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:cellular response to virus; P:chemotaxis; P:chondrocyte differentiation; P:DNA damage checkpoint; P:fatty acid oxidation; P:glucose metabolic process; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of hippo signaling; P:negative regulation of inflammatory response to antigenic stimulus; P:neutrophil degranulation; P:osteoclast differentiation; P:p38MAPK cascade; P:peptidyl-serine phosphorylation; P:placenta development; P:platelet activation; P:positive regulation of brown fat cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cyclase activity; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of myoblast fusion; P:positive regulation of myotube differentiation; P:positive regulation of protein import into nucleus; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:Ras protein signal transduction; P:regulation of cytokine production involved in inflammatory response; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of ossification; P:regulation of signal transduction by p53 class mediator; P:regulation of synaptic membrane adhesion; P:regulation of transcription by RNA polymerase II; P:response to muramyl dipeptide; P:response to muscle stretch; P:signal transduction; P:signal transduction in response to DNA damage; P:skeletal muscle tissue development; P:stress-induced premature senescence; P:striated muscle cell differentiation; P:transmembrane receptor protein serine/threonine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold40 indexed_genome mRNA 2452886 2461350 . + . ID=transcript_8170;O15264 O14739 O15124 Q5U4A5 Q6FI46 Q9UNU0,Mitogen-activated protein kinase 13,Mitogen-activated protein kinase p38 delta;Stress-activated protein kinase 4;, PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0072740;GO:0070301;GO:0071347;GO:1903936;GO:0072709;GO:0034644;GO:0035556;GO:0018105;GO:0050729;GO:0032755;GO:0010468;GO:0006970;GO:0051403;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cellular response to anisomycin; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-1; P:cellular response to sodium arsenite; P:cellular response to sorbitol; P:cellular response to UV; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6 production; P:regulation of gene expression; P:response to osmotic stress; P:stress-activated MAPK cascade;|O15264 O14739 O15124 Q5U4A5 Q6FI46 Q9UNU0,Mitogen-activated protein kinase 13,Mitogen-activated protein kinase p38 delta;Stress-activated protein kinase 4;, PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0072740;GO:0070301;GO:0071347;GO:1903936;GO:0072709;GO:0034644;GO:0035556;GO:0018105;GO:0050729;GO:0032755;GO:0010468;GO:0006970;GO:0051403;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cellular response to anisomycin; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-1; P:cellular response to sodium arsenite; P:cellular response to sorbitol; P:cellular response to UV; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6 production; P:regulation of gene expression; P:response to osmotic stress; P:stress-activated MAPK cascade;|O15264 O14739 O15124 Q5U4A5 Q6FI46 Q9UNU0,Mitogen-activated protein kinase 13,Mitogen-activated protein kinase p38 delta;Stress-activated protein kinase 4;, PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0072740;GO:0070301;GO:0071347;GO:1903936;GO:0072709;GO:0034644;GO:0035556;GO:0018105;GO:0050729;GO:0032755;GO:0010468;GO:0006970;GO:0051403;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cellular response to anisomycin; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-1; P:cellular response to sodium arsenite; P:cellular response to sorbitol; P:cellular response to UV; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-6 production; P:regulation of gene expression; P:response to osmotic stress; P:stress-activated MAPK cascade; scaffold40 indexed_genome mRNA 2517390 2552450 . + . ID=transcript_8171;Q9ULD4 A6ND56 A6NJE2 B7ZLN5 E7EX85 Q17RB6 Q5R3K8,Bromodomain and PHD finger-containing protein 3 {ECO:0000303|PubMed:26620551},, PF00439;PF10513;PF00855;, GO:0005829;GO:0005576;GO:0000123;GO:0070776;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0002576;GO:0045740;, C:cytosol; C:extracellular region; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex;, F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:platelet degranulation; P:positive regulation of DNA replication;|Q9ULD4 A6ND56 A6NJE2 B7ZLN5 E7EX85 Q17RB6 Q5R3K8,Bromodomain and PHD finger-containing protein 3 {ECO:0000303|PubMed:26620551},, PF00439;PF10513;PF00855;, GO:0005829;GO:0005576;GO:0000123;GO:0070776;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0002576;GO:0045740;, C:cytosol; C:extracellular region; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex;, F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:platelet degranulation; P:positive regulation of DNA replication;|Q9ULD4 A6ND56 A6NJE2 B7ZLN5 E7EX85 Q17RB6 Q5R3K8,Bromodomain and PHD finger-containing protein 3 {ECO:0000303|PubMed:26620551},, PF00439;PF10513;PF00855;, GO:0005829;GO:0005576;GO:0000123;GO:0070776;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0002576;GO:0045740;, C:cytosol; C:extracellular region; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex;, F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:platelet degranulation; P:positive regulation of DNA replication;|Q9ULD4 A6ND56 A6NJE2 B7ZLN5 E7EX85 Q17RB6 Q5R3K8,Bromodomain and PHD finger-containing protein 3 {ECO:0000303|PubMed:26620551},, PF00439;PF10513;PF00855;, GO:0005829;GO:0005576;GO:0000123;GO:0070776;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0002576;GO:0045740;, C:cytosol; C:extracellular region; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex;, F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:platelet degranulation; P:positive regulation of DNA replication;|Q9ULD4 A6ND56 A6NJE2 B7ZLN5 E7EX85 Q17RB6 Q5R3K8,Bromodomain and PHD finger-containing protein 3 {ECO:0000303|PubMed:26620551},, PF00439;PF10513;PF00855;, GO:0005829;GO:0005576;GO:0000123;GO:0070776;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0002576;GO:0045740;, C:cytosol; C:extracellular region; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex;, F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:platelet degranulation; P:positive regulation of DNA replication;|Q9ULD4 A6ND56 A6NJE2 B7ZLN5 E7EX85 Q17RB6 Q5R3K8,Bromodomain and PHD finger-containing protein 3 {ECO:0000303|PubMed:26620551},, PF00439;PF10513;PF00855;, GO:0005829;GO:0005576;GO:0000123;GO:0070776;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0002576;GO:0045740;, C:cytosol; C:extracellular region; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex;, F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:platelet degranulation; P:positive regulation of DNA replication;|Q9ULD4 A6ND56 A6NJE2 B7ZLN5 E7EX85 Q17RB6 Q5R3K8,Bromodomain and PHD finger-containing protein 3 {ECO:0000303|PubMed:26620551},, PF00439;PF10513;PF00855;, GO:0005829;GO:0005576;GO:0000123;GO:0070776;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0002576;GO:0045740;, C:cytosol; C:extracellular region; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex;, F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:platelet degranulation; P:positive regulation of DNA replication; scaffold40 indexed_genome mRNA 2739195 2739702 . + . ID=transcript_8172;Q8NFP0 J3KR74,Peroxisomal testis-specific protein 1,Small testis-specific peroxisomal protein;, PF15214;, GO:0005634;GO:0005777;GO:0043065;, C:nucleus; C:peroxisome;, , P:positive regulation of apoptotic process; scaffold40 indexed_genome mRNA 2800803 2819460 . + . ID=transcript_8173;Q7Z5Y7 B4DZD3 B4E2Q3 F5H3T3 Q5W105 Q69YQ7 Q8IZ55,BTB/POZ domain-containing protein KCTD20,Potassium channel tetramerization domain containing 20;, PF16017;, GO:0005737;GO:0042802;GO:0042327;, C:cytoplasm;, F:identical protein binding;, P:positive regulation of phosphorylation;|Q7Z5Y7 B4DZD3 B4E2Q3 F5H3T3 Q5W105 Q69YQ7 Q8IZ55,BTB/POZ domain-containing protein KCTD20,Potassium channel tetramerization domain containing 20;, PF16017;, GO:0005737;GO:0042802;GO:0042327;, C:cytoplasm;, F:identical protein binding;, P:positive regulation of phosphorylation;|Q7Z5Y7 B4DZD3 B4E2Q3 F5H3T3 Q5W105 Q69YQ7 Q8IZ55,BTB/POZ domain-containing protein KCTD20,Potassium channel tetramerization domain containing 20;, PF16017;, GO:0005737;GO:0042802;GO:0042327;, C:cytoplasm;, F:identical protein binding;, P:positive regulation of phosphorylation; scaffold40 indexed_genome mRNA 2822669 2864348 . - . ID=transcript_8174;Q15208 Q503A1,Serine/threonine-protein kinase 38,NDR1 protein kinase;Nuclear Dbf2-related kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0045296;GO:0000287;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0006464;GO:0035556;GO:0043407;GO:0018105;GO:0006468;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:cadherin binding; F:magnesium ion binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular protein modification process; P:intracellular signal transduction; P:negative regulation of MAP kinase activity; P:peptidyl-serine phosphorylation; P:protein phosphorylation;|Q15208 Q503A1,Serine/threonine-protein kinase 38,NDR1 protein kinase;Nuclear Dbf2-related kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0045296;GO:0000287;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0006464;GO:0035556;GO:0043407;GO:0018105;GO:0006468;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:cadherin binding; F:magnesium ion binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular protein modification process; P:intracellular signal transduction; P:negative regulation of MAP kinase activity; P:peptidyl-serine phosphorylation; P:protein phosphorylation;|Q15208 Q503A1,Serine/threonine-protein kinase 38,NDR1 protein kinase;Nuclear Dbf2-related kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0045296;GO:0000287;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0006464;GO:0035556;GO:0043407;GO:0018105;GO:0006468;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:cadherin binding; F:magnesium ion binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular protein modification process; P:intracellular signal transduction; P:negative regulation of MAP kinase activity; P:peptidyl-serine phosphorylation; P:protein phosphorylation;|Q15208 Q503A1,Serine/threonine-protein kinase 38,NDR1 protein kinase;Nuclear Dbf2-related kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0045296;GO:0000287;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0006464;GO:0035556;GO:0043407;GO:0018105;GO:0006468;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:cadherin binding; F:magnesium ion binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular protein modification process; P:intracellular signal transduction; P:negative regulation of MAP kinase activity; P:peptidyl-serine phosphorylation; P:protein phosphorylation; scaffold40 indexed_genome mRNA 2905763 2911990 . + . ID=transcript_8175;P84103 B4E241 O08831 P23152 Q5R3K0,Serine/arginine-rich splicing factor 3,Pre-mRNA-splicing factor SRP20;Splicing factor, arginine/serine-rich 3;, PF00076;, GO:0005737;GO:0016607;GO:0005654;GO:0043274;GO:0003723;GO:1990825;GO:1990830;GO:0031124;GO:0006406;GO:0000398;GO:0048024;GO:0006405;, C:cytoplasm; C:nuclear speck; C:nucleoplasm;, F:phospholipase binding; F:RNA binding; F:sequence-specific mRNA binding;, P:cellular response to leukemia inhibitory factor; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:RNA export from nucleus; scaffold40 indexed_genome mRNA 2942451 2956031 . - . ID=transcript_8176;P62701 P12631 P12750 P27576 P55831 Q14727 Q6IPY4,40S ribosomal protein S4, X isoform,SCR10;Single copy abundant mRNA protein;Small ribosomal subunit protein eS4 {ECO:0000303|PubMed:24524803};, PF16121;PF00467;PF00900;PF08071;PF01479;, GO:0036464;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005844;GO:1990904;GO:0005840;GO:0015935;GO:0045202;GO:0003723;GO:0019843;GO:0003735;GO:0007275;GO:0000184;GO:0008284;GO:0045727;GO:0045471;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:polysome; C:ribonucleoprotein complex; C:ribosome; C:small ribosomal subunit; C:synapse;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:multicellular organism development; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell population proliferation; P:positive regulation of translation; P:response to ethanol; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold40 indexed_genome mRNA 2962765 2984991 . + . ID=transcript_8177;P38936 Q14010 Q6FI05 Q9BUT4,Cyclin-dependent kinase inhibitor 1,CDK-interacting protein 1;Melanoma differentiation-associated protein 6;p21;, PF02234;, GO:0000307;GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0070557;GO:0048471;GO:0032991;GO:0030332;GO:0019912;GO:0004861;GO:0046872;GO:0019901;GO:0004860;GO:0140311;GO:0044877;GO:0031625;GO:0031100;GO:0007050;GO:0034198;GO:0006974;GO:0031668;GO:0071480;GO:0034605;GO:0071479;GO:0071493;GO:0090398;GO:0019221;GO:0006977;GO:0006978;GO:0000082;GO:0000086;GO:0030851;GO:0007507;GO:0060574;GO:0097193;GO:0042771;GO:0071850;GO:0007095;GO:0043066;GO:1905179;GO:0030308;GO:0008285;GO:1904030;GO:2000279;GO:2000134;GO:0010629;GO:0042326;GO:0032091;GO:1904706;GO:0030890;GO:0048146;GO:0043068;GO:0045860;GO:2000379;GO:0006606;GO:0050821;GO:0007265;GO:1902806;GO:0000079;GO:0006357;GO:0060260;GO:0090399;GO:0046685;GO:0051412;GO:0042493;GO:0055093;GO:0010243;GO:0009636;GO:0010165;GO:0090400;GO:0042246;GO:0042060;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PCNA-p21 complex; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:cyclin binding; F:cyclin-dependent protein kinase activating kinase activity; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:metal ion binding; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein sequestering activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:animal organ regeneration; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to DNA damage stimulus; P:cellular response to extracellular stimulus; P:cellular response to gamma radiation; P:cellular response to heat; P:cellular response to ionizing radiation; P:cellular response to UV-B; P:cellular senescence; P:cytokine-mediated signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:granulocyte differentiation; P:heart development; P:intestinal epithelial cell maturation; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic cell cycle arrest; P:mitotic G2 DNA damage checkpoint; P:negative regulation of apoptotic process; P:negative regulation of cardiac muscle tissue regeneration; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein kinase activity; P:negative regulation of DNA biosynthetic process; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of phosphorylation; P:negative regulation of protein binding; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of B cell proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of programmed cell death; P:positive regulation of protein kinase activity; P:positive regulation of reactive oxygen species metabolic process; P:protein import into nucleus; P:protein stabilization; P:Ras protein signal transduction; P:regulation of cell cycle G1/S phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:replicative senescence; P:response to arsenic-containing substance; P:response to corticosterone; P:response to drug; P:response to hyperoxia; P:response to organonitrogen compound; P:response to toxic substance; P:response to X-ray; P:stress-induced premature senescence; P:tissue regeneration; P:wound healing;|P38936 Q14010 Q6FI05 Q9BUT4,Cyclin-dependent kinase inhibitor 1,CDK-interacting protein 1;Melanoma differentiation-associated protein 6;p21;, PF02234;, GO:0000307;GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0070557;GO:0048471;GO:0032991;GO:0030332;GO:0019912;GO:0004861;GO:0046872;GO:0019901;GO:0004860;GO:0140311;GO:0044877;GO:0031625;GO:0031100;GO:0007050;GO:0034198;GO:0006974;GO:0031668;GO:0071480;GO:0034605;GO:0071479;GO:0071493;GO:0090398;GO:0019221;GO:0006977;GO:0006978;GO:0000082;GO:0000086;GO:0030851;GO:0007507;GO:0060574;GO:0097193;GO:0042771;GO:0071850;GO:0007095;GO:0043066;GO:1905179;GO:0030308;GO:0008285;GO:1904030;GO:2000279;GO:2000134;GO:0010629;GO:0042326;GO:0032091;GO:1904706;GO:0030890;GO:0048146;GO:0043068;GO:0045860;GO:2000379;GO:0006606;GO:0050821;GO:0007265;GO:1902806;GO:0000079;GO:0006357;GO:0060260;GO:0090399;GO:0046685;GO:0051412;GO:0042493;GO:0055093;GO:0010243;GO:0009636;GO:0010165;GO:0090400;GO:0042246;GO:0042060;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PCNA-p21 complex; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:cyclin binding; F:cyclin-dependent protein kinase activating kinase activity; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:metal ion binding; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein sequestering activity; F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:animal organ regeneration; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to DNA damage stimulus; P:cellular response to extracellular stimulus; P:cellular response to gamma radiation; P:cellular response to heat; P:cellular response to ionizing radiation; P:cellular response to UV-B; P:cellular senescence; P:cytokine-mediated signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:granulocyte differentiation; P:heart development; P:intestinal epithelial cell maturation; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic cell cycle arrest; P:mitotic G2 DNA damage checkpoint; P:negative regulation of apoptotic process; P:negative regulation of cardiac muscle tissue regeneration; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein kinase activity; P:negative regulation of DNA biosynthetic process; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of phosphorylation; P:negative regulation of protein binding; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of B cell proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of programmed cell death; P:positive regulation of protein kinase activity; P:positive regulation of reactive oxygen species metabolic process; P:protein import into nucleus; P:protein stabilization; P:Ras protein signal transduction; P:regulation of cell cycle G1/S phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:replicative senescence; P:response to arsenic-containing substance; P:response to corticosterone; P:response to drug; P:response to hyperoxia; P:response to organonitrogen compound; P:response to toxic substance; P:response to X-ray; P:stress-induced premature senescence; P:tissue regeneration; P:wound healing; scaffold40 indexed_genome mRNA 3015731 3019889 . + . ID=transcript_8178;Q7Z6P3 A0A087WXI0,Ras-related protein Rab-44,, PF00071;, GO:0035577;GO:0005886;GO:0035579;GO:0005509;GO:0005525;GO:0003924;GO:0043312;, C:azurophil granule membrane; C:plasma membrane; C:specific granule membrane;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:neutrophil degranulation; scaffold40 indexed_genome mRNA 3025544 3032850 . + . ID=transcript_8179;Q7Z6P3 A0A087WXI0,Ras-related protein Rab-44,, PF00071;, GO:0035577;GO:0005886;GO:0035579;GO:0005509;GO:0005525;GO:0003924;GO:0043312;, C:azurophil granule membrane; C:plasma membrane; C:specific granule membrane;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:neutrophil degranulation; scaffold40 indexed_genome mRNA 3159898 3180793 . - . ID=transcript_8180;Q9Y3C6 O15001 Q5TDC9,Peptidyl-prolyl cis-trans isomerase-like 1,Rotamase PPIL1;, PF00160;, GO:0071013;GO:0005654;GO:0005634;GO:0071007;GO:0016018;GO:0097718;GO:0003755;GO:0000398;GO:0006457;GO:0000413;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 2 spliceosome;, F:cyclosporin A binding; F:disordered domain specific binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:mRNA splicing, via spliceosome; P:protein folding; P:protein peptidyl-prolyl isomerization; scaffold40 indexed_genome mRNA 3184805 3219066 . + . ID=transcript_8181;Q6UWU4 B4DTT1 B7Z9L9 F4NAR0 F4NAR1 Q5TDC5 Q6ZMG5 Q7Z356 Q8IZ35,Bombesin receptor-activated protein C6orf89,Amfion {ECO:0000303|PubMed:23460338};, , GO:0005737;GO:0000139;GO:0016021;GO:0030496;GO:0005730;GO:0005886;GO:0050673;GO:0045787;GO:1901727;GO:0042060;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane; C:midbody; C:nucleolus; C:plasma membrane;, , P:epithelial cell proliferation; P:positive regulation of cell cycle; P:positive regulation of histone deacetylase activity; P:wound healing;|Q6UWU4 B4DTT1 B7Z9L9 F4NAR0 F4NAR1 Q5TDC5 Q6ZMG5 Q7Z356 Q8IZ35,Bombesin receptor-activated protein C6orf89,Amfion {ECO:0000303|PubMed:23460338};, , GO:0005737;GO:0000139;GO:0016021;GO:0030496;GO:0005730;GO:0005886;GO:0050673;GO:0045787;GO:1901727;GO:0042060;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane; C:midbody; C:nucleolus; C:plasma membrane;, , P:epithelial cell proliferation; P:positive regulation of cell cycle; P:positive regulation of histone deacetylase activity; P:wound healing; scaffold40 indexed_genome mRNA 3244435 3256929 . + . ID=transcript_8182;Q6UXB8 Q6ZVG9 Q8IYL8 Q8NBK0 Q8TCB8,Peptidase inhibitor 16,Cysteine-rich secretory protein 9;PSP94-binding protein;, PF00188;, GO:0005615;GO:0030414;GO:0061052;, C:extracellular space;, F:peptidase inhibitor activity;, P:negative regulation of cell growth involved in cardiac muscle cell development; scaffold40 indexed_genome mRNA 3260194 3270112 . - . ID=transcript_8183;Q9NZJ7 A8KAX5 B2RCE3 Q6PK60 Q6UX45 Q7L465 Q9BW23 Q9NZR6 Q9UJZ5,Mitochondrial carrier homolog 1,Presenilin-associated protein;, PF00153;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0006919;GO:0006915;GO:0045161;GO:0043065;GO:0009966;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:neuronal ion channel clustering; P:positive regulation of apoptotic process; P:regulation of signal transduction;|Q9NZJ7 A8KAX5 B2RCE3 Q6PK60 Q6UX45 Q7L465 Q9BW23 Q9NZR6 Q9UJZ5,Mitochondrial carrier homolog 1,Presenilin-associated protein;, PF00153;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0006919;GO:0006915;GO:0045161;GO:0043065;GO:0009966;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:neuronal ion channel clustering; P:positive regulation of apoptotic process; P:regulation of signal transduction;|Q9NZJ7 A8KAX5 B2RCE3 Q6PK60 Q6UX45 Q7L465 Q9BW23 Q9NZR6 Q9UJZ5,Mitochondrial carrier homolog 1,Presenilin-associated protein;, PF00153;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0006919;GO:0006915;GO:0045161;GO:0043065;GO:0009966;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:neuronal ion channel clustering; P:positive regulation of apoptotic process; P:regulation of signal transduction; scaffold40 indexed_genome mRNA 3295245 3322061 . + . ID=transcript_8184;Q7Z6J4 Q5T8I1 Q6P6A8 Q6ZNL5 Q8IZ32 Q8N868 Q9H7M2,FYVE, RhoGEF and PH domain-containing protein 2,Zinc finger FYVE domain-containing protein 4;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0031901;GO:0005794;GO:0030027;GO:0005634;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:1901981;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0043507;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:lamellipodium; C:nucleus; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of JUN kinase activity; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q7Z6J4 Q5T8I1 Q6P6A8 Q6ZNL5 Q8IZ32 Q8N868 Q9H7M2,FYVE, RhoGEF and PH domain-containing protein 2,Zinc finger FYVE domain-containing protein 4;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0031901;GO:0005794;GO:0030027;GO:0005634;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:1901981;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0043507;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:lamellipodium; C:nucleus; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of JUN kinase activity; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q7Z6J4 Q5T8I1 Q6P6A8 Q6ZNL5 Q8IZ32 Q8N868 Q9H7M2,FYVE, RhoGEF and PH domain-containing protein 2,Zinc finger FYVE domain-containing protein 4;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0031901;GO:0005794;GO:0030027;GO:0005634;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:1901981;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0043507;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:lamellipodium; C:nucleus; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of JUN kinase activity; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q7Z6J4 Q5T8I1 Q6P6A8 Q6ZNL5 Q8IZ32 Q8N868 Q9H7M2,FYVE, RhoGEF and PH domain-containing protein 2,Zinc finger FYVE domain-containing protein 4;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0031901;GO:0005794;GO:0030027;GO:0005634;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:1901981;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0043507;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:lamellipodium; C:nucleus; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of JUN kinase activity; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q7Z6J4 Q5T8I1 Q6P6A8 Q6ZNL5 Q8IZ32 Q8N868 Q9H7M2,FYVE, RhoGEF and PH domain-containing protein 2,Zinc finger FYVE domain-containing protein 4;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0031901;GO:0005794;GO:0030027;GO:0005634;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:1901981;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0007186;GO:0043065;GO:0043507;GO:0008360;GO:0043087;GO:0051056;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:lamellipodium; C:nucleus; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of JUN kinase activity; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold40 indexed_genome mRNA 3509406 3577653 . + . ID=transcript_8185;Q9NU19 A8KA28 Q32MQ8 Q5VUK9 Q6P4C3 Q7Z6P7 Q9BPV6 Q9BUT5 Q9NXB6,TBC1 domain family member 22B,, PF00566;, GO:0071889;GO:0005096;GO:0090630;GO:0006886;, , F:14-3-3 protein binding; F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; scaffold40 indexed_genome mRNA 3600040 3636774 . + . ID=transcript_8186;O76064 A6NN24 A8MYC0 B4DPG0 Q53H16 Q5NKW5,E3 ubiquitin-protein ligase RNF8 {ECO:0000255|HAMAP-Rule:MF_03067},RING finger protein 8 {ECO:0000255|HAMAP-Rule:MF_03067};RING-type E3 ubiquitin transferase RNF8 {ECO:0000255|HAMAP-Rule:MF_03067};, PF00498;, GO:0000781;GO:0005829;GO:0030496;GO:0005654;GO:0005634;GO:0035861;GO:0000151;GO:0003682;GO:0042393;GO:0042802;GO:0042803;GO:0043130;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:0007049;GO:0051301;GO:0006974;GO:0006302;GO:0006303;GO:0043486;GO:0070535;GO:0033522;GO:0033523;GO:0036297;GO:0045190;GO:0034244;GO:0045739;GO:0051865;GO:0070936;GO:0070534;GO:0016567;GO:0010212;GO:0007286;GO:0035093;GO:0006511;GO:0016032;, C:chromosome, telomeric region; C:cytosol; C:midbody; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:ubiquitin ligase complex;, F:chromatin binding; F:histone binding; F:identical protein binding; F:protein homodimerization activity; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cell cycle; P:cell division; P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone exchange; P:histone H2A K63-linked ubiquitination; P:histone H2A ubiquitination; P:histone H2B ubiquitination; P:interstrand cross-link repair; P:isotype switching; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of DNA repair; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein ubiquitination; P:response to ionizing radiation; P:spermatid development; P:spermatogenesis, exchange of chromosomal proteins; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold40 indexed_genome mRNA 3665819 3673264 . + . ID=transcript_8187;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold40 indexed_genome mRNA 3676044 3733263 . + . ID=transcript_8188;Q8N1G2 A8K949 Q14670 Q96FJ9,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1,Cap methyltransferase 1;Cap1 2'O-ribose methyltransferase 1;FtsJ methyltransferase domain-containing protein 2;Interferon-stimulated gene 95 kDa protein;, PF01728;PF01585;, GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0004483;GO:0003676;GO:0006370;GO:0097309;GO:0080009;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:mRNA (nucleoside-2'-O-)-methyltransferase activity; F:nucleic acid binding;, P:7-methylguanosine mRNA capping; P:cap1 mRNA methylation; P:mRNA methylation;|Q8N1G2 A8K949 Q14670 Q96FJ9,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1,Cap methyltransferase 1;Cap1 2'O-ribose methyltransferase 1;FtsJ methyltransferase domain-containing protein 2;Interferon-stimulated gene 95 kDa protein;, PF01728;PF01585;, GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0004483;GO:0003676;GO:0006370;GO:0097309;GO:0080009;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:mRNA (nucleoside-2'-O-)-methyltransferase activity; F:nucleic acid binding;, P:7-methylguanosine mRNA capping; P:cap1 mRNA methylation; P:mRNA methylation;|Q8N1G2 A8K949 Q14670 Q96FJ9,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1,Cap methyltransferase 1;Cap1 2'O-ribose methyltransferase 1;FtsJ methyltransferase domain-containing protein 2;Interferon-stimulated gene 95 kDa protein;, PF01728;PF01585;, GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0004483;GO:0003676;GO:0006370;GO:0097309;GO:0080009;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:mRNA (nucleoside-2'-O-)-methyltransferase activity; F:nucleic acid binding;, P:7-methylguanosine mRNA capping; P:cap1 mRNA methylation; P:mRNA methylation;|Q9P0B6 Q5T7F7 Q9BTQ9,Coiled-coil domain-containing protein 167,, PF15188;, GO:0016021;, C:integral component of membrane; scaffold40 indexed_genome mRNA 3891437 3904349 . - . ID=transcript_8189;Q8NFP4 A6NHG0 Q8NBE3,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,GPI and MAM protein;Glycosylphosphatidylinositol-MAM;MAM domain-containing protein 3;, PF00629;, GO:0046658;GO:0005576;GO:0005615;GO:0098982;GO:0005794;GO:0005886;GO:0007420;GO:0001764;GO:1905606;GO:0099179;GO:0021527;, C:anchored component of plasma membrane; C:extracellular region; C:extracellular space; C:GABA-ergic synapse; C:Golgi apparatus; C:plasma membrane;, , P:brain development; P:neuron migration; P:regulation of presynapse assembly; P:regulation of synaptic membrane adhesion; P:spinal cord association neuron differentiation;|Q8NFP4 A6NHG0 Q8NBE3,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,GPI and MAM protein;Glycosylphosphatidylinositol-MAM;MAM domain-containing protein 3;, PF00629;, GO:0046658;GO:0005576;GO:0005615;GO:0098982;GO:0005794;GO:0005886;GO:0007420;GO:0001764;GO:1905606;GO:0099179;GO:0021527;, C:anchored component of plasma membrane; C:extracellular region; C:extracellular space; C:GABA-ergic synapse; C:Golgi apparatus; C:plasma membrane;, , P:brain development; P:neuron migration; P:regulation of presynapse assembly; P:regulation of synaptic membrane adhesion; P:spinal cord association neuron differentiation; scaffold40 indexed_genome mRNA 4055190 4391093 . + . ID=transcript_8190;Q9H8U3 Q5SZZ0 Q5SZZ1,AN1-type zinc finger protein 3,Testis-expressed protein 27;, PF01754;PF01428;, GO:0003677;GO:0008270;, , F:DNA binding; F:zinc ion binding;|Q9H8U3 Q5SZZ0 Q5SZZ1,AN1-type zinc finger protein 3,Testis-expressed protein 27;, PF01754;PF01428;, GO:0003677;GO:0008270;, , F:DNA binding; F:zinc ion binding; scaffold40 indexed_genome mRNA 4392097 4396105 . - . ID=transcript_8191;Q96Q07 Q494V9 Q494W1 Q96M00,BTB/POZ domain-containing protein 9,, PF07707;PF00651;PF00754;, GO:0008344;GO:0048512;GO:0042748;GO:0007616;GO:0050804;GO:0060586;GO:1900242;GO:0050951;GO:0042428;, , , P:adult locomotory behavior; P:circadian behavior; P:circadian sleep/wake cycle, non-REM sleep; P:long-term memory; P:modulation of chemical synaptic transmission; P:multicellular organismal iron ion homeostasis; P:regulation of synaptic vesicle endocytosis; P:sensory perception of temperature stimulus; P:serotonin metabolic process;|Q96Q07 Q494V9 Q494W1 Q96M00,BTB/POZ domain-containing protein 9,, PF07707;PF00651;PF00754;, GO:0008344;GO:0048512;GO:0042748;GO:0007616;GO:0050804;GO:0060586;GO:1900242;GO:0050951;GO:0042428;, , , P:adult locomotory behavior; P:circadian behavior; P:circadian sleep/wake cycle, non-REM sleep; P:long-term memory; P:modulation of chemical synaptic transmission; P:multicellular organismal iron ion homeostasis; P:regulation of synaptic vesicle endocytosis; P:sensory perception of temperature stimulus; P:serotonin metabolic process; scaffold40 indexed_genome mRNA 4812837 4839266 . - . ID=transcript_8192;Q04760 B2R6P7 B4DDV0 P78375 Q59EL0 Q5TZW3 Q96FC0 Q96J41,Lactoylglutathione lyase,Aldoketomutase;Glyoxalase I;Ketone-aldehyde mutase;Methylglyoxalase;S-D-lactoylglutathione methylglyoxal lyase;, PF00903;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005886;GO:0004462;GO:0008270;GO:0005975;GO:0006749;GO:0009438;GO:0043066;GO:0030316;GO:0006090;GO:0006357;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:plasma membrane;, F:lactoylglutathione lyase activity; F:zinc ion binding;, P:carbohydrate metabolic process; P:glutathione metabolic process; P:methylglyoxal metabolic process; P:negative regulation of apoptotic process; P:osteoclast differentiation; P:pyruvate metabolic process; P:regulation of transcription by RNA polymerase II;|Q04760 B2R6P7 B4DDV0 P78375 Q59EL0 Q5TZW3 Q96FC0 Q96J41,Lactoylglutathione lyase,Aldoketomutase;Glyoxalase I;Ketone-aldehyde mutase;Methylglyoxalase;S-D-lactoylglutathione methylglyoxal lyase;, PF00903;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005886;GO:0004462;GO:0008270;GO:0005975;GO:0006749;GO:0009438;GO:0043066;GO:0030316;GO:0006090;GO:0006357;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:plasma membrane;, F:lactoylglutathione lyase activity; F:zinc ion binding;, P:carbohydrate metabolic process; P:glutathione metabolic process; P:methylglyoxal metabolic process; P:negative regulation of apoptotic process; P:osteoclast differentiation; P:pyruvate metabolic process; P:regulation of transcription by RNA polymerase II;|Q04760 B2R6P7 B4DDV0 P78375 Q59EL0 Q5TZW3 Q96FC0 Q96J41,Lactoylglutathione lyase,Aldoketomutase;Glyoxalase I;Ketone-aldehyde mutase;Methylglyoxalase;S-D-lactoylglutathione methylglyoxal lyase;, PF00903;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005886;GO:0004462;GO:0008270;GO:0005975;GO:0006749;GO:0009438;GO:0043066;GO:0030316;GO:0006090;GO:0006357;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:plasma membrane;, F:lactoylglutathione lyase activity; F:zinc ion binding;, P:carbohydrate metabolic process; P:glutathione metabolic process; P:methylglyoxal metabolic process; P:negative regulation of apoptotic process; P:osteoclast differentiation; P:pyruvate metabolic process; P:regulation of transcription by RNA polymerase II; scaffold40 indexed_genome mRNA 5353231 5393264 . - . ID=transcript_8193;O95279 B2RAQ6 B5TJL2 Q5VV76,Potassium channel subfamily K member 5,Acid-sensitive potassium channel protein TASK-2;TWIK-related acid-sensitive K(+) channel 2;, PF07885;, GO:0005887;GO:0005267;GO:0022841;GO:0005244;GO:0007588;GO:0097623;GO:0071805;GO:0006813;GO:0034765;GO:0060075;GO:0030322;, C:integral component of plasma membrane;, F:potassium channel activity; F:potassium ion leak channel activity; F:voltage-gated ion channel activity;, P:excretion; P:potassium ion export across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:regulation of resting membrane potential; P:stabilization of membrane potential; scaffold40 indexed_genome mRNA 5463063 5464659 . + . ID=transcript_8194;Q96T54 E9PB46 Q5TCF4 Q8TAW4 Q9BXD1 Q9H592,Potassium channel subfamily K member 17,2P domain potassium channel Talk-2;Acid-sensitive potassium channel protein TASK-4;TWIK-related acid-sensitive K(+) channel 4;TWIK-related alkaline pH-activated K(+) channel 2;, PF07885;, GO:0005887;GO:0005886;GO:0005267;GO:0022841;GO:0005244;GO:0071805;GO:0006813;GO:0034765;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane;, F:potassium channel activity; F:potassium ion leak channel activity; F:voltage-gated ion channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:stabilization of membrane potential; scaffold40 indexed_genome mRNA 5469202 5476697 . - . ID=transcript_8195;Q96T54 E9PB46 Q5TCF4 Q8TAW4 Q9BXD1 Q9H592,Potassium channel subfamily K member 17,2P domain potassium channel Talk-2;Acid-sensitive potassium channel protein TASK-4;TWIK-related acid-sensitive K(+) channel 4;TWIK-related alkaline pH-activated K(+) channel 2;, PF07885;, GO:0005887;GO:0005886;GO:0005267;GO:0022841;GO:0005244;GO:0071805;GO:0006813;GO:0034765;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane;, F:potassium channel activity; F:potassium ion leak channel activity; F:voltage-gated ion channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:stabilization of membrane potential; scaffold40 indexed_genome mRNA 5502729 5727535 . - . ID=transcript_8196;Q6ZMV9 Q2MDE3 Q2MDE4 Q5T8J6 Q6ZWE3 Q86T87 Q8WTV4,Kinesin-like protein KIF6,, PF00225;, GO:0005737;GO:0005871;GO:0001673;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytoplasm; C:kinesin complex; C:male germ cell nucleus; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; scaffold40 indexed_genome mRNA 5960044 6120944 . + . ID=transcript_8197;Q86T65 G5EA45 Q5T4T8 Q5T4U0 Q9NQI5 Q9Y4G0,Disheveled-associated activator of morphogenesis 2,, PF06367;PF06371;PF02181;, GO:0070062;GO:0003779;GO:0031267;GO:0030036;GO:0021516;GO:0048715;GO:0090263;GO:0060828;GO:2000050;GO:0016055;, C:extracellular exosome;, F:actin binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:dorsal spinal cord development; P:negative regulation of oligodendrocyte differentiation; P:positive regulation of canonical Wnt signaling pathway; P:regulation of canonical Wnt signaling pathway; P:regulation of non-canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q86T65 G5EA45 Q5T4T8 Q5T4U0 Q9NQI5 Q9Y4G0,Disheveled-associated activator of morphogenesis 2,, PF06367;PF06371;PF02181;, GO:0070062;GO:0003779;GO:0031267;GO:0030036;GO:0021516;GO:0048715;GO:0090263;GO:0060828;GO:2000050;GO:0016055;, C:extracellular exosome;, F:actin binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:dorsal spinal cord development; P:negative regulation of oligodendrocyte differentiation; P:positive regulation of canonical Wnt signaling pathway; P:regulation of canonical Wnt signaling pathway; P:regulation of non-canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q86T65 G5EA45 Q5T4T8 Q5T4U0 Q9NQI5 Q9Y4G0,Disheveled-associated activator of morphogenesis 2,, PF06367;PF06371;PF02181;, GO:0070062;GO:0003779;GO:0031267;GO:0030036;GO:0021516;GO:0048715;GO:0090263;GO:0060828;GO:2000050;GO:0016055;, C:extracellular exosome;, F:actin binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:dorsal spinal cord development; P:negative regulation of oligodendrocyte differentiation; P:positive regulation of canonical Wnt signaling pathway; P:regulation of canonical Wnt signaling pathway; P:regulation of non-canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q86T65 G5EA45 Q5T4T8 Q5T4U0 Q9NQI5 Q9Y4G0,Disheveled-associated activator of morphogenesis 2,, PF06367;PF06371;PF02181;, GO:0070062;GO:0003779;GO:0031267;GO:0030036;GO:0021516;GO:0048715;GO:0090263;GO:0060828;GO:2000050;GO:0016055;, C:extracellular exosome;, F:actin binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:dorsal spinal cord development; P:negative regulation of oligodendrocyte differentiation; P:positive regulation of canonical Wnt signaling pathway; P:regulation of canonical Wnt signaling pathway; P:regulation of non-canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q5TCE6 Q5TCE9 Q5TCF0 Q5TCF1 Q8N418 Q9NZB7 Q9UEM1,Molybdenum cofactor biosynthesis protein 1,Cell migration-inducing gene 11 protein;Molybdenum cofactor synthesis-step 1 protein A-B;, PF01967;PF06463;PF04055;, GO:0005829;GO:0019008;GO:0005634;GO:0051539;GO:0061799;GO:0061798;GO:0005525;GO:0046872;GO:0006777;GO:0032324;, C:cytosol; C:molybdopterin synthase complex; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:cyclic pyranopterin monophosphate synthase activity; F:GTP 3',8'-cyclase activity; F:GTP binding; F:metal ion binding;, P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process;|Q86T65 G5EA45 Q5T4T8 Q5T4U0 Q9NQI5 Q9Y4G0,Disheveled-associated activator of morphogenesis 2,, PF06367;PF06371;PF02181;, GO:0070062;GO:0003779;GO:0031267;GO:0030036;GO:0021516;GO:0048715;GO:0090263;GO:0060828;GO:2000050;GO:0016055;, C:extracellular exosome;, F:actin binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:dorsal spinal cord development; P:negative regulation of oligodendrocyte differentiation; P:positive regulation of canonical Wnt signaling pathway; P:regulation of canonical Wnt signaling pathway; P:regulation of non-canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q5TCE6 Q5TCE9 Q5TCF0 Q5TCF1 Q8N418 Q9NZB7 Q9UEM1,Molybdenum cofactor biosynthesis protein 1,Cell migration-inducing gene 11 protein;Molybdenum cofactor synthesis-step 1 protein A-B;, PF01967;PF06463;PF04055;, GO:0005829;GO:0019008;GO:0005634;GO:0051539;GO:0061799;GO:0061798;GO:0005525;GO:0046872;GO:0006777;GO:0032324;, C:cytosol; C:molybdopterin synthase complex; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:cyclic pyranopterin monophosphate synthase activity; F:GTP 3',8'-cyclase activity; F:GTP binding; F:metal ion binding;, P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process; scaffold40 indexed_genome mRNA 7151705 7198292 . + . ID=transcript_8198;Q9Y235 B2R899 Q53F28 Q5TGU5 Q5TGU6,C->U-editing enzyme APOBEC-2,mRNA(cytosine(6666)) deaminase 2;, , GO:0005737;GO:0005634;GO:0004126;GO:0042802;GO:0046872;GO:0003723;GO:0016554;GO:0080111;GO:0016556;GO:0006397;, C:cytoplasm; C:nucleus;, F:cytidine deaminase activity; F:identical protein binding; F:metal ion binding; F:RNA binding;, P:cytidine to uridine editing; P:DNA demethylation; P:mRNA modification; P:mRNA processing;|Q9Y235 B2R899 Q53F28 Q5TGU5 Q5TGU6,C->U-editing enzyme APOBEC-2,mRNA(cytosine(6666)) deaminase 2;, , GO:0005737;GO:0005634;GO:0004126;GO:0042802;GO:0046872;GO:0003723;GO:0016554;GO:0080111;GO:0016556;GO:0006397;, C:cytoplasm; C:nucleus;, F:cytidine deaminase activity; F:identical protein binding; F:metal ion binding; F:RNA binding;, P:cytidine to uridine editing; P:DNA demethylation; P:mRNA modification; P:mRNA processing;|Q9Y235 B2R899 Q53F28 Q5TGU5 Q5TGU6,C->U-editing enzyme APOBEC-2,mRNA(cytosine(6666)) deaminase 2;, , GO:0005737;GO:0005634;GO:0004126;GO:0042802;GO:0046872;GO:0003723;GO:0016554;GO:0080111;GO:0016556;GO:0006397;, C:cytoplasm; C:nucleus;, F:cytidine deaminase activity; F:identical protein binding; F:metal ion binding; F:RNA binding;, P:cytidine to uridine editing; P:DNA demethylation; P:mRNA modification; P:mRNA processing;|Q9Y530 A6NEK4 A8K4H4 Q96F23,ADP-ribose glycohydrolase OARD1 {ECO:0000305},O-acetyl-ADP-ribose deacetylase 1;Terminal ADP-ribose protein glycohydrolase 1 {ECO:0000303|PubMed:23481255};[Protein ADP-ribosylglutamate] hydrolase OARD1 {ECO:0000305};, PF01661;, GO:0005730;GO:0005654;GO:0090734;GO:0140293;GO:0061463;GO:0001883;GO:0006974;GO:0140291;GO:0051725;GO:0042278;, C:nucleolus; C:nucleoplasm; C:site of DNA damage;, F:ADP-ribosylglutamate hydrolase activity; F:O-acetyl-ADP-ribose deacetylase activity; F:purine nucleoside binding;, P:cellular response to DNA damage stimulus; P:peptidyl-glutamate ADP-deribosylation; P:protein de-ADP-ribosylation; P:purine nucleoside metabolic process;|Q9Y530 A6NEK4 A8K4H4 Q96F23,ADP-ribose glycohydrolase OARD1 {ECO:0000305},O-acetyl-ADP-ribose deacetylase 1;Terminal ADP-ribose protein glycohydrolase 1 {ECO:0000303|PubMed:23481255};[Protein ADP-ribosylglutamate] hydrolase OARD1 {ECO:0000305};, PF01661;, GO:0005730;GO:0005654;GO:0090734;GO:0140293;GO:0061463;GO:0001883;GO:0006974;GO:0140291;GO:0051725;GO:0042278;, C:nucleolus; C:nucleoplasm; C:site of DNA damage;, F:ADP-ribosylglutamate hydrolase activity; F:O-acetyl-ADP-ribose deacetylase activity; F:purine nucleoside binding;, P:cellular response to DNA damage stimulus; P:peptidyl-glutamate ADP-deribosylation; P:protein de-ADP-ribosylation; P:purine nucleoside metabolic process;|Q9Y530 A6NEK4 A8K4H4 Q96F23,ADP-ribose glycohydrolase OARD1 {ECO:0000305},O-acetyl-ADP-ribose deacetylase 1;Terminal ADP-ribose protein glycohydrolase 1 {ECO:0000303|PubMed:23481255};[Protein ADP-ribosylglutamate] hydrolase OARD1 {ECO:0000305};, PF01661;, GO:0005730;GO:0005654;GO:0090734;GO:0140293;GO:0061463;GO:0001883;GO:0006974;GO:0140291;GO:0051725;GO:0042278;, C:nucleolus; C:nucleoplasm; C:site of DNA damage;, F:ADP-ribosylglutamate hydrolase activity; F:O-acetyl-ADP-ribose deacetylase activity; F:purine nucleoside binding;, P:cellular response to DNA damage stimulus; P:peptidyl-glutamate ADP-deribosylation; P:protein de-ADP-ribosylation; P:purine nucleoside metabolic process;|P23511 Q8IXU0,Nuclear transcription factor Y subunit alpha,CAAT box DNA-binding protein subunit A;Nuclear transcription factor Y subunit A;, PF02045;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:0045893;GO:0019216;GO:0006357;GO:0006355;GO:0048511;GO:0006366;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:rhythmic process; P:transcription by RNA polymerase II;|P23511 Q8IXU0,Nuclear transcription factor Y subunit alpha,CAAT box DNA-binding protein subunit A;Nuclear transcription factor Y subunit A;, PF02045;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:0045893;GO:0019216;GO:0006357;GO:0006355;GO:0048511;GO:0006366;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:rhythmic process; P:transcription by RNA polymerase II;|P23511 Q8IXU0,Nuclear transcription factor Y subunit alpha,CAAT box DNA-binding protein subunit A;Nuclear transcription factor Y subunit A;, PF02045;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:0045893;GO:0019216;GO:0006357;GO:0006355;GO:0048511;GO:0006366;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:rhythmic process; P:transcription by RNA polymerase II;|P23511 Q8IXU0,Nuclear transcription factor Y subunit alpha,CAAT box DNA-binding protein subunit A;Nuclear transcription factor Y subunit A;, PF02045;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:0045893;GO:0019216;GO:0006357;GO:0006355;GO:0048511;GO:0006366;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:rhythmic process; P:transcription by RNA polymerase II; scaffold40 indexed_genome mRNA 7199735 7227830 . + . ID=transcript_8199;Q96PN6 B4DZF0 F5GWS5 O95558 Q5R329 Q5R330 Q8WXV4 Q9NNX0,Adenylate cyclase type 10,AH-related protein;Adenylate cyclase homolog;Germ cell soluble adenylyl cyclase {ECO:0000303|PubMed:11423534};Testicular soluble adenylyl cyclase;, PF00211;, GO:0016324;GO:0045178;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005576;GO:0030426;GO:0005739;GO:0043025;GO:0005634;GO:0048471;GO:0004016;GO:0005524;GO:0051117;GO:0071890;GO:0000287;GO:0030145;GO:0006171;GO:0071241;GO:0003351;GO:0035556;GO:0043065;GO:0007283;, C:apical plasma membrane; C:basal part of cell; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:extracellular region; C:growth cone; C:mitochondrion; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm;, F:adenylate cyclase activity; F:ATP binding; F:ATPase binding; F:bicarbonate binding; F:magnesium ion binding; F:manganese ion binding;, P:cAMP biosynthetic process; P:cellular response to inorganic substance; P:epithelial cilium movement involved in extracellular fluid movement; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:spermatogenesis;|Q96PN6 B4DZF0 F5GWS5 O95558 Q5R329 Q5R330 Q8WXV4 Q9NNX0,Adenylate cyclase type 10,AH-related protein;Adenylate cyclase homolog;Germ cell soluble adenylyl cyclase {ECO:0000303|PubMed:11423534};Testicular soluble adenylyl cyclase;, PF00211;, GO:0016324;GO:0045178;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005576;GO:0030426;GO:0005739;GO:0043025;GO:0005634;GO:0048471;GO:0004016;GO:0005524;GO:0051117;GO:0071890;GO:0000287;GO:0030145;GO:0006171;GO:0071241;GO:0003351;GO:0035556;GO:0043065;GO:0007283;, C:apical plasma membrane; C:basal part of cell; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:extracellular region; C:growth cone; C:mitochondrion; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm;, F:adenylate cyclase activity; F:ATP binding; F:ATPase binding; F:bicarbonate binding; F:magnesium ion binding; F:manganese ion binding;, P:cAMP biosynthetic process; P:cellular response to inorganic substance; P:epithelial cilium movement involved in extracellular fluid movement; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:spermatogenesis;|Q96PN6 B4DZF0 F5GWS5 O95558 Q5R329 Q5R330 Q8WXV4 Q9NNX0,Adenylate cyclase type 10,AH-related protein;Adenylate cyclase homolog;Germ cell soluble adenylyl cyclase {ECO:0000303|PubMed:11423534};Testicular soluble adenylyl cyclase;, PF00211;, GO:0016324;GO:0045178;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005576;GO:0030426;GO:0005739;GO:0043025;GO:0005634;GO:0048471;GO:0004016;GO:0005524;GO:0051117;GO:0071890;GO:0000287;GO:0030145;GO:0006171;GO:0071241;GO:0003351;GO:0035556;GO:0043065;GO:0007283;, C:apical plasma membrane; C:basal part of cell; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:extracellular region; C:growth cone; C:mitochondrion; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm;, F:adenylate cyclase activity; F:ATP binding; F:ATPase binding; F:bicarbonate binding; F:magnesium ion binding; F:manganese ion binding;, P:cAMP biosynthetic process; P:cellular response to inorganic substance; P:epithelial cilium movement involved in extracellular fluid movement; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:spermatogenesis; scaffold40 indexed_genome mRNA 7229669 7243789 . + . ID=transcript_8200;Q96PN6 B4DZF0 F5GWS5 O95558 Q5R329 Q5R330 Q8WXV4 Q9NNX0,Adenylate cyclase type 10,AH-related protein;Adenylate cyclase homolog;Germ cell soluble adenylyl cyclase {ECO:0000303|PubMed:11423534};Testicular soluble adenylyl cyclase;, PF00211;, GO:0016324;GO:0045178;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005576;GO:0030426;GO:0005739;GO:0043025;GO:0005634;GO:0048471;GO:0004016;GO:0005524;GO:0051117;GO:0071890;GO:0000287;GO:0030145;GO:0006171;GO:0071241;GO:0003351;GO:0035556;GO:0043065;GO:0007283;, C:apical plasma membrane; C:basal part of cell; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:extracellular region; C:growth cone; C:mitochondrion; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm;, F:adenylate cyclase activity; F:ATP binding; F:ATPase binding; F:bicarbonate binding; F:magnesium ion binding; F:manganese ion binding;, P:cAMP biosynthetic process; P:cellular response to inorganic substance; P:epithelial cilium movement involved in extracellular fluid movement; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:spermatogenesis; scaffold40 indexed_genome mRNA 7256696 7261389 . - . ID=transcript_8201;Q9NZC2 Q8N5H8 Q8WYN6,Triggering receptor expressed on myeloid cells 2,Triggering receptor expressed on monocytes 2;, PF07686;, GO:0005576;GO:0016021;GO:0005887;GO:0031226;GO:0005886;GO:0044853;GO:0001540;GO:0034186;GO:0034185;GO:0008035;GO:0008289;GO:0001530;GO:0071813;GO:0070891;GO:0030169;GO:0042834;GO:0005543;GO:1990782;GO:0044877;GO:0097110;GO:0038023;GO:0004888;GO:0034189;GO:0097242;GO:0043277;GO:0048143;GO:1904646;GO:0071223;GO:0071224;GO:0150062;GO:0042742;GO:0097028;GO:0032497;GO:0070392;GO:0032499;GO:0006959;GO:0098657;GO:0045087;GO:0001774;GO:0002282;GO:0061518;GO:0043066;GO:1904093;GO:0010507;GO:0032691;GO:0032720;GO:0150076;GO:0030316;GO:0006911;GO:1900223;GO:0002588;GO:2001171;GO:1903082;GO:0050850;GO:1905291;GO:2000350;GO:0050921;GO:1901076;GO:0070374;GO:0010628;GO:0032733;GO:1901980;GO:0034241;GO:1903980;GO:1904141;GO:0010822;GO:1901224;GO:0045672;GO:0050731;GO:0060100;GO:1901800;GO:1903078;GO:0001934;GO:0050714;GO:0032008;GO:0010468;GO:0050776;GO:0045088;GO:0032675;GO:1902531;GO:0071640;GO:0050730;GO:0120035;GO:0060075;GO:0032006;GO:0002931;, C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane; C:plasma membrane raft;, F:amyloid-beta binding; F:apolipoprotein A-I binding; F:apolipoprotein binding; F:high-density lipoprotein particle binding; F:lipid binding; F:lipopolysaccharide binding; F:lipoprotein particle binding; F:lipoteichoic acid binding; F:low-density lipoprotein particle binding; F:peptidoglycan binding; F:phospholipid binding; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:scaffold protein binding; F:signaling receptor activity; F:transmembrane signaling receptor activity; F:very-low-density lipoprotein particle binding;, P:amyloid-beta clearance; P:apoptotic cell clearance; P:astrocyte activation; P:cellular response to amyloid-beta; P:cellular response to lipoteichoic acid; P:cellular response to peptidoglycan; P:complement-mediated synapse pruning; P:defense response to bacterium; P:dendritic cell differentiation; P:detection of lipopolysaccharide; P:detection of lipoteichoic acid; P:detection of peptidoglycan; P:humoral immune response; P:import into cell; P:innate immune response; P:microglial cell activation; P:microglial cell activation involved in immune response; P:microglial cell proliferation; P:negative regulation of apoptotic process; P:negative regulation of autophagic cell death; P:negative regulation of autophagy; P:negative regulation of interleukin-1 beta production; P:negative regulation of tumor necrosis factor production; P:neuroinflammatory response; P:osteoclast differentiation; P:phagocytosis, engulfment; P:positive regulation of amyloid-beta clearance; P:positive regulation of antigen processing and presentation of peptide antigen via MHC class II; P:positive regulation of ATP biosynthetic process; P:positive regulation of C-C chemokine receptor CCR7 signaling pathway; P:positive regulation of calcium-mediated signaling; P:positive regulation of CAMKK-AMPK signaling cascade; P:positive regulation of CD40 signaling pathway; P:positive regulation of chemotaxis; P:positive regulation of engulfment of apoptotic cell; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of interleukin-10 production; P:positive regulation of inward rectifier potassium channel activity; P:positive regulation of macrophage fusion; P:positive regulation of microglial cell activation; P:positive regulation of microglial cell migration; P:positive regulation of mitochondrion organization; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of osteoclast differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis, engulfment; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of protein secretion; P:positive regulation of TOR signaling; P:regulation of gene expression; P:regulation of immune response; P:regulation of innate immune response; P:regulation of interleukin-6 production; P:regulation of intracellular signal transduction; P:regulation of macrophage inflammatory protein 1 alpha production; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of plasma membrane bounded cell projection organization; P:regulation of resting membrane potential; P:regulation of TOR signaling; P:response to ischemia; scaffold40 indexed_genome mRNA 7584508 7605633 . + . ID=transcript_8202;Q8IVH2 Q5W098 Q7Z7F8 Q8IW55 Q96E19,Forkhead box protein P4,Fork head-related protein-like A;, PF00250;PF16159;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold40 indexed_genome mRNA 7651557 7655217 . + . ID=transcript_8203;Q99750,MyoD family inhibitor,Myogenic repressor I-mf;, PF15316;, GO:0005737;GO:0005634;GO:0042802;GO:0008134;GO:0140416;GO:0042994;GO:0009950;GO:0048704;GO:0043392;GO:0000122;GO:0030178;GO:0060707;, C:cytoplasm; C:nucleus;, F:identical protein binding; F:transcription factor binding; F:transcription regulator inhibitor activity;, P:cytoplasmic sequestering of transcription factor; P:dorsal/ventral axis specification; P:embryonic skeletal system morphogenesis; P:negative regulation of DNA binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of Wnt signaling pathway; P:trophoblast giant cell differentiation; scaffold40 indexed_genome mRNA 7682929 7690183 . - . ID=transcript_8204;P19484 Q709B3 Q7Z6P9 Q9BRJ5 Q9UJD8,Transcription factor EB {ECO:0000303|PubMed:2115126},Class E basic helix-loop-helix protein 35;, PF11851;PF00010;PF15951;, GO:0000785;GO:0005737;GO:0005829;GO:0005765;GO:0005634;GO:0003700;GO:0000981;GO:0019899;GO:0046983;GO:0000978;GO:1990837;GO:0000976;GO:0002250;GO:0006914;GO:0034198;GO:0009267;GO:0001892;GO:0006959;GO:0032418;GO:0007040;GO:0010508;GO:0045944;GO:0045893;GO:0010468;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:adaptive immune response; P:autophagy; P:cellular response to amino acid starvation; P:cellular response to starvation; P:embryonic placenta development; P:humoral immune response; P:lysosome localization; P:lysosome organization; P:positive regulation of autophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P19484 Q709B3 Q7Z6P9 Q9BRJ5 Q9UJD8,Transcription factor EB {ECO:0000303|PubMed:2115126},Class E basic helix-loop-helix protein 35;, PF11851;PF00010;PF15951;, GO:0000785;GO:0005737;GO:0005829;GO:0005765;GO:0005634;GO:0003700;GO:0000981;GO:0019899;GO:0046983;GO:0000978;GO:1990837;GO:0000976;GO:0002250;GO:0006914;GO:0034198;GO:0009267;GO:0001892;GO:0006959;GO:0032418;GO:0007040;GO:0010508;GO:0045944;GO:0045893;GO:0010468;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:adaptive immune response; P:autophagy; P:cellular response to amino acid starvation; P:cellular response to starvation; P:embryonic placenta development; P:humoral immune response; P:lysosome localization; P:lysosome organization; P:positive regulation of autophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold40 indexed_genome mRNA 7732701 7735495 . - . ID=transcript_8205;P20142 B4DVZ3 Q5T3D7 Q5T3D8,Gastricsin,Pepsinogen C;, PF07966;PF00026;, GO:0005615;GO:0004190;GO:0007586;GO:0002803;GO:0006508;, C:extracellular space;, F:aspartic-type endopeptidase activity;, P:digestion; P:positive regulation of antibacterial peptide production; P:proteolysis; scaffold40 indexed_genome mRNA 7765965 7775635 . - . ID=transcript_8206;O43559 Q5T3D5,Fibroblast growth factor receptor substrate 3,FGFR-signaling adaptor SNT2;Suc1-associated neurotrophic factor target 2;, PF02174;, GO:0005886;GO:0005104;GO:0042802;GO:0008543;GO:0000165;GO:0007165;, C:plasma membrane;, F:fibroblast growth factor receptor binding; F:identical protein binding;, P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:signal transduction; scaffold40 indexed_genome mRNA 7775952 7782351 . + . ID=transcript_8207;Q2TBC4 A2A3M0 A6PVU1 B3KQ15 Q5T3D4 Q9NSV1,Prickle-like protein 4,Overexpressed breast tumor protein;, PF00412;PF06297;, GO:0005912;GO:0031941;GO:0005634;GO:0001725;GO:0030018;GO:0003779;GO:0051371;GO:0008270;GO:0030036;GO:0007507;GO:0061061;, C:adherens junction; C:filamentous actin; C:nucleus; C:stress fiber; C:Z disc;, F:actin binding; F:muscle alpha-actinin binding; F:zinc ion binding;, P:actin cytoskeleton organization; P:heart development; P:muscle structure development; scaffold40 indexed_genome mRNA 7782375 7787208 . + . ID=transcript_8208;Q96B49 B2DG15 Q9UH52,Mitochondrial import receptor subunit TOM6 homolog,Overexpressed breast tumor protein;Translocase of outer membrane 6 kDa subunit homolog;, PF15184;, GO:0005741;GO:0005742;GO:0005739;GO:0016236;GO:0015031;, C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, , P:macroautophagy; P:protein transport; scaffold40 indexed_genome mRNA 7787243 7790952 . - . ID=transcript_8209;Q70CQ1 Q5T3D9 Q5T3E0 Q96CK4,Ubiquitin carboxyl-terminal hydrolase 49,Deubiquitinating enzyme 49;Ubiquitin thioesterase 49;Ubiquitin-specific-processing protease 49;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0004197;GO:0042393;GO:0004843;GO:0008270;GO:0035616;GO:0000398;GO:0016579;GO:0006511;, C:cytoplasm; C:nucleoplasm;, F:cysteine-type endopeptidase activity; F:histone binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:histone H2B conserved C-terminal lysine deubiquitination; P:mRNA splicing, via spliceosome; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold40 indexed_genome mRNA 7791340 7794249 . - . ID=transcript_8210;Q70CQ1 Q5T3D9 Q5T3E0 Q96CK4,Ubiquitin carboxyl-terminal hydrolase 49,Deubiquitinating enzyme 49;Ubiquitin thioesterase 49;Ubiquitin-specific-processing protease 49;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0004197;GO:0042393;GO:0004843;GO:0008270;GO:0035616;GO:0000398;GO:0016579;GO:0006511;, C:cytoplasm; C:nucleoplasm;, F:cysteine-type endopeptidase activity; F:histone binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:histone H2B conserved C-terminal lysine deubiquitination; P:mRNA splicing, via spliceosome; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold40 indexed_genome mRNA 7795441 7797431 . - . ID=transcript_8211;Q70CQ1 Q5T3D9 Q5T3E0 Q96CK4,Ubiquitin carboxyl-terminal hydrolase 49,Deubiquitinating enzyme 49;Ubiquitin thioesterase 49;Ubiquitin-specific-processing protease 49;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0004197;GO:0042393;GO:0004843;GO:0008270;GO:0035616;GO:0000398;GO:0016579;GO:0006511;, C:cytoplasm; C:nucleoplasm;, F:cysteine-type endopeptidase activity; F:histone binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:histone H2B conserved C-terminal lysine deubiquitination; P:mRNA splicing, via spliceosome; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold40 indexed_genome mRNA 7865911 7866677 . + . ID=transcript_8212;Q9H944 B4DE08 O95821 Q5T8J4 Q9Y429,Mediator of RNA polymerase II transcription subunit 20,Mediator complex subunit 20;TRF-proximal protein homolog;, PF08612;, GO:0016592;GO:0005654;GO:0000151;GO:0003899;GO:0003713;GO:0061630;GO:0006357;GO:0060260;GO:0006366;GO:0006351;, C:mediator complex; C:nucleoplasm; C:ubiquitin ligase complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:transcription coactivator activity; F:ubiquitin protein ligase activity;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold40 indexed_genome mRNA 7873478 7889537 . + . ID=transcript_8213;Q13895 Q6P5W4 Q86W44 Q96IP8,Bystin {ECO:0000305},, PF05291;, GO:0045177;GO:0005694;GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005730;GO:0005654;GO:0030688;GO:0003723;GO:0030515;GO:0008283;GO:0000462;GO:1904749;GO:0042254;GO:0006364;GO:0001829;, C:apical part of cell; C:chromosome; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleoplasm; C:preribosome, small subunit precursor;, F:RNA binding; F:snoRNA binding;, P:cell population proliferation; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of protein localization to nucleolus; P:ribosome biogenesis; P:rRNA processing; P:trophectodermal cell differentiation;|P30281 B2RD63 B3KQ22 E9PAS4 E9PB36 Q5T8J0 Q6FG62 Q96F49,G1/S-specific cyclin-D3,, PF02984;PF00134;, GO:0000307;GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0004693;GO:0016538;GO:0019901;GO:0051301;GO:0044772;GO:0000122;GO:0045737;GO:1900087;GO:0001934;GO:0042127;GO:0000079;GO:0046626;GO:0007165;GO:0042098;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:mitotic cell cycle phase transition; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein phosphorylation; P:regulation of cell population proliferation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of insulin receptor signaling pathway; P:signal transduction; P:T cell proliferation; scaffold40 indexed_genome mRNA 7980644 8002767 . + . ID=transcript_8214;Q7Z7C8 Q5T0K1 Q8N4R9 Q96M52,Transcription initiation factor TFIID subunit 8,Protein taube nuss;TBP-associated factor 43 kDa;TBP-associated factor 8;Transcription initiation factor TFIID 43 kDa subunit;, PF07524;PF10406;, GO:0005654;GO:0005634;GO:0048471;GO:0005669;GO:0046982;GO:0016251;GO:0030154;GO:0001112;GO:0001833;GO:0051457;GO:0045598;GO:0042795;GO:0006367;, C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:transcription factor TFIID complex;, F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity;, P:cell differentiation; P:DNA-templated transcription open complex formation; P:inner cell mass cell proliferation; P:maintenance of protein location in nucleus; P:regulation of fat cell differentiation; P:snRNA transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q7Z7C8 Q5T0K1 Q8N4R9 Q96M52,Transcription initiation factor TFIID subunit 8,Protein taube nuss;TBP-associated factor 43 kDa;TBP-associated factor 8;Transcription initiation factor TFIID 43 kDa subunit;, PF07524;PF10406;, GO:0005654;GO:0005634;GO:0048471;GO:0005669;GO:0046982;GO:0016251;GO:0030154;GO:0001112;GO:0001833;GO:0051457;GO:0045598;GO:0042795;GO:0006367;, C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:transcription factor TFIID complex;, F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity;, P:cell differentiation; P:DNA-templated transcription open complex formation; P:inner cell mass cell proliferation; P:maintenance of protein location in nucleus; P:regulation of fat cell differentiation; P:snRNA transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold40 indexed_genome mRNA 8020381 8025691 . - . ID=transcript_8215;Q5T0Z8 A6NI05,Uncharacterized protein C6orf132 scaffold40 indexed_genome mRNA 8026285 8055076 . - . ID=transcript_8216;Q5T0Z8 A6NI05,Uncharacterized protein C6orf132 scaffold40 indexed_genome mRNA 8075866 8076485 . + . ID=transcript_8217;X6R8D5,Putative uncharacterized protein GUCA1ANB {ECO:0000305},GUCA1A neighbor {ECO:0000312|HGNC:HGNC:55126}; scaffold40 indexed_genome mRNA 8111397 8118457 . - . ID=transcript_8218;P82664 B2RE89 Q9H3E5 Q9NVR3,28S ribosomal protein S10, mitochondrial,Mitochondrial small ribosomal subunit protein uS10m {ECO:0000303|PubMed:25838379};, PF00338;, GO:0005743;GO:0005763;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination;|P82664 B2RE89 Q9H3E5 Q9NVR3,28S ribosomal protein S10, mitochondrial,Mitochondrial small ribosomal subunit protein uS10m {ECO:0000303|PubMed:25838379};, PF00338;, GO:0005743;GO:0005763;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination;|P82664 B2RE89 Q9H3E5 Q9NVR3,28S ribosomal protein S10, mitochondrial,Mitochondrial small ribosomal subunit protein uS10m {ECO:0000303|PubMed:25838379};, PF00338;, GO:0005743;GO:0005763;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination;|P82664 B2RE89 Q9H3E5 Q9NVR3,28S ribosomal protein S10, mitochondrial,Mitochondrial small ribosomal subunit protein uS10m {ECO:0000303|PubMed:25838379};, PF00338;, GO:0005743;GO:0005763;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold40 indexed_genome mRNA 8128947 8157269 . - . ID=transcript_8219;Q96PN7 Q05GC6 Q7Z6T2 Q7Z6T3 Q9NQ72 Q9NQ73 Q9NUN9,Transcriptional-regulating factor 1,Breast cancer anti-estrogen resistance 2;Transcriptional-regulating protein 132;Zinc finger protein rapa;Zinc finger transcription factor TReP-132;, PF01448;, GO:0005829;GO:0001650;GO:0000118;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0046872;GO:0030374;GO:0033142;GO:0003713;GO:0003714;GO:0008134;GO:0071393;GO:0016575;GO:0045892;GO:0045944;GO:0045893;GO:0050847;GO:0006357;, C:cytosol; C:fibrillar center; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:metal ion binding; F:nuclear receptor coactivator activity; F:progesterone receptor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:cellular response to progesterone stimulus; P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:progesterone receptor signaling pathway; P:regulation of transcription by RNA polymerase II; scaffold40 indexed_genome mRNA 8163437 8166279 . - . ID=transcript_8220;Q96PN7 Q05GC6 Q7Z6T2 Q7Z6T3 Q9NQ72 Q9NQ73 Q9NUN9,Transcriptional-regulating factor 1,Breast cancer anti-estrogen resistance 2;Transcriptional-regulating protein 132;Zinc finger protein rapa;Zinc finger transcription factor TReP-132;, PF01448;, GO:0005829;GO:0001650;GO:0000118;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0046872;GO:0030374;GO:0033142;GO:0003713;GO:0003714;GO:0008134;GO:0071393;GO:0016575;GO:0045892;GO:0045944;GO:0045893;GO:0050847;GO:0006357;, C:cytosol; C:fibrillar center; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:metal ion binding; F:nuclear receptor coactivator activity; F:progesterone receptor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:cellular response to progesterone stimulus; P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:progesterone receptor signaling pathway; P:regulation of transcription by RNA polymerase II;|Q96PN7 Q05GC6 Q7Z6T2 Q7Z6T3 Q9NQ72 Q9NQ73 Q9NUN9,Transcriptional-regulating factor 1,Breast cancer anti-estrogen resistance 2;Transcriptional-regulating protein 132;Zinc finger protein rapa;Zinc finger transcription factor TReP-132;, PF01448;, GO:0005829;GO:0001650;GO:0000118;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0046872;GO:0030374;GO:0033142;GO:0003713;GO:0003714;GO:0008134;GO:0071393;GO:0016575;GO:0045892;GO:0045944;GO:0045893;GO:0050847;GO:0006357;, C:cytosol; C:fibrillar center; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:metal ion binding; F:nuclear receptor coactivator activity; F:progesterone receptor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:cellular response to progesterone stimulus; P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:progesterone receptor signaling pathway; P:regulation of transcription by RNA polymerase II; scaffold40 indexed_genome mRNA 8444183 8492183 . + . ID=transcript_8221;Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; scaffold40 indexed_genome mRNA 8499272 8542483 . + . ID=transcript_8222;Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; scaffold40 indexed_genome mRNA 8542498 8543962 . - . ID=transcript_8223;Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway;|Q8IWV8 O15057 Q4VXK2 Q5TFH6 Q6P2I2 Q6ZUD0,E3 ubiquitin-protein ligase UBR2,N-recognin-2;RING-type E3 ubiquitin transferase UBR2;Ubiquitin-protein ligase E3-alpha-2;Ubiquitin-protein ligase E3-alpha-II;, PF02617;PF18995;PF02207;, GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0000151;GO:0070728;GO:0061630;GO:0008270;GO:0071233;GO:0006342;GO:0033522;GO:0007141;GO:0007140;GO:0032007;GO:0010529;GO:0000209;GO:0016567;GO:0007131;GO:0007283;GO:0071596;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:ubiquitin ligase complex;, F:leucine binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cellular response to leucine; P:chromatin silencing; P:histone H2A ubiquitination; P:male meiosis I; P:male meiotic nuclear division; P:negative regulation of TOR signaling; P:negative regulation of transposition; P:protein polyubiquitination; P:protein ubiquitination; P:reciprocal meiotic recombination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; scaffold40 indexed_genome mRNA 8577383 8581474 . - . ID=transcript_8224;Q15814 Q53Y43 Q5T787,Tubulin-specific chaperone C,Tubulin-folding cofactor C;, PF07986;PF16752;, GO:0005737;GO:0005856;GO:0005829;GO:0005874;GO:0032391;GO:0051087;GO:0003924;GO:0015631;GO:0000902;GO:0007023;GO:0006457;GO:0007021;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:microtubule; C:photoreceptor connecting cilium;, F:chaperone binding; F:GTPase activity; F:tubulin binding;, P:cell morphogenesis; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly; scaffold40 indexed_genome mRNA 8693320 8698068 . - . ID=transcript_8225;Q6DKI1 A8K7D4 B7Z652 Q5TFZ5 Q6PEK3,60S ribosomal protein L7-like 1,Large ribosomal subunit protein uL30-like 1;, PF00327;PF08079;, GO:0022625;GO:0005730;GO:0003723;GO:0003735;GO:0001825;GO:0000463;, C:cytosolic large ribosomal subunit; C:nucleolus;, F:RNA binding; F:structural constituent of ribosome;, P:blastocyst formation; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q6DKI1 A8K7D4 B7Z652 Q5TFZ5 Q6PEK3,60S ribosomal protein L7-like 1,Large ribosomal subunit protein uL30-like 1;, PF00327;PF08079;, GO:0022625;GO:0005730;GO:0003723;GO:0003735;GO:0001825;GO:0000463;, C:cytosolic large ribosomal subunit; C:nucleolus;, F:RNA binding; F:structural constituent of ribosome;, P:blastocyst formation; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q6DKI1 A8K7D4 B7Z652 Q5TFZ5 Q6PEK3,60S ribosomal protein L7-like 1,Large ribosomal subunit protein uL30-like 1;, PF00327;PF08079;, GO:0022625;GO:0005730;GO:0003723;GO:0003735;GO:0001825;GO:0000463;, C:cytosolic large ribosomal subunit; C:nucleolus;, F:RNA binding; F:structural constituent of ribosome;, P:blastocyst formation; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); scaffold40 indexed_genome mRNA 8708920 8714006 . - . ID=transcript_8226;Q4VY36 Q4VY37 Q4VY38 Q9GZP2 Q9GZU4 Q9GZZ4,Polyglutamine-binding protein 1 {ECO:0000303|PubMed:10332029, ECO:0000303|PubMed:11163963},38 kDa nuclear protein containing a WW domain {ECO:0000303|PubMed:10198427};Polyglutamine tract-binding protein 1 {ECO:0000303|PubMed:10332029};, , GO:0005737;GO:0010494;GO:0071598;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0043021;GO:0003713;GO:0002218;GO:0000380;GO:0071360;GO:0051607;GO:0045087;GO:0000398;GO:0031175;GO:0002230;GO:0032481;GO:0048814;GO:0043484;GO:0006355;, C:cytoplasm; C:cytoplasmic stress granule; C:neuronal ribonucleoprotein granule; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:ribonucleoprotein complex binding; F:transcription coactivator activity;, P:activation of innate immune response; P:alternative mRNA splicing, via spliceosome; P:cellular response to exogenous dsRNA; P:defense response to virus; P:innate immune response; P:mRNA splicing, via spliceosome; P:neuron projection development; P:positive regulation of defense response to virus by host; P:positive regulation of type I interferon production; P:regulation of dendrite morphogenesis; P:regulation of RNA splicing; P:regulation of transcription, DNA-templated; scaffold40 indexed_genome mRNA 8735047 8744549 . + . ID=transcript_8227;Q9BT09 O15412 Q0P6I2 Q8NF54 Q8WTU8 Q9P0F2,Protein canopy homolog 3,CTG repeat protein 4a;Expanded repeat-domain protein CAG/CTG 5;Protein associated with TLR4;Trinucleotide repeat-containing gene 5 protein;, PF11938;, GO:0005788;GO:0005102;GO:0045087;GO:0002224;, C:endoplasmic reticulum lumen;, F:signaling receptor binding;, P:innate immune response; P:toll-like receptor signaling pathway;|Q9BT09 O15412 Q0P6I2 Q8NF54 Q8WTU8 Q9P0F2,Protein canopy homolog 3,CTG repeat protein 4a;Expanded repeat-domain protein CAG/CTG 5;Protein associated with TLR4;Trinucleotide repeat-containing gene 5 protein;, PF11938;, GO:0005788;GO:0005102;GO:0045087;GO:0002224;, C:endoplasmic reticulum lumen;, F:signaling receptor binding;, P:innate immune response; P:toll-like receptor signaling pathway;|Q9BT09 O15412 Q0P6I2 Q8NF54 Q8WTU8 Q9P0F2,Protein canopy homolog 3,CTG repeat protein 4a;Expanded repeat-domain protein CAG/CTG 5;Protein associated with TLR4;Trinucleotide repeat-containing gene 5 protein;, PF11938;, GO:0005788;GO:0005102;GO:0045087;GO:0002224;, C:endoplasmic reticulum lumen;, F:signaling receptor binding;, P:innate immune response; P:toll-like receptor signaling pathway; scaffold40 indexed_genome mRNA 8750841 8764614 . + . ID=transcript_8228;Q13608 Q5T8W1 Q8WYQ0 Q8WYQ1 Q8WYQ2 Q99476,Peroxisome assembly factor 2,Peroxin-6;Peroxisomal biogenesis factor 6;Peroxisomal-type ATPase 1;, PF00004;, GO:0005737;GO:0005829;GO:0005778;GO:0005777;GO:0097733;GO:0001750;GO:0005524;GO:0016887;GO:0008022;GO:0044877;GO:0007031;GO:0016558;GO:0016561;GO:0008104;GO:0050821;GO:0006625;, C:cytoplasm; C:cytosol; C:peroxisomal membrane; C:peroxisome; C:photoreceptor cell cilium; C:photoreceptor outer segment;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein-containing complex binding;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, translocation; P:protein localization; P:protein stabilization; P:protein targeting to peroxisome;|Q13608 Q5T8W1 Q8WYQ0 Q8WYQ1 Q8WYQ2 Q99476,Peroxisome assembly factor 2,Peroxin-6;Peroxisomal biogenesis factor 6;Peroxisomal-type ATPase 1;, PF00004;, GO:0005737;GO:0005829;GO:0005778;GO:0005777;GO:0097733;GO:0001750;GO:0005524;GO:0016887;GO:0008022;GO:0044877;GO:0007031;GO:0016558;GO:0016561;GO:0008104;GO:0050821;GO:0006625;, C:cytoplasm; C:cytosol; C:peroxisomal membrane; C:peroxisome; C:photoreceptor cell cilium; C:photoreceptor outer segment;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein-containing complex binding;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, translocation; P:protein localization; P:protein stabilization; P:protein targeting to peroxisome; scaffold40 indexed_genome mRNA 8764859 8772810 . - . ID=transcript_8229;Q13608 Q5T8W1 Q8WYQ0 Q8WYQ1 Q8WYQ2 Q99476,Peroxisome assembly factor 2,Peroxin-6;Peroxisomal biogenesis factor 6;Peroxisomal-type ATPase 1;, PF00004;, GO:0005737;GO:0005829;GO:0005778;GO:0005777;GO:0097733;GO:0001750;GO:0005524;GO:0016887;GO:0008022;GO:0044877;GO:0007031;GO:0016558;GO:0016561;GO:0008104;GO:0050821;GO:0006625;, C:cytoplasm; C:cytosol; C:peroxisomal membrane; C:peroxisome; C:photoreceptor cell cilium; C:photoreceptor outer segment;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein-containing complex binding;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, translocation; P:protein localization; P:protein stabilization; P:protein targeting to peroxisome;|Q13608 Q5T8W1 Q8WYQ0 Q8WYQ1 Q8WYQ2 Q99476,Peroxisome assembly factor 2,Peroxin-6;Peroxisomal biogenesis factor 6;Peroxisomal-type ATPase 1;, PF00004;, GO:0005737;GO:0005829;GO:0005778;GO:0005777;GO:0097733;GO:0001750;GO:0005524;GO:0016887;GO:0008022;GO:0044877;GO:0007031;GO:0016558;GO:0016561;GO:0008104;GO:0050821;GO:0006625;, C:cytoplasm; C:cytosol; C:peroxisomal membrane; C:peroxisome; C:photoreceptor cell cilium; C:photoreceptor outer segment;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein-containing complex binding;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, translocation; P:protein localization; P:protein stabilization; P:protein targeting to peroxisome;|Q13608 Q5T8W1 Q8WYQ0 Q8WYQ1 Q8WYQ2 Q99476,Peroxisome assembly factor 2,Peroxin-6;Peroxisomal biogenesis factor 6;Peroxisomal-type ATPase 1;, PF00004;, GO:0005737;GO:0005829;GO:0005778;GO:0005777;GO:0097733;GO:0001750;GO:0005524;GO:0016887;GO:0008022;GO:0044877;GO:0007031;GO:0016558;GO:0016561;GO:0008104;GO:0050821;GO:0006625;, C:cytoplasm; C:cytosol; C:peroxisomal membrane; C:peroxisome; C:photoreceptor cell cilium; C:photoreceptor outer segment;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein-containing complex binding;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, translocation; P:protein localization; P:protein stabilization; P:protein targeting to peroxisome; scaffold40 indexed_genome mRNA 8776662 8829449 . + . ID=transcript_8230;Q14738 A8K3I9 B5BUA6 O00494 O00696 Q15171 Q5TC39,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform,PP2A B subunit isoform B'-delta;PP2A B subunit isoform B56-delta;PP2A B subunit isoform PR61-delta;PP2A B subunit isoform R5-delta;, PF01603;, GO:0005829;GO:0005654;GO:0005634;GO:0000159;GO:0004721;GO:0072542;GO:0019888;GO:0010801;GO:0007399;GO:0035307;GO:0006470;GO:0031952;GO:0007165;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:phosphoprotein phosphatase activity; F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:negative regulation of peptidyl-threonine phosphorylation; P:nervous system development; P:positive regulation of protein dephosphorylation; P:protein dephosphorylation; P:regulation of protein autophosphorylation; P:signal transduction;|Q14738 A8K3I9 B5BUA6 O00494 O00696 Q15171 Q5TC39,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform,PP2A B subunit isoform B'-delta;PP2A B subunit isoform B56-delta;PP2A B subunit isoform PR61-delta;PP2A B subunit isoform R5-delta;, PF01603;, GO:0005829;GO:0005654;GO:0005634;GO:0000159;GO:0004721;GO:0072542;GO:0019888;GO:0010801;GO:0007399;GO:0035307;GO:0006470;GO:0031952;GO:0007165;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:phosphoprotein phosphatase activity; F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:negative regulation of peptidyl-threonine phosphorylation; P:nervous system development; P:positive regulation of protein dephosphorylation; P:protein dephosphorylation; P:regulation of protein autophosphorylation; P:signal transduction;|Q9BQ90 A8K2W9,Kelch domain-containing protein 3,Protein Peas;Testis intracellular mediator protein;, PF07646;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0003682;GO:0036498;GO:0007131;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:chromatin binding;, P:IRE1-mediated unfolded protein response; P:reciprocal meiotic recombination;|Q9BQ90 A8K2W9,Kelch domain-containing protein 3,Protein Peas;Testis intracellular mediator protein;, PF07646;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0003682;GO:0036498;GO:0007131;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:chromatin binding;, P:IRE1-mediated unfolded protein response; P:reciprocal meiotic recombination;|Q9BQ90 A8K2W9,Kelch domain-containing protein 3,Protein Peas;Testis intracellular mediator protein;, PF07646;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0003682;GO:0036498;GO:0007131;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:chromatin binding;, P:IRE1-mediated unfolded protein response; P:reciprocal meiotic recombination;|Q9BQ90 A8K2W9,Kelch domain-containing protein 3,Protein Peas;Testis intracellular mediator protein;, PF07646;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0003682;GO:0036498;GO:0007131;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:chromatin binding;, P:IRE1-mediated unfolded protein response; P:reciprocal meiotic recombination;|Q9BQ90 A8K2W9,Kelch domain-containing protein 3,Protein Peas;Testis intracellular mediator protein;, PF07646;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0003682;GO:0036498;GO:0007131;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:chromatin binding;, P:IRE1-mediated unfolded protein response; P:reciprocal meiotic recombination;|Q96EU6 Q9BRF6 Q9P0C8,Ribosomal RNA processing protein 36 homolog,, PF06102;, GO:0030686;GO:0005730;GO:0005654;GO:0003723;GO:0000469;GO:0000462;GO:0042274;GO:0006364;, C:90S preribosome; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit biogenesis; P:rRNA processing;|Q96EU6 Q9BRF6 Q9P0C8,Ribosomal RNA processing protein 36 homolog,, PF06102;, GO:0030686;GO:0005730;GO:0005654;GO:0003723;GO:0000469;GO:0000462;GO:0042274;GO:0006364;, C:90S preribosome; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit biogenesis; P:rRNA processing;|Q96EU6 Q9BRF6 Q9P0C8,Ribosomal RNA processing protein 36 homolog,, PF06102;, GO:0030686;GO:0005730;GO:0005654;GO:0003723;GO:0000469;GO:0000462;GO:0042274;GO:0006364;, C:90S preribosome; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:cleavage involved in rRNA processing; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit biogenesis; P:rRNA processing;|Q14999 B4DYZ0 F5H0L1 Q5T654,Cullin-7,, PF03256;PF11515;PF00888;, GO:1990393;GO:0005680;GO:0005813;GO:0031467;GO:0031461;GO:0005737;GO:0005829;GO:0005794;GO:0048471;GO:0031625;GO:0001837;GO:0007030;GO:0036498;GO:0000226;GO:0000281;GO:0001890;GO:0050775;GO:0043687;GO:0016567;GO:0006508;GO:0007088;GO:0006511;GO:0001570;GO:0016032;, C:3M complex; C:anaphase-promoting complex; C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:ubiquitin protein ligase binding;, P:epithelial to mesenchymal transition; P:Golgi organization; P:IRE1-mediated unfolded protein response; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:placenta development; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process; P:vasculogenesis; P:viral process;|Q14999 B4DYZ0 F5H0L1 Q5T654,Cullin-7,, PF03256;PF11515;PF00888;, GO:1990393;GO:0005680;GO:0005813;GO:0031467;GO:0031461;GO:0005737;GO:0005829;GO:0005794;GO:0048471;GO:0031625;GO:0001837;GO:0007030;GO:0036498;GO:0000226;GO:0000281;GO:0001890;GO:0050775;GO:0043687;GO:0016567;GO:0006508;GO:0007088;GO:0006511;GO:0001570;GO:0016032;, C:3M complex; C:anaphase-promoting complex; C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:ubiquitin protein ligase binding;, P:epithelial to mesenchymal transition; P:Golgi organization; P:IRE1-mediated unfolded protein response; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:placenta development; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process; P:vasculogenesis; P:viral process;|Q14999 B4DYZ0 F5H0L1 Q5T654,Cullin-7,, PF03256;PF11515;PF00888;, GO:1990393;GO:0005680;GO:0005813;GO:0031467;GO:0031461;GO:0005737;GO:0005829;GO:0005794;GO:0048471;GO:0031625;GO:0001837;GO:0007030;GO:0036498;GO:0000226;GO:0000281;GO:0001890;GO:0050775;GO:0043687;GO:0016567;GO:0006508;GO:0007088;GO:0006511;GO:0001570;GO:0016032;, C:3M complex; C:anaphase-promoting complex; C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:ubiquitin protein ligase binding;, P:epithelial to mesenchymal transition; P:Golgi organization; P:IRE1-mediated unfolded protein response; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:placenta development; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process; P:vasculogenesis; P:viral process;|Q14999 B4DYZ0 F5H0L1 Q5T654,Cullin-7,, PF03256;PF11515;PF00888;, GO:1990393;GO:0005680;GO:0005813;GO:0031467;GO:0031461;GO:0005737;GO:0005829;GO:0005794;GO:0048471;GO:0031625;GO:0001837;GO:0007030;GO:0036498;GO:0000226;GO:0000281;GO:0001890;GO:0050775;GO:0043687;GO:0016567;GO:0006508;GO:0007088;GO:0006511;GO:0001570;GO:0016032;, C:3M complex; C:anaphase-promoting complex; C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:ubiquitin protein ligase binding;, P:epithelial to mesenchymal transition; P:Golgi organization; P:IRE1-mediated unfolded protein response; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:placenta development; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process; P:vasculogenesis; P:viral process;|Q14999 B4DYZ0 F5H0L1 Q5T654,Cullin-7,, PF03256;PF11515;PF00888;, GO:1990393;GO:0005680;GO:0005813;GO:0031467;GO:0031461;GO:0005737;GO:0005829;GO:0005794;GO:0048471;GO:0031625;GO:0001837;GO:0007030;GO:0036498;GO:0000226;GO:0000281;GO:0001890;GO:0050775;GO:0043687;GO:0016567;GO:0006508;GO:0007088;GO:0006511;GO:0001570;GO:0016032;, C:3M complex; C:anaphase-promoting complex; C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:ubiquitin protein ligase binding;, P:epithelial to mesenchymal transition; P:Golgi organization; P:IRE1-mediated unfolded protein response; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:placenta development; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process; P:vasculogenesis; P:viral process;|Q14999 B4DYZ0 F5H0L1 Q5T654,Cullin-7,, PF03256;PF11515;PF00888;, GO:1990393;GO:0005680;GO:0005813;GO:0031467;GO:0031461;GO:0005737;GO:0005829;GO:0005794;GO:0048471;GO:0031625;GO:0001837;GO:0007030;GO:0036498;GO:0000226;GO:0000281;GO:0001890;GO:0050775;GO:0043687;GO:0016567;GO:0006508;GO:0007088;GO:0006511;GO:0001570;GO:0016032;, C:3M complex; C:anaphase-promoting complex; C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:ubiquitin protein ligase binding;, P:epithelial to mesenchymal transition; P:Golgi organization; P:IRE1-mediated unfolded protein response; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:placenta development; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process; P:vasculogenesis; P:viral process;|Q14999 B4DYZ0 F5H0L1 Q5T654,Cullin-7,, PF03256;PF11515;PF00888;, GO:1990393;GO:0005680;GO:0005813;GO:0031467;GO:0031461;GO:0005737;GO:0005829;GO:0005794;GO:0048471;GO:0031625;GO:0001837;GO:0007030;GO:0036498;GO:0000226;GO:0000281;GO:0001890;GO:0050775;GO:0043687;GO:0016567;GO:0006508;GO:0007088;GO:0006511;GO:0001570;GO:0016032;, C:3M complex; C:anaphase-promoting complex; C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:ubiquitin protein ligase binding;, P:epithelial to mesenchymal transition; P:Golgi organization; P:IRE1-mediated unfolded protein response; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:placenta development; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process; P:vasculogenesis; P:viral process;|Q14999 B4DYZ0 F5H0L1 Q5T654,Cullin-7,, PF03256;PF11515;PF00888;, GO:1990393;GO:0005680;GO:0005813;GO:0031467;GO:0031461;GO:0005737;GO:0005829;GO:0005794;GO:0048471;GO:0031625;GO:0001837;GO:0007030;GO:0036498;GO:0000226;GO:0000281;GO:0001890;GO:0050775;GO:0043687;GO:0016567;GO:0006508;GO:0007088;GO:0006511;GO:0001570;GO:0016032;, C:3M complex; C:anaphase-promoting complex; C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:ubiquitin protein ligase binding;, P:epithelial to mesenchymal transition; P:Golgi organization; P:IRE1-mediated unfolded protein response; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:placenta development; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process; P:vasculogenesis; P:viral process;|Q14999 B4DYZ0 F5H0L1 Q5T654,Cullin-7,, PF03256;PF11515;PF00888;, GO:1990393;GO:0005680;GO:0005813;GO:0031467;GO:0031461;GO:0005737;GO:0005829;GO:0005794;GO:0048471;GO:0031625;GO:0001837;GO:0007030;GO:0036498;GO:0000226;GO:0000281;GO:0001890;GO:0050775;GO:0043687;GO:0016567;GO:0006508;GO:0007088;GO:0006511;GO:0001570;GO:0016032;, C:3M complex; C:anaphase-promoting complex; C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:ubiquitin protein ligase binding;, P:epithelial to mesenchymal transition; P:Golgi organization; P:IRE1-mediated unfolded protein response; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:placenta development; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process; P:vasculogenesis; P:viral process; scaffold40 indexed_genome mRNA 8839643 8844037 . - . ID=transcript_8231;Q5T653 B2RC56 Q8WUL1 Q96Q56 Q9Y311,39S ribosomal protein L2, mitochondrial,Mitochondrial large ribosomal subunit protein uL2m {ECO:0000303|PubMed:25278503};, PF00181;PF03947;, GO:0005743;GO:0005762;GO:0005739;GO:0005654;GO:0003723;GO:0003735;GO:0032543;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold40 indexed_genome mRNA 8844990 8858871 . + . ID=transcript_8232;Q9NSK0 B3KNY4 B3KPI3 B3KSQ3 B4DME9 Q66K28 Q96EG6,Kinesin light chain 4,Kinesin-like protein 8;, , GO:0005737;GO:0005871;GO:0005874;, C:cytoplasm; C:kinesin complex; C:microtubule;|Q9NSK0 B3KNY4 B3KPI3 B3KSQ3 B4DME9 Q66K28 Q96EG6,Kinesin light chain 4,Kinesin-like protein 8;, , GO:0005737;GO:0005871;GO:0005874;, C:cytoplasm; C:kinesin complex; C:microtubule;|Q9NSK0 B3KNY4 B3KPI3 B3KSQ3 B4DME9 Q66K28 Q96EG6,Kinesin light chain 4,Kinesin-like protein 8;, , GO:0005737;GO:0005871;GO:0005874;, C:cytoplasm; C:kinesin complex; C:microtubule;|Q9NSK0 B3KNY4 B3KPI3 B3KSQ3 B4DME9 Q66K28 Q96EG6,Kinesin light chain 4,Kinesin-like protein 8;, , GO:0005737;GO:0005871;GO:0005874;, C:cytoplasm; C:kinesin complex; C:microtubule;|Q9NSK0 B3KNY4 B3KPI3 B3KSQ3 B4DME9 Q66K28 Q96EG6,Kinesin light chain 4,Kinesin-like protein 8;, , GO:0005737;GO:0005871;GO:0005874;, C:cytoplasm; C:kinesin complex; C:microtubule; scaffold40 indexed_genome mRNA 8859262 8925847 . + . ID=transcript_8233;Q8NFA7 Q8NFA8,Inactive tyrosine-protein kinase 7,Colon carcinoma kinase 4;Protein-tyrosine kinase 7;Pseudo tyrosine kinase receptor 7;Tyrosine-protein kinase-like 7;, PF07679;PF07714;, GO:0005911;GO:0005925;GO:0005887;GO:0005886;GO:0005524;GO:0050839;GO:1904929;GO:0004672;GO:0031532;GO:0003401;GO:0007155;GO:0016477;GO:0071300;GO:0090103;GO:0060026;GO:0060976;GO:0045198;GO:0001736;GO:0001822;GO:0060484;GO:0090179;GO:0090263;GO:0010976;GO:0060828;GO:0007165;GO:0003281;GO:0042060;, C:cell-cell junction; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:cell adhesion molecule binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:protein kinase activity;, P:actin cytoskeleton reorganization; P:axis elongation; P:cell adhesion; P:cell migration; P:cellular response to retinoic acid; P:cochlea morphogenesis; P:convergent extension; P:coronary vasculature development; P:establishment of epithelial cell apical/basal polarity; P:establishment of planar polarity; P:kidney development; P:lung-associated mesenchyme development; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of neuron projection development; P:regulation of canonical Wnt signaling pathway; P:signal transduction; P:ventricular septum development; P:wound healing;|Q8NFA7 Q8NFA8,Inactive tyrosine-protein kinase 7,Colon carcinoma kinase 4;Protein-tyrosine kinase 7;Pseudo tyrosine kinase receptor 7;Tyrosine-protein kinase-like 7;, PF07679;PF07714;, GO:0005911;GO:0005925;GO:0005887;GO:0005886;GO:0005524;GO:0050839;GO:1904929;GO:0004672;GO:0031532;GO:0003401;GO:0007155;GO:0016477;GO:0071300;GO:0090103;GO:0060026;GO:0060976;GO:0045198;GO:0001736;GO:0001822;GO:0060484;GO:0090179;GO:0090263;GO:0010976;GO:0060828;GO:0007165;GO:0003281;GO:0042060;, C:cell-cell junction; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:cell adhesion molecule binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:protein kinase activity;, P:actin cytoskeleton reorganization; P:axis elongation; P:cell adhesion; P:cell migration; P:cellular response to retinoic acid; P:cochlea morphogenesis; P:convergent extension; P:coronary vasculature development; P:establishment of epithelial cell apical/basal polarity; P:establishment of planar polarity; P:kidney development; P:lung-associated mesenchyme development; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of neuron projection development; P:regulation of canonical Wnt signaling pathway; P:signal transduction; P:ventricular septum development; P:wound healing;|Q8NFA7 Q8NFA8,Inactive tyrosine-protein kinase 7,Colon carcinoma kinase 4;Protein-tyrosine kinase 7;Pseudo tyrosine kinase receptor 7;Tyrosine-protein kinase-like 7;, PF07679;PF07714;, GO:0005911;GO:0005925;GO:0005887;GO:0005886;GO:0005524;GO:0050839;GO:1904929;GO:0004672;GO:0031532;GO:0003401;GO:0007155;GO:0016477;GO:0071300;GO:0090103;GO:0060026;GO:0060976;GO:0045198;GO:0001736;GO:0001822;GO:0060484;GO:0090179;GO:0090263;GO:0010976;GO:0060828;GO:0007165;GO:0003281;GO:0042060;, C:cell-cell junction; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:cell adhesion molecule binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:protein kinase activity;, P:actin cytoskeleton reorganization; P:axis elongation; P:cell adhesion; P:cell migration; P:cellular response to retinoic acid; P:cochlea morphogenesis; P:convergent extension; P:coronary vasculature development; P:establishment of epithelial cell apical/basal polarity; P:establishment of planar polarity; P:kidney development; P:lung-associated mesenchyme development; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of neuron projection development; P:regulation of canonical Wnt signaling pathway; P:signal transduction; P:ventricular septum development; P:wound healing;|Q8NFA7 Q8NFA8,Inactive tyrosine-protein kinase 7,Colon carcinoma kinase 4;Protein-tyrosine kinase 7;Pseudo tyrosine kinase receptor 7;Tyrosine-protein kinase-like 7;, PF07679;PF07714;, GO:0005911;GO:0005925;GO:0005887;GO:0005886;GO:0005524;GO:0050839;GO:1904929;GO:0004672;GO:0031532;GO:0003401;GO:0007155;GO:0016477;GO:0071300;GO:0090103;GO:0060026;GO:0060976;GO:0045198;GO:0001736;GO:0001822;GO:0060484;GO:0090179;GO:0090263;GO:0010976;GO:0060828;GO:0007165;GO:0003281;GO:0042060;, C:cell-cell junction; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:cell adhesion molecule binding; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; F:protein kinase activity;, P:actin cytoskeleton reorganization; P:axis elongation; P:cell adhesion; P:cell migration; P:cellular response to retinoic acid; P:cochlea morphogenesis; P:convergent extension; P:coronary vasculature development; P:establishment of epithelial cell apical/basal polarity; P:establishment of planar polarity; P:kidney development; P:lung-associated mesenchyme development; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of neuron projection development; P:regulation of canonical Wnt signaling pathway; P:signal transduction; P:ventricular septum development; P:wound healing; scaffold40 indexed_genome mRNA 8942698 8950129 . + . ID=transcript_8234;P11831 Q5T648,Serum response factor,, PF00319;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0031490;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0070878;GO:0042803;GO:0000978;GO:0061629;GO:1990837;GO:0010736;GO:0008134;GO:0030036;GO:0060055;GO:0008306;GO:0070830;GO:0001569;GO:0060532;GO:0055003;GO:0060947;GO:0002042;GO:0007160;GO:0071333;GO:0090398;GO:0048589;GO:0035912;GO:0090136;GO:0010669;GO:0048821;GO:0061029;GO:0060324;GO:0007507;GO:0001947;GO:0060347;GO:0060218;GO:0021766;GO:0007616;GO:0060292;GO:0060425;GO:0061145;GO:0035855;GO:0001707;GO:0002011;GO:0046716;GO:1900222;GO:0030336;GO:0008285;GO:1902894;GO:0048666;GO:0001764;GO:0031175;GO:0030168;GO:0030220;GO:0045773;GO:0045597;GO:0051091;GO:0051491;GO:1902895;GO:0045987;GO:0046016;GO:0045944;GO:0003257;GO:0060261;GO:0010735;GO:0045059;GO:0090009;GO:0030155;GO:0051150;GO:0006357;GO:0033561;GO:0034097;GO:0009725;GO:0001666;GO:0009636;GO:0045214;GO:0043589;GO:0043149;GO:0022028;GO:0048538;GO:0030878;GO:0060534;GO:0001829;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:primary miRNA binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific double-stranded DNA binding; F:serum response element binding; F:transcription factor binding;, P:actin cytoskeleton organization; P:angiogenesis involved in wound healing; P:associative learning; P:bicellular tight junction assembly; P:branching involved in blood vessel morphogenesis; P:bronchus cartilage development; P:cardiac myofibril assembly; P:cardiac vascular smooth muscle cell differentiation; P:cell migration involved in sprouting angiogenesis; P:cell-matrix adhesion; P:cellular response to glucose stimulus; P:cellular senescence; P:developmental growth; P:dorsal aorta morphogenesis; P:epithelial cell-cell adhesion; P:epithelial structure maintenance; P:erythrocyte development; P:eyelid development in camera-type eye; P:face development; P:heart development; P:heart looping; P:heart trabecula formation; P:hematopoietic stem cell differentiation; P:hippocampus development; P:long-term memory; P:long-term synaptic depression; P:lung morphogenesis; P:lung smooth muscle development; P:megakaryocyte development; P:mesoderm formation; P:morphogenesis of an epithelial sheet; P:muscle cell cellular homeostasis; P:negative regulation of amyloid-beta clearance; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:neuron development; P:neuron migration; P:neuron projection development; P:platelet activation; P:platelet formation; P:positive regulation of axon extension; P:positive regulation of cell differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of filopodium assembly; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of smooth muscle contraction; P:positive regulation of transcription by glucose; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription via serum response element binding; P:positive thymic T cell selection; P:primitive streak formation; P:regulation of cell adhesion; P:regulation of smooth muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of water loss via skin; P:response to cytokine; P:response to hormone; P:response to hypoxia; P:response to toxic substance; P:sarcomere organization; P:skin morphogenesis; P:stress fiber assembly; P:tangential migration from the subventricular zone to the olfactory bulb; P:thymus development; P:thyroid gland development; P:trachea cartilage development; P:trophectodermal cell differentiation;|P11831 Q5T648,Serum response factor,, PF00319;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0031490;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0070878;GO:0042803;GO:0000978;GO:0061629;GO:1990837;GO:0010736;GO:0008134;GO:0030036;GO:0060055;GO:0008306;GO:0070830;GO:0001569;GO:0060532;GO:0055003;GO:0060947;GO:0002042;GO:0007160;GO:0071333;GO:0090398;GO:0048589;GO:0035912;GO:0090136;GO:0010669;GO:0048821;GO:0061029;GO:0060324;GO:0007507;GO:0001947;GO:0060347;GO:0060218;GO:0021766;GO:0007616;GO:0060292;GO:0060425;GO:0061145;GO:0035855;GO:0001707;GO:0002011;GO:0046716;GO:1900222;GO:0030336;GO:0008285;GO:1902894;GO:0048666;GO:0001764;GO:0031175;GO:0030168;GO:0030220;GO:0045773;GO:0045597;GO:0051091;GO:0051491;GO:1902895;GO:0045987;GO:0046016;GO:0045944;GO:0003257;GO:0060261;GO:0010735;GO:0045059;GO:0090009;GO:0030155;GO:0051150;GO:0006357;GO:0033561;GO:0034097;GO:0009725;GO:0001666;GO:0009636;GO:0045214;GO:0043589;GO:0043149;GO:0022028;GO:0048538;GO:0030878;GO:0060534;GO:0001829;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:primary miRNA binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific double-stranded DNA binding; F:serum response element binding; F:transcription factor binding;, P:actin cytoskeleton organization; P:angiogenesis involved in wound healing; P:associative learning; P:bicellular tight junction assembly; P:branching involved in blood vessel morphogenesis; P:bronchus cartilage development; P:cardiac myofibril assembly; P:cardiac vascular smooth muscle cell differentiation; P:cell migration involved in sprouting angiogenesis; P:cell-matrix adhesion; P:cellular response to glucose stimulus; P:cellular senescence; P:developmental growth; P:dorsal aorta morphogenesis; P:epithelial cell-cell adhesion; P:epithelial structure maintenance; P:erythrocyte development; P:eyelid development in camera-type eye; P:face development; P:heart development; P:heart looping; P:heart trabecula formation; P:hematopoietic stem cell differentiation; P:hippocampus development; P:long-term memory; P:long-term synaptic depression; P:lung morphogenesis; P:lung smooth muscle development; P:megakaryocyte development; P:mesoderm formation; P:morphogenesis of an epithelial sheet; P:muscle cell cellular homeostasis; P:negative regulation of amyloid-beta clearance; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:neuron development; P:neuron migration; P:neuron projection development; P:platelet activation; P:platelet formation; P:positive regulation of axon extension; P:positive regulation of cell differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of filopodium assembly; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of smooth muscle contraction; P:positive regulation of transcription by glucose; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription via serum response element binding; P:positive thymic T cell selection; P:primitive streak formation; P:regulation of cell adhesion; P:regulation of smooth muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of water loss via skin; P:response to cytokine; P:response to hormone; P:response to hypoxia; P:response to toxic substance; P:sarcomere organization; P:skin morphogenesis; P:stress fiber assembly; P:tangential migration from the subventricular zone to the olfactory bulb; P:thymus development; P:thyroid gland development; P:trachea cartilage development; P:trophectodermal cell differentiation;|P11831 Q5T648,Serum response factor,, PF00319;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0031490;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0070878;GO:0042803;GO:0000978;GO:0061629;GO:1990837;GO:0010736;GO:0008134;GO:0030036;GO:0060055;GO:0008306;GO:0070830;GO:0001569;GO:0060532;GO:0055003;GO:0060947;GO:0002042;GO:0007160;GO:0071333;GO:0090398;GO:0048589;GO:0035912;GO:0090136;GO:0010669;GO:0048821;GO:0061029;GO:0060324;GO:0007507;GO:0001947;GO:0060347;GO:0060218;GO:0021766;GO:0007616;GO:0060292;GO:0060425;GO:0061145;GO:0035855;GO:0001707;GO:0002011;GO:0046716;GO:1900222;GO:0030336;GO:0008285;GO:1902894;GO:0048666;GO:0001764;GO:0031175;GO:0030168;GO:0030220;GO:0045773;GO:0045597;GO:0051091;GO:0051491;GO:1902895;GO:0045987;GO:0046016;GO:0045944;GO:0003257;GO:0060261;GO:0010735;GO:0045059;GO:0090009;GO:0030155;GO:0051150;GO:0006357;GO:0033561;GO:0034097;GO:0009725;GO:0001666;GO:0009636;GO:0045214;GO:0043589;GO:0043149;GO:0022028;GO:0048538;GO:0030878;GO:0060534;GO:0001829;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:primary miRNA binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific double-stranded DNA binding; F:serum response element binding; F:transcription factor binding;, P:actin cytoskeleton organization; P:angiogenesis involved in wound healing; P:associative learning; P:bicellular tight junction assembly; P:branching involved in blood vessel morphogenesis; P:bronchus cartilage development; P:cardiac myofibril assembly; P:cardiac vascular smooth muscle cell differentiation; P:cell migration involved in sprouting angiogenesis; P:cell-matrix adhesion; P:cellular response to glucose stimulus; P:cellular senescence; P:developmental growth; P:dorsal aorta morphogenesis; P:epithelial cell-cell adhesion; P:epithelial structure maintenance; P:erythrocyte development; P:eyelid development in camera-type eye; P:face development; P:heart development; P:heart looping; P:heart trabecula formation; P:hematopoietic stem cell differentiation; P:hippocampus development; P:long-term memory; P:long-term synaptic depression; P:lung morphogenesis; P:lung smooth muscle development; P:megakaryocyte development; P:mesoderm formation; P:morphogenesis of an epithelial sheet; P:muscle cell cellular homeostasis; P:negative regulation of amyloid-beta clearance; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:neuron development; P:neuron migration; P:neuron projection development; P:platelet activation; P:platelet formation; P:positive regulation of axon extension; P:positive regulation of cell differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of filopodium assembly; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of smooth muscle contraction; P:positive regulation of transcription by glucose; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription via serum response element binding; P:positive thymic T cell selection; P:primitive streak formation; P:regulation of cell adhesion; P:regulation of smooth muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of water loss via skin; P:response to cytokine; P:response to hormone; P:response to hypoxia; P:response to toxic substance; P:sarcomere organization; P:skin morphogenesis; P:stress fiber assembly; P:tangential migration from the subventricular zone to the olfactory bulb; P:thymus development; P:thyroid gland development; P:trachea cartilage development; P:trophectodermal cell differentiation;|P11831 Q5T648,Serum response factor,, PF00319;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0031490;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0070878;GO:0042803;GO:0000978;GO:0061629;GO:1990837;GO:0010736;GO:0008134;GO:0030036;GO:0060055;GO:0008306;GO:0070830;GO:0001569;GO:0060532;GO:0055003;GO:0060947;GO:0002042;GO:0007160;GO:0071333;GO:0090398;GO:0048589;GO:0035912;GO:0090136;GO:0010669;GO:0048821;GO:0061029;GO:0060324;GO:0007507;GO:0001947;GO:0060347;GO:0060218;GO:0021766;GO:0007616;GO:0060292;GO:0060425;GO:0061145;GO:0035855;GO:0001707;GO:0002011;GO:0046716;GO:1900222;GO:0030336;GO:0008285;GO:1902894;GO:0048666;GO:0001764;GO:0031175;GO:0030168;GO:0030220;GO:0045773;GO:0045597;GO:0051091;GO:0051491;GO:1902895;GO:0045987;GO:0046016;GO:0045944;GO:0003257;GO:0060261;GO:0010735;GO:0045059;GO:0090009;GO:0030155;GO:0051150;GO:0006357;GO:0033561;GO:0034097;GO:0009725;GO:0001666;GO:0009636;GO:0045214;GO:0043589;GO:0043149;GO:0022028;GO:0048538;GO:0030878;GO:0060534;GO:0001829;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:primary miRNA binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific double-stranded DNA binding; F:serum response element binding; F:transcription factor binding;, P:actin cytoskeleton organization; P:angiogenesis involved in wound healing; P:associative learning; P:bicellular tight junction assembly; P:branching involved in blood vessel morphogenesis; P:bronchus cartilage development; P:cardiac myofibril assembly; P:cardiac vascular smooth muscle cell differentiation; P:cell migration involved in sprouting angiogenesis; P:cell-matrix adhesion; P:cellular response to glucose stimulus; P:cellular senescence; P:developmental growth; P:dorsal aorta morphogenesis; P:epithelial cell-cell adhesion; P:epithelial structure maintenance; P:erythrocyte development; P:eyelid development in camera-type eye; P:face development; P:heart development; P:heart looping; P:heart trabecula formation; P:hematopoietic stem cell differentiation; P:hippocampus development; P:long-term memory; P:long-term synaptic depression; P:lung morphogenesis; P:lung smooth muscle development; P:megakaryocyte development; P:mesoderm formation; P:morphogenesis of an epithelial sheet; P:muscle cell cellular homeostasis; P:negative regulation of amyloid-beta clearance; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:neuron development; P:neuron migration; P:neuron projection development; P:platelet activation; P:platelet formation; P:positive regulation of axon extension; P:positive regulation of cell differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of filopodium assembly; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of smooth muscle contraction; P:positive regulation of transcription by glucose; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription via serum response element binding; P:positive thymic T cell selection; P:primitive streak formation; P:regulation of cell adhesion; P:regulation of smooth muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of water loss via skin; P:response to cytokine; P:response to hormone; P:response to hypoxia; P:response to toxic substance; P:sarcomere organization; P:skin morphogenesis; P:stress fiber assembly; P:tangential migration from the subventricular zone to the olfactory bulb; P:thymus development; P:thyroid gland development; P:trachea cartilage development; P:trophectodermal cell differentiation; scaffold40 indexed_genome mRNA 8951917 8987291 . + . ID=transcript_8235;Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process;|Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process;|Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process;|Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process;|Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process;|Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process;|Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process;|Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process;|Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process;|Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process;|Q8IWT3 O75188 Q5TCY3 Q68CP2 Q68D92 Q8N3W9 Q9BU56,Cullin-9,UbcH7-associated protein 1;p53-associated parkin-like cytoplasmic protein;, PF03256;PF11515;PF00888;PF01485;, GO:0031461;GO:0005829;GO:0005524;GO:0046872;GO:0016740;GO:0031625;GO:0000226;GO:0043687;GO:0016567;GO:0007088;GO:0006511;, C:cullin-RING ubiquitin ligase complex; C:cytosol;, F:ATP binding; F:metal ion binding; F:transferase activity; F:ubiquitin protein ligase binding;, P:microtubule cytoskeleton organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of mitotic nuclear division; P:ubiquitin-dependent protein catabolic process; scaffold40 indexed_genome mRNA 9013444 9048646 . + . ID=transcript_8236;Q5TCY1 A2A2U5 Q2L6C6 Q6ZNH0 Q8N444 Q96JH2,Tau-tubulin kinase 1,Brain-derived tau kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005875;GO:0043025;GO:0005654;GO:0005634;GO:0048471;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0048156;GO:0050321;GO:0007611;GO:0010629;GO:0032091;GO:0018105;GO:0018107;GO:0018108;GO:0061890;GO:1904031;GO:2001056;GO:0010628;GO:1903980;GO:0032273;GO:0006468;GO:0021762;, C:cytoplasm; C:cytosol; C:microtubule associated complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:learning or memory; P:negative regulation of gene expression; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of astrocyte activation; P:positive regulation of cyclin-dependent protein kinase activity; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of gene expression; P:positive regulation of microglial cell activation; P:positive regulation of protein polymerization; P:protein phosphorylation; P:substantia nigra development;|Q5TCY1 A2A2U5 Q2L6C6 Q6ZNH0 Q8N444 Q96JH2,Tau-tubulin kinase 1,Brain-derived tau kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005875;GO:0043025;GO:0005654;GO:0005634;GO:0048471;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0048156;GO:0050321;GO:0007611;GO:0010629;GO:0032091;GO:0018105;GO:0018107;GO:0018108;GO:0061890;GO:1904031;GO:2001056;GO:0010628;GO:1903980;GO:0032273;GO:0006468;GO:0021762;, C:cytoplasm; C:cytosol; C:microtubule associated complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:learning or memory; P:negative regulation of gene expression; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of astrocyte activation; P:positive regulation of cyclin-dependent protein kinase activity; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of gene expression; P:positive regulation of microglial cell activation; P:positive regulation of protein polymerization; P:protein phosphorylation; P:substantia nigra development; scaffold40 indexed_genome mRNA 9054690 9059917 . + . ID=transcript_8237;Q5TCY1 A2A2U5 Q2L6C6 Q6ZNH0 Q8N444 Q96JH2,Tau-tubulin kinase 1,Brain-derived tau kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005875;GO:0043025;GO:0005654;GO:0005634;GO:0048471;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0048156;GO:0050321;GO:0007611;GO:0010629;GO:0032091;GO:0018105;GO:0018107;GO:0018108;GO:0061890;GO:1904031;GO:2001056;GO:0010628;GO:1903980;GO:0032273;GO:0006468;GO:0021762;, C:cytoplasm; C:cytosol; C:microtubule associated complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:learning or memory; P:negative regulation of gene expression; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of astrocyte activation; P:positive regulation of cyclin-dependent protein kinase activity; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of gene expression; P:positive regulation of microglial cell activation; P:positive regulation of protein polymerization; P:protein phosphorylation; P:substantia nigra development; scaffold40 indexed_genome mRNA 9063535 9073486 . + . ID=transcript_8238;Q9Y694 B2CZX6 Q5T046 Q5T048 Q5T050 Q9H2W5,Solute carrier family 22 member 7,Novel liver transporter;Organic anion transporter 2;, PF07690;, GO:0016323;GO:0005887;GO:0016020;GO:0005886;GO:0015347;GO:0015711;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity;, P:organic anion transport;|Q9Y694 B2CZX6 Q5T046 Q5T048 Q5T050 Q9H2W5,Solute carrier family 22 member 7,Novel liver transporter;Organic anion transporter 2;, PF07690;, GO:0016323;GO:0005887;GO:0016020;GO:0005886;GO:0015347;GO:0015711;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity;, P:organic anion transport;|Q9Y694 B2CZX6 Q5T046 Q5T048 Q5T050 Q9H2W5,Solute carrier family 22 member 7,Novel liver transporter;Organic anion transporter 2;, PF07690;, GO:0016323;GO:0005887;GO:0016020;GO:0005886;GO:0015347;GO:0015711;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity;, P:organic anion transport;|Q9Y694 B2CZX6 Q5T046 Q5T048 Q5T050 Q9H2W5,Solute carrier family 22 member 7,Novel liver transporter;Organic anion transporter 2;, PF07690;, GO:0016323;GO:0005887;GO:0016020;GO:0005886;GO:0015347;GO:0015711;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity;, P:organic anion transport;|Q9Y694 B2CZX6 Q5T046 Q5T048 Q5T050 Q9H2W5,Solute carrier family 22 member 7,Novel liver transporter;Organic anion transporter 2;, PF07690;, GO:0016323;GO:0005887;GO:0016020;GO:0005886;GO:0015347;GO:0015711;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity;, P:organic anion transport;|Q9Y694 B2CZX6 Q5T046 Q5T048 Q5T050 Q9H2W5,Solute carrier family 22 member 7,Novel liver transporter;Organic anion transporter 2;, PF07690;, GO:0016323;GO:0005887;GO:0016020;GO:0005886;GO:0015347;GO:0015711;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity;, P:organic anion transport;|Q6Q6R5 A2A436 Q5T043 Q6Q6R4 Q6Q6R6 Q6Q6R7,Cysteine-rich protein 3,Chromosome 6 LIM domain only protein;, PF00412;, GO:0005737;GO:0046872;, C:cytoplasm;, F:metal ion binding;|Q6Q6R5 A2A436 Q5T043 Q6Q6R4 Q6Q6R6 Q6Q6R7,Cysteine-rich protein 3,Chromosome 6 LIM domain only protein;, PF00412;, GO:0005737;GO:0046872;, C:cytoplasm;, F:metal ion binding; scaffold40 indexed_genome mRNA 9094648 9123576 . - . ID=transcript_8239;Q5VUA4 O94796 Q4G0E4 Q8NEM6 Q9UNU8 Q9Y2W9,Zinc finger protein 318,Endocrine regulatory protein;, , GO:0005829;GO:0005654;GO:0003676;GO:0042803;GO:0008270;GO:0051321;GO:0045892;GO:0045893;, C:cytosol; C:nucleoplasm;, F:nucleic acid binding; F:protein homodimerization activity; F:zinc ion binding;, P:meiotic cell cycle; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated;|Q5VUA4 O94796 Q4G0E4 Q8NEM6 Q9UNU8 Q9Y2W9,Zinc finger protein 318,Endocrine regulatory protein;, , GO:0005829;GO:0005654;GO:0003676;GO:0042803;GO:0008270;GO:0051321;GO:0045892;GO:0045893;, C:cytosol; C:nucleoplasm;, F:nucleic acid binding; F:protein homodimerization activity; F:zinc ion binding;, P:meiotic cell cycle; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated;|Q5VUA4 O94796 Q4G0E4 Q8NEM6 Q9UNU8 Q9Y2W9,Zinc finger protein 318,Endocrine regulatory protein;, , GO:0005829;GO:0005654;GO:0003676;GO:0042803;GO:0008270;GO:0051321;GO:0045892;GO:0045893;, C:cytosol; C:nucleoplasm;, F:nucleic acid binding; F:protein homodimerization activity; F:zinc ion binding;, P:meiotic cell cycle; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; scaffold40 indexed_genome mRNA 9153029 9176760 . + . ID=transcript_8240;Q5T3U5 Q8NHX7 Q9H7N2 Q9NXY3 Q9UF48,ATP-binding cassette sub-family C member 10,Multidrug resistance-associated protein 7;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0006691;GO:0071716;GO:0055085;, C:basolateral plasma membrane; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:leukotriene metabolic process; P:leukotriene transport; P:transmembrane transport;|Q5T3U5 Q8NHX7 Q9H7N2 Q9NXY3 Q9UF48,ATP-binding cassette sub-family C member 10,Multidrug resistance-associated protein 7;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0006691;GO:0071716;GO:0055085;, C:basolateral plasma membrane; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:leukotriene metabolic process; P:leukotriene transport; P:transmembrane transport;|Q5T3U5 Q8NHX7 Q9H7N2 Q9NXY3 Q9UF48,ATP-binding cassette sub-family C member 10,Multidrug resistance-associated protein 7;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0006691;GO:0071716;GO:0055085;, C:basolateral plasma membrane; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:leukotriene metabolic process; P:leukotriene transport; P:transmembrane transport;|Q5T3U5 Q8NHX7 Q9H7N2 Q9NXY3 Q9UF48,ATP-binding cassette sub-family C member 10,Multidrug resistance-associated protein 7;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0006691;GO:0071716;GO:0055085;, C:basolateral plasma membrane; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:leukotriene metabolic process; P:leukotriene transport; P:transmembrane transport;|Q5T3U5 Q8NHX7 Q9H7N2 Q9NXY3 Q9UF48,ATP-binding cassette sub-family C member 10,Multidrug resistance-associated protein 7;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0006691;GO:0071716;GO:0055085;, C:basolateral plasma membrane; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:leukotriene metabolic process; P:leukotriene transport; P:transmembrane transport;|Q5T3U5 Q8NHX7 Q9H7N2 Q9NXY3 Q9UF48,ATP-binding cassette sub-family C member 10,Multidrug resistance-associated protein 7;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0006691;GO:0071716;GO:0055085;, C:basolateral plasma membrane; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:leukotriene metabolic process; P:leukotriene transport; P:transmembrane transport;|Q5T3U5 Q8NHX7 Q9H7N2 Q9NXY3 Q9UF48,ATP-binding cassette sub-family C member 10,Multidrug resistance-associated protein 7;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0006691;GO:0071716;GO:0055085;, C:basolateral plasma membrane; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:leukotriene metabolic process; P:leukotriene transport; P:transmembrane transport;|Q6UY11 B3KNZ7 Q5T3T8 Q9BQ54,Protein delta homolog 2,Epidermal growth factor-like protein 9;, PF00008;PF12661;, GO:0016021;GO:0005509;GO:0005112;GO:0045746;GO:0045598;, C:integral component of membrane;, F:calcium ion binding; F:Notch binding;, P:negative regulation of Notch signaling pathway; P:regulation of fat cell differentiation;|Q5T3U5 Q8NHX7 Q9H7N2 Q9NXY3 Q9UF48,ATP-binding cassette sub-family C member 10,Multidrug resistance-associated protein 7;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0015431;GO:0140359;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0006691;GO:0071716;GO:0055085;, C:basolateral plasma membrane; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:leukotriene metabolic process; P:leukotriene transport; P:transmembrane transport;|Q6UY11 B3KNZ7 Q5T3T8 Q9BQ54,Protein delta homolog 2,Epidermal growth factor-like protein 9;, PF00008;PF12661;, GO:0016021;GO:0005509;GO:0005112;GO:0045746;GO:0045598;, C:integral component of membrane;, F:calcium ion binding; F:Notch binding;, P:negative regulation of Notch signaling pathway; P:regulation of fat cell differentiation; scaffold40 indexed_genome mRNA 9196960 9220537 . + . ID=transcript_8241;Q5JTD0 Q05BH9 Q5JTD1 Q5JWW1 Q68DB2 Q6P2P3 Q9H7V7,Tight junction-associated protein 1,Protein incorporated later into tight junctions;Tight junction protein 4;, PF15453;, GO:0005923;GO:0005794;GO:0005802;GO:0007030;, C:bicellular tight junction; C:Golgi apparatus; C:trans-Golgi network;, , P:Golgi organization;|Q5JTD0 Q05BH9 Q5JTD1 Q5JWW1 Q68DB2 Q6P2P3 Q9H7V7,Tight junction-associated protein 1,Protein incorporated later into tight junctions;Tight junction protein 4;, PF15453;, GO:0005923;GO:0005794;GO:0005802;GO:0007030;, C:bicellular tight junction; C:Golgi apparatus; C:trans-Golgi network;, , P:Golgi organization;|Q5JTD0 Q05BH9 Q5JTD1 Q5JWW1 Q68DB2 Q6P2P3 Q9H7V7,Tight junction-associated protein 1,Protein incorporated later into tight junctions;Tight junction protein 4;, PF15453;, GO:0005923;GO:0005794;GO:0005802;GO:0007030;, C:bicellular tight junction; C:Golgi apparatus; C:trans-Golgi network;, , P:Golgi organization; scaffold40 indexed_genome mRNA 9222108 9222679 . - . ID=transcript_8242;Q5JTD7,Leucine-rich repeat-containing protein 73 scaffold40 indexed_genome mRNA 9230736 9235232 . - . ID=transcript_8243;Q9GZM5 Q5JTD2 Q6FI85 Q8NI57 Q9NWE3 Q9Y3U9,Protein YIPF3,Killer lineage protein 1;Natural killer cell-specific antigen KLIP1;YIP1 family member 3;, , GO:0005794;GO:0016021;GO:0043231;GO:0005886;GO:0030133;GO:0030154;, C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:transport vesicle;, , P:cell differentiation;|Q9GZM5 Q5JTD2 Q6FI85 Q8NI57 Q9NWE3 Q9Y3U9,Protein YIPF3,Killer lineage protein 1;Natural killer cell-specific antigen KLIP1;YIP1 family member 3;, , GO:0005794;GO:0016021;GO:0043231;GO:0005886;GO:0030133;GO:0030154;, C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:transport vesicle;, , P:cell differentiation; scaffold40 indexed_genome mRNA 9235865 9293843 . + . ID=transcript_8244;O15160 O75395 Q5JTE3,DNA-directed RNA polymerases I and III subunit RPAC1,AC40;DNA-directed RNA polymerases I and III 40 kDa polypeptide;RPA39;RPC40;, PF01000;PF01193;, GO:0005829;GO:0005654;GO:0005736;GO:0005666;GO:0003677;GO:0003899;GO:0046983;GO:0001054;GO:0001056;GO:0045815;GO:0032481;GO:0006363;GO:0006360;GO:0006361;, C:cytosol; C:nucleoplasm; C:RNA polymerase I complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:protein dimerization activity; F:RNA polymerase I activity; F:RNA polymerase III activity;, P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription initiation from RNA polymerase I promoter;|O15160 O75395 Q5JTE3,DNA-directed RNA polymerases I and III subunit RPAC1,AC40;DNA-directed RNA polymerases I and III 40 kDa polypeptide;RPA39;RPC40;, PF01000;PF01193;, GO:0005829;GO:0005654;GO:0005736;GO:0005666;GO:0003677;GO:0003899;GO:0046983;GO:0001054;GO:0001056;GO:0045815;GO:0032481;GO:0006363;GO:0006360;GO:0006361;, C:cytosol; C:nucleoplasm; C:RNA polymerase I complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:protein dimerization activity; F:RNA polymerase I activity; F:RNA polymerase III activity;, P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription initiation from RNA polymerase I promoter;|O15160 O75395 Q5JTE3,DNA-directed RNA polymerases I and III subunit RPAC1,AC40;DNA-directed RNA polymerases I and III 40 kDa polypeptide;RPA39;RPC40;, PF01000;PF01193;, GO:0005829;GO:0005654;GO:0005736;GO:0005666;GO:0003677;GO:0003899;GO:0046983;GO:0001054;GO:0001056;GO:0045815;GO:0032481;GO:0006363;GO:0006360;GO:0006361;, C:cytosol; C:nucleoplasm; C:RNA polymerase I complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:protein dimerization activity; F:RNA polymerase I activity; F:RNA polymerase III activity;, P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription initiation from RNA polymerase I promoter;|Q9ULC9,Exportin-5,Ran-binding protein 21;, PF08389;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016442;GO:0042565;GO:0003729;GO:0005049;GO:0070883;GO:1905172;GO:0003723;GO:0031267;GO:0000049;GO:0010586;GO:1900370;GO:0035281;GO:0006611;GO:0006405;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:RISC complex; C:RNA nuclear export complex;, F:mRNA binding; F:nuclear export signal receptor activity; F:pre-miRNA binding; F:RISC complex binding; F:RNA binding; F:small GTPase binding; F:tRNA binding;, P:miRNA metabolic process; P:positive regulation of RNA interference; P:pre-miRNA export from nucleus; P:protein export from nucleus; P:RNA export from nucleus; P:viral process;|Q9ULC9,Exportin-5,Ran-binding protein 21;, PF08389;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016442;GO:0042565;GO:0003729;GO:0005049;GO:0070883;GO:1905172;GO:0003723;GO:0031267;GO:0000049;GO:0010586;GO:1900370;GO:0035281;GO:0006611;GO:0006405;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:RISC complex; C:RNA nuclear export complex;, F:mRNA binding; F:nuclear export signal receptor activity; F:pre-miRNA binding; F:RISC complex binding; F:RNA binding; F:small GTPase binding; F:tRNA binding;, P:miRNA metabolic process; P:positive regulation of RNA interference; P:pre-miRNA export from nucleus; P:protein export from nucleus; P:RNA export from nucleus; P:viral process;|Q9ULC9,Exportin-5,Ran-binding protein 21;, PF08389;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016442;GO:0042565;GO:0003729;GO:0005049;GO:0070883;GO:1905172;GO:0003723;GO:0031267;GO:0000049;GO:0010586;GO:1900370;GO:0035281;GO:0006611;GO:0006405;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:RISC complex; C:RNA nuclear export complex;, F:mRNA binding; F:nuclear export signal receptor activity; F:pre-miRNA binding; F:RISC complex binding; F:RNA binding; F:small GTPase binding; F:tRNA binding;, P:miRNA metabolic process; P:positive regulation of RNA interference; P:pre-miRNA export from nucleus; P:protein export from nucleus; P:RNA export from nucleus; P:viral process;|Q9ULC9,Exportin-5,Ran-binding protein 21;, PF08389;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016442;GO:0042565;GO:0003729;GO:0005049;GO:0070883;GO:1905172;GO:0003723;GO:0031267;GO:0000049;GO:0010586;GO:1900370;GO:0035281;GO:0006611;GO:0006405;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:RISC complex; C:RNA nuclear export complex;, F:mRNA binding; F:nuclear export signal receptor activity; F:pre-miRNA binding; F:RISC complex binding; F:RNA binding; F:small GTPase binding; F:tRNA binding;, P:miRNA metabolic process; P:positive regulation of RNA interference; P:pre-miRNA export from nucleus; P:protein export from nucleus; P:RNA export from nucleus; P:viral process;|Q9ULC9,Exportin-5,Ran-binding protein 21;, PF08389;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016442;GO:0042565;GO:0003729;GO:0005049;GO:0070883;GO:1905172;GO:0003723;GO:0031267;GO:0000049;GO:0010586;GO:1900370;GO:0035281;GO:0006611;GO:0006405;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:RISC complex; C:RNA nuclear export complex;, F:mRNA binding; F:nuclear export signal receptor activity; F:pre-miRNA binding; F:RISC complex binding; F:RNA binding; F:small GTPase binding; F:tRNA binding;, P:miRNA metabolic process; P:positive regulation of RNA interference; P:pre-miRNA export from nucleus; P:protein export from nucleus; P:RNA export from nucleus; P:viral process; scaffold40 indexed_genome mRNA 9293937 9299667 . + . ID=transcript_8245;Q9Y253 Q7L8E3 Q96BC4 Q9BX13,DNA polymerase eta,RAD30 homolog A;Xeroderma pigmentosum variant type protein;, PF00817;PF11799;PF18439;, GO:0005829;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0003887;GO:0046872;GO:0071494;GO:0006281;GO:0006260;GO:0000731;GO:0070987;GO:0042276;GO:0006290;GO:0006282;GO:0009314;GO:0010225;GO:0019985;, C:cytosol; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to UV-C; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:pyrimidine dimer repair; P:regulation of DNA repair; P:response to radiation; P:response to UV-C; P:translesion synthesis;|Q9Y253 Q7L8E3 Q96BC4 Q9BX13,DNA polymerase eta,RAD30 homolog A;Xeroderma pigmentosum variant type protein;, PF00817;PF11799;PF18439;, GO:0005829;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0003887;GO:0046872;GO:0071494;GO:0006281;GO:0006260;GO:0000731;GO:0070987;GO:0042276;GO:0006290;GO:0006282;GO:0009314;GO:0010225;GO:0019985;, C:cytosol; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to UV-C; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:pyrimidine dimer repair; P:regulation of DNA repair; P:response to radiation; P:response to UV-C; P:translesion synthesis;|Q9Y253 Q7L8E3 Q96BC4 Q9BX13,DNA polymerase eta,RAD30 homolog A;Xeroderma pigmentosum variant type protein;, PF00817;PF11799;PF18439;, GO:0005829;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0003887;GO:0046872;GO:0071494;GO:0006281;GO:0006260;GO:0000731;GO:0070987;GO:0042276;GO:0006290;GO:0006282;GO:0009314;GO:0010225;GO:0019985;, C:cytosol; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to UV-C; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:pyrimidine dimer repair; P:regulation of DNA repair; P:response to radiation; P:response to UV-C; P:translesion synthesis; scaffold40 indexed_genome mRNA 9309041 9331253 . + . ID=transcript_8246;Q9Y253 Q7L8E3 Q96BC4 Q9BX13,DNA polymerase eta,RAD30 homolog A;Xeroderma pigmentosum variant type protein;, PF00817;PF11799;PF18439;, GO:0005829;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0003887;GO:0046872;GO:0071494;GO:0006281;GO:0006260;GO:0000731;GO:0070987;GO:0042276;GO:0006290;GO:0006282;GO:0009314;GO:0010225;GO:0019985;, C:cytosol; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to UV-C; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:pyrimidine dimer repair; P:regulation of DNA repair; P:response to radiation; P:response to UV-C; P:translesion synthesis;|Q9Y253 Q7L8E3 Q96BC4 Q9BX13,DNA polymerase eta,RAD30 homolog A;Xeroderma pigmentosum variant type protein;, PF00817;PF11799;PF18439;, GO:0005829;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0003887;GO:0046872;GO:0071494;GO:0006281;GO:0006260;GO:0000731;GO:0070987;GO:0042276;GO:0006290;GO:0006282;GO:0009314;GO:0010225;GO:0019985;, C:cytosol; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to UV-C; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:pyrimidine dimer repair; P:regulation of DNA repair; P:response to radiation; P:response to UV-C; P:translesion synthesis;|Q9Y253 Q7L8E3 Q96BC4 Q9BX13,DNA polymerase eta,RAD30 homolog A;Xeroderma pigmentosum variant type protein;, PF00817;PF11799;PF18439;, GO:0005829;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0003887;GO:0046872;GO:0071494;GO:0006281;GO:0006260;GO:0000731;GO:0070987;GO:0042276;GO:0006290;GO:0006282;GO:0009314;GO:0010225;GO:0019985;, C:cytosol; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to UV-C; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:pyrimidine dimer repair; P:regulation of DNA repair; P:response to radiation; P:response to UV-C; P:translesion synthesis;|Q9Y253 Q7L8E3 Q96BC4 Q9BX13,DNA polymerase eta,RAD30 homolog A;Xeroderma pigmentosum variant type protein;, PF00817;PF11799;PF18439;, GO:0005829;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0003887;GO:0046872;GO:0071494;GO:0006281;GO:0006260;GO:0000731;GO:0070987;GO:0042276;GO:0006290;GO:0006282;GO:0009314;GO:0010225;GO:0019985;, C:cytosol; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to UV-C; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:pyrimidine dimer repair; P:regulation of DNA repair; P:response to radiation; P:response to UV-C; P:translesion synthesis;|Q9Y253 Q7L8E3 Q96BC4 Q9BX13,DNA polymerase eta,RAD30 homolog A;Xeroderma pigmentosum variant type protein;, PF00817;PF11799;PF18439;, GO:0005829;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0003887;GO:0046872;GO:0071494;GO:0006281;GO:0006260;GO:0000731;GO:0070987;GO:0042276;GO:0006290;GO:0006282;GO:0009314;GO:0010225;GO:0019985;, C:cytosol; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to UV-C; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:pyrimidine dimer repair; P:regulation of DNA repair; P:response to radiation; P:response to UV-C; P:translesion synthesis;|Q9Y253 Q7L8E3 Q96BC4 Q9BX13,DNA polymerase eta,RAD30 homolog A;Xeroderma pigmentosum variant type protein;, PF00817;PF11799;PF18439;, GO:0005829;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0003887;GO:0046872;GO:0071494;GO:0006281;GO:0006260;GO:0000731;GO:0070987;GO:0042276;GO:0006290;GO:0006282;GO:0009314;GO:0010225;GO:0019985;, C:cytosol; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to UV-C; P:DNA repair; P:DNA replication; P:DNA synthesis involved in DNA repair; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:pyrimidine dimer repair; P:regulation of DNA repair; P:response to radiation; P:response to UV-C; P:translesion synthesis;|Q9BX10 Q5T7E8 Q8ND84 Q8TAH7 Q8WUA5 Q9HCS9 Q9NRU4 Q9NX60,GTP-binding protein 2,, PF00009;, GO:0005576;GO:0031093;GO:0005525;GO:0003924;GO:0042802;GO:0003746;GO:0002576;GO:0006414;, C:extracellular region; C:platelet alpha granule lumen;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:translation elongation factor activity;, P:platelet degranulation; P:translational elongation;|Q9BX10 Q5T7E8 Q8ND84 Q8TAH7 Q8WUA5 Q9HCS9 Q9NRU4 Q9NX60,GTP-binding protein 2,, PF00009;, GO:0005576;GO:0031093;GO:0005525;GO:0003924;GO:0042802;GO:0003746;GO:0002576;GO:0006414;, C:extracellular region; C:platelet alpha granule lumen;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:translation elongation factor activity;, P:platelet degranulation; P:translational elongation;|Q9BX10 Q5T7E8 Q8ND84 Q8TAH7 Q8WUA5 Q9HCS9 Q9NRU4 Q9NX60,GTP-binding protein 2,, PF00009;, GO:0005576;GO:0031093;GO:0005525;GO:0003924;GO:0042802;GO:0003746;GO:0002576;GO:0006414;, C:extracellular region; C:platelet alpha granule lumen;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:translation elongation factor activity;, P:platelet degranulation; P:translational elongation;|Q9BX10 Q5T7E8 Q8ND84 Q8TAH7 Q8WUA5 Q9HCS9 Q9NRU4 Q9NX60,GTP-binding protein 2,, PF00009;, GO:0005576;GO:0031093;GO:0005525;GO:0003924;GO:0042802;GO:0003746;GO:0002576;GO:0006414;, C:extracellular region; C:platelet alpha granule lumen;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:translation elongation factor activity;, P:platelet degranulation; P:translational elongation; scaffold40 indexed_genome mRNA 9344746 9350511 . + . ID=transcript_8247;Q15013 B4DLV3 E9PAT7 Q6IBB1,MAD2L1-binding protein,Caught by MAD2 protein;p31(comet) {ECO:0000303|PubMed:18022368};, PF06581;, GO:0005737;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:1902426;GO:0007096;, C:cytoplasm; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;, , P:deactivation of mitotic spindle assembly checkpoint; P:regulation of exit from mitosis;|Q15013 B4DLV3 E9PAT7 Q6IBB1,MAD2L1-binding protein,Caught by MAD2 protein;p31(comet) {ECO:0000303|PubMed:18022368};, PF06581;, GO:0005737;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:1902426;GO:0007096;, C:cytoplasm; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;, , P:deactivation of mitotic spindle assembly checkpoint; P:regulation of exit from mitosis; scaffold40 indexed_genome mRNA 9355451 9381623 . + . ID=transcript_8248;Q9H1X1 A8K5T4 Q96NH9,Radial spoke head protein 9 homolog,, PF04712;, GO:0097729;GO:0005930;GO:0060091;GO:0031514;GO:0001534;GO:1904158;GO:0035082;GO:0003341;GO:0060294;GO:0044458;GO:0062177;, C:9+2 motile cilium; C:axoneme; C:kinocilium; C:motile cilium; C:radial spoke;, , P:axonemal central apparatus assembly; P:axoneme assembly; P:cilium movement; P:cilium movement involved in cell motility; P:motile cilium assembly; P:radial spoke assembly;|Q9NVS2 A6XND3 Q5QPA4,39S ribosomal protein S18a, mitochondrial,39S ribosomal protein S18-3, mitochondrial;Mitochondrial large ribosomal subunit protein bS18a {ECO:0000303|PubMed:25278503};Mitochondrial large ribosomal subunit protein mL66 {ECO:0000303|PubMed:27023846};, PF01084;, GO:0005743;GO:0005762;GO:0005763;GO:0005739;GO:0070181;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold40 indexed_genome mRNA 9465524 9493911 . + . ID=transcript_8249;Q9H1W9 Q9UH58 Q9UL23,Vascular endothelial growth factor A,Vascular permeability factor;, PF00341;PF14554;, GO:0005912;GO:0009986;GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0016020;GO:0031093;GO:0030141;GO:0042056;GO:0005125;GO:0050840;GO:0001968;GO:0008083;GO:0008201;GO:0042802;GO:0038191;GO:0005161;GO:0042803;GO:0048018;GO:0043183;GO:0043184;GO:0005172;GO:0032147;GO:0001525;GO:0048844;GO:0002575;GO:0001569;GO:0048754;GO:0048593;GO:0048739;GO:0060948;GO:0048469;GO:0002042;GO:0071456;GO:0035924;GO:0097533;GO:0071679;GO:0060982;GO:0003169;GO:0019221;GO:0071542;GO:0035767;GO:0030855;GO:0042462;GO:0003007;GO:0001701;GO:0050930;GO:0001822;GO:0007595;GO:0030324;GO:0036303;GO:0030225;GO:0060749;GO:0007498;GO:0030224;GO:0097475;GO:1903392;GO:0043066;GO:1905604;GO:2000048;GO:0043154;GO:1903141;GO:0010629;GO:0000122;GO:0007399;GO:0003151;GO:0001541;GO:0002576;GO:0050918;GO:0045766;GO:0048842;GO:0043536;GO:1903589;GO:0090190;GO:0045785;GO:0051781;GO:0030335;GO:0038089;GO:0090050;GO:0008284;GO:0038091;GO:0051272;GO:0120162;GO:0032793;GO:2000573;GO:0038033;GO:0010595;GO:0001938;GO:0050679;GO:1905278;GO:0070374;GO:0051894;GO:0010628;GO:1901727;GO:0002687;GO:0043406;GO:0043410;GO:0060754;GO:0002053;GO:0002052;GO:1900745;GO:0033138;GO:1900086;GO:0050731;GO:0014068;GO:0042327;GO:0050927;GO:0031954;GO:0051897;GO:0090037;GO:1903572;GO:1902966;GO:0001934;GO:0031334;GO:0002092;GO:1902336;GO:1903672;GO:0045944;GO:0061419;GO:1901165;GO:0043117;GO:0031077;GO:0060319;GO:0008360;GO:0010749;GO:0090259;GO:0006357;GO:0061418;GO:0001666;GO:0002040;GO:0043129;GO:0035148;GO:0048010;GO:0036324;GO:0038084;GO:0061042;GO:0001570;GO:0038190;, C:adherens junction; C:cell surface; C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:membrane; C:platelet alpha granule lumen; C:secretory granule;, F:chemoattractant activity; F:cytokine activity; F:extracellular matrix binding; F:fibronectin binding; F:growth factor activity; F:heparin binding; F:identical protein binding; F:neuropilin binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity; F:receptor ligand activity; F:vascular endothelial growth factor receptor 1 binding; F:vascular endothelial growth factor receptor 2 binding; F:vascular endothelial growth factor receptor binding;, P:activation of protein kinase activity; P:angiogenesis; P:artery morphogenesis; P:basophil chemotaxis; P:branching involved in blood vessel morphogenesis; P:branching morphogenesis of an epithelial tube; P:camera-type eye morphogenesis; P:cardiac muscle fiber development; P:cardiac vascular smooth muscle cell development; P:cell maturation; P:cell migration involved in sprouting angiogenesis; P:cellular response to hypoxia; P:cellular response to vascular endothelial growth factor stimulus; P:cellular stress response to acid chemical; P:commissural neuron axon guidance; P:coronary artery morphogenesis; P:coronary vein morphogenesis; P:cytokine-mediated signaling pathway; P:dopaminergic neuron differentiation; P:endothelial cell chemotaxis; P:epithelial cell differentiation; P:eye photoreceptor cell development; P:heart morphogenesis; P:in utero embryonic development; P:induction of positive chemotaxis; P:kidney development; P:lactation; P:lung development; P:lymph vessel morphogenesis; P:macrophage differentiation; P:mammary gland alveolus development; P:mesoderm development; P:monocyte differentiation; P:motor neuron migration; P:negative regulation of adherens junction organization; P:negative regulation of apoptotic process; P:negative regulation of blood-brain barrier permeability; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of establishment of endothelial barrier; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:outflow tract morphogenesis; P:ovarian follicle development; P:platelet degranulation; P:positive chemotaxis; P:positive regulation of angiogenesis; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cell adhesion; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; P:positive regulation of cellular component movement; P:positive regulation of cold-induced thermogenesis; P:positive regulation of CREB transcription factor activity; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of histone deacetylase activity; P:positive regulation of leukocyte migration; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mast cell chemotaxis; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of p38MAPK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phosphorylation; P:positive regulation of positive chemotaxis; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein kinase C signaling; P:positive regulation of protein kinase D signaling; P:positive regulation of protein localization to early endosome; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of receptor internalization; P:positive regulation of retinal ganglion cell axon guidance; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of trophoblast cell migration; P:positive regulation of vascular permeability; P:post-embryonic camera-type eye development; P:primitive erythrocyte differentiation; P:regulation of cell shape; P:regulation of nitric oxide mediated signal transduction; P:regulation of retinal ganglion cell axon guidance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to hypoxia; P:sprouting angiogenesis; P:surfactant homeostasis; P:tube formation; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor receptor-2 signaling pathway; P:vascular endothelial growth factor signaling pathway; P:vascular wound healing; P:vasculogenesis; P:VEGF-activated neuropilin signaling pathway;|Q9H1W9 Q9UH58 Q9UL23,Vascular endothelial growth factor A,Vascular permeability factor;, PF00341;PF14554;, GO:0005912;GO:0009986;GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0016020;GO:0031093;GO:0030141;GO:0042056;GO:0005125;GO:0050840;GO:0001968;GO:0008083;GO:0008201;GO:0042802;GO:0038191;GO:0005161;GO:0042803;GO:0048018;GO:0043183;GO:0043184;GO:0005172;GO:0032147;GO:0001525;GO:0048844;GO:0002575;GO:0001569;GO:0048754;GO:0048593;GO:0048739;GO:0060948;GO:0048469;GO:0002042;GO:0071456;GO:0035924;GO:0097533;GO:0071679;GO:0060982;GO:0003169;GO:0019221;GO:0071542;GO:0035767;GO:0030855;GO:0042462;GO:0003007;GO:0001701;GO:0050930;GO:0001822;GO:0007595;GO:0030324;GO:0036303;GO:0030225;GO:0060749;GO:0007498;GO:0030224;GO:0097475;GO:1903392;GO:0043066;GO:1905604;GO:2000048;GO:0043154;GO:1903141;GO:0010629;GO:0000122;GO:0007399;GO:0003151;GO:0001541;GO:0002576;GO:0050918;GO:0045766;GO:0048842;GO:0043536;GO:1903589;GO:0090190;GO:0045785;GO:0051781;GO:0030335;GO:0038089;GO:0090050;GO:0008284;GO:0038091;GO:0051272;GO:0120162;GO:0032793;GO:2000573;GO:0038033;GO:0010595;GO:0001938;GO:0050679;GO:1905278;GO:0070374;GO:0051894;GO:0010628;GO:1901727;GO:0002687;GO:0043406;GO:0043410;GO:0060754;GO:0002053;GO:0002052;GO:1900745;GO:0033138;GO:1900086;GO:0050731;GO:0014068;GO:0042327;GO:0050927;GO:0031954;GO:0051897;GO:0090037;GO:1903572;GO:1902966;GO:0001934;GO:0031334;GO:0002092;GO:1902336;GO:1903672;GO:0045944;GO:0061419;GO:1901165;GO:0043117;GO:0031077;GO:0060319;GO:0008360;GO:0010749;GO:0090259;GO:0006357;GO:0061418;GO:0001666;GO:0002040;GO:0043129;GO:0035148;GO:0048010;GO:0036324;GO:0038084;GO:0061042;GO:0001570;GO:0038190;, C:adherens junction; C:cell surface; C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:membrane; C:platelet alpha granule lumen; C:secretory granule;, F:chemoattractant activity; F:cytokine activity; F:extracellular matrix binding; F:fibronectin binding; F:growth factor activity; F:heparin binding; F:identical protein binding; F:neuropilin binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity; F:receptor ligand activity; F:vascular endothelial growth factor receptor 1 binding; F:vascular endothelial growth factor receptor 2 binding; F:vascular endothelial growth factor receptor binding;, P:activation of protein kinase activity; P:angiogenesis; P:artery morphogenesis; P:basophil chemotaxis; P:branching involved in blood vessel morphogenesis; P:branching morphogenesis of an epithelial tube; P:camera-type eye morphogenesis; P:cardiac muscle fiber development; P:cardiac vascular smooth muscle cell development; P:cell maturation; P:cell migration involved in sprouting angiogenesis; P:cellular response to hypoxia; P:cellular response to vascular endothelial growth factor stimulus; P:cellular stress response to acid chemical; P:commissural neuron axon guidance; P:coronary artery morphogenesis; P:coronary vein morphogenesis; P:cytokine-mediated signaling pathway; P:dopaminergic neuron differentiation; P:endothelial cell chemotaxis; P:epithelial cell differentiation; P:eye photoreceptor cell development; P:heart morphogenesis; P:in utero embryonic development; P:induction of positive chemotaxis; P:kidney development; P:lactation; P:lung development; P:lymph vessel morphogenesis; P:macrophage differentiation; P:mammary gland alveolus development; P:mesoderm development; P:monocyte differentiation; P:motor neuron migration; P:negative regulation of adherens junction organization; P:negative regulation of apoptotic process; P:negative regulation of blood-brain barrier permeability; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of establishment of endothelial barrier; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:outflow tract morphogenesis; P:ovarian follicle development; P:platelet degranulation; P:positive chemotaxis; P:positive regulation of angiogenesis; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cell adhesion; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; P:positive regulation of cellular component movement; P:positive regulation of cold-induced thermogenesis; P:positive regulation of CREB transcription factor activity; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of histone deacetylase activity; P:positive regulation of leukocyte migration; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mast cell chemotaxis; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of p38MAPK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phosphorylation; P:positive regulation of positive chemotaxis; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein kinase C signaling; P:positive regulation of protein kinase D signaling; P:positive regulation of protein localization to early endosome; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of receptor internalization; P:positive regulation of retinal ganglion cell axon guidance; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of trophoblast cell migration; P:positive regulation of vascular permeability; P:post-embryonic camera-type eye development; P:primitive erythrocyte differentiation; P:regulation of cell shape; P:regulation of nitric oxide mediated signal transduction; P:regulation of retinal ganglion cell axon guidance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to hypoxia; P:sprouting angiogenesis; P:surfactant homeostasis; P:tube formation; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor receptor-2 signaling pathway; P:vascular endothelial growth factor signaling pathway; P:vascular wound healing; P:vasculogenesis; P:VEGF-activated neuropilin signaling pathway;|Q9H1W9 Q9UH58 Q9UL23,Vascular endothelial growth factor A,Vascular permeability factor;, PF00341;PF14554;, GO:0005912;GO:0009986;GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0016020;GO:0031093;GO:0030141;GO:0042056;GO:0005125;GO:0050840;GO:0001968;GO:0008083;GO:0008201;GO:0042802;GO:0038191;GO:0005161;GO:0042803;GO:0048018;GO:0043183;GO:0043184;GO:0005172;GO:0032147;GO:0001525;GO:0048844;GO:0002575;GO:0001569;GO:0048754;GO:0048593;GO:0048739;GO:0060948;GO:0048469;GO:0002042;GO:0071456;GO:0035924;GO:0097533;GO:0071679;GO:0060982;GO:0003169;GO:0019221;GO:0071542;GO:0035767;GO:0030855;GO:0042462;GO:0003007;GO:0001701;GO:0050930;GO:0001822;GO:0007595;GO:0030324;GO:0036303;GO:0030225;GO:0060749;GO:0007498;GO:0030224;GO:0097475;GO:1903392;GO:0043066;GO:1905604;GO:2000048;GO:0043154;GO:1903141;GO:0010629;GO:0000122;GO:0007399;GO:0003151;GO:0001541;GO:0002576;GO:0050918;GO:0045766;GO:0048842;GO:0043536;GO:1903589;GO:0090190;GO:0045785;GO:0051781;GO:0030335;GO:0038089;GO:0090050;GO:0008284;GO:0038091;GO:0051272;GO:0120162;GO:0032793;GO:2000573;GO:0038033;GO:0010595;GO:0001938;GO:0050679;GO:1905278;GO:0070374;GO:0051894;GO:0010628;GO:1901727;GO:0002687;GO:0043406;GO:0043410;GO:0060754;GO:0002053;GO:0002052;GO:1900745;GO:0033138;GO:1900086;GO:0050731;GO:0014068;GO:0042327;GO:0050927;GO:0031954;GO:0051897;GO:0090037;GO:1903572;GO:1902966;GO:0001934;GO:0031334;GO:0002092;GO:1902336;GO:1903672;GO:0045944;GO:0061419;GO:1901165;GO:0043117;GO:0031077;GO:0060319;GO:0008360;GO:0010749;GO:0090259;GO:0006357;GO:0061418;GO:0001666;GO:0002040;GO:0043129;GO:0035148;GO:0048010;GO:0036324;GO:0038084;GO:0061042;GO:0001570;GO:0038190;, C:adherens junction; C:cell surface; C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:membrane; C:platelet alpha granule lumen; C:secretory granule;, F:chemoattractant activity; F:cytokine activity; F:extracellular matrix binding; F:fibronectin binding; F:growth factor activity; F:heparin binding; F:identical protein binding; F:neuropilin binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity; F:receptor ligand activity; F:vascular endothelial growth factor receptor 1 binding; F:vascular endothelial growth factor receptor 2 binding; F:vascular endothelial growth factor receptor binding;, P:activation of protein kinase activity; P:angiogenesis; P:artery morphogenesis; P:basophil chemotaxis; P:branching involved in blood vessel morphogenesis; P:branching morphogenesis of an epithelial tube; P:camera-type eye morphogenesis; P:cardiac muscle fiber development; P:cardiac vascular smooth muscle cell development; P:cell maturation; P:cell migration involved in sprouting angiogenesis; P:cellular response to hypoxia; P:cellular response to vascular endothelial growth factor stimulus; P:cellular stress response to acid chemical; P:commissural neuron axon guidance; P:coronary artery morphogenesis; P:coronary vein morphogenesis; P:cytokine-mediated signaling pathway; P:dopaminergic neuron differentiation; P:endothelial cell chemotaxis; P:epithelial cell differentiation; P:eye photoreceptor cell development; P:heart morphogenesis; P:in utero embryonic development; P:induction of positive chemotaxis; P:kidney development; P:lactation; P:lung development; P:lymph vessel morphogenesis; P:macrophage differentiation; P:mammary gland alveolus development; P:mesoderm development; P:monocyte differentiation; P:motor neuron migration; P:negative regulation of adherens junction organization; P:negative regulation of apoptotic process; P:negative regulation of blood-brain barrier permeability; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of establishment of endothelial barrier; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:outflow tract morphogenesis; P:ovarian follicle development; P:platelet degranulation; P:positive chemotaxis; P:positive regulation of angiogenesis; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cell adhesion; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; P:positive regulation of cellular component movement; P:positive regulation of cold-induced thermogenesis; P:positive regulation of CREB transcription factor activity; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of histone deacetylase activity; P:positive regulation of leukocyte migration; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mast cell chemotaxis; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of p38MAPK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phosphorylation; P:positive regulation of positive chemotaxis; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein kinase C signaling; P:positive regulation of protein kinase D signaling; P:positive regulation of protein localization to early endosome; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of receptor internalization; P:positive regulation of retinal ganglion cell axon guidance; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of trophoblast cell migration; P:positive regulation of vascular permeability; P:post-embryonic camera-type eye development; P:primitive erythrocyte differentiation; P:regulation of cell shape; P:regulation of nitric oxide mediated signal transduction; P:regulation of retinal ganglion cell axon guidance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to hypoxia; P:sprouting angiogenesis; P:surfactant homeostasis; P:tube formation; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor receptor-2 signaling pathway; P:vascular endothelial growth factor signaling pathway; P:vascular wound healing; P:vasculogenesis; P:VEGF-activated neuropilin signaling pathway;|Q9H1W9 Q9UH58 Q9UL23,Vascular endothelial growth factor A,Vascular permeability factor;, PF00341;PF14554;, GO:0005912;GO:0009986;GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0016020;GO:0031093;GO:0030141;GO:0042056;GO:0005125;GO:0050840;GO:0001968;GO:0008083;GO:0008201;GO:0042802;GO:0038191;GO:0005161;GO:0042803;GO:0048018;GO:0043183;GO:0043184;GO:0005172;GO:0032147;GO:0001525;GO:0048844;GO:0002575;GO:0001569;GO:0048754;GO:0048593;GO:0048739;GO:0060948;GO:0048469;GO:0002042;GO:0071456;GO:0035924;GO:0097533;GO:0071679;GO:0060982;GO:0003169;GO:0019221;GO:0071542;GO:0035767;GO:0030855;GO:0042462;GO:0003007;GO:0001701;GO:0050930;GO:0001822;GO:0007595;GO:0030324;GO:0036303;GO:0030225;GO:0060749;GO:0007498;GO:0030224;GO:0097475;GO:1903392;GO:0043066;GO:1905604;GO:2000048;GO:0043154;GO:1903141;GO:0010629;GO:0000122;GO:0007399;GO:0003151;GO:0001541;GO:0002576;GO:0050918;GO:0045766;GO:0048842;GO:0043536;GO:1903589;GO:0090190;GO:0045785;GO:0051781;GO:0030335;GO:0038089;GO:0090050;GO:0008284;GO:0038091;GO:0051272;GO:0120162;GO:0032793;GO:2000573;GO:0038033;GO:0010595;GO:0001938;GO:0050679;GO:1905278;GO:0070374;GO:0051894;GO:0010628;GO:1901727;GO:0002687;GO:0043406;GO:0043410;GO:0060754;GO:0002053;GO:0002052;GO:1900745;GO:0033138;GO:1900086;GO:0050731;GO:0014068;GO:0042327;GO:0050927;GO:0031954;GO:0051897;GO:0090037;GO:1903572;GO:1902966;GO:0001934;GO:0031334;GO:0002092;GO:1902336;GO:1903672;GO:0045944;GO:0061419;GO:1901165;GO:0043117;GO:0031077;GO:0060319;GO:0008360;GO:0010749;GO:0090259;GO:0006357;GO:0061418;GO:0001666;GO:0002040;GO:0043129;GO:0035148;GO:0048010;GO:0036324;GO:0038084;GO:0061042;GO:0001570;GO:0038190;, C:adherens junction; C:cell surface; C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:membrane; C:platelet alpha granule lumen; C:secretory granule;, F:chemoattractant activity; F:cytokine activity; F:extracellular matrix binding; F:fibronectin binding; F:growth factor activity; F:heparin binding; F:identical protein binding; F:neuropilin binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity; F:receptor ligand activity; F:vascular endothelial growth factor receptor 1 binding; F:vascular endothelial growth factor receptor 2 binding; F:vascular endothelial growth factor receptor binding;, P:activation of protein kinase activity; P:angiogenesis; P:artery morphogenesis; P:basophil chemotaxis; P:branching involved in blood vessel morphogenesis; P:branching morphogenesis of an epithelial tube; P:camera-type eye morphogenesis; P:cardiac muscle fiber development; P:cardiac vascular smooth muscle cell development; P:cell maturation; P:cell migration involved in sprouting angiogenesis; P:cellular response to hypoxia; P:cellular response to vascular endothelial growth factor stimulus; P:cellular stress response to acid chemical; P:commissural neuron axon guidance; P:coronary artery morphogenesis; P:coronary vein morphogenesis; P:cytokine-mediated signaling pathway; P:dopaminergic neuron differentiation; P:endothelial cell chemotaxis; P:epithelial cell differentiation; P:eye photoreceptor cell development; P:heart morphogenesis; P:in utero embryonic development; P:induction of positive chemotaxis; P:kidney development; P:lactation; P:lung development; P:lymph vessel morphogenesis; P:macrophage differentiation; P:mammary gland alveolus development; P:mesoderm development; P:monocyte differentiation; P:motor neuron migration; P:negative regulation of adherens junction organization; P:negative regulation of apoptotic process; P:negative regulation of blood-brain barrier permeability; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of establishment of endothelial barrier; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:outflow tract morphogenesis; P:ovarian follicle development; P:platelet degranulation; P:positive chemotaxis; P:positive regulation of angiogenesis; P:positive regulation of axon extension involved in axon guidance; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cell adhesion; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; P:positive regulation of cellular component movement; P:positive regulation of cold-induced thermogenesis; P:positive regulation of CREB transcription factor activity; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of histone deacetylase activity; P:positive regulation of leukocyte migration; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mast cell chemotaxis; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of p38MAPK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phosphorylation; P:positive regulation of positive chemotaxis; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein kinase C signaling; P:positive regulation of protein kinase D signaling; P:positive regulation of protein localization to early endosome; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of receptor internalization; P:positive regulation of retinal ganglion cell axon guidance; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of trophoblast cell migration; P:positive regulation of vascular permeability; P:post-embryonic camera-type eye development; P:primitive erythrocyte differentiation; P:regulation of cell shape; P:regulation of nitric oxide mediated signal transduction; P:regulation of retinal ganglion cell axon guidance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to hypoxia; P:sprouting angiogenesis; P:surfactant homeostasis; P:tube formation; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor receptor-2 signaling pathway; P:vascular endothelial growth factor signaling pathway; P:vascular wound healing; P:vasculogenesis; P:VEGF-activated neuropilin signaling pathway; scaffold40 indexed_genome mRNA 9834299 9843697 . - . ID=transcript_8250;Q6P1L8 B2R575 Q96Q72,39S ribosomal protein L14, mitochondrial,39S ribosomal protein L32, mitochondrial;Mitochondrial large ribosomal subunit protein uL14m {ECO:0000303|PubMed:25278503};, PF00238;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold40 indexed_genome mRNA 9844911 9872329 . + . ID=transcript_8251;Q5T3F8 B9EGU3 Q5T3F9 Q6AHX4 Q6P5A0 Q8N219 Q8NDE1 Q9NSG5,CSC1-like protein 2,Transmembrane protein 63B;, PF14703;PF02714;PF13967;, GO:0015629;GO:0016021;GO:0005886;GO:0005227;GO:0008381;GO:1990760;, C:actin cytoskeleton; C:integral component of membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:osmolarity-sensing cation channel activity;|Q5T3F8 B9EGU3 Q5T3F9 Q6AHX4 Q6P5A0 Q8N219 Q8NDE1 Q9NSG5,CSC1-like protein 2,Transmembrane protein 63B;, PF14703;PF02714;PF13967;, GO:0015629;GO:0016021;GO:0005886;GO:0005227;GO:0008381;GO:1990760;, C:actin cytoskeleton; C:integral component of membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:osmolarity-sensing cation channel activity;|Q5T3F8 B9EGU3 Q5T3F9 Q6AHX4 Q6P5A0 Q8N219 Q8NDE1 Q9NSG5,CSC1-like protein 2,Transmembrane protein 63B;, PF14703;PF02714;PF13967;, GO:0015629;GO:0016021;GO:0005886;GO:0005227;GO:0008381;GO:1990760;, C:actin cytoskeleton; C:integral component of membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:osmolarity-sensing cation channel activity;|Q5T3F8 B9EGU3 Q5T3F9 Q6AHX4 Q6P5A0 Q8N219 Q8NDE1 Q9NSG5,CSC1-like protein 2,Transmembrane protein 63B;, PF14703;PF02714;PF13967;, GO:0015629;GO:0016021;GO:0005886;GO:0005227;GO:0008381;GO:1990760;, C:actin cytoskeleton; C:integral component of membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:osmolarity-sensing cation channel activity;|Q5T3F8 B9EGU3 Q5T3F9 Q6AHX4 Q6P5A0 Q8N219 Q8NDE1 Q9NSG5,CSC1-like protein 2,Transmembrane protein 63B;, PF14703;PF02714;PF13967;, GO:0015629;GO:0016021;GO:0005886;GO:0005227;GO:0008381;GO:1990760;, C:actin cytoskeleton; C:integral component of membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:osmolarity-sensing cation channel activity;|Q5T3F8 B9EGU3 Q5T3F9 Q6AHX4 Q6P5A0 Q8N219 Q8NDE1 Q9NSG5,CSC1-like protein 2,Transmembrane protein 63B;, PF14703;PF02714;PF13967;, GO:0015629;GO:0016021;GO:0005886;GO:0005227;GO:0008381;GO:1990760;, C:actin cytoskeleton; C:integral component of membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:mechanosensitive ion channel activity; F:osmolarity-sensing cation channel activity; scaffold40 indexed_genome mRNA 9925812 9933628 . + . ID=transcript_8252;Q99808 B3KQV7 B3KQY5 Q5T9W9 Q9UJY2,Equilibrative nucleoside transporter 1,Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter;Nucleoside transporter, es-type;Solute carrier family 29 member 1;, PF01733;, GO:0016324;GO:0016323;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0032238;GO:0071333;GO:0071456;GO:0060079;GO:0007595;GO:0098810;GO:0006836;GO:0001504;GO:0006139;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0030431;GO:0150104;GO:0015862;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenosine transport; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:excitatory postsynaptic potential; P:lactation; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleobase-containing compound metabolic process; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:sleep; P:transport across blood-brain barrier; P:uridine transport;|Q99808 B3KQV7 B3KQY5 Q5T9W9 Q9UJY2,Equilibrative nucleoside transporter 1,Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter;Nucleoside transporter, es-type;Solute carrier family 29 member 1;, PF01733;, GO:0016324;GO:0016323;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0032238;GO:0071333;GO:0071456;GO:0060079;GO:0007595;GO:0098810;GO:0006836;GO:0001504;GO:0006139;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0030431;GO:0150104;GO:0015862;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenosine transport; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:excitatory postsynaptic potential; P:lactation; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleobase-containing compound metabolic process; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:sleep; P:transport across blood-brain barrier; P:uridine transport;|Q99808 B3KQV7 B3KQY5 Q5T9W9 Q9UJY2,Equilibrative nucleoside transporter 1,Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter;Nucleoside transporter, es-type;Solute carrier family 29 member 1;, PF01733;, GO:0016324;GO:0016323;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0032238;GO:0071333;GO:0071456;GO:0060079;GO:0007595;GO:0098810;GO:0006836;GO:0001504;GO:0006139;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0030431;GO:0150104;GO:0015862;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenosine transport; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:excitatory postsynaptic potential; P:lactation; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleobase-containing compound metabolic process; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:sleep; P:transport across blood-brain barrier; P:uridine transport;|Q99808 B3KQV7 B3KQY5 Q5T9W9 Q9UJY2,Equilibrative nucleoside transporter 1,Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter;Nucleoside transporter, es-type;Solute carrier family 29 member 1;, PF01733;, GO:0016324;GO:0016323;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0032238;GO:0071333;GO:0071456;GO:0060079;GO:0007595;GO:0098810;GO:0006836;GO:0001504;GO:0006139;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0030431;GO:0150104;GO:0015862;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenosine transport; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:excitatory postsynaptic potential; P:lactation; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleobase-containing compound metabolic process; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:sleep; P:transport across blood-brain barrier; P:uridine transport; scaffold40 indexed_genome mRNA 9948372 9948876 . - . ID=transcript_8253;P08238 B2R5P0 Q5T9W7 Q9NQW0 Q9NTK6,Heat shock protein HSP 90-beta,Heat shock 84 kDa;, PF02518;PF00183;, GO:0016324;GO:0034751;GO:0044295;GO:0016323;GO:0031526;GO:0009986;GO:0005737;GO:0005829;GO:0044294;GO:0070062;GO:0005576;GO:1904813;GO:1990565;GO:0016234;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:1990917;GO:0048471;GO:0005886;GO:0032991;GO:0034774;GO:1990913;GO:0005524;GO:0043008;GO:0016887;GO:0045296;GO:0002135;GO:0032564;GO:0097718;GO:0070182;GO:0003725;GO:0008144;GO:0005525;GO:0031072;GO:0042826;GO:1990226;GO:0042802;GO:0044325;GO:0019900;GO:0023026;GO:0030235;GO:0042277;GO:0046983;GO:0044183;GO:0042803;GO:0019901;GO:0019887;GO:0003723;GO:0017098;GO:0048156;GO:0030911;GO:0031625;GO:0051082;GO:0002134;GO:0048675;GO:0035690;GO:0034605;GO:0071353;GO:0071407;GO:0021955;GO:0051131;GO:0030010;GO:0038096;GO:0071157;GO:1903660;GO:0043524;GO:1901799;GO:0032435;GO:0051248;GO:1901389;GO:0043312;GO:0001890;GO:0045597;GO:0045793;GO:1904031;GO:0045429;GO:0033138;GO:0032516;GO:0032092;GO:0042307;GO:0051897;GO:2000010;GO:0071902;GO:1902949;GO:0051973;GO:0030511;GO:0006457;GO:0050821;GO:0035590;GO:1903827;GO:1900034;GO:0060334;GO:0031396;GO:0060338;GO:0042220;GO:0009651;GO:0006986;GO:0097435;GO:1905323;GO:0007004;GO:0019062;GO:0006805;, C:apical plasma membrane; C:aryl hydrocarbon receptor complex; C:axonal growth cone; C:basolateral plasma membrane; C:brush border membrane; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic growth cone; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:HSP90-CDC37 chaperone complex; C:inclusion body; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:ooplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen; C:sperm head plasma membrane;, F:ATP binding; F:ATP-dependent protein binding; F:ATPase activity; F:cadherin binding; F:CTP binding; F:dATP binding; F:disordered domain specific binding; F:DNA polymerase binding; F:double-stranded RNA binding; F:drug binding; F:GTP binding; F:heat shock protein binding; F:histone deacetylase binding; F:histone methyltransferase binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:MHC class II protein complex binding; F:nitric-oxide synthase regulator activity; F:peptide binding; F:protein dimerization activity; F:protein folding chaperone; F:protein homodimerization activity; F:protein kinase binding; F:protein kinase regulator activity; F:RNA binding; F:sulfonylurea receptor binding; F:tau protein binding; F:TPR domain binding; F:ubiquitin protein ligase binding; F:unfolded protein binding; F:UTP binding;, P:axon extension; P:cellular response to drug; P:cellular response to heat; P:cellular response to interleukin-4; P:cellular response to organic cyclic compound; P:central nervous system neuron axonogenesis; P:chaperone-mediated protein complex assembly; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of cell cycle arrest; P:negative regulation of complement-dependent cytotoxicity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein metabolic process; P:negative regulation of transforming growth factor beta activation; P:neutrophil degranulation; P:placenta development; P:positive regulation of cell differentiation; P:positive regulation of cell size; P:positive regulation of cyclin-dependent protein kinase activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to cell surface; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of tau-protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein folding; P:protein stabilization; P:purinergic nucleotide receptor signaling pathway; P:regulation of cellular protein localization; P:regulation of cellular response to heat; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of protein ubiquitination; P:regulation of type I interferon-mediated signaling pathway; P:response to cocaine; P:response to salt stress; P:response to unfolded protein; P:supramolecular fiber organization; P:telomerase holoenzyme complex assembly; P:telomere maintenance via telomerase; P:virion attachment to host cell; P:xenobiotic metabolic process; scaffold40 indexed_genome mRNA 9949423 9950842 . + . ID=transcript_8254;P08238 B2R5P0 Q5T9W7 Q9NQW0 Q9NTK6,Heat shock protein HSP 90-beta,Heat shock 84 kDa;, PF02518;PF00183;, GO:0016324;GO:0034751;GO:0044295;GO:0016323;GO:0031526;GO:0009986;GO:0005737;GO:0005829;GO:0044294;GO:0070062;GO:0005576;GO:1904813;GO:1990565;GO:0016234;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:1990917;GO:0048471;GO:0005886;GO:0032991;GO:0034774;GO:1990913;GO:0005524;GO:0043008;GO:0016887;GO:0045296;GO:0002135;GO:0032564;GO:0097718;GO:0070182;GO:0003725;GO:0008144;GO:0005525;GO:0031072;GO:0042826;GO:1990226;GO:0042802;GO:0044325;GO:0019900;GO:0023026;GO:0030235;GO:0042277;GO:0046983;GO:0044183;GO:0042803;GO:0019901;GO:0019887;GO:0003723;GO:0017098;GO:0048156;GO:0030911;GO:0031625;GO:0051082;GO:0002134;GO:0048675;GO:0035690;GO:0034605;GO:0071353;GO:0071407;GO:0021955;GO:0051131;GO:0030010;GO:0038096;GO:0071157;GO:1903660;GO:0043524;GO:1901799;GO:0032435;GO:0051248;GO:1901389;GO:0043312;GO:0001890;GO:0045597;GO:0045793;GO:1904031;GO:0045429;GO:0033138;GO:0032516;GO:0032092;GO:0042307;GO:0051897;GO:2000010;GO:0071902;GO:1902949;GO:0051973;GO:0030511;GO:0006457;GO:0050821;GO:0035590;GO:1903827;GO:1900034;GO:0060334;GO:0031396;GO:0060338;GO:0042220;GO:0009651;GO:0006986;GO:0097435;GO:1905323;GO:0007004;GO:0019062;GO:0006805;, C:apical plasma membrane; C:aryl hydrocarbon receptor complex; C:axonal growth cone; C:basolateral plasma membrane; C:brush border membrane; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic growth cone; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:HSP90-CDC37 chaperone complex; C:inclusion body; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:ooplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen; C:sperm head plasma membrane;, F:ATP binding; F:ATP-dependent protein binding; F:ATPase activity; F:cadherin binding; F:CTP binding; F:dATP binding; F:disordered domain specific binding; F:DNA polymerase binding; F:double-stranded RNA binding; F:drug binding; F:GTP binding; F:heat shock protein binding; F:histone deacetylase binding; F:histone methyltransferase binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:MHC class II protein complex binding; F:nitric-oxide synthase regulator activity; F:peptide binding; F:protein dimerization activity; F:protein folding chaperone; F:protein homodimerization activity; F:protein kinase binding; F:protein kinase regulator activity; F:RNA binding; F:sulfonylurea receptor binding; F:tau protein binding; F:TPR domain binding; F:ubiquitin protein ligase binding; F:unfolded protein binding; F:UTP binding;, P:axon extension; P:cellular response to drug; P:cellular response to heat; P:cellular response to interleukin-4; P:cellular response to organic cyclic compound; P:central nervous system neuron axonogenesis; P:chaperone-mediated protein complex assembly; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of cell cycle arrest; P:negative regulation of complement-dependent cytotoxicity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein metabolic process; P:negative regulation of transforming growth factor beta activation; P:neutrophil degranulation; P:placenta development; P:positive regulation of cell differentiation; P:positive regulation of cell size; P:positive regulation of cyclin-dependent protein kinase activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to cell surface; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of tau-protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein folding; P:protein stabilization; P:purinergic nucleotide receptor signaling pathway; P:regulation of cellular protein localization; P:regulation of cellular response to heat; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of protein ubiquitination; P:regulation of type I interferon-mediated signaling pathway; P:response to cocaine; P:response to salt stress; P:response to unfolded protein; P:supramolecular fiber organization; P:telomerase holoenzyme complex assembly; P:telomere maintenance via telomerase; P:virion attachment to host cell; P:xenobiotic metabolic process;|P08238 B2R5P0 Q5T9W7 Q9NQW0 Q9NTK6,Heat shock protein HSP 90-beta,Heat shock 84 kDa;, PF02518;PF00183;, GO:0016324;GO:0034751;GO:0044295;GO:0016323;GO:0031526;GO:0009986;GO:0005737;GO:0005829;GO:0044294;GO:0070062;GO:0005576;GO:1904813;GO:1990565;GO:0016234;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:1990917;GO:0048471;GO:0005886;GO:0032991;GO:0034774;GO:1990913;GO:0005524;GO:0043008;GO:0016887;GO:0045296;GO:0002135;GO:0032564;GO:0097718;GO:0070182;GO:0003725;GO:0008144;GO:0005525;GO:0031072;GO:0042826;GO:1990226;GO:0042802;GO:0044325;GO:0019900;GO:0023026;GO:0030235;GO:0042277;GO:0046983;GO:0044183;GO:0042803;GO:0019901;GO:0019887;GO:0003723;GO:0017098;GO:0048156;GO:0030911;GO:0031625;GO:0051082;GO:0002134;GO:0048675;GO:0035690;GO:0034605;GO:0071353;GO:0071407;GO:0021955;GO:0051131;GO:0030010;GO:0038096;GO:0071157;GO:1903660;GO:0043524;GO:1901799;GO:0032435;GO:0051248;GO:1901389;GO:0043312;GO:0001890;GO:0045597;GO:0045793;GO:1904031;GO:0045429;GO:0033138;GO:0032516;GO:0032092;GO:0042307;GO:0051897;GO:2000010;GO:0071902;GO:1902949;GO:0051973;GO:0030511;GO:0006457;GO:0050821;GO:0035590;GO:1903827;GO:1900034;GO:0060334;GO:0031396;GO:0060338;GO:0042220;GO:0009651;GO:0006986;GO:0097435;GO:1905323;GO:0007004;GO:0019062;GO:0006805;, C:apical plasma membrane; C:aryl hydrocarbon receptor complex; C:axonal growth cone; C:basolateral plasma membrane; C:brush border membrane; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic growth cone; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:HSP90-CDC37 chaperone complex; C:inclusion body; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:ooplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen; C:sperm head plasma membrane;, F:ATP binding; F:ATP-dependent protein binding; F:ATPase activity; F:cadherin binding; F:CTP binding; F:dATP binding; F:disordered domain specific binding; F:DNA polymerase binding; F:double-stranded RNA binding; F:drug binding; F:GTP binding; F:heat shock protein binding; F:histone deacetylase binding; F:histone methyltransferase binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:MHC class II protein complex binding; F:nitric-oxide synthase regulator activity; F:peptide binding; F:protein dimerization activity; F:protein folding chaperone; F:protein homodimerization activity; F:protein kinase binding; F:protein kinase regulator activity; F:RNA binding; F:sulfonylurea receptor binding; F:tau protein binding; F:TPR domain binding; F:ubiquitin protein ligase binding; F:unfolded protein binding; F:UTP binding;, P:axon extension; P:cellular response to drug; P:cellular response to heat; P:cellular response to interleukin-4; P:cellular response to organic cyclic compound; P:central nervous system neuron axonogenesis; P:chaperone-mediated protein complex assembly; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of cell cycle arrest; P:negative regulation of complement-dependent cytotoxicity; P:negative regulation of neuron apoptotic process; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein metabolic process; P:negative regulation of transforming growth factor beta activation; P:neutrophil degranulation; P:placenta development; P:positive regulation of cell differentiation; P:positive regulation of cell size; P:positive regulation of cyclin-dependent protein kinase activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to cell surface; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of tau-protein kinase activity; P:positive regulation of telomerase activity; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein folding; P:protein stabilization; P:purinergic nucleotide receptor signaling pathway; P:regulation of cellular protein localization; P:regulation of cellular response to heat; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of protein ubiquitination; P:regulation of type I interferon-mediated signaling pathway; P:response to cocaine; P:response to salt stress; P:response to unfolded protein; P:supramolecular fiber organization; P:telomerase holoenzyme complex assembly; P:telomere maintenance via telomerase; P:virion attachment to host cell; P:xenobiotic metabolic process; scaffold40 indexed_genome mRNA 9952320 9955383 . - . ID=transcript_8255;Q8NBK6 Q96AR6,Adenosine 3'-phospho 5'-phosphosulfate transporter 1,PAPS transporter 1;Putative MAPK-activating protein PM15;Putative NF-kappa-B-activating protein 48;Solute carrier family 35 member B2;, PF08449;, GO:0005794;GO:0000139;GO:0030176;GO:0030173;GO:0016021;GO:0016020;GO:0046964;GO:0022857;GO:0050428;GO:0046963;GO:0043123;, C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:integral component of membrane; C:membrane;, F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; F:transmembrane transporter activity;, P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; P:3'-phosphoadenosine 5'-phosphosulfate transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold40 indexed_genome mRNA 9959065 9966690 . - . ID=transcript_8256;O00221 Q5T9V9,NF-kappa-B inhibitor epsilon,I-kappa-B-epsilon;, PF12796;, GO:0005737;GO:0005829;GO:0001650;GO:0005794;GO:0005654;GO:0048471;GO:0042994;GO:0042942;, C:cytoplasm; C:cytosol; C:fibrillar center; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm;, , P:cytoplasmic sequestering of transcription factor; P:D-serine transport; scaffold40 indexed_genome mRNA 9969764 9975924 . - . ID=transcript_8257;Q8IW70 Q5T9V7,Transmembrane protein 151B,Transmembrane protein 193;, PF14857;, GO:0016021;, C:integral component of membrane; scaffold40 indexed_genome mRNA 9978639 9981282 . - . ID=transcript_8258;Q5JU00 B4DX59 Q8IYS6,Dynein regulatory complex subunit 5 {ECO:0000250|UniProtKB:A6H639},T-complex-associated testis-expressed protein 1;, PF13516;, GO:0005737;GO:0005856;GO:0036126;GO:0030317;, C:cytoplasm; C:cytoskeleton; C:sperm flagellum;, , P:flagellated sperm motility; scaffold40 indexed_genome mRNA 9983222 9985491 . - . ID=transcript_8259;Q5JU00 B4DX59 Q8IYS6,Dynein regulatory complex subunit 5 {ECO:0000250|UniProtKB:A6H639},T-complex-associated testis-expressed protein 1;, PF13516;, GO:0005737;GO:0005856;GO:0036126;GO:0030317;, C:cytoplasm; C:cytoskeleton; C:sperm flagellum;, , P:flagellated sperm motility; scaffold40 indexed_genome mRNA 9995467 10007674 . - . ID=transcript_8260;Q5JTZ9 A2RRN5 Q8N198 Q96D02 Q9ULF0,Alanine--tRNA ligase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03133},Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};, PF01411;PF07973;, GO:0005739;GO:0004813;GO:0016597;GO:0002161;GO:0005524;GO:0000049;GO:0008270;GO:0006419;GO:0070143;GO:0006400;, C:mitochondrion;, F:alanine-tRNA ligase activity; F:amino acid binding; F:aminoacyl-tRNA editing activity; F:ATP binding; F:tRNA binding; F:zinc ion binding;, P:alanyl-tRNA aminoacylation; P:mitochondrial alanyl-tRNA aminoacylation; P:tRNA modification;|Q5JTZ9 A2RRN5 Q8N198 Q96D02 Q9ULF0,Alanine--tRNA ligase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03133},Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};, PF01411;PF07973;, GO:0005739;GO:0004813;GO:0016597;GO:0002161;GO:0005524;GO:0000049;GO:0008270;GO:0006419;GO:0070143;GO:0006400;, C:mitochondrion;, F:alanine-tRNA ligase activity; F:amino acid binding; F:aminoacyl-tRNA editing activity; F:ATP binding; F:tRNA binding; F:zinc ion binding;, P:alanyl-tRNA aminoacylation; P:mitochondrial alanyl-tRNA aminoacylation; P:tRNA modification;|Q5JTZ9 A2RRN5 Q8N198 Q96D02 Q9ULF0,Alanine--tRNA ligase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03133},Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};, PF01411;PF07973;, GO:0005739;GO:0004813;GO:0016597;GO:0002161;GO:0005524;GO:0000049;GO:0008270;GO:0006419;GO:0070143;GO:0006400;, C:mitochondrion;, F:alanine-tRNA ligase activity; F:amino acid binding; F:aminoacyl-tRNA editing activity; F:ATP binding; F:tRNA binding; F:zinc ion binding;, P:alanyl-tRNA aminoacylation; P:mitochondrial alanyl-tRNA aminoacylation; P:tRNA modification;|Q5JTZ9 A2RRN5 Q8N198 Q96D02 Q9ULF0,Alanine--tRNA ligase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03133},Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};, PF01411;PF07973;, GO:0005739;GO:0004813;GO:0016597;GO:0002161;GO:0005524;GO:0000049;GO:0008270;GO:0006419;GO:0070143;GO:0006400;, C:mitochondrion;, F:alanine-tRNA ligase activity; F:amino acid binding; F:aminoacyl-tRNA editing activity; F:ATP binding; F:tRNA binding; F:zinc ion binding;, P:alanyl-tRNA aminoacylation; P:mitochondrial alanyl-tRNA aminoacylation; P:tRNA modification; scaffold40 indexed_genome mRNA 10045047 10055688 . + . ID=transcript_8261;Q496A3 Q496A2 Q496A5 Q96LJ0,Spermatogenesis-associated serine-rich protein 1,, PF15160; scaffold40 indexed_genome mRNA 10061424 10106837 . + . ID=transcript_8262;Q99459 Q76N46 Q99974,Cell division cycle 5-like protein,Pombe cdc5-related protein;, PF11831;, GO:0071013;GO:0005737;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0048471;GO:0032993;GO:0000974;GO:0005681;GO:0071007;GO:0003677;GO:0001228;GO:0000981;GO:0043522;GO:0019901;GO:0008157;GO:0003723;GO:0000977;GO:0001222;GO:0071987;GO:0044344;GO:0071352;GO:1990090;GO:1990646;GO:1904568;GO:0006281;GO:0000278;GO:0000398;GO:0045944;GO:0006357;GO:0072422;, C:catalytic step 2 spliceosome; C:cytoplasm; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-DNA complex; C:Prp19 complex; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:leucine zipper domain binding; F:protein kinase binding; F:protein phosphatase 1 binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor binding; F:WD40-repeat domain binding;, P:cellular response to fibroblast growth factor stimulus; P:cellular response to interleukin-2; P:cellular response to nerve growth factor stimulus; P:cellular response to prolactin; P:cellular response to wortmannin; P:DNA repair; P:mitotic cell cycle; P:mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:signal transduction involved in DNA damage checkpoint; scaffold40 indexed_genome mRNA 10425587 10797836 . - . ID=transcript_8263;O75486 A6NKG9 B2R9Q5 O76066 Q5TAV9 Q86VN7,Transcription initiation protein SPT3 homolog,SPT3-like protein;, PF02269;, GO:0005654;GO:0005634;GO:0030914;GO:0033276;GO:0046982;GO:0003713;GO:0016578;GO:0043966;GO:0045893;GO:0006357;GO:0006355;GO:0006366;, C:nucleoplasm; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:protein heterodimerization activity; F:transcription coactivator activity;, P:histone deubiquitination; P:histone H3 acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II;|O75486 A6NKG9 B2R9Q5 O76066 Q5TAV9 Q86VN7,Transcription initiation protein SPT3 homolog,SPT3-like protein;, PF02269;, GO:0005654;GO:0005634;GO:0030914;GO:0033276;GO:0046982;GO:0003713;GO:0016578;GO:0043966;GO:0045893;GO:0006357;GO:0006355;GO:0006366;, C:nucleoplasm; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:protein heterodimerization activity; F:transcription coactivator activity;, P:histone deubiquitination; P:histone H3 acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II;|O75486 A6NKG9 B2R9Q5 O76066 Q5TAV9 Q86VN7,Transcription initiation protein SPT3 homolog,SPT3-like protein;, PF02269;, GO:0005654;GO:0005634;GO:0030914;GO:0033276;GO:0046982;GO:0003713;GO:0016578;GO:0043966;GO:0045893;GO:0006357;GO:0006355;GO:0006366;, C:nucleoplasm; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:protein heterodimerization activity; F:transcription coactivator activity;, P:histone deubiquitination; P:histone H3 acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II;|O75486 A6NKG9 B2R9Q5 O76066 Q5TAV9 Q86VN7,Transcription initiation protein SPT3 homolog,SPT3-like protein;, PF02269;, GO:0005654;GO:0005634;GO:0030914;GO:0033276;GO:0046982;GO:0003713;GO:0016578;GO:0043966;GO:0045893;GO:0006357;GO:0006355;GO:0006366;, C:nucleoplasm; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:protein heterodimerization activity; F:transcription coactivator activity;, P:histone deubiquitination; P:histone H3 acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; scaffold40 indexed_genome mRNA 11339758 11449615 . - . ID=transcript_8264;Q9NZA1 B3KUF1 Q5T4Z0 Q8NBY3 Q96JT5 Q9BWZ0,Chloride intracellular channel protein 5,, PF13409;, GO:0015629;GO:0016324;GO:0005938;GO:0034707;GO:0070062;GO:0005794;GO:0005815;GO:0005254;GO:0005244;GO:0006821;GO:0007565;GO:0006749;GO:0034765;GO:0050896;GO:0007605;GO:0007601;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:chloride channel complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule organizing center;, F:chloride channel activity; F:voltage-gated ion channel activity;, P:chloride transport; P:female pregnancy; P:glutathione metabolic process; P:regulation of ion transmembrane transport; P:response to stimulus; P:sensory perception of sound; P:visual perception;|Q9NZA1 B3KUF1 Q5T4Z0 Q8NBY3 Q96JT5 Q9BWZ0,Chloride intracellular channel protein 5,, PF13409;, GO:0015629;GO:0016324;GO:0005938;GO:0034707;GO:0070062;GO:0005794;GO:0005815;GO:0005254;GO:0005244;GO:0006821;GO:0007565;GO:0006749;GO:0034765;GO:0050896;GO:0007605;GO:0007601;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:chloride channel complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule organizing center;, F:chloride channel activity; F:voltage-gated ion channel activity;, P:chloride transport; P:female pregnancy; P:glutathione metabolic process; P:regulation of ion transmembrane transport; P:response to stimulus; P:sensory perception of sound; P:visual perception; scaffold40 indexed_genome mRNA 11493460 11497605 . - . ID=transcript_8265;Q9NZA1 B3KUF1 Q5T4Z0 Q8NBY3 Q96JT5 Q9BWZ0,Chloride intracellular channel protein 5,, PF13409;, GO:0015629;GO:0016324;GO:0005938;GO:0034707;GO:0070062;GO:0005794;GO:0005815;GO:0005254;GO:0005244;GO:0006821;GO:0007565;GO:0006749;GO:0034765;GO:0050896;GO:0007605;GO:0007601;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:chloride channel complex; C:extracellular exosome; C:Golgi apparatus; C:microtubule organizing center;, F:chloride channel activity; F:voltage-gated ion channel activity;, P:chloride transport; P:female pregnancy; P:glutathione metabolic process; P:regulation of ion transmembrane transport; P:response to stimulus; P:sensory perception of sound; P:visual perception; scaffold40 indexed_genome mRNA 11530543 11538477 . + . ID=transcript_8266;Q9Y6X5 A8K5G1 Q7L2N1,Bis(5'-adenosyl)-triphosphatase ENPP4,AP3A hydrolase;Ectonucleotide pyrophosphatase/phosphodiesterase family member 4;, PF01663;, GO:0070062;GO:0101003;GO:0016021;GO:0016020;GO:0005886;GO:0047710;GO:0046872;GO:0007596;GO:0043312;GO:0030194;GO:0046130;, C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:bis(5'-adenosyl)-triphosphatase activity; F:metal ion binding;, P:blood coagulation; P:neutrophil degranulation; P:positive regulation of blood coagulation; P:purine ribonucleoside catabolic process;|Q9Y6X5 A8K5G1 Q7L2N1,Bis(5'-adenosyl)-triphosphatase ENPP4,AP3A hydrolase;Ectonucleotide pyrophosphatase/phosphodiesterase family member 4;, PF01663;, GO:0070062;GO:0101003;GO:0016021;GO:0016020;GO:0005886;GO:0047710;GO:0046872;GO:0007596;GO:0043312;GO:0030194;GO:0046130;, C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:bis(5'-adenosyl)-triphosphatase activity; F:metal ion binding;, P:blood coagulation; P:neutrophil degranulation; P:positive regulation of blood coagulation; P:purine ribonucleoside catabolic process; scaffold40 indexed_genome mRNA 11540517 11552512 . - . ID=transcript_8267;Q9UJA9 Q5TFV2 Q6UX49,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,, PF01663;, GO:0005576;GO:0016021;GO:0005886;GO:0000210;GO:0008270;GO:0007154;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:NAD+ diphosphatase activity; F:zinc ion binding;, P:cell communication;|Q9UJA9 Q5TFV2 Q6UX49,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,, PF01663;, GO:0005576;GO:0016021;GO:0005886;GO:0000210;GO:0008270;GO:0007154;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:NAD+ diphosphatase activity; F:zinc ion binding;, P:cell communication; scaffold40 indexed_genome mRNA 11591943 11593525 . - . ID=transcript_8268;Q14206 A6ND07 B3KR46 Q5VWF7 Q5VWF8 Q8N116,Calcipressin-2,Down syndrome candidate region 1-like 1;Myocyte-enriched calcineurin-interacting protein 2;Regulator of calcineurin 2;Thyroid hormone-responsive protein ZAKI-4;, PF04847;, GO:0005737;GO:0005634;GO:0008597;GO:0003676;GO:0019722;, C:cytoplasm; C:nucleus;, F:calcium-dependent protein serine/threonine phosphatase regulator activity; F:nucleic acid binding;, P:calcium-mediated signaling; scaffold40 indexed_genome mRNA 11613282 11875023 . - . ID=transcript_8269;G1FLF0 Q5ECL3 Q5TGC6 Q9NUC8 Q9UKA7,Calcipressin-3,Down syndrome candidate region 1-like protein 2;Myocyte-enriched calcineurin-interacting protein 3;Regulator of calcineurin 3;, PF04847;, GO:0005737;GO:0005634;GO:0008597;GO:0019902;GO:0003723;GO:0031013;GO:0009653;GO:0019722;, C:cytoplasm; C:nucleus;, F:calcium-dependent protein serine/threonine phosphatase regulator activity; F:phosphatase binding; F:RNA binding; F:troponin I binding;, P:anatomical structure morphogenesis; P:calcium-mediated signaling; scaffold40 indexed_genome mRNA 11937846 12021121 . - . ID=transcript_8270;Q9NYL5 Q5VTT0 Q96FW5,24-hydroxycholesterol 7-alpha-hydroxylase {ECO:0000303|PubMed:10748047},Cytochrome P450 39A1;Oxysterol 7-alpha-hydroxylase;, PF00067;, GO:0005789;GO:0016021;GO:0043231;GO:0020037;GO:0005506;GO:0008396;GO:0008387;GO:0008395;GO:0006699;GO:0006707;GO:0042632;GO:0007586;GO:0016125;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:heme binding; F:iron ion binding; F:oxysterol 7-alpha-hydroxylase activity; F:steroid 7-alpha-hydroxylase activity; F:steroid hydroxylase activity;, P:bile acid biosynthetic process; P:cholesterol catabolic process; P:cholesterol homeostasis; P:digestion; P:sterol metabolic process; scaffold40 indexed_genome mRNA 12021159 12048477 . + . ID=transcript_8271;O95847 F5GWR4 Q5VTS9 Q8N518,Mitochondrial uncoupling protein 4,Solute carrier family 25 member 27;, PF00153;, GO:0045177;GO:0016021;GO:0005743;GO:0031966;GO:0005739;GO:0043025;GO:0035356;GO:0048839;GO:0043066;GO:0051562;GO:0010917;GO:0070997;GO:0008284;GO:1902600;GO:0046324;GO:0009409;, C:apical part of cell; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:neuronal cell body;, , P:cellular triglyceride homeostasis; P:inner ear development; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial calcium ion concentration; P:negative regulation of mitochondrial membrane potential; P:neuron death; P:positive regulation of cell population proliferation; P:proton transmembrane transport; P:regulation of glucose import; P:response to cold;|O95847 F5GWR4 Q5VTS9 Q8N518,Mitochondrial uncoupling protein 4,Solute carrier family 25 member 27;, PF00153;, GO:0045177;GO:0016021;GO:0005743;GO:0031966;GO:0005739;GO:0043025;GO:0035356;GO:0048839;GO:0043066;GO:0051562;GO:0010917;GO:0070997;GO:0008284;GO:1902600;GO:0046324;GO:0009409;, C:apical part of cell; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:neuronal cell body;, , P:cellular triglyceride homeostasis; P:inner ear development; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial calcium ion concentration; P:negative regulation of mitochondrial membrane potential; P:neuron death; P:positive regulation of cell population proliferation; P:proton transmembrane transport; P:regulation of glucose import; P:response to cold;|O95847 F5GWR4 Q5VTS9 Q8N518,Mitochondrial uncoupling protein 4,Solute carrier family 25 member 27;, PF00153;, GO:0045177;GO:0016021;GO:0005743;GO:0031966;GO:0005739;GO:0043025;GO:0035356;GO:0048839;GO:0043066;GO:0051562;GO:0010917;GO:0070997;GO:0008284;GO:1902600;GO:0046324;GO:0009409;, C:apical part of cell; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:neuronal cell body;, , P:cellular triglyceride homeostasis; P:inner ear development; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial calcium ion concentration; P:negative regulation of mitochondrial membrane potential; P:neuron death; P:positive regulation of cell population proliferation; P:proton transmembrane transport; P:regulation of glucose import; P:response to cold;|O95847 F5GWR4 Q5VTS9 Q8N518,Mitochondrial uncoupling protein 4,Solute carrier family 25 member 27;, PF00153;, GO:0045177;GO:0016021;GO:0005743;GO:0031966;GO:0005739;GO:0043025;GO:0035356;GO:0048839;GO:0043066;GO:0051562;GO:0010917;GO:0070997;GO:0008284;GO:1902600;GO:0046324;GO:0009409;, C:apical part of cell; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:neuronal cell body;, , P:cellular triglyceride homeostasis; P:inner ear development; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial calcium ion concentration; P:negative regulation of mitochondrial membrane potential; P:neuron death; P:positive regulation of cell population proliferation; P:proton transmembrane transport; P:regulation of glucose import; P:response to cold; scaffold40 indexed_genome mRNA 12064327 12100691 . - . ID=transcript_8272;Q13093 A5HTT5 Q15692 Q5VTT1 Q8IVA2,Platelet-activating factor acetylhydrolase,1-alkyl-2-acetylglycerophosphocholine esterase;2-acetyl-1-alkylglycerophosphocholine esterase;Group-VIIA phospholipase A2;LDL-associated phospholipase A2;PAF 2-acylhydrolase;, PF03403;, GO:0005737;GO:0005576;GO:0034364;GO:0034362;GO:0003847;GO:0047499;GO:0005543;GO:0034440;GO:0034374;GO:0034638;GO:0034441;GO:0062234;GO:0046469;GO:0050729;GO:0090026;, C:cytoplasm; C:extracellular region; C:high-density lipoprotein particle; C:low-density lipoprotein particle;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:calcium-independent phospholipase A2 activity; F:phospholipid binding;, P:lipid oxidation; P:low-density lipoprotein particle remodeling; P:phosphatidylcholine catabolic process; P:plasma lipoprotein particle oxidation; P:platelet activating factor catabolic process; P:platelet activating factor metabolic process; P:positive regulation of inflammatory response; P:positive regulation of monocyte chemotaxis;|Q13093 A5HTT5 Q15692 Q5VTT1 Q8IVA2,Platelet-activating factor acetylhydrolase,1-alkyl-2-acetylglycerophosphocholine esterase;2-acetyl-1-alkylglycerophosphocholine esterase;Group-VIIA phospholipase A2;LDL-associated phospholipase A2;PAF 2-acylhydrolase;, PF03403;, GO:0005737;GO:0005576;GO:0034364;GO:0034362;GO:0003847;GO:0047499;GO:0005543;GO:0034440;GO:0034374;GO:0034638;GO:0034441;GO:0062234;GO:0046469;GO:0050729;GO:0090026;, C:cytoplasm; C:extracellular region; C:high-density lipoprotein particle; C:low-density lipoprotein particle;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:calcium-independent phospholipase A2 activity; F:phospholipid binding;, P:lipid oxidation; P:low-density lipoprotein particle remodeling; P:phosphatidylcholine catabolic process; P:plasma lipoprotein particle oxidation; P:platelet activating factor catabolic process; P:platelet activating factor metabolic process; P:positive regulation of inflammatory response; P:positive regulation of monocyte chemotaxis;|Q13093 A5HTT5 Q15692 Q5VTT1 Q8IVA2,Platelet-activating factor acetylhydrolase,1-alkyl-2-acetylglycerophosphocholine esterase;2-acetyl-1-alkylglycerophosphocholine esterase;Group-VIIA phospholipase A2;LDL-associated phospholipase A2;PAF 2-acylhydrolase;, PF03403;, GO:0005737;GO:0005576;GO:0034364;GO:0034362;GO:0003847;GO:0047499;GO:0005543;GO:0034440;GO:0034374;GO:0034638;GO:0034441;GO:0062234;GO:0046469;GO:0050729;GO:0090026;, C:cytoplasm; C:extracellular region; C:high-density lipoprotein particle; C:low-density lipoprotein particle;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:calcium-independent phospholipase A2 activity; F:phospholipid binding;, P:lipid oxidation; P:low-density lipoprotein particle remodeling; P:phosphatidylcholine catabolic process; P:plasma lipoprotein particle oxidation; P:platelet activating factor catabolic process; P:platelet activating factor metabolic process; P:positive regulation of inflammatory response; P:positive regulation of monocyte chemotaxis;|Q13093 A5HTT5 Q15692 Q5VTT1 Q8IVA2,Platelet-activating factor acetylhydrolase,1-alkyl-2-acetylglycerophosphocholine esterase;2-acetyl-1-alkylglycerophosphocholine esterase;Group-VIIA phospholipase A2;LDL-associated phospholipase A2;PAF 2-acylhydrolase;, PF03403;, GO:0005737;GO:0005576;GO:0034364;GO:0034362;GO:0003847;GO:0047499;GO:0005543;GO:0034440;GO:0034374;GO:0034638;GO:0034441;GO:0062234;GO:0046469;GO:0050729;GO:0090026;, C:cytoplasm; C:extracellular region; C:high-density lipoprotein particle; C:low-density lipoprotein particle;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:calcium-independent phospholipase A2 activity; F:phospholipid binding;, P:lipid oxidation; P:low-density lipoprotein particle remodeling; P:phosphatidylcholine catabolic process; P:plasma lipoprotein particle oxidation; P:platelet activating factor catabolic process; P:platelet activating factor metabolic process; P:positive regulation of inflammatory response; P:positive regulation of monocyte chemotaxis;|Q13093 A5HTT5 Q15692 Q5VTT1 Q8IVA2,Platelet-activating factor acetylhydrolase,1-alkyl-2-acetylglycerophosphocholine esterase;2-acetyl-1-alkylglycerophosphocholine esterase;Group-VIIA phospholipase A2;LDL-associated phospholipase A2;PAF 2-acylhydrolase;, PF03403;, GO:0005737;GO:0005576;GO:0034364;GO:0034362;GO:0003847;GO:0047499;GO:0005543;GO:0034440;GO:0034374;GO:0034638;GO:0034441;GO:0062234;GO:0046469;GO:0050729;GO:0090026;, C:cytoplasm; C:extracellular region; C:high-density lipoprotein particle; C:low-density lipoprotein particle;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:calcium-independent phospholipase A2 activity; F:phospholipid binding;, P:lipid oxidation; P:low-density lipoprotein particle remodeling; P:phosphatidylcholine catabolic process; P:plasma lipoprotein particle oxidation; P:platelet activating factor catabolic process; P:platelet activating factor metabolic process; P:positive regulation of inflammatory response; P:positive regulation of monocyte chemotaxis; scaffold40 indexed_genome mRNA 12194112 12252675 . - . ID=transcript_8273;Q8IZF2 O94858 Q5TF06 Q6RGN2 Q86SP0 Q9Y3Z2,Adhesion G protein-coupled receptor F5 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 116;, PF00002;PF01825;PF01390;, GO:0045177;GO:0009986;GO:0031410;GO:0016021;GO:0005886;GO:0004930;GO:0007166;GO:0006112;GO:0048821;GO:0045444;GO:0007186;GO:0003094;GO:0042593;GO:0043031;GO:0061626;GO:0071073;GO:0043129;, C:apical part of cell; C:cell surface; C:cytoplasmic vesicle; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:energy reserve metabolic process; P:erythrocyte development; P:fat cell differentiation; P:G protein-coupled receptor signaling pathway; P:glomerular filtration; P:glucose homeostasis; P:negative regulation of macrophage activation; P:pharyngeal arch artery morphogenesis; P:positive regulation of phospholipid biosynthetic process; P:surfactant homeostasis;|Q8IZF2 O94858 Q5TF06 Q6RGN2 Q86SP0 Q9Y3Z2,Adhesion G protein-coupled receptor F5 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 116;, PF00002;PF01825;PF01390;, GO:0045177;GO:0009986;GO:0031410;GO:0016021;GO:0005886;GO:0004930;GO:0007166;GO:0006112;GO:0048821;GO:0045444;GO:0007186;GO:0003094;GO:0042593;GO:0043031;GO:0061626;GO:0071073;GO:0043129;, C:apical part of cell; C:cell surface; C:cytoplasmic vesicle; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:energy reserve metabolic process; P:erythrocyte development; P:fat cell differentiation; P:G protein-coupled receptor signaling pathway; P:glomerular filtration; P:glucose homeostasis; P:negative regulation of macrophage activation; P:pharyngeal arch artery morphogenesis; P:positive regulation of phospholipid biosynthetic process; P:surfactant homeostasis; scaffold40 indexed_genome mRNA 12533812 12614053 . - . ID=transcript_8274;O75509 B2RDI9 Q0D2P5 Q96D86,Tumor necrosis factor receptor superfamily member 21,Death receptor 6;, PF00531;PF00020;, GO:0030424;GO:0005737;GO:0005887;GO:0031226;GO:0005886;GO:0002250;GO:0006915;GO:0007413;GO:0001783;GO:0071356;GO:0006959;GO:0042552;GO:0030889;GO:0032693;GO:0032696;GO:0032714;GO:0031642;GO:0042130;GO:0051402;GO:0097252;GO:0019222;GO:0048713;GO:0050852;GO:0016032;, C:axon; C:cytoplasm; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, , P:adaptive immune response; P:apoptotic process; P:axonal fasciculation; P:B cell apoptotic process; P:cellular response to tumor necrosis factor; P:humoral immune response; P:myelination; P:negative regulation of B cell proliferation; P:negative regulation of interleukin-10 production; P:negative regulation of interleukin-13 production; P:negative regulation of interleukin-5 production; P:negative regulation of myelination; P:negative regulation of T cell proliferation; P:neuron apoptotic process; P:oligodendrocyte apoptotic process; P:regulation of metabolic process; P:regulation of oligodendrocyte differentiation; P:T cell receptor signaling pathway; P:viral process;|O75509 B2RDI9 Q0D2P5 Q96D86,Tumor necrosis factor receptor superfamily member 21,Death receptor 6;, PF00531;PF00020;, GO:0030424;GO:0005737;GO:0005887;GO:0031226;GO:0005886;GO:0002250;GO:0006915;GO:0007413;GO:0001783;GO:0071356;GO:0006959;GO:0042552;GO:0030889;GO:0032693;GO:0032696;GO:0032714;GO:0031642;GO:0042130;GO:0051402;GO:0097252;GO:0019222;GO:0048713;GO:0050852;GO:0016032;, C:axon; C:cytoplasm; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, , P:adaptive immune response; P:apoptotic process; P:axonal fasciculation; P:B cell apoptotic process; P:cellular response to tumor necrosis factor; P:humoral immune response; P:myelination; P:negative regulation of B cell proliferation; P:negative regulation of interleukin-10 production; P:negative regulation of interleukin-13 production; P:negative regulation of interleukin-5 production; P:negative regulation of myelination; P:negative regulation of T cell proliferation; P:neuron apoptotic process; P:oligodendrocyte apoptotic process; P:regulation of metabolic process; P:regulation of oligodendrocyte differentiation; P:T cell receptor signaling pathway; P:viral process;|O75509 B2RDI9 Q0D2P5 Q96D86,Tumor necrosis factor receptor superfamily member 21,Death receptor 6;, PF00531;PF00020;, GO:0030424;GO:0005737;GO:0005887;GO:0031226;GO:0005886;GO:0002250;GO:0006915;GO:0007413;GO:0001783;GO:0071356;GO:0006959;GO:0042552;GO:0030889;GO:0032693;GO:0032696;GO:0032714;GO:0031642;GO:0042130;GO:0051402;GO:0097252;GO:0019222;GO:0048713;GO:0050852;GO:0016032;, C:axon; C:cytoplasm; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, , P:adaptive immune response; P:apoptotic process; P:axonal fasciculation; P:B cell apoptotic process; P:cellular response to tumor necrosis factor; P:humoral immune response; P:myelination; P:negative regulation of B cell proliferation; P:negative regulation of interleukin-10 production; P:negative regulation of interleukin-13 production; P:negative regulation of interleukin-5 production; P:negative regulation of myelination; P:negative regulation of T cell proliferation; P:neuron apoptotic process; P:oligodendrocyte apoptotic process; P:regulation of metabolic process; P:regulation of oligodendrocyte differentiation; P:T cell receptor signaling pathway; P:viral process; scaffold40 indexed_genome mRNA 12733739 12817739 . + . ID=transcript_8275;Q9Y5K6 A6NL34 Q5VYA3 Q9UG97,CD2-associated protein,Adapter protein CMS;Cas ligand with multiple SH3 domains;, PF00018;PF14604;, GO:0015629;GO:0030424;GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0070062;GO:0001650;GO:0031941;GO:0048471;GO:0005886;GO:0001726;GO:0008013;GO:0045296;GO:0042802;GO:0008022;GO:0044877;GO:0017124;GO:0005200;GO:0005172;GO:0007015;GO:0007049;GO:0051301;GO:0098609;GO:0051058;GO:0032911;GO:1900182;GO:0050714;GO:0043161;GO:0065003;GO:2000249;GO:0048259;GO:0007165;GO:0006930;GO:0016050;, C:actin cytoskeleton; C:axon; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:extracellular exosome; C:fibrillar center; C:filamentous actin; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle;, F:beta-catenin binding; F:cadherin binding; F:identical protein binding; F:protein C-terminus binding; F:protein-containing complex binding; F:SH3 domain binding; F:structural constituent of cytoskeleton; F:vascular endothelial growth factor receptor binding;, P:actin filament organization; P:cell cycle; P:cell division; P:cell-cell adhesion; P:negative regulation of small GTPase mediated signal transduction; P:negative regulation of transforming growth factor beta1 production; P:positive regulation of protein localization to nucleus; P:positive regulation of protein secretion; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of receptor-mediated endocytosis; P:signal transduction; P:substrate-dependent cell migration, cell extension; P:vesicle organization;|Q9Y5K6 A6NL34 Q5VYA3 Q9UG97,CD2-associated protein,Adapter protein CMS;Cas ligand with multiple SH3 domains;, PF00018;PF14604;, GO:0015629;GO:0030424;GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0070062;GO:0001650;GO:0031941;GO:0048471;GO:0005886;GO:0001726;GO:0008013;GO:0045296;GO:0042802;GO:0008022;GO:0044877;GO:0017124;GO:0005200;GO:0005172;GO:0007015;GO:0007049;GO:0051301;GO:0098609;GO:0051058;GO:0032911;GO:1900182;GO:0050714;GO:0043161;GO:0065003;GO:2000249;GO:0048259;GO:0007165;GO:0006930;GO:0016050;, C:actin cytoskeleton; C:axon; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:extracellular exosome; C:fibrillar center; C:filamentous actin; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle;, F:beta-catenin binding; F:cadherin binding; F:identical protein binding; F:protein C-terminus binding; F:protein-containing complex binding; F:SH3 domain binding; F:structural constituent of cytoskeleton; F:vascular endothelial growth factor receptor binding;, P:actin filament organization; P:cell cycle; P:cell division; P:cell-cell adhesion; P:negative regulation of small GTPase mediated signal transduction; P:negative regulation of transforming growth factor beta1 production; P:positive regulation of protein localization to nucleus; P:positive regulation of protein secretion; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of receptor-mediated endocytosis; P:signal transduction; P:substrate-dependent cell migration, cell extension; P:vesicle organization;|Q9Y5K6 A6NL34 Q5VYA3 Q9UG97,CD2-associated protein,Adapter protein CMS;Cas ligand with multiple SH3 domains;, PF00018;PF14604;, GO:0015629;GO:0030424;GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0070062;GO:0001650;GO:0031941;GO:0048471;GO:0005886;GO:0001726;GO:0008013;GO:0045296;GO:0042802;GO:0008022;GO:0044877;GO:0017124;GO:0005200;GO:0005172;GO:0007015;GO:0007049;GO:0051301;GO:0098609;GO:0051058;GO:0032911;GO:1900182;GO:0050714;GO:0043161;GO:0065003;GO:2000249;GO:0048259;GO:0007165;GO:0006930;GO:0016050;, C:actin cytoskeleton; C:axon; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:extracellular exosome; C:fibrillar center; C:filamentous actin; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle;, F:beta-catenin binding; F:cadherin binding; F:identical protein binding; F:protein C-terminus binding; F:protein-containing complex binding; F:SH3 domain binding; F:structural constituent of cytoskeleton; F:vascular endothelial growth factor receptor binding;, P:actin filament organization; P:cell cycle; P:cell division; P:cell-cell adhesion; P:negative regulation of small GTPase mediated signal transduction; P:negative regulation of transforming growth factor beta1 production; P:positive regulation of protein localization to nucleus; P:positive regulation of protein secretion; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of receptor-mediated endocytosis; P:signal transduction; P:substrate-dependent cell migration, cell extension; P:vesicle organization;|Q9Y5K6 A6NL34 Q5VYA3 Q9UG97,CD2-associated protein,Adapter protein CMS;Cas ligand with multiple SH3 domains;, PF00018;PF14604;, GO:0015629;GO:0030424;GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0070062;GO:0001650;GO:0031941;GO:0048471;GO:0005886;GO:0001726;GO:0008013;GO:0045296;GO:0042802;GO:0008022;GO:0044877;GO:0017124;GO:0005200;GO:0005172;GO:0007015;GO:0007049;GO:0051301;GO:0098609;GO:0051058;GO:0032911;GO:1900182;GO:0050714;GO:0043161;GO:0065003;GO:2000249;GO:0048259;GO:0007165;GO:0006930;GO:0016050;, C:actin cytoskeleton; C:axon; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:extracellular exosome; C:fibrillar center; C:filamentous actin; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle;, F:beta-catenin binding; F:cadherin binding; F:identical protein binding; F:protein C-terminus binding; F:protein-containing complex binding; F:SH3 domain binding; F:structural constituent of cytoskeleton; F:vascular endothelial growth factor receptor binding;, P:actin filament organization; P:cell cycle; P:cell division; P:cell-cell adhesion; P:negative regulation of small GTPase mediated signal transduction; P:negative regulation of transforming growth factor beta1 production; P:positive regulation of protein localization to nucleus; P:positive regulation of protein secretion; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of receptor-mediated endocytosis; P:signal transduction; P:substrate-dependent cell migration, cell extension; P:vesicle organization;|Q9Y5K6 A6NL34 Q5VYA3 Q9UG97,CD2-associated protein,Adapter protein CMS;Cas ligand with multiple SH3 domains;, PF00018;PF14604;, GO:0015629;GO:0030424;GO:0005911;GO:0034451;GO:0005737;GO:0005829;GO:0030425;GO:0030139;GO:0070062;GO:0001650;GO:0031941;GO:0048471;GO:0005886;GO:0001726;GO:0008013;GO:0045296;GO:0042802;GO:0008022;GO:0044877;GO:0017124;GO:0005200;GO:0005172;GO:0007015;GO:0007049;GO:0051301;GO:0098609;GO:0051058;GO:0032911;GO:1900182;GO:0050714;GO:0043161;GO:0065003;GO:2000249;GO:0048259;GO:0007165;GO:0006930;GO:0016050;, C:actin cytoskeleton; C:axon; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:dendrite; C:endocytic vesicle; C:extracellular exosome; C:fibrillar center; C:filamentous actin; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle;, F:beta-catenin binding; F:cadherin binding; F:identical protein binding; F:protein C-terminus binding; F:protein-containing complex binding; F:SH3 domain binding; F:structural constituent of cytoskeleton; F:vascular endothelial growth factor receptor binding;, P:actin filament organization; P:cell cycle; P:cell division; P:cell-cell adhesion; P:negative regulation of small GTPase mediated signal transduction; P:negative regulation of transforming growth factor beta1 production; P:positive regulation of protein localization to nucleus; P:positive regulation of protein secretion; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein-containing complex assembly; P:regulation of actin cytoskeleton reorganization; P:regulation of receptor-mediated endocytosis; P:signal transduction; P:substrate-dependent cell migration, cell extension; P:vesicle organization; scaffold40 indexed_genome mRNA 13211376 13227839 . - . ID=transcript_8276;Q6ZW05 A0A0A7EN49 B0QZ29 B2RPC0 B4DRK3 B4DTR9 Q5T884,Patched domain-containing protein 4,p53-regulated patched protein;, PF02460;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane; scaffold40 indexed_genome mRNA 13973220 14032694 . - . ID=transcript_8277;P22033 A8K953 Q5SYZ3 Q96B11 Q9UD64,Methylmalonyl-CoA mutase, mitochondrial {ECO:0000305},Methylmalonyl-CoA isomerase;, PF02310;PF01642;, GO:0005737;GO:0005759;GO:0005739;GO:0031419;GO:0003924;GO:0042802;GO:0046872;GO:0004494;GO:0072341;GO:0042803;GO:0009235;GO:0050667;GO:0043547;GO:0009791;GO:0019626;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:cobalamin binding; F:GTPase activity; F:identical protein binding; F:metal ion binding; F:methylmalonyl-CoA mutase activity; F:modified amino acid binding; F:protein homodimerization activity;, P:cobalamin metabolic process; P:homocysteine metabolic process; P:positive regulation of GTPase activity; P:post-embryonic development; P:short-chain fatty acid catabolic process;|P22033 A8K953 Q5SYZ3 Q96B11 Q9UD64,Methylmalonyl-CoA mutase, mitochondrial {ECO:0000305},Methylmalonyl-CoA isomerase;, PF02310;PF01642;, GO:0005737;GO:0005759;GO:0005739;GO:0031419;GO:0003924;GO:0042802;GO:0046872;GO:0004494;GO:0072341;GO:0042803;GO:0009235;GO:0050667;GO:0043547;GO:0009791;GO:0019626;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:cobalamin binding; F:GTPase activity; F:identical protein binding; F:metal ion binding; F:methylmalonyl-CoA mutase activity; F:modified amino acid binding; F:protein homodimerization activity;, P:cobalamin metabolic process; P:homocysteine metabolic process; P:positive regulation of GTPase activity; P:post-embryonic development; P:short-chain fatty acid catabolic process;|P22033 A8K953 Q5SYZ3 Q96B11 Q9UD64,Methylmalonyl-CoA mutase, mitochondrial {ECO:0000305},Methylmalonyl-CoA isomerase;, PF02310;PF01642;, GO:0005737;GO:0005759;GO:0005739;GO:0031419;GO:0003924;GO:0042802;GO:0046872;GO:0004494;GO:0072341;GO:0042803;GO:0009235;GO:0050667;GO:0043547;GO:0009791;GO:0019626;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:cobalamin binding; F:GTPase activity; F:identical protein binding; F:metal ion binding; F:methylmalonyl-CoA mutase activity; F:modified amino acid binding; F:protein homodimerization activity;, P:cobalamin metabolic process; P:homocysteine metabolic process; P:positive regulation of GTPase activity; P:post-embryonic development; P:short-chain fatty acid catabolic process;|P22033 A8K953 Q5SYZ3 Q96B11 Q9UD64,Methylmalonyl-CoA mutase, mitochondrial {ECO:0000305},Methylmalonyl-CoA isomerase;, PF02310;PF01642;, GO:0005737;GO:0005759;GO:0005739;GO:0031419;GO:0003924;GO:0042802;GO:0046872;GO:0004494;GO:0072341;GO:0042803;GO:0009235;GO:0050667;GO:0043547;GO:0009791;GO:0019626;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:cobalamin binding; F:GTPase activity; F:identical protein binding; F:metal ion binding; F:methylmalonyl-CoA mutase activity; F:modified amino acid binding; F:protein homodimerization activity;, P:cobalamin metabolic process; P:homocysteine metabolic process; P:positive regulation of GTPase activity; P:post-embryonic development; P:short-chain fatty acid catabolic process;|P22033 A8K953 Q5SYZ3 Q96B11 Q9UD64,Methylmalonyl-CoA mutase, mitochondrial {ECO:0000305},Methylmalonyl-CoA isomerase;, PF02310;PF01642;, GO:0005737;GO:0005759;GO:0005739;GO:0031419;GO:0003924;GO:0042802;GO:0046872;GO:0004494;GO:0072341;GO:0042803;GO:0009235;GO:0050667;GO:0043547;GO:0009791;GO:0019626;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:cobalamin binding; F:GTPase activity; F:identical protein binding; F:metal ion binding; F:methylmalonyl-CoA mutase activity; F:modified amino acid binding; F:protein homodimerization activity;, P:cobalamin metabolic process; P:homocysteine metabolic process; P:positive regulation of GTPase activity; P:post-embryonic development; P:short-chain fatty acid catabolic process; scaffold40 indexed_genome mRNA 14036242 14050564 . + . ID=transcript_8278;Q7L2Z9 A8KAF1 Q6IN61 Q9NVS5,Centromere protein Q,, PF13094;, GO:0015629;GO:0005829;GO:0000776;GO:0005654;GO:0005634;GO:0034080;GO:0051310;GO:0007052;GO:1905342;, C:actin cytoskeleton; C:cytosol; C:kinetochore; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:metaphase plate congression; P:mitotic spindle organization; P:positive regulation of protein localization to kinetochore;|Q7L2Z9 A8KAF1 Q6IN61 Q9NVS5,Centromere protein Q,, PF13094;, GO:0015629;GO:0005829;GO:0000776;GO:0005654;GO:0005634;GO:0034080;GO:0051310;GO:0007052;GO:1905342;, C:actin cytoskeleton; C:cytosol; C:kinetochore; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:metaphase plate congression; P:mitotic spindle organization; P:positive regulation of protein localization to kinetochore;|Q7L2Z9 A8KAF1 Q6IN61 Q9NVS5,Centromere protein Q,, PF13094;, GO:0015629;GO:0005829;GO:0000776;GO:0005654;GO:0005634;GO:0034080;GO:0051310;GO:0007052;GO:1905342;, C:actin cytoskeleton; C:cytosol; C:kinetochore; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:metaphase plate congression; P:mitotic spindle organization; P:positive regulation of protein localization to kinetochore;|Q7L2Z9 A8KAF1 Q6IN61 Q9NVS5,Centromere protein Q,, PF13094;, GO:0015629;GO:0005829;GO:0000776;GO:0005654;GO:0005634;GO:0034080;GO:0051310;GO:0007052;GO:1905342;, C:actin cytoskeleton; C:cytosol; C:kinetochore; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:metaphase plate congression; P:mitotic spindle organization; P:positive regulation of protein localization to kinetochore; scaffold40 indexed_genome mRNA 15066311 15090726 . + . ID=transcript_8279;Q92481 Q5JYX6 Q9NQ63 Q9NU99 Q9UJI7 Q9Y214 Q9Y3K3,Transcription factor AP-2-beta,Activating enhancer-binding protein 2-beta;, PF03299;, GO:0000785;GO:0005654;GO:0005634;GO:0003682;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0048856;GO:0035909;GO:0055074;GO:0097275;GO:0097276;GO:0097277;GO:0072044;GO:0072017;GO:0097070;GO:0045444;GO:0035136;GO:0042593;GO:0006006;GO:0035137;GO:0001822;GO:0010960;GO:0072210;GO:0043066;GO:0008285;GO:0043524;GO:0000122;GO:0045892;GO:0055062;GO:0008284;GO:0043525;GO:0045944;GO:0045893;GO:0035810;GO:0055075;GO:0030510;GO:0045595;GO:0042127;GO:0050796;GO:0006357;GO:0003091;GO:0042493;GO:0010842;GO:0043588;GO:0055078;GO:0048485;, C:chromatin; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure development; P:aorta morphogenesis; P:calcium ion homeostasis; P:cellular ammonium homeostasis; P:cellular creatinine homeostasis; P:cellular urea homeostasis; P:collecting duct development; P:distal tubule development; P:ductus arteriosus closure; P:fat cell differentiation; P:forelimb morphogenesis; P:glucose homeostasis; P:glucose metabolic process; P:hindlimb morphogenesis; P:kidney development; P:magnesium ion homeostasis; P:metanephric nephron development; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:phosphate ion homeostasis; P:positive regulation of cell population proliferation; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of urine volume; P:potassium ion homeostasis; P:regulation of BMP signaling pathway; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of insulin secretion; P:regulation of transcription by RNA polymerase II; P:renal water homeostasis; P:response to drug; P:retina layer formation; P:skin development; P:sodium ion homeostasis; P:sympathetic nervous system development; scaffold40 indexed_genome mRNA 16057337 16071537 . - . ID=transcript_8280;P08F94 Q5VUA2 Q5VUA3 Q5VWV1 Q86Z26 Q8TCZ9,Fibrocystin {ECO:0000305},Polycystic kidney and hepatic disease 1 protein;Polyductin;Tigmin;, PF13229;PF10162;PF01833;, GO:0097731;GO:0031362;GO:0016324;GO:0005813;GO:0000775;GO:0036064;GO:0005929;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0072686;GO:0005634;GO:0048471;GO:0038023;GO:0048754;GO:0098609;GO:0045216;GO:0006874;GO:0060271;GO:0003382;GO:0051660;GO:0000132;GO:0042592;GO:0001822;GO:0043066;GO:0051271;GO:1904036;GO:0032088;GO:0051898;GO:0008284;GO:0050679;GO:0030155;GO:0022407;GO:0001952;GO:0010824;GO:1904054;GO:0070372;GO:0090175;GO:0032006;, C:9+0 non-motile cilium; C:anchored component of external side of plasma membrane; C:apical plasma membrane; C:centrosome; C:chromosome, centromeric region; C:ciliary basal body; C:cilium; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:signaling receptor activity;, P:branching morphogenesis of an epithelial tube; P:cell-cell adhesion; P:cell-cell junction organization; P:cellular calcium ion homeostasis; P:cilium assembly; P:epithelial cell morphogenesis; P:establishment of centrosome localization; P:establishment of mitotic spindle orientation; P:homeostatic process; P:kidney development; P:negative regulation of apoptotic process; P:negative regulation of cellular component movement; P:negative regulation of epithelial cell apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase B signaling; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:regulation of cell adhesion; P:regulation of cell-cell adhesion; P:regulation of cell-matrix adhesion; P:regulation of centrosome duplication; P:regulation of cholangiocyte proliferation; P:regulation of ERK1 and ERK2 cascade; P:regulation of establishment of planar polarity; P:regulation of TOR signaling; scaffold40 indexed_genome mRNA 16073857 16085648 . - . ID=transcript_8281;P08F94 Q5VUA2 Q5VUA3 Q5VWV1 Q86Z26 Q8TCZ9,Fibrocystin {ECO:0000305},Polycystic kidney and hepatic disease 1 protein;Polyductin;Tigmin;, PF13229;PF10162;PF01833;, GO:0097731;GO:0031362;GO:0016324;GO:0005813;GO:0000775;GO:0036064;GO:0005929;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0072686;GO:0005634;GO:0048471;GO:0038023;GO:0048754;GO:0098609;GO:0045216;GO:0006874;GO:0060271;GO:0003382;GO:0051660;GO:0000132;GO:0042592;GO:0001822;GO:0043066;GO:0051271;GO:1904036;GO:0032088;GO:0051898;GO:0008284;GO:0050679;GO:0030155;GO:0022407;GO:0001952;GO:0010824;GO:1904054;GO:0070372;GO:0090175;GO:0032006;, C:9+0 non-motile cilium; C:anchored component of external side of plasma membrane; C:apical plasma membrane; C:centrosome; C:chromosome, centromeric region; C:ciliary basal body; C:cilium; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:signaling receptor activity;, P:branching morphogenesis of an epithelial tube; P:cell-cell adhesion; P:cell-cell junction organization; P:cellular calcium ion homeostasis; P:cilium assembly; P:epithelial cell morphogenesis; P:establishment of centrosome localization; P:establishment of mitotic spindle orientation; P:homeostatic process; P:kidney development; P:negative regulation of apoptotic process; P:negative regulation of cellular component movement; P:negative regulation of epithelial cell apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase B signaling; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:regulation of cell adhesion; P:regulation of cell-cell adhesion; P:regulation of cell-matrix adhesion; P:regulation of centrosome duplication; P:regulation of cholangiocyte proliferation; P:regulation of ERK1 and ERK2 cascade; P:regulation of establishment of planar polarity; P:regulation of TOR signaling; scaffold40 indexed_genome mRNA 16088710 16096194 . - . ID=transcript_8282;P08F94 Q5VUA2 Q5VUA3 Q5VWV1 Q86Z26 Q8TCZ9,Fibrocystin {ECO:0000305},Polycystic kidney and hepatic disease 1 protein;Polyductin;Tigmin;, PF13229;PF10162;PF01833;, GO:0097731;GO:0031362;GO:0016324;GO:0005813;GO:0000775;GO:0036064;GO:0005929;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0072686;GO:0005634;GO:0048471;GO:0038023;GO:0048754;GO:0098609;GO:0045216;GO:0006874;GO:0060271;GO:0003382;GO:0051660;GO:0000132;GO:0042592;GO:0001822;GO:0043066;GO:0051271;GO:1904036;GO:0032088;GO:0051898;GO:0008284;GO:0050679;GO:0030155;GO:0022407;GO:0001952;GO:0010824;GO:1904054;GO:0070372;GO:0090175;GO:0032006;, C:9+0 non-motile cilium; C:anchored component of external side of plasma membrane; C:apical plasma membrane; C:centrosome; C:chromosome, centromeric region; C:ciliary basal body; C:cilium; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:signaling receptor activity;, P:branching morphogenesis of an epithelial tube; P:cell-cell adhesion; P:cell-cell junction organization; P:cellular calcium ion homeostasis; P:cilium assembly; P:epithelial cell morphogenesis; P:establishment of centrosome localization; P:establishment of mitotic spindle orientation; P:homeostatic process; P:kidney development; P:negative regulation of apoptotic process; P:negative regulation of cellular component movement; P:negative regulation of epithelial cell apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase B signaling; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:regulation of cell adhesion; P:regulation of cell-cell adhesion; P:regulation of cell-matrix adhesion; P:regulation of centrosome duplication; P:regulation of cholangiocyte proliferation; P:regulation of ERK1 and ERK2 cascade; P:regulation of establishment of planar polarity; P:regulation of TOR signaling; scaffold40 indexed_genome mRNA 16302536 16318977 . - . ID=transcript_8283;P25205 B4DWW4 Q92660 Q9BTR3 Q9NUE7,DNA replication licensing factor MCM3,DNA polymerase alpha holoenzyme-associated protein P1;P1-MCM3;RLF subunit beta;p102;, PF00493;PF17855;PF14551;PF17207;, GO:0005658;GO:0005813;GO:0000781;GO:0071162;GO:0042555;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005524;GO:0003677;GO:0003678;GO:0003688;GO:0003697;GO:0006260;GO:0006270;GO:0006271;GO:0000727;GO:1902975;GO:0036388;GO:0006267;, C:alpha DNA polymerase:primase complex; C:centrosome; C:chromosome, telomeric region; C:CMG complex; C:MCM complex; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:single-stranded DNA binding;, P:DNA replication; P:DNA replication initiation; P:DNA strand elongation involved in DNA replication; P:double-strand break repair via break-induced replication; P:mitotic DNA replication initiation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication;|P25205 B4DWW4 Q92660 Q9BTR3 Q9NUE7,DNA replication licensing factor MCM3,DNA polymerase alpha holoenzyme-associated protein P1;P1-MCM3;RLF subunit beta;p102;, PF00493;PF17855;PF14551;PF17207;, GO:0005658;GO:0005813;GO:0000781;GO:0071162;GO:0042555;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005524;GO:0003677;GO:0003678;GO:0003688;GO:0003697;GO:0006260;GO:0006270;GO:0006271;GO:0000727;GO:1902975;GO:0036388;GO:0006267;, C:alpha DNA polymerase:primase complex; C:centrosome; C:chromosome, telomeric region; C:CMG complex; C:MCM complex; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:single-stranded DNA binding;, P:DNA replication; P:DNA replication initiation; P:DNA strand elongation involved in DNA replication; P:double-strand break repair via break-induced replication; P:mitotic DNA replication initiation; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; scaffold40 indexed_genome mRNA 16396247 16436799 . + . ID=transcript_8284;Q8TEZ7 B2RCF6 Q86WL0 Q8N6D3 Q9HD02,Membrane progestin receptor beta {ECO:0000303|PubMed:23763432},Lysosomal membrane protein in brain 1 {ECO:0000303|PubMed:11676489};Membrane progesterone P4 receptor beta {ECO:0000303|PubMed:23763432};Membrane progesterone receptor beta {ECO:0000303|PubMed:23763432};Progesterone and adipoQ receptor family member 8;Progestin and adipoQ receptor family member 8 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member VIII;, PF03006;, GO:0005794;GO:0016021;GO:0005886;GO:0038023;GO:0005496;GO:0003707;GO:0007275;GO:0048477;GO:0048545;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:signaling receptor activity; F:steroid binding; F:steroid hormone receptor activity;, P:multicellular organism development; P:oogenesis; P:response to steroid hormone; scaffold40 indexed_genome mRNA 16448115 16487880 . + . ID=transcript_8285;Q5JVL4 B4DMU3 F5GZD8 Q5XKM4 Q6E1U7 Q6E1U8 Q8WUL2 Q9NVW6,EF-hand domain-containing protein 1,Myoclonin-1;, PF06565;, GO:0005930;GO:0005813;GO:0072686;GO:0043025;GO:0000922;GO:0043014;GO:0005509;GO:0008022;GO:0021795;GO:0060285;GO:0000281;GO:0007052;GO:0051302;, C:axoneme; C:centrosome; C:mitotic spindle; C:neuronal cell body; C:spindle pole;, F:alpha-tubulin binding; F:calcium ion binding; F:protein C-terminus binding;, P:cerebral cortex cell migration; P:cilium-dependent cell motility; P:mitotic cytokinesis; P:mitotic spindle organization; P:regulation of cell division;|Q5JVL4 B4DMU3 F5GZD8 Q5XKM4 Q6E1U7 Q6E1U8 Q8WUL2 Q9NVW6,EF-hand domain-containing protein 1,Myoclonin-1;, PF06565;, GO:0005930;GO:0005813;GO:0072686;GO:0043025;GO:0000922;GO:0043014;GO:0005509;GO:0008022;GO:0021795;GO:0060285;GO:0000281;GO:0007052;GO:0051302;, C:axoneme; C:centrosome; C:mitotic spindle; C:neuronal cell body; C:spindle pole;, F:alpha-tubulin binding; F:calcium ion binding; F:protein C-terminus binding;, P:cerebral cortex cell migration; P:cilium-dependent cell motility; P:mitotic cytokinesis; P:mitotic spindle organization; P:regulation of cell division; scaffold40 indexed_genome mRNA 16490550 16497912 . - . ID=transcript_8286;Q15035 A8K6T6,Translocating chain-associated membrane protein 2,, PF08390;PF03798;, GO:0030176;GO:0032964;GO:0045048;GO:0006616;, C:integral component of endoplasmic reticulum membrane;, , P:collagen biosynthetic process; P:protein insertion into ER membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; scaffold40 indexed_genome mRNA 16663439 16671889 . + . ID=transcript_8287;Q9Y6G1 B2R552,Transmembrane protein 14A,, PF03647;, GO:0005789;GO:0016021;GO:0031966;GO:0006915;GO:0006839;GO:0043066;GO:1901029;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial membrane;, , P:apoptotic process; P:mitochondrial transport; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;|Q9Y6G1 B2R552,Transmembrane protein 14A,, PF03647;, GO:0005789;GO:0016021;GO:0031966;GO:0006915;GO:0006839;GO:0043066;GO:1901029;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial membrane;, , P:apoptotic process; P:mitochondrial transport; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;|Q9Y6G1 B2R552,Transmembrane protein 14A,, PF03647;, GO:0005789;GO:0016021;GO:0031966;GO:0006915;GO:0006839;GO:0043066;GO:1901029;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial membrane;, , P:apoptotic process; P:mitochondrial transport; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;|Q9Y6G1 B2R552,Transmembrane protein 14A,, PF03647;, GO:0005789;GO:0016021;GO:0031966;GO:0006915;GO:0006839;GO:0043066;GO:1901029;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial membrane;, , P:apoptotic process; P:mitochondrial transport; P:negative regulation of apoptotic process; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; scaffold40 indexed_genome mRNA 16679392 16690250 . - . ID=transcript_8288;P08263 Q14750 Q5GHF8 Q5SZC1,Glutathione S-transferase A1 {ECO:0000305|PubMed:20606271, ECO:0000305|PubMed:9084911},13-hydroperoxyoctadecadienoate peroxidase {ECO:0000305|PubMed:16624487};Androst-5-ene-3,17-dione isomerase {ECO:0000305|PubMed:11152686};GST HA subunit 1;GST class-alpha member 1;GST-epsilon;GSTA1-1;GTH1;, PF00043;PF02798;, GO:0005829;GO:0070062;GO:0005504;GO:0004602;GO:0004364;GO:0004769;GO:0030855;GO:1901687;GO:0006749;GO:0042167;GO:0043651;GO:0006693;GO:0006805;, C:cytosol; C:extracellular exosome;, F:fatty acid binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:steroid delta-isomerase activity;, P:epithelial cell differentiation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:heme catabolic process; P:linoleic acid metabolic process; P:prostaglandin metabolic process; P:xenobiotic metabolic process;|Q7RTV2 Q5SZC2,Glutathione S-transferase A5,GST class-alpha member 5;Glutathione S-transferase A5-5;, PF14497;PF02798;, GO:0005829;GO:0070062;GO:0004364;GO:0006749;GO:0006805;, C:cytosol; C:extracellular exosome;, F:glutathione transferase activity;, P:glutathione metabolic process; P:xenobiotic metabolic process;|P09210 Q12759 Q16491 Q9NTY6,Glutathione S-transferase A2,GST HA subunit 2;GST class-alpha member 2;GST-gamma;GSTA2-2;GTH2;, PF14497;PF02798;, GO:0005829;GO:0070062;GO:0004364;GO:0030855;GO:1901687;GO:0006749;GO:0035722;GO:0006805;, C:cytosol; C:extracellular exosome;, F:glutathione transferase activity;, P:epithelial cell differentiation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:interleukin-12-mediated signaling pathway; P:xenobiotic metabolic process;|P08263 Q14750 Q5GHF8 Q5SZC1,Glutathione S-transferase A1 {ECO:0000305|PubMed:20606271, ECO:0000305|PubMed:9084911},13-hydroperoxyoctadecadienoate peroxidase {ECO:0000305|PubMed:16624487};Androst-5-ene-3,17-dione isomerase {ECO:0000305|PubMed:11152686};GST HA subunit 1;GST class-alpha member 1;GST-epsilon;GSTA1-1;GTH1;, PF00043;PF02798;, GO:0005829;GO:0070062;GO:0005504;GO:0004602;GO:0004364;GO:0004769;GO:0030855;GO:1901687;GO:0006749;GO:0042167;GO:0043651;GO:0006693;GO:0006805;, C:cytosol; C:extracellular exosome;, F:fatty acid binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:steroid delta-isomerase activity;, P:epithelial cell differentiation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:heme catabolic process; P:linoleic acid metabolic process; P:prostaglandin metabolic process; P:xenobiotic metabolic process;|Q7RTV2 Q5SZC2,Glutathione S-transferase A5,GST class-alpha member 5;Glutathione S-transferase A5-5;, PF14497;PF02798;, GO:0005829;GO:0070062;GO:0004364;GO:0006749;GO:0006805;, C:cytosol; C:extracellular exosome;, F:glutathione transferase activity;, P:glutathione metabolic process; P:xenobiotic metabolic process; scaffold40 indexed_genome mRNA 16706176 16711708 . - . ID=transcript_8289;P08263 Q14750 Q5GHF8 Q5SZC1,Glutathione S-transferase A1 {ECO:0000305|PubMed:20606271, ECO:0000305|PubMed:9084911},13-hydroperoxyoctadecadienoate peroxidase {ECO:0000305|PubMed:16624487};Androst-5-ene-3,17-dione isomerase {ECO:0000305|PubMed:11152686};GST HA subunit 1;GST class-alpha member 1;GST-epsilon;GSTA1-1;GTH1;, PF00043;PF02798;, GO:0005829;GO:0070062;GO:0005504;GO:0004602;GO:0004364;GO:0004769;GO:0030855;GO:1901687;GO:0006749;GO:0042167;GO:0043651;GO:0006693;GO:0006805;, C:cytosol; C:extracellular exosome;, F:fatty acid binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:steroid delta-isomerase activity;, P:epithelial cell differentiation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:heme catabolic process; P:linoleic acid metabolic process; P:prostaglandin metabolic process; P:xenobiotic metabolic process;|P08263 Q14750 Q5GHF8 Q5SZC1,Glutathione S-transferase A1 {ECO:0000305|PubMed:20606271, ECO:0000305|PubMed:9084911},13-hydroperoxyoctadecadienoate peroxidase {ECO:0000305|PubMed:16624487};Androst-5-ene-3,17-dione isomerase {ECO:0000305|PubMed:11152686};GST HA subunit 1;GST class-alpha member 1;GST-epsilon;GSTA1-1;GTH1;, PF00043;PF02798;, GO:0005829;GO:0070062;GO:0005504;GO:0004602;GO:0004364;GO:0004769;GO:0030855;GO:1901687;GO:0006749;GO:0042167;GO:0043651;GO:0006693;GO:0006805;, C:cytosol; C:extracellular exosome;, F:fatty acid binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:steroid delta-isomerase activity;, P:epithelial cell differentiation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:heme catabolic process; P:linoleic acid metabolic process; P:prostaglandin metabolic process; P:xenobiotic metabolic process; scaffold40 indexed_genome mRNA 16786547 16800590 . - . ID=transcript_8290;O15217 B2RD15 Q5T7Q8 Q6P4G1 Q9BX18 Q9H414,Glutathione S-transferase A4,GST class-alpha member 4;Glutathione S-transferase A4-4;, PF14497;PF02798;, GO:0005829;GO:0004364;GO:0042802;GO:0042803;GO:1901687;GO:0006749;GO:0006805;, C:cytosol;, F:glutathione transferase activity; F:identical protein binding; F:protein homodimerization activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:xenobiotic metabolic process;|O15217 B2RD15 Q5T7Q8 Q6P4G1 Q9BX18 Q9H414,Glutathione S-transferase A4,GST class-alpha member 4;Glutathione S-transferase A4-4;, PF14497;PF02798;, GO:0005829;GO:0004364;GO:0042802;GO:0042803;GO:1901687;GO:0006749;GO:0006805;, C:cytosol;, F:glutathione transferase activity; F:identical protein binding; F:protein homodimerization activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:xenobiotic metabolic process;|O15217 B2RD15 Q5T7Q8 Q6P4G1 Q9BX18 Q9H414,Glutathione S-transferase A4,GST class-alpha member 4;Glutathione S-transferase A4-4;, PF14497;PF02798;, GO:0005829;GO:0004364;GO:0042802;GO:0042803;GO:1901687;GO:0006749;GO:0006805;, C:cytosol;, F:glutathione transferase activity; F:identical protein binding; F:protein homodimerization activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:xenobiotic metabolic process;|O15217 B2RD15 Q5T7Q8 Q6P4G1 Q9BX18 Q9H414,Glutathione S-transferase A4,GST class-alpha member 4;Glutathione S-transferase A4-4;, PF14497;PF02798;, GO:0005829;GO:0004364;GO:0042802;GO:0042803;GO:1901687;GO:0006749;GO:0006805;, C:cytosol;, F:glutathione transferase activity; F:identical protein binding; F:protein homodimerization activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:xenobiotic metabolic process; scaffold40 indexed_genome mRNA 16820932 16828360 . - . ID=transcript_8291;Q9UPZ9 A7MD41 O75985 Q5THL2 Q8IYH8 Q9BX17 Q9NYX3,Serine/threonine-protein kinase ICK,Ciliogenesis associated kinase 1 {ECO:0000305};Intestinal cell kinase;Laryngeal cancer kinase 2;MAK-related kinase;, PF00069;, GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0005737;GO:0005829;GO:0001650;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0060271;GO:0035556;GO:0035720;GO:0035721;GO:0042073;GO:0007275;GO:0006468;GO:0010468;GO:0007165;, C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cilium assembly; P:intracellular signal transduction; P:intraciliary anterograde transport; P:intraciliary retrograde transport; P:intraciliary transport; P:multicellular organism development; P:protein phosphorylation; P:regulation of gene expression; P:signal transduction;|Q9UPZ9 A7MD41 O75985 Q5THL2 Q8IYH8 Q9BX17 Q9NYX3,Serine/threonine-protein kinase ICK,Ciliogenesis associated kinase 1 {ECO:0000305};Intestinal cell kinase;Laryngeal cancer kinase 2;MAK-related kinase;, PF00069;, GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0005737;GO:0005829;GO:0001650;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0060271;GO:0035556;GO:0035720;GO:0035721;GO:0042073;GO:0007275;GO:0006468;GO:0010468;GO:0007165;, C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cilium assembly; P:intracellular signal transduction; P:intraciliary anterograde transport; P:intraciliary retrograde transport; P:intraciliary transport; P:multicellular organism development; P:protein phosphorylation; P:regulation of gene expression; P:signal transduction;|Q9UPZ9 A7MD41 O75985 Q5THL2 Q8IYH8 Q9BX17 Q9NYX3,Serine/threonine-protein kinase ICK,Ciliogenesis associated kinase 1 {ECO:0000305};Intestinal cell kinase;Laryngeal cancer kinase 2;MAK-related kinase;, PF00069;, GO:0036064;GO:0097546;GO:0097542;GO:0005929;GO:0005737;GO:0005829;GO:0001650;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0060271;GO:0035556;GO:0035720;GO:0035721;GO:0042073;GO:0007275;GO:0006468;GO:0010468;GO:0007165;, C:ciliary basal body; C:ciliary base; C:ciliary tip; C:cilium; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cilium assembly; P:intracellular signal transduction; P:intraciliary anterograde transport; P:intraciliary retrograde transport; P:intraciliary transport; P:multicellular organism development; P:protein phosphorylation; P:regulation of gene expression; P:signal transduction; scaffold40 indexed_genome mRNA 16867338 16888440 . + . ID=transcript_8292;Q9UK97 A6NFW3 B3KMM6 O75986 Q59EH8 Q6PKH7 Q9NT57 Q9Y593,F-box only protein 9,Cross-immune reaction antigen 1;Renal carcinoma antigen NY-REN-57;, PF12937;, GO:0005737;GO:0005829;GO:0019005;GO:0000151;GO:0004842;GO:0045444;GO:0045087;GO:0043687;GO:0000209;GO:0016567;GO:0032006;GO:0031146;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:fat cell differentiation; P:innate immune response; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of TOR signaling; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9UK97 A6NFW3 B3KMM6 O75986 Q59EH8 Q6PKH7 Q9NT57 Q9Y593,F-box only protein 9,Cross-immune reaction antigen 1;Renal carcinoma antigen NY-REN-57;, PF12937;, GO:0005737;GO:0005829;GO:0019005;GO:0000151;GO:0004842;GO:0045444;GO:0045087;GO:0043687;GO:0000209;GO:0016567;GO:0032006;GO:0031146;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:fat cell differentiation; P:innate immune response; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of TOR signaling; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9UK97 A6NFW3 B3KMM6 O75986 Q59EH8 Q6PKH7 Q9NT57 Q9Y593,F-box only protein 9,Cross-immune reaction antigen 1;Renal carcinoma antigen NY-REN-57;, PF12937;, GO:0005737;GO:0005829;GO:0019005;GO:0000151;GO:0004842;GO:0045444;GO:0045087;GO:0043687;GO:0000209;GO:0016567;GO:0032006;GO:0031146;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:fat cell differentiation; P:innate immune response; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of TOR signaling; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9UK97 A6NFW3 B3KMM6 O75986 Q59EH8 Q6PKH7 Q9NT57 Q9Y593,F-box only protein 9,Cross-immune reaction antigen 1;Renal carcinoma antigen NY-REN-57;, PF12937;, GO:0005737;GO:0005829;GO:0019005;GO:0000151;GO:0004842;GO:0045444;GO:0045087;GO:0043687;GO:0000209;GO:0016567;GO:0032006;GO:0031146;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:fat cell differentiation; P:innate immune response; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of TOR signaling; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9UK97 A6NFW3 B3KMM6 O75986 Q59EH8 Q6PKH7 Q9NT57 Q9Y593,F-box only protein 9,Cross-immune reaction antigen 1;Renal carcinoma antigen NY-REN-57;, PF12937;, GO:0005737;GO:0005829;GO:0019005;GO:0000151;GO:0004842;GO:0045444;GO:0045087;GO:0043687;GO:0000209;GO:0016567;GO:0032006;GO:0031146;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:fat cell differentiation; P:innate immune response; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of TOR signaling; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9UK97 A6NFW3 B3KMM6 O75986 Q59EH8 Q6PKH7 Q9NT57 Q9Y593,F-box only protein 9,Cross-immune reaction antigen 1;Renal carcinoma antigen NY-REN-57;, PF12937;, GO:0005737;GO:0005829;GO:0019005;GO:0000151;GO:0004842;GO:0045444;GO:0045087;GO:0043687;GO:0000209;GO:0016567;GO:0032006;GO:0031146;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:fat cell differentiation; P:innate immune response; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of TOR signaling; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9UK97 A6NFW3 B3KMM6 O75986 Q59EH8 Q6PKH7 Q9NT57 Q9Y593,F-box only protein 9,Cross-immune reaction antigen 1;Renal carcinoma antigen NY-REN-57;, PF12937;, GO:0005737;GO:0005829;GO:0019005;GO:0000151;GO:0004842;GO:0045444;GO:0045087;GO:0043687;GO:0000209;GO:0016567;GO:0032006;GO:0031146;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:fat cell differentiation; P:innate immune response; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of TOR signaling; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold40 indexed_genome mRNA 16988102 17052960 . - . ID=transcript_8293;Q9NYP7 B4DZJ2 F6SH78 Q59EL3 Q5TGH5 Q6NXE7 Q7L2S5 Q8NCG4 Q9UI22,Elongation of very long chain fatty acids protein 5 {ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000305},3-keto acyl-CoA synthase ELOVL5 {ECO:0000255|HAMAP-Rule:MF_03205};ELOVL fatty acid elongase 5 {ECO:0000255|HAMAP-Rule:MF_03205};Fatty acid elongase 1;Very long chain 3-ketoacyl-CoA synthase 5 {ECO:0000255|HAMAP-Rule:MF_03205};Very long chain 3-oxoacyl-CoA synthase 5 {ECO:0000255|HAMAP-Rule:MF_03205};, PF01151;, GO:0030425;GO:0097447;GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0043025;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0036109;GO:0034625;GO:0034626;GO:0019367;GO:0043651;GO:0035338;GO:0045723;GO:0030148;GO:0006636;GO:0042761;, C:dendrite; C:dendritic tree; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:neuronal cell body;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:alpha-linolenic acid metabolic process; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:linoleic acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of fatty acid biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9NYP7 B4DZJ2 F6SH78 Q59EL3 Q5TGH5 Q6NXE7 Q7L2S5 Q8NCG4 Q9UI22,Elongation of very long chain fatty acids protein 5 {ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000305},3-keto acyl-CoA synthase ELOVL5 {ECO:0000255|HAMAP-Rule:MF_03205};ELOVL fatty acid elongase 5 {ECO:0000255|HAMAP-Rule:MF_03205};Fatty acid elongase 1;Very long chain 3-ketoacyl-CoA synthase 5 {ECO:0000255|HAMAP-Rule:MF_03205};Very long chain 3-oxoacyl-CoA synthase 5 {ECO:0000255|HAMAP-Rule:MF_03205};, PF01151;, GO:0030425;GO:0097447;GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0043025;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0036109;GO:0034625;GO:0034626;GO:0019367;GO:0043651;GO:0035338;GO:0045723;GO:0030148;GO:0006636;GO:0042761;, C:dendrite; C:dendritic tree; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:neuronal cell body;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:alpha-linolenic acid metabolic process; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:linoleic acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of fatty acid biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9NYP7 B4DZJ2 F6SH78 Q59EL3 Q5TGH5 Q6NXE7 Q7L2S5 Q8NCG4 Q9UI22,Elongation of very long chain fatty acids protein 5 {ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000305},3-keto acyl-CoA synthase ELOVL5 {ECO:0000255|HAMAP-Rule:MF_03205};ELOVL fatty acid elongase 5 {ECO:0000255|HAMAP-Rule:MF_03205};Fatty acid elongase 1;Very long chain 3-ketoacyl-CoA synthase 5 {ECO:0000255|HAMAP-Rule:MF_03205};Very long chain 3-oxoacyl-CoA synthase 5 {ECO:0000255|HAMAP-Rule:MF_03205};, PF01151;, GO:0030425;GO:0097447;GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0043025;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0036109;GO:0034625;GO:0034626;GO:0019367;GO:0043651;GO:0035338;GO:0045723;GO:0030148;GO:0006636;GO:0042761;, C:dendrite; C:dendritic tree; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:neuronal cell body;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:alpha-linolenic acid metabolic process; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:linoleic acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of fatty acid biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold40 indexed_genome mRNA 17284034 17288802 . - . ID=transcript_8294;Q8WLT9 Q9BS54,HLA class II histocompatibility antigen, DR beta 4 chain,MHC class II antigen DRB4;, PF07654;PF00969;, GO:0030669;GO:0030666;GO:0012507;GO:0000139;GO:0071556;GO:0031902;GO:0005765;GO:0042613;GO:0005886;GO:0032588;GO:0030658;GO:0002250;GO:0019886;GO:0060333;GO:0050852;, C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:late endosome membrane; C:lysosomal membrane; C:MHC class II protein complex; C:plasma membrane; C:trans-Golgi network membrane; C:transport vesicle membrane;, , P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:interferon-gamma-mediated signaling pathway; P:T cell receptor signaling pathway;|Q9UIN5,HLA class II histocompatibility antigen, DR beta 3 chain,MHC class II antigen DRB3;, PF07654;PF00969;, GO:0030669;GO:0030666;GO:0012507;GO:0000139;GO:0071556;GO:0005887;GO:0031902;GO:0005765;GO:0016020;GO:0042613;GO:0005886;GO:0032588;GO:0030658;GO:0032395;GO:0042605;GO:0002250;GO:0019886;GO:0060333;GO:0002469;GO:2000516;GO:0002842;GO:0007165;GO:0050852;, C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:MHC class II protein complex; C:plasma membrane; C:trans-Golgi network membrane; C:transport vesicle membrane;, F:MHC class II receptor activity; F:peptide antigen binding;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:interferon-gamma-mediated signaling pathway; P:myeloid dendritic cell antigen processing and presentation; P:positive regulation of CD4-positive, alpha-beta T cell activation; P:positive regulation of T cell mediated immune response to tumor cell; P:signal transduction; P:T cell receptor signaling pathway;|Q30126 Q30150 Q30199 Q6SJR2 Q7M2H9 Q8HWS7 Q8WLR5 Q9MY54 Q9XRX6,HLA class II histocompatibility antigen, DR beta 5 chain,DR beta-5;DR2-beta-2;Dw2;MHC class II antigen DRB5;, PF07654;PF00969;, GO:0030669;GO:0030666;GO:0012507;GO:0070062;GO:0000139;GO:0071556;GO:0031902;GO:0005765;GO:0042613;GO:0005886;GO:0032588;GO:0030658;GO:0042605;GO:0002250;GO:0019886;GO:0060333;GO:0050852;, C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:late endosome membrane; C:lysosomal membrane; C:MHC class II protein complex; C:plasma membrane; C:trans-Golgi network membrane; C:transport vesicle membrane;, F:peptide antigen binding;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:interferon-gamma-mediated signaling pathway; P:T cell receptor signaling pathway; scaffold40 indexed_genome mRNA 17384833 17389609 . - . ID=transcript_8295;P01903 A2BET4 Q30160 Q6IAZ1 Q861I2 Q9TP70,HLA class II histocompatibility antigen, DR alpha chain,MHC class II antigen DRA;, PF07654;PF00993;, GO:0009986;GO:0030669;GO:0031901;GO:0030666;GO:0012507;GO:0070062;GO:0000139;GO:0001772;GO:0071556;GO:0005887;GO:0031902;GO:0005765;GO:0005764;GO:0042613;GO:0005886;GO:0032588;GO:0030658;GO:0023026;GO:0032395;GO:0042605;GO:0030247;GO:0042608;GO:0002250;GO:0002491;GO:0019886;GO:0002504;GO:0050890;GO:0006955;GO:0060333;GO:0002469;GO:0002503;GO:2000516;GO:0032831;GO:0043382;GO:0001916;GO:0045622;GO:0050852;GO:0016032;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:early endosome membrane; C:endocytic vesicle membrane; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:Golgi membrane; C:immunological synapse; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:MHC class II protein complex; C:plasma membrane; C:trans-Golgi network membrane; C:transport vesicle membrane;, F:MHC class II protein complex binding; F:MHC class II receptor activity; F:peptide antigen binding; F:polysaccharide binding; F:T cell receptor binding;, P:adaptive immune response; P:antigen processing and presentation of endogenous peptide antigen via MHC class II; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; P:cognition; P:immune response; P:interferon-gamma-mediated signaling pathway; P:myeloid dendritic cell antigen processing and presentation; P:peptide antigen assembly with MHC class II protein complex; P:positive regulation of CD4-positive, alpha-beta T cell activation; P:positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; P:positive regulation of memory T cell differentiation; P:positive regulation of T cell mediated cytotoxicity; P:regulation of T-helper cell differentiation; P:T cell receptor signaling pathway; P:viral process; scaffold40 indexed_genome mRNA 18477359 18482562 . - . ID=transcript_8296;O00478 B4DWI7 E9PCP5,Butyrophilin subfamily 3 member A3,, PF13765;PF00622;PF07686;, GO:0009897;GO:0016021;GO:0016020;GO:0005886;GO:0005102;GO:0002250;GO:0001817;GO:0002456;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:signaling receptor binding;, P:adaptive immune response; P:regulation of cytokine production; P:T cell mediated immunity; P:T cell receptor signaling pathway; scaffold40 indexed_genome mRNA 18483930 18540657 . - . ID=transcript_8297;Q9BU81 Q9NR44,Butyrophilin subfamily 3 member A2,, PF07686;, GO:0009897;GO:0016021;GO:0016020;GO:0005886;GO:0005102;GO:0002250;GO:0032729;GO:0001817;GO:0002456;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:signaling receptor binding;, P:adaptive immune response; P:positive regulation of interferon-gamma production; P:regulation of cytokine production; P:T cell mediated immunity; P:T cell receptor signaling pathway;|Q9UIJ0,Neurogenic locus notch homolog protein 4 {ECO:0000305},, PF00023;PF12796;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0009986;GO:0005829;GO:0005789;GO:0005576;GO:0000139;GO:0005887;GO:0005654;GO:0005634;GO:0005886;GO:0005509;GO:0005112;GO:0038023;GO:0001569;GO:0030154;GO:0001709;GO:0001886;GO:0001837;GO:0030097;GO:0030879;GO:0035278;GO:0001763;GO:0060354;GO:0045596;GO:2000048;GO:0045602;GO:0000122;GO:0045747;GO:0007221;GO:0045893;GO:0006367;GO:0001944;GO:0042060;, C:cell surface; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of plasma membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:Notch binding; F:signaling receptor activity;, P:branching involved in blood vessel morphogenesis; P:cell differentiation; P:cell fate determination; P:endothelial cell morphogenesis; P:epithelial to mesenchymal transition; P:hemopoiesis; P:mammary gland development; P:miRNA mediated inhibition of translation; P:morphogenesis of a branching structure; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell differentiation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of endothelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter; P:vasculature development; P:wound healing;|Q9UIJ0,Neurogenic locus notch homolog protein 4 {ECO:0000305},, PF00023;PF12796;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0009986;GO:0005829;GO:0005789;GO:0005576;GO:0000139;GO:0005887;GO:0005654;GO:0005634;GO:0005886;GO:0005509;GO:0005112;GO:0038023;GO:0001569;GO:0030154;GO:0001709;GO:0001886;GO:0001837;GO:0030097;GO:0030879;GO:0035278;GO:0001763;GO:0060354;GO:0045596;GO:2000048;GO:0045602;GO:0000122;GO:0045747;GO:0007221;GO:0045893;GO:0006367;GO:0001944;GO:0042060;, C:cell surface; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of plasma membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:Notch binding; F:signaling receptor activity;, P:branching involved in blood vessel morphogenesis; P:cell differentiation; P:cell fate determination; P:endothelial cell morphogenesis; P:epithelial to mesenchymal transition; P:hemopoiesis; P:mammary gland development; P:miRNA mediated inhibition of translation; P:morphogenesis of a branching structure; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell differentiation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of endothelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter; P:vasculature development; P:wound healing;|Q9UIJ0,Neurogenic locus notch homolog protein 4 {ECO:0000305},, PF00023;PF12796;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0009986;GO:0005829;GO:0005789;GO:0005576;GO:0000139;GO:0005887;GO:0005654;GO:0005634;GO:0005886;GO:0005509;GO:0005112;GO:0038023;GO:0001569;GO:0030154;GO:0001709;GO:0001886;GO:0001837;GO:0030097;GO:0030879;GO:0035278;GO:0001763;GO:0060354;GO:0045596;GO:2000048;GO:0045602;GO:0000122;GO:0045747;GO:0007221;GO:0045893;GO:0006367;GO:0001944;GO:0042060;, C:cell surface; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of plasma membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:Notch binding; F:signaling receptor activity;, P:branching involved in blood vessel morphogenesis; P:cell differentiation; P:cell fate determination; P:endothelial cell morphogenesis; P:epithelial to mesenchymal transition; P:hemopoiesis; P:mammary gland development; P:miRNA mediated inhibition of translation; P:morphogenesis of a branching structure; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell differentiation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of endothelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter; P:vasculature development; P:wound healing;|Q9UIJ0,Neurogenic locus notch homolog protein 4 {ECO:0000305},, PF00023;PF12796;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0009986;GO:0005829;GO:0005789;GO:0005576;GO:0000139;GO:0005887;GO:0005654;GO:0005634;GO:0005886;GO:0005509;GO:0005112;GO:0038023;GO:0001569;GO:0030154;GO:0001709;GO:0001886;GO:0001837;GO:0030097;GO:0030879;GO:0035278;GO:0001763;GO:0060354;GO:0045596;GO:2000048;GO:0045602;GO:0000122;GO:0045747;GO:0007221;GO:0045893;GO:0006367;GO:0001944;GO:0042060;, C:cell surface; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of plasma membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:Notch binding; F:signaling receptor activity;, P:branching involved in blood vessel morphogenesis; P:cell differentiation; P:cell fate determination; P:endothelial cell morphogenesis; P:epithelial to mesenchymal transition; P:hemopoiesis; P:mammary gland development; P:miRNA mediated inhibition of translation; P:morphogenesis of a branching structure; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell differentiation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of endothelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter; P:vasculature development; P:wound healing;|Q9UIJ0,Neurogenic locus notch homolog protein 4 {ECO:0000305},, PF00023;PF12796;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0009986;GO:0005829;GO:0005789;GO:0005576;GO:0000139;GO:0005887;GO:0005654;GO:0005634;GO:0005886;GO:0005509;GO:0005112;GO:0038023;GO:0001569;GO:0030154;GO:0001709;GO:0001886;GO:0001837;GO:0030097;GO:0030879;GO:0035278;GO:0001763;GO:0060354;GO:0045596;GO:2000048;GO:0045602;GO:0000122;GO:0045747;GO:0007221;GO:0045893;GO:0006367;GO:0001944;GO:0042060;, C:cell surface; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of plasma membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:Notch binding; F:signaling receptor activity;, P:branching involved in blood vessel morphogenesis; P:cell differentiation; P:cell fate determination; P:endothelial cell morphogenesis; P:epithelial to mesenchymal transition; P:hemopoiesis; P:mammary gland development; P:miRNA mediated inhibition of translation; P:morphogenesis of a branching structure; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell differentiation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of endothelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter; P:vasculature development; P:wound healing;|Q9Y4H4 A2BFJ3,G-protein-signaling modulator 3,Activator of G-protein signaling 4;G18.1b;Protein G18;, PF02188;, GO:0005737;GO:0005886;GO:0030695;GO:1900017;GO:0050729;GO:0002690;, C:cytoplasm; C:plasma membrane;, F:GTPase regulator activity;, P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of inflammatory response; P:positive regulation of leukocyte chemotaxis;|P40425 A2BFJ2,Pre-B-cell leukemia transcription factor 2,Homeobox protein PBX2;Protein G17;, PF00046;PF03792;, GO:0000785;GO:0005634;GO:0005667;GO:0003682;GO:0001228;GO:0000981;GO:0000978;GO:0000977;GO:0008134;GO:0009887;GO:0007420;GO:0030326;GO:0048568;GO:0001654;GO:0048666;GO:0045944;GO:0009954;GO:0006357;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:animal organ morphogenesis; P:brain development; P:embryonic limb morphogenesis; P:embryonic organ development; P:eye development; P:neuron development; P:positive regulation of transcription by RNA polymerase II; P:proximal/distal pattern formation; P:regulation of transcription by RNA polymerase II;|P40425 A2BFJ2,Pre-B-cell leukemia transcription factor 2,Homeobox protein PBX2;Protein G17;, PF00046;PF03792;, GO:0000785;GO:0005634;GO:0005667;GO:0003682;GO:0001228;GO:0000981;GO:0000978;GO:0000977;GO:0008134;GO:0009887;GO:0007420;GO:0030326;GO:0048568;GO:0001654;GO:0048666;GO:0045944;GO:0009954;GO:0006357;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:animal organ morphogenesis; P:brain development; P:embryonic limb morphogenesis; P:embryonic organ development; P:eye development; P:neuron development; P:positive regulation of transcription by RNA polymerase II; P:proximal/distal pattern formation; P:regulation of transcription by RNA polymerase II; scaffold40 indexed_genome mRNA 18541957 18545155 . + . ID=transcript_8298;Q3L1R7 Q3L1R8 Q3L1S0 Q86SN1 Q9H2X7 Q9Y3R3 V5R6A3,Advanced glycosylation end product-specific receptor,Receptor for advanced glycosylation end products;, PF08205;PF00047;PF13895;, GO:0016324;GO:0030054;GO:0009986;GO:0005576;GO:0001650;GO:0005887;GO:0005886;GO:0098794;GO:0050785;GO:0001540;GO:0042802;GO:0044877;GO:0044548;GO:0005044;GO:0038023;GO:0004888;GO:0048143;GO:0007166;GO:1904646;GO:0010255;GO:0050930;GO:0006954;GO:0045087;GO:0007611;GO:0001774;GO:0090647;GO:1903523;GO:1904597;GO:0032693;GO:1900453;GO:1900272;GO:0031175;GO:0042104;GO:1902961;GO:0032722;GO:2001200;GO:1904472;GO:0070374;GO:0034116;GO:0032731;GO:0032735;GO:0032755;GO:0046330;GO:0043507;GO:0071639;GO:2000439;GO:0051092;GO:1901224;GO:1900745;GO:0001934;GO:0032760;GO:0072657;GO:2000514;GO:0051101;GO:0050727;GO:1900271;GO:1901222;GO:1900744;GO:0150003;GO:0048167;GO:0001914;GO:1904645;GO:0001666;GO:0009611;GO:0045056;GO:0150104;, C:apical plasma membrane; C:cell junction; C:cell surface; C:extracellular region; C:fibrillar center; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse;, F:advanced glycation end-product receptor activity; F:amyloid-beta binding; F:identical protein binding; F:protein-containing complex binding; F:S100 protein binding; F:scavenger receptor activity; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:astrocyte activation; P:cell surface receptor signaling pathway; P:cellular response to amyloid-beta; P:glucose mediated signaling pathway; P:induction of positive chemotaxis; P:inflammatory response; P:innate immune response; P:learning or memory; P:microglial cell activation; P:modulation of age-related behavioral decline; P:negative regulation of blood circulation; P:negative regulation of connective tissue replacement involved in inflammatory response wound healing; P:negative regulation of interleukin-10 production; P:negative regulation of long-term synaptic depression; P:negative regulation of long-term synaptic potentiation; P:neuron projection development; P:positive regulation of activated T cell proliferation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of chemokine production; P:positive regulation of dendritic cell differentiation; P:positive regulation of endothelin production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of monocyte extravasation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:positive regulation of protein phosphorylation; P:positive regulation of tumor necrosis factor production; P:protein localization to membrane; P:regulation of CD4-positive, alpha-beta T cell activation; P:regulation of DNA binding; P:regulation of inflammatory response; P:regulation of long-term synaptic potentiation; P:regulation of NIK/NF-kappaB signaling; P:regulation of p38MAPK cascade; P:regulation of spontaneous synaptic transmission; P:regulation of synaptic plasticity; P:regulation of T cell mediated cytotoxicity; P:response to amyloid-beta; P:response to hypoxia; P:response to wounding; P:transcytosis; P:transport across blood-brain barrier;|Q3L1R7 Q3L1R8 Q3L1S0 Q86SN1 Q9H2X7 Q9Y3R3 V5R6A3,Advanced glycosylation end product-specific receptor,Receptor for advanced glycosylation end products;, PF08205;PF00047;PF13895;, GO:0016324;GO:0030054;GO:0009986;GO:0005576;GO:0001650;GO:0005887;GO:0005886;GO:0098794;GO:0050785;GO:0001540;GO:0042802;GO:0044877;GO:0044548;GO:0005044;GO:0038023;GO:0004888;GO:0048143;GO:0007166;GO:1904646;GO:0010255;GO:0050930;GO:0006954;GO:0045087;GO:0007611;GO:0001774;GO:0090647;GO:1903523;GO:1904597;GO:0032693;GO:1900453;GO:1900272;GO:0031175;GO:0042104;GO:1902961;GO:0032722;GO:2001200;GO:1904472;GO:0070374;GO:0034116;GO:0032731;GO:0032735;GO:0032755;GO:0046330;GO:0043507;GO:0071639;GO:2000439;GO:0051092;GO:1901224;GO:1900745;GO:0001934;GO:0032760;GO:0072657;GO:2000514;GO:0051101;GO:0050727;GO:1900271;GO:1901222;GO:1900744;GO:0150003;GO:0048167;GO:0001914;GO:1904645;GO:0001666;GO:0009611;GO:0045056;GO:0150104;, C:apical plasma membrane; C:cell junction; C:cell surface; C:extracellular region; C:fibrillar center; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse;, F:advanced glycation end-product receptor activity; F:amyloid-beta binding; F:identical protein binding; F:protein-containing complex binding; F:S100 protein binding; F:scavenger receptor activity; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:astrocyte activation; P:cell surface receptor signaling pathway; P:cellular response to amyloid-beta; P:glucose mediated signaling pathway; P:induction of positive chemotaxis; P:inflammatory response; P:innate immune response; P:learning or memory; P:microglial cell activation; P:modulation of age-related behavioral decline; P:negative regulation of blood circulation; P:negative regulation of connective tissue replacement involved in inflammatory response wound healing; P:negative regulation of interleukin-10 production; P:negative regulation of long-term synaptic depression; P:negative regulation of long-term synaptic potentiation; P:neuron projection development; P:positive regulation of activated T cell proliferation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of chemokine production; P:positive regulation of dendritic cell differentiation; P:positive regulation of endothelin production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of monocyte extravasation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:positive regulation of protein phosphorylation; P:positive regulation of tumor necrosis factor production; P:protein localization to membrane; P:regulation of CD4-positive, alpha-beta T cell activation; P:regulation of DNA binding; P:regulation of inflammatory response; P:regulation of long-term synaptic potentiation; P:regulation of NIK/NF-kappaB signaling; P:regulation of p38MAPK cascade; P:regulation of spontaneous synaptic transmission; P:regulation of synaptic plasticity; P:regulation of T cell mediated cytotoxicity; P:response to amyloid-beta; P:response to hypoxia; P:response to wounding; P:transcytosis; P:transport across blood-brain barrier;|Q3L1R7 Q3L1R8 Q3L1S0 Q86SN1 Q9H2X7 Q9Y3R3 V5R6A3,Advanced glycosylation end product-specific receptor,Receptor for advanced glycosylation end products;, PF08205;PF00047;PF13895;, GO:0016324;GO:0030054;GO:0009986;GO:0005576;GO:0001650;GO:0005887;GO:0005886;GO:0098794;GO:0050785;GO:0001540;GO:0042802;GO:0044877;GO:0044548;GO:0005044;GO:0038023;GO:0004888;GO:0048143;GO:0007166;GO:1904646;GO:0010255;GO:0050930;GO:0006954;GO:0045087;GO:0007611;GO:0001774;GO:0090647;GO:1903523;GO:1904597;GO:0032693;GO:1900453;GO:1900272;GO:0031175;GO:0042104;GO:1902961;GO:0032722;GO:2001200;GO:1904472;GO:0070374;GO:0034116;GO:0032731;GO:0032735;GO:0032755;GO:0046330;GO:0043507;GO:0071639;GO:2000439;GO:0051092;GO:1901224;GO:1900745;GO:0001934;GO:0032760;GO:0072657;GO:2000514;GO:0051101;GO:0050727;GO:1900271;GO:1901222;GO:1900744;GO:0150003;GO:0048167;GO:0001914;GO:1904645;GO:0001666;GO:0009611;GO:0045056;GO:0150104;, C:apical plasma membrane; C:cell junction; C:cell surface; C:extracellular region; C:fibrillar center; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse;, F:advanced glycation end-product receptor activity; F:amyloid-beta binding; F:identical protein binding; F:protein-containing complex binding; F:S100 protein binding; F:scavenger receptor activity; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:astrocyte activation; P:cell surface receptor signaling pathway; P:cellular response to amyloid-beta; P:glucose mediated signaling pathway; P:induction of positive chemotaxis; P:inflammatory response; P:innate immune response; P:learning or memory; P:microglial cell activation; P:modulation of age-related behavioral decline; P:negative regulation of blood circulation; P:negative regulation of connective tissue replacement involved in inflammatory response wound healing; P:negative regulation of interleukin-10 production; P:negative regulation of long-term synaptic depression; P:negative regulation of long-term synaptic potentiation; P:neuron projection development; P:positive regulation of activated T cell proliferation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of chemokine production; P:positive regulation of dendritic cell differentiation; P:positive regulation of endothelin production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of monocyte extravasation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:positive regulation of protein phosphorylation; P:positive regulation of tumor necrosis factor production; P:protein localization to membrane; P:regulation of CD4-positive, alpha-beta T cell activation; P:regulation of DNA binding; P:regulation of inflammatory response; P:regulation of long-term synaptic potentiation; P:regulation of NIK/NF-kappaB signaling; P:regulation of p38MAPK cascade; P:regulation of spontaneous synaptic transmission; P:regulation of synaptic plasticity; P:regulation of T cell mediated cytotoxicity; P:response to amyloid-beta; P:response to hypoxia; P:response to wounding; P:transcytosis; P:transport across blood-brain barrier;|Q3L1R7 Q3L1R8 Q3L1S0 Q86SN1 Q9H2X7 Q9Y3R3 V5R6A3,Advanced glycosylation end product-specific receptor,Receptor for advanced glycosylation end products;, PF08205;PF00047;PF13895;, GO:0016324;GO:0030054;GO:0009986;GO:0005576;GO:0001650;GO:0005887;GO:0005886;GO:0098794;GO:0050785;GO:0001540;GO:0042802;GO:0044877;GO:0044548;GO:0005044;GO:0038023;GO:0004888;GO:0048143;GO:0007166;GO:1904646;GO:0010255;GO:0050930;GO:0006954;GO:0045087;GO:0007611;GO:0001774;GO:0090647;GO:1903523;GO:1904597;GO:0032693;GO:1900453;GO:1900272;GO:0031175;GO:0042104;GO:1902961;GO:0032722;GO:2001200;GO:1904472;GO:0070374;GO:0034116;GO:0032731;GO:0032735;GO:0032755;GO:0046330;GO:0043507;GO:0071639;GO:2000439;GO:0051092;GO:1901224;GO:1900745;GO:0001934;GO:0032760;GO:0072657;GO:2000514;GO:0051101;GO:0050727;GO:1900271;GO:1901222;GO:1900744;GO:0150003;GO:0048167;GO:0001914;GO:1904645;GO:0001666;GO:0009611;GO:0045056;GO:0150104;, C:apical plasma membrane; C:cell junction; C:cell surface; C:extracellular region; C:fibrillar center; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse;, F:advanced glycation end-product receptor activity; F:amyloid-beta binding; F:identical protein binding; F:protein-containing complex binding; F:S100 protein binding; F:scavenger receptor activity; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:astrocyte activation; P:cell surface receptor signaling pathway; P:cellular response to amyloid-beta; P:glucose mediated signaling pathway; P:induction of positive chemotaxis; P:inflammatory response; P:innate immune response; P:learning or memory; P:microglial cell activation; P:modulation of age-related behavioral decline; P:negative regulation of blood circulation; P:negative regulation of connective tissue replacement involved in inflammatory response wound healing; P:negative regulation of interleukin-10 production; P:negative regulation of long-term synaptic depression; P:negative regulation of long-term synaptic potentiation; P:neuron projection development; P:positive regulation of activated T cell proliferation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of chemokine production; P:positive regulation of dendritic cell differentiation; P:positive regulation of endothelin production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of monocyte extravasation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:positive regulation of protein phosphorylation; P:positive regulation of tumor necrosis factor production; P:protein localization to membrane; P:regulation of CD4-positive, alpha-beta T cell activation; P:regulation of DNA binding; P:regulation of inflammatory response; P:regulation of long-term synaptic potentiation; P:regulation of NIK/NF-kappaB signaling; P:regulation of p38MAPK cascade; P:regulation of spontaneous synaptic transmission; P:regulation of synaptic plasticity; P:regulation of T cell mediated cytotoxicity; P:response to amyloid-beta; P:response to hypoxia; P:response to wounding; P:transcytosis; P:transport across blood-brain barrier; scaffold40 indexed_genome mRNA 18545273 18547627 . - . ID=transcript_8299;Q99942 A2BFI6 B2R4K3 Q0VDB7 Q9UMQ2,E3 ubiquitin-protein ligase RNF5,Protein G16;RING finger protein 5;RING-type E3 ubiquitin transferase RNF5 {ECO:0000305};Ram1 homolog;, , GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0031966;GO:0042802;GO:0044877;GO:0061630;GO:0044390;GO:0004842;GO:0008270;GO:0044257;GO:1904380;GO:0071712;GO:0036503;GO:0010507;GO:0031648;GO:0070936;GO:0070534;GO:2000785;GO:0009617;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:mitochondrial membrane;, F:identical protein binding; F:protein-containing complex binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein conjugating enzyme binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular protein catabolic process; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:negative regulation of autophagy; P:protein destabilization; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:regulation of autophagosome assembly; P:response to bacterium; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q99942 A2BFI6 B2R4K3 Q0VDB7 Q9UMQ2,E3 ubiquitin-protein ligase RNF5,Protein G16;RING finger protein 5;RING-type E3 ubiquitin transferase RNF5 {ECO:0000305};Ram1 homolog;, , GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0031966;GO:0042802;GO:0044877;GO:0061630;GO:0044390;GO:0004842;GO:0008270;GO:0044257;GO:1904380;GO:0071712;GO:0036503;GO:0010507;GO:0031648;GO:0070936;GO:0070534;GO:2000785;GO:0009617;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:mitochondrial membrane;, F:identical protein binding; F:protein-containing complex binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein conjugating enzyme binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular protein catabolic process; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:negative regulation of autophagy; P:protein destabilization; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:regulation of autophagosome assembly; P:response to bacterium; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q99942 A2BFI6 B2R4K3 Q0VDB7 Q9UMQ2,E3 ubiquitin-protein ligase RNF5,Protein G16;RING finger protein 5;RING-type E3 ubiquitin transferase RNF5 {ECO:0000305};Ram1 homolog;, , GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0031966;GO:0042802;GO:0044877;GO:0061630;GO:0044390;GO:0004842;GO:0008270;GO:0044257;GO:1904380;GO:0071712;GO:0036503;GO:0010507;GO:0031648;GO:0070936;GO:0070534;GO:2000785;GO:0009617;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:mitochondrial membrane;, F:identical protein binding; F:protein-containing complex binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein conjugating enzyme binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular protein catabolic process; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:negative regulation of autophagy; P:protein destabilization; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:regulation of autophagosome assembly; P:response to bacterium; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold40 indexed_genome mRNA 18550381 18568124 . + . ID=transcript_8300;Q99943 A2BFI5 Q5BL03,1-acyl-sn-glycerol-3-phosphate acyltransferase alpha,1-acylglycerol-3-phosphate O-acyltransferase 1;Lysophosphatidic acid acyltransferase alpha {ECO:0000303|PubMed:9461603};Protein G15;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003841;GO:0016024;GO:0006654;GO:0006644;GO:0031325;GO:0001819;GO:0001961;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity;, P:CDP-diacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phospholipid metabolic process; P:positive regulation of cellular metabolic process; P:positive regulation of cytokine production; P:positive regulation of cytokine-mediated signaling pathway;|Q99943 A2BFI5 Q5BL03,1-acyl-sn-glycerol-3-phosphate acyltransferase alpha,1-acylglycerol-3-phosphate O-acyltransferase 1;Lysophosphatidic acid acyltransferase alpha {ECO:0000303|PubMed:9461603};Protein G15;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003841;GO:0016024;GO:0006654;GO:0006644;GO:0031325;GO:0001819;GO:0001961;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity;, P:CDP-diacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phospholipid metabolic process; P:positive regulation of cellular metabolic process; P:positive regulation of cytokine production; P:positive regulation of cytokine-mediated signaling pathway;|Q99943 A2BFI5 Q5BL03,1-acyl-sn-glycerol-3-phosphate acyltransferase alpha,1-acylglycerol-3-phosphate O-acyltransferase 1;Lysophosphatidic acid acyltransferase alpha {ECO:0000303|PubMed:9461603};Protein G15;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003841;GO:0016024;GO:0006654;GO:0006644;GO:0031325;GO:0001819;GO:0001961;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity;, P:CDP-diacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phospholipid metabolic process; P:positive regulation of cellular metabolic process; P:positive regulation of cytokine production; P:positive regulation of cytokine-mediated signaling pathway;|Q99944 B0S884 G5E9Q0 Q5JP23 Q5SSX3 Q8IV30,Epidermal growth factor-like protein 8,Vascular endothelial statin-2;, PF00008;PF07645;PF07546;, GO:0009986;GO:0005576;GO:0005509;GO:0005102;GO:0048856;, C:cell surface; C:extracellular region;, F:calcium ion binding; F:signaling receptor binding;, P:anatomical structure development;|Q5STJ4 Q5STJ5 Q5STJ6 Q6FI80 Q99945,Lysosomal thioesterase PPT2,S-thioesterase G14;, , GO:0070062;GO:0043231;GO:0043202;GO:0005764;GO:0098599;GO:0008474;GO:0016790;GO:0046949;, C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome;, F:palmitoyl hydrolase activity; F:palmitoyl-(protein) hydrolase activity; F:thiolester hydrolase activity;, P:fatty-acyl-CoA biosynthetic process;|Q5STJ4 Q5STJ5 Q5STJ6 Q6FI80 Q99945,Lysosomal thioesterase PPT2,S-thioesterase G14;, , GO:0070062;GO:0043231;GO:0043202;GO:0005764;GO:0098599;GO:0008474;GO:0016790;GO:0046949;, C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome;, F:palmitoyl hydrolase activity; F:palmitoyl-(protein) hydrolase activity; F:thiolester hydrolase activity;, P:fatty-acyl-CoA biosynthetic process;|Q5STJ4 Q5STJ5 Q5STJ6 Q6FI80 Q99945,Lysosomal thioesterase PPT2,S-thioesterase G14;, , GO:0070062;GO:0043231;GO:0043202;GO:0005764;GO:0098599;GO:0008474;GO:0016790;GO:0046949;, C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome;, F:palmitoyl hydrolase activity; F:palmitoyl-(protein) hydrolase activity; F:thiolester hydrolase activity;, P:fatty-acyl-CoA biosynthetic process;|Q5STJ4 Q5STJ5 Q5STJ6 Q6FI80 Q99945,Lysosomal thioesterase PPT2,S-thioesterase G14;, , GO:0070062;GO:0043231;GO:0043202;GO:0005764;GO:0098599;GO:0008474;GO:0016790;GO:0046949;, C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome;, F:palmitoyl hydrolase activity; F:palmitoyl-(protein) hydrolase activity; F:thiolester hydrolase activity;, P:fatty-acyl-CoA biosynthetic process;|Q5STJ4 Q5STJ5 Q5STJ6 Q6FI80 Q99945,Lysosomal thioesterase PPT2,S-thioesterase G14;, , GO:0070062;GO:0043231;GO:0043202;GO:0005764;GO:0098599;GO:0008474;GO:0016790;GO:0046949;, C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome;, F:palmitoyl hydrolase activity; F:palmitoyl-(protein) hydrolase activity; F:thiolester hydrolase activity;, P:fatty-acyl-CoA biosynthetic process; scaffold40 indexed_genome mRNA 18569925 18574214 . - . ID=transcript_8301;Q99946 A6ND08 A6ND40 B0S869 Q5SSW4 Q5SSX7 Q5STI1 Q96DW3 Q96NQ8,Proline-rich transmembrane protein 1,Dispanin subfamily D member 1;Synapse differentiation-induced protein 4 {ECO:0000250|UniProtKB:O35449};, PF04505;, GO:0098978;GO:0099055;GO:0016020;GO:0098839;GO:0030672;GO:0042802;GO:0030545;GO:0007611;GO:0060292;GO:0060291;GO:0034394;GO:0006468;GO:2000311;GO:0050808;, C:glutamatergic synapse; C:integral component of postsynaptic membrane; C:membrane; C:postsynaptic density membrane; C:synaptic vesicle membrane;, F:identical protein binding; F:receptor regulator activity;, P:learning or memory; P:long-term synaptic depression; P:long-term synaptic potentiation; P:protein localization to cell surface; P:protein phosphorylation; P:regulation of AMPA receptor activity; P:synapse organization; scaffold40 indexed_genome mRNA 18586665 18588460 . + . ID=transcript_8302;Q9UIM3 A8K5V3 B0UYX8 Q9H5G3,FK506-binding protein-like,WAF-1/CIP1 stabilizing protein 39;, PF00515;, GO:0005829;GO:0005576;GO:0050821;GO:1905553;GO:0009314;, C:cytosol; C:extracellular region;, , P:protein stabilization; P:regulation of blood vessel branching; P:response to radiation; scaffold40 indexed_genome mRNA 18589096 18598674 . + . ID=transcript_8303;Q9H3W1 Q9NPL0,Cyclic AMP-dependent transcription factor ATF-6 beta,Activating transcription factor 6 beta;Protein G13;cAMP response element-binding protein-related protein;cAMP-responsive element-binding protein-like 1;, PF00170;, GO:0000785;GO:0005789;GO:0005794;GO:0030176;GO:0005634;GO:0032993;GO:0090575;GO:0035497;GO:0003700;GO:0000981;GO:1990837;GO:0000976;GO:0036500;GO:0030968;GO:1903892;GO:0045944;GO:1990440;GO:0006357;GO:0007165;, C:chromatin; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:ATF6-mediated unfolded protein response; P:endoplasmic reticulum unfolded protein response; P:negative regulation of ATF6-mediated unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II; P:signal transduction;|Q9H3W1 Q9NPL0,Cyclic AMP-dependent transcription factor ATF-6 beta,Activating transcription factor 6 beta;Protein G13;cAMP response element-binding protein-related protein;cAMP-responsive element-binding protein-like 1;, PF00170;, GO:0000785;GO:0005789;GO:0005794;GO:0030176;GO:0005634;GO:0032993;GO:0090575;GO:0035497;GO:0003700;GO:0000981;GO:1990837;GO:0000976;GO:0036500;GO:0030968;GO:1903892;GO:0045944;GO:1990440;GO:0006357;GO:0007165;, C:chromatin; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:ATF6-mediated unfolded protein response; P:endoplasmic reticulum unfolded protein response; P:negative regulation of ATF6-mediated unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II; P:signal transduction;|Q9H3W1 Q9NPL0,Cyclic AMP-dependent transcription factor ATF-6 beta,Activating transcription factor 6 beta;Protein G13;cAMP response element-binding protein-related protein;cAMP-responsive element-binding protein-like 1;, PF00170;, GO:0000785;GO:0005789;GO:0005794;GO:0030176;GO:0005634;GO:0032993;GO:0090575;GO:0035497;GO:0003700;GO:0000981;GO:1990837;GO:0000976;GO:0036500;GO:0030968;GO:1903892;GO:0045944;GO:1990440;GO:0006357;GO:0007165;, C:chromatin; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:ATF6-mediated unfolded protein response; P:endoplasmic reticulum unfolded protein response; P:negative regulation of ATF6-mediated unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II; P:signal transduction;|Q9H3W1 Q9NPL0,Cyclic AMP-dependent transcription factor ATF-6 beta,Activating transcription factor 6 beta;Protein G13;cAMP response element-binding protein-related protein;cAMP-responsive element-binding protein-like 1;, PF00170;, GO:0000785;GO:0005789;GO:0005794;GO:0030176;GO:0005634;GO:0032993;GO:0090575;GO:0035497;GO:0003700;GO:0000981;GO:1990837;GO:0000976;GO:0036500;GO:0030968;GO:1903892;GO:0045944;GO:1990440;GO:0006357;GO:0007165;, C:chromatin; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:ATF6-mediated unfolded protein response; P:endoplasmic reticulum unfolded protein response; P:negative regulation of ATF6-mediated unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II; P:signal transduction;|Q9H3W1 Q9NPL0,Cyclic AMP-dependent transcription factor ATF-6 beta,Activating transcription factor 6 beta;Protein G13;cAMP response element-binding protein-related protein;cAMP-responsive element-binding protein-like 1;, PF00170;, GO:0000785;GO:0005789;GO:0005794;GO:0030176;GO:0005634;GO:0032993;GO:0090575;GO:0035497;GO:0003700;GO:0000981;GO:1990837;GO:0000976;GO:0036500;GO:0030968;GO:1903892;GO:0045944;GO:1990440;GO:0006357;GO:0007165;, C:chromatin; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:ATF6-mediated unfolded protein response; P:endoplasmic reticulum unfolded protein response; P:negative regulation of ATF6-mediated unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II; P:signal transduction;|Q9H3W1 Q9NPL0,Cyclic AMP-dependent transcription factor ATF-6 beta,Activating transcription factor 6 beta;Protein G13;cAMP response element-binding protein-related protein;cAMP-responsive element-binding protein-like 1;, PF00170;, GO:0000785;GO:0005789;GO:0005794;GO:0030176;GO:0005634;GO:0032993;GO:0090575;GO:0035497;GO:0003700;GO:0000981;GO:1990837;GO:0000976;GO:0036500;GO:0030968;GO:1903892;GO:0045944;GO:1990440;GO:0006357;GO:0007165;, C:chromatin; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:ATF6-mediated unfolded protein response; P:endoplasmic reticulum unfolded protein response; P:negative regulation of ATF6-mediated unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II; P:signal transduction;|Q9H3W1 Q9NPL0,Cyclic AMP-dependent transcription factor ATF-6 beta,Activating transcription factor 6 beta;Protein G13;cAMP response element-binding protein-related protein;cAMP-responsive element-binding protein-like 1;, PF00170;, GO:0000785;GO:0005789;GO:0005794;GO:0030176;GO:0005634;GO:0032993;GO:0090575;GO:0035497;GO:0003700;GO:0000981;GO:1990837;GO:0000976;GO:0036500;GO:0030968;GO:1903892;GO:0045944;GO:1990440;GO:0006357;GO:0007165;, C:chromatin; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:ATF6-mediated unfolded protein response; P:endoplasmic reticulum unfolded protein response; P:negative regulation of ATF6-mediated unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II; P:signal transduction;|Q9H3W1 Q9NPL0,Cyclic AMP-dependent transcription factor ATF-6 beta,Activating transcription factor 6 beta;Protein G13;cAMP response element-binding protein-related protein;cAMP-responsive element-binding protein-like 1;, PF00170;, GO:0000785;GO:0005789;GO:0005794;GO:0030176;GO:0005634;GO:0032993;GO:0090575;GO:0035497;GO:0003700;GO:0000981;GO:1990837;GO:0000976;GO:0036500;GO:0030968;GO:1903892;GO:0045944;GO:1990440;GO:0006357;GO:0007165;, C:chromatin; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:ATF6-mediated unfolded protein response; P:endoplasmic reticulum unfolded protein response; P:negative regulation of ATF6-mediated unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II; P:signal transduction; scaffold40 indexed_genome mRNA 18604436 18641146 . + . ID=transcript_8304;Q7L8Q4 Q8N4R1 Q9NPK9 Q9UC10 Q9UC11 Q9UC12 Q9UC13 Q9UMG7,Tenascin-X {ECO:0000305},Hexabrachion-like protein;, PF07974;PF18720;PF00147;PF00041;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0098633;GO:0005201;GO:0008201;GO:0005178;GO:0030036;GO:0007155;GO:0030199;GO:0032963;GO:0048251;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:collagen fibril binding; F:extracellular matrix structural constituent; F:heparin binding; F:integrin binding;, P:actin cytoskeleton organization; P:cell adhesion; P:collagen fibril organization; P:collagen metabolic process; P:elastic fiber assembly; scaffold40 indexed_genome mRNA 18646140 18655053 . - . ID=transcript_8305;Q7L8Q4 Q8N4R1 Q9NPK9 Q9UC10 Q9UC11 Q9UC12 Q9UC13 Q9UMG7,Tenascin-X {ECO:0000305},Hexabrachion-like protein;, PF07974;PF18720;PF00147;PF00041;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0098633;GO:0005201;GO:0008201;GO:0005178;GO:0030036;GO:0007155;GO:0030199;GO:0032963;GO:0048251;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:collagen fibril binding; F:extracellular matrix structural constituent; F:heparin binding; F:integrin binding;, P:actin cytoskeleton organization; P:cell adhesion; P:collagen fibril organization; P:collagen metabolic process; P:elastic fiber assembly;|Q7L8Q4 Q8N4R1 Q9NPK9 Q9UC10 Q9UC11 Q9UC12 Q9UC13 Q9UMG7,Tenascin-X {ECO:0000305},Hexabrachion-like protein;, PF07974;PF18720;PF00147;PF00041;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0098633;GO:0005201;GO:0008201;GO:0005178;GO:0030036;GO:0007155;GO:0030199;GO:0032963;GO:0048251;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:collagen fibril binding; F:extracellular matrix structural constituent; F:heparin binding; F:integrin binding;, P:actin cytoskeleton organization; P:cell adhesion; P:collagen fibril organization; P:collagen metabolic process; P:elastic fiber assembly; scaffold40 indexed_genome mRNA 18661159 18671958 . - . ID=transcript_8306;Q9UIP5,Complement C4-B,Basic complement C4;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3;, PF00207;PF07703;PF07677;PF01821;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0030424;GO:0072562;GO:0030425;GO:0070062;GO:0005576;GO:0005615;GO:0044216;GO:0005886;GO:0045202;GO:0030246;GO:0001848;GO:0004866;GO:0006956;GO:0006958;GO:0032490;GO:0006954;GO:0045087;GO:0008228;GO:2000427;GO:0030449;, C:axon; C:blood microparticle; C:dendrite; C:extracellular exosome; C:extracellular region; C:extracellular space; C:other organism cell; C:plasma membrane; C:synapse;, F:carbohydrate binding; F:complement binding; F:endopeptidase inhibitor activity;, P:complement activation; P:complement activation, classical pathway; P:detection of molecule of bacterial origin; P:inflammatory response; P:innate immune response; P:opsonization; P:positive regulation of apoptotic cell clearance; P:regulation of complement activation;|Q96SA8 Q9NPK5 Q9UIP5,Complement C4-A,Acidic complement C4;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2;, PF00207;PF07703;PF07677;PF01821;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0030424;GO:0072562;GO:0030425;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0043025;GO:0005886;GO:0045202;GO:0001849;GO:0004866;GO:0044267;GO:0006956;GO:0006958;GO:0006954;GO:0045087;GO:2000427;GO:0043687;GO:0030449;, C:axon; C:blood microparticle; C:dendrite; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:neuronal cell body; C:plasma membrane; C:synapse;, F:complement component C1q complex binding; F:endopeptidase inhibitor activity;, P:cellular protein metabolic process; P:complement activation; P:complement activation, classical pathway; P:inflammatory response; P:innate immune response; P:positive regulation of apoptotic cell clearance; P:post-translational protein modification; P:regulation of complement activation;|Q9UIP5,Complement C4-B,Basic complement C4;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3;, PF00207;PF07703;PF07677;PF01821;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0030424;GO:0072562;GO:0030425;GO:0070062;GO:0005576;GO:0005615;GO:0044216;GO:0005886;GO:0045202;GO:0030246;GO:0001848;GO:0004866;GO:0006956;GO:0006958;GO:0032490;GO:0006954;GO:0045087;GO:0008228;GO:2000427;GO:0030449;, C:axon; C:blood microparticle; C:dendrite; C:extracellular exosome; C:extracellular region; C:extracellular space; C:other organism cell; C:plasma membrane; C:synapse;, F:carbohydrate binding; F:complement binding; F:endopeptidase inhibitor activity;, P:complement activation; P:complement activation, classical pathway; P:detection of molecule of bacterial origin; P:inflammatory response; P:innate immune response; P:opsonization; P:positive regulation of apoptotic cell clearance; P:regulation of complement activation;|Q96SA8 Q9NPK5 Q9UIP5,Complement C4-A,Acidic complement C4;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2;, PF00207;PF07703;PF07677;PF01821;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0030424;GO:0072562;GO:0030425;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0043025;GO:0005886;GO:0045202;GO:0001849;GO:0004866;GO:0044267;GO:0006956;GO:0006958;GO:0006954;GO:0045087;GO:2000427;GO:0043687;GO:0030449;, C:axon; C:blood microparticle; C:dendrite; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:neuronal cell body; C:plasma membrane; C:synapse;, F:complement component C1q complex binding; F:endopeptidase inhibitor activity;, P:cellular protein metabolic process; P:complement activation; P:complement activation, classical pathway; P:inflammatory response; P:innate immune response; P:positive regulation of apoptotic cell clearance; P:post-translational protein modification; P:regulation of complement activation;|Q96SA8 Q9NPK5 Q9UIP5,Complement C4-A,Acidic complement C4;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2;, PF00207;PF07703;PF07677;PF01821;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0030424;GO:0072562;GO:0030425;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0043025;GO:0005886;GO:0045202;GO:0001849;GO:0004866;GO:0044267;GO:0006956;GO:0006958;GO:0006954;GO:0045087;GO:2000427;GO:0043687;GO:0030449;, C:axon; C:blood microparticle; C:dendrite; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:neuronal cell body; C:plasma membrane; C:synapse;, F:complement component C1q complex binding; F:endopeptidase inhibitor activity;, P:cellular protein metabolic process; P:complement activation; P:complement activation, classical pathway; P:inflammatory response; P:innate immune response; P:positive regulation of apoptotic cell clearance; P:post-translational protein modification; P:regulation of complement activation; scaffold40 indexed_genome mRNA 18678713 18679615 . - . ID=transcript_8307;P49842 A6NF95 A6NFW8 B0QZR5 Q13159 Q31617 Q5JP77 Q5ST72 Q5ST75,Serine/threonine-protein kinase 19 {ECO:0000305},Protein G11 {ECO:0000303|PubMed:8012361};Protein RP1 {ECO:0000303|PubMed:8132574};, PF10494;, GO:0016607;GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0046579;GO:0006468;, C:nuclear speck; C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:positive regulation of Ras protein signal transduction; P:protein phosphorylation; scaffold40 indexed_genome mRNA 18683514 18684920 . + . ID=transcript_8308;P49842 A6NF95 A6NFW8 B0QZR5 Q13159 Q31617 Q5JP77 Q5ST72 Q5ST75,Serine/threonine-protein kinase 19 {ECO:0000305},Protein G11 {ECO:0000303|PubMed:8012361};Protein RP1 {ECO:0000303|PubMed:8132574};, PF10494;, GO:0016607;GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0046579;GO:0006468;, C:nuclear speck; C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:positive regulation of Ras protein signal transduction; P:protein phosphorylation; scaffold40 indexed_genome mRNA 18685078 18687288 . + . ID=transcript_8309;O77932 A2CER3 B0UZ80 O15004 O78127 O78128 Q5ST60 Q6IPZ2 Q9NPK4,Decapping and exoribonuclease protein {ECO:0000303|PubMed:29601584},5'-3' exoribonuclease DXO {ECO:0000305};Dom-3 homolog Z {ECO:0000303|PubMed:9799600};NAD-capped RNA hydrolase DXO {ECO:0000305};, PF08652;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0008409;GO:0000287;GO:0003729;GO:0000166;GO:0110152;GO:0034353;GO:0006402;GO:0110155;GO:0071028;GO:0000956;GO:0090305;GO:0050779;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:5'-3' exonuclease activity; F:magnesium ion binding; F:mRNA binding; F:nucleotide binding; F:RNA NAD-cap (NAD-forming) hydrolase activity; F:RNA pyrophosphohydrolase activity;, P:mRNA catabolic process; P:NAD-cap decapping; P:nuclear mRNA surveillance; P:nuclear-transcribed mRNA catabolic process; P:nucleic acid phosphodiester bond hydrolysis; P:RNA destabilization;|O77932 A2CER3 B0UZ80 O15004 O78127 O78128 Q5ST60 Q6IPZ2 Q9NPK4,Decapping and exoribonuclease protein {ECO:0000303|PubMed:29601584},5'-3' exoribonuclease DXO {ECO:0000305};Dom-3 homolog Z {ECO:0000303|PubMed:9799600};NAD-capped RNA hydrolase DXO {ECO:0000305};, PF08652;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0008409;GO:0000287;GO:0003729;GO:0000166;GO:0110152;GO:0034353;GO:0006402;GO:0110155;GO:0071028;GO:0000956;GO:0090305;GO:0050779;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:5'-3' exonuclease activity; F:magnesium ion binding; F:mRNA binding; F:nucleotide binding; F:RNA NAD-cap (NAD-forming) hydrolase activity; F:RNA pyrophosphohydrolase activity;, P:mRNA catabolic process; P:NAD-cap decapping; P:nuclear mRNA surveillance; P:nuclear-transcribed mRNA catabolic process; P:nucleic acid phosphodiester bond hydrolysis; P:RNA destabilization; scaffold40 indexed_genome mRNA 18687457 18697508 . - . ID=transcript_8310;Q15477 O15005 Q12902 Q15476 Q5ST66,Helicase SKI2W,Helicase-like protein;, PF00270;PF08148;PF00271;PF13234;PF17911;, GO:0005829;GO:0005634;GO:0055087;GO:0005524;GO:0003723;GO:0003724;GO:0043928;GO:0070478;GO:0006401;, C:cytosol; C:nucleus; C:Ski complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay; P:RNA catabolic process;|Q15477 O15005 Q12902 Q15476 Q5ST66,Helicase SKI2W,Helicase-like protein;, PF00270;PF08148;PF00271;PF13234;PF17911;, GO:0005829;GO:0005634;GO:0055087;GO:0005524;GO:0003723;GO:0003724;GO:0043928;GO:0070478;GO:0006401;, C:cytosol; C:nucleus; C:Ski complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay; P:RNA catabolic process; scaffold40 indexed_genome mRNA 18698578 18709622 . + . ID=transcript_8311;P18615 A2BE08 B4DUN1 B4DYX9 Q5JP74 Q5JP75 Q96F56 Q9NPK2,Negative elongation factor E,RNA-binding protein RD;, PF00076;, GO:0032021;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0003723;GO:1900364;GO:0000122;GO:0034244;GO:0070374;GO:0051571;GO:0045944;GO:0050434;GO:0006366;GO:0006368;, C:NELF complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of histone H3-K4 methylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P18615 A2BE08 B4DUN1 B4DYX9 Q5JP74 Q5JP75 Q96F56 Q9NPK2,Negative elongation factor E,RNA-binding protein RD;, PF00076;, GO:0032021;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0003723;GO:1900364;GO:0000122;GO:0034244;GO:0070374;GO:0051571;GO:0045944;GO:0050434;GO:0006366;GO:0006368;, C:NELF complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of histone H3-K4 methylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9BX92,Complement factor B,C3/C5 convertase;Glycine-rich beta glycoprotein;PBF2;Properdin factor B;, PF00084;PF00089;PF00092;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0001848;GO:0004252;GO:0006956;GO:0006957;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:complement binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, alternative pathway; P:regulation of complement activation;|Q9BX92,Complement factor B,C3/C5 convertase;Glycine-rich beta glycoprotein;PBF2;Properdin factor B;, PF00084;PF00089;PF00092;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0001848;GO:0004252;GO:0006956;GO:0006957;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:complement binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, alternative pathway; P:regulation of complement activation;|Q9BX92,Complement factor B,C3/C5 convertase;Glycine-rich beta glycoprotein;PBF2;Properdin factor B;, PF00084;PF00089;PF00092;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0001848;GO:0004252;GO:0006956;GO:0006957;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:complement binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, alternative pathway; P:regulation of complement activation;|Q9BX92,Complement factor B,C3/C5 convertase;Glycine-rich beta glycoprotein;PBF2;Properdin factor B;, PF00084;PF00089;PF00092;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0001848;GO:0004252;GO:0006956;GO:0006957;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:complement binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, alternative pathway; P:regulation of complement activation;|Q9BX92,Complement factor B,C3/C5 convertase;Glycine-rich beta glycoprotein;PBF2;Properdin factor B;, PF00084;PF00089;PF00092;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0001848;GO:0004252;GO:0006956;GO:0006957;GO:0030449;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:complement binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, alternative pathway; P:regulation of complement activation; scaffold40 indexed_genome mRNA 18709994 18721625 . - . ID=transcript_8312;P06681 B4DPF3 B4DV20 E9PFN7 O19694 Q13904,Complement C2,C3/C5 convertase;, PF00084;PF00089;PF00092;, GO:0070062;GO:0005576;GO:0005615;GO:0046872;GO:0004252;GO:0006956;GO:0006958;GO:0045087;GO:2000427;GO:0030449;GO:0007584;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:metal ion binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:innate immune response; P:positive regulation of apoptotic cell clearance; P:regulation of complement activation; P:response to nutrient;|P06681 B4DPF3 B4DV20 E9PFN7 O19694 Q13904,Complement C2,C3/C5 convertase;, PF00084;PF00089;PF00092;, GO:0070062;GO:0005576;GO:0005615;GO:0046872;GO:0004252;GO:0006956;GO:0006958;GO:0045087;GO:2000427;GO:0030449;GO:0007584;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:metal ion binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:innate immune response; P:positive regulation of apoptotic cell clearance; P:regulation of complement activation; P:response to nutrient;|P06681 B4DPF3 B4DV20 E9PFN7 O19694 Q13904,Complement C2,C3/C5 convertase;, PF00084;PF00089;PF00092;, GO:0070062;GO:0005576;GO:0005615;GO:0046872;GO:0004252;GO:0006956;GO:0006958;GO:0045087;GO:2000427;GO:0030449;GO:0007584;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:metal ion binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:innate immune response; P:positive regulation of apoptotic cell clearance; P:regulation of complement activation; P:response to nutrient;|P06681 B4DPF3 B4DV20 E9PFN7 O19694 Q13904,Complement C2,C3/C5 convertase;, PF00084;PF00089;PF00092;, GO:0070062;GO:0005576;GO:0005615;GO:0046872;GO:0004252;GO:0006956;GO:0006958;GO:0045087;GO:2000427;GO:0030449;GO:0007584;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:metal ion binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:innate immune response; P:positive regulation of apoptotic cell clearance; P:regulation of complement activation; P:response to nutrient; scaffold40 indexed_genome mRNA 18751225 18753081 . + . ID=transcript_8313;Q96QD0 Q9UQL8 Q9Y331,Histone-lysine N-methyltransferase EHMT2,Euchromatic histone-lysine N-methyltransferase 2;HLA-B-associated transcript 8;Histone H3-K9 methyltransferase 3;Lysine N-methyltransferase 1C;Protein G9a;, PF12796;PF05033;PF00856;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0002039;GO:1990841;GO:0016279;GO:0001226;GO:0008270;GO:0009267;GO:0006306;GO:0034968;GO:0016571;GO:0070317;GO:0000122;GO:0018027;GO:0006275;GO:1901796;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:p53 binding; F:promoter-specific chromatin binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:cellular response to starvation; P:DNA methylation; P:histone lysine methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-lysine dimethylation; P:regulation of DNA replication; P:regulation of signal transduction by p53 class mediator; scaffold40 indexed_genome mRNA 18753100 18763005 . + . ID=transcript_8314;Q96QD0 Q9UQL8 Q9Y331,Histone-lysine N-methyltransferase EHMT2,Euchromatic histone-lysine N-methyltransferase 2;HLA-B-associated transcript 8;Histone H3-K9 methyltransferase 3;Lysine N-methyltransferase 1C;Protein G9a;, PF12796;PF05033;PF00856;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0002039;GO:1990841;GO:0016279;GO:0001226;GO:0008270;GO:0009267;GO:0006306;GO:0034968;GO:0016571;GO:0070317;GO:0000122;GO:0018027;GO:0006275;GO:1901796;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:p53 binding; F:promoter-specific chromatin binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:cellular response to starvation; P:DNA methylation; P:histone lysine methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-lysine dimethylation; P:regulation of DNA replication; P:regulation of signal transduction by p53 class mediator;|Q96QD0 Q9UQL8 Q9Y331,Histone-lysine N-methyltransferase EHMT2,Euchromatic histone-lysine N-methyltransferase 2;HLA-B-associated transcript 8;Histone H3-K9 methyltransferase 3;Lysine N-methyltransferase 1C;Protein G9a;, PF12796;PF05033;PF00856;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0002039;GO:1990841;GO:0016279;GO:0001226;GO:0008270;GO:0009267;GO:0006306;GO:0034968;GO:0016571;GO:0070317;GO:0000122;GO:0018027;GO:0006275;GO:1901796;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:p53 binding; F:promoter-specific chromatin binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:cellular response to starvation; P:DNA methylation; P:histone lysine methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-lysine dimethylation; P:regulation of DNA replication; P:regulation of signal transduction by p53 class mediator;|Q96QD0 Q9UQL8 Q9Y331,Histone-lysine N-methyltransferase EHMT2,Euchromatic histone-lysine N-methyltransferase 2;HLA-B-associated transcript 8;Histone H3-K9 methyltransferase 3;Lysine N-methyltransferase 1C;Protein G9a;, PF12796;PF05033;PF00856;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0002039;GO:1990841;GO:0016279;GO:0001226;GO:0008270;GO:0009267;GO:0006306;GO:0034968;GO:0016571;GO:0070317;GO:0000122;GO:0018027;GO:0006275;GO:1901796;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:p53 binding; F:promoter-specific chromatin binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:cellular response to starvation; P:DNA methylation; P:histone lysine methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-lysine dimethylation; P:regulation of DNA replication; P:regulation of signal transduction by p53 class mediator;|Q96QD0 Q9UQL8 Q9Y331,Histone-lysine N-methyltransferase EHMT2,Euchromatic histone-lysine N-methyltransferase 2;HLA-B-associated transcript 8;Histone H3-K9 methyltransferase 3;Lysine N-methyltransferase 1C;Protein G9a;, PF12796;PF05033;PF00856;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0002039;GO:1990841;GO:0016279;GO:0001226;GO:0008270;GO:0009267;GO:0006306;GO:0034968;GO:0016571;GO:0070317;GO:0000122;GO:0018027;GO:0006275;GO:1901796;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:p53 binding; F:promoter-specific chromatin binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:cellular response to starvation; P:DNA methylation; P:histone lysine methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-lysine dimethylation; P:regulation of DNA replication; P:regulation of signal transduction by p53 class mediator; scaffold40 indexed_genome mRNA 18763458 18776516 . + . ID=transcript_8315;Q658S8 Q6UX89 Q8TEW4 Q96C58 Q96K59 Q9Y332,Choline transporter-like protein 4 {ECO:0000303|PubMed:23651124},Solute carrier family 44 member 4 {ECO:0000312|HGNC:HGNC:13941};Thiamine pyrophosphate transporter 1 {ECO:0000303|PubMed:24379411};, PF04515;, GO:0016324;GO:0070062;GO:0016021;GO:0016020;GO:0005886;GO:0015220;GO:0090422;GO:0022857;GO:0008292;GO:0061526;GO:0015871;GO:0035675;GO:0032475;GO:0006656;GO:0030307;GO:0030974;GO:0055085;, C:apical plasma membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:choline transmembrane transporter activity; F:thiamine pyrophosphate transmembrane transporter activity; F:transmembrane transporter activity;, P:acetylcholine biosynthetic process; P:acetylcholine secretion; P:choline transport; P:neuromast hair cell development; P:otolith formation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cell growth; P:thiamine pyrophosphate transmembrane transport; P:transmembrane transport; scaffold40 indexed_genome mRNA 18776805 18780907 . + . ID=transcript_8316;Q99519,Sialidase-1,Acetylneuraminyl hydrolase;G9 sialidase;Lysosomal sialidase;N-acetyl-alpha-neuraminidase 1;, PF13088;, GO:0030054;GO:0005737;GO:0070062;GO:0005576;GO:0043231;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0035580;GO:0016997;GO:0052794;GO:0052795;GO:0052796;GO:0004308;GO:0006689;GO:0006687;GO:0043312;GO:0009313;, C:cell junction; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:specific granule lumen;, F:alpha-sialidase activity; F:exo-alpha-(2->3)-sialidase activity; F:exo-alpha-(2->6)-sialidase activity; F:exo-alpha-(2->8)-sialidase activity; F:exo-alpha-sialidase activity;, P:ganglioside catabolic process; P:glycosphingolipid metabolic process; P:neutrophil degranulation; P:oligosaccharide catabolic process; scaffold40 indexed_genome mRNA 18799113 18806651 . + . ID=transcript_8317;P34931 A6NNB0 B0UXW8 O75634 Q2HXR3 Q8NE72 Q96QC9 Q9UQM1,Heat shock 70 kDa protein 1-like,Heat shock 70 kDa protein 1-Hom;, PF00012;, GO:0072562;GO:0044297;GO:0005737;GO:0005829;GO:0005759;GO:0005654;GO:0005634;GO:0005886;GO:0002199;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0031625;GO:0051082;GO:0007339;GO:0034620;GO:0051085;GO:1903955;GO:0042026;GO:1900034;GO:0006986;GO:0016192;, C:blood microparticle; C:cell body; C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:plasma membrane; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:positive regulation of protein targeting to mitochondrion; P:protein refolding; P:regulation of cellular response to heat; P:response to unfolded protein; P:vesicle-mediated transport;|P34931 A6NNB0 B0UXW8 O75634 Q2HXR3 Q8NE72 Q96QC9 Q9UQM1,Heat shock 70 kDa protein 1-like,Heat shock 70 kDa protein 1-Hom;, PF00012;, GO:0072562;GO:0044297;GO:0005737;GO:0005829;GO:0005759;GO:0005654;GO:0005634;GO:0005886;GO:0002199;GO:0005524;GO:0016887;GO:0031072;GO:0051787;GO:0044183;GO:0031625;GO:0051082;GO:0007339;GO:0034620;GO:0051085;GO:1903955;GO:0042026;GO:1900034;GO:0006986;GO:0016192;, C:blood microparticle; C:cell body; C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:plasma membrane; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:positive regulation of protein targeting to mitochondrion; P:protein refolding; P:regulation of cellular response to heat; P:response to unfolded protein; P:vesicle-mediated transport; scaffold40 indexed_genome mRNA 18807707 18812832 . + . ID=transcript_8318;Q9Y333 Q6FGG1,U6 snRNA-associated Sm-like protein LSm2,Protein G7b;Small nuclear ribonuclear protein D homolog;snRNP core Sm-like protein Sm-x5;, PF01423;, GO:0071013;GO:0005737;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0000932;GO:0071011;GO:0071005;GO:0046540;GO:0005688;GO:0003723;GO:0031267;GO:0017070;GO:0043928;GO:0006402;GO:0000398;GO:0000244;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:P-body; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:RNA binding; F:small GTPase binding; F:U6 snRNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA catabolic process; P:mRNA splicing, via spliceosome; P:spliceosomal tri-snRNP complex assembly;|Q9Y333 Q6FGG1,U6 snRNA-associated Sm-like protein LSm2,Protein G7b;Small nuclear ribonuclear protein D homolog;snRNP core Sm-like protein Sm-x5;, PF01423;, GO:0071013;GO:0005737;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0000932;GO:0071011;GO:0071005;GO:0046540;GO:0005688;GO:0003723;GO:0031267;GO:0017070;GO:0043928;GO:0006402;GO:0000398;GO:0000244;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:P-body; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:RNA binding; F:small GTPase binding; F:U6 snRNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA catabolic process; P:mRNA splicing, via spliceosome; P:spliceosomal tri-snRNP complex assembly;|Q9Y333 Q6FGG1,U6 snRNA-associated Sm-like protein LSm2,Protein G7b;Small nuclear ribonuclear protein D homolog;snRNP core Sm-like protein Sm-x5;, PF01423;, GO:0071013;GO:0005737;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0000932;GO:0071011;GO:0071005;GO:0046540;GO:0005688;GO:0003723;GO:0031267;GO:0017070;GO:0043928;GO:0006402;GO:0000398;GO:0000244;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:P-body; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:RNA binding; F:small GTPase binding; F:U6 snRNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA catabolic process; P:mRNA splicing, via spliceosome; P:spliceosomal tri-snRNP complex assembly;|Q9Y333 Q6FGG1,U6 snRNA-associated Sm-like protein LSm2,Protein G7b;Small nuclear ribonuclear protein D homolog;snRNP core Sm-like protein Sm-x5;, PF01423;, GO:0071013;GO:0005737;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0000932;GO:0071011;GO:0071005;GO:0046540;GO:0005688;GO:0003723;GO:0031267;GO:0017070;GO:0043928;GO:0006402;GO:0000398;GO:0000244;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:P-body; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:RNA binding; F:small GTPase binding; F:U6 snRNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA catabolic process; P:mRNA splicing, via spliceosome; P:spliceosomal tri-snRNP complex assembly; scaffold40 indexed_genome mRNA 18818565 18830252 . + . ID=transcript_8319;P26640 B0V1N1 B4DZ61 Q5JQ90 Q96E77 Q9UQM2,Valine--tRNA ligase,Protein G7a;Valyl-tRNA synthetase;, PF08264;PF00043;PF00133;, GO:0005829;GO:0002161;GO:0005524;GO:0004832;GO:0006418;GO:0006438;, C:cytosol;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:tRNA aminoacylation for protein translation; P:valyl-tRNA aminoacylation;|P26640 B0V1N1 B4DZ61 Q5JQ90 Q96E77 Q9UQM2,Valine--tRNA ligase,Protein G7a;Valyl-tRNA synthetase;, PF08264;PF00043;PF00133;, GO:0005829;GO:0002161;GO:0005524;GO:0004832;GO:0006418;GO:0006438;, C:cytosol;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:tRNA aminoacylation for protein translation; P:valyl-tRNA aminoacylation;|P26640 B0V1N1 B4DZ61 Q5JQ90 Q96E77 Q9UQM2,Valine--tRNA ligase,Protein G7a;Valyl-tRNA synthetase;, PF08264;PF00043;PF00133;, GO:0005829;GO:0002161;GO:0005524;GO:0004832;GO:0006418;GO:0006438;, C:cytosol;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:tRNA aminoacylation for protein translation; P:valyl-tRNA aminoacylation;|P26640 B0V1N1 B4DZ61 Q5JQ90 Q96E77 Q9UQM2,Valine--tRNA ligase,Protein G7a;Valyl-tRNA synthetase;, PF08264;PF00043;PF00133;, GO:0005829;GO:0002161;GO:0005524;GO:0004832;GO:0006418;GO:0006438;, C:cytosol;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:tRNA aminoacylation for protein translation; P:valyl-tRNA aminoacylation;|P26640 B0V1N1 B4DZ61 Q5JQ90 Q96E77 Q9UQM2,Valine--tRNA ligase,Protein G7a;Valyl-tRNA synthetase;, PF08264;PF00043;PF00133;, GO:0005829;GO:0002161;GO:0005524;GO:0004832;GO:0006418;GO:0006438;, C:cytosol;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:tRNA aminoacylation for protein translation; P:valyl-tRNA aminoacylation;|P26640 B0V1N1 B4DZ61 Q5JQ90 Q96E77 Q9UQM2,Valine--tRNA ligase,Protein G7a;Valyl-tRNA synthetase;, PF08264;PF00043;PF00133;, GO:0005829;GO:0002161;GO:0005524;GO:0004832;GO:0006418;GO:0006438;, C:cytosol;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:tRNA aminoacylation for protein translation; P:valyl-tRNA aminoacylation; scaffold40 indexed_genome mRNA 18830963 18840476 . + . ID=transcript_8320;Q9Y334 A2BEX8 A6NHR6 B0V041 Q5SSR5 Q96QC8 Q9UMP9,von Willebrand factor A domain-containing protein 7,Protein G7c;, , GO:0005576;, C:extracellular region;|Q9Y334 A2BEX8 A6NHR6 B0V041 Q5SSR5 Q96QC8 Q9UMP9,von Willebrand factor A domain-containing protein 7,Protein G7c;, , GO:0005576;, C:extracellular region;|Q9Y334 A2BEX8 A6NHR6 B0V041 Q5SSR5 Q96QC8 Q9UMP9,von Willebrand factor A domain-containing protein 7,Protein G7c;, , GO:0005576;, C:extracellular region;|Q9Y334 A2BEX8 A6NHR6 B0V041 Q5SSR5 Q96QC8 Q9UMP9,von Willebrand factor A domain-containing protein 7,Protein G7c;, , GO:0005576;, C:extracellular region;|Q5SSQ6 A2ABF2 A2ABS9 Q9Y335,Suppressor APC domain-containing protein 1,Protein G7d; scaffold40 indexed_genome mRNA 18841909 18853113 . - . ID=transcript_8321;O43196 B0V033 B0V034 O60586 Q5BLU9 Q5SSR1 Q8IW44 Q9BQC7,MutS protein homolog 5,, PF05192;PF05190;PF00488;, GO:0000228;GO:0005524;GO:0008094;GO:0030983;GO:0000710;GO:0007131;, C:nuclear chromosome;, F:ATP binding; F:DNA-dependent ATPase activity; F:mismatched DNA binding;, P:meiotic mismatch repair; P:reciprocal meiotic recombination;|O43196 B0V033 B0V034 O60586 Q5BLU9 Q5SSR1 Q8IW44 Q9BQC7,MutS protein homolog 5,, PF05192;PF05190;PF00488;, GO:0000228;GO:0005524;GO:0008094;GO:0030983;GO:0000710;GO:0007131;, C:nuclear chromosome;, F:ATP binding; F:DNA-dependent ATPase activity; F:mismatched DNA binding;, P:meiotic mismatch repair; P:reciprocal meiotic recombination; scaffold40 indexed_genome mRNA 18853574 18855560 . - . ID=transcript_8322;O43196 B0V033 B0V034 O60586 Q5BLU9 Q5SSR1 Q8IW44 Q9BQC7,MutS protein homolog 5,, PF05192;PF05190;PF00488;, GO:0000228;GO:0005524;GO:0008094;GO:0030983;GO:0000710;GO:0007131;, C:nuclear chromosome;, F:ATP binding; F:DNA-dependent ATPase activity; F:mismatched DNA binding;, P:meiotic mismatch repair; P:reciprocal meiotic recombination;|O43196 B0V033 B0V034 O60586 Q5BLU9 Q5SSR1 Q8IW44 Q9BQC7,MutS protein homolog 5,, PF05192;PF05190;PF00488;, GO:0000228;GO:0005524;GO:0008094;GO:0030983;GO:0000710;GO:0007131;, C:nuclear chromosome;, F:ATP binding; F:DNA-dependent ATPase activity; F:mismatched DNA binding;, P:meiotic mismatch repair; P:reciprocal meiotic recombination;|O43196 B0V033 B0V034 O60586 Q5BLU9 Q5SSR1 Q8IW44 Q9BQC7,MutS protein homolog 5,, PF05192;PF05190;PF00488;, GO:0000228;GO:0005524;GO:0008094;GO:0030983;GO:0000710;GO:0007131;, C:nuclear chromosome;, F:ATP binding; F:DNA-dependent ATPase activity; F:mismatched DNA binding;, P:meiotic mismatch repair; P:reciprocal meiotic recombination; scaffold40 indexed_genome mRNA 18859192 18864870 . + . ID=transcript_8323;O00299 Q15089 Q502X1,Chloride intracellular channel protein 1,Chloride channel ABP;Nuclear chloride ion channel 27;Regulatory nuclear chloride ion channel protein;, PF13409;, GO:0072562;GO:0005903;GO:0034707;GO:0005737;GO:0070062;GO:0005615;GO:0016020;GO:0005739;GO:0005635;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:0031982;GO:0045296;GO:0005254;GO:0005244;GO:0006821;GO:0006749;GO:0070527;GO:0045669;GO:0051726;GO:0034765;GO:0051881;GO:0007165;, C:blood microparticle; C:brush border; C:chloride channel complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:membrane; C:mitochondrion; C:nuclear envelope; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, F:cadherin binding; F:chloride channel activity; F:voltage-gated ion channel activity;, P:chloride transport; P:glutathione metabolic process; P:platelet aggregation; P:positive regulation of osteoblast differentiation; P:regulation of cell cycle; P:regulation of ion transmembrane transport; P:regulation of mitochondrial membrane potential; P:signal transduction;|O00299 Q15089 Q502X1,Chloride intracellular channel protein 1,Chloride channel ABP;Nuclear chloride ion channel 27;Regulatory nuclear chloride ion channel protein;, PF13409;, GO:0072562;GO:0005903;GO:0034707;GO:0005737;GO:0070062;GO:0005615;GO:0016020;GO:0005739;GO:0005635;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:0031982;GO:0045296;GO:0005254;GO:0005244;GO:0006821;GO:0006749;GO:0070527;GO:0045669;GO:0051726;GO:0034765;GO:0051881;GO:0007165;, C:blood microparticle; C:brush border; C:chloride channel complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:membrane; C:mitochondrion; C:nuclear envelope; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, F:cadherin binding; F:chloride channel activity; F:voltage-gated ion channel activity;, P:chloride transport; P:glutathione metabolic process; P:platelet aggregation; P:positive regulation of osteoblast differentiation; P:regulation of cell cycle; P:regulation of ion transmembrane transport; P:regulation of mitochondrial membrane potential; P:signal transduction; scaffold40 indexed_genome mRNA 18865265 18868615 . - . ID=transcript_8324;O95865 A2BEZ7,N(G),N(G)-dimethylarginine dimethylaminohydrolase 2,DDAHII;Dimethylargininase-2;Protein G6a;S-phase protein;, , GO:0005829;GO:0070062;GO:0005739;GO:0016597;GO:0003824;GO:0016403;GO:0006527;GO:0006525;GO:0000052;GO:0043066;GO:0006809;GO:0007263;GO:0045429;GO:0050999;, C:cytosol; C:extracellular exosome; C:mitochondrion;, F:amino acid binding; F:catalytic activity; F:dimethylargininase activity;, P:arginine catabolic process; P:arginine metabolic process; P:citrulline metabolic process; P:negative regulation of apoptotic process; P:nitric oxide biosynthetic process; P:nitric oxide mediated signal transduction; P:positive regulation of nitric oxide biosynthetic process; P:regulation of nitric-oxide synthase activity;|O95865 A2BEZ7,N(G),N(G)-dimethylarginine dimethylaminohydrolase 2,DDAHII;Dimethylargininase-2;Protein G6a;S-phase protein;, , GO:0005829;GO:0070062;GO:0005739;GO:0016597;GO:0003824;GO:0016403;GO:0006527;GO:0006525;GO:0000052;GO:0043066;GO:0006809;GO:0007263;GO:0045429;GO:0050999;, C:cytosol; C:extracellular exosome; C:mitochondrion;, F:amino acid binding; F:catalytic activity; F:dimethylargininase activity;, P:arginine catabolic process; P:arginine metabolic process; P:citrulline metabolic process; P:negative regulation of apoptotic process; P:nitric oxide biosynthetic process; P:nitric oxide mediated signal transduction; P:positive regulation of nitric oxide biosynthetic process; P:regulation of nitric-oxide synthase activity; scaffold40 indexed_genome mRNA 18889101 18901568 . + . ID=transcript_8325;O95870 A2BEY3 B7Z4R6 Q5SRR1 Q5SRR2 Q8WYH0 Q9NW33,Phosphatidylserine lipase ABHD16A {ECO:0000305},Alpha/beta hydrolase domain-containing protein 16A {ECO:0000305};HLA-B-associated transcript 5 {ECO:0000303|PubMed:25290914};Monoacylglycerol lipase ABHD16A {ECO:0000305};Protein G5;, PF00561;, GO:0016021;GO:0016020;GO:0047372;GO:0008474;GO:0004620;GO:0052651;GO:0006660;GO:1905344;, C:integral component of membrane; C:membrane;, F:acylglycerol lipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:monoacylglycerol catabolic process; P:phosphatidylserine catabolic process; P:prostaglandin catabolic process;|O95870 A2BEY3 B7Z4R6 Q5SRR1 Q5SRR2 Q8WYH0 Q9NW33,Phosphatidylserine lipase ABHD16A {ECO:0000305},Alpha/beta hydrolase domain-containing protein 16A {ECO:0000305};HLA-B-associated transcript 5 {ECO:0000303|PubMed:25290914};Monoacylglycerol lipase ABHD16A {ECO:0000305};Protein G5;, PF00561;, GO:0016021;GO:0016020;GO:0047372;GO:0008474;GO:0004620;GO:0052651;GO:0006660;GO:1905344;, C:integral component of membrane; C:membrane;, F:acylglycerol lipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:monoacylglycerol catabolic process; P:phosphatidylserine catabolic process; P:prostaglandin catabolic process;|O95870 A2BEY3 B7Z4R6 Q5SRR1 Q5SRR2 Q8WYH0 Q9NW33,Phosphatidylserine lipase ABHD16A {ECO:0000305},Alpha/beta hydrolase domain-containing protein 16A {ECO:0000305};HLA-B-associated transcript 5 {ECO:0000303|PubMed:25290914};Monoacylglycerol lipase ABHD16A {ECO:0000305};Protein G5;, PF00561;, GO:0016021;GO:0016020;GO:0047372;GO:0008474;GO:0004620;GO:0052651;GO:0006660;GO:1905344;, C:integral component of membrane; C:membrane;, F:acylglycerol lipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:monoacylglycerol catabolic process; P:phosphatidylserine catabolic process; P:prostaglandin catabolic process;|O95870 A2BEY3 B7Z4R6 Q5SRR1 Q5SRR2 Q8WYH0 Q9NW33,Phosphatidylserine lipase ABHD16A {ECO:0000305},Alpha/beta hydrolase domain-containing protein 16A {ECO:0000305};HLA-B-associated transcript 5 {ECO:0000303|PubMed:25290914};Monoacylglycerol lipase ABHD16A {ECO:0000305};Protein G5;, PF00561;, GO:0016021;GO:0016020;GO:0047372;GO:0008474;GO:0004620;GO:0052651;GO:0006660;GO:1905344;, C:integral component of membrane; C:membrane;, F:acylglycerol lipase activity; F:palmitoyl-(protein) hydrolase activity; F:phospholipase activity;, P:monoacylglycerol catabolic process; P:phosphatidylserine catabolic process; P:prostaglandin catabolic process; scaffold40 indexed_genome mRNA 18910826 18917212 . - . ID=transcript_8326;Q8NDX9 B0UXB2 B0UZ65 B0UZP8 B7ZCA3 Q5SQ62 Q5SST3 Q9UKT0 Q9UMQ0,Lymphocyte antigen 6 complex locus protein G5b,, , GO:0005576;GO:0032991;GO:0042802;, C:extracellular region; C:protein-containing complex;, F:identical protein binding;|P67870 B0UXA9 P07312 P13862 Q4VX47,Casein kinase II subunit beta,Phosvitin;Protein G5a;, PF01214;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0005956;GO:0034774;GO:0003682;GO:0042802;GO:0046872;GO:0019904;GO:0019887;GO:0004674;GO:0005102;GO:0008134;GO:0033211;GO:0034622;GO:0061154;GO:0016236;GO:0007076;GO:0043537;GO:0008285;GO:0043312;GO:0018107;GO:0006656;GO:0032927;GO:0010862;GO:0006457;GO:0051101;GO:1901796;GO:0007165;GO:0016055;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:protein kinase CK2 complex; C:secretory granule lumen;, F:chromatin binding; F:identical protein binding; F:metal ion binding; F:protein domain specific binding; F:protein kinase regulator activity; F:protein serine/threonine kinase activity; F:signaling receptor binding; F:transcription factor binding;, P:adiponectin-activated signaling pathway; P:cellular protein-containing complex assembly; P:endothelial tube morphogenesis; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell population proliferation; P:neutrophil degranulation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of activin receptor signaling pathway; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:protein folding; P:regulation of DNA binding; P:regulation of signal transduction by p53 class mediator; P:signal transduction; P:Wnt signaling pathway;|P67870 B0UXA9 P07312 P13862 Q4VX47,Casein kinase II subunit beta,Phosvitin;Protein G5a;, PF01214;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0005956;GO:0034774;GO:0003682;GO:0042802;GO:0046872;GO:0019904;GO:0019887;GO:0004674;GO:0005102;GO:0008134;GO:0033211;GO:0034622;GO:0061154;GO:0016236;GO:0007076;GO:0043537;GO:0008285;GO:0043312;GO:0018107;GO:0006656;GO:0032927;GO:0010862;GO:0006457;GO:0051101;GO:1901796;GO:0007165;GO:0016055;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:protein kinase CK2 complex; C:secretory granule lumen;, F:chromatin binding; F:identical protein binding; F:metal ion binding; F:protein domain specific binding; F:protein kinase regulator activity; F:protein serine/threonine kinase activity; F:signaling receptor binding; F:transcription factor binding;, P:adiponectin-activated signaling pathway; P:cellular protein-containing complex assembly; P:endothelial tube morphogenesis; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell population proliferation; P:neutrophil degranulation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of activin receptor signaling pathway; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:protein folding; P:regulation of DNA binding; P:regulation of signal transduction by p53 class mediator; P:signal transduction; P:Wnt signaling pathway;|P67870 B0UXA9 P07312 P13862 Q4VX47,Casein kinase II subunit beta,Phosvitin;Protein G5a;, PF01214;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0005956;GO:0034774;GO:0003682;GO:0042802;GO:0046872;GO:0019904;GO:0019887;GO:0004674;GO:0005102;GO:0008134;GO:0033211;GO:0034622;GO:0061154;GO:0016236;GO:0007076;GO:0043537;GO:0008285;GO:0043312;GO:0018107;GO:0006656;GO:0032927;GO:0010862;GO:0006457;GO:0051101;GO:1901796;GO:0007165;GO:0016055;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:protein kinase CK2 complex; C:secretory granule lumen;, F:chromatin binding; F:identical protein binding; F:metal ion binding; F:protein domain specific binding; F:protein kinase regulator activity; F:protein serine/threonine kinase activity; F:signaling receptor binding; F:transcription factor binding;, P:adiponectin-activated signaling pathway; P:cellular protein-containing complex assembly; P:endothelial tube morphogenesis; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell population proliferation; P:neutrophil degranulation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of activin receptor signaling pathway; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:protein folding; P:regulation of DNA binding; P:regulation of signal transduction by p53 class mediator; P:signal transduction; P:Wnt signaling pathway; scaffold40 indexed_genome mRNA 18918270 18920593 . + . ID=transcript_8327;O95872 A6NG25 B0UXA2 Q5SQ49,G patch domain and ankyrin repeat-containing protein 1,Ankyrin repeat domain-containing protein 59;G patch domain-containing protein 10;HLA-B-associated transcript 4;Protein G5;, PF01585;, GO:0003676;, , F:nucleic acid binding;|O95872 A6NG25 B0UXA2 Q5SQ49,G patch domain and ankyrin repeat-containing protein 1,Ankyrin repeat domain-containing protein 59;G patch domain-containing protein 10;HLA-B-associated transcript 4;Protein G5;, PF01585;, GO:0003676;, , F:nucleic acid binding; scaffold40 indexed_genome mRNA 18921871 18923555 . - . ID=transcript_8328;O95873 B0UXA1 B0UZ50 Q5SSS6 Q95IG0,Uncharacterized protein C6orf47,Protein G4;, PF15576; scaffold40 indexed_genome mRNA 18924487 18939849 . - . ID=transcript_8329;O95445 B0UX98 Q5SRP4 Q9P046 Q9UMP6,Apolipoprotein M,Protein G3a;, PF11032;, GO:0034365;GO:0005576;GO:0034364;GO:0034362;GO:0034366;GO:0034361;GO:0016209;GO:0005319;GO:0005543;GO:0033344;GO:0042632;GO:0034380;GO:0034384;GO:0034375;GO:0042157;GO:0034445;GO:0009749;GO:0001523;GO:0043691;, C:discoidal high-density lipoprotein particle; C:extracellular region; C:high-density lipoprotein particle; C:low-density lipoprotein particle; C:spherical high-density lipoprotein particle; C:very-low-density lipoprotein particle;, F:antioxidant activity; F:lipid transporter activity; F:phospholipid binding;, P:cholesterol efflux; P:cholesterol homeostasis; P:high-density lipoprotein particle assembly; P:high-density lipoprotein particle clearance; P:high-density lipoprotein particle remodeling; P:lipoprotein metabolic process; P:negative regulation of plasma lipoprotein oxidation; P:response to glucose; P:retinoid metabolic process; P:reverse cholesterol transport;|O95445 B0UX98 Q5SRP4 Q9P046 Q9UMP6,Apolipoprotein M,Protein G3a;, PF11032;, GO:0034365;GO:0005576;GO:0034364;GO:0034362;GO:0034366;GO:0034361;GO:0016209;GO:0005319;GO:0005543;GO:0033344;GO:0042632;GO:0034380;GO:0034384;GO:0034375;GO:0042157;GO:0034445;GO:0009749;GO:0001523;GO:0043691;, C:discoidal high-density lipoprotein particle; C:extracellular region; C:high-density lipoprotein particle; C:low-density lipoprotein particle; C:spherical high-density lipoprotein particle; C:very-low-density lipoprotein particle;, F:antioxidant activity; F:lipid transporter activity; F:phospholipid binding;, P:cholesterol efflux; P:cholesterol homeostasis; P:high-density lipoprotein particle assembly; P:high-density lipoprotein particle clearance; P:high-density lipoprotein particle remodeling; P:lipoprotein metabolic process; P:negative regulation of plasma lipoprotein oxidation; P:response to glucose; P:retinoid metabolic process; P:reverse cholesterol transport;|Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold40 indexed_genome mRNA 18940757 18946845 . - . ID=transcript_8330;Q5ST84 Q5STX6 Q5STX7 Q68DW9 Q6P9P7 Q6PIN1 Q8MGQ9 Q96QC6,Protein PRRC2A,HLA-B-associated transcript 2;Large proline-rich protein BAT2;Proline-rich and coiled-coil-containing protein 2A;Protein G2;, PF07001;, GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0003723;GO:0030154;, C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:RNA binding;, P:cell differentiation; scaffold40 indexed_genome mRNA 18946868 18956135 . - . ID=transcript_8331;Q5ST84 Q5STX6 Q5STX7 Q68DW9 Q6P9P7 Q6PIN1 Q8MGQ9 Q96QC6,Protein PRRC2A,HLA-B-associated transcript 2;Large proline-rich protein BAT2;Proline-rich and coiled-coil-containing protein 2A;Protein G2;, PF07001;, GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0003723;GO:0030154;, C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:RNA binding;, P:cell differentiation;|Q5ST84 Q5STX6 Q5STX7 Q68DW9 Q6P9P7 Q6PIN1 Q8MGQ9 Q96QC6,Protein PRRC2A,HLA-B-associated transcript 2;Large proline-rich protein BAT2;Proline-rich and coiled-coil-containing protein 2A;Protein G2;, PF07001;, GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0003723;GO:0030154;, C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:RNA binding;, P:cell differentiation; scaffold40 indexed_genome mRNA 18960830 18970552 . - . ID=transcript_8332;P55008 A8K406 O43904 Q9UIV4 Q9UKS9,Allograft inflammatory factor 1,Ionized calcium-binding adapter molecule 1;Protein G1;, , GO:0005884;GO:0005737;GO:0005829;GO:0030027;GO:0005634;GO:0048471;GO:0001891;GO:0001726;GO:0032587;GO:0051015;GO:0005509;GO:0051764;GO:0051017;GO:0030041;GO:0071346;GO:0034599;GO:0006954;GO:0001774;GO:0071672;GO:0048662;GO:0030046;GO:0006911;GO:0030335;GO:0008284;GO:0032722;GO:0050921;GO:0090271;GO:1900087;GO:0032755;GO:0090026;GO:0071677;GO:0071673;GO:0048661;GO:2000406;GO:0042102;GO:0016601;GO:0010468;GO:0097178;, C:actin filament; C:cytoplasm; C:cytosol; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:phagocytic cup; C:ruffle; C:ruffle membrane;, F:actin filament binding; F:calcium ion binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:actin filament polymerization; P:cellular response to interferon-gamma; P:cellular response to oxidative stress; P:inflammatory response; P:microglial cell activation; P:negative regulation of smooth muscle cell chemotaxis; P:negative regulation of smooth muscle cell proliferation; P:parallel actin filament bundle assembly; P:phagocytosis, engulfment; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemokine production; P:positive regulation of chemotaxis; P:positive regulation of fibroblast growth factor production; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of interleukin-6 production; P:positive regulation of monocyte chemotaxis; P:positive regulation of mononuclear cell migration; P:positive regulation of smooth muscle cell chemotaxis; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T cell migration; P:positive regulation of T cell proliferation; P:Rac protein signal transduction; P:regulation of gene expression; P:ruffle assembly;|P55008 A8K406 O43904 Q9UIV4 Q9UKS9,Allograft inflammatory factor 1,Ionized calcium-binding adapter molecule 1;Protein G1;, , GO:0005884;GO:0005737;GO:0005829;GO:0030027;GO:0005634;GO:0048471;GO:0001891;GO:0001726;GO:0032587;GO:0051015;GO:0005509;GO:0051764;GO:0051017;GO:0030041;GO:0071346;GO:0034599;GO:0006954;GO:0001774;GO:0071672;GO:0048662;GO:0030046;GO:0006911;GO:0030335;GO:0008284;GO:0032722;GO:0050921;GO:0090271;GO:1900087;GO:0032755;GO:0090026;GO:0071677;GO:0071673;GO:0048661;GO:2000406;GO:0042102;GO:0016601;GO:0010468;GO:0097178;, C:actin filament; C:cytoplasm; C:cytosol; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm; C:phagocytic cup; C:ruffle; C:ruffle membrane;, F:actin filament binding; F:calcium ion binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:actin filament polymerization; P:cellular response to interferon-gamma; P:cellular response to oxidative stress; P:inflammatory response; P:microglial cell activation; P:negative regulation of smooth muscle cell chemotaxis; P:negative regulation of smooth muscle cell proliferation; P:parallel actin filament bundle assembly; P:phagocytosis, engulfment; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemokine production; P:positive regulation of chemotaxis; P:positive regulation of fibroblast growth factor production; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of interleukin-6 production; P:positive regulation of monocyte chemotaxis; P:positive regulation of mononuclear cell migration; P:positive regulation of smooth muscle cell chemotaxis; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T cell migration; P:positive regulation of T cell proliferation; P:Rac protein signal transduction; P:regulation of gene expression; P:ruffle assembly; scaffold40 indexed_genome mRNA 18986203 18987447 . + . ID=transcript_8333;Q5ST89 Q5ST90 Q5ST91 Q5ST92 Q5STA3,Natural cytotoxicity triggering receptor 3,Activating natural killer receptor p30;Natural killer cell p30-related protein;, PF07686;, GO:0005887;GO:0005886;GO:0042802;GO:0008037;GO:0006955;GO:0002429;GO:0006954;GO:0030101;GO:0045954;GO:0050776;, C:integral component of plasma membrane; C:plasma membrane;, F:identical protein binding;, P:cell recognition; P:immune response; P:immune response-activating cell surface receptor signaling pathway; P:inflammatory response; P:natural killer cell activation; P:positive regulation of natural killer cell mediated cytotoxicity; P:regulation of immune response; scaffold40 indexed_genome mRNA 18987456 18990714 . - . ID=transcript_8334;Q9UJR8 Q9UJS1,Leukocyte-specific transcript 1 protein,Protein B144;, PF05083;, GO:0005737;GO:0005794;GO:0000139;GO:0016021;GO:0009653;GO:0000902;GO:0016358;GO:0006955;GO:0050672;GO:0008360;, C:cytoplasm; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:anatomical structure morphogenesis; P:cell morphogenesis; P:dendrite development; P:immune response; P:negative regulation of lymphocyte proliferation; P:regulation of cell shape; scaffold40 indexed_genome mRNA 18993551 18995529 . - . ID=transcript_8335;Q06643 P78370 Q52LU8 Q99761,Lymphotoxin-beta,Tumor necrosis factor C;Tumor necrosis factor ligand superfamily member 3;, PF00229;, GO:0005615;GO:0016021;GO:0005886;GO:0005125;GO:0005102;GO:0005164;GO:0007267;GO:0010467;GO:0006955;GO:0048535;GO:0032735;GO:0007165;GO:0043588;GO:0033209;, C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:cytokine activity; F:signaling receptor binding; F:tumor necrosis factor receptor binding;, P:cell-cell signaling; P:gene expression; P:immune response; P:lymph node development; P:positive regulation of interleukin-12 production; P:signal transduction; P:skin development; P:tumor necrosis factor-mediated signaling pathway;|Q06643 P78370 Q52LU8 Q99761,Lymphotoxin-beta,Tumor necrosis factor C;Tumor necrosis factor ligand superfamily member 3;, PF00229;, GO:0005615;GO:0016021;GO:0005886;GO:0005125;GO:0005102;GO:0005164;GO:0007267;GO:0010467;GO:0006955;GO:0048535;GO:0032735;GO:0007165;GO:0043588;GO:0033209;, C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:cytokine activity; F:signaling receptor binding; F:tumor necrosis factor receptor binding;, P:cell-cell signaling; P:gene expression; P:immune response; P:lymph node development; P:positive regulation of interleukin-12 production; P:signal transduction; P:skin development; P:tumor necrosis factor-mediated signaling pathway; scaffold40 indexed_genome mRNA 19012282 19022582 . - . ID=transcript_8336;Q9UBX4,NF-kappa-B inhibitor-like protein 1,Inhibitor of kappa B-like protein;Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1;, , GO:0005829;GO:0005654;GO:0005634;GO:0071222;GO:0007249;GO:0031665;GO:0032088;GO:0034122;GO:0032720;, C:cytosol; C:nucleoplasm; C:nucleus;, , P:cellular response to lipopolysaccharide; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; scaffold40 indexed_genome mRNA 19024067 19039250 . - . ID=transcript_8337;O95670 B5MEF0 Q2L6F8 Q5HYU8 Q5RJ63,V-type proton ATPase subunit G 2,V-ATPase 13 kDa subunit 2;Vacuolar proton pump subunit G 2;, PF03179;, GO:0005829;GO:0042470;GO:0016471;GO:0042626;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:cytosol; C:melanosome; C:vacuolar proton-transporting V-type ATPase complex;, F:ATPase-coupled transmembrane transporter activity;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|O95670 B5MEF0 Q2L6F8 Q5HYU8 Q5RJ63,V-type proton ATPase subunit G 2,V-ATPase 13 kDa subunit 2;Vacuolar proton pump subunit G 2;, PF03179;, GO:0005829;GO:0042470;GO:0016471;GO:0042626;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:cytosol; C:melanosome; C:vacuolar proton-transporting V-type ATPase complex;, F:ATPase-coupled transmembrane transporter activity;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|Q5STB4 Q5STB5 Q5STB7 Q5STB8 Q5STU4 Q5STU5 Q5STU6 Q5STU8 Q71V76,Spliceosome RNA helicase DDX39B {ECO:0000305},56 kDa U2AF65-associated protein;ATP-dependent RNA helicase p47;DEAD box protein UAP56;HLA-B-associated transcript 1 protein;, PF00270;PF00271;, GO:0005737;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0000346;GO:0005524;GO:0043008;GO:0016887;GO:0042802;GO:0044877;GO:0003723;GO:0003724;GO:0008186;GO:0030621;GO:0017070;GO:0001889;GO:0031124;GO:0006406;GO:0000398;GO:2000002;GO:0061051;GO:2000573;GO:0032786;GO:0045727;GO:1904707;GO:0006405;GO:0010501;GO:0008380;GO:0000245;GO:0046784;, C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:transcription export complex;, F:ATP binding; F:ATP-dependent protein binding; F:ATPase activity; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:RNA helicase activity; F:RNA-dependent ATPase activity; F:U4 snRNA binding; F:U6 snRNA binding;, P:liver development; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of DNA damage checkpoint; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of translation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:RNA export from nucleus; P:RNA secondary structure unwinding; P:RNA splicing; P:spliceosomal complex assembly; P:viral mRNA export from host cell nucleus;|Q5STB4 Q5STB5 Q5STB7 Q5STB8 Q5STU4 Q5STU5 Q5STU6 Q5STU8 Q71V76,Spliceosome RNA helicase DDX39B {ECO:0000305},56 kDa U2AF65-associated protein;ATP-dependent RNA helicase p47;DEAD box protein UAP56;HLA-B-associated transcript 1 protein;, PF00270;PF00271;, GO:0005737;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0000346;GO:0005524;GO:0043008;GO:0016887;GO:0042802;GO:0044877;GO:0003723;GO:0003724;GO:0008186;GO:0030621;GO:0017070;GO:0001889;GO:0031124;GO:0006406;GO:0000398;GO:2000002;GO:0061051;GO:2000573;GO:0032786;GO:0045727;GO:1904707;GO:0006405;GO:0010501;GO:0008380;GO:0000245;GO:0046784;, C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:transcription export complex;, F:ATP binding; F:ATP-dependent protein binding; F:ATPase activity; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:RNA helicase activity; F:RNA-dependent ATPase activity; F:U4 snRNA binding; F:U6 snRNA binding;, P:liver development; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of DNA damage checkpoint; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of translation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:RNA export from nucleus; P:RNA secondary structure unwinding; P:RNA splicing; P:spliceosomal complex assembly; P:viral mRNA export from host cell nucleus;|Q5STB4 Q5STB5 Q5STB7 Q5STB8 Q5STU4 Q5STU5 Q5STU6 Q5STU8 Q71V76,Spliceosome RNA helicase DDX39B {ECO:0000305},56 kDa U2AF65-associated protein;ATP-dependent RNA helicase p47;DEAD box protein UAP56;HLA-B-associated transcript 1 protein;, PF00270;PF00271;, GO:0005737;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0000346;GO:0005524;GO:0043008;GO:0016887;GO:0042802;GO:0044877;GO:0003723;GO:0003724;GO:0008186;GO:0030621;GO:0017070;GO:0001889;GO:0031124;GO:0006406;GO:0000398;GO:2000002;GO:0061051;GO:2000573;GO:0032786;GO:0045727;GO:1904707;GO:0006405;GO:0010501;GO:0008380;GO:0000245;GO:0046784;, C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:transcription export complex;, F:ATP binding; F:ATP-dependent protein binding; F:ATPase activity; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:RNA helicase activity; F:RNA-dependent ATPase activity; F:U4 snRNA binding; F:U6 snRNA binding;, P:liver development; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of DNA damage checkpoint; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of translation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:RNA export from nucleus; P:RNA secondary structure unwinding; P:RNA splicing; P:spliceosomal complex assembly; P:viral mRNA export from host cell nucleus; scaffold40 indexed_genome mRNA 19040527 19041287 . - . ID=transcript_8338;P59942 A2AB29 A2RUP7 B0UZB2 Q7RTY2,Mitochondrial coiled-coil domain protein 1,, PF15707;, GO:0005739;, C:mitochondrion; scaffold40 indexed_genome mRNA 19063143 19090750 . + . ID=transcript_8339;Q9TQH6 Q9TQH7 Q9TQH8 Q9TQH9 Q9TQM2 Q9TQN4 Q9TQN6 Q9UQS8 Q9UQT0,HLA class I histocompatibility antigen, B alpha chain,Human leukocyte antigen B;, PF07654;PF00129;PF06623;, GO:0009986;GO:0031901;GO:0005783;GO:0012507;GO:0070062;GO:0005794;GO:0000139;GO:0071556;GO:0005887;GO:0016020;GO:0042612;GO:0030670;GO:0005886;GO:0055038;GO:0030667;GO:0051087;GO:0042605;GO:0005102;GO:0046977;GO:0002250;GO:0002486;GO:0002479;GO:0002480;GO:0002474;GO:0006952;GO:0016045;GO:0006955;GO:0060333;GO:0043312;GO:0001916;GO:0042270;GO:2001198;GO:0050776;GO:0032655;GO:0032675;GO:0002667;GO:0060337;GO:0016032;, C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane; C:MHC class I protein complex; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome membrane; C:secretory granule membrane;, F:chaperone binding; F:peptide antigen binding; F:signaling receptor binding; F:TAP binding;, P:adaptive immune response; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; P:antigen processing and presentation of peptide antigen via MHC class I; P:defense response; P:detection of bacterium; P:immune response; P:interferon-gamma-mediated signaling pathway; P:neutrophil degranulation; P:positive regulation of T cell mediated cytotoxicity; P:protection from natural killer cell mediated cytotoxicity; P:regulation of dendritic cell differentiation; P:regulation of immune response; P:regulation of interleukin-12 production; P:regulation of interleukin-6 production; P:regulation of T cell anergy; P:type I interferon signaling pathway; P:viral process; scaffold40 indexed_genome mRNA 19104712 19106257 . + . ID=transcript_8340;P30511 Q5JQI8 Q5JQJ1 Q5SPT5 Q860R0 Q8MGQ1 Q8WLP5 Q95HC0 Q9TP68,HLA class I histocompatibility antigen, alpha chain F,CDA12;HLA F antigen;Leukocyte antigen F {ECO:0000303|PubMed:1688605};MHC class I antigen F;, PF07654;PF00129;, GO:0009986;GO:0031901;GO:0005783;GO:0012507;GO:0009897;GO:0005615;GO:0000139;GO:0071556;GO:0005765;GO:0016020;GO:0042612;GO:0032398;GO:0030670;GO:0005886;GO:0055038;GO:0071889;GO:0030881;GO:0042605;GO:0046978;GO:0046979;GO:0002476;GO:0002479;GO:0002480;GO:0002477;GO:0002474;GO:0060333;GO:0002728;GO:0043322;GO:0045953;GO:1901215;GO:0002725;GO:0002729;GO:0043323;GO:0001916;GO:0050776;GO:0060337;, C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:ER to Golgi transport vesicle membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:lysosomal membrane; C:membrane; C:MHC class I protein complex; C:MHC class Ib protein complex; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome membrane;, F:14-3-3 protein binding; F:beta-2-microglobulin binding; F:peptide antigen binding; F:TAP1 binding; F:TAP2 binding;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; P:antigen processing and presentation of exogenous peptide antigen via MHC class Ib; P:antigen processing and presentation of peptide antigen via MHC class I; P:interferon-gamma-mediated signaling pathway; P:negative regulation of natural killer cell cytokine production; P:negative regulation of natural killer cell degranulation; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of neuron death; P:negative regulation of T cell cytokine production; P:positive regulation of natural killer cell cytokine production; P:positive regulation of natural killer cell degranulation; P:positive regulation of T cell mediated cytotoxicity; P:regulation of immune response; P:type I interferon signaling pathway; scaffold40 indexed_genome mRNA 19213975 19217608 . - . ID=transcript_8341;Q9BUM2 Q9UBH7,Transcription factor 19,Transcription factor SC1;, PF00498;, GO:0005634;GO:0046872;GO:0010468;, C:nucleus;, F:metal ion binding;, P:regulation of gene expression; scaffold40 indexed_genome mRNA 19218505 19229372 . + . ID=transcript_8342;Q9NXK3 Q9Y6W1 Q9Y6W2,Coiled-coil alpha-helical rod protein 1,Alpha-helical coiled-coil rod protein;Putative gene 8 protein;, PF07111;, GO:0005814;GO:0005829;GO:0005634;GO:0042802;GO:0030154;GO:0007275;GO:0006611;, C:centriole; C:cytosol; C:nucleus;, F:identical protein binding;, P:cell differentiation; P:multicellular organism development; P:protein export from nucleus;|Q9NXK3 Q9Y6W1 Q9Y6W2,Coiled-coil alpha-helical rod protein 1,Alpha-helical coiled-coil rod protein;Putative gene 8 protein;, PF07111;, GO:0005814;GO:0005829;GO:0005634;GO:0042802;GO:0030154;GO:0007275;GO:0006611;, C:centriole; C:cytosol; C:nucleus;, F:identical protein binding;, P:cell differentiation; P:multicellular organism development; P:protein export from nucleus;|Q9NXK3 Q9Y6W1 Q9Y6W2,Coiled-coil alpha-helical rod protein 1,Alpha-helical coiled-coil rod protein;Putative gene 8 protein;, PF07111;, GO:0005814;GO:0005829;GO:0005634;GO:0042802;GO:0030154;GO:0007275;GO:0006611;, C:centriole; C:cytosol; C:nucleus;, F:identical protein binding;, P:cell differentiation; P:multicellular organism development; P:protein export from nucleus;|Q9NXK3 Q9Y6W1 Q9Y6W2,Coiled-coil alpha-helical rod protein 1,Alpha-helical coiled-coil rod protein;Putative gene 8 protein;, PF07111;, GO:0005814;GO:0005829;GO:0005634;GO:0042802;GO:0030154;GO:0007275;GO:0006611;, C:centriole; C:cytosol; C:nucleus;, F:identical protein binding;, P:cell differentiation; P:multicellular organism development; P:protein export from nucleus;|Q9NXK3 Q9Y6W1 Q9Y6W2,Coiled-coil alpha-helical rod protein 1,Alpha-helical coiled-coil rod protein;Putative gene 8 protein;, PF07111;, GO:0005814;GO:0005829;GO:0005634;GO:0042802;GO:0030154;GO:0007275;GO:0006611;, C:centriole; C:cytosol; C:nucleus;, F:identical protein binding;, P:cell differentiation; P:multicellular organism development; P:protein export from nucleus;|Q9NXK3 Q9Y6W1 Q9Y6W2,Coiled-coil alpha-helical rod protein 1,Alpha-helical coiled-coil rod protein;Putative gene 8 protein;, PF07111;, GO:0005814;GO:0005829;GO:0005634;GO:0042802;GO:0030154;GO:0007275;GO:0006611;, C:centriole; C:cytosol; C:nucleus;, F:identical protein binding;, P:cell differentiation; P:multicellular organism development; P:protein export from nucleus; scaffold40 indexed_genome mRNA 19278908 19282080 . + . ID=transcript_8343;Q9UQU7,HLA class I histocompatibility antigen, A alpha chain,Human leukocyte antigen A;, PF07654;PF00129;PF06623;, GO:0009986;GO:0031901;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0070062;GO:0005794;GO:0005797;GO:0000139;GO:0071556;GO:0005887;GO:0016020;GO:0042824;GO:0042612;GO:0030670;GO:0005886;GO:0055038;GO:0030881;GO:0042610;GO:0042605;GO:0003723;GO:0005102;GO:0042608;GO:0046977;GO:0062061;GO:0019731;GO:0019885;GO:0002485;GO:0002486;GO:0042590;GO:0002479;GO:0002480;GO:0002474;GO:0036037;GO:0050830;GO:0016045;GO:0006955;GO:0060333;GO:2001187;GO:2000566;GO:0032729;GO:2000568;GO:0002726;GO:0001916;GO:0042270;GO:0016567;GO:0050776;GO:0001913;GO:0002419;GO:0050852;GO:0060337;GO:0016032;, C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane; C:MHC class I peptide loading complex; C:MHC class I protein complex; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome membrane;, F:beta-2-microglobulin binding; F:CD8 receptor binding; F:peptide antigen binding; F:RNA binding; F:signaling receptor binding; F:T cell receptor binding; F:TAP binding; F:TAP complex binding;, P:antibacterial humoral response; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; P:antigen processing and presentation of peptide antigen via MHC class I; P:CD8-positive, alpha-beta T cell activation; P:defense response to Gram-positive bacterium; P:detection of bacterium; P:immune response; P:interferon-gamma-mediated signaling pathway; P:positive regulation of CD8-positive, alpha-beta T cell activation; P:positive regulation of CD8-positive, alpha-beta T cell proliferation; P:positive regulation of interferon-gamma production; P:positive regulation of memory T cell activation; P:positive regulation of T cell cytokine production; P:positive regulation of T cell mediated cytotoxicity; P:protection from natural killer cell mediated cytotoxicity; P:protein ubiquitination; P:regulation of immune response; P:T cell mediated cytotoxicity; P:T cell mediated cytotoxicity directed against tumor cell target; P:T cell receptor signaling pathway; P:type I interferon signaling pathway; P:viral process; scaffold40 indexed_genome mRNA 19352647 19354031 . + . ID=transcript_8344;Q6UW10 A2ABK7 A2ACH1 B7ZCJ7,Surfactant-associated protein 2,Surfactant-associated protein G;, PF15210;, GO:0005576;GO:0005794;GO:0030133;, C:extracellular region; C:Golgi apparatus; C:transport vesicle; scaffold40 indexed_genome mRNA 19356769 19377126 . - . ID=transcript_8345;Q5SS98 Q6DKJ5 Q6ZV24 Q96GN2 Q96H77 Q96Q02 Q9H6R2 Q9UFH7,Valine--tRNA ligase, mitochondrial,Valyl-tRNA synthetase;Valyl-tRNA synthetase-like;, PF08264;PF00133;, GO:0005829;GO:0005739;GO:0002161;GO:0005524;GO:0004832;GO:0006438;, C:cytosol; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:valyl-tRNA aminoacylation;|Q5SS98 Q6DKJ5 Q6ZV24 Q96GN2 Q96H77 Q96Q02 Q9H6R2 Q9UFH7,Valine--tRNA ligase, mitochondrial,Valyl-tRNA synthetase;Valyl-tRNA synthetase-like;, PF08264;PF00133;, GO:0005829;GO:0005739;GO:0002161;GO:0005524;GO:0004832;GO:0006438;, C:cytosol; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:valyl-tRNA aminoacylation;|Q5SS98 Q6DKJ5 Q6ZV24 Q96GN2 Q96H77 Q96Q02 Q9H6R2 Q9UFH7,Valine--tRNA ligase, mitochondrial,Valyl-tRNA synthetase;Valyl-tRNA synthetase-like;, PF08264;PF00133;, GO:0005829;GO:0005739;GO:0002161;GO:0005524;GO:0004832;GO:0006438;, C:cytosol; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:valyl-tRNA aminoacylation;|Q5SS98 Q6DKJ5 Q6ZV24 Q96GN2 Q96H77 Q96Q02 Q9H6R2 Q9UFH7,Valine--tRNA ligase, mitochondrial,Valyl-tRNA synthetase;Valyl-tRNA synthetase-like;, PF08264;PF00133;, GO:0005829;GO:0005739;GO:0002161;GO:0005524;GO:0004832;GO:0006438;, C:cytosol; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:valyl-tRNA aminoacylation;|Q5SS98 Q6DKJ5 Q6ZV24 Q96GN2 Q96H77 Q96Q02 Q9H6R2 Q9UFH7,Valine--tRNA ligase, mitochondrial,Valyl-tRNA synthetase;Valyl-tRNA synthetase-like;, PF08264;PF00133;, GO:0005829;GO:0005739;GO:0002161;GO:0005524;GO:0004832;GO:0006438;, C:cytosol; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:valyl-tRNA aminoacylation;|Q5SS98 Q6DKJ5 Q6ZV24 Q96GN2 Q96H77 Q96Q02 Q9H6R2 Q9UFH7,Valine--tRNA ligase, mitochondrial,Valyl-tRNA synthetase;Valyl-tRNA synthetase-like;, PF08264;PF00133;, GO:0005829;GO:0005739;GO:0002161;GO:0005524;GO:0004832;GO:0006438;, C:cytosol; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:valine-tRNA ligase activity;, P:valyl-tRNA aminoacylation;|Q92759 B4DTJ5 Q76KU4,General transcription factor IIH subunit 4,Basic transcription factor 2 52 kDa subunit;General transcription factor IIH polypeptide 4;TFIIH basal transcription factor complex p52 subunit;, PF03849;PF18307;, GO:0000438;GO:0016607;GO:0005654;GO:0005634;GO:0005669;GO:0000439;GO:0005675;GO:0001671;GO:0003690;GO:0016251;GO:0006370;GO:0006281;GO:0070911;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:core TFIIH complex portion of holo TFIIH complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, F:ATPase activator activity; F:double-stranded DNA binding; F:RNA polymerase II general transcription initiation factor activity;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; scaffold40 indexed_genome mRNA 19383152 19403615 . - . ID=transcript_8346;Q5ST12 Q6NSK4 Q9UD35 Q9UD36 Q9UD37 Q9UD86 Q9UDL2,Epithelial discoidin domain-containing receptor 1,CD167 antigen-like family member A;Cell adhesion kinase;Discoidin receptor tyrosine kinase;HGK2;Mammary carcinoma kinase 10;Protein-tyrosine kinase 3A;Protein-tyrosine kinase RTK-6;TRK E;Tyrosine kinase DDR;Tyrosine-protein kinase CAK;, PF00754;PF07714;, GO:0070062;GO:0005615;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0005518;GO:0046872;GO:0038062;GO:0004714;GO:0061564;GO:0060444;GO:0007155;GO:0038063;GO:0043583;GO:0007566;GO:0030198;GO:0007595;GO:0060749;GO:0007275;GO:0008285;GO:1990138;GO:0038083;GO:0033674;GO:0046777;GO:0001558;GO:0001952;GO:0010715;GO:0014909;GO:0061302;GO:0007169;GO:0044319;, C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:collagen binding; F:metal ion binding; F:protein tyrosine kinase collagen receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:axon development; P:branching involved in mammary gland duct morphogenesis; P:cell adhesion; P:collagen-activated tyrosine kinase receptor signaling pathway; P:ear development; P:embryo implantation; P:extracellular matrix organization; P:lactation; P:mammary gland alveolus development; P:multicellular organism development; P:negative regulation of cell population proliferation; P:neuron projection extension; P:peptidyl-tyrosine autophosphorylation; P:positive regulation of kinase activity; P:protein autophosphorylation; P:regulation of cell growth; P:regulation of cell-matrix adhesion; P:regulation of extracellular matrix disassembly; P:smooth muscle cell migration; P:smooth muscle cell-matrix adhesion; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing, spreading of cells;|Q5ST12 Q6NSK4 Q9UD35 Q9UD36 Q9UD37 Q9UD86 Q9UDL2,Epithelial discoidin domain-containing receptor 1,CD167 antigen-like family member A;Cell adhesion kinase;Discoidin receptor tyrosine kinase;HGK2;Mammary carcinoma kinase 10;Protein-tyrosine kinase 3A;Protein-tyrosine kinase RTK-6;TRK E;Tyrosine kinase DDR;Tyrosine-protein kinase CAK;, PF00754;PF07714;, GO:0070062;GO:0005615;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0005518;GO:0046872;GO:0038062;GO:0004714;GO:0061564;GO:0060444;GO:0007155;GO:0038063;GO:0043583;GO:0007566;GO:0030198;GO:0007595;GO:0060749;GO:0007275;GO:0008285;GO:1990138;GO:0038083;GO:0033674;GO:0046777;GO:0001558;GO:0001952;GO:0010715;GO:0014909;GO:0061302;GO:0007169;GO:0044319;, C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:collagen binding; F:metal ion binding; F:protein tyrosine kinase collagen receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:axon development; P:branching involved in mammary gland duct morphogenesis; P:cell adhesion; P:collagen-activated tyrosine kinase receptor signaling pathway; P:ear development; P:embryo implantation; P:extracellular matrix organization; P:lactation; P:mammary gland alveolus development; P:multicellular organism development; P:negative regulation of cell population proliferation; P:neuron projection extension; P:peptidyl-tyrosine autophosphorylation; P:positive regulation of kinase activity; P:protein autophosphorylation; P:regulation of cell growth; P:regulation of cell-matrix adhesion; P:regulation of extracellular matrix disassembly; P:smooth muscle cell migration; P:smooth muscle cell-matrix adhesion; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing, spreading of cells;|Q5ST12 Q6NSK4 Q9UD35 Q9UD36 Q9UD37 Q9UD86 Q9UDL2,Epithelial discoidin domain-containing receptor 1,CD167 antigen-like family member A;Cell adhesion kinase;Discoidin receptor tyrosine kinase;HGK2;Mammary carcinoma kinase 10;Protein-tyrosine kinase 3A;Protein-tyrosine kinase RTK-6;TRK E;Tyrosine kinase DDR;Tyrosine-protein kinase CAK;, PF00754;PF07714;, GO:0070062;GO:0005615;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0005518;GO:0046872;GO:0038062;GO:0004714;GO:0061564;GO:0060444;GO:0007155;GO:0038063;GO:0043583;GO:0007566;GO:0030198;GO:0007595;GO:0060749;GO:0007275;GO:0008285;GO:1990138;GO:0038083;GO:0033674;GO:0046777;GO:0001558;GO:0001952;GO:0010715;GO:0014909;GO:0061302;GO:0007169;GO:0044319;, C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:collagen binding; F:metal ion binding; F:protein tyrosine kinase collagen receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:axon development; P:branching involved in mammary gland duct morphogenesis; P:cell adhesion; P:collagen-activated tyrosine kinase receptor signaling pathway; P:ear development; P:embryo implantation; P:extracellular matrix organization; P:lactation; P:mammary gland alveolus development; P:multicellular organism development; P:negative regulation of cell population proliferation; P:neuron projection extension; P:peptidyl-tyrosine autophosphorylation; P:positive regulation of kinase activity; P:protein autophosphorylation; P:regulation of cell growth; P:regulation of cell-matrix adhesion; P:regulation of extracellular matrix disassembly; P:smooth muscle cell migration; P:smooth muscle cell-matrix adhesion; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing, spreading of cells; scaffold40 indexed_genome mRNA 19500522 19501840 . + . ID=transcript_8347;P46695 Q5SU30 Q92691 Q93044,Radiation-inducible immediate-early gene IEX-1,Differentiation-dependent gene 2 protein;Immediate early protein GLY96;Immediate early response 3 protein;PACAP-responsive gene 1 protein;, , GO:0005829;GO:0016021;GO:0005634;GO:0009653;GO:0006915;GO:0043066;GO:0014066;GO:2001020;, C:cytosol; C:integral component of membrane; C:nucleus;, , P:anatomical structure morphogenesis; P:apoptotic process; P:negative regulation of apoptotic process; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of response to DNA damage stimulus; scaffold40 indexed_genome mRNA 19502000 19512735 . + . ID=transcript_8348;O75955 B4DVY7 Q969J8 Q9UHW1 Q9UNV8,Flotillin-1,, PF01145;, GO:0005912;GO:0016323;GO:0005901;GO:0044291;GO:0005911;GO:0034451;GO:0031410;GO:0098691;GO:0005769;GO:0005768;GO:0009897;GO:0070062;GO:0016600;GO:0005925;GO:0098982;GO:0098978;GO:0030027;GO:0005765;GO:0042470;GO:0016020;GO:0045121;GO:0005815;GO:0005886;GO:0048786;GO:0042383;GO:0001931;GO:0035255;GO:0002020;GO:0007409;GO:0071360;GO:0033227;GO:0022617;GO:0001765;GO:0044854;GO:0060355;GO:1901890;GO:2000049;GO:0001819;GO:0045807;GO:0034116;GO:0032728;GO:1901741;GO:0051092;GO:0032092;GO:0001934;GO:0048643;GO:0032226;GO:0034141;GO:0070528;GO:1903044;GO:0072659;GO:0050821;GO:0060544;GO:0051580;GO:0002090;GO:0035023;GO:0034976;, C:adherens junction; C:basolateral plasma membrane; C:caveola; C:cell-cell contact zone; C:cell-cell junction; C:centriolar satellite; C:cytoplasmic vesicle; C:dopaminergic synapse; C:early endosome; C:endosome; C:external side of plasma membrane; C:extracellular exosome; C:flotillin complex; C:focal adhesion; C:GABA-ergic synapse; C:glutamatergic synapse; C:lamellipodium; C:lysosomal membrane; C:melanosome; C:membrane; C:membrane raft; C:microtubule organizing center; C:plasma membrane; C:presynaptic active zone; C:sarcolemma; C:uropod;, F:ionotropic glutamate receptor binding; F:protease binding;, P:axonogenesis; P:cellular response to exogenous dsRNA; P:dsRNA transport; P:extracellular matrix disassembly; P:membrane raft assembly; P:plasma membrane raft assembly; P:positive regulation of cell adhesion molecule production; P:positive regulation of cell junction assembly; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of cytokine production; P:positive regulation of endocytosis; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of interferon-beta production; P:positive regulation of myoblast fusion; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of skeletal muscle tissue development; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of toll-like receptor 3 signaling pathway; P:protein kinase C signaling; P:protein localization to membrane raft; P:protein localization to plasma membrane; P:protein stabilization; P:regulation of necroptotic process; P:regulation of neurotransmitter uptake; P:regulation of receptor internalization; P:regulation of Rho protein signal transduction; P:response to endoplasmic reticulum stress; scaffold40 indexed_genome mRNA 19519391 19533345 . + . ID=transcript_8349;Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2,Mediator of DNA damage checkpoint protein 1,Nuclear factor with BRCT domains 1;, PF00498;PF16770;, GO:0005694;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0070975;GO:0008022;GO:0006302;GO:0006303;GO:0031573;, C:chromosome; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:FHA domain binding; F:protein C-terminus binding;, P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intra-S DNA damage checkpoint;|Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2,Mediator of DNA damage checkpoint protein 1,Nuclear factor with BRCT domains 1;, PF00498;PF16770;, GO:0005694;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0070975;GO:0008022;GO:0006302;GO:0006303;GO:0031573;, C:chromosome; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:FHA domain binding; F:protein C-terminus binding;, P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intra-S DNA damage checkpoint;|Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2,Mediator of DNA damage checkpoint protein 1,Nuclear factor with BRCT domains 1;, PF00498;PF16770;, GO:0005694;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0070975;GO:0008022;GO:0006302;GO:0006303;GO:0031573;, C:chromosome; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:FHA domain binding; F:protein C-terminus binding;, P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intra-S DNA damage checkpoint;|Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2,Mediator of DNA damage checkpoint protein 1,Nuclear factor with BRCT domains 1;, PF00498;PF16770;, GO:0005694;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0070975;GO:0008022;GO:0006302;GO:0006303;GO:0031573;, C:chromosome; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:FHA domain binding; F:protein C-terminus binding;, P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intra-S DNA damage checkpoint;|Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2,Mediator of DNA damage checkpoint protein 1,Nuclear factor with BRCT domains 1;, PF00498;PF16770;, GO:0005694;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0070975;GO:0008022;GO:0006302;GO:0006303;GO:0031573;, C:chromosome; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:FHA domain binding; F:protein C-terminus binding;, P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intra-S DNA damage checkpoint; scaffold40 indexed_genome mRNA 19540896 19543252 . + . ID=transcript_8350;Q8WU45 Q9BSX3 Q9UN92,Nurim,Nuclear envelope membrane protein;Nuclear rim protein;, , GO:0016021;GO:0016020;GO:0005635;GO:0005637;GO:0031965;, C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane;|Q8WU45 Q9BSX3 Q9UN92,Nurim,Nuclear envelope membrane protein;Nuclear rim protein;, , GO:0016021;GO:0016020;GO:0005635;GO:0005637;GO:0031965;, C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; scaffold40 indexed_genome mRNA 19543410 19553584 . + . ID=transcript_8351;Q6ZUJ6 Q8NDQ4 Q8TF52 Q9BRL9,Phostensin,Protein phosphatase 1 F-actin cytoskeleton-targeting subunit;Protein phosphatase 1 regulatory subunit 18;, PF13914;PF13916;, GO:0005737;GO:0005856;GO:0003779;GO:0019902;, C:cytoplasm; C:cytoskeleton;, F:actin binding; F:phosphatase binding;|Q6ZUJ6 Q8NDQ4 Q8TF52 Q9BRL9,Phostensin,Protein phosphatase 1 F-actin cytoskeleton-targeting subunit;Protein phosphatase 1 regulatory subunit 18;, PF13914;PF13916;, GO:0005737;GO:0005856;GO:0003779;GO:0019902;, C:cytoplasm; C:cytoskeleton;, F:actin binding; F:phosphatase binding; scaffold40 indexed_genome mRNA 19558081 19562008 . + . ID=transcript_8352;O60231 O60322 Q5JP45 Q969X7 Q96QC1,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16,ATP-dependent RNA helicase #3;DEAH-box protein 16;, PF00270;PF04408;PF00271;PF07717;, GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0005524;GO:0016887;GO:0003723;GO:0003724;GO:0000398;GO:0008380;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome;, F:ATP binding; F:ATPase activity; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA splicing; scaffold40 indexed_genome mRNA 19562016 19572657 . + . ID=transcript_8353;O60231 O60322 Q5JP45 Q969X7 Q96QC1,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16,ATP-dependent RNA helicase #3;DEAH-box protein 16;, PF00270;PF04408;PF00271;PF07717;, GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0005524;GO:0016887;GO:0003723;GO:0003724;GO:0000398;GO:0008380;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome;, F:ATP binding; F:ATPase activity; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA splicing;|O60231 O60322 Q5JP45 Q969X7 Q96QC1,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16,ATP-dependent RNA helicase #3;DEAH-box protein 16;, PF00270;PF04408;PF00271;PF07717;, GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0005524;GO:0016887;GO:0003723;GO:0003724;GO:0000398;GO:0008380;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome;, F:ATP binding; F:ATPase activity; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA splicing;|O60231 O60322 Q5JP45 Q969X7 Q96QC1,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16,ATP-dependent RNA helicase #3;DEAH-box protein 16;, PF00270;PF04408;PF00271;PF07717;, GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0005524;GO:0016887;GO:0003723;GO:0003724;GO:0000398;GO:0008380;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome;, F:ATP binding; F:ATPase activity; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA splicing;|O60231 O60322 Q5JP45 Q969X7 Q96QC1,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16,ATP-dependent RNA helicase #3;DEAH-box protein 16;, PF00270;PF04408;PF00271;PF07717;, GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0005524;GO:0016887;GO:0003723;GO:0003724;GO:0000398;GO:0008380;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome;, F:ATP binding; F:ATPase activity; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA splicing;|O60231 O60322 Q5JP45 Q969X7 Q96QC1,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16,ATP-dependent RNA helicase #3;DEAH-box protein 16;, PF00270;PF04408;PF00271;PF07717;, GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0005524;GO:0016887;GO:0003723;GO:0003724;GO:0000398;GO:0008380;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome;, F:ATP binding; F:ATPase activity; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA splicing; scaffold40 indexed_genome mRNA 19573582 19577578 . - . ID=transcript_8354;Q5SQH8 A9R9P9 F8VX15 Q5SU01 Q6ZSB7 Q8TB84,Uncharacterized protein C6orf136,, PF10184;|Q5SQH8 A9R9P9 F8VX15 Q5SU01 Q6ZSB7 Q8TB84,Uncharacterized protein C6orf136,, PF10184;|Q5SQH8 A9R9P9 F8VX15 Q5SU01 Q6ZSB7 Q8TB84,Uncharacterized protein C6orf136,, PF10184; scaffold40 indexed_genome mRNA 19577769 19579464 . - . ID=transcript_8355;Q8NDK9 Q9BRS1 Q9H8X5,Alpha-tubulin N-acetyltransferase 1 {ECO:0000255|HAMAP-Rule:MF_03130},Acetyltransferase mec-17 homolog {ECO:0000255|HAMAP-Rule:MF_03130};, PF05301;, GO:0030424;GO:0005905;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0097427;GO:0072686;GO:0004468;GO:0019799;GO:0071929;GO:0060271;GO:0021542;GO:0048666;GO:1900227;GO:0045598;GO:0070507;GO:0007283;, C:axon; C:clathrin-coated pit; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:microtubule bundle; C:mitotic spindle;, F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:tubulin N-acetyltransferase activity;, P:alpha-tubulin acetylation; P:cilium assembly; P:dentate gyrus development; P:neuron development; P:positive regulation of NLRP3 inflammasome complex assembly; P:regulation of fat cell differentiation; P:regulation of microtubule cytoskeleton organization; P:spermatogenesis; scaffold40 indexed_genome mRNA 19579470 19590599 . - . ID=transcript_8356;Q8NDK9 Q9BRS1 Q9H8X5,Alpha-tubulin N-acetyltransferase 1 {ECO:0000255|HAMAP-Rule:MF_03130},Acetyltransferase mec-17 homolog {ECO:0000255|HAMAP-Rule:MF_03130};, PF05301;, GO:0030424;GO:0005905;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0097427;GO:0072686;GO:0004468;GO:0019799;GO:0071929;GO:0060271;GO:0021542;GO:0048666;GO:1900227;GO:0045598;GO:0070507;GO:0007283;, C:axon; C:clathrin-coated pit; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:microtubule bundle; C:mitotic spindle;, F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:tubulin N-acetyltransferase activity;, P:alpha-tubulin acetylation; P:cilium assembly; P:dentate gyrus development; P:neuron development; P:positive regulation of NLRP3 inflammasome complex assembly; P:regulation of fat cell differentiation; P:regulation of microtubule cytoskeleton organization; P:spermatogenesis;|Q8NDK9 Q9BRS1 Q9H8X5,Alpha-tubulin N-acetyltransferase 1 {ECO:0000255|HAMAP-Rule:MF_03130},Acetyltransferase mec-17 homolog {ECO:0000255|HAMAP-Rule:MF_03130};, PF05301;, GO:0030424;GO:0005905;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0097427;GO:0072686;GO:0004468;GO:0019799;GO:0071929;GO:0060271;GO:0021542;GO:0048666;GO:1900227;GO:0045598;GO:0070507;GO:0007283;, C:axon; C:clathrin-coated pit; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:microtubule bundle; C:mitotic spindle;, F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:tubulin N-acetyltransferase activity;, P:alpha-tubulin acetylation; P:cilium assembly; P:dentate gyrus development; P:neuron development; P:positive regulation of NLRP3 inflammasome complex assembly; P:regulation of fat cell differentiation; P:regulation of microtubule cytoskeleton organization; P:spermatogenesis; scaffold40 indexed_genome mRNA 19591488 19593027 . - . ID=transcript_8357;Q9Y676 A6NDQ0 Q659G4 Q9BS27,28S ribosomal protein S18b, mitochondrial,28S ribosomal protein S18-2, mitochondrial;Mitochondrial small ribosomal subunit protein bS18b {ECO:0000303|PubMed:25838379};Mitochondrial small ribosomal subunit protein mS40 {ECO:0000303|PubMed:27023846};, PF01084;, GO:0030054;GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:cell junction; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9Y676 A6NDQ0 Q659G4 Q9BS27,28S ribosomal protein S18b, mitochondrial,28S ribosomal protein S18-2, mitochondrial;Mitochondrial small ribosomal subunit protein bS18b {ECO:0000303|PubMed:25838379};Mitochondrial small ribosomal subunit protein mS40 {ECO:0000303|PubMed:27023846};, PF01084;, GO:0030054;GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:cell junction; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold40 indexed_genome mRNA 19593089 19594611 . - . ID=transcript_8358;Q9Y676 A6NDQ0 Q659G4 Q9BS27,28S ribosomal protein S18b, mitochondrial,28S ribosomal protein S18-2, mitochondrial;Mitochondrial small ribosomal subunit protein bS18b {ECO:0000303|PubMed:25838379};Mitochondrial small ribosomal subunit protein mS40 {ECO:0000303|PubMed:27023846};, PF01084;, GO:0030054;GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:cell junction; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold40 indexed_genome mRNA 19604494 19605726 . - . ID=transcript_8359;Q96QC0 O00405,Serine/threonine-protein phosphatase 1 regulatory subunit 10,MHC class I region proline-rich protein CAT53;PP1-binding protein of 114 kDa;Phosphatase 1 nuclear targeting subunit;Protein FB19;p99;, PF08711;PF00642;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0072357;GO:0003677;GO:0046872;GO:0004864;GO:0003723;GO:0010667;GO:1904290;GO:0032206;GO:0006606;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:PTW/PP1 phosphatase complex;, F:DNA binding; F:metal ion binding; F:protein phosphatase inhibitor activity; F:RNA binding;, P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of mitotic DNA damage checkpoint; P:positive regulation of telomere maintenance; P:protein import into nucleus;|Q96QC0 O00405,Serine/threonine-protein phosphatase 1 regulatory subunit 10,MHC class I region proline-rich protein CAT53;PP1-binding protein of 114 kDa;Phosphatase 1 nuclear targeting subunit;Protein FB19;p99;, PF08711;PF00642;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0072357;GO:0003677;GO:0046872;GO:0004864;GO:0003723;GO:0010667;GO:1904290;GO:0032206;GO:0006606;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:PTW/PP1 phosphatase complex;, F:DNA binding; F:metal ion binding; F:protein phosphatase inhibitor activity; F:RNA binding;, P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of mitotic DNA damage checkpoint; P:positive regulation of telomere maintenance; P:protein import into nucleus; scaffold40 indexed_genome mRNA 19605995 19607508 . + . ID=transcript_8360;Q96QC0 O00405,Serine/threonine-protein phosphatase 1 regulatory subunit 10,MHC class I region proline-rich protein CAT53;PP1-binding protein of 114 kDa;Phosphatase 1 nuclear targeting subunit;Protein FB19;p99;, PF08711;PF00642;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0072357;GO:0003677;GO:0046872;GO:0004864;GO:0003723;GO:0010667;GO:1904290;GO:0032206;GO:0006606;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:PTW/PP1 phosphatase complex;, F:DNA binding; F:metal ion binding; F:protein phosphatase inhibitor activity; F:RNA binding;, P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of mitotic DNA damage checkpoint; P:positive regulation of telomere maintenance; P:protein import into nucleus; scaffold40 indexed_genome mRNA 19608978 19609637 . - . ID=transcript_8361;Q96QC0 O00405,Serine/threonine-protein phosphatase 1 regulatory subunit 10,MHC class I region proline-rich protein CAT53;PP1-binding protein of 114 kDa;Phosphatase 1 nuclear targeting subunit;Protein FB19;p99;, PF08711;PF00642;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0072357;GO:0003677;GO:0046872;GO:0004864;GO:0003723;GO:0010667;GO:1904290;GO:0032206;GO:0006606;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:PTW/PP1 phosphatase complex;, F:DNA binding; F:metal ion binding; F:protein phosphatase inhibitor activity; F:RNA binding;, P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of mitotic DNA damage checkpoint; P:positive regulation of telomere maintenance; P:protein import into nucleus; scaffold40 indexed_genome mRNA 19609942 19614116 . + . ID=transcript_8362;Q96QC0 O00405,Serine/threonine-protein phosphatase 1 regulatory subunit 10,MHC class I region proline-rich protein CAT53;PP1-binding protein of 114 kDa;Phosphatase 1 nuclear targeting subunit;Protein FB19;p99;, PF08711;PF00642;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0072357;GO:0003677;GO:0046872;GO:0004864;GO:0003723;GO:0010667;GO:1904290;GO:0032206;GO:0006606;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:PTW/PP1 phosphatase complex;, F:DNA binding; F:metal ion binding; F:protein phosphatase inhibitor activity; F:RNA binding;, P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of mitotic DNA damage checkpoint; P:positive regulation of telomere maintenance; P:protein import into nucleus;|Q96QC0 O00405,Serine/threonine-protein phosphatase 1 regulatory subunit 10,MHC class I region proline-rich protein CAT53;PP1-binding protein of 114 kDa;Phosphatase 1 nuclear targeting subunit;Protein FB19;p99;, PF08711;PF00642;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0072357;GO:0003677;GO:0046872;GO:0004864;GO:0003723;GO:0010667;GO:1904290;GO:0032206;GO:0006606;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:PTW/PP1 phosphatase complex;, F:DNA binding; F:metal ion binding; F:protein phosphatase inhibitor activity; F:RNA binding;, P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of mitotic DNA damage checkpoint; P:positive regulation of telomere maintenance; P:protein import into nucleus;|Q96QC0 O00405,Serine/threonine-protein phosphatase 1 regulatory subunit 10,MHC class I region proline-rich protein CAT53;PP1-binding protein of 114 kDa;Phosphatase 1 nuclear targeting subunit;Protein FB19;p99;, PF08711;PF00642;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0072357;GO:0003677;GO:0046872;GO:0004864;GO:0003723;GO:0010667;GO:1904290;GO:0032206;GO:0006606;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:PTW/PP1 phosphatase complex;, F:DNA binding; F:metal ion binding; F:protein phosphatase inhibitor activity; F:RNA binding;, P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of mitotic DNA damage checkpoint; P:positive regulation of telomere maintenance; P:protein import into nucleus; scaffold40 indexed_genome mRNA 19617561 19631683 . - . ID=transcript_8363;Q8NE71 A2BF75 O14897 Q69YP6,ATP-binding cassette sub-family F member 1,ATP-binding cassette 50;TNF-alpha-stimulated ABC protein;, PF00005;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0005654;GO:0042788;GO:0005524;GO:0016887;GO:0043022;GO:0003723;GO:0008494;GO:0008135;GO:0006954;GO:0045727;GO:0006412;GO:0006413;GO:0055085;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope; C:nucleoplasm; C:polysomal ribosome;, F:ATP binding; F:ATPase activity; F:ribosome binding; F:RNA binding; F:translation activator activity; F:translation factor activity, RNA binding;, P:inflammatory response; P:positive regulation of translation; P:translation; P:translational initiation; P:transmembrane transport;|Q8NE71 A2BF75 O14897 Q69YP6,ATP-binding cassette sub-family F member 1,ATP-binding cassette 50;TNF-alpha-stimulated ABC protein;, PF00005;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0005654;GO:0042788;GO:0005524;GO:0016887;GO:0043022;GO:0003723;GO:0008494;GO:0008135;GO:0006954;GO:0045727;GO:0006412;GO:0006413;GO:0055085;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope; C:nucleoplasm; C:polysomal ribosome;, F:ATP binding; F:ATPase activity; F:ribosome binding; F:RNA binding; F:translation activator activity; F:translation factor activity, RNA binding;, P:inflammatory response; P:positive regulation of translation; P:translation; P:translational initiation; P:transmembrane transport;|Q8NE71 A2BF75 O14897 Q69YP6,ATP-binding cassette sub-family F member 1,ATP-binding cassette 50;TNF-alpha-stimulated ABC protein;, PF00005;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0005654;GO:0042788;GO:0005524;GO:0016887;GO:0043022;GO:0003723;GO:0008494;GO:0008135;GO:0006954;GO:0045727;GO:0006412;GO:0006413;GO:0055085;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope; C:nucleoplasm; C:polysomal ribosome;, F:ATP binding; F:ATPase activity; F:ribosome binding; F:RNA binding; F:translation activator activity; F:translation factor activity, RNA binding;, P:inflammatory response; P:positive regulation of translation; P:translation; P:translational initiation; P:transmembrane transport; scaffold40 indexed_genome mRNA 19638170 19656917 . - . ID=transcript_8364;P36915 B0S838 Q96CT5,Guanine nucleotide-binding protein-like 1,GTP-binding protein HSR1;, PF01926;, GO:0005615;GO:0005634;GO:0005525;GO:0003924;GO:0005198;GO:0006974;GO:0007165;GO:0002456;, C:extracellular space; C:nucleus;, F:GTP binding; F:GTPase activity; F:structural molecule activity;, P:cellular response to DNA damage stimulus; P:signal transduction; P:T cell mediated immunity;|P36915 B0S838 Q96CT5,Guanine nucleotide-binding protein-like 1,GTP-binding protein HSR1;, PF01926;, GO:0005615;GO:0005634;GO:0005525;GO:0003924;GO:0005198;GO:0006974;GO:0007165;GO:0002456;, C:extracellular space; C:nucleus;, F:GTP binding; F:GTPase activity; F:structural molecule activity;, P:cellular response to DNA damage stimulus; P:signal transduction; P:T cell mediated immunity;|P36915 B0S838 Q96CT5,Guanine nucleotide-binding protein-like 1,GTP-binding protein HSR1;, PF01926;, GO:0005615;GO:0005634;GO:0005525;GO:0003924;GO:0005198;GO:0006974;GO:0007165;GO:0002456;, C:extracellular space; C:nucleus;, F:GTP binding; F:GTPase activity; F:structural molecule activity;, P:cellular response to DNA damage stimulus; P:signal transduction; P:T cell mediated immunity;|P36915 B0S838 Q96CT5,Guanine nucleotide-binding protein-like 1,GTP-binding protein HSR1;, PF01926;, GO:0005615;GO:0005634;GO:0005525;GO:0003924;GO:0005198;GO:0006974;GO:0007165;GO:0002456;, C:extracellular space; C:nucleus;, F:GTP binding; F:GTPase activity; F:structural molecule activity;, P:cellular response to DNA damage stimulus; P:signal transduction; P:T cell mediated immunity; scaffold40 indexed_genome mRNA 19674547 19677106 . - . ID=transcript_8365;Q5SU41 Q5SU42 Q86Y49 Q86Y50 Q86Y51 Q96F16,Ribonuclease P protein subunit p21,Ribonuclease P/MRP 21 kDa subunit;Ribonucleoprotein V;, PF04032;, GO:0030681;GO:0005655;GO:0005654;GO:0046872;GO:0004526;GO:0033204;GO:0042493;GO:0001682;GO:0008033;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleoplasm;, F:metal ion binding; F:ribonuclease P activity; F:ribonuclease P RNA binding;, P:response to drug; P:tRNA 5'-leader removal; P:tRNA processing; scaffold40 indexed_genome mRNA 19677699 19688686 . - . ID=transcript_8366;Q9HCM9 Q5STG3 Q5STG4 Q76BL3 Q8IYT9 Q96IB6,E3 ubiquitin-protein ligase TRIM39,RING finger protein 23;RING-type E3 ubiquitin transferase TRIM39 {ECO:0000305};Testis-abundant finger protein;Tripartite motif-containing protein 39;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0042802;GO:0061630;GO:0008270;GO:0006915;GO:0045087;GO:0007095;GO:0043124;GO:0032435;GO:2000059;GO:2001235;GO:0050821;GO:0016567;GO:1902806;GO:0010468;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:apoptotic process; P:innate immune response; P:mitotic G2 DNA damage checkpoint; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of apoptotic signaling pathway; P:protein stabilization; P:protein ubiquitination; P:regulation of cell cycle G1/S phase transition; P:regulation of gene expression;|Q9HCM9 Q5STG3 Q5STG4 Q76BL3 Q8IYT9 Q96IB6,E3 ubiquitin-protein ligase TRIM39,RING finger protein 23;RING-type E3 ubiquitin transferase TRIM39 {ECO:0000305};Testis-abundant finger protein;Tripartite motif-containing protein 39;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0042802;GO:0061630;GO:0008270;GO:0006915;GO:0045087;GO:0007095;GO:0043124;GO:0032435;GO:2000059;GO:2001235;GO:0050821;GO:0016567;GO:1902806;GO:0010468;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:apoptotic process; P:innate immune response; P:mitotic G2 DNA damage checkpoint; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of apoptotic signaling pathway; P:protein stabilization; P:protein ubiquitination; P:regulation of cell cycle G1/S phase transition; P:regulation of gene expression;|Q9HCM9 Q5STG3 Q5STG4 Q76BL3 Q8IYT9 Q96IB6,E3 ubiquitin-protein ligase TRIM39,RING finger protein 23;RING-type E3 ubiquitin transferase TRIM39 {ECO:0000305};Testis-abundant finger protein;Tripartite motif-containing protein 39;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0042802;GO:0061630;GO:0008270;GO:0006915;GO:0045087;GO:0007095;GO:0043124;GO:0032435;GO:2000059;GO:2001235;GO:0050821;GO:0016567;GO:1902806;GO:0010468;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:apoptotic process; P:innate immune response; P:mitotic G2 DNA damage checkpoint; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of apoptotic signaling pathway; P:protein stabilization; P:protein ubiquitination; P:regulation of cell cycle G1/S phase transition; P:regulation of gene expression; scaffold40 indexed_genome mRNA 19690138 19691222 . + . ID=transcript_8367;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold40 indexed_genome mRNA 19699028 19702048 . - . ID=transcript_8368;Q9Y3C4 D6W5H6 Q8IWR6 Q8IWR7 Q9H3K4,EKC/KEOPS complex subunit TPRKB {ECO:0000305},PRPK-binding protein {ECO:0000303|PubMed:12659830};TP53RK-binding protein {ECO:0000303|PubMed:12659830};, PF08617;, GO:0005737;GO:0005829;GO:0000408;GO:0005634;GO:0019901;GO:0000722;GO:0002949;, C:cytoplasm; C:cytosol; C:EKC/KEOPS complex; C:nucleus;, F:protein kinase binding;, P:telomere maintenance via recombination; P:tRNA threonylcarbamoyladenosine modification; scaffold40 indexed_genome mRNA 19714393 19727886 . + . ID=transcript_8369;P01893,Putative HLA class I histocompatibility antigen, alpha chain H,HLA-12.4;HLA-AR;MHC class I antigen H;, PF07654;PF00129;PF06623;, GO:0035577;GO:0009986;GO:0031901;GO:0012507;GO:0009897;GO:0005615;GO:0000139;GO:0071556;GO:0005887;GO:0042612;GO:0030670;GO:0005886;GO:0055038;GO:0030881;GO:0002476;GO:0002479;GO:0002480;GO:0002474;GO:0006955;GO:0060333;GO:0043312;GO:0050776;GO:0060337;, C:azurophil granule membrane; C:cell surface; C:early endosome membrane; C:ER to Golgi transport vesicle membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:MHC class I protein complex; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome membrane;, F:beta-2-microglobulin binding;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; P:antigen processing and presentation of peptide antigen via MHC class I; P:immune response; P:interferon-gamma-mediated signaling pathway; P:neutrophil degranulation; P:regulation of immune response; P:type I interferon signaling pathway;|P01893,Putative HLA class I histocompatibility antigen, alpha chain H,HLA-12.4;HLA-AR;MHC class I antigen H;, PF07654;PF00129;PF06623;, GO:0035577;GO:0009986;GO:0031901;GO:0012507;GO:0009897;GO:0005615;GO:0000139;GO:0071556;GO:0005887;GO:0042612;GO:0030670;GO:0005886;GO:0055038;GO:0030881;GO:0002476;GO:0002479;GO:0002480;GO:0002474;GO:0006955;GO:0060333;GO:0043312;GO:0050776;GO:0060337;, C:azurophil granule membrane; C:cell surface; C:early endosome membrane; C:ER to Golgi transport vesicle membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:MHC class I protein complex; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome membrane;, F:beta-2-microglobulin binding;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; P:antigen processing and presentation of peptide antigen via MHC class I; P:immune response; P:interferon-gamma-mediated signaling pathway; P:neutrophil degranulation; P:regulation of immune response; P:type I interferon signaling pathway;|P01893,Putative HLA class I histocompatibility antigen, alpha chain H,HLA-12.4;HLA-AR;MHC class I antigen H;, PF07654;PF00129;PF06623;, GO:0035577;GO:0009986;GO:0031901;GO:0012507;GO:0009897;GO:0005615;GO:0000139;GO:0071556;GO:0005887;GO:0042612;GO:0030670;GO:0005886;GO:0055038;GO:0030881;GO:0002476;GO:0002479;GO:0002480;GO:0002474;GO:0006955;GO:0060333;GO:0043312;GO:0050776;GO:0060337;, C:azurophil granule membrane; C:cell surface; C:early endosome membrane; C:ER to Golgi transport vesicle membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:MHC class I protein complex; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome membrane;, F:beta-2-microglobulin binding;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; P:antigen processing and presentation of peptide antigen via MHC class I; P:immune response; P:interferon-gamma-mediated signaling pathway; P:neutrophil degranulation; P:regulation of immune response; P:type I interferon signaling pathway; scaffold40 indexed_genome mRNA 19743402 19751058 . + . ID=transcript_8370;Q96HA7 B5MDP0 C9JKB1 C9JNV8 Q13006 Q9UGJ2,Tonsoku-like protein,Inhibitor of kappa B-related protein;NF-kappa-B inhibitor-like protein 2;Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2;, PF12796;PF13516;PF13181;, GO:0005737;GO:0016604;GO:0043596;GO:0005654;GO:0042393;GO:0000724;GO:0031297;, C:cytoplasm; C:nuclear body; C:nuclear replication fork; C:nucleoplasm;, F:histone binding;, P:double-strand break repair via homologous recombination; P:replication fork processing;|Q9TQH6 Q9TQH7 Q9TQH8 Q9TQH9 Q9TQM2 Q9TQN4 Q9TQN6 Q9UQS8 Q9UQT0,HLA class I histocompatibility antigen, B alpha chain,Human leukocyte antigen B;, PF07654;PF00129;PF06623;, GO:0009986;GO:0031901;GO:0005783;GO:0012507;GO:0070062;GO:0005794;GO:0000139;GO:0071556;GO:0005887;GO:0016020;GO:0042612;GO:0030670;GO:0005886;GO:0055038;GO:0030667;GO:0051087;GO:0042605;GO:0005102;GO:0046977;GO:0002250;GO:0002486;GO:0002479;GO:0002480;GO:0002474;GO:0006952;GO:0016045;GO:0006955;GO:0060333;GO:0043312;GO:0001916;GO:0042270;GO:2001198;GO:0050776;GO:0032655;GO:0032675;GO:0002667;GO:0060337;GO:0016032;, C:cell surface; C:early endosome membrane; C:endoplasmic reticulum; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane; C:MHC class I protein complex; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome membrane; C:secretory granule membrane;, F:chaperone binding; F:peptide antigen binding; F:signaling receptor binding; F:TAP binding;, P:adaptive immune response; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; P:antigen processing and presentation of peptide antigen via MHC class I; P:defense response; P:detection of bacterium; P:immune response; P:interferon-gamma-mediated signaling pathway; P:neutrophil degranulation; P:positive regulation of T cell mediated cytotoxicity; P:protection from natural killer cell mediated cytotoxicity; P:regulation of dendritic cell differentiation; P:regulation of immune response; P:regulation of interleukin-12 production; P:regulation of interleukin-6 production; P:regulation of T cell anergy; P:type I interferon signaling pathway; P:viral process; scaffold40 indexed_genome mRNA 19793847 19809460 . + . ID=transcript_8371;Q12899 A6NG96 Q5SRL2,Tripartite motif-containing protein 26,Acid finger protein;RING finger protein 95;Zinc finger protein 173;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0046872;GO:0061630;GO:0008270;GO:0045087;GO:0060333;GO:0046597;GO:1902187;GO:0051091;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination; P:regulation of gene expression; scaffold40 indexed_genome mRNA 19830787 19841209 . + . ID=transcript_8372;Q12899 A6NG96 Q5SRL2,Tripartite motif-containing protein 26,Acid finger protein;RING finger protein 95;Zinc finger protein 173;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0046872;GO:0061630;GO:0008270;GO:0045087;GO:0060333;GO:0046597;GO:1902187;GO:0051091;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination; P:regulation of gene expression;|Q12899 A6NG96 Q5SRL2,Tripartite motif-containing protein 26,Acid finger protein;RING finger protein 95;Zinc finger protein 173;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0046872;GO:0061630;GO:0008270;GO:0045087;GO:0060333;GO:0046597;GO:1902187;GO:0051091;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination; P:regulation of gene expression; scaffold40 indexed_genome mRNA 19841216 19844986 . - . ID=transcript_8373;Q12899 A6NG96 Q5SRL2,Tripartite motif-containing protein 26,Acid finger protein;RING finger protein 95;Zinc finger protein 173;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0046872;GO:0061630;GO:0008270;GO:0045087;GO:0060333;GO:0046597;GO:1902187;GO:0051091;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination; P:regulation of gene expression; scaffold40 indexed_genome mRNA 19933288 19933856 . + . ID=transcript_8374;Q96AP8 Q99579 Q9BZY8,E3 ubiquitin-protein ligase TRIM31,RING-type E3 ubiquitin transferase TRIM31 {ECO:0000305};Tripartite motif-containing protein 31;, PF00643;, GO:0005737;GO:0005829;GO:0005739;GO:0003713;GO:0061630;GO:0008270;GO:0045087;GO:0060333;GO:0046597;GO:0032897;GO:0051091;GO:0016567;GO:0010468;GO:1902186;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral entry into host cell; P:negative regulation of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:protein ubiquitination; P:regulation of gene expression; P:regulation of viral release from host cell; scaffold40 indexed_genome mRNA 19967223 19968623 . + . ID=transcript_8375;Q5SS29 Q9H2S3 Q9H2S4,RING finger protein 39,Protein HZFw;, PF13765;PF00097;, GO:0005737;GO:0046872;GO:0061630;GO:0045087;GO:0016567;GO:0010468;, C:cytoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:innate immune response; P:protein ubiquitination; P:regulation of gene expression; scaffold40 indexed_genome mRNA 19976750 19977911 . + . ID=transcript_8376;O60927,E3 ubiquitin-protein ligase PPP1R11 {ECO:0000303|PubMed:27805901},Hemochromatosis candidate gene V protein;Protein phosphatase 1 regulatory subunit 11;Protein phosphatase inhibitor 3;, PF07491;, GO:0005737;GO:0005634;GO:0008157;GO:0004865;GO:0061630;GO:0050830;GO:0001818;GO:0032515;GO:0006511;, C:cytoplasm; C:nucleus;, F:protein phosphatase 1 binding; F:protein serine/threonine phosphatase inhibitor activity; F:ubiquitin protein ligase activity;, P:defense response to Gram-positive bacterium; P:negative regulation of cytokine production; P:negative regulation of phosphoprotein phosphatase activity; P:ubiquitin-dependent protein catabolic process;|O60927,E3 ubiquitin-protein ligase PPP1R11 {ECO:0000303|PubMed:27805901},Hemochromatosis candidate gene V protein;Protein phosphatase 1 regulatory subunit 11;Protein phosphatase inhibitor 3;, PF07491;, GO:0005737;GO:0005634;GO:0008157;GO:0004865;GO:0061630;GO:0050830;GO:0001818;GO:0032515;GO:0006511;, C:cytoplasm; C:nucleus;, F:protein phosphatase 1 binding; F:protein serine/threonine phosphatase inhibitor activity; F:ubiquitin protein ligase activity;, P:defense response to Gram-positive bacterium; P:negative regulation of cytokine production; P:negative regulation of phosphoprotein phosphatase activity; P:ubiquitin-dependent protein catabolic process; scaffold40 indexed_genome mRNA 19981160 19982998 . - . ID=transcript_8377;Q9H061 B2R570 E9PI16,Transmembrane protein 126A,, PF07114;, GO:0016021;GO:0005743;GO:0005739;GO:0032981;GO:0021554;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial respiratory chain complex I assembly; P:optic nerve development; scaffold40 indexed_genome mRNA 19983637 19985881 . + . ID=transcript_8378;Q9P1U0,DNA-directed RNA polymerase I subunit RPA12 {ECO:0000305|Ref.2},DNA-directed RNA polymerase I subunit H {ECO:0000312|HGNC:HGNC:13182};Zinc ribbon domain-containing protein 1 {ECO:0000303|PubMed:10662553};, PF01096;, GO:0005654;GO:0005736;GO:0003899;GO:0003676;GO:0008270;GO:0006379;GO:0006139;GO:0045815;GO:0006363;GO:0006361;, C:nucleoplasm; C:RNA polymerase I complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:nucleic acid binding; F:zinc ion binding;, P:mRNA cleavage; P:nucleobase-containing compound metabolic process; P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; scaffold40 indexed_genome mRNA 20001298 20016498 . + . ID=transcript_8379;Q9NU63 B0S894 B0V254 B2RXJ7 Q5SSB1,Zinc finger protein 57 homolog {ECO:0000305},Zinc finger protein 698;, PF01352;PF00096;, GO:0005634;GO:0003682;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0043045;GO:0000122;GO:0006349;GO:0006357;, C:nucleus;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:DNA methylation involved in embryo development; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression by genetic imprinting; P:regulation of transcription by RNA polymerase II;|Q9NU63 B0S894 B0V254 B2RXJ7 Q5SSB1,Zinc finger protein 57 homolog {ECO:0000305},Zinc finger protein 698;, PF01352;PF00096;, GO:0005634;GO:0003682;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0043045;GO:0000122;GO:0006349;GO:0006357;, C:nucleus;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:DNA methylation involved in embryo development; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression by genetic imprinting; P:regulation of transcription by RNA polymerase II;|Q92894 Q92895 Q93053 Q96KU9 Q96KV0 Q96KV1 Q99605,Myelin-oligodendrocyte glycoprotein,, PF07686;, GO:0009897;GO:0016021;GO:0005886;GO:0005102;GO:0001618;GO:0007155;GO:0007417;GO:0001817;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, F:signaling receptor binding; F:virus receptor activity;, P:cell adhesion; P:central nervous system development; P:regulation of cytokine production; P:T cell receptor signaling pathway;|Q92894 Q92895 Q93053 Q96KU9 Q96KV0 Q96KV1 Q99605,Myelin-oligodendrocyte glycoprotein,, PF07686;, GO:0009897;GO:0016021;GO:0005886;GO:0005102;GO:0001618;GO:0007155;GO:0007417;GO:0001817;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, F:signaling receptor binding; F:virus receptor activity;, P:cell adhesion; P:central nervous system development; P:regulation of cytokine production; P:T cell receptor signaling pathway;|Q92894 Q92895 Q93053 Q96KU9 Q96KV0 Q96KV1 Q99605,Myelin-oligodendrocyte glycoprotein,, PF07686;, GO:0009897;GO:0016021;GO:0005886;GO:0005102;GO:0001618;GO:0007155;GO:0007417;GO:0001817;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, F:signaling receptor binding; F:virus receptor activity;, P:cell adhesion; P:central nervous system development; P:regulation of cytokine production; P:T cell receptor signaling pathway; scaffold40 indexed_genome mRNA 20035775 20063586 . + . ID=transcript_8380;Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|Q71SG6 Q86W60 Q9UQQ0,Gamma-aminobutyric acid type B receptor subunit 1,, PF00003;PF01094;PF00084;, GO:0005737;GO:0030425;GO:0005576;GO:0038039;GO:0098982;GO:0005887;GO:0005886;GO:0045211;GO:0042734;GO:0098685;GO:0004965;GO:0099579;GO:0004888;GO:0007193;GO:0007186;GO:0007214;GO:0150099;GO:1901381;, C:cytoplasm; C:dendrite; C:extracellular region; C:G protein-coupled receptor heterodimeric complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:G protein-coupled GABA receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:transmembrane signaling receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport; scaffold40 indexed_genome mRNA 20085353 20086271 . + . ID=transcript_8381;O15205 B0UZT6 Q5STL2 Q5SUK2 Q96EC7,Ubiquitin D,Diubiquitin;Ubiquitin-like protein FAT10;, PF00240;, GO:0016235;GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0070628;GO:0070842;GO:0043011;GO:0043065;GO:0043123;GO:0043687;GO:0032446;GO:0016567;GO:0006508;GO:1901990;GO:0034341;GO:0034612;GO:0006511;, C:aggresome; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:proteasome binding;, P:aggresome assembly; P:myeloid dendritic cell differentiation; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic cell cycle phase transition; P:response to interferon-gamma; P:response to tumor necrosis factor; P:ubiquitin-dependent protein catabolic process; scaffold40 indexed_genome mRNA 20114752 20116993 . + . ID=transcript_8382;O15205 B0UZT6 Q5STL2 Q5SUK2 Q96EC7,Ubiquitin D,Diubiquitin;Ubiquitin-like protein FAT10;, PF00240;, GO:0016235;GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0070628;GO:0070842;GO:0043011;GO:0043065;GO:0043123;GO:0043687;GO:0032446;GO:0016567;GO:0006508;GO:1901990;GO:0034341;GO:0034612;GO:0006511;, C:aggresome; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:proteasome binding;, P:aggresome assembly; P:myeloid dendritic cell differentiation; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:post-translational protein modification; P:protein modification by small protein conjugation; P:protein ubiquitination; P:proteolysis; P:regulation of mitotic cell cycle phase transition; P:response to interferon-gamma; P:response to tumor necrosis factor; P:ubiquitin-dependent protein catabolic process; scaffold41 indexed_genome mRNA 199545 266478 . + . ID=transcript_8383;Q541A4 Q8TAY3 Q9NP15 Q9NYE2 Q9P1P8,Glutamate carboxypeptidase 2,Cell growth-inhibiting gene 27 protein;Folate hydrolase 1;Folylpoly-gamma-glutamate carboxypeptidase;Glutamate carboxypeptidase II;Membrane glutamate carboxypeptidase;N-acetylated-alpha-linked acidic dipeptidase I;Prostate-specific membrane antigen;Pteroylpoly-gamma-glutamate carboxypeptidase;, PF02225;PF04389;PF04253;, GO:0009986;GO:0005737;GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:1904492;GO:0004180;GO:0016805;GO:0046872;GO:0004181;GO:0008233;GO:1904493;GO:0009066;GO:0035609;GO:0006508;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:Ac-Asp-Glu binding; F:carboxypeptidase activity; F:dipeptidase activity; F:metal ion binding; F:metallocarboxypeptidase activity; F:peptidase activity; F:tetrahydrofolyl-poly(glutamate) polymer binding;, P:aspartate family amino acid metabolic process; P:C-terminal protein deglutamylation; P:proteolysis; scaffold41 indexed_genome mRNA 591788 592292 . - . ID=transcript_8384;Q86V92,NADPH oxidase 4,Kidney oxidase-1;Kidney superoxide-producing NADPH oxidase;Renal NAD(P)H-oxidase;, PF08022;PF01794;PF08030;, GO:0016324;GO:0005789;GO:0005925;GO:0016021;GO:0005739;GO:0043020;GO:0005730;GO:0005654;GO:0005634;GO:0097038;GO:0048471;GO:0005886;GO:0001725;GO:0009055;GO:0050660;GO:0020037;GO:0072341;GO:0016174;GO:0000166;GO:0019826;GO:1990782;GO:0016175;GO:0007569;GO:0000902;GO:0071320;GO:0071480;GO:0034599;GO:0071560;GO:0006952;GO:0010467;GO:0003015;GO:0050667;GO:0006954;GO:0008285;GO:0043065;GO:0061098;GO:2000379;GO:0014911;GO:0051496;GO:1903409;GO:0072593;GO:0001666;GO:0042554;GO:0006801;, C:apical plasma membrane; C:endoplasmic reticulum membrane; C:focal adhesion; C:integral component of membrane; C:mitochondrion; C:NADPH oxidase complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear endoplasmic reticulum; C:perinuclear region of cytoplasm; C:plasma membrane; C:stress fiber;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:heme binding; F:modified amino acid binding; F:NAD(P)H oxidase H2O2-forming activity; F:nucleotide binding; F:oxygen sensor activity; F:protein tyrosine kinase binding; F:superoxide-generating NAD(P)H oxidase activity;, P:cell aging; P:cell morphogenesis; P:cellular response to cAMP; P:cellular response to gamma radiation; P:cellular response to oxidative stress; P:cellular response to transforming growth factor beta stimulus; P:defense response; P:gene expression; P:heart process; P:homocysteine metabolic process; P:inflammatory response; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of smooth muscle cell migration; P:positive regulation of stress fiber assembly; P:reactive oxygen species biosynthetic process; P:reactive oxygen species metabolic process; P:response to hypoxia; P:superoxide anion generation; P:superoxide metabolic process; scaffold41 indexed_genome mRNA 848044 1422064 . + . ID=transcript_8385;P41594 Q6J164,Metabotropic glutamate receptor 5,, PF00003;PF01094;PF10606;PF07562;, GO:0005737;GO:0005887;GO:0043005;GO:0005886;GO:0098839;GO:0098685;GO:0001640;GO:0004930;GO:0099530;GO:0008066;GO:0042802;GO:0099583;GO:0030296;GO:1990782;GO:0035584;GO:1904646;GO:0007268;GO:0050890;GO:0007216;GO:0007186;GO:0007612;GO:0007611;GO:0007626;GO:0090647;GO:0007206;GO:0061098;GO:0099170;GO:1902938;GO:0048169;GO:0001932;GO:0051966;GO:0006417;GO:0006448;GO:0050808;GO:0099553;, C:cytoplasm; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density membrane; C:Schaffer collateral - CA1 synapse;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled receptor activity; F:G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential; F:glutamate receptor activity; F:identical protein binding; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:protein tyrosine kinase activator activity; F:protein tyrosine kinase binding;, P:calcium-mediated signaling using intracellular calcium source; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:cognition; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:learning; P:learning or memory; P:locomotory behavior; P:modulation of age-related behavioral decline; P:phospholipase C-activating G protein-coupled glutamate receptor signaling pathway; P:positive regulation of protein tyrosine kinase activity; P:postsynaptic modulation of chemical synaptic transmission; P:regulation of intracellular calcium activated chloride channel activity; P:regulation of long-term neuronal synaptic plasticity; P:regulation of protein phosphorylation; P:regulation of synaptic transmission, glutamatergic; P:regulation of translation; P:regulation of translational elongation; P:synapse organization; P:trans-synaptic signaling by endocannabinoid, modulating synaptic transmission; scaffold41 indexed_genome mRNA 1607142 1647664 . + . ID=transcript_8386;Q7Z5U7 Q8WY99 Q8WYA7 Q8WYA8,Dipeptidyl peptidase 1,Cathepsin C;Cathepsin J;Dipeptidyl peptidase I;Dipeptidyl transferase;, PF08773;PF00112;, GO:0035578;GO:0005813;GO:0062023;GO:0030134;GO:0005788;GO:0033116;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0043231;GO:0005764;GO:0016020;GO:0005654;GO:0051087;GO:0031404;GO:0004197;GO:0008234;GO:0008239;GO:0042802;GO:0016505;GO:0019902;GO:0043621;GO:0004252;GO:0007568;GO:0048208;GO:0006888;GO:0006955;GO:0031642;GO:0043312;GO:2001235;GO:1903980;GO:1903052;GO:0006508;GO:0051603;GO:0010033;GO:0001913;, C:azurophil granule lumen; C:centrosome; C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:nucleoplasm;, F:chaperone binding; F:chloride ion binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:peptidase activator activity involved in apoptotic process; F:phosphatase binding; F:protein self-association; F:serine-type endopeptidase activity;, P:aging; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:immune response; P:negative regulation of myelination; P:neutrophil degranulation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of microglial cell activation; P:positive regulation of proteolysis involved in cellular protein catabolic process; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:response to organic substance; P:T cell mediated cytotoxicity;|Q7Z5U7 Q8WY99 Q8WYA7 Q8WYA8,Dipeptidyl peptidase 1,Cathepsin C;Cathepsin J;Dipeptidyl peptidase I;Dipeptidyl transferase;, PF08773;PF00112;, GO:0035578;GO:0005813;GO:0062023;GO:0030134;GO:0005788;GO:0033116;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0043231;GO:0005764;GO:0016020;GO:0005654;GO:0051087;GO:0031404;GO:0004197;GO:0008234;GO:0008239;GO:0042802;GO:0016505;GO:0019902;GO:0043621;GO:0004252;GO:0007568;GO:0048208;GO:0006888;GO:0006955;GO:0031642;GO:0043312;GO:2001235;GO:1903980;GO:1903052;GO:0006508;GO:0051603;GO:0010033;GO:0001913;, C:azurophil granule lumen; C:centrosome; C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:nucleoplasm;, F:chaperone binding; F:chloride ion binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:peptidase activator activity involved in apoptotic process; F:phosphatase binding; F:protein self-association; F:serine-type endopeptidase activity;, P:aging; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:immune response; P:negative regulation of myelination; P:neutrophil degranulation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of microglial cell activation; P:positive regulation of proteolysis involved in cellular protein catabolic process; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:response to organic substance; P:T cell mediated cytotoxicity;|Q7Z5U7 Q8WY99 Q8WYA7 Q8WYA8,Dipeptidyl peptidase 1,Cathepsin C;Cathepsin J;Dipeptidyl peptidase I;Dipeptidyl transferase;, PF08773;PF00112;, GO:0035578;GO:0005813;GO:0062023;GO:0030134;GO:0005788;GO:0033116;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0043231;GO:0005764;GO:0016020;GO:0005654;GO:0051087;GO:0031404;GO:0004197;GO:0008234;GO:0008239;GO:0042802;GO:0016505;GO:0019902;GO:0043621;GO:0004252;GO:0007568;GO:0048208;GO:0006888;GO:0006955;GO:0031642;GO:0043312;GO:2001235;GO:1903980;GO:1903052;GO:0006508;GO:0051603;GO:0010033;GO:0001913;, C:azurophil granule lumen; C:centrosome; C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:nucleoplasm;, F:chaperone binding; F:chloride ion binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:peptidase activator activity involved in apoptotic process; F:phosphatase binding; F:protein self-association; F:serine-type endopeptidase activity;, P:aging; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:immune response; P:negative regulation of myelination; P:neutrophil degranulation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of microglial cell activation; P:positive regulation of proteolysis involved in cellular protein catabolic process; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:response to organic substance; P:T cell mediated cytotoxicity; scaffold41 indexed_genome mRNA 1749398 1786188 . + . ID=transcript_8387;P57729 Q53XK7,Ras-related protein Rab-38,Melanoma antigen NY-MEL-1;, PF00071;, GO:0005829;GO:0005769;GO:0012505;GO:0005783;GO:0005764;GO:0042470;GO:0033162;GO:0016020;GO:0044233;GO:0005739;GO:0045335;GO:0030670;GO:0005886;GO:0005802;GO:0035650;GO:0035651;GO:0036461;GO:0005525;GO:0030742;GO:0003924;GO:0035646;GO:0006886;GO:1903232;GO:0032438;GO:0007005;GO:0090383;GO:0060155;GO:2001247;GO:0043687;GO:0072657;GO:0015031;GO:0007264;GO:0016192;, C:cytosol; C:early endosome; C:endomembrane system; C:endoplasmic reticulum; C:lysosome; C:melanosome; C:melanosome membrane; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:trans-Golgi network;, F:AP-1 adaptor complex binding; F:AP-3 adaptor complex binding; F:BLOC-2 complex binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity;, P:endosome to melanosome transport; P:intracellular protein transport; P:melanosome assembly; P:melanosome organization; P:mitochondrion organization; P:phagosome acidification; P:platelet dense granule organization; P:positive regulation of phosphatidylcholine biosynthetic process; P:post-translational protein modification; P:protein localization to membrane; P:protein transport; P:small GTPase mediated signal transduction; P:vesicle-mediated transport; scaffold41 indexed_genome mRNA 2404958 2654857 . - . ID=transcript_8388;Q86UB9 Q6AW91 Q8ND01 Q9H6M3,Transmembrane protein 135,Peroxisomal membrane protein 52 {ECO:0000250|UniProtKB:Q9CYV5};, PF15982;, GO:0016021;GO:0005811;GO:0031966;GO:0005778;GO:0005777;GO:0007031;GO:0090140;GO:0009409;GO:0032094;, C:integral component of membrane; C:lipid droplet; C:mitochondrial membrane; C:peroxisomal membrane; C:peroxisome;, , P:peroxisome organization; P:regulation of mitochondrial fission; P:response to cold; P:response to food;|Q86UB9 Q6AW91 Q8ND01 Q9H6M3,Transmembrane protein 135,Peroxisomal membrane protein 52 {ECO:0000250|UniProtKB:Q9CYV5};, PF15982;, GO:0016021;GO:0005811;GO:0031966;GO:0005778;GO:0005777;GO:0007031;GO:0090140;GO:0009409;GO:0032094;, C:integral component of membrane; C:lipid droplet; C:mitochondrial membrane; C:peroxisomal membrane; C:peroxisome;, , P:peroxisome organization; P:regulation of mitochondrial fission; P:response to cold; P:response to food;|Q86UB9 Q6AW91 Q8ND01 Q9H6M3,Transmembrane protein 135,Peroxisomal membrane protein 52 {ECO:0000250|UniProtKB:Q9CYV5};, PF15982;, GO:0016021;GO:0005811;GO:0031966;GO:0005778;GO:0005777;GO:0007031;GO:0090140;GO:0009409;GO:0032094;, C:integral component of membrane; C:lipid droplet; C:mitochondrial membrane; C:peroxisomal membrane; C:peroxisome;, , P:peroxisome organization; P:regulation of mitochondrial fission; P:response to cold; P:response to food;|Q86UB9 Q6AW91 Q8ND01 Q9H6M3,Transmembrane protein 135,Peroxisomal membrane protein 52 {ECO:0000250|UniProtKB:Q9CYV5};, PF15982;, GO:0016021;GO:0005811;GO:0031966;GO:0005778;GO:0005777;GO:0007031;GO:0090140;GO:0009409;GO:0032094;, C:integral component of membrane; C:lipid droplet; C:mitochondrial membrane; C:peroxisomal membrane; C:peroxisome;, , P:peroxisome organization; P:regulation of mitochondrial fission; P:response to cold; P:response to food; scaffold41 indexed_genome mRNA 2738501 2747305 . - . ID=transcript_8389;Q9ULV1 A8K9Q3 Q14C97 Q6S9E4,Frizzled-4,FzE4;, PF01534;PF01392;, GO:0009986;GO:0005911;GO:0030669;GO:0030425;GO:0005615;GO:0098978;GO:0005887;GO:0005886;GO:0001540;GO:0019955;GO:0004896;GO:0004930;GO:0030165;GO:0046982;GO:0042803;GO:0044877;GO:0038023;GO:0031625;GO:0042813;GO:0017147;GO:0060070;GO:1990830;GO:0071300;GO:0061301;GO:0035426;GO:0031987;GO:0061024;GO:0090090;GO:0010812;GO:0030182;GO:0035567;GO:0110135;GO:0051091;GO:0043507;GO:0150012;GO:0045893;GO:0042701;GO:0030947;GO:0061299;GO:0061304;GO:0007605;GO:0034446;GO:0001570;GO:0016055;GO:0007223;GO:0060071;, C:cell surface; C:cell-cell junction; C:clathrin-coated endocytic vesicle membrane; C:dendrite; C:extracellular space; C:glutamatergic synapse; C:integral component of plasma membrane; C:plasma membrane;, F:amyloid-beta binding; F:cytokine binding; F:cytokine receptor activity; F:G protein-coupled receptor activity; F:PDZ domain binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:cellular response to leukemia inhibitory factor; P:cellular response to retinoic acid; P:cerebellum vasculature morphogenesis; P:extracellular matrix-cell signaling; P:locomotion involved in locomotory behavior; P:membrane organization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell-substrate adhesion; P:neuron differentiation; P:non-canonical Wnt signaling pathway; P:Norrin signaling pathway; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection arborization; P:positive regulation of transcription, DNA-templated; P:progesterone secretion; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:retina vasculature morphogenesis in camera-type eye; P:retinal blood vessel morphogenesis; P:sensory perception of sound; P:substrate adhesion-dependent cell spreading; P:vasculogenesis; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q9ULV1 A8K9Q3 Q14C97 Q6S9E4,Frizzled-4,FzE4;, PF01534;PF01392;, GO:0009986;GO:0005911;GO:0030669;GO:0030425;GO:0005615;GO:0098978;GO:0005887;GO:0005886;GO:0001540;GO:0019955;GO:0004896;GO:0004930;GO:0030165;GO:0046982;GO:0042803;GO:0044877;GO:0038023;GO:0031625;GO:0042813;GO:0017147;GO:0060070;GO:1990830;GO:0071300;GO:0061301;GO:0035426;GO:0031987;GO:0061024;GO:0090090;GO:0010812;GO:0030182;GO:0035567;GO:0110135;GO:0051091;GO:0043507;GO:0150012;GO:0045893;GO:0042701;GO:0030947;GO:0061299;GO:0061304;GO:0007605;GO:0034446;GO:0001570;GO:0016055;GO:0007223;GO:0060071;, C:cell surface; C:cell-cell junction; C:clathrin-coated endocytic vesicle membrane; C:dendrite; C:extracellular space; C:glutamatergic synapse; C:integral component of plasma membrane; C:plasma membrane;, F:amyloid-beta binding; F:cytokine binding; F:cytokine receptor activity; F:G protein-coupled receptor activity; F:PDZ domain binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:cellular response to leukemia inhibitory factor; P:cellular response to retinoic acid; P:cerebellum vasculature morphogenesis; P:extracellular matrix-cell signaling; P:locomotion involved in locomotory behavior; P:membrane organization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell-substrate adhesion; P:neuron differentiation; P:non-canonical Wnt signaling pathway; P:Norrin signaling pathway; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection arborization; P:positive regulation of transcription, DNA-templated; P:progesterone secretion; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:retina vasculature morphogenesis in camera-type eye; P:retinal blood vessel morphogenesis; P:sensory perception of sound; P:substrate adhesion-dependent cell spreading; P:vasculogenesis; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q9ULV1 A8K9Q3 Q14C97 Q6S9E4,Frizzled-4,FzE4;, PF01534;PF01392;, GO:0009986;GO:0005911;GO:0030669;GO:0030425;GO:0005615;GO:0098978;GO:0005887;GO:0005886;GO:0001540;GO:0019955;GO:0004896;GO:0004930;GO:0030165;GO:0046982;GO:0042803;GO:0044877;GO:0038023;GO:0031625;GO:0042813;GO:0017147;GO:0060070;GO:1990830;GO:0071300;GO:0061301;GO:0035426;GO:0031987;GO:0061024;GO:0090090;GO:0010812;GO:0030182;GO:0035567;GO:0110135;GO:0051091;GO:0043507;GO:0150012;GO:0045893;GO:0042701;GO:0030947;GO:0061299;GO:0061304;GO:0007605;GO:0034446;GO:0001570;GO:0016055;GO:0007223;GO:0060071;, C:cell surface; C:cell-cell junction; C:clathrin-coated endocytic vesicle membrane; C:dendrite; C:extracellular space; C:glutamatergic synapse; C:integral component of plasma membrane; C:plasma membrane;, F:amyloid-beta binding; F:cytokine binding; F:cytokine receptor activity; F:G protein-coupled receptor activity; F:PDZ domain binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding; F:signaling receptor activity; F:ubiquitin protein ligase binding; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:cellular response to leukemia inhibitory factor; P:cellular response to retinoic acid; P:cerebellum vasculature morphogenesis; P:extracellular matrix-cell signaling; P:locomotion involved in locomotory behavior; P:membrane organization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell-substrate adhesion; P:neuron differentiation; P:non-canonical Wnt signaling pathway; P:Norrin signaling pathway; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection arborization; P:positive regulation of transcription, DNA-templated; P:progesterone secretion; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:retina vasculature morphogenesis in camera-type eye; P:retinal blood vessel morphogenesis; P:sensory perception of sound; P:substrate adhesion-dependent cell spreading; P:vasculogenesis; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold41 indexed_genome mRNA 2849429 2853021 . + . ID=transcript_8390;O95084 B2RDJ1 B4E2J3 Q6IBI0,Serine protease 23,Putative secreted protein Zsig13;, PF00089;, GO:0005788;GO:0070062;GO:0005634;GO:0004252;GO:0044267;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:nucleus;, F:serine-type endopeptidase activity;, P:cellular protein metabolic process; P:post-translational protein modification; scaffold41 indexed_genome mRNA 3103385 3222352 . + . ID=transcript_8391;Q16798 B7Z6V0 Q8TBJ0,NADP-dependent malic enzyme, mitochondrial,Malic enzyme 3;, PF00390;PF03949;, GO:0005759;GO:0005739;GO:0004471;GO:0004473;GO:0004470;GO:0046872;GO:0051287;GO:0070401;GO:0008948;GO:0009060;GO:0006108;GO:0072592;GO:0006090;GO:0006099;, C:mitochondrial matrix; C:mitochondrion;, F:malate dehydrogenase (decarboxylating) (NAD+) activity; F:malate dehydrogenase (decarboxylating) (NADP+) activity; F:malic enzyme activity; F:metal ion binding; F:NAD binding; F:NADP+ binding; F:oxaloacetate decarboxylase activity;, P:aerobic respiration; P:malate metabolic process; P:oxygen metabolic process; P:pyruvate metabolic process; P:tricarboxylic acid cycle;|Q16798 B7Z6V0 Q8TBJ0,NADP-dependent malic enzyme, mitochondrial,Malic enzyme 3;, PF00390;PF03949;, GO:0005759;GO:0005739;GO:0004471;GO:0004473;GO:0004470;GO:0046872;GO:0051287;GO:0070401;GO:0008948;GO:0009060;GO:0006108;GO:0072592;GO:0006090;GO:0006099;, C:mitochondrial matrix; C:mitochondrion;, F:malate dehydrogenase (decarboxylating) (NAD+) activity; F:malate dehydrogenase (decarboxylating) (NADP+) activity; F:malic enzyme activity; F:metal ion binding; F:NAD binding; F:NADP+ binding; F:oxaloacetate decarboxylase activity;, P:aerobic respiration; P:malate metabolic process; P:oxygen metabolic process; P:pyruvate metabolic process; P:tricarboxylic acid cycle;|Q16798 B7Z6V0 Q8TBJ0,NADP-dependent malic enzyme, mitochondrial,Malic enzyme 3;, PF00390;PF03949;, GO:0005759;GO:0005739;GO:0004471;GO:0004473;GO:0004470;GO:0046872;GO:0051287;GO:0070401;GO:0008948;GO:0009060;GO:0006108;GO:0072592;GO:0006090;GO:0006099;, C:mitochondrial matrix; C:mitochondrion;, F:malate dehydrogenase (decarboxylating) (NAD+) activity; F:malate dehydrogenase (decarboxylating) (NADP+) activity; F:malic enzyme activity; F:metal ion binding; F:NAD binding; F:NADP+ binding; F:oxaloacetate decarboxylase activity;, P:aerobic respiration; P:malate metabolic process; P:oxygen metabolic process; P:pyruvate metabolic process; P:tricarboxylic acid cycle; scaffold41 indexed_genome mRNA 3226267 3227254 . + . ID=transcript_8392;Q93096 B2R6C8 O00648 Q49A54,Protein tyrosine phosphatase type IVA 1,PTP(CAAXI);Protein-tyrosine phosphatase 4a1;Protein-tyrosine phosphatase of regenerating liver 1;, , GO:0005737;GO:0009898;GO:0005769;GO:0005783;GO:0005634;GO:0005819;GO:0004725;GO:0007049;GO:0007275;GO:0030335;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:early endosome; C:endoplasmic reticulum; C:nucleus; C:spindle;, F:protein tyrosine phosphatase activity;, P:cell cycle; P:multicellular organism development; P:positive regulation of cell migration; scaffold41 indexed_genome mRNA 3245265 3248262 . - . ID=transcript_8393;Q6ZN84 A0AVL7 Q53FW3 Q9H5E5,Coiled-coil domain-containing protein 81,, PF14908;PF18289;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm; scaffold41 indexed_genome mRNA 3304791 3343178 . - . ID=transcript_8394;Q53FT3 Q8WVE8 Q9NVQ2 Q9NZZ1 Q9P022 Q9P0N1,Protein Hikeshi {ECO:0000305},, PF05603;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0030544;GO:0061608;GO:0034605;GO:0007030;GO:0030324;GO:0006606;GO:0015031;GO:1900034;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:Hsp70 protein binding; F:nuclear import signal receptor activity;, P:cellular response to heat; P:Golgi organization; P:lung development; P:protein import into nucleus; P:protein transport; P:regulation of cellular response to heat;|Q53FT3 Q8WVE8 Q9NVQ2 Q9NZZ1 Q9P022 Q9P0N1,Protein Hikeshi {ECO:0000305},, PF05603;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0030544;GO:0061608;GO:0034605;GO:0007030;GO:0030324;GO:0006606;GO:0015031;GO:1900034;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:Hsp70 protein binding; F:nuclear import signal receptor activity;, P:cellular response to heat; P:Golgi organization; P:lung development; P:protein import into nucleus; P:protein transport; P:regulation of cellular response to heat;|Q53FT3 Q8WVE8 Q9NVQ2 Q9NZZ1 Q9P022 Q9P0N1,Protein Hikeshi {ECO:0000305},, PF05603;, GO:0005829;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0030544;GO:0061608;GO:0034605;GO:0007030;GO:0030324;GO:0006606;GO:0015031;GO:1900034;, C:cytosol; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:Hsp70 protein binding; F:nuclear import signal receptor activity;, P:cellular response to heat; P:Golgi organization; P:lung development; P:protein import into nucleus; P:protein transport; P:regulation of cellular response to heat;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold41 indexed_genome mRNA 3367628 3403950 . + . ID=transcript_8395;O75530 A8K7V5 O00149 Q6NTH2 Q7LDA5 Q7LDG8 Q86VV2 Q9UNY7,Polycomb protein EED {ECO:0000305},Embryonic ectoderm development protein {ECO:0000303|PubMed:28229514};WD protein associating with integrin cytoplasmic tails 1;, PF00400;, GO:0005694;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0042054;GO:0042802;GO:0001226;GO:0006342;GO:0070734;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0019058;, C:chromosome; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity; F:identical protein binding; F:RNA polymerase II transcription corepressor binding;, P:chromatin silencing; P:histone H3-K27 methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:viral life cycle;|O75530 A8K7V5 O00149 Q6NTH2 Q7LDA5 Q7LDG8 Q86VV2 Q9UNY7,Polycomb protein EED {ECO:0000305},Embryonic ectoderm development protein {ECO:0000303|PubMed:28229514};WD protein associating with integrin cytoplasmic tails 1;, PF00400;, GO:0005694;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0042054;GO:0042802;GO:0001226;GO:0006342;GO:0070734;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0019058;, C:chromosome; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity; F:identical protein binding; F:RNA polymerase II transcription corepressor binding;, P:chromatin silencing; P:histone H3-K27 methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:viral life cycle;|O75530 A8K7V5 O00149 Q6NTH2 Q7LDA5 Q7LDG8 Q86VV2 Q9UNY7,Polycomb protein EED {ECO:0000305},Embryonic ectoderm development protein {ECO:0000303|PubMed:28229514};WD protein associating with integrin cytoplasmic tails 1;, PF00400;, GO:0005694;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0042054;GO:0042802;GO:0001226;GO:0006342;GO:0070734;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0019058;, C:chromosome; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity; F:identical protein binding; F:RNA polymerase II transcription corepressor binding;, P:chromatin silencing; P:histone H3-K27 methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:viral life cycle;|O75530 A8K7V5 O00149 Q6NTH2 Q7LDA5 Q7LDG8 Q86VV2 Q9UNY7,Polycomb protein EED {ECO:0000305},Embryonic ectoderm development protein {ECO:0000303|PubMed:28229514};WD protein associating with integrin cytoplasmic tails 1;, PF00400;, GO:0005694;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0042054;GO:0042802;GO:0001226;GO:0006342;GO:0070734;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0019058;, C:chromosome; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity; F:identical protein binding; F:RNA polymerase II transcription corepressor binding;, P:chromatin silencing; P:histone H3-K27 methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:viral life cycle;|O75530 A8K7V5 O00149 Q6NTH2 Q7LDA5 Q7LDG8 Q86VV2 Q9UNY7,Polycomb protein EED {ECO:0000305},Embryonic ectoderm development protein {ECO:0000303|PubMed:28229514};WD protein associating with integrin cytoplasmic tails 1;, PF00400;, GO:0005694;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0042054;GO:0042802;GO:0001226;GO:0006342;GO:0070734;GO:0070317;GO:0045814;GO:0000122;GO:0045892;GO:0019058;, C:chromosome; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity; F:identical protein binding; F:RNA polymerase II transcription corepressor binding;, P:chromatin silencing; P:histone H3-K27 methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:viral life cycle; scaffold41 indexed_genome mRNA 3643976 3708253 . + . ID=transcript_8396;Q13492 B4DTM3 E9PN05 F8VPG7 O60700 Q4LE54 Q6GMQ6 Q86XZ9,Phosphatidylinositol-binding clathrin assembly protein,Clathrin assembly lymphoid myeloid leukemia protein;, PF07651;, GO:0009986;GO:0045334;GO:0005905;GO:0030136;GO:0005829;GO:0005769;GO:0070381;GO:0098894;GO:0005794;GO:0043231;GO:0031224;GO:0016020;GO:0097418;GO:0043025;GO:0005634;GO:0048471;GO:0005886;GO:0045211;GO:0042734;GO:0008021;GO:0031982;GO:0005545;GO:0001540;GO:0045296;GO:0030276;GO:0032050;GO:0050750;GO:0005546;GO:0031267;GO:0000149;GO:0048156;GO:0150093;GO:0007409;GO:0048268;GO:1905224;GO:0072583;GO:0048813;GO:0006897;GO:0016197;GO:0030097;GO:0055072;GO:0007611;GO:0097753;GO:0061024;GO:0090647;GO:0010629;GO:1902963;GO:2000009;GO:1903077;GO:0048261;GO:1902004;GO:1902961;GO:0043547;GO:1901216;GO:0045893;GO:0065003;GO:0031623;GO:0006898;GO:1902959;GO:0030100;GO:0032880;GO:0097494;GO:0016185;GO:0016188;GO:0006900;GO:0035459;GO:0016192;, C:cell surface; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:endosome to plasma membrane transport vesicle; C:extrinsic component of presynaptic endocytic zone membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:intrinsic component of membrane; C:membrane; C:neurofibrillary tangle; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:synaptic vesicle; C:vesicle;, F:1-phosphatidylinositol binding; F:amyloid-beta binding; F:cadherin binding; F:clathrin binding; F:clathrin heavy chain binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding; F:SNARE binding; F:tau protein binding;, P:amyloid-beta clearance by transcytosis; P:axonogenesis; P:clathrin coat assembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:dendrite morphogenesis; P:endocytosis; P:endosomal transport; P:hemopoiesis; P:iron ion homeostasis; P:learning or memory; P:membrane bending; P:membrane organization; P:modulation of age-related behavioral decline; P:negative regulation of gene expression; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of protein localization to cell surface; P:negative regulation of protein localization to plasma membrane; P:negative regulation of receptor-mediated endocytosis; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of GTPase activity; P:positive regulation of neuron death; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:regulation of endocytosis; P:regulation of protein localization; P:regulation of vesicle size; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:synaptic vesicle maturation; P:vesicle budding from membrane; P:vesicle cargo loading; P:vesicle-mediated transport;|Q13492 B4DTM3 E9PN05 F8VPG7 O60700 Q4LE54 Q6GMQ6 Q86XZ9,Phosphatidylinositol-binding clathrin assembly protein,Clathrin assembly lymphoid myeloid leukemia protein;, PF07651;, GO:0009986;GO:0045334;GO:0005905;GO:0030136;GO:0005829;GO:0005769;GO:0070381;GO:0098894;GO:0005794;GO:0043231;GO:0031224;GO:0016020;GO:0097418;GO:0043025;GO:0005634;GO:0048471;GO:0005886;GO:0045211;GO:0042734;GO:0008021;GO:0031982;GO:0005545;GO:0001540;GO:0045296;GO:0030276;GO:0032050;GO:0050750;GO:0005546;GO:0031267;GO:0000149;GO:0048156;GO:0150093;GO:0007409;GO:0048268;GO:1905224;GO:0072583;GO:0048813;GO:0006897;GO:0016197;GO:0030097;GO:0055072;GO:0007611;GO:0097753;GO:0061024;GO:0090647;GO:0010629;GO:1902963;GO:2000009;GO:1903077;GO:0048261;GO:1902004;GO:1902961;GO:0043547;GO:1901216;GO:0045893;GO:0065003;GO:0031623;GO:0006898;GO:1902959;GO:0030100;GO:0032880;GO:0097494;GO:0016185;GO:0016188;GO:0006900;GO:0035459;GO:0016192;, C:cell surface; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:endosome to plasma membrane transport vesicle; C:extrinsic component of presynaptic endocytic zone membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:intrinsic component of membrane; C:membrane; C:neurofibrillary tangle; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:synaptic vesicle; C:vesicle;, F:1-phosphatidylinositol binding; F:amyloid-beta binding; F:cadherin binding; F:clathrin binding; F:clathrin heavy chain binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding; F:SNARE binding; F:tau protein binding;, P:amyloid-beta clearance by transcytosis; P:axonogenesis; P:clathrin coat assembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:dendrite morphogenesis; P:endocytosis; P:endosomal transport; P:hemopoiesis; P:iron ion homeostasis; P:learning or memory; P:membrane bending; P:membrane organization; P:modulation of age-related behavioral decline; P:negative regulation of gene expression; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of protein localization to cell surface; P:negative regulation of protein localization to plasma membrane; P:negative regulation of receptor-mediated endocytosis; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of GTPase activity; P:positive regulation of neuron death; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:regulation of endocytosis; P:regulation of protein localization; P:regulation of vesicle size; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:synaptic vesicle maturation; P:vesicle budding from membrane; P:vesicle cargo loading; P:vesicle-mediated transport;|Q13492 B4DTM3 E9PN05 F8VPG7 O60700 Q4LE54 Q6GMQ6 Q86XZ9,Phosphatidylinositol-binding clathrin assembly protein,Clathrin assembly lymphoid myeloid leukemia protein;, PF07651;, GO:0009986;GO:0045334;GO:0005905;GO:0030136;GO:0005829;GO:0005769;GO:0070381;GO:0098894;GO:0005794;GO:0043231;GO:0031224;GO:0016020;GO:0097418;GO:0043025;GO:0005634;GO:0048471;GO:0005886;GO:0045211;GO:0042734;GO:0008021;GO:0031982;GO:0005545;GO:0001540;GO:0045296;GO:0030276;GO:0032050;GO:0050750;GO:0005546;GO:0031267;GO:0000149;GO:0048156;GO:0150093;GO:0007409;GO:0048268;GO:1905224;GO:0072583;GO:0048813;GO:0006897;GO:0016197;GO:0030097;GO:0055072;GO:0007611;GO:0097753;GO:0061024;GO:0090647;GO:0010629;GO:1902963;GO:2000009;GO:1903077;GO:0048261;GO:1902004;GO:1902961;GO:0043547;GO:1901216;GO:0045893;GO:0065003;GO:0031623;GO:0006898;GO:1902959;GO:0030100;GO:0032880;GO:0097494;GO:0016185;GO:0016188;GO:0006900;GO:0035459;GO:0016192;, C:cell surface; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:endosome to plasma membrane transport vesicle; C:extrinsic component of presynaptic endocytic zone membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:intrinsic component of membrane; C:membrane; C:neurofibrillary tangle; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:synaptic vesicle; C:vesicle;, F:1-phosphatidylinositol binding; F:amyloid-beta binding; F:cadherin binding; F:clathrin binding; F:clathrin heavy chain binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding; F:SNARE binding; F:tau protein binding;, P:amyloid-beta clearance by transcytosis; P:axonogenesis; P:clathrin coat assembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:dendrite morphogenesis; P:endocytosis; P:endosomal transport; P:hemopoiesis; P:iron ion homeostasis; P:learning or memory; P:membrane bending; P:membrane organization; P:modulation of age-related behavioral decline; P:negative regulation of gene expression; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of protein localization to cell surface; P:negative regulation of protein localization to plasma membrane; P:negative regulation of receptor-mediated endocytosis; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of GTPase activity; P:positive regulation of neuron death; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:regulation of endocytosis; P:regulation of protein localization; P:regulation of vesicle size; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:synaptic vesicle maturation; P:vesicle budding from membrane; P:vesicle cargo loading; P:vesicle-mediated transport;|Q13492 B4DTM3 E9PN05 F8VPG7 O60700 Q4LE54 Q6GMQ6 Q86XZ9,Phosphatidylinositol-binding clathrin assembly protein,Clathrin assembly lymphoid myeloid leukemia protein;, PF07651;, GO:0009986;GO:0045334;GO:0005905;GO:0030136;GO:0005829;GO:0005769;GO:0070381;GO:0098894;GO:0005794;GO:0043231;GO:0031224;GO:0016020;GO:0097418;GO:0043025;GO:0005634;GO:0048471;GO:0005886;GO:0045211;GO:0042734;GO:0008021;GO:0031982;GO:0005545;GO:0001540;GO:0045296;GO:0030276;GO:0032050;GO:0050750;GO:0005546;GO:0031267;GO:0000149;GO:0048156;GO:0150093;GO:0007409;GO:0048268;GO:1905224;GO:0072583;GO:0048813;GO:0006897;GO:0016197;GO:0030097;GO:0055072;GO:0007611;GO:0097753;GO:0061024;GO:0090647;GO:0010629;GO:1902963;GO:2000009;GO:1903077;GO:0048261;GO:1902004;GO:1902961;GO:0043547;GO:1901216;GO:0045893;GO:0065003;GO:0031623;GO:0006898;GO:1902959;GO:0030100;GO:0032880;GO:0097494;GO:0016185;GO:0016188;GO:0006900;GO:0035459;GO:0016192;, C:cell surface; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:endosome to plasma membrane transport vesicle; C:extrinsic component of presynaptic endocytic zone membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:intrinsic component of membrane; C:membrane; C:neurofibrillary tangle; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:synaptic vesicle; C:vesicle;, F:1-phosphatidylinositol binding; F:amyloid-beta binding; F:cadherin binding; F:clathrin binding; F:clathrin heavy chain binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding; F:SNARE binding; F:tau protein binding;, P:amyloid-beta clearance by transcytosis; P:axonogenesis; P:clathrin coat assembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:dendrite morphogenesis; P:endocytosis; P:endosomal transport; P:hemopoiesis; P:iron ion homeostasis; P:learning or memory; P:membrane bending; P:membrane organization; P:modulation of age-related behavioral decline; P:negative regulation of gene expression; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of protein localization to cell surface; P:negative regulation of protein localization to plasma membrane; P:negative regulation of receptor-mediated endocytosis; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of GTPase activity; P:positive regulation of neuron death; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:regulation of endocytosis; P:regulation of protein localization; P:regulation of vesicle size; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:synaptic vesicle maturation; P:vesicle budding from membrane; P:vesicle cargo loading; P:vesicle-mediated transport;|Q13492 B4DTM3 E9PN05 F8VPG7 O60700 Q4LE54 Q6GMQ6 Q86XZ9,Phosphatidylinositol-binding clathrin assembly protein,Clathrin assembly lymphoid myeloid leukemia protein;, PF07651;, GO:0009986;GO:0045334;GO:0005905;GO:0030136;GO:0005829;GO:0005769;GO:0070381;GO:0098894;GO:0005794;GO:0043231;GO:0031224;GO:0016020;GO:0097418;GO:0043025;GO:0005634;GO:0048471;GO:0005886;GO:0045211;GO:0042734;GO:0008021;GO:0031982;GO:0005545;GO:0001540;GO:0045296;GO:0030276;GO:0032050;GO:0050750;GO:0005546;GO:0031267;GO:0000149;GO:0048156;GO:0150093;GO:0007409;GO:0048268;GO:1905224;GO:0072583;GO:0048813;GO:0006897;GO:0016197;GO:0030097;GO:0055072;GO:0007611;GO:0097753;GO:0061024;GO:0090647;GO:0010629;GO:1902963;GO:2000009;GO:1903077;GO:0048261;GO:1902004;GO:1902961;GO:0043547;GO:1901216;GO:0045893;GO:0065003;GO:0031623;GO:0006898;GO:1902959;GO:0030100;GO:0032880;GO:0097494;GO:0016185;GO:0016188;GO:0006900;GO:0035459;GO:0016192;, C:cell surface; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:endosome to plasma membrane transport vesicle; C:extrinsic component of presynaptic endocytic zone membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:intrinsic component of membrane; C:membrane; C:neurofibrillary tangle; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:synaptic vesicle; C:vesicle;, F:1-phosphatidylinositol binding; F:amyloid-beta binding; F:cadherin binding; F:clathrin binding; F:clathrin heavy chain binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding; F:SNARE binding; F:tau protein binding;, P:amyloid-beta clearance by transcytosis; P:axonogenesis; P:clathrin coat assembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:dendrite morphogenesis; P:endocytosis; P:endosomal transport; P:hemopoiesis; P:iron ion homeostasis; P:learning or memory; P:membrane bending; P:membrane organization; P:modulation of age-related behavioral decline; P:negative regulation of gene expression; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of protein localization to cell surface; P:negative regulation of protein localization to plasma membrane; P:negative regulation of receptor-mediated endocytosis; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of GTPase activity; P:positive regulation of neuron death; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:regulation of endocytosis; P:regulation of protein localization; P:regulation of vesicle size; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:synaptic vesicle maturation; P:vesicle budding from membrane; P:vesicle cargo loading; P:vesicle-mediated transport; scaffold41 indexed_genome mRNA 3875748 3942369 . + . ID=transcript_8397;Q6TV07 Q6ZN59 Q6ZVC5 Q8ND34 Q96BJ2 Q9H768 Q9NXM1,Synaptotagmin-like protein 2,Breast cancer-associated antigen SGA-72M;Exophilin-4;, PF00168;PF02318;, GO:0005737;GO:0070382;GO:0019897;GO:0042470;GO:0016020;GO:0005886;GO:0042043;GO:0019902;GO:0005546;GO:0001786;GO:0031267;GO:0006887;GO:0006886;GO:0010923;GO:0006904;GO:0016192;, C:cytoplasm; C:exocytic vesicle; C:extrinsic component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:neurexin family protein binding; F:phosphatase binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:negative regulation of phosphatase activity; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q6TV07 Q6ZN59 Q6ZVC5 Q8ND34 Q96BJ2 Q9H768 Q9NXM1,Synaptotagmin-like protein 2,Breast cancer-associated antigen SGA-72M;Exophilin-4;, PF00168;PF02318;, GO:0005737;GO:0070382;GO:0019897;GO:0042470;GO:0016020;GO:0005886;GO:0042043;GO:0019902;GO:0005546;GO:0001786;GO:0031267;GO:0006887;GO:0006886;GO:0010923;GO:0006904;GO:0016192;, C:cytoplasm; C:exocytic vesicle; C:extrinsic component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:neurexin family protein binding; F:phosphatase binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:negative regulation of phosphatase activity; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q6TV07 Q6ZN59 Q6ZVC5 Q8ND34 Q96BJ2 Q9H768 Q9NXM1,Synaptotagmin-like protein 2,Breast cancer-associated antigen SGA-72M;Exophilin-4;, PF00168;PF02318;, GO:0005737;GO:0070382;GO:0019897;GO:0042470;GO:0016020;GO:0005886;GO:0042043;GO:0019902;GO:0005546;GO:0001786;GO:0031267;GO:0006887;GO:0006886;GO:0010923;GO:0006904;GO:0016192;, C:cytoplasm; C:exocytic vesicle; C:extrinsic component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:neurexin family protein binding; F:phosphatase binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:negative regulation of phosphatase activity; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q6TV07 Q6ZN59 Q6ZVC5 Q8ND34 Q96BJ2 Q9H768 Q9NXM1,Synaptotagmin-like protein 2,Breast cancer-associated antigen SGA-72M;Exophilin-4;, PF00168;PF02318;, GO:0005737;GO:0070382;GO:0019897;GO:0042470;GO:0016020;GO:0005886;GO:0042043;GO:0019902;GO:0005546;GO:0001786;GO:0031267;GO:0006887;GO:0006886;GO:0010923;GO:0006904;GO:0016192;, C:cytoplasm; C:exocytic vesicle; C:extrinsic component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:neurexin family protein binding; F:phosphatase binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:negative regulation of phosphatase activity; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q6TV07 Q6ZN59 Q6ZVC5 Q8ND34 Q96BJ2 Q9H768 Q9NXM1,Synaptotagmin-like protein 2,Breast cancer-associated antigen SGA-72M;Exophilin-4;, PF00168;PF02318;, GO:0005737;GO:0070382;GO:0019897;GO:0042470;GO:0016020;GO:0005886;GO:0042043;GO:0019902;GO:0005546;GO:0001786;GO:0031267;GO:0006887;GO:0006886;GO:0010923;GO:0006904;GO:0016192;, C:cytoplasm; C:exocytic vesicle; C:extrinsic component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:neurexin family protein binding; F:phosphatase binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:negative regulation of phosphatase activity; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q6TV07 Q6ZN59 Q6ZVC5 Q8ND34 Q96BJ2 Q9H768 Q9NXM1,Synaptotagmin-like protein 2,Breast cancer-associated antigen SGA-72M;Exophilin-4;, PF00168;PF02318;, GO:0005737;GO:0070382;GO:0019897;GO:0042470;GO:0016020;GO:0005886;GO:0042043;GO:0019902;GO:0005546;GO:0001786;GO:0031267;GO:0006887;GO:0006886;GO:0010923;GO:0006904;GO:0016192;, C:cytoplasm; C:exocytic vesicle; C:extrinsic component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:neurexin family protein binding; F:phosphatase binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:negative regulation of phosphatase activity; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q6TV07 Q6ZN59 Q6ZVC5 Q8ND34 Q96BJ2 Q9H768 Q9NXM1,Synaptotagmin-like protein 2,Breast cancer-associated antigen SGA-72M;Exophilin-4;, PF00168;PF02318;, GO:0005737;GO:0070382;GO:0019897;GO:0042470;GO:0016020;GO:0005886;GO:0042043;GO:0019902;GO:0005546;GO:0001786;GO:0031267;GO:0006887;GO:0006886;GO:0010923;GO:0006904;GO:0016192;, C:cytoplasm; C:exocytic vesicle; C:extrinsic component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:neurexin family protein binding; F:phosphatase binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:negative regulation of phosphatase activity; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q6TV07 Q6ZN59 Q6ZVC5 Q8ND34 Q96BJ2 Q9H768 Q9NXM1,Synaptotagmin-like protein 2,Breast cancer-associated antigen SGA-72M;Exophilin-4;, PF00168;PF02318;, GO:0005737;GO:0070382;GO:0019897;GO:0042470;GO:0016020;GO:0005886;GO:0042043;GO:0019902;GO:0005546;GO:0001786;GO:0031267;GO:0006887;GO:0006886;GO:0010923;GO:0006904;GO:0016192;, C:cytoplasm; C:exocytic vesicle; C:extrinsic component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:neurexin family protein binding; F:phosphatase binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:negative regulation of phosphatase activity; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport; scaffold41 indexed_genome mRNA 3948350 3950399 . + . ID=transcript_8398;Q8N998,Coiled-coil domain-containing protein 89,Bc8 orange-interacting protein;, , GO:0005737;GO:0005634;, C:cytoplasm; C:nucleus; scaffold41 indexed_genome mRNA 3971792 3982305 . + . ID=transcript_8399;Q9NS37 B2R8Q9 Q0P5U9 Q52LT3,CREB/ATF bZIP transcription factor,Host cell factor-binding transcription factor Zhangfei;, PF00170;, GO:0000785;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0042802;GO:0000976;GO:0045814;GO:0045892;GO:0051090;GO:0006357;GO:0009615;, C:chromatin; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:transcription regulatory region sequence-specific DNA binding;, P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription, DNA-templated; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription by RNA polymerase II; P:response to virus;|Q9H061 B2R570 E9PI16,Transmembrane protein 126A,, PF07114;, GO:0016021;GO:0005743;GO:0005739;GO:0032981;GO:0021554;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial respiratory chain complex I assembly; P:optic nerve development; scaffold41 indexed_genome mRNA 3982307 3990036 . - . ID=transcript_8400;Q9H061 B2R570 E9PI16,Transmembrane protein 126A,, PF07114;, GO:0016021;GO:0005743;GO:0005739;GO:0032981;GO:0021554;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial respiratory chain complex I assembly; P:optic nerve development; scaffold41 indexed_genome mRNA 4004346 4329875 . - . ID=transcript_8401;Q8IUX1 A8K535 A8MSS0 Q32Q09 Q8WVU3 Q96EP3 Q9NZ29,Complex I assembly factor TMEM126B, mitochondrial,Transmembrane protein 126B;, PF07114;, GO:0016021;GO:0005743;GO:0005739;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial respiratory chain complex I assembly;|Q8IUX1 A8K535 A8MSS0 Q32Q09 Q8WVU3 Q96EP3 Q9NZ29,Complex I assembly factor TMEM126B, mitochondrial,Transmembrane protein 126B;, PF07114;, GO:0016021;GO:0005743;GO:0005739;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial respiratory chain complex I assembly;|Q8IUX1 A8K535 A8MSS0 Q32Q09 Q8WVU3 Q96EP3 Q9NZ29,Complex I assembly factor TMEM126B, mitochondrial,Transmembrane protein 126B;, PF07114;, GO:0016021;GO:0005743;GO:0005739;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial respiratory chain complex I assembly;|E9PG21 Q12958,Disks large homolog 1 {ECO:0000305},Synapse-associated protein 97;hDlg;, PF00625;PF09058;PF10608;PF00595;PF10600;PF00018;, GO:0016324;GO:0005604;GO:0016323;GO:0005923;GO:0030054;GO:0031253;GO:0005911;GO:0005737;GO:0009898;GO:0005829;GO:0005783;GO:0005789;GO:0070062;GO:0098978;GO:0005794;GO:0001772;GO:0014704;GO:0043219;GO:0016328;GO:0045121;GO:0005874;GO:0097025;GO:0035748;GO:0031594;GO:0043005;GO:0033268;GO:0005634;GO:0048471;GO:0005886;GO:0098839;GO:0042383;GO:0097060;GO:0045296;GO:0008092;GO:0004385;GO:0044325;GO:0097016;GO:0031434;GO:0060090;GO:0019902;GO:0004721;GO:0015459;GO:0008022;GO:0019901;GO:0098919;GO:0007015;GO:0032147;GO:0042982;GO:0030953;GO:0070830;GO:0001658;GO:0098609;GO:0034629;GO:0007268;GO:0030866;GO:0043622;GO:0048704;GO:0001935;GO:0051660;GO:0007163;GO:0045197;GO:0060022;GO:0001771;GO:0002088;GO:0000165;GO:0031579;GO:0050680;GO:0070373;GO:2000134;GO:1903753;GO:0051898;GO:0042130;GO:0000122;GO:0099645;GO:0030432;GO:0030838;GO:0008284;GO:0043268;GO:1903078;GO:0072659;GO:0043113;GO:0097120;GO:0008360;GO:0042391;GO:0031641;GO:2000310;GO:1903764;GO:1903286;GO:1902473;GO:1902305;GO:0098911;GO:1903760;GO:0048608;GO:0048745;GO:0042110;GO:0016032;, C:apical plasma membrane; C:basement membrane; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection membrane; C:cell-cell junction; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:immunological synapse; C:intercalated disc; C:lateral loop; C:lateral plasma membrane; C:membrane raft; C:microtubule; C:MPP7-DLG1-LIN7 complex; C:myelin sheath abaxonal region; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density membrane; C:sarcolemma; C:synaptic membrane;, F:cadherin binding; F:cytoskeletal protein binding; F:guanylate kinase activity; F:ion channel binding; F:L27 domain binding; F:mitogen-activated protein kinase kinase binding; F:molecular adaptor activity; F:phosphatase binding; F:phosphoprotein phosphatase activity; F:potassium channel regulator activity; F:protein C-terminus binding; F:protein kinase binding; F:structural constituent of postsynaptic density;, P:actin filament organization; P:activation of protein kinase activity; P:amyloid precursor protein metabolic process; P:astral microtubule organization; P:bicellular tight junction assembly; P:branching involved in ureteric bud morphogenesis; P:cell-cell adhesion; P:cellular protein-containing complex localization; P:chemical synaptic transmission; P:cortical actin cytoskeleton organization; P:cortical microtubule organization; P:embryonic skeletal system morphogenesis; P:endothelial cell proliferation; P:establishment of centrosome localization; P:establishment or maintenance of cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:hard palate development; P:immunological synapse formation; P:lens development in camera-type eye; P:MAPK cascade; P:membrane raft organization; P:negative regulation of epithelial cell proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of p38MAPK cascade; P:negative regulation of protein kinase B signaling; P:negative regulation of T cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:peristalsis; P:positive regulation of actin filament polymerization; P:positive regulation of cell population proliferation; P:positive regulation of potassium ion transport; P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:receptor clustering; P:receptor localization to synapse; P:regulation of cell shape; P:regulation of membrane potential; P:regulation of myelination; P:regulation of NMDA receptor activity; P:regulation of potassium ion export across plasma membrane; P:regulation of potassium ion import; P:regulation of protein localization to synapse; P:regulation of sodium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell action potential; P:regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:reproductive structure development; P:smooth muscle tissue development; P:T cell activation; P:viral process; scaffold41 indexed_genome mRNA 4880665 6249787 . + . ID=transcript_8402;Q15700 B7WNY8 F8W9V6 Q59G57 Q5H9Q4 Q68CQ8 Q6ZTA8,Disks large homolog 2,Channel-associated protein of synapse-110;Postsynaptic density protein PSD-93;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:1904115;GO:0016323;GO:0030054;GO:0005829;GO:0044224;GO:0016020;GO:0031594;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0004385;GO:0019900;GO:0099641;GO:0098609;GO:0035865;GO:0007268;GO:0045197;GO:0000165;GO:0010923;GO:0043113;GO:0097120;GO:2000310;GO:0099642;, C:axon cytoplasm; C:basolateral plasma membrane; C:cell junction; C:cytosol; C:juxtaparanode region of axon; C:membrane; C:neuromuscular junction; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:guanylate kinase activity; F:kinase binding;, P:anterograde axonal protein transport; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of phosphatase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity; P:retrograde axonal protein transport;|Q15700 B7WNY8 F8W9V6 Q59G57 Q5H9Q4 Q68CQ8 Q6ZTA8,Disks large homolog 2,Channel-associated protein of synapse-110;Postsynaptic density protein PSD-93;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:1904115;GO:0016323;GO:0030054;GO:0005829;GO:0044224;GO:0016020;GO:0031594;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0004385;GO:0019900;GO:0099641;GO:0098609;GO:0035865;GO:0007268;GO:0045197;GO:0000165;GO:0010923;GO:0043113;GO:0097120;GO:2000310;GO:0099642;, C:axon cytoplasm; C:basolateral plasma membrane; C:cell junction; C:cytosol; C:juxtaparanode region of axon; C:membrane; C:neuromuscular junction; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:guanylate kinase activity; F:kinase binding;, P:anterograde axonal protein transport; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of phosphatase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity; P:retrograde axonal protein transport;|Q15700 B7WNY8 F8W9V6 Q59G57 Q5H9Q4 Q68CQ8 Q6ZTA8,Disks large homolog 2,Channel-associated protein of synapse-110;Postsynaptic density protein PSD-93;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:1904115;GO:0016323;GO:0030054;GO:0005829;GO:0044224;GO:0016020;GO:0031594;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0004385;GO:0019900;GO:0099641;GO:0098609;GO:0035865;GO:0007268;GO:0045197;GO:0000165;GO:0010923;GO:0043113;GO:0097120;GO:2000310;GO:0099642;, C:axon cytoplasm; C:basolateral plasma membrane; C:cell junction; C:cytosol; C:juxtaparanode region of axon; C:membrane; C:neuromuscular junction; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:guanylate kinase activity; F:kinase binding;, P:anterograde axonal protein transport; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of phosphatase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity; P:retrograde axonal protein transport;|Q15700 B7WNY8 F8W9V6 Q59G57 Q5H9Q4 Q68CQ8 Q6ZTA8,Disks large homolog 2,Channel-associated protein of synapse-110;Postsynaptic density protein PSD-93;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:1904115;GO:0016323;GO:0030054;GO:0005829;GO:0044224;GO:0016020;GO:0031594;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0004385;GO:0019900;GO:0099641;GO:0098609;GO:0035865;GO:0007268;GO:0045197;GO:0000165;GO:0010923;GO:0043113;GO:0097120;GO:2000310;GO:0099642;, C:axon cytoplasm; C:basolateral plasma membrane; C:cell junction; C:cytosol; C:juxtaparanode region of axon; C:membrane; C:neuromuscular junction; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:guanylate kinase activity; F:kinase binding;, P:anterograde axonal protein transport; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of phosphatase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity; P:retrograde axonal protein transport;|Q15700 B7WNY8 F8W9V6 Q59G57 Q5H9Q4 Q68CQ8 Q6ZTA8,Disks large homolog 2,Channel-associated protein of synapse-110;Postsynaptic density protein PSD-93;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:1904115;GO:0016323;GO:0030054;GO:0005829;GO:0044224;GO:0016020;GO:0031594;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0004385;GO:0019900;GO:0099641;GO:0098609;GO:0035865;GO:0007268;GO:0045197;GO:0000165;GO:0010923;GO:0043113;GO:0097120;GO:2000310;GO:0099642;, C:axon cytoplasm; C:basolateral plasma membrane; C:cell junction; C:cytosol; C:juxtaparanode region of axon; C:membrane; C:neuromuscular junction; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:guanylate kinase activity; F:kinase binding;, P:anterograde axonal protein transport; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of phosphatase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity; P:retrograde axonal protein transport;|Q92796 B4E0H1 D3DVU5 Q5JUW6 Q5JUW7 Q9ULI8,Disks large homolog 3,Neuroendocrine-DLG;Synapse-associated protein 102;XLMR;, PF00625;PF00595;PF10600;PF00018;, GO:0016323;GO:0030054;GO:0005829;GO:0005615;GO:0005886;GO:0019900;GO:0019902;GO:0098609;GO:0045197;GO:0000165;GO:0008285;GO:0010923;GO:0061098;GO:0043113;GO:0097120;GO:2000310;, C:basolateral plasma membrane; C:cell junction; C:cytosol; C:extracellular space; C:plasma membrane;, F:kinase binding; F:phosphatase binding;, P:cell-cell adhesion; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of phosphatase activity; P:positive regulation of protein tyrosine kinase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity;|E9PG21 Q12958,Disks large homolog 1 {ECO:0000305},Synapse-associated protein 97;hDlg;, PF00625;PF09058;PF10608;PF00595;PF10600;PF00018;, GO:0016324;GO:0005604;GO:0016323;GO:0005923;GO:0030054;GO:0031253;GO:0005911;GO:0005737;GO:0009898;GO:0005829;GO:0005783;GO:0005789;GO:0070062;GO:0098978;GO:0005794;GO:0001772;GO:0014704;GO:0043219;GO:0016328;GO:0045121;GO:0005874;GO:0097025;GO:0035748;GO:0031594;GO:0043005;GO:0033268;GO:0005634;GO:0048471;GO:0005886;GO:0098839;GO:0042383;GO:0097060;GO:0045296;GO:0008092;GO:0004385;GO:0044325;GO:0097016;GO:0031434;GO:0060090;GO:0019902;GO:0004721;GO:0015459;GO:0008022;GO:0019901;GO:0098919;GO:0007015;GO:0032147;GO:0042982;GO:0030953;GO:0070830;GO:0001658;GO:0098609;GO:0034629;GO:0007268;GO:0030866;GO:0043622;GO:0048704;GO:0001935;GO:0051660;GO:0007163;GO:0045197;GO:0060022;GO:0001771;GO:0002088;GO:0000165;GO:0031579;GO:0050680;GO:0070373;GO:2000134;GO:1903753;GO:0051898;GO:0042130;GO:0000122;GO:0099645;GO:0030432;GO:0030838;GO:0008284;GO:0043268;GO:1903078;GO:0072659;GO:0043113;GO:0097120;GO:0008360;GO:0042391;GO:0031641;GO:2000310;GO:1903764;GO:1903286;GO:1902473;GO:1902305;GO:0098911;GO:1903760;GO:0048608;GO:0048745;GO:0042110;GO:0016032;, C:apical plasma membrane; C:basement membrane; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection membrane; C:cell-cell junction; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:immunological synapse; C:intercalated disc; C:lateral loop; C:lateral plasma membrane; C:membrane raft; C:microtubule; C:MPP7-DLG1-LIN7 complex; C:myelin sheath abaxonal region; C:neuromuscular junction; C:neuron projection; C:node of Ranvier; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density membrane; C:sarcolemma; C:synaptic membrane;, F:cadherin binding; F:cytoskeletal protein binding; F:guanylate kinase activity; F:ion channel binding; F:L27 domain binding; F:mitogen-activated protein kinase kinase binding; F:molecular adaptor activity; F:phosphatase binding; F:phosphoprotein phosphatase activity; F:potassium channel regulator activity; F:protein C-terminus binding; F:protein kinase binding; F:structural constituent of postsynaptic density;, P:actin filament organization; P:activation of protein kinase activity; P:amyloid precursor protein metabolic process; P:astral microtubule organization; P:bicellular tight junction assembly; P:branching involved in ureteric bud morphogenesis; P:cell-cell adhesion; P:cellular protein-containing complex localization; P:chemical synaptic transmission; P:cortical actin cytoskeleton organization; P:cortical microtubule organization; P:embryonic skeletal system morphogenesis; P:endothelial cell proliferation; P:establishment of centrosome localization; P:establishment or maintenance of cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:hard palate development; P:immunological synapse formation; P:lens development in camera-type eye; P:MAPK cascade; P:membrane raft organization; P:negative regulation of epithelial cell proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of p38MAPK cascade; P:negative regulation of protein kinase B signaling; P:negative regulation of T cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:neurotransmitter receptor localization to postsynaptic specialization membrane; P:peristalsis; P:positive regulation of actin filament polymerization; P:positive regulation of cell population proliferation; P:positive regulation of potassium ion transport; P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:receptor clustering; P:receptor localization to synapse; P:regulation of cell shape; P:regulation of membrane potential; P:regulation of myelination; P:regulation of NMDA receptor activity; P:regulation of potassium ion export across plasma membrane; P:regulation of potassium ion import; P:regulation of protein localization to synapse; P:regulation of sodium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell action potential; P:regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:reproductive structure development; P:smooth muscle tissue development; P:T cell activation; P:viral process;|Q15700 B7WNY8 F8W9V6 Q59G57 Q5H9Q4 Q68CQ8 Q6ZTA8,Disks large homolog 2,Channel-associated protein of synapse-110;Postsynaptic density protein PSD-93;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:1904115;GO:0016323;GO:0030054;GO:0005829;GO:0044224;GO:0016020;GO:0031594;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0004385;GO:0019900;GO:0099641;GO:0098609;GO:0035865;GO:0007268;GO:0045197;GO:0000165;GO:0010923;GO:0043113;GO:0097120;GO:2000310;GO:0099642;, C:axon cytoplasm; C:basolateral plasma membrane; C:cell junction; C:cytosol; C:juxtaparanode region of axon; C:membrane; C:neuromuscular junction; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:guanylate kinase activity; F:kinase binding;, P:anterograde axonal protein transport; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of phosphatase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity; P:retrograde axonal protein transport;|Q15700 B7WNY8 F8W9V6 Q59G57 Q5H9Q4 Q68CQ8 Q6ZTA8,Disks large homolog 2,Channel-associated protein of synapse-110;Postsynaptic density protein PSD-93;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:1904115;GO:0016323;GO:0030054;GO:0005829;GO:0044224;GO:0016020;GO:0031594;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0004385;GO:0019900;GO:0099641;GO:0098609;GO:0035865;GO:0007268;GO:0045197;GO:0000165;GO:0010923;GO:0043113;GO:0097120;GO:2000310;GO:0099642;, C:axon cytoplasm; C:basolateral plasma membrane; C:cell junction; C:cytosol; C:juxtaparanode region of axon; C:membrane; C:neuromuscular junction; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:guanylate kinase activity; F:kinase binding;, P:anterograde axonal protein transport; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of phosphatase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity; P:retrograde axonal protein transport; scaffold41 indexed_genome mRNA 6375825 6403612 . + . ID=transcript_8403;Q9GZT6 A8K8I4 B3KP87 B4E3L2 Q3B781 Q9GZU6,Coiled-coil domain-containing protein 90B, mitochondrial,, PF07798;, GO:0016021;GO:0031966;GO:0005739;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;|Q9GZT6 A8K8I4 B3KP87 B4E3L2 Q3B781 Q9GZU6,Coiled-coil domain-containing protein 90B, mitochondrial,, PF07798;, GO:0016021;GO:0031966;GO:0005739;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;|Q9GZT6 A8K8I4 B3KP87 B4E3L2 Q3B781 Q9GZU6,Coiled-coil domain-containing protein 90B, mitochondrial,, PF07798;, GO:0016021;GO:0031966;GO:0005739;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;|Q9GZT6 A8K8I4 B3KP87 B4E3L2 Q3B781 Q9GZU6,Coiled-coil domain-containing protein 90B, mitochondrial,, PF07798;, GO:0016021;GO:0031966;GO:0005739;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;|Q9GZT6 A8K8I4 B3KP87 B4E3L2 Q3B781 Q9GZU6,Coiled-coil domain-containing protein 90B, mitochondrial,, PF07798;, GO:0016021;GO:0031966;GO:0005739;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;|Q9GZT6 A8K8I4 B3KP87 B4E3L2 Q3B781 Q9GZU6,Coiled-coil domain-containing protein 90B, mitochondrial,, PF07798;, GO:0016021;GO:0031966;GO:0005739;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion; scaffold41 indexed_genome mRNA 6409398 6424392 . - . ID=transcript_8404;Q8N9B4 Q49A49,Ankyrin repeat domain-containing protein 42,, PF12796; scaffold41 indexed_genome mRNA 6425029 6462111 . - . ID=transcript_8405;Q8N9B4 Q49A49,Ankyrin repeat domain-containing protein 42,, PF12796; scaffold41 indexed_genome mRNA 6466083 6488362 . - . ID=transcript_8406;O94913 A6H8W7 O43671 Q6P0X8,Pre-mRNA cleavage complex 2 protein Pcf11,Pre-mRNA cleavage complex II protein Pcf11;, PF04818;, GO:0005737;GO:0005739;GO:0005849;GO:0005654;GO:0003729;GO:0000993;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0006369;, C:cytoplasm; C:mitochondrion; C:mRNA cleavage factor complex; C:nucleoplasm;, F:mRNA binding; F:RNA polymerase II complex binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription;|O94913 A6H8W7 O43671 Q6P0X8,Pre-mRNA cleavage complex 2 protein Pcf11,Pre-mRNA cleavage complex II protein Pcf11;, PF04818;, GO:0005737;GO:0005739;GO:0005849;GO:0005654;GO:0003729;GO:0000993;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0006369;, C:cytoplasm; C:mitochondrion; C:mRNA cleavage factor complex; C:nucleoplasm;, F:mRNA binding; F:RNA polymerase II complex binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription;|O94913 A6H8W7 O43671 Q6P0X8,Pre-mRNA cleavage complex 2 protein Pcf11,Pre-mRNA cleavage complex II protein Pcf11;, PF04818;, GO:0005737;GO:0005739;GO:0005849;GO:0005654;GO:0003729;GO:0000993;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0006369;, C:cytoplasm; C:mitochondrion; C:mRNA cleavage factor complex; C:nucleoplasm;, F:mRNA binding; F:RNA polymerase II complex binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription;|O94913 A6H8W7 O43671 Q6P0X8,Pre-mRNA cleavage complex 2 protein Pcf11,Pre-mRNA cleavage complex II protein Pcf11;, PF04818;, GO:0005737;GO:0005739;GO:0005849;GO:0005654;GO:0003729;GO:0000993;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0006369;, C:cytoplasm; C:mitochondrion; C:mRNA cleavage factor complex; C:nucleoplasm;, F:mRNA binding; F:RNA polymerase II complex binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription;|O94913 A6H8W7 O43671 Q6P0X8,Pre-mRNA cleavage complex 2 protein Pcf11,Pre-mRNA cleavage complex II protein Pcf11;, PF04818;, GO:0005737;GO:0005739;GO:0005849;GO:0005654;GO:0003729;GO:0000993;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0006369;, C:cytoplasm; C:mitochondrion; C:mRNA cleavage factor complex; C:nucleoplasm;, F:mRNA binding; F:RNA polymerase II complex binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription;|O94913 A6H8W7 O43671 Q6P0X8,Pre-mRNA cleavage complex 2 protein Pcf11,Pre-mRNA cleavage complex II protein Pcf11;, PF04818;, GO:0005737;GO:0005739;GO:0005849;GO:0005654;GO:0003729;GO:0000993;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0006369;, C:cytoplasm; C:mitochondrion; C:mRNA cleavage factor complex; C:nucleoplasm;, F:mRNA binding; F:RNA polymerase II complex binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription;|O94913 A6H8W7 O43671 Q6P0X8,Pre-mRNA cleavage complex 2 protein Pcf11,Pre-mRNA cleavage complex II protein Pcf11;, PF04818;, GO:0005737;GO:0005739;GO:0005849;GO:0005654;GO:0003729;GO:0000993;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0006369;, C:cytoplasm; C:mitochondrion; C:mRNA cleavage factor complex; C:nucleoplasm;, F:mRNA binding; F:RNA polymerase II complex binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription; scaffold41 indexed_genome mRNA 6491056 6492268 . + . ID=transcript_8407;O94913 A6H8W7 O43671 Q6P0X8,Pre-mRNA cleavage complex 2 protein Pcf11,Pre-mRNA cleavage complex II protein Pcf11;, PF04818;, GO:0005737;GO:0005739;GO:0005849;GO:0005654;GO:0003729;GO:0000993;GO:0031124;GO:0006379;GO:0006378;GO:0000398;GO:0006369;, C:cytoplasm; C:mitochondrion; C:mRNA cleavage factor complex; C:nucleoplasm;, F:mRNA binding; F:RNA polymerase II complex binding;, P:mRNA 3'-end processing; P:mRNA cleavage; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription; scaffold41 indexed_genome mRNA 6619820 6620405 . - . ID=transcript_8408;Q4G0N0 A2JVH9,Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase {ECO:0000305},Glycoprotein alpha-galactosyltransferase 1 pseudogene;, , GO:0031985;GO:0032580;GO:0016021;GO:0016758;GO:0005975;GO:1901750;GO:0033580;, C:Golgi cisterna; C:Golgi cisterna membrane; C:integral component of membrane;, F:transferase activity, transferring hexosyl groups;, P:carbohydrate metabolic process; P:leukotriene D4 biosynthetic process; P:protein galactosylation at cell surface; scaffold41 indexed_genome mRNA 6645619 6665403 . + . ID=transcript_8409;Q15771 Q6FGK1 Q6MZH2 Q96CI8,Ras-related protein Rab-30,, PF00071;, GO:0005801;GO:0031985;GO:0000139;GO:0005795;GO:0043231;GO:0005802;GO:0005525;GO:0003924;GO:0007030;GO:0032482;, C:cis-Golgi network; C:Golgi cisterna; C:Golgi membrane; C:Golgi stack; C:intracellular membrane-bounded organelle; C:trans-Golgi network;, F:GTP binding; F:GTPase activity;, P:Golgi organization; P:Rab protein signal transduction; scaffold41 indexed_genome mRNA 6706628 6707417 . + . ID=transcript_8410;Q8IXT1 Q96LK6 Q9H856,DNA damage-induced apoptosis suppressor protein,Nitric oxide-inducible gene protein;, PF08646;, GO:0005737;GO:0005634;GO:0006915;GO:0071850;GO:1902230;GO:0097752;, C:cytoplasm; C:nucleus;, , P:apoptotic process; P:mitotic cell cycle arrest; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:regulation of DNA stability; scaffold41 indexed_genome mRNA 6709940 6725720 . - . ID=transcript_8411;Q8IXT1 Q96LK6 Q9H856,DNA damage-induced apoptosis suppressor protein,Nitric oxide-inducible gene protein;, PF08646;, GO:0005737;GO:0005634;GO:0006915;GO:0071850;GO:1902230;GO:0097752;, C:cytoplasm; C:nucleus;, , P:apoptotic process; P:mitotic cell cycle arrest; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:regulation of DNA stability; scaffold41 indexed_genome mRNA 6726443 6806109 . + . ID=transcript_8412;P42785 A8MU24 B2R7B7 B3KRK5 B5BU34,Lysosomal Pro-X carboxypeptidase,Angiotensinase C;Lysosomal carboxypeptidase C;Proline carboxypeptidase;Prolylcarboxypeptidase;, PF05577;, GO:0035577;GO:0045178;GO:0070062;GO:0101003;GO:0043231;GO:0005886;GO:0008239;GO:0004185;GO:0060055;GO:0007597;GO:0097009;GO:0042593;GO:0003085;GO:0043312;GO:0002353;GO:0006508;GO:0043535;GO:2000377;GO:0002155;, C:azurophil granule membrane; C:basal part of cell; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:dipeptidyl-peptidase activity; F:serine-type carboxypeptidase activity;, P:angiogenesis involved in wound healing; P:blood coagulation, intrinsic pathway; P:energy homeostasis; P:glucose homeostasis; P:negative regulation of systemic arterial blood pressure; P:neutrophil degranulation; P:plasma kallikrein-kinin cascade; P:proteolysis; P:regulation of blood vessel endothelial cell migration; P:regulation of reactive oxygen species metabolic process; P:regulation of thyroid hormone mediated signaling pathway; scaffold41 indexed_genome mRNA 6905890 6907344 . + . ID=transcript_8413;A6NEQ2 B2RWP1,Protein FAM181B,, PF15238; scaffold41 indexed_genome mRNA 11015559 11016090 . + . ID=transcript_8414;Q6N022 A6ND26 Q7Z3C7 Q96MS6 Q9P2P4 Q9Y4S2,Teneurin-4,Protein Odd Oz/ten-m homolog 4;Tenascin-M4;Teneurin transmembrane protein 4;, PF07974;PF06484;PF15636;, GO:0005737;GO:0005887;GO:0043005;GO:0005634;GO:0005886;GO:0050839;GO:0046982;GO:0042803;GO:0060912;GO:0060038;GO:0032289;GO:0001702;GO:0007157;GO:0048666;GO:2000543;GO:0031643;GO:0048714;GO:0031641;GO:0007165;, C:cytoplasm; C:integral component of plasma membrane; C:neuron projection; C:nucleus; C:plasma membrane;, F:cell adhesion molecule binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:cardiac cell fate specification; P:cardiac muscle cell proliferation; P:central nervous system myelin formation; P:gastrulation with mouth forming second; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:neuron development; P:positive regulation of gastrulation; P:positive regulation of myelination; P:positive regulation of oligodendrocyte differentiation; P:regulation of myelination; P:signal transduction; scaffold41 indexed_genome mRNA 11016497 11027202 . + . ID=transcript_8415;Q6N022 A6ND26 Q7Z3C7 Q96MS6 Q9P2P4 Q9Y4S2,Teneurin-4,Protein Odd Oz/ten-m homolog 4;Tenascin-M4;Teneurin transmembrane protein 4;, PF07974;PF06484;PF15636;, GO:0005737;GO:0005887;GO:0043005;GO:0005634;GO:0005886;GO:0050839;GO:0046982;GO:0042803;GO:0060912;GO:0060038;GO:0032289;GO:0001702;GO:0007157;GO:0048666;GO:2000543;GO:0031643;GO:0048714;GO:0031641;GO:0007165;, C:cytoplasm; C:integral component of plasma membrane; C:neuron projection; C:nucleus; C:plasma membrane;, F:cell adhesion molecule binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:cardiac cell fate specification; P:cardiac muscle cell proliferation; P:central nervous system myelin formation; P:gastrulation with mouth forming second; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:neuron development; P:positive regulation of gastrulation; P:positive regulation of myelination; P:positive regulation of oligodendrocyte differentiation; P:regulation of myelination; P:signal transduction; scaffold41 indexed_genome mRNA 11085011 11214820 . + . ID=transcript_8416;Q96I59 G3V178,Probable asparagine--tRNA ligase, mitochondrial,Asparaginyl-tRNA synthetase;, PF00152;PF01336;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0004816;GO:0005524;GO:0003676;GO:0006421;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:asparagine-tRNA ligase activity; F:ATP binding; F:nucleic acid binding;, P:asparaginyl-tRNA aminoacylation;|Q96I59 G3V178,Probable asparagine--tRNA ligase, mitochondrial,Asparaginyl-tRNA synthetase;, PF00152;PF01336;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0004816;GO:0005524;GO:0003676;GO:0006421;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:asparagine-tRNA ligase activity; F:ATP binding; F:nucleic acid binding;, P:asparaginyl-tRNA aminoacylation; scaffold41 indexed_genome mRNA 11408982 11417347 . + . ID=transcript_8417;Q9UQC2 A2RRM2 A6NEW9 A7MD36 O60317,GRB2-associated-binding protein 2,GRB2-associated binder 2;Growth factor receptor bound protein 2-associated protein 2;pp100;, PF00169;, GO:0005737;GO:0005829;GO:0005886;GO:0005547;GO:0043325;GO:0005068;GO:0007411;GO:0019221;GO:0038095;GO:0030316;GO:0048015;GO:0008284;GO:0043306;GO:0051897;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:axon guidance; P:cytokine-mediated signaling pathway; P:Fc-epsilon receptor signaling pathway; P:osteoclast differentiation; P:phosphatidylinositol-mediated signaling; P:positive regulation of cell population proliferation; P:positive regulation of mast cell degranulation; P:positive regulation of protein kinase B signaling; scaffold41 indexed_genome mRNA 11420898 11424101 . - . ID=transcript_8418;Q9P2H5,Ubiquitin carboxyl-terminal hydrolase 35,Deubiquitinating enzyme 35;Ubiquitin thioesterase 35;Ubiquitin-specific-processing protease 35;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold41 indexed_genome mRNA 11424415 11489728 . - . ID=transcript_8419;Q9P2H5,Ubiquitin carboxyl-terminal hydrolase 35,Deubiquitinating enzyme 35;Ubiquitin thioesterase 35;Ubiquitin-specific-processing protease 35;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold41 indexed_genome mRNA 11489932 11505301 . - . ID=transcript_8420;Q4G0X4 B4DTR0,BTB/POZ domain-containing protein KCTD21,KCASH2 protein {ECO:0000303|PubMed:21472142};Potassium channel tetramerization domain-containing protein 21;, PF02214;, GO:0097602;GO:0042826;GO:0042802;GO:0045879;GO:0051260;GO:0016567;GO:0040008;GO:0006511;, , F:cullin family protein binding; F:histone deacetylase binding; F:identical protein binding;, P:negative regulation of smoothened signaling pathway; P:protein homooligomerization; P:protein ubiquitination; P:regulation of growth; P:ubiquitin-dependent protein catabolic process; scaffold41 indexed_genome mRNA 11548158 11574182 . + . ID=transcript_8421;Q9BVK2 A6NDW6 O60860,Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase {ECO:0000250|UniProtKB:P40351},Asparagine-linked glycosylation protein 8 homolog;Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase {ECO:0000250|UniProtKB:P40351};Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase {ECO:0000250|UniProtKB:P40351};, PF03155;, GO:0005789;GO:0016021;GO:0000033;GO:0042283;GO:0006488;GO:0006490;GO:0006487;GO:0018279;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:alpha-1,3-mannosyltransferase activity; F:dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide-lipid intermediate biosynthetic process; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; scaffold41 indexed_genome mRNA 11581923 11740961 . + . ID=transcript_8422;Q92748 B2R4W7,Thyroid hormone-inducible hepatic protein,Spot 14 protein;, PF07084;, GO:0005829;GO:0005654;GO:0042802;GO:0042803;GO:0006853;GO:0006629;GO:0046890;GO:0010866;GO:0009617;, C:cytosol; C:nucleoplasm;, F:identical protein binding; F:protein homodimerization activity;, P:carnitine shuttle; P:lipid metabolic process; P:regulation of lipid biosynthetic process; P:regulation of triglyceride biosynthetic process; P:response to bacterium;|O95298 E9PNU8 E9PRB2 Q549M5 Q6FIH8 Q9UBJ9,NADH dehydrogenase [ubiquinone] 1 subunit C2,Complex I-B14.5b;Human lung cancer oncogene 1 protein;NADH-ubiquinone oxidoreductase subunit B14.5b;, PF06374;, GO:0035577;GO:0005737;GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0005886;GO:0008137;GO:0006120;GO:0032981;GO:0043312;, C:azurophil granule membrane; C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:plasma membrane;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:neutrophil degranulation;|O95298 E9PNU8 E9PRB2 Q549M5 Q6FIH8 Q9UBJ9,NADH dehydrogenase [ubiquinone] 1 subunit C2,Complex I-B14.5b;Human lung cancer oncogene 1 protein;NADH-ubiquinone oxidoreductase subunit B14.5b;, PF06374;, GO:0035577;GO:0005737;GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0005886;GO:0008137;GO:0006120;GO:0032981;GO:0043312;, C:azurophil granule membrane; C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:plasma membrane;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:neutrophil degranulation;|Q9BQ13 B2R9R8,BTB/POZ domain-containing protein KCTD14,, PF02214;, GO:0051260;, , , P:protein homooligomerization;|Q96HW7 Q2YD62 Q6PJG4 Q7Z4E7 Q96G32 Q96GA1 Q9BRC0,Integrator complex subunit 4,, PF12765;, GO:0032039;GO:0005730;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:integrator complex; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q06323 A6NJG9 H0YNE3 Q6IBM2 Q9UEF4,Proteasome activator complex subunit 1,11S regulator complex subunit alpha;Activator of multicatalytic protease subunit 1;Interferon gamma up-regulated I-5111 protein;Proteasome activator 28 subunit alpha;, PF02251;PF02252;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0008537;GO:0000502;GO:0061133;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0010950;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:2000045;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:proteasome activator complex; C:proteasome complex;, F:endopeptidase activator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endopeptidase activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q06323 A6NJG9 H0YNE3 Q6IBM2 Q9UEF4,Proteasome activator complex subunit 1,11S regulator complex subunit alpha;Activator of multicatalytic protease subunit 1;Interferon gamma up-regulated I-5111 protein;Proteasome activator 28 subunit alpha;, PF02251;PF02252;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0008537;GO:0000502;GO:0061133;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0010950;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:2000045;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:proteasome activator complex; C:proteasome complex;, F:endopeptidase activator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endopeptidase activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q96HW7 Q2YD62 Q6PJG4 Q7Z4E7 Q96G32 Q96GA1 Q9BRC0,Integrator complex subunit 4,, PF12765;, GO:0032039;GO:0005730;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:integrator complex; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold41 indexed_genome mRNA 11741027 11754425 . - . ID=transcript_8423;Q9H7C9 Q96AQ4 Q9Y6B1,Mth938 domain-containing protein,Adipogenesis associated Mth938 domain-containing protein;, PF04430;, GO:0005737;GO:0045600;, C:cytoplasm;, , P:positive regulation of fat cell differentiation;|Q9H7C9 Q96AQ4 Q9Y6B1,Mth938 domain-containing protein,Adipogenesis associated Mth938 domain-containing protein;, PF04430;, GO:0005737;GO:0045600;, C:cytoplasm;, , P:positive regulation of fat cell differentiation;|Q9H7C9 Q96AQ4 Q9Y6B1,Mth938 domain-containing protein,Adipogenesis associated Mth938 domain-containing protein;, PF04430;, GO:0005737;GO:0045600;, C:cytoplasm;, , P:positive regulation of fat cell differentiation; scaffold41 indexed_genome mRNA 11761364 11768810 . - . ID=transcript_8424;Q9H7C9 Q96AQ4 Q9Y6B1,Mth938 domain-containing protein,Adipogenesis associated Mth938 domain-containing protein;, PF04430;, GO:0005737;GO:0045600;, C:cytoplasm;, , P:positive regulation of fat cell differentiation; scaffold41 indexed_genome mRNA 11854263 11924226 . + . ID=transcript_8425;Q96T23 Q86X86 Q9H3L8 Q9NVZ8 Q9NYU0,Remodeling and spacing factor 1,HBV pX-associated protein 8;Hepatitis B virus X-associated protein;p325 subunit of RSF chromatin-remodeling complex;, PF00628;PF15612;, GO:0005654;GO:0005634;GO:0031213;GO:0042393;GO:0046872;GO:0003712;GO:0034080;GO:0006338;GO:0006352;GO:0043392;GO:0045892;GO:0006334;GO:0016584;GO:0045944;GO:0045893;GO:0050434;, C:nucleoplasm; C:nucleus; C:RSF complex;, F:histone binding; F:metal ion binding; F:transcription coregulator activity;, P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA-templated transcription, initiation; P:negative regulation of DNA binding; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:nucleosome positioning; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral transcription;|Q96T23 Q86X86 Q9H3L8 Q9NVZ8 Q9NYU0,Remodeling and spacing factor 1,HBV pX-associated protein 8;Hepatitis B virus X-associated protein;p325 subunit of RSF chromatin-remodeling complex;, PF00628;PF15612;, GO:0005654;GO:0005634;GO:0031213;GO:0042393;GO:0046872;GO:0003712;GO:0034080;GO:0006338;GO:0006352;GO:0043392;GO:0045892;GO:0006334;GO:0016584;GO:0045944;GO:0045893;GO:0050434;, C:nucleoplasm; C:nucleus; C:RSF complex;, F:histone binding; F:metal ion binding; F:transcription coregulator activity;, P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA-templated transcription, initiation; P:negative regulation of DNA binding; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:nucleosome positioning; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral transcription; scaffold41 indexed_genome mRNA 11935451 11954612 . + . ID=transcript_8426;P54105 B2RCS9 Q0VDK6 Q9NRD2 Q9NRD3,Methylosome subunit pICln,Chloride channel, nucleotide sensitive 1A;Chloride conductance regulatory protein ICln;Chloride ion current inducer protein;Reticulocyte pICln;, PF03517;, GO:0005856;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0034715;GO:0005886;GO:0003723;GO:0006884;GO:0006821;GO:0000387;, C:cytoskeleton; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:plasma membrane;, F:RNA binding;, P:cell volume homeostasis; P:chloride transport; P:spliceosomal snRNP assembly;|P54105 B2RCS9 Q0VDK6 Q9NRD2 Q9NRD3,Methylosome subunit pICln,Chloride channel, nucleotide sensitive 1A;Chloride conductance regulatory protein ICln;Chloride ion current inducer protein;Reticulocyte pICln;, PF03517;, GO:0005856;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0034715;GO:0005886;GO:0003723;GO:0006884;GO:0006821;GO:0000387;, C:cytoskeleton; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:plasma membrane;, F:RNA binding;, P:cell volume homeostasis; P:chloride transport; P:spliceosomal snRNP assembly; scaffold41 indexed_genome mRNA 11964356 11977463 . - . ID=transcript_8427;Q8NBQ7,Aquaporin-11 {ECO:0000305|Ref.1},, PF00230;, GO:0009986;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0005783;GO:0005789;GO:0016021;GO:0048471;GO:0005886;GO:0015267;GO:0015254;GO:0042802;GO:0015250;GO:0009992;GO:0048388;GO:0015793;GO:0080170;GO:0050680;GO:1904293;GO:1903573;GO:0032364;GO:0008284;GO:0033577;GO:0051260;GO:0006612;GO:0072014;GO:0030104;GO:0006833;, C:cell surface; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:channel activity; F:glycerol channel activity; F:identical protein binding; F:water channel activity;, P:cellular water homeostasis; P:endosomal lumen acidification; P:glycerol transport; P:hydrogen peroxide transmembrane transport; P:negative regulation of epithelial cell proliferation; P:negative regulation of ERAD pathway; P:negative regulation of response to endoplasmic reticulum stress; P:oxygen homeostasis; P:positive regulation of cell population proliferation; P:protein glycosylation in endoplasmic reticulum; P:protein homooligomerization; P:protein targeting to membrane; P:proximal tubule development; P:water homeostasis; P:water transport; scaffold41 indexed_genome mRNA 12080415 12162965 . + . ID=transcript_8428;Q13153 O75561 Q13567 Q32M53 Q32M54 Q86W79,Serine/threonine-protein kinase PAK 1 {ECO:0000303|PubMed:8805275},Alpha-PAK {ECO:0000303|PubMed:9528787};p21-activated kinase 1 {ECO:0000303|PubMed:9395435};p65-PAK {ECO:0000250|UniProtKB:P35465};, PF00786;PF00069;, GO:0005884;GO:0030424;GO:0005911;GO:0005694;GO:0005737;GO:0005829;GO:0030425;GO:0005925;GO:0014704;GO:0030027;GO:0031965;GO:0005654;GO:0005886;GO:0032991;GO:0001726;GO:0032587;GO:0030018;GO:0005524;GO:0005518;GO:0043015;GO:0042802;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0006915;GO:0048754;GO:0016477;GO:0006974;GO:0032869;GO:0021549;GO:0006338;GO:0048013;GO:0030010;GO:0006887;GO:0038095;GO:0038096;GO:0048012;GO:0061052;GO:0060244;GO:0048812;GO:0016310;GO:0045773;GO:0030335;GO:0008284;GO:0010763;GO:0046628;GO:0033148;GO:0043507;GO:0090063;GO:0031116;GO:0033138;GO:0001934;GO:0090314;GO:0051496;GO:1904754;GO:1904707;GO:0046777;GO:0006468;GO:0050770;GO:0001666;GO:0002223;GO:0031098;GO:0031295;GO:0050852;GO:0042060;, C:actin filament; C:axon; C:cell-cell junction; C:chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:focal adhesion; C:intercalated disc; C:lamellipodium; C:nuclear membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:ruffle; C:ruffle membrane; C:Z disc;, F:ATP binding; F:collagen binding; F:gamma-tubulin binding; F:identical protein binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:apoptotic process; P:branching morphogenesis of an epithelial tube; P:cell migration; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cerebellum development; P:chromatin remodeling; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:exocytosis; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:hepatocyte growth factor receptor signaling pathway; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of cell proliferation involved in contact inhibition; P:neuron projection morphogenesis; P:phosphorylation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of JUN kinase activity; P:positive regulation of microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of stress fiber assembly; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:response to hypoxia; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated protein kinase signaling cascade; P:T cell costimulation; P:T cell receptor signaling pathway; P:wound healing; scaffold41 indexed_genome mRNA 12173461 12245375 . + . ID=transcript_8429;Q13153 O75561 Q13567 Q32M53 Q32M54 Q86W79,Serine/threonine-protein kinase PAK 1 {ECO:0000303|PubMed:8805275},Alpha-PAK {ECO:0000303|PubMed:9528787};p21-activated kinase 1 {ECO:0000303|PubMed:9395435};p65-PAK {ECO:0000250|UniProtKB:P35465};, PF00786;PF00069;, GO:0005884;GO:0030424;GO:0005911;GO:0005694;GO:0005737;GO:0005829;GO:0030425;GO:0005925;GO:0014704;GO:0030027;GO:0031965;GO:0005654;GO:0005886;GO:0032991;GO:0001726;GO:0032587;GO:0030018;GO:0005524;GO:0005518;GO:0043015;GO:0042802;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0006915;GO:0048754;GO:0016477;GO:0006974;GO:0032869;GO:0021549;GO:0006338;GO:0048013;GO:0030010;GO:0006887;GO:0038095;GO:0038096;GO:0048012;GO:0061052;GO:0060244;GO:0048812;GO:0016310;GO:0045773;GO:0030335;GO:0008284;GO:0010763;GO:0046628;GO:0033148;GO:0043507;GO:0090063;GO:0031116;GO:0033138;GO:0001934;GO:0090314;GO:0051496;GO:1904754;GO:1904707;GO:0046777;GO:0006468;GO:0050770;GO:0001666;GO:0002223;GO:0031098;GO:0031295;GO:0050852;GO:0042060;, C:actin filament; C:axon; C:cell-cell junction; C:chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:focal adhesion; C:intercalated disc; C:lamellipodium; C:nuclear membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:ruffle; C:ruffle membrane; C:Z disc;, F:ATP binding; F:collagen binding; F:gamma-tubulin binding; F:identical protein binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:apoptotic process; P:branching morphogenesis of an epithelial tube; P:cell migration; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cerebellum development; P:chromatin remodeling; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:exocytosis; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:hepatocyte growth factor receptor signaling pathway; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of cell proliferation involved in contact inhibition; P:neuron projection morphogenesis; P:phosphorylation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of JUN kinase activity; P:positive regulation of microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of stress fiber assembly; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:response to hypoxia; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated protein kinase signaling cascade; P:T cell costimulation; P:T cell receptor signaling pathway; P:wound healing;|Q13153 O75561 Q13567 Q32M53 Q32M54 Q86W79,Serine/threonine-protein kinase PAK 1 {ECO:0000303|PubMed:8805275},Alpha-PAK {ECO:0000303|PubMed:9528787};p21-activated kinase 1 {ECO:0000303|PubMed:9395435};p65-PAK {ECO:0000250|UniProtKB:P35465};, PF00786;PF00069;, GO:0005884;GO:0030424;GO:0005911;GO:0005694;GO:0005737;GO:0005829;GO:0030425;GO:0005925;GO:0014704;GO:0030027;GO:0031965;GO:0005654;GO:0005886;GO:0032991;GO:0001726;GO:0032587;GO:0030018;GO:0005524;GO:0005518;GO:0043015;GO:0042802;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0006915;GO:0048754;GO:0016477;GO:0006974;GO:0032869;GO:0021549;GO:0006338;GO:0048013;GO:0030010;GO:0006887;GO:0038095;GO:0038096;GO:0048012;GO:0061052;GO:0060244;GO:0048812;GO:0016310;GO:0045773;GO:0030335;GO:0008284;GO:0010763;GO:0046628;GO:0033148;GO:0043507;GO:0090063;GO:0031116;GO:0033138;GO:0001934;GO:0090314;GO:0051496;GO:1904754;GO:1904707;GO:0046777;GO:0006468;GO:0050770;GO:0001666;GO:0002223;GO:0031098;GO:0031295;GO:0050852;GO:0042060;, C:actin filament; C:axon; C:cell-cell junction; C:chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:focal adhesion; C:intercalated disc; C:lamellipodium; C:nuclear membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:ruffle; C:ruffle membrane; C:Z disc;, F:ATP binding; F:collagen binding; F:gamma-tubulin binding; F:identical protein binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:apoptotic process; P:branching morphogenesis of an epithelial tube; P:cell migration; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cerebellum development; P:chromatin remodeling; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:exocytosis; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:hepatocyte growth factor receptor signaling pathway; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of cell proliferation involved in contact inhibition; P:neuron projection morphogenesis; P:phosphorylation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of JUN kinase activity; P:positive regulation of microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of stress fiber assembly; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:response to hypoxia; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated protein kinase signaling cascade; P:T cell costimulation; P:T cell receptor signaling pathway; P:wound healing;|Q13153 O75561 Q13567 Q32M53 Q32M54 Q86W79,Serine/threonine-protein kinase PAK 1 {ECO:0000303|PubMed:8805275},Alpha-PAK {ECO:0000303|PubMed:9528787};p21-activated kinase 1 {ECO:0000303|PubMed:9395435};p65-PAK {ECO:0000250|UniProtKB:P35465};, PF00786;PF00069;, GO:0005884;GO:0030424;GO:0005911;GO:0005694;GO:0005737;GO:0005829;GO:0030425;GO:0005925;GO:0014704;GO:0030027;GO:0031965;GO:0005654;GO:0005886;GO:0032991;GO:0001726;GO:0032587;GO:0030018;GO:0005524;GO:0005518;GO:0043015;GO:0042802;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0006915;GO:0048754;GO:0016477;GO:0006974;GO:0032869;GO:0021549;GO:0006338;GO:0048013;GO:0030010;GO:0006887;GO:0038095;GO:0038096;GO:0048012;GO:0061052;GO:0060244;GO:0048812;GO:0016310;GO:0045773;GO:0030335;GO:0008284;GO:0010763;GO:0046628;GO:0033148;GO:0043507;GO:0090063;GO:0031116;GO:0033138;GO:0001934;GO:0090314;GO:0051496;GO:1904754;GO:1904707;GO:0046777;GO:0006468;GO:0050770;GO:0001666;GO:0002223;GO:0031098;GO:0031295;GO:0050852;GO:0042060;, C:actin filament; C:axon; C:cell-cell junction; C:chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:focal adhesion; C:intercalated disc; C:lamellipodium; C:nuclear membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:ruffle; C:ruffle membrane; C:Z disc;, F:ATP binding; F:collagen binding; F:gamma-tubulin binding; F:identical protein binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:apoptotic process; P:branching morphogenesis of an epithelial tube; P:cell migration; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cerebellum development; P:chromatin remodeling; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:exocytosis; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:hepatocyte growth factor receptor signaling pathway; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of cell proliferation involved in contact inhibition; P:neuron projection morphogenesis; P:phosphorylation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of JUN kinase activity; P:positive regulation of microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of stress fiber assembly; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:response to hypoxia; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated protein kinase signaling cascade; P:T cell costimulation; P:T cell receptor signaling pathway; P:wound healing;|Q13153 O75561 Q13567 Q32M53 Q32M54 Q86W79,Serine/threonine-protein kinase PAK 1 {ECO:0000303|PubMed:8805275},Alpha-PAK {ECO:0000303|PubMed:9528787};p21-activated kinase 1 {ECO:0000303|PubMed:9395435};p65-PAK {ECO:0000250|UniProtKB:P35465};, PF00786;PF00069;, GO:0005884;GO:0030424;GO:0005911;GO:0005694;GO:0005737;GO:0005829;GO:0030425;GO:0005925;GO:0014704;GO:0030027;GO:0031965;GO:0005654;GO:0005886;GO:0032991;GO:0001726;GO:0032587;GO:0030018;GO:0005524;GO:0005518;GO:0043015;GO:0042802;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0006915;GO:0048754;GO:0016477;GO:0006974;GO:0032869;GO:0021549;GO:0006338;GO:0048013;GO:0030010;GO:0006887;GO:0038095;GO:0038096;GO:0048012;GO:0061052;GO:0060244;GO:0048812;GO:0016310;GO:0045773;GO:0030335;GO:0008284;GO:0010763;GO:0046628;GO:0033148;GO:0043507;GO:0090063;GO:0031116;GO:0033138;GO:0001934;GO:0090314;GO:0051496;GO:1904754;GO:1904707;GO:0046777;GO:0006468;GO:0050770;GO:0001666;GO:0002223;GO:0031098;GO:0031295;GO:0050852;GO:0042060;, C:actin filament; C:axon; C:cell-cell junction; C:chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:focal adhesion; C:intercalated disc; C:lamellipodium; C:nuclear membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex; C:ruffle; C:ruffle membrane; C:Z disc;, F:ATP binding; F:collagen binding; F:gamma-tubulin binding; F:identical protein binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:apoptotic process; P:branching morphogenesis of an epithelial tube; P:cell migration; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:cerebellum development; P:chromatin remodeling; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:exocytosis; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:hepatocyte growth factor receptor signaling pathway; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of cell proliferation involved in contact inhibition; P:neuron projection morphogenesis; P:phosphorylation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of JUN kinase activity; P:positive regulation of microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of stress fiber assembly; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:response to hypoxia; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated protein kinase signaling cascade; P:T cell costimulation; P:T cell receptor signaling pathway; P:wound healing; scaffold41 indexed_genome mRNA 13535754 14022453 . - . ID=transcript_8430;Q86TE4 A2RUB8 E9PN53 Q6UXE7 Q6ZS65,Leucine zipper protein 2,, , GO:0005576;, C:extracellular region; scaffold41 indexed_genome mRNA 15298735 15309203 . + . ID=transcript_8431;Q8NHG7,Small VCP/p97-interacting protein,, PF15811;, GO:0031225;GO:0005789;GO:0070062;GO:0000139;GO:0005886;GO:0030667;GO:0030868;GO:0070821;GO:0051117;GO:0043621;GO:1903070;GO:0031333;GO:1904153;GO:1904240;GO:0043312;GO:0010508;GO:1903061;, C:anchored component of membrane; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi membrane; C:plasma membrane; C:secretory granule membrane; C:smooth endoplasmic reticulum membrane; C:tertiary granule membrane;, F:ATPase binding; F:protein self-association;, P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:negative regulation of protein-containing complex assembly; P:negative regulation of retrograde protein transport, ER to cytosol; P:negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly; P:neutrophil degranulation; P:positive regulation of autophagy; P:positive regulation of protein lipidation; scaffold41 indexed_genome mRNA 15310596 15378238 . - . ID=transcript_8432;O43903 B2R9C8 D3DQZ0 Q6ICV8 Q7Z3X8,Growth arrest-specific protein 2,, PF00307;PF02187;, GO:0005884;GO:0005829;GO:0016020;GO:0005874;GO:0051015;GO:0008093;GO:0008017;GO:0051764;GO:0001547;GO:0006915;GO:0071711;GO:0007050;GO:0001544;GO:0000226;GO:0030728;GO:0008360;GO:0008593;, C:actin filament; C:cytosol; C:membrane; C:microtubule;, F:actin filament binding; F:cytoskeletal anchor activity; F:microtubule binding;, P:actin crosslink formation; P:antral ovarian follicle growth; P:apoptotic process; P:basement membrane organization; P:cell cycle arrest; P:initiation of primordial ovarian follicle growth; P:microtubule cytoskeleton organization; P:ovulation; P:regulation of cell shape; P:regulation of Notch signaling pathway; scaffold41 indexed_genome mRNA 15476552 15477963 . + . ID=transcript_8433;Q9NPI8 Q52LM0,Fanconi anemia group F protein,, PF11107;, GO:0043240;GO:0005654;GO:0006974;GO:0036297;, C:Fanconi anaemia nuclear complex; C:nucleoplasm;, , P:cellular response to DNA damage stimulus; P:interstrand cross-link repair; scaffold41 indexed_genome mRNA 15698991 15735792 . - . ID=transcript_8434;Q9P2U8 A6NKS2,Vesicular glutamate transporter 2,Differentiation-associated BNPI;Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter;Solute carrier family 17 member 6;, PF07690;, GO:0060076;GO:0016021;GO:0030285;GO:0043005;GO:0030672;GO:0005313;GO:0005326;GO:0015293;GO:0022857;GO:0006820;GO:1990384;GO:0006811;GO:0098700;GO:0050803;GO:0006814;GO:0035249;, C:excitatory synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:neuron projection; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:symporter activity; F:transmembrane transporter activity;, P:anion transport; P:hyaloid vascular plexus regression; P:ion transport; P:neurotransmitter loading into synaptic vesicle; P:regulation of synapse structure or activity; P:sodium ion transport; P:synaptic transmission, glutamatergic; scaffold41 indexed_genome mRNA 15780066 15849644 . - . ID=transcript_8435;Q75V66,Anoctamin-5,Gnathodiaphyseal dysplasia 1 protein;Transmembrane protein 16E;, PF16178;PF04547;, GO:0005789;GO:0016021;GO:0005886;GO:0031982;GO:0005254;GO:0005229;GO:0046983;GO:1902476;GO:0006821;GO:0034220;GO:0055085;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:vesicle;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:protein dimerization activity;, P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:transmembrane transport; scaffold41 indexed_genome mRNA 15851672 15873287 . - . ID=transcript_8436;Q75V66,Anoctamin-5,Gnathodiaphyseal dysplasia 1 protein;Transmembrane protein 16E;, PF16178;PF04547;, GO:0005789;GO:0016021;GO:0005886;GO:0031982;GO:0005254;GO:0005229;GO:0046983;GO:1902476;GO:0006821;GO:0034220;GO:0055085;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:vesicle;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:protein dimerization activity;, P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:transmembrane transport; scaffold41 indexed_genome mRNA 16466284 16506747 . - . ID=transcript_8437;Q92832 B2CKC1 Q4VB90 Q4VB91 Q6NSY8 Q9Y472,Protein kinase C-binding protein NELL1,NEL-like protein 1;Nel-related protein 1;, PF12947;PF07645;PF00093;, GO:0005737;GO:0005576;GO:0005635;GO:0048471;GO:0005509;GO:0008201;GO:0005080;GO:0030154;GO:1903363;GO:0033689;GO:0007399;GO:0030501;GO:0045669;GO:0010468;, C:cytoplasm; C:extracellular region; C:nuclear envelope; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding; F:protein kinase C binding;, P:cell differentiation; P:negative regulation of cellular protein catabolic process; P:negative regulation of osteoblast proliferation; P:nervous system development; P:positive regulation of bone mineralization; P:positive regulation of osteoblast differentiation; P:regulation of gene expression; scaffold41 indexed_genome mRNA 17591885 17718605 . - . ID=transcript_8438;O60678 A0A0A0MSN7 B4DUC7,Protein arginine N-methyltransferase 3,Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3;, , GO:0005737;GO:0005829;GO:0046872;GO:0008168;GO:0016274;GO:0043022;GO:0031397;GO:0006479;, C:cytoplasm; C:cytosol;, F:metal ion binding; F:methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:ribosome binding;, P:negative regulation of protein ubiquitination; P:protein methylation;|O60678 A0A0A0MSN7 B4DUC7,Protein arginine N-methyltransferase 3,Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3;, , GO:0005737;GO:0005829;GO:0046872;GO:0008168;GO:0016274;GO:0043022;GO:0031397;GO:0006479;, C:cytoplasm; C:cytosol;, F:metal ion binding; F:methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:ribosome binding;, P:negative regulation of protein ubiquitination; P:protein methylation; scaffold41 indexed_genome mRNA 17724621 17725287 . - . ID=transcript_8439;Q9BUP3 A8K7S7 D3DQY8 O15383 O60520 O95345 Q53GC1 Q53GG2 Q6IBI3,Oxidoreductase HTATIP2,30 kDa HIV-1 TAT-interacting protein;HIV-1 TAT-interactive protein 2;, PF13460;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0005634;GO:0016491;GO:0004674;GO:0003713;GO:0001525;GO:0006915;GO:0030154;GO:0051170;GO:0043066;GO:0043068;GO:0045944;GO:0046777;GO:0045765;GO:0006357;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope; C:nucleus;, F:oxidoreductase activity; F:protein serine/threonine kinase activity; F:transcription coactivator activity;, P:angiogenesis; P:apoptotic process; P:cell differentiation; P:import into nucleus; P:negative regulation of apoptotic process; P:positive regulation of programmed cell death; P:positive regulation of transcription by RNA polymerase II; P:protein autophosphorylation; P:regulation of angiogenesis; P:regulation of transcription by RNA polymerase II; P:viral process; scaffold41 indexed_genome mRNA 17956428 18015520 . - . ID=transcript_8440;Q8NHD0 Q8TDE9 Q8TDF0 Q8TEB3 Q96B30 Q9NUZ6 Q9NVM7 Q9P2C8,Neuron navigator 2,Helicase APC down-regulated 1;Pore membrane and/or filament-interacting-like protein 2;Retinoic acid inducible in neuroblastoma 1;Steerin-2;Unc-53 homolog 2;, PF00307;, GO:0005654;GO:0043138;GO:0005524;GO:0007399;GO:0022008;, C:nucleoplasm;, F:3'-5' DNA helicase activity; F:ATP binding;, P:nervous system development; P:neurogenesis;|Q8NHD0 Q8TDE9 Q8TDF0 Q8TEB3 Q96B30 Q9NUZ6 Q9NVM7 Q9P2C8,Neuron navigator 2,Helicase APC down-regulated 1;Pore membrane and/or filament-interacting-like protein 2;Retinoic acid inducible in neuroblastoma 1;Steerin-2;Unc-53 homolog 2;, PF00307;, GO:0005654;GO:0043138;GO:0005524;GO:0007399;GO:0022008;, C:nucleoplasm;, F:3'-5' DNA helicase activity; F:ATP binding;, P:nervous system development; P:neurogenesis;|Q8NHD0 Q8TDE9 Q8TDF0 Q8TEB3 Q96B30 Q9NUZ6 Q9NVM7 Q9P2C8,Neuron navigator 2,Helicase APC down-regulated 1;Pore membrane and/or filament-interacting-like protein 2;Retinoic acid inducible in neuroblastoma 1;Steerin-2;Unc-53 homolog 2;, PF00307;, GO:0005654;GO:0043138;GO:0005524;GO:0007399;GO:0022008;, C:nucleoplasm;, F:3'-5' DNA helicase activity; F:ATP binding;, P:nervous system development; P:neurogenesis;|Q8NHD0 Q8TDE9 Q8TDF0 Q8TEB3 Q96B30 Q9NUZ6 Q9NVM7 Q9P2C8,Neuron navigator 2,Helicase APC down-regulated 1;Pore membrane and/or filament-interacting-like protein 2;Retinoic acid inducible in neuroblastoma 1;Steerin-2;Unc-53 homolog 2;, PF00307;, GO:0005654;GO:0043138;GO:0005524;GO:0007399;GO:0022008;, C:nucleoplasm;, F:3'-5' DNA helicase activity; F:ATP binding;, P:nervous system development; P:neurogenesis;|Q8NHD0 Q8TDE9 Q8TDF0 Q8TEB3 Q96B30 Q9NUZ6 Q9NVM7 Q9P2C8,Neuron navigator 2,Helicase APC down-regulated 1;Pore membrane and/or filament-interacting-like protein 2;Retinoic acid inducible in neuroblastoma 1;Steerin-2;Unc-53 homolog 2;, PF00307;, GO:0005654;GO:0043138;GO:0005524;GO:0007399;GO:0022008;, C:nucleoplasm;, F:3'-5' DNA helicase activity; F:ATP binding;, P:nervous system development; P:neurogenesis;|Q8NHD0 Q8TDE9 Q8TDF0 Q8TEB3 Q96B30 Q9NUZ6 Q9NVM7 Q9P2C8,Neuron navigator 2,Helicase APC down-regulated 1;Pore membrane and/or filament-interacting-like protein 2;Retinoic acid inducible in neuroblastoma 1;Steerin-2;Unc-53 homolog 2;, PF00307;, GO:0005654;GO:0043138;GO:0005524;GO:0007399;GO:0022008;, C:nucleoplasm;, F:3'-5' DNA helicase activity; F:ATP binding;, P:nervous system development; P:neurogenesis; scaffold41 indexed_genome mRNA 18016303 18239908 . - . ID=transcript_8441;Q8NHD0 Q8TDE9 Q8TDF0 Q8TEB3 Q96B30 Q9NUZ6 Q9NVM7 Q9P2C8,Neuron navigator 2,Helicase APC down-regulated 1;Pore membrane and/or filament-interacting-like protein 2;Retinoic acid inducible in neuroblastoma 1;Steerin-2;Unc-53 homolog 2;, PF00307;, GO:0005654;GO:0043138;GO:0005524;GO:0007399;GO:0022008;, C:nucleoplasm;, F:3'-5' DNA helicase activity; F:ATP binding;, P:nervous system development; P:neurogenesis; scaffold41 indexed_genome mRNA 18850823 18851788 . + . ID=transcript_8442;A0AVK6 A8K9H3 Q2VPJ3 Q3C1U6 Q5BKY4 Q8N340 Q9H5M0,Transcription factor E2F8,, PF02319;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0001217;GO:0001227;GO:0042802;GO:0000978;GO:1990837;GO:0033301;GO:0008283;GO:0060718;GO:0006977;GO:0070365;GO:0032466;GO:0000122;GO:0001890;GO:0032877;GO:0045944;GO:0006357;GO:0002040;GO:0060707;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell cycle comprising mitosis without cytokinesis; P:cell population proliferation; P:chorionic trophoblast cell differentiation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:hepatocyte differentiation; P:negative regulation of cytokinesis; P:negative regulation of transcription by RNA polymerase II; P:placenta development; P:positive regulation of DNA endoreduplication; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:sprouting angiogenesis; P:trophoblast giant cell differentiation; scaffold41 indexed_genome mRNA 18876723 18897402 . + . ID=transcript_8443;P50461 Q9P131 S4S7M7,Cysteine and glycine-rich protein 3,Cardiac LIM protein;Cysteine-rich protein 3;LIM domain protein, cardiac;Muscle LIM protein;, PF00412;, GO:0005737;GO:0005856;GO:0005634;GO:0030018;GO:0003779;GO:0042805;GO:0042802;GO:0046872;GO:0008307;GO:0031433;GO:0030036;GO:0060048;GO:0003300;GO:0048738;GO:0055003;GO:0006874;GO:0035995;GO:0042593;GO:0006954;GO:0008286;GO:0060537;GO:1903919;GO:0045662;GO:1903920;GO:0045663;GO:0045944;GO:0070528;GO:0033365;GO:1903076;GO:0002026;GO:0045214;GO:0007519;GO:0033292;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:Z disc;, F:actin binding; F:actinin binding; F:identical protein binding; F:metal ion binding; F:structural constituent of muscle; F:telethonin binding;, P:actin cytoskeleton organization; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cardiac muscle tissue development; P:cardiac myofibril assembly; P:cellular calcium ion homeostasis; P:detection of muscle stretch; P:glucose homeostasis; P:inflammatory response; P:insulin receptor signaling pathway; P:muscle tissue development; P:negative regulation of actin filament severing; P:negative regulation of myoblast differentiation; P:positive regulation of actin filament severing; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein kinase C signaling; P:protein localization to organelle; P:regulation of protein localization to plasma membrane; P:regulation of the force of heart contraction; P:sarcomere organization; P:skeletal muscle tissue development; P:T-tubule organization;|P50461 Q9P131 S4S7M7,Cysteine and glycine-rich protein 3,Cardiac LIM protein;Cysteine-rich protein 3;LIM domain protein, cardiac;Muscle LIM protein;, PF00412;, GO:0005737;GO:0005856;GO:0005634;GO:0030018;GO:0003779;GO:0042805;GO:0042802;GO:0046872;GO:0008307;GO:0031433;GO:0030036;GO:0060048;GO:0003300;GO:0048738;GO:0055003;GO:0006874;GO:0035995;GO:0042593;GO:0006954;GO:0008286;GO:0060537;GO:1903919;GO:0045662;GO:1903920;GO:0045663;GO:0045944;GO:0070528;GO:0033365;GO:1903076;GO:0002026;GO:0045214;GO:0007519;GO:0033292;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:Z disc;, F:actin binding; F:actinin binding; F:identical protein binding; F:metal ion binding; F:structural constituent of muscle; F:telethonin binding;, P:actin cytoskeleton organization; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cardiac muscle tissue development; P:cardiac myofibril assembly; P:cellular calcium ion homeostasis; P:detection of muscle stretch; P:glucose homeostasis; P:inflammatory response; P:insulin receptor signaling pathway; P:muscle tissue development; P:negative regulation of actin filament severing; P:negative regulation of myoblast differentiation; P:positive regulation of actin filament severing; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein kinase C signaling; P:protein localization to organelle; P:regulation of protein localization to plasma membrane; P:regulation of the force of heart contraction; P:sarcomere organization; P:skeletal muscle tissue development; P:T-tubule organization; scaffold41 indexed_genome mRNA 18906808 18958364 . - . ID=transcript_8444;Q8IUH4 Q7Z2D3 Q86VK2 Q9NV30 Q9NV99,Palmitoyltransferase ZDHHC13 {ECO:0000305},Huntingtin-interacting protein 14-related protein {ECO:0000303|PubMed:12393793};Huntingtin-interacting protein HIP3RP {ECO:0000312|EMBL:BAC22090.1};Putative MAPK-activating protein PM03 {ECO:0000312|EMBL:BAC77380.1};Putative NF-kappa-B-activating protein 209 {ECO:0000312|EMBL:BAC77367.1};Zinc finger DHHC domain-containing protein 13 {ECO:0000312|HGNC:HGNC:18413};, PF12796;PF01529;, GO:0030659;GO:0005783;GO:0000139;GO:0030660;GO:0016021;GO:0016020;GO:0015095;GO:0016409;GO:0019706;GO:0043123;GO:0018345;, C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:membrane;, F:magnesium ion transmembrane transporter activity; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein palmitoylation;|Q8IUH4 Q7Z2D3 Q86VK2 Q9NV30 Q9NV99,Palmitoyltransferase ZDHHC13 {ECO:0000305},Huntingtin-interacting protein 14-related protein {ECO:0000303|PubMed:12393793};Huntingtin-interacting protein HIP3RP {ECO:0000312|EMBL:BAC22090.1};Putative MAPK-activating protein PM03 {ECO:0000312|EMBL:BAC77380.1};Putative NF-kappa-B-activating protein 209 {ECO:0000312|EMBL:BAC77367.1};Zinc finger DHHC domain-containing protein 13 {ECO:0000312|HGNC:HGNC:18413};, PF12796;PF01529;, GO:0030659;GO:0005783;GO:0000139;GO:0030660;GO:0016021;GO:0016020;GO:0015095;GO:0016409;GO:0019706;GO:0043123;GO:0018345;, C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:membrane;, F:magnesium ion transmembrane transporter activity; F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein palmitoylation; scaffold41 indexed_genome mRNA 19190872 19194936 . - . ID=transcript_8445;Q8N2M4 Q96AJ0,Lysoplasmalogenase-like protein TMEM86A,Transmembrane protein 86A;, PF07947;, GO:0016021;GO:0047408;GO:0047409;, C:integral component of membrane;, F:alkenylglycerophosphocholine hydrolase activity; F:alkenylglycerophosphoethanolamine hydrolase activity; scaffold41 indexed_genome mRNA 19238100 19258559 . + . ID=transcript_8446;Q68D10 Q6AWA5 Q6MZI5 Q7Z390 Q7Z470 Q86VG8 Q8N3E7 Q8N417 Q8N8I3,Protein SPT2 homolog,Protein KU002155;SPT2 domain-containing protein 1;, PF08243;, GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0001042;GO:0043486;GO:0006334;GO:0010847;GO:0006355;, C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:RNA polymerase I core binding;, P:histone exchange; P:nucleosome assembly; P:regulation of chromatin assembly; P:regulation of transcription, DNA-templated; scaffold41 indexed_genome mRNA 19263583 19264838 . - . ID=transcript_8447;A0A0U1RRN3,Putative transmembrane protein SPTY2D1OS {ECO:0000305},SPTY2D1 antisense RNA 1 {ECO:0000312|HGNC:HGNC:44122};SPTY2D1 opposite strand {ECO:0000312|HGNC:HGNC:44122};, , GO:0016021;, C:integral component of membrane; scaffold41 indexed_genome mRNA 19273987 19332401 . + . ID=transcript_8448;Q8IX04 B2RB69 B4DL43 F5H6L6 H7BYD6 Q6P2F0 Q96FF5 Q9NUX7,Ubiquitin-conjugating enzyme E2 variant 3,EV and lactate/malate dehydrogenase domain-containing protein;, PF02866;PF00056;PF05743;, GO:0070062;GO:0016616;GO:0005975;GO:0019752;GO:0006464;GO:0015031;, C:extracellular exosome;, F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:carbohydrate metabolic process; P:carboxylic acid metabolic process; P:cellular protein modification process; P:protein transport;|Q8IX04 B2RB69 B4DL43 F5H6L6 H7BYD6 Q6P2F0 Q96FF5 Q9NUX7,Ubiquitin-conjugating enzyme E2 variant 3,EV and lactate/malate dehydrogenase domain-containing protein;, PF02866;PF00056;PF05743;, GO:0070062;GO:0016616;GO:0005975;GO:0019752;GO:0006464;GO:0015031;, C:extracellular exosome;, F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:carbohydrate metabolic process; P:carboxylic acid metabolic process; P:cellular protein modification process; P:protein transport;|Q8IX04 B2RB69 B4DL43 F5H6L6 H7BYD6 Q6P2F0 Q96FF5 Q9NUX7,Ubiquitin-conjugating enzyme E2 variant 3,EV and lactate/malate dehydrogenase domain-containing protein;, PF02866;PF00056;PF05743;, GO:0070062;GO:0016616;GO:0005975;GO:0019752;GO:0006464;GO:0015031;, C:extracellular exosome;, F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:carbohydrate metabolic process; P:carboxylic acid metabolic process; P:cellular protein modification process; P:protein transport;|Q8IX04 B2RB69 B4DL43 F5H6L6 H7BYD6 Q6P2F0 Q96FF5 Q9NUX7,Ubiquitin-conjugating enzyme E2 variant 3,EV and lactate/malate dehydrogenase domain-containing protein;, PF02866;PF00056;PF05743;, GO:0070062;GO:0016616;GO:0005975;GO:0019752;GO:0006464;GO:0015031;, C:extracellular exosome;, F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:carbohydrate metabolic process; P:carboxylic acid metabolic process; P:cellular protein modification process; P:protein transport;|Q8IX04 B2RB69 B4DL43 F5H6L6 H7BYD6 Q6P2F0 Q96FF5 Q9NUX7,Ubiquitin-conjugating enzyme E2 variant 3,EV and lactate/malate dehydrogenase domain-containing protein;, PF02866;PF00056;PF05743;, GO:0070062;GO:0016616;GO:0005975;GO:0019752;GO:0006464;GO:0015031;, C:extracellular exosome;, F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:carbohydrate metabolic process; P:carboxylic acid metabolic process; P:cellular protein modification process; P:protein transport;|Q8IX04 B2RB69 B4DL43 F5H6L6 H7BYD6 Q6P2F0 Q96FF5 Q9NUX7,Ubiquitin-conjugating enzyme E2 variant 3,EV and lactate/malate dehydrogenase domain-containing protein;, PF02866;PF00056;PF05743;, GO:0070062;GO:0016616;GO:0005975;GO:0019752;GO:0006464;GO:0015031;, C:extracellular exosome;, F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:carbohydrate metabolic process; P:carboxylic acid metabolic process; P:cellular protein modification process; P:protein transport; scaffold41 indexed_genome mRNA 19332928 19335779 . - . ID=transcript_8449;P19404 Q9BV41,NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial,NADH-ubiquinone oxidoreductase 24 kDa subunit;, , GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0051537;GO:0009055;GO:0046872;GO:0008137;GO:0048738;GO:0006120;GO:0032981;GO:0007399;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:cardiac muscle tissue development; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:nervous system development; scaffold41 indexed_genome mRNA 19337284 19375949 . + . ID=transcript_8450;Q99816 Q9BUM5,Tumor susceptibility gene 101 protein,ESCRT-I complex subunit TSG101;, PF05743;PF09454;, GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0010008;GO:0000813;GO:0070062;GO:0090543;GO:0043657;GO:0005770;GO:0031902;GO:0005815;GO:0005771;GO:0005730;GO:0005886;GO:0048306;GO:0003677;GO:0030374;GO:0042803;GO:0044877;GO:0003714;GO:0043130;GO:0031625;GO:0046790;GO:0097352;GO:0007050;GO:0051301;GO:0016197;GO:0008333;GO:1990182;GO:0006858;GO:0075733;GO:0030216;GO:0016236;GO:0036258;GO:0008285;GO:0042059;GO:0007175;GO:0000122;GO:1903543;GO:2000397;GO:1903774;GO:1902188;GO:0006513;GO:0015031;GO:0001558;GO:1903551;GO:0043405;GO:0043162;GO:0046755;GO:0039702;GO:0019058;, C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:Flemming body; C:host cell; C:late endosome; C:late endosome membrane; C:microtubule organizing center; C:multivesicular body; C:nucleolus; C:plasma membrane;, F:calcium-dependent protein binding; F:DNA binding; F:nuclear receptor coactivator activity; F:protein homodimerization activity; F:protein-containing complex binding; F:transcription corepressor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:virion binding;, P:autophagosome maturation; P:cell cycle arrest; P:cell division; P:endosomal transport; P:endosome to lysosome transport; P:exosomal secretion; P:extracellular transport; P:intracellular transport of virus; P:keratinocyte differentiation; P:macroautophagy; P:multivesicular body assembly; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of exosomal secretion; P:positive regulation of ubiquitin-dependent endocytosis; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral release from host cell; P:protein monoubiquitination; P:protein transport; P:regulation of cell growth; P:regulation of extracellular exosome assembly; P:regulation of MAP kinase activity; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle;|Q99816 Q9BUM5,Tumor susceptibility gene 101 protein,ESCRT-I complex subunit TSG101;, PF05743;PF09454;, GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0010008;GO:0000813;GO:0070062;GO:0090543;GO:0043657;GO:0005770;GO:0031902;GO:0005815;GO:0005771;GO:0005730;GO:0005886;GO:0048306;GO:0003677;GO:0030374;GO:0042803;GO:0044877;GO:0003714;GO:0043130;GO:0031625;GO:0046790;GO:0097352;GO:0007050;GO:0051301;GO:0016197;GO:0008333;GO:1990182;GO:0006858;GO:0075733;GO:0030216;GO:0016236;GO:0036258;GO:0008285;GO:0042059;GO:0007175;GO:0000122;GO:1903543;GO:2000397;GO:1903774;GO:1902188;GO:0006513;GO:0015031;GO:0001558;GO:1903551;GO:0043405;GO:0043162;GO:0046755;GO:0039702;GO:0019058;, C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:Flemming body; C:host cell; C:late endosome; C:late endosome membrane; C:microtubule organizing center; C:multivesicular body; C:nucleolus; C:plasma membrane;, F:calcium-dependent protein binding; F:DNA binding; F:nuclear receptor coactivator activity; F:protein homodimerization activity; F:protein-containing complex binding; F:transcription corepressor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:virion binding;, P:autophagosome maturation; P:cell cycle arrest; P:cell division; P:endosomal transport; P:endosome to lysosome transport; P:exosomal secretion; P:extracellular transport; P:intracellular transport of virus; P:keratinocyte differentiation; P:macroautophagy; P:multivesicular body assembly; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of exosomal secretion; P:positive regulation of ubiquitin-dependent endocytosis; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral release from host cell; P:protein monoubiquitination; P:protein transport; P:regulation of cell growth; P:regulation of extracellular exosome assembly; P:regulation of MAP kinase activity; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle;|Q99816 Q9BUM5,Tumor susceptibility gene 101 protein,ESCRT-I complex subunit TSG101;, PF05743;PF09454;, GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0010008;GO:0000813;GO:0070062;GO:0090543;GO:0043657;GO:0005770;GO:0031902;GO:0005815;GO:0005771;GO:0005730;GO:0005886;GO:0048306;GO:0003677;GO:0030374;GO:0042803;GO:0044877;GO:0003714;GO:0043130;GO:0031625;GO:0046790;GO:0097352;GO:0007050;GO:0051301;GO:0016197;GO:0008333;GO:1990182;GO:0006858;GO:0075733;GO:0030216;GO:0016236;GO:0036258;GO:0008285;GO:0042059;GO:0007175;GO:0000122;GO:1903543;GO:2000397;GO:1903774;GO:1902188;GO:0006513;GO:0015031;GO:0001558;GO:1903551;GO:0043405;GO:0043162;GO:0046755;GO:0039702;GO:0019058;, C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:Flemming body; C:host cell; C:late endosome; C:late endosome membrane; C:microtubule organizing center; C:multivesicular body; C:nucleolus; C:plasma membrane;, F:calcium-dependent protein binding; F:DNA binding; F:nuclear receptor coactivator activity; F:protein homodimerization activity; F:protein-containing complex binding; F:transcription corepressor activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:virion binding;, P:autophagosome maturation; P:cell cycle arrest; P:cell division; P:endosomal transport; P:endosome to lysosome transport; P:exosomal secretion; P:extracellular transport; P:intracellular transport of virus; P:keratinocyte differentiation; P:macroautophagy; P:multivesicular body assembly; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of exosomal secretion; P:positive regulation of ubiquitin-dependent endocytosis; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral release from host cell; P:protein monoubiquitination; P:protein transport; P:regulation of cell growth; P:regulation of extracellular exosome assembly; P:regulation of MAP kinase activity; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold41 indexed_genome mRNA 19382978 19383759 . - . ID=transcript_8451;P25398 Q76M58,40S ribosomal protein S12,Small ribosomal subunit protein eS12 {ECO:0000303|PubMed:24524803};, PF01248;, GO:0005829;GO:0022627;GO:0005794;GO:0043231;GO:0016020;GO:0005654;GO:0003723;GO:0003735;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold41 indexed_genome mRNA 19424900 19432966 . - . ID=transcript_8452;Q9UDE9,L-lactate dehydrogenase A chain,Cell proliferation-inducing gene 19 protein;LDH muscle subunit;Renal carcinoma antigen NY-REN-59;, PF02866;PF00056;, GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0045296;GO:0042802;GO:0019900;GO:0004459;GO:0051287;GO:0006096;GO:0006089;GO:0019674;GO:0043065;GO:0048569;GO:0006090;GO:0051591;GO:0042493;GO:0043627;GO:0009749;GO:0042542;GO:0001666;GO:0007584;GO:0021762;, C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:cadherin binding; F:identical protein binding; F:kinase binding; F:L-lactate dehydrogenase activity; F:NAD binding;, P:glycolytic process; P:lactate metabolic process; P:NAD metabolic process; P:positive regulation of apoptotic process; P:post-embryonic animal organ development; P:pyruvate metabolic process; P:response to cAMP; P:response to drug; P:response to estrogen; P:response to glucose; P:response to hydrogen peroxide; P:response to hypoxia; P:response to nutrient; P:substantia nigra development;|Q9UDE9,L-lactate dehydrogenase A chain,Cell proliferation-inducing gene 19 protein;LDH muscle subunit;Renal carcinoma antigen NY-REN-59;, PF02866;PF00056;, GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0045296;GO:0042802;GO:0019900;GO:0004459;GO:0051287;GO:0006096;GO:0006089;GO:0019674;GO:0043065;GO:0048569;GO:0006090;GO:0051591;GO:0042493;GO:0043627;GO:0009749;GO:0042542;GO:0001666;GO:0007584;GO:0021762;, C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:cadherin binding; F:identical protein binding; F:kinase binding; F:L-lactate dehydrogenase activity; F:NAD binding;, P:glycolytic process; P:lactate metabolic process; P:NAD metabolic process; P:positive regulation of apoptotic process; P:post-embryonic animal organ development; P:pyruvate metabolic process; P:response to cAMP; P:response to drug; P:response to estrogen; P:response to glucose; P:response to hydrogen peroxide; P:response to hypoxia; P:response to nutrient; P:substantia nigra development;|Q9UDE9,L-lactate dehydrogenase A chain,Cell proliferation-inducing gene 19 protein;LDH muscle subunit;Renal carcinoma antigen NY-REN-59;, PF02866;PF00056;, GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0045296;GO:0042802;GO:0019900;GO:0004459;GO:0051287;GO:0006096;GO:0006089;GO:0019674;GO:0043065;GO:0048569;GO:0006090;GO:0051591;GO:0042493;GO:0043627;GO:0009749;GO:0042542;GO:0001666;GO:0007584;GO:0021762;, C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:cadherin binding; F:identical protein binding; F:kinase binding; F:L-lactate dehydrogenase activity; F:NAD binding;, P:glycolytic process; P:lactate metabolic process; P:NAD metabolic process; P:positive regulation of apoptotic process; P:post-embryonic animal organ development; P:pyruvate metabolic process; P:response to cAMP; P:response to drug; P:response to estrogen; P:response to glucose; P:response to hydrogen peroxide; P:response to hypoxia; P:response to nutrient; P:substantia nigra development;|Q9UDE9,L-lactate dehydrogenase A chain,Cell proliferation-inducing gene 19 protein;LDH muscle subunit;Renal carcinoma antigen NY-REN-59;, PF02866;PF00056;, GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0045296;GO:0042802;GO:0019900;GO:0004459;GO:0051287;GO:0006096;GO:0006089;GO:0019674;GO:0043065;GO:0048569;GO:0006090;GO:0051591;GO:0042493;GO:0043627;GO:0009749;GO:0042542;GO:0001666;GO:0007584;GO:0021762;, C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:cadherin binding; F:identical protein binding; F:kinase binding; F:L-lactate dehydrogenase activity; F:NAD binding;, P:glycolytic process; P:lactate metabolic process; P:NAD metabolic process; P:positive regulation of apoptotic process; P:post-embryonic animal organ development; P:pyruvate metabolic process; P:response to cAMP; P:response to drug; P:response to estrogen; P:response to glucose; P:response to hydrogen peroxide; P:response to hypoxia; P:response to nutrient; P:substantia nigra development;|Q9UDE9,L-lactate dehydrogenase A chain,Cell proliferation-inducing gene 19 protein;LDH muscle subunit;Renal carcinoma antigen NY-REN-59;, PF02866;PF00056;, GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0045296;GO:0042802;GO:0019900;GO:0004459;GO:0051287;GO:0006096;GO:0006089;GO:0019674;GO:0043065;GO:0048569;GO:0006090;GO:0051591;GO:0042493;GO:0043627;GO:0009749;GO:0042542;GO:0001666;GO:0007584;GO:0021762;, C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:cadherin binding; F:identical protein binding; F:kinase binding; F:L-lactate dehydrogenase activity; F:NAD binding;, P:glycolytic process; P:lactate metabolic process; P:NAD metabolic process; P:positive regulation of apoptotic process; P:post-embryonic animal organ development; P:pyruvate metabolic process; P:response to cAMP; P:response to drug; P:response to estrogen; P:response to glucose; P:response to hydrogen peroxide; P:response to hypoxia; P:response to nutrient; P:substantia nigra development;|Q9UDE9,L-lactate dehydrogenase A chain,Cell proliferation-inducing gene 19 protein;LDH muscle subunit;Renal carcinoma antigen NY-REN-59;, PF02866;PF00056;, GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0045296;GO:0042802;GO:0019900;GO:0004459;GO:0051287;GO:0006096;GO:0006089;GO:0019674;GO:0043065;GO:0048569;GO:0006090;GO:0051591;GO:0042493;GO:0043627;GO:0009749;GO:0042542;GO:0001666;GO:0007584;GO:0021762;, C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:cadherin binding; F:identical protein binding; F:kinase binding; F:L-lactate dehydrogenase activity; F:NAD binding;, P:glycolytic process; P:lactate metabolic process; P:NAD metabolic process; P:positive regulation of apoptotic process; P:post-embryonic animal organ development; P:pyruvate metabolic process; P:response to cAMP; P:response to drug; P:response to estrogen; P:response to glucose; P:response to hydrogen peroxide; P:response to hypoxia; P:response to nutrient; P:substantia nigra development; scaffold41 indexed_genome mRNA 19457688 19463710 . - . ID=transcript_8453;P32780 B3KXE0 D3DQY2 Q6I9Y7 Q9H5K5 Q9NQD9,General transcription factor IIH subunit 1,Basic transcription factor 2 62 kDa subunit;General transcription factor IIH polypeptide 1;TFIIH basal transcription factor complex p62 subunit;, PF03909;PF08567;, GO:0005654;GO:0000439;GO:0005675;GO:0003682;GO:0046966;GO:0006370;GO:0006281;GO:0070911;GO:0009755;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0045893;GO:0000079;GO:0006363;GO:0006360;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:nucleoplasm; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, F:chromatin binding; F:thyroid hormone receptor binding;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:hormone-mediated signaling pathway; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of transcription, DNA-templated; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P32780 B3KXE0 D3DQY2 Q6I9Y7 Q9H5K5 Q9NQD9,General transcription factor IIH subunit 1,Basic transcription factor 2 62 kDa subunit;General transcription factor IIH polypeptide 1;TFIIH basal transcription factor complex p62 subunit;, PF03909;PF08567;, GO:0005654;GO:0000439;GO:0005675;GO:0003682;GO:0046966;GO:0006370;GO:0006281;GO:0070911;GO:0009755;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0045893;GO:0000079;GO:0006363;GO:0006360;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:nucleoplasm; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, F:chromatin binding; F:thyroid hormone receptor binding;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:hormone-mediated signaling pathway; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of transcription, DNA-templated; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P32780 B3KXE0 D3DQY2 Q6I9Y7 Q9H5K5 Q9NQD9,General transcription factor IIH subunit 1,Basic transcription factor 2 62 kDa subunit;General transcription factor IIH polypeptide 1;TFIIH basal transcription factor complex p62 subunit;, PF03909;PF08567;, GO:0005654;GO:0000439;GO:0005675;GO:0003682;GO:0046966;GO:0006370;GO:0006281;GO:0070911;GO:0009755;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0045893;GO:0000079;GO:0006363;GO:0006360;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:nucleoplasm; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, F:chromatin binding; F:thyroid hormone receptor binding;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:hormone-mediated signaling pathway; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of transcription, DNA-templated; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; scaffold41 indexed_genome mRNA 19465542 19517188 . + . ID=transcript_8454;P32780 B3KXE0 D3DQY2 Q6I9Y7 Q9H5K5 Q9NQD9,General transcription factor IIH subunit 1,Basic transcription factor 2 62 kDa subunit;General transcription factor IIH polypeptide 1;TFIIH basal transcription factor complex p62 subunit;, PF03909;PF08567;, GO:0005654;GO:0000439;GO:0005675;GO:0003682;GO:0046966;GO:0006370;GO:0006281;GO:0070911;GO:0009755;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0045893;GO:0000079;GO:0006363;GO:0006360;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:nucleoplasm; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, F:chromatin binding; F:thyroid hormone receptor binding;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:hormone-mediated signaling pathway; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of transcription, DNA-templated; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P32780 B3KXE0 D3DQY2 Q6I9Y7 Q9H5K5 Q9NQD9,General transcription factor IIH subunit 1,Basic transcription factor 2 62 kDa subunit;General transcription factor IIH polypeptide 1;TFIIH basal transcription factor complex p62 subunit;, PF03909;PF08567;, GO:0005654;GO:0000439;GO:0005675;GO:0003682;GO:0046966;GO:0006370;GO:0006281;GO:0070911;GO:0009755;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0045893;GO:0000079;GO:0006363;GO:0006360;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:nucleoplasm; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, F:chromatin binding; F:thyroid hormone receptor binding;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:hormone-mediated signaling pathway; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of transcription, DNA-templated; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|P32780 B3KXE0 D3DQY2 Q6I9Y7 Q9H5K5 Q9NQD9,General transcription factor IIH subunit 1,Basic transcription factor 2 62 kDa subunit;General transcription factor IIH polypeptide 1;TFIIH basal transcription factor complex p62 subunit;, PF03909;PF08567;, GO:0005654;GO:0000439;GO:0005675;GO:0003682;GO:0046966;GO:0006370;GO:0006281;GO:0070911;GO:0009755;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0045893;GO:0000079;GO:0006363;GO:0006360;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:nucleoplasm; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, F:chromatin binding; F:thyroid hormone receptor binding;, P:7-methylguanosine mRNA capping; P:DNA repair; P:global genome nucleotide-excision repair; P:hormone-mediated signaling pathway; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of transcription, DNA-templated; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair;|Q9UPZ3 A8K6J8 A8K8S1 D3DQX9 D3DQY0 O95942 Q8N4U0,Hermansky-Pudlak syndrome 5 protein,Alpha-integrin-binding protein 63;Ruby-eye protein 2 homolog;, , GO:0031084;GO:0005829;GO:0007596;GO:0006996;GO:0043473;, C:BLOC-2 complex; C:cytosol;, , P:blood coagulation; P:organelle organization; P:pigmentation;|Q9UPZ3 A8K6J8 A8K8S1 D3DQX9 D3DQY0 O95942 Q8N4U0,Hermansky-Pudlak syndrome 5 protein,Alpha-integrin-binding protein 63;Ruby-eye protein 2 homolog;, , GO:0031084;GO:0005829;GO:0007596;GO:0006996;GO:0043473;, C:BLOC-2 complex; C:cytosol;, , P:blood coagulation; P:organelle organization; P:pigmentation;|Q9UPZ3 A8K6J8 A8K8S1 D3DQX9 D3DQY0 O95942 Q8N4U0,Hermansky-Pudlak syndrome 5 protein,Alpha-integrin-binding protein 63;Ruby-eye protein 2 homolog;, , GO:0031084;GO:0005829;GO:0007596;GO:0006996;GO:0043473;, C:BLOC-2 complex; C:cytosol;, , P:blood coagulation; P:organelle organization; P:pigmentation;|Q9UPZ3 A8K6J8 A8K8S1 D3DQX9 D3DQY0 O95942 Q8N4U0,Hermansky-Pudlak syndrome 5 protein,Alpha-integrin-binding protein 63;Ruby-eye protein 2 homolog;, , GO:0031084;GO:0005829;GO:0007596;GO:0006996;GO:0043473;, C:BLOC-2 complex; C:cytosol;, , P:blood coagulation; P:organelle organization; P:pigmentation;|Q9UPZ3 A8K6J8 A8K8S1 D3DQX9 D3DQY0 O95942 Q8N4U0,Hermansky-Pudlak syndrome 5 protein,Alpha-integrin-binding protein 63;Ruby-eye protein 2 homolog;, , GO:0031084;GO:0005829;GO:0007596;GO:0006996;GO:0043473;, C:BLOC-2 complex; C:cytosol;, , P:blood coagulation; P:organelle organization; P:pigmentation; scaffold41 indexed_genome mRNA 19594074 19604443 . + . ID=transcript_8455;P35542 Q6FHJ4,Serum amyloid A-4 protein {ECO:0000305},Constitutively expressed serum amyloid A protein;, PF00277;, GO:0070062;GO:0005576;GO:0034364;GO:0006953;, C:extracellular exosome; C:extracellular region; C:high-density lipoprotein particle;, , P:acute-phase response;|P35542 Q6FHJ4,Serum amyloid A-4 protein {ECO:0000305},Constitutively expressed serum amyloid A protein;, PF00277;, GO:0070062;GO:0005576;GO:0034364;GO:0006953;, C:extracellular exosome; C:extracellular region; C:high-density lipoprotein particle;, , P:acute-phase response; scaffold41 indexed_genome mRNA 20054223 20079715 . + . ID=transcript_8456;O00534 Q6UN19 Q6UN20 Q9BVF8,von Willebrand factor A domain-containing protein 5A,Breast cancer suppressor candidate 1;Loss of heterozygosity 11 chromosomal region 2 gene A protein;, PF08487;PF13768;, GO:0005654;, C:nucleoplasm; scaffold42 indexed_genome mRNA 20561 21250 . - . ID=transcript_8457;Q9Y696 Q9UFW9 Q9UQJ6,Chloride intracellular channel protein 4,Intracellular chloride ion channel protein p64H1;, , GO:0015629;GO:0045177;GO:0009986;GO:0005911;GO:0005813;GO:0034707;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0005902;GO:0030496;GO:0005739;GO:0016363;GO:0005634;GO:0048471;GO:0005886;GO:0005254;GO:0005244;GO:0001525;GO:0048754;GO:0030154;GO:0071277;GO:0006821;GO:0001886;GO:0035088;GO:0009566;GO:0030216;GO:0035264;GO:0030336;GO:0051493;GO:0034765;GO:0061299;GO:0007035;, C:actin cytoskeleton; C:apical part of cell; C:cell surface; C:cell-cell junction; C:centrosome; C:chloride channel complex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:microvillus; C:midbody; C:mitochondrion; C:nuclear matrix; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:chloride channel activity; F:voltage-gated ion channel activity;, P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:cell differentiation; P:cellular response to calcium ion; P:chloride transport; P:endothelial cell morphogenesis; P:establishment or maintenance of apical/basal cell polarity; P:fertilization; P:keratinocyte differentiation; P:multicellular organism growth; P:negative regulation of cell migration; P:regulation of cytoskeleton organization; P:regulation of ion transmembrane transport; P:retina vasculature morphogenesis in camera-type eye; P:vacuolar acidification; scaffold42 indexed_genome mRNA 176428 178540 . + . ID=transcript_8458;Q9BSY9 B1APK6 Q5VVC6 Q9NYS2 Q9Y3E4,Deubiquitinase DESI2 {ECO:0000305},Desumoylating isopeptidase 2;PPPDE peptidase domain-containing protein 1 {ECO:0000303|PubMed:28483520};Protein FAM152A;, PF05903;, GO:0005737;GO:1990380;GO:0061578;GO:0004843;GO:0101005;GO:0016579;GO:0070646;, C:cytoplasm;, F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:protein deubiquitination; P:protein modification by small protein removal; scaffold42 indexed_genome mRNA 307865 614296 . + . ID=transcript_8459;P23508 D3DT05 Q6ZR04,Colorectal mutant cancer protein,, PF10506;, GO:0005737;GO:0036464;GO:0005829;GO:0030027;GO:0005654;GO:0005634;GO:0005886;GO:0038023;GO:0045184;GO:0090090;GO:0010633;GO:0050680;GO:0007165;GO:0016055;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:lamellipodium; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:signaling receptor activity;, P:establishment of protein localization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:signal transduction; P:Wnt signaling pathway;|P23508 D3DT05 Q6ZR04,Colorectal mutant cancer protein,, PF10506;, GO:0005737;GO:0036464;GO:0005829;GO:0030027;GO:0005654;GO:0005634;GO:0005886;GO:0038023;GO:0045184;GO:0090090;GO:0010633;GO:0050680;GO:0007165;GO:0016055;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:lamellipodium; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:signaling receptor activity;, P:establishment of protein localization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:signal transduction; P:Wnt signaling pathway;|P23508 D3DT05 Q6ZR04,Colorectal mutant cancer protein,, PF10506;, GO:0005737;GO:0036464;GO:0005829;GO:0030027;GO:0005654;GO:0005634;GO:0005886;GO:0038023;GO:0045184;GO:0090090;GO:0010633;GO:0050680;GO:0007165;GO:0016055;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:lamellipodium; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:signaling receptor activity;, P:establishment of protein localization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:signal transduction; P:Wnt signaling pathway;|P23508 D3DT05 Q6ZR04,Colorectal mutant cancer protein,, PF10506;, GO:0005737;GO:0036464;GO:0005829;GO:0030027;GO:0005654;GO:0005634;GO:0005886;GO:0038023;GO:0045184;GO:0090090;GO:0010633;GO:0050680;GO:0007165;GO:0016055;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:lamellipodium; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:signaling receptor activity;, P:establishment of protein localization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:signal transduction; P:Wnt signaling pathway; scaffold42 indexed_genome mRNA 614299 666447 . - . ID=transcript_8460;Q8IU60 C9J778 Q6P2D4 Q7Z5W5 Q8NBG5,m7GpppN-mRNA hydrolase {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 20;mRNA-decapping enzyme 2;, PF05026;PF00293;, GO:0030054;GO:0005737;GO:0036464;GO:0005829;GO:0005654;GO:0000932;GO:0016442;GO:0004534;GO:0050072;GO:0030145;GO:0070034;GO:0000290;GO:0043928;GO:0071044;GO:0006402;GO:0032211;GO:0000184;GO:0043488;GO:1904872;, C:cell junction; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nucleoplasm; C:P-body; C:RISC complex;, F:5'-3' exoribonuclease activity; F:m7G(5')pppN diphosphatase activity; F:manganese ion binding; F:telomerase RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:histone mRNA catabolic process; P:mRNA catabolic process; P:negative regulation of telomere maintenance via telomerase; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of mRNA stability; P:regulation of telomerase RNA localization to Cajal body;|Q8IU60 C9J778 Q6P2D4 Q7Z5W5 Q8NBG5,m7GpppN-mRNA hydrolase {ECO:0000305},Nucleoside diphosphate-linked moiety X motif 20;mRNA-decapping enzyme 2;, PF05026;PF00293;, GO:0030054;GO:0005737;GO:0036464;GO:0005829;GO:0005654;GO:0000932;GO:0016442;GO:0004534;GO:0050072;GO:0030145;GO:0070034;GO:0000290;GO:0043928;GO:0071044;GO:0006402;GO:0032211;GO:0000184;GO:0043488;GO:1904872;, C:cell junction; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nucleoplasm; C:P-body; C:RISC complex;, F:5'-3' exoribonuclease activity; F:m7G(5')pppN diphosphatase activity; F:manganese ion binding; F:telomerase RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:histone mRNA catabolic process; P:mRNA catabolic process; P:negative regulation of telomere maintenance via telomerase; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of mRNA stability; P:regulation of telomerase RNA localization to Cajal body; scaffold42 indexed_genome mRNA 761853 778203 . - . ID=transcript_8461;Q00765 B7Z681 D3DT04 Q04198 Q5QGT0 Q9BWH9,Receptor expression-enhancing protein 5,Polyposis locus protein 1;Protein TB2;, PF03134;, GO:0005783;GO:0071782;GO:0016021;GO:0007029;GO:0032386;, C:endoplasmic reticulum; C:endoplasmic reticulum tubular network; C:integral component of membrane;, , P:endoplasmic reticulum organization; P:regulation of intracellular transport; scaffold42 indexed_genome mRNA 789457 797333 . - . ID=transcript_8462;P09132 B2R4E9 D6RCQ5 Q05D77 Q96FG6,Signal recognition particle 19 kDa protein,, PF01922;, GO:0005829;GO:0005730;GO:0048500;GO:0005786;GO:0008312;GO:0003723;GO:0006613;GO:0006614;GO:0006617;, C:cytosol; C:nucleolus; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:RNA binding;, P:cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition;|P09132 B2R4E9 D6RCQ5 Q05D77 Q96FG6,Signal recognition particle 19 kDa protein,, PF01922;, GO:0005829;GO:0005730;GO:0048500;GO:0005786;GO:0008312;GO:0003723;GO:0006613;GO:0006614;GO:0006617;, C:cytosol; C:nucleolus; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:RNA binding;, P:cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition;|P09132 B2R4E9 D6RCQ5 Q05D77 Q96FG6,Signal recognition particle 19 kDa protein,, PF01922;, GO:0005829;GO:0005730;GO:0048500;GO:0005786;GO:0008312;GO:0003723;GO:0006613;GO:0006614;GO:0006617;, C:cytosol; C:nucleolus; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:RNA binding;, P:cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; scaffold42 indexed_genome mRNA 803226 856067 . - . ID=transcript_8463;P25054 B7Z2B6 D3DT03 Q15162 Q15163 Q93042,Adenomatous polyposis coli protein,Deleted in polyposis 2.5;, PF05972;PF05956;PF16689;PF05923;PF18797;PF00514;PF05937;PF05924;, GO:0005912;GO:0030877;GO:0005923;GO:0016342;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0000776;GO:0030027;GO:0016328;GO:0005874;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:1990909;GO:0008013;GO:0070840;GO:0045295;GO:0008017;GO:0051010;GO:0019901;GO:0019887;GO:0031625;GO:1904885;GO:1904886;GO:0070830;GO:0007155;GO:0007050;GO:0001708;GO:0016477;GO:0006974;GO:0008286;GO:0000281;GO:0007094;GO:0090090;GO:0008285;GO:0045736;GO:2000134;GO:0007026;GO:0007399;GO:0007389;GO:0043065;GO:0010942;GO:0030335;GO:0120162;GO:0045732;GO:1904781;GO:0031274;GO:0016579;GO:0065003;GO:0051988;GO:0045595;GO:0032886;GO:0016055;, C:adherens junction; C:beta-catenin destruction complex; C:bicellular tight junction; C:catenin complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:kinetochore; C:lamellipodium; C:lateral plasma membrane; C:microtubule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:Wnt signalosome;, F:beta-catenin binding; F:dynein complex binding; F:gamma-catenin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:protein kinase regulator activity; F:ubiquitin protein ligase binding;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:bicellular tight junction assembly; P:cell adhesion; P:cell cycle arrest; P:cell fate specification; P:cell migration; P:cellular response to DNA damage stimulus; P:insulin receptor signaling pathway; P:mitotic cytokinesis; P:mitotic spindle assembly checkpoint; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of cell migration; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein catabolic process; P:positive regulation of protein localization to centrosome; P:positive regulation of pseudopodium assembly; P:protein deubiquitination; P:protein-containing complex assembly; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of cell differentiation; P:regulation of microtubule-based process; P:Wnt signaling pathway;|P25054 B7Z2B6 D3DT03 Q15162 Q15163 Q93042,Adenomatous polyposis coli protein,Deleted in polyposis 2.5;, PF05972;PF05956;PF16689;PF05923;PF18797;PF00514;PF05937;PF05924;, GO:0005912;GO:0030877;GO:0005923;GO:0016342;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0000776;GO:0030027;GO:0016328;GO:0005874;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:1990909;GO:0008013;GO:0070840;GO:0045295;GO:0008017;GO:0051010;GO:0019901;GO:0019887;GO:0031625;GO:1904885;GO:1904886;GO:0070830;GO:0007155;GO:0007050;GO:0001708;GO:0016477;GO:0006974;GO:0008286;GO:0000281;GO:0007094;GO:0090090;GO:0008285;GO:0045736;GO:2000134;GO:0007026;GO:0007399;GO:0007389;GO:0043065;GO:0010942;GO:0030335;GO:0120162;GO:0045732;GO:1904781;GO:0031274;GO:0016579;GO:0065003;GO:0051988;GO:0045595;GO:0032886;GO:0016055;, C:adherens junction; C:beta-catenin destruction complex; C:bicellular tight junction; C:catenin complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:kinetochore; C:lamellipodium; C:lateral plasma membrane; C:microtubule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:Wnt signalosome;, F:beta-catenin binding; F:dynein complex binding; F:gamma-catenin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:protein kinase regulator activity; F:ubiquitin protein ligase binding;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:bicellular tight junction assembly; P:cell adhesion; P:cell cycle arrest; P:cell fate specification; P:cell migration; P:cellular response to DNA damage stimulus; P:insulin receptor signaling pathway; P:mitotic cytokinesis; P:mitotic spindle assembly checkpoint; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of cell migration; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein catabolic process; P:positive regulation of protein localization to centrosome; P:positive regulation of pseudopodium assembly; P:protein deubiquitination; P:protein-containing complex assembly; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of cell differentiation; P:regulation of microtubule-based process; P:Wnt signaling pathway;|P25054 B7Z2B6 D3DT03 Q15162 Q15163 Q93042,Adenomatous polyposis coli protein,Deleted in polyposis 2.5;, PF05972;PF05956;PF16689;PF05923;PF18797;PF00514;PF05937;PF05924;, GO:0005912;GO:0030877;GO:0005923;GO:0016342;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0000776;GO:0030027;GO:0016328;GO:0005874;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:1990909;GO:0008013;GO:0070840;GO:0045295;GO:0008017;GO:0051010;GO:0019901;GO:0019887;GO:0031625;GO:1904885;GO:1904886;GO:0070830;GO:0007155;GO:0007050;GO:0001708;GO:0016477;GO:0006974;GO:0008286;GO:0000281;GO:0007094;GO:0090090;GO:0008285;GO:0045736;GO:2000134;GO:0007026;GO:0007399;GO:0007389;GO:0043065;GO:0010942;GO:0030335;GO:0120162;GO:0045732;GO:1904781;GO:0031274;GO:0016579;GO:0065003;GO:0051988;GO:0045595;GO:0032886;GO:0016055;, C:adherens junction; C:beta-catenin destruction complex; C:bicellular tight junction; C:catenin complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:kinetochore; C:lamellipodium; C:lateral plasma membrane; C:microtubule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:Wnt signalosome;, F:beta-catenin binding; F:dynein complex binding; F:gamma-catenin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:protein kinase regulator activity; F:ubiquitin protein ligase binding;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:bicellular tight junction assembly; P:cell adhesion; P:cell cycle arrest; P:cell fate specification; P:cell migration; P:cellular response to DNA damage stimulus; P:insulin receptor signaling pathway; P:mitotic cytokinesis; P:mitotic spindle assembly checkpoint; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of cell migration; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein catabolic process; P:positive regulation of protein localization to centrosome; P:positive regulation of pseudopodium assembly; P:protein deubiquitination; P:protein-containing complex assembly; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of cell differentiation; P:regulation of microtubule-based process; P:Wnt signaling pathway;|P25054 B7Z2B6 D3DT03 Q15162 Q15163 Q93042,Adenomatous polyposis coli protein,Deleted in polyposis 2.5;, PF05972;PF05956;PF16689;PF05923;PF18797;PF00514;PF05937;PF05924;, GO:0005912;GO:0030877;GO:0005923;GO:0016342;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0000776;GO:0030027;GO:0016328;GO:0005874;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:1990909;GO:0008013;GO:0070840;GO:0045295;GO:0008017;GO:0051010;GO:0019901;GO:0019887;GO:0031625;GO:1904885;GO:1904886;GO:0070830;GO:0007155;GO:0007050;GO:0001708;GO:0016477;GO:0006974;GO:0008286;GO:0000281;GO:0007094;GO:0090090;GO:0008285;GO:0045736;GO:2000134;GO:0007026;GO:0007399;GO:0007389;GO:0043065;GO:0010942;GO:0030335;GO:0120162;GO:0045732;GO:1904781;GO:0031274;GO:0016579;GO:0065003;GO:0051988;GO:0045595;GO:0032886;GO:0016055;, C:adherens junction; C:beta-catenin destruction complex; C:bicellular tight junction; C:catenin complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:kinetochore; C:lamellipodium; C:lateral plasma membrane; C:microtubule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:Wnt signalosome;, F:beta-catenin binding; F:dynein complex binding; F:gamma-catenin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:protein kinase regulator activity; F:ubiquitin protein ligase binding;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:bicellular tight junction assembly; P:cell adhesion; P:cell cycle arrest; P:cell fate specification; P:cell migration; P:cellular response to DNA damage stimulus; P:insulin receptor signaling pathway; P:mitotic cytokinesis; P:mitotic spindle assembly checkpoint; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of cell migration; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein catabolic process; P:positive regulation of protein localization to centrosome; P:positive regulation of pseudopodium assembly; P:protein deubiquitination; P:protein-containing complex assembly; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of cell differentiation; P:regulation of microtubule-based process; P:Wnt signaling pathway;|P25054 B7Z2B6 D3DT03 Q15162 Q15163 Q93042,Adenomatous polyposis coli protein,Deleted in polyposis 2.5;, PF05972;PF05956;PF16689;PF05923;PF18797;PF00514;PF05937;PF05924;, GO:0005912;GO:0030877;GO:0005923;GO:0016342;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0000776;GO:0030027;GO:0016328;GO:0005874;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:1990909;GO:0008013;GO:0070840;GO:0045295;GO:0008017;GO:0051010;GO:0019901;GO:0019887;GO:0031625;GO:1904885;GO:1904886;GO:0070830;GO:0007155;GO:0007050;GO:0001708;GO:0016477;GO:0006974;GO:0008286;GO:0000281;GO:0007094;GO:0090090;GO:0008285;GO:0045736;GO:2000134;GO:0007026;GO:0007399;GO:0007389;GO:0043065;GO:0010942;GO:0030335;GO:0120162;GO:0045732;GO:1904781;GO:0031274;GO:0016579;GO:0065003;GO:0051988;GO:0045595;GO:0032886;GO:0016055;, C:adherens junction; C:beta-catenin destruction complex; C:bicellular tight junction; C:catenin complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:kinetochore; C:lamellipodium; C:lateral plasma membrane; C:microtubule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:Wnt signalosome;, F:beta-catenin binding; F:dynein complex binding; F:gamma-catenin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:protein kinase regulator activity; F:ubiquitin protein ligase binding;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:bicellular tight junction assembly; P:cell adhesion; P:cell cycle arrest; P:cell fate specification; P:cell migration; P:cellular response to DNA damage stimulus; P:insulin receptor signaling pathway; P:mitotic cytokinesis; P:mitotic spindle assembly checkpoint; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of cell migration; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein catabolic process; P:positive regulation of protein localization to centrosome; P:positive regulation of pseudopodium assembly; P:protein deubiquitination; P:protein-containing complex assembly; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of cell differentiation; P:regulation of microtubule-based process; P:Wnt signaling pathway;|P25054 B7Z2B6 D3DT03 Q15162 Q15163 Q93042,Adenomatous polyposis coli protein,Deleted in polyposis 2.5;, PF05972;PF05956;PF16689;PF05923;PF18797;PF00514;PF05937;PF05924;, GO:0005912;GO:0030877;GO:0005923;GO:0016342;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0000776;GO:0030027;GO:0016328;GO:0005874;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:1990909;GO:0008013;GO:0070840;GO:0045295;GO:0008017;GO:0051010;GO:0019901;GO:0019887;GO:0031625;GO:1904885;GO:1904886;GO:0070830;GO:0007155;GO:0007050;GO:0001708;GO:0016477;GO:0006974;GO:0008286;GO:0000281;GO:0007094;GO:0090090;GO:0008285;GO:0045736;GO:2000134;GO:0007026;GO:0007399;GO:0007389;GO:0043065;GO:0010942;GO:0030335;GO:0120162;GO:0045732;GO:1904781;GO:0031274;GO:0016579;GO:0065003;GO:0051988;GO:0045595;GO:0032886;GO:0016055;, C:adherens junction; C:beta-catenin destruction complex; C:bicellular tight junction; C:catenin complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:kinetochore; C:lamellipodium; C:lateral plasma membrane; C:microtubule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:Wnt signalosome;, F:beta-catenin binding; F:dynein complex binding; F:gamma-catenin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein kinase binding; F:protein kinase regulator activity; F:ubiquitin protein ligase binding;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:bicellular tight junction assembly; P:cell adhesion; P:cell cycle arrest; P:cell fate specification; P:cell migration; P:cellular response to DNA damage stimulus; P:insulin receptor signaling pathway; P:mitotic cytokinesis; P:mitotic spindle assembly checkpoint; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of microtubule depolymerization; P:nervous system development; P:pattern specification process; P:positive regulation of apoptotic process; P:positive regulation of cell death; P:positive regulation of cell migration; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein catabolic process; P:positive regulation of protein localization to centrosome; P:positive regulation of pseudopodium assembly; P:protein deubiquitination; P:protein-containing complex assembly; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of cell differentiation; P:regulation of microtubule-based process; P:Wnt signaling pathway; scaffold42 indexed_genome mRNA 1123976 1386833 . + . ID=transcript_8464;Q9HCS5 A4FUI6,Band 4.1-like protein 4A,Erythrocyte membrane protein band 4.1-like 4A {ECO:0000312|HGNC:HGNC:13278};Protein NBL4;, PF08736;PF09380;PF00373;PF09379;, GO:0005737;GO:0005856;GO:0008092;GO:0031032;, C:cytoplasm; C:cytoskeleton;, F:cytoskeletal protein binding;, P:actomyosin structure organization; scaffold42 indexed_genome mRNA 1388056 1389113 . + . ID=transcript_8465;Q9HCS5 A4FUI6,Band 4.1-like protein 4A,Erythrocyte membrane protein band 4.1-like 4A {ECO:0000312|HGNC:HGNC:13278};Protein NBL4;, PF08736;PF09380;PF00373;PF09379;, GO:0005737;GO:0005856;GO:0008092;GO:0031032;, C:cytoplasm; C:cytoskeleton;, F:cytoskeletal protein binding;, P:actomyosin structure organization; scaffold42 indexed_genome mRNA 1391129 1394169 . + . ID=transcript_8466;Q9HCS5 A4FUI6,Band 4.1-like protein 4A,Erythrocyte membrane protein band 4.1-like 4A {ECO:0000312|HGNC:HGNC:13278};Protein NBL4;, PF08736;PF09380;PF00373;PF09379;, GO:0005737;GO:0005856;GO:0008092;GO:0031032;, C:cytoplasm; C:cytoskeleton;, F:cytoskeletal protein binding;, P:actomyosin structure organization;|Q9HCS5 A4FUI6,Band 4.1-like protein 4A,Erythrocyte membrane protein band 4.1-like 4A {ECO:0000312|HGNC:HGNC:13278};Protein NBL4;, PF08736;PF09380;PF00373;PF09379;, GO:0005737;GO:0005856;GO:0008092;GO:0031032;, C:cytoplasm; C:cytoskeleton;, F:cytoskeletal protein binding;, P:actomyosin structure organization; scaffold42 indexed_genome mRNA 1789083 1820577 . + . ID=transcript_8467;Q16612 B2RDN8 B7Z5D2 D3DSZ8,Neuronal regeneration-related protein,Neuronal protein 3.1;Protein p311;, PF11092;, GO:0005737;GO:0005634;GO:0031103;GO:0045664;GO:0017015;, C:cytoplasm; C:nucleus;, , P:axon regeneration; P:regulation of neuron differentiation; P:regulation of transforming growth factor beta receptor signaling pathway;|Q16612 B2RDN8 B7Z5D2 D3DSZ8,Neuronal regeneration-related protein,Neuronal protein 3.1;Protein p311;, PF11092;, GO:0005737;GO:0005634;GO:0031103;GO:0045664;GO:0017015;, C:cytoplasm; C:nucleus;, , P:axon regeneration; P:regulation of neuron differentiation; P:regulation of transforming growth factor beta receptor signaling pathway;|Q16612 B2RDN8 B7Z5D2 D3DSZ8,Neuronal regeneration-related protein,Neuronal protein 3.1;Protein p311;, PF11092;, GO:0005737;GO:0005634;GO:0031103;GO:0045664;GO:0017015;, C:cytoplasm; C:nucleus;, , P:axon regeneration; P:regulation of neuron differentiation; P:regulation of transforming growth factor beta receptor signaling pathway; scaffold42 indexed_genome mRNA 2001325 2002168 . - . ID=transcript_8468;Q9H6S0 B2RP66,3'-5' RNA helicase YTHDC2 {ECO:0000305},YTH domain-containing protein 2 {ECO:0000303|PubMed:29033321};, PF00270;PF04408;PF00271;PF07717;PF01424;PF04146;, GO:0005783;GO:0005634;GO:0035770;GO:0034458;GO:0005524;GO:1990247;GO:0003723;GO:0070063;GO:0008186;GO:0051729;GO:0051321;GO:0048599;GO:0044829;GO:0070555;GO:0034612;GO:0007286;, C:endoplasmic reticulum; C:nucleus; C:ribonucleoprotein granule;, F:3'-5' RNA helicase activity; F:ATP binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding; F:RNA polymerase binding; F:RNA-dependent ATPase activity;, P:germline cell cycle switching, mitotic to meiotic cell cycle; P:meiotic cell cycle; P:oocyte development; P:positive regulation by host of viral genome replication; P:response to interleukin-1; P:response to tumor necrosis factor; P:spermatid development; scaffold42 indexed_genome mRNA 2018292 2020284 . - . ID=transcript_8469;Q9H6S0 B2RP66,3'-5' RNA helicase YTHDC2 {ECO:0000305},YTH domain-containing protein 2 {ECO:0000303|PubMed:29033321};, PF00270;PF04408;PF00271;PF07717;PF01424;PF04146;, GO:0005783;GO:0005634;GO:0035770;GO:0034458;GO:0005524;GO:1990247;GO:0003723;GO:0070063;GO:0008186;GO:0051729;GO:0051321;GO:0048599;GO:0044829;GO:0070555;GO:0034612;GO:0007286;, C:endoplasmic reticulum; C:nucleus; C:ribonucleoprotein granule;, F:3'-5' RNA helicase activity; F:ATP binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding; F:RNA polymerase binding; F:RNA-dependent ATPase activity;, P:germline cell cycle switching, mitotic to meiotic cell cycle; P:meiotic cell cycle; P:oocyte development; P:positive regulation by host of viral genome replication; P:response to interleukin-1; P:response to tumor necrosis factor; P:spermatid development; scaffold42 indexed_genome mRNA 2023501 2045547 . + . ID=transcript_8470;Q9H6S0 B2RP66,3'-5' RNA helicase YTHDC2 {ECO:0000305},YTH domain-containing protein 2 {ECO:0000303|PubMed:29033321};, PF00270;PF04408;PF00271;PF07717;PF01424;PF04146;, GO:0005783;GO:0005634;GO:0035770;GO:0034458;GO:0005524;GO:1990247;GO:0003723;GO:0070063;GO:0008186;GO:0051729;GO:0051321;GO:0048599;GO:0044829;GO:0070555;GO:0034612;GO:0007286;, C:endoplasmic reticulum; C:nucleus; C:ribonucleoprotein granule;, F:3'-5' RNA helicase activity; F:ATP binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding; F:RNA polymerase binding; F:RNA-dependent ATPase activity;, P:germline cell cycle switching, mitotic to meiotic cell cycle; P:meiotic cell cycle; P:oocyte development; P:positive regulation by host of viral genome replication; P:response to interleukin-1; P:response to tumor necrosis factor; P:spermatid development;|Q9H6S0 B2RP66,3'-5' RNA helicase YTHDC2 {ECO:0000305},YTH domain-containing protein 2 {ECO:0000303|PubMed:29033321};, PF00270;PF04408;PF00271;PF07717;PF01424;PF04146;, GO:0005783;GO:0005634;GO:0035770;GO:0034458;GO:0005524;GO:1990247;GO:0003723;GO:0070063;GO:0008186;GO:0051729;GO:0051321;GO:0048599;GO:0044829;GO:0070555;GO:0034612;GO:0007286;, C:endoplasmic reticulum; C:nucleus; C:ribonucleoprotein granule;, F:3'-5' RNA helicase activity; F:ATP binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding; F:RNA polymerase binding; F:RNA-dependent ATPase activity;, P:germline cell cycle switching, mitotic to meiotic cell cycle; P:meiotic cell cycle; P:oocyte development; P:positive regulation by host of viral genome replication; P:response to interleukin-1; P:response to tumor necrosis factor; P:spermatid development;|Q9H6S0 B2RP66,3'-5' RNA helicase YTHDC2 {ECO:0000305},YTH domain-containing protein 2 {ECO:0000303|PubMed:29033321};, PF00270;PF04408;PF00271;PF07717;PF01424;PF04146;, GO:0005783;GO:0005634;GO:0035770;GO:0034458;GO:0005524;GO:1990247;GO:0003723;GO:0070063;GO:0008186;GO:0051729;GO:0051321;GO:0048599;GO:0044829;GO:0070555;GO:0034612;GO:0007286;, C:endoplasmic reticulum; C:nucleus; C:ribonucleoprotein granule;, F:3'-5' RNA helicase activity; F:ATP binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding; F:RNA polymerase binding; F:RNA-dependent ATPase activity;, P:germline cell cycle switching, mitotic to meiotic cell cycle; P:meiotic cell cycle; P:oocyte development; P:positive regulation by host of viral genome replication; P:response to interleukin-1; P:response to tumor necrosis factor; P:spermatid development;|Q9H6S0 B2RP66,3'-5' RNA helicase YTHDC2 {ECO:0000305},YTH domain-containing protein 2 {ECO:0000303|PubMed:29033321};, PF00270;PF04408;PF00271;PF07717;PF01424;PF04146;, GO:0005783;GO:0005634;GO:0035770;GO:0034458;GO:0005524;GO:1990247;GO:0003723;GO:0070063;GO:0008186;GO:0051729;GO:0051321;GO:0048599;GO:0044829;GO:0070555;GO:0034612;GO:0007286;, C:endoplasmic reticulum; C:nucleus; C:ribonucleoprotein granule;, F:3'-5' RNA helicase activity; F:ATP binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding; F:RNA polymerase binding; F:RNA-dependent ATPase activity;, P:germline cell cycle switching, mitotic to meiotic cell cycle; P:meiotic cell cycle; P:oocyte development; P:positive regulation by host of viral genome replication; P:response to interleukin-1; P:response to tumor necrosis factor; P:spermatid development; scaffold42 indexed_genome mRNA 2045593 2048474 . + . ID=transcript_8471;Q9H6S0 B2RP66,3'-5' RNA helicase YTHDC2 {ECO:0000305},YTH domain-containing protein 2 {ECO:0000303|PubMed:29033321};, PF00270;PF04408;PF00271;PF07717;PF01424;PF04146;, GO:0005783;GO:0005634;GO:0035770;GO:0034458;GO:0005524;GO:1990247;GO:0003723;GO:0070063;GO:0008186;GO:0051729;GO:0051321;GO:0048599;GO:0044829;GO:0070555;GO:0034612;GO:0007286;, C:endoplasmic reticulum; C:nucleus; C:ribonucleoprotein granule;, F:3'-5' RNA helicase activity; F:ATP binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding; F:RNA polymerase binding; F:RNA-dependent ATPase activity;, P:germline cell cycle switching, mitotic to meiotic cell cycle; P:meiotic cell cycle; P:oocyte development; P:positive regulation by host of viral genome replication; P:response to interleukin-1; P:response to tumor necrosis factor; P:spermatid development; scaffold42 indexed_genome mRNA 2789160 2950903 . + . ID=transcript_8472;Q9H2S1 A6NF94 Q0VFZ4 Q6PJI0 Q6X2Y2,Small conductance calcium-activated potassium channel protein 2,KCa2.2;, PF02888;PF07885;PF03530;, GO:0009986;GO:0043197;GO:0016021;GO:0043005;GO:0043025;GO:0005886;GO:0030018;GO:0051393;GO:0015269;GO:0005516;GO:0019904;GO:0042803;GO:0016286;GO:0006811;GO:0098914;GO:1901381;GO:0071805;GO:0006813;GO:1901379;, C:cell surface; C:dendritic spine; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:Z disc;, F:alpha-actinin binding; F:calcium-activated potassium channel activity; F:calmodulin binding; F:protein domain specific binding; F:protein homodimerization activity; F:small conductance calcium-activated potassium channel activity;, P:ion transport; P:membrane repolarization during atrial cardiac muscle cell action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport;|Q9H2S1 A6NF94 Q0VFZ4 Q6PJI0 Q6X2Y2,Small conductance calcium-activated potassium channel protein 2,KCa2.2;, PF02888;PF07885;PF03530;, GO:0009986;GO:0043197;GO:0016021;GO:0043005;GO:0043025;GO:0005886;GO:0030018;GO:0051393;GO:0015269;GO:0005516;GO:0019904;GO:0042803;GO:0016286;GO:0006811;GO:0098914;GO:1901381;GO:0071805;GO:0006813;GO:1901379;, C:cell surface; C:dendritic spine; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:Z disc;, F:alpha-actinin binding; F:calcium-activated potassium channel activity; F:calmodulin binding; F:protein domain specific binding; F:protein homodimerization activity; F:small conductance calcium-activated potassium channel activity;, P:ion transport; P:membrane repolarization during atrial cardiac muscle cell action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport;|Q9H2S1 A6NF94 Q0VFZ4 Q6PJI0 Q6X2Y2,Small conductance calcium-activated potassium channel protein 2,KCa2.2;, PF02888;PF07885;PF03530;, GO:0009986;GO:0043197;GO:0016021;GO:0043005;GO:0043025;GO:0005886;GO:0030018;GO:0051393;GO:0015269;GO:0005516;GO:0019904;GO:0042803;GO:0016286;GO:0006811;GO:0098914;GO:1901381;GO:0071805;GO:0006813;GO:1901379;, C:cell surface; C:dendritic spine; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:Z disc;, F:alpha-actinin binding; F:calcium-activated potassium channel activity; F:calmodulin binding; F:protein domain specific binding; F:protein homodimerization activity; F:small conductance calcium-activated potassium channel activity;, P:ion transport; P:membrane repolarization during atrial cardiac muscle cell action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport;|Q9H2S1 A6NF94 Q0VFZ4 Q6PJI0 Q6X2Y2,Small conductance calcium-activated potassium channel protein 2,KCa2.2;, PF02888;PF07885;PF03530;, GO:0009986;GO:0043197;GO:0016021;GO:0043005;GO:0043025;GO:0005886;GO:0030018;GO:0051393;GO:0015269;GO:0005516;GO:0019904;GO:0042803;GO:0016286;GO:0006811;GO:0098914;GO:1901381;GO:0071805;GO:0006813;GO:1901379;, C:cell surface; C:dendritic spine; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:Z disc;, F:alpha-actinin binding; F:calcium-activated potassium channel activity; F:calmodulin binding; F:protein domain specific binding; F:protein homodimerization activity; F:small conductance calcium-activated potassium channel activity;, P:ion transport; P:membrane repolarization during atrial cardiac muscle cell action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport;|Q9H2S1 A6NF94 Q0VFZ4 Q6PJI0 Q6X2Y2,Small conductance calcium-activated potassium channel protein 2,KCa2.2;, PF02888;PF07885;PF03530;, GO:0009986;GO:0043197;GO:0016021;GO:0043005;GO:0043025;GO:0005886;GO:0030018;GO:0051393;GO:0015269;GO:0005516;GO:0019904;GO:0042803;GO:0016286;GO:0006811;GO:0098914;GO:1901381;GO:0071805;GO:0006813;GO:1901379;, C:cell surface; C:dendritic spine; C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:Z disc;, F:alpha-actinin binding; F:calcium-activated potassium channel activity; F:calmodulin binding; F:protein domain specific binding; F:protein homodimerization activity; F:small conductance calcium-activated potassium channel activity;, P:ion transport; P:membrane repolarization during atrial cardiac muscle cell action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport; scaffold42 indexed_genome mRNA 3468908 3498571 . - . ID=transcript_8473;Q9NQ86 A1L3Z1 A6NDD0 B7Z3V4 B7ZAV7 E9PFI8 Q0P5Z9,E3 ubiquitin-protein ligase TRIM36,RING finger protein 98;RING-type E3 ubiquitin transferase TRIM36 {ECO:0000305};Tripartite motif-containing protein 36;Zinc-binding protein Rbcc728;, PF18568;PF00041;PF00643;PF13445;, GO:0001669;GO:0005737;GO:0005856;GO:0005829;GO:0043014;GO:0004842;GO:0008270;GO:0007340;GO:0000281;GO:0000209;GO:0051726;GO:0070507;GO:0007051;, C:acrosomal vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:alpha-tubulin binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:acrosome reaction; P:mitotic cytokinesis; P:protein polyubiquitination; P:regulation of cell cycle; P:regulation of microtubule cytoskeleton organization; P:spindle organization; scaffold42 indexed_genome mRNA 3551726 3574504 . - . ID=transcript_8474;P53609 Q5MJP9,Geranylgeranyl transferase type-1 subunit beta,Geranylgeranyl transferase type I subunit beta;Type I protein geranyl-geranyltransferase subunit beta;, PF00432;, GO:0005953;GO:0004662;GO:0008144;GO:0019840;GO:0042277;GO:0004661;GO:0008270;GO:0051771;GO:0045787;GO:0008284;GO:0018344;GO:0018342;GO:0034097;, C:CAAX-protein geranylgeranyltransferase complex;, F:CAAX-protein geranylgeranyltransferase activity; F:drug binding; F:isoprenoid binding; F:peptide binding; F:protein geranylgeranyltransferase activity; F:zinc ion binding;, P:negative regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:protein geranylgeranylation; P:protein prenylation; P:response to cytokine;|P53609 Q5MJP9,Geranylgeranyl transferase type-1 subunit beta,Geranylgeranyl transferase type I subunit beta;Type I protein geranyl-geranyltransferase subunit beta;, PF00432;, GO:0005953;GO:0004662;GO:0008144;GO:0019840;GO:0042277;GO:0004661;GO:0008270;GO:0051771;GO:0045787;GO:0008284;GO:0018344;GO:0018342;GO:0034097;, C:CAAX-protein geranylgeranyltransferase complex;, F:CAAX-protein geranylgeranyltransferase activity; F:drug binding; F:isoprenoid binding; F:peptide binding; F:protein geranylgeranyltransferase activity; F:zinc ion binding;, P:negative regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:protein geranylgeranylation; P:protein prenylation; P:response to cytokine; scaffold42 indexed_genome mRNA 3577809 3579444 . - . ID=transcript_8475;P53609 Q5MJP9,Geranylgeranyl transferase type-1 subunit beta,Geranylgeranyl transferase type I subunit beta;Type I protein geranyl-geranyltransferase subunit beta;, PF00432;, GO:0005953;GO:0004662;GO:0008144;GO:0019840;GO:0042277;GO:0004661;GO:0008270;GO:0051771;GO:0045787;GO:0008284;GO:0018344;GO:0018342;GO:0034097;, C:CAAX-protein geranylgeranyltransferase complex;, F:CAAX-protein geranylgeranyltransferase activity; F:drug binding; F:isoprenoid binding; F:peptide binding; F:protein geranylgeranyltransferase activity; F:zinc ion binding;, P:negative regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:protein geranylgeranylation; P:protein prenylation; P:response to cytokine; scaffold42 indexed_genome mRNA 3608487 3609342 . - . ID=transcript_8476;Q8NEF3 Q6A334,Coiled-coil domain-containing protein 112,Mutated in bladder cancer protein 1; scaffold42 indexed_genome mRNA 3609365 3610283 . + . ID=transcript_8477;Q8NEF3 Q6A334,Coiled-coil domain-containing protein 112,Mutated in bladder cancer protein 1;|Q8NEF3 Q6A334,Coiled-coil domain-containing protein 112,Mutated in bladder cancer protein 1; scaffold42 indexed_genome mRNA 3611285 3627156 . - . ID=transcript_8478;Q8NEF3 Q6A334,Coiled-coil domain-containing protein 112,Mutated in bladder cancer protein 1;|Q8NEF3 Q6A334,Coiled-coil domain-containing protein 112,Mutated in bladder cancer protein 1; scaffold42 indexed_genome mRNA 3843142 3872147 . - . ID=transcript_8479;Q96JP0 B2RE47 Q8N3V8 Q9H704 Q9NPL6 Q9NPL9,Protein fem-1 homolog C,FEM1-gamma;, PF12796;, GO:0005829;GO:0005654;GO:0000151;GO:0043687;GO:0016567;GO:0006511;, C:cytosol; C:nucleoplasm; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold42 indexed_genome mRNA 3921861 3924737 . + . ID=transcript_8480;Q86XR7 B3Y698 Q6JUT2,TIR domain-containing adapter molecule 2,Putative NF-kappa-B-activating protein 502;TRIF-related adapter molecule;Toll-like receptor adaptor protein 3;Toll/interleukin-1 receptor domain-containing protein;, PF13676;, GO:0042995;GO:0030134;GO:0005769;GO:0031901;GO:0005783;GO:0005793;GO:0010008;GO:0005794;GO:0005770;GO:0031902;GO:0001891;GO:0005886;GO:0030667;GO:0097190;GO:0071222;GO:0006888;GO:0007030;GO:0007249;GO:0006954;GO:0045087;GO:0006886;GO:0002756;GO:0070266;GO:0071650;GO:0034128;GO:0034144;GO:0043312;GO:0006909;GO:0071651;GO:0043123;GO:2000494;GO:0034145;GO:0034142;GO:0035669;GO:0035666;, C:cell projection; C:COPII-coated ER to Golgi transport vesicle; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome membrane; C:Golgi apparatus; C:late endosome; C:late endosome membrane; C:phagocytic cup; C:plasma membrane; C:secretory granule membrane;, , P:apoptotic signaling pathway; P:cellular response to lipopolysaccharide; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:intracellular protein transport; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:negative regulation of chemokine (C-C motif) ligand 5 production; P:negative regulation of MyD88-independent toll-like receptor signaling pathway; P:negative regulation of toll-like receptor 4 signaling pathway; P:neutrophil degranulation; P:phagocytosis; P:positive regulation of chemokine (C-C motif) ligand 5 production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-18-mediated signaling pathway; P:positive regulation of toll-like receptor 4 signaling pathway; P:toll-like receptor 4 signaling pathway; P:TRAM-dependent toll-like receptor 4 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; scaffold42 indexed_genome mRNA 3951339 3968982 . - . ID=transcript_8481;Q9Y3B3 Q8NBU8 Q8WUU6 Q96K51,Transmembrane emp24 domain-containing protein 7,p24 family protein gamma-3;p27;, PF01105;, GO:0030126;GO:0030127;GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0000139;GO:0016021;GO:0030133;GO:0006888;GO:0007030;GO:0006886;GO:0006890;, C:COPI vesicle coat; C:COPII vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y3B3 Q8NBU8 Q8WUU6 Q96K51,Transmembrane emp24 domain-containing protein 7,p24 family protein gamma-3;p27;, PF01105;, GO:0030126;GO:0030127;GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0000139;GO:0016021;GO:0030133;GO:0006888;GO:0007030;GO:0006886;GO:0006890;, C:COPI vesicle coat; C:COPII vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold42 indexed_genome mRNA 4158697 4181453 . - . ID=transcript_8482;O94817 Q6PJV2,Ubiquitin-like protein ATG12,Autophagy-related protein 12;, PF04110;, GO:0034274;GO:0005776;GO:0005829;GO:0030670;GO:0034045;GO:0000045;GO:0000422;GO:0044804;GO:0006501;GO:0016236;GO:0016032;, C:Atg12-Atg5-Atg16 complex; C:autophagosome; C:cytosol; C:phagocytic vesicle membrane; C:phagophore assembly site membrane;, , P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:C-terminal protein lipidation; P:macroautophagy; P:viral process;|O94817 Q6PJV2,Ubiquitin-like protein ATG12,Autophagy-related protein 12;, PF04110;, GO:0034274;GO:0005776;GO:0005829;GO:0030670;GO:0034045;GO:0000045;GO:0000422;GO:0044804;GO:0006501;GO:0016236;GO:0016032;, C:Atg12-Atg5-Atg16 complex; C:autophagosome; C:cytosol; C:phagocytic vesicle membrane; C:phagophore assembly site membrane;, , P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:C-terminal protein lipidation; P:macroautophagy; P:viral process; scaffold42 indexed_genome mRNA 4219618 4262737 . + . ID=transcript_8483;Q92572 O00647 O00676 O00721 O00727 Q53XL4 Q6ICQ2,AP-3 complex subunit sigma-1,AP-3 complex subunit sigma-3A;Adaptor-related protein complex 3 subunit sigma-1;Clathrin-associated/assembly/adaptor protein, small 3;Sigma-3A-adaptin;Sigma-adaptin 3a;, PF01217;, GO:0030123;GO:0030119;GO:1904115;GO:0030659;GO:0005794;GO:0043231;GO:0030133;GO:0008089;GO:0048490;GO:0008286;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:AP-type membrane coat adaptor complex; C:axon cytoplasm; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:transport vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:insulin receptor signaling pathway; P:intracellular protein transport; P:vesicle-mediated transport; scaffold42 indexed_genome mRNA 4262756 4268097 . - . ID=transcript_8484;Q92572 O00647 O00676 O00721 O00727 Q53XL4 Q6ICQ2,AP-3 complex subunit sigma-1,AP-3 complex subunit sigma-3A;Adaptor-related protein complex 3 subunit sigma-1;Clathrin-associated/assembly/adaptor protein, small 3;Sigma-3A-adaptin;Sigma-adaptin 3a;, PF01217;, GO:0030123;GO:0030119;GO:1904115;GO:0030659;GO:0005794;GO:0043231;GO:0030133;GO:0008089;GO:0048490;GO:0008286;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:AP-type membrane coat adaptor complex; C:axon cytoplasm; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:transport vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:insulin receptor signaling pathway; P:intracellular protein transport; P:vesicle-mediated transport; scaffold42 indexed_genome mRNA 4501520 4549832 . - . ID=transcript_8485;Q96A73 B2RD69 B8K1S6 Q6IA24 Q8NDU3 Q9BRE5 Q9H7D5 Q9ULM9,Putative monooxygenase p33MONOX,Brain-derived rescue factor p60MONOX;Flavin monooxygenase motif-containing protein of 33 kDa;, PF15302;, GO:0005737;GO:0016491;, C:cytoplasm;, F:oxidoreductase activity;|Q96A73 B2RD69 B8K1S6 Q6IA24 Q8NDU3 Q9BRE5 Q9H7D5 Q9ULM9,Putative monooxygenase p33MONOX,Brain-derived rescue factor p60MONOX;Flavin monooxygenase motif-containing protein of 33 kDa;, PF15302;, GO:0005737;GO:0016491;, C:cytoplasm;, F:oxidoreductase activity;|Q8NDZ2 F6R0L0 J3KQQ8 Q6NXN8 Q6ZTU4 Q8IZ15 R9TJD7,SUMO-interacting motif-containing protein 1,Platform element for inhibition of autolytic degradation {ECO:0000303|PubMed:23707407};, , GO:0005737;GO:0030017;GO:0030414;GO:0032184;, C:cytoplasm; C:sarcomere;, F:peptidase inhibitor activity; F:SUMO polymer binding;|Q8NDZ2 F6R0L0 J3KQQ8 Q6NXN8 Q6ZTU4 Q8IZ15 R9TJD7,SUMO-interacting motif-containing protein 1,Platform element for inhibition of autolytic degradation {ECO:0000303|PubMed:23707407};, , GO:0005737;GO:0030017;GO:0030414;GO:0032184;, C:cytoplasm; C:sarcomere;, F:peptidase inhibitor activity; F:SUMO polymer binding;|Q8NDZ2 F6R0L0 J3KQQ8 Q6NXN8 Q6ZTU4 Q8IZ15 R9TJD7,SUMO-interacting motif-containing protein 1,Platform element for inhibition of autolytic degradation {ECO:0000303|PubMed:23707407};, , GO:0005737;GO:0030017;GO:0030414;GO:0032184;, C:cytoplasm; C:sarcomere;, F:peptidase inhibitor activity; F:SUMO polymer binding;|Q8NDZ2 F6R0L0 J3KQQ8 Q6NXN8 Q6ZTU4 Q8IZ15 R9TJD7,SUMO-interacting motif-containing protein 1,Platform element for inhibition of autolytic degradation {ECO:0000303|PubMed:23707407};, , GO:0005737;GO:0030017;GO:0030414;GO:0032184;, C:cytoplasm; C:sarcomere;, F:peptidase inhibitor activity; F:SUMO polymer binding;|Q8NDZ2 F6R0L0 J3KQQ8 Q6NXN8 Q6ZTU4 Q8IZ15 R9TJD7,SUMO-interacting motif-containing protein 1,Platform element for inhibition of autolytic degradation {ECO:0000303|PubMed:23707407};, , GO:0005737;GO:0030017;GO:0030414;GO:0032184;, C:cytoplasm; C:sarcomere;, F:peptidase inhibitor activity; F:SUMO polymer binding; scaffold42 indexed_genome mRNA 4658100 4669549 . + . ID=transcript_8486;Q96J01 Q6NZ53,THO complex subunit 3,TEX1 homolog;hTREX45;, PF12894;PF08662;PF00400;, GO:0016607;GO:0005654;GO:0000445;GO:0000346;GO:0003723;GO:0031124;GO:0006406;GO:0006405;GO:0008380;GO:0046784;, C:nuclear speck; C:nucleoplasm; C:THO complex part of transcription export complex; C:transcription export complex;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus; scaffold42 indexed_genome mRNA 4746482 4829709 . - . ID=transcript_8487;Q6PUV4 B2RAG2 O09056 Q13329 Q28184 Q52M15 Q64386,Complexin-2,Complexin II;Synaphin-1;, PF05835;, GO:0044305;GO:0005829;GO:0030425;GO:0098978;GO:0005634;GO:0043204;GO:0098794;GO:0031201;GO:0070033;GO:0070554;GO:0043195;GO:0048306;GO:0000149;GO:0017075;GO:0030154;GO:0043303;GO:0007399;GO:0031915;GO:0017157;GO:0046928;GO:0031630;GO:0016079;GO:0006904;, C:calyx of Held; C:cytosol; C:dendrite; C:glutamatergic synapse; C:nucleus; C:perikaryon; C:postsynapse; C:SNARE complex; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex; C:synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex; C:terminal bouton;, F:calcium-dependent protein binding; F:SNARE binding; F:syntaxin-1 binding;, P:cell differentiation; P:mast cell degranulation; P:nervous system development; P:positive regulation of synaptic plasticity; P:regulation of exocytosis; P:regulation of neurotransmitter secretion; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle exocytosis; P:vesicle docking involved in exocytosis; scaffold42 indexed_genome mRNA 4915348 4936566 . - . ID=transcript_8488;P25021 B5BUP7 Q14464 Q7Z5R9,Histamine H2 receptor,Gastric receptor I;, PF00001;, GO:0030425;GO:0005887;GO:0005886;GO:0045202;GO:0004993;GO:0004969;GO:0030594;GO:0007268;GO:0007186;GO:0007187;GO:0001696;GO:0006955;GO:0002862;GO:0045907;, C:dendrite; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:G protein-coupled serotonin receptor activity; F:histamine receptor activity; F:neurotransmitter receptor activity;, P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:gastric acid secretion; P:immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of vasoconstriction;|P25021 B5BUP7 Q14464 Q7Z5R9,Histamine H2 receptor,Gastric receptor I;, PF00001;, GO:0030425;GO:0005887;GO:0005886;GO:0045202;GO:0004993;GO:0004969;GO:0030594;GO:0007268;GO:0007186;GO:0007187;GO:0001696;GO:0006955;GO:0002862;GO:0045907;, C:dendrite; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:G protein-coupled serotonin receptor activity; F:histamine receptor activity; F:neurotransmitter receptor activity;, P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:gastric acid secretion; P:immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of vasoconstriction; scaffold42 indexed_genome mRNA 5068010 5082015 . - . ID=transcript_8489;Q9H9B4 B3KPW3 D3DQN2 Q9HA53,Sideroflexin-1 {ECO:0000250|UniProtKB:Q99JR1},, PF03820;, GO:0031305;GO:0005739;GO:0042945;GO:0015194;GO:0022889;GO:0022857;GO:0042942;GO:0015825;GO:1990542;GO:0006730;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:D-serine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:D-serine transport; P:L-serine transport; P:mitochondrial transmembrane transport; P:one-carbon metabolic process; P:serine import into mitochondrion;|Q9H9B4 B3KPW3 D3DQN2 Q9HA53,Sideroflexin-1 {ECO:0000250|UniProtKB:Q99JR1},, PF03820;, GO:0031305;GO:0005739;GO:0042945;GO:0015194;GO:0022889;GO:0022857;GO:0042942;GO:0015825;GO:1990542;GO:0006730;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:D-serine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:D-serine transport; P:L-serine transport; P:mitochondrial transmembrane transport; P:one-carbon metabolic process; P:serine import into mitochondrion;|Q9H9B4 B3KPW3 D3DQN2 Q9HA53,Sideroflexin-1 {ECO:0000250|UniProtKB:Q99JR1},, PF03820;, GO:0031305;GO:0005739;GO:0042945;GO:0015194;GO:0022889;GO:0022857;GO:0042942;GO:0015825;GO:1990542;GO:0006730;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:D-serine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:D-serine transport; P:L-serine transport; P:mitochondrial transmembrane transport; P:one-carbon metabolic process; P:serine import into mitochondrion; scaffold42 indexed_genome mRNA 5086463 5118678 . - . ID=transcript_8490;Q9H9B4 B3KPW3 D3DQN2 Q9HA53,Sideroflexin-1 {ECO:0000250|UniProtKB:Q99JR1},, PF03820;, GO:0031305;GO:0005739;GO:0042945;GO:0015194;GO:0022889;GO:0022857;GO:0042942;GO:0015825;GO:1990542;GO:0006730;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:D-serine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:D-serine transport; P:L-serine transport; P:mitochondrial transmembrane transport; P:one-carbon metabolic process; P:serine import into mitochondrion;|Q9H9B4 B3KPW3 D3DQN2 Q9HA53,Sideroflexin-1 {ECO:0000250|UniProtKB:Q99JR1},, PF03820;, GO:0031305;GO:0005739;GO:0042945;GO:0015194;GO:0022889;GO:0022857;GO:0042942;GO:0015825;GO:1990542;GO:0006730;GO:0140300;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:D-serine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:serine transmembrane transporter activity; F:transmembrane transporter activity;, P:D-serine transport; P:L-serine transport; P:mitochondrial transmembrane transport; P:one-carbon metabolic process; P:serine import into mitochondrion; scaffold42 indexed_genome mRNA 6020110 6046888 . - . ID=transcript_8491;Q8N7Z5,Ankyrin repeat domain-containing protein 31 {ECO:0000305},, PF00023;PF12796;PF18755;, GO:0000785;GO:0005634;GO:0007129;GO:0010780;GO:1903343;, C:chromatin; C:nucleus;, , P:homologous chromosome pairing at meiosis; P:meiotic DNA double-strand break formation involved in reciprocal meiotic recombination; P:positive regulation of meiotic DNA double-strand break formation;|Q8N7Z5,Ankyrin repeat domain-containing protein 31 {ECO:0000305},, PF00023;PF12796;PF18755;, GO:0000785;GO:0005634;GO:0007129;GO:0010780;GO:1903343;, C:chromatin; C:nucleus;, , P:homologous chromosome pairing at meiosis; P:meiotic DNA double-strand break formation involved in reciprocal meiotic recombination; P:positive regulation of meiotic DNA double-strand break formation; scaffold42 indexed_genome mRNA 6208951 6229726 . + . ID=transcript_8492;P04035 B7Z3Y9 Q8N190,3-hydroxy-3-methylglutaryl-coenzyme A reductase,, PF00368;PF12349;, GO:0005783;GO:0005789;GO:0016021;GO:0005778;GO:0120225;GO:0004420;GO:0042282;GO:0070402;GO:0006695;GO:0015936;GO:0008299;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0019222;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:peroxisomal membrane;, F:coenzyme A binding; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity; F:hydroxymethylglutaryl-CoA reductase activity; F:NADPH binding;, P:cholesterol biosynthetic process; P:coenzyme A metabolic process; P:isoprenoid biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:sterol biosynthetic process;|P04035 B7Z3Y9 Q8N190,3-hydroxy-3-methylglutaryl-coenzyme A reductase,, PF00368;PF12349;, GO:0005783;GO:0005789;GO:0016021;GO:0005778;GO:0120225;GO:0004420;GO:0042282;GO:0070402;GO:0006695;GO:0015936;GO:0008299;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0019222;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:peroxisomal membrane;, F:coenzyme A binding; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity; F:hydroxymethylglutaryl-CoA reductase activity; F:NADPH binding;, P:cholesterol biosynthetic process; P:coenzyme A metabolic process; P:isoprenoid biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:sterol biosynthetic process;|P04035 B7Z3Y9 Q8N190,3-hydroxy-3-methylglutaryl-coenzyme A reductase,, PF00368;PF12349;, GO:0005783;GO:0005789;GO:0016021;GO:0005778;GO:0120225;GO:0004420;GO:0042282;GO:0070402;GO:0006695;GO:0015936;GO:0008299;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0019222;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:peroxisomal membrane;, F:coenzyme A binding; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity; F:hydroxymethylglutaryl-CoA reductase activity; F:NADPH binding;, P:cholesterol biosynthetic process; P:coenzyme A metabolic process; P:isoprenoid biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:sterol biosynthetic process;|P04035 B7Z3Y9 Q8N190,3-hydroxy-3-methylglutaryl-coenzyme A reductase,, PF00368;PF12349;, GO:0005783;GO:0005789;GO:0016021;GO:0005778;GO:0120225;GO:0004420;GO:0042282;GO:0070402;GO:0006695;GO:0015936;GO:0008299;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0019222;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:peroxisomal membrane;, F:coenzyme A binding; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity; F:hydroxymethylglutaryl-CoA reductase activity; F:NADPH binding;, P:cholesterol biosynthetic process; P:coenzyme A metabolic process; P:isoprenoid biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:sterol biosynthetic process;|P04035 B7Z3Y9 Q8N190,3-hydroxy-3-methylglutaryl-coenzyme A reductase,, PF00368;PF12349;, GO:0005783;GO:0005789;GO:0016021;GO:0005778;GO:0120225;GO:0004420;GO:0042282;GO:0070402;GO:0006695;GO:0015936;GO:0008299;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0019222;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:peroxisomal membrane;, F:coenzyme A binding; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity; F:hydroxymethylglutaryl-CoA reductase activity; F:NADPH binding;, P:cholesterol biosynthetic process; P:coenzyme A metabolic process; P:isoprenoid biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:sterol biosynthetic process; scaffold42 indexed_genome mRNA 6236114 6437695 . - . ID=transcript_8493;Q9Y5P4 A8K7S2 B3KUB7 Q53YV1 Q53YV2 Q96Q85 Q96Q88 Q9H2S7 Q9H2S8,Ceramide transfer protein {ECO:0000303|PubMed:14685229, ECO:0000305},Collagen type IV alpha-3-binding protein {ECO:0000305};Goodpasture antigen-binding protein {ECO:0000303|PubMed:10212244};START domain-containing protein 11;StAR-related lipid transfer protein 11;, PF00169;PF01852;, GO:0005829;GO:0005789;GO:0005794;GO:0016020;GO:0005739;GO:0005654;GO:1902387;GO:1902388;GO:0097001;GO:0120017;GO:0042802;GO:0016301;GO:0070273;GO:0000902;GO:0008283;GO:0006672;GO:0035627;GO:0007029;GO:0035621;GO:0003007;GO:0006955;GO:0001701;GO:0120009;GO:0120012;GO:0055088;GO:0070584;GO:0006936;GO:0034976;GO:0007165;GO:0030148;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:membrane; C:mitochondrion; C:nucleoplasm;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:ceramide binding; F:ceramide transfer activity; F:identical protein binding; F:kinase activity; F:phosphatidylinositol-4-phosphate binding;, P:cell morphogenesis; P:cell population proliferation; P:ceramide metabolic process; P:ceramide transport; P:endoplasmic reticulum organization; P:ER to Golgi ceramide transport; P:heart morphogenesis; P:immune response; P:in utero embryonic development; P:intermembrane lipid transfer; P:intermembrane sphingolipid transfer; P:lipid homeostasis; P:mitochondrion morphogenesis; P:muscle contraction; P:response to endoplasmic reticulum stress; P:signal transduction; P:sphingolipid biosynthetic process;|Q9Y5P4 A8K7S2 B3KUB7 Q53YV1 Q53YV2 Q96Q85 Q96Q88 Q9H2S7 Q9H2S8,Ceramide transfer protein {ECO:0000303|PubMed:14685229, ECO:0000305},Collagen type IV alpha-3-binding protein {ECO:0000305};Goodpasture antigen-binding protein {ECO:0000303|PubMed:10212244};START domain-containing protein 11;StAR-related lipid transfer protein 11;, PF00169;PF01852;, GO:0005829;GO:0005789;GO:0005794;GO:0016020;GO:0005739;GO:0005654;GO:1902387;GO:1902388;GO:0097001;GO:0120017;GO:0042802;GO:0016301;GO:0070273;GO:0000902;GO:0008283;GO:0006672;GO:0035627;GO:0007029;GO:0035621;GO:0003007;GO:0006955;GO:0001701;GO:0120009;GO:0120012;GO:0055088;GO:0070584;GO:0006936;GO:0034976;GO:0007165;GO:0030148;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:membrane; C:mitochondrion; C:nucleoplasm;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:ceramide binding; F:ceramide transfer activity; F:identical protein binding; F:kinase activity; F:phosphatidylinositol-4-phosphate binding;, P:cell morphogenesis; P:cell population proliferation; P:ceramide metabolic process; P:ceramide transport; P:endoplasmic reticulum organization; P:ER to Golgi ceramide transport; P:heart morphogenesis; P:immune response; P:in utero embryonic development; P:intermembrane lipid transfer; P:intermembrane sphingolipid transfer; P:lipid homeostasis; P:mitochondrion morphogenesis; P:muscle contraction; P:response to endoplasmic reticulum stress; P:signal transduction; P:sphingolipid biosynthetic process;|Q9Y5P4 A8K7S2 B3KUB7 Q53YV1 Q53YV2 Q96Q85 Q96Q88 Q9H2S7 Q9H2S8,Ceramide transfer protein {ECO:0000303|PubMed:14685229, ECO:0000305},Collagen type IV alpha-3-binding protein {ECO:0000305};Goodpasture antigen-binding protein {ECO:0000303|PubMed:10212244};START domain-containing protein 11;StAR-related lipid transfer protein 11;, PF00169;PF01852;, GO:0005829;GO:0005789;GO:0005794;GO:0016020;GO:0005739;GO:0005654;GO:1902387;GO:1902388;GO:0097001;GO:0120017;GO:0042802;GO:0016301;GO:0070273;GO:0000902;GO:0008283;GO:0006672;GO:0035627;GO:0007029;GO:0035621;GO:0003007;GO:0006955;GO:0001701;GO:0120009;GO:0120012;GO:0055088;GO:0070584;GO:0006936;GO:0034976;GO:0007165;GO:0030148;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:membrane; C:mitochondrion; C:nucleoplasm;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:ceramide binding; F:ceramide transfer activity; F:identical protein binding; F:kinase activity; F:phosphatidylinositol-4-phosphate binding;, P:cell morphogenesis; P:cell population proliferation; P:ceramide metabolic process; P:ceramide transport; P:endoplasmic reticulum organization; P:ER to Golgi ceramide transport; P:heart morphogenesis; P:immune response; P:in utero embryonic development; P:intermembrane lipid transfer; P:intermembrane sphingolipid transfer; P:lipid homeostasis; P:mitochondrion morphogenesis; P:muscle contraction; P:response to endoplasmic reticulum stress; P:signal transduction; P:sphingolipid biosynthetic process;|Q9Y5P4 A8K7S2 B3KUB7 Q53YV1 Q53YV2 Q96Q85 Q96Q88 Q9H2S7 Q9H2S8,Ceramide transfer protein {ECO:0000303|PubMed:14685229, ECO:0000305},Collagen type IV alpha-3-binding protein {ECO:0000305};Goodpasture antigen-binding protein {ECO:0000303|PubMed:10212244};START domain-containing protein 11;StAR-related lipid transfer protein 11;, PF00169;PF01852;, GO:0005829;GO:0005789;GO:0005794;GO:0016020;GO:0005739;GO:0005654;GO:1902387;GO:1902388;GO:0097001;GO:0120017;GO:0042802;GO:0016301;GO:0070273;GO:0000902;GO:0008283;GO:0006672;GO:0035627;GO:0007029;GO:0035621;GO:0003007;GO:0006955;GO:0001701;GO:0120009;GO:0120012;GO:0055088;GO:0070584;GO:0006936;GO:0034976;GO:0007165;GO:0030148;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:membrane; C:mitochondrion; C:nucleoplasm;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:ceramide binding; F:ceramide transfer activity; F:identical protein binding; F:kinase activity; F:phosphatidylinositol-4-phosphate binding;, P:cell morphogenesis; P:cell population proliferation; P:ceramide metabolic process; P:ceramide transport; P:endoplasmic reticulum organization; P:ER to Golgi ceramide transport; P:heart morphogenesis; P:immune response; P:in utero embryonic development; P:intermembrane lipid transfer; P:intermembrane sphingolipid transfer; P:lipid homeostasis; P:mitochondrion morphogenesis; P:muscle contraction; P:response to endoplasmic reticulum stress; P:signal transduction; P:sphingolipid biosynthetic process;|Q8NB30 Q96L01 Q96Q86 Q96Q87 Q9UHC5,DNA polymerase kappa,DINB protein;, PF00817;PF11799;PF11798;, GO:0016604;GO:0005654;GO:0005634;GO:0003684;GO:0003887;GO:0046872;GO:0006974;GO:0034644;GO:0006281;GO:0006260;GO:0042276;GO:0006297;GO:0033683;GO:0006296;GO:0006283;GO:0019985;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|Q8NB30 Q96L01 Q96Q86 Q96Q87 Q9UHC5,DNA polymerase kappa,DINB protein;, PF00817;PF11799;PF11798;, GO:0016604;GO:0005654;GO:0005634;GO:0003684;GO:0003887;GO:0046872;GO:0006974;GO:0034644;GO:0006281;GO:0006260;GO:0042276;GO:0006297;GO:0033683;GO:0006296;GO:0006283;GO:0019985;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|Q8NB30 Q96L01 Q96Q86 Q96Q87 Q9UHC5,DNA polymerase kappa,DINB protein;, PF00817;PF11799;PF11798;, GO:0016604;GO:0005654;GO:0005634;GO:0003684;GO:0003887;GO:0046872;GO:0006974;GO:0034644;GO:0006281;GO:0006260;GO:0042276;GO:0006297;GO:0033683;GO:0006296;GO:0006283;GO:0019985;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|Q8NB30 Q96L01 Q96Q86 Q96Q87 Q9UHC5,DNA polymerase kappa,DINB protein;, PF00817;PF11799;PF11798;, GO:0016604;GO:0005654;GO:0005634;GO:0003684;GO:0003887;GO:0046872;GO:0006974;GO:0034644;GO:0006281;GO:0006260;GO:0042276;GO:0006297;GO:0033683;GO:0006296;GO:0006283;GO:0019985;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;, P:cellular response to DNA damage stimulus; P:cellular response to UV; P:DNA repair; P:DNA replication; P:error-prone translesion synthesis; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold42 indexed_genome mRNA 6510129 6532522 . + . ID=transcript_8494;Q8NA72 B4DJG7 Q494X7 Q494X9 Q6P085,Centrosomal protein POC5,Protein of centriole 5;, , GO:0005814;GO:0005813;GO:0005829;GO:0005654;GO:0007049;, C:centriole; C:centrosome; C:cytosol; C:nucleoplasm;, , P:cell cycle; scaffold42 indexed_genome mRNA 6832856 6995320 . + . ID=transcript_8495;Q496J9 Q496K1 Q9UPU8,Synaptic vesicle glycoprotein 2C,, PF07690;PF13599;PF00083;, GO:0016021;GO:0030285;GO:0043005;GO:0005886;GO:0008021;GO:0030672;GO:0022857;GO:0007268;GO:0006836;, C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:neuron projection; C:plasma membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:transmembrane transporter activity;, P:chemical synaptic transmission; P:neurotransmitter transport; scaffold42 indexed_genome mRNA 7207371 7348295 . + . ID=transcript_8496;Q13576 A8K4V1 B7Z8A4 J3KR91,Ras GTPase-activating-like protein IQGAP2,, PF00307;PF00612;PF00616;PF03836;, GO:0015629;GO:0009986;GO:0005737;GO:0005829;GO:0070062;GO:0030175;GO:0030027;GO:0005874;GO:0005902;GO:0005886;GO:0030667;GO:0003779;GO:0051015;GO:0071933;GO:0005516;GO:0005096;GO:0005095;GO:0005547;GO:0031267;GO:0034314;GO:0043312;GO:0032956;GO:2000249;GO:0007165;GO:0070493;, C:actin cytoskeleton; C:cell surface; C:cytoplasm; C:cytosol; C:extracellular exosome; C:filopodium; C:lamellipodium; C:microtubule; C:microvillus; C:plasma membrane; C:secretory granule membrane;, F:actin binding; F:actin filament binding; F:Arp2/3 complex binding; F:calmodulin binding; F:GTPase activator activity; F:GTPase inhibitor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:small GTPase binding;, P:Arp2/3 complex-mediated actin nucleation; P:neutrophil degranulation; P:regulation of actin cytoskeleton organization; P:regulation of actin cytoskeleton reorganization; P:signal transduction; P:thrombin-activated receptor signaling pathway;|O00254 B2R754 B4DQ13 Q52M68 Q7Z3W3,Proteinase-activated receptor 3,Coagulation factor II receptor-like 2;Thrombin receptor-like 2;, PF00001;, GO:0016324;GO:0005576;GO:0005887;GO:0005886;GO:0032991;GO:0004930;GO:0004435;GO:0015057;GO:0007596;GO:0007186;GO:0030168;GO:0051482;GO:0035025;GO:0009611;, C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex;, F:G protein-coupled receptor activity; F:phosphatidylinositol phospholipase C activity; F:thrombin-activated receptor activity;, P:blood coagulation; P:G protein-coupled receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of Rho protein signal transduction; P:response to wounding; scaffold42 indexed_genome mRNA 7384570 7387833 . + . ID=transcript_8497;P25116 Q53XV0 Q96RF7 Q9BUN4,Proteinase-activated receptor 1,Coagulation factor II receptor;Thrombin receptor;, PF00001;, GO:0005901;GO:0009986;GO:0005769;GO:0005576;GO:0005794;GO:0005887;GO:0005770;GO:0031594;GO:0005886;GO:0031094;GO:0045211;GO:0004930;GO:0001965;GO:0031681;GO:0005102;GO:0015057;GO:0006919;GO:0000186;GO:0009653;GO:0007596;GO:0045217;GO:0002248;GO:0007529;GO:0007186;GO:0048873;GO:0006954;GO:0008285;GO:0003105;GO:0043524;GO:1900134;GO:0007200;GO:0030168;GO:0060155;GO:0030194;GO:0051928;GO:0030335;GO:0008284;GO:0032967;GO:0043280;GO:0007204;GO:0051482;GO:0070374;GO:0043547;GO:0043123;GO:0032755;GO:0032757;GO:0043410;GO:0014068;GO:0046427;GO:0051281;GO:0035025;GO:0045987;GO:0045893;GO:0045907;GO:0007205;GO:0030193;GO:0032651;GO:0051930;GO:0051209;GO:0032496;GO:0009611;GO:0099553;, C:caveola; C:cell surface; C:early endosome; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:neuromuscular junction; C:plasma membrane; C:platelet dense tubular network; C:postsynaptic membrane;, F:G protein-coupled receptor activity; F:G-protein alpha-subunit binding; F:G-protein beta-subunit binding; F:signaling receptor binding; F:thrombin-activated receptor activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of MAPKK activity; P:anatomical structure morphogenesis; P:blood coagulation; P:cell-cell junction maintenance; P:connective tissue replacement involved in inflammatory response wound healing; P:establishment of synaptic specificity at neuromuscular junction; P:G protein-coupled receptor signaling pathway; P:homeostasis of number of cells within a tissue; P:inflammatory response; P:negative regulation of cell population proliferation; P:negative regulation of glomerular filtration; P:negative regulation of neuron apoptotic process; P:negative regulation of renin secretion into blood stream; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:platelet activation; P:platelet dense granule organization; P:positive regulation of blood coagulation; P:positive regulation of calcium ion transport; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of Rho protein signal transduction; P:positive regulation of smooth muscle contraction; P:positive regulation of transcription, DNA-templated; P:positive regulation of vasoconstriction; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of blood coagulation; P:regulation of interleukin-1 beta production; P:regulation of sensory perception of pain; P:release of sequestered calcium ion into cytosol; P:response to lipopolysaccharide; P:response to wounding; P:trans-synaptic signaling by endocannabinoid, modulating synaptic transmission; scaffold42 indexed_genome mRNA 7596762 7639582 . + . ID=transcript_8498;Q8N302 O00581 Q53YS3 Q9BU84 Q9NW66,Angiogenic factor with G patch and FHA domains 1,Angiogenic factor VG5Q;G patch domain-containing protein 7;Vasculogenesis gene on 5q protein;, PF00498;PF01585;PF17780;, GO:0005737;GO:0005576;GO:0048471;GO:0003676;GO:0001525;GO:0007155;GO:0045766;GO:0001938;GO:0001570;, C:cytoplasm; C:extracellular region; C:perinuclear region of cytoplasm;, F:nucleic acid binding;, P:angiogenesis; P:cell adhesion; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:vasculogenesis;|Q8N302 O00581 Q53YS3 Q9BU84 Q9NW66,Angiogenic factor with G patch and FHA domains 1,Angiogenic factor VG5Q;G patch domain-containing protein 7;Vasculogenesis gene on 5q protein;, PF00498;PF01585;PF17780;, GO:0005737;GO:0005576;GO:0048471;GO:0003676;GO:0001525;GO:0007155;GO:0045766;GO:0001938;GO:0001570;, C:cytoplasm; C:extracellular region; C:perinuclear region of cytoplasm;, F:nucleic acid binding;, P:angiogenesis; P:cell adhesion; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:vasculogenesis;|Q8N302 O00581 Q53YS3 Q9BU84 Q9NW66,Angiogenic factor with G patch and FHA domains 1,Angiogenic factor VG5Q;G patch domain-containing protein 7;Vasculogenesis gene on 5q protein;, PF00498;PF01585;PF17780;, GO:0005737;GO:0005576;GO:0048471;GO:0003676;GO:0001525;GO:0007155;GO:0045766;GO:0001938;GO:0001570;, C:cytoplasm; C:extracellular region; C:perinuclear region of cytoplasm;, F:nucleic acid binding;, P:angiogenesis; P:cell adhesion; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:vasculogenesis; scaffold42 indexed_genome mRNA 7912546 8052237 . + . ID=transcript_8499;O95263 Q5J7V7 Q86XK8 Q8IUJ7 Q8IUJ8 Q8IUJ9 Q8IUK0 Q8N3T2,High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B,Cell proliferation-inducing gene 22 protein;, PF13426;PF08629;PF00233;, GO:0005829;GO:0004115;GO:0004114;GO:0046872;GO:0006198;GO:0007186;GO:0007165;, C:cytosol;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:G protein-coupled receptor signaling pathway; P:signal transduction;|Q9UMB7 Q9UMC3,High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A,, PF00989;PF00233;, GO:0005829;GO:0070062;GO:0004115;GO:0047555;GO:0004114;GO:0019900;GO:0046872;GO:0006198;GO:0071364;GO:0007186;GO:0060548;GO:1903206;GO:0070374;GO:0001934;GO:0006355;GO:0007165;, C:cytosol; C:extracellular exosome;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:kinase binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to epidermal growth factor stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of cell death; P:negative regulation of hydrogen peroxide-induced cell death; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:signal transduction;|Q9HAD4 B4DT55 Q7Z792 Q8IWG3 Q8IXA9 Q8NDA7 Q9NV62,WD repeat-containing protein 41 {ECO:0000305},, PF00400;, GO:0005737;GO:0032045;GO:0005765;GO:0006914;GO:0010506;GO:0050790;, C:cytoplasm; C:guanyl-nucleotide exchange factor complex; C:lysosomal membrane;, , P:autophagy; P:regulation of autophagy; P:regulation of catalytic activity;|Q9HAD4 B4DT55 Q7Z792 Q8IWG3 Q8IXA9 Q8NDA7 Q9NV62,WD repeat-containing protein 41 {ECO:0000305},, PF00400;, GO:0005737;GO:0032045;GO:0005765;GO:0006914;GO:0010506;GO:0050790;, C:cytoplasm; C:guanyl-nucleotide exchange factor complex; C:lysosomal membrane;, , P:autophagy; P:regulation of autophagy; P:regulation of catalytic activity;|Q9HAD4 B4DT55 Q7Z792 Q8IWG3 Q8IXA9 Q8NDA7 Q9NV62,WD repeat-containing protein 41 {ECO:0000305},, PF00400;, GO:0005737;GO:0032045;GO:0005765;GO:0006914;GO:0010506;GO:0050790;, C:cytoplasm; C:guanyl-nucleotide exchange factor complex; C:lysosomal membrane;, , P:autophagy; P:regulation of autophagy; P:regulation of catalytic activity;|Q9HAD4 B4DT55 Q7Z792 Q8IWG3 Q8IXA9 Q8NDA7 Q9NV62,WD repeat-containing protein 41 {ECO:0000305},, PF00400;, GO:0005737;GO:0032045;GO:0005765;GO:0006914;GO:0010506;GO:0050790;, C:cytoplasm; C:guanyl-nucleotide exchange factor complex; C:lysosomal membrane;, , P:autophagy; P:regulation of autophagy; P:regulation of catalytic activity;|Q9HAD4 B4DT55 Q7Z792 Q8IWG3 Q8IXA9 Q8NDA7 Q9NV62,WD repeat-containing protein 41 {ECO:0000305},, PF00400;, GO:0005737;GO:0032045;GO:0005765;GO:0006914;GO:0010506;GO:0050790;, C:cytoplasm; C:guanyl-nucleotide exchange factor complex; C:lysosomal membrane;, , P:autophagy; P:regulation of autophagy; P:regulation of catalytic activity;|Q9HAD4 B4DT55 Q7Z792 Q8IWG3 Q8IXA9 Q8NDA7 Q9NV62,WD repeat-containing protein 41 {ECO:0000305},, PF00400;, GO:0005737;GO:0032045;GO:0005765;GO:0006914;GO:0010506;GO:0050790;, C:cytoplasm; C:guanyl-nucleotide exchange factor complex; C:lysosomal membrane;, , P:autophagy; P:regulation of autophagy; P:regulation of catalytic activity;|Q9HAD4 B4DT55 Q7Z792 Q8IWG3 Q8IXA9 Q8NDA7 Q9NV62,WD repeat-containing protein 41 {ECO:0000305},, PF00400;, GO:0005737;GO:0032045;GO:0005765;GO:0006914;GO:0010506;GO:0050790;, C:cytoplasm; C:guanyl-nucleotide exchange factor complex; C:lysosomal membrane;, , P:autophagy; P:regulation of autophagy; P:regulation of catalytic activity; scaffold42 indexed_genome mRNA 8186516 8213484 . - . ID=transcript_8500;O75347 B4DT30,Tubulin-specific chaperone A,TCP1-chaperonin cofactor A;Tubulin-folding cofactor A;, PF02970;, GO:0005737;GO:0005829;GO:0005874;GO:0015630;GO:0005730;GO:0048487;GO:0051087;GO:0003723;GO:0015631;GO:0007023;GO:0006457;GO:0007021;, C:cytoplasm; C:cytosol; C:microtubule; C:microtubule cytoskeleton; C:nucleolus;, F:beta-tubulin binding; F:chaperone binding; F:RNA binding; F:tubulin binding;, P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|O75347 B4DT30,Tubulin-specific chaperone A,TCP1-chaperonin cofactor A;Tubulin-folding cofactor A;, PF02970;, GO:0005737;GO:0005829;GO:0005874;GO:0015630;GO:0005730;GO:0048487;GO:0051087;GO:0003723;GO:0015631;GO:0007023;GO:0006457;GO:0007021;, C:cytoplasm; C:cytosol; C:microtubule; C:microtubule cytoskeleton; C:nucleolus;, F:beta-tubulin binding; F:chaperone binding; F:RNA binding; F:tubulin binding;, P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|O75347 B4DT30,Tubulin-specific chaperone A,TCP1-chaperonin cofactor A;Tubulin-folding cofactor A;, PF02970;, GO:0005737;GO:0005829;GO:0005874;GO:0015630;GO:0005730;GO:0048487;GO:0051087;GO:0003723;GO:0015631;GO:0007023;GO:0006457;GO:0007021;, C:cytoplasm; C:cytosol; C:microtubule; C:microtubule cytoskeleton; C:nucleolus;, F:beta-tubulin binding; F:chaperone binding; F:RNA binding; F:tubulin binding;, P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly; scaffold42 indexed_genome mRNA 8478812 8559507 . - . ID=transcript_8501;O00203 E5RJ68 O00580 Q7Z393 Q9HD66,AP-3 complex subunit beta-1,Adaptor protein complex AP-3 subunit beta-1;Adaptor-related protein complex 3 subunit beta-1;Beta-3A-adaptin;Clathrin assembly protein complex 3 beta-1 large chain;, PF01602;PF14796;PF14797;, GO:0030123;GO:1904115;GO:0030131;GO:0030665;GO:0005794;GO:0005765;GO:0016020;GO:0005739;GO:0045202;GO:0030742;GO:0019903;GO:0008089;GO:0048490;GO:0048007;GO:0007596;GO:0000902;GO:0006464;GO:0006882;GO:0090152;GO:0030851;GO:0002244;GO:0048872;GO:0006954;GO:0006886;GO:0060425;GO:0007040;GO:0032438;GO:0042789;GO:0060155;GO:0051138;GO:0045944;GO:0034394;GO:0006622;GO:0050790;GO:0003016;GO:0007338;GO:0098773;GO:0007283;GO:0016182;GO:0002224;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin adaptor complex; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:lysosomal membrane; C:membrane; C:mitochondrion; C:synapse;, F:GTP-dependent protein binding; F:protein phosphatase binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:blood coagulation; P:cell morphogenesis; P:cellular protein modification process; P:cellular zinc ion homeostasis; P:establishment of protein localization to mitochondrial membrane involved in mitochondrial fission; P:granulocyte differentiation; P:hematopoietic progenitor cell differentiation; P:homeostasis of number of cells; P:inflammatory response; P:intracellular protein transport; P:lung morphogenesis; P:lysosome organization; P:melanosome organization; P:mRNA transcription by RNA polymerase II; P:platelet dense granule organization; P:positive regulation of NK T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to cell surface; P:protein targeting to lysosome; P:regulation of catalytic activity; P:respiratory system process; P:single fertilization; P:skin epidermis development; P:spermatogenesis; P:synaptic vesicle budding from endosome; P:toll-like receptor signaling pathway; P:vesicle-mediated transport; scaffold42 indexed_genome mRNA 8568444 8709595 . - . ID=transcript_8502;O00203 E5RJ68 O00580 Q7Z393 Q9HD66,AP-3 complex subunit beta-1,Adaptor protein complex AP-3 subunit beta-1;Adaptor-related protein complex 3 subunit beta-1;Beta-3A-adaptin;Clathrin assembly protein complex 3 beta-1 large chain;, PF01602;PF14796;PF14797;, GO:0030123;GO:1904115;GO:0030131;GO:0030665;GO:0005794;GO:0005765;GO:0016020;GO:0005739;GO:0045202;GO:0030742;GO:0019903;GO:0008089;GO:0048490;GO:0048007;GO:0007596;GO:0000902;GO:0006464;GO:0006882;GO:0090152;GO:0030851;GO:0002244;GO:0048872;GO:0006954;GO:0006886;GO:0060425;GO:0007040;GO:0032438;GO:0042789;GO:0060155;GO:0051138;GO:0045944;GO:0034394;GO:0006622;GO:0050790;GO:0003016;GO:0007338;GO:0098773;GO:0007283;GO:0016182;GO:0002224;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin adaptor complex; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:lysosomal membrane; C:membrane; C:mitochondrion; C:synapse;, F:GTP-dependent protein binding; F:protein phosphatase binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:blood coagulation; P:cell morphogenesis; P:cellular protein modification process; P:cellular zinc ion homeostasis; P:establishment of protein localization to mitochondrial membrane involved in mitochondrial fission; P:granulocyte differentiation; P:hematopoietic progenitor cell differentiation; P:homeostasis of number of cells; P:inflammatory response; P:intracellular protein transport; P:lung morphogenesis; P:lysosome organization; P:melanosome organization; P:mRNA transcription by RNA polymerase II; P:platelet dense granule organization; P:positive regulation of NK T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to cell surface; P:protein targeting to lysosome; P:regulation of catalytic activity; P:respiratory system process; P:single fertilization; P:skin epidermis development; P:spermatogenesis; P:synaptic vesicle budding from endosome; P:toll-like receptor signaling pathway; P:vesicle-mediated transport; scaffold42 indexed_genome mRNA 8776742 8901346 . + . ID=transcript_8503;O15126 O43587 Q6FG23 Q96BX1 Q96QK5,Secretory carrier-associated membrane protein 1,, PF04144;, GO:0030136;GO:0016021;GO:0005886;GO:0055038;GO:0035579;GO:0030672;GO:0005802;GO:0032588;GO:0042589;GO:0043312;GO:0006892;GO:0015031;, C:clathrin-coated vesicle; C:integral component of membrane; C:plasma membrane; C:recycling endosome membrane; C:specific granule membrane; C:synaptic vesicle membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:zymogen granule membrane;, , P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; P:protein transport; scaffold42 indexed_genome mRNA 8909180 8934074 . - . ID=transcript_8504;Q6ZUX7 B2RMQ6 Q7Z5P0 Q92605,LHFPL tetraspan subfamily member 2 protein {ECO:0000312|HGNC:HGNC:6588},Lipoma HMGIC fusion partner-like 2 protein {ECO:0000312|HGNC:HGNC:6588};, PF10242;, GO:0016021;GO:0016020;GO:0005886;GO:0031092;GO:0046545;GO:0046546;GO:0002576;GO:1905516;GO:0007338;, C:integral component of membrane; C:membrane; C:plasma membrane; C:platelet alpha granule membrane;, , P:development of primary female sexual characteristics; P:development of primary male sexual characteristics; P:platelet degranulation; P:positive regulation of fertilization; P:single fertilization; scaffold42 indexed_genome mRNA 9197441 9340323 . + . ID=transcript_8505;P15848 B2RC20 Q8N322 Q9UDI9,Arylsulfatase B,N-acetylgalactosamine-4-sulfatase;, PF00884;, GO:0035578;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:1904813;GO:0005794;GO:0043202;GO:0005764;GO:0005739;GO:0005791;GO:0004065;GO:0046872;GO:0003943;GO:0006914;GO:0007417;GO:0030207;GO:0061580;GO:0007041;GO:0007040;GO:0043312;GO:0010976;GO:0010632;GO:0043627;GO:0051597;GO:0007584;GO:0009268;, C:azurophil granule lumen; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:lysosomal lumen; C:lysosome; C:mitochondrion; C:rough endoplasmic reticulum;, F:arylsulfatase activity; F:metal ion binding; F:N-acetylgalactosamine-4-sulfatase activity;, P:autophagy; P:central nervous system development; P:chondroitin sulfate catabolic process; P:colon epithelial cell migration; P:lysosomal transport; P:lysosome organization; P:neutrophil degranulation; P:positive regulation of neuron projection development; P:regulation of epithelial cell migration; P:response to estrogen; P:response to methylmercury; P:response to nutrient; P:response to pH; scaffold42 indexed_genome mRNA 9371182 9374013 . + . ID=transcript_8506;Q9UI17 B2RBN0 B4E1J9,Dimethylglycine dehydrogenase, mitochondrial,ME2GLYDH;, PF01266;PF16350;PF01571;PF08669;, GO:0005737;GO:0005759;GO:0005739;GO:0047865;GO:0009055;GO:0016491;GO:0003723;GO:0006579;GO:0042426;GO:0019695;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:dimethylglycine dehydrogenase activity; F:electron transfer activity; F:oxidoreductase activity; F:RNA binding;, P:amino-acid betaine catabolic process; P:choline catabolic process; P:choline metabolic process; scaffold42 indexed_genome mRNA 9378045 9460277 . - . ID=transcript_8507;Q9UI17 B2RBN0 B4E1J9,Dimethylglycine dehydrogenase, mitochondrial,ME2GLYDH;, PF01266;PF16350;PF01571;PF08669;, GO:0005737;GO:0005759;GO:0005739;GO:0047865;GO:0009055;GO:0016491;GO:0003723;GO:0006579;GO:0042426;GO:0019695;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:dimethylglycine dehydrogenase activity; F:electron transfer activity; F:oxidoreductase activity; F:RNA binding;, P:amino-acid betaine catabolic process; P:choline catabolic process; P:choline metabolic process;|Q9H2M3 B7Z516 Q9NXX7,S-methylmethionine--homocysteine S-methyltransferase BHMT2,Betaine--homocysteine S-methyltransferase 2;, PF02574;, GO:0005829;GO:0070062;GO:0061627;GO:0008270;GO:0071267;GO:0032259;GO:0046500;GO:0033477;GO:0000096;, C:cytosol; C:extracellular exosome;, F:S-methylmethionine-homocysteine S-methyltransferase activity; F:zinc ion binding;, P:L-methionine salvage; P:methylation; P:S-adenosylmethionine metabolic process; P:S-methylmethionine metabolic process; P:sulfur amino acid metabolic process;|Q9H2M3 B7Z516 Q9NXX7,S-methylmethionine--homocysteine S-methyltransferase BHMT2,Betaine--homocysteine S-methyltransferase 2;, PF02574;, GO:0005829;GO:0070062;GO:0061627;GO:0008270;GO:0071267;GO:0032259;GO:0046500;GO:0033477;GO:0000096;, C:cytosol; C:extracellular exosome;, F:S-methylmethionine-homocysteine S-methyltransferase activity; F:zinc ion binding;, P:L-methionine salvage; P:methylation; P:S-adenosylmethionine metabolic process; P:S-methylmethionine metabolic process; P:sulfur amino acid metabolic process;|Q9H2M3 B7Z516 Q9NXX7,S-methylmethionine--homocysteine S-methyltransferase BHMT2,Betaine--homocysteine S-methyltransferase 2;, PF02574;, GO:0005829;GO:0070062;GO:0061627;GO:0008270;GO:0071267;GO:0032259;GO:0046500;GO:0033477;GO:0000096;, C:cytosol; C:extracellular exosome;, F:S-methylmethionine-homocysteine S-methyltransferase activity; F:zinc ion binding;, P:L-methionine salvage; P:methylation; P:S-adenosylmethionine metabolic process; P:S-methylmethionine metabolic process; P:sulfur amino acid metabolic process;|Q9H2M3 B7Z516 Q9NXX7,S-methylmethionine--homocysteine S-methyltransferase BHMT2,Betaine--homocysteine S-methyltransferase 2;, PF02574;, GO:0005829;GO:0070062;GO:0061627;GO:0008270;GO:0071267;GO:0032259;GO:0046500;GO:0033477;GO:0000096;, C:cytosol; C:extracellular exosome;, F:S-methylmethionine-homocysteine S-methyltransferase activity; F:zinc ion binding;, P:L-methionine salvage; P:methylation; P:S-adenosylmethionine metabolic process; P:S-methylmethionine metabolic process; P:sulfur amino acid metabolic process; scaffold42 indexed_genome mRNA 9644620 9667559 . + . ID=transcript_8508;Q8N9B5 A1L4P5 B5MDS2 B5MDT0,Junction-mediating and -regulatory protein,, PF15871;PF15920;, GO:0031252;GO:0005737;GO:0005856;GO:0005654;GO:0005634;GO:0003779;GO:0071933;GO:0003713;GO:0070060;GO:0070358;GO:0034314;GO:0007050;GO:0006281;GO:0072332;GO:0043065;GO:0051091;GO:1901796;GO:0006357;, C:cell leading edge; C:cytoplasm; C:cytoskeleton; C:nucleoplasm; C:nucleus;, F:actin binding; F:Arp2/3 complex binding; F:transcription coactivator activity;, P:'de novo' actin filament nucleation; P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:cell cycle arrest; P:DNA repair; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; scaffold42 indexed_genome mRNA 9668299 9669347 . + . ID=transcript_8509;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold42 indexed_genome mRNA 9699738 9829747 . - . ID=transcript_8510;Q86YM7 B2R688 O96003 Q86YM5,Homer protein homolog 1 {ECO:0000305},, PF00568;, GO:0045177;GO:0030424;GO:0043034;GO:0005737;GO:0005829;GO:0030425;GO:0043197;GO:0098978;GO:0044309;GO:0005886;GO:0099524;GO:0014069;GO:0030018;GO:0035256;GO:0044325;GO:0035591;GO:0048148;GO:0048875;GO:0007268;GO:0007216;GO:0007206;GO:0051928;GO:0009967;GO:0051262;GO:0090279;GO:2001257;GO:1902950;GO:0098962;GO:2001256;GO:0051966;GO:0051592;GO:0003009;GO:0048741;, C:apical part of cell; C:axon; C:costamere; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:neuron spine; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic density; C:Z disc;, F:G protein-coupled glutamate receptor binding; F:ion channel binding; F:signaling adaptor activity;, P:behavioral response to cocaine; P:chemical homeostasis within a tissue; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:phospholipase C-activating G protein-coupled glutamate receptor signaling pathway; P:positive regulation of calcium ion transport; P:positive regulation of signal transduction; P:protein tetramerization; P:regulation of calcium ion import; P:regulation of cation channel activity; P:regulation of dendritic spine maintenance; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of store-operated calcium entry; P:regulation of synaptic transmission, glutamatergic; P:response to calcium ion; P:skeletal muscle contraction; P:skeletal muscle fiber development;|Q86YM7 B2R688 O96003 Q86YM5,Homer protein homolog 1 {ECO:0000305},, PF00568;, GO:0045177;GO:0030424;GO:0043034;GO:0005737;GO:0005829;GO:0030425;GO:0043197;GO:0098978;GO:0044309;GO:0005886;GO:0099524;GO:0014069;GO:0030018;GO:0035256;GO:0044325;GO:0035591;GO:0048148;GO:0048875;GO:0007268;GO:0007216;GO:0007206;GO:0051928;GO:0009967;GO:0051262;GO:0090279;GO:2001257;GO:1902950;GO:0098962;GO:2001256;GO:0051966;GO:0051592;GO:0003009;GO:0048741;, C:apical part of cell; C:axon; C:costamere; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:neuron spine; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic density; C:Z disc;, F:G protein-coupled glutamate receptor binding; F:ion channel binding; F:signaling adaptor activity;, P:behavioral response to cocaine; P:chemical homeostasis within a tissue; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:phospholipase C-activating G protein-coupled glutamate receptor signaling pathway; P:positive regulation of calcium ion transport; P:positive regulation of signal transduction; P:protein tetramerization; P:regulation of calcium ion import; P:regulation of cation channel activity; P:regulation of dendritic spine maintenance; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of store-operated calcium entry; P:regulation of synaptic transmission, glutamatergic; P:response to calcium ion; P:skeletal muscle contraction; P:skeletal muscle fiber development;|Q86YM7 B2R688 O96003 Q86YM5,Homer protein homolog 1 {ECO:0000305},, PF00568;, GO:0045177;GO:0030424;GO:0043034;GO:0005737;GO:0005829;GO:0030425;GO:0043197;GO:0098978;GO:0044309;GO:0005886;GO:0099524;GO:0014069;GO:0030018;GO:0035256;GO:0044325;GO:0035591;GO:0048148;GO:0048875;GO:0007268;GO:0007216;GO:0007206;GO:0051928;GO:0009967;GO:0051262;GO:0090279;GO:2001257;GO:1902950;GO:0098962;GO:2001256;GO:0051966;GO:0051592;GO:0003009;GO:0048741;, C:apical part of cell; C:axon; C:costamere; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:neuron spine; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic density; C:Z disc;, F:G protein-coupled glutamate receptor binding; F:ion channel binding; F:signaling adaptor activity;, P:behavioral response to cocaine; P:chemical homeostasis within a tissue; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:phospholipase C-activating G protein-coupled glutamate receptor signaling pathway; P:positive regulation of calcium ion transport; P:positive regulation of signal transduction; P:protein tetramerization; P:regulation of calcium ion import; P:regulation of cation channel activity; P:regulation of dendritic spine maintenance; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of store-operated calcium entry; P:regulation of synaptic transmission, glutamatergic; P:response to calcium ion; P:skeletal muscle contraction; P:skeletal muscle fiber development; scaffold42 indexed_genome mRNA 9903679 9966921 . + . ID=transcript_8511;Q6PIY7 Q86WZ2 Q8N927,Poly(A) RNA polymerase GLD2 {ECO:0000305},PAP-associated domain-containing protein 4;Terminal nucleotidyltransferase 2 {ECO:0000312|HGNC:HGNC:26776};Terminal uridylyltransferase 2;, PF03828;, GO:0005737;GO:0005829;GO:0031380;GO:0005634;GO:0034062;GO:0070566;GO:0005524;GO:0046872;GO:0016779;GO:0004652;GO:1990603;GO:0002244;GO:0021766;GO:0071044;GO:0006378;GO:0006397;GO:2000626;GO:0030182;GO:0060041;GO:0043631;GO:0043489;, C:cytoplasm; C:cytosol; C:nuclear RNA-directed RNA polymerase complex; C:nucleus;, F:5'-3' RNA polymerase activity; F:adenylyltransferase activity; F:ATP binding; F:metal ion binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity;, P:dark adaptation; P:hematopoietic progenitor cell differentiation; P:hippocampus development; P:histone mRNA catabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of miRNA catabolic process; P:neuron differentiation; P:retina development in camera-type eye; P:RNA polyadenylation; P:RNA stabilization;|Q6PIY7 Q86WZ2 Q8N927,Poly(A) RNA polymerase GLD2 {ECO:0000305},PAP-associated domain-containing protein 4;Terminal nucleotidyltransferase 2 {ECO:0000312|HGNC:HGNC:26776};Terminal uridylyltransferase 2;, PF03828;, GO:0005737;GO:0005829;GO:0031380;GO:0005634;GO:0034062;GO:0070566;GO:0005524;GO:0046872;GO:0016779;GO:0004652;GO:1990603;GO:0002244;GO:0021766;GO:0071044;GO:0006378;GO:0006397;GO:2000626;GO:0030182;GO:0060041;GO:0043631;GO:0043489;, C:cytoplasm; C:cytosol; C:nuclear RNA-directed RNA polymerase complex; C:nucleus;, F:5'-3' RNA polymerase activity; F:adenylyltransferase activity; F:ATP binding; F:metal ion binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity;, P:dark adaptation; P:hematopoietic progenitor cell differentiation; P:hippocampus development; P:histone mRNA catabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of miRNA catabolic process; P:neuron differentiation; P:retina development in camera-type eye; P:RNA polyadenylation; P:RNA stabilization;|Q6PIY7 Q86WZ2 Q8N927,Poly(A) RNA polymerase GLD2 {ECO:0000305},PAP-associated domain-containing protein 4;Terminal nucleotidyltransferase 2 {ECO:0000312|HGNC:HGNC:26776};Terminal uridylyltransferase 2;, PF03828;, GO:0005737;GO:0005829;GO:0031380;GO:0005634;GO:0034062;GO:0070566;GO:0005524;GO:0046872;GO:0016779;GO:0004652;GO:1990603;GO:0002244;GO:0021766;GO:0071044;GO:0006378;GO:0006397;GO:2000626;GO:0030182;GO:0060041;GO:0043631;GO:0043489;, C:cytoplasm; C:cytosol; C:nuclear RNA-directed RNA polymerase complex; C:nucleus;, F:5'-3' RNA polymerase activity; F:adenylyltransferase activity; F:ATP binding; F:metal ion binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity;, P:dark adaptation; P:hematopoietic progenitor cell differentiation; P:hippocampus development; P:histone mRNA catabolic process; P:mRNA polyadenylation; P:mRNA processing; P:negative regulation of miRNA catabolic process; P:neuron differentiation; P:retina development in camera-type eye; P:RNA polyadenylation; P:RNA stabilization; scaffold42 indexed_genome mRNA 10018812 10019851 . + . ID=transcript_8512;Q7Z4I1 Q86T34 Q86T49 Q8N3S4 Q8N3S7 Q8NAG8 Q9UK88,Cardiomyopathy-associated protein 5,Dystrobrevin-binding protein 2;Genethonin-3;Myospryn {ECO:0000303|PubMed:14688250};SPRY domain-containing protein 2;Tripartite motif-containing protein 76;, PF00041;, GO:0005829;GO:0043231;GO:0031430;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0016529;, C:cytosol; C:intracellular membrane-bounded organelle; C:M band; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcoplasmic reticulum; scaffold42 indexed_genome mRNA 10021188 10071930 . + . ID=transcript_8513;Q7Z4I1 Q86T34 Q86T49 Q8N3S4 Q8N3S7 Q8NAG8 Q9UK88,Cardiomyopathy-associated protein 5,Dystrobrevin-binding protein 2;Genethonin-3;Myospryn {ECO:0000303|PubMed:14688250};SPRY domain-containing protein 2;Tripartite motif-containing protein 76;, PF00041;, GO:0005829;GO:0043231;GO:0031430;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0016529;, C:cytosol; C:intracellular membrane-bounded organelle; C:M band; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcoplasmic reticulum;|Q7Z4I1 Q86T34 Q86T49 Q8N3S4 Q8N3S7 Q8NAG8 Q9UK88,Cardiomyopathy-associated protein 5,Dystrobrevin-binding protein 2;Genethonin-3;Myospryn {ECO:0000303|PubMed:14688250};SPRY domain-containing protein 2;Tripartite motif-containing protein 76;, PF00041;, GO:0005829;GO:0043231;GO:0031430;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0016529;, C:cytosol; C:intracellular membrane-bounded organelle; C:M band; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcoplasmic reticulum; scaffold42 indexed_genome mRNA 10235428 10244423 . - . ID=transcript_8514;Q5HYI7 B4DL65 E9PB57 Q7Z380 Q8NB92,Metaxin-3,, PF17171;PF10568;, GO:0005737;GO:0140275;GO:0001401;GO:0007007;GO:0007005;GO:0015031;, C:cytoplasm; C:MIB complex; C:SAM complex;, , P:inner mitochondrial membrane organization; P:mitochondrion organization; P:protein transport;|Q5HYI7 B4DL65 E9PB57 Q7Z380 Q8NB92,Metaxin-3,, PF17171;PF10568;, GO:0005737;GO:0140275;GO:0001401;GO:0007007;GO:0007005;GO:0015031;, C:cytoplasm; C:MIB complex; C:SAM complex;, , P:inner mitochondrial membrane organization; P:mitochondrion organization; P:protein transport;|Q5HYI7 B4DL65 E9PB57 Q7Z380 Q8NB92,Metaxin-3,, PF17171;PF10568;, GO:0005737;GO:0140275;GO:0001401;GO:0007007;GO:0007005;GO:0015031;, C:cytoplasm; C:MIB complex; C:SAM complex;, , P:inner mitochondrial membrane organization; P:mitochondrion organization; P:protein transport; scaffold42 indexed_genome mRNA 10286347 10339356 . + . ID=transcript_8515;P35443 B2R909 Q86TG2,Thrombospondin-4,, PF11598;PF07645;PF02412;PF05735;, GO:0005604;GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0016529;GO:0005509;GO:0008083;GO:0008201;GO:0005178;GO:0048266;GO:0071603;GO:0051451;GO:0016525;GO:0051781;GO:0001938;GO:0090023;GO:0050731;GO:0034103;GO:0034976;GO:0006986;GO:0048771;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:sarcoplasmic reticulum;, F:calcium ion binding; F:growth factor activity; F:heparin binding; F:integrin binding;, P:behavioral response to pain; P:endothelial cell-cell adhesion; P:myoblast migration; P:negative regulation of angiogenesis; P:positive regulation of cell division; P:positive regulation of endothelial cell proliferation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:regulation of tissue remodeling; P:response to endoplasmic reticulum stress; P:response to unfolded protein; P:tissue remodeling; scaffold42 indexed_genome mRNA 10394410 10396330 . - . ID=transcript_8516;Q86VE9 B4DMH7 Q495A4 Q495A6,Serine incorporator 5 {ECO:0000305},, PF03348;, GO:0005813;GO:0005829;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0043209;GO:0048471;GO:0005886;GO:0051607;GO:0009597;GO:0045087;GO:0006564;GO:0042552;GO:0006658;GO:0008654;GO:1904219;GO:1904222;GO:0006665;GO:0016032;, C:centrosome; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:myelin sheath; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:defense response to virus; P:detection of virus; P:innate immune response; P:L-serine biosynthetic process; P:myelination; P:phosphatidylserine metabolic process; P:phospholipid biosynthetic process; P:positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity; P:positive regulation of serine C-palmitoyltransferase activity; P:sphingolipid metabolic process; P:viral process;|Q86VE9 B4DMH7 Q495A4 Q495A6,Serine incorporator 5 {ECO:0000305},, PF03348;, GO:0005813;GO:0005829;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0043209;GO:0048471;GO:0005886;GO:0051607;GO:0009597;GO:0045087;GO:0006564;GO:0042552;GO:0006658;GO:0008654;GO:1904219;GO:1904222;GO:0006665;GO:0016032;, C:centrosome; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:myelin sheath; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:defense response to virus; P:detection of virus; P:innate immune response; P:L-serine biosynthetic process; P:myelination; P:phosphatidylserine metabolic process; P:phospholipid biosynthetic process; P:positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity; P:positive regulation of serine C-palmitoyltransferase activity; P:sphingolipid metabolic process; P:viral process; scaffold42 indexed_genome mRNA 10668758 10681685 . + . ID=transcript_8517;Q96EK6,Glucosamine 6-phosphate N-acetyltransferase,Phosphoglucosamine acetylase;Phosphoglucosamine transacetylase;, PF00583;, GO:0005829;GO:0005783;GO:0005793;GO:0010008;GO:0005794;GO:0000139;GO:0004343;GO:0042802;GO:0048029;GO:0008080;GO:0006041;GO:0001889;GO:0006044;GO:0006048;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane;, F:glucosamine 6-phosphate N-acetyltransferase activity; F:identical protein binding; F:monosaccharide binding; F:N-acetyltransferase activity;, P:glucosamine metabolic process; P:liver development; P:N-acetylglucosamine metabolic process; P:UDP-N-acetylglucosamine biosynthetic process;|Q96EK6,Glucosamine 6-phosphate N-acetyltransferase,Phosphoglucosamine acetylase;Phosphoglucosamine transacetylase;, PF00583;, GO:0005829;GO:0005783;GO:0005793;GO:0010008;GO:0005794;GO:0000139;GO:0004343;GO:0042802;GO:0048029;GO:0008080;GO:0006041;GO:0001889;GO:0006044;GO:0006048;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane;, F:glucosamine 6-phosphate N-acetyltransferase activity; F:identical protein binding; F:monosaccharide binding; F:N-acetyltransferase activity;, P:glucosamine metabolic process; P:liver development; P:N-acetylglucosamine metabolic process; P:UDP-N-acetylglucosamine biosynthetic process;|Q96EK6,Glucosamine 6-phosphate N-acetyltransferase,Phosphoglucosamine acetylase;Phosphoglucosamine transacetylase;, PF00583;, GO:0005829;GO:0005783;GO:0005793;GO:0010008;GO:0005794;GO:0000139;GO:0004343;GO:0042802;GO:0048029;GO:0008080;GO:0006041;GO:0001889;GO:0006044;GO:0006048;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane;, F:glucosamine 6-phosphate N-acetyltransferase activity; F:identical protein binding; F:monosaccharide binding; F:N-acetyltransferase activity;, P:glucosamine metabolic process; P:liver development; P:N-acetylglucosamine metabolic process; P:UDP-N-acetylglucosamine biosynthetic process;|Q96EK6,Glucosamine 6-phosphate N-acetyltransferase,Phosphoglucosamine acetylase;Phosphoglucosamine transacetylase;, PF00583;, GO:0005829;GO:0005783;GO:0005793;GO:0010008;GO:0005794;GO:0000139;GO:0004343;GO:0042802;GO:0048029;GO:0008080;GO:0006041;GO:0001889;GO:0006044;GO:0006048;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane;, F:glucosamine 6-phosphate N-acetyltransferase activity; F:identical protein binding; F:monosaccharide binding; F:N-acetyltransferase activity;, P:glucosamine metabolic process; P:liver development; P:N-acetylglucosamine metabolic process; P:UDP-N-acetylglucosamine biosynthetic process;|Q96EK6,Glucosamine 6-phosphate N-acetyltransferase,Phosphoglucosamine acetylase;Phosphoglucosamine transacetylase;, PF00583;, GO:0005829;GO:0005783;GO:0005793;GO:0010008;GO:0005794;GO:0000139;GO:0004343;GO:0042802;GO:0048029;GO:0008080;GO:0006041;GO:0001889;GO:0006044;GO:0006048;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane;, F:glucosamine 6-phosphate N-acetyltransferase activity; F:identical protein binding; F:monosaccharide binding; F:N-acetyltransferase activity;, P:glucosamine metabolic process; P:liver development; P:N-acetylglucosamine metabolic process; P:UDP-N-acetylglucosamine biosynthetic process; scaffold42 indexed_genome mRNA 10684791 10727722 . + . ID=transcript_8518;Q8WUJ0 B9EJG0 Q99850,Serine/threonine/tyrosine-interacting protein {ECO:0000305},Inactive tyrosine-protein phosphatase STYX {ECO:0000305};Phosphoserine/threonine/tyrosine interaction protein {ECO:0000250|UniProtKB:Q60969};, , GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:1990444;GO:0008138;GO:0001691;GO:0045204;GO:0032091;GO:0062026;GO:0070372;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:F-box domain binding; F:protein tyrosine/serine/threonine phosphatase activity; F:pseudophosphatase activity;, P:MAPK export from nucleus; P:negative regulation of protein binding; P:negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process; P:regulation of ERK1 and ERK2 cascade;|Q8WUJ0 B9EJG0 Q99850,Serine/threonine/tyrosine-interacting protein {ECO:0000305},Inactive tyrosine-protein phosphatase STYX {ECO:0000305};Phosphoserine/threonine/tyrosine interaction protein {ECO:0000250|UniProtKB:Q60969};, , GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:1990444;GO:0008138;GO:0001691;GO:0045204;GO:0032091;GO:0062026;GO:0070372;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:F-box domain binding; F:protein tyrosine/serine/threonine phosphatase activity; F:pseudophosphatase activity;, P:MAPK export from nucleus; P:negative regulation of protein binding; P:negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process; P:regulation of ERK1 and ERK2 cascade;|Q8WUJ0 B9EJG0 Q99850,Serine/threonine/tyrosine-interacting protein {ECO:0000305},Inactive tyrosine-protein phosphatase STYX {ECO:0000305};Phosphoserine/threonine/tyrosine interaction protein {ECO:0000250|UniProtKB:Q60969};, , GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:1990444;GO:0008138;GO:0001691;GO:0045204;GO:0032091;GO:0062026;GO:0070372;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:F-box domain binding; F:protein tyrosine/serine/threonine phosphatase activity; F:pseudophosphatase activity;, P:MAPK export from nucleus; P:negative regulation of protein binding; P:negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process; P:regulation of ERK1 and ERK2 cascade;|Q8WUJ0 B9EJG0 Q99850,Serine/threonine/tyrosine-interacting protein {ECO:0000305},Inactive tyrosine-protein phosphatase STYX {ECO:0000305};Phosphoserine/threonine/tyrosine interaction protein {ECO:0000250|UniProtKB:Q60969};, , GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:1990444;GO:0008138;GO:0001691;GO:0045204;GO:0032091;GO:0062026;GO:0070372;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:F-box domain binding; F:protein tyrosine/serine/threonine phosphatase activity; F:pseudophosphatase activity;, P:MAPK export from nucleus; P:negative regulation of protein binding; P:negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process; P:regulation of ERK1 and ERK2 cascade; scaffold42 indexed_genome mRNA 10729144 10753265 . - . ID=transcript_8519;P62333 B2R975 P49719 Q6IBU3 Q92524,26S proteasome regulatory subunit 10B,26S proteasome AAA-ATPase subunit RPT4;Proteasome 26S subunit ATPase 6;Proteasome subunit p42;, PF00004;PF17862;PF16450;, GO:0005829;GO:0031597;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0030674;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0030433;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity; F:protein-macromolecule adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P62333 B2R975 P49719 Q6IBU3 Q92524,26S proteasome regulatory subunit 10B,26S proteasome AAA-ATPase subunit RPT4;Proteasome 26S subunit ATPase 6;Proteasome subunit p42;, PF00004;PF17862;PF16450;, GO:0005829;GO:0031597;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0030674;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0030433;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity; F:protein-macromolecule adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P62333 B2R975 P49719 Q6IBU3 Q92524,26S proteasome regulatory subunit 10B,26S proteasome AAA-ATPase subunit RPT4;Proteasome 26S subunit ATPase 6;Proteasome subunit p42;, PF00004;PF17862;PF16450;, GO:0005829;GO:0031597;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0030674;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0030433;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity; F:protein-macromolecule adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P62333 B2R975 P49719 Q6IBU3 Q92524,26S proteasome regulatory subunit 10B,26S proteasome AAA-ATPase subunit RPT4;Proteasome 26S subunit ATPase 6;Proteasome subunit p42;, PF00004;PF17862;PF16450;, GO:0005829;GO:0031597;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0030674;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0030433;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity; F:protein-macromolecule adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P62333 B2R975 P49719 Q6IBU3 Q92524,26S proteasome regulatory subunit 10B,26S proteasome AAA-ATPase subunit RPT4;Proteasome 26S subunit ATPase 6;Proteasome subunit p42;, PF00004;PF17862;PF16450;, GO:0005829;GO:0031597;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0030674;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0030433;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity; F:protein-macromolecule adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P62333 B2R975 P49719 Q6IBU3 Q92524,26S proteasome regulatory subunit 10B,26S proteasome AAA-ATPase subunit RPT4;Proteasome 26S subunit ATPase 6;Proteasome subunit p42;, PF00004;PF17862;PF16450;, GO:0005829;GO:0031597;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0030674;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0030433;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity; F:protein-macromolecule adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|P62333 B2R975 P49719 Q6IBU3 Q92524,26S proteasome regulatory subunit 10B,26S proteasome AAA-ATPase subunit RPT4;Proteasome 26S subunit ATPase 6;Proteasome subunit p42;, PF00004;PF17862;PF16450;, GO:0005829;GO:0031597;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0042802;GO:0036402;GO:0030674;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0030433;GO:0006511;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:proteasome-activating ATPase activity; F:protein-macromolecule adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold42 indexed_genome mRNA 10765576 10808656 . + . ID=transcript_8520;Q96HE7 A8K9X4 A8MYW1 Q7LD45 Q9P1Q9 Q9UKV6,ERO1-like protein alpha,Endoplasmic oxidoreductin-1-like protein;Endoplasmic reticulum oxidoreductase alpha {ECO:0000312|HGNC:HGNC:13280};Oxidoreductin-1-L-alpha;, PF04137;, GO:0030425;GO:0005783;GO:0005788;GO:0005789;GO:0043231;GO:0016020;GO:0016491;GO:0016671;GO:0003756;GO:0015035;GO:0010260;GO:0050873;GO:0045454;GO:0006464;GO:0071456;GO:0034599;GO:0051085;GO:0030968;GO:0030198;GO:0070059;GO:0018401;GO:0006457;GO:0034975;GO:0022417;GO:0051209;GO:0034976;GO:0009266;, C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity;, P:animal organ senescence; P:brown fat cell differentiation; P:cell redox homeostasis; P:cellular protein modification process; P:cellular response to hypoxia; P:cellular response to oxidative stress; P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum unfolded protein response; P:extracellular matrix organization; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein maturation by protein folding; P:release of sequestered calcium ion into cytosol; P:response to endoplasmic reticulum stress; P:response to temperature stimulus;|Q96HE7 A8K9X4 A8MYW1 Q7LD45 Q9P1Q9 Q9UKV6,ERO1-like protein alpha,Endoplasmic oxidoreductin-1-like protein;Endoplasmic reticulum oxidoreductase alpha {ECO:0000312|HGNC:HGNC:13280};Oxidoreductin-1-L-alpha;, PF04137;, GO:0030425;GO:0005783;GO:0005788;GO:0005789;GO:0043231;GO:0016020;GO:0016491;GO:0016671;GO:0003756;GO:0015035;GO:0010260;GO:0050873;GO:0045454;GO:0006464;GO:0071456;GO:0034599;GO:0051085;GO:0030968;GO:0030198;GO:0070059;GO:0018401;GO:0006457;GO:0034975;GO:0022417;GO:0051209;GO:0034976;GO:0009266;, C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity;, P:animal organ senescence; P:brown fat cell differentiation; P:cell redox homeostasis; P:cellular protein modification process; P:cellular response to hypoxia; P:cellular response to oxidative stress; P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum unfolded protein response; P:extracellular matrix organization; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein maturation by protein folding; P:release of sequestered calcium ion into cytosol; P:response to endoplasmic reticulum stress; P:response to temperature stimulus;|Q96HE7 A8K9X4 A8MYW1 Q7LD45 Q9P1Q9 Q9UKV6,ERO1-like protein alpha,Endoplasmic oxidoreductin-1-like protein;Endoplasmic reticulum oxidoreductase alpha {ECO:0000312|HGNC:HGNC:13280};Oxidoreductin-1-L-alpha;, PF04137;, GO:0030425;GO:0005783;GO:0005788;GO:0005789;GO:0043231;GO:0016020;GO:0016491;GO:0016671;GO:0003756;GO:0015035;GO:0010260;GO:0050873;GO:0045454;GO:0006464;GO:0071456;GO:0034599;GO:0051085;GO:0030968;GO:0030198;GO:0070059;GO:0018401;GO:0006457;GO:0034975;GO:0022417;GO:0051209;GO:0034976;GO:0009266;, C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity;, P:animal organ senescence; P:brown fat cell differentiation; P:cell redox homeostasis; P:cellular protein modification process; P:cellular response to hypoxia; P:cellular response to oxidative stress; P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum unfolded protein response; P:extracellular matrix organization; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein maturation by protein folding; P:release of sequestered calcium ion into cytosol; P:response to endoplasmic reticulum stress; P:response to temperature stimulus; scaffold42 indexed_genome mRNA 10812210 10817862 . + . ID=transcript_8521;Q96HE7 A8K9X4 A8MYW1 Q7LD45 Q9P1Q9 Q9UKV6,ERO1-like protein alpha,Endoplasmic oxidoreductin-1-like protein;Endoplasmic reticulum oxidoreductase alpha {ECO:0000312|HGNC:HGNC:13280};Oxidoreductin-1-L-alpha;, PF04137;, GO:0030425;GO:0005783;GO:0005788;GO:0005789;GO:0043231;GO:0016020;GO:0016491;GO:0016671;GO:0003756;GO:0015035;GO:0010260;GO:0050873;GO:0045454;GO:0006464;GO:0071456;GO:0034599;GO:0051085;GO:0030968;GO:0030198;GO:0070059;GO:0018401;GO:0006457;GO:0034975;GO:0022417;GO:0051209;GO:0034976;GO:0009266;, C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity;, P:animal organ senescence; P:brown fat cell differentiation; P:cell redox homeostasis; P:cellular protein modification process; P:cellular response to hypoxia; P:cellular response to oxidative stress; P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum unfolded protein response; P:extracellular matrix organization; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein maturation by protein folding; P:release of sequestered calcium ion into cytosol; P:response to endoplasmic reticulum stress; P:response to temperature stimulus;|Q96HE7 A8K9X4 A8MYW1 Q7LD45 Q9P1Q9 Q9UKV6,ERO1-like protein alpha,Endoplasmic oxidoreductin-1-like protein;Endoplasmic reticulum oxidoreductase alpha {ECO:0000312|HGNC:HGNC:13280};Oxidoreductin-1-L-alpha;, PF04137;, GO:0030425;GO:0005783;GO:0005788;GO:0005789;GO:0043231;GO:0016020;GO:0016491;GO:0016671;GO:0003756;GO:0015035;GO:0010260;GO:0050873;GO:0045454;GO:0006464;GO:0071456;GO:0034599;GO:0051085;GO:0030968;GO:0030198;GO:0070059;GO:0018401;GO:0006457;GO:0034975;GO:0022417;GO:0051209;GO:0034976;GO:0009266;, C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity;, P:animal organ senescence; P:brown fat cell differentiation; P:cell redox homeostasis; P:cellular protein modification process; P:cellular response to hypoxia; P:cellular response to oxidative stress; P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum unfolded protein response; P:extracellular matrix organization; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein maturation by protein folding; P:release of sequestered calcium ion into cytosol; P:response to endoplasmic reticulum stress; P:response to temperature stimulus; scaffold42 indexed_genome mRNA 10819131 10837783 . - . ID=transcript_8522;Q8N3F9 Q86SM2,Integral membrane protein GPR137C,Transmembrane 7 superfamily member 1-like 2 protein;, , GO:0016021;GO:0005765;GO:1904263;, C:integral component of membrane; C:lysosomal membrane;, , P:positive regulation of TORC1 signaling;|Q8N3F9 Q86SM2,Integral membrane protein GPR137C,Transmembrane 7 superfamily member 1-like 2 protein;, , GO:0016021;GO:0005765;GO:1904263;, C:integral component of membrane; C:lysosomal membrane;, , P:positive regulation of TORC1 signaling;|Q8N3F9 Q86SM2,Integral membrane protein GPR137C,Transmembrane 7 superfamily member 1-like 2 protein;, , GO:0016021;GO:0005765;GO:1904263;, C:integral component of membrane; C:lysosomal membrane;, , P:positive regulation of TORC1 signaling;|Q8N3F9 Q86SM2,Integral membrane protein GPR137C,Transmembrane 7 superfamily member 1-like 2 protein;, , GO:0016021;GO:0005765;GO:1904263;, C:integral component of membrane; C:lysosomal membrane;, , P:positive regulation of TORC1 signaling;|Q8TCP9 A4D293 A8K3V9 B2RD92 C9J6A8 D6W5T2 Q8N9P3,Protein FAM200A,, , GO:0016021;, C:integral component of membrane; scaffold42 indexed_genome mRNA 10841714 10877489 . - . ID=transcript_8523;Q8N3F9 Q86SM2,Integral membrane protein GPR137C,Transmembrane 7 superfamily member 1-like 2 protein;, , GO:0016021;GO:0005765;GO:1904263;, C:integral component of membrane; C:lysosomal membrane;, , P:positive regulation of TORC1 signaling; scaffold42 indexed_genome mRNA 10888039 10973846 . + . ID=transcript_8524;Q9P2K2 A5PKW9 A7E260 A7MD07 B9EH67 Q9H9W7,Thioredoxin domain-containing protein 16 {ECO:0000312|HGNC:HGNC:19965},, PF00085;, GO:0005788;GO:0070062;, C:endoplasmic reticulum lumen; C:extracellular exosome; scaffold42 indexed_genome mRNA 11170743 11188234 . - . ID=transcript_8525;Q9NZD8 B4DW44 Q6ZMB6,Maspardin,Acid cluster protein 33;Spastic paraplegia 21 autosomal recessive Mast syndrome protein;Spastic paraplegia 21 protein;, PF00561;, GO:0005829;GO:0010008;GO:0005794;GO:0043231;GO:0030140;GO:0042609;GO:0050851;, C:cytosol; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:trans-Golgi network transport vesicle;, F:CD4 receptor binding;, P:antigen receptor-mediated signaling pathway;|Q9NZD8 B4DW44 Q6ZMB6,Maspardin,Acid cluster protein 33;Spastic paraplegia 21 autosomal recessive Mast syndrome protein;Spastic paraplegia 21 protein;, PF00561;, GO:0005829;GO:0010008;GO:0005794;GO:0043231;GO:0030140;GO:0042609;GO:0050851;, C:cytosol; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:trans-Golgi network transport vesicle;, F:CD4 receptor binding;, P:antigen receptor-mediated signaling pathway; scaffold42 indexed_genome mRNA 11205605 11208317 . + . ID=transcript_8526;Q96DP5 B7Z734,Methionyl-tRNA formyltransferase, mitochondrial,, PF02911;PF00551;, GO:0005739;GO:0004479;GO:0071951;, C:mitochondrion;, F:methionyl-tRNA formyltransferase activity;, P:conversion of methionyl-tRNA to N-formyl-methionyl-tRNA; scaffold42 indexed_genome mRNA 11250721 11278501 . + . ID=transcript_8527;Q86UW2 Q3SYF5,Organic solute transporter subunit beta,Solute carrier family 51 subunit beta;, PF15048;, GO:0016323;GO:0016021;GO:0005886;GO:0032991;GO:0015125;GO:0046982;GO:0015721;GO:0032782;GO:0070863;GO:0060050;GO:0090314;GO:0031647;, C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:bile acid transmembrane transporter activity; F:protein heterodimerization activity;, P:bile acid and bile salt transport; P:bile acid secretion; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein glycosylation; P:positive regulation of protein targeting to membrane; P:regulation of protein stability;|Q9NYN1 B2RC29 B4DJW2 B4DU82,Ras-like protein family member 12,Ras-like protein Ris;, PF00071;, GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0007165;, C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:signal transduction; scaffold42 indexed_genome mRNA 11290683 11291202 . - . ID=transcript_8528;C9JR72,Kelch repeat and BTB domain-containing protein 13,, PF00651;PF01344;, GO:0005829;GO:0051015;GO:0007015;GO:0043687;GO:0016567;GO:0014728;GO:0090076;, C:cytosol;, F:actin filament binding;, P:actin filament organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of the force of skeletal muscle contraction; P:relaxation of skeletal muscle; scaffold42 indexed_genome mRNA 11291243 11291750 . + . ID=transcript_8529;C9JR72,Kelch repeat and BTB domain-containing protein 13,, PF00651;PF01344;, GO:0005829;GO:0051015;GO:0007015;GO:0043687;GO:0016567;GO:0014728;GO:0090076;, C:cytosol;, F:actin filament binding;, P:actin filament organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of the force of skeletal muscle contraction; P:relaxation of skeletal muscle; scaffold42 indexed_genome mRNA 11291775 11293763 . - . ID=transcript_8530;C9JR72,Kelch repeat and BTB domain-containing protein 13,, PF00651;PF01344;, GO:0005829;GO:0051015;GO:0007015;GO:0043687;GO:0016567;GO:0014728;GO:0090076;, C:cytosol;, F:actin filament binding;, P:actin filament organization; P:post-translational protein modification; P:protein ubiquitination; P:regulation of the force of skeletal muscle contraction; P:relaxation of skeletal muscle; scaffold42 indexed_genome mRNA 11314829 11326394 . - . ID=transcript_8531;F5GYI3,Ubiquitin-associated protein 1-like,, , GO:0000813;GO:0043130;GO:0043162;, C:ESCRT I complex;, F:ubiquitin binding;, P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|F5GYI3,Ubiquitin-associated protein 1-like,, , GO:0000813;GO:0043130;GO:0043162;, C:ESCRT I complex;, F:ubiquitin binding;, P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold42 indexed_genome mRNA 11341883 11343452 . - . ID=transcript_8532;Q8N8D1 Q96AK8 Q9Y6D7,Programmed cell death protein 7,ES18;, PF16021;, GO:0005654;GO:0005689;GO:0006915;GO:0000398;GO:0051384;GO:0008380;, C:nucleoplasm; C:U12-type spliceosomal complex;, , P:apoptotic process; P:mRNA splicing, via spliceosome; P:response to glucocorticoid; P:RNA splicing; scaffold42 indexed_genome mRNA 11367093 11404515 . - . ID=transcript_8533;O76031 A1L428 A8K8F1 B9EGI8 Q9H4D9,ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial,, PF07724;PF10431;, GO:0005829;GO:0009368;GO:0009841;GO:0005743;GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0005524;GO:0016887;GO:0016504;GO:0046983;GO:0051082;GO:0008270;GO:0046034;GO:0030163;GO:0006457;GO:0006508;GO:0051603;, C:cytosol; C:endopeptidase Clp complex; C:mitochondrial endopeptidase Clp complex; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:peptidase activator activity; F:protein dimerization activity; F:unfolded protein binding; F:zinc ion binding;, P:ATP metabolic process; P:protein catabolic process; P:protein folding; P:proteolysis; P:proteolysis involved in cellular protein catabolic process;|O76031 A1L428 A8K8F1 B9EGI8 Q9H4D9,ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial,, PF07724;PF10431;, GO:0005829;GO:0009368;GO:0009841;GO:0005743;GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0005524;GO:0016887;GO:0016504;GO:0046983;GO:0051082;GO:0008270;GO:0046034;GO:0030163;GO:0006457;GO:0006508;GO:0051603;, C:cytosol; C:endopeptidase Clp complex; C:mitochondrial endopeptidase Clp complex; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:peptidase activator activity; F:protein dimerization activity; F:unfolded protein binding; F:zinc ion binding;, P:ATP metabolic process; P:protein catabolic process; P:protein folding; P:proteolysis; P:proteolysis involved in cellular protein catabolic process;|O76031 A1L428 A8K8F1 B9EGI8 Q9H4D9,ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial,, PF07724;PF10431;, GO:0005829;GO:0009368;GO:0009841;GO:0005743;GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0005524;GO:0016887;GO:0016504;GO:0046983;GO:0051082;GO:0008270;GO:0046034;GO:0030163;GO:0006457;GO:0006508;GO:0051603;, C:cytosol; C:endopeptidase Clp complex; C:mitochondrial endopeptidase Clp complex; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:peptidase activator activity; F:protein dimerization activity; F:unfolded protein binding; F:zinc ion binding;, P:ATP metabolic process; P:protein catabolic process; P:protein folding; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; scaffold42 indexed_genome mRNA 11431581 11446813 . - . ID=transcript_8534;O75339 B2R8F7 Q6UW99 Q8IYI5,Cartilage intermediate layer protein 1,Cartilage intermediate-layer protein;, PF13330;PF00090;, GO:0062023;GO:0070062;GO:0005615;GO:0071560;GO:0016311;GO:0010629;GO:0043569;GO:0060392;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space;, , P:cellular response to transforming growth factor beta stimulus; P:dephosphorylation; P:negative regulation of gene expression; P:negative regulation of insulin-like growth factor receptor signaling pathway; P:negative regulation of SMAD protein signal transduction; scaffold42 indexed_genome mRNA 11474155 11493601 . - . ID=transcript_8535;Q8N5Y8 A0A024R5Y7 Q6PK64 Q9NX03,Protein mono-ADP-ribosyltransferase PARP16 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 15 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 16 {ECO:0000303|PubMed:20106667};, PF18084;PF00644;, GO:0005829;GO:0005783;GO:0005789;GO:0071782;GO:0016021;GO:0016020;GO:0005635;GO:0019900;GO:0003950;GO:1990404;GO:0043539;GO:1990830;GO:0030968;GO:0036498;GO:0034356;GO:0060548;GO:0071902;GO:0006471;GO:0070213;GO:0140289;GO:0019082;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of membrane; C:membrane; C:nuclear envelope;, F:kinase binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:protein serine/threonine kinase activator activity;, P:cellular response to leukemia inhibitory factor; P:endoplasmic reticulum unfolded protein response; P:IRE1-mediated unfolded protein response; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of cell death; P:positive regulation of protein serine/threonine kinase activity; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:viral protein processing;|Q8N5Y8 A0A024R5Y7 Q6PK64 Q9NX03,Protein mono-ADP-ribosyltransferase PARP16 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 15 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 16 {ECO:0000303|PubMed:20106667};, PF18084;PF00644;, GO:0005829;GO:0005783;GO:0005789;GO:0071782;GO:0016021;GO:0016020;GO:0005635;GO:0019900;GO:0003950;GO:1990404;GO:0043539;GO:1990830;GO:0030968;GO:0036498;GO:0034356;GO:0060548;GO:0071902;GO:0006471;GO:0070213;GO:0140289;GO:0019082;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of membrane; C:membrane; C:nuclear envelope;, F:kinase binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:protein serine/threonine kinase activator activity;, P:cellular response to leukemia inhibitory factor; P:endoplasmic reticulum unfolded protein response; P:IRE1-mediated unfolded protein response; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of cell death; P:positive regulation of protein serine/threonine kinase activity; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:viral protein processing;|Q8N5Y8 A0A024R5Y7 Q6PK64 Q9NX03,Protein mono-ADP-ribosyltransferase PARP16 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 15 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 16 {ECO:0000303|PubMed:20106667};, PF18084;PF00644;, GO:0005829;GO:0005783;GO:0005789;GO:0071782;GO:0016021;GO:0016020;GO:0005635;GO:0019900;GO:0003950;GO:1990404;GO:0043539;GO:1990830;GO:0030968;GO:0036498;GO:0034356;GO:0060548;GO:0071902;GO:0006471;GO:0070213;GO:0140289;GO:0019082;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of membrane; C:membrane; C:nuclear envelope;, F:kinase binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:protein serine/threonine kinase activator activity;, P:cellular response to leukemia inhibitory factor; P:endoplasmic reticulum unfolded protein response; P:IRE1-mediated unfolded protein response; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of cell death; P:positive regulation of protein serine/threonine kinase activity; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:viral protein processing; scaffold42 indexed_genome mRNA 11494623 11495397 . - . ID=transcript_8536;Q8N5Y8 A0A024R5Y7 Q6PK64 Q9NX03,Protein mono-ADP-ribosyltransferase PARP16 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 15 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 16 {ECO:0000303|PubMed:20106667};, PF18084;PF00644;, GO:0005829;GO:0005783;GO:0005789;GO:0071782;GO:0016021;GO:0016020;GO:0005635;GO:0019900;GO:0003950;GO:1990404;GO:0043539;GO:1990830;GO:0030968;GO:0036498;GO:0034356;GO:0060548;GO:0071902;GO:0006471;GO:0070213;GO:0140289;GO:0019082;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:integral component of membrane; C:membrane; C:nuclear envelope;, F:kinase binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:protein serine/threonine kinase activator activity;, P:cellular response to leukemia inhibitory factor; P:endoplasmic reticulum unfolded protein response; P:IRE1-mediated unfolded protein response; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of cell death; P:positive regulation of protein serine/threonine kinase activity; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:viral protein processing; scaffold42 indexed_genome mRNA 11536382 11537801 . - . ID=transcript_8537;Q8IVU1 O95215,Immunoglobulin superfamily DCC subclass member 3,Putative neuronal cell adhesion molecule;, PF00041;PF07679;, GO:0005887;GO:0050885;, C:integral component of plasma membrane;, , P:neuromuscular process controlling balance; scaffold42 indexed_genome mRNA 11537881 11538800 . - . ID=transcript_8538;Q8IVU1 O95215,Immunoglobulin superfamily DCC subclass member 3,Putative neuronal cell adhesion molecule;, PF00041;PF07679;, GO:0005887;GO:0050885;, C:integral component of plasma membrane;, , P:neuromuscular process controlling balance; scaffold42 indexed_genome mRNA 11539616 11547532 . - . ID=transcript_8539;Q8IVU1 O95215,Immunoglobulin superfamily DCC subclass member 3,Putative neuronal cell adhesion molecule;, PF00041;PF07679;, GO:0005887;GO:0050885;, C:integral component of plasma membrane;, , P:neuromuscular process controlling balance; scaffold42 indexed_genome mRNA 11633610 11688006 . + . ID=transcript_8540;Q9HBM4 Q9HBM5 Q9NXF4,Dipeptidyl peptidase 8,Dipeptidyl peptidase IV-related protein 1;Dipeptidyl peptidase VIII;Prolyl dipeptidase DPP8;, PF00930;PF00326;, GO:0005737;GO:0005829;GO:0004177;GO:0008239;GO:0008236;GO:0006915;GO:0006955;GO:0006508;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:immune response; P:proteolysis;|Q9HBM4 Q9HBM5 Q9NXF4,Dipeptidyl peptidase 8,Dipeptidyl peptidase IV-related protein 1;Dipeptidyl peptidase VIII;Prolyl dipeptidase DPP8;, PF00930;PF00326;, GO:0005737;GO:0005829;GO:0004177;GO:0008239;GO:0008236;GO:0006915;GO:0006955;GO:0006508;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:immune response; P:proteolysis;|Q9HBM4 Q9HBM5 Q9NXF4,Dipeptidyl peptidase 8,Dipeptidyl peptidase IV-related protein 1;Dipeptidyl peptidase VIII;Prolyl dipeptidase DPP8;, PF00930;PF00326;, GO:0005737;GO:0005829;GO:0004177;GO:0008239;GO:0008236;GO:0006915;GO:0006955;GO:0006508;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:immune response; P:proteolysis;|Q9HBM4 Q9HBM5 Q9NXF4,Dipeptidyl peptidase 8,Dipeptidyl peptidase IV-related protein 1;Dipeptidyl peptidase VIII;Prolyl dipeptidase DPP8;, PF00930;PF00326;, GO:0005737;GO:0005829;GO:0004177;GO:0008239;GO:0008236;GO:0006915;GO:0006955;GO:0006508;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:immune response; P:proteolysis;|Q9HBM4 Q9HBM5 Q9NXF4,Dipeptidyl peptidase 8,Dipeptidyl peptidase IV-related protein 1;Dipeptidyl peptidase VIII;Prolyl dipeptidase DPP8;, PF00930;PF00326;, GO:0005737;GO:0005829;GO:0004177;GO:0008239;GO:0008236;GO:0006915;GO:0006955;GO:0006508;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:immune response; P:proteolysis;|Q9HBM4 Q9HBM5 Q9NXF4,Dipeptidyl peptidase 8,Dipeptidyl peptidase IV-related protein 1;Dipeptidyl peptidase VIII;Prolyl dipeptidase DPP8;, PF00930;PF00326;, GO:0005737;GO:0005829;GO:0004177;GO:0008239;GO:0008236;GO:0006915;GO:0006955;GO:0006508;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:immune response; P:proteolysis;|Q9HBM4 Q9HBM5 Q9NXF4,Dipeptidyl peptidase 8,Dipeptidyl peptidase IV-related protein 1;Dipeptidyl peptidase VIII;Prolyl dipeptidase DPP8;, PF00930;PF00326;, GO:0005737;GO:0005829;GO:0004177;GO:0008239;GO:0008236;GO:0006915;GO:0006955;GO:0006508;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:immune response; P:proteolysis;|Q9HBM4 Q9HBM5 Q9NXF4,Dipeptidyl peptidase 8,Dipeptidyl peptidase IV-related protein 1;Dipeptidyl peptidase VIII;Prolyl dipeptidase DPP8;, PF00930;PF00326;, GO:0005737;GO:0005829;GO:0004177;GO:0008239;GO:0008236;GO:0006915;GO:0006955;GO:0006508;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:immune response; P:proteolysis;|Q9HBM4 Q9HBM5 Q9NXF4,Dipeptidyl peptidase 8,Dipeptidyl peptidase IV-related protein 1;Dipeptidyl peptidase VIII;Prolyl dipeptidase DPP8;, PF00930;PF00326;, GO:0005737;GO:0005829;GO:0004177;GO:0008239;GO:0008236;GO:0006915;GO:0006955;GO:0006508;, C:cytoplasm; C:cytosol;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:apoptotic process; P:immune response; P:proteolysis; scaffold42 indexed_genome mRNA 11704242 11732547 . + . ID=transcript_8541;Q9NQA7,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 3 {ECO:0000303|PubMed:18554506};Butyrate-induced protein 1 {ECO:0000303|PubMed:10747961};Protein-tyrosine phosphatase-like A domain-containing protein 1 {ECO:0000312|HGNC:HGNC:24175};, PF04387;, GO:0005783;GO:0005925;GO:0030176;GO:0031965;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0005096;GO:0102158;GO:0007257;GO:0030497;GO:0007249;GO:0046726;GO:0045070;GO:0016601;GO:0007264;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:focal adhesion; C:integral component of endoplasmic reticulum membrane; C:nuclear membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:GTPase activator activity; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:activation of JUN kinase activity; P:fatty acid elongation; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of viral genome replication; P:Rac protein signal transduction; P:small GTPase mediated signal transduction; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9NQA7,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 3 {ECO:0000303|PubMed:18554506};Butyrate-induced protein 1 {ECO:0000303|PubMed:10747961};Protein-tyrosine phosphatase-like A domain-containing protein 1 {ECO:0000312|HGNC:HGNC:24175};, PF04387;, GO:0005783;GO:0005925;GO:0030176;GO:0031965;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0005096;GO:0102158;GO:0007257;GO:0030497;GO:0007249;GO:0046726;GO:0045070;GO:0016601;GO:0007264;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:focal adhesion; C:integral component of endoplasmic reticulum membrane; C:nuclear membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:GTPase activator activity; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:activation of JUN kinase activity; P:fatty acid elongation; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of viral genome replication; P:Rac protein signal transduction; P:small GTPase mediated signal transduction; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9NQA7,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 3 {ECO:0000303|PubMed:18554506};Butyrate-induced protein 1 {ECO:0000303|PubMed:10747961};Protein-tyrosine phosphatase-like A domain-containing protein 1 {ECO:0000312|HGNC:HGNC:24175};, PF04387;, GO:0005783;GO:0005925;GO:0030176;GO:0031965;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0005096;GO:0102158;GO:0007257;GO:0030497;GO:0007249;GO:0046726;GO:0045070;GO:0016601;GO:0007264;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:focal adhesion; C:integral component of endoplasmic reticulum membrane; C:nuclear membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:GTPase activator activity; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:activation of JUN kinase activity; P:fatty acid elongation; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of viral genome replication; P:Rac protein signal transduction; P:small GTPase mediated signal transduction; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9NQA7,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 3 {ECO:0000303|PubMed:18554506};Butyrate-induced protein 1 {ECO:0000303|PubMed:10747961};Protein-tyrosine phosphatase-like A domain-containing protein 1 {ECO:0000312|HGNC:HGNC:24175};, PF04387;, GO:0005783;GO:0005925;GO:0030176;GO:0031965;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0005096;GO:0102158;GO:0007257;GO:0030497;GO:0007249;GO:0046726;GO:0045070;GO:0016601;GO:0007264;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:focal adhesion; C:integral component of endoplasmic reticulum membrane; C:nuclear membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:GTPase activator activity; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:activation of JUN kinase activity; P:fatty acid elongation; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of viral genome replication; P:Rac protein signal transduction; P:small GTPase mediated signal transduction; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9NQA7,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 3 {ECO:0000303|PubMed:18554506};Butyrate-induced protein 1 {ECO:0000303|PubMed:10747961};Protein-tyrosine phosphatase-like A domain-containing protein 1 {ECO:0000312|HGNC:HGNC:24175};, PF04387;, GO:0005783;GO:0005925;GO:0030176;GO:0031965;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0005096;GO:0102158;GO:0007257;GO:0030497;GO:0007249;GO:0046726;GO:0045070;GO:0016601;GO:0007264;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:focal adhesion; C:integral component of endoplasmic reticulum membrane; C:nuclear membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:GTPase activator activity; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:activation of JUN kinase activity; P:fatty acid elongation; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of viral genome replication; P:Rac protein signal transduction; P:small GTPase mediated signal transduction; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9NQA7,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 3 {ECO:0000303|PubMed:18554506};Butyrate-induced protein 1 {ECO:0000303|PubMed:10747961};Protein-tyrosine phosphatase-like A domain-containing protein 1 {ECO:0000312|HGNC:HGNC:24175};, PF04387;, GO:0005783;GO:0005925;GO:0030176;GO:0031965;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0005096;GO:0102158;GO:0007257;GO:0030497;GO:0007249;GO:0046726;GO:0045070;GO:0016601;GO:0007264;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:focal adhesion; C:integral component of endoplasmic reticulum membrane; C:nuclear membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:GTPase activator activity; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:activation of JUN kinase activity; P:fatty acid elongation; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of viral genome replication; P:Rac protein signal transduction; P:small GTPase mediated signal transduction; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold42 indexed_genome mRNA 11733007 11767025 . - . ID=transcript_8542;Q96SY0 B4DDI6 B4DVD5 Q49AH8 Q96HX5 Q9H0S5,Integrator complex subunit 14 {ECO:0000312|HGNC:HGNC:25372},von Willebrand factor A domain-containing protein 9;, PF13519;, GO:0032039;GO:0005654;GO:0034472;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA transcription by RNA polymerase II;|Q96SY0 B4DDI6 B4DVD5 Q49AH8 Q96HX5 Q9H0S5,Integrator complex subunit 14 {ECO:0000312|HGNC:HGNC:25372},von Willebrand factor A domain-containing protein 9;, PF13519;, GO:0032039;GO:0005654;GO:0034472;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA transcription by RNA polymerase II;|Q96SY0 B4DDI6 B4DVD5 Q49AH8 Q96HX5 Q9H0S5,Integrator complex subunit 14 {ECO:0000312|HGNC:HGNC:25372},von Willebrand factor A domain-containing protein 9;, PF13519;, GO:0032039;GO:0005654;GO:0034472;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA transcription by RNA polymerase II;|Q96SY0 B4DDI6 B4DVD5 Q49AH8 Q96HX5 Q9H0S5,Integrator complex subunit 14 {ECO:0000312|HGNC:HGNC:25372},von Willebrand factor A domain-containing protein 9;, PF13519;, GO:0032039;GO:0005654;GO:0034472;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA transcription by RNA polymerase II;|Q96SY0 B4DDI6 B4DVD5 Q49AH8 Q96HX5 Q9H0S5,Integrator complex subunit 14 {ECO:0000312|HGNC:HGNC:25372},von Willebrand factor A domain-containing protein 9;, PF13519;, GO:0032039;GO:0005654;GO:0034472;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA transcription by RNA polymerase II;|Q96SY0 B4DDI6 B4DVD5 Q49AH8 Q96HX5 Q9H0S5,Integrator complex subunit 14 {ECO:0000312|HGNC:HGNC:25372},von Willebrand factor A domain-containing protein 9;, PF13519;, GO:0032039;GO:0005654;GO:0034472;GO:0042795;, C:integrator complex; C:nucleoplasm;, , P:snRNA 3'-end processing; P:snRNA transcription by RNA polymerase II; scaffold42 indexed_genome mRNA 11812652 11816123 . + . ID=transcript_8543;O60721 O43485 O75184 Q17RM9,Sodium/potassium/calcium exchanger 1,Na(+)/K(+)/Ca(2+)-exchange protein 1;Retinal rod Na-Ca+K exchanger;Solute carrier family 24 member 1;, PF01699;, GO:0005887;GO:0016020;GO:0043025;GO:0019867;GO:0005886;GO:0005262;GO:0008273;GO:0015293;GO:0098703;GO:0070588;GO:0006816;GO:0006874;GO:0006811;GO:0060292;GO:0060291;GO:0071805;GO:0009642;GO:0035725;GO:0007601;, C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:outer membrane; C:plasma membrane;, F:calcium channel activity; F:calcium, potassium:sodium antiporter activity; F:symporter activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular calcium ion homeostasis; P:ion transport; P:long-term synaptic depression; P:long-term synaptic potentiation; P:potassium ion transmembrane transport; P:response to light intensity; P:sodium ion transmembrane transport; P:visual perception; scaffold42 indexed_genome mRNA 11819095 11819651 . - . ID=transcript_8544;O60721 O43485 O75184 Q17RM9,Sodium/potassium/calcium exchanger 1,Na(+)/K(+)/Ca(2+)-exchange protein 1;Retinal rod Na-Ca+K exchanger;Solute carrier family 24 member 1;, PF01699;, GO:0005887;GO:0016020;GO:0043025;GO:0019867;GO:0005886;GO:0005262;GO:0008273;GO:0015293;GO:0098703;GO:0070588;GO:0006816;GO:0006874;GO:0006811;GO:0060292;GO:0060291;GO:0071805;GO:0009642;GO:0035725;GO:0007601;, C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:outer membrane; C:plasma membrane;, F:calcium channel activity; F:calcium, potassium:sodium antiporter activity; F:symporter activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular calcium ion homeostasis; P:ion transport; P:long-term synaptic depression; P:long-term synaptic potentiation; P:potassium ion transmembrane transport; P:response to light intensity; P:sodium ion transmembrane transport; P:visual perception; scaffold42 indexed_genome mRNA 11832134 11937212 . - . ID=transcript_8545;Q7Z401 E7EPL3 Q14655 Q86T77 Q8IVX2 Q8NB93,C-myc promoter-binding protein,DENN domain-containing protein 4A;, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005634;GO:0003677;GO:0005085;GO:0032483;GO:0006355;, C:cytoplasmic vesicle; C:cytosol; C:nucleus;, F:DNA binding; F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction; P:regulation of transcription, DNA-templated;|Q7Z401 E7EPL3 Q14655 Q86T77 Q8IVX2 Q8NB93,C-myc promoter-binding protein,DENN domain-containing protein 4A;, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005634;GO:0003677;GO:0005085;GO:0032483;GO:0006355;, C:cytoplasmic vesicle; C:cytosol; C:nucleus;, F:DNA binding; F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction; P:regulation of transcription, DNA-templated;|Q7Z401 E7EPL3 Q14655 Q86T77 Q8IVX2 Q8NB93,C-myc promoter-binding protein,DENN domain-containing protein 4A;, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005634;GO:0003677;GO:0005085;GO:0032483;GO:0006355;, C:cytoplasmic vesicle; C:cytosol; C:nucleus;, F:DNA binding; F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction; P:regulation of transcription, DNA-templated;|Q8WVK2 Q15410,U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein,Nucleic acid-binding protein RY-1;U4/U6.U5 tri-snRNP-associated 27 kDa protein;U4/U6.U5 tri-snRNP-associated protein 3;, PF08648;, GO:0005654;GO:0003676;GO:0000398;, C:nucleoplasm;, F:nucleic acid binding;, P:mRNA splicing, via spliceosome;|Q7Z401 E7EPL3 Q14655 Q86T77 Q8IVX2 Q8NB93,C-myc promoter-binding protein,DENN domain-containing protein 4A;, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005634;GO:0003677;GO:0005085;GO:0032483;GO:0006355;, C:cytoplasmic vesicle; C:cytosol; C:nucleus;, F:DNA binding; F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction; P:regulation of transcription, DNA-templated; scaffold42 indexed_genome mRNA 12005871 12282213 . + . ID=transcript_8546;P62491 B2R4B6 B4DT13 P24410 Q5TZN9 Q9JLX1,Ras-related protein Rab-11A,YL8;, PF00071;, GO:0030424;GO:0034451;GO:0005813;GO:0032154;GO:0031410;GO:0030659;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0005794;GO:0043231;GO:0005771;GO:0048471;GO:0045335;GO:0098837;GO:0032991;GO:0055037;GO:0055038;GO:0098685;GO:0000922;GO:0005802;GO:0030133;GO:0031982;GO:0005525;GO:0003924;GO:0008017;GO:0031489;GO:0019905;GO:0150093;GO:0030953;GO:0097711;GO:0060271;GO:0090150;GO:0072594;GO:0051650;GO:0006887;GO:1990182;GO:0032402;GO:0007080;GO:0090307;GO:0036258;GO:0031175;GO:0098887;GO:0048227;GO:0045773;GO:0010634;GO:0010971;GO:1903078;GO:0043687;GO:0034394;GO:0072659;GO:0032465;GO:0048169;GO:0010796;GO:0051223;GO:0060627;GO:0003091;GO:0016192;GO:0099003;, C:axon; C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:multivesicular body; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:postsynaptic recycling endosome; C:protein-containing complex; C:recycling endosome; C:recycling endosome membrane; C:Schaffer collateral - CA1 synapse; C:spindle pole; C:trans-Golgi network; C:transport vesicle; C:vesicle;, F:GTP binding; F:GTPase activity; F:microtubule binding; F:myosin V binding; F:syntaxin binding;, P:amyloid-beta clearance by transcytosis; P:astral microtubule organization; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of protein localization to membrane; P:establishment of protein localization to organelle; P:establishment of vesicle localization; P:exocytosis; P:exosomal secretion; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle assembly; P:multivesicular body assembly; P:neuron projection development; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:plasma membrane to endosome transport; P:positive regulation of axon extension; P:positive regulation of epithelial cell migration; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of protein localization to plasma membrane; P:post-translational protein modification; P:protein localization to cell surface; P:protein localization to plasma membrane; P:regulation of cytokinesis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of multivesicular body size; P:regulation of protein transport; P:regulation of vesicle-mediated transport; P:renal water homeostasis; P:vesicle-mediated transport; P:vesicle-mediated transport in synapse;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|A6BM72 Q17R86 Q6UXS5 Q8ND91 Q96KG6,Multiple epidermal growth factor-like domains protein 11,, PF12661;PF00053;, GO:0016323;GO:0016021;GO:0034109;GO:0010842;, C:basolateral plasma membrane; C:integral component of membrane;, , P:homotypic cell-cell adhesion; P:retina layer formation;|A6BM72 Q17R86 Q6UXS5 Q8ND91 Q96KG6,Multiple epidermal growth factor-like domains protein 11,, PF12661;PF00053;, GO:0016323;GO:0016021;GO:0034109;GO:0010842;, C:basolateral plasma membrane; C:integral component of membrane;, , P:homotypic cell-cell adhesion; P:retina layer formation;|A6BM72 Q17R86 Q6UXS5 Q8ND91 Q96KG6,Multiple epidermal growth factor-like domains protein 11,, PF12661;PF00053;, GO:0016323;GO:0016021;GO:0034109;GO:0010842;, C:basolateral plasma membrane; C:integral component of membrane;, , P:homotypic cell-cell adhesion; P:retina layer formation;|A6BM72 Q17R86 Q6UXS5 Q8ND91 Q96KG6,Multiple epidermal growth factor-like domains protein 11,, PF12661;PF00053;, GO:0016323;GO:0016021;GO:0034109;GO:0010842;, C:basolateral plasma membrane; C:integral component of membrane;, , P:homotypic cell-cell adhesion; P:retina layer formation; scaffold42 indexed_genome mRNA 12474492 12487347 . + . ID=transcript_8547;Q8TF46 Q8N1N8 Q8WTU9 Q96CM7,DIS3-like exonuclease 1,, PF17849;PF00773;PF17216;PF17215;, GO:0005813;GO:0000177;GO:0005829;GO:0000178;GO:0005886;GO:0000175;GO:0019899;GO:0003723;GO:0016075;, C:centrosome; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:plasma membrane;, F:3'-5'-exoribonuclease activity; F:enzyme binding; F:RNA binding;, P:rRNA catabolic process;|Q8TF46 Q8N1N8 Q8WTU9 Q96CM7,DIS3-like exonuclease 1,, PF17849;PF00773;PF17216;PF17215;, GO:0005813;GO:0000177;GO:0005829;GO:0000178;GO:0005886;GO:0000175;GO:0019899;GO:0003723;GO:0016075;, C:centrosome; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:plasma membrane;, F:3'-5'-exoribonuclease activity; F:enzyme binding; F:RNA binding;, P:rRNA catabolic process; scaffold42 indexed_genome mRNA 12488833 12498306 . - . ID=transcript_8548;Q9BVW5 B2CW64 Q9NWZ6,TIMELESS-interacting protein,, PF07962;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0031298;GO:0003677;GO:0044770;GO:0051301;GO:0006260;GO:0000076;GO:0031573;GO:0008284;GO:0033262;GO:0043111;GO:0048478;GO:0009411;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:replication fork protection complex;, F:DNA binding;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication checkpoint; P:intra-S DNA damage checkpoint; P:positive regulation of cell population proliferation; P:regulation of nuclear cell cycle DNA replication; P:replication fork arrest; P:replication fork protection; P:response to UV;|Q9BVW5 B2CW64 Q9NWZ6,TIMELESS-interacting protein,, PF07962;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0031298;GO:0003677;GO:0044770;GO:0051301;GO:0006260;GO:0000076;GO:0031573;GO:0008284;GO:0033262;GO:0043111;GO:0048478;GO:0009411;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:replication fork protection complex;, F:DNA binding;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication checkpoint; P:intra-S DNA damage checkpoint; P:positive regulation of cell population proliferation; P:regulation of nuclear cell cycle DNA replication; P:replication fork arrest; P:replication fork protection; P:response to UV;|Q9BVW5 B2CW64 Q9NWZ6,TIMELESS-interacting protein,, PF07962;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0031298;GO:0003677;GO:0044770;GO:0051301;GO:0006260;GO:0000076;GO:0031573;GO:0008284;GO:0033262;GO:0043111;GO:0048478;GO:0009411;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:replication fork protection complex;, F:DNA binding;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication checkpoint; P:intra-S DNA damage checkpoint; P:positive regulation of cell population proliferation; P:regulation of nuclear cell cycle DNA replication; P:replication fork arrest; P:replication fork protection; P:response to UV;|Q9BVW5 B2CW64 Q9NWZ6,TIMELESS-interacting protein,, PF07962;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0031298;GO:0003677;GO:0044770;GO:0051301;GO:0006260;GO:0000076;GO:0031573;GO:0008284;GO:0033262;GO:0043111;GO:0048478;GO:0009411;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:replication fork protection complex;, F:DNA binding;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication checkpoint; P:intra-S DNA damage checkpoint; P:positive regulation of cell population proliferation; P:regulation of nuclear cell cycle DNA replication; P:replication fork arrest; P:replication fork protection; P:response to UV;|Q9BVW5 B2CW64 Q9NWZ6,TIMELESS-interacting protein,, PF07962;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0031298;GO:0003677;GO:0044770;GO:0051301;GO:0006260;GO:0000076;GO:0031573;GO:0008284;GO:0033262;GO:0043111;GO:0048478;GO:0009411;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:replication fork protection complex;, F:DNA binding;, P:cell cycle phase transition; P:cell division; P:DNA replication; P:DNA replication checkpoint; P:intra-S DNA damage checkpoint; P:positive regulation of cell population proliferation; P:regulation of nuclear cell cycle DNA replication; P:replication fork arrest; P:replication fork protection; P:response to UV; scaffold42 indexed_genome mRNA 12527013 12607328 . + . ID=transcript_8549;Q02750,Dual specificity mitogen-activated protein kinase kinase 1 {ECO:0000305},ERK activator kinase 1;MAPK/ERK kinase 1;, PF00069;, GO:0005829;GO:0005769;GO:0005783;GO:0005925;GO:0005794;GO:0005770;GO:0005815;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004708;GO:0005078;GO:0008022;GO:0004672;GO:0047485;GO:0106310;GO:0043539;GO:0004674;GO:0004712;GO:0106311;GO:0097110;GO:0004714;GO:0000187;GO:0000186;GO:0060020;GO:0007050;GO:0048870;GO:0090398;GO:0021697;GO:0006935;GO:0060502;GO:0070371;GO:0060324;GO:0007507;GO:0030216;GO:0060711;GO:0000165;GO:0008285;GO:0010629;GO:0030182;GO:0018107;GO:0060674;GO:0050772;GO:0070374;GO:0010628;GO:1903800;GO:0071902;GO:0045893;GO:0006468;GO:0048679;GO:2000641;GO:0090170;GO:0032872;GO:0007165;GO:0048538;GO:0030878;GO:0060440;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule organizing center; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:MAP kinase kinase activity; F:MAP-kinase scaffold activity; F:protein C-terminus binding; F:protein kinase activity; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:activation of MAPKK activity; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cell motility; P:cellular senescence; P:cerebellar cortex formation; P:chemotaxis; P:epithelial cell proliferation involved in lung morphogenesis; P:ERK1 and ERK2 cascade; P:face development; P:heart development; P:keratinocyte differentiation; P:labyrinthine layer development; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:neuron differentiation; P:peptidyl-threonine phosphorylation; P:placenta blood vessel development; P:positive regulation of axonogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of axon regeneration; P:regulation of early endosome to late endosome transport; P:regulation of Golgi inheritance; P:regulation of stress-activated MAPK cascade; P:signal transduction; P:thymus development; P:thyroid gland development; P:trachea formation;|Q02750,Dual specificity mitogen-activated protein kinase kinase 1 {ECO:0000305},ERK activator kinase 1;MAPK/ERK kinase 1;, PF00069;, GO:0005829;GO:0005769;GO:0005783;GO:0005925;GO:0005794;GO:0005770;GO:0005815;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004708;GO:0005078;GO:0008022;GO:0004672;GO:0047485;GO:0106310;GO:0043539;GO:0004674;GO:0004712;GO:0106311;GO:0097110;GO:0004714;GO:0000187;GO:0000186;GO:0060020;GO:0007050;GO:0048870;GO:0090398;GO:0021697;GO:0006935;GO:0060502;GO:0070371;GO:0060324;GO:0007507;GO:0030216;GO:0060711;GO:0000165;GO:0008285;GO:0010629;GO:0030182;GO:0018107;GO:0060674;GO:0050772;GO:0070374;GO:0010628;GO:1903800;GO:0071902;GO:0045893;GO:0006468;GO:0048679;GO:2000641;GO:0090170;GO:0032872;GO:0007165;GO:0048538;GO:0030878;GO:0060440;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule organizing center; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:MAP kinase kinase activity; F:MAP-kinase scaffold activity; F:protein C-terminus binding; F:protein kinase activity; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:activation of MAPKK activity; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cell motility; P:cellular senescence; P:cerebellar cortex formation; P:chemotaxis; P:epithelial cell proliferation involved in lung morphogenesis; P:ERK1 and ERK2 cascade; P:face development; P:heart development; P:keratinocyte differentiation; P:labyrinthine layer development; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:neuron differentiation; P:peptidyl-threonine phosphorylation; P:placenta blood vessel development; P:positive regulation of axonogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of axon regeneration; P:regulation of early endosome to late endosome transport; P:regulation of Golgi inheritance; P:regulation of stress-activated MAPK cascade; P:signal transduction; P:thymus development; P:thyroid gland development; P:trachea formation;|Q02750,Dual specificity mitogen-activated protein kinase kinase 1 {ECO:0000305},ERK activator kinase 1;MAPK/ERK kinase 1;, PF00069;, GO:0005829;GO:0005769;GO:0005783;GO:0005925;GO:0005794;GO:0005770;GO:0005815;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004708;GO:0005078;GO:0008022;GO:0004672;GO:0047485;GO:0106310;GO:0043539;GO:0004674;GO:0004712;GO:0106311;GO:0097110;GO:0004714;GO:0000187;GO:0000186;GO:0060020;GO:0007050;GO:0048870;GO:0090398;GO:0021697;GO:0006935;GO:0060502;GO:0070371;GO:0060324;GO:0007507;GO:0030216;GO:0060711;GO:0000165;GO:0008285;GO:0010629;GO:0030182;GO:0018107;GO:0060674;GO:0050772;GO:0070374;GO:0010628;GO:1903800;GO:0071902;GO:0045893;GO:0006468;GO:0048679;GO:2000641;GO:0090170;GO:0032872;GO:0007165;GO:0048538;GO:0030878;GO:0060440;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule organizing center; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:MAP kinase kinase activity; F:MAP-kinase scaffold activity; F:protein C-terminus binding; F:protein kinase activity; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:activation of MAPKK activity; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cell motility; P:cellular senescence; P:cerebellar cortex formation; P:chemotaxis; P:epithelial cell proliferation involved in lung morphogenesis; P:ERK1 and ERK2 cascade; P:face development; P:heart development; P:keratinocyte differentiation; P:labyrinthine layer development; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:neuron differentiation; P:peptidyl-threonine phosphorylation; P:placenta blood vessel development; P:positive regulation of axonogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of axon regeneration; P:regulation of early endosome to late endosome transport; P:regulation of Golgi inheritance; P:regulation of stress-activated MAPK cascade; P:signal transduction; P:thymus development; P:thyroid gland development; P:trachea formation;|Q02750,Dual specificity mitogen-activated protein kinase kinase 1 {ECO:0000305},ERK activator kinase 1;MAPK/ERK kinase 1;, PF00069;, GO:0005829;GO:0005769;GO:0005783;GO:0005925;GO:0005794;GO:0005770;GO:0005815;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004708;GO:0005078;GO:0008022;GO:0004672;GO:0047485;GO:0106310;GO:0043539;GO:0004674;GO:0004712;GO:0106311;GO:0097110;GO:0004714;GO:0000187;GO:0000186;GO:0060020;GO:0007050;GO:0048870;GO:0090398;GO:0021697;GO:0006935;GO:0060502;GO:0070371;GO:0060324;GO:0007507;GO:0030216;GO:0060711;GO:0000165;GO:0008285;GO:0010629;GO:0030182;GO:0018107;GO:0060674;GO:0050772;GO:0070374;GO:0010628;GO:1903800;GO:0071902;GO:0045893;GO:0006468;GO:0048679;GO:2000641;GO:0090170;GO:0032872;GO:0007165;GO:0048538;GO:0030878;GO:0060440;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule organizing center; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:MAP kinase kinase activity; F:MAP-kinase scaffold activity; F:protein C-terminus binding; F:protein kinase activity; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:activation of MAPKK activity; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cell motility; P:cellular senescence; P:cerebellar cortex formation; P:chemotaxis; P:epithelial cell proliferation involved in lung morphogenesis; P:ERK1 and ERK2 cascade; P:face development; P:heart development; P:keratinocyte differentiation; P:labyrinthine layer development; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:neuron differentiation; P:peptidyl-threonine phosphorylation; P:placenta blood vessel development; P:positive regulation of axonogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of axon regeneration; P:regulation of early endosome to late endosome transport; P:regulation of Golgi inheritance; P:regulation of stress-activated MAPK cascade; P:signal transduction; P:thymus development; P:thyroid gland development; P:trachea formation;|Q02750,Dual specificity mitogen-activated protein kinase kinase 1 {ECO:0000305},ERK activator kinase 1;MAPK/ERK kinase 1;, PF00069;, GO:0005829;GO:0005769;GO:0005783;GO:0005925;GO:0005794;GO:0005770;GO:0005815;GO:0005739;GO:0005634;GO:0005886;GO:0005524;GO:0004708;GO:0005078;GO:0008022;GO:0004672;GO:0047485;GO:0106310;GO:0043539;GO:0004674;GO:0004712;GO:0106311;GO:0097110;GO:0004714;GO:0000187;GO:0000186;GO:0060020;GO:0007050;GO:0048870;GO:0090398;GO:0021697;GO:0006935;GO:0060502;GO:0070371;GO:0060324;GO:0007507;GO:0030216;GO:0060711;GO:0000165;GO:0008285;GO:0010629;GO:0030182;GO:0018107;GO:0060674;GO:0050772;GO:0070374;GO:0010628;GO:1903800;GO:0071902;GO:0045893;GO:0006468;GO:0048679;GO:2000641;GO:0090170;GO:0032872;GO:0007165;GO:0048538;GO:0030878;GO:0060440;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule organizing center; C:mitochondrion; C:nucleus; C:plasma membrane;, F:ATP binding; F:MAP kinase kinase activity; F:MAP-kinase scaffold activity; F:protein C-terminus binding; F:protein kinase activity; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:activation of MAPKK activity; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cell motility; P:cellular senescence; P:cerebellar cortex formation; P:chemotaxis; P:epithelial cell proliferation involved in lung morphogenesis; P:ERK1 and ERK2 cascade; P:face development; P:heart development; P:keratinocyte differentiation; P:labyrinthine layer development; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:neuron differentiation; P:peptidyl-threonine phosphorylation; P:placenta blood vessel development; P:positive regulation of axonogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of axon regeneration; P:regulation of early endosome to late endosome transport; P:regulation of Golgi inheritance; P:regulation of stress-activated MAPK cascade; P:signal transduction; P:thymus development; P:thyroid gland development; P:trachea formation;|O75971 A8K7N6 Q96CF3,snRNA-activating protein complex subunit 5,Small nuclear RNA-activating complex polypeptide 5;snRNA-activating protein complex 19 kDa subunit;, PF15497;, GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0016251;GO:0000995;GO:0042795;GO:0042796;GO:0006384;, C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase III general transcription initiation factor activity;, P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; scaffold42 indexed_genome mRNA 12608336 12613042 . - . ID=transcript_8550;P36578 A8K502 P39029 Q4VBR0 Q969Z9,60S ribosomal protein L4,60S ribosomal protein L1;Large ribosomal subunit protein uL4 {ECO:0000303|PubMed:24524803};, PF14374;PF00573;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:1990904;GO:0005791;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:ribonucleoprotein complex; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P36578 A8K502 P39029 Q4VBR0 Q969Z9,60S ribosomal protein L4,60S ribosomal protein L1;Large ribosomal subunit protein uL4 {ECO:0000303|PubMed:24524803};, PF14374;PF00573;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:1990904;GO:0005791;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:ribonucleoprotein complex; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P36578 A8K502 P39029 Q4VBR0 Q969Z9,60S ribosomal protein L4,60S ribosomal protein L1;Large ribosomal subunit protein uL4 {ECO:0000303|PubMed:24524803};, PF14374;PF00573;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:1990904;GO:0005791;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:ribonucleoprotein complex; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P36578 A8K502 P39029 Q4VBR0 Q969Z9,60S ribosomal protein L4,60S ribosomal protein L1;Large ribosomal subunit protein uL4 {ECO:0000303|PubMed:24524803};, PF14374;PF00573;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:1990904;GO:0005791;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:ribonucleoprotein complex; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P36578 A8K502 P39029 Q4VBR0 Q969Z9,60S ribosomal protein L4,60S ribosomal protein L1;Large ribosomal subunit protein uL4 {ECO:0000303|PubMed:24524803};, PF14374;PF00573;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:1990904;GO:0005791;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:ribonucleoprotein complex; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold42 indexed_genome mRNA 12613539 12636043 . + . ID=transcript_8551;Q9H900 B3KVB8 Q6N049 Q8N404 Q96SY7 Q9NWG7,Protein zwilch homolog,, PF09817;, GO:0000777;GO:0005829;GO:0000776;GO:1990423;GO:0051301;GO:0007052;GO:0034501;GO:0072413;, C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:RZZ complex;, , P:cell division; P:mitotic spindle organization; P:protein localization to kinetochore; P:signal transduction involved in mitotic cell cycle checkpoint; scaffold42 indexed_genome mRNA 12636894 12653872 . + . ID=transcript_8552;Q9H900 B3KVB8 Q6N049 Q8N404 Q96SY7 Q9NWG7,Protein zwilch homolog,, PF09817;, GO:0000777;GO:0005829;GO:0000776;GO:1990423;GO:0051301;GO:0007052;GO:0034501;GO:0072413;, C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:RZZ complex;, , P:cell division; P:mitotic spindle organization; P:protein localization to kinetochore; P:signal transduction involved in mitotic cell cycle checkpoint; scaffold42 indexed_genome mRNA 12655137 12669996 . + . ID=transcript_8553;Q6UWM7 B3KQY0,Lactase-like protein,Klotho/lactase-phlorizin hydrolase-related protein;, PF00232;, GO:0005903;GO:0005783;GO:0005789;GO:0016021;GO:0008422;GO:0005975;GO:0002089;GO:0050896;GO:0007601;, C:brush border; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:beta-glucosidase activity;, P:carbohydrate metabolic process; P:lens morphogenesis in camera-type eye; P:response to stimulus; P:visual perception;|Q6UWM7 B3KQY0,Lactase-like protein,Klotho/lactase-phlorizin hydrolase-related protein;, PF00232;, GO:0005903;GO:0005783;GO:0005789;GO:0016021;GO:0008422;GO:0005975;GO:0002089;GO:0050896;GO:0007601;, C:brush border; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:beta-glucosidase activity;, P:carbohydrate metabolic process; P:lens morphogenesis in camera-type eye; P:response to stimulus; P:visual perception; scaffold42 indexed_genome mRNA 12867250 12872444 . - . ID=transcript_8554;O43541 A9J6M5 O43654 Q15799 Q7Z7L4 Q96E31 Q9UKZ3,Mothers against decapentaplegic homolog 6,SMAD family member 6;, PF03165;PF03166;, GO:0000785;GO:0005737;GO:0005829;GO:0005794;GO:0071144;GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0070410;GO:0070411;GO:0042802;GO:0046872;GO:0070412;GO:0140416;GO:0000976;GO:0070698;GO:0034713;GO:0031625;GO:0009653;GO:0035904;GO:0003180;GO:0030509;GO:0030154;GO:0031589;GO:0060976;GO:0045444;GO:0006955;GO:0003183;GO:0043066;GO:0030514;GO:0008285;GO:0030279;GO:0045668;GO:0060394;GO:0010991;GO:0030512;GO:0003148;GO:1902895;GO:0003184;GO:0043627;GO:0034616;GO:0032496;GO:0060395;GO:0007179;GO:0001657;GO:0003281;GO:0007352;, C:chromatin; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:heteromeric SMAD protein complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:co-SMAD binding; F:I-SMAD binding; F:identical protein binding; F:metal ion binding; F:R-SMAD binding; F:transcription regulator inhibitor activity; F:transcription regulatory region sequence-specific DNA binding; F:type I activin receptor binding; F:type I transforming growth factor beta receptor binding; F:ubiquitin protein ligase binding;, P:anatomical structure morphogenesis; P:aorta development; P:aortic valve morphogenesis; P:BMP signaling pathway; P:cell differentiation; P:cell-substrate adhesion; P:coronary vasculature development; P:fat cell differentiation; P:immune response; P:mitral valve morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of BMP signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of ossification; P:negative regulation of osteoblast differentiation; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of SMAD protein complex assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:outflow tract septum morphogenesis; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:pulmonary valve morphogenesis; P:response to estrogen; P:response to laminar fluid shear stress; P:response to lipopolysaccharide; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ureteric bud development; P:ventricular septum development; P:zygotic specification of dorsal/ventral axis; scaffold42 indexed_genome mRNA 13031631 13136710 . + . ID=transcript_8555;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold42 indexed_genome mRNA 13288006 13360975 . - . ID=transcript_8556;Q6PD74 B4DG44 Q6FI86 Q7Z5X9 Q9H0P1 Q9HAK0,Alpha- and gamma-adaptin-binding protein p34,, , GO:0005737;GO:0005829;GO:0016607;GO:0015031;, C:cytoplasm; C:cytosol; C:nuclear speck;, , P:protein transport; scaffold42 indexed_genome mRNA 13610876 13611392 . + . ID=transcript_8557;A4D0T7 Q32Q38,Small integral membrane protein 30,, PF15873;, GO:0016021;, C:integral component of membrane; scaffold42 indexed_genome mRNA 13786300 13851195 . + . ID=transcript_8558;Q13163 B4DE43 Q92961 Q92962,Dual specificity mitogen-activated protein kinase kinase 5,MAPK/ERK kinase 5;, PF00564;PF00069;, GO:0005829;GO:0005634;GO:0005819;GO:0005524;GO:0004708;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0004714;GO:0000187;GO:0071363;GO:0071499;GO:0070375;GO:0007507;GO:0090051;GO:2000342;GO:0043154;GO:2001240;GO:0034115;GO:0032717;GO:0032088;GO:0060761;GO:0000122;GO:0030307;GO:0050679;GO:0051247;GO:0045944;GO:0007165;, C:cytosol; C:nucleus; C:spindle;, F:ATP binding; F:MAP kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:cellular response to growth factor stimulus; P:cellular response to laminar fluid shear stress; P:ERK5 cascade; P:heart development; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of chemokine (C-X-C motif) ligand 2 production; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of interleukin-8 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of response to cytokine stimulus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:positive regulation of epithelial cell proliferation; P:positive regulation of protein metabolic process; P:positive regulation of transcription by RNA polymerase II; P:signal transduction;|Q13163 B4DE43 Q92961 Q92962,Dual specificity mitogen-activated protein kinase kinase 5,MAPK/ERK kinase 5;, PF00564;PF00069;, GO:0005829;GO:0005634;GO:0005819;GO:0005524;GO:0004708;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0004714;GO:0000187;GO:0071363;GO:0071499;GO:0070375;GO:0007507;GO:0090051;GO:2000342;GO:0043154;GO:2001240;GO:0034115;GO:0032717;GO:0032088;GO:0060761;GO:0000122;GO:0030307;GO:0050679;GO:0051247;GO:0045944;GO:0007165;, C:cytosol; C:nucleus; C:spindle;, F:ATP binding; F:MAP kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:cellular response to growth factor stimulus; P:cellular response to laminar fluid shear stress; P:ERK5 cascade; P:heart development; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of chemokine (C-X-C motif) ligand 2 production; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of interleukin-8 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of response to cytokine stimulus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:positive regulation of epithelial cell proliferation; P:positive regulation of protein metabolic process; P:positive regulation of transcription by RNA polymerase II; P:signal transduction;|Q13163 B4DE43 Q92961 Q92962,Dual specificity mitogen-activated protein kinase kinase 5,MAPK/ERK kinase 5;, PF00564;PF00069;, GO:0005829;GO:0005634;GO:0005819;GO:0005524;GO:0004708;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0004714;GO:0000187;GO:0071363;GO:0071499;GO:0070375;GO:0007507;GO:0090051;GO:2000342;GO:0043154;GO:2001240;GO:0034115;GO:0032717;GO:0032088;GO:0060761;GO:0000122;GO:0030307;GO:0050679;GO:0051247;GO:0045944;GO:0007165;, C:cytosol; C:nucleus; C:spindle;, F:ATP binding; F:MAP kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:cellular response to growth factor stimulus; P:cellular response to laminar fluid shear stress; P:ERK5 cascade; P:heart development; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of chemokine (C-X-C motif) ligand 2 production; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of interleukin-8 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of response to cytokine stimulus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:positive regulation of epithelial cell proliferation; P:positive regulation of protein metabolic process; P:positive regulation of transcription by RNA polymerase II; P:signal transduction; scaffold42 indexed_genome mRNA 13873005 13879680 . + . ID=transcript_8559;P84550 A6NIP4 A6NJY0 Q2VWA5,SKI family transcriptional corepressor 1,Functional Smad-suppressing element on chromosome 15;LBX1 corepressor 1;Ladybird homeobox corepressor 1;, PF08782;PF02437;, GO:0030425;GO:0043025;GO:0005634;GO:0005667;GO:0000981;GO:0000978;GO:1990837;GO:0046332;GO:0030514;GO:0000122;GO:0006355;, C:dendrite; C:neuronal cell body; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SMAD binding;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P84550 A6NIP4 A6NJY0 Q2VWA5,SKI family transcriptional corepressor 1,Functional Smad-suppressing element on chromosome 15;LBX1 corepressor 1;Ladybird homeobox corepressor 1;, PF08782;PF02437;, GO:0030425;GO:0043025;GO:0005634;GO:0005667;GO:0000981;GO:0000978;GO:1990837;GO:0046332;GO:0030514;GO:0000122;GO:0006355;, C:dendrite; C:neuronal cell body; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SMAD binding;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold42 indexed_genome mRNA 14124065 14210801 . + . ID=transcript_8560;O75925 B2RB67 B3KSY9 C5J4B4 Q147X4 Q99751 Q9UN02,E3 SUMO-protein ligase PIAS1,DEAD/H box-binding protein 1;E3 SUMO-protein transferase PIAS1 {ECO:0000305};Gu-binding protein;Protein inhibitor of activated STAT protein 1;RNA helicase II-binding protein;, PF14324;PF02891;, GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0019899;GO:0008022;GO:0019904;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0003714;GO:0031625;GO:0008270;GO:0045444;GO:0000082;GO:0043066;GO:0000122;GO:0032436;GO:0033235;GO:0051152;GO:0045893;GO:0016925;GO:0065004;GO:0007259;GO:0042127;GO:0060334;GO:0006357;GO:0007283;GO:0016032;GO:0008542;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:enzyme binding; F:protein C-terminus binding; F:protein domain specific binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:transcription corepressor activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:fat cell differentiation; P:G1/S transition of mitotic cell cycle; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein sumoylation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription, DNA-templated; P:protein sumoylation; P:protein-DNA complex assembly; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:viral process; P:visual learning;|O75925 B2RB67 B3KSY9 C5J4B4 Q147X4 Q99751 Q9UN02,E3 SUMO-protein ligase PIAS1,DEAD/H box-binding protein 1;E3 SUMO-protein transferase PIAS1 {ECO:0000305};Gu-binding protein;Protein inhibitor of activated STAT protein 1;RNA helicase II-binding protein;, PF14324;PF02891;, GO:0016607;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0019899;GO:0008022;GO:0019904;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0003714;GO:0031625;GO:0008270;GO:0045444;GO:0000082;GO:0043066;GO:0000122;GO:0032436;GO:0033235;GO:0051152;GO:0045893;GO:0016925;GO:0065004;GO:0007259;GO:0042127;GO:0060334;GO:0006357;GO:0007283;GO:0016032;GO:0008542;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:enzyme binding; F:protein C-terminus binding; F:protein domain specific binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:transcription corepressor activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:fat cell differentiation; P:G1/S transition of mitotic cell cycle; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein sumoylation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription, DNA-templated; P:protein sumoylation; P:protein-DNA complex assembly; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:viral process; P:visual learning; scaffold42 indexed_genome mRNA 14216367 14226091 . - . ID=transcript_8561;Q96GE6 B4DL15 F8W6Y4 Q6MZY3 Q6N048 Q9H286,Calmodulin-like protein 4,Serologically defined breast cancer antigen NY-BR-20;, PF13499;, GO:0005509;GO:0030234;, , F:calcium ion binding; F:enzyme regulator activity;|Q96GE6 B4DL15 F8W6Y4 Q6MZY3 Q6N048 Q9H286,Calmodulin-like protein 4,Serologically defined breast cancer antigen NY-BR-20;, PF13499;, GO:0005509;GO:0030234;, , F:calcium ion binding; F:enzyme regulator activity;|Q9HCI6 A8K4M3 Q8IW25,E3 SUMO-protein ligase KIAA1586 {ECO:0000305},E3 SUMO-protein transferase KIAA1586 {ECO:0000305};, , GO:0061665;GO:0016925;, , F:SUMO ligase activity;, P:protein sumoylation; scaffold42 indexed_genome mRNA 14231168 14252857 . - . ID=transcript_8562;Q9NWW5 A8K560 B4DDH6 Q6IAB1 Q96SR0,Ceroid-lipofuscinosis neuronal protein 6,, PF15156;, GO:0005769;GO:0005783;GO:0005788;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0045121;GO:0005730;GO:0035727;GO:0042803;GO:0120146;GO:0044265;GO:0008203;GO:0001573;GO:0030203;GO:0031987;GO:0007042;GO:0007040;GO:0045862;GO:0030163;GO:0007601;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:nucleolus;, F:lysophosphatidic acid binding; F:protein homodimerization activity; F:sulfatide binding;, P:cellular macromolecule catabolic process; P:cholesterol metabolic process; P:ganglioside metabolic process; P:glycosaminoglycan metabolic process; P:locomotion involved in locomotory behavior; P:lysosomal lumen acidification; P:lysosome organization; P:positive regulation of proteolysis; P:protein catabolic process; P:visual perception; scaffold42 indexed_genome mRNA 14305351 14313235 . - . ID=transcript_8563;Q9UK73 O43146,Protein fem-1 homolog B,FEM1-beta;Fem-1-like death receptor-binding protein alpha;Fem-1-like in apoptotic pathway protein alpha;, PF00023;PF12796;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005123;GO:0006915;GO:0060442;GO:0060743;GO:0043687;GO:0016567;GO:2000001;GO:1902041;GO:0051438;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:death receptor binding;, P:apoptotic process; P:branching involved in prostate gland morphogenesis; P:epithelial cell maturation involved in prostate gland development; P:post-translational protein modification; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of ubiquitin-protein transferase activity;|Q9UK73 O43146,Protein fem-1 homolog B,FEM1-beta;Fem-1-like death receptor-binding protein alpha;Fem-1-like in apoptotic pathway protein alpha;, PF00023;PF12796;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005123;GO:0006915;GO:0060442;GO:0060743;GO:0043687;GO:0016567;GO:2000001;GO:1902041;GO:0051438;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:death receptor binding;, P:apoptotic process; P:branching involved in prostate gland morphogenesis; P:epithelial cell maturation involved in prostate gland development; P:post-translational protein modification; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of ubiquitin-protein transferase activity; scaffold42 indexed_genome mRNA 14325138 14375042 . - . ID=transcript_8564;Q9UKX5 J3KQM2 Q8WYI8 Q9UKQ1,Integrin alpha-11,, PF01839;PF08441;PF00092;, GO:0005925;GO:0034681;GO:0008305;GO:0016020;GO:0005886;GO:0005518;GO:0098639;GO:0038064;GO:0046872;GO:0007155;GO:0033627;GO:0007160;GO:0038065;GO:0030198;GO:0007229;GO:0007517;GO:0001649;GO:0006929;, C:focal adhesion; C:integrin alpha11-beta1 complex; C:integrin complex; C:membrane; C:plasma membrane;, F:collagen binding; F:collagen binding involved in cell-matrix adhesion; F:collagen receptor activity; F:metal ion binding;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cell-matrix adhesion; P:collagen-activated signaling pathway; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:muscle organ development; P:osteoblast differentiation; P:substrate-dependent cell migration; scaffold42 indexed_genome mRNA 14755228 14758658 . + . ID=transcript_8565;Q9UQ03 A8K0W3 O94767 Q8TAN1,Coronin-2B,Coronin-like protein C;Protein FC96;, PF08953;PF00400;, GO:0015629;GO:0005737;GO:0005925;GO:0016020;GO:0003779;GO:0051015;GO:1990147;GO:0017166;GO:0030036;GO:0048041;GO:0010812;GO:1904950;GO:0051497;GO:1904951;GO:0032956;GO:0080135;GO:0003093;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:membrane;, F:actin binding; F:actin filament binding; F:talin binding; F:vinculin binding;, P:actin cytoskeleton organization; P:focal adhesion assembly; P:negative regulation of cell-substrate adhesion; P:negative regulation of establishment of protein localization; P:negative regulation of stress fiber assembly; P:positive regulation of establishment of protein localization; P:regulation of actin cytoskeleton organization; P:regulation of cellular response to stress; P:regulation of glomerular filtration;|Q9UQ03 A8K0W3 O94767 Q8TAN1,Coronin-2B,Coronin-like protein C;Protein FC96;, PF08953;PF00400;, GO:0015629;GO:0005737;GO:0005925;GO:0016020;GO:0003779;GO:0051015;GO:1990147;GO:0017166;GO:0030036;GO:0048041;GO:0010812;GO:1904950;GO:0051497;GO:1904951;GO:0032956;GO:0080135;GO:0003093;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:membrane;, F:actin binding; F:actin filament binding; F:talin binding; F:vinculin binding;, P:actin cytoskeleton organization; P:focal adhesion assembly; P:negative regulation of cell-substrate adhesion; P:negative regulation of establishment of protein localization; P:negative regulation of stress fiber assembly; P:positive regulation of establishment of protein localization; P:regulation of actin cytoskeleton organization; P:regulation of cellular response to stress; P:regulation of glomerular filtration; scaffold42 indexed_genome mRNA 14760882 14772865 . + . ID=transcript_8566;Q9UQ03 A8K0W3 O94767 Q8TAN1,Coronin-2B,Coronin-like protein C;Protein FC96;, PF08953;PF00400;, GO:0015629;GO:0005737;GO:0005925;GO:0016020;GO:0003779;GO:0051015;GO:1990147;GO:0017166;GO:0030036;GO:0048041;GO:0010812;GO:1904950;GO:0051497;GO:1904951;GO:0032956;GO:0080135;GO:0003093;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:membrane;, F:actin binding; F:actin filament binding; F:talin binding; F:vinculin binding;, P:actin cytoskeleton organization; P:focal adhesion assembly; P:negative regulation of cell-substrate adhesion; P:negative regulation of establishment of protein localization; P:negative regulation of stress fiber assembly; P:positive regulation of establishment of protein localization; P:regulation of actin cytoskeleton organization; P:regulation of cellular response to stress; P:regulation of glomerular filtration;|Q9UQ03 A8K0W3 O94767 Q8TAN1,Coronin-2B,Coronin-like protein C;Protein FC96;, PF08953;PF00400;, GO:0015629;GO:0005737;GO:0005925;GO:0016020;GO:0003779;GO:0051015;GO:1990147;GO:0017166;GO:0030036;GO:0048041;GO:0010812;GO:1904950;GO:0051497;GO:1904951;GO:0032956;GO:0080135;GO:0003093;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:membrane;, F:actin binding; F:actin filament binding; F:talin binding; F:vinculin binding;, P:actin cytoskeleton organization; P:focal adhesion assembly; P:negative regulation of cell-substrate adhesion; P:negative regulation of establishment of protein localization; P:negative regulation of stress fiber assembly; P:positive regulation of establishment of protein localization; P:regulation of actin cytoskeleton organization; P:regulation of cellular response to stress; P:regulation of glomerular filtration; scaffold42 indexed_genome mRNA 14819612 14821957 . - . ID=transcript_8567;P39687 B2R6T4 Q53FK4 Q5J8L8 Q7M4N6,Acidic leucine-rich nuclear phosphoprotein 32 family member A {ECO:0000303|PubMed:33045004, ECO:0000303|PubMed:33208942},Acidic nuclear phosphoprotein pp32;Leucine-rich acidic nuclear protein;Mapmodulin;Potent heat-stable protein phosphatase 2A inhibitor I1PP2A;Putative HLA-DR-associated protein I;, , GO:0005737;GO:0005783;GO:0005654;GO:0005634;GO:0048471;GO:0042393;GO:0003723;GO:0035556;GO:0006913;GO:0042981;GO:0043488;, C:cytoplasm; C:endoplasmic reticulum; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:histone binding; F:RNA binding;, P:intracellular signal transduction; P:nucleocytoplasmic transport; P:regulation of apoptotic process; P:regulation of mRNA stability; scaffold42 indexed_genome mRNA 14822427 14826020 . + . ID=transcript_8568;P39687 B2R6T4 Q53FK4 Q5J8L8 Q7M4N6,Acidic leucine-rich nuclear phosphoprotein 32 family member A {ECO:0000303|PubMed:33045004, ECO:0000303|PubMed:33208942},Acidic nuclear phosphoprotein pp32;Leucine-rich acidic nuclear protein;Mapmodulin;Potent heat-stable protein phosphatase 2A inhibitor I1PP2A;Putative HLA-DR-associated protein I;, , GO:0005737;GO:0005783;GO:0005654;GO:0005634;GO:0048471;GO:0042393;GO:0003723;GO:0035556;GO:0006913;GO:0042981;GO:0043488;, C:cytoplasm; C:endoplasmic reticulum; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:histone binding; F:RNA binding;, P:intracellular signal transduction; P:nucleocytoplasmic transport; P:regulation of apoptotic process; P:regulation of mRNA stability;|O43423 Q4W5F9,Acidic leucine-rich nuclear phosphoprotein 32 family member C,Phosphoprotein 32-related protein 1;Tumorigenic protein pp32r1;, , GO:0048471;GO:0042393;GO:0006913;GO:0042981;, C:perinuclear region of cytoplasm;, F:histone binding;, P:nucleocytoplasmic transport; P:regulation of apoptotic process; scaffold42 indexed_genome mRNA 14878039 14878990 . + . ID=transcript_8569;Q92628 A7E2D2,Uncharacterized protein KIAA0232,, PF15376;, GO:0005524;, , F:ATP binding; scaffold42 indexed_genome mRNA 15061933 15081057 . + . ID=transcript_8570;Q9H6E0 Q9HAM8,NADPH oxidase 5,, PF13202;PF13405;PF08022;PF01794;PF08030;, GO:0005783;GO:0005789;GO:0016021;GO:0005886;GO:0005509;GO:0000293;GO:0050660;GO:0020037;GO:0050661;GO:0015252;GO:0016175;GO:0001525;GO:0006915;GO:0034599;GO:0061640;GO:0001935;GO:0001819;GO:2000379;GO:1902600;GO:0033215;GO:0043012;GO:0042554;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:ferric-chelate reductase activity; F:flavin adenine dinucleotide binding; F:heme binding; F:NADP binding; F:proton channel activity; F:superoxide-generating NAD(P)H oxidase activity;, P:angiogenesis; P:apoptotic process; P:cellular response to oxidative stress; P:cytoskeleton-dependent cytokinesis; P:endothelial cell proliferation; P:positive regulation of cytokine production; P:positive regulation of reactive oxygen species metabolic process; P:proton transmembrane transport; P:reductive iron assimilation; P:regulation of fusion of sperm to egg plasma membrane; P:superoxide anion generation; scaffold42 indexed_genome mRNA 15295609 15296249 . - . ID=transcript_8571;O71037 Q69386 Q9YNA7,Endogenous retrovirus group K member 19 Env polyprotein,EnvK3 protein;Envelope polyprotein;HERV-K(C19) envelope protein;HERV-K_19q11 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity; scaffold42 indexed_genome mRNA 15326866 15338805 . - . ID=transcript_8572;O94923 Q6GUQ2,D-glucuronyl C5-epimerase,Heparan sulfate C5-epimerase;Heparin/heparan sulfate:glucuronic acid C5-epimerase;Heparosan-N-sulfate-glucuronate 5-epimerase;, PF06662;, GO:0005794;GO:0000139;GO:0016021;GO:0005509;GO:0047464;GO:0042803;GO:0016857;GO:0015012;GO:0030210;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:heparosan-N-sulfate-glucuronate 5-epimerase activity; F:protein homodimerization activity; F:racemase and epimerase activity, acting on carbohydrates and derivatives;, P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process;|O94923 Q6GUQ2,D-glucuronyl C5-epimerase,Heparan sulfate C5-epimerase;Heparin/heparan sulfate:glucuronic acid C5-epimerase;Heparosan-N-sulfate-glucuronate 5-epimerase;, PF06662;, GO:0005794;GO:0000139;GO:0016021;GO:0005509;GO:0047464;GO:0042803;GO:0016857;GO:0015012;GO:0030210;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:heparosan-N-sulfate-glucuronate 5-epimerase activity; F:protein homodimerization activity; F:racemase and epimerase activity, acting on carbohydrates and derivatives;, P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process;|O94923 Q6GUQ2,D-glucuronyl C5-epimerase,Heparan sulfate C5-epimerase;Heparin/heparan sulfate:glucuronic acid C5-epimerase;Heparosan-N-sulfate-glucuronate 5-epimerase;, PF06662;, GO:0005794;GO:0000139;GO:0016021;GO:0005509;GO:0047464;GO:0042803;GO:0016857;GO:0015012;GO:0030210;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:heparosan-N-sulfate-glucuronate 5-epimerase activity; F:protein homodimerization activity; F:racemase and epimerase activity, acting on carbohydrates and derivatives;, P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process;|O94923 Q6GUQ2,D-glucuronyl C5-epimerase,Heparan sulfate C5-epimerase;Heparin/heparan sulfate:glucuronic acid C5-epimerase;Heparosan-N-sulfate-glucuronate 5-epimerase;, PF06662;, GO:0005794;GO:0000139;GO:0016021;GO:0005509;GO:0047464;GO:0042803;GO:0016857;GO:0015012;GO:0030210;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:calcium ion binding; F:heparosan-N-sulfate-glucuronate 5-epimerase activity; F:protein homodimerization activity; F:racemase and epimerase activity, acting on carbohydrates and derivatives;, P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process; scaffold42 indexed_genome mRNA 15445635 15465946 . + . ID=transcript_8573;Q9NXK6 Q8IXU2,Membrane progestin receptor gamma {ECO:0000303|PubMed:23763432},Membrane progesterone P4 receptor gamma {ECO:0000303|PubMed:23763432};Membrane progesterone receptor gamma {ECO:0000303|PubMed:23763432};Progesterone and adipoQ receptor family member 5;Progestin and adipoQ receptor family member 5 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member V;, PF03006;, GO:0016021;GO:0005886;GO:0038023;GO:0005496;GO:0007275;GO:0048477;, C:integral component of membrane; C:plasma membrane;, F:signaling receptor activity; F:steroid binding;, P:multicellular organism development; P:oogenesis; scaffold42 indexed_genome mRNA 15501759 15517831 . + . ID=transcript_8574;Q02241 B4E1K0 Q8WVP0,Kinesin-like protein KIF23,Kinesin-like protein 5;Mitotic kinesin-like protein 1;, PF00225;PF16540;, GO:0097149;GO:0005813;GO:0005829;GO:0090543;GO:0005925;GO:0005871;GO:0005874;GO:0030496;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0019886;GO:0007018;GO:0000281;GO:0000022;GO:0051256;GO:0032467;GO:0006890;, C:centralspindlin complex; C:centrosome; C:cytosol; C:Flemming body; C:focal adhesion; C:kinesin complex; C:microtubule; C:midbody; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cytokinesis; P:mitotic spindle elongation; P:mitotic spindle midzone assembly; P:positive regulation of cytokinesis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q02241 B4E1K0 Q8WVP0,Kinesin-like protein KIF23,Kinesin-like protein 5;Mitotic kinesin-like protein 1;, PF00225;PF16540;, GO:0097149;GO:0005813;GO:0005829;GO:0090543;GO:0005925;GO:0005871;GO:0005874;GO:0030496;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0019886;GO:0007018;GO:0000281;GO:0000022;GO:0051256;GO:0032467;GO:0006890;, C:centralspindlin complex; C:centrosome; C:cytosol; C:Flemming body; C:focal adhesion; C:kinesin complex; C:microtubule; C:midbody; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cytokinesis; P:mitotic spindle elongation; P:mitotic spindle midzone assembly; P:positive regulation of cytokinesis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q02241 B4E1K0 Q8WVP0,Kinesin-like protein KIF23,Kinesin-like protein 5;Mitotic kinesin-like protein 1;, PF00225;PF16540;, GO:0097149;GO:0005813;GO:0005829;GO:0090543;GO:0005925;GO:0005871;GO:0005874;GO:0030496;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0019886;GO:0007018;GO:0000281;GO:0000022;GO:0051256;GO:0032467;GO:0006890;, C:centralspindlin complex; C:centrosome; C:cytosol; C:Flemming body; C:focal adhesion; C:kinesin complex; C:microtubule; C:midbody; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cytokinesis; P:mitotic spindle elongation; P:mitotic spindle midzone assembly; P:positive regulation of cytokinesis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold42 indexed_genome mRNA 15529999 15531660 . + . ID=transcript_8575;P05386 A6NIB2,60S acidic ribosomal protein P1,Large ribosomal subunit protein P1 {ECO:0000303|PubMed:24524803};, , GO:0005829;GO:0022625;GO:0005925;GO:0030295;GO:0043021;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006414;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion;, F:protein kinase activator activity; F:ribonucleoprotein complex binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational elongation; P:translational initiation; P:viral transcription; scaffold42 indexed_genome mRNA 16078897 16129888 . - . ID=transcript_8576;Q04726 B4DPT0 E9PD64 F8W964 Q6PI57 Q8IVV6 Q8WVR2 Q9HCM5,Transducin-like enhancer protein 3,Enhancer of split groucho-like protein 3;, PF03920;PF00400;, GO:1990907;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0009887;GO:1904837;GO:0090090;GO:0120163;GO:0007165;GO:0016055;, C:beta-catenin-TCF complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cold-induced thermogenesis; P:signal transduction; P:Wnt signaling pathway;|Q04724 A8K495 Q5T3G4 Q969V9,Transducin-like enhancer protein 1,E(Sp1) homolog;Enhancer of split groucho-like protein 1;, PF03920;PF00400;, GO:1990907;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0042802;GO:0070491;GO:0003714;GO:0008134;GO:0009887;GO:1904837;GO:0007275;GO:2000811;GO:0090090;GO:0043124;GO:0045892;GO:0030178;GO:0010628;GO:0007165;GO:0016055;, C:beta-catenin-TCF complex; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:multicellular organism development; P:negative regulation of anoikis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:positive regulation of gene expression; P:signal transduction; P:Wnt signaling pathway;|Q04726 B4DPT0 E9PD64 F8W964 Q6PI57 Q8IVV6 Q8WVR2 Q9HCM5,Transducin-like enhancer protein 3,Enhancer of split groucho-like protein 3;, PF03920;PF00400;, GO:1990907;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0009887;GO:1904837;GO:0090090;GO:0120163;GO:0007165;GO:0016055;, C:beta-catenin-TCF complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cold-induced thermogenesis; P:signal transduction; P:Wnt signaling pathway;|Q04726 B4DPT0 E9PD64 F8W964 Q6PI57 Q8IVV6 Q8WVR2 Q9HCM5,Transducin-like enhancer protein 3,Enhancer of split groucho-like protein 3;, PF03920;PF00400;, GO:1990907;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0009887;GO:1904837;GO:0090090;GO:0120163;GO:0007165;GO:0016055;, C:beta-catenin-TCF complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cold-induced thermogenesis; P:signal transduction; P:Wnt signaling pathway; scaffold42 indexed_genome mRNA 16680219 16726823 . - . ID=transcript_8577;Q9BZF9 G3XAG2 Q14DD3 Q8N3B8 Q96NH6 Q9HCL1 Q9NWC6,Uveal autoantigen with coiled-coil domains and ankyrin repeats,, PF12796;, GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0097190;GO:1901223;GO:0043280;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus;, , P:apoptotic signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;|Q9BZF9 G3XAG2 Q14DD3 Q8N3B8 Q96NH6 Q9HCL1 Q9NWC6,Uveal autoantigen with coiled-coil domains and ankyrin repeats,, PF12796;, GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0097190;GO:1901223;GO:0043280;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus;, , P:apoptotic signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;|Q9BZF9 G3XAG2 Q14DD3 Q8N3B8 Q96NH6 Q9HCL1 Q9NWC6,Uveal autoantigen with coiled-coil domains and ankyrin repeats,, PF12796;, GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0097190;GO:1901223;GO:0043280;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus;, , P:apoptotic signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;|Q9BZF9 G3XAG2 Q14DD3 Q8N3B8 Q96NH6 Q9HCL1 Q9NWC6,Uveal autoantigen with coiled-coil domains and ankyrin repeats,, PF12796;, GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0097190;GO:1901223;GO:0043280;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus;, , P:apoptotic signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;|Q9BZF9 G3XAG2 Q14DD3 Q8N3B8 Q96NH6 Q9HCL1 Q9NWC6,Uveal autoantigen with coiled-coil domains and ankyrin repeats,, PF12796;, GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005654;GO:0005634;GO:0097190;GO:1901223;GO:0043280;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleoplasm; C:nucleus;, , P:apoptotic signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; scaffold42 indexed_genome mRNA 16792003 16798041 . - . ID=transcript_8578;P11712 P11713 Q16756 Q16872 Q5VX92 Q6IRV8 Q8WW80,Cytochrome P450 2C9 {ECO:0000303|PubMed:8809086},(R)-limonene 6-monooxygenase;(S)-limonene 6-monooxygenase;(S)-limonene 7-monooxygenase;CYPIIC9;Cholesterol 25-hydroxylase {ECO:0000303|PubMed:3079764};Cytochrome P-450MP;Cytochrome P450 MP-4;Cytochrome P450 MP-8;Cytochrome P450 PB-1;S-mephenytoin 4-hydroxylase {ECO:0000303|PubMed:3079764};, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0052741;GO:0018675;GO:0018676;GO:0008405;GO:0008404;GO:0008392;GO:0070330;GO:0034875;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0008395;GO:0043603;GO:0008203;GO:0042737;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046456;GO:0042759;GO:0032787;GO:0016098;GO:0097267;GO:0006082;GO:0070989;GO:0008202;GO:0019627;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:(R)-limonene 6-monooxygenase activity; F:(S)-limonene 6-monooxygenase activity; F:(S)-limonene 7-monooxygenase activity; F:arachidonic acid 11,12-epoxygenase activity; F:arachidonic acid 14,15-epoxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:caffeine oxidase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:cellular amide metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:icosanoid biosynthetic process; P:long-chain fatty acid biosynthetic process; P:monocarboxylic acid metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:organic acid metabolic process; P:oxidative demethylation; P:steroid metabolic process; P:urea metabolic process; P:xenobiotic metabolic process; scaffold42 indexed_genome mRNA 16896181 17049848 . + . ID=transcript_8579;Q8IUZ0 B3KVX1 B7Z366 F5H1J4 G5E9T5 H0YLN4 Q9NXM6,Leucine-rich repeat-containing protein 49,Tubulin polyglutamylase complex subunit 4;, , GO:0005737;GO:0005874;GO:0036158;, C:cytoplasm; C:microtubule;, , P:outer dynein arm assembly;|Q8IUZ0 B3KVX1 B7Z366 F5H1J4 G5E9T5 H0YLN4 Q9NXM6,Leucine-rich repeat-containing protein 49,Tubulin polyglutamylase complex subunit 4;, , GO:0005737;GO:0005874;GO:0036158;, C:cytoplasm; C:microtubule;, , P:outer dynein arm assembly; scaffold42 indexed_genome mRNA 17701468 17719595 . + . ID=transcript_8580;Q6ZMP0 B2RTY3 B4DR13 Q6MZI3 Q6UXZ8 Q9H8E4,Thrombospondin type-1 domain-containing protein 4,A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6;, PF05986;PF08686;PF00090;, GO:0062023;GO:0070062;GO:0031012;GO:0001527;GO:0004222;GO:0048251;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:microfibril;, F:metalloendopeptidase activity;, P:elastic fiber assembly; P:extracellular matrix organization; scaffold42 indexed_genome mRNA 17779492 18039401 . - . ID=transcript_8581;Q9NTG2 Q9NUY2 Q9UEP3 Q9UNJ2,Unconventional myosin-IXa,Unconventional myosin-9a;, PF00612;PF00063;PF00788;PF00620;, GO:0044295;GO:0005829;GO:0016021;GO:0045202;GO:0016461;GO:0003779;GO:0005524;GO:0005096;GO:0046872;GO:0003774;GO:0034329;GO:0045198;GO:0035556;GO:0150011;GO:0051056;GO:0007601;, C:axonal growth cone; C:cytosol; C:integral component of membrane; C:synapse; C:unconventional myosin complex;, F:actin binding; F:ATP binding; F:GTPase activator activity; F:metal ion binding; F:motor activity;, P:cell junction assembly; P:establishment of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:regulation of neuron projection arborization; P:regulation of small GTPase mediated signal transduction; P:visual perception;|Q9NTG2 Q9NUY2 Q9UEP3 Q9UNJ2,Unconventional myosin-IXa,Unconventional myosin-9a;, PF00612;PF00063;PF00788;PF00620;, GO:0044295;GO:0005829;GO:0016021;GO:0045202;GO:0016461;GO:0003779;GO:0005524;GO:0005096;GO:0046872;GO:0003774;GO:0034329;GO:0045198;GO:0035556;GO:0150011;GO:0051056;GO:0007601;, C:axonal growth cone; C:cytosol; C:integral component of membrane; C:synapse; C:unconventional myosin complex;, F:actin binding; F:ATP binding; F:GTPase activator activity; F:metal ion binding; F:motor activity;, P:cell junction assembly; P:establishment of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:regulation of neuron projection arborization; P:regulation of small GTPase mediated signal transduction; P:visual perception;|Q9NTG2 Q9NUY2 Q9UEP3 Q9UNJ2,Unconventional myosin-IXa,Unconventional myosin-9a;, PF00612;PF00063;PF00788;PF00620;, GO:0044295;GO:0005829;GO:0016021;GO:0045202;GO:0016461;GO:0003779;GO:0005524;GO:0005096;GO:0046872;GO:0003774;GO:0034329;GO:0045198;GO:0035556;GO:0150011;GO:0051056;GO:0007601;, C:axonal growth cone; C:cytosol; C:integral component of membrane; C:synapse; C:unconventional myosin complex;, F:actin binding; F:ATP binding; F:GTPase activator activity; F:metal ion binding; F:motor activity;, P:cell junction assembly; P:establishment of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:regulation of neuron projection arborization; P:regulation of small GTPase mediated signal transduction; P:visual perception; scaffold42 indexed_genome mRNA 18039728 18056467 . + . ID=transcript_8582;Q96LD8 Q96QA4,Sentrin-specific protease 8,Deneddylase-1;NEDD8-specific protease 1;Protease, cysteine 2;Sentrin/SUMO-specific protease SENP8;, PF02902;, GO:0005829;GO:0008234;GO:0043687;GO:0016579;, C:cytosol;, F:cysteine-type peptidase activity;, P:post-translational protein modification; P:protein deubiquitination; scaffold42 indexed_genome mRNA 18074632 18104999 . + . ID=transcript_8583;Q8IUY3 B3KT68,GRAM domain-containing protein 2A {ECO:0000305},, PF02893;, GO:0031234;GO:0016021;GO:0031227;GO:0044232;GO:0035091;GO:0005546;GO:0061817;GO:2001256;, C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site;, F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:endoplasmic reticulum-plasma membrane tethering; P:regulation of store-operated calcium entry;|Q8IUY3 B3KT68,GRAM domain-containing protein 2A {ECO:0000305},, PF02893;, GO:0031234;GO:0016021;GO:0031227;GO:0044232;GO:0035091;GO:0005546;GO:0061817;GO:2001256;, C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site;, F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:endoplasmic reticulum-plasma membrane tethering; P:regulation of store-operated calcium entry;|Q8IUY3 B3KT68,GRAM domain-containing protein 2A {ECO:0000305},, PF02893;, GO:0031234;GO:0016021;GO:0031227;GO:0044232;GO:0035091;GO:0005546;GO:0061817;GO:2001256;, C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site;, F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:endoplasmic reticulum-plasma membrane tethering; P:regulation of store-operated calcium entry;|Q8IUY3 B3KT68,GRAM domain-containing protein 2A {ECO:0000305},, PF02893;, GO:0031234;GO:0016021;GO:0031227;GO:0044232;GO:0035091;GO:0005546;GO:0061817;GO:2001256;, C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site;, F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:endoplasmic reticulum-plasma membrane tethering; P:regulation of store-operated calcium entry;|Q8IUY3 B3KT68,GRAM domain-containing protein 2A {ECO:0000305},, PF02893;, GO:0031234;GO:0016021;GO:0031227;GO:0044232;GO:0035091;GO:0005546;GO:0061817;GO:2001256;, C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site;, F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:endoplasmic reticulum-plasma membrane tethering; P:regulation of store-operated calcium entry; scaffold42 indexed_genome mRNA 18107707 18134038 . - . ID=transcript_8584;Q9BWB5 Q9UCV6 Q9UPF2,Pyruvate kinase PKM,Cytosolic thyroid hormone-binding protein;Opa-interacting protein 3;Pyruvate kinase 2/3;Pyruvate kinase muscle isozyme;Thyroid hormone-binding protein 1;Tumor M2-PK;p58;, PF00224;PF02887;, GO:0005929;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:1904813;GO:0005739;GO:0005634;GO:1902912;GO:0005791;GO:0034774;GO:0031982;GO:0043531;GO:0005524;GO:0045296;GO:0042802;GO:0016301;GO:0000287;GO:0023026;GO:0003729;GO:0030955;GO:0004743;GO:0003723;GO:0070324;GO:0031100;GO:0006754;GO:0061621;GO:0032869;GO:0006096;GO:0001889;GO:0043312;GO:2000767;GO:1903672;GO:0012501;GO:0042866;GO:0009629;GO:0001666;GO:0014870;GO:0007584;GO:0043403;, C:cilium; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:ficolin-1-rich granule lumen; C:mitochondrion; C:nucleus; C:pyruvate kinase complex; C:rough endoplasmic reticulum; C:secretory granule lumen; C:vesicle;, F:ADP binding; F:ATP binding; F:cadherin binding; F:identical protein binding; F:kinase activity; F:magnesium ion binding; F:MHC class II protein complex binding; F:mRNA binding; F:potassium ion binding; F:pyruvate kinase activity; F:RNA binding; F:thyroid hormone binding;, P:animal organ regeneration; P:ATP biosynthetic process; P:canonical glycolysis; P:cellular response to insulin stimulus; P:glycolytic process; P:liver development; P:neutrophil degranulation; P:positive regulation of cytoplasmic translation; P:positive regulation of sprouting angiogenesis; P:programmed cell death; P:pyruvate biosynthetic process; P:response to gravity; P:response to hypoxia; P:response to muscle inactivity; P:response to nutrient; P:skeletal muscle tissue regeneration;|Q9BWB5 Q9UCV6 Q9UPF2,Pyruvate kinase PKM,Cytosolic thyroid hormone-binding protein;Opa-interacting protein 3;Pyruvate kinase 2/3;Pyruvate kinase muscle isozyme;Thyroid hormone-binding protein 1;Tumor M2-PK;p58;, PF00224;PF02887;, GO:0005929;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:1904813;GO:0005739;GO:0005634;GO:1902912;GO:0005791;GO:0034774;GO:0031982;GO:0043531;GO:0005524;GO:0045296;GO:0042802;GO:0016301;GO:0000287;GO:0023026;GO:0003729;GO:0030955;GO:0004743;GO:0003723;GO:0070324;GO:0031100;GO:0006754;GO:0061621;GO:0032869;GO:0006096;GO:0001889;GO:0043312;GO:2000767;GO:1903672;GO:0012501;GO:0042866;GO:0009629;GO:0001666;GO:0014870;GO:0007584;GO:0043403;, C:cilium; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:ficolin-1-rich granule lumen; C:mitochondrion; C:nucleus; C:pyruvate kinase complex; C:rough endoplasmic reticulum; C:secretory granule lumen; C:vesicle;, F:ADP binding; F:ATP binding; F:cadherin binding; F:identical protein binding; F:kinase activity; F:magnesium ion binding; F:MHC class II protein complex binding; F:mRNA binding; F:potassium ion binding; F:pyruvate kinase activity; F:RNA binding; F:thyroid hormone binding;, P:animal organ regeneration; P:ATP biosynthetic process; P:canonical glycolysis; P:cellular response to insulin stimulus; P:glycolytic process; P:liver development; P:neutrophil degranulation; P:positive regulation of cytoplasmic translation; P:positive regulation of sprouting angiogenesis; P:programmed cell death; P:pyruvate biosynthetic process; P:response to gravity; P:response to hypoxia; P:response to muscle inactivity; P:response to nutrient; P:skeletal muscle tissue regeneration;|Q9BWB5 Q9UCV6 Q9UPF2,Pyruvate kinase PKM,Cytosolic thyroid hormone-binding protein;Opa-interacting protein 3;Pyruvate kinase 2/3;Pyruvate kinase muscle isozyme;Thyroid hormone-binding protein 1;Tumor M2-PK;p58;, PF00224;PF02887;, GO:0005929;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:1904813;GO:0005739;GO:0005634;GO:1902912;GO:0005791;GO:0034774;GO:0031982;GO:0043531;GO:0005524;GO:0045296;GO:0042802;GO:0016301;GO:0000287;GO:0023026;GO:0003729;GO:0030955;GO:0004743;GO:0003723;GO:0070324;GO:0031100;GO:0006754;GO:0061621;GO:0032869;GO:0006096;GO:0001889;GO:0043312;GO:2000767;GO:1903672;GO:0012501;GO:0042866;GO:0009629;GO:0001666;GO:0014870;GO:0007584;GO:0043403;, C:cilium; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:ficolin-1-rich granule lumen; C:mitochondrion; C:nucleus; C:pyruvate kinase complex; C:rough endoplasmic reticulum; C:secretory granule lumen; C:vesicle;, F:ADP binding; F:ATP binding; F:cadherin binding; F:identical protein binding; F:kinase activity; F:magnesium ion binding; F:MHC class II protein complex binding; F:mRNA binding; F:potassium ion binding; F:pyruvate kinase activity; F:RNA binding; F:thyroid hormone binding;, P:animal organ regeneration; P:ATP biosynthetic process; P:canonical glycolysis; P:cellular response to insulin stimulus; P:glycolytic process; P:liver development; P:neutrophil degranulation; P:positive regulation of cytoplasmic translation; P:positive regulation of sprouting angiogenesis; P:programmed cell death; P:pyruvate biosynthetic process; P:response to gravity; P:response to hypoxia; P:response to muscle inactivity; P:response to nutrient; P:skeletal muscle tissue regeneration;|Q9BWB5 Q9UCV6 Q9UPF2,Pyruvate kinase PKM,Cytosolic thyroid hormone-binding protein;Opa-interacting protein 3;Pyruvate kinase 2/3;Pyruvate kinase muscle isozyme;Thyroid hormone-binding protein 1;Tumor M2-PK;p58;, PF00224;PF02887;, GO:0005929;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1903561;GO:1904813;GO:0005739;GO:0005634;GO:1902912;GO:0005791;GO:0034774;GO:0031982;GO:0043531;GO:0005524;GO:0045296;GO:0042802;GO:0016301;GO:0000287;GO:0023026;GO:0003729;GO:0030955;GO:0004743;GO:0003723;GO:0070324;GO:0031100;GO:0006754;GO:0061621;GO:0032869;GO:0006096;GO:0001889;GO:0043312;GO:2000767;GO:1903672;GO:0012501;GO:0042866;GO:0009629;GO:0001666;GO:0014870;GO:0007584;GO:0043403;, C:cilium; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular vesicle; C:ficolin-1-rich granule lumen; C:mitochondrion; C:nucleus; C:pyruvate kinase complex; C:rough endoplasmic reticulum; C:secretory granule lumen; C:vesicle;, F:ADP binding; F:ATP binding; F:cadherin binding; F:identical protein binding; F:kinase activity; F:magnesium ion binding; F:MHC class II protein complex binding; F:mRNA binding; F:potassium ion binding; F:pyruvate kinase activity; F:RNA binding; F:thyroid hormone binding;, P:animal organ regeneration; P:ATP biosynthetic process; P:canonical glycolysis; P:cellular response to insulin stimulus; P:glycolytic process; P:liver development; P:neutrophil degranulation; P:positive regulation of cytoplasmic translation; P:positive regulation of sprouting angiogenesis; P:programmed cell death; P:pyruvate biosynthetic process; P:response to gravity; P:response to hypoxia; P:response to muscle inactivity; P:response to nutrient; P:skeletal muscle tissue regeneration; scaffold42 indexed_genome mRNA 18138762 18166652 . - . ID=transcript_8585;Q2NL67 Q9H7C5 Q9H9X6 Q9HAF3 Q9NPS6 Q9UFG4,Protein mono-ADP-ribosyltransferase PARP6 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 17;Poly [ADP-ribose] polymerase 6;, PF00644;, GO:0003950;GO:1990404;GO:0050775;GO:0006471;GO:0070213;GO:0140289;, , F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:positive regulation of dendrite morphogenesis; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation;|Q2NL67 Q9H7C5 Q9H9X6 Q9HAF3 Q9NPS6 Q9UFG4,Protein mono-ADP-ribosyltransferase PARP6 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 17;Poly [ADP-ribose] polymerase 6;, PF00644;, GO:0003950;GO:1990404;GO:0050775;GO:0006471;GO:0070213;GO:0140289;, , F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:positive regulation of dendrite morphogenesis; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation;|Q2NL67 Q9H7C5 Q9H9X6 Q9HAF3 Q9NPS6 Q9UFG4,Protein mono-ADP-ribosyltransferase PARP6 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 17;Poly [ADP-ribose] polymerase 6;, PF00644;, GO:0003950;GO:1990404;GO:0050775;GO:0006471;GO:0070213;GO:0140289;, , F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:positive regulation of dendrite morphogenesis; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation;|Q2NL67 Q9H7C5 Q9H9X6 Q9HAF3 Q9NPS6 Q9UFG4,Protein mono-ADP-ribosyltransferase PARP6 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 17;Poly [ADP-ribose] polymerase 6;, PF00644;, GO:0003950;GO:1990404;GO:0050775;GO:0006471;GO:0070213;GO:0140289;, , F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:positive regulation of dendrite morphogenesis; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation;|Q2NL67 Q9H7C5 Q9H9X6 Q9HAF3 Q9NPS6 Q9UFG4,Protein mono-ADP-ribosyltransferase PARP6 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 17;Poly [ADP-ribose] polymerase 6;, PF00644;, GO:0003950;GO:1990404;GO:0050775;GO:0006471;GO:0070213;GO:0140289;, , F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:positive regulation of dendrite morphogenesis; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; scaffold42 indexed_genome mRNA 18183692 18213577 . - . ID=transcript_8586;Q96J87 B4DG28 B4DJB6 Q6PII4 Q6ZNJ7 Q8N607,CUGBP Elav-like family member 6,Bruno-like protein 6;CUG-BP- and ETR-3-like factor 6;RNA-binding protein BRUNOL-6;, PF00076;, GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0003723;GO:0006376;GO:0000381;, C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:regulation of alternative mRNA splicing, via spliceosome; scaffold42 indexed_genome mRNA 18237451 18269157 . - . ID=transcript_8587;P06865 B4DKE7 E7ENH7 Q53HS8 Q6AI32,Beta-hexosaminidase subunit alpha {ECO:0000305},Beta-N-acetylhexosaminidase subunit alpha;N-acetyl-beta-glucosaminidase subunit alpha;, PF00728;PF14845;, GO:0042582;GO:0005829;GO:0070062;GO:0043231;GO:0043202;GO:0016020;GO:0008375;GO:0004563;GO:0102148;GO:0046982;GO:0005975;GO:0030207;GO:0006689;GO:0006024;GO:0006687;GO:0030214;GO:0042340;, C:azurophil granule; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:membrane;, F:acetylglucosaminyltransferase activity; F:beta-N-acetylhexosaminidase activity; F:N-acetyl-beta-D-galactosaminidase activity; F:protein heterodimerization activity;, P:carbohydrate metabolic process; P:chondroitin sulfate catabolic process; P:ganglioside catabolic process; P:glycosaminoglycan biosynthetic process; P:glycosphingolipid metabolic process; P:hyaluronan catabolic process; P:keratan sulfate catabolic process;|P06865 B4DKE7 E7ENH7 Q53HS8 Q6AI32,Beta-hexosaminidase subunit alpha {ECO:0000305},Beta-N-acetylhexosaminidase subunit alpha;N-acetyl-beta-glucosaminidase subunit alpha;, PF00728;PF14845;, GO:0042582;GO:0005829;GO:0070062;GO:0043231;GO:0043202;GO:0016020;GO:0008375;GO:0004563;GO:0102148;GO:0046982;GO:0005975;GO:0030207;GO:0006689;GO:0006024;GO:0006687;GO:0030214;GO:0042340;, C:azurophil granule; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:membrane;, F:acetylglucosaminyltransferase activity; F:beta-N-acetylhexosaminidase activity; F:N-acetyl-beta-D-galactosaminidase activity; F:protein heterodimerization activity;, P:carbohydrate metabolic process; P:chondroitin sulfate catabolic process; P:ganglioside catabolic process; P:glycosaminoglycan biosynthetic process; P:glycosphingolipid metabolic process; P:hyaluronan catabolic process; P:keratan sulfate catabolic process;|P06865 B4DKE7 E7ENH7 Q53HS8 Q6AI32,Beta-hexosaminidase subunit alpha {ECO:0000305},Beta-N-acetylhexosaminidase subunit alpha;N-acetyl-beta-glucosaminidase subunit alpha;, PF00728;PF14845;, GO:0042582;GO:0005829;GO:0070062;GO:0043231;GO:0043202;GO:0016020;GO:0008375;GO:0004563;GO:0102148;GO:0046982;GO:0005975;GO:0030207;GO:0006689;GO:0006024;GO:0006687;GO:0030214;GO:0042340;, C:azurophil granule; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:membrane;, F:acetylglucosaminyltransferase activity; F:beta-N-acetylhexosaminidase activity; F:N-acetyl-beta-D-galactosaminidase activity; F:protein heterodimerization activity;, P:carbohydrate metabolic process; P:chondroitin sulfate catabolic process; P:ganglioside catabolic process; P:glycosaminoglycan biosynthetic process; P:glycosphingolipid metabolic process; P:hyaluronan catabolic process; P:keratan sulfate catabolic process;|P06865 B4DKE7 E7ENH7 Q53HS8 Q6AI32,Beta-hexosaminidase subunit alpha {ECO:0000305},Beta-N-acetylhexosaminidase subunit alpha;N-acetyl-beta-glucosaminidase subunit alpha;, PF00728;PF14845;, GO:0042582;GO:0005829;GO:0070062;GO:0043231;GO:0043202;GO:0016020;GO:0008375;GO:0004563;GO:0102148;GO:0046982;GO:0005975;GO:0030207;GO:0006689;GO:0006024;GO:0006687;GO:0030214;GO:0042340;, C:azurophil granule; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:membrane;, F:acetylglucosaminyltransferase activity; F:beta-N-acetylhexosaminidase activity; F:N-acetyl-beta-D-galactosaminidase activity; F:protein heterodimerization activity;, P:carbohydrate metabolic process; P:chondroitin sulfate catabolic process; P:ganglioside catabolic process; P:glycosaminoglycan biosynthetic process; P:glycosphingolipid metabolic process; P:hyaluronan catabolic process; P:keratan sulfate catabolic process;|P06865 B4DKE7 E7ENH7 Q53HS8 Q6AI32,Beta-hexosaminidase subunit alpha {ECO:0000305},Beta-N-acetylhexosaminidase subunit alpha;N-acetyl-beta-glucosaminidase subunit alpha;, PF00728;PF14845;, GO:0042582;GO:0005829;GO:0070062;GO:0043231;GO:0043202;GO:0016020;GO:0008375;GO:0004563;GO:0102148;GO:0046982;GO:0005975;GO:0030207;GO:0006689;GO:0006024;GO:0006687;GO:0030214;GO:0042340;, C:azurophil granule; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:membrane;, F:acetylglucosaminyltransferase activity; F:beta-N-acetylhexosaminidase activity; F:N-acetyl-beta-D-galactosaminidase activity; F:protein heterodimerization activity;, P:carbohydrate metabolic process; P:chondroitin sulfate catabolic process; P:ganglioside catabolic process; P:glycosaminoglycan biosynthetic process; P:glycosphingolipid metabolic process; P:hyaluronan catabolic process; P:keratan sulfate catabolic process; scaffold42 indexed_genome mRNA 18301683 18303068 . + . ID=transcript_8588;A6NGA9,Transmembrane protein 202,, , GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold42 indexed_genome mRNA 18348462 18372169 . + . ID=transcript_8589;Q9Y4X5 B2R6U3 O76026 Q9H3T6 Q9UEN0 Q9UP39,E3 ubiquitin-protein ligase ARIH1,H7-AP2 {ECO:0000303|PubMed:10521492};HHARI {ECO:0000303|PubMed:11278816};Monocyte protein 6 {ECO:0000303|Ref.10};Protein ariadne-1 homolog {ECO:0000303|Ref.3};UbcH7-binding protein {ECO:0000303|PubMed:11278816};UbcM4-interacting protein;Ubiquitin-conjugating enzyme E2-binding protein 1 {ECO:0000303|PubMed:10521492};, PF01485;, GO:0015030;GO:0005737;GO:0005829;GO:0097413;GO:0016604;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0031625;GO:0019787;GO:0004842;GO:0008270;GO:0032436;GO:0000209;GO:0016567;GO:0006511;, C:Cajal body; C:cytoplasm; C:cytosol; C:Lewy body; C:nuclear body; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-like protein transferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold42 indexed_genome mRNA 18412272 18447981 . + . ID=transcript_8590;Q9Y4X5 B2R6U3 O76026 Q9H3T6 Q9UEN0 Q9UP39,E3 ubiquitin-protein ligase ARIH1,H7-AP2 {ECO:0000303|PubMed:10521492};HHARI {ECO:0000303|PubMed:11278816};Monocyte protein 6 {ECO:0000303|Ref.10};Protein ariadne-1 homolog {ECO:0000303|Ref.3};UbcH7-binding protein {ECO:0000303|PubMed:11278816};UbcM4-interacting protein;Ubiquitin-conjugating enzyme E2-binding protein 1 {ECO:0000303|PubMed:10521492};, PF01485;, GO:0015030;GO:0005737;GO:0005829;GO:0097413;GO:0016604;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0031625;GO:0019787;GO:0004842;GO:0008270;GO:0032436;GO:0000209;GO:0016567;GO:0006511;, C:Cajal body; C:cytoplasm; C:cytosol; C:Lewy body; C:nuclear body; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-like protein transferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9Y4X5 B2R6U3 O76026 Q9H3T6 Q9UEN0 Q9UP39,E3 ubiquitin-protein ligase ARIH1,H7-AP2 {ECO:0000303|PubMed:10521492};HHARI {ECO:0000303|PubMed:11278816};Monocyte protein 6 {ECO:0000303|Ref.10};Protein ariadne-1 homolog {ECO:0000303|Ref.3};UbcH7-binding protein {ECO:0000303|PubMed:11278816};UbcM4-interacting protein;Ubiquitin-conjugating enzyme E2-binding protein 1 {ECO:0000303|PubMed:10521492};, PF01485;, GO:0015030;GO:0005737;GO:0005829;GO:0097413;GO:0016604;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0031625;GO:0019787;GO:0004842;GO:0008270;GO:0032436;GO:0000209;GO:0016567;GO:0006511;, C:Cajal body; C:cytoplasm; C:cytosol; C:Lewy body; C:nuclear body; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-like protein transferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9Y4X5 B2R6U3 O76026 Q9H3T6 Q9UEN0 Q9UP39,E3 ubiquitin-protein ligase ARIH1,H7-AP2 {ECO:0000303|PubMed:10521492};HHARI {ECO:0000303|PubMed:11278816};Monocyte protein 6 {ECO:0000303|Ref.10};Protein ariadne-1 homolog {ECO:0000303|Ref.3};UbcH7-binding protein {ECO:0000303|PubMed:11278816};UbcM4-interacting protein;Ubiquitin-conjugating enzyme E2-binding protein 1 {ECO:0000303|PubMed:10521492};, PF01485;, GO:0015030;GO:0005737;GO:0005829;GO:0097413;GO:0016604;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0031625;GO:0019787;GO:0004842;GO:0008270;GO:0032436;GO:0000209;GO:0016567;GO:0006511;, C:Cajal body; C:cytoplasm; C:cytosol; C:Lewy body; C:nuclear body; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-like protein transferase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold42 indexed_genome mRNA 18488486 18489919 . + . ID=transcript_8591;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold42 indexed_genome mRNA 18510117 18516061 . - . ID=transcript_8592;Q96RK4 B4E178 Q53DZ5 Q8NHU9 Q96H45,Bardet-Biedl syndrome 4 protein,, PF13181;, GO:0034464;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0060170;GO:0035869;GO:0005929;GO:0005829;GO:0031514;GO:0097730;GO:0005634;GO:0000242;GO:0043014;GO:0048487;GO:0034452;GO:0030674;GO:0001103;GO:0030534;GO:0048854;GO:0007098;GO:0021987;GO:0060271;GO:0016358;GO:0045444;GO:0001947;GO:0021766;GO:0046907;GO:0051457;GO:0032402;GO:0034454;GO:0000226;GO:0000281;GO:0038108;GO:0001843;GO:1905515;GO:0045494;GO:0045724;GO:0071539;GO:0061512;GO:0033365;GO:0015031;GO:0060296;GO:0032465;GO:0019216;GO:0001895;GO:0046548;GO:0007608;GO:0050893;GO:0007286;GO:0021756;GO:0007601;, C:BBSome; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:ciliary transition zone; C:cilium; C:cytosol; C:motile cilium; C:non-motile cilium; C:nucleus; C:pericentriolar material;, F:alpha-tubulin binding; F:beta-tubulin binding; F:dynactin binding; F:protein-macromolecule adaptor activity; F:RNA polymerase II repressing transcription factor binding;, P:adult behavior; P:brain morphogenesis; P:centrosome cycle; P:cerebral cortex development; P:cilium assembly; P:dendrite development; P:fat cell differentiation; P:heart looping; P:hippocampus development; P:intracellular transport; P:maintenance of protein location in nucleus; P:melanosome transport; P:microtubule anchoring at centrosome; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:negative regulation of appetite by leptin-mediated signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:protein localization to centrosome; P:protein localization to cilium; P:protein localization to organelle; P:protein transport; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of cytokinesis; P:regulation of lipid metabolic process; P:retina homeostasis; P:retinal rod cell development; P:sensory perception of smell; P:sensory processing; P:spermatid development; P:striatum development; P:visual perception;|Q96RK4 B4E178 Q53DZ5 Q8NHU9 Q96H45,Bardet-Biedl syndrome 4 protein,, PF13181;, GO:0034464;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0060170;GO:0035869;GO:0005929;GO:0005829;GO:0031514;GO:0097730;GO:0005634;GO:0000242;GO:0043014;GO:0048487;GO:0034452;GO:0030674;GO:0001103;GO:0030534;GO:0048854;GO:0007098;GO:0021987;GO:0060271;GO:0016358;GO:0045444;GO:0001947;GO:0021766;GO:0046907;GO:0051457;GO:0032402;GO:0034454;GO:0000226;GO:0000281;GO:0038108;GO:0001843;GO:1905515;GO:0045494;GO:0045724;GO:0071539;GO:0061512;GO:0033365;GO:0015031;GO:0060296;GO:0032465;GO:0019216;GO:0001895;GO:0046548;GO:0007608;GO:0050893;GO:0007286;GO:0021756;GO:0007601;, C:BBSome; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:ciliary transition zone; C:cilium; C:cytosol; C:motile cilium; C:non-motile cilium; C:nucleus; C:pericentriolar material;, F:alpha-tubulin binding; F:beta-tubulin binding; F:dynactin binding; F:protein-macromolecule adaptor activity; F:RNA polymerase II repressing transcription factor binding;, P:adult behavior; P:brain morphogenesis; P:centrosome cycle; P:cerebral cortex development; P:cilium assembly; P:dendrite development; P:fat cell differentiation; P:heart looping; P:hippocampus development; P:intracellular transport; P:maintenance of protein location in nucleus; P:melanosome transport; P:microtubule anchoring at centrosome; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:negative regulation of appetite by leptin-mediated signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:protein localization to centrosome; P:protein localization to cilium; P:protein localization to organelle; P:protein transport; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of cytokinesis; P:regulation of lipid metabolic process; P:retina homeostasis; P:retinal rod cell development; P:sensory perception of smell; P:sensory processing; P:spermatid development; P:striatum development; P:visual perception;|Q96RK4 B4E178 Q53DZ5 Q8NHU9 Q96H45,Bardet-Biedl syndrome 4 protein,, PF13181;, GO:0034464;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0060170;GO:0035869;GO:0005929;GO:0005829;GO:0031514;GO:0097730;GO:0005634;GO:0000242;GO:0043014;GO:0048487;GO:0034452;GO:0030674;GO:0001103;GO:0030534;GO:0048854;GO:0007098;GO:0021987;GO:0060271;GO:0016358;GO:0045444;GO:0001947;GO:0021766;GO:0046907;GO:0051457;GO:0032402;GO:0034454;GO:0000226;GO:0000281;GO:0038108;GO:0001843;GO:1905515;GO:0045494;GO:0045724;GO:0071539;GO:0061512;GO:0033365;GO:0015031;GO:0060296;GO:0032465;GO:0019216;GO:0001895;GO:0046548;GO:0007608;GO:0050893;GO:0007286;GO:0021756;GO:0007601;, C:BBSome; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:ciliary transition zone; C:cilium; C:cytosol; C:motile cilium; C:non-motile cilium; C:nucleus; C:pericentriolar material;, F:alpha-tubulin binding; F:beta-tubulin binding; F:dynactin binding; F:protein-macromolecule adaptor activity; F:RNA polymerase II repressing transcription factor binding;, P:adult behavior; P:brain morphogenesis; P:centrosome cycle; P:cerebral cortex development; P:cilium assembly; P:dendrite development; P:fat cell differentiation; P:heart looping; P:hippocampus development; P:intracellular transport; P:maintenance of protein location in nucleus; P:melanosome transport; P:microtubule anchoring at centrosome; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:negative regulation of appetite by leptin-mediated signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:protein localization to centrosome; P:protein localization to cilium; P:protein localization to organelle; P:protein transport; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of cytokinesis; P:regulation of lipid metabolic process; P:retina homeostasis; P:retinal rod cell development; P:sensory perception of smell; P:sensory processing; P:spermatid development; P:striatum development; P:visual perception; scaffold42 indexed_genome mRNA 18516177 18523529 . + . ID=transcript_8593;Q96RK4 B4E178 Q53DZ5 Q8NHU9 Q96H45,Bardet-Biedl syndrome 4 protein,, PF13181;, GO:0034464;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0060170;GO:0035869;GO:0005929;GO:0005829;GO:0031514;GO:0097730;GO:0005634;GO:0000242;GO:0043014;GO:0048487;GO:0034452;GO:0030674;GO:0001103;GO:0030534;GO:0048854;GO:0007098;GO:0021987;GO:0060271;GO:0016358;GO:0045444;GO:0001947;GO:0021766;GO:0046907;GO:0051457;GO:0032402;GO:0034454;GO:0000226;GO:0000281;GO:0038108;GO:0001843;GO:1905515;GO:0045494;GO:0045724;GO:0071539;GO:0061512;GO:0033365;GO:0015031;GO:0060296;GO:0032465;GO:0019216;GO:0001895;GO:0046548;GO:0007608;GO:0050893;GO:0007286;GO:0021756;GO:0007601;, C:BBSome; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:ciliary transition zone; C:cilium; C:cytosol; C:motile cilium; C:non-motile cilium; C:nucleus; C:pericentriolar material;, F:alpha-tubulin binding; F:beta-tubulin binding; F:dynactin binding; F:protein-macromolecule adaptor activity; F:RNA polymerase II repressing transcription factor binding;, P:adult behavior; P:brain morphogenesis; P:centrosome cycle; P:cerebral cortex development; P:cilium assembly; P:dendrite development; P:fat cell differentiation; P:heart looping; P:hippocampus development; P:intracellular transport; P:maintenance of protein location in nucleus; P:melanosome transport; P:microtubule anchoring at centrosome; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:negative regulation of appetite by leptin-mediated signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:protein localization to centrosome; P:protein localization to cilium; P:protein localization to organelle; P:protein transport; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of cytokinesis; P:regulation of lipid metabolic process; P:retina homeostasis; P:retinal rod cell development; P:sensory perception of smell; P:sensory processing; P:spermatid development; P:striatum development; P:visual perception;|Q96RK4 B4E178 Q53DZ5 Q8NHU9 Q96H45,Bardet-Biedl syndrome 4 protein,, PF13181;, GO:0034464;GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0060170;GO:0035869;GO:0005929;GO:0005829;GO:0031514;GO:0097730;GO:0005634;GO:0000242;GO:0043014;GO:0048487;GO:0034452;GO:0030674;GO:0001103;GO:0030534;GO:0048854;GO:0007098;GO:0021987;GO:0060271;GO:0016358;GO:0045444;GO:0001947;GO:0021766;GO:0046907;GO:0051457;GO:0032402;GO:0034454;GO:0000226;GO:0000281;GO:0038108;GO:0001843;GO:1905515;GO:0045494;GO:0045724;GO:0071539;GO:0061512;GO:0033365;GO:0015031;GO:0060296;GO:0032465;GO:0019216;GO:0001895;GO:0046548;GO:0007608;GO:0050893;GO:0007286;GO:0021756;GO:0007601;, C:BBSome; C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:ciliary transition zone; C:cilium; C:cytosol; C:motile cilium; C:non-motile cilium; C:nucleus; C:pericentriolar material;, F:alpha-tubulin binding; F:beta-tubulin binding; F:dynactin binding; F:protein-macromolecule adaptor activity; F:RNA polymerase II repressing transcription factor binding;, P:adult behavior; P:brain morphogenesis; P:centrosome cycle; P:cerebral cortex development; P:cilium assembly; P:dendrite development; P:fat cell differentiation; P:heart looping; P:hippocampus development; P:intracellular transport; P:maintenance of protein location in nucleus; P:melanosome transport; P:microtubule anchoring at centrosome; P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:negative regulation of appetite by leptin-mediated signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:protein localization to centrosome; P:protein localization to cilium; P:protein localization to organelle; P:protein transport; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of cytokinesis; P:regulation of lipid metabolic process; P:retina homeostasis; P:retinal rod cell development; P:sensory perception of smell; P:sensory processing; P:spermatid development; P:striatum development; P:visual perception; scaffold42 indexed_genome mRNA 18527295 18560253 . - . ID=transcript_8594;Q9BRR6 Q49AU7 Q8NBI1 Q8WZ90 Q96NF8 Q9H0A7,ADP-dependent glucokinase,RbBP-35;, PF04587;, GO:0005783;GO:0005789;GO:0005576;GO:0016020;GO:0043843;GO:0046872;GO:0006006;GO:0061620;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:membrane;, F:ADP-specific glucokinase activity; F:metal ion binding;, P:glucose metabolic process; P:glycolytic process through glucose-6-phosphate;|Q9BRR6 Q49AU7 Q8NBI1 Q8WZ90 Q96NF8 Q9H0A7,ADP-dependent glucokinase,RbBP-35;, PF04587;, GO:0005783;GO:0005789;GO:0005576;GO:0016020;GO:0043843;GO:0046872;GO:0006006;GO:0061620;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:membrane;, F:ADP-specific glucokinase activity; F:metal ion binding;, P:glucose metabolic process; P:glycolytic process through glucose-6-phosphate;|Q9BRR6 Q49AU7 Q8NBI1 Q8WZ90 Q96NF8 Q9H0A7,ADP-dependent glucokinase,RbBP-35;, PF04587;, GO:0005783;GO:0005789;GO:0005576;GO:0016020;GO:0043843;GO:0046872;GO:0006006;GO:0061620;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:membrane;, F:ADP-specific glucokinase activity; F:metal ion binding;, P:glucose metabolic process; P:glycolytic process through glucose-6-phosphate; scaffold42 indexed_genome mRNA 18928601 19083405 . + . ID=transcript_8595;Q92859 B7ZKM9 B7ZKN0 O00340 Q17RX1,Neogenin,Immunoglobulin superfamily DCC subclass member 2;, PF00041;PF07679;PF13895;PF06583;, GO:0005794;GO:0005887;GO:0005654;GO:0005886;GO:0098797;GO:0039706;GO:0038023;GO:0007411;GO:0007155;GO:0055072;GO:0030513;, C:Golgi apparatus; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:plasma membrane protein complex;, F:co-receptor binding; F:signaling receptor activity;, P:axon guidance; P:cell adhesion; P:iron ion homeostasis; P:positive regulation of BMP signaling pathway;|Q92859 B7ZKM9 B7ZKN0 O00340 Q17RX1,Neogenin,Immunoglobulin superfamily DCC subclass member 2;, PF00041;PF07679;PF13895;PF06583;, GO:0005794;GO:0005887;GO:0005654;GO:0005886;GO:0098797;GO:0039706;GO:0038023;GO:0007411;GO:0007155;GO:0055072;GO:0030513;, C:Golgi apparatus; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:plasma membrane protein complex;, F:co-receptor binding; F:signaling receptor activity;, P:axon guidance; P:cell adhesion; P:iron ion homeostasis; P:positive regulation of BMP signaling pathway;|Q92859 B7ZKM9 B7ZKN0 O00340 Q17RX1,Neogenin,Immunoglobulin superfamily DCC subclass member 2;, PF00041;PF07679;PF13895;PF06583;, GO:0005794;GO:0005887;GO:0005654;GO:0005886;GO:0098797;GO:0039706;GO:0038023;GO:0007411;GO:0007155;GO:0055072;GO:0030513;, C:Golgi apparatus; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:plasma membrane protein complex;, F:co-receptor binding; F:signaling receptor activity;, P:axon guidance; P:cell adhesion; P:iron ion homeostasis; P:positive regulation of BMP signaling pathway;|Q92859 B7ZKM9 B7ZKN0 O00340 Q17RX1,Neogenin,Immunoglobulin superfamily DCC subclass member 2;, PF00041;PF07679;PF13895;PF06583;, GO:0005794;GO:0005887;GO:0005654;GO:0005886;GO:0098797;GO:0039706;GO:0038023;GO:0007411;GO:0007155;GO:0055072;GO:0030513;, C:Golgi apparatus; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:plasma membrane protein complex;, F:co-receptor binding; F:signaling receptor activity;, P:axon guidance; P:cell adhesion; P:iron ion homeostasis; P:positive regulation of BMP signaling pathway;|Q92859 B7ZKM9 B7ZKN0 O00340 Q17RX1,Neogenin,Immunoglobulin superfamily DCC subclass member 2;, PF00041;PF07679;PF13895;PF06583;, GO:0005794;GO:0005887;GO:0005654;GO:0005886;GO:0098797;GO:0039706;GO:0038023;GO:0007411;GO:0007155;GO:0055072;GO:0030513;, C:Golgi apparatus; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:plasma membrane protein complex;, F:co-receptor binding; F:signaling receptor activity;, P:axon guidance; P:cell adhesion; P:iron ion homeostasis; P:positive regulation of BMP signaling pathway; scaffold42 indexed_genome mRNA 19321645 19325656 . - . ID=transcript_8596;Q7Z4M0,Meiotic recombination protein REC114,, PF15165;, GO:0006310;GO:0051321;, , , P:DNA recombination; P:meiotic cell cycle; scaffold42 indexed_genome mRNA 19330079 19397547 . - . ID=transcript_8597;Q9Y639 B2RAL7 B7Z4D3 B7ZLL2 Q17R52 Q59EJ9 Q6NVX7 Q9Y640,Neuroplastin,Stromal cell-derived receptor 1;, , GO:0030424;GO:0009986;GO:0030425;GO:0098982;GO:0098978;GO:0001772;GO:0060077;GO:0099061;GO:0099059;GO:0005886;GO:0042734;GO:0098685;GO:0050839;GO:0098632;GO:0044325;GO:0005105;GO:0007411;GO:0006874;GO:0070593;GO:1904861;GO:0007156;GO:0060291;GO:0001818;GO:1903829;GO:0007204;GO:0070374;GO:0045743;GO:0048170;GO:1900273;GO:0010976;GO:0001934;GO:1902683;GO:0099557;GO:0008542;, C:axon; C:cell surface; C:dendrite; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:inhibitory synapse; C:integral component of postsynaptic density membrane; C:integral component of presynaptic active zone membrane; C:plasma membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:cell-cell adhesion mediator activity; F:ion channel binding; F:type 1 fibroblast growth factor receptor binding;, P:axon guidance; P:cellular calcium ion homeostasis; P:dendrite self-avoidance; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:long-term synaptic potentiation; P:negative regulation of cytokine production; P:positive regulation of cellular protein localization; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of neuron projection development; P:positive regulation of protein phosphorylation; P:regulation of receptor localization to synapse; P:trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission; P:visual learning;|Q9Y639 B2RAL7 B7Z4D3 B7ZLL2 Q17R52 Q59EJ9 Q6NVX7 Q9Y640,Neuroplastin,Stromal cell-derived receptor 1;, , GO:0030424;GO:0009986;GO:0030425;GO:0098982;GO:0098978;GO:0001772;GO:0060077;GO:0099061;GO:0099059;GO:0005886;GO:0042734;GO:0098685;GO:0050839;GO:0098632;GO:0044325;GO:0005105;GO:0007411;GO:0006874;GO:0070593;GO:1904861;GO:0007156;GO:0060291;GO:0001818;GO:1903829;GO:0007204;GO:0070374;GO:0045743;GO:0048170;GO:1900273;GO:0010976;GO:0001934;GO:1902683;GO:0099557;GO:0008542;, C:axon; C:cell surface; C:dendrite; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:inhibitory synapse; C:integral component of postsynaptic density membrane; C:integral component of presynaptic active zone membrane; C:plasma membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:cell-cell adhesion mediator activity; F:ion channel binding; F:type 1 fibroblast growth factor receptor binding;, P:axon guidance; P:cellular calcium ion homeostasis; P:dendrite self-avoidance; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:long-term synaptic potentiation; P:negative regulation of cytokine production; P:positive regulation of cellular protein localization; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of neuron projection development; P:positive regulation of protein phosphorylation; P:regulation of receptor localization to synapse; P:trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission; P:visual learning;|Q9Y639 B2RAL7 B7Z4D3 B7ZLL2 Q17R52 Q59EJ9 Q6NVX7 Q9Y640,Neuroplastin,Stromal cell-derived receptor 1;, , GO:0030424;GO:0009986;GO:0030425;GO:0098982;GO:0098978;GO:0001772;GO:0060077;GO:0099061;GO:0099059;GO:0005886;GO:0042734;GO:0098685;GO:0050839;GO:0098632;GO:0044325;GO:0005105;GO:0007411;GO:0006874;GO:0070593;GO:1904861;GO:0007156;GO:0060291;GO:0001818;GO:1903829;GO:0007204;GO:0070374;GO:0045743;GO:0048170;GO:1900273;GO:0010976;GO:0001934;GO:1902683;GO:0099557;GO:0008542;, C:axon; C:cell surface; C:dendrite; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:inhibitory synapse; C:integral component of postsynaptic density membrane; C:integral component of presynaptic active zone membrane; C:plasma membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:cell-cell adhesion mediator activity; F:ion channel binding; F:type 1 fibroblast growth factor receptor binding;, P:axon guidance; P:cellular calcium ion homeostasis; P:dendrite self-avoidance; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:long-term synaptic potentiation; P:negative regulation of cytokine production; P:positive regulation of cellular protein localization; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of neuron projection development; P:positive regulation of protein phosphorylation; P:regulation of receptor localization to synapse; P:trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission; P:visual learning;|Q9Y639 B2RAL7 B7Z4D3 B7ZLL2 Q17R52 Q59EJ9 Q6NVX7 Q9Y640,Neuroplastin,Stromal cell-derived receptor 1;, , GO:0030424;GO:0009986;GO:0030425;GO:0098982;GO:0098978;GO:0001772;GO:0060077;GO:0099061;GO:0099059;GO:0005886;GO:0042734;GO:0098685;GO:0050839;GO:0098632;GO:0044325;GO:0005105;GO:0007411;GO:0006874;GO:0070593;GO:1904861;GO:0007156;GO:0060291;GO:0001818;GO:1903829;GO:0007204;GO:0070374;GO:0045743;GO:0048170;GO:1900273;GO:0010976;GO:0001934;GO:1902683;GO:0099557;GO:0008542;, C:axon; C:cell surface; C:dendrite; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:inhibitory synapse; C:integral component of postsynaptic density membrane; C:integral component of presynaptic active zone membrane; C:plasma membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:cell-cell adhesion mediator activity; F:ion channel binding; F:type 1 fibroblast growth factor receptor binding;, P:axon guidance; P:cellular calcium ion homeostasis; P:dendrite self-avoidance; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:long-term synaptic potentiation; P:negative regulation of cytokine production; P:positive regulation of cellular protein localization; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of neuron projection development; P:positive regulation of protein phosphorylation; P:regulation of receptor localization to synapse; P:trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission; P:visual learning;|Q9Y639 B2RAL7 B7Z4D3 B7ZLL2 Q17R52 Q59EJ9 Q6NVX7 Q9Y640,Neuroplastin,Stromal cell-derived receptor 1;, , GO:0030424;GO:0009986;GO:0030425;GO:0098982;GO:0098978;GO:0001772;GO:0060077;GO:0099061;GO:0099059;GO:0005886;GO:0042734;GO:0098685;GO:0050839;GO:0098632;GO:0044325;GO:0005105;GO:0007411;GO:0006874;GO:0070593;GO:1904861;GO:0007156;GO:0060291;GO:0001818;GO:1903829;GO:0007204;GO:0070374;GO:0045743;GO:0048170;GO:1900273;GO:0010976;GO:0001934;GO:1902683;GO:0099557;GO:0008542;, C:axon; C:cell surface; C:dendrite; C:GABA-ergic synapse; C:glutamatergic synapse; C:immunological synapse; C:inhibitory synapse; C:integral component of postsynaptic density membrane; C:integral component of presynaptic active zone membrane; C:plasma membrane; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:cell adhesion molecule binding; F:cell-cell adhesion mediator activity; F:ion channel binding; F:type 1 fibroblast growth factor receptor binding;, P:axon guidance; P:cellular calcium ion homeostasis; P:dendrite self-avoidance; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:long-term synaptic potentiation; P:negative regulation of cytokine production; P:positive regulation of cellular protein localization; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of neuron projection development; P:positive regulation of protein phosphorylation; P:regulation of receptor localization to synapse; P:trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission; P:visual learning; scaffold42 indexed_genome mRNA 19476921 19487709 . + . ID=transcript_8598;Q5ZPR3 Q6P5Y4 Q6UXI2 Q8NBI8 Q8NC34 Q8NCB6 Q9BXR1,CD276 antigen,4Ig-B7-H3;B7 homolog 3;Costimulatory molecule;, PF07686;, GO:0009897;GO:0016021;GO:0005102;GO:0032729;GO:0042102;GO:0001817;GO:0050776;GO:0042110;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane;, F:signaling receptor binding;, P:positive regulation of interferon-gamma production; P:positive regulation of T cell proliferation; P:regulation of cytokine production; P:regulation of immune response; P:T cell activation; P:T cell receptor signaling pathway; scaffold42 indexed_genome mRNA 19515440 19528960 . - . ID=transcript_8599;Q2T9L4,Inhibitory synaptic factor 1 {ECO:0000305},, PF15252;, GO:0014069;GO:0060080;, C:postsynaptic density;, , P:inhibitory postsynaptic potential;|Q2T9L4,Inhibitory synaptic factor 1 {ECO:0000305},, PF15252;, GO:0014069;GO:0060080;, C:postsynaptic density;, , P:inhibitory postsynaptic potential; scaffold42 indexed_genome mRNA 19698231 19711177 . + . ID=transcript_8600;Q9NRG7 Q6ZW71 Q9BVQ3,Epimerase family protein SDR39U1 {ECO:0000305},Short-chain dehydrogenase/reductase family 39U member 1 {ECO:0000303|PubMed:19027726};, PF08338;PF01370;, GO:0005634;GO:0016491;, C:nucleus;, F:oxidoreductase activity;|Q9NRG7 Q6ZW71 Q9BVQ3,Epimerase family protein SDR39U1 {ECO:0000305},Short-chain dehydrogenase/reductase family 39U member 1 {ECO:0000303|PubMed:19027726};, PF08338;PF01370;, GO:0005634;GO:0016491;, C:nucleus;, F:oxidoreductase activity;|O15037 Q86TZ6 Q8IUQ2 Q96BA9,Protein KHNYN,KH and NYN domain-containing protein;, PF11977;, GO:0036464;GO:0005634;GO:0004521;GO:0003729;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic;|O15037 Q86TZ6 Q8IUQ2 Q96BA9,Protein KHNYN,KH and NYN domain-containing protein;, PF11977;, GO:0036464;GO:0005634;GO:0004521;GO:0003729;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic;|O15037 Q86TZ6 Q8IUQ2 Q96BA9,Protein KHNYN,KH and NYN domain-containing protein;, PF11977;, GO:0036464;GO:0005634;GO:0004521;GO:0003729;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic;|O15037 Q86TZ6 Q8IUQ2 Q96BA9,Protein KHNYN,KH and NYN domain-containing protein;, PF11977;, GO:0036464;GO:0005634;GO:0004521;GO:0003729;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic;|O15037 Q86TZ6 Q8IUQ2 Q96BA9,Protein KHNYN,KH and NYN domain-containing protein;, PF11977;, GO:0036464;GO:0005634;GO:0004521;GO:0003729;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold42 indexed_genome mRNA 19714267 19727538 . + . ID=transcript_8601;Q9P2P1 Q6P153 Q86TR3 Q9HAC4,Protein NYNRIN,NYN domain and retroviral integrase catalytic domain-containing protein;Protein cousin of GIN1;, PF17921;PF11977;PF17919;, GO:0036464;GO:0016021;GO:0005634;GO:0004521;GO:0003729;GO:0015074;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:integral component of membrane; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:DNA integration; P:RNA phosphodiester bond hydrolysis, endonucleolytic;|Q6UW01,Cerebellin-3,, PF00386;, GO:0005783;GO:0005615;GO:0005794;GO:0045202;, C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus; C:synapse;|Q6UW01,Cerebellin-3,, PF00386;, GO:0005783;GO:0005615;GO:0005794;GO:0045202;, C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus; C:synapse; scaffold42 indexed_genome mRNA 19727545 19731735 . - . ID=transcript_8602;Q9P2P1 Q6P153 Q86TR3 Q9HAC4,Protein NYNRIN,NYN domain and retroviral integrase catalytic domain-containing protein;Protein cousin of GIN1;, PF17921;PF11977;PF17919;, GO:0036464;GO:0016021;GO:0005634;GO:0004521;GO:0003729;GO:0015074;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:integral component of membrane; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:DNA integration; P:RNA phosphodiester bond hydrolysis, endonucleolytic;|Q9P2P1 Q6P153 Q86TR3 Q9HAC4,Protein NYNRIN,NYN domain and retroviral integrase catalytic domain-containing protein;Protein cousin of GIN1;, PF17921;PF11977;PF17919;, GO:0036464;GO:0016021;GO:0005634;GO:0004521;GO:0003729;GO:0015074;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:integral component of membrane; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:DNA integration; P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold42 indexed_genome mRNA 19733825 19745224 . - . ID=transcript_8603;Q9P2P1 Q6P153 Q86TR3 Q9HAC4,Protein NYNRIN,NYN domain and retroviral integrase catalytic domain-containing protein;Protein cousin of GIN1;, PF17921;PF11977;PF17919;, GO:0036464;GO:0016021;GO:0005634;GO:0004521;GO:0003729;GO:0015074;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:integral component of membrane; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:DNA integration; P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold42 indexed_genome mRNA 19767049 19774324 . - . ID=transcript_8604;Q96H68,Nuclear factor of activated T-cells, cytoplasmic 4,T-cell transcription factor NFAT3 {ECO:0000303|PubMed:17875713, ECO:0000303|PubMed:7749981};, PF16179;PF00554;, GO:0000785;GO:0005829;GO:0016607;GO:0005634;GO:0005667;GO:0000981;GO:0001227;GO:0042975;GO:0000978;GO:1990837;GO:0008134;GO:0031547;GO:0001569;GO:0033173;GO:0045333;GO:1904637;GO:0071285;GO:0034644;GO:0007507;GO:0006954;GO:0008630;GO:0007616;GO:0060291;GO:0055001;GO:0035562;GO:0050774;GO:0043524;GO:1902894;GO:0032091;GO:2000297;GO:0030178;GO:2001235;GO:0045944;GO:0032760;GO:0006357;GO:0051145;, C:chromatin; C:cytosol; C:nuclear speck; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:peroxisome proliferator activated receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:brain-derived neurotrophic factor receptor signaling pathway; P:branching involved in blood vessel morphogenesis; P:calcineurin-NFAT signaling cascade; P:cellular respiration; P:cellular response to ionomycin; P:cellular response to lithium ion; P:cellular response to UV; P:heart development; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:long-term memory; P:long-term synaptic potentiation; P:muscle cell development; P:negative regulation of chromatin binding; P:negative regulation of dendrite morphogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein binding; P:negative regulation of synapse maturation; P:negative regulation of Wnt signaling pathway; P:positive regulation of apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of transcription by RNA polymerase II; P:smooth muscle cell differentiation;|Q96H68,Nuclear factor of activated T-cells, cytoplasmic 4,T-cell transcription factor NFAT3 {ECO:0000303|PubMed:17875713, ECO:0000303|PubMed:7749981};, PF16179;PF00554;, GO:0000785;GO:0005829;GO:0016607;GO:0005634;GO:0005667;GO:0000981;GO:0001227;GO:0042975;GO:0000978;GO:1990837;GO:0008134;GO:0031547;GO:0001569;GO:0033173;GO:0045333;GO:1904637;GO:0071285;GO:0034644;GO:0007507;GO:0006954;GO:0008630;GO:0007616;GO:0060291;GO:0055001;GO:0035562;GO:0050774;GO:0043524;GO:1902894;GO:0032091;GO:2000297;GO:0030178;GO:2001235;GO:0045944;GO:0032760;GO:0006357;GO:0051145;, C:chromatin; C:cytosol; C:nuclear speck; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:peroxisome proliferator activated receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:brain-derived neurotrophic factor receptor signaling pathway; P:branching involved in blood vessel morphogenesis; P:calcineurin-NFAT signaling cascade; P:cellular respiration; P:cellular response to ionomycin; P:cellular response to lithium ion; P:cellular response to UV; P:heart development; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:long-term memory; P:long-term synaptic potentiation; P:muscle cell development; P:negative regulation of chromatin binding; P:negative regulation of dendrite morphogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein binding; P:negative regulation of synapse maturation; P:negative regulation of Wnt signaling pathway; P:positive regulation of apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of transcription by RNA polymerase II; P:smooth muscle cell differentiation; scaffold42 indexed_genome mRNA 19774351 19776054 . - . ID=transcript_8605;Q96H68,Nuclear factor of activated T-cells, cytoplasmic 4,T-cell transcription factor NFAT3 {ECO:0000303|PubMed:17875713, ECO:0000303|PubMed:7749981};, PF16179;PF00554;, GO:0000785;GO:0005829;GO:0016607;GO:0005634;GO:0005667;GO:0000981;GO:0001227;GO:0042975;GO:0000978;GO:1990837;GO:0008134;GO:0031547;GO:0001569;GO:0033173;GO:0045333;GO:1904637;GO:0071285;GO:0034644;GO:0007507;GO:0006954;GO:0008630;GO:0007616;GO:0060291;GO:0055001;GO:0035562;GO:0050774;GO:0043524;GO:1902894;GO:0032091;GO:2000297;GO:0030178;GO:2001235;GO:0045944;GO:0032760;GO:0006357;GO:0051145;, C:chromatin; C:cytosol; C:nuclear speck; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:peroxisome proliferator activated receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:brain-derived neurotrophic factor receptor signaling pathway; P:branching involved in blood vessel morphogenesis; P:calcineurin-NFAT signaling cascade; P:cellular respiration; P:cellular response to ionomycin; P:cellular response to lithium ion; P:cellular response to UV; P:heart development; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:long-term memory; P:long-term synaptic potentiation; P:muscle cell development; P:negative regulation of chromatin binding; P:negative regulation of dendrite morphogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein binding; P:negative regulation of synapse maturation; P:negative regulation of Wnt signaling pathway; P:positive regulation of apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of transcription by RNA polymerase II; P:smooth muscle cell differentiation; scaffold42 indexed_genome mRNA 19796904 19801017 . + . ID=transcript_8606;Q9Y572 B4DJL9 C4AM87 Q5J795 Q5J796 Q6P5Y1,Receptor-interacting serine/threonine-protein kinase 3 {ECO:0000305},RIP-like protein kinase 3 {ECO:0000303|PubMed:10339433};Receptor-interacting protein 3 {ECO:0000303|PubMed:10339433};, PF00069;PF12721;, GO:0005737;GO:0005829;GO:0005634;GO:0032991;GO:0005524;GO:0042802;GO:0004704;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0003713;GO:0032147;GO:1990000;GO:0097190;GO:0006464;GO:0070301;GO:0051607;GO:0097528;GO:0007249;GO:0048535;GO:0019054;GO:0070266;GO:0097527;GO:0062099;GO:2001244;GO:0051351;GO:0060545;GO:0051092;GO:0051353;GO:0010922;GO:2000379;GO:0097300;GO:0046777;GO:0046006;GO:0070235;GO:0002819;GO:0042981;GO:2000452;GO:0032649;GO:0060544;GO:0001914;GO:0007165;GO:0048536;GO:0033077;GO:0043029;GO:0048538;, C:cytoplasm; C:cytosol; C:nucleus; C:protein-containing complex;, F:ATP binding; F:identical protein binding; F:NF-kappaB-inducing kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:transcription coactivator activity;, P:activation of protein kinase activity; P:amyloid fibril formation; P:apoptotic signaling pathway; P:cellular protein modification process; P:cellular response to hydrogen peroxide; P:defense response to virus; P:execution phase of necroptosis; P:I-kappaB kinase/NF-kappaB signaling; P:lymph node development; P:modulation by virus of host cellular process; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of programmed necrotic cell death; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of ligase activity; P:positive regulation of necroptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of phosphatase activity; P:positive regulation of reactive oxygen species metabolic process; P:programmed necrotic cell death; P:protein autophosphorylation; P:regulation of activated T cell proliferation; P:regulation of activation-induced cell death of T cells; P:regulation of adaptive immune response; P:regulation of apoptotic process; P:regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation; P:regulation of interferon-gamma production; P:regulation of necroptotic process; P:regulation of T cell mediated cytotoxicity; P:signal transduction; P:spleen development; P:T cell differentiation in thymus; P:T cell homeostasis; P:thymus development; scaffold42 indexed_genome mRNA 19804958 19812845 . + . ID=transcript_8607;Q8NFM4 B3KV74 D3DS75 Q17R40 Q6ZTM6 Q96ML7,Adenylate cyclase type 4,ATP pyrophosphate-lyase 4;Adenylate cyclase type IV;Adenylyl cyclase 4;, PF16214;PF06327;PF00211;, GO:0005737;GO:0030425;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0046872;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007188;GO:0006171;GO:0071377;GO:0007186;GO:0002862;GO:0003091;, C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis;|Q8NFM4 B3KV74 D3DS75 Q17R40 Q6ZTM6 Q96ML7,Adenylate cyclase type 4,ATP pyrophosphate-lyase 4;Adenylate cyclase type IV;Adenylyl cyclase 4;, PF16214;PF06327;PF00211;, GO:0005737;GO:0030425;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0046872;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007188;GO:0006171;GO:0071377;GO:0007186;GO:0002862;GO:0003091;, C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis;|Q8NFM4 B3KV74 D3DS75 Q17R40 Q6ZTM6 Q96ML7,Adenylate cyclase type 4,ATP pyrophosphate-lyase 4;Adenylate cyclase type IV;Adenylyl cyclase 4;, PF16214;PF06327;PF00211;, GO:0005737;GO:0030425;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0046872;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007188;GO:0006171;GO:0071377;GO:0007186;GO:0002862;GO:0003091;, C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis;|Q8NFM4 B3KV74 D3DS75 Q17R40 Q6ZTM6 Q96ML7,Adenylate cyclase type 4,ATP pyrophosphate-lyase 4;Adenylate cyclase type IV;Adenylyl cyclase 4;, PF16214;PF06327;PF00211;, GO:0005737;GO:0030425;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0046872;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007188;GO:0006171;GO:0071377;GO:0007186;GO:0002862;GO:0003091;, C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis;|Q8NFM4 B3KV74 D3DS75 Q17R40 Q6ZTM6 Q96ML7,Adenylate cyclase type 4,ATP pyrophosphate-lyase 4;Adenylate cyclase type IV;Adenylyl cyclase 4;, PF16214;PF06327;PF00211;, GO:0005737;GO:0030425;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0046872;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007188;GO:0006171;GO:0071377;GO:0007186;GO:0002862;GO:0003091;, C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis; scaffold42 indexed_genome mRNA 19813329 19814328 . + . ID=transcript_8608;Q8NFM4 B3KV74 D3DS75 Q17R40 Q6ZTM6 Q96ML7,Adenylate cyclase type 4,ATP pyrophosphate-lyase 4;Adenylate cyclase type IV;Adenylyl cyclase 4;, PF16214;PF06327;PF00211;, GO:0005737;GO:0030425;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0046872;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007188;GO:0006171;GO:0071377;GO:0007186;GO:0002862;GO:0003091;, C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis; scaffold42 indexed_genome mRNA 19814871 19817581 . + . ID=transcript_8609;Q8NFM4 B3KV74 D3DS75 Q17R40 Q6ZTM6 Q96ML7,Adenylate cyclase type 4,ATP pyrophosphate-lyase 4;Adenylate cyclase type IV;Adenylyl cyclase 4;, PF16214;PF06327;PF00211;, GO:0005737;GO:0030425;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0046872;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007188;GO:0006171;GO:0071377;GO:0007186;GO:0002862;GO:0003091;, C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis;|Q8NFM4 B3KV74 D3DS75 Q17R40 Q6ZTM6 Q96ML7,Adenylate cyclase type 4,ATP pyrophosphate-lyase 4;Adenylate cyclase type IV;Adenylyl cyclase 4;, PF16214;PF06327;PF00211;, GO:0005737;GO:0030425;GO:0005887;GO:0016020;GO:0005886;GO:0004016;GO:0005524;GO:0046872;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0007188;GO:0006171;GO:0071377;GO:0007186;GO:0002862;GO:0003091;, C:cytoplasm; C:dendrite; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis; scaffold42 indexed_genome mRNA 19818059 19819795 . - . ID=transcript_8610;Q15722 Q13305 Q53XV5 Q92641 Q9BSU5,Leukotriene B4 receptor 1,Chemoattractant receptor-like 1;G-protein coupled receptor 16;P2Y purinoceptor 7;, PF00001;, GO:0005887;GO:0045121;GO:0005886;GO:0008528;GO:0001632;GO:0004974;GO:0000166;GO:0007186;GO:0006955;GO:0006954;GO:0006936;GO:0007218;GO:0007200;, C:integral component of plasma membrane; C:membrane raft; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:leukotriene B4 receptor activity; F:leukotriene receptor activity; F:nucleotide binding;, P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:muscle contraction; P:neuropeptide signaling pathway; P:phospholipase C-activating G protein-coupled receptor signaling pathway; scaffold42 indexed_genome mRNA 19822431 19823831 . - . ID=transcript_8611;Q9NPC1 Q5KU28 Q9NPE5,Leukotriene B4 receptor 2,LTB4 receptor JULF2;Leukotriene B4 receptor BLT2;Seven transmembrane receptor BLTR2;, PF00001;, GO:0005887;GO:0016020;GO:0005654;GO:0005886;GO:0008528;GO:0001632;GO:0004974;GO:0006935;GO:0007186;GO:0006954;GO:0007194;GO:0007218;, C:integral component of plasma membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:leukotriene B4 receptor activity; F:leukotriene receptor activity;, P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of adenylate cyclase activity; P:neuropeptide signaling pathway; scaffold42 indexed_genome mRNA 19830568 19847742 . + . ID=transcript_8612;Q9UHD4 D3DS73 Q546V8 Q9NNW9,Cell death activator CIDE-B,Cell death-inducing DFFA-like effector B;, PF02017;, GO:0005829;GO:0048471;GO:0042802;GO:0097202;GO:0006915;GO:0038183;GO:0097194;GO:0008630;GO:0010942;GO:0090200;GO:0042981;GO:0031667;GO:0016032;, C:cytosol; C:perinuclear region of cytoplasm;, F:identical protein binding;, P:activation of cysteine-type endopeptidase activity; P:apoptotic process; P:bile acid signaling pathway; P:execution phase of apoptosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of cell death; P:positive regulation of release of cytochrome c from mitochondria; P:regulation of apoptotic process; P:response to nutrient levels; P:viral process;|Q9UHD4 D3DS73 Q546V8 Q9NNW9,Cell death activator CIDE-B,Cell death-inducing DFFA-like effector B;, PF02017;, GO:0005829;GO:0048471;GO:0042802;GO:0097202;GO:0006915;GO:0038183;GO:0097194;GO:0008630;GO:0010942;GO:0090200;GO:0042981;GO:0031667;GO:0016032;, C:cytosol; C:perinuclear region of cytoplasm;, F:identical protein binding;, P:activation of cysteine-type endopeptidase activity; P:apoptotic process; P:bile acid signaling pathway; P:execution phase of apoptosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of cell death; P:positive regulation of release of cytochrome c from mitochondria; P:regulation of apoptotic process; P:response to nutrient levels; P:viral process;|Q86U38 A8MY76 Q8IVF0 Q8TBS6,Nucleolar protein 9,, , GO:0030686;GO:0005730;GO:0030688;GO:0003723;GO:0000480;GO:0000447;GO:0000472;GO:0000056;, C:90S preribosome; C:nucleolus; C:preribosome, small subunit precursor;, F:RNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit export from nucleus;|Q96LJ7 D3DS71 Q8NDG3 Q96B59 Q96CQ5,Dehydrogenase/reductase SDR family member 1,Short chain dehydrogenase/reductase family 19C member 1;, PF00106;, GO:0005783;GO:0016491;, C:endoplasmic reticulum;, F:oxidoreductase activity;|Q96LJ7 D3DS71 Q8NDG3 Q96B59 Q96CQ5,Dehydrogenase/reductase SDR family member 1,Short chain dehydrogenase/reductase family 19C member 1;, PF00106;, GO:0005783;GO:0016491;, C:endoplasmic reticulum;, F:oxidoreductase activity;|Q96LJ7 D3DS71 Q8NDG3 Q96B59 Q96CQ5,Dehydrogenase/reductase SDR family member 1,Short chain dehydrogenase/reductase family 19C member 1;, PF00106;, GO:0005783;GO:0016491;, C:endoplasmic reticulum;, F:oxidoreductase activity;|Q96LJ7 D3DS71 Q8NDG3 Q96B59 Q96CQ5,Dehydrogenase/reductase SDR family member 1,Short chain dehydrogenase/reductase family 19C member 1;, PF00106;, GO:0005783;GO:0016491;, C:endoplasmic reticulum;, F:oxidoreductase activity;|Q96LJ7 D3DS71 Q8NDG3 Q96B59 Q96CQ5,Dehydrogenase/reductase SDR family member 1,Short chain dehydrogenase/reductase family 19C member 1;, PF00106;, GO:0005783;GO:0016491;, C:endoplasmic reticulum;, F:oxidoreductase activity; scaffold42 indexed_genome mRNA 19861703 19867477 . + . ID=transcript_8613;Q92696 A8K5N2 D3DS69,Geranylgeranyl transferase type-2 subunit alpha,Geranylgeranyl transferase type II subunit alpha;Rab geranyl-geranyltransferase subunit alpha;Rab geranylgeranyltransferase subunit alpha;, PF01239;PF07711;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0005968;GO:0004663;GO:0031267;GO:0008270;GO:0006464;GO:0043687;GO:0018344;GO:0042981;GO:0007601;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane; C:Rab-protein geranylgeranyltransferase complex;, F:Rab geranylgeranyltransferase activity; F:small GTPase binding; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein geranylgeranylation; P:regulation of apoptotic process; P:visual perception;|Q92696 A8K5N2 D3DS69,Geranylgeranyl transferase type-2 subunit alpha,Geranylgeranyl transferase type II subunit alpha;Rab geranyl-geranyltransferase subunit alpha;Rab geranylgeranyltransferase subunit alpha;, PF01239;PF07711;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0005968;GO:0004663;GO:0031267;GO:0008270;GO:0006464;GO:0043687;GO:0018344;GO:0042981;GO:0007601;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane; C:Rab-protein geranylgeranyltransferase complex;, F:Rab geranylgeranyltransferase activity; F:small GTPase binding; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein geranylgeranylation; P:regulation of apoptotic process; P:visual perception;|Q92696 A8K5N2 D3DS69,Geranylgeranyl transferase type-2 subunit alpha,Geranylgeranyl transferase type II subunit alpha;Rab geranyl-geranyltransferase subunit alpha;Rab geranylgeranyltransferase subunit alpha;, PF01239;PF07711;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0005968;GO:0004663;GO:0031267;GO:0008270;GO:0006464;GO:0043687;GO:0018344;GO:0042981;GO:0007601;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane; C:Rab-protein geranylgeranyltransferase complex;, F:Rab geranylgeranyltransferase activity; F:small GTPase binding; F:zinc ion binding;, P:cellular protein modification process; P:post-translational protein modification; P:protein geranylgeranylation; P:regulation of apoptotic process; P:visual perception; scaffold42 indexed_genome mRNA 19871190 19886304 . + . ID=transcript_8614;P22735 B4DWR7 Q197M4,Protein-glutamine gamma-glutamyltransferase K,Epidermal TGase;Transglutaminase K;Transglutaminase-1;, PF00927;PF01841;PF00868;, GO:0001533;GO:0005829;GO:0070062;GO:0031224;GO:0016020;GO:0005886;GO:0042802;GO:0046872;GO:0003810;GO:0043163;GO:0006464;GO:0070268;GO:0030216;GO:0018149;GO:0045787;GO:0010838;, C:cornified envelope; C:cytosol; C:extracellular exosome; C:intrinsic component of membrane; C:membrane; C:plasma membrane;, F:identical protein binding; F:metal ion binding; F:protein-glutamine gamma-glutamyltransferase activity;, P:cell envelope organization; P:cellular protein modification process; P:cornification; P:keratinocyte differentiation; P:peptide cross-linking; P:positive regulation of cell cycle; P:positive regulation of keratinocyte proliferation; scaffold42 indexed_genome mRNA 19894522 19904138 . + . ID=transcript_8615;Q9BSI4 B3W5Q7 Q9H904 Q9UHC2,TERF1-interacting nuclear factor 2,TRF1-interacting nuclear protein 2;, PF14973;, GO:0000781;GO:0016604;GO:0016363;GO:0000783;GO:0005654;GO:0010370;GO:0070187;GO:0042162;GO:0045007;GO:0048239;GO:0050680;GO:0010836;GO:0032211;GO:1900051;GO:0070198;GO:1904356;GO:0032202;GO:0016233;GO:0000723;GO:0032201;GO:0007004;, C:chromosome, telomeric region; C:nuclear body; C:nuclear matrix; C:nuclear telomere cap complex; C:nucleoplasm; C:perinucleolar chromocenter; C:shelterin complex;, F:telomeric DNA binding;, P:depurination; P:negative regulation of DNA recombination at telomere; P:negative regulation of epithelial cell proliferation; P:negative regulation of protein ADP-ribosylation; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of histone exchange; P:protein localization to chromosome, telomeric region; P:regulation of telomere maintenance via telomere lengthening; P:telomere assembly; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase;|Q9BSI4 B3W5Q7 Q9H904 Q9UHC2,TERF1-interacting nuclear factor 2,TRF1-interacting nuclear protein 2;, PF14973;, GO:0000781;GO:0016604;GO:0016363;GO:0000783;GO:0005654;GO:0010370;GO:0070187;GO:0042162;GO:0045007;GO:0048239;GO:0050680;GO:0010836;GO:0032211;GO:1900051;GO:0070198;GO:1904356;GO:0032202;GO:0016233;GO:0000723;GO:0032201;GO:0007004;, C:chromosome, telomeric region; C:nuclear body; C:nuclear matrix; C:nuclear telomere cap complex; C:nucleoplasm; C:perinucleolar chromocenter; C:shelterin complex;, F:telomeric DNA binding;, P:depurination; P:negative regulation of DNA recombination at telomere; P:negative regulation of epithelial cell proliferation; P:negative regulation of protein ADP-ribosylation; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of histone exchange; P:protein localization to chromosome, telomeric region; P:regulation of telomere maintenance via telomere lengthening; P:telomere assembly; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase;|Q9P2T1 D3DS66 Q567T0 Q6IAJ8 Q86T14,GMP reductase 2 {ECO:0000255|HAMAP-Rule:MF_03195},Guanosine 5'-monophosphate oxidoreductase 2 {ECO:0000255|HAMAP-Rule:MF_03195};, PF00478;, GO:0005829;GO:1902560;GO:0003920;GO:0046872;GO:0046037;GO:0006144;GO:0043101;, C:cytosol; C:GMP reductase complex;, F:GMP reductase activity; F:metal ion binding;, P:GMP metabolic process; P:purine nucleobase metabolic process; P:purine-containing compound salvage;|Q9P2T1 D3DS66 Q567T0 Q6IAJ8 Q86T14,GMP reductase 2 {ECO:0000255|HAMAP-Rule:MF_03195},Guanosine 5'-monophosphate oxidoreductase 2 {ECO:0000255|HAMAP-Rule:MF_03195};, PF00478;, GO:0005829;GO:1902560;GO:0003920;GO:0046872;GO:0046037;GO:0006144;GO:0043101;, C:cytosol; C:GMP reductase complex;, F:GMP reductase activity; F:metal ion binding;, P:GMP metabolic process; P:purine nucleobase metabolic process; P:purine-containing compound salvage;|Q9P2T1 D3DS66 Q567T0 Q6IAJ8 Q86T14,GMP reductase 2 {ECO:0000255|HAMAP-Rule:MF_03195},Guanosine 5'-monophosphate oxidoreductase 2 {ECO:0000255|HAMAP-Rule:MF_03195};, PF00478;, GO:0005829;GO:1902560;GO:0003920;GO:0046872;GO:0046037;GO:0006144;GO:0043101;, C:cytosol; C:GMP reductase complex;, F:GMP reductase activity; F:metal ion binding;, P:GMP metabolic process; P:purine nucleobase metabolic process; P:purine-containing compound salvage;|Q9P2T1 D3DS66 Q567T0 Q6IAJ8 Q86T14,GMP reductase 2 {ECO:0000255|HAMAP-Rule:MF_03195},Guanosine 5'-monophosphate oxidoreductase 2 {ECO:0000255|HAMAP-Rule:MF_03195};, PF00478;, GO:0005829;GO:1902560;GO:0003920;GO:0046872;GO:0046037;GO:0006144;GO:0043101;, C:cytosol; C:GMP reductase complex;, F:GMP reductase activity; F:metal ion binding;, P:GMP metabolic process; P:purine nucleobase metabolic process; P:purine-containing compound salvage;|Q9P2T1 D3DS66 Q567T0 Q6IAJ8 Q86T14,GMP reductase 2 {ECO:0000255|HAMAP-Rule:MF_03195},Guanosine 5'-monophosphate oxidoreductase 2 {ECO:0000255|HAMAP-Rule:MF_03195};, PF00478;, GO:0005829;GO:1902560;GO:0003920;GO:0046872;GO:0046037;GO:0006144;GO:0043101;, C:cytosol; C:GMP reductase complex;, F:GMP reductase activity; F:metal ion binding;, P:GMP metabolic process; P:purine nucleobase metabolic process; P:purine-containing compound salvage; scaffold42 indexed_genome mRNA 19904491 19913260 . + . ID=transcript_8616;Q15843 Q3SXN8 Q6LES6,NEDD8,Neddylin;Neural precursor cell expressed developmentally down-regulated protein 8;Ubiquitin-like protein Nedd8;, PF00240;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0031386;GO:0031625;GO:0009653;GO:0006879;GO:0006464;GO:0019941;GO:0043687;GO:0016579;GO:0008104;GO:0045116;GO:0016567;GO:0006508;GO:0030162;GO:0006357;GO:0014070;GO:0006511;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:protein tag; F:ubiquitin protein ligase binding;, P:anatomical structure morphogenesis; P:cellular iron ion homeostasis; P:cellular protein modification process; P:modification-dependent protein catabolic process; P:post-translational protein modification; P:protein deubiquitination; P:protein localization; P:protein neddylation; P:protein ubiquitination; P:proteolysis; P:regulation of proteolysis; P:regulation of transcription by RNA polymerase II; P:response to organic cyclic compound; P:ubiquitin-dependent protein catabolic process;|Q15843 Q3SXN8 Q6LES6,NEDD8,Neddylin;Neural precursor cell expressed developmentally down-regulated protein 8;Ubiquitin-like protein Nedd8;, PF00240;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0031386;GO:0031625;GO:0009653;GO:0006879;GO:0006464;GO:0019941;GO:0043687;GO:0016579;GO:0008104;GO:0045116;GO:0016567;GO:0006508;GO:0030162;GO:0006357;GO:0014070;GO:0006511;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:protein tag; F:ubiquitin protein ligase binding;, P:anatomical structure morphogenesis; P:cellular iron ion homeostasis; P:cellular protein modification process; P:modification-dependent protein catabolic process; P:post-translational protein modification; P:protein deubiquitination; P:protein localization; P:protein neddylation; P:protein ubiquitination; P:proteolysis; P:regulation of proteolysis; P:regulation of transcription by RNA polymerase II; P:response to organic cyclic compound; P:ubiquitin-dependent protein catabolic process; scaffold42 indexed_genome mRNA 19914199 19923059 . + . ID=transcript_8617;Q86V88 Q86Y84 Q8NAD9,Magnesium-dependent phosphatase 1,, PF12689;, GO:0003993;GO:0046872;GO:0004725;GO:0030389;, , F:acid phosphatase activity; F:metal ion binding; F:protein tyrosine phosphatase activity;, P:fructosamine metabolic process;|Q86V88 Q86Y84 Q8NAD9,Magnesium-dependent phosphatase 1,, PF12689;, GO:0003993;GO:0046872;GO:0004725;GO:0030389;, , F:acid phosphatase activity; F:metal ion binding; F:protein tyrosine phosphatase activity;, P:fructosamine metabolic process;|Q86V88 Q86Y84 Q8NAD9,Magnesium-dependent phosphatase 1,, PF12689;, GO:0003993;GO:0046872;GO:0004725;GO:0030389;, , F:acid phosphatase activity; F:metal ion binding; F:protein tyrosine phosphatase activity;, P:fructosamine metabolic process;|Q9BY43 Q14D22 Q32Q79 Q86SZ8 Q96QJ9 Q9P026,Charged multivesicular body protein 4a,Chromatin-modifying protein 4a;SNF7 homolog associated with Alix-2;SNF7-1;Vacuolar protein sorting-associated protein 32-1;, PF03357;, GO:0005737;GO:0009898;GO:0030659;GO:0005829;GO:0000815;GO:0031902;GO:0030117;GO:0030496;GO:0005771;GO:0005634;GO:0051117;GO:0042802;GO:0008289;GO:0042803;GO:0016197;GO:0032511;GO:0016236;GO:0010324;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:1902902;GO:1901215;GO:0006997;GO:0097320;GO:0006620;GO:0051258;GO:0006900;GO:0039702;GO:0019058;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:ESCRT III complex; C:late endosome membrane; C:membrane coat; C:midbody; C:multivesicular body; C:nucleus;, F:ATPase binding; F:identical protein binding; F:lipid binding; F:protein homodimerization activity;, P:endosomal transport; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:macroautophagy; P:membrane invagination; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of autophagosome assembly; P:negative regulation of neuron death; P:nucleus organization; P:plasma membrane tubulation; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:protein polymerization; P:vesicle budding from membrane; P:viral budding via host ESCRT complex; P:viral life cycle;|Q6SA08 Q2TA60 Q6ZNM2,Testis-specific serine/threonine-protein kinase 4 {ECO:0000312|HGNC:HGNC:19825},Serine/threonine-protein kinase 22E {ECO:0000312|HGNC:HGNC:19825};, PF00069;, GO:0001669;GO:0005737;GO:0005634;GO:0036126;GO:0005524;GO:0000287;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0009566;GO:0030317;GO:0035556;GO:0007275;GO:0018105;GO:1990443;GO:0032793;GO:0006468;GO:0007286;, C:acrosomal vesicle; C:cytoplasm; C:nucleus; C:sperm flagellum;, F:ATP binding; F:magnesium ion binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:fertilization; P:flagellated sperm motility; P:intracellular signal transduction; P:multicellular organism development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine autophosphorylation; P:positive regulation of CREB transcription factor activity; P:protein phosphorylation; P:spermatid development; scaffold42 indexed_genome mRNA 19927855 19945101 . + . ID=transcript_8618;O15321 D3DS65 Q86SZ6 Q96FI8,Transmembrane 9 superfamily member 1,MP70 protein family member;, PF02990;, GO:0000421;GO:0031410;GO:0016021;GO:0005765;GO:0016020;GO:0006914;GO:0072657;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:lysosomal membrane; C:membrane;, , P:autophagy; P:protein localization to membrane;|O15321 D3DS65 Q86SZ6 Q96FI8,Transmembrane 9 superfamily member 1,MP70 protein family member;, PF02990;, GO:0000421;GO:0031410;GO:0016021;GO:0005765;GO:0016020;GO:0006914;GO:0072657;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:lysosomal membrane; C:membrane;, , P:autophagy; P:protein localization to membrane;|O15321 D3DS65 Q86SZ6 Q96FI8,Transmembrane 9 superfamily member 1,MP70 protein family member;, PF02990;, GO:0000421;GO:0031410;GO:0016021;GO:0005765;GO:0016020;GO:0006914;GO:0072657;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:lysosomal membrane; C:membrane;, , P:autophagy; P:protein localization to membrane;|O15321 D3DS65 Q86SZ6 Q96FI8,Transmembrane 9 superfamily member 1,MP70 protein family member;, PF02990;, GO:0000421;GO:0031410;GO:0016021;GO:0005765;GO:0016020;GO:0006914;GO:0072657;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:lysosomal membrane; C:membrane;, , P:autophagy; P:protein localization to membrane;|O15321 D3DS65 Q86SZ6 Q96FI8,Transmembrane 9 superfamily member 1,MP70 protein family member;, PF02990;, GO:0000421;GO:0031410;GO:0016021;GO:0005765;GO:0016020;GO:0006914;GO:0072657;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:lysosomal membrane; C:membrane;, , P:autophagy; P:protein localization to membrane;|Q8TEX9 B2RN95 Q2NL96 Q86TZ9 Q8NCG8 Q96SJ3 Q9BTI4 Q9H5L0,Importin-4,Importin-4b;Ran-binding protein 4;, PF02985;PF03810;, GO:0000785;GO:0005737;GO:0016020;GO:0005634;GO:0032991;GO:0061608;GO:0008139;GO:0031267;GO:0006335;GO:0006336;GO:0006606;, C:chromatin; C:cytoplasm; C:membrane; C:nucleus; C:protein-containing complex;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:protein import into nucleus;|Q8TEX9 B2RN95 Q2NL96 Q86TZ9 Q8NCG8 Q96SJ3 Q9BTI4 Q9H5L0,Importin-4,Importin-4b;Ran-binding protein 4;, PF02985;PF03810;, GO:0000785;GO:0005737;GO:0016020;GO:0005634;GO:0032991;GO:0061608;GO:0008139;GO:0031267;GO:0006335;GO:0006336;GO:0006606;, C:chromatin; C:cytoplasm; C:membrane; C:nucleus; C:protein-containing complex;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:protein import into nucleus; scaffold42 indexed_genome mRNA 19946143 19949233 . - . ID=transcript_8619;O95072 A8K576 D3DS62 Q658V5 Q6IA92 Q8WUV8 Q9BTF2 Q9NVQ9,Meiotic recombination protein REC8 homolog,Cohesin Rec8p;, PF04824;PF04825;, GO:0000778;GO:0000800;GO:0001673;GO:0034991;GO:0034990;GO:0005634;GO:0000795;GO:0003682;GO:0009566;GO:0007141;GO:0051321;GO:0051177;GO:0007064;GO:0001556;GO:0007131;GO:1990414;GO:0072520;GO:0007062;GO:0007286;GO:0007283;GO:0007130;, C:condensed nuclear chromosome kinetochore; C:lateral element; C:male germ cell nucleus; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:fertilization; P:male meiosis I; P:meiotic cell cycle; P:meiotic sister chromatid cohesion; P:mitotic sister chromatid cohesion; P:oocyte maturation; P:reciprocal meiotic recombination; P:replication-born double-strand break repair via sister chromatid exchange; P:seminiferous tubule development; P:sister chromatid cohesion; P:spermatid development; P:spermatogenesis; P:synaptonemal complex assembly;|O95072 A8K576 D3DS62 Q658V5 Q6IA92 Q8WUV8 Q9BTF2 Q9NVQ9,Meiotic recombination protein REC8 homolog,Cohesin Rec8p;, PF04824;PF04825;, GO:0000778;GO:0000800;GO:0001673;GO:0034991;GO:0034990;GO:0005634;GO:0000795;GO:0003682;GO:0009566;GO:0007141;GO:0051321;GO:0051177;GO:0007064;GO:0001556;GO:0007131;GO:1990414;GO:0072520;GO:0007062;GO:0007286;GO:0007283;GO:0007130;, C:condensed nuclear chromosome kinetochore; C:lateral element; C:male germ cell nucleus; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:fertilization; P:male meiosis I; P:meiotic cell cycle; P:meiotic sister chromatid cohesion; P:mitotic sister chromatid cohesion; P:oocyte maturation; P:reciprocal meiotic recombination; P:replication-born double-strand break repair via sister chromatid exchange; P:seminiferous tubule development; P:sister chromatid cohesion; P:spermatid development; P:spermatogenesis; P:synaptonemal complex assembly;|O95072 A8K576 D3DS62 Q658V5 Q6IA92 Q8WUV8 Q9BTF2 Q9NVQ9,Meiotic recombination protein REC8 homolog,Cohesin Rec8p;, PF04824;PF04825;, GO:0000778;GO:0000800;GO:0001673;GO:0034991;GO:0034990;GO:0005634;GO:0000795;GO:0003682;GO:0009566;GO:0007141;GO:0051321;GO:0051177;GO:0007064;GO:0001556;GO:0007131;GO:1990414;GO:0072520;GO:0007062;GO:0007286;GO:0007283;GO:0007130;, C:condensed nuclear chromosome kinetochore; C:lateral element; C:male germ cell nucleus; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:fertilization; P:male meiosis I; P:meiotic cell cycle; P:meiotic sister chromatid cohesion; P:mitotic sister chromatid cohesion; P:oocyte maturation; P:reciprocal meiotic recombination; P:replication-born double-strand break repair via sister chromatid exchange; P:seminiferous tubule development; P:sister chromatid cohesion; P:spermatid development; P:spermatogenesis; P:synaptonemal complex assembly;|O95072 A8K576 D3DS62 Q658V5 Q6IA92 Q8WUV8 Q9BTF2 Q9NVQ9,Meiotic recombination protein REC8 homolog,Cohesin Rec8p;, PF04824;PF04825;, GO:0000778;GO:0000800;GO:0001673;GO:0034991;GO:0034990;GO:0005634;GO:0000795;GO:0003682;GO:0009566;GO:0007141;GO:0051321;GO:0051177;GO:0007064;GO:0001556;GO:0007131;GO:1990414;GO:0072520;GO:0007062;GO:0007286;GO:0007283;GO:0007130;, C:condensed nuclear chromosome kinetochore; C:lateral element; C:male germ cell nucleus; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:fertilization; P:male meiosis I; P:meiotic cell cycle; P:meiotic sister chromatid cohesion; P:mitotic sister chromatid cohesion; P:oocyte maturation; P:reciprocal meiotic recombination; P:replication-born double-strand break repair via sister chromatid exchange; P:seminiferous tubule development; P:sister chromatid cohesion; P:spermatid development; P:spermatogenesis; P:synaptonemal complex assembly; scaffold42 indexed_genome mRNA 19955695 19972802 . - . ID=transcript_8620;Q00978 D3DS61,Interferon regulatory factor 9,IFN-alpha-responsive transcription factor subunit;ISGF3 p48 subunit;Interferon-stimulated gene factor 3 gamma;Transcriptional regulator ISGF3 subunit gamma;, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0007166;GO:0051607;GO:0002376;GO:0060333;GO:0006357;GO:0006366;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell surface receptor signaling pathway; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:type I interferon signaling pathway;|Q00978 D3DS61,Interferon regulatory factor 9,IFN-alpha-responsive transcription factor subunit;ISGF3 p48 subunit;Interferon-stimulated gene factor 3 gamma;Transcriptional regulator ISGF3 subunit gamma;, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0007166;GO:0051607;GO:0002376;GO:0060333;GO:0006357;GO:0006366;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell surface receptor signaling pathway; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:type I interferon signaling pathway;|Q00978 D3DS61,Interferon regulatory factor 9,IFN-alpha-responsive transcription factor subunit;ISGF3 p48 subunit;Interferon-stimulated gene factor 3 gamma;Transcriptional regulator ISGF3 subunit gamma;, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0007166;GO:0051607;GO:0002376;GO:0060333;GO:0006357;GO:0006366;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell surface receptor signaling pathway; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:type I interferon signaling pathway;|Q96EP0 A0A962 Q86VI2 Q8TEI0 Q96GB4 Q96NF1 Q9H5F1 Q9NWD2,E3 ubiquitin-protein ligase RNF31,HOIL-1-interacting protein {ECO:0000303|PubMed:22863777};RING finger protein 31 {ECO:0000312|HGNC:HGNC:16031};RING-type E3 ubiquitin transferase RNF31 {ECO:0000305};Zinc in-between-RING-finger ubiquitin-associated domain protein {ECO:0000303|PubMed:15093743};, PF18091;PF16678;PF01485;PF09409;PF18486;, GO:0035631;GO:0009898;GO:0005829;GO:0071797;GO:0042802;GO:0046872;GO:0043130;GO:0031625;GO:0004842;GO:0023035;GO:0007249;GO:0043123;GO:0051092;GO:1903955;GO:0097039;GO:0000209;GO:0010803;GO:0050852;, C:CD40 receptor complex; C:cytoplasmic side of plasma membrane; C:cytosol; C:LUBAC complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:CD40 signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein targeting to mitochondrion; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway;|Q96EP0 A0A962 Q86VI2 Q8TEI0 Q96GB4 Q96NF1 Q9H5F1 Q9NWD2,E3 ubiquitin-protein ligase RNF31,HOIL-1-interacting protein {ECO:0000303|PubMed:22863777};RING finger protein 31 {ECO:0000312|HGNC:HGNC:16031};RING-type E3 ubiquitin transferase RNF31 {ECO:0000305};Zinc in-between-RING-finger ubiquitin-associated domain protein {ECO:0000303|PubMed:15093743};, PF18091;PF16678;PF01485;PF09409;PF18486;, GO:0035631;GO:0009898;GO:0005829;GO:0071797;GO:0042802;GO:0046872;GO:0043130;GO:0031625;GO:0004842;GO:0023035;GO:0007249;GO:0043123;GO:0051092;GO:1903955;GO:0097039;GO:0000209;GO:0010803;GO:0050852;, C:CD40 receptor complex; C:cytoplasmic side of plasma membrane; C:cytosol; C:LUBAC complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:CD40 signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein targeting to mitochondrion; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway;|Q96EP0 A0A962 Q86VI2 Q8TEI0 Q96GB4 Q96NF1 Q9H5F1 Q9NWD2,E3 ubiquitin-protein ligase RNF31,HOIL-1-interacting protein {ECO:0000303|PubMed:22863777};RING finger protein 31 {ECO:0000312|HGNC:HGNC:16031};RING-type E3 ubiquitin transferase RNF31 {ECO:0000305};Zinc in-between-RING-finger ubiquitin-associated domain protein {ECO:0000303|PubMed:15093743};, PF18091;PF16678;PF01485;PF09409;PF18486;, GO:0035631;GO:0009898;GO:0005829;GO:0071797;GO:0042802;GO:0046872;GO:0043130;GO:0031625;GO:0004842;GO:0023035;GO:0007249;GO:0043123;GO:0051092;GO:1903955;GO:0097039;GO:0000209;GO:0010803;GO:0050852;, C:CD40 receptor complex; C:cytoplasmic side of plasma membrane; C:cytosol; C:LUBAC complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:CD40 signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein targeting to mitochondrion; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway;|Q96EP0 A0A962 Q86VI2 Q8TEI0 Q96GB4 Q96NF1 Q9H5F1 Q9NWD2,E3 ubiquitin-protein ligase RNF31,HOIL-1-interacting protein {ECO:0000303|PubMed:22863777};RING finger protein 31 {ECO:0000312|HGNC:HGNC:16031};RING-type E3 ubiquitin transferase RNF31 {ECO:0000305};Zinc in-between-RING-finger ubiquitin-associated domain protein {ECO:0000303|PubMed:15093743};, PF18091;PF16678;PF01485;PF09409;PF18486;, GO:0035631;GO:0009898;GO:0005829;GO:0071797;GO:0042802;GO:0046872;GO:0043130;GO:0031625;GO:0004842;GO:0023035;GO:0007249;GO:0043123;GO:0051092;GO:1903955;GO:0097039;GO:0000209;GO:0010803;GO:0050852;, C:CD40 receptor complex; C:cytoplasmic side of plasma membrane; C:cytosol; C:LUBAC complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:CD40 signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein targeting to mitochondrion; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway;|Q96EP0 A0A962 Q86VI2 Q8TEI0 Q96GB4 Q96NF1 Q9H5F1 Q9NWD2,E3 ubiquitin-protein ligase RNF31,HOIL-1-interacting protein {ECO:0000303|PubMed:22863777};RING finger protein 31 {ECO:0000312|HGNC:HGNC:16031};RING-type E3 ubiquitin transferase RNF31 {ECO:0000305};Zinc in-between-RING-finger ubiquitin-associated domain protein {ECO:0000303|PubMed:15093743};, PF18091;PF16678;PF01485;PF09409;PF18486;, GO:0035631;GO:0009898;GO:0005829;GO:0071797;GO:0042802;GO:0046872;GO:0043130;GO:0031625;GO:0004842;GO:0023035;GO:0007249;GO:0043123;GO:0051092;GO:1903955;GO:0097039;GO:0000209;GO:0010803;GO:0050852;, C:CD40 receptor complex; C:cytoplasmic side of plasma membrane; C:cytosol; C:LUBAC complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:CD40 signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein targeting to mitochondrion; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway; scaffold42 indexed_genome mRNA 19973547 19976607 . + . ID=transcript_8621;Q9UL46 Q15129,Proteasome activator complex subunit 2,11S regulator complex subunit beta;Activator of multicatalytic protease subunit 2;Proteasome activator 28 subunit beta;, PF02251;PF02252;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0008537;GO:0000502;GO:0061133;GO:0042802;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0035722;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0010950;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:2000045;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:proteasome activator complex; C:proteasome complex;, F:endopeptidase activator activity; F:identical protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endopeptidase activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q9UL46 Q15129,Proteasome activator complex subunit 2,11S regulator complex subunit beta;Activator of multicatalytic protease subunit 2;Proteasome activator 28 subunit beta;, PF02251;PF02252;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0008537;GO:0000502;GO:0061133;GO:0042802;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0035722;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0010950;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:2000045;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:proteasome activator complex; C:proteasome complex;, F:endopeptidase activator activity; F:identical protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endopeptidase activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold42 indexed_genome mRNA 19979497 19984783 . + . ID=transcript_8622;Q9Y3B6 D3DS60 Q9BUM3,ER membrane protein complex subunit 9,Protein FAM158A;, PF03665;, GO:0005737;GO:0072546;GO:0045050;GO:0071816;, C:cytoplasm; C:EMC complex;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q9Y3B6 D3DS60 Q9BUM3,ER membrane protein complex subunit 9,Protein FAM158A;, PF03665;, GO:0005737;GO:0072546;GO:0045050;GO:0071816;, C:cytoplasm; C:EMC complex;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q06323 A6NJG9 H0YNE3 Q6IBM2 Q9UEF4,Proteasome activator complex subunit 1,11S regulator complex subunit alpha;Activator of multicatalytic protease subunit 1;Interferon gamma up-regulated I-5111 protein;Proteasome activator 28 subunit alpha;, PF02251;PF02252;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0008537;GO:0000502;GO:0061133;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0010950;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:2000045;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:proteasome activator complex; C:proteasome complex;, F:endopeptidase activator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endopeptidase activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q06323 A6NJG9 H0YNE3 Q6IBM2 Q9UEF4,Proteasome activator complex subunit 1,11S regulator complex subunit alpha;Activator of multicatalytic protease subunit 1;Interferon gamma up-regulated I-5111 protein;Proteasome activator 28 subunit alpha;, PF02251;PF02252;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0008537;GO:0000502;GO:0061133;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0010950;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:2000045;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:proteasome activator complex; C:proteasome complex;, F:endopeptidase activator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endopeptidase activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold42 indexed_genome mRNA 19986266 19998972 . + . ID=transcript_8623;A5D6W6 Q8IUQ7,Fat storage-inducing transmembrane protein 1 {ECO:0000255|HAMAP-Rule:MF_03229, ECO:0000303|PubMed:18160536},Fat-inducing protein 1 {ECO:0000255|HAMAP-Rule:MF_03229};, , GO:0005789;GO:0030176;GO:0019992;GO:0017129;GO:0140042;GO:0034389;GO:0019915;GO:0008654;GO:0010890;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:diacylglycerol binding; F:triglyceride binding;, P:lipid droplet formation; P:lipid droplet organization; P:lipid storage; P:phospholipid biosynthetic process; P:positive regulation of sequestering of triglyceride;|Q9H5C9,DDB1- and CUL4-associated factor 11,WD repeat-containing protein 23;, PF00400;, GO:0080008;GO:0005654;GO:0043687;GO:0043161;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q9H5C9,DDB1- and CUL4-associated factor 11,WD repeat-containing protein 23;, PF00400;, GO:0080008;GO:0005654;GO:0043687;GO:0043161;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q9H5C9,DDB1- and CUL4-associated factor 11,WD repeat-containing protein 23;, PF00400;, GO:0080008;GO:0005654;GO:0043687;GO:0043161;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q9H5C9,DDB1- and CUL4-associated factor 11,WD repeat-containing protein 23;, PF00400;, GO:0080008;GO:0005654;GO:0043687;GO:0043161;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q9H5C9,DDB1- and CUL4-associated factor 11,WD repeat-containing protein 23;, PF00400;, GO:0080008;GO:0005654;GO:0043687;GO:0043161;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; scaffold42 indexed_genome mRNA 19999746 20028704 . - . ID=transcript_8624;Q16822 B4DW73 O43253 Q86U01 Q9BV62,Phosphoenolpyruvate carboxykinase [GTP], mitochondrial,, PF00821;PF17297;, GO:0005829;GO:0005759;GO:0005739;GO:0005525;GO:0030145;GO:0004613;GO:0004611;GO:0071549;GO:0071333;GO:0032869;GO:0071356;GO:0006094;GO:0046327;GO:0070365;GO:0006116;GO:0006107;GO:0032024;GO:0019543;GO:0033993;GO:0032496;GO:0042594;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:manganese ion binding; F:phosphoenolpyruvate carboxykinase (GTP) activity; F:phosphoenolpyruvate carboxykinase activity;, P:cellular response to dexamethasone stimulus; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:cellular response to tumor necrosis factor; P:gluconeogenesis; P:glycerol biosynthetic process from pyruvate; P:hepatocyte differentiation; P:NADH oxidation; P:oxaloacetate metabolic process; P:positive regulation of insulin secretion; P:propionate catabolic process; P:response to lipid; P:response to lipopolysaccharide; P:response to starvation;|P54845 A8MX14 Q53XD0,Neural retina-specific leucine zipper protein,, PF03131;PF08383;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0043522;GO:1990841;GO:0000978;GO:1990837;GO:0045944;GO:0006357;GO:0050896;GO:0046548;GO:0007601;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:leucine zipper domain binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to stimulus; P:retinal rod cell development; P:visual perception; scaffold42 indexed_genome mRNA 20030911 20035325 . - . ID=transcript_8625;O95741 B2RAG6 B7Z1M3 D3DS55 F5GXN1 Q53HA6 Q8WVG1,Copine-6 {ECO:0000305},Copine VI {ECO:0000250|UniProtKB:Q99829, ECO:0000312|HGNC:HGNC:2319};Neuronal-copine {ECO:0000303|PubMed:9645480};, PF00168;PF07002;, GO:0030424;GO:0045334;GO:0030425;GO:0005768;GO:0070062;GO:0016020;GO:0043204;GO:0005886;GO:0045202;GO:0005509;GO:0005544;GO:0001786;GO:0005215;GO:0030154;GO:0071277;GO:0007268;GO:0046474;GO:0006629;GO:0007399;GO:1903861;GO:0016192;, C:axon; C:clathrin-coated endocytic vesicle; C:dendrite; C:endosome; C:extracellular exosome; C:membrane; C:perikaryon; C:plasma membrane; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phosphatidylserine binding; F:transporter activity;, P:cell differentiation; P:cellular response to calcium ion; P:chemical synaptic transmission; P:glycerophospholipid biosynthetic process; P:lipid metabolic process; P:nervous system development; P:positive regulation of dendrite extension; P:vesicle-mediated transport; scaffold42 indexed_genome mRNA 20039084 20055839 . - . ID=transcript_8626;Q8ND23 Q8TEF7 Q96HS9,Capping protein, Arp2/3 and myosin-I linker protein 3 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker protein 3;Leucine-rich repeat-containing protein 16B;, PF17888;PF16000;PF13516;, GO:0005737;GO:0005886;, C:cytoplasm; C:plasma membrane;|Q8ND23 Q8TEF7 Q96HS9,Capping protein, Arp2/3 and myosin-I linker protein 3 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker protein 3;Leucine-rich repeat-containing protein 16B;, PF17888;PF16000;PF13516;, GO:0005737;GO:0005886;, C:cytoplasm; C:plasma membrane;|Q8ND23 Q8TEF7 Q96HS9,Capping protein, Arp2/3 and myosin-I linker protein 3 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker protein 3;Leucine-rich repeat-containing protein 16B;, PF17888;PF16000;PF13516;, GO:0005737;GO:0005886;, C:cytoplasm; C:plasma membrane;|Q8ND23 Q8TEF7 Q96HS9,Capping protein, Arp2/3 and myosin-I linker protein 3 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker protein 3;Leucine-rich repeat-containing protein 16B;, PF17888;PF16000;PF13516;, GO:0005737;GO:0005886;, C:cytoplasm; C:plasma membrane;|Q8ND23 Q8TEF7 Q96HS9,Capping protein, Arp2/3 and myosin-I linker protein 3 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker protein 3;Leucine-rich repeat-containing protein 16B;, PF17888;PF16000;PF13516;, GO:0005737;GO:0005886;, C:cytoplasm; C:plasma membrane;|Q8ND23 Q8TEF7 Q96HS9,Capping protein, Arp2/3 and myosin-I linker protein 3 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker protein 3;Leucine-rich repeat-containing protein 16B;, PF17888;PF16000;PF13516;, GO:0005737;GO:0005886;, C:cytoplasm; C:plasma membrane;|Q8ND23 Q8TEF7 Q96HS9,Capping protein, Arp2/3 and myosin-I linker protein 3 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker protein 3;Leucine-rich repeat-containing protein 16B;, PF17888;PF16000;PF13516;, GO:0005737;GO:0005886;, C:cytoplasm; C:plasma membrane;|Q8ND23 Q8TEF7 Q96HS9,Capping protein, Arp2/3 and myosin-I linker protein 3 {ECO:0000303|PubMed:19846667},Capping protein regulator and myosin 1 linker protein 3;Leucine-rich repeat-containing protein 16B;, PF17888;PF16000;PF13516;, GO:0005737;GO:0005886;, C:cytoplasm; C:plasma membrane; scaffold42 indexed_genome mRNA 20056926 20068668 . - . ID=transcript_8627;Q58IU4 Q6E0Y1 Q6UWU3 Q71UQ6 Q8TD03 Q9H3N5 Q9NV08,Dehydrogenase/reductase SDR family member 4,NADPH-dependent carbonyl reductase/NADP-retinol dehydrogenase;NADPH-dependent retinol dehydrogenase/reductase;Peroxisomal short-chain alcohol dehydrogenase;SCAD-SRL;Short chain dehydrogenase/reductase family 25C member 2;Short-chain dehydrogenase/reductase family member 4;, , GO:0005829;GO:0005789;GO:0005739;GO:0005634;GO:0005782;GO:0005778;GO:0005777;GO:0000253;GO:0018455;GO:0004090;GO:0042802;GO:0016655;GO:0006066;GO:0042180;GO:0008104;GO:0008202;, C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion; C:nucleus; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:3-keto sterol reductase activity; F:alcohol dehydrogenase [NAD(P)+] activity; F:carbonyl reductase (NADPH) activity; F:identical protein binding; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;, P:alcohol metabolic process; P:cellular ketone metabolic process; P:protein localization; P:steroid metabolic process;|Q58IU4 Q6E0Y1 Q6UWU3 Q71UQ6 Q8TD03 Q9H3N5 Q9NV08,Dehydrogenase/reductase SDR family member 4,NADPH-dependent carbonyl reductase/NADP-retinol dehydrogenase;NADPH-dependent retinol dehydrogenase/reductase;Peroxisomal short-chain alcohol dehydrogenase;SCAD-SRL;Short chain dehydrogenase/reductase family 25C member 2;Short-chain dehydrogenase/reductase family member 4;, , GO:0005829;GO:0005789;GO:0005739;GO:0005634;GO:0005782;GO:0005778;GO:0005777;GO:0000253;GO:0018455;GO:0004090;GO:0042802;GO:0016655;GO:0006066;GO:0042180;GO:0008104;GO:0008202;, C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion; C:nucleus; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:3-keto sterol reductase activity; F:alcohol dehydrogenase [NAD(P)+] activity; F:carbonyl reductase (NADPH) activity; F:identical protein binding; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;, P:alcohol metabolic process; P:cellular ketone metabolic process; P:protein localization; P:steroid metabolic process; scaffold42 indexed_genome mRNA 20079746 20100104 . - . ID=transcript_8628;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q9Y3C0 B2RC74 Q53FF0 Q6IAI4 Q96QK0,WASH complex subunit 3 {ECO:0000312|HGNC:HGNC:24256},Coiled-coil domain-containing protein 53;, PF10152;, GO:0005769;GO:0071203;GO:0030041;GO:0006887;GO:0015031;, C:early endosome; C:WASH complex;, , P:actin filament polymerization; P:exocytosis; P:protein transport; scaffold42 indexed_genome mRNA 20336402 20350618 . - . ID=transcript_8629;Q96JJ6 D3DS53 Q8ND44 Q96DQ0,Junctophilin-4,Junctophilin-like 1 protein;, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0060402;GO:0060314;GO:0048167;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane;, , P:calcium ion transport into cytosol; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic plasticity;|Q96JJ6 D3DS53 Q8ND44 Q96DQ0,Junctophilin-4,Junctophilin-like 1 protein;, PF02493;, GO:0005789;GO:0016021;GO:0030314;GO:0014701;GO:0005886;GO:0060402;GO:0060314;GO:0048167;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:junctional membrane complex; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane;, , P:calcium ion transport into cytosol; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic plasticity;|O75843 D3DS51 O75504,AP-1 complex subunit gamma-like 2,Gamma2-adaptin;, PF01602;PF02883;, GO:0030121;GO:0010008;GO:0005794;GO:0000139;GO:0005798;GO:0016020;GO:0030133;GO:0140312;GO:0035615;GO:0006896;GO:0006886;GO:0006892;GO:0006898;GO:0016192;GO:0016032;, C:AP-1 adaptor complex; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:membrane; C:transport vesicle;, F:cargo adaptor activity; F:clathrin adaptor activity;, P:Golgi to vacuole transport; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:vesicle-mediated transport; P:viral process;|O75843 D3DS51 O75504,AP-1 complex subunit gamma-like 2,Gamma2-adaptin;, PF01602;PF02883;, GO:0030121;GO:0010008;GO:0005794;GO:0000139;GO:0005798;GO:0016020;GO:0030133;GO:0140312;GO:0035615;GO:0006896;GO:0006886;GO:0006892;GO:0006898;GO:0016192;GO:0016032;, C:AP-1 adaptor complex; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:membrane; C:transport vesicle;, F:cargo adaptor activity; F:clathrin adaptor activity;, P:Golgi to vacuole transport; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:vesicle-mediated transport; P:viral process;|O75843 D3DS51 O75504,AP-1 complex subunit gamma-like 2,Gamma2-adaptin;, PF01602;PF02883;, GO:0030121;GO:0010008;GO:0005794;GO:0000139;GO:0005798;GO:0016020;GO:0030133;GO:0140312;GO:0035615;GO:0006896;GO:0006886;GO:0006892;GO:0006898;GO:0016192;GO:0016032;, C:AP-1 adaptor complex; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:membrane; C:transport vesicle;, F:cargo adaptor activity; F:clathrin adaptor activity;, P:Golgi to vacuole transport; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:vesicle-mediated transport; P:viral process;|O75843 D3DS51 O75504,AP-1 complex subunit gamma-like 2,Gamma2-adaptin;, PF01602;PF02883;, GO:0030121;GO:0010008;GO:0005794;GO:0000139;GO:0005798;GO:0016020;GO:0030133;GO:0140312;GO:0035615;GO:0006896;GO:0006886;GO:0006892;GO:0006898;GO:0016192;GO:0016032;, C:AP-1 adaptor complex; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:membrane; C:transport vesicle;, F:cargo adaptor activity; F:clathrin adaptor activity;, P:Golgi to vacuole transport; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:vesicle-mediated transport; P:viral process;|O75843 D3DS51 O75504,AP-1 complex subunit gamma-like 2,Gamma2-adaptin;, PF01602;PF02883;, GO:0030121;GO:0010008;GO:0005794;GO:0000139;GO:0005798;GO:0016020;GO:0030133;GO:0140312;GO:0035615;GO:0006896;GO:0006886;GO:0006892;GO:0006898;GO:0016192;GO:0016032;, C:AP-1 adaptor complex; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:membrane; C:transport vesicle;, F:cargo adaptor activity; F:clathrin adaptor activity;, P:Golgi to vacuole transport; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:vesicle-mediated transport; P:viral process; scaffold42 indexed_genome mRNA 20350632 20355506 . + . ID=transcript_8630;O75843 D3DS51 O75504,AP-1 complex subunit gamma-like 2,Gamma2-adaptin;, PF01602;PF02883;, GO:0030121;GO:0010008;GO:0005794;GO:0000139;GO:0005798;GO:0016020;GO:0030133;GO:0140312;GO:0035615;GO:0006896;GO:0006886;GO:0006892;GO:0006898;GO:0016192;GO:0016032;, C:AP-1 adaptor complex; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:membrane; C:transport vesicle;, F:cargo adaptor activity; F:clathrin adaptor activity;, P:Golgi to vacuole transport; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:vesicle-mediated transport; P:viral process;|Q9BU02 D3DS50 G3V4J3,Thiamine-triphosphatase,, PF01928;, GO:0005829;GO:0016787;GO:0000287;GO:0050333;GO:0016311;GO:0006091;GO:0042357;GO:0006772;GO:0042723;, C:cytosol;, F:hydrolase activity; F:magnesium ion binding; F:thiamin-triphosphatase activity;, P:dephosphorylation; P:generation of precursor metabolites and energy; P:thiamine diphosphate metabolic process; P:thiamine metabolic process; P:thiamine-containing compound metabolic process; scaffold42 indexed_genome mRNA 20370494 20386673 . + . ID=transcript_8631;Q9C0A1 Q9UPU6,Zinc finger homeobox protein 2,Zinc finger homeodomain protein 2;, PF00046;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0030534;GO:0007420;GO:0045664;GO:0051930;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:adult behavior; P:brain development; P:regulation of neuron differentiation; P:regulation of sensory perception of pain; P:regulation of transcription by RNA polymerase II;|Q9C0A1 Q9UPU6,Zinc finger homeobox protein 2,Zinc finger homeodomain protein 2;, PF00046;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0030534;GO:0007420;GO:0045664;GO:0051930;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:adult behavior; P:brain development; P:regulation of neuron differentiation; P:regulation of sensory perception of pain; P:regulation of transcription by RNA polymerase II;|Q9C0A1 Q9UPU6,Zinc finger homeobox protein 2,Zinc finger homeodomain protein 2;, PF00046;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0030534;GO:0007420;GO:0045664;GO:0051930;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:adult behavior; P:brain development; P:regulation of neuron differentiation; P:regulation of sensory perception of pain; P:regulation of transcription by RNA polymerase II; scaffold42 indexed_genome mRNA 20421643 20430459 . - . ID=transcript_8632;Q8NEJ9 A8K760 Q9Y400,Neuroguidin,Centromere accumulated nuclear protein 1;EIF4E-binding protein;, PF04000;, GO:0030424;GO:0000775;GO:0030425;GO:0030175;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0000462;GO:0006417;, C:axon; C:chromosome, centromeric region; C:dendrite; C:filopodium; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of translation;|Q8NEJ9 A8K760 Q9Y400,Neuroguidin,Centromere accumulated nuclear protein 1;EIF4E-binding protein;, PF04000;, GO:0030424;GO:0000775;GO:0030425;GO:0030175;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0000462;GO:0006417;, C:axon; C:chromosome, centromeric region; C:dendrite; C:filopodium; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of translation;|Q8NEJ9 A8K760 Q9Y400,Neuroguidin,Centromere accumulated nuclear protein 1;EIF4E-binding protein;, PF04000;, GO:0030424;GO:0000775;GO:0030425;GO:0030175;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0000462;GO:0006417;, C:axon; C:chromosome, centromeric region; C:dendrite; C:filopodium; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of translation;|Q8NEJ9 A8K760 Q9Y400,Neuroguidin,Centromere accumulated nuclear protein 1;EIF4E-binding protein;, PF04000;, GO:0030424;GO:0000775;GO:0030425;GO:0030175;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0000462;GO:0006417;, C:axon; C:chromosome, centromeric region; C:dendrite; C:filopodium; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of translation; scaffold42 indexed_genome mRNA 20450369 20502025 . + . ID=transcript_8633;Q9H1D5 Q9UDA2 Q9UMM8,Myosin-7,Myosin heavy chain 7;Myosin heavy chain slow isoform;Myosin heavy chain, cardiac muscle beta isoform;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0007512;GO:0046034;GO:0060048;GO:0014898;GO:0006936;GO:0030049;GO:0002027;GO:0031449;GO:0002026;GO:0014728;GO:0003009;GO:0006941;GO:0014883;GO:0055010;, C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:adult heart development; P:ATP metabolic process; P:cardiac muscle contraction; P:cardiac muscle hypertrophy in response to stress; P:muscle contraction; P:muscle filament sliding; P:regulation of heart rate; P:regulation of slow-twitch skeletal muscle fiber contraction; P:regulation of the force of heart contraction; P:regulation of the force of skeletal muscle contraction; P:skeletal muscle contraction; P:striated muscle contraction; P:transition between fast and slow fiber; P:ventricular cardiac muscle tissue morphogenesis;|P12882 Q14CA4 Q9Y622,Myosin-1,Myosin heavy chain 1;Myosin heavy chain 2x;Myosin heavy chain IIx/d;Myosin heavy chain, skeletal muscle, adult 1;, PF00063;PF02736;PF01576;, GO:0031672;GO:0036464;GO:0014704;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0006936;, C:A band; C:cytoplasmic ribonucleoprotein granule; C:intercalated disc; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity;, P:muscle contraction;|Q9H1D5 Q9UDA2 Q9UMM8,Myosin-7,Myosin heavy chain 7;Myosin heavy chain slow isoform;Myosin heavy chain, cardiac muscle beta isoform;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0007512;GO:0046034;GO:0060048;GO:0014898;GO:0006936;GO:0030049;GO:0002027;GO:0031449;GO:0002026;GO:0014728;GO:0003009;GO:0006941;GO:0014883;GO:0055010;, C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:adult heart development; P:ATP metabolic process; P:cardiac muscle contraction; P:cardiac muscle hypertrophy in response to stress; P:muscle contraction; P:muscle filament sliding; P:regulation of heart rate; P:regulation of slow-twitch skeletal muscle fiber contraction; P:regulation of the force of heart contraction; P:regulation of the force of skeletal muscle contraction; P:skeletal muscle contraction; P:striated muscle contraction; P:transition between fast and slow fiber; P:ventricular cardiac muscle tissue morphogenesis;|Q9H1D5 Q9UDA2 Q9UMM8,Myosin-7,Myosin heavy chain 7;Myosin heavy chain slow isoform;Myosin heavy chain, cardiac muscle beta isoform;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0007512;GO:0046034;GO:0060048;GO:0014898;GO:0006936;GO:0030049;GO:0002027;GO:0031449;GO:0002026;GO:0014728;GO:0003009;GO:0006941;GO:0014883;GO:0055010;, C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:adult heart development; P:ATP metabolic process; P:cardiac muscle contraction; P:cardiac muscle hypertrophy in response to stress; P:muscle contraction; P:muscle filament sliding; P:regulation of heart rate; P:regulation of slow-twitch skeletal muscle fiber contraction; P:regulation of the force of heart contraction; P:regulation of the force of skeletal muscle contraction; P:skeletal muscle contraction; P:striated muscle contraction; P:transition between fast and slow fiber; P:ventricular cardiac muscle tissue morphogenesis;|Q9H1D5 Q9UDA2 Q9UMM8,Myosin-7,Myosin heavy chain 7;Myosin heavy chain slow isoform;Myosin heavy chain, cardiac muscle beta isoform;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0007512;GO:0046034;GO:0060048;GO:0014898;GO:0006936;GO:0030049;GO:0002027;GO:0031449;GO:0002026;GO:0014728;GO:0003009;GO:0006941;GO:0014883;GO:0055010;, C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:adult heart development; P:ATP metabolic process; P:cardiac muscle contraction; P:cardiac muscle hypertrophy in response to stress; P:muscle contraction; P:muscle filament sliding; P:regulation of heart rate; P:regulation of slow-twitch skeletal muscle fiber contraction; P:regulation of the force of heart contraction; P:regulation of the force of skeletal muscle contraction; P:skeletal muscle contraction; P:striated muscle contraction; P:transition between fast and slow fiber; P:ventricular cardiac muscle tissue morphogenesis;|Q9H1D5 Q9UDA2 Q9UMM8,Myosin-7,Myosin heavy chain 7;Myosin heavy chain slow isoform;Myosin heavy chain, cardiac muscle beta isoform;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0007512;GO:0046034;GO:0060048;GO:0014898;GO:0006936;GO:0030049;GO:0002027;GO:0031449;GO:0002026;GO:0014728;GO:0003009;GO:0006941;GO:0014883;GO:0055010;, C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:adult heart development; P:ATP metabolic process; P:cardiac muscle contraction; P:cardiac muscle hypertrophy in response to stress; P:muscle contraction; P:muscle filament sliding; P:regulation of heart rate; P:regulation of slow-twitch skeletal muscle fiber contraction; P:regulation of the force of heart contraction; P:regulation of the force of skeletal muscle contraction; P:skeletal muscle contraction; P:striated muscle contraction; P:transition between fast and slow fiber; P:ventricular cardiac muscle tissue morphogenesis;|Q9H1D5 Q9UDA2 Q9UMM8,Myosin-7,Myosin heavy chain 7;Myosin heavy chain slow isoform;Myosin heavy chain, cardiac muscle beta isoform;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0007512;GO:0046034;GO:0060048;GO:0014898;GO:0006936;GO:0030049;GO:0002027;GO:0031449;GO:0002026;GO:0014728;GO:0003009;GO:0006941;GO:0014883;GO:0055010;, C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:adult heart development; P:ATP metabolic process; P:cardiac muscle contraction; P:cardiac muscle hypertrophy in response to stress; P:muscle contraction; P:muscle filament sliding; P:regulation of heart rate; P:regulation of slow-twitch skeletal muscle fiber contraction; P:regulation of the force of heart contraction; P:regulation of the force of skeletal muscle contraction; P:skeletal muscle contraction; P:striated muscle contraction; P:transition between fast and slow fiber; P:ventricular cardiac muscle tissue morphogenesis;|P13533 A2RTX1 D9YZU2 Q13943 Q14906 Q14907,Myosin-6,Myosin heavy chain 6;Myosin heavy chain, cardiac muscle alpha isoform;, PF00063;PF02736;PF01576;, GO:0005829;GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0019901;GO:0007512;GO:0046034;GO:0055009;GO:0060048;GO:0048739;GO:0014898;GO:0001701;GO:0006936;GO:0030049;GO:0030239;GO:0006470;GO:0043462;GO:0008217;GO:0008016;GO:0060420;GO:0002027;GO:0002026;GO:0045214;GO:0006941;GO:0055010;GO:0007522;, C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:protein kinase binding;, P:adult heart development; P:ATP metabolic process; P:atrial cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy in response to stress; P:in utero embryonic development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:protein dephosphorylation; P:regulation of ATPase activity; P:regulation of blood pressure; P:regulation of heart contraction; P:regulation of heart growth; P:regulation of heart rate; P:regulation of the force of heart contraction; P:sarcomere organization; P:striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; P:visceral muscle development;|P13533 A2RTX1 D9YZU2 Q13943 Q14906 Q14907,Myosin-6,Myosin heavy chain 6;Myosin heavy chain, cardiac muscle alpha isoform;, PF00063;PF02736;PF01576;, GO:0005829;GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0019901;GO:0007512;GO:0046034;GO:0055009;GO:0060048;GO:0048739;GO:0014898;GO:0001701;GO:0006936;GO:0030049;GO:0030239;GO:0006470;GO:0043462;GO:0008217;GO:0008016;GO:0060420;GO:0002027;GO:0002026;GO:0045214;GO:0006941;GO:0055010;GO:0007522;, C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:protein kinase binding;, P:adult heart development; P:ATP metabolic process; P:atrial cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy in response to stress; P:in utero embryonic development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:protein dephosphorylation; P:regulation of ATPase activity; P:regulation of blood pressure; P:regulation of heart contraction; P:regulation of heart growth; P:regulation of heart rate; P:regulation of the force of heart contraction; P:sarcomere organization; P:striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; P:visceral muscle development;|Q9H1D5 Q9UDA2 Q9UMM8,Myosin-7,Myosin heavy chain 7;Myosin heavy chain slow isoform;Myosin heavy chain, cardiac muscle beta isoform;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0007512;GO:0046034;GO:0060048;GO:0014898;GO:0006936;GO:0030049;GO:0002027;GO:0031449;GO:0002026;GO:0014728;GO:0003009;GO:0006941;GO:0014883;GO:0055010;, C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:adult heart development; P:ATP metabolic process; P:cardiac muscle contraction; P:cardiac muscle hypertrophy in response to stress; P:muscle contraction; P:muscle filament sliding; P:regulation of heart rate; P:regulation of slow-twitch skeletal muscle fiber contraction; P:regulation of the force of heart contraction; P:regulation of the force of skeletal muscle contraction; P:skeletal muscle contraction; P:striated muscle contraction; P:transition between fast and slow fiber; P:ventricular cardiac muscle tissue morphogenesis;|P11055 Q15492,Myosin-3,Muscle embryonic myosin heavy chain;Myosin heavy chain 3;Myosin heavy chain, fast skeletal muscle, embryonic;SMHCE;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0005859;GO:0032982;GO:0030017;GO:0051015;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0030048;GO:0046034;GO:0030326;GO:0060325;GO:0030049;GO:0007517;GO:0006470;GO:0045214;GO:0003009;, C:cytosol; C:extracellular exosome; C:muscle myosin complex; C:myosin filament; C:sarcomere;, F:actin filament binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:actin filament-based movement; P:ATP metabolic process; P:embryonic limb morphogenesis; P:face morphogenesis; P:muscle filament sliding; P:muscle organ development; P:protein dephosphorylation; P:sarcomere organization; P:skeletal muscle contraction;|Q9H1D5 Q9UDA2 Q9UMM8,Myosin-7,Myosin heavy chain 7;Myosin heavy chain slow isoform;Myosin heavy chain, cardiac muscle beta isoform;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0007512;GO:0046034;GO:0060048;GO:0014898;GO:0006936;GO:0030049;GO:0002027;GO:0031449;GO:0002026;GO:0014728;GO:0003009;GO:0006941;GO:0014883;GO:0055010;, C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:adult heart development; P:ATP metabolic process; P:cardiac muscle contraction; P:cardiac muscle hypertrophy in response to stress; P:muscle contraction; P:muscle filament sliding; P:regulation of heart rate; P:regulation of slow-twitch skeletal muscle fiber contraction; P:regulation of the force of heart contraction; P:regulation of the force of skeletal muscle contraction; P:skeletal muscle contraction; P:striated muscle contraction; P:transition between fast and slow fiber; P:ventricular cardiac muscle tissue morphogenesis;|Q9H1D5 Q9UDA2 Q9UMM8,Myosin-7,Myosin heavy chain 7;Myosin heavy chain slow isoform;Myosin heavy chain, cardiac muscle beta isoform;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0007512;GO:0046034;GO:0060048;GO:0014898;GO:0006936;GO:0030049;GO:0002027;GO:0031449;GO:0002026;GO:0014728;GO:0003009;GO:0006941;GO:0014883;GO:0055010;, C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:adult heart development; P:ATP metabolic process; P:cardiac muscle contraction; P:cardiac muscle hypertrophy in response to stress; P:muscle contraction; P:muscle filament sliding; P:regulation of heart rate; P:regulation of slow-twitch skeletal muscle fiber contraction; P:regulation of the force of heart contraction; P:regulation of the force of skeletal muscle contraction; P:skeletal muscle contraction; P:striated muscle contraction; P:transition between fast and slow fiber; P:ventricular cardiac muscle tissue morphogenesis;|Q8TAC4 Q8TCX2 Q8TD99 Q9UHN5 Q9UJ80,Desmin,, PF00038;PF04732;, GO:0097512;GO:0005829;GO:0070062;GO:0005916;GO:0014704;GO:0005882;GO:0045111;GO:0031594;GO:0005634;GO:0042383;GO:0030018;GO:0008092;GO:0042802;GO:0005200;GO:0007010;GO:0045109;GO:0006936;GO:0030049;GO:0008016;, C:cardiac myofibril; C:cytosol; C:extracellular exosome; C:fascia adherens; C:intercalated disc; C:intermediate filament; C:intermediate filament cytoskeleton; C:neuromuscular junction; C:nucleus; C:sarcolemma; C:Z disc;, F:cytoskeletal protein binding; F:identical protein binding; F:structural constituent of cytoskeleton;, P:cytoskeleton organization; P:intermediate filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of heart contraction;|P13533 A2RTX1 D9YZU2 Q13943 Q14906 Q14907,Myosin-6,Myosin heavy chain 6;Myosin heavy chain, cardiac muscle alpha isoform;, PF00063;PF02736;PF01576;, GO:0005829;GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0019901;GO:0007512;GO:0046034;GO:0055009;GO:0060048;GO:0048739;GO:0014898;GO:0001701;GO:0006936;GO:0030049;GO:0030239;GO:0006470;GO:0043462;GO:0008217;GO:0008016;GO:0060420;GO:0002027;GO:0002026;GO:0045214;GO:0006941;GO:0055010;GO:0007522;, C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:protein kinase binding;, P:adult heart development; P:ATP metabolic process; P:atrial cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy in response to stress; P:in utero embryonic development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:protein dephosphorylation; P:regulation of ATPase activity; P:regulation of blood pressure; P:regulation of heart contraction; P:regulation of heart growth; P:regulation of heart rate; P:regulation of the force of heart contraction; P:sarcomere organization; P:striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; P:visceral muscle development;|P13533 A2RTX1 D9YZU2 Q13943 Q14906 Q14907,Myosin-6,Myosin heavy chain 6;Myosin heavy chain, cardiac muscle alpha isoform;, PF00063;PF02736;PF01576;, GO:0005829;GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0019901;GO:0007512;GO:0046034;GO:0055009;GO:0060048;GO:0048739;GO:0014898;GO:0001701;GO:0006936;GO:0030049;GO:0030239;GO:0006470;GO:0043462;GO:0008217;GO:0008016;GO:0060420;GO:0002027;GO:0002026;GO:0045214;GO:0006941;GO:0055010;GO:0007522;, C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:protein kinase binding;, P:adult heart development; P:ATP metabolic process; P:atrial cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy in response to stress; P:in utero embryonic development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:protein dephosphorylation; P:regulation of ATPase activity; P:regulation of blood pressure; P:regulation of heart contraction; P:regulation of heart growth; P:regulation of heart rate; P:regulation of the force of heart contraction; P:sarcomere organization; P:striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; P:visceral muscle development;|P13533 A2RTX1 D9YZU2 Q13943 Q14906 Q14907,Myosin-6,Myosin heavy chain 6;Myosin heavy chain, cardiac muscle alpha isoform;, PF00063;PF02736;PF01576;, GO:0005829;GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0019901;GO:0007512;GO:0046034;GO:0055009;GO:0060048;GO:0048739;GO:0014898;GO:0001701;GO:0006936;GO:0030049;GO:0030239;GO:0006470;GO:0043462;GO:0008217;GO:0008016;GO:0060420;GO:0002027;GO:0002026;GO:0045214;GO:0006941;GO:0055010;GO:0007522;, C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:protein kinase binding;, P:adult heart development; P:ATP metabolic process; P:atrial cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy in response to stress; P:in utero embryonic development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:protein dephosphorylation; P:regulation of ATPase activity; P:regulation of blood pressure; P:regulation of heart contraction; P:regulation of heart growth; P:regulation of heart rate; P:regulation of the force of heart contraction; P:sarcomere organization; P:striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; P:visceral muscle development;|P13533 A2RTX1 D9YZU2 Q13943 Q14906 Q14907,Myosin-6,Myosin heavy chain 6;Myosin heavy chain, cardiac muscle alpha isoform;, PF00063;PF02736;PF01576;, GO:0005829;GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0019901;GO:0007512;GO:0046034;GO:0055009;GO:0060048;GO:0048739;GO:0014898;GO:0001701;GO:0006936;GO:0030049;GO:0030239;GO:0006470;GO:0043462;GO:0008217;GO:0008016;GO:0060420;GO:0002027;GO:0002026;GO:0045214;GO:0006941;GO:0055010;GO:0007522;, C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:protein kinase binding;, P:adult heart development; P:ATP metabolic process; P:atrial cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy in response to stress; P:in utero embryonic development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:protein dephosphorylation; P:regulation of ATPase activity; P:regulation of blood pressure; P:regulation of heart contraction; P:regulation of heart growth; P:regulation of heart rate; P:regulation of the force of heart contraction; P:sarcomere organization; P:striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; P:visceral muscle development;|P13533 A2RTX1 D9YZU2 Q13943 Q14906 Q14907,Myosin-6,Myosin heavy chain 6;Myosin heavy chain, cardiac muscle alpha isoform;, PF00063;PF02736;PF01576;, GO:0005829;GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0019901;GO:0007512;GO:0046034;GO:0055009;GO:0060048;GO:0048739;GO:0014898;GO:0001701;GO:0006936;GO:0030049;GO:0030239;GO:0006470;GO:0043462;GO:0008217;GO:0008016;GO:0060420;GO:0002027;GO:0002026;GO:0045214;GO:0006941;GO:0055010;GO:0007522;, C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:protein kinase binding;, P:adult heart development; P:ATP metabolic process; P:atrial cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy in response to stress; P:in utero embryonic development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:protein dephosphorylation; P:regulation of ATPase activity; P:regulation of blood pressure; P:regulation of heart contraction; P:regulation of heart growth; P:regulation of heart rate; P:regulation of the force of heart contraction; P:sarcomere organization; P:striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; P:visceral muscle development;|Q9H1D5 Q9UDA2 Q9UMM8,Myosin-7,Myosin heavy chain 7;Myosin heavy chain slow isoform;Myosin heavy chain, cardiac muscle beta isoform;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0007512;GO:0046034;GO:0060048;GO:0014898;GO:0006936;GO:0030049;GO:0002027;GO:0031449;GO:0002026;GO:0014728;GO:0003009;GO:0006941;GO:0014883;GO:0055010;, C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:adult heart development; P:ATP metabolic process; P:cardiac muscle contraction; P:cardiac muscle hypertrophy in response to stress; P:muscle contraction; P:muscle filament sliding; P:regulation of heart rate; P:regulation of slow-twitch skeletal muscle fiber contraction; P:regulation of the force of heart contraction; P:regulation of the force of skeletal muscle contraction; P:skeletal muscle contraction; P:striated muscle contraction; P:transition between fast and slow fiber; P:ventricular cardiac muscle tissue morphogenesis;|P13533 A2RTX1 D9YZU2 Q13943 Q14906 Q14907,Myosin-6,Myosin heavy chain 6;Myosin heavy chain, cardiac muscle alpha isoform;, PF00063;PF02736;PF01576;, GO:0005829;GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0019901;GO:0007512;GO:0046034;GO:0055009;GO:0060048;GO:0048739;GO:0014898;GO:0001701;GO:0006936;GO:0030049;GO:0030239;GO:0006470;GO:0043462;GO:0008217;GO:0008016;GO:0060420;GO:0002027;GO:0002026;GO:0045214;GO:0006941;GO:0055010;GO:0007522;, C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:protein kinase binding;, P:adult heart development; P:ATP metabolic process; P:atrial cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy in response to stress; P:in utero embryonic development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:protein dephosphorylation; P:regulation of ATPase activity; P:regulation of blood pressure; P:regulation of heart contraction; P:regulation of heart growth; P:regulation of heart rate; P:regulation of the force of heart contraction; P:sarcomere organization; P:striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; P:visceral muscle development; scaffold42 indexed_genome mRNA 20502036 20504182 . + . ID=transcript_8634;P13533 A2RTX1 D9YZU2 Q13943 Q14906 Q14907,Myosin-6,Myosin heavy chain 6;Myosin heavy chain, cardiac muscle alpha isoform;, PF00063;PF02736;PF01576;, GO:0005829;GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0019901;GO:0007512;GO:0046034;GO:0055009;GO:0060048;GO:0048739;GO:0014898;GO:0001701;GO:0006936;GO:0030049;GO:0030239;GO:0006470;GO:0043462;GO:0008217;GO:0008016;GO:0060420;GO:0002027;GO:0002026;GO:0045214;GO:0006941;GO:0055010;GO:0007522;, C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:protein kinase binding;, P:adult heart development; P:ATP metabolic process; P:atrial cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy in response to stress; P:in utero embryonic development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:protein dephosphorylation; P:regulation of ATPase activity; P:regulation of blood pressure; P:regulation of heart contraction; P:regulation of heart growth; P:regulation of heart rate; P:regulation of the force of heart contraction; P:sarcomere organization; P:striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; P:visceral muscle development; scaffold42 indexed_genome mRNA 20506573 20509607 . - . ID=transcript_8635;Q96DZ9 E9PH91 Q5PY48,CKLF-like MARVEL transmembrane domain-containing protein 5,Chemokine-like factor superfamily member 5;, PF01284;, GO:0005615;GO:0016021;GO:0005125;GO:0006935;GO:0045662;, C:extracellular space; C:integral component of membrane;, F:cytokine activity;, P:chemotaxis; P:negative regulation of myoblast differentiation; scaffold42 indexed_genome mRNA 20520798 20527477 . + . ID=transcript_8636;O43281 B2RAJ7 B4DJ56 E9PGU2 O43282,Embryonal Fyn-associated substrate,Cas scaffolding protein family member 3;, PF12026;PF14604;, GO:0005737;GO:0005925;GO:0019904;GO:0017124;GO:0090527;GO:0007155;GO:0016477;GO:0035556;GO:0007169;, C:cytoplasm; C:focal adhesion;, F:protein domain specific binding; F:SH3 domain binding;, P:actin filament reorganization; P:cell adhesion; P:cell migration; P:intracellular signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold42 indexed_genome mRNA 20528119 20530666 . + . ID=transcript_8637;O43281 B2RAJ7 B4DJ56 E9PGU2 O43282,Embryonal Fyn-associated substrate,Cas scaffolding protein family member 3;, PF12026;PF14604;, GO:0005737;GO:0005925;GO:0019904;GO:0017124;GO:0090527;GO:0007155;GO:0016477;GO:0035556;GO:0007169;, C:cytoplasm; C:focal adhesion;, F:protein domain specific binding; F:SH3 domain binding;, P:actin filament reorganization; P:cell adhesion; P:cell migration; P:intracellular signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold42 indexed_genome mRNA 20533981 20537332 . + . ID=transcript_8638;Q8WUG5 A4UA13 A8MUT0 Q2TAB0 Q5BKY8 Q86U04 Q9H1D3 Q9NQD5,Solute carrier family 22 member 17,24p3 receptor;Brain-type organic cation transporter;Lipocalin-2 receptor;Neutrophil gelatinase-associated lipocalin receptor;, PF00083;, GO:0031301;GO:0005887;GO:0005886;GO:0005774;GO:0004888;GO:0022857;GO:0006879;GO:0015891;, C:integral component of organelle membrane; C:integral component of plasma membrane; C:plasma membrane; C:vacuolar membrane;, F:transmembrane signaling receptor activity; F:transmembrane transporter activity;, P:cellular iron ion homeostasis; P:siderophore transport; scaffold42 indexed_genome mRNA 20537994 20542134 . + . ID=transcript_8639;Q8WUG5 A4UA13 A8MUT0 Q2TAB0 Q5BKY8 Q86U04 Q9H1D3 Q9NQD5,Solute carrier family 22 member 17,24p3 receptor;Brain-type organic cation transporter;Lipocalin-2 receptor;Neutrophil gelatinase-associated lipocalin receptor;, PF00083;, GO:0031301;GO:0005887;GO:0005886;GO:0005774;GO:0004888;GO:0022857;GO:0006879;GO:0015891;, C:integral component of organelle membrane; C:integral component of plasma membrane; C:plasma membrane; C:vacuolar membrane;, F:transmembrane signaling receptor activity; F:transmembrane transporter activity;, P:cellular iron ion homeostasis; P:siderophore transport;|Q8WUG5 A4UA13 A8MUT0 Q2TAB0 Q5BKY8 Q86U04 Q9H1D3 Q9NQD5,Solute carrier family 22 member 17,24p3 receptor;Brain-type organic cation transporter;Lipocalin-2 receptor;Neutrophil gelatinase-associated lipocalin receptor;, PF00083;, GO:0031301;GO:0005887;GO:0005886;GO:0005774;GO:0004888;GO:0022857;GO:0006879;GO:0015891;, C:integral component of organelle membrane; C:integral component of plasma membrane; C:plasma membrane; C:vacuolar membrane;, F:transmembrane signaling receptor activity; F:transmembrane transporter activity;, P:cellular iron ion homeostasis; P:siderophore transport;|Q8WUG5 A4UA13 A8MUT0 Q2TAB0 Q5BKY8 Q86U04 Q9H1D3 Q9NQD5,Solute carrier family 22 member 17,24p3 receptor;Brain-type organic cation transporter;Lipocalin-2 receptor;Neutrophil gelatinase-associated lipocalin receptor;, PF00083;, GO:0031301;GO:0005887;GO:0005886;GO:0005774;GO:0004888;GO:0022857;GO:0006879;GO:0015891;, C:integral component of organelle membrane; C:integral component of plasma membrane; C:plasma membrane; C:vacuolar membrane;, F:transmembrane signaling receptor activity; F:transmembrane transporter activity;, P:cellular iron ion homeostasis; P:siderophore transport; scaffold42 indexed_genome mRNA 20567921 20572978 . - . ID=transcript_8640;Q92843 A8K0F4 Q2M3U0 Q5U0H4,Bcl-2-like protein 2,Apoptosis regulator Bcl-W;, PF00452;PF02180;, GO:0097136;GO:0005741;GO:0097718;GO:0042802;GO:0046982;GO:0042803;GO:0097192;GO:0008630;GO:0043066;GO:2001243;GO:0007283;, C:Bcl-2 family protein complex; C:mitochondrial outer membrane;, F:disordered domain specific binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway; P:spermatogenesis; scaffold42 indexed_genome mRNA 20576367 20579463 . + . ID=transcript_8641;Q9H7J1 D3DS47,Protein phosphatase 1 regulatory subunit 3E,, PF03370;, GO:0042587;GO:0000164;GO:0050196;GO:2001069;GO:0008157;GO:0005977;GO:0045725;GO:0005979;, C:glycogen granule; C:protein phosphatase type 1 complex;, F:[phosphorylase] phosphatase activity; F:glycogen binding; F:protein phosphatase 1 binding;, P:glycogen metabolic process; P:positive regulation of glycogen biosynthetic process; P:regulation of glycogen biosynthetic process; scaffold42 indexed_genome mRNA 20591021 20593458 . - . ID=transcript_8642;Q8IX15 A1L445 B4DZ80 F8WCA3 Q6P049 Q86XB6 Q9P2A5,Homeobox and leucine zipper protein Homez,Homeodomain leucine zipper-containing factor;, PF05920;PF11569;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0006357;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific;, P:regulation of transcription by RNA polymerase II; scaffold43 indexed_genome mRNA 379620 416662 . + . ID=transcript_8643;Q9UPH0,Collagen alpha-2(I) chain,Alpha-2 type I collagen;, PF01410;PF01391;, GO:0005584;GO:0062023;GO:0005783;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0042802;GO:0046872;GO:0048407;GO:0002020;GO:0030674;GO:0046332;GO:0007596;GO:0001568;GO:0030282;GO:0071230;GO:0030199;GO:0032963;GO:0019221;GO:0085029;GO:0030198;GO:0050900;GO:0042476;GO:0030168;GO:0070208;GO:0008217;GO:0050776;GO:0007266;GO:0001501;GO:0043589;GO:0007179;, C:collagen type I trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:identical protein binding; F:metal ion binding; F:platelet-derived growth factor binding; F:protease binding; F:protein-macromolecule adaptor activity; F:SMAD binding;, P:blood coagulation; P:blood vessel development; P:bone mineralization; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:collagen metabolic process; P:cytokine-mediated signaling pathway; P:extracellular matrix assembly; P:extracellular matrix organization; P:leukocyte migration; P:odontogenesis; P:platelet activation; P:protein heterotrimerization; P:regulation of blood pressure; P:regulation of immune response; P:Rho protein signal transduction; P:skeletal system development; P:skin morphogenesis; P:transforming growth factor beta receptor signaling pathway;|Q9UPH0,Collagen alpha-2(I) chain,Alpha-2 type I collagen;, PF01410;PF01391;, GO:0005584;GO:0062023;GO:0005783;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0042802;GO:0046872;GO:0048407;GO:0002020;GO:0030674;GO:0046332;GO:0007596;GO:0001568;GO:0030282;GO:0071230;GO:0030199;GO:0032963;GO:0019221;GO:0085029;GO:0030198;GO:0050900;GO:0042476;GO:0030168;GO:0070208;GO:0008217;GO:0050776;GO:0007266;GO:0001501;GO:0043589;GO:0007179;, C:collagen type I trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:identical protein binding; F:metal ion binding; F:platelet-derived growth factor binding; F:protease binding; F:protein-macromolecule adaptor activity; F:SMAD binding;, P:blood coagulation; P:blood vessel development; P:bone mineralization; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:collagen metabolic process; P:cytokine-mediated signaling pathway; P:extracellular matrix assembly; P:extracellular matrix organization; P:leukocyte migration; P:odontogenesis; P:platelet activation; P:protein heterotrimerization; P:regulation of blood pressure; P:regulation of immune response; P:Rho protein signal transduction; P:skeletal system development; P:skin morphogenesis; P:transforming growth factor beta receptor signaling pathway; scaffold43 indexed_genome mRNA 513016 520375 . + . ID=transcript_8644;Q96PB1 B3KW13 O14574 Q3LIE2 Q6P4R4 Q9H6T9 Q9H770,N-acetylneuraminate 9-O-acetyltransferase {ECO:0000305},CAS1 domain-containing protein 1 {ECO:0000305};Sialate O-acetyltransferase {ECO:0000303|PubMed:20947662, ECO:0000303|PubMed:26169044};, PF07779;, GO:0030173;GO:0047186;GO:0005975;, C:integral component of Golgi membrane;, F:N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity;, P:carbohydrate metabolic process;|Q96PB1 B3KW13 O14574 Q3LIE2 Q6P4R4 Q9H6T9 Q9H770,N-acetylneuraminate 9-O-acetyltransferase {ECO:0000305},CAS1 domain-containing protein 1 {ECO:0000305};Sialate O-acetyltransferase {ECO:0000303|PubMed:20947662, ECO:0000303|PubMed:26169044};, PF07779;, GO:0030173;GO:0047186;GO:0005975;, C:integral component of Golgi membrane;, F:N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity;, P:carbohydrate metabolic process;|Q96PB1 B3KW13 O14574 Q3LIE2 Q6P4R4 Q9H6T9 Q9H770,N-acetylneuraminate 9-O-acetyltransferase {ECO:0000305},CAS1 domain-containing protein 1 {ECO:0000305};Sialate O-acetyltransferase {ECO:0000303|PubMed:20947662, ECO:0000303|PubMed:26169044};, PF07779;, GO:0030173;GO:0047186;GO:0005975;, C:integral component of Golgi membrane;, F:N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity;, P:carbohydrate metabolic process; scaffold43 indexed_genome mRNA 581849 653097 . - . ID=transcript_8645;O43556 B2R8N2 D6W5Q8 E9PF60 G5E9K6 Q6L8P0 Q75MH8 Q8NFG8 Q8WW28,Epsilon-sarcoglycan,, PF05510;, GO:0005856;GO:0032590;GO:0016010;GO:0005794;GO:0005887;GO:0005886;GO:0016012;GO:0042383;GO:0007160;GO:0007517;, C:cytoskeleton; C:dendrite membrane; C:dystrophin-associated glycoprotein complex; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:sarcoglycan complex; C:sarcolemma;, , P:cell-matrix adhesion; P:muscle organ development;|O43556 B2R8N2 D6W5Q8 E9PF60 G5E9K6 Q6L8P0 Q75MH8 Q8NFG8 Q8WW28,Epsilon-sarcoglycan,, PF05510;, GO:0005856;GO:0032590;GO:0016010;GO:0005794;GO:0005887;GO:0005886;GO:0016012;GO:0042383;GO:0007160;GO:0007517;, C:cytoskeleton; C:dendrite membrane; C:dystrophin-associated glycoprotein complex; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:sarcoglycan complex; C:sarcolemma;, , P:cell-matrix adhesion; P:muscle organ development;|O43556 B2R8N2 D6W5Q8 E9PF60 G5E9K6 Q6L8P0 Q75MH8 Q8NFG8 Q8WW28,Epsilon-sarcoglycan,, PF05510;, GO:0005856;GO:0032590;GO:0016010;GO:0005794;GO:0005887;GO:0005886;GO:0016012;GO:0042383;GO:0007160;GO:0007517;, C:cytoskeleton; C:dendrite membrane; C:dystrophin-associated glycoprotein complex; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:sarcoglycan complex; C:sarcolemma;, , P:cell-matrix adhesion; P:muscle organ development; scaffold43 indexed_genome mRNA 653282 663959 . + . ID=transcript_8646;Q86TG7 Q96A68 Q9UPV1,Retrotransposon-derived protein PEG10,Embryonal carcinoma differentiation-regulated protein;Mammalian retrotransposon-derived protein 2;Myelin expression factor 3-like protein 1;Paternally expressed gene 10 protein;Retrotransposon gag domain-containing protein 3;Retrotransposon-derived gag-like polyprotein;Ty3/Gypsy-like protein;, PF16297;, GO:0005737;GO:0005829;GO:0005654;GO:0003677;GO:0003723;GO:0008270;GO:0006915;GO:0030154;GO:0030512;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:DNA binding; F:RNA binding; F:zinc ion binding;, P:apoptotic process; P:cell differentiation; P:negative regulation of transforming growth factor beta receptor signaling pathway; scaffold43 indexed_genome mRNA 782143 1085290 . + . ID=transcript_8647;Q9ULJ8 A1L494 B2RWQ1 E9PCA0 E9PCK6 E9PDX1 F8W7J9 O76059 Q9NXT2,Neurabin-1,Neurabin-I;Neural tissue-specific F-actin-binding protein I;Protein phosphatase 1 regulatory subunit 9A;, PF00595;PF17817;PF07647;, GO:0015629;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0044326;GO:0030175;GO:0098978;GO:1990761;GO:0031594;GO:0043025;GO:0098871;GO:0014069;GO:0051015;GO:0051020;GO:0042802;GO:0044325;GO:0008022;GO:0019904;GO:0019901;GO:0008157;GO:0007015;GO:0007568;GO:0019722;GO:0097237;GO:0060079;GO:1900272;GO:1904049;GO:0051497;GO:0031175;GO:0060999;GO:1900454;GO:0010976;GO:0045860;GO:0098974;GO:0030833;GO:0061001;GO:0051489;GO:0051963;GO:0051823;, C:actin cytoskeleton; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine neck; C:filopodium; C:glutamatergic synapse; C:growth cone lamellipodium; C:neuromuscular junction; C:neuronal cell body; C:postsynaptic actin cytoskeleton; C:postsynaptic density;, F:actin filament binding; F:GTPase binding; F:identical protein binding; F:ion channel binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase 1 binding;, P:actin filament organization; P:aging; P:calcium-mediated signaling; P:cellular response to toxic substance; P:excitatory postsynaptic potential; P:negative regulation of long-term synaptic potentiation; P:negative regulation of spontaneous neurotransmitter secretion; P:negative regulation of stress fiber assembly; P:neuron projection development; P:positive regulation of dendritic spine development; P:positive regulation of long-term synaptic depression; P:positive regulation of neuron projection development; P:positive regulation of protein kinase activity; P:postsynaptic actin cytoskeleton organization; P:regulation of actin filament polymerization; P:regulation of dendritic spine morphogenesis; P:regulation of filopodium assembly; P:regulation of synapse assembly; P:regulation of synapse structural plasticity; scaffold43 indexed_genome mRNA 1099132 1109447 . + . ID=transcript_8648;Q9ULJ8 A1L494 B2RWQ1 E9PCA0 E9PCK6 E9PDX1 F8W7J9 O76059 Q9NXT2,Neurabin-1,Neurabin-I;Neural tissue-specific F-actin-binding protein I;Protein phosphatase 1 regulatory subunit 9A;, PF00595;PF17817;PF07647;, GO:0015629;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0044326;GO:0030175;GO:0098978;GO:1990761;GO:0031594;GO:0043025;GO:0098871;GO:0014069;GO:0051015;GO:0051020;GO:0042802;GO:0044325;GO:0008022;GO:0019904;GO:0019901;GO:0008157;GO:0007015;GO:0007568;GO:0019722;GO:0097237;GO:0060079;GO:1900272;GO:1904049;GO:0051497;GO:0031175;GO:0060999;GO:1900454;GO:0010976;GO:0045860;GO:0098974;GO:0030833;GO:0061001;GO:0051489;GO:0051963;GO:0051823;, C:actin cytoskeleton; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine neck; C:filopodium; C:glutamatergic synapse; C:growth cone lamellipodium; C:neuromuscular junction; C:neuronal cell body; C:postsynaptic actin cytoskeleton; C:postsynaptic density;, F:actin filament binding; F:GTPase binding; F:identical protein binding; F:ion channel binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase 1 binding;, P:actin filament organization; P:aging; P:calcium-mediated signaling; P:cellular response to toxic substance; P:excitatory postsynaptic potential; P:negative regulation of long-term synaptic potentiation; P:negative regulation of spontaneous neurotransmitter secretion; P:negative regulation of stress fiber assembly; P:neuron projection development; P:positive regulation of dendritic spine development; P:positive regulation of long-term synaptic depression; P:positive regulation of neuron projection development; P:positive regulation of protein kinase activity; P:postsynaptic actin cytoskeleton organization; P:regulation of actin filament polymerization; P:regulation of dendritic spine morphogenesis; P:regulation of filopodium assembly; P:regulation of synapse assembly; P:regulation of synapse structural plasticity;|Q9ULJ8 A1L494 B2RWQ1 E9PCA0 E9PCK6 E9PDX1 F8W7J9 O76059 Q9NXT2,Neurabin-1,Neurabin-I;Neural tissue-specific F-actin-binding protein I;Protein phosphatase 1 regulatory subunit 9A;, PF00595;PF17817;PF07647;, GO:0015629;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0044326;GO:0030175;GO:0098978;GO:1990761;GO:0031594;GO:0043025;GO:0098871;GO:0014069;GO:0051015;GO:0051020;GO:0042802;GO:0044325;GO:0008022;GO:0019904;GO:0019901;GO:0008157;GO:0007015;GO:0007568;GO:0019722;GO:0097237;GO:0060079;GO:1900272;GO:1904049;GO:0051497;GO:0031175;GO:0060999;GO:1900454;GO:0010976;GO:0045860;GO:0098974;GO:0030833;GO:0061001;GO:0051489;GO:0051963;GO:0051823;, C:actin cytoskeleton; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine neck; C:filopodium; C:glutamatergic synapse; C:growth cone lamellipodium; C:neuromuscular junction; C:neuronal cell body; C:postsynaptic actin cytoskeleton; C:postsynaptic density;, F:actin filament binding; F:GTPase binding; F:identical protein binding; F:ion channel binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase 1 binding;, P:actin filament organization; P:aging; P:calcium-mediated signaling; P:cellular response to toxic substance; P:excitatory postsynaptic potential; P:negative regulation of long-term synaptic potentiation; P:negative regulation of spontaneous neurotransmitter secretion; P:negative regulation of stress fiber assembly; P:neuron projection development; P:positive regulation of dendritic spine development; P:positive regulation of long-term synaptic depression; P:positive regulation of neuron projection development; P:positive regulation of protein kinase activity; P:postsynaptic actin cytoskeleton organization; P:regulation of actin filament polymerization; P:regulation of dendritic spine morphogenesis; P:regulation of filopodium assembly; P:regulation of synapse assembly; P:regulation of synapse structural plasticity;|Q9ULJ8 A1L494 B2RWQ1 E9PCA0 E9PCK6 E9PDX1 F8W7J9 O76059 Q9NXT2,Neurabin-1,Neurabin-I;Neural tissue-specific F-actin-binding protein I;Protein phosphatase 1 regulatory subunit 9A;, PF00595;PF17817;PF07647;, GO:0015629;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0044326;GO:0030175;GO:0098978;GO:1990761;GO:0031594;GO:0043025;GO:0098871;GO:0014069;GO:0051015;GO:0051020;GO:0042802;GO:0044325;GO:0008022;GO:0019904;GO:0019901;GO:0008157;GO:0007015;GO:0007568;GO:0019722;GO:0097237;GO:0060079;GO:1900272;GO:1904049;GO:0051497;GO:0031175;GO:0060999;GO:1900454;GO:0010976;GO:0045860;GO:0098974;GO:0030833;GO:0061001;GO:0051489;GO:0051963;GO:0051823;, C:actin cytoskeleton; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine neck; C:filopodium; C:glutamatergic synapse; C:growth cone lamellipodium; C:neuromuscular junction; C:neuronal cell body; C:postsynaptic actin cytoskeleton; C:postsynaptic density;, F:actin filament binding; F:GTPase binding; F:identical protein binding; F:ion channel binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase 1 binding;, P:actin filament organization; P:aging; P:calcium-mediated signaling; P:cellular response to toxic substance; P:excitatory postsynaptic potential; P:negative regulation of long-term synaptic potentiation; P:negative regulation of spontaneous neurotransmitter secretion; P:negative regulation of stress fiber assembly; P:neuron projection development; P:positive regulation of dendritic spine development; P:positive regulation of long-term synaptic depression; P:positive regulation of neuron projection development; P:positive regulation of protein kinase activity; P:postsynaptic actin cytoskeleton organization; P:regulation of actin filament polymerization; P:regulation of dendritic spine morphogenesis; P:regulation of filopodium assembly; P:regulation of synapse assembly; P:regulation of synapse structural plasticity;|Q9ULJ8 A1L494 B2RWQ1 E9PCA0 E9PCK6 E9PDX1 F8W7J9 O76059 Q9NXT2,Neurabin-1,Neurabin-I;Neural tissue-specific F-actin-binding protein I;Protein phosphatase 1 regulatory subunit 9A;, PF00595;PF17817;PF07647;, GO:0015629;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0044326;GO:0030175;GO:0098978;GO:1990761;GO:0031594;GO:0043025;GO:0098871;GO:0014069;GO:0051015;GO:0051020;GO:0042802;GO:0044325;GO:0008022;GO:0019904;GO:0019901;GO:0008157;GO:0007015;GO:0007568;GO:0019722;GO:0097237;GO:0060079;GO:1900272;GO:1904049;GO:0051497;GO:0031175;GO:0060999;GO:1900454;GO:0010976;GO:0045860;GO:0098974;GO:0030833;GO:0061001;GO:0051489;GO:0051963;GO:0051823;, C:actin cytoskeleton; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:dendritic spine neck; C:filopodium; C:glutamatergic synapse; C:growth cone lamellipodium; C:neuromuscular junction; C:neuronal cell body; C:postsynaptic actin cytoskeleton; C:postsynaptic density;, F:actin filament binding; F:GTPase binding; F:identical protein binding; F:ion channel binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase 1 binding;, P:actin filament organization; P:aging; P:calcium-mediated signaling; P:cellular response to toxic substance; P:excitatory postsynaptic potential; P:negative regulation of long-term synaptic potentiation; P:negative regulation of spontaneous neurotransmitter secretion; P:negative regulation of stress fiber assembly; P:neuron projection development; P:positive regulation of dendritic spine development; P:positive regulation of long-term synaptic depression; P:positive regulation of neuron projection development; P:positive regulation of protein kinase activity; P:postsynaptic actin cytoskeleton organization; P:regulation of actin filament polymerization; P:regulation of dendritic spine morphogenesis; P:regulation of filopodium assembly; P:regulation of synapse assembly; P:regulation of synapse structural plasticity; scaffold43 indexed_genome mRNA 1112190 1115925 . - . ID=transcript_8649;P27169 B2RA40 Q16052 Q6B0J6 Q9UCB1,Serum paraoxonase/arylesterase 1 {ECO:0000303|PubMed:7916578},Aromatic esterase 1;K-45;Serum aryldialkylphosphatase 1;, PF01731;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0043231;GO:0034366;GO:0102007;GO:0004063;GO:0004064;GO:0005509;GO:0005543;GO:0042803;GO:0019439;GO:0046395;GO:0008203;GO:0019372;GO:0046434;GO:0046470;GO:0051099;GO:0010875;GO:0032411;GO:0070542;GO:1902617;GO:0031667;GO:0009636;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:intracellular membrane-bounded organelle; C:spherical high-density lipoprotein particle;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:aryldialkylphosphatase activity; F:arylesterase activity; F:calcium ion binding; F:phospholipid binding; F:protein homodimerization activity;, P:aromatic compound catabolic process; P:carboxylic acid catabolic process; P:cholesterol metabolic process; P:lipoxygenase pathway; P:organophosphate catabolic process; P:phosphatidylcholine metabolic process; P:positive regulation of binding; P:positive regulation of cholesterol efflux; P:positive regulation of transporter activity; P:response to fatty acid; P:response to fluoride; P:response to nutrient levels; P:response to toxic substance;|P27169 B2RA40 Q16052 Q6B0J6 Q9UCB1,Serum paraoxonase/arylesterase 1 {ECO:0000303|PubMed:7916578},Aromatic esterase 1;K-45;Serum aryldialkylphosphatase 1;, PF01731;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0043231;GO:0034366;GO:0102007;GO:0004063;GO:0004064;GO:0005509;GO:0005543;GO:0042803;GO:0019439;GO:0046395;GO:0008203;GO:0019372;GO:0046434;GO:0046470;GO:0051099;GO:0010875;GO:0032411;GO:0070542;GO:1902617;GO:0031667;GO:0009636;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:intracellular membrane-bounded organelle; C:spherical high-density lipoprotein particle;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:aryldialkylphosphatase activity; F:arylesterase activity; F:calcium ion binding; F:phospholipid binding; F:protein homodimerization activity;, P:aromatic compound catabolic process; P:carboxylic acid catabolic process; P:cholesterol metabolic process; P:lipoxygenase pathway; P:organophosphate catabolic process; P:phosphatidylcholine metabolic process; P:positive regulation of binding; P:positive regulation of cholesterol efflux; P:positive regulation of transporter activity; P:response to fatty acid; P:response to fluoride; P:response to nutrient levels; P:response to toxic substance; scaffold43 indexed_genome mRNA 1119077 1140604 . - . ID=transcript_8650;P27169 B2RA40 Q16052 Q6B0J6 Q9UCB1,Serum paraoxonase/arylesterase 1 {ECO:0000303|PubMed:7916578},Aromatic esterase 1;K-45;Serum aryldialkylphosphatase 1;, PF01731;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0043231;GO:0034366;GO:0102007;GO:0004063;GO:0004064;GO:0005509;GO:0005543;GO:0042803;GO:0019439;GO:0046395;GO:0008203;GO:0019372;GO:0046434;GO:0046470;GO:0051099;GO:0010875;GO:0032411;GO:0070542;GO:1902617;GO:0031667;GO:0009636;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:intracellular membrane-bounded organelle; C:spherical high-density lipoprotein particle;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:aryldialkylphosphatase activity; F:arylesterase activity; F:calcium ion binding; F:phospholipid binding; F:protein homodimerization activity;, P:aromatic compound catabolic process; P:carboxylic acid catabolic process; P:cholesterol metabolic process; P:lipoxygenase pathway; P:organophosphate catabolic process; P:phosphatidylcholine metabolic process; P:positive regulation of binding; P:positive regulation of cholesterol efflux; P:positive regulation of transporter activity; P:response to fatty acid; P:response to fluoride; P:response to nutrient levels; P:response to toxic substance; scaffold43 indexed_genome mRNA 1156136 1184353 . - . ID=transcript_8651;Q15166 A4D1H8 O75855 O76060 Q6IRU9 Q8IX97 Q9BZH9,Serum paraoxonase/lactonase 3,, PF01731;, GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0018733;GO:0102007;GO:0004063;GO:0004064;GO:0046872;GO:0042803;GO:0019439;GO:0046395;GO:0046226;GO:0019372;GO:0032929;GO:0010124;GO:0009636;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:3,4-dihydrocoumarin hydrolase activity; F:acyl-L-homoserine-lactone lactonohydrolase activity; F:aryldialkylphosphatase activity; F:arylesterase activity; F:metal ion binding; F:protein homodimerization activity;, P:aromatic compound catabolic process; P:carboxylic acid catabolic process; P:coumarin catabolic process; P:lipoxygenase pathway; P:negative regulation of superoxide anion generation; P:phenylacetate catabolic process; P:response to toxic substance;|Q15165 A4D1H7 B2RCP9 B4DJD5 O15114 O15115 O75856 Q5FBX7 Q86YL0,Serum paraoxonase/arylesterase 2,Aromatic esterase 2;Serum aryldialkylphosphatase 2;, PF01731;, GO:0005576;GO:0005886;GO:0102007;GO:0004064;GO:0042802;GO:0046872;GO:0019439;GO:0019372;GO:0009636;, C:extracellular region; C:plasma membrane;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:arylesterase activity; F:identical protein binding; F:metal ion binding;, P:aromatic compound catabolic process; P:lipoxygenase pathway; P:response to toxic substance;|Q15166 A4D1H8 O75855 O76060 Q6IRU9 Q8IX97 Q9BZH9,Serum paraoxonase/lactonase 3,, PF01731;, GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0018733;GO:0102007;GO:0004063;GO:0004064;GO:0046872;GO:0042803;GO:0019439;GO:0046395;GO:0046226;GO:0019372;GO:0032929;GO:0010124;GO:0009636;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:3,4-dihydrocoumarin hydrolase activity; F:acyl-L-homoserine-lactone lactonohydrolase activity; F:aryldialkylphosphatase activity; F:arylesterase activity; F:metal ion binding; F:protein homodimerization activity;, P:aromatic compound catabolic process; P:carboxylic acid catabolic process; P:coumarin catabolic process; P:lipoxygenase pathway; P:negative regulation of superoxide anion generation; P:phenylacetate catabolic process; P:response to toxic substance;|Q15166 A4D1H8 O75855 O76060 Q6IRU9 Q8IX97 Q9BZH9,Serum paraoxonase/lactonase 3,, PF01731;, GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0018733;GO:0102007;GO:0004063;GO:0004064;GO:0046872;GO:0042803;GO:0019439;GO:0046395;GO:0046226;GO:0019372;GO:0032929;GO:0010124;GO:0009636;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:3,4-dihydrocoumarin hydrolase activity; F:acyl-L-homoserine-lactone lactonohydrolase activity; F:aryldialkylphosphatase activity; F:arylesterase activity; F:metal ion binding; F:protein homodimerization activity;, P:aromatic compound catabolic process; P:carboxylic acid catabolic process; P:coumarin catabolic process; P:lipoxygenase pathway; P:negative regulation of superoxide anion generation; P:phenylacetate catabolic process; P:response to toxic substance;|Q15166 A4D1H8 O75855 O76060 Q6IRU9 Q8IX97 Q9BZH9,Serum paraoxonase/lactonase 3,, PF01731;, GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0018733;GO:0102007;GO:0004063;GO:0004064;GO:0046872;GO:0042803;GO:0019439;GO:0046395;GO:0046226;GO:0019372;GO:0032929;GO:0010124;GO:0009636;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:3,4-dihydrocoumarin hydrolase activity; F:acyl-L-homoserine-lactone lactonohydrolase activity; F:aryldialkylphosphatase activity; F:arylesterase activity; F:metal ion binding; F:protein homodimerization activity;, P:aromatic compound catabolic process; P:carboxylic acid catabolic process; P:coumarin catabolic process; P:lipoxygenase pathway; P:negative regulation of superoxide anion generation; P:phenylacetate catabolic process; P:response to toxic substance;|Q15166 A4D1H8 O75855 O76060 Q6IRU9 Q8IX97 Q9BZH9,Serum paraoxonase/lactonase 3,, PF01731;, GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0018733;GO:0102007;GO:0004063;GO:0004064;GO:0046872;GO:0042803;GO:0019439;GO:0046395;GO:0046226;GO:0019372;GO:0032929;GO:0010124;GO:0009636;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:3,4-dihydrocoumarin hydrolase activity; F:acyl-L-homoserine-lactone lactonohydrolase activity; F:aryldialkylphosphatase activity; F:arylesterase activity; F:metal ion binding; F:protein homodimerization activity;, P:aromatic compound catabolic process; P:carboxylic acid catabolic process; P:coumarin catabolic process; P:lipoxygenase pathway; P:negative regulation of superoxide anion generation; P:phenylacetate catabolic process; P:response to toxic substance;|Q15166 A4D1H8 O75855 O76060 Q6IRU9 Q8IX97 Q9BZH9,Serum paraoxonase/lactonase 3,, PF01731;, GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0018733;GO:0102007;GO:0004063;GO:0004064;GO:0046872;GO:0042803;GO:0019439;GO:0046395;GO:0046226;GO:0019372;GO:0032929;GO:0010124;GO:0009636;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:3,4-dihydrocoumarin hydrolase activity; F:acyl-L-homoserine-lactone lactonohydrolase activity; F:aryldialkylphosphatase activity; F:arylesterase activity; F:metal ion binding; F:protein homodimerization activity;, P:aromatic compound catabolic process; P:carboxylic acid catabolic process; P:coumarin catabolic process; P:lipoxygenase pathway; P:negative regulation of superoxide anion generation; P:phenylacetate catabolic process; P:response to toxic substance;|Q15166 A4D1H8 O75855 O76060 Q6IRU9 Q8IX97 Q9BZH9,Serum paraoxonase/lactonase 3,, PF01731;, GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0018733;GO:0102007;GO:0004063;GO:0004064;GO:0046872;GO:0042803;GO:0019439;GO:0046395;GO:0046226;GO:0019372;GO:0032929;GO:0010124;GO:0009636;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:3,4-dihydrocoumarin hydrolase activity; F:acyl-L-homoserine-lactone lactonohydrolase activity; F:aryldialkylphosphatase activity; F:arylesterase activity; F:metal ion binding; F:protein homodimerization activity;, P:aromatic compound catabolic process; P:carboxylic acid catabolic process; P:coumarin catabolic process; P:lipoxygenase pathway; P:negative regulation of superoxide anion generation; P:phenylacetate catabolic process; P:response to toxic substance; scaffold43 indexed_genome mRNA 1193569 1214957 . - . ID=transcript_8652;Q15165 A4D1H7 B2RCP9 B4DJD5 O15114 O15115 O75856 Q5FBX7 Q86YL0,Serum paraoxonase/arylesterase 2,Aromatic esterase 2;Serum aryldialkylphosphatase 2;, PF01731;, GO:0005576;GO:0005886;GO:0102007;GO:0004064;GO:0042802;GO:0046872;GO:0019439;GO:0019372;GO:0009636;, C:extracellular region; C:plasma membrane;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:arylesterase activity; F:identical protein binding; F:metal ion binding;, P:aromatic compound catabolic process; P:lipoxygenase pathway; P:response to toxic substance;|Q15165 A4D1H7 B2RCP9 B4DJD5 O15114 O15115 O75856 Q5FBX7 Q86YL0,Serum paraoxonase/arylesterase 2,Aromatic esterase 2;Serum aryldialkylphosphatase 2;, PF01731;, GO:0005576;GO:0005886;GO:0102007;GO:0004064;GO:0042802;GO:0046872;GO:0019439;GO:0019372;GO:0009636;, C:extracellular region; C:plasma membrane;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:arylesterase activity; F:identical protein binding; F:metal ion binding;, P:aromatic compound catabolic process; P:lipoxygenase pathway; P:response to toxic substance;|Q15165 A4D1H7 B2RCP9 B4DJD5 O15114 O15115 O75856 Q5FBX7 Q86YL0,Serum paraoxonase/arylesterase 2,Aromatic esterase 2;Serum aryldialkylphosphatase 2;, PF01731;, GO:0005576;GO:0005886;GO:0102007;GO:0004064;GO:0042802;GO:0046872;GO:0019439;GO:0019372;GO:0009636;, C:extracellular region; C:plasma membrane;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:arylesterase activity; F:identical protein binding; F:metal ion binding;, P:aromatic compound catabolic process; P:lipoxygenase pathway; P:response to toxic substance;|Q15165 A4D1H7 B2RCP9 B4DJD5 O15114 O15115 O75856 Q5FBX7 Q86YL0,Serum paraoxonase/arylesterase 2,Aromatic esterase 2;Serum aryldialkylphosphatase 2;, PF01731;, GO:0005576;GO:0005886;GO:0102007;GO:0004064;GO:0042802;GO:0046872;GO:0019439;GO:0019372;GO:0009636;, C:extracellular region; C:plasma membrane;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:arylesterase activity; F:identical protein binding; F:metal ion binding;, P:aromatic compound catabolic process; P:lipoxygenase pathway; P:response to toxic substance;|Q15165 A4D1H7 B2RCP9 B4DJD5 O15114 O15115 O75856 Q5FBX7 Q86YL0,Serum paraoxonase/arylesterase 2,Aromatic esterase 2;Serum aryldialkylphosphatase 2;, PF01731;, GO:0005576;GO:0005886;GO:0102007;GO:0004064;GO:0042802;GO:0046872;GO:0019439;GO:0019372;GO:0009636;, C:extracellular region; C:plasma membrane;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:arylesterase activity; F:identical protein binding; F:metal ion binding;, P:aromatic compound catabolic process; P:lipoxygenase pathway; P:response to toxic substance;|Q15165 A4D1H7 B2RCP9 B4DJD5 O15114 O15115 O75856 Q5FBX7 Q86YL0,Serum paraoxonase/arylesterase 2,Aromatic esterase 2;Serum aryldialkylphosphatase 2;, PF01731;, GO:0005576;GO:0005886;GO:0102007;GO:0004064;GO:0042802;GO:0046872;GO:0019439;GO:0019372;GO:0009636;, C:extracellular region; C:plasma membrane;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:arylesterase activity; F:identical protein binding; F:metal ion binding;, P:aromatic compound catabolic process; P:lipoxygenase pathway; P:response to toxic substance;|Q15165 A4D1H7 B2RCP9 B4DJD5 O15114 O15115 O75856 Q5FBX7 Q86YL0,Serum paraoxonase/arylesterase 2,Aromatic esterase 2;Serum aryldialkylphosphatase 2;, PF01731;, GO:0005576;GO:0005886;GO:0102007;GO:0004064;GO:0042802;GO:0046872;GO:0019439;GO:0019372;GO:0009636;, C:extracellular region; C:plasma membrane;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:arylesterase activity; F:identical protein binding; F:metal ion binding;, P:aromatic compound catabolic process; P:lipoxygenase pathway; P:response to toxic substance;|Q15165 A4D1H7 B2RCP9 B4DJD5 O15114 O15115 O75856 Q5FBX7 Q86YL0,Serum paraoxonase/arylesterase 2,Aromatic esterase 2;Serum aryldialkylphosphatase 2;, PF01731;, GO:0005576;GO:0005886;GO:0102007;GO:0004064;GO:0042802;GO:0046872;GO:0019439;GO:0019372;GO:0009636;, C:extracellular region; C:plasma membrane;, F:acyl-L-homoserine-lactone lactonohydrolase activity; F:arylesterase activity; F:identical protein binding; F:metal ion binding;, P:aromatic compound catabolic process; P:lipoxygenase pathway; P:response to toxic substance; scaffold43 indexed_genome mRNA 1348177 1368911 . + . ID=transcript_8653;Q9Y574 A4D1H6 O14586 Q14D68 Q8TBT2,Ankyrin repeat and SOCS box protein 4,, PF12796;PF07525;, GO:0031462;GO:0031466;GO:0005829;GO:0061630;GO:0031625;GO:0004842;GO:0035556;GO:2001214;GO:0043687;GO:0051865;, C:Cul2-RING ubiquitin ligase complex; C:Cul5-RING ubiquitin ligase complex; C:cytosol;, F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:intracellular signal transduction; P:positive regulation of vasculogenesis; P:post-translational protein modification; P:protein autoubiquitination; scaffold43 indexed_genome mRNA 1416248 1427556 . - . ID=transcript_8654;Q16654,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial,Pyruvate dehydrogenase kinase isoform 4;, PF10436;PF02518;, GO:0005759;GO:0005739;GO:0005524;GO:0004672;GO:0004740;GO:0071398;GO:0009267;GO:0042593;GO:0006006;GO:0008286;GO:2000811;GO:0006468;GO:0072593;GO:0010510;GO:0045124;GO:0010565;GO:0042304;GO:0046320;GO:0010906;GO:0006885;GO:0042594;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cellular response to fatty acid; P:cellular response to starvation; P:glucose homeostasis; P:glucose metabolic process; P:insulin receptor signaling pathway; P:negative regulation of anoikis; P:protein phosphorylation; P:reactive oxygen species metabolic process; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of bone resorption; P:regulation of cellular ketone metabolic process; P:regulation of fatty acid biosynthetic process; P:regulation of fatty acid oxidation; P:regulation of glucose metabolic process; P:regulation of pH; P:response to starvation;|Q16654,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial,Pyruvate dehydrogenase kinase isoform 4;, PF10436;PF02518;, GO:0005759;GO:0005739;GO:0005524;GO:0004672;GO:0004740;GO:0071398;GO:0009267;GO:0042593;GO:0006006;GO:0008286;GO:2000811;GO:0006468;GO:0072593;GO:0010510;GO:0045124;GO:0010565;GO:0042304;GO:0046320;GO:0010906;GO:0006885;GO:0042594;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cellular response to fatty acid; P:cellular response to starvation; P:glucose homeostasis; P:glucose metabolic process; P:insulin receptor signaling pathway; P:negative regulation of anoikis; P:protein phosphorylation; P:reactive oxygen species metabolic process; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of bone resorption; P:regulation of cellular ketone metabolic process; P:regulation of fatty acid biosynthetic process; P:regulation of fatty acid oxidation; P:regulation of glucose metabolic process; P:regulation of pH; P:response to starvation;|Q16654,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial,Pyruvate dehydrogenase kinase isoform 4;, PF10436;PF02518;, GO:0005759;GO:0005739;GO:0005524;GO:0004672;GO:0004740;GO:0071398;GO:0009267;GO:0042593;GO:0006006;GO:0008286;GO:2000811;GO:0006468;GO:0072593;GO:0010510;GO:0045124;GO:0010565;GO:0042304;GO:0046320;GO:0010906;GO:0006885;GO:0042594;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cellular response to fatty acid; P:cellular response to starvation; P:glucose homeostasis; P:glucose metabolic process; P:insulin receptor signaling pathway; P:negative regulation of anoikis; P:protein phosphorylation; P:reactive oxygen species metabolic process; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of bone resorption; P:regulation of cellular ketone metabolic process; P:regulation of fatty acid biosynthetic process; P:regulation of fatty acid oxidation; P:regulation of glucose metabolic process; P:regulation of pH; P:response to starvation; scaffold43 indexed_genome mRNA 1648928 1969640 . + . ID=transcript_8655;O14576 B4DME3 F5H050 G5E9K1 Q8TBF7 Q9Y2X1,Cytoplasmic dynein 1 intermediate chain 1,Cytoplasmic dynein intermediate chain 1;Dynein intermediate chain 1, cytosolic;, PF11540;PF00400;, GO:0000777;GO:0005737;GO:0005868;GO:0036464;GO:0005829;GO:0000776;GO:0005874;GO:0005634;GO:0048471;GO:0055037;GO:0000922;GO:0031982;GO:0045504;GO:0045503;GO:0008017;GO:0003777;GO:0003774;GO:0030507;GO:0035973;GO:0019886;GO:0006888;GO:0007018;GO:0007052;GO:0010970;GO:0047496;GO:0019058;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic dynein complex; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:kinetochore; C:microtubule; C:nucleus; C:perinuclear region of cytoplasm; C:recycling endosome; C:spindle pole; C:vesicle;, F:dynein heavy chain binding; F:dynein light chain binding; F:microtubule binding; F:microtubule motor activity; F:motor activity; F:spectrin binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule-based movement; P:mitotic spindle organization; P:transport along microtubule; P:vesicle transport along microtubule; P:viral life cycle; scaffold43 indexed_genome mRNA 1987627 2212789 . - . ID=transcript_8656;Q9UJS0 O14566 O14575 Q546F9 Q9NZW1 Q9UNI7,Calcium-binding mitochondrial carrier protein Aralar2,Citrin;Mitochondrial aspartate glutamate carrier 2;Solute carrier family 25 member 13;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0005509;GO:0042802;GO:0015183;GO:0005313;GO:0022857;GO:0009066;GO:0015810;GO:0006754;GO:0045333;GO:0006094;GO:0015813;GO:0043490;GO:0006839;GO:0051592;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:identical protein binding; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:transmembrane transporter activity;, P:aspartate family amino acid metabolic process; P:aspartate transmembrane transport; P:ATP biosynthetic process; P:cellular respiration; P:gluconeogenesis; P:L-glutamate transmembrane transport; P:malate-aspartate shuttle; P:mitochondrial transport; P:response to calcium ion;|Q9UJS0 O14566 O14575 Q546F9 Q9NZW1 Q9UNI7,Calcium-binding mitochondrial carrier protein Aralar2,Citrin;Mitochondrial aspartate glutamate carrier 2;Solute carrier family 25 member 13;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0005509;GO:0042802;GO:0015183;GO:0005313;GO:0022857;GO:0009066;GO:0015810;GO:0006754;GO:0045333;GO:0006094;GO:0015813;GO:0043490;GO:0006839;GO:0051592;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:identical protein binding; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:transmembrane transporter activity;, P:aspartate family amino acid metabolic process; P:aspartate transmembrane transport; P:ATP biosynthetic process; P:cellular respiration; P:gluconeogenesis; P:L-glutamate transmembrane transport; P:malate-aspartate shuttle; P:mitochondrial transport; P:response to calcium ion;|Q9UJS0 O14566 O14575 Q546F9 Q9NZW1 Q9UNI7,Calcium-binding mitochondrial carrier protein Aralar2,Citrin;Mitochondrial aspartate glutamate carrier 2;Solute carrier family 25 member 13;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0005509;GO:0042802;GO:0015183;GO:0005313;GO:0022857;GO:0009066;GO:0015810;GO:0006754;GO:0045333;GO:0006094;GO:0015813;GO:0043490;GO:0006839;GO:0051592;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:identical protein binding; F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:transmembrane transporter activity;, P:aspartate family amino acid metabolic process; P:aspartate transmembrane transport; P:ATP biosynthetic process; P:cellular respiration; P:gluconeogenesis; P:L-glutamate transmembrane transport; P:malate-aspartate shuttle; P:mitochondrial transport; P:response to calcium ion; scaffold43 indexed_genome mRNA 3045939 3047421 . + . ID=transcript_8657;Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold43 indexed_genome mRNA 3594876 3736466 . - . ID=transcript_8658;Q549T9 Q96HD0,Asparagine synthetase [glutamine-hydrolyzing],Cell cycle control protein TS11;Glutamine-dependent asparagine synthetase;, PF00733;PF13537;, GO:0005829;GO:0004066;GO:0005524;GO:0042802;GO:0006529;GO:0009066;GO:0042149;GO:0032870;GO:0006541;GO:0070981;GO:0001889;GO:0043066;GO:0045931;GO:0043200;GO:0032354;GO:0009416;GO:0009612;GO:0031427;GO:0009636;, C:cytosol;, F:asparagine synthase (glutamine-hydrolyzing) activity; F:ATP binding; F:identical protein binding;, P:asparagine biosynthetic process; P:aspartate family amino acid metabolic process; P:cellular response to glucose starvation; P:cellular response to hormone stimulus; P:glutamine metabolic process; P:L-asparagine biosynthetic process; P:liver development; P:negative regulation of apoptotic process; P:positive regulation of mitotic cell cycle; P:response to amino acid; P:response to follicle-stimulating hormone; P:response to light stimulus; P:response to mechanical stimulus; P:response to methotrexate; P:response to toxic substance;|Q549T9 Q96HD0,Asparagine synthetase [glutamine-hydrolyzing],Cell cycle control protein TS11;Glutamine-dependent asparagine synthetase;, PF00733;PF13537;, GO:0005829;GO:0004066;GO:0005524;GO:0042802;GO:0006529;GO:0009066;GO:0042149;GO:0032870;GO:0006541;GO:0070981;GO:0001889;GO:0043066;GO:0045931;GO:0043200;GO:0032354;GO:0009416;GO:0009612;GO:0031427;GO:0009636;, C:cytosol;, F:asparagine synthase (glutamine-hydrolyzing) activity; F:ATP binding; F:identical protein binding;, P:asparagine biosynthetic process; P:aspartate family amino acid metabolic process; P:cellular response to glucose starvation; P:cellular response to hormone stimulus; P:glutamine metabolic process; P:L-asparagine biosynthetic process; P:liver development; P:negative regulation of apoptotic process; P:positive regulation of mitotic cell cycle; P:response to amino acid; P:response to follicle-stimulating hormone; P:response to light stimulus; P:response to mechanical stimulus; P:response to methotrexate; P:response to toxic substance;|Q549T9 Q96HD0,Asparagine synthetase [glutamine-hydrolyzing],Cell cycle control protein TS11;Glutamine-dependent asparagine synthetase;, PF00733;PF13537;, GO:0005829;GO:0004066;GO:0005524;GO:0042802;GO:0006529;GO:0009066;GO:0042149;GO:0032870;GO:0006541;GO:0070981;GO:0001889;GO:0043066;GO:0045931;GO:0043200;GO:0032354;GO:0009416;GO:0009612;GO:0031427;GO:0009636;, C:cytosol;, F:asparagine synthase (glutamine-hydrolyzing) activity; F:ATP binding; F:identical protein binding;, P:asparagine biosynthetic process; P:aspartate family amino acid metabolic process; P:cellular response to glucose starvation; P:cellular response to hormone stimulus; P:glutamine metabolic process; P:L-asparagine biosynthetic process; P:liver development; P:negative regulation of apoptotic process; P:positive regulation of mitotic cell cycle; P:response to amino acid; P:response to follicle-stimulating hormone; P:response to light stimulus; P:response to mechanical stimulus; P:response to methotrexate; P:response to toxic substance; scaffold43 indexed_genome mRNA 3789023 3793996 . + . ID=transcript_8659;Q9NS00 Q96QH4 Q9BTU1,Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1,B3Gal-T8;Core 1 O-glycan T-synthase;Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1;Core 1 beta1,3-galactosyltransferase 1;, PF02434;, GO:0000139;GO:0016021;GO:0016263;GO:0046872;GO:0001525;GO:0030154;GO:0001822;GO:0016266;GO:0016267;, C:Golgi membrane; C:integral component of membrane;, F:glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity; F:metal ion binding;, P:angiogenesis; P:cell differentiation; P:kidney development; P:O-glycan processing; P:O-glycan processing, core 1; scaffold43 indexed_genome mRNA 4100361 4142260 . + . ID=transcript_8660;Q9NXC5 B2RTV6 O75216 Q7L551 Q9H092,GATOR complex protein MIOS {ECO:0000305},Missing oocyte meiosis regulator homolog {ECO:0000312|HGNC:HGNC:21905};, PF17034;, GO:0030054;GO:0005737;GO:0005829;GO:0061700;GO:0005765;GO:0005654;GO:0034629;GO:0034198;GO:0032008;, C:cell junction; C:cytoplasm; C:cytosol; C:GATOR2 complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular protein-containing complex localization; P:cellular response to amino acid starvation; P:positive regulation of TOR signaling; scaffold43 indexed_genome mRNA 4158793 4162243 . - . ID=transcript_8661;P35244 Q549U6,Replication protein A 14 kDa subunit,Replication factor A protein 3;, PF08661;, GO:0005662;GO:0005654;GO:0035861;GO:0003684;GO:0003697;GO:0006284;GO:0006287;GO:0042769;GO:0006260;GO:0006270;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0006298;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0042127;GO:1900034;GO:0007346;GO:1901796;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:DNA replication factor A complex; C:nucleoplasm; C:site of double-strand break;, F:damaged DNA binding; F:single-stranded DNA binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of cell population proliferation; P:regulation of cellular response to heat; P:regulation of mitotic cell cycle; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P35244 Q549U6,Replication protein A 14 kDa subunit,Replication factor A protein 3;, PF08661;, GO:0005662;GO:0005654;GO:0035861;GO:0003684;GO:0003697;GO:0006284;GO:0006287;GO:0042769;GO:0006260;GO:0006270;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0006298;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0042127;GO:1900034;GO:0007346;GO:1901796;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:DNA replication factor A complex; C:nucleoplasm; C:site of double-strand break;, F:damaged DNA binding; F:single-stranded DNA binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:regulation of cell population proliferation; P:regulation of cellular response to heat; P:regulation of mitotic cell cycle; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold43 indexed_genome mRNA 4613247 4614471 . - . ID=transcript_8662;Q86VQ1 A4D103 Q96FD0,Glucocorticoid-induced transcript 1 protein,, PF15388;, GO:0005737;, C:cytoplasm; scaffold43 indexed_genome mRNA 4626870 4631262 . - . ID=transcript_8663;Q86VQ1 A4D103 Q96FD0,Glucocorticoid-induced transcript 1 protein,, PF15388;, GO:0005737;, C:cytoplasm; scaffold43 indexed_genome mRNA 4661152 4664551 . + . ID=transcript_8664;Q05084 A8K7U1 B3FTQ2 P78506 Q13824 Q96HG3,Islet cell autoantigen 1,69 kDa islet cell autoantigen;Islet cell autoantigen p69;, PF06456;PF04629;, GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0030667;GO:0030672;GO:0140090;GO:0019904;GO:0006836;GO:0050796;GO:0051049;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:secretory granule membrane; C:synaptic vesicle membrane;, F:membrane curvature sensor activity; F:protein domain specific binding;, P:neurotransmitter transport; P:regulation of insulin secretion; P:regulation of transport;|Q05084 A8K7U1 B3FTQ2 P78506 Q13824 Q96HG3,Islet cell autoantigen 1,69 kDa islet cell autoantigen;Islet cell autoantigen p69;, PF06456;PF04629;, GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0030667;GO:0030672;GO:0140090;GO:0019904;GO:0006836;GO:0050796;GO:0051049;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:secretory granule membrane; C:synaptic vesicle membrane;, F:membrane curvature sensor activity; F:protein domain specific binding;, P:neurotransmitter transport; P:regulation of insulin secretion; P:regulation of transport; scaffold43 indexed_genome mRNA 4675242 4826650 . - . ID=transcript_8665;Q05084 A8K7U1 B3FTQ2 P78506 Q13824 Q96HG3,Islet cell autoantigen 1,69 kDa islet cell autoantigen;Islet cell autoantigen p69;, PF06456;PF04629;, GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0030667;GO:0030672;GO:0140090;GO:0019904;GO:0006836;GO:0050796;GO:0051049;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:secretory granule membrane; C:synaptic vesicle membrane;, F:membrane curvature sensor activity; F:protein domain specific binding;, P:neurotransmitter transport; P:regulation of insulin secretion; P:regulation of transport;|Q05084 A8K7U1 B3FTQ2 P78506 Q13824 Q96HG3,Islet cell autoantigen 1,69 kDa islet cell autoantigen;Islet cell autoantigen p69;, PF06456;PF04629;, GO:0005737;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0030667;GO:0030672;GO:0140090;GO:0019904;GO:0006836;GO:0050796;GO:0051049;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:secretory granule membrane; C:synaptic vesicle membrane;, F:membrane curvature sensor activity; F:protein domain specific binding;, P:neurotransmitter transport; P:regulation of insulin secretion; P:regulation of transport; scaffold43 indexed_genome mRNA 4989330 5327217 . + . ID=transcript_8666;P58417 Q8NB31,Neurexophilin-1,, PF06312;, GO:0005576;GO:0005102;, C:extracellular region;, F:signaling receptor binding; scaffold43 indexed_genome mRNA 7283432 7299404 . + . ID=transcript_8667;O00483 A4D109 Q6FHN5,Cytochrome c oxidase subunit NDUFA4,Complex I-MLRQ;NADH-ubiquinone oxidoreductase MLRQ subunit;, PF06522;, GO:0016021;GO:0005743;GO:0005747;GO:0005751;GO:0005739;GO:0008137;GO:0044877;GO:0006123;GO:0006120;GO:1902600;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrial respiratory chain complex IV; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity; F:protein-containing complex binding;, P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial electron transport, NADH to ubiquinone; P:proton transmembrane transport;|O00483 A4D109 Q6FHN5,Cytochrome c oxidase subunit NDUFA4,Complex I-MLRQ;NADH-ubiquinone oxidoreductase MLRQ subunit;, PF06522;, GO:0016021;GO:0005743;GO:0005747;GO:0005751;GO:0005739;GO:0008137;GO:0044877;GO:0006123;GO:0006120;GO:1902600;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrial respiratory chain complex IV; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity; F:protein-containing complex binding;, P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial electron transport, NADH to ubiquinone; P:proton transmembrane transport; scaffold43 indexed_genome mRNA 7309577 7472728 . + . ID=transcript_8668;O94880 A7MCZ3 B4DI82,PHD finger protein 14,, PF00628;, GO:0070776;GO:0042393;GO:0046872;GO:0044154;GO:0043972;GO:0006357;, C:MOZ/MORF histone acetyltransferase complex;, F:histone binding; F:metal ion binding;, P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:regulation of transcription by RNA polymerase II;|O94880 A7MCZ3 B4DI82,PHD finger protein 14,, PF00628;, GO:0070776;GO:0042393;GO:0046872;GO:0044154;GO:0043972;GO:0006357;, C:MOZ/MORF histone acetyltransferase complex;, F:histone binding; F:metal ion binding;, P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:regulation of transcription by RNA polymerase II;|O94880 A7MCZ3 B4DI82,PHD finger protein 14,, PF00628;, GO:0070776;GO:0042393;GO:0046872;GO:0044154;GO:0043972;GO:0006357;, C:MOZ/MORF histone acetyltransferase complex;, F:histone binding; F:metal ion binding;, P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:regulation of transcription by RNA polymerase II; scaffold43 indexed_genome mRNA 7771837 7817846 . - . ID=transcript_8669;Q9UPZ6,Thrombospondin type-1 domain-containing protein 7A,, PF19028;PF00090;, GO:0042995;GO:0005576;GO:0016021;GO:0005886;GO:0031532;GO:0001525;GO:0030154;, C:cell projection; C:extracellular region; C:integral component of membrane; C:plasma membrane;, , P:actin cytoskeleton reorganization; P:angiogenesis; P:cell differentiation; scaffold43 indexed_genome mRNA 7817903 7850123 . - . ID=transcript_8670;Q9UPZ6,Thrombospondin type-1 domain-containing protein 7A,, PF19028;PF00090;, GO:0042995;GO:0005576;GO:0016021;GO:0005886;GO:0031532;GO:0001525;GO:0030154;, C:cell projection; C:extracellular region; C:integral component of membrane; C:plasma membrane;, , P:actin cytoskeleton reorganization; P:angiogenesis; P:cell differentiation; scaffold43 indexed_genome mRNA 7976987 8029892 . - . ID=transcript_8671;Q9UPZ6,Thrombospondin type-1 domain-containing protein 7A,, PF19028;PF00090;, GO:0042995;GO:0005576;GO:0016021;GO:0005886;GO:0031532;GO:0001525;GO:0030154;, C:cell projection; C:extracellular region; C:integral component of membrane; C:plasma membrane;, , P:actin cytoskeleton reorganization; P:angiogenesis; P:cell differentiation; scaffold43 indexed_genome mRNA 8561988 8587576 . + . ID=transcript_8672;Q9NUM4 A4D108 Q53FL9 Q8N4L0,Transmembrane protein 106B,, PF07092;, GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0048813;GO:0007041;GO:0032418;GO:0007040;, C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, , P:dendrite morphogenesis; P:lysosomal transport; P:lysosome localization; P:lysosome organization;|Q9NUM4 A4D108 Q53FL9 Q8N4L0,Transmembrane protein 106B,, PF07092;, GO:0005768;GO:0016021;GO:0031902;GO:0005765;GO:0005764;GO:0048813;GO:0007041;GO:0032418;GO:0007040;, C:endosome; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, , P:dendrite morphogenesis; P:lysosomal transport; P:lysosome localization; P:lysosome organization; scaffold43 indexed_genome mRNA 8636869 8637399 . + . ID=transcript_8673;Q8N2E2 B7ZM77 Q96SQ3,von Willebrand factor D and EGF domain-containing protein,, PF00094;, GO:0009986;GO:0005576;GO:0005102;GO:0048856;, C:cell surface; C:extracellular region;, F:signaling receptor binding;, P:anatomical structure development; scaffold43 indexed_genome mRNA 8639440 8640512 . - . ID=transcript_8674;Q8N2E2 B7ZM77 Q96SQ3,von Willebrand factor D and EGF domain-containing protein,, PF00094;, GO:0009986;GO:0005576;GO:0005102;GO:0048856;, C:cell surface; C:extracellular region;, F:signaling receptor binding;, P:anatomical structure development; scaffold43 indexed_genome mRNA 8640845 8642466 . + . ID=transcript_8675;Q8N2E2 B7ZM77 Q96SQ3,von Willebrand factor D and EGF domain-containing protein,, PF00094;, GO:0009986;GO:0005576;GO:0005102;GO:0048856;, C:cell surface; C:extracellular region;, F:signaling receptor binding;, P:anatomical structure development; scaffold43 indexed_genome mRNA 8657851 8674382 . - . ID=transcript_8676;Q8N2E2 B7ZM77 Q96SQ3,von Willebrand factor D and EGF domain-containing protein,, PF00094;, GO:0009986;GO:0005576;GO:0005102;GO:0048856;, C:cell surface; C:extracellular region;, F:signaling receptor binding;, P:anatomical structure development; scaffold43 indexed_genome mRNA 8837768 8919081 . + . ID=transcript_8677;Q9Y6U3 A8K2U8 Q8NBZ6 Q8WU97 Q96JC7 Q96PY2,Adseverin,Scinderin;, PF00626;, GO:0015629;GO:0005938;GO:0030054;GO:0042995;GO:0005737;GO:0070062;GO:0005886;GO:0002102;GO:0032991;GO:0005545;GO:0003779;GO:0051015;GO:0005509;GO:0005546;GO:0001786;GO:0051693;GO:0051014;GO:0045010;GO:0008154;GO:0051016;GO:0017156;GO:0030031;GO:0007417;GO:0008285;GO:0051127;GO:0043065;GO:0045654;GO:0051047;GO:0032330;GO:0042989;, C:actin cytoskeleton; C:cell cortex; C:cell junction; C:cell projection; C:cytoplasm; C:extracellular exosome; C:plasma membrane; C:podosome; C:protein-containing complex;, F:1-phosphatidylinositol binding; F:actin binding; F:actin filament binding; F:calcium ion binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:actin filament capping; P:actin filament severing; P:actin nucleation; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:calcium-ion regulated exocytosis; P:cell projection assembly; P:central nervous system development; P:negative regulation of cell population proliferation; P:positive regulation of actin nucleation; P:positive regulation of apoptotic process; P:positive regulation of megakaryocyte differentiation; P:positive regulation of secretion; P:regulation of chondrocyte differentiation; P:sequestering of actin monomers;|Q92819 Q32MM3,Hyaluronan synthase 2,Hyaluronate synthase 2;Hyaluronic acid synthase 2;, , GO:0031410;GO:0005887;GO:0044853;GO:0050501;GO:0036302;GO:0060349;GO:0071498;GO:0071347;GO:0036120;GO:0071356;GO:0090500;GO:0044849;GO:0085029;GO:0045226;GO:0030213;GO:0001822;GO:0030335;GO:0008284;GO:1900127;GO:0051549;GO:0010838;GO:1900625;GO:0014911;GO:1900026;GO:0035810;GO:1901201;GO:0070295;GO:0001570;, C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane raft;, F:hyaluronan synthase activity;, P:atrioventricular canal development; P:bone morphogenesis; P:cellular response to fluid shear stress; P:cellular response to interleukin-1; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to tumor necrosis factor; P:endocardial cushion to mesenchymal transition; P:estrous cycle; P:extracellular matrix assembly; P:extracellular polysaccharide biosynthetic process; P:hyaluronan biosynthetic process; P:kidney development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of keratinocyte migration; P:positive regulation of keratinocyte proliferation; P:positive regulation of monocyte aggregation; P:positive regulation of smooth muscle cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of urine volume; P:regulation of extracellular matrix assembly; P:renal water absorption; P:vasculogenesis; scaffold43 indexed_genome mRNA 8978006 8980486 . + . ID=transcript_8678;P40617 A4D119 P80418 Q49AF5,ADP-ribosylation factor-like protein 4A,, PF00025;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005525;GO:0050873;GO:0006886;GO:0016192;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:GTP binding;, P:brown fat cell differentiation; P:intracellular protein transport; P:vesicle-mediated transport; scaffold43 indexed_genome mRNA 10209463 10300605 . - . ID=transcript_8679;O75849 Q4KMQ6 Q59GA7 Q6AI30 Q9UQ71 Q9Y636,ETS translocation variant 1,Ets-related protein 81;, PF00178;PF04621;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0048935;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:peripheral nervous system neuron development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75849 Q4KMQ6 Q59GA7 Q6AI30 Q9UQ71 Q9Y636,ETS translocation variant 1,Ets-related protein 81;, PF00178;PF04621;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0048935;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:peripheral nervous system neuron development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75849 Q4KMQ6 Q59GA7 Q6AI30 Q9UQ71 Q9Y636,ETS translocation variant 1,Ets-related protein 81;, PF00178;PF04621;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0048935;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:peripheral nervous system neuron development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75849 Q4KMQ6 Q59GA7 Q6AI30 Q9UQ71 Q9Y636,ETS translocation variant 1,Ets-related protein 81;, PF00178;PF04621;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0048935;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:peripheral nervous system neuron development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75849 Q4KMQ6 Q59GA7 Q6AI30 Q9UQ71 Q9Y636,ETS translocation variant 1,Ets-related protein 81;, PF00178;PF04621;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0048935;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:peripheral nervous system neuron development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75849 Q4KMQ6 Q59GA7 Q6AI30 Q9UQ71 Q9Y636,ETS translocation variant 1,Ets-related protein 81;, PF00178;PF04621;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0048935;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:peripheral nervous system neuron development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75849 Q4KMQ6 Q59GA7 Q6AI30 Q9UQ71 Q9Y636,ETS translocation variant 1,Ets-related protein 81;, PF00178;PF04621;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0048935;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:peripheral nervous system neuron development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75849 Q4KMQ6 Q59GA7 Q6AI30 Q9UQ71 Q9Y636,ETS translocation variant 1,Ets-related protein 81;, PF00178;PF04621;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0048935;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:peripheral nervous system neuron development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold43 indexed_genome mRNA 10488700 11242655 . - . ID=transcript_8680;Q86UM9 Q9UQ29,Diacylglycerol kinase beta,90 kDa diacylglycerol kinase;Diglyceride kinase beta;, PF00130;PF14513;PF00609;PF00781;PF13499;, GO:0005737;GO:0005829;GO:0098978;GO:0005886;GO:0045211;GO:0098685;GO:0005524;GO:0005509;GO:0004143;GO:0008289;GO:0003951;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0050804;GO:0006654;GO:0030168;GO:0007205;GO:0099175;GO:0009617;, C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:plasma membrane; C:postsynaptic membrane; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:lipid binding; F:NAD+ kinase activity;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:modulation of chemical synaptic transmission; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of postsynapse organization; P:response to bacterium; scaffold43 indexed_genome mRNA 11612292 11980138 . - . ID=transcript_8681;Q6ZNB7 A4D114 A6NCH5,Alkylglycerol monooxygenase,Transmembrane protein 195;, PF04116;, GO:0005783;GO:0005789;GO:0016021;GO:0050479;GO:0005506;GO:0046485;GO:0006643;GO:0019432;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:glyceryl-ether monooxygenase activity; F:iron ion binding;, P:ether lipid metabolic process; P:membrane lipid metabolic process; P:triglyceride biosynthetic process; scaffold43 indexed_genome mRNA 12035894 12108339 . + . ID=transcript_8682;P50222 A4D127 B2R8I7 O75263 Q9UPL6,Homeobox protein MOX-2 {ECO:0000303|PubMed:7607679},Growth arrest-specific homeobox {ECO:0000303|PubMed:7713505};Mesenchyme homeobox 2 {ECO:0000303|PubMed:7607679};, PF00046;, GO:0000785;GO:0005737;GO:0016607;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0001525;GO:0008015;GO:0060173;GO:0007275;GO:0090051;GO:0045944;GO:0006357;GO:0060021;GO:0007519;GO:0061053;GO:0001757;, C:chromatin; C:cytoplasm; C:nuclear speck; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:blood circulation; P:limb development; P:multicellular organism development; P:negative regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; P:skeletal muscle tissue development; P:somite development; P:somite specification; scaffold43 indexed_genome mRNA 12549823 12886185 . - . ID=transcript_8683;A4D126 A8MU35 H9KVB2,D-ribitol-5-phosphate cytidylyltransferase {ECO:0000305},2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein;Isoprenoid synthase domain-containing protein {ECO:0000312|HGNC:HGNC:37276};, PF01128;PF18706;, GO:0005829;GO:0070567;GO:0047349;GO:0042803;GO:0007411;GO:0008299;GO:0035269;, C:cytosol;, F:cytidylyltransferase activity; F:D-ribitol-5-phosphate cytidylyltransferase activity; F:protein homodimerization activity;, P:axon guidance; P:isoprenoid biosynthetic process; P:protein O-linked mannosylation; scaffold43 indexed_genome mRNA 13023757 13025004 . + . ID=transcript_8684;A6NJI9,Leucine-rich repeat-containing protein 72 scaffold43 indexed_genome mRNA 13046804 13086632 . - . ID=transcript_8685;Q8IV38 A4D124 Q659G1 Q96BL3,Ankyrin repeat and MYND domain-containing protein 2,, PF12796;PF01753;, GO:0005929;GO:0019899;GO:0046872;, C:cilium;, F:enzyme binding; F:metal ion binding;|Q8IV38 A4D124 Q659G1 Q96BL3,Ankyrin repeat and MYND domain-containing protein 2,, PF12796;PF01753;, GO:0005929;GO:0019899;GO:0046872;, C:cilium;, F:enzyme binding; F:metal ion binding; scaffold43 indexed_genome mRNA 13134522 13143200 . - . ID=transcript_8686;Q9Y6E2 A4D123 Q3B779 Q96JW5 Q9H3F7,Basic leucine zipper and W2 domain-containing protein 2,, PF02020;, GO:0005737;GO:0016020;GO:0045296;GO:0030154;GO:0007399;, C:cytoplasm; C:membrane;, F:cadherin binding;, P:cell differentiation; P:nervous system development;|Q9Y6E2 A4D123 Q3B779 Q96JW5 Q9H3F7,Basic leucine zipper and W2 domain-containing protein 2,, PF02020;, GO:0005737;GO:0016020;GO:0045296;GO:0030154;GO:0007399;, C:cytoplasm; C:membrane;, F:cadherin binding;, P:cell differentiation; P:nervous system development;|Q9Y6E2 A4D123 Q3B779 Q96JW5 Q9H3F7,Basic leucine zipper and W2 domain-containing protein 2,, PF02020;, GO:0005737;GO:0016020;GO:0045296;GO:0030154;GO:0007399;, C:cytoplasm; C:membrane;, F:cadherin binding;, P:cell differentiation; P:nervous system development; scaffold43 indexed_genome mRNA 13210873 13213866 . + . ID=transcript_8687;O95857,Tetraspanin-13,Tetraspan NET-6;Transmembrane 4 superfamily member 13;, PF00335;, GO:0005887;GO:0016020;GO:0005246;GO:1903169;, C:integral component of plasma membrane; C:membrane;, F:calcium channel regulator activity;, P:regulation of calcium ion transmembrane transport; scaffold43 indexed_genome mRNA 13221930 13223344 . + . ID=transcript_8688;O95857,Tetraspanin-13,Tetraspan NET-6;Transmembrane 4 superfamily member 13;, PF00335;, GO:0005887;GO:0016020;GO:0005246;GO:1903169;, C:integral component of plasma membrane; C:membrane;, F:calcium channel regulator activity;, P:regulation of calcium ion transmembrane transport; scaffold43 indexed_genome mRNA 13230957 13240942 . - . ID=transcript_8689;O95994,Anterior gradient protein 2 homolog,HPC8;Secreted cement gland protein XAG-2 homolog;, , GO:0005783;GO:0005615;GO:0002162;GO:0005154;GO:0042802;GO:0048546;GO:0070254;GO:0060548;GO:0010811;GO:0048639;GO:0045742;GO:0010628;GO:1903896;GO:1903899;GO:1903078;, C:endoplasmic reticulum; C:extracellular space;, F:dystroglycan binding; F:epidermal growth factor receptor binding; F:identical protein binding;, P:digestive tract morphogenesis; P:mucus secretion; P:negative regulation of cell death; P:positive regulation of cell-substrate adhesion; P:positive regulation of developmental growth; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of PERK-mediated unfolded protein response; P:positive regulation of protein localization to plasma membrane; scaffold43 indexed_genome mRNA 13715773 13768307 . + . ID=transcript_8690;P35869 A4D130 Q13728 Q13803 Q13804,Aryl hydrocarbon receptor {ECO:0000303|PubMed:8393992},Class E basic helix-loop-helix protein 76;, PF00010;PF00989;PF08447;, GO:0034751;GO:0000785;GO:0005737;GO:0005829;GO:0034752;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0000987;GO:0003677;GO:0003700;GO:0000981;GO:0070888;GO:0051879;GO:0004879;GO:0046982;GO:0042803;GO:1990837;GO:0017025;GO:0001094;GO:0001223;GO:0008134;GO:0000976;GO:0006915;GO:0001568;GO:0019933;GO:0007049;GO:1904613;GO:0071320;GO:1904322;GO:0032922;GO:0002841;GO:0045892;GO:0045944;GO:0045893;GO:0002819;GO:0030888;GO:0010468;GO:0006357;GO:0006355;GO:0009636;GO:0009410;GO:0006805;, C:aryl hydrocarbon receptor complex; C:chromatin; C:cytoplasm; C:cytosol; C:cytosolic aryl hydrocarbon receptor complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:Hsp90 protein binding; F:nuclear receptor activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:sequence-specific double-stranded DNA binding; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:blood vessel development; P:cAMP-mediated signaling; P:cell cycle; P:cellular response to 2,3,7,8-tetrachlorodibenzodioxine; P:cellular response to cAMP; P:cellular response to forskolin; P:circadian regulation of gene expression; P:negative regulation of T cell mediated immune response to tumor cell; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of adaptive immune response; P:regulation of B cell proliferation; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to toxic substance; P:response to xenobiotic stimulus; P:xenobiotic metabolic process; scaffold43 indexed_genome mRNA 14205152 14344250 . - . ID=transcript_8691;Q9Y5W8 B2RCI9 O94821 Q8WVZ2 Q8WXH8,Sorting nexin-13,RGS domain- and PHOX domain-containing protein;RGS-PX1;, PF08628;PF00787;PF02194;PF00615;, GO:0005769;GO:0031901;GO:0035091;GO:0032266;GO:0006886;GO:0009968;GO:0043547;, C:early endosome; C:early endosome membrane;, F:phosphatidylinositol binding; F:phosphatidylinositol-3-phosphate binding;, P:intracellular protein transport; P:negative regulation of signal transduction; P:positive regulation of GTPase activity;|Q9Y5W8 B2RCI9 O94821 Q8WVZ2 Q8WXH8,Sorting nexin-13,RGS domain- and PHOX domain-containing protein;RGS-PX1;, PF08628;PF00787;PF02194;PF00615;, GO:0005769;GO:0031901;GO:0035091;GO:0032266;GO:0006886;GO:0009968;GO:0043547;, C:early endosome; C:early endosome membrane;, F:phosphatidylinositol binding; F:phosphatidylinositol-3-phosphate binding;, P:intracellular protein transport; P:negative regulation of signal transduction; P:positive regulation of GTPase activity;|Q9Y5W8 B2RCI9 O94821 Q8WVZ2 Q8WXH8,Sorting nexin-13,RGS domain- and PHOX domain-containing protein;RGS-PX1;, PF08628;PF00787;PF02194;PF00615;, GO:0005769;GO:0031901;GO:0035091;GO:0032266;GO:0006886;GO:0009968;GO:0043547;, C:early endosome; C:early endosome membrane;, F:phosphatidylinositol binding; F:phosphatidylinositol-3-phosphate binding;, P:intracellular protein transport; P:negative regulation of signal transduction; P:positive regulation of GTPase activity;|Q9Y5W8 B2RCI9 O94821 Q8WVZ2 Q8WXH8,Sorting nexin-13,RGS domain- and PHOX domain-containing protein;RGS-PX1;, PF08628;PF00787;PF02194;PF00615;, GO:0005769;GO:0031901;GO:0035091;GO:0032266;GO:0006886;GO:0009968;GO:0043547;, C:early endosome; C:early endosome membrane;, F:phosphatidylinositol binding; F:phosphatidylinositol-3-phosphate binding;, P:intracellular protein transport; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; scaffold43 indexed_genome mRNA 14920833 15110121 . + . ID=transcript_8692;O94845 O95028 Q2M2R6 Q86SL1 Q86US3,Histone deacetylase 9,Histone deacetylase 7B;Histone deacetylase-related protein;MEF2-interacting transcription repressor MITR;, PF12203;PF00850;, GO:0005737;GO:0000118;GO:0035097;GO:0005654;GO:0005634;GO:0005667;GO:0004407;GO:0034739;GO:0042826;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0003714;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0042632;GO:0007507;GO:0016575;GO:0070932;GO:0070933;GO:1990678;GO:0006954;GO:0001818;GO:0051005;GO:0000122;GO:0045892;GO:0030182;GO:0034983;GO:0090050;GO:0048742;GO:0051153;GO:0001975;GO:0006367;, C:cytoplasm; C:histone deacetylase complex; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:histone deacetylase activity; F:histone deacetylase activity (H4-K16 specific); F:histone deacetylase binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cholesterol homeostasis; P:heart development; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:histone H4-K16 deacetylation; P:inflammatory response; P:negative regulation of cytokine production; P:negative regulation of lipoprotein lipase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:peptidyl-lysine deacetylation; P:positive regulation of cell migration involved in sprouting angiogenesis; P:regulation of skeletal muscle fiber development; P:regulation of striated muscle cell differentiation; P:response to amphetamine; P:transcription initiation from RNA polymerase II promoter; scaffold43 indexed_genome mRNA 15603130 15604297 . - . ID=transcript_8693;Q15672 A4D128 Q92487 Q99804,Twist-related protein 1,Class A basic helix-loop-helix protein 38;H-twist;, PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0043425;GO:0000981;GO:0070888;GO:0019904;GO:0042803;GO:0000977;GO:0008134;GO:0003180;GO:0003253;GO:2000793;GO:0071363;GO:0071456;GO:0060363;GO:0019221;GO:0032502;GO:0060900;GO:0048701;GO:0042733;GO:0035115;GO:0035116;GO:0003203;GO:0061029;GO:0001701;GO:0003183;GO:0007517;GO:0043066;GO:2000773;GO:0043518;GO:0043433;GO:2000780;GO:0035067;GO:0033128;GO:0045668;GO:2000276;GO:0035359;GO:0014067;GO:0048642;GO:0000122;GO:0045892;GO:0032720;GO:0001843;GO:0001764;GO:0042476;GO:0001503;GO:0001649;GO:0042473;GO:0045766;GO:2000147;GO:2000144;GO:2000802;GO:0050679;GO:0010718;GO:0032000;GO:0010628;GO:0032755;GO:0071639;GO:0045944;GO:2000679;GO:0032760;GO:0030500;GO:0006357;GO:0048511;GO:0060021;, C:chromatin; C:nucleoplasm; C:nucleus;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:protein domain specific binding; F:protein homodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:aortic valve morphogenesis; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; P:cell proliferation involved in heart valve development; P:cellular response to growth factor stimulus; P:cellular response to hypoxia; P:cranial suture morphogenesis; P:cytokine-mediated signaling pathway; P:developmental process; P:embryonic camera-type eye formation; P:embryonic cranial skeleton morphogenesis; P:embryonic digit morphogenesis; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:endocardial cushion morphogenesis; P:eyelid development in camera-type eye; P:in utero embryonic development; P:mitral valve morphogenesis; P:muscle organ development; P:negative regulation of apoptotic process; P:negative regulation of cellular senescence; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of double-strand break repair; P:negative regulation of histone acetylation; P:negative regulation of histone phosphorylation; P:negative regulation of osteoblast differentiation; P:negative regulation of oxidative phosphorylation uncoupler activity; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of skeletal muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:neural tube closure; P:neuron migration; P:odontogenesis; P:ossification; P:osteoblast differentiation; P:outer ear morphogenesis; P:positive regulation of angiogenesis; P:positive regulation of cell motility; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation; P:positive regulation of epithelial cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of gene expression; P:positive regulation of interleukin-6 production; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of tumor necrosis factor production; P:regulation of bone mineralization; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:roof of mouth development; scaffold43 indexed_genome mRNA 16158304 16160544 . + . ID=transcript_8694;Q3B726 A0PJ45 B7Z724,DNA-directed RNA polymerase I subunit RPA43,DNA-directed RNA polymerase I subunit F {ECO:0000312|HGNC:HGNC:18027};Twist neighbor protein {ECO:0000305|PubMed:12438708};, PF17875;, GO:0005654;GO:0005736;GO:0003899;GO:0045815;GO:0006363;GO:0006361;, C:nucleoplasm; C:RNA polymerase I complex;, F:DNA-directed 5'-3' RNA polymerase activity;, P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; scaffold43 indexed_genome mRNA 16174821 16182729 . - . ID=transcript_8695;Q3B726 A0PJ45 B7Z724,DNA-directed RNA polymerase I subunit RPA43,DNA-directed RNA polymerase I subunit F {ECO:0000312|HGNC:HGNC:18027};Twist neighbor protein {ECO:0000305|PubMed:12438708};, PF17875;, GO:0005654;GO:0005736;GO:0003899;GO:0045815;GO:0006363;GO:0006361;, C:nucleoplasm; C:RNA polymerase I complex;, F:DNA-directed 5'-3' RNA polymerase activity;, P:positive regulation of gene expression, epigenetic; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; scaffold43 indexed_genome mRNA 16182739 16191584 . - . ID=transcript_8696;Q5HYL7 Q8N6I6,Transmembrane protein 196,, , GO:0016021;, C:integral component of membrane; scaffold43 indexed_genome mRNA 16698990 16793249 . + . ID=transcript_8697;P26012 A4D133 B4DHD4,Integrin beta-8 {ECO:0000305},, PF07974;PF00362;PF17205;, GO:0009986;GO:0070062;GO:0005925;GO:0034686;GO:0008305;GO:0005886;GO:1990430;GO:0005178;GO:0038023;GO:0051216;GO:0007155;GO:0033627;GO:0016477;GO:0030198;GO:0001573;GO:0060022;GO:0006955;GO:0007229;GO:0061520;GO:0010629;GO:0060674;GO:0045766;GO:0010628;GO:1901388;GO:0009615;GO:0007179;GO:0001570;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:integrin alphav-beta8 complex; C:integrin complex; C:plasma membrane;, F:extracellular matrix protein binding; F:integrin binding; F:signaling receptor activity;, P:cartilage development; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:extracellular matrix organization; P:ganglioside metabolic process; P:hard palate development; P:immune response; P:integrin-mediated signaling pathway; P:Langerhans cell differentiation; P:negative regulation of gene expression; P:placenta blood vessel development; P:positive regulation of angiogenesis; P:positive regulation of gene expression; P:regulation of transforming growth factor beta activation; P:response to virus; P:transforming growth factor beta receptor signaling pathway; P:vasculogenesis; scaffold43 indexed_genome mRNA 17785350 17865636 . + . ID=transcript_8698;Q02446 O60402 Q32M52,Transcription factor Sp4,SPR-1;, PF00096;, GO:0000785;GO:0005829;GO:0005654;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0043565;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold43 indexed_genome mRNA 18132052 18196396 . + . ID=transcript_8699;Q96DT5 Q9UJ82,Dynein heavy chain 11, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 11;Ciliary dynein heavy chain 11;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0097729;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0120134;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003341;GO:0007368;GO:0030317;GO:0007018;GO:0003356;, C:9+2 motile cilium; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:proximal portion of axoneme;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium movement; P:determination of left/right symmetry; P:flagellated sperm motility; P:microtubule-based movement; P:regulation of cilium beat frequency; scaffold43 indexed_genome mRNA 18196445 18228372 . - . ID=transcript_8700;Q96DT5 Q9UJ82,Dynein heavy chain 11, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 11;Ciliary dynein heavy chain 11;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0097729;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0120134;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003341;GO:0007368;GO:0030317;GO:0007018;GO:0003356;, C:9+2 motile cilium; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:proximal portion of axoneme;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cilium movement; P:determination of left/right symmetry; P:flagellated sperm motility; P:microtubule-based movement; P:regulation of cilium beat frequency; scaffold43 indexed_genome mRNA 18230124 18237173 . - . ID=transcript_8701;Q96C70 Q9H9A2 Q9NPV2,Cell division cycle-associated 7-like protein,Protein JPO2;Transcription factor RAM2;, PF10497;, GO:0005829;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0008284;GO:0006355;, C:cytosol; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:positive regulation of cell population proliferation; P:regulation of transcription, DNA-templated; scaffold43 indexed_genome mRNA 18448904 18641035 . - . ID=transcript_8702;Q92565 A4D140 Q8IXU5,Rap guanine nucleotide exchange factor 5,Guanine nucleotide exchange factor for Rap1;M-Ras-regulated Rap GEF;Related to Epac;, PF00617;PF00618;, GO:0016604;GO:0005654;GO:0005634;GO:0030742;GO:0005085;GO:0007399;GO:0007264;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:GTP-dependent protein binding; F:guanyl-nucleotide exchange factor activity;, P:nervous system development; P:small GTPase mediated signal transduction;|Q92565 A4D140 Q8IXU5,Rap guanine nucleotide exchange factor 5,Guanine nucleotide exchange factor for Rap1;M-Ras-regulated Rap GEF;Related to Epac;, PF00617;PF00618;, GO:0016604;GO:0005654;GO:0005634;GO:0030742;GO:0005085;GO:0007399;GO:0007264;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:GTP-dependent protein binding; F:guanyl-nucleotide exchange factor activity;, P:nervous system development; P:small GTPase mediated signal transduction;|Q92565 A4D140 Q8IXU5,Rap guanine nucleotide exchange factor 5,Guanine nucleotide exchange factor for Rap1;M-Ras-regulated Rap GEF;Related to Epac;, PF00617;PF00618;, GO:0016604;GO:0005654;GO:0005634;GO:0030742;GO:0005085;GO:0007399;GO:0007264;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:GTP-dependent protein binding; F:guanyl-nucleotide exchange factor activity;, P:nervous system development; P:small GTPase mediated signal transduction;|Q92565 A4D140 Q8IXU5,Rap guanine nucleotide exchange factor 5,Guanine nucleotide exchange factor for Rap1;M-Ras-regulated Rap GEF;Related to Epac;, PF00617;PF00618;, GO:0016604;GO:0005654;GO:0005634;GO:0030742;GO:0005085;GO:0007399;GO:0007264;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:GTP-dependent protein binding; F:guanyl-nucleotide exchange factor activity;, P:nervous system development; P:small GTPase mediated signal transduction; scaffold43 indexed_genome mRNA 18857998 19052458 . - . ID=transcript_8703;Q9P0U1 O95939,Mitochondrial import receptor subunit TOM7 homolog,Translocase of outer membrane 7 kDa subunit homolog;, PF08038;, GO:0016021;GO:0005741;GO:0005742;GO:0005739;GO:0008320;GO:0016236;GO:0098779;GO:1903955;GO:0030150;GO:0006626;GO:0031647;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:protein transmembrane transporter activity;, P:macroautophagy; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein targeting to mitochondrion; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:regulation of protein stability;|Q9P0U1 O95939,Mitochondrial import receptor subunit TOM7 homolog,Translocase of outer membrane 7 kDa subunit homolog;, PF08038;, GO:0016021;GO:0005741;GO:0005742;GO:0005739;GO:0008320;GO:0016236;GO:0098779;GO:1903955;GO:0030150;GO:0006626;GO:0031647;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:protein transmembrane transporter activity;, P:macroautophagy; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein targeting to mitochondrion; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:regulation of protein stability;|Q9P0U1 O95939,Mitochondrial import receptor subunit TOM7 homolog,Translocase of outer membrane 7 kDa subunit homolog;, PF08038;, GO:0016021;GO:0005741;GO:0005742;GO:0005739;GO:0008320;GO:0016236;GO:0098779;GO:1903955;GO:0030150;GO:0006626;GO:0031647;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:protein transmembrane transporter activity;, P:macroautophagy; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein targeting to mitochondrion; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:regulation of protein stability; scaffold43 indexed_genome mRNA 19141641 19225644 . - . ID=transcript_8704;Q9BYI3 A0A024RA06 A4D145 B8ZZJ1 Q6N010 Q75MR4 Q7LDZ4 Q96MX1 Q96NQ6,Hyccin {ECO:0000303|PubMed:16951682},Down-regulated by CTNNB1 protein A {ECO:0000303|PubMed:10910037};Protein FAM126A {ECO:0000305};, PF09790;, GO:0005829;GO:0005886;GO:0042552;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:myelination; P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q9BYI3 A0A024RA06 A4D145 B8ZZJ1 Q6N010 Q75MR4 Q7LDZ4 Q96MX1 Q96NQ6,Hyccin {ECO:0000303|PubMed:16951682},Down-regulated by CTNNB1 protein A {ECO:0000303|PubMed:10910037};Protein FAM126A {ECO:0000305};, PF09790;, GO:0005829;GO:0005886;GO:0042552;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:myelination; P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane; scaffold43 indexed_genome mRNA 19296320 19344611 . + . ID=transcript_8705;Q8IXQ5 A4D144 B7Z5I9 G5E9G3 Q7Z765 Q96MV2 Q9BQF8 Q9UDQ9,Kelch-like protein 7,, PF07707;PF00651;PF01344;, GO:0031463;GO:0005829;GO:0005730;GO:0005654;GO:0048471;GO:0005886;GO:0042802;GO:0042803;GO:0016567;, C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding; F:protein homodimerization activity;, P:protein ubiquitination;|Q8IXQ5 A4D144 B7Z5I9 G5E9G3 Q7Z765 Q96MV2 Q9BQF8 Q9UDQ9,Kelch-like protein 7,, PF07707;PF00651;PF01344;, GO:0031463;GO:0005829;GO:0005730;GO:0005654;GO:0048471;GO:0005886;GO:0042802;GO:0042803;GO:0016567;, C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding; F:protein homodimerization activity;, P:protein ubiquitination; scaffold43 indexed_genome mRNA 19347848 19370725 . - . ID=transcript_8706;O15504 A4D143 B4DP42 Q49AE7 Q9BS49,Nucleoporin NUP42 {ECO:0000305},NLP-1;NUP42 homolog;Nucleoporin hCG1;Nucleoporin-42 {ECO:0000312|HGNC:HGNC:17010};Nucleoporin-like protein 2;, , GO:0005829;GO:0043657;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0046872;GO:0005049;GO:0003723;GO:0075733;GO:0006406;GO:0006611;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:nuclear export signal receptor activity; F:RNA binding;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8IXQ5 A4D144 B7Z5I9 G5E9G3 Q7Z765 Q96MV2 Q9BQF8 Q9UDQ9,Kelch-like protein 7,, PF07707;PF00651;PF01344;, GO:0031463;GO:0005829;GO:0005730;GO:0005654;GO:0048471;GO:0005886;GO:0042802;GO:0042803;GO:0016567;, C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding; F:protein homodimerization activity;, P:protein ubiquitination;|O15504 A4D143 B4DP42 Q49AE7 Q9BS49,Nucleoporin NUP42 {ECO:0000305},NLP-1;NUP42 homolog;Nucleoporin hCG1;Nucleoporin-42 {ECO:0000312|HGNC:HGNC:17010};Nucleoporin-like protein 2;, , GO:0005829;GO:0043657;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0046872;GO:0005049;GO:0003723;GO:0075733;GO:0006406;GO:0006611;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:nuclear export signal receptor activity; F:RNA binding;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|O15504 A4D143 B4DP42 Q49AE7 Q9BS49,Nucleoporin NUP42 {ECO:0000305},NLP-1;NUP42 homolog;Nucleoporin hCG1;Nucleoporin-42 {ECO:0000312|HGNC:HGNC:17010};Nucleoporin-like protein 2;, , GO:0005829;GO:0043657;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0046872;GO:0005049;GO:0003723;GO:0075733;GO:0006406;GO:0006611;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:nuclear export signal receptor activity; F:RNA binding;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|O15504 A4D143 B4DP42 Q49AE7 Q9BS49,Nucleoporin NUP42 {ECO:0000305},NLP-1;NUP42 homolog;Nucleoporin hCG1;Nucleoporin-42 {ECO:0000312|HGNC:HGNC:17010};Nucleoporin-like protein 2;, , GO:0005829;GO:0043657;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0046872;GO:0005049;GO:0003723;GO:0075733;GO:0006406;GO:0006611;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:nuclear export signal receptor activity; F:RNA binding;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold43 indexed_genome mRNA 19404703 19432496 . + . ID=transcript_8707;Q14956 A4D155 Q6UVX1 Q8N1A1,Transmembrane glycoprotein NMB,Hematopoietic growth factor inducible neurokinin-1 type {ECO:0000303|PubMed:12609765};, PF00801;, GO:0031901;GO:0016021;GO:0005887;GO:0033162;GO:0005886;GO:0042056;GO:0008201;GO:0005178;GO:0048018;GO:0045545;GO:0007155;GO:0007267;GO:0008285;GO:0001818;GO:2000134;GO:1901215;GO:0050868;GO:0042130;GO:0050918;GO:0030335;GO:0070374;GO:0031954;GO:0001934;GO:0045765;GO:0034103;GO:0007165;, C:early endosome membrane; C:integral component of membrane; C:integral component of plasma membrane; C:melanosome membrane; C:plasma membrane;, F:chemoattractant activity; F:heparin binding; F:integrin binding; F:receptor ligand activity; F:syndecan binding;, P:cell adhesion; P:cell-cell signaling; P:negative regulation of cell population proliferation; P:negative regulation of cytokine production; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of neuron death; P:negative regulation of T cell activation; P:negative regulation of T cell proliferation; P:positive chemotaxis; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein autophosphorylation; P:positive regulation of protein phosphorylation; P:regulation of angiogenesis; P:regulation of tissue remodeling; P:signal transduction;|Q14956 A4D155 Q6UVX1 Q8N1A1,Transmembrane glycoprotein NMB,Hematopoietic growth factor inducible neurokinin-1 type {ECO:0000303|PubMed:12609765};, PF00801;, GO:0031901;GO:0016021;GO:0005887;GO:0033162;GO:0005886;GO:0042056;GO:0008201;GO:0005178;GO:0048018;GO:0045545;GO:0007155;GO:0007267;GO:0008285;GO:0001818;GO:2000134;GO:1901215;GO:0050868;GO:0042130;GO:0050918;GO:0030335;GO:0070374;GO:0031954;GO:0001934;GO:0045765;GO:0034103;GO:0007165;, C:early endosome membrane; C:integral component of membrane; C:integral component of plasma membrane; C:melanosome membrane; C:plasma membrane;, F:chemoattractant activity; F:heparin binding; F:integrin binding; F:receptor ligand activity; F:syndecan binding;, P:cell adhesion; P:cell-cell signaling; P:negative regulation of cell population proliferation; P:negative regulation of cytokine production; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of neuron death; P:negative regulation of T cell activation; P:negative regulation of T cell proliferation; P:positive chemotaxis; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein autophosphorylation; P:positive regulation of protein phosphorylation; P:regulation of angiogenesis; P:regulation of tissue remodeling; P:signal transduction;|Q14956 A4D155 Q6UVX1 Q8N1A1,Transmembrane glycoprotein NMB,Hematopoietic growth factor inducible neurokinin-1 type {ECO:0000303|PubMed:12609765};, PF00801;, GO:0031901;GO:0016021;GO:0005887;GO:0033162;GO:0005886;GO:0042056;GO:0008201;GO:0005178;GO:0048018;GO:0045545;GO:0007155;GO:0007267;GO:0008285;GO:0001818;GO:2000134;GO:1901215;GO:0050868;GO:0042130;GO:0050918;GO:0030335;GO:0070374;GO:0031954;GO:0001934;GO:0045765;GO:0034103;GO:0007165;, C:early endosome membrane; C:integral component of membrane; C:integral component of plasma membrane; C:melanosome membrane; C:plasma membrane;, F:chemoattractant activity; F:heparin binding; F:integrin binding; F:receptor ligand activity; F:syndecan binding;, P:cell adhesion; P:cell-cell signaling; P:negative regulation of cell population proliferation; P:negative regulation of cytokine production; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of neuron death; P:negative regulation of T cell activation; P:negative regulation of T cell proliferation; P:positive chemotaxis; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein autophosphorylation; P:positive regulation of protein phosphorylation; P:regulation of angiogenesis; P:regulation of tissue remodeling; P:signal transduction; scaffold43 indexed_genome mRNA 19454796 19491682 . + . ID=transcript_8708;Q96EH3 A4D154,Mitochondrial assembly of ribosomal large subunit protein 1,, , GO:0005829;GO:0005759;GO:0005739;GO:0043023;GO:0070130;GO:0090071;GO:0017148;GO:0042273;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ribosomal large subunit binding;, P:negative regulation of mitochondrial translation; P:negative regulation of ribosome biogenesis; P:negative regulation of translation; P:ribosomal large subunit biogenesis;|Q96EH3 A4D154,Mitochondrial assembly of ribosomal large subunit protein 1,, , GO:0005829;GO:0005759;GO:0005739;GO:0043023;GO:0070130;GO:0090071;GO:0017148;GO:0042273;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ribosomal large subunit binding;, P:negative regulation of mitochondrial translation; P:negative regulation of ribosome biogenesis; P:negative regulation of translation; P:ribosomal large subunit biogenesis;|Q96EH3 A4D154,Mitochondrial assembly of ribosomal large subunit protein 1,, , GO:0005829;GO:0005759;GO:0005739;GO:0043023;GO:0070130;GO:0090071;GO:0017148;GO:0042273;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ribosomal large subunit binding;, P:negative regulation of mitochondrial translation; P:negative regulation of ribosome biogenesis; P:negative regulation of translation; P:ribosomal large subunit biogenesis;|Q96EH3 A4D154,Mitochondrial assembly of ribosomal large subunit protein 1,, , GO:0005829;GO:0005759;GO:0005739;GO:0043023;GO:0070130;GO:0090071;GO:0017148;GO:0042273;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ribosomal large subunit binding;, P:negative regulation of mitochondrial translation; P:negative regulation of ribosome biogenesis; P:negative regulation of translation; P:ribosomal large subunit biogenesis; scaffold43 indexed_genome mRNA 19493438 19500665 . + . ID=transcript_8709;O00425 A0A4Z5 Q63HM0 Q6MZZ2 Q86VB1,Insulin-like growth factor 2 mRNA-binding protein 3,IGF-II mRNA-binding protein 3;KH domain-containing protein overexpressed in cancer;VICKZ family member 3;, PF00013;PF00076;, GO:0005737;GO:0005829;GO:0005634;GO:0003730;GO:0048027;GO:0003729;GO:0003723;GO:0045182;GO:0009653;GO:0051028;GO:0017148;GO:0007399;GO:0001817;GO:0010468;GO:0043488;GO:0051252;GO:0006412;, C:cytoplasm; C:cytosol; C:nucleus;, F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:mRNA binding; F:RNA binding; F:translation regulator activity;, P:anatomical structure morphogenesis; P:mRNA transport; P:negative regulation of translation; P:nervous system development; P:regulation of cytokine production; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of RNA metabolic process; P:translation; scaffold43 indexed_genome mRNA 19663622 19673381 . - . ID=transcript_8710;Q13595 B4DQI6 B4DUA9 E9PD75,Transformer-2 protein homolog alpha,Transformer-2 protein homolog A;, PF00076;, GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0000398;GO:0048026;, C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:positive regulation of mRNA splicing, via spliceosome;|Q13595 B4DQI6 B4DUA9 E9PD75,Transformer-2 protein homolog alpha,Transformer-2 protein homolog A;, PF00076;, GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0000398;GO:0048026;, C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:positive regulation of mRNA splicing, via spliceosome; scaffold43 indexed_genome mRNA 19763831 19805303 . + . ID=transcript_8711;Q96EE4 A8K1J6 Q6UWP1 Q75MQ6,Coiled-coil domain-containing protein 126,, PF15027;, GO:0005576;GO:0016020;, C:extracellular region; C:membrane; scaffold44 indexed_genome mRNA 112367 191666 . - . ID=transcript_8712;Q149N8 Q149N9 Q5VV79 Q68DS5 Q7Z5J5 Q8IVE8 Q8IWQ9 Q8N1S8 Q8NBR7,E3 ubiquitin-protein ligase SHPRH,RING-type E3 ubiquitin transferase SHPRH {ECO:0000305};SNF2, histone-linker, PHD and RING finger domain-containing helicase;, PF00271;PF00538;PF00176;, GO:0005654;GO:0000786;GO:0005524;GO:0003677;GO:0004386;GO:0046872;GO:0070615;GO:0061630;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0006334;GO:0000209;GO:0016567;, C:nucleoplasm; C:nucleosome;, F:ATP binding; F:DNA binding; F:helicase activity; F:metal ion binding; F:nucleosome-dependent ATPase activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:nucleosome assembly; P:protein polyubiquitination; P:protein ubiquitination;|Q149N8 Q149N9 Q5VV79 Q68DS5 Q7Z5J5 Q8IVE8 Q8IWQ9 Q8N1S8 Q8NBR7,E3 ubiquitin-protein ligase SHPRH,RING-type E3 ubiquitin transferase SHPRH {ECO:0000305};SNF2, histone-linker, PHD and RING finger domain-containing helicase;, PF00271;PF00538;PF00176;, GO:0005654;GO:0000786;GO:0005524;GO:0003677;GO:0004386;GO:0046872;GO:0070615;GO:0061630;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0006334;GO:0000209;GO:0016567;, C:nucleoplasm; C:nucleosome;, F:ATP binding; F:DNA binding; F:helicase activity; F:metal ion binding; F:nucleosome-dependent ATPase activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:nucleosome assembly; P:protein polyubiquitination; P:protein ubiquitination; scaffold44 indexed_genome mRNA 235866 572351 . + . ID=transcript_8713;Q9UGS9 Q9UGT0,Metabotropic glutamate receptor 1,, PF00003;PF01094;PF10606;PF07562;, GO:0030425;GO:0038037;GO:0038038;GO:0098978;GO:0005887;GO:0005634;GO:0005886;GO:0098839;GO:0098685;GO:0001640;GO:0098872;GO:0004930;GO:0099530;GO:0008066;GO:0042802;GO:0099583;GO:0000187;GO:0000186;GO:0071257;GO:0007268;GO:0007216;GO:0007186;GO:0098712;GO:0007626;GO:0051482;GO:0051930;GO:0051966;GO:0019233;, C:dendrite; C:G protein-coupled receptor dimeric complex; C:G protein-coupled receptor homodimeric complex; C:glutamatergic synapse; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:postsynaptic density membrane; C:Schaffer collateral - CA1 synapse;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:G protein-coupled receptor activity; F:G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential; F:glutamate receptor activity; F:identical protein binding; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration;, P:activation of MAPK activity; P:activation of MAPKK activity; P:cellular response to electrical stimulus; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:L-glutamate import across plasma membrane; P:locomotory behavior; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:regulation of sensory perception of pain; P:regulation of synaptic transmission, glutamatergic; P:sensory perception of pain; scaffold44 indexed_genome mRNA 602950 637020 . + . ID=transcript_8714;Q9UGS9 Q9UGT0,Metabotropic glutamate receptor 1,, PF00003;PF01094;PF10606;PF07562;, GO:0030425;GO:0038037;GO:0038038;GO:0098978;GO:0005887;GO:0005634;GO:0005886;GO:0098839;GO:0098685;GO:0001640;GO:0098872;GO:0004930;GO:0099530;GO:0008066;GO:0042802;GO:0099583;GO:0000187;GO:0000186;GO:0071257;GO:0007268;GO:0007216;GO:0007186;GO:0098712;GO:0007626;GO:0051482;GO:0051930;GO:0051966;GO:0019233;, C:dendrite; C:G protein-coupled receptor dimeric complex; C:G protein-coupled receptor homodimeric complex; C:glutamatergic synapse; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:postsynaptic density membrane; C:Schaffer collateral - CA1 synapse;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:G protein-coupled receptor activity; F:G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential; F:glutamate receptor activity; F:identical protein binding; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration;, P:activation of MAPK activity; P:activation of MAPKK activity; P:cellular response to electrical stimulus; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:L-glutamate import across plasma membrane; P:locomotory behavior; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:regulation of sensory perception of pain; P:regulation of synaptic transmission, glutamatergic; P:sensory perception of pain;|Q9UGS9 Q9UGT0,Metabotropic glutamate receptor 1,, PF00003;PF01094;PF10606;PF07562;, GO:0030425;GO:0038037;GO:0038038;GO:0098978;GO:0005887;GO:0005634;GO:0005886;GO:0098839;GO:0098685;GO:0001640;GO:0098872;GO:0004930;GO:0099530;GO:0008066;GO:0042802;GO:0099583;GO:0000187;GO:0000186;GO:0071257;GO:0007268;GO:0007216;GO:0007186;GO:0098712;GO:0007626;GO:0051482;GO:0051930;GO:0051966;GO:0019233;, C:dendrite; C:G protein-coupled receptor dimeric complex; C:G protein-coupled receptor homodimeric complex; C:glutamatergic synapse; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:postsynaptic density membrane; C:Schaffer collateral - CA1 synapse;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:G protein-coupled receptor activity; F:G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential; F:glutamate receptor activity; F:identical protein binding; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration;, P:activation of MAPK activity; P:activation of MAPKK activity; P:cellular response to electrical stimulus; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:L-glutamate import across plasma membrane; P:locomotory behavior; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:regulation of sensory perception of pain; P:regulation of synaptic transmission, glutamatergic; P:sensory perception of pain;|Q9UGS9 Q9UGT0,Metabotropic glutamate receptor 1,, PF00003;PF01094;PF10606;PF07562;, GO:0030425;GO:0038037;GO:0038038;GO:0098978;GO:0005887;GO:0005634;GO:0005886;GO:0098839;GO:0098685;GO:0001640;GO:0098872;GO:0004930;GO:0099530;GO:0008066;GO:0042802;GO:0099583;GO:0000187;GO:0000186;GO:0071257;GO:0007268;GO:0007216;GO:0007186;GO:0098712;GO:0007626;GO:0051482;GO:0051930;GO:0051966;GO:0019233;, C:dendrite; C:G protein-coupled receptor dimeric complex; C:G protein-coupled receptor homodimeric complex; C:glutamatergic synapse; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:postsynaptic density membrane; C:Schaffer collateral - CA1 synapse;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:G protein-coupled receptor activity; F:G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential; F:glutamate receptor activity; F:identical protein binding; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration;, P:activation of MAPK activity; P:activation of MAPKK activity; P:cellular response to electrical stimulus; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:L-glutamate import across plasma membrane; P:locomotory behavior; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:regulation of sensory perception of pain; P:regulation of synaptic transmission, glutamatergic; P:sensory perception of pain; scaffold44 indexed_genome mRNA 744717 778873 . + . ID=transcript_8715;Q13637,Ras-related protein Rab-32,, PF00071;, GO:0005829;GO:0005769;GO:0012505;GO:0005783;GO:0042470;GO:0033162;GO:0016020;GO:0044233;GO:0005741;GO:0005739;GO:0045335;GO:0030670;GO:0005802;GO:0035650;GO:0035651;GO:0036461;GO:0005525;GO:0030742;GO:0003924;GO:0019882;GO:0035646;GO:0006886;GO:1903232;GO:0032438;GO:0007005;GO:0090382;GO:0072657;GO:0016192;, C:cytosol; C:early endosome; C:endomembrane system; C:endoplasmic reticulum; C:melanosome; C:melanosome membrane; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrion; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:trans-Golgi network;, F:AP-1 adaptor complex binding; F:AP-3 adaptor complex binding; F:BLOC-2 complex binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity;, P:antigen processing and presentation; P:endosome to melanosome transport; P:intracellular protein transport; P:melanosome assembly; P:melanosome organization; P:mitochondrion organization; P:phagosome maturation; P:protein localization to membrane; P:vesicle-mediated transport; scaffold44 indexed_genome mRNA 865323 900481 . + . ID=transcript_8716;Q8N7X0 Q5T402 Q5T904 Q5T905,Androglobin,Calpain-7-like protein;, PF00648;, GO:0004198;GO:0020037;GO:0019825;, , F:calcium-dependent cysteine-type endopeptidase activity; F:heme binding; F:oxygen binding; scaffold44 indexed_genome mRNA 903902 940797 . - . ID=transcript_8717;Q8N7X0 Q5T402 Q5T904 Q5T905,Androglobin,Calpain-7-like protein;, PF00648;, GO:0004198;GO:0020037;GO:0019825;, , F:calcium-dependent cysteine-type endopeptidase activity; F:heme binding; F:oxygen binding; scaffold44 indexed_genome mRNA 948137 994500 . + . ID=transcript_8718;Q8N7X0 Q5T402 Q5T904 Q5T905,Androglobin,Calpain-7-like protein;, PF00648;, GO:0004198;GO:0020037;GO:0019825;, , F:calcium-dependent cysteine-type endopeptidase activity; F:heme binding; F:oxygen binding; scaffold44 indexed_genome mRNA 1382116 1502898 . + . ID=transcript_8719;Q5T5C0 Q14DF3 Q5T5C1 Q5T5C2 Q8NBG8 Q96NG9,Syntaxin-binding protein 5,Lethal(2) giant larvae protein homolog 3;Tomosyn-1;, PF08596;PF08366;PF00400;, GO:0005892;GO:0005737;GO:0005829;GO:0098674;GO:0098888;GO:0098686;GO:0031594;GO:0005886;GO:0099523;GO:0098685;GO:0031201;GO:0008021;GO:0005096;GO:0045159;GO:0019905;GO:0017075;GO:0006887;GO:0045921;GO:0015031;GO:0017157;GO:0050708;GO:2000300;GO:0010807;GO:0099504;, C:acetylcholine-gated channel complex; C:cytoplasm; C:cytosol; C:extrinsic component of neuronal dense core vesicle membrane; C:extrinsic component of presynaptic membrane; C:hippocampal mossy fiber to CA3 synapse; C:neuromuscular junction; C:plasma membrane; C:presynaptic cytosol; C:Schaffer collateral - CA1 synapse; C:SNARE complex; C:synaptic vesicle;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding; F:syntaxin-1 binding;, P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis; P:regulation of synaptic vesicle priming; P:synaptic vesicle cycle;|Q9H1Q7 Q5JUA5 Q5JUA6 Q6PK19 Q86WF5 Q96CG7 Q9H1Q6 Q9H6D1,PC-esterase domain-containing protein 1A,Protein FAM113A;Sarcoma antigen NY-SAR-23;, PF13839; scaffold44 indexed_genome mRNA 1513596 1539526 . + . ID=transcript_8720;Q5T5C0 Q14DF3 Q5T5C1 Q5T5C2 Q8NBG8 Q96NG9,Syntaxin-binding protein 5,Lethal(2) giant larvae protein homolog 3;Tomosyn-1;, PF08596;PF08366;PF00400;, GO:0005892;GO:0005737;GO:0005829;GO:0098674;GO:0098888;GO:0098686;GO:0031594;GO:0005886;GO:0099523;GO:0098685;GO:0031201;GO:0008021;GO:0005096;GO:0045159;GO:0019905;GO:0017075;GO:0006887;GO:0045921;GO:0015031;GO:0017157;GO:0050708;GO:2000300;GO:0010807;GO:0099504;, C:acetylcholine-gated channel complex; C:cytoplasm; C:cytosol; C:extrinsic component of neuronal dense core vesicle membrane; C:extrinsic component of presynaptic membrane; C:hippocampal mossy fiber to CA3 synapse; C:neuromuscular junction; C:plasma membrane; C:presynaptic cytosol; C:Schaffer collateral - CA1 synapse; C:SNARE complex; C:synaptic vesicle;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding; F:syntaxin-1 binding;, P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis; P:regulation of synaptic vesicle priming; P:synaptic vesicle cycle;|Q5T5C0 Q14DF3 Q5T5C1 Q5T5C2 Q8NBG8 Q96NG9,Syntaxin-binding protein 5,Lethal(2) giant larvae protein homolog 3;Tomosyn-1;, PF08596;PF08366;PF00400;, GO:0005892;GO:0005737;GO:0005829;GO:0098674;GO:0098888;GO:0098686;GO:0031594;GO:0005886;GO:0099523;GO:0098685;GO:0031201;GO:0008021;GO:0005096;GO:0045159;GO:0019905;GO:0017075;GO:0006887;GO:0045921;GO:0015031;GO:0017157;GO:0050708;GO:2000300;GO:0010807;GO:0099504;, C:acetylcholine-gated channel complex; C:cytoplasm; C:cytosol; C:extrinsic component of neuronal dense core vesicle membrane; C:extrinsic component of presynaptic membrane; C:hippocampal mossy fiber to CA3 synapse; C:neuromuscular junction; C:plasma membrane; C:presynaptic cytosol; C:Schaffer collateral - CA1 synapse; C:SNARE complex; C:synaptic vesicle;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding; F:syntaxin-1 binding;, P:exocytosis; P:positive regulation of exocytosis; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis; P:regulation of synaptic vesicle priming; P:synaptic vesicle cycle; scaffold44 indexed_genome mRNA 1643563 1644810 . - . ID=transcript_8721;Q5TGI4,Sterile alpha motif domain-containing protein 5,, PF00536;, GO:0005737;, C:cytoplasm; scaffold44 indexed_genome mRNA 2391176 2577580 . + . ID=transcript_8722;O94885 Q5TGN5 Q8TAI0 Q9H7R7,SAM and SH3 domain-containing protein 1,Proline-glutamate repeat-containing protein;, PF00536;PF07647;PF07653;PF12485;, GO:0005737;GO:0032991;GO:0001965;GO:0031435;GO:0060090;GO:0008022;GO:0019901;GO:0045766;GO:0010595;GO:0043507;GO:0031666;GO:1901224;GO:1900745;GO:0000209;GO:0010632;GO:1902498;GO:1900044;, C:cytoplasm; C:protein-containing complex;, F:G-protein alpha-subunit binding; F:mitogen-activated protein kinase kinase kinase binding; F:molecular adaptor activity; F:protein C-terminus binding; F:protein kinase binding;, P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of JUN kinase activity; P:positive regulation of lipopolysaccharide-mediated signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:protein polyubiquitination; P:regulation of epithelial cell migration; P:regulation of protein autoubiquitination; P:regulation of protein K63-linked ubiquitination;|O94885 Q5TGN5 Q8TAI0 Q9H7R7,SAM and SH3 domain-containing protein 1,Proline-glutamate repeat-containing protein;, PF00536;PF07647;PF07653;PF12485;, GO:0005737;GO:0032991;GO:0001965;GO:0031435;GO:0060090;GO:0008022;GO:0019901;GO:0045766;GO:0010595;GO:0043507;GO:0031666;GO:1901224;GO:1900745;GO:0000209;GO:0010632;GO:1902498;GO:1900044;, C:cytoplasm; C:protein-containing complex;, F:G-protein alpha-subunit binding; F:mitogen-activated protein kinase kinase kinase binding; F:molecular adaptor activity; F:protein C-terminus binding; F:protein kinase binding;, P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of JUN kinase activity; P:positive regulation of lipopolysaccharide-mediated signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:protein polyubiquitination; P:regulation of epithelial cell migration; P:regulation of protein autoubiquitination; P:regulation of protein K63-linked ubiquitination;|O94885 Q5TGN5 Q8TAI0 Q9H7R7,SAM and SH3 domain-containing protein 1,Proline-glutamate repeat-containing protein;, PF00536;PF07647;PF07653;PF12485;, GO:0005737;GO:0032991;GO:0001965;GO:0031435;GO:0060090;GO:0008022;GO:0019901;GO:0045766;GO:0010595;GO:0043507;GO:0031666;GO:1901224;GO:1900745;GO:0000209;GO:0010632;GO:1902498;GO:1900044;, C:cytoplasm; C:protein-containing complex;, F:G-protein alpha-subunit binding; F:mitogen-activated protein kinase kinase kinase binding; F:molecular adaptor activity; F:protein C-terminus binding; F:protein kinase binding;, P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of JUN kinase activity; P:positive regulation of lipopolysaccharide-mediated signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:protein polyubiquitination; P:regulation of epithelial cell migration; P:regulation of protein autoubiquitination; P:regulation of protein K63-linked ubiquitination; scaffold44 indexed_genome mRNA 2700865 2701790 . + . ID=transcript_8723;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold44 indexed_genome mRNA 2725033 3028136 . + . ID=transcript_8724;Q9Y2C2 B2RCX6,Uronyl 2-sulfotransferase,, PF03567;, GO:0000139;GO:0016021;GO:0008146;GO:0030208;GO:0030010;GO:0006477;GO:0050770;, C:Golgi membrane; C:integral component of membrane;, F:sulfotransferase activity;, P:dermatan sulfate biosynthetic process; P:establishment of cell polarity; P:protein sulfation; P:regulation of axonogenesis; scaffold44 indexed_genome mRNA 3263659 3343486 . + . ID=transcript_8725;Q9NYJ8 B2RCC4 E1P5A0 O94838 Q6I9W8 Q76N06 Q9UFP7,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mitogen-activated protein kinase kinase kinase 7-interacting protein 2;TAK1-binding protein 2;TGF-beta-activated kinase 1-binding protein 2;, PF02845;, GO:0005829;GO:0010008;GO:0005654;GO:0005886;GO:0070530;GO:0046872;GO:0043130;GO:0000187;GO:0002753;GO:0038095;GO:0007507;GO:0007249;GO:0070498;GO:0007254;GO:0002755;GO:0010507;GO:0070423;GO:0043123;GO:0051092;GO:0045860;GO:0032496;GO:0002223;GO:0050852;, C:cytosol; C:endosome membrane; C:nucleoplasm; C:plasma membrane;, F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:ubiquitin binding;, P:activation of MAPK activity; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:heart development; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of autophagy; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase activity; P:response to lipopolysaccharide; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; scaffold44 indexed_genome mRNA 3372456 3411491 . - . ID=transcript_8726;A2A288 A1L178 B2RXF4 B7WNU7 B9ZZP9 B9ZZQ0 Q6ZRW2,Probable ribonuclease ZC3H12D,MCP-induced protein 4 {ECO:0000303|PubMed:18178554};Transformed follicular lymphoma;Zinc finger CCCH domain-containing protein 12D;p34 {ECO:0000303|PubMed:17210687};, PF11977;PF18039;, GO:0005737;GO:0036464;GO:0005654;GO:0005634;GO:0000932;GO:0004521;GO:0046872;GO:0003729;GO:0061158;GO:0006402;GO:0030308;GO:2000134;GO:0090502;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:nucleoplasm; C:nucleus; C:P-body;, F:endoribonuclease activity; F:metal ion binding; F:mRNA binding;, P:3'-UTR-mediated mRNA destabilization; P:mRNA catabolic process; P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold44 indexed_genome mRNA 3438758 3812655 . - . ID=transcript_8727;Q8WUA2 B2RD34 Q7Z3Q5,Peptidyl-prolyl cis-trans isomerase-like 4,Cyclophilin-like protein PPIL4;Rotamase PPIL4;, PF00160;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0003755;GO:0003723;GO:1901407;, C:cytosol; C:nucleoplasm; C:nucleus;, F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:regulation of phosphorylation of RNA polymerase II C-terminal domain;|Q8WUA2 B2RD34 Q7Z3Q5,Peptidyl-prolyl cis-trans isomerase-like 4,Cyclophilin-like protein PPIL4;Rotamase PPIL4;, PF00160;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0003755;GO:0003723;GO:1901407;, C:cytosol; C:nucleoplasm; C:nucleus;, F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:regulation of phosphorylation of RNA polymerase II C-terminal domain;|Q8WUA2 B2RD34 Q7Z3Q5,Peptidyl-prolyl cis-trans isomerase-like 4,Cyclophilin-like protein PPIL4;Rotamase PPIL4;, PF00160;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0003755;GO:0003723;GO:1901407;, C:cytosol; C:nucleoplasm; C:nucleus;, F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:regulation of phosphorylation of RNA polymerase II C-terminal domain;|Q8WUA2 B2RD34 Q7Z3Q5,Peptidyl-prolyl cis-trans isomerase-like 4,Cyclophilin-like protein PPIL4;Rotamase PPIL4;, PF00160;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0003755;GO:0003723;GO:1901407;, C:cytosol; C:nucleoplasm; C:nucleus;, F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:regulation of phosphorylation of RNA polymerase II C-terminal domain;|Q8WUA2 B2RD34 Q7Z3Q5,Peptidyl-prolyl cis-trans isomerase-like 4,Cyclophilin-like protein PPIL4;Rotamase PPIL4;, PF00160;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0003755;GO:0003723;GO:1901407;, C:cytosol; C:nucleoplasm; C:nucleus;, F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:regulation of phosphorylation of RNA polymerase II C-terminal domain;|Q8WUA2 B2RD34 Q7Z3Q5,Peptidyl-prolyl cis-trans isomerase-like 4,Cyclophilin-like protein PPIL4;Rotamase PPIL4;, PF00160;PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0003755;GO:0003723;GO:1901407;, C:cytosol; C:nucleoplasm; C:nucleus;, F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:regulation of phosphorylation of RNA polymerase II C-terminal domain;|Q9NU53 B2RDY7 E1P5A2,Glycoprotein integral membrane protein 1,, , GO:0016021;, C:integral component of membrane;|Q9NU53 B2RDY7 E1P5A2,Glycoprotein integral membrane protein 1,, , GO:0016021;, C:integral component of membrane;|Q9NU53 B2RDY7 E1P5A2,Glycoprotein integral membrane protein 1,, , GO:0016021;, C:integral component of membrane;|Q9NU53 B2RDY7 E1P5A2,Glycoprotein integral membrane protein 1,, , GO:0016021;, C:integral component of membrane;|O75449 E1P5A3 Q5TFA8 Q5TFA9 Q86VN2 Q9NU52,Katanin p60 ATPase-containing subunit A1 {ECO:0000255|HAMAP-Rule:MF_03023},p60 katanin {ECO:0000255|HAMAP-Rule:MF_03023};, PF00004;PF17862;PF09336;, GO:0005813;GO:0005737;GO:0005874;GO:0015630;GO:0030496;GO:0097431;GO:0005634;GO:0005819;GO:0000922;GO:0005524;GO:0016887;GO:0016853;GO:0008017;GO:0008568;GO:0046982;GO:0007049;GO:0051301;GO:0031122;GO:0051013;, C:centrosome; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle pole; C:nucleus; C:spindle; C:spindle pole;, F:ATP binding; F:ATPase activity; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein heterodimerization activity;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; P:microtubule severing;|O75449 E1P5A3 Q5TFA8 Q5TFA9 Q86VN2 Q9NU52,Katanin p60 ATPase-containing subunit A1 {ECO:0000255|HAMAP-Rule:MF_03023},p60 katanin {ECO:0000255|HAMAP-Rule:MF_03023};, PF00004;PF17862;PF09336;, GO:0005813;GO:0005737;GO:0005874;GO:0015630;GO:0030496;GO:0097431;GO:0005634;GO:0005819;GO:0000922;GO:0005524;GO:0016887;GO:0016853;GO:0008017;GO:0008568;GO:0046982;GO:0007049;GO:0051301;GO:0031122;GO:0051013;, C:centrosome; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle pole; C:nucleus; C:spindle; C:spindle pole;, F:ATP binding; F:ATPase activity; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein heterodimerization activity;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; P:microtubule severing;|O75449 E1P5A3 Q5TFA8 Q5TFA9 Q86VN2 Q9NU52,Katanin p60 ATPase-containing subunit A1 {ECO:0000255|HAMAP-Rule:MF_03023},p60 katanin {ECO:0000255|HAMAP-Rule:MF_03023};, PF00004;PF17862;PF09336;, GO:0005813;GO:0005737;GO:0005874;GO:0015630;GO:0030496;GO:0097431;GO:0005634;GO:0005819;GO:0000922;GO:0005524;GO:0016887;GO:0016853;GO:0008017;GO:0008568;GO:0046982;GO:0007049;GO:0051301;GO:0031122;GO:0051013;, C:centrosome; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle pole; C:nucleus; C:spindle; C:spindle pole;, F:ATP binding; F:ATPase activity; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein heterodimerization activity;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; P:microtubule severing;|O75449 E1P5A3 Q5TFA8 Q5TFA9 Q86VN2 Q9NU52,Katanin p60 ATPase-containing subunit A1 {ECO:0000255|HAMAP-Rule:MF_03023},p60 katanin {ECO:0000255|HAMAP-Rule:MF_03023};, PF00004;PF17862;PF09336;, GO:0005813;GO:0005737;GO:0005874;GO:0015630;GO:0030496;GO:0097431;GO:0005634;GO:0005819;GO:0000922;GO:0005524;GO:0016887;GO:0016853;GO:0008017;GO:0008568;GO:0046982;GO:0007049;GO:0051301;GO:0031122;GO:0051013;, C:centrosome; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle pole; C:nucleus; C:spindle; C:spindle pole;, F:ATP binding; F:ATPase activity; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein heterodimerization activity;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; P:microtubule severing;|O75449 E1P5A3 Q5TFA8 Q5TFA9 Q86VN2 Q9NU52,Katanin p60 ATPase-containing subunit A1 {ECO:0000255|HAMAP-Rule:MF_03023},p60 katanin {ECO:0000255|HAMAP-Rule:MF_03023};, PF00004;PF17862;PF09336;, GO:0005813;GO:0005737;GO:0005874;GO:0015630;GO:0030496;GO:0097431;GO:0005634;GO:0005819;GO:0000922;GO:0005524;GO:0016887;GO:0016853;GO:0008017;GO:0008568;GO:0046982;GO:0007049;GO:0051301;GO:0031122;GO:0051013;, C:centrosome; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle pole; C:nucleus; C:spindle; C:spindle pole;, F:ATP binding; F:ATPase activity; F:isomerase activity; F:microtubule binding; F:microtubule-severing ATPase activity; F:protein heterodimerization activity;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; P:microtubule severing;|O95835 Q6PKD0,Serine/threonine-protein kinase LATS1,Large tumor suppressor homolog 1;WARTS protein kinase;, PF00069;PF00627;, GO:0005829;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005524;GO:0030331;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0034613;GO:0051220;GO:0000082;GO:0000086;GO:0035329;GO:0009755;GO:0001827;GO:0001828;GO:0035556;GO:0030216;GO:0060644;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0033138;GO:0006468;GO:0030833;GO:0033146;GO:0046620;GO:0043254;GO:0017015;GO:2000058;GO:0000819;, C:cytosol; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole;, F:ATP binding; F:estrogen receptor binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular protein localization; P:cytoplasmic sequestering of protein; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:inner cell mass cell fate commitment; P:inner cell mass cellular morphogenesis; P:intracellular signal transduction; P:keratinocyte differentiation; P:mammary gland epithelial cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of actin filament polymerization; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of organ growth; P:regulation of protein-containing complex assembly; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ubiquitin-dependent protein catabolic process; P:sister chromatid segregation;|O95835 Q6PKD0,Serine/threonine-protein kinase LATS1,Large tumor suppressor homolog 1;WARTS protein kinase;, PF00069;PF00627;, GO:0005829;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005524;GO:0030331;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0034613;GO:0051220;GO:0000082;GO:0000086;GO:0035329;GO:0009755;GO:0001827;GO:0001828;GO:0035556;GO:0030216;GO:0060644;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0033138;GO:0006468;GO:0030833;GO:0033146;GO:0046620;GO:0043254;GO:0017015;GO:2000058;GO:0000819;, C:cytosol; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole;, F:ATP binding; F:estrogen receptor binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular protein localization; P:cytoplasmic sequestering of protein; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:inner cell mass cell fate commitment; P:inner cell mass cellular morphogenesis; P:intracellular signal transduction; P:keratinocyte differentiation; P:mammary gland epithelial cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of actin filament polymerization; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of organ growth; P:regulation of protein-containing complex assembly; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ubiquitin-dependent protein catabolic process; P:sister chromatid segregation;|O95835 Q6PKD0,Serine/threonine-protein kinase LATS1,Large tumor suppressor homolog 1;WARTS protein kinase;, PF00069;PF00627;, GO:0005829;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005524;GO:0030331;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0034613;GO:0051220;GO:0000082;GO:0000086;GO:0035329;GO:0009755;GO:0001827;GO:0001828;GO:0035556;GO:0030216;GO:0060644;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0033138;GO:0006468;GO:0030833;GO:0033146;GO:0046620;GO:0043254;GO:0017015;GO:2000058;GO:0000819;, C:cytosol; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole;, F:ATP binding; F:estrogen receptor binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular protein localization; P:cytoplasmic sequestering of protein; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:inner cell mass cell fate commitment; P:inner cell mass cellular morphogenesis; P:intracellular signal transduction; P:keratinocyte differentiation; P:mammary gland epithelial cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of actin filament polymerization; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of organ growth; P:regulation of protein-containing complex assembly; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ubiquitin-dependent protein catabolic process; P:sister chromatid segregation;|O95835 Q6PKD0,Serine/threonine-protein kinase LATS1,Large tumor suppressor homolog 1;WARTS protein kinase;, PF00069;PF00627;, GO:0005829;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005524;GO:0030331;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0034613;GO:0051220;GO:0000082;GO:0000086;GO:0035329;GO:0009755;GO:0001827;GO:0001828;GO:0035556;GO:0030216;GO:0060644;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0033138;GO:0006468;GO:0030833;GO:0033146;GO:0046620;GO:0043254;GO:0017015;GO:2000058;GO:0000819;, C:cytosol; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole;, F:ATP binding; F:estrogen receptor binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular protein localization; P:cytoplasmic sequestering of protein; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:inner cell mass cell fate commitment; P:inner cell mass cellular morphogenesis; P:intracellular signal transduction; P:keratinocyte differentiation; P:mammary gland epithelial cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of actin filament polymerization; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of organ growth; P:regulation of protein-containing complex assembly; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ubiquitin-dependent protein catabolic process; P:sister chromatid segregation;|O95835 Q6PKD0,Serine/threonine-protein kinase LATS1,Large tumor suppressor homolog 1;WARTS protein kinase;, PF00069;PF00627;, GO:0005829;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005524;GO:0030331;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0034613;GO:0051220;GO:0000082;GO:0000086;GO:0035329;GO:0009755;GO:0001827;GO:0001828;GO:0035556;GO:0030216;GO:0060644;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0033138;GO:0006468;GO:0030833;GO:0033146;GO:0046620;GO:0043254;GO:0017015;GO:2000058;GO:0000819;, C:cytosol; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole;, F:ATP binding; F:estrogen receptor binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular protein localization; P:cytoplasmic sequestering of protein; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:inner cell mass cell fate commitment; P:inner cell mass cellular morphogenesis; P:intracellular signal transduction; P:keratinocyte differentiation; P:mammary gland epithelial cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of actin filament polymerization; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of organ growth; P:regulation of protein-containing complex assembly; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ubiquitin-dependent protein catabolic process; P:sister chromatid segregation;|O95835 Q6PKD0,Serine/threonine-protein kinase LATS1,Large tumor suppressor homolog 1;WARTS protein kinase;, PF00069;PF00627;, GO:0005829;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005524;GO:0030331;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0034613;GO:0051220;GO:0000082;GO:0000086;GO:0035329;GO:0009755;GO:0001827;GO:0001828;GO:0035556;GO:0030216;GO:0060644;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0033138;GO:0006468;GO:0030833;GO:0033146;GO:0046620;GO:0043254;GO:0017015;GO:2000058;GO:0000819;, C:cytosol; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole;, F:ATP binding; F:estrogen receptor binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular protein localization; P:cytoplasmic sequestering of protein; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:inner cell mass cell fate commitment; P:inner cell mass cellular morphogenesis; P:intracellular signal transduction; P:keratinocyte differentiation; P:mammary gland epithelial cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of actin filament polymerization; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of organ growth; P:regulation of protein-containing complex assembly; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ubiquitin-dependent protein catabolic process; P:sister chromatid segregation;|O95835 Q6PKD0,Serine/threonine-protein kinase LATS1,Large tumor suppressor homolog 1;WARTS protein kinase;, PF00069;PF00627;, GO:0005829;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005524;GO:0030331;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0034613;GO:0051220;GO:0000082;GO:0000086;GO:0035329;GO:0009755;GO:0001827;GO:0001828;GO:0035556;GO:0030216;GO:0060644;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0033138;GO:0006468;GO:0030833;GO:0033146;GO:0046620;GO:0043254;GO:0017015;GO:2000058;GO:0000819;, C:cytosol; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole;, F:ATP binding; F:estrogen receptor binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular protein localization; P:cytoplasmic sequestering of protein; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:inner cell mass cell fate commitment; P:inner cell mass cellular morphogenesis; P:intracellular signal transduction; P:keratinocyte differentiation; P:mammary gland epithelial cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of actin filament polymerization; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of organ growth; P:regulation of protein-containing complex assembly; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ubiquitin-dependent protein catabolic process; P:sister chromatid segregation;|O95835 Q6PKD0,Serine/threonine-protein kinase LATS1,Large tumor suppressor homolog 1;WARTS protein kinase;, PF00069;PF00627;, GO:0005829;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005524;GO:0030331;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0051301;GO:0034613;GO:0051220;GO:0000082;GO:0000086;GO:0035329;GO:0009755;GO:0001827;GO:0001828;GO:0035556;GO:0030216;GO:0060644;GO:0090090;GO:0045736;GO:1900181;GO:0018105;GO:0043065;GO:0033138;GO:0006468;GO:0030833;GO:0033146;GO:0046620;GO:0043254;GO:0017015;GO:2000058;GO:0000819;, C:cytosol; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole;, F:ATP binding; F:estrogen receptor binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cellular protein localization; P:cytoplasmic sequestering of protein; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:hormone-mediated signaling pathway; P:inner cell mass cell fate commitment; P:inner cell mass cellular morphogenesis; P:intracellular signal transduction; P:keratinocyte differentiation; P:mammary gland epithelial cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of protein localization to nucleus; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of actin filament polymerization; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of organ growth; P:regulation of protein-containing complex assembly; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ubiquitin-dependent protein catabolic process; P:sister chromatid segregation;|Q8NFH3 B4E2F0 Q9H8S0,Nucleoporin Nup43,Nup107-160 subcomplex subunit Nup43;p42;, PF00400;, GO:0000777;GO:0005829;GO:0043657;GO:0005635;GO:0031080;GO:0016607;GO:0005654;GO:0051301;GO:0007059;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:nuclear envelope; C:nuclear pore outer ring; C:nuclear speck; C:nucleoplasm;, , P:cell division; P:chromosome segregation; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q99625 Q9BQV7 Q9BQV8 Q9NP03,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,L-isoaspartyl protein carboxyl methyltransferase;Protein L-isoaspartyl/D-aspartyl methyltransferase;Protein-beta-aspartate methyltransferase;, , GO:0005737;GO:0005829;GO:0070062;GO:1903561;GO:0045296;GO:0004719;GO:0006479;GO:0030091;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular vesicle;, F:cadherin binding; F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;, P:protein methylation; P:protein repair;|Q99625 Q9BQV7 Q9BQV8 Q9NP03,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,L-isoaspartyl protein carboxyl methyltransferase;Protein L-isoaspartyl/D-aspartyl methyltransferase;Protein-beta-aspartate methyltransferase;, , GO:0005737;GO:0005829;GO:0070062;GO:1903561;GO:0045296;GO:0004719;GO:0006479;GO:0030091;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular vesicle;, F:cadherin binding; F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;, P:protein methylation; P:protein repair;|Q99625 Q9BQV7 Q9BQV8 Q9NP03,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,L-isoaspartyl protein carboxyl methyltransferase;Protein L-isoaspartyl/D-aspartyl methyltransferase;Protein-beta-aspartate methyltransferase;, , GO:0005737;GO:0005829;GO:0070062;GO:1903561;GO:0045296;GO:0004719;GO:0006479;GO:0030091;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular vesicle;, F:cadherin binding; F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;, P:protein methylation; P:protein repair;|Q99625 Q9BQV7 Q9BQV8 Q9NP03,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,L-isoaspartyl protein carboxyl methyltransferase;Protein L-isoaspartyl/D-aspartyl methyltransferase;Protein-beta-aspartate methyltransferase;, , GO:0005737;GO:0005829;GO:0070062;GO:1903561;GO:0045296;GO:0004719;GO:0006479;GO:0030091;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular vesicle;, F:cadherin binding; F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;, P:protein methylation; P:protein repair;|Q86VZ4 Q5VYC0 Q96SN6,Low-density lipoprotein receptor-related protein 11,, PF00057;PF07502;, GO:0016021;GO:0005886;GO:0051219;, C:integral component of membrane; C:plasma membrane;, F:phosphoprotein binding;|Q9BZM6 Q5VY81 Q8IZW3 Q8IZX6,UL16-binding protein 1,ALCAN-beta;NKG2D ligand 1;Retinoic acid early transcript 1I;, PF00129;, GO:0046658;GO:0005829;GO:0005783;GO:0009897;GO:0005615;GO:0005886;GO:0046703;GO:0030101;GO:0042267;GO:0050776;GO:0016032;, C:anchored component of plasma membrane; C:cytosol; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular space; C:plasma membrane;, F:natural killer cell lectin-like receptor binding;, P:natural killer cell activation; P:natural killer cell mediated cytotoxicity; P:regulation of immune response; P:viral process;|Q9BZM6 Q5VY81 Q8IZW3 Q8IZX6,UL16-binding protein 1,ALCAN-beta;NKG2D ligand 1;Retinoic acid early transcript 1I;, PF00129;, GO:0046658;GO:0005829;GO:0005783;GO:0009897;GO:0005615;GO:0005886;GO:0046703;GO:0030101;GO:0042267;GO:0050776;GO:0016032;, C:anchored component of plasma membrane; C:cytosol; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular space; C:plasma membrane;, F:natural killer cell lectin-like receptor binding;, P:natural killer cell activation; P:natural killer cell mediated cytotoxicity; P:regulation of immune response; P:viral process;|Q9BZM6 Q5VY81 Q8IZW3 Q8IZX6,UL16-binding protein 1,ALCAN-beta;NKG2D ligand 1;Retinoic acid early transcript 1I;, PF00129;, GO:0046658;GO:0005829;GO:0005783;GO:0009897;GO:0005615;GO:0005886;GO:0046703;GO:0030101;GO:0042267;GO:0050776;GO:0016032;, C:anchored component of plasma membrane; C:cytosol; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular space; C:plasma membrane;, F:natural killer cell lectin-like receptor binding;, P:natural killer cell activation; P:natural killer cell mediated cytotoxicity; P:regulation of immune response; P:viral process; scaffold44 indexed_genome mRNA 4157996 4160517 . + . ID=transcript_8728;Q7Z7D8,Iodotyrosine deiodinase 1 {ECO:0000303|PubMed:25395621},Iodotyrosine dehalogenase 1 {ECO:0000303|PubMed:15289438, ECO:0000303|Ref.2};, PF00881;, GO:0030659;GO:0005887;GO:0005654;GO:0005886;GO:0010181;GO:0004447;GO:0016491;GO:0006590;GO:0042403;GO:0006570;, C:cytoplasmic vesicle membrane; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:FMN binding; F:iodide peroxidase activity; F:oxidoreductase activity;, P:thyroid hormone generation; P:thyroid hormone metabolic process; P:tyrosine metabolic process; scaffold44 indexed_genome mRNA 4516406 4566687 . + . ID=transcript_8729;Q9ULL1 Q5T1F2,Pleckstrin homology domain-containing family G member 1,, PF00621;, GO:0005654;GO:0005085;, C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity; scaffold44 indexed_genome mRNA 4575693 4755683 . + . ID=transcript_8730;Q6UB35 Q2TBF3 Q8WVW0 Q96HG8 Q9H789 Q9UFU8,Monofunctional C1-tetrahydrofolate synthase, mitochondrial,Formyltetrahydrofolate synthetase;, PF01268;PF00763;PF02882;, GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0005524;GO:0004329;GO:0004488;GO:0042803;GO:0009257;GO:0048702;GO:0048703;GO:0046655;GO:0006760;GO:0015942;GO:0001843;GO:0035999;, C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:formate-tetrahydrofolate ligase activity; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; F:protein homodimerization activity;, P:10-formyltetrahydrofolate biosynthetic process; P:embryonic neurocranium morphogenesis; P:embryonic viscerocranium morphogenesis; P:folic acid metabolic process; P:folic acid-containing compound metabolic process; P:formate metabolic process; P:neural tube closure; P:tetrahydrofolate interconversion; scaffold44 indexed_genome mRNA 4882986 4984150 . + . ID=transcript_8731;Q02952 O00310 O00498 Q4LE68 Q5SZ80 Q5TGN1 Q68D82 Q99970,A-kinase anchor protein 12,A-kinase anchor protein 250 kDa;Gravin;Myasthenia gravis autoantigen;, PF10522;PF03832;, GO:0005938;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0043025;GO:0005886;GO:0098685;GO:0008179;GO:0005516;GO:0051018;GO:0007193;GO:0071347;GO:0071356;GO:0007186;GO:0035733;GO:0050804;GO:0043116;GO:0070374;GO:0061870;GO:0051770;GO:1900143;GO:0010739;GO:0010738;GO:0090036;GO:0051602;GO:0032496;, C:cell cortex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:neuronal cell body; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:adenylate cyclase binding; F:calmodulin binding; F:protein kinase A binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:hepatic stellate cell activation; P:modulation of chemical synaptic transmission; P:negative regulation of vascular permeability; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of hepatic stellate cell migration; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of oligodendrocyte apoptotic process; P:positive regulation of protein kinase A signaling; P:regulation of protein kinase A signaling; P:regulation of protein kinase C signaling; P:response to electrical stimulus; P:response to lipopolysaccharide; scaffold44 indexed_genome mRNA 4984160 4990114 . + . ID=transcript_8732;Q02952 O00310 O00498 Q4LE68 Q5SZ80 Q5TGN1 Q68D82 Q99970,A-kinase anchor protein 12,A-kinase anchor protein 250 kDa;Gravin;Myasthenia gravis autoantigen;, PF10522;PF03832;, GO:0005938;GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0043025;GO:0005886;GO:0098685;GO:0008179;GO:0005516;GO:0051018;GO:0007193;GO:0071347;GO:0071356;GO:0007186;GO:0035733;GO:0050804;GO:0043116;GO:0070374;GO:0061870;GO:0051770;GO:1900143;GO:0010739;GO:0010738;GO:0090036;GO:0051602;GO:0032496;, C:cell cortex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:neuronal cell body; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:adenylate cyclase binding; F:calmodulin binding; F:protein kinase A binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:hepatic stellate cell activation; P:modulation of chemical synaptic transmission; P:negative regulation of vascular permeability; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of hepatic stellate cell migration; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of oligodendrocyte apoptotic process; P:positive regulation of protein kinase A signaling; P:regulation of protein kinase A signaling; P:regulation of protein kinase C signaling; P:response to electrical stimulus; P:response to lipopolysaccharide; scaffold44 indexed_genome mRNA 5000002 5041678 . - . ID=transcript_8733;Q8N680 A8K7C7 Q5SZ81 Q9P245,Zinc finger and BTB domain-containing protein 2,, PF00651;PF00096;, GO:0005654;GO:0001227;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0000122;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold44 indexed_genome mRNA 5050031 5085043 . - . ID=transcript_8734;Q9NWS8 A8K8H4 Q0VDG6 Q5SZ48 Q5SZ83 Q6NSC5 Q96EN7,Required for meiotic nuclear division protein 1 homolog,, PF02582;, GO:0005739;GO:0070131;GO:0006412;, C:mitochondrion;, , P:positive regulation of mitochondrial translation; P:translation;|Q9NWS8 A8K8H4 Q0VDG6 Q5SZ48 Q5SZ83 Q6NSC5 Q96EN7,Required for meiotic nuclear division protein 1 homolog,, PF02582;, GO:0005739;GO:0070131;GO:0006412;, C:mitochondrion;, , P:positive regulation of mitochondrial translation; P:translation;|Q9NWS8 A8K8H4 Q0VDG6 Q5SZ48 Q5SZ83 Q6NSC5 Q96EN7,Required for meiotic nuclear division protein 1 homolog,, PF02582;, GO:0005739;GO:0070131;GO:0006412;, C:mitochondrion;, , P:positive regulation of mitochondrial translation; P:translation;|Q9NWS8 A8K8H4 Q0VDG6 Q5SZ48 Q5SZ83 Q6NSC5 Q96EN7,Required for meiotic nuclear division protein 1 homolog,, PF02582;, GO:0005739;GO:0070131;GO:0006412;, C:mitochondrion;, , P:positive regulation of mitochondrial translation; P:translation; scaffold44 indexed_genome mRNA 5087840 5096202 . + . ID=transcript_8735;Q9H993 Q96FC6 Q9UFY5,Damage-control phosphatase ARMT1 {ECO:0000250|UniProtKB:Q04371},Acidic residue methyltransferase 1 {ECO:0000303|PubMed:25732820};Protein-glutamate O-methyltransferase {ECO:0000305};Sugar phosphate phosphatase ARMT1 {ECO:0000250|UniProtKB:Q04371};, PF01937;, GO:0019899;GO:0097023;GO:0103026;GO:0046872;GO:0016791;GO:0051998;GO:0008983;GO:0008757;GO:0006974;GO:0032259;GO:2001020;, , F:enzyme binding; F:fructose 6-phosphate aldolase activity; F:fructose-1-phosphatase activity; F:metal ion binding; F:phosphatase activity; F:protein carboxyl O-methyltransferase activity; F:protein-glutamate O-methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:cellular response to DNA damage stimulus; P:methylation; P:regulation of response to DNA damage stimulus;|Q9H993 Q96FC6 Q9UFY5,Damage-control phosphatase ARMT1 {ECO:0000250|UniProtKB:Q04371},Acidic residue methyltransferase 1 {ECO:0000303|PubMed:25732820};Protein-glutamate O-methyltransferase {ECO:0000305};Sugar phosphate phosphatase ARMT1 {ECO:0000250|UniProtKB:Q04371};, PF01937;, GO:0019899;GO:0097023;GO:0103026;GO:0046872;GO:0016791;GO:0051998;GO:0008983;GO:0008757;GO:0006974;GO:0032259;GO:2001020;, , F:enzyme binding; F:fructose 6-phosphate aldolase activity; F:fructose-1-phosphatase activity; F:metal ion binding; F:phosphatase activity; F:protein carboxyl O-methyltransferase activity; F:protein-glutamate O-methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:cellular response to DNA damage stimulus; P:methylation; P:regulation of response to DNA damage stimulus;|Q9H993 Q96FC6 Q9UFY5,Damage-control phosphatase ARMT1 {ECO:0000250|UniProtKB:Q04371},Acidic residue methyltransferase 1 {ECO:0000303|PubMed:25732820};Protein-glutamate O-methyltransferase {ECO:0000305};Sugar phosphate phosphatase ARMT1 {ECO:0000250|UniProtKB:Q04371};, PF01937;, GO:0019899;GO:0097023;GO:0103026;GO:0046872;GO:0016791;GO:0051998;GO:0008983;GO:0008757;GO:0006974;GO:0032259;GO:2001020;, , F:enzyme binding; F:fructose 6-phosphate aldolase activity; F:fructose-1-phosphatase activity; F:metal ion binding; F:phosphatase activity; F:protein carboxyl O-methyltransferase activity; F:protein-glutamate O-methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity;, P:cellular response to DNA damage stimulus; P:methylation; P:regulation of response to DNA damage stimulus; scaffold44 indexed_genome mRNA 5154594 5180630 . + . ID=transcript_8736;Q8IYT3 Q5VXB7 Q6P9E4 Q96KA9 Q9H5M3,Coiled-coil domain-containing protein 170 {ECO:0000305},, , GO:0036064;GO:0005794;GO:0008017;GO:0000226;, C:ciliary basal body; C:Golgi apparatus;, F:microtubule binding;, P:microtubule cytoskeleton organization; scaffold44 indexed_genome mRNA 5180757 5212545 . + . ID=transcript_8737;Q8IYT3 Q5VXB7 Q6P9E4 Q96KA9 Q9H5M3,Coiled-coil domain-containing protein 170 {ECO:0000305},, , GO:0036064;GO:0005794;GO:0008017;GO:0000226;, C:ciliary basal body; C:Golgi apparatus;, F:microtubule binding;, P:microtubule cytoskeleton organization; scaffold44 indexed_genome mRNA 5535020 5681442 . + . ID=transcript_8738;P03372 Q13511 Q14276 Q5T5H7 Q6MZQ9 Q9NU51 Q9UDZ7 Q9UIS7,Estrogen receptor,ER-alpha;Estradiol receptor;Nuclear receptor subfamily 3 group A member 1;, PF12743;PF00104;PF02159;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005794;GO:0016021;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0097550;GO:0035327;GO:0051117;GO:0008013;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0030284;GO:0030331;GO:0034056;GO:0042802;GO:0030235;GO:0004879;GO:0019901;GO:0000978;GO:0001226;GO:1990837;GO:0005496;GO:0017025;GO:0001093;GO:0001223;GO:0008134;GO:0008270;GO:0008209;GO:0001547;GO:0071392;GO:0071391;GO:0006338;GO:0002064;GO:0060750;GO:0030520;GO:0030518;GO:0008584;GO:0060749;GO:0060745;GO:0043433;GO:0010629;GO:0043124;GO:1903799;GO:0000122;GO:0007200;GO:0007204;GO:0051091;GO:0048146;GO:0045429;GO:0051000;GO:0010863;GO:0051897;GO:0045899;GO:0045944;GO:0045893;GO:0060527;GO:0060523;GO:0016579;GO:0071168;GO:0042981;GO:0060687;GO:0050727;GO:0033146;GO:0034121;GO:0006357;GO:0006355;GO:0030111;GO:0032355;GO:0043627;GO:0007165;GO:0048863;GO:0006367;GO:0060065;GO:0060068;, C:chromatin; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:transcription preinitiation complex; C:transcriptionally active chromatin;, F:ATPase binding; F:beta-catenin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:estrogen receptor activity; F:estrogen receptor binding; F:estrogen response element binding; F:identical protein binding; F:nitric-oxide synthase regulator activity; F:nuclear receptor activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:sequence-specific double-stranded DNA binding; F:steroid binding; F:TBP-class protein binding; F:TFIIB-class transcription factor binding; F:transcription coactivator binding; F:transcription factor binding; F:zinc ion binding;, P:androgen metabolic process; P:antral ovarian follicle growth; P:cellular response to estradiol stimulus; P:cellular response to estrogen stimulus; P:chromatin remodeling; P:epithelial cell development; P:epithelial cell proliferation involved in mammary gland duct elongation; P:intracellular estrogen receptor signaling pathway; P:intracellular steroid hormone receptor signaling pathway; P:male gonad development; P:mammary gland alveolus development; P:mammary gland branching involved in pregnancy; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of fibroblast proliferation; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; P:prostate epithelial cord elongation; P:protein deubiquitination; P:protein localization to chromatin; P:regulation of apoptotic process; P:regulation of branching involved in prostate gland morphogenesis; P:regulation of inflammatory response; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of toll-like receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to estradiol; P:response to estrogen; P:signal transduction; P:stem cell differentiation; P:transcription initiation from RNA polymerase II promoter; P:uterus development; P:vagina development; scaffold44 indexed_genome mRNA 5699598 6078294 . - . ID=transcript_8739;Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis;|Q9NU50 Q9UJ06 Q9UJ07 Q9ULF8,Nesprin-1,Enaptin;KASH domain-containing protein 1;Myocyte nuclear envelope protein 1;Nuclear envelope spectrin repeat protein 1;Synaptic nuclear envelope protein 1;, PF00307;PF10541;PF00435;, GO:0005737;GO:0005856;GO:0005794;GO:0016021;GO:0034993;GO:0005635;GO:0031965;GO:0005640;GO:0005730;GO:0005654;GO:0005634;GO:0000932;GO:0045211;GO:0030017;GO:0003779;GO:0051015;GO:0140444;GO:0019899;GO:0042802;GO:0005521;GO:0042803;GO:0003723;GO:0007030;GO:0042692;GO:0090292;GO:0006997;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic membrane; C:sarcomere;, F:actin binding; F:actin filament binding; F:cytoskeleton-nuclear membrane anchor activity; F:enzyme binding; F:identical protein binding; F:lamin binding; F:protein homodimerization activity; F:RNA binding;, P:Golgi organization; P:muscle cell differentiation; P:nuclear matrix anchoring at nuclear membrane; P:nucleus organization; P:spermatogenesis; scaffold44 indexed_genome mRNA 6228860 6244390 . - . ID=transcript_8740;Q8N699 Q8N396 Q8TBE8 Q9H763,Myc target protein 1,Myc target in myeloid cells protein 1;, PF15179;, GO:0043231;GO:0005654;GO:0061484;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:hematopoietic stem cell homeostasis;|Q8N699 Q8N396 Q8TBE8 Q9H763,Myc target protein 1,Myc target in myeloid cells protein 1;, PF15179;, GO:0043231;GO:0005654;GO:0061484;, C:intracellular membrane-bounded organelle; C:nucleoplasm;, , P:hematopoietic stem cell homeostasis; scaffold44 indexed_genome mRNA 6415849 6421102 . - . ID=transcript_8741;Q9UKT4 B3KNX5 Q5TF47 Q8WV29 Q9UGC8,F-box only protein 5 {ECO:0000305},Early mitotic inhibitor 1 {ECO:0000303|PubMed:15148369};, PF00646;, GO:0005737;GO:0005829;GO:0072687;GO:0005654;GO:0005634;GO:0005819;GO:0010997;GO:0046872;GO:0019901;GO:1990948;GO:0031145;GO:0051301;GO:0046785;GO:2000773;GO:0032876;GO:0045835;GO:0045841;GO:2001021;GO:1904667;GO:0051444;GO:0001556;GO:0070169;GO:0008284;GO:0010971;GO:1905322;GO:0045669;GO:0016567;GO:0006275;GO:0007346;GO:1901990;GO:0007088;GO:0000083;GO:0007057;GO:0016050;, C:cytoplasm; C:cytosol; C:meiotic spindle; C:nucleoplasm; C:nucleus; C:spindle;, F:anaphase-promoting complex binding; F:metal ion binding; F:protein kinase binding; F:ubiquitin ligase inhibitor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:microtubule polymerization; P:negative regulation of cellular senescence; P:negative regulation of DNA endoreduplication; P:negative regulation of meiotic nuclear division; P:negative regulation of mitotic metaphase/anaphase transition; P:negative regulation of response to DNA damage stimulus; P:negative regulation of ubiquitin protein ligase activity; P:negative regulation of ubiquitin-protein transferase activity; P:oocyte maturation; P:positive regulation of biomineral tissue development; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of mesenchymal stem cell migration; P:positive regulation of osteoblast differentiation; P:protein ubiquitination; P:regulation of DNA replication; P:regulation of mitotic cell cycle; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic nuclear division; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:spindle assembly involved in female meiosis I; P:vesicle organization; scaffold44 indexed_genome mRNA 6439704 6441452 . - . ID=transcript_8742;Q9UGC7 B3KTA0 Q3KR06 Q5TF44 Q5TF50 Q96CC5 Q96EX4 Q96K40,Peptide chain release factor 1-like, mitochondrial,Mitochondrial translational release factor 1-like;mtRF1a;, PF03462;PF00472;, GO:0005759;GO:0005739;GO:0003747;GO:0070126;, C:mitochondrial matrix; C:mitochondrion;, F:translation release factor activity;, P:mitochondrial translational termination;|Q9UGC7 B3KTA0 Q3KR06 Q5TF44 Q5TF50 Q96CC5 Q96EX4 Q96K40,Peptide chain release factor 1-like, mitochondrial,Mitochondrial translational release factor 1-like;mtRF1a;, PF03462;PF00472;, GO:0005759;GO:0005739;GO:0003747;GO:0070126;, C:mitochondrial matrix; C:mitochondrion;, F:translation release factor activity;, P:mitochondrial translational termination; scaffold44 indexed_genome mRNA 6445807 6451831 . - . ID=transcript_8743;Q9UGC7 B3KTA0 Q3KR06 Q5TF44 Q5TF50 Q96CC5 Q96EX4 Q96K40,Peptide chain release factor 1-like, mitochondrial,Mitochondrial translational release factor 1-like;mtRF1a;, PF03462;PF00472;, GO:0005759;GO:0005739;GO:0003747;GO:0070126;, C:mitochondrial matrix; C:mitochondrion;, F:translation release factor activity;, P:mitochondrial translational termination;|Q9UGC7 B3KTA0 Q3KR06 Q5TF44 Q5TF50 Q96CC5 Q96EX4 Q96K40,Peptide chain release factor 1-like, mitochondrial,Mitochondrial translational release factor 1-like;mtRF1a;, PF03462;PF00472;, GO:0005759;GO:0005739;GO:0003747;GO:0070126;, C:mitochondrial matrix; C:mitochondrion;, F:translation release factor activity;, P:mitochondrial translational termination;|Q9UGC7 B3KTA0 Q3KR06 Q5TF44 Q5TF50 Q96CC5 Q96EX4 Q96K40,Peptide chain release factor 1-like, mitochondrial,Mitochondrial translational release factor 1-like;mtRF1a;, PF03462;PF00472;, GO:0005759;GO:0005739;GO:0003747;GO:0070126;, C:mitochondrial matrix; C:mitochondrion;, F:translation release factor activity;, P:mitochondrial translational termination;|Q9UGC7 B3KTA0 Q3KR06 Q5TF44 Q5TF50 Q96CC5 Q96EX4 Q96K40,Peptide chain release factor 1-like, mitochondrial,Mitochondrial translational release factor 1-like;mtRF1a;, PF03462;PF00472;, GO:0005759;GO:0005739;GO:0003747;GO:0070126;, C:mitochondrial matrix; C:mitochondrion;, F:translation release factor activity;, P:mitochondrial translational termination; scaffold44 indexed_genome mRNA 6458571 6471522 . - . ID=transcript_8744;Q9UGC6 Q5TF49 Q8TD61 Q9UJS8,Regulator of G-protein signaling 17,, PF00615;, GO:0005737;GO:0043005;GO:0005634;GO:0005886;GO:0045202;GO:0005096;GO:0007186;GO:0009968;GO:0001975;, C:cytoplasm; C:neuron projection; C:nucleus; C:plasma membrane; C:synapse;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:response to amphetamine;|Q9UGC6 Q5TF49 Q8TD61 Q9UJS8,Regulator of G-protein signaling 17,, PF00615;, GO:0005737;GO:0043005;GO:0005634;GO:0005886;GO:0045202;GO:0005096;GO:0007186;GO:0009968;GO:0001975;, C:cytoplasm; C:neuron projection; C:nucleus; C:plasma membrane; C:synapse;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:response to amphetamine;|Q9UGC6 Q5TF49 Q8TD61 Q9UJS8,Regulator of G-protein signaling 17,, PF00615;, GO:0005737;GO:0043005;GO:0005634;GO:0005886;GO:0045202;GO:0005096;GO:0007186;GO:0009968;GO:0001975;, C:cytoplasm; C:neuron projection; C:nucleus; C:plasma membrane; C:synapse;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:response to amphetamine; scaffold44 indexed_genome mRNA 7236957 7275751 . + . ID=transcript_8745;Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57,Mu-type opioid receptor,Mu opiate receptor;Mu opioid receptor;, PF00001;, GO:0030424;GO:0030425;GO:0032839;GO:0032590;GO:0005783;GO:0005768;GO:0005925;GO:0005794;GO:0005887;GO:0099055;GO:0099056;GO:0045121;GO:0043005;GO:0043204;GO:0005886;GO:0042383;GO:0097444;GO:0004979;GO:0031005;GO:0004930;GO:0001965;GO:0031681;GO:0038047;GO:0042923;GO:0042277;GO:0008022;GO:0019904;GO:0005245;GO:0002438;GO:0007197;GO:0031635;GO:0048149;GO:0019221;GO:0042755;GO:0044849;GO:0060079;GO:0007186;GO:0007187;GO:0106072;GO:0043951;GO:0008285;GO:0051481;GO:0045019;GO:0061358;GO:0007218;GO:0038003;GO:0007200;GO:0032100;GO:0043950;GO:0007204;GO:0070374;GO:0050769;GO:0045429;GO:0080135;GO:2000310;GO:0051930;GO:0042220;GO:0032094;GO:0070848;GO:0032496;GO:0009314;GO:0007600;GO:0019233;GO:0042060;, C:axon; C:dendrite; C:dendrite cytoplasm; C:dendrite membrane; C:endoplasmic reticulum; C:endosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:membrane raft; C:neuron projection; C:perikaryon; C:plasma membrane; C:sarcolemma; C:spine apparatus;, F:beta-endorphin receptor activity; F:filamin binding; F:G protein-coupled receptor activity; F:G-protein alpha-subunit binding; F:G-protein beta-subunit binding; F:morphine receptor activity; F:neuropeptide binding; F:peptide binding; F:protein C-terminus binding; F:protein domain specific binding; F:voltage-gated calcium channel activity;, P:acute inflammatory response to antigenic stimulus; P:adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway; P:adenylate cyclase-inhibiting opioid receptor signaling pathway; P:behavioral response to ethanol; P:cytokine-mediated signaling pathway; P:eating behavior; P:estrous cycle; P:excitatory postsynaptic potential; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cell population proliferation; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of Wnt protein secretion; P:neuropeptide signaling pathway; P:opioid receptor signaling pathway; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of appetite; P:positive regulation of cAMP-mediated signaling; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of neurogenesis; P:positive regulation of nitric oxide biosynthetic process; P:regulation of cellular response to stress; P:regulation of NMDA receptor activity; P:regulation of sensory perception of pain; P:response to cocaine; P:response to food; P:response to growth factor; P:response to lipopolysaccharide; P:response to radiation; P:sensory perception; P:sensory perception of pain; P:wound healing; scaffold44 indexed_genome mRNA 7328496 7367279 . - . ID=transcript_8746;Q8WWN9 A8K1K2 B7ZL78 B7ZL80 G3V132 O43153 Q5HYL8,Interactor protein for cytohesin exchange factors 1,Phosphoinositide-binding protein PIP3-E;, PF00169;, GO:0005829;GO:0005886;GO:0005344;GO:0004601;GO:0019904;GO:0015671;GO:0006979;, C:cytosol; C:plasma membrane;, F:oxygen carrier activity; F:peroxidase activity; F:protein domain specific binding;, P:oxygen transport; P:response to oxidative stress;|Q8WWN9 A8K1K2 B7ZL78 B7ZL80 G3V132 O43153 Q5HYL8,Interactor protein for cytohesin exchange factors 1,Phosphoinositide-binding protein PIP3-E;, PF00169;, GO:0005829;GO:0005886;GO:0005344;GO:0004601;GO:0019904;GO:0015671;GO:0006979;, C:cytosol; C:plasma membrane;, F:oxygen carrier activity; F:peroxidase activity; F:protein domain specific binding;, P:oxygen transport; P:response to oxidative stress;|Q8WWN9 A8K1K2 B7ZL78 B7ZL80 G3V132 O43153 Q5HYL8,Interactor protein for cytohesin exchange factors 1,Phosphoinositide-binding protein PIP3-E;, PF00169;, GO:0005829;GO:0005886;GO:0005344;GO:0004601;GO:0019904;GO:0015671;GO:0006979;, C:cytosol; C:plasma membrane;, F:oxygen carrier activity; F:peroxidase activity; F:protein domain specific binding;, P:oxygen transport; P:response to oxidative stress; scaffold44 indexed_genome mRNA 7531328 7638977 . - . ID=transcript_8747;Q6P9H4 C9IZX4 Q5SGD5 Q96N65,Connector enhancer of kinase suppressor of ras 3,CNK homolog protein 3;CNKSR family member 3;Maguin-like protein;, PF10534;PF06663;PF00595;PF00536;, GO:0016324;GO:0005737;GO:0070373;GO:0033137;GO:0010765;, C:apical plasma membrane; C:cytoplasm;, , P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of peptidyl-serine phosphorylation; P:positive regulation of sodium ion transport; scaffold44 indexed_genome mRNA 7825767 7906718 . + . ID=transcript_8748;Q9UPN6 B7Z888 Q5TBU6 Q6NSK3 Q9BQN8 Q9BX43,SR-related and CTD-associated factor 8 {ECO:0000303|PubMed:9528809},CDC5L complex-associated protein 7 {ECO:0000303|PubMed:11101529};RNA-binding motif protein 16 {ECO:0000305};, PF04818;PF00076;, GO:0005737;GO:0005849;GO:0016363;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0043175;GO:1990269;GO:0000993;GO:0006378;GO:2000805;GO:0032786;GO:0006369;, C:cytoplasm; C:mRNA cleavage factor complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:RNA polymerase core enzyme binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:RNA polymerase II complex binding;, P:mRNA polyadenylation; P:negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled; P:positive regulation of DNA-templated transcription, elongation; P:termination of RNA polymerase II transcription; scaffold44 indexed_genome mRNA 7909815 7973492 . + . ID=transcript_8749;Q9UPN6 B7Z888 Q5TBU6 Q6NSK3 Q9BQN8 Q9BX43,SR-related and CTD-associated factor 8 {ECO:0000303|PubMed:9528809},CDC5L complex-associated protein 7 {ECO:0000303|PubMed:11101529};RNA-binding motif protein 16 {ECO:0000305};, PF04818;PF00076;, GO:0005737;GO:0005849;GO:0016363;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0043175;GO:1990269;GO:0000993;GO:0006378;GO:2000805;GO:0032786;GO:0006369;, C:cytoplasm; C:mRNA cleavage factor complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:RNA polymerase core enzyme binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:RNA polymerase II complex binding;, P:mRNA polyadenylation; P:negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled; P:positive regulation of DNA-templated transcription, elongation; P:termination of RNA polymerase II transcription;|Q9UPN6 B7Z888 Q5TBU6 Q6NSK3 Q9BQN8 Q9BX43,SR-related and CTD-associated factor 8 {ECO:0000303|PubMed:9528809},CDC5L complex-associated protein 7 {ECO:0000303|PubMed:11101529};RNA-binding motif protein 16 {ECO:0000305};, PF04818;PF00076;, GO:0005737;GO:0005849;GO:0016363;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0043175;GO:1990269;GO:0000993;GO:0006378;GO:2000805;GO:0032786;GO:0006369;, C:cytoplasm; C:mRNA cleavage factor complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:RNA polymerase core enzyme binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:RNA polymerase II complex binding;, P:mRNA polyadenylation; P:negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled; P:positive regulation of DNA-templated transcription, elongation; P:termination of RNA polymerase II transcription; scaffold44 indexed_genome mRNA 8040374 8167931 . + . ID=transcript_8750;Q8IVF5 B2RP56 C9JZV2 Q6NXN9 Q6ZUP9 Q9UFG6 Q9UKV9 Q9UKW0,T-lymphoma invasion and metastasis-inducing protein 2,SIF and TIAM1-like exchange factor;, PF00595;PF00169;PF00621;PF18385;, GO:0005829;GO:0070062;GO:0030175;GO:0030426;GO:0030027;GO:0016020;GO:0043204;GO:0045202;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0043065;GO:0050772;GO:0019222;GO:0051056;GO:0007264;, C:cytosol; C:extracellular exosome; C:filopodium; C:growth cone; C:lamellipodium; C:membrane; C:perikaryon; C:synapse;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:regulation of metabolic process; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; scaffold44 indexed_genome mRNA 8167932 8281348 . + . ID=transcript_8751;Q8IVF5 B2RP56 C9JZV2 Q6NXN9 Q6ZUP9 Q9UFG6 Q9UKV9 Q9UKW0,T-lymphoma invasion and metastasis-inducing protein 2,SIF and TIAM1-like exchange factor;, PF00595;PF00169;PF00621;PF18385;, GO:0005829;GO:0070062;GO:0030175;GO:0030426;GO:0030027;GO:0016020;GO:0043204;GO:0045202;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0043065;GO:0050772;GO:0019222;GO:0051056;GO:0007264;, C:cytosol; C:extracellular exosome; C:filopodium; C:growth cone; C:lamellipodium; C:membrane; C:perikaryon; C:synapse;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:regulation of metabolic process; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; scaffold44 indexed_genome mRNA 8281684 8345921 . + . ID=transcript_8752;Q8IVF5 B2RP56 C9JZV2 Q6NXN9 Q6ZUP9 Q9UFG6 Q9UKV9 Q9UKW0,T-lymphoma invasion and metastasis-inducing protein 2,SIF and TIAM1-like exchange factor;, PF00595;PF00169;PF00621;PF18385;, GO:0005829;GO:0070062;GO:0030175;GO:0030426;GO:0030027;GO:0016020;GO:0043204;GO:0045202;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0043065;GO:0050772;GO:0019222;GO:0051056;GO:0007264;, C:cytosol; C:extracellular exosome; C:filopodium; C:growth cone; C:lamellipodium; C:membrane; C:perikaryon; C:synapse;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:regulation of metabolic process; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction;|Q8WVM0 Q05DR0 Q9Y384,Dimethyladenosine transferase 1, mitochondrial,Mitochondrial 12S rRNA dimethylase 1;Mitochondrial transcription factor B1;S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1;, PF00398;, GO:0005759;GO:0042645;GO:0003677;GO:0034246;GO:0003723;GO:0000179;GO:0007005;GO:0031167;GO:0000154;GO:0006391;, C:mitochondrial matrix; C:mitochondrial nucleoid;, F:DNA binding; F:mitochondrial transcription factor activity; F:RNA binding; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity;, P:mitochondrion organization; P:rRNA methylation; P:rRNA modification; P:transcription initiation from mitochondrial promoter;|P56880,Claudin-20,, PF00822;, GO:0005923;GO:0016021;GO:0005886;GO:0070160;GO:0042802;GO:0005198;GO:0070830;GO:0016338;GO:0007155;, C:bicellular tight junction; C:integral component of membrane; C:plasma membrane; C:tight junction;, F:identical protein binding; F:structural molecule activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; scaffold44 indexed_genome mRNA 10041893 10161902 . + . ID=transcript_8753;Q8NFD5 Q5JRD1 Q5VYC4 Q8IZY8 Q8TEV0 Q8TF02 Q99491 Q9ULI5,AT-rich interactive domain-containing protein 1B,BRG1-associated factor 250b;BRG1-binding protein hELD/OSA1;Osa homolog 2;p250R;, PF01388;PF12031;, GO:0035060;GO:0005829;GO:0071565;GO:0005654;GO:0005886;GO:0016514;GO:0003677;GO:0003713;GO:0043044;GO:1904385;GO:0048096;GO:0007399;GO:0045893;GO:0006357;GO:0002931;, C:brahma complex; C:cytosol; C:nBAF complex; C:nucleoplasm; C:plasma membrane; C:SWI/SNF complex;, F:DNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:cellular response to angiotensin; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to ischemia;|Q8NFD5 Q5JRD1 Q5VYC4 Q8IZY8 Q8TEV0 Q8TF02 Q99491 Q9ULI5,AT-rich interactive domain-containing protein 1B,BRG1-associated factor 250b;BRG1-binding protein hELD/OSA1;Osa homolog 2;p250R;, PF01388;PF12031;, GO:0035060;GO:0005829;GO:0071565;GO:0005654;GO:0005886;GO:0016514;GO:0003677;GO:0003713;GO:0043044;GO:1904385;GO:0048096;GO:0007399;GO:0045893;GO:0006357;GO:0002931;, C:brahma complex; C:cytosol; C:nBAF complex; C:nucleoplasm; C:plasma membrane; C:SWI/SNF complex;, F:DNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:cellular response to angiotensin; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to ischemia;|Q8NFD5 Q5JRD1 Q5VYC4 Q8IZY8 Q8TEV0 Q8TF02 Q99491 Q9ULI5,AT-rich interactive domain-containing protein 1B,BRG1-associated factor 250b;BRG1-binding protein hELD/OSA1;Osa homolog 2;p250R;, PF01388;PF12031;, GO:0035060;GO:0005829;GO:0071565;GO:0005654;GO:0005886;GO:0016514;GO:0003677;GO:0003713;GO:0043044;GO:1904385;GO:0048096;GO:0007399;GO:0045893;GO:0006357;GO:0002931;, C:brahma complex; C:cytosol; C:nBAF complex; C:nucleoplasm; C:plasma membrane; C:SWI/SNF complex;, F:DNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:cellular response to angiotensin; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to ischemia;|Q8NFD5 Q5JRD1 Q5VYC4 Q8IZY8 Q8TEV0 Q8TF02 Q99491 Q9ULI5,AT-rich interactive domain-containing protein 1B,BRG1-associated factor 250b;BRG1-binding protein hELD/OSA1;Osa homolog 2;p250R;, PF01388;PF12031;, GO:0035060;GO:0005829;GO:0071565;GO:0005654;GO:0005886;GO:0016514;GO:0003677;GO:0003713;GO:0043044;GO:1904385;GO:0048096;GO:0007399;GO:0045893;GO:0006357;GO:0002931;, C:brahma complex; C:cytosol; C:nBAF complex; C:nucleoplasm; C:plasma membrane; C:SWI/SNF complex;, F:DNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:cellular response to angiotensin; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to ischemia;|Q8NFD5 Q5JRD1 Q5VYC4 Q8IZY8 Q8TEV0 Q8TF02 Q99491 Q9ULI5,AT-rich interactive domain-containing protein 1B,BRG1-associated factor 250b;BRG1-binding protein hELD/OSA1;Osa homolog 2;p250R;, PF01388;PF12031;, GO:0035060;GO:0005829;GO:0071565;GO:0005654;GO:0005886;GO:0016514;GO:0003677;GO:0003713;GO:0043044;GO:1904385;GO:0048096;GO:0007399;GO:0045893;GO:0006357;GO:0002931;, C:brahma complex; C:cytosol; C:nBAF complex; C:nucleoplasm; C:plasma membrane; C:SWI/SNF complex;, F:DNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:cellular response to angiotensin; P:chromatin-mediated maintenance of transcription; P:nervous system development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to ischemia; scaffold44 indexed_genome mRNA 10243080 10284185 . - . ID=transcript_8754;Q9NWH2 B9EJD0 Q9NZ88 Q9P094,Transmembrane protein 242,, PF07096;, GO:0016021;, C:integral component of membrane;|Q9NWH2 B9EJD0 Q9NZ88 Q9P094,Transmembrane protein 242,, PF07096;, GO:0016021;, C:integral component of membrane;|Q9BYZ2 Q6DUY4 Q96LI2,L-lactate dehydrogenase A-like 6B,, PF02866;PF00056;, GO:0005759;GO:0005634;GO:0004459;GO:0005975;GO:0006090;, C:mitochondrial matrix; C:nucleus;, F:L-lactate dehydrogenase activity;, P:carbohydrate metabolic process; P:pyruvate metabolic process; scaffold44 indexed_genome mRNA 10499881 10616783 . + . ID=transcript_8755;Q8IZN3 A6NDB7 Q5JS07 Q5JS08 Q6PHS4 Q8IZN2 Q9H7F1,Palmitoyltransferase ZDHHC14 {ECO:0000305|PubMed:27481942},DHHC domain-containing cysteine-rich protein 14 {ECO:0000303|PubMed:16647879};NEW1 domain-containing protein {ECO:0000303|Ref.1};Zinc finger DHHC domain-containing protein 14 {ECO:0000312|HGNC:HGNC:20341};, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0032580;GO:0016021;GO:0016409;GO:0019706;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane;|Q8IZN3 A6NDB7 Q5JS07 Q5JS08 Q6PHS4 Q8IZN2 Q9H7F1,Palmitoyltransferase ZDHHC14 {ECO:0000305|PubMed:27481942},DHHC domain-containing cysteine-rich protein 14 {ECO:0000303|PubMed:16647879};NEW1 domain-containing protein {ECO:0000303|Ref.1};Zinc finger DHHC domain-containing protein 14 {ECO:0000312|HGNC:HGNC:20341};, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0032580;GO:0016021;GO:0016409;GO:0019706;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane;|Q8IZN3 A6NDB7 Q5JS07 Q5JS08 Q6PHS4 Q8IZN2 Q9H7F1,Palmitoyltransferase ZDHHC14 {ECO:0000305|PubMed:27481942},DHHC domain-containing cysteine-rich protein 14 {ECO:0000303|PubMed:16647879};NEW1 domain-containing protein {ECO:0000303|Ref.1};Zinc finger DHHC domain-containing protein 14 {ECO:0000312|HGNC:HGNC:20341};, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0032580;GO:0016021;GO:0016409;GO:0019706;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane; scaffold44 indexed_genome mRNA 10783430 10794411 . + . ID=transcript_8756;Q9Y5X1 Q9BSI7 Q9BVM1 Q9UJH6 Q9UP20,Sorting nexin-9,SH3 and PX domain-containing protein 1;SH3 and PX domain-containing protein 3A;, PF10456;PF00787;PF00018;, GO:0030136;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0031234;GO:0005886;GO:0001726;GO:0005802;GO:0005545;GO:0071933;GO:0045296;GO:0042802;GO:0035091;GO:0042803;GO:0031625;GO:0036089;GO:0006897;GO:0016197;GO:0006886;GO:0060988;GO:0061024;GO:0000281;GO:0097320;GO:0030838;GO:0043547;GO:0051044;GO:0045860;GO:0065003;GO:0006898;, C:clathrin-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane; C:ruffle; C:trans-Golgi network;, F:1-phosphatidylinositol binding; F:Arp2/3 complex binding; F:cadherin binding; F:identical protein binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:cleavage furrow formation; P:endocytosis; P:endosomal transport; P:intracellular protein transport; P:lipid tube assembly; P:membrane organization; P:mitotic cytokinesis; P:plasma membrane tubulation; P:positive regulation of actin filament polymerization; P:positive regulation of GTPase activity; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein kinase activity; P:protein-containing complex assembly; P:receptor-mediated endocytosis; scaffold44 indexed_genome mRNA 10803089 10803708 . + . ID=transcript_8757;Q9Y5X1 Q9BSI7 Q9BVM1 Q9UJH6 Q9UP20,Sorting nexin-9,SH3 and PX domain-containing protein 1;SH3 and PX domain-containing protein 3A;, PF10456;PF00787;PF00018;, GO:0030136;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0031234;GO:0005886;GO:0001726;GO:0005802;GO:0005545;GO:0071933;GO:0045296;GO:0042802;GO:0035091;GO:0042803;GO:0031625;GO:0036089;GO:0006897;GO:0016197;GO:0006886;GO:0060988;GO:0061024;GO:0000281;GO:0097320;GO:0030838;GO:0043547;GO:0051044;GO:0045860;GO:0065003;GO:0006898;, C:clathrin-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane; C:ruffle; C:trans-Golgi network;, F:1-phosphatidylinositol binding; F:Arp2/3 complex binding; F:cadherin binding; F:identical protein binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:cleavage furrow formation; P:endocytosis; P:endosomal transport; P:intracellular protein transport; P:lipid tube assembly; P:membrane organization; P:mitotic cytokinesis; P:plasma membrane tubulation; P:positive regulation of actin filament polymerization; P:positive regulation of GTPase activity; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein kinase activity; P:protein-containing complex assembly; P:receptor-mediated endocytosis; scaffold44 indexed_genome mRNA 10811585 10812588 . + . ID=transcript_8758;Q9Y5X1 Q9BSI7 Q9BVM1 Q9UJH6 Q9UP20,Sorting nexin-9,SH3 and PX domain-containing protein 1;SH3 and PX domain-containing protein 3A;, PF10456;PF00787;PF00018;, GO:0030136;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0031234;GO:0005886;GO:0001726;GO:0005802;GO:0005545;GO:0071933;GO:0045296;GO:0042802;GO:0035091;GO:0042803;GO:0031625;GO:0036089;GO:0006897;GO:0016197;GO:0006886;GO:0060988;GO:0061024;GO:0000281;GO:0097320;GO:0030838;GO:0043547;GO:0051044;GO:0045860;GO:0065003;GO:0006898;, C:clathrin-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane; C:ruffle; C:trans-Golgi network;, F:1-phosphatidylinositol binding; F:Arp2/3 complex binding; F:cadherin binding; F:identical protein binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:cleavage furrow formation; P:endocytosis; P:endosomal transport; P:intracellular protein transport; P:lipid tube assembly; P:membrane organization; P:mitotic cytokinesis; P:plasma membrane tubulation; P:positive regulation of actin filament polymerization; P:positive regulation of GTPase activity; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein kinase activity; P:protein-containing complex assembly; P:receptor-mediated endocytosis; scaffold44 indexed_genome mRNA 10816103 10831197 . + . ID=transcript_8759;Q9Y5X1 Q9BSI7 Q9BVM1 Q9UJH6 Q9UP20,Sorting nexin-9,SH3 and PX domain-containing protein 1;SH3 and PX domain-containing protein 3A;, PF10456;PF00787;PF00018;, GO:0030136;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0031234;GO:0005886;GO:0001726;GO:0005802;GO:0005545;GO:0071933;GO:0045296;GO:0042802;GO:0035091;GO:0042803;GO:0031625;GO:0036089;GO:0006897;GO:0016197;GO:0006886;GO:0060988;GO:0061024;GO:0000281;GO:0097320;GO:0030838;GO:0043547;GO:0051044;GO:0045860;GO:0065003;GO:0006898;, C:clathrin-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane; C:ruffle; C:trans-Golgi network;, F:1-phosphatidylinositol binding; F:Arp2/3 complex binding; F:cadherin binding; F:identical protein binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:cleavage furrow formation; P:endocytosis; P:endosomal transport; P:intracellular protein transport; P:lipid tube assembly; P:membrane organization; P:mitotic cytokinesis; P:plasma membrane tubulation; P:positive regulation of actin filament polymerization; P:positive regulation of GTPase activity; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein kinase activity; P:protein-containing complex assembly; P:receptor-mediated endocytosis;|Q9Y5X1 Q9BSI7 Q9BVM1 Q9UJH6 Q9UP20,Sorting nexin-9,SH3 and PX domain-containing protein 1;SH3 and PX domain-containing protein 3A;, PF10456;PF00787;PF00018;, GO:0030136;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0031234;GO:0005886;GO:0001726;GO:0005802;GO:0005545;GO:0071933;GO:0045296;GO:0042802;GO:0035091;GO:0042803;GO:0031625;GO:0036089;GO:0006897;GO:0016197;GO:0006886;GO:0060988;GO:0061024;GO:0000281;GO:0097320;GO:0030838;GO:0043547;GO:0051044;GO:0045860;GO:0065003;GO:0006898;, C:clathrin-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane; C:ruffle; C:trans-Golgi network;, F:1-phosphatidylinositol binding; F:Arp2/3 complex binding; F:cadherin binding; F:identical protein binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:cleavage furrow formation; P:endocytosis; P:endosomal transport; P:intracellular protein transport; P:lipid tube assembly; P:membrane organization; P:mitotic cytokinesis; P:plasma membrane tubulation; P:positive regulation of actin filament polymerization; P:positive regulation of GTPase activity; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein kinase activity; P:protein-containing complex assembly; P:receptor-mediated endocytosis;|Q9Y5X1 Q9BSI7 Q9BVM1 Q9UJH6 Q9UP20,Sorting nexin-9,SH3 and PX domain-containing protein 1;SH3 and PX domain-containing protein 3A;, PF10456;PF00787;PF00018;, GO:0030136;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0031234;GO:0005886;GO:0001726;GO:0005802;GO:0005545;GO:0071933;GO:0045296;GO:0042802;GO:0035091;GO:0042803;GO:0031625;GO:0036089;GO:0006897;GO:0016197;GO:0006886;GO:0060988;GO:0061024;GO:0000281;GO:0097320;GO:0030838;GO:0043547;GO:0051044;GO:0045860;GO:0065003;GO:0006898;, C:clathrin-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane; C:ruffle; C:trans-Golgi network;, F:1-phosphatidylinositol binding; F:Arp2/3 complex binding; F:cadherin binding; F:identical protein binding; F:phosphatidylinositol binding; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:cleavage furrow formation; P:endocytosis; P:endosomal transport; P:intracellular protein transport; P:lipid tube assembly; P:membrane organization; P:mitotic cytokinesis; P:plasma membrane tubulation; P:positive regulation of actin filament polymerization; P:positive regulation of GTPase activity; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein kinase activity; P:protein-containing complex assembly; P:receptor-mediated endocytosis; scaffold44 indexed_genome mRNA 10855685 10950893 . + . ID=transcript_8760;O15056 Q5TA13 Q5TA16 Q5TA19 Q86XK0 Q8IZA8 Q9H226,Synaptojanin-2,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 2;, PF08952;PF03372;PF02383;, GO:0042995;GO:0005856;GO:0005829;GO:0045121;GO:0048471;GO:0005886;GO:0098793;GO:0004439;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0061024;GO:0006661;GO:0046856;GO:0048488;, C:cell projection; C:cytoskeleton; C:cytosol; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynapse;, F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:synaptic vesicle endocytosis; scaffold44 indexed_genome mRNA 10952250 10953287 . - . ID=transcript_8761;O15056 Q5TA13 Q5TA16 Q5TA19 Q86XK0 Q8IZA8 Q9H226,Synaptojanin-2,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 2;, PF08952;PF03372;PF02383;, GO:0042995;GO:0005856;GO:0005829;GO:0045121;GO:0048471;GO:0005886;GO:0098793;GO:0004439;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0061024;GO:0006661;GO:0046856;GO:0048488;, C:cell projection; C:cytoskeleton; C:cytosol; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynapse;, F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:synaptic vesicle endocytosis; scaffold44 indexed_genome mRNA 10961362 10963400 . + . ID=transcript_8762;Q96JX3 Q49AT1 Q5VTX3 Q6PKF3,Protein SERAC1,Serine active site-containing protein 1;, , GO:0005783;GO:0031012;GO:0016021;GO:0044233;GO:0005739;GO:0030198;GO:0032367;GO:0036148;GO:0008654;, C:endoplasmic reticulum; C:extracellular matrix; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion;, , P:extracellular matrix organization; P:intracellular cholesterol transport; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process;|Q96JX3 Q49AT1 Q5VTX3 Q6PKF3,Protein SERAC1,Serine active site-containing protein 1;, , GO:0005783;GO:0031012;GO:0016021;GO:0044233;GO:0005739;GO:0030198;GO:0032367;GO:0036148;GO:0008654;, C:endoplasmic reticulum; C:extracellular matrix; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion;, , P:extracellular matrix organization; P:intracellular cholesterol transport; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; scaffold44 indexed_genome mRNA 10963913 10964442 . - . ID=transcript_8763;Q96JX3 Q49AT1 Q5VTX3 Q6PKF3,Protein SERAC1,Serine active site-containing protein 1;, , GO:0005783;GO:0031012;GO:0016021;GO:0044233;GO:0005739;GO:0030198;GO:0032367;GO:0036148;GO:0008654;, C:endoplasmic reticulum; C:extracellular matrix; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion;, , P:extracellular matrix organization; P:intracellular cholesterol transport; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; scaffold44 indexed_genome mRNA 10965882 11015186 . + . ID=transcript_8764;Q96JX3 Q49AT1 Q5VTX3 Q6PKF3,Protein SERAC1,Serine active site-containing protein 1;, , GO:0005783;GO:0031012;GO:0016021;GO:0044233;GO:0005739;GO:0030198;GO:0032367;GO:0036148;GO:0008654;, C:endoplasmic reticulum; C:extracellular matrix; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion;, , P:extracellular matrix organization; P:intracellular cholesterol transport; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process;|Q96JX3 Q49AT1 Q5VTX3 Q6PKF3,Protein SERAC1,Serine active site-containing protein 1;, , GO:0005783;GO:0031012;GO:0016021;GO:0044233;GO:0005739;GO:0030198;GO:0032367;GO:0036148;GO:0008654;, C:endoplasmic reticulum; C:extracellular matrix; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion;, , P:extracellular matrix organization; P:intracellular cholesterol transport; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process;|Q96JX3 Q49AT1 Q5VTX3 Q6PKF3,Protein SERAC1,Serine active site-containing protein 1;, , GO:0005783;GO:0031012;GO:0016021;GO:0044233;GO:0005739;GO:0030198;GO:0032367;GO:0036148;GO:0008654;, C:endoplasmic reticulum; C:extracellular matrix; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion;, , P:extracellular matrix organization; P:intracellular cholesterol transport; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process;|Q96JX3 Q49AT1 Q5VTX3 Q6PKF3,Protein SERAC1,Serine active site-containing protein 1;, , GO:0005783;GO:0031012;GO:0016021;GO:0044233;GO:0005739;GO:0030198;GO:0032367;GO:0036148;GO:0008654;, C:endoplasmic reticulum; C:extracellular matrix; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion;, , P:extracellular matrix organization; P:intracellular cholesterol transport; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; scaffold44 indexed_genome mRNA 11015325 11027765 . + . ID=transcript_8765;Q6ZYL4 Q0P5V8,General transcription factor IIH subunit 5,General transcription factor IIH polypeptide 5;TFB5 ortholog;TFIIH basal transcription factor complex TTD-A subunit;, PF06331;, GO:0005730;GO:0005654;GO:0005669;GO:0000439;GO:0005675;GO:0006370;GO:0071480;GO:0070911;GO:0000462;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0070816;GO:0006363;GO:0006366;GO:0006362;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:nucleolus; C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, , P:7-methylguanosine mRNA capping; P:cellular response to gamma radiation; P:global genome nucleotide-excision repair; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:phosphorylation of RNA polymerase II C-terminal domain; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase I promoter; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; scaffold44 indexed_genome mRNA 11117506 11251661 . + . ID=transcript_8766;Q9NRJ4 Q5T3M2 Q5T3M3 Q9HD22 Q9P2F0,Tubby-related protein 4,Tubby superfamily protein;Tubby-like protein 4;, PF01167;, GO:0005737;GO:0005829;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol;, , P:post-translational protein modification; P:protein ubiquitination;|Q9NRJ4 Q5T3M2 Q5T3M3 Q9HD22 Q9P2F0,Tubby-related protein 4,Tubby superfamily protein;Tubby-like protein 4;, PF01167;, GO:0005737;GO:0005829;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol;, , P:post-translational protein modification; P:protein ubiquitination; scaffold44 indexed_genome mRNA 11252295 11257553 . + . ID=transcript_8767;Q9NRJ4 Q5T3M2 Q5T3M3 Q9HD22 Q9P2F0,Tubby-related protein 4,Tubby superfamily protein;Tubby-like protein 4;, PF01167;, GO:0005737;GO:0005829;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol;, , P:post-translational protein modification; P:protein ubiquitination;|Q9NRJ4 Q5T3M2 Q5T3M3 Q9HD22 Q9P2F0,Tubby-related protein 4,Tubby superfamily protein;Tubby-like protein 4;, PF01167;, GO:0005737;GO:0005829;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol;, , P:post-translational protein modification; P:protein ubiquitination; scaffold44 indexed_genome mRNA 11313355 11345643 . + . ID=transcript_8768;Q9P2C4 Q5VTU1,Transmembrane protein 181,, , GO:0016021;GO:0015643;GO:0009405;, C:integral component of membrane;, F:toxic substance binding;, P:pathogenesis;|Q9P2C4 Q5VTU1,Transmembrane protein 181,, , GO:0016021;GO:0015643;GO:0009405;, C:integral component of membrane;, F:toxic substance binding;, P:pathogenesis;|Q9P2C4 Q5VTU1,Transmembrane protein 181,, , GO:0016021;GO:0015643;GO:0009405;, C:integral component of membrane;, F:toxic substance binding;, P:pathogenesis;|Q9P2C4 Q5VTU1,Transmembrane protein 181,, , GO:0016021;GO:0015643;GO:0009405;, C:integral component of membrane;, F:toxic substance binding;, P:pathogenesis;|Q9P2C4 Q5VTU1,Transmembrane protein 181,, , GO:0016021;GO:0015643;GO:0009405;, C:integral component of membrane;, F:toxic substance binding;, P:pathogenesis;|Q9P2C4 Q5VTU1,Transmembrane protein 181,, , GO:0016021;GO:0015643;GO:0009405;, C:integral component of membrane;, F:toxic substance binding;, P:pathogenesis;|Q9P2C4 Q5VTU1,Transmembrane protein 181,, , GO:0016021;GO:0015643;GO:0009405;, C:integral component of membrane;, F:toxic substance binding;, P:pathogenesis;|Q9P2C4 Q5VTU1,Transmembrane protein 181,, , GO:0016021;GO:0015643;GO:0009405;, C:integral component of membrane;, F:toxic substance binding;, P:pathogenesis;|Q9P2C4 Q5VTU1,Transmembrane protein 181,, , GO:0016021;GO:0015643;GO:0009405;, C:integral component of membrane;, F:toxic substance binding;, P:pathogenesis; scaffold44 indexed_genome mRNA 11346312 11354092 . - . ID=transcript_8769;P63172 Q15763 Q5VTU4,Dynein light chain Tctex-type 1,Protein CW-1;T-complex testis-specific protein 1 homolog;, PF03645;, GO:0044295;GO:0005868;GO:0005881;GO:0005576;GO:1904813;GO:0005794;GO:0043657;GO:0030027;GO:0005739;GO:0043025;GO:0034774;GO:0099503;GO:0005819;GO:0042802;GO:0008022;GO:0061564;GO:0051301;GO:0016358;GO:0000132;GO:0019060;GO:0075521;GO:0060548;GO:0035795;GO:0050768;GO:0048812;GO:0043312;GO:0010976;GO:0035022;GO:0051493;GO:0008277;GO:0043087;GO:0046718;, C:axonal growth cone; C:cytoplasmic dynein complex; C:cytoplasmic microtubule; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:host cell; C:lamellipodium; C:mitochondrion; C:neuronal cell body; C:secretory granule lumen; C:secretory vesicle; C:spindle;, F:identical protein binding; F:protein C-terminus binding;, P:axon development; P:cell division; P:dendrite development; P:establishment of mitotic spindle orientation; P:intracellular transport of viral protein in host cell; P:microtubule-dependent intracellular transport of viral material towards nucleus; P:negative regulation of cell death; P:negative regulation of mitochondrial membrane permeability; P:negative regulation of neurogenesis; P:neuron projection morphogenesis; P:neutrophil degranulation; P:positive regulation of neuron projection development; P:positive regulation of Rac protein signal transduction; P:regulation of cytoskeleton organization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of GTPase activity; P:viral entry into host cell;|P63172 Q15763 Q5VTU4,Dynein light chain Tctex-type 1,Protein CW-1;T-complex testis-specific protein 1 homolog;, PF03645;, GO:0044295;GO:0005868;GO:0005881;GO:0005576;GO:1904813;GO:0005794;GO:0043657;GO:0030027;GO:0005739;GO:0043025;GO:0034774;GO:0099503;GO:0005819;GO:0042802;GO:0008022;GO:0061564;GO:0051301;GO:0016358;GO:0000132;GO:0019060;GO:0075521;GO:0060548;GO:0035795;GO:0050768;GO:0048812;GO:0043312;GO:0010976;GO:0035022;GO:0051493;GO:0008277;GO:0043087;GO:0046718;, C:axonal growth cone; C:cytoplasmic dynein complex; C:cytoplasmic microtubule; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:host cell; C:lamellipodium; C:mitochondrion; C:neuronal cell body; C:secretory granule lumen; C:secretory vesicle; C:spindle;, F:identical protein binding; F:protein C-terminus binding;, P:axon development; P:cell division; P:dendrite development; P:establishment of mitotic spindle orientation; P:intracellular transport of viral protein in host cell; P:microtubule-dependent intracellular transport of viral material towards nucleus; P:negative regulation of cell death; P:negative regulation of mitochondrial membrane permeability; P:negative regulation of neurogenesis; P:neuron projection morphogenesis; P:neutrophil degranulation; P:positive regulation of neuron projection development; P:positive regulation of Rac protein signal transduction; P:regulation of cytoskeleton organization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of GTPase activity; P:viral entry into host cell; scaffold44 indexed_genome mRNA 11443801 11449756 . + . ID=transcript_8770;Q4VX76 Q496J4 Q496J6 Q5U3B9,Synaptotagmin-like protein 3,Exophilin-6;, PF00168;PF02318;, GO:0070382;GO:0019897;GO:0005886;GO:0005544;GO:0042043;GO:0031267;GO:0006887;GO:0006886;, C:exocytic vesicle; C:extrinsic component of plasma membrane; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:neurexin family protein binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; scaffold44 indexed_genome mRNA 11455178 11455747 . + . ID=transcript_8771;P26038,Moesin {ECO:0000303|PubMed:1924289},Membrane-organizing extension spike protein;, PF00769;PF09380;PF00373;PF09379;, GO:0045177;GO:0016324;GO:0016323;GO:0072562;GO:0071944;GO:0009986;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0005902;GO:0031528;GO:0005634;GO:0048471;GO:0005886;GO:0031143;GO:0001931;GO:0031982;GO:0003779;GO:0050839;GO:0003725;GO:0019899;GO:0019901;GO:0005102;GO:0005200;GO:0071394;GO:0061028;GO:0045198;GO:0022612;GO:0001771;GO:0035722;GO:0007159;GO:0050900;GO:0022614;GO:1903364;GO:2000643;GO:0010628;GO:0071803;GO:1902966;GO:0008360;GO:0008361;GO:2000401;GO:1902115;GO:0070489;GO:0072678;GO:0042098;GO:0016032;, C:apical part of cell; C:apical plasma membrane; C:basolateral plasma membrane; C:blood microparticle; C:cell periphery; C:cell surface; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:microvillus; C:microvillus membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:pseudopodium; C:uropod; C:vesicle;, F:actin binding; F:cell adhesion molecule binding; F:double-stranded RNA binding; F:enzyme binding; F:protein kinase binding; F:signaling receptor binding; F:structural constituent of cytoskeleton;, P:cellular response to testosterone stimulus; P:establishment of endothelial barrier; P:establishment of epithelial cell apical/basal polarity; P:gland morphogenesis; P:immunological synapse formation; P:interleukin-12-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:membrane to membrane docking; P:positive regulation of cellular protein catabolic process; P:positive regulation of early endosome to late endosome transport; P:positive regulation of gene expression; P:positive regulation of podosome assembly; P:positive regulation of protein localization to early endosome; P:regulation of cell shape; P:regulation of cell size; P:regulation of lymphocyte migration; P:regulation of organelle assembly; P:T cell aggregation; P:T cell migration; P:T cell proliferation; P:viral process; scaffold44 indexed_genome mRNA 11615607 11617773 . + . ID=transcript_8772;Q86UC2 Q96LQ5 Q96LX2 Q9BX75,Radial spoke head protein 3 homolog,A-kinase anchor protein RSPH3;Radial spoke head-like protein 2;, PF06098;, GO:0005929;GO:0005737;GO:0005856;, C:cilium; C:cytoplasm; C:cytoskeleton;|Q86UC2 Q96LQ5 Q96LX2 Q9BX75,Radial spoke head protein 3 homolog,A-kinase anchor protein RSPH3;Radial spoke head-like protein 2;, PF06098;, GO:0005929;GO:0005737;GO:0005856;, C:cilium; C:cytoplasm; C:cytoskeleton; scaffold44 indexed_genome mRNA 11619898 11628984 . - . ID=transcript_8773;Q86UC2 Q96LQ5 Q96LX2 Q9BX75,Radial spoke head protein 3 homolog,A-kinase anchor protein RSPH3;Radial spoke head-like protein 2;, PF06098;, GO:0005929;GO:0005737;GO:0005856;, C:cilium; C:cytoplasm; C:cytoskeleton; scaffold44 indexed_genome mRNA 11654244 11663179 . - . ID=transcript_8774;Q8N103 Q2NKM8 Q8NI40 Q96KZ2 Q96QA2,T-cell activation Rho GTPase-activating protein,T-cell activation GTPase-activating protein;, PF00620;, GO:0005829;GO:0005096;GO:0005085;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q8N103 Q2NKM8 Q8NI40 Q96KZ2 Q96QA2,T-cell activation Rho GTPase-activating protein,T-cell activation GTPase-activating protein;, PF00620;, GO:0005829;GO:0005096;GO:0005085;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold44 indexed_genome mRNA 11856538 11878778 . + . ID=transcript_8775;Q70CQ6 Q96JG1,Fibronectin type III domain-containing protein 1,Activation-associated cDNA protein;Expressed in synovial lining protein;, PF00041;, GO:0005576;GO:0016607;, C:extracellular region; C:nuclear speck; scaffold44 indexed_genome mRNA 12234493 12246305 . - . ID=transcript_8776;Q96EE6 Q9P2Z3,Superoxide dismutase [Mn], mitochondrial,, PF02777;PF00081;, GO:0070062;GO:0005759;GO:0042645;GO:0005739;GO:0003677;GO:0019899;GO:0042802;GO:0030145;GO:0019825;GO:0004784;GO:0003069;GO:0001315;GO:0071361;GO:0034599;GO:0050665;GO:0035722;GO:0008285;GO:1902631;GO:0043524;GO:1902176;GO:1904706;GO:0032364;GO:0030335;GO:0010729;GO:1905461;GO:1905932;GO:0051289;GO:0008217;GO:0006357;GO:0001836;GO:0019430;GO:0014823;GO:0046686;GO:0009409;GO:0042493;GO:0051602;GO:0042542;GO:0001666;GO:0035902;GO:0035900;GO:0033591;GO:0032496;GO:0071000;GO:0010042;GO:0009314;GO:0010269;GO:0034021;GO:0000303;GO:0010043;GO:0006801;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:DNA binding; F:enzyme binding; F:identical protein binding; F:manganese ion binding; F:oxygen binding; F:superoxide dismutase activity;, P:acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure; P:age-dependent response to reactive oxygen species; P:cellular response to ethanol; P:cellular response to oxidative stress; P:hydrogen peroxide biosynthetic process; P:interleukin-12-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of membrane hyperpolarization; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of vascular associated smooth muscle cell proliferation; P:oxygen homeostasis; P:positive regulation of cell migration; P:positive regulation of hydrogen peroxide biosynthetic process; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching; P:protein homotetramerization; P:regulation of blood pressure; P:regulation of transcription by RNA polymerase II; P:release of cytochrome c from mitochondria; P:removal of superoxide radicals; P:response to activity; P:response to cadmium ion; P:response to cold; P:response to drug; P:response to electrical stimulus; P:response to hydrogen peroxide; P:response to hypoxia; P:response to immobilization stress; P:response to isolation stress; P:response to L-ascorbic acid; P:response to lipopolysaccharide; P:response to magnetism; P:response to manganese ion; P:response to radiation; P:response to selenium ion; P:response to silicon dioxide; P:response to superoxide; P:response to zinc ion; P:superoxide metabolic process;|Q96EE6 Q9P2Z3,Superoxide dismutase [Mn], mitochondrial,, PF02777;PF00081;, GO:0070062;GO:0005759;GO:0042645;GO:0005739;GO:0003677;GO:0019899;GO:0042802;GO:0030145;GO:0019825;GO:0004784;GO:0003069;GO:0001315;GO:0071361;GO:0034599;GO:0050665;GO:0035722;GO:0008285;GO:1902631;GO:0043524;GO:1902176;GO:1904706;GO:0032364;GO:0030335;GO:0010729;GO:1905461;GO:1905932;GO:0051289;GO:0008217;GO:0006357;GO:0001836;GO:0019430;GO:0014823;GO:0046686;GO:0009409;GO:0042493;GO:0051602;GO:0042542;GO:0001666;GO:0035902;GO:0035900;GO:0033591;GO:0032496;GO:0071000;GO:0010042;GO:0009314;GO:0010269;GO:0034021;GO:0000303;GO:0010043;GO:0006801;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:DNA binding; F:enzyme binding; F:identical protein binding; F:manganese ion binding; F:oxygen binding; F:superoxide dismutase activity;, P:acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure; P:age-dependent response to reactive oxygen species; P:cellular response to ethanol; P:cellular response to oxidative stress; P:hydrogen peroxide biosynthetic process; P:interleukin-12-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of membrane hyperpolarization; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of vascular associated smooth muscle cell proliferation; P:oxygen homeostasis; P:positive regulation of cell migration; P:positive regulation of hydrogen peroxide biosynthetic process; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching; P:protein homotetramerization; P:regulation of blood pressure; P:regulation of transcription by RNA polymerase II; P:release of cytochrome c from mitochondria; P:removal of superoxide radicals; P:response to activity; P:response to cadmium ion; P:response to cold; P:response to drug; P:response to electrical stimulus; P:response to hydrogen peroxide; P:response to hypoxia; P:response to immobilization stress; P:response to isolation stress; P:response to L-ascorbic acid; P:response to lipopolysaccharide; P:response to magnetism; P:response to manganese ion; P:response to radiation; P:response to selenium ion; P:response to silicon dioxide; P:response to superoxide; P:response to zinc ion; P:superoxide metabolic process;|Q96EE6 Q9P2Z3,Superoxide dismutase [Mn], mitochondrial,, PF02777;PF00081;, GO:0070062;GO:0005759;GO:0042645;GO:0005739;GO:0003677;GO:0019899;GO:0042802;GO:0030145;GO:0019825;GO:0004784;GO:0003069;GO:0001315;GO:0071361;GO:0034599;GO:0050665;GO:0035722;GO:0008285;GO:1902631;GO:0043524;GO:1902176;GO:1904706;GO:0032364;GO:0030335;GO:0010729;GO:1905461;GO:1905932;GO:0051289;GO:0008217;GO:0006357;GO:0001836;GO:0019430;GO:0014823;GO:0046686;GO:0009409;GO:0042493;GO:0051602;GO:0042542;GO:0001666;GO:0035902;GO:0035900;GO:0033591;GO:0032496;GO:0071000;GO:0010042;GO:0009314;GO:0010269;GO:0034021;GO:0000303;GO:0010043;GO:0006801;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:DNA binding; F:enzyme binding; F:identical protein binding; F:manganese ion binding; F:oxygen binding; F:superoxide dismutase activity;, P:acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure; P:age-dependent response to reactive oxygen species; P:cellular response to ethanol; P:cellular response to oxidative stress; P:hydrogen peroxide biosynthetic process; P:interleukin-12-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of membrane hyperpolarization; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of vascular associated smooth muscle cell proliferation; P:oxygen homeostasis; P:positive regulation of cell migration; P:positive regulation of hydrogen peroxide biosynthetic process; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching; P:protein homotetramerization; P:regulation of blood pressure; P:regulation of transcription by RNA polymerase II; P:release of cytochrome c from mitochondria; P:removal of superoxide radicals; P:response to activity; P:response to cadmium ion; P:response to cold; P:response to drug; P:response to electrical stimulus; P:response to hydrogen peroxide; P:response to hypoxia; P:response to immobilization stress; P:response to isolation stress; P:response to L-ascorbic acid; P:response to lipopolysaccharide; P:response to magnetism; P:response to manganese ion; P:response to radiation; P:response to selenium ion; P:response to silicon dioxide; P:response to superoxide; P:response to zinc ion; P:superoxide metabolic process; scaffold44 indexed_genome mRNA 12246836 12295084 . + . ID=transcript_8777;Q15007 Q5TCL8 Q5TCL9 Q96T28 Q9BYJ7 Q9H4E2,Pre-mRNA-splicing regulator WTAP {ECO:0000305},Female-lethal(2)D homolog {ECO:0000303|PubMed:12444081};WT1-associated protein {ECO:0000303|PubMed:11001926};Wilms tumor 1-associating protein {ECO:0000303|PubMed:11001926};, PF17098;, GO:0005737;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0036396;GO:0042802;GO:0007049;GO:0080009;GO:0006397;GO:0007275;GO:0000381;GO:0016070;GO:0008380;, C:cytoplasm; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:identical protein binding;, P:cell cycle; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA metabolic process; P:RNA splicing; scaffold44 indexed_genome mRNA 12297234 12299511 . + . ID=transcript_8778;Q15007 Q5TCL8 Q5TCL9 Q96T28 Q9BYJ7 Q9H4E2,Pre-mRNA-splicing regulator WTAP {ECO:0000305},Female-lethal(2)D homolog {ECO:0000303|PubMed:12444081};WT1-associated protein {ECO:0000303|PubMed:11001926};Wilms tumor 1-associating protein {ECO:0000303|PubMed:11001926};, PF17098;, GO:0005737;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0036396;GO:0042802;GO:0007049;GO:0080009;GO:0006397;GO:0007275;GO:0000381;GO:0016070;GO:0008380;, C:cytoplasm; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:identical protein binding;, P:cell cycle; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA metabolic process; P:RNA splicing; scaffold44 indexed_genome mRNA 12299547 12301757 . + . ID=transcript_8779;Q15007 Q5TCL8 Q5TCL9 Q96T28 Q9BYJ7 Q9H4E2,Pre-mRNA-splicing regulator WTAP {ECO:0000305},Female-lethal(2)D homolog {ECO:0000303|PubMed:12444081};WT1-associated protein {ECO:0000303|PubMed:11001926};Wilms tumor 1-associating protein {ECO:0000303|PubMed:11001926};, PF17098;, GO:0005737;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0036396;GO:0042802;GO:0007049;GO:0080009;GO:0006397;GO:0007275;GO:0000381;GO:0016070;GO:0008380;, C:cytoplasm; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:identical protein binding;, P:cell cycle; P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA metabolic process; P:RNA splicing; scaffold44 indexed_genome mRNA 12306934 12328210 . - . ID=transcript_8780;P17987 E1P5B2 Q15556 Q5TCM3,T-complex protein 1 subunit alpha,CCT-alpha;, PF00118;, GO:0001669;GO:0044297;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0005794;GO:0000792;GO:0005874;GO:0000242;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0007339;GO:0035722;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:2000109;GO:0090666;GO:1901998;GO:0044053;GO:0007021;, C:acrosomal vesicle; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:heterochromatin; C:microtubule; C:pericentriolar material; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:interleukin-12-mediated signaling pathway; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:regulation of macrophage apoptotic process; P:scaRNA localization to Cajal body; P:toxin transport; P:translocation of peptides or proteins into host cell cytoplasm; P:tubulin complex assembly;|P17987 E1P5B2 Q15556 Q5TCM3,T-complex protein 1 subunit alpha,CCT-alpha;, PF00118;, GO:0001669;GO:0044297;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0005794;GO:0000792;GO:0005874;GO:0000242;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0007339;GO:0035722;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:2000109;GO:0090666;GO:1901998;GO:0044053;GO:0007021;, C:acrosomal vesicle; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:heterochromatin; C:microtubule; C:pericentriolar material; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:interleukin-12-mediated signaling pathway; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:regulation of macrophage apoptotic process; P:scaRNA localization to Cajal body; P:toxin transport; P:translocation of peptides or proteins into host cell cytoplasm; P:tubulin complex assembly;|P17987 E1P5B2 Q15556 Q5TCM3,T-complex protein 1 subunit alpha,CCT-alpha;, PF00118;, GO:0001669;GO:0044297;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0005794;GO:0000792;GO:0005874;GO:0000242;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0007339;GO:0035722;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:2000109;GO:0090666;GO:1901998;GO:0044053;GO:0007021;, C:acrosomal vesicle; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:heterochromatin; C:microtubule; C:pericentriolar material; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:interleukin-12-mediated signaling pathway; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:regulation of macrophage apoptotic process; P:scaRNA localization to Cajal body; P:toxin transport; P:translocation of peptides or proteins into host cell cytoplasm; P:tubulin complex assembly;|P17987 E1P5B2 Q15556 Q5TCM3,T-complex protein 1 subunit alpha,CCT-alpha;, PF00118;, GO:0001669;GO:0044297;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0005794;GO:0000792;GO:0005874;GO:0000242;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0007339;GO:0035722;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:2000109;GO:0090666;GO:1901998;GO:0044053;GO:0007021;, C:acrosomal vesicle; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:heterochromatin; C:microtubule; C:pericentriolar material; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:interleukin-12-mediated signaling pathway; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:regulation of macrophage apoptotic process; P:scaRNA localization to Cajal body; P:toxin transport; P:translocation of peptides or proteins into host cell cytoplasm; P:tubulin complex assembly;|P17987 E1P5B2 Q15556 Q5TCM3,T-complex protein 1 subunit alpha,CCT-alpha;, PF00118;, GO:0001669;GO:0044297;GO:0005813;GO:0005832;GO:0005829;GO:0070062;GO:0005794;GO:0000792;GO:0005874;GO:0000242;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0007339;GO:0035722;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:2000109;GO:0090666;GO:1901998;GO:0044053;GO:0007021;, C:acrosomal vesicle; C:cell body; C:centrosome; C:chaperonin-containing T-complex; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:heterochromatin; C:microtubule; C:pericentriolar material; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:interleukin-12-mediated signaling pathway; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:regulation of macrophage apoptotic process; P:scaRNA localization to Cajal body; P:toxin transport; P:translocation of peptides or proteins into host cell cytoplasm; P:tubulin complex assembly; scaffold44 indexed_genome mRNA 12333554 12335438 . + . ID=transcript_8781;Q9H0U6 Q5TAP9 Q9NZW8,39S ribosomal protein L18, mitochondrial,Mitochondrial large ribosomal subunit protein uL18m {ECO:0000303|PubMed:25278503};, PF00861;, GO:0005615;GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0008097;GO:0003735;GO:0070125;GO:0070126;GO:0035928;GO:0006412;, C:extracellular space; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:5S rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:rRNA import into mitochondrion; P:translation; scaffold44 indexed_genome mRNA 12335440 12346452 . + . ID=transcript_8782;Q8NA58 Q5TAP7 Q8N7X5,Poly(A)-specific ribonuclease PNLDC1 {ECO:0000305},PARN-like domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};Poly(A)-specific ribonuclease domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};, PF04857;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0001825;GO:0000184;GO:0000289;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:blastocyst formation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA poly(A) tail shortening;|Q8NA58 Q5TAP7 Q8N7X5,Poly(A)-specific ribonuclease PNLDC1 {ECO:0000305},PARN-like domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};Poly(A)-specific ribonuclease domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};, PF04857;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0001825;GO:0000184;GO:0000289;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:blastocyst formation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA poly(A) tail shortening; scaffold44 indexed_genome mRNA 12346478 12348687 . + . ID=transcript_8783;Q8NA58 Q5TAP7 Q8N7X5,Poly(A)-specific ribonuclease PNLDC1 {ECO:0000305},PARN-like domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};Poly(A)-specific ribonuclease domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};, PF04857;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0001825;GO:0000184;GO:0000289;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:blastocyst formation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA poly(A) tail shortening; scaffold44 indexed_genome mRNA 12351070 12357319 . + . ID=transcript_8784;Q8NA58 Q5TAP7 Q8N7X5,Poly(A)-specific ribonuclease PNLDC1 {ECO:0000305},PARN-like domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};Poly(A)-specific ribonuclease domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};, PF04857;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0001825;GO:0000184;GO:0000289;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:blastocyst formation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA poly(A) tail shortening;|Q8NA58 Q5TAP7 Q8N7X5,Poly(A)-specific ribonuclease PNLDC1 {ECO:0000305},PARN-like domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};Poly(A)-specific ribonuclease domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};, PF04857;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0001825;GO:0000184;GO:0000289;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:blastocyst formation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA poly(A) tail shortening;|Q8NA58 Q5TAP7 Q8N7X5,Poly(A)-specific ribonuclease PNLDC1 {ECO:0000305},PARN-like domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};Poly(A)-specific ribonuclease domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21185};, PF04857;, GO:0005737;GO:0005783;GO:0005789;GO:0016021;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0001825;GO:0000184;GO:0000289;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:blastocyst formation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA poly(A) tail shortening; scaffold44 indexed_genome mRNA 12392107 12393079 . + . ID=transcript_8785;P04201 E1P5B3 Q2TBC9 Q6FG47,Proto-oncogene Mas,, PF00001;, GO:0009986;GO:0005887;GO:0005886;GO:0001595;GO:0004945;GO:0004930;GO:0042277;GO:0007250;GO:0007186;GO:0021766;GO:0008584;GO:0001933;GO:0008284;GO:0045740;GO:0060732;GO:0070528;GO:0050727;GO:0014823;GO:0042493;GO:0034698;GO:0007283;, C:cell surface; C:integral component of plasma membrane; C:plasma membrane;, F:angiotensin receptor activity; F:angiotensin type II receptor activity; F:G protein-coupled receptor activity; F:peptide binding;, P:activation of NF-kappaB-inducing kinase activity; P:G protein-coupled receptor signaling pathway; P:hippocampus development; P:male gonad development; P:negative regulation of protein phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of DNA replication; P:positive regulation of inositol phosphate biosynthetic process; P:protein kinase C signaling; P:regulation of inflammatory response; P:response to activity; P:response to drug; P:response to gonadotropin; P:spermatogenesis; scaffold44 indexed_genome mRNA 12506574 12545846 . + . ID=transcript_8786;O15245 A6NFF3 A8K1H2 C9JSU6 O15395 Q9NQD4,Solute carrier family 22 member 1,Organic cation transporter 1;, PF00083;, GO:0016324;GO:0016323;GO:0005887;GO:0016020;GO:0005886;GO:0098793;GO:0005277;GO:0005330;GO:0042802;GO:0008504;GO:0005326;GO:0005334;GO:0015101;GO:0015214;GO:0015651;GO:0008513;GO:0019534;GO:0042910;GO:0090494;GO:0048241;GO:0010248;GO:0006836;GO:0015874;GO:0015695;GO:0072530;GO:0015697;GO:0051610;GO:1901998;GO:0150104;GO:0042908;GO:1990962;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:presynapse;, F:acetylcholine transmembrane transporter activity; F:dopamine:sodium symporter activity; F:identical protein binding; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:norepinephrine:sodium symporter activity; F:organic cation transmembrane transporter activity; F:pyrimidine nucleoside transmembrane transporter activity; F:quaternary ammonium group transmembrane transporter activity; F:secondary active organic cation transmembrane transporter activity; F:toxin transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:dopamine uptake; P:epinephrine transport; P:establishment or maintenance of transmembrane electrochemical gradient; P:neurotransmitter transport; P:norepinephrine transport; P:organic cation transport; P:purine-containing compound transmembrane transport; P:quaternary ammonium group transport; P:serotonin uptake; P:toxin transport; P:transport across blood-brain barrier; P:xenobiotic transport; P:xenobiotic transport across blood-brain barrier;|O15245 A6NFF3 A8K1H2 C9JSU6 O15395 Q9NQD4,Solute carrier family 22 member 1,Organic cation transporter 1;, PF00083;, GO:0016324;GO:0016323;GO:0005887;GO:0016020;GO:0005886;GO:0098793;GO:0005277;GO:0005330;GO:0042802;GO:0008504;GO:0005326;GO:0005334;GO:0015101;GO:0015214;GO:0015651;GO:0008513;GO:0019534;GO:0042910;GO:0090494;GO:0048241;GO:0010248;GO:0006836;GO:0015874;GO:0015695;GO:0072530;GO:0015697;GO:0051610;GO:1901998;GO:0150104;GO:0042908;GO:1990962;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:presynapse;, F:acetylcholine transmembrane transporter activity; F:dopamine:sodium symporter activity; F:identical protein binding; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:norepinephrine:sodium symporter activity; F:organic cation transmembrane transporter activity; F:pyrimidine nucleoside transmembrane transporter activity; F:quaternary ammonium group transmembrane transporter activity; F:secondary active organic cation transmembrane transporter activity; F:toxin transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:dopamine uptake; P:epinephrine transport; P:establishment or maintenance of transmembrane electrochemical gradient; P:neurotransmitter transport; P:norepinephrine transport; P:organic cation transport; P:purine-containing compound transmembrane transport; P:quaternary ammonium group transport; P:serotonin uptake; P:toxin transport; P:transport across blood-brain barrier; P:xenobiotic transport; P:xenobiotic transport across blood-brain barrier;|O15245 A6NFF3 A8K1H2 C9JSU6 O15395 Q9NQD4,Solute carrier family 22 member 1,Organic cation transporter 1;, PF00083;, GO:0016324;GO:0016323;GO:0005887;GO:0016020;GO:0005886;GO:0098793;GO:0005277;GO:0005330;GO:0042802;GO:0008504;GO:0005326;GO:0005334;GO:0015101;GO:0015214;GO:0015651;GO:0008513;GO:0019534;GO:0042910;GO:0090494;GO:0048241;GO:0010248;GO:0006836;GO:0015874;GO:0015695;GO:0072530;GO:0015697;GO:0051610;GO:1901998;GO:0150104;GO:0042908;GO:1990962;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:presynapse;, F:acetylcholine transmembrane transporter activity; F:dopamine:sodium symporter activity; F:identical protein binding; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:norepinephrine:sodium symporter activity; F:organic cation transmembrane transporter activity; F:pyrimidine nucleoside transmembrane transporter activity; F:quaternary ammonium group transmembrane transporter activity; F:secondary active organic cation transmembrane transporter activity; F:toxin transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:dopamine uptake; P:epinephrine transport; P:establishment or maintenance of transmembrane electrochemical gradient; P:neurotransmitter transport; P:norepinephrine transport; P:organic cation transport; P:purine-containing compound transmembrane transport; P:quaternary ammonium group transport; P:serotonin uptake; P:toxin transport; P:transport across blood-brain barrier; P:xenobiotic transport; P:xenobiotic transport across blood-brain barrier; scaffold44 indexed_genome mRNA 12578185 12587265 . - . ID=transcript_8787;O15244 Q5T7Q6 Q6PIQ8 Q8NG62 Q9NQB9,Solute carrier family 22 member 2,Organic cation transporter 2;, PF00083;, GO:0016324;GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0098793;GO:0005275;GO:0015220;GO:0015562;GO:0015179;GO:0061459;GO:0008504;GO:0005326;GO:0015101;GO:0015214;GO:0019534;GO:0042910;GO:0006919;GO:0015837;GO:0089718;GO:0007589;GO:0015871;GO:0090494;GO:0140115;GO:0051615;GO:1902475;GO:0097638;GO:0042136;GO:0006836;GO:0051620;GO:0015695;GO:0010628;GO:0072530;GO:0051610;GO:1901998;GO:0150104;GO:0042908;GO:1990962;, C:apical plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:presynapse;, F:amine transmembrane transporter activity; F:choline transmembrane transporter activity; F:efflux transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-arginine transmembrane transporter activity; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:organic cation transmembrane transporter activity; F:pyrimidine nucleoside transmembrane transporter activity; F:toxin transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:amine transport; P:amino acid import across plasma membrane; P:body fluid secretion; P:choline transport; P:dopamine uptake; P:export across plasma membrane; P:histamine uptake; P:L-alpha-amino acid transmembrane transport; P:L-arginine import across plasma membrane; P:neurotransmitter biosynthetic process; P:neurotransmitter transport; P:norepinephrine uptake; P:organic cation transport; P:positive regulation of gene expression; P:purine-containing compound transmembrane transport; P:serotonin uptake; P:toxin transport; P:transport across blood-brain barrier; P:xenobiotic transport; P:xenobiotic transport across blood-brain barrier; scaffold44 indexed_genome mRNA 12680871 12780058 . + . ID=transcript_8788;O75751 Q5SYN6 Q9UP02,Solute carrier family 22 member 3,Extraneuronal monoamine transporter;Organic cation transporter 3;, PF07690;, GO:0005887;GO:0016020;GO:0043025;GO:0005886;GO:0098793;GO:0005330;GO:0008504;GO:0005326;GO:0008514;GO:0015101;GO:0015651;GO:0019534;GO:0090494;GO:0051625;GO:0001692;GO:0051615;GO:0015844;GO:0015718;GO:0006836;GO:0051620;GO:0015711;GO:0015695;GO:0072530;GO:0015697;GO:0032098;GO:0051610;GO:1901998;GO:0150104;GO:0042908;, C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:plasma membrane; C:presynapse;, F:dopamine:sodium symporter activity; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:organic cation transmembrane transporter activity; F:quaternary ammonium group transmembrane transporter activity; F:toxin transmembrane transporter activity;, P:dopamine uptake; P:epinephrine uptake; P:histamine metabolic process; P:histamine uptake; P:monoamine transport; P:monocarboxylic acid transport; P:neurotransmitter transport; P:norepinephrine uptake; P:organic anion transport; P:organic cation transport; P:purine-containing compound transmembrane transport; P:quaternary ammonium group transport; P:regulation of appetite; P:serotonin uptake; P:toxin transport; P:transport across blood-brain barrier; P:xenobiotic transport; scaffold44 indexed_genome mRNA 12780482 12827974 . - . ID=transcript_8789;P00747 Q15146 Q5TEH4 Q6PA00,Plasminogen,, PF00051;PF00024;PF00089;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:0005886;GO:0031093;GO:0034185;GO:0051087;GO:0004175;GO:0019899;GO:0019900;GO:1990405;GO:0019904;GO:0004252;GO:0008236;GO:0005102;GO:0051702;GO:0007596;GO:0044267;GO:0022617;GO:0042730;GO:0008285;GO:2000048;GO:0010812;GO:0051918;GO:0002576;GO:0043536;GO:0051919;GO:0006508;GO:0048771;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:plasma membrane; C:platelet alpha granule lumen;, F:apolipoprotein binding; F:chaperone binding; F:endopeptidase activity; F:enzyme binding; F:kinase binding; F:protein antigen binding; F:protein domain specific binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding;, P:biological process involved in interaction with symbiont; P:blood coagulation; P:cellular protein metabolic process; P:extracellular matrix disassembly; P:fibrinolysis; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-substrate adhesion; P:negative regulation of fibrinolysis; P:platelet degranulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of fibrinolysis; P:proteolysis; P:tissue remodeling;|P00747 Q15146 Q5TEH4 Q6PA00,Plasminogen,, PF00051;PF00024;PF00089;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:0005886;GO:0031093;GO:0034185;GO:0051087;GO:0004175;GO:0019899;GO:0019900;GO:1990405;GO:0019904;GO:0004252;GO:0008236;GO:0005102;GO:0051702;GO:0007596;GO:0044267;GO:0022617;GO:0042730;GO:0008285;GO:2000048;GO:0010812;GO:0051918;GO:0002576;GO:0043536;GO:0051919;GO:0006508;GO:0048771;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:plasma membrane; C:platelet alpha granule lumen;, F:apolipoprotein binding; F:chaperone binding; F:endopeptidase activity; F:enzyme binding; F:kinase binding; F:protein antigen binding; F:protein domain specific binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding;, P:biological process involved in interaction with symbiont; P:blood coagulation; P:cellular protein metabolic process; P:extracellular matrix disassembly; P:fibrinolysis; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-substrate adhesion; P:negative regulation of fibrinolysis; P:platelet degranulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of fibrinolysis; P:proteolysis; P:tissue remodeling;|P00747 Q15146 Q5TEH4 Q6PA00,Plasminogen,, PF00051;PF00024;PF00089;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:0005886;GO:0031093;GO:0034185;GO:0051087;GO:0004175;GO:0019899;GO:0019900;GO:1990405;GO:0019904;GO:0004252;GO:0008236;GO:0005102;GO:0051702;GO:0007596;GO:0044267;GO:0022617;GO:0042730;GO:0008285;GO:2000048;GO:0010812;GO:0051918;GO:0002576;GO:0043536;GO:0051919;GO:0006508;GO:0048771;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:plasma membrane; C:platelet alpha granule lumen;, F:apolipoprotein binding; F:chaperone binding; F:endopeptidase activity; F:enzyme binding; F:kinase binding; F:protein antigen binding; F:protein domain specific binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding;, P:biological process involved in interaction with symbiont; P:blood coagulation; P:cellular protein metabolic process; P:extracellular matrix disassembly; P:fibrinolysis; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-substrate adhesion; P:negative regulation of fibrinolysis; P:platelet degranulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of fibrinolysis; P:proteolysis; P:tissue remodeling;|P00747 Q15146 Q5TEH4 Q6PA00,Plasminogen,, PF00051;PF00024;PF00089;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:0005886;GO:0031093;GO:0034185;GO:0051087;GO:0004175;GO:0019899;GO:0019900;GO:1990405;GO:0019904;GO:0004252;GO:0008236;GO:0005102;GO:0051702;GO:0007596;GO:0044267;GO:0022617;GO:0042730;GO:0008285;GO:2000048;GO:0010812;GO:0051918;GO:0002576;GO:0043536;GO:0051919;GO:0006508;GO:0048771;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:plasma membrane; C:platelet alpha granule lumen;, F:apolipoprotein binding; F:chaperone binding; F:endopeptidase activity; F:enzyme binding; F:kinase binding; F:protein antigen binding; F:protein domain specific binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding;, P:biological process involved in interaction with symbiont; P:blood coagulation; P:cellular protein metabolic process; P:extracellular matrix disassembly; P:fibrinolysis; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-substrate adhesion; P:negative regulation of fibrinolysis; P:platelet degranulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of fibrinolysis; P:proteolysis; P:tissue remodeling;|P08519 Q5VTD7 Q9UD88,Apolipoprotein(a),, PF00051;PF00089;, GO:0005576;GO:0034358;GO:0034185;GO:0004866;GO:0001968;GO:0008201;GO:0004252;GO:0008015;GO:0006629;GO:0006869;GO:0034374;, C:extracellular region; C:plasma lipoprotein particle;, F:apolipoprotein binding; F:endopeptidase inhibitor activity; F:fibronectin binding; F:heparin binding; F:serine-type endopeptidase activity;, P:blood circulation; P:lipid metabolic process; P:lipid transport; P:low-density lipoprotein particle remodeling;|P00747 Q15146 Q5TEH4 Q6PA00,Plasminogen,, PF00051;PF00024;PF00089;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0031232;GO:0005886;GO:0031093;GO:0034185;GO:0051087;GO:0004175;GO:0019899;GO:0019900;GO:1990405;GO:0019904;GO:0004252;GO:0008236;GO:0005102;GO:0051702;GO:0007596;GO:0044267;GO:0022617;GO:0042730;GO:0008285;GO:2000048;GO:0010812;GO:0051918;GO:0002576;GO:0043536;GO:0051919;GO:0006508;GO:0048771;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of external side of plasma membrane; C:plasma membrane; C:platelet alpha granule lumen;, F:apolipoprotein binding; F:chaperone binding; F:endopeptidase activity; F:enzyme binding; F:kinase binding; F:protein antigen binding; F:protein domain specific binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding;, P:biological process involved in interaction with symbiont; P:blood coagulation; P:cellular protein metabolic process; P:extracellular matrix disassembly; P:fibrinolysis; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-substrate adhesion; P:negative regulation of fibrinolysis; P:platelet degranulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of fibrinolysis; P:proteolysis; P:tissue remodeling;|Q16609 E1P5B4,Putative apolipoprotein(a)-like protein 2,Apolipoprotein a-related gene C protein;, PF00051;, GO:0005576;GO:0004252;, C:extracellular region;, F:serine-type endopeptidase activity; scaffold44 indexed_genome mRNA 12842033 12981872 . + . ID=transcript_8790;Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;|Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408,Mitogen-activated protein kinase kinase kinase 4,MAP three kinase 1;MAPK/ERK kinase kinase 4;, PF00069;, GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C; scaffold44 indexed_genome mRNA 12988219 12992191 . + . ID=transcript_8791;Q9NRZ5 B4DSF9 Q5TEF0,1-acyl-sn-glycerol-3-phosphate acyltransferase delta,1-acylglycerol-3-phosphate O-acyltransferase 4;Lysophosphatidic acid acyltransferase delta;, PF16076;PF01553;, GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0005741;GO:0003841;GO:0016746;GO:0016024;GO:0006654;GO:0008654;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:CDP-diacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process;|Q9NRZ5 B4DSF9 Q5TEF0,1-acyl-sn-glycerol-3-phosphate acyltransferase delta,1-acylglycerol-3-phosphate O-acyltransferase 4;Lysophosphatidic acid acyltransferase delta;, PF16076;PF01553;, GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0005741;GO:0003841;GO:0016746;GO:0016024;GO:0006654;GO:0008654;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:CDP-diacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process;|Q9NRZ5 B4DSF9 Q5TEF0,1-acyl-sn-glycerol-3-phosphate acyltransferase delta,1-acylglycerol-3-phosphate O-acyltransferase 4;Lysophosphatidic acid acyltransferase delta;, PF16076;PF01553;, GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0005741;GO:0003841;GO:0016746;GO:0016024;GO:0006654;GO:0008654;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:CDP-diacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; scaffold44 indexed_genome mRNA 13015376 13109573 . - . ID=transcript_8792;Q9NRZ5 B4DSF9 Q5TEF0,1-acyl-sn-glycerol-3-phosphate acyltransferase delta,1-acylglycerol-3-phosphate O-acyltransferase 4;Lysophosphatidic acid acyltransferase delta;, PF16076;PF01553;, GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0005741;GO:0003841;GO:0016746;GO:0016024;GO:0006654;GO:0008654;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:CDP-diacylglycerol biosynthetic process; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; scaffold44 indexed_genome mRNA 14375181 14870982 . + . ID=transcript_8793;Q96M98 E1P5B5 Q6IMB8 Q8IZM1 Q8NHP5 Q9H1V9,Parkin coregulated gene protein,Molecular chaperone/chaperonin-binding protein;PARK2 coregulated gene protein;, PF10274;, GO:0044297;GO:0005829;GO:0002177;GO:0043005;GO:0005634;GO:0097225;GO:0031982;GO:0003779;GO:0043014;GO:0048487;GO:0051087;GO:0001664;GO:0031072;GO:0030544;GO:0051879;GO:0031625;GO:0034613;GO:0034620;GO:0060548;GO:0007286;, C:cell body; C:cytosol; C:manchette; C:neuron projection; C:nucleus; C:sperm midpiece; C:vesicle;, F:actin binding; F:alpha-tubulin binding; F:beta-tubulin binding; F:chaperone binding; F:G protein-coupled receptor binding; F:heat shock protein binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:ubiquitin protein ligase binding;, P:cellular protein localization; P:cellular response to unfolded protein; P:negative regulation of cell death; P:spermatid development; scaffold44 indexed_genome mRNA 15002260 15003166 . - . ID=transcript_8794;Q9P0X7 Q9P0X8 Q9P0X9 Q9P0Y0 Q9P0Y1,Protein quaking,, PF00013;PF16551;PF16544;, GO:0005737;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0017124;GO:0042759;GO:0006397;GO:0051028;GO:0042692;GO:0042552;GO:0010628;GO:0048024;GO:0006417;GO:0008380;GO:0007286;GO:0001570;, C:cytoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding; F:SH3 domain binding;, P:long-chain fatty acid biosynthetic process; P:mRNA processing; P:mRNA transport; P:muscle cell differentiation; P:myelination; P:positive regulation of gene expression; P:regulation of mRNA splicing, via spliceosome; P:regulation of translation; P:RNA splicing; P:spermatid development; P:vasculogenesis; scaffold44 indexed_genome mRNA 15068131 15108622 . + . ID=transcript_8795;Q9P0X7 Q9P0X8 Q9P0X9 Q9P0Y0 Q9P0Y1,Protein quaking,, PF00013;PF16551;PF16544;, GO:0005737;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0017124;GO:0042759;GO:0006397;GO:0051028;GO:0042692;GO:0042552;GO:0010628;GO:0048024;GO:0006417;GO:0008380;GO:0007286;GO:0001570;, C:cytoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding; F:SH3 domain binding;, P:long-chain fatty acid biosynthetic process; P:mRNA processing; P:mRNA transport; P:muscle cell differentiation; P:myelination; P:positive regulation of gene expression; P:regulation of mRNA splicing, via spliceosome; P:regulation of translation; P:RNA splicing; P:spermatid development; P:vasculogenesis;|Q9P0X7 Q9P0X8 Q9P0X9 Q9P0Y0 Q9P0Y1,Protein quaking,, PF00013;PF16551;PF16544;, GO:0005737;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0017124;GO:0042759;GO:0006397;GO:0051028;GO:0042692;GO:0042552;GO:0010628;GO:0048024;GO:0006417;GO:0008380;GO:0007286;GO:0001570;, C:cytoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding; F:SH3 domain binding;, P:long-chain fatty acid biosynthetic process; P:mRNA processing; P:mRNA transport; P:muscle cell differentiation; P:myelination; P:positive regulation of gene expression; P:regulation of mRNA splicing, via spliceosome; P:regulation of translation; P:RNA splicing; P:spermatid development; P:vasculogenesis;|Q9P0X7 Q9P0X8 Q9P0X9 Q9P0Y0 Q9P0Y1,Protein quaking,, PF00013;PF16551;PF16544;, GO:0005737;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0017124;GO:0042759;GO:0006397;GO:0051028;GO:0042692;GO:0042552;GO:0010628;GO:0048024;GO:0006417;GO:0008380;GO:0007286;GO:0001570;, C:cytoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding; F:SH3 domain binding;, P:long-chain fatty acid biosynthetic process; P:mRNA processing; P:mRNA transport; P:muscle cell differentiation; P:myelination; P:positive regulation of gene expression; P:regulation of mRNA splicing, via spliceosome; P:regulation of translation; P:RNA splicing; P:spermatid development; P:vasculogenesis;|Q9P0X7 Q9P0X8 Q9P0X9 Q9P0Y0 Q9P0Y1,Protein quaking,, PF00013;PF16551;PF16544;, GO:0005737;GO:0005634;GO:0045202;GO:0003729;GO:0003723;GO:0017124;GO:0042759;GO:0006397;GO:0051028;GO:0042692;GO:0042552;GO:0010628;GO:0048024;GO:0006417;GO:0008380;GO:0007286;GO:0001570;, C:cytoplasm; C:nucleus; C:synapse;, F:mRNA binding; F:RNA binding; F:SH3 domain binding;, P:long-chain fatty acid biosynthetic process; P:mRNA processing; P:mRNA transport; P:muscle cell differentiation; P:myelination; P:positive regulation of gene expression; P:regulation of mRNA splicing, via spliceosome; P:regulation of translation; P:RNA splicing; P:spermatid development; P:vasculogenesis; scaffold44 indexed_genome mRNA 16479813 16485908 . - . ID=transcript_8796;Q9Y233 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1,cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A,, PF01590;PF00233;, GO:0005829;GO:0047555;GO:0004114;GO:0030552;GO:0030553;GO:0004118;GO:0046872;GO:0006198;GO:0046069;GO:0007186;GO:0010754;GO:0007165;, C:cytosol;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:cGMP binding; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:cGMP catabolic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of cGMP-mediated signaling; P:signal transduction; scaffold44 indexed_genome mRNA 16485950 17028100 . + . ID=transcript_8797;Q9Y233 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1,cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A,, PF01590;PF00233;, GO:0005829;GO:0047555;GO:0004114;GO:0030552;GO:0030553;GO:0004118;GO:0046872;GO:0006198;GO:0046069;GO:0007186;GO:0010754;GO:0007165;, C:cytosol;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:cGMP binding; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:cGMP catabolic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of cGMP-mediated signaling; P:signal transduction;|Q9Y233 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1,cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A,, PF01590;PF00233;, GO:0005829;GO:0047555;GO:0004114;GO:0030552;GO:0030553;GO:0004118;GO:0046872;GO:0006198;GO:0046069;GO:0007186;GO:0010754;GO:0007165;, C:cytosol;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:cGMP binding; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:cGMP catabolic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of cGMP-mediated signaling; P:signal transduction;|Q9Y233 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1,cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A,, PF01590;PF00233;, GO:0005829;GO:0047555;GO:0004114;GO:0030552;GO:0030553;GO:0004118;GO:0046872;GO:0006198;GO:0046069;GO:0007186;GO:0010754;GO:0007165;, C:cytosol;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:cGMP binding; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:cGMP catabolic process; P:G protein-coupled receptor signaling pathway; P:negative regulation of cGMP-mediated signaling; P:signal transduction; scaffold44 indexed_genome mRNA 17268807 17281421 . - . ID=transcript_8798;Q8WV19 Q5TI64 Q9UIC7,Vesicle transport protein SFT2A,SFT2 domain-containing protein 1;pRGR1;, PF04178;, GO:0016021;GO:0015031;GO:0016192;, C:integral component of membrane;, , P:protein transport; P:vesicle-mediated transport;|Q8WV19 Q5TI64 Q9UIC7,Vesicle transport protein SFT2A,SFT2 domain-containing protein 1;pRGR1;, PF04178;, GO:0016021;GO:0015031;GO:0016192;, C:integral component of membrane;, , P:protein transport; P:vesicle-mediated transport; scaffold44 indexed_genome mRNA 17310505 17323415 . - . ID=transcript_8799;Q9Y5U8 B2R5I7 Q5TI66 Q9HB67 Q9UQN4,Mitochondrial pyruvate carrier 1,Brain protein 44-like protein;, PF03650;, GO:0031305;GO:0005739;GO:0050833;GO:0006850;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:pyruvate transmembrane transporter activity;, P:mitochondrial pyruvate transmembrane transport;|Q9Y5U8 B2R5I7 Q5TI66 Q9HB67 Q9UQN4,Mitochondrial pyruvate carrier 1,Brain protein 44-like protein;, PF03650;, GO:0031305;GO:0005739;GO:0050833;GO:0006850;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, F:pyruvate transmembrane transporter activity;, P:mitochondrial pyruvate transmembrane transport; scaffold44 indexed_genome mRNA 17346405 17456850 . - . ID=transcript_8800;Q15349 B3KTK9 Q15419 Q59GJ3 Q5TI68 Q96J38 Q9UJN5,Ribosomal protein S6 kinase alpha-2,90 kDa ribosomal protein S6 kinase 2;MAP kinase-activated protein kinase 1c;Ribosomal S6 kinase 3;pp90RSK3;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007268;GO:0035556;GO:0045786;GO:0008285;GO:0018105;GO:0043065;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:chemical synaptic transmission; P:intracellular signal transduction; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:signal transduction;|Q15349 B3KTK9 Q15419 Q59GJ3 Q5TI68 Q96J38 Q9UJN5,Ribosomal protein S6 kinase alpha-2,90 kDa ribosomal protein S6 kinase 2;MAP kinase-activated protein kinase 1c;Ribosomal S6 kinase 3;pp90RSK3;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007268;GO:0035556;GO:0045786;GO:0008285;GO:0018105;GO:0043065;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:chemical synaptic transmission; P:intracellular signal transduction; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:signal transduction;|Q15349 B3KTK9 Q15419 Q59GJ3 Q5TI68 Q96J38 Q9UJN5,Ribosomal protein S6 kinase alpha-2,90 kDa ribosomal protein S6 kinase 2;MAP kinase-activated protein kinase 1c;Ribosomal S6 kinase 3;pp90RSK3;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007268;GO:0035556;GO:0045786;GO:0008285;GO:0018105;GO:0043065;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:chemical synaptic transmission; P:intracellular signal transduction; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic process; P:signal transduction; scaffold44 indexed_genome mRNA 17627359 17631027 . + . ID=transcript_8801;P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q9BXR3 Q6KH04 Q9BXR4 Q9UKH5 Q9UP31 Q9WIK9 Q9WJR4,Endogenous retrovirus group K member 6 Pol protein,HERV-K(C7) Pol protein;HERV-K(HML-2.HOM) Pol protein;HERV-K108 Pol protein;HERV-K_7p22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold44 indexed_genome mRNA 17647711 17648873 . - . ID=transcript_8802;Q9BXR3 Q6KH04 Q9BXR4 Q9UKH5 Q9UP31 Q9WIK9 Q9WJR4,Endogenous retrovirus group K member 6 Pol protein,HERV-K(C7) Pol protein;HERV-K(HML-2.HOM) Pol protein;HERV-K108 Pol protein;HERV-K_7p22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold44 indexed_genome mRNA 17661667 17673090 . - . ID=transcript_8803;O00584 B2RDA7 E1P5C3 Q5T8Q0 Q8TCU2 Q9BZ46 Q9BZ47,Ribonuclease T2,Ribonuclease 6;, PF00445;, GO:0035578;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0043202;GO:0005764;GO:0005758;GO:0004521;GO:0016829;GO:0004540;GO:0033897;GO:0003723;GO:0045087;GO:0043312;GO:0006401;, C:azurophil granule lumen; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal lumen; C:lysosome; C:mitochondrial intermembrane space;, F:endoribonuclease activity; F:lyase activity; F:ribonuclease activity; F:ribonuclease T2 activity; F:RNA binding;, P:innate immune response; P:neutrophil degranulation; P:RNA catabolic process;|O00584 B2RDA7 E1P5C3 Q5T8Q0 Q8TCU2 Q9BZ46 Q9BZ47,Ribonuclease T2,Ribonuclease 6;, PF00445;, GO:0035578;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0043202;GO:0005764;GO:0005758;GO:0004521;GO:0016829;GO:0004540;GO:0033897;GO:0003723;GO:0045087;GO:0043312;GO:0006401;, C:azurophil granule lumen; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal lumen; C:lysosome; C:mitochondrial intermembrane space;, F:endoribonuclease activity; F:lyase activity; F:ribonuclease activity; F:ribonuclease T2 activity; F:RNA binding;, P:innate immune response; P:neutrophil degranulation; P:RNA catabolic process; scaffold44 indexed_genome mRNA 17712465 17736099 . - . ID=transcript_8804;O95684 A8K1D1 B2R705 Q49AI0 Q5R3F6 Q96EW1,Centrosomal protein 43 {ECO:0000305},FGFR1 oncogene partner;, PF09398;, GO:0042995;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0048471;GO:0042803;GO:0019901;GO:0030292;GO:0097711;GO:0000086;GO:0034453;GO:0006469;GO:0030307;GO:0030335;GO:0008284;GO:0010389;, C:cell projection; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:protein kinase binding; F:protein tyrosine kinase inhibitor activity;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring; P:negative regulation of protein kinase activity; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of G2/M transition of mitotic cell cycle;|O95684 A8K1D1 B2R705 Q49AI0 Q5R3F6 Q96EW1,Centrosomal protein 43 {ECO:0000305},FGFR1 oncogene partner;, PF09398;, GO:0042995;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0048471;GO:0042803;GO:0019901;GO:0030292;GO:0097711;GO:0000086;GO:0034453;GO:0006469;GO:0030307;GO:0030335;GO:0008284;GO:0010389;, C:cell projection; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:protein kinase binding; F:protein tyrosine kinase inhibitor activity;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring; P:negative regulation of protein kinase activity; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of G2/M transition of mitotic cell cycle;|O95684 A8K1D1 B2R705 Q49AI0 Q5R3F6 Q96EW1,Centrosomal protein 43 {ECO:0000305},FGFR1 oncogene partner;, PF09398;, GO:0042995;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0048471;GO:0042803;GO:0019901;GO:0030292;GO:0097711;GO:0000086;GO:0034453;GO:0006469;GO:0030307;GO:0030335;GO:0008284;GO:0010389;, C:cell projection; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:protein kinase binding; F:protein tyrosine kinase inhibitor activity;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring; P:negative regulation of protein kinase activity; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of G2/M transition of mitotic cell cycle; scaffold44 indexed_genome mRNA 17737290 17740040 . + . ID=transcript_8805;O95684 A8K1D1 B2R705 Q49AI0 Q5R3F6 Q96EW1,Centrosomal protein 43 {ECO:0000305},FGFR1 oncogene partner;, PF09398;, GO:0042995;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0048471;GO:0042803;GO:0019901;GO:0030292;GO:0097711;GO:0000086;GO:0034453;GO:0006469;GO:0030307;GO:0030335;GO:0008284;GO:0010389;, C:cell projection; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:protein kinase binding; F:protein tyrosine kinase inhibitor activity;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring; P:negative regulation of protein kinase activity; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:regulation of G2/M transition of mitotic cell cycle; scaffold44 indexed_genome mRNA 17815501 17816711 . + . ID=transcript_8806;P51684 E1P5C6 P78553 Q92846,C-C chemokine receptor type 6,Chemokine receptor-like 3;DRY6;G-protein coupled receptor 29;GPR-CY4;LARC receptor;, PF00001;, GO:0009986;GO:0009897;GO:0005887;GO:0005886;GO:0036126;GO:0097225;GO:0097524;GO:0097228;GO:0019957;GO:0016493;GO:0004950;GO:0038023;GO:0019722;GO:0060326;GO:0006968;GO:0006935;GO:0002407;GO:1904155;GO:1904156;GO:0007186;GO:0006959;GO:0006955;GO:0048290;GO:0002523;GO:0072676;GO:0007204;GO:2000510;GO:0010634;GO:0060474;GO:2000404;GO:0007165;GO:0072678;GO:0072679;, C:cell surface; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane; C:sperm flagellum; C:sperm midpiece; C:sperm plasma membrane; C:sperm principal piece;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:chemokine receptor activity; F:signaling receptor activity;, P:calcium-mediated signaling; P:cell chemotaxis; P:cellular defense response; P:chemotaxis; P:dendritic cell chemotaxis; P:DN2 thymocyte differentiation; P:DN3 thymocyte differentiation; P:G protein-coupled receptor signaling pathway; P:humoral immune response; P:immune response; P:isotype switching to IgA isotypes; P:leukocyte migration involved in inflammatory response; P:lymphocyte migration; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of epithelial cell migration; P:positive regulation of flagellated sperm motility involved in capacitation; P:regulation of T cell migration; P:signal transduction; P:T cell migration; P:thymocyte migration; scaffold44 indexed_genome mRNA 17894401 17920977 . - . ID=transcript_8807;Q86WB7 B3KRP5 Q4QQJ4 Q5JZD6,Protein unc-93 homolog A,, PF05978;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold44 indexed_genome mRNA 18221672 18261621 . + . ID=transcript_8808;P55196 O75087 O75088 O75089 Q59FP0 Q5TIG6 Q5TIG7 Q9NSN7 Q9NU92,Afadin,ALL1-fused gene from chromosome 6 protein;Afadin adherens junction formation factor {ECO:0000312|HGNC:HGNC:7137};, PF01843;PF00498;PF00595;PF00788;, GO:0005912;GO:0030054;GO:0044291;GO:0005911;GO:0005829;GO:0016607;GO:0005654;GO:0005886;GO:0046930;GO:0070160;GO:0051015;GO:0045296;GO:0050839;GO:0008022;GO:0031267;GO:0034332;GO:0070830;GO:0007155;GO:0044331;GO:0007267;GO:0090557;GO:0061951;GO:0030336;GO:0046931;GO:0022409;GO:2000049;GO:0010628;GO:0043547;GO:0032880;GO:0007165;, C:adherens junction; C:cell junction; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:nuclear speck; C:nucleoplasm; C:plasma membrane; C:pore complex; C:tight junction;, F:actin filament binding; F:cadherin binding; F:cell adhesion molecule binding; F:protein C-terminus binding; F:small GTPase binding;, P:adherens junction organization; P:bicellular tight junction assembly; P:cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell signaling; P:establishment of endothelial intestinal barrier; P:establishment of protein localization to plasma membrane; P:negative regulation of cell migration; P:pore complex assembly; P:positive regulation of cell-cell adhesion; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:regulation of protein localization; P:signal transduction;|P55196 O75087 O75088 O75089 Q59FP0 Q5TIG6 Q5TIG7 Q9NSN7 Q9NU92,Afadin,ALL1-fused gene from chromosome 6 protein;Afadin adherens junction formation factor {ECO:0000312|HGNC:HGNC:7137};, PF01843;PF00498;PF00595;PF00788;, GO:0005912;GO:0030054;GO:0044291;GO:0005911;GO:0005829;GO:0016607;GO:0005654;GO:0005886;GO:0046930;GO:0070160;GO:0051015;GO:0045296;GO:0050839;GO:0008022;GO:0031267;GO:0034332;GO:0070830;GO:0007155;GO:0044331;GO:0007267;GO:0090557;GO:0061951;GO:0030336;GO:0046931;GO:0022409;GO:2000049;GO:0010628;GO:0043547;GO:0032880;GO:0007165;, C:adherens junction; C:cell junction; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:nuclear speck; C:nucleoplasm; C:plasma membrane; C:pore complex; C:tight junction;, F:actin filament binding; F:cadherin binding; F:cell adhesion molecule binding; F:protein C-terminus binding; F:small GTPase binding;, P:adherens junction organization; P:bicellular tight junction assembly; P:cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell signaling; P:establishment of endothelial intestinal barrier; P:establishment of protein localization to plasma membrane; P:negative regulation of cell migration; P:pore complex assembly; P:positive regulation of cell-cell adhesion; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:regulation of protein localization; P:signal transduction;|P55196 O75087 O75088 O75089 Q59FP0 Q5TIG6 Q5TIG7 Q9NSN7 Q9NU92,Afadin,ALL1-fused gene from chromosome 6 protein;Afadin adherens junction formation factor {ECO:0000312|HGNC:HGNC:7137};, PF01843;PF00498;PF00595;PF00788;, GO:0005912;GO:0030054;GO:0044291;GO:0005911;GO:0005829;GO:0016607;GO:0005654;GO:0005886;GO:0046930;GO:0070160;GO:0051015;GO:0045296;GO:0050839;GO:0008022;GO:0031267;GO:0034332;GO:0070830;GO:0007155;GO:0044331;GO:0007267;GO:0090557;GO:0061951;GO:0030336;GO:0046931;GO:0022409;GO:2000049;GO:0010628;GO:0043547;GO:0032880;GO:0007165;, C:adherens junction; C:cell junction; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:nuclear speck; C:nucleoplasm; C:plasma membrane; C:pore complex; C:tight junction;, F:actin filament binding; F:cadherin binding; F:cell adhesion molecule binding; F:protein C-terminus binding; F:small GTPase binding;, P:adherens junction organization; P:bicellular tight junction assembly; P:cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell signaling; P:establishment of endothelial intestinal barrier; P:establishment of protein localization to plasma membrane; P:negative regulation of cell migration; P:pore complex assembly; P:positive regulation of cell-cell adhesion; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:regulation of protein localization; P:signal transduction; scaffold44 indexed_genome mRNA 18276617 18281207 . + . ID=transcript_8809;P55196 O75087 O75088 O75089 Q59FP0 Q5TIG6 Q5TIG7 Q9NSN7 Q9NU92,Afadin,ALL1-fused gene from chromosome 6 protein;Afadin adherens junction formation factor {ECO:0000312|HGNC:HGNC:7137};, PF01843;PF00498;PF00595;PF00788;, GO:0005912;GO:0030054;GO:0044291;GO:0005911;GO:0005829;GO:0016607;GO:0005654;GO:0005886;GO:0046930;GO:0070160;GO:0051015;GO:0045296;GO:0050839;GO:0008022;GO:0031267;GO:0034332;GO:0070830;GO:0007155;GO:0044331;GO:0007267;GO:0090557;GO:0061951;GO:0030336;GO:0046931;GO:0022409;GO:2000049;GO:0010628;GO:0043547;GO:0032880;GO:0007165;, C:adherens junction; C:cell junction; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:nuclear speck; C:nucleoplasm; C:plasma membrane; C:pore complex; C:tight junction;, F:actin filament binding; F:cadherin binding; F:cell adhesion molecule binding; F:protein C-terminus binding; F:small GTPase binding;, P:adherens junction organization; P:bicellular tight junction assembly; P:cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell signaling; P:establishment of endothelial intestinal barrier; P:establishment of protein localization to plasma membrane; P:negative regulation of cell migration; P:pore complex assembly; P:positive regulation of cell-cell adhesion; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:regulation of protein localization; P:signal transduction;|P55196 O75087 O75088 O75089 Q59FP0 Q5TIG6 Q5TIG7 Q9NSN7 Q9NU92,Afadin,ALL1-fused gene from chromosome 6 protein;Afadin adherens junction formation factor {ECO:0000312|HGNC:HGNC:7137};, PF01843;PF00498;PF00595;PF00788;, GO:0005912;GO:0030054;GO:0044291;GO:0005911;GO:0005829;GO:0016607;GO:0005654;GO:0005886;GO:0046930;GO:0070160;GO:0051015;GO:0045296;GO:0050839;GO:0008022;GO:0031267;GO:0034332;GO:0070830;GO:0007155;GO:0044331;GO:0007267;GO:0090557;GO:0061951;GO:0030336;GO:0046931;GO:0022409;GO:2000049;GO:0010628;GO:0043547;GO:0032880;GO:0007165;, C:adherens junction; C:cell junction; C:cell-cell contact zone; C:cell-cell junction; C:cytosol; C:nuclear speck; C:nucleoplasm; C:plasma membrane; C:pore complex; C:tight junction;, F:actin filament binding; F:cadherin binding; F:cell adhesion molecule binding; F:protein C-terminus binding; F:small GTPase binding;, P:adherens junction organization; P:bicellular tight junction assembly; P:cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell signaling; P:establishment of endothelial intestinal barrier; P:establishment of protein localization to plasma membrane; P:negative regulation of cell migration; P:pore complex assembly; P:positive regulation of cell-cell adhesion; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:regulation of protein localization; P:signal transduction; scaffold44 indexed_genome mRNA 18590601 18706540 . + . ID=transcript_8810;Q9H3U0 Q9H4F7 Q9HCV2,SPARC-related modular calcium-binding protein 2,Secreted modular calcium-binding protein 2;Smooth muscle-associated protein 2;, PF07648;PF10591;PF00086;, GO:0005604;GO:0071944;GO:0005615;GO:0005509;GO:0050840;GO:0008201;GO:0030198;GO:0045766;GO:2000573;GO:2001028;GO:0010595;GO:0045743;GO:0045931;GO:1900748;GO:0035470;, C:basement membrane; C:cell periphery; C:extracellular space;, F:calcium ion binding; F:extracellular matrix binding; F:heparin binding;, P:extracellular matrix organization; P:positive regulation of angiogenesis; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell migration; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of mitotic cell cycle; P:positive regulation of vascular endothelial growth factor signaling pathway; P:positive regulation of vascular wound healing; scaffold44 indexed_genome mRNA 19031112 19034565 . - . ID=transcript_8811;P35442 A6H8N1 A7E232 Q5RI52,Thrombospondin-2,, PF12947;PF07645;PF00090;PF02412;PF05735;PF00093;, GO:0062023;GO:0005576;GO:0031091;GO:0005509;GO:0008201;GO:0007155;GO:0016525;, C:collagen-containing extracellular matrix; C:extracellular region; C:platelet alpha granule;, F:calcium ion binding; F:heparin binding;, P:cell adhesion; P:negative regulation of angiogenesis; scaffold44 indexed_genome mRNA 19035135 19039429 . - . ID=transcript_8812;P35442 A6H8N1 A7E232 Q5RI52,Thrombospondin-2,, PF12947;PF07645;PF00090;PF02412;PF05735;PF00093;, GO:0062023;GO:0005576;GO:0031091;GO:0005509;GO:0008201;GO:0007155;GO:0016525;, C:collagen-containing extracellular matrix; C:extracellular region; C:platelet alpha granule;, F:calcium ion binding; F:heparin binding;, P:cell adhesion; P:negative regulation of angiogenesis; scaffold44 indexed_genome mRNA 19039466 19046726 . - . ID=transcript_8813;P35442 A6H8N1 A7E232 Q5RI52,Thrombospondin-2,, PF12947;PF07645;PF00090;PF02412;PF05735;PF00093;, GO:0062023;GO:0005576;GO:0031091;GO:0005509;GO:0008201;GO:0007155;GO:0016525;, C:collagen-containing extracellular matrix; C:extracellular region; C:platelet alpha granule;, F:calcium ion binding; F:heparin binding;, P:cell adhesion; P:negative regulation of angiogenesis; scaffold44 indexed_genome mRNA 19047664 19056741 . - . ID=transcript_8814;P35442 A6H8N1 A7E232 Q5RI52,Thrombospondin-2,, PF12947;PF07645;PF00090;PF02412;PF05735;PF00093;, GO:0062023;GO:0005576;GO:0031091;GO:0005509;GO:0008201;GO:0007155;GO:0016525;, C:collagen-containing extracellular matrix; C:extracellular region; C:platelet alpha granule;, F:calcium ion binding; F:heparin binding;, P:cell adhesion; P:negative regulation of angiogenesis; scaffold44 indexed_genome mRNA 19280400 19282696 . + . ID=transcript_8815;A2RRH5 A5PLM8 C9JGV0 Q5T066,WD repeat-containing protein 27,, PF00400;, GO:0005654;, C:nucleoplasm; scaffold44 indexed_genome mRNA 19286665 19347014 . - . ID=transcript_8816;A2RRH5 A5PLM8 C9JGV0 Q5T066,WD repeat-containing protein 27,, PF00400;, GO:0005654;, C:nucleoplasm;|A2RRH5 A5PLM8 C9JGV0 Q5T066,WD repeat-containing protein 27,, PF00400;, GO:0005654;, C:nucleoplasm;|A2RRH5 A5PLM8 C9JGV0 Q5T066,WD repeat-containing protein 27,, PF00400;, GO:0005654;, C:nucleoplasm; scaffold44 indexed_genome mRNA 19354352 19370736 . + . ID=transcript_8817;Q7Z4R8 B4DHE9 E1P5C9,UPF0669 protein C6orf120,, PF17065;, GO:0035578;GO:0005576;GO:0006915;GO:0043312;, C:azurophil granule lumen; C:extracellular region;, , P:apoptotic process; P:neutrophil degranulation;|Q8WUB8 Q2YDA3 Q53HG8 Q9BXD2 Q9NV26,PHD finger protein 10,BRG1-associated factor 45a;XAP135;, PF00628;, GO:0071564;GO:0005654;GO:0042393;GO:0046872;GO:0003712;GO:0045892;GO:0007399;GO:0045944;, C:npBAF complex; C:nucleoplasm;, F:histone binding; F:metal ion binding; F:transcription coregulator activity;, P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II;|Q8WUB8 Q2YDA3 Q53HG8 Q9BXD2 Q9NV26,PHD finger protein 10,BRG1-associated factor 45a;XAP135;, PF00628;, GO:0071564;GO:0005654;GO:0042393;GO:0046872;GO:0003712;GO:0045892;GO:0007399;GO:0045944;, C:npBAF complex; C:nucleoplasm;, F:histone binding; F:metal ion binding; F:transcription coregulator activity;, P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II;|Q8WUB8 Q2YDA3 Q53HG8 Q9BXD2 Q9NV26,PHD finger protein 10,BRG1-associated factor 45a;XAP135;, PF00628;, GO:0071564;GO:0005654;GO:0042393;GO:0046872;GO:0003712;GO:0045892;GO:0007399;GO:0045944;, C:npBAF complex; C:nucleoplasm;, F:histone binding; F:metal ion binding; F:transcription coregulator activity;, P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II; scaffold44 indexed_genome mRNA 19388934 19394041 . - . ID=transcript_8818;Q8IZS6,Dynein light chain Tctex-type protein 2 {ECO:0000305},T-complex testis-specific protein 3;T-complex-associated testis-expressed protein 3;Tctex1 domain-containing protein 3;, PF03645;, GO:0005737;GO:0030286;GO:0016020;GO:0005874;, C:cytoplasm; C:dynein complex; C:membrane; C:microtubule; scaffold44 indexed_genome mRNA 19399464 19404176 . + . ID=transcript_8819;Q5T6L9 B4DFH0 F8WAF1 Q3ZCS8 Q5T6L8 Q9NUT5 Q9NVU2,Endoplasmic reticulum membrane-associated RNA degradation protein,, PF13910;, GO:0005789;GO:0016021;GO:0007275;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:multicellular organism development; scaffold44 indexed_genome mRNA 19404182 19420213 . + . ID=transcript_8820;Q5T6L9 B4DFH0 F8WAF1 Q3ZCS8 Q5T6L8 Q9NUT5 Q9NVU2,Endoplasmic reticulum membrane-associated RNA degradation protein,, PF13910;, GO:0005789;GO:0016021;GO:0007275;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:multicellular organism development;|Q5T6L9 B4DFH0 F8WAF1 Q3ZCS8 Q5T6L8 Q9NUT5 Q9NVU2,Endoplasmic reticulum membrane-associated RNA degradation protein,, PF13910;, GO:0005789;GO:0016021;GO:0007275;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:multicellular organism development;|Q5T6L9 B4DFH0 F8WAF1 Q3ZCS8 Q5T6L8 Q9NUT5 Q9NVU2,Endoplasmic reticulum membrane-associated RNA degradation protein,, PF13910;, GO:0005789;GO:0016021;GO:0007275;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:multicellular organism development;|Q5T6L9 B4DFH0 F8WAF1 Q3ZCS8 Q5T6L8 Q9NUT5 Q9NVU2,Endoplasmic reticulum membrane-associated RNA degradation protein,, PF13910;, GO:0005789;GO:0016021;GO:0007275;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:multicellular organism development;|Q5T6L9 B4DFH0 F8WAF1 Q3ZCS8 Q5T6L8 Q9NUT5 Q9NVU2,Endoplasmic reticulum membrane-associated RNA degradation protein,, PF13910;, GO:0005789;GO:0016021;GO:0007275;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:multicellular organism development;|Q5T6L9 B4DFH0 F8WAF1 Q3ZCS8 Q5T6L8 Q9NUT5 Q9NVU2,Endoplasmic reticulum membrane-associated RNA degradation protein,, PF13910;, GO:0005789;GO:0016021;GO:0007275;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:multicellular organism development; scaffold44 indexed_genome mRNA 19425036 19430824 . - . ID=transcript_8821;Q5T6L9 B4DFH0 F8WAF1 Q3ZCS8 Q5T6L8 Q9NUT5 Q9NVU2,Endoplasmic reticulum membrane-associated RNA degradation protein,, PF13910;, GO:0005789;GO:0016021;GO:0007275;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:multicellular organism development;|Q5T6L9 B4DFH0 F8WAF1 Q3ZCS8 Q5T6L8 Q9NUT5 Q9NVU2,Endoplasmic reticulum membrane-associated RNA degradation protein,, PF13910;, GO:0005789;GO:0016021;GO:0007275;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:multicellular organism development; scaffold45 indexed_genome mRNA 618230 708550 . - . ID=transcript_8822;P28472 B7Z2W1 B7Z825 F5H3D2 H7BYV8 Q14352 Q96FM5,Gamma-aminobutyric acid receptor subunit beta-3,GABA(A) receptor subunit beta-3;, PF02931;PF02932;, GO:0034707;GO:0030659;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0004890;GO:0022851;GO:0042802;GO:0030594;GO:0071420;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0042391;GO:0060021;GO:0007165;, C:chloride channel complex; C:cytoplasmic vesicle membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:identical protein binding; F:neurotransmitter receptor activity;, P:cellular response to histamine; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:roof of mouth development; P:signal transduction; scaffold45 indexed_genome mRNA 1170492 1943741 . + . ID=transcript_8823;Q99928 G3V594 Q9HD46 Q9NYT2,Gamma-aminobutyric acid receptor subunit gamma-3,GABA(A) receptor subunit gamma-3;, PF02931;PF02932;, GO:0034707;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0099699;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0042493;GO:0007165;GO:0051932;, C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:integral component of synaptic membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:response to drug; P:signal transduction; P:synaptic transmission, GABAergic; scaffold45 indexed_genome mRNA 1997398 2006268 . + . ID=transcript_8824;Q9BQE4 Q3B771 Q9P0I6,Selenoprotein S {ECO:0000303|PubMed:27645994},VCP-interacting membrane protein {ECO:0000303|PubMed:15215856};, PF06936;, GO:0005881;GO:0036513;GO:0036502;GO:0005783;GO:0005789;GO:0030176;GO:0034362;GO:0005886;GO:0034361;GO:0016209;GO:0051117;GO:0019899;GO:0038023;GO:1990381;GO:0045454;GO:0032869;GO:0071222;GO:0034599;GO:0030968;GO:0006983;GO:0045184;GO:0002865;GO:1902236;GO:0046325;GO:0045719;GO:0050728;GO:0032715;GO:2000110;GO:0051771;GO:0032720;GO:0016567;GO:0006111;GO:0080164;GO:0009749;GO:0051775;GO:0030970;GO:0030433;, C:cytoplasmic microtubule; C:Derlin-1 retrotranslocation complex; C:Derlin-1-VIMP complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:low-density lipoprotein particle; C:plasma membrane; C:very-low-density lipoprotein particle;, F:antioxidant activity; F:ATPase binding; F:enzyme binding; F:signaling receptor activity; F:ubiquitin-specific protease binding;, P:cell redox homeostasis; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:endoplasmic reticulum unfolded protein response; P:ER overload response; P:establishment of protein localization; P:negative regulation of acute inflammatory response to antigenic stimulus; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of inflammatory response; P:negative regulation of interleukin-6 production; P:negative regulation of macrophage apoptotic process; P:negative regulation of nitric-oxide synthase biosynthetic process; P:negative regulation of tumor necrosis factor production; P:protein ubiquitination; P:regulation of gluconeogenesis; P:regulation of nitric oxide metabolic process; P:response to glucose; P:response to redox state; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway;|Q9BQE4 Q3B771 Q9P0I6,Selenoprotein S {ECO:0000303|PubMed:27645994},VCP-interacting membrane protein {ECO:0000303|PubMed:15215856};, PF06936;, GO:0005881;GO:0036513;GO:0036502;GO:0005783;GO:0005789;GO:0030176;GO:0034362;GO:0005886;GO:0034361;GO:0016209;GO:0051117;GO:0019899;GO:0038023;GO:1990381;GO:0045454;GO:0032869;GO:0071222;GO:0034599;GO:0030968;GO:0006983;GO:0045184;GO:0002865;GO:1902236;GO:0046325;GO:0045719;GO:0050728;GO:0032715;GO:2000110;GO:0051771;GO:0032720;GO:0016567;GO:0006111;GO:0080164;GO:0009749;GO:0051775;GO:0030970;GO:0030433;, C:cytoplasmic microtubule; C:Derlin-1 retrotranslocation complex; C:Derlin-1-VIMP complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:low-density lipoprotein particle; C:plasma membrane; C:very-low-density lipoprotein particle;, F:antioxidant activity; F:ATPase binding; F:enzyme binding; F:signaling receptor activity; F:ubiquitin-specific protease binding;, P:cell redox homeostasis; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:endoplasmic reticulum unfolded protein response; P:ER overload response; P:establishment of protein localization; P:negative regulation of acute inflammatory response to antigenic stimulus; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of inflammatory response; P:negative regulation of interleukin-6 production; P:negative regulation of macrophage apoptotic process; P:negative regulation of nitric-oxide synthase biosynthetic process; P:negative regulation of tumor necrosis factor production; P:protein ubiquitination; P:regulation of gluconeogenesis; P:regulation of nitric oxide metabolic process; P:response to glucose; P:response to redox state; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; scaffold45 indexed_genome mRNA 2127575 2130325 . + . ID=transcript_8825;Q86X52 Q6UX38 Q7LFU5 Q9Y2J5,Chondroitin sulfate synthase 1,Chondroitin glucuronyltransferase 1;Chondroitin synthase 1;Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1;N-acetylgalactosaminyltransferase 1;, PF05679;, GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0008376;GO:0047238;GO:0046872;GO:0050510;GO:0060349;GO:0002063;GO:0030206;GO:0030279;GO:0045880;GO:0009954;GO:0031667;GO:0051923;, C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:metal ion binding; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity;, P:bone morphogenesis; P:chondrocyte development; P:chondroitin sulfate biosynthetic process; P:negative regulation of ossification; P:positive regulation of smoothened signaling pathway; P:proximal/distal pattern formation; P:response to nutrient levels; P:sulfation; scaffold45 indexed_genome mRNA 2243460 2280204 . - . ID=transcript_8826;Q38SD2 Q6NVH5 Q6NYC0 Q6ZNL9 Q6ZNM9 Q96JN5 Q9H5S3,Leucine-rich repeat serine/threonine-protein kinase 1,, PF16095;PF00069;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005524;GO:0005525;GO:0042802;GO:0046872;GO:0106310;GO:0004722;GO:0106311;GO:0045453;GO:0050732;GO:0036035;GO:0090263;GO:1902533;GO:0050731;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:ATP binding; F:GTP binding; F:identical protein binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine phosphatase activity; F:protein threonine kinase activity;, P:bone resorption; P:negative regulation of peptidyl-tyrosine phosphorylation; P:osteoclast development; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of intracellular signal transduction; P:positive regulation of peptidyl-tyrosine phosphorylation; P:signal transduction;|Q38SD2 Q6NVH5 Q6NYC0 Q6ZNL9 Q6ZNM9 Q96JN5 Q9H5S3,Leucine-rich repeat serine/threonine-protein kinase 1,, PF16095;PF00069;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005524;GO:0005525;GO:0042802;GO:0046872;GO:0106310;GO:0004722;GO:0106311;GO:0045453;GO:0050732;GO:0036035;GO:0090263;GO:1902533;GO:0050731;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:ATP binding; F:GTP binding; F:identical protein binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine phosphatase activity; F:protein threonine kinase activity;, P:bone resorption; P:negative regulation of peptidyl-tyrosine phosphorylation; P:osteoclast development; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of intracellular signal transduction; P:positive regulation of peptidyl-tyrosine phosphorylation; P:signal transduction; scaffold45 indexed_genome mRNA 2281235 2323775 . - . ID=transcript_8827;Q38SD2 Q6NVH5 Q6NYC0 Q6ZNL9 Q6ZNM9 Q96JN5 Q9H5S3,Leucine-rich repeat serine/threonine-protein kinase 1,, PF16095;PF00069;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005524;GO:0005525;GO:0042802;GO:0046872;GO:0106310;GO:0004722;GO:0106311;GO:0045453;GO:0050732;GO:0036035;GO:0090263;GO:1902533;GO:0050731;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:ATP binding; F:GTP binding; F:identical protein binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine phosphatase activity; F:protein threonine kinase activity;, P:bone resorption; P:negative regulation of peptidyl-tyrosine phosphorylation; P:osteoclast development; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of intracellular signal transduction; P:positive regulation of peptidyl-tyrosine phosphorylation; P:signal transduction; scaffold45 indexed_genome mRNA 2323779 2371085 . - . ID=transcript_8828;Q38SD2 Q6NVH5 Q6NYC0 Q6ZNL9 Q6ZNM9 Q96JN5 Q9H5S3,Leucine-rich repeat serine/threonine-protein kinase 1,, PF16095;PF00069;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005524;GO:0005525;GO:0042802;GO:0046872;GO:0106310;GO:0004722;GO:0106311;GO:0045453;GO:0050732;GO:0036035;GO:0090263;GO:1902533;GO:0050731;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:ATP binding; F:GTP binding; F:identical protein binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine phosphatase activity; F:protein threonine kinase activity;, P:bone resorption; P:negative regulation of peptidyl-tyrosine phosphorylation; P:osteoclast development; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of intracellular signal transduction; P:positive regulation of peptidyl-tyrosine phosphorylation; P:signal transduction; scaffold45 indexed_genome mRNA 2382733 2415328 . - . ID=transcript_8829;P47895 Q6NT64,Aldehyde dehydrogenase family 1 member A3,Aldehyde dehydrogenase 6;Retinaldehyde dehydrogenase 3;, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0004030;GO:0070403;GO:0042803;GO:0001758;GO:0070324;GO:0031076;GO:0048048;GO:0060324;GO:0070384;GO:0042472;GO:0007626;GO:0050885;GO:0021768;GO:0060166;GO:0002072;GO:0043065;GO:0051289;GO:0042574;GO:0002138;GO:0042573;GO:0042572;GO:0060013;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:aldehyde dehydrogenase [NAD(P)+] activity; F:NAD+ binding; F:protein homodimerization activity; F:retinal dehydrogenase activity; F:thyroid hormone binding;, P:embryonic camera-type eye development; P:embryonic eye morphogenesis; P:face development; P:Harderian gland development; P:inner ear morphogenesis; P:locomotory behavior; P:neuromuscular process controlling balance; P:nucleus accumbens development; P:olfactory pit development; P:optic cup morphogenesis involved in camera-type eye development; P:positive regulation of apoptotic process; P:protein homotetramerization; P:retinal metabolic process; P:retinoic acid biosynthetic process; P:retinoic acid metabolic process; P:retinol metabolic process; P:righting reflex; scaffold45 indexed_genome mRNA 2688859 2741011 . + . ID=transcript_8830;Q9H672 A8K1E5 Q6GSJ6 Q7Z4S3,Ankyrin repeat and SOCS box protein 7,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q9H672 A8K1E5 Q6GSJ6 Q7Z4S3,Ankyrin repeat and SOCS box protein 7,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q9H672 A8K1E5 Q6GSJ6 Q7Z4S3,Ankyrin repeat and SOCS box protein 7,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; scaffold45 indexed_genome mRNA 2751544 2789143 . + . ID=transcript_8831;Q8NG48 Q96FW2 Q9NVQ3,Protein Lines homolog 1 {ECO:0000312|HGNC:HGNC:30922},Wnt-signaling molecule Lines homolog 1 {ECO:0000305};, PF14695;PF14694;, GO:0050890;, , , P:cognition;|Q6R2W3 Q2NKL9 Q5SRJ3 Q8TCN2 Q96MV9 Q96PW3,SCAN domain-containing protein 3,Transposon-derived Buster4 transposase-like protein;Zinc finger BED domain-containing protein 9;, PF02023;, GO:0005737;GO:0005634;GO:0003676;GO:0015074;GO:0045787;GO:0050679;, C:cytoplasm; C:nucleus;, F:nucleic acid binding;, P:DNA integration; P:positive regulation of cell cycle; P:positive regulation of epithelial cell proliferation;|Q8NG48 Q96FW2 Q9NVQ3,Protein Lines homolog 1 {ECO:0000312|HGNC:HGNC:30922},Wnt-signaling molecule Lines homolog 1 {ECO:0000305};, PF14695;PF14694;, GO:0050890;, , , P:cognition; scaffold45 indexed_genome mRNA 3029217 3317292 . + . ID=transcript_8832;Q8TE56 Q2I7G4 Q6ZN75,A disintegrin and metalloproteinase with thrombospondin motifs 17,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q8TE56 Q2I7G4 Q6ZN75,A disintegrin and metalloproteinase with thrombospondin motifs 17,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold45 indexed_genome mRNA 3358187 3359172 . + . ID=transcript_8833;P13693 B2R7E5 Q6YLS2 Q7Z4J4 Q8TBK7 Q96EE2 Q9UC70,Translationally-controlled tumor protein,Fortilin;Histamine-releasing factor;p23;, PF00838;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0005615;GO:0005771;GO:0005634;GO:0000922;GO:0005509;GO:0003723;GO:0006816;GO:0006874;GO:0043066;GO:1902230;GO:0042981;GO:0009615;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extracellular space; C:multivesicular body; C:nucleus; C:spindle pole;, F:calcium ion binding; F:RNA binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:regulation of apoptotic process; P:response to virus; scaffold45 indexed_genome mRNA 3359330 3443244 . - . ID=transcript_8834;P13693 B2R7E5 Q6YLS2 Q7Z4J4 Q8TBK7 Q96EE2 Q9UC70,Translationally-controlled tumor protein,Fortilin;Histamine-releasing factor;p23;, PF00838;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0005615;GO:0005771;GO:0005634;GO:0000922;GO:0005509;GO:0003723;GO:0006816;GO:0006874;GO:0043066;GO:1902230;GO:0042981;GO:0009615;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extracellular space; C:multivesicular body; C:nucleus; C:spindle pole;, F:calcium ion binding; F:RNA binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:regulation of apoptotic process; P:response to virus;|Q8TE56 Q2I7G4 Q6ZN75,A disintegrin and metalloproteinase with thrombospondin motifs 17,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q8TE56 Q2I7G4 Q6ZN75,A disintegrin and metalloproteinase with thrombospondin motifs 17,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q8TE56 Q2I7G4 Q6ZN75,A disintegrin and metalloproteinase with thrombospondin motifs 17,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q8TE56 Q2I7G4 Q6ZN75,A disintegrin and metalloproteinase with thrombospondin motifs 17,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold45 indexed_genome mRNA 3521527 3527469 . + . ID=transcript_8835;Q5XG99 A6NII6 A8K2N1 Q96LY7,LysM and putative peptidoglycan-binding domain-containing protein 4,, , GO:0016021;, C:integral component of membrane;|Q5XG99 A6NII6 A8K2N1 Q96LY7,LysM and putative peptidoglycan-binding domain-containing protein 4,, , GO:0016021;, C:integral component of membrane; scaffold45 indexed_genome mRNA 3583862 3744737 . - . ID=transcript_8836;Q02078 B4DFQ7 F6XG23 O43814 Q14223 Q14224 Q59GX4 Q7Z6C9 Q96D14,Myocyte-specific enhancer factor 2A,Serum response factor-like protein 1;, PF12347;PF00319;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0033613;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0042826;GO:0046982;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:0046332;GO:0006915;GO:0061337;GO:0030154;GO:0071277;GO:0048813;GO:0070375;GO:0007507;GO:0000165;GO:0000002;GO:0048311;GO:0007517;GO:0000122;GO:0010613;GO:0046326;GO:0051149;GO:0045944;GO:0006357;GO:0006351;GO:0055005;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:activating transcription factor binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:SMAD binding;, P:apoptotic process; P:cardiac conduction; P:cell differentiation; P:cellular response to calcium ion; P:dendrite morphogenesis; P:ERK5 cascade; P:heart development; P:MAPK cascade; P:mitochondrial genome maintenance; P:mitochondrion distribution; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of glucose import; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:ventricular cardiac myofibril assembly;|Q02078 B4DFQ7 F6XG23 O43814 Q14223 Q14224 Q59GX4 Q7Z6C9 Q96D14,Myocyte-specific enhancer factor 2A,Serum response factor-like protein 1;, PF12347;PF00319;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0033613;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0042826;GO:0046982;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:0046332;GO:0006915;GO:0061337;GO:0030154;GO:0071277;GO:0048813;GO:0070375;GO:0007507;GO:0000165;GO:0000002;GO:0048311;GO:0007517;GO:0000122;GO:0010613;GO:0046326;GO:0051149;GO:0045944;GO:0006357;GO:0006351;GO:0055005;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:activating transcription factor binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:SMAD binding;, P:apoptotic process; P:cardiac conduction; P:cell differentiation; P:cellular response to calcium ion; P:dendrite morphogenesis; P:ERK5 cascade; P:heart development; P:MAPK cascade; P:mitochondrial genome maintenance; P:mitochondrion distribution; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of glucose import; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:ventricular cardiac myofibril assembly;|Q02078 B4DFQ7 F6XG23 O43814 Q14223 Q14224 Q59GX4 Q7Z6C9 Q96D14,Myocyte-specific enhancer factor 2A,Serum response factor-like protein 1;, PF12347;PF00319;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0033613;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0042826;GO:0046982;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:0046332;GO:0006915;GO:0061337;GO:0030154;GO:0071277;GO:0048813;GO:0070375;GO:0007507;GO:0000165;GO:0000002;GO:0048311;GO:0007517;GO:0000122;GO:0010613;GO:0046326;GO:0051149;GO:0045944;GO:0006357;GO:0006351;GO:0055005;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:activating transcription factor binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:SMAD binding;, P:apoptotic process; P:cardiac conduction; P:cell differentiation; P:cellular response to calcium ion; P:dendrite morphogenesis; P:ERK5 cascade; P:heart development; P:MAPK cascade; P:mitochondrial genome maintenance; P:mitochondrion distribution; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of glucose import; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:ventricular cardiac myofibril assembly;|Q02078 B4DFQ7 F6XG23 O43814 Q14223 Q14224 Q59GX4 Q7Z6C9 Q96D14,Myocyte-specific enhancer factor 2A,Serum response factor-like protein 1;, PF12347;PF00319;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0033613;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0042826;GO:0046982;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:0046332;GO:0006915;GO:0061337;GO:0030154;GO:0071277;GO:0048813;GO:0070375;GO:0007507;GO:0000165;GO:0000002;GO:0048311;GO:0007517;GO:0000122;GO:0010613;GO:0046326;GO:0051149;GO:0045944;GO:0006357;GO:0006351;GO:0055005;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:activating transcription factor binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:SMAD binding;, P:apoptotic process; P:cardiac conduction; P:cell differentiation; P:cellular response to calcium ion; P:dendrite morphogenesis; P:ERK5 cascade; P:heart development; P:MAPK cascade; P:mitochondrial genome maintenance; P:mitochondrion distribution; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of glucose import; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:ventricular cardiac myofibril assembly;|Q02078 B4DFQ7 F6XG23 O43814 Q14223 Q14224 Q59GX4 Q7Z6C9 Q96D14,Myocyte-specific enhancer factor 2A,Serum response factor-like protein 1;, PF12347;PF00319;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0033613;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0042826;GO:0046982;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:0046332;GO:0006915;GO:0061337;GO:0030154;GO:0071277;GO:0048813;GO:0070375;GO:0007507;GO:0000165;GO:0000002;GO:0048311;GO:0007517;GO:0000122;GO:0010613;GO:0046326;GO:0051149;GO:0045944;GO:0006357;GO:0006351;GO:0055005;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:activating transcription factor binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:SMAD binding;, P:apoptotic process; P:cardiac conduction; P:cell differentiation; P:cellular response to calcium ion; P:dendrite morphogenesis; P:ERK5 cascade; P:heart development; P:MAPK cascade; P:mitochondrial genome maintenance; P:mitochondrion distribution; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of glucose import; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:ventricular cardiac myofibril assembly;|Q02078 B4DFQ7 F6XG23 O43814 Q14223 Q14224 Q59GX4 Q7Z6C9 Q96D14,Myocyte-specific enhancer factor 2A,Serum response factor-like protein 1;, PF12347;PF00319;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0033613;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0042826;GO:0046982;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:0046332;GO:0006915;GO:0061337;GO:0030154;GO:0071277;GO:0048813;GO:0070375;GO:0007507;GO:0000165;GO:0000002;GO:0048311;GO:0007517;GO:0000122;GO:0010613;GO:0046326;GO:0051149;GO:0045944;GO:0006357;GO:0006351;GO:0055005;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:activating transcription factor binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:SMAD binding;, P:apoptotic process; P:cardiac conduction; P:cell differentiation; P:cellular response to calcium ion; P:dendrite morphogenesis; P:ERK5 cascade; P:heart development; P:MAPK cascade; P:mitochondrial genome maintenance; P:mitochondrion distribution; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of glucose import; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:ventricular cardiac myofibril assembly;|Q02078 B4DFQ7 F6XG23 O43814 Q14223 Q14224 Q59GX4 Q7Z6C9 Q96D14,Myocyte-specific enhancer factor 2A,Serum response factor-like protein 1;, PF12347;PF00319;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0033613;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0042826;GO:0046982;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:0046332;GO:0006915;GO:0061337;GO:0030154;GO:0071277;GO:0048813;GO:0070375;GO:0007507;GO:0000165;GO:0000002;GO:0048311;GO:0007517;GO:0000122;GO:0010613;GO:0046326;GO:0051149;GO:0045944;GO:0006357;GO:0006351;GO:0055005;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:activating transcription factor binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:SMAD binding;, P:apoptotic process; P:cardiac conduction; P:cell differentiation; P:cellular response to calcium ion; P:dendrite morphogenesis; P:ERK5 cascade; P:heart development; P:MAPK cascade; P:mitochondrial genome maintenance; P:mitochondrion distribution; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of glucose import; P:positive regulation of muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:ventricular cardiac myofibril assembly; scaffold45 indexed_genome mRNA 3964962 4157934 . - . ID=transcript_8837;Q86X40 A8KA22 Q6UY49 Q6ZSS6,Leucine-rich repeat-containing protein 28,, PF13855;|Q86X40 A8KA22 Q6UY49 Q6ZSS6,Leucine-rich repeat-containing protein 28,, PF13855; scaffold45 indexed_genome mRNA 4173137 4295146 . + . ID=transcript_8838;Q5W5X9 A8K6M5 Q53HK0 Q96BC9 Q9H8W9 Q9H9S7,Tetratricopeptide repeat protein 23,Cervical cancer proto-oncogene 8 protein;, , GO:0005929;GO:0045880;, C:cilium;, , P:positive regulation of smoothened signaling pathway;|Q5W5X9 A8K6M5 Q53HK0 Q96BC9 Q9H8W9 Q9H9S7,Tetratricopeptide repeat protein 23,Cervical cancer proto-oncogene 8 protein;, , GO:0005929;GO:0045880;, C:cilium;, , P:positive regulation of smoothened signaling pathway;|Q5W5X9 A8K6M5 Q53HK0 Q96BC9 Q9H8W9 Q9H9S7,Tetratricopeptide repeat protein 23,Cervical cancer proto-oncogene 8 protein;, , GO:0005929;GO:0045880;, C:cilium;, , P:positive regulation of smoothened signaling pathway; scaffold45 indexed_genome mRNA 4309485 4333435 . - . ID=transcript_8839;O15061 A7E2Y2 Q2TBJ4 Q5NJJ9 Q8TE61 Q8TE62,Synemin,Desmuslin;, PF00038;, GO:0005912;GO:0043034;GO:0005882;GO:0045111;GO:0060053;GO:0042383;GO:0019215;GO:0005200;GO:0008307;GO:0017166;GO:0031443;GO:0045104;, C:adherens junction; C:costamere; C:intermediate filament; C:intermediate filament cytoskeleton; C:neurofilament cytoskeleton; C:sarcolemma;, F:intermediate filament binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:vinculin binding;, P:fast-twitch skeletal muscle fiber contraction; P:intermediate filament cytoskeleton organization; scaffold45 indexed_genome mRNA 4762341 4809711 . + . ID=transcript_8840;P08069 B1B5Y2 Q14CV2 Q9UCC0,Insulin-like growth factor 1 receptor,Insulin-like growth factor I receptor;, PF00757;PF07714;PF01030;, GO:0035867;GO:0030424;GO:0005899;GO:0005887;GO:0043231;GO:0016020;GO:0005886;GO:1902911;GO:0043235;GO:0005524;GO:0042802;GO:0043559;GO:0005158;GO:0043560;GO:0005009;GO:0005520;GO:0031994;GO:0005010;GO:0043548;GO:0140318;GO:0004713;GO:0005198;GO:0004714;GO:0097242;GO:1904646;GO:0071333;GO:0097062;GO:0042593;GO:0006955;GO:0051389;GO:0008286;GO:0048009;GO:0007275;GO:0043066;GO:0038083;GO:0014065;GO:0048015;GO:0030335;GO:0008284;GO:0120162;GO:0033674;GO:0043410;GO:0014068;GO:0051897;GO:0043243;GO:0046777;GO:0046328;GO:0007165;GO:0045056;GO:0007169;GO:0016032;, C:alphav-beta3 integrin-IGF-1-IGF1R complex; C:axon; C:insulin receptor complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:protein kinase complex; C:receptor complex;, F:ATP binding; F:identical protein binding; F:insulin binding; F:insulin receptor binding; F:insulin receptor substrate binding; F:insulin-activated receptor activity; F:insulin-like growth factor binding; F:insulin-like growth factor I binding; F:insulin-like growth factor-activated receptor activity; F:phosphatidylinositol 3-kinase binding; F:protein transporter activity; F:protein tyrosine kinase activity; F:structural molecule activity; F:transmembrane receptor protein tyrosine kinase activity;, P:amyloid-beta clearance; P:cellular response to amyloid-beta; P:cellular response to glucose stimulus; P:dendritic spine maintenance; P:glucose homeostasis; P:immune response; P:inactivation of MAPKK activity; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:multicellular organism development; P:negative regulation of apoptotic process; P:peptidyl-tyrosine autophosphorylation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol-mediated signaling; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein-containing complex disassembly; P:protein autophosphorylation; P:regulation of JNK cascade; P:signal transduction; P:transcytosis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process; scaffold45 indexed_genome mRNA 4809760 4827550 . + . ID=transcript_8841;P08069 B1B5Y2 Q14CV2 Q9UCC0,Insulin-like growth factor 1 receptor,Insulin-like growth factor I receptor;, PF00757;PF07714;PF01030;, GO:0035867;GO:0030424;GO:0005899;GO:0005887;GO:0043231;GO:0016020;GO:0005886;GO:1902911;GO:0043235;GO:0005524;GO:0042802;GO:0043559;GO:0005158;GO:0043560;GO:0005009;GO:0005520;GO:0031994;GO:0005010;GO:0043548;GO:0140318;GO:0004713;GO:0005198;GO:0004714;GO:0097242;GO:1904646;GO:0071333;GO:0097062;GO:0042593;GO:0006955;GO:0051389;GO:0008286;GO:0048009;GO:0007275;GO:0043066;GO:0038083;GO:0014065;GO:0048015;GO:0030335;GO:0008284;GO:0120162;GO:0033674;GO:0043410;GO:0014068;GO:0051897;GO:0043243;GO:0046777;GO:0046328;GO:0007165;GO:0045056;GO:0007169;GO:0016032;, C:alphav-beta3 integrin-IGF-1-IGF1R complex; C:axon; C:insulin receptor complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:protein kinase complex; C:receptor complex;, F:ATP binding; F:identical protein binding; F:insulin binding; F:insulin receptor binding; F:insulin receptor substrate binding; F:insulin-activated receptor activity; F:insulin-like growth factor binding; F:insulin-like growth factor I binding; F:insulin-like growth factor-activated receptor activity; F:phosphatidylinositol 3-kinase binding; F:protein transporter activity; F:protein tyrosine kinase activity; F:structural molecule activity; F:transmembrane receptor protein tyrosine kinase activity;, P:amyloid-beta clearance; P:cellular response to amyloid-beta; P:cellular response to glucose stimulus; P:dendritic spine maintenance; P:glucose homeostasis; P:immune response; P:inactivation of MAPKK activity; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:multicellular organism development; P:negative regulation of apoptotic process; P:peptidyl-tyrosine autophosphorylation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol-mediated signaling; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein-containing complex disassembly; P:protein autophosphorylation; P:regulation of JNK cascade; P:signal transduction; P:transcytosis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|P59052 Q0VDC1 Q547X5,Putative uncharacterized protein B3GALT5-AS1 {ECO:0000312|HGNC:HGNC:16424},B3GALT5 antisense RNA 1 {ECO:0000312|HGNC:HGNC:16424};B3GALT5 antisense gene protein 1 {ECO:0000305};|P08069 B1B5Y2 Q14CV2 Q9UCC0,Insulin-like growth factor 1 receptor,Insulin-like growth factor I receptor;, PF00757;PF07714;PF01030;, GO:0035867;GO:0030424;GO:0005899;GO:0005887;GO:0043231;GO:0016020;GO:0005886;GO:1902911;GO:0043235;GO:0005524;GO:0042802;GO:0043559;GO:0005158;GO:0043560;GO:0005009;GO:0005520;GO:0031994;GO:0005010;GO:0043548;GO:0140318;GO:0004713;GO:0005198;GO:0004714;GO:0097242;GO:1904646;GO:0071333;GO:0097062;GO:0042593;GO:0006955;GO:0051389;GO:0008286;GO:0048009;GO:0007275;GO:0043066;GO:0038083;GO:0014065;GO:0048015;GO:0030335;GO:0008284;GO:0120162;GO:0033674;GO:0043410;GO:0014068;GO:0051897;GO:0043243;GO:0046777;GO:0046328;GO:0007165;GO:0045056;GO:0007169;GO:0016032;, C:alphav-beta3 integrin-IGF-1-IGF1R complex; C:axon; C:insulin receptor complex; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:protein kinase complex; C:receptor complex;, F:ATP binding; F:identical protein binding; F:insulin binding; F:insulin receptor binding; F:insulin receptor substrate binding; F:insulin-activated receptor activity; F:insulin-like growth factor binding; F:insulin-like growth factor I binding; F:insulin-like growth factor-activated receptor activity; F:phosphatidylinositol 3-kinase binding; F:protein transporter activity; F:protein tyrosine kinase activity; F:structural molecule activity; F:transmembrane receptor protein tyrosine kinase activity;, P:amyloid-beta clearance; P:cellular response to amyloid-beta; P:cellular response to glucose stimulus; P:dendritic spine maintenance; P:glucose homeostasis; P:immune response; P:inactivation of MAPKK activity; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:multicellular organism development; P:negative regulation of apoptotic process; P:peptidyl-tyrosine autophosphorylation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol-mediated signaling; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein-containing complex disassembly; P:protein autophosphorylation; P:regulation of JNK cascade; P:signal transduction; P:transcytosis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process; scaffold45 indexed_genome mRNA 4939373 5007757 . + . ID=transcript_8842;Q8N8A8 B5MDL8,Protein FAM169B scaffold45 indexed_genome mRNA 5455745 5460208 . - . ID=transcript_8843;Q8NCT1 Q6NSI9,Arrestin domain-containing protein 4,, PF02752;PF00339;, GO:0005737;GO:0005769;GO:0005768;GO:1903561;GO:0043231;GO:0005886;GO:1990756;GO:0140112;GO:0051443;GO:0015031;GO:0016567;, C:cytoplasm; C:early endosome; C:endosome; C:extracellular vesicle; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ubiquitin ligase-substrate adaptor activity;, P:extracellular vesicle biogenesis; P:positive regulation of ubiquitin-protein transferase activity; P:protein transport; P:protein ubiquitination; scaffold45 indexed_genome mRNA 7162998 7175008 . - . ID=transcript_8844;P24468 B4DQJ2 B6ZGU1 Q03754 Q3KQR7,COUP transcription factor 2,Apolipoprotein A-I regulatory protein 1;COUP transcription factor II;Nuclear receptor subfamily 2 group F member 2;, PF00104;PF00105;, GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0004879;GO:0042803;GO:0001972;GO:0000978;GO:0043565;GO:0008270;GO:0048856;GO:0009952;GO:0048514;GO:0030154;GO:0008585;GO:0009566;GO:0030900;GO:0060173;GO:0060838;GO:0001893;GO:0045736;GO:0010596;GO:0001937;GO:0000122;GO:0045892;GO:0001764;GO:0060674;GO:0003084;GO:0045944;GO:0045893;GO:0009956;GO:0006357;GO:0032355;GO:0007519;GO:0060707;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:nuclear receptor activity; F:protein homodimerization activity; F:retinoic acid binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:zinc ion binding;, P:anatomical structure development; P:anterior/posterior pattern specification; P:blood vessel morphogenesis; P:cell differentiation; P:female gonad development; P:fertilization; P:forebrain development; P:limb development; P:lymphatic endothelial cell fate commitment; P:maternal placenta development; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron migration; P:placenta blood vessel development; P:positive regulation of systemic arterial blood pressure; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:radial pattern formation; P:regulation of transcription by RNA polymerase II; P:response to estradiol; P:skeletal muscle tissue development; P:trophoblast giant cell differentiation; scaffold45 indexed_genome mRNA 9077629 9253138 . - . ID=transcript_8845;Q6DN12 A2RRC2 C6G483 C6G484 Q49AB0 Q8TAX2 Q9NUS2 Q9NUW7,Multiple C2 and transmembrane domain-containing protein 2,, PF00168;PF08372;, GO:0005829;GO:0016021;GO:0016020;GO:0005654;GO:0030672;GO:0005509;GO:0019722;GO:0007275;GO:0046928;, C:cytosol; C:integral component of membrane; C:membrane; C:nucleoplasm; C:synaptic vesicle membrane;, F:calcium ion binding;, P:calcium-mediated signaling; P:multicellular organism development; P:regulation of neurotransmitter secretion;|Q6DN12 A2RRC2 C6G483 C6G484 Q49AB0 Q8TAX2 Q9NUS2 Q9NUW7,Multiple C2 and transmembrane domain-containing protein 2,, PF00168;PF08372;, GO:0005829;GO:0016021;GO:0016020;GO:0005654;GO:0030672;GO:0005509;GO:0019722;GO:0007275;GO:0046928;, C:cytosol; C:integral component of membrane; C:membrane; C:nucleoplasm; C:synaptic vesicle membrane;, F:calcium ion binding;, P:calcium-mediated signaling; P:multicellular organism development; P:regulation of neurotransmitter secretion; scaffold45 indexed_genome mRNA 9270651 9331063 . - . ID=transcript_8846;Q6DN12 A2RRC2 C6G483 C6G484 Q49AB0 Q8TAX2 Q9NUS2 Q9NUW7,Multiple C2 and transmembrane domain-containing protein 2,, PF00168;PF08372;, GO:0005829;GO:0016021;GO:0016020;GO:0005654;GO:0030672;GO:0005509;GO:0019722;GO:0007275;GO:0046928;, C:cytosol; C:integral component of membrane; C:membrane; C:nucleoplasm; C:synaptic vesicle membrane;, F:calcium ion binding;, P:calcium-mediated signaling; P:multicellular organism development; P:regulation of neurotransmitter secretion; scaffold45 indexed_genome mRNA 10420568 10474879 . + . ID=transcript_8847;Q9NPM3,Repulsive guidance molecule A,RGM domain family member A;, PF06534;PF06535;, GO:0031225;GO:0005783;GO:0005886;GO:0015026;GO:1990459;GO:0030509;GO:0048681;GO:0045944;, C:anchored component of membrane; C:endoplasmic reticulum; C:plasma membrane;, F:coreceptor activity; F:transferrin receptor binding;, P:BMP signaling pathway; P:negative regulation of axon regeneration; P:positive regulation of transcription by RNA polymerase II;|Q9NPM3,Repulsive guidance molecule A,RGM domain family member A;, PF06534;PF06535;, GO:0031225;GO:0005783;GO:0005886;GO:0015026;GO:1990459;GO:0030509;GO:0048681;GO:0045944;, C:anchored component of membrane; C:endoplasmic reticulum; C:plasma membrane;, F:coreceptor activity; F:transferrin receptor binding;, P:BMP signaling pathway; P:negative regulation of axon regeneration; P:positive regulation of transcription by RNA polymerase II; scaffold45 indexed_genome mRNA 10493664 10604261 . - . ID=transcript_8848;O14647 C6G482 Q96IP5,Chromodomain-helicase-DNA-binding protein 2,ATP-dependent helicase CHD2;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0042393;GO:0070615;GO:0003723;GO:0000978;GO:0006325;GO:0007517;GO:0006357;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:histone binding; F:nucleosome-dependent ATPase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin organization; P:muscle organ development; P:regulation of transcription by RNA polymerase II;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|O14647 C6G482 Q96IP5,Chromodomain-helicase-DNA-binding protein 2,ATP-dependent helicase CHD2;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0042393;GO:0070615;GO:0003723;GO:0000978;GO:0006325;GO:0007517;GO:0006357;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:histone binding; F:nucleosome-dependent ATPase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin organization; P:muscle organ development; P:regulation of transcription by RNA polymerase II;|O14647 C6G482 Q96IP5,Chromodomain-helicase-DNA-binding protein 2,ATP-dependent helicase CHD2;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0042393;GO:0070615;GO:0003723;GO:0000978;GO:0006325;GO:0007517;GO:0006357;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:histone binding; F:nucleosome-dependent ATPase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin organization; P:muscle organ development; P:regulation of transcription by RNA polymerase II;|O14647 C6G482 Q96IP5,Chromodomain-helicase-DNA-binding protein 2,ATP-dependent helicase CHD2;, PF18375;PF00385;PF13907;PF00271;PF00176;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0042393;GO:0070615;GO:0003723;GO:0000978;GO:0006325;GO:0007517;GO:0006357;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:histone binding; F:nucleosome-dependent ATPase activity; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin organization; P:muscle organ development; P:regulation of transcription by RNA polymerase II; scaffold45 indexed_genome mRNA 10787860 10828018 . + . ID=transcript_8849;Q3ZCQ3 Q3ZCR9 Q8NBH7,Membrane protein FAM174B,, PF06679;, GO:0005794;GO:0016021;GO:0005886;GO:0007030;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, , P:Golgi organization; scaffold45 indexed_genome mRNA 11296936 11308095 . - . ID=transcript_8850;Q9UIG8 A8K4A7 B3KPY5 B3KUR7 C6G486 Q9BW73 Q9GZV2,Solute carrier organic anion transporter family member 3A1,Organic anion transporter polypeptide-related protein 3;Organic anion-transporting polypeptide D;PGE1 transporter;Sodium-independent organic anion transporter D;Solute carrier family 21 member 11;, PF07648;PF03137;, GO:0005887;GO:0005886;GO:0015347;GO:0051092;GO:0001934;GO:0015732;GO:0043252;GO:0150104;, C:integral component of plasma membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity;, P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein phosphorylation; P:prostaglandin transport; P:sodium-independent organic anion transport; P:transport across blood-brain barrier;|Q9UIG8 A8K4A7 B3KPY5 B3KUR7 C6G486 Q9BW73 Q9GZV2,Solute carrier organic anion transporter family member 3A1,Organic anion transporter polypeptide-related protein 3;Organic anion-transporting polypeptide D;PGE1 transporter;Sodium-independent organic anion transporter D;Solute carrier family 21 member 11;, PF07648;PF03137;, GO:0005887;GO:0005886;GO:0015347;GO:0051092;GO:0001934;GO:0015732;GO:0043252;GO:0150104;, C:integral component of plasma membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity;, P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein phosphorylation; P:prostaglandin transport; P:sodium-independent organic anion transport; P:transport across blood-brain barrier; scaffold45 indexed_genome mRNA 11318936 11665415 . - . ID=transcript_8851;Q9UIG8 A8K4A7 B3KPY5 B3KUR7 C6G486 Q9BW73 Q9GZV2,Solute carrier organic anion transporter family member 3A1,Organic anion transporter polypeptide-related protein 3;Organic anion-transporting polypeptide D;PGE1 transporter;Sodium-independent organic anion transporter D;Solute carrier family 21 member 11;, PF07648;PF03137;, GO:0005887;GO:0005886;GO:0015347;GO:0051092;GO:0001934;GO:0015732;GO:0043252;GO:0150104;, C:integral component of plasma membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity;, P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein phosphorylation; P:prostaglandin transport; P:sodium-independent organic anion transport; P:transport across blood-brain barrier; scaffold45 indexed_genome mRNA 12259468 12488476 . - . ID=transcript_8852;Q7L1I2 B4DH30 C6G489 O94840 Q6IAR8,Synaptic vesicle glycoprotein 2B,, PF07690;PF00083;, GO:0001669;GO:0016021;GO:0016020;GO:0043005;GO:0005886;GO:0008021;GO:0030672;GO:0022857;GO:0007268;GO:0006836;, C:acrosomal vesicle; C:integral component of membrane; C:membrane; C:neuron projection; C:plasma membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:transmembrane transporter activity;, P:chemical synaptic transmission; P:neurotransmitter transport;|Q7L1I2 B4DH30 C6G489 O94840 Q6IAR8,Synaptic vesicle glycoprotein 2B,, PF07690;PF00083;, GO:0001669;GO:0016021;GO:0016020;GO:0043005;GO:0005886;GO:0008021;GO:0030672;GO:0022857;GO:0007268;GO:0006836;, C:acrosomal vesicle; C:integral component of membrane; C:membrane; C:neuron projection; C:plasma membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:transmembrane transporter activity;, P:chemical synaptic transmission; P:neurotransmitter transport; scaffold45 indexed_genome mRNA 12804578 12897397 . + . ID=transcript_8853;Q12802 Q14572 Q59FP6 Q86W90 Q8WXQ6 Q96JP6 Q96P79 Q9Y5T0 Q9Y5T6,A-kinase anchor protein 13,AKAP-Lbc {ECO:0000303|PubMed:11546812};Breast cancer nuclear receptor-binding auxiliary protein {ECO:0000303|PubMed:9627117};Guanine nucleotide exchange factor Lbc;Human thyroid-anchoring protein 31 {ECO:0000303|PubMed:11696353};Lymphoid blast crisis oncogene {ECO:0000303|PubMed:24993829};Non-oncogenic Rho GTPase-specific GTP exchange factor;Protein kinase A-anchoring protein 13;p47;, PF17838;PF00621;PF10522;, GO:0005938;GO:0005829;GO:0016020;GO:0005634;GO:0048471;GO:0004691;GO:0005085;GO:0005078;GO:0046872;GO:0060090;GO:0051018;GO:0031267;GO:0086023;GO:0071875;GO:0060348;GO:0055007;GO:0061049;GO:0007186;GO:0007507;GO:0051168;GO:0043065;GO:0043123;GO:0043406;GO:0035025;GO:0035023;GO:0060297;GO:0051056;, C:cell cortex; C:cytosol; C:membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:cAMP-dependent protein kinase activity; F:guanyl-nucleotide exchange factor activity; F:MAP-kinase scaffold activity; F:metal ion binding; F:molecular adaptor activity; F:protein kinase A binding; F:small GTPase binding;, P:adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:adrenergic receptor signaling pathway; P:bone development; P:cardiac muscle cell differentiation; P:cell growth involved in cardiac muscle cell development; P:G protein-coupled receptor signaling pathway; P:heart development; P:nuclear export; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of Rho protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of sarcomere organization; P:regulation of small GTPase mediated signal transduction;|Q12802 Q14572 Q59FP6 Q86W90 Q8WXQ6 Q96JP6 Q96P79 Q9Y5T0 Q9Y5T6,A-kinase anchor protein 13,AKAP-Lbc {ECO:0000303|PubMed:11546812};Breast cancer nuclear receptor-binding auxiliary protein {ECO:0000303|PubMed:9627117};Guanine nucleotide exchange factor Lbc;Human thyroid-anchoring protein 31 {ECO:0000303|PubMed:11696353};Lymphoid blast crisis oncogene {ECO:0000303|PubMed:24993829};Non-oncogenic Rho GTPase-specific GTP exchange factor;Protein kinase A-anchoring protein 13;p47;, PF17838;PF00621;PF10522;, GO:0005938;GO:0005829;GO:0016020;GO:0005634;GO:0048471;GO:0004691;GO:0005085;GO:0005078;GO:0046872;GO:0060090;GO:0051018;GO:0031267;GO:0086023;GO:0071875;GO:0060348;GO:0055007;GO:0061049;GO:0007186;GO:0007507;GO:0051168;GO:0043065;GO:0043123;GO:0043406;GO:0035025;GO:0035023;GO:0060297;GO:0051056;, C:cell cortex; C:cytosol; C:membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:cAMP-dependent protein kinase activity; F:guanyl-nucleotide exchange factor activity; F:MAP-kinase scaffold activity; F:metal ion binding; F:molecular adaptor activity; F:protein kinase A binding; F:small GTPase binding;, P:adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:adrenergic receptor signaling pathway; P:bone development; P:cardiac muscle cell differentiation; P:cell growth involved in cardiac muscle cell development; P:G protein-coupled receptor signaling pathway; P:heart development; P:nuclear export; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of Rho protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of sarcomere organization; P:regulation of small GTPase mediated signal transduction; scaffold45 indexed_genome mRNA 12944160 12946674 . + . ID=transcript_8854;Q12802 Q14572 Q59FP6 Q86W90 Q8WXQ6 Q96JP6 Q96P79 Q9Y5T0 Q9Y5T6,A-kinase anchor protein 13,AKAP-Lbc {ECO:0000303|PubMed:11546812};Breast cancer nuclear receptor-binding auxiliary protein {ECO:0000303|PubMed:9627117};Guanine nucleotide exchange factor Lbc;Human thyroid-anchoring protein 31 {ECO:0000303|PubMed:11696353};Lymphoid blast crisis oncogene {ECO:0000303|PubMed:24993829};Non-oncogenic Rho GTPase-specific GTP exchange factor;Protein kinase A-anchoring protein 13;p47;, PF17838;PF00621;PF10522;, GO:0005938;GO:0005829;GO:0016020;GO:0005634;GO:0048471;GO:0004691;GO:0005085;GO:0005078;GO:0046872;GO:0060090;GO:0051018;GO:0031267;GO:0086023;GO:0071875;GO:0060348;GO:0055007;GO:0061049;GO:0007186;GO:0007507;GO:0051168;GO:0043065;GO:0043123;GO:0043406;GO:0035025;GO:0035023;GO:0060297;GO:0051056;, C:cell cortex; C:cytosol; C:membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:cAMP-dependent protein kinase activity; F:guanyl-nucleotide exchange factor activity; F:MAP-kinase scaffold activity; F:metal ion binding; F:molecular adaptor activity; F:protein kinase A binding; F:small GTPase binding;, P:adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:adrenergic receptor signaling pathway; P:bone development; P:cardiac muscle cell differentiation; P:cell growth involved in cardiac muscle cell development; P:G protein-coupled receptor signaling pathway; P:heart development; P:nuclear export; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of Rho protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of sarcomere organization; P:regulation of small GTPase mediated signal transduction; scaffold45 indexed_genome mRNA 12949083 12951227 . + . ID=transcript_8855;Q12802 Q14572 Q59FP6 Q86W90 Q8WXQ6 Q96JP6 Q96P79 Q9Y5T0 Q9Y5T6,A-kinase anchor protein 13,AKAP-Lbc {ECO:0000303|PubMed:11546812};Breast cancer nuclear receptor-binding auxiliary protein {ECO:0000303|PubMed:9627117};Guanine nucleotide exchange factor Lbc;Human thyroid-anchoring protein 31 {ECO:0000303|PubMed:11696353};Lymphoid blast crisis oncogene {ECO:0000303|PubMed:24993829};Non-oncogenic Rho GTPase-specific GTP exchange factor;Protein kinase A-anchoring protein 13;p47;, PF17838;PF00621;PF10522;, GO:0005938;GO:0005829;GO:0016020;GO:0005634;GO:0048471;GO:0004691;GO:0005085;GO:0005078;GO:0046872;GO:0060090;GO:0051018;GO:0031267;GO:0086023;GO:0071875;GO:0060348;GO:0055007;GO:0061049;GO:0007186;GO:0007507;GO:0051168;GO:0043065;GO:0043123;GO:0043406;GO:0035025;GO:0035023;GO:0060297;GO:0051056;, C:cell cortex; C:cytosol; C:membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:cAMP-dependent protein kinase activity; F:guanyl-nucleotide exchange factor activity; F:MAP-kinase scaffold activity; F:metal ion binding; F:molecular adaptor activity; F:protein kinase A binding; F:small GTPase binding;, P:adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:adrenergic receptor signaling pathway; P:bone development; P:cardiac muscle cell differentiation; P:cell growth involved in cardiac muscle cell development; P:G protein-coupled receptor signaling pathway; P:heart development; P:nuclear export; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of Rho protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of sarcomere organization; P:regulation of small GTPase mediated signal transduction; scaffold45 indexed_genome mRNA 13001982 13023775 . - . ID=transcript_8856;Q9H0H3 B2RDH2 B3KRT7,Kelch-like protein 25,Ectoderm-neural cortex protein 2;, PF07707;PF00651;PF01344;, GO:0031463;GO:0005737;GO:0005829;GO:0043687;GO:0016567;GO:0006446;GO:0006511;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol;, , P:post-translational protein modification; P:protein ubiquitination; P:regulation of translational initiation; P:ubiquitin-dependent protein catabolic process;|Q9H0H3 B2RDH2 B3KRT7,Kelch-like protein 25,Ectoderm-neural cortex protein 2;, PF07707;PF00651;PF01344;, GO:0031463;GO:0005737;GO:0005829;GO:0043687;GO:0016567;GO:0006446;GO:0006511;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol;, , P:post-translational protein modification; P:protein ubiquitination; P:regulation of translational initiation; P:ubiquitin-dependent protein catabolic process; scaffold45 indexed_genome mRNA 15208305 15270377 . - . ID=transcript_8857;Q16288 B7Z4C5 E9PG56 H0YND1 O75682 Q12827 Q16289,NT-3 growth factor receptor,GP145-TrkC;Neurotrophic tyrosine kinase receptor type 3;TrkC tyrosine kinase;, PF07679;PF00047;PF13855;PF01462;PF07714;PF16920;, GO:0030424;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0043121;GO:0005030;GO:0002039;GO:0004714;GO:0090630;GO:0000187;GO:0032148;GO:0030154;GO:1990090;GO:0007507;GO:0007275;GO:0001933;GO:0007399;GO:2000251;GO:0030335;GO:0008284;GO:0010628;GO:0033674;GO:0043410;GO:0010976;GO:0051388;GO:0033138;GO:0014068;GO:0010863;GO:0050927;GO:0001934;GO:0051896;GO:0007169;, C:axon; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:neurotrophin binding; F:neurotrophin receptor activity; F:p53 binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of GTPase activity; P:activation of MAPK activity; P:activation of protein kinase B activity; P:cell differentiation; P:cellular response to nerve growth factor stimulus; P:heart development; P:multicellular organism development; P:negative regulation of protein phosphorylation; P:nervous system development; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of positive chemotaxis; P:positive regulation of protein phosphorylation; P:regulation of protein kinase B signaling; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold45 indexed_genome mRNA 15311251 15541315 . - . ID=transcript_8858;Q16288 B7Z4C5 E9PG56 H0YND1 O75682 Q12827 Q16289,NT-3 growth factor receptor,GP145-TrkC;Neurotrophic tyrosine kinase receptor type 3;TrkC tyrosine kinase;, PF07679;PF00047;PF13855;PF01462;PF07714;PF16920;, GO:0030424;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0043121;GO:0005030;GO:0002039;GO:0004714;GO:0090630;GO:0000187;GO:0032148;GO:0030154;GO:1990090;GO:0007507;GO:0007275;GO:0001933;GO:0007399;GO:2000251;GO:0030335;GO:0008284;GO:0010628;GO:0033674;GO:0043410;GO:0010976;GO:0051388;GO:0033138;GO:0014068;GO:0010863;GO:0050927;GO:0001934;GO:0051896;GO:0007169;, C:axon; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:neurotrophin binding; F:neurotrophin receptor activity; F:p53 binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of GTPase activity; P:activation of MAPK activity; P:activation of protein kinase B activity; P:cell differentiation; P:cellular response to nerve growth factor stimulus; P:heart development; P:multicellular organism development; P:negative regulation of protein phosphorylation; P:nervous system development; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of positive chemotaxis; P:positive regulation of protein phosphorylation; P:regulation of protein kinase B signaling; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q16288 B7Z4C5 E9PG56 H0YND1 O75682 Q12827 Q16289,NT-3 growth factor receptor,GP145-TrkC;Neurotrophic tyrosine kinase receptor type 3;TrkC tyrosine kinase;, PF07679;PF00047;PF13855;PF01462;PF07714;PF16920;, GO:0030424;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0043121;GO:0005030;GO:0002039;GO:0004714;GO:0090630;GO:0000187;GO:0032148;GO:0030154;GO:1990090;GO:0007507;GO:0007275;GO:0001933;GO:0007399;GO:2000251;GO:0030335;GO:0008284;GO:0010628;GO:0033674;GO:0043410;GO:0010976;GO:0051388;GO:0033138;GO:0014068;GO:0010863;GO:0050927;GO:0001934;GO:0051896;GO:0007169;, C:axon; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:neurotrophin binding; F:neurotrophin receptor activity; F:p53 binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of GTPase activity; P:activation of MAPK activity; P:activation of protein kinase B activity; P:cell differentiation; P:cellular response to nerve growth factor stimulus; P:heart development; P:multicellular organism development; P:negative regulation of protein phosphorylation; P:nervous system development; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of positive chemotaxis; P:positive regulation of protein phosphorylation; P:regulation of protein kinase B signaling; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold45 indexed_genome mRNA 15822540 15832012 . - . ID=transcript_8859;Q9H2W6 B2RD75 Q9HBU8,39S ribosomal protein L46, mitochondrial,Mitochondrial large ribosomal subunit protein mL46 {ECO:0000303|PubMed:25278503};P2ECSL;, PF11788;, GO:0030054;GO:0005743;GO:0005762;GO:0005739;GO:0005654;GO:0016787;GO:0003735;GO:0070125;GO:0070126;, C:cell junction; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:hydrolase activity; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold45 indexed_genome mRNA 15832124 15846169 . + . ID=transcript_8860;P82912 B2RD52 Q969D7 Q96GI3 Q9BYC3,28S ribosomal protein S11, mitochondrial,Cervical cancer proto-oncogene 2 protein;Mitochondrial small ribosomal subunit protein uS11m {ECO:0000303|PubMed:25838379};, PF00411;, GO:0022627;GO:0005743;GO:0005763;GO:0005739;GO:0048027;GO:0003723;GO:0070181;GO:0003735;GO:0042769;GO:0000462;GO:0032543;GO:0070125;GO:0070126;GO:0000028;GO:0006412;, C:cytosolic small ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:mRNA 5'-UTR binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome;, P:DNA damage response, detection of DNA damage; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosomal small subunit assembly; P:translation;|P82912 B2RD52 Q969D7 Q96GI3 Q9BYC3,28S ribosomal protein S11, mitochondrial,Cervical cancer proto-oncogene 2 protein;Mitochondrial small ribosomal subunit protein uS11m {ECO:0000303|PubMed:25838379};, PF00411;, GO:0022627;GO:0005743;GO:0005763;GO:0005739;GO:0048027;GO:0003723;GO:0070181;GO:0003735;GO:0042769;GO:0000462;GO:0032543;GO:0070125;GO:0070126;GO:0000028;GO:0006412;, C:cytosolic small ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:mRNA 5'-UTR binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome;, P:DNA damage response, detection of DNA damage; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosomal small subunit assembly; P:translation;|P82912 B2RD52 Q969D7 Q96GI3 Q9BYC3,28S ribosomal protein S11, mitochondrial,Cervical cancer proto-oncogene 2 protein;Mitochondrial small ribosomal subunit protein uS11m {ECO:0000303|PubMed:25838379};, PF00411;, GO:0022627;GO:0005743;GO:0005763;GO:0005739;GO:0048027;GO:0003723;GO:0070181;GO:0003735;GO:0042769;GO:0000462;GO:0032543;GO:0070125;GO:0070126;GO:0000028;GO:0006412;, C:cytosolic small ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:mRNA 5'-UTR binding; F:RNA binding; F:small ribosomal subunit rRNA binding; F:structural constituent of ribosome;, P:DNA damage response, detection of DNA damage; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosomal small subunit assembly; P:translation; scaffold45 indexed_genome mRNA 15874607 15898753 . - . ID=transcript_8861;Q7L5Y6 B3KNN6 Q2VPC0 Q9NWD5,DET1 homolog,De-etiolated-1 homolog;, PF09737;, GO:0080008;GO:0031464;GO:0031461;GO:0005634;GO:0044877;GO:1990756;GO:0031625;GO:0032436;GO:0016567;GO:0065003;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleus;, F:protein-containing complex binding; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:protein-containing complex assembly; scaffold45 indexed_genome mRNA 15943763 15954060 . + . ID=transcript_8862;Q8WTP8 C9J571 Q9BSA5 Q9H9X7,Apoptosis-enhancing nuclease,Interferon-stimulated 20 kDa exonuclease-like 1;, PF00929;, GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0004527;GO:0003676;GO:0042771;GO:0010212;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:exonuclease activity; F:nucleic acid binding;, P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:response to ionizing radiation; scaffold45 indexed_genome mRNA 15959584 15976938 . + . ID=transcript_8863;Q96AZ6 O00441 O00586,Interferon-stimulated gene 20 kDa protein,Estrogen-regulated transcript 45 protein;Promyelocytic leukemia nuclear body-associated protein ISG20;, PF00929;, GO:0015030;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0000175;GO:0004527;GO:0008859;GO:0046872;GO:0008310;GO:0030619;GO:0030620;GO:0034511;GO:0051607;GO:0000738;GO:0045071;GO:0009615;GO:0006401;GO:0006364;GO:0060337;, C:Cajal body; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:3'-5'-exoribonuclease activity; F:exonuclease activity; F:exoribonuclease II activity; F:metal ion binding; F:single-stranded DNA 3'-5' exodeoxyribonuclease activity; F:U1 snRNA binding; F:U2 snRNA binding; F:U3 snoRNA binding;, P:defense response to virus; P:DNA catabolic process, exonucleolytic; P:negative regulation of viral genome replication; P:response to virus; P:RNA catabolic process; P:rRNA processing; P:type I interferon signaling pathway; scaffold45 indexed_genome mRNA 16040782 16048659 . + . ID=transcript_8864;P62685,Endogenous retrovirus group K member 8 Gag polyprotein,HERV-K115 Gag protein;HERV-K_8p23.1 provirus ancestral Gag polyprotein;, PF02337;PF00607;PF00098;, GO:0005886;GO:0003676;GO:0005198;GO:0008270;GO:0016032;, C:plasma membrane;, F:nucleic acid binding; F:structural molecule activity; F:zinc ion binding;, P:viral process; scaffold45 indexed_genome mRNA 16096491 16107406 . + . ID=transcript_8865;Q96S97 B2RE58 Q542Z1 Q7Z507 Q8N9R4 Q96CS6 Q96SK9,Myeloid-associated differentiation marker,Protein SB135;, PF01284;, GO:0005911;GO:0030864;GO:0016021;GO:0045121;GO:0005886;GO:0001726;GO:0061028;GO:0031579;GO:0030837;GO:0010629;GO:0034115;GO:0090038;GO:0001933;GO:0030335;GO:1900026;GO:0072659;, C:cell-cell junction; C:cortical actin cytoskeleton; C:integral component of membrane; C:membrane raft; C:plasma membrane; C:ruffle;, , P:establishment of endothelial barrier; P:membrane raft organization; P:negative regulation of actin filament polymerization; P:negative regulation of gene expression; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of protein kinase C signaling; P:negative regulation of protein phosphorylation; P:positive regulation of cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to plasma membrane; scaffold45 indexed_genome mRNA 16200387 16201165 . + . ID=transcript_8866;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold45 indexed_genome mRNA 16387690 16388323 . + . ID=transcript_8867;Q96S97 B2RE58 Q542Z1 Q7Z507 Q8N9R4 Q96CS6 Q96SK9,Myeloid-associated differentiation marker,Protein SB135;, PF01284;, GO:0005911;GO:0030864;GO:0016021;GO:0045121;GO:0005886;GO:0001726;GO:0061028;GO:0031579;GO:0030837;GO:0010629;GO:0034115;GO:0090038;GO:0001933;GO:0030335;GO:1900026;GO:0072659;, C:cell-cell junction; C:cortical actin cytoskeleton; C:integral component of membrane; C:membrane raft; C:plasma membrane; C:ruffle;, , P:establishment of endothelial barrier; P:membrane raft organization; P:negative regulation of actin filament polymerization; P:negative regulation of gene expression; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of protein kinase C signaling; P:negative regulation of protein phosphorylation; P:positive regulation of cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to plasma membrane; scaffold45 indexed_genome mRNA 16581759 16590872 . - . ID=transcript_8868;Q96S86 A8K7P0,Hyaluronan and proteoglycan link protein 3,, PF07686;PF00193;, GO:0031012;GO:0005615;GO:0005540;GO:0007155;GO:0007417;GO:0001501;, C:extracellular matrix; C:extracellular space;, F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:skeletal system development;|P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold45 indexed_genome mRNA 16710244 16811187 . + . ID=transcript_8869;P08910 Q53G48 Q53GU0 Q5FVD9 Q8TC79,Monoacylglycerol lipase ABHD2 {ECO:0000305},2-arachidonoylglycerol hydrolase {ECO:0000305};Abhydrolase domain-containing protein 2 {ECO:0000305};Acetylesterase {ECO:0000305};Lung alpha/beta hydrolase 2 {ECO:0000250|UniProtKB:Q9QXM0};Progesterone-sensitive lipase {ECO:0000305};Protein PHPS1-2 {ECO:0000303|PubMed:2843827};, PF00561;, GO:0001669;GO:0016021;GO:0036126;GO:0097524;GO:0008126;GO:0047372;GO:0042562;GO:0033878;GO:0034338;GO:0003707;GO:0004806;GO:0007340;GO:0046464;GO:0044255;GO:0051792;GO:0051793;GO:0030336;GO:0032570;GO:0009611;GO:0048240;GO:0043401;, C:acrosomal vesicle; C:integral component of membrane; C:sperm flagellum; C:sperm plasma membrane;, F:acetylesterase activity; F:acylglycerol lipase activity; F:hormone binding; F:hormone-sensitive lipase activity; F:short-chain carboxylesterase activity; F:steroid hormone receptor activity; F:triglyceride lipase activity;, P:acrosome reaction; P:acylglycerol catabolic process; P:cellular lipid metabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty acid catabolic process; P:negative regulation of cell migration; P:response to progesterone; P:response to wounding; P:sperm capacitation; P:steroid hormone mediated signaling pathway;|P08910 Q53G48 Q53GU0 Q5FVD9 Q8TC79,Monoacylglycerol lipase ABHD2 {ECO:0000305},2-arachidonoylglycerol hydrolase {ECO:0000305};Abhydrolase domain-containing protein 2 {ECO:0000305};Acetylesterase {ECO:0000305};Lung alpha/beta hydrolase 2 {ECO:0000250|UniProtKB:Q9QXM0};Progesterone-sensitive lipase {ECO:0000305};Protein PHPS1-2 {ECO:0000303|PubMed:2843827};, PF00561;, GO:0001669;GO:0016021;GO:0036126;GO:0097524;GO:0008126;GO:0047372;GO:0042562;GO:0033878;GO:0034338;GO:0003707;GO:0004806;GO:0007340;GO:0046464;GO:0044255;GO:0051792;GO:0051793;GO:0030336;GO:0032570;GO:0009611;GO:0048240;GO:0043401;, C:acrosomal vesicle; C:integral component of membrane; C:sperm flagellum; C:sperm plasma membrane;, F:acetylesterase activity; F:acylglycerol lipase activity; F:hormone binding; F:hormone-sensitive lipase activity; F:short-chain carboxylesterase activity; F:steroid hormone receptor activity; F:triglyceride lipase activity;, P:acrosome reaction; P:acylglycerol catabolic process; P:cellular lipid metabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty acid catabolic process; P:negative regulation of cell migration; P:response to progesterone; P:response to wounding; P:sperm capacitation; P:steroid hormone mediated signaling pathway;|P08910 Q53G48 Q53GU0 Q5FVD9 Q8TC79,Monoacylglycerol lipase ABHD2 {ECO:0000305},2-arachidonoylglycerol hydrolase {ECO:0000305};Abhydrolase domain-containing protein 2 {ECO:0000305};Acetylesterase {ECO:0000305};Lung alpha/beta hydrolase 2 {ECO:0000250|UniProtKB:Q9QXM0};Progesterone-sensitive lipase {ECO:0000305};Protein PHPS1-2 {ECO:0000303|PubMed:2843827};, PF00561;, GO:0001669;GO:0016021;GO:0036126;GO:0097524;GO:0008126;GO:0047372;GO:0042562;GO:0033878;GO:0034338;GO:0003707;GO:0004806;GO:0007340;GO:0046464;GO:0044255;GO:0051792;GO:0051793;GO:0030336;GO:0032570;GO:0009611;GO:0048240;GO:0043401;, C:acrosomal vesicle; C:integral component of membrane; C:sperm flagellum; C:sperm plasma membrane;, F:acetylesterase activity; F:acylglycerol lipase activity; F:hormone binding; F:hormone-sensitive lipase activity; F:short-chain carboxylesterase activity; F:steroid hormone receptor activity; F:triglyceride lipase activity;, P:acrosome reaction; P:acylglycerol catabolic process; P:cellular lipid metabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty acid catabolic process; P:negative regulation of cell migration; P:response to progesterone; P:response to wounding; P:sperm capacitation; P:steroid hormone mediated signaling pathway; scaffold45 indexed_genome mRNA 16821322 16835479 . + . ID=transcript_8870;P12271 B2R667,Retinaldehyde-binding protein 1,Cellular retinaldehyde-binding protein;, PF00650;PF03765;, GO:0044297;GO:0005813;GO:0005829;GO:0005654;GO:0005502;GO:1902936;GO:0019841;GO:0050896;GO:0001523;GO:0007601;GO:0006776;, C:cell body; C:centrosome; C:cytosol; C:nucleoplasm;, F:11-cis retinal binding; F:phosphatidylinositol bisphosphate binding; F:retinol binding;, P:response to stimulus; P:retinoid metabolic process; P:visual perception; P:vitamin A metabolic process;|P12271 B2R667,Retinaldehyde-binding protein 1,Cellular retinaldehyde-binding protein;, PF00650;PF03765;, GO:0044297;GO:0005813;GO:0005829;GO:0005654;GO:0005502;GO:1902936;GO:0019841;GO:0050896;GO:0001523;GO:0007601;GO:0006776;, C:cell body; C:centrosome; C:cytosol; C:nucleoplasm;, F:11-cis retinal binding; F:phosphatidylinositol bisphosphate binding; F:retinol binding;, P:response to stimulus; P:retinoid metabolic process; P:visual perception; P:vitamin A metabolic process;|P12271 B2R667,Retinaldehyde-binding protein 1,Cellular retinaldehyde-binding protein;, PF00650;PF03765;, GO:0044297;GO:0005813;GO:0005829;GO:0005654;GO:0005502;GO:1902936;GO:0019841;GO:0050896;GO:0001523;GO:0007601;GO:0006776;, C:cell body; C:centrosome; C:cytosol; C:nucleoplasm;, F:11-cis retinal binding; F:phosphatidylinositol bisphosphate binding; F:retinol binding;, P:response to stimulus; P:retinoid metabolic process; P:visual perception; P:vitamin A metabolic process; scaffold45 indexed_genome mRNA 16844847 16916432 . + . ID=transcript_8871;Q9NVI1 A4ZVE4 A5YMH4 A6NJZ0 Q96JN1 Q96ST0 Q9BT96,Fanconi anemia group I protein,, PF14679;PF14680;PF14675;PF14674;PF14676;PF14677;PF14678;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0003677;GO:0070182;GO:0007049;GO:0036297;GO:0031398;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm;, F:DNA binding; F:DNA polymerase binding;, P:cell cycle; P:interstrand cross-link repair; P:positive regulation of protein ubiquitination;|Q9NVI1 A4ZVE4 A5YMH4 A6NJZ0 Q96JN1 Q96ST0 Q9BT96,Fanconi anemia group I protein,, PF14679;PF14680;PF14675;PF14674;PF14676;PF14677;PF14678;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0003677;GO:0070182;GO:0007049;GO:0036297;GO:0031398;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm;, F:DNA binding; F:DNA polymerase binding;, P:cell cycle; P:interstrand cross-link repair; P:positive regulation of protein ubiquitination;|P54098 Q8NFM2 Q92515,DNA polymerase subunit gamma-1,Mitochondrial DNA polymerase catalytic subunit;PolG-alpha;, PF00476;PF18136;, GO:0005760;GO:0042645;GO:0005739;GO:0032991;GO:0043195;GO:0008408;GO:0003682;GO:0003677;GO:0003887;GO:0002020;GO:0007568;GO:0006287;GO:0071333;GO:0006259;GO:0006261;GO:0006264;GO:0010332;GO:0055093;GO:0009416;, C:gamma DNA polymerase complex; C:mitochondrial nucleoid; C:mitochondrion; C:protein-containing complex; C:terminal bouton;, F:3'-5' exonuclease activity; F:chromatin binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:protease binding;, P:aging; P:base-excision repair, gap-filling; P:cellular response to glucose stimulus; P:DNA metabolic process; P:DNA-dependent DNA replication; P:mitochondrial DNA replication; P:response to gamma radiation; P:response to hyperoxia; P:response to light stimulus;|P54098 Q8NFM2 Q92515,DNA polymerase subunit gamma-1,Mitochondrial DNA polymerase catalytic subunit;PolG-alpha;, PF00476;PF18136;, GO:0005760;GO:0042645;GO:0005739;GO:0032991;GO:0043195;GO:0008408;GO:0003682;GO:0003677;GO:0003887;GO:0002020;GO:0007568;GO:0006287;GO:0071333;GO:0006259;GO:0006261;GO:0006264;GO:0010332;GO:0055093;GO:0009416;, C:gamma DNA polymerase complex; C:mitochondrial nucleoid; C:mitochondrion; C:protein-containing complex; C:terminal bouton;, F:3'-5' exonuclease activity; F:chromatin binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:protease binding;, P:aging; P:base-excision repair, gap-filling; P:cellular response to glucose stimulus; P:DNA metabolic process; P:DNA-dependent DNA replication; P:mitochondrial DNA replication; P:response to gamma radiation; P:response to hyperoxia; P:response to light stimulus; scaffold45 indexed_genome mRNA 16917620 16927470 . - . ID=transcript_8872;P54098 Q8NFM2 Q92515,DNA polymerase subunit gamma-1,Mitochondrial DNA polymerase catalytic subunit;PolG-alpha;, PF00476;PF18136;, GO:0005760;GO:0042645;GO:0005739;GO:0032991;GO:0043195;GO:0008408;GO:0003682;GO:0003677;GO:0003887;GO:0002020;GO:0007568;GO:0006287;GO:0071333;GO:0006259;GO:0006261;GO:0006264;GO:0010332;GO:0055093;GO:0009416;, C:gamma DNA polymerase complex; C:mitochondrial nucleoid; C:mitochondrion; C:protein-containing complex; C:terminal bouton;, F:3'-5' exonuclease activity; F:chromatin binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:protease binding;, P:aging; P:base-excision repair, gap-filling; P:cellular response to glucose stimulus; P:DNA metabolic process; P:DNA-dependent DNA replication; P:mitochondrial DNA replication; P:response to gamma radiation; P:response to hyperoxia; P:response to light stimulus;|P54098 Q8NFM2 Q92515,DNA polymerase subunit gamma-1,Mitochondrial DNA polymerase catalytic subunit;PolG-alpha;, PF00476;PF18136;, GO:0005760;GO:0042645;GO:0005739;GO:0032991;GO:0043195;GO:0008408;GO:0003682;GO:0003677;GO:0003887;GO:0002020;GO:0007568;GO:0006287;GO:0071333;GO:0006259;GO:0006261;GO:0006264;GO:0010332;GO:0055093;GO:0009416;, C:gamma DNA polymerase complex; C:mitochondrial nucleoid; C:mitochondrion; C:protein-containing complex; C:terminal bouton;, F:3'-5' exonuclease activity; F:chromatin binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:protease binding;, P:aging; P:base-excision repair, gap-filling; P:cellular response to glucose stimulus; P:DNA metabolic process; P:DNA-dependent DNA replication; P:mitochondrial DNA replication; P:response to gamma radiation; P:response to hyperoxia; P:response to light stimulus;|P54098 Q8NFM2 Q92515,DNA polymerase subunit gamma-1,Mitochondrial DNA polymerase catalytic subunit;PolG-alpha;, PF00476;PF18136;, GO:0005760;GO:0042645;GO:0005739;GO:0032991;GO:0043195;GO:0008408;GO:0003682;GO:0003677;GO:0003887;GO:0002020;GO:0007568;GO:0006287;GO:0071333;GO:0006259;GO:0006261;GO:0006264;GO:0010332;GO:0055093;GO:0009416;, C:gamma DNA polymerase complex; C:mitochondrial nucleoid; C:mitochondrion; C:protein-containing complex; C:terminal bouton;, F:3'-5' exonuclease activity; F:chromatin binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:protease binding;, P:aging; P:base-excision repair, gap-filling; P:cellular response to glucose stimulus; P:DNA metabolic process; P:DNA-dependent DNA replication; P:mitochondrial DNA replication; P:response to gamma radiation; P:response to hyperoxia; P:response to light stimulus;|P54098 Q8NFM2 Q92515,DNA polymerase subunit gamma-1,Mitochondrial DNA polymerase catalytic subunit;PolG-alpha;, PF00476;PF18136;, GO:0005760;GO:0042645;GO:0005739;GO:0032991;GO:0043195;GO:0008408;GO:0003682;GO:0003677;GO:0003887;GO:0002020;GO:0007568;GO:0006287;GO:0071333;GO:0006259;GO:0006261;GO:0006264;GO:0010332;GO:0055093;GO:0009416;, C:gamma DNA polymerase complex; C:mitochondrial nucleoid; C:mitochondrion; C:protein-containing complex; C:terminal bouton;, F:3'-5' exonuclease activity; F:chromatin binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:protease binding;, P:aging; P:base-excision repair, gap-filling; P:cellular response to glucose stimulus; P:DNA metabolic process; P:DNA-dependent DNA replication; P:mitochondrial DNA replication; P:response to gamma radiation; P:response to hyperoxia; P:response to light stimulus; scaffold45 indexed_genome mRNA 17192987 17198847 . - . ID=transcript_8873;Q2M1P5 Q3SXY0 Q6UXE9 Q8IW72,Kinesin-like protein KIF7,, PF00225;, GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;GO:0045879;GO:0045880;, C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:negative regulation of smoothened signaling pathway; P:positive regulation of smoothened signaling pathway;|Q2M1P5 Q3SXY0 Q6UXE9 Q8IW72,Kinesin-like protein KIF7,, PF00225;, GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;GO:0045879;GO:0045880;, C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:negative regulation of smoothened signaling pathway; P:positive regulation of smoothened signaling pathway;|Q2M1P5 Q3SXY0 Q6UXE9 Q8IW72,Kinesin-like protein KIF7,, PF00225;, GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;GO:0045879;GO:0045880;, C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:negative regulation of smoothened signaling pathway; P:positive regulation of smoothened signaling pathway; scaffold45 indexed_genome mRNA 17199120 17210885 . - . ID=transcript_8874;Q2M1P5 Q3SXY0 Q6UXE9 Q8IW72,Kinesin-like protein KIF7,, PF00225;, GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;GO:0045879;GO:0045880;, C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:negative regulation of smoothened signaling pathway; P:positive regulation of smoothened signaling pathway; scaffold45 indexed_genome mRNA 17214935 17217243 . - . ID=transcript_8875;O60240 Q8N5Y6,Perilipin-1,Lipid droplet-associated protein;, PF03036;, GO:0005829;GO:0005783;GO:0005811;GO:0008289;GO:0030522;GO:0016042;GO:0006629;, C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:lipid binding;, P:intracellular receptor signaling pathway; P:lipid catabolic process; P:lipid metabolic process; scaffold45 indexed_genome mRNA 17217377 17242327 . - . ID=transcript_8876;O60240 Q8N5Y6,Perilipin-1,Lipid droplet-associated protein;, PF03036;, GO:0005829;GO:0005783;GO:0005811;GO:0008289;GO:0030522;GO:0016042;GO:0006629;, C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:lipid binding;, P:intracellular receptor signaling pathway; P:lipid catabolic process; P:lipid metabolic process;|O60240 Q8N5Y6,Perilipin-1,Lipid droplet-associated protein;, PF03036;, GO:0005829;GO:0005783;GO:0005811;GO:0008289;GO:0030522;GO:0016042;GO:0006629;, C:cytosol; C:endoplasmic reticulum; C:lipid droplet;, F:lipid binding;, P:intracellular receptor signaling pathway; P:lipid catabolic process; P:lipid metabolic process;|O75192 B4DV88,Peroxisomal membrane protein 11A,28 kDa peroxisomal integral membrane protein;Peroxin-11A;Peroxisomal biogenesis factor 11A;Protein PEX11 homolog alpha;, PF05648;, GO:0005779;GO:0005778;GO:0005777;GO:0032991;GO:0042803;GO:0050873;GO:0016559;GO:0016557;GO:0007031;GO:0019222;GO:0044375;GO:0007165;, C:integral component of peroxisomal membrane; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:protein homodimerization activity;, P:brown fat cell differentiation; P:peroxisome fission; P:peroxisome membrane biogenesis; P:peroxisome organization; P:regulation of metabolic process; P:regulation of peroxisome size; P:signal transduction;|O75192 B4DV88,Peroxisomal membrane protein 11A,28 kDa peroxisomal integral membrane protein;Peroxin-11A;Peroxisomal biogenesis factor 11A;Protein PEX11 homolog alpha;, PF05648;, GO:0005779;GO:0005778;GO:0005777;GO:0032991;GO:0042803;GO:0050873;GO:0016559;GO:0016557;GO:0007031;GO:0019222;GO:0044375;GO:0007165;, C:integral component of peroxisomal membrane; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:protein homodimerization activity;, P:brown fat cell differentiation; P:peroxisome fission; P:peroxisome membrane biogenesis; P:peroxisome organization; P:regulation of metabolic process; P:regulation of peroxisome size; P:signal transduction; scaffold45 indexed_genome mRNA 17278839 17288320 . + . ID=transcript_8877;Q6P2C0 Q8N7Y8 Q9NP89,WD repeat-containing protein 93,, , GO:0005747;GO:0016651;GO:0022900;, C:mitochondrial respiratory chain complex I;, F:oxidoreductase activity, acting on NAD(P)H;, P:electron transport chain; scaffold45 indexed_genome mRNA 17322720 17351609 . - . ID=transcript_8878;P15144 Q16728 Q6GT90 Q8IUK3 Q8IVH3 Q9UCE0,Aminopeptidase N {ECO:0000305},Alanyl aminopeptidase;Aminopeptidase M;Microsomal aminopeptidase;Myeloid plasma membrane glycoprotein CD13;gp150;, PF11838;PF01433;, GO:0005737;GO:0005793;GO:0070062;GO:0005615;GO:0016021;GO:0005765;GO:0005886;GO:0030667;GO:0004177;GO:0070006;GO:0008237;GO:0042277;GO:0038023;GO:0001618;GO:0008270;GO:0001525;GO:0030154;GO:0043312;GO:0043171;GO:0006508;GO:0008217;GO:0007165;, C:cytoplasm; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane; C:secretory granule membrane;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:metallopeptidase activity; F:peptide binding; F:signaling receptor activity; F:virus receptor activity; F:zinc ion binding;, P:angiogenesis; P:cell differentiation; P:neutrophil degranulation; P:peptide catabolic process; P:proteolysis; P:regulation of blood pressure; P:signal transduction; scaffold45 indexed_genome mRNA 17380080 17422582 . - . ID=transcript_8879;P59780 B2R677 B4DGQ3 O09077 O09149 Q53H83 Q99589,AP-3 complex subunit sigma-2,AP-3 complex subunit sigma-3B;Adaptor-related protein complex 3 subunit sigma-2;Sigma-3B-adaptin;Sigma-adaptin 3b;, PF01217;, GO:0030123;GO:1904115;GO:0030659;GO:0005794;GO:0043231;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|P59780 B2R677 B4DGQ3 O09077 O09149 Q53H83 Q99589,AP-3 complex subunit sigma-2,AP-3 complex subunit sigma-3B;Adaptor-related protein complex 3 subunit sigma-2;Sigma-3B-adaptin;Sigma-adaptin 3b;, PF01217;, GO:0030123;GO:1904115;GO:0030659;GO:0005794;GO:0043231;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|P59780 B2R677 B4DGQ3 O09077 O09149 Q53H83 Q99589,AP-3 complex subunit sigma-2,AP-3 complex subunit sigma-3B;Adaptor-related protein complex 3 subunit sigma-2;Sigma-3B-adaptin;Sigma-adaptin 3b;, PF01217;, GO:0030123;GO:1904115;GO:0030659;GO:0005794;GO:0043231;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|P59780 B2R677 B4DGQ3 O09077 O09149 Q53H83 Q99589,AP-3 complex subunit sigma-2,AP-3 complex subunit sigma-3B;Adaptor-related protein complex 3 subunit sigma-2;Sigma-3B-adaptin;Sigma-adaptin 3b;, PF01217;, GO:0030123;GO:1904115;GO:0030659;GO:0005794;GO:0043231;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport; scaffold45 indexed_genome mRNA 17425099 17431344 . - . ID=transcript_8880;Q7Z6K5 E2QRD5,Arpin,Arp2/3 inhibition protein;, PF10574;, GO:0030027;GO:0033058;GO:0051126;GO:0030336;GO:2000393;, C:lamellipodium;, , P:directional locomotion; P:negative regulation of actin nucleation; P:negative regulation of cell migration; P:negative regulation of lamellipodium morphogenesis;|Q7Z6K5 E2QRD5,Arpin,Arp2/3 inhibition protein;, PF10574;, GO:0030027;GO:0033058;GO:0051126;GO:0030336;GO:2000393;, C:lamellipodium;, , P:directional locomotion; P:negative regulation of actin nucleation; P:negative regulation of cell migration; P:negative regulation of lamellipodium morphogenesis;|Q7Z6K5 E2QRD5,Arpin,Arp2/3 inhibition protein;, PF10574;, GO:0030027;GO:0033058;GO:0051126;GO:0030336;GO:2000393;, C:lamellipodium;, , P:directional locomotion; P:negative regulation of actin nucleation; P:negative regulation of cell migration; P:negative regulation of lamellipodium morphogenesis; scaffold45 indexed_genome mRNA 17582294 17594233 . + . ID=transcript_8881;Q8N1W2 A0AVS3 Q6ZMK9 Q8NDU0,Zinc finger protein 710,, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold45 indexed_genome mRNA 17601828 17602902 . + . ID=transcript_8882;P48735 B2R6L6 B4DFL2 Q96GT3,Isocitrate dehydrogenase [NADP], mitochondrial,ICD-M;IDP;NADP(+)-specific ICDH;Oxalosuccinate decarboxylase;, PF00180;, GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005777;GO:0004450;GO:0000287;GO:0051287;GO:0006103;GO:0005975;GO:0006097;GO:0006102;GO:0006741;GO:0006739;GO:1903976;GO:0060253;GO:1904465;GO:0006099;, C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:peroxisome;, F:isocitrate dehydrogenase (NADP+) activity; F:magnesium ion binding; F:NAD binding;, P:2-oxoglutarate metabolic process; P:carbohydrate metabolic process; P:glyoxylate cycle; P:isocitrate metabolic process; P:NADP biosynthetic process; P:NADP metabolic process; P:negative regulation of glial cell migration; P:negative regulation of glial cell proliferation; P:negative regulation of matrix metallopeptidase secretion; P:tricarboxylic acid cycle; scaffold45 indexed_genome mRNA 17603706 17604640 . - . ID=transcript_8883;P48735 B2R6L6 B4DFL2 Q96GT3,Isocitrate dehydrogenase [NADP], mitochondrial,ICD-M;IDP;NADP(+)-specific ICDH;Oxalosuccinate decarboxylase;, PF00180;, GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005777;GO:0004450;GO:0000287;GO:0051287;GO:0006103;GO:0005975;GO:0006097;GO:0006102;GO:0006741;GO:0006739;GO:1903976;GO:0060253;GO:1904465;GO:0006099;, C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:peroxisome;, F:isocitrate dehydrogenase (NADP+) activity; F:magnesium ion binding; F:NAD binding;, P:2-oxoglutarate metabolic process; P:carbohydrate metabolic process; P:glyoxylate cycle; P:isocitrate metabolic process; P:NADP biosynthetic process; P:NADP metabolic process; P:negative regulation of glial cell migration; P:negative regulation of glial cell proliferation; P:negative regulation of matrix metallopeptidase secretion; P:tricarboxylic acid cycle; scaffold45 indexed_genome mRNA 17604645 17605332 . + . ID=transcript_8884;P48735 B2R6L6 B4DFL2 Q96GT3,Isocitrate dehydrogenase [NADP], mitochondrial,ICD-M;IDP;NADP(+)-specific ICDH;Oxalosuccinate decarboxylase;, PF00180;, GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005777;GO:0004450;GO:0000287;GO:0051287;GO:0006103;GO:0005975;GO:0006097;GO:0006102;GO:0006741;GO:0006739;GO:1903976;GO:0060253;GO:1904465;GO:0006099;, C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:peroxisome;, F:isocitrate dehydrogenase (NADP+) activity; F:magnesium ion binding; F:NAD binding;, P:2-oxoglutarate metabolic process; P:carbohydrate metabolic process; P:glyoxylate cycle; P:isocitrate metabolic process; P:NADP biosynthetic process; P:NADP metabolic process; P:negative regulation of glial cell migration; P:negative regulation of glial cell proliferation; P:negative regulation of matrix metallopeptidase secretion; P:tricarboxylic acid cycle; scaffold45 indexed_genome mRNA 17706343 17733776 . + . ID=transcript_8885;Q9NPR2 J3KNP4 Q6UXE3 Q8WVP9 Q96FK5 Q9C0B8 Q9H691 Q9NPM8 Q9NPN0,Semaphorin-4B {ECO:0000305|Ref.1},Semaphorin-C {ECO:0000250|UniProtKB:Q62179};, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045202;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane; C:synapse;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9NPR2 J3KNP4 Q6UXE3 Q8WVP9 Q96FK5 Q9C0B8 Q9H691 Q9NPM8 Q9NPN0,Semaphorin-4B {ECO:0000305|Ref.1},Semaphorin-C {ECO:0000250|UniProtKB:Q62179};, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045202;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane; C:synapse;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9NPR2 J3KNP4 Q6UXE3 Q8WVP9 Q96FK5 Q9C0B8 Q9H691 Q9NPM8 Q9NPN0,Semaphorin-4B {ECO:0000305|Ref.1},Semaphorin-C {ECO:0000250|UniProtKB:Q62179};, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045202;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane; C:synapse;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9NPR2 J3KNP4 Q6UXE3 Q8WVP9 Q96FK5 Q9C0B8 Q9H691 Q9NPM8 Q9NPN0,Semaphorin-4B {ECO:0000305|Ref.1},Semaphorin-C {ECO:0000250|UniProtKB:Q62179};, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045202;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane; C:synapse;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9NPR2 J3KNP4 Q6UXE3 Q8WVP9 Q96FK5 Q9C0B8 Q9H691 Q9NPM8 Q9NPN0,Semaphorin-4B {ECO:0000305|Ref.1},Semaphorin-C {ECO:0000250|UniProtKB:Q62179};, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045202;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane; C:synapse;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9NPR2 J3KNP4 Q6UXE3 Q8WVP9 Q96FK5 Q9C0B8 Q9H691 Q9NPM8 Q9NPN0,Semaphorin-4B {ECO:0000305|Ref.1},Semaphorin-C {ECO:0000250|UniProtKB:Q62179};, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045202;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane; C:synapse;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold45 indexed_genome mRNA 17734401 17737533 . - . ID=transcript_8886;Q99828 B5BU40 H6WJF3 O00693 O00735 Q6IB49 Q96J54 Q99971,Calcium and integrin-binding protein 1,Calcium- and integrin-binding protein;Calmyrin;DNA-PKcs-interacting protein;Kinase-interacting protein;SNK-interacting protein 2-28;, PF13499;, GO:0016324;GO:0071944;GO:0005813;GO:0005737;GO:0030425;GO:0005783;GO:0070062;GO:0032433;GO:0005794;GO:0030426;GO:0030027;GO:0016020;GO:0043005;GO:0043025;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0032587;GO:0042383;GO:0031982;GO:0005509;GO:0008427;GO:0044325;GO:0008022;GO:0019901;GO:0030291;GO:0043495;GO:0031267;GO:0001525;GO:0006915;GO:0007155;GO:0051301;GO:0006974;GO:0071363;GO:1990090;GO:0071356;GO:0031122;GO:0006302;GO:0007113;GO:0097191;GO:0043066;GO:0008285;GO:0045653;GO:0007026;GO:0010977;GO:0051898;GO:0001933;GO:0030220;GO:0070886;GO:0043085;GO:0033630;GO:0030307;GO:0030335;GO:0090050;GO:0008284;GO:0001954;GO:0070374;GO:2000256;GO:0051092;GO:1903078;GO:0001934;GO:0071902;GO:0090314;GO:1900026;GO:0051302;GO:0042127;GO:0002931;GO:0007286;GO:0038163;, C:apical plasma membrane; C:cell periphery; C:centrosome; C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:filopodium tip; C:Golgi apparatus; C:growth cone; C:lamellipodium; C:membrane; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:sarcolemma; C:vesicle;, F:calcium ion binding; F:calcium-dependent protein kinase inhibitor activity; F:ion channel binding; F:protein C-terminus binding; F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; F:protein-membrane adaptor activity; F:small GTPase binding;, P:angiogenesis; P:apoptotic process; P:cell adhesion; P:cell division; P:cellular response to DNA damage stimulus; P:cellular response to growth factor stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to tumor necrosis factor; P:cytoplasmic microtubule organization; P:double-strand break repair; P:endomitotic cell cycle; P:extrinsic apoptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of megakaryocyte differentiation; P:negative regulation of microtubule depolymerization; P:negative regulation of neuron projection development; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:platelet formation; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of catalytic activity; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of male germ cell proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of cell division; P:regulation of cell population proliferation; P:response to ischemia; P:spermatid development; P:thrombopoietin-mediated signaling pathway;|Q99828 B5BU40 H6WJF3 O00693 O00735 Q6IB49 Q96J54 Q99971,Calcium and integrin-binding protein 1,Calcium- and integrin-binding protein;Calmyrin;DNA-PKcs-interacting protein;Kinase-interacting protein;SNK-interacting protein 2-28;, PF13499;, GO:0016324;GO:0071944;GO:0005813;GO:0005737;GO:0030425;GO:0005783;GO:0070062;GO:0032433;GO:0005794;GO:0030426;GO:0030027;GO:0016020;GO:0043005;GO:0043025;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0032587;GO:0042383;GO:0031982;GO:0005509;GO:0008427;GO:0044325;GO:0008022;GO:0019901;GO:0030291;GO:0043495;GO:0031267;GO:0001525;GO:0006915;GO:0007155;GO:0051301;GO:0006974;GO:0071363;GO:1990090;GO:0071356;GO:0031122;GO:0006302;GO:0007113;GO:0097191;GO:0043066;GO:0008285;GO:0045653;GO:0007026;GO:0010977;GO:0051898;GO:0001933;GO:0030220;GO:0070886;GO:0043085;GO:0033630;GO:0030307;GO:0030335;GO:0090050;GO:0008284;GO:0001954;GO:0070374;GO:2000256;GO:0051092;GO:1903078;GO:0001934;GO:0071902;GO:0090314;GO:1900026;GO:0051302;GO:0042127;GO:0002931;GO:0007286;GO:0038163;, C:apical plasma membrane; C:cell periphery; C:centrosome; C:cytoplasm; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:filopodium tip; C:Golgi apparatus; C:growth cone; C:lamellipodium; C:membrane; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane; C:sarcolemma; C:vesicle;, F:calcium ion binding; F:calcium-dependent protein kinase inhibitor activity; F:ion channel binding; F:protein C-terminus binding; F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; F:protein-membrane adaptor activity; F:small GTPase binding;, P:angiogenesis; P:apoptotic process; P:cell adhesion; P:cell division; P:cellular response to DNA damage stimulus; P:cellular response to growth factor stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to tumor necrosis factor; P:cytoplasmic microtubule organization; P:double-strand break repair; P:endomitotic cell cycle; P:extrinsic apoptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of megakaryocyte differentiation; P:negative regulation of microtubule depolymerization; P:negative regulation of neuron projection development; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:platelet formation; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of catalytic activity; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of male germ cell proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of cell division; P:regulation of cell population proliferation; P:response to ischemia; P:spermatid development; P:thrombopoietin-mediated signaling pathway; scaffold45 indexed_genome mRNA 17742677 17760665 . + . ID=transcript_8887;Q6ZNW5,GDP-D-glucose phosphorylase 1,, , GO:0005737;GO:0080048;GO:0005085;GO:0016787;GO:0000166;GO:0016779;GO:0006006;, C:cytoplasm;, F:GDP-D-glucose phosphorylase activity; F:guanyl-nucleotide exchange factor activity; F:hydrolase activity; F:nucleotide binding; F:nucleotidyltransferase activity;, P:glucose metabolic process;|Q9NPE2 B2R6M8 Q4V9L7 Q9HBL4,Neugrin,Mesenchymal stem cell protein DSC92;Neurite outgrowth-associated protein;Spinal cord-derived protein FI58G;, PF06413;, GO:0045171;GO:0031966;GO:0005739;GO:0072686;GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0019843;GO:0030182;GO:0070131;, C:intercellular bridge; C:mitochondrial membrane; C:mitochondrion; C:mitotic spindle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:rRNA binding;, P:neuron differentiation; P:positive regulation of mitochondrial translation;|Q9NPE2 B2R6M8 Q4V9L7 Q9HBL4,Neugrin,Mesenchymal stem cell protein DSC92;Neurite outgrowth-associated protein;Spinal cord-derived protein FI58G;, PF06413;, GO:0045171;GO:0031966;GO:0005739;GO:0072686;GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0019843;GO:0030182;GO:0070131;, C:intercellular bridge; C:mitochondrial membrane; C:mitochondrion; C:mitotic spindle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:rRNA binding;, P:neuron differentiation; P:positive regulation of mitochondrial translation;|Q9NPE2 B2R6M8 Q4V9L7 Q9HBL4,Neugrin,Mesenchymal stem cell protein DSC92;Neurite outgrowth-associated protein;Spinal cord-derived protein FI58G;, PF06413;, GO:0045171;GO:0031966;GO:0005739;GO:0072686;GO:0016604;GO:0005654;GO:0005634;GO:0003723;GO:0019843;GO:0030182;GO:0070131;, C:intercellular bridge; C:mitochondrial membrane; C:mitochondrion; C:mitotic spindle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA binding; F:rRNA binding;, P:neuron differentiation; P:positive regulation of mitochondrial translation; scaffold45 indexed_genome mRNA 17764870 17780234 . + . ID=transcript_8888;Q9H267 B3KQF6 Q96K14 Q9NRP6 Q9NSF3,Vacuolar protein sorting-associated protein 33B,, PF00995;, GO:0030136;GO:0033263;GO:0005737;GO:0005829;GO:0031901;GO:0005794;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0031091;GO:0055037;GO:0044877;GO:0032963;GO:0007032;GO:0006886;GO:0032418;GO:0032400;GO:0061025;GO:0017185;GO:0070889;GO:0015031;GO:0016192;, C:clathrin-coated vesicle; C:CORVET complex; C:cytoplasm; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:platelet alpha granule; C:recycling endosome;, F:protein-containing complex binding;, P:collagen metabolic process; P:endosome organization; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:membrane fusion; P:peptidyl-lysine hydroxylation; P:platelet alpha granule organization; P:protein transport; P:vesicle-mediated transport;|Q9H267 B3KQF6 Q96K14 Q9NRP6 Q9NSF3,Vacuolar protein sorting-associated protein 33B,, PF00995;, GO:0030136;GO:0033263;GO:0005737;GO:0005829;GO:0031901;GO:0005794;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0031091;GO:0055037;GO:0044877;GO:0032963;GO:0007032;GO:0006886;GO:0032418;GO:0032400;GO:0061025;GO:0017185;GO:0070889;GO:0015031;GO:0016192;, C:clathrin-coated vesicle; C:CORVET complex; C:cytoplasm; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:platelet alpha granule; C:recycling endosome;, F:protein-containing complex binding;, P:collagen metabolic process; P:endosome organization; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:membrane fusion; P:peptidyl-lysine hydroxylation; P:platelet alpha granule organization; P:protein transport; P:vesicle-mediated transport;|Q9H267 B3KQF6 Q96K14 Q9NRP6 Q9NSF3,Vacuolar protein sorting-associated protein 33B,, PF00995;, GO:0030136;GO:0033263;GO:0005737;GO:0005829;GO:0031901;GO:0005794;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0031091;GO:0055037;GO:0044877;GO:0032963;GO:0007032;GO:0006886;GO:0032418;GO:0032400;GO:0061025;GO:0017185;GO:0070889;GO:0015031;GO:0016192;, C:clathrin-coated vesicle; C:CORVET complex; C:cytoplasm; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:platelet alpha granule; C:recycling endosome;, F:protein-containing complex binding;, P:collagen metabolic process; P:endosome organization; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:membrane fusion; P:peptidyl-lysine hydroxylation; P:platelet alpha granule organization; P:protein transport; P:vesicle-mediated transport;|Q9H267 B3KQF6 Q96K14 Q9NRP6 Q9NSF3,Vacuolar protein sorting-associated protein 33B,, PF00995;, GO:0030136;GO:0033263;GO:0005737;GO:0005829;GO:0031901;GO:0005794;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0031091;GO:0055037;GO:0044877;GO:0032963;GO:0007032;GO:0006886;GO:0032418;GO:0032400;GO:0061025;GO:0017185;GO:0070889;GO:0015031;GO:0016192;, C:clathrin-coated vesicle; C:CORVET complex; C:cytoplasm; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:platelet alpha granule; C:recycling endosome;, F:protein-containing complex binding;, P:collagen metabolic process; P:endosome organization; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:membrane fusion; P:peptidyl-lysine hydroxylation; P:platelet alpha granule organization; P:protein transport; P:vesicle-mediated transport;|Q9H267 B3KQF6 Q96K14 Q9NRP6 Q9NSF3,Vacuolar protein sorting-associated protein 33B,, PF00995;, GO:0030136;GO:0033263;GO:0005737;GO:0005829;GO:0031901;GO:0005794;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0031091;GO:0055037;GO:0044877;GO:0032963;GO:0007032;GO:0006886;GO:0032418;GO:0032400;GO:0061025;GO:0017185;GO:0070889;GO:0015031;GO:0016192;, C:clathrin-coated vesicle; C:CORVET complex; C:cytoplasm; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:platelet alpha granule; C:recycling endosome;, F:protein-containing complex binding;, P:collagen metabolic process; P:endosome organization; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:membrane fusion; P:peptidyl-lysine hydroxylation; P:platelet alpha granule organization; P:protein transport; P:vesicle-mediated transport;|Q9H267 B3KQF6 Q96K14 Q9NRP6 Q9NSF3,Vacuolar protein sorting-associated protein 33B,, PF00995;, GO:0030136;GO:0033263;GO:0005737;GO:0005829;GO:0031901;GO:0005794;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0031091;GO:0055037;GO:0044877;GO:0032963;GO:0007032;GO:0006886;GO:0032418;GO:0032400;GO:0061025;GO:0017185;GO:0070889;GO:0015031;GO:0016192;, C:clathrin-coated vesicle; C:CORVET complex; C:cytoplasm; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:platelet alpha granule; C:recycling endosome;, F:protein-containing complex binding;, P:collagen metabolic process; P:endosome organization; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:membrane fusion; P:peptidyl-lysine hydroxylation; P:platelet alpha granule organization; P:protein transport; P:vesicle-mediated transport;|Q9H267 B3KQF6 Q96K14 Q9NRP6 Q9NSF3,Vacuolar protein sorting-associated protein 33B,, PF00995;, GO:0030136;GO:0033263;GO:0005737;GO:0005829;GO:0031901;GO:0005794;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0031091;GO:0055037;GO:0044877;GO:0032963;GO:0007032;GO:0006886;GO:0032418;GO:0032400;GO:0061025;GO:0017185;GO:0070889;GO:0015031;GO:0016192;, C:clathrin-coated vesicle; C:CORVET complex; C:cytoplasm; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:platelet alpha granule; C:recycling endosome;, F:protein-containing complex binding;, P:collagen metabolic process; P:endosome organization; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:membrane fusion; P:peptidyl-lysine hydroxylation; P:platelet alpha granule organization; P:protein transport; P:vesicle-mediated transport;|Q9H267 B3KQF6 Q96K14 Q9NRP6 Q9NSF3,Vacuolar protein sorting-associated protein 33B,, PF00995;, GO:0030136;GO:0033263;GO:0005737;GO:0005829;GO:0031901;GO:0005794;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0031091;GO:0055037;GO:0044877;GO:0032963;GO:0007032;GO:0006886;GO:0032418;GO:0032400;GO:0061025;GO:0017185;GO:0070889;GO:0015031;GO:0016192;, C:clathrin-coated vesicle; C:CORVET complex; C:cytoplasm; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:platelet alpha granule; C:recycling endosome;, F:protein-containing complex binding;, P:collagen metabolic process; P:endosome organization; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:membrane fusion; P:peptidyl-lysine hydroxylation; P:platelet alpha granule organization; P:protein transport; P:vesicle-mediated transport; scaffold45 indexed_genome mRNA 17780492 17797982 . + . ID=transcript_8889;O43663 A6NC44 B4DLR1 H9KV59 Q9BSB6,Protein regulator of cytokinesis 1 {ECO:0000312|HGNC:HGNC:9341},, , GO:0005694;GO:0070938;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0005876;GO:0000922;GO:0042802;GO:0019894;GO:0008017;GO:0019901;GO:0051301;GO:0001578;GO:0000226;GO:0000022;GO:0051256;GO:0008284;GO:0032465;, C:chromosome; C:contractile ring; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle; C:spindle microtubule; C:spindle pole;, F:identical protein binding; F:kinesin binding; F:microtubule binding; F:protein kinase binding;, P:cell division; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:mitotic spindle elongation; P:mitotic spindle midzone assembly; P:positive regulation of cell population proliferation; P:regulation of cytokinesis;|Q9H267 B3KQF6 Q96K14 Q9NRP6 Q9NSF3,Vacuolar protein sorting-associated protein 33B,, PF00995;, GO:0030136;GO:0033263;GO:0005737;GO:0005829;GO:0031901;GO:0005794;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0048471;GO:0031091;GO:0055037;GO:0044877;GO:0032963;GO:0007032;GO:0006886;GO:0032418;GO:0032400;GO:0061025;GO:0017185;GO:0070889;GO:0015031;GO:0016192;, C:clathrin-coated vesicle; C:CORVET complex; C:cytoplasm; C:cytosol; C:early endosome membrane; C:Golgi apparatus; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:platelet alpha granule; C:recycling endosome;, F:protein-containing complex binding;, P:collagen metabolic process; P:endosome organization; P:intracellular protein transport; P:lysosome localization; P:melanosome localization; P:membrane fusion; P:peptidyl-lysine hydroxylation; P:platelet alpha granule organization; P:protein transport; P:vesicle-mediated transport; scaffold45 indexed_genome mRNA 17798010 18631457 . + . ID=transcript_8890;O43663 A6NC44 B4DLR1 H9KV59 Q9BSB6,Protein regulator of cytokinesis 1 {ECO:0000312|HGNC:HGNC:9341},, , GO:0005694;GO:0070938;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0005876;GO:0000922;GO:0042802;GO:0019894;GO:0008017;GO:0019901;GO:0051301;GO:0001578;GO:0000226;GO:0000022;GO:0051256;GO:0008284;GO:0032465;, C:chromosome; C:contractile ring; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle; C:spindle microtubule; C:spindle pole;, F:identical protein binding; F:kinesin binding; F:microtubule binding; F:protein kinase binding;, P:cell division; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:mitotic spindle elongation; P:mitotic spindle midzone assembly; P:positive regulation of cell population proliferation; P:regulation of cytokinesis;|O43663 A6NC44 B4DLR1 H9KV59 Q9BSB6,Protein regulator of cytokinesis 1 {ECO:0000312|HGNC:HGNC:9341},, , GO:0005694;GO:0070938;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0005876;GO:0000922;GO:0042802;GO:0019894;GO:0008017;GO:0019901;GO:0051301;GO:0001578;GO:0000226;GO:0000022;GO:0051256;GO:0008284;GO:0032465;, C:chromosome; C:contractile ring; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle; C:spindle microtubule; C:spindle pole;, F:identical protein binding; F:kinesin binding; F:microtubule binding; F:protein kinase binding;, P:cell division; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:mitotic spindle elongation; P:mitotic spindle midzone assembly; P:positive regulation of cell population proliferation; P:regulation of cytokinesis;|O43663 A6NC44 B4DLR1 H9KV59 Q9BSB6,Protein regulator of cytokinesis 1 {ECO:0000312|HGNC:HGNC:9341},, , GO:0005694;GO:0070938;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0005876;GO:0000922;GO:0042802;GO:0019894;GO:0008017;GO:0019901;GO:0051301;GO:0001578;GO:0000226;GO:0000022;GO:0051256;GO:0008284;GO:0032465;, C:chromosome; C:contractile ring; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle; C:spindle microtubule; C:spindle pole;, F:identical protein binding; F:kinesin binding; F:microtubule binding; F:protein kinase binding;, P:cell division; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:mitotic spindle elongation; P:mitotic spindle midzone assembly; P:positive regulation of cell population proliferation; P:regulation of cytokinesis;|O43663 A6NC44 B4DLR1 H9KV59 Q9BSB6,Protein regulator of cytokinesis 1 {ECO:0000312|HGNC:HGNC:9341},, , GO:0005694;GO:0070938;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0005876;GO:0000922;GO:0042802;GO:0019894;GO:0008017;GO:0019901;GO:0051301;GO:0001578;GO:0000226;GO:0000022;GO:0051256;GO:0008284;GO:0032465;, C:chromosome; C:contractile ring; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle; C:spindle microtubule; C:spindle pole;, F:identical protein binding; F:kinesin binding; F:microtubule binding; F:protein kinase binding;, P:cell division; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:mitotic spindle elongation; P:mitotic spindle midzone assembly; P:positive regulation of cell population proliferation; P:regulation of cytokinesis;|O43663 A6NC44 B4DLR1 H9KV59 Q9BSB6,Protein regulator of cytokinesis 1 {ECO:0000312|HGNC:HGNC:9341},, , GO:0005694;GO:0070938;GO:0005737;GO:0005829;GO:0045171;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0005876;GO:0000922;GO:0042802;GO:0019894;GO:0008017;GO:0019901;GO:0051301;GO:0001578;GO:0000226;GO:0000022;GO:0051256;GO:0008284;GO:0032465;, C:chromosome; C:contractile ring; C:cytoplasm; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle; C:spindle microtubule; C:spindle pole;, F:identical protein binding; F:kinesin binding; F:microtubule binding; F:protein kinase binding;, P:cell division; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:mitotic spindle elongation; P:mitotic spindle midzone assembly; P:positive regulation of cell population proliferation; P:regulation of cytokinesis;|A6NED2 B2RTP9 Q29RX6,RCC1 domain-containing protein 1,, PF00415;, GO:0005694;GO:0005829;GO:0005886;GO:0006325;, C:chromosome; C:cytosol; C:plasma membrane;, , P:chromatin organization;|A6NED2 B2RTP9 Q29RX6,RCC1 domain-containing protein 1,, PF00415;, GO:0005694;GO:0005829;GO:0005886;GO:0006325;, C:chromosome; C:cytosol; C:plasma membrane;, , P:chromatin organization;|Q9H3U1 A8K6F7 Q7L3Y6 Q9H3U8 Q9NSE8 Q9NSE9,Protein unc-45 homolog A,GCUNC-45;Smooth muscle cell-associated protein 1;, PF13181;PF11701;, GO:0005829;GO:0005794;GO:0016607;GO:0048471;GO:0045296;GO:0051879;GO:0030154;GO:0061077;GO:0007517;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:perinuclear region of cytoplasm;, F:cadherin binding; F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:muscle organ development;|Q9H3U1 A8K6F7 Q7L3Y6 Q9H3U8 Q9NSE8 Q9NSE9,Protein unc-45 homolog A,GCUNC-45;Smooth muscle cell-associated protein 1;, PF13181;PF11701;, GO:0005829;GO:0005794;GO:0016607;GO:0048471;GO:0045296;GO:0051879;GO:0030154;GO:0061077;GO:0007517;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:perinuclear region of cytoplasm;, F:cadherin binding; F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:muscle organ development;|Q9H3U1 A8K6F7 Q7L3Y6 Q9H3U8 Q9NSE8 Q9NSE9,Protein unc-45 homolog A,GCUNC-45;Smooth muscle cell-associated protein 1;, PF13181;PF11701;, GO:0005829;GO:0005794;GO:0016607;GO:0048471;GO:0045296;GO:0051879;GO:0030154;GO:0061077;GO:0007517;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:perinuclear region of cytoplasm;, F:cadherin binding; F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:muscle organ development;|Q9H3U1 A8K6F7 Q7L3Y6 Q9H3U8 Q9NSE8 Q9NSE9,Protein unc-45 homolog A,GCUNC-45;Smooth muscle cell-associated protein 1;, PF13181;PF11701;, GO:0005829;GO:0005794;GO:0016607;GO:0048471;GO:0045296;GO:0051879;GO:0030154;GO:0061077;GO:0007517;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:perinuclear region of cytoplasm;, F:cadherin binding; F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:muscle organ development;|Q9H3U1 A8K6F7 Q7L3Y6 Q9H3U8 Q9NSE8 Q9NSE9,Protein unc-45 homolog A,GCUNC-45;Smooth muscle cell-associated protein 1;, PF13181;PF11701;, GO:0005829;GO:0005794;GO:0016607;GO:0048471;GO:0045296;GO:0051879;GO:0030154;GO:0061077;GO:0007517;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:perinuclear region of cytoplasm;, F:cadherin binding; F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:muscle organ development;|Q9H3U1 A8K6F7 Q7L3Y6 Q9H3U8 Q9NSE8 Q9NSE9,Protein unc-45 homolog A,GCUNC-45;Smooth muscle cell-associated protein 1;, PF13181;PF11701;, GO:0005829;GO:0005794;GO:0016607;GO:0048471;GO:0045296;GO:0051879;GO:0030154;GO:0061077;GO:0007517;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:perinuclear region of cytoplasm;, F:cadherin binding; F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:muscle organ development;|Q9H3U1 A8K6F7 Q7L3Y6 Q9H3U8 Q9NSE8 Q9NSE9,Protein unc-45 homolog A,GCUNC-45;Smooth muscle cell-associated protein 1;, PF13181;PF11701;, GO:0005829;GO:0005794;GO:0016607;GO:0048471;GO:0045296;GO:0051879;GO:0030154;GO:0061077;GO:0007517;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:perinuclear region of cytoplasm;, F:cadherin binding; F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:muscle organ development;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|Q8N4P3,Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1,HD domain-containing protein 3;Metazoan SpoT homolog 1;Penta-phosphate guanosine-3'-pyrophosphohydrolase;, , GO:0008893;GO:0046872;, , F:guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity; F:metal ion binding;|Q8N4P3,Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1,HD domain-containing protein 3;Metazoan SpoT homolog 1;Penta-phosphate guanosine-3'-pyrophosphohydrolase;, , GO:0008893;GO:0046872;, , F:guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity; F:metal ion binding;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|P49641 A6NH12 A8K1E8 Q13754,Alpha-mannosidase 2x,Alpha-mannosidase IIx;Mannosidase alpha class 2A member 2;Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase;, PF09261;PF07748;PF01074;, GO:0000139;GO:0016021;GO:0004559;GO:0030246;GO:0016799;GO:0004572;GO:0046872;GO:0006013;GO:0006491;GO:0006517;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing N-glycosyl compounds; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; F:metal ion binding;, P:mannose metabolic process; P:N-glycan processing; P:protein deglycosylation; P:protein glycosylation;|P07332 B2R6E6 B4DUD0 E9PC94 E9PC95 Q2VXS7 Q2VXS8 Q2VXT0 Q6GTU5,Tyrosine-protein kinase Fes/Fps,Feline sarcoma/Fujinami avian sarcoma oncogene homolog;Proto-oncogene c-Fes;Proto-oncogene c-Fps;p93c-fes;, PF00611;PF07714;PF00017;, GO:0005737;GO:0031410;GO:0005829;GO:0031234;GO:0005925;GO:0005794;GO:0015630;GO:0005524;GO:0034987;GO:0008017;GO:0004715;GO:0035091;GO:0004713;GO:0005102;GO:0004714;GO:0007155;GO:0030154;GO:0071305;GO:0007098;GO:0006935;GO:0045087;GO:0001578;GO:0018108;GO:2000251;GO:0031116;GO:0045657;GO:0045639;GO:0010976;GO:0046777;GO:0030155;GO:0045595;GO:2000145;GO:0042127;GO:0008360;GO:0043304;GO:0060627;GO:0007169;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:microtubule cytoskeleton;, F:ATP binding; F:immunoglobulin receptor binding; F:microtubule binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphatidylinositol binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell adhesion; P:cell differentiation; P:cellular response to vitamin D; P:centrosome cycle; P:chemotaxis; P:innate immune response; P:microtubule bundle formation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of microtubule polymerization; P:positive regulation of monocyte differentiation; P:positive regulation of myeloid cell differentiation; P:positive regulation of neuron projection development; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of cell motility; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of mast cell degranulation; P:regulation of vesicle-mediated transport; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P09958 Q14336 Q6LBS3 Q9UCZ5,Furin,Dibasic-processing enzyme;Paired basic amino acid residue-cleaving enzyme;, PF01483;PF00082;PF16470;, GO:0009986;GO:0005783;GO:0010008;GO:0070062;GO:0005576;GO:0005796;GO:0000139;GO:0030173;GO:0016020;GO:0045121;GO:0005886;GO:0005802;GO:0030140;GO:0004175;GO:0046872;GO:0048406;GO:0008233;GO:0042277;GO:0002020;GO:0004252;GO:0004867;GO:1990000;GO:0001825;GO:0030574;GO:0070268;GO:0090472;GO:0022617;GO:0030198;GO:0002862;GO:0032804;GO:0032911;GO:0032455;GO:0032902;GO:0043043;GO:0016486;GO:0051044;GO:1901394;GO:0016485;GO:0032374;GO:0052548;GO:0051004;GO:0042176;GO:0009966;GO:0032940;GO:0006465;GO:0007179;GO:0019058;GO:0019082;GO:0031638;GO:0097341;, C:cell surface; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:Golgi lumen; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:membrane raft; C:plasma membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle;, F:endopeptidase activity; F:metal ion binding; F:nerve growth factor binding; F:peptidase activity; F:peptide binding; F:protease binding; F:serine-type endopeptidase activity; F:serine-type endopeptidase inhibitor activity;, P:amyloid fibril formation; P:blastocyst formation; P:collagen catabolic process; P:cornification; P:dibasic protein processing; P:extracellular matrix disassembly; P:extracellular matrix organization; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of low-density lipoprotein particle receptor catabolic process; P:negative regulation of transforming growth factor beta1 production; P:nerve growth factor processing; P:nerve growth factor production; P:peptide biosynthetic process; P:peptide hormone processing; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of transforming growth factor beta1 activation; P:protein processing; P:regulation of cholesterol transport; P:regulation of endopeptidase activity; P:regulation of lipoprotein lipase activity; P:regulation of protein catabolic process; P:regulation of signal transduction; P:secretion by cell; P:signal peptide processing; P:transforming growth factor beta receptor signaling pathway; P:viral life cycle; P:viral protein processing; P:zymogen activation; P:zymogen inhibition;|P09958 Q14336 Q6LBS3 Q9UCZ5,Furin,Dibasic-processing enzyme;Paired basic amino acid residue-cleaving enzyme;, PF01483;PF00082;PF16470;, GO:0009986;GO:0005783;GO:0010008;GO:0070062;GO:0005576;GO:0005796;GO:0000139;GO:0030173;GO:0016020;GO:0045121;GO:0005886;GO:0005802;GO:0030140;GO:0004175;GO:0046872;GO:0048406;GO:0008233;GO:0042277;GO:0002020;GO:0004252;GO:0004867;GO:1990000;GO:0001825;GO:0030574;GO:0070268;GO:0090472;GO:0022617;GO:0030198;GO:0002862;GO:0032804;GO:0032911;GO:0032455;GO:0032902;GO:0043043;GO:0016486;GO:0051044;GO:1901394;GO:0016485;GO:0032374;GO:0052548;GO:0051004;GO:0042176;GO:0009966;GO:0032940;GO:0006465;GO:0007179;GO:0019058;GO:0019082;GO:0031638;GO:0097341;, C:cell surface; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:Golgi lumen; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:membrane raft; C:plasma membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle;, F:endopeptidase activity; F:metal ion binding; F:nerve growth factor binding; F:peptidase activity; F:peptide binding; F:protease binding; F:serine-type endopeptidase activity; F:serine-type endopeptidase inhibitor activity;, P:amyloid fibril formation; P:blastocyst formation; P:collagen catabolic process; P:cornification; P:dibasic protein processing; P:extracellular matrix disassembly; P:extracellular matrix organization; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of low-density lipoprotein particle receptor catabolic process; P:negative regulation of transforming growth factor beta1 production; P:nerve growth factor processing; P:nerve growth factor production; P:peptide biosynthetic process; P:peptide hormone processing; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of transforming growth factor beta1 activation; P:protein processing; P:regulation of cholesterol transport; P:regulation of endopeptidase activity; P:regulation of lipoprotein lipase activity; P:regulation of protein catabolic process; P:regulation of signal transduction; P:secretion by cell; P:signal peptide processing; P:transforming growth factor beta receptor signaling pathway; P:viral life cycle; P:viral protein processing; P:zymogen activation; P:zymogen inhibition;|P09958 Q14336 Q6LBS3 Q9UCZ5,Furin,Dibasic-processing enzyme;Paired basic amino acid residue-cleaving enzyme;, PF01483;PF00082;PF16470;, GO:0009986;GO:0005783;GO:0010008;GO:0070062;GO:0005576;GO:0005796;GO:0000139;GO:0030173;GO:0016020;GO:0045121;GO:0005886;GO:0005802;GO:0030140;GO:0004175;GO:0046872;GO:0048406;GO:0008233;GO:0042277;GO:0002020;GO:0004252;GO:0004867;GO:1990000;GO:0001825;GO:0030574;GO:0070268;GO:0090472;GO:0022617;GO:0030198;GO:0002862;GO:0032804;GO:0032911;GO:0032455;GO:0032902;GO:0043043;GO:0016486;GO:0051044;GO:1901394;GO:0016485;GO:0032374;GO:0052548;GO:0051004;GO:0042176;GO:0009966;GO:0032940;GO:0006465;GO:0007179;GO:0019058;GO:0019082;GO:0031638;GO:0097341;, C:cell surface; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:Golgi lumen; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:membrane raft; C:plasma membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle;, F:endopeptidase activity; F:metal ion binding; F:nerve growth factor binding; F:peptidase activity; F:peptide binding; F:protease binding; F:serine-type endopeptidase activity; F:serine-type endopeptidase inhibitor activity;, P:amyloid fibril formation; P:blastocyst formation; P:collagen catabolic process; P:cornification; P:dibasic protein processing; P:extracellular matrix disassembly; P:extracellular matrix organization; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of low-density lipoprotein particle receptor catabolic process; P:negative regulation of transforming growth factor beta1 production; P:nerve growth factor processing; P:nerve growth factor production; P:peptide biosynthetic process; P:peptide hormone processing; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of transforming growth factor beta1 activation; P:protein processing; P:regulation of cholesterol transport; P:regulation of endopeptidase activity; P:regulation of lipoprotein lipase activity; P:regulation of protein catabolic process; P:regulation of signal transduction; P:secretion by cell; P:signal peptide processing; P:transforming growth factor beta receptor signaling pathway; P:viral life cycle; P:viral protein processing; P:zymogen activation; P:zymogen inhibition;|P09958 Q14336 Q6LBS3 Q9UCZ5,Furin,Dibasic-processing enzyme;Paired basic amino acid residue-cleaving enzyme;, PF01483;PF00082;PF16470;, GO:0009986;GO:0005783;GO:0010008;GO:0070062;GO:0005576;GO:0005796;GO:0000139;GO:0030173;GO:0016020;GO:0045121;GO:0005886;GO:0005802;GO:0030140;GO:0004175;GO:0046872;GO:0048406;GO:0008233;GO:0042277;GO:0002020;GO:0004252;GO:0004867;GO:1990000;GO:0001825;GO:0030574;GO:0070268;GO:0090472;GO:0022617;GO:0030198;GO:0002862;GO:0032804;GO:0032911;GO:0032455;GO:0032902;GO:0043043;GO:0016486;GO:0051044;GO:1901394;GO:0016485;GO:0032374;GO:0052548;GO:0051004;GO:0042176;GO:0009966;GO:0032940;GO:0006465;GO:0007179;GO:0019058;GO:0019082;GO:0031638;GO:0097341;, C:cell surface; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:Golgi lumen; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:membrane raft; C:plasma membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle;, F:endopeptidase activity; F:metal ion binding; F:nerve growth factor binding; F:peptidase activity; F:peptide binding; F:protease binding; F:serine-type endopeptidase activity; F:serine-type endopeptidase inhibitor activity;, P:amyloid fibril formation; P:blastocyst formation; P:collagen catabolic process; P:cornification; P:dibasic protein processing; P:extracellular matrix disassembly; P:extracellular matrix organization; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of low-density lipoprotein particle receptor catabolic process; P:negative regulation of transforming growth factor beta1 production; P:nerve growth factor processing; P:nerve growth factor production; P:peptide biosynthetic process; P:peptide hormone processing; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of transforming growth factor beta1 activation; P:protein processing; P:regulation of cholesterol transport; P:regulation of endopeptidase activity; P:regulation of lipoprotein lipase activity; P:regulation of protein catabolic process; P:regulation of signal transduction; P:secretion by cell; P:signal peptide processing; P:transforming growth factor beta receptor signaling pathway; P:viral life cycle; P:viral protein processing; P:zymogen activation; P:zymogen inhibition;|P09958 Q14336 Q6LBS3 Q9UCZ5,Furin,Dibasic-processing enzyme;Paired basic amino acid residue-cleaving enzyme;, PF01483;PF00082;PF16470;, GO:0009986;GO:0005783;GO:0010008;GO:0070062;GO:0005576;GO:0005796;GO:0000139;GO:0030173;GO:0016020;GO:0045121;GO:0005886;GO:0005802;GO:0030140;GO:0004175;GO:0046872;GO:0048406;GO:0008233;GO:0042277;GO:0002020;GO:0004252;GO:0004867;GO:1990000;GO:0001825;GO:0030574;GO:0070268;GO:0090472;GO:0022617;GO:0030198;GO:0002862;GO:0032804;GO:0032911;GO:0032455;GO:0032902;GO:0043043;GO:0016486;GO:0051044;GO:1901394;GO:0016485;GO:0032374;GO:0052548;GO:0051004;GO:0042176;GO:0009966;GO:0032940;GO:0006465;GO:0007179;GO:0019058;GO:0019082;GO:0031638;GO:0097341;, C:cell surface; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:Golgi lumen; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:membrane raft; C:plasma membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle;, F:endopeptidase activity; F:metal ion binding; F:nerve growth factor binding; F:peptidase activity; F:peptide binding; F:protease binding; F:serine-type endopeptidase activity; F:serine-type endopeptidase inhibitor activity;, P:amyloid fibril formation; P:blastocyst formation; P:collagen catabolic process; P:cornification; P:dibasic protein processing; P:extracellular matrix disassembly; P:extracellular matrix organization; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of low-density lipoprotein particle receptor catabolic process; P:negative regulation of transforming growth factor beta1 production; P:nerve growth factor processing; P:nerve growth factor production; P:peptide biosynthetic process; P:peptide hormone processing; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of transforming growth factor beta1 activation; P:protein processing; P:regulation of cholesterol transport; P:regulation of endopeptidase activity; P:regulation of lipoprotein lipase activity; P:regulation of protein catabolic process; P:regulation of signal transduction; P:secretion by cell; P:signal peptide processing; P:transforming growth factor beta receptor signaling pathway; P:viral life cycle; P:viral protein processing; P:zymogen activation; P:zymogen inhibition;|P09958 Q14336 Q6LBS3 Q9UCZ5,Furin,Dibasic-processing enzyme;Paired basic amino acid residue-cleaving enzyme;, PF01483;PF00082;PF16470;, GO:0009986;GO:0005783;GO:0010008;GO:0070062;GO:0005576;GO:0005796;GO:0000139;GO:0030173;GO:0016020;GO:0045121;GO:0005886;GO:0005802;GO:0030140;GO:0004175;GO:0046872;GO:0048406;GO:0008233;GO:0042277;GO:0002020;GO:0004252;GO:0004867;GO:1990000;GO:0001825;GO:0030574;GO:0070268;GO:0090472;GO:0022617;GO:0030198;GO:0002862;GO:0032804;GO:0032911;GO:0032455;GO:0032902;GO:0043043;GO:0016486;GO:0051044;GO:1901394;GO:0016485;GO:0032374;GO:0052548;GO:0051004;GO:0042176;GO:0009966;GO:0032940;GO:0006465;GO:0007179;GO:0019058;GO:0019082;GO:0031638;GO:0097341;, C:cell surface; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:Golgi lumen; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane; C:membrane raft; C:plasma membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle;, F:endopeptidase activity; F:metal ion binding; F:nerve growth factor binding; F:peptidase activity; F:peptide binding; F:protease binding; F:serine-type endopeptidase activity; F:serine-type endopeptidase inhibitor activity;, P:amyloid fibril formation; P:blastocyst formation; P:collagen catabolic process; P:cornification; P:dibasic protein processing; P:extracellular matrix disassembly; P:extracellular matrix organization; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of low-density lipoprotein particle receptor catabolic process; P:negative regulation of transforming growth factor beta1 production; P:nerve growth factor processing; P:nerve growth factor production; P:peptide biosynthetic process; P:peptide hormone processing; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of transforming growth factor beta1 activation; P:protein processing; P:regulation of cholesterol transport; P:regulation of endopeptidase activity; P:regulation of lipoprotein lipase activity; P:regulation of protein catabolic process; P:regulation of signal transduction; P:secretion by cell; P:signal peptide processing; P:transforming growth factor beta receptor signaling pathway; P:viral life cycle; P:viral protein processing; P:zymogen activation; P:zymogen inhibition;|P54132 Q52M96,Bloom syndrome protein,DNA helicase, RecQ-like type 2;RecQ protein-like 3;, PF08072;PF16204;PF16202;PF00270;PF00271;PF00570;PF16124;PF09382;, GO:0005694;GO:0005737;GO:0005829;GO:0000800;GO:0000228;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0005657;GO:0043138;GO:1905773;GO:0036310;GO:0005524;GO:0016887;GO:0000405;GO:0003677;GO:0003678;GO:0008094;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0042802;GO:0002039;GO:0042803;GO:0003697;GO:0061821;GO:0061849;GO:0000403;GO:0008270;GO:0072757;GO:0006974;GO:0072711;GO:0071479;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006268;GO:0000724;GO:0044806;GO:0007095;GO:0051782;GO:0045910;GO:0045893;GO:0051259;GO:0051260;GO:0000079;GO:0090329;GO:1901796;GO:0031297;GO:0048478;GO:0010165;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:chromosome; C:cytoplasm; C:cytosol; C:lateral element; C:nuclear chromosome; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex; C:replication fork;, F:3'-5' DNA helicase activity; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:annealing helicase activity; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:identical protein binding; F:p53 binding; F:protein homodimerization activity; F:single-stranded DNA binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding; F:zinc ion binding;, P:cellular response to camptothecin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to ionizing radiation; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:mitotic G2 DNA damage checkpoint; P:negative regulation of cell division; P:negative regulation of DNA recombination; P:positive regulation of transcription, DNA-templated; P:protein complex oligomerization; P:protein homooligomerization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of DNA-dependent DNA replication; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replication fork protection; P:response to X-ray; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly;|P54132 Q52M96,Bloom syndrome protein,DNA helicase, RecQ-like type 2;RecQ protein-like 3;, PF08072;PF16204;PF16202;PF00270;PF00271;PF00570;PF16124;PF09382;, GO:0005694;GO:0005737;GO:0005829;GO:0000800;GO:0000228;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0005657;GO:0043138;GO:1905773;GO:0036310;GO:0005524;GO:0016887;GO:0000405;GO:0003677;GO:0003678;GO:0008094;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0042802;GO:0002039;GO:0042803;GO:0003697;GO:0061821;GO:0061849;GO:0000403;GO:0008270;GO:0072757;GO:0006974;GO:0072711;GO:0071479;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006268;GO:0000724;GO:0044806;GO:0007095;GO:0051782;GO:0045910;GO:0045893;GO:0051259;GO:0051260;GO:0000079;GO:0090329;GO:1901796;GO:0031297;GO:0048478;GO:0010165;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:chromosome; C:cytoplasm; C:cytosol; C:lateral element; C:nuclear chromosome; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex; C:replication fork;, F:3'-5' DNA helicase activity; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:annealing helicase activity; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:identical protein binding; F:p53 binding; F:protein homodimerization activity; F:single-stranded DNA binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding; F:zinc ion binding;, P:cellular response to camptothecin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to ionizing radiation; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:mitotic G2 DNA damage checkpoint; P:negative regulation of cell division; P:negative regulation of DNA recombination; P:positive regulation of transcription, DNA-templated; P:protein complex oligomerization; P:protein homooligomerization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of DNA-dependent DNA replication; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replication fork protection; P:response to X-ray; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly;|P54132 Q52M96,Bloom syndrome protein,DNA helicase, RecQ-like type 2;RecQ protein-like 3;, PF08072;PF16204;PF16202;PF00270;PF00271;PF00570;PF16124;PF09382;, GO:0005694;GO:0005737;GO:0005829;GO:0000800;GO:0000228;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0005657;GO:0043138;GO:1905773;GO:0036310;GO:0005524;GO:0016887;GO:0000405;GO:0003677;GO:0003678;GO:0008094;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0042802;GO:0002039;GO:0042803;GO:0003697;GO:0061821;GO:0061849;GO:0000403;GO:0008270;GO:0072757;GO:0006974;GO:0072711;GO:0071479;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006268;GO:0000724;GO:0044806;GO:0007095;GO:0051782;GO:0045910;GO:0045893;GO:0051259;GO:0051260;GO:0000079;GO:0090329;GO:1901796;GO:0031297;GO:0048478;GO:0010165;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:chromosome; C:cytoplasm; C:cytosol; C:lateral element; C:nuclear chromosome; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex; C:replication fork;, F:3'-5' DNA helicase activity; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:annealing helicase activity; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:identical protein binding; F:p53 binding; F:protein homodimerization activity; F:single-stranded DNA binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding; F:zinc ion binding;, P:cellular response to camptothecin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to ionizing radiation; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:mitotic G2 DNA damage checkpoint; P:negative regulation of cell division; P:negative regulation of DNA recombination; P:positive regulation of transcription, DNA-templated; P:protein complex oligomerization; P:protein homooligomerization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of DNA-dependent DNA replication; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replication fork protection; P:response to X-ray; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly;|P54132 Q52M96,Bloom syndrome protein,DNA helicase, RecQ-like type 2;RecQ protein-like 3;, PF08072;PF16204;PF16202;PF00270;PF00271;PF00570;PF16124;PF09382;, GO:0005694;GO:0005737;GO:0005829;GO:0000800;GO:0000228;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0005657;GO:0043138;GO:1905773;GO:0036310;GO:0005524;GO:0016887;GO:0000405;GO:0003677;GO:0003678;GO:0008094;GO:0061749;GO:0000400;GO:0009378;GO:0051880;GO:0004386;GO:0042802;GO:0002039;GO:0042803;GO:0003697;GO:0061821;GO:0061849;GO:0000403;GO:0008270;GO:0072757;GO:0006974;GO:0072711;GO:0071479;GO:0000729;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0006268;GO:0000724;GO:0044806;GO:0007095;GO:0051782;GO:0045910;GO:0045893;GO:0051259;GO:0051260;GO:0000079;GO:0090329;GO:1901796;GO:0031297;GO:0048478;GO:0010165;GO:0090656;GO:0000723;GO:0032201;GO:0061820;, C:chromosome; C:cytoplasm; C:cytosol; C:lateral element; C:nuclear chromosome; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex; C:replication fork;, F:3'-5' DNA helicase activity; F:8-hydroxy-2'-deoxyguanosine DNA binding; F:annealing helicase activity; F:ATP binding; F:ATPase activity; F:bubble DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:forked DNA-dependent helicase activity; F:four-way junction DNA binding; F:four-way junction helicase activity; F:G-quadruplex DNA binding; F:helicase activity; F:identical protein binding; F:p53 binding; F:protein homodimerization activity; F:single-stranded DNA binding; F:telomeric D-loop binding; F:telomeric G-quadruplex DNA binding; F:Y-form DNA binding; F:zinc ion binding;, P:cellular response to camptothecin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to ionizing radiation; P:DNA double-strand break processing; P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:G-quadruplex DNA unwinding; P:mitotic G2 DNA damage checkpoint; P:negative regulation of cell division; P:negative regulation of DNA recombination; P:positive regulation of transcription, DNA-templated; P:protein complex oligomerization; P:protein homooligomerization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of DNA-dependent DNA replication; P:regulation of signal transduction by p53 class mediator; P:replication fork processing; P:replication fork protection; P:response to X-ray; P:t-circle formation; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomeric D-loop disassembly;|Q6UUV7 Q6DK61 Q6DK62 Q8NF38 Q9H6U2,CREB-regulated transcription coactivator 3,Transducer of regulated cAMP response element-binding protein 3;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008140;GO:0097009;GO:0042116;GO:0043951;GO:0050995;GO:0032793;GO:0045944;GO:0051289;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:macrophage activation; P:negative regulation of cAMP-mediated signaling; P:negative regulation of lipid catabolic process; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:viral process;|Q6UUV7 Q6DK61 Q6DK62 Q8NF38 Q9H6U2,CREB-regulated transcription coactivator 3,Transducer of regulated cAMP response element-binding protein 3;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008140;GO:0097009;GO:0042116;GO:0043951;GO:0050995;GO:0032793;GO:0045944;GO:0051289;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:macrophage activation; P:negative regulation of cAMP-mediated signaling; P:negative regulation of lipid catabolic process; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:viral process;|Q6UUV7 Q6DK61 Q6DK62 Q8NF38 Q9H6U2,CREB-regulated transcription coactivator 3,Transducer of regulated cAMP response element-binding protein 3;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008140;GO:0097009;GO:0042116;GO:0043951;GO:0050995;GO:0032793;GO:0045944;GO:0051289;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:macrophage activation; P:negative regulation of cAMP-mediated signaling; P:negative regulation of lipid catabolic process; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:viral process;|Q6UUV7 Q6DK61 Q6DK62 Q8NF38 Q9H6U2,CREB-regulated transcription coactivator 3,Transducer of regulated cAMP response element-binding protein 3;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008140;GO:0097009;GO:0042116;GO:0043951;GO:0050995;GO:0032793;GO:0045944;GO:0051289;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:macrophage activation; P:negative regulation of cAMP-mediated signaling; P:negative regulation of lipid catabolic process; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:viral process;|Q6UUV7 Q6DK61 Q6DK62 Q8NF38 Q9H6U2,CREB-regulated transcription coactivator 3,Transducer of regulated cAMP response element-binding protein 3;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008140;GO:0097009;GO:0042116;GO:0043951;GO:0050995;GO:0032793;GO:0045944;GO:0051289;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:macrophage activation; P:negative regulation of cAMP-mediated signaling; P:negative regulation of lipid catabolic process; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:viral process;|P46940 A7MBM3,Ras GTPase-activating-like protein IQGAP1,p195;, PF00307;PF00612;PF00616;PF03836;, GO:0005884;GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0030426;GO:0045121;GO:0005874;GO:0030496;GO:0043005;GO:0005634;GO:0005886;GO:0032991;GO:0001726;GO:0030667;GO:0036057;GO:0051015;GO:0045296;GO:0005509;GO:0005516;GO:0005096;GO:0005095;GO:0005078;GO:0051019;GO:0060090;GO:0005547;GO:0019904;GO:0019901;GO:0019903;GO:0043539;GO:0044548;GO:0031267;GO:0016477;GO:0071277;GO:0071364;GO:0007173;GO:0072015;GO:1990138;GO:0043312;GO:1903829;GO:1900006;GO:0051894;GO:0043406;GO:0043410;GO:1900086;GO:0045860;GO:1904754;GO:0032956;GO:0007346;GO:1990776;GO:0007165;GO:0016032;, C:actin filament; C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:growth cone; C:membrane raft; C:microtubule; C:midbody; C:neuron projection; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle; C:secretory granule membrane; C:slit diaphragm;, F:actin filament binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:GTPase activator activity; F:GTPase inhibitor activity; F:MAP-kinase scaffold activity; F:mitogen-activated protein kinase binding; F:molecular adaptor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase binding; F:protein serine/threonine kinase activator activity; F:S100 protein binding; F:small GTPase binding;, P:cell migration; P:cellular response to calcium ion; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:glomerular visceral epithelial cell development; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of cellular protein localization; P:positive regulation of dendrite development; P:positive regulation of focal adhesion assembly; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of actin cytoskeleton organization; P:regulation of mitotic cell cycle; P:response to angiotensin; P:signal transduction; P:viral process;|P46940 A7MBM3,Ras GTPase-activating-like protein IQGAP1,p195;, PF00307;PF00612;PF00616;PF03836;, GO:0005884;GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0030426;GO:0045121;GO:0005874;GO:0030496;GO:0043005;GO:0005634;GO:0005886;GO:0032991;GO:0001726;GO:0030667;GO:0036057;GO:0051015;GO:0045296;GO:0005509;GO:0005516;GO:0005096;GO:0005095;GO:0005078;GO:0051019;GO:0060090;GO:0005547;GO:0019904;GO:0019901;GO:0019903;GO:0043539;GO:0044548;GO:0031267;GO:0016477;GO:0071277;GO:0071364;GO:0007173;GO:0072015;GO:1990138;GO:0043312;GO:1903829;GO:1900006;GO:0051894;GO:0043406;GO:0043410;GO:1900086;GO:0045860;GO:1904754;GO:0032956;GO:0007346;GO:1990776;GO:0007165;GO:0016032;, C:actin filament; C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:growth cone; C:membrane raft; C:microtubule; C:midbody; C:neuron projection; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle; C:secretory granule membrane; C:slit diaphragm;, F:actin filament binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:GTPase activator activity; F:GTPase inhibitor activity; F:MAP-kinase scaffold activity; F:mitogen-activated protein kinase binding; F:molecular adaptor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase binding; F:protein serine/threonine kinase activator activity; F:S100 protein binding; F:small GTPase binding;, P:cell migration; P:cellular response to calcium ion; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:glomerular visceral epithelial cell development; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of cellular protein localization; P:positive regulation of dendrite development; P:positive regulation of focal adhesion assembly; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of actin cytoskeleton organization; P:regulation of mitotic cell cycle; P:response to angiotensin; P:signal transduction; P:viral process;|P46940 A7MBM3,Ras GTPase-activating-like protein IQGAP1,p195;, PF00307;PF00612;PF00616;PF03836;, GO:0005884;GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0030426;GO:0045121;GO:0005874;GO:0030496;GO:0043005;GO:0005634;GO:0005886;GO:0032991;GO:0001726;GO:0030667;GO:0036057;GO:0051015;GO:0045296;GO:0005509;GO:0005516;GO:0005096;GO:0005095;GO:0005078;GO:0051019;GO:0060090;GO:0005547;GO:0019904;GO:0019901;GO:0019903;GO:0043539;GO:0044548;GO:0031267;GO:0016477;GO:0071277;GO:0071364;GO:0007173;GO:0072015;GO:1990138;GO:0043312;GO:1903829;GO:1900006;GO:0051894;GO:0043406;GO:0043410;GO:1900086;GO:0045860;GO:1904754;GO:0032956;GO:0007346;GO:1990776;GO:0007165;GO:0016032;, C:actin filament; C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:growth cone; C:membrane raft; C:microtubule; C:midbody; C:neuron projection; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle; C:secretory granule membrane; C:slit diaphragm;, F:actin filament binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:GTPase activator activity; F:GTPase inhibitor activity; F:MAP-kinase scaffold activity; F:mitogen-activated protein kinase binding; F:molecular adaptor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase binding; F:protein serine/threonine kinase activator activity; F:S100 protein binding; F:small GTPase binding;, P:cell migration; P:cellular response to calcium ion; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:glomerular visceral epithelial cell development; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of cellular protein localization; P:positive regulation of dendrite development; P:positive regulation of focal adhesion assembly; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of actin cytoskeleton organization; P:regulation of mitotic cell cycle; P:response to angiotensin; P:signal transduction; P:viral process;|P46940 A7MBM3,Ras GTPase-activating-like protein IQGAP1,p195;, PF00307;PF00612;PF00616;PF03836;, GO:0005884;GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0030426;GO:0045121;GO:0005874;GO:0030496;GO:0043005;GO:0005634;GO:0005886;GO:0032991;GO:0001726;GO:0030667;GO:0036057;GO:0051015;GO:0045296;GO:0005509;GO:0005516;GO:0005096;GO:0005095;GO:0005078;GO:0051019;GO:0060090;GO:0005547;GO:0019904;GO:0019901;GO:0019903;GO:0043539;GO:0044548;GO:0031267;GO:0016477;GO:0071277;GO:0071364;GO:0007173;GO:0072015;GO:1990138;GO:0043312;GO:1903829;GO:1900006;GO:0051894;GO:0043406;GO:0043410;GO:1900086;GO:0045860;GO:1904754;GO:0032956;GO:0007346;GO:1990776;GO:0007165;GO:0016032;, C:actin filament; C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:growth cone; C:membrane raft; C:microtubule; C:midbody; C:neuron projection; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle; C:secretory granule membrane; C:slit diaphragm;, F:actin filament binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:GTPase activator activity; F:GTPase inhibitor activity; F:MAP-kinase scaffold activity; F:mitogen-activated protein kinase binding; F:molecular adaptor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase binding; F:protein serine/threonine kinase activator activity; F:S100 protein binding; F:small GTPase binding;, P:cell migration; P:cellular response to calcium ion; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:glomerular visceral epithelial cell development; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of cellular protein localization; P:positive regulation of dendrite development; P:positive regulation of focal adhesion assembly; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of actin cytoskeleton organization; P:regulation of mitotic cell cycle; P:response to angiotensin; P:signal transduction; P:viral process;|P46940 A7MBM3,Ras GTPase-activating-like protein IQGAP1,p195;, PF00307;PF00612;PF00616;PF03836;, GO:0005884;GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0030426;GO:0045121;GO:0005874;GO:0030496;GO:0043005;GO:0005634;GO:0005886;GO:0032991;GO:0001726;GO:0030667;GO:0036057;GO:0051015;GO:0045296;GO:0005509;GO:0005516;GO:0005096;GO:0005095;GO:0005078;GO:0051019;GO:0060090;GO:0005547;GO:0019904;GO:0019901;GO:0019903;GO:0043539;GO:0044548;GO:0031267;GO:0016477;GO:0071277;GO:0071364;GO:0007173;GO:0072015;GO:1990138;GO:0043312;GO:1903829;GO:1900006;GO:0051894;GO:0043406;GO:0043410;GO:1900086;GO:0045860;GO:1904754;GO:0032956;GO:0007346;GO:1990776;GO:0007165;GO:0016032;, C:actin filament; C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:growth cone; C:membrane raft; C:microtubule; C:midbody; C:neuron projection; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle; C:secretory granule membrane; C:slit diaphragm;, F:actin filament binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:GTPase activator activity; F:GTPase inhibitor activity; F:MAP-kinase scaffold activity; F:mitogen-activated protein kinase binding; F:molecular adaptor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase binding; F:protein serine/threonine kinase activator activity; F:S100 protein binding; F:small GTPase binding;, P:cell migration; P:cellular response to calcium ion; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:glomerular visceral epithelial cell development; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of cellular protein localization; P:positive regulation of dendrite development; P:positive regulation of focal adhesion assembly; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of actin cytoskeleton organization; P:regulation of mitotic cell cycle; P:response to angiotensin; P:signal transduction; P:viral process;|P46940 A7MBM3,Ras GTPase-activating-like protein IQGAP1,p195;, PF00307;PF00612;PF00616;PF03836;, GO:0005884;GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0070062;GO:0031234;GO:0005925;GO:0030426;GO:0045121;GO:0005874;GO:0030496;GO:0043005;GO:0005634;GO:0005886;GO:0032991;GO:0001726;GO:0030667;GO:0036057;GO:0051015;GO:0045296;GO:0005509;GO:0005516;GO:0005096;GO:0005095;GO:0005078;GO:0051019;GO:0060090;GO:0005547;GO:0019904;GO:0019901;GO:0019903;GO:0043539;GO:0044548;GO:0031267;GO:0016477;GO:0071277;GO:0071364;GO:0007173;GO:0072015;GO:1990138;GO:0043312;GO:1903829;GO:1900006;GO:0051894;GO:0043406;GO:0043410;GO:1900086;GO:0045860;GO:1904754;GO:0032956;GO:0007346;GO:1990776;GO:0007165;GO:0016032;, C:actin filament; C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:growth cone; C:membrane raft; C:microtubule; C:midbody; C:neuron projection; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle; C:secretory granule membrane; C:slit diaphragm;, F:actin filament binding; F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:GTPase activator activity; F:GTPase inhibitor activity; F:MAP-kinase scaffold activity; F:mitogen-activated protein kinase binding; F:molecular adaptor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase binding; F:protein serine/threonine kinase activator activity; F:S100 protein binding; F:small GTPase binding;, P:cell migration; P:cellular response to calcium ion; P:cellular response to epidermal growth factor stimulus; P:epidermal growth factor receptor signaling pathway; P:glomerular visceral epithelial cell development; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of cellular protein localization; P:positive regulation of dendrite development; P:positive regulation of focal adhesion assembly; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of vascular associated smooth muscle cell migration; P:regulation of actin cytoskeleton organization; P:regulation of mitotic cell cycle; P:response to angiotensin; P:signal transduction; P:viral process;|Q6NX45 A8K020,Zinc finger protein 774,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q6NX45 A8K020,Zinc finger protein 774,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q7Z7L9 A6NG83 B2RMQ9 Q6ZQY9 Q9NWU4,Zinc finger and SCAN domain-containing protein 2,Zinc finger protein 29 homolog;Zinc finger protein 854;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0030154;GO:0007275;GO:0006357;GO:0007283;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:multicellular organism development; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q6P4I2 Q96JZ1 Q9P0B7,WD repeat-containing protein 73,, , GO:0032154;GO:0005829;GO:0000922;GO:0031122;GO:0043066;GO:0006997;, C:cleavage furrow; C:cytosol; C:spindle pole;, , P:cytoplasmic microtubule organization; P:negative regulation of apoptotic process; P:nucleus organization;|Q6P4I2 Q96JZ1 Q9P0B7,WD repeat-containing protein 73,, , GO:0032154;GO:0005829;GO:0000922;GO:0031122;GO:0043066;GO:0006997;, C:cleavage furrow; C:cytosol; C:spindle pole;, , P:cytoplasmic microtubule organization; P:negative regulation of apoptotic process; P:nucleus organization;|Q6P4I2 Q96JZ1 Q9P0B7,WD repeat-containing protein 73,, , GO:0032154;GO:0005829;GO:0000922;GO:0031122;GO:0043066;GO:0006997;, C:cleavage furrow; C:cytosol; C:spindle pole;, , P:cytoplasmic microtubule organization; P:negative regulation of apoptotic process; P:nucleus organization;|Q6P4I2 Q96JZ1 Q9P0B7,WD repeat-containing protein 73,, , GO:0032154;GO:0005829;GO:0000922;GO:0031122;GO:0043066;GO:0006997;, C:cleavage furrow; C:cytosol; C:spindle pole;, , P:cytoplasmic microtubule organization; P:negative regulation of apoptotic process; P:nucleus organization;|Q6P4I2 Q96JZ1 Q9P0B7,WD repeat-containing protein 73,, , GO:0032154;GO:0005829;GO:0000922;GO:0031122;GO:0043066;GO:0006997;, C:cleavage furrow; C:cytosol; C:spindle pole;, , P:cytoplasmic microtubule organization; P:negative regulation of apoptotic process; P:nucleus organization;|P67812 B2RAD7 B4DUL4 H0YK72 H0YK83 O75957 P21378 Q53FQ8,Signal peptidase complex catalytic subunit SEC11A,Endopeptidase SP18;Microsomal signal peptidase 18 kDa subunit;SEC11 homolog A;SEC11-like protein 1;SPC18;, PF00717;, GO:0005789;GO:0016021;GO:0005787;GO:0008233;GO:0004252;GO:0006465;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:signal peptidase complex;, F:peptidase activity; F:serine-type endopeptidase activity;, P:signal peptide processing;|P67812 B2RAD7 B4DUL4 H0YK72 H0YK83 O75957 P21378 Q53FQ8,Signal peptidase complex catalytic subunit SEC11A,Endopeptidase SP18;Microsomal signal peptidase 18 kDa subunit;SEC11 homolog A;SEC11-like protein 1;SPC18;, PF00717;, GO:0005789;GO:0016021;GO:0005787;GO:0008233;GO:0004252;GO:0006465;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:signal peptidase complex;, F:peptidase activity; F:serine-type endopeptidase activity;, P:signal peptide processing;|P67812 B2RAD7 B4DUL4 H0YK72 H0YK83 O75957 P21378 Q53FQ8,Signal peptidase complex catalytic subunit SEC11A,Endopeptidase SP18;Microsomal signal peptidase 18 kDa subunit;SEC11 homolog A;SEC11-like protein 1;SPC18;, PF00717;, GO:0005789;GO:0016021;GO:0005787;GO:0008233;GO:0004252;GO:0006465;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:signal peptidase complex;, F:peptidase activity; F:serine-type endopeptidase activity;, P:signal peptide processing;|P67812 B2RAD7 B4DUL4 H0YK72 H0YK83 O75957 P21378 Q53FQ8,Signal peptidase complex catalytic subunit SEC11A,Endopeptidase SP18;Microsomal signal peptidase 18 kDa subunit;SEC11 homolog A;SEC11-like protein 1;SPC18;, PF00717;, GO:0005789;GO:0016021;GO:0005787;GO:0008233;GO:0004252;GO:0006465;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:signal peptidase complex;, F:peptidase activity; F:serine-type endopeptidase activity;, P:signal peptide processing;|P62750 B2R5B2 P29316 P39024 Q92774,60S ribosomal protein L23a,Large ribosomal subunit protein uL23 {ECO:0000303|PubMed:24524803};, PF00276;PF03939;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005730;GO:0005634;GO:0045296;GO:0003723;GO:0019843;GO:0003735;GO:1904841;GO:0000184;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:nucleolus; C:nucleus;, F:cadherin binding; F:RNA binding; F:rRNA binding; F:structural constituent of ribosome; F:TORC2 complex binding;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q92610 Q2M1T2 Q504Y9,Zinc finger protein 592,, PF00096;PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q92610 Q2M1T2 Q504Y9,Zinc finger protein 592,, PF00096;PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q92610 Q2M1T2 Q504Y9,Zinc finger protein 592,, PF00096;PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q92610 Q2M1T2 Q504Y9,Zinc finger protein 592,, PF00096;PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q92610 Q2M1T2 Q504Y9,Zinc finger protein 592,, PF00096;PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q92610 Q2M1T2 Q504Y9,Zinc finger protein 592,, PF00096;PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q92610 Q2M1T2 Q504Y9,Zinc finger protein 592,, PF00096;PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q96L96 Q9P2L6,Alpha-protein kinase 3 {ECO:0000305},Muscle alpha-protein kinase {ECO:0000303|PubMed:10021370};, PF02816;PF07679;, GO:0005634;GO:0005524;GO:0106310;GO:0106311;GO:0055013;GO:0007507;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell development; P:heart development;|Q96L96 Q9P2L6,Alpha-protein kinase 3 {ECO:0000305},Muscle alpha-protein kinase {ECO:0000303|PubMed:10021370};, PF02816;PF07679;, GO:0005634;GO:0005524;GO:0106310;GO:0106311;GO:0055013;GO:0007507;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell development; P:heart development;|Q96L96 Q9P2L6,Alpha-protein kinase 3 {ECO:0000305},Muscle alpha-protein kinase {ECO:0000303|PubMed:10021370};, PF02816;PF07679;, GO:0005634;GO:0005524;GO:0106310;GO:0106311;GO:0055013;GO:0007507;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell development; P:heart development;|Q96L96 Q9P2L6,Alpha-protein kinase 3 {ECO:0000305},Muscle alpha-protein kinase {ECO:0000303|PubMed:10021370};, PF02816;PF07679;, GO:0005634;GO:0005524;GO:0106310;GO:0106311;GO:0055013;GO:0007507;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell development; P:heart development;|Q96L96 Q9P2L6,Alpha-protein kinase 3 {ECO:0000305},Muscle alpha-protein kinase {ECO:0000303|PubMed:10021370};, PF02816;PF07679;, GO:0005634;GO:0005524;GO:0106310;GO:0106311;GO:0055013;GO:0007507;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell development; P:heart development;|Q96L96 Q9P2L6,Alpha-protein kinase 3 {ECO:0000305},Muscle alpha-protein kinase {ECO:0000303|PubMed:10021370};, PF02816;PF07679;, GO:0005634;GO:0005524;GO:0106310;GO:0106311;GO:0055013;GO:0007507;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell development; P:heart development;|Q96L96 Q9P2L6,Alpha-protein kinase 3 {ECO:0000305},Muscle alpha-protein kinase {ECO:0000303|PubMed:10021370};, PF02816;PF07679;, GO:0005634;GO:0005524;GO:0106310;GO:0106311;GO:0055013;GO:0007507;, C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cardiac muscle cell development; P:heart development; scaffold45 indexed_genome mRNA 18677377 18698383 . + . ID=transcript_8891;O00337 A0AV42 A8K7I2 O00335 O00336 Q5U5S6 Q5U648 Q9UEZ9,Sodium/nucleoside cotransporter 1,Concentrative nucleoside transporter 1;Na(+)/nucleoside cotransporter 1;Sodium-coupled nucleoside transporter 1;Solute carrier family 28 member 1;, PF07670;PF07662;PF01773;, GO:0031526;GO:0005829;GO:0005887;GO:0016020;GO:0016607;GO:0005886;GO:1901474;GO:0015212;GO:0005337;GO:0005415;GO:0005345;GO:0015389;GO:0015293;GO:0015213;GO:0045117;GO:0015861;GO:0006139;GO:1901642;GO:0015858;GO:1904823;GO:0015855;GO:0072531;GO:0015862;, C:brush border membrane; C:cytosol; C:integral component of plasma membrane; C:membrane; C:nuclear speck; C:plasma membrane;, F:azole transmembrane transporter activity; F:cytidine transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:nucleoside:sodium symporter activity; F:purine nucleobase transmembrane transporter activity; F:pyrimidine- and adenine-specific:sodium symporter activity; F:symporter activity; F:uridine transmembrane transporter activity;, P:azole transmembrane transport; P:cytidine transport; P:nucleobase-containing compound metabolic process; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleobase transmembrane transport; P:pyrimidine nucleobase transport; P:pyrimidine-containing compound transmembrane transport; P:uridine transport; scaffold45 indexed_genome mRNA 18910191 18933804 . + . ID=transcript_8892;Q9UMB7 Q9UMC3,High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A,, PF00989;PF00233;, GO:0005829;GO:0070062;GO:0004115;GO:0047555;GO:0004114;GO:0019900;GO:0046872;GO:0006198;GO:0071364;GO:0007186;GO:0060548;GO:1903206;GO:0070374;GO:0001934;GO:0006355;GO:0007165;, C:cytosol; C:extracellular exosome;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:kinase binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to epidermal growth factor stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of cell death; P:negative regulation of hydrogen peroxide-induced cell death; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:signal transduction;|Q9UMB7 Q9UMC3,High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A,, PF00989;PF00233;, GO:0005829;GO:0070062;GO:0004115;GO:0047555;GO:0004114;GO:0019900;GO:0046872;GO:0006198;GO:0071364;GO:0007186;GO:0060548;GO:1903206;GO:0070374;GO:0001934;GO:0006355;GO:0007165;, C:cytosol; C:extracellular exosome;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:kinase binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to epidermal growth factor stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of cell death; P:negative regulation of hydrogen peroxide-induced cell death; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:signal transduction;|Q9UMB7 Q9UMC3,High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A,, PF00989;PF00233;, GO:0005829;GO:0070062;GO:0004115;GO:0047555;GO:0004114;GO:0019900;GO:0046872;GO:0006198;GO:0071364;GO:0007186;GO:0060548;GO:1903206;GO:0070374;GO:0001934;GO:0006355;GO:0007165;, C:cytosol; C:extracellular exosome;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:kinase binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to epidermal growth factor stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of cell death; P:negative regulation of hydrogen peroxide-induced cell death; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:signal transduction;|Q9UMB7 Q9UMC3,High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A,, PF00989;PF00233;, GO:0005829;GO:0070062;GO:0004115;GO:0047555;GO:0004114;GO:0019900;GO:0046872;GO:0006198;GO:0071364;GO:0007186;GO:0060548;GO:1903206;GO:0070374;GO:0001934;GO:0006355;GO:0007165;, C:cytosol; C:extracellular exosome;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:kinase binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to epidermal growth factor stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of cell death; P:negative regulation of hydrogen peroxide-induced cell death; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:signal transduction;|Q9UMB7 Q9UMC3,High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A,, PF00989;PF00233;, GO:0005829;GO:0070062;GO:0004115;GO:0047555;GO:0004114;GO:0019900;GO:0046872;GO:0006198;GO:0071364;GO:0007186;GO:0060548;GO:1903206;GO:0070374;GO:0001934;GO:0006355;GO:0007165;, C:cytosol; C:extracellular exosome;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:kinase binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to epidermal growth factor stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of cell death; P:negative regulation of hydrogen peroxide-induced cell death; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:signal transduction;|Q9UMB7 Q9UMC3,High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A,, PF00989;PF00233;, GO:0005829;GO:0070062;GO:0004115;GO:0047555;GO:0004114;GO:0019900;GO:0046872;GO:0006198;GO:0071364;GO:0007186;GO:0060548;GO:1903206;GO:0070374;GO:0001934;GO:0006355;GO:0007165;, C:cytosol; C:extracellular exosome;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:kinase binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to epidermal growth factor stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of cell death; P:negative regulation of hydrogen peroxide-induced cell death; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of protein phosphorylation; P:regulation of transcription, DNA-templated; P:signal transduction; scaffold45 indexed_genome mRNA 18970177 18973611 . - . ID=transcript_8893;P08708 B2R4U4 P0CW22,40S ribosomal protein S17 {ECO:0000305},Small ribosomal subunit protein eS17 {ECO:0000303|PubMed:24524803};, PF00833;, GO:0005829;GO:0022627;GO:0005925;GO:0016020;GO:0005654;GO:0005840;GO:0003723;GO:0003735;GO:0034101;GO:0000184;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:focal adhesion; C:membrane; C:nucleoplasm; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:erythrocyte homeostasis; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P08708 B2R4U4 P0CW22,40S ribosomal protein S17 {ECO:0000305},Small ribosomal subunit protein eS17 {ECO:0000303|PubMed:24524803};, PF00833;, GO:0005829;GO:0022627;GO:0005925;GO:0016020;GO:0005654;GO:0005840;GO:0003723;GO:0003735;GO:0034101;GO:0000184;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:focal adhesion; C:membrane; C:nucleoplasm; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:erythrocyte homeostasis; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold45 indexed_genome mRNA 18978129 19089747 . - . ID=transcript_8894;Q9BZB8 B7Z6C6 Q86W46 Q8IV41 Q9BZB7 Q9H8V5,Cytoplasmic polyadenylation element-binding protein 1,, PF16368;PF16366;PF16367;, GO:0005737;GO:0005829;GO:0030425;GO:0016020;GO:1990124;GO:0043005;GO:0005654;GO:0005634;GO:0000932;GO:0014069;GO:0045202;GO:0046872;GO:0035925;GO:0003730;GO:0043022;GO:0008135;GO:0000900;GO:0071230;GO:0071456;GO:0032869;GO:0006397;GO:2000766;GO:1900365;, C:cytoplasm; C:cytosol; C:dendrite; C:membrane; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:mRNA processing; P:negative regulation of cytoplasmic translation; P:positive regulation of mRNA polyadenylation;|Q9BZB8 B7Z6C6 Q86W46 Q8IV41 Q9BZB7 Q9H8V5,Cytoplasmic polyadenylation element-binding protein 1,, PF16368;PF16366;PF16367;, GO:0005737;GO:0005829;GO:0030425;GO:0016020;GO:1990124;GO:0043005;GO:0005654;GO:0005634;GO:0000932;GO:0014069;GO:0045202;GO:0046872;GO:0035925;GO:0003730;GO:0043022;GO:0008135;GO:0000900;GO:0071230;GO:0071456;GO:0032869;GO:0006397;GO:2000766;GO:1900365;, C:cytoplasm; C:cytosol; C:dendrite; C:membrane; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:mRNA processing; P:negative regulation of cytoplasmic translation; P:positive regulation of mRNA polyadenylation;|Q9BZB8 B7Z6C6 Q86W46 Q8IV41 Q9BZB7 Q9H8V5,Cytoplasmic polyadenylation element-binding protein 1,, PF16368;PF16366;PF16367;, GO:0005737;GO:0005829;GO:0030425;GO:0016020;GO:1990124;GO:0043005;GO:0005654;GO:0005634;GO:0000932;GO:0014069;GO:0045202;GO:0046872;GO:0035925;GO:0003730;GO:0043022;GO:0008135;GO:0000900;GO:0071230;GO:0071456;GO:0032869;GO:0006397;GO:2000766;GO:1900365;, C:cytoplasm; C:cytosol; C:dendrite; C:membrane; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:mRNA processing; P:negative regulation of cytoplasmic translation; P:positive regulation of mRNA polyadenylation;|Q9BZB8 B7Z6C6 Q86W46 Q8IV41 Q9BZB7 Q9H8V5,Cytoplasmic polyadenylation element-binding protein 1,, PF16368;PF16366;PF16367;, GO:0005737;GO:0005829;GO:0030425;GO:0016020;GO:1990124;GO:0043005;GO:0005654;GO:0005634;GO:0000932;GO:0014069;GO:0045202;GO:0046872;GO:0035925;GO:0003730;GO:0043022;GO:0008135;GO:0000900;GO:0071230;GO:0071456;GO:0032869;GO:0006397;GO:2000766;GO:1900365;, C:cytoplasm; C:cytosol; C:dendrite; C:membrane; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:mRNA processing; P:negative regulation of cytoplasmic translation; P:positive regulation of mRNA polyadenylation;|Q9BZB8 B7Z6C6 Q86W46 Q8IV41 Q9BZB7 Q9H8V5,Cytoplasmic polyadenylation element-binding protein 1,, PF16368;PF16366;PF16367;, GO:0005737;GO:0005829;GO:0030425;GO:0016020;GO:1990124;GO:0043005;GO:0005654;GO:0005634;GO:0000932;GO:0014069;GO:0045202;GO:0046872;GO:0035925;GO:0003730;GO:0043022;GO:0008135;GO:0000900;GO:0071230;GO:0071456;GO:0032869;GO:0006397;GO:2000766;GO:1900365;, C:cytoplasm; C:cytosol; C:dendrite; C:membrane; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:mRNA processing; P:negative regulation of cytoplasmic translation; P:positive regulation of mRNA polyadenylation;|Q9BZB8 B7Z6C6 Q86W46 Q8IV41 Q9BZB7 Q9H8V5,Cytoplasmic polyadenylation element-binding protein 1,, PF16368;PF16366;PF16367;, GO:0005737;GO:0005829;GO:0030425;GO:0016020;GO:1990124;GO:0043005;GO:0005654;GO:0005634;GO:0000932;GO:0014069;GO:0045202;GO:0046872;GO:0035925;GO:0003730;GO:0043022;GO:0008135;GO:0000900;GO:0071230;GO:0071456;GO:0032869;GO:0006397;GO:2000766;GO:1900365;, C:cytoplasm; C:cytosol; C:dendrite; C:membrane; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:mRNA processing; P:negative regulation of cytoplasmic translation; P:positive regulation of mRNA polyadenylation;|Q9BZB8 B7Z6C6 Q86W46 Q8IV41 Q9BZB7 Q9H8V5,Cytoplasmic polyadenylation element-binding protein 1,, PF16368;PF16366;PF16367;, GO:0005737;GO:0005829;GO:0030425;GO:0016020;GO:1990124;GO:0043005;GO:0005654;GO:0005634;GO:0000932;GO:0014069;GO:0045202;GO:0046872;GO:0035925;GO:0003730;GO:0043022;GO:0008135;GO:0000900;GO:0071230;GO:0071456;GO:0032869;GO:0006397;GO:2000766;GO:1900365;, C:cytoplasm; C:cytosol; C:dendrite; C:membrane; C:messenger ribonucleoprotein complex; C:neuron projection; C:nucleoplasm; C:nucleus; C:P-body; C:postsynaptic density; C:synapse;, F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:ribosome binding; F:translation factor activity, RNA binding; F:translation repressor activity, mRNA regulatory element binding;, P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:mRNA processing; P:negative regulation of cytoplasmic translation; P:positive regulation of mRNA polyadenylation; scaffold45 indexed_genome mRNA 19105142 19141338 . + . ID=transcript_8895;Q13367 A4Z4T7 B7ZKR7 B7ZKS0 O14808 Q52LY8,AP-3 complex subunit beta-2,Adaptor protein complex AP-3 subunit beta-2;Adaptor-related protein complex 3 subunit beta-2;Beta-3B-adaptin;Clathrin assembly protein complex 3 beta-2 large chain;Neuron-specific vesicle coat protein beta-NAP;, PF01602;PF14796;, GO:0030123;GO:1904115;GO:0030665;GO:0005794;GO:0097708;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:intracellular vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|Q13367 A4Z4T7 B7ZKR7 B7ZKS0 O14808 Q52LY8,AP-3 complex subunit beta-2,Adaptor protein complex AP-3 subunit beta-2;Adaptor-related protein complex 3 subunit beta-2;Beta-3B-adaptin;Clathrin assembly protein complex 3 beta-2 large chain;Neuron-specific vesicle coat protein beta-NAP;, PF01602;PF14796;, GO:0030123;GO:1904115;GO:0030665;GO:0005794;GO:0097708;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:intracellular vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|Q13367 A4Z4T7 B7ZKR7 B7ZKS0 O14808 Q52LY8,AP-3 complex subunit beta-2,Adaptor protein complex AP-3 subunit beta-2;Adaptor-related protein complex 3 subunit beta-2;Beta-3B-adaptin;Clathrin assembly protein complex 3 beta-2 large chain;Neuron-specific vesicle coat protein beta-NAP;, PF01602;PF14796;, GO:0030123;GO:1904115;GO:0030665;GO:0005794;GO:0097708;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:intracellular vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|Q13367 A4Z4T7 B7ZKR7 B7ZKS0 O14808 Q52LY8,AP-3 complex subunit beta-2,Adaptor protein complex AP-3 subunit beta-2;Adaptor-related protein complex 3 subunit beta-2;Beta-3B-adaptin;Clathrin assembly protein complex 3 beta-2 large chain;Neuron-specific vesicle coat protein beta-NAP;, PF01602;PF14796;, GO:0030123;GO:1904115;GO:0030665;GO:0005794;GO:0097708;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:intracellular vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|Q13367 A4Z4T7 B7ZKR7 B7ZKS0 O14808 Q52LY8,AP-3 complex subunit beta-2,Adaptor protein complex AP-3 subunit beta-2;Adaptor-related protein complex 3 subunit beta-2;Beta-3B-adaptin;Clathrin assembly protein complex 3 beta-2 large chain;Neuron-specific vesicle coat protein beta-NAP;, PF01602;PF14796;, GO:0030123;GO:1904115;GO:0030665;GO:0005794;GO:0097708;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:intracellular vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|Q13367 A4Z4T7 B7ZKR7 B7ZKS0 O14808 Q52LY8,AP-3 complex subunit beta-2,Adaptor protein complex AP-3 subunit beta-2;Adaptor-related protein complex 3 subunit beta-2;Beta-3B-adaptin;Clathrin assembly protein complex 3 beta-2 large chain;Neuron-specific vesicle coat protein beta-NAP;, PF01602;PF14796;, GO:0030123;GO:1904115;GO:0030665;GO:0005794;GO:0097708;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:intracellular vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|Q13367 A4Z4T7 B7ZKR7 B7ZKS0 O14808 Q52LY8,AP-3 complex subunit beta-2,Adaptor protein complex AP-3 subunit beta-2;Adaptor-related protein complex 3 subunit beta-2;Beta-3B-adaptin;Clathrin assembly protein complex 3 beta-2 large chain;Neuron-specific vesicle coat protein beta-NAP;, PF01602;PF14796;, GO:0030123;GO:1904115;GO:0030665;GO:0005794;GO:0097708;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:intracellular vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|Q13367 A4Z4T7 B7ZKR7 B7ZKS0 O14808 Q52LY8,AP-3 complex subunit beta-2,Adaptor protein complex AP-3 subunit beta-2;Adaptor-related protein complex 3 subunit beta-2;Beta-3B-adaptin;Clathrin assembly protein complex 3 beta-2 large chain;Neuron-specific vesicle coat protein beta-NAP;, PF01602;PF14796;, GO:0030123;GO:1904115;GO:0030665;GO:0005794;GO:0097708;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:intracellular vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|Q13367 A4Z4T7 B7ZKR7 B7ZKS0 O14808 Q52LY8,AP-3 complex subunit beta-2,Adaptor protein complex AP-3 subunit beta-2;Adaptor-related protein complex 3 subunit beta-2;Beta-3B-adaptin;Clathrin assembly protein complex 3 beta-2 large chain;Neuron-specific vesicle coat protein beta-NAP;, PF01602;PF14796;, GO:0030123;GO:1904115;GO:0030665;GO:0005794;GO:0097708;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:intracellular vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport;|Q13367 A4Z4T7 B7ZKR7 B7ZKS0 O14808 Q52LY8,AP-3 complex subunit beta-2,Adaptor protein complex AP-3 subunit beta-2;Adaptor-related protein complex 3 subunit beta-2;Beta-3B-adaptin;Clathrin assembly protein complex 3 beta-2 large chain;Neuron-specific vesicle coat protein beta-NAP;, PF01602;PF14796;, GO:0030123;GO:1904115;GO:0030665;GO:0005794;GO:0097708;GO:0008089;GO:0048490;GO:0006886;GO:0016192;, C:AP-3 adaptor complex; C:axon cytoplasm; C:clathrin-coated vesicle membrane; C:Golgi apparatus; C:intracellular vesicle;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:intracellular protein transport; P:vesicle-mediated transport; scaffold45 indexed_genome mRNA 19149420 19151084 . + . ID=transcript_8896;Q9H329 Q5T4G5 Q5T4G6 Q9H328 Q9P2V3,Band 4.1-like protein 4B,Erythrocyte membrane protein band 4.1-like 4B {ECO:0000312|HGNC:HGNC:19818};FERM-containing protein CG1;Protein EHM2;, PF08736;PF09380;PF00373;PF09379;, GO:0045177;GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0008092;GO:0005200;GO:0031032;GO:0045785;GO:0010628;GO:0051549;GO:0042060;, C:apical part of cell; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:cytoskeletal protein binding; F:structural constituent of cytoskeleton;, P:actomyosin structure organization; P:positive regulation of cell adhesion; P:positive regulation of gene expression; P:positive regulation of keratinocyte migration; P:wound healing; scaffold45 indexed_genome mRNA 19171622 19196483 . + . ID=transcript_8897;A1L4K1 B3KVG1 B7ZM02,Fibronectin type III and SPRY domain-containing protein 2,SPRY domain-containing protein 1;, PF00041;PF00622;, GO:0005634;GO:0048471;GO:0016529;, C:nucleus; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum;|A1L4K1 B3KVG1 B7ZM02,Fibronectin type III and SPRY domain-containing protein 2,SPRY domain-containing protein 1;, PF00041;PF00622;, GO:0005634;GO:0048471;GO:0016529;, C:nucleus; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum;|A1L4K1 B3KVG1 B7ZM02,Fibronectin type III and SPRY domain-containing protein 2,SPRY domain-containing protein 1;, PF00041;PF00622;, GO:0005634;GO:0048471;GO:0016529;, C:nucleus; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum;|A1L4K1 B3KVG1 B7ZM02,Fibronectin type III and SPRY domain-containing protein 2,SPRY domain-containing protein 1;, PF00041;PF00622;, GO:0005634;GO:0048471;GO:0016529;, C:nucleus; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum; scaffold45 indexed_genome mRNA 19227346 19239359 . + . ID=transcript_8898;Q8TF30 Q8N1J9,WASP homolog-associated protein with actin, membranes and microtubules,WAS protein homology region 2 domain-containing protein 1;, PF15871;PF15920;, GO:0005737;GO:0030659;GO:0005829;GO:0033116;GO:0000139;GO:0005874;GO:0003779;GO:0071933;GO:0008017;GO:0031267;GO:0007015;GO:0090527;GO:0034314;GO:0007050;GO:0006888;GO:0048041;GO:0030032;GO:0097320;GO:0051127;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:microtubule;, F:actin binding; F:Arp2/3 complex binding; F:microtubule binding; F:small GTPase binding;, P:actin filament organization; P:actin filament reorganization; P:Arp2/3 complex-mediated actin nucleation; P:cell cycle arrest; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:focal adhesion assembly; P:lamellipodium assembly; P:plasma membrane tubulation; P:positive regulation of actin nucleation;|Q8TF30 Q8N1J9,WASP homolog-associated protein with actin, membranes and microtubules,WAS protein homology region 2 domain-containing protein 1;, PF15871;PF15920;, GO:0005737;GO:0030659;GO:0005829;GO:0033116;GO:0000139;GO:0005874;GO:0003779;GO:0071933;GO:0008017;GO:0031267;GO:0007015;GO:0090527;GO:0034314;GO:0007050;GO:0006888;GO:0048041;GO:0030032;GO:0097320;GO:0051127;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:microtubule;, F:actin binding; F:Arp2/3 complex binding; F:microtubule binding; F:small GTPase binding;, P:actin filament organization; P:actin filament reorganization; P:Arp2/3 complex-mediated actin nucleation; P:cell cycle arrest; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:focal adhesion assembly; P:lamellipodium assembly; P:plasma membrane tubulation; P:positive regulation of actin nucleation; scaffold45 indexed_genome mRNA 19381046 19384964 . + . ID=transcript_8899;Q9BTL3 Q2M1J8,RNA guanine-N7 methyltransferase activating subunit {ECO:0000305},Protein FAM103A1;RNA guanine-7 methyltransferase activating subunit {ECO:0000312|HGNC:HGNC:31022};RNMT-activating mRNA cap methyltransferase subunit {ECO:0000312|HGNC:HGNC:31022};RNMT-activating mini protein {ECO:0000303|PubMed:22099306};, PF15320;, GO:0005845;GO:0031533;GO:0005654;GO:0005634;GO:0008047;GO:0003723;GO:0006370;GO:0032259;GO:0036031;GO:0106005;, C:mRNA cap binding complex; C:mRNA cap methyltransferase complex; C:nucleoplasm; C:nucleus;, F:enzyme activator activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:methylation; P:recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex; P:RNA 5'-cap (guanine-N7)-methylation; scaffold45 indexed_genome mRNA 19384965 19387704 . + . ID=transcript_8900;Q9BTL3 Q2M1J8,RNA guanine-N7 methyltransferase activating subunit {ECO:0000305},Protein FAM103A1;RNA guanine-7 methyltransferase activating subunit {ECO:0000312|HGNC:HGNC:31022};RNMT-activating mRNA cap methyltransferase subunit {ECO:0000312|HGNC:HGNC:31022};RNMT-activating mini protein {ECO:0000303|PubMed:22099306};, PF15320;, GO:0005845;GO:0031533;GO:0005654;GO:0005634;GO:0008047;GO:0003723;GO:0006370;GO:0032259;GO:0036031;GO:0106005;, C:mRNA cap binding complex; C:mRNA cap methyltransferase complex; C:nucleoplasm; C:nucleus;, F:enzyme activator activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:methylation; P:recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex; P:RNA 5'-cap (guanine-N7)-methylation; scaffold45 indexed_genome mRNA 19388830 19402347 . - . ID=transcript_8901;Q8WUR7 A6NIC9 B2R5E7 F5GX92 F8WD31 G5EA00,UPF0235 protein C15orf40,, PF02594;, GO:0005737;, C:cytoplasm;|Q8WUR7 A6NIC9 B2R5E7 F5GX92 F8WD31 G5EA00,UPF0235 protein C15orf40,, PF02594;, GO:0005737;, C:cytoplasm; scaffold46 indexed_genome mRNA 26474 32731 . - . ID=transcript_8902;P09327 B2R9A7 Q53S11 Q96AC8,Villin-1,, PF00626;PF02209;, GO:0015629;GO:0032432;GO:0005903;GO:0005737;GO:0070062;GO:0030175;GO:0032433;GO:0030027;GO:0005902;GO:0005886;GO:0001726;GO:0051015;GO:0005509;GO:0043027;GO:0042802;GO:0035727;GO:0005546;GO:0042803;GO:0051693;GO:0030042;GO:0030041;GO:0051014;GO:0045010;GO:0008154;GO:0051016;GO:0071364;GO:0035729;GO:0060327;GO:0007173;GO:0030855;GO:0001951;GO:0032233;GO:0030836;GO:0030335;GO:0010634;GO:2000394;GO:0040018;GO:1903078;GO:0065003;GO:0051125;GO:0008360;GO:2000392;GO:0032532;GO:0061041;GO:0009617;GO:1902896;, C:actin cytoskeleton; C:actin filament bundle; C:brush border; C:cytoplasm; C:extracellular exosome; C:filopodium; C:filopodium tip; C:lamellipodium; C:microvillus; C:plasma membrane; C:ruffle;, F:actin filament binding; F:calcium ion binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:lysophosphatidic acid binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein homodimerization activity;, P:actin filament capping; P:actin filament depolymerization; P:actin filament polymerization; P:actin filament severing; P:actin nucleation; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:cellular response to epidermal growth factor stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cytoplasmic actin-based contraction involved in cell motility; P:epidermal growth factor receptor signaling pathway; P:epithelial cell differentiation; P:intestinal D-glucose absorption; P:positive regulation of actin filament bundle assembly; P:positive regulation of actin filament depolymerization; P:positive regulation of cell migration; P:positive regulation of epithelial cell migration; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of multicellular organism growth; P:positive regulation of protein localization to plasma membrane; P:protein-containing complex assembly; P:regulation of actin nucleation; P:regulation of cell shape; P:regulation of lamellipodium morphogenesis; P:regulation of microvillus length; P:regulation of wound healing; P:response to bacterium; P:terminal web assembly; scaffold46 indexed_genome mRNA 33313 120795 . - . ID=transcript_8903;Q86T82 A2RUQ8 B7ZM38 B7ZM41 E9PHL3 Q2KHT2 Q53S10 Q7Z3A5 Q9HCH8,Ubiquitin carboxyl-terminal hydrolase 37,Deubiquitinating enzyme 37;Ubiquitin thioesterase 37;Ubiquitin-specific-processing protease 37;, PF00443;PF16674;PF02809;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0019901;GO:0004843;GO:0051301;GO:0000082;GO:0016579;GO:0035871;GO:0071108;GO:0006275;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:protein kinase binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cell division; P:G1/S transition of mitotic cell cycle; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K48-linked deubiquitination; P:regulation of DNA replication; P:ubiquitin-dependent protein catabolic process; scaffold46 indexed_genome mRNA 121267 180820 . + . ID=transcript_8904;Q92600 B2RPI0 B5MDQ4 B7Z1E5 Q96IX4,CCR4-NOT transcription complex subunit 9 {ECO:0000312|HGNC:HGNC:10445},Cell differentiation protein RQCD1 homolog;, , GO:0030014;GO:0030015;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0032991;GO:0005154;GO:0019900;GO:0030374;GO:0019904;GO:0042803;GO:0019221;GO:0006977;GO:0031047;GO:0033147;GO:0017148;GO:0000289;GO:0045742;GO:0033138;GO:0007548;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:membrane; C:nucleus; C:P-body; C:protein-containing complex;, F:epidermal growth factor receptor binding; F:kinase binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:protein homodimerization activity;, P:cytokine-mediated signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:sex differentiation;|Q92600 B2RPI0 B5MDQ4 B7Z1E5 Q96IX4,CCR4-NOT transcription complex subunit 9 {ECO:0000312|HGNC:HGNC:10445},Cell differentiation protein RQCD1 homolog;, , GO:0030014;GO:0030015;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0032991;GO:0005154;GO:0019900;GO:0030374;GO:0019904;GO:0042803;GO:0019221;GO:0006977;GO:0031047;GO:0033147;GO:0017148;GO:0000289;GO:0045742;GO:0033138;GO:0007548;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:membrane; C:nucleus; C:P-body; C:protein-containing complex;, F:epidermal growth factor receptor binding; F:kinase binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:protein homodimerization activity;, P:cytokine-mediated signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:sex differentiation;|Q92600 B2RPI0 B5MDQ4 B7Z1E5 Q96IX4,CCR4-NOT transcription complex subunit 9 {ECO:0000312|HGNC:HGNC:10445},Cell differentiation protein RQCD1 homolog;, , GO:0030014;GO:0030015;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0032991;GO:0005154;GO:0019900;GO:0030374;GO:0019904;GO:0042803;GO:0019221;GO:0006977;GO:0031047;GO:0033147;GO:0017148;GO:0000289;GO:0045742;GO:0033138;GO:0007548;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:membrane; C:nucleus; C:P-body; C:protein-containing complex;, F:epidermal growth factor receptor binding; F:kinase binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:protein homodimerization activity;, P:cytokine-mediated signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:sex differentiation;|Q9BRC7 Q53FS8,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 {ECO:0000305},Phosphoinositide phospholipase C-delta-4;Phospholipase C-delta-4;, PF00168;PF13202;PF09279;PF00169;PF00388;PF00387;, GO:0005829;GO:0005783;GO:0005789;GO:0005634;GO:0005886;GO:0005509;GO:0001965;GO:0005085;GO:0004435;GO:0007340;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0007264;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol phospholipase C activity;, P:acrosome reaction; P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:small GTPase mediated signal transduction;|Q92600 B2RPI0 B5MDQ4 B7Z1E5 Q96IX4,CCR4-NOT transcription complex subunit 9 {ECO:0000312|HGNC:HGNC:10445},Cell differentiation protein RQCD1 homolog;, , GO:0030014;GO:0030015;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0032991;GO:0005154;GO:0019900;GO:0030374;GO:0019904;GO:0042803;GO:0019221;GO:0006977;GO:0031047;GO:0033147;GO:0017148;GO:0000289;GO:0045742;GO:0033138;GO:0007548;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:membrane; C:nucleus; C:P-body; C:protein-containing complex;, F:epidermal growth factor receptor binding; F:kinase binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:protein homodimerization activity;, P:cytokine-mediated signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:sex differentiation;|Q9BRC7 Q53FS8,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 {ECO:0000305},Phosphoinositide phospholipase C-delta-4;Phospholipase C-delta-4;, PF00168;PF13202;PF09279;PF00169;PF00388;PF00387;, GO:0005829;GO:0005783;GO:0005789;GO:0005634;GO:0005886;GO:0005509;GO:0001965;GO:0005085;GO:0004435;GO:0007340;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0007264;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol phospholipase C activity;, P:acrosome reaction; P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:small GTPase mediated signal transduction;|Q9BRC7 Q53FS8,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 {ECO:0000305},Phosphoinositide phospholipase C-delta-4;Phospholipase C-delta-4;, PF00168;PF13202;PF09279;PF00169;PF00388;PF00387;, GO:0005829;GO:0005783;GO:0005789;GO:0005634;GO:0005886;GO:0005509;GO:0001965;GO:0005085;GO:0004435;GO:0007340;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0007264;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol phospholipase C activity;, P:acrosome reaction; P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:small GTPase mediated signal transduction; scaffold46 indexed_genome mRNA 181505 200267 . - . ID=transcript_8905;P52746 Q92510,Zinc finger protein 142 {ECO:0000305},, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P52746 Q92510,Zinc finger protein 142 {ECO:0000305},, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P52746 Q92510,Zinc finger protein 142 {ECO:0000305},, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P52746 Q92510,Zinc finger protein 142 {ECO:0000305},, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P52746 Q92510,Zinc finger protein 142 {ECO:0000305},, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P52746 Q92510,Zinc finger protein 142 {ECO:0000305},, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold46 indexed_genome mRNA 200644 204363 . + . ID=transcript_8906;Q9Y276 B3KTW9 Q7Z2V7,Mitochondrial chaperone BCS1,BCS1-like protein;, PF00004;PF08740;, GO:0016021;GO:0005743;GO:0005750;GO:0005739;GO:0005524;GO:0016887;GO:0033617;GO:0032981;GO:0034551;GO:0007005;GO:0032979;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:ATP binding; F:ATPase activity;, P:mitochondrial cytochrome c oxidase assembly; P:mitochondrial respiratory chain complex I assembly; P:mitochondrial respiratory chain complex III assembly; P:mitochondrion organization; P:protein insertion into mitochondrial inner membrane from matrix;|Q9Y276 B3KTW9 Q7Z2V7,Mitochondrial chaperone BCS1,BCS1-like protein;, PF00004;PF08740;, GO:0016021;GO:0005743;GO:0005750;GO:0005739;GO:0005524;GO:0016887;GO:0033617;GO:0032981;GO:0034551;GO:0007005;GO:0032979;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:ATP binding; F:ATPase activity;, P:mitochondrial cytochrome c oxidase assembly; P:mitochondrial respiratory chain complex I assembly; P:mitochondrial respiratory chain complex III assembly; P:mitochondrion organization; P:protein insertion into mitochondrial inner membrane from matrix;|Q9Y276 B3KTW9 Q7Z2V7,Mitochondrial chaperone BCS1,BCS1-like protein;, PF00004;PF08740;, GO:0016021;GO:0005743;GO:0005750;GO:0005739;GO:0005524;GO:0016887;GO:0033617;GO:0032981;GO:0034551;GO:0007005;GO:0032979;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:ATP binding; F:ATPase activity;, P:mitochondrial cytochrome c oxidase assembly; P:mitochondrial respiratory chain complex I assembly; P:mitochondrial respiratory chain complex III assembly; P:mitochondrion organization; P:protein insertion into mitochondrial inner membrane from matrix; scaffold46 indexed_genome mRNA 204814 212831 . - . ID=transcript_8907;Q96BH1 A8K0D6 Q53HQ5 Q9H874,E3 ubiquitin-protein ligase RNF25,RING finger protein 25;RING-type E3 ubiquitin transferase RNF25 {ECO:0000305};, PF05773;PF17123;, GO:0005829;GO:0005634;GO:0046872;GO:0051059;GO:0061630;GO:0004842;GO:0051092;GO:0016567;, C:cytosol; C:nucleus;, F:metal ion binding; F:NF-kappaB binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of NF-kappaB transcription factor activity; P:protein ubiquitination;|Q96BH1 A8K0D6 Q53HQ5 Q9H874,E3 ubiquitin-protein ligase RNF25,RING finger protein 25;RING-type E3 ubiquitin transferase RNF25 {ECO:0000305};, PF05773;PF17123;, GO:0005829;GO:0005634;GO:0046872;GO:0051059;GO:0061630;GO:0004842;GO:0051092;GO:0016567;, C:cytosol; C:nucleus;, F:metal ion binding; F:NF-kappaB binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of NF-kappaB transcription factor activity; P:protein ubiquitination;|Q96BH1 A8K0D6 Q53HQ5 Q9H874,E3 ubiquitin-protein ligase RNF25,RING finger protein 25;RING-type E3 ubiquitin transferase RNF25 {ECO:0000305};, PF05773;PF17123;, GO:0005829;GO:0005634;GO:0046872;GO:0051059;GO:0061630;GO:0004842;GO:0051092;GO:0016567;, C:cytosol; C:nucleus;, F:metal ion binding; F:NF-kappaB binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of NF-kappaB transcription factor activity; P:protein ubiquitination;|Q96BH1 A8K0D6 Q53HQ5 Q9H874,E3 ubiquitin-protein ligase RNF25,RING finger protein 25;RING-type E3 ubiquitin transferase RNF25 {ECO:0000305};, PF05773;PF17123;, GO:0005829;GO:0005634;GO:0046872;GO:0051059;GO:0061630;GO:0004842;GO:0051092;GO:0016567;, C:cytosol; C:nucleus;, F:metal ion binding; F:NF-kappaB binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of NF-kappaB transcription factor activity; P:protein ubiquitination;|Q96BH1 A8K0D6 Q53HQ5 Q9H874,E3 ubiquitin-protein ligase RNF25,RING finger protein 25;RING-type E3 ubiquitin transferase RNF25 {ECO:0000305};, PF05773;PF17123;, GO:0005829;GO:0005634;GO:0046872;GO:0051059;GO:0061630;GO:0004842;GO:0051092;GO:0016567;, C:cytosol; C:nucleus;, F:metal ion binding; F:NF-kappaB binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of NF-kappaB transcription factor activity; P:protein ubiquitination;|Q96BH1 A8K0D6 Q53HQ5 Q9H874,E3 ubiquitin-protein ligase RNF25,RING finger protein 25;RING-type E3 ubiquitin transferase RNF25 {ECO:0000305};, PF05773;PF17123;, GO:0005829;GO:0005634;GO:0046872;GO:0051059;GO:0061630;GO:0004842;GO:0051092;GO:0016567;, C:cytosol; C:nucleus;, F:metal ion binding; F:NF-kappaB binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of NF-kappaB transcription factor activity; P:protein ubiquitination;|Q96BH1 A8K0D6 Q53HQ5 Q9H874,E3 ubiquitin-protein ligase RNF25,RING finger protein 25;RING-type E3 ubiquitin transferase RNF25 {ECO:0000305};, PF05773;PF17123;, GO:0005829;GO:0005634;GO:0046872;GO:0051059;GO:0061630;GO:0004842;GO:0051092;GO:0016567;, C:cytosol; C:nucleus;, F:metal ion binding; F:NF-kappaB binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:positive regulation of NF-kappaB transcription factor activity; P:protein ubiquitination; scaffold46 indexed_genome mRNA 215167 215702 . + . ID=transcript_8908;Q9NRP7 B7WPM3 Q8TC32 Q9H9N9 Q9UF35 Q9ULE2,Serine/threonine-protein kinase 36,Fused homolog;, PF00069;, GO:0005737;GO:0005829;GO:0005576;GO:0005634;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0008134;GO:0007420;GO:0060271;GO:0003351;GO:0007228;GO:0045880;GO:0009791;GO:0006468;GO:0051090;GO:0007224;, C:cytoplasm; C:cytosol; C:extracellular region; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transcription factor binding;, P:brain development; P:cilium assembly; P:epithelial cilium movement involved in extracellular fluid movement; P:positive regulation of hh target transcription factor activity; P:positive regulation of smoothened signaling pathway; P:post-embryonic development; P:protein phosphorylation; P:regulation of DNA-binding transcription factor activity; P:smoothened signaling pathway; scaffold46 indexed_genome mRNA 217087 238861 . + . ID=transcript_8909;Q9NRP7 B7WPM3 Q8TC32 Q9H9N9 Q9UF35 Q9ULE2,Serine/threonine-protein kinase 36,Fused homolog;, PF00069;, GO:0005737;GO:0005829;GO:0005576;GO:0005634;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0008134;GO:0007420;GO:0060271;GO:0003351;GO:0007228;GO:0045880;GO:0009791;GO:0006468;GO:0051090;GO:0007224;, C:cytoplasm; C:cytosol; C:extracellular region; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transcription factor binding;, P:brain development; P:cilium assembly; P:epithelial cilium movement involved in extracellular fluid movement; P:positive regulation of hh target transcription factor activity; P:positive regulation of smoothened signaling pathway; P:post-embryonic development; P:protein phosphorylation; P:regulation of DNA-binding transcription factor activity; P:smoothened signaling pathway; scaffold46 indexed_genome mRNA 246376 279222 . + . ID=transcript_8910;Q14679 A8K6V5 Q8WW29,Tubulin polyglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4;, PF03133;, GO:0097731;GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0070739;GO:0015631;GO:0070740;GO:0000226;GO:0018200;GO:0018095;GO:0120222;, C:9+0 non-motile cilium; C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:protein-glutamic acid ligase activity; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:peptidyl-glutamic acid modification; P:protein polyglutamylation; P:regulation of blastocyst development;|Q14679 A8K6V5 Q8WW29,Tubulin polyglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4;, PF03133;, GO:0097731;GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0070739;GO:0015631;GO:0070740;GO:0000226;GO:0018200;GO:0018095;GO:0120222;, C:9+0 non-motile cilium; C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:protein-glutamic acid ligase activity; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:peptidyl-glutamic acid modification; P:protein polyglutamylation; P:regulation of blastocyst development;|Q14679 A8K6V5 Q8WW29,Tubulin polyglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4;, PF03133;, GO:0097731;GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0070739;GO:0015631;GO:0070740;GO:0000226;GO:0018200;GO:0018095;GO:0120222;, C:9+0 non-motile cilium; C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:protein-glutamic acid ligase activity; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:peptidyl-glutamic acid modification; P:protein polyglutamylation; P:regulation of blastocyst development;|Q14679 A8K6V5 Q8WW29,Tubulin polyglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4;, PF03133;, GO:0097731;GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0070739;GO:0015631;GO:0070740;GO:0000226;GO:0018200;GO:0018095;GO:0120222;, C:9+0 non-motile cilium; C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:protein-glutamic acid ligase activity; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:peptidyl-glutamic acid modification; P:protein polyglutamylation; P:regulation of blastocyst development;|Q14679 A8K6V5 Q8WW29,Tubulin polyglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4;, PF03133;, GO:0097731;GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0070739;GO:0015631;GO:0070740;GO:0000226;GO:0018200;GO:0018095;GO:0120222;, C:9+0 non-motile cilium; C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:protein-glutamic acid ligase activity; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:peptidyl-glutamic acid modification; P:protein polyglutamylation; P:regulation of blastocyst development;|Q14679 A8K6V5 Q8WW29,Tubulin polyglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4;, PF03133;, GO:0097731;GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0070739;GO:0015631;GO:0070740;GO:0000226;GO:0018200;GO:0018095;GO:0120222;, C:9+0 non-motile cilium; C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:protein-glutamic acid ligase activity; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:peptidyl-glutamic acid modification; P:protein polyglutamylation; P:regulation of blastocyst development;|Q14679 A8K6V5 Q8WW29,Tubulin polyglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4;, PF03133;, GO:0097731;GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0070739;GO:0015631;GO:0070740;GO:0000226;GO:0018200;GO:0018095;GO:0120222;, C:9+0 non-motile cilium; C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:protein-glutamic acid ligase activity; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:peptidyl-glutamic acid modification; P:protein polyglutamylation; P:regulation of blastocyst development;|Q14679 A8K6V5 Q8WW29,Tubulin polyglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4;, PF03133;, GO:0097731;GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0070739;GO:0015631;GO:0070740;GO:0000226;GO:0018200;GO:0018095;GO:0120222;, C:9+0 non-motile cilium; C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:protein-glutamic acid ligase activity; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:peptidyl-glutamic acid modification; P:protein polyglutamylation; P:regulation of blastocyst development;|Q14679 A8K6V5 Q8WW29,Tubulin polyglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4;, PF03133;, GO:0097731;GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0070739;GO:0015631;GO:0070740;GO:0000226;GO:0018200;GO:0018095;GO:0120222;, C:9+0 non-motile cilium; C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:protein-glutamic acid ligase activity; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:peptidyl-glutamic acid modification; P:protein polyglutamylation; P:regulation of blastocyst development;|Q14679 A8K6V5 Q8WW29,Tubulin polyglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4;, PF03133;, GO:0097731;GO:0036064;GO:0005929;GO:0005829;GO:0005874;GO:0005524;GO:0070739;GO:0015631;GO:0070740;GO:0000226;GO:0018200;GO:0018095;GO:0120222;, C:9+0 non-motile cilium; C:ciliary basal body; C:cilium; C:cytosol; C:microtubule;, F:ATP binding; F:protein-glutamic acid ligase activity; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:peptidyl-glutamic acid modification; P:protein polyglutamylation; P:regulation of blastocyst development; scaffold46 indexed_genome mRNA 299057 331896 . + . ID=transcript_8911;Q02318 A8K303 Q6LDB4 Q86YQ6,Sterol 26-hydroxylase, mitochondrial {ECO:0000250|UniProtKB:P17177},5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase {ECO:0000303|PubMed:1708392};Cytochrome P-450C27/25;Cytochrome P450 27;Sterol 27-hydroxylase {ECO:0000303|PubMed:1708392};Vitamin D(3) 25-hydroxylase {ECO:0000303|PubMed:15465040};, PF00067;, GO:0005743;GO:0005759;GO:0005739;GO:0047748;GO:0047749;GO:0031073;GO:0020037;GO:0005506;GO:0008395;GO:0030343;GO:0006699;GO:0036378;GO:0006707;GO:0008203;GO:0016125;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:cholestanetetraol 26-dehydrogenase activity; F:cholestanetriol 26-monooxygenase activity; F:cholesterol 26-hydroxylase activity; F:heme binding; F:iron ion binding; F:steroid hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:bile acid biosynthetic process; P:calcitriol biosynthetic process from calciol; P:cholesterol catabolic process; P:cholesterol metabolic process; P:sterol metabolic process; scaffold46 indexed_genome mRNA 334040 338587 . + . ID=transcript_8912;Q02318 A8K303 Q6LDB4 Q86YQ6,Sterol 26-hydroxylase, mitochondrial {ECO:0000250|UniProtKB:P17177},5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase {ECO:0000303|PubMed:1708392};Cytochrome P-450C27/25;Cytochrome P450 27;Sterol 27-hydroxylase {ECO:0000303|PubMed:1708392};Vitamin D(3) 25-hydroxylase {ECO:0000303|PubMed:15465040};, PF00067;, GO:0005743;GO:0005759;GO:0005739;GO:0047748;GO:0047749;GO:0031073;GO:0020037;GO:0005506;GO:0008395;GO:0030343;GO:0006699;GO:0036378;GO:0006707;GO:0008203;GO:0016125;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:cholestanetetraol 26-dehydrogenase activity; F:cholestanetriol 26-monooxygenase activity; F:cholesterol 26-hydroxylase activity; F:heme binding; F:iron ion binding; F:steroid hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:bile acid biosynthetic process; P:calcitriol biosynthetic process from calciol; P:cholesterol catabolic process; P:cholesterol metabolic process; P:sterol metabolic process;|Q02318 A8K303 Q6LDB4 Q86YQ6,Sterol 26-hydroxylase, mitochondrial {ECO:0000250|UniProtKB:P17177},5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase {ECO:0000303|PubMed:1708392};Cytochrome P-450C27/25;Cytochrome P450 27;Sterol 27-hydroxylase {ECO:0000303|PubMed:1708392};Vitamin D(3) 25-hydroxylase {ECO:0000303|PubMed:15465040};, PF00067;, GO:0005743;GO:0005759;GO:0005739;GO:0047748;GO:0047749;GO:0031073;GO:0020037;GO:0005506;GO:0008395;GO:0030343;GO:0006699;GO:0036378;GO:0006707;GO:0008203;GO:0016125;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:cholestanetetraol 26-dehydrogenase activity; F:cholestanetriol 26-monooxygenase activity; F:cholesterol 26-hydroxylase activity; F:heme binding; F:iron ion binding; F:steroid hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:bile acid biosynthetic process; P:calcitriol biosynthetic process from calciol; P:cholesterol catabolic process; P:cholesterol metabolic process; P:sterol metabolic process; scaffold46 indexed_genome mRNA 341307 351368 . - . ID=transcript_8913;Q9UGI9 Q4QQG8 Q4V779 Q9NRL1,5'-AMP-activated protein kinase subunit gamma-3,, PF00571;, GO:0005737;GO:0005829;GO:0005615;GO:0005654;GO:0031588;GO:0005634;GO:0016208;GO:0004679;GO:0005524;GO:0019901;GO:0019887;GO:0007050;GO:0042149;GO:0006633;GO:0005978;GO:0006096;GO:0035556;GO:0016236;GO:0006468;GO:0050790;GO:0016241;GO:0071900;GO:1901796;GO:0014873;, C:cytoplasm; C:cytosol; C:extracellular space; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:AMP binding; F:AMP-activated protein kinase activity; F:ATP binding; F:protein kinase binding; F:protein kinase regulator activity;, P:cell cycle arrest; P:cellular response to glucose starvation; P:fatty acid biosynthetic process; P:glycogen biosynthetic process; P:glycolytic process; P:intracellular signal transduction; P:macroautophagy; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of protein serine/threonine kinase activity; P:regulation of signal transduction by p53 class mediator; P:response to muscle activity involved in regulation of muscle adaptation; scaffold46 indexed_genome mRNA 395129 395818 . + . ID=transcript_8914;Q9Y6F9 Q9H1J6 Q9H238,Protein Wnt-6,, PF00110;, GO:0009986;GO:0030666;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0005125;GO:0005109;GO:0009798;GO:0001658;GO:0060070;GO:0045165;GO:0071300;GO:0061303;GO:0060684;GO:0072079;GO:0030182;GO:0042475;GO:0010628;GO:0070172;GO:0045893;GO:0016055;, C:cell surface; C:endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane;, F:cytokine activity; F:frizzled binding;, P:axis specification; P:branching involved in ureteric bud morphogenesis; P:canonical Wnt signaling pathway; P:cell fate commitment; P:cellular response to retinoic acid; P:cornea development in camera-type eye; P:epithelial-mesenchymal cell signaling; P:nephron tubule formation; P:neuron differentiation; P:odontogenesis of dentin-containing tooth; P:positive regulation of gene expression; P:positive regulation of tooth mineralization; P:positive regulation of transcription, DNA-templated; P:Wnt signaling pathway; scaffold46 indexed_genome mRNA 559041 564983 . - . ID=transcript_8915;Q14623 B9EGM5 O43322 Q8N4B9,Indian hedgehog protein,HHG-2;, PF01085;PF01079;, GO:0031012;GO:0005615;GO:0005886;GO:0005509;GO:0005113;GO:0008233;GO:0045453;GO:0001569;GO:0060220;GO:0051216;GO:0001708;GO:0048469;GO:0007267;GO:0003413;GO:0035988;GO:0048596;GO:0048557;GO:0042733;GO:0009880;GO:0072498;GO:0003382;GO:0090136;GO:0060323;GO:0001947;GO:0001701;GO:0016539;GO:0097421;GO:0060135;GO:0035264;GO:0046639;GO:0043066;GO:0048074;GO:0033088;GO:0033085;GO:0048666;GO:0001649;GO:0031016;GO:0046638;GO:0032967;GO:0050679;GO:0002053;GO:0045880;GO:0033089;GO:0045944;GO:0016540;GO:0006029;GO:0010468;GO:0040008;GO:0032355;GO:0009612;GO:0003406;GO:0001501;GO:0048745;GO:0007224;GO:0061053;GO:0030704;, C:extracellular matrix; C:extracellular space; C:plasma membrane;, F:calcium ion binding; F:patched binding; F:peptidase activity;, P:bone resorption; P:branching involved in blood vessel morphogenesis; P:camera-type eye photoreceptor cell fate commitment; P:cartilage development; P:cell fate specification; P:cell maturation; P:cell-cell signaling; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:chondrocyte proliferation; P:embryonic camera-type eye morphogenesis; P:embryonic digestive tract morphogenesis; P:embryonic digit morphogenesis; P:embryonic pattern specification; P:embryonic skeletal joint development; P:epithelial cell morphogenesis; P:epithelial cell-cell adhesion; P:head morphogenesis; P:heart looping; P:in utero embryonic development; P:intein-mediated protein splicing; P:liver regeneration; P:maternal process involved in female pregnancy; P:multicellular organism growth; P:negative regulation of alpha-beta T cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of eye pigmentation; P:negative regulation of immature T cell proliferation in thymus; P:negative regulation of T cell differentiation in thymus; P:neuron development; P:osteoblast differentiation; P:pancreas development; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial cell proliferation; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of smoothened signaling pathway; P:positive regulation of T cell differentiation in thymus; P:positive regulation of transcription by RNA polymerase II; P:protein autoprocessing; P:proteoglycan metabolic process; P:regulation of gene expression; P:regulation of growth; P:response to estradiol; P:response to mechanical stimulus; P:retinal pigment epithelium development; P:skeletal system development; P:smooth muscle tissue development; P:smoothened signaling pathway; P:somite development; P:vitelline membrane formation; scaffold46 indexed_genome mRNA 582909 673420 . - . ID=transcript_8916;Q9H9Q4 B8ZZA4 Q4ZFW7 Q6IA64 Q96JS9,Non-homologous end-joining factor 1,Protein cernunnos;XRCC4-like factor;, PF09302;, GO:0032807;GO:0001650;GO:0070419;GO:0005654;GO:0005634;GO:0045027;GO:0030183;GO:0007417;GO:0006303;GO:0051351;GO:0010212;GO:0030217;, C:DNA ligase IV complex; C:fibrillar center; C:nonhomologous end joining complex; C:nucleoplasm; C:nucleus;, F:DNA end binding;, P:B cell differentiation; P:central nervous system development; P:double-strand break repair via nonhomologous end joining; P:positive regulation of ligase activity; P:response to ionizing radiation; P:T cell differentiation; scaffold46 indexed_genome mRNA 677883 688817 . - . ID=transcript_8917;Q6PIS1 B7Z512 Q2PYN6 Q96NA6,Solute carrier family 23 member 3,HPC E2-binding protein 3;Na(+)/L-ascorbic acid transporter 3;Sodium-dependent vitamin C transporter 3;, PF00860;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q6PIS1 B7Z512 Q2PYN6 Q96NA6,Solute carrier family 23 member 3,HPC E2-binding protein 3;Na(+)/L-ascorbic acid transporter 3;Sodium-dependent vitamin C transporter 3;, PF00860;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q9BV87 B2RC77 O75548 Q9H4N0 Q9UQN0,Protein CNPPD1,Cyclin Pas1/PHO80 domain-containing protein 1;, PF08613;, GO:0000307;GO:0016021;GO:0005634;GO:0016538;GO:0019901;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:integral component of membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BV87 B2RC77 O75548 Q9H4N0 Q9UQN0,Protein CNPPD1,Cyclin Pas1/PHO80 domain-containing protein 1;, PF08613;, GO:0000307;GO:0016021;GO:0005634;GO:0016538;GO:0019901;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:integral component of membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BV87 B2RC77 O75548 Q9H4N0 Q9UQN0,Protein CNPPD1,Cyclin Pas1/PHO80 domain-containing protein 1;, PF08613;, GO:0000307;GO:0016021;GO:0005634;GO:0016538;GO:0019901;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:integral component of membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BV87 B2RC77 O75548 Q9H4N0 Q9UQN0,Protein CNPPD1,Cyclin Pas1/PHO80 domain-containing protein 1;, PF08613;, GO:0000307;GO:0016021;GO:0005634;GO:0016538;GO:0019901;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:integral component of membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q9BV87 B2RC77 O75548 Q9H4N0 Q9UQN0,Protein CNPPD1,Cyclin Pas1/PHO80 domain-containing protein 1;, PF08613;, GO:0000307;GO:0016021;GO:0005634;GO:0016538;GO:0019901;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:integral component of membrane; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold46 indexed_genome mRNA 688980 695528 . + . ID=transcript_8918;Q8NC44 Q6P1P5 Q9H0K7,Reticulophagy regulator 2 {ECO:0000312|HGNC:HGNC:28450},, , GO:0016021;, C:integral component of membrane;|Q8NC44 Q6P1P5 Q9H0K7,Reticulophagy regulator 2 {ECO:0000312|HGNC:HGNC:28450},, , GO:0016021;, C:integral component of membrane; scaffold46 indexed_genome mRNA 712121 732679 . + . ID=transcript_8919;Q8WV99 Q8NB98,AN1-type zinc finger protein 2B {ECO:0000305},Arsenite-inducible RNA-associated protein-like protein {ECO:0000305};, PF01428;, GO:0031225;GO:0005783;GO:0005789;GO:0000502;GO:0036435;GO:0043130;GO:0008270;GO:0043161;GO:0045047;GO:0043567;GO:0006616;, C:anchored component of membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:proteasome complex;, F:K48-linked polyubiquitin modification-dependent protein binding; F:ubiquitin binding; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein targeting to ER; P:regulation of insulin-like growth factor receptor signaling pathway; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|Q8WV99 Q8NB98,AN1-type zinc finger protein 2B {ECO:0000305},Arsenite-inducible RNA-associated protein-like protein {ECO:0000305};, PF01428;, GO:0031225;GO:0005783;GO:0005789;GO:0000502;GO:0036435;GO:0043130;GO:0008270;GO:0043161;GO:0045047;GO:0043567;GO:0006616;, C:anchored component of membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:proteasome complex;, F:K48-linked polyubiquitin modification-dependent protein binding; F:ubiquitin binding; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein targeting to ER; P:regulation of insulin-like growth factor receptor signaling pathway; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|Q9NP58 O75542 Q49A66 Q59GQ5 Q6ZME6 Q96ME8 Q9HAQ6 Q9HAQ7,ATP-binding cassette sub-family B member 6, mitochondrial,Mitochondrial ABC transporter 3;P-glycoprotein-related protein;Ubiquitously-expressed mammalian ABC half transporter;, PF00664;PF00005;PF16185;, GO:0043190;GO:0005829;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0031307;GO:0005740;GO:0005741;GO:0005739;GO:0005654;GO:0005886;GO:0005774;GO:0015439;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0020037;GO:0007420;GO:0006879;GO:0015886;GO:0006779;GO:0043588;GO:0055085;, C:ATP-binding cassette (ABC) transporter complex; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of mitochondrial outer membrane; C:mitochondrial envelope; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:vacuolar membrane;, F:ABC-type heme transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:heme binding;, P:brain development; P:cellular iron ion homeostasis; P:heme transport; P:porphyrin-containing compound biosynthetic process; P:skin development; P:transmembrane transport;|Q8WV99 Q8NB98,AN1-type zinc finger protein 2B {ECO:0000305},Arsenite-inducible RNA-associated protein-like protein {ECO:0000305};, PF01428;, GO:0031225;GO:0005783;GO:0005789;GO:0000502;GO:0036435;GO:0043130;GO:0008270;GO:0043161;GO:0045047;GO:0043567;GO:0006616;, C:anchored component of membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:proteasome complex;, F:K48-linked polyubiquitin modification-dependent protein binding; F:ubiquitin binding; F:zinc ion binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein targeting to ER; P:regulation of insulin-like growth factor receptor signaling pathway; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|Q9NP58 O75542 Q49A66 Q59GQ5 Q6ZME6 Q96ME8 Q9HAQ6 Q9HAQ7,ATP-binding cassette sub-family B member 6, mitochondrial,Mitochondrial ABC transporter 3;P-glycoprotein-related protein;Ubiquitously-expressed mammalian ABC half transporter;, PF00664;PF00005;PF16185;, GO:0043190;GO:0005829;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0031307;GO:0005740;GO:0005741;GO:0005739;GO:0005654;GO:0005886;GO:0005774;GO:0015439;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0020037;GO:0007420;GO:0006879;GO:0015886;GO:0006779;GO:0043588;GO:0055085;, C:ATP-binding cassette (ABC) transporter complex; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of mitochondrial outer membrane; C:mitochondrial envelope; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:vacuolar membrane;, F:ABC-type heme transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:heme binding;, P:brain development; P:cellular iron ion homeostasis; P:heme transport; P:porphyrin-containing compound biosynthetic process; P:skin development; P:transmembrane transport;|Q9NP58 O75542 Q49A66 Q59GQ5 Q6ZME6 Q96ME8 Q9HAQ6 Q9HAQ7,ATP-binding cassette sub-family B member 6, mitochondrial,Mitochondrial ABC transporter 3;P-glycoprotein-related protein;Ubiquitously-expressed mammalian ABC half transporter;, PF00664;PF00005;PF16185;, GO:0043190;GO:0005829;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0031307;GO:0005740;GO:0005741;GO:0005739;GO:0005654;GO:0005886;GO:0005774;GO:0015439;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0020037;GO:0007420;GO:0006879;GO:0015886;GO:0006779;GO:0043588;GO:0055085;, C:ATP-binding cassette (ABC) transporter complex; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of mitochondrial outer membrane; C:mitochondrial envelope; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:vacuolar membrane;, F:ABC-type heme transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:heme binding;, P:brain development; P:cellular iron ion homeostasis; P:heme transport; P:porphyrin-containing compound biosynthetic process; P:skin development; P:transmembrane transport;|Q9NP58 O75542 Q49A66 Q59GQ5 Q6ZME6 Q96ME8 Q9HAQ6 Q9HAQ7,ATP-binding cassette sub-family B member 6, mitochondrial,Mitochondrial ABC transporter 3;P-glycoprotein-related protein;Ubiquitously-expressed mammalian ABC half transporter;, PF00664;PF00005;PF16185;, GO:0043190;GO:0005829;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0031307;GO:0005740;GO:0005741;GO:0005739;GO:0005654;GO:0005886;GO:0005774;GO:0015439;GO:0005524;GO:0016887;GO:0042626;GO:0015562;GO:0020037;GO:0007420;GO:0006879;GO:0015886;GO:0006779;GO:0043588;GO:0055085;, C:ATP-binding cassette (ABC) transporter complex; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of mitochondrial outer membrane; C:mitochondrial envelope; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:vacuolar membrane;, F:ABC-type heme transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:efflux transmembrane transporter activity; F:heme binding;, P:brain development; P:cellular iron ion homeostasis; P:heme transport; P:porphyrin-containing compound biosynthetic process; P:skin development; P:transmembrane transport;|Q9HAG7,Autophagy-related protein 9A,APG9-like 1;mATG9;, PF04109;, GO:0005776;GO:0005789;GO:0005768;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0016020;GO:0000407;GO:0055037;GO:0005802;GO:0000045;GO:0000422;GO:0044805;GO:0034497;GO:0015031;, C:autophagosome; C:endoplasmic reticulum membrane; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:membrane; C:phagophore assembly site; C:recycling endosome; C:trans-Golgi network;, , P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:protein localization to phagophore assembly site; P:protein transport;|Q9HAG7,Autophagy-related protein 9A,APG9-like 1;mATG9;, PF04109;, GO:0005776;GO:0005789;GO:0005768;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0016020;GO:0000407;GO:0055037;GO:0005802;GO:0000045;GO:0000422;GO:0044805;GO:0034497;GO:0015031;, C:autophagosome; C:endoplasmic reticulum membrane; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:membrane; C:phagophore assembly site; C:recycling endosome; C:trans-Golgi network;, , P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:protein localization to phagophore assembly site; P:protein transport;|Q9HAG7,Autophagy-related protein 9A,APG9-like 1;mATG9;, PF04109;, GO:0005776;GO:0005789;GO:0005768;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0016020;GO:0000407;GO:0055037;GO:0005802;GO:0000045;GO:0000422;GO:0044805;GO:0034497;GO:0015031;, C:autophagosome; C:endoplasmic reticulum membrane; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:membrane; C:phagophore assembly site; C:recycling endosome; C:trans-Golgi network;, , P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:protein localization to phagophore assembly site; P:protein transport;|Q9HAG7,Autophagy-related protein 9A,APG9-like 1;mATG9;, PF04109;, GO:0005776;GO:0005789;GO:0005768;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0016020;GO:0000407;GO:0055037;GO:0005802;GO:0000045;GO:0000422;GO:0044805;GO:0034497;GO:0015031;, C:autophagosome; C:endoplasmic reticulum membrane; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:membrane; C:phagophore assembly site; C:recycling endosome; C:trans-Golgi network;, , P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:protein localization to phagophore assembly site; P:protein transport;|Q9HAG7,Autophagy-related protein 9A,APG9-like 1;mATG9;, PF04109;, GO:0005776;GO:0005789;GO:0005768;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0016020;GO:0000407;GO:0055037;GO:0005802;GO:0000045;GO:0000422;GO:0044805;GO:0034497;GO:0015031;, C:autophagosome; C:endoplasmic reticulum membrane; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:membrane; C:phagophore assembly site; C:recycling endosome; C:trans-Golgi network;, , P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:protein localization to phagophore assembly site; P:protein transport; scaffold46 indexed_genome mRNA 732850 747353 . + . ID=transcript_8920;Q9H8Y5 Q9NVZ4,Ankyrin repeat and zinc finger domain-containing protein 1,Zinc finger protein 744;, PF00023;PF18826;PF18716;, GO:0005737;GO:0016020;GO:0046872;GO:0070301;GO:0030433;, C:cytoplasm; C:membrane;, F:metal ion binding;, P:cellular response to hydrogen peroxide; P:ubiquitin-dependent ERAD pathway;|Q9H8Y5 Q9NVZ4,Ankyrin repeat and zinc finger domain-containing protein 1,Zinc finger protein 744;, PF00023;PF18826;PF18716;, GO:0005737;GO:0016020;GO:0046872;GO:0070301;GO:0030433;, C:cytoplasm; C:membrane;, F:metal ion binding;, P:cellular response to hydrogen peroxide; P:ubiquitin-dependent ERAD pathway;|Q9H8Y5 Q9NVZ4,Ankyrin repeat and zinc finger domain-containing protein 1,Zinc finger protein 744;, PF00023;PF18826;PF18716;, GO:0005737;GO:0016020;GO:0046872;GO:0070301;GO:0030433;, C:cytoplasm; C:membrane;, F:metal ion binding;, P:cellular response to hydrogen peroxide; P:ubiquitin-dependent ERAD pathway;|Q9H8Y5 Q9NVZ4,Ankyrin repeat and zinc finger domain-containing protein 1,Zinc finger protein 744;, PF00023;PF18826;PF18716;, GO:0005737;GO:0016020;GO:0046872;GO:0070301;GO:0030433;, C:cytoplasm; C:membrane;, F:metal ion binding;, P:cellular response to hydrogen peroxide; P:ubiquitin-dependent ERAD pathway;|Q6UWU2 Q96DR0,Beta-galactosidase-1-like protein,, PF01301;, GO:0005576;GO:0005773;GO:0004565;GO:0005975;, C:extracellular region; C:vacuole;, F:beta-galactosidase activity;, P:carbohydrate metabolic process;|Q6UWU2 Q96DR0,Beta-galactosidase-1-like protein,, PF01301;, GO:0005576;GO:0005773;GO:0004565;GO:0005975;, C:extracellular region; C:vacuole;, F:beta-galactosidase activity;, P:carbohydrate metabolic process;|Q6UWU2 Q96DR0,Beta-galactosidase-1-like protein,, PF01301;, GO:0005576;GO:0005773;GO:0004565;GO:0005975;, C:extracellular region; C:vacuole;, F:beta-galactosidase activity;, P:carbohydrate metabolic process; scaffold46 indexed_genome mRNA 747888 750673 . - . ID=transcript_8921;O75716 A8K9H9 Q5U0F8 Q96KI2 Q9BUH4 Q9UEN3 Q9UP78,Serine/threonine-protein kinase 16,Myristoylated and palmitoylated serine/threonine-protein kinase;Protein kinase PKL12;TGF-beta-stimulated factor 1;Tyrosine-protein kinase STK16;hPSK;, PF00069;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0048471;GO:0005886;GO:0005524;GO:0004715;GO:0106310;GO:0004674;GO:0106311;GO:0004714;GO:0046777;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation;|O75716 A8K9H9 Q5U0F8 Q96KI2 Q9BUH4 Q9UEN3 Q9UP78,Serine/threonine-protein kinase 16,Myristoylated and palmitoylated serine/threonine-protein kinase;Protein kinase PKL12;TGF-beta-stimulated factor 1;Tyrosine-protein kinase STK16;hPSK;, PF00069;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0048471;GO:0005886;GO:0005524;GO:0004715;GO:0106310;GO:0004674;GO:0106311;GO:0004714;GO:0046777;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; scaffold46 indexed_genome mRNA 751649 755287 . - . ID=transcript_8922;P68366 A8MUB1 B3KNQ6 P05215,Tubulin alpha-4A chain,Alpha-tubulin 1;Testis-specific alpha-tubulin;Tubulin H2-alpha;Tubulin alpha-1 chain;, PF00091;PF03953;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005874;GO:0015630;GO:0005525;GO:0003924;GO:0019901;GO:0005200;GO:0097711;GO:0000086;GO:0000226;GO:0000278;GO:0002576;GO:0010389;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:microtubule; C:microtubule cytoskeleton;, F:GTP binding; F:GTPase activity; F:protein kinase binding; F:structural constituent of cytoskeleton;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:platelet degranulation; P:regulation of G2/M transition of mitotic cell cycle; scaffold46 indexed_genome mRNA 771714 776827 . + . ID=transcript_8923;Q9BQE3,Tubulin alpha-1C chain,Alpha-tubulin 6;Tubulin alpha-6 chain;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0015630;GO:0005634;GO:0031982;GO:0005525;GO:0003924;GO:0005200;GO:0005198;GO:0051301;GO:0030705;GO:0000226;GO:0007017;GO:0000278;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:vesicle;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cell division; P:cytoskeleton-dependent intracellular transport; P:microtubule cytoskeleton organization; P:microtubule-based process; P:mitotic cell cycle; scaffold46 indexed_genome mRNA 786128 793462 . + . ID=transcript_8924;P25686 A8K9P6 Q53QD7 Q8IUK1 Q8IUK2 Q96F52,DnaJ homolog subfamily B member 2 {ECO:0000305},Heat shock 40 kDa protein 3 {ECO:0000312|MIM:604139};Heat shock protein J1 {ECO:0000303|PubMed:1599432};, PF00226;, GO:0005737;GO:0098554;GO:0005829;GO:0042406;GO:0016234;GO:0031227;GO:0031965;GO:0005634;GO:0048471;GO:0001671;GO:0051087;GO:0030544;GO:0031593;GO:0070628;GO:0043130;GO:0031625;GO:0140036;GO:0051082;GO:0061077;GO:0030308;GO:0008285;GO:0090084;GO:0032091;GO:0090086;GO:0070050;GO:0032781;GO:0032436;GO:0031398;GO:0043161;GO:0042026;GO:1903644;GO:0032880;GO:0031396;GO:0006986;GO:0030433;, C:cytoplasm; C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:extrinsic component of endoplasmic reticulum membrane; C:inclusion body; C:intrinsic component of endoplasmic reticulum membrane; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:ATPase activator activity; F:chaperone binding; F:Hsp70 protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-dependent protein binding; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of inclusion body assembly; P:negative regulation of protein binding; P:negative regulation of protein deubiquitination; P:neuron cellular homeostasis; P:positive regulation of ATPase activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein refolding; P:regulation of chaperone-mediated protein folding; P:regulation of protein localization; P:regulation of protein ubiquitination; P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|P25686 A8K9P6 Q53QD7 Q8IUK1 Q8IUK2 Q96F52,DnaJ homolog subfamily B member 2 {ECO:0000305},Heat shock 40 kDa protein 3 {ECO:0000312|MIM:604139};Heat shock protein J1 {ECO:0000303|PubMed:1599432};, PF00226;, GO:0005737;GO:0098554;GO:0005829;GO:0042406;GO:0016234;GO:0031227;GO:0031965;GO:0005634;GO:0048471;GO:0001671;GO:0051087;GO:0030544;GO:0031593;GO:0070628;GO:0043130;GO:0031625;GO:0140036;GO:0051082;GO:0061077;GO:0030308;GO:0008285;GO:0090084;GO:0032091;GO:0090086;GO:0070050;GO:0032781;GO:0032436;GO:0031398;GO:0043161;GO:0042026;GO:1903644;GO:0032880;GO:0031396;GO:0006986;GO:0030433;, C:cytoplasm; C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:extrinsic component of endoplasmic reticulum membrane; C:inclusion body; C:intrinsic component of endoplasmic reticulum membrane; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:ATPase activator activity; F:chaperone binding; F:Hsp70 protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-dependent protein binding; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of inclusion body assembly; P:negative regulation of protein binding; P:negative regulation of protein deubiquitination; P:neuron cellular homeostasis; P:positive regulation of ATPase activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein refolding; P:regulation of chaperone-mediated protein folding; P:regulation of protein localization; P:regulation of protein ubiquitination; P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway;|P25686 A8K9P6 Q53QD7 Q8IUK1 Q8IUK2 Q96F52,DnaJ homolog subfamily B member 2 {ECO:0000305},Heat shock 40 kDa protein 3 {ECO:0000312|MIM:604139};Heat shock protein J1 {ECO:0000303|PubMed:1599432};, PF00226;, GO:0005737;GO:0098554;GO:0005829;GO:0042406;GO:0016234;GO:0031227;GO:0031965;GO:0005634;GO:0048471;GO:0001671;GO:0051087;GO:0030544;GO:0031593;GO:0070628;GO:0043130;GO:0031625;GO:0140036;GO:0051082;GO:0061077;GO:0030308;GO:0008285;GO:0090084;GO:0032091;GO:0090086;GO:0070050;GO:0032781;GO:0032436;GO:0031398;GO:0043161;GO:0042026;GO:1903644;GO:0032880;GO:0031396;GO:0006986;GO:0030433;, C:cytoplasm; C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:extrinsic component of endoplasmic reticulum membrane; C:inclusion body; C:intrinsic component of endoplasmic reticulum membrane; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:ATPase activator activity; F:chaperone binding; F:Hsp70 protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:ubiquitin-dependent protein binding; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of inclusion body assembly; P:negative regulation of protein binding; P:negative regulation of protein deubiquitination; P:neuron cellular homeostasis; P:positive regulation of ATPase activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein refolding; P:regulation of chaperone-mediated protein folding; P:regulation of protein localization; P:regulation of protein ubiquitination; P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway; scaffold46 indexed_genome mRNA 795191 813957 . + . ID=transcript_8925;Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species;|Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species;|Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species;|Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species;|Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species;|Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species;|Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species;|Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species;|Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species;|Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species; scaffold46 indexed_genome mRNA 825300 830941 . - . ID=transcript_8926;Q5W5W9 A8MQ49 Q38I23 Q5W5X0,Regulated endocrine-specific protein 18,, PF14948;, GO:0031410;GO:0005783;GO:0005794;, C:cytoplasmic vesicle; C:endoplasmic reticulum; C:Golgi apparatus;|Q5W5W9 A8MQ49 Q38I23 Q5W5X0,Regulated endocrine-specific protein 18,, PF14948;, GO:0031410;GO:0005783;GO:0005794;, C:cytoplasmic vesicle; C:endoplasmic reticulum; C:Golgi apparatus; scaffold46 indexed_genome mRNA 859651 868922 . + . ID=transcript_8927;Q9ULA0 Q9BW44 Q9NUV5 Q9NV55,Aspartyl aminopeptidase {ECO:0000305},, PF02127;, GO:0072562;GO:0005737;GO:0005829;GO:0005634;GO:0004177;GO:0042802;GO:0008237;GO:0008270;GO:0006518;, C:blood microparticle; C:cytoplasm; C:cytosol; C:nucleus;, F:aminopeptidase activity; F:identical protein binding; F:metallopeptidase activity; F:zinc ion binding;, P:peptide metabolic process;|Q9ULA0 Q9BW44 Q9NUV5 Q9NV55,Aspartyl aminopeptidase {ECO:0000305},, PF02127;, GO:0072562;GO:0005737;GO:0005829;GO:0005634;GO:0004177;GO:0042802;GO:0008237;GO:0008270;GO:0006518;, C:blood microparticle; C:cytoplasm; C:cytosol; C:nucleus;, F:aminopeptidase activity; F:identical protein binding; F:metallopeptidase activity; F:zinc ion binding;, P:peptide metabolic process;|Q9ULA0 Q9BW44 Q9NUV5 Q9NV55,Aspartyl aminopeptidase {ECO:0000305},, PF02127;, GO:0072562;GO:0005737;GO:0005829;GO:0005634;GO:0004177;GO:0042802;GO:0008237;GO:0008270;GO:0006518;, C:blood microparticle; C:cytoplasm; C:cytosol; C:nucleus;, F:aminopeptidase activity; F:identical protein binding; F:metallopeptidase activity; F:zinc ion binding;, P:peptide metabolic process; scaffold46 indexed_genome mRNA 899066 908147 . + . ID=transcript_8928;Q8TAC4 Q8TCX2 Q8TD99 Q9UHN5 Q9UJ80,Desmin,, PF00038;PF04732;, GO:0097512;GO:0005829;GO:0070062;GO:0005916;GO:0014704;GO:0005882;GO:0045111;GO:0031594;GO:0005634;GO:0042383;GO:0030018;GO:0008092;GO:0042802;GO:0005200;GO:0007010;GO:0045109;GO:0006936;GO:0030049;GO:0008016;, C:cardiac myofibril; C:cytosol; C:extracellular exosome; C:fascia adherens; C:intercalated disc; C:intermediate filament; C:intermediate filament cytoskeleton; C:neuromuscular junction; C:nucleus; C:sarcolemma; C:Z disc;, F:cytoskeletal protein binding; F:identical protein binding; F:structural constituent of cytoskeleton;, P:cytoskeleton organization; P:intermediate filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of heart contraction;|Q8TAC4 Q8TCX2 Q8TD99 Q9UHN5 Q9UJ80,Desmin,, PF00038;PF04732;, GO:0097512;GO:0005829;GO:0070062;GO:0005916;GO:0014704;GO:0005882;GO:0045111;GO:0031594;GO:0005634;GO:0042383;GO:0030018;GO:0008092;GO:0042802;GO:0005200;GO:0007010;GO:0045109;GO:0006936;GO:0030049;GO:0008016;, C:cardiac myofibril; C:cytosol; C:extracellular exosome; C:fascia adherens; C:intercalated disc; C:intermediate filament; C:intermediate filament cytoskeleton; C:neuromuscular junction; C:nucleus; C:sarcolemma; C:Z disc;, F:cytoskeletal protein binding; F:identical protein binding; F:structural constituent of cytoskeleton;, P:cytoskeleton organization; P:intermediate filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of heart contraction;|Q8TAC4 Q8TCX2 Q8TD99 Q9UHN5 Q9UJ80,Desmin,, PF00038;PF04732;, GO:0097512;GO:0005829;GO:0070062;GO:0005916;GO:0014704;GO:0005882;GO:0045111;GO:0031594;GO:0005634;GO:0042383;GO:0030018;GO:0008092;GO:0042802;GO:0005200;GO:0007010;GO:0045109;GO:0006936;GO:0030049;GO:0008016;, C:cardiac myofibril; C:cytosol; C:extracellular exosome; C:fascia adherens; C:intercalated disc; C:intermediate filament; C:intermediate filament cytoskeleton; C:neuromuscular junction; C:nucleus; C:sarcolemma; C:Z disc;, F:cytoskeletal protein binding; F:identical protein binding; F:structural constituent of cytoskeleton;, P:cytoskeleton organization; P:intermediate filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of heart contraction; scaffold46 indexed_genome mRNA 917491 919737 . - . ID=transcript_8929;Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation; scaffold46 indexed_genome mRNA 922539 923666 . + . ID=transcript_8930;Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation; scaffold46 indexed_genome mRNA 927373 929311 . + . ID=transcript_8931;Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation; scaffold46 indexed_genome mRNA 941427 971181 . + . ID=transcript_8932;Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation;|Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation;|Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation;|Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation;|Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation;|Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation;|Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation;|Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation; scaffold46 indexed_genome mRNA 976342 982659 . + . ID=transcript_8933;Q96IJ6 A6NJ74 A8K3Q6 B3KMT4 Q53GI0 Q9NWC3 Q9Y5P5,Mannose-1-phosphate guanyltransferase alpha,GDP-mannose pyrophosphorylase A;GTP-mannose-1-phosphate guanylyltransferase alpha;, PF00132;PF00483;, GO:0005737;GO:0070062;GO:0016779;GO:0009058;, C:cytoplasm; C:extracellular exosome;, F:nucleotidyltransferase activity;, P:biosynthetic process;|Q96IJ6 A6NJ74 A8K3Q6 B3KMT4 Q53GI0 Q9NWC3 Q9Y5P5,Mannose-1-phosphate guanyltransferase alpha,GDP-mannose pyrophosphorylase A;GTP-mannose-1-phosphate guanylyltransferase alpha;, PF00132;PF00483;, GO:0005737;GO:0070062;GO:0016779;GO:0009058;, C:cytoplasm; C:extracellular exosome;, F:nucleotidyltransferase activity;, P:biosynthetic process;|Q96IJ6 A6NJ74 A8K3Q6 B3KMT4 Q53GI0 Q9NWC3 Q9Y5P5,Mannose-1-phosphate guanyltransferase alpha,GDP-mannose pyrophosphorylase A;GTP-mannose-1-phosphate guanylyltransferase alpha;, PF00132;PF00483;, GO:0005737;GO:0070062;GO:0016779;GO:0009058;, C:cytoplasm; C:extracellular exosome;, F:nucleotidyltransferase activity;, P:biosynthetic process;|Q96IJ6 A6NJ74 A8K3Q6 B3KMT4 Q53GI0 Q9NWC3 Q9Y5P5,Mannose-1-phosphate guanyltransferase alpha,GDP-mannose pyrophosphorylase A;GTP-mannose-1-phosphate guanylyltransferase alpha;, PF00132;PF00483;, GO:0005737;GO:0070062;GO:0016779;GO:0009058;, C:cytoplasm; C:extracellular exosome;, F:nucleotidyltransferase activity;, P:biosynthetic process; scaffold46 indexed_genome mRNA 990661 991669 . + . ID=transcript_8934;Q96FT7 Q53SB7 Q6GMS1 Q6PIN9 Q9NQA4,Acid-sensing ion channel 4,Amiloride-sensitive cation channel 4;Amiloride-sensitive cation channel 4, pituitary;, PF00858;, GO:0005887;GO:0005216;GO:0015280;GO:0015081;GO:0001662;GO:0035725;, C:integral component of plasma membrane;, F:ion channel activity; F:ligand-gated sodium channel activity; F:sodium ion transmembrane transporter activity;, P:behavioral fear response; P:sodium ion transmembrane transport; scaffold46 indexed_genome mRNA 991689 1008029 . + . ID=transcript_8935;Q96FT7 Q53SB7 Q6GMS1 Q6PIN9 Q9NQA4,Acid-sensing ion channel 4,Amiloride-sensitive cation channel 4;Amiloride-sensitive cation channel 4, pituitary;, PF00858;, GO:0005887;GO:0005216;GO:0015280;GO:0015081;GO:0001662;GO:0035725;, C:integral component of plasma membrane;, F:ion channel activity; F:ligand-gated sodium channel activity; F:sodium ion transmembrane transporter activity;, P:behavioral fear response; P:sodium ion transmembrane transport; scaffold46 indexed_genome mRNA 1009026 1013236 . + . ID=transcript_8936;Q96FT7 Q53SB7 Q6GMS1 Q6PIN9 Q9NQA4,Acid-sensing ion channel 4,Amiloride-sensitive cation channel 4;Amiloride-sensitive cation channel 4, pituitary;, PF00858;, GO:0005887;GO:0005216;GO:0015280;GO:0015081;GO:0001662;GO:0035725;, C:integral component of plasma membrane;, F:ion channel activity; F:ligand-gated sodium channel activity; F:sodium ion transmembrane transporter activity;, P:behavioral fear response; P:sodium ion transmembrane transport; scaffold46 indexed_genome mRNA 1013877 1020086 . + . ID=transcript_8937;Q8IZ52 B4DXU0 Q6UXD6 Q7L4G1 Q9H0F8 Q9H618,Chondroitin sulfate synthase 2,Chondroitin glucuronyltransferase 2;Chondroitin-polymerizing factor;Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II;N-acetylgalactosaminyltransferase 2;, PF05679;, GO:0005829;GO:0032580;GO:0000139;GO:0016021;GO:0005759;GO:0008376;GO:0047238;GO:0046872;GO:0050510;GO:0030206;, C:cytosol; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:mitochondrial matrix;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:metal ion binding; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity;, P:chondroitin sulfate biosynthetic process;|Q66K66,Transmembrane protein 198,, PF13886;, GO:0031410;GO:0016021;GO:0005886;GO:0007275;GO:0090263;GO:0016055;, C:cytoplasmic vesicle; C:integral component of membrane; C:plasma membrane;, , P:multicellular organism development; P:positive regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold46 indexed_genome mRNA 1021689 1033195 . + . ID=transcript_8938;Q66K66,Transmembrane protein 198,, PF13886;, GO:0031410;GO:0016021;GO:0005886;GO:0007275;GO:0090263;GO:0016055;, C:cytoplasmic vesicle; C:integral component of membrane; C:plasma membrane;, , P:multicellular organism development; P:positive regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q66K66,Transmembrane protein 198,, PF13886;, GO:0031410;GO:0016021;GO:0005886;GO:0007275;GO:0090263;GO:0016055;, C:cytoplasmic vesicle; C:integral component of membrane; C:plasma membrane;, , P:multicellular organism development; P:positive regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|O75147 A4KVA4 A4KVA5 Q96IW3 S4R3M6,Obscurin-like protein 1,, PF07679;, GO:1990393;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0014704;GO:0031430;GO:0048471;GO:0045202;GO:0030018;GO:0008093;GO:0055003;GO:0007010;GO:0007030;GO:0007156;GO:0000226;GO:0050775;GO:0043687;GO:0034067;GO:0007088;GO:0010842;GO:0007416;, C:3M complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercalated disc; C:M band; C:perinuclear region of cytoplasm; C:synapse; C:Z disc;, F:cytoskeletal anchor activity;, P:cardiac myofibril assembly; P:cytoskeleton organization; P:Golgi organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:microtubule cytoskeleton organization; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein localization to Golgi apparatus; P:regulation of mitotic nuclear division; P:retina layer formation; P:synapse assembly;|O75147 A4KVA4 A4KVA5 Q96IW3 S4R3M6,Obscurin-like protein 1,, PF07679;, GO:1990393;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0014704;GO:0031430;GO:0048471;GO:0045202;GO:0030018;GO:0008093;GO:0055003;GO:0007010;GO:0007030;GO:0007156;GO:0000226;GO:0050775;GO:0043687;GO:0034067;GO:0007088;GO:0010842;GO:0007416;, C:3M complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercalated disc; C:M band; C:perinuclear region of cytoplasm; C:synapse; C:Z disc;, F:cytoskeletal anchor activity;, P:cardiac myofibril assembly; P:cytoskeleton organization; P:Golgi organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:microtubule cytoskeleton organization; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein localization to Golgi apparatus; P:regulation of mitotic nuclear division; P:retina layer formation; P:synapse assembly;|O75147 A4KVA4 A4KVA5 Q96IW3 S4R3M6,Obscurin-like protein 1,, PF07679;, GO:1990393;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0014704;GO:0031430;GO:0048471;GO:0045202;GO:0030018;GO:0008093;GO:0055003;GO:0007010;GO:0007030;GO:0007156;GO:0000226;GO:0050775;GO:0043687;GO:0034067;GO:0007088;GO:0010842;GO:0007416;, C:3M complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercalated disc; C:M band; C:perinuclear region of cytoplasm; C:synapse; C:Z disc;, F:cytoskeletal anchor activity;, P:cardiac myofibril assembly; P:cytoskeleton organization; P:Golgi organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:microtubule cytoskeleton organization; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein localization to Golgi apparatus; P:regulation of mitotic nuclear division; P:retina layer formation; P:synapse assembly;|O75147 A4KVA4 A4KVA5 Q96IW3 S4R3M6,Obscurin-like protein 1,, PF07679;, GO:1990393;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0014704;GO:0031430;GO:0048471;GO:0045202;GO:0030018;GO:0008093;GO:0055003;GO:0007010;GO:0007030;GO:0007156;GO:0000226;GO:0050775;GO:0043687;GO:0034067;GO:0007088;GO:0010842;GO:0007416;, C:3M complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercalated disc; C:M band; C:perinuclear region of cytoplasm; C:synapse; C:Z disc;, F:cytoskeletal anchor activity;, P:cardiac myofibril assembly; P:cytoskeleton organization; P:Golgi organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:microtubule cytoskeleton organization; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein localization to Golgi apparatus; P:regulation of mitotic nuclear division; P:retina layer formation; P:synapse assembly;|O75147 A4KVA4 A4KVA5 Q96IW3 S4R3M6,Obscurin-like protein 1,, PF07679;, GO:1990393;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0014704;GO:0031430;GO:0048471;GO:0045202;GO:0030018;GO:0008093;GO:0055003;GO:0007010;GO:0007030;GO:0007156;GO:0000226;GO:0050775;GO:0043687;GO:0034067;GO:0007088;GO:0010842;GO:0007416;, C:3M complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercalated disc; C:M band; C:perinuclear region of cytoplasm; C:synapse; C:Z disc;, F:cytoskeletal anchor activity;, P:cardiac myofibril assembly; P:cytoskeleton organization; P:Golgi organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:microtubule cytoskeleton organization; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein localization to Golgi apparatus; P:regulation of mitotic nuclear division; P:retina layer formation; P:synapse assembly; scaffold46 indexed_genome mRNA 1038968 1039897 . + . ID=transcript_8939;O75147 A4KVA4 A4KVA5 Q96IW3 S4R3M6,Obscurin-like protein 1,, PF07679;, GO:1990393;GO:0005813;GO:0005737;GO:0005829;GO:0005794;GO:0014704;GO:0031430;GO:0048471;GO:0045202;GO:0030018;GO:0008093;GO:0055003;GO:0007010;GO:0007030;GO:0007156;GO:0000226;GO:0050775;GO:0043687;GO:0034067;GO:0007088;GO:0010842;GO:0007416;, C:3M complex; C:centrosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:intercalated disc; C:M band; C:perinuclear region of cytoplasm; C:synapse; C:Z disc;, F:cytoskeletal anchor activity;, P:cardiac myofibril assembly; P:cytoskeleton organization; P:Golgi organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:microtubule cytoskeleton organization; P:positive regulation of dendrite morphogenesis; P:post-translational protein modification; P:protein localization to Golgi apparatus; P:regulation of mitotic nuclear division; P:retina layer formation; P:synapse assembly; scaffold46 indexed_genome mRNA 1052599 1055785 . + . ID=transcript_8940;P05111 A8K8H5,Inhibin alpha chain,, PF00019;, GO:0005737;GO:0005576;GO:0005615;GO:0043512;GO:0043513;GO:0034673;GO:0043025;GO:0001917;GO:0001750;GO:0005125;GO:0008083;GO:0005179;GO:0034711;GO:0044877;GO:0005102;GO:0007050;GO:0030154;GO:0007166;GO:0007267;GO:0030218;GO:0042541;GO:0008584;GO:0045578;GO:0045786;GO:0046882;GO:0032689;GO:0045650;GO:0042326;GO:0001541;GO:0046881;GO:0010862;GO:0051726;GO:0042127;GO:0007165;GO:0001501;GO:0060395;, C:cytoplasm; C:extracellular region; C:extracellular space; C:inhibin A complex; C:inhibin B complex; C:inhibin-betaglycan-ActRII complex; C:neuronal cell body; C:photoreceptor inner segment; C:photoreceptor outer segment;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:inhibin binding; F:protein-containing complex binding; F:signaling receptor binding;, P:cell cycle arrest; P:cell differentiation; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:erythrocyte differentiation; P:hemoglobin biosynthetic process; P:male gonad development; P:negative regulation of B cell differentiation; P:negative regulation of cell cycle; P:negative regulation of follicle-stimulating hormone secretion; P:negative regulation of interferon-gamma production; P:negative regulation of macrophage differentiation; P:negative regulation of phosphorylation; P:ovarian follicle development; P:positive regulation of follicle-stimulating hormone secretion; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:regulation of cell cycle; P:regulation of cell population proliferation; P:signal transduction; P:skeletal system development; P:SMAD protein signal transduction; scaffold46 indexed_genome mRNA 1069225 1086747 . + . ID=transcript_8941;Q8N1F8 C9JQV3 Q8NAW9 Q8WXE4 Q96CN3 Q96PY9,Serine/threonine-protein kinase 11-interacting protein,LKB1-interacting protein 1;, PF15904;, GO:0035578;GO:0005737;GO:0005576;GO:0005765;GO:0019901;GO:0043312;GO:0008104;, C:azurophil granule lumen; C:cytoplasm; C:extracellular region; C:lysosomal membrane;, F:protein kinase binding;, P:neutrophil degranulation; P:protein localization;|Q8N1F8 C9JQV3 Q8NAW9 Q8WXE4 Q96CN3 Q96PY9,Serine/threonine-protein kinase 11-interacting protein,LKB1-interacting protein 1;, PF15904;, GO:0035578;GO:0005737;GO:0005576;GO:0005765;GO:0019901;GO:0043312;GO:0008104;, C:azurophil granule lumen; C:cytoplasm; C:extracellular region; C:lysosomal membrane;, F:protein kinase binding;, P:neutrophil degranulation; P:protein localization;|Q8N1F8 C9JQV3 Q8NAW9 Q8WXE4 Q96CN3 Q96PY9,Serine/threonine-protein kinase 11-interacting protein,LKB1-interacting protein 1;, PF15904;, GO:0035578;GO:0005737;GO:0005576;GO:0005765;GO:0019901;GO:0043312;GO:0008104;, C:azurophil granule lumen; C:cytoplasm; C:extracellular region; C:lysosomal membrane;, F:protein kinase binding;, P:neutrophil degranulation; P:protein localization;|Q8N1F8 C9JQV3 Q8NAW9 Q8WXE4 Q96CN3 Q96PY9,Serine/threonine-protein kinase 11-interacting protein,LKB1-interacting protein 1;, PF15904;, GO:0035578;GO:0005737;GO:0005576;GO:0005765;GO:0019901;GO:0043312;GO:0008104;, C:azurophil granule lumen; C:cytoplasm; C:extracellular region; C:lysosomal membrane;, F:protein kinase binding;, P:neutrophil degranulation; P:protein localization; scaffold46 indexed_genome mRNA 1098214 1112337 . + . ID=transcript_8942;P48751 A6H8L2 A8K1Q9 B7ZVX6 B9EGD1 Q6YIQ9,Anion exchange protein 3,CAE3/BAE3;Cardiac/brain band 3-like protein;Neuronal band 3-like protein;Solute carrier family 4 member 3;, PF07565;PF00955;, GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0015301;GO:0015106;GO:0005452;GO:0022857;GO:0015701;GO:0061337;GO:0086001;GO:0050801;GO:0051453;GO:0055085;GO:0150104;, C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:inorganic anion exchanger activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:cardiac conduction; P:cardiac muscle cell action potential; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport; P:transport across blood-brain barrier;|P48751 A6H8L2 A8K1Q9 B7ZVX6 B9EGD1 Q6YIQ9,Anion exchange protein 3,CAE3/BAE3;Cardiac/brain band 3-like protein;Neuronal band 3-like protein;Solute carrier family 4 member 3;, PF07565;PF00955;, GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0015301;GO:0015106;GO:0005452;GO:0022857;GO:0015701;GO:0061337;GO:0086001;GO:0050801;GO:0051453;GO:0055085;GO:0150104;, C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:inorganic anion exchanger activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:cardiac conduction; P:cardiac muscle cell action potential; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport; P:transport across blood-brain barrier;|P48751 A6H8L2 A8K1Q9 B7ZVX6 B9EGD1 Q6YIQ9,Anion exchange protein 3,CAE3/BAE3;Cardiac/brain band 3-like protein;Neuronal band 3-like protein;Solute carrier family 4 member 3;, PF07565;PF00955;, GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0015301;GO:0015106;GO:0005452;GO:0022857;GO:0015701;GO:0061337;GO:0086001;GO:0050801;GO:0051453;GO:0055085;GO:0150104;, C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:inorganic anion exchanger activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:cardiac conduction; P:cardiac muscle cell action potential; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport; P:transport across blood-brain barrier;|P48751 A6H8L2 A8K1Q9 B7ZVX6 B9EGD1 Q6YIQ9,Anion exchange protein 3,CAE3/BAE3;Cardiac/brain band 3-like protein;Neuronal band 3-like protein;Solute carrier family 4 member 3;, PF07565;PF00955;, GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0015301;GO:0015106;GO:0005452;GO:0022857;GO:0015701;GO:0061337;GO:0086001;GO:0050801;GO:0051453;GO:0055085;GO:0150104;, C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:inorganic anion exchanger activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:cardiac conduction; P:cardiac muscle cell action potential; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport; P:transport across blood-brain barrier; scaffold46 indexed_genome mRNA 2948204 2966762 . - . ID=transcript_8943;P54764 A8K2P1 B2R601 B7Z6Q8 Q2M380,Ephrin type-A receptor 4,EPH-like kinase 8;Tyrosine-protein kinase TYRO1;Tyrosine-protein kinase receptor SEK;, PF14575;PF01404;PF00041;PF07714;PF07647;, GO:0005912;GO:0030424;GO:0043679;GO:0044295;GO:0009986;GO:0005737;GO:0030425;GO:0043198;GO:0043197;GO:0031901;GO:0005783;GO:0030175;GO:0098978;GO:0005794;GO:0005887;GO:0099055;GO:0099056;GO:0005741;GO:0031594;GO:0043005;GO:0043204;GO:0005886;GO:0098839;GO:0043235;GO:0098685;GO:0001540;GO:0005524;GO:0097161;GO:0046875;GO:0005004;GO:0042802;GO:0016301;GO:0042731;GO:0004672;GO:1990782;GO:0004714;GO:0005005;GO:0034332;GO:0007628;GO:0007411;GO:0007155;GO:1904646;GO:0090102;GO:0021957;GO:0048013;GO:0097156;GO:0097155;GO:0008347;GO:0008045;GO:0007275;GO:0048681;GO:1900272;GO:0010977;GO:1903051;GO:0072178;GO:0106030;GO:0097485;GO:0018108;GO:1902004;GO:1902961;GO:0050775;GO:0043507;GO:0033674;GO:0061098;GO:2001108;GO:0046777;GO:0050821;GO:0048710;GO:0050770;GO:0061001;GO:0043087;GO:1905244;GO:0098883;GO:0007169;, C:adherens junction; C:axon; C:axon terminus; C:axonal growth cone; C:cell surface; C:cytoplasm; C:dendrite; C:dendritic shaft; C:dendritic spine; C:early endosome membrane; C:endoplasmic reticulum; C:filopodium; C:glutamatergic synapse; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:mitochondrial outer membrane; C:neuromuscular junction; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:amyloid-beta binding; F:ATP binding; F:DH domain binding; F:ephrin receptor binding; F:GPI-linked ephrin receptor activity; F:identical protein binding; F:kinase activity; F:PH domain binding; F:protein kinase activity; F:protein tyrosine kinase binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:adherens junction organization; P:adult walking behavior; P:axon guidance; P:cell adhesion; P:cellular response to amyloid-beta; P:cochlea development; P:corticospinal tract morphogenesis; P:ephrin receptor signaling pathway; P:fasciculation of motor neuron axon; P:fasciculation of sensory neuron axon; P:glial cell migration; P:motor neuron axon guidance; P:multicellular organism development; P:negative regulation of axon regeneration; P:negative regulation of long-term synaptic potentiation; P:negative regulation of neuron projection development; P:negative regulation of proteolysis involved in cellular protein catabolic process; P:nephric duct morphogenesis; P:neuron projection fasciculation; P:neuron projection guidance; P:peptidyl-tyrosine phosphorylation; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of JUN kinase activity; P:positive regulation of kinase activity; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of Rho guanyl-nucleotide exchange factor activity; P:protein autophosphorylation; P:protein stabilization; P:regulation of astrocyte differentiation; P:regulation of axonogenesis; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of modification of synaptic structure; P:synapse pruning; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold46 indexed_genome mRNA 2966819 3097663 . - . ID=transcript_8944;P54764 A8K2P1 B2R601 B7Z6Q8 Q2M380,Ephrin type-A receptor 4,EPH-like kinase 8;Tyrosine-protein kinase TYRO1;Tyrosine-protein kinase receptor SEK;, PF14575;PF01404;PF00041;PF07714;PF07647;, GO:0005912;GO:0030424;GO:0043679;GO:0044295;GO:0009986;GO:0005737;GO:0030425;GO:0043198;GO:0043197;GO:0031901;GO:0005783;GO:0030175;GO:0098978;GO:0005794;GO:0005887;GO:0099055;GO:0099056;GO:0005741;GO:0031594;GO:0043005;GO:0043204;GO:0005886;GO:0098839;GO:0043235;GO:0098685;GO:0001540;GO:0005524;GO:0097161;GO:0046875;GO:0005004;GO:0042802;GO:0016301;GO:0042731;GO:0004672;GO:1990782;GO:0004714;GO:0005005;GO:0034332;GO:0007628;GO:0007411;GO:0007155;GO:1904646;GO:0090102;GO:0021957;GO:0048013;GO:0097156;GO:0097155;GO:0008347;GO:0008045;GO:0007275;GO:0048681;GO:1900272;GO:0010977;GO:1903051;GO:0072178;GO:0106030;GO:0097485;GO:0018108;GO:1902004;GO:1902961;GO:0050775;GO:0043507;GO:0033674;GO:0061098;GO:2001108;GO:0046777;GO:0050821;GO:0048710;GO:0050770;GO:0061001;GO:0043087;GO:1905244;GO:0098883;GO:0007169;, C:adherens junction; C:axon; C:axon terminus; C:axonal growth cone; C:cell surface; C:cytoplasm; C:dendrite; C:dendritic shaft; C:dendritic spine; C:early endosome membrane; C:endoplasmic reticulum; C:filopodium; C:glutamatergic synapse; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:mitochondrial outer membrane; C:neuromuscular junction; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:amyloid-beta binding; F:ATP binding; F:DH domain binding; F:ephrin receptor binding; F:GPI-linked ephrin receptor activity; F:identical protein binding; F:kinase activity; F:PH domain binding; F:protein kinase activity; F:protein tyrosine kinase binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:adherens junction organization; P:adult walking behavior; P:axon guidance; P:cell adhesion; P:cellular response to amyloid-beta; P:cochlea development; P:corticospinal tract morphogenesis; P:ephrin receptor signaling pathway; P:fasciculation of motor neuron axon; P:fasciculation of sensory neuron axon; P:glial cell migration; P:motor neuron axon guidance; P:multicellular organism development; P:negative regulation of axon regeneration; P:negative regulation of long-term synaptic potentiation; P:negative regulation of neuron projection development; P:negative regulation of proteolysis involved in cellular protein catabolic process; P:nephric duct morphogenesis; P:neuron projection fasciculation; P:neuron projection guidance; P:peptidyl-tyrosine phosphorylation; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of JUN kinase activity; P:positive regulation of kinase activity; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of Rho guanyl-nucleotide exchange factor activity; P:protein autophosphorylation; P:protein stabilization; P:regulation of astrocyte differentiation; P:regulation of axonogenesis; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of modification of synaptic structure; P:synapse pruning; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P54764 A8K2P1 B2R601 B7Z6Q8 Q2M380,Ephrin type-A receptor 4,EPH-like kinase 8;Tyrosine-protein kinase TYRO1;Tyrosine-protein kinase receptor SEK;, PF14575;PF01404;PF00041;PF07714;PF07647;, GO:0005912;GO:0030424;GO:0043679;GO:0044295;GO:0009986;GO:0005737;GO:0030425;GO:0043198;GO:0043197;GO:0031901;GO:0005783;GO:0030175;GO:0098978;GO:0005794;GO:0005887;GO:0099055;GO:0099056;GO:0005741;GO:0031594;GO:0043005;GO:0043204;GO:0005886;GO:0098839;GO:0043235;GO:0098685;GO:0001540;GO:0005524;GO:0097161;GO:0046875;GO:0005004;GO:0042802;GO:0016301;GO:0042731;GO:0004672;GO:1990782;GO:0004714;GO:0005005;GO:0034332;GO:0007628;GO:0007411;GO:0007155;GO:1904646;GO:0090102;GO:0021957;GO:0048013;GO:0097156;GO:0097155;GO:0008347;GO:0008045;GO:0007275;GO:0048681;GO:1900272;GO:0010977;GO:1903051;GO:0072178;GO:0106030;GO:0097485;GO:0018108;GO:1902004;GO:1902961;GO:0050775;GO:0043507;GO:0033674;GO:0061098;GO:2001108;GO:0046777;GO:0050821;GO:0048710;GO:0050770;GO:0061001;GO:0043087;GO:1905244;GO:0098883;GO:0007169;, C:adherens junction; C:axon; C:axon terminus; C:axonal growth cone; C:cell surface; C:cytoplasm; C:dendrite; C:dendritic shaft; C:dendritic spine; C:early endosome membrane; C:endoplasmic reticulum; C:filopodium; C:glutamatergic synapse; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:mitochondrial outer membrane; C:neuromuscular junction; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:amyloid-beta binding; F:ATP binding; F:DH domain binding; F:ephrin receptor binding; F:GPI-linked ephrin receptor activity; F:identical protein binding; F:kinase activity; F:PH domain binding; F:protein kinase activity; F:protein tyrosine kinase binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:adherens junction organization; P:adult walking behavior; P:axon guidance; P:cell adhesion; P:cellular response to amyloid-beta; P:cochlea development; P:corticospinal tract morphogenesis; P:ephrin receptor signaling pathway; P:fasciculation of motor neuron axon; P:fasciculation of sensory neuron axon; P:glial cell migration; P:motor neuron axon guidance; P:multicellular organism development; P:negative regulation of axon regeneration; P:negative regulation of long-term synaptic potentiation; P:negative regulation of neuron projection development; P:negative regulation of proteolysis involved in cellular protein catabolic process; P:nephric duct morphogenesis; P:neuron projection fasciculation; P:neuron projection guidance; P:peptidyl-tyrosine phosphorylation; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of dendrite morphogenesis; P:positive regulation of JUN kinase activity; P:positive regulation of kinase activity; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of Rho guanyl-nucleotide exchange factor activity; P:protein autophosphorylation; P:protein stabilization; P:regulation of astrocyte differentiation; P:regulation of axonogenesis; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of modification of synaptic structure; P:synapse pruning; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold46 indexed_genome mRNA 3766979 3861549 . - . ID=transcript_8945;P23760 G5E9C1 Q16448 Q494Z3 Q494Z4 Q53T90 Q6GSJ9 Q86UQ2 Q86UQ3,Paired box protein Pax-3,HuP2;, PF00046;PF00292;PF12360;, GO:0000785;GO:0005654;GO:0003700;GO:0000981;GO:0071837;GO:0000978;GO:0043565;GO:1990837;GO:0048856;GO:0009887;GO:0006915;GO:0007517;GO:0007399;GO:0045944;GO:0045893;GO:0006357;GO:0007605;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:HMG box domain binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure development; P:animal organ morphogenesis; P:apoptotic process; P:muscle organ development; P:nervous system development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:sensory perception of sound;|P23760 G5E9C1 Q16448 Q494Z3 Q494Z4 Q53T90 Q6GSJ9 Q86UQ2 Q86UQ3,Paired box protein Pax-3,HuP2;, PF00046;PF00292;PF12360;, GO:0000785;GO:0005654;GO:0003700;GO:0000981;GO:0071837;GO:0000978;GO:0043565;GO:1990837;GO:0048856;GO:0009887;GO:0006915;GO:0007517;GO:0007399;GO:0045944;GO:0045893;GO:0006357;GO:0007605;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:HMG box domain binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure development; P:animal organ morphogenesis; P:apoptotic process; P:muscle organ development; P:nervous system development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:sensory perception of sound; scaffold46 indexed_genome mRNA 3987685 4134488 . + . ID=transcript_8946;Q8IWX5 A3KPB4 Q8N8Q6,Sphingosine-1-phosphate phosphatase 2 {ECO:0000305},Sphingosine-1-phosphatase 2;, PF01569;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0070780;GO:0042392;GO:0046839;GO:0061469;GO:0030148;GO:0006670;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:dihydrosphingosine-1-phosphate phosphatase activity; F:sphingosine-1-phosphate phosphatase activity;, P:phospholipid dephosphorylation; P:regulation of type B pancreatic cell proliferation; P:sphingolipid biosynthetic process; P:sphingosine metabolic process; scaffold46 indexed_genome mRNA 4138485 4212901 . - . ID=transcript_8947;Q9NSD9 B4DFM0 O95708 Q4ZFX1 Q57ZJ5 Q9NZZ6,Phenylalanine--tRNA ligase beta subunit,Phenylalanyl-tRNA synthetase beta subunit;, PF03483;PF03484;PF18262;PF17759;, GO:0005737;GO:0005829;GO:0016020;GO:0009328;GO:0005524;GO:0000287;GO:0004826;GO:0003723;GO:0006432;GO:0051290;GO:0006412;GO:0006418;, C:cytoplasm; C:cytosol; C:membrane; C:phenylalanine-tRNA ligase complex;, F:ATP binding; F:magnesium ion binding; F:phenylalanine-tRNA ligase activity; F:RNA binding;, P:phenylalanyl-tRNA aminoacylation; P:protein heterotetramerization; P:translation; P:tRNA aminoacylation for protein translation;|Q9NSD9 B4DFM0 O95708 Q4ZFX1 Q57ZJ5 Q9NZZ6,Phenylalanine--tRNA ligase beta subunit,Phenylalanyl-tRNA synthetase beta subunit;, PF03483;PF03484;PF18262;PF17759;, GO:0005737;GO:0005829;GO:0016020;GO:0009328;GO:0005524;GO:0000287;GO:0004826;GO:0003723;GO:0006432;GO:0051290;GO:0006412;GO:0006418;, C:cytoplasm; C:cytosol; C:membrane; C:phenylalanine-tRNA ligase complex;, F:ATP binding; F:magnesium ion binding; F:phenylalanine-tRNA ligase activity; F:RNA binding;, P:phenylalanyl-tRNA aminoacylation; P:protein heterotetramerization; P:translation; P:tRNA aminoacylation for protein translation; scaffold46 indexed_genome mRNA 4234479 4265828 . + . ID=transcript_8948;Q96PD6 Q6IEE5,2-acylglycerol O-acyltransferase 1 {ECO:0000305},Acyl-CoA:monoacylglycerol acyltransferase 1;Diacylglycerol O-acyltransferase candidate 2;Diacylglycerol acyltransferase 2-like protein 1;Monoacylglycerol O-acyltransferase 1;, PF03982;, GO:0005789;GO:0016021;GO:0003846;GO:0004144;GO:0008374;GO:0006651;GO:0006071;GO:0006629;GO:0019432;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:O-acyltransferase activity;, P:diacylglycerol biosynthetic process; P:glycerol metabolic process; P:lipid metabolic process; P:triglyceride biosynthetic process; scaffold46 indexed_genome mRNA 4462715 4490129 . + . ID=transcript_8949;O95573 Q60I92 Q8IUM9,Long-chain-fatty-acid--CoA ligase 3 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000250|UniProtKB:Q63151};Long-chain acyl-CoA synthetase 3;, PF00501;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005811;GO:0016020;GO:0005741;GO:0048471;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0019904;GO:0019901;GO:0007420;GO:0006633;GO:0006631;GO:0044539;GO:0001676;GO:0035338;GO:0035336;GO:0030182;GO:0042998;GO:2001247;GO:0051047;GO:0007584;GO:0014070;GO:0034379;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:lipid droplet; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:protein domain specific binding; F:protein kinase binding;, P:brain development; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:long-chain fatty-acyl-CoA metabolic process; P:neuron differentiation; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of phosphatidylcholine biosynthetic process; P:positive regulation of secretion; P:response to nutrient; P:response to organic cyclic compound; P:very-low-density lipoprotein particle assembly;|O95573 Q60I92 Q8IUM9,Long-chain-fatty-acid--CoA ligase 3 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000250|UniProtKB:Q63151};Long-chain acyl-CoA synthetase 3;, PF00501;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005811;GO:0016020;GO:0005741;GO:0048471;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0019904;GO:0019901;GO:0007420;GO:0006633;GO:0006631;GO:0044539;GO:0001676;GO:0035338;GO:0035336;GO:0030182;GO:0042998;GO:2001247;GO:0051047;GO:0007584;GO:0014070;GO:0034379;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:lipid droplet; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:protein domain specific binding; F:protein kinase binding;, P:brain development; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:long-chain fatty-acyl-CoA metabolic process; P:neuron differentiation; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of phosphatidylcholine biosynthetic process; P:positive regulation of secretion; P:response to nutrient; P:response to organic cyclic compound; P:very-low-density lipoprotein particle assembly;|O95573 Q60I92 Q8IUM9,Long-chain-fatty-acid--CoA ligase 3 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000250|UniProtKB:Q63151};Long-chain acyl-CoA synthetase 3;, PF00501;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005811;GO:0016020;GO:0005741;GO:0048471;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0019904;GO:0019901;GO:0007420;GO:0006633;GO:0006631;GO:0044539;GO:0001676;GO:0035338;GO:0035336;GO:0030182;GO:0042998;GO:2001247;GO:0051047;GO:0007584;GO:0014070;GO:0034379;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:lipid droplet; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:protein domain specific binding; F:protein kinase binding;, P:brain development; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:long-chain fatty-acyl-CoA metabolic process; P:neuron differentiation; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of phosphatidylcholine biosynthetic process; P:positive regulation of secretion; P:response to nutrient; P:response to organic cyclic compound; P:very-low-density lipoprotein particle assembly;|O95573 Q60I92 Q8IUM9,Long-chain-fatty-acid--CoA ligase 3 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000250|UniProtKB:Q63151};Long-chain acyl-CoA synthetase 3;, PF00501;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005811;GO:0016020;GO:0005741;GO:0048471;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0019904;GO:0019901;GO:0007420;GO:0006633;GO:0006631;GO:0044539;GO:0001676;GO:0035338;GO:0035336;GO:0030182;GO:0042998;GO:2001247;GO:0051047;GO:0007584;GO:0014070;GO:0034379;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:lipid droplet; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:protein domain specific binding; F:protein kinase binding;, P:brain development; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:long-chain fatty-acyl-CoA metabolic process; P:neuron differentiation; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of phosphatidylcholine biosynthetic process; P:positive regulation of secretion; P:response to nutrient; P:response to organic cyclic compound; P:very-low-density lipoprotein particle assembly; scaffold46 indexed_genome mRNA 4490132 4496710 . - . ID=transcript_8950;O95573 Q60I92 Q8IUM9,Long-chain-fatty-acid--CoA ligase 3 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000250|UniProtKB:Q63151};Long-chain acyl-CoA synthetase 3;, PF00501;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005811;GO:0016020;GO:0005741;GO:0048471;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0019904;GO:0019901;GO:0007420;GO:0006633;GO:0006631;GO:0044539;GO:0001676;GO:0035338;GO:0035336;GO:0030182;GO:0042998;GO:2001247;GO:0051047;GO:0007584;GO:0014070;GO:0034379;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:lipid droplet; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:protein domain specific binding; F:protein kinase binding;, P:brain development; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty acid import into cell; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:long-chain fatty-acyl-CoA metabolic process; P:neuron differentiation; P:positive regulation of Golgi to plasma membrane protein transport; P:positive regulation of phosphatidylcholine biosynthetic process; P:positive regulation of secretion; P:response to nutrient; P:response to organic cyclic compound; P:very-low-density lipoprotein particle assembly; scaffold46 indexed_genome mRNA 4592619 4594013 . + . ID=transcript_8951;Q8WWG9 B7Z275 Q53SM4 Q96CC4,Potassium voltage-gated channel subfamily E member 4,MinK-related peptide 3;Minimum potassium ion channel-related peptide 3;Potassium channel subunit beta MiRP3;, PF02060;, GO:0016324;GO:0016021;GO:0044325;GO:0015459;GO:0005249;GO:0086011;GO:0098915;GO:1902260;GO:0097623;GO:0086091;GO:0060307;GO:0086005;, C:apical plasma membrane; C:integral component of membrane;, F:ion channel binding; F:potassium channel regulator activity; F:voltage-gated potassium channel activity;, P:membrane repolarization during action potential; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:negative regulation of delayed rectifier potassium channel activity; P:potassium ion export across plasma membrane; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:ventricular cardiac muscle cell action potential; scaffold46 indexed_genome mRNA 4926457 4929115 . - . ID=transcript_8952;P13521 B2R662 Q53T11 Q8TBH3,Secretogranin-2,Chromogranin-C;Secretogranin II;, PF01271;, GO:0005788;GO:0005615;GO:0098992;GO:0030141;GO:0042056;GO:0005125;GO:0001525;GO:0044267;GO:0043542;GO:0048245;GO:0050930;GO:0006954;GO:0035556;GO:0000165;GO:2000352;GO:0001937;GO:2001237;GO:0050918;GO:0001938;GO:0043687;GO:0009306;, C:endoplasmic reticulum lumen; C:extracellular space; C:neuronal dense core vesicle; C:secretory granule;, F:chemoattractant activity; F:cytokine activity;, P:angiogenesis; P:cellular protein metabolic process; P:endothelial cell migration; P:eosinophil chemotaxis; P:induction of positive chemotaxis; P:inflammatory response; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of endothelial cell proliferation; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive chemotaxis; P:positive regulation of endothelial cell proliferation; P:post-translational protein modification; P:protein secretion; scaffold46 indexed_genome mRNA 5048623 5059075 . - . ID=transcript_8953;Q96PC3 B4DQZ1 Q8WTY1 Q96DD1,AP-1 complex subunit sigma-3,Adaptor protein complex AP-1 subunit sigma-1C;Adaptor-related protein complex 1 subunit sigma-1C;Clathrin assembly protein complex 1 sigma-1C small chain;Golgi adaptor HA1/AP1 adaptin sigma-1C subunit;Sigma 1C subunit of AP-1 clathrin;Sigma-adaptin 1C;Sigma1C-adaptin;, PF01217;, GO:0005905;GO:0030659;GO:0005829;GO:0000139;GO:0043231;GO:0005765;GO:0030117;GO:0032588;GO:0019886;GO:0006892;GO:0006605;GO:0050690;GO:0016192;, C:clathrin-coated pit; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane coat; C:trans-Golgi network membrane;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:post-Golgi vesicle-mediated transport; P:protein targeting; P:regulation of defense response to virus by virus; P:vesicle-mediated transport; scaffold46 indexed_genome mRNA 5065046 5067096 . + . ID=transcript_8954;Q96PC3 B4DQZ1 Q8WTY1 Q96DD1,AP-1 complex subunit sigma-3,Adaptor protein complex AP-1 subunit sigma-1C;Adaptor-related protein complex 1 subunit sigma-1C;Clathrin assembly protein complex 1 sigma-1C small chain;Golgi adaptor HA1/AP1 adaptin sigma-1C subunit;Sigma 1C subunit of AP-1 clathrin;Sigma-adaptin 1C;Sigma1C-adaptin;, PF01217;, GO:0005905;GO:0030659;GO:0005829;GO:0000139;GO:0043231;GO:0005765;GO:0030117;GO:0032588;GO:0019886;GO:0006892;GO:0006605;GO:0050690;GO:0016192;, C:clathrin-coated pit; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane coat; C:trans-Golgi network membrane;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:post-Golgi vesicle-mediated transport; P:protein targeting; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q96PC3 B4DQZ1 Q8WTY1 Q96DD1,AP-1 complex subunit sigma-3,Adaptor protein complex AP-1 subunit sigma-1C;Adaptor-related protein complex 1 subunit sigma-1C;Clathrin assembly protein complex 1 sigma-1C small chain;Golgi adaptor HA1/AP1 adaptin sigma-1C subunit;Sigma 1C subunit of AP-1 clathrin;Sigma-adaptin 1C;Sigma1C-adaptin;, PF01217;, GO:0005905;GO:0030659;GO:0005829;GO:0000139;GO:0043231;GO:0005765;GO:0030117;GO:0032588;GO:0019886;GO:0006892;GO:0006605;GO:0050690;GO:0016192;, C:clathrin-coated pit; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane coat; C:trans-Golgi network membrane;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:post-Golgi vesicle-mediated transport; P:protein targeting; P:regulation of defense response to virus by virus; P:vesicle-mediated transport; scaffold46 indexed_genome mRNA 5154082 5206059 . - . ID=transcript_8955;Q8IWB7 Q53S17 Q9H9D5 Q9P2B3,WD repeat and FYVE domain-containing protein 1,FYVE domain-containing protein localized to endosomes 1 {ECO:0000303|PubMed:11739631};Phosphoinositide-binding protein 1;WD40- and FYVE domain-containing protein 1;Zinc finger FYVE domain-containing protein 17;, PF01363;PF00400;, GO:0005829;GO:0005769;GO:0005634;GO:0005545;GO:0008270;GO:0034141;GO:0034145;, C:cytosol; C:early endosome; C:nucleus;, F:1-phosphatidylinositol binding; F:zinc ion binding;, P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of toll-like receptor 4 signaling pathway;|Q8IWB7 Q53S17 Q9H9D5 Q9P2B3,WD repeat and FYVE domain-containing protein 1,FYVE domain-containing protein localized to endosomes 1 {ECO:0000303|PubMed:11739631};Phosphoinositide-binding protein 1;WD40- and FYVE domain-containing protein 1;Zinc finger FYVE domain-containing protein 17;, PF01363;PF00400;, GO:0005829;GO:0005769;GO:0005634;GO:0005545;GO:0008270;GO:0034141;GO:0034145;, C:cytosol; C:early endosome; C:nucleus;, F:1-phosphatidylinositol binding; F:zinc ion binding;, P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of toll-like receptor 4 signaling pathway;|Q8IWB7 Q53S17 Q9H9D5 Q9P2B3,WD repeat and FYVE domain-containing protein 1,FYVE domain-containing protein localized to endosomes 1 {ECO:0000303|PubMed:11739631};Phosphoinositide-binding protein 1;WD40- and FYVE domain-containing protein 1;Zinc finger FYVE domain-containing protein 17;, PF01363;PF00400;, GO:0005829;GO:0005769;GO:0005634;GO:0005545;GO:0008270;GO:0034141;GO:0034145;, C:cytosol; C:early endosome; C:nucleus;, F:1-phosphatidylinositol binding; F:zinc ion binding;, P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of toll-like receptor 4 signaling pathway;|Q8IWB7 Q53S17 Q9H9D5 Q9P2B3,WD repeat and FYVE domain-containing protein 1,FYVE domain-containing protein localized to endosomes 1 {ECO:0000303|PubMed:11739631};Phosphoinositide-binding protein 1;WD40- and FYVE domain-containing protein 1;Zinc finger FYVE domain-containing protein 17;, PF01363;PF00400;, GO:0005829;GO:0005769;GO:0005634;GO:0005545;GO:0008270;GO:0034141;GO:0034145;, C:cytosol; C:early endosome; C:nucleus;, F:1-phosphatidylinositol binding; F:zinc ion binding;, P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of toll-like receptor 4 signaling pathway; scaffold46 indexed_genome mRNA 5209949 5217828 . + . ID=transcript_8956;Q9H9J2 Q53S16 Q6IA62 Q9H821,39S ribosomal protein L44, mitochondrial,Mitochondrial large ribosomal subunit protein mL44 {ECO:0000303|PubMed:25278503};, , GO:0005743;GO:0005762;GO:0005739;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0003725;GO:0004525;GO:0003723;GO:0070125;GO:0070126;GO:0031054;GO:0031053;GO:0030422;GO:0006396;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:double-stranded RNA binding; F:ribonuclease III activity; F:RNA binding;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:pre-miRNA processing; P:primary miRNA processing; P:production of siRNA involved in RNA interference; P:RNA processing; scaffold46 indexed_genome mRNA 5227363 5255612 . - . ID=transcript_8957;P07093 B2R6A4 B4DIF2 Q53S15 Q5D0C4,Glia-derived nexin,Peptidase inhibitor 7;Protease nexin 1;Protease nexin I;Serpin E2;, PF00079;, GO:0062023;GO:0005829;GO:0005576;GO:0005615;GO:1903561;GO:0031232;GO:0031594;GO:0031091;GO:0005539;GO:0008201;GO:0004867;GO:0005102;GO:0007596;GO:0021683;GO:0050974;GO:0060384;GO:0060291;GO:0042628;GO:0030195;GO:0030308;GO:0008285;GO:0010951;GO:0014067;GO:0010757;GO:0090331;GO:0042177;GO:0010955;GO:0045861;GO:0045879;GO:0010766;GO:0048711;GO:0030334;GO:0051966;GO:0048505;GO:0032940;GO:0033363;GO:0061108;, C:collagen-containing extracellular matrix; C:cytosol; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:extrinsic component of external side of plasma membrane; C:neuromuscular junction; C:platelet alpha granule;, F:glycosaminoglycan binding; F:heparin binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding;, P:blood coagulation; P:cerebellar granular layer morphogenesis; P:detection of mechanical stimulus involved in sensory perception; P:innervation; P:long-term synaptic potentiation; P:mating plug formation; P:negative regulation of blood coagulation; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of endopeptidase activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of plasminogen activation; P:negative regulation of platelet aggregation; P:negative regulation of protein catabolic process; P:negative regulation of protein processing; P:negative regulation of proteolysis; P:negative regulation of smoothened signaling pathway; P:negative regulation of sodium ion transport; P:positive regulation of astrocyte differentiation; P:regulation of cell migration; P:regulation of synaptic transmission, glutamatergic; P:regulation of timing of cell differentiation; P:secretion by cell; P:secretory granule organization; P:seminal vesicle epithelium development;|P07093 B2R6A4 B4DIF2 Q53S15 Q5D0C4,Glia-derived nexin,Peptidase inhibitor 7;Protease nexin 1;Protease nexin I;Serpin E2;, PF00079;, GO:0062023;GO:0005829;GO:0005576;GO:0005615;GO:1903561;GO:0031232;GO:0031594;GO:0031091;GO:0005539;GO:0008201;GO:0004867;GO:0005102;GO:0007596;GO:0021683;GO:0050974;GO:0060384;GO:0060291;GO:0042628;GO:0030195;GO:0030308;GO:0008285;GO:0010951;GO:0014067;GO:0010757;GO:0090331;GO:0042177;GO:0010955;GO:0045861;GO:0045879;GO:0010766;GO:0048711;GO:0030334;GO:0051966;GO:0048505;GO:0032940;GO:0033363;GO:0061108;, C:collagen-containing extracellular matrix; C:cytosol; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:extrinsic component of external side of plasma membrane; C:neuromuscular junction; C:platelet alpha granule;, F:glycosaminoglycan binding; F:heparin binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding;, P:blood coagulation; P:cerebellar granular layer morphogenesis; P:detection of mechanical stimulus involved in sensory perception; P:innervation; P:long-term synaptic potentiation; P:mating plug formation; P:negative regulation of blood coagulation; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of endopeptidase activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of plasminogen activation; P:negative regulation of platelet aggregation; P:negative regulation of protein catabolic process; P:negative regulation of protein processing; P:negative regulation of proteolysis; P:negative regulation of smoothened signaling pathway; P:negative regulation of sodium ion transport; P:positive regulation of astrocyte differentiation; P:regulation of cell migration; P:regulation of synaptic transmission, glutamatergic; P:regulation of timing of cell differentiation; P:secretion by cell; P:secretory granule organization; P:seminal vesicle epithelium development; scaffold46 indexed_genome mRNA 5697071 5766973 . - . ID=transcript_8958;Q13618 A8K536 B8ZZC3 O75415 Q569L3 Q9UBI8 Q9UET7,Cullin-3,, PF00888;PF10557;, GO:0005813;GO:0031463;GO:0031461;GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0016020;GO:0072686;GO:0005654;GO:0005634;GO:0005886;GO:0005827;GO:0036126;GO:0000922;GO:0030332;GO:0005112;GO:0031208;GO:0061630;GO:0031625;GO:0031145;GO:0016477;GO:0030030;GO:0048208;GO:0040016;GO:0006888;GO:0044346;GO:0000082;GO:0007369;GO:0007229;GO:0097193;GO:0072576;GO:0000165;GO:0007080;GO:0090090;GO:0035024;GO:0000122;GO:0071630;GO:0008284;GO:0032467;GO:1901992;GO:0045842;GO:0031398;GO:0043687;GO:0043161;GO:0051865;GO:0031648;GO:0006513;GO:0000209;GO:0016567;GO:0017145;GO:0043149;GO:0001831;GO:0006511;GO:0016055;, C:centrosome; C:Cul3-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:polar microtubule; C:sperm flagellum; C:spindle pole;, F:cyclin binding; F:Notch binding; F:POZ domain binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell migration; P:cell projection organization; P:COPII vesicle coating; P:embryonic cleavage; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fibroblast apoptotic process; P:G1/S transition of mitotic cell cycle; P:gastrulation; P:integrin-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:liver morphogenesis; P:MAPK cascade; P:mitotic metaphase plate congression; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of Rho protein signal transduction; P:negative regulation of transcription by RNA polymerase II; P:nuclear protein quality control by the ubiquitin-proteasome system; P:positive regulation of cell population proliferation; P:positive regulation of cytokinesis; P:positive regulation of mitotic cell cycle phase transition; P:positive regulation of mitotic metaphase/anaphase transition; P:positive regulation of protein ubiquitination; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein destabilization; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:stem cell division; P:stress fiber assembly; P:trophectodermal cellular morphogenesis; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q13618 A8K536 B8ZZC3 O75415 Q569L3 Q9UBI8 Q9UET7,Cullin-3,, PF00888;PF10557;, GO:0005813;GO:0031463;GO:0031461;GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0016020;GO:0072686;GO:0005654;GO:0005634;GO:0005886;GO:0005827;GO:0036126;GO:0000922;GO:0030332;GO:0005112;GO:0031208;GO:0061630;GO:0031625;GO:0031145;GO:0016477;GO:0030030;GO:0048208;GO:0040016;GO:0006888;GO:0044346;GO:0000082;GO:0007369;GO:0007229;GO:0097193;GO:0072576;GO:0000165;GO:0007080;GO:0090090;GO:0035024;GO:0000122;GO:0071630;GO:0008284;GO:0032467;GO:1901992;GO:0045842;GO:0031398;GO:0043687;GO:0043161;GO:0051865;GO:0031648;GO:0006513;GO:0000209;GO:0016567;GO:0017145;GO:0043149;GO:0001831;GO:0006511;GO:0016055;, C:centrosome; C:Cul3-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:polar microtubule; C:sperm flagellum; C:spindle pole;, F:cyclin binding; F:Notch binding; F:POZ domain binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell migration; P:cell projection organization; P:COPII vesicle coating; P:embryonic cleavage; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fibroblast apoptotic process; P:G1/S transition of mitotic cell cycle; P:gastrulation; P:integrin-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:liver morphogenesis; P:MAPK cascade; P:mitotic metaphase plate congression; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of Rho protein signal transduction; P:negative regulation of transcription by RNA polymerase II; P:nuclear protein quality control by the ubiquitin-proteasome system; P:positive regulation of cell population proliferation; P:positive regulation of cytokinesis; P:positive regulation of mitotic cell cycle phase transition; P:positive regulation of mitotic metaphase/anaphase transition; P:positive regulation of protein ubiquitination; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein destabilization; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:stem cell division; P:stress fiber assembly; P:trophectodermal cellular morphogenesis; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway; scaffold46 indexed_genome mRNA 5947434 5955427 . - . ID=transcript_8959;Q96BY6 B3FL70 O75178 Q68DA4 Q9NW06 Q9NXI8,Dedicator of cytokinesis protein 10 {ECO:0000305},Zizimin-3;, PF06920;PF14429;PF11878;PF00169;, GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005085;GO:0001782;GO:0060997;GO:0002315;GO:0043547;GO:0030334;GO:0007264;, C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity;, P:B cell homeostasis; P:dendritic spine morphogenesis; P:marginal zone B cell differentiation; P:positive regulation of GTPase activity; P:regulation of cell migration; P:small GTPase mediated signal transduction; scaffold46 indexed_genome mRNA 5959950 6061903 . - . ID=transcript_8960;Q96BY6 B3FL70 O75178 Q68DA4 Q9NW06 Q9NXI8,Dedicator of cytokinesis protein 10 {ECO:0000305},Zizimin-3;, PF06920;PF14429;PF11878;PF00169;, GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005085;GO:0001782;GO:0060997;GO:0002315;GO:0043547;GO:0030334;GO:0007264;, C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity;, P:B cell homeostasis; P:dendritic spine morphogenesis; P:marginal zone B cell differentiation; P:positive regulation of GTPase activity; P:regulation of cell migration; P:small GTPase mediated signal transduction;|Q96BY6 B3FL70 O75178 Q68DA4 Q9NW06 Q9NXI8,Dedicator of cytokinesis protein 10 {ECO:0000305},Zizimin-3;, PF06920;PF14429;PF11878;PF00169;, GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005085;GO:0001782;GO:0060997;GO:0002315;GO:0043547;GO:0030334;GO:0007264;, C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity;, P:B cell homeostasis; P:dendritic spine morphogenesis; P:marginal zone B cell differentiation; P:positive regulation of GTPase activity; P:regulation of cell migration; P:small GTPase mediated signal transduction; scaffold46 indexed_genome mRNA 6061912 6175385 . - . ID=transcript_8961;Q96BY6 B3FL70 O75178 Q68DA4 Q9NW06 Q9NXI8,Dedicator of cytokinesis protein 10 {ECO:0000305},Zizimin-3;, PF06920;PF14429;PF11878;PF00169;, GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005085;GO:0001782;GO:0060997;GO:0002315;GO:0043547;GO:0030334;GO:0007264;, C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity;, P:B cell homeostasis; P:dendritic spine morphogenesis; P:marginal zone B cell differentiation; P:positive regulation of GTPase activity; P:regulation of cell migration; P:small GTPase mediated signal transduction; scaffold46 indexed_genome mRNA 6709514 6765708 . + . ID=transcript_8962;Q9P242 A2RRN4 Q96NL2,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2,, PF15452;PF15439;, GO:0048812;GO:0014065;, , , P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling; scaffold46 indexed_genome mRNA 7917088 7921778 . + . ID=transcript_8963;P46778 Q16699,60S ribosomal protein L21,Large ribosomal subunit protein eL21 {ECO:0000303|PubMed:24524803};, PF01157;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold46 indexed_genome mRNA 7946524 8077489 . + . ID=transcript_8964;Q8TEB9 Q495B9 Q53S43 Q5EBM8 Q6P5V8 Q8IV60 Q9H057,Rhomboid-related protein 4,Rhomboid domain-containing protein 1;Rhomboid-like protein 4;, PF01694;, GO:0005783;GO:0005789;GO:0044322;GO:0030176;GO:0031966;GO:0004175;GO:0004252;GO:0006915;GO:0034620;GO:0034644;GO:0036503;GO:0031293;GO:0033619;GO:1904211;GO:0043066;GO:0045732;GO:0010954;GO:0051047;GO:0043687;GO:0048515;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of endoplasmic reticulum membrane; C:mitochondrial membrane;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:apoptotic process; P:cellular response to unfolded protein; P:cellular response to UV; P:ERAD pathway; P:membrane protein intracellular domain proteolysis; P:membrane protein proteolysis; P:membrane protein proteolysis involved in retrograde protein transport, ER to cytosol; P:negative regulation of apoptotic process; P:positive regulation of protein catabolic process; P:positive regulation of protein processing; P:positive regulation of secretion; P:post-translational protein modification; P:spermatid differentiation; scaffold46 indexed_genome mRNA 8087243 8229452 . - . ID=transcript_8965;P53420 A8MTZ1 Q53RW9 Q53S42 Q53WR1,Collagen alpha-4(IV) chain,, PF01413;PF01391;, GO:0005604;GO:0005587;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030199;GO:0030198;GO:0032836;, C:basement membrane; C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:collagen fibril organization; P:extracellular matrix organization; P:glomerular basement membrane development;|P53420 A8MTZ1 Q53RW9 Q53S42 Q53WR1,Collagen alpha-4(IV) chain,, PF01413;PF01391;, GO:0005604;GO:0005587;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030199;GO:0030198;GO:0032836;, C:basement membrane; C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:collagen fibril organization; P:extracellular matrix organization; P:glomerular basement membrane development; scaffold46 indexed_genome mRNA 8229461 8391331 . + . ID=transcript_8966;Q9UDL1,Collagen alpha-3(IV) chain,Goodpasture antigen;, PF01413;PF01391;, GO:0005604;GO:0005587;GO:0062023;GO:0005783;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0043231;GO:0005201;GO:0030020;GO:0005178;GO:0008191;GO:0005198;GO:0006919;GO:0008015;GO:0007155;GO:0007166;GO:0030199;GO:0038063;GO:0072577;GO:0030198;GO:0032836;GO:0016525;GO:0008285;GO:1905563;GO:0009749;GO:0007605;, C:basement membrane; C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:integrin binding; F:metalloendopeptidase inhibitor activity; F:structural molecule activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:blood circulation; P:cell adhesion; P:cell surface receptor signaling pathway; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:endothelial cell apoptotic process; P:extracellular matrix organization; P:glomerular basement membrane development; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of vascular endothelial cell proliferation; P:response to glucose; P:sensory perception of sound; scaffold46 indexed_genome mRNA 8398209 8427032 . + . ID=transcript_8967;Q9GZY8 Q567U1 Q658R6 Q9BVZ1 Q9H690 Q9NRG8,Mitochondrial fission factor,, PF05644;, GO:0032592;GO:0031307;GO:0005741;GO:0005739;GO:0005777;GO:0032991;GO:0008021;GO:0042802;GO:0042803;GO:0000266;GO:0043653;GO:0008053;GO:0070584;GO:0016559;GO:0090141;GO:0090314;GO:0090200;GO:0006626;GO:0010821;GO:1900063;GO:0001836;, C:integral component of mitochondrial membrane; C:integral component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisome; C:protein-containing complex; C:synaptic vesicle;, F:identical protein binding; F:protein homodimerization activity;, P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:peroxisome fission; P:positive regulation of mitochondrial fission; P:positive regulation of protein targeting to membrane; P:positive regulation of release of cytochrome c from mitochondria; P:protein targeting to mitochondrion; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:release of cytochrome c from mitochondria;|Q9GZY8 Q567U1 Q658R6 Q9BVZ1 Q9H690 Q9NRG8,Mitochondrial fission factor,, PF05644;, GO:0032592;GO:0031307;GO:0005741;GO:0005739;GO:0005777;GO:0032991;GO:0008021;GO:0042802;GO:0042803;GO:0000266;GO:0043653;GO:0008053;GO:0070584;GO:0016559;GO:0090141;GO:0090314;GO:0090200;GO:0006626;GO:0010821;GO:1900063;GO:0001836;, C:integral component of mitochondrial membrane; C:integral component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisome; C:protein-containing complex; C:synaptic vesicle;, F:identical protein binding; F:protein homodimerization activity;, P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:peroxisome fission; P:positive regulation of mitochondrial fission; P:positive regulation of protein targeting to membrane; P:positive regulation of release of cytochrome c from mitochondria; P:protein targeting to mitochondrion; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:release of cytochrome c from mitochondria;|Q9GZY8 Q567U1 Q658R6 Q9BVZ1 Q9H690 Q9NRG8,Mitochondrial fission factor,, PF05644;, GO:0032592;GO:0031307;GO:0005741;GO:0005739;GO:0005777;GO:0032991;GO:0008021;GO:0042802;GO:0042803;GO:0000266;GO:0043653;GO:0008053;GO:0070584;GO:0016559;GO:0090141;GO:0090314;GO:0090200;GO:0006626;GO:0010821;GO:1900063;GO:0001836;, C:integral component of mitochondrial membrane; C:integral component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisome; C:protein-containing complex; C:synaptic vesicle;, F:identical protein binding; F:protein homodimerization activity;, P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:peroxisome fission; P:positive regulation of mitochondrial fission; P:positive regulation of protein targeting to membrane; P:positive regulation of release of cytochrome c from mitochondria; P:protein targeting to mitochondrion; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:release of cytochrome c from mitochondria;|Q9GZY8 Q567U1 Q658R6 Q9BVZ1 Q9H690 Q9NRG8,Mitochondrial fission factor,, PF05644;, GO:0032592;GO:0031307;GO:0005741;GO:0005739;GO:0005777;GO:0032991;GO:0008021;GO:0042802;GO:0042803;GO:0000266;GO:0043653;GO:0008053;GO:0070584;GO:0016559;GO:0090141;GO:0090314;GO:0090200;GO:0006626;GO:0010821;GO:1900063;GO:0001836;, C:integral component of mitochondrial membrane; C:integral component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisome; C:protein-containing complex; C:synaptic vesicle;, F:identical protein binding; F:protein homodimerization activity;, P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:peroxisome fission; P:positive regulation of mitochondrial fission; P:positive regulation of protein targeting to membrane; P:positive regulation of release of cytochrome c from mitochondria; P:protein targeting to mitochondrion; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:release of cytochrome c from mitochondria;|Q9GZY8 Q567U1 Q658R6 Q9BVZ1 Q9H690 Q9NRG8,Mitochondrial fission factor,, PF05644;, GO:0032592;GO:0031307;GO:0005741;GO:0005739;GO:0005777;GO:0032991;GO:0008021;GO:0042802;GO:0042803;GO:0000266;GO:0043653;GO:0008053;GO:0070584;GO:0016559;GO:0090141;GO:0090314;GO:0090200;GO:0006626;GO:0010821;GO:1900063;GO:0001836;, C:integral component of mitochondrial membrane; C:integral component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisome; C:protein-containing complex; C:synaptic vesicle;, F:identical protein binding; F:protein homodimerization activity;, P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:peroxisome fission; P:positive regulation of mitochondrial fission; P:positive regulation of protein targeting to membrane; P:positive regulation of release of cytochrome c from mitochondria; P:protein targeting to mitochondrion; P:regulation of mitochondrion organization; P:regulation of peroxisome organization; P:release of cytochrome c from mitochondria; scaffold46 indexed_genome mRNA 8428962 8441568 . - . ID=transcript_8968;Q53R12 B2RP42 Q5U609 Q6UWS1 Q9H5X9,Transmembrane 4 L6 family member 20,, PF05805;, GO:0005789;GO:0005925;GO:0016021;GO:0005886;GO:0045861;, C:endoplasmic reticulum membrane; C:focal adhesion; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of proteolysis;|Q53R12 B2RP42 Q5U609 Q6UWS1 Q9H5X9,Transmembrane 4 L6 family member 20,, PF05805;, GO:0005789;GO:0005925;GO:0016021;GO:0005886;GO:0045861;, C:endoplasmic reticulum membrane; C:focal adhesion; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of proteolysis; scaffold46 indexed_genome mRNA 8530156 8610013 . + . ID=transcript_8969;P52594 B3KUL1 E9PHX7 Q15277 Q4VAS0 Q4VAS1 Q4VAS3 Q53QT8 Q53R11,Arf-GAP domain and FG repeat-containing protein 1,HIV-1 Rev-binding protein;Nucleoporin-like protein RIP;Rev-interacting protein;Rev/Rex activation domain-binding protein;, PF01412;, GO:0031410;GO:0005829;GO:0043231;GO:0005643;GO:0003677;GO:0005096;GO:0046872;GO:0003723;GO:0030154;GO:0061024;GO:0006406;GO:0007275;GO:0007283;, C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear pore;, F:DNA binding; F:GTPase activator activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:membrane organization; P:mRNA export from nucleus; P:multicellular organism development; P:spermatogenesis;|P52594 B3KUL1 E9PHX7 Q15277 Q4VAS0 Q4VAS1 Q4VAS3 Q53QT8 Q53R11,Arf-GAP domain and FG repeat-containing protein 1,HIV-1 Rev-binding protein;Nucleoporin-like protein RIP;Rev-interacting protein;Rev/Rex activation domain-binding protein;, PF01412;, GO:0031410;GO:0005829;GO:0043231;GO:0005643;GO:0003677;GO:0005096;GO:0046872;GO:0003723;GO:0030154;GO:0061024;GO:0006406;GO:0007275;GO:0007283;, C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear pore;, F:DNA binding; F:GTPase activator activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:membrane organization; P:mRNA export from nucleus; P:multicellular organism development; P:spermatogenesis;|P52594 B3KUL1 E9PHX7 Q15277 Q4VAS0 Q4VAS1 Q4VAS3 Q53QT8 Q53R11,Arf-GAP domain and FG repeat-containing protein 1,HIV-1 Rev-binding protein;Nucleoporin-like protein RIP;Rev-interacting protein;Rev/Rex activation domain-binding protein;, PF01412;, GO:0031410;GO:0005829;GO:0043231;GO:0005643;GO:0003677;GO:0005096;GO:0046872;GO:0003723;GO:0030154;GO:0061024;GO:0006406;GO:0007275;GO:0007283;, C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear pore;, F:DNA binding; F:GTPase activator activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:membrane organization; P:mRNA export from nucleus; P:multicellular organism development; P:spermatogenesis;|P52594 B3KUL1 E9PHX7 Q15277 Q4VAS0 Q4VAS1 Q4VAS3 Q53QT8 Q53R11,Arf-GAP domain and FG repeat-containing protein 1,HIV-1 Rev-binding protein;Nucleoporin-like protein RIP;Rev-interacting protein;Rev/Rex activation domain-binding protein;, PF01412;, GO:0031410;GO:0005829;GO:0043231;GO:0005643;GO:0003677;GO:0005096;GO:0046872;GO:0003723;GO:0030154;GO:0061024;GO:0006406;GO:0007275;GO:0007283;, C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear pore;, F:DNA binding; F:GTPase activator activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:membrane organization; P:mRNA export from nucleus; P:multicellular organism development; P:spermatogenesis;|P52594 B3KUL1 E9PHX7 Q15277 Q4VAS0 Q4VAS1 Q4VAS3 Q53QT8 Q53R11,Arf-GAP domain and FG repeat-containing protein 1,HIV-1 Rev-binding protein;Nucleoporin-like protein RIP;Rev-interacting protein;Rev/Rex activation domain-binding protein;, PF01412;, GO:0031410;GO:0005829;GO:0043231;GO:0005643;GO:0003677;GO:0005096;GO:0046872;GO:0003723;GO:0030154;GO:0061024;GO:0006406;GO:0007275;GO:0007283;, C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear pore;, F:DNA binding; F:GTPase activator activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:membrane organization; P:mRNA export from nucleus; P:multicellular organism development; P:spermatogenesis;|P52594 B3KUL1 E9PHX7 Q15277 Q4VAS0 Q4VAS1 Q4VAS3 Q53QT8 Q53R11,Arf-GAP domain and FG repeat-containing protein 1,HIV-1 Rev-binding protein;Nucleoporin-like protein RIP;Rev-interacting protein;Rev/Rex activation domain-binding protein;, PF01412;, GO:0031410;GO:0005829;GO:0043231;GO:0005643;GO:0003677;GO:0005096;GO:0046872;GO:0003723;GO:0030154;GO:0061024;GO:0006406;GO:0007275;GO:0007283;, C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear pore;, F:DNA binding; F:GTPase activator activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:membrane organization; P:mRNA export from nucleus; P:multicellular organism development; P:spermatogenesis;|P52594 B3KUL1 E9PHX7 Q15277 Q4VAS0 Q4VAS1 Q4VAS3 Q53QT8 Q53R11,Arf-GAP domain and FG repeat-containing protein 1,HIV-1 Rev-binding protein;Nucleoporin-like protein RIP;Rev-interacting protein;Rev/Rex activation domain-binding protein;, PF01412;, GO:0031410;GO:0005829;GO:0043231;GO:0005643;GO:0003677;GO:0005096;GO:0046872;GO:0003723;GO:0030154;GO:0061024;GO:0006406;GO:0007275;GO:0007283;, C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear pore;, F:DNA binding; F:GTPase activator activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:membrane organization; P:mRNA export from nucleus; P:multicellular organism development; P:spermatogenesis;|P52594 B3KUL1 E9PHX7 Q15277 Q4VAS0 Q4VAS1 Q4VAS3 Q53QT8 Q53R11,Arf-GAP domain and FG repeat-containing protein 1,HIV-1 Rev-binding protein;Nucleoporin-like protein RIP;Rev-interacting protein;Rev/Rex activation domain-binding protein;, PF01412;, GO:0031410;GO:0005829;GO:0043231;GO:0005643;GO:0003677;GO:0005096;GO:0046872;GO:0003723;GO:0030154;GO:0061024;GO:0006406;GO:0007275;GO:0007283;, C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear pore;, F:DNA binding; F:GTPase activator activity; F:metal ion binding; F:RNA binding;, P:cell differentiation; P:membrane organization; P:mRNA export from nucleus; P:multicellular organism development; P:spermatogenesis; scaffold46 indexed_genome mRNA 8727690 8747125 . - . ID=transcript_8970;Q9BZV2,Thiamine transporter 2,Solute carrier family 19 member 3;, PF01770;, GO:0016021;GO:0005886;GO:0015234;GO:0071934;GO:0042723;GO:0055085;, C:integral component of membrane; C:plasma membrane;, F:thiamine transmembrane transporter activity;, P:thiamine transmembrane transport; P:thiamine-containing compound metabolic process; P:transmembrane transport; scaffold46 indexed_genome mRNA 8862867 8866018 . + . ID=transcript_8971;P78556 Q53S51 Q99664,C-C motif chemokine 20,Beta-chemokine exodus-1;CC chemokine LARC;Liver and activation-regulated chemokine;Macrophage inflammatory protein 3 alpha;Small-inducible cytokine A20;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0031731;GO:0008009;GO:0061844;GO:0035584;GO:0060326;GO:0007267;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0019221;GO:0042742;GO:0007186;GO:0006955;GO:0006954;GO:0031640;GO:0048247;GO:0002548;GO:0030593;GO:0070374;GO:0043547;GO:2000406;GO:0007165;GO:0072678;GO:0072679;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:CCR6 chemokine receptor binding; F:chemokine activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:calcium-mediated signaling using intracellular calcium source; P:cell chemotaxis; P:cell-cell signaling; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:killing of cells of other organism; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:neutrophil chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of T cell migration; P:signal transduction; P:T cell migration; P:thymocyte migration; scaffold46 indexed_genome mRNA 8907273 8942532 . + . ID=transcript_8972;Q8N136 Q6ZRY1 Q8N776,Dynein assembly factor with WDR repeat domains 1,Outer row dynein assembly protein 16 homolog;WD repeat-containing protein 69;, PF00400;, GO:0005929;GO:0005576;GO:0090660;GO:0007368;GO:0051649;GO:0007507;GO:0036158;, C:cilium; C:extracellular region;, , P:cerebrospinal fluid circulation; P:determination of left/right symmetry; P:establishment of localization in cell; P:heart development; P:outer dynein arm assembly; scaffold46 indexed_genome mRNA 8990640 9165571 . - . ID=transcript_8973;Q2M3C7 Q68DA3 Q68DR8 Q9C0I5,A-kinase anchor protein SPHKAP,SPHK1-interactor and AKAP domain-containing protein;Sphingosine kinase type 1-interacting protein;, PF05716;, GO:0005737;GO:0005739;GO:0051018;, C:cytoplasm; C:mitochondrion;, F:protein kinase A binding;|Q2M3C7 Q68DA3 Q68DR8 Q9C0I5,A-kinase anchor protein SPHKAP,SPHK1-interactor and AKAP domain-containing protein;Sphingosine kinase type 1-interacting protein;, PF05716;, GO:0005737;GO:0005739;GO:0051018;, C:cytoplasm; C:mitochondrion;, F:protein kinase A binding;|Q2M3C7 Q68DA3 Q68DR8 Q9C0I5,A-kinase anchor protein SPHKAP,SPHK1-interactor and AKAP domain-containing protein;Sphingosine kinase type 1-interacting protein;, PF05716;, GO:0005737;GO:0005739;GO:0051018;, C:cytoplasm; C:mitochondrion;, F:protein kinase A binding;|Q2M3C7 Q68DA3 Q68DR8 Q9C0I5,A-kinase anchor protein SPHKAP,SPHK1-interactor and AKAP domain-containing protein;Sphingosine kinase type 1-interacting protein;, PF05716;, GO:0005737;GO:0005739;GO:0051018;, C:cytoplasm; C:mitochondrion;, F:protein kinase A binding; scaffold46 indexed_genome mRNA 9808045 10053323 . - . ID=transcript_8974;Q7Z2X4 B3KU82 Q68CJ2 Q6ZUS3 Q8IXL0 Q9NWP6,PTB-containing, cubilin and LRP1-interacting protein,Phosphotyrosine interaction domain-containing protein 1;Protein NYGGF4;, PF14719;, GO:0005737;GO:0071345;GO:0071398;GO:0071354;GO:0044320;GO:0071356;GO:0006112;GO:0070584;GO:2001170;GO:0046325;GO:0046627;GO:1903077;GO:0001933;GO:2001171;GO:0070346;GO:0010628;GO:2000379;GO:0045944;GO:0010635;GO:0051881;GO:2000377;, C:cytoplasm;, , P:cellular response to cytokine stimulus; P:cellular response to fatty acid; P:cellular response to interleukin-6; P:cellular response to leptin stimulus; P:cellular response to tumor necrosis factor; P:energy reserve metabolic process; P:mitochondrion morphogenesis; P:negative regulation of ATP biosynthetic process; P:negative regulation of glucose import; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of protein localization to plasma membrane; P:negative regulation of protein phosphorylation; P:positive regulation of ATP biosynthetic process; P:positive regulation of fat cell proliferation; P:positive regulation of gene expression; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of mitochondrial fusion; P:regulation of mitochondrial membrane potential; P:regulation of reactive oxygen species metabolic process; scaffold46 indexed_genome mRNA 10147932 10522561 . - . ID=transcript_8975;Q8NFT8 A6NP39 Q53R88 Q53TP7 Q53TQ5 Q8IYT0 Q8TB42 Q9NTF1 Q9UDM2,Delta and Notch-like epidermal growth factor-related receptor,, PF00008;PF12661;, GO:0030425;GO:0005769;GO:0016021;GO:0043025;GO:0005886;GO:0005509;GO:0030276;GO:0005112;GO:0004888;GO:0007417;GO:0006897;GO:0010001;GO:0001764;GO:0007220;GO:0007219;GO:0048741;GO:0007416;, C:dendrite; C:early endosome; C:integral component of membrane; C:neuronal cell body; C:plasma membrane;, F:calcium ion binding; F:clathrin binding; F:Notch binding; F:transmembrane signaling receptor activity;, P:central nervous system development; P:endocytosis; P:glial cell differentiation; P:neuron migration; P:Notch receptor processing; P:Notch signaling pathway; P:skeletal muscle fiber development; P:synapse assembly; scaffold46 indexed_genome mRNA 10562489 10677268 . - . ID=transcript_8976;Q14669 D4HL82 Q14CA3 Q14CF1 Q15644 Q53R87 Q53TE7,E3 ubiquitin-protein ligase TRIP12,E3 ubiquitin-protein ligase for Arf;HECT-type E3 ubiquitin transferase TRIP12;Thyroid receptor-interacting protein 12;, PF00632;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0046966;GO:0061630;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0000209;GO:2000779;GO:0045995;GO:0006511;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:thyroid hormone receptor binding; F:ubiquitin protein ligase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:regulation of embryonic development; P:ubiquitin-dependent protein catabolic process;|Q14669 D4HL82 Q14CA3 Q14CF1 Q15644 Q53R87 Q53TE7,E3 ubiquitin-protein ligase TRIP12,E3 ubiquitin-protein ligase for Arf;HECT-type E3 ubiquitin transferase TRIP12;Thyroid receptor-interacting protein 12;, PF00632;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0046966;GO:0061630;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0000209;GO:2000779;GO:0045995;GO:0006511;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:thyroid hormone receptor binding; F:ubiquitin protein ligase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:regulation of embryonic development; P:ubiquitin-dependent protein catabolic process;|Q14669 D4HL82 Q14CA3 Q14CF1 Q15644 Q53R87 Q53TE7,E3 ubiquitin-protein ligase TRIP12,E3 ubiquitin-protein ligase for Arf;HECT-type E3 ubiquitin transferase TRIP12;Thyroid receptor-interacting protein 12;, PF00632;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0046966;GO:0061630;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0000209;GO:2000779;GO:0045995;GO:0006511;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:thyroid hormone receptor binding; F:ubiquitin protein ligase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:regulation of embryonic development; P:ubiquitin-dependent protein catabolic process;|Q14669 D4HL82 Q14CA3 Q14CF1 Q15644 Q53R87 Q53TE7,E3 ubiquitin-protein ligase TRIP12,E3 ubiquitin-protein ligase for Arf;HECT-type E3 ubiquitin transferase TRIP12;Thyroid receptor-interacting protein 12;, PF00632;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0046966;GO:0061630;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0000209;GO:2000779;GO:0045995;GO:0006511;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:thyroid hormone receptor binding; F:ubiquitin protein ligase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:regulation of embryonic development; P:ubiquitin-dependent protein catabolic process;|Q14669 D4HL82 Q14CA3 Q14CF1 Q15644 Q53R87 Q53TE7,E3 ubiquitin-protein ligase TRIP12,E3 ubiquitin-protein ligase for Arf;HECT-type E3 ubiquitin transferase TRIP12;Thyroid receptor-interacting protein 12;, PF00632;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0046966;GO:0061630;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0000209;GO:2000779;GO:0045995;GO:0006511;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:thyroid hormone receptor binding; F:ubiquitin protein ligase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of double-strand break repair; P:regulation of embryonic development; P:ubiquitin-dependent protein catabolic process; scaffold46 indexed_genome mRNA 10710983 10712172 . + . ID=transcript_8977;Q8NEA4 B3KVQ6 Q53TE6 Q8WWD4,F-box only protein 36,, PF00646; scaffold46 indexed_genome mRNA 10764512 10803384 . + . ID=transcript_8978;Q8NEA4 B3KVQ6 Q53TE6 Q8WWD4,F-box only protein 36,, PF00646; scaffold46 indexed_genome mRNA 10810086 10835227 . - . ID=transcript_8979;Q7RTX9 A8KA08 Q53R92 Q96NI7,Monocarboxylate transporter 14,Solute carrier family 16 member 14;, PF07690;, GO:0016021;GO:0005887;GO:0008028;GO:0015293;GO:0015718;, C:integral component of membrane; C:integral component of plasma membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport;|Q7RTX9 A8KA08 Q53R92 Q96NI7,Monocarboxylate transporter 14,Solute carrier family 16 member 14;, PF07690;, GO:0016021;GO:0005887;GO:0008028;GO:0015293;GO:0015718;, C:integral component of membrane; C:integral component of plasma membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport; scaffold46 indexed_genome mRNA 10914947 10919138 . - . ID=transcript_8980;Q9HB58 B4DVI4 F5H1M1 Q14976 Q14977 Q53TG2 Q8WUZ6 Q9HCT8,Sp110 nuclear body protein,Interferon-induced protein 41/75;Speckled 110 kDa;Transcriptional coactivator Sp110;, PF03172;PF01342;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0006357;GO:0016032;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of transcription by RNA polymerase II; P:viral process;|Q9HB58 B4DVI4 F5H1M1 Q14976 Q14977 Q53TG2 Q8WUZ6 Q9HCT8,Sp110 nuclear body protein,Interferon-induced protein 41/75;Speckled 110 kDa;Transcriptional coactivator Sp110;, PF03172;PF01342;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0006357;GO:0016032;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of transcription by RNA polymerase II; P:viral process;|Q9HB58 B4DVI4 F5H1M1 Q14976 Q14977 Q53TG2 Q8WUZ6 Q9HCT8,Sp110 nuclear body protein,Interferon-induced protein 41/75;Speckled 110 kDa;Transcriptional coactivator Sp110;, PF03172;PF01342;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0006357;GO:0016032;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of transcription by RNA polymerase II; P:viral process; scaffold46 indexed_genome mRNA 10924497 10953686 . + . ID=transcript_8981;Q96F70 Q96T24 Q96T95 Q9NP33 Q9UE32,Nuclear autoantigen Sp-100,Nuclear dot-associated Sp100 protein;Speckled 100 kDa;, PF00505;PF09011;PF03172;PF01342;, GO:0000781;GO:0005737;GO:0016604;GO:0034399;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0070087;GO:0003677;GO:0000981;GO:0042802;GO:0019900;GO:0046983;GO:0019904;GO:0042803;GO:0008134;GO:0006978;GO:0060333;GO:0045185;GO:0051271;GO:0043392;GO:0043433;GO:0010596;GO:0046826;GO:0000122;GO:0045892;GO:0032897;GO:0051091;GO:0045893;GO:0045765;GO:1902041;GO:1902044;GO:0006357;GO:0034097;GO:0034341;GO:0032526;GO:0034340;GO:0048384;GO:0000723;GO:0060337;GO:0016032;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear body; C:nuclear periphery; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:chromo shadow domain binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:kinase binding; F:protein dimerization activity; F:protein domain specific binding; F:protein homodimerization activity; F:transcription factor binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:interferon-gamma-mediated signaling pathway; P:maintenance of protein location; P:negative regulation of cellular component movement; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of endothelial cell migration; P:negative regulation of protein export from nucleus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription, DNA-templated; P:regulation of angiogenesis; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Fas signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to cytokine; P:response to interferon-gamma; P:response to retinoic acid; P:response to type I interferon; P:retinoic acid receptor signaling pathway; P:telomere maintenance; P:type I interferon signaling pathway; P:viral process;|Q9HB58 B4DVI4 F5H1M1 Q14976 Q14977 Q53TG2 Q8WUZ6 Q9HCT8,Sp110 nuclear body protein,Interferon-induced protein 41/75;Speckled 110 kDa;Transcriptional coactivator Sp110;, PF03172;PF01342;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0006357;GO:0016032;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of transcription by RNA polymerase II; P:viral process; scaffold46 indexed_genome mRNA 10957519 10980922 . + . ID=transcript_8982;Q6NSG4 Q92881 Q96TG3,Nuclear body protein SP140 {ECO:0000312|HGNC:HGNC:17133},Lymphoid-restricted homolog of Sp100 {ECO:0000303|PubMed:8695863};Nuclear autoantigen Sp-140 {ECO:0000303|PubMed:8910577};Speckled 140 kDa {ECO:0000303|PubMed:8910577};, PF00439;PF03172;PF01342;, GO:0001650;GO:0005739;GO:0005634;GO:0016605;GO:0003677;GO:0000981;GO:0046872;GO:0006952;GO:0006357;, C:fibrillar center; C:mitochondrion; C:nucleus; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:defense response; P:regulation of transcription by RNA polymerase II; scaffold46 indexed_genome mRNA 10980923 11048382 . + . ID=transcript_8983;Q6NSG4 Q92881 Q96TG3,Nuclear body protein SP140 {ECO:0000312|HGNC:HGNC:17133},Lymphoid-restricted homolog of Sp100 {ECO:0000303|PubMed:8695863};Nuclear autoantigen Sp-140 {ECO:0000303|PubMed:8910577};Speckled 140 kDa {ECO:0000303|PubMed:8910577};, PF00439;PF03172;PF01342;, GO:0001650;GO:0005739;GO:0005634;GO:0016605;GO:0003677;GO:0000981;GO:0046872;GO:0006952;GO:0006357;, C:fibrillar center; C:mitochondrion; C:nucleus; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:defense response; P:regulation of transcription by RNA polymerase II;|Q6NSG4 Q92881 Q96TG3,Nuclear body protein SP140 {ECO:0000312|HGNC:HGNC:17133},Lymphoid-restricted homolog of Sp100 {ECO:0000303|PubMed:8695863};Nuclear autoantigen Sp-140 {ECO:0000303|PubMed:8910577};Speckled 140 kDa {ECO:0000303|PubMed:8910577};, PF00439;PF03172;PF01342;, GO:0001650;GO:0005739;GO:0005634;GO:0016605;GO:0003677;GO:0000981;GO:0046872;GO:0006952;GO:0006357;, C:fibrillar center; C:mitochondrion; C:nucleus; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:defense response; P:regulation of transcription by RNA polymerase II;|Q6NSG4 Q92881 Q96TG3,Nuclear body protein SP140 {ECO:0000312|HGNC:HGNC:17133},Lymphoid-restricted homolog of Sp100 {ECO:0000303|PubMed:8695863};Nuclear autoantigen Sp-140 {ECO:0000303|PubMed:8910577};Speckled 140 kDa {ECO:0000303|PubMed:8910577};, PF00439;PF03172;PF01342;, GO:0001650;GO:0005739;GO:0005634;GO:0016605;GO:0003677;GO:0000981;GO:0046872;GO:0006952;GO:0006357;, C:fibrillar center; C:mitochondrion; C:nucleus; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:defense response; P:regulation of transcription by RNA polymerase II; scaffold46 indexed_genome mRNA 11137284 11199211 . - . ID=transcript_8984;Q96F70 Q96T24 Q96T95 Q9NP33 Q9UE32,Nuclear autoantigen Sp-100,Nuclear dot-associated Sp100 protein;Speckled 100 kDa;, PF00505;PF09011;PF03172;PF01342;, GO:0000781;GO:0005737;GO:0016604;GO:0034399;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0070087;GO:0003677;GO:0000981;GO:0042802;GO:0019900;GO:0046983;GO:0019904;GO:0042803;GO:0008134;GO:0006978;GO:0060333;GO:0045185;GO:0051271;GO:0043392;GO:0043433;GO:0010596;GO:0046826;GO:0000122;GO:0045892;GO:0032897;GO:0051091;GO:0045893;GO:0045765;GO:1902041;GO:1902044;GO:0006357;GO:0034097;GO:0034341;GO:0032526;GO:0034340;GO:0048384;GO:0000723;GO:0060337;GO:0016032;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear body; C:nuclear periphery; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:chromo shadow domain binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:kinase binding; F:protein dimerization activity; F:protein domain specific binding; F:protein homodimerization activity; F:transcription factor binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:interferon-gamma-mediated signaling pathway; P:maintenance of protein location; P:negative regulation of cellular component movement; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of endothelial cell migration; P:negative regulation of protein export from nucleus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription, DNA-templated; P:regulation of angiogenesis; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Fas signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to cytokine; P:response to interferon-gamma; P:response to retinoic acid; P:response to type I interferon; P:retinoic acid receptor signaling pathway; P:telomere maintenance; P:type I interferon signaling pathway; P:viral process;|Q96F70 Q96T24 Q96T95 Q9NP33 Q9UE32,Nuclear autoantigen Sp-100,Nuclear dot-associated Sp100 protein;Speckled 100 kDa;, PF00505;PF09011;PF03172;PF01342;, GO:0000781;GO:0005737;GO:0016604;GO:0034399;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0070087;GO:0003677;GO:0000981;GO:0042802;GO:0019900;GO:0046983;GO:0019904;GO:0042803;GO:0008134;GO:0006978;GO:0060333;GO:0045185;GO:0051271;GO:0043392;GO:0043433;GO:0010596;GO:0046826;GO:0000122;GO:0045892;GO:0032897;GO:0051091;GO:0045893;GO:0045765;GO:1902041;GO:1902044;GO:0006357;GO:0034097;GO:0034341;GO:0032526;GO:0034340;GO:0048384;GO:0000723;GO:0060337;GO:0016032;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear body; C:nuclear periphery; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:chromo shadow domain binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:kinase binding; F:protein dimerization activity; F:protein domain specific binding; F:protein homodimerization activity; F:transcription factor binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:interferon-gamma-mediated signaling pathway; P:maintenance of protein location; P:negative regulation of cellular component movement; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of endothelial cell migration; P:negative regulation of protein export from nucleus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription, DNA-templated; P:regulation of angiogenesis; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of Fas signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to cytokine; P:response to interferon-gamma; P:response to retinoic acid; P:response to type I interferon; P:retinoic acid receptor signaling pathway; P:telomere maintenance; P:type I interferon signaling pathway; P:viral process;|Q9H930 Q2M375 Q4ZG65 Q9BSP3,Nuclear body protein SP140-like protein,, PF00439;PF03172;PF00628;PF01342;, GO:0016604;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0006357;, C:nuclear body; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of transcription by RNA polymerase II; scaffold46 indexed_genome mRNA 11339798 11368733 . + . ID=transcript_8985;Q9Y376 A8K8L7,Calcium-binding protein 39,MO25alpha;Protein Mo25;, PF08569;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0034774;GO:1902554;GO:0030018;GO:0019900;GO:0030295;GO:0043539;GO:0007050;GO:0071476;GO:0035556;GO:1901380;GO:1901017;GO:0043312;GO:0018105;GO:0010800;GO:0071902;GO:0014823;GO:0097066;GO:0007165;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:secretory granule lumen; C:serine/threonine protein kinase complex; C:Z disc;, F:kinase binding; F:protein kinase activator activity; F:protein serine/threonine kinase activator activity;, P:cell cycle arrest; P:cellular hypotonic response; P:intracellular signal transduction; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:response to activity; P:response to thyroid hormone; P:signal transduction;|Q9Y376 A8K8L7,Calcium-binding protein 39,MO25alpha;Protein Mo25;, PF08569;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0034774;GO:1902554;GO:0030018;GO:0019900;GO:0030295;GO:0043539;GO:0007050;GO:0071476;GO:0035556;GO:1901380;GO:1901017;GO:0043312;GO:0018105;GO:0010800;GO:0071902;GO:0014823;GO:0097066;GO:0007165;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:secretory granule lumen; C:serine/threonine protein kinase complex; C:Z disc;, F:kinase binding; F:protein kinase activator activity; F:protein serine/threonine kinase activator activity;, P:cell cycle arrest; P:cellular hypotonic response; P:intracellular signal transduction; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:neutrophil degranulation; P:peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:response to activity; P:response to thyroid hormone; P:signal transduction; scaffold46 indexed_genome mRNA 11584834 11590209 . + . ID=transcript_8986;A6NCS6,Uncharacterized protein C2orf72,, PF15443;|A6NCS6,Uncharacterized protein C2orf72,, PF15443; scaffold46 indexed_genome mRNA 11598835 11685620 . + . ID=transcript_8987;Q8IV79,26S proteasome non-ATPase regulatory subunit 1,26S proteasome regulatory subunit RPN2;26S proteasome regulatory subunit S1;26S proteasome subunit p112;, PF01851;PF18004;, GO:0035578;GO:0005829;GO:0005576;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008540;GO:0034515;GO:0030234;GO:0031625;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, base subcomplex; C:proteasome storage granule;, F:enzyme regulator activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P41595 B2R9D5 Q53TI1 Q62221 Q6P523,5-hydroxytryptamine receptor 2B,Serotonin receptor 2B;, PF00001;, GO:0005737;GO:0030425;GO:0098666;GO:0005887;GO:0005654;GO:0005886;GO:0045202;GO:0004993;GO:0001965;GO:0001587;GO:0005096;GO:0030594;GO:0051378;GO:0007202;GO:0007610;GO:0019722;GO:0003300;GO:0006874;GO:0071502;GO:0019934;GO:0007268;GO:0048598;GO:0070371;GO:0002031;GO:0007186;GO:0007187;GO:0098664;GO:0003007;GO:0014827;GO:0043066;GO:0010507;GO:0060548;GO:0014033;GO:0001755;GO:0014065;GO:0007200;GO:0007208;GO:0016310;GO:0051781;GO:0008284;GO:0001819;GO:0001938;GO:0070374;GO:0043123;GO:0043406;GO:0051000;GO:0010513;GO:0070528;GO:0007205;GO:0050795;GO:0051209;GO:0042493;GO:0042310;, C:cytoplasm; C:dendrite; C:G protein-coupled serotonin receptor complex; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:synapse;, F:G protein-coupled serotonin receptor activity; F:G-protein alpha-subunit binding; F:Gq/11-coupled serotonin receptor activity; F:GTPase activator activity; F:neurotransmitter receptor activity; F:serotonin binding;, P:activation of phospholipase C activity; P:behavior; P:calcium-mediated signaling; P:cardiac muscle hypertrophy; P:cellular calcium ion homeostasis; P:cellular response to temperature stimulus; P:cGMP-mediated signaling; P:chemical synaptic transmission; P:embryonic morphogenesis; P:ERK1 and ERK2 cascade; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:G protein-coupled serotonin receptor signaling pathway; P:heart morphogenesis; P:intestine smooth muscle contraction; P:negative regulation of apoptotic process; P:negative regulation of autophagy; P:negative regulation of cell death; P:neural crest cell differentiation; P:neural crest cell migration; P:phosphatidylinositol 3-kinase signaling; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:phospholipase C-activating serotonin receptor signaling pathway; P:phosphorylation; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of cytokine production; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of phosphatidylinositol biosynthetic process; P:protein kinase C signaling; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of behavior; P:release of sequestered calcium ion into cytosol; P:response to drug; P:vasoconstriction;|Q8IV79,26S proteasome non-ATPase regulatory subunit 1,26S proteasome regulatory subunit RPN2;26S proteasome regulatory subunit S1;26S proteasome subunit p112;, PF01851;PF18004;, GO:0035578;GO:0005829;GO:0005576;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008540;GO:0034515;GO:0030234;GO:0031625;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, base subcomplex; C:proteasome storage granule;, F:enzyme regulator activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q8IV79,26S proteasome non-ATPase regulatory subunit 1,26S proteasome regulatory subunit RPN2;26S proteasome regulatory subunit S1;26S proteasome subunit p112;, PF01851;PF18004;, GO:0035578;GO:0005829;GO:0005576;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008540;GO:0034515;GO:0030234;GO:0031625;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:azurophil granule lumen; C:cytosol; C:extracellular region; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, base subcomplex; C:proteasome storage granule;, F:enzyme regulator activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold46 indexed_genome mRNA 11700898 11869633 . + . ID=transcript_8988;Q7Z3E5 A0A087X1I8 Q53TI3 Q6P162 Q7L594 Q86WG2 Q96JF9 Q9H9R8,LisH domain-containing protein ARMC9,Armadillo repeat-containing protein 9;Melanoma/melanocyte-specific tumor antigen KU-MEL-1;NS21;, , GO:0005814;GO:0036064;GO:0097542;GO:0005737;GO:0070062;GO:0060271;GO:0045880;, C:centriole; C:ciliary basal body; C:ciliary tip; C:cytoplasm; C:extracellular exosome;, , P:cilium assembly; P:positive regulation of smoothened signaling pathway; scaffold46 indexed_genome mRNA 11901582 11910426 . + . ID=transcript_8989;Q8NFL0 B3KWY4 B7WNP0,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7,, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0008532;GO:0018146;GO:0016266;GO:0030311;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity;, P:keratan sulfate biosynthetic process; P:O-glycan processing; P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation; scaffold46 indexed_genome mRNA 11910472 11911874 . - . ID=transcript_8990;Q8NFL0 B3KWY4 B7WNP0,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7,, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0008532;GO:0018146;GO:0016266;GO:0030311;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity;, P:keratan sulfate biosynthetic process; P:O-glycan processing; P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation; scaffold46 indexed_genome mRNA 11955292 11970791 . - . ID=transcript_8991;P19338 Q53SK1 Q8NB06 Q9UCF0 Q9UDG1,Nucleolin,Protein C23;, PF00076;, GO:0005938;GO:0005694;GO:0036464;GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005681;GO:0044547;GO:0042802;GO:0048027;GO:0008022;GO:0003723;GO:0042162;GO:0001525;GO:0017148;GO:0048026;GO:1901838;, C:cell cortex; C:chromosome; C:cytoplasmic ribonucleoprotein granule; C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal complex;, F:DNA topoisomerase binding; F:identical protein binding; F:mRNA 5'-UTR binding; F:protein C-terminus binding; F:RNA binding; F:telomeric DNA binding;, P:angiogenesis; P:negative regulation of translation; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;|P19338 Q53SK1 Q8NB06 Q9UCF0 Q9UDG1,Nucleolin,Protein C23;, PF00076;, GO:0005938;GO:0005694;GO:0036464;GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005681;GO:0044547;GO:0042802;GO:0048027;GO:0008022;GO:0003723;GO:0042162;GO:0001525;GO:0017148;GO:0048026;GO:1901838;, C:cell cortex; C:chromosome; C:cytoplasmic ribonucleoprotein granule; C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal complex;, F:DNA topoisomerase binding; F:identical protein binding; F:mRNA 5'-UTR binding; F:protein C-terminus binding; F:RNA binding; F:telomeric DNA binding;, P:angiogenesis; P:negative regulation of translation; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; scaffold46 indexed_genome mRNA 12132836 12133726 . + . ID=transcript_8992;O43924 O43250,Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta,Protein p17;, PF05351;, GO:0005929;GO:0005737;GO:0031410;GO:0030659;GO:0005856;GO:0005829;GO:0005095;GO:0031267;GO:0060271;GO:0000165;GO:0007601;, C:cilium; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol;, F:GTPase inhibitor activity; F:small GTPase binding;, P:cilium assembly; P:MAPK cascade; P:visual perception; scaffold46 indexed_genome mRNA 12134565 12186641 . - . ID=transcript_8993;O43924 O43250,Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta,Protein p17;, PF05351;, GO:0005929;GO:0005737;GO:0031410;GO:0030659;GO:0005856;GO:0005829;GO:0005095;GO:0031267;GO:0060271;GO:0000165;GO:0007601;, C:cilium; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol;, F:GTPase inhibitor activity; F:small GTPase binding;, P:cilium assembly; P:MAPK cascade; P:visual perception;|O43924 O43250,Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta,Protein p17;, PF05351;, GO:0005929;GO:0005737;GO:0031410;GO:0030659;GO:0005856;GO:0005829;GO:0005095;GO:0031267;GO:0060271;GO:0000165;GO:0007601;, C:cilium; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol;, F:GTPase inhibitor activity; F:small GTPase binding;, P:cilium assembly; P:MAPK cascade; P:visual perception; scaffold46 indexed_genome mRNA 12187042 12211628 . + . ID=transcript_8994;Q9H9Q2 Q53S22 Q5BJG3 Q9H7V6,COP9 signalosome complex subunit 7b,JAB1-containing signalosome subunit 7b;, PF18392;PF01399;, GO:0008180;GO:0005829;GO:0005654;GO:0010387;GO:0000715;GO:0043687;GO:0000338;GO:0006283;GO:0016032;, C:COP9 signalosome; C:cytosol; C:nucleoplasm;, , P:COP9 signalosome assembly; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q9H9Q2 Q53S22 Q5BJG3 Q9H7V6,COP9 signalosome complex subunit 7b,JAB1-containing signalosome subunit 7b;, PF18392;PF01399;, GO:0008180;GO:0005829;GO:0005654;GO:0010387;GO:0000715;GO:0043687;GO:0000338;GO:0006283;GO:0016032;, C:COP9 signalosome; C:cytosol; C:nucleoplasm;, , P:COP9 signalosome assembly; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q9H9Q2 Q53S22 Q5BJG3 Q9H7V6,COP9 signalosome complex subunit 7b,JAB1-containing signalosome subunit 7b;, PF18392;PF01399;, GO:0008180;GO:0005829;GO:0005654;GO:0010387;GO:0000715;GO:0043687;GO:0000338;GO:0006283;GO:0016032;, C:COP9 signalosome; C:cytosol; C:nucleoplasm;, , P:COP9 signalosome assembly; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q9H9Q2 Q53S22 Q5BJG3 Q9H7V6,COP9 signalosome complex subunit 7b,JAB1-containing signalosome subunit 7b;, PF18392;PF01399;, GO:0008180;GO:0005829;GO:0005654;GO:0010387;GO:0000715;GO:0043687;GO:0000338;GO:0006283;GO:0016032;, C:COP9 signalosome; C:cytosol; C:nucleoplasm;, , P:COP9 signalosome assembly; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair; P:viral process; scaffold46 indexed_genome mRNA 12271329 12275435 . - . ID=transcript_8995;P23582 Q4ZG41,C-type natriuretic peptide,, PF00212;, GO:0005576;GO:0005615;GO:0032991;GO:0030141;GO:0005179;GO:0051427;GO:0005102;GO:0006182;GO:0019934;GO:0003418;GO:0003419;GO:0008285;GO:0032966;GO:2000279;GO:0051447;GO:1900194;GO:0001503;GO:0010753;GO:0045669;GO:0009791;GO:0006457;GO:0007168;GO:1903779;GO:0040014;GO:0048660;GO:0022414;GO:0042493;GO:0045471;GO:0001666;, C:extracellular region; C:extracellular space; C:protein-containing complex; C:secretory granule;, F:hormone activity; F:hormone receptor binding; F:signaling receptor binding;, P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:growth plate cartilage chondrocyte differentiation; P:growth plate cartilage chondrocyte proliferation; P:negative regulation of cell population proliferation; P:negative regulation of collagen biosynthetic process; P:negative regulation of DNA biosynthetic process; P:negative regulation of meiotic cell cycle; P:negative regulation of oocyte maturation; P:ossification; P:positive regulation of cGMP-mediated signaling; P:positive regulation of osteoblast differentiation; P:post-embryonic development; P:protein folding; P:receptor guanylyl cyclase signaling pathway; P:regulation of cardiac conduction; P:regulation of multicellular organism growth; P:regulation of smooth muscle cell proliferation; P:reproductive process; P:response to drug; P:response to ethanol; P:response to hypoxia; scaffold46 indexed_genome mRNA 12370185 12675799 . + . ID=transcript_8996;Q8IYB7 Q53S79 Q580W6 Q5XKH0 Q69YG5 Q6AW99 Q7Z4T6 Q8N9K9,DIS3-like exonuclease 2 {ECO:0000255|HAMAP-Rule:MF_03045},, PF17877;PF17849;PF00773;PF17216;, GO:0005737;GO:0000178;GO:0000932;GO:0005844;GO:0000175;GO:0000287;GO:0008266;GO:0004540;GO:0051301;GO:0010587;GO:0000278;GO:0051306;GO:0006402;GO:0008285;GO:0000291;GO:0034427;GO:1990074;GO:0019827;, C:cytoplasm; C:exosome (RNase complex); C:P-body; C:polysome;, F:3'-5'-exoribonuclease activity; F:magnesium ion binding; F:poly(U) RNA binding; F:ribonuclease activity;, P:cell division; P:miRNA catabolic process; P:mitotic cell cycle; P:mitotic sister chromatid separation; P:mRNA catabolic process; P:negative regulation of cell population proliferation; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyuridylation-dependent mRNA catabolic process; P:stem cell population maintenance;|Q8IYB7 Q53S79 Q580W6 Q5XKH0 Q69YG5 Q6AW99 Q7Z4T6 Q8N9K9,DIS3-like exonuclease 2 {ECO:0000255|HAMAP-Rule:MF_03045},, PF17877;PF17849;PF00773;PF17216;, GO:0005737;GO:0000178;GO:0000932;GO:0005844;GO:0000175;GO:0000287;GO:0008266;GO:0004540;GO:0051301;GO:0010587;GO:0000278;GO:0051306;GO:0006402;GO:0008285;GO:0000291;GO:0034427;GO:1990074;GO:0019827;, C:cytoplasm; C:exosome (RNase complex); C:P-body; C:polysome;, F:3'-5'-exoribonuclease activity; F:magnesium ion binding; F:poly(U) RNA binding; F:ribonuclease activity;, P:cell division; P:miRNA catabolic process; P:mitotic cell cycle; P:mitotic sister chromatid separation; P:mRNA catabolic process; P:negative regulation of cell population proliferation; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyuridylation-dependent mRNA catabolic process; P:stem cell population maintenance;|Q8IYB7 Q53S79 Q580W6 Q5XKH0 Q69YG5 Q6AW99 Q7Z4T6 Q8N9K9,DIS3-like exonuclease 2 {ECO:0000255|HAMAP-Rule:MF_03045},, PF17877;PF17849;PF00773;PF17216;, GO:0005737;GO:0000178;GO:0000932;GO:0005844;GO:0000175;GO:0000287;GO:0008266;GO:0004540;GO:0051301;GO:0010587;GO:0000278;GO:0051306;GO:0006402;GO:0008285;GO:0000291;GO:0034427;GO:1990074;GO:0019827;, C:cytoplasm; C:exosome (RNase complex); C:P-body; C:polysome;, F:3'-5'-exoribonuclease activity; F:magnesium ion binding; F:poly(U) RNA binding; F:ribonuclease activity;, P:cell division; P:miRNA catabolic process; P:mitotic cell cycle; P:mitotic sister chromatid separation; P:mRNA catabolic process; P:negative regulation of cell population proliferation; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyuridylation-dependent mRNA catabolic process; P:stem cell population maintenance;|Q8IYB7 Q53S79 Q580W6 Q5XKH0 Q69YG5 Q6AW99 Q7Z4T6 Q8N9K9,DIS3-like exonuclease 2 {ECO:0000255|HAMAP-Rule:MF_03045},, PF17877;PF17849;PF00773;PF17216;, GO:0005737;GO:0000178;GO:0000932;GO:0005844;GO:0000175;GO:0000287;GO:0008266;GO:0004540;GO:0051301;GO:0010587;GO:0000278;GO:0051306;GO:0006402;GO:0008285;GO:0000291;GO:0034427;GO:1990074;GO:0019827;, C:cytoplasm; C:exosome (RNase complex); C:P-body; C:polysome;, F:3'-5'-exoribonuclease activity; F:magnesium ion binding; F:poly(U) RNA binding; F:ribonuclease activity;, P:cell division; P:miRNA catabolic process; P:mitotic cell cycle; P:mitotic sister chromatid separation; P:mRNA catabolic process; P:negative regulation of cell population proliferation; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyuridylation-dependent mRNA catabolic process; P:stem cell population maintenance;|Q8IYB7 Q53S79 Q580W6 Q5XKH0 Q69YG5 Q6AW99 Q7Z4T6 Q8N9K9,DIS3-like exonuclease 2 {ECO:0000255|HAMAP-Rule:MF_03045},, PF17877;PF17849;PF00773;PF17216;, GO:0005737;GO:0000178;GO:0000932;GO:0005844;GO:0000175;GO:0000287;GO:0008266;GO:0004540;GO:0051301;GO:0010587;GO:0000278;GO:0051306;GO:0006402;GO:0008285;GO:0000291;GO:0034427;GO:1990074;GO:0019827;, C:cytoplasm; C:exosome (RNase complex); C:P-body; C:polysome;, F:3'-5'-exoribonuclease activity; F:magnesium ion binding; F:poly(U) RNA binding; F:ribonuclease activity;, P:cell division; P:miRNA catabolic process; P:mitotic cell cycle; P:mitotic sister chromatid separation; P:mRNA catabolic process; P:negative regulation of cell population proliferation; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyuridylation-dependent mRNA catabolic process; P:stem cell population maintenance; scaffold46 indexed_genome mRNA 12793240 12795831 . - . ID=transcript_8997;O95672 Q45UD9 Q53RF9 Q6UW86 Q86TH4 Q9NY95,Endothelin-converting enzyme-like 1,Xce protein;, PF01431;PF05649;, GO:0005887;GO:0005886;GO:0046872;GO:0004222;GO:0008237;GO:0007218;GO:0016485;GO:0003016;, C:integral component of plasma membrane; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:neuropeptide signaling pathway; P:protein processing; P:respiratory system process; scaffold46 indexed_genome mRNA 12796093 12798964 . - . ID=transcript_8998;O95672 Q45UD9 Q53RF9 Q6UW86 Q86TH4 Q9NY95,Endothelin-converting enzyme-like 1,Xce protein;, PF01431;PF05649;, GO:0005887;GO:0005886;GO:0046872;GO:0004222;GO:0008237;GO:0007218;GO:0016485;GO:0003016;, C:integral component of plasma membrane; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:neuropeptide signaling pathway; P:protein processing; P:respiratory system process; scaffold46 indexed_genome mRNA 12833734 12837050 . + . ID=transcript_8999;P0CW18,Serine protease 56,, PF00089;, GO:0005783;GO:0005615;GO:0004252;GO:0007596;GO:0043010;GO:0002690;GO:0006508;, C:endoplasmic reticulum; C:extracellular space;, F:serine-type endopeptidase activity;, P:blood coagulation; P:camera-type eye development; P:positive regulation of leukocyte chemotaxis; P:proteolysis; scaffold46 indexed_genome mRNA 12837287 12840751 . + . ID=transcript_9000;Q07001 A8K661 B4DT92 Q52LH4,Acetylcholine receptor subunit delta,, PF02931;PF02932;, GO:0005892;GO:0005829;GO:0005887;GO:0099060;GO:0031594;GO:0043005;GO:0005654;GO:0005886;GO:0045211;GO:0045202;GO:0042166;GO:0022848;GO:0030594;GO:0004888;GO:1904315;GO:0007268;GO:0034220;GO:0006936;GO:0050881;GO:0050877;GO:0050905;GO:0042391;GO:0007165;GO:0003009;GO:0048630;, C:acetylcholine-gated channel complex; C:cytosol; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuromuscular junction; C:neuron projection; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine binding; F:acetylcholine-gated cation-selective channel activity; F:neurotransmitter receptor activity; F:transmembrane signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:ion transmembrane transport; P:muscle contraction; P:musculoskeletal movement; P:nervous system process; P:neuromuscular process; P:regulation of membrane potential; P:signal transduction; P:skeletal muscle contraction; P:skeletal muscle tissue growth;|Q07001 A8K661 B4DT92 Q52LH4,Acetylcholine receptor subunit delta,, PF02931;PF02932;, GO:0005892;GO:0005829;GO:0005887;GO:0099060;GO:0031594;GO:0043005;GO:0005654;GO:0005886;GO:0045211;GO:0045202;GO:0042166;GO:0022848;GO:0030594;GO:0004888;GO:1904315;GO:0007268;GO:0034220;GO:0006936;GO:0050881;GO:0050877;GO:0050905;GO:0042391;GO:0007165;GO:0003009;GO:0048630;, C:acetylcholine-gated channel complex; C:cytosol; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuromuscular junction; C:neuron projection; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine binding; F:acetylcholine-gated cation-selective channel activity; F:neurotransmitter receptor activity; F:transmembrane signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:ion transmembrane transport; P:muscle contraction; P:musculoskeletal movement; P:nervous system process; P:neuromuscular process; P:regulation of membrane potential; P:signal transduction; P:skeletal muscle contraction; P:skeletal muscle tissue growth; scaffold46 indexed_genome mRNA 12840756 12844247 . + . ID=transcript_9001;Q07001 A8K661 B4DT92 Q52LH4,Acetylcholine receptor subunit delta,, PF02931;PF02932;, GO:0005892;GO:0005829;GO:0005887;GO:0099060;GO:0031594;GO:0043005;GO:0005654;GO:0005886;GO:0045211;GO:0045202;GO:0042166;GO:0022848;GO:0030594;GO:0004888;GO:1904315;GO:0007268;GO:0034220;GO:0006936;GO:0050881;GO:0050877;GO:0050905;GO:0042391;GO:0007165;GO:0003009;GO:0048630;, C:acetylcholine-gated channel complex; C:cytosol; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuromuscular junction; C:neuron projection; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine binding; F:acetylcholine-gated cation-selective channel activity; F:neurotransmitter receptor activity; F:transmembrane signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:ion transmembrane transport; P:muscle contraction; P:musculoskeletal movement; P:nervous system process; P:neuromuscular process; P:regulation of membrane potential; P:signal transduction; P:skeletal muscle contraction; P:skeletal muscle tissue growth; scaffold46 indexed_genome mRNA 12852286 12856019 . + . ID=transcript_9002;P07510 B3KWM8 Q14DU4 Q53RG2,Acetylcholine receptor subunit gamma,, PF02931;PF02932;, GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0015464;GO:0022848;GO:0015267;GO:0030594;GO:0007268;GO:0034220;GO:0006936;GO:0050877;GO:0042391;GO:0007165;, C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:channel activity; F:neurotransmitter receptor activity;, P:chemical synaptic transmission; P:ion transmembrane transport; P:muscle contraction; P:nervous system process; P:regulation of membrane potential; P:signal transduction; scaffold46 indexed_genome mRNA 12858160 12875341 . + . ID=transcript_9003;O60573 B8ZZJ9 O75349,Eukaryotic translation initiation factor 4E type 2 {ECO:0000303|PubMed:15153109},Eukaryotic translation initiation factor 4E homologous protein;Eukaryotic translation initiation factor 4E-like 3;eIF4E-like protein 4E-LP {ECO:0000303|PubMed:15153109};mRNA cap-binding protein 4EHP {ECO:0000303|PubMed:23991149};mRNA cap-binding protein type 3;, PF01652;, GO:0005737;GO:0005829;GO:0016281;GO:0005845;GO:0000932;GO:0000340;GO:0003723;GO:0000339;GO:0008135;GO:0003743;GO:0031625;GO:0031047;GO:0017148;GO:1905618;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:mRNA cap binding complex; C:P-body;, F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:ubiquitin protein ligase binding;, P:gene silencing by RNA; P:negative regulation of translation; P:positive regulation of miRNA mediated inhibition of translation; scaffold46 indexed_genome mRNA 12946490 13033505 . + . ID=transcript_9004;Q8TAG8 Q96BL4 Q9Y4Y7,Polyhomeotic-like protein 2,Early development regulatory protein 2;, PF00536;, GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0042802;GO:0008270;GO:0007275;GO:0045892;GO:0007283;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:identical protein binding; F:zinc ion binding;, P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:spermatogenesis; scaffold46 indexed_genome mRNA 13041643 13060893 . - . ID=transcript_9005;Q8TAG8 Q96BL4 Q9Y4Y7,Polyhomeotic-like protein 2,Early development regulatory protein 2;, PF00536;, GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0042802;GO:0008270;GO:0007275;GO:0045892;GO:0007283;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:identical protein binding; F:zinc ion binding;, P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:spermatogenesis;|Q8TAG8 Q96BL4 Q9Y4Y7,Polyhomeotic-like protein 2,Early development regulatory protein 2;, PF00536;, GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0042802;GO:0008270;GO:0007275;GO:0045892;GO:0007283;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:identical protein binding; F:zinc ion binding;, P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:spermatogenesis;|Q8TAG8 Q96BL4 Q9Y4Y7,Polyhomeotic-like protein 2,Early development regulatory protein 2;, PF00536;, GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0042802;GO:0008270;GO:0007275;GO:0045892;GO:0007283;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:identical protein binding; F:zinc ion binding;, P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:spermatogenesis;|Q8TAG8 Q96BL4 Q9Y4Y7,Polyhomeotic-like protein 2,Early development regulatory protein 2;, PF00536;, GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0042802;GO:0008270;GO:0007275;GO:0045892;GO:0007283;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:identical protein binding; F:zinc ion binding;, P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:spermatogenesis;|Q8TAG8 Q96BL4 Q9Y4Y7,Polyhomeotic-like protein 2,Early development regulatory protein 2;, PF00536;, GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0042802;GO:0008270;GO:0007275;GO:0045892;GO:0007283;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:identical protein binding; F:zinc ion binding;, P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:spermatogenesis;|Q8TAG8 Q96BL4 Q9Y4Y7,Polyhomeotic-like protein 2,Early development regulatory protein 2;, PF00536;, GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0042802;GO:0008270;GO:0007275;GO:0045892;GO:0007283;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:identical protein binding; F:zinc ion binding;, P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:spermatogenesis; scaffold46 indexed_genome mRNA 13075524 13104470 . - . ID=transcript_9006;Q5T0B9 Q8WYU4,Zinc finger protein 362,, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5T0B9 Q8WYU4,Zinc finger protein 362,, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5T0B9 Q8WYU4,Zinc finger protein 362,, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold46 indexed_genome mRNA 13179736 13216294 . + . ID=transcript_9007;Q9BVG3 B3KVH5 B4DTE4 D3DPR1 Q9NVG0,E3 ubiquitin-protein ligase TRIM62,RING-type E3 ubiquitin transferase TRIM62 {ECO:0000305};Tripartite motif-containing protein 62;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0042802;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0045087;GO:0060333;GO:0010719;GO:0032897;GO:0051091;GO:0043123;GO:0051092;GO:0016567;GO:0046596;GO:1902186;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein ubiquitination; P:regulation of viral entry into host cell; P:regulation of viral release from host cell;|Q9BVG3 B3KVH5 B4DTE4 D3DPR1 Q9NVG0,E3 ubiquitin-protein ligase TRIM62,RING-type E3 ubiquitin transferase TRIM62 {ECO:0000305};Tripartite motif-containing protein 62;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0042802;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0045087;GO:0060333;GO:0010719;GO:0032897;GO:0051091;GO:0043123;GO:0051092;GO:0016567;GO:0046596;GO:1902186;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein ubiquitination; P:regulation of viral entry into host cell; P:regulation of viral release from host cell;|Q9BVG3 B3KVH5 B4DTE4 D3DPR1 Q9NVG0,E3 ubiquitin-protein ligase TRIM62,RING-type E3 ubiquitin transferase TRIM62 {ECO:0000305};Tripartite motif-containing protein 62;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0042802;GO:0003713;GO:0061630;GO:0004842;GO:0008270;GO:0045087;GO:0060333;GO:0010719;GO:0032897;GO:0051091;GO:0043123;GO:0051092;GO:0016567;GO:0046596;GO:1902186;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein ubiquitination; P:regulation of viral entry into host cell; P:regulation of viral release from host cell; scaffold46 indexed_genome mRNA 13237477 13277004 . - . ID=transcript_9008;Q96L56 Q96L57 Q96MD9,Antizyme inhibitor 2,Arginine decarboxylase;Ornithine decarboxylase-like protein;ornithine decarboxylase paralog;, PF02784;PF00278;, GO:0030424;GO:0005801;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0033116;GO:1990005;GO:0005739;GO:0005634;GO:0043204;GO:0048471;GO:0005802;GO:0030133;GO:0003824;GO:0042978;GO:0097055;GO:0042177;GO:0043085;GO:1902269;GO:0033387;GO:0007283;GO:0098629;, C:axon; C:cis-Golgi network; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:granular vesicle; C:mitochondrion; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:trans-Golgi network; C:transport vesicle;, F:catalytic activity; F:ornithine decarboxylase activator activity;, P:agmatine biosynthetic process; P:negative regulation of protein catabolic process; P:positive regulation of catalytic activity; P:positive regulation of polyamine transmembrane transport; P:putrescine biosynthetic process from ornithine; P:spermatogenesis; P:trans-Golgi network membrane organization; scaffold46 indexed_genome mRNA 13315596 13335699 . + . ID=transcript_9009;P54819 A8K6L1 B4DHH7 B4DL64 Q16856 Q5EB54 Q5TIF7 Q8TCY2 Q8TCY3,Adenylate kinase 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03168},ATP-AMP transphosphorylase 2 {ECO:0000255|HAMAP-Rule:MF_03168};ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03168};Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03168};, PF05191;, GO:0005737;GO:0070062;GO:0005758;GO:0005739;GO:0097226;GO:0004017;GO:0005524;GO:0006172;GO:0046033;GO:0046034;GO:0015949;, C:cytoplasm; C:extracellular exosome; C:mitochondrial intermembrane space; C:mitochondrion; C:sperm mitochondrial sheath;, F:adenylate kinase activity; F:ATP binding;, P:ADP biosynthetic process; P:AMP metabolic process; P:ATP metabolic process; P:nucleobase-containing small molecule interconversion;|P54819 A8K6L1 B4DHH7 B4DL64 Q16856 Q5EB54 Q5TIF7 Q8TCY2 Q8TCY3,Adenylate kinase 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03168},ATP-AMP transphosphorylase 2 {ECO:0000255|HAMAP-Rule:MF_03168};ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03168};Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03168};, PF05191;, GO:0005737;GO:0070062;GO:0005758;GO:0005739;GO:0097226;GO:0004017;GO:0005524;GO:0006172;GO:0046033;GO:0046034;GO:0015949;, C:cytoplasm; C:extracellular exosome; C:mitochondrial intermembrane space; C:mitochondrion; C:sperm mitochondrial sheath;, F:adenylate kinase activity; F:ATP binding;, P:ADP biosynthetic process; P:AMP metabolic process; P:ATP metabolic process; P:nucleobase-containing small molecule interconversion;|P54819 A8K6L1 B4DHH7 B4DL64 Q16856 Q5EB54 Q5TIF7 Q8TCY2 Q8TCY3,Adenylate kinase 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03168},ATP-AMP transphosphorylase 2 {ECO:0000255|HAMAP-Rule:MF_03168};ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03168};Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03168};, PF05191;, GO:0005737;GO:0070062;GO:0005758;GO:0005739;GO:0097226;GO:0004017;GO:0005524;GO:0006172;GO:0046033;GO:0046034;GO:0015949;, C:cytoplasm; C:extracellular exosome; C:mitochondrial intermembrane space; C:mitochondrion; C:sperm mitochondrial sheath;, F:adenylate kinase activity; F:ATP binding;, P:ADP biosynthetic process; P:AMP metabolic process; P:ATP metabolic process; P:nucleobase-containing small molecule interconversion;|P54819 A8K6L1 B4DHH7 B4DL64 Q16856 Q5EB54 Q5TIF7 Q8TCY2 Q8TCY3,Adenylate kinase 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03168},ATP-AMP transphosphorylase 2 {ECO:0000255|HAMAP-Rule:MF_03168};ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03168};Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03168};, PF05191;, GO:0005737;GO:0070062;GO:0005758;GO:0005739;GO:0097226;GO:0004017;GO:0005524;GO:0006172;GO:0046033;GO:0046034;GO:0015949;, C:cytoplasm; C:extracellular exosome; C:mitochondrial intermembrane space; C:mitochondrion; C:sperm mitochondrial sheath;, F:adenylate kinase activity; F:ATP binding;, P:ADP biosynthetic process; P:AMP metabolic process; P:ATP metabolic process; P:nucleobase-containing small molecule interconversion;|P54819 A8K6L1 B4DHH7 B4DL64 Q16856 Q5EB54 Q5TIF7 Q8TCY2 Q8TCY3,Adenylate kinase 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03168},ATP-AMP transphosphorylase 2 {ECO:0000255|HAMAP-Rule:MF_03168};ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03168};Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03168};, PF05191;, GO:0005737;GO:0070062;GO:0005758;GO:0005739;GO:0097226;GO:0004017;GO:0005524;GO:0006172;GO:0046033;GO:0046034;GO:0015949;, C:cytoplasm; C:extracellular exosome; C:mitochondrial intermembrane space; C:mitochondrion; C:sperm mitochondrial sheath;, F:adenylate kinase activity; F:ATP binding;, P:ADP biosynthetic process; P:AMP metabolic process; P:ATP metabolic process; P:nucleobase-containing small molecule interconversion;|P54819 A8K6L1 B4DHH7 B4DL64 Q16856 Q5EB54 Q5TIF7 Q8TCY2 Q8TCY3,Adenylate kinase 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03168},ATP-AMP transphosphorylase 2 {ECO:0000255|HAMAP-Rule:MF_03168};ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03168};Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03168};, PF05191;, GO:0005737;GO:0070062;GO:0005758;GO:0005739;GO:0097226;GO:0004017;GO:0005524;GO:0006172;GO:0046033;GO:0046034;GO:0015949;, C:cytoplasm; C:extracellular exosome; C:mitochondrial intermembrane space; C:mitochondrion; C:sperm mitochondrial sheath;, F:adenylate kinase activity; F:ATP binding;, P:ADP biosynthetic process; P:AMP metabolic process; P:ATP metabolic process; P:nucleobase-containing small molecule interconversion; scaffold46 indexed_genome mRNA 13399558 13400347 . + . ID=transcript_9010;Q8WUF3,E3 ubiquitin-protein ligase RNF19B,IBR domain-containing protein 3;Natural killer lytic-associated molecule;RING finger protein 19B;, PF01485;, GO:0044194;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0000151;GO:0046872;GO:0043130;GO:0031624;GO:0061630;GO:0002250;GO:0042267;GO:0032436;GO:0051865;GO:0000209;GO:0006511;, C:cytolytic granule; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:adaptive immune response; P:natural killer cell mediated cytotoxicity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold46 indexed_genome mRNA 13404832 13414016 . - . ID=transcript_9011;Q8WUF3,E3 ubiquitin-protein ligase RNF19B,IBR domain-containing protein 3;Natural killer lytic-associated molecule;RING finger protein 19B;, PF01485;, GO:0044194;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0000151;GO:0046872;GO:0043130;GO:0031624;GO:0061630;GO:0002250;GO:0042267;GO:0032436;GO:0051865;GO:0000209;GO:0006511;, C:cytolytic granule; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:adaptive immune response; P:natural killer cell mediated cytotoxicity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8WUF3,E3 ubiquitin-protein ligase RNF19B,IBR domain-containing protein 3;Natural killer lytic-associated molecule;RING finger protein 19B;, PF01485;, GO:0044194;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0000151;GO:0046872;GO:0043130;GO:0031624;GO:0061630;GO:0002250;GO:0042267;GO:0032436;GO:0051865;GO:0000209;GO:0006511;, C:cytolytic granule; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:adaptive immune response; P:natural killer cell mediated cytotoxicity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8WUF3,E3 ubiquitin-protein ligase RNF19B,IBR domain-containing protein 3;Natural killer lytic-associated molecule;RING finger protein 19B;, PF01485;, GO:0044194;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0000151;GO:0046872;GO:0043130;GO:0031624;GO:0061630;GO:0002250;GO:0042267;GO:0032436;GO:0051865;GO:0000209;GO:0006511;, C:cytolytic granule; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:adaptive immune response; P:natural killer cell mediated cytotoxicity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold46 indexed_genome mRNA 13440563 13463290 . + . ID=transcript_9012;P84074 B2R9T3 D3DPQ7 P32076 P41211 P70510,Neuron-specific calcium-binding protein hippocalcin {ECO:0000305},Calcium-binding protein BDR-2;, PF13499;PF13833;, GO:0030424;GO:0005737;GO:0005829;GO:0032839;GO:0032590;GO:0044327;GO:0019898;GO:0098978;GO:0032809;GO:0043204;GO:0003779;GO:0005509;GO:0042802;GO:0019900;GO:0031584;GO:0007420;GO:0019722;GO:0071277;GO:0071257;GO:1904009;GO:0048839;GO:0031283;GO:0045762;GO:0090314;GO:0099149;GO:1901385;GO:1904010;GO:1901986;GO:1902065;GO:0060041;, C:axon; C:cytoplasm; C:cytosol; C:dendrite cytoplasm; C:dendrite membrane; C:dendritic spine head; C:extrinsic component of membrane; C:glutamatergic synapse; C:neuronal cell body membrane; C:perikaryon;, F:actin binding; F:calcium ion binding; F:identical protein binding; F:kinase binding;, P:activation of phospholipase D activity; P:brain development; P:calcium-mediated signaling; P:cellular response to calcium ion; P:cellular response to electrical stimulus; P:cellular response to monosodium glutamate; P:inner ear development; P:negative regulation of guanylate cyclase activity; P:positive regulation of adenylate cyclase activity; P:positive regulation of protein targeting to membrane; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of voltage-gated calcium channel activity; P:response to Aroclor 1254; P:response to ketamine; P:response to L-glutamate; P:retina development in camera-type eye; scaffold46 indexed_genome mRNA 13465707 13467351 . - . ID=transcript_9013;P35268 B2R495 Q6IBD1,60S ribosomal protein L22,EBER-associated protein;Epstein-Barr virus small RNA-associated protein;Heparin-binding protein HBp15;Large ribosomal subunit protein eL22 {ECO:0000303|PubMed:24524803};, PF01776;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0098978;GO:0005634;GO:0098793;GO:1990904;GO:0008201;GO:0042802;GO:0003723;GO:0003735;GO:0045182;GO:0046632;GO:0002181;GO:0000184;GO:0099577;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:presynapse; C:ribonucleoprotein complex;, F:heparin binding; F:identical protein binding; F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:alpha-beta T cell differentiation; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation at presynapse, modulating synaptic transmission; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold46 indexed_genome mRNA 13477791 13481863 . + . ID=transcript_9014;Q8NAU1 A6NMC9 D3DPQ6 Q6P6D9 Q7Z676,Fibronectin type III domain-containing protein 5,Fibronectin type III repeat-containing protein 2;, PF16066;PF00041;, GO:0005783;GO:0005576;GO:0016021;GO:0005778;GO:0005886;GO:0005179;GO:0090336;GO:0014850;, C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:peroxisomal membrane; C:plasma membrane;, F:hormone activity;, P:positive regulation of brown fat cell differentiation; P:response to muscle activity;|Q8NAU1 A6NMC9 D3DPQ6 Q6P6D9 Q7Z676,Fibronectin type III domain-containing protein 5,Fibronectin type III repeat-containing protein 2;, PF16066;PF00041;, GO:0005783;GO:0005576;GO:0016021;GO:0005778;GO:0005886;GO:0005179;GO:0090336;GO:0014850;, C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:peroxisomal membrane; C:plasma membrane;, F:hormone activity;, P:positive regulation of brown fat cell differentiation; P:response to muscle activity;|Q8NAU1 A6NMC9 D3DPQ6 Q6P6D9 Q7Z676,Fibronectin type III domain-containing protein 5,Fibronectin type III repeat-containing protein 2;, PF16066;PF00041;, GO:0005783;GO:0005576;GO:0016021;GO:0005778;GO:0005886;GO:0005179;GO:0090336;GO:0014850;, C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:peroxisomal membrane; C:plasma membrane;, F:hormone activity;, P:positive regulation of brown fat cell differentiation; P:response to muscle activity;|Q8NAU1 A6NMC9 D3DPQ6 Q6P6D9 Q7Z676,Fibronectin type III domain-containing protein 5,Fibronectin type III repeat-containing protein 2;, PF16066;PF00041;, GO:0005783;GO:0005576;GO:0016021;GO:0005778;GO:0005886;GO:0005179;GO:0090336;GO:0014850;, C:endoplasmic reticulum; C:extracellular region; C:integral component of membrane; C:peroxisomal membrane; C:plasma membrane;, F:hormone activity;, P:positive regulation of brown fat cell differentiation; P:response to muscle activity; scaffold46 indexed_genome mRNA 13488553 13522485 . - . ID=transcript_9015;Q96BU1 B3KR04 D3DPQ5 Q5HYH3 Q9H997,S100P-binding protein,S100P-binding protein Riken;, PF15427;, GO:0005829;GO:0016607;GO:0005634;GO:0048306;, C:cytosol; C:nuclear speck; C:nucleus;, F:calcium-dependent protein binding;|Q96BU1 B3KR04 D3DPQ5 Q5HYH3 Q9H997,S100P-binding protein,S100P-binding protein Riken;, PF15427;, GO:0005829;GO:0016607;GO:0005634;GO:0048306;, C:cytosol; C:nuclear speck; C:nucleus;, F:calcium-dependent protein binding;|Q96BU1 B3KR04 D3DPQ5 Q5HYH3 Q9H997,S100P-binding protein,S100P-binding protein Riken;, PF15427;, GO:0005829;GO:0016607;GO:0005634;GO:0048306;, C:cytosol; C:nuclear speck; C:nucleus;, F:calcium-dependent protein binding; scaffold46 indexed_genome mRNA 13525447 13568031 . + . ID=transcript_9016;P54577 B3KWK4 D3DPQ4 O43276 Q53EN1,Tyrosine--tRNA ligase, cytoplasmic,Tyrosyl-tRNA synthetase;, PF00579;PF01588;, GO:0005737;GO:0005829;GO:0005615;GO:0016604;GO:0005524;GO:0005153;GO:0003723;GO:0000049;GO:0004831;GO:0006915;GO:0006418;GO:0006437;, C:cytoplasm; C:cytosol; C:extracellular space; C:nuclear body;, F:ATP binding; F:interleukin-8 receptor binding; F:RNA binding; F:tRNA binding; F:tyrosine-tRNA ligase activity;, P:apoptotic process; P:tRNA aminoacylation for protein translation; P:tyrosyl-tRNA aminoacylation;|Q9P206 B4DQU8 B5MDY0 C9JH84 Q8TCQ0,Uncharacterized protein KIAA1522,, , GO:0030154;, , , P:cell differentiation;|P54577 B3KWK4 D3DPQ4 O43276 Q53EN1,Tyrosine--tRNA ligase, cytoplasmic,Tyrosyl-tRNA synthetase;, PF00579;PF01588;, GO:0005737;GO:0005829;GO:0005615;GO:0016604;GO:0005524;GO:0005153;GO:0003723;GO:0000049;GO:0004831;GO:0006915;GO:0006418;GO:0006437;, C:cytoplasm; C:cytosol; C:extracellular space; C:nuclear body;, F:ATP binding; F:interleukin-8 receptor binding; F:RNA binding; F:tRNA binding; F:tyrosine-tRNA ligase activity;, P:apoptotic process; P:tRNA aminoacylation for protein translation; P:tyrosyl-tRNA aminoacylation; scaffold46 indexed_genome mRNA 13633926 13666188 . - . ID=transcript_9017;Q9H7C4 B4DNK8 B4DY58 C9IY41,Syncoilin,Syncoilin intermediate filament 1;Syncoilin-1;, PF00038;, GO:0005829;GO:0005882;GO:0031594;GO:0048471;GO:0042383;GO:0030018;GO:0045103;, C:cytosol; C:intermediate filament; C:neuromuscular junction; C:perinuclear region of cytoplasm; C:sarcolemma; C:Z disc;, , P:intermediate filament-based process;|Q09028 B2R6G9 B4DRH0 D3DPQ3 P31149 Q53H02 Q96BV9,Histone-binding protein RBBP4,Chromatin assembly factor 1 subunit C;Chromatin assembly factor I p48 subunit;Nucleosome-remodeling factor subunit RBAP48;Retinoblastoma-binding protein 4;Retinoblastoma-binding protein p48;, PF12265;PF00400;, GO:0033186;GO:0000785;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0016589;GO:0032991;GO:0016580;GO:0042393;GO:0042826;GO:0000978;GO:0043044;GO:0007049;GO:0034080;GO:0031497;GO:0006338;GO:0006260;GO:0006335;GO:0006336;GO:0008285;GO:0070317;GO:0045814;GO:0051726;GO:1901796;GO:0060416;GO:0019058;, C:CAF-1 complex; C:chromatin; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex; C:NURF complex; C:protein-containing complex; C:Sin3 complex;, F:histone binding; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:CENP-A containing nucleosome assembly; P:chromatin assembly; P:chromatin remodeling; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:negative regulation of cell population proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:regulation of cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to growth hormone; P:viral life cycle;|Q09028 B2R6G9 B4DRH0 D3DPQ3 P31149 Q53H02 Q96BV9,Histone-binding protein RBBP4,Chromatin assembly factor 1 subunit C;Chromatin assembly factor I p48 subunit;Nucleosome-remodeling factor subunit RBAP48;Retinoblastoma-binding protein 4;Retinoblastoma-binding protein p48;, PF12265;PF00400;, GO:0033186;GO:0000785;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0016589;GO:0032991;GO:0016580;GO:0042393;GO:0042826;GO:0000978;GO:0043044;GO:0007049;GO:0034080;GO:0031497;GO:0006338;GO:0006260;GO:0006335;GO:0006336;GO:0008285;GO:0070317;GO:0045814;GO:0051726;GO:1901796;GO:0060416;GO:0019058;, C:CAF-1 complex; C:chromatin; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex; C:NURF complex; C:protein-containing complex; C:Sin3 complex;, F:histone binding; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:CENP-A containing nucleosome assembly; P:chromatin assembly; P:chromatin remodeling; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:negative regulation of cell population proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:regulation of cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to growth hormone; P:viral life cycle;|Q09028 B2R6G9 B4DRH0 D3DPQ3 P31149 Q53H02 Q96BV9,Histone-binding protein RBBP4,Chromatin assembly factor 1 subunit C;Chromatin assembly factor I p48 subunit;Nucleosome-remodeling factor subunit RBAP48;Retinoblastoma-binding protein 4;Retinoblastoma-binding protein p48;, PF12265;PF00400;, GO:0033186;GO:0000785;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0016589;GO:0032991;GO:0016580;GO:0042393;GO:0042826;GO:0000978;GO:0043044;GO:0007049;GO:0034080;GO:0031497;GO:0006338;GO:0006260;GO:0006335;GO:0006336;GO:0008285;GO:0070317;GO:0045814;GO:0051726;GO:1901796;GO:0060416;GO:0019058;, C:CAF-1 complex; C:chromatin; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex; C:NURF complex; C:protein-containing complex; C:Sin3 complex;, F:histone binding; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:CENP-A containing nucleosome assembly; P:chromatin assembly; P:chromatin remodeling; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:negative regulation of cell population proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:regulation of cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to growth hormone; P:viral life cycle;|Q09028 B2R6G9 B4DRH0 D3DPQ3 P31149 Q53H02 Q96BV9,Histone-binding protein RBBP4,Chromatin assembly factor 1 subunit C;Chromatin assembly factor I p48 subunit;Nucleosome-remodeling factor subunit RBAP48;Retinoblastoma-binding protein 4;Retinoblastoma-binding protein p48;, PF12265;PF00400;, GO:0033186;GO:0000785;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0016589;GO:0032991;GO:0016580;GO:0042393;GO:0042826;GO:0000978;GO:0043044;GO:0007049;GO:0034080;GO:0031497;GO:0006338;GO:0006260;GO:0006335;GO:0006336;GO:0008285;GO:0070317;GO:0045814;GO:0051726;GO:1901796;GO:0060416;GO:0019058;, C:CAF-1 complex; C:chromatin; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex; C:NURF complex; C:protein-containing complex; C:Sin3 complex;, F:histone binding; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:CENP-A containing nucleosome assembly; P:chromatin assembly; P:chromatin remodeling; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:negative regulation of cell population proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:regulation of cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to growth hormone; P:viral life cycle;|Q09028 B2R6G9 B4DRH0 D3DPQ3 P31149 Q53H02 Q96BV9,Histone-binding protein RBBP4,Chromatin assembly factor 1 subunit C;Chromatin assembly factor I p48 subunit;Nucleosome-remodeling factor subunit RBAP48;Retinoblastoma-binding protein 4;Retinoblastoma-binding protein p48;, PF12265;PF00400;, GO:0033186;GO:0000785;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0016589;GO:0032991;GO:0016580;GO:0042393;GO:0042826;GO:0000978;GO:0043044;GO:0007049;GO:0034080;GO:0031497;GO:0006338;GO:0006260;GO:0006335;GO:0006336;GO:0008285;GO:0070317;GO:0045814;GO:0051726;GO:1901796;GO:0060416;GO:0019058;, C:CAF-1 complex; C:chromatin; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex; C:NURF complex; C:protein-containing complex; C:Sin3 complex;, F:histone binding; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:CENP-A containing nucleosome assembly; P:chromatin assembly; P:chromatin remodeling; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:negative regulation of cell population proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:regulation of cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to growth hormone; P:viral life cycle;|Q09028 B2R6G9 B4DRH0 D3DPQ3 P31149 Q53H02 Q96BV9,Histone-binding protein RBBP4,Chromatin assembly factor 1 subunit C;Chromatin assembly factor I p48 subunit;Nucleosome-remodeling factor subunit RBAP48;Retinoblastoma-binding protein 4;Retinoblastoma-binding protein p48;, PF12265;PF00400;, GO:0033186;GO:0000785;GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0016589;GO:0032991;GO:0016580;GO:0042393;GO:0042826;GO:0000978;GO:0043044;GO:0007049;GO:0034080;GO:0031497;GO:0006338;GO:0006260;GO:0006335;GO:0006336;GO:0008285;GO:0070317;GO:0045814;GO:0051726;GO:1901796;GO:0060416;GO:0019058;, C:CAF-1 complex; C:chromatin; C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex; C:NURF complex; C:protein-containing complex; C:Sin3 complex;, F:histone binding; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:CENP-A containing nucleosome assembly; P:chromatin assembly; P:chromatin remodeling; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:negative regulation of cell population proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:regulation of cell cycle; P:regulation of signal transduction by p53 class mediator; P:response to growth hormone; P:viral life cycle; scaffold46 indexed_genome mRNA 13666564 13681585 . + . ID=transcript_9018;Q8IWT0 Q5TGK5 Q6PDA1 Q8IWS9 Q8NEV6 Q8NEV7,Protein archease,Protein ZBTB8OS;Zinc finger and BTB domain-containing opposite strand protein 8;, PF01951;, GO:0005654;GO:0072669;GO:0046872;GO:0006388;, C:nucleoplasm; C:tRNA-splicing ligase complex;, F:metal ion binding;, P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q8IWT0 Q5TGK5 Q6PDA1 Q8IWS9 Q8NEV6 Q8NEV7,Protein archease,Protein ZBTB8OS;Zinc finger and BTB domain-containing opposite strand protein 8;, PF01951;, GO:0005654;GO:0072669;GO:0046872;GO:0006388;, C:nucleoplasm; C:tRNA-splicing ligase complex;, F:metal ion binding;, P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q8IWT0 Q5TGK5 Q6PDA1 Q8IWS9 Q8NEV6 Q8NEV7,Protein archease,Protein ZBTB8OS;Zinc finger and BTB domain-containing opposite strand protein 8;, PF01951;, GO:0005654;GO:0072669;GO:0046872;GO:0006388;, C:nucleoplasm; C:tRNA-splicing ligase complex;, F:metal ion binding;, P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold46 indexed_genome mRNA 13690335 13703373 . - . ID=transcript_9019;Q96BR9 Q8IUL5 Q8IWR9 Q8N2Y5 Q96BX0,Zinc finger and BTB domain-containing protein 8A,BTB/POZ and zinc-finger domain-containing factor;BTB/POZ and zinc-finger domains factor on chromosome 1;, PF00651;PF00096;, GO:0005634;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold46 indexed_genome mRNA 13809294 13824455 . - . ID=transcript_9020;Q8NAP8 Q15DG5 Q5VXR5 Q69YT7,Zinc finger and BTB domain-containing protein 8B,, PF00651;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8NAP8 Q15DG5 Q5VXR5 Q69YT7,Zinc finger and BTB domain-containing protein 8B,, PF00651;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold46 indexed_genome mRNA 13867092 13888094 . + . ID=transcript_9021;Q6UXS1 Q9HAL9,BSD domain-containing protein 1,, PF03909;|Q6UXS1 Q9HAL9,BSD domain-containing protein 1,, PF03909;|Q6UXS1 Q9HAL9,BSD domain-containing protein 1,, PF03909;|Q96PN8 Q5TEE5,Testis-specific serine/threonine-protein kinase 3,Serine/threonine-protein kinase 22C;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0030154;GO:0035556;GO:0007275;GO:0006468;GO:0007283;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:intracellular signal transduction; P:multicellular organism development; P:protein phosphorylation; P:spermatogenesis; scaffold46 indexed_genome mRNA 13911969 13913097 . - . ID=transcript_9022;Q13547 Q92534,Histone deacetylase 1 {ECO:0000305},, PF00850;, GO:0000785;GO:0005737;GO:0005829;GO:0000792;GO:0000118;GO:0043025;GO:0005654;GO:0005634;GO:0016581;GO:0032991;GO:0016580;GO:0033613;GO:0001046;GO:0019213;GO:0070888;GO:0019899;GO:0004407;GO:0042826;GO:0035851;GO:0032041;GO:0051059;GO:0002039;GO:1990841;GO:0033558;GO:0047485;GO:0070491;GO:0000978;GO:0000979;GO:0001103;GO:0001085;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0007596;GO:0006325;GO:0006338;GO:0032922;GO:0006346;GO:0042733;GO:0007492;GO:0009913;GO:0061029;GO:0061198;GO:0060789;GO:0021766;GO:0016575;GO:0070932;GO:0070933;GO:0043922;GO:0060766;GO:0043066;GO:0090090;GO:0010629;GO:0043124;GO:2001243;GO:0000122;GO:0045892;GO:0030182;GO:0042475;GO:0008284;GO:0048714;GO:2000273;GO:0045944;GO:0045893;GO:0006476;GO:1900221;GO:0052548;GO:0045652;GO:1901796;GO:0006357;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:heterochromatin; C:histone deacetylase complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:NuRD complex; C:protein-containing complex; C:Sin3 complex;, F:activating transcription factor binding; F:core promoter sequence-specific DNA binding; F:deacetylase activity; F:E-box binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:Krueppel-associated box domain binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:protein N-terminus binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:blood coagulation; P:chromatin organization; P:chromatin remodeling; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:embryonic digit morphogenesis; P:endoderm development; P:epidermal cell differentiation; P:eyelid development in camera-type eye; P:fungiform papilla formation; P:hair follicle placode formation; P:hippocampus development; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation by host of viral transcription; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deacetylation; P:regulation of amyloid-beta clearance; P:regulation of endopeptidase activity; P:regulation of megakaryocyte differentiation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold46 indexed_genome mRNA 13913359 13942904 . - . ID=transcript_9023;Q13547 Q92534,Histone deacetylase 1 {ECO:0000305},, PF00850;, GO:0000785;GO:0005737;GO:0005829;GO:0000792;GO:0000118;GO:0043025;GO:0005654;GO:0005634;GO:0016581;GO:0032991;GO:0016580;GO:0033613;GO:0001046;GO:0019213;GO:0070888;GO:0019899;GO:0004407;GO:0042826;GO:0035851;GO:0032041;GO:0051059;GO:0002039;GO:1990841;GO:0033558;GO:0047485;GO:0070491;GO:0000978;GO:0000979;GO:0001103;GO:0001085;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0007596;GO:0006325;GO:0006338;GO:0032922;GO:0006346;GO:0042733;GO:0007492;GO:0009913;GO:0061029;GO:0061198;GO:0060789;GO:0021766;GO:0016575;GO:0070932;GO:0070933;GO:0043922;GO:0060766;GO:0043066;GO:0090090;GO:0010629;GO:0043124;GO:2001243;GO:0000122;GO:0045892;GO:0030182;GO:0042475;GO:0008284;GO:0048714;GO:2000273;GO:0045944;GO:0045893;GO:0006476;GO:1900221;GO:0052548;GO:0045652;GO:1901796;GO:0006357;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:heterochromatin; C:histone deacetylase complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:NuRD complex; C:protein-containing complex; C:Sin3 complex;, F:activating transcription factor binding; F:core promoter sequence-specific DNA binding; F:deacetylase activity; F:E-box binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:Krueppel-associated box domain binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:protein N-terminus binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:blood coagulation; P:chromatin organization; P:chromatin remodeling; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:embryonic digit morphogenesis; P:endoderm development; P:epidermal cell differentiation; P:eyelid development in camera-type eye; P:fungiform papilla formation; P:hair follicle placode formation; P:hippocampus development; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation by host of viral transcription; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deacetylation; P:regulation of amyloid-beta clearance; P:regulation of endopeptidase activity; P:regulation of megakaryocyte differentiation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q13547 Q92534,Histone deacetylase 1 {ECO:0000305},, PF00850;, GO:0000785;GO:0005737;GO:0005829;GO:0000792;GO:0000118;GO:0043025;GO:0005654;GO:0005634;GO:0016581;GO:0032991;GO:0016580;GO:0033613;GO:0001046;GO:0019213;GO:0070888;GO:0019899;GO:0004407;GO:0042826;GO:0035851;GO:0032041;GO:0051059;GO:0002039;GO:1990841;GO:0033558;GO:0047485;GO:0070491;GO:0000978;GO:0000979;GO:0001103;GO:0001085;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0007596;GO:0006325;GO:0006338;GO:0032922;GO:0006346;GO:0042733;GO:0007492;GO:0009913;GO:0061029;GO:0061198;GO:0060789;GO:0021766;GO:0016575;GO:0070932;GO:0070933;GO:0043922;GO:0060766;GO:0043066;GO:0090090;GO:0010629;GO:0043124;GO:2001243;GO:0000122;GO:0045892;GO:0030182;GO:0042475;GO:0008284;GO:0048714;GO:2000273;GO:0045944;GO:0045893;GO:0006476;GO:1900221;GO:0052548;GO:0045652;GO:1901796;GO:0006357;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:heterochromatin; C:histone deacetylase complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:NuRD complex; C:protein-containing complex; C:Sin3 complex;, F:activating transcription factor binding; F:core promoter sequence-specific DNA binding; F:deacetylase activity; F:E-box binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:Krueppel-associated box domain binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:protein N-terminus binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:blood coagulation; P:chromatin organization; P:chromatin remodeling; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:embryonic digit morphogenesis; P:endoderm development; P:epidermal cell differentiation; P:eyelid development in camera-type eye; P:fungiform papilla formation; P:hair follicle placode formation; P:hippocampus development; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation by host of viral transcription; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deacetylation; P:regulation of amyloid-beta clearance; P:regulation of endopeptidase activity; P:regulation of megakaryocyte differentiation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q13547 Q92534,Histone deacetylase 1 {ECO:0000305},, PF00850;, GO:0000785;GO:0005737;GO:0005829;GO:0000792;GO:0000118;GO:0043025;GO:0005654;GO:0005634;GO:0016581;GO:0032991;GO:0016580;GO:0033613;GO:0001046;GO:0019213;GO:0070888;GO:0019899;GO:0004407;GO:0042826;GO:0035851;GO:0032041;GO:0051059;GO:0002039;GO:1990841;GO:0033558;GO:0047485;GO:0070491;GO:0000978;GO:0000979;GO:0001103;GO:0001085;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0007596;GO:0006325;GO:0006338;GO:0032922;GO:0006346;GO:0042733;GO:0007492;GO:0009913;GO:0061029;GO:0061198;GO:0060789;GO:0021766;GO:0016575;GO:0070932;GO:0070933;GO:0043922;GO:0060766;GO:0043066;GO:0090090;GO:0010629;GO:0043124;GO:2001243;GO:0000122;GO:0045892;GO:0030182;GO:0042475;GO:0008284;GO:0048714;GO:2000273;GO:0045944;GO:0045893;GO:0006476;GO:1900221;GO:0052548;GO:0045652;GO:1901796;GO:0006357;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:heterochromatin; C:histone deacetylase complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:NuRD complex; C:protein-containing complex; C:Sin3 complex;, F:activating transcription factor binding; F:core promoter sequence-specific DNA binding; F:deacetylase activity; F:E-box binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:Krueppel-associated box domain binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:protein N-terminus binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:blood coagulation; P:chromatin organization; P:chromatin remodeling; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:embryonic digit morphogenesis; P:endoderm development; P:epidermal cell differentiation; P:eyelid development in camera-type eye; P:fungiform papilla formation; P:hair follicle placode formation; P:hippocampus development; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation by host of viral transcription; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deacetylation; P:regulation of amyloid-beta clearance; P:regulation of endopeptidase activity; P:regulation of megakaryocyte differentiation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q13547 Q92534,Histone deacetylase 1 {ECO:0000305},, PF00850;, GO:0000785;GO:0005737;GO:0005829;GO:0000792;GO:0000118;GO:0043025;GO:0005654;GO:0005634;GO:0016581;GO:0032991;GO:0016580;GO:0033613;GO:0001046;GO:0019213;GO:0070888;GO:0019899;GO:0004407;GO:0042826;GO:0035851;GO:0032041;GO:0051059;GO:0002039;GO:1990841;GO:0033558;GO:0047485;GO:0070491;GO:0000978;GO:0000979;GO:0001103;GO:0001085;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0007596;GO:0006325;GO:0006338;GO:0032922;GO:0006346;GO:0042733;GO:0007492;GO:0009913;GO:0061029;GO:0061198;GO:0060789;GO:0021766;GO:0016575;GO:0070932;GO:0070933;GO:0043922;GO:0060766;GO:0043066;GO:0090090;GO:0010629;GO:0043124;GO:2001243;GO:0000122;GO:0045892;GO:0030182;GO:0042475;GO:0008284;GO:0048714;GO:2000273;GO:0045944;GO:0045893;GO:0006476;GO:1900221;GO:0052548;GO:0045652;GO:1901796;GO:0006357;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:heterochromatin; C:histone deacetylase complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:NuRD complex; C:protein-containing complex; C:Sin3 complex;, F:activating transcription factor binding; F:core promoter sequence-specific DNA binding; F:deacetylase activity; F:E-box binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:Krueppel-associated box domain binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:NF-kappaB binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:protein N-terminus binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:blood coagulation; P:chromatin organization; P:chromatin remodeling; P:circadian regulation of gene expression; P:DNA methylation-dependent heterochromatin assembly; P:embryonic digit morphogenesis; P:endoderm development; P:epidermal cell differentiation; P:eyelid development in camera-type eye; P:fungiform papilla formation; P:hair follicle placode formation; P:hippocampus development; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation by host of viral transcription; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell population proliferation; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of signaling receptor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deacetylation; P:regulation of amyloid-beta clearance; P:regulation of endopeptidase activity; P:regulation of megakaryocyte differentiation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold46 indexed_genome mRNA 13946861 13955112 . - . ID=transcript_9024;Q9NYT8,Tyrosine-protein kinase Lck,Leukocyte C-terminal Src kinase;Lymphocyte cell-specific protein-tyrosine kinase;Protein YT16;Proto-oncogene Lck;T cell-specific protein-tyrosine kinase;p56-LCK;, PF07714;PF00017;PF00018;, GO:0005829;GO:0070062;GO:0031234;GO:0001772;GO:0045121;GO:0000242;GO:0005886;GO:0005524;GO:0051117;GO:0042609;GO:0042610;GO:0042802;GO:0004715;GO:0043548;GO:0001784;GO:0008022;GO:0019901;GO:0019903;GO:0004722;GO:0004713;GO:0042169;GO:0005102;GO:0042608;GO:0004714;GO:0006919;GO:0050853;GO:0030154;GO:0006882;GO:0019221;GO:0030097;GO:0045087;GO:0050900;GO:0018108;GO:0030168;GO:0034116;GO:2001244;GO:1903039;GO:0051897;GO:0050870;GO:0050862;GO:0006468;GO:0050690;GO:0051249;GO:0051209;GO:0042493;GO:0031295;GO:0030217;GO:0050852;GO:0007169;, C:cytosol; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:immunological synapse; C:membrane raft; C:pericentriolar material; C:plasma membrane;, F:ATP binding; F:ATPase binding; F:CD4 receptor binding; F:CD8 receptor binding; F:identical protein binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphatidylinositol 3-kinase binding; F:phosphotyrosine residue binding; F:protein C-terminus binding; F:protein kinase binding; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:T cell receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:B cell receptor signaling pathway; P:cell differentiation; P:cellular zinc ion homeostasis; P:cytokine-mediated signaling pathway; P:hemopoiesis; P:innate immune response; P:leukocyte migration; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of leukocyte cell-cell adhesion; P:positive regulation of protein kinase B signaling; P:positive regulation of T cell activation; P:positive regulation of T cell receptor signaling pathway; P:protein phosphorylation; P:regulation of defense response to virus by virus; P:regulation of lymphocyte activation; P:release of sequestered calcium ion into cytosol; P:response to drug; P:T cell costimulation; P:T cell differentiation; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold46 indexed_genome mRNA 13973106 14005628 . + . ID=transcript_9025;Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation;|Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation;|Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation;|Q13347,Eukaryotic translation initiation factor 3 subunit I {ECO:0000255|HAMAP-Rule:MF_03008},Eukaryotic translation initiation factor 3 subunit 2 {ECO:0000255|HAMAP-Rule:MF_03008};TGF-beta receptor-interacting protein 1;eIF-3-beta {ECO:0000255|HAMAP-Rule:MF_03008};eIF3 p36 {ECO:0000255|HAMAP-Rule:MF_03008};, PF00400;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0003723;GO:0003743;GO:0002183;GO:0001732;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome;, F:RNA binding; F:translation initiation factor activity;, P:cytoplasmic translational initiation; P:formation of cytoplasmic translation initiation complex; P:translational initiation;|Q13347,Eukaryotic translation initiation factor 3 subunit I {ECO:0000255|HAMAP-Rule:MF_03008},Eukaryotic translation initiation factor 3 subunit 2 {ECO:0000255|HAMAP-Rule:MF_03008};TGF-beta receptor-interacting protein 1;eIF-3-beta {ECO:0000255|HAMAP-Rule:MF_03008};eIF3 p36 {ECO:0000255|HAMAP-Rule:MF_03008};, PF00400;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0003723;GO:0003743;GO:0002183;GO:0001732;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome;, F:RNA binding; F:translation initiation factor activity;, P:cytoplasmic translational initiation; P:formation of cytoplasmic translation initiation complex; P:translational initiation;|Q13347,Eukaryotic translation initiation factor 3 subunit I {ECO:0000255|HAMAP-Rule:MF_03008},Eukaryotic translation initiation factor 3 subunit 2 {ECO:0000255|HAMAP-Rule:MF_03008};TGF-beta receptor-interacting protein 1;eIF-3-beta {ECO:0000255|HAMAP-Rule:MF_03008};eIF3 p36 {ECO:0000255|HAMAP-Rule:MF_03008};, PF00400;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0003723;GO:0003743;GO:0002183;GO:0001732;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome;, F:RNA binding; F:translation initiation factor activity;, P:cytoplasmic translational initiation; P:formation of cytoplasmic translation initiation complex; P:translational initiation;|Q13347,Eukaryotic translation initiation factor 3 subunit I {ECO:0000255|HAMAP-Rule:MF_03008},Eukaryotic translation initiation factor 3 subunit 2 {ECO:0000255|HAMAP-Rule:MF_03008};TGF-beta receptor-interacting protein 1;eIF-3-beta {ECO:0000255|HAMAP-Rule:MF_03008};eIF3 p36 {ECO:0000255|HAMAP-Rule:MF_03008};, PF00400;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0003723;GO:0003743;GO:0002183;GO:0001732;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome;, F:RNA binding; F:translation initiation factor activity;, P:cytoplasmic translational initiation; P:formation of cytoplasmic translation initiation complex; P:translational initiation;|Q13347,Eukaryotic translation initiation factor 3 subunit I {ECO:0000255|HAMAP-Rule:MF_03008},Eukaryotic translation initiation factor 3 subunit 2 {ECO:0000255|HAMAP-Rule:MF_03008};TGF-beta receptor-interacting protein 1;eIF-3-beta {ECO:0000255|HAMAP-Rule:MF_03008};eIF3 p36 {ECO:0000255|HAMAP-Rule:MF_03008};, PF00400;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0003723;GO:0003743;GO:0002183;GO:0001732;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome;, F:RNA binding; F:translation initiation factor activity;, P:cytoplasmic translational initiation; P:formation of cytoplasmic translation initiation complex; P:translational initiation;|Q8WY98 B2R535 D3DPP7 Q6UWY9 Q8N2H6 Q9BSR2 Q9NU76,Transmembrane protein 234,, PF10639;, GO:0016021;, C:integral component of membrane;|A2VCK2 B7ZBC6,Doublecortin domain-containing protein 2B,, PF03607;, GO:0005874;GO:0005815;GO:0035556;, C:microtubule; C:microtubule organizing center;, , P:intracellular signal transduction;|A2VCK2 B7ZBC6,Doublecortin domain-containing protein 2B,, PF03607;, GO:0005874;GO:0005815;GO:0035556;, C:microtubule; C:microtubule organizing center;, , P:intracellular signal transduction;|A2VCK2 B7ZBC6,Doublecortin domain-containing protein 2B,, PF03607;, GO:0005874;GO:0005815;GO:0035556;, C:microtubule; C:microtubule organizing center;, , P:intracellular signal transduction;|Q4KMZ1 F5H7T8 Q4KMS3 Q4KMZ5 Q53FL2 Q5TFJ8 Q9NVS3,IQ domain-containing protein C scaffold46 indexed_genome mRNA 14009125 14021581 . - . ID=transcript_9026;Q8N2Y3,Alpha-taxilin,, PF09728;, GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0019905;GO:0042113;GO:0019221;GO:0006887;, C:cytoplasm; C:cytosol; C:extracellular region; C:membrane;, F:syntaxin binding;, P:B cell activation; P:cytokine-mediated signaling pathway; P:exocytosis;|Q8N2Y3,Alpha-taxilin,, PF09728;, GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0019905;GO:0042113;GO:0019221;GO:0006887;, C:cytoplasm; C:cytosol; C:extracellular region; C:membrane;, F:syntaxin binding;, P:B cell activation; P:cytokine-mediated signaling pathway; P:exocytosis;|Q8N2Y3,Alpha-taxilin,, PF09728;, GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0019905;GO:0042113;GO:0019221;GO:0006887;, C:cytoplasm; C:cytosol; C:extracellular region; C:membrane;, F:syntaxin binding;, P:B cell activation; P:cytokine-mediated signaling pathway; P:exocytosis;|Q8N2Y3,Alpha-taxilin,, PF09728;, GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0019905;GO:0042113;GO:0019221;GO:0006887;, C:cytoplasm; C:cytosol; C:extracellular region; C:membrane;, F:syntaxin binding;, P:B cell activation; P:cytokine-mediated signaling pathway; P:exocytosis;|Q8N2Y3,Alpha-taxilin,, PF09728;, GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0019905;GO:0042113;GO:0019221;GO:0006887;, C:cytoplasm; C:cytosol; C:extracellular region; C:membrane;, F:syntaxin binding;, P:B cell activation; P:cytokine-mediated signaling pathway; P:exocytosis;|Q8N2Y3,Alpha-taxilin,, PF09728;, GO:0005737;GO:0005829;GO:0005576;GO:0016020;GO:0019905;GO:0042113;GO:0019221;GO:0006887;, C:cytoplasm; C:cytosol; C:extracellular region; C:membrane;, F:syntaxin binding;, P:B cell activation; P:cytokine-mediated signaling pathway; P:exocytosis; scaffold46 indexed_genome mRNA 14026155 14080172 . - . ID=transcript_9027;O60684 B2RDC7 D3DPP5 Q5VVU3,Importin subunit alpha-7,Karyopherin subunit alpha-6;, PF00514;PF16186;PF01749;, GO:0005737;GO:0043657;GO:0016020;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0075506;GO:0060135;GO:0030682;GO:0006607;GO:1900017;GO:0045944;GO:1903902;GO:0019079;, C:cytoplasm; C:host cell; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:entry of viral genome into host nucleus through nuclear pore complex via importin; P:maternal process involved in female pregnancy; P:mitigation of host defenses by symbiont; P:NLS-bearing protein import into nucleus; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral life cycle; P:viral genome replication;|O60684 B2RDC7 D3DPP5 Q5VVU3,Importin subunit alpha-7,Karyopherin subunit alpha-6;, PF00514;PF16186;PF01749;, GO:0005737;GO:0043657;GO:0016020;GO:0005654;GO:0005634;GO:0061608;GO:0008139;GO:0075506;GO:0060135;GO:0030682;GO:0006607;GO:1900017;GO:0045944;GO:1903902;GO:0019079;, C:cytoplasm; C:host cell; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:entry of viral genome into host nucleus through nuclear pore complex via importin; P:maternal process involved in female pregnancy; P:mitigation of host defenses by symbiont; P:NLS-bearing protein import into nucleus; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral life cycle; P:viral genome replication; scaffold46 indexed_genome mRNA 14083915 14101337 . + . ID=transcript_9028;Q9GZU3 B4DKN8 B4DQE6 B4DTN8 D3DPP4 Q6IA44,Transmembrane protein 39B,, PF10271;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q9GZU3 B4DKN8 B4DQE6 B4DTN8 D3DPP4 Q6IA44,Transmembrane protein 39B,, PF10271;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q9GZU3 B4DKN8 B4DQE6 B4DTN8 D3DPP4 Q6IA44,Transmembrane protein 39B,, PF10271;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q9GZU3 B4DKN8 B4DQE6 B4DTN8 D3DPP4 Q6IA44,Transmembrane protein 39B,, PF10271;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q9GZU3 B4DKN8 B4DQE6 B4DTN8 D3DPP4 Q6IA44,Transmembrane protein 39B,, PF10271;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane; scaffold46 indexed_genome mRNA 14118957 14142986 . - . ID=transcript_9029;Q07666 D3DPP3 Q6PJX7 Q8NB97 Q99760,KH domain-containing, RNA-binding, signal transduction-associated protein 1,GAP-associated tyrosine phosphoprotein p62;Src-associated in mitosis 68 kDa protein;p21 Ras GTPase-activating protein-associated p62;p68;, PF00013;PF16274;PF16568;, GO:0005737;GO:0005829;GO:0070618;GO:0016020;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042802;GO:0003729;GO:0008143;GO:0008266;GO:0019904;GO:1990782;GO:0044877;GO:0003723;GO:0042169;GO:0017124;GO:0035591;GO:0000082;GO:0000086;GO:0006397;GO:0000122;GO:0045892;GO:0046833;GO:0045948;GO:0000381;GO:0048024;GO:0046831;GO:0007283;GO:0050852;, C:cytoplasm; C:cytosol; C:Grb2-Sos complex; C:membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:identical protein binding; F:mRNA binding; F:poly(A) binding; F:poly(U) RNA binding; F:protein domain specific binding; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:RNA binding; F:SH2 domain binding; F:SH3 domain binding; F:signaling adaptor activity;, P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of RNA export from nucleus; P:positive regulation of translational initiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:regulation of RNA export from nucleus; P:spermatogenesis; P:T cell receptor signaling pathway;|Q07666 D3DPP3 Q6PJX7 Q8NB97 Q99760,KH domain-containing, RNA-binding, signal transduction-associated protein 1,GAP-associated tyrosine phosphoprotein p62;Src-associated in mitosis 68 kDa protein;p21 Ras GTPase-activating protein-associated p62;p68;, PF00013;PF16274;PF16568;, GO:0005737;GO:0005829;GO:0070618;GO:0016020;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042802;GO:0003729;GO:0008143;GO:0008266;GO:0019904;GO:1990782;GO:0044877;GO:0003723;GO:0042169;GO:0017124;GO:0035591;GO:0000082;GO:0000086;GO:0006397;GO:0000122;GO:0045892;GO:0046833;GO:0045948;GO:0000381;GO:0048024;GO:0046831;GO:0007283;GO:0050852;, C:cytoplasm; C:cytosol; C:Grb2-Sos complex; C:membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:identical protein binding; F:mRNA binding; F:poly(A) binding; F:poly(U) RNA binding; F:protein domain specific binding; F:protein tyrosine kinase binding; F:protein-containing complex binding; F:RNA binding; F:SH2 domain binding; F:SH3 domain binding; F:signaling adaptor activity;, P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of RNA export from nucleus; P:positive regulation of translational initiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:regulation of RNA export from nucleus; P:spermatogenesis; P:T cell receptor signaling pathway; scaffold46 indexed_genome mRNA 14233464 14250810 . + . ID=transcript_9030;Q15261 R4GN50,Protein tyrosine phosphatase type IVA 2,HU-PP-1;OV-1;PTP(CAAXII);Protein-tyrosine phosphatase 4a2;Protein-tyrosine phosphatase of regenerating liver 2;, PF00102;, GO:0005737;GO:0005829;GO:0005769;GO:0005634;GO:0005886;GO:0004727;GO:0004725;GO:0043687;, C:cytoplasm; C:cytosol; C:early endosome; C:nucleus; C:plasma membrane;, F:prenylated protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:post-translational protein modification;|Q15261 R4GN50,Protein tyrosine phosphatase type IVA 2,HU-PP-1;OV-1;PTP(CAAXII);Protein-tyrosine phosphatase 4a2;Protein-tyrosine phosphatase of regenerating liver 2;, PF00102;, GO:0005737;GO:0005829;GO:0005769;GO:0005634;GO:0005886;GO:0004727;GO:0004725;GO:0043687;, C:cytoplasm; C:cytosol; C:early endosome; C:nucleus; C:plasma membrane;, F:prenylated protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:post-translational protein modification;|Q15261 R4GN50,Protein tyrosine phosphatase type IVA 2,HU-PP-1;OV-1;PTP(CAAXII);Protein-tyrosine phosphatase 4a2;Protein-tyrosine phosphatase of regenerating liver 2;, PF00102;, GO:0005737;GO:0005829;GO:0005769;GO:0005634;GO:0005886;GO:0004727;GO:0004725;GO:0043687;, C:cytoplasm; C:cytosol; C:early endosome; C:nucleus; C:plasma membrane;, F:prenylated protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:post-translational protein modification;|Q15261 R4GN50,Protein tyrosine phosphatase type IVA 2,HU-PP-1;OV-1;PTP(CAAXII);Protein-tyrosine phosphatase 4a2;Protein-tyrosine phosphatase of regenerating liver 2;, PF00102;, GO:0005737;GO:0005829;GO:0005769;GO:0005634;GO:0005886;GO:0004727;GO:0004725;GO:0043687;, C:cytoplasm; C:cytosol; C:early endosome; C:nucleus; C:plasma membrane;, F:prenylated protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:post-translational protein modification;|Q15261 R4GN50,Protein tyrosine phosphatase type IVA 2,HU-PP-1;OV-1;PTP(CAAXII);Protein-tyrosine phosphatase 4a2;Protein-tyrosine phosphatase of regenerating liver 2;, PF00102;, GO:0005737;GO:0005829;GO:0005769;GO:0005634;GO:0005886;GO:0004727;GO:0004725;GO:0043687;, C:cytoplasm; C:cytosol; C:early endosome; C:nucleus; C:plasma membrane;, F:prenylated protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:post-translational protein modification; scaffold46 indexed_genome mRNA 14347542 14355766 . + . ID=transcript_9031;Q6ZMY3 Q24JU3 Q6PI90 Q8N869 Q8N8U0 Q8NBC6 Q96LN6,SPOC domain-containing protein 1,, PF07744;PF07500;, GO:0005694;GO:0005634;GO:0030154;GO:0006306;GO:0031047;GO:0010923;GO:0010529;GO:0007283;GO:0006351;, C:chromosome; C:nucleus;, , P:cell differentiation; P:DNA methylation; P:gene silencing by RNA; P:negative regulation of phosphatase activity; P:negative regulation of transposition; P:spermatogenesis; P:transcription, DNA-templated; scaffold46 indexed_genome mRNA 14406532 14417959 . + . ID=transcript_9032;O60241 B9EGK9 Q5T6K0 Q8NGW8 Q96GZ9,Adhesion G protein-coupled receptor B2 {ECO:0000303|PubMed:25713288},Brain-specific angiogenesis inhibitor 2;, PF00002;PF19188;PF16489;PF01825;PF00090;, GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0007189;GO:0033173;GO:0007166;GO:0007186;GO:0016525;GO:0007422;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcineurin-NFAT signaling cascade; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of angiogenesis; P:peripheral nervous system development;|O60241 B9EGK9 Q5T6K0 Q8NGW8 Q96GZ9,Adhesion G protein-coupled receptor B2 {ECO:0000303|PubMed:25713288},Brain-specific angiogenesis inhibitor 2;, PF00002;PF19188;PF16489;PF01825;PF00090;, GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0007189;GO:0033173;GO:0007166;GO:0007186;GO:0016525;GO:0007422;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcineurin-NFAT signaling cascade; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of angiogenesis; P:peripheral nervous system development; scaffold46 indexed_genome mRNA 14418283 14424109 . + . ID=transcript_9033;O60241 B9EGK9 Q5T6K0 Q8NGW8 Q96GZ9,Adhesion G protein-coupled receptor B2 {ECO:0000303|PubMed:25713288},Brain-specific angiogenesis inhibitor 2;, PF00002;PF19188;PF16489;PF01825;PF00090;, GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0007189;GO:0033173;GO:0007166;GO:0007186;GO:0016525;GO:0007422;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcineurin-NFAT signaling cascade; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of angiogenesis; P:peripheral nervous system development;|O60241 B9EGK9 Q5T6K0 Q8NGW8 Q96GZ9,Adhesion G protein-coupled receptor B2 {ECO:0000303|PubMed:25713288},Brain-specific angiogenesis inhibitor 2;, PF00002;PF19188;PF16489;PF01825;PF00090;, GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0007189;GO:0033173;GO:0007166;GO:0007186;GO:0016525;GO:0007422;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcineurin-NFAT signaling cascade; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of angiogenesis; P:peripheral nervous system development; scaffold46 indexed_genome mRNA 14446694 14498408 . + . ID=transcript_9034;Q07092 Q16593 Q59F89 Q71RG9,Collagen alpha-1(XVI) chain,, PF01391;, GO:0005588;GO:0005597;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0005178;GO:0007155;GO:0033627;GO:0071230;GO:0030199;GO:0030198;GO:0007565;GO:0033622;GO:0007229;GO:0051894;, C:collagen type V trimer; C:collagen type XVI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:integrin binding;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:extracellular matrix organization; P:female pregnancy; P:integrin activation; P:integrin-mediated signaling pathway; P:positive regulation of focal adhesion assembly;|Q07092 Q16593 Q59F89 Q71RG9,Collagen alpha-1(XVI) chain,, PF01391;, GO:0005588;GO:0005597;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0005178;GO:0007155;GO:0033627;GO:0071230;GO:0030199;GO:0030198;GO:0007565;GO:0033622;GO:0007229;GO:0051894;, C:collagen type V trimer; C:collagen type XVI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:integrin binding;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cellular response to amino acid stimulus; P:collagen fibril organization; P:extracellular matrix organization; P:female pregnancy; P:integrin activation; P:integrin-mediated signaling pathway; P:positive regulation of focal adhesion assembly; scaffold46 indexed_genome mRNA 14506628 14524302 . + . ID=transcript_9035;Q9UBV8,Peflin {ECO:0000303|PubMed:10486255},PEF protein with a long N-terminal hydrophobic domain {ECO:0000303|PubMed:10486255};Penta-EF hand domain-containing protein 1 {ECO:0000312|HGNC:HGNC:30009};, PF13405;PF13499;, GO:0030127;GO:0031463;GO:0005737;GO:0005783;GO:0070062;GO:0005509;GO:0048306;GO:0042802;GO:0046983;GO:0046982;GO:0003723;GO:1990756;GO:0048208;GO:0006888;GO:0014032;GO:0014029;GO:1902527;GO:0051592;, C:COPII vesicle coat; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome;, F:calcium ion binding; F:calcium-dependent protein binding; F:identical protein binding; F:protein dimerization activity; F:protein heterodimerization activity; F:RNA binding; F:ubiquitin ligase-substrate adaptor activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:neural crest cell development; P:neural crest formation; P:positive regulation of protein monoubiquitination; P:response to calcium ion;|Q9UBV8,Peflin {ECO:0000303|PubMed:10486255},PEF protein with a long N-terminal hydrophobic domain {ECO:0000303|PubMed:10486255};Penta-EF hand domain-containing protein 1 {ECO:0000312|HGNC:HGNC:30009};, PF13405;PF13499;, GO:0030127;GO:0031463;GO:0005737;GO:0005783;GO:0070062;GO:0005509;GO:0048306;GO:0042802;GO:0046983;GO:0046982;GO:0003723;GO:1990756;GO:0048208;GO:0006888;GO:0014032;GO:0014029;GO:1902527;GO:0051592;, C:COPII vesicle coat; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome;, F:calcium ion binding; F:calcium-dependent protein binding; F:identical protein binding; F:protein dimerization activity; F:protein heterodimerization activity; F:RNA binding; F:ubiquitin ligase-substrate adaptor activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:neural crest cell development; P:neural crest formation; P:positive regulation of protein monoubiquitination; P:response to calcium ion; scaffold46 indexed_genome mRNA 14572253 14582146 . + . ID=transcript_9036;Q9GZM7 A8K9Q5 B4DPK6 D3DPN8 Q8TEJ9 Q8WZ23 Q96GZ4 Q96JW3,Tubulointerstitial nephritis antigen-like,Glucocorticoid-inducible protein 5;Oxidized LDL-responsive gene 2 protein;Tubulointerstitial nephritis antigen-related protein;, PF00112;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005764;GO:0005201;GO:0043236;GO:0016197;GO:0006508;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosome;, F:extracellular matrix structural constituent; F:laminin binding;, P:endosomal transport; P:proteolysis;|Q9GZM7 A8K9Q5 B4DPK6 D3DPN8 Q8TEJ9 Q8WZ23 Q96GZ4 Q96JW3,Tubulointerstitial nephritis antigen-like,Glucocorticoid-inducible protein 5;Oxidized LDL-responsive gene 2 protein;Tubulointerstitial nephritis antigen-related protein;, PF00112;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005764;GO:0005201;GO:0043236;GO:0016197;GO:0006508;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosome;, F:extracellular matrix structural constituent; F:laminin binding;, P:endosomal transport; P:proteolysis;|Q9GZM7 A8K9Q5 B4DPK6 D3DPN8 Q8TEJ9 Q8WZ23 Q96GZ4 Q96JW3,Tubulointerstitial nephritis antigen-like,Glucocorticoid-inducible protein 5;Oxidized LDL-responsive gene 2 protein;Tubulointerstitial nephritis antigen-related protein;, PF00112;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005764;GO:0005201;GO:0043236;GO:0016197;GO:0006508;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosome;, F:extracellular matrix structural constituent; F:laminin binding;, P:endosomal transport; P:proteolysis;|Q9GZM7 A8K9Q5 B4DPK6 D3DPN8 Q8TEJ9 Q8WZ23 Q96GZ4 Q96JW3,Tubulointerstitial nephritis antigen-like,Glucocorticoid-inducible protein 5;Oxidized LDL-responsive gene 2 protein;Tubulointerstitial nephritis antigen-related protein;, PF00112;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005764;GO:0005201;GO:0043236;GO:0016197;GO:0006508;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosome;, F:extracellular matrix structural constituent; F:laminin binding;, P:endosomal transport; P:proteolysis;|Q9GZM7 A8K9Q5 B4DPK6 D3DPN8 Q8TEJ9 Q8WZ23 Q96GZ4 Q96JW3,Tubulointerstitial nephritis antigen-like,Glucocorticoid-inducible protein 5;Oxidized LDL-responsive gene 2 protein;Tubulointerstitial nephritis antigen-related protein;, PF00112;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005764;GO:0005201;GO:0043236;GO:0016197;GO:0006508;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosome;, F:extracellular matrix structural constituent; F:laminin binding;, P:endosomal transport; P:proteolysis; scaffold46 indexed_genome mRNA 14661255 14672905 . - . ID=transcript_9037;Q96SA4 A0AVB4 B4DJK5 B7Z567 B7ZAP2 E7EUZ9 Q86Y23,Serine incorporator 2,Tumor differentially expressed protein 2-like;, PF03348;, GO:0070062;GO:0016021;GO:0016020;GO:0006658;GO:1904219;GO:1904222;GO:0006665;, C:extracellular exosome; C:integral component of membrane; C:membrane;, , P:phosphatidylserine metabolic process; P:positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity; P:positive regulation of serine C-palmitoyltransferase activity; P:sphingolipid metabolic process; scaffold46 indexed_genome mRNA 14716387 14750859 . - . ID=transcript_9038;Q9NP64 B4DY38 D3DPN4 Q6PKH4 Q9NYG4 Q9P0M8,Nucleolar protein of 40 kDa,Pnn-interacting nucleolar protein;Putative S1 RNA-binding domain protein;Zinc finger CCHC domain-containing protein 17;, PF00575;, GO:0005730;GO:0042802;GO:0003723;GO:0008270;GO:0043489;, C:nucleolus;, F:identical protein binding; F:RNA binding; F:zinc ion binding;, P:RNA stabilization;|P05413 B2RAB6 Q5VV93 Q99957,Fatty acid-binding protein, heart,Fatty acid-binding protein 3;Heart-type fatty acid-binding protein;Mammary-derived growth inhibitor;Muscle fatty acid-binding protein;, PF00061;, GO:0005829;GO:0070062;GO:0005615;GO:0016528;GO:0008092;GO:0050543;GO:0036041;GO:0005324;GO:0070538;GO:0050873;GO:0042632;GO:0006631;GO:0032365;GO:0015909;GO:0008285;GO:0055091;GO:0140214;GO:0071073;GO:0046320;GO:2001245;GO:0042493;GO:0070542;GO:0032868;GO:0019433;, C:cytosol; C:extracellular exosome; C:extracellular space; C:sarcoplasm;, F:cytoskeletal protein binding; F:icosatetraenoic acid binding; F:long-chain fatty acid binding; F:long-chain fatty acid transporter activity; F:oleic acid binding;, P:brown fat cell differentiation; P:cholesterol homeostasis; P:fatty acid metabolic process; P:intracellular lipid transport; P:long-chain fatty acid transport; P:negative regulation of cell population proliferation; P:phospholipid homeostasis; P:positive regulation of long-chain fatty acid import into cell; P:positive regulation of phospholipid biosynthetic process; P:regulation of fatty acid oxidation; P:regulation of phosphatidylcholine biosynthetic process; P:response to drug; P:response to fatty acid; P:response to insulin; P:triglyceride catabolic process;|P05413 B2RAB6 Q5VV93 Q99957,Fatty acid-binding protein, heart,Fatty acid-binding protein 3;Heart-type fatty acid-binding protein;Mammary-derived growth inhibitor;Muscle fatty acid-binding protein;, PF00061;, GO:0005829;GO:0070062;GO:0005615;GO:0016528;GO:0008092;GO:0050543;GO:0036041;GO:0005324;GO:0070538;GO:0050873;GO:0042632;GO:0006631;GO:0032365;GO:0015909;GO:0008285;GO:0055091;GO:0140214;GO:0071073;GO:0046320;GO:2001245;GO:0042493;GO:0070542;GO:0032868;GO:0019433;, C:cytosol; C:extracellular exosome; C:extracellular space; C:sarcoplasm;, F:cytoskeletal protein binding; F:icosatetraenoic acid binding; F:long-chain fatty acid binding; F:long-chain fatty acid transporter activity; F:oleic acid binding;, P:brown fat cell differentiation; P:cholesterol homeostasis; P:fatty acid metabolic process; P:intracellular lipid transport; P:long-chain fatty acid transport; P:negative regulation of cell population proliferation; P:phospholipid homeostasis; P:positive regulation of long-chain fatty acid import into cell; P:positive regulation of phospholipid biosynthetic process; P:regulation of fatty acid oxidation; P:regulation of phosphatidylcholine biosynthetic process; P:response to drug; P:response to fatty acid; P:response to insulin; P:triglyceride catabolic process;|P05413 B2RAB6 Q5VV93 Q99957,Fatty acid-binding protein, heart,Fatty acid-binding protein 3;Heart-type fatty acid-binding protein;Mammary-derived growth inhibitor;Muscle fatty acid-binding protein;, PF00061;, GO:0005829;GO:0070062;GO:0005615;GO:0016528;GO:0008092;GO:0050543;GO:0036041;GO:0005324;GO:0070538;GO:0050873;GO:0042632;GO:0006631;GO:0032365;GO:0015909;GO:0008285;GO:0055091;GO:0140214;GO:0071073;GO:0046320;GO:2001245;GO:0042493;GO:0070542;GO:0032868;GO:0019433;, C:cytosol; C:extracellular exosome; C:extracellular space; C:sarcoplasm;, F:cytoskeletal protein binding; F:icosatetraenoic acid binding; F:long-chain fatty acid binding; F:long-chain fatty acid transporter activity; F:oleic acid binding;, P:brown fat cell differentiation; P:cholesterol homeostasis; P:fatty acid metabolic process; P:intracellular lipid transport; P:long-chain fatty acid transport; P:negative regulation of cell population proliferation; P:phospholipid homeostasis; P:positive regulation of long-chain fatty acid import into cell; P:positive regulation of phospholipid biosynthetic process; P:regulation of fatty acid oxidation; P:regulation of phosphatidylcholine biosynthetic process; P:response to drug; P:response to fatty acid; P:response to insulin; P:triglyceride catabolic process;|Q9NP64 B4DY38 D3DPN4 Q6PKH4 Q9NYG4 Q9P0M8,Nucleolar protein of 40 kDa,Pnn-interacting nucleolar protein;Putative S1 RNA-binding domain protein;Zinc finger CCHC domain-containing protein 17;, PF00575;, GO:0005730;GO:0042802;GO:0003723;GO:0008270;GO:0043489;, C:nucleolus;, F:identical protein binding; F:RNA binding; F:zinc ion binding;, P:RNA stabilization; scaffold46 indexed_genome mRNA 14799012 14801580 . - . ID=transcript_9039;Q96DI7 B4DQJ1 O75938 O95320,U5 small nuclear ribonucleoprotein 40 kDa protein,38 kDa-splicing factor;Prp8-binding protein;U5 snRNP-specific 40 kDa protein;WD repeat-containing protein 57;, PF00400;, GO:0071013;GO:0005829;GO:0016607;GO:0005654;GO:0005732;GO:0071007;GO:0005682;GO:0003723;GO:0000398;GO:0006396;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear speck; C:nucleoplasm; C:sno(s)RNA-containing ribonucleoprotein complex; C:U2-type catalytic step 2 spliceosome; C:U5 snRNP;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold46 indexed_genome mRNA 14807114 14807814 . - . ID=transcript_9040;Q96DI7 B4DQJ1 O75938 O95320,U5 small nuclear ribonucleoprotein 40 kDa protein,38 kDa-splicing factor;Prp8-binding protein;U5 snRNP-specific 40 kDa protein;WD repeat-containing protein 57;, PF00400;, GO:0071013;GO:0005829;GO:0016607;GO:0005654;GO:0005732;GO:0071007;GO:0005682;GO:0003723;GO:0000398;GO:0006396;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear speck; C:nucleoplasm; C:sno(s)RNA-containing ribonucleoprotein complex; C:U2-type catalytic step 2 spliceosome; C:U5 snRNP;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold46 indexed_genome mRNA 14872386 14873956 . + . ID=transcript_9041;Q4KMZ8 A2VDJ3 B7Z5F5 B7Z5W9 Q9H9M7,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1,Protein FAM77C;, PF05640;, GO:0016021;GO:0005886;GO:0051117;GO:0002028;, C:integral component of membrane; C:plasma membrane;, F:ATPase binding;, P:regulation of sodium ion transport; scaffold46 indexed_genome mRNA 14974462 15097184 . + . ID=transcript_9042;Q14671 A8K6W4 B4DG92 D3DPN3 E9PCJ0 Q53HH5 Q5VXY7 Q9HAN1,Pumilio homolog 1 {ECO:0000305},, PF00806;, GO:0005737;GO:0010494;GO:0005829;GO:0005654;GO:0000932;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:0008344;GO:0061157;GO:2000637;GO:1900246;GO:0006892;GO:0016441;GO:0010608;GO:0035196;GO:0051726;GO:0051983;GO:0060964;GO:0043488;GO:0007283;GO:0048863;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm; C:P-body;, F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:adult locomotory behavior; P:mRNA destabilization; P:positive regulation of gene silencing by miRNA; P:positive regulation of RIG-I signaling pathway; P:post-Golgi vesicle-mediated transport; P:posttranscriptional gene silencing; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of cell cycle; P:regulation of chromosome segregation; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:spermatogenesis; P:stem cell differentiation;|Q14671 A8K6W4 B4DG92 D3DPN3 E9PCJ0 Q53HH5 Q5VXY7 Q9HAN1,Pumilio homolog 1 {ECO:0000305},, PF00806;, GO:0005737;GO:0010494;GO:0005829;GO:0005654;GO:0000932;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:0008344;GO:0061157;GO:2000637;GO:1900246;GO:0006892;GO:0016441;GO:0010608;GO:0035196;GO:0051726;GO:0051983;GO:0060964;GO:0043488;GO:0007283;GO:0048863;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm; C:P-body;, F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:adult locomotory behavior; P:mRNA destabilization; P:positive regulation of gene silencing by miRNA; P:positive regulation of RIG-I signaling pathway; P:post-Golgi vesicle-mediated transport; P:posttranscriptional gene silencing; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of cell cycle; P:regulation of chromosome segregation; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:spermatogenesis; P:stem cell differentiation;|Q14671 A8K6W4 B4DG92 D3DPN3 E9PCJ0 Q53HH5 Q5VXY7 Q9HAN1,Pumilio homolog 1 {ECO:0000305},, PF00806;, GO:0005737;GO:0010494;GO:0005829;GO:0005654;GO:0000932;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:0008344;GO:0061157;GO:2000637;GO:1900246;GO:0006892;GO:0016441;GO:0010608;GO:0035196;GO:0051726;GO:0051983;GO:0060964;GO:0043488;GO:0007283;GO:0048863;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm; C:P-body;, F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:adult locomotory behavior; P:mRNA destabilization; P:positive regulation of gene silencing by miRNA; P:positive regulation of RIG-I signaling pathway; P:post-Golgi vesicle-mediated transport; P:posttranscriptional gene silencing; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of cell cycle; P:regulation of chromosome segregation; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:spermatogenesis; P:stem cell differentiation;|Q14671 A8K6W4 B4DG92 D3DPN3 E9PCJ0 Q53HH5 Q5VXY7 Q9HAN1,Pumilio homolog 1 {ECO:0000305},, PF00806;, GO:0005737;GO:0010494;GO:0005829;GO:0005654;GO:0000932;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:0008344;GO:0061157;GO:2000637;GO:1900246;GO:0006892;GO:0016441;GO:0010608;GO:0035196;GO:0051726;GO:0051983;GO:0060964;GO:0043488;GO:0007283;GO:0048863;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm; C:P-body;, F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:adult locomotory behavior; P:mRNA destabilization; P:positive regulation of gene silencing by miRNA; P:positive regulation of RIG-I signaling pathway; P:post-Golgi vesicle-mediated transport; P:posttranscriptional gene silencing; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of cell cycle; P:regulation of chromosome segregation; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:spermatogenesis; P:stem cell differentiation;|Q14671 A8K6W4 B4DG92 D3DPN3 E9PCJ0 Q53HH5 Q5VXY7 Q9HAN1,Pumilio homolog 1 {ECO:0000305},, PF00806;, GO:0005737;GO:0010494;GO:0005829;GO:0005654;GO:0000932;GO:0035198;GO:0003730;GO:0003729;GO:0003723;GO:0008344;GO:0061157;GO:2000637;GO:1900246;GO:0006892;GO:0016441;GO:0010608;GO:0035196;GO:0051726;GO:0051983;GO:0060964;GO:0043488;GO:0007283;GO:0048863;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleoplasm; C:P-body;, F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:adult locomotory behavior; P:mRNA destabilization; P:positive regulation of gene silencing by miRNA; P:positive regulation of RIG-I signaling pathway; P:post-Golgi vesicle-mediated transport; P:posttranscriptional gene silencing; P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of cell cycle; P:regulation of chromosome segregation; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:spermatogenesis; P:stem cell differentiation; scaffold46 indexed_genome mRNA 15142068 15152174 . + . ID=transcript_9043;O75056 Q5T1Z6 Q5T1Z7 Q96CT3 Q96PR8,Syndecan-3,, PF01034;, GO:0009986;GO:0062023;GO:0005796;GO:0016021;GO:0043202;GO:0016020;GO:0044393;GO:0005886;GO:0042802;GO:0016477;GO:0006024;GO:0006027;GO:0050900;GO:0001523;, C:cell surface; C:collagen-containing extracellular matrix; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:membrane; C:microspike; C:plasma membrane;, F:identical protein binding;, P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:leukocyte migration; P:retinoid metabolic process;|O75056 Q5T1Z6 Q5T1Z7 Q96CT3 Q96PR8,Syndecan-3,, PF01034;, GO:0009986;GO:0062023;GO:0005796;GO:0016021;GO:0043202;GO:0016020;GO:0044393;GO:0005886;GO:0042802;GO:0016477;GO:0006024;GO:0006027;GO:0050900;GO:0001523;, C:cell surface; C:collagen-containing extracellular matrix; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:membrane; C:microspike; C:plasma membrane;, F:identical protein binding;, P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:leukocyte migration; P:retinoid metabolic process;|O75056 Q5T1Z6 Q5T1Z7 Q96CT3 Q96PR8,Syndecan-3,, PF01034;, GO:0009986;GO:0062023;GO:0005796;GO:0016021;GO:0043202;GO:0016020;GO:0044393;GO:0005886;GO:0042802;GO:0016477;GO:0006024;GO:0006027;GO:0050900;GO:0001523;, C:cell surface; C:collagen-containing extracellular matrix; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:membrane; C:microspike; C:plasma membrane;, F:identical protein binding;, P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:leukocyte migration; P:retinoid metabolic process; scaffold46 indexed_genome mRNA 15270004 15279842 . + . ID=transcript_9044;Q13571 Q13240 Q14698 Q3KP54,Lysosomal-associated transmembrane protein 5,Lysosomal-associated multitransmembrane protein 5;Retinoic acid-inducible E3 protein;, PF03821;, GO:0031410;GO:0005829;GO:0005887;GO:0005765;GO:0005764;GO:0048471;GO:0032991;GO:0030133;GO:0140311;GO:0031625;GO:0140036;GO:0006919;GO:0002357;GO:0090160;GO:0012502;GO:0006886;GO:1904093;GO:0050869;GO:0032689;GO:0032703;GO:0050868;GO:0050860;GO:0002720;GO:0032735;GO:0097214;GO:0060907;GO:0043410;GO:1901224;GO:0031398;GO:2000646;GO:1903265;GO:2000060;GO:0006622;, C:cytoplasmic vesicle; C:cytosol; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:protein-containing complex; C:transport vesicle;, F:protein sequestering activity; F:ubiquitin protein ligase binding; F:ubiquitin-dependent protein binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:defense response to tumor cell; P:Golgi to lysosome transport; P:induction of programmed cell death; P:intracellular protein transport; P:negative regulation of autophagic cell death; P:negative regulation of B cell activation; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-2 production; P:negative regulation of T cell activation; P:negative regulation of T cell receptor signaling pathway; P:positive regulation of cytokine production involved in immune response; P:positive regulation of interleukin-12 production; P:positive regulation of lysosomal membrane permeability; P:positive regulation of macrophage cytokine production; P:positive regulation of MAPK cascade; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein ubiquitination; P:positive regulation of receptor catabolic process; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein targeting to lysosome;|Q13571 Q13240 Q14698 Q3KP54,Lysosomal-associated transmembrane protein 5,Lysosomal-associated multitransmembrane protein 5;Retinoic acid-inducible E3 protein;, PF03821;, GO:0031410;GO:0005829;GO:0005887;GO:0005765;GO:0005764;GO:0048471;GO:0032991;GO:0030133;GO:0140311;GO:0031625;GO:0140036;GO:0006919;GO:0002357;GO:0090160;GO:0012502;GO:0006886;GO:1904093;GO:0050869;GO:0032689;GO:0032703;GO:0050868;GO:0050860;GO:0002720;GO:0032735;GO:0097214;GO:0060907;GO:0043410;GO:1901224;GO:0031398;GO:2000646;GO:1903265;GO:2000060;GO:0006622;, C:cytoplasmic vesicle; C:cytosol; C:integral component of plasma membrane; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:protein-containing complex; C:transport vesicle;, F:protein sequestering activity; F:ubiquitin protein ligase binding; F:ubiquitin-dependent protein binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:defense response to tumor cell; P:Golgi to lysosome transport; P:induction of programmed cell death; P:intracellular protein transport; P:negative regulation of autophagic cell death; P:negative regulation of B cell activation; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-2 production; P:negative regulation of T cell activation; P:negative regulation of T cell receptor signaling pathway; P:positive regulation of cytokine production involved in immune response; P:positive regulation of interleukin-12 production; P:positive regulation of lysosomal membrane permeability; P:positive regulation of macrophage cytokine production; P:positive regulation of MAPK cascade; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein ubiquitination; P:positive regulation of receptor catabolic process; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein targeting to lysosome; scaffold46 indexed_genome mRNA 16604587 16624171 . - . ID=transcript_9045;Q92729 A6H8L1 O00197 P78399 Q59HA4 Q5SYU4 Q5SYU5 Q92735 Q92850,Receptor-type tyrosine-protein phosphatase U,Pancreatic carcinoma phosphatase 2;Protein-tyrosine phosphatase J;Protein-tyrosine phosphatase pi;Protein-tyrosine phosphatase receptor omicron;Receptor-type protein-tyrosine phosphatase psi;, PF00041;PF00629;PF00102;, GO:0005911;GO:0005887;GO:0005886;GO:0008013;GO:0004725;GO:0005001;GO:0031100;GO:0007155;GO:0030154;GO:0034109;GO:0090090;GO:0030336;GO:0008285;GO:2000049;GO:0006470;GO:0034394;GO:0051384;GO:0007185;, C:cell-cell junction; C:integral component of plasma membrane; C:plasma membrane;, F:beta-catenin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:animal organ regeneration; P:cell adhesion; P:cell differentiation; P:homotypic cell-cell adhesion; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:protein dephosphorylation; P:protein localization to cell surface; P:response to glucocorticoid; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; scaffold46 indexed_genome mRNA 16624656 16648834 . - . ID=transcript_9046;Q92729 A6H8L1 O00197 P78399 Q59HA4 Q5SYU4 Q5SYU5 Q92735 Q92850,Receptor-type tyrosine-protein phosphatase U,Pancreatic carcinoma phosphatase 2;Protein-tyrosine phosphatase J;Protein-tyrosine phosphatase pi;Protein-tyrosine phosphatase receptor omicron;Receptor-type protein-tyrosine phosphatase psi;, PF00041;PF00629;PF00102;, GO:0005911;GO:0005887;GO:0005886;GO:0008013;GO:0004725;GO:0005001;GO:0031100;GO:0007155;GO:0030154;GO:0034109;GO:0090090;GO:0030336;GO:0008285;GO:2000049;GO:0006470;GO:0034394;GO:0051384;GO:0007185;, C:cell-cell junction; C:integral component of plasma membrane; C:plasma membrane;, F:beta-catenin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:animal organ regeneration; P:cell adhesion; P:cell differentiation; P:homotypic cell-cell adhesion; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:protein dephosphorylation; P:protein localization to cell surface; P:response to glucocorticoid; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; scaffold46 indexed_genome mRNA 16649129 16674114 . - . ID=transcript_9047;Q92729 A6H8L1 O00197 P78399 Q59HA4 Q5SYU4 Q5SYU5 Q92735 Q92850,Receptor-type tyrosine-protein phosphatase U,Pancreatic carcinoma phosphatase 2;Protein-tyrosine phosphatase J;Protein-tyrosine phosphatase pi;Protein-tyrosine phosphatase receptor omicron;Receptor-type protein-tyrosine phosphatase psi;, PF00041;PF00629;PF00102;, GO:0005911;GO:0005887;GO:0005886;GO:0008013;GO:0004725;GO:0005001;GO:0031100;GO:0007155;GO:0030154;GO:0034109;GO:0090090;GO:0030336;GO:0008285;GO:2000049;GO:0006470;GO:0034394;GO:0051384;GO:0007185;, C:cell-cell junction; C:integral component of plasma membrane; C:plasma membrane;, F:beta-catenin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:animal organ regeneration; P:cell adhesion; P:cell differentiation; P:homotypic cell-cell adhesion; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:protein dephosphorylation; P:protein localization to cell surface; P:response to glucocorticoid; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; scaffold46 indexed_genome mRNA 16702945 16740135 . + . ID=transcript_9048;Q9BV79 B3KT72 Q5SYU0 Q5SYU1 Q5SYU2 Q6IBU9 Q9Y373,Enoyl-[acyl-carrier-protein] reductase, mitochondrial {ECO:0000305},2-enoyl thioester reductase {ECO:0000303|PubMed:12654921, ECO:0000303|PubMed:18479707};Nuclear receptor-binding factor 1;, PF08240;PF00107;, GO:0005759;GO:0005739;GO:0005634;GO:0019166;GO:0006635;GO:0006633;GO:0006631;, C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:trans-2-enoyl-CoA reductase (NADPH) activity;, P:fatty acid beta-oxidation; P:fatty acid biosynthetic process; P:fatty acid metabolic process; scaffold46 indexed_genome mRNA 16768118 16782045 . + . ID=transcript_9049;Q08170 Q5VXP1 Q9BUA4 Q9UEB5,Serine/arginine-rich splicing factor 4,Pre-mRNA-splicing factor SRP75;SRP001LB;Splicing factor, arginine/serine-rich 4;, PF00076;, GO:0016607;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:1990825;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0032868;GO:0006405;GO:0008380;GO:0000375;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:sequence-specific mRNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:response to insulin; P:RNA export from nucleus; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q08170 Q5VXP1 Q9BUA4 Q9UEB5,Serine/arginine-rich splicing factor 4,Pre-mRNA-splicing factor SRP75;SRP001LB;Splicing factor, arginine/serine-rich 4;, PF00076;, GO:0016607;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:1990825;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0032868;GO:0006405;GO:0008380;GO:0000375;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:sequence-specific mRNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:response to insulin; P:RNA export from nucleus; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q08170 Q5VXP1 Q9BUA4 Q9UEB5,Serine/arginine-rich splicing factor 4,Pre-mRNA-splicing factor SRP75;SRP001LB;Splicing factor, arginine/serine-rich 4;, PF00076;, GO:0016607;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:1990825;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0032868;GO:0006405;GO:0008380;GO:0000375;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:sequence-specific mRNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:response to insulin; P:RNA export from nucleus; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q08170 Q5VXP1 Q9BUA4 Q9UEB5,Serine/arginine-rich splicing factor 4,Pre-mRNA-splicing factor SRP75;SRP001LB;Splicing factor, arginine/serine-rich 4;, PF00076;, GO:0016607;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:1990825;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0032868;GO:0006405;GO:0008380;GO:0000375;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:sequence-specific mRNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:response to insulin; P:RNA export from nucleus; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold46 indexed_genome mRNA 16815610 16837142 . - . ID=transcript_9050;Q8IXV9 Q9Y578 Q9Y579,Protein 4.1,4.1R;Band 4.1;EPB4.1;Erythrocyte membrane protein band 4.1 {ECO:0000312|HGNC:HGNC:3377};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0016323;GO:0099738;GO:0030054;GO:0030863;GO:0009898;GO:0005856;GO:0005829;GO:0045171;GO:0072686;GO:0016604;GO:0005886;GO:0014069;GO:0032991;GO:0014731;GO:0005545;GO:0003779;GO:0005516;GO:0051219;GO:0008022;GO:0047485;GO:0030507;GO:0005200;GO:0030036;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:0032092;GO:1904778;GO:0065003;GO:0051924;GO:0008360;GO:1904478;, C:basolateral plasma membrane; C:cell cortex region; C:cell junction; C:cortical cytoskeleton; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:intercellular bridge; C:mitotic spindle; C:nuclear body; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:spectrin-associated cytoskeleton;, F:1-phosphatidylinositol binding; F:actin binding; F:calmodulin binding; F:phosphoprotein binding; F:protein C-terminus binding; F:protein N-terminus binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein binding; P:positive regulation of protein localization to cell cortex; P:protein-containing complex assembly; P:regulation of calcium ion transport; P:regulation of cell shape; P:regulation of intestinal absorption;|Q8IXV9 Q9Y578 Q9Y579,Protein 4.1,4.1R;Band 4.1;EPB4.1;Erythrocyte membrane protein band 4.1 {ECO:0000312|HGNC:HGNC:3377};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0016323;GO:0099738;GO:0030054;GO:0030863;GO:0009898;GO:0005856;GO:0005829;GO:0045171;GO:0072686;GO:0016604;GO:0005886;GO:0014069;GO:0032991;GO:0014731;GO:0005545;GO:0003779;GO:0005516;GO:0051219;GO:0008022;GO:0047485;GO:0030507;GO:0005200;GO:0030036;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:0032092;GO:1904778;GO:0065003;GO:0051924;GO:0008360;GO:1904478;, C:basolateral plasma membrane; C:cell cortex region; C:cell junction; C:cortical cytoskeleton; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:intercellular bridge; C:mitotic spindle; C:nuclear body; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:spectrin-associated cytoskeleton;, F:1-phosphatidylinositol binding; F:actin binding; F:calmodulin binding; F:phosphoprotein binding; F:protein C-terminus binding; F:protein N-terminus binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein binding; P:positive regulation of protein localization to cell cortex; P:protein-containing complex assembly; P:regulation of calcium ion transport; P:regulation of cell shape; P:regulation of intestinal absorption;|Q8IXV9 Q9Y578 Q9Y579,Protein 4.1,4.1R;Band 4.1;EPB4.1;Erythrocyte membrane protein band 4.1 {ECO:0000312|HGNC:HGNC:3377};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0016323;GO:0099738;GO:0030054;GO:0030863;GO:0009898;GO:0005856;GO:0005829;GO:0045171;GO:0072686;GO:0016604;GO:0005886;GO:0014069;GO:0032991;GO:0014731;GO:0005545;GO:0003779;GO:0005516;GO:0051219;GO:0008022;GO:0047485;GO:0030507;GO:0005200;GO:0030036;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:0032092;GO:1904778;GO:0065003;GO:0051924;GO:0008360;GO:1904478;, C:basolateral plasma membrane; C:cell cortex region; C:cell junction; C:cortical cytoskeleton; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:intercellular bridge; C:mitotic spindle; C:nuclear body; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:spectrin-associated cytoskeleton;, F:1-phosphatidylinositol binding; F:actin binding; F:calmodulin binding; F:phosphoprotein binding; F:protein C-terminus binding; F:protein N-terminus binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein binding; P:positive regulation of protein localization to cell cortex; P:protein-containing complex assembly; P:regulation of calcium ion transport; P:regulation of cell shape; P:regulation of intestinal absorption; scaffold46 indexed_genome mRNA 16852458 16994002 . - . ID=transcript_9051;Q8IXV9 Q9Y578 Q9Y579,Protein 4.1,4.1R;Band 4.1;EPB4.1;Erythrocyte membrane protein band 4.1 {ECO:0000312|HGNC:HGNC:3377};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0016323;GO:0099738;GO:0030054;GO:0030863;GO:0009898;GO:0005856;GO:0005829;GO:0045171;GO:0072686;GO:0016604;GO:0005886;GO:0014069;GO:0032991;GO:0014731;GO:0005545;GO:0003779;GO:0005516;GO:0051219;GO:0008022;GO:0047485;GO:0030507;GO:0005200;GO:0030036;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:0032092;GO:1904778;GO:0065003;GO:0051924;GO:0008360;GO:1904478;, C:basolateral plasma membrane; C:cell cortex region; C:cell junction; C:cortical cytoskeleton; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:intercellular bridge; C:mitotic spindle; C:nuclear body; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:spectrin-associated cytoskeleton;, F:1-phosphatidylinositol binding; F:actin binding; F:calmodulin binding; F:phosphoprotein binding; F:protein C-terminus binding; F:protein N-terminus binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein binding; P:positive regulation of protein localization to cell cortex; P:protein-containing complex assembly; P:regulation of calcium ion transport; P:regulation of cell shape; P:regulation of intestinal absorption;|Q8IXV9 Q9Y578 Q9Y579,Protein 4.1,4.1R;Band 4.1;EPB4.1;Erythrocyte membrane protein band 4.1 {ECO:0000312|HGNC:HGNC:3377};, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0016323;GO:0099738;GO:0030054;GO:0030863;GO:0009898;GO:0005856;GO:0005829;GO:0045171;GO:0072686;GO:0016604;GO:0005886;GO:0014069;GO:0032991;GO:0014731;GO:0005545;GO:0003779;GO:0005516;GO:0051219;GO:0008022;GO:0047485;GO:0030507;GO:0005200;GO:0030036;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:0032092;GO:1904778;GO:0065003;GO:0051924;GO:0008360;GO:1904478;, C:basolateral plasma membrane; C:cell cortex region; C:cell junction; C:cortical cytoskeleton; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:intercellular bridge; C:mitotic spindle; C:nuclear body; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:spectrin-associated cytoskeleton;, F:1-phosphatidylinositol binding; F:actin binding; F:calmodulin binding; F:phosphoprotein binding; F:protein C-terminus binding; F:protein N-terminus binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin cytoskeleton organization; P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein binding; P:positive regulation of protein localization to cell cortex; P:protein-containing complex assembly; P:regulation of calcium ion transport; P:regulation of cell shape; P:regulation of intestinal absorption; scaffold46 indexed_genome mRNA 17095224 17124370 . - . ID=transcript_9052;Q9Y5A9 A6NKG4 A8K966 B4E1G7 D3DPM8 Q5VSZ9 Q8TDH0 Q9BUJ5,YTH domain-containing family protein 2 {ECO:0000305},CLL-associated antigen KW-14 {ECO:0000303|Ref.3};High-glucose-regulated protein 8 {ECO:0000303|Ref.2};Renal carcinoma antigen NY-REN-2 {ECO:0000303|PubMed:10508479};, PF04146;, GO:0034451;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0005634;GO:0000932;GO:0062153;GO:0003729;GO:1990247;GO:0003723;GO:0048598;GO:0098508;GO:0007276;GO:0071425;GO:0006959;GO:0045087;GO:0006402;GO:0061157;GO:0045746;GO:2000737;GO:0060339;GO:0001556;GO:0070925;GO:1903679;GO:0030155;GO:1902036;GO:1903538;GO:0043488;GO:0050767;GO:2000232;GO:0007284;GO:0034063;GO:0016032;, C:centriolar satellite; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:nucleus; C:P-body;, F:C5-methylcytidine-containing RNA binding; F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:RNA binding;, P:embryonic morphogenesis; P:endothelial to hematopoietic transition; P:gamete generation; P:hematopoietic stem cell proliferation; P:humoral immune response; P:innate immune response; P:mRNA catabolic process; P:mRNA destabilization; P:negative regulation of Notch signaling pathway; P:negative regulation of stem cell differentiation; P:negative regulation of type I interferon-mediated signaling pathway; P:oocyte maturation; P:organelle assembly; P:positive regulation of cap-independent translational initiation; P:regulation of cell adhesion; P:regulation of hematopoietic stem cell differentiation; P:regulation of meiotic cell cycle process involved in oocyte maturation; P:regulation of mRNA stability; P:regulation of neurogenesis; P:regulation of rRNA processing; P:spermatogonial cell division; P:stress granule assembly; P:viral process; scaffold46 indexed_genome mRNA 17142409 17174423 . - . ID=transcript_9053;Q9Y692 B1AT48 Q9NWH1 Q9UKD0,Glucocorticoid modulatory element-binding protein 1,DNA-binding protein p96PIF;Parvovirus initiation factor p96;, PF01342;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0051008;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:Hsp27 protein binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold46 indexed_genome mRNA 17193345 17220333 . + . ID=transcript_9054;Q16514 D3DPM5 Q15775 Q5T077,Transcription initiation factor TFIID subunit 12,Transcription initiation factor TFIID 20/15 kDa subunits;, PF03847;, GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0046695;GO:0030914;GO:0005669;GO:0033276;GO:0003677;GO:0046982;GO:0017025;GO:0003713;GO:0008134;GO:0006352;GO:0043966;GO:0051091;GO:1901796;GO:0051123;GO:0006366;GO:0006367;, C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:SLIK (SAGA-like) complex; C:STAGA complex; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:DNA binding; F:protein heterodimerization activity; F:TBP-class protein binding; F:transcription coactivator activity; F:transcription factor binding;, P:DNA-templated transcription, initiation; P:histone H3 acetylation; P:positive regulation of DNA-binding transcription factor activity; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold46 indexed_genome mRNA 17220625 17221187 . + . ID=transcript_9055;Q96DA2 Q5JT79 Q8NEX3,Ras-related protein Rab-39B,, PF00071;, GO:0030659;GO:0005794;GO:0000139;GO:0043005;GO:0005886;GO:0031982;GO:0005525;GO:0003924;GO:0031489;GO:0006914;GO:0015031;GO:0032482;GO:0010506;GO:0050808;GO:0016192;, C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:neuron projection; C:plasma membrane; C:vesicle;, F:GTP binding; F:GTPase activity; F:myosin V binding;, P:autophagy; P:protein transport; P:Rab protein signal transduction; P:regulation of autophagy; P:synapse organization; P:vesicle-mediated transport; scaffold46 indexed_genome mRNA 17237452 17251082 . + . ID=transcript_9056;Q9NX07 Q86SU7,tRNA selenocysteine 1-associated protein 1,SECp43;tRNA selenocysteine-associated protein 1;, PF00076;PF17654;, GO:0005737;GO:0005634;GO:0003723;GO:0000049;GO:0001514;, C:cytoplasm; C:nucleus;, F:RNA binding; F:tRNA binding;, P:selenocysteine incorporation;|Q9NX07 Q86SU7,tRNA selenocysteine 1-associated protein 1,SECp43;tRNA selenocysteine-associated protein 1;, PF00076;PF17654;, GO:0005737;GO:0005634;GO:0003723;GO:0000049;GO:0001514;, C:cytoplasm; C:nucleus;, F:RNA binding; F:tRNA binding;, P:selenocysteine incorporation;|Q9NX07 Q86SU7,tRNA selenocysteine 1-associated protein 1,SECp43;tRNA selenocysteine-associated protein 1;, PF00076;PF17654;, GO:0005737;GO:0005634;GO:0003723;GO:0000049;GO:0001514;, C:cytoplasm; C:nucleus;, F:RNA binding; F:tRNA binding;, P:selenocysteine incorporation;|Q9NX07 Q86SU7,tRNA selenocysteine 1-associated protein 1,SECp43;tRNA selenocysteine-associated protein 1;, PF00076;PF17654;, GO:0005737;GO:0005634;GO:0003723;GO:0000049;GO:0001514;, C:cytoplasm; C:nucleus;, F:RNA binding; F:tRNA binding;, P:selenocysteine incorporation; scaffold46 indexed_genome mRNA 17251103 17258625 . - . ID=transcript_9057;Q9NX07 Q86SU7,tRNA selenocysteine 1-associated protein 1,SECp43;tRNA selenocysteine-associated protein 1;, PF00076;PF17654;, GO:0005737;GO:0005634;GO:0003723;GO:0000049;GO:0001514;, C:cytoplasm; C:nucleus;, F:RNA binding; F:tRNA binding;, P:selenocysteine incorporation; scaffold46 indexed_genome mRNA 17261764 17274615 . - . ID=transcript_9058;P18754 Q16269 Q6NT97,Regulator of chromosome condensation,Cell cycle regulatory protein;Chromosome condensation protein 1;, PF00415;, GO:0000785;GO:0005694;GO:0000794;GO:0005737;GO:0031965;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0005085;GO:0042393;GO:0031492;GO:0031491;GO:0046982;GO:0031267;GO:0043199;GO:0051301;GO:0007059;GO:0000082;GO:0007084;GO:0007052;GO:0031291;GO:0007088;GO:1901673;GO:0051225;GO:0016032;, C:chromatin; C:chromosome; C:condensed nuclear chromosome; C:cytoplasm; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:guanyl-nucleotide exchange factor activity; F:histone binding; F:nucleosomal DNA binding; F:nucleosome binding; F:protein heterodimerization activity; F:small GTPase binding; F:sulfate binding;, P:cell division; P:chromosome segregation; P:G1/S transition of mitotic cell cycle; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:Ran protein signal transduction; P:regulation of mitotic nuclear division; P:regulation of mitotic spindle assembly; P:spindle assembly; P:viral process;|P18754 Q16269 Q6NT97,Regulator of chromosome condensation,Cell cycle regulatory protein;Chromosome condensation protein 1;, PF00415;, GO:0000785;GO:0005694;GO:0000794;GO:0005737;GO:0031965;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0005085;GO:0042393;GO:0031492;GO:0031491;GO:0046982;GO:0031267;GO:0043199;GO:0051301;GO:0007059;GO:0000082;GO:0007084;GO:0007052;GO:0031291;GO:0007088;GO:1901673;GO:0051225;GO:0016032;, C:chromatin; C:chromosome; C:condensed nuclear chromosome; C:cytoplasm; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:guanyl-nucleotide exchange factor activity; F:histone binding; F:nucleosomal DNA binding; F:nucleosome binding; F:protein heterodimerization activity; F:small GTPase binding; F:sulfate binding;, P:cell division; P:chromosome segregation; P:G1/S transition of mitotic cell cycle; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:Ran protein signal transduction; P:regulation of mitotic nuclear division; P:regulation of mitotic spindle assembly; P:spindle assembly; P:viral process; scaffold46 indexed_genome mRNA 17307645 17336468 . - . ID=transcript_9059;Q9H8W6,Phosphatase and actin regulator 4,, PF02755;, GO:0005737;GO:0030027;GO:0003779;GO:0008157;GO:0072542;GO:0030036;GO:0061386;GO:0048484;GO:2001045;GO:0001755;GO:0001843;GO:0043085;GO:0051726;GO:0007266;, C:cytoplasm; C:lamellipodium;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase activator activity;, P:actin cytoskeleton organization; P:closure of optic fissure; P:enteric nervous system development; P:negative regulation of integrin-mediated signaling pathway; P:neural crest cell migration; P:neural tube closure; P:positive regulation of catalytic activity; P:regulation of cell cycle; P:Rho protein signal transduction;|Q9H8W6,Phosphatase and actin regulator 4,, PF02755;, GO:0005737;GO:0030027;GO:0003779;GO:0008157;GO:0072542;GO:0030036;GO:0061386;GO:0048484;GO:2001045;GO:0001755;GO:0001843;GO:0043085;GO:0051726;GO:0007266;, C:cytoplasm; C:lamellipodium;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase activator activity;, P:actin cytoskeleton organization; P:closure of optic fissure; P:enteric nervous system development; P:negative regulation of integrin-mediated signaling pathway; P:neural crest cell migration; P:neural tube closure; P:positive regulation of catalytic activity; P:regulation of cell cycle; P:Rho protein signal transduction;|Q9H8W6,Phosphatase and actin regulator 4,, PF02755;, GO:0005737;GO:0030027;GO:0003779;GO:0008157;GO:0072542;GO:0030036;GO:0061386;GO:0048484;GO:2001045;GO:0001755;GO:0001843;GO:0043085;GO:0051726;GO:0007266;, C:cytoplasm; C:lamellipodium;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase activator activity;, P:actin cytoskeleton organization; P:closure of optic fissure; P:enteric nervous system development; P:negative regulation of integrin-mediated signaling pathway; P:neural crest cell migration; P:neural tube closure; P:positive regulation of catalytic activity; P:regulation of cell cycle; P:Rho protein signal transduction; scaffold46 indexed_genome mRNA 17447860 17452988 . - . ID=transcript_9060;Q9BUE0 D3DPM1 Q9NXU9,Mediator of RNA polymerase II transcription subunit 18,Mediator complex subunit 18;p28b;, PF09637;, GO:0070847;GO:0016592;GO:0000151;GO:0003712;GO:0061630;GO:0006357;GO:0006369;, C:core mediator complex; C:mediator complex; C:ubiquitin ligase complex;, F:transcription coregulator activity; F:ubiquitin protein ligase activity;, P:regulation of transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; scaffold46 indexed_genome mRNA 17490027 17507578 . - . ID=transcript_9061;P58004 Q5T7D0 Q96SI5,Sestrin-2 {ECO:0000305},Hypoxia-induced gene {ECO:0000303|PubMed:12203114};, PF04636;, GO:0005737;GO:0005829;GO:0005739;GO:0031588;GO:0005634;GO:0031932;GO:0005092;GO:0070728;GO:0016684;GO:0032542;GO:0098869;GO:0034198;GO:0071230;GO:0042149;GO:0071233;GO:1990253;GO:0034599;GO:0030330;GO:0006635;GO:0042593;GO:0046323;GO:0032042;GO:0030308;GO:1904262;GO:1902010;GO:1904504;GO:0016239;GO:1900182;GO:0036091;GO:0043491;GO:0072593;GO:2000479;GO:0006111;GO:0001932;GO:1901031;GO:0009749;GO:0032868;GO:0070328;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleotide-activated protein kinase complex; C:nucleus; C:TORC2 complex;, F:GDP-dissociation inhibitor activity; F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:sulfiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to oxidative stress; P:DNA damage response, signal transduction by p53 class mediator; P:fatty acid beta-oxidation; P:glucose homeostasis; P:glucose import; P:mitochondrial DNA metabolic process; P:negative regulation of cell growth; P:negative regulation of TORC1 signaling; P:negative regulation of translation in response to endoplasmic reticulum stress; P:positive regulation of lipophagy; P:positive regulation of macroautophagy; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:protein kinase B signaling; P:reactive oxygen species metabolic process; P:regulation of cAMP-dependent protein kinase activity; P:regulation of gluconeogenesis; P:regulation of protein phosphorylation; P:regulation of response to reactive oxygen species; P:response to glucose; P:response to insulin; P:triglyceride homeostasis;|P58004 Q5T7D0 Q96SI5,Sestrin-2 {ECO:0000305},Hypoxia-induced gene {ECO:0000303|PubMed:12203114};, PF04636;, GO:0005737;GO:0005829;GO:0005739;GO:0031588;GO:0005634;GO:0031932;GO:0005092;GO:0070728;GO:0016684;GO:0032542;GO:0098869;GO:0034198;GO:0071230;GO:0042149;GO:0071233;GO:1990253;GO:0034599;GO:0030330;GO:0006635;GO:0042593;GO:0046323;GO:0032042;GO:0030308;GO:1904262;GO:1902010;GO:1904504;GO:0016239;GO:1900182;GO:0036091;GO:0043491;GO:0072593;GO:2000479;GO:0006111;GO:0001932;GO:1901031;GO:0009749;GO:0032868;GO:0070328;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleotide-activated protein kinase complex; C:nucleus; C:TORC2 complex;, F:GDP-dissociation inhibitor activity; F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:sulfiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to oxidative stress; P:DNA damage response, signal transduction by p53 class mediator; P:fatty acid beta-oxidation; P:glucose homeostasis; P:glucose import; P:mitochondrial DNA metabolic process; P:negative regulation of cell growth; P:negative regulation of TORC1 signaling; P:negative regulation of translation in response to endoplasmic reticulum stress; P:positive regulation of lipophagy; P:positive regulation of macroautophagy; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:protein kinase B signaling; P:reactive oxygen species metabolic process; P:regulation of cAMP-dependent protein kinase activity; P:regulation of gluconeogenesis; P:regulation of protein phosphorylation; P:regulation of response to reactive oxygen species; P:response to glucose; P:response to insulin; P:triglyceride homeostasis;|P58004 Q5T7D0 Q96SI5,Sestrin-2 {ECO:0000305},Hypoxia-induced gene {ECO:0000303|PubMed:12203114};, PF04636;, GO:0005737;GO:0005829;GO:0005739;GO:0031588;GO:0005634;GO:0031932;GO:0005092;GO:0070728;GO:0016684;GO:0032542;GO:0098869;GO:0034198;GO:0071230;GO:0042149;GO:0071233;GO:1990253;GO:0034599;GO:0030330;GO:0006635;GO:0042593;GO:0046323;GO:0032042;GO:0030308;GO:1904262;GO:1902010;GO:1904504;GO:0016239;GO:1900182;GO:0036091;GO:0043491;GO:0072593;GO:2000479;GO:0006111;GO:0001932;GO:1901031;GO:0009749;GO:0032868;GO:0070328;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleotide-activated protein kinase complex; C:nucleus; C:TORC2 complex;, F:GDP-dissociation inhibitor activity; F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:sulfiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to oxidative stress; P:DNA damage response, signal transduction by p53 class mediator; P:fatty acid beta-oxidation; P:glucose homeostasis; P:glucose import; P:mitochondrial DNA metabolic process; P:negative regulation of cell growth; P:negative regulation of TORC1 signaling; P:negative regulation of translation in response to endoplasmic reticulum stress; P:positive regulation of lipophagy; P:positive regulation of macroautophagy; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:protein kinase B signaling; P:reactive oxygen species metabolic process; P:regulation of cAMP-dependent protein kinase activity; P:regulation of gluconeogenesis; P:regulation of protein phosphorylation; P:regulation of response to reactive oxygen species; P:response to glucose; P:response to insulin; P:triglyceride homeostasis;|P58004 Q5T7D0 Q96SI5,Sestrin-2 {ECO:0000305},Hypoxia-induced gene {ECO:0000303|PubMed:12203114};, PF04636;, GO:0005737;GO:0005829;GO:0005739;GO:0031588;GO:0005634;GO:0031932;GO:0005092;GO:0070728;GO:0016684;GO:0032542;GO:0098869;GO:0034198;GO:0071230;GO:0042149;GO:0071233;GO:1990253;GO:0034599;GO:0030330;GO:0006635;GO:0042593;GO:0046323;GO:0032042;GO:0030308;GO:1904262;GO:1902010;GO:1904504;GO:0016239;GO:1900182;GO:0036091;GO:0043491;GO:0072593;GO:2000479;GO:0006111;GO:0001932;GO:1901031;GO:0009749;GO:0032868;GO:0070328;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleotide-activated protein kinase complex; C:nucleus; C:TORC2 complex;, F:GDP-dissociation inhibitor activity; F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:sulfiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to oxidative stress; P:DNA damage response, signal transduction by p53 class mediator; P:fatty acid beta-oxidation; P:glucose homeostasis; P:glucose import; P:mitochondrial DNA metabolic process; P:negative regulation of cell growth; P:negative regulation of TORC1 signaling; P:negative regulation of translation in response to endoplasmic reticulum stress; P:positive regulation of lipophagy; P:positive regulation of macroautophagy; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:protein kinase B signaling; P:reactive oxygen species metabolic process; P:regulation of cAMP-dependent protein kinase activity; P:regulation of gluconeogenesis; P:regulation of protein phosphorylation; P:regulation of response to reactive oxygen species; P:response to glucose; P:response to insulin; P:triglyceride homeostasis;|P58004 Q5T7D0 Q96SI5,Sestrin-2 {ECO:0000305},Hypoxia-induced gene {ECO:0000303|PubMed:12203114};, PF04636;, GO:0005737;GO:0005829;GO:0005739;GO:0031588;GO:0005634;GO:0031932;GO:0005092;GO:0070728;GO:0016684;GO:0032542;GO:0098869;GO:0034198;GO:0071230;GO:0042149;GO:0071233;GO:1990253;GO:0034599;GO:0030330;GO:0006635;GO:0042593;GO:0046323;GO:0032042;GO:0030308;GO:1904262;GO:1902010;GO:1904504;GO:0016239;GO:1900182;GO:0036091;GO:0043491;GO:0072593;GO:2000479;GO:0006111;GO:0001932;GO:1901031;GO:0009749;GO:0032868;GO:0070328;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleotide-activated protein kinase complex; C:nucleus; C:TORC2 complex;, F:GDP-dissociation inhibitor activity; F:leucine binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:sulfiredoxin activity;, P:cellular oxidant detoxification; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to glucose starvation; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to oxidative stress; P:DNA damage response, signal transduction by p53 class mediator; P:fatty acid beta-oxidation; P:glucose homeostasis; P:glucose import; P:mitochondrial DNA metabolic process; P:negative regulation of cell growth; P:negative regulation of TORC1 signaling; P:negative regulation of translation in response to endoplasmic reticulum stress; P:positive regulation of lipophagy; P:positive regulation of macroautophagy; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:protein kinase B signaling; P:reactive oxygen species metabolic process; P:regulation of cAMP-dependent protein kinase activity; P:regulation of gluconeogenesis; P:regulation of protein phosphorylation; P:regulation of response to reactive oxygen species; P:response to glucose; P:response to insulin; P:triglyceride homeostasis; scaffold46 indexed_genome mRNA 17521151 17522555 . - . ID=transcript_9062;Q9UII2 Q5JXL8 Q6IAQ7 Q9BSL9,ATPase inhibitor, mitochondrial {ECO:0000305},ATP synthase F1 subunit epsilon {ECO:0000305};Inhibitor of F(1)F(o)-ATPase;, PF04568;, GO:0009986;GO:0005739;GO:0032991;GO:0043532;GO:0051117;GO:0042030;GO:0005516;GO:0019899;GO:0004857;GO:0042802;GO:0140260;GO:0042803;GO:0001525;GO:0030218;GO:0006091;GO:0006783;GO:0051882;GO:0032780;GO:0001937;GO:0051346;GO:1904925;GO:1901030;GO:1903052;GO:0072593;GO:1903578;GO:1903214;, C:cell surface; C:mitochondrion; C:protein-containing complex;, F:angiostatin binding; F:ATPase binding; F:ATPase inhibitor activity; F:calmodulin binding; F:enzyme binding; F:enzyme inhibitor activity; F:identical protein binding; F:mitochondrial proton-transporting ATP synthase complex binding; F:protein homodimerization activity;, P:angiogenesis; P:erythrocyte differentiation; P:generation of precursor metabolites and energy; P:heme biosynthetic process; P:mitochondrial depolarization; P:negative regulation of ATPase activity; P:negative regulation of endothelial cell proliferation; P:negative regulation of hydrolase activity; P:positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of proteolysis involved in cellular protein catabolic process; P:reactive oxygen species metabolic process; P:regulation of ATP metabolic process; P:regulation of protein targeting to mitochondrion; scaffold46 indexed_genome mRNA 17525637 17548425 . + . ID=transcript_9063;O75937 B4DUU4 D3DPM0 Q6IBA4 Q8N4Z5 Q9P051 Q9P067,DnaJ homolog subfamily C member 8,Splicing protein spf31;, PF00226;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0030544;GO:0000398;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:Hsp70 protein binding;, P:mRNA splicing, via spliceosome;|O75937 B4DUU4 D3DPM0 Q6IBA4 Q8N4Z5 Q9P051 Q9P067,DnaJ homolog subfamily C member 8,Splicing protein spf31;, PF00226;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0030544;GO:0000398;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:Hsp70 protein binding;, P:mRNA splicing, via spliceosome;|O75937 B4DUU4 D3DPM0 Q6IBA4 Q8N4Z5 Q9P051 Q9P067,DnaJ homolog subfamily C member 8,Splicing protein spf31;, PF00226;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0030544;GO:0000398;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:Hsp70 protein binding;, P:mRNA splicing, via spliceosome; scaffold46 indexed_genome mRNA 17578634 17579870 . + . ID=transcript_9064;Q99590 A6NEU9 A6NLW5 Q8IW59,Protein SCAF11,CTD-associated SR protein 11;Renal carcinoma antigen NY-REN-40;SC35-interacting protein 1;SR-related and CTD-associated factor 11;SRSF2-interacting protein;Serine/arginine-rich splicing factor 2-interacting protein;Splicing factor, arginine/serine-rich 2-interacting protein;Splicing regulatory protein 129;, PF13639;, GO:0016604;GO:0005730;GO:0005654;GO:0046872;GO:0003723;GO:0006397;GO:0008380;GO:0000375;GO:0000245;, C:nuclear body; C:nucleolus; C:nucleoplasm;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; scaffold46 indexed_genome mRNA 17582469 17609663 . - . ID=transcript_9065;P25105 A3KMC8 A8K2H5,Platelet-activating factor receptor,, PF00001;, GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0030667;GO:0070821;GO:0045028;GO:0004930;GO:0001530;GO:0001875;GO:0051019;GO:0005543;GO:0004992;GO:1904317;GO:0071320;GO:0071398;GO:0071258;GO:0006935;GO:0019221;GO:0007186;GO:0006955;GO:0006954;GO:0032959;GO:0060333;GO:0045776;GO:0043312;GO:0007567;GO:0048015;GO:0002693;GO:1904306;GO:0060732;GO:0032755;GO:1903238;GO:1904303;GO:0043315;GO:0010863;GO:1904058;GO:0048661;GO:1904300;GO:0045727;GO:0032760;GO:0045907;GO:1902943;GO:0006357;GO:0071548;GO:0009609;GO:0045056;, C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:secretory granule membrane; C:tertiary granule membrane;, F:G protein-coupled purinergic nucleotide receptor activity; F:G protein-coupled receptor activity; F:lipopolysaccharide binding; F:lipopolysaccharide immune receptor activity; F:mitogen-activated protein kinase binding; F:phospholipid binding; F:platelet activating factor receptor activity;, P:cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine; P:cellular response to cAMP; P:cellular response to fatty acid; P:cellular response to gravity; P:chemotaxis; P:cytokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:inositol trisphosphate biosynthetic process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of blood pressure; P:neutrophil degranulation; P:parturition; P:phosphatidylinositol-mediated signaling; P:positive regulation of cellular extravasation; P:positive regulation of gastro-intestinal system smooth muscle contraction; P:positive regulation of inositol phosphate biosynthetic process; P:positive regulation of interleukin-6 production; P:positive regulation of leukocyte tethering or rolling; P:positive regulation of maternal process involved in parturition; P:positive regulation of neutrophil degranulation; P:positive regulation of phospholipase C activity; P:positive regulation of sensory perception of pain; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcytosis; P:positive regulation of translation; P:positive regulation of tumor necrosis factor production; P:positive regulation of vasoconstriction; P:positive regulation of voltage-gated chloride channel activity; P:regulation of transcription by RNA polymerase II; P:response to dexamethasone; P:response to symbiotic bacterium; P:transcytosis; scaffold46 indexed_genome mRNA 17689991 17759660 . + . ID=transcript_9066;Q99504 A8K190 B4DIR7 B4DNZ7 O95463 Q8IVX7 Q99813,Eyes absent homolog 3,, , GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0005667;GO:0046872;GO:0004725;GO:0048856;GO:0009653;GO:0030154;GO:0006302;GO:0016576;GO:0007275;GO:2001240;GO:0045739;GO:0010212;GO:0007601;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:metal ion binding; F:protein tyrosine phosphatase activity;, P:anatomical structure development; P:anatomical structure morphogenesis; P:cell differentiation; P:double-strand break repair; P:histone dephosphorylation; P:multicellular organism development; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:response to ionizing radiation; P:visual perception;|Q99504 A8K190 B4DIR7 B4DNZ7 O95463 Q8IVX7 Q99813,Eyes absent homolog 3,, , GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0005667;GO:0046872;GO:0004725;GO:0048856;GO:0009653;GO:0030154;GO:0006302;GO:0016576;GO:0007275;GO:2001240;GO:0045739;GO:0010212;GO:0007601;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:metal ion binding; F:protein tyrosine phosphatase activity;, P:anatomical structure development; P:anatomical structure morphogenesis; P:cell differentiation; P:double-strand break repair; P:histone dephosphorylation; P:multicellular organism development; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:response to ionizing radiation; P:visual perception;|Q99504 A8K190 B4DIR7 B4DNZ7 O95463 Q8IVX7 Q99813,Eyes absent homolog 3,, , GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0005667;GO:0046872;GO:0004725;GO:0048856;GO:0009653;GO:0030154;GO:0006302;GO:0016576;GO:0007275;GO:2001240;GO:0045739;GO:0010212;GO:0007601;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:metal ion binding; F:protein tyrosine phosphatase activity;, P:anatomical structure development; P:anatomical structure morphogenesis; P:cell differentiation; P:double-strand break repair; P:histone dephosphorylation; P:multicellular organism development; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:response to ionizing radiation; P:visual perception;|O75071 D3DQ23 Q5SXB8,EF-hand calcium-binding domain-containing protein 14,, , GO:0005509;, , F:calcium ion binding;|Q99504 A8K190 B4DIR7 B4DNZ7 O95463 Q8IVX7 Q99813,Eyes absent homolog 3,, , GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0005667;GO:0046872;GO:0004725;GO:0048856;GO:0009653;GO:0030154;GO:0006302;GO:0016576;GO:0007275;GO:2001240;GO:0045739;GO:0010212;GO:0007601;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:metal ion binding; F:protein tyrosine phosphatase activity;, P:anatomical structure development; P:anatomical structure morphogenesis; P:cell differentiation; P:double-strand break repair; P:histone dephosphorylation; P:multicellular organism development; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:response to ionizing radiation; P:visual perception;|Q99504 A8K190 B4DIR7 B4DNZ7 O95463 Q8IVX7 Q99813,Eyes absent homolog 3,, , GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0005667;GO:0046872;GO:0004725;GO:0048856;GO:0009653;GO:0030154;GO:0006302;GO:0016576;GO:0007275;GO:2001240;GO:0045739;GO:0010212;GO:0007601;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:metal ion binding; F:protein tyrosine phosphatase activity;, P:anatomical structure development; P:anatomical structure morphogenesis; P:cell differentiation; P:double-strand break repair; P:histone dephosphorylation; P:multicellular organism development; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:response to ionizing radiation; P:visual perception; scaffold46 indexed_genome mRNA 17762083 17763602 . + . ID=transcript_9067;Q9H6D3,XK-related protein 8,, PF09815;, GO:0016021;GO:0016020;GO:0005886;GO:1902742;GO:0043652;GO:0051649;GO:0070782;GO:0002513;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:apoptotic process involved in development; P:engulfment of apoptotic cell; P:establishment of localization in cell; P:phosphatidylserine exposure on apoptotic cell surface; P:tolerance induction to self antigen; scaffold46 indexed_genome mRNA 17764955 17767815 . + . ID=transcript_9068;Q9H6D3,XK-related protein 8,, PF09815;, GO:0016021;GO:0016020;GO:0005886;GO:1902742;GO:0043652;GO:0051649;GO:0070782;GO:0002513;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:apoptotic process involved in development; P:engulfment of apoptotic cell; P:establishment of localization in cell; P:phosphatidylserine exposure on apoptotic cell surface; P:tolerance induction to self antigen; scaffold46 indexed_genome mRNA 17767847 17769171 . - . ID=transcript_9069;Q9H6D3,XK-related protein 8,, PF09815;, GO:0016021;GO:0016020;GO:0005886;GO:1902742;GO:0043652;GO:0051649;GO:0070782;GO:0002513;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:apoptotic process involved in development; P:engulfment of apoptotic cell; P:establishment of localization in cell; P:phosphatidylserine exposure on apoptotic cell surface; P:tolerance induction to self antigen; scaffold46 indexed_genome mRNA 17832098 17855736 . + . ID=transcript_9070;P15927 Q52II0 Q5TEI9 Q5TEJ5,Replication protein A 32 kDa subunit,Replication factor A protein 2;Replication protein A 34 kDa subunit;, PF08784;, GO:0000785;GO:0000781;GO:0005662;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003684;GO:0019899;GO:0098505;GO:0047485;GO:0019903;GO:0003697;GO:0031625;GO:0006284;GO:0006287;GO:0042769;GO:0006260;GO:0006270;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0006298;GO:0031571;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034502;GO:1900034;GO:2000001;GO:0010569;GO:1901796;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:chromatin; C:chromosome, telomeric region; C:DNA replication factor A complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:damaged DNA binding; F:enzyme binding; F:G-rich strand telomeric DNA binding; F:protein N-terminus binding; F:protein phosphatase binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:mismatch repair; P:mitotic G1 DNA damage checkpoint; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to chromosome; P:regulation of cellular response to heat; P:regulation of DNA damage checkpoint; P:regulation of double-strand break repair via homologous recombination; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P15927 Q52II0 Q5TEI9 Q5TEJ5,Replication protein A 32 kDa subunit,Replication factor A protein 2;Replication protein A 34 kDa subunit;, PF08784;, GO:0000785;GO:0000781;GO:0005662;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003684;GO:0019899;GO:0098505;GO:0047485;GO:0019903;GO:0003697;GO:0031625;GO:0006284;GO:0006287;GO:0042769;GO:0006260;GO:0006270;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0006298;GO:0031571;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034502;GO:1900034;GO:2000001;GO:0010569;GO:1901796;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:chromatin; C:chromosome, telomeric region; C:DNA replication factor A complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:damaged DNA binding; F:enzyme binding; F:G-rich strand telomeric DNA binding; F:protein N-terminus binding; F:protein phosphatase binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:mismatch repair; P:mitotic G1 DNA damage checkpoint; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to chromosome; P:regulation of cellular response to heat; P:regulation of DNA damage checkpoint; P:regulation of double-strand break repair via homologous recombination; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P15927 Q52II0 Q5TEI9 Q5TEJ5,Replication protein A 32 kDa subunit,Replication factor A protein 2;Replication protein A 34 kDa subunit;, PF08784;, GO:0000785;GO:0000781;GO:0005662;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003684;GO:0019899;GO:0098505;GO:0047485;GO:0019903;GO:0003697;GO:0031625;GO:0006284;GO:0006287;GO:0042769;GO:0006260;GO:0006270;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0006298;GO:0031571;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034502;GO:1900034;GO:2000001;GO:0010569;GO:1901796;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:chromatin; C:chromosome, telomeric region; C:DNA replication factor A complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:damaged DNA binding; F:enzyme binding; F:G-rich strand telomeric DNA binding; F:protein N-terminus binding; F:protein phosphatase binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA replication; P:DNA replication initiation; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:mismatch repair; P:mitotic G1 DNA damage checkpoint; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to chromosome; P:regulation of cellular response to heat; P:regulation of DNA damage checkpoint; P:regulation of double-strand break repair via homologous recombination; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold46 indexed_genome mRNA 17856638 17868101 . - . ID=transcript_9071;Q9BYB6 Q9NS90,Protein THEMIS2,Induced by contact to basement membrane 1 protein;Thymocyte-expressed molecule involved in selection protein 2;, PF12736;, GO:0005737;GO:0005634;GO:0007155;GO:0006954;GO:0050852;, C:cytoplasm; C:nucleus;, , P:cell adhesion; P:inflammatory response; P:T cell receptor signaling pathway;|Q9BYB6 Q9NS90,Protein THEMIS2,Induced by contact to basement membrane 1 protein;Thymocyte-expressed molecule involved in selection protein 2;, PF12736;, GO:0005737;GO:0005634;GO:0007155;GO:0006954;GO:0050852;, C:cytoplasm; C:nucleus;, , P:cell adhesion; P:inflammatory response; P:T cell receptor signaling pathway;|Q9BYB6 Q9NS90,Protein THEMIS2,Induced by contact to basement membrane 1 protein;Thymocyte-expressed molecule involved in selection protein 2;, PF12736;, GO:0005737;GO:0005634;GO:0007155;GO:0006954;GO:0050852;, C:cytoplasm; C:nucleus;, , P:cell adhesion; P:inflammatory response; P:T cell receptor signaling pathway; scaffold46 indexed_genome mRNA 17879806 17880381 . - . ID=transcript_9072;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold46 indexed_genome mRNA 17911851 17929890 . - . ID=transcript_9073;Q12972 Q5TEJ2 Q5TEJ4 Q5TIF2 Q6PKF6 Q9UBH1 Q9UBZ0,Nuclear inhibitor of protein phosphatase 1,Protein phosphatase 1 regulatory inhibitor subunit 8;, PF00498;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0004519;GO:0003729;GO:0004865;GO:0008995;GO:0003723;GO:0008283;GO:0006397;GO:0035308;GO:0006401;GO:0008380;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:endonuclease activity; F:mRNA binding; F:protein serine/threonine phosphatase inhibitor activity; F:ribonuclease E activity; F:RNA binding;, P:cell population proliferation; P:mRNA processing; P:negative regulation of protein dephosphorylation; P:RNA catabolic process; P:RNA splicing;|Q12972 Q5TEJ2 Q5TEJ4 Q5TIF2 Q6PKF6 Q9UBH1 Q9UBZ0,Nuclear inhibitor of protein phosphatase 1,Protein phosphatase 1 regulatory inhibitor subunit 8;, PF00498;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0004519;GO:0003729;GO:0004865;GO:0008995;GO:0003723;GO:0008283;GO:0006397;GO:0035308;GO:0006401;GO:0008380;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:endonuclease activity; F:mRNA binding; F:protein serine/threonine phosphatase inhibitor activity; F:ribonuclease E activity; F:RNA binding;, P:cell population proliferation; P:mRNA processing; P:negative regulation of protein dephosphorylation; P:RNA catabolic process; P:RNA splicing;|Q12972 Q5TEJ2 Q5TEJ4 Q5TIF2 Q6PKF6 Q9UBH1 Q9UBZ0,Nuclear inhibitor of protein phosphatase 1,Protein phosphatase 1 regulatory inhibitor subunit 8;, PF00498;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0004519;GO:0003729;GO:0004865;GO:0008995;GO:0003723;GO:0008283;GO:0006397;GO:0035308;GO:0006401;GO:0008380;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:endonuclease activity; F:mRNA binding; F:protein serine/threonine phosphatase inhibitor activity; F:ribonuclease E activity; F:RNA binding;, P:cell population proliferation; P:mRNA processing; P:negative regulation of protein dephosphorylation; P:RNA catabolic process; P:RNA splicing;|Q12972 Q5TEJ2 Q5TEJ4 Q5TIF2 Q6PKF6 Q9UBH1 Q9UBZ0,Nuclear inhibitor of protein phosphatase 1,Protein phosphatase 1 regulatory inhibitor subunit 8;, PF00498;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0004519;GO:0003729;GO:0004865;GO:0008995;GO:0003723;GO:0008283;GO:0006397;GO:0035308;GO:0006401;GO:0008380;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:endonuclease activity; F:mRNA binding; F:protein serine/threonine phosphatase inhibitor activity; F:ribonuclease E activity; F:RNA binding;, P:cell population proliferation; P:mRNA processing; P:negative regulation of protein dephosphorylation; P:RNA catabolic process; P:RNA splicing;|Q12972 Q5TEJ2 Q5TEJ4 Q5TIF2 Q6PKF6 Q9UBH1 Q9UBZ0,Nuclear inhibitor of protein phosphatase 1,Protein phosphatase 1 regulatory inhibitor subunit 8;, PF00498;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0004519;GO:0003729;GO:0004865;GO:0008995;GO:0003723;GO:0008283;GO:0006397;GO:0035308;GO:0006401;GO:0008380;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:endonuclease activity; F:mRNA binding; F:protein serine/threonine phosphatase inhibitor activity; F:ribonuclease E activity; F:RNA binding;, P:cell population proliferation; P:mRNA processing; P:negative regulation of protein dephosphorylation; P:RNA catabolic process; P:RNA splicing;|Q12972 Q5TEJ2 Q5TEJ4 Q5TIF2 Q6PKF6 Q9UBH1 Q9UBZ0,Nuclear inhibitor of protein phosphatase 1,Protein phosphatase 1 regulatory inhibitor subunit 8;, PF00498;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0004519;GO:0003729;GO:0004865;GO:0008995;GO:0003723;GO:0008283;GO:0006397;GO:0035308;GO:0006401;GO:0008380;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:endonuclease activity; F:mRNA binding; F:protein serine/threonine phosphatase inhibitor activity; F:ribonuclease E activity; F:RNA binding;, P:cell population proliferation; P:mRNA processing; P:negative regulation of protein dephosphorylation; P:RNA catabolic process; P:RNA splicing; scaffold46 indexed_genome mRNA 17934412 17966533 . - . ID=transcript_9074;Q86Y82 B1AJQ7 O95564,Syntaxin-12,, PF05739;PF14523;, GO:0031901;GO:0012505;GO:0005794;GO:0000139;GO:0016021;GO:0030285;GO:0043231;GO:0045121;GO:0005654;GO:0045335;GO:0000407;GO:0098837;GO:0055038;GO:0031201;GO:0008021;GO:0031982;GO:0005484;GO:0000149;GO:0000045;GO:0033344;GO:0006886;GO:0050821;GO:0048278;GO:0006906;, C:early endosome membrane; C:endomembrane system; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:membrane raft; C:nucleoplasm; C:phagocytic vesicle; C:phagophore assembly site; C:postsynaptic recycling endosome; C:recycling endosome membrane; C:SNARE complex; C:synaptic vesicle; C:vesicle;, F:SNAP receptor activity; F:SNARE binding;, P:autophagosome assembly; P:cholesterol efflux; P:intracellular protein transport; P:protein stabilization; P:vesicle docking; P:vesicle fusion;|P62750 B2R5B2 P29316 P39024 Q92774,60S ribosomal protein L23a,Large ribosomal subunit protein uL23 {ECO:0000303|PubMed:24524803};, PF00276;PF03939;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005730;GO:0005634;GO:0045296;GO:0003723;GO:0019843;GO:0003735;GO:1904841;GO:0000184;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:nucleolus; C:nucleus;, F:cadherin binding; F:RNA binding; F:rRNA binding; F:structural constituent of ribosome; F:TORC2 complex binding;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold46 indexed_genome mRNA 17982566 18009110 . - . ID=transcript_9075;Q8TAV0 B4DWT3 O95565 O95566 Q8N7J5,Protein FAM76A,, PF16046;, GO:0005654;, C:nucleoplasm;|Q8TAV0 B4DWT3 O95565 O95566 Q8N7J5,Protein FAM76A,, PF16046;, GO:0005654;, C:nucleoplasm;|Q8TAV0 B4DWT3 O95565 O95566 Q8N7J5,Protein FAM76A,, PF16046;, GO:0005654;, C:nucleoplasm;|Q8TAV0 B4DWT3 O95565 O95566 Q8N7J5,Protein FAM76A,, PF16046;, GO:0005654;, C:nucleoplasm;|P62753 P08227 P10660 Q4VBY7 Q8N6Z7,40S ribosomal protein S6 {ECO:0000303|PubMed:29563586},Phosphoprotein NP33;Small ribosomal subunit protein eS6 {ECO:0000303|PubMed:24524803};, PF01092;, GO:0044297;GO:0036464;GO:0005829;GO:0022627;GO:0030425;GO:0005783;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005844;GO:1990904;GO:0015935;GO:0019901;GO:0003723;GO:0003735;GO:0006924;GO:0048821;GO:0000082;GO:0007369;GO:0042593;GO:0022605;GO:0043066;GO:0000184;GO:0001890;GO:0043065;GO:0008284;GO:0042274;GO:0006364;GO:0006614;GO:0033077;GO:0002309;GO:0031929;GO:0006412;GO:0006413;GO:0019083;, C:cell body; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic small ribosomal subunit; C:dendrite; C:endoplasmic reticulum; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:small ribosomal subunit;, F:protein kinase binding; F:RNA binding; F:structural constituent of ribosome;, P:activation-induced cell death of T cells; P:erythrocyte development; P:G1/S transition of mitotic cell cycle; P:gastrulation; P:glucose homeostasis; P:mammalian oogenesis stage; P:negative regulation of apoptotic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:placenta development; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:T cell differentiation in thymus; P:T cell proliferation involved in immune response; P:TOR signaling; P:translation; P:translational initiation; P:viral transcription;|P62753 P08227 P10660 Q4VBY7 Q8N6Z7,40S ribosomal protein S6 {ECO:0000303|PubMed:29563586},Phosphoprotein NP33;Small ribosomal subunit protein eS6 {ECO:0000303|PubMed:24524803};, PF01092;, GO:0044297;GO:0036464;GO:0005829;GO:0022627;GO:0030425;GO:0005783;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005844;GO:1990904;GO:0015935;GO:0019901;GO:0003723;GO:0003735;GO:0006924;GO:0048821;GO:0000082;GO:0007369;GO:0042593;GO:0022605;GO:0043066;GO:0000184;GO:0001890;GO:0043065;GO:0008284;GO:0042274;GO:0006364;GO:0006614;GO:0033077;GO:0002309;GO:0031929;GO:0006412;GO:0006413;GO:0019083;, C:cell body; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic small ribosomal subunit; C:dendrite; C:endoplasmic reticulum; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:small ribosomal subunit;, F:protein kinase binding; F:RNA binding; F:structural constituent of ribosome;, P:activation-induced cell death of T cells; P:erythrocyte development; P:G1/S transition of mitotic cell cycle; P:gastrulation; P:glucose homeostasis; P:mammalian oogenesis stage; P:negative regulation of apoptotic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:placenta development; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:T cell differentiation in thymus; P:T cell proliferation involved in immune response; P:TOR signaling; P:translation; P:translational initiation; P:viral transcription; scaffold46 indexed_genome mRNA 18034461 18038017 . + . ID=transcript_9076;P09912 Q13141 Q13142 Q5VVR2 Q5VVR3 Q6IE95 Q969M8,Interferon alpha-inducible protein 6 {ECO:0000305},Interferon-induced protein 6-16 {ECO:0000303|PubMed:14728724};, PF06140;, GO:0016021;GO:0005743;GO:0031966;GO:0005739;GO:0005886;GO:0006915;GO:0097190;GO:0098586;GO:0051607;GO:0006955;GO:0045087;GO:0097193;GO:0043066;GO:0043154;GO:2001240;GO:0051902;GO:0072593;GO:0042058;GO:0001836;GO:0060337;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:plasma membrane;, , P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to virus; P:defense response to virus; P:immune response; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of mitochondrial depolarization; P:reactive oxygen species metabolic process; P:regulation of epidermal growth factor receptor signaling pathway; P:release of cytochrome c from mitochondria; P:type I interferon signaling pathway; scaffold46 indexed_genome mRNA 18060108 18079365 . + . ID=transcript_9077;P09769 D3DPL7 Q9UIQ3,Tyrosine-protein kinase Fgr,Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog;Proto-oncogene c-Fgr;p55-Fgr;p58-Fgr;p58c-Fgr;, PF07714;PF00017;PF00018;, GO:0015629;GO:0016235;GO:0005829;GO:0070062;GO:0005576;GO:0031234;GO:0005743;GO:0005758;GO:0005886;GO:0032587;GO:0034774;GO:0005524;GO:0034988;GO:0034987;GO:0004715;GO:0001784;GO:0019901;GO:0004713;GO:0005102;GO:0004714;GO:0030282;GO:0030154;GO:0050830;GO:0038096;GO:0002768;GO:0045087;GO:0007229;GO:0002862;GO:0032815;GO:0043312;GO:0018108;GO:0030335;GO:0001819;GO:0043306;GO:0043552;GO:0014068;GO:0046777;GO:0006468;GO:0008360;GO:0045088;GO:0050764;GO:0045859;GO:0009615;GO:0048705;GO:0007169;, C:actin cytoskeleton; C:aggresome; C:cytosol; C:extracellular exosome; C:extracellular region; C:extrinsic component of cytoplasmic side of plasma membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:plasma membrane; C:ruffle membrane; C:secretory granule lumen;, F:ATP binding; F:Fc-gamma receptor I complex binding; F:immunoglobulin receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:bone mineralization; P:cell differentiation; P:defense response to Gram-positive bacterium; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:immune response-regulating cell surface receptor signaling pathway; P:innate immune response; P:integrin-mediated signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of natural killer cell activation; P:neutrophil degranulation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell migration; P:positive regulation of cytokine production; P:positive regulation of mast cell degranulation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell shape; P:regulation of innate immune response; P:regulation of phagocytosis; P:regulation of protein kinase activity; P:response to virus; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P09769 D3DPL7 Q9UIQ3,Tyrosine-protein kinase Fgr,Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog;Proto-oncogene c-Fgr;p55-Fgr;p58-Fgr;p58c-Fgr;, PF07714;PF00017;PF00018;, GO:0015629;GO:0016235;GO:0005829;GO:0070062;GO:0005576;GO:0031234;GO:0005743;GO:0005758;GO:0005886;GO:0032587;GO:0034774;GO:0005524;GO:0034988;GO:0034987;GO:0004715;GO:0001784;GO:0019901;GO:0004713;GO:0005102;GO:0004714;GO:0030282;GO:0030154;GO:0050830;GO:0038096;GO:0002768;GO:0045087;GO:0007229;GO:0002862;GO:0032815;GO:0043312;GO:0018108;GO:0030335;GO:0001819;GO:0043306;GO:0043552;GO:0014068;GO:0046777;GO:0006468;GO:0008360;GO:0045088;GO:0050764;GO:0045859;GO:0009615;GO:0048705;GO:0007169;, C:actin cytoskeleton; C:aggresome; C:cytosol; C:extracellular exosome; C:extracellular region; C:extrinsic component of cytoplasmic side of plasma membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:plasma membrane; C:ruffle membrane; C:secretory granule lumen;, F:ATP binding; F:Fc-gamma receptor I complex binding; F:immunoglobulin receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:bone mineralization; P:cell differentiation; P:defense response to Gram-positive bacterium; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:immune response-regulating cell surface receptor signaling pathway; P:innate immune response; P:integrin-mediated signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of natural killer cell activation; P:neutrophil degranulation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell migration; P:positive regulation of cytokine production; P:positive regulation of mast cell degranulation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell shape; P:regulation of innate immune response; P:regulation of phagocytosis; P:regulation of protein kinase activity; P:response to virus; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P09769 D3DPL7 Q9UIQ3,Tyrosine-protein kinase Fgr,Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog;Proto-oncogene c-Fgr;p55-Fgr;p58-Fgr;p58c-Fgr;, PF07714;PF00017;PF00018;, GO:0015629;GO:0016235;GO:0005829;GO:0070062;GO:0005576;GO:0031234;GO:0005743;GO:0005758;GO:0005886;GO:0032587;GO:0034774;GO:0005524;GO:0034988;GO:0034987;GO:0004715;GO:0001784;GO:0019901;GO:0004713;GO:0005102;GO:0004714;GO:0030282;GO:0030154;GO:0050830;GO:0038096;GO:0002768;GO:0045087;GO:0007229;GO:0002862;GO:0032815;GO:0043312;GO:0018108;GO:0030335;GO:0001819;GO:0043306;GO:0043552;GO:0014068;GO:0046777;GO:0006468;GO:0008360;GO:0045088;GO:0050764;GO:0045859;GO:0009615;GO:0048705;GO:0007169;, C:actin cytoskeleton; C:aggresome; C:cytosol; C:extracellular exosome; C:extracellular region; C:extrinsic component of cytoplasmic side of plasma membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:plasma membrane; C:ruffle membrane; C:secretory granule lumen;, F:ATP binding; F:Fc-gamma receptor I complex binding; F:immunoglobulin receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:bone mineralization; P:cell differentiation; P:defense response to Gram-positive bacterium; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:immune response-regulating cell surface receptor signaling pathway; P:innate immune response; P:integrin-mediated signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of natural killer cell activation; P:neutrophil degranulation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell migration; P:positive regulation of cytokine production; P:positive regulation of mast cell degranulation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell shape; P:regulation of innate immune response; P:regulation of phagocytosis; P:regulation of protein kinase activity; P:response to virus; P:skeletal system morphogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold47 indexed_genome mRNA 274619 276035 . + . ID=transcript_9078;P48067 A6NDH1 A6NII2 A6NNZ8 Q5TAB8 Q5TAB9 Q5TAC0,Sodium- and chloride-dependent glycine transporter 1,Solute carrier family 6 member 9;, PF00209;, GO:0016324;GO:0009925;GO:0016323;GO:0031045;GO:0005768;GO:0098686;GO:0005887;GO:0099055;GO:0099056;GO:0030285;GO:0016328;GO:0016020;GO:0098688;GO:0005886;GO:0014069;GO:0015187;GO:0015375;GO:1903804;GO:0015816;GO:1904782;GO:0006836;GO:0070455;GO:0046985;GO:1904440;GO:1904256;GO:0035725;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:dense core granule; C:endosome; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:lateral plasma membrane; C:membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic density;, F:glycine transmembrane transporter activity; F:glycine:sodium symporter activity;, P:glycine import across plasma membrane; P:glycine transport; P:negative regulation of NMDA glutamate receptor activity; P:neurotransmitter transport; P:positive regulation of heme biosynthetic process; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of iron ion import across plasma membrane; P:positive regulation of iron ion transmembrane transporter activity; P:sodium ion transmembrane transport; P:transport across blood-brain barrier; scaffold47 indexed_genome mRNA 277526 278524 . + . ID=transcript_9079;P48067 A6NDH1 A6NII2 A6NNZ8 Q5TAB8 Q5TAB9 Q5TAC0,Sodium- and chloride-dependent glycine transporter 1,Solute carrier family 6 member 9;, PF00209;, GO:0016324;GO:0009925;GO:0016323;GO:0031045;GO:0005768;GO:0098686;GO:0005887;GO:0099055;GO:0099056;GO:0030285;GO:0016328;GO:0016020;GO:0098688;GO:0005886;GO:0014069;GO:0015187;GO:0015375;GO:1903804;GO:0015816;GO:1904782;GO:0006836;GO:0070455;GO:0046985;GO:1904440;GO:1904256;GO:0035725;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:dense core granule; C:endosome; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:lateral plasma membrane; C:membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic density;, F:glycine transmembrane transporter activity; F:glycine:sodium symporter activity;, P:glycine import across plasma membrane; P:glycine transport; P:negative regulation of NMDA glutamate receptor activity; P:neurotransmitter transport; P:positive regulation of heme biosynthetic process; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of iron ion import across plasma membrane; P:positive regulation of iron ion transmembrane transporter activity; P:sodium ion transmembrane transport; P:transport across blood-brain barrier; scaffold47 indexed_genome mRNA 835389 864184 . + . ID=transcript_9080;O95935 A2RU13 Q7Z6U4 Q9UJI6,T-box transcription factor TBX18,, PF00907;, GO:0000785;GO:0005654;GO:0005634;GO:0090571;GO:0000981;GO:0001227;GO:0042803;GO:0000978;GO:1990837;GO:0000976;GO:0001708;GO:0090103;GO:0016331;GO:0060829;GO:0098907;GO:0006357;GO:0060931;GO:0060930;GO:0003163;GO:0051145;GO:0001756;GO:0072189;, C:chromatin; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription repressor complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell fate specification; P:cochlea morphogenesis; P:morphogenesis of embryonic epithelium; P:negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation; P:regulation of SA node cell action potential; P:regulation of transcription by RNA polymerase II; P:sinoatrial node cell development; P:sinoatrial node cell fate commitment; P:sinoatrial node development; P:smooth muscle cell differentiation; P:somitogenesis; P:ureter development; scaffold47 indexed_genome mRNA 1306697 1384039 . + . ID=transcript_9081;Q5TB80 A6PVL7 A6PVL8 Q6P475 Q9Y2L2,Centrosomal protein of 162 kDa,Protein QN1 homolog;, , GO:0005879;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0005819;GO:0097711;GO:0060271;, C:axonemal microtubule; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:spindle;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; scaffold47 indexed_genome mRNA 1396718 1406599 . + . ID=transcript_9082;Q5TB80 A6PVL7 A6PVL8 Q6P475 Q9Y2L2,Centrosomal protein of 162 kDa,Protein QN1 homolog;, , GO:0005879;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0005819;GO:0097711;GO:0060271;, C:axonemal microtubule; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:spindle;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly;|Q5TB80 A6PVL7 A6PVL8 Q6P475 Q9Y2L2,Centrosomal protein of 162 kDa,Protein QN1 homolog;, , GO:0005879;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0005819;GO:0097711;GO:0060271;, C:axonemal microtubule; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:spindle;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; scaffold47 indexed_genome mRNA 1418743 1420455 . + . ID=transcript_9083;Q96G30 A8K9M1 Q8IXM9 Q8N2D1,Melanocortin-2 receptor accessory protein 2,, PF15183;, GO:0005783;GO:0005789;GO:0016021;GO:0005886;GO:0031780;GO:0042802;GO:0030545;GO:0070996;GO:0031781;GO:0031782;GO:0031783;GO:0097009;GO:0006112;GO:0007631;GO:0106072;GO:1903077;GO:0106071;GO:0072659;GO:0106070;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:corticotropin hormone receptor binding; F:identical protein binding; F:receptor regulator activity; F:type 1 melanocortin receptor binding; F:type 3 melanocortin receptor binding; F:type 4 melanocortin receptor binding; F:type 5 melanocortin receptor binding;, P:energy homeostasis; P:energy reserve metabolic process; P:feeding behavior; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:negative regulation of protein localization to plasma membrane; P:positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:protein localization to plasma membrane; P:regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; scaffold47 indexed_genome mRNA 1558387 1597092 . - . ID=transcript_9084;Q7L1T6 B1AEM2 Q5TGI9 Q9NUE4 Q9UHI9,Cytochrome b5 reductase 4,Flavohemoprotein b5/b5R;N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein;cb5/cb5R;, PF04969;PF00173;PF00970;PF00175;, GO:0005783;GO:0005789;GO:0048471;GO:0004128;GO:0020037;GO:0046872;GO:0016174;GO:0016653;GO:0015701;GO:0048468;GO:0003032;GO:0006091;GO:0042593;GO:0030073;GO:0046677;GO:0006801;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:heme binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor;, P:bicarbonate transport; P:cell development; P:detection of oxygen; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:insulin secretion; P:response to antibiotic; P:superoxide metabolic process;|Q7L1T6 B1AEM2 Q5TGI9 Q9NUE4 Q9UHI9,Cytochrome b5 reductase 4,Flavohemoprotein b5/b5R;N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein;cb5/cb5R;, PF04969;PF00173;PF00970;PF00175;, GO:0005783;GO:0005789;GO:0048471;GO:0004128;GO:0020037;GO:0046872;GO:0016174;GO:0016653;GO:0015701;GO:0048468;GO:0003032;GO:0006091;GO:0042593;GO:0030073;GO:0046677;GO:0006801;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:heme binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor;, P:bicarbonate transport; P:cell development; P:detection of oxygen; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:insulin secretion; P:response to antibiotic; P:superoxide metabolic process;|Q7L1T6 B1AEM2 Q5TGI9 Q9NUE4 Q9UHI9,Cytochrome b5 reductase 4,Flavohemoprotein b5/b5R;N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein;cb5/cb5R;, PF04969;PF00173;PF00970;PF00175;, GO:0005783;GO:0005789;GO:0048471;GO:0004128;GO:0020037;GO:0046872;GO:0016174;GO:0016653;GO:0015701;GO:0048468;GO:0003032;GO:0006091;GO:0042593;GO:0030073;GO:0046677;GO:0006801;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:heme binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor;, P:bicarbonate transport; P:cell development; P:detection of oxygen; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:insulin secretion; P:response to antibiotic; P:superoxide metabolic process;|Q7L1T6 B1AEM2 Q5TGI9 Q9NUE4 Q9UHI9,Cytochrome b5 reductase 4,Flavohemoprotein b5/b5R;N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein;cb5/cb5R;, PF04969;PF00173;PF00970;PF00175;, GO:0005783;GO:0005789;GO:0048471;GO:0004128;GO:0020037;GO:0046872;GO:0016174;GO:0016653;GO:0015701;GO:0048468;GO:0003032;GO:0006091;GO:0042593;GO:0030073;GO:0046677;GO:0006801;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:heme binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor;, P:bicarbonate transport; P:cell development; P:detection of oxygen; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:insulin secretion; P:response to antibiotic; P:superoxide metabolic process;|Q7L1T6 B1AEM2 Q5TGI9 Q9NUE4 Q9UHI9,Cytochrome b5 reductase 4,Flavohemoprotein b5/b5R;N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein;cb5/cb5R;, PF04969;PF00173;PF00970;PF00175;, GO:0005783;GO:0005789;GO:0048471;GO:0004128;GO:0020037;GO:0046872;GO:0016174;GO:0016653;GO:0015701;GO:0048468;GO:0003032;GO:0006091;GO:0042593;GO:0030073;GO:0046677;GO:0006801;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:heme binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor;, P:bicarbonate transport; P:cell development; P:detection of oxygen; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:insulin secretion; P:response to antibiotic; P:superoxide metabolic process; scaffold47 indexed_genome mRNA 1599583 1658220 . - . ID=transcript_9085;Q7L1T6 B1AEM2 Q5TGI9 Q9NUE4 Q9UHI9,Cytochrome b5 reductase 4,Flavohemoprotein b5/b5R;N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein;cb5/cb5R;, PF04969;PF00173;PF00970;PF00175;, GO:0005783;GO:0005789;GO:0048471;GO:0004128;GO:0020037;GO:0046872;GO:0016174;GO:0016653;GO:0015701;GO:0048468;GO:0003032;GO:0006091;GO:0042593;GO:0030073;GO:0046677;GO:0006801;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:heme binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor;, P:bicarbonate transport; P:cell development; P:detection of oxygen; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:insulin secretion; P:response to antibiotic; P:superoxide metabolic process;|Q7L1T6 B1AEM2 Q5TGI9 Q9NUE4 Q9UHI9,Cytochrome b5 reductase 4,Flavohemoprotein b5/b5R;N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein;cb5/cb5R;, PF04969;PF00173;PF00970;PF00175;, GO:0005783;GO:0005789;GO:0048471;GO:0004128;GO:0020037;GO:0046872;GO:0016174;GO:0016653;GO:0015701;GO:0048468;GO:0003032;GO:0006091;GO:0042593;GO:0030073;GO:0046677;GO:0006801;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:heme binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor;, P:bicarbonate transport; P:cell development; P:detection of oxygen; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:insulin secretion; P:response to antibiotic; P:superoxide metabolic process;|Q7L1T6 B1AEM2 Q5TGI9 Q9NUE4 Q9UHI9,Cytochrome b5 reductase 4,Flavohemoprotein b5/b5R;N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein;cb5/cb5R;, PF04969;PF00173;PF00970;PF00175;, GO:0005783;GO:0005789;GO:0048471;GO:0004128;GO:0020037;GO:0046872;GO:0016174;GO:0016653;GO:0015701;GO:0048468;GO:0003032;GO:0006091;GO:0042593;GO:0030073;GO:0046677;GO:0006801;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:heme binding; F:metal ion binding; F:NAD(P)H oxidase H2O2-forming activity; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor;, P:bicarbonate transport; P:cell development; P:detection of oxygen; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:insulin secretion; P:response to antibiotic; P:superoxide metabolic process; scaffold47 indexed_genome mRNA 1660449 1663913 . + . ID=transcript_9086;Q5TAB7 Q5TAB6,Protein ripply2,, PF14998;, GO:0005634;GO:0060349;GO:0007368;GO:0009880;GO:0000122;GO:0007219;GO:0001503;GO:0036342;GO:0032525;GO:0001756;, C:nucleus;, , P:bone morphogenesis; P:determination of left/right symmetry; P:embryonic pattern specification; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:ossification; P:post-anal tail morphogenesis; P:somite rostral/caudal axis specification; P:somitogenesis; scaffold47 indexed_genome mRNA 2108814 2235293 . - . ID=transcript_9087;Q15262 B2RTQ8 B7ZMG0 Q14763 Q5TG10 Q5TG11,Receptor-type tyrosine-protein phosphatase kappa,, PF00041;PF07679;PF00629;PF18861;PF00102;, GO:0005912;GO:0030054;GO:0009986;GO:0005911;GO:0016021;GO:0005887;GO:0043231;GO:0031256;GO:0005886;GO:0008013;GO:0045295;GO:0019901;GO:0004725;GO:0005001;GO:0007155;GO:0016477;GO:0034614;GO:0034644;GO:0048041;GO:0045786;GO:0030336;GO:0008285;GO:0010839;GO:0045892;GO:0006470;GO:0034394;GO:0007165;GO:0007179;, C:adherens junction; C:cell junction; C:cell surface; C:cell-cell junction; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:leading edge membrane; C:plasma membrane;, F:beta-catenin binding; F:gamma-catenin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:cell adhesion; P:cell migration; P:cellular response to reactive oxygen species; P:cellular response to UV; P:focal adhesion assembly; P:negative regulation of cell cycle; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription, DNA-templated; P:protein dephosphorylation; P:protein localization to cell surface; P:signal transduction; P:transforming growth factor beta receptor signaling pathway;|Q15262 B2RTQ8 B7ZMG0 Q14763 Q5TG10 Q5TG11,Receptor-type tyrosine-protein phosphatase kappa,, PF00041;PF07679;PF00629;PF18861;PF00102;, GO:0005912;GO:0030054;GO:0009986;GO:0005911;GO:0016021;GO:0005887;GO:0043231;GO:0031256;GO:0005886;GO:0008013;GO:0045295;GO:0019901;GO:0004725;GO:0005001;GO:0007155;GO:0016477;GO:0034614;GO:0034644;GO:0048041;GO:0045786;GO:0030336;GO:0008285;GO:0010839;GO:0045892;GO:0006470;GO:0034394;GO:0007165;GO:0007179;, C:adherens junction; C:cell junction; C:cell surface; C:cell-cell junction; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:leading edge membrane; C:plasma membrane;, F:beta-catenin binding; F:gamma-catenin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:cell adhesion; P:cell migration; P:cellular response to reactive oxygen species; P:cellular response to UV; P:focal adhesion assembly; P:negative regulation of cell cycle; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription, DNA-templated; P:protein dephosphorylation; P:protein localization to cell surface; P:signal transduction; P:transforming growth factor beta receptor signaling pathway;|Q15262 B2RTQ8 B7ZMG0 Q14763 Q5TG10 Q5TG11,Receptor-type tyrosine-protein phosphatase kappa,, PF00041;PF07679;PF00629;PF18861;PF00102;, GO:0005912;GO:0030054;GO:0009986;GO:0005911;GO:0016021;GO:0005887;GO:0043231;GO:0031256;GO:0005886;GO:0008013;GO:0045295;GO:0019901;GO:0004725;GO:0005001;GO:0007155;GO:0016477;GO:0034614;GO:0034644;GO:0048041;GO:0045786;GO:0030336;GO:0008285;GO:0010839;GO:0045892;GO:0006470;GO:0034394;GO:0007165;GO:0007179;, C:adherens junction; C:cell junction; C:cell surface; C:cell-cell junction; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:leading edge membrane; C:plasma membrane;, F:beta-catenin binding; F:gamma-catenin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:cell adhesion; P:cell migration; P:cellular response to reactive oxygen species; P:cellular response to UV; P:focal adhesion assembly; P:negative regulation of cell cycle; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription, DNA-templated; P:protein dephosphorylation; P:protein localization to cell surface; P:signal transduction; P:transforming growth factor beta receptor signaling pathway;|Q15262 B2RTQ8 B7ZMG0 Q14763 Q5TG10 Q5TG11,Receptor-type tyrosine-protein phosphatase kappa,, PF00041;PF07679;PF00629;PF18861;PF00102;, GO:0005912;GO:0030054;GO:0009986;GO:0005911;GO:0016021;GO:0005887;GO:0043231;GO:0031256;GO:0005886;GO:0008013;GO:0045295;GO:0019901;GO:0004725;GO:0005001;GO:0007155;GO:0016477;GO:0034614;GO:0034644;GO:0048041;GO:0045786;GO:0030336;GO:0008285;GO:0010839;GO:0045892;GO:0006470;GO:0034394;GO:0007165;GO:0007179;, C:adherens junction; C:cell junction; C:cell surface; C:cell-cell junction; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:leading edge membrane; C:plasma membrane;, F:beta-catenin binding; F:gamma-catenin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:cell adhesion; P:cell migration; P:cellular response to reactive oxygen species; P:cellular response to UV; P:focal adhesion assembly; P:negative regulation of cell cycle; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription, DNA-templated; P:protein dephosphorylation; P:protein localization to cell surface; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; scaffold47 indexed_genome mRNA 2342525 2709699 . + . ID=transcript_9088;Q15262 B2RTQ8 B7ZMG0 Q14763 Q5TG10 Q5TG11,Receptor-type tyrosine-protein phosphatase kappa,, PF00041;PF07679;PF00629;PF18861;PF00102;, GO:0005912;GO:0030054;GO:0009986;GO:0005911;GO:0016021;GO:0005887;GO:0043231;GO:0031256;GO:0005886;GO:0008013;GO:0045295;GO:0019901;GO:0004725;GO:0005001;GO:0007155;GO:0016477;GO:0034614;GO:0034644;GO:0048041;GO:0045786;GO:0030336;GO:0008285;GO:0010839;GO:0045892;GO:0006470;GO:0034394;GO:0007165;GO:0007179;, C:adherens junction; C:cell junction; C:cell surface; C:cell-cell junction; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:leading edge membrane; C:plasma membrane;, F:beta-catenin binding; F:gamma-catenin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:cell adhesion; P:cell migration; P:cellular response to reactive oxygen species; P:cellular response to UV; P:focal adhesion assembly; P:negative regulation of cell cycle; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription, DNA-templated; P:protein dephosphorylation; P:protein localization to cell surface; P:signal transduction; P:transforming growth factor beta receptor signaling pathway;|Q15262 B2RTQ8 B7ZMG0 Q14763 Q5TG10 Q5TG11,Receptor-type tyrosine-protein phosphatase kappa,, PF00041;PF07679;PF00629;PF18861;PF00102;, GO:0005912;GO:0030054;GO:0009986;GO:0005911;GO:0016021;GO:0005887;GO:0043231;GO:0031256;GO:0005886;GO:0008013;GO:0045295;GO:0019901;GO:0004725;GO:0005001;GO:0007155;GO:0016477;GO:0034614;GO:0034644;GO:0048041;GO:0045786;GO:0030336;GO:0008285;GO:0010839;GO:0045892;GO:0006470;GO:0034394;GO:0007165;GO:0007179;, C:adherens junction; C:cell junction; C:cell surface; C:cell-cell junction; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:leading edge membrane; C:plasma membrane;, F:beta-catenin binding; F:gamma-catenin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:cell adhesion; P:cell migration; P:cellular response to reactive oxygen species; P:cellular response to UV; P:focal adhesion assembly; P:negative regulation of cell cycle; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of keratinocyte proliferation; P:negative regulation of transcription, DNA-templated; P:protein dephosphorylation; P:protein localization to cell surface; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; scaffold47 indexed_genome mRNA 3054164 3718994 . + . ID=transcript_9089;P24043 Q14736 Q5VUM2 Q93022,Laminin subunit alpha-2,Laminin M chain;Laminin-12 subunit alpha;Laminin-2 subunit alpha;Laminin-4 subunit alpha;Merosin heavy chain;, PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0043197;GO:0005576;GO:0031594;GO:0042383;GO:0043083;GO:0005201;GO:0005102;GO:0005198;GO:0009887;GO:0007411;GO:0007155;GO:0030198;GO:0035633;GO:0007517;GO:0032224;GO:0030155;GO:0030334;GO:0045995;GO:0014037;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:dendritic spine; C:extracellular region; C:neuromuscular junction; C:sarcolemma; C:synaptic cleft;, F:extracellular matrix structural constituent; F:signaling receptor binding; F:structural molecule activity;, P:animal organ morphogenesis; P:axon guidance; P:cell adhesion; P:extracellular matrix organization; P:maintenance of blood-brain barrier; P:muscle organ development; P:positive regulation of synaptic transmission, cholinergic; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:Schwann cell differentiation; P:tissue development;|P24043 Q14736 Q5VUM2 Q93022,Laminin subunit alpha-2,Laminin M chain;Laminin-12 subunit alpha;Laminin-2 subunit alpha;Laminin-4 subunit alpha;Merosin heavy chain;, PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0043197;GO:0005576;GO:0031594;GO:0042383;GO:0043083;GO:0005201;GO:0005102;GO:0005198;GO:0009887;GO:0007411;GO:0007155;GO:0030198;GO:0035633;GO:0007517;GO:0032224;GO:0030155;GO:0030334;GO:0045995;GO:0014037;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:dendritic spine; C:extracellular region; C:neuromuscular junction; C:sarcolemma; C:synaptic cleft;, F:extracellular matrix structural constituent; F:signaling receptor binding; F:structural molecule activity;, P:animal organ morphogenesis; P:axon guidance; P:cell adhesion; P:extracellular matrix organization; P:maintenance of blood-brain barrier; P:muscle organ development; P:positive regulation of synaptic transmission, cholinergic; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:Schwann cell differentiation; P:tissue development;|P24043 Q14736 Q5VUM2 Q93022,Laminin subunit alpha-2,Laminin M chain;Laminin-12 subunit alpha;Laminin-2 subunit alpha;Laminin-4 subunit alpha;Merosin heavy chain;, PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0043197;GO:0005576;GO:0031594;GO:0042383;GO:0043083;GO:0005201;GO:0005102;GO:0005198;GO:0009887;GO:0007411;GO:0007155;GO:0030198;GO:0035633;GO:0007517;GO:0032224;GO:0030155;GO:0030334;GO:0045995;GO:0014037;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:dendritic spine; C:extracellular region; C:neuromuscular junction; C:sarcolemma; C:synaptic cleft;, F:extracellular matrix structural constituent; F:signaling receptor binding; F:structural molecule activity;, P:animal organ morphogenesis; P:axon guidance; P:cell adhesion; P:extracellular matrix organization; P:maintenance of blood-brain barrier; P:muscle organ development; P:positive regulation of synaptic transmission, cholinergic; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:Schwann cell differentiation; P:tissue development; scaffold47 indexed_genome mRNA 3762718 3891260 . - . ID=transcript_9090;Q8N392 E1P575 Q58EZ3 Q6P679 Q6PJD7 Q96S64,Rho GTPase-activating protein 18,MacGAP {ECO:0000303|PubMed:21865595};Rho-type GTPase-activating protein 18;, PF00620;, GO:0005737;GO:0005881;GO:0005829;GO:0016607;GO:0005886;GO:0001726;GO:0045296;GO:0005096;GO:0032956;GO:0030833;GO:2000145;GO:0008360;GO:0051056;GO:0007264;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:nuclear speck; C:plasma membrane; C:ruffle;, F:cadherin binding; F:GTPase activator activity;, P:regulation of actin cytoskeleton organization; P:regulation of actin filament polymerization; P:regulation of cell motility; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; scaffold47 indexed_genome mRNA 4213395 4299236 . + . ID=transcript_9091;Q96JM7 Q4VXE1 Q5VUM9 Q6P9B5,Lethal(3)malignant brain tumor-like protein 3,MBT-1;, PF02820;PF00536;, GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0042802;GO:0008270;GO:0006325;GO:0043249;GO:0030851;GO:0030225;GO:0045892;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:identical protein binding; F:zinc ion binding;, P:chromatin organization; P:erythrocyte maturation; P:granulocyte differentiation; P:macrophage differentiation; P:negative regulation of transcription, DNA-templated; scaffold47 indexed_genome mRNA 4304417 4328552 . - . ID=transcript_9092;Q8N6K7 B4DY20 E1P576 J3KQK4 Q4VXD8 Q8NAY1 Q8NB96,Sterile alpha motif domain-containing protein 3,, PF00536; scaffold47 indexed_genome mRNA 4341462 4345528 . - . ID=transcript_9093;Q8N6K7 B4DY20 E1P576 J3KQK4 Q4VXD8 Q8NAY1 Q8NB96,Sterile alpha motif domain-containing protein 3,, PF00536; scaffold47 indexed_genome mRNA 4564280 4564862 . + . ID=transcript_9094;Q86VY9 Q96PX5,Transmembrane protein 200A,, PF10177;, GO:0016021;, C:integral component of membrane; scaffold47 indexed_genome mRNA 4921653 4929680 . + . ID=transcript_9095;H3BR10,Small leucine-rich protein 1,, , GO:0016021;, C:integral component of membrane; scaffold47 indexed_genome mRNA 4933618 5137766 . - . ID=transcript_9096;O43491 B4DHI8 E9PPD9 Q5T4F0 Q68DV2,Band 4.1-like protein 2,Erythrocyte membrane protein band 4.1-like 2 {ECO:0000312|HGNC:HGNC:3379};Generally expressed protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0099738;GO:0030054;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005654;GO:0005886;GO:0008091;GO:0003779;GO:0042731;GO:0030507;GO:0005198;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:1904778;, C:cell cortex region; C:cell junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:nucleoplasm; C:plasma membrane; C:spectrin;, F:actin binding; F:PH domain binding; F:spectrin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein localization to cell cortex;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|O43491 B4DHI8 E9PPD9 Q5T4F0 Q68DV2,Band 4.1-like protein 2,Erythrocyte membrane protein band 4.1-like 2 {ECO:0000312|HGNC:HGNC:3379};Generally expressed protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0099738;GO:0030054;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005654;GO:0005886;GO:0008091;GO:0003779;GO:0042731;GO:0030507;GO:0005198;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:1904778;, C:cell cortex region; C:cell junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:nucleoplasm; C:plasma membrane; C:spectrin;, F:actin binding; F:PH domain binding; F:spectrin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein localization to cell cortex;|O43491 B4DHI8 E9PPD9 Q5T4F0 Q68DV2,Band 4.1-like protein 2,Erythrocyte membrane protein band 4.1-like 2 {ECO:0000312|HGNC:HGNC:3379};Generally expressed protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0099738;GO:0030054;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005654;GO:0005886;GO:0008091;GO:0003779;GO:0042731;GO:0030507;GO:0005198;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:1904778;, C:cell cortex region; C:cell junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:nucleoplasm; C:plasma membrane; C:spectrin;, F:actin binding; F:PH domain binding; F:spectrin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein localization to cell cortex;|O43491 B4DHI8 E9PPD9 Q5T4F0 Q68DV2,Band 4.1-like protein 2,Erythrocyte membrane protein band 4.1-like 2 {ECO:0000312|HGNC:HGNC:3379};Generally expressed protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0099738;GO:0030054;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005654;GO:0005886;GO:0008091;GO:0003779;GO:0042731;GO:0030507;GO:0005198;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:1904778;, C:cell cortex region; C:cell junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:nucleoplasm; C:plasma membrane; C:spectrin;, F:actin binding; F:PH domain binding; F:spectrin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein localization to cell cortex;|O43491 B4DHI8 E9PPD9 Q5T4F0 Q68DV2,Band 4.1-like protein 2,Erythrocyte membrane protein band 4.1-like 2 {ECO:0000312|HGNC:HGNC:3379};Generally expressed protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0099738;GO:0030054;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005654;GO:0005886;GO:0008091;GO:0003779;GO:0042731;GO:0030507;GO:0005198;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:1904778;, C:cell cortex region; C:cell junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:nucleoplasm; C:plasma membrane; C:spectrin;, F:actin binding; F:PH domain binding; F:spectrin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein localization to cell cortex;|O43491 B4DHI8 E9PPD9 Q5T4F0 Q68DV2,Band 4.1-like protein 2,Erythrocyte membrane protein band 4.1-like 2 {ECO:0000312|HGNC:HGNC:3379};Generally expressed protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0099738;GO:0030054;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005654;GO:0005886;GO:0008091;GO:0003779;GO:0042731;GO:0030507;GO:0005198;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:1904778;, C:cell cortex region; C:cell junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:nucleoplasm; C:plasma membrane; C:spectrin;, F:actin binding; F:PH domain binding; F:spectrin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein localization to cell cortex;|O43491 B4DHI8 E9PPD9 Q5T4F0 Q68DV2,Band 4.1-like protein 2,Erythrocyte membrane protein band 4.1-like 2 {ECO:0000312|HGNC:HGNC:3379};Generally expressed protein 4.1;, PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;, GO:0099738;GO:0030054;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0005654;GO:0005886;GO:0008091;GO:0003779;GO:0042731;GO:0030507;GO:0005198;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:1904778;, C:cell cortex region; C:cell junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:nucleoplasm; C:plasma membrane; C:spectrin;, F:actin binding; F:PH domain binding; F:spectrin binding; F:structural molecule activity;, P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein localization to cell cortex; scaffold47 indexed_genome mRNA 5188911 5317001 . + . ID=transcript_9097;Q9P0M2 B4DUC3 Q9HCZ8,A-kinase anchor protein 7 isoform gamma,A-kinase anchor protein 18 kDa;Protein kinase A-anchoring protein 7 isoform gamma;, PF10469;PF10470;, GO:0005829;GO:0005634;GO:0032991;GO:0000166;GO:0051018;GO:0034237;GO:0010738;, C:cytosol; C:nucleus; C:protein-containing complex;, F:nucleotide binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding;, P:regulation of protein kinase A signaling;|O43687 A8K2K6 Q5TBR9 Q5TBS0 Q9HCZ8 Q9P0G4,A-kinase anchor protein 7 isoforms alpha and beta,A-kinase anchor protein 18 kDa;Protein kinase A-anchoring protein 7 isoforms alpha/beta;, PF10470;, GO:0016324;GO:0016328;GO:0005886;GO:0051018;GO:0001508;GO:0071320;GO:0035556;GO:0006811;GO:1902261;GO:1901381;GO:0008104;GO:0060306;, C:apical plasma membrane; C:lateral plasma membrane; C:plasma membrane;, F:protein kinase A binding;, P:action potential; P:cellular response to cAMP; P:intracellular signal transduction; P:ion transport; P:positive regulation of delayed rectifier potassium channel activity; P:positive regulation of potassium ion transmembrane transport; P:protein localization; P:regulation of membrane repolarization;|O43687 A8K2K6 Q5TBR9 Q5TBS0 Q9HCZ8 Q9P0G4,A-kinase anchor protein 7 isoforms alpha and beta,A-kinase anchor protein 18 kDa;Protein kinase A-anchoring protein 7 isoforms alpha/beta;, PF10470;, GO:0016324;GO:0016328;GO:0005886;GO:0051018;GO:0001508;GO:0071320;GO:0035556;GO:0006811;GO:1902261;GO:1901381;GO:0008104;GO:0060306;, C:apical plasma membrane; C:lateral plasma membrane; C:plasma membrane;, F:protein kinase A binding;, P:action potential; P:cellular response to cAMP; P:intracellular signal transduction; P:ion transport; P:positive regulation of delayed rectifier potassium channel activity; P:positive regulation of potassium ion transmembrane transport; P:protein localization; P:regulation of membrane repolarization; scaffold47 indexed_genome mRNA 5507971 5567006 . + . ID=transcript_9098;P05089 A6NEA0 Q5JWT5 Q5JWT6 Q8TE72 Q9BS50,Arginase-1,Liver-type arginase;Type I arginase;, PF00491;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0005741;GO:0043005;GO:0043025;GO:0005634;GO:0035580;GO:0004053;GO:0042802;GO:0030145;GO:0002250;GO:0007568;GO:0006527;GO:0019547;GO:0071549;GO:0071377;GO:0070301;GO:0071353;GO:0071222;GO:0071560;GO:0032964;GO:0042832;GO:0045087;GO:0001889;GO:0030324;GO:0060056;GO:0060135;GO:0046007;GO:0060336;GO:0042130;GO:2000552;GO:0043312;GO:0001938;GO:0070965;GO:0010963;GO:0014075;GO:0043200;GO:0048678;GO:0046686;GO:0042493;GO:0009635;GO:0010042;GO:0051597;GO:0010269;GO:0033189;GO:0033197;GO:0010043;GO:0000050;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:mitochondrial outer membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:specific granule lumen;, F:arginase activity; F:identical protein binding; F:manganese ion binding;, P:adaptive immune response; P:aging; P:arginine catabolic process; P:arginine catabolic process to ornithine; P:cellular response to dexamethasone stimulus; P:cellular response to glucagon stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:cellular response to transforming growth factor beta stimulus; P:collagen biosynthetic process; P:defense response to protozoan; P:innate immune response; P:liver development; P:lung development; P:mammary gland involution; P:maternal process involved in female pregnancy; P:negative regulation of activated T cell proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of T cell proliferation; P:negative regulation of T-helper 2 cell cytokine production; P:neutrophil degranulation; P:positive regulation of endothelial cell proliferation; P:positive regulation of neutrophil mediated killing of fungus; P:regulation of L-arginine import; P:response to amine; P:response to amino acid; P:response to axon injury; P:response to cadmium ion; P:response to drug; P:response to herbicide; P:response to manganese ion; P:response to methylmercury; P:response to selenium ion; P:response to vitamin A; P:response to vitamin E; P:response to zinc ion; P:urea cycle;|P05089 A6NEA0 Q5JWT5 Q5JWT6 Q8TE72 Q9BS50,Arginase-1,Liver-type arginase;Type I arginase;, PF00491;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0005741;GO:0043005;GO:0043025;GO:0005634;GO:0035580;GO:0004053;GO:0042802;GO:0030145;GO:0002250;GO:0007568;GO:0006527;GO:0019547;GO:0071549;GO:0071377;GO:0070301;GO:0071353;GO:0071222;GO:0071560;GO:0032964;GO:0042832;GO:0045087;GO:0001889;GO:0030324;GO:0060056;GO:0060135;GO:0046007;GO:0060336;GO:0042130;GO:2000552;GO:0043312;GO:0001938;GO:0070965;GO:0010963;GO:0014075;GO:0043200;GO:0048678;GO:0046686;GO:0042493;GO:0009635;GO:0010042;GO:0051597;GO:0010269;GO:0033189;GO:0033197;GO:0010043;GO:0000050;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:mitochondrial outer membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:specific granule lumen;, F:arginase activity; F:identical protein binding; F:manganese ion binding;, P:adaptive immune response; P:aging; P:arginine catabolic process; P:arginine catabolic process to ornithine; P:cellular response to dexamethasone stimulus; P:cellular response to glucagon stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:cellular response to transforming growth factor beta stimulus; P:collagen biosynthetic process; P:defense response to protozoan; P:innate immune response; P:liver development; P:lung development; P:mammary gland involution; P:maternal process involved in female pregnancy; P:negative regulation of activated T cell proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of T cell proliferation; P:negative regulation of T-helper 2 cell cytokine production; P:neutrophil degranulation; P:positive regulation of endothelial cell proliferation; P:positive regulation of neutrophil mediated killing of fungus; P:regulation of L-arginine import; P:response to amine; P:response to amino acid; P:response to axon injury; P:response to cadmium ion; P:response to drug; P:response to herbicide; P:response to manganese ion; P:response to methylmercury; P:response to selenium ion; P:response to vitamin A; P:response to vitamin E; P:response to zinc ion; P:urea cycle;|P05089 A6NEA0 Q5JWT5 Q5JWT6 Q8TE72 Q9BS50,Arginase-1,Liver-type arginase;Type I arginase;, PF00491;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0005741;GO:0043005;GO:0043025;GO:0005634;GO:0035580;GO:0004053;GO:0042802;GO:0030145;GO:0002250;GO:0007568;GO:0006527;GO:0019547;GO:0071549;GO:0071377;GO:0070301;GO:0071353;GO:0071222;GO:0071560;GO:0032964;GO:0042832;GO:0045087;GO:0001889;GO:0030324;GO:0060056;GO:0060135;GO:0046007;GO:0060336;GO:0042130;GO:2000552;GO:0043312;GO:0001938;GO:0070965;GO:0010963;GO:0014075;GO:0043200;GO:0048678;GO:0046686;GO:0042493;GO:0009635;GO:0010042;GO:0051597;GO:0010269;GO:0033189;GO:0033197;GO:0010043;GO:0000050;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:mitochondrial outer membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:specific granule lumen;, F:arginase activity; F:identical protein binding; F:manganese ion binding;, P:adaptive immune response; P:aging; P:arginine catabolic process; P:arginine catabolic process to ornithine; P:cellular response to dexamethasone stimulus; P:cellular response to glucagon stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:cellular response to transforming growth factor beta stimulus; P:collagen biosynthetic process; P:defense response to protozoan; P:innate immune response; P:liver development; P:lung development; P:mammary gland involution; P:maternal process involved in female pregnancy; P:negative regulation of activated T cell proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of T cell proliferation; P:negative regulation of T-helper 2 cell cytokine production; P:neutrophil degranulation; P:positive regulation of endothelial cell proliferation; P:positive regulation of neutrophil mediated killing of fungus; P:regulation of L-arginine import; P:response to amine; P:response to amino acid; P:response to axon injury; P:response to cadmium ion; P:response to drug; P:response to herbicide; P:response to manganese ion; P:response to methylmercury; P:response to selenium ion; P:response to vitamin A; P:response to vitamin E; P:response to zinc ion; P:urea cycle;|P05089 A6NEA0 Q5JWT5 Q5JWT6 Q8TE72 Q9BS50,Arginase-1,Liver-type arginase;Type I arginase;, PF00491;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0005741;GO:0043005;GO:0043025;GO:0005634;GO:0035580;GO:0004053;GO:0042802;GO:0030145;GO:0002250;GO:0007568;GO:0006527;GO:0019547;GO:0071549;GO:0071377;GO:0070301;GO:0071353;GO:0071222;GO:0071560;GO:0032964;GO:0042832;GO:0045087;GO:0001889;GO:0030324;GO:0060056;GO:0060135;GO:0046007;GO:0060336;GO:0042130;GO:2000552;GO:0043312;GO:0001938;GO:0070965;GO:0010963;GO:0014075;GO:0043200;GO:0048678;GO:0046686;GO:0042493;GO:0009635;GO:0010042;GO:0051597;GO:0010269;GO:0033189;GO:0033197;GO:0010043;GO:0000050;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:mitochondrial outer membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:specific granule lumen;, F:arginase activity; F:identical protein binding; F:manganese ion binding;, P:adaptive immune response; P:aging; P:arginine catabolic process; P:arginine catabolic process to ornithine; P:cellular response to dexamethasone stimulus; P:cellular response to glucagon stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:cellular response to transforming growth factor beta stimulus; P:collagen biosynthetic process; P:defense response to protozoan; P:innate immune response; P:liver development; P:lung development; P:mammary gland involution; P:maternal process involved in female pregnancy; P:negative regulation of activated T cell proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of T cell proliferation; P:negative regulation of T-helper 2 cell cytokine production; P:neutrophil degranulation; P:positive regulation of endothelial cell proliferation; P:positive regulation of neutrophil mediated killing of fungus; P:regulation of L-arginine import; P:response to amine; P:response to amino acid; P:response to axon injury; P:response to cadmium ion; P:response to drug; P:response to herbicide; P:response to manganese ion; P:response to methylmercury; P:response to selenium ion; P:response to vitamin A; P:response to vitamin E; P:response to zinc ion; P:urea cycle;|P05089 A6NEA0 Q5JWT5 Q5JWT6 Q8TE72 Q9BS50,Arginase-1,Liver-type arginase;Type I arginase;, PF00491;, GO:0035578;GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0005741;GO:0043005;GO:0043025;GO:0005634;GO:0035580;GO:0004053;GO:0042802;GO:0030145;GO:0002250;GO:0007568;GO:0006527;GO:0019547;GO:0071549;GO:0071377;GO:0070301;GO:0071353;GO:0071222;GO:0071560;GO:0032964;GO:0042832;GO:0045087;GO:0001889;GO:0030324;GO:0060056;GO:0060135;GO:0046007;GO:0060336;GO:0042130;GO:2000552;GO:0043312;GO:0001938;GO:0070965;GO:0010963;GO:0014075;GO:0043200;GO:0048678;GO:0046686;GO:0042493;GO:0009635;GO:0010042;GO:0051597;GO:0010269;GO:0033189;GO:0033197;GO:0010043;GO:0000050;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:mitochondrial outer membrane; C:neuron projection; C:neuronal cell body; C:nucleus; C:specific granule lumen;, F:arginase activity; F:identical protein binding; F:manganese ion binding;, P:adaptive immune response; P:aging; P:arginine catabolic process; P:arginine catabolic process to ornithine; P:cellular response to dexamethasone stimulus; P:cellular response to glucagon stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:cellular response to transforming growth factor beta stimulus; P:collagen biosynthetic process; P:defense response to protozoan; P:innate immune response; P:liver development; P:lung development; P:mammary gland involution; P:maternal process involved in female pregnancy; P:negative regulation of activated T cell proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of T cell proliferation; P:negative regulation of T-helper 2 cell cytokine production; P:neutrophil degranulation; P:positive regulation of endothelial cell proliferation; P:positive regulation of neutrophil mediated killing of fungus; P:regulation of L-arginine import; P:response to amine; P:response to amino acid; P:response to axon injury; P:response to cadmium ion; P:response to drug; P:response to herbicide; P:response to manganese ion; P:response to methylmercury; P:response to selenium ion; P:response to vitamin A; P:response to vitamin E; P:response to zinc ion; P:urea cycle;|Q9Y5P7 Q9Y667,Mediator of RNA polymerase II transcription subunit 23,Activator-recruited cofactor 130 kDa component;Cofactor required for Sp1 transcriptional activation subunit 3;Mediator complex subunit 23;Protein sur-2 homolog;Transcriptional coactivator CRSP130;Vitamin D3 receptor-interacting protein complex 130 kDa component;, PF11573;, GO:0016592;GO:0005654;GO:0005667;GO:0003713;GO:0010628;GO:0006357;GO:0060260;GO:0006355;GO:0006367;, C:mediator complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription coactivator activity;, P:positive regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y5P7 Q9Y667,Mediator of RNA polymerase II transcription subunit 23,Activator-recruited cofactor 130 kDa component;Cofactor required for Sp1 transcriptional activation subunit 3;Mediator complex subunit 23;Protein sur-2 homolog;Transcriptional coactivator CRSP130;Vitamin D3 receptor-interacting protein complex 130 kDa component;, PF11573;, GO:0016592;GO:0005654;GO:0005667;GO:0003713;GO:0010628;GO:0006357;GO:0060260;GO:0006355;GO:0006367;, C:mediator complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription coactivator activity;, P:positive regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y5P7 Q9Y667,Mediator of RNA polymerase II transcription subunit 23,Activator-recruited cofactor 130 kDa component;Cofactor required for Sp1 transcriptional activation subunit 3;Mediator complex subunit 23;Protein sur-2 homolog;Transcriptional coactivator CRSP130;Vitamin D3 receptor-interacting protein complex 130 kDa component;, PF11573;, GO:0016592;GO:0005654;GO:0005667;GO:0003713;GO:0010628;GO:0006357;GO:0060260;GO:0006355;GO:0006367;, C:mediator complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription coactivator activity;, P:positive regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y5P7 Q9Y667,Mediator of RNA polymerase II transcription subunit 23,Activator-recruited cofactor 130 kDa component;Cofactor required for Sp1 transcriptional activation subunit 3;Mediator complex subunit 23;Protein sur-2 homolog;Transcriptional coactivator CRSP130;Vitamin D3 receptor-interacting protein complex 130 kDa component;, PF11573;, GO:0016592;GO:0005654;GO:0005667;GO:0003713;GO:0010628;GO:0006357;GO:0060260;GO:0006355;GO:0006367;, C:mediator complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription coactivator activity;, P:positive regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y5P7 Q9Y667,Mediator of RNA polymerase II transcription subunit 23,Activator-recruited cofactor 130 kDa component;Cofactor required for Sp1 transcriptional activation subunit 3;Mediator complex subunit 23;Protein sur-2 homolog;Transcriptional coactivator CRSP130;Vitamin D3 receptor-interacting protein complex 130 kDa component;, PF11573;, GO:0016592;GO:0005654;GO:0005667;GO:0003713;GO:0010628;GO:0006357;GO:0060260;GO:0006355;GO:0006367;, C:mediator complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription coactivator activity;, P:positive regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y5P7 Q9Y667,Mediator of RNA polymerase II transcription subunit 23,Activator-recruited cofactor 130 kDa component;Cofactor required for Sp1 transcriptional activation subunit 3;Mediator complex subunit 23;Protein sur-2 homolog;Transcriptional coactivator CRSP130;Vitamin D3 receptor-interacting protein complex 130 kDa component;, PF11573;, GO:0016592;GO:0005654;GO:0005667;GO:0003713;GO:0010628;GO:0006357;GO:0060260;GO:0006355;GO:0006367;, C:mediator complex; C:nucleoplasm; C:transcription regulator complex;, F:transcription coactivator activity;, P:positive regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter; scaffold47 indexed_genome mRNA 5582468 5665288 . + . ID=transcript_9099;O14638 Q5JTL3,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3,Phosphodiesterase I beta {ECO:0000303|PubMed:9344668};Phosphodiesterase I/nucleotide pyrophosphatase 3;, PF01223;PF01663;PF01033;, GO:0016324;GO:0009897;GO:0070062;GO:0016021;GO:0048471;GO:0005509;GO:0036218;GO:0035529;GO:0003676;GO:0047429;GO:0004528;GO:0008270;GO:0046034;GO:0002276;GO:0050728;GO:0033007;GO:0070667;GO:0009143;GO:0006796;GO:0006220;, C:apical plasma membrane; C:external side of plasma membrane; C:extracellular exosome; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:dTTP diphosphatase activity; F:NADH pyrophosphatase activity; F:nucleic acid binding; F:nucleoside-triphosphate diphosphatase activity; F:phosphodiesterase I activity; F:zinc ion binding;, P:ATP metabolic process; P:basophil activation involved in immune response; P:negative regulation of inflammatory response; P:negative regulation of mast cell activation involved in immune response; P:negative regulation of mast cell proliferation; P:nucleoside triphosphate catabolic process; P:phosphate-containing compound metabolic process; P:pyrimidine nucleotide metabolic process; scaffold47 indexed_genome mRNA 5723074 5793273 . + . ID=transcript_9100;P22413 Q5T9R6 Q9NPZ3 Q9P1P6 Q9UP61 Q9Y6K3,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,Membrane component chromosome 6 surface marker 1;Phosphodiesterase I/nucleotide pyrophosphatase 1;Plasma-cell membrane glycoprotein PC-1 {ECO:0000303|PubMed:2211644};, PF01223;PF01663;PF01033;, GO:0016323;GO:0009986;GO:0005615;GO:0016021;GO:0005887;GO:0005765;GO:0005886;GO:0050656;GO:0005524;GO:0005509;GO:0106177;GO:0036218;GO:0004527;GO:0005158;GO:0035529;GO:0003676;GO:0047429;GO:0004551;GO:0004528;GO:0030247;GO:0042803;GO:0005044;GO:0008270;GO:0050427;GO:0046034;GO:0031214;GO:0030643;GO:0032869;GO:0006091;GO:0006955;GO:0030505;GO:0030318;GO:0030502;GO:0030308;GO:0045599;GO:0046325;GO:0045719;GO:1990787;GO:0046627;GO:0031953;GO:0090305;GO:0009143;GO:0006796;GO:0030500;GO:0006771;GO:0030730;, C:basolateral plasma membrane; C:cell surface; C:extracellular space; C:integral component of membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:ATP binding; F:calcium ion binding; F:cyclic-GMP-AMP hydrolase activity; F:dTTP diphosphatase activity; F:exonuclease activity; F:insulin receptor binding; F:NADH pyrophosphatase activity; F:nucleic acid binding; F:nucleoside-triphosphate diphosphatase activity; F:nucleotide diphosphatase activity; F:phosphodiesterase I activity; F:polysaccharide binding; F:protein homodimerization activity; F:scavenger receptor activity; F:zinc ion binding;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:ATP metabolic process; P:biomineral tissue development; P:cellular phosphate ion homeostasis; P:cellular response to insulin stimulus; P:generation of precursor metabolites and energy; P:immune response; P:inorganic diphosphate transport; P:melanocyte differentiation; P:negative regulation of bone mineralization; P:negative regulation of cell growth; P:negative regulation of fat cell differentiation; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of hh target transcription factor activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of protein autophosphorylation; P:nucleic acid phosphodiester bond hydrolysis; P:nucleoside triphosphate catabolic process; P:phosphate-containing compound metabolic process; P:regulation of bone mineralization; P:riboflavin metabolic process; P:sequestering of triglyceride; scaffold47 indexed_genome mRNA 6345361 6359991 . - . ID=transcript_9101;O15400 E1P579 Q5SZW2 Q96ES9,Syntaxin-7,, PF05739;PF14523;, GO:0042582;GO:0005769;GO:0031901;GO:0030139;GO:0012505;GO:0005768;GO:0070062;GO:0001772;GO:0016021;GO:0005770;GO:0005765;GO:0005764;GO:0048471;GO:0005886;GO:0055037;GO:0031201;GO:0008021;GO:0070820;GO:0031982;GO:0019869;GO:0005484;GO:0000149;GO:0019905;GO:0006886;GO:0070925;GO:0051640;GO:1902685;GO:0001916;GO:1903076;GO:0048278;GO:0006906;, C:azurophil granule; C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endomembrane system; C:endosome; C:extracellular exosome; C:immunological synapse; C:integral component of membrane; C:late endosome; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:SNARE complex; C:synaptic vesicle; C:tertiary granule; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:intracellular protein transport; P:organelle assembly; P:organelle localization; P:positive regulation of receptor localization to synapse; P:positive regulation of T cell mediated cytotoxicity; P:regulation of protein localization to plasma membrane; P:vesicle docking; P:vesicle fusion;|O15400 E1P579 Q5SZW2 Q96ES9,Syntaxin-7,, PF05739;PF14523;, GO:0042582;GO:0005769;GO:0031901;GO:0030139;GO:0012505;GO:0005768;GO:0070062;GO:0001772;GO:0016021;GO:0005770;GO:0005765;GO:0005764;GO:0048471;GO:0005886;GO:0055037;GO:0031201;GO:0008021;GO:0070820;GO:0031982;GO:0019869;GO:0005484;GO:0000149;GO:0019905;GO:0006886;GO:0070925;GO:0051640;GO:1902685;GO:0001916;GO:1903076;GO:0048278;GO:0006906;, C:azurophil granule; C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endomembrane system; C:endosome; C:extracellular exosome; C:immunological synapse; C:integral component of membrane; C:late endosome; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:SNARE complex; C:synaptic vesicle; C:tertiary granule; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:intracellular protein transport; P:organelle assembly; P:organelle localization; P:positive regulation of receptor localization to synapse; P:positive regulation of T cell mediated cytotoxicity; P:regulation of protein localization to plasma membrane; P:vesicle docking; P:vesicle fusion;|O15400 E1P579 Q5SZW2 Q96ES9,Syntaxin-7,, PF05739;PF14523;, GO:0042582;GO:0005769;GO:0031901;GO:0030139;GO:0012505;GO:0005768;GO:0070062;GO:0001772;GO:0016021;GO:0005770;GO:0005765;GO:0005764;GO:0048471;GO:0005886;GO:0055037;GO:0031201;GO:0008021;GO:0070820;GO:0031982;GO:0019869;GO:0005484;GO:0000149;GO:0019905;GO:0006886;GO:0070925;GO:0051640;GO:1902685;GO:0001916;GO:1903076;GO:0048278;GO:0006906;, C:azurophil granule; C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endomembrane system; C:endosome; C:extracellular exosome; C:immunological synapse; C:integral component of membrane; C:late endosome; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:SNARE complex; C:synaptic vesicle; C:tertiary granule; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:intracellular protein transport; P:organelle assembly; P:organelle localization; P:positive regulation of receptor localization to synapse; P:positive regulation of T cell mediated cytotoxicity; P:regulation of protein localization to plasma membrane; P:vesicle docking; P:vesicle fusion; scaffold47 indexed_genome mRNA 6580851 6596040 . - . ID=transcript_9102;O95497 A8K310 Q4JFW6 Q4VAS7 Q4VAS8 Q4VAS9 Q9UF16 Q9UJF4,Pantetheinase,Pantetheine hydrolase;Tiff66;Vascular non-inflammatory molecule 1;, PF00795;PF19018;, GO:0031225;GO:0035577;GO:0005576;GO:0016021;GO:0005886;GO:0017159;GO:0002526;GO:0098609;GO:0002544;GO:0006954;GO:0045087;GO:1902176;GO:0043312;GO:0015939;GO:0033089;GO:0006979;, C:anchored component of membrane; C:azurophil granule membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:pantetheine hydrolase activity;, P:acute inflammatory response; P:cell-cell adhesion; P:chronic inflammatory response; P:inflammatory response; P:innate immune response; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:neutrophil degranulation; P:pantothenate metabolic process; P:positive regulation of T cell differentiation in thymus; P:response to oxidative stress; scaffold47 indexed_genome mRNA 6621598 6641459 . - . ID=transcript_9103;F6XL73 Q2XUN1 Q9UJF3 Q9UMW2,Vascular non-inflammatory molecule 2,Glycosylphosphatidyl inositol-anchored protein GPI-80;Protein FOAP-4;, PF00795;PF19018;, GO:0031225;GO:0005576;GO:0005886;GO:0017159;GO:0015939;, C:anchored component of membrane; C:extracellular region; C:plasma membrane;, F:pantetheine hydrolase activity;, P:pantothenate metabolic process; scaffold47 indexed_genome mRNA 6658443 6686468 . - . ID=transcript_9104;Q6NT16 A8K1K3 B3KW77 Q6ISF2,MFS-type transporter SLC18B1,Solute carrier family 18 member B1;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q6NT16 A8K1K3 B3KW77 Q6ISF2,MFS-type transporter SLC18B1,Solute carrier family 18 member B1;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q6NT16 A8K1K3 B3KW77 Q6ISF2,MFS-type transporter SLC18B1,Solute carrier family 18 member B1;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold47 indexed_genome mRNA 6698625 6701925 . + . ID=transcript_9105;P25398 Q76M58,40S ribosomal protein S12,Small ribosomal subunit protein eS12 {ECO:0000303|PubMed:24524803};, PF01248;, GO:0005829;GO:0022627;GO:0005794;GO:0043231;GO:0016020;GO:0005654;GO:0003723;GO:0003735;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold47 indexed_genome mRNA 7051251 7390087 . + . ID=transcript_9106;O95677 B7Z7F7 O95464 O95679 Q8IW39 Q9NTR7,Eyes absent homolog 4,, , GO:0005737;GO:0005634;GO:0046872;GO:0004725;GO:0048856;GO:0009653;GO:0030154;GO:0006281;GO:0016576;GO:0007275;GO:2001240;GO:0045739;GO:0007605;GO:0007601;, C:cytoplasm; C:nucleus;, F:metal ion binding; F:protein tyrosine phosphatase activity;, P:anatomical structure development; P:anatomical structure morphogenesis; P:cell differentiation; P:DNA repair; P:histone dephosphorylation; P:multicellular organism development; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:sensory perception of sound; P:visual perception;|O95677 B7Z7F7 O95464 O95679 Q8IW39 Q9NTR7,Eyes absent homolog 4,, , GO:0005737;GO:0005634;GO:0046872;GO:0004725;GO:0048856;GO:0009653;GO:0030154;GO:0006281;GO:0016576;GO:0007275;GO:2001240;GO:0045739;GO:0007605;GO:0007601;, C:cytoplasm; C:nucleus;, F:metal ion binding; F:protein tyrosine phosphatase activity;, P:anatomical structure development; P:anatomical structure morphogenesis; P:cell differentiation; P:DNA repair; P:histone dephosphorylation; P:multicellular organism development; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:sensory perception of sound; P:visual perception; scaffold47 indexed_genome mRNA 7674524 7677586 . + . ID=transcript_9107;O43680 E1P581 O43545 Q6ICV0 Q9BZ14,Transcription factor 21,Capsulin;Class A basic helix-loop-helix protein 23;Epicardin;Podocyte-expressed 1;, PF00010;, GO:0000785;GO:0005634;GO:0050681;GO:0043425;GO:0001228;GO:0000981;GO:0001227;GO:0070888;GO:0042826;GO:0046983;GO:0000977;GO:1990837;GO:0001658;GO:0014707;GO:0060435;GO:0032502;GO:0060539;GO:0048557;GO:0030855;GO:0048732;GO:0032835;GO:0001822;GO:0048286;GO:0060425;GO:0060426;GO:0072277;GO:0072162;GO:0001763;GO:0060766;GO:0000122;GO:0045944;GO:0006357;GO:0048608;GO:0060541;GO:0060021;GO:0060008;GO:0007530;GO:0048536;GO:0001657;GO:0001944;, C:chromatin; C:nucleus;, F:androgen receptor binding; F:bHLH transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:histone deacetylase binding; F:protein dimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:branching involved in ureteric bud morphogenesis; P:branchiomeric skeletal muscle development; P:bronchiole development; P:developmental process; P:diaphragm development; P:embryonic digestive tract morphogenesis; P:epithelial cell differentiation; P:gland development; P:glomerulus development; P:kidney development; P:lung alveolus development; P:lung morphogenesis; P:lung vasculature development; P:metanephric glomerular capillary formation; P:metanephric mesenchymal cell differentiation; P:morphogenesis of a branching structure; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:reproductive structure development; P:respiratory system development; P:roof of mouth development; P:Sertoli cell differentiation; P:sex determination; P:spleen development; P:ureteric bud development; P:vasculature development;|O43680 E1P581 O43545 Q6ICV0 Q9BZ14,Transcription factor 21,Capsulin;Class A basic helix-loop-helix protein 23;Epicardin;Podocyte-expressed 1;, PF00010;, GO:0000785;GO:0005634;GO:0050681;GO:0043425;GO:0001228;GO:0000981;GO:0001227;GO:0070888;GO:0042826;GO:0046983;GO:0000977;GO:1990837;GO:0001658;GO:0014707;GO:0060435;GO:0032502;GO:0060539;GO:0048557;GO:0030855;GO:0048732;GO:0032835;GO:0001822;GO:0048286;GO:0060425;GO:0060426;GO:0072277;GO:0072162;GO:0001763;GO:0060766;GO:0000122;GO:0045944;GO:0006357;GO:0048608;GO:0060541;GO:0060021;GO:0060008;GO:0007530;GO:0048536;GO:0001657;GO:0001944;, C:chromatin; C:nucleus;, F:androgen receptor binding; F:bHLH transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:histone deacetylase binding; F:protein dimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:branching involved in ureteric bud morphogenesis; P:branchiomeric skeletal muscle development; P:bronchiole development; P:developmental process; P:diaphragm development; P:embryonic digestive tract morphogenesis; P:epithelial cell differentiation; P:gland development; P:glomerulus development; P:kidney development; P:lung alveolus development; P:lung morphogenesis; P:lung vasculature development; P:metanephric glomerular capillary formation; P:metanephric mesenchymal cell differentiation; P:morphogenesis of a branching structure; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:reproductive structure development; P:respiratory system development; P:roof of mouth development; P:Sertoli cell differentiation; P:sex determination; P:spleen development; P:ureteric bud development; P:vasculature development; scaffold47 indexed_genome mRNA 7712059 7810997 . + . ID=transcript_9108;P62380 A8K8F5 O95753 Q9BWD5 Q9Z2Z0,TATA box-binding protein-like 1,21 kDa TBP-like protein;Second TBP of unique DNA protein;TATA box-binding protein-related factor 2;TBP-like factor;TBP-related protein;, PF00352;, GO:0005737;GO:0005672;GO:0140223;GO:0000979;GO:0016251;GO:0001675;GO:0006352;GO:0006235;GO:0007289;GO:0006366;, C:cytoplasm; C:transcription factor TFIIA complex;, F:general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity;, P:acrosome assembly; P:DNA-templated transcription, initiation; P:dTTP biosynthetic process; P:spermatid nucleus differentiation; P:transcription by RNA polymerase II;|P62380 A8K8F5 O95753 Q9BWD5 Q9Z2Z0,TATA box-binding protein-like 1,21 kDa TBP-like protein;Second TBP of unique DNA protein;TATA box-binding protein-related factor 2;TBP-like factor;TBP-related protein;, PF00352;, GO:0005737;GO:0005672;GO:0140223;GO:0000979;GO:0016251;GO:0001675;GO:0006352;GO:0006235;GO:0007289;GO:0006366;, C:cytoplasm; C:transcription factor TFIIA complex;, F:general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity;, P:acrosome assembly; P:DNA-templated transcription, initiation; P:dTTP biosynthetic process; P:spermatid nucleus differentiation; P:transcription by RNA polymerase II;|P62380 A8K8F5 O95753 Q9BWD5 Q9Z2Z0,TATA box-binding protein-like 1,21 kDa TBP-like protein;Second TBP of unique DNA protein;TATA box-binding protein-related factor 2;TBP-like factor;TBP-related protein;, PF00352;, GO:0005737;GO:0005672;GO:0140223;GO:0000979;GO:0016251;GO:0001675;GO:0006352;GO:0006235;GO:0007289;GO:0006366;, C:cytoplasm; C:transcription factor TFIIA complex;, F:general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity;, P:acrosome assembly; P:DNA-templated transcription, initiation; P:dTTP biosynthetic process; P:spermatid nucleus differentiation; P:transcription by RNA polymerase II;|Q8TD20 B3KV17 Q7Z6U3 Q96MR8,Solute carrier family 2, facilitated glucose transporter member 12 {ECO:0000305},Glucose transporter type 12 {ECO:0000303|PubMed:11832379};, PF00083;, GO:0012505;GO:0016021;GO:0048471;GO:0005886;GO:0022857;GO:1904659;GO:0008645;, C:endomembrane system; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:transmembrane transporter activity;, P:glucose transmembrane transport; P:hexose transmembrane transport; scaffold47 indexed_genome mRNA 7889128 8004296 . - . ID=transcript_9109;Q5VY65 Q9UN56,Serine/threonine-protein kinase Sgk1,Serum/glucocorticoid-regulated kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005246;GO:0017081;GO:0015459;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0017080;GO:0006915;GO:1904045;GO:0006974;GO:0035556;GO:0034220;GO:0007616;GO:0048812;GO:0018105;GO:0032411;GO:0006468;GO:0042981;GO:0008217;GO:0050790;GO:0001558;GO:0030334;GO:0042127;GO:0051090;GO:0060453;GO:1901796;GO:0070294;GO:0006814;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:chloride channel regulator activity; F:potassium channel regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:apoptotic process; P:cellular response to aldosterone; P:cellular response to DNA damage stimulus; P:intracellular signal transduction; P:ion transmembrane transport; P:long-term memory; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:positive regulation of transporter activity; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of cell growth; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of gastric acid secretion; P:regulation of signal transduction by p53 class mediator; P:renal sodium ion absorption; P:sodium ion transport;|Q5VY65 Q9UN56,Serine/threonine-protein kinase Sgk1,Serum/glucocorticoid-regulated kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005246;GO:0017081;GO:0015459;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0017080;GO:0006915;GO:1904045;GO:0006974;GO:0035556;GO:0034220;GO:0007616;GO:0048812;GO:0018105;GO:0032411;GO:0006468;GO:0042981;GO:0008217;GO:0050790;GO:0001558;GO:0030334;GO:0042127;GO:0051090;GO:0060453;GO:1901796;GO:0070294;GO:0006814;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:chloride channel regulator activity; F:potassium channel regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:apoptotic process; P:cellular response to aldosterone; P:cellular response to DNA damage stimulus; P:intracellular signal transduction; P:ion transmembrane transport; P:long-term memory; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:positive regulation of transporter activity; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of cell growth; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of gastric acid secretion; P:regulation of signal transduction by p53 class mediator; P:renal sodium ion absorption; P:sodium ion transport;|Q5VY65 Q9UN56,Serine/threonine-protein kinase Sgk1,Serum/glucocorticoid-regulated kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005246;GO:0017081;GO:0015459;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0017080;GO:0006915;GO:1904045;GO:0006974;GO:0035556;GO:0034220;GO:0007616;GO:0048812;GO:0018105;GO:0032411;GO:0006468;GO:0042981;GO:0008217;GO:0050790;GO:0001558;GO:0030334;GO:0042127;GO:0051090;GO:0060453;GO:1901796;GO:0070294;GO:0006814;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:chloride channel regulator activity; F:potassium channel regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:apoptotic process; P:cellular response to aldosterone; P:cellular response to DNA damage stimulus; P:intracellular signal transduction; P:ion transmembrane transport; P:long-term memory; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:positive regulation of transporter activity; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of cell growth; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of gastric acid secretion; P:regulation of signal transduction by p53 class mediator; P:renal sodium ion absorption; P:sodium ion transport;|Q5VY65 Q9UN56,Serine/threonine-protein kinase Sgk1,Serum/glucocorticoid-regulated kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005246;GO:0017081;GO:0015459;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0017080;GO:0006915;GO:1904045;GO:0006974;GO:0035556;GO:0034220;GO:0007616;GO:0048812;GO:0018105;GO:0032411;GO:0006468;GO:0042981;GO:0008217;GO:0050790;GO:0001558;GO:0030334;GO:0042127;GO:0051090;GO:0060453;GO:1901796;GO:0070294;GO:0006814;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:chloride channel regulator activity; F:potassium channel regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:apoptotic process; P:cellular response to aldosterone; P:cellular response to DNA damage stimulus; P:intracellular signal transduction; P:ion transmembrane transport; P:long-term memory; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:positive regulation of transporter activity; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of cell growth; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of gastric acid secretion; P:regulation of signal transduction by p53 class mediator; P:renal sodium ion absorption; P:sodium ion transport;|Q5VY65 Q9UN56,Serine/threonine-protein kinase Sgk1,Serum/glucocorticoid-regulated kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005246;GO:0017081;GO:0015459;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0017080;GO:0006915;GO:1904045;GO:0006974;GO:0035556;GO:0034220;GO:0007616;GO:0048812;GO:0018105;GO:0032411;GO:0006468;GO:0042981;GO:0008217;GO:0050790;GO:0001558;GO:0030334;GO:0042127;GO:0051090;GO:0060453;GO:1901796;GO:0070294;GO:0006814;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:chloride channel regulator activity; F:potassium channel regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:apoptotic process; P:cellular response to aldosterone; P:cellular response to DNA damage stimulus; P:intracellular signal transduction; P:ion transmembrane transport; P:long-term memory; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:positive regulation of transporter activity; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of cell growth; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of gastric acid secretion; P:regulation of signal transduction by p53 class mediator; P:renal sodium ion absorption; P:sodium ion transport;|Q5VY65 Q9UN56,Serine/threonine-protein kinase Sgk1,Serum/glucocorticoid-regulated kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005246;GO:0017081;GO:0015459;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0017080;GO:0006915;GO:1904045;GO:0006974;GO:0035556;GO:0034220;GO:0007616;GO:0048812;GO:0018105;GO:0032411;GO:0006468;GO:0042981;GO:0008217;GO:0050790;GO:0001558;GO:0030334;GO:0042127;GO:0051090;GO:0060453;GO:1901796;GO:0070294;GO:0006814;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:chloride channel regulator activity; F:potassium channel regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:apoptotic process; P:cellular response to aldosterone; P:cellular response to DNA damage stimulus; P:intracellular signal transduction; P:ion transmembrane transport; P:long-term memory; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:positive regulation of transporter activity; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of cell growth; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of gastric acid secretion; P:regulation of signal transduction by p53 class mediator; P:renal sodium ion absorption; P:sodium ion transport;|Q5VY65 Q9UN56,Serine/threonine-protein kinase Sgk1,Serum/glucocorticoid-regulated kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005246;GO:0017081;GO:0015459;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0017080;GO:0006915;GO:1904045;GO:0006974;GO:0035556;GO:0034220;GO:0007616;GO:0048812;GO:0018105;GO:0032411;GO:0006468;GO:0042981;GO:0008217;GO:0050790;GO:0001558;GO:0030334;GO:0042127;GO:0051090;GO:0060453;GO:1901796;GO:0070294;GO:0006814;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:chloride channel regulator activity; F:potassium channel regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:apoptotic process; P:cellular response to aldosterone; P:cellular response to DNA damage stimulus; P:intracellular signal transduction; P:ion transmembrane transport; P:long-term memory; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:positive regulation of transporter activity; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of cell growth; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of gastric acid secretion; P:regulation of signal transduction by p53 class mediator; P:renal sodium ion absorption; P:sodium ion transport;|Q5VY65 Q9UN56,Serine/threonine-protein kinase Sgk1,Serum/glucocorticoid-regulated kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005789;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005246;GO:0017081;GO:0015459;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0017080;GO:0006915;GO:1904045;GO:0006974;GO:0035556;GO:0034220;GO:0007616;GO:0048812;GO:0018105;GO:0032411;GO:0006468;GO:0042981;GO:0008217;GO:0050790;GO:0001558;GO:0030334;GO:0042127;GO:0051090;GO:0060453;GO:1901796;GO:0070294;GO:0006814;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium channel regulator activity; F:chloride channel regulator activity; F:potassium channel regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:sodium channel regulator activity;, P:apoptotic process; P:cellular response to aldosterone; P:cellular response to DNA damage stimulus; P:intracellular signal transduction; P:ion transmembrane transport; P:long-term memory; P:neuron projection morphogenesis; P:peptidyl-serine phosphorylation; P:positive regulation of transporter activity; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of cell growth; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA-binding transcription factor activity; P:regulation of gastric acid secretion; P:regulation of signal transduction by p53 class mediator; P:renal sodium ion absorption; P:sodium ion transport; scaffold47 indexed_genome mRNA 8521456 8547516 . - . ID=transcript_9110;Q9H2A2 B7Z521 O60793 Q24JS9 Q53GT3 Q5TI80,2-aminomuconic semialdehyde dehydrogenase {ECO:0000305|PubMed:29703752},Aldehyde dehydrogenase 12;Aldehyde dehydrogenase family 8 member A1 {ECO:0000312|HGNC:HGNC:15471};, PF00171;, GO:0005829;GO:0070062;GO:0047102;GO:0001758;GO:0042904;GO:0097053;GO:0042574;GO:0042573;, C:cytosol; C:extracellular exosome;, F:aminomuconate-semialdehyde dehydrogenase activity; F:retinal dehydrogenase activity;, P:9-cis-retinoic acid biosynthetic process; P:L-kynurenine catabolic process; P:retinal metabolic process; P:retinoic acid metabolic process;|Q9H2A2 B7Z521 O60793 Q24JS9 Q53GT3 Q5TI80,2-aminomuconic semialdehyde dehydrogenase {ECO:0000305|PubMed:29703752},Aldehyde dehydrogenase 12;Aldehyde dehydrogenase family 8 member A1 {ECO:0000312|HGNC:HGNC:15471};, PF00171;, GO:0005829;GO:0070062;GO:0047102;GO:0001758;GO:0042904;GO:0097053;GO:0042574;GO:0042573;, C:cytosol; C:extracellular exosome;, F:aminomuconate-semialdehyde dehydrogenase activity; F:retinal dehydrogenase activity;, P:9-cis-retinoic acid biosynthetic process; P:L-kynurenine catabolic process; P:retinal metabolic process; P:retinoic acid metabolic process;|Q9H2A2 B7Z521 O60793 Q24JS9 Q53GT3 Q5TI80,2-aminomuconic semialdehyde dehydrogenase {ECO:0000305|PubMed:29703752},Aldehyde dehydrogenase 12;Aldehyde dehydrogenase family 8 member A1 {ECO:0000312|HGNC:HGNC:15471};, PF00171;, GO:0005829;GO:0070062;GO:0047102;GO:0001758;GO:0042904;GO:0097053;GO:0042574;GO:0042573;, C:cytosol; C:extracellular exosome;, F:aminomuconate-semialdehyde dehydrogenase activity; F:retinal dehydrogenase activity;, P:9-cis-retinoic acid biosynthetic process; P:L-kynurenine catabolic process; P:retinal metabolic process; P:retinoic acid metabolic process;|Q9H2A2 B7Z521 O60793 Q24JS9 Q53GT3 Q5TI80,2-aminomuconic semialdehyde dehydrogenase {ECO:0000305|PubMed:29703752},Aldehyde dehydrogenase 12;Aldehyde dehydrogenase family 8 member A1 {ECO:0000312|HGNC:HGNC:15471};, PF00171;, GO:0005829;GO:0070062;GO:0047102;GO:0001758;GO:0042904;GO:0097053;GO:0042574;GO:0042573;, C:cytosol; C:extracellular exosome;, F:aminomuconate-semialdehyde dehydrogenase activity; F:retinal dehydrogenase activity;, P:9-cis-retinoic acid biosynthetic process; P:L-kynurenine catabolic process; P:retinal metabolic process; P:retinoic acid metabolic process; scaffold47 indexed_genome mRNA 8556263 8638750 . - . ID=transcript_9111;Q9Y450 B7Z365 Q4VX89 Q4VX90 Q5T7G3 Q8NDW9 Q9UPW3,HBS1-like protein,ERFS;, PF00009;PF03144;PF03143;PF08938;, GO:0005829;GO:0070062;GO:0016020;GO:0005525;GO:0003924;GO:0003746;GO:0043928;GO:0007165;GO:0006412;, C:cytosol; C:extracellular exosome; C:membrane;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:signal transduction; P:translation;|Q9Y450 B7Z365 Q4VX89 Q4VX90 Q5T7G3 Q8NDW9 Q9UPW3,HBS1-like protein,ERFS;, PF00009;PF03144;PF03143;PF08938;, GO:0005829;GO:0070062;GO:0016020;GO:0005525;GO:0003924;GO:0003746;GO:0043928;GO:0007165;GO:0006412;, C:cytosol; C:extracellular exosome; C:membrane;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:signal transduction; P:translation;|Q9Y450 B7Z365 Q4VX89 Q4VX90 Q5T7G3 Q8NDW9 Q9UPW3,HBS1-like protein,ERFS;, PF00009;PF03144;PF03143;PF08938;, GO:0005829;GO:0070062;GO:0016020;GO:0005525;GO:0003924;GO:0003746;GO:0043928;GO:0007165;GO:0006412;, C:cytosol; C:extracellular exosome; C:membrane;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:signal transduction; P:translation;|Q9Y450 B7Z365 Q4VX89 Q4VX90 Q5T7G3 Q8NDW9 Q9UPW3,HBS1-like protein,ERFS;, PF00009;PF03144;PF03143;PF08938;, GO:0005829;GO:0070062;GO:0016020;GO:0005525;GO:0003924;GO:0003746;GO:0043928;GO:0007165;GO:0006412;, C:cytosol; C:extracellular exosome; C:membrane;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:signal transduction; P:translation;|Q9Y450 B7Z365 Q4VX89 Q4VX90 Q5T7G3 Q8NDW9 Q9UPW3,HBS1-like protein,ERFS;, PF00009;PF03144;PF03143;PF08938;, GO:0005829;GO:0070062;GO:0016020;GO:0005525;GO:0003924;GO:0003746;GO:0043928;GO:0007165;GO:0006412;, C:cytosol; C:extracellular exosome; C:membrane;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:signal transduction; P:translation;|Q9Y450 B7Z365 Q4VX89 Q4VX90 Q5T7G3 Q8NDW9 Q9UPW3,HBS1-like protein,ERFS;, PF00009;PF03144;PF03143;PF08938;, GO:0005829;GO:0070062;GO:0016020;GO:0005525;GO:0003924;GO:0003746;GO:0043928;GO:0007165;GO:0006412;, C:cytosol; C:extracellular exosome; C:membrane;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:signal transduction; P:translation;|Q9Y450 B7Z365 Q4VX89 Q4VX90 Q5T7G3 Q8NDW9 Q9UPW3,HBS1-like protein,ERFS;, PF00009;PF03144;PF03143;PF08938;, GO:0005829;GO:0070062;GO:0016020;GO:0005525;GO:0003924;GO:0003746;GO:0043928;GO:0007165;GO:0006412;, C:cytosol; C:extracellular exosome; C:membrane;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:exonucleolytic catabolism of deadenylated mRNA; P:signal transduction; P:translation; scaffold47 indexed_genome mRNA 8761417 8794253 . + . ID=transcript_9112;P78526 Q14023 Q14024 Q708E4 Q708E7 Q9UE83,Transcriptional activator Myb,Proto-oncogene c-Myb;, PF09316;PF07988;PF00249;, GO:0005829;GO:0016363;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0070301;GO:0071300;GO:0006338;GO:0000278;GO:1901533;GO:0000122;GO:0045892;GO:0032967;GO:0060252;GO:2000491;GO:1904899;GO:0051571;GO:0051574;GO:0043525;GO:0048661;GO:0045624;GO:2000845;GO:0045944;GO:0045893;GO:0071636;GO:1902036;GO:0006355;GO:0001666;, C:cytosol; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to hydrogen peroxide; P:cellular response to retinoic acid; P:chromatin remodeling; P:mitotic cell cycle; P:negative regulation of hematopoietic progenitor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of collagen biosynthetic process; P:positive regulation of glial cell proliferation; P:positive regulation of hepatic stellate cell activation; P:positive regulation of hepatic stellate cell proliferation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K9 methylation; P:positive regulation of neuron apoptotic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T-helper cell differentiation; P:positive regulation of testosterone secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta production; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription, DNA-templated; P:response to hypoxia;|P78526 Q14023 Q14024 Q708E4 Q708E7 Q9UE83,Transcriptional activator Myb,Proto-oncogene c-Myb;, PF09316;PF07988;PF00249;, GO:0005829;GO:0016363;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0070301;GO:0071300;GO:0006338;GO:0000278;GO:1901533;GO:0000122;GO:0045892;GO:0032967;GO:0060252;GO:2000491;GO:1904899;GO:0051571;GO:0051574;GO:0043525;GO:0048661;GO:0045624;GO:2000845;GO:0045944;GO:0045893;GO:0071636;GO:1902036;GO:0006355;GO:0001666;, C:cytosol; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to hydrogen peroxide; P:cellular response to retinoic acid; P:chromatin remodeling; P:mitotic cell cycle; P:negative regulation of hematopoietic progenitor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of collagen biosynthetic process; P:positive regulation of glial cell proliferation; P:positive regulation of hepatic stellate cell activation; P:positive regulation of hepatic stellate cell proliferation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K9 methylation; P:positive regulation of neuron apoptotic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T-helper cell differentiation; P:positive regulation of testosterone secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta production; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription, DNA-templated; P:response to hypoxia;|P78526 Q14023 Q14024 Q708E4 Q708E7 Q9UE83,Transcriptional activator Myb,Proto-oncogene c-Myb;, PF09316;PF07988;PF00249;, GO:0005829;GO:0016363;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0070301;GO:0071300;GO:0006338;GO:0000278;GO:1901533;GO:0000122;GO:0045892;GO:0032967;GO:0060252;GO:2000491;GO:1904899;GO:0051571;GO:0051574;GO:0043525;GO:0048661;GO:0045624;GO:2000845;GO:0045944;GO:0045893;GO:0071636;GO:1902036;GO:0006355;GO:0001666;, C:cytosol; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to hydrogen peroxide; P:cellular response to retinoic acid; P:chromatin remodeling; P:mitotic cell cycle; P:negative regulation of hematopoietic progenitor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of collagen biosynthetic process; P:positive regulation of glial cell proliferation; P:positive regulation of hepatic stellate cell activation; P:positive regulation of hepatic stellate cell proliferation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K9 methylation; P:positive regulation of neuron apoptotic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T-helper cell differentiation; P:positive regulation of testosterone secretion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta production; P:regulation of hematopoietic stem cell differentiation; P:regulation of transcription, DNA-templated; P:response to hypoxia; scaffold47 indexed_genome mRNA 8888881 9059101 . + . ID=transcript_9113;Q8N157 E1P584 Q4FD35 Q504T3 Q5TCP9 Q6P098 Q6PIT6 Q8NDX0 Q9H0H2,Jouberin,Abelson helper integration site 1 protein homolog;, PF00018;PF00400;, GO:0005912;GO:0005911;GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0036038;GO:0097730;GO:0042802;GO:0034613;GO:0007417;GO:0097711;GO:0060271;GO:0035844;GO:0001947;GO:0030902;GO:0070121;GO:0070986;GO:0001738;GO:0043066;GO:0071599;GO:0035845;GO:0030862;GO:0002092;GO:0045944;GO:0039023;GO:0039008;GO:0050795;GO:0010842;GO:0065001;GO:0007169;GO:0016192;, C:adherens junction; C:cell-cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:MKS complex; C:non-motile cilium;, F:identical protein binding;, P:cellular protein localization; P:central nervous system development; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:cloaca development; P:heart looping; P:hindbrain development; P:Kupffer's vesicle development; P:left/right axis specification; P:morphogenesis of a polarized epithelium; P:negative regulation of apoptotic process; P:otic vesicle development; P:photoreceptor cell outer segment organization; P:positive regulation of polarized epithelial cell differentiation; P:positive regulation of receptor internalization; P:positive regulation of transcription by RNA polymerase II; P:pronephric duct morphogenesis; P:pronephric nephron tubule morphogenesis; P:regulation of behavior; P:retina layer formation; P:specification of axis polarity; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vesicle-mediated transport;|Q8N157 E1P584 Q4FD35 Q504T3 Q5TCP9 Q6P098 Q6PIT6 Q8NDX0 Q9H0H2,Jouberin,Abelson helper integration site 1 protein homolog;, PF00018;PF00400;, GO:0005912;GO:0005911;GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0036038;GO:0097730;GO:0042802;GO:0034613;GO:0007417;GO:0097711;GO:0060271;GO:0035844;GO:0001947;GO:0030902;GO:0070121;GO:0070986;GO:0001738;GO:0043066;GO:0071599;GO:0035845;GO:0030862;GO:0002092;GO:0045944;GO:0039023;GO:0039008;GO:0050795;GO:0010842;GO:0065001;GO:0007169;GO:0016192;, C:adherens junction; C:cell-cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:MKS complex; C:non-motile cilium;, F:identical protein binding;, P:cellular protein localization; P:central nervous system development; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:cloaca development; P:heart looping; P:hindbrain development; P:Kupffer's vesicle development; P:left/right axis specification; P:morphogenesis of a polarized epithelium; P:negative regulation of apoptotic process; P:otic vesicle development; P:photoreceptor cell outer segment organization; P:positive regulation of polarized epithelial cell differentiation; P:positive regulation of receptor internalization; P:positive regulation of transcription by RNA polymerase II; P:pronephric duct morphogenesis; P:pronephric nephron tubule morphogenesis; P:regulation of behavior; P:retina layer formation; P:specification of axis polarity; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vesicle-mediated transport;|Q8N157 E1P584 Q4FD35 Q504T3 Q5TCP9 Q6P098 Q6PIT6 Q8NDX0 Q9H0H2,Jouberin,Abelson helper integration site 1 protein homolog;, PF00018;PF00400;, GO:0005912;GO:0005911;GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0036038;GO:0097730;GO:0042802;GO:0034613;GO:0007417;GO:0097711;GO:0060271;GO:0035844;GO:0001947;GO:0030902;GO:0070121;GO:0070986;GO:0001738;GO:0043066;GO:0071599;GO:0035845;GO:0030862;GO:0002092;GO:0045944;GO:0039023;GO:0039008;GO:0050795;GO:0010842;GO:0065001;GO:0007169;GO:0016192;, C:adherens junction; C:cell-cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:MKS complex; C:non-motile cilium;, F:identical protein binding;, P:cellular protein localization; P:central nervous system development; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:cloaca development; P:heart looping; P:hindbrain development; P:Kupffer's vesicle development; P:left/right axis specification; P:morphogenesis of a polarized epithelium; P:negative regulation of apoptotic process; P:otic vesicle development; P:photoreceptor cell outer segment organization; P:positive regulation of polarized epithelial cell differentiation; P:positive regulation of receptor internalization; P:positive regulation of transcription by RNA polymerase II; P:pronephric duct morphogenesis; P:pronephric nephron tubule morphogenesis; P:regulation of behavior; P:retina layer formation; P:specification of axis polarity; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vesicle-mediated transport; scaffold47 indexed_genome mRNA 9502299 9670647 . - . ID=transcript_9114;Q9NP56 Q5W154,cAMP-specific 3',5'-cyclic phosphodiesterase 7B,, PF00233;, GO:0005829;GO:0045202;GO:0004115;GO:0004114;GO:0046872;GO:0006198;GO:0019933;GO:0007268;GO:0007186;GO:0007165;, C:cytosol; C:synapse;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:cAMP-mediated signaling; P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:signal transduction; scaffold47 indexed_genome mRNA 9732248 9762080 . - . ID=transcript_9115;Q9NYF8 A2RU75 B7ZM58 E1P586 Q14673 Q86WU6 Q86WY0,Bcl-2-associated transcription factor 1,BCLAF1 and THRAP3 family member 1;, PF15440;, GO:0005737;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0003712;GO:0006915;GO:1990830;GO:0045892;GO:0043065;GO:2000144;GO:2001244;GO:2001022;GO:0045944;GO:0043620;, C:cytoplasm; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding; F:transcription coregulator activity;, P:apoptotic process; P:cellular response to leukemia inhibitory factor; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-templated transcription in response to stress;|Q9NYF8 A2RU75 B7ZM58 E1P586 Q14673 Q86WU6 Q86WY0,Bcl-2-associated transcription factor 1,BCLAF1 and THRAP3 family member 1;, PF15440;, GO:0005737;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0003712;GO:0006915;GO:1990830;GO:0045892;GO:0043065;GO:2000144;GO:2001244;GO:2001022;GO:0045944;GO:0043620;, C:cytoplasm; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding; F:transcription coregulator activity;, P:apoptotic process; P:cellular response to leukemia inhibitory factor; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-templated transcription in response to stress;|Q9NYF8 A2RU75 B7ZM58 E1P586 Q14673 Q86WU6 Q86WY0,Bcl-2-associated transcription factor 1,BCLAF1 and THRAP3 family member 1;, PF15440;, GO:0005737;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0003712;GO:0006915;GO:1990830;GO:0045892;GO:0043065;GO:2000144;GO:2001244;GO:2001022;GO:0045944;GO:0043620;, C:cytoplasm; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding; F:transcription coregulator activity;, P:apoptotic process; P:cellular response to leukemia inhibitory factor; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-templated transcription in response to stress;|Q9NYF8 A2RU75 B7ZM58 E1P586 Q14673 Q86WU6 Q86WY0,Bcl-2-associated transcription factor 1,BCLAF1 and THRAP3 family member 1;, PF15440;, GO:0005737;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0003712;GO:0006915;GO:1990830;GO:0045892;GO:0043065;GO:2000144;GO:2001244;GO:2001022;GO:0045944;GO:0043620;, C:cytoplasm; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding; F:transcription coregulator activity;, P:apoptotic process; P:cellular response to leukemia inhibitory factor; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-templated transcription in response to stress;|Q9NYF8 A2RU75 B7ZM58 E1P586 Q14673 Q86WU6 Q86WY0,Bcl-2-associated transcription factor 1,BCLAF1 and THRAP3 family member 1;, PF15440;, GO:0005737;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0003712;GO:0006915;GO:1990830;GO:0045892;GO:0043065;GO:2000144;GO:2001244;GO:2001022;GO:0045944;GO:0043620;, C:cytoplasm; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding; F:transcription coregulator activity;, P:apoptotic process; P:cellular response to leukemia inhibitory factor; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-templated transcription in response to stress; scaffold47 indexed_genome mRNA 9824180 9974977 . - . ID=transcript_9116;Q8TAU5 Q9NY82 Q9NY83,Ensconsin,Epithelial microtubule-associated protein of 115 kDa;Microtubule-associated protein 7;, PF05672;, GO:0030424;GO:0016323;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0048471;GO:0005102;GO:0005198;GO:0007163;GO:0000226;GO:0072659;GO:0006970;, C:axon; C:basolateral plasma membrane; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perinuclear region of cytoplasm;, F:signaling receptor binding; F:structural molecule activity;, P:establishment or maintenance of cell polarity; P:microtubule cytoskeleton organization; P:protein localization to plasma membrane; P:response to osmotic stress;|Q8TAU5 Q9NY82 Q9NY83,Ensconsin,Epithelial microtubule-associated protein of 115 kDa;Microtubule-associated protein 7;, PF05672;, GO:0030424;GO:0016323;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0048471;GO:0005102;GO:0005198;GO:0007163;GO:0000226;GO:0072659;GO:0006970;, C:axon; C:basolateral plasma membrane; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perinuclear region of cytoplasm;, F:signaling receptor binding; F:structural molecule activity;, P:establishment or maintenance of cell polarity; P:microtubule cytoskeleton organization; P:protein localization to plasma membrane; P:response to osmotic stress;|Q8TAU5 Q9NY82 Q9NY83,Ensconsin,Epithelial microtubule-associated protein of 115 kDa;Microtubule-associated protein 7;, PF05672;, GO:0030424;GO:0016323;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0048471;GO:0005102;GO:0005198;GO:0007163;GO:0000226;GO:0072659;GO:0006970;, C:axon; C:basolateral plasma membrane; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perinuclear region of cytoplasm;, F:signaling receptor binding; F:structural molecule activity;, P:establishment or maintenance of cell polarity; P:microtubule cytoskeleton organization; P:protein localization to plasma membrane; P:response to osmotic stress;|Q8TAU5 Q9NY82 Q9NY83,Ensconsin,Epithelial microtubule-associated protein of 115 kDa;Microtubule-associated protein 7;, PF05672;, GO:0030424;GO:0016323;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0048471;GO:0005102;GO:0005198;GO:0007163;GO:0000226;GO:0072659;GO:0006970;, C:axon; C:basolateral plasma membrane; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perinuclear region of cytoplasm;, F:signaling receptor binding; F:structural molecule activity;, P:establishment or maintenance of cell polarity; P:microtubule cytoskeleton organization; P:protein localization to plasma membrane; P:response to osmotic stress;|Q8TAU5 Q9NY82 Q9NY83,Ensconsin,Epithelial microtubule-associated protein of 115 kDa;Microtubule-associated protein 7;, PF05672;, GO:0030424;GO:0016323;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0048471;GO:0005102;GO:0005198;GO:0007163;GO:0000226;GO:0072659;GO:0006970;, C:axon; C:basolateral plasma membrane; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perinuclear region of cytoplasm;, F:signaling receptor binding; F:structural molecule activity;, P:establishment or maintenance of cell polarity; P:microtubule cytoskeleton organization; P:protein localization to plasma membrane; P:response to osmotic stress;|Q8TAU5 Q9NY82 Q9NY83,Ensconsin,Epithelial microtubule-associated protein of 115 kDa;Microtubule-associated protein 7;, PF05672;, GO:0030424;GO:0016323;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0048471;GO:0005102;GO:0005198;GO:0007163;GO:0000226;GO:0072659;GO:0006970;, C:axon; C:basolateral plasma membrane; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:perinuclear region of cytoplasm;, F:signaling receptor binding; F:structural molecule activity;, P:establishment or maintenance of cell polarity; P:microtubule cytoskeleton organization; P:protein localization to plasma membrane; P:response to osmotic stress; scaffold47 indexed_genome mRNA 10007622 10222766 . - . ID=transcript_9117;Q99683 A6NIA0 B4DGB2 Q5THN3 Q99461,Mitogen-activated protein kinase kinase kinase 5,Apoptosis signal-regulating kinase 1;MAPK/ERK kinase kinase 5;, PF19039;PF13281;PF00069;, GO:0005737;GO:0005829;GO:0009897;GO:1990604;GO:1902911;GO:0032991;GO:0005524;GO:0042802;GO:0000287;GO:0004709;GO:0019904;GO:0042803;GO:0004672;GO:0019901;GO:0019903;GO:0106310;GO:0106311;GO:0007257;GO:0000186;GO:0097190;GO:0034198;GO:0070301;GO:1902170;GO:0071356;GO:0072577;GO:0045087;GO:0070059;GO:0008631;GO:0007254;GO:0000165;GO:0038066;GO:0043065;GO:0010666;GO:0043280;GO:0046330;GO:0043507;GO:0045663;GO:1901216;GO:1900745;GO:0045893;GO:1904707;GO:0097300;GO:0006468;GO:0034976;GO:0002931;GO:0051403;GO:0016032;GO:0042060;, C:cytoplasm; C:cytosol; C:external side of plasma membrane; C:IRE1-TRAF2-ASK1 complex; C:protein kinase complex; C:protein-containing complex;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:MAP kinase kinase kinase activity; F:protein domain specific binding; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPKK activity; P:apoptotic signaling pathway; P:cellular response to amino acid starvation; P:cellular response to hydrogen peroxide; P:cellular response to reactive nitrogen species; P:cellular response to tumor necrosis factor; P:endothelial cell apoptotic process; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:JNK cascade; P:MAPK cascade; P:p38MAPK cascade; P:positive regulation of apoptotic process; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of myoblast differentiation; P:positive regulation of neuron death; P:positive regulation of p38MAPK cascade; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular associated smooth muscle cell proliferation; P:programmed necrotic cell death; P:protein phosphorylation; P:response to endoplasmic reticulum stress; P:response to ischemia; P:stress-activated MAPK cascade; P:viral process; P:wound healing; scaffold47 indexed_genome mRNA 10259637 10337401 . + . ID=transcript_9118;O00628 C0H5X6,Peroxisomal targeting signal 2 receptor,Peroxin-7;, PF00400;, GO:0005829;GO:0005782;GO:0005778;GO:0005777;GO:0019899;GO:0005053;GO:0042803;GO:0001958;GO:0008611;GO:0006635;GO:0001764;GO:0007031;GO:0016558;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:enzyme binding; F:peroxisome matrix targeting signal-2 binding; F:protein homodimerization activity;, P:endochondral ossification; P:ether lipid biosynthetic process; P:fatty acid beta-oxidation; P:neuron migration; P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization;|O00628 C0H5X6,Peroxisomal targeting signal 2 receptor,Peroxin-7;, PF00400;, GO:0005829;GO:0005782;GO:0005778;GO:0005777;GO:0019899;GO:0005053;GO:0042803;GO:0001958;GO:0008611;GO:0006635;GO:0001764;GO:0007031;GO:0016558;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:enzyme binding; F:peroxisome matrix targeting signal-2 binding; F:protein homodimerization activity;, P:endochondral ossification; P:ether lipid biosynthetic process; P:fatty acid beta-oxidation; P:neuron migration; P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization;|O00628 C0H5X6,Peroxisomal targeting signal 2 receptor,Peroxin-7;, PF00400;, GO:0005829;GO:0005782;GO:0005778;GO:0005777;GO:0019899;GO:0005053;GO:0042803;GO:0001958;GO:0008611;GO:0006635;GO:0001764;GO:0007031;GO:0016558;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:enzyme binding; F:peroxisome matrix targeting signal-2 binding; F:protein homodimerization activity;, P:endochondral ossification; P:ether lipid biosynthetic process; P:fatty acid beta-oxidation; P:neuron migration; P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization; scaffold47 indexed_genome mRNA 10413760 10414325 . + . ID=transcript_9119;Q9UHF4 B4DLR5 F5H675 Q14CW2 Q6UWA9 Q96SH8,Interleukin-20 receptor subunit alpha,Cytokine receptor class-II member 8;Cytokine receptor family 2 member 8;IL-20R1;ZcytoR7;, PF09294;PF01108;, GO:0016021;GO:0005886;GO:0004896;GO:0042015;GO:0019221;GO:2001244;GO:0045124;, C:integral component of membrane; C:plasma membrane;, F:cytokine receptor activity; F:interleukin-20 binding;, P:cytokine-mediated signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway; P:regulation of bone resorption; scaffold47 indexed_genome mRNA 10520610 10547101 . - . ID=transcript_9120;P15260 B4DFT7 E1P587 Q53Y96,Interferon gamma receptor 1 {ECO:0000312|HGNC:HGNC:5439},CDw119;Interferon gamma receptor alpha-chain {ECO:0000303|PubMed:7615558, ECO:0000303|PubMed:9367779};, PF07140;PF01108;, GO:0016021;GO:0005887;GO:0005886;GO:0019955;GO:0004896;GO:0004906;GO:0048143;GO:0019221;GO:0060333;GO:0001774;GO:1900222;GO:1902004;GO:0010628;GO:0032760;GO:0060334;GO:0009615;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine binding; F:cytokine receptor activity; F:interferon-gamma receptor activity;, P:astrocyte activation; P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:microglial cell activation; P:negative regulation of amyloid-beta clearance; P:positive regulation of amyloid-beta formation; P:positive regulation of gene expression; P:positive regulation of tumor necrosis factor production; P:regulation of interferon-gamma-mediated signaling pathway; P:response to virus; P:signal transduction;|P15260 B4DFT7 E1P587 Q53Y96,Interferon gamma receptor 1 {ECO:0000312|HGNC:HGNC:5439},CDw119;Interferon gamma receptor alpha-chain {ECO:0000303|PubMed:7615558, ECO:0000303|PubMed:9367779};, PF07140;PF01108;, GO:0016021;GO:0005887;GO:0005886;GO:0019955;GO:0004896;GO:0004906;GO:0048143;GO:0019221;GO:0060333;GO:0001774;GO:1900222;GO:1902004;GO:0010628;GO:0032760;GO:0060334;GO:0009615;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine binding; F:cytokine receptor activity; F:interferon-gamma receptor activity;, P:astrocyte activation; P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:microglial cell activation; P:negative regulation of amyloid-beta clearance; P:positive regulation of amyloid-beta formation; P:positive regulation of gene expression; P:positive regulation of tumor necrosis factor production; P:regulation of interferon-gamma-mediated signaling pathway; P:response to virus; P:signal transduction;|P15260 B4DFT7 E1P587 Q53Y96,Interferon gamma receptor 1 {ECO:0000312|HGNC:HGNC:5439},CDw119;Interferon gamma receptor alpha-chain {ECO:0000303|PubMed:7615558, ECO:0000303|PubMed:9367779};, PF07140;PF01108;, GO:0016021;GO:0005887;GO:0005886;GO:0019955;GO:0004896;GO:0004906;GO:0048143;GO:0019221;GO:0060333;GO:0001774;GO:1900222;GO:1902004;GO:0010628;GO:0032760;GO:0060334;GO:0009615;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine binding; F:cytokine receptor activity; F:interferon-gamma receptor activity;, P:astrocyte activation; P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:microglial cell activation; P:negative regulation of amyloid-beta clearance; P:positive regulation of amyloid-beta formation; P:positive regulation of gene expression; P:positive regulation of tumor necrosis factor production; P:regulation of interferon-gamma-mediated signaling pathway; P:response to virus; P:signal transduction;|P15260 B4DFT7 E1P587 Q53Y96,Interferon gamma receptor 1 {ECO:0000312|HGNC:HGNC:5439},CDw119;Interferon gamma receptor alpha-chain {ECO:0000303|PubMed:7615558, ECO:0000303|PubMed:9367779};, PF07140;PF01108;, GO:0016021;GO:0005887;GO:0005886;GO:0019955;GO:0004896;GO:0004906;GO:0048143;GO:0019221;GO:0060333;GO:0001774;GO:1900222;GO:1902004;GO:0010628;GO:0032760;GO:0060334;GO:0009615;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine binding; F:cytokine receptor activity; F:interferon-gamma receptor activity;, P:astrocyte activation; P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:microglial cell activation; P:negative regulation of amyloid-beta clearance; P:positive regulation of amyloid-beta formation; P:positive regulation of gene expression; P:positive regulation of tumor necrosis factor production; P:regulation of interferon-gamma-mediated signaling pathway; P:response to virus; P:signal transduction;|P15260 B4DFT7 E1P587 Q53Y96,Interferon gamma receptor 1 {ECO:0000312|HGNC:HGNC:5439},CDw119;Interferon gamma receptor alpha-chain {ECO:0000303|PubMed:7615558, ECO:0000303|PubMed:9367779};, PF07140;PF01108;, GO:0016021;GO:0005887;GO:0005886;GO:0019955;GO:0004896;GO:0004906;GO:0048143;GO:0019221;GO:0060333;GO:0001774;GO:1900222;GO:1902004;GO:0010628;GO:0032760;GO:0060334;GO:0009615;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cytokine binding; F:cytokine receptor activity; F:interferon-gamma receptor activity;, P:astrocyte activation; P:cytokine-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:microglial cell activation; P:negative regulation of amyloid-beta clearance; P:positive regulation of amyloid-beta formation; P:positive regulation of gene expression; P:positive regulation of tumor necrosis factor production; P:regulation of interferon-gamma-mediated signaling pathway; P:response to virus; P:signal transduction; scaffold47 indexed_genome mRNA 11124873 11140440 . + . ID=transcript_9121;P21580 B2R767 E1P588 Q2HIX9 Q5VXQ7 Q9NSR6,Tumor necrosis factor alpha-induced protein 3,OTU domain-containing protein 7C;Putative DNA-binding protein A20;Zinc finger protein A20;, PF02338;PF01754;, GO:0005737;GO:0005829;GO:0070062;GO:0005764;GO:0005634;GO:0008234;GO:0003677;GO:0042802;GO:0070530;GO:0019900;GO:0061578;GO:0002020;GO:0008022;GO:0043621;GO:0004843;GO:0043130;GO:0004842;GO:0008270;GO:0006915;GO:0001922;GO:0016477;GO:0070301;GO:0071222;GO:0007010;GO:0072666;GO:0006954;GO:0050869;GO:0045779;GO:2000349;GO:0002677;GO:0045736;GO:2000352;GO:1902042;GO:0043124;GO:0050728;GO:0045824;GO:0032691;GO:0032703;GO:0032715;GO:0032088;GO:0070429;GO:0070433;GO:0090291;GO:0031397;GO:0048662;GO:0034136;GO:0034140;GO:0034144;GO:0034148;GO:0032720;GO:0032480;GO:0070423;GO:1903364;GO:2000347;GO:0045732;GO:0030177;GO:0016579;GO:0071947;GO:0035871;GO:0035523;GO:1990168;GO:0071108;GO:0070936;GO:0070536;GO:0050691;GO:0002634;GO:0010803;GO:0061043;GO:0002237;GO:0032495;GO:0072573;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosome; C:nucleus;, F:cysteine-type peptidase activity; F:DNA binding; F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:kinase binding; F:Lys63-specific deubiquitinase activity; F:protease binding; F:protein C-terminus binding; F:protein self-association; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:apoptotic process; P:B-1 B cell homeostasis; P:cell migration; P:cellular response to hydrogen peroxide; P:cellular response to lipopolysaccharide; P:cytoskeleton organization; P:establishment of protein localization to vacuole; P:inflammatory response; P:negative regulation of B cell activation; P:negative regulation of bone resorption; P:negative regulation of CD40 signaling pathway; P:negative regulation of chronic inflammatory response; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-2 production; P:negative regulation of interleukin-6 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:negative regulation of osteoclast proliferation; P:negative regulation of protein ubiquitination; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of toll-like receptor 2 signaling pathway; P:negative regulation of toll-like receptor 3 signaling pathway; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of toll-like receptor 5 signaling pathway; P:negative regulation of tumor necrosis factor production; P:negative regulation of type I interferon production; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of cellular protein catabolic process; P:positive regulation of hepatocyte proliferation; P:positive regulation of protein catabolic process; P:positive regulation of Wnt signaling pathway; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein K11-linked deubiquitination; P:protein K29-linked deubiquitination; P:protein K33-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked deubiquitination; P:regulation of defense response to virus by host; P:regulation of germinal center formation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:regulation of vascular wound healing; P:response to molecule of bacterial origin; P:response to muramyl dipeptide; P:tolerance induction to lipopolysaccharide;|P21580 B2R767 E1P588 Q2HIX9 Q5VXQ7 Q9NSR6,Tumor necrosis factor alpha-induced protein 3,OTU domain-containing protein 7C;Putative DNA-binding protein A20;Zinc finger protein A20;, PF02338;PF01754;, GO:0005737;GO:0005829;GO:0070062;GO:0005764;GO:0005634;GO:0008234;GO:0003677;GO:0042802;GO:0070530;GO:0019900;GO:0061578;GO:0002020;GO:0008022;GO:0043621;GO:0004843;GO:0043130;GO:0004842;GO:0008270;GO:0006915;GO:0001922;GO:0016477;GO:0070301;GO:0071222;GO:0007010;GO:0072666;GO:0006954;GO:0050869;GO:0045779;GO:2000349;GO:0002677;GO:0045736;GO:2000352;GO:1902042;GO:0043124;GO:0050728;GO:0045824;GO:0032691;GO:0032703;GO:0032715;GO:0032088;GO:0070429;GO:0070433;GO:0090291;GO:0031397;GO:0048662;GO:0034136;GO:0034140;GO:0034144;GO:0034148;GO:0032720;GO:0032480;GO:0070423;GO:1903364;GO:2000347;GO:0045732;GO:0030177;GO:0016579;GO:0071947;GO:0035871;GO:0035523;GO:1990168;GO:0071108;GO:0070936;GO:0070536;GO:0050691;GO:0002634;GO:0010803;GO:0061043;GO:0002237;GO:0032495;GO:0072573;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosome; C:nucleus;, F:cysteine-type peptidase activity; F:DNA binding; F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:kinase binding; F:Lys63-specific deubiquitinase activity; F:protease binding; F:protein C-terminus binding; F:protein self-association; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:apoptotic process; P:B-1 B cell homeostasis; P:cell migration; P:cellular response to hydrogen peroxide; P:cellular response to lipopolysaccharide; P:cytoskeleton organization; P:establishment of protein localization to vacuole; P:inflammatory response; P:negative regulation of B cell activation; P:negative regulation of bone resorption; P:negative regulation of CD40 signaling pathway; P:negative regulation of chronic inflammatory response; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-2 production; P:negative regulation of interleukin-6 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; P:negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:negative regulation of osteoclast proliferation; P:negative regulation of protein ubiquitination; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of toll-like receptor 2 signaling pathway; P:negative regulation of toll-like receptor 3 signaling pathway; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of toll-like receptor 5 signaling pathway; P:negative regulation of tumor necrosis factor production; P:negative regulation of type I interferon production; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of cellular protein catabolic process; P:positive regulation of hepatocyte proliferation; P:positive regulation of protein catabolic process; P:positive regulation of Wnt signaling pathway; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein K11-linked deubiquitination; P:protein K29-linked deubiquitination; P:protein K33-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked deubiquitination; P:regulation of defense response to virus by host; P:regulation of germinal center formation; P:regulation of tumor necrosis factor-mediated signaling pathway; P:regulation of vascular wound healing; P:response to molecule of bacterial origin; P:response to muramyl dipeptide; P:tolerance induction to lipopolysaccharide; scaffold47 indexed_genome mRNA 11282677 11297449 . - . ID=transcript_9122;Q96FX8 B2RB73 E1P590 Q8IWS3 Q8N1J6 Q8NC16 Q9H1C5 Q9H230,p53 apoptosis effector related to PMP-22,Keratinocyte-associated protein 1;P53-induced protein PIGPC1;Transmembrane protein THW;, PF00822;, GO:0005911;GO:0030057;GO:0005794;GO:0005887;GO:0005739;GO:0005886;GO:0097202;GO:0097186;GO:0098609;GO:0070268;GO:0002934;GO:0034113;GO:0072332;GO:0007219;GO:0045862;GO:0042981;, C:cell-cell junction; C:desmosome; C:Golgi apparatus; C:integral component of plasma membrane; C:mitochondrion; C:plasma membrane;, , P:activation of cysteine-type endopeptidase activity; P:amelogenesis; P:cell-cell adhesion; P:cornification; P:desmosome organization; P:heterotypic cell-cell adhesion; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:Notch signaling pathway; P:positive regulation of proteolysis; P:regulation of apoptotic process; scaffold47 indexed_genome mRNA 11337466 11508127 . + . ID=transcript_9123;Q5TH69 C5NM88 Q76MU8 Q8N4Y4 Q96CH9 Q96P46 Q9ULH6,Brefeldin A-inhibited guanine nucleotide-exchange protein 3 {ECO:0000305},ARFGEF family member 3 {ECO:0000312|HGNC:HGNC:21213};, PF16213;PF09324;, GO:0016021;GO:0030658;GO:0005085;GO:0030036;GO:0010923;GO:0032012;, C:integral component of membrane; C:transport vesicle membrane;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:negative regulation of phosphatase activity; P:regulation of ARF protein signal transduction;|Q5TH69 C5NM88 Q76MU8 Q8N4Y4 Q96CH9 Q96P46 Q9ULH6,Brefeldin A-inhibited guanine nucleotide-exchange protein 3 {ECO:0000305},ARFGEF family member 3 {ECO:0000312|HGNC:HGNC:21213};, PF16213;PF09324;, GO:0016021;GO:0030658;GO:0005085;GO:0030036;GO:0010923;GO:0032012;, C:integral component of membrane; C:transport vesicle membrane;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:negative regulation of phosphatase activity; P:regulation of ARF protein signal transduction;|Q5TH69 C5NM88 Q76MU8 Q8N4Y4 Q96CH9 Q96P46 Q9ULH6,Brefeldin A-inhibited guanine nucleotide-exchange protein 3 {ECO:0000305},ARFGEF family member 3 {ECO:0000312|HGNC:HGNC:21213};, PF16213;PF09324;, GO:0016021;GO:0030658;GO:0005085;GO:0030036;GO:0010923;GO:0032012;, C:integral component of membrane; C:transport vesicle membrane;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:negative regulation of phosphatase activity; P:regulation of ARF protein signal transduction;|Q5TH69 C5NM88 Q76MU8 Q8N4Y4 Q96CH9 Q96P46 Q9ULH6,Brefeldin A-inhibited guanine nucleotide-exchange protein 3 {ECO:0000305},ARFGEF family member 3 {ECO:0000312|HGNC:HGNC:21213};, PF16213;PF09324;, GO:0016021;GO:0030658;GO:0005085;GO:0030036;GO:0010923;GO:0032012;, C:integral component of membrane; C:transport vesicle membrane;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:negative regulation of phosphatase activity; P:regulation of ARF protein signal transduction;|Q5TH69 C5NM88 Q76MU8 Q8N4Y4 Q96CH9 Q96P46 Q9ULH6,Brefeldin A-inhibited guanine nucleotide-exchange protein 3 {ECO:0000305},ARFGEF family member 3 {ECO:0000312|HGNC:HGNC:21213};, PF16213;PF09324;, GO:0016021;GO:0030658;GO:0005085;GO:0030036;GO:0010923;GO:0032012;, C:integral component of membrane; C:transport vesicle membrane;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:negative regulation of phosphatase activity; P:regulation of ARF protein signal transduction; scaffold47 indexed_genome mRNA 11518218 11521855 . + . ID=transcript_9124;Q5TH69 C5NM88 Q76MU8 Q8N4Y4 Q96CH9 Q96P46 Q9ULH6,Brefeldin A-inhibited guanine nucleotide-exchange protein 3 {ECO:0000305},ARFGEF family member 3 {ECO:0000312|HGNC:HGNC:21213};, PF16213;PF09324;, GO:0016021;GO:0030658;GO:0005085;GO:0030036;GO:0010923;GO:0032012;, C:integral component of membrane; C:transport vesicle membrane;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:negative regulation of phosphatase activity; P:regulation of ARF protein signal transduction; scaffold47 indexed_genome mRNA 11578959 11585100 . + . ID=transcript_9125;Q9Y5Z4 Q96P57,Heme-binding protein 2,Placental protein 23;Protein SOUL;, PF04832;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0005739;GO:0020037;GO:0010917;GO:0043312;GO:0035794;GO:0010940;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:mitochondrion;, F:heme binding;, P:negative regulation of mitochondrial membrane potential; P:neutrophil degranulation; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of necrotic cell death;|Q9Y5Z4 Q96P57,Heme-binding protein 2,Placental protein 23;Protein SOUL;, PF04832;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0005739;GO:0020037;GO:0010917;GO:0043312;GO:0035794;GO:0010940;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:mitochondrion;, F:heme binding;, P:negative regulation of mitochondrial membrane potential; P:neutrophil degranulation; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of necrotic cell death;|Q9Y5Z4 Q96P57,Heme-binding protein 2,Placental protein 23;Protein SOUL;, PF04832;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0005739;GO:0020037;GO:0010917;GO:0043312;GO:0035794;GO:0010940;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:mitochondrion;, F:heme binding;, P:negative regulation of mitochondrial membrane potential; P:neutrophil degranulation; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of necrotic cell death; scaffold47 indexed_genome mRNA 11595241 11732479 . - . ID=transcript_9126;Q5SYE7 Q3ZCS5 Q5SYE8 Q9P2J0,NHS-like protein 1,, PF15273;, GO:0030154;, , , P:cell differentiation;|Q5SYE7 Q3ZCS5 Q5SYE8 Q9P2J0,NHS-like protein 1,, PF15273;, GO:0030154;, , , P:cell differentiation; scaffold47 indexed_genome mRNA 11915646 11929797 . + . ID=transcript_9127;Q8IWP9 E1P591 Q32NC7 Q66K67 Q96E23 Q9Y430,Coiled-coil domain-containing protein 28A,CCRL1AP;, PF13270;|Q8IWP9 E1P591 Q32NC7 Q66K67 Q96E23 Q9Y430,Coiled-coil domain-containing protein 28A,CCRL1AP;, PF13270; scaffold47 indexed_genome mRNA 11975856 12006074 . + . ID=transcript_9128;Q008S8 B2RUV6 Q5JWK2 Q5JWK3 Q5JWK4,Epithelial cell-transforming sequence 2 oncogene-like,Lung-specific F-box and DH domain-containing protein;Putative guanine nucleotide exchange factor LFDH;, PF14252;PF12937;PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity; scaffold47 indexed_genome mRNA 12007224 12018862 . + . ID=transcript_9129;Q008S8 B2RUV6 Q5JWK2 Q5JWK3 Q5JWK4,Epithelial cell-transforming sequence 2 oncogene-like,Lung-specific F-box and DH domain-containing protein;Putative guanine nucleotide exchange factor LFDH;, PF14252;PF12937;PF00621;, GO:0005085;, , F:guanyl-nucleotide exchange factor activity; scaffold47 indexed_genome mRNA 12019894 12110083 . - . ID=transcript_9130;Q8WU62 Q9BXY9,RalBP1-associated Eps domain-containing protein 1,RalBP1-interacting protein 1;, PF12763;, GO:0005905;GO:0005829;GO:0005886;GO:0005509;GO:0017124;GO:0006897;GO:0016197;GO:0061024;GO:0006898;, C:clathrin-coated pit; C:cytosol; C:plasma membrane;, F:calcium ion binding; F:SH3 domain binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:receptor-mediated endocytosis;|Q8WU62 Q9BXY9,RalBP1-associated Eps domain-containing protein 1,RalBP1-interacting protein 1;, PF12763;, GO:0005905;GO:0005829;GO:0005886;GO:0005509;GO:0017124;GO:0006897;GO:0016197;GO:0061024;GO:0006898;, C:clathrin-coated pit; C:cytosol; C:plasma membrane;, F:calcium ion binding; F:SH3 domain binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:receptor-mediated endocytosis;|Q8WU62 Q9BXY9,RalBP1-associated Eps domain-containing protein 1,RalBP1-interacting protein 1;, PF12763;, GO:0005905;GO:0005829;GO:0005886;GO:0005509;GO:0017124;GO:0006897;GO:0016197;GO:0061024;GO:0006898;, C:clathrin-coated pit; C:cytosol; C:plasma membrane;, F:calcium ion binding; F:SH3 domain binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:receptor-mediated endocytosis;|Q8WU62 Q9BXY9,RalBP1-associated Eps domain-containing protein 1,RalBP1-interacting protein 1;, PF12763;, GO:0005905;GO:0005829;GO:0005886;GO:0005509;GO:0017124;GO:0006897;GO:0016197;GO:0061024;GO:0006898;, C:clathrin-coated pit; C:cytosol; C:plasma membrane;, F:calcium ion binding; F:SH3 domain binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:receptor-mediated endocytosis;|Q8WU62 Q9BXY9,RalBP1-associated Eps domain-containing protein 1,RalBP1-interacting protein 1;, PF12763;, GO:0005905;GO:0005829;GO:0005886;GO:0005509;GO:0017124;GO:0006897;GO:0016197;GO:0061024;GO:0006898;, C:clathrin-coated pit; C:cytosol; C:plasma membrane;, F:calcium ion binding; F:SH3 domain binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:receptor-mediated endocytosis;|Q8WU62 Q9BXY9,RalBP1-associated Eps domain-containing protein 1,RalBP1-interacting protein 1;, PF12763;, GO:0005905;GO:0005829;GO:0005886;GO:0005509;GO:0017124;GO:0006897;GO:0016197;GO:0061024;GO:0006898;, C:clathrin-coated pit; C:cytosol; C:plasma membrane;, F:calcium ion binding; F:SH3 domain binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:receptor-mediated endocytosis;|Q8WU62 Q9BXY9,RalBP1-associated Eps domain-containing protein 1,RalBP1-interacting protein 1;, PF12763;, GO:0005905;GO:0005829;GO:0005886;GO:0005509;GO:0017124;GO:0006897;GO:0016197;GO:0061024;GO:0006898;, C:clathrin-coated pit; C:cytosol; C:plasma membrane;, F:calcium ion binding; F:SH3 domain binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:receptor-mediated endocytosis; scaffold47 indexed_genome mRNA 12141025 12156105 . + . ID=transcript_9131;Q9P1F3 Q5SZC8 Q9P0A1,Costars family protein ABRACL,ABRA C-terminal-like protein;, PF14705;, GO:0032970;, , , P:regulation of actin filament-based process; scaffold47 indexed_genome mRNA 12213507 12266035 . + . ID=transcript_9132;Q9UBI9,Headcase protein homolog,, PF16002;PF15353;, GO:0005737;GO:0016020;GO:0005634;GO:0045930;GO:0030323;, C:cytoplasm; C:membrane; C:nucleus;, , P:negative regulation of mitotic cell cycle; P:respiratory tube development;|Q9UBI9,Headcase protein homolog,, PF16002;PF15353;, GO:0005737;GO:0016020;GO:0005634;GO:0045930;GO:0030323;, C:cytoplasm; C:membrane; C:nucleus;, , P:negative regulation of mitotic cell cycle; P:respiratory tube development; scaffold47 indexed_genome mRNA 12288182 12309764 . + . ID=transcript_9133;Q8N3L3 Q5HYH7 Q5VTF3 Q76L25 Q86T52 Q8N3S2,Beta-taxilin,Muscle-derived protein 77;, PF09728;, GO:0005737;GO:0019905;, C:cytoplasm;, F:syntaxin binding;|Q8N3L3 Q5HYH7 Q5VTF3 Q76L25 Q86T52 Q8N3S2,Beta-taxilin,Muscle-derived protein 77;, PF09728;, GO:0005737;GO:0019905;, C:cytoplasm;, F:syntaxin binding;|Q8N3L3 Q5HYH7 Q5VTF3 Q76L25 Q86T52 Q8N3S2,Beta-taxilin,Muscle-derived protein 77;, PF09728;, GO:0005737;GO:0019905;, C:cytoplasm;, F:syntaxin binding; scaffold47 indexed_genome mRNA 12310879 12314850 . - . ID=transcript_9134;Q8N3L3 Q5HYH7 Q5VTF3 Q76L25 Q86T52 Q8N3S2,Beta-taxilin,Muscle-derived protein 77;, PF09728;, GO:0005737;GO:0019905;, C:cytoplasm;, F:syntaxin binding; scaffold47 indexed_genome mRNA 12416511 12424314 . + . ID=transcript_9135;Q99967 O95426 Q5VTF4,Cbp/p300-interacting transactivator 2,MSG-related protein 1;P35srj;, PF04487;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0035035;GO:0050693;GO:0019904;GO:0003713;GO:0003714;GO:0035802;GO:0030154;GO:0008283;GO:0007368;GO:0060971;GO:0007507;GO:0070986;GO:0060972;GO:0001889;GO:0043066;GO:0030336;GO:0010629;GO:0000122;GO:0061428;GO:0045892;GO:1900164;GO:0003151;GO:0045787;GO:0022409;GO:0010628;GO:2000020;GO:0035360;GO:0045944;GO:0045893;GO:0030511;GO:0003156;GO:0043627;GO:0034405;GO:0001666;GO:0007530;GO:0048536;GO:0060412;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:histone acetyltransferase binding; F:LBD domain binding; F:protein domain specific binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:adrenal cortex formation; P:cell differentiation; P:cell population proliferation; P:determination of left/right symmetry; P:embryonic heart tube left/right pattern formation; P:heart development; P:left/right axis specification; P:left/right pattern formation; P:liver development; P:negative regulation of apoptotic process; P:negative regulation of cell migration; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:negative regulation of transcription, DNA-templated; P:nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry; P:outflow tract morphogenesis; P:positive regulation of cell cycle; P:positive regulation of cell-cell adhesion; P:positive regulation of gene expression; P:positive regulation of male gonad development; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of animal organ formation; P:response to estrogen; P:response to fluid shear stress; P:response to hypoxia; P:sex determination; P:spleen development; P:ventricular septum morphogenesis; scaffold47 indexed_genome mRNA 14544577 14545704 . + . ID=transcript_9136;P63208 D3DQ97 D3DQ98 P34991 Q8TAY2,S-phase kinase-associated protein 1,Cyclin-A/CDK2-associated protein p19;Organ of Corti protein 2;Organ of Corti protein II;RNA polymerase II elongation factor-like protein;SIII;Transcription elongation factor B polypeptide 1-like;p19skp1;, PF01466;PF03931;, GO:0005813;GO:0031467;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0008013;GO:0097602;GO:1990444;GO:0019904;GO:1990756;GO:0006879;GO:0038095;GO:0000086;GO:0035518;GO:0070498;GO:0051457;GO:0010972;GO:0038061;GO:1904668;GO:0043687;GO:0070936;GO:0000209;GO:0016567;GO:1901990;GO:0010265;GO:0031146;GO:0002223;GO:0051403;GO:0050852;GO:0016032;GO:0016055;, C:centrosome; C:Cul7-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:beta-catenin binding; F:cullin family protein binding; F:F-box domain binding; F:protein domain specific binding; F:ubiquitin ligase-substrate adaptor activity;, P:cellular iron ion homeostasis; P:Fc-epsilon receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:histone H2A monoubiquitination; P:interleukin-1-mediated signaling pathway; P:maintenance of protein location in nucleus; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:viral process; P:Wnt signaling pathway; scaffold47 indexed_genome mRNA 14710393 14780102 . + . ID=transcript_9137;Q9NP79 B4DW55 E1P594 E7ETQ7 Q5TGM1 Q6IAE8 Q9H0R2 Q9H3K9 Q9P0Q0,Vacuolar protein sorting-associated protein VTA1 homolog,Dopamine-responsive gene 1 protein;LYST-interacting protein 5;SKD1-binding protein 1;, PF04652;PF18097;, GO:0005829;GO:0010008;GO:0070062;GO:0043231;GO:0005771;GO:0005654;GO:0008022;GO:0016197;GO:1904903;GO:0032511;GO:0016236;GO:0036258;GO:0071985;GO:0015031;GO:0046755;GO:0019058;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:multivesicular body; C:nucleoplasm;, F:protein C-terminus binding;, P:endosomal transport; P:ESCRT III complex disassembly; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:macroautophagy; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:protein transport; P:viral budding; P:viral life cycle;|Q9NP79 B4DW55 E1P594 E7ETQ7 Q5TGM1 Q6IAE8 Q9H0R2 Q9H3K9 Q9P0Q0,Vacuolar protein sorting-associated protein VTA1 homolog,Dopamine-responsive gene 1 protein;LYST-interacting protein 5;SKD1-binding protein 1;, PF04652;PF18097;, GO:0005829;GO:0010008;GO:0070062;GO:0043231;GO:0005771;GO:0005654;GO:0008022;GO:0016197;GO:1904903;GO:0032511;GO:0016236;GO:0036258;GO:0071985;GO:0015031;GO:0046755;GO:0019058;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:multivesicular body; C:nucleoplasm;, F:protein C-terminus binding;, P:endosomal transport; P:ESCRT III complex disassembly; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:macroautophagy; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:protein transport; P:viral budding; P:viral life cycle;|Q9NP79 B4DW55 E1P594 E7ETQ7 Q5TGM1 Q6IAE8 Q9H0R2 Q9H3K9 Q9P0Q0,Vacuolar protein sorting-associated protein VTA1 homolog,Dopamine-responsive gene 1 protein;LYST-interacting protein 5;SKD1-binding protein 1;, PF04652;PF18097;, GO:0005829;GO:0010008;GO:0070062;GO:0043231;GO:0005771;GO:0005654;GO:0008022;GO:0016197;GO:1904903;GO:0032511;GO:0016236;GO:0036258;GO:0071985;GO:0015031;GO:0046755;GO:0019058;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:multivesicular body; C:nucleoplasm;, F:protein C-terminus binding;, P:endosomal transport; P:ESCRT III complex disassembly; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:macroautophagy; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:protein transport; P:viral budding; P:viral life cycle; scaffold47 indexed_genome mRNA 14847153 14884114 . + . ID=transcript_9138;Q8NC14 Q96JW0,Adhesion G-protein coupled receptor G6,Developmentally regulated G-protein-coupled receptor {ECO:0000303|PubMed:15189448};G-protein coupled receptor 126;Vascular inducible G protein-coupled receptor {ECO:0000303|PubMed:15225624};, PF00002;PF00431;PF01825;PF00354;, GO:0009986;GO:0005737;GO:0005789;GO:0016021;GO:0005887;GO:0005886;GO:0005518;GO:0050840;GO:0004930;GO:0043236;GO:0007189;GO:0019933;GO:0007166;GO:0007186;GO:0060347;GO:0042552;GO:0022011;GO:0007399;GO:0014037;, C:cell surface; C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:collagen binding; F:extracellular matrix binding; F:G protein-coupled receptor activity; F:laminin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cAMP-mediated signaling; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heart trabecula formation; P:myelination; P:myelination in peripheral nervous system; P:nervous system development; P:Schwann cell differentiation; scaffold47 indexed_genome mRNA 14915515 15000157 . + . ID=transcript_9139;Q8NC14 Q96JW0,Adhesion G-protein coupled receptor G6,Developmentally regulated G-protein-coupled receptor {ECO:0000303|PubMed:15189448};G-protein coupled receptor 126;Vascular inducible G protein-coupled receptor {ECO:0000303|PubMed:15225624};, PF00002;PF00431;PF01825;PF00354;, GO:0009986;GO:0005737;GO:0005789;GO:0016021;GO:0005887;GO:0005886;GO:0005518;GO:0050840;GO:0004930;GO:0043236;GO:0007189;GO:0019933;GO:0007166;GO:0007186;GO:0060347;GO:0042552;GO:0022011;GO:0007399;GO:0014037;, C:cell surface; C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:collagen binding; F:extracellular matrix binding; F:G protein-coupled receptor activity; F:laminin binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cAMP-mediated signaling; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heart trabecula formation; P:myelination; P:myelination in peripheral nervous system; P:nervous system development; P:Schwann cell differentiation; scaffold47 indexed_genome mRNA 15259167 15418146 . + . ID=transcript_9140;P31629 Q02646 Q5THT5 Q9NS05,Transcription factor HIVEP2,Human immunodeficiency virus type I enhancer-binding protein 2;MHC-binding protein 2;, PF00096;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P31629 Q02646 Q5THT5 Q9NS05,Transcription factor HIVEP2,Human immunodeficiency virus type I enhancer-binding protein 2;MHC-binding protein 2;, PF00096;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P31629 Q02646 Q5THT5 Q9NS05,Transcription factor HIVEP2,Human immunodeficiency virus type I enhancer-binding protein 2;MHC-binding protein 2;, PF00096;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold47 indexed_genome mRNA 15554343 15810866 . + . ID=transcript_9141;Q9NVV5 B4DPX2 C9J569 Q5T2H2 Q6N047 Q7Z378 Q8TB14 Q9Y3A9 Q9Y5B4,Androgen-induced gene 1 protein,Fatty acid esters of hydroxy fatty acids hydrolase AIG1 {ECO:0000303|PubMed:27018888};, PF04750;, GO:0016021;GO:0016020;GO:0005886;GO:0016787;GO:0042758;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:hydrolase activity;, P:long-chain fatty acid catabolic process; scaffold47 indexed_genome mRNA 15910616 15919973 . - . ID=transcript_9142;Q7Z6V5 A6NL12 B3KWY3 Q7Z327 Q8IY39,tRNA-specific adenosine deaminase 2,Deaminase domain-containing protein 1;tRNA-specific adenosine-34 deaminase subunit ADAT2;, PF00383;, GO:0005654;GO:0052717;GO:0008270;GO:0006400;GO:0002100;, C:nucleoplasm;, F:tRNA-specific adenosine-34 deaminase activity; F:zinc ion binding;, P:tRNA modification; P:tRNA wobble adenosine to inosine editing;|Q7Z6V5 A6NL12 B3KWY3 Q7Z327 Q8IY39,tRNA-specific adenosine deaminase 2,Deaminase domain-containing protein 1;tRNA-specific adenosine-34 deaminase subunit ADAT2;, PF00383;, GO:0005654;GO:0052717;GO:0008270;GO:0006400;GO:0002100;, C:nucleoplasm;, F:tRNA-specific adenosine-34 deaminase activity; F:zinc ion binding;, P:tRNA modification; P:tRNA wobble adenosine to inosine editing;|Q7Z6V5 A6NL12 B3KWY3 Q7Z327 Q8IY39,tRNA-specific adenosine deaminase 2,Deaminase domain-containing protein 1;tRNA-specific adenosine-34 deaminase subunit ADAT2;, PF00383;, GO:0005654;GO:0052717;GO:0008270;GO:0006400;GO:0002100;, C:nucleoplasm;, F:tRNA-specific adenosine-34 deaminase activity; F:zinc ion binding;, P:tRNA modification; P:tRNA wobble adenosine to inosine editing; scaffold47 indexed_genome mRNA 15938842 15964400 . + . ID=transcript_9143;P56589 Q6FGP5,Peroxisomal biogenesis factor 3,Peroxin-3;Peroxisomal assembly protein PEX3;, PF04882;, GO:0005829;GO:0005783;GO:0005779;GO:0016020;GO:0005654;GO:0005778;GO:0005777;GO:0032991;GO:0032994;GO:0008289;GO:0030674;GO:0006869;GO:0016557;GO:0007031;GO:0045046;, C:cytosol; C:endoplasmic reticulum; C:integral component of peroxisomal membrane; C:membrane; C:nucleoplasm; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex; C:protein-lipid complex;, F:lipid binding; F:protein-macromolecule adaptor activity;, P:lipid transport; P:peroxisome membrane biogenesis; P:peroxisome organization; P:protein import into peroxisome membrane;|P56589 Q6FGP5,Peroxisomal biogenesis factor 3,Peroxin-3;Peroxisomal assembly protein PEX3;, PF04882;, GO:0005829;GO:0005783;GO:0005779;GO:0016020;GO:0005654;GO:0005778;GO:0005777;GO:0032991;GO:0032994;GO:0008289;GO:0030674;GO:0006869;GO:0016557;GO:0007031;GO:0045046;, C:cytosol; C:endoplasmic reticulum; C:integral component of peroxisomal membrane; C:membrane; C:nucleoplasm; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex; C:protein-lipid complex;, F:lipid binding; F:protein-macromolecule adaptor activity;, P:lipid transport; P:peroxisome membrane biogenesis; P:peroxisome organization; P:protein import into peroxisome membrane; scaffold47 indexed_genome mRNA 15968418 15974200 . + . ID=transcript_9144;P56589 Q6FGP5,Peroxisomal biogenesis factor 3,Peroxin-3;Peroxisomal assembly protein PEX3;, PF04882;, GO:0005829;GO:0005783;GO:0005779;GO:0016020;GO:0005654;GO:0005778;GO:0005777;GO:0032991;GO:0032994;GO:0008289;GO:0030674;GO:0006869;GO:0016557;GO:0007031;GO:0045046;, C:cytosol; C:endoplasmic reticulum; C:integral component of peroxisomal membrane; C:membrane; C:nucleoplasm; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex; C:protein-lipid complex;, F:lipid binding; F:protein-macromolecule adaptor activity;, P:lipid transport; P:peroxisome membrane biogenesis; P:peroxisome organization; P:protein import into peroxisome membrane; scaffold47 indexed_genome mRNA 15979697 15998965 . - . ID=transcript_9145;Q9BTY2 E9PEB6 Q7Z6V1 Q7Z6Y2 Q8NBK4,Plasma alpha-L-fucosidase,Alpha-L-fucoside fucohydrolase 2;, PF01120;PF16757;, GO:0035578;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005764;GO:0004560;GO:0044267;GO:0006004;GO:0016139;GO:0043312;GO:0043687;GO:2000535;GO:0009617;, C:azurophil granule lumen; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosome;, F:alpha-L-fucosidase activity;, P:cellular protein metabolic process; P:fucose metabolic process; P:glycoside catabolic process; P:neutrophil degranulation; P:post-translational protein modification; P:regulation of entry of bacterium into host cell; P:response to bacterium; scaffold47 indexed_genome mRNA 16173114 16310366 . + . ID=transcript_9146;Q68DM2,Phosphatase and actin regulator 2,, PF02755;, GO:0005886;GO:0031092;GO:0003779;GO:0004864;GO:0030036;GO:0002576;, C:plasma membrane; C:platelet alpha granule membrane;, F:actin binding; F:protein phosphatase inhibitor activity;, P:actin cytoskeleton organization; P:platelet degranulation;|Q68DM2,Phosphatase and actin regulator 2,, PF02755;, GO:0005886;GO:0031092;GO:0003779;GO:0004864;GO:0030036;GO:0002576;, C:plasma membrane; C:platelet alpha granule membrane;, F:actin binding; F:protein phosphatase inhibitor activity;, P:actin cytoskeleton organization; P:platelet degranulation; scaffold47 indexed_genome mRNA 16323033 16339327 . + . ID=transcript_9147;Q96GA3 Q96JX8,Protein LTV1 homolog,, PF04180;, GO:0005829;GO:0005654;GO:0005634;GO:0030688;GO:0042274;GO:0000056;, C:cytosol; C:nucleoplasm; C:nucleus; C:preribosome, small subunit precursor;, , P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus;|Q96GA3 Q96JX8,Protein LTV1 homolog,, PF04180;, GO:0005829;GO:0005654;GO:0005634;GO:0030688;GO:0042274;GO:0000056;, C:cytosol; C:nucleoplasm; C:nucleus; C:preribosome, small subunit precursor;, , P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q96GA3 Q96JX8,Protein LTV1 homolog,, PF04180;, GO:0005829;GO:0005654;GO:0005634;GO:0030688;GO:0042274;GO:0000056;, C:cytosol; C:nucleoplasm; C:nucleus; C:preribosome, small subunit precursor;, , P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus;|Q96GA3 Q96JX8,Protein LTV1 homolog,, PF04180;, GO:0005829;GO:0005654;GO:0005634;GO:0030688;GO:0042274;GO:0000056;, C:cytosol; C:nucleoplasm; C:nucleus; C:preribosome, small subunit precursor;, , P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus; scaffold47 indexed_genome mRNA 16346797 16379818 . + . ID=transcript_9148;Q5TFG8 B2RUZ7 Q5TFG9,Zinc finger C2HC domain-containing protein 1B,, , GO:0046872;, , F:metal ion binding;|Q5TFG8 B2RUZ7 Q5TFG9,Zinc finger C2HC domain-containing protein 1B,, , GO:0046872;, , F:metal ion binding;|Q5TFG8 B2RUZ7 Q5TFG9,Zinc finger C2HC domain-containing protein 1B,, , GO:0046872;, , F:metal ion binding; scaffold47 indexed_genome mRNA 16380904 16387792 . - . ID=transcript_9149;Q9UIZ0,Zinc finger protein PLAGL1,Lost on transformation 1;Pleiomorphic adenoma-like protein 1;Tumor suppressor ZAC;, PF00096;, GO:0005794;GO:0043231;GO:0016604;GO:0005654;GO:0003677;GO:0001228;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:0006915;GO:0007050;GO:0006977;GO:0045944;GO:0006357;, C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9UIZ0,Zinc finger protein PLAGL1,Lost on transformation 1;Pleiomorphic adenoma-like protein 1;Tumor suppressor ZAC;, PF00096;, GO:0005794;GO:0043231;GO:0016604;GO:0005654;GO:0003677;GO:0001228;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:0006915;GO:0007050;GO:0006977;GO:0045944;GO:0006357;, C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold47 indexed_genome mRNA 16409550 16466952 . - . ID=transcript_9150;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold47 indexed_genome mRNA 16501895 16502613 . - . ID=transcript_9151;Q9BWJ5 B2R568 Q7RTV1,Splicing factor 3B subunit 5,Pre-mRNA-splicing factor SF3b 10 kDa subunit;, PF07189;, GO:0005654;GO:0005634;GO:0071011;GO:0005689;GO:0005686;GO:0071005;GO:0003723;GO:1990935;GO:0000398;, C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:RNA binding; F:splicing factor binding;, P:mRNA splicing, via spliceosome; scaffold47 indexed_genome mRNA 16549768 16581431 . - . ID=transcript_9152;O75558 E1P598 O75378 O95148 Q5TCL6,Syntaxin-11,, PF00804;, GO:0012505;GO:0005794;GO:0016021;GO:0005886;GO:0048787;GO:0031201;GO:0008021;GO:0005484;GO:0000149;GO:0006887;GO:0006886;GO:0061025;GO:0031629;GO:0048278;GO:0006906;, C:endomembrane system; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:presynaptic active zone membrane; C:SNARE complex; C:synaptic vesicle;, F:SNAP receptor activity; F:SNARE binding;, P:exocytosis; P:intracellular protein transport; P:membrane fusion; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle fusion; scaffold47 indexed_genome mRNA 16797361 17218184 . + . ID=transcript_9153;P46939 Q5SYY1 Q5SZ57 Q9UJ40,Utrophin,Dystrophin-related protein 1;, PF00307;PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0030864;GO:0005737;GO:0005856;GO:0016010;GO:0070062;GO:0030175;GO:0031527;GO:0030426;GO:0016020;GO:0031594;GO:0005654;GO:0005886;GO:0045211;GO:0032991;GO:0042383;GO:0003779;GO:0051015;GO:0005178;GO:0019901;GO:0017166;GO:0008270;GO:0006936;GO:0007517;GO:0007528;GO:0001954;GO:2000649;GO:0014894;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:extracellular exosome; C:filopodium; C:filopodium membrane; C:growth cone; C:membrane; C:neuromuscular junction; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma;, F:actin binding; F:actin filament binding; F:integrin binding; F:protein kinase binding; F:vinculin binding; F:zinc ion binding;, P:muscle contraction; P:muscle organ development; P:neuromuscular junction development; P:positive regulation of cell-matrix adhesion; P:regulation of sodium ion transmembrane transporter activity; P:response to denervation involved in regulation of muscle adaptation; scaffold47 indexed_genome mRNA 17354207 17354899 . + . ID=transcript_9154;Q92539 A7MD25 D3DUH3,Phosphatidate phosphatase LPIN2 {ECO:0000305},Lipin-2 {ECO:0000250|UniProtKB:Q99PI5};, PF16876;PF04571;PF08235;, GO:0005829;GO:0005789;GO:0005634;GO:0008195;GO:0003713;GO:0044255;GO:0032869;GO:0009062;GO:0006629;GO:0006656;GO:0006646;GO:0045944;GO:0019432;, C:cytosol; C:endoplasmic reticulum membrane; C:nucleus;, F:phosphatidate phosphatase activity; F:transcription coactivator activity;, P:cellular lipid metabolic process; P:cellular response to insulin stimulus; P:fatty acid catabolic process; P:lipid metabolic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:triglyceride biosynthetic process; scaffold47 indexed_genome mRNA 18037075 18050303 . - . ID=transcript_9155;Q8TB52 Q9BXZ7,F-box only protein 30,, PF15966;PF15965;, GO:0005829;GO:0061630;GO:0008270;GO:0043687;GO:0000209;, C:cytosol;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:post-translational protein modification; P:protein polyubiquitination; scaffold47 indexed_genome mRNA 18121839 18122587 . + . ID=transcript_9156;Q149N8 Q149N9 Q5VV79 Q68DS5 Q7Z5J5 Q8IVE8 Q8IWQ9 Q8N1S8 Q8NBR7,E3 ubiquitin-protein ligase SHPRH,RING-type E3 ubiquitin transferase SHPRH {ECO:0000305};SNF2, histone-linker, PHD and RING finger domain-containing helicase;, PF00271;PF00538;PF00176;, GO:0005654;GO:0000786;GO:0005524;GO:0003677;GO:0004386;GO:0046872;GO:0070615;GO:0061630;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0006334;GO:0000209;GO:0016567;, C:nucleoplasm; C:nucleosome;, F:ATP binding; F:DNA binding; F:helicase activity; F:metal ion binding; F:nucleosome-dependent ATPase activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:nucleosome assembly; P:protein polyubiquitination; P:protein ubiquitination; scaffold47 indexed_genome mRNA 18122857 18125295 . - . ID=transcript_9157;Q149N8 Q149N9 Q5VV79 Q68DS5 Q7Z5J5 Q8IVE8 Q8IWQ9 Q8N1S8 Q8NBR7,E3 ubiquitin-protein ligase SHPRH,RING-type E3 ubiquitin transferase SHPRH {ECO:0000305};SNF2, histone-linker, PHD and RING finger domain-containing helicase;, PF00271;PF00538;PF00176;, GO:0005654;GO:0000786;GO:0005524;GO:0003677;GO:0004386;GO:0046872;GO:0070615;GO:0061630;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0006334;GO:0000209;GO:0016567;, C:nucleoplasm; C:nucleosome;, F:ATP binding; F:DNA binding; F:helicase activity; F:metal ion binding; F:nucleosome-dependent ATPase activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:nucleosome assembly; P:protein polyubiquitination; P:protein ubiquitination; scaffold48 indexed_genome mRNA 81457 124154 . + . ID=transcript_9158;O95199 B2RDW8,RCC1 and BTB domain-containing protein 2,Chromosome condensation 1-like;RCC1-like G exchanging factor;Regulator of chromosome condensation and BTB domain-containing protein 2;, PF00651;PF00415;, GO:0001669;GO:0005085;, C:acrosomal vesicle;, F:guanyl-nucleotide exchange factor activity;|O95199 B2RDW8,RCC1 and BTB domain-containing protein 2,Chromosome condensation 1-like;RCC1-like G exchanging factor;Regulator of chromosome condensation and BTB domain-containing protein 2;, PF00651;PF00415;, GO:0001669;GO:0005085;, C:acrosomal vesicle;, F:guanyl-nucleotide exchange factor activity;|O95199 B2RDW8,RCC1 and BTB domain-containing protein 2,Chromosome condensation 1-like;RCC1-like G exchanging factor;Regulator of chromosome condensation and BTB domain-containing protein 2;, PF00651;PF00415;, GO:0001669;GO:0005085;, C:acrosomal vesicle;, F:guanyl-nucleotide exchange factor activity;|O95199 B2RDW8,RCC1 and BTB domain-containing protein 2,Chromosome condensation 1-like;RCC1-like G exchanging factor;Regulator of chromosome condensation and BTB domain-containing protein 2;, PF00651;PF00415;, GO:0001669;GO:0005085;, C:acrosomal vesicle;, F:guanyl-nucleotide exchange factor activity;|O95199 B2RDW8,RCC1 and BTB domain-containing protein 2,Chromosome condensation 1-like;RCC1-like G exchanging factor;Regulator of chromosome condensation and BTB domain-containing protein 2;, PF00651;PF00415;, GO:0001669;GO:0005085;, C:acrosomal vesicle;, F:guanyl-nucleotide exchange factor activity;|O95199 B2RDW8,RCC1 and BTB domain-containing protein 2,Chromosome condensation 1-like;RCC1-like G exchanging factor;Regulator of chromosome condensation and BTB domain-containing protein 2;, PF00651;PF00415;, GO:0001669;GO:0005085;, C:acrosomal vesicle;, F:guanyl-nucleotide exchange factor activity; scaffold48 indexed_genome mRNA 125801 181523 . + . ID=transcript_9159;P06400 A8K5E3 P78499 Q5VW46 Q8IZL4,Retinoblastoma-associated protein,p105-Rb;p110-RB1 {ECO:0000303|PubMed:8336704};pRb;pp110;, PF11934;PF01858;PF01857;PF08934;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0035189;GO:0005819;GO:0016514;GO:0005667;GO:0097718;GO:0042802;GO:0061676;GO:0019900;GO:0051219;GO:0001102;GO:0000977;GO:0003714;GO:0008134;GO:0031625;GO:0031145;GO:0003180;GO:0007050;GO:0030154;GO:0051301;GO:0048667;GO:0071466;GO:0006338;GO:0048565;GO:0043353;GO:0000082;GO:0034349;GO:0097284;GO:0034088;GO:0007076;GO:0045445;GO:2001234;GO:0045786;GO:0030308;GO:0120163;GO:0043433;GO:0050680;GO:2000134;GO:0010629;GO:0050728;GO:1904761;GO:0006469;GO:0071901;GO:0045879;GO:1902948;GO:0000122;GO:0071930;GO:0045892;GO:0051402;GO:0042551;GO:0031175;GO:1904028;GO:1903055;GO:0045651;GO:0045842;GO:0045944;GO:2000679;GO:0071459;GO:0007265;GO:0090230;GO:0071922;GO:0043550;GO:0007346;GO:0006355;GO:0031134;GO:0035914;GO:0051146;GO:0001894;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:Rb-E2F complex; C:spindle; C:SWI/SNF complex; C:transcription regulator complex;, F:disordered domain specific binding; F:identical protein binding; F:importin-alpha family protein binding; F:kinase binding; F:phosphoprotein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:aortic valve morphogenesis; P:cell cycle arrest; P:cell differentiation; P:cell division; P:cell morphogenesis involved in neuron differentiation; P:cellular response to xenobiotic stimulus; P:chromatin remodeling; P:digestive tract development; P:enucleate erythrocyte differentiation; P:G1/S transition of mitotic cell cycle; P:glial cell apoptotic process; P:hepatocyte apoptotic process; P:maintenance of mitotic sister chromatid cohesion; P:mitotic chromosome condensation; P:myoblast differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cold-induced thermogenesis; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of myofibroblast differentiation; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of tau-protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:neuron apoptotic process; P:neuron maturation; P:neuron projection development; P:positive regulation of collagen fibril organization; P:positive regulation of extracellular matrix organization; P:positive regulation of macrophage differentiation; P:positive regulation of mitotic metaphase/anaphase transition; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein localization to chromosome, centromeric region; P:Ras protein signal transduction; P:regulation of centromere complex assembly; P:regulation of cohesin loading; P:regulation of lipid kinase activity; P:regulation of mitotic cell cycle; P:regulation of transcription, DNA-templated; P:sister chromatid biorientation; P:skeletal muscle cell differentiation; P:striated muscle cell differentiation; P:tissue homeostasis; P:viral process;|P06400 A8K5E3 P78499 Q5VW46 Q8IZL4,Retinoblastoma-associated protein,p105-Rb;p110-RB1 {ECO:0000303|PubMed:8336704};pRb;pp110;, PF11934;PF01858;PF01857;PF08934;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0035189;GO:0005819;GO:0016514;GO:0005667;GO:0097718;GO:0042802;GO:0061676;GO:0019900;GO:0051219;GO:0001102;GO:0000977;GO:0003714;GO:0008134;GO:0031625;GO:0031145;GO:0003180;GO:0007050;GO:0030154;GO:0051301;GO:0048667;GO:0071466;GO:0006338;GO:0048565;GO:0043353;GO:0000082;GO:0034349;GO:0097284;GO:0034088;GO:0007076;GO:0045445;GO:2001234;GO:0045786;GO:0030308;GO:0120163;GO:0043433;GO:0050680;GO:2000134;GO:0010629;GO:0050728;GO:1904761;GO:0006469;GO:0071901;GO:0045879;GO:1902948;GO:0000122;GO:0071930;GO:0045892;GO:0051402;GO:0042551;GO:0031175;GO:1904028;GO:1903055;GO:0045651;GO:0045842;GO:0045944;GO:2000679;GO:0071459;GO:0007265;GO:0090230;GO:0071922;GO:0043550;GO:0007346;GO:0006355;GO:0031134;GO:0035914;GO:0051146;GO:0001894;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:Rb-E2F complex; C:spindle; C:SWI/SNF complex; C:transcription regulator complex;, F:disordered domain specific binding; F:identical protein binding; F:importin-alpha family protein binding; F:kinase binding; F:phosphoprotein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:aortic valve morphogenesis; P:cell cycle arrest; P:cell differentiation; P:cell division; P:cell morphogenesis involved in neuron differentiation; P:cellular response to xenobiotic stimulus; P:chromatin remodeling; P:digestive tract development; P:enucleate erythrocyte differentiation; P:G1/S transition of mitotic cell cycle; P:glial cell apoptotic process; P:hepatocyte apoptotic process; P:maintenance of mitotic sister chromatid cohesion; P:mitotic chromosome condensation; P:myoblast differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cold-induced thermogenesis; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of myofibroblast differentiation; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of tau-protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:neuron apoptotic process; P:neuron maturation; P:neuron projection development; P:positive regulation of collagen fibril organization; P:positive regulation of extracellular matrix organization; P:positive regulation of macrophage differentiation; P:positive regulation of mitotic metaphase/anaphase transition; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein localization to chromosome, centromeric region; P:Ras protein signal transduction; P:regulation of centromere complex assembly; P:regulation of cohesin loading; P:regulation of lipid kinase activity; P:regulation of mitotic cell cycle; P:regulation of transcription, DNA-templated; P:sister chromatid biorientation; P:skeletal muscle cell differentiation; P:striated muscle cell differentiation; P:tissue homeostasis; P:viral process;|P06400 A8K5E3 P78499 Q5VW46 Q8IZL4,Retinoblastoma-associated protein,p105-Rb;p110-RB1 {ECO:0000303|PubMed:8336704};pRb;pp110;, PF11934;PF01858;PF01857;PF08934;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0035189;GO:0005819;GO:0016514;GO:0005667;GO:0097718;GO:0042802;GO:0061676;GO:0019900;GO:0051219;GO:0001102;GO:0000977;GO:0003714;GO:0008134;GO:0031625;GO:0031145;GO:0003180;GO:0007050;GO:0030154;GO:0051301;GO:0048667;GO:0071466;GO:0006338;GO:0048565;GO:0043353;GO:0000082;GO:0034349;GO:0097284;GO:0034088;GO:0007076;GO:0045445;GO:2001234;GO:0045786;GO:0030308;GO:0120163;GO:0043433;GO:0050680;GO:2000134;GO:0010629;GO:0050728;GO:1904761;GO:0006469;GO:0071901;GO:0045879;GO:1902948;GO:0000122;GO:0071930;GO:0045892;GO:0051402;GO:0042551;GO:0031175;GO:1904028;GO:1903055;GO:0045651;GO:0045842;GO:0045944;GO:2000679;GO:0071459;GO:0007265;GO:0090230;GO:0071922;GO:0043550;GO:0007346;GO:0006355;GO:0031134;GO:0035914;GO:0051146;GO:0001894;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:Rb-E2F complex; C:spindle; C:SWI/SNF complex; C:transcription regulator complex;, F:disordered domain specific binding; F:identical protein binding; F:importin-alpha family protein binding; F:kinase binding; F:phosphoprotein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:aortic valve morphogenesis; P:cell cycle arrest; P:cell differentiation; P:cell division; P:cell morphogenesis involved in neuron differentiation; P:cellular response to xenobiotic stimulus; P:chromatin remodeling; P:digestive tract development; P:enucleate erythrocyte differentiation; P:G1/S transition of mitotic cell cycle; P:glial cell apoptotic process; P:hepatocyte apoptotic process; P:maintenance of mitotic sister chromatid cohesion; P:mitotic chromosome condensation; P:myoblast differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cold-induced thermogenesis; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of myofibroblast differentiation; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of tau-protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:neuron apoptotic process; P:neuron maturation; P:neuron projection development; P:positive regulation of collagen fibril organization; P:positive regulation of extracellular matrix organization; P:positive regulation of macrophage differentiation; P:positive regulation of mitotic metaphase/anaphase transition; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein localization to chromosome, centromeric region; P:Ras protein signal transduction; P:regulation of centromere complex assembly; P:regulation of cohesin loading; P:regulation of lipid kinase activity; P:regulation of mitotic cell cycle; P:regulation of transcription, DNA-templated; P:sister chromatid biorientation; P:skeletal muscle cell differentiation; P:striated muscle cell differentiation; P:tissue homeostasis; P:viral process;|P06400 A8K5E3 P78499 Q5VW46 Q8IZL4,Retinoblastoma-associated protein,p105-Rb;p110-RB1 {ECO:0000303|PubMed:8336704};pRb;pp110;, PF11934;PF01858;PF01857;PF08934;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0035189;GO:0005819;GO:0016514;GO:0005667;GO:0097718;GO:0042802;GO:0061676;GO:0019900;GO:0051219;GO:0001102;GO:0000977;GO:0003714;GO:0008134;GO:0031625;GO:0031145;GO:0003180;GO:0007050;GO:0030154;GO:0051301;GO:0048667;GO:0071466;GO:0006338;GO:0048565;GO:0043353;GO:0000082;GO:0034349;GO:0097284;GO:0034088;GO:0007076;GO:0045445;GO:2001234;GO:0045786;GO:0030308;GO:0120163;GO:0043433;GO:0050680;GO:2000134;GO:0010629;GO:0050728;GO:1904761;GO:0006469;GO:0071901;GO:0045879;GO:1902948;GO:0000122;GO:0071930;GO:0045892;GO:0051402;GO:0042551;GO:0031175;GO:1904028;GO:1903055;GO:0045651;GO:0045842;GO:0045944;GO:2000679;GO:0071459;GO:0007265;GO:0090230;GO:0071922;GO:0043550;GO:0007346;GO:0006355;GO:0031134;GO:0035914;GO:0051146;GO:0001894;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:Rb-E2F complex; C:spindle; C:SWI/SNF complex; C:transcription regulator complex;, F:disordered domain specific binding; F:identical protein binding; F:importin-alpha family protein binding; F:kinase binding; F:phosphoprotein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:aortic valve morphogenesis; P:cell cycle arrest; P:cell differentiation; P:cell division; P:cell morphogenesis involved in neuron differentiation; P:cellular response to xenobiotic stimulus; P:chromatin remodeling; P:digestive tract development; P:enucleate erythrocyte differentiation; P:G1/S transition of mitotic cell cycle; P:glial cell apoptotic process; P:hepatocyte apoptotic process; P:maintenance of mitotic sister chromatid cohesion; P:mitotic chromosome condensation; P:myoblast differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cold-induced thermogenesis; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of myofibroblast differentiation; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of tau-protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:neuron apoptotic process; P:neuron maturation; P:neuron projection development; P:positive regulation of collagen fibril organization; P:positive regulation of extracellular matrix organization; P:positive regulation of macrophage differentiation; P:positive regulation of mitotic metaphase/anaphase transition; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein localization to chromosome, centromeric region; P:Ras protein signal transduction; P:regulation of centromere complex assembly; P:regulation of cohesin loading; P:regulation of lipid kinase activity; P:regulation of mitotic cell cycle; P:regulation of transcription, DNA-templated; P:sister chromatid biorientation; P:skeletal muscle cell differentiation; P:striated muscle cell differentiation; P:tissue homeostasis; P:viral process;|P06400 A8K5E3 P78499 Q5VW46 Q8IZL4,Retinoblastoma-associated protein,p105-Rb;p110-RB1 {ECO:0000303|PubMed:8336704};pRb;pp110;, PF11934;PF01858;PF01857;PF08934;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0035189;GO:0005819;GO:0016514;GO:0005667;GO:0097718;GO:0042802;GO:0061676;GO:0019900;GO:0051219;GO:0001102;GO:0000977;GO:0003714;GO:0008134;GO:0031625;GO:0031145;GO:0003180;GO:0007050;GO:0030154;GO:0051301;GO:0048667;GO:0071466;GO:0006338;GO:0048565;GO:0043353;GO:0000082;GO:0034349;GO:0097284;GO:0034088;GO:0007076;GO:0045445;GO:2001234;GO:0045786;GO:0030308;GO:0120163;GO:0043433;GO:0050680;GO:2000134;GO:0010629;GO:0050728;GO:1904761;GO:0006469;GO:0071901;GO:0045879;GO:1902948;GO:0000122;GO:0071930;GO:0045892;GO:0051402;GO:0042551;GO:0031175;GO:1904028;GO:1903055;GO:0045651;GO:0045842;GO:0045944;GO:2000679;GO:0071459;GO:0007265;GO:0090230;GO:0071922;GO:0043550;GO:0007346;GO:0006355;GO:0031134;GO:0035914;GO:0051146;GO:0001894;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:Rb-E2F complex; C:spindle; C:SWI/SNF complex; C:transcription regulator complex;, F:disordered domain specific binding; F:identical protein binding; F:importin-alpha family protein binding; F:kinase binding; F:phosphoprotein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:aortic valve morphogenesis; P:cell cycle arrest; P:cell differentiation; P:cell division; P:cell morphogenesis involved in neuron differentiation; P:cellular response to xenobiotic stimulus; P:chromatin remodeling; P:digestive tract development; P:enucleate erythrocyte differentiation; P:G1/S transition of mitotic cell cycle; P:glial cell apoptotic process; P:hepatocyte apoptotic process; P:maintenance of mitotic sister chromatid cohesion; P:mitotic chromosome condensation; P:myoblast differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cold-induced thermogenesis; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of myofibroblast differentiation; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of tau-protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:neuron apoptotic process; P:neuron maturation; P:neuron projection development; P:positive regulation of collagen fibril organization; P:positive regulation of extracellular matrix organization; P:positive regulation of macrophage differentiation; P:positive regulation of mitotic metaphase/anaphase transition; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein localization to chromosome, centromeric region; P:Ras protein signal transduction; P:regulation of centromere complex assembly; P:regulation of cohesin loading; P:regulation of lipid kinase activity; P:regulation of mitotic cell cycle; P:regulation of transcription, DNA-templated; P:sister chromatid biorientation; P:skeletal muscle cell differentiation; P:striated muscle cell differentiation; P:tissue homeostasis; P:viral process;|Q7Z3S6,Lysophosphatidic acid receptor 6,Oleoyl-L-alpha-lysophosphatidic acid receptor;P2Y purinoceptor 5;Purinergic receptor 5;RB intron encoded G-protein coupled receptor;, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0070915;GO:0001835;GO:0007186;GO:0051482;GO:0035025;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:lysophosphatidic acid receptor activity;, P:blastocyst hatching; P:G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of Rho protein signal transduction;|P06400 A8K5E3 P78499 Q5VW46 Q8IZL4,Retinoblastoma-associated protein,p105-Rb;p110-RB1 {ECO:0000303|PubMed:8336704};pRb;pp110;, PF11934;PF01858;PF01857;PF08934;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0035189;GO:0005819;GO:0016514;GO:0005667;GO:0097718;GO:0042802;GO:0061676;GO:0019900;GO:0051219;GO:0001102;GO:0000977;GO:0003714;GO:0008134;GO:0031625;GO:0031145;GO:0003180;GO:0007050;GO:0030154;GO:0051301;GO:0048667;GO:0071466;GO:0006338;GO:0048565;GO:0043353;GO:0000082;GO:0034349;GO:0097284;GO:0034088;GO:0007076;GO:0045445;GO:2001234;GO:0045786;GO:0030308;GO:0120163;GO:0043433;GO:0050680;GO:2000134;GO:0010629;GO:0050728;GO:1904761;GO:0006469;GO:0071901;GO:0045879;GO:1902948;GO:0000122;GO:0071930;GO:0045892;GO:0051402;GO:0042551;GO:0031175;GO:1904028;GO:1903055;GO:0045651;GO:0045842;GO:0045944;GO:2000679;GO:0071459;GO:0007265;GO:0090230;GO:0071922;GO:0043550;GO:0007346;GO:0006355;GO:0031134;GO:0035914;GO:0051146;GO:0001894;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:Rb-E2F complex; C:spindle; C:SWI/SNF complex; C:transcription regulator complex;, F:disordered domain specific binding; F:identical protein binding; F:importin-alpha family protein binding; F:kinase binding; F:phosphoprotein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:aortic valve morphogenesis; P:cell cycle arrest; P:cell differentiation; P:cell division; P:cell morphogenesis involved in neuron differentiation; P:cellular response to xenobiotic stimulus; P:chromatin remodeling; P:digestive tract development; P:enucleate erythrocyte differentiation; P:G1/S transition of mitotic cell cycle; P:glial cell apoptotic process; P:hepatocyte apoptotic process; P:maintenance of mitotic sister chromatid cohesion; P:mitotic chromosome condensation; P:myoblast differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cold-induced thermogenesis; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of myofibroblast differentiation; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of tau-protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:neuron apoptotic process; P:neuron maturation; P:neuron projection development; P:positive regulation of collagen fibril organization; P:positive regulation of extracellular matrix organization; P:positive regulation of macrophage differentiation; P:positive regulation of mitotic metaphase/anaphase transition; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein localization to chromosome, centromeric region; P:Ras protein signal transduction; P:regulation of centromere complex assembly; P:regulation of cohesin loading; P:regulation of lipid kinase activity; P:regulation of mitotic cell cycle; P:regulation of transcription, DNA-templated; P:sister chromatid biorientation; P:skeletal muscle cell differentiation; P:striated muscle cell differentiation; P:tissue homeostasis; P:viral process; scaffold48 indexed_genome mRNA 234935 241094 . - . ID=transcript_9160;P06400 A8K5E3 P78499 Q5VW46 Q8IZL4,Retinoblastoma-associated protein,p105-Rb;p110-RB1 {ECO:0000303|PubMed:8336704};pRb;pp110;, PF11934;PF01858;PF01857;PF08934;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0035189;GO:0005819;GO:0016514;GO:0005667;GO:0097718;GO:0042802;GO:0061676;GO:0019900;GO:0051219;GO:0001102;GO:0000977;GO:0003714;GO:0008134;GO:0031625;GO:0031145;GO:0003180;GO:0007050;GO:0030154;GO:0051301;GO:0048667;GO:0071466;GO:0006338;GO:0048565;GO:0043353;GO:0000082;GO:0034349;GO:0097284;GO:0034088;GO:0007076;GO:0045445;GO:2001234;GO:0045786;GO:0030308;GO:0120163;GO:0043433;GO:0050680;GO:2000134;GO:0010629;GO:0050728;GO:1904761;GO:0006469;GO:0071901;GO:0045879;GO:1902948;GO:0000122;GO:0071930;GO:0045892;GO:0051402;GO:0042551;GO:0031175;GO:1904028;GO:1903055;GO:0045651;GO:0045842;GO:0045944;GO:2000679;GO:0071459;GO:0007265;GO:0090230;GO:0071922;GO:0043550;GO:0007346;GO:0006355;GO:0031134;GO:0035914;GO:0051146;GO:0001894;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:Rb-E2F complex; C:spindle; C:SWI/SNF complex; C:transcription regulator complex;, F:disordered domain specific binding; F:identical protein binding; F:importin-alpha family protein binding; F:kinase binding; F:phosphoprotein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:aortic valve morphogenesis; P:cell cycle arrest; P:cell differentiation; P:cell division; P:cell morphogenesis involved in neuron differentiation; P:cellular response to xenobiotic stimulus; P:chromatin remodeling; P:digestive tract development; P:enucleate erythrocyte differentiation; P:G1/S transition of mitotic cell cycle; P:glial cell apoptotic process; P:hepatocyte apoptotic process; P:maintenance of mitotic sister chromatid cohesion; P:mitotic chromosome condensation; P:myoblast differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cold-induced thermogenesis; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of myofibroblast differentiation; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of tau-protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:neuron apoptotic process; P:neuron maturation; P:neuron projection development; P:positive regulation of collagen fibril organization; P:positive regulation of extracellular matrix organization; P:positive regulation of macrophage differentiation; P:positive regulation of mitotic metaphase/anaphase transition; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein localization to chromosome, centromeric region; P:Ras protein signal transduction; P:regulation of centromere complex assembly; P:regulation of cohesin loading; P:regulation of lipid kinase activity; P:regulation of mitotic cell cycle; P:regulation of transcription, DNA-templated; P:sister chromatid biorientation; P:skeletal muscle cell differentiation; P:striated muscle cell differentiation; P:tissue homeostasis; P:viral process;|P06400 A8K5E3 P78499 Q5VW46 Q8IZL4,Retinoblastoma-associated protein,p105-Rb;p110-RB1 {ECO:0000303|PubMed:8336704};pRb;pp110;, PF11934;PF01858;PF01857;PF08934;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0035189;GO:0005819;GO:0016514;GO:0005667;GO:0097718;GO:0042802;GO:0061676;GO:0019900;GO:0051219;GO:0001102;GO:0000977;GO:0003714;GO:0008134;GO:0031625;GO:0031145;GO:0003180;GO:0007050;GO:0030154;GO:0051301;GO:0048667;GO:0071466;GO:0006338;GO:0048565;GO:0043353;GO:0000082;GO:0034349;GO:0097284;GO:0034088;GO:0007076;GO:0045445;GO:2001234;GO:0045786;GO:0030308;GO:0120163;GO:0043433;GO:0050680;GO:2000134;GO:0010629;GO:0050728;GO:1904761;GO:0006469;GO:0071901;GO:0045879;GO:1902948;GO:0000122;GO:0071930;GO:0045892;GO:0051402;GO:0042551;GO:0031175;GO:1904028;GO:1903055;GO:0045651;GO:0045842;GO:0045944;GO:2000679;GO:0071459;GO:0007265;GO:0090230;GO:0071922;GO:0043550;GO:0007346;GO:0006355;GO:0031134;GO:0035914;GO:0051146;GO:0001894;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body; C:Rb-E2F complex; C:spindle; C:SWI/SNF complex; C:transcription regulator complex;, F:disordered domain specific binding; F:identical protein binding; F:importin-alpha family protein binding; F:kinase binding; F:phosphoprotein binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:aortic valve morphogenesis; P:cell cycle arrest; P:cell differentiation; P:cell division; P:cell morphogenesis involved in neuron differentiation; P:cellular response to xenobiotic stimulus; P:chromatin remodeling; P:digestive tract development; P:enucleate erythrocyte differentiation; P:G1/S transition of mitotic cell cycle; P:glial cell apoptotic process; P:hepatocyte apoptotic process; P:maintenance of mitotic sister chromatid cohesion; P:mitotic chromosome condensation; P:myoblast differentiation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cold-induced thermogenesis; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of myofibroblast differentiation; P:negative regulation of protein kinase activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of tau-protein kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:neuron apoptotic process; P:neuron maturation; P:neuron projection development; P:positive regulation of collagen fibril organization; P:positive regulation of extracellular matrix organization; P:positive regulation of macrophage differentiation; P:positive regulation of mitotic metaphase/anaphase transition; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:protein localization to chromosome, centromeric region; P:Ras protein signal transduction; P:regulation of centromere complex assembly; P:regulation of cohesin loading; P:regulation of lipid kinase activity; P:regulation of mitotic cell cycle; P:regulation of transcription, DNA-templated; P:sister chromatid biorientation; P:skeletal muscle cell differentiation; P:striated muscle cell differentiation; P:tissue homeostasis; P:viral process; scaffold48 indexed_genome mRNA 305153 331130 . - . ID=transcript_9161;Q9Y287 Q5W0A3 Q96B24 Q9NYH1,Integral membrane protein 2B,Immature BRI2;Protein E25B;Transmembrane protein BRI;, PF04089;, GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0030660;GO:0031301;GO:0043231;GO:0016020;GO:0005886;GO:0001540;GO:0005524;GO:1990000;GO:0042985;GO:0007399;, C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of organelle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, F:amyloid-beta binding; F:ATP binding;, P:amyloid fibril formation; P:negative regulation of amyloid precursor protein biosynthetic process; P:nervous system development;|Q9Y287 Q5W0A3 Q96B24 Q9NYH1,Integral membrane protein 2B,Immature BRI2;Protein E25B;Transmembrane protein BRI;, PF04089;, GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0030660;GO:0031301;GO:0043231;GO:0016020;GO:0005886;GO:0001540;GO:0005524;GO:1990000;GO:0042985;GO:0007399;, C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of organelle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, F:amyloid-beta binding; F:ATP binding;, P:amyloid fibril formation; P:negative regulation of amyloid precursor protein biosynthetic process; P:nervous system development;|Q9Y287 Q5W0A3 Q96B24 Q9NYH1,Integral membrane protein 2B,Immature BRI2;Protein E25B;Transmembrane protein BRI;, PF04089;, GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0000139;GO:0030660;GO:0031301;GO:0043231;GO:0016020;GO:0005886;GO:0001540;GO:0005524;GO:1990000;GO:0042985;GO:0007399;, C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of organelle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, F:amyloid-beta binding; F:ATP binding;, P:amyloid fibril formation; P:negative regulation of amyloid precursor protein biosynthetic process; P:nervous system development; scaffold48 indexed_genome mRNA 447515 449803 . + . ID=transcript_9162;Q9NPJ6 B4DX67 Q53GB4 Q53H68 Q5T912 Q6FHC4 Q6IA79 Q9BS95 Q9NYR5,Mediator of RNA polymerase II transcription subunit 4,Activator-recruited cofactor 36 kDa component;Mediator complex subunit 4;TRAP/SMCC/PC2 subunit p36 subunit;Vitamin D3 receptor-interacting protein complex 36 kDa component;, PF10018;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II; scaffold48 indexed_genome mRNA 449828 457016 . - . ID=transcript_9163;Q9NPJ6 B4DX67 Q53GB4 Q53H68 Q5T912 Q6FHC4 Q6IA79 Q9BS95 Q9NYR5,Mediator of RNA polymerase II transcription subunit 4,Activator-recruited cofactor 36 kDa component;Mediator complex subunit 4;TRAP/SMCC/PC2 subunit p36 subunit;Vitamin D3 receptor-interacting protein complex 36 kDa component;, PF10018;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II;|Q9NPJ6 B4DX67 Q53GB4 Q53H68 Q5T912 Q6FHC4 Q6IA79 Q9BS95 Q9NYR5,Mediator of RNA polymerase II transcription subunit 4,Activator-recruited cofactor 36 kDa component;Mediator complex subunit 4;TRAP/SMCC/PC2 subunit p36 subunit;Vitamin D3 receptor-interacting protein complex 36 kDa component;, PF10018;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II;|Q9NPJ6 B4DX67 Q53GB4 Q53H68 Q5T912 Q6FHC4 Q6IA79 Q9BS95 Q9NYR5,Mediator of RNA polymerase II transcription subunit 4,Activator-recruited cofactor 36 kDa component;Mediator complex subunit 4;TRAP/SMCC/PC2 subunit p36 subunit;Vitamin D3 receptor-interacting protein complex 36 kDa component;, PF10018;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II;|Q9NPJ6 B4DX67 Q53GB4 Q53H68 Q5T912 Q6FHC4 Q6IA79 Q9BS95 Q9NYR5,Mediator of RNA polymerase II transcription subunit 4,Activator-recruited cofactor 36 kDa component;Mediator complex subunit 4;TRAP/SMCC/PC2 subunit p36 subunit;Vitamin D3 receptor-interacting protein complex 36 kDa component;, PF10018;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006366;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription by RNA polymerase II; scaffold48 indexed_genome mRNA 461633 463868 . - . ID=transcript_9164;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold48 indexed_genome mRNA 463882 469715 . - . ID=transcript_9165;Q9NV35 A2RUR6 Q32Q27 Q6P2C9,Nucleotide triphosphate diphosphatase NUDT15 {ECO:0000305},MutT homolog 2 {ECO:0000303|PubMed:19419956};Nucleoside diphosphate-linked moiety X motif 15 {ECO:0000305};Nucleoside diphosphate-linked to another moiety X hydrolase 15 {ECO:0000303|PubMed:8810257};, PF00293;, GO:0005829;GO:0035539;GO:0008413;GO:0036218;GO:0046872;GO:0035529;GO:0017110;GO:0047429;GO:0006203;GO:0042262;GO:0042738;GO:0000278;GO:0034656;GO:1901292;GO:0006195;GO:0061136;GO:0000302;, C:cytosol;, F:8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity; F:8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity; F:dTTP diphosphatase activity; F:metal ion binding; F:NADH pyrophosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphate diphosphatase activity;, P:dGTP catabolic process; P:DNA protection; P:exogenous drug catabolic process; P:mitotic cell cycle; P:nucleobase-containing small molecule catabolic process; P:nucleoside phosphate catabolic process; P:purine nucleotide catabolic process; P:regulation of proteasomal protein catabolic process; P:response to reactive oxygen species; scaffold48 indexed_genome mRNA 535147 544936 . + . ID=transcript_9166;Q9P2R7 B2RDE7 O95194 Q5T9Q4 Q5T9Q6 Q9NV21 Q9NVP7,Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03220},ATP-specific succinyl-CoA synthetase subunit beta {ECO:0000255|HAMAP-Rule:MF_03220};Succinyl-CoA synthetase beta-A chain {ECO:0000255|HAMAP-Rule:MF_03220};, PF08442;PF00549;, GO:0070062;GO:0005759;GO:0005739;GO:0042709;GO:0005524;GO:0000287;GO:0004775;GO:0004776;GO:0006104;GO:0006781;GO:0006099;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:succinate-CoA ligase complex;, F:ATP binding; F:magnesium ion binding; F:succinate-CoA ligase (ADP-forming) activity; F:succinate-CoA ligase (GDP-forming) activity;, P:succinyl-CoA metabolic process; P:succinyl-CoA pathway; P:tricarboxylic acid cycle;|Q9P2R7 B2RDE7 O95194 Q5T9Q4 Q5T9Q6 Q9NV21 Q9NVP7,Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03220},ATP-specific succinyl-CoA synthetase subunit beta {ECO:0000255|HAMAP-Rule:MF_03220};Succinyl-CoA synthetase beta-A chain {ECO:0000255|HAMAP-Rule:MF_03220};, PF08442;PF00549;, GO:0070062;GO:0005759;GO:0005739;GO:0042709;GO:0005524;GO:0000287;GO:0004775;GO:0004776;GO:0006104;GO:0006781;GO:0006099;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:succinate-CoA ligase complex;, F:ATP binding; F:magnesium ion binding; F:succinate-CoA ligase (ADP-forming) activity; F:succinate-CoA ligase (GDP-forming) activity;, P:succinyl-CoA metabolic process; P:succinyl-CoA pathway; P:tricarboxylic acid cycle;|Q9P2R7 B2RDE7 O95194 Q5T9Q4 Q5T9Q6 Q9NV21 Q9NVP7,Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03220},ATP-specific succinyl-CoA synthetase subunit beta {ECO:0000255|HAMAP-Rule:MF_03220};Succinyl-CoA synthetase beta-A chain {ECO:0000255|HAMAP-Rule:MF_03220};, PF08442;PF00549;, GO:0070062;GO:0005759;GO:0005739;GO:0042709;GO:0005524;GO:0000287;GO:0004775;GO:0004776;GO:0006104;GO:0006781;GO:0006099;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:succinate-CoA ligase complex;, F:ATP binding; F:magnesium ion binding; F:succinate-CoA ligase (ADP-forming) activity; F:succinate-CoA ligase (GDP-forming) activity;, P:succinyl-CoA metabolic process; P:succinyl-CoA pathway; P:tricarboxylic acid cycle; scaffold48 indexed_genome mRNA 1529344 1529946 . - . ID=transcript_9167;P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0,5-hydroxytryptamine receptor 2A,Serotonin receptor 2A;, PF00001;, GO:0030424;GO:0005901;GO:0070852;GO:0031410;GO:0005829;GO:0030425;GO:0043198;GO:0098666;GO:0098978;GO:0005887;GO:0099055;GO:0099056;GO:0043025;GO:0005886;GO:0071886;GO:0004993;GO:0001965;GO:0001587;GO:0042802;GO:0030594;GO:0044877;GO:0051378;GO:0001618;GO:0007202;GO:0007568;GO:0014824;GO:0048148;GO:0008219;GO:0006874;GO:0007268;GO:0050966;GO:0050965;GO:0007186;GO:0007187;GO:0098664;GO:0007613;GO:0043267;GO:0051967;GO:0014065;GO:0007200;GO:0007208;GO:0008284;GO:0070374;GO:0045600;GO:0045821;GO:0043406;GO:0050731;GO:0010513;GO:0045907;GO:0044380;GO:0014059;GO:2000300;GO:0051209;GO:0042493;GO:0007210;GO:0030431;GO:0001659;GO:0014832;, C:axon; C:caveola; C:cell body fiber; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:dendritic shaft; C:G protein-coupled serotonin receptor complex; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:neuronal cell body; C:plasma membrane;, F:1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding; F:G protein-coupled serotonin receptor activity; F:G-protein alpha-subunit binding; F:Gq/11-coupled serotonin receptor activity; F:identical protein binding; F:neurotransmitter receptor activity; F:protein-containing complex binding; F:serotonin binding; F:virus receptor activity;, P:activation of phospholipase C activity; P:aging; P:artery smooth muscle contraction; P:behavioral response to cocaine; P:cell death; P:cellular calcium ion homeostasis; P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception of pain; P:detection of temperature stimulus involved in sensory perception of pain; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:G protein-coupled serotonin receptor signaling pathway; P:memory; P:negative regulation of potassium ion transport; P:negative regulation of synaptic transmission, glutamatergic; P:phosphatidylinositol 3-kinase signaling; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:phospholipase C-activating serotonin receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fat cell differentiation; P:positive regulation of glycolytic process; P:positive regulation of MAP kinase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol biosynthetic process; P:positive regulation of vasoconstriction; P:protein localization to cytoskeleton; P:regulation of dopamine secretion; P:regulation of synaptic vesicle exocytosis; P:release of sequestered calcium ion into cytosol; P:response to drug; P:serotonin receptor signaling pathway; P:sleep; P:temperature homeostasis; P:urinary bladder smooth muscle contraction; scaffold48 indexed_genome mRNA 1560032 1580463 . + . ID=transcript_9168;P10768 Q5TBU8 Q5TBV0 Q5TBV2 Q9BVJ2,S-formylglutathione hydrolase,Esterase D;Methylumbelliferyl-acetate deacetylase;, PF00756;, GO:0031410;GO:0005829;GO:0005788;GO:0070062;GO:0052689;GO:0016788;GO:0042802;GO:0047374;GO:0018738;GO:0046294;GO:1901687;, C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome;, F:carboxylic ester hydrolase activity; F:hydrolase activity, acting on ester bonds; F:identical protein binding; F:methylumbelliferyl-acetate deacetylase activity; F:S-formylglutathione hydrolase activity;, P:formaldehyde catabolic process; P:glutathione derivative biosynthetic process;|P10768 Q5TBU8 Q5TBV0 Q5TBV2 Q9BVJ2,S-formylglutathione hydrolase,Esterase D;Methylumbelliferyl-acetate deacetylase;, PF00756;, GO:0031410;GO:0005829;GO:0005788;GO:0070062;GO:0052689;GO:0016788;GO:0042802;GO:0047374;GO:0018738;GO:0046294;GO:1901687;, C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome;, F:carboxylic ester hydrolase activity; F:hydrolase activity, acting on ester bonds; F:identical protein binding; F:methylumbelliferyl-acetate deacetylase activity; F:S-formylglutathione hydrolase activity;, P:formaldehyde catabolic process; P:glutathione derivative biosynthetic process;|P10768 Q5TBU8 Q5TBV0 Q5TBV2 Q9BVJ2,S-formylglutathione hydrolase,Esterase D;Methylumbelliferyl-acetate deacetylase;, PF00756;, GO:0031410;GO:0005829;GO:0005788;GO:0070062;GO:0052689;GO:0016788;GO:0042802;GO:0047374;GO:0018738;GO:0046294;GO:1901687;, C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome;, F:carboxylic ester hydrolase activity; F:hydrolase activity, acting on ester bonds; F:identical protein binding; F:methylumbelliferyl-acetate deacetylase activity; F:S-formylglutathione hydrolase activity;, P:formaldehyde catabolic process; P:glutathione derivative biosynthetic process; scaffold48 indexed_genome mRNA 1596491 1650151 . - . ID=transcript_9169;Q9Y2L9 B7ZLL5 F8W6F0 Q17R43 Q2KHR1 Q5TBU9 Q7Z5F6 Q7Z5F7,Leucine-rich repeat and calponin homology domain-containing protein 1,Calponin homology domain-containing protein 1;Neuronal protein 81;, PF00307;PF13855;, GO:0005737;GO:1990869;GO:0034260;GO:2000405;, C:cytoplasm;, , P:cellular response to chemokine; P:negative regulation of GTPase activity; P:negative regulation of T cell migration;|Q5VUJ6 F5H2T1 Q08AD5 Q9HA88 Q9P233,Leucine-rich repeat and calponin homology domain-containing protein 2,, PF00307;PF13855;|Q9Y2L9 B7ZLL5 F8W6F0 Q17R43 Q2KHR1 Q5TBU9 Q7Z5F6 Q7Z5F7,Leucine-rich repeat and calponin homology domain-containing protein 1,Calponin homology domain-containing protein 1;Neuronal protein 81;, PF00307;PF13855;, GO:0005737;GO:1990869;GO:0034260;GO:2000405;, C:cytoplasm;, , P:cellular response to chemokine; P:negative regulation of GTPase activity; P:negative regulation of T cell migration;|Q9Y2L9 B7ZLL5 F8W6F0 Q17R43 Q2KHR1 Q5TBU9 Q7Z5F6 Q7Z5F7,Leucine-rich repeat and calponin homology domain-containing protein 1,Calponin homology domain-containing protein 1;Neuronal protein 81;, PF00307;PF13855;, GO:0005737;GO:1990869;GO:0034260;GO:2000405;, C:cytoplasm;, , P:cellular response to chemokine; P:negative regulation of GTPase activity; P:negative regulation of T cell migration;|Q9Y2L9 B7ZLL5 F8W6F0 Q17R43 Q2KHR1 Q5TBU9 Q7Z5F6 Q7Z5F7,Leucine-rich repeat and calponin homology domain-containing protein 1,Calponin homology domain-containing protein 1;Neuronal protein 81;, PF00307;PF13855;, GO:0005737;GO:1990869;GO:0034260;GO:2000405;, C:cytoplasm;, , P:cellular response to chemokine; P:negative regulation of GTPase activity; P:negative regulation of T cell migration;|Q9Y2L9 B7ZLL5 F8W6F0 Q17R43 Q2KHR1 Q5TBU9 Q7Z5F6 Q7Z5F7,Leucine-rich repeat and calponin homology domain-containing protein 1,Calponin homology domain-containing protein 1;Neuronal protein 81;, PF00307;PF13855;, GO:0005737;GO:1990869;GO:0034260;GO:2000405;, C:cytoplasm;, , P:cellular response to chemokine; P:negative regulation of GTPase activity; P:negative regulation of T cell migration;|Q9Y2L9 B7ZLL5 F8W6F0 Q17R43 Q2KHR1 Q5TBU9 Q7Z5F6 Q7Z5F7,Leucine-rich repeat and calponin homology domain-containing protein 1,Calponin homology domain-containing protein 1;Neuronal protein 81;, PF00307;PF13855;, GO:0005737;GO:1990869;GO:0034260;GO:2000405;, C:cytoplasm;, , P:cellular response to chemokine; P:negative regulation of GTPase activity; P:negative regulation of T cell migration; scaffold48 indexed_genome mRNA 1913972 1919264 . + . ID=transcript_9170;Q8N5J6,Protein associated with UVRAG as autophagy enhancer {ECO:0000303|PubMed:28306502},Protein Rubicon-like {ECO:0000305};, PF13901;, GO:0000421;GO:0031410;GO:0043231;GO:1901981;GO:0032266;GO:0070273;GO:0010314;GO:0097352;GO:0061910;GO:0061909;GO:0006629;GO:0070873;GO:0019216;, C:autophagosome membrane; C:cytoplasmic vesicle; C:intracellular membrane-bounded organelle;, F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:autophagosome maturation; P:autophagosome-endosome fusion; P:autophagosome-lysosome fusion; P:lipid metabolic process; P:regulation of glycogen metabolic process; P:regulation of lipid metabolic process; scaffold48 indexed_genome mRNA 2061799 2108359 . + . ID=transcript_9171;P13796 B2R613 B4DUA0 Q5TBN4,Plastin-2,L-plastin;LC64P;Lymphocyte cytosolic protein 1;, PF00307;PF13499;, GO:0015629;GO:0005884;GO:0032432;GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0001891;GO:0005886;GO:0002102;GO:0001726;GO:0032587;GO:0003779;GO:0051015;GO:0005509;GO:0051020;GO:0042802;GO:0005178;GO:0051764;GO:0051017;GO:0051639;GO:0031100;GO:0016477;GO:0030866;GO:0022617;GO:0035722;GO:0071803;GO:0010737;GO:0033157;GO:0002286;, C:actin cytoskeleton; C:actin filament; C:actin filament bundle; C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:phagocytic cup; C:plasma membrane; C:podosome; C:ruffle; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:GTPase binding; F:identical protein binding; F:integrin binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:actin filament network formation; P:animal organ regeneration; P:cell migration; P:cortical actin cytoskeleton organization; P:extracellular matrix disassembly; P:interleukin-12-mediated signaling pathway; P:positive regulation of podosome assembly; P:protein kinase A signaling; P:regulation of intracellular protein transport; P:T cell activation involved in immune response;|P13796 B2R613 B4DUA0 Q5TBN4,Plastin-2,L-plastin;LC64P;Lymphocyte cytosolic protein 1;, PF00307;PF13499;, GO:0015629;GO:0005884;GO:0032432;GO:0030054;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0001891;GO:0005886;GO:0002102;GO:0001726;GO:0032587;GO:0003779;GO:0051015;GO:0005509;GO:0051020;GO:0042802;GO:0005178;GO:0051764;GO:0051017;GO:0051639;GO:0031100;GO:0016477;GO:0030866;GO:0022617;GO:0035722;GO:0071803;GO:0010737;GO:0033157;GO:0002286;, C:actin cytoskeleton; C:actin filament; C:actin filament bundle; C:cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:phagocytic cup; C:plasma membrane; C:podosome; C:ruffle; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:GTPase binding; F:identical protein binding; F:integrin binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:actin filament network formation; P:animal organ regeneration; P:cell migration; P:cortical actin cytoskeleton organization; P:extracellular matrix disassembly; P:interleukin-12-mediated signaling pathway; P:positive regulation of podosome assembly; P:protein kinase A signaling; P:regulation of intracellular protein transport; P:T cell activation involved in immune response; scaffold48 indexed_genome mRNA 2134934 2172910 . + . ID=transcript_9172;Q96IY4 A8K464 Q15114 Q5T9K1 Q5T9K2 Q9P2Y6,Carboxypeptidase B2,Carboxypeptidase U;Plasma carboxypeptidase B;Thrombin-activable fibrinolysis inhibitor;, PF00246;PF02244;, GO:0070062;GO:0005576;GO:0005615;GO:0004181;GO:0008270;GO:0007596;GO:0071333;GO:0042730;GO:0097421;GO:0051918;GO:2000346;GO:0010757;GO:0003331;GO:0006508;GO:0030449;GO:0042493;GO:0009408;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:blood coagulation; P:cellular response to glucose stimulus; P:fibrinolysis; P:liver regeneration; P:negative regulation of fibrinolysis; P:negative regulation of hepatocyte proliferation; P:negative regulation of plasminogen activation; P:positive regulation of extracellular matrix constituent secretion; P:proteolysis; P:regulation of complement activation; P:response to drug; P:response to heat; scaffold48 indexed_genome mRNA 2173749 2269458 . + . ID=transcript_9173;Q5T200 A2A323 O94936 Q5T1Z9 Q7Z7J3 Q8NDT6 Q9H0L6,Zinc finger CCCH domain-containing protein 13 {ECO:0000305},, PF00642;, GO:0016607;GO:0005654;GO:0036396;GO:0046872;GO:0003723;GO:0080009;GO:0006397;GO:0007275;GO:2000036;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:metal ion binding; F:RNA binding;, P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:regulation of stem cell population maintenance; P:RNA splicing;|Q5T200 A2A323 O94936 Q5T1Z9 Q7Z7J3 Q8NDT6 Q9H0L6,Zinc finger CCCH domain-containing protein 13 {ECO:0000305},, PF00642;, GO:0016607;GO:0005654;GO:0036396;GO:0046872;GO:0003723;GO:0080009;GO:0006397;GO:0007275;GO:2000036;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:metal ion binding; F:RNA binding;, P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:regulation of stem cell population maintenance; P:RNA splicing;|Q5T200 A2A323 O94936 Q5T1Z9 Q7Z7J3 Q8NDT6 Q9H0L6,Zinc finger CCCH domain-containing protein 13 {ECO:0000305},, PF00642;, GO:0016607;GO:0005654;GO:0036396;GO:0046872;GO:0003723;GO:0080009;GO:0006397;GO:0007275;GO:2000036;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:metal ion binding; F:RNA binding;, P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:regulation of stem cell population maintenance; P:RNA splicing;|Q5T200 A2A323 O94936 Q5T1Z9 Q7Z7J3 Q8NDT6 Q9H0L6,Zinc finger CCCH domain-containing protein 13 {ECO:0000305},, PF00642;, GO:0016607;GO:0005654;GO:0036396;GO:0046872;GO:0003723;GO:0080009;GO:0006397;GO:0007275;GO:2000036;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:metal ion binding; F:RNA binding;, P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:regulation of stem cell population maintenance; P:RNA splicing;|Q5T200 A2A323 O94936 Q5T1Z9 Q7Z7J3 Q8NDT6 Q9H0L6,Zinc finger CCCH domain-containing protein 13 {ECO:0000305},, PF00642;, GO:0016607;GO:0005654;GO:0036396;GO:0046872;GO:0003723;GO:0080009;GO:0006397;GO:0007275;GO:2000036;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:RNA N6-methyladenosine methyltransferase complex;, F:metal ion binding; F:RNA binding;, P:mRNA methylation; P:mRNA processing; P:multicellular organism development; P:regulation of stem cell population maintenance; P:RNA splicing; scaffold48 indexed_genome mRNA 2272042 2342205 . - . ID=transcript_9174;O75582 B7Z2Y5 O95316 Q96AF7,Ribosomal protein S6 kinase alpha-5,90 kDa ribosomal protein S6 kinase 5;Nuclear mitogen- and stress-activated protein kinase 1;RSK-like protein kinase;, PF00069;PF00433;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007173;GO:0043990;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0045892;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;GO:0002223;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:epidermal growth factor receptor signaling pathway; P:histone H2A-S1 phosphorylation; P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated; P:stimulatory C-type lectin receptor signaling pathway; scaffold48 indexed_genome mRNA 2662798 2671316 . - . ID=transcript_9175;Q96JB2 B2RAW5 Q5VT70 Q8IXX4 Q9BZ92,Conserved oligomeric Golgi complex subunit 3,Component of oligomeric Golgi complex 3;Vesicle-docking protein SEC34 homolog;p94;, PF04136;, GO:0005801;GO:0005829;GO:0005794;GO:0032580;GO:0000139;GO:0017119;GO:0005886;GO:0032588;GO:0006888;GO:0007030;GO:0006891;GO:0006886;GO:0006486;GO:0033365;GO:0050821;GO:0006890;, C:cis-Golgi network; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi transport complex; C:plasma membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein glycosylation; P:protein localization to organelle; P:protein stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q96JB2 B2RAW5 Q5VT70 Q8IXX4 Q9BZ92,Conserved oligomeric Golgi complex subunit 3,Component of oligomeric Golgi complex 3;Vesicle-docking protein SEC34 homolog;p94;, PF04136;, GO:0005801;GO:0005829;GO:0005794;GO:0032580;GO:0000139;GO:0017119;GO:0005886;GO:0032588;GO:0006888;GO:0007030;GO:0006891;GO:0006886;GO:0006486;GO:0033365;GO:0050821;GO:0006890;, C:cis-Golgi network; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi transport complex; C:plasma membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein glycosylation; P:protein localization to organelle; P:protein stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold48 indexed_genome mRNA 2671324 2722575 . - . ID=transcript_9176;Q96JB2 B2RAW5 Q5VT70 Q8IXX4 Q9BZ92,Conserved oligomeric Golgi complex subunit 3,Component of oligomeric Golgi complex 3;Vesicle-docking protein SEC34 homolog;p94;, PF04136;, GO:0005801;GO:0005829;GO:0005794;GO:0032580;GO:0000139;GO:0017119;GO:0005886;GO:0032588;GO:0006888;GO:0007030;GO:0006891;GO:0006886;GO:0006486;GO:0033365;GO:0050821;GO:0006890;, C:cis-Golgi network; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi transport complex; C:plasma membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein glycosylation; P:protein localization to organelle; P:protein stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q96JB2 B2RAW5 Q5VT70 Q8IXX4 Q9BZ92,Conserved oligomeric Golgi complex subunit 3,Component of oligomeric Golgi complex 3;Vesicle-docking protein SEC34 homolog;p94;, PF04136;, GO:0005801;GO:0005829;GO:0005794;GO:0032580;GO:0000139;GO:0017119;GO:0005886;GO:0032588;GO:0006888;GO:0007030;GO:0006891;GO:0006886;GO:0006486;GO:0033365;GO:0050821;GO:0006890;, C:cis-Golgi network; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi transport complex; C:plasma membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein glycosylation; P:protein localization to organelle; P:protein stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q96JB2 B2RAW5 Q5VT70 Q8IXX4 Q9BZ92,Conserved oligomeric Golgi complex subunit 3,Component of oligomeric Golgi complex 3;Vesicle-docking protein SEC34 homolog;p94;, PF04136;, GO:0005801;GO:0005829;GO:0005794;GO:0032580;GO:0000139;GO:0017119;GO:0005886;GO:0032588;GO:0006888;GO:0007030;GO:0006891;GO:0006886;GO:0006486;GO:0033365;GO:0050821;GO:0006890;, C:cis-Golgi network; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi transport complex; C:plasma membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein glycosylation; P:protein localization to organelle; P:protein stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q96JB2 B2RAW5 Q5VT70 Q8IXX4 Q9BZ92,Conserved oligomeric Golgi complex subunit 3,Component of oligomeric Golgi complex 3;Vesicle-docking protein SEC34 homolog;p94;, PF04136;, GO:0005801;GO:0005829;GO:0005794;GO:0032580;GO:0000139;GO:0017119;GO:0005886;GO:0032588;GO:0006888;GO:0007030;GO:0006891;GO:0006886;GO:0006486;GO:0033365;GO:0050821;GO:0006890;, C:cis-Golgi network; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi transport complex; C:plasma membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein glycosylation; P:protein localization to organelle; P:protein stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q96JB2 B2RAW5 Q5VT70 Q8IXX4 Q9BZ92,Conserved oligomeric Golgi complex subunit 3,Component of oligomeric Golgi complex 3;Vesicle-docking protein SEC34 homolog;p94;, PF04136;, GO:0005801;GO:0005829;GO:0005794;GO:0032580;GO:0000139;GO:0017119;GO:0005886;GO:0032588;GO:0006888;GO:0007030;GO:0006891;GO:0006886;GO:0006486;GO:0033365;GO:0050821;GO:0006890;, C:cis-Golgi network; C:cytosol; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi transport complex; C:plasma membrane; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein glycosylation; P:protein localization to organelle; P:protein stabilization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold48 indexed_genome mRNA 2744150 2761443 . - . ID=transcript_9177;Q5SVS4 B2RN96 B4DZK3 F5H8H8,Kidney mitochondrial carrier protein 1,Solute carrier family 25 member 30;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015297;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:0071422;GO:0008272;GO:0015709;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:thiosulfate transport;|O95258 D3DTG2 Q0VDH7 Q9HC60 Q9HC61,Brain mitochondrial carrier protein 1,Mitochondrial uncoupling protein 5;Solute carrier family 25 member 14;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0015297;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0009060;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:1902600;GO:0071422;GO:0008272;GO:0015709;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:aerobic respiration; P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:proton transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:thiosulfate transport;|Q5SVS4 B2RN96 B4DZK3 F5H8H8,Kidney mitochondrial carrier protein 1,Solute carrier family 25 member 30;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015297;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:0071422;GO:0008272;GO:0015709;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:thiosulfate transport; scaffold48 indexed_genome mRNA 2848334 2851423 . + . ID=transcript_9178;P13693 B2R7E5 Q6YLS2 Q7Z4J4 Q8TBK7 Q96EE2 Q9UC70,Translationally-controlled tumor protein,Fortilin;Histamine-releasing factor;p23;, PF00838;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0005615;GO:0005771;GO:0005634;GO:0000922;GO:0005509;GO:0003723;GO:0006816;GO:0006874;GO:0043066;GO:1902230;GO:0042981;GO:0009615;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extracellular space; C:multivesicular body; C:nucleus; C:spindle pole;, F:calcium ion binding; F:RNA binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:regulation of apoptotic process; P:response to virus;|P13693 B2R7E5 Q6YLS2 Q7Z4J4 Q8TBK7 Q96EE2 Q9UC70,Translationally-controlled tumor protein,Fortilin;Histamine-releasing factor;p23;, PF00838;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0005615;GO:0005771;GO:0005634;GO:0000922;GO:0005509;GO:0003723;GO:0006816;GO:0006874;GO:0043066;GO:1902230;GO:0042981;GO:0009615;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extracellular space; C:multivesicular body; C:nucleus; C:spindle pole;, F:calcium ion binding; F:RNA binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:regulation of apoptotic process; P:response to virus; scaffold48 indexed_genome mRNA 2903823 3041163 . - . ID=transcript_9179;P13984 A6NNS5 Q5W0H3,General transcription factor IIF subunit 2,ATP-dependent helicase GTF2F2;General transcription factor IIF 30 kDa subunit;Transcription initiation factor IIF subunit beta;Transcription initiation factor RAP30;, PF02270;PF17683;, GO:0015630;GO:0005654;GO:0005634;GO:0005674;GO:0097550;GO:0005524;GO:0003677;GO:0003678;GO:0016251;GO:0006370;GO:0008543;GO:0000398;GO:0050434;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;, C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:transcription factor TFIIF complex; C:transcription preinitiation complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:RNA polymerase II general transcription initiation factor activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:positive regulation of viral transcription; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter;|Q8WVF5 Q5W0P9,BTB/POZ domain-containing protein KCTD4,, PF02214;, GO:0051260;, , , P:protein homooligomerization; scaffold48 indexed_genome mRNA 3123212 3155825 . - . ID=transcript_9180;Q8IXQ4 A8K8X8 Q05BX8 Q05D87 Q5T3Z3 Q5T3Z5 Q9C0F9 Q9H2R0 Q9P0W6,GPALPP motifs-containing protein 1,Lipopolysaccharide-specific response protein 7;, PF12572; scaffold48 indexed_genome mRNA 3156177 3186106 . + . ID=transcript_9181;Q9UHK0 Q8WVM5 Q96SG1,Nuclear fragile X mental retardation-interacting protein 1,Nuclear FMRP-interacting protein 1;, PF10453;PF12171;, GO:0001650;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0070761;GO:0048786;GO:0032991;GO:0008023;GO:0051117;GO:0042802;GO:0046872;GO:0030674;GO:0003723;GO:0000492;GO:0045944;GO:0006396;, C:fibrillar center; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:pre-snoRNP complex; C:presynaptic active zone; C:protein-containing complex; C:transcription elongation factor complex;, F:ATPase binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:RNA binding;, P:box C/D snoRNP assembly; P:positive regulation of transcription by RNA polymerase II; P:RNA processing;|Q9UHK0 Q8WVM5 Q96SG1,Nuclear fragile X mental retardation-interacting protein 1,Nuclear FMRP-interacting protein 1;, PF10453;PF12171;, GO:0001650;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0005726;GO:0070761;GO:0048786;GO:0032991;GO:0008023;GO:0051117;GO:0042802;GO:0046872;GO:0030674;GO:0003723;GO:0000492;GO:0045944;GO:0006396;, C:fibrillar center; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:perichromatin fibrils; C:pre-snoRNP complex; C:presynaptic active zone; C:protein-containing complex; C:transcription elongation factor complex;, F:ATPase binding; F:identical protein binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:RNA binding;, P:box C/D snoRNP assembly; P:positive regulation of transcription by RNA polymerase II; P:RNA processing; scaffold48 indexed_genome mRNA 3504261 3627989 . + . ID=transcript_9182;Q15714 B3KRL7 B9EGI0 O00666 Q6AHX5 Q6IBU1 Q8NCN1 Q96JS5,TSC22 domain family protein 1,Cerebral protein 2;Regulatory protein TSC-22;TGFB-stimulated clone 22 homolog;Transforming growth factor beta-1-induced transcript 4 protein;, PF01166;, GO:0005737;GO:0005634;GO:0006357;GO:0006366;, C:cytoplasm; C:nucleus;, , P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q99576 Q5H9S3 Q5JRI9 Q6FIH6 Q8NAI1 Q8WVB9 Q9UBN5 Q9UG13,TSC22 domain family protein 3,DSIP-immunoreactive peptide;Delta sleep-inducing peptide immunoreactor;Glucocorticoid-induced leucine zipper protein;TSC-22-like protein;TSC-22-related protein;, PF01166;, GO:0005829;GO:0005634;GO:0034220;GO:0070236;GO:0006357;GO:0006970;, C:cytosol; C:nucleus;, , P:ion transmembrane transport; P:negative regulation of activation-induced cell death of T cells; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress;|Q99576 Q5H9S3 Q5JRI9 Q6FIH6 Q8NAI1 Q8WVB9 Q9UBN5 Q9UG13,TSC22 domain family protein 3,DSIP-immunoreactive peptide;Delta sleep-inducing peptide immunoreactor;Glucocorticoid-induced leucine zipper protein;TSC-22-like protein;TSC-22-related protein;, PF01166;, GO:0005829;GO:0005634;GO:0034220;GO:0070236;GO:0006357;GO:0006970;, C:cytosol; C:nucleus;, , P:ion transmembrane transport; P:negative regulation of activation-induced cell death of T cells; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress;|Q99576 Q5H9S3 Q5JRI9 Q6FIH6 Q8NAI1 Q8WVB9 Q9UBN5 Q9UG13,TSC22 domain family protein 3,DSIP-immunoreactive peptide;Delta sleep-inducing peptide immunoreactor;Glucocorticoid-induced leucine zipper protein;TSC-22-like protein;TSC-22-related protein;, PF01166;, GO:0005829;GO:0005634;GO:0034220;GO:0070236;GO:0006357;GO:0006970;, C:cytosol; C:nucleus;, , P:ion transmembrane transport; P:negative regulation of activation-induced cell death of T cells; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress;|Q99576 Q5H9S3 Q5JRI9 Q6FIH6 Q8NAI1 Q8WVB9 Q9UBN5 Q9UG13,TSC22 domain family protein 3,DSIP-immunoreactive peptide;Delta sleep-inducing peptide immunoreactor;Glucocorticoid-induced leucine zipper protein;TSC-22-like protein;TSC-22-related protein;, PF01166;, GO:0005829;GO:0005634;GO:0034220;GO:0070236;GO:0006357;GO:0006970;, C:cytosol; C:nucleus;, , P:ion transmembrane transport; P:negative regulation of activation-induced cell death of T cells; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress;|Q99576 Q5H9S3 Q5JRI9 Q6FIH6 Q8NAI1 Q8WVB9 Q9UBN5 Q9UG13,TSC22 domain family protein 3,DSIP-immunoreactive peptide;Delta sleep-inducing peptide immunoreactor;Glucocorticoid-induced leucine zipper protein;TSC-22-like protein;TSC-22-related protein;, PF01166;, GO:0005829;GO:0005634;GO:0034220;GO:0070236;GO:0006357;GO:0006970;, C:cytosol; C:nucleus;, , P:ion transmembrane transport; P:negative regulation of activation-induced cell death of T cells; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress;|Q15714 B3KRL7 B9EGI0 O00666 Q6AHX5 Q6IBU1 Q8NCN1 Q96JS5,TSC22 domain family protein 1,Cerebral protein 2;Regulatory protein TSC-22;TGFB-stimulated clone 22 homolog;Transforming growth factor beta-1-induced transcript 4 protein;, PF01166;, GO:0005737;GO:0005634;GO:0006357;GO:0006366;, C:cytoplasm; C:nucleus;, , P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold48 indexed_genome mRNA 3664903 3677457 . - . ID=transcript_9183;Q8N6R1,Stress-associated endoplasmic reticulum protein 2,Ribosome-associated membrane protein RAMP4-2;, PF06624;, GO:0005789;GO:0016021;GO:0030968;GO:0006486;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:endoplasmic reticulum unfolded protein response; P:protein glycosylation; P:protein transport; scaffold48 indexed_genome mRNA 4193984 4207093 . - . ID=transcript_9184;Q8IV20 A2A3Z6 Q8N8X5,Purine nucleoside phosphorylase LACC1 {ECO:0000305},Adenosine deaminase LACC1 {ECO:0000305};Fatty acid metabolism-immunity nexus {ECO:0000303|PubMed:27478939, ECO:0000303|PubMed:31978345};Guanosine phosphorylase LACC1 {ECO:0000305};Laccase domain-containing protein 1 {ECO:0000305};S-methyl-5'-thioadenosine phosphorylase LACC1 {ECO:0000305};, PF02578;, GO:0005783;GO:0005634;GO:0005777;GO:0004000;GO:0005507;GO:0047975;GO:0004731;GO:0017061;GO:0006954;GO:0045087;GO:0070431;GO:0002221;GO:0002720;GO:0030641;GO:0050727;GO:1900542;, C:endoplasmic reticulum; C:nucleus; C:peroxisome;, F:adenosine deaminase activity; F:copper ion binding; F:guanosine phosphorylase activity; F:purine-nucleoside phosphorylase activity; F:S-methyl-5-thioadenosine phosphorylase activity;, P:inflammatory response; P:innate immune response; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:pattern recognition receptor signaling pathway; P:positive regulation of cytokine production involved in immune response; P:regulation of cellular pH; P:regulation of inflammatory response; P:regulation of purine nucleotide metabolic process;|Q8IV20 A2A3Z6 Q8N8X5,Purine nucleoside phosphorylase LACC1 {ECO:0000305},Adenosine deaminase LACC1 {ECO:0000305};Fatty acid metabolism-immunity nexus {ECO:0000303|PubMed:27478939, ECO:0000303|PubMed:31978345};Guanosine phosphorylase LACC1 {ECO:0000305};Laccase domain-containing protein 1 {ECO:0000305};S-methyl-5'-thioadenosine phosphorylase LACC1 {ECO:0000305};, PF02578;, GO:0005783;GO:0005634;GO:0005777;GO:0004000;GO:0005507;GO:0047975;GO:0004731;GO:0017061;GO:0006954;GO:0045087;GO:0070431;GO:0002221;GO:0002720;GO:0030641;GO:0050727;GO:1900542;, C:endoplasmic reticulum; C:nucleus; C:peroxisome;, F:adenosine deaminase activity; F:copper ion binding; F:guanosine phosphorylase activity; F:purine-nucleoside phosphorylase activity; F:S-methyl-5-thioadenosine phosphorylase activity;, P:inflammatory response; P:innate immune response; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:pattern recognition receptor signaling pathway; P:positive regulation of cytokine production involved in immune response; P:regulation of cellular pH; P:regulation of inflammatory response; P:regulation of purine nucleotide metabolic process;|Q8IV20 A2A3Z6 Q8N8X5,Purine nucleoside phosphorylase LACC1 {ECO:0000305},Adenosine deaminase LACC1 {ECO:0000305};Fatty acid metabolism-immunity nexus {ECO:0000303|PubMed:27478939, ECO:0000303|PubMed:31978345};Guanosine phosphorylase LACC1 {ECO:0000305};Laccase domain-containing protein 1 {ECO:0000305};S-methyl-5'-thioadenosine phosphorylase LACC1 {ECO:0000305};, PF02578;, GO:0005783;GO:0005634;GO:0005777;GO:0004000;GO:0005507;GO:0047975;GO:0004731;GO:0017061;GO:0006954;GO:0045087;GO:0070431;GO:0002221;GO:0002720;GO:0030641;GO:0050727;GO:1900542;, C:endoplasmic reticulum; C:nucleus; C:peroxisome;, F:adenosine deaminase activity; F:copper ion binding; F:guanosine phosphorylase activity; F:purine-nucleoside phosphorylase activity; F:S-methyl-5-thioadenosine phosphorylase activity;, P:inflammatory response; P:innate immune response; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:pattern recognition receptor signaling pathway; P:positive regulation of cytokine production involved in immune response; P:regulation of cellular pH; P:regulation of inflammatory response; P:regulation of purine nucleotide metabolic process;|Q8IV20 A2A3Z6 Q8N8X5,Purine nucleoside phosphorylase LACC1 {ECO:0000305},Adenosine deaminase LACC1 {ECO:0000305};Fatty acid metabolism-immunity nexus {ECO:0000303|PubMed:27478939, ECO:0000303|PubMed:31978345};Guanosine phosphorylase LACC1 {ECO:0000305};Laccase domain-containing protein 1 {ECO:0000305};S-methyl-5'-thioadenosine phosphorylase LACC1 {ECO:0000305};, PF02578;, GO:0005783;GO:0005634;GO:0005777;GO:0004000;GO:0005507;GO:0047975;GO:0004731;GO:0017061;GO:0006954;GO:0045087;GO:0070431;GO:0002221;GO:0002720;GO:0030641;GO:0050727;GO:1900542;, C:endoplasmic reticulum; C:nucleus; C:peroxisome;, F:adenosine deaminase activity; F:copper ion binding; F:guanosine phosphorylase activity; F:purine-nucleoside phosphorylase activity; F:S-methyl-5-thioadenosine phosphorylase activity;, P:inflammatory response; P:innate immune response; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:pattern recognition receptor signaling pathway; P:positive regulation of cytokine production involved in immune response; P:regulation of cellular pH; P:regulation of inflammatory response; P:regulation of purine nucleotide metabolic process; scaffold48 indexed_genome mRNA 4220375 4244216 . + . ID=transcript_9185;Q5T0U0 B2RP70 B7ZMI9 Q96MV0,Coiled-coil domain-containing protein 122 scaffold48 indexed_genome mRNA 4705481 4940757 . + . ID=transcript_9186;Q8TC92 A4GU15 A6NMH9 B7Z5K1 Q2TU81 Q5VT11 Q9NWE0,Ecto-NOX disulfide-thiol exchanger 1,Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase;Cell proliferation-inducing gene 38 protein;Constitutive Ecto-NOX;, PF00076;, GO:0009897;GO:0005615;GO:0005886;GO:0003676;GO:0016491;GO:0007624;, C:external side of plasma membrane; C:extracellular space; C:plasma membrane;, F:nucleic acid binding; F:oxidoreductase activity;, P:ultradian rhythm; scaffold48 indexed_genome mRNA 5039706 5159081 . - . ID=transcript_9187;Q9Y5T4 B2R4L0 Q5T219 Q6X963,DnaJ homolog subfamily C member 15,Cell growth-inhibiting gene 22 protein;Methylation-controlled J protein;, , GO:0016021;GO:0001405;GO:0001671;GO:0009267;GO:1902957;GO:0031333;GO:0030150;GO:0019216;, C:integral component of membrane; C:PAM complex, Tim23 associated import motor;, F:ATPase activator activity;, P:cellular response to starvation; P:negative regulation of mitochondrial electron transport, NADH to ubiquinone; P:negative regulation of protein-containing complex assembly; P:protein import into mitochondrial matrix; P:regulation of lipid metabolic process; scaffold48 indexed_genome mRNA 5189906 5287625 . + . ID=transcript_9188;Q96J88 Q8IVC7 Q8NDQ7,Epithelial-stromal interaction protein 1 scaffold48 indexed_genome mRNA 5367704 5377574 . - . ID=transcript_9189;Q8N7L0 B1ALI3,Protein FAM216B,, PF15107; scaffold48 indexed_genome mRNA 5809019 5821244 . - . ID=transcript_9190;Q9UKA4 O75124 Q9NUK7,A-kinase anchor protein 11,A-kinase anchor protein 220 kDa;Protein kinase A-anchoring protein 11;, , GO:0005737;GO:0005829;GO:0005815;GO:0005730;GO:0005777;GO:0005886;GO:0019207;GO:0051018;GO:0034237;GO:0008157;GO:0030866;GO:0035556;GO:0008104;GO:0036010;GO:0003091;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleolus; C:peroxisome; C:plasma membrane;, F:kinase regulator activity; F:protein kinase A binding; F:protein kinase A regulatory subunit binding; F:protein phosphatase 1 binding;, P:cortical actin cytoskeleton organization; P:intracellular signal transduction; P:protein localization; P:protein localization to endosome; P:renal water homeostasis;|Q9UKA4 O75124 Q9NUK7,A-kinase anchor protein 11,A-kinase anchor protein 220 kDa;Protein kinase A-anchoring protein 11;, , GO:0005737;GO:0005829;GO:0005815;GO:0005730;GO:0005777;GO:0005886;GO:0019207;GO:0051018;GO:0034237;GO:0008157;GO:0030866;GO:0035556;GO:0008104;GO:0036010;GO:0003091;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleolus; C:peroxisome; C:plasma membrane;, F:kinase regulator activity; F:protein kinase A binding; F:protein kinase A regulatory subunit binding; F:protein phosphatase 1 binding;, P:cortical actin cytoskeleton organization; P:intracellular signal transduction; P:protein localization; P:protein localization to endosome; P:renal water homeostasis; scaffold48 indexed_genome mRNA 5821245 5824056 . - . ID=transcript_9191;Q9UKA4 O75124 Q9NUK7,A-kinase anchor protein 11,A-kinase anchor protein 220 kDa;Protein kinase A-anchoring protein 11;, , GO:0005737;GO:0005829;GO:0005815;GO:0005730;GO:0005777;GO:0005886;GO:0019207;GO:0051018;GO:0034237;GO:0008157;GO:0030866;GO:0035556;GO:0008104;GO:0036010;GO:0003091;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleolus; C:peroxisome; C:plasma membrane;, F:kinase regulator activity; F:protein kinase A binding; F:protein kinase A regulatory subunit binding; F:protein phosphatase 1 binding;, P:cortical actin cytoskeleton organization; P:intracellular signal transduction; P:protein localization; P:protein localization to endosome; P:renal water homeostasis;|Q9UKA4 O75124 Q9NUK7,A-kinase anchor protein 11,A-kinase anchor protein 220 kDa;Protein kinase A-anchoring protein 11;, , GO:0005737;GO:0005829;GO:0005815;GO:0005730;GO:0005777;GO:0005886;GO:0019207;GO:0051018;GO:0034237;GO:0008157;GO:0030866;GO:0035556;GO:0008104;GO:0036010;GO:0003091;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleolus; C:peroxisome; C:plasma membrane;, F:kinase regulator activity; F:protein kinase A binding; F:protein kinase A regulatory subunit binding; F:protein phosphatase 1 binding;, P:cortical actin cytoskeleton organization; P:intracellular signal transduction; P:protein localization; P:protein localization to endosome; P:renal water homeostasis; scaffold48 indexed_genome mRNA 5824105 5846834 . - . ID=transcript_9192;Q9UKA4 O75124 Q9NUK7,A-kinase anchor protein 11,A-kinase anchor protein 220 kDa;Protein kinase A-anchoring protein 11;, , GO:0005737;GO:0005829;GO:0005815;GO:0005730;GO:0005777;GO:0005886;GO:0019207;GO:0051018;GO:0034237;GO:0008157;GO:0030866;GO:0035556;GO:0008104;GO:0036010;GO:0003091;, C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleolus; C:peroxisome; C:plasma membrane;, F:kinase regulator activity; F:protein kinase A binding; F:protein kinase A regulatory subunit binding; F:protein phosphatase 1 binding;, P:cortical actin cytoskeleton organization; P:intracellular signal transduction; P:protein localization; P:protein localization to endosome; P:renal water homeostasis; scaffold48 indexed_genome mRNA 5903195 5966610 . - . ID=transcript_9193;Q86XP1 A2A2W7 A6NFX7 B4DZ34 Q5VZW0 Q6PI56 Q86XP2 Q8N3N0 Q8N7J9,Diacylglycerol kinase eta {ECO:0000305},Diglyceride kinase eta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0015629;GO:0005737;GO:0005768;GO:0043231;GO:0005886;GO:0032991;GO:0005524;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0032093;GO:0046339;GO:0035556;GO:0046834;GO:0043086;GO:0006654;GO:0046473;GO:0030168;GO:0007205;, C:actin cytoskeleton; C:cytoplasm; C:endosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:protein-containing complex;, F:ATP binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:SAM domain binding;, P:diacylglycerol metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:negative regulation of catalytic activity; P:phosphatidic acid biosynthetic process; P:phosphatidic acid metabolic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; scaffold48 indexed_genome mRNA 6243954 6392109 . + . ID=transcript_9194;A3KMH1 O60310 Q5JTP6 Q5VW08 Q7Z6I9 Q86YC9 Q8N3E4,von Willebrand factor A domain-containing protein 8,PEX7-binding protein 2 {ECO:0000303|PubMed:30204880};, PF07728;, GO:0005737;GO:0005739;GO:0005777;GO:0005524;GO:0016887;, C:cytoplasm; C:mitochondrion; C:peroxisome;, F:ATP binding; F:ATPase activity;|A3KMH1 O60310 Q5JTP6 Q5VW08 Q7Z6I9 Q86YC9 Q8N3E4,von Willebrand factor A domain-containing protein 8,PEX7-binding protein 2 {ECO:0000303|PubMed:30204880};, PF07728;, GO:0005737;GO:0005739;GO:0005777;GO:0005524;GO:0016887;, C:cytoplasm; C:mitochondrion; C:peroxisome;, F:ATP binding; F:ATPase activity;|A3KMH1 O60310 Q5JTP6 Q5VW08 Q7Z6I9 Q86YC9 Q8N3E4,von Willebrand factor A domain-containing protein 8,PEX7-binding protein 2 {ECO:0000303|PubMed:30204880};, PF07728;, GO:0005737;GO:0005739;GO:0005777;GO:0005524;GO:0016887;, C:cytoplasm; C:mitochondrion; C:peroxisome;, F:ATP binding; F:ATPase activity;|A3KMH1 O60310 Q5JTP6 Q5VW08 Q7Z6I9 Q86YC9 Q8N3E4,von Willebrand factor A domain-containing protein 8,PEX7-binding protein 2 {ECO:0000303|PubMed:30204880};, PF07728;, GO:0005737;GO:0005739;GO:0005777;GO:0005524;GO:0016887;, C:cytoplasm; C:mitochondrion; C:peroxisome;, F:ATP binding; F:ATPase activity; scaffold48 indexed_genome mRNA 6407456 6568216 . + . ID=transcript_9195;A3KMH1 O60310 Q5JTP6 Q5VW08 Q7Z6I9 Q86YC9 Q8N3E4,von Willebrand factor A domain-containing protein 8,PEX7-binding protein 2 {ECO:0000303|PubMed:30204880};, PF07728;, GO:0005737;GO:0005739;GO:0005777;GO:0005524;GO:0016887;, C:cytoplasm; C:mitochondrion; C:peroxisome;, F:ATP binding; F:ATPase activity;|A3KMH1 O60310 Q5JTP6 Q5VW08 Q7Z6I9 Q86YC9 Q8N3E4,von Willebrand factor A domain-containing protein 8,PEX7-binding protein 2 {ECO:0000303|PubMed:30204880};, PF07728;, GO:0005737;GO:0005739;GO:0005777;GO:0005524;GO:0016887;, C:cytoplasm; C:mitochondrion; C:peroxisome;, F:ATP binding; F:ATPase activity; scaffold48 indexed_genome mRNA 6631115 6644254 . - . ID=transcript_9196;Q9H4X1 Q6NZ48 Q9UL69,Regulator of cell cycle RGCC,Response gene to complement 32 protein;, PF15151;, GO:0005813;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0030295;GO:0019901;GO:0070412;GO:0071456;GO:0006956;GO:0006977;GO:0072537;GO:0071850;GO:0016525;GO:0043537;GO:0008285;GO:2000048;GO:0001818;GO:0001937;GO:0001100;GO:0090272;GO:1901991;GO:0071158;GO:0032967;GO:0045737;GO:0001819;GO:2000573;GO:0051091;GO:2000353;GO:0010718;GO:1901203;GO:0003331;GO:1900087;GO:0010628;GO:0045840;GO:0051496;GO:0045944;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein kinase activator activity; F:protein kinase binding; F:R-SMAD binding;, P:cellular response to hypoxia; P:complement activation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:fibroblast activation; P:mitotic cell cycle arrest; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cytokine production; P:negative regulation of endothelial cell proliferation; P:negative regulation of exit from mitosis; P:negative regulation of fibroblast growth factor production; P:negative regulation of mitotic cell cycle phase transition; P:positive regulation of cell cycle arrest; P:positive regulation of collagen biosynthetic process; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytokine production; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of extracellular matrix assembly; P:positive regulation of extracellular matrix constituent secretion; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of mitotic nuclear division; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; scaffold48 indexed_genome mRNA 6644476 6645072 . + . ID=transcript_9197;Q9H4X1 Q6NZ48 Q9UL69,Regulator of cell cycle RGCC,Response gene to complement 32 protein;, PF15151;, GO:0005813;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0030295;GO:0019901;GO:0070412;GO:0071456;GO:0006956;GO:0006977;GO:0072537;GO:0071850;GO:0016525;GO:0043537;GO:0008285;GO:2000048;GO:0001818;GO:0001937;GO:0001100;GO:0090272;GO:1901991;GO:0071158;GO:0032967;GO:0045737;GO:0001819;GO:2000573;GO:0051091;GO:2000353;GO:0010718;GO:1901203;GO:0003331;GO:1900087;GO:0010628;GO:0045840;GO:0051496;GO:0045944;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:protein kinase activator activity; F:protein kinase binding; F:R-SMAD binding;, P:cellular response to hypoxia; P:complement activation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:fibroblast activation; P:mitotic cell cycle arrest; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cytokine production; P:negative regulation of endothelial cell proliferation; P:negative regulation of exit from mitosis; P:negative regulation of fibroblast growth factor production; P:negative regulation of mitotic cell cycle phase transition; P:positive regulation of cell cycle arrest; P:positive regulation of collagen biosynthetic process; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytokine production; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of extracellular matrix assembly; P:positive regulation of extracellular matrix constituent secretion; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of mitotic nuclear division; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; scaffold48 indexed_genome mRNA 6695773 6765319 . - . ID=transcript_9198;Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization;|Q6N069 B0QZ59 Q5VSP9 Q6P2D5 Q8N5J3 Q8N870,N-alpha-acetyltransferase 16, NatA auxiliary subunit,NMDA receptor-regulated 1-like protein;, PF12569;PF07719;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0005667;GO:0043022;GO:0017196;GO:0006474;GO:0043066;GO:0045893;GO:0050821;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus; C:transcription regulator complex;, F:ribosome binding;, P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:protein stabilization; scaffold48 indexed_genome mRNA 6781307 6819044 . + . ID=transcript_9199;O75570 B4DG01 Q5T6Y5 Q8IUQ6,Peptide chain release factor 1, mitochondrial,, PF03462;PF00472;, GO:0005739;GO:0003747;GO:0070126;GO:0006449;, C:mitochondrion;, F:translation release factor activity;, P:mitochondrial translational termination; P:regulation of translational termination; scaffold48 indexed_genome mRNA 6825517 6830046 . + . ID=transcript_9200;Q8WVZ9 B5TZ86 Q5T6Y7 Q8NB99 Q9H0I6,Kelch repeat and BTB domain-containing protein 7,, PF07707;PF00651;PF01344;, GO:0005829;GO:0000165;GO:0043687;, C:cytosol;, , P:MAPK cascade; P:post-translational protein modification;|Q8WVZ9 B5TZ86 Q5T6Y7 Q8NB99 Q9H0I6,Kelch repeat and BTB domain-containing protein 7,, PF07707;PF00651;PF01344;, GO:0005829;GO:0000165;GO:0043687;, C:cytosol;, , P:MAPK cascade; P:post-translational protein modification; scaffold48 indexed_genome mRNA 6893054 6893589 . + . ID=transcript_9201;Q86V97 Q5T6Y8 Q8N8L0 Q8NDM5 Q96MP6,Kelch repeat and BTB domain-containing protein 6,, PF07707;PF00651;PF01344;, GO:0005829;GO:0043687;, C:cytosol;, , P:post-translational protein modification; scaffold48 indexed_genome mRNA 6893775 6897772 . - . ID=transcript_9202;Q86V97 Q5T6Y8 Q8N8L0 Q8NDM5 Q96MP6,Kelch repeat and BTB domain-containing protein 6,, PF07707;PF00651;PF01344;, GO:0005829;GO:0043687;, C:cytosol;, , P:post-translational protein modification;|Q86V97 Q5T6Y8 Q8N8L0 Q8NDM5 Q96MP6,Kelch repeat and BTB domain-containing protein 6,, PF07707;PF00651;PF01344;, GO:0005829;GO:0043687;, C:cytosol;, , P:post-translational protein modification; scaffold48 indexed_genome mRNA 6924552 6947478 . - . ID=transcript_9203;O75554 B7Z4M2 Q32P29,WW domain-binding protein 4,Formin-binding protein 21 {ECO:0000303|PubMed:19592703};WW domain-containing-binding protein 4;, PF00397;PF06220;, GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0071005;GO:0070064;GO:0003723;GO:0008270;GO:0045292;GO:0000398;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome;, F:proline-rich region binding; F:RNA binding; F:zinc ion binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:RNA splicing;|O75554 B7Z4M2 Q32P29,WW domain-binding protein 4,Formin-binding protein 21 {ECO:0000303|PubMed:19592703};WW domain-containing-binding protein 4;, PF00397;PF06220;, GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0071005;GO:0070064;GO:0003723;GO:0008270;GO:0045292;GO:0000398;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome;, F:proline-rich region binding; F:RNA binding; F:zinc ion binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:RNA splicing;|O75554 B7Z4M2 Q32P29,WW domain-binding protein 4,Formin-binding protein 21 {ECO:0000303|PubMed:19592703};WW domain-containing-binding protein 4;, PF00397;PF06220;, GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0071005;GO:0070064;GO:0003723;GO:0008270;GO:0045292;GO:0000398;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome;, F:proline-rich region binding; F:RNA binding; F:zinc ion binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:RNA splicing;|O75554 B7Z4M2 Q32P29,WW domain-binding protein 4,Formin-binding protein 21 {ECO:0000303|PubMed:19592703};WW domain-containing-binding protein 4;, PF00397;PF06220;, GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0071005;GO:0070064;GO:0003723;GO:0008270;GO:0045292;GO:0000398;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome;, F:proline-rich region binding; F:RNA binding; F:zinc ion binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:RNA splicing; scaffold48 indexed_genome mRNA 7043895 7072025 . + . ID=transcript_9204;P32519 B4E2I5 E9PDQ9 Q8N6F6 Q9UDE1,ETS-related transcription factor Elf-1,E74-like factor 1;, PF12310;PF00178;, GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0045944;GO:0045893;GO:0050855;GO:0001959;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of cytokine-mediated signaling pathway; P:regulation of transcription by RNA polymerase II;|P32519 B4E2I5 E9PDQ9 Q8N6F6 Q9UDE1,ETS-related transcription factor Elf-1,E74-like factor 1;, PF12310;PF00178;, GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0045944;GO:0045893;GO:0050855;GO:0001959;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of cytokine-mediated signaling pathway; P:regulation of transcription by RNA polymerase II;|P32519 B4E2I5 E9PDQ9 Q8N6F6 Q9UDE1,ETS-related transcription factor Elf-1,E74-like factor 1;, PF12310;PF00178;, GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0045944;GO:0045893;GO:0050855;GO:0001959;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of B cell receptor signaling pathway; P:regulation of cytokine-mediated signaling pathway; P:regulation of transcription by RNA polymerase II; scaffold48 indexed_genome mRNA 7081890 7126735 . + . ID=transcript_9205;Q9Y2Z0 A2A303 Q5JAK5 Q5TAM6 Q6VXY6,Protein SGT1 homolog {ECO:0000250|UniProtKB:Q08446},Protein 40-6-3 {ECO:0000312|EMBL:CAC51433.1};Sgt1 {ECO:0000303|PubMed:10445024};Suppressor of G2 allele of SKP1 homolog {ECO:0000250|UniProtKB:Q08446};, PF04969;PF05002;, GO:0005829;GO:0000776;GO:0005634;GO:0032991;GO:0000151;GO:0000278;GO:0043947;GO:0050821;GO:0035590;GO:0031647;, C:cytosol; C:kinetochore; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, , P:mitotic cell cycle; P:positive regulation by host of symbiont catalytic activity; P:protein stabilization; P:purinergic nucleotide receptor signaling pathway; P:regulation of protein stability;|Q9Y2Z0 A2A303 Q5JAK5 Q5TAM6 Q6VXY6,Protein SGT1 homolog {ECO:0000250|UniProtKB:Q08446},Protein 40-6-3 {ECO:0000312|EMBL:CAC51433.1};Sgt1 {ECO:0000303|PubMed:10445024};Suppressor of G2 allele of SKP1 homolog {ECO:0000250|UniProtKB:Q08446};, PF04969;PF05002;, GO:0005829;GO:0000776;GO:0005634;GO:0032991;GO:0000151;GO:0000278;GO:0043947;GO:0050821;GO:0035590;GO:0031647;, C:cytosol; C:kinetochore; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, , P:mitotic cell cycle; P:positive regulation by host of symbiont catalytic activity; P:protein stabilization; P:purinergic nucleotide receptor signaling pathway; P:regulation of protein stability;|Q9Y2Z0 A2A303 Q5JAK5 Q5TAM6 Q6VXY6,Protein SGT1 homolog {ECO:0000250|UniProtKB:Q08446},Protein 40-6-3 {ECO:0000312|EMBL:CAC51433.1};Sgt1 {ECO:0000303|PubMed:10445024};Suppressor of G2 allele of SKP1 homolog {ECO:0000250|UniProtKB:Q08446};, PF04969;PF05002;, GO:0005829;GO:0000776;GO:0005634;GO:0032991;GO:0000151;GO:0000278;GO:0043947;GO:0050821;GO:0035590;GO:0031647;, C:cytosol; C:kinetochore; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, , P:mitotic cell cycle; P:positive regulation by host of symbiont catalytic activity; P:protein stabilization; P:purinergic nucleotide receptor signaling pathway; P:regulation of protein stability;|Q9Y2Z0 A2A303 Q5JAK5 Q5TAM6 Q6VXY6,Protein SGT1 homolog {ECO:0000250|UniProtKB:Q08446},Protein 40-6-3 {ECO:0000312|EMBL:CAC51433.1};Sgt1 {ECO:0000303|PubMed:10445024};Suppressor of G2 allele of SKP1 homolog {ECO:0000250|UniProtKB:Q08446};, PF04969;PF05002;, GO:0005829;GO:0000776;GO:0005634;GO:0032991;GO:0000151;GO:0000278;GO:0043947;GO:0050821;GO:0035590;GO:0031647;, C:cytosol; C:kinetochore; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, , P:mitotic cell cycle; P:positive regulation by host of symbiont catalytic activity; P:protein stabilization; P:purinergic nucleotide receptor signaling pathway; P:regulation of protein stability;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9Y2Z0 A2A303 Q5JAK5 Q5TAM6 Q6VXY6,Protein SGT1 homolog {ECO:0000250|UniProtKB:Q08446},Protein 40-6-3 {ECO:0000312|EMBL:CAC51433.1};Sgt1 {ECO:0000303|PubMed:10445024};Suppressor of G2 allele of SKP1 homolog {ECO:0000250|UniProtKB:Q08446};, PF04969;PF05002;, GO:0005829;GO:0000776;GO:0005634;GO:0032991;GO:0000151;GO:0000278;GO:0043947;GO:0050821;GO:0035590;GO:0031647;, C:cytosol; C:kinetochore; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, , P:mitotic cell cycle; P:positive regulation by host of symbiont catalytic activity; P:protein stabilization; P:purinergic nucleotide receptor signaling pathway; P:regulation of protein stability;|Q9Y2Z0 A2A303 Q5JAK5 Q5TAM6 Q6VXY6,Protein SGT1 homolog {ECO:0000250|UniProtKB:Q08446},Protein 40-6-3 {ECO:0000312|EMBL:CAC51433.1};Sgt1 {ECO:0000303|PubMed:10445024};Suppressor of G2 allele of SKP1 homolog {ECO:0000250|UniProtKB:Q08446};, PF04969;PF05002;, GO:0005829;GO:0000776;GO:0005634;GO:0032991;GO:0000151;GO:0000278;GO:0043947;GO:0050821;GO:0035590;GO:0031647;, C:cytosol; C:kinetochore; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, , P:mitotic cell cycle; P:positive regulation by host of symbiont catalytic activity; P:protein stabilization; P:purinergic nucleotide receptor signaling pathway; P:regulation of protein stability; scaffold48 indexed_genome mRNA 7128946 7138652 . - . ID=transcript_9206;Q8NHQ9 Q658L6 Q8IYH0 Q9HCH7,ATP-dependent RNA helicase DDX55,DEAD box protein 55;, PF00270;PF13959;PF00271;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity; scaffold48 indexed_genome mRNA 7140209 7154472 . - . ID=transcript_9207;O75829 Q5TAM4 Q8TAY6 Q9UM18,Leukocyte cell-derived chemotaxin 1 {ECO:0000305},Chondromodulin {ECO:0000312|HGNC:HGNC:17005};, PF04089;, GO:0012505;GO:0005576;GO:0016021;GO:0051216;GO:0001886;GO:0016525;GO:0001937;GO:0030948;GO:0006029;GO:0001501;, C:endomembrane system; C:extracellular region; C:integral component of membrane;, , P:cartilage development; P:endothelial cell morphogenesis; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell proliferation; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:proteoglycan metabolic process; P:skeletal system development; scaffold48 indexed_genome mRNA 7292856 7293643 . + . ID=transcript_9208;O95206 B4DMV7 Q5TAN1 Q5TAN2 Q8IYE9 Q96SF1,Protocadherin-8,Arcadlin;, PF00028;PF08266;, GO:0030425;GO:0098978;GO:0005887;GO:0099055;GO:0005886;GO:0042734;GO:0005509;GO:0007155;GO:0007267;GO:0007268;GO:0007156;GO:0016331;GO:0099179;GO:0001756;, C:dendrite; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:presynaptic membrane;, F:calcium ion binding;, P:cell adhesion; P:cell-cell signaling; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:morphogenesis of embryonic epithelium; P:regulation of synaptic membrane adhesion; P:somitogenesis; scaffold48 indexed_genome mRNA 12467520 12579004 . - . ID=transcript_9209;O14917 A8K1R5 Q5VVW9 Q5VVX0,Protocadherin-17,Protocadherin-68;, PF00028;PF08266;, GO:0098982;GO:0098978;GO:0005887;GO:0099055;GO:0099056;GO:0005509;GO:0030534;GO:0007155;GO:0007156;GO:0050805;GO:1904071;GO:2000807;GO:0099560;, C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane;, F:calcium ion binding;, P:adult behavior; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of synaptic transmission; P:presynaptic active zone assembly; P:regulation of synaptic vesicle clustering; P:synaptic membrane adhesion;|O14917 A8K1R5 Q5VVW9 Q5VVX0,Protocadherin-17,Protocadherin-68;, PF00028;PF08266;, GO:0098982;GO:0098978;GO:0005887;GO:0099055;GO:0099056;GO:0005509;GO:0030534;GO:0007155;GO:0007156;GO:0050805;GO:1904071;GO:2000807;GO:0099560;, C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane;, F:calcium ion binding;, P:adult behavior; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of synaptic transmission; P:presynaptic active zone assembly; P:regulation of synaptic vesicle clustering; P:synaptic membrane adhesion;|O14917 A8K1R5 Q5VVW9 Q5VVX0,Protocadherin-17,Protocadherin-68;, PF00028;PF08266;, GO:0098982;GO:0098978;GO:0005887;GO:0099055;GO:0099056;GO:0005509;GO:0030534;GO:0007155;GO:0007156;GO:0050805;GO:1904071;GO:2000807;GO:0099560;, C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane;, F:calcium ion binding;, P:adult behavior; P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of synaptic transmission; P:presynaptic active zone assembly; P:regulation of synaptic vesicle clustering; P:synaptic membrane adhesion; scaffold48 indexed_genome mRNA 14708878 15046038 . - . ID=transcript_9210;Q5JTP8 Q5T2S7 Q5XKF6 Q6MZF0 Q6NUP0 Q86VS4 Q8NAV4,Protein diaphanous homolog 3,Diaphanous-related formin-3;MDia2;, PF06345;PF06367;PF06371;PF02181;, GO:0005737;GO:0005829;GO:0005634;GO:0003779;GO:0045296;GO:0031267;GO:0030036;GO:0030041;GO:0007010;, C:cytoplasm; C:cytosol; C:nucleus;, F:actin binding; F:cadherin binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cytoskeleton organization; scaffold48 indexed_genome mRNA 15583548 15784733 . + . ID=transcript_9211;Q9H7E2 B2MWP9 Q53XA6 Q6P992,Tudor domain-containing protein 3,, PF08585;PF00567;PF00627;, GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0035064;GO:0003723;GO:0003713;GO:0006325;, C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:methylated histone binding; F:RNA binding; F:transcription coactivator activity;, P:chromatin organization;|Q00610 D3DU00 Q6N0A0 Q86TF2,Clathrin heavy chain 1 {ECO:0000303|PubMed:26822784, ECO:0000303|PubMed:29100083},Clathrin heavy chain on chromosome 17;, PF00637;PF09268;PF01394;, GO:0030118;GO:0030132;GO:0030130;GO:0071439;GO:0045334;GO:0030669;GO:0030136;GO:0005829;GO:0036020;GO:0005768;GO:0070062;GO:1903561;GO:0005925;GO:0005764;GO:0042470;GO:0016020;GO:0072686;GO:1990498;GO:0005886;GO:0032991;GO:0005819;GO:0032588;GO:0032051;GO:0097718;GO:0003725;GO:0050750;GO:0019901;GO:0003723;GO:0005198;GO:1990381;GO:0150093;GO:0019886;GO:0006914;GO:0051301;GO:0048268;GO:0072583;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0000278;GO:1900126;GO:1903077;GO:0001649;GO:0006892;GO:0031623;GO:0006898;GO:0060236;GO:0042147;GO:0033572;GO:0060071;, C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated vesicle; C:cytosol; C:endolysosome membrane; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:focal adhesion; C:lysosome; C:melanosome; C:membrane; C:mitotic spindle; C:mitotic spindle microtubule; C:plasma membrane; C:protein-containing complex; C:spindle; C:trans-Golgi network membrane;, F:clathrin light chain binding; F:disordered domain specific binding; F:double-stranded RNA binding; F:low-density lipoprotein particle receptor binding; F:protein kinase binding; F:RNA binding; F:structural molecule activity; F:ubiquitin-specific protease binding;, P:amyloid-beta clearance by transcytosis; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:autophagy; P:cell division; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:mitotic cell cycle; P:negative regulation of hyaluronan biosynthetic process; P:negative regulation of protein localization to plasma membrane; P:osteoblast differentiation; P:post-Golgi vesicle-mediated transport; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of mitotic spindle organization; P:retrograde transport, endosome to Golgi; P:transferrin transport; P:Wnt signaling pathway, planar cell polarity pathway;|Q9H7E2 B2MWP9 Q53XA6 Q6P992,Tudor domain-containing protein 3,, PF08585;PF00567;PF00627;, GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0035064;GO:0003723;GO:0003713;GO:0006325;, C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:methylated histone binding; F:RNA binding; F:transcription coactivator activity;, P:chromatin organization;|Q9H7E2 B2MWP9 Q53XA6 Q6P992,Tudor domain-containing protein 3,, PF08585;PF00567;PF00627;, GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0035064;GO:0003723;GO:0003713;GO:0006325;, C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:methylated histone binding; F:RNA binding; F:transcription coactivator activity;, P:chromatin organization; scaffold49 indexed_genome mRNA 443849 446583 . + . ID=transcript_9212;P06702 D3DV36 Q6FGA1 Q9NYM0 Q9UCJ1,Protein S100-A9,Calgranulin-B;Calprotectin L1H subunit;Leukocyte L1 complex heavy chain;Migration inhibitory factor-related protein 14;S100 calcium-binding protein A9;, PF01023;, GO:0030054;GO:0062023;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005654;GO:0005634;GO:0005886;GO:0034774;GO:0016209;GO:0050544;GO:0005509;GO:0048306;GO:0008017;GO:0050786;GO:0035662;GO:0008270;GO:0006919;GO:0061844;GO:0019730;GO:0006915;GO:0014002;GO:0035425;GO:0006914;GO:0007267;GO:0002544;GO:0042742;GO:0050832;GO:0006954;GO:0045087;GO:0002523;GO:0035821;GO:0070488;GO:0030593;GO:0043312;GO:0018119;GO:0035606;GO:0030307;GO:0050729;GO:2001244;GO:0010976;GO:0051092;GO:0051493;GO:0045113;GO:0032496;GO:0032119;GO:0002224;, C:cell junction; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleoplasm; C:nucleus; C:plasma membrane; C:secretory granule lumen;, F:antioxidant activity; F:arachidonic acid binding; F:calcium ion binding; F:calcium-dependent protein binding; F:microtubule binding; F:RAGE receptor binding; F:Toll-like receptor 4 binding; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:antimicrobial humoral response; P:apoptotic process; P:astrocyte development; P:autocrine signaling; P:autophagy; P:cell-cell signaling; P:chronic inflammatory response; P:defense response to bacterium; P:defense response to fungus; P:inflammatory response; P:innate immune response; P:leukocyte migration involved in inflammatory response; P:modulation of process of other organism; P:neutrophil aggregation; P:neutrophil chemotaxis; P:neutrophil degranulation; P:peptidyl-cysteine S-nitrosylation; P:peptidyl-cysteine S-trans-nitrosylation; P:positive regulation of cell growth; P:positive regulation of inflammatory response; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of cytoskeleton organization; P:regulation of integrin biosynthetic process; P:response to lipopolysaccharide; P:sequestering of zinc ion; P:toll-like receptor signaling pathway; scaffold49 indexed_genome mRNA 457365 459030 . - . ID=transcript_9213;P80511 P83219 Q5SY66 Q7M4R1,Protein S100-A12,CGRP;Calcium-binding protein in amniotic fluid 1;Calgranulin-C;Extracellular newly identified RAGE-binding protein;Migration inhibitory factor-related protein 6;Neutrophil S100 protein;S100 calcium-binding protein A12;, PF01023;, GO:0005737;GO:0005856;GO:0005829;GO:0005576;GO:0005615;GO:0005634;GO:0005886;GO:0034774;GO:0005509;GO:0048306;GO:0005507;GO:0050786;GO:0008270;GO:0061844;GO:0042742;GO:0050832;GO:0006954;GO:0045087;GO:0031640;GO:0045576;GO:0002548;GO:0030593;GO:0043312;GO:0043123;GO:0050729;GO:0043406;GO:0051092;GO:0006805;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular region; C:extracellular space; C:nucleus; C:plasma membrane; C:secretory granule lumen;, F:calcium ion binding; F:calcium-dependent protein binding; F:copper ion binding; F:RAGE receptor binding; F:zinc ion binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:defense response to bacterium; P:defense response to fungus; P:inflammatory response; P:innate immune response; P:killing of cells of other organism; P:mast cell activation; P:monocyte chemotaxis; P:neutrophil chemotaxis; P:neutrophil degranulation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of MAP kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:xenobiotic metabolic process; scaffold49 indexed_genome mRNA 742551 743085 . - . ID=transcript_9214;P29034 O00266 Q3KRB9 Q5RHS8 Q9BU83,Protein S100-A2,CAN19;Protein S-100L;S100 calcium-binding protein A2;, PF01023;, GO:0005509;GO:0048306;GO:0042802;GO:0046914;GO:0043542;, , F:calcium ion binding; F:calcium-dependent protein binding; F:identical protein binding; F:transition metal ion binding;, P:endothelial cell migration; scaffold49 indexed_genome mRNA 777775 779793 . - . ID=transcript_9215;Q96FQ6 A8K439 D3DV52 Q5RHS6,Protein S100-A16,Aging-associated gene 13 protein;Protein S100-F;S100 calcium-binding protein A16;, PF01023;, GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0005730;GO:0005634;GO:0005886;GO:0005509;GO:0048306;GO:0042803;GO:0003723;GO:0051592;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:nucleolus; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent protein binding; F:protein homodimerization activity; F:RNA binding;, P:response to calcium ion; scaffold49 indexed_genome mRNA 785291 787376 . - . ID=transcript_9216;Q9HCY8 Q5RHT0,Protein S100-A14,S100 calcium-binding protein A14;, PF01023;, GO:0070062;GO:0005615;GO:0048471;GO:0005509;GO:0048306;GO:0042379;GO:0006915;GO:0055074;GO:0042742;GO:0071624;GO:0090026;GO:0032496;GO:0034142;, C:extracellular exosome; C:extracellular space; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:calcium-dependent protein binding; F:chemokine receptor binding;, P:apoptotic process; P:calcium ion homeostasis; P:defense response to bacterium; P:positive regulation of granulocyte chemotaxis; P:positive regulation of monocyte chemotaxis; P:response to lipopolysaccharide; P:toll-like receptor 4 signaling pathway;|Q9HCY8 Q5RHT0,Protein S100-A14,S100 calcium-binding protein A14;, PF01023;, GO:0070062;GO:0005615;GO:0048471;GO:0005509;GO:0048306;GO:0042379;GO:0006915;GO:0055074;GO:0042742;GO:0071624;GO:0090026;GO:0032496;GO:0034142;, C:extracellular exosome; C:extracellular space; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:calcium-dependent protein binding; F:chemokine receptor binding;, P:apoptotic process; P:calcium ion homeostasis; P:defense response to bacterium; P:positive regulation of granulocyte chemotaxis; P:positive regulation of monocyte chemotaxis; P:response to lipopolysaccharide; P:toll-like receptor 4 signaling pathway; scaffold49 indexed_genome mRNA 789745 797364 . - . ID=transcript_9217;Q99584 Q52PI9 Q6FGF8,Protein S100-A13,S100 calcium-binding protein A13;, PF01023;, GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0048306;GO:0005507;GO:0017134;GO:0008289;GO:0042803;GO:0050786;GO:0008270;GO:0043303;GO:0008284;GO:0001819;GO:0043123;GO:0032730;GO:0015031;GO:0008360;GO:0046688;GO:0051602;, C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent protein binding; F:copper ion binding; F:fibroblast growth factor binding; F:lipid binding; F:protein homodimerization activity; F:RAGE receptor binding; F:zinc ion binding;, P:mast cell degranulation; P:positive regulation of cell population proliferation; P:positive regulation of cytokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 alpha production; P:protein transport; P:regulation of cell shape; P:response to copper ion; P:response to electrical stimulus;|Q99584 Q52PI9 Q6FGF8,Protein S100-A13,S100 calcium-binding protein A13;, PF01023;, GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0048306;GO:0005507;GO:0017134;GO:0008289;GO:0042803;GO:0050786;GO:0008270;GO:0043303;GO:0008284;GO:0001819;GO:0043123;GO:0032730;GO:0015031;GO:0008360;GO:0046688;GO:0051602;, C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent protein binding; F:copper ion binding; F:fibroblast growth factor binding; F:lipid binding; F:protein homodimerization activity; F:RAGE receptor binding; F:zinc ion binding;, P:mast cell degranulation; P:positive regulation of cell population proliferation; P:positive regulation of cytokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 alpha production; P:protein transport; P:regulation of cell shape; P:response to copper ion; P:response to electrical stimulus;|Q99584 Q52PI9 Q6FGF8,Protein S100-A13,S100 calcium-binding protein A13;, PF01023;, GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0048306;GO:0005507;GO:0017134;GO:0008289;GO:0042803;GO:0050786;GO:0008270;GO:0043303;GO:0008284;GO:0001819;GO:0043123;GO:0032730;GO:0015031;GO:0008360;GO:0046688;GO:0051602;, C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent protein binding; F:copper ion binding; F:fibroblast growth factor binding; F:lipid binding; F:protein homodimerization activity; F:RAGE receptor binding; F:zinc ion binding;, P:mast cell degranulation; P:positive regulation of cell population proliferation; P:positive regulation of cytokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 alpha production; P:protein transport; P:regulation of cell shape; P:response to copper ion; P:response to electrical stimulus;|Q99584 Q52PI9 Q6FGF8,Protein S100-A13,S100 calcium-binding protein A13;, PF01023;, GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0048306;GO:0005507;GO:0017134;GO:0008289;GO:0042803;GO:0050786;GO:0008270;GO:0043303;GO:0008284;GO:0001819;GO:0043123;GO:0032730;GO:0015031;GO:0008360;GO:0046688;GO:0051602;, C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent protein binding; F:copper ion binding; F:fibroblast growth factor binding; F:lipid binding; F:protein homodimerization activity; F:RAGE receptor binding; F:zinc ion binding;, P:mast cell degranulation; P:positive regulation of cell population proliferation; P:positive regulation of cytokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 alpha production; P:protein transport; P:regulation of cell shape; P:response to copper ion; P:response to electrical stimulus;|Q99584 Q52PI9 Q6FGF8,Protein S100-A13,S100 calcium-binding protein A13;, PF01023;, GO:0005737;GO:0005829;GO:0005576;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005509;GO:0048306;GO:0005507;GO:0017134;GO:0008289;GO:0042803;GO:0050786;GO:0008270;GO:0043303;GO:0008284;GO:0001819;GO:0043123;GO:0032730;GO:0015031;GO:0008360;GO:0046688;GO:0051602;, C:cytoplasm; C:cytosol; C:extracellular region; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent protein binding; F:copper ion binding; F:fibroblast growth factor binding; F:lipid binding; F:protein homodimerization activity; F:RAGE receptor binding; F:zinc ion binding;, P:mast cell degranulation; P:positive regulation of cell population proliferation; P:positive regulation of cytokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 alpha production; P:protein transport; P:regulation of cell shape; P:response to copper ion; P:response to electrical stimulus; scaffold49 indexed_genome mRNA 799088 800680 . + . ID=transcript_9218;P23297 B2R5D9 Q5T7Y3,Protein S100-A1,S-100 protein alpha chain;S-100 protein subunit alpha;S100 calcium-binding protein A1;, PF00036;PF01023;, GO:0005737;GO:0005829;GO:0005576;GO:0005794;GO:0005654;GO:0005634;GO:0032991;GO:0016529;GO:0051117;GO:0005509;GO:0048306;GO:0042802;GO:0042803;GO:0044548;GO:0035556;GO:0051000;GO:1903672;GO:0008016;GO:0021762;GO:0002224;, C:cytoplasm; C:cytosol; C:extracellular region; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:sarcoplasmic reticulum;, F:ATPase binding; F:calcium ion binding; F:calcium-dependent protein binding; F:identical protein binding; F:protein homodimerization activity; F:S100 protein binding;, P:intracellular signal transduction; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of sprouting angiogenesis; P:regulation of heart contraction; P:substantia nigra development; P:toll-like receptor signaling pathway; scaffold49 indexed_genome mRNA 800811 801987 . - . ID=transcript_9219;P23297 B2R5D9 Q5T7Y3,Protein S100-A1,S-100 protein alpha chain;S-100 protein subunit alpha;S100 calcium-binding protein A1;, PF00036;PF01023;, GO:0005737;GO:0005829;GO:0005576;GO:0005794;GO:0005654;GO:0005634;GO:0032991;GO:0016529;GO:0051117;GO:0005509;GO:0048306;GO:0042802;GO:0042803;GO:0044548;GO:0035556;GO:0051000;GO:1903672;GO:0008016;GO:0021762;GO:0002224;, C:cytoplasm; C:cytosol; C:extracellular region; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:sarcoplasmic reticulum;, F:ATPase binding; F:calcium ion binding; F:calcium-dependent protein binding; F:identical protein binding; F:protein homodimerization activity; F:S100 protein binding;, P:intracellular signal transduction; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of sprouting angiogenesis; P:regulation of heart contraction; P:substantia nigra development; P:toll-like receptor signaling pathway; scaffold49 indexed_genome mRNA 803304 813455 . + . ID=transcript_9220;Q8WYT9 Q9BUC5 Q9H034 Q9H2L0,Chromatin target of PRMT1 protein,Friend of PRMT1 protein;Small arginine- and glycine-rich protein;, PF13865;, GO:0036464;GO:0016607;GO:0005730;GO:0005654;GO:0000346;GO:0008327;GO:0003723;GO:0001701;GO:0031124;GO:0006406;GO:0032781;GO:0008284;GO:0051096;GO:0031062;GO:0006405;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:transcription export complex;, F:methyl-CpG binding; F:RNA binding;, P:in utero embryonic development; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:positive regulation of ATPase activity; P:positive regulation of cell population proliferation; P:positive regulation of helicase activity; P:positive regulation of histone methylation; P:RNA export from nucleus;|Q8WYT9 Q9BUC5 Q9H034 Q9H2L0,Chromatin target of PRMT1 protein,Friend of PRMT1 protein;Small arginine- and glycine-rich protein;, PF13865;, GO:0036464;GO:0016607;GO:0005730;GO:0005654;GO:0000346;GO:0008327;GO:0003723;GO:0001701;GO:0031124;GO:0006406;GO:0032781;GO:0008284;GO:0051096;GO:0031062;GO:0006405;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:transcription export complex;, F:methyl-CpG binding; F:RNA binding;, P:in utero embryonic development; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:positive regulation of ATPase activity; P:positive regulation of cell population proliferation; P:positive regulation of helicase activity; P:positive regulation of histone methylation; P:RNA export from nucleus; scaffold49 indexed_genome mRNA 830414 832345 . + . ID=transcript_9221;O95295 D3DV56 Q5SXU8,SNARE-associated protein Snapin,Biogenesis of lysosome-related organelles complex 1 subunit 7;Synaptosomal-associated protein 25-binding protein;, PF14712;, GO:0001669;GO:1904115;GO:0031083;GO:0099078;GO:0000139;GO:0005765;GO:0002177;GO:0048471;GO:0030141;GO:0045202;GO:0008021;GO:0030672;GO:0000149;GO:0008089;GO:0048490;GO:0097352;GO:0034629;GO:0008333;GO:0006886;GO:1902774;GO:0007042;GO:0032418;GO:0007040;GO:0032438;GO:0010977;GO:0031175;GO:0007269;GO:1902824;GO:0051604;GO:0043393;GO:2000300;GO:0008090;GO:0016079;GO:0031629;GO:0016188;GO:0048489;GO:0072553;GO:0016032;, C:acrosomal vesicle; C:axon cytoplasm; C:BLOC-1 complex; C:BORC complex; C:Golgi membrane; C:lysosomal membrane; C:manchette; C:perinuclear region of cytoplasm; C:secretory granule; C:synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:SNARE binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:autophagosome maturation; P:cellular protein-containing complex localization; P:endosome to lysosome transport; P:intracellular protein transport; P:late endosome to lysosome transport; P:lysosomal lumen acidification; P:lysosome localization; P:lysosome organization; P:melanosome organization; P:negative regulation of neuron projection development; P:neuron projection development; P:neurotransmitter secretion; P:positive regulation of late endosome to lysosome transport; P:protein maturation; P:regulation of protein binding; P:regulation of synaptic vesicle exocytosis; P:retrograde axonal transport; P:synaptic vesicle exocytosis; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle maturation; P:synaptic vesicle transport; P:terminal button organization; P:viral process; scaffold49 indexed_genome mRNA 832366 838975 . - . ID=transcript_9222;Q12905 A6NDB0 B2R8G7 Q5SR10 Q5SR11 Q7L7R3 Q9BWD4 Q9P1N0,Interleukin enhancer-binding factor 2,Nuclear factor of activated T-cells 45 kDa;, PF07528;, GO:0005576;GO:1904813;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0035580;GO:1904724;GO:0003677;GO:0003725;GO:0003723;GO:0043312;GO:0045893;, C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:specific granule lumen; C:tertiary granule lumen;, F:DNA binding; F:double-stranded RNA binding; F:RNA binding;, P:neutrophil degranulation; P:positive regulation of transcription, DNA-templated;|Q12905 A6NDB0 B2R8G7 Q5SR10 Q5SR11 Q7L7R3 Q9BWD4 Q9P1N0,Interleukin enhancer-binding factor 2,Nuclear factor of activated T-cells 45 kDa;, PF07528;, GO:0005576;GO:1904813;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0035580;GO:1904724;GO:0003677;GO:0003725;GO:0003723;GO:0043312;GO:0045893;, C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:specific granule lumen; C:tertiary granule lumen;, F:DNA binding; F:double-stranded RNA binding; F:RNA binding;, P:neutrophil degranulation; P:positive regulation of transcription, DNA-templated;|Q12905 A6NDB0 B2R8G7 Q5SR10 Q5SR11 Q7L7R3 Q9BWD4 Q9P1N0,Interleukin enhancer-binding factor 2,Nuclear factor of activated T-cells 45 kDa;, PF07528;, GO:0005576;GO:1904813;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0035580;GO:1904724;GO:0003677;GO:0003725;GO:0003723;GO:0043312;GO:0045893;, C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:specific granule lumen; C:tertiary granule lumen;, F:DNA binding; F:double-stranded RNA binding; F:RNA binding;, P:neutrophil degranulation; P:positive regulation of transcription, DNA-templated;|Q12905 A6NDB0 B2R8G7 Q5SR10 Q5SR11 Q7L7R3 Q9BWD4 Q9P1N0,Interleukin enhancer-binding factor 2,Nuclear factor of activated T-cells 45 kDa;, PF07528;, GO:0005576;GO:1904813;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0035580;GO:1904724;GO:0003677;GO:0003725;GO:0003723;GO:0043312;GO:0045893;, C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:specific granule lumen; C:tertiary granule lumen;, F:DNA binding; F:double-stranded RNA binding; F:RNA binding;, P:neutrophil degranulation; P:positive regulation of transcription, DNA-templated; scaffold49 indexed_genome mRNA 849435 863300 . + . ID=transcript_9223;P16066 B0ZBF0 Q5SR08 Q6P4Q3,Atrial natriuretic peptide receptor 1,Atrial natriuretic peptide receptor type A;Guanylate cyclase A;, PF01094;PF00211;PF07714;, GO:0016021;GO:0005886;GO:0043235;GO:0005524;GO:0008528;GO:0005525;GO:0004383;GO:0042562;GO:0016941;GO:0017046;GO:0001653;GO:0004672;GO:0019901;GO:0097746;GO:0007589;GO:0007166;GO:0006182;GO:0019934;GO:0042417;GO:0016525;GO:0030308;GO:0048662;GO:0010753;GO:0035815;GO:0035810;GO:0007168;GO:0008217;GO:1903779;GO:0043114;GO:0007165;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:G protein-coupled peptide receptor activity; F:GTP binding; F:guanylate cyclase activity; F:hormone binding; F:natriuretic peptide receptor activity; F:peptide hormone binding; F:peptide receptor activity; F:protein kinase activity; F:protein kinase binding;, P:blood vessel diameter maintenance; P:body fluid secretion; P:cell surface receptor signaling pathway; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:dopamine metabolic process; P:negative regulation of angiogenesis; P:negative regulation of cell growth; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of cGMP-mediated signaling; P:positive regulation of renal sodium excretion; P:positive regulation of urine volume; P:receptor guanylyl cyclase signaling pathway; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of vascular permeability; P:signal transduction;|P16066 B0ZBF0 Q5SR08 Q6P4Q3,Atrial natriuretic peptide receptor 1,Atrial natriuretic peptide receptor type A;Guanylate cyclase A;, PF01094;PF00211;PF07714;, GO:0016021;GO:0005886;GO:0043235;GO:0005524;GO:0008528;GO:0005525;GO:0004383;GO:0042562;GO:0016941;GO:0017046;GO:0001653;GO:0004672;GO:0019901;GO:0097746;GO:0007589;GO:0007166;GO:0006182;GO:0019934;GO:0042417;GO:0016525;GO:0030308;GO:0048662;GO:0010753;GO:0035815;GO:0035810;GO:0007168;GO:0008217;GO:1903779;GO:0043114;GO:0007165;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:G protein-coupled peptide receptor activity; F:GTP binding; F:guanylate cyclase activity; F:hormone binding; F:natriuretic peptide receptor activity; F:peptide hormone binding; F:peptide receptor activity; F:protein kinase activity; F:protein kinase binding;, P:blood vessel diameter maintenance; P:body fluid secretion; P:cell surface receptor signaling pathway; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:dopamine metabolic process; P:negative regulation of angiogenesis; P:negative regulation of cell growth; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of cGMP-mediated signaling; P:positive regulation of renal sodium excretion; P:positive regulation of urine volume; P:receptor guanylyl cyclase signaling pathway; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of vascular permeability; P:signal transduction;|P16066 B0ZBF0 Q5SR08 Q6P4Q3,Atrial natriuretic peptide receptor 1,Atrial natriuretic peptide receptor type A;Guanylate cyclase A;, PF01094;PF00211;PF07714;, GO:0016021;GO:0005886;GO:0043235;GO:0005524;GO:0008528;GO:0005525;GO:0004383;GO:0042562;GO:0016941;GO:0017046;GO:0001653;GO:0004672;GO:0019901;GO:0097746;GO:0007589;GO:0007166;GO:0006182;GO:0019934;GO:0042417;GO:0016525;GO:0030308;GO:0048662;GO:0010753;GO:0035815;GO:0035810;GO:0007168;GO:0008217;GO:1903779;GO:0043114;GO:0007165;, C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:G protein-coupled peptide receptor activity; F:GTP binding; F:guanylate cyclase activity; F:hormone binding; F:natriuretic peptide receptor activity; F:peptide hormone binding; F:peptide receptor activity; F:protein kinase activity; F:protein kinase binding;, P:blood vessel diameter maintenance; P:body fluid secretion; P:cell surface receptor signaling pathway; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:dopamine metabolic process; P:negative regulation of angiogenesis; P:negative regulation of cell growth; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of cGMP-mediated signaling; P:positive regulation of renal sodium excretion; P:positive regulation of urine volume; P:receptor guanylyl cyclase signaling pathway; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of vascular permeability; P:signal transduction; scaffold49 indexed_genome mRNA 884146 922902 . + . ID=transcript_9224;Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H6S9,Integrator complex subunit 3,SOSS complex subunit A;Sensor of single-strand DNA complex subunit A;, PF10189;, GO:0005737;GO:0032039;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0006974;GO:0006281;GO:0044818;GO:0010212;GO:0016180;GO:0042795;, C:cytoplasm; C:integrator complex; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, , P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2/M transition checkpoint; P:response to ionizing radiation; P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold49 indexed_genome mRNA 930402 933019 . + . ID=transcript_9225;Q9BTY5,Solute carrier family 27 member 3 {ECO:0000312|HGNC:HGNC:10997},Arachidonate--CoA ligase {ECO:0000303|PubMed:23936004};Long-chain fatty acid transport protein 3 {ECO:0000250|UniProtKB:O88561};Very long-chain acyl-CoA synthetase homolog 3 {ECO:0000312|EMBL:CAE12159.1};, PF00501;PF13193;, GO:0005783;GO:0016021;GO:0016020;GO:0031966;GO:0005739;GO:0047676;GO:0005524;GO:0005324;GO:0004467;GO:0031957;GO:0015908;GO:0001676;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:fatty acid transport; P:long-chain fatty acid metabolic process;|Q9BTY5,Solute carrier family 27 member 3 {ECO:0000312|HGNC:HGNC:10997},Arachidonate--CoA ligase {ECO:0000303|PubMed:23936004};Long-chain fatty acid transport protein 3 {ECO:0000250|UniProtKB:O88561};Very long-chain acyl-CoA synthetase homolog 3 {ECO:0000312|EMBL:CAE12159.1};, PF00501;PF13193;, GO:0005783;GO:0016021;GO:0016020;GO:0031966;GO:0005739;GO:0047676;GO:0005524;GO:0005324;GO:0004467;GO:0031957;GO:0015908;GO:0001676;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:fatty acid transport; P:long-chain fatty acid metabolic process; scaffold49 indexed_genome mRNA 968871 973867 . - . ID=transcript_9226;Q8WXI9 D3DUZ2 Q5VUR2 Q7LG68 Q9ULS0,Transcriptional repressor p66-beta,GATA zinc finger domain-containing protein 2B;p66/p68;, PF00320;PF16563;, GO:0000785;GO:0016607;GO:0005654;GO:0016581;GO:0032991;GO:0043565;GO:0008270;GO:0043044;GO:0000122;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:negative regulation of transcription by RNA polymerase II;|Q8WXI9 D3DUZ2 Q5VUR2 Q7LG68 Q9ULS0,Transcriptional repressor p66-beta,GATA zinc finger domain-containing protein 2B;p66/p68;, PF00320;PF16563;, GO:0000785;GO:0016607;GO:0005654;GO:0016581;GO:0032991;GO:0043565;GO:0008270;GO:0043044;GO:0000122;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:negative regulation of transcription by RNA polymerase II; scaffold49 indexed_genome mRNA 973875 975168 . + . ID=transcript_9227;Q8WXI9 D3DUZ2 Q5VUR2 Q7LG68 Q9ULS0,Transcriptional repressor p66-beta,GATA zinc finger domain-containing protein 2B;p66/p68;, PF00320;PF16563;, GO:0000785;GO:0016607;GO:0005654;GO:0016581;GO:0032991;GO:0043565;GO:0008270;GO:0043044;GO:0000122;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:negative regulation of transcription by RNA polymerase II;|Q8WXI9 D3DUZ2 Q5VUR2 Q7LG68 Q9ULS0,Transcriptional repressor p66-beta,GATA zinc finger domain-containing protein 2B;p66/p68;, PF00320;PF16563;, GO:0000785;GO:0016607;GO:0005654;GO:0016581;GO:0032991;GO:0043565;GO:0008270;GO:0043044;GO:0000122;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:negative regulation of transcription by RNA polymerase II; scaffold49 indexed_genome mRNA 975620 1052628 . - . ID=transcript_9228;Q8WXI9 D3DUZ2 Q5VUR2 Q7LG68 Q9ULS0,Transcriptional repressor p66-beta,GATA zinc finger domain-containing protein 2B;p66/p68;, PF00320;PF16563;, GO:0000785;GO:0016607;GO:0005654;GO:0016581;GO:0032991;GO:0043565;GO:0008270;GO:0043044;GO:0000122;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:negative regulation of transcription by RNA polymerase II;|Q8WXI9 D3DUZ2 Q5VUR2 Q7LG68 Q9ULS0,Transcriptional repressor p66-beta,GATA zinc finger domain-containing protein 2B;p66/p68;, PF00320;PF16563;, GO:0000785;GO:0016607;GO:0005654;GO:0016581;GO:0032991;GO:0043565;GO:0008270;GO:0043044;GO:0000122;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:negative regulation of transcription by RNA polymerase II;|Q8WXI9 D3DUZ2 Q5VUR2 Q7LG68 Q9ULS0,Transcriptional repressor p66-beta,GATA zinc finger domain-containing protein 2B;p66/p68;, PF00320;PF16563;, GO:0000785;GO:0016607;GO:0005654;GO:0016581;GO:0032991;GO:0043565;GO:0008270;GO:0043044;GO:0000122;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:negative regulation of transcription by RNA polymerase II;|Q8WXI9 D3DUZ2 Q5VUR2 Q7LG68 Q9ULS0,Transcriptional repressor p66-beta,GATA zinc finger domain-containing protein 2B;p66/p68;, PF00320;PF16563;, GO:0000785;GO:0016607;GO:0005654;GO:0016581;GO:0032991;GO:0043565;GO:0008270;GO:0043044;GO:0000122;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;, F:sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:negative regulation of transcription by RNA polymerase II; scaffold49 indexed_genome mRNA 1055630 1069451 . - . ID=transcript_9229;O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction;|O75064 Q5T4K0,DENN domain-containing protein 4B,, PF03455;PF02141;PF03456;, GO:0031410;GO:0005829;GO:0005794;GO:0005654;GO:0005085;GO:0032483;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity;, P:regulation of Rab protein signal transduction; scaffold49 indexed_genome mRNA 1081867 1091534 . - . ID=transcript_9230;Q53ET0 Q6UUV8 Q7Z3X7 Q8N332,CREB-regulated transcription coactivator 2,Transducer of regulated cAMP response element-binding protein 2;, PF12886;PF12885;PF12884;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0008140;GO:0003682;GO:0006094;GO:0042593;GO:0043970;GO:0032793;GO:0045944;GO:0051289;GO:1901998;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding; F:chromatin binding;, P:gluconeogenesis; P:glucose homeostasis; P:histone H3-K9 acetylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:toxin transport; P:viral process;|Q53ET0 Q6UUV8 Q7Z3X7 Q8N332,CREB-regulated transcription coactivator 2,Transducer of regulated cAMP response element-binding protein 2;, PF12886;PF12885;PF12884;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0008140;GO:0003682;GO:0006094;GO:0042593;GO:0043970;GO:0032793;GO:0045944;GO:0051289;GO:1901998;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding; F:chromatin binding;, P:gluconeogenesis; P:glucose homeostasis; P:histone H3-K9 acetylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:toxin transport; P:viral process;|Q53ET0 Q6UUV8 Q7Z3X7 Q8N332,CREB-regulated transcription coactivator 2,Transducer of regulated cAMP response element-binding protein 2;, PF12886;PF12885;PF12884;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0008140;GO:0003682;GO:0006094;GO:0042593;GO:0043970;GO:0032793;GO:0045944;GO:0051289;GO:1901998;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding; F:chromatin binding;, P:gluconeogenesis; P:glucose homeostasis; P:histone H3-K9 acetylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:toxin transport; P:viral process;|Q53ET0 Q6UUV8 Q7Z3X7 Q8N332,CREB-regulated transcription coactivator 2,Transducer of regulated cAMP response element-binding protein 2;, PF12886;PF12885;PF12884;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0008140;GO:0003682;GO:0006094;GO:0042593;GO:0043970;GO:0032793;GO:0045944;GO:0051289;GO:1901998;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding; F:chromatin binding;, P:gluconeogenesis; P:glucose homeostasis; P:histone H3-K9 acetylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:toxin transport; P:viral process;|Q53ET0 Q6UUV8 Q7Z3X7 Q8N332,CREB-regulated transcription coactivator 2,Transducer of regulated cAMP response element-binding protein 2;, PF12886;PF12885;PF12884;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0008140;GO:0003682;GO:0006094;GO:0042593;GO:0043970;GO:0032793;GO:0045944;GO:0051289;GO:1901998;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding; F:chromatin binding;, P:gluconeogenesis; P:glucose homeostasis; P:histone H3-K9 acetylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:toxin transport; P:viral process;|Q53ET0 Q6UUV8 Q7Z3X7 Q8N332,CREB-regulated transcription coactivator 2,Transducer of regulated cAMP response element-binding protein 2;, PF12886;PF12885;PF12884;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0008140;GO:0003682;GO:0006094;GO:0042593;GO:0043970;GO:0032793;GO:0045944;GO:0051289;GO:1901998;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding; F:chromatin binding;, P:gluconeogenesis; P:glucose homeostasis; P:histone H3-K9 acetylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:toxin transport; P:viral process;|Q53ET0 Q6UUV8 Q7Z3X7 Q8N332,CREB-regulated transcription coactivator 2,Transducer of regulated cAMP response element-binding protein 2;, PF12886;PF12885;PF12884;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0008140;GO:0003682;GO:0006094;GO:0042593;GO:0043970;GO:0032793;GO:0045944;GO:0051289;GO:1901998;GO:0016032;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:cAMP response element binding protein binding; F:chromatin binding;, P:gluconeogenesis; P:glucose homeostasis; P:histone H3-K9 acetylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein homotetramerization; P:toxin transport; P:viral process; scaffold49 indexed_genome mRNA 1091867 1095909 . - . ID=transcript_9231;Q9NY26 B4DDY7 Q5T4K1 Q8N2H7 Q9BTV0 Q9UBI7 Q9Y2Z7 Q9Y380,Zinc transporter ZIP1,Solute carrier family 39 member 1;Zinc-iron-regulated transporter-like;Zrt- and Irt-like protein 1;, PF02535;, GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0022890;GO:0005102;GO:0005385;GO:0006812;GO:0048701;GO:0001701;GO:0060173;GO:0071577;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:inorganic cation transmembrane transporter activity; F:signaling receptor binding; F:zinc ion transmembrane transporter activity;, P:cation transport; P:embryonic cranial skeleton morphogenesis; P:in utero embryonic development; P:limb development; P:zinc ion transmembrane transport; scaffold49 indexed_genome mRNA 1099479 1101664 . - . ID=transcript_9232;Q8TEY5 D3DV62 Q5T4L0 Q86YW6,Cyclic AMP-responsive element-binding protein 3-like protein 4,Androgen-induced basic leucine zipper protein;Attaching to CRE-like 1;Cyclic AMP-responsive element-binding protein 4;Transcript induced in spermiogenesis protein 40;hJAL;, PF00170;, GO:0000785;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005739;GO:0031965;GO:0005654;GO:0005634;GO:0035497;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0030968;GO:0045944;GO:0006357;GO:0007283;, C:chromatin; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:mitochondrion; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:endoplasmic reticulum unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold49 indexed_genome mRNA 1103490 1106724 . + . ID=transcript_9233;Q8TEY5 D3DV62 Q5T4L0 Q86YW6,Cyclic AMP-responsive element-binding protein 3-like protein 4,Androgen-induced basic leucine zipper protein;Attaching to CRE-like 1;Cyclic AMP-responsive element-binding protein 4;Transcript induced in spermiogenesis protein 40;hJAL;, PF00170;, GO:0000785;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005739;GO:0031965;GO:0005654;GO:0005634;GO:0035497;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0030968;GO:0045944;GO:0006357;GO:0007283;, C:chromatin; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:mitochondrion; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:endoplasmic reticulum unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|O76095 O95442 Q6IB19 Q9P0Q4,Protein JTB,Jumping translocation breakpoint protein;Prostate androgen-regulated protein;, PF05439;, GO:0005737;GO:0005887;GO:0016020;GO:0005815;GO:0030496;GO:0005739;GO:0005819;GO:0019901;GO:0006915;GO:0000278;GO:0000281;GO:0045860;, C:cytoplasm; C:integral component of plasma membrane; C:membrane; C:microtubule organizing center; C:midbody; C:mitochondrion; C:spindle;, F:protein kinase binding;, P:apoptotic process; P:mitotic cell cycle; P:mitotic cytokinesis; P:positive regulation of protein kinase activity;|O76095 O95442 Q6IB19 Q9P0Q4,Protein JTB,Jumping translocation breakpoint protein;Prostate androgen-regulated protein;, PF05439;, GO:0005737;GO:0005887;GO:0016020;GO:0005815;GO:0030496;GO:0005739;GO:0005819;GO:0019901;GO:0006915;GO:0000278;GO:0000281;GO:0045860;, C:cytoplasm; C:integral component of plasma membrane; C:membrane; C:microtubule organizing center; C:midbody; C:mitochondrion; C:spindle;, F:protein kinase binding;, P:apoptotic process; P:mitotic cell cycle; P:mitotic cytokinesis; P:positive regulation of protein kinase activity;|O76095 O95442 Q6IB19 Q9P0Q4,Protein JTB,Jumping translocation breakpoint protein;Prostate androgen-regulated protein;, PF05439;, GO:0005737;GO:0005887;GO:0016020;GO:0005815;GO:0030496;GO:0005739;GO:0005819;GO:0019901;GO:0006915;GO:0000278;GO:0000281;GO:0045860;, C:cytoplasm; C:integral component of plasma membrane; C:membrane; C:microtubule organizing center; C:midbody; C:mitochondrion; C:spindle;, F:protein kinase binding;, P:apoptotic process; P:mitotic cell cycle; P:mitotic cytokinesis; P:positive regulation of protein kinase activity;|O76095 O95442 Q6IB19 Q9P0Q4,Protein JTB,Jumping translocation breakpoint protein;Prostate androgen-regulated protein;, PF05439;, GO:0005737;GO:0005887;GO:0016020;GO:0005815;GO:0030496;GO:0005739;GO:0005819;GO:0019901;GO:0006915;GO:0000278;GO:0000281;GO:0045860;, C:cytoplasm; C:integral component of plasma membrane; C:membrane; C:microtubule organizing center; C:midbody; C:mitochondrion; C:spindle;, F:protein kinase binding;, P:apoptotic process; P:mitotic cell cycle; P:mitotic cytokinesis; P:positive regulation of protein kinase activity; scaffold49 indexed_genome mRNA 1110605 1114597 . - . ID=transcript_9234;P51153 A8K6B5 D3DV67 Q5U0A6 Q6GPG6 Q96GU4,Ras-related protein Rab-13,Cell growth-inhibiting gene 4 protein;, PF00071;, GO:0005923;GO:0030054;GO:0031410;GO:0030659;GO:0005829;GO:0030139;GO:0005768;GO:0070062;GO:0032593;GO:0030027;GO:0016328;GO:0043005;GO:0005886;GO:0055037;GO:0055038;GO:0008021;GO:0005802;GO:0030140;GO:0005525;GO:0003924;GO:0070830;GO:0032869;GO:0030866;GO:0032456;GO:0016197;GO:0035767;GO:0097368;GO:0048210;GO:0031175;GO:0043687;GO:0010737;GO:0072659;GO:0009306;GO:0017157;GO:0044795;GO:0006904;, C:bicellular tight junction; C:cell junction; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:endocytic vesicle; C:endosome; C:extracellular exosome; C:insulin-responsive compartment; C:lamellipodium; C:lateral plasma membrane; C:neuron projection; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:synaptic vesicle; C:trans-Golgi network; C:trans-Golgi network transport vesicle;, F:GTP binding; F:GTPase activity;, P:bicellular tight junction assembly; P:cellular response to insulin stimulus; P:cortical actin cytoskeleton organization; P:endocytic recycling; P:endosomal transport; P:endothelial cell chemotaxis; P:establishment of Sertoli cell barrier; P:Golgi vesicle fusion to target membrane; P:neuron projection development; P:post-translational protein modification; P:protein kinase A signaling; P:protein localization to plasma membrane; P:protein secretion; P:regulation of exocytosis; P:trans-Golgi network to recycling endosome transport; P:vesicle docking involved in exocytosis; scaffold49 indexed_genome mRNA 1117944 1124312 . + . ID=transcript_9235;P42677 Q5T4L6,40S ribosomal protein S27,Metallopan-stimulin 1;Small ribosomal subunit protein eS27 {ECO:0000303|PubMed:24524803};, PF01667;, GO:0005829;GO:0022627;GO:0098982;GO:0098978;GO:0005654;GO:0005634;GO:0014069;GO:0098793;GO:0005840;GO:0003677;GO:0003723;GO:0003735;GO:0008270;GO:0007052;GO:0000184;GO:0000028;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:GABA-ergic synapse; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynaptic density; C:presynapse; C:ribosome;, F:DNA binding; F:RNA binding; F:structural constituent of ribosome; F:zinc ion binding;, P:mitotic spindle organization; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q71UM5 Q9BTJ1,40S ribosomal protein S27-like,Small ribosomal subunit protein eS27-like;, PF01667;, GO:0022627;GO:0005634;GO:0008656;GO:0046872;GO:0003723;GO:0003735;GO:0008494;GO:0006919;GO:0006978;GO:0042771;GO:0031571;GO:0045727;GO:0000028;GO:0006412;, C:cytosolic small ribosomal subunit; C:nucleus;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:metal ion binding; F:RNA binding; F:structural constituent of ribosome; F:translation activator activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic G1 DNA damage checkpoint; P:positive regulation of translation; P:ribosomal small subunit assembly; P:translation;|Q5VU65 E7EP56 Q5T4L7 Q6ZRN1 Q6ZRT4 Q6ZU81 Q8NDI6 Q9UF31,Nuclear pore membrane glycoprotein 210-like,Nucleoporin 210 kDa-like;Nucleoporin Nup210-like;, PF02368;, GO:0016021;GO:0005643;, C:integral component of membrane; C:nuclear pore; scaffold49 indexed_genome mRNA 1129075 1129576 . - . ID=transcript_9236;Q99595 B2RDM5 Q9BWF5,Mitochondrial import inner membrane translocase subunit Tim17-A,Inner membrane preprotein translocase Tim17a;, , GO:0031305;GO:0005743;GO:0005739;GO:0005654;GO:0005744;GO:0008320;GO:0010954;GO:0030150;GO:0006626;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:TIM23 mitochondrial import inner membrane translocase complex;, F:protein transmembrane transporter activity;, P:positive regulation of protein processing; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; scaffold49 indexed_genome mRNA 1131290 1135523 . - . ID=transcript_9237;Q5VU65 E7EP56 Q5T4L7 Q6ZRN1 Q6ZRT4 Q6ZU81 Q8NDI6 Q9UF31,Nuclear pore membrane glycoprotein 210-like,Nucleoporin 210 kDa-like;Nucleoporin Nup210-like;, PF02368;, GO:0016021;GO:0005643;, C:integral component of membrane; C:nuclear pore;|Q5VU65 E7EP56 Q5T4L7 Q6ZRN1 Q6ZRT4 Q6ZU81 Q8NDI6 Q9UF31,Nuclear pore membrane glycoprotein 210-like,Nucleoporin 210 kDa-like;Nucleoporin Nup210-like;, PF02368;, GO:0016021;GO:0005643;, C:integral component of membrane; C:nuclear pore;|Q5VU65 E7EP56 Q5T4L7 Q6ZRN1 Q6ZRT4 Q6ZU81 Q8NDI6 Q9UF31,Nuclear pore membrane glycoprotein 210-like,Nucleoporin 210 kDa-like;Nucleoporin Nup210-like;, PF02368;, GO:0016021;GO:0005643;, C:integral component of membrane; C:nuclear pore; scaffold49 indexed_genome mRNA 1135579 1146722 . + . ID=transcript_9238;P02792 B2R4B9 Q6IBT7 Q7Z2W1 Q86WI9 Q8WU07 Q96AU9 Q96CU0 Q9BTZ8,Ferritin light chain,, PF00210;, GO:0044754;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0008043;GO:0016020;GO:0008199;GO:0008198;GO:0042802;GO:0005506;GO:0006879;GO:0006880;GO:0055072;GO:0006826;GO:0043312;GO:0006892;, C:autolysosome; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular ferritin complex; C:membrane;, F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:iron ion binding;, P:cellular iron ion homeostasis; P:intracellular sequestering of iron ion; P:iron ion homeostasis; P:iron ion transport; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport;|Q5VU65 E7EP56 Q5T4L7 Q6ZRN1 Q6ZRT4 Q6ZU81 Q8NDI6 Q9UF31,Nuclear pore membrane glycoprotein 210-like,Nucleoporin 210 kDa-like;Nucleoporin Nup210-like;, PF02368;, GO:0016021;GO:0005643;, C:integral component of membrane; C:nuclear pore; scaffold49 indexed_genome mRNA 1215921 1217200 . + . ID=transcript_9239;Q5VU65 E7EP56 Q5T4L7 Q6ZRN1 Q6ZRT4 Q6ZU81 Q8NDI6 Q9UF31,Nuclear pore membrane glycoprotein 210-like,Nucleoporin 210 kDa-like;Nucleoporin Nup210-like;, PF02368;, GO:0016021;GO:0005643;, C:integral component of membrane; C:nuclear pore; scaffold49 indexed_genome mRNA 1218700 1248434 . - . ID=transcript_9240;Q8TCG3 Q969Q2 Q9NQH8,Tropomyosin alpha-3 chain,Gamma-tropomyosin;Tropomyosin-3;Tropomyosin-5;, PF00261;, GO:0015629;GO:0005884;GO:0005856;GO:0005829;GO:0070062;GO:0005862;GO:0001725;GO:0051015;GO:0007015;GO:0006936;GO:0030049;, C:actin cytoskeleton; C:actin filament; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:muscle thin filament tropomyosin; C:stress fiber;, F:actin filament binding;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding;|Q8TCG3 Q969Q2 Q9NQH8,Tropomyosin alpha-3 chain,Gamma-tropomyosin;Tropomyosin-3;Tropomyosin-5;, PF00261;, GO:0015629;GO:0005884;GO:0005856;GO:0005829;GO:0070062;GO:0005862;GO:0001725;GO:0051015;GO:0007015;GO:0006936;GO:0030049;, C:actin cytoskeleton; C:actin filament; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:muscle thin filament tropomyosin; C:stress fiber;, F:actin filament binding;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding;|Q8TCG3 Q969Q2 Q9NQH8,Tropomyosin alpha-3 chain,Gamma-tropomyosin;Tropomyosin-3;Tropomyosin-5;, PF00261;, GO:0015629;GO:0005884;GO:0005856;GO:0005829;GO:0070062;GO:0005862;GO:0001725;GO:0051015;GO:0007015;GO:0006936;GO:0030049;, C:actin cytoskeleton; C:actin filament; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:muscle thin filament tropomyosin; C:stress fiber;, F:actin filament binding;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding;|Q8TCG3 Q969Q2 Q9NQH8,Tropomyosin alpha-3 chain,Gamma-tropomyosin;Tropomyosin-3;Tropomyosin-5;, PF00261;, GO:0015629;GO:0005884;GO:0005856;GO:0005829;GO:0070062;GO:0005862;GO:0001725;GO:0051015;GO:0007015;GO:0006936;GO:0030049;, C:actin cytoskeleton; C:actin filament; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:muscle thin filament tropomyosin; C:stress fiber;, F:actin filament binding;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding;|Q7Z6L8 Q86W64 Q96IK2 Q9UCI1 Q9UCI2 Q9UCY9 Q9Y427,Tropomyosin alpha-1 chain,Alpha-tropomyosin;Tropomyosin-1;, PF00261;, GO:0015629;GO:0005884;GO:0032059;GO:0005856;GO:0005829;GO:0005862;GO:0032587;GO:0030017;GO:0001725;GO:0003779;GO:0051015;GO:0008092;GO:0042802;GO:0046982;GO:0042803;GO:0005200;GO:0008307;GO:0007015;GO:0060048;GO:0034614;GO:0007010;GO:0006936;GO:0030049;GO:0030336;GO:1904753;GO:1904706;GO:0032781;GO:0045785;GO:0003065;GO:0051496;GO:0008360;GO:0008016;GO:0006937;GO:0031529;GO:0045214;GO:0055010;GO:0042060;, C:actin cytoskeleton; C:actin filament; C:bleb; C:cytoskeleton; C:cytosol; C:muscle thin filament tropomyosin; C:ruffle membrane; C:sarcomere; C:stress fiber;, F:actin binding; F:actin filament binding; F:cytoskeletal protein binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cardiac muscle contraction; P:cellular response to reactive oxygen species; P:cytoskeleton organization; P:muscle contraction; P:muscle filament sliding; P:negative regulation of cell migration; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of ATPase activity; P:positive regulation of cell adhesion; P:positive regulation of heart rate by epinephrine; P:positive regulation of stress fiber assembly; P:regulation of cell shape; P:regulation of heart contraction; P:regulation of muscle contraction; P:ruffle organization; P:sarcomere organization; P:ventricular cardiac muscle tissue morphogenesis; P:wound healing;|Q9UCS4,Tropomyosin alpha-4 chain,TM30p1;Tropomyosin-4;, PF00261;, GO:0005884;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005862;GO:0001725;GO:0051015;GO:0005509;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0001649;, C:actin filament; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:muscle thin filament tropomyosin; C:stress fiber;, F:actin filament binding; F:calcium ion binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:osteoblast differentiation;|Q7Z6L8 Q86W64 Q96IK2 Q9UCI1 Q9UCI2 Q9UCY9 Q9Y427,Tropomyosin alpha-1 chain,Alpha-tropomyosin;Tropomyosin-1;, PF00261;, GO:0015629;GO:0005884;GO:0032059;GO:0005856;GO:0005829;GO:0005862;GO:0032587;GO:0030017;GO:0001725;GO:0003779;GO:0051015;GO:0008092;GO:0042802;GO:0046982;GO:0042803;GO:0005200;GO:0008307;GO:0007015;GO:0060048;GO:0034614;GO:0007010;GO:0006936;GO:0030049;GO:0030336;GO:1904753;GO:1904706;GO:0032781;GO:0045785;GO:0003065;GO:0051496;GO:0008360;GO:0008016;GO:0006937;GO:0031529;GO:0045214;GO:0055010;GO:0042060;, C:actin cytoskeleton; C:actin filament; C:bleb; C:cytoskeleton; C:cytosol; C:muscle thin filament tropomyosin; C:ruffle membrane; C:sarcomere; C:stress fiber;, F:actin binding; F:actin filament binding; F:cytoskeletal protein binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:actin filament organization; P:cardiac muscle contraction; P:cellular response to reactive oxygen species; P:cytoskeleton organization; P:muscle contraction; P:muscle filament sliding; P:negative regulation of cell migration; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of ATPase activity; P:positive regulation of cell adhesion; P:positive regulation of heart rate by epinephrine; P:positive regulation of stress fiber assembly; P:regulation of cell shape; P:regulation of heart contraction; P:regulation of muscle contraction; P:ruffle organization; P:sarcomere organization; P:ventricular cardiac muscle tissue morphogenesis; P:wound healing; scaffold49 indexed_genome mRNA 1250372 1263461 . + . ID=transcript_9241;Q5VU69 A1L4E3,Uncharacterized protein C1orf189,, PF15104;|Q9UGL7 Q9UGL8 Q9Y2R6,Protein C1orf43,Hepatitis C virus NS5A-transactivated protein 4 {ECO:0000303|Ref.3};Protein NICE-3;S863-3;, PF07406;, GO:0005794;GO:0016021;GO:0005739;GO:0006909;, C:Golgi apparatus; C:integral component of membrane; C:mitochondrion;, , P:phagocytosis;|Q9UGL7 Q9UGL8 Q9Y2R6,Protein C1orf43,Hepatitis C virus NS5A-transactivated protein 4 {ECO:0000303|Ref.3};Protein NICE-3;S863-3;, PF07406;, GO:0005794;GO:0016021;GO:0005739;GO:0006909;, C:Golgi apparatus; C:integral component of membrane; C:mitochondrion;, , P:phagocytosis;|Q9UGL7 Q9UGL8 Q9Y2R6,Protein C1orf43,Hepatitis C virus NS5A-transactivated protein 4 {ECO:0000303|Ref.3};Protein NICE-3;S863-3;, PF07406;, GO:0005794;GO:0016021;GO:0005739;GO:0006909;, C:Golgi apparatus; C:integral component of membrane; C:mitochondrion;, , P:phagocytosis; scaffold49 indexed_genome mRNA 1314916 1315417 . + . ID=transcript_9242;P98198 B4E3P4 Q6NT69 Q7Z486 Q96I43 Q96NQ7,Phospholipid-transporting ATPase ID,ATPase class I type 8B member 2;P4-ATPase flippase complex alpha subunit ATP8B2;, PF16212;PF16209;, GO:0005789;GO:0005794;GO:0005887;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0140345;GO:0007030;GO:0034220;GO:0045332;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:Golgi organization; P:ion transmembrane transport; P:phospholipid translocation; scaffold49 indexed_genome mRNA 1316053 1329839 . + . ID=transcript_9243;P98198 B4E3P4 Q6NT69 Q7Z486 Q96I43 Q96NQ7,Phospholipid-transporting ATPase ID,ATPase class I type 8B member 2;P4-ATPase flippase complex alpha subunit ATP8B2;, PF16212;PF16209;, GO:0005789;GO:0005794;GO:0005887;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0140345;GO:0007030;GO:0034220;GO:0045332;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:Golgi organization; P:ion transmembrane transport; P:phospholipid translocation;|P98198 B4E3P4 Q6NT69 Q7Z486 Q96I43 Q96NQ7,Phospholipid-transporting ATPase ID,ATPase class I type 8B member 2;P4-ATPase flippase complex alpha subunit ATP8B2;, PF16212;PF16209;, GO:0005789;GO:0005794;GO:0005887;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0140345;GO:0007030;GO:0034220;GO:0045332;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:Golgi organization; P:ion transmembrane transport; P:phospholipid translocation;|P98198 B4E3P4 Q6NT69 Q7Z486 Q96I43 Q96NQ7,Phospholipid-transporting ATPase ID,ATPase class I type 8B member 2;P4-ATPase flippase complex alpha subunit ATP8B2;, PF16212;PF16209;, GO:0005789;GO:0005794;GO:0005887;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0140345;GO:0007030;GO:0034220;GO:0045332;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:Golgi organization; P:ion transmembrane transport; P:phospholipid translocation;|P98198 B4E3P4 Q6NT69 Q7Z486 Q96I43 Q96NQ7,Phospholipid-transporting ATPase ID,ATPase class I type 8B member 2;P4-ATPase flippase complex alpha subunit ATP8B2;, PF16212;PF16209;, GO:0005789;GO:0005794;GO:0005887;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0140345;GO:0007030;GO:0034220;GO:0045332;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:Golgi organization; P:ion transmembrane transport; P:phospholipid translocation;|P98198 B4E3P4 Q6NT69 Q7Z486 Q96I43 Q96NQ7,Phospholipid-transporting ATPase ID,ATPase class I type 8B member 2;P4-ATPase flippase complex alpha subunit ATP8B2;, PF16212;PF16209;, GO:0005789;GO:0005794;GO:0005887;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0140345;GO:0007030;GO:0034220;GO:0045332;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:Golgi organization; P:ion transmembrane transport; P:phospholipid translocation;|P98198 B4E3P4 Q6NT69 Q7Z486 Q96I43 Q96NQ7,Phospholipid-transporting ATPase ID,ATPase class I type 8B member 2;P4-ATPase flippase complex alpha subunit ATP8B2;, PF16212;PF16209;, GO:0005789;GO:0005794;GO:0005887;GO:0005886;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0140345;GO:0007030;GO:0034220;GO:0045332;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:Golgi organization; P:ion transmembrane transport; P:phospholipid translocation; scaffold49 indexed_genome mRNA 1390008 1421830 . + . ID=transcript_9244;P08887 A8KAE8 B2R6V4 Q16202 Q53EQ7 Q5FWG2 Q5VZ23,Interleukin-6 receptor subunit alpha {ECO:0000305},IL-6R 1;Membrane glycoprotein 80;, PF00047;PF09240;, GO:0016324;GO:0070110;GO:0009897;GO:0005576;GO:0005615;GO:0005896;GO:0005886;GO:0043235;GO:0070119;GO:0019955;GO:0004896;GO:0019899;GO:0019970;GO:0004921;GO:0019981;GO:0004915;GO:0042803;GO:0006953;GO:0070120;GO:0019221;GO:0050829;GO:0050830;GO:0031018;GO:0097191;GO:0002384;GO:0070102;GO:0002548;GO:0032966;GO:0032717;GO:0002446;GO:0010536;GO:0008284;GO:0032722;GO:0072126;GO:0032755;GO:0002690;GO:0043410;GO:0045669;GO:0050731;GO:0048661;GO:0042531;GO:0034097;GO:0072540;GO:0010573;, C:apical plasma membrane; C:ciliary neurotrophic factor receptor complex; C:external side of plasma membrane; C:extracellular region; C:extracellular space; C:interleukin-6 receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor binding; F:cytokine binding; F:cytokine receptor activity; F:enzyme binding; F:interleukin-11 binding; F:interleukin-11 receptor activity; F:interleukin-6 binding; F:interleukin-6 receptor activity; F:protein homodimerization activity;, P:acute-phase response; P:ciliary neurotrophic factor-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:endocrine pancreas development; P:extrinsic apoptotic signaling pathway; P:hepatic immune response; P:interleukin-6-mediated signaling pathway; P:monocyte chemotaxis; P:negative regulation of collagen biosynthetic process; P:negative regulation of interleukin-8 production; P:neutrophil mediated immunity; P:positive regulation of activation of Janus kinase activity; P:positive regulation of cell population proliferation; P:positive regulation of chemokine production; P:positive regulation of glomerular mesangial cell proliferation; P:positive regulation of interleukin-6 production; P:positive regulation of leukocyte chemotaxis; P:positive regulation of MAPK cascade; P:positive regulation of osteoblast differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of tyrosine phosphorylation of STAT protein; P:response to cytokine; P:T-helper 17 cell lineage commitment; P:vascular endothelial growth factor production; scaffold49 indexed_genome mRNA 1440876 1458799 . - . ID=transcript_9245;Q5VZ18 Q8TEQ5,SH2 domain-containing adapter protein E,, PF00017;, GO:0001784;, , F:phosphotyrosine residue binding;|Q5VZ18 Q8TEQ5,SH2 domain-containing adapter protein E,, PF00017;, GO:0001784;, , F:phosphotyrosine residue binding; scaffold49 indexed_genome mRNA 1513735 1518294 . - . ID=transcript_9246;Q9UGL6,Ubiquitin-conjugating enzyme E2 Q1,E2 ubiquitin-conjugating enzyme Q1;Protein NICE-5;Ubiquitin carrier protein Q1;Ubiquitin-protein ligase Q1;, PF00179;, GO:0005829;GO:0030175;GO:0005634;GO:0005524;GO:0061631;GO:0007566;GO:0009566;GO:0007617;GO:0070459;GO:0000209;GO:0061458;GO:0001967;, C:cytosol; C:filopodium; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity;, P:embryo implantation; P:fertilization; P:mating behavior; P:prolactin secretion; P:protein polyubiquitination; P:reproductive system development; P:suckling behavior;|Q9UGL6,Ubiquitin-conjugating enzyme E2 Q1,E2 ubiquitin-conjugating enzyme Q1;Protein NICE-5;Ubiquitin carrier protein Q1;Ubiquitin-protein ligase Q1;, PF00179;, GO:0005829;GO:0030175;GO:0005634;GO:0005524;GO:0061631;GO:0007566;GO:0009566;GO:0007617;GO:0070459;GO:0000209;GO:0061458;GO:0001967;, C:cytosol; C:filopodium; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity;, P:embryo implantation; P:fertilization; P:mating behavior; P:prolactin secretion; P:protein polyubiquitination; P:reproductive system development; P:suckling behavior; scaffold49 indexed_genome mRNA 1518325 1521364 . + . ID=transcript_9247;Q9UGL6,Ubiquitin-conjugating enzyme E2 Q1,E2 ubiquitin-conjugating enzyme Q1;Protein NICE-5;Ubiquitin carrier protein Q1;Ubiquitin-protein ligase Q1;, PF00179;, GO:0005829;GO:0030175;GO:0005634;GO:0005524;GO:0061631;GO:0007566;GO:0009566;GO:0007617;GO:0070459;GO:0000209;GO:0061458;GO:0001967;, C:cytosol; C:filopodium; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity;, P:embryo implantation; P:fertilization; P:mating behavior; P:prolactin secretion; P:protein polyubiquitination; P:reproductive system development; P:suckling behavior; scaffold49 indexed_genome mRNA 1543380 1545849 . + . ID=transcript_9248;P17787 Q9UEH9,Neuronal acetylcholine receptor subunit beta-2,, PF02931;PF02932;, GO:0005892;GO:0009897;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0044853;GO:0045211;GO:0045202;GO:0042166;GO:0015464;GO:0022848;GO:0015276;GO:0030594;GO:0095500;GO:0008306;GO:0042113;GO:0035095;GO:0006816;GO:0021952;GO:0007268;GO:0050890;GO:0034220;GO:0006811;GO:0021771;GO:0007612;GO:0007626;GO:0051899;GO:0007613;GO:0045759;GO:0050877;GO:0021631;GO:0030890;GO:0033603;GO:0042320;GO:0048814;GO:0042053;GO:0014059;GO:0042391;GO:0051963;GO:0032225;GO:1905144;GO:0042220;GO:0045471;GO:0001666;GO:0035094;GO:0019233;GO:0007605;GO:0007165;GO:0006939;GO:0035176;GO:0060084;GO:0007271;GO:0021562;GO:0008542;GO:0007601;, C:acetylcholine-gated channel complex; C:external side of plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:plasma membrane raft; C:postsynaptic membrane; C:synapse;, F:acetylcholine binding; F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity;, P:acetylcholine receptor signaling pathway; P:associative learning; P:B cell activation; P:behavioral response to nicotine; P:calcium ion transport; P:central nervous system projection neuron axonogenesis; P:chemical synaptic transmission; P:cognition; P:ion transmembrane transport; P:ion transport; P:lateral geniculate nucleus development; P:learning; P:locomotory behavior; P:membrane depolarization; P:memory; P:negative regulation of action potential; P:nervous system process; P:optic nerve morphogenesis; P:positive regulation of B cell proliferation; P:positive regulation of dopamine secretion; P:regulation of circadian sleep/wake cycle, REM sleep; P:regulation of dendrite morphogenesis; P:regulation of dopamine metabolic process; P:regulation of dopamine secretion; P:regulation of membrane potential; P:regulation of synapse assembly; P:regulation of synaptic transmission, dopaminergic; P:response to acetylcholine; P:response to cocaine; P:response to ethanol; P:response to hypoxia; P:response to nicotine; P:sensory perception of pain; P:sensory perception of sound; P:signal transduction; P:smooth muscle contraction; P:social behavior; P:synaptic transmission involved in micturition; P:synaptic transmission, cholinergic; P:vestibulocochlear nerve development; P:visual learning; P:visual perception; scaffold49 indexed_genome mRNA 1546379 1553907 . + . ID=transcript_9249;P17787 Q9UEH9,Neuronal acetylcholine receptor subunit beta-2,, PF02931;PF02932;, GO:0005892;GO:0009897;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0044853;GO:0045211;GO:0045202;GO:0042166;GO:0015464;GO:0022848;GO:0015276;GO:0030594;GO:0095500;GO:0008306;GO:0042113;GO:0035095;GO:0006816;GO:0021952;GO:0007268;GO:0050890;GO:0034220;GO:0006811;GO:0021771;GO:0007612;GO:0007626;GO:0051899;GO:0007613;GO:0045759;GO:0050877;GO:0021631;GO:0030890;GO:0033603;GO:0042320;GO:0048814;GO:0042053;GO:0014059;GO:0042391;GO:0051963;GO:0032225;GO:1905144;GO:0042220;GO:0045471;GO:0001666;GO:0035094;GO:0019233;GO:0007605;GO:0007165;GO:0006939;GO:0035176;GO:0060084;GO:0007271;GO:0021562;GO:0008542;GO:0007601;, C:acetylcholine-gated channel complex; C:external side of plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:plasma membrane raft; C:postsynaptic membrane; C:synapse;, F:acetylcholine binding; F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity;, P:acetylcholine receptor signaling pathway; P:associative learning; P:B cell activation; P:behavioral response to nicotine; P:calcium ion transport; P:central nervous system projection neuron axonogenesis; P:chemical synaptic transmission; P:cognition; P:ion transmembrane transport; P:ion transport; P:lateral geniculate nucleus development; P:learning; P:locomotory behavior; P:membrane depolarization; P:memory; P:negative regulation of action potential; P:nervous system process; P:optic nerve morphogenesis; P:positive regulation of B cell proliferation; P:positive regulation of dopamine secretion; P:regulation of circadian sleep/wake cycle, REM sleep; P:regulation of dendrite morphogenesis; P:regulation of dopamine metabolic process; P:regulation of dopamine secretion; P:regulation of membrane potential; P:regulation of synapse assembly; P:regulation of synaptic transmission, dopaminergic; P:response to acetylcholine; P:response to cocaine; P:response to ethanol; P:response to hypoxia; P:response to nicotine; P:sensory perception of pain; P:sensory perception of sound; P:signal transduction; P:smooth muscle contraction; P:social behavior; P:synaptic transmission involved in micturition; P:synaptic transmission, cholinergic; P:vestibulocochlear nerve development; P:visual learning; P:visual perception;|P17787 Q9UEH9,Neuronal acetylcholine receptor subunit beta-2,, PF02931;PF02932;, GO:0005892;GO:0009897;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0044853;GO:0045211;GO:0045202;GO:0042166;GO:0015464;GO:0022848;GO:0015276;GO:0030594;GO:0095500;GO:0008306;GO:0042113;GO:0035095;GO:0006816;GO:0021952;GO:0007268;GO:0050890;GO:0034220;GO:0006811;GO:0021771;GO:0007612;GO:0007626;GO:0051899;GO:0007613;GO:0045759;GO:0050877;GO:0021631;GO:0030890;GO:0033603;GO:0042320;GO:0048814;GO:0042053;GO:0014059;GO:0042391;GO:0051963;GO:0032225;GO:1905144;GO:0042220;GO:0045471;GO:0001666;GO:0035094;GO:0019233;GO:0007605;GO:0007165;GO:0006939;GO:0035176;GO:0060084;GO:0007271;GO:0021562;GO:0008542;GO:0007601;, C:acetylcholine-gated channel complex; C:external side of plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:plasma membrane raft; C:postsynaptic membrane; C:synapse;, F:acetylcholine binding; F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity;, P:acetylcholine receptor signaling pathway; P:associative learning; P:B cell activation; P:behavioral response to nicotine; P:calcium ion transport; P:central nervous system projection neuron axonogenesis; P:chemical synaptic transmission; P:cognition; P:ion transmembrane transport; P:ion transport; P:lateral geniculate nucleus development; P:learning; P:locomotory behavior; P:membrane depolarization; P:memory; P:negative regulation of action potential; P:nervous system process; P:optic nerve morphogenesis; P:positive regulation of B cell proliferation; P:positive regulation of dopamine secretion; P:regulation of circadian sleep/wake cycle, REM sleep; P:regulation of dendrite morphogenesis; P:regulation of dopamine metabolic process; P:regulation of dopamine secretion; P:regulation of membrane potential; P:regulation of synapse assembly; P:regulation of synaptic transmission, dopaminergic; P:response to acetylcholine; P:response to cocaine; P:response to ethanol; P:response to hypoxia; P:response to nicotine; P:sensory perception of pain; P:sensory perception of sound; P:signal transduction; P:smooth muscle contraction; P:social behavior; P:synaptic transmission involved in micturition; P:synaptic transmission, cholinergic; P:vestibulocochlear nerve development; P:visual learning; P:visual perception; scaffold49 indexed_genome mRNA 1556466 1585498 . - . ID=transcript_9250;P55265 B1AQQ9 B1AQR0 D3DV76 O15223 O43859 O43860 Q9BYM3 Q9BYM4,Double-stranded RNA-specific adenosine deaminase,136 kDa double-stranded RNA-binding protein;Interferon-inducible protein 4;K88DSRBP;, PF02137;PF00035;PF02295;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0044530;GO:0003677;GO:0003726;GO:0003725;GO:0046872;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0098586;GO:0051607;GO:0060216;GO:0030218;GO:0002244;GO:0061484;GO:0045087;GO:0035280;GO:0006397;GO:0043066;GO:0044387;GO:1900369;GO:0060339;GO:0001649;GO:0045070;GO:0031054;GO:0006611;GO:0006606;GO:0035455;GO:0009615;GO:0006396;GO:0002566;GO:0060337;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:supraspliceosomal complex;, F:DNA binding; F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:cellular response to virus; P:defense response to virus; P:definitive hemopoiesis; P:erythrocyte differentiation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell homeostasis; P:innate immune response; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:mRNA processing; P:negative regulation of apoptotic process; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of RNA interference; P:negative regulation of type I interferon-mediated signaling pathway; P:osteoblast differentiation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:protein export from nucleus; P:protein import into nucleus; P:response to interferon-alpha; P:response to virus; P:RNA processing; P:somatic diversification of immune receptors via somatic mutation; P:type I interferon signaling pathway;|P55265 B1AQQ9 B1AQR0 D3DV76 O15223 O43859 O43860 Q9BYM3 Q9BYM4,Double-stranded RNA-specific adenosine deaminase,136 kDa double-stranded RNA-binding protein;Interferon-inducible protein 4;K88DSRBP;, PF02137;PF00035;PF02295;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0044530;GO:0003677;GO:0003726;GO:0003725;GO:0046872;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0098586;GO:0051607;GO:0060216;GO:0030218;GO:0002244;GO:0061484;GO:0045087;GO:0035280;GO:0006397;GO:0043066;GO:0044387;GO:1900369;GO:0060339;GO:0001649;GO:0045070;GO:0031054;GO:0006611;GO:0006606;GO:0035455;GO:0009615;GO:0006396;GO:0002566;GO:0060337;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:supraspliceosomal complex;, F:DNA binding; F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:cellular response to virus; P:defense response to virus; P:definitive hemopoiesis; P:erythrocyte differentiation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell homeostasis; P:innate immune response; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:mRNA processing; P:negative regulation of apoptotic process; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of RNA interference; P:negative regulation of type I interferon-mediated signaling pathway; P:osteoblast differentiation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:protein export from nucleus; P:protein import into nucleus; P:response to interferon-alpha; P:response to virus; P:RNA processing; P:somatic diversification of immune receptors via somatic mutation; P:type I interferon signaling pathway;|P55265 B1AQQ9 B1AQR0 D3DV76 O15223 O43859 O43860 Q9BYM3 Q9BYM4,Double-stranded RNA-specific adenosine deaminase,136 kDa double-stranded RNA-binding protein;Interferon-inducible protein 4;K88DSRBP;, PF02137;PF00035;PF02295;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0044530;GO:0003677;GO:0003726;GO:0003725;GO:0046872;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0098586;GO:0051607;GO:0060216;GO:0030218;GO:0002244;GO:0061484;GO:0045087;GO:0035280;GO:0006397;GO:0043066;GO:0044387;GO:1900369;GO:0060339;GO:0001649;GO:0045070;GO:0031054;GO:0006611;GO:0006606;GO:0035455;GO:0009615;GO:0006396;GO:0002566;GO:0060337;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:supraspliceosomal complex;, F:DNA binding; F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:cellular response to virus; P:defense response to virus; P:definitive hemopoiesis; P:erythrocyte differentiation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell homeostasis; P:innate immune response; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:mRNA processing; P:negative regulation of apoptotic process; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of RNA interference; P:negative regulation of type I interferon-mediated signaling pathway; P:osteoblast differentiation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:protein export from nucleus; P:protein import into nucleus; P:response to interferon-alpha; P:response to virus; P:RNA processing; P:somatic diversification of immune receptors via somatic mutation; P:type I interferon signaling pathway;|P55265 B1AQQ9 B1AQR0 D3DV76 O15223 O43859 O43860 Q9BYM3 Q9BYM4,Double-stranded RNA-specific adenosine deaminase,136 kDa double-stranded RNA-binding protein;Interferon-inducible protein 4;K88DSRBP;, PF02137;PF00035;PF02295;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0044530;GO:0003677;GO:0003726;GO:0003725;GO:0046872;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0098586;GO:0051607;GO:0060216;GO:0030218;GO:0002244;GO:0061484;GO:0045087;GO:0035280;GO:0006397;GO:0043066;GO:0044387;GO:1900369;GO:0060339;GO:0001649;GO:0045070;GO:0031054;GO:0006611;GO:0006606;GO:0035455;GO:0009615;GO:0006396;GO:0002566;GO:0060337;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:supraspliceosomal complex;, F:DNA binding; F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:cellular response to virus; P:defense response to virus; P:definitive hemopoiesis; P:erythrocyte differentiation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell homeostasis; P:innate immune response; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:mRNA processing; P:negative regulation of apoptotic process; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of RNA interference; P:negative regulation of type I interferon-mediated signaling pathway; P:osteoblast differentiation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:protein export from nucleus; P:protein import into nucleus; P:response to interferon-alpha; P:response to virus; P:RNA processing; P:somatic diversification of immune receptors via somatic mutation; P:type I interferon signaling pathway;|P55265 B1AQQ9 B1AQR0 D3DV76 O15223 O43859 O43860 Q9BYM3 Q9BYM4,Double-stranded RNA-specific adenosine deaminase,136 kDa double-stranded RNA-binding protein;Interferon-inducible protein 4;K88DSRBP;, PF02137;PF00035;PF02295;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0044530;GO:0003677;GO:0003726;GO:0003725;GO:0046872;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0098586;GO:0051607;GO:0060216;GO:0030218;GO:0002244;GO:0061484;GO:0045087;GO:0035280;GO:0006397;GO:0043066;GO:0044387;GO:1900369;GO:0060339;GO:0001649;GO:0045070;GO:0031054;GO:0006611;GO:0006606;GO:0035455;GO:0009615;GO:0006396;GO:0002566;GO:0060337;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:supraspliceosomal complex;, F:DNA binding; F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:cellular response to virus; P:defense response to virus; P:definitive hemopoiesis; P:erythrocyte differentiation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell homeostasis; P:innate immune response; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:mRNA processing; P:negative regulation of apoptotic process; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of RNA interference; P:negative regulation of type I interferon-mediated signaling pathway; P:osteoblast differentiation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:protein export from nucleus; P:protein import into nucleus; P:response to interferon-alpha; P:response to virus; P:RNA processing; P:somatic diversification of immune receptors via somatic mutation; P:type I interferon signaling pathway;|P55265 B1AQQ9 B1AQR0 D3DV76 O15223 O43859 O43860 Q9BYM3 Q9BYM4,Double-stranded RNA-specific adenosine deaminase,136 kDa double-stranded RNA-binding protein;Interferon-inducible protein 4;K88DSRBP;, PF02137;PF00035;PF02295;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0044530;GO:0003677;GO:0003726;GO:0003725;GO:0046872;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0098586;GO:0051607;GO:0060216;GO:0030218;GO:0002244;GO:0061484;GO:0045087;GO:0035280;GO:0006397;GO:0043066;GO:0044387;GO:1900369;GO:0060339;GO:0001649;GO:0045070;GO:0031054;GO:0006611;GO:0006606;GO:0035455;GO:0009615;GO:0006396;GO:0002566;GO:0060337;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:supraspliceosomal complex;, F:DNA binding; F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:cellular response to virus; P:defense response to virus; P:definitive hemopoiesis; P:erythrocyte differentiation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell homeostasis; P:innate immune response; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:mRNA processing; P:negative regulation of apoptotic process; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of RNA interference; P:negative regulation of type I interferon-mediated signaling pathway; P:osteoblast differentiation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:protein export from nucleus; P:protein import into nucleus; P:response to interferon-alpha; P:response to virus; P:RNA processing; P:somatic diversification of immune receptors via somatic mutation; P:type I interferon signaling pathway;|P55265 B1AQQ9 B1AQR0 D3DV76 O15223 O43859 O43860 Q9BYM3 Q9BYM4,Double-stranded RNA-specific adenosine deaminase,136 kDa double-stranded RNA-binding protein;Interferon-inducible protein 4;K88DSRBP;, PF02137;PF00035;PF02295;, GO:0005737;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0044530;GO:0003677;GO:0003726;GO:0003725;GO:0046872;GO:0003723;GO:0008251;GO:0006382;GO:0016553;GO:0098586;GO:0051607;GO:0060216;GO:0030218;GO:0002244;GO:0061484;GO:0045087;GO:0035280;GO:0006397;GO:0043066;GO:0044387;GO:1900369;GO:0060339;GO:0001649;GO:0045070;GO:0031054;GO:0006611;GO:0006606;GO:0035455;GO:0009615;GO:0006396;GO:0002566;GO:0060337;, C:cytoplasm; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:supraspliceosomal complex;, F:DNA binding; F:double-stranded RNA adenosine deaminase activity; F:double-stranded RNA binding; F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:adenosine to inosine editing; P:base conversion or substitution editing; P:cellular response to virus; P:defense response to virus; P:definitive hemopoiesis; P:erythrocyte differentiation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell homeostasis; P:innate immune response; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:mRNA processing; P:negative regulation of apoptotic process; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of RNA interference; P:negative regulation of type I interferon-mediated signaling pathway; P:osteoblast differentiation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:protein export from nucleus; P:protein import into nucleus; P:response to interferon-alpha; P:response to virus; P:RNA processing; P:somatic diversification of immune receptors via somatic mutation; P:type I interferon signaling pathway; scaffold49 indexed_genome mRNA 1653462 1815863 . - . ID=transcript_9251;Q9UGI6 B1ANX0 O43517 Q86VF9 Q8WXG7,Small conductance calcium-activated potassium channel protein 3,KCa2.3;, PF02888;PF07885;PF03530;, GO:0016021;GO:0043005;GO:0043025;GO:0005886;GO:0005516;GO:0016286;GO:0006811;GO:1901381;GO:0071805;, C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:calmodulin binding; F:small conductance calcium-activated potassium channel activity;, P:ion transport; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transmembrane transport; scaffold49 indexed_genome mRNA 1865075 1879043 . - . ID=transcript_9252;Q15126 Q5TZW9,Phosphomevalonate kinase,, PF04275;, GO:0005829;GO:0070062;GO:0016020;GO:0005777;GO:0005524;GO:0004631;GO:0006695;GO:0019287;GO:0019216;GO:0070723;GO:0016126;, C:cytosol; C:extracellular exosome; C:membrane; C:peroxisome;, F:ATP binding; F:phosphomevalonate kinase activity;, P:cholesterol biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:regulation of lipid metabolic process; P:response to cholesterol; P:sterol biosynthetic process;|Q15126 Q5TZW9,Phosphomevalonate kinase,, PF04275;, GO:0005829;GO:0070062;GO:0016020;GO:0005777;GO:0005524;GO:0004631;GO:0006695;GO:0019287;GO:0019216;GO:0070723;GO:0016126;, C:cytosol; C:extracellular exosome; C:membrane; C:peroxisome;, F:ATP binding; F:phosphomevalonate kinase activity;, P:cholesterol biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:regulation of lipid metabolic process; P:response to cholesterol; P:sterol biosynthetic process; scaffold49 indexed_genome mRNA 1893833 1903351 . - . ID=transcript_9253;Q96AQ6 Q5T174 Q5T176 Q9H8X6 Q9HA02 Q9HD85,Pre-B-cell leukemia transcription factor-interacting protein 1,Hematopoietic PBX-interacting protein;, , GO:0005829;GO:0016020;GO:0005874;GO:0005634;GO:0003714;GO:0030154;GO:0007275;GO:0045892;GO:2001106;, C:cytosol; C:membrane; C:microtubule; C:nucleus;, F:transcription corepressor activity;, P:cell differentiation; P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:regulation of Rho guanyl-nucleotide exchange factor activity;|Q96AQ6 Q5T174 Q5T176 Q9H8X6 Q9HA02 Q9HD85,Pre-B-cell leukemia transcription factor-interacting protein 1,Hematopoietic PBX-interacting protein;, , GO:0005829;GO:0016020;GO:0005874;GO:0005634;GO:0003714;GO:0030154;GO:0007275;GO:0045892;GO:2001106;, C:cytosol; C:membrane; C:microtubule; C:nucleus;, F:transcription corepressor activity;, P:cell differentiation; P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:regulation of Rho guanyl-nucleotide exchange factor activity;|Q96AQ6 Q5T174 Q5T176 Q9H8X6 Q9HA02 Q9HD85,Pre-B-cell leukemia transcription factor-interacting protein 1,Hematopoietic PBX-interacting protein;, , GO:0005829;GO:0016020;GO:0005874;GO:0005634;GO:0003714;GO:0030154;GO:0007275;GO:0045892;GO:2001106;, C:cytosol; C:membrane; C:microtubule; C:nucleus;, F:transcription corepressor activity;, P:cell differentiation; P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:regulation of Rho guanyl-nucleotide exchange factor activity;|Q96AQ6 Q5T174 Q5T176 Q9H8X6 Q9HA02 Q9HD85,Pre-B-cell leukemia transcription factor-interacting protein 1,Hematopoietic PBX-interacting protein;, , GO:0005829;GO:0016020;GO:0005874;GO:0005634;GO:0003714;GO:0030154;GO:0007275;GO:0045892;GO:2001106;, C:cytosol; C:membrane; C:microtubule; C:nucleus;, F:transcription corepressor activity;, P:cell differentiation; P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:regulation of Rho guanyl-nucleotide exchange factor activity; scaffold49 indexed_genome mRNA 1906191 1910437 . + . ID=transcript_9254;Q9BRQ0 Q8WYZ4 Q96CY2,Pygopus homolog 2,, PF00628;, GO:1990907;GO:0005654;GO:0003682;GO:0035034;GO:0042393;GO:0046872;GO:1904837;GO:0007420;GO:0060070;GO:0048589;GO:0001822;GO:0002088;GO:0030879;GO:0035563;GO:0051569;GO:0033599;GO:0060021;GO:0007289;, C:beta-catenin-TCF complex; C:nucleoplasm;, F:chromatin binding; F:histone acetyltransferase regulator activity; F:histone binding; F:metal ion binding;, P:beta-catenin-TCF complex assembly; P:brain development; P:canonical Wnt signaling pathway; P:developmental growth; P:kidney development; P:lens development in camera-type eye; P:mammary gland development; P:positive regulation of chromatin binding; P:regulation of histone H3-K4 methylation; P:regulation of mammary gland epithelial cell proliferation; P:roof of mouth development; P:spermatid nucleus differentiation; scaffold49 indexed_genome mRNA 1910829 1921330 . - . ID=transcript_9255;Q8N4K5 Q96CL1,SHC-transforming protein 1,SHC-transforming protein 3;SHC-transforming protein A;Src homology 2 domain-containing-transforming protein C1;, PF00640;PF00017;, GO:0005829;GO:0005759;GO:0005886;GO:0070435;GO:0046875;GO:0048408;GO:0005154;GO:0005158;GO:0005159;GO:0005168;GO:0005543;GO:0001784;GO:0019901;GO:0030971;GO:0005068;GO:0031532;GO:0000187;GO:0001525;GO:0007411;GO:0098609;GO:0071363;GO:0019221;GO:0042742;GO:0007173;GO:0038128;GO:0038095;GO:0007507;GO:0008286;GO:0035723;GO:0038110;GO:0036498;GO:0050900;GO:0000165;GO:0016525;GO:0043066;GO:0045892;GO:0008284;GO:0071864;GO:0070374;GO:0043410;GO:0046579;GO:0045893;GO:0007265;GO:0007176;GO:0040008;GO:0090322;GO:0007169;GO:0016032;, C:cytosol; C:mitochondrial matrix; C:plasma membrane; C:Shc-EGFR complex;, F:ephrin receptor binding; F:epidermal growth factor binding; F:epidermal growth factor receptor binding; F:insulin receptor binding; F:insulin-like growth factor receptor binding; F:neurotrophin TRKA receptor binding; F:phospholipid binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:receptor tyrosine kinase binding; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:actin cytoskeleton reorganization; P:activation of MAPK activity; P:angiogenesis; P:axon guidance; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:heart development; P:insulin receptor signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:leukocyte migration; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of MAPK cascade; P:positive regulation of Ras protein signal transduction; P:positive regulation of transcription, DNA-templated; P:Ras protein signal transduction; P:regulation of epidermal growth factor-activated receptor activity; P:regulation of growth; P:regulation of superoxide metabolic process; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|Q8N4K5 Q96CL1,SHC-transforming protein 1,SHC-transforming protein 3;SHC-transforming protein A;Src homology 2 domain-containing-transforming protein C1;, PF00640;PF00017;, GO:0005829;GO:0005759;GO:0005886;GO:0070435;GO:0046875;GO:0048408;GO:0005154;GO:0005158;GO:0005159;GO:0005168;GO:0005543;GO:0001784;GO:0019901;GO:0030971;GO:0005068;GO:0031532;GO:0000187;GO:0001525;GO:0007411;GO:0098609;GO:0071363;GO:0019221;GO:0042742;GO:0007173;GO:0038128;GO:0038095;GO:0007507;GO:0008286;GO:0035723;GO:0038110;GO:0036498;GO:0050900;GO:0000165;GO:0016525;GO:0043066;GO:0045892;GO:0008284;GO:0071864;GO:0070374;GO:0043410;GO:0046579;GO:0045893;GO:0007265;GO:0007176;GO:0040008;GO:0090322;GO:0007169;GO:0016032;, C:cytosol; C:mitochondrial matrix; C:plasma membrane; C:Shc-EGFR complex;, F:ephrin receptor binding; F:epidermal growth factor binding; F:epidermal growth factor receptor binding; F:insulin receptor binding; F:insulin-like growth factor receptor binding; F:neurotrophin TRKA receptor binding; F:phospholipid binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:receptor tyrosine kinase binding; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:actin cytoskeleton reorganization; P:activation of MAPK activity; P:angiogenesis; P:axon guidance; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:heart development; P:insulin receptor signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:leukocyte migration; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of MAPK cascade; P:positive regulation of Ras protein signal transduction; P:positive regulation of transcription, DNA-templated; P:Ras protein signal transduction; P:regulation of epidermal growth factor-activated receptor activity; P:regulation of growth; P:regulation of superoxide metabolic process; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|Q8N4K5 Q96CL1,SHC-transforming protein 1,SHC-transforming protein 3;SHC-transforming protein A;Src homology 2 domain-containing-transforming protein C1;, PF00640;PF00017;, GO:0005829;GO:0005759;GO:0005886;GO:0070435;GO:0046875;GO:0048408;GO:0005154;GO:0005158;GO:0005159;GO:0005168;GO:0005543;GO:0001784;GO:0019901;GO:0030971;GO:0005068;GO:0031532;GO:0000187;GO:0001525;GO:0007411;GO:0098609;GO:0071363;GO:0019221;GO:0042742;GO:0007173;GO:0038128;GO:0038095;GO:0007507;GO:0008286;GO:0035723;GO:0038110;GO:0036498;GO:0050900;GO:0000165;GO:0016525;GO:0043066;GO:0045892;GO:0008284;GO:0071864;GO:0070374;GO:0043410;GO:0046579;GO:0045893;GO:0007265;GO:0007176;GO:0040008;GO:0090322;GO:0007169;GO:0016032;, C:cytosol; C:mitochondrial matrix; C:plasma membrane; C:Shc-EGFR complex;, F:ephrin receptor binding; F:epidermal growth factor binding; F:epidermal growth factor receptor binding; F:insulin receptor binding; F:insulin-like growth factor receptor binding; F:neurotrophin TRKA receptor binding; F:phospholipid binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:receptor tyrosine kinase binding; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:actin cytoskeleton reorganization; P:activation of MAPK activity; P:angiogenesis; P:axon guidance; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:heart development; P:insulin receptor signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:leukocyte migration; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of MAPK cascade; P:positive regulation of Ras protein signal transduction; P:positive regulation of transcription, DNA-templated; P:Ras protein signal transduction; P:regulation of epidermal growth factor-activated receptor activity; P:regulation of growth; P:regulation of superoxide metabolic process; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|Q8N4K5 Q96CL1,SHC-transforming protein 1,SHC-transforming protein 3;SHC-transforming protein A;Src homology 2 domain-containing-transforming protein C1;, PF00640;PF00017;, GO:0005829;GO:0005759;GO:0005886;GO:0070435;GO:0046875;GO:0048408;GO:0005154;GO:0005158;GO:0005159;GO:0005168;GO:0005543;GO:0001784;GO:0019901;GO:0030971;GO:0005068;GO:0031532;GO:0000187;GO:0001525;GO:0007411;GO:0098609;GO:0071363;GO:0019221;GO:0042742;GO:0007173;GO:0038128;GO:0038095;GO:0007507;GO:0008286;GO:0035723;GO:0038110;GO:0036498;GO:0050900;GO:0000165;GO:0016525;GO:0043066;GO:0045892;GO:0008284;GO:0071864;GO:0070374;GO:0043410;GO:0046579;GO:0045893;GO:0007265;GO:0007176;GO:0040008;GO:0090322;GO:0007169;GO:0016032;, C:cytosol; C:mitochondrial matrix; C:plasma membrane; C:Shc-EGFR complex;, F:ephrin receptor binding; F:epidermal growth factor binding; F:epidermal growth factor receptor binding; F:insulin receptor binding; F:insulin-like growth factor receptor binding; F:neurotrophin TRKA receptor binding; F:phospholipid binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:receptor tyrosine kinase binding; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:actin cytoskeleton reorganization; P:activation of MAPK activity; P:angiogenesis; P:axon guidance; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:heart development; P:insulin receptor signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:leukocyte migration; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of MAPK cascade; P:positive regulation of Ras protein signal transduction; P:positive regulation of transcription, DNA-templated; P:Ras protein signal transduction; P:regulation of epidermal growth factor-activated receptor activity; P:regulation of growth; P:regulation of superoxide metabolic process; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process;|Q8N4K5 Q96CL1,SHC-transforming protein 1,SHC-transforming protein 3;SHC-transforming protein A;Src homology 2 domain-containing-transforming protein C1;, PF00640;PF00017;, GO:0005829;GO:0005759;GO:0005886;GO:0070435;GO:0046875;GO:0048408;GO:0005154;GO:0005158;GO:0005159;GO:0005168;GO:0005543;GO:0001784;GO:0019901;GO:0030971;GO:0005068;GO:0031532;GO:0000187;GO:0001525;GO:0007411;GO:0098609;GO:0071363;GO:0019221;GO:0042742;GO:0007173;GO:0038128;GO:0038095;GO:0007507;GO:0008286;GO:0035723;GO:0038110;GO:0036498;GO:0050900;GO:0000165;GO:0016525;GO:0043066;GO:0045892;GO:0008284;GO:0071864;GO:0070374;GO:0043410;GO:0046579;GO:0045893;GO:0007265;GO:0007176;GO:0040008;GO:0090322;GO:0007169;GO:0016032;, C:cytosol; C:mitochondrial matrix; C:plasma membrane; C:Shc-EGFR complex;, F:ephrin receptor binding; F:epidermal growth factor binding; F:epidermal growth factor receptor binding; F:insulin receptor binding; F:insulin-like growth factor receptor binding; F:neurotrophin TRKA receptor binding; F:phospholipid binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:receptor tyrosine kinase binding; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:actin cytoskeleton reorganization; P:activation of MAPK activity; P:angiogenesis; P:axon guidance; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:heart development; P:insulin receptor signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:leukocyte migration; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of MAPK cascade; P:positive regulation of Ras protein signal transduction; P:positive regulation of transcription, DNA-templated; P:Ras protein signal transduction; P:regulation of epidermal growth factor-activated receptor activity; P:regulation of growth; P:regulation of superoxide metabolic process; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process; scaffold49 indexed_genome mRNA 1921657 1925532 . + . ID=transcript_9256;P61024 P33551,Cyclin-dependent kinases regulatory subunit 1,, PF01111;, GO:0000307;GO:0005654;GO:0019005;GO:0061575;GO:0042393;GO:0019901;GO:0043130;GO:0051301;GO:0008283;GO:0044772;GO:0007346;GO:0006355;, C:cyclin-dependent protein kinase holoenzyme complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:cyclin-dependent protein serine/threonine kinase activator activity; F:histone binding; F:protein kinase binding; F:ubiquitin binding;, P:cell division; P:cell population proliferation; P:mitotic cell cycle phase transition; P:regulation of mitotic cell cycle; P:regulation of transcription, DNA-templated; scaffold49 indexed_genome mRNA 1928250 1934156 . + . ID=transcript_9257;Q8NFF5 Q8N5J1 Q8N686 Q8WU93 Q8WUJ4 Q96CR8 Q99764 Q9HBN6,FAD synthase,FAD pyrophosphorylase;FMN adenylyltransferase;Flavin adenine dinucleotide synthase;, PF00994;PF01507;, GO:0005829;GO:0005759;GO:0005886;GO:0005524;GO:0003919;GO:0042802;GO:0006747;GO:0006771;, C:cytosol; C:mitochondrial matrix; C:plasma membrane;, F:ATP binding; F:FMN adenylyltransferase activity; F:identical protein binding;, P:FAD biosynthetic process; P:riboflavin metabolic process;|Q8NFF5 Q8N5J1 Q8N686 Q8WU93 Q8WUJ4 Q96CR8 Q99764 Q9HBN6,FAD synthase,FAD pyrophosphorylase;FMN adenylyltransferase;Flavin adenine dinucleotide synthase;, PF00994;PF01507;, GO:0005829;GO:0005759;GO:0005886;GO:0005524;GO:0003919;GO:0042802;GO:0006747;GO:0006771;, C:cytosol; C:mitochondrial matrix; C:plasma membrane;, F:ATP binding; F:FMN adenylyltransferase activity; F:identical protein binding;, P:FAD biosynthetic process; P:riboflavin metabolic process;|Q8NFF5 Q8N5J1 Q8N686 Q8WU93 Q8WUJ4 Q96CR8 Q99764 Q9HBN6,FAD synthase,FAD pyrophosphorylase;FMN adenylyltransferase;Flavin adenine dinucleotide synthase;, PF00994;PF01507;, GO:0005829;GO:0005759;GO:0005886;GO:0005524;GO:0003919;GO:0042802;GO:0006747;GO:0006771;, C:cytosol; C:mitochondrial matrix; C:plasma membrane;, F:ATP binding; F:FMN adenylyltransferase activity; F:identical protein binding;, P:FAD biosynthetic process; P:riboflavin metabolic process;|Q8NFF5 Q8N5J1 Q8N686 Q8WU93 Q8WUJ4 Q96CR8 Q99764 Q9HBN6,FAD synthase,FAD pyrophosphorylase;FMN adenylyltransferase;Flavin adenine dinucleotide synthase;, PF00994;PF01507;, GO:0005829;GO:0005759;GO:0005886;GO:0005524;GO:0003919;GO:0042802;GO:0006747;GO:0006771;, C:cytosol; C:mitochondrial matrix; C:plasma membrane;, F:ATP binding; F:FMN adenylyltransferase activity; F:identical protein binding;, P:FAD biosynthetic process; P:riboflavin metabolic process; scaffold49 indexed_genome mRNA 1953961 1958608 . + . ID=transcript_9258;O15156 B4E3K5 D3DV83 J3KQQ3 Q68DR2 Q96EP2,Zinc finger and BTB domain-containing protein 7B {ECO:0000305},Krueppel-related zinc finger protein cKrox;T-helper-inducing POZ/Krueppel-like factor;Zinc finger and BTB domain-containing protein 15;Zinc finger protein 67 homolog;Zinc finger protein 857B;Zinc finger protein Th-POK;, PF00651;PF00096;, GO:0005654;GO:0000987;GO:0001228;GO:0000981;GO:0042826;GO:0046872;GO:0042803;GO:0000978;GO:1990837;GO:1990845;GO:0007398;GO:0007595;GO:0043377;GO:0051141;GO:2000320;GO:0000122;GO:0001865;GO:0090336;GO:0043372;GO:0120162;GO:0010628;GO:0031065;GO:0046628;GO:0032740;GO:2000640;GO:0006357;GO:0032868;GO:0006366;, C:nucleoplasm;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:metal ion binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adaptive thermogenesis; P:ectoderm development; P:lactation; P:negative regulation of CD8-positive, alpha-beta T cell differentiation; P:negative regulation of NK T cell proliferation; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:NK T cell differentiation; P:positive regulation of brown fat cell differentiation; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of gene expression; P:positive regulation of histone deacetylation; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interleukin-17 production; P:positive regulation of SREBP signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to insulin; P:transcription by RNA polymerase II; scaffold49 indexed_genome mRNA 1999794 2000442 . + . ID=transcript_9259;Q71S69 Q96C78 U3KQL5,Disintegrin and metalloproteinase domain-containing protein 15,Metalloprotease RGD disintegrin protein;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15;Metargidin;, PF08516;PF00200;PF01562;PF01421;, GO:0001669;GO:0005912;GO:0009986;GO:0070062;GO:0005615;GO:0016021;GO:0031514;GO:0005886;GO:0005178;GO:0046872;GO:0004222;GO:0008237;GO:0017124;GO:0001525;GO:0060317;GO:0007160;GO:1904628;GO:0030574;GO:0022617;GO:0030198;GO:0002418;GO:0045087;GO:0007229;GO:0008584;GO:0030308;GO:0030336;GO:0001953;GO:1900121;GO:1990910;GO:0042246;, C:acrosomal vesicle; C:adherens junction; C:cell surface; C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:motile cilium; C:plasma membrane;, F:integrin binding; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:SH3 domain binding;, P:angiogenesis; P:cardiac epithelial to mesenchymal transition; P:cell-matrix adhesion; P:cellular response to phorbol 13-acetate 12-myristate; P:collagen catabolic process; P:extracellular matrix disassembly; P:extracellular matrix organization; P:immune response to tumor cell; P:innate immune response; P:integrin-mediated signaling pathway; P:male gonad development; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell-matrix adhesion; P:negative regulation of receptor binding; P:response to hypobaric hypoxia; P:tissue regeneration; scaffold49 indexed_genome mRNA 2001390 2001957 . + . ID=transcript_9260;Q71S69 Q96C78 U3KQL5,Disintegrin and metalloproteinase domain-containing protein 15,Metalloprotease RGD disintegrin protein;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15;Metargidin;, PF08516;PF00200;PF01562;PF01421;, GO:0001669;GO:0005912;GO:0009986;GO:0070062;GO:0005615;GO:0016021;GO:0031514;GO:0005886;GO:0005178;GO:0046872;GO:0004222;GO:0008237;GO:0017124;GO:0001525;GO:0060317;GO:0007160;GO:1904628;GO:0030574;GO:0022617;GO:0030198;GO:0002418;GO:0045087;GO:0007229;GO:0008584;GO:0030308;GO:0030336;GO:0001953;GO:1900121;GO:1990910;GO:0042246;, C:acrosomal vesicle; C:adherens junction; C:cell surface; C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:motile cilium; C:plasma membrane;, F:integrin binding; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:SH3 domain binding;, P:angiogenesis; P:cardiac epithelial to mesenchymal transition; P:cell-matrix adhesion; P:cellular response to phorbol 13-acetate 12-myristate; P:collagen catabolic process; P:extracellular matrix disassembly; P:extracellular matrix organization; P:immune response to tumor cell; P:innate immune response; P:integrin-mediated signaling pathway; P:male gonad development; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell-matrix adhesion; P:negative regulation of receptor binding; P:response to hypobaric hypoxia; P:tissue regeneration; scaffold49 indexed_genome mRNA 2003232 2006369 . + . ID=transcript_9261;Q71S69 Q96C78 U3KQL5,Disintegrin and metalloproteinase domain-containing protein 15,Metalloprotease RGD disintegrin protein;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15;Metargidin;, PF08516;PF00200;PF01562;PF01421;, GO:0001669;GO:0005912;GO:0009986;GO:0070062;GO:0005615;GO:0016021;GO:0031514;GO:0005886;GO:0005178;GO:0046872;GO:0004222;GO:0008237;GO:0017124;GO:0001525;GO:0060317;GO:0007160;GO:1904628;GO:0030574;GO:0022617;GO:0030198;GO:0002418;GO:0045087;GO:0007229;GO:0008584;GO:0030308;GO:0030336;GO:0001953;GO:1900121;GO:1990910;GO:0042246;, C:acrosomal vesicle; C:adherens junction; C:cell surface; C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:motile cilium; C:plasma membrane;, F:integrin binding; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:SH3 domain binding;, P:angiogenesis; P:cardiac epithelial to mesenchymal transition; P:cell-matrix adhesion; P:cellular response to phorbol 13-acetate 12-myristate; P:collagen catabolic process; P:extracellular matrix disassembly; P:extracellular matrix organization; P:immune response to tumor cell; P:innate immune response; P:integrin-mediated signaling pathway; P:male gonad development; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell-matrix adhesion; P:negative regulation of receptor binding; P:response to hypobaric hypoxia; P:tissue regeneration;|Q71S69 Q96C78 U3KQL5,Disintegrin and metalloproteinase domain-containing protein 15,Metalloprotease RGD disintegrin protein;Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15;Metargidin;, PF08516;PF00200;PF01562;PF01421;, GO:0001669;GO:0005912;GO:0009986;GO:0070062;GO:0005615;GO:0016021;GO:0031514;GO:0005886;GO:0005178;GO:0046872;GO:0004222;GO:0008237;GO:0017124;GO:0001525;GO:0060317;GO:0007160;GO:1904628;GO:0030574;GO:0022617;GO:0030198;GO:0002418;GO:0045087;GO:0007229;GO:0008584;GO:0030308;GO:0030336;GO:0001953;GO:1900121;GO:1990910;GO:0042246;, C:acrosomal vesicle; C:adherens junction; C:cell surface; C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:motile cilium; C:plasma membrane;, F:integrin binding; F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:SH3 domain binding;, P:angiogenesis; P:cardiac epithelial to mesenchymal transition; P:cell-matrix adhesion; P:cellular response to phorbol 13-acetate 12-myristate; P:collagen catabolic process; P:extracellular matrix disassembly; P:extracellular matrix organization; P:immune response to tumor cell; P:innate immune response; P:integrin-mediated signaling pathway; P:male gonad development; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell-matrix adhesion; P:negative regulation of receptor binding; P:response to hypobaric hypoxia; P:tissue regeneration; scaffold49 indexed_genome mRNA 2028295 2031168 . + . ID=transcript_9262;P52797 B7ZAD3 D3DV85 Q0VGC9 Q5SR70,Ephrin-A3,EFL-2;EHK1 ligand;EPH-related receptor tyrosine kinase ligand 3;, PF00812;, GO:0031225;GO:0031226;GO:0005886;GO:0046875;GO:0005005;GO:0007411;GO:0007267;GO:0048013;GO:0016525;GO:1902961;GO:0045664;, C:anchored component of membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:ephrin receptor binding; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:cell-cell signaling; P:ephrin receptor signaling pathway; P:negative regulation of angiogenesis; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:regulation of neuron differentiation;|P52797 B7ZAD3 D3DV85 Q0VGC9 Q5SR70,Ephrin-A3,EFL-2;EHK1 ligand;EPH-related receptor tyrosine kinase ligand 3;, PF00812;, GO:0031225;GO:0031226;GO:0005886;GO:0046875;GO:0005005;GO:0007411;GO:0007267;GO:0048013;GO:0016525;GO:1902961;GO:0045664;, C:anchored component of membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:ephrin receptor binding; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:cell-cell signaling; P:ephrin receptor signaling pathway; P:negative regulation of angiogenesis; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:regulation of neuron differentiation; scaffold49 indexed_genome mRNA 2065953 2067038 . + . ID=transcript_9263;P20827 D3DV86 Q5SR60 Q5SR61 Q6I9T9 Q8N578,Ephrin-A1,EPH-related receptor tyrosine kinase ligand 1;Immediate early response protein B61;Tumor necrosis factor alpha-induced protein 4;, PF00812;, GO:0046658;GO:0005576;GO:0005886;GO:0046875;GO:0005102;GO:0001525;GO:0003180;GO:0007411;GO:0016477;GO:0007267;GO:0003199;GO:0048013;GO:0003183;GO:0061002;GO:0010719;GO:0043409;GO:1903051;GO:0070244;GO:0000122;GO:0014028;GO:1902004;GO:1902961;GO:0043410;GO:0050731;GO:0001934;GO:0061098;GO:0050821;GO:0045765;GO:0050770;GO:0043535;GO:0033628;GO:0050730;GO:0034446;, C:anchored component of plasma membrane; C:extracellular region; C:plasma membrane;, F:ephrin receptor binding; F:signaling receptor binding;, P:angiogenesis; P:aortic valve morphogenesis; P:axon guidance; P:cell migration; P:cell-cell signaling; P:endocardial cushion to mesenchymal transition involved in heart valve formation; P:ephrin receptor signaling pathway; P:mitral valve morphogenesis; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of MAPK cascade; P:negative regulation of proteolysis involved in cellular protein catabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:notochord formation; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:protein stabilization; P:regulation of angiogenesis; P:regulation of axonogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of peptidyl-tyrosine phosphorylation; P:substrate adhesion-dependent cell spreading; scaffold49 indexed_genome mRNA 2072118 2079648 . + . ID=transcript_9264;P20827 D3DV86 Q5SR60 Q5SR61 Q6I9T9 Q8N578,Ephrin-A1,EPH-related receptor tyrosine kinase ligand 1;Immediate early response protein B61;Tumor necrosis factor alpha-induced protein 4;, PF00812;, GO:0046658;GO:0005576;GO:0005886;GO:0046875;GO:0005102;GO:0001525;GO:0003180;GO:0007411;GO:0016477;GO:0007267;GO:0003199;GO:0048013;GO:0003183;GO:0061002;GO:0010719;GO:0043409;GO:1903051;GO:0070244;GO:0000122;GO:0014028;GO:1902004;GO:1902961;GO:0043410;GO:0050731;GO:0001934;GO:0061098;GO:0050821;GO:0045765;GO:0050770;GO:0043535;GO:0033628;GO:0050730;GO:0034446;, C:anchored component of plasma membrane; C:extracellular region; C:plasma membrane;, F:ephrin receptor binding; F:signaling receptor binding;, P:angiogenesis; P:aortic valve morphogenesis; P:axon guidance; P:cell migration; P:cell-cell signaling; P:endocardial cushion to mesenchymal transition involved in heart valve formation; P:ephrin receptor signaling pathway; P:mitral valve morphogenesis; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of MAPK cascade; P:negative regulation of proteolysis involved in cellular protein catabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:notochord formation; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:protein stabilization; P:regulation of angiogenesis; P:regulation of axonogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of peptidyl-tyrosine phosphorylation; P:substrate adhesion-dependent cell spreading;|P20827 D3DV86 Q5SR60 Q5SR61 Q6I9T9 Q8N578,Ephrin-A1,EPH-related receptor tyrosine kinase ligand 1;Immediate early response protein B61;Tumor necrosis factor alpha-induced protein 4;, PF00812;, GO:0046658;GO:0005576;GO:0005886;GO:0046875;GO:0005102;GO:0001525;GO:0003180;GO:0007411;GO:0016477;GO:0007267;GO:0003199;GO:0048013;GO:0003183;GO:0061002;GO:0010719;GO:0043409;GO:1903051;GO:0070244;GO:0000122;GO:0014028;GO:1902004;GO:1902961;GO:0043410;GO:0050731;GO:0001934;GO:0061098;GO:0050821;GO:0045765;GO:0050770;GO:0043535;GO:0033628;GO:0050730;GO:0034446;, C:anchored component of plasma membrane; C:extracellular region; C:plasma membrane;, F:ephrin receptor binding; F:signaling receptor binding;, P:angiogenesis; P:aortic valve morphogenesis; P:axon guidance; P:cell migration; P:cell-cell signaling; P:endocardial cushion to mesenchymal transition involved in heart valve formation; P:ephrin receptor signaling pathway; P:mitral valve morphogenesis; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of MAPK cascade; P:negative regulation of proteolysis involved in cellular protein catabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:notochord formation; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:protein stabilization; P:regulation of angiogenesis; P:regulation of axonogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of peptidyl-tyrosine phosphorylation; P:substrate adhesion-dependent cell spreading;|P20827 D3DV86 Q5SR60 Q5SR61 Q6I9T9 Q8N578,Ephrin-A1,EPH-related receptor tyrosine kinase ligand 1;Immediate early response protein B61;Tumor necrosis factor alpha-induced protein 4;, PF00812;, GO:0046658;GO:0005576;GO:0005886;GO:0046875;GO:0005102;GO:0001525;GO:0003180;GO:0007411;GO:0016477;GO:0007267;GO:0003199;GO:0048013;GO:0003183;GO:0061002;GO:0010719;GO:0043409;GO:1903051;GO:0070244;GO:0000122;GO:0014028;GO:1902004;GO:1902961;GO:0043410;GO:0050731;GO:0001934;GO:0061098;GO:0050821;GO:0045765;GO:0050770;GO:0043535;GO:0033628;GO:0050730;GO:0034446;, C:anchored component of plasma membrane; C:extracellular region; C:plasma membrane;, F:ephrin receptor binding; F:signaling receptor binding;, P:angiogenesis; P:aortic valve morphogenesis; P:axon guidance; P:cell migration; P:cell-cell signaling; P:endocardial cushion to mesenchymal transition involved in heart valve formation; P:ephrin receptor signaling pathway; P:mitral valve morphogenesis; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of MAPK cascade; P:negative regulation of proteolysis involved in cellular protein catabolic process; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:notochord formation; P:positive regulation of amyloid-beta formation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:protein stabilization; P:regulation of angiogenesis; P:regulation of axonogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of peptidyl-tyrosine phosphorylation; P:substrate adhesion-dependent cell spreading; scaffold49 indexed_genome mRNA 2079862 2083042 . + . ID=transcript_9265;Q9BRV3 Q5SR64 Q6IAK6 Q96DC5 Q9UHQ2 Q9UHQ3,Sugar transporter SWEET1,RAG1-activating protein 1;Solute carrier family 50 member 1;Stromal cell protein;, PF03083;, GO:0012505;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0042947;GO:0051119;GO:0008643;GO:0008645;, C:endomembrane system; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:glucoside transmembrane transporter activity; F:sugar transmembrane transporter activity;, P:carbohydrate transport; P:hexose transmembrane transport; scaffold49 indexed_genome mRNA 2093991 2100768 . - . ID=transcript_9266;Q8N6L1 B2R4Q1 Q6PG45 Q86XW2 Q8IWS4,Keratinocyte-associated protein 2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2;, PF09775;, GO:0016021;GO:0008250;GO:0008047;GO:0006487;GO:0042543;, C:integral component of membrane; C:oligosaccharyltransferase complex;, F:enzyme activator activity;, P:protein N-linked glycosylation; P:protein N-linked glycosylation via arginine;|Q8N6L1 B2R4Q1 Q6PG45 Q86XW2 Q8IWS4,Keratinocyte-associated protein 2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2;, PF09775;, GO:0016021;GO:0008250;GO:0008047;GO:0006487;GO:0042543;, C:integral component of membrane; C:oligosaccharyltransferase complex;, F:enzyme activator activity;, P:protein N-linked glycosylation; P:protein N-linked glycosylation via arginine;|Q8N6L1 B2R4Q1 Q6PG45 Q86XW2 Q8IWS4,Keratinocyte-associated protein 2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2;, PF09775;, GO:0016021;GO:0008250;GO:0008047;GO:0006487;GO:0042543;, C:integral component of membrane; C:oligosaccharyltransferase complex;, F:enzyme activator activity;, P:protein N-linked glycosylation; P:protein N-linked glycosylation via arginine;|Q7Z4K8 A0AVI6 B1AVQ4 Q5VT60 Q5VT62 Q6NT17 Q6NT41 Q6ZRL7 Q9H5P2,Tripartite motif-containing protein 46,Gene Y protein;Tripartite, fibronectin type-III and C-terminal SPRY motif protein;, PF18568;PF00643;PF13445;, GO:1904115;GO:0043194;GO:0005856;GO:0044304;GO:1990769;GO:0008270;GO:0048490;GO:0007409;GO:0001578;GO:0030517;GO:0001764;GO:1901953;GO:0099612;GO:1903827;, C:axon cytoplasm; C:axon initial segment; C:cytoskeleton; C:main axon; C:proximal neuron projection;, F:zinc ion binding;, P:anterograde synaptic vesicle transport; P:axonogenesis; P:microtubule bundle formation; P:negative regulation of axon extension; P:neuron migration; P:positive regulation of anterograde dense core granule transport; P:protein localization to axon; P:regulation of cellular protein localization;|Q7Z4K8 A0AVI6 B1AVQ4 Q5VT60 Q5VT62 Q6NT17 Q6NT41 Q6ZRL7 Q9H5P2,Tripartite motif-containing protein 46,Gene Y protein;Tripartite, fibronectin type-III and C-terminal SPRY motif protein;, PF18568;PF00643;PF13445;, GO:1904115;GO:0043194;GO:0005856;GO:0044304;GO:1990769;GO:0008270;GO:0048490;GO:0007409;GO:0001578;GO:0030517;GO:0001764;GO:1901953;GO:0099612;GO:1903827;, C:axon cytoplasm; C:axon initial segment; C:cytoskeleton; C:main axon; C:proximal neuron projection;, F:zinc ion binding;, P:anterograde synaptic vesicle transport; P:axonogenesis; P:microtubule bundle formation; P:negative regulation of axon extension; P:neuron migration; P:positive regulation of anterograde dense core granule transport; P:protein localization to axon; P:regulation of cellular protein localization; scaffold49 indexed_genome mRNA 2101635 2108946 . + . ID=transcript_9267;Q7Z4K8 A0AVI6 B1AVQ4 Q5VT60 Q5VT62 Q6NT17 Q6NT41 Q6ZRL7 Q9H5P2,Tripartite motif-containing protein 46,Gene Y protein;Tripartite, fibronectin type-III and C-terminal SPRY motif protein;, PF18568;PF00643;PF13445;, GO:1904115;GO:0043194;GO:0005856;GO:0044304;GO:1990769;GO:0008270;GO:0048490;GO:0007409;GO:0001578;GO:0030517;GO:0001764;GO:1901953;GO:0099612;GO:1903827;, C:axon cytoplasm; C:axon initial segment; C:cytoskeleton; C:main axon; C:proximal neuron projection;, F:zinc ion binding;, P:anterograde synaptic vesicle transport; P:axonogenesis; P:microtubule bundle formation; P:negative regulation of axon extension; P:neuron migration; P:positive regulation of anterograde dense core granule transport; P:protein localization to axon; P:regulation of cellular protein localization;|Q7Z4K8 A0AVI6 B1AVQ4 Q5VT60 Q5VT62 Q6NT17 Q6NT41 Q6ZRL7 Q9H5P2,Tripartite motif-containing protein 46,Gene Y protein;Tripartite, fibronectin type-III and C-terminal SPRY motif protein;, PF18568;PF00643;PF13445;, GO:1904115;GO:0043194;GO:0005856;GO:0044304;GO:1990769;GO:0008270;GO:0048490;GO:0007409;GO:0001578;GO:0030517;GO:0001764;GO:1901953;GO:0099612;GO:1903827;, C:axon cytoplasm; C:axon initial segment; C:cytoskeleton; C:main axon; C:proximal neuron projection;, F:zinc ion binding;, P:anterograde synaptic vesicle transport; P:axonogenesis; P:microtubule bundle formation; P:negative regulation of axon extension; P:neuron migration; P:positive regulation of anterograde dense core granule transport; P:protein localization to axon; P:regulation of cellular protein localization;|Q7Z4K8 A0AVI6 B1AVQ4 Q5VT60 Q5VT62 Q6NT17 Q6NT41 Q6ZRL7 Q9H5P2,Tripartite motif-containing protein 46,Gene Y protein;Tripartite, fibronectin type-III and C-terminal SPRY motif protein;, PF18568;PF00643;PF13445;, GO:1904115;GO:0043194;GO:0005856;GO:0044304;GO:1990769;GO:0008270;GO:0048490;GO:0007409;GO:0001578;GO:0030517;GO:0001764;GO:1901953;GO:0099612;GO:1903827;, C:axon cytoplasm; C:axon initial segment; C:cytoskeleton; C:main axon; C:proximal neuron projection;, F:zinc ion binding;, P:anterograde synaptic vesicle transport; P:axonogenesis; P:microtubule bundle formation; P:negative regulation of axon extension; P:neuron migration; P:positive regulation of anterograde dense core granule transport; P:protein localization to axon; P:regulation of cellular protein localization; scaffold49 indexed_genome mRNA 2110001 2113870 . + . ID=transcript_9268;Q9UQL1 Q9Y4J2,Mucin-1,Breast carcinoma-associated antigen DF3;Cancer antigen 15-3;Carcinoma-associated mucin;Episialin;H23AG;Krebs von den Lungen-6;PEMT;Peanut-reactive urinary mucin;Polymorphic epithelial mucin;Tumor-associated epithelial membrane antigen;Tumor-associated mucin;, PF01390;, GO:0016324;GO:0000785;GO:0070062;GO:0005615;GO:0005796;GO:0005887;GO:0005634;GO:0005886;GO:0031982;GO:0002039;GO:0000978;GO:0003712;GO:0019221;GO:0006977;GO:0006978;GO:0033629;GO:1902166;GO:0010944;GO:0016266;GO:0090240;GO:0036003;GO:0043618;GO:0002223;, C:apical plasma membrane; C:chromatin; C:extracellular exosome; C:extracellular space; C:Golgi lumen; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:vesicle;, F:p53 binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coregulator activity;, P:cytokine-mediated signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of transcription by competitive promoter binding; P:O-glycan processing; P:positive regulation of histone H4 acetylation; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:regulation of transcription from RNA polymerase II promoter in response to stress; P:stimulatory C-type lectin receptor signaling pathway; scaffold49 indexed_genome mRNA 2116087 2125412 . - . ID=transcript_9269;P49746 B1AVR8 B4DQ20 Q8WV34,Thrombospondin-3,, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0005576;GO:0048471;GO:0005509;GO:0008201;GO:0060346;GO:0007160;GO:0003417;GO:0043931;, C:collagen-containing extracellular matrix; C:extracellular region; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding;, P:bone trabecula formation; P:cell-matrix adhesion; P:growth plate cartilage development; P:ossification involved in bone maturation;|P49746 B1AVR8 B4DQ20 Q8WV34,Thrombospondin-3,, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0005576;GO:0048471;GO:0005509;GO:0008201;GO:0060346;GO:0007160;GO:0003417;GO:0043931;, C:collagen-containing extracellular matrix; C:extracellular region; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding;, P:bone trabecula formation; P:cell-matrix adhesion; P:growth plate cartilage development; P:ossification involved in bone maturation;|P49746 B1AVR8 B4DQ20 Q8WV34,Thrombospondin-3,, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0005576;GO:0048471;GO:0005509;GO:0008201;GO:0060346;GO:0007160;GO:0003417;GO:0043931;, C:collagen-containing extracellular matrix; C:extracellular region; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding;, P:bone trabecula formation; P:cell-matrix adhesion; P:growth plate cartilage development; P:ossification involved in bone maturation;|P49746 B1AVR8 B4DQ20 Q8WV34,Thrombospondin-3,, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0005576;GO:0048471;GO:0005509;GO:0008201;GO:0060346;GO:0007160;GO:0003417;GO:0043931;, C:collagen-containing extracellular matrix; C:extracellular region; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding;, P:bone trabecula formation; P:cell-matrix adhesion; P:growth plate cartilage development; P:ossification involved in bone maturation;|P49746 B1AVR8 B4DQ20 Q8WV34,Thrombospondin-3,, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0005576;GO:0048471;GO:0005509;GO:0008201;GO:0060346;GO:0007160;GO:0003417;GO:0043931;, C:collagen-containing extracellular matrix; C:extracellular region; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding;, P:bone trabecula formation; P:cell-matrix adhesion; P:growth plate cartilage development; P:ossification involved in bone maturation;|P49746 B1AVR8 B4DQ20 Q8WV34,Thrombospondin-3,, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0005576;GO:0048471;GO:0005509;GO:0008201;GO:0060346;GO:0007160;GO:0003417;GO:0043931;, C:collagen-containing extracellular matrix; C:extracellular region; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding;, P:bone trabecula formation; P:cell-matrix adhesion; P:growth plate cartilage development; P:ossification involved in bone maturation;|P49746 B1AVR8 B4DQ20 Q8WV34,Thrombospondin-3,, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0005576;GO:0048471;GO:0005509;GO:0008201;GO:0060346;GO:0007160;GO:0003417;GO:0043931;, C:collagen-containing extracellular matrix; C:extracellular region; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding;, P:bone trabecula formation; P:cell-matrix adhesion; P:growth plate cartilage development; P:ossification involved in bone maturation;|P49746 B1AVR8 B4DQ20 Q8WV34,Thrombospondin-3,, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0005576;GO:0048471;GO:0005509;GO:0008201;GO:0060346;GO:0007160;GO:0003417;GO:0043931;, C:collagen-containing extracellular matrix; C:extracellular region; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding;, P:bone trabecula formation; P:cell-matrix adhesion; P:growth plate cartilage development; P:ossification involved in bone maturation;|P49746 B1AVR8 B4DQ20 Q8WV34,Thrombospondin-3,, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0005576;GO:0048471;GO:0005509;GO:0008201;GO:0060346;GO:0007160;GO:0003417;GO:0043931;, C:collagen-containing extracellular matrix; C:extracellular region; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding;, P:bone trabecula formation; P:cell-matrix adhesion; P:growth plate cartilage development; P:ossification involved in bone maturation;|P49746 B1AVR8 B4DQ20 Q8WV34,Thrombospondin-3,, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0005576;GO:0048471;GO:0005509;GO:0008201;GO:0060346;GO:0007160;GO:0003417;GO:0043931;, C:collagen-containing extracellular matrix; C:extracellular region; C:perinuclear region of cytoplasm;, F:calcium ion binding; F:heparin binding;, P:bone trabecula formation; P:cell-matrix adhesion; P:growth plate cartilage development; P:ossification involved in bone maturation; scaffold49 indexed_genome mRNA 2127665 2138690 . + . ID=transcript_9270;Q9UMJ8,Lysosomal acid glucosylceramidase {ECO:0000305},Acid beta-glucosidase;Alglucerase;Beta-glucocerebrosidase;Cholesterol glucosyltransferase {ECO:0000305|PubMed:24211208};Cholesteryl-beta-glucosidase {ECO:0000305|PubMed:24211208};D-glucosyl-N-acylsphingosine glucohydrolase;Imiglucerase;, PF02055;PF17189;, GO:0005783;GO:0070062;GO:0019898;GO:0005794;GO:0043202;GO:0005765;GO:0005764;GO:0005802;GO:0004348;GO:0046527;GO:0005124;GO:0005102;GO:0050295;GO:0019882;GO:1905037;GO:0006914;GO:1901805;GO:0048854;GO:0048469;GO:0009267;GO:0071356;GO:0046513;GO:0021694;GO:0008203;GO:0008340;GO:0006680;GO:0006687;GO:0071425;GO:0048872;GO:0030259;GO:0019915;GO:0072676;GO:0007040;GO:0014004;GO:0061518;GO:0061744;GO:0050728;GO:0032715;GO:0043407;GO:0043524;GO:1901215;GO:0031333;GO:0050905;GO:0051402;GO:1904925;GO:1904457;GO:0032436;GO:0035307;GO:1903061;GO:0051247;GO:0043243;GO:1903052;GO:0021859;GO:0032268;GO:1905165;GO:0016241;GO:0032006;GO:0033561;GO:0071548;GO:0043627;GO:0009268;GO:0033574;GO:0097066;GO:0043589;GO:0046512;GO:0033077;GO:0023021;, C:endoplasmic reticulum; C:extracellular exosome; C:extrinsic component of membrane; C:Golgi apparatus; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:trans-Golgi network;, F:glucosylceramidase activity; F:glucosyltransferase activity; F:scavenger receptor binding; F:signaling receptor binding; F:steryl-beta-glucosidase activity;, P:antigen processing and presentation; P:autophagosome organization; P:autophagy; P:beta-glucoside catabolic process; P:brain morphogenesis; P:cell maturation; P:cellular response to starvation; P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:cerebellar Purkinje cell layer formation; P:cholesterol metabolic process; P:determination of adult lifespan; P:glucosylceramide catabolic process; P:glycosphingolipid metabolic process; P:hematopoietic stem cell proliferation; P:homeostasis of number of cells; P:lipid glycosylation; P:lipid storage; P:lymphocyte migration; P:lysosome organization; P:microglia differentiation; P:microglial cell proliferation; P:motor behavior; P:negative regulation of inflammatory response; P:negative regulation of interleukin-6 production; P:negative regulation of MAP kinase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of protein-containing complex assembly; P:neuromuscular process; P:neuron apoptotic process; P:positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization; P:positive regulation of neuronal action potential; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein dephosphorylation; P:positive regulation of protein lipidation; P:positive regulation of protein metabolic process; P:positive regulation of protein-containing complex disassembly; P:positive regulation of proteolysis involved in cellular protein catabolic process; P:pyramidal neuron differentiation; P:regulation of cellular protein metabolic process; P:regulation of lysosomal protein catabolic process; P:regulation of macroautophagy; P:regulation of TOR signaling; P:regulation of water loss via skin; P:response to dexamethasone; P:response to estrogen; P:response to pH; P:response to testosterone; P:response to thyroid hormone; P:skin morphogenesis; P:sphingosine biosynthetic process; P:T cell differentiation in thymus; P:termination of signal transduction;|Q13505 A0A0A0MRK6 B1AVR9 B1AVS0 B2R9P4 Q9BUU3,Metaxin-1,Mitochondrial outer membrane import complex protein 1;, PF17171;PF10568;, GO:0005737;GO:0016021;GO:0140275;GO:0001401;GO:0007007;GO:0007595;GO:0007005;GO:0015031;, C:cytoplasm; C:integral component of membrane; C:MIB complex; C:SAM complex;, , P:inner mitochondrial membrane organization; P:lactation; P:mitochondrion organization; P:protein transport;|Q9UMJ8,Lysosomal acid glucosylceramidase {ECO:0000305},Acid beta-glucosidase;Alglucerase;Beta-glucocerebrosidase;Cholesterol glucosyltransferase {ECO:0000305|PubMed:24211208};Cholesteryl-beta-glucosidase {ECO:0000305|PubMed:24211208};D-glucosyl-N-acylsphingosine glucohydrolase;Imiglucerase;, PF02055;PF17189;, GO:0005783;GO:0070062;GO:0019898;GO:0005794;GO:0043202;GO:0005765;GO:0005764;GO:0005802;GO:0004348;GO:0046527;GO:0005124;GO:0005102;GO:0050295;GO:0019882;GO:1905037;GO:0006914;GO:1901805;GO:0048854;GO:0048469;GO:0009267;GO:0071356;GO:0046513;GO:0021694;GO:0008203;GO:0008340;GO:0006680;GO:0006687;GO:0071425;GO:0048872;GO:0030259;GO:0019915;GO:0072676;GO:0007040;GO:0014004;GO:0061518;GO:0061744;GO:0050728;GO:0032715;GO:0043407;GO:0043524;GO:1901215;GO:0031333;GO:0050905;GO:0051402;GO:1904925;GO:1904457;GO:0032436;GO:0035307;GO:1903061;GO:0051247;GO:0043243;GO:1903052;GO:0021859;GO:0032268;GO:1905165;GO:0016241;GO:0032006;GO:0033561;GO:0071548;GO:0043627;GO:0009268;GO:0033574;GO:0097066;GO:0043589;GO:0046512;GO:0033077;GO:0023021;, C:endoplasmic reticulum; C:extracellular exosome; C:extrinsic component of membrane; C:Golgi apparatus; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:trans-Golgi network;, F:glucosylceramidase activity; F:glucosyltransferase activity; F:scavenger receptor binding; F:signaling receptor binding; F:steryl-beta-glucosidase activity;, P:antigen processing and presentation; P:autophagosome organization; P:autophagy; P:beta-glucoside catabolic process; P:brain morphogenesis; P:cell maturation; P:cellular response to starvation; P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:cerebellar Purkinje cell layer formation; P:cholesterol metabolic process; P:determination of adult lifespan; P:glucosylceramide catabolic process; P:glycosphingolipid metabolic process; P:hematopoietic stem cell proliferation; P:homeostasis of number of cells; P:lipid glycosylation; P:lipid storage; P:lymphocyte migration; P:lysosome organization; P:microglia differentiation; P:microglial cell proliferation; P:motor behavior; P:negative regulation of inflammatory response; P:negative regulation of interleukin-6 production; P:negative regulation of MAP kinase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of protein-containing complex assembly; P:neuromuscular process; P:neuron apoptotic process; P:positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization; P:positive regulation of neuronal action potential; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein dephosphorylation; P:positive regulation of protein lipidation; P:positive regulation of protein metabolic process; P:positive regulation of protein-containing complex disassembly; P:positive regulation of proteolysis involved in cellular protein catabolic process; P:pyramidal neuron differentiation; P:regulation of cellular protein metabolic process; P:regulation of lysosomal protein catabolic process; P:regulation of macroautophagy; P:regulation of TOR signaling; P:regulation of water loss via skin; P:response to dexamethasone; P:response to estrogen; P:response to pH; P:response to testosterone; P:response to thyroid hormone; P:skin morphogenesis; P:sphingosine biosynthetic process; P:T cell differentiation in thymus; P:termination of signal transduction; scaffold49 indexed_genome mRNA 2153410 2159348 . - . ID=transcript_9271;P81408 B1AVS5 Q8IXL3 Q9BR66,Protein FAM189B,Protein COTE1;, PF04103;, GO:0016021;GO:0050699;, C:integral component of membrane;, F:WW domain binding;|P81408 B1AVS5 Q8IXL3 Q9BR66,Protein FAM189B,Protein COTE1;, PF04103;, GO:0016021;GO:0050699;, C:integral component of membrane;, F:WW domain binding;|P81408 B1AVS5 Q8IXL3 Q9BR66,Protein FAM189B,Protein COTE1;, PF04103;, GO:0016021;GO:0050699;, C:integral component of membrane;, F:WW domain binding;|P81408 B1AVS5 Q8IXL3 Q9BR66,Protein FAM189B,Protein COTE1;, PF04103;, GO:0016021;GO:0050699;, C:integral component of membrane;, F:WW domain binding;|P81408 B1AVS5 Q8IXL3 Q9BR66,Protein FAM189B,Protein COTE1;, PF04103;, GO:0016021;GO:0050699;, C:integral component of membrane;, F:WW domain binding;|P81408 B1AVS5 Q8IXL3 Q9BR66,Protein FAM189B,Protein COTE1;, PF04103;, GO:0016021;GO:0050699;, C:integral component of membrane;, F:WW domain binding; scaffold49 indexed_genome mRNA 2159811 2170933 . - . ID=transcript_9272;O14828 A9Z1W6 B1AVS6 O15128 Q96FR8 Q9BPY0,Secretory carrier-associated membrane protein 3,, PF04144;, GO:0070062;GO:0016021;GO:0043231;GO:0055038;GO:0032588;GO:0031625;GO:0006892;GO:0015031;, C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:recycling endosome membrane; C:trans-Golgi network membrane;, F:ubiquitin protein ligase binding;, P:post-Golgi vesicle-mediated transport; P:protein transport;|O14828 A9Z1W6 B1AVS6 O15128 Q96FR8 Q9BPY0,Secretory carrier-associated membrane protein 3,, PF04144;, GO:0070062;GO:0016021;GO:0043231;GO:0055038;GO:0032588;GO:0031625;GO:0006892;GO:0015031;, C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:recycling endosome membrane; C:trans-Golgi network membrane;, F:ubiquitin protein ligase binding;, P:post-Golgi vesicle-mediated transport; P:protein transport;|P49760 B1AVS9 B5MBX6 Q96CQ0,Dual specificity protein kinase CLK2,CDC-like kinase 2;, PF00069;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0045721;GO:0046777;GO:0006468;GO:0043484;GO:0010212;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:negative regulation of gluconeogenesis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing; P:response to ionizing radiation;|O14828 A9Z1W6 B1AVS6 O15128 Q96FR8 Q9BPY0,Secretory carrier-associated membrane protein 3,, PF04144;, GO:0070062;GO:0016021;GO:0043231;GO:0055038;GO:0032588;GO:0031625;GO:0006892;GO:0015031;, C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:recycling endosome membrane; C:trans-Golgi network membrane;, F:ubiquitin protein ligase binding;, P:post-Golgi vesicle-mediated transport; P:protein transport;|O14828 A9Z1W6 B1AVS6 O15128 Q96FR8 Q9BPY0,Secretory carrier-associated membrane protein 3,, PF04144;, GO:0070062;GO:0016021;GO:0043231;GO:0055038;GO:0032588;GO:0031625;GO:0006892;GO:0015031;, C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:recycling endosome membrane; C:trans-Golgi network membrane;, F:ubiquitin protein ligase binding;, P:post-Golgi vesicle-mediated transport; P:protein transport;|O14828 A9Z1W6 B1AVS6 O15128 Q96FR8 Q9BPY0,Secretory carrier-associated membrane protein 3,, PF04144;, GO:0070062;GO:0016021;GO:0043231;GO:0055038;GO:0032588;GO:0031625;GO:0006892;GO:0015031;, C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:recycling endosome membrane; C:trans-Golgi network membrane;, F:ubiquitin protein ligase binding;, P:post-Golgi vesicle-mediated transport; P:protein transport;|P49760 B1AVS9 B5MBX6 Q96CQ0,Dual specificity protein kinase CLK2,CDC-like kinase 2;, PF00069;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0045721;GO:0046777;GO:0006468;GO:0043484;GO:0010212;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:negative regulation of gluconeogenesis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing; P:response to ionizing radiation;|P49760 B1AVS9 B5MBX6 Q96CQ0,Dual specificity protein kinase CLK2,CDC-like kinase 2;, PF00069;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0045721;GO:0046777;GO:0006468;GO:0043484;GO:0010212;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:negative regulation of gluconeogenesis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing; P:response to ionizing radiation;|P49760 B1AVS9 B5MBX6 Q96CQ0,Dual specificity protein kinase CLK2,CDC-like kinase 2;, PF00069;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0045721;GO:0046777;GO:0006468;GO:0043484;GO:0010212;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:negative regulation of gluconeogenesis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing; P:response to ionizing radiation;|P49760 B1AVS9 B5MBX6 Q96CQ0,Dual specificity protein kinase CLK2,CDC-like kinase 2;, PF00069;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0045721;GO:0046777;GO:0006468;GO:0043484;GO:0010212;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:negative regulation of gluconeogenesis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing; P:response to ionizing radiation; scaffold49 indexed_genome mRNA 2171788 2173677 . - . ID=transcript_9273;P49760 B1AVS9 B5MBX6 Q96CQ0,Dual specificity protein kinase CLK2,CDC-like kinase 2;, PF00069;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0045721;GO:0046777;GO:0006468;GO:0043484;GO:0010212;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:negative regulation of gluconeogenesis; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing; P:response to ionizing radiation; scaffold49 indexed_genome mRNA 2176194 2195812 . + . ID=transcript_9274;Q9P1Z3 D3DV90 Q4VX12 Q8N6W6 Q9BWQ2,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,, PF00027;PF00520;PF08412;, GO:0044316;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0030552;GO:0005249;GO:0005248;GO:1903351;GO:0071805;GO:0034765;GO:0042391;GO:0072718;GO:0035725;, C:cone cell pedicle; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane;, F:cAMP binding; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:cellular response to dopamine; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to cisplatin; P:sodium ion transmembrane transport;|Q9P1Z3 D3DV90 Q4VX12 Q8N6W6 Q9BWQ2,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,, PF00027;PF00520;PF08412;, GO:0044316;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0030552;GO:0005249;GO:0005248;GO:1903351;GO:0071805;GO:0034765;GO:0042391;GO:0072718;GO:0035725;, C:cone cell pedicle; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane;, F:cAMP binding; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:cellular response to dopamine; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to cisplatin; P:sodium ion transmembrane transport;|Q9P1Z3 D3DV90 Q4VX12 Q8N6W6 Q9BWQ2,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,, PF00027;PF00520;PF08412;, GO:0044316;GO:0030425;GO:0005887;GO:0043025;GO:0005886;GO:0030552;GO:0005249;GO:0005248;GO:1903351;GO:0071805;GO:0034765;GO:0042391;GO:0072718;GO:0035725;, C:cone cell pedicle; C:dendrite; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane;, F:cAMP binding; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;, P:cellular response to dopamine; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to cisplatin; P:sodium ion transmembrane transport;|P30613 O75758 P11973,Pyruvate kinase PKLR,Pyruvate kinase 1;Pyruvate kinase isozymes L/R;R-type/L-type pyruvate kinase;Red cell/liver pyruvate kinase;, PF00224;PF02887;, GO:0005737;GO:0005829;GO:0070062;GO:0005524;GO:0016301;GO:0000287;GO:0030955;GO:0004743;GO:0006754;GO:0061621;GO:0071872;GO:0032869;GO:0006096;GO:0042866;GO:0033198;GO:0051591;GO:0009749;GO:0009408;GO:0001666;GO:0010226;GO:0007584;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:ATP binding; F:kinase activity; F:magnesium ion binding; F:potassium ion binding; F:pyruvate kinase activity;, P:ATP biosynthetic process; P:canonical glycolysis; P:cellular response to epinephrine stimulus; P:cellular response to insulin stimulus; P:glycolytic process; P:pyruvate biosynthetic process; P:response to ATP; P:response to cAMP; P:response to glucose; P:response to heat; P:response to hypoxia; P:response to lithium ion; P:response to nutrient;|P30613 O75758 P11973,Pyruvate kinase PKLR,Pyruvate kinase 1;Pyruvate kinase isozymes L/R;R-type/L-type pyruvate kinase;Red cell/liver pyruvate kinase;, PF00224;PF02887;, GO:0005737;GO:0005829;GO:0070062;GO:0005524;GO:0016301;GO:0000287;GO:0030955;GO:0004743;GO:0006754;GO:0061621;GO:0071872;GO:0032869;GO:0006096;GO:0042866;GO:0033198;GO:0051591;GO:0009749;GO:0009408;GO:0001666;GO:0010226;GO:0007584;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:ATP binding; F:kinase activity; F:magnesium ion binding; F:potassium ion binding; F:pyruvate kinase activity;, P:ATP biosynthetic process; P:canonical glycolysis; P:cellular response to epinephrine stimulus; P:cellular response to insulin stimulus; P:glycolytic process; P:pyruvate biosynthetic process; P:response to ATP; P:response to cAMP; P:response to glucose; P:response to heat; P:response to hypoxia; P:response to lithium ion; P:response to nutrient;|P30613 O75758 P11973,Pyruvate kinase PKLR,Pyruvate kinase 1;Pyruvate kinase isozymes L/R;R-type/L-type pyruvate kinase;Red cell/liver pyruvate kinase;, PF00224;PF02887;, GO:0005737;GO:0005829;GO:0070062;GO:0005524;GO:0016301;GO:0000287;GO:0030955;GO:0004743;GO:0006754;GO:0061621;GO:0071872;GO:0032869;GO:0006096;GO:0042866;GO:0033198;GO:0051591;GO:0009749;GO:0009408;GO:0001666;GO:0010226;GO:0007584;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:ATP binding; F:kinase activity; F:magnesium ion binding; F:potassium ion binding; F:pyruvate kinase activity;, P:ATP biosynthetic process; P:canonical glycolysis; P:cellular response to epinephrine stimulus; P:cellular response to insulin stimulus; P:glycolytic process; P:pyruvate biosynthetic process; P:response to ATP; P:response to cAMP; P:response to glucose; P:response to heat; P:response to hypoxia; P:response to lithium ion; P:response to nutrient;|P30613 O75758 P11973,Pyruvate kinase PKLR,Pyruvate kinase 1;Pyruvate kinase isozymes L/R;R-type/L-type pyruvate kinase;Red cell/liver pyruvate kinase;, PF00224;PF02887;, GO:0005737;GO:0005829;GO:0070062;GO:0005524;GO:0016301;GO:0000287;GO:0030955;GO:0004743;GO:0006754;GO:0061621;GO:0071872;GO:0032869;GO:0006096;GO:0042866;GO:0033198;GO:0051591;GO:0009749;GO:0009408;GO:0001666;GO:0010226;GO:0007584;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:ATP binding; F:kinase activity; F:magnesium ion binding; F:potassium ion binding; F:pyruvate kinase activity;, P:ATP biosynthetic process; P:canonical glycolysis; P:cellular response to epinephrine stimulus; P:cellular response to insulin stimulus; P:glycolytic process; P:pyruvate biosynthetic process; P:response to ATP; P:response to cAMP; P:response to glucose; P:response to heat; P:response to hypoxia; P:response to lithium ion; P:response to nutrient; scaffold49 indexed_genome mRNA 2208560 2234795 . - . ID=transcript_9275;P14324 D3DV91 E9PCI9 Q96G29,Farnesyl pyrophosphate synthase {ECO:0000305},(2E,6E)-farnesyl diphosphate synthase;Dimethylallyltranstransferase;Farnesyl diphosphate synthase;Geranyltranstransferase;, PF00348;, GO:0005737;GO:0005829;GO:0005654;GO:0004161;GO:0004337;GO:0046872;GO:0003723;GO:0006695;GO:0045337;GO:0033384;GO:0019216;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:dimethylallyltranstransferase activity; F:geranyltranstransferase activity; F:metal ion binding; F:RNA binding;, P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process; P:geranyl diphosphate biosynthetic process; P:regulation of lipid metabolic process; P:viral process;|P14324 D3DV91 E9PCI9 Q96G29,Farnesyl pyrophosphate synthase {ECO:0000305},(2E,6E)-farnesyl diphosphate synthase;Dimethylallyltranstransferase;Farnesyl diphosphate synthase;Geranyltranstransferase;, PF00348;, GO:0005737;GO:0005829;GO:0005654;GO:0004161;GO:0004337;GO:0046872;GO:0003723;GO:0006695;GO:0045337;GO:0033384;GO:0019216;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:dimethylallyltranstransferase activity; F:geranyltranstransferase activity; F:metal ion binding; F:RNA binding;, P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process; P:geranyl diphosphate biosynthetic process; P:regulation of lipid metabolic process; P:viral process;|P14324 D3DV91 E9PCI9 Q96G29,Farnesyl pyrophosphate synthase {ECO:0000305},(2E,6E)-farnesyl diphosphate synthase;Dimethylallyltranstransferase;Farnesyl diphosphate synthase;Geranyltranstransferase;, PF00348;, GO:0005737;GO:0005829;GO:0005654;GO:0004161;GO:0004337;GO:0046872;GO:0003723;GO:0006695;GO:0045337;GO:0033384;GO:0019216;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:dimethylallyltranstransferase activity; F:geranyltranstransferase activity; F:metal ion binding; F:RNA binding;, P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process; P:geranyl diphosphate biosynthetic process; P:regulation of lipid metabolic process; P:viral process;|P14324 D3DV91 E9PCI9 Q96G29,Farnesyl pyrophosphate synthase {ECO:0000305},(2E,6E)-farnesyl diphosphate synthase;Dimethylallyltranstransferase;Farnesyl diphosphate synthase;Geranyltranstransferase;, PF00348;, GO:0005737;GO:0005829;GO:0005654;GO:0004161;GO:0004337;GO:0046872;GO:0003723;GO:0006695;GO:0045337;GO:0033384;GO:0019216;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:dimethylallyltranstransferase activity; F:geranyltranstransferase activity; F:metal ion binding; F:RNA binding;, P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process; P:geranyl diphosphate biosynthetic process; P:regulation of lipid metabolic process; P:viral process;|P14324 D3DV91 E9PCI9 Q96G29,Farnesyl pyrophosphate synthase {ECO:0000305},(2E,6E)-farnesyl diphosphate synthase;Dimethylallyltranstransferase;Farnesyl diphosphate synthase;Geranyltranstransferase;, PF00348;, GO:0005737;GO:0005829;GO:0005654;GO:0004161;GO:0004337;GO:0046872;GO:0003723;GO:0006695;GO:0045337;GO:0033384;GO:0019216;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:dimethylallyltranstransferase activity; F:geranyltranstransferase activity; F:metal ion binding; F:RNA binding;, P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process; P:geranyl diphosphate biosynthetic process; P:regulation of lipid metabolic process; P:viral process;|P14324 D3DV91 E9PCI9 Q96G29,Farnesyl pyrophosphate synthase {ECO:0000305},(2E,6E)-farnesyl diphosphate synthase;Dimethylallyltranstransferase;Farnesyl diphosphate synthase;Geranyltranstransferase;, PF00348;, GO:0005737;GO:0005829;GO:0005654;GO:0004161;GO:0004337;GO:0046872;GO:0003723;GO:0006695;GO:0045337;GO:0033384;GO:0019216;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:dimethylallyltranstransferase activity; F:geranyltranstransferase activity; F:metal ion binding; F:RNA binding;, P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process; P:geranyl diphosphate biosynthetic process; P:regulation of lipid metabolic process; P:viral process;|Q9BVN2 B3KWM9 Q5T9U9 Q5T9V0 Q5T9V1 Q5T9V2 Q9UPY4 Q9Y4T5,RUN and SH3 domain-containing protein 1,New molecule containing SH3 at the carboxy-terminus;, PF02759;PF14604;, GO:0031410;GO:0005829;GO:0005769;GO:0005794;GO:0005874;GO:0015630;GO:0005634;GO:0014069;GO:0003779;GO:0000209;, C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:Golgi apparatus; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:postsynaptic density;, F:actin binding;, P:protein polyubiquitination;|Q9BVN2 B3KWM9 Q5T9U9 Q5T9V0 Q5T9V1 Q5T9V2 Q9UPY4 Q9Y4T5,RUN and SH3 domain-containing protein 1,New molecule containing SH3 at the carboxy-terminus;, PF02759;PF14604;, GO:0031410;GO:0005829;GO:0005769;GO:0005794;GO:0005874;GO:0015630;GO:0005634;GO:0014069;GO:0003779;GO:0000209;, C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:Golgi apparatus; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:postsynaptic density;, F:actin binding;, P:protein polyubiquitination;|Q9BVN2 B3KWM9 Q5T9U9 Q5T9V0 Q5T9V1 Q5T9V2 Q9UPY4 Q9Y4T5,RUN and SH3 domain-containing protein 1,New molecule containing SH3 at the carboxy-terminus;, PF02759;PF14604;, GO:0031410;GO:0005829;GO:0005769;GO:0005794;GO:0005874;GO:0015630;GO:0005634;GO:0014069;GO:0003779;GO:0000209;, C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:Golgi apparatus; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:postsynaptic density;, F:actin binding;, P:protein polyubiquitination; scaffold49 indexed_genome mRNA 2236599 2240818 . - . ID=transcript_9276;Q9NR48 Q59GP1 Q5T714 Q5T715 Q9P2C7,Histone-lysine N-methyltransferase ASH1L,ASH1-like protein;Absent small and homeotic disks protein 1 homolog;Lysine N-methyltransferase 2H;, PF17907;PF01426;PF00439;PF00856;, GO:0005923;GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046975;GO:0042800;GO:0046974;GO:0046872;GO:0046697;GO:0030317;GO:0097676;GO:0002674;GO:0043124;GO:0043409;GO:0045944;GO:0009791;GO:0007338;GO:0001501;GO:1903699;GO:1903709;GO:0061038;, C:bicellular tight junction; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding;, P:decidualization; P:flagellated sperm motility; P:histone H3-K36 dimethylation; P:negative regulation of acute inflammatory response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAPK cascade; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:single fertilization; P:skeletal system development; P:tarsal gland development; P:uterine gland development; P:uterus morphogenesis; scaffold49 indexed_genome mRNA 2241710 2375103 . + . ID=transcript_9277;Q9NR48 Q59GP1 Q5T714 Q5T715 Q9P2C7,Histone-lysine N-methyltransferase ASH1L,ASH1-like protein;Absent small and homeotic disks protein 1 homolog;Lysine N-methyltransferase 2H;, PF17907;PF01426;PF00439;PF00856;, GO:0005923;GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046975;GO:0042800;GO:0046974;GO:0046872;GO:0046697;GO:0030317;GO:0097676;GO:0002674;GO:0043124;GO:0043409;GO:0045944;GO:0009791;GO:0007338;GO:0001501;GO:1903699;GO:1903709;GO:0061038;, C:bicellular tight junction; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding;, P:decidualization; P:flagellated sperm motility; P:histone H3-K36 dimethylation; P:negative regulation of acute inflammatory response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAPK cascade; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:single fertilization; P:skeletal system development; P:tarsal gland development; P:uterine gland development; P:uterus morphogenesis;|Q9NR48 Q59GP1 Q5T714 Q5T715 Q9P2C7,Histone-lysine N-methyltransferase ASH1L,ASH1-like protein;Absent small and homeotic disks protein 1 homolog;Lysine N-methyltransferase 2H;, PF17907;PF01426;PF00439;PF00856;, GO:0005923;GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046975;GO:0042800;GO:0046974;GO:0046872;GO:0046697;GO:0030317;GO:0097676;GO:0002674;GO:0043124;GO:0043409;GO:0045944;GO:0009791;GO:0007338;GO:0001501;GO:1903699;GO:1903709;GO:0061038;, C:bicellular tight junction; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding;, P:decidualization; P:flagellated sperm motility; P:histone H3-K36 dimethylation; P:negative regulation of acute inflammatory response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAPK cascade; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:single fertilization; P:skeletal system development; P:tarsal gland development; P:uterine gland development; P:uterus morphogenesis;|Q9NR48 Q59GP1 Q5T714 Q5T715 Q9P2C7,Histone-lysine N-methyltransferase ASH1L,ASH1-like protein;Absent small and homeotic disks protein 1 homolog;Lysine N-methyltransferase 2H;, PF17907;PF01426;PF00439;PF00856;, GO:0005923;GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046975;GO:0042800;GO:0046974;GO:0046872;GO:0046697;GO:0030317;GO:0097676;GO:0002674;GO:0043124;GO:0043409;GO:0045944;GO:0009791;GO:0007338;GO:0001501;GO:1903699;GO:1903709;GO:0061038;, C:bicellular tight junction; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding;, P:decidualization; P:flagellated sperm motility; P:histone H3-K36 dimethylation; P:negative regulation of acute inflammatory response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAPK cascade; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:single fertilization; P:skeletal system development; P:tarsal gland development; P:uterine gland development; P:uterus morphogenesis;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9NR48 Q59GP1 Q5T714 Q5T715 Q9P2C7,Histone-lysine N-methyltransferase ASH1L,ASH1-like protein;Absent small and homeotic disks protein 1 homolog;Lysine N-methyltransferase 2H;, PF17907;PF01426;PF00439;PF00856;, GO:0005923;GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046975;GO:0042800;GO:0046974;GO:0046872;GO:0046697;GO:0030317;GO:0097676;GO:0002674;GO:0043124;GO:0043409;GO:0045944;GO:0009791;GO:0007338;GO:0001501;GO:1903699;GO:1903709;GO:0061038;, C:bicellular tight junction; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding;, P:decidualization; P:flagellated sperm motility; P:histone H3-K36 dimethylation; P:negative regulation of acute inflammatory response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAPK cascade; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:single fertilization; P:skeletal system development; P:tarsal gland development; P:uterine gland development; P:uterus morphogenesis;|Q9NR48 Q59GP1 Q5T714 Q5T715 Q9P2C7,Histone-lysine N-methyltransferase ASH1L,ASH1-like protein;Absent small and homeotic disks protein 1 homolog;Lysine N-methyltransferase 2H;, PF17907;PF01426;PF00439;PF00856;, GO:0005923;GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046975;GO:0042800;GO:0046974;GO:0046872;GO:0046697;GO:0030317;GO:0097676;GO:0002674;GO:0043124;GO:0043409;GO:0045944;GO:0009791;GO:0007338;GO:0001501;GO:1903699;GO:1903709;GO:0061038;, C:bicellular tight junction; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding;, P:decidualization; P:flagellated sperm motility; P:histone H3-K36 dimethylation; P:negative regulation of acute inflammatory response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAPK cascade; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:single fertilization; P:skeletal system development; P:tarsal gland development; P:uterine gland development; P:uterus morphogenesis; scaffold49 indexed_genome mRNA 2409076 2426046 . - . ID=transcript_9278;Q9NR48 Q59GP1 Q5T714 Q5T715 Q9P2C7,Histone-lysine N-methyltransferase ASH1L,ASH1-like protein;Absent small and homeotic disks protein 1 homolog;Lysine N-methyltransferase 2H;, PF17907;PF01426;PF00439;PF00856;, GO:0005923;GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046975;GO:0042800;GO:0046974;GO:0046872;GO:0046697;GO:0030317;GO:0097676;GO:0002674;GO:0043124;GO:0043409;GO:0045944;GO:0009791;GO:0007338;GO:0001501;GO:1903699;GO:1903709;GO:0061038;, C:bicellular tight junction; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding;, P:decidualization; P:flagellated sperm motility; P:histone H3-K36 dimethylation; P:negative regulation of acute inflammatory response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAPK cascade; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:single fertilization; P:skeletal system development; P:tarsal gland development; P:uterine gland development; P:uterus morphogenesis;|Q9NR48 Q59GP1 Q5T714 Q5T715 Q9P2C7,Histone-lysine N-methyltransferase ASH1L,ASH1-like protein;Absent small and homeotic disks protein 1 homolog;Lysine N-methyltransferase 2H;, PF17907;PF01426;PF00439;PF00856;, GO:0005923;GO:0005694;GO:0005794;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046975;GO:0042800;GO:0046974;GO:0046872;GO:0046697;GO:0030317;GO:0097676;GO:0002674;GO:0043124;GO:0043409;GO:0045944;GO:0009791;GO:0007338;GO:0001501;GO:1903699;GO:1903709;GO:0061038;, C:bicellular tight junction; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding;, P:decidualization; P:flagellated sperm motility; P:histone H3-K36 dimethylation; P:negative regulation of acute inflammatory response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MAPK cascade; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:single fertilization; P:skeletal system development; P:tarsal gland development; P:uterine gland development; P:uterus morphogenesis; scaffold49 indexed_genome mRNA 2439342 2476342 . + . ID=transcript_9279;P51398 B4DP59 B4DY62 E7EM60 Q13044 Q68CT7 Q96Q20,28S ribosomal protein S29, mitochondrial,Death-associated protein 3;Ionizing radiation resistance conferring protein;Mitochondrial small ribosomal subunit protein mS29 {ECO:0000303|PubMed:25838379};, PF10236;, GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0005525;GO:0003723;GO:0003735;GO:0097190;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:RNA binding; F:structural constituent of ribosome;, P:apoptotic signaling pathway; P:mitochondrial translational elongation; P:mitochondrial translational termination;|P08865 P11085 P12030 Q16471 Q6IPD1 Q6IPD2 Q6NSD1 Q6NXQ8 Q86VC0,40S ribosomal protein SA {ECO:0000255|HAMAP-Rule:MF_03016},37 kDa laminin receptor precursor {ECO:0000255|HAMAP-Rule:MF_03016};37/67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};Colon carcinoma laminin-binding protein;Laminin receptor 1 {ECO:0000255|HAMAP-Rule:MF_03016};Laminin-binding protein precursor p40 {ECO:0000255|HAMAP-Rule:MF_03016};Multidrug resistance-associated protein MGr1-Ag;NEM/1CHD4;Small ribosomal subunit protein uS2 {ECO:0000303|PubMed:24524803};, PF16122;PF00318;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0043236;GO:0005055;GO:0043022;GO:0003723;GO:0003735;GO:0001618;GO:0007155;GO:0002181;GO:0000184;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:laminin binding; F:laminin receptor activity; F:ribosome binding; F:RNA binding; F:structural constituent of ribosome; F:virus receptor activity;, P:cell adhesion; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P51398 B4DP59 B4DY62 E7EM60 Q13044 Q68CT7 Q96Q20,28S ribosomal protein S29, mitochondrial,Death-associated protein 3;Ionizing radiation resistance conferring protein;Mitochondrial small ribosomal subunit protein mS29 {ECO:0000303|PubMed:25838379};, PF10236;, GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0005525;GO:0003723;GO:0003735;GO:0097190;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:RNA binding; F:structural constituent of ribosome;, P:apoptotic signaling pathway; P:mitochondrial translational elongation; P:mitochondrial translational termination;|P51398 B4DP59 B4DY62 E7EM60 Q13044 Q68CT7 Q96Q20,28S ribosomal protein S29, mitochondrial,Death-associated protein 3;Ionizing radiation resistance conferring protein;Mitochondrial small ribosomal subunit protein mS29 {ECO:0000303|PubMed:25838379};, PF10236;, GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0005525;GO:0003723;GO:0003735;GO:0097190;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:RNA binding; F:structural constituent of ribosome;, P:apoptotic signaling pathway; P:mitochondrial translational elongation; P:mitochondrial translational termination;|P51398 B4DP59 B4DY62 E7EM60 Q13044 Q68CT7 Q96Q20,28S ribosomal protein S29, mitochondrial,Death-associated protein 3;Ionizing radiation resistance conferring protein;Mitochondrial small ribosomal subunit protein mS29 {ECO:0000303|PubMed:25838379};, PF10236;, GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0005525;GO:0003723;GO:0003735;GO:0097190;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:RNA binding; F:structural constituent of ribosome;, P:apoptotic signaling pathway; P:mitochondrial translational elongation; P:mitochondrial translational termination;|P51398 B4DP59 B4DY62 E7EM60 Q13044 Q68CT7 Q96Q20,28S ribosomal protein S29, mitochondrial,Death-associated protein 3;Ionizing radiation resistance conferring protein;Mitochondrial small ribosomal subunit protein mS29 {ECO:0000303|PubMed:25838379};, PF10236;, GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0005525;GO:0003723;GO:0003735;GO:0097190;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:RNA binding; F:structural constituent of ribosome;, P:apoptotic signaling pathway; P:mitochondrial translational elongation; P:mitochondrial translational termination;|P51398 B4DP59 B4DY62 E7EM60 Q13044 Q68CT7 Q96Q20,28S ribosomal protein S29, mitochondrial,Death-associated protein 3;Ionizing radiation resistance conferring protein;Mitochondrial small ribosomal subunit protein mS29 {ECO:0000303|PubMed:25838379};, PF10236;, GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0005525;GO:0003723;GO:0003735;GO:0097190;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:RNA binding; F:structural constituent of ribosome;, P:apoptotic signaling pathway; P:mitochondrial translational elongation; P:mitochondrial translational termination;|P51398 B4DP59 B4DY62 E7EM60 Q13044 Q68CT7 Q96Q20,28S ribosomal protein S29, mitochondrial,Death-associated protein 3;Ionizing radiation resistance conferring protein;Mitochondrial small ribosomal subunit protein mS29 {ECO:0000303|PubMed:25838379};, PF10236;, GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0005525;GO:0003723;GO:0003735;GO:0097190;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:RNA binding; F:structural constituent of ribosome;, P:apoptotic signaling pathway; P:mitochondrial translational elongation; P:mitochondrial translational termination;|P51398 B4DP59 B4DY62 E7EM60 Q13044 Q68CT7 Q96Q20,28S ribosomal protein S29, mitochondrial,Death-associated protein 3;Ionizing radiation resistance conferring protein;Mitochondrial small ribosomal subunit protein mS29 {ECO:0000303|PubMed:25838379};, PF10236;, GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0005525;GO:0003723;GO:0003735;GO:0097190;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:GTP binding; F:RNA binding; F:structural constituent of ribosome;, P:apoptotic signaling pathway; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold49 indexed_genome mRNA 2484001 2577156 . + . ID=transcript_9280;Q9NQX2 Q9NVU4,Protein misato homolog 1,, PF10644;PF14881;, GO:0005737;GO:0005829;GO:0005741;GO:0048311;GO:0007005;, C:cytoplasm; C:cytosol; C:mitochondrial outer membrane;, , P:mitochondrion distribution; P:mitochondrion organization;|Q9NQX2 Q9NVU4,Protein misato homolog 1,, PF10644;PF14881;, GO:0005737;GO:0005829;GO:0005741;GO:0048311;GO:0007005;, C:cytoplasm; C:cytosol; C:mitochondrial outer membrane;, , P:mitochondrion distribution; P:mitochondrion organization;|Q9NQX2 Q9NVU4,Protein misato homolog 1,, PF10644;PF14881;, GO:0005737;GO:0005829;GO:0005741;GO:0048311;GO:0007005;, C:cytoplasm; C:cytosol; C:mitochondrial outer membrane;, , P:mitochondrion distribution; P:mitochondrion organization;|Q9NQX2 Q9NVU4,Protein misato homolog 1,, PF10644;PF14881;, GO:0005737;GO:0005829;GO:0005741;GO:0048311;GO:0007005;, C:cytoplasm; C:cytosol; C:mitochondrial outer membrane;, , P:mitochondrion distribution; P:mitochondrion organization;|Q8IY79 Q9BQI1 Q9HCG6,GON-4-like protein,GON-4 homolog;, PF02671;, GO:0016604;GO:0005654;GO:0005634;GO:0003712;GO:0003714;GO:0030183;GO:0006355;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription corepressor activity;, P:B cell differentiation; P:regulation of transcription, DNA-templated;|Q8IY79 Q9BQI1 Q9HCG6,GON-4-like protein,GON-4 homolog;, PF02671;, GO:0016604;GO:0005654;GO:0005634;GO:0003712;GO:0003714;GO:0030183;GO:0006355;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription corepressor activity;, P:B cell differentiation; P:regulation of transcription, DNA-templated;|Q8IY79 Q9BQI1 Q9HCG6,GON-4-like protein,GON-4 homolog;, PF02671;, GO:0016604;GO:0005654;GO:0005634;GO:0003712;GO:0003714;GO:0030183;GO:0006355;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription corepressor activity;, P:B cell differentiation; P:regulation of transcription, DNA-templated;|Q8IY79 Q9BQI1 Q9HCG6,GON-4-like protein,GON-4 homolog;, PF02671;, GO:0016604;GO:0005654;GO:0005634;GO:0003712;GO:0003714;GO:0030183;GO:0006355;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription corepressor activity;, P:B cell differentiation; P:regulation of transcription, DNA-templated;|Q9Y4A0 A8K3G4 B2RAJ3 Q32MC2,Jerky protein homolog-like,Human homolog of mouse jerky gene protein;, PF04218;PF03184;PF03221;, GO:0005634;GO:0003677;GO:0007417;, C:nucleus;, F:DNA binding;, P:central nervous system development; scaffold49 indexed_genome mRNA 2585100 2596375 . + . ID=transcript_9281;Q8IY79 Q9BQI1 Q9HCG6,GON-4-like protein,GON-4 homolog;, PF02671;, GO:0016604;GO:0005654;GO:0005634;GO:0003712;GO:0003714;GO:0030183;GO:0006355;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription corepressor activity;, P:B cell differentiation; P:regulation of transcription, DNA-templated; scaffold49 indexed_genome mRNA 2600952 2602785 . + . ID=transcript_9282;Q8IY79 Q9BQI1 Q9HCG6,GON-4-like protein,GON-4 homolog;, PF02671;, GO:0016604;GO:0005654;GO:0005634;GO:0003712;GO:0003714;GO:0030183;GO:0006355;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription corepressor activity;, P:B cell differentiation; P:regulation of transcription, DNA-templated; scaffold49 indexed_genome mRNA 2603431 2605164 . - . ID=transcript_9283;Q8IY79 Q9BQI1 Q9HCG6,GON-4-like protein,GON-4 homolog;, PF02671;, GO:0016604;GO:0005654;GO:0005634;GO:0003712;GO:0003714;GO:0030183;GO:0006355;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription corepressor activity;, P:B cell differentiation; P:regulation of transcription, DNA-templated; scaffold49 indexed_genome mRNA 2605724 2606435 . - . ID=transcript_9284;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold49 indexed_genome mRNA 2607252 2620693 . - . ID=transcript_9285;Q8IY79 Q9BQI1 Q9HCG6,GON-4-like protein,GON-4 homolog;, PF02671;, GO:0016604;GO:0005654;GO:0005634;GO:0003712;GO:0003714;GO:0030183;GO:0006355;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription corepressor activity;, P:B cell differentiation; P:regulation of transcription, DNA-templated;|Q8IY79 Q9BQI1 Q9HCG6,GON-4-like protein,GON-4 homolog;, PF02671;, GO:0016604;GO:0005654;GO:0005634;GO:0003712;GO:0003714;GO:0030183;GO:0006355;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription corepressor activity;, P:B cell differentiation; P:regulation of transcription, DNA-templated;|Q8IY79 Q9BQI1 Q9HCG6,GON-4-like protein,GON-4 homolog;, PF02671;, GO:0016604;GO:0005654;GO:0005634;GO:0003712;GO:0003714;GO:0030183;GO:0006355;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription corepressor activity;, P:B cell differentiation; P:regulation of transcription, DNA-templated; scaffold49 indexed_genome mRNA 2641615 2661846 . + . ID=transcript_9286;Q9BT88 Q14998 Q5W0D4 Q68CT5 Q8IXU3 Q96SU2,Synaptotagmin-11 {ECO:0000305},Synaptotagmin XI;, PF00168;, GO:0030424;GO:0030665;GO:0030425;GO:0043197;GO:0032009;GO:0060076;GO:0070382;GO:0060077;GO:0099059;GO:0005765;GO:0005764;GO:0043005;GO:0043204;GO:0048471;GO:0001891;GO:0045335;GO:0005886;GO:0014069;GO:0098793;GO:0048787;GO:0055037;GO:0055038;GO:0098685;GO:0045202;GO:0008021;GO:0043195;GO:0005802;GO:0031982;GO:0048487;GO:0005509;GO:0005544;GO:0030276;GO:0042802;GO:0001786;GO:0000149;GO:0031369;GO:0031625;GO:0006914;GO:1990927;GO:0017156;GO:0071277;GO:0051650;GO:0007612;GO:0007613;GO:1905469;GO:1900186;GO:0001818;GO:0033602;GO:0045806;GO:0032715;GO:1905154;GO:1903979;GO:0046929;GO:0050765;GO:1900243;GO:0032720;GO:0001778;GO:1905171;GO:0017158;GO:1900424;GO:0014059;GO:1905162;GO:0006906;GO:0016192;, C:axon; C:clathrin-coated vesicle membrane; C:dendrite; C:dendritic spine; C:early phagosome; C:excitatory synapse; C:exocytic vesicle; C:inhibitory synapse; C:integral component of presynaptic active zone membrane; C:lysosomal membrane; C:lysosome; C:neuron projection; C:perikaryon; C:perinuclear region of cytoplasm; C:phagocytic cup; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:presynapse; C:presynaptic active zone membrane; C:recycling endosome; C:recycling endosome membrane; C:Schaffer collateral - CA1 synapse; C:synapse; C:synaptic vesicle; C:terminal bouton; C:trans-Golgi network; C:vesicle;, F:beta-tubulin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:identical protein binding; F:phosphatidylserine binding; F:SNARE binding; F:translation initiation factor binding; F:ubiquitin protein ligase binding;, P:autophagy; P:calcium ion regulated lysosome exocytosis; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:establishment of vesicle localization; P:learning; P:memory; P:negative regulation of clathrin-coated pit assembly; P:negative regulation of clathrin-dependent endocytosis; P:negative regulation of cytokine production; P:negative regulation of dopamine secretion; P:negative regulation of endocytosis; P:negative regulation of interleukin-6 production; P:negative regulation of membrane invagination; P:negative regulation of microglial cell activation; P:negative regulation of neurotransmitter secretion; P:negative regulation of phagocytosis; P:negative regulation of synaptic vesicle endocytosis; P:negative regulation of tumor necrosis factor production; P:plasma membrane repair; P:positive regulation of protein localization to phagocytic vesicle; P:regulation of calcium ion-dependent exocytosis; P:regulation of defense response to bacterium; P:regulation of dopamine secretion; P:regulation of phagosome maturation; P:vesicle fusion; P:vesicle-mediated transport;|Q9BT88 Q14998 Q5W0D4 Q68CT5 Q8IXU3 Q96SU2,Synaptotagmin-11 {ECO:0000305},Synaptotagmin XI;, PF00168;, GO:0030424;GO:0030665;GO:0030425;GO:0043197;GO:0032009;GO:0060076;GO:0070382;GO:0060077;GO:0099059;GO:0005765;GO:0005764;GO:0043005;GO:0043204;GO:0048471;GO:0001891;GO:0045335;GO:0005886;GO:0014069;GO:0098793;GO:0048787;GO:0055037;GO:0055038;GO:0098685;GO:0045202;GO:0008021;GO:0043195;GO:0005802;GO:0031982;GO:0048487;GO:0005509;GO:0005544;GO:0030276;GO:0042802;GO:0001786;GO:0000149;GO:0031369;GO:0031625;GO:0006914;GO:1990927;GO:0017156;GO:0071277;GO:0051650;GO:0007612;GO:0007613;GO:1905469;GO:1900186;GO:0001818;GO:0033602;GO:0045806;GO:0032715;GO:1905154;GO:1903979;GO:0046929;GO:0050765;GO:1900243;GO:0032720;GO:0001778;GO:1905171;GO:0017158;GO:1900424;GO:0014059;GO:1905162;GO:0006906;GO:0016192;, C:axon; C:clathrin-coated vesicle membrane; C:dendrite; C:dendritic spine; C:early phagosome; C:excitatory synapse; C:exocytic vesicle; C:inhibitory synapse; C:integral component of presynaptic active zone membrane; C:lysosomal membrane; C:lysosome; C:neuron projection; C:perikaryon; C:perinuclear region of cytoplasm; C:phagocytic cup; C:phagocytic vesicle; C:plasma membrane; C:postsynaptic density; C:presynapse; C:presynaptic active zone membrane; C:recycling endosome; C:recycling endosome membrane; C:Schaffer collateral - CA1 synapse; C:synapse; C:synaptic vesicle; C:terminal bouton; C:trans-Golgi network; C:vesicle;, F:beta-tubulin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:identical protein binding; F:phosphatidylserine binding; F:SNARE binding; F:translation initiation factor binding; F:ubiquitin protein ligase binding;, P:autophagy; P:calcium ion regulated lysosome exocytosis; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:establishment of vesicle localization; P:learning; P:memory; P:negative regulation of clathrin-coated pit assembly; P:negative regulation of clathrin-dependent endocytosis; P:negative regulation of cytokine production; P:negative regulation of dopamine secretion; P:negative regulation of endocytosis; P:negative regulation of interleukin-6 production; P:negative regulation of membrane invagination; P:negative regulation of microglial cell activation; P:negative regulation of neurotransmitter secretion; P:negative regulation of phagocytosis; P:negative regulation of synaptic vesicle endocytosis; P:negative regulation of tumor necrosis factor production; P:plasma membrane repair; P:positive regulation of protein localization to phagocytic vesicle; P:regulation of calcium ion-dependent exocytosis; P:regulation of defense response to bacterium; P:regulation of dopamine secretion; P:regulation of phagosome maturation; P:vesicle fusion; P:vesicle-mediated transport; scaffold49 indexed_genome mRNA 2671318 2698833 . - . ID=transcript_9287;Q92963 B4DQE8 O00646 O00720 Q5VY89 Q5VY90,GTP-binding protein Rit1,Ras-like protein expressed in many tissues;Ras-like without CAAX protein 1;, PF00071;, GO:0005886;GO:0005516;GO:0019003;GO:0005525;GO:0003924;GO:0007265;GO:0007165;, C:plasma membrane;, F:calmodulin binding; F:GDP binding; F:GTP binding; F:GTPase activity;, P:Ras protein signal transduction; P:signal transduction;|Q92963 B4DQE8 O00646 O00720 Q5VY89 Q5VY90,GTP-binding protein Rit1,Ras-like protein expressed in many tissues;Ras-like without CAAX protein 1;, PF00071;, GO:0005886;GO:0005516;GO:0019003;GO:0005525;GO:0003924;GO:0007265;GO:0007165;, C:plasma membrane;, F:calmodulin binding; F:GDP binding; F:GTP binding; F:GTPase activity;, P:Ras protein signal transduction; P:signal transduction;|Q92963 B4DQE8 O00646 O00720 Q5VY89 Q5VY90,GTP-binding protein Rit1,Ras-like protein expressed in many tissues;Ras-like without CAAX protein 1;, PF00071;, GO:0005886;GO:0005516;GO:0019003;GO:0005525;GO:0003924;GO:0007265;GO:0007165;, C:plasma membrane;, F:calmodulin binding; F:GDP binding; F:GTP binding; F:GTPase activity;, P:Ras protein signal transduction; P:signal transduction;|Q92963 B4DQE8 O00646 O00720 Q5VY89 Q5VY90,GTP-binding protein Rit1,Ras-like protein expressed in many tissues;Ras-like without CAAX protein 1;, PF00071;, GO:0005886;GO:0005516;GO:0019003;GO:0005525;GO:0003924;GO:0007265;GO:0007165;, C:plasma membrane;, F:calmodulin binding; F:GDP binding; F:GTP binding; F:GTPase activity;, P:Ras protein signal transduction; P:signal transduction;|Q92963 B4DQE8 O00646 O00720 Q5VY89 Q5VY90,GTP-binding protein Rit1,Ras-like protein expressed in many tissues;Ras-like without CAAX protein 1;, PF00071;, GO:0005886;GO:0005516;GO:0019003;GO:0005525;GO:0003924;GO:0007265;GO:0007165;, C:plasma membrane;, F:calmodulin binding; F:GDP binding; F:GTP binding; F:GTPase activity;, P:Ras protein signal transduction; P:signal transduction;|Q7Z7F0 O94981 Q7L7Q2 Q7Z7E9 Q8TBQ0,KH homology domain-containing protein 4 {ECO:0000312|HGNC:HGNC:29145},Brings lots of money 7 {ECO:0000303|PubMed:19641227};Pre-mRNA splicing factor protein KHDC4 {ECO:0000305};, , GO:0005737;GO:0005654;GO:0005634;GO:0003723;GO:0006376;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splice site selection;|Q7Z7F0 O94981 Q7L7Q2 Q7Z7E9 Q8TBQ0,KH homology domain-containing protein 4 {ECO:0000312|HGNC:HGNC:29145},Brings lots of money 7 {ECO:0000303|PubMed:19641227};Pre-mRNA splicing factor protein KHDC4 {ECO:0000305};, , GO:0005737;GO:0005654;GO:0005634;GO:0003723;GO:0006376;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splice site selection;|Q7Z7F0 O94981 Q7L7Q2 Q7Z7E9 Q8TBQ0,KH homology domain-containing protein 4 {ECO:0000312|HGNC:HGNC:29145},Brings lots of money 7 {ECO:0000303|PubMed:19641227};Pre-mRNA splicing factor protein KHDC4 {ECO:0000305};, , GO:0005737;GO:0005654;GO:0005634;GO:0003723;GO:0006376;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splice site selection;|Q7Z7F0 O94981 Q7L7Q2 Q7Z7E9 Q8TBQ0,KH homology domain-containing protein 4 {ECO:0000312|HGNC:HGNC:29145},Brings lots of money 7 {ECO:0000303|PubMed:19641227};Pre-mRNA splicing factor protein KHDC4 {ECO:0000305};, , GO:0005737;GO:0005654;GO:0005634;GO:0003723;GO:0006376;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splice site selection;|Q7Z7F0 O94981 Q7L7Q2 Q7Z7E9 Q8TBQ0,KH homology domain-containing protein 4 {ECO:0000312|HGNC:HGNC:29145},Brings lots of money 7 {ECO:0000303|PubMed:19641227};Pre-mRNA splicing factor protein KHDC4 {ECO:0000305};, , GO:0005737;GO:0005654;GO:0005634;GO:0003723;GO:0006376;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splice site selection;|Q7Z7F0 O94981 Q7L7Q2 Q7Z7E9 Q8TBQ0,KH homology domain-containing protein 4 {ECO:0000312|HGNC:HGNC:29145},Brings lots of money 7 {ECO:0000303|PubMed:19641227};Pre-mRNA splicing factor protein KHDC4 {ECO:0000305};, , GO:0005737;GO:0005654;GO:0005634;GO:0003723;GO:0006376;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA splice site selection; scaffold49 indexed_genome mRNA 2719016 2744913 . - . ID=transcript_9288;Q92974 D3DVA6 O75142 Q15079 Q5VY92 Q8TDA3 Q8WUG4 Q9H023,Rho guanine nucleotide exchange factor 2,Guanine nucleotide exchange factor H1;Microtubule-regulated Rho-GEF;Proliferating cell nucleolar antigen p40;, PF17838;PF00621;, GO:0005923;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0032991;GO:0032587;GO:0005819;GO:0031982;GO:0005085;GO:0008017;GO:0031267;GO:0008134;GO:0008270;GO:0007015;GO:0055059;GO:0007049;GO:0000902;GO:0071474;GO:0071225;GO:0071356;GO:0007186;GO:0045087;GO:0006886;GO:0035556;GO:1902042;GO:1902219;GO:0007026;GO:0060546;GO:0043065;GO:0032755;GO:0045666;GO:2001224;GO:0051092;GO:0050731;GO:0045944;GO:0032760;GO:0042127;GO:0035023;GO:0051056;, C:bicellular tight junction; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:protein-containing complex; C:ruffle membrane; C:spindle; C:vesicle;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:small GTPase binding; F:transcription factor binding; F:zinc ion binding;, P:actin filament organization; P:asymmetric neuroblast division; P:cell cycle; P:cell morphogenesis; P:cellular hyperosmotic response; P:cellular response to muramyl dipeptide; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:intracellular protein transport; P:intracellular signal transduction; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:negative regulation of microtubule depolymerization; P:negative regulation of necroptotic process; P:positive regulation of apoptotic process; P:positive regulation of interleukin-6 production; P:positive regulation of neuron differentiation; P:positive regulation of neuron migration; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of cell population proliferation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q92974 D3DVA6 O75142 Q15079 Q5VY92 Q8TDA3 Q8WUG4 Q9H023,Rho guanine nucleotide exchange factor 2,Guanine nucleotide exchange factor H1;Microtubule-regulated Rho-GEF;Proliferating cell nucleolar antigen p40;, PF17838;PF00621;, GO:0005923;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0032991;GO:0032587;GO:0005819;GO:0031982;GO:0005085;GO:0008017;GO:0031267;GO:0008134;GO:0008270;GO:0007015;GO:0055059;GO:0007049;GO:0000902;GO:0071474;GO:0071225;GO:0071356;GO:0007186;GO:0045087;GO:0006886;GO:0035556;GO:1902042;GO:1902219;GO:0007026;GO:0060546;GO:0043065;GO:0032755;GO:0045666;GO:2001224;GO:0051092;GO:0050731;GO:0045944;GO:0032760;GO:0042127;GO:0035023;GO:0051056;, C:bicellular tight junction; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:protein-containing complex; C:ruffle membrane; C:spindle; C:vesicle;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:small GTPase binding; F:transcription factor binding; F:zinc ion binding;, P:actin filament organization; P:asymmetric neuroblast division; P:cell cycle; P:cell morphogenesis; P:cellular hyperosmotic response; P:cellular response to muramyl dipeptide; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:intracellular protein transport; P:intracellular signal transduction; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:negative regulation of microtubule depolymerization; P:negative regulation of necroptotic process; P:positive regulation of apoptotic process; P:positive regulation of interleukin-6 production; P:positive regulation of neuron differentiation; P:positive regulation of neuron migration; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of cell population proliferation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q92974 D3DVA6 O75142 Q15079 Q5VY92 Q8TDA3 Q8WUG4 Q9H023,Rho guanine nucleotide exchange factor 2,Guanine nucleotide exchange factor H1;Microtubule-regulated Rho-GEF;Proliferating cell nucleolar antigen p40;, PF17838;PF00621;, GO:0005923;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0032991;GO:0032587;GO:0005819;GO:0031982;GO:0005085;GO:0008017;GO:0031267;GO:0008134;GO:0008270;GO:0007015;GO:0055059;GO:0007049;GO:0000902;GO:0071474;GO:0071225;GO:0071356;GO:0007186;GO:0045087;GO:0006886;GO:0035556;GO:1902042;GO:1902219;GO:0007026;GO:0060546;GO:0043065;GO:0032755;GO:0045666;GO:2001224;GO:0051092;GO:0050731;GO:0045944;GO:0032760;GO:0042127;GO:0035023;GO:0051056;, C:bicellular tight junction; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:protein-containing complex; C:ruffle membrane; C:spindle; C:vesicle;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:small GTPase binding; F:transcription factor binding; F:zinc ion binding;, P:actin filament organization; P:asymmetric neuroblast division; P:cell cycle; P:cell morphogenesis; P:cellular hyperosmotic response; P:cellular response to muramyl dipeptide; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:intracellular protein transport; P:intracellular signal transduction; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:negative regulation of microtubule depolymerization; P:negative regulation of necroptotic process; P:positive regulation of apoptotic process; P:positive regulation of interleukin-6 production; P:positive regulation of neuron differentiation; P:positive regulation of neuron migration; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of cell population proliferation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q92974 D3DVA6 O75142 Q15079 Q5VY92 Q8TDA3 Q8WUG4 Q9H023,Rho guanine nucleotide exchange factor 2,Guanine nucleotide exchange factor H1;Microtubule-regulated Rho-GEF;Proliferating cell nucleolar antigen p40;, PF17838;PF00621;, GO:0005923;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0032991;GO:0032587;GO:0005819;GO:0031982;GO:0005085;GO:0008017;GO:0031267;GO:0008134;GO:0008270;GO:0007015;GO:0055059;GO:0007049;GO:0000902;GO:0071474;GO:0071225;GO:0071356;GO:0007186;GO:0045087;GO:0006886;GO:0035556;GO:1902042;GO:1902219;GO:0007026;GO:0060546;GO:0043065;GO:0032755;GO:0045666;GO:2001224;GO:0051092;GO:0050731;GO:0045944;GO:0032760;GO:0042127;GO:0035023;GO:0051056;, C:bicellular tight junction; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:protein-containing complex; C:ruffle membrane; C:spindle; C:vesicle;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:small GTPase binding; F:transcription factor binding; F:zinc ion binding;, P:actin filament organization; P:asymmetric neuroblast division; P:cell cycle; P:cell morphogenesis; P:cellular hyperosmotic response; P:cellular response to muramyl dipeptide; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:intracellular protein transport; P:intracellular signal transduction; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:negative regulation of microtubule depolymerization; P:negative regulation of necroptotic process; P:positive regulation of apoptotic process; P:positive regulation of interleukin-6 production; P:positive regulation of neuron differentiation; P:positive regulation of neuron migration; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of cell population proliferation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q92974 D3DVA6 O75142 Q15079 Q5VY92 Q8TDA3 Q8WUG4 Q9H023,Rho guanine nucleotide exchange factor 2,Guanine nucleotide exchange factor H1;Microtubule-regulated Rho-GEF;Proliferating cell nucleolar antigen p40;, PF17838;PF00621;, GO:0005923;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0032991;GO:0032587;GO:0005819;GO:0031982;GO:0005085;GO:0008017;GO:0031267;GO:0008134;GO:0008270;GO:0007015;GO:0055059;GO:0007049;GO:0000902;GO:0071474;GO:0071225;GO:0071356;GO:0007186;GO:0045087;GO:0006886;GO:0035556;GO:1902042;GO:1902219;GO:0007026;GO:0060546;GO:0043065;GO:0032755;GO:0045666;GO:2001224;GO:0051092;GO:0050731;GO:0045944;GO:0032760;GO:0042127;GO:0035023;GO:0051056;, C:bicellular tight junction; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:protein-containing complex; C:ruffle membrane; C:spindle; C:vesicle;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:small GTPase binding; F:transcription factor binding; F:zinc ion binding;, P:actin filament organization; P:asymmetric neuroblast division; P:cell cycle; P:cell morphogenesis; P:cellular hyperosmotic response; P:cellular response to muramyl dipeptide; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:intracellular protein transport; P:intracellular signal transduction; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:negative regulation of microtubule depolymerization; P:negative regulation of necroptotic process; P:positive regulation of apoptotic process; P:positive regulation of interleukin-6 production; P:positive regulation of neuron differentiation; P:positive regulation of neuron migration; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of cell population proliferation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q92974 D3DVA6 O75142 Q15079 Q5VY92 Q8TDA3 Q8WUG4 Q9H023,Rho guanine nucleotide exchange factor 2,Guanine nucleotide exchange factor H1;Microtubule-regulated Rho-GEF;Proliferating cell nucleolar antigen p40;, PF17838;PF00621;, GO:0005923;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0032991;GO:0032587;GO:0005819;GO:0031982;GO:0005085;GO:0008017;GO:0031267;GO:0008134;GO:0008270;GO:0007015;GO:0055059;GO:0007049;GO:0000902;GO:0071474;GO:0071225;GO:0071356;GO:0007186;GO:0045087;GO:0006886;GO:0035556;GO:1902042;GO:1902219;GO:0007026;GO:0060546;GO:0043065;GO:0032755;GO:0045666;GO:2001224;GO:0051092;GO:0050731;GO:0045944;GO:0032760;GO:0042127;GO:0035023;GO:0051056;, C:bicellular tight junction; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:protein-containing complex; C:ruffle membrane; C:spindle; C:vesicle;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:small GTPase binding; F:transcription factor binding; F:zinc ion binding;, P:actin filament organization; P:asymmetric neuroblast division; P:cell cycle; P:cell morphogenesis; P:cellular hyperosmotic response; P:cellular response to muramyl dipeptide; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:intracellular protein transport; P:intracellular signal transduction; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:negative regulation of microtubule depolymerization; P:negative regulation of necroptotic process; P:positive regulation of apoptotic process; P:positive regulation of interleukin-6 production; P:positive regulation of neuron differentiation; P:positive regulation of neuron migration; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of cell population proliferation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q92974 D3DVA6 O75142 Q15079 Q5VY92 Q8TDA3 Q8WUG4 Q9H023,Rho guanine nucleotide exchange factor 2,Guanine nucleotide exchange factor H1;Microtubule-regulated Rho-GEF;Proliferating cell nucleolar antigen p40;, PF17838;PF00621;, GO:0005923;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0032991;GO:0032587;GO:0005819;GO:0031982;GO:0005085;GO:0008017;GO:0031267;GO:0008134;GO:0008270;GO:0007015;GO:0055059;GO:0007049;GO:0000902;GO:0071474;GO:0071225;GO:0071356;GO:0007186;GO:0045087;GO:0006886;GO:0035556;GO:1902042;GO:1902219;GO:0007026;GO:0060546;GO:0043065;GO:0032755;GO:0045666;GO:2001224;GO:0051092;GO:0050731;GO:0045944;GO:0032760;GO:0042127;GO:0035023;GO:0051056;, C:bicellular tight junction; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:protein-containing complex; C:ruffle membrane; C:spindle; C:vesicle;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:small GTPase binding; F:transcription factor binding; F:zinc ion binding;, P:actin filament organization; P:asymmetric neuroblast division; P:cell cycle; P:cell morphogenesis; P:cellular hyperosmotic response; P:cellular response to muramyl dipeptide; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:intracellular protein transport; P:intracellular signal transduction; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:negative regulation of microtubule depolymerization; P:negative regulation of necroptotic process; P:positive regulation of apoptotic process; P:positive regulation of interleukin-6 production; P:positive regulation of neuron differentiation; P:positive regulation of neuron migration; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of cell population proliferation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q92974 D3DVA6 O75142 Q15079 Q5VY92 Q8TDA3 Q8WUG4 Q9H023,Rho guanine nucleotide exchange factor 2,Guanine nucleotide exchange factor H1;Microtubule-regulated Rho-GEF;Proliferating cell nucleolar antigen p40;, PF17838;PF00621;, GO:0005923;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0032991;GO:0032587;GO:0005819;GO:0031982;GO:0005085;GO:0008017;GO:0031267;GO:0008134;GO:0008270;GO:0007015;GO:0055059;GO:0007049;GO:0000902;GO:0071474;GO:0071225;GO:0071356;GO:0007186;GO:0045087;GO:0006886;GO:0035556;GO:1902042;GO:1902219;GO:0007026;GO:0060546;GO:0043065;GO:0032755;GO:0045666;GO:2001224;GO:0051092;GO:0050731;GO:0045944;GO:0032760;GO:0042127;GO:0035023;GO:0051056;, C:bicellular tight junction; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:protein-containing complex; C:ruffle membrane; C:spindle; C:vesicle;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:small GTPase binding; F:transcription factor binding; F:zinc ion binding;, P:actin filament organization; P:asymmetric neuroblast division; P:cell cycle; P:cell morphogenesis; P:cellular hyperosmotic response; P:cellular response to muramyl dipeptide; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:intracellular protein transport; P:intracellular signal transduction; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:negative regulation of microtubule depolymerization; P:negative regulation of necroptotic process; P:positive regulation of apoptotic process; P:positive regulation of interleukin-6 production; P:positive regulation of neuron differentiation; P:positive regulation of neuron migration; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:regulation of cell population proliferation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; scaffold49 indexed_genome mRNA 2772544 2779534 . - . ID=transcript_9289;P43308 B2R9K9 D3DVA7 Q53HI0 Q5VY95 Q5VY96 Q6IB31 Q9BWE4,Translocon-associated protein subunit beta,Signal sequence receptor subunit beta;, , GO:0005783;GO:0005789;GO:0016021;GO:0006613;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:cotranslational protein targeting to membrane;|P43308 B2R9K9 D3DVA7 Q53HI0 Q5VY95 Q5VY96 Q6IB31 Q9BWE4,Translocon-associated protein subunit beta,Signal sequence receptor subunit beta;, , GO:0005783;GO:0005789;GO:0016021;GO:0006613;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:cotranslational protein targeting to membrane; scaffold49 indexed_genome mRNA 2805804 2809254 . - . ID=transcript_9290;Q9NRR5 A6ND44 B2RAY7 Q5VYA0 Q5VYA1 Q9BR98 Q9UHX4,Ubiquilin-4 {ECO:0000305},Ataxin-1 interacting ubiquitin-like protein {ECO:0000303|PubMed:11001934};Ataxin-1 ubiquitin-like-interacting protein A1U;Connexin43-interacting protein of 75 kDa {ECO:0000250|UniProtKB:Q99NB8};, PF00627;PF00240;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0090734;GO:0042802;GO:0036435;GO:0031593;GO:0006914;GO:0006974;GO:0006281;GO:1901097;GO:2000042;GO:0032434;GO:0006511;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:site of DNA damage;, F:identical protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding;, P:autophagy; P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of autophagosome maturation; P:negative regulation of double-strand break repair via homologous recombination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9NRR5 A6ND44 B2RAY7 Q5VYA0 Q5VYA1 Q9BR98 Q9UHX4,Ubiquilin-4 {ECO:0000305},Ataxin-1 interacting ubiquitin-like protein {ECO:0000303|PubMed:11001934};Ataxin-1 ubiquitin-like-interacting protein A1U;Connexin43-interacting protein of 75 kDa {ECO:0000250|UniProtKB:Q99NB8};, PF00627;PF00240;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0090734;GO:0042802;GO:0036435;GO:0031593;GO:0006914;GO:0006974;GO:0006281;GO:1901097;GO:2000042;GO:0032434;GO:0006511;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:site of DNA damage;, F:identical protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding;, P:autophagy; P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of autophagosome maturation; P:negative regulation of double-strand break repair via homologous recombination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process; scaffold49 indexed_genome mRNA 2809273 2821199 . - . ID=transcript_9291;Q9NRR5 A6ND44 B2RAY7 Q5VYA0 Q5VYA1 Q9BR98 Q9UHX4,Ubiquilin-4 {ECO:0000305},Ataxin-1 interacting ubiquitin-like protein {ECO:0000303|PubMed:11001934};Ataxin-1 ubiquitin-like-interacting protein A1U;Connexin43-interacting protein of 75 kDa {ECO:0000250|UniProtKB:Q99NB8};, PF00627;PF00240;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0090734;GO:0042802;GO:0036435;GO:0031593;GO:0006914;GO:0006974;GO:0006281;GO:1901097;GO:2000042;GO:0032434;GO:0006511;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:site of DNA damage;, F:identical protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding;, P:autophagy; P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of autophagosome maturation; P:negative regulation of double-strand break repair via homologous recombination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9NRR5 A6ND44 B2RAY7 Q5VYA0 Q5VYA1 Q9BR98 Q9UHX4,Ubiquilin-4 {ECO:0000305},Ataxin-1 interacting ubiquitin-like protein {ECO:0000303|PubMed:11001934};Ataxin-1 ubiquitin-like-interacting protein A1U;Connexin43-interacting protein of 75 kDa {ECO:0000250|UniProtKB:Q99NB8};, PF00627;PF00240;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0090734;GO:0042802;GO:0036435;GO:0031593;GO:0006914;GO:0006974;GO:0006281;GO:1901097;GO:2000042;GO:0032434;GO:0006511;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:site of DNA damage;, F:identical protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding;, P:autophagy; P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of autophagosome maturation; P:negative regulation of double-strand break repair via homologous recombination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9NRR5 A6ND44 B2RAY7 Q5VYA0 Q5VYA1 Q9BR98 Q9UHX4,Ubiquilin-4 {ECO:0000305},Ataxin-1 interacting ubiquitin-like protein {ECO:0000303|PubMed:11001934};Ataxin-1 ubiquitin-like-interacting protein A1U;Connexin43-interacting protein of 75 kDa {ECO:0000250|UniProtKB:Q99NB8};, PF00627;PF00240;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0090734;GO:0042802;GO:0036435;GO:0031593;GO:0006914;GO:0006974;GO:0006281;GO:1901097;GO:2000042;GO:0032434;GO:0006511;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:site of DNA damage;, F:identical protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding;, P:autophagy; P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of autophagosome maturation; P:negative regulation of double-strand break repair via homologous recombination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9NRR5 A6ND44 B2RAY7 Q5VYA0 Q5VYA1 Q9BR98 Q9UHX4,Ubiquilin-4 {ECO:0000305},Ataxin-1 interacting ubiquitin-like protein {ECO:0000303|PubMed:11001934};Ataxin-1 ubiquitin-like-interacting protein A1U;Connexin43-interacting protein of 75 kDa {ECO:0000250|UniProtKB:Q99NB8};, PF00627;PF00240;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0090734;GO:0042802;GO:0036435;GO:0031593;GO:0006914;GO:0006974;GO:0006281;GO:1901097;GO:2000042;GO:0032434;GO:0006511;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:site of DNA damage;, F:identical protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding;, P:autophagy; P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of autophagosome maturation; P:negative regulation of double-strand break repair via homologous recombination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process; scaffold49 indexed_genome mRNA 2831979 2835123 . + . ID=transcript_9292;Q9Y2Q5 Q5VY97 Q5VY98 Q5VY99,Ragulator complex protein LAMTOR2,Endosomal adaptor protein p14;Late endosomal/lysosomal Mp1-interacting protein;Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2;Mitogen-activated protein-binding protein-interacting protein;Roadblock domain-containing protein 3;, PF03259;, GO:0010008;GO:0005770;GO:0005765;GO:0005886;GO:0071986;GO:0035579;GO:0070821;GO:0005085;GO:0060090;GO:0000186;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:0010761;GO:0000165;GO:0043312;GO:0032008;GO:1902414;GO:0001558;GO:0150116;GO:0016241;, C:endosome membrane; C:late endosome; C:lysosomal membrane; C:plasma membrane; C:Ragulator complex; C:specific granule membrane; C:tertiary granule membrane;, F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:activation of MAPKK activity; P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:fibroblast migration; P:MAPK cascade; P:neutrophil degranulation; P:positive regulation of TOR signaling; P:protein localization to cell junction; P:regulation of cell growth; P:regulation of cell-substrate junction organization; P:regulation of macroautophagy;|Q9Y2Q5 Q5VY97 Q5VY98 Q5VY99,Ragulator complex protein LAMTOR2,Endosomal adaptor protein p14;Late endosomal/lysosomal Mp1-interacting protein;Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2;Mitogen-activated protein-binding protein-interacting protein;Roadblock domain-containing protein 3;, PF03259;, GO:0010008;GO:0005770;GO:0005765;GO:0005886;GO:0071986;GO:0035579;GO:0070821;GO:0005085;GO:0060090;GO:0000186;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:0010761;GO:0000165;GO:0043312;GO:0032008;GO:1902414;GO:0001558;GO:0150116;GO:0016241;, C:endosome membrane; C:late endosome; C:lysosomal membrane; C:plasma membrane; C:Ragulator complex; C:specific granule membrane; C:tertiary granule membrane;, F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:activation of MAPKK activity; P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:fibroblast migration; P:MAPK cascade; P:neutrophil degranulation; P:positive regulation of TOR signaling; P:protein localization to cell junction; P:regulation of cell growth; P:regulation of cell-substrate junction organization; P:regulation of macroautophagy; scaffold49 indexed_genome mRNA 2836100 2842687 . + . ID=transcript_9293;P57735 Q5VYA2 Q8NG24 Q96GB1 Q9BT12,Ras-related protein Rab-25,CATX-8;, PF00071;, GO:0031410;GO:0005768;GO:0070062;GO:0031143;GO:0031260;GO:0055037;GO:0005525;GO:0003924;GO:0031489;GO:0003382;GO:0006887;GO:0008284;GO:0010634;GO:0015031;GO:0031268;GO:0060627;, C:cytoplasmic vesicle; C:endosome; C:extracellular exosome; C:pseudopodium; C:pseudopodium membrane; C:recycling endosome;, F:GTP binding; F:GTPase activity; F:myosin V binding;, P:epithelial cell morphogenesis; P:exocytosis; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell migration; P:protein transport; P:pseudopodium organization; P:regulation of vesicle-mediated transport;|P57735 Q5VYA2 Q8NG24 Q96GB1 Q9BT12,Ras-related protein Rab-25,CATX-8;, PF00071;, GO:0031410;GO:0005768;GO:0070062;GO:0031143;GO:0031260;GO:0055037;GO:0005525;GO:0003924;GO:0031489;GO:0003382;GO:0006887;GO:0008284;GO:0010634;GO:0015031;GO:0031268;GO:0060627;, C:cytoplasmic vesicle; C:endosome; C:extracellular exosome; C:pseudopodium; C:pseudopodium membrane; C:recycling endosome;, F:GTP binding; F:GTPase activity; F:myosin V binding;, P:epithelial cell morphogenesis; P:exocytosis; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell migration; P:protein transport; P:pseudopodium organization; P:regulation of vesicle-mediated transport; scaffold49 indexed_genome mRNA 2885628 2905305 . + . ID=transcript_9294;Q5TCJ3 Q6UYC3 Q969I8 Q96JA2,Prelamin-A/C,, PF00038;PF00932;, GO:0005829;GO:0005882;GO:0005638;GO:0016604;GO:0005635;GO:0005652;GO:0016363;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0048471;GO:0035861;GO:0042802;GO:0005198;GO:0034613;GO:0071456;GO:1990683;GO:0030951;GO:0036498;GO:0007084;GO:0007517;GO:1903243;GO:0008285;GO:0006998;GO:0090343;GO:0034504;GO:0030334;GO:0032204;, C:cytosol; C:intermediate filament; C:lamin filament; C:nuclear body; C:nuclear envelope; C:nuclear lamina; C:nuclear matrix; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:site of double-strand break;, F:identical protein binding; F:structural molecule activity;, P:cellular protein localization; P:cellular response to hypoxia; P:DNA double-strand break attachment to nuclear envelope; P:establishment or maintenance of microtubule cytoskeleton polarity; P:IRE1-mediated unfolded protein response; P:mitotic nuclear envelope reassembly; P:muscle organ development; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of cell population proliferation; P:nuclear envelope organization; P:positive regulation of cell aging; P:protein localization to nucleus; P:regulation of cell migration; P:regulation of telomere maintenance;|Q5TCJ3 Q6UYC3 Q969I8 Q96JA2,Prelamin-A/C,, PF00038;PF00932;, GO:0005829;GO:0005882;GO:0005638;GO:0016604;GO:0005635;GO:0005652;GO:0016363;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0048471;GO:0035861;GO:0042802;GO:0005198;GO:0034613;GO:0071456;GO:1990683;GO:0030951;GO:0036498;GO:0007084;GO:0007517;GO:1903243;GO:0008285;GO:0006998;GO:0090343;GO:0034504;GO:0030334;GO:0032204;, C:cytosol; C:intermediate filament; C:lamin filament; C:nuclear body; C:nuclear envelope; C:nuclear lamina; C:nuclear matrix; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:site of double-strand break;, F:identical protein binding; F:structural molecule activity;, P:cellular protein localization; P:cellular response to hypoxia; P:DNA double-strand break attachment to nuclear envelope; P:establishment or maintenance of microtubule cytoskeleton polarity; P:IRE1-mediated unfolded protein response; P:mitotic nuclear envelope reassembly; P:muscle organ development; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of cell population proliferation; P:nuclear envelope organization; P:positive regulation of cell aging; P:protein localization to nucleus; P:regulation of cell migration; P:regulation of telomere maintenance; scaffold49 indexed_genome mRNA 2910275 2935526 . + . ID=transcript_9295;Q9H3S1 B2RDH8 B3KR76 Q5TCI5 Q5TCJ6 Q8WUA9,Semaphorin-4A,Semaphorin-B;, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0005886;GO:0045499;GO:0030215;GO:0001525;GO:0007411;GO:0050919;GO:0016525;GO:0048843;GO:0001755;GO:0030335;GO:1904891;GO:1905704;GO:0008360;GO:0010594;GO:0071526;GO:0045063;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:angiogenesis; P:axon guidance; P:negative chemotaxis; P:negative regulation of angiogenesis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:positive regulation of excitatory synapse assembly; P:positive regulation of inhibitory synapse assembly; P:regulation of cell shape; P:regulation of endothelial cell migration; P:semaphorin-plexin signaling pathway; P:T-helper 1 cell differentiation;|Q9H3S1 B2RDH8 B3KR76 Q5TCI5 Q5TCJ6 Q8WUA9,Semaphorin-4A,Semaphorin-B;, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0005886;GO:0045499;GO:0030215;GO:0001525;GO:0007411;GO:0050919;GO:0016525;GO:0048843;GO:0001755;GO:0030335;GO:1904891;GO:1905704;GO:0008360;GO:0010594;GO:0071526;GO:0045063;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:angiogenesis; P:axon guidance; P:negative chemotaxis; P:negative regulation of angiogenesis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:positive regulation of excitatory synapse assembly; P:positive regulation of inhibitory synapse assembly; P:regulation of cell shape; P:regulation of endothelial cell migration; P:semaphorin-plexin signaling pathway; P:T-helper 1 cell differentiation;|Q9H3S1 B2RDH8 B3KR76 Q5TCI5 Q5TCJ6 Q8WUA9,Semaphorin-4A,Semaphorin-B;, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0005886;GO:0045499;GO:0030215;GO:0001525;GO:0007411;GO:0050919;GO:0016525;GO:0048843;GO:0001755;GO:0030335;GO:1904891;GO:1905704;GO:0008360;GO:0010594;GO:0071526;GO:0045063;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:angiogenesis; P:axon guidance; P:negative chemotaxis; P:negative regulation of angiogenesis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:positive regulation of excitatory synapse assembly; P:positive regulation of inhibitory synapse assembly; P:regulation of cell shape; P:regulation of endothelial cell migration; P:semaphorin-plexin signaling pathway; P:T-helper 1 cell differentiation; scaffold49 indexed_genome mRNA 2935622 2936248 . + . ID=transcript_9296;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold49 indexed_genome mRNA 2937364 2938476 . + . ID=transcript_9297;Q9H3S1 B2RDH8 B3KR76 Q5TCI5 Q5TCJ6 Q8WUA9,Semaphorin-4A,Semaphorin-B;, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0005886;GO:0045499;GO:0030215;GO:0001525;GO:0007411;GO:0050919;GO:0016525;GO:0048843;GO:0001755;GO:0030335;GO:1904891;GO:1905704;GO:0008360;GO:0010594;GO:0071526;GO:0045063;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:angiogenesis; P:axon guidance; P:negative chemotaxis; P:negative regulation of angiogenesis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:positive regulation of excitatory synapse assembly; P:positive regulation of inhibitory synapse assembly; P:regulation of cell shape; P:regulation of endothelial cell migration; P:semaphorin-plexin signaling pathway; P:T-helper 1 cell differentiation; scaffold49 indexed_genome mRNA 2954029 2971095 . + . ID=transcript_9298;Q96H78 O75034,Solute carrier family 25 member 44,, PF00153;, GO:0016021;GO:0031966;GO:0005739;GO:0015658;GO:0009083;GO:0015803;GO:0120161;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;, F:branched-chain amino acid transmembrane transporter activity;, P:branched-chain amino acid catabolic process; P:branched-chain amino acid transport; P:regulation of cold-induced thermogenesis; scaffold49 indexed_genome mRNA 2971202 2999526 . + . ID=transcript_9299;Q6ZVE6 Q86VJ6 Q8N4T6 Q9UBQ3,Polyamine-modulated factor 1,, PF03980;, GO:0000777;GO:0005829;GO:0005794;GO:0043231;GO:0000444;GO:0000818;GO:0005654;GO:0005667;GO:0043522;GO:0003713;GO:0051301;GO:0007059;GO:0007052;GO:0006366;, C:condensed chromosome kinetochore; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:MIS12/MIND type complex; C:nuclear MIS12/MIND complex; C:nucleoplasm; C:transcription regulator complex;, F:leucine zipper domain binding; F:transcription coactivator activity;, P:cell division; P:chromosome segregation; P:mitotic spindle organization; P:transcription by RNA polymerase II;|Q6ZVE6 Q86VJ6 Q8N4T6 Q9UBQ3,Polyamine-modulated factor 1,, PF03980;, GO:0000777;GO:0005829;GO:0005794;GO:0043231;GO:0000444;GO:0000818;GO:0005654;GO:0005667;GO:0043522;GO:0003713;GO:0051301;GO:0007059;GO:0007052;GO:0006366;, C:condensed chromosome kinetochore; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:MIS12/MIND type complex; C:nuclear MIS12/MIND complex; C:nucleoplasm; C:transcription regulator complex;, F:leucine zipper domain binding; F:transcription coactivator activity;, P:cell division; P:chromosome segregation; P:mitotic spindle organization; P:transcription by RNA polymerase II;|Q6ZVE6 Q86VJ6 Q8N4T6 Q9UBQ3,Polyamine-modulated factor 1,, PF03980;, GO:0000777;GO:0005829;GO:0005794;GO:0043231;GO:0000444;GO:0000818;GO:0005654;GO:0005667;GO:0043522;GO:0003713;GO:0051301;GO:0007059;GO:0007052;GO:0006366;, C:condensed chromosome kinetochore; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:MIS12/MIND type complex; C:nuclear MIS12/MIND complex; C:nucleoplasm; C:transcription regulator complex;, F:leucine zipper domain binding; F:transcription coactivator activity;, P:cell division; P:chromosome segregation; P:mitotic spindle organization; P:transcription by RNA polymerase II;|Q6ZVE6 Q86VJ6 Q8N4T6 Q9UBQ3,Polyamine-modulated factor 1,, PF03980;, GO:0000777;GO:0005829;GO:0005794;GO:0043231;GO:0000444;GO:0000818;GO:0005654;GO:0005667;GO:0043522;GO:0003713;GO:0051301;GO:0007059;GO:0007052;GO:0006366;, C:condensed chromosome kinetochore; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:MIS12/MIND type complex; C:nuclear MIS12/MIND complex; C:nucleoplasm; C:transcription regulator complex;, F:leucine zipper domain binding; F:transcription coactivator activity;, P:cell division; P:chromosome segregation; P:mitotic spindle organization; P:transcription by RNA polymerase II; scaffold49 indexed_genome mRNA 3001652 3035081 . - . ID=transcript_9300;Q9UPR3 D3DVB7 Q5QJE7 Q659C7 Q8IXC0 Q8IY09 Q96IJ7,Protein SMG5,EST1-like protein B;LPTS-RP1;LPTS-interacting protein;SMG-5 homolog;, PF10374;PF10373;PF13638;, GO:0005737;GO:0005829;GO:0005634;GO:0005697;GO:0042826;GO:0051721;GO:0070034;GO:0042162;GO:0031625;GO:0006406;GO:0000184;GO:0035303;GO:0032204;GO:0032210;, C:cytoplasm; C:cytosol; C:nucleus; C:telomerase holoenzyme complex;, F:histone deacetylase binding; F:protein phosphatase 2A binding; F:telomerase RNA binding; F:telomeric DNA binding; F:ubiquitin protein ligase binding;, P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of dephosphorylation; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase;|Q8N3M2 Q9H621,Membrane progestin receptor delta {ECO:0000303|PubMed:23763432},Membrane progesterone P4 receptor delta {ECO:0000303|PubMed:23763432};Membrane progesterone receptor delta {ECO:0000303|PubMed:23763432};Progesterone and adipoQ receptor family member 6;Progestin and adipoQ receptor family member 6 {ECO:0000303|PubMed:16044242};, PF03006;, GO:0016021;GO:0005886;GO:0038023;GO:0005496;, C:integral component of membrane; C:plasma membrane;, F:signaling receptor activity; F:steroid binding;|Q9UPR3 D3DVB7 Q5QJE7 Q659C7 Q8IXC0 Q8IY09 Q96IJ7,Protein SMG5,EST1-like protein B;LPTS-RP1;LPTS-interacting protein;SMG-5 homolog;, PF10374;PF10373;PF13638;, GO:0005737;GO:0005829;GO:0005634;GO:0005697;GO:0042826;GO:0051721;GO:0070034;GO:0042162;GO:0031625;GO:0006406;GO:0000184;GO:0035303;GO:0032204;GO:0032210;, C:cytoplasm; C:cytosol; C:nucleus; C:telomerase holoenzyme complex;, F:histone deacetylase binding; F:protein phosphatase 2A binding; F:telomerase RNA binding; F:telomeric DNA binding; F:ubiquitin protein ligase binding;, P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of dephosphorylation; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase;|Q9UPR3 D3DVB7 Q5QJE7 Q659C7 Q8IXC0 Q8IY09 Q96IJ7,Protein SMG5,EST1-like protein B;LPTS-RP1;LPTS-interacting protein;SMG-5 homolog;, PF10374;PF10373;PF13638;, GO:0005737;GO:0005829;GO:0005634;GO:0005697;GO:0042826;GO:0051721;GO:0070034;GO:0042162;GO:0031625;GO:0006406;GO:0000184;GO:0035303;GO:0032204;GO:0032210;, C:cytoplasm; C:cytosol; C:nucleus; C:telomerase holoenzyme complex;, F:histone deacetylase binding; F:protein phosphatase 2A binding; F:telomerase RNA binding; F:telomeric DNA binding; F:ubiquitin protein ligase binding;, P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of dephosphorylation; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase;|Q9UPR3 D3DVB7 Q5QJE7 Q659C7 Q8IXC0 Q8IY09 Q96IJ7,Protein SMG5,EST1-like protein B;LPTS-RP1;LPTS-interacting protein;SMG-5 homolog;, PF10374;PF10373;PF13638;, GO:0005737;GO:0005829;GO:0005634;GO:0005697;GO:0042826;GO:0051721;GO:0070034;GO:0042162;GO:0031625;GO:0006406;GO:0000184;GO:0035303;GO:0032204;GO:0032210;, C:cytoplasm; C:cytosol; C:nucleus; C:telomerase holoenzyme complex;, F:histone deacetylase binding; F:protein phosphatase 2A binding; F:telomerase RNA binding; F:telomeric DNA binding; F:ubiquitin protein ligase binding;, P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of dephosphorylation; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase;|Q9UPR3 D3DVB7 Q5QJE7 Q659C7 Q8IXC0 Q8IY09 Q96IJ7,Protein SMG5,EST1-like protein B;LPTS-RP1;LPTS-interacting protein;SMG-5 homolog;, PF10374;PF10373;PF13638;, GO:0005737;GO:0005829;GO:0005634;GO:0005697;GO:0042826;GO:0051721;GO:0070034;GO:0042162;GO:0031625;GO:0006406;GO:0000184;GO:0035303;GO:0032204;GO:0032210;, C:cytoplasm; C:cytosol; C:nucleus; C:telomerase holoenzyme complex;, F:histone deacetylase binding; F:protein phosphatase 2A binding; F:telomerase RNA binding; F:telomeric DNA binding; F:ubiquitin protein ligase binding;, P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of dephosphorylation; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase; scaffold49 indexed_genome mRNA 3040959 3045847 . - . ID=transcript_9301;Q8WWB7 A6NH16 B4DJN4 Q5SZX4 Q6UX96 Q8IV07 Q96F65,Glycosylated lysosomal membrane protein {ECO:0000312|HGNC:HGNC:29436},Lysosomal protein NCU-G1 {ECO:0000305};, PF15065;, GO:0005829;GO:0016021;GO:0005765;GO:0005764;GO:0005634;GO:0045944;GO:0061462;GO:0050821;, C:cytosol; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:nucleus;, , P:positive regulation of transcription by RNA polymerase II; P:protein localization to lysosome; P:protein stabilization;|Q8WWB7 A6NH16 B4DJN4 Q5SZX4 Q6UX96 Q8IV07 Q96F65,Glycosylated lysosomal membrane protein {ECO:0000312|HGNC:HGNC:29436},Lysosomal protein NCU-G1 {ECO:0000305};, PF15065;, GO:0005829;GO:0016021;GO:0005765;GO:0005764;GO:0005634;GO:0045944;GO:0061462;GO:0050821;, C:cytosol; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:nucleus;, , P:positive regulation of transcription by RNA polymerase II; P:protein localization to lysosome; P:protein stabilization;|Q8WWB7 A6NH16 B4DJN4 Q5SZX4 Q6UX96 Q8IV07 Q96F65,Glycosylated lysosomal membrane protein {ECO:0000312|HGNC:HGNC:29436},Lysosomal protein NCU-G1 {ECO:0000305};, PF15065;, GO:0005829;GO:0016021;GO:0005765;GO:0005764;GO:0005634;GO:0045944;GO:0061462;GO:0050821;, C:cytosol; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:nucleus;, , P:positive regulation of transcription by RNA polymerase II; P:protein localization to lysosome; P:protein stabilization; scaffold49 indexed_genome mRNA 3050528 3064637 . - . ID=transcript_9302;P49368 A6NE14 Q5SZY1 Q9BR64,T-complex protein 1 subunit gamma,CCT-gamma;hTRiC5;, PF00118;, GO:0044297;GO:0005832;GO:0005856;GO:0005829;GO:0070062;GO:0005874;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:cell body; C:chaperonin-containing T-complex; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:microtubule; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|P49368 A6NE14 Q5SZY1 Q9BR64,T-complex protein 1 subunit gamma,CCT-gamma;hTRiC5;, PF00118;, GO:0044297;GO:0005832;GO:0005856;GO:0005829;GO:0070062;GO:0005874;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:cell body; C:chaperonin-containing T-complex; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:microtubule; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|P49368 A6NE14 Q5SZY1 Q9BR64,T-complex protein 1 subunit gamma,CCT-gamma;hTRiC5;, PF00118;, GO:0044297;GO:0005832;GO:0005856;GO:0005829;GO:0070062;GO:0005874;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:cell body; C:chaperonin-containing T-complex; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:microtubule; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|P49368 A6NE14 Q5SZY1 Q9BR64,T-complex protein 1 subunit gamma,CCT-gamma;hTRiC5;, PF00118;, GO:0044297;GO:0005832;GO:0005856;GO:0005829;GO:0070062;GO:0005874;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:cell body; C:chaperonin-containing T-complex; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:microtubule; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport;|P49368 A6NE14 Q5SZY1 Q9BR64,T-complex protein 1 subunit gamma,CCT-gamma;hTRiC5;, PF00118;, GO:0044297;GO:0005832;GO:0005856;GO:0005829;GO:0070062;GO:0005874;GO:0002199;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0007339;GO:0046931;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;GO:1901998;, C:cell body; C:chaperonin-containing T-complex; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:microtubule; C:zona pellucida receptor complex;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding;, P:binding of sperm to zona pellucida; P:pore complex assembly; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; P:toxin transport; scaffold49 indexed_genome mRNA 3098565 3110796 . + . ID=transcript_9303;Q9H310 A8K475 Q5SZW4 Q5SZW6 Q5SZW7 Q6P193 Q6YJI2 Q6YJI3,Ammonium transporter Rh type B,Rhesus blood group family type B glycoprotein;, PF00909;, GO:0046658;GO:0016323;GO:0030659;GO:0005887;GO:0005886;GO:0014731;GO:0008519;GO:0030506;GO:0072488;GO:0015696;GO:0070634;, C:anchored component of plasma membrane; C:basolateral plasma membrane; C:cytoplasmic vesicle membrane; C:integral component of plasma membrane; C:plasma membrane; C:spectrin-associated cytoskeleton;, F:ammonium transmembrane transporter activity; F:ankyrin binding;, P:ammonium transmembrane transport; P:ammonium transport; P:transepithelial ammonium transport;|Q9H310 A8K475 Q5SZW4 Q5SZW6 Q5SZW7 Q6P193 Q6YJI2 Q6YJI3,Ammonium transporter Rh type B,Rhesus blood group family type B glycoprotein;, PF00909;, GO:0046658;GO:0016323;GO:0030659;GO:0005887;GO:0005886;GO:0014731;GO:0008519;GO:0030506;GO:0072488;GO:0015696;GO:0070634;, C:anchored component of plasma membrane; C:basolateral plasma membrane; C:cytoplasmic vesicle membrane; C:integral component of plasma membrane; C:plasma membrane; C:spectrin-associated cytoskeleton;, F:ammonium transmembrane transporter activity; F:ankyrin binding;, P:ammonium transmembrane transport; P:ammonium transport; P:transepithelial ammonium transport;|Q9H310 A8K475 Q5SZW4 Q5SZW6 Q5SZW7 Q6P193 Q6YJI2 Q6YJI3,Ammonium transporter Rh type B,Rhesus blood group family type B glycoprotein;, PF00909;, GO:0046658;GO:0016323;GO:0030659;GO:0005887;GO:0005886;GO:0014731;GO:0008519;GO:0030506;GO:0072488;GO:0015696;GO:0070634;, C:anchored component of plasma membrane; C:basolateral plasma membrane; C:cytoplasmic vesicle membrane; C:integral component of plasma membrane; C:plasma membrane; C:spectrin-associated cytoskeleton;, F:ammonium transmembrane transporter activity; F:ankyrin binding;, P:ammonium transmembrane transport; P:ammonium transport; P:transepithelial ammonium transport; scaffold49 indexed_genome mRNA 3127591 3142555 . - . ID=transcript_9304;Q13536 B1ALL5 B1ALL8,Protein CROC-4,Contingent replication of cDNA 4;MIR9-1 host gene {ECO:0000312|HGNC:HGNC:30780};, , GO:0005634;GO:0045944;, C:nucleus;, , P:positive regulation of transcription by RNA polymerase II; scaffold49 indexed_genome mRNA 3187487 3202845 . - . ID=transcript_9305;Q14814 D3DVC0 Q14815 Q5T9U5 Q5T9U6,Myocyte-specific enhancer factor 2D,, PF12347;PF00319;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0033613;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0007512;GO:0006915;GO:0030154;GO:0002062;GO:0001958;GO:0007517;GO:0007399;GO:0001649;GO:0045944;GO:1904707;GO:0006357;GO:0035914;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adult heart development; P:apoptotic process; P:cell differentiation; P:chondrocyte differentiation; P:endochondral ossification; P:muscle organ development; P:nervous system development; P:osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation;|Q14814 D3DVC0 Q14815 Q5T9U5 Q5T9U6,Myocyte-specific enhancer factor 2D,, PF12347;PF00319;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0033613;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0007512;GO:0006915;GO:0030154;GO:0002062;GO:0001958;GO:0007517;GO:0007399;GO:0001649;GO:0045944;GO:1904707;GO:0006357;GO:0035914;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adult heart development; P:apoptotic process; P:cell differentiation; P:chondrocyte differentiation; P:endochondral ossification; P:muscle organ development; P:nervous system development; P:osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation;|Q14814 D3DVC0 Q14815 Q5T9U5 Q5T9U6,Myocyte-specific enhancer factor 2D,, PF12347;PF00319;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0033613;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0007512;GO:0006915;GO:0030154;GO:0002062;GO:0001958;GO:0007517;GO:0007399;GO:0001649;GO:0045944;GO:1904707;GO:0006357;GO:0035914;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adult heart development; P:apoptotic process; P:cell differentiation; P:chondrocyte differentiation; P:endochondral ossification; P:muscle organ development; P:nervous system development; P:osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation;|Q14814 D3DVC0 Q14815 Q5T9U5 Q5T9U6,Myocyte-specific enhancer factor 2D,, PF12347;PF00319;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0033613;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0007512;GO:0006915;GO:0030154;GO:0002062;GO:0001958;GO:0007517;GO:0007399;GO:0001649;GO:0045944;GO:1904707;GO:0006357;GO:0035914;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adult heart development; P:apoptotic process; P:cell differentiation; P:chondrocyte differentiation; P:endochondral ossification; P:muscle organ development; P:nervous system development; P:osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation;|Q14814 D3DVC0 Q14815 Q5T9U5 Q5T9U6,Myocyte-specific enhancer factor 2D,, PF12347;PF00319;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0033613;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0007512;GO:0006915;GO:0030154;GO:0002062;GO:0001958;GO:0007517;GO:0007399;GO:0001649;GO:0045944;GO:1904707;GO:0006357;GO:0035914;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adult heart development; P:apoptotic process; P:cell differentiation; P:chondrocyte differentiation; P:endochondral ossification; P:muscle organ development; P:nervous system development; P:osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation;|Q14814 D3DVC0 Q14815 Q5T9U5 Q5T9U6,Myocyte-specific enhancer factor 2D,, PF12347;PF00319;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0033613;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0007512;GO:0006915;GO:0030154;GO:0002062;GO:0001958;GO:0007517;GO:0007399;GO:0001649;GO:0045944;GO:1904707;GO:0006357;GO:0035914;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adult heart development; P:apoptotic process; P:cell differentiation; P:chondrocyte differentiation; P:endochondral ossification; P:muscle organ development; P:nervous system development; P:osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation;|Q14814 D3DVC0 Q14815 Q5T9U5 Q5T9U6,Myocyte-specific enhancer factor 2D,, PF12347;PF00319;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0033613;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0007512;GO:0006915;GO:0030154;GO:0002062;GO:0001958;GO:0007517;GO:0007399;GO:0001649;GO:0045944;GO:1904707;GO:0006357;GO:0035914;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adult heart development; P:apoptotic process; P:cell differentiation; P:chondrocyte differentiation; P:endochondral ossification; P:muscle organ development; P:nervous system development; P:osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; scaffold49 indexed_genome mRNA 3316686 3327237 . + . ID=transcript_9306;Q8NCW5 B4DGY3 Q496C6 Q5T3I2,NAD(P)H-hydrate epimerase {ECO:0000255|HAMAP-Rule:MF_03159},Apolipoprotein A-I-binding protein {ECO:0000255|HAMAP-Rule:MF_03159};NAD(P)HX epimerase {ECO:0000312|HGNC:HGNC:18453};YjeF N-terminal domain-containing protein 1;, PF03853;, GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005759;GO:0005739;GO:0046872;GO:0052856;GO:0052857;GO:0000166;GO:0006869;GO:0031580;GO:0034356;GO:0016525;GO:0046496;GO:0010874;GO:0002040;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:NADHX epimerase activity; F:NADPHX epimerase activity; F:nucleotide binding;, P:lipid transport; P:membrane raft distribution; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of angiogenesis; P:nicotinamide nucleotide metabolic process; P:regulation of cholesterol efflux; P:sprouting angiogenesis;|Q8NCW5 B4DGY3 Q496C6 Q5T3I2,NAD(P)H-hydrate epimerase {ECO:0000255|HAMAP-Rule:MF_03159},Apolipoprotein A-I-binding protein {ECO:0000255|HAMAP-Rule:MF_03159};NAD(P)HX epimerase {ECO:0000312|HGNC:HGNC:18453};YjeF N-terminal domain-containing protein 1;, PF03853;, GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005759;GO:0005739;GO:0046872;GO:0052856;GO:0052857;GO:0000166;GO:0006869;GO:0031580;GO:0034356;GO:0016525;GO:0046496;GO:0010874;GO:0002040;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:NADHX epimerase activity; F:NADPHX epimerase activity; F:nucleotide binding;, P:lipid transport; P:membrane raft distribution; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of angiogenesis; P:nicotinamide nucleotide metabolic process; P:regulation of cholesterol efflux; P:sprouting angiogenesis;|Q5T3I0 Q5T3I1 Q6ZUE7 Q8IWG8 Q9NXH4,G patch domain-containing protein 4,, PF01585;, GO:0003723;, , F:RNA binding;|Q5T3I0 Q5T3I1 Q6ZUE7 Q8IWG8 Q9NXH4,G patch domain-containing protein 4,, PF01585;, GO:0003723;, , F:RNA binding; scaffold49 indexed_genome mRNA 3344354 3349736 . + . ID=transcript_9307;Q9GZV7 Q5T3J0,Hyaluronan and proteoglycan link protein 2,Brain link protein 1;, PF07686;PF00193;, GO:0031012;GO:0005576;GO:0005540;GO:0007155;GO:0007417;GO:0008065;GO:0085029;GO:0001501;, C:extracellular matrix; C:extracellular region;, F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:establishment of blood-nerve barrier; P:extracellular matrix assembly; P:skeletal system development;|Q9GZV7 Q5T3J0,Hyaluronan and proteoglycan link protein 2,Brain link protein 1;, PF07686;PF00193;, GO:0031012;GO:0005576;GO:0005540;GO:0007155;GO:0007417;GO:0008065;GO:0085029;GO:0001501;, C:extracellular matrix; C:extracellular region;, F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:establishment of blood-nerve barrier; P:extracellular matrix assembly; P:skeletal system development; scaffold49 indexed_genome mRNA 3361802 3375861 . + . ID=transcript_9308;Q96GW7 D3DVC2 Q5SZ10 Q5T3I5 Q8TBB9 Q9HBK1 Q9HBK4,Brevican core protein,Brain-enriched hyaluronan-binding protein;Chondroitin sulfate proteoglycan 7;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0031225;GO:0031012;GO:0005576;GO:0098978;GO:0005796;GO:0043202;GO:0030246;GO:0005540;GO:0007155;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0021766;GO:0001501;GO:0060074;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:glutamatergic synapse; C:Golgi lumen; C:lysosomal lumen;, F:carbohydrate binding; F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:hippocampus development; P:skeletal system development; P:synapse maturation;|Q96GW7 D3DVC2 Q5SZ10 Q5T3I5 Q8TBB9 Q9HBK1 Q9HBK4,Brevican core protein,Brain-enriched hyaluronan-binding protein;Chondroitin sulfate proteoglycan 7;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0031225;GO:0031012;GO:0005576;GO:0098978;GO:0005796;GO:0043202;GO:0030246;GO:0005540;GO:0007155;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0021766;GO:0001501;GO:0060074;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:glutamatergic synapse; C:Golgi lumen; C:lysosomal lumen;, F:carbohydrate binding; F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:hippocampus development; P:skeletal system development; P:synapse maturation; scaffold49 indexed_genome mRNA 3375956 3379511 . + . ID=transcript_9309;Q96GW7 D3DVC2 Q5SZ10 Q5T3I5 Q8TBB9 Q9HBK1 Q9HBK4,Brevican core protein,Brain-enriched hyaluronan-binding protein;Chondroitin sulfate proteoglycan 7;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0031225;GO:0031012;GO:0005576;GO:0098978;GO:0005796;GO:0043202;GO:0030246;GO:0005540;GO:0007155;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0021766;GO:0001501;GO:0060074;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:glutamatergic synapse; C:Golgi lumen; C:lysosomal lumen;, F:carbohydrate binding; F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:hippocampus development; P:skeletal system development; P:synapse maturation;|Q96GW7 D3DVC2 Q5SZ10 Q5T3I5 Q8TBB9 Q9HBK1 Q9HBK4,Brevican core protein,Brain-enriched hyaluronan-binding protein;Chondroitin sulfate proteoglycan 7;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0031225;GO:0031012;GO:0005576;GO:0098978;GO:0005796;GO:0043202;GO:0030246;GO:0005540;GO:0007155;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0021766;GO:0001501;GO:0060074;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:glutamatergic synapse; C:Golgi lumen; C:lysosomal lumen;, F:carbohydrate binding; F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:hippocampus development; P:skeletal system development; P:synapse maturation;|Q96GW7 D3DVC2 Q5SZ10 Q5T3I5 Q8TBB9 Q9HBK1 Q9HBK4,Brevican core protein,Brain-enriched hyaluronan-binding protein;Chondroitin sulfate proteoglycan 7;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0031225;GO:0031012;GO:0005576;GO:0098978;GO:0005796;GO:0043202;GO:0030246;GO:0005540;GO:0007155;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0021766;GO:0001501;GO:0060074;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:glutamatergic synapse; C:Golgi lumen; C:lysosomal lumen;, F:carbohydrate binding; F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:hippocampus development; P:skeletal system development; P:synapse maturation; scaffold49 indexed_genome mRNA 3387922 3395662 . - . ID=transcript_9310;P48681 O00552 Q3LIF5 Q5SYZ6,Nestin,, PF00038;, GO:0005737;GO:0005882;GO:0045111;GO:0031730;GO:0019215;GO:0007420;GO:0048858;GO:0007417;GO:0031076;GO:0000086;GO:0043086;GO:0043524;GO:0032091;GO:0030844;GO:2000179;GO:0072089;, C:cytoplasm; C:intermediate filament; C:intermediate filament cytoskeleton;, F:CCR5 chemokine receptor binding; F:intermediate filament binding;, P:brain development; P:cell projection morphogenesis; P:central nervous system development; P:embryonic camera-type eye development; P:G2/M transition of mitotic cell cycle; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of protein binding; P:positive regulation of intermediate filament depolymerization; P:positive regulation of neural precursor cell proliferation; P:stem cell proliferation;|P48681 O00552 Q3LIF5 Q5SYZ6,Nestin,, PF00038;, GO:0005737;GO:0005882;GO:0045111;GO:0031730;GO:0019215;GO:0007420;GO:0048858;GO:0007417;GO:0031076;GO:0000086;GO:0043086;GO:0043524;GO:0032091;GO:0030844;GO:2000179;GO:0072089;, C:cytoplasm; C:intermediate filament; C:intermediate filament cytoskeleton;, F:CCR5 chemokine receptor binding; F:intermediate filament binding;, P:brain development; P:cell projection morphogenesis; P:central nervous system development; P:embryonic camera-type eye development; P:G2/M transition of mitotic cell cycle; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of protein binding; P:positive regulation of intermediate filament depolymerization; P:positive regulation of neural precursor cell proliferation; P:stem cell proliferation;|P48681 O00552 Q3LIF5 Q5SYZ6,Nestin,, PF00038;, GO:0005737;GO:0005882;GO:0045111;GO:0031730;GO:0019215;GO:0007420;GO:0048858;GO:0007417;GO:0031076;GO:0000086;GO:0043086;GO:0043524;GO:0032091;GO:0030844;GO:2000179;GO:0072089;, C:cytoplasm; C:intermediate filament; C:intermediate filament cytoskeleton;, F:CCR5 chemokine receptor binding; F:intermediate filament binding;, P:brain development; P:cell projection morphogenesis; P:central nervous system development; P:embryonic camera-type eye development; P:G2/M transition of mitotic cell cycle; P:negative regulation of catalytic activity; P:negative regulation of neuron apoptotic process; P:negative regulation of protein binding; P:positive regulation of intermediate filament depolymerization; P:positive regulation of neural precursor cell proliferation; P:stem cell proliferation; scaffold49 indexed_genome mRNA 3421395 3426666 . - . ID=transcript_9311;P29373 B2R4Z8 D3DVC5 F1T098 Q6ICN6,Cellular retinoic acid-binding protein 2,Cellular retinoic acid-binding protein II;, PF00061;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005654;GO:0005634;GO:0030332;GO:0016918;GO:0001972;GO:0005501;GO:0019841;GO:0035115;GO:0008544;GO:0048672;GO:0006355;GO:0042573;GO:0007165;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:retinal binding; F:retinoic acid binding; F:retinoid binding; F:retinol binding;, P:embryonic forelimb morphogenesis; P:epidermis development; P:positive regulation of collateral sprouting; P:regulation of transcription, DNA-templated; P:retinoic acid metabolic process; P:signal transduction; scaffold49 indexed_genome mRNA 3438724 3449809 . + . ID=transcript_9312;Q9H9L3 D3DVC6 Q64KA2,Interferon-stimulated 20 kDa exonuclease-like 2,, PF00929;, GO:0005730;GO:0005634;GO:0000175;GO:0004527;GO:0003723;GO:0042254;, C:nucleolus; C:nucleus;, F:3'-5'-exoribonuclease activity; F:exonuclease activity; F:RNA binding;, P:ribosome biogenesis;|Q9H9L3 D3DVC6 Q64KA2,Interferon-stimulated 20 kDa exonuclease-like 2,, PF00929;, GO:0005730;GO:0005634;GO:0000175;GO:0004527;GO:0003723;GO:0042254;, C:nucleolus; C:nucleus;, F:3'-5'-exoribonuclease activity; F:exonuclease activity; F:RNA binding;, P:ribosome biogenesis;|Q9H9L3 D3DVC6 Q64KA2,Interferon-stimulated 20 kDa exonuclease-like 2,, PF00929;, GO:0005730;GO:0005634;GO:0000175;GO:0004527;GO:0003723;GO:0042254;, C:nucleolus; C:nucleus;, F:3'-5'-exoribonuclease activity; F:exonuclease activity; F:RNA binding;, P:ribosome biogenesis;|Q9H9L3 D3DVC6 Q64KA2,Interferon-stimulated 20 kDa exonuclease-like 2,, PF00929;, GO:0005730;GO:0005634;GO:0000175;GO:0004527;GO:0003723;GO:0042254;, C:nucleolus; C:nucleus;, F:3'-5'-exoribonuclease activity; F:exonuclease activity; F:RNA binding;, P:ribosome biogenesis;|Q9H9L3 D3DVC6 Q64KA2,Interferon-stimulated 20 kDa exonuclease-like 2,, PF00929;, GO:0005730;GO:0005634;GO:0000175;GO:0004527;GO:0003723;GO:0042254;, C:nucleolus; C:nucleus;, F:3'-5'-exoribonuclease activity; F:exonuclease activity; F:RNA binding;, P:ribosome biogenesis;|Q96FB5 D3DVC7 Q4VX71 Q5SZ03 Q9Y358,Protein RRNAD1,Ribosomal RNA adenine dimethylase domain-containing protein 1;, PF13679;, GO:0016021;GO:0000179;, C:integral component of membrane;, F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; scaffold49 indexed_genome mRNA 3450089 3450834 . - . ID=transcript_9313;Q96FB5 D3DVC7 Q4VX71 Q5SZ03 Q9Y358,Protein RRNAD1,Ribosomal RNA adenine dimethylase domain-containing protein 1;, PF13679;, GO:0016021;GO:0000179;, C:integral component of membrane;, F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; scaffold49 indexed_genome mRNA 3451231 3452154 . - . ID=transcript_9314;Q96FB5 D3DVC7 Q4VX71 Q5SZ03 Q9Y358,Protein RRNAD1,Ribosomal RNA adenine dimethylase domain-containing protein 1;, PF13679;, GO:0016021;GO:0000179;, C:integral component of membrane;, F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; scaffold49 indexed_genome mRNA 3452993 3454132 . - . ID=transcript_9315;Q96A35 D3DVC8 Q53G65 Q53HT0 Q5SYZ9 Q5SZ00 Q5SZ02 Q96Q70 Q9H7G3,39S ribosomal protein L24, mitochondrial,Mitochondrial large ribosomal subunit protein uL24m {ECO:0000303|PubMed:25278503};, PF00467;PF17136;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q96A35 D3DVC8 Q53G65 Q53HT0 Q5SYZ9 Q5SZ00 Q5SZ02 Q96Q70 Q9H7G3,39S ribosomal protein L24, mitochondrial,Mitochondrial large ribosomal subunit protein uL24m {ECO:0000303|PubMed:25278503};, PF00467;PF17136;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold49 indexed_genome mRNA 3459494 3469022 . - . ID=transcript_9316;P51858 B3KU21 D3DVC9 Q5SZ07 Q5SZ08 Q5SZ09,Hepatoma-derived growth factor,High mobility group protein 1-like 2;, PF00855;, GO:0062023;GO:0005737;GO:0005576;GO:0005615;GO:0005654;GO:0005634;GO:0017053;GO:0003779;GO:0003690;GO:0008083;GO:0008201;GO:0000166;GO:0003723;GO:0003712;GO:0003714;GO:0001222;GO:0015631;GO:0098761;GO:0036498;GO:0000122;GO:0051781;GO:0006357;GO:0007165;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular region; C:extracellular space; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:actin binding; F:double-stranded DNA binding; F:growth factor activity; F:heparin binding; F:nucleotide binding; F:RNA binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription corepressor binding; F:tubulin binding;, P:cellular response to interleukin-7; P:IRE1-mediated unfolded protein response; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell division; P:regulation of transcription by RNA polymerase II; P:signal transduction; scaffold49 indexed_genome mRNA 3482307 3506620 . + . ID=transcript_9317;Q92733 A8K1F7 O00665 O00724 Q5SZ06,Proline-rich protein PRCC,Papillary renal cell carcinoma translocation-associated gene protein;, PF10253;, GO:0016607;GO:0005654;GO:0005634;GO:0007049;GO:0000398;GO:0051726;, C:nuclear speck; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:mRNA splicing, via spliceosome; P:regulation of cell cycle;|Q92733 A8K1F7 O00665 O00724 Q5SZ06,Proline-rich protein PRCC,Papillary renal cell carcinoma translocation-associated gene protein;, PF10253;, GO:0016607;GO:0005654;GO:0005634;GO:0007049;GO:0000398;GO:0051726;, C:nuclear speck; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:mRNA splicing, via spliceosome; P:regulation of cell cycle;|Q92733 A8K1F7 O00665 O00724 Q5SZ06,Proline-rich protein PRCC,Papillary renal cell carcinoma translocation-associated gene protein;, PF10253;, GO:0016607;GO:0005654;GO:0005634;GO:0007049;GO:0000398;GO:0051726;, C:nuclear speck; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:mRNA splicing, via spliceosome; P:regulation of cell cycle;|Q92733 A8K1F7 O00665 O00724 Q5SZ06,Proline-rich protein PRCC,Papillary renal cell carcinoma translocation-associated gene protein;, PF10253;, GO:0016607;GO:0005654;GO:0005634;GO:0007049;GO:0000398;GO:0051726;, C:nuclear speck; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:mRNA splicing, via spliceosome; P:regulation of cell cycle;|Q9BTW2,Nuclear autoantigenic sperm protein,, PF10516;PF13181;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0042393;GO:0044877;GO:0001824;GO:0034080;GO:0006260;GO:0006335;GO:0006336;GO:0000082;GO:0043486;GO:0008584;GO:0006334;GO:0015031;GO:0033574;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:histone binding; F:protein-containing complex binding;, P:blastocyst development; P:CENP-A containing nucleosome assembly; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:G1/S transition of mitotic cell cycle; P:histone exchange; P:male gonad development; P:nucleosome assembly; P:protein transport; P:response to testosterone; scaffold49 indexed_genome mRNA 3598118 3610081 . + . ID=transcript_9318;Q5VY43 Q8TEK2,Platelet endothelial aggregation receptor 1,Multiple epidermal growth factor-like domains protein 12;, PF00053;, GO:0016021;GO:0016020;GO:0001891;GO:0038023;GO:0014065;GO:0070527;GO:0043491;GO:0043654;, C:integral component of membrane; C:membrane; C:phagocytic cup;, F:signaling receptor activity;, P:phosphatidylinositol 3-kinase signaling; P:platelet aggregation; P:protein kinase B signaling; P:recognition of apoptotic cell;|Q5VY43 Q8TEK2,Platelet endothelial aggregation receptor 1,Multiple epidermal growth factor-like domains protein 12;, PF00053;, GO:0016021;GO:0016020;GO:0001891;GO:0038023;GO:0014065;GO:0070527;GO:0043491;GO:0043654;, C:integral component of membrane; C:membrane; C:phagocytic cup;, F:signaling receptor activity;, P:phosphatidylinositol 3-kinase signaling; P:platelet aggregation; P:protein kinase B signaling; P:recognition of apoptotic cell;|Q5VY43 Q8TEK2,Platelet endothelial aggregation receptor 1,Multiple epidermal growth factor-like domains protein 12;, PF00053;, GO:0016021;GO:0016020;GO:0001891;GO:0038023;GO:0014065;GO:0070527;GO:0043491;GO:0043654;, C:integral component of membrane; C:membrane; C:phagocytic cup;, F:signaling receptor activity;, P:phosphatidylinositol 3-kinase signaling; P:platelet aggregation; P:protein kinase B signaling; P:recognition of apoptotic cell;|Q5VY43 Q8TEK2,Platelet endothelial aggregation receptor 1,Multiple epidermal growth factor-like domains protein 12;, PF00053;, GO:0016021;GO:0016020;GO:0001891;GO:0038023;GO:0014065;GO:0070527;GO:0043491;GO:0043654;, C:integral component of membrane; C:membrane; C:phagocytic cup;, F:signaling receptor activity;, P:phosphatidylinositol 3-kinase signaling; P:platelet aggregation; P:protein kinase B signaling; P:recognition of apoptotic cell;|Q5VY43 Q8TEK2,Platelet endothelial aggregation receptor 1,Multiple epidermal growth factor-like domains protein 12;, PF00053;, GO:0016021;GO:0016020;GO:0001891;GO:0038023;GO:0014065;GO:0070527;GO:0043491;GO:0043654;, C:integral component of membrane; C:membrane; C:phagocytic cup;, F:signaling receptor activity;, P:phosphatidylinositol 3-kinase signaling; P:platelet aggregation; P:protein kinase B signaling; P:recognition of apoptotic cell;|Q5VY43 Q8TEK2,Platelet endothelial aggregation receptor 1,Multiple epidermal growth factor-like domains protein 12;, PF00053;, GO:0016021;GO:0016020;GO:0001891;GO:0038023;GO:0014065;GO:0070527;GO:0043491;GO:0043654;, C:integral component of membrane; C:membrane; C:phagocytic cup;, F:signaling receptor activity;, P:phosphatidylinositol 3-kinase signaling; P:platelet aggregation; P:protein kinase B signaling; P:recognition of apoptotic cell;|Q5VY43 Q8TEK2,Platelet endothelial aggregation receptor 1,Multiple epidermal growth factor-like domains protein 12;, PF00053;, GO:0016021;GO:0016020;GO:0001891;GO:0038023;GO:0014065;GO:0070527;GO:0043491;GO:0043654;, C:integral component of membrane; C:membrane; C:phagocytic cup;, F:signaling receptor activity;, P:phosphatidylinositol 3-kinase signaling; P:platelet aggregation; P:protein kinase B signaling; P:recognition of apoptotic cell;|Q5VY43 Q8TEK2,Platelet endothelial aggregation receptor 1,Multiple epidermal growth factor-like domains protein 12;, PF00053;, GO:0016021;GO:0016020;GO:0001891;GO:0038023;GO:0014065;GO:0070527;GO:0043491;GO:0043654;, C:integral component of membrane; C:membrane; C:phagocytic cup;, F:signaling receptor activity;, P:phosphatidylinositol 3-kinase signaling; P:platelet aggregation; P:protein kinase B signaling; P:recognition of apoptotic cell; scaffold49 indexed_genome mRNA 3611050 3624118 . + . ID=transcript_9319;Q8N4P6 Q96M24,Leucine-rich repeat-containing protein 71,, PF13516;|Q8N4P6 Q96M24,Leucine-rich repeat-containing protein 71,, PF13516;|Q8N4P6 Q96M24,Leucine-rich repeat-containing protein 71,, PF13516; scaffold49 indexed_genome mRNA 3624227 3673252 . - . ID=transcript_9320;O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction;|O15085 D3DVD0 Q5VY40 Q6PFW2,Rho guanine nucleotide exchange factor 11,PDZ-RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0030036;GO:0030010;GO:0007186;GO:0043065;GO:0045893;GO:0001558;GO:0051056;GO:0007266;GO:0006941;, C:cytoplasm; C:cytosol; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:establishment of cell polarity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:striated muscle contraction; scaffold49 indexed_genome mRNA 3809169 3821400 . - . ID=transcript_9321;P41162 B4E3M7 Q8TAC8 Q9BX30,ETS translocation variant 3,ETS domain transcriptional repressor PE1;Mitogenic Ets transcriptional suppressor;, PF00178;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0090571;GO:0017151;GO:0000981;GO:0001227;GO:0000977;GO:1990837;GO:0030154;GO:0097011;GO:0008285;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription repressor complex;, F:DEAD/H-box RNA helicase binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:negative regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II;|P41162 B4E3M7 Q8TAC8 Q9BX30,ETS translocation variant 3,ETS domain transcriptional repressor PE1;Mitogenic Ets transcriptional suppressor;, PF00178;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0090571;GO:0017151;GO:0000981;GO:0001227;GO:0000977;GO:1990837;GO:0030154;GO:0097011;GO:0008285;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription repressor complex;, F:DEAD/H-box RNA helicase binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:negative regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; scaffold49 indexed_genome mRNA 4634698 4652117 . + . ID=transcript_9322;P09326 Q5U055 Q8MGR0,CD48 antigen,B-lymphocyte activation marker BLAST-1;BCM1 surface antigen;Leukocyte antigen MEM-102;SLAM family member 2;Signaling lymphocytic activation molecule 2;TCT.1;, PF13895;PF07686;, GO:0031225;GO:0070062;GO:0031226;GO:0016020;GO:0045121;GO:0005886;GO:0003823;GO:0038023;GO:0006952;GO:0050900;GO:0002819;, C:anchored component of membrane; C:extracellular exosome; C:intrinsic component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:antigen binding; F:signaling receptor activity;, P:defense response; P:leukocyte migration; P:regulation of adaptive immune response; scaffold49 indexed_genome mRNA 4961935 4971775 . - . ID=transcript_9323;Q96LA6 B2RE05 Q8N759 Q8NDI0 Q96PJ6,Fc receptor-like protein 1,Fc receptor homolog 1;IFGP family protein 1;Immune receptor translocation-associated protein 5;, PF13895;PF17736;, GO:0009986;GO:0005887;GO:0015026;GO:0004888;GO:0042113;GO:0007166;, C:cell surface; C:integral component of plasma membrane;, F:coreceptor activity; F:transmembrane signaling receptor activity;, P:B cell activation; P:cell surface receptor signaling pathway; scaffold49 indexed_genome mRNA 5334441 5354476 . + . ID=transcript_9324;Q96J84 Q5W0F8 Q5XKC6 Q7Z696 Q7Z7N8 Q8TB15 Q9H9N1 Q9NVA5,Kin of IRRE-like protein 1,Kin of irregular chiasm-like protein 1;Nephrin-like protein 1;, PF08205;PF07679;, GO:0031253;GO:0005911;GO:0005887;GO:0045121;GO:0048471;GO:0005886;GO:0050839;GO:0017022;GO:0098609;, C:cell projection membrane; C:cell-cell junction; C:integral component of plasma membrane; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:myosin binding;, P:cell-cell adhesion; scaffold49 indexed_genome mRNA 5631271 5633207 . + . ID=transcript_9325;P29016 Q5TDK9 Q5TDL0 Q9UMM2,T-cell surface glycoprotein CD1b,, PF07654;PF16497;, GO:0009986;GO:0005829;GO:0010008;GO:0009897;GO:0005615;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0005886;GO:0030883;GO:0030884;GO:0071723;GO:0002250;GO:0048006;GO:0048007;GO:0001916;GO:0050776;, C:cell surface; C:cytosol; C:endosome membrane; C:external side of plasma membrane; C:extracellular space; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:plasma membrane;, F:endogenous lipid antigen binding; F:exogenous lipid antigen binding; F:lipopeptide binding;, P:adaptive immune response; P:antigen processing and presentation, endogenous lipid antigen via MHC class Ib; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:positive regulation of T cell mediated cytotoxicity; P:regulation of immune response; scaffold49 indexed_genome mRNA 5740886 5744379 . + . ID=transcript_9326;Q712F2 Q712F3 Q712F4 Q712F5 Q96TD0 Q96TD1 Q9UMM1 Q9Y5M3,T-cell surface glycoprotein CD1e, membrane-associated,R2G1;, PF07654;PF16497;, GO:0005769;GO:0009897;GO:0005615;GO:0000139;GO:0005887;GO:0005770;GO:0043202;GO:0030883;GO:0030884;GO:0071723;GO:0002250;GO:0048006;GO:0048007;GO:0006955;GO:0001916;, C:early endosome; C:external side of plasma membrane; C:extracellular space; C:Golgi membrane; C:integral component of plasma membrane; C:late endosome; C:lysosomal lumen;, F:endogenous lipid antigen binding; F:exogenous lipid antigen binding; F:lipopeptide binding;, P:adaptive immune response; P:antigen processing and presentation, endogenous lipid antigen via MHC class Ib; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:immune response; P:positive regulation of T cell mediated cytotoxicity; scaffold49 indexed_genome mRNA 5894264 5898215 . + . ID=transcript_9327;P06126 D3DVD7 Q13962 Q5TDJ8 Q9UMM4 Q9Y5M5,T-cell surface glycoprotein CD1a,T-cell surface antigen T6/Leu-6;, PF07654;PF16497;, GO:0010008;GO:0009897;GO:0005615;GO:0005887;GO:0045121;GO:0005886;GO:0030883;GO:0030884;GO:0071723;GO:0002250;GO:0048006;GO:0048007;GO:0006955;GO:0001916;GO:0050776;, C:endosome membrane; C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane;, F:endogenous lipid antigen binding; F:exogenous lipid antigen binding; F:lipopeptide binding;, P:adaptive immune response; P:antigen processing and presentation, endogenous lipid antigen via MHC class Ib; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:immune response; P:positive regulation of T cell mediated cytotoxicity; P:regulation of immune response; scaffold49 indexed_genome mRNA 6538578 6541569 . - . ID=transcript_9328;Q8N9E5 Q8NEQ7 Q96AJ5 Q9UH78,Gamma-interferon-inducible protein 16,Interferon-inducible myeloid differentiation transcriptional activator;, PF02760;PF02758;, GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0001227;GO:0003690;GO:0042802;GO:0003723;GO:0000978;GO:0008134;GO:0097202;GO:0002218;GO:0006914;GO:0042149;GO:0035458;GO:0071479;GO:0051607;GO:0006954;GO:0045087;GO:0072332;GO:0042771;GO:0030224;GO:0030099;GO:2000117;GO:0043392;GO:0045824;GO:0000122;GO:0045892;GO:0045071;GO:0001819;GO:0032731;GO:0045944;GO:0032481;GO:0010506;GO:0040029;, C:cytosol; C:membrane; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:identical protein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:activation of cysteine-type endopeptidase activity; P:activation of innate immune response; P:autophagy; P:cellular response to glucose starvation; P:cellular response to interferon-beta; P:cellular response to ionizing radiation; P:defense response to virus; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:monocyte differentiation; P:myeloid cell differentiation; P:negative regulation of cysteine-type endopeptidase activity; P:negative regulation of DNA binding; P:negative regulation of innate immune response; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral genome replication; P:positive regulation of cytokine production; P:positive regulation of interleukin-1 beta production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:regulation of autophagy; P:regulation of gene expression, epigenetic;|Q8N9E5 Q8NEQ7 Q96AJ5 Q9UH78,Gamma-interferon-inducible protein 16,Interferon-inducible myeloid differentiation transcriptional activator;, PF02760;PF02758;, GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0001227;GO:0003690;GO:0042802;GO:0003723;GO:0000978;GO:0008134;GO:0097202;GO:0002218;GO:0006914;GO:0042149;GO:0035458;GO:0071479;GO:0051607;GO:0006954;GO:0045087;GO:0072332;GO:0042771;GO:0030224;GO:0030099;GO:2000117;GO:0043392;GO:0045824;GO:0000122;GO:0045892;GO:0045071;GO:0001819;GO:0032731;GO:0045944;GO:0032481;GO:0010506;GO:0040029;, C:cytosol; C:membrane; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:identical protein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:activation of cysteine-type endopeptidase activity; P:activation of innate immune response; P:autophagy; P:cellular response to glucose starvation; P:cellular response to interferon-beta; P:cellular response to ionizing radiation; P:defense response to virus; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:monocyte differentiation; P:myeloid cell differentiation; P:negative regulation of cysteine-type endopeptidase activity; P:negative regulation of DNA binding; P:negative regulation of innate immune response; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral genome replication; P:positive regulation of cytokine production; P:positive regulation of interleukin-1 beta production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:regulation of autophagy; P:regulation of gene expression, epigenetic; scaffold49 indexed_genome mRNA 6699085 6711183 . - . ID=transcript_9329;Q8N126 Q8IZQ9 Q9NVJ5 Q9UJP1,Cell adhesion molecule 3,Brain immunoglobulin receptor;Immunoglobulin superfamily member 4B;Nectin-like protein 1;Synaptic cell adhesion molecule 3;TSLC1-like protein 1;, PF08205;PF07686;, GO:0005911;GO:0016021;GO:0005886;GO:0042803;GO:0034332;GO:0007157;GO:0007156;, C:cell-cell junction; C:integral component of membrane; C:plasma membrane;, F:protein homodimerization activity;, P:adherens junction organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q8N126 Q8IZQ9 Q9NVJ5 Q9UJP1,Cell adhesion molecule 3,Brain immunoglobulin receptor;Immunoglobulin superfamily member 4B;Nectin-like protein 1;Synaptic cell adhesion molecule 3;TSLC1-like protein 1;, PF08205;PF07686;, GO:0005911;GO:0016021;GO:0005886;GO:0042803;GO:0034332;GO:0007157;GO:0007156;, C:cell-cell junction; C:integral component of membrane; C:plasma membrane;, F:protein homodimerization activity;, P:adherens junction organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q8N126 Q8IZQ9 Q9NVJ5 Q9UJP1,Cell adhesion molecule 3,Brain immunoglobulin receptor;Immunoglobulin superfamily member 4B;Nectin-like protein 1;Synaptic cell adhesion molecule 3;TSLC1-like protein 1;, PF08205;PF07686;, GO:0005911;GO:0016021;GO:0005886;GO:0042803;GO:0034332;GO:0007157;GO:0007156;, C:cell-cell junction; C:integral component of membrane; C:plasma membrane;, F:protein homodimerization activity;, P:adherens junction organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q8N126 Q8IZQ9 Q9NVJ5 Q9UJP1,Cell adhesion molecule 3,Brain immunoglobulin receptor;Immunoglobulin superfamily member 4B;Nectin-like protein 1;Synaptic cell adhesion molecule 3;TSLC1-like protein 1;, PF08205;PF07686;, GO:0005911;GO:0016021;GO:0005886;GO:0042803;GO:0034332;GO:0007157;GO:0007156;, C:cell-cell junction; C:integral component of membrane; C:plasma membrane;, F:protein homodimerization activity;, P:adherens junction organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q8N126 Q8IZQ9 Q9NVJ5 Q9UJP1,Cell adhesion molecule 3,Brain immunoglobulin receptor;Immunoglobulin superfamily member 4B;Nectin-like protein 1;Synaptic cell adhesion molecule 3;TSLC1-like protein 1;, PF08205;PF07686;, GO:0005911;GO:0016021;GO:0005886;GO:0042803;GO:0034332;GO:0007157;GO:0007156;, C:cell-cell junction; C:integral component of membrane; C:plasma membrane;, F:protein homodimerization activity;, P:adherens junction organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold49 indexed_genome mRNA 6711198 6714509 . - . ID=transcript_9330;Q16570 A8YPG5 O75898 Q16300 Q8WWE3 Q9UJP0 Q9UKZ5 Q9UKZ6 Q9UQE1,Atypical chemokine receptor 1,Duffy antigen/chemokine receptor;Fy glycoprotein;Glycoprotein D;Plasmodium vivax receptor;, , GO:0005769;GO:0016021;GO:0005886;GO:0055037;GO:0019957;GO:0004930;GO:0038023;GO:0004888;GO:0070098;GO:0006952;GO:0007186;GO:0006954;GO:0032642;, C:early endosome; C:integral component of membrane; C:plasma membrane; C:recycling endosome;, F:C-C chemokine binding; F:G protein-coupled receptor activity; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:chemokine-mediated signaling pathway; P:defense response; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:regulation of chemokine production; scaffold49 indexed_genome mRNA 6811558 6819325 . + . ID=transcript_9331;P12319,High affinity immunoglobulin epsilon receptor subunit alpha,Fc-epsilon RI-alpha;IgE Fc receptor subunit alpha;, PF13895;, GO:0009986;GO:0005887;GO:0005886;GO:0019863;GO:0004888;GO:0007166;GO:0038095;GO:0050776;, C:cell surface; C:integral component of plasma membrane; C:plasma membrane;, F:IgE binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:regulation of immune response; scaffold49 indexed_genome mRNA 7247472 7322777 . + . ID=transcript_9332;P02741 A8K078 D3DVD9 D3DVE0 Q08AK3 Q8WW75,C-reactive protein,, PF00354;, GO:0005576;GO:0005615;GO:0005509;GO:0033265;GO:0001849;GO:0042802;GO:0030169;GO:0050750;GO:0006953;GO:0006958;GO:0050830;GO:0006954;GO:0045087;GO:0044793;GO:0010888;GO:0010745;GO:0032945;GO:0008228;GO:0010628;GO:0032930;GO:0032677;GO:0042310;, C:extracellular region; C:extracellular space;, F:calcium ion binding; F:choline binding; F:complement component C1q complex binding; F:identical protein binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor binding;, P:acute-phase response; P:complement activation, classical pathway; P:defense response to Gram-positive bacterium; P:inflammatory response; P:innate immune response; P:negative regulation by host of viral process; P:negative regulation of lipid storage; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of mononuclear cell proliferation; P:opsonization; P:positive regulation of gene expression; P:positive regulation of superoxide anion generation; P:regulation of interleukin-8 production; P:vasoconstriction;|P02741 A8K078 D3DVD9 D3DVE0 Q08AK3 Q8WW75,C-reactive protein,, PF00354;, GO:0005576;GO:0005615;GO:0005509;GO:0033265;GO:0001849;GO:0042802;GO:0030169;GO:0050750;GO:0006953;GO:0006958;GO:0050830;GO:0006954;GO:0045087;GO:0044793;GO:0010888;GO:0010745;GO:0032945;GO:0008228;GO:0010628;GO:0032930;GO:0032677;GO:0042310;, C:extracellular region; C:extracellular space;, F:calcium ion binding; F:choline binding; F:complement component C1q complex binding; F:identical protein binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor binding;, P:acute-phase response; P:complement activation, classical pathway; P:defense response to Gram-positive bacterium; P:inflammatory response; P:innate immune response; P:negative regulation by host of viral process; P:negative regulation of lipid storage; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of mononuclear cell proliferation; P:opsonization; P:positive regulation of gene expression; P:positive regulation of superoxide anion generation; P:regulation of interleukin-8 production; P:vasoconstriction;|Q9BVJ7 Q9NX48,Dual specificity protein phosphatase 23,Low molecular mass dual specificity phosphatase 3;VH1-like phosphatase Z;, , GO:0005737;GO:0005829;GO:0005654;GO:0016791;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0016311;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dephosphorylation;|Q9BVJ7 Q9NX48,Dual specificity protein phosphatase 23,Low molecular mass dual specificity phosphatase 3;VH1-like phosphatase Z;, , GO:0005737;GO:0005829;GO:0005654;GO:0016791;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0016311;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dephosphorylation;|Q9BVJ7 Q9NX48,Dual specificity protein phosphatase 23,Low molecular mass dual specificity phosphatase 3;VH1-like phosphatase Z;, , GO:0005737;GO:0005829;GO:0005654;GO:0016791;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0016311;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dephosphorylation; scaffold49 indexed_genome mRNA 7359346 7368897 . + . ID=transcript_9333;Q9P0V8 Q32MC6 Q5VU15,SLAM family member 8,B-lymphocyte activator macrophage expressed;BCM-like membrane protein;, , GO:0009986;GO:0016021;GO:0042802;GO:0038023;GO:0002336;GO:0035690;GO:0042742;GO:0002232;GO:2000509;GO:0010760;GO:0090027;GO:1902623;GO:0060266;GO:0090383;GO:0045577;GO:0043549;GO:0033860;, C:cell surface; C:integral component of membrane;, F:identical protein binding; F:signaling receptor activity;, P:B-1 B cell lineage commitment; P:cellular response to drug; P:defense response to bacterium; P:leukocyte chemotaxis involved in inflammatory response; P:negative regulation of dendritic cell chemotaxis; P:negative regulation of macrophage chemotaxis; P:negative regulation of monocyte chemotaxis; P:negative regulation of neutrophil migration; P:negative regulation of respiratory burst involved in inflammatory response; P:phagosome acidification; P:regulation of B cell differentiation; P:regulation of kinase activity; P:regulation of NAD(P)H oxidase activity; scaffold49 indexed_genome mRNA 7387268 7389897 . + . ID=transcript_9334;P0DPA2 Q5VU13 Q5VU14,V-set and immunoglobulin domain-containing protein 8,, PF07686;, GO:0016021;GO:0003723;, C:integral component of membrane;, F:RNA binding;|P0DPA2 Q5VU13 Q5VU14,V-set and immunoglobulin domain-containing protein 8,, PF07686;, GO:0016021;GO:0003723;, C:integral component of membrane;, F:RNA binding; scaffold49 indexed_genome mRNA 7410186 7420040 . - . ID=transcript_9335;Q9UL16 C9JH28 Q05BA3 Q5VU18,Cilia- and flagella-associated protein 45 {ECO:0000312|HGNC:HGNC:17229},Coiled-coil domain-containing protein 19 {ECO:0000312|HGNC:HGNC:17229};Nasopharyngeal epithelium-specific protein 1 {ECO:0000312|EMBL:AAD55817.1};, PF13868;, GO:0005929;GO:0005654;GO:0005634;, C:cilium; C:nucleoplasm; C:nucleus; scaffold49 indexed_genome mRNA 7449121 7455273 . - . ID=transcript_9336;P37802 E9KL39 Q5JRQ6 Q5JRQ7 Q6FGI1 Q9BUH5 Q9H4P0,Transgelin-2,Epididymis tissue protein Li 7e;SM22-alpha homolog;, PF00402;PF00307;, GO:0005829;GO:0070062;GO:0005576;GO:0031982;GO:0045296;GO:0030855;GO:0002576;, C:cytosol; C:extracellular exosome; C:extracellular region; C:vesicle;, F:cadherin binding;, P:epithelial cell differentiation; P:platelet degranulation;|P37802 E9KL39 Q5JRQ6 Q5JRQ7 Q6FGI1 Q9BUH5 Q9H4P0,Transgelin-2,Epididymis tissue protein Li 7e;SM22-alpha homolog;, PF00402;PF00307;, GO:0005829;GO:0070062;GO:0005576;GO:0031982;GO:0045296;GO:0030855;GO:0002576;, C:cytosol; C:extracellular exosome; C:extracellular region; C:vesicle;, F:cadherin binding;, P:epithelial cell differentiation; P:platelet degranulation; scaffold49 indexed_genome mRNA 7565323 7608288 . - . ID=transcript_9337;Q9H3S5,GPI mannosyltransferase 1,GPI mannosyltransferase I;Phosphatidylinositol-glycan biosynthesis class M protein;, PF05007;, GO:0005789;GO:1990529;GO:0016021;GO:0051751;GO:0004376;GO:0000030;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-mannosyltransferase I complex; C:integral component of membrane;, F:alpha-1,4-mannosyltransferase activity; F:glycolipid mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|P78508 A3KME7 Q5VUT9 Q8N4I7 Q92808,ATP-sensitive inward rectifier potassium channel 10,ATP-dependent inwardly rectifying potassium channel Kir4.1;Inward rectifier K(+) channel Kir1.2;Potassium channel, inwardly rectifying subfamily J member 10;, PF01007;PF17655;, GO:0097449;GO:0016323;GO:0044297;GO:0005887;GO:0005886;GO:0098793;GO:0005524;GO:0015272;GO:0005242;GO:0007628;GO:0022010;GO:0051935;GO:1901381;GO:0055075;GO:1990573;GO:0071805;GO:0006813;GO:0034765;GO:0048169;GO:0060075;GO:0007601;, C:astrocyte projection; C:basolateral plasma membrane; C:cell body; C:integral component of plasma membrane; C:plasma membrane; C:presynapse;, F:ATP binding; F:ATP-activated inward rectifier potassium channel activity; F:inward rectifier potassium channel activity;, P:adult walking behavior; P:central nervous system myelination; P:glutamate reuptake; P:positive regulation of potassium ion transmembrane transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:regulation of long-term neuronal synaptic plasticity; P:regulation of resting membrane potential; P:visual perception; scaffold49 indexed_genome mRNA 7622800 7623916 . - . ID=transcript_9338;Q92806 Q5JW75,G protein-activated inward rectifier potassium channel 3,Inward rectifier K(+) channel Kir3.3;Potassium channel, inwardly rectifying subfamily J member 9;, PF01007;PF17655;, GO:0016021;GO:0005886;GO:0015467;GO:0005242;GO:1901381;GO:1990573;GO:0034765;, C:integral component of membrane; C:plasma membrane;, F:G-protein activated inward rectifier potassium channel activity; F:inward rectifier potassium channel activity;, P:positive regulation of potassium ion transmembrane transport; P:potassium ion import across plasma membrane; P:regulation of ion transmembrane transport; scaffold49 indexed_genome mRNA 7627503 7634530 . - . ID=transcript_9339;Q969P0 Q8NG09 Q96DP4 Q9BTG9,Immunoglobulin superfamily member 8,CD81 partner 3;Glu-Trp-Ile EWI motif-containing protein 2;Keratinocytes-associated transmembrane protein 4;LIR-D1;Prostaglandin regulatory-like protein;, PF07686;, GO:0070062;GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0048870;GO:0007399;GO:0007338;GO:0007519;, C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, , P:cell motility; P:nervous system development; P:single fertilization; P:skeletal muscle tissue development;|Q969P0 Q8NG09 Q96DP4 Q9BTG9,Immunoglobulin superfamily member 8,CD81 partner 3;Glu-Trp-Ile EWI motif-containing protein 2;Keratinocytes-associated transmembrane protein 4;LIR-D1;Prostaglandin regulatory-like protein;, PF07686;, GO:0070062;GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0048870;GO:0007399;GO:0007338;GO:0007519;, C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, , P:cell motility; P:nervous system development; P:single fertilization; P:skeletal muscle tissue development;|Q969P0 Q8NG09 Q96DP4 Q9BTG9,Immunoglobulin superfamily member 8,CD81 partner 3;Glu-Trp-Ile EWI motif-containing protein 2;Keratinocytes-associated transmembrane protein 4;LIR-D1;Prostaglandin regulatory-like protein;, PF07686;, GO:0070062;GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0048870;GO:0007399;GO:0007338;GO:0007519;, C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, , P:cell motility; P:nervous system development; P:single fertilization; P:skeletal muscle tissue development; scaffold49 indexed_genome mRNA 7664540 7682473 . - . ID=transcript_9340;P50993 D3DVE4 Q07059 Q5JW74 Q86UZ5 Q9UQ25,Sodium/potassium-transporting ATPase subunit alpha-2,Sodium pump subunit alpha-2;, PF00689;PF00690;, GO:0005901;GO:0042995;GO:0005737;GO:0043197;GO:0005768;GO:1903561;GO:0014704;GO:0016020;GO:0043025;GO:0031090;GO:0005886;GO:0005890;GO:0030315;GO:0005524;GO:0016887;GO:0019829;GO:0051087;GO:0005391;GO:0016791;GO:0030955;GO:0008556;GO:0046982;GO:0031402;GO:0005496;GO:1990239;GO:0008344;GO:0021764;GO:0046034;GO:0001662;GO:0060048;GO:0098655;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0040011;GO:0035641;GO:0086012;GO:0086009;GO:1903170;GO:1903280;GO:0051481;GO:0045822;GO:0045988;GO:0001504;GO:0021989;GO:0045823;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0010881;GO:0051946;GO:0006937;GO:0002087;GO:0006940;GO:0006942;GO:0051966;GO:0002026;GO:0019229;GO:0055119;GO:0010996;GO:1903416;GO:0035094;GO:0036376;GO:0035725;GO:0006814;GO:0150104;GO:0008542;, C:caveola; C:cell projection; C:cytoplasm; C:dendritic spine; C:endosome; C:extracellular vesicle; C:intercalated disc; C:membrane; C:neuronal cell body; C:organelle membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein heterodimerization activity; F:sodium ion binding; F:steroid binding; F:steroid hormone binding;, P:adult locomotory behavior; P:amygdala development; P:ATP metabolic process; P:behavioral fear response; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:locomotion; P:locomotory exploration behavior; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization; P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium:sodium antiporter activity; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of heart contraction; P:negative regulation of striated muscle contraction; P:neurotransmitter uptake; P:olfactory cortex development; P:positive regulation of heart contraction; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of muscle contraction; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of smooth muscle contraction; P:regulation of striated muscle contraction; P:regulation of synaptic transmission, glutamatergic; P:regulation of the force of heart contraction; P:regulation of vasoconstriction; P:relaxation of cardiac muscle; P:response to auditory stimulus; P:response to glycoside; P:response to nicotine; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier; P:visual learning;|P50993 D3DVE4 Q07059 Q5JW74 Q86UZ5 Q9UQ25,Sodium/potassium-transporting ATPase subunit alpha-2,Sodium pump subunit alpha-2;, PF00689;PF00690;, GO:0005901;GO:0042995;GO:0005737;GO:0043197;GO:0005768;GO:1903561;GO:0014704;GO:0016020;GO:0043025;GO:0031090;GO:0005886;GO:0005890;GO:0030315;GO:0005524;GO:0016887;GO:0019829;GO:0051087;GO:0005391;GO:0016791;GO:0030955;GO:0008556;GO:0046982;GO:0031402;GO:0005496;GO:1990239;GO:0008344;GO:0021764;GO:0046034;GO:0001662;GO:0060048;GO:0098655;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0040011;GO:0035641;GO:0086012;GO:0086009;GO:1903170;GO:1903280;GO:0051481;GO:0045822;GO:0045988;GO:0001504;GO:0021989;GO:0045823;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0010881;GO:0051946;GO:0006937;GO:0002087;GO:0006940;GO:0006942;GO:0051966;GO:0002026;GO:0019229;GO:0055119;GO:0010996;GO:1903416;GO:0035094;GO:0036376;GO:0035725;GO:0006814;GO:0150104;GO:0008542;, C:caveola; C:cell projection; C:cytoplasm; C:dendritic spine; C:endosome; C:extracellular vesicle; C:intercalated disc; C:membrane; C:neuronal cell body; C:organelle membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein heterodimerization activity; F:sodium ion binding; F:steroid binding; F:steroid hormone binding;, P:adult locomotory behavior; P:amygdala development; P:ATP metabolic process; P:behavioral fear response; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:locomotion; P:locomotory exploration behavior; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization; P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium:sodium antiporter activity; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of heart contraction; P:negative regulation of striated muscle contraction; P:neurotransmitter uptake; P:olfactory cortex development; P:positive regulation of heart contraction; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of muscle contraction; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of smooth muscle contraction; P:regulation of striated muscle contraction; P:regulation of synaptic transmission, glutamatergic; P:regulation of the force of heart contraction; P:regulation of vasoconstriction; P:relaxation of cardiac muscle; P:response to auditory stimulus; P:response to glycoside; P:response to nicotine; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier; P:visual learning;|P50993 D3DVE4 Q07059 Q5JW74 Q86UZ5 Q9UQ25,Sodium/potassium-transporting ATPase subunit alpha-2,Sodium pump subunit alpha-2;, PF00689;PF00690;, GO:0005901;GO:0042995;GO:0005737;GO:0043197;GO:0005768;GO:1903561;GO:0014704;GO:0016020;GO:0043025;GO:0031090;GO:0005886;GO:0005890;GO:0030315;GO:0005524;GO:0016887;GO:0019829;GO:0051087;GO:0005391;GO:0016791;GO:0030955;GO:0008556;GO:0046982;GO:0031402;GO:0005496;GO:1990239;GO:0008344;GO:0021764;GO:0046034;GO:0001662;GO:0060048;GO:0098655;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0040011;GO:0035641;GO:0086012;GO:0086009;GO:1903170;GO:1903280;GO:0051481;GO:0045822;GO:0045988;GO:0001504;GO:0021989;GO:0045823;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0010881;GO:0051946;GO:0006937;GO:0002087;GO:0006940;GO:0006942;GO:0051966;GO:0002026;GO:0019229;GO:0055119;GO:0010996;GO:1903416;GO:0035094;GO:0036376;GO:0035725;GO:0006814;GO:0150104;GO:0008542;, C:caveola; C:cell projection; C:cytoplasm; C:dendritic spine; C:endosome; C:extracellular vesicle; C:intercalated disc; C:membrane; C:neuronal cell body; C:organelle membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein heterodimerization activity; F:sodium ion binding; F:steroid binding; F:steroid hormone binding;, P:adult locomotory behavior; P:amygdala development; P:ATP metabolic process; P:behavioral fear response; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:locomotion; P:locomotory exploration behavior; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization; P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium:sodium antiporter activity; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of heart contraction; P:negative regulation of striated muscle contraction; P:neurotransmitter uptake; P:olfactory cortex development; P:positive regulation of heart contraction; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of muscle contraction; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of smooth muscle contraction; P:regulation of striated muscle contraction; P:regulation of synaptic transmission, glutamatergic; P:regulation of the force of heart contraction; P:regulation of vasoconstriction; P:relaxation of cardiac muscle; P:response to auditory stimulus; P:response to glycoside; P:response to nicotine; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier; P:visual learning;|P50993 D3DVE4 Q07059 Q5JW74 Q86UZ5 Q9UQ25,Sodium/potassium-transporting ATPase subunit alpha-2,Sodium pump subunit alpha-2;, PF00689;PF00690;, GO:0005901;GO:0042995;GO:0005737;GO:0043197;GO:0005768;GO:1903561;GO:0014704;GO:0016020;GO:0043025;GO:0031090;GO:0005886;GO:0005890;GO:0030315;GO:0005524;GO:0016887;GO:0019829;GO:0051087;GO:0005391;GO:0016791;GO:0030955;GO:0008556;GO:0046982;GO:0031402;GO:0005496;GO:1990239;GO:0008344;GO:0021764;GO:0046034;GO:0001662;GO:0060048;GO:0098655;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0040011;GO:0035641;GO:0086012;GO:0086009;GO:1903170;GO:1903280;GO:0051481;GO:0045822;GO:0045988;GO:0001504;GO:0021989;GO:0045823;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0010881;GO:0051946;GO:0006937;GO:0002087;GO:0006940;GO:0006942;GO:0051966;GO:0002026;GO:0019229;GO:0055119;GO:0010996;GO:1903416;GO:0035094;GO:0036376;GO:0035725;GO:0006814;GO:0150104;GO:0008542;, C:caveola; C:cell projection; C:cytoplasm; C:dendritic spine; C:endosome; C:extracellular vesicle; C:intercalated disc; C:membrane; C:neuronal cell body; C:organelle membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein heterodimerization activity; F:sodium ion binding; F:steroid binding; F:steroid hormone binding;, P:adult locomotory behavior; P:amygdala development; P:ATP metabolic process; P:behavioral fear response; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:locomotion; P:locomotory exploration behavior; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization; P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium:sodium antiporter activity; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of heart contraction; P:negative regulation of striated muscle contraction; P:neurotransmitter uptake; P:olfactory cortex development; P:positive regulation of heart contraction; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of muscle contraction; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of smooth muscle contraction; P:regulation of striated muscle contraction; P:regulation of synaptic transmission, glutamatergic; P:regulation of the force of heart contraction; P:regulation of vasoconstriction; P:relaxation of cardiac muscle; P:response to auditory stimulus; P:response to glycoside; P:response to nicotine; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier; P:visual learning;|P50993 D3DVE4 Q07059 Q5JW74 Q86UZ5 Q9UQ25,Sodium/potassium-transporting ATPase subunit alpha-2,Sodium pump subunit alpha-2;, PF00689;PF00690;, GO:0005901;GO:0042995;GO:0005737;GO:0043197;GO:0005768;GO:1903561;GO:0014704;GO:0016020;GO:0043025;GO:0031090;GO:0005886;GO:0005890;GO:0030315;GO:0005524;GO:0016887;GO:0019829;GO:0051087;GO:0005391;GO:0016791;GO:0030955;GO:0008556;GO:0046982;GO:0031402;GO:0005496;GO:1990239;GO:0008344;GO:0021764;GO:0046034;GO:0001662;GO:0060048;GO:0098655;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0040011;GO:0035641;GO:0086012;GO:0086009;GO:1903170;GO:1903280;GO:0051481;GO:0045822;GO:0045988;GO:0001504;GO:0021989;GO:0045823;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0010881;GO:0051946;GO:0006937;GO:0002087;GO:0006940;GO:0006942;GO:0051966;GO:0002026;GO:0019229;GO:0055119;GO:0010996;GO:1903416;GO:0035094;GO:0036376;GO:0035725;GO:0006814;GO:0150104;GO:0008542;, C:caveola; C:cell projection; C:cytoplasm; C:dendritic spine; C:endosome; C:extracellular vesicle; C:intercalated disc; C:membrane; C:neuronal cell body; C:organelle membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein heterodimerization activity; F:sodium ion binding; F:steroid binding; F:steroid hormone binding;, P:adult locomotory behavior; P:amygdala development; P:ATP metabolic process; P:behavioral fear response; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:locomotion; P:locomotory exploration behavior; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization; P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium:sodium antiporter activity; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of heart contraction; P:negative regulation of striated muscle contraction; P:neurotransmitter uptake; P:olfactory cortex development; P:positive regulation of heart contraction; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of muscle contraction; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of smooth muscle contraction; P:regulation of striated muscle contraction; P:regulation of synaptic transmission, glutamatergic; P:regulation of the force of heart contraction; P:regulation of vasoconstriction; P:relaxation of cardiac muscle; P:response to auditory stimulus; P:response to glycoside; P:response to nicotine; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier; P:visual learning;|P50993 D3DVE4 Q07059 Q5JW74 Q86UZ5 Q9UQ25,Sodium/potassium-transporting ATPase subunit alpha-2,Sodium pump subunit alpha-2;, PF00689;PF00690;, GO:0005901;GO:0042995;GO:0005737;GO:0043197;GO:0005768;GO:1903561;GO:0014704;GO:0016020;GO:0043025;GO:0031090;GO:0005886;GO:0005890;GO:0030315;GO:0005524;GO:0016887;GO:0019829;GO:0051087;GO:0005391;GO:0016791;GO:0030955;GO:0008556;GO:0046982;GO:0031402;GO:0005496;GO:1990239;GO:0008344;GO:0021764;GO:0046034;GO:0001662;GO:0060048;GO:0098655;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0040011;GO:0035641;GO:0086012;GO:0086009;GO:1903170;GO:1903280;GO:0051481;GO:0045822;GO:0045988;GO:0001504;GO:0021989;GO:0045823;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0010881;GO:0051946;GO:0006937;GO:0002087;GO:0006940;GO:0006942;GO:0051966;GO:0002026;GO:0019229;GO:0055119;GO:0010996;GO:1903416;GO:0035094;GO:0036376;GO:0035725;GO:0006814;GO:0150104;GO:0008542;, C:caveola; C:cell projection; C:cytoplasm; C:dendritic spine; C:endosome; C:extracellular vesicle; C:intercalated disc; C:membrane; C:neuronal cell body; C:organelle membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein heterodimerization activity; F:sodium ion binding; F:steroid binding; F:steroid hormone binding;, P:adult locomotory behavior; P:amygdala development; P:ATP metabolic process; P:behavioral fear response; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:locomotion; P:locomotory exploration behavior; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization; P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium:sodium antiporter activity; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of heart contraction; P:negative regulation of striated muscle contraction; P:neurotransmitter uptake; P:olfactory cortex development; P:positive regulation of heart contraction; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of muscle contraction; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of smooth muscle contraction; P:regulation of striated muscle contraction; P:regulation of synaptic transmission, glutamatergic; P:regulation of the force of heart contraction; P:regulation of vasoconstriction; P:relaxation of cardiac muscle; P:response to auditory stimulus; P:response to glycoside; P:response to nicotine; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier; P:visual learning;|P50993 D3DVE4 Q07059 Q5JW74 Q86UZ5 Q9UQ25,Sodium/potassium-transporting ATPase subunit alpha-2,Sodium pump subunit alpha-2;, PF00689;PF00690;, GO:0005901;GO:0042995;GO:0005737;GO:0043197;GO:0005768;GO:1903561;GO:0014704;GO:0016020;GO:0043025;GO:0031090;GO:0005886;GO:0005890;GO:0030315;GO:0005524;GO:0016887;GO:0019829;GO:0051087;GO:0005391;GO:0016791;GO:0030955;GO:0008556;GO:0046982;GO:0031402;GO:0005496;GO:1990239;GO:0008344;GO:0021764;GO:0046034;GO:0001662;GO:0060048;GO:0098655;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0040011;GO:0035641;GO:0086012;GO:0086009;GO:1903170;GO:1903280;GO:0051481;GO:0045822;GO:0045988;GO:0001504;GO:0021989;GO:0045823;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0010881;GO:0051946;GO:0006937;GO:0002087;GO:0006940;GO:0006942;GO:0051966;GO:0002026;GO:0019229;GO:0055119;GO:0010996;GO:1903416;GO:0035094;GO:0036376;GO:0035725;GO:0006814;GO:0150104;GO:0008542;, C:caveola; C:cell projection; C:cytoplasm; C:dendritic spine; C:endosome; C:extracellular vesicle; C:intercalated disc; C:membrane; C:neuronal cell body; C:organelle membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein heterodimerization activity; F:sodium ion binding; F:steroid binding; F:steroid hormone binding;, P:adult locomotory behavior; P:amygdala development; P:ATP metabolic process; P:behavioral fear response; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:locomotion; P:locomotory exploration behavior; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization; P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium:sodium antiporter activity; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of heart contraction; P:negative regulation of striated muscle contraction; P:neurotransmitter uptake; P:olfactory cortex development; P:positive regulation of heart contraction; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of muscle contraction; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of smooth muscle contraction; P:regulation of striated muscle contraction; P:regulation of synaptic transmission, glutamatergic; P:regulation of the force of heart contraction; P:regulation of vasoconstriction; P:relaxation of cardiac muscle; P:response to auditory stimulus; P:response to glycoside; P:response to nicotine; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier; P:visual learning;|P50993 D3DVE4 Q07059 Q5JW74 Q86UZ5 Q9UQ25,Sodium/potassium-transporting ATPase subunit alpha-2,Sodium pump subunit alpha-2;, PF00689;PF00690;, GO:0005901;GO:0042995;GO:0005737;GO:0043197;GO:0005768;GO:1903561;GO:0014704;GO:0016020;GO:0043025;GO:0031090;GO:0005886;GO:0005890;GO:0030315;GO:0005524;GO:0016887;GO:0019829;GO:0051087;GO:0005391;GO:0016791;GO:0030955;GO:0008556;GO:0046982;GO:0031402;GO:0005496;GO:1990239;GO:0008344;GO:0021764;GO:0046034;GO:0001662;GO:0060048;GO:0098655;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0040011;GO:0035641;GO:0086012;GO:0086009;GO:1903170;GO:1903280;GO:0051481;GO:0045822;GO:0045988;GO:0001504;GO:0021989;GO:0045823;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0010881;GO:0051946;GO:0006937;GO:0002087;GO:0006940;GO:0006942;GO:0051966;GO:0002026;GO:0019229;GO:0055119;GO:0010996;GO:1903416;GO:0035094;GO:0036376;GO:0035725;GO:0006814;GO:0150104;GO:0008542;, C:caveola; C:cell projection; C:cytoplasm; C:dendritic spine; C:endosome; C:extracellular vesicle; C:intercalated disc; C:membrane; C:neuronal cell body; C:organelle membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein heterodimerization activity; F:sodium ion binding; F:steroid binding; F:steroid hormone binding;, P:adult locomotory behavior; P:amygdala development; P:ATP metabolic process; P:behavioral fear response; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:locomotion; P:locomotory exploration behavior; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization; P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium:sodium antiporter activity; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of heart contraction; P:negative regulation of striated muscle contraction; P:neurotransmitter uptake; P:olfactory cortex development; P:positive regulation of heart contraction; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of muscle contraction; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of smooth muscle contraction; P:regulation of striated muscle contraction; P:regulation of synaptic transmission, glutamatergic; P:regulation of the force of heart contraction; P:regulation of vasoconstriction; P:relaxation of cardiac muscle; P:response to auditory stimulus; P:response to glycoside; P:response to nicotine; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier; P:visual learning;|P50993 D3DVE4 Q07059 Q5JW74 Q86UZ5 Q9UQ25,Sodium/potassium-transporting ATPase subunit alpha-2,Sodium pump subunit alpha-2;, PF00689;PF00690;, GO:0005901;GO:0042995;GO:0005737;GO:0043197;GO:0005768;GO:1903561;GO:0014704;GO:0016020;GO:0043025;GO:0031090;GO:0005886;GO:0005890;GO:0030315;GO:0005524;GO:0016887;GO:0019829;GO:0051087;GO:0005391;GO:0016791;GO:0030955;GO:0008556;GO:0046982;GO:0031402;GO:0005496;GO:1990239;GO:0008344;GO:0021764;GO:0046034;GO:0001662;GO:0060048;GO:0098655;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0040011;GO:0035641;GO:0086012;GO:0086009;GO:1903170;GO:1903280;GO:0051481;GO:0045822;GO:0045988;GO:0001504;GO:0021989;GO:0045823;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0010881;GO:0051946;GO:0006937;GO:0002087;GO:0006940;GO:0006942;GO:0051966;GO:0002026;GO:0019229;GO:0055119;GO:0010996;GO:1903416;GO:0035094;GO:0036376;GO:0035725;GO:0006814;GO:0150104;GO:0008542;, C:caveola; C:cell projection; C:cytoplasm; C:dendritic spine; C:endosome; C:extracellular vesicle; C:intercalated disc; C:membrane; C:neuronal cell body; C:organelle membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein heterodimerization activity; F:sodium ion binding; F:steroid binding; F:steroid hormone binding;, P:adult locomotory behavior; P:amygdala development; P:ATP metabolic process; P:behavioral fear response; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:locomotion; P:locomotory exploration behavior; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization; P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium:sodium antiporter activity; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of heart contraction; P:negative regulation of striated muscle contraction; P:neurotransmitter uptake; P:olfactory cortex development; P:positive regulation of heart contraction; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of muscle contraction; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of smooth muscle contraction; P:regulation of striated muscle contraction; P:regulation of synaptic transmission, glutamatergic; P:regulation of the force of heart contraction; P:regulation of vasoconstriction; P:relaxation of cardiac muscle; P:response to auditory stimulus; P:response to glycoside; P:response to nicotine; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier; P:visual learning;|P50993 D3DVE4 Q07059 Q5JW74 Q86UZ5 Q9UQ25,Sodium/potassium-transporting ATPase subunit alpha-2,Sodium pump subunit alpha-2;, PF00689;PF00690;, GO:0005901;GO:0042995;GO:0005737;GO:0043197;GO:0005768;GO:1903561;GO:0014704;GO:0016020;GO:0043025;GO:0031090;GO:0005886;GO:0005890;GO:0030315;GO:0005524;GO:0016887;GO:0019829;GO:0051087;GO:0005391;GO:0016791;GO:0030955;GO:0008556;GO:0046982;GO:0031402;GO:0005496;GO:1990239;GO:0008344;GO:0021764;GO:0046034;GO:0001662;GO:0060048;GO:0098655;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0040011;GO:0035641;GO:0086012;GO:0086009;GO:1903170;GO:1903280;GO:0051481;GO:0045822;GO:0045988;GO:0001504;GO:0021989;GO:0045823;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0010881;GO:0051946;GO:0006937;GO:0002087;GO:0006940;GO:0006942;GO:0051966;GO:0002026;GO:0019229;GO:0055119;GO:0010996;GO:1903416;GO:0035094;GO:0036376;GO:0035725;GO:0006814;GO:0150104;GO:0008542;, C:caveola; C:cell projection; C:cytoplasm; C:dendritic spine; C:endosome; C:extracellular vesicle; C:intercalated disc; C:membrane; C:neuronal cell body; C:organelle membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein heterodimerization activity; F:sodium ion binding; F:steroid binding; F:steroid hormone binding;, P:adult locomotory behavior; P:amygdala development; P:ATP metabolic process; P:behavioral fear response; P:cardiac muscle contraction; P:cation transmembrane transport; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:locomotion; P:locomotory exploration behavior; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization; P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium:sodium antiporter activity; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of heart contraction; P:negative regulation of striated muscle contraction; P:neurotransmitter uptake; P:olfactory cortex development; P:positive regulation of heart contraction; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of muscle contraction; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of smooth muscle contraction; P:regulation of striated muscle contraction; P:regulation of synaptic transmission, glutamatergic; P:regulation of the force of heart contraction; P:regulation of vasoconstriction; P:relaxation of cardiac muscle; P:response to auditory stimulus; P:response to glycoside; P:response to nicotine; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier; P:visual learning; scaffold49 indexed_genome mRNA 7698402 7699251 . + . ID=transcript_9341;Q9UJ21,Sodium/potassium-transporting ATPase subunit alpha-1,Sodium pump subunit alpha-1;, PF00689;PF00690;, GO:0016324;GO:0016323;GO:0005901;GO:0005783;GO:0005768;GO:0070062;GO:1903561;GO:0005794;GO:0016021;GO:0014704;GO:0016328;GO:0042470;GO:0016020;GO:0045121;GO:0031090;GO:0060342;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0043531;GO:0030506;GO:0005524;GO:0051087;GO:0005391;GO:0016791;GO:0043548;GO:0030955;GO:0008556;GO:0019904;GO:0046982;GO:0019901;GO:0031402;GO:1990239;GO:0086002;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0060081;GO:0086009;GO:0086013;GO:0031947;GO:0045822;GO:0045823;GO:0045989;GO:1990573;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0002028;GO:0002026;GO:0055119;GO:0042493;GO:1903416;GO:0036376;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:melanosome; C:membrane; C:membrane raft; C:organelle membrane; C:photoreceptor inner segment membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ADP binding; F:ankyrin binding; F:ATP binding; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:phosphatidylinositol 3-kinase binding; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:sodium ion binding; F:steroid hormone binding;, P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:membrane hyperpolarization; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of glucocorticoid biosynthetic process; P:negative regulation of heart contraction; P:positive regulation of heart contraction; P:positive regulation of striated muscle contraction; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to drug; P:response to glycoside; P:sodium ion export across plasma membrane; scaffold49 indexed_genome mRNA 7702616 7706729 . - . ID=transcript_9342;Q13733 Q504T2 Q7Z4I9 Q8TBN8 Q8WXA7 Q8WXH7 Q8WY13,Sodium/potassium-transporting ATPase subunit alpha-4 {ECO:0000305},Sodium pump subunit alpha-4;, PF00689;PF00690;, GO:0005887;GO:0045121;GO:0097733;GO:0005886;GO:0120200;GO:0005890;GO:0097225;GO:0005524;GO:0019829;GO:0019900;GO:0046872;GO:0005391;GO:0008556;GO:0007166;GO:0030007;GO:0006883;GO:0009566;GO:0030317;GO:0034220;GO:0006811;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:1903779;GO:0030641;GO:0042391;GO:0036376;GO:0035725;GO:0006814;GO:0007283;GO:0150104;, C:integral component of plasma membrane; C:membrane raft; C:photoreceptor cell cilium; C:plasma membrane; C:rod photoreceptor outer segment; C:sodium:potassium-exchanging ATPase complex; C:sperm midpiece;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:kinase binding; F:metal ion binding; F:P-type sodium:potassium-exchanging ATPase activity; F:potassium transmembrane transporter activity, phosphorylative mechanism;, P:cell surface receptor signaling pathway; P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:fertilization; P:flagellated sperm motility; P:ion transmembrane transport; P:ion transport; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of cardiac conduction; P:regulation of cellular pH; P:regulation of membrane potential; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:spermatogenesis; P:transport across blood-brain barrier; scaffold49 indexed_genome mRNA 7710515 7713953 . - . ID=transcript_9343;Q13733 Q504T2 Q7Z4I9 Q8TBN8 Q8WXA7 Q8WXH7 Q8WY13,Sodium/potassium-transporting ATPase subunit alpha-4 {ECO:0000305},Sodium pump subunit alpha-4;, PF00689;PF00690;, GO:0005887;GO:0045121;GO:0097733;GO:0005886;GO:0120200;GO:0005890;GO:0097225;GO:0005524;GO:0019829;GO:0019900;GO:0046872;GO:0005391;GO:0008556;GO:0007166;GO:0030007;GO:0006883;GO:0009566;GO:0030317;GO:0034220;GO:0006811;GO:1990573;GO:0071805;GO:0006813;GO:1902600;GO:1903779;GO:0030641;GO:0042391;GO:0036376;GO:0035725;GO:0006814;GO:0007283;GO:0150104;, C:integral component of plasma membrane; C:membrane raft; C:photoreceptor cell cilium; C:plasma membrane; C:rod photoreceptor outer segment; C:sodium:potassium-exchanging ATPase complex; C:sperm midpiece;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:kinase binding; F:metal ion binding; F:P-type sodium:potassium-exchanging ATPase activity; F:potassium transmembrane transporter activity, phosphorylative mechanism;, P:cell surface receptor signaling pathway; P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:fertilization; P:flagellated sperm motility; P:ion transmembrane transport; P:ion transport; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:proton transmembrane transport; P:regulation of cardiac conduction; P:regulation of cellular pH; P:regulation of membrane potential; P:sodium ion export across plasma membrane; P:sodium ion transmembrane transport; P:sodium ion transport; P:spermatogenesis; P:transport across blood-brain barrier; scaffold49 indexed_genome mRNA 7724796 7734429 . + . ID=transcript_9344;P31415 B1AKZ2 B2R863 Q8TBW7,Calsequestrin-1,Calmitine {ECO:0000303|PubMed:7945294};Calsequestrin, skeletal muscle isoform;, PF01216;, GO:0005783;GO:0005794;GO:0005759;GO:0005739;GO:0016529;GO:0033018;GO:0033017;GO:0005790;GO:0030315;GO:0014804;GO:0030018;GO:0005509;GO:0042802;GO:0007029;GO:0034220;GO:0051281;GO:1901341;GO:0051258;GO:1903779;GO:0051279;GO:0014809;GO:2001256;GO:0014894;GO:0009408;GO:0010033;GO:0045214;GO:0007519;, C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrial matrix; C:mitochondrion; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:T-tubule; C:terminal cisterna lumen; C:Z disc;, F:calcium ion binding; F:identical protein binding;, P:endoplasmic reticulum organization; P:ion transmembrane transport; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of store-operated calcium channel activity; P:protein polymerization; P:regulation of cardiac conduction; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of store-operated calcium entry; P:response to denervation involved in regulation of muscle adaptation; P:response to heat; P:response to organic substance; P:sarcomere organization; P:skeletal muscle tissue development;|P31415 B1AKZ2 B2R863 Q8TBW7,Calsequestrin-1,Calmitine {ECO:0000303|PubMed:7945294};Calsequestrin, skeletal muscle isoform;, PF01216;, GO:0005783;GO:0005794;GO:0005759;GO:0005739;GO:0016529;GO:0033018;GO:0033017;GO:0005790;GO:0030315;GO:0014804;GO:0030018;GO:0005509;GO:0042802;GO:0007029;GO:0034220;GO:0051281;GO:1901341;GO:0051258;GO:1903779;GO:0051279;GO:0014809;GO:2001256;GO:0014894;GO:0009408;GO:0010033;GO:0045214;GO:0007519;, C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrial matrix; C:mitochondrion; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:T-tubule; C:terminal cisterna lumen; C:Z disc;, F:calcium ion binding; F:identical protein binding;, P:endoplasmic reticulum organization; P:ion transmembrane transport; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of store-operated calcium channel activity; P:protein polymerization; P:regulation of cardiac conduction; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of store-operated calcium entry; P:response to denervation involved in regulation of muscle adaptation; P:response to heat; P:response to organic substance; P:sarcomere organization; P:skeletal muscle tissue development;|P31415 B1AKZ2 B2R863 Q8TBW7,Calsequestrin-1,Calmitine {ECO:0000303|PubMed:7945294};Calsequestrin, skeletal muscle isoform;, PF01216;, GO:0005783;GO:0005794;GO:0005759;GO:0005739;GO:0016529;GO:0033018;GO:0033017;GO:0005790;GO:0030315;GO:0014804;GO:0030018;GO:0005509;GO:0042802;GO:0007029;GO:0034220;GO:0051281;GO:1901341;GO:0051258;GO:1903779;GO:0051279;GO:0014809;GO:2001256;GO:0014894;GO:0009408;GO:0010033;GO:0045214;GO:0007519;, C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrial matrix; C:mitochondrion; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:T-tubule; C:terminal cisterna lumen; C:Z disc;, F:calcium ion binding; F:identical protein binding;, P:endoplasmic reticulum organization; P:ion transmembrane transport; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of store-operated calcium channel activity; P:protein polymerization; P:regulation of cardiac conduction; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of store-operated calcium entry; P:response to denervation involved in regulation of muscle adaptation; P:response to heat; P:response to organic substance; P:sarcomere organization; P:skeletal muscle tissue development; scaffold49 indexed_genome mRNA 7736848 7772461 . - . ID=transcript_9345;Q15121 B1AKZ3 O00511,Astrocytic phosphoprotein PEA-15,15 kDa phosphoprotein enriched in astrocytes;Phosphoprotein enriched in diabetes;, PF01335;, GO:0005829;GO:0005875;GO:0005654;GO:0000187;GO:0006915;GO:0008643;GO:0000165;GO:1902042;GO:0046325;GO:1902043;GO:0043278;, C:cytosol; C:microtubule associated complex; C:nucleoplasm;, , P:activation of MAPK activity; P:apoptotic process; P:carbohydrate transport; P:MAPK cascade; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of glucose import; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:response to morphine;|Q15121 B1AKZ3 O00511,Astrocytic phosphoprotein PEA-15,15 kDa phosphoprotein enriched in astrocytes;Phosphoprotein enriched in diabetes;, PF01335;, GO:0005829;GO:0005875;GO:0005654;GO:0000187;GO:0006915;GO:0008643;GO:0000165;GO:1902042;GO:0046325;GO:1902043;GO:0043278;, C:cytosol; C:microtubule associated complex; C:nucleoplasm;, , P:activation of MAPK activity; P:apoptotic process; P:carbohydrate transport; P:MAPK cascade; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of glucose import; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:response to morphine;|Q5TAQ9 D3DVE6 Q12839 Q4QQI6 Q53F14 Q66K50 Q68CS7 Q96E00,DDB1- and CUL4-associated factor 8,WD repeat-containing protein 42A;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, , P:post-translational protein modification; P:protein ubiquitination;|Q5TAQ9 D3DVE6 Q12839 Q4QQI6 Q53F14 Q66K50 Q68CS7 Q96E00,DDB1- and CUL4-associated factor 8,WD repeat-containing protein 42A;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, , P:post-translational protein modification; P:protein ubiquitination; scaffold49 indexed_genome mRNA 7773482 7793647 . - . ID=transcript_9346;Q5TAQ9 D3DVE6 Q12839 Q4QQI6 Q53F14 Q66K50 Q68CS7 Q96E00,DDB1- and CUL4-associated factor 8,WD repeat-containing protein 42A;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, , P:post-translational protein modification; P:protein ubiquitination;|Q5TAQ9 D3DVE6 Q12839 Q4QQI6 Q53F14 Q66K50 Q68CS7 Q96E00,DDB1- and CUL4-associated factor 8,WD repeat-containing protein 42A;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, , P:post-translational protein modification; P:protein ubiquitination; scaffold49 indexed_genome mRNA 7795718 7811292 . - . ID=transcript_9347;P40855 D3DVE7 Q5QNY4 Q8NI97,Peroxisomal biogenesis factor 19,33 kDa housekeeping protein;Peroxin-19;Peroxisomal farnesylated protein;, PF04614;, GO:0031526;GO:0005737;GO:0005829;GO:0016021;GO:0005654;GO:0005634;GO:0005778;GO:0005777;GO:0032991;GO:0051117;GO:0036105;GO:0033328;GO:0047485;GO:0061077;GO:0072321;GO:0072663;GO:0006869;GO:1900131;GO:0016559;GO:0016557;GO:0007031;GO:0045046;GO:0050821;GO:0006625;, C:brush border membrane; C:cytoplasm; C:cytosol; C:integral component of membrane; C:nucleoplasm; C:nucleus; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:ATPase binding; F:peroxisome membrane class-1 targeting sequence binding; F:peroxisome membrane targeting sequence binding; F:protein N-terminus binding;, P:chaperone-mediated protein folding; P:chaperone-mediated protein transport; P:establishment of protein localization to peroxisome; P:lipid transport; P:negative regulation of lipid binding; P:peroxisome fission; P:peroxisome membrane biogenesis; P:peroxisome organization; P:protein import into peroxisome membrane; P:protein stabilization; P:protein targeting to peroxisome; scaffold49 indexed_genome mRNA 7816840 7874682 . + . ID=transcript_9348;P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P53621 Q5T201 Q8IXZ9,Coatomer subunit alpha,Alpha-coat protein;HEP-COP;, PF12894;PF04053;PF06957;PF00400;, GO:0030126;GO:0005737;GO:0005829;GO:0005789;GO:0070062;GO:0005615;GO:0000139;GO:0030426;GO:0016020;GO:0030133;GO:0005179;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0030157;GO:0006890;, C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi membrane; C:growth cone; C:membrane; C:transport vesicle;, F:hormone activity; F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:pancreatic juice secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q92542 Q5T207 Q5T208 Q86VV5,Nicastrin,, PF18266;, GO:0035577;GO:0005769;GO:0005783;GO:0010008;GO:0070062;GO:0005925;GO:0070765;GO:0005794;GO:0016021;GO:0005887;GO:0099056;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0005886;GO:0042383;GO:0008021;GO:0051117;GO:0004175;GO:0070851;GO:0030674;GO:0030534;GO:1990000;GO:0042983;GO:0042987;GO:0042982;GO:0034205;GO:0071277;GO:0022010;GO:0021549;GO:0007212;GO:0048013;GO:0050673;GO:0007215;GO:0007611;GO:0006509;GO:0031293;GO:0002262;GO:0051402;GO:0043312;GO:0007220;GO:0035333;GO:0042986;GO:0043065;GO:0043085;GO:0010950;GO:0016485;GO:0006508;GO:1900271;GO:1990926;GO:0042098;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:gamma-secretase complex; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:plasma membrane; C:sarcolemma; C:synaptic vesicle;, F:ATPase binding; F:endopeptidase activity; F:growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:adult behavior; P:amyloid fibril formation; P:amyloid precursor protein biosynthetic process; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:cellular response to calcium ion; P:central nervous system myelination; P:cerebellum development; P:dopamine receptor signaling pathway; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:glutamate receptor signaling pathway; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:myeloid cell homeostasis; P:neuron apoptotic process; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; P:proteolysis; P:regulation of long-term synaptic potentiation; P:short-term synaptic potentiation; P:T cell proliferation;|Q92542 Q5T207 Q5T208 Q86VV5,Nicastrin,, PF18266;, GO:0035577;GO:0005769;GO:0005783;GO:0010008;GO:0070062;GO:0005925;GO:0070765;GO:0005794;GO:0016021;GO:0005887;GO:0099056;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0005886;GO:0042383;GO:0008021;GO:0051117;GO:0004175;GO:0070851;GO:0030674;GO:0030534;GO:1990000;GO:0042983;GO:0042987;GO:0042982;GO:0034205;GO:0071277;GO:0022010;GO:0021549;GO:0007212;GO:0048013;GO:0050673;GO:0007215;GO:0007611;GO:0006509;GO:0031293;GO:0002262;GO:0051402;GO:0043312;GO:0007220;GO:0035333;GO:0042986;GO:0043065;GO:0043085;GO:0010950;GO:0016485;GO:0006508;GO:1900271;GO:1990926;GO:0042098;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:gamma-secretase complex; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:plasma membrane; C:sarcolemma; C:synaptic vesicle;, F:ATPase binding; F:endopeptidase activity; F:growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:adult behavior; P:amyloid fibril formation; P:amyloid precursor protein biosynthetic process; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:cellular response to calcium ion; P:central nervous system myelination; P:cerebellum development; P:dopamine receptor signaling pathway; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:glutamate receptor signaling pathway; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:myeloid cell homeostasis; P:neuron apoptotic process; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; P:proteolysis; P:regulation of long-term synaptic potentiation; P:short-term synaptic potentiation; P:T cell proliferation;|Q92542 Q5T207 Q5T208 Q86VV5,Nicastrin,, PF18266;, GO:0035577;GO:0005769;GO:0005783;GO:0010008;GO:0070062;GO:0005925;GO:0070765;GO:0005794;GO:0016021;GO:0005887;GO:0099056;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0005886;GO:0042383;GO:0008021;GO:0051117;GO:0004175;GO:0070851;GO:0030674;GO:0030534;GO:1990000;GO:0042983;GO:0042987;GO:0042982;GO:0034205;GO:0071277;GO:0022010;GO:0021549;GO:0007212;GO:0048013;GO:0050673;GO:0007215;GO:0007611;GO:0006509;GO:0031293;GO:0002262;GO:0051402;GO:0043312;GO:0007220;GO:0035333;GO:0042986;GO:0043065;GO:0043085;GO:0010950;GO:0016485;GO:0006508;GO:1900271;GO:1990926;GO:0042098;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:gamma-secretase complex; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:plasma membrane; C:sarcolemma; C:synaptic vesicle;, F:ATPase binding; F:endopeptidase activity; F:growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:adult behavior; P:amyloid fibril formation; P:amyloid precursor protein biosynthetic process; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:cellular response to calcium ion; P:central nervous system myelination; P:cerebellum development; P:dopamine receptor signaling pathway; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:glutamate receptor signaling pathway; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:myeloid cell homeostasis; P:neuron apoptotic process; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; P:proteolysis; P:regulation of long-term synaptic potentiation; P:short-term synaptic potentiation; P:T cell proliferation;|Q92542 Q5T207 Q5T208 Q86VV5,Nicastrin,, PF18266;, GO:0035577;GO:0005769;GO:0005783;GO:0010008;GO:0070062;GO:0005925;GO:0070765;GO:0005794;GO:0016021;GO:0005887;GO:0099056;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0005886;GO:0042383;GO:0008021;GO:0051117;GO:0004175;GO:0070851;GO:0030674;GO:0030534;GO:1990000;GO:0042983;GO:0042987;GO:0042982;GO:0034205;GO:0071277;GO:0022010;GO:0021549;GO:0007212;GO:0048013;GO:0050673;GO:0007215;GO:0007611;GO:0006509;GO:0031293;GO:0002262;GO:0051402;GO:0043312;GO:0007220;GO:0035333;GO:0042986;GO:0043065;GO:0043085;GO:0010950;GO:0016485;GO:0006508;GO:1900271;GO:1990926;GO:0042098;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:gamma-secretase complex; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:plasma membrane; C:sarcolemma; C:synaptic vesicle;, F:ATPase binding; F:endopeptidase activity; F:growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:adult behavior; P:amyloid fibril formation; P:amyloid precursor protein biosynthetic process; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:cellular response to calcium ion; P:central nervous system myelination; P:cerebellum development; P:dopamine receptor signaling pathway; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:glutamate receptor signaling pathway; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:myeloid cell homeostasis; P:neuron apoptotic process; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; P:proteolysis; P:regulation of long-term synaptic potentiation; P:short-term synaptic potentiation; P:T cell proliferation;|Q92542 Q5T207 Q5T208 Q86VV5,Nicastrin,, PF18266;, GO:0035577;GO:0005769;GO:0005783;GO:0010008;GO:0070062;GO:0005925;GO:0070765;GO:0005794;GO:0016021;GO:0005887;GO:0099056;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0005886;GO:0042383;GO:0008021;GO:0051117;GO:0004175;GO:0070851;GO:0030674;GO:0030534;GO:1990000;GO:0042983;GO:0042987;GO:0042982;GO:0034205;GO:0071277;GO:0022010;GO:0021549;GO:0007212;GO:0048013;GO:0050673;GO:0007215;GO:0007611;GO:0006509;GO:0031293;GO:0002262;GO:0051402;GO:0043312;GO:0007220;GO:0035333;GO:0042986;GO:0043065;GO:0043085;GO:0010950;GO:0016485;GO:0006508;GO:1900271;GO:1990926;GO:0042098;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:gamma-secretase complex; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:plasma membrane; C:sarcolemma; C:synaptic vesicle;, F:ATPase binding; F:endopeptidase activity; F:growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:adult behavior; P:amyloid fibril formation; P:amyloid precursor protein biosynthetic process; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:cellular response to calcium ion; P:central nervous system myelination; P:cerebellum development; P:dopamine receptor signaling pathway; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:glutamate receptor signaling pathway; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:myeloid cell homeostasis; P:neuron apoptotic process; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; P:proteolysis; P:regulation of long-term synaptic potentiation; P:short-term synaptic potentiation; P:T cell proliferation;|Q92542 Q5T207 Q5T208 Q86VV5,Nicastrin,, PF18266;, GO:0035577;GO:0005769;GO:0005783;GO:0010008;GO:0070062;GO:0005925;GO:0070765;GO:0005794;GO:0016021;GO:0005887;GO:0099056;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0005886;GO:0042383;GO:0008021;GO:0051117;GO:0004175;GO:0070851;GO:0030674;GO:0030534;GO:1990000;GO:0042983;GO:0042987;GO:0042982;GO:0034205;GO:0071277;GO:0022010;GO:0021549;GO:0007212;GO:0048013;GO:0050673;GO:0007215;GO:0007611;GO:0006509;GO:0031293;GO:0002262;GO:0051402;GO:0043312;GO:0007220;GO:0035333;GO:0042986;GO:0043065;GO:0043085;GO:0010950;GO:0016485;GO:0006508;GO:1900271;GO:1990926;GO:0042098;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:gamma-secretase complex; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:plasma membrane; C:sarcolemma; C:synaptic vesicle;, F:ATPase binding; F:endopeptidase activity; F:growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:adult behavior; P:amyloid fibril formation; P:amyloid precursor protein biosynthetic process; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:cellular response to calcium ion; P:central nervous system myelination; P:cerebellum development; P:dopamine receptor signaling pathway; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:glutamate receptor signaling pathway; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:myeloid cell homeostasis; P:neuron apoptotic process; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; P:proteolysis; P:regulation of long-term synaptic potentiation; P:short-term synaptic potentiation; P:T cell proliferation;|Q92542 Q5T207 Q5T208 Q86VV5,Nicastrin,, PF18266;, GO:0035577;GO:0005769;GO:0005783;GO:0010008;GO:0070062;GO:0005925;GO:0070765;GO:0005794;GO:0016021;GO:0005887;GO:0099056;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0005886;GO:0042383;GO:0008021;GO:0051117;GO:0004175;GO:0070851;GO:0030674;GO:0030534;GO:1990000;GO:0042983;GO:0042987;GO:0042982;GO:0034205;GO:0071277;GO:0022010;GO:0021549;GO:0007212;GO:0048013;GO:0050673;GO:0007215;GO:0007611;GO:0006509;GO:0031293;GO:0002262;GO:0051402;GO:0043312;GO:0007220;GO:0035333;GO:0042986;GO:0043065;GO:0043085;GO:0010950;GO:0016485;GO:0006508;GO:1900271;GO:1990926;GO:0042098;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:gamma-secretase complex; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:plasma membrane; C:sarcolemma; C:synaptic vesicle;, F:ATPase binding; F:endopeptidase activity; F:growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:adult behavior; P:amyloid fibril formation; P:amyloid precursor protein biosynthetic process; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:cellular response to calcium ion; P:central nervous system myelination; P:cerebellum development; P:dopamine receptor signaling pathway; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:glutamate receptor signaling pathway; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:myeloid cell homeostasis; P:neuron apoptotic process; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; P:proteolysis; P:regulation of long-term synaptic potentiation; P:short-term synaptic potentiation; P:T cell proliferation;|Q92542 Q5T207 Q5T208 Q86VV5,Nicastrin,, PF18266;, GO:0035577;GO:0005769;GO:0005783;GO:0010008;GO:0070062;GO:0005925;GO:0070765;GO:0005794;GO:0016021;GO:0005887;GO:0099056;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0005886;GO:0042383;GO:0008021;GO:0051117;GO:0004175;GO:0070851;GO:0030674;GO:0030534;GO:1990000;GO:0042983;GO:0042987;GO:0042982;GO:0034205;GO:0071277;GO:0022010;GO:0021549;GO:0007212;GO:0048013;GO:0050673;GO:0007215;GO:0007611;GO:0006509;GO:0031293;GO:0002262;GO:0051402;GO:0043312;GO:0007220;GO:0035333;GO:0042986;GO:0043065;GO:0043085;GO:0010950;GO:0016485;GO:0006508;GO:1900271;GO:1990926;GO:0042098;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:gamma-secretase complex; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:plasma membrane; C:sarcolemma; C:synaptic vesicle;, F:ATPase binding; F:endopeptidase activity; F:growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:adult behavior; P:amyloid fibril formation; P:amyloid precursor protein biosynthetic process; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:cellular response to calcium ion; P:central nervous system myelination; P:cerebellum development; P:dopamine receptor signaling pathway; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:glutamate receptor signaling pathway; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:myeloid cell homeostasis; P:neuron apoptotic process; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; P:proteolysis; P:regulation of long-term synaptic potentiation; P:short-term synaptic potentiation; P:T cell proliferation;|Q92542 Q5T207 Q5T208 Q86VV5,Nicastrin,, PF18266;, GO:0035577;GO:0005769;GO:0005783;GO:0010008;GO:0070062;GO:0005925;GO:0070765;GO:0005794;GO:0016021;GO:0005887;GO:0099056;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0005886;GO:0042383;GO:0008021;GO:0051117;GO:0004175;GO:0070851;GO:0030674;GO:0030534;GO:1990000;GO:0042983;GO:0042987;GO:0042982;GO:0034205;GO:0071277;GO:0022010;GO:0021549;GO:0007212;GO:0048013;GO:0050673;GO:0007215;GO:0007611;GO:0006509;GO:0031293;GO:0002262;GO:0051402;GO:0043312;GO:0007220;GO:0035333;GO:0042986;GO:0043065;GO:0043085;GO:0010950;GO:0016485;GO:0006508;GO:1900271;GO:1990926;GO:0042098;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:gamma-secretase complex; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:plasma membrane; C:sarcolemma; C:synaptic vesicle;, F:ATPase binding; F:endopeptidase activity; F:growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:adult behavior; P:amyloid fibril formation; P:amyloid precursor protein biosynthetic process; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:cellular response to calcium ion; P:central nervous system myelination; P:cerebellum development; P:dopamine receptor signaling pathway; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:glutamate receptor signaling pathway; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:myeloid cell homeostasis; P:neuron apoptotic process; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; P:proteolysis; P:regulation of long-term synaptic potentiation; P:short-term synaptic potentiation; P:T cell proliferation;|Q92542 Q5T207 Q5T208 Q86VV5,Nicastrin,, PF18266;, GO:0035577;GO:0005769;GO:0005783;GO:0010008;GO:0070062;GO:0005925;GO:0070765;GO:0005794;GO:0016021;GO:0005887;GO:0099056;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0005886;GO:0042383;GO:0008021;GO:0051117;GO:0004175;GO:0070851;GO:0030674;GO:0030534;GO:1990000;GO:0042983;GO:0042987;GO:0042982;GO:0034205;GO:0071277;GO:0022010;GO:0021549;GO:0007212;GO:0048013;GO:0050673;GO:0007215;GO:0007611;GO:0006509;GO:0031293;GO:0002262;GO:0051402;GO:0043312;GO:0007220;GO:0035333;GO:0042986;GO:0043065;GO:0043085;GO:0010950;GO:0016485;GO:0006508;GO:1900271;GO:1990926;GO:0042098;, C:azurophil granule membrane; C:early endosome; C:endoplasmic reticulum; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:gamma-secretase complex; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:plasma membrane; C:sarcolemma; C:synaptic vesicle;, F:ATPase binding; F:endopeptidase activity; F:growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:adult behavior; P:amyloid fibril formation; P:amyloid precursor protein biosynthetic process; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:cellular response to calcium ion; P:central nervous system myelination; P:cerebellum development; P:dopamine receptor signaling pathway; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:glutamate receptor signaling pathway; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:myeloid cell homeostasis; P:neuron apoptotic process; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; P:proteolysis; P:regulation of long-term synaptic potentiation; P:short-term synaptic potentiation; P:T cell proliferation; scaffold49 indexed_genome mRNA 7913148 7939743 . + . ID=transcript_9349;Q9ULK5 D3DVE9 Q5T212,Vang-like protein 2,Loop-tail protein 1 homolog;Strabismus 1;Van Gogh-like protein 2;, PF06638;, GO:0016324;GO:0005911;GO:0016021;GO:0016328;GO:0005886;GO:0045176;GO:0035787;GO:0001736;GO:0001947;GO:0001843;GO:1905515;GO:0060071;, C:apical plasma membrane; C:cell-cell junction; C:integral component of membrane; C:lateral plasma membrane; C:plasma membrane;, , P:apical protein localization; P:cell migration involved in kidney development; P:establishment of planar polarity; P:heart looping; P:neural tube closure; P:non-motile cilium assembly; P:Wnt signaling pathway, planar cell polarity pathway;|Q9ULK5 D3DVE9 Q5T212,Vang-like protein 2,Loop-tail protein 1 homolog;Strabismus 1;Van Gogh-like protein 2;, PF06638;, GO:0016324;GO:0005911;GO:0016021;GO:0016328;GO:0005886;GO:0045176;GO:0035787;GO:0001736;GO:0001947;GO:0001843;GO:1905515;GO:0060071;, C:apical plasma membrane; C:cell-cell junction; C:integral component of membrane; C:lateral plasma membrane; C:plasma membrane;, , P:apical protein localization; P:cell migration involved in kidney development; P:establishment of planar polarity; P:heart looping; P:neural tube closure; P:non-motile cilium assembly; P:Wnt signaling pathway, planar cell polarity pathway; scaffold49 indexed_genome mRNA 8015184 8033586 . - . ID=transcript_9350;Q96DU3 A6NMW2 B2R8X8 Q14CF0 Q5TAS4 Q5TAS6 Q5TAT3 Q96DV0,SLAM family member 6,Activating NK receptor;NK-T-B-antigen;, PF07686;, GO:0070062;GO:0016021;GO:0005886;GO:0045087;GO:0032729;GO:0032740;GO:0045954;GO:0050776;GO:0072540;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:innate immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-17 production; P:positive regulation of natural killer cell mediated cytotoxicity; P:regulation of immune response; P:T-helper 17 cell lineage commitment;|Q96DU3 A6NMW2 B2R8X8 Q14CF0 Q5TAS4 Q5TAS6 Q5TAT3 Q96DV0,SLAM family member 6,Activating NK receptor;NK-T-B-antigen;, PF07686;, GO:0070062;GO:0016021;GO:0005886;GO:0045087;GO:0032729;GO:0032740;GO:0045954;GO:0050776;GO:0072540;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, , P:innate immune response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-17 production; P:positive regulation of natural killer cell mediated cytotoxicity; P:regulation of immune response; P:T-helper 17 cell lineage commitment; scaffold49 indexed_genome mRNA 8059900 8083135 . - . ID=transcript_9351;Q8WWI8 Q9UF04 Q9UIB6 Q9UIB7 Q9UIT7,SLAM family member 5,Cell surface antigen MAX.3;Hly9-beta;Leukocyte differentiation antigen CD84;Signaling lymphocytic activation molecule 5;, , GO:0005887;GO:0043231;GO:0005886;GO:0042802;GO:0002250;GO:0006914;GO:0006952;GO:0007156;GO:0045087;GO:0050900;GO:0032685;GO:0032701;GO:0033004;GO:0043305;GO:2001256;, C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:identical protein binding;, P:adaptive immune response; P:autophagy; P:defense response; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:innate immune response; P:leukocyte migration; P:negative regulation of granulocyte macrophage colony-stimulating factor production; P:negative regulation of interleukin-18 production; P:negative regulation of mast cell activation; P:negative regulation of mast cell degranulation; P:regulation of store-operated calcium entry; scaffold49 indexed_genome mRNA 8188606 8209891 . - . ID=transcript_9352;P09326 Q5U055 Q8MGR0,CD48 antigen,B-lymphocyte activation marker BLAST-1;BCM1 surface antigen;Leukocyte antigen MEM-102;SLAM family member 2;Signaling lymphocytic activation molecule 2;TCT.1;, PF13895;PF07686;, GO:0031225;GO:0070062;GO:0031226;GO:0016020;GO:0045121;GO:0005886;GO:0003823;GO:0038023;GO:0006952;GO:0050900;GO:0002819;, C:anchored component of membrane; C:extracellular exosome; C:intrinsic component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:antigen binding; F:signaling receptor activity;, P:defense response; P:leukocyte migration; P:regulation of adaptive immune response;|P09326 Q5U055 Q8MGR0,CD48 antigen,B-lymphocyte activation marker BLAST-1;BCM1 surface antigen;Leukocyte antigen MEM-102;SLAM family member 2;Signaling lymphocytic activation molecule 2;TCT.1;, PF13895;PF07686;, GO:0031225;GO:0070062;GO:0031226;GO:0016020;GO:0045121;GO:0005886;GO:0003823;GO:0038023;GO:0006952;GO:0050900;GO:0002819;, C:anchored component of membrane; C:extracellular exosome; C:intrinsic component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:antigen binding; F:signaling receptor activity;, P:defense response; P:leukocyte migration; P:regulation of adaptive immune response; scaffold49 indexed_genome mRNA 8268039 8274129 . + . ID=transcript_9353;Q9NQ25 A8K3U1 B4DPU4 B4DPY3 B4DWA3 Q8N6Y8 Q8ND32 Q9NY08 Q9NY23,SLAM family member 7,CD2 subset 1;CD2-like receptor-activating cytotoxic cells;Membrane protein FOAP-12;Novel Ly9;Protein 19A;, , GO:0016021;GO:0005886;GO:0042802;GO:0002250;GO:0007155;GO:0030101;GO:0042267;GO:0050776;, C:integral component of membrane; C:plasma membrane;, F:identical protein binding;, P:adaptive immune response; P:cell adhesion; P:natural killer cell activation; P:natural killer cell mediated cytotoxicity; P:regulation of immune response; scaffold49 indexed_genome mRNA 8304537 8306955 . - . ID=transcript_9354;Q9NQ25 A8K3U1 B4DPU4 B4DPY3 B4DWA3 Q8N6Y8 Q8ND32 Q9NY08 Q9NY23,SLAM family member 7,CD2 subset 1;CD2-like receptor-activating cytotoxic cells;Membrane protein FOAP-12;Novel Ly9;Protein 19A;, , GO:0016021;GO:0005886;GO:0042802;GO:0002250;GO:0007155;GO:0030101;GO:0042267;GO:0050776;, C:integral component of membrane; C:plasma membrane;, F:identical protein binding;, P:adaptive immune response; P:cell adhesion; P:natural killer cell activation; P:natural killer cell mediated cytotoxicity; P:regulation of immune response; scaffold49 indexed_genome mRNA 8346879 8347623 . - . ID=transcript_9355;Q9HBG7 A8K7N3 Q14775 Q5VYI3 Q6P2J4 Q9H4N5 Q9NQ24,T-lymphocyte surface antigen Ly-9,Cell surface molecule Ly-9;Lymphocyte antigen 9;SLAM family member 3;Signaling lymphocytic activation molecule 3;, , GO:0009986;GO:0016021;GO:0005886;GO:0007155;GO:0045087;GO:0032740;GO:0072540;, C:cell surface; C:integral component of membrane; C:plasma membrane;, , P:cell adhesion; P:innate immune response; P:positive regulation of interleukin-17 production; P:T-helper 17 cell lineage commitment; scaffold49 indexed_genome mRNA 8359801 8371377 . - . ID=transcript_9356;Q9BZW8 Q5VYI2 Q5VYI6 Q5VYI7 Q96T47 Q9NQD2 Q9NQD3 Q9Y288,Natural killer cell receptor 2B4,NK cell activation-inducing ligand;NK cell type I receptor protein 2B4;SLAM family member 4;Signaling lymphocytic activation molecule 4;, PF13895;PF11465;, GO:0009897;GO:0016021;GO:0005886;GO:0042288;GO:0038023;GO:0002250;GO:0045087;GO:0050900;GO:0002323;GO:0071663;GO:0060732;GO:0032729;GO:0032757;GO:0007165;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, F:MHC class I protein binding; F:signaling receptor activity;, P:adaptive immune response; P:innate immune response; P:leukocyte migration; P:natural killer cell activation involved in immune response; P:positive regulation of granzyme B production; P:positive regulation of inositol phosphate biosynthetic process; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-8 production; P:signal transduction; scaffold49 indexed_genome mRNA 8629670 8631425 . - . ID=transcript_9357;Q9Y624 B7Z941,Junctional adhesion molecule A,Junctional adhesion molecule 1;Platelet F11 receptor;Platelet adhesion molecule 1;, PF07686;, GO:0005923;GO:0030054;GO:0005911;GO:0031410;GO:0070062;GO:0016021;GO:0005886;GO:0032991;GO:0036057;GO:0070160;GO:0045296;GO:0005178;GO:0030165;GO:0042803;GO:0001618;GO:0031032;GO:0070830;GO:0098609;GO:0071260;GO:0090557;GO:0030198;GO:0006954;GO:0050892;GO:0007159;GO:0050900;GO:0035633;GO:0035683;GO:0034260;GO:0051497;GO:0045777;GO:1903142;GO:0043547;GO:1901731;GO:0035025;GO:1902396;GO:0072659;GO:0032956;GO:2000249;GO:2000810;GO:0008360;GO:0001817;GO:0051493;GO:0090559;GO:0009314;GO:0007179;, C:bicellular tight junction; C:cell junction; C:cell-cell junction; C:cytoplasmic vesicle; C:extracellular exosome; C:integral component of membrane; C:plasma membrane; C:protein-containing complex; C:slit diaphragm; C:tight junction;, F:cadherin binding; F:integrin binding; F:PDZ domain binding; F:protein homodimerization activity; F:virus receptor activity;, P:actomyosin structure organization; P:bicellular tight junction assembly; P:cell-cell adhesion; P:cellular response to mechanical stimulus; P:establishment of endothelial intestinal barrier; P:extracellular matrix organization; P:inflammatory response; P:intestinal absorption; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:maintenance of blood-brain barrier; P:memory T cell extravasation; P:negative regulation of GTPase activity; P:negative regulation of stress fiber assembly; P:positive regulation of blood pressure; P:positive regulation of establishment of endothelial barrier; P:positive regulation of GTPase activity; P:positive regulation of platelet aggregation; P:positive regulation of Rho protein signal transduction; P:protein localization to bicellular tight junction; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of actin cytoskeleton reorganization; P:regulation of bicellular tight junction assembly; P:regulation of cell shape; P:regulation of cytokine production; P:regulation of cytoskeleton organization; P:regulation of membrane permeability; P:response to radiation; P:transforming growth factor beta receptor signaling pathway;|Q9Y624 B7Z941,Junctional adhesion molecule A,Junctional adhesion molecule 1;Platelet F11 receptor;Platelet adhesion molecule 1;, PF07686;, GO:0005923;GO:0030054;GO:0005911;GO:0031410;GO:0070062;GO:0016021;GO:0005886;GO:0032991;GO:0036057;GO:0070160;GO:0045296;GO:0005178;GO:0030165;GO:0042803;GO:0001618;GO:0031032;GO:0070830;GO:0098609;GO:0071260;GO:0090557;GO:0030198;GO:0006954;GO:0050892;GO:0007159;GO:0050900;GO:0035633;GO:0035683;GO:0034260;GO:0051497;GO:0045777;GO:1903142;GO:0043547;GO:1901731;GO:0035025;GO:1902396;GO:0072659;GO:0032956;GO:2000249;GO:2000810;GO:0008360;GO:0001817;GO:0051493;GO:0090559;GO:0009314;GO:0007179;, C:bicellular tight junction; C:cell junction; C:cell-cell junction; C:cytoplasmic vesicle; C:extracellular exosome; C:integral component of membrane; C:plasma membrane; C:protein-containing complex; C:slit diaphragm; C:tight junction;, F:cadherin binding; F:integrin binding; F:PDZ domain binding; F:protein homodimerization activity; F:virus receptor activity;, P:actomyosin structure organization; P:bicellular tight junction assembly; P:cell-cell adhesion; P:cellular response to mechanical stimulus; P:establishment of endothelial intestinal barrier; P:extracellular matrix organization; P:inflammatory response; P:intestinal absorption; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:maintenance of blood-brain barrier; P:memory T cell extravasation; P:negative regulation of GTPase activity; P:negative regulation of stress fiber assembly; P:positive regulation of blood pressure; P:positive regulation of establishment of endothelial barrier; P:positive regulation of GTPase activity; P:positive regulation of platelet aggregation; P:positive regulation of Rho protein signal transduction; P:protein localization to bicellular tight junction; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of actin cytoskeleton reorganization; P:regulation of bicellular tight junction assembly; P:regulation of cell shape; P:regulation of cytokine production; P:regulation of cytoskeleton organization; P:regulation of membrane permeability; P:response to radiation; P:transforming growth factor beta receptor signaling pathway; scaffold49 indexed_genome mRNA 8674564 8675659 . - . ID=transcript_9358;Q8NFU3 Q5SY48 Q5SY49 Q5SY50 Q5SY51 Q8NFU2 Q9BV22,Thiosulfate:glutathione sulfurtransferase {ECO:0000303|PubMed:24981631},, PF00581;, GO:0005737;GO:0036464;GO:0005829;GO:0048471;GO:0050337;GO:0070221;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:perinuclear region of cytoplasm;, F:thiosulfate-thiol sulfurtransferase activity;, P:sulfide oxidation, using sulfide:quinone oxidoreductase;|Q8NFU3 Q5SY48 Q5SY49 Q5SY50 Q5SY51 Q8NFU2 Q9BV22,Thiosulfate:glutathione sulfurtransferase {ECO:0000303|PubMed:24981631},, PF00581;, GO:0005737;GO:0036464;GO:0005829;GO:0048471;GO:0050337;GO:0070221;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:perinuclear region of cytoplasm;, F:thiosulfate-thiol sulfurtransferase activity;, P:sulfide oxidation, using sulfide:quinone oxidoreductase; scaffold49 indexed_genome mRNA 8676014 8681665 . - . ID=transcript_9359;P22415 B2RBZ4 Q5SY46 Q7Z5Y1,Upstream stimulatory factor 1,Class B basic helix-loop-helix protein 11;Major late transcription factor 1;, PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0043425;GO:0000981;GO:0019899;GO:0042826;GO:0042802;GO:0046982;GO:0042803;GO:0019901;GO:0044877;GO:0000978;GO:0043565;GO:1990837;GO:0045990;GO:0032869;GO:0042593;GO:0006006;GO:0019086;GO:0055088;GO:0051918;GO:0045944;GO:0000432;GO:0006357;GO:0000430;GO:0001666;GO:0009411;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:carbon catabolite regulation of transcription; P:cellular response to insulin stimulus; P:glucose homeostasis; P:glucose metabolic process; P:late viral transcription; P:lipid homeostasis; P:negative regulation of fibrinolysis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter by glucose; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter by glucose; P:response to hypoxia; P:response to UV;|P22415 B2RBZ4 Q5SY46 Q7Z5Y1,Upstream stimulatory factor 1,Class B basic helix-loop-helix protein 11;Major late transcription factor 1;, PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0043425;GO:0000981;GO:0019899;GO:0042826;GO:0042802;GO:0046982;GO:0042803;GO:0019901;GO:0044877;GO:0000978;GO:0043565;GO:1990837;GO:0045990;GO:0032869;GO:0042593;GO:0006006;GO:0019086;GO:0055088;GO:0051918;GO:0045944;GO:0000432;GO:0006357;GO:0000430;GO:0001666;GO:0009411;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:carbon catabolite regulation of transcription; P:cellular response to insulin stimulus; P:glucose homeostasis; P:glucose metabolic process; P:late viral transcription; P:lipid homeostasis; P:negative regulation of fibrinolysis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter by glucose; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter by glucose; P:response to hypoxia; P:response to UV;|P22415 B2RBZ4 Q5SY46 Q7Z5Y1,Upstream stimulatory factor 1,Class B basic helix-loop-helix protein 11;Major late transcription factor 1;, PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0043425;GO:0000981;GO:0019899;GO:0042826;GO:0042802;GO:0046982;GO:0042803;GO:0019901;GO:0044877;GO:0000978;GO:0043565;GO:1990837;GO:0045990;GO:0032869;GO:0042593;GO:0006006;GO:0019086;GO:0055088;GO:0051918;GO:0045944;GO:0000432;GO:0006357;GO:0000430;GO:0001666;GO:0009411;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:carbon catabolite regulation of transcription; P:cellular response to insulin stimulus; P:glucose homeostasis; P:glucose metabolic process; P:late viral transcription; P:lipid homeostasis; P:negative regulation of fibrinolysis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter by glucose; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter by glucose; P:response to hypoxia; P:response to UV;|P22415 B2RBZ4 Q5SY46 Q7Z5Y1,Upstream stimulatory factor 1,Class B basic helix-loop-helix protein 11;Major late transcription factor 1;, PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0043425;GO:0000981;GO:0019899;GO:0042826;GO:0042802;GO:0046982;GO:0042803;GO:0019901;GO:0044877;GO:0000978;GO:0043565;GO:1990837;GO:0045990;GO:0032869;GO:0042593;GO:0006006;GO:0019086;GO:0055088;GO:0051918;GO:0045944;GO:0000432;GO:0006357;GO:0000430;GO:0001666;GO:0009411;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:carbon catabolite regulation of transcription; P:cellular response to insulin stimulus; P:glucose homeostasis; P:glucose metabolic process; P:late viral transcription; P:lipid homeostasis; P:negative regulation of fibrinolysis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter by glucose; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter by glucose; P:response to hypoxia; P:response to UV;|P22415 B2RBZ4 Q5SY46 Q7Z5Y1,Upstream stimulatory factor 1,Class B basic helix-loop-helix protein 11;Major late transcription factor 1;, PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0043425;GO:0000981;GO:0019899;GO:0042826;GO:0042802;GO:0046982;GO:0042803;GO:0019901;GO:0044877;GO:0000978;GO:0043565;GO:1990837;GO:0045990;GO:0032869;GO:0042593;GO:0006006;GO:0019086;GO:0055088;GO:0051918;GO:0045944;GO:0000432;GO:0006357;GO:0000430;GO:0001666;GO:0009411;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:carbon catabolite regulation of transcription; P:cellular response to insulin stimulus; P:glucose homeostasis; P:glucose metabolic process; P:late viral transcription; P:lipid homeostasis; P:negative regulation of fibrinolysis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter by glucose; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter by glucose; P:response to hypoxia; P:response to UV; scaffold49 indexed_genome mRNA 8683298 8697952 . - . ID=transcript_9360;Q7Z6I6 Q5SY52 Q5SY53 Q5SY54 Q6ZML6 Q7Z3J8 Q86XI7,Rho GTPase-activating protein 30,Rho-type GTPase-activating protein 30;, PF00620;, GO:0031410;GO:0005829;GO:0043231;GO:0005096;GO:0051056;GO:0007264;, C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; scaffold49 indexed_genome mRNA 8702183 8705952 . - . ID=transcript_9361;Q96NY8 B4DQW3 Q96K15,Nectin-4,Ig superfamily receptor LNIR;Nectin cell adhesion molecule 4 {ECO:0000312|HGNC:HGNC:19688};Poliovirus receptor-related protein 4;, PF08205;PF07686;, GO:0005912;GO:0070062;GO:0016021;GO:0005886;GO:0042802;GO:0001618;GO:0034332;GO:0007157;GO:0007156;, C:adherens junction; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:virus receptor activity;, P:adherens junction organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold49 indexed_genome mRNA 8724446 8778070 . + . ID=transcript_9362;O75618 D3DVF5 O60737,Death effector domain-containing protein,DEDPro1;Death effector domain-containing testicular molecule;FLDED-1;, PF01335;, GO:0005737;GO:0005730;GO:0003677;GO:0008625;GO:0042981;GO:0007283;, C:cytoplasm; C:nucleolus;, F:DNA binding;, P:extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of apoptotic process; P:spermatogenesis;|Q9UHV9 Q9P0P7 Q9UN05,Prefoldin subunit 2,, PF01920;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0016272;GO:0001540;GO:0044183;GO:0051082;GO:1905907;GO:0051495;GO:0006457;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:prefoldin complex;, F:amyloid-beta binding; F:protein folding chaperone; F:unfolded protein binding;, P:negative regulation of amyloid fibril formation; P:positive regulation of cytoskeleton organization; P:protein folding;|Q86X76 B1AQP3 D3DVF4 O76091,Deaminated glutathione amidase,Nitrilase homolog 1;, PF00795;, GO:0005737;GO:0005739;GO:0005634;GO:0110050;GO:0043605;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:deaminated glutathione amidase activity;, P:cellular amide catabolic process;|O75618 D3DVF5 O60737,Death effector domain-containing protein,DEDPro1;Death effector domain-containing testicular molecule;FLDED-1;, PF01335;, GO:0005737;GO:0005730;GO:0003677;GO:0008625;GO:0042981;GO:0007283;, C:cytoplasm; C:nucleolus;, F:DNA binding;, P:extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of apoptotic process; P:spermatogenesis;|O75618 D3DVF5 O60737,Death effector domain-containing protein,DEDPro1;Death effector domain-containing testicular molecule;FLDED-1;, PF01335;, GO:0005737;GO:0005730;GO:0003677;GO:0008625;GO:0042981;GO:0007283;, C:cytoplasm; C:nucleolus;, F:DNA binding;, P:extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of apoptotic process; P:spermatogenesis;|O75618 D3DVF5 O60737,Death effector domain-containing protein,DEDPro1;Death effector domain-containing testicular molecule;FLDED-1;, PF01335;, GO:0005737;GO:0005730;GO:0003677;GO:0008625;GO:0042981;GO:0007283;, C:cytoplasm; C:nucleolus;, F:DNA binding;, P:extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of apoptotic process; P:spermatogenesis;|Q9Y3C8 A8K9R1 D3DVF9 Q549X0 Q5VTX1 Q9BS96 Q9P009,Ubiquitin-fold modifier-conjugating enzyme 1 {ECO:0000305},, PF08694;, GO:0070062;GO:0061657;GO:0071568;GO:0007420;GO:1990592;GO:0071569;GO:0034976;GO:0061709;, C:extracellular exosome;, F:UFM1 conjugating enzyme activity; F:UFM1 transferase activity;, P:brain development; P:protein K69-linked ufmylation; P:protein ufmylation; P:response to endoplasmic reticulum stress; P:reticulophagy;|Q9UK80 Q59H60 Q5BKT5 Q5VTW9 Q5VTX0 Q9BTV1 Q9HBS2 Q9NYN4,Ubiquitin carboxyl-terminal hydrolase 21,Deubiquitinating enzyme 21;Ubiquitin thioesterase 21;Ubiquitin-specific-processing protease 21;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0008234;GO:0046872;GO:0019784;GO:0004843;GO:0003713;GO:0016578;GO:0031175;GO:0045893;GO:0016579;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:cysteine-type peptidase activity; F:metal ion binding; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:histone deubiquitination; P:neuron projection development; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UK80 Q59H60 Q5BKT5 Q5VTW9 Q5VTX0 Q9BTV1 Q9HBS2 Q9NYN4,Ubiquitin carboxyl-terminal hydrolase 21,Deubiquitinating enzyme 21;Ubiquitin thioesterase 21;Ubiquitin-specific-processing protease 21;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0008234;GO:0046872;GO:0019784;GO:0004843;GO:0003713;GO:0016578;GO:0031175;GO:0045893;GO:0016579;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:cysteine-type peptidase activity; F:metal ion binding; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:histone deubiquitination; P:neuron projection development; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UK80 Q59H60 Q5BKT5 Q5VTW9 Q5VTX0 Q9BTV1 Q9HBS2 Q9NYN4,Ubiquitin carboxyl-terminal hydrolase 21,Deubiquitinating enzyme 21;Ubiquitin thioesterase 21;Ubiquitin-specific-processing protease 21;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0008234;GO:0046872;GO:0019784;GO:0004843;GO:0003713;GO:0016578;GO:0031175;GO:0045893;GO:0016579;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:cysteine-type peptidase activity; F:metal ion binding; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:histone deubiquitination; P:neuron projection development; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UK80 Q59H60 Q5BKT5 Q5VTW9 Q5VTX0 Q9BTV1 Q9HBS2 Q9NYN4,Ubiquitin carboxyl-terminal hydrolase 21,Deubiquitinating enzyme 21;Ubiquitin thioesterase 21;Ubiquitin-specific-processing protease 21;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0008234;GO:0046872;GO:0019784;GO:0004843;GO:0003713;GO:0016578;GO:0031175;GO:0045893;GO:0016579;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:cysteine-type peptidase activity; F:metal ion binding; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:histone deubiquitination; P:neuron projection development; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UK80 Q59H60 Q5BKT5 Q5VTW9 Q5VTX0 Q9BTV1 Q9HBS2 Q9NYN4,Ubiquitin carboxyl-terminal hydrolase 21,Deubiquitinating enzyme 21;Ubiquitin thioesterase 21;Ubiquitin-specific-processing protease 21;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0008234;GO:0046872;GO:0019784;GO:0004843;GO:0003713;GO:0016578;GO:0031175;GO:0045893;GO:0016579;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:cysteine-type peptidase activity; F:metal ion binding; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:histone deubiquitination; P:neuron projection development; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UK80 Q59H60 Q5BKT5 Q5VTW9 Q5VTX0 Q9BTV1 Q9HBS2 Q9NYN4,Ubiquitin carboxyl-terminal hydrolase 21,Deubiquitinating enzyme 21;Ubiquitin thioesterase 21;Ubiquitin-specific-processing protease 21;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0008234;GO:0046872;GO:0019784;GO:0004843;GO:0003713;GO:0016578;GO:0031175;GO:0045893;GO:0016579;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:cysteine-type peptidase activity; F:metal ion binding; F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:histone deubiquitination; P:neuron projection development; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold49 indexed_genome mRNA 8778725 8788565 . + . ID=transcript_9363;P50336 D3DVG0 Q5VTW8,Protoporphyrinogen oxidase,, PF01593;, GO:0031305;GO:0031304;GO:0005758;GO:0031966;GO:0050660;GO:0016491;GO:0004729;GO:0006783;GO:0006779;GO:0006782;GO:0042493;, C:integral component of mitochondrial inner membrane; C:intrinsic component of mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane;, F:flavin adenine dinucleotide binding; F:oxidoreductase activity; F:oxygen-dependent protoporphyrinogen oxidase activity;, P:heme biosynthetic process; P:porphyrin-containing compound biosynthetic process; P:protoporphyrinogen IX biosynthetic process; P:response to drug;|P50336 D3DVG0 Q5VTW8,Protoporphyrinogen oxidase,, PF01593;, GO:0031305;GO:0031304;GO:0005758;GO:0031966;GO:0050660;GO:0016491;GO:0004729;GO:0006783;GO:0006779;GO:0006782;GO:0042493;, C:integral component of mitochondrial inner membrane; C:intrinsic component of mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane;, F:flavin adenine dinucleotide binding; F:oxidoreductase activity; F:oxygen-dependent protoporphyrinogen oxidase activity;, P:heme biosynthetic process; P:porphyrin-containing compound biosynthetic process; P:protoporphyrinogen IX biosynthetic process; P:response to drug;|O60512 D3DVG3 O60910 Q9BPZ4 Q9H8T2,Beta-1,4-galactosyltransferase 3 {ECO:0000305},Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:9405390};N-acetyllactosamine synthase {ECO:0000303|PubMed:9405390};Nal synthase;Neolactotriaosylceramide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:9405390};UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3;, PF02709;PF13733;, GO:0005829;GO:0070062;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0003831;GO:0008378;GO:0046872;GO:0003945;GO:0005975;GO:0006682;GO:0018146;GO:0006486;, C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; F:galactosyltransferase activity; F:metal ion binding; F:N-acetyllactosamine synthase activity;, P:carbohydrate metabolic process; P:galactosylceramide biosynthetic process; P:keratan sulfate biosynthetic process; P:protein glycosylation;|P50336 D3DVG0 Q5VTW8,Protoporphyrinogen oxidase,, PF01593;, GO:0031305;GO:0031304;GO:0005758;GO:0031966;GO:0050660;GO:0016491;GO:0004729;GO:0006783;GO:0006779;GO:0006782;GO:0042493;, C:integral component of mitochondrial inner membrane; C:intrinsic component of mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane;, F:flavin adenine dinucleotide binding; F:oxidoreductase activity; F:oxygen-dependent protoporphyrinogen oxidase activity;, P:heme biosynthetic process; P:porphyrin-containing compound biosynthetic process; P:protoporphyrinogen IX biosynthetic process; P:response to drug;|P50336 D3DVG0 Q5VTW8,Protoporphyrinogen oxidase,, PF01593;, GO:0031305;GO:0031304;GO:0005758;GO:0031966;GO:0050660;GO:0016491;GO:0004729;GO:0006783;GO:0006779;GO:0006782;GO:0042493;, C:integral component of mitochondrial inner membrane; C:intrinsic component of mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane;, F:flavin adenine dinucleotide binding; F:oxidoreductase activity; F:oxygen-dependent protoporphyrinogen oxidase activity;, P:heme biosynthetic process; P:porphyrin-containing compound biosynthetic process; P:protoporphyrinogen IX biosynthetic process; P:response to drug;|O60512 D3DVG3 O60910 Q9BPZ4 Q9H8T2,Beta-1,4-galactosyltransferase 3 {ECO:0000305},Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:9405390};N-acetyllactosamine synthase {ECO:0000303|PubMed:9405390};Nal synthase;Neolactotriaosylceramide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:9405390};UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3;, PF02709;PF13733;, GO:0005829;GO:0070062;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0003831;GO:0008378;GO:0046872;GO:0003945;GO:0005975;GO:0006682;GO:0018146;GO:0006486;, C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; F:galactosyltransferase activity; F:metal ion binding; F:N-acetyllactosamine synthase activity;, P:carbohydrate metabolic process; P:galactosylceramide biosynthetic process; P:keratan sulfate biosynthetic process; P:protein glycosylation; scaffold49 indexed_genome mRNA 8797842 8806015 . - . ID=transcript_9364;O75173 Q2HYD0 Q5VTW2 Q6P4Q8 Q6UWA8 Q9UN83,A disintegrin and metalloproteinase with thrombospondin motifs 4,ADMP-1;Aggrecanase-1;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0016607;GO:0046872;GO:0004222;GO:0008237;GO:0008233;GO:0002020;GO:0022617;GO:0030198;GO:0006508;GO:0001501;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nuclear speck;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:protease binding;, P:extracellular matrix disassembly; P:extracellular matrix organization; P:proteolysis; P:skeletal system development;|O75173 Q2HYD0 Q5VTW2 Q6P4Q8 Q6UWA8 Q9UN83,A disintegrin and metalloproteinase with thrombospondin motifs 4,ADMP-1;Aggrecanase-1;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0016607;GO:0046872;GO:0004222;GO:0008237;GO:0008233;GO:0002020;GO:0022617;GO:0030198;GO:0006508;GO:0001501;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nuclear speck;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:protease binding;, P:extracellular matrix disassembly; P:extracellular matrix organization; P:proteolysis; P:skeletal system development;|O75173 Q2HYD0 Q5VTW2 Q6P4Q8 Q6UWA8 Q9UN83,A disintegrin and metalloproteinase with thrombospondin motifs 4,ADMP-1;Aggrecanase-1;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0016607;GO:0046872;GO:0004222;GO:0008237;GO:0008233;GO:0002020;GO:0022617;GO:0030198;GO:0006508;GO:0001501;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nuclear speck;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:protease binding;, P:extracellular matrix disassembly; P:extracellular matrix organization; P:proteolysis; P:skeletal system development;|O75173 Q2HYD0 Q5VTW2 Q6P4Q8 Q6UWA8 Q9UN83,A disintegrin and metalloproteinase with thrombospondin motifs 4,ADMP-1;Aggrecanase-1;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0016607;GO:0046872;GO:0004222;GO:0008237;GO:0008233;GO:0002020;GO:0022617;GO:0030198;GO:0006508;GO:0001501;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:nuclear speck;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:protease binding;, P:extracellular matrix disassembly; P:extracellular matrix organization; P:proteolysis; P:skeletal system development; scaffold49 indexed_genome mRNA 8809038 8818154 . + . ID=transcript_9365;O75306 D3DVG7 J3KPM7 Q5VTW0 Q969P3 Q9UEV3,NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial,Complex I-49kD;NADH-ubiquinone oxidoreductase 49 kDa subunit;, PF00346;, GO:0005759;GO:0005747;GO:0005739;GO:0005654;GO:0051539;GO:0009055;GO:0046872;GO:0051287;GO:0008137;GO:0019826;GO:0048038;GO:0031625;GO:0071453;GO:0042063;GO:0042775;GO:0006120;GO:0032981;GO:0061351;GO:0022008;GO:0006979;, C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity; F:oxygen sensor activity; F:quinone binding; F:ubiquitin protein ligase binding;, P:cellular response to oxygen levels; P:gliogenesis; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:neural precursor cell proliferation; P:neurogenesis; P:response to oxidative stress;|O75306 D3DVG7 J3KPM7 Q5VTW0 Q969P3 Q9UEV3,NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial,Complex I-49kD;NADH-ubiquinone oxidoreductase 49 kDa subunit;, PF00346;, GO:0005759;GO:0005747;GO:0005739;GO:0005654;GO:0051539;GO:0009055;GO:0046872;GO:0051287;GO:0008137;GO:0019826;GO:0048038;GO:0031625;GO:0071453;GO:0042063;GO:0042775;GO:0006120;GO:0032981;GO:0061351;GO:0022008;GO:0006979;, C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity; F:oxygen sensor activity; F:quinone binding; F:ubiquitin protein ligase binding;, P:cellular response to oxygen levels; P:gliogenesis; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:neural precursor cell proliferation; P:neurogenesis; P:response to oxidative stress;|O75306 D3DVG7 J3KPM7 Q5VTW0 Q969P3 Q9UEV3,NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial,Complex I-49kD;NADH-ubiquinone oxidoreductase 49 kDa subunit;, PF00346;, GO:0005759;GO:0005747;GO:0005739;GO:0005654;GO:0051539;GO:0009055;GO:0046872;GO:0051287;GO:0008137;GO:0019826;GO:0048038;GO:0031625;GO:0071453;GO:0042063;GO:0042775;GO:0006120;GO:0032981;GO:0061351;GO:0022008;GO:0006979;, C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity; F:oxygen sensor activity; F:quinone binding; F:ubiquitin protein ligase binding;, P:cellular response to oxygen levels; P:gliogenesis; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:neural precursor cell proliferation; P:neurogenesis; P:response to oxidative stress;|O75306 D3DVG7 J3KPM7 Q5VTW0 Q969P3 Q9UEV3,NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial,Complex I-49kD;NADH-ubiquinone oxidoreductase 49 kDa subunit;, PF00346;, GO:0005759;GO:0005747;GO:0005739;GO:0005654;GO:0051539;GO:0009055;GO:0046872;GO:0051287;GO:0008137;GO:0019826;GO:0048038;GO:0031625;GO:0071453;GO:0042063;GO:0042775;GO:0006120;GO:0032981;GO:0061351;GO:0022008;GO:0006979;, C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity; F:oxygen sensor activity; F:quinone binding; F:ubiquitin protein ligase binding;, P:cellular response to oxygen levels; P:gliogenesis; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:neural precursor cell proliferation; P:neurogenesis; P:response to oxidative stress; scaffold49 indexed_genome mRNA 8818725 8821999 . + . ID=transcript_9366;P30273 Q5VTW4,High affinity immunoglobulin epsilon receptor subunit gamma,Fc receptor gamma-chain;Fc-epsilon RI-gamma;IgE Fc receptor subunit gamma;, PF02189;PF11628;, GO:0009986;GO:0009897;GO:0032998;GO:0101003;GO:0005887;GO:0005886;GO:0070821;GO:0042802;GO:0019863;GO:0019767;GO:0019864;GO:0042590;GO:0019886;GO:0007596;GO:0071404;GO:0042742;GO:0002431;GO:0038095;GO:0038094;GO:0016064;GO:0045087;GO:0038156;GO:0050900;GO:0002283;GO:0030593;GO:0043312;GO:0030168;GO:0032753;GO:0050766;GO:0031623;GO:0010543;GO:0002223;GO:0002292;, C:cell surface; C:external side of plasma membrane; C:Fc-epsilon receptor I complex; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:plasma membrane; C:tertiary granule membrane;, F:identical protein binding; F:IgE binding; F:IgE receptor activity; F:IgG binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:blood coagulation; P:cellular response to low-density lipoprotein particle stimulus; P:defense response to bacterium; P:Fc receptor mediated stimulatory signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway; P:immunoglobulin mediated immune response; P:innate immune response; P:interleukin-3-mediated signaling pathway; P:leukocyte migration; P:neutrophil activation involved in immune response; P:neutrophil chemotaxis; P:neutrophil degranulation; P:platelet activation; P:positive regulation of interleukin-4 production; P:positive regulation of phagocytosis; P:receptor internalization; P:regulation of platelet activation; P:stimulatory C-type lectin receptor signaling pathway; P:T cell differentiation involved in immune response;|P30273 Q5VTW4,High affinity immunoglobulin epsilon receptor subunit gamma,Fc receptor gamma-chain;Fc-epsilon RI-gamma;IgE Fc receptor subunit gamma;, PF02189;PF11628;, GO:0009986;GO:0009897;GO:0032998;GO:0101003;GO:0005887;GO:0005886;GO:0070821;GO:0042802;GO:0019863;GO:0019767;GO:0019864;GO:0042590;GO:0019886;GO:0007596;GO:0071404;GO:0042742;GO:0002431;GO:0038095;GO:0038094;GO:0016064;GO:0045087;GO:0038156;GO:0050900;GO:0002283;GO:0030593;GO:0043312;GO:0030168;GO:0032753;GO:0050766;GO:0031623;GO:0010543;GO:0002223;GO:0002292;, C:cell surface; C:external side of plasma membrane; C:Fc-epsilon receptor I complex; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:plasma membrane; C:tertiary granule membrane;, F:identical protein binding; F:IgE binding; F:IgE receptor activity; F:IgG binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:blood coagulation; P:cellular response to low-density lipoprotein particle stimulus; P:defense response to bacterium; P:Fc receptor mediated stimulatory signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway; P:immunoglobulin mediated immune response; P:innate immune response; P:interleukin-3-mediated signaling pathway; P:leukocyte migration; P:neutrophil activation involved in immune response; P:neutrophil chemotaxis; P:neutrophil degranulation; P:platelet activation; P:positive regulation of interleukin-4 production; P:positive regulation of phagocytosis; P:receptor internalization; P:regulation of platelet activation; P:stimulatory C-type lectin receptor signaling pathway; P:T cell differentiation involved in immune response; scaffold49 indexed_genome mRNA 8824540 8826088 . - . ID=transcript_9367;P02652 B2R524,Apolipoprotein A-II,Apolipoprotein A2;, PF04711;, GO:0072562;GO:0042627;GO:0005829;GO:0005769;GO:0005788;GO:0070062;GO:0005576;GO:0034364;GO:0034366;GO:0034361;GO:0034190;GO:0015485;GO:0031072;GO:0008035;GO:0070653;GO:0055102;GO:0008289;GO:0005319;GO:0031210;GO:0060228;GO:0005543;GO:0046982;GO:0042803;GO:0005102;GO:0044267;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0034378;GO:0034371;GO:0046340;GO:0034380;GO:0034384;GO:0034375;GO:0120009;GO:0042157;GO:0034374;GO:0060621;GO:0032375;GO:0060695;GO:0002719;GO:0060192;GO:0050995;GO:0010903;GO:0018206;GO:0006656;GO:0009395;GO:0033700;GO:0010873;GO:0032757;GO:0050996;GO:0050766;GO:0043687;GO:0018158;GO:0050821;GO:0019222;GO:0031647;GO:0009749;GO:0001523;GO:0043691;GO:0006641;GO:0034370;GO:0016032;, C:blood microparticle; C:chylomicron; C:cytosol; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:high-density lipoprotein particle; C:spherical high-density lipoprotein particle; C:very-low-density lipoprotein particle;, F:apolipoprotein receptor binding; F:cholesterol binding; F:heat shock protein binding; F:high-density lipoprotein particle binding; F:high-density lipoprotein particle receptor binding; F:lipase inhibitor activity; F:lipid binding; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine-sterol O-acyltransferase activator activity; F:phospholipid binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:signaling receptor binding;, P:cellular protein metabolic process; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:chylomicron assembly; P:chylomicron remodeling; P:diacylglycerol catabolic process; P:high-density lipoprotein particle assembly; P:high-density lipoprotein particle clearance; P:high-density lipoprotein particle remodeling; P:intermembrane lipid transfer; P:lipoprotein metabolic process; P:low-density lipoprotein particle remodeling; P:negative regulation of cholesterol import; P:negative regulation of cholesterol transport; P:negative regulation of cholesterol transporter activity; P:negative regulation of cytokine production involved in immune response; P:negative regulation of lipase activity; P:negative regulation of lipid catabolic process; P:negative regulation of very-low-density lipoprotein particle remodeling; P:peptidyl-methionine modification; P:phosphatidylcholine biosynthetic process; P:phospholipid catabolic process; P:phospholipid efflux; P:positive regulation of cholesterol esterification; P:positive regulation of interleukin-8 production; P:positive regulation of lipid catabolic process; P:positive regulation of phagocytosis; P:post-translational protein modification; P:protein oxidation; P:protein stabilization; P:regulation of metabolic process; P:regulation of protein stability; P:response to glucose; P:retinoid metabolic process; P:reverse cholesterol transport; P:triglyceride metabolic process; P:triglyceride-rich lipoprotein particle remodeling; P:viral process;|P02652 B2R524,Apolipoprotein A-II,Apolipoprotein A2;, PF04711;, GO:0072562;GO:0042627;GO:0005829;GO:0005769;GO:0005788;GO:0070062;GO:0005576;GO:0034364;GO:0034366;GO:0034361;GO:0034190;GO:0015485;GO:0031072;GO:0008035;GO:0070653;GO:0055102;GO:0008289;GO:0005319;GO:0031210;GO:0060228;GO:0005543;GO:0046982;GO:0042803;GO:0005102;GO:0044267;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0034378;GO:0034371;GO:0046340;GO:0034380;GO:0034384;GO:0034375;GO:0120009;GO:0042157;GO:0034374;GO:0060621;GO:0032375;GO:0060695;GO:0002719;GO:0060192;GO:0050995;GO:0010903;GO:0018206;GO:0006656;GO:0009395;GO:0033700;GO:0010873;GO:0032757;GO:0050996;GO:0050766;GO:0043687;GO:0018158;GO:0050821;GO:0019222;GO:0031647;GO:0009749;GO:0001523;GO:0043691;GO:0006641;GO:0034370;GO:0016032;, C:blood microparticle; C:chylomicron; C:cytosol; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:high-density lipoprotein particle; C:spherical high-density lipoprotein particle; C:very-low-density lipoprotein particle;, F:apolipoprotein receptor binding; F:cholesterol binding; F:heat shock protein binding; F:high-density lipoprotein particle binding; F:high-density lipoprotein particle receptor binding; F:lipase inhibitor activity; F:lipid binding; F:lipid transporter activity; F:phosphatidylcholine binding; F:phosphatidylcholine-sterol O-acyltransferase activator activity; F:phospholipid binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:signaling receptor binding;, P:cellular protein metabolic process; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:chylomicron assembly; P:chylomicron remodeling; P:diacylglycerol catabolic process; P:high-density lipoprotein particle assembly; P:high-density lipoprotein particle clearance; P:high-density lipoprotein particle remodeling; P:intermembrane lipid transfer; P:lipoprotein metabolic process; P:low-density lipoprotein particle remodeling; P:negative regulation of cholesterol import; P:negative regulation of cholesterol transport; P:negative regulation of cholesterol transporter activity; P:negative regulation of cytokine production involved in immune response; P:negative regulation of lipase activity; P:negative regulation of lipid catabolic process; P:negative regulation of very-low-density lipoprotein particle remodeling; P:peptidyl-methionine modification; P:phosphatidylcholine biosynthetic process; P:phospholipid catabolic process; P:phospholipid efflux; P:positive regulation of cholesterol esterification; P:positive regulation of interleukin-8 production; P:positive regulation of lipid catabolic process; P:positive regulation of phagocytosis; P:post-translational protein modification; P:protein oxidation; P:protein stabilization; P:regulation of metabolic process; P:regulation of protein stability; P:response to glucose; P:retinoid metabolic process; P:reverse cholesterol transport; P:triglyceride metabolic process; P:triglyceride-rich lipoprotein particle remodeling; P:viral process; scaffold49 indexed_genome mRNA 8827252 8836408 . + . ID=transcript_9368;Q969M1 B7Z4U0 D3DVG9,Mitochondrial import receptor subunit TOM40B,Protein TOMM40-like;, PF01459;, GO:0005742;GO:0046930;GO:0032991;GO:0030943;GO:0015288;GO:0070678;GO:0008320;GO:0030150;, C:mitochondrial outer membrane translocase complex; C:pore complex; C:protein-containing complex;, F:mitochondrion targeting sequence binding; F:porin activity; F:preprotein binding; F:protein transmembrane transporter activity;, P:protein import into mitochondrial matrix;|Q969M1 B7Z4U0 D3DVG9,Mitochondrial import receptor subunit TOM40B,Protein TOMM40-like;, PF01459;, GO:0005742;GO:0046930;GO:0032991;GO:0030943;GO:0015288;GO:0070678;GO:0008320;GO:0030150;, C:mitochondrial outer membrane translocase complex; C:pore complex; C:protein-containing complex;, F:mitochondrion targeting sequence binding; F:porin activity; F:preprotein binding; F:protein transmembrane transporter activity;, P:protein import into mitochondrial matrix;|Q969M1 B7Z4U0 D3DVG9,Mitochondrial import receptor subunit TOM40B,Protein TOMM40-like;, PF01459;, GO:0005742;GO:0046930;GO:0032991;GO:0030943;GO:0015288;GO:0070678;GO:0008320;GO:0030150;, C:mitochondrial outer membrane translocase complex; C:pore complex; C:protein-containing complex;, F:mitochondrion targeting sequence binding; F:porin activity; F:preprotein binding; F:protein transmembrane transporter activity;, P:protein import into mitochondrial matrix;|Q969M1 B7Z4U0 D3DVG9,Mitochondrial import receptor subunit TOM40B,Protein TOMM40-like;, PF01459;, GO:0005742;GO:0046930;GO:0032991;GO:0030943;GO:0015288;GO:0070678;GO:0008320;GO:0030150;, C:mitochondrial outer membrane translocase complex; C:pore complex; C:protein-containing complex;, F:mitochondrion targeting sequence binding; F:porin activity; F:preprotein binding; F:protein transmembrane transporter activity;, P:protein import into mitochondrial matrix;|Q6GZ79 Q6GZ82 Q6GZ83 Q6GZ84 Q6GZ85 Q6GZ87 Q6GZ89,Nuclear receptor subfamily 1 group I member 3,Constitutive activator of retinoid response;Constitutive androstane receptor;Orphan nuclear receptor MB67;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0000978;GO:0000977;GO:1990837;GO:0008270;GO:0030154;GO:0000122;GO:0045944;GO:0007165;GO:0006367;, C:chromatin; C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; scaffold49 indexed_genome mRNA 8848362 8876170 . + . ID=transcript_9369;A6NKN8 B2RV24 B9EJG4,Purkinje cell protein 4-like protein 1|A6NKN8 B2RV24 B9EJG4,Purkinje cell protein 4-like protein 1 scaffold49 indexed_genome mRNA 8889883 8894834 . - . ID=transcript_9370;P25189 Q16072 Q5VTH4 Q92677 Q9BR67,Myelin protein P0,Myelin peripheral protein;Myelin protein zero;, PF10570;PF07686;, GO:0005887;GO:0043209;GO:0005886;GO:0045202;GO:0005198;GO:0098743;GO:0098742;GO:0007268;GO:0042552;GO:0007399;, C:integral component of plasma membrane; C:myelin sheath; C:plasma membrane; C:synapse;, F:structural molecule activity;, P:cell aggregation; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:chemical synaptic transmission; P:myelination; P:nervous system development; scaffold49 indexed_genome mRNA 8897983 8961140 . + . ID=transcript_9371;Q99643 O75609 Q3C259 Q3C2D8 Q3C2H4 Q5VTH3,Succinate dehydrogenase cytochrome b560 subunit, mitochondrial,Integral membrane protein CII-3;QPs-1;Succinate dehydrogenase complex subunit C;Succinate-ubiquinone oxidoreductase cytochrome B large subunit;, PF01127;, GO:0016021;GO:0005743;GO:0005749;GO:0005739;GO:0045273;GO:0009055;GO:0020037;GO:0046872;GO:0000104;GO:0009060;GO:0006121;GO:0006099;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:respiratory chain complex II;, F:electron transfer activity; F:heme binding; F:metal ion binding; F:succinate dehydrogenase activity;, P:aerobic respiration; P:mitochondrial electron transport, succinate to ubiquinone; P:tricarboxylic acid cycle;|Q99643 O75609 Q3C259 Q3C2D8 Q3C2H4 Q5VTH3,Succinate dehydrogenase cytochrome b560 subunit, mitochondrial,Integral membrane protein CII-3;QPs-1;Succinate dehydrogenase complex subunit C;Succinate-ubiquinone oxidoreductase cytochrome B large subunit;, PF01127;, GO:0016021;GO:0005743;GO:0005749;GO:0005739;GO:0045273;GO:0009055;GO:0020037;GO:0046872;GO:0000104;GO:0009060;GO:0006121;GO:0006099;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:respiratory chain complex II;, F:electron transfer activity; F:heme binding; F:metal ion binding; F:succinate dehydrogenase activity;, P:aerobic respiration; P:mitochondrial electron transport, succinate to ubiquinone; P:tricarboxylic acid cycle; scaffold49 indexed_genome mRNA 9076771 9079217 . + . ID=transcript_9372;P17066 Q1HBA8 Q8IYK7 Q9BT95,Heat shock 70 kDa protein 6,Heat shock 70 kDa protein B';, PF00012;, GO:0072562;GO:0005814;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0005886;GO:0034774;GO:0005524;GO:0016887;GO:0019899;GO:0031072;GO:0051787;GO:0044183;GO:0031625;GO:0051082;GO:0034605;GO:0034620;GO:0051085;GO:0043312;GO:0042026;GO:0006986;GO:0016192;, C:blood microparticle; C:centriole; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:plasma membrane; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:enzyme binding; F:heat shock protein binding; F:misfolded protein binding; F:protein folding chaperone; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:cellular response to heat; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:neutrophil degranulation; P:protein refolding; P:response to unfolded protein; P:vesicle-mediated transport; scaffold49 indexed_genome mRNA 9095654 9106563 . - . ID=transcript_9373;P08637 A2N6W9 Q53FJ0 Q53FL6 Q5EBR4 Q65ZM6 Q6PIJ0,Low affinity immunoglobulin gamma Fc region receptor III-A,CD16a antigen;Fc-gamma RIII-alpha;FcR-10;IgG Fc receptor III-2;, PF13895;, GO:0009897;GO:0070062;GO:0005887;GO:0005886;GO:0019864;GO:0004888;GO:0007166;GO:0038096;GO:0006955;GO:0002862;GO:0018149;GO:0050776;, C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:IgG binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:peptide cross-linking; P:regulation of immune response; scaffold49 indexed_genome mRNA 9168798 9185010 . + . ID=transcript_9374;P31994 A6H8N3 O95649 Q53X85 Q5VXA9 Q8NIA1,Low affinity immunoglobulin gamma Fc region receptor II-b,CDw32;Fc-gamma RII-b;, PF13895;, GO:0044297;GO:0043197;GO:0009897;GO:0005887;GO:0005886;GO:0001540;GO:0019864;GO:0019772;GO:0044877;GO:0004888;GO:0019886;GO:0007166;GO:1904646;GO:0071219;GO:0021549;GO:0006952;GO:0038096;GO:0002316;GO:0002266;GO:0002436;GO:0006955;GO:0016064;GO:0006954;GO:0002313;GO:0002865;GO:0001814;GO:0050869;GO:0030889;GO:0050859;GO:0001818;GO:0043318;GO:0002605;GO:2001199;GO:0002924;GO:0050777;GO:0002638;GO:0032693;GO:0043031;GO:1902564;GO:0050765;GO:0001811;GO:0006911;GO:0002922;GO:0046330;GO:1901216;GO:0050766;GO:1905898;GO:0006898;GO:0002819;GO:0002622;GO:1902950;GO:0090264;GO:0050776;GO:0045088;GO:0010469;GO:0009617;GO:0007165;GO:0016032;, C:cell body; C:dendritic spine; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amyloid-beta binding; F:IgG binding; F:low-affinity IgG receptor activity; F:protein-containing complex binding; F:transmembrane signaling receptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell surface receptor signaling pathway; P:cellular response to amyloid-beta; P:cellular response to molecule of bacterial origin; P:cerebellum development; P:defense response; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:follicular B cell differentiation; P:follicular dendritic cell activation; P:immune complex clearance by monocytes and macrophages; P:immune response; P:immunoglobulin mediated immune response; P:inflammatory response; P:mature B cell differentiation involved in immune response; P:negative regulation of acute inflammatory response to antigenic stimulus; P:negative regulation of antibody-dependent cellular cytotoxicity; P:negative regulation of B cell activation; P:negative regulation of B cell proliferation; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of cytokine production; P:negative regulation of cytotoxic T cell degranulation; P:negative regulation of dendritic cell antigen processing and presentation; P:negative regulation of dendritic cell differentiation; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; P:negative regulation of immune response; P:negative regulation of immunoglobulin production; P:negative regulation of interleukin-10 production; P:negative regulation of macrophage activation; P:negative regulation of neutrophil activation; P:negative regulation of phagocytosis; P:negative regulation of type I hypersensitivity; P:phagocytosis, engulfment; P:positive regulation of humoral immune response; P:positive regulation of JNK cascade; P:positive regulation of neuron death; P:positive regulation of phagocytosis; P:positive regulation of response to endoplasmic reticulum stress; P:receptor-mediated endocytosis; P:regulation of adaptive immune response; P:regulation of B cell antigen processing and presentation; P:regulation of dendritic spine maintenance; P:regulation of immune complex clearance by monocytes and macrophages; P:regulation of immune response; P:regulation of innate immune response; P:regulation of signaling receptor activity; P:response to bacterium; P:signal transduction; P:viral process;|P31995 O00523 O00524 O00525,Low affinity immunoglobulin gamma Fc region receptor II-c,CDw32;Fc-gamma RII-c;, PF13895;, GO:0005737;GO:0016021;GO:0005887;GO:0019864;GO:0004888;GO:0007166;GO:0006955;GO:0050776;, C:cytoplasm; C:integral component of membrane; C:integral component of plasma membrane;, F:IgG binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:immune response; P:regulation of immune response;|P31994 A6H8N3 O95649 Q53X85 Q5VXA9 Q8NIA1,Low affinity immunoglobulin gamma Fc region receptor II-b,CDw32;Fc-gamma RII-b;, PF13895;, GO:0044297;GO:0043197;GO:0009897;GO:0005887;GO:0005886;GO:0001540;GO:0019864;GO:0019772;GO:0044877;GO:0004888;GO:0019886;GO:0007166;GO:1904646;GO:0071219;GO:0021549;GO:0006952;GO:0038096;GO:0002316;GO:0002266;GO:0002436;GO:0006955;GO:0016064;GO:0006954;GO:0002313;GO:0002865;GO:0001814;GO:0050869;GO:0030889;GO:0050859;GO:0001818;GO:0043318;GO:0002605;GO:2001199;GO:0002924;GO:0050777;GO:0002638;GO:0032693;GO:0043031;GO:1902564;GO:0050765;GO:0001811;GO:0006911;GO:0002922;GO:0046330;GO:1901216;GO:0050766;GO:1905898;GO:0006898;GO:0002819;GO:0002622;GO:1902950;GO:0090264;GO:0050776;GO:0045088;GO:0010469;GO:0009617;GO:0007165;GO:0016032;, C:cell body; C:dendritic spine; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amyloid-beta binding; F:IgG binding; F:low-affinity IgG receptor activity; F:protein-containing complex binding; F:transmembrane signaling receptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell surface receptor signaling pathway; P:cellular response to amyloid-beta; P:cellular response to molecule of bacterial origin; P:cerebellum development; P:defense response; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:follicular B cell differentiation; P:follicular dendritic cell activation; P:immune complex clearance by monocytes and macrophages; P:immune response; P:immunoglobulin mediated immune response; P:inflammatory response; P:mature B cell differentiation involved in immune response; P:negative regulation of acute inflammatory response to antigenic stimulus; P:negative regulation of antibody-dependent cellular cytotoxicity; P:negative regulation of B cell activation; P:negative regulation of B cell proliferation; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of cytokine production; P:negative regulation of cytotoxic T cell degranulation; P:negative regulation of dendritic cell antigen processing and presentation; P:negative regulation of dendritic cell differentiation; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; P:negative regulation of immune response; P:negative regulation of immunoglobulin production; P:negative regulation of interleukin-10 production; P:negative regulation of macrophage activation; P:negative regulation of neutrophil activation; P:negative regulation of phagocytosis; P:negative regulation of type I hypersensitivity; P:phagocytosis, engulfment; P:positive regulation of humoral immune response; P:positive regulation of JNK cascade; P:positive regulation of neuron death; P:positive regulation of phagocytosis; P:positive regulation of response to endoplasmic reticulum stress; P:receptor-mediated endocytosis; P:regulation of adaptive immune response; P:regulation of B cell antigen processing and presentation; P:regulation of dendritic spine maintenance; P:regulation of immune complex clearance by monocytes and macrophages; P:regulation of immune response; P:regulation of innate immune response; P:regulation of signaling receptor activity; P:response to bacterium; P:signal transduction; P:viral process; scaffold49 indexed_genome mRNA 9245399 9256083 . + . ID=transcript_9375;Q9UNI6 Q5VXA8,Dual specificity protein phosphatase 12,Dual specificity tyrosine phosphatase YVH1;, , GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019900;GO:0016791;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0008270;GO:0006464;GO:0016311;GO:0033133;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:kinase binding; F:phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:zinc ion binding;, P:cellular protein modification process; P:dephosphorylation; P:positive regulation of glucokinase activity; P:protein dephosphorylation;|Q9UNI6 Q5VXA8,Dual specificity protein phosphatase 12,Dual specificity tyrosine phosphatase YVH1;, , GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019900;GO:0016791;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0008270;GO:0006464;GO:0016311;GO:0033133;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:kinase binding; F:phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:zinc ion binding;, P:cellular protein modification process; P:dephosphorylation; P:positive regulation of glucokinase activity; P:protein dephosphorylation; scaffold49 indexed_genome mRNA 9258698 9493981 . + . ID=transcript_9376;P18850 O15139 Q5VW62 Q6IPB5 Q9UEC9,Cyclic AMP-dependent transcription factor ATF-6 alpha,Activating transcription factor 6 alpha;, PF00170;, GO:0000785;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0030176;GO:0016020;GO:0005635;GO:0005654;GO:0005634;GO:0035497;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0046982;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0000976;GO:0036500;GO:0030968;GO:0001654;GO:0043065;GO:1903893;GO:0010508;GO:0045944;GO:1990440;GO:0006457;GO:0006357;GO:0007165;GO:0007601;, C:chromatin; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:ATF6-mediated unfolded protein response; P:endoplasmic reticulum unfolded protein response; P:eye development; P:positive regulation of apoptotic process; P:positive regulation of ATF6-mediated unfolded protein response; P:positive regulation of autophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:protein folding; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:visual perception; scaffold49 indexed_genome mRNA 9530160 9574805 . - . ID=transcript_9377;Q68BL8 B7ZA39 Q5VU96 Q6NX46 Q86X11 Q9Y3X6,Olfactomedin-like protein 2B,Photomedin-2;, PF02191;, GO:0005576;, C:extracellular region;|Q68BL8 B7ZA39 Q5VU96 Q6NX46 Q86X11 Q9Y3X6,Olfactomedin-like protein 2B,Photomedin-2;, PF02191;, GO:0005576;, C:extracellular region; scaffold49 indexed_genome mRNA 9966802 9974196 . + . ID=transcript_9378;O75052 B7ZLF5 O43564 Q3T551 Q5VU95,Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein,C-terminal PDZ ligand of neuronal nitric oxide synthase protein;Nitric oxide synthase 1 adaptor protein;, PF00640;, GO:0005901;GO:0005829;GO:0098978;GO:0005739;GO:0005634;GO:0048471;GO:0042383;GO:0033017;GO:0030315;GO:0030018;GO:0050998;GO:1902261;GO:0010628;GO:0045429;GO:0010750;GO:0051000;GO:2000170;GO:1901381;GO:1903762;GO:0098974;GO:1902514;GO:0098901;GO:0003062;GO:1901841;GO:0045428;GO:0050999;GO:0060307;, C:caveola; C:cytosol; C:glutamatergic synapse; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:sarcolemma; C:sarcoplasmic reticulum membrane; C:T-tubule; C:Z disc;, F:nitric-oxide synthase binding;, P:positive regulation of delayed rectifier potassium channel activity; P:positive regulation of gene expression; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric oxide mediated signal transduction; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:postsynaptic actin cytoskeleton organization; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac muscle cell action potential; P:regulation of heart rate by chemical signal; P:regulation of high voltage-gated calcium channel activity; P:regulation of nitric oxide biosynthetic process; P:regulation of nitric-oxide synthase activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; scaffold49 indexed_genome mRNA 9981260 9984979 . + . ID=transcript_9379;A1L170 B4DF31,Uncharacterized protein C1orf226,, PF15429; scaffold49 indexed_genome mRNA 9998229 10026053 . - . ID=transcript_9380;O14796 B2RBN6 Q5T0L1 Q8NI18 Q969K9,SH2 domain-containing protein 1B,EWS/FLI1-activated transcript 2;, PF00017;, GO:0005829;GO:0030674;GO:0002250;GO:0045087;GO:0002366;GO:0045089;GO:0002717;GO:0050776;, C:cytosol;, F:protein-macromolecule adaptor activity;, P:adaptive immune response; P:innate immune response; P:leukocyte activation involved in immune response; P:positive regulation of innate immune response; P:positive regulation of natural killer cell mediated immunity; P:regulation of immune response; scaffold49 indexed_genome mRNA 10084434 10105488 . + . ID=transcript_9381;Q8TAS1 A0A0A6YYC2 A8K8K4 G3V1M1 Q96C22,Serine/threonine-protein kinase Kist,Kinase interacting with stathmin;PAM COOH-terminal interactor protein 2;U2AF homology motif kinase 1;, PF00069;PF00076;, GO:0030424;GO:0032839;GO:0005794;GO:0030496;GO:0071598;GO:0005654;GO:0005634;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0043021;GO:0003723;GO:0016740;GO:0007050;GO:0031175;GO:0018105;GO:0045948;GO:0046777;GO:0046825;, C:axon; C:dendrite cytoplasm; C:Golgi apparatus; C:midbody; C:neuronal ribonucleoprotein granule; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribonucleoprotein complex binding; F:RNA binding; F:transferase activity;, P:cell cycle arrest; P:neuron projection development; P:peptidyl-serine phosphorylation; P:positive regulation of translational initiation; P:protein autophosphorylation; P:regulation of protein export from nucleus; scaffold49 indexed_genome mRNA 10142514 10169577 . + . ID=transcript_9382;Q16222 B2R6R8 Q5VTA9 Q5VTB0 Q5VTB1 Q96GM2,UDP-N-acetylhexosamine pyrophosphorylase,Antigen X;Sperm-associated antigen 2;, PF01704;, GO:0005829;GO:0005654;GO:0005886;GO:0030246;GO:0042802;GO:0052630;GO:0003977;GO:0006048;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:carbohydrate binding; F:identical protein binding; F:UDP-N-acetylgalactosamine diphosphorylase activity; F:UDP-N-acetylglucosamine diphosphorylase activity;, P:UDP-N-acetylglucosamine biosynthetic process;|Q16222 B2R6R8 Q5VTA9 Q5VTB0 Q5VTB1 Q96GM2,UDP-N-acetylhexosamine pyrophosphorylase,Antigen X;Sperm-associated antigen 2;, PF01704;, GO:0005829;GO:0005654;GO:0005886;GO:0030246;GO:0042802;GO:0052630;GO:0003977;GO:0006048;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:carbohydrate binding; F:identical protein binding; F:UDP-N-acetylgalactosamine diphosphorylase activity; F:UDP-N-acetylglucosamine diphosphorylase activity;, P:UDP-N-acetylglucosamine biosynthetic process; scaffold49 indexed_genome mRNA 10169769 10173995 . - . ID=transcript_9383;Q16222 B2R6R8 Q5VTA9 Q5VTB0 Q5VTB1 Q96GM2,UDP-N-acetylhexosamine pyrophosphorylase,Antigen X;Sperm-associated antigen 2;, PF01704;, GO:0005829;GO:0005654;GO:0005886;GO:0030246;GO:0042802;GO:0052630;GO:0003977;GO:0006048;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:carbohydrate binding; F:identical protein binding; F:UDP-N-acetylgalactosamine diphosphorylase activity; F:UDP-N-acetylglucosamine diphosphorylase activity;, P:UDP-N-acetylglucosamine biosynthetic process; scaffold49 indexed_genome mRNA 10174059 10175338 . + . ID=transcript_9384;Q16222 B2R6R8 Q5VTA9 Q5VTB0 Q5VTB1 Q96GM2,UDP-N-acetylhexosamine pyrophosphorylase,Antigen X;Sperm-associated antigen 2;, PF01704;, GO:0005829;GO:0005654;GO:0005886;GO:0030246;GO:0042802;GO:0052630;GO:0003977;GO:0006048;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:carbohydrate binding; F:identical protein binding; F:UDP-N-acetylgalactosamine diphosphorylase activity; F:UDP-N-acetylglucosamine diphosphorylase activity;, P:UDP-N-acetylglucosamine biosynthetic process; scaffold49 indexed_genome mRNA 10369754 10400580 . + . ID=transcript_9385;Q16832 Q7Z730,Discoidin domain-containing receptor 2,CD167 antigen-like family member B;Discoidin domain-containing receptor tyrosine kinase 2;Neurotrophic tyrosine kinase, receptor-related 3;Receptor protein-tyrosine kinase TKT;Tyrosine-protein kinase TYRO10;, PF00754;PF07714;, GO:0015629;GO:0016324;GO:0005925;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0005518;GO:0038062;GO:0004714;GO:0031214;GO:0007155;GO:0035988;GO:0030199;GO:0038063;GO:0003416;GO:0030198;GO:0007275;GO:0001503;GO:0018108;GO:0051091;GO:0090091;GO:0010763;GO:0048146;GO:0033674;GO:0045669;GO:0045860;GO:0046777;GO:0030500;GO:0010715;GO:0034103;GO:0007165;GO:0007169;, C:actin cytoskeleton; C:apical plasma membrane; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:collagen binding; F:protein tyrosine kinase collagen receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:biomineral tissue development; P:cell adhesion; P:chondrocyte proliferation; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:endochondral bone growth; P:extracellular matrix organization; P:multicellular organism development; P:ossification; P:peptidyl-tyrosine phosphorylation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of extracellular matrix disassembly; P:positive regulation of fibroblast migration; P:positive regulation of fibroblast proliferation; P:positive regulation of kinase activity; P:positive regulation of osteoblast differentiation; P:positive regulation of protein kinase activity; P:protein autophosphorylation; P:regulation of bone mineralization; P:regulation of extracellular matrix disassembly; P:regulation of tissue remodeling; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold49 indexed_genome mRNA 10405118 10432540 . + . ID=transcript_9386;P56937 Q5T246 Q7Z4V9 Q8WWS2 Q9UF00,3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 {ECO:0000305},17-beta-hydroxysteroid dehydrogenase 7;3-keto-steroid reductase;Dihydrotestosterone oxidoreductase;Estradiol 17-beta-dehydrogenase 7;Short chain dehydrogenase/reductase family 37C member 1;, PF00106;, GO:0005783;GO:0005789;GO:0016021;GO:0072582;GO:0000253;GO:0047024;GO:0004303;GO:0008209;GO:0006695;GO:0006703;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3-keto sterol reductase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:estradiol 17-beta-dehydrogenase activity;, P:androgen metabolic process; P:cholesterol biosynthetic process; P:estrogen biosynthetic process;|P56937 Q5T246 Q7Z4V9 Q8WWS2 Q9UF00,3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 {ECO:0000305},17-beta-hydroxysteroid dehydrogenase 7;3-keto-steroid reductase;Dihydrotestosterone oxidoreductase;Estradiol 17-beta-dehydrogenase 7;Short chain dehydrogenase/reductase family 37C member 1;, PF00106;, GO:0005783;GO:0005789;GO:0016021;GO:0072582;GO:0000253;GO:0047024;GO:0004303;GO:0008209;GO:0006695;GO:0006703;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3-keto sterol reductase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:estradiol 17-beta-dehydrogenase activity;, P:androgen metabolic process; P:cholesterol biosynthetic process; P:estrogen biosynthetic process;|P56937 Q5T246 Q7Z4V9 Q8WWS2 Q9UF00,3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 {ECO:0000305},17-beta-hydroxysteroid dehydrogenase 7;3-keto-steroid reductase;Dihydrotestosterone oxidoreductase;Estradiol 17-beta-dehydrogenase 7;Short chain dehydrogenase/reductase family 37C member 1;, PF00106;, GO:0005783;GO:0005789;GO:0016021;GO:0072582;GO:0000253;GO:0047024;GO:0004303;GO:0008209;GO:0006695;GO:0006703;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3-keto sterol reductase activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:estradiol 17-beta-dehydrogenase activity;, P:androgen metabolic process; P:cholesterol biosynthetic process; P:estrogen biosynthetic process; scaffold49 indexed_genome mRNA 10478266 10485751 . - . ID=transcript_9387;Q86UF4 Q5JSG1 Q6ZW57,Coiled-coil domain-containing protein 190,, PF15768; scaffold49 indexed_genome mRNA 10731243 10738253 . + . ID=transcript_9388;P49798 A7XA56 A7XA58 A7XA59 A7YVV7 B1APZ3,Regulator of G-protein signaling 4,, PF00615;, GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0032991;GO:0005516;GO:0001965;GO:0005096;GO:0007420;GO:1990791;GO:0007186;GO:0000188;GO:0061052;GO:0060160;GO:0045744;GO:1900924;GO:1901380;GO:2000463;GO:0010460;GO:0110053;GO:0051924;GO:0008277;GO:0001975;GO:0042220;GO:0045471;GO:0043278;, C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:calmodulin binding; F:G-protein alpha-subunit binding; F:GTPase activator activity;, P:brain development; P:dorsal root ganglion development; P:G protein-coupled receptor signaling pathway; P:inactivation of MAPK activity; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of dopamine receptor signaling pathway; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of glycine import across plasma membrane; P:negative regulation of potassium ion transmembrane transport; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of heart rate; P:regulation of actin filament organization; P:regulation of calcium ion transport; P:regulation of G protein-coupled receptor signaling pathway; P:response to amphetamine; P:response to cocaine; P:response to ethanol; P:response to morphine; scaffold49 indexed_genome mRNA 11017628 11056152 . + . ID=transcript_9389;Q9BZD4 Q8WU69 Q96HJ4 Q96Q78,Kinetochore protein Nuf2,Cell division cycle-associated protein 1;, PF03800;, GO:0000775;GO:0000778;GO:0005829;GO:0000776;GO:0016020;GO:0031262;GO:0005654;GO:0044877;GO:0051315;GO:0051301;GO:0007059;GO:0051383;GO:0045132;GO:0007052;, C:chromosome, centromeric region; C:condensed nuclear chromosome kinetochore; C:cytosol; C:kinetochore; C:membrane; C:Ndc80 complex; C:nucleoplasm;, F:protein-containing complex binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore organization; P:meiotic chromosome segregation; P:mitotic spindle organization;|Q9BZD4 Q8WU69 Q96HJ4 Q96Q78,Kinetochore protein Nuf2,Cell division cycle-associated protein 1;, PF03800;, GO:0000775;GO:0000778;GO:0005829;GO:0000776;GO:0016020;GO:0031262;GO:0005654;GO:0044877;GO:0051315;GO:0051301;GO:0007059;GO:0051383;GO:0045132;GO:0007052;, C:chromosome, centromeric region; C:condensed nuclear chromosome kinetochore; C:cytosol; C:kinetochore; C:membrane; C:Ndc80 complex; C:nucleoplasm;, F:protein-containing complex binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore organization; P:meiotic chromosome segregation; P:mitotic spindle organization; scaffold49 indexed_genome mRNA 12398359 12687558 . + . ID=transcript_9390;P40424 B4DSC1 F5H4U9 Q5T488,Pre-B-cell leukemia transcription factor 1,Homeobox protein PBX1;Homeobox protein PRL;, PF00046;PF03792;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0090575;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0030325;GO:0009887;GO:0009952;GO:0007420;GO:0001658;GO:0035162;GO:0030326;GO:0048568;GO:0048706;GO:0001654;GO:0043433;GO:0045665;GO:0048666;GO:0008284;GO:0010971;GO:0007221;GO:0009954;GO:0030278;GO:0006357;GO:0007548;GO:0035019;GO:0048536;GO:0006694;GO:0048538;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:adrenal gland development; P:animal organ morphogenesis; P:anterior/posterior pattern specification; P:brain development; P:branching involved in ureteric bud morphogenesis; P:embryonic hemopoiesis; P:embryonic limb morphogenesis; P:embryonic organ development; P:embryonic skeletal system development; P:eye development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron differentiation; P:neuron development; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of transcription of Notch receptor target; P:proximal/distal pattern formation; P:regulation of ossification; P:regulation of transcription by RNA polymerase II; P:sex differentiation; P:somatic stem cell population maintenance; P:spleen development; P:steroid biosynthetic process; P:thymus development; scaffold49 indexed_genome mRNA 13250735 13301599 . + . ID=transcript_9391;P48443 A6NIP1 Q6IBU7,Retinoic acid receptor RXR-gamma,Nuclear receptor subfamily 2 group B member 3;Retinoid X receptor gamma;, PF00104;PF11825;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0090575;GO:0000981;GO:0004879;GO:0044323;GO:0000978;GO:1990837;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0045944;GO:0006357;GO:0032526;GO:0048384;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; scaffold49 indexed_genome mRNA 13540320 13561909 . + . ID=transcript_9392;O14880 B2R592 Q6ICN4,Microsomal glutathione S-transferase 3 {ECO:0000305},Glutathione peroxidase MGST3 {ECO:0000305|PubMed:9278457};LTC4 synthase MGST3 {ECO:0000305|PubMed:9278457};Microsomal glutathione S-transferase III {ECO:0000303|PubMed:9278457};, PF01124;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005635;GO:0004602;GO:0042802;GO:0004464;GO:0016740;GO:0046222;GO:1901687;GO:0019370;GO:0006629;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope;, F:glutathione peroxidase activity; F:identical protein binding; F:leukotriene-C4 synthase activity; F:transferase activity;, P:aflatoxin metabolic process; P:glutathione derivative biosynthetic process; P:leukotriene biosynthetic process; P:lipid metabolic process;|O14880 B2R592 Q6ICN4,Microsomal glutathione S-transferase 3 {ECO:0000305},Glutathione peroxidase MGST3 {ECO:0000305|PubMed:9278457};LTC4 synthase MGST3 {ECO:0000305|PubMed:9278457};Microsomal glutathione S-transferase III {ECO:0000303|PubMed:9278457};, PF01124;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005635;GO:0004602;GO:0042802;GO:0004464;GO:0016740;GO:0046222;GO:1901687;GO:0019370;GO:0006629;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope;, F:glutathione peroxidase activity; F:identical protein binding; F:leukotriene-C4 synthase activity; F:transferase activity;, P:aflatoxin metabolic process; P:glutathione derivative biosynthetic process; P:leukotriene biosynthetic process; P:lipid metabolic process;|O14880 B2R592 Q6ICN4,Microsomal glutathione S-transferase 3 {ECO:0000305},Glutathione peroxidase MGST3 {ECO:0000305|PubMed:9278457};LTC4 synthase MGST3 {ECO:0000305|PubMed:9278457};Microsomal glutathione S-transferase III {ECO:0000303|PubMed:9278457};, PF01124;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005635;GO:0004602;GO:0042802;GO:0004464;GO:0016740;GO:0046222;GO:1901687;GO:0019370;GO:0006629;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope;, F:glutathione peroxidase activity; F:identical protein binding; F:leukotriene-C4 synthase activity; F:transferase activity;, P:aflatoxin metabolic process; P:glutathione derivative biosynthetic process; P:leukotriene biosynthetic process; P:lipid metabolic process;|O14880 B2R592 Q6ICN4,Microsomal glutathione S-transferase 3 {ECO:0000305},Glutathione peroxidase MGST3 {ECO:0000305|PubMed:9278457};LTC4 synthase MGST3 {ECO:0000305|PubMed:9278457};Microsomal glutathione S-transferase III {ECO:0000303|PubMed:9278457};, PF01124;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005635;GO:0004602;GO:0042802;GO:0004464;GO:0016740;GO:0046222;GO:1901687;GO:0019370;GO:0006629;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope;, F:glutathione peroxidase activity; F:identical protein binding; F:leukotriene-C4 synthase activity; F:transferase activity;, P:aflatoxin metabolic process; P:glutathione derivative biosynthetic process; P:leukotriene biosynthetic process; P:lipid metabolic process;|O14880 B2R592 Q6ICN4,Microsomal glutathione S-transferase 3 {ECO:0000305},Glutathione peroxidase MGST3 {ECO:0000305|PubMed:9278457};LTC4 synthase MGST3 {ECO:0000305|PubMed:9278457};Microsomal glutathione S-transferase III {ECO:0000303|PubMed:9278457};, PF01124;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005635;GO:0004602;GO:0042802;GO:0004464;GO:0016740;GO:0046222;GO:1901687;GO:0019370;GO:0006629;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope;, F:glutathione peroxidase activity; F:identical protein binding; F:leukotriene-C4 synthase activity; F:transferase activity;, P:aflatoxin metabolic process; P:glutathione derivative biosynthetic process; P:leukotriene biosynthetic process; P:lipid metabolic process; scaffold49 indexed_genome mRNA 13574852 13577857 . - . ID=transcript_9393;P49189 B2R6X1 B4DXY7 B9EKV4 Q5VV90 Q6LCL1 Q9NZT7,4-trimethylaminobutyraldehyde dehydrogenase,Aldehyde dehydrogenase E3 isozyme {ECO:0000303|PubMed:8645224};Aldehyde dehydrogenase family 9 member A1;Gamma-aminobutyraldehyde dehydrogenase {ECO:0000303|PubMed:10702312};R-aminobutyraldehyde dehydrogenase;, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0033737;GO:0047105;GO:0004029;GO:0019145;GO:0043878;GO:0045329;GO:0006081;GO:0042445;GO:0042136;GO:0051289;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:1-pyrroline dehydrogenase activity; F:4-trimethylammoniobutyraldehyde dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:aminobutyraldehyde dehydrogenase activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity;, P:carnitine biosynthetic process; P:cellular aldehyde metabolic process; P:hormone metabolic process; P:neurotransmitter biosynthetic process; P:protein homotetramerization;|P49189 B2R6X1 B4DXY7 B9EKV4 Q5VV90 Q6LCL1 Q9NZT7,4-trimethylaminobutyraldehyde dehydrogenase,Aldehyde dehydrogenase E3 isozyme {ECO:0000303|PubMed:8645224};Aldehyde dehydrogenase family 9 member A1;Gamma-aminobutyraldehyde dehydrogenase {ECO:0000303|PubMed:10702312};R-aminobutyraldehyde dehydrogenase;, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0033737;GO:0047105;GO:0004029;GO:0019145;GO:0043878;GO:0045329;GO:0006081;GO:0042445;GO:0042136;GO:0051289;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:1-pyrroline dehydrogenase activity; F:4-trimethylammoniobutyraldehyde dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:aminobutyraldehyde dehydrogenase activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity;, P:carnitine biosynthetic process; P:cellular aldehyde metabolic process; P:hormone metabolic process; P:neurotransmitter biosynthetic process; P:protein homotetramerization; scaffold49 indexed_genome mRNA 13580511 13604499 . - . ID=transcript_9394;P49189 B2R6X1 B4DXY7 B9EKV4 Q5VV90 Q6LCL1 Q9NZT7,4-trimethylaminobutyraldehyde dehydrogenase,Aldehyde dehydrogenase E3 isozyme {ECO:0000303|PubMed:8645224};Aldehyde dehydrogenase family 9 member A1;Gamma-aminobutyraldehyde dehydrogenase {ECO:0000303|PubMed:10702312};R-aminobutyraldehyde dehydrogenase;, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0033737;GO:0047105;GO:0004029;GO:0019145;GO:0043878;GO:0045329;GO:0006081;GO:0042445;GO:0042136;GO:0051289;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:1-pyrroline dehydrogenase activity; F:4-trimethylammoniobutyraldehyde dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:aminobutyraldehyde dehydrogenase activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity;, P:carnitine biosynthetic process; P:cellular aldehyde metabolic process; P:hormone metabolic process; P:neurotransmitter biosynthetic process; P:protein homotetramerization;|P49189 B2R6X1 B4DXY7 B9EKV4 Q5VV90 Q6LCL1 Q9NZT7,4-trimethylaminobutyraldehyde dehydrogenase,Aldehyde dehydrogenase E3 isozyme {ECO:0000303|PubMed:8645224};Aldehyde dehydrogenase family 9 member A1;Gamma-aminobutyraldehyde dehydrogenase {ECO:0000303|PubMed:10702312};R-aminobutyraldehyde dehydrogenase;, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0033737;GO:0047105;GO:0004029;GO:0019145;GO:0043878;GO:0045329;GO:0006081;GO:0042445;GO:0042136;GO:0051289;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:1-pyrroline dehydrogenase activity; F:4-trimethylammoniobutyraldehyde dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:aminobutyraldehyde dehydrogenase activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity;, P:carnitine biosynthetic process; P:cellular aldehyde metabolic process; P:hormone metabolic process; P:neurotransmitter biosynthetic process; P:protein homotetramerization; scaffold49 indexed_genome mRNA 13629015 13696942 . - . ID=transcript_9395;Q9UM00 B2REA0 J9JIE6 O75545 Q9BZS3 Q9BZU8,Calcium load-activated calcium channel {ECO:0000305|PubMed:27212239},Transmembrane and coiled-coil domain-containing protein 1 {ECO:0000305};Transmembrane and coiled-coil domains protein 4 {ECO:0000305};Xenogeneic cross-immune protein PCIA3 {ECO:0000303|Ref.2};, PF01956;, GO:0005737;GO:0005783;GO:0000139;GO:0030176;GO:0005262;GO:0070588;GO:0006874;GO:0032469;GO:0006983;, C:cytoplasm; C:endoplasmic reticulum; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane;, F:calcium channel activity;, P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:endoplasmic reticulum calcium ion homeostasis; P:ER overload response;|Q9UM00 B2REA0 J9JIE6 O75545 Q9BZS3 Q9BZU8,Calcium load-activated calcium channel {ECO:0000305|PubMed:27212239},Transmembrane and coiled-coil domain-containing protein 1 {ECO:0000305};Transmembrane and coiled-coil domains protein 4 {ECO:0000305};Xenogeneic cross-immune protein PCIA3 {ECO:0000303|Ref.2};, PF01956;, GO:0005737;GO:0005783;GO:0000139;GO:0030176;GO:0005262;GO:0070588;GO:0006874;GO:0032469;GO:0006983;, C:cytoplasm; C:endoplasmic reticulum; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane;, F:calcium channel activity;, P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:endoplasmic reticulum calcium ion homeostasis; P:ER overload response; scaffold49 indexed_genome mRNA 13826721 13827338 . + . ID=transcript_9396;Q9BZX2 Q5VV91 Q7KZV3 Q92528 Q96KG5 Q9BU42,Uridine-cytidine kinase 2,Cytidine monophosphokinase 2;Testis-specific protein TSA903;Uridine monophosphokinase 2;, PF00485;, GO:0005829;GO:0005524;GO:0042802;GO:0016301;GO:0004849;GO:0044211;GO:0043097;GO:0044206;, C:cytosol;, F:ATP binding; F:identical protein binding; F:kinase activity; F:uridine kinase activity;, P:CTP salvage; P:pyrimidine nucleoside salvage; P:UMP salvage; scaffold49 indexed_genome mRNA 14007292 14116650 . - . ID=transcript_9397;Q5VT40 B7Z693,Protein FAM78B scaffold49 indexed_genome mRNA 14430257 14431769 . - . ID=transcript_9398;Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport; scaffold49 indexed_genome mRNA 14434001 14454635 . - . ID=transcript_9399;Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport;|Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport; scaffold49 indexed_genome mRNA 14480996 14508411 . + . ID=transcript_9400;O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold49 indexed_genome mRNA 14643547 14665780 . - . ID=transcript_9401;O95562 A8K2R0 Q6UWR8,Vesicle transport protein SFT2B,SFT2 domain-containing protein 2;, PF04178;, GO:0070062;GO:0016021;GO:0015031;GO:0016192;, C:extracellular exosome; C:integral component of membrane;, , P:protein transport; P:vesicle-mediated transport; scaffold49 indexed_genome mRNA 14683309 14746133 . - . ID=transcript_9402;O75663 B2R8V3 Q5HYB2 Q8IZ86,TIP41-like protein,Putative MAPK-activating protein PM10;Type 2A-interacting protein;, PF04176;, GO:0005829;GO:0000077;GO:0032515;GO:0043666;GO:0031929;, C:cytosol;, , P:DNA damage checkpoint; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of phosphoprotein phosphatase activity; P:TOR signaling;|O75663 B2R8V3 Q5HYB2 Q8IZ86,TIP41-like protein,Putative MAPK-activating protein PM10;Type 2A-interacting protein;, PF04176;, GO:0005829;GO:0000077;GO:0032515;GO:0043666;GO:0031929;, C:cytosol;, , P:DNA damage checkpoint; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of phosphoprotein phosphatase activity; P:TOR signaling;|O75663 B2R8V3 Q5HYB2 Q8IZ86,TIP41-like protein,Putative MAPK-activating protein PM10;Type 2A-interacting protein;, PF04176;, GO:0005829;GO:0000077;GO:0032515;GO:0043666;GO:0031929;, C:cytosol;, , P:DNA damage checkpoint; P:negative regulation of phosphoprotein phosphatase activity; P:regulation of phosphoprotein phosphatase activity; P:TOR signaling; scaffold49 indexed_genome mRNA 14812718 14840695 . + . ID=transcript_9403;Q5TGK1 Q5TGK2,G-protein coupled receptor 161,G-protein coupled receptor RE2;, PF00001;, GO:0060170;GO:0005929;GO:0030666;GO:0016021;GO:0055037;GO:0004930;GO:0007189;GO:0007186;GO:0007275;GO:1901621;, C:ciliary membrane; C:cilium; C:endocytic vesicle membrane; C:integral component of membrane; C:recycling endosome;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning;|Q5TGK1 Q5TGK2,G-protein coupled receptor 161,G-protein coupled receptor RE2;, PF00001;, GO:0060170;GO:0005929;GO:0030666;GO:0016021;GO:0055037;GO:0004930;GO:0007189;GO:0007186;GO:0007275;GO:1901621;, C:ciliary membrane; C:cilium; C:endocytic vesicle membrane; C:integral component of membrane; C:recycling endosome;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; scaffold49 indexed_genome mRNA 14847382 14919430 . - . ID=transcript_9404;Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination;|Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination;|Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination;|Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination;|Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination;|Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination;|Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination;|Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination; scaffold49 indexed_genome mRNA 14929508 15030715 . - . ID=transcript_9405;Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination;|Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination;|Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination;|Q96AT9 A8K4S0 B4E016 C9JPQ7 O43767 Q53TV9 Q8N215 Q96N34 Q9BSB5,Ribulose-phosphate 3-epimerase,Ribulose-5-phosphate-3-epimerase;, PF00834;, GO:0005829;GO:0070062;GO:0042802;GO:0046872;GO:0042803;GO:0004750;GO:0005975;GO:0044262;GO:0019323;GO:0006098;GO:0009052;, C:cytosol; C:extracellular exosome;, F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:ribulose-phosphate 3-epimerase activity;, P:carbohydrate metabolic process; P:cellular carbohydrate metabolic process; P:pentose catabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch;|Q58WW2 A2A295 B4DNB8 Q7L8I0 Q8IXH3 Q8TB19,DDB1- and CUL4-associated factor 6,Androgen receptor complex-associated protein;IQ motif and WD repeat-containing protein 1;Nuclear receptor interaction protein;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0030374;GO:0045944;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity;, P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination; scaffold49 indexed_genome mRNA 15051081 15054468 . + . ID=transcript_9406;O95563 A8K261 Q3SXR6 Q6FIF3,Mitochondrial pyruvate carrier 2,Brain protein 44;, PF03650;, GO:0031305;GO:0005739;GO:0005634;GO:0042802;GO:0050833;GO:0061732;GO:0006850;GO:0035774;, C:integral component of mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:identical protein binding; F:pyruvate transmembrane transporter activity;, P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:mitochondrial pyruvate transmembrane transport; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; scaffold49 indexed_genome mRNA 15073689 15074784 . - . ID=transcript_9407;Q96PN6 B4DZF0 F5GWS5 O95558 Q5R329 Q5R330 Q8WXV4 Q9NNX0,Adenylate cyclase type 10,AH-related protein;Adenylate cyclase homolog;Germ cell soluble adenylyl cyclase {ECO:0000303|PubMed:11423534};Testicular soluble adenylyl cyclase;, PF00211;, GO:0016324;GO:0045178;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005576;GO:0030426;GO:0005739;GO:0043025;GO:0005634;GO:0048471;GO:0004016;GO:0005524;GO:0051117;GO:0071890;GO:0000287;GO:0030145;GO:0006171;GO:0071241;GO:0003351;GO:0035556;GO:0043065;GO:0007283;, C:apical plasma membrane; C:basal part of cell; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:extracellular region; C:growth cone; C:mitochondrion; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm;, F:adenylate cyclase activity; F:ATP binding; F:ATPase binding; F:bicarbonate binding; F:magnesium ion binding; F:manganese ion binding;, P:cAMP biosynthetic process; P:cellular response to inorganic substance; P:epithelial cilium movement involved in extracellular fluid movement; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:spermatogenesis; scaffold49 indexed_genome mRNA 15123814 15124465 . + . ID=transcript_9408;Q96PN6 B4DZF0 F5GWS5 O95558 Q5R329 Q5R330 Q8WXV4 Q9NNX0,Adenylate cyclase type 10,AH-related protein;Adenylate cyclase homolog;Germ cell soluble adenylyl cyclase {ECO:0000303|PubMed:11423534};Testicular soluble adenylyl cyclase;, PF00211;, GO:0016324;GO:0045178;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005576;GO:0030426;GO:0005739;GO:0043025;GO:0005634;GO:0048471;GO:0004016;GO:0005524;GO:0051117;GO:0071890;GO:0000287;GO:0030145;GO:0006171;GO:0071241;GO:0003351;GO:0035556;GO:0043065;GO:0007283;, C:apical plasma membrane; C:basal part of cell; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:extracellular region; C:growth cone; C:mitochondrion; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm;, F:adenylate cyclase activity; F:ATP binding; F:ATPase binding; F:bicarbonate binding; F:magnesium ion binding; F:manganese ion binding;, P:cAMP biosynthetic process; P:cellular response to inorganic substance; P:epithelial cilium movement involved in extracellular fluid movement; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:spermatogenesis; scaffold49 indexed_genome mRNA 15151747 15153189 . + . ID=transcript_9409;Q96PN6 B4DZF0 F5GWS5 O95558 Q5R329 Q5R330 Q8WXV4 Q9NNX0,Adenylate cyclase type 10,AH-related protein;Adenylate cyclase homolog;Germ cell soluble adenylyl cyclase {ECO:0000303|PubMed:11423534};Testicular soluble adenylyl cyclase;, PF00211;, GO:0016324;GO:0045178;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0030425;GO:0005576;GO:0030426;GO:0005739;GO:0043025;GO:0005634;GO:0048471;GO:0004016;GO:0005524;GO:0051117;GO:0071890;GO:0000287;GO:0030145;GO:0006171;GO:0071241;GO:0003351;GO:0035556;GO:0043065;GO:0007283;, C:apical plasma membrane; C:basal part of cell; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite; C:extracellular region; C:growth cone; C:mitochondrion; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm;, F:adenylate cyclase activity; F:ATP binding; F:ATPase binding; F:bicarbonate binding; F:magnesium ion binding; F:manganese ion binding;, P:cAMP biosynthetic process; P:cellular response to inorganic substance; P:epithelial cilium movement involved in extracellular fluid movement; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:spermatogenesis; scaffold49 indexed_genome mRNA 15177596 15204966 . + . ID=transcript_9410;O95297 B2REB9 B2REC0 Q5R332 Q8IX11 Q9BWZ3 Q9NYK4 Q9UL20,Myelin protein zero-like protein 1,Protein zero-related;, PF07686;, GO:0009986;GO:0005925;GO:0005887;GO:0005198;GO:0007267;GO:0007169;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane;, F:structural molecule activity;, P:cell-cell signaling; P:transmembrane receptor protein tyrosine kinase signaling pathway;|O95297 B2REB9 B2REC0 Q5R332 Q8IX11 Q9BWZ3 Q9NYK4 Q9UL20,Myelin protein zero-like protein 1,Protein zero-related;, PF07686;, GO:0009986;GO:0005925;GO:0005887;GO:0005198;GO:0007267;GO:0007169;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane;, F:structural molecule activity;, P:cell-cell signaling; P:transmembrane receptor protein tyrosine kinase signaling pathway;|O95297 B2REB9 B2REC0 Q5R332 Q8IX11 Q9BWZ3 Q9NYK4 Q9UL20,Myelin protein zero-like protein 1,Protein zero-related;, PF07686;, GO:0009986;GO:0005925;GO:0005887;GO:0005198;GO:0007267;GO:0007169;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane;, F:structural molecule activity;, P:cell-cell signaling; P:transmembrane receptor protein tyrosine kinase signaling pathway;|O95297 B2REB9 B2REC0 Q5R332 Q8IX11 Q9BWZ3 Q9NYK4 Q9UL20,Myelin protein zero-like protein 1,Protein zero-related;, PF07686;, GO:0009986;GO:0005925;GO:0005887;GO:0005198;GO:0007267;GO:0007169;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane;, F:structural molecule activity;, P:cell-cell signaling; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold49 indexed_genome mRNA 15391723 15395073 . - . ID=transcript_9411;P63132,Endogenous retrovirus group K member 113 Pol protein,HERV-K113 Pol protein;HERV-K_19p13.11 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold49 indexed_genome mRNA 15524677 15531618 . + . ID=transcript_9412;P20963 B1AK49 Q5VX13 Q8TAX4,T-cell surface glycoprotein CD3 zeta chain,T-cell receptor T3 zeta chain;, PF02189;PF11628;, GO:0042105;GO:0005737;GO:0005794;GO:0016021;GO:0005886;GO:0042101;GO:0042802;GO:1990782;GO:0004888;GO:0002250;GO:0038096;GO:0002862;GO:0018149;GO:2000010;GO:0050690;GO:0050776;GO:0050852;, C:alpha-beta T cell receptor complex; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:T cell receptor complex;, F:identical protein binding; F:protein tyrosine kinase binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of inflammatory response to antigenic stimulus; P:peptide cross-linking; P:positive regulation of protein localization to cell surface; P:regulation of defense response to virus by virus; P:regulation of immune response; P:T cell receptor signaling pathway;|P20963 B1AK49 Q5VX13 Q8TAX4,T-cell surface glycoprotein CD3 zeta chain,T-cell receptor T3 zeta chain;, PF02189;PF11628;, GO:0042105;GO:0005737;GO:0005794;GO:0016021;GO:0005886;GO:0042101;GO:0042802;GO:1990782;GO:0004888;GO:0002250;GO:0038096;GO:0002862;GO:0018149;GO:2000010;GO:0050690;GO:0050776;GO:0050852;, C:alpha-beta T cell receptor complex; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:T cell receptor complex;, F:identical protein binding; F:protein tyrosine kinase binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of inflammatory response to antigenic stimulus; P:peptide cross-linking; P:positive regulation of protein localization to cell surface; P:regulation of defense response to virus by virus; P:regulation of immune response; P:T cell receptor signaling pathway;|P20963 B1AK49 Q5VX13 Q8TAX4,T-cell surface glycoprotein CD3 zeta chain,T-cell receptor T3 zeta chain;, PF02189;PF11628;, GO:0042105;GO:0005737;GO:0005794;GO:0016021;GO:0005886;GO:0042101;GO:0042802;GO:1990782;GO:0004888;GO:0002250;GO:0038096;GO:0002862;GO:0018149;GO:2000010;GO:0050690;GO:0050776;GO:0050852;, C:alpha-beta T cell receptor complex; C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:T cell receptor complex;, F:identical protein binding; F:protein tyrosine kinase binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of inflammatory response to antigenic stimulus; P:peptide cross-linking; P:positive regulation of protein localization to cell surface; P:regulation of defense response to virus by virus; P:regulation of immune response; P:T cell receptor signaling pathway; scaffold49 indexed_genome mRNA 15544543 15578775 . - . ID=transcript_9413;P14859 B1AL91 B1AL93 B4E029 J3KP77 Q5TBT7 Q6PK46 Q8NEU9 Q9BPV1,POU domain, class 2, transcription factor 1,NF-A1;Octamer-binding protein 1;Octamer-binding transcription factor 1;, PF00046;PF00157;, GO:0000785;GO:0005783;GO:0043231;GO:0005654;GO:0005634;GO:0090575;GO:0003677;GO:0000981;GO:0042802;GO:0000978;GO:0000979;GO:0043565;GO:0019221;GO:0045892;GO:0045944;GO:0006357;GO:0042795;, C:chromatin; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II; scaffold49 indexed_genome mRNA 15580380 15740519 . - . ID=transcript_9414;P14859 B1AL91 B1AL93 B4E029 J3KP77 Q5TBT7 Q6PK46 Q8NEU9 Q9BPV1,POU domain, class 2, transcription factor 1,NF-A1;Octamer-binding protein 1;Octamer-binding transcription factor 1;, PF00046;PF00157;, GO:0000785;GO:0005783;GO:0043231;GO:0005654;GO:0005634;GO:0090575;GO:0003677;GO:0000981;GO:0042802;GO:0000978;GO:0000979;GO:0043565;GO:0019221;GO:0045892;GO:0045944;GO:0006357;GO:0042795;, C:chromatin; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II; scaffold49 indexed_genome mRNA 15862983 15925816 . - . ID=transcript_9415;Q5VZP5 A0AUM4 Q9C074,Serine/threonine/tyrosine-interacting-like protein 2,Inactive dual specificity phosphatase 27 {ECO:0000305};, , GO:0030017;GO:0008138;, C:sarcomere;, F:protein tyrosine/serine/threonine phosphatase activity;|Q5VZP5 A0AUM4 Q9C074,Serine/threonine/tyrosine-interacting-like protein 2,Inactive dual specificity phosphatase 27 {ECO:0000305};, , GO:0030017;GO:0008138;, C:sarcomere;, F:protein tyrosine/serine/threonine phosphatase activity;|Q5VZP5 A0AUM4 Q9C074,Serine/threonine/tyrosine-interacting-like protein 2,Inactive dual specificity phosphatase 27 {ECO:0000305};, , GO:0030017;GO:0008138;, C:sarcomere;, F:protein tyrosine/serine/threonine phosphatase activity; scaffold49 indexed_genome mRNA 16148920 16192762 . + . ID=transcript_9416;Q71H61,Immunoglobulin-like domain-containing receptor 2,, PF05624;, GO:0005789;GO:0016021;GO:0030154;GO:0048873;GO:0030073;GO:0031016;GO:0009749;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:cell differentiation; P:homeostasis of number of cells within a tissue; P:insulin secretion; P:pancreas development; P:response to glucose;|Q71H61,Immunoglobulin-like domain-containing receptor 2,, PF05624;, GO:0005789;GO:0016021;GO:0030154;GO:0048873;GO:0030073;GO:0031016;GO:0009749;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:cell differentiation; P:homeostasis of number of cells within a tissue; P:insulin secretion; P:pancreas development; P:response to glucose;|Q71H61,Immunoglobulin-like domain-containing receptor 2,, PF05624;, GO:0005789;GO:0016021;GO:0030154;GO:0048873;GO:0030073;GO:0031016;GO:0009749;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:cell differentiation; P:homeostasis of number of cells within a tissue; P:insulin secretion; P:pancreas development; P:response to glucose; scaffold49 indexed_genome mRNA 16243075 16262685 . + . ID=transcript_9417;Q96BN2 A8K4J9,Transcriptional adapter 1,SPT3-associated factor 42;Transcriptional adapter 1-like protein;, PF12767;, GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0003713;GO:0043966;GO:0006357;, C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of transcription by RNA polymerase II;|Q96BN2 A8K4J9,Transcriptional adapter 1,SPT3-associated factor 42;Transcriptional adapter 1-like protein;, PF12767;, GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0003713;GO:0043966;GO:0006357;, C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of transcription by RNA polymerase II;|Q96BN2 A8K4J9,Transcriptional adapter 1,SPT3-associated factor 42;Transcriptional adapter 1-like protein;, PF12767;, GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0003713;GO:0043966;GO:0006357;, C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of transcription by RNA polymerase II;|Q96BN2 A8K4J9,Transcriptional adapter 1,SPT3-associated factor 42;Transcriptional adapter 1-like protein;, PF12767;, GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0003713;GO:0043966;GO:0006357;, C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of transcription by RNA polymerase II;|Q96BN2 A8K4J9,Transcriptional adapter 1,SPT3-associated factor 42;Transcriptional adapter 1-like protein;, PF12767;, GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0003713;GO:0043966;GO:0006357;, C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of transcription by RNA polymerase II;|Q96BN2 A8K4J9,Transcriptional adapter 1,SPT3-associated factor 42;Transcriptional adapter 1-like protein;, PF12767;, GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0003713;GO:0043966;GO:0006357;, C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of transcription by RNA polymerase II;|Q96BN2 A8K4J9,Transcriptional adapter 1,SPT3-associated factor 42;Transcriptional adapter 1-like protein;, PF12767;, GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0003713;GO:0043966;GO:0006357;, C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of transcription by RNA polymerase II; scaffold50 indexed_genome mRNA 428718 455920 . + . ID=transcript_9418;Q5SR56 B4DUE6 E9PD58 Q3KQT4 Q53GU5 Q8WU95 Q96SM4,Hippocampus abundant transcript-like protein 1 {ECO:0000312|HGNC:HGNC:23376},Major facilitator superfamily domain-containing 14B {ECO:0000312|HGNC:HGNC:23376};, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q5SR56 B4DUE6 E9PD58 Q3KQT4 Q53GU5 Q8WU95 Q96SM4,Hippocampus abundant transcript-like protein 1 {ECO:0000312|HGNC:HGNC:23376},Major facilitator superfamily domain-containing 14B {ECO:0000312|HGNC:HGNC:23376};, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q5SR56 B4DUE6 E9PD58 Q3KQT4 Q53GU5 Q8WU95 Q96SM4,Hippocampus abundant transcript-like protein 1 {ECO:0000312|HGNC:HGNC:23376},Major facilitator superfamily domain-containing 14B {ECO:0000312|HGNC:HGNC:23376};, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q5SR56 B4DUE6 E9PD58 Q3KQT4 Q53GU5 Q8WU95 Q96SM4,Hippocampus abundant transcript-like protein 1 {ECO:0000312|HGNC:HGNC:23376},Major facilitator superfamily domain-containing 14B {ECO:0000312|HGNC:HGNC:23376};, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold50 indexed_genome mRNA 464623 465186 . - . ID=transcript_9419;Q9H8M1 B7Z1Y4,Coenzyme Q-binding protein COQ10 homolog B, mitochondrial,, PF03364;, GO:0005743;GO:0005739;GO:0048039;GO:0045333;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:ubiquinone binding;, P:cellular respiration; P:ubiquinone biosynthetic process; scaffold50 indexed_genome mRNA 774794 1112730 . + . ID=transcript_9420;Q9UQF5 Q9Y2J6 Q9Y3E9,Palladin,SIH002;Sarcoma antigen NY-SAR-77;, PF07679;, GO:0015629;GO:0005884;GO:0030424;GO:0005829;GO:0060076;GO:0005925;GO:0030426;GO:0030027;GO:0005634;GO:0005886;GO:0002102;GO:0001726;GO:0001725;GO:0030018;GO:0003779;GO:0098632;GO:0051371;GO:0030036;GO:0007411;GO:0016477;GO:0007010;GO:0070593;GO:0003382;GO:0007156;GO:0003334;, C:actin cytoskeleton; C:actin filament; C:axon; C:cytosol; C:excitatory synapse; C:focal adhesion; C:growth cone; C:lamellipodium; C:nucleus; C:plasma membrane; C:podosome; C:ruffle; C:stress fiber; C:Z disc;, F:actin binding; F:cell-cell adhesion mediator activity; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:axon guidance; P:cell migration; P:cytoskeleton organization; P:dendrite self-avoidance; P:epithelial cell morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinocyte development; scaffold50 indexed_genome mRNA 1115920 1137812 . + . ID=transcript_9421;Q9UQF5 Q9Y2J6 Q9Y3E9,Palladin,SIH002;Sarcoma antigen NY-SAR-77;, PF07679;, GO:0015629;GO:0005884;GO:0030424;GO:0005829;GO:0060076;GO:0005925;GO:0030426;GO:0030027;GO:0005634;GO:0005886;GO:0002102;GO:0001726;GO:0001725;GO:0030018;GO:0003779;GO:0098632;GO:0051371;GO:0030036;GO:0007411;GO:0016477;GO:0007010;GO:0070593;GO:0003382;GO:0007156;GO:0003334;, C:actin cytoskeleton; C:actin filament; C:axon; C:cytosol; C:excitatory synapse; C:focal adhesion; C:growth cone; C:lamellipodium; C:nucleus; C:plasma membrane; C:podosome; C:ruffle; C:stress fiber; C:Z disc;, F:actin binding; F:cell-cell adhesion mediator activity; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:axon guidance; P:cell migration; P:cytoskeleton organization; P:dendrite self-avoidance; P:epithelial cell morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinocyte development;|Q9UQF5 Q9Y2J6 Q9Y3E9,Palladin,SIH002;Sarcoma antigen NY-SAR-77;, PF07679;, GO:0015629;GO:0005884;GO:0030424;GO:0005829;GO:0060076;GO:0005925;GO:0030426;GO:0030027;GO:0005634;GO:0005886;GO:0002102;GO:0001726;GO:0001725;GO:0030018;GO:0003779;GO:0098632;GO:0051371;GO:0030036;GO:0007411;GO:0016477;GO:0007010;GO:0070593;GO:0003382;GO:0007156;GO:0003334;, C:actin cytoskeleton; C:actin filament; C:axon; C:cytosol; C:excitatory synapse; C:focal adhesion; C:growth cone; C:lamellipodium; C:nucleus; C:plasma membrane; C:podosome; C:ruffle; C:stress fiber; C:Z disc;, F:actin binding; F:cell-cell adhesion mediator activity; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:axon guidance; P:cell migration; P:cytoskeleton organization; P:dendrite self-avoidance; P:epithelial cell morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinocyte development;|Q9UQF5 Q9Y2J6 Q9Y3E9,Palladin,SIH002;Sarcoma antigen NY-SAR-77;, PF07679;, GO:0015629;GO:0005884;GO:0030424;GO:0005829;GO:0060076;GO:0005925;GO:0030426;GO:0030027;GO:0005634;GO:0005886;GO:0002102;GO:0001726;GO:0001725;GO:0030018;GO:0003779;GO:0098632;GO:0051371;GO:0030036;GO:0007411;GO:0016477;GO:0007010;GO:0070593;GO:0003382;GO:0007156;GO:0003334;, C:actin cytoskeleton; C:actin filament; C:axon; C:cytosol; C:excitatory synapse; C:focal adhesion; C:growth cone; C:lamellipodium; C:nucleus; C:plasma membrane; C:podosome; C:ruffle; C:stress fiber; C:Z disc;, F:actin binding; F:cell-cell adhesion mediator activity; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:axon guidance; P:cell migration; P:cytoskeleton organization; P:dendrite self-avoidance; P:epithelial cell morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinocyte development;|Q9UQF5 Q9Y2J6 Q9Y3E9,Palladin,SIH002;Sarcoma antigen NY-SAR-77;, PF07679;, GO:0015629;GO:0005884;GO:0030424;GO:0005829;GO:0060076;GO:0005925;GO:0030426;GO:0030027;GO:0005634;GO:0005886;GO:0002102;GO:0001726;GO:0001725;GO:0030018;GO:0003779;GO:0098632;GO:0051371;GO:0030036;GO:0007411;GO:0016477;GO:0007010;GO:0070593;GO:0003382;GO:0007156;GO:0003334;, C:actin cytoskeleton; C:actin filament; C:axon; C:cytosol; C:excitatory synapse; C:focal adhesion; C:growth cone; C:lamellipodium; C:nucleus; C:plasma membrane; C:podosome; C:ruffle; C:stress fiber; C:Z disc;, F:actin binding; F:cell-cell adhesion mediator activity; F:muscle alpha-actinin binding;, P:actin cytoskeleton organization; P:axon guidance; P:cell migration; P:cytoskeleton organization; P:dendrite self-avoidance; P:epithelial cell morphogenesis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:keratinocyte development; scaffold50 indexed_genome mRNA 1148295 1168864 . - . ID=transcript_9422;Q8N4T8 Q8WTW8 Q96K93,Carbonyl reductase family member 4,3-ketoacyl-[acyl-carrier-protein] reductase beta subunit {ECO:0000303|PubMed:25203508};3-oxoacyl-[acyl-carrier-protein] reductase;Quinone reductase CBR4 {ECO:0000305|PubMed:19000905};Short chain dehydrogenase/reductase family 45C member 1;, , GO:0005759;GO:1990204;GO:0047025;GO:0003955;GO:0070402;GO:0008753;GO:0016616;GO:0048038;GO:0044597;GO:0044598;GO:0006633;GO:0046949;GO:0051290;GO:0051289;, C:mitochondrial matrix; C:oxidoreductase complex;, F:3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity; F:NAD(P)H dehydrogenase (quinone) activity; F:NADPH binding; F:NADPH dehydrogenase (quinone) activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:quinone binding;, P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:protein heterotetramerization; P:protein homotetramerization;|Q8N4T8 Q8WTW8 Q96K93,Carbonyl reductase family member 4,3-ketoacyl-[acyl-carrier-protein] reductase beta subunit {ECO:0000303|PubMed:25203508};3-oxoacyl-[acyl-carrier-protein] reductase;Quinone reductase CBR4 {ECO:0000305|PubMed:19000905};Short chain dehydrogenase/reductase family 45C member 1;, , GO:0005759;GO:1990204;GO:0047025;GO:0003955;GO:0070402;GO:0008753;GO:0016616;GO:0048038;GO:0044597;GO:0044598;GO:0006633;GO:0046949;GO:0051290;GO:0051289;, C:mitochondrial matrix; C:oxidoreductase complex;, F:3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity; F:NAD(P)H dehydrogenase (quinone) activity; F:NADPH binding; F:NADPH dehydrogenase (quinone) activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:quinone binding;, P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:protein heterotetramerization; P:protein homotetramerization;|Q8N4T8 Q8WTW8 Q96K93,Carbonyl reductase family member 4,3-ketoacyl-[acyl-carrier-protein] reductase beta subunit {ECO:0000303|PubMed:25203508};3-oxoacyl-[acyl-carrier-protein] reductase;Quinone reductase CBR4 {ECO:0000305|PubMed:19000905};Short chain dehydrogenase/reductase family 45C member 1;, , GO:0005759;GO:1990204;GO:0047025;GO:0003955;GO:0070402;GO:0008753;GO:0016616;GO:0048038;GO:0044597;GO:0044598;GO:0006633;GO:0046949;GO:0051290;GO:0051289;, C:mitochondrial matrix; C:oxidoreductase complex;, F:3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity; F:NAD(P)H dehydrogenase (quinone) activity; F:NADPH binding; F:NADPH dehydrogenase (quinone) activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:quinone binding;, P:daunorubicin metabolic process; P:doxorubicin metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:protein heterotetramerization; P:protein homotetramerization; scaffold50 indexed_genome mRNA 1229589 1380632 . - . ID=transcript_9423;Q7Z6J0 Q05BT2 Q8IW46 Q9HAM2 Q9P234,E3 ubiquitin-protein ligase SH3RF1,Plenty of SH3s;RING finger protein 142;RING-type E3 ubiquitin transferase SH3RF1 {ECO:0000305};SH3 domain-containing RING finger protein 1;SH3 multiple domains protein 2;, PF00018;PF14604;, GO:0005829;GO:0005794;GO:0030027;GO:0048471;GO:0005078;GO:0046872;GO:0061630;GO:0043066;GO:0043154;GO:2001237;GO:0001764;GO:0046330;GO:0051865;GO:0043370;GO:2000564;GO:0016032;, C:cytosol; C:Golgi apparatus; C:lamellipodium; C:perinuclear region of cytoplasm;, F:MAP-kinase scaffold activity; F:metal ion binding; F:ubiquitin protein ligase activity;, P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:neuron migration; P:positive regulation of JNK cascade; P:protein autoubiquitination; P:regulation of CD4-positive, alpha-beta T cell differentiation; P:regulation of CD8-positive, alpha-beta T cell proliferation; P:viral process;|Q7Z6J0 Q05BT2 Q8IW46 Q9HAM2 Q9P234,E3 ubiquitin-protein ligase SH3RF1,Plenty of SH3s;RING finger protein 142;RING-type E3 ubiquitin transferase SH3RF1 {ECO:0000305};SH3 domain-containing RING finger protein 1;SH3 multiple domains protein 2;, PF00018;PF14604;, GO:0005829;GO:0005794;GO:0030027;GO:0048471;GO:0005078;GO:0046872;GO:0061630;GO:0043066;GO:0043154;GO:2001237;GO:0001764;GO:0046330;GO:0051865;GO:0043370;GO:2000564;GO:0016032;, C:cytosol; C:Golgi apparatus; C:lamellipodium; C:perinuclear region of cytoplasm;, F:MAP-kinase scaffold activity; F:metal ion binding; F:ubiquitin protein ligase activity;, P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:neuron migration; P:positive regulation of JNK cascade; P:protein autoubiquitination; P:regulation of CD4-positive, alpha-beta T cell differentiation; P:regulation of CD8-positive, alpha-beta T cell proliferation; P:viral process; scaffold50 indexed_genome mRNA 1466667 1599531 . - . ID=transcript_9424;Q96PY6 G5E9Z3 Q05DG5 Q14CB7 Q5H9T1 Q6PIB8 Q96SS2 Q9H6P7 Q9Y594,Serine/threonine-protein kinase Nek1,Never in mitosis A-related kinase 1;Renal carcinoma antigen NY-REN-55;, PF00069;, GO:0034451;GO:0005813;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000242;GO:0071889;GO:0005524;GO:0016301;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0004713;GO:0007049;GO:0051301;GO:0060271;GO:0042769;GO:0006468;, C:centriolar satellite; C:centrosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:pericentriolar material;, F:14-3-3 protein binding; F:ATP binding; F:kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:cell cycle; P:cell division; P:cilium assembly; P:DNA damage response, detection of DNA damage; P:protein phosphorylation;|Q96PY6 G5E9Z3 Q05DG5 Q14CB7 Q5H9T1 Q6PIB8 Q96SS2 Q9H6P7 Q9Y594,Serine/threonine-protein kinase Nek1,Never in mitosis A-related kinase 1;Renal carcinoma antigen NY-REN-55;, PF00069;, GO:0034451;GO:0005813;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000242;GO:0071889;GO:0005524;GO:0016301;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0004713;GO:0007049;GO:0051301;GO:0060271;GO:0042769;GO:0006468;, C:centriolar satellite; C:centrosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:pericentriolar material;, F:14-3-3 protein binding; F:ATP binding; F:kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:cell cycle; P:cell division; P:cilium assembly; P:DNA damage response, detection of DNA damage; P:protein phosphorylation;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold50 indexed_genome mRNA 1620338 1706696 . + . ID=transcript_9425;P51790 B7Z932 B9EGJ9 D3DP34 E9PB97 O14918 Q86Z21,H(+)/Cl(-) exchange transporter 3,Chloride channel protein 3;Chloride transporter ClC-3;, PF00571;PF00654;, GO:0043679;GO:0009986;GO:0031410;GO:0005769;GO:0031901;GO:0010008;GO:0009897;GO:0098982;GO:0098978;GO:0005794;GO:0000139;GO:0016021;GO:0005887;GO:0030285;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0016020;GO:0045335;GO:0005886;GO:0055037;GO:0032587;GO:0030141;GO:0042581;GO:0008021;GO:0012506;GO:0015297;GO:0005524;GO:0005254;GO:0030165;GO:0015299;GO:0005247;GO:0072320;GO:0008344;GO:1902476;GO:0048388;GO:0045794;GO:0006911;GO:0045494;GO:1903428;GO:0006885;GO:0051932;GO:0035249;GO:0097401;, C:axon terminus; C:cell surface; C:cytoplasmic vesicle; C:early endosome; C:early endosome membrane; C:endosome membrane; C:external side of plasma membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:phagocytic vesicle; C:plasma membrane; C:recycling endosome; C:ruffle membrane; C:secretory granule; C:specific granule; C:synaptic vesicle; C:vesicle membrane;, F:antiporter activity; F:ATP binding; F:chloride channel activity; F:PDZ domain binding; F:solute:proton antiporter activity; F:voltage-gated chloride channel activity; F:volume-sensitive chloride channel activity;, P:adult locomotory behavior; P:chloride transmembrane transport; P:endosomal lumen acidification; P:negative regulation of cell volume; P:phagocytosis, engulfment; P:photoreceptor cell maintenance; P:positive regulation of reactive oxygen species biosynthetic process; P:regulation of pH; P:synaptic transmission, GABAergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle lumen acidification;|P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold50 indexed_genome mRNA 1706748 1723910 . + . ID=transcript_9426;P51790 B7Z932 B9EGJ9 D3DP34 E9PB97 O14918 Q86Z21,H(+)/Cl(-) exchange transporter 3,Chloride channel protein 3;Chloride transporter ClC-3;, PF00571;PF00654;, GO:0043679;GO:0009986;GO:0031410;GO:0005769;GO:0031901;GO:0010008;GO:0009897;GO:0098982;GO:0098978;GO:0005794;GO:0000139;GO:0016021;GO:0005887;GO:0030285;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0016020;GO:0045335;GO:0005886;GO:0055037;GO:0032587;GO:0030141;GO:0042581;GO:0008021;GO:0012506;GO:0015297;GO:0005524;GO:0005254;GO:0030165;GO:0015299;GO:0005247;GO:0072320;GO:0008344;GO:1902476;GO:0048388;GO:0045794;GO:0006911;GO:0045494;GO:1903428;GO:0006885;GO:0051932;GO:0035249;GO:0097401;, C:axon terminus; C:cell surface; C:cytoplasmic vesicle; C:early endosome; C:early endosome membrane; C:endosome membrane; C:external side of plasma membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:phagocytic vesicle; C:plasma membrane; C:recycling endosome; C:ruffle membrane; C:secretory granule; C:specific granule; C:synaptic vesicle; C:vesicle membrane;, F:antiporter activity; F:ATP binding; F:chloride channel activity; F:PDZ domain binding; F:solute:proton antiporter activity; F:voltage-gated chloride channel activity; F:volume-sensitive chloride channel activity;, P:adult locomotory behavior; P:chloride transmembrane transport; P:endosomal lumen acidification; P:negative regulation of cell volume; P:phagocytosis, engulfment; P:photoreceptor cell maintenance; P:positive regulation of reactive oxygen species biosynthetic process; P:regulation of pH; P:synaptic transmission, GABAergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle lumen acidification;|P51790 B7Z932 B9EGJ9 D3DP34 E9PB97 O14918 Q86Z21,H(+)/Cl(-) exchange transporter 3,Chloride channel protein 3;Chloride transporter ClC-3;, PF00571;PF00654;, GO:0043679;GO:0009986;GO:0031410;GO:0005769;GO:0031901;GO:0010008;GO:0009897;GO:0098982;GO:0098978;GO:0005794;GO:0000139;GO:0016021;GO:0005887;GO:0030285;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0016020;GO:0045335;GO:0005886;GO:0055037;GO:0032587;GO:0030141;GO:0042581;GO:0008021;GO:0012506;GO:0015297;GO:0005524;GO:0005254;GO:0030165;GO:0015299;GO:0005247;GO:0072320;GO:0008344;GO:1902476;GO:0048388;GO:0045794;GO:0006911;GO:0045494;GO:1903428;GO:0006885;GO:0051932;GO:0035249;GO:0097401;, C:axon terminus; C:cell surface; C:cytoplasmic vesicle; C:early endosome; C:early endosome membrane; C:endosome membrane; C:external side of plasma membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:phagocytic vesicle; C:plasma membrane; C:recycling endosome; C:ruffle membrane; C:secretory granule; C:specific granule; C:synaptic vesicle; C:vesicle membrane;, F:antiporter activity; F:ATP binding; F:chloride channel activity; F:PDZ domain binding; F:solute:proton antiporter activity; F:voltage-gated chloride channel activity; F:volume-sensitive chloride channel activity;, P:adult locomotory behavior; P:chloride transmembrane transport; P:endosomal lumen acidification; P:negative regulation of cell volume; P:phagocytosis, engulfment; P:photoreceptor cell maintenance; P:positive regulation of reactive oxygen species biosynthetic process; P:regulation of pH; P:synaptic transmission, GABAergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle lumen acidification;|P51790 B7Z932 B9EGJ9 D3DP34 E9PB97 O14918 Q86Z21,H(+)/Cl(-) exchange transporter 3,Chloride channel protein 3;Chloride transporter ClC-3;, PF00571;PF00654;, GO:0043679;GO:0009986;GO:0031410;GO:0005769;GO:0031901;GO:0010008;GO:0009897;GO:0098982;GO:0098978;GO:0005794;GO:0000139;GO:0016021;GO:0005887;GO:0030285;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0016020;GO:0045335;GO:0005886;GO:0055037;GO:0032587;GO:0030141;GO:0042581;GO:0008021;GO:0012506;GO:0015297;GO:0005524;GO:0005254;GO:0030165;GO:0015299;GO:0005247;GO:0072320;GO:0008344;GO:1902476;GO:0048388;GO:0045794;GO:0006911;GO:0045494;GO:1903428;GO:0006885;GO:0051932;GO:0035249;GO:0097401;, C:axon terminus; C:cell surface; C:cytoplasmic vesicle; C:early endosome; C:early endosome membrane; C:endosome membrane; C:external side of plasma membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:phagocytic vesicle; C:plasma membrane; C:recycling endosome; C:ruffle membrane; C:secretory granule; C:specific granule; C:synaptic vesicle; C:vesicle membrane;, F:antiporter activity; F:ATP binding; F:chloride channel activity; F:PDZ domain binding; F:solute:proton antiporter activity; F:voltage-gated chloride channel activity; F:volume-sensitive chloride channel activity;, P:adult locomotory behavior; P:chloride transmembrane transport; P:endosomal lumen acidification; P:negative regulation of cell volume; P:phagocytosis, engulfment; P:photoreceptor cell maintenance; P:positive regulation of reactive oxygen species biosynthetic process; P:regulation of pH; P:synaptic transmission, GABAergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle lumen acidification;|P51790 B7Z932 B9EGJ9 D3DP34 E9PB97 O14918 Q86Z21,H(+)/Cl(-) exchange transporter 3,Chloride channel protein 3;Chloride transporter ClC-3;, PF00571;PF00654;, GO:0043679;GO:0009986;GO:0031410;GO:0005769;GO:0031901;GO:0010008;GO:0009897;GO:0098982;GO:0098978;GO:0005794;GO:0000139;GO:0016021;GO:0005887;GO:0030285;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0016020;GO:0045335;GO:0005886;GO:0055037;GO:0032587;GO:0030141;GO:0042581;GO:0008021;GO:0012506;GO:0015297;GO:0005524;GO:0005254;GO:0030165;GO:0015299;GO:0005247;GO:0072320;GO:0008344;GO:1902476;GO:0048388;GO:0045794;GO:0006911;GO:0045494;GO:1903428;GO:0006885;GO:0051932;GO:0035249;GO:0097401;, C:axon terminus; C:cell surface; C:cytoplasmic vesicle; C:early endosome; C:early endosome membrane; C:endosome membrane; C:external side of plasma membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:phagocytic vesicle; C:plasma membrane; C:recycling endosome; C:ruffle membrane; C:secretory granule; C:specific granule; C:synaptic vesicle; C:vesicle membrane;, F:antiporter activity; F:ATP binding; F:chloride channel activity; F:PDZ domain binding; F:solute:proton antiporter activity; F:voltage-gated chloride channel activity; F:volume-sensitive chloride channel activity;, P:adult locomotory behavior; P:chloride transmembrane transport; P:endosomal lumen acidification; P:negative regulation of cell volume; P:phagocytosis, engulfment; P:photoreceptor cell maintenance; P:positive regulation of reactive oxygen species biosynthetic process; P:regulation of pH; P:synaptic transmission, GABAergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle lumen acidification; scaffold50 indexed_genome mRNA 1728770 1738596 . - . ID=transcript_9427;Q9NWY4,Histone PARylation factor 1 {ECO:0000303|PubMed:27067600},, PF10228;, GO:0000785;GO:0005634;GO:0090734;GO:0003682;GO:0042393;GO:0072572;GO:0008270;GO:0006974;GO:0006302;GO:0018312;GO:0031056;GO:0010835;, C:chromatin; C:nucleus; C:site of DNA damage;, F:chromatin binding; F:histone binding; F:poly-ADP-D-ribose binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:peptidyl-serine ADP-ribosylation; P:regulation of histone modification; P:regulation of protein ADP-ribosylation;|Q9NWY4,Histone PARylation factor 1 {ECO:0000303|PubMed:27067600},, PF10228;, GO:0000785;GO:0005634;GO:0090734;GO:0003682;GO:0042393;GO:0072572;GO:0008270;GO:0006974;GO:0006302;GO:0018312;GO:0031056;GO:0010835;, C:chromatin; C:nucleus; C:site of DNA damage;, F:chromatin binding; F:histone binding; F:poly-ADP-D-ribose binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:peptidyl-serine ADP-ribosylation; P:regulation of histone modification; P:regulation of protein ADP-ribosylation;|Q9NWY4,Histone PARylation factor 1 {ECO:0000303|PubMed:27067600},, PF10228;, GO:0000785;GO:0005634;GO:0090734;GO:0003682;GO:0042393;GO:0072572;GO:0008270;GO:0006974;GO:0006302;GO:0018312;GO:0031056;GO:0010835;, C:chromatin; C:nucleus; C:site of DNA damage;, F:chromatin binding; F:histone binding; F:poly-ADP-D-ribose binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:peptidyl-serine ADP-ribosylation; P:regulation of histone modification; P:regulation of protein ADP-ribosylation; scaffold50 indexed_genome mRNA 1738627 1752553 . - . ID=transcript_9428;Q9NWY4,Histone PARylation factor 1 {ECO:0000303|PubMed:27067600},, PF10228;, GO:0000785;GO:0005634;GO:0090734;GO:0003682;GO:0042393;GO:0072572;GO:0008270;GO:0006974;GO:0006302;GO:0018312;GO:0031056;GO:0010835;, C:chromatin; C:nucleus; C:site of DNA damage;, F:chromatin binding; F:histone binding; F:poly-ADP-D-ribose binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:peptidyl-serine ADP-ribosylation; P:regulation of histone modification; P:regulation of protein ADP-ribosylation; scaffold50 indexed_genome mRNA 1905051 1910921 . - . ID=transcript_9429;O75121 A8K1X6 D3DP35 Q4W5N7 Q4W5N9 Q6TNA8 Q9BVE1 Q9BXK0,Microfibrillar-associated protein 3-like,Testis development protein NYD-SP9 {ECO:0000303|Ref.1};, PF07679;, GO:0030054;GO:0005737;GO:0016021;GO:0005654;GO:0005634;GO:0005886;, C:cell junction; C:cytoplasm; C:integral component of membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; scaffold50 indexed_genome mRNA 2020302 2041876 . - . ID=transcript_9430;Q8N5Z0 B3KP84 Q9UL02,Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial,2-aminoadipate aminotransferase;2-aminoadipate transaminase;Alpha-aminoadipate aminotransferase;Kynurenine aminotransferase II;Kynurenine--oxoglutarate aminotransferase II;Kynurenine--oxoglutarate transaminase 2;Kynurenine--oxoglutarate transaminase II;, PF00155;, GO:0005759;GO:0047536;GO:0016212;GO:0042803;GO:0030170;GO:0008483;GO:0006103;GO:1901605;GO:0009058;GO:0006536;GO:0070189;GO:0033512;GO:0006554;GO:0006569;, C:mitochondrial matrix;, F:2-aminoadipate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:2-oxoglutarate metabolic process; P:alpha-amino acid metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:kynurenine metabolic process; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:tryptophan catabolic process;|Q8N5Z0 B3KP84 Q9UL02,Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial,2-aminoadipate aminotransferase;2-aminoadipate transaminase;Alpha-aminoadipate aminotransferase;Kynurenine aminotransferase II;Kynurenine--oxoglutarate aminotransferase II;Kynurenine--oxoglutarate transaminase 2;Kynurenine--oxoglutarate transaminase II;, PF00155;, GO:0005759;GO:0047536;GO:0016212;GO:0042803;GO:0030170;GO:0008483;GO:0006103;GO:1901605;GO:0009058;GO:0006536;GO:0070189;GO:0033512;GO:0006554;GO:0006569;, C:mitochondrial matrix;, F:2-aminoadipate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:2-oxoglutarate metabolic process; P:alpha-amino acid metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:kynurenine metabolic process; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:tryptophan catabolic process;|Q8N5Z0 B3KP84 Q9UL02,Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial,2-aminoadipate aminotransferase;2-aminoadipate transaminase;Alpha-aminoadipate aminotransferase;Kynurenine aminotransferase II;Kynurenine--oxoglutarate aminotransferase II;Kynurenine--oxoglutarate transaminase 2;Kynurenine--oxoglutarate transaminase II;, PF00155;, GO:0005759;GO:0047536;GO:0016212;GO:0042803;GO:0030170;GO:0008483;GO:0006103;GO:1901605;GO:0009058;GO:0006536;GO:0070189;GO:0033512;GO:0006554;GO:0006569;, C:mitochondrial matrix;, F:2-aminoadipate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:2-oxoglutarate metabolic process; P:alpha-amino acid metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:kynurenine metabolic process; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:tryptophan catabolic process;|Q8N5Z0 B3KP84 Q9UL02,Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial,2-aminoadipate aminotransferase;2-aminoadipate transaminase;Alpha-aminoadipate aminotransferase;Kynurenine aminotransferase II;Kynurenine--oxoglutarate aminotransferase II;Kynurenine--oxoglutarate transaminase 2;Kynurenine--oxoglutarate transaminase II;, PF00155;, GO:0005759;GO:0047536;GO:0016212;GO:0042803;GO:0030170;GO:0008483;GO:0006103;GO:1901605;GO:0009058;GO:0006536;GO:0070189;GO:0033512;GO:0006554;GO:0006569;, C:mitochondrial matrix;, F:2-aminoadipate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:2-oxoglutarate metabolic process; P:alpha-amino acid metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:kynurenine metabolic process; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:tryptophan catabolic process;|Q8N5Z0 B3KP84 Q9UL02,Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial,2-aminoadipate aminotransferase;2-aminoadipate transaminase;Alpha-aminoadipate aminotransferase;Kynurenine aminotransferase II;Kynurenine--oxoglutarate aminotransferase II;Kynurenine--oxoglutarate transaminase 2;Kynurenine--oxoglutarate transaminase II;, PF00155;, GO:0005759;GO:0047536;GO:0016212;GO:0042803;GO:0030170;GO:0008483;GO:0006103;GO:1901605;GO:0009058;GO:0006536;GO:0070189;GO:0033512;GO:0006554;GO:0006569;, C:mitochondrial matrix;, F:2-aminoadipate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:2-oxoglutarate metabolic process; P:alpha-amino acid metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:kynurenine metabolic process; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:tryptophan catabolic process;|Q8N5Z0 B3KP84 Q9UL02,Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial,2-aminoadipate aminotransferase;2-aminoadipate transaminase;Alpha-aminoadipate aminotransferase;Kynurenine aminotransferase II;Kynurenine--oxoglutarate aminotransferase II;Kynurenine--oxoglutarate transaminase 2;Kynurenine--oxoglutarate transaminase II;, PF00155;, GO:0005759;GO:0047536;GO:0016212;GO:0042803;GO:0030170;GO:0008483;GO:0006103;GO:1901605;GO:0009058;GO:0006536;GO:0070189;GO:0033512;GO:0006554;GO:0006569;, C:mitochondrial matrix;, F:2-aminoadipate transaminase activity; F:kynurenine-oxoglutarate transaminase activity; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:2-oxoglutarate metabolic process; P:alpha-amino acid metabolic process; P:biosynthetic process; P:glutamate metabolic process; P:kynurenine metabolic process; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:tryptophan catabolic process; scaffold50 indexed_genome mRNA 5462647 5508036 . + . ID=transcript_9431;Q86SF2 B3KQU3 Q7Z5W7 Q9UJ28,N-acetylgalactosaminyltransferase 7,Polypeptide GalNAc transferase 7;Protein-UDP acetylgalactosaminyltransferase 7;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7;, PF00535;PF00652;, GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0030246;GO:0046872;GO:0004653;GO:0005975;GO:0016266;GO:0006493;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:O-glycan processing; P:protein O-linked glycosylation; scaffold50 indexed_genome mRNA 5508081 5527164 . + . ID=transcript_9432;Q86SF2 B3KQU3 Q7Z5W7 Q9UJ28,N-acetylgalactosaminyltransferase 7,Polypeptide GalNAc transferase 7;Protein-UDP acetylgalactosaminyltransferase 7;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7;, PF00535;PF00652;, GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0030246;GO:0046872;GO:0004653;GO:0005975;GO:0016266;GO:0006493;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:O-glycan processing; P:protein O-linked glycosylation;|Q86SF2 B3KQU3 Q7Z5W7 Q9UJ28,N-acetylgalactosaminyltransferase 7,Polypeptide GalNAc transferase 7;Protein-UDP acetylgalactosaminyltransferase 7;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7;, PF00535;PF00652;, GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0030246;GO:0046872;GO:0004653;GO:0005975;GO:0016266;GO:0006493;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:O-glycan processing; P:protein O-linked glycosylation;|Q86SF2 B3KQU3 Q7Z5W7 Q9UJ28,N-acetylgalactosaminyltransferase 7,Polypeptide GalNAc transferase 7;Protein-UDP acetylgalactosaminyltransferase 7;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7;, PF00535;PF00652;, GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0030246;GO:0046872;GO:0004653;GO:0005975;GO:0016266;GO:0006493;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:O-glycan processing; P:protein O-linked glycosylation;|Q86SF2 B3KQU3 Q7Z5W7 Q9UJ28,N-acetylgalactosaminyltransferase 7,Polypeptide GalNAc transferase 7;Protein-UDP acetylgalactosaminyltransferase 7;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7;, PF00535;PF00652;, GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0030246;GO:0046872;GO:0004653;GO:0005975;GO:0016266;GO:0006493;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:O-glycan processing; P:protein O-linked glycosylation;|Q86SF2 B3KQU3 Q7Z5W7 Q9UJ28,N-acetylgalactosaminyltransferase 7,Polypeptide GalNAc transferase 7;Protein-UDP acetylgalactosaminyltransferase 7;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7;, PF00535;PF00652;, GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0030246;GO:0046872;GO:0004653;GO:0005975;GO:0016266;GO:0006493;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:carbohydrate metabolic process; P:O-glycan processing; P:protein O-linked glycosylation; scaffold50 indexed_genome mRNA 5534426 5536861 . - . ID=transcript_9433;P26583 B2R4K8 D3DP37 Q5U072,High mobility group protein B2,High mobility group protein 2;, PF00505;PF09011;, GO:0000785;GO:0000793;GO:0005737;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0042056;GO:0000987;GO:0003684;GO:0003677;GO:0008301;GO:0003690;GO:0000400;GO:0044378;GO:0019904;GO:0050786;GO:0003723;GO:0003697;GO:0097100;GO:0003713;GO:0008134;GO:0000976;GO:0006309;GO:0060326;GO:0071222;GO:0006325;GO:0050829;GO:0050830;GO:0032392;GO:0006265;GO:0006303;GO:0002437;GO:0045087;GO:0008584;GO:1902042;GO:0045892;GO:0006334;GO:0043388;GO:0001938;GO:0045648;GO:0045089;GO:0032728;GO:0045654;GO:0032075;GO:0045944;GO:0045893;GO:0050767;GO:0072091;GO:0006357;GO:0032496;GO:0048545;GO:0007289;GO:0033151;, C:chromatin; C:condensed chromosome; C:cytoplasm; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:chemoattractant activity; F:cis-regulatory region sequence-specific DNA binding; F:damaged DNA binding; F:DNA binding; F:DNA binding, bending; F:double-stranded DNA binding; F:four-way junction DNA binding; F:non-sequence-specific DNA binding, bending; F:protein domain specific binding; F:RAGE receptor binding; F:RNA binding; F:single-stranded DNA binding; F:supercoiled DNA binding; F:transcription coactivator activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic DNA fragmentation; P:cell chemotaxis; P:cellular response to lipopolysaccharide; P:chromatin organization; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:DNA geometric change; P:DNA topological change; P:double-strand break repair via nonhomologous end joining; P:inflammatory response to antigenic stimulus; P:innate immune response; P:male gonad development; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of DNA binding; P:positive regulation of endothelial cell proliferation; P:positive regulation of erythrocyte differentiation; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of megakaryocyte differentiation; P:positive regulation of nuclease activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of neurogenesis; P:regulation of stem cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to lipopolysaccharide; P:response to steroid hormone; P:spermatid nucleus differentiation; P:V(D)J recombination;|P26583 B2R4K8 D3DP37 Q5U072,High mobility group protein B2,High mobility group protein 2;, PF00505;PF09011;, GO:0000785;GO:0000793;GO:0005737;GO:0005615;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0042056;GO:0000987;GO:0003684;GO:0003677;GO:0008301;GO:0003690;GO:0000400;GO:0044378;GO:0019904;GO:0050786;GO:0003723;GO:0003697;GO:0097100;GO:0003713;GO:0008134;GO:0000976;GO:0006309;GO:0060326;GO:0071222;GO:0006325;GO:0050829;GO:0050830;GO:0032392;GO:0006265;GO:0006303;GO:0002437;GO:0045087;GO:0008584;GO:1902042;GO:0045892;GO:0006334;GO:0043388;GO:0001938;GO:0045648;GO:0045089;GO:0032728;GO:0045654;GO:0032075;GO:0045944;GO:0045893;GO:0050767;GO:0072091;GO:0006357;GO:0032496;GO:0048545;GO:0007289;GO:0033151;, C:chromatin; C:condensed chromosome; C:cytoplasm; C:extracellular space; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:chemoattractant activity; F:cis-regulatory region sequence-specific DNA binding; F:damaged DNA binding; F:DNA binding; F:DNA binding, bending; F:double-stranded DNA binding; F:four-way junction DNA binding; F:non-sequence-specific DNA binding, bending; F:protein domain specific binding; F:RAGE receptor binding; F:RNA binding; F:single-stranded DNA binding; F:supercoiled DNA binding; F:transcription coactivator activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:apoptotic DNA fragmentation; P:cell chemotaxis; P:cellular response to lipopolysaccharide; P:chromatin organization; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:DNA geometric change; P:DNA topological change; P:double-strand break repair via nonhomologous end joining; P:inflammatory response to antigenic stimulus; P:innate immune response; P:male gonad development; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of DNA binding; P:positive regulation of endothelial cell proliferation; P:positive regulation of erythrocyte differentiation; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of megakaryocyte differentiation; P:positive regulation of nuclease activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of neurogenesis; P:regulation of stem cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to lipopolysaccharide; P:response to steroid hormone; P:spermatid nucleus differentiation; P:V(D)J recombination; scaffold50 indexed_genome mRNA 5568856 5571464 . + . ID=transcript_9434;O75446 D3DP38,Histone deacetylase complex subunit SAP30,30 kDa Sin3-associated polypeptide;Sin3 corepressor complex subunit SAP30;Sin3-associated polypeptide p30;, PF13867;PF13866;, GO:0000118;GO:0005654;GO:0003677;GO:0046872;GO:0003712;GO:0003714;GO:0000122;GO:0006355;GO:0035914;, C:histone deacetylase complex; C:nucleoplasm;, F:DNA binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:skeletal muscle cell differentiation; scaffold50 indexed_genome mRNA 5590861 5591404 . + . ID=transcript_9435;O75711,Scrapie-responsive protein 1,Scrapie-responsive gene 1 protein;, PF15224;, GO:0005615;GO:0005794;GO:0044306;GO:0007399;, C:extracellular space; C:Golgi apparatus; C:neuron projection terminus;, , P:nervous system development; scaffold50 indexed_genome mRNA 5700866 5703790 . - . ID=transcript_9436;P61296 B6ECG9 O95300 O95301 P97833 Q494T1,Heart- and neural crest derivatives-expressed protein 2,Class A basic helix-loop-helix protein 26;Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2;, PF00010;, GO:0000785;GO:0005634;GO:0032991;GO:0005667;GO:0033613;GO:0001228;GO:0000981;GO:0070888;GO:0003680;GO:0042803;GO:0000977;GO:1990837;GO:0008134;GO:0007512;GO:0001525;GO:0003278;GO:0061309;GO:0003253;GO:0003219;GO:0060536;GO:0061325;GO:0060982;GO:0032502;GO:0042733;GO:0007507;GO:0001947;GO:0001701;GO:0010463;GO:0010667;GO:0043392;GO:0043433;GO:0010629;GO:0045668;GO:0003357;GO:0042475;GO:0048935;GO:0010613;GO:0070374;GO:0010628;GO:1900745;GO:2000764;GO:0045944;GO:2000763;GO:2000679;GO:0045893;GO:1903929;GO:0003266;GO:0034103;GO:0006357;GO:0001967;GO:0048485;GO:0048538;GO:0043586;GO:0061032;, C:chromatin; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein homodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:adult heart development; P:angiogenesis; P:apoptotic process involved in heart morphogenesis; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; P:cardiac right ventricle formation; P:cartilage morphogenesis; P:cell proliferation involved in outflow tract morphogenesis; P:coronary artery morphogenesis; P:developmental process; P:embryonic digit morphogenesis; P:heart development; P:heart looping; P:in utero embryonic development; P:mesenchymal cell proliferation; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of osteoblast differentiation; P:noradrenergic neuron differentiation; P:odontogenesis of dentin-containing tooth; P:peripheral nervous system neuron development; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of p38MAPK cascade; P:positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated; P:primary palate development; P:regulation of secondary heart field cardioblast proliferation; P:regulation of tissue remodeling; P:regulation of transcription by RNA polymerase II; P:suckling behavior; P:sympathetic nervous system development; P:thymus development; P:tongue development; P:visceral serous pericardium development;|P61296 B6ECG9 O95300 O95301 P97833 Q494T1,Heart- and neural crest derivatives-expressed protein 2,Class A basic helix-loop-helix protein 26;Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2;, PF00010;, GO:0000785;GO:0005634;GO:0032991;GO:0005667;GO:0033613;GO:0001228;GO:0000981;GO:0070888;GO:0003680;GO:0042803;GO:0000977;GO:1990837;GO:0008134;GO:0007512;GO:0001525;GO:0003278;GO:0061309;GO:0003253;GO:0003219;GO:0060536;GO:0061325;GO:0060982;GO:0032502;GO:0042733;GO:0007507;GO:0001947;GO:0001701;GO:0010463;GO:0010667;GO:0043392;GO:0043433;GO:0010629;GO:0045668;GO:0003357;GO:0042475;GO:0048935;GO:0010613;GO:0070374;GO:0010628;GO:1900745;GO:2000764;GO:0045944;GO:2000763;GO:2000679;GO:0045893;GO:1903929;GO:0003266;GO:0034103;GO:0006357;GO:0001967;GO:0048485;GO:0048538;GO:0043586;GO:0061032;, C:chromatin; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein homodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:adult heart development; P:angiogenesis; P:apoptotic process involved in heart morphogenesis; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; P:cardiac right ventricle formation; P:cartilage morphogenesis; P:cell proliferation involved in outflow tract morphogenesis; P:coronary artery morphogenesis; P:developmental process; P:embryonic digit morphogenesis; P:heart development; P:heart looping; P:in utero embryonic development; P:mesenchymal cell proliferation; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of osteoblast differentiation; P:noradrenergic neuron differentiation; P:odontogenesis of dentin-containing tooth; P:peripheral nervous system neuron development; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of p38MAPK cascade; P:positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated; P:primary palate development; P:regulation of secondary heart field cardioblast proliferation; P:regulation of tissue remodeling; P:regulation of transcription by RNA polymerase II; P:suckling behavior; P:sympathetic nervous system development; P:thymus development; P:tongue development; P:visceral serous pericardium development; scaffold50 indexed_genome mRNA 6330594 6369476 . + . ID=transcript_9437;Q9NRD0 B2RB40 D3DP41 G5E9Z0 Q6UWN4 Q8IWE1 Q9NRP5 Q9UKC4,F-box only protein 8,F-box/SEC7 protein FBS;, PF12937;PF01369;, GO:0000151;GO:0005085;GO:0032012;GO:0006511;, C:ubiquitin ligase complex;, F:guanyl-nucleotide exchange factor activity;, P:regulation of ARF protein signal transduction; P:ubiquitin-dependent protein catabolic process;|Q9NRD0 B2RB40 D3DP41 G5E9Z0 Q6UWN4 Q8IWE1 Q9NRP5 Q9UKC4,F-box only protein 8,F-box/SEC7 protein FBS;, PF12937;PF01369;, GO:0000151;GO:0005085;GO:0032012;GO:0006511;, C:ubiquitin ligase complex;, F:guanyl-nucleotide exchange factor activity;, P:regulation of ARF protein signal transduction; P:ubiquitin-dependent protein catabolic process;|Q9NRD0 B2RB40 D3DP41 G5E9Z0 Q6UWN4 Q8IWE1 Q9NRP5 Q9UKC4,F-box only protein 8,F-box/SEC7 protein FBS;, PF12937;PF01369;, GO:0000151;GO:0005085;GO:0032012;GO:0006511;, C:ubiquitin ligase complex;, F:guanyl-nucleotide exchange factor activity;, P:regulation of ARF protein signal transduction; P:ubiquitin-dependent protein catabolic process;|Q9NRD0 B2RB40 D3DP41 G5E9Z0 Q6UWN4 Q8IWE1 Q9NRP5 Q9UKC4,F-box only protein 8,F-box/SEC7 protein FBS;, PF12937;PF01369;, GO:0000151;GO:0005085;GO:0032012;GO:0006511;, C:ubiquitin ligase complex;, F:guanyl-nucleotide exchange factor activity;, P:regulation of ARF protein signal transduction; P:ubiquitin-dependent protein catabolic process; scaffold50 indexed_genome mRNA 6385321 6391096 . + . ID=transcript_9438;Q9C0F1 A8K8W9 A8MW11 B3KT53 D3DP42 Q8IXZ4,Centrosomal protein of 44 kDa,HBV PreS1-transactivated protein 3;, PF15007;, GO:0005814;GO:0005813;GO:0005737;GO:0030496;GO:0000922;GO:0008017;GO:0007099;GO:0010457;GO:0007098;, C:centriole; C:centrosome; C:cytoplasm; C:midbody; C:spindle pole;, F:microtubule binding;, P:centriole replication; P:centriole-centriole cohesion; P:centrosome cycle;|Q9C0F1 A8K8W9 A8MW11 B3KT53 D3DP42 Q8IXZ4,Centrosomal protein of 44 kDa,HBV PreS1-transactivated protein 3;, PF15007;, GO:0005814;GO:0005813;GO:0005737;GO:0030496;GO:0000922;GO:0008017;GO:0007099;GO:0010457;GO:0007098;, C:centriole; C:centrosome; C:cytoplasm; C:midbody; C:spindle pole;, F:microtubule binding;, P:centriole replication; P:centriole-centriole cohesion; P:centrosome cycle;|Q9C0F1 A8K8W9 A8MW11 B3KT53 D3DP42 Q8IXZ4,Centrosomal protein of 44 kDa,HBV PreS1-transactivated protein 3;, PF15007;, GO:0005814;GO:0005813;GO:0005737;GO:0030496;GO:0000922;GO:0008017;GO:0007099;GO:0010457;GO:0007098;, C:centriole; C:centrosome; C:cytoplasm; C:midbody; C:spindle pole;, F:microtubule binding;, P:centriole replication; P:centriole-centriole cohesion; P:centrosome cycle; scaffold50 indexed_genome mRNA 6561749 6598683 . - . ID=transcript_9439;P15428 B4DTA4 B4DU74 B4DV57 D3DP43 E7EV11 O00749 Q06F08 Q12998,15-hydroxyprostaglandin dehydrogenase [NAD(+)] {ECO:0000305},Prostaglandin dehydrogenase 1;Short chain dehydrogenase/reductase family 36C member 1;, PF00106;, GO:0016323;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0016404;GO:0042802;GO:0051287;GO:0070403;GO:0016616;GO:0004957;GO:0097070;GO:0007565;GO:0001822;GO:2001301;GO:0019372;GO:0042759;GO:0045786;GO:0030728;GO:0007567;GO:0043065;GO:1904707;GO:0006693;GO:1905828;GO:0032355;GO:0045471;GO:0032496;GO:0070493;GO:0007179;, C:basolateral plasma membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; F:identical protein binding; F:NAD binding; F:NAD+ binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:prostaglandin E receptor activity;, P:ductus arteriosus closure; P:female pregnancy; P:kidney development; P:lipoxin biosynthetic process; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:negative regulation of cell cycle; P:ovulation; P:parturition; P:positive regulation of apoptotic process; P:positive regulation of vascular associated smooth muscle cell proliferation; P:prostaglandin metabolic process; P:regulation of prostaglandin catabolic process; P:response to estradiol; P:response to ethanol; P:response to lipopolysaccharide; P:thrombin-activated receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway; scaffold50 indexed_genome mRNA 6761737 6829482 . - . ID=transcript_9440;O75311 D3DP44 O75816 Q5D0E3,Glycine receptor subunit alpha-3,, PF02931;PF02932;, GO:0030425;GO:0016935;GO:0005887;GO:0043005;GO:0043204;GO:0005886;GO:0045211;GO:0045202;GO:0016934;GO:0016594;GO:0022852;GO:0046872;GO:0030594;GO:0004888;GO:0007268;GO:1902476;GO:0034220;GO:0050877;GO:0007218;GO:0051260;GO:0042391;GO:0043200;GO:0007165;GO:0060012;, C:dendrite; C:glycine-gated chloride channel complex; C:integral component of plasma membrane; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:extracellularly glycine-gated chloride channel activity; F:glycine binding; F:glycine-gated chloride ion channel activity; F:metal ion binding; F:neurotransmitter receptor activity; F:transmembrane signaling receptor activity;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:ion transmembrane transport; P:nervous system process; P:neuropeptide signaling pathway; P:protein homooligomerization; P:regulation of membrane potential; P:response to amino acid; P:signal transduction; P:synaptic transmission, glycinergic; scaffold50 indexed_genome mRNA 7253378 7255259 . - . ID=transcript_9441;Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response; scaffold50 indexed_genome mRNA 7256863 7257947 . - . ID=transcript_9442;P60508,Syncytin-2,Endogenous retrovirus group FRD member 1;Envelope polyprotein;HERV-FRD;HERV-FRD_6p24.1 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;GO:0007520;GO:0006949;GO:0000768;, C:integral component of membrane; C:plasma membrane;, , P:myoblast fusion; P:syncytium formation; P:syncytium formation by plasma membrane fusion; scaffold50 indexed_genome mRNA 7280069 7288518 . + . ID=transcript_9443;P07858 B3KQR5 B3KRR5 Q503A6 Q96D87,Cathepsin B,APP secretase;Cathepsin B1;, PF00112;PF08127;, GO:0016324;GO:0062023;GO:0036021;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005622;GO:0005764;GO:0042470;GO:0048471;GO:0005518;GO:0004197;GO:0008234;GO:0008233;GO:0043394;GO:0097067;GO:0030574;GO:0030855;GO:0043312;GO:0006508;GO:0051603;GO:0042981;GO:0050790;GO:0002224;, C:apical plasma membrane; C:collagen-containing extracellular matrix; C:endolysosome lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular anatomical structure; C:lysosome; C:melanosome; C:perinuclear region of cytoplasm;, F:collagen binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:peptidase activity; F:proteoglycan binding;, P:cellular response to thyroid hormone stimulus; P:collagen catabolic process; P:epithelial cell differentiation; P:neutrophil degranulation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of apoptotic process; P:regulation of catalytic activity; P:toll-like receptor signaling pathway;|P07858 B3KQR5 B3KRR5 Q503A6 Q96D87,Cathepsin B,APP secretase;Cathepsin B1;, PF00112;PF08127;, GO:0016324;GO:0062023;GO:0036021;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005622;GO:0005764;GO:0042470;GO:0048471;GO:0005518;GO:0004197;GO:0008234;GO:0008233;GO:0043394;GO:0097067;GO:0030574;GO:0030855;GO:0043312;GO:0006508;GO:0051603;GO:0042981;GO:0050790;GO:0002224;, C:apical plasma membrane; C:collagen-containing extracellular matrix; C:endolysosome lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular anatomical structure; C:lysosome; C:melanosome; C:perinuclear region of cytoplasm;, F:collagen binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:peptidase activity; F:proteoglycan binding;, P:cellular response to thyroid hormone stimulus; P:collagen catabolic process; P:epithelial cell differentiation; P:neutrophil degranulation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of apoptotic process; P:regulation of catalytic activity; P:toll-like receptor signaling pathway;|P07858 B3KQR5 B3KRR5 Q503A6 Q96D87,Cathepsin B,APP secretase;Cathepsin B1;, PF00112;PF08127;, GO:0016324;GO:0062023;GO:0036021;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005622;GO:0005764;GO:0042470;GO:0048471;GO:0005518;GO:0004197;GO:0008234;GO:0008233;GO:0043394;GO:0097067;GO:0030574;GO:0030855;GO:0043312;GO:0006508;GO:0051603;GO:0042981;GO:0050790;GO:0002224;, C:apical plasma membrane; C:collagen-containing extracellular matrix; C:endolysosome lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular anatomical structure; C:lysosome; C:melanosome; C:perinuclear region of cytoplasm;, F:collagen binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:peptidase activity; F:proteoglycan binding;, P:cellular response to thyroid hormone stimulus; P:collagen catabolic process; P:epithelial cell differentiation; P:neutrophil degranulation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of apoptotic process; P:regulation of catalytic activity; P:toll-like receptor signaling pathway; scaffold50 indexed_genome mRNA 7290883 7301616 . - . ID=transcript_9444;P37268 B3KQ95 B4DJE5 B4DT56 B7Z1J3 Q96GT0,Squalene synthase,FPP:FPP farnesyltransferase;Farnesyl-diphosphate farnesyltransferase;Farnesyl-diphosphate farnesyltransferase 1 {ECO:0000312|HGNC:HGNC:3629};, , GO:0005783;GO:0005789;GO:0016021;GO:0004310;GO:0046872;GO:0051996;GO:0006695;GO:0045338;GO:0019216;GO:0019222;GO:0006694;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:farnesyl-diphosphate farnesyltransferase activity; F:metal ion binding; F:squalene synthase activity;, P:cholesterol biosynthetic process; P:farnesyl diphosphate metabolic process; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:steroid biosynthetic process;|P37268 B3KQ95 B4DJE5 B4DT56 B7Z1J3 Q96GT0,Squalene synthase,FPP:FPP farnesyltransferase;Farnesyl-diphosphate farnesyltransferase;Farnesyl-diphosphate farnesyltransferase 1 {ECO:0000312|HGNC:HGNC:3629};, , GO:0005783;GO:0005789;GO:0016021;GO:0004310;GO:0046872;GO:0051996;GO:0006695;GO:0045338;GO:0019216;GO:0019222;GO:0006694;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:farnesyl-diphosphate farnesyltransferase activity; F:metal ion binding; F:squalene synthase activity;, P:cholesterol biosynthetic process; P:farnesyl diphosphate metabolic process; P:regulation of lipid metabolic process; P:regulation of metabolic process; P:steroid biosynthetic process; scaffold50 indexed_genome mRNA 7338865 7344520 . - . ID=transcript_9445;P43694 B7ZKX0 B7ZKZ4 Q3MJ45 Q5IFM8,Transcription factor GATA-4,GATA-binding factor 4;, PF00320;PF05349;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0090575;GO:0033613;GO:0070410;GO:0003677;GO:0001216;GO:0001228;GO:0000981;GO:0051525;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:1990837;GO:0008134;GO:0000976;GO:0008270;GO:0003180;GO:0060413;GO:0003289;GO:0003290;GO:0003190;GO:0007596;GO:0061026;GO:0003215;GO:0003208;GO:0045165;GO:0061049;GO:0007267;GO:0071333;GO:0048617;GO:0035054;GO:0003197;GO:0007492;GO:0001947;GO:0060575;GO:0008584;GO:2001234;GO:0010507;GO:0010667;GO:1903202;GO:0045766;GO:0030513;GO:0051891;GO:0070374;GO:0045944;GO:0045893;GO:0010575;GO:0086004;GO:0051896;GO:0006357;GO:0006355;GO:0042493;GO:0009612;GO:0033189;GO:0060290;GO:0003281;GO:0042060;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:activating transcription factor binding; F:co-SMAD binding; F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:NFAT protein binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:aortic valve morphogenesis; P:atrial septum morphogenesis; P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:atrioventricular valve formation; P:blood coagulation; P:cardiac muscle tissue regeneration; P:cardiac right ventricle morphogenesis; P:cardiac ventricle morphogenesis; P:cell fate commitment; P:cell growth involved in cardiac muscle cell development; P:cell-cell signaling; P:cellular response to glucose stimulus; P:embryonic foregut morphogenesis; P:embryonic heart tube anterior/posterior pattern specification; P:endocardial cushion development; P:endoderm development; P:heart looping; P:intestinal epithelial cell differentiation; P:male gonad development; P:negative regulation of apoptotic signaling pathway; P:negative regulation of autophagy; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cardioblast differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:regulation of cardiac muscle cell contraction; P:regulation of protein kinase B signaling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to drug; P:response to mechanical stimulus; P:response to vitamin A; P:transdifferentiation; P:ventricular septum development; P:wound healing;|P43694 B7ZKX0 B7ZKZ4 Q3MJ45 Q5IFM8,Transcription factor GATA-4,GATA-binding factor 4;, PF00320;PF05349;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0090575;GO:0033613;GO:0070410;GO:0003677;GO:0001216;GO:0001228;GO:0000981;GO:0051525;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:1990837;GO:0008134;GO:0000976;GO:0008270;GO:0003180;GO:0060413;GO:0003289;GO:0003290;GO:0003190;GO:0007596;GO:0061026;GO:0003215;GO:0003208;GO:0045165;GO:0061049;GO:0007267;GO:0071333;GO:0048617;GO:0035054;GO:0003197;GO:0007492;GO:0001947;GO:0060575;GO:0008584;GO:2001234;GO:0010507;GO:0010667;GO:1903202;GO:0045766;GO:0030513;GO:0051891;GO:0070374;GO:0045944;GO:0045893;GO:0010575;GO:0086004;GO:0051896;GO:0006357;GO:0006355;GO:0042493;GO:0009612;GO:0033189;GO:0060290;GO:0003281;GO:0042060;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:activating transcription factor binding; F:co-SMAD binding; F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:NFAT protein binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:aortic valve morphogenesis; P:atrial septum morphogenesis; P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:atrioventricular valve formation; P:blood coagulation; P:cardiac muscle tissue regeneration; P:cardiac right ventricle morphogenesis; P:cardiac ventricle morphogenesis; P:cell fate commitment; P:cell growth involved in cardiac muscle cell development; P:cell-cell signaling; P:cellular response to glucose stimulus; P:embryonic foregut morphogenesis; P:embryonic heart tube anterior/posterior pattern specification; P:endocardial cushion development; P:endoderm development; P:heart looping; P:intestinal epithelial cell differentiation; P:male gonad development; P:negative regulation of apoptotic signaling pathway; P:negative regulation of autophagy; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cardioblast differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:regulation of cardiac muscle cell contraction; P:regulation of protein kinase B signaling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to drug; P:response to mechanical stimulus; P:response to vitamin A; P:transdifferentiation; P:ventricular septum development; P:wound healing;|P43694 B7ZKX0 B7ZKZ4 Q3MJ45 Q5IFM8,Transcription factor GATA-4,GATA-binding factor 4;, PF00320;PF05349;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0090575;GO:0033613;GO:0070410;GO:0003677;GO:0001216;GO:0001228;GO:0000981;GO:0051525;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:1990837;GO:0008134;GO:0000976;GO:0008270;GO:0003180;GO:0060413;GO:0003289;GO:0003290;GO:0003190;GO:0007596;GO:0061026;GO:0003215;GO:0003208;GO:0045165;GO:0061049;GO:0007267;GO:0071333;GO:0048617;GO:0035054;GO:0003197;GO:0007492;GO:0001947;GO:0060575;GO:0008584;GO:2001234;GO:0010507;GO:0010667;GO:1903202;GO:0045766;GO:0030513;GO:0051891;GO:0070374;GO:0045944;GO:0045893;GO:0010575;GO:0086004;GO:0051896;GO:0006357;GO:0006355;GO:0042493;GO:0009612;GO:0033189;GO:0060290;GO:0003281;GO:0042060;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:activating transcription factor binding; F:co-SMAD binding; F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:NFAT protein binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:aortic valve morphogenesis; P:atrial septum morphogenesis; P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:atrioventricular valve formation; P:blood coagulation; P:cardiac muscle tissue regeneration; P:cardiac right ventricle morphogenesis; P:cardiac ventricle morphogenesis; P:cell fate commitment; P:cell growth involved in cardiac muscle cell development; P:cell-cell signaling; P:cellular response to glucose stimulus; P:embryonic foregut morphogenesis; P:embryonic heart tube anterior/posterior pattern specification; P:endocardial cushion development; P:endoderm development; P:heart looping; P:intestinal epithelial cell differentiation; P:male gonad development; P:negative regulation of apoptotic signaling pathway; P:negative regulation of autophagy; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cardioblast differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:regulation of cardiac muscle cell contraction; P:regulation of protein kinase B signaling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to drug; P:response to mechanical stimulus; P:response to vitamin A; P:transdifferentiation; P:ventricular septum development; P:wound healing;|P43694 B7ZKX0 B7ZKZ4 Q3MJ45 Q5IFM8,Transcription factor GATA-4,GATA-binding factor 4;, PF00320;PF05349;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0090575;GO:0033613;GO:0070410;GO:0003677;GO:0001216;GO:0001228;GO:0000981;GO:0051525;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:1990837;GO:0008134;GO:0000976;GO:0008270;GO:0003180;GO:0060413;GO:0003289;GO:0003290;GO:0003190;GO:0007596;GO:0061026;GO:0003215;GO:0003208;GO:0045165;GO:0061049;GO:0007267;GO:0071333;GO:0048617;GO:0035054;GO:0003197;GO:0007492;GO:0001947;GO:0060575;GO:0008584;GO:2001234;GO:0010507;GO:0010667;GO:1903202;GO:0045766;GO:0030513;GO:0051891;GO:0070374;GO:0045944;GO:0045893;GO:0010575;GO:0086004;GO:0051896;GO:0006357;GO:0006355;GO:0042493;GO:0009612;GO:0033189;GO:0060290;GO:0003281;GO:0042060;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:activating transcription factor binding; F:co-SMAD binding; F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:NFAT protein binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:aortic valve morphogenesis; P:atrial septum morphogenesis; P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:atrioventricular valve formation; P:blood coagulation; P:cardiac muscle tissue regeneration; P:cardiac right ventricle morphogenesis; P:cardiac ventricle morphogenesis; P:cell fate commitment; P:cell growth involved in cardiac muscle cell development; P:cell-cell signaling; P:cellular response to glucose stimulus; P:embryonic foregut morphogenesis; P:embryonic heart tube anterior/posterior pattern specification; P:endocardial cushion development; P:endoderm development; P:heart looping; P:intestinal epithelial cell differentiation; P:male gonad development; P:negative regulation of apoptotic signaling pathway; P:negative regulation of autophagy; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cardioblast differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:regulation of cardiac muscle cell contraction; P:regulation of protein kinase B signaling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to drug; P:response to mechanical stimulus; P:response to vitamin A; P:transdifferentiation; P:ventricular septum development; P:wound healing; scaffold50 indexed_genome mRNA 7380925 7384936 . - . ID=transcript_9446;P43694 B7ZKX0 B7ZKZ4 Q3MJ45 Q5IFM8,Transcription factor GATA-4,GATA-binding factor 4;, PF00320;PF05349;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0090575;GO:0033613;GO:0070410;GO:0003677;GO:0001216;GO:0001228;GO:0000981;GO:0051525;GO:0019901;GO:0000978;GO:0001085;GO:0000977;GO:0043565;GO:1990837;GO:0008134;GO:0000976;GO:0008270;GO:0003180;GO:0060413;GO:0003289;GO:0003290;GO:0003190;GO:0007596;GO:0061026;GO:0003215;GO:0003208;GO:0045165;GO:0061049;GO:0007267;GO:0071333;GO:0048617;GO:0035054;GO:0003197;GO:0007492;GO:0001947;GO:0060575;GO:0008584;GO:2001234;GO:0010507;GO:0010667;GO:1903202;GO:0045766;GO:0030513;GO:0051891;GO:0070374;GO:0045944;GO:0045893;GO:0010575;GO:0086004;GO:0051896;GO:0006357;GO:0006355;GO:0042493;GO:0009612;GO:0033189;GO:0060290;GO:0003281;GO:0042060;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:activating transcription factor binding; F:co-SMAD binding; F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:NFAT protein binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:aortic valve morphogenesis; P:atrial septum morphogenesis; P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:atrioventricular valve formation; P:blood coagulation; P:cardiac muscle tissue regeneration; P:cardiac right ventricle morphogenesis; P:cardiac ventricle morphogenesis; P:cell fate commitment; P:cell growth involved in cardiac muscle cell development; P:cell-cell signaling; P:cellular response to glucose stimulus; P:embryonic foregut morphogenesis; P:embryonic heart tube anterior/posterior pattern specification; P:endocardial cushion development; P:endoderm development; P:heart looping; P:intestinal epithelial cell differentiation; P:male gonad development; P:negative regulation of apoptotic signaling pathway; P:negative regulation of autophagy; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:positive regulation of angiogenesis; P:positive regulation of BMP signaling pathway; P:positive regulation of cardioblast differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:regulation of cardiac muscle cell contraction; P:regulation of protein kinase B signaling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to drug; P:response to mechanical stimulus; P:response to vitamin A; P:transdifferentiation; P:ventricular septum development; P:wound healing; scaffold50 indexed_genome mRNA 7521785 7525266 . - . ID=transcript_9447;P51451 Q16291 Q96IN1,Tyrosine-protein kinase Blk,B lymphocyte kinase;p55-Blk;, PF07714;PF00017;PF00018;, GO:0005829;GO:0031234;GO:0005524;GO:0004715;GO:0004713;GO:0005102;GO:0004714;GO:0050853;GO:0030154;GO:0006974;GO:0097028;GO:0002431;GO:0045087;GO:0035556;GO:0030889;GO:0070667;GO:0031175;GO:0018108;GO:0002576;GO:2000670;GO:0032024;GO:0002902;GO:0050855;GO:0043304;GO:0090330;GO:0002513;GO:0007169;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:B cell receptor signaling pathway; P:cell differentiation; P:cellular response to DNA damage stimulus; P:dendritic cell differentiation; P:Fc receptor mediated stimulatory signaling pathway; P:innate immune response; P:intracellular signal transduction; P:negative regulation of B cell proliferation; P:negative regulation of mast cell proliferation; P:neuron projection development; P:peptidyl-tyrosine phosphorylation; P:platelet degranulation; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of insulin secretion; P:regulation of B cell apoptotic process; P:regulation of B cell receptor signaling pathway; P:regulation of mast cell degranulation; P:regulation of platelet aggregation; P:tolerance induction to self antigen; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold50 indexed_genome mRNA 7606443 7622126 . - . ID=transcript_9448;Q96KS9 A8K3T9 Q3SXY1 Q3SXY3 Q8N3M3 Q9NSR0,Protein FAM167A,, PF11652; scaffold50 indexed_genome mRNA 7642083 7653949 . - . ID=transcript_9449;Q8IZJ6 Q8IZJ5 Q96LV6,Inactive L-threonine 3-dehydrogenase, mitochondrial,Short chain dehydrogenase/reductase family 14E member 1 pseudogene;, PF01370;, GO:0005743;GO:0008743;GO:0019518;GO:0006567;, C:mitochondrial inner membrane;, F:L-threonine 3-dehydrogenase activity;, P:L-threonine catabolic process to glycine; P:threonine catabolic process; scaffold50 indexed_genome mRNA 7685269 7751452 . + . ID=transcript_9450;Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation;|Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation;|Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation;|Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation;|Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation;|Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation;|Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation;|Q96QG7 B7Z291 Q52LU3 Q8WW11 Q96QG6 Q9NX50,Myotubularin-related protein 9,Inactive phosphatidylinositol 3-phosphatase 9 {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005783;GO:0048471;GO:0032991;GO:0032587;GO:0030234;GO:0004438;GO:0019903;GO:0006897;GO:0010507;GO:0006661;GO:0046856;GO:0010922;GO:0050821;GO:0060304;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:protein-containing complex; C:ruffle membrane;, F:enzyme regulator activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding;, P:endocytosis; P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol dephosphorylation; scaffold50 indexed_genome mRNA 8152735 8214328 . + . ID=transcript_9451;Q96BK5 B2R9B1 Q548A5 Q6QWG9 Q7Z7J8 Q96QD7 Q9HBU7 Q9NWW2,PIN2/TERF1-interacting telomerase inhibitor 1,Liver-related putative tumor suppressor;Pin2-interacting protein X1;Protein 67-11-3;TRF1-interacting protein 1;, PF01585;, GO:0000781;GO:0000777;GO:0000776;GO:0005739;GO:0000228;GO:0005730;GO:0005654;GO:0005819;GO:0044877;GO:0010521;GO:0070034;GO:0007080;GO:0008285;GO:0010972;GO:0031397;GO:0051974;GO:0032211;GO:1904357;GO:1904751;GO:1904744;GO:0070198;GO:1902570;GO:0031647;GO:0051972;GO:0007004;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:kinetochore; C:mitochondrion; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:spindle;, F:protein-containing complex binding; F:telomerase inhibitor activity; F:telomerase RNA binding;, P:mitotic metaphase plate congression; P:negative regulation of cell population proliferation; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of protein ubiquitination; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of telomere maintenance via telomere lengthening; P:positive regulation of protein localization to nucleolus; P:positive regulation of telomeric DNA binding; P:protein localization to chromosome, telomeric region; P:protein localization to nucleolus; P:regulation of protein stability; P:regulation of telomerase activity; P:telomere maintenance via telomerase; scaffold50 indexed_genome mRNA 8230537 8235413 . + . ID=transcript_9452;Q9BT81 B4DKV0 Q53YD0,Transcription factor SOX-7,, PF00505;PF12067;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0009653;GO:0030154;GO:0001706;GO:0008285;GO:0045892;GO:0043280;GO:0045893;GO:0060828;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell differentiation; P:endoderm formation; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of transcription, DNA-templated; P:regulation of canonical Wnt signaling pathway; P:regulation of transcription, DNA-templated; scaffold50 indexed_genome mRNA 8395523 8403759 . - . ID=transcript_9453;Q6UWB4 E5RJX5,Serine protease 55,Testis serine protease 1 {ECO:0000303|PubMed:18844450};, PF00089;, GO:0001669;GO:0031225;GO:0005829;GO:0005886;GO:0004252;GO:0007339;GO:0030317;, C:acrosomal vesicle; C:anchored component of membrane; C:cytosol; C:plasma membrane;, F:serine-type endopeptidase activity;, P:binding of sperm to zona pellucida; P:flagellated sperm motility; scaffold50 indexed_genome mRNA 8511412 8810443 . - . ID=transcript_9454;Q9UJ68 E9PAS8 Q52TC4 Q549N4 Q66MI7,Mitochondrial peptide methionine sulfoxide reductase,Peptide-methionine (S)-S-oxide reductase;Protein-methionine-S-oxide reductase;, PF01625;, GO:0015629;GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005886;GO:0036456;GO:0008113;GO:0006464;GO:0034599;GO:0006555;GO:0030091;GO:0006979;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:L-methionine-(S)-S-oxide reductase activity; F:peptide-methionine (S)-S-oxide reductase activity;, P:cellular protein modification process; P:cellular response to oxidative stress; P:methionine metabolic process; P:protein repair; P:response to oxidative stress;|Q9UJ68 E9PAS8 Q52TC4 Q549N4 Q66MI7,Mitochondrial peptide methionine sulfoxide reductase,Peptide-methionine (S)-S-oxide reductase;Protein-methionine-S-oxide reductase;, PF01625;, GO:0015629;GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005886;GO:0036456;GO:0008113;GO:0006464;GO:0034599;GO:0006555;GO:0030091;GO:0006979;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:L-methionine-(S)-S-oxide reductase activity; F:peptide-methionine (S)-S-oxide reductase activity;, P:cellular protein modification process; P:cellular response to oxidative stress; P:methionine metabolic process; P:protein repair; P:response to oxidative stress; scaffold50 indexed_genome mRNA 9066296 9283870 . + . ID=transcript_9455;Q9NQT8 B4DGY5 B5MC45 F8VPJ2 O75134 Q9BYJ6,Kinesin-like protein KIF13B,Kinesin-like protein GAKIN;, PF01302;PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0030424;GO:0005737;GO:0005829;GO:0005871;GO:0005874;GO:0005902;GO:0033270;GO:0071889;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0019901;GO:0007018;GO:0006605;GO:0050770;GO:0007165;GO:0042110;, C:axon; C:cytoplasm; C:cytosol; C:kinesin complex; C:microtubule; C:microvillus; C:paranode region of axon;, F:14-3-3 protein binding; F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein kinase binding;, P:microtubule-based movement; P:protein targeting; P:regulation of axonogenesis; P:signal transduction; P:T cell activation;|Q9NQT8 B4DGY5 B5MC45 F8VPJ2 O75134 Q9BYJ6,Kinesin-like protein KIF13B,Kinesin-like protein GAKIN;, PF01302;PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0030424;GO:0005737;GO:0005829;GO:0005871;GO:0005874;GO:0005902;GO:0033270;GO:0071889;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0019901;GO:0007018;GO:0006605;GO:0050770;GO:0007165;GO:0042110;, C:axon; C:cytoplasm; C:cytosol; C:kinesin complex; C:microtubule; C:microvillus; C:paranode region of axon;, F:14-3-3 protein binding; F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein kinase binding;, P:microtubule-based movement; P:protein targeting; P:regulation of axonogenesis; P:signal transduction; P:T cell activation;|Q9NQT8 B4DGY5 B5MC45 F8VPJ2 O75134 Q9BYJ6,Kinesin-like protein KIF13B,Kinesin-like protein GAKIN;, PF01302;PF12473;PF00498;PF12423;PF00225;PF16183;, GO:0030424;GO:0005737;GO:0005829;GO:0005871;GO:0005874;GO:0005902;GO:0033270;GO:0071889;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0019901;GO:0007018;GO:0006605;GO:0050770;GO:0007165;GO:0042110;, C:axon; C:cytoplasm; C:cytosol; C:kinesin complex; C:microtubule; C:microvillus; C:paranode region of axon;, F:14-3-3 protein binding; F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:protein kinase binding;, P:microtubule-based movement; P:protein targeting; P:regulation of axonogenesis; P:signal transduction; P:T cell activation; scaffold50 indexed_genome mRNA 9294192 9419622 . - . ID=transcript_9456;Q6NT76 A4K385 A8K3R8 B4DHY5 D3DSU0 Q3Y6P1 Q96GS5 Q9H701,Homeobox-containing protein 1 {ECO:0000303|PubMed:16825764},Homeobox telomere-binding protein 1 {ECO:0000303|PubMed:23685356};Telomere-associated homeobox-containing protein 1 {ECO:0000303|PubMed:23813958};, PF04814;PF00046;, GO:0015030;GO:0005813;GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003691;GO:0042802;GO:0044877;GO:0043565;GO:1990837;GO:0042162;GO:0000122;GO:0045892;GO:0035563;GO:0051973;GO:0032212;GO:0045893;GO:0051972;, C:Cajal body; C:centrosome; C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:double-stranded telomeric DNA binding; F:identical protein binding; F:protein-containing complex binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:telomeric DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin binding; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription, DNA-templated; P:regulation of telomerase activity;|Q6NT76 A4K385 A8K3R8 B4DHY5 D3DSU0 Q3Y6P1 Q96GS5 Q9H701,Homeobox-containing protein 1 {ECO:0000303|PubMed:16825764},Homeobox telomere-binding protein 1 {ECO:0000303|PubMed:23685356};Telomere-associated homeobox-containing protein 1 {ECO:0000303|PubMed:23813958};, PF04814;PF00046;, GO:0015030;GO:0005813;GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003691;GO:0042802;GO:0044877;GO:0043565;GO:1990837;GO:0042162;GO:0000122;GO:0045892;GO:0035563;GO:0051973;GO:0032212;GO:0045893;GO:0051972;, C:Cajal body; C:centrosome; C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:double-stranded telomeric DNA binding; F:identical protein binding; F:protein-containing complex binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:telomeric DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin binding; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription, DNA-templated; P:regulation of telomerase activity;|Q6NT76 A4K385 A8K3R8 B4DHY5 D3DSU0 Q3Y6P1 Q96GS5 Q9H701,Homeobox-containing protein 1 {ECO:0000303|PubMed:16825764},Homeobox telomere-binding protein 1 {ECO:0000303|PubMed:23685356};Telomere-associated homeobox-containing protein 1 {ECO:0000303|PubMed:23813958};, PF04814;PF00046;, GO:0015030;GO:0005813;GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003691;GO:0042802;GO:0044877;GO:0043565;GO:1990837;GO:0042162;GO:0000122;GO:0045892;GO:0035563;GO:0051973;GO:0032212;GO:0045893;GO:0051972;, C:Cajal body; C:centrosome; C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:double-stranded telomeric DNA binding; F:identical protein binding; F:protein-containing complex binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:telomeric DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin binding; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription, DNA-templated; P:regulation of telomerase activity; scaffold50 indexed_genome mRNA 9495814 9617297 . + . ID=transcript_9457;Q9NV88 B7Z560 B7Z6M5 O00224 Q8TB16,Integrator complex subunit 9,Protein related to CPSF subunits of 74 kDa;, PF16661;, GO:0005829;GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:cytosol; C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NV88 B7Z560 B7Z6M5 O00224 Q8TB16,Integrator complex subunit 9,Protein related to CPSF subunits of 74 kDa;, PF16661;, GO:0005829;GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:cytosol; C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NV88 B7Z560 B7Z6M5 O00224 Q8TB16,Integrator complex subunit 9,Protein related to CPSF subunits of 74 kDa;, PF16661;, GO:0005829;GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:cytosol; C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NV88 B7Z560 B7Z6M5 O00224 Q8TB16,Integrator complex subunit 9,Protein related to CPSF subunits of 74 kDa;, PF16661;, GO:0005829;GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:cytosol; C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NV88 B7Z560 B7Z6M5 O00224 Q8TB16,Integrator complex subunit 9,Protein related to CPSF subunits of 74 kDa;, PF16661;, GO:0005829;GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:cytosol; C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NV88 B7Z560 B7Z6M5 O00224 Q8TB16,Integrator complex subunit 9,Protein related to CPSF subunits of 74 kDa;, PF16661;, GO:0005829;GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:cytosol; C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9NV88 B7Z560 B7Z6M5 O00224 Q8TB16,Integrator complex subunit 9,Protein related to CPSF subunits of 74 kDa;, PF16661;, GO:0005829;GO:0032039;GO:0005654;GO:0005634;GO:0016180;GO:0042795;, C:cytosol; C:integrator complex; C:nucleoplasm; C:nucleus;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold50 indexed_genome mRNA 9625194 9685513 . - . ID=transcript_9458;O43909 D3DST8 O00225 Q53XT3,Exostosin-like 3 {ECO:0000303|PubMed:9479495},EXT-related protein 1 {ECO:0000303|PubMed:9473480};Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Hereditary multiple exostoses gene isolog {ECO:0000303|Ref.9};Multiple exostosis-like protein 3 {ECO:0000303|Ref.6};Putative tumor suppressor protein EXTL3 {ECO:0000303|PubMed:9479495};, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0001888;GO:0046872;GO:0016757;GO:0015012;GO:0036498;GO:0030307;GO:0006486;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:metal ion binding; F:transferase activity, transferring glycosyl groups;, P:heparan sulfate proteoglycan biosynthetic process; P:IRE1-mediated unfolded protein response; P:positive regulation of cell growth; P:protein glycosylation;|O43909 D3DST8 O00225 Q53XT3,Exostosin-like 3 {ECO:0000303|PubMed:9479495},EXT-related protein 1 {ECO:0000303|PubMed:9473480};Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Hereditary multiple exostoses gene isolog {ECO:0000303|Ref.9};Multiple exostosis-like protein 3 {ECO:0000303|Ref.6};Putative tumor suppressor protein EXTL3 {ECO:0000303|PubMed:9479495};, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0001888;GO:0046872;GO:0016757;GO:0015012;GO:0036498;GO:0030307;GO:0006486;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:metal ion binding; F:transferase activity, transferring glycosyl groups;, P:heparan sulfate proteoglycan biosynthetic process; P:IRE1-mediated unfolded protein response; P:positive regulation of cell growth; P:protein glycosylation;|O43909 D3DST8 O00225 Q53XT3,Exostosin-like 3 {ECO:0000303|PubMed:9479495},EXT-related protein 1 {ECO:0000303|PubMed:9473480};Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Hereditary multiple exostoses gene isolog {ECO:0000303|Ref.9};Multiple exostosis-like protein 3 {ECO:0000303|Ref.6};Putative tumor suppressor protein EXTL3 {ECO:0000303|PubMed:9479495};, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0001888;GO:0046872;GO:0016757;GO:0015012;GO:0036498;GO:0030307;GO:0006486;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:metal ion binding; F:transferase activity, transferring glycosyl groups;, P:heparan sulfate proteoglycan biosynthetic process; P:IRE1-mediated unfolded protein response; P:positive regulation of cell growth; P:protein glycosylation;|O43909 D3DST8 O00225 Q53XT3,Exostosin-like 3 {ECO:0000303|PubMed:9479495},EXT-related protein 1 {ECO:0000303|PubMed:9473480};Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Hereditary multiple exostoses gene isolog {ECO:0000303|Ref.9};Multiple exostosis-like protein 3 {ECO:0000303|Ref.6};Putative tumor suppressor protein EXTL3 {ECO:0000303|PubMed:9479495};, PF03016;PF09258;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0001888;GO:0046872;GO:0016757;GO:0015012;GO:0036498;GO:0030307;GO:0006486;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:metal ion binding; F:transferase activity, transferring glycosyl groups;, P:heparan sulfate proteoglycan biosynthetic process; P:IRE1-mediated unfolded protein response; P:positive regulation of cell growth; P:protein glycosylation; scaffold50 indexed_genome mRNA 9785881 9831206 . - . ID=transcript_9459;Q9NPG1 A8K615,Frizzled-3,, PF01534;PF01392;, GO:0016324;GO:0030424;GO:0009986;GO:0005737;GO:0030425;GO:0032433;GO:0016021;GO:0016328;GO:0043025;GO:0005886;GO:0048786;GO:0004930;GO:0030165;GO:0042813;GO:0017147;GO:0060070;GO:0033278;GO:0071679;GO:0036514;GO:0001736;GO:0001942;GO:0042472;GO:1904693;GO:1900118;GO:0045976;GO:0001843;GO:0030182;GO:0001764;GO:1904938;GO:0002052;GO:0036342;GO:0042493;GO:0051602;GO:0036515;GO:0061549;GO:0007223;GO:0060071;, C:apical plasma membrane; C:axon; C:cell surface; C:cytoplasm; C:dendrite; C:filopodium tip; C:integral component of membrane; C:lateral plasma membrane; C:neuronal cell body; C:plasma membrane; C:presynaptic active zone;, F:G protein-coupled receptor activity; F:PDZ domain binding; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:cell proliferation in midbrain; P:commissural neuron axon guidance; P:dopaminergic neuron axon guidance; P:establishment of planar polarity; P:hair follicle development; P:inner ear morphogenesis; P:midbrain morphogenesis; P:negative regulation of execution phase of apoptosis; P:negative regulation of mitotic cell cycle, embryonic; P:neural tube closure; P:neuron differentiation; P:neuron migration; P:planar cell polarity pathway involved in axon guidance; P:positive regulation of neuroblast proliferation; P:post-anal tail morphogenesis; P:response to drug; P:response to electrical stimulus; P:serotonergic neuron axon guidance; P:sympathetic ganglion development; P:Wnt signaling pathway, calcium modulating pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold50 indexed_genome mRNA 9900249 9925895 . + . ID=transcript_9460;Q8IX29 Q3T1B2 Q3T1B3 Q3T1B4,F-box only protein 16,, PF12937; scaffold50 indexed_genome mRNA 9993488 10009768 . + . ID=transcript_9461;Q9H8N7 B3KUY7 D3DST4 Q6F6H2 Q9BY72 Q9NPB2 Q9NS57 Q9NS58 Q9NS59,Zinc finger protein 395,HD-regulating factor 2;Huntington disease gene regulatory region-binding protein 2;Papillomavirus regulatory factor 1;Papillomavirus-binding factor;, PF15997;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0046872;GO:0000978;GO:0045944;GO:0006357;GO:0006355;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9H8N7 B3KUY7 D3DST4 Q6F6H2 Q9BY72 Q9NPB2 Q9NS57 Q9NS58 Q9NS59,Zinc finger protein 395,HD-regulating factor 2;Huntington disease gene regulatory region-binding protein 2;Papillomavirus regulatory factor 1;Papillomavirus-binding factor;, PF15997;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0046872;GO:0000978;GO:0045944;GO:0006357;GO:0006355;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9H8N7 B3KUY7 D3DST4 Q6F6H2 Q9BY72 Q9NPB2 Q9NS57 Q9NS58 Q9NS59,Zinc finger protein 395,HD-regulating factor 2;Huntington disease gene regulatory region-binding protein 2;Papillomavirus regulatory factor 1;Papillomavirus-binding factor;, PF15997;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0046872;GO:0000978;GO:0045944;GO:0006357;GO:0006355;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold50 indexed_genome mRNA 10214701 10334900 . - . ID=transcript_9462;Q9H9T3 B4DE19 B4DIG1 E2QRI5 Q53G84 Q6AWB0 Q9BVF7 Q9NVZ1,Elongator complex protein 3 {ECO:0000303|PubMed:11714725},Protein lysine acetyltransferase ELP3 {ECO:0000305};tRNA uridine(34) acetyltransferase {ECO:0000305};, PF00583;PF04055;PF16199;, GO:0005737;GO:0005829;GO:0033588;GO:0005730;GO:0005634;GO:0051539;GO:0016407;GO:0046872;GO:0008080;GO:0008607;GO:0000049;GO:0106261;GO:0007417;GO:0001764;GO:0030335;GO:0006357;GO:0002926;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleolus; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:acetyltransferase activity; F:metal ion binding; F:N-acetyltransferase activity; F:phosphorylase kinase regulator activity; F:tRNA binding; F:tRNA uridine(34) acetyltransferase activity;, P:central nervous system development; P:neuron migration; P:positive regulation of cell migration; P:regulation of transcription by RNA polymerase II; P:tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation; P:tRNA wobble uridine modification;|Q9H9T3 B4DE19 B4DIG1 E2QRI5 Q53G84 Q6AWB0 Q9BVF7 Q9NVZ1,Elongator complex protein 3 {ECO:0000303|PubMed:11714725},Protein lysine acetyltransferase ELP3 {ECO:0000305};tRNA uridine(34) acetyltransferase {ECO:0000305};, PF00583;PF04055;PF16199;, GO:0005737;GO:0005829;GO:0033588;GO:0005730;GO:0005634;GO:0051539;GO:0016407;GO:0046872;GO:0008080;GO:0008607;GO:0000049;GO:0106261;GO:0007417;GO:0001764;GO:0030335;GO:0006357;GO:0002926;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleolus; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:acetyltransferase activity; F:metal ion binding; F:N-acetyltransferase activity; F:phosphorylase kinase regulator activity; F:tRNA binding; F:tRNA uridine(34) acetyltransferase activity;, P:central nervous system development; P:neuron migration; P:positive regulation of cell migration; P:regulation of transcription by RNA polymerase II; P:tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation; P:tRNA wobble uridine modification; scaffold50 indexed_genome mRNA 10346910 10387999 . + . ID=transcript_9463;Q68CJ6 Q6ZP73,Nuclear GTPase SLIP-GC,Speckled-like pattern in the germinal center;, PF00350;, GO:0016607;GO:0005525;GO:0003924;GO:0071222;GO:0043066;GO:0033262;, C:nuclear speck;, F:GTP binding; F:GTPase activity;, P:cellular response to lipopolysaccharide; P:negative regulation of apoptotic process; P:regulation of nuclear cell cycle DNA replication; scaffold50 indexed_genome mRNA 10415999 10546577 . + . ID=transcript_9464;Q6ZMJ2 Q6UXZ1 Q7Z4A1 Q8N4Z7,Scavenger receptor class A member 5 {ECO:0000255|HAMAP-Rule:MF_03070},Scavenger receptor hlg;, PF01391;PF00530;, GO:0009897;GO:0005887;GO:0070287;GO:0005044;GO:0006879;GO:0034605;GO:0006897;GO:0034755;GO:0070207;, C:external side of plasma membrane; C:integral component of plasma membrane;, F:ferritin receptor activity; F:scavenger receptor activity;, P:cellular iron ion homeostasis; P:cellular response to heat; P:endocytosis; P:iron ion transmembrane transport; P:protein homotrimerization; scaffold50 indexed_genome mRNA 10595876 10618156 . - . ID=transcript_9465;Q56NI9 B3KW59 Q49AP4,N-acetyltransferase ESCO2,Establishment factor-like protein 2;Establishment of cohesion 1 homolog 2;, PF13880;PF13878;, GO:0030054;GO:0000785;GO:0010369;GO:0005694;GO:0005794;GO:0005654;GO:0005721;GO:0035861;GO:0001741;GO:0016407;GO:0004468;GO:0046872;GO:0006302;GO:0002244;GO:0034421;GO:0071168;GO:0006275;GO:0007062;, C:cell junction; C:chromatin; C:chromocenter; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:pericentric heterochromatin; C:site of double-strand break; C:XY body;, F:acetyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:metal ion binding;, P:double-strand break repair; P:hematopoietic progenitor cell differentiation; P:post-translational protein acetylation; P:protein localization to chromatin; P:regulation of DNA replication; P:sister chromatid cohesion;|Q56NI9 B3KW59 Q49AP4,N-acetyltransferase ESCO2,Establishment factor-like protein 2;Establishment of cohesion 1 homolog 2;, PF13880;PF13878;, GO:0030054;GO:0000785;GO:0010369;GO:0005694;GO:0005794;GO:0005654;GO:0005721;GO:0035861;GO:0001741;GO:0016407;GO:0004468;GO:0046872;GO:0006302;GO:0002244;GO:0034421;GO:0071168;GO:0006275;GO:0007062;, C:cell junction; C:chromatin; C:chromocenter; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:pericentric heterochromatin; C:site of double-strand break; C:XY body;, F:acetyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:metal ion binding;, P:double-strand break repair; P:hematopoietic progenitor cell differentiation; P:post-translational protein acetylation; P:protein localization to chromatin; P:regulation of DNA replication; P:sister chromatid cohesion; scaffold50 indexed_genome mRNA 10618508 10621328 . - . ID=transcript_9466;Q56NI9 B3KW59 Q49AP4,N-acetyltransferase ESCO2,Establishment factor-like protein 2;Establishment of cohesion 1 homolog 2;, PF13880;PF13878;, GO:0030054;GO:0000785;GO:0010369;GO:0005694;GO:0005794;GO:0005654;GO:0005721;GO:0035861;GO:0001741;GO:0016407;GO:0004468;GO:0046872;GO:0006302;GO:0002244;GO:0034421;GO:0071168;GO:0006275;GO:0007062;, C:cell junction; C:chromatin; C:chromocenter; C:chromosome; C:Golgi apparatus; C:nucleoplasm; C:pericentric heterochromatin; C:site of double-strand break; C:XY body;, F:acetyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:metal ion binding;, P:double-strand break repair; P:hematopoietic progenitor cell differentiation; P:post-translational protein acetylation; P:protein localization to chromatin; P:regulation of DNA replication; P:sister chromatid cohesion; scaffold50 indexed_genome mRNA 10624152 10659983 . + . ID=transcript_9467;Q86WR0 Q0P663 Q96SI2 Q9NV98,Coiled-coil domain-containing protein 25 {ECO:0000305},, PF05670;, GO:0012505;GO:0005887;GO:0003677;GO:2000147;, C:endomembrane system; C:integral component of plasma membrane;, F:DNA binding;, P:positive regulation of cell motility;|Q86WR0 Q0P663 Q96SI2 Q9NV98,Coiled-coil domain-containing protein 25 {ECO:0000305},, PF05670;, GO:0012505;GO:0005887;GO:0003677;GO:2000147;, C:endomembrane system; C:integral component of plasma membrane;, F:DNA binding;, P:positive regulation of cell motility; scaffold50 indexed_genome mRNA 10721551 10745917 . - . ID=transcript_9468;Q6AZY7 Q9UM15 Q9UM16,Scavenger receptor class A member 3,Cellular stress response gene protein;, PF01391;, GO:0005581;GO:0062023;GO:0005783;GO:0005789;GO:0005615;GO:0000139;GO:0016021;GO:0005044;GO:0006979;GO:0009650;, C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:Golgi membrane; C:integral component of membrane;, F:scavenger receptor activity;, P:response to oxidative stress; P:UV protection; scaffold50 indexed_genome mRNA 10760134 10777130 . + . ID=transcript_9469;P10909 B2R9Q1 B3KSE6 P11380 P11381 Q2TU75 Q5HYC1 Q7Z5B9,Clusterin,Aging-associated gene 4 protein {ECO:0000303|Ref.20};Apolipoprotein J {ECO:0000303|PubMed:2387851};Complement cytolysis inhibitor {ECO:0000303|PubMed:2780565};Complement-associated protein SP-40,40 {ECO:0000303|PubMed:1903064};Ku70-binding protein 1;NA1/NA2 {ECO:0000303|PubMed:1903064};Sulfated glycoprotein 2 {ECO:0000303|PubMed:1924317};Testosterone-repressed prostate message 2 {ECO:0000250|UniProtKB:P05371};, PF01093;, GO:0097440;GO:0072562;GO:0009986;GO:0042583;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0043231;GO:0005743;GO:0005739;GO:0097418;GO:0005634;GO:0099020;GO:0048471;GO:0031093;GO:0032991;GO:0034366;GO:0045202;GO:0001540;GO:0051087;GO:0050750;GO:0051787;GO:0046982;GO:0044877;GO:0005102;GO:0048156;GO:0031625;GO:0051082;GO:0019730;GO:0000902;GO:0032286;GO:0051131;GO:0061077;GO:0061741;GO:0006956;GO:0006958;GO:0002434;GO:0045087;GO:0097193;GO:0006629;GO:0001774;GO:0061518;GO:1905907;GO:1902430;GO:0060548;GO:1905892;GO:1905895;GO:1902230;GO:0031333;GO:0090201;GO:1903573;GO:0002576;GO:1905908;GO:1902004;GO:0043065;GO:0010628;GO:2001244;GO:1902998;GO:1901216;GO:0051092;GO:0045429;GO:0032436;GO:0031334;GO:0048260;GO:1902949;GO:0032760;GO:2000060;GO:0017038;GO:0050821;GO:0061740;GO:1900221;GO:0042981;GO:0042127;GO:0030449;GO:1901214;GO:1902847;GO:0001836;GO:0051788;GO:0009615;GO:0043691;, C:apical dendrite; C:blood microparticle; C:cell surface; C:chromaffin granule; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrion; C:neurofibrillary tangle; C:nucleus; C:perinuclear endoplasmic reticulum lumen; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:protein-containing complex; C:spherical high-density lipoprotein particle; C:synapse;, F:amyloid-beta binding; F:chaperone binding; F:low-density lipoprotein particle receptor binding; F:misfolded protein binding; F:protein heterodimerization activity; F:protein-containing complex binding; F:signaling receptor binding; F:tau protein binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:antimicrobial humoral response; P:cell morphogenesis; P:central nervous system myelin maintenance; P:chaperone-mediated protein complex assembly; P:chaperone-mediated protein folding; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; P:complement activation; P:complement activation, classical pathway; P:immune complex clearance; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:lipid metabolic process; P:microglial cell activation; P:microglial cell proliferation; P:negative regulation of amyloid fibril formation; P:negative regulation of amyloid-beta formation; P:negative regulation of cell death; P:negative regulation of cellular response to thapsigargin; P:negative regulation of cellular response to tunicamycin; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of protein-containing complex assembly; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of response to endoplasmic reticulum stress; P:platelet degranulation; P:positive regulation of amyloid fibril formation; P:positive regulation of amyloid-beta formation; P:positive regulation of apoptotic process; P:positive regulation of gene expression; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of neurofibrillary tangle assembly; P:positive regulation of neuron death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein-containing complex assembly; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of tau-protein kinase activity; P:positive regulation of tumor necrosis factor production; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein import; P:protein stabilization; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:regulation of amyloid-beta clearance; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of complement activation; P:regulation of neuron death; P:regulation of neuronal signal transduction; P:release of cytochrome c from mitochondria; P:response to misfolded protein; P:response to virus; P:reverse cholesterol transport;|P10909 B2R9Q1 B3KSE6 P11380 P11381 Q2TU75 Q5HYC1 Q7Z5B9,Clusterin,Aging-associated gene 4 protein {ECO:0000303|Ref.20};Apolipoprotein J {ECO:0000303|PubMed:2387851};Complement cytolysis inhibitor {ECO:0000303|PubMed:2780565};Complement-associated protein SP-40,40 {ECO:0000303|PubMed:1903064};Ku70-binding protein 1;NA1/NA2 {ECO:0000303|PubMed:1903064};Sulfated glycoprotein 2 {ECO:0000303|PubMed:1924317};Testosterone-repressed prostate message 2 {ECO:0000250|UniProtKB:P05371};, PF01093;, GO:0097440;GO:0072562;GO:0009986;GO:0042583;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0043231;GO:0005743;GO:0005739;GO:0097418;GO:0005634;GO:0099020;GO:0048471;GO:0031093;GO:0032991;GO:0034366;GO:0045202;GO:0001540;GO:0051087;GO:0050750;GO:0051787;GO:0046982;GO:0044877;GO:0005102;GO:0048156;GO:0031625;GO:0051082;GO:0019730;GO:0000902;GO:0032286;GO:0051131;GO:0061077;GO:0061741;GO:0006956;GO:0006958;GO:0002434;GO:0045087;GO:0097193;GO:0006629;GO:0001774;GO:0061518;GO:1905907;GO:1902430;GO:0060548;GO:1905892;GO:1905895;GO:1902230;GO:0031333;GO:0090201;GO:1903573;GO:0002576;GO:1905908;GO:1902004;GO:0043065;GO:0010628;GO:2001244;GO:1902998;GO:1901216;GO:0051092;GO:0045429;GO:0032436;GO:0031334;GO:0048260;GO:1902949;GO:0032760;GO:2000060;GO:0017038;GO:0050821;GO:0061740;GO:1900221;GO:0042981;GO:0042127;GO:0030449;GO:1901214;GO:1902847;GO:0001836;GO:0051788;GO:0009615;GO:0043691;, C:apical dendrite; C:blood microparticle; C:cell surface; C:chromaffin granule; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrion; C:neurofibrillary tangle; C:nucleus; C:perinuclear endoplasmic reticulum lumen; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:protein-containing complex; C:spherical high-density lipoprotein particle; C:synapse;, F:amyloid-beta binding; F:chaperone binding; F:low-density lipoprotein particle receptor binding; F:misfolded protein binding; F:protein heterodimerization activity; F:protein-containing complex binding; F:signaling receptor binding; F:tau protein binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:antimicrobial humoral response; P:cell morphogenesis; P:central nervous system myelin maintenance; P:chaperone-mediated protein complex assembly; P:chaperone-mediated protein folding; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; P:complement activation; P:complement activation, classical pathway; P:immune complex clearance; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:lipid metabolic process; P:microglial cell activation; P:microglial cell proliferation; P:negative regulation of amyloid fibril formation; P:negative regulation of amyloid-beta formation; P:negative regulation of cell death; P:negative regulation of cellular response to thapsigargin; P:negative regulation of cellular response to tunicamycin; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of protein-containing complex assembly; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of response to endoplasmic reticulum stress; P:platelet degranulation; P:positive regulation of amyloid fibril formation; P:positive regulation of amyloid-beta formation; P:positive regulation of apoptotic process; P:positive regulation of gene expression; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of neurofibrillary tangle assembly; P:positive regulation of neuron death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein-containing complex assembly; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of tau-protein kinase activity; P:positive regulation of tumor necrosis factor production; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein import; P:protein stabilization; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:regulation of amyloid-beta clearance; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of complement activation; P:regulation of neuron death; P:regulation of neuronal signal transduction; P:release of cytochrome c from mitochondria; P:response to misfolded protein; P:response to virus; P:reverse cholesterol transport;|P10909 B2R9Q1 B3KSE6 P11380 P11381 Q2TU75 Q5HYC1 Q7Z5B9,Clusterin,Aging-associated gene 4 protein {ECO:0000303|Ref.20};Apolipoprotein J {ECO:0000303|PubMed:2387851};Complement cytolysis inhibitor {ECO:0000303|PubMed:2780565};Complement-associated protein SP-40,40 {ECO:0000303|PubMed:1903064};Ku70-binding protein 1;NA1/NA2 {ECO:0000303|PubMed:1903064};Sulfated glycoprotein 2 {ECO:0000303|PubMed:1924317};Testosterone-repressed prostate message 2 {ECO:0000250|UniProtKB:P05371};, PF01093;, GO:0097440;GO:0072562;GO:0009986;GO:0042583;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0043231;GO:0005743;GO:0005739;GO:0097418;GO:0005634;GO:0099020;GO:0048471;GO:0031093;GO:0032991;GO:0034366;GO:0045202;GO:0001540;GO:0051087;GO:0050750;GO:0051787;GO:0046982;GO:0044877;GO:0005102;GO:0048156;GO:0031625;GO:0051082;GO:0019730;GO:0000902;GO:0032286;GO:0051131;GO:0061077;GO:0061741;GO:0006956;GO:0006958;GO:0002434;GO:0045087;GO:0097193;GO:0006629;GO:0001774;GO:0061518;GO:1905907;GO:1902430;GO:0060548;GO:1905892;GO:1905895;GO:1902230;GO:0031333;GO:0090201;GO:1903573;GO:0002576;GO:1905908;GO:1902004;GO:0043065;GO:0010628;GO:2001244;GO:1902998;GO:1901216;GO:0051092;GO:0045429;GO:0032436;GO:0031334;GO:0048260;GO:1902949;GO:0032760;GO:2000060;GO:0017038;GO:0050821;GO:0061740;GO:1900221;GO:0042981;GO:0042127;GO:0030449;GO:1901214;GO:1902847;GO:0001836;GO:0051788;GO:0009615;GO:0043691;, C:apical dendrite; C:blood microparticle; C:cell surface; C:chromaffin granule; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrion; C:neurofibrillary tangle; C:nucleus; C:perinuclear endoplasmic reticulum lumen; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:protein-containing complex; C:spherical high-density lipoprotein particle; C:synapse;, F:amyloid-beta binding; F:chaperone binding; F:low-density lipoprotein particle receptor binding; F:misfolded protein binding; F:protein heterodimerization activity; F:protein-containing complex binding; F:signaling receptor binding; F:tau protein binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:antimicrobial humoral response; P:cell morphogenesis; P:central nervous system myelin maintenance; P:chaperone-mediated protein complex assembly; P:chaperone-mediated protein folding; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; P:complement activation; P:complement activation, classical pathway; P:immune complex clearance; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:lipid metabolic process; P:microglial cell activation; P:microglial cell proliferation; P:negative regulation of amyloid fibril formation; P:negative regulation of amyloid-beta formation; P:negative regulation of cell death; P:negative regulation of cellular response to thapsigargin; P:negative regulation of cellular response to tunicamycin; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of protein-containing complex assembly; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of response to endoplasmic reticulum stress; P:platelet degranulation; P:positive regulation of amyloid fibril formation; P:positive regulation of amyloid-beta formation; P:positive regulation of apoptotic process; P:positive regulation of gene expression; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of neurofibrillary tangle assembly; P:positive regulation of neuron death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein-containing complex assembly; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of tau-protein kinase activity; P:positive regulation of tumor necrosis factor production; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein import; P:protein stabilization; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:regulation of amyloid-beta clearance; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of complement activation; P:regulation of neuron death; P:regulation of neuronal signal transduction; P:release of cytochrome c from mitochondria; P:response to misfolded protein; P:response to virus; P:reverse cholesterol transport;|P10909 B2R9Q1 B3KSE6 P11380 P11381 Q2TU75 Q5HYC1 Q7Z5B9,Clusterin,Aging-associated gene 4 protein {ECO:0000303|Ref.20};Apolipoprotein J {ECO:0000303|PubMed:2387851};Complement cytolysis inhibitor {ECO:0000303|PubMed:2780565};Complement-associated protein SP-40,40 {ECO:0000303|PubMed:1903064};Ku70-binding protein 1;NA1/NA2 {ECO:0000303|PubMed:1903064};Sulfated glycoprotein 2 {ECO:0000303|PubMed:1924317};Testosterone-repressed prostate message 2 {ECO:0000250|UniProtKB:P05371};, PF01093;, GO:0097440;GO:0072562;GO:0009986;GO:0042583;GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0043231;GO:0005743;GO:0005739;GO:0097418;GO:0005634;GO:0099020;GO:0048471;GO:0031093;GO:0032991;GO:0034366;GO:0045202;GO:0001540;GO:0051087;GO:0050750;GO:0051787;GO:0046982;GO:0044877;GO:0005102;GO:0048156;GO:0031625;GO:0051082;GO:0019730;GO:0000902;GO:0032286;GO:0051131;GO:0061077;GO:0061741;GO:0006956;GO:0006958;GO:0002434;GO:0045087;GO:0097193;GO:0006629;GO:0001774;GO:0061518;GO:1905907;GO:1902430;GO:0060548;GO:1905892;GO:1905895;GO:1902230;GO:0031333;GO:0090201;GO:1903573;GO:0002576;GO:1905908;GO:1902004;GO:0043065;GO:0010628;GO:2001244;GO:1902998;GO:1901216;GO:0051092;GO:0045429;GO:0032436;GO:0031334;GO:0048260;GO:1902949;GO:0032760;GO:2000060;GO:0017038;GO:0050821;GO:0061740;GO:1900221;GO:0042981;GO:0042127;GO:0030449;GO:1901214;GO:1902847;GO:0001836;GO:0051788;GO:0009615;GO:0043691;, C:apical dendrite; C:blood microparticle; C:cell surface; C:chromaffin granule; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrion; C:neurofibrillary tangle; C:nucleus; C:perinuclear endoplasmic reticulum lumen; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:protein-containing complex; C:spherical high-density lipoprotein particle; C:synapse;, F:amyloid-beta binding; F:chaperone binding; F:low-density lipoprotein particle receptor binding; F:misfolded protein binding; F:protein heterodimerization activity; F:protein-containing complex binding; F:signaling receptor binding; F:tau protein binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:antimicrobial humoral response; P:cell morphogenesis; P:central nervous system myelin maintenance; P:chaperone-mediated protein complex assembly; P:chaperone-mediated protein folding; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; P:complement activation; P:complement activation, classical pathway; P:immune complex clearance; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:lipid metabolic process; P:microglial cell activation; P:microglial cell proliferation; P:negative regulation of amyloid fibril formation; P:negative regulation of amyloid-beta formation; P:negative regulation of cell death; P:negative regulation of cellular response to thapsigargin; P:negative regulation of cellular response to tunicamycin; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of protein-containing complex assembly; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of response to endoplasmic reticulum stress; P:platelet degranulation; P:positive regulation of amyloid fibril formation; P:positive regulation of amyloid-beta formation; P:positive regulation of apoptotic process; P:positive regulation of gene expression; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of neurofibrillary tangle assembly; P:positive regulation of neuron death; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein-containing complex assembly; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of tau-protein kinase activity; P:positive regulation of tumor necrosis factor production; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein import; P:protein stabilization; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:regulation of amyloid-beta clearance; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of complement activation; P:regulation of neuron death; P:regulation of neuronal signal transduction; P:release of cytochrome c from mitochondria; P:response to misfolded protein; P:response to virus; P:reverse cholesterol transport; scaffold50 indexed_genome mRNA 11057674 11083877 . + . ID=transcript_9470;O95139 A8K0Y7 Q5VYT2 Q6IB84,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6,Complex I-B17;NADH-ubiquinone oxidoreductase B17 subunit;, PF09782;, GO:0016021;GO:0005743;GO:0031966;GO:0005747;GO:0005739;GO:0005654;GO:0008137;GO:0042775;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|Q9NS56 O43273 Q6P987 Q9NS55 Q9UNR9,E3 ubiquitin-protein ligase Topors,RING-type E3 ubiquitin transferase Topors {ECO:0000305};SUMO1-protein E3 ligase Topors;Topoisomerase I-binding RING finger protein;Topoisomerase I-binding arginine/serine-rich protein;Tumor suppressor p53-binding protein 3;, , GO:0005814;GO:0036064;GO:0000930;GO:0030496;GO:0016607;GO:0005654;GO:0005634;GO:0032391;GO:0016605;GO:0000922;GO:0000151;GO:0003823;GO:0003677;GO:0044547;GO:0046872;GO:0019789;GO:0061630;GO:0004842;GO:0006974;GO:0008630;GO:0042771;GO:0051457;GO:0043066;GO:0035845;GO:0045893;GO:0051443;GO:0043161;GO:0070936;GO:0034504;GO:0006513;GO:0000209;GO:0016925;GO:0042127;GO:0010842;GO:0046549;GO:0046548;GO:0006351;GO:0006511;, C:centriole; C:ciliary basal body; C:gamma-tubulin complex; C:midbody; C:nuclear speck; C:nucleoplasm; C:nucleus; C:photoreceptor connecting cilium; C:PML body; C:spindle pole; C:ubiquitin ligase complex;, F:antigen binding; F:DNA binding; F:DNA topoisomerase binding; F:metal ion binding; F:SUMO transferase activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:maintenance of protein location in nucleus; P:negative regulation of apoptotic process; P:photoreceptor cell outer segment organization; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin-protein transferase activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein localization to nucleus; P:protein monoubiquitination; P:protein polyubiquitination; P:protein sumoylation; P:regulation of cell population proliferation; P:retina layer formation; P:retinal cone cell development; P:retinal rod cell development; P:transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process;|Q9NS56 O43273 Q6P987 Q9NS55 Q9UNR9,E3 ubiquitin-protein ligase Topors,RING-type E3 ubiquitin transferase Topors {ECO:0000305};SUMO1-protein E3 ligase Topors;Topoisomerase I-binding RING finger protein;Topoisomerase I-binding arginine/serine-rich protein;Tumor suppressor p53-binding protein 3;, , GO:0005814;GO:0036064;GO:0000930;GO:0030496;GO:0016607;GO:0005654;GO:0005634;GO:0032391;GO:0016605;GO:0000922;GO:0000151;GO:0003823;GO:0003677;GO:0044547;GO:0046872;GO:0019789;GO:0061630;GO:0004842;GO:0006974;GO:0008630;GO:0042771;GO:0051457;GO:0043066;GO:0035845;GO:0045893;GO:0051443;GO:0043161;GO:0070936;GO:0034504;GO:0006513;GO:0000209;GO:0016925;GO:0042127;GO:0010842;GO:0046549;GO:0046548;GO:0006351;GO:0006511;, C:centriole; C:ciliary basal body; C:gamma-tubulin complex; C:midbody; C:nuclear speck; C:nucleoplasm; C:nucleus; C:photoreceptor connecting cilium; C:PML body; C:spindle pole; C:ubiquitin ligase complex;, F:antigen binding; F:DNA binding; F:DNA topoisomerase binding; F:metal ion binding; F:SUMO transferase activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:maintenance of protein location in nucleus; P:negative regulation of apoptotic process; P:photoreceptor cell outer segment organization; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin-protein transferase activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein localization to nucleus; P:protein monoubiquitination; P:protein polyubiquitination; P:protein sumoylation; P:regulation of cell population proliferation; P:retina layer formation; P:retinal cone cell development; P:retinal rod cell development; P:transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process; scaffold50 indexed_genome mRNA 11111377 11151233 . + . ID=transcript_9471;O95786 A2RU81 Q5HYE1 Q5VYT1 Q9NT04,Antiviral innate immune response receptor RIG-I {ECO:0000305},DEAD box protein 58;Probable ATP-dependent RNA helicase DDX58;RIG-I-like receptor 1;Retinoic acid-inducible gene 1 protein;Retinoic acid-inducible gene I protein;, PF16739;PF00270;PF00271;PF18119;PF11648;, GO:0015629;GO:0005923;GO:0005737;GO:0005829;GO:0005886;GO:1990904;GO:0032587;GO:0005524;GO:0003725;GO:0042802;GO:0003724;GO:0003727;GO:0031625;GO:0008270;GO:0140374;GO:0071360;GO:0039528;GO:0051607;GO:0009597;GO:0045087;GO:0032480;GO:0002230;GO:0051091;GO:0010628;GO:0032725;GO:0032727;GO:0032728;GO:0032755;GO:0032757;GO:0002735;GO:0060760;GO:0045944;GO:0032760;GO:0016579;GO:0030334;GO:0034344;GO:0043330;GO:0009615;GO:0039529;GO:0016032;, C:actin cytoskeleton; C:bicellular tight junction; C:cytoplasm; C:cytosol; C:plasma membrane; C:ribonucleoprotein complex; C:ruffle membrane;, F:ATP binding; F:double-stranded RNA binding; F:identical protein binding; F:RNA helicase activity; F:single-stranded RNA binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:antiviral innate immune response; P:cellular response to exogenous dsRNA; P:cytoplasmic pattern recognition receptor signaling pathway in response to virus; P:defense response to virus; P:detection of virus; P:innate immune response; P:negative regulation of type I interferon production; P:positive regulation of defense response to virus by host; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of response to cytokine stimulus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:protein deubiquitination; P:regulation of cell migration; P:regulation of type III interferon production; P:response to exogenous dsRNA; P:response to virus; P:RIG-I signaling pathway; P:viral process;|O95786 A2RU81 Q5HYE1 Q5VYT1 Q9NT04,Antiviral innate immune response receptor RIG-I {ECO:0000305},DEAD box protein 58;Probable ATP-dependent RNA helicase DDX58;RIG-I-like receptor 1;Retinoic acid-inducible gene 1 protein;Retinoic acid-inducible gene I protein;, PF16739;PF00270;PF00271;PF18119;PF11648;, GO:0015629;GO:0005923;GO:0005737;GO:0005829;GO:0005886;GO:1990904;GO:0032587;GO:0005524;GO:0003725;GO:0042802;GO:0003724;GO:0003727;GO:0031625;GO:0008270;GO:0140374;GO:0071360;GO:0039528;GO:0051607;GO:0009597;GO:0045087;GO:0032480;GO:0002230;GO:0051091;GO:0010628;GO:0032725;GO:0032727;GO:0032728;GO:0032755;GO:0032757;GO:0002735;GO:0060760;GO:0045944;GO:0032760;GO:0016579;GO:0030334;GO:0034344;GO:0043330;GO:0009615;GO:0039529;GO:0016032;, C:actin cytoskeleton; C:bicellular tight junction; C:cytoplasm; C:cytosol; C:plasma membrane; C:ribonucleoprotein complex; C:ruffle membrane;, F:ATP binding; F:double-stranded RNA binding; F:identical protein binding; F:RNA helicase activity; F:single-stranded RNA binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:antiviral innate immune response; P:cellular response to exogenous dsRNA; P:cytoplasmic pattern recognition receptor signaling pathway in response to virus; P:defense response to virus; P:detection of virus; P:innate immune response; P:negative regulation of type I interferon production; P:positive regulation of defense response to virus by host; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of response to cytokine stimulus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:protein deubiquitination; P:regulation of cell migration; P:regulation of type III interferon production; P:response to exogenous dsRNA; P:response to virus; P:RIG-I signaling pathway; P:viral process; scaffold50 indexed_genome mRNA 11156094 11221670 . - . ID=transcript_9472;P21399 D3DRK7 Q14652 Q5VZA7,Cytoplasmic aconitate hydratase,Citrate hydro-lyase;Ferritin repressor protein;Iron regulatory protein 1;Iron-responsive element-binding protein 1;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005794;GO:0005739;GO:0051538;GO:0051539;GO:0003994;GO:0047780;GO:0030350;GO:0046872;GO:0003723;GO:0006879;GO:0006101;GO:0050892;GO:0009791;GO:0006417;GO:0010040;GO:0006099;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:mitochondrion;, F:3 iron, 4 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:intestinal absorption; P:post-embryonic development; P:regulation of translation; P:response to iron(II) ion; P:tricarboxylic acid cycle;|P21399 D3DRK7 Q14652 Q5VZA7,Cytoplasmic aconitate hydratase,Citrate hydro-lyase;Ferritin repressor protein;Iron regulatory protein 1;Iron-responsive element-binding protein 1;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005794;GO:0005739;GO:0051538;GO:0051539;GO:0003994;GO:0047780;GO:0030350;GO:0046872;GO:0003723;GO:0006879;GO:0006101;GO:0050892;GO:0009791;GO:0006417;GO:0010040;GO:0006099;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:mitochondrion;, F:3 iron, 4 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:intestinal absorption; P:post-embryonic development; P:regulation of translation; P:response to iron(II) ion; P:tricarboxylic acid cycle;|P21399 D3DRK7 Q14652 Q5VZA7,Cytoplasmic aconitate hydratase,Citrate hydro-lyase;Ferritin repressor protein;Iron regulatory protein 1;Iron-responsive element-binding protein 1;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005794;GO:0005739;GO:0051538;GO:0051539;GO:0003994;GO:0047780;GO:0030350;GO:0046872;GO:0003723;GO:0006879;GO:0006101;GO:0050892;GO:0009791;GO:0006417;GO:0010040;GO:0006099;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:mitochondrion;, F:3 iron, 4 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:intestinal absorption; P:post-embryonic development; P:regulation of translation; P:response to iron(II) ion; P:tricarboxylic acid cycle;|P21399 D3DRK7 Q14652 Q5VZA7,Cytoplasmic aconitate hydratase,Citrate hydro-lyase;Ferritin repressor protein;Iron regulatory protein 1;Iron-responsive element-binding protein 1;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005794;GO:0005739;GO:0051538;GO:0051539;GO:0003994;GO:0047780;GO:0030350;GO:0046872;GO:0003723;GO:0006879;GO:0006101;GO:0050892;GO:0009791;GO:0006417;GO:0010040;GO:0006099;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:mitochondrion;, F:3 iron, 4 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:intestinal absorption; P:post-embryonic development; P:regulation of translation; P:response to iron(II) ion; P:tricarboxylic acid cycle;|P21399 D3DRK7 Q14652 Q5VZA7,Cytoplasmic aconitate hydratase,Citrate hydro-lyase;Ferritin repressor protein;Iron regulatory protein 1;Iron-responsive element-binding protein 1;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005794;GO:0005739;GO:0051538;GO:0051539;GO:0003994;GO:0047780;GO:0030350;GO:0046872;GO:0003723;GO:0006879;GO:0006101;GO:0050892;GO:0009791;GO:0006417;GO:0010040;GO:0006099;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:mitochondrion;, F:3 iron, 4 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:intestinal absorption; P:post-embryonic development; P:regulation of translation; P:response to iron(II) ion; P:tricarboxylic acid cycle; scaffold50 indexed_genome mRNA 15748947 15770116 . + . ID=transcript_9473;Q96LT7 A8K5W0 D3DRK6 G8I0B6 Q6NUS9,Guanine nucleotide exchange C9orf72 {ECO:0000305},, PF15019;, GO:0005776;GO:0044295;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0005768;GO:0005615;GO:0090543;GO:0032045;GO:0043231;GO:0005764;GO:0044304;GO:0031965;GO:0005634;GO:0000932;GO:0043204;GO:0005085;GO:0031267;GO:0006914;GO:0048675;GO:0006897;GO:1902774;GO:0001933;GO:0016239;GO:0110053;GO:2000785;GO:0010506;GO:1903432;GO:0034063;, C:autophagosome; C:axonal growth cone; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:endosome; C:extracellular space; C:Flemming body; C:guanyl-nucleotide exchange factor complex; C:intracellular membrane-bounded organelle; C:lysosome; C:main axon; C:nuclear membrane; C:nucleus; C:P-body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:autophagy; P:axon extension; P:endocytosis; P:late endosome to lysosome transport; P:negative regulation of protein phosphorylation; P:positive regulation of macroautophagy; P:regulation of actin filament organization; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of TORC1 signaling; P:stress granule assembly;|Q96LT7 A8K5W0 D3DRK6 G8I0B6 Q6NUS9,Guanine nucleotide exchange C9orf72 {ECO:0000305},, PF15019;, GO:0005776;GO:0044295;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0005768;GO:0005615;GO:0090543;GO:0032045;GO:0043231;GO:0005764;GO:0044304;GO:0031965;GO:0005634;GO:0000932;GO:0043204;GO:0005085;GO:0031267;GO:0006914;GO:0048675;GO:0006897;GO:1902774;GO:0001933;GO:0016239;GO:0110053;GO:2000785;GO:0010506;GO:1903432;GO:0034063;, C:autophagosome; C:axonal growth cone; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:endosome; C:extracellular space; C:Flemming body; C:guanyl-nucleotide exchange factor complex; C:intracellular membrane-bounded organelle; C:lysosome; C:main axon; C:nuclear membrane; C:nucleus; C:P-body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:autophagy; P:axon extension; P:endocytosis; P:late endosome to lysosome transport; P:negative regulation of protein phosphorylation; P:positive regulation of macroautophagy; P:regulation of actin filament organization; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of TORC1 signaling; P:stress granule assembly;|Q96LT7 A8K5W0 D3DRK6 G8I0B6 Q6NUS9,Guanine nucleotide exchange C9orf72 {ECO:0000305},, PF15019;, GO:0005776;GO:0044295;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0005768;GO:0005615;GO:0090543;GO:0032045;GO:0043231;GO:0005764;GO:0044304;GO:0031965;GO:0005634;GO:0000932;GO:0043204;GO:0005085;GO:0031267;GO:0006914;GO:0048675;GO:0006897;GO:1902774;GO:0001933;GO:0016239;GO:0110053;GO:2000785;GO:0010506;GO:1903432;GO:0034063;, C:autophagosome; C:axonal growth cone; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:endosome; C:extracellular space; C:Flemming body; C:guanyl-nucleotide exchange factor complex; C:intracellular membrane-bounded organelle; C:lysosome; C:main axon; C:nuclear membrane; C:nucleus; C:P-body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:autophagy; P:axon extension; P:endocytosis; P:late endosome to lysosome transport; P:negative regulation of protein phosphorylation; P:positive regulation of macroautophagy; P:regulation of actin filament organization; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of TORC1 signaling; P:stress granule assembly;|Q96LT7 A8K5W0 D3DRK6 G8I0B6 Q6NUS9,Guanine nucleotide exchange C9orf72 {ECO:0000305},, PF15019;, GO:0005776;GO:0044295;GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0005768;GO:0005615;GO:0090543;GO:0032045;GO:0043231;GO:0005764;GO:0044304;GO:0031965;GO:0005634;GO:0000932;GO:0043204;GO:0005085;GO:0031267;GO:0006914;GO:0048675;GO:0006897;GO:1902774;GO:0001933;GO:0016239;GO:0110053;GO:2000785;GO:0010506;GO:1903432;GO:0034063;, C:autophagosome; C:axonal growth cone; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:endosome; C:extracellular space; C:Flemming body; C:guanyl-nucleotide exchange factor complex; C:intracellular membrane-bounded organelle; C:lysosome; C:main axon; C:nuclear membrane; C:nucleus; C:P-body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:autophagy; P:axon extension; P:endocytosis; P:late endosome to lysosome transport; P:negative regulation of protein phosphorylation; P:positive regulation of macroautophagy; P:regulation of actin filament organization; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of TORC1 signaling; P:stress granule assembly; scaffold50 indexed_genome mRNA 15793366 16011264 . + . ID=transcript_9474;Q86TA1 Q8NEB4 Q9H8V4,MOB kinase activator 3B,Mob1 homolog 2b;Mps one binder kinase activator-like 2B;, PF03637;, GO:0046872;GO:0035330;, , F:metal ion binding;, P:regulation of hippo signaling; scaffold50 indexed_genome mRNA 16030753 16037603 . + . ID=transcript_9475;Q9NQ60 B2RPB3 B7ZMK1 Q5TCU1 Q96L22,Equatorin,Acrosome formation-associated factor;, PF15339;, GO:0002079;GO:0016021;GO:0002081;GO:0005886;GO:0060478;GO:0006897;GO:0007342;, C:inner acrosomal membrane; C:integral component of membrane; C:outer acrosomal membrane; C:plasma membrane;, , P:acrosomal vesicle exocytosis; P:endocytosis; P:fusion of sperm to egg plasma membrane involved in single fertilization; scaffold50 indexed_genome mRNA 16040141 16110232 . + . ID=transcript_9476;Q8N1G1 Q9ULT2,RNA exonuclease 1 homolog,Elongin-A-binding protein 1;Transcription elongation factor B polypeptide 3-binding protein 1;, PF15870;, GO:0016604;GO:0005654;GO:0005634;GO:0004527;GO:0003676;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:exonuclease activity; F:nucleic acid binding;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold50 indexed_genome mRNA 16112419 16196196 . - . ID=transcript_9477;Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q02763 A8K6W0 B4DH20 B4DHD3 D3DRK5 E7EWI2 Q5TCU2 Q8IV34,Angiopoietin-1 receptor,Endothelial tyrosine kinase;Tunica interna endothelial cell kinase;Tyrosine kinase with Ig and EGF homology domains-2;Tyrosine-protein kinase receptor TEK;Tyrosine-protein kinase receptor TIE-2;p140 TEK;, PF00041;PF10430;PF07714;, GO:0016324;GO:0009925;GO:0016323;GO:0009986;GO:0005911;GO:0034451;GO:0005737;GO:0005576;GO:0005925;GO:0005887;GO:0045121;GO:0005902;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042802;GO:0004672;GO:0004713;GO:0038023;GO:0004714;GO:0001525;GO:0007267;GO:0060216;GO:0001958;GO:0001935;GO:0072012;GO:0007507;GO:0060347;GO:0050900;GO:0000165;GO:0007275;GO:0016525;GO:0043066;GO:2000352;GO:0050728;GO:0018108;GO:2000251;GO:0045766;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:1902533;GO:0033674;GO:0043410;GO:0043552;GO:0014068;GO:0051897;GO:0001934;GO:0046777;GO:2000351;GO:0032878;GO:0043114;GO:0051591;GO:0043627;GO:0001666;GO:0043434;GO:0007165;GO:0002040;GO:0034446;GO:0048014;GO:0007169;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell junction; C:centriolar satellite; C:cytoplasm; C:extracellular region; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:microvillus; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:identical protein binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:signaling receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:cell-cell signaling; P:definitive hemopoiesis; P:endochondral ossification; P:endothelial cell proliferation; P:glomerulus vasculature development; P:heart development; P:heart trabecula formation; P:leukocyte migration; P:MAPK cascade; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of intracellular signal transduction; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:protein autophosphorylation; P:regulation of endothelial cell apoptotic process; P:regulation of establishment or maintenance of cell polarity; P:regulation of vascular permeability; P:response to cAMP; P:response to estrogen; P:response to hypoxia; P:response to peptide hormone; P:signal transduction; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; P:Tie signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold50 indexed_genome mRNA 16229819 16285018 . - . ID=transcript_9478;Q96LB3 Q3B789 Q5VY34 Q6PGQ8 Q9H643 Q9H8G7,Intraflagellar transport protein 74 homolog,Capillary morphogenesis gene 1 protein;Coiled-coil domain-containing protein 2;, , GO:0005813;GO:0097542;GO:0005929;GO:0031410;GO:0030992;GO:0031514;GO:0005634;GO:0048487;GO:0003682;GO:0060271;GO:0007368;GO:0007507;GO:0035735;GO:0003334;GO:0050680;GO:1905515;GO:0007219;GO:0033630;GO:0045944;, C:centrosome; C:ciliary tip; C:cilium; C:cytoplasmic vesicle; C:intraciliary transport particle B; C:motile cilium; C:nucleus;, F:beta-tubulin binding; F:chromatin binding;, P:cilium assembly; P:determination of left/right symmetry; P:heart development; P:intraciliary transport involved in cilium assembly; P:keratinocyte development; P:negative regulation of epithelial cell proliferation; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of transcription by RNA polymerase II;|Q96LB3 Q3B789 Q5VY34 Q6PGQ8 Q9H643 Q9H8G7,Intraflagellar transport protein 74 homolog,Capillary morphogenesis gene 1 protein;Coiled-coil domain-containing protein 2;, , GO:0005813;GO:0097542;GO:0005929;GO:0031410;GO:0030992;GO:0031514;GO:0005634;GO:0048487;GO:0003682;GO:0060271;GO:0007368;GO:0007507;GO:0035735;GO:0003334;GO:0050680;GO:1905515;GO:0007219;GO:0033630;GO:0045944;, C:centrosome; C:ciliary tip; C:cilium; C:cytoplasmic vesicle; C:intraciliary transport particle B; C:motile cilium; C:nucleus;, F:beta-tubulin binding; F:chromatin binding;, P:cilium assembly; P:determination of left/right symmetry; P:heart development; P:intraciliary transport involved in cilium assembly; P:keratinocyte development; P:negative regulation of epithelial cell proliferation; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of transcription by RNA polymerase II;|Q96LB3 Q3B789 Q5VY34 Q6PGQ8 Q9H643 Q9H8G7,Intraflagellar transport protein 74 homolog,Capillary morphogenesis gene 1 protein;Coiled-coil domain-containing protein 2;, , GO:0005813;GO:0097542;GO:0005929;GO:0031410;GO:0030992;GO:0031514;GO:0005634;GO:0048487;GO:0003682;GO:0060271;GO:0007368;GO:0007507;GO:0035735;GO:0003334;GO:0050680;GO:1905515;GO:0007219;GO:0033630;GO:0045944;, C:centrosome; C:ciliary tip; C:cilium; C:cytoplasmic vesicle; C:intraciliary transport particle B; C:motile cilium; C:nucleus;, F:beta-tubulin binding; F:chromatin binding;, P:cilium assembly; P:determination of left/right symmetry; P:heart development; P:intraciliary transport involved in cilium assembly; P:keratinocyte development; P:negative regulation of epithelial cell proliferation; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of transcription by RNA polymerase II; scaffold50 indexed_genome mRNA 16288546 16326937 . - . ID=transcript_9479;Q96LB3 Q3B789 Q5VY34 Q6PGQ8 Q9H643 Q9H8G7,Intraflagellar transport protein 74 homolog,Capillary morphogenesis gene 1 protein;Coiled-coil domain-containing protein 2;, , GO:0005813;GO:0097542;GO:0005929;GO:0031410;GO:0030992;GO:0031514;GO:0005634;GO:0048487;GO:0003682;GO:0060271;GO:0007368;GO:0007507;GO:0035735;GO:0003334;GO:0050680;GO:1905515;GO:0007219;GO:0033630;GO:0045944;, C:centrosome; C:ciliary tip; C:cilium; C:cytoplasmic vesicle; C:intraciliary transport particle B; C:motile cilium; C:nucleus;, F:beta-tubulin binding; F:chromatin binding;, P:cilium assembly; P:determination of left/right symmetry; P:heart development; P:intraciliary transport involved in cilium assembly; P:keratinocyte development; P:negative regulation of epithelial cell proliferation; P:non-motile cilium assembly; P:Notch signaling pathway; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of transcription by RNA polymerase II; scaffold50 indexed_genome mRNA 16328974 16348629 . + . ID=transcript_9480;Q9Y263 Q53EU5 Q5VY33 Q9NUL8 Q9NVE9 Q9UF53 Q9Y5L1,Phospholipase A-2-activating protein,, PF09070;PF08324;PF00400;, GO:0005737;GO:0070062;GO:0005634;GO:0045202;GO:0016005;GO:0043130;GO:0071222;GO:0006954;GO:0016236;GO:1900045;GO:0007399;GO:0006644;GO:1903861;GO:2001224;GO:0032430;GO:1903423;GO:0006693;GO:0043161;GO:0007165;GO:0010992;GO:0043162;, C:cytoplasm; C:extracellular exosome; C:nucleus; C:synapse;, F:phospholipase A2 activator activity; F:ubiquitin binding;, P:cellular response to lipopolysaccharide; P:inflammatory response; P:macroautophagy; P:negative regulation of protein K63-linked ubiquitination; P:nervous system development; P:phospholipid metabolic process; P:positive regulation of dendrite extension; P:positive regulation of neuron migration; P:positive regulation of phospholipase A2 activity; P:positive regulation of synaptic vesicle recycling; P:prostaglandin metabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction; P:ubiquitin recycling; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9Y263 Q53EU5 Q5VY33 Q9NUL8 Q9NVE9 Q9UF53 Q9Y5L1,Phospholipase A-2-activating protein,, PF09070;PF08324;PF00400;, GO:0005737;GO:0070062;GO:0005634;GO:0045202;GO:0016005;GO:0043130;GO:0071222;GO:0006954;GO:0016236;GO:1900045;GO:0007399;GO:0006644;GO:1903861;GO:2001224;GO:0032430;GO:1903423;GO:0006693;GO:0043161;GO:0007165;GO:0010992;GO:0043162;, C:cytoplasm; C:extracellular exosome; C:nucleus; C:synapse;, F:phospholipase A2 activator activity; F:ubiquitin binding;, P:cellular response to lipopolysaccharide; P:inflammatory response; P:macroautophagy; P:negative regulation of protein K63-linked ubiquitination; P:nervous system development; P:phospholipid metabolic process; P:positive regulation of dendrite extension; P:positive regulation of neuron migration; P:positive regulation of phospholipase A2 activity; P:positive regulation of synaptic vesicle recycling; P:prostaglandin metabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction; P:ubiquitin recycling; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold50 indexed_genome mRNA 16354189 16361226 . + . ID=transcript_9481;Q9Y263 Q53EU5 Q5VY33 Q9NUL8 Q9NVE9 Q9UF53 Q9Y5L1,Phospholipase A-2-activating protein,, PF09070;PF08324;PF00400;, GO:0005737;GO:0070062;GO:0005634;GO:0045202;GO:0016005;GO:0043130;GO:0071222;GO:0006954;GO:0016236;GO:1900045;GO:0007399;GO:0006644;GO:1903861;GO:2001224;GO:0032430;GO:1903423;GO:0006693;GO:0043161;GO:0007165;GO:0010992;GO:0043162;, C:cytoplasm; C:extracellular exosome; C:nucleus; C:synapse;, F:phospholipase A2 activator activity; F:ubiquitin binding;, P:cellular response to lipopolysaccharide; P:inflammatory response; P:macroautophagy; P:negative regulation of protein K63-linked ubiquitination; P:nervous system development; P:phospholipid metabolic process; P:positive regulation of dendrite extension; P:positive regulation of neuron migration; P:positive regulation of phospholipase A2 activity; P:positive regulation of synaptic vesicle recycling; P:prostaglandin metabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction; P:ubiquitin recycling; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold50 indexed_genome mRNA 16364707 16365502 . + . ID=transcript_9482;Q9Y263 Q53EU5 Q5VY33 Q9NUL8 Q9NVE9 Q9UF53 Q9Y5L1,Phospholipase A-2-activating protein,, PF09070;PF08324;PF00400;, GO:0005737;GO:0070062;GO:0005634;GO:0045202;GO:0016005;GO:0043130;GO:0071222;GO:0006954;GO:0016236;GO:1900045;GO:0007399;GO:0006644;GO:1903861;GO:2001224;GO:0032430;GO:1903423;GO:0006693;GO:0043161;GO:0007165;GO:0010992;GO:0043162;, C:cytoplasm; C:extracellular exosome; C:nucleus; C:synapse;, F:phospholipase A2 activator activity; F:ubiquitin binding;, P:cellular response to lipopolysaccharide; P:inflammatory response; P:macroautophagy; P:negative regulation of protein K63-linked ubiquitination; P:nervous system development; P:phospholipid metabolic process; P:positive regulation of dendrite extension; P:positive regulation of neuron migration; P:positive regulation of phospholipase A2 activity; P:positive regulation of synaptic vesicle recycling; P:prostaglandin metabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction; P:ubiquitin recycling; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold51 indexed_genome mRNA 77998 233913 . - . ID=transcript_9483;Q6ZWH5 A8MWG1 B9ZVR0 Q45VJ4 Q6ZR11 Q7Z671 Q86XB1 Q96MB3,Serine/threonine-protein kinase Nek10 {ECO:0000305},Never in mitosis A-related kinase 10;, PF00069;, GO:0005576;GO:1902911;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0120197;GO:0043406;GO:0031954;GO:0006468;GO:1902749;GO:0070372;, C:extracellular region; C:protein kinase complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:mucociliary clearance; P:positive regulation of MAP kinase activity; P:positive regulation of protein autophosphorylation; P:protein phosphorylation; P:regulation of cell cycle G2/M phase transition; P:regulation of ERK1 and ERK2 cascade;|Q6ZWH5 A8MWG1 B9ZVR0 Q45VJ4 Q6ZR11 Q7Z671 Q86XB1 Q96MB3,Serine/threonine-protein kinase Nek10 {ECO:0000305},Never in mitosis A-related kinase 10;, PF00069;, GO:0005576;GO:1902911;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0120197;GO:0043406;GO:0031954;GO:0006468;GO:1902749;GO:0070372;, C:extracellular region; C:protein kinase complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:mucociliary clearance; P:positive regulation of MAP kinase activity; P:positive regulation of protein autophosphorylation; P:protein phosphorylation; P:regulation of cell cycle G2/M phase transition; P:regulation of ERK1 and ERK2 cascade; scaffold51 indexed_genome mRNA 347166 369364 . - . ID=transcript_9484;C9JST9 D3K174 D3K175 O60350 Q6AHZ9 Q9HC88 Q9UIB9,Sodium bicarbonate cotransporter 3,Electroneutral Na/HCO(3) cotransporter;Sodium bicarbonate cotransporter 2;Sodium bicarbonate cotransporter 2b;Solute carrier family 4 member 7;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0031410;GO:0016021;GO:0016020;GO:0005886;GO:0032420;GO:0045202;GO:0005452;GO:0008510;GO:0022857;GO:0060117;GO:0015701;GO:0050801;GO:0051453;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:membrane; C:plasma membrane; C:stereocilium; C:synapse;, F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:auditory receptor cell development; P:bicarbonate transport; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport;|Q8N3U2 Q8TC60 Q9UKX8,Electroneutral sodium bicarbonate exchanger 1,Electroneutral Na(+)-driven Cl-HCO3 exchanger;Solute carrier family 4 member 8;k-NBC3;, PF07565;PF00955;, GO:0032279;GO:0043679;GO:0030425;GO:0097386;GO:0098978;GO:0097457;GO:0016021;GO:0016020;GO:0043005;GO:0032809;GO:0005886;GO:0098793;GO:0042734;GO:0032280;GO:0008021;GO:0043195;GO:0015301;GO:0015106;GO:0015108;GO:0005452;GO:0015081;GO:0008510;GO:0022857;GO:0015701;GO:1902476;GO:0050801;GO:0050804;GO:2000302;GO:0051453;GO:0042391;GO:0035725;GO:0055085;GO:0150104;, C:asymmetric synapse; C:axon terminus; C:dendrite; C:glial cell projection; C:glutamatergic synapse; C:hippocampal mossy fiber; C:integral component of membrane; C:membrane; C:neuron projection; C:neuronal cell body membrane; C:plasma membrane; C:presynapse; C:presynaptic membrane; C:symmetric synapse; C:synaptic vesicle; C:terminal bouton;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride transmembrane transporter activity; F:inorganic anion exchanger activity; F:sodium ion transmembrane transporter activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:chloride transmembrane transport; P:ion homeostasis; P:modulation of chemical synaptic transmission; P:positive regulation of synaptic vesicle exocytosis; P:regulation of intracellular pH; P:regulation of membrane potential; P:sodium ion transmembrane transport; P:transmembrane transport; P:transport across blood-brain barrier; scaffold51 indexed_genome mRNA 369405 400739 . - . ID=transcript_9485;C9JST9 D3K174 D3K175 O60350 Q6AHZ9 Q9HC88 Q9UIB9,Sodium bicarbonate cotransporter 3,Electroneutral Na/HCO(3) cotransporter;Sodium bicarbonate cotransporter 2;Sodium bicarbonate cotransporter 2b;Solute carrier family 4 member 7;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0031410;GO:0016021;GO:0016020;GO:0005886;GO:0032420;GO:0045202;GO:0005452;GO:0008510;GO:0022857;GO:0060117;GO:0015701;GO:0050801;GO:0051453;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:membrane; C:plasma membrane; C:stereocilium; C:synapse;, F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:auditory receptor cell development; P:bicarbonate transport; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport;|C9JST9 D3K174 D3K175 O60350 Q6AHZ9 Q9HC88 Q9UIB9,Sodium bicarbonate cotransporter 3,Electroneutral Na/HCO(3) cotransporter;Sodium bicarbonate cotransporter 2;Sodium bicarbonate cotransporter 2b;Solute carrier family 4 member 7;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0031410;GO:0016021;GO:0016020;GO:0005886;GO:0032420;GO:0045202;GO:0005452;GO:0008510;GO:0022857;GO:0060117;GO:0015701;GO:0050801;GO:0051453;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:membrane; C:plasma membrane; C:stereocilium; C:synapse;, F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:auditory receptor cell development; P:bicarbonate transport; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport;|C9JST9 D3K174 D3K175 O60350 Q6AHZ9 Q9HC88 Q9UIB9,Sodium bicarbonate cotransporter 3,Electroneutral Na/HCO(3) cotransporter;Sodium bicarbonate cotransporter 2;Sodium bicarbonate cotransporter 2b;Solute carrier family 4 member 7;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0031410;GO:0016021;GO:0016020;GO:0005886;GO:0032420;GO:0045202;GO:0005452;GO:0008510;GO:0022857;GO:0060117;GO:0015701;GO:0050801;GO:0051453;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:membrane; C:plasma membrane; C:stereocilium; C:synapse;, F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:auditory receptor cell development; P:bicarbonate transport; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport;|C9JST9 D3K174 D3K175 O60350 Q6AHZ9 Q9HC88 Q9UIB9,Sodium bicarbonate cotransporter 3,Electroneutral Na/HCO(3) cotransporter;Sodium bicarbonate cotransporter 2;Sodium bicarbonate cotransporter 2b;Solute carrier family 4 member 7;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0031410;GO:0016021;GO:0016020;GO:0005886;GO:0032420;GO:0045202;GO:0005452;GO:0008510;GO:0022857;GO:0060117;GO:0015701;GO:0050801;GO:0051453;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:membrane; C:plasma membrane; C:stereocilium; C:synapse;, F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:auditory receptor cell development; P:bicarbonate transport; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport; scaffold51 indexed_genome mRNA 402236 422494 . - . ID=transcript_9486;C9JST9 D3K174 D3K175 O60350 Q6AHZ9 Q9HC88 Q9UIB9,Sodium bicarbonate cotransporter 3,Electroneutral Na/HCO(3) cotransporter;Sodium bicarbonate cotransporter 2;Sodium bicarbonate cotransporter 2b;Solute carrier family 4 member 7;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0031410;GO:0016021;GO:0016020;GO:0005886;GO:0032420;GO:0045202;GO:0005452;GO:0008510;GO:0022857;GO:0060117;GO:0015701;GO:0050801;GO:0051453;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:membrane; C:plasma membrane; C:stereocilium; C:synapse;, F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;, P:auditory receptor cell development; P:bicarbonate transport; P:ion homeostasis; P:regulation of intracellular pH; P:transmembrane transport; scaffold51 indexed_genome mRNA 696360 701949 . - . ID=transcript_9487;O95936 B7Z4I2 B7ZA51 G3XAI5 Q8TAZ2 Q9UPM7,Eomesodermin homolog,T-box brain protein 2;, PF00907;PF16176;, GO:0005634;GO:0003677;GO:0000981;GO:0001102;GO:0000978;GO:0043565;GO:1990837;GO:0002250;GO:0007420;GO:0002302;GO:0060706;GO:0001708;GO:0001706;GO:0001714;GO:0001947;GO:0001707;GO:0060809;GO:0043433;GO:0000122;GO:0045944;GO:0045893;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adaptive immune response; P:brain development; P:CD8-positive, alpha-beta T cell differentiation involved in immune response; P:cell differentiation involved in embryonic placenta development; P:cell fate specification; P:endoderm formation; P:endodermal cell fate specification; P:heart looping; P:mesoderm formation; P:mesodermal to mesenchymal transition involved in gastrulation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|O95936 B7Z4I2 B7ZA51 G3XAI5 Q8TAZ2 Q9UPM7,Eomesodermin homolog,T-box brain protein 2;, PF00907;PF16176;, GO:0005634;GO:0003677;GO:0000981;GO:0001102;GO:0000978;GO:0043565;GO:1990837;GO:0002250;GO:0007420;GO:0002302;GO:0060706;GO:0001708;GO:0001706;GO:0001714;GO:0001947;GO:0001707;GO:0060809;GO:0043433;GO:0000122;GO:0045944;GO:0045893;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adaptive immune response; P:brain development; P:CD8-positive, alpha-beta T cell differentiation involved in immune response; P:cell differentiation involved in embryonic placenta development; P:cell fate specification; P:endoderm formation; P:endodermal cell fate specification; P:heart looping; P:mesoderm formation; P:mesodermal to mesenchymal transition involved in gastrulation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 1226028 1231304 . + . ID=transcript_9488;Q7Z7K0 Q68DJ7,COX assembly mitochondrial protein homolog,, PF08583;, GO:0005739;GO:0046872;, C:mitochondrion;, F:metal ion binding;|Q7Z7K0 Q68DJ7,COX assembly mitochondrial protein homolog,, PF08583;, GO:0005739;GO:0046872;, C:mitochondrion;, F:metal ion binding; scaffold51 indexed_genome mRNA 1235534 1269228 . - . ID=transcript_9489;Q9H6S1 A8K3M2 C9JB40 H7BXU6 Q86W99 Q9BQF1,5-azacytidine-induced protein 2,NF-kappa-B-activating kinase-associated protein 1;TILP;, PF12845;, GO:0005737;GO:0097028;GO:0044565;GO:0007249;GO:0000278;GO:0042110;GO:0016032;, C:cytoplasm;, , P:dendritic cell differentiation; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:mitotic cell cycle; P:T cell activation; P:viral process;|Q9H6S1 A8K3M2 C9JB40 H7BXU6 Q86W99 Q9BQF1,5-azacytidine-induced protein 2,NF-kappa-B-activating kinase-associated protein 1;TILP;, PF12845;, GO:0005737;GO:0097028;GO:0044565;GO:0007249;GO:0000278;GO:0042110;GO:0016032;, C:cytoplasm;, , P:dendritic cell differentiation; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:mitotic cell cycle; P:T cell activation; P:viral process;|Q9H6S1 A8K3M2 C9JB40 H7BXU6 Q86W99 Q9BQF1,5-azacytidine-induced protein 2,NF-kappa-B-activating kinase-associated protein 1;TILP;, PF12845;, GO:0005737;GO:0097028;GO:0044565;GO:0007249;GO:0000278;GO:0042110;GO:0016032;, C:cytoplasm;, , P:dendritic cell differentiation; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:mitotic cell cycle; P:T cell activation; P:viral process;|Q9H6S1 A8K3M2 C9JB40 H7BXU6 Q86W99 Q9BQF1,5-azacytidine-induced protein 2,NF-kappa-B-activating kinase-associated protein 1;TILP;, PF12845;, GO:0005737;GO:0097028;GO:0044565;GO:0007249;GO:0000278;GO:0042110;GO:0016032;, C:cytoplasm;, , P:dendritic cell differentiation; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:mitotic cell cycle; P:T cell activation; P:viral process;|Q9H6S1 A8K3M2 C9JB40 H7BXU6 Q86W99 Q9BQF1,5-azacytidine-induced protein 2,NF-kappa-B-activating kinase-associated protein 1;TILP;, PF12845;, GO:0005737;GO:0097028;GO:0044565;GO:0007249;GO:0000278;GO:0042110;GO:0016032;, C:cytoplasm;, , P:dendritic cell differentiation; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:mitotic cell cycle; P:T cell activation; P:viral process;|Q9H6S1 A8K3M2 C9JB40 H7BXU6 Q86W99 Q9BQF1,5-azacytidine-induced protein 2,NF-kappa-B-activating kinase-associated protein 1;TILP;, PF12845;, GO:0005737;GO:0097028;GO:0044565;GO:0007249;GO:0000278;GO:0042110;GO:0016032;, C:cytoplasm;, , P:dendritic cell differentiation; P:dendritic cell proliferation; P:I-kappaB kinase/NF-kappaB signaling; P:mitotic cell cycle; P:T cell activation; P:viral process; scaffold51 indexed_genome mRNA 1334654 1422673 . + . ID=transcript_9490;Q504Y3,Zinc finger CW-type PWWP domain protein 2,, PF00855;PF07496;, GO:0035064;GO:0008270;, , F:methylated histone binding; F:zinc ion binding;|Q504Y3,Zinc finger CW-type PWWP domain protein 2,, PF00855;PF07496;, GO:0035064;GO:0008270;, , F:methylated histone binding; F:zinc ion binding; scaffold51 indexed_genome mRNA 2735815 2952771 . + . ID=transcript_9491;Q6XE24 A8K9S4 B7ZL17 G5E9J9 O75876 Q17RI0 Q6XE23,RNA-binding motif, single-stranded-interacting protein 3,, PF00076;, GO:0005737;GO:0005829;GO:0005634;GO:1990904;GO:0035925;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0002357;GO:0090090;GO:0010629;GO:0010628;, C:cytoplasm; C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:defense response to tumor cell; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:positive regulation of gene expression; scaffold51 indexed_genome mRNA 2952783 3021173 . + . ID=transcript_9492;Q6XE24 A8K9S4 B7ZL17 G5E9J9 O75876 Q17RI0 Q6XE23,RNA-binding motif, single-stranded-interacting protein 3,, PF00076;, GO:0005737;GO:0005829;GO:0005634;GO:1990904;GO:0035925;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0002357;GO:0090090;GO:0010629;GO:0010628;, C:cytoplasm; C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:defense response to tumor cell; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:positive regulation of gene expression; scaffold51 indexed_genome mRNA 3445772 3533744 . + . ID=transcript_9493;P37173 B4DTV5 Q15580 Q6DKT6 Q99474,TGF-beta receptor type-2,TGF-beta type II receptor;Transforming growth factor-beta receptor type II;, PF08917;PF07714;, GO:0005901;GO:0005829;GO:0009897;GO:0016021;GO:0005887;GO:0045121;GO:0005886;GO:0043235;GO:0048185;GO:0017002;GO:0005524;GO:0005539;GO:0046872;GO:0031435;GO:0004674;GO:0046332;GO:0050431;GO:0005026;GO:0005024;GO:0004675;GO:0034713;GO:0034714;GO:0032147;GO:0007568;GO:0031100;GO:0006915;GO:0003181;GO:0001568;GO:0007420;GO:0001569;GO:0060434;GO:0003214;GO:0071363;GO:0007182;GO:0048565;GO:0007566;GO:0048701;GO:0035162;GO:0003274;GO:0007369;GO:0003430;GO:0007507;GO:0001947;GO:0001701;GO:1905317;GO:0002088;GO:1990086;GO:0060463;GO:0060443;GO:0003149;GO:1990428;GO:0043011;GO:0060044;GO:0030512;GO:0007219;GO:0003151;GO:0003148;GO:0060389;GO:0018105;GO:0018107;GO:0045766;GO:0002663;GO:2000563;GO:0008284;GO:0010634;GO:0010718;GO:1905007;GO:0002053;GO:0051138;GO:2000379;GO:0043415;GO:0048661;GO:0002666;GO:0002651;GO:0006468;GO:0006898;GO:0042127;GO:0010468;GO:0070723;GO:0042493;GO:0043627;GO:0009749;GO:0001666;GO:0009612;GO:0007584;GO:0048545;GO:0062009;GO:0007224;GO:0060440;GO:0007179;GO:0003186;GO:0001570;GO:0060412;GO:0042060;, C:caveola; C:cytosol; C:external side of plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane; C:receptor complex;, F:activin binding; F:activin-activated receptor activity; F:ATP binding; F:glycosaminoglycan binding; F:metal ion binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine/threonine kinase activity; F:SMAD binding; F:transforming growth factor beta binding; F:transforming growth factor beta receptor activity, type II; F:transforming growth factor beta-activated receptor activity; F:transmembrane receptor protein serine/threonine kinase activity; F:type I transforming growth factor beta receptor binding; F:type III transforming growth factor beta receptor binding;, P:activation of protein kinase activity; P:aging; P:animal organ regeneration; P:apoptotic process; P:atrioventricular valve morphogenesis; P:blood vessel development; P:brain development; P:branching involved in blood vessel morphogenesis; P:bronchus morphogenesis; P:cardiac left ventricle morphogenesis; P:cellular response to growth factor stimulus; P:common-partner SMAD protein phosphorylation; P:digestive tract development; P:embryo implantation; P:embryonic cranial skeleton morphogenesis; P:embryonic hemopoiesis; P:endocardial cushion fusion; P:gastrulation; P:growth plate cartilage chondrocyte growth; P:heart development; P:heart looping; P:in utero embryonic development; P:inferior endocardial cushion morphogenesis; P:lens development in camera-type eye; P:lens fiber cell apoptotic process; P:lung lobe morphogenesis; P:mammary gland morphogenesis; P:membranous septum morphogenesis; P:miRNA transport; P:myeloid dendritic cell differentiation; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:Notch signaling pathway; P:outflow tract morphogenesis; P:outflow tract septum morphogenesis; P:pathway-restricted SMAD protein phosphorylation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of B cell tolerance induction; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of NK T cell differentiation; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of skeletal muscle tissue regeneration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T cell tolerance induction; P:positive regulation of tolerance induction to self antigen; P:protein phosphorylation; P:receptor-mediated endocytosis; P:regulation of cell population proliferation; P:regulation of gene expression; P:response to cholesterol; P:response to drug; P:response to estrogen; P:response to glucose; P:response to hypoxia; P:response to mechanical stimulus; P:response to nutrient; P:response to steroid hormone; P:secondary palate development; P:smoothened signaling pathway; P:trachea formation; P:transforming growth factor beta receptor signaling pathway; P:tricuspid valve morphogenesis; P:vasculogenesis; P:ventricular septum morphogenesis; P:wound healing; scaffold51 indexed_genome mRNA 3557933 3738241 . - . ID=transcript_9494;Q6ZQY3,Acidic amino acid decarboxylase GADL1,Aspartate 1-decarboxylase;Cysteine sulfinic acid decarboxylase;Glutamate decarboxylase-like protein 1;, PF00282;, GO:0005829;GO:0004068;GO:0030170;GO:0004782;GO:0009066;GO:0000098;, C:cytosol;, F:aspartate 1-decarboxylase activity; F:pyridoxal phosphate binding; F:sulfinoalanine decarboxylase activity;, P:aspartate family amino acid metabolic process; P:sulfur amino acid catabolic process; scaffold51 indexed_genome mRNA 4348543 4455548 . + . ID=transcript_9495;Q8TCJ2 Q96JZ4 Q96KY7,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B,Source of immunodominant MHC-associated peptides homolog;, PF02516;, GO:0005783;GO:0016021;GO:0016020;GO:0008250;GO:0034998;GO:0032991;GO:0004579;GO:0046872;GO:0043686;GO:0006516;GO:0043687;GO:0006487;GO:0018279;GO:0006986;GO:0030433;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:oligosaccharyltransferase complex; C:oligosaccharyltransferase I complex; C:protein-containing complex;, F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; F:metal ion binding;, P:co-translational protein modification; P:glycoprotein catabolic process; P:post-translational protein modification; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:response to unfolded protein; P:ubiquitin-dependent ERAD pathway; scaffold51 indexed_genome mRNA 4473920 4787713 . - . ID=transcript_9496;Q9BXB5 B4E212 Q9BTU5,Oxysterol-binding protein-related protein 10,, PF01237;PF15409;, GO:0005856;GO:0005829;GO:0043231;GO:0016020;GO:0015485;GO:0001786;GO:0032934;GO:0015248;GO:0036150;GO:0015914;, C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:phosphatidylserine binding; F:sterol binding; F:sterol transporter activity;, P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9BXB5 B4E212 Q9BTU5,Oxysterol-binding protein-related protein 10,, PF01237;PF15409;, GO:0005856;GO:0005829;GO:0043231;GO:0016020;GO:0015485;GO:0001786;GO:0032934;GO:0015248;GO:0036150;GO:0015914;, C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:phosphatidylserine binding; F:sterol binding; F:sterol transporter activity;, P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9BXB5 B4E212 Q9BTU5,Oxysterol-binding protein-related protein 10,, PF01237;PF15409;, GO:0005856;GO:0005829;GO:0043231;GO:0016020;GO:0015485;GO:0001786;GO:0032934;GO:0015248;GO:0036150;GO:0015914;, C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:phosphatidylserine binding; F:sterol binding; F:sterol transporter activity;, P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9BXB5 B4E212 Q9BTU5,Oxysterol-binding protein-related protein 10,, PF01237;PF15409;, GO:0005856;GO:0005829;GO:0043231;GO:0016020;GO:0015485;GO:0001786;GO:0032934;GO:0015248;GO:0036150;GO:0015914;, C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:phosphatidylserine binding; F:sterol binding; F:sterol transporter activity;, P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; scaffold51 indexed_genome mRNA 4909976 4954868 . + . ID=transcript_9497;Q8N335 A8K9U3 Q14702 Q9BRM5,Glycerol-3-phosphate dehydrogenase 1-like protein,, PF07479;PF01210;, GO:0005829;GO:0070062;GO:0009331;GO:0005886;GO:0044325;GO:0051287;GO:0016616;GO:0042803;GO:0017080;GO:0005975;GO:0046168;GO:0019674;GO:0006734;GO:0033137;GO:0090038;GO:0006654;GO:2000010;GO:0010765;GO:0002027;GO:2000649;GO:0060373;GO:0086005;, C:cytosol; C:extracellular exosome; C:glycerol-3-phosphate dehydrogenase complex; C:plasma membrane;, F:ion channel binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein homodimerization activity; F:sodium channel regulator activity;, P:carbohydrate metabolic process; P:glycerol-3-phosphate catabolic process; P:NAD metabolic process; P:NADH metabolic process; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:positive regulation of protein localization to cell surface; P:positive regulation of sodium ion transport; P:regulation of heart rate; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:ventricular cardiac muscle cell action potential;|Q8N335 A8K9U3 Q14702 Q9BRM5,Glycerol-3-phosphate dehydrogenase 1-like protein,, PF07479;PF01210;, GO:0005829;GO:0070062;GO:0009331;GO:0005886;GO:0044325;GO:0051287;GO:0016616;GO:0042803;GO:0017080;GO:0005975;GO:0046168;GO:0019674;GO:0006734;GO:0033137;GO:0090038;GO:0006654;GO:2000010;GO:0010765;GO:0002027;GO:2000649;GO:0060373;GO:0086005;, C:cytosol; C:extracellular exosome; C:glycerol-3-phosphate dehydrogenase complex; C:plasma membrane;, F:ion channel binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein homodimerization activity; F:sodium channel regulator activity;, P:carbohydrate metabolic process; P:glycerol-3-phosphate catabolic process; P:NAD metabolic process; P:NADH metabolic process; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:positive regulation of protein localization to cell surface; P:positive regulation of sodium ion transport; P:regulation of heart rate; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:ventricular cardiac muscle cell action potential; scaffold51 indexed_genome mRNA 5099638 5108376 . + . ID=transcript_9498;Q8IZV2 A5D6I7 Q8IW01,CKLF-like MARVEL transmembrane domain-containing protein 8,Chemokine-like factor superfamily member 8;, PF01284;, GO:0005737;GO:0005615;GO:0016021;GO:0005654;GO:0005125;GO:0019911;GO:0006935;GO:0042552;, C:cytoplasm; C:extracellular space; C:integral component of membrane; C:nucleoplasm;, F:cytokine activity; F:structural constituent of myelin sheath;, P:chemotaxis; P:myelination; scaffold51 indexed_genome mRNA 5158105 5167527 . + . ID=transcript_9499;Q96FZ5 Q5VLK1,CKLF-like MARVEL transmembrane domain-containing protein 7,Chemokine-like factor superfamily member 7;, PF01284;, GO:0005615;GO:0016021;GO:0016020;GO:0005125;GO:0002337;GO:0006935;, C:extracellular space; C:integral component of membrane; C:membrane;, F:cytokine activity;, P:B-1a B cell differentiation; P:chemotaxis;|Q96FZ5 Q5VLK1,CKLF-like MARVEL transmembrane domain-containing protein 7,Chemokine-like factor superfamily member 7;, PF01284;, GO:0005615;GO:0016021;GO:0016020;GO:0005125;GO:0002337;GO:0006935;, C:extracellular space; C:integral component of membrane; C:membrane;, F:cytokine activity;, P:B-1a B cell differentiation; P:chemotaxis;|Q96FZ5 Q5VLK1,CKLF-like MARVEL transmembrane domain-containing protein 7,Chemokine-like factor superfamily member 7;, PF01284;, GO:0005615;GO:0016021;GO:0016020;GO:0005125;GO:0002337;GO:0006935;, C:extracellular space; C:integral component of membrane; C:membrane;, F:cytokine activity;, P:B-1a B cell differentiation; P:chemotaxis; scaffold51 indexed_genome mRNA 5186518 5187031 . - . ID=transcript_9500;P03915 Q34773 Q8WCY3,NADH-ubiquinone oxidoreductase chain 5,NADH dehydrogenase subunit 5;, PF06455;PF00361;PF00662;, GO:0016021;GO:0005743;GO:0005747;GO:0043005;GO:0008137;GO:0003954;GO:0015990;GO:0006120;GO:0032981;GO:0042542;GO:0001666;GO:0010243;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:neuron projection;, F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity;, P:electron transport coupled proton transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to hydrogen peroxide; P:response to hypoxia; P:response to organonitrogen compound; scaffold51 indexed_genome mRNA 5222044 5222555 . - . ID=transcript_9501;P00414 Q14Y83,Cytochrome c oxidase subunit 3,Cytochrome c oxidase polypeptide III;, PF00510;, GO:0016021;GO:0005743;GO:0005739;GO:0045277;GO:0004129;GO:0009055;GO:0015453;GO:0009060;GO:0006123;GO:0008535;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:electron transfer activity; F:oxidoreduction-driven active transmembrane transporter activity;, P:aerobic respiration; P:mitochondrial electron transport, cytochrome c to oxygen; P:respiratory chain complex IV assembly; scaffold51 indexed_genome mRNA 5245567 5272603 . - . ID=transcript_9502;Q9NX76 Q6IAC4,CKLF-like MARVEL transmembrane domain-containing protein 6 {ECO:0000303|PubMed:28813417},Chemokine-like factor superfamily member 6 {ECO:0000303|PubMed:12782130};, PF01284;, GO:0035577;GO:0031901;GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0055038;GO:0035579;GO:0032456;GO:0043312;GO:0015031;GO:0031647;, C:azurophil granule membrane; C:early endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:recycling endosome membrane; C:specific granule membrane;, , P:endocytic recycling; P:neutrophil degranulation; P:protein transport; P:regulation of protein stability;|Q9NX76 Q6IAC4,CKLF-like MARVEL transmembrane domain-containing protein 6 {ECO:0000303|PubMed:28813417},Chemokine-like factor superfamily member 6 {ECO:0000303|PubMed:12782130};, PF01284;, GO:0035577;GO:0031901;GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0055038;GO:0035579;GO:0032456;GO:0043312;GO:0015031;GO:0031647;, C:azurophil granule membrane; C:early endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:recycling endosome membrane; C:specific granule membrane;, , P:endocytic recycling; P:neutrophil degranulation; P:protein transport; P:regulation of protein stability;|Q9NX76 Q6IAC4,CKLF-like MARVEL transmembrane domain-containing protein 6 {ECO:0000303|PubMed:28813417},Chemokine-like factor superfamily member 6 {ECO:0000303|PubMed:12782130};, PF01284;, GO:0035577;GO:0031901;GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0055038;GO:0035579;GO:0032456;GO:0043312;GO:0015031;GO:0031647;, C:azurophil granule membrane; C:early endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:recycling endosome membrane; C:specific granule membrane;, , P:endocytic recycling; P:neutrophil degranulation; P:protein transport; P:regulation of protein stability;|Q9NX76 Q6IAC4,CKLF-like MARVEL transmembrane domain-containing protein 6 {ECO:0000303|PubMed:28813417},Chemokine-like factor superfamily member 6 {ECO:0000303|PubMed:12782130};, PF01284;, GO:0035577;GO:0031901;GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0055038;GO:0035579;GO:0032456;GO:0043312;GO:0015031;GO:0031647;, C:azurophil granule membrane; C:early endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:recycling endosome membrane; C:specific granule membrane;, , P:endocytic recycling; P:neutrophil degranulation; P:protein transport; P:regulation of protein stability;|Q9NX76 Q6IAC4,CKLF-like MARVEL transmembrane domain-containing protein 6 {ECO:0000303|PubMed:28813417},Chemokine-like factor superfamily member 6 {ECO:0000303|PubMed:12782130};, PF01284;, GO:0035577;GO:0031901;GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0055038;GO:0035579;GO:0032456;GO:0043312;GO:0015031;GO:0031647;, C:azurophil granule membrane; C:early endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:recycling endosome membrane; C:specific granule membrane;, , P:endocytic recycling; P:neutrophil degranulation; P:protein transport; P:regulation of protein stability; scaffold51 indexed_genome mRNA 5291376 5345257 . - . ID=transcript_9503;Q9Y6G9 A2RRG7 Q53HC8 Q53HK7,Cytoplasmic dynein 1 light intermediate chain 1,Dynein light chain A;Dynein light intermediate chain 1, cytosolic;, PF05783;, GO:0005813;GO:0000777;GO:0005868;GO:0005829;GO:0101003;GO:0000776;GO:0016020;GO:0005874;GO:0005886;GO:0030667;GO:0000922;GO:0005524;GO:0045504;GO:0019003;GO:0003723;GO:0035973;GO:0019886;GO:0051301;GO:0006888;GO:0000226;GO:0007018;GO:0007052;GO:0043312;GO:0090267;GO:0019058;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasmic dynein complex; C:cytosol; C:ficolin-1-rich granule membrane; C:kinetochore; C:membrane; C:microtubule; C:plasma membrane; C:secretory granule membrane; C:spindle pole;, F:ATP binding; F:dynein heavy chain binding; F:GDP binding; F:RNA binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule cytoskeleton organization; P:microtubule-based movement; P:mitotic spindle organization; P:neutrophil degranulation; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:viral life cycle;|Q9Y6G9 A2RRG7 Q53HC8 Q53HK7,Cytoplasmic dynein 1 light intermediate chain 1,Dynein light chain A;Dynein light intermediate chain 1, cytosolic;, PF05783;, GO:0005813;GO:0000777;GO:0005868;GO:0005829;GO:0101003;GO:0000776;GO:0016020;GO:0005874;GO:0005886;GO:0030667;GO:0000922;GO:0005524;GO:0045504;GO:0019003;GO:0003723;GO:0035973;GO:0019886;GO:0051301;GO:0006888;GO:0000226;GO:0007018;GO:0007052;GO:0043312;GO:0090267;GO:0019058;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasmic dynein complex; C:cytosol; C:ficolin-1-rich granule membrane; C:kinetochore; C:membrane; C:microtubule; C:plasma membrane; C:secretory granule membrane; C:spindle pole;, F:ATP binding; F:dynein heavy chain binding; F:GDP binding; F:RNA binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule cytoskeleton organization; P:microtubule-based movement; P:mitotic spindle organization; P:neutrophil degranulation; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:viral life cycle;|Q9Y6G9 A2RRG7 Q53HC8 Q53HK7,Cytoplasmic dynein 1 light intermediate chain 1,Dynein light chain A;Dynein light intermediate chain 1, cytosolic;, PF05783;, GO:0005813;GO:0000777;GO:0005868;GO:0005829;GO:0101003;GO:0000776;GO:0016020;GO:0005874;GO:0005886;GO:0030667;GO:0000922;GO:0005524;GO:0045504;GO:0019003;GO:0003723;GO:0035973;GO:0019886;GO:0051301;GO:0006888;GO:0000226;GO:0007018;GO:0007052;GO:0043312;GO:0090267;GO:0019058;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasmic dynein complex; C:cytosol; C:ficolin-1-rich granule membrane; C:kinetochore; C:membrane; C:microtubule; C:plasma membrane; C:secretory granule membrane; C:spindle pole;, F:ATP binding; F:dynein heavy chain binding; F:GDP binding; F:RNA binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule cytoskeleton organization; P:microtubule-based movement; P:mitotic spindle organization; P:neutrophil degranulation; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:viral life cycle;|Q9Y6G9 A2RRG7 Q53HC8 Q53HK7,Cytoplasmic dynein 1 light intermediate chain 1,Dynein light chain A;Dynein light intermediate chain 1, cytosolic;, PF05783;, GO:0005813;GO:0000777;GO:0005868;GO:0005829;GO:0101003;GO:0000776;GO:0016020;GO:0005874;GO:0005886;GO:0030667;GO:0000922;GO:0005524;GO:0045504;GO:0019003;GO:0003723;GO:0035973;GO:0019886;GO:0051301;GO:0006888;GO:0000226;GO:0007018;GO:0007052;GO:0043312;GO:0090267;GO:0019058;, C:centrosome; C:condensed chromosome kinetochore; C:cytoplasmic dynein complex; C:cytosol; C:ficolin-1-rich granule membrane; C:kinetochore; C:membrane; C:microtubule; C:plasma membrane; C:secretory granule membrane; C:spindle pole;, F:ATP binding; F:dynein heavy chain binding; F:GDP binding; F:RNA binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:microtubule cytoskeleton organization; P:microtubule-based movement; P:mitotic spindle organization; P:neutrophil degranulation; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:viral life cycle; scaffold51 indexed_genome mRNA 5444882 5503613 . + . ID=transcript_9504;Q9H9A5 B7Z7L1 F8WAF2 Q9BU30 Q9H5J7 Q9H8X1 Q9H9W0 Q9HAH3 Q9UFJ2,CCR4-NOT transcription complex subunit 10,, , GO:0030014;GO:0005829;GO:0016020;GO:0005634;GO:0006977;GO:0031047;GO:0006402;GO:0017148;GO:0000289;, C:CCR4-NOT complex; C:cytosol; C:membrane; C:nucleus;, , P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:mRNA catabolic process; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening;|Q9H9A5 B7Z7L1 F8WAF2 Q9BU30 Q9H5J7 Q9H8X1 Q9H9W0 Q9HAH3 Q9UFJ2,CCR4-NOT transcription complex subunit 10,, , GO:0030014;GO:0005829;GO:0016020;GO:0005634;GO:0006977;GO:0031047;GO:0006402;GO:0017148;GO:0000289;, C:CCR4-NOT complex; C:cytosol; C:membrane; C:nucleus;, , P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:mRNA catabolic process; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening;|Q9H9A5 B7Z7L1 F8WAF2 Q9BU30 Q9H5J7 Q9H8X1 Q9H9W0 Q9HAH3 Q9UFJ2,CCR4-NOT transcription complex subunit 10,, , GO:0030014;GO:0005829;GO:0016020;GO:0005634;GO:0006977;GO:0031047;GO:0006402;GO:0017148;GO:0000289;, C:CCR4-NOT complex; C:cytosol; C:membrane; C:nucleus;, , P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:mRNA catabolic process; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening;|Q9H9A5 B7Z7L1 F8WAF2 Q9BU30 Q9H5J7 Q9H8X1 Q9H9W0 Q9HAH3 Q9UFJ2,CCR4-NOT transcription complex subunit 10,, , GO:0030014;GO:0005829;GO:0016020;GO:0005634;GO:0006977;GO:0031047;GO:0006402;GO:0017148;GO:0000289;, C:CCR4-NOT complex; C:cytosol; C:membrane; C:nucleus;, , P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:mRNA catabolic process; P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening; scaffold51 indexed_genome mRNA 5639755 5640355 . + . ID=transcript_9505;P51679 Q9ULY6 Q9ULY7,C-C chemokine receptor type 4,K5-5;, PF00001;, GO:0009897;GO:0005887;GO:0043025;GO:0005886;GO:0019957;GO:0016493;GO:0004950;GO:0019722;GO:0060326;GO:0006935;GO:0007186;GO:0048872;GO:0006955;GO:0006954;GO:0001764;GO:0007204;GO:0050927;GO:0046677;GO:0009617;GO:0009314;GO:0002507;, C:external side of plasma membrane; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:chemokine receptor activity;, P:calcium-mediated signaling; P:cell chemotaxis; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:homeostasis of number of cells; P:immune response; P:inflammatory response; P:neuron migration; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of positive chemotaxis; P:response to antibiotic; P:response to bacterium; P:response to radiation; P:tolerance induction; scaffold51 indexed_genome mRNA 5685064 5733711 . - . ID=transcript_9506;P16278 B2R7H8 B7Z6B0 P16279,Beta-galactosidase,Acid beta-galactosidase;Elastin receptor 1;, PF13364;PF01301;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:1904813;GO:0005794;GO:0043231;GO:0043202;GO:0048471;GO:0005773;GO:0004565;GO:0016936;GO:0042803;GO:0044262;GO:0019388;GO:0006027;GO:0006687;GO:0042340;GO:0043312;GO:0051413;GO:1904016;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:perinuclear region of cytoplasm; C:vacuole;, F:beta-galactosidase activity; F:galactoside binding; F:protein homodimerization activity;, P:cellular carbohydrate metabolic process; P:galactose catabolic process; P:glycosaminoglycan catabolic process; P:glycosphingolipid metabolic process; P:keratan sulfate catabolic process; P:neutrophil degranulation; P:response to cortisone; P:response to Thyroglobulin triiodothyronine;|P16278 B2R7H8 B7Z6B0 P16279,Beta-galactosidase,Acid beta-galactosidase;Elastin receptor 1;, PF13364;PF01301;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:1904813;GO:0005794;GO:0043231;GO:0043202;GO:0048471;GO:0005773;GO:0004565;GO:0016936;GO:0042803;GO:0044262;GO:0019388;GO:0006027;GO:0006687;GO:0042340;GO:0043312;GO:0051413;GO:1904016;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:perinuclear region of cytoplasm; C:vacuole;, F:beta-galactosidase activity; F:galactoside binding; F:protein homodimerization activity;, P:cellular carbohydrate metabolic process; P:galactose catabolic process; P:glycosaminoglycan catabolic process; P:glycosphingolipid metabolic process; P:keratan sulfate catabolic process; P:neutrophil degranulation; P:response to cortisone; P:response to Thyroglobulin triiodothyronine; scaffold51 indexed_genome mRNA 5735203 5739861 . - . ID=transcript_9507;P16278 B2R7H8 B7Z6B0 P16279,Beta-galactosidase,Acid beta-galactosidase;Elastin receptor 1;, PF13364;PF01301;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:1904813;GO:0005794;GO:0043231;GO:0043202;GO:0048471;GO:0005773;GO:0004565;GO:0016936;GO:0042803;GO:0044262;GO:0019388;GO:0006027;GO:0006687;GO:0042340;GO:0043312;GO:0051413;GO:1904016;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:perinuclear region of cytoplasm; C:vacuole;, F:beta-galactosidase activity; F:galactoside binding; F:protein homodimerization activity;, P:cellular carbohydrate metabolic process; P:galactose catabolic process; P:glycosaminoglycan catabolic process; P:glycosphingolipid metabolic process; P:keratan sulfate catabolic process; P:neutrophil degranulation; P:response to cortisone; P:response to Thyroglobulin triiodothyronine; scaffold51 indexed_genome mRNA 5764574 5765281 . + . ID=transcript_9508;Q6ZT21 B2RNG5 Q6ZRG1,Transmembrane protein with metallophosphoesterase domain,, PF00149;, GO:0016021;GO:0016787;GO:0046872;, C:integral component of membrane;, F:hydrolase activity; F:metal ion binding; scaffold51 indexed_genome mRNA 5783642 5833174 . + . ID=transcript_9509;O75718 B2RBL6,Cartilage-associated protein,, , GO:0005783;GO:0005788;GO:0005615;GO:0032991;GO:0061077;GO:0030199;GO:1901874;GO:0018400;GO:0050821;GO:0007283;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:protein-containing complex;, , P:chaperone-mediated protein folding; P:collagen fibril organization; P:negative regulation of post-translational protein modification; P:peptidyl-proline hydroxylation to 3-hydroxy-L-proline; P:protein stabilization; P:spermatogenesis;|O60279,Sushi domain-containing protein 5,, PF00193;, GO:0016021;GO:0005540;GO:0007155;GO:0007219;, C:integral component of membrane;, F:hyaluronic acid binding;, P:cell adhesion; P:Notch signaling pathway; scaffold51 indexed_genome mRNA 5901912 5986721 . + . ID=transcript_9510;Q9UKC9 B4DQV0 E9PD06 Q6IAN3 Q9NVQ8 Q9UK27 Q9UKA5 Q9Y3Y9,F-box/LRR-repeat protein 2 {ECO:0000305},F-box and leucine-rich repeat protein 2 {ECO:0000312|HGNC:HGNC:13598};F-box protein FBL2/FBL3 {ECO:0000303|PubMed:10945468, ECO:0000312|EMBL:AAF04510.1};, PF12937;PF13516;, GO:0005737;GO:0016020;GO:0019005;GO:0005516;GO:0036312;GO:0019903;GO:0006464;GO:0044830;GO:0006513;GO:0016567;GO:0006508;GO:0010506;GO:0014066;GO:0031146;GO:0016032;, C:cytoplasm; C:membrane; C:SCF ubiquitin ligase complex;, F:calmodulin binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein phosphatase binding;, P:cellular protein modification process; P:modulation by host of viral RNA genome replication; P:protein monoubiquitination; P:protein ubiquitination; P:proteolysis; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process;|Q9UKC9 B4DQV0 E9PD06 Q6IAN3 Q9NVQ8 Q9UK27 Q9UKA5 Q9Y3Y9,F-box/LRR-repeat protein 2 {ECO:0000305},F-box and leucine-rich repeat protein 2 {ECO:0000312|HGNC:HGNC:13598};F-box protein FBL2/FBL3 {ECO:0000303|PubMed:10945468, ECO:0000312|EMBL:AAF04510.1};, PF12937;PF13516;, GO:0005737;GO:0016020;GO:0019005;GO:0005516;GO:0036312;GO:0019903;GO:0006464;GO:0044830;GO:0006513;GO:0016567;GO:0006508;GO:0010506;GO:0014066;GO:0031146;GO:0016032;, C:cytoplasm; C:membrane; C:SCF ubiquitin ligase complex;, F:calmodulin binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein phosphatase binding;, P:cellular protein modification process; P:modulation by host of viral RNA genome replication; P:protein monoubiquitination; P:protein ubiquitination; P:proteolysis; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:viral process; scaffold51 indexed_genome mRNA 5987315 5995464 . + . ID=transcript_9511;Q9NZI7 Q68CT0 Q86Y57 Q9H8V0 Q9UD76 Q9UD78,Upstream-binding protein 1,Transcription factor LBP-1;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003837;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0001525;GO:0006248;GO:0006249;GO:0032897;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-ureidopropionase activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:CMP catabolic process; P:dCMP catabolic process; P:negative regulation of viral transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9NZI7 Q68CT0 Q86Y57 Q9H8V0 Q9UD76 Q9UD78,Upstream-binding protein 1,Transcription factor LBP-1;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003837;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0001525;GO:0006248;GO:0006249;GO:0032897;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-ureidopropionase activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:CMP catabolic process; P:dCMP catabolic process; P:negative regulation of viral transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9NZI7 Q68CT0 Q86Y57 Q9H8V0 Q9UD76 Q9UD78,Upstream-binding protein 1,Transcription factor LBP-1;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003837;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0001525;GO:0006248;GO:0006249;GO:0032897;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-ureidopropionase activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:CMP catabolic process; P:dCMP catabolic process; P:negative regulation of viral transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 5999386 6001630 . - . ID=transcript_9512;Q9NZI7 Q68CT0 Q86Y57 Q9H8V0 Q9UD76 Q9UD78,Upstream-binding protein 1,Transcription factor LBP-1;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003837;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0001525;GO:0006248;GO:0006249;GO:0032897;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-ureidopropionase activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:CMP catabolic process; P:dCMP catabolic process; P:negative regulation of viral transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 6001733 6003844 . + . ID=transcript_9513;Q9NZI7 Q68CT0 Q86Y57 Q9H8V0 Q9UD76 Q9UD78,Upstream-binding protein 1,Transcription factor LBP-1;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003837;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0001525;GO:0006248;GO:0006249;GO:0032897;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-ureidopropionase activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:CMP catabolic process; P:dCMP catabolic process; P:negative regulation of viral transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 6004079 6009235 . - . ID=transcript_9514;Q9NZI7 Q68CT0 Q86Y57 Q9H8V0 Q9UD76 Q9UD78,Upstream-binding protein 1,Transcription factor LBP-1;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003837;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0001525;GO:0006248;GO:0006249;GO:0032897;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-ureidopropionase activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:CMP catabolic process; P:dCMP catabolic process; P:negative regulation of viral transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 6033485 6034066 . - . ID=transcript_9515;Q9NZI7 Q68CT0 Q86Y57 Q9H8V0 Q9UD76 Q9UD78,Upstream-binding protein 1,Transcription factor LBP-1;, PF04516;PF18016;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003837;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0001525;GO:0006248;GO:0006249;GO:0032897;GO:0045944;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-ureidopropionase activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:CMP catabolic process; P:dCMP catabolic process; P:negative regulation of viral transcription; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 6079975 6132090 . - . ID=transcript_9516;O75122 B2RTR1 F5H604 Q7L8F6 Q8N6R6 Q9BQT3 Q9BQT4 Q9H7A3 Q9NSZ2,CLIP-associating protein 2,Cytoplasmic linker-associated protein 2;Protein Orbit homolog 2;, PF12348;, GO:0044295;GO:0045180;GO:0005938;GO:0031252;GO:0000777;GO:1903754;GO:0005737;GO:0005881;GO:0005829;GO:0005794;GO:0005828;GO:0016020;GO:0005874;GO:0005815;GO:0005886;GO:0032587;GO:0005876;GO:0005802;GO:0051015;GO:0002162;GO:0008017;GO:0051010;GO:1990782;GO:0051301;GO:0040001;GO:0007163;GO:0010458;GO:0007030;GO:0034453;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0051895;GO:0007026;GO:0051497;GO:1903690;GO:0035791;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0072659;GO:0032956;GO:0030516;GO:0010717;GO:0010470;GO:0031113;GO:0031110;GO:0032886;GO:0006903;, C:axonal growth cone; C:basal cortex; C:cell cortex; C:cell leading edge; C:condensed chromosome kinetochore; C:cortical microtubule plus-end; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule organizing center; C:plasma membrane; C:ruffle membrane; C:spindle microtubule; C:trans-Golgi network;, F:actin filament binding; F:dystroglycan binding; F:microtubule binding; F:microtubule plus-end binding; F:protein tyrosine kinase binding;, P:cell division; P:establishment of mitotic spindle localization; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:Golgi organization; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of microtubule depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of axon extension; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of microtubule-based process; P:vesicle targeting;|O75122 B2RTR1 F5H604 Q7L8F6 Q8N6R6 Q9BQT3 Q9BQT4 Q9H7A3 Q9NSZ2,CLIP-associating protein 2,Cytoplasmic linker-associated protein 2;Protein Orbit homolog 2;, PF12348;, GO:0044295;GO:0045180;GO:0005938;GO:0031252;GO:0000777;GO:1903754;GO:0005737;GO:0005881;GO:0005829;GO:0005794;GO:0005828;GO:0016020;GO:0005874;GO:0005815;GO:0005886;GO:0032587;GO:0005876;GO:0005802;GO:0051015;GO:0002162;GO:0008017;GO:0051010;GO:1990782;GO:0051301;GO:0040001;GO:0007163;GO:0010458;GO:0007030;GO:0034453;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0051895;GO:0007026;GO:0051497;GO:1903690;GO:0035791;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0072659;GO:0032956;GO:0030516;GO:0010717;GO:0010470;GO:0031113;GO:0031110;GO:0032886;GO:0006903;, C:axonal growth cone; C:basal cortex; C:cell cortex; C:cell leading edge; C:condensed chromosome kinetochore; C:cortical microtubule plus-end; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule organizing center; C:plasma membrane; C:ruffle membrane; C:spindle microtubule; C:trans-Golgi network;, F:actin filament binding; F:dystroglycan binding; F:microtubule binding; F:microtubule plus-end binding; F:protein tyrosine kinase binding;, P:cell division; P:establishment of mitotic spindle localization; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:Golgi organization; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of microtubule depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of axon extension; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of microtubule-based process; P:vesicle targeting;|O75122 B2RTR1 F5H604 Q7L8F6 Q8N6R6 Q9BQT3 Q9BQT4 Q9H7A3 Q9NSZ2,CLIP-associating protein 2,Cytoplasmic linker-associated protein 2;Protein Orbit homolog 2;, PF12348;, GO:0044295;GO:0045180;GO:0005938;GO:0031252;GO:0000777;GO:1903754;GO:0005737;GO:0005881;GO:0005829;GO:0005794;GO:0005828;GO:0016020;GO:0005874;GO:0005815;GO:0005886;GO:0032587;GO:0005876;GO:0005802;GO:0051015;GO:0002162;GO:0008017;GO:0051010;GO:1990782;GO:0051301;GO:0040001;GO:0007163;GO:0010458;GO:0007030;GO:0034453;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0051895;GO:0007026;GO:0051497;GO:1903690;GO:0035791;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0072659;GO:0032956;GO:0030516;GO:0010717;GO:0010470;GO:0031113;GO:0031110;GO:0032886;GO:0006903;, C:axonal growth cone; C:basal cortex; C:cell cortex; C:cell leading edge; C:condensed chromosome kinetochore; C:cortical microtubule plus-end; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule organizing center; C:plasma membrane; C:ruffle membrane; C:spindle microtubule; C:trans-Golgi network;, F:actin filament binding; F:dystroglycan binding; F:microtubule binding; F:microtubule plus-end binding; F:protein tyrosine kinase binding;, P:cell division; P:establishment of mitotic spindle localization; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:Golgi organization; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of microtubule depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of axon extension; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of microtubule-based process; P:vesicle targeting;|O75122 B2RTR1 F5H604 Q7L8F6 Q8N6R6 Q9BQT3 Q9BQT4 Q9H7A3 Q9NSZ2,CLIP-associating protein 2,Cytoplasmic linker-associated protein 2;Protein Orbit homolog 2;, PF12348;, GO:0044295;GO:0045180;GO:0005938;GO:0031252;GO:0000777;GO:1903754;GO:0005737;GO:0005881;GO:0005829;GO:0005794;GO:0005828;GO:0016020;GO:0005874;GO:0005815;GO:0005886;GO:0032587;GO:0005876;GO:0005802;GO:0051015;GO:0002162;GO:0008017;GO:0051010;GO:1990782;GO:0051301;GO:0040001;GO:0007163;GO:0010458;GO:0007030;GO:0034453;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0051895;GO:0007026;GO:0051497;GO:1903690;GO:0035791;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0072659;GO:0032956;GO:0030516;GO:0010717;GO:0010470;GO:0031113;GO:0031110;GO:0032886;GO:0006903;, C:axonal growth cone; C:basal cortex; C:cell cortex; C:cell leading edge; C:condensed chromosome kinetochore; C:cortical microtubule plus-end; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule organizing center; C:plasma membrane; C:ruffle membrane; C:spindle microtubule; C:trans-Golgi network;, F:actin filament binding; F:dystroglycan binding; F:microtubule binding; F:microtubule plus-end binding; F:protein tyrosine kinase binding;, P:cell division; P:establishment of mitotic spindle localization; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:Golgi organization; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of microtubule depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of axon extension; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of microtubule-based process; P:vesicle targeting;|O75122 B2RTR1 F5H604 Q7L8F6 Q8N6R6 Q9BQT3 Q9BQT4 Q9H7A3 Q9NSZ2,CLIP-associating protein 2,Cytoplasmic linker-associated protein 2;Protein Orbit homolog 2;, PF12348;, GO:0044295;GO:0045180;GO:0005938;GO:0031252;GO:0000777;GO:1903754;GO:0005737;GO:0005881;GO:0005829;GO:0005794;GO:0005828;GO:0016020;GO:0005874;GO:0005815;GO:0005886;GO:0032587;GO:0005876;GO:0005802;GO:0051015;GO:0002162;GO:0008017;GO:0051010;GO:1990782;GO:0051301;GO:0040001;GO:0007163;GO:0010458;GO:0007030;GO:0034453;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0051895;GO:0007026;GO:0051497;GO:1903690;GO:0035791;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0072659;GO:0032956;GO:0030516;GO:0010717;GO:0010470;GO:0031113;GO:0031110;GO:0032886;GO:0006903;, C:axonal growth cone; C:basal cortex; C:cell cortex; C:cell leading edge; C:condensed chromosome kinetochore; C:cortical microtubule plus-end; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule organizing center; C:plasma membrane; C:ruffle membrane; C:spindle microtubule; C:trans-Golgi network;, F:actin filament binding; F:dystroglycan binding; F:microtubule binding; F:microtubule plus-end binding; F:protein tyrosine kinase binding;, P:cell division; P:establishment of mitotic spindle localization; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:Golgi organization; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of microtubule depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of axon extension; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of microtubule-based process; P:vesicle targeting;|O75122 B2RTR1 F5H604 Q7L8F6 Q8N6R6 Q9BQT3 Q9BQT4 Q9H7A3 Q9NSZ2,CLIP-associating protein 2,Cytoplasmic linker-associated protein 2;Protein Orbit homolog 2;, PF12348;, GO:0044295;GO:0045180;GO:0005938;GO:0031252;GO:0000777;GO:1903754;GO:0005737;GO:0005881;GO:0005829;GO:0005794;GO:0005828;GO:0016020;GO:0005874;GO:0005815;GO:0005886;GO:0032587;GO:0005876;GO:0005802;GO:0051015;GO:0002162;GO:0008017;GO:0051010;GO:1990782;GO:0051301;GO:0040001;GO:0007163;GO:0010458;GO:0007030;GO:0034453;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0051895;GO:0007026;GO:0051497;GO:1903690;GO:0035791;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0072659;GO:0032956;GO:0030516;GO:0010717;GO:0010470;GO:0031113;GO:0031110;GO:0032886;GO:0006903;, C:axonal growth cone; C:basal cortex; C:cell cortex; C:cell leading edge; C:condensed chromosome kinetochore; C:cortical microtubule plus-end; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule organizing center; C:plasma membrane; C:ruffle membrane; C:spindle microtubule; C:trans-Golgi network;, F:actin filament binding; F:dystroglycan binding; F:microtubule binding; F:microtubule plus-end binding; F:protein tyrosine kinase binding;, P:cell division; P:establishment of mitotic spindle localization; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:Golgi organization; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of microtubule depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of axon extension; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of microtubule-based process; P:vesicle targeting;|O75122 B2RTR1 F5H604 Q7L8F6 Q8N6R6 Q9BQT3 Q9BQT4 Q9H7A3 Q9NSZ2,CLIP-associating protein 2,Cytoplasmic linker-associated protein 2;Protein Orbit homolog 2;, PF12348;, GO:0044295;GO:0045180;GO:0005938;GO:0031252;GO:0000777;GO:1903754;GO:0005737;GO:0005881;GO:0005829;GO:0005794;GO:0005828;GO:0016020;GO:0005874;GO:0005815;GO:0005886;GO:0032587;GO:0005876;GO:0005802;GO:0051015;GO:0002162;GO:0008017;GO:0051010;GO:1990782;GO:0051301;GO:0040001;GO:0007163;GO:0010458;GO:0007030;GO:0034453;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0051895;GO:0007026;GO:0051497;GO:1903690;GO:0035791;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0072659;GO:0032956;GO:0030516;GO:0010717;GO:0010470;GO:0031113;GO:0031110;GO:0032886;GO:0006903;, C:axonal growth cone; C:basal cortex; C:cell cortex; C:cell leading edge; C:condensed chromosome kinetochore; C:cortical microtubule plus-end; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule organizing center; C:plasma membrane; C:ruffle membrane; C:spindle microtubule; C:trans-Golgi network;, F:actin filament binding; F:dystroglycan binding; F:microtubule binding; F:microtubule plus-end binding; F:protein tyrosine kinase binding;, P:cell division; P:establishment of mitotic spindle localization; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:Golgi organization; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of microtubule depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of axon extension; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of microtubule-based process; P:vesicle targeting;|O75122 B2RTR1 F5H604 Q7L8F6 Q8N6R6 Q9BQT3 Q9BQT4 Q9H7A3 Q9NSZ2,CLIP-associating protein 2,Cytoplasmic linker-associated protein 2;Protein Orbit homolog 2;, PF12348;, GO:0044295;GO:0045180;GO:0005938;GO:0031252;GO:0000777;GO:1903754;GO:0005737;GO:0005881;GO:0005829;GO:0005794;GO:0005828;GO:0016020;GO:0005874;GO:0005815;GO:0005886;GO:0032587;GO:0005876;GO:0005802;GO:0051015;GO:0002162;GO:0008017;GO:0051010;GO:1990782;GO:0051301;GO:0040001;GO:0007163;GO:0010458;GO:0007030;GO:0034453;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0051895;GO:0007026;GO:0051497;GO:1903690;GO:0035791;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0072659;GO:0032956;GO:0030516;GO:0010717;GO:0010470;GO:0031113;GO:0031110;GO:0032886;GO:0006903;, C:axonal growth cone; C:basal cortex; C:cell cortex; C:cell leading edge; C:condensed chromosome kinetochore; C:cortical microtubule plus-end; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule organizing center; C:plasma membrane; C:ruffle membrane; C:spindle microtubule; C:trans-Golgi network;, F:actin filament binding; F:dystroglycan binding; F:microtubule binding; F:microtubule plus-end binding; F:protein tyrosine kinase binding;, P:cell division; P:establishment of mitotic spindle localization; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:Golgi organization; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of microtubule depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of axon extension; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of microtubule-based process; P:vesicle targeting; scaffold51 indexed_genome mRNA 6138046 6173218 . - . ID=transcript_9517;O75122 B2RTR1 F5H604 Q7L8F6 Q8N6R6 Q9BQT3 Q9BQT4 Q9H7A3 Q9NSZ2,CLIP-associating protein 2,Cytoplasmic linker-associated protein 2;Protein Orbit homolog 2;, PF12348;, GO:0044295;GO:0045180;GO:0005938;GO:0031252;GO:0000777;GO:1903754;GO:0005737;GO:0005881;GO:0005829;GO:0005794;GO:0005828;GO:0016020;GO:0005874;GO:0005815;GO:0005886;GO:0032587;GO:0005876;GO:0005802;GO:0051015;GO:0002162;GO:0008017;GO:0051010;GO:1990782;GO:0051301;GO:0040001;GO:0007163;GO:0010458;GO:0007030;GO:0034453;GO:0000226;GO:0007020;GO:0031023;GO:0090307;GO:0007052;GO:0051895;GO:0007026;GO:0051497;GO:1903690;GO:0035791;GO:1904261;GO:0010634;GO:0045921;GO:0090091;GO:0072659;GO:0032956;GO:0030516;GO:0010717;GO:0010470;GO:0031113;GO:0031110;GO:0032886;GO:0006903;, C:axonal growth cone; C:basal cortex; C:cell cortex; C:cell leading edge; C:condensed chromosome kinetochore; C:cortical microtubule plus-end; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:Golgi apparatus; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule organizing center; C:plasma membrane; C:ruffle membrane; C:spindle microtubule; C:trans-Golgi network;, F:actin filament binding; F:dystroglycan binding; F:microtubule binding; F:microtubule plus-end binding; F:protein tyrosine kinase binding;, P:cell division; P:establishment of mitotic spindle localization; P:establishment or maintenance of cell polarity; P:exit from mitosis; P:Golgi organization; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:microtubule organizing center organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of microtubule depolymerization; P:negative regulation of stress fiber assembly; P:negative regulation of wound healing, spreading of epidermal cells; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of epithelial cell migration; P:positive regulation of exocytosis; P:positive regulation of extracellular matrix disassembly; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of axon extension; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of microtubule-based process; P:vesicle targeting; scaffold51 indexed_genome mRNA 6354879 6424749 . + . ID=transcript_9518;Q8WUM4 C5MQH7 E9PFU1 Q6NUS1 Q9BX86 Q9NUN0 Q9P2H2 Q9UKL5,Programmed cell death 6-interacting protein,ALG-2-interacting protein 1;ALG-2-interacting protein X;Hp95;, PF13949;PF03097;, GO:0042641;GO:0005923;GO:0005829;GO:0070971;GO:0070062;GO:1903561;GO:0090543;GO:0005925;GO:0001772;GO:0043231;GO:0042470;GO:0016020;GO:0005815;GO:0048306;GO:0042803;GO:0031871;GO:0000915;GO:0006915;GO:0070830;GO:0045199;GO:0061952;GO:0000281;GO:0036258;GO:1903543;GO:1903553;GO:0051260;GO:0015031;GO:0010824;GO:1903551;GO:0090559;GO:0060544;GO:0090611;GO:0046755;GO:0039702;GO:0019058;, C:actomyosin; C:bicellular tight junction; C:cytosol; C:endoplasmic reticulum exit site; C:extracellular exosome; C:extracellular vesicle; C:Flemming body; C:focal adhesion; C:immunological synapse; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:microtubule organizing center;, F:calcium-dependent protein binding; F:protein homodimerization activity; F:proteinase activated receptor binding;, P:actomyosin contractile ring assembly; P:apoptotic process; P:bicellular tight junction assembly; P:maintenance of epithelial cell apical/basal polarity; P:midbody abscission; P:mitotic cytokinesis; P:multivesicular body assembly; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:protein homooligomerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of extracellular exosome assembly; P:regulation of membrane permeability; P:regulation of necroptotic process; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8WUM4 C5MQH7 E9PFU1 Q6NUS1 Q9BX86 Q9NUN0 Q9P2H2 Q9UKL5,Programmed cell death 6-interacting protein,ALG-2-interacting protein 1;ALG-2-interacting protein X;Hp95;, PF13949;PF03097;, GO:0042641;GO:0005923;GO:0005829;GO:0070971;GO:0070062;GO:1903561;GO:0090543;GO:0005925;GO:0001772;GO:0043231;GO:0042470;GO:0016020;GO:0005815;GO:0048306;GO:0042803;GO:0031871;GO:0000915;GO:0006915;GO:0070830;GO:0045199;GO:0061952;GO:0000281;GO:0036258;GO:1903543;GO:1903553;GO:0051260;GO:0015031;GO:0010824;GO:1903551;GO:0090559;GO:0060544;GO:0090611;GO:0046755;GO:0039702;GO:0019058;, C:actomyosin; C:bicellular tight junction; C:cytosol; C:endoplasmic reticulum exit site; C:extracellular exosome; C:extracellular vesicle; C:Flemming body; C:focal adhesion; C:immunological synapse; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:microtubule organizing center;, F:calcium-dependent protein binding; F:protein homodimerization activity; F:proteinase activated receptor binding;, P:actomyosin contractile ring assembly; P:apoptotic process; P:bicellular tight junction assembly; P:maintenance of epithelial cell apical/basal polarity; P:midbody abscission; P:mitotic cytokinesis; P:multivesicular body assembly; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:protein homooligomerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of extracellular exosome assembly; P:regulation of membrane permeability; P:regulation of necroptotic process; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8WUM4 C5MQH7 E9PFU1 Q6NUS1 Q9BX86 Q9NUN0 Q9P2H2 Q9UKL5,Programmed cell death 6-interacting protein,ALG-2-interacting protein 1;ALG-2-interacting protein X;Hp95;, PF13949;PF03097;, GO:0042641;GO:0005923;GO:0005829;GO:0070971;GO:0070062;GO:1903561;GO:0090543;GO:0005925;GO:0001772;GO:0043231;GO:0042470;GO:0016020;GO:0005815;GO:0048306;GO:0042803;GO:0031871;GO:0000915;GO:0006915;GO:0070830;GO:0045199;GO:0061952;GO:0000281;GO:0036258;GO:1903543;GO:1903553;GO:0051260;GO:0015031;GO:0010824;GO:1903551;GO:0090559;GO:0060544;GO:0090611;GO:0046755;GO:0039702;GO:0019058;, C:actomyosin; C:bicellular tight junction; C:cytosol; C:endoplasmic reticulum exit site; C:extracellular exosome; C:extracellular vesicle; C:Flemming body; C:focal adhesion; C:immunological synapse; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:microtubule organizing center;, F:calcium-dependent protein binding; F:protein homodimerization activity; F:proteinase activated receptor binding;, P:actomyosin contractile ring assembly; P:apoptotic process; P:bicellular tight junction assembly; P:maintenance of epithelial cell apical/basal polarity; P:midbody abscission; P:mitotic cytokinesis; P:multivesicular body assembly; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:protein homooligomerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of extracellular exosome assembly; P:regulation of membrane permeability; P:regulation of necroptotic process; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle;|Q8WUM4 C5MQH7 E9PFU1 Q6NUS1 Q9BX86 Q9NUN0 Q9P2H2 Q9UKL5,Programmed cell death 6-interacting protein,ALG-2-interacting protein 1;ALG-2-interacting protein X;Hp95;, PF13949;PF03097;, GO:0042641;GO:0005923;GO:0005829;GO:0070971;GO:0070062;GO:1903561;GO:0090543;GO:0005925;GO:0001772;GO:0043231;GO:0042470;GO:0016020;GO:0005815;GO:0048306;GO:0042803;GO:0031871;GO:0000915;GO:0006915;GO:0070830;GO:0045199;GO:0061952;GO:0000281;GO:0036258;GO:1903543;GO:1903553;GO:0051260;GO:0015031;GO:0010824;GO:1903551;GO:0090559;GO:0060544;GO:0090611;GO:0046755;GO:0039702;GO:0019058;, C:actomyosin; C:bicellular tight junction; C:cytosol; C:endoplasmic reticulum exit site; C:extracellular exosome; C:extracellular vesicle; C:Flemming body; C:focal adhesion; C:immunological synapse; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:microtubule organizing center;, F:calcium-dependent protein binding; F:protein homodimerization activity; F:proteinase activated receptor binding;, P:actomyosin contractile ring assembly; P:apoptotic process; P:bicellular tight junction assembly; P:maintenance of epithelial cell apical/basal polarity; P:midbody abscission; P:mitotic cytokinesis; P:multivesicular body assembly; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:protein homooligomerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of extracellular exosome assembly; P:regulation of membrane permeability; P:regulation of necroptotic process; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold51 indexed_genome mRNA 7798572 7799134 . + . ID=transcript_9519;Q9UBL0 B4DG96 Q49AK3 Q49AS6 Q4G0V4 Q6NYC3 Q86V31 Q9UF93,cAMP-regulated phosphoprotein 21,Thymocyte cAMP-regulated phosphoprotein;, PF01424;PF12752;, GO:0005737;GO:0005516;GO:0003676;GO:0034605;, C:cytoplasm;, F:calmodulin binding; F:nucleic acid binding;, P:cellular response to heat; scaffold51 indexed_genome mRNA 7817211 7818396 . + . ID=transcript_9520;Q9UBL0 B4DG96 Q49AK3 Q49AS6 Q4G0V4 Q6NYC3 Q86V31 Q9UF93,cAMP-regulated phosphoprotein 21,Thymocyte cAMP-regulated phosphoprotein;, PF01424;PF12752;, GO:0005737;GO:0005516;GO:0003676;GO:0034605;, C:cytoplasm;, F:calmodulin binding; F:nucleic acid binding;, P:cellular response to heat; scaffold51 indexed_genome mRNA 7905397 7908754 . + . ID=transcript_9521;Q9UBL0 B4DG96 Q49AK3 Q49AS6 Q4G0V4 Q6NYC3 Q86V31 Q9UF93,cAMP-regulated phosphoprotein 21,Thymocyte cAMP-regulated phosphoprotein;, PF01424;PF12752;, GO:0005737;GO:0005516;GO:0003676;GO:0034605;, C:cytoplasm;, F:calmodulin binding; F:nucleic acid binding;, P:cellular response to heat;|Q9UBL0 B4DG96 Q49AK3 Q49AS6 Q4G0V4 Q6NYC3 Q86V31 Q9UF93,cAMP-regulated phosphoprotein 21,Thymocyte cAMP-regulated phosphoprotein;, PF01424;PF12752;, GO:0005737;GO:0005516;GO:0003676;GO:0034605;, C:cytoplasm;, F:calmodulin binding; F:nucleic acid binding;, P:cellular response to heat;|Q9UBL0 B4DG96 Q49AK3 Q49AS6 Q4G0V4 Q6NYC3 Q86V31 Q9UF93,cAMP-regulated phosphoprotein 21,Thymocyte cAMP-regulated phosphoprotein;, PF01424;PF12752;, GO:0005737;GO:0005516;GO:0003676;GO:0034605;, C:cytoplasm;, F:calmodulin binding; F:nucleic acid binding;, P:cellular response to heat; scaffold51 indexed_genome mRNA 8275250 8387242 . + . ID=transcript_9522;Q99469 B2R8S8,SH3 and cysteine-rich domain-containing protein,Src homology 3 and cysteine-rich domain-containing protein;, PF00130;PF14604;, GO:0005829;GO:0031234;GO:0030315;GO:0044325;GO:0046872;GO:0034605;GO:0035556;GO:2001259;GO:1903078;GO:1901387;GO:0007165;GO:0003009;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:T-tubule;, F:ion channel binding; F:metal ion binding;, P:cellular response to heat; P:intracellular signal transduction; P:positive regulation of cation channel activity; P:positive regulation of protein localization to plasma membrane; P:positive regulation of voltage-gated calcium channel activity; P:signal transduction; P:skeletal muscle contraction; scaffold51 indexed_genome mRNA 8526150 8609076 . + . ID=transcript_9523;Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway;|Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway;|Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway;|Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway;|Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway;|Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway;|Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway;|Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway; scaffold51 indexed_genome mRNA 8609115 8693825 . - . ID=transcript_9524;P40692 B4DI13 B4DQ11 E9PCU2,DNA mismatch repair protein Mlh1,MutL protein homolog 1;, PF01119;PF16413;, GO:0005712;GO:0005694;GO:0005715;GO:0001673;GO:0016020;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0003682;GO:0019899;GO:0032137;GO:0006303;GO:0016321;GO:0007129;GO:0008630;GO:0045190;GO:0007060;GO:0043060;GO:0051257;GO:0045141;GO:0006298;GO:0045950;GO:0000289;GO:0048477;GO:0048298;GO:0048304;GO:0000712;GO:0009617;GO:0016446;GO:0007283;, C:chiasma; C:chromosome; C:late recombination nodule; C:male germ cell nucleus; C:membrane; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:enzyme binding; F:guanine/thymine mispair binding;, P:double-strand break repair via nonhomologous end joining; P:female meiosis chromosome segregation; P:homologous chromosome pairing at meiosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:male meiosis chromosome segregation; P:meiotic metaphase I plate congression; P:meiotic spindle midzone assembly; P:meiotic telomere clustering; P:mismatch repair; P:negative regulation of mitotic recombination; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oogenesis; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:resolution of meiotic recombination intermediates; P:response to bacterium; P:somatic hypermutation of immunoglobulin genes; P:spermatogenesis;|P40692 B4DI13 B4DQ11 E9PCU2,DNA mismatch repair protein Mlh1,MutL protein homolog 1;, PF01119;PF16413;, GO:0005712;GO:0005694;GO:0005715;GO:0001673;GO:0016020;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0003682;GO:0019899;GO:0032137;GO:0006303;GO:0016321;GO:0007129;GO:0008630;GO:0045190;GO:0007060;GO:0043060;GO:0051257;GO:0045141;GO:0006298;GO:0045950;GO:0000289;GO:0048477;GO:0048298;GO:0048304;GO:0000712;GO:0009617;GO:0016446;GO:0007283;, C:chiasma; C:chromosome; C:late recombination nodule; C:male germ cell nucleus; C:membrane; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:enzyme binding; F:guanine/thymine mispair binding;, P:double-strand break repair via nonhomologous end joining; P:female meiosis chromosome segregation; P:homologous chromosome pairing at meiosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:male meiosis chromosome segregation; P:meiotic metaphase I plate congression; P:meiotic spindle midzone assembly; P:meiotic telomere clustering; P:mismatch repair; P:negative regulation of mitotic recombination; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oogenesis; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:resolution of meiotic recombination intermediates; P:response to bacterium; P:somatic hypermutation of immunoglobulin genes; P:spermatogenesis;|P40692 B4DI13 B4DQ11 E9PCU2,DNA mismatch repair protein Mlh1,MutL protein homolog 1;, PF01119;PF16413;, GO:0005712;GO:0005694;GO:0005715;GO:0001673;GO:0016020;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0003682;GO:0019899;GO:0032137;GO:0006303;GO:0016321;GO:0007129;GO:0008630;GO:0045190;GO:0007060;GO:0043060;GO:0051257;GO:0045141;GO:0006298;GO:0045950;GO:0000289;GO:0048477;GO:0048298;GO:0048304;GO:0000712;GO:0009617;GO:0016446;GO:0007283;, C:chiasma; C:chromosome; C:late recombination nodule; C:male germ cell nucleus; C:membrane; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:enzyme binding; F:guanine/thymine mispair binding;, P:double-strand break repair via nonhomologous end joining; P:female meiosis chromosome segregation; P:homologous chromosome pairing at meiosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:male meiosis chromosome segregation; P:meiotic metaphase I plate congression; P:meiotic spindle midzone assembly; P:meiotic telomere clustering; P:mismatch repair; P:negative regulation of mitotic recombination; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oogenesis; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:resolution of meiotic recombination intermediates; P:response to bacterium; P:somatic hypermutation of immunoglobulin genes; P:spermatogenesis;|P40692 B4DI13 B4DQ11 E9PCU2,DNA mismatch repair protein Mlh1,MutL protein homolog 1;, PF01119;PF16413;, GO:0005712;GO:0005694;GO:0005715;GO:0001673;GO:0016020;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0003682;GO:0019899;GO:0032137;GO:0006303;GO:0016321;GO:0007129;GO:0008630;GO:0045190;GO:0007060;GO:0043060;GO:0051257;GO:0045141;GO:0006298;GO:0045950;GO:0000289;GO:0048477;GO:0048298;GO:0048304;GO:0000712;GO:0009617;GO:0016446;GO:0007283;, C:chiasma; C:chromosome; C:late recombination nodule; C:male germ cell nucleus; C:membrane; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:enzyme binding; F:guanine/thymine mispair binding;, P:double-strand break repair via nonhomologous end joining; P:female meiosis chromosome segregation; P:homologous chromosome pairing at meiosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:male meiosis chromosome segregation; P:meiotic metaphase I plate congression; P:meiotic spindle midzone assembly; P:meiotic telomere clustering; P:mismatch repair; P:negative regulation of mitotic recombination; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oogenesis; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:resolution of meiotic recombination intermediates; P:response to bacterium; P:somatic hypermutation of immunoglobulin genes; P:spermatogenesis;|P40692 B4DI13 B4DQ11 E9PCU2,DNA mismatch repair protein Mlh1,MutL protein homolog 1;, PF01119;PF16413;, GO:0005712;GO:0005694;GO:0005715;GO:0001673;GO:0016020;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0003682;GO:0019899;GO:0032137;GO:0006303;GO:0016321;GO:0007129;GO:0008630;GO:0045190;GO:0007060;GO:0043060;GO:0051257;GO:0045141;GO:0006298;GO:0045950;GO:0000289;GO:0048477;GO:0048298;GO:0048304;GO:0000712;GO:0009617;GO:0016446;GO:0007283;, C:chiasma; C:chromosome; C:late recombination nodule; C:male germ cell nucleus; C:membrane; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:enzyme binding; F:guanine/thymine mispair binding;, P:double-strand break repair via nonhomologous end joining; P:female meiosis chromosome segregation; P:homologous chromosome pairing at meiosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:male meiosis chromosome segregation; P:meiotic metaphase I plate congression; P:meiotic spindle midzone assembly; P:meiotic telomere clustering; P:mismatch repair; P:negative regulation of mitotic recombination; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oogenesis; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:resolution of meiotic recombination intermediates; P:response to bacterium; P:somatic hypermutation of immunoglobulin genes; P:spermatogenesis;|P40692 B4DI13 B4DQ11 E9PCU2,DNA mismatch repair protein Mlh1,MutL protein homolog 1;, PF01119;PF16413;, GO:0005712;GO:0005694;GO:0005715;GO:0001673;GO:0016020;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0003682;GO:0019899;GO:0032137;GO:0006303;GO:0016321;GO:0007129;GO:0008630;GO:0045190;GO:0007060;GO:0043060;GO:0051257;GO:0045141;GO:0006298;GO:0045950;GO:0000289;GO:0048477;GO:0048298;GO:0048304;GO:0000712;GO:0009617;GO:0016446;GO:0007283;, C:chiasma; C:chromosome; C:late recombination nodule; C:male germ cell nucleus; C:membrane; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:enzyme binding; F:guanine/thymine mispair binding;, P:double-strand break repair via nonhomologous end joining; P:female meiosis chromosome segregation; P:homologous chromosome pairing at meiosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:male meiosis chromosome segregation; P:meiotic metaphase I plate congression; P:meiotic spindle midzone assembly; P:meiotic telomere clustering; P:mismatch repair; P:negative regulation of mitotic recombination; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oogenesis; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:resolution of meiotic recombination intermediates; P:response to bacterium; P:somatic hypermutation of immunoglobulin genes; P:spermatogenesis;|P40692 B4DI13 B4DQ11 E9PCU2,DNA mismatch repair protein Mlh1,MutL protein homolog 1;, PF01119;PF16413;, GO:0005712;GO:0005694;GO:0005715;GO:0001673;GO:0016020;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0003682;GO:0019899;GO:0032137;GO:0006303;GO:0016321;GO:0007129;GO:0008630;GO:0045190;GO:0007060;GO:0043060;GO:0051257;GO:0045141;GO:0006298;GO:0045950;GO:0000289;GO:0048477;GO:0048298;GO:0048304;GO:0000712;GO:0009617;GO:0016446;GO:0007283;, C:chiasma; C:chromosome; C:late recombination nodule; C:male germ cell nucleus; C:membrane; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:enzyme binding; F:guanine/thymine mispair binding;, P:double-strand break repair via nonhomologous end joining; P:female meiosis chromosome segregation; P:homologous chromosome pairing at meiosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:male meiosis chromosome segregation; P:meiotic metaphase I plate congression; P:meiotic spindle midzone assembly; P:meiotic telomere clustering; P:mismatch repair; P:negative regulation of mitotic recombination; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oogenesis; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:resolution of meiotic recombination intermediates; P:response to bacterium; P:somatic hypermutation of immunoglobulin genes; P:spermatogenesis;|P40692 B4DI13 B4DQ11 E9PCU2,DNA mismatch repair protein Mlh1,MutL protein homolog 1;, PF01119;PF16413;, GO:0005712;GO:0005694;GO:0005715;GO:0001673;GO:0016020;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0003682;GO:0019899;GO:0032137;GO:0006303;GO:0016321;GO:0007129;GO:0008630;GO:0045190;GO:0007060;GO:0043060;GO:0051257;GO:0045141;GO:0006298;GO:0045950;GO:0000289;GO:0048477;GO:0048298;GO:0048304;GO:0000712;GO:0009617;GO:0016446;GO:0007283;, C:chiasma; C:chromosome; C:late recombination nodule; C:male germ cell nucleus; C:membrane; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:enzyme binding; F:guanine/thymine mispair binding;, P:double-strand break repair via nonhomologous end joining; P:female meiosis chromosome segregation; P:homologous chromosome pairing at meiosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:male meiosis chromosome segregation; P:meiotic metaphase I plate congression; P:meiotic spindle midzone assembly; P:meiotic telomere clustering; P:mismatch repair; P:negative regulation of mitotic recombination; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oogenesis; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:resolution of meiotic recombination intermediates; P:response to bacterium; P:somatic hypermutation of immunoglobulin genes; P:spermatogenesis;|P40692 B4DI13 B4DQ11 E9PCU2,DNA mismatch repair protein Mlh1,MutL protein homolog 1;, PF01119;PF16413;, GO:0005712;GO:0005694;GO:0005715;GO:0001673;GO:0016020;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0003682;GO:0019899;GO:0032137;GO:0006303;GO:0016321;GO:0007129;GO:0008630;GO:0045190;GO:0007060;GO:0043060;GO:0051257;GO:0045141;GO:0006298;GO:0045950;GO:0000289;GO:0048477;GO:0048298;GO:0048304;GO:0000712;GO:0009617;GO:0016446;GO:0007283;, C:chiasma; C:chromosome; C:late recombination nodule; C:male germ cell nucleus; C:membrane; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:enzyme binding; F:guanine/thymine mispair binding;, P:double-strand break repair via nonhomologous end joining; P:female meiosis chromosome segregation; P:homologous chromosome pairing at meiosis; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:isotype switching; P:male meiosis chromosome segregation; P:meiotic metaphase I plate congression; P:meiotic spindle midzone assembly; P:meiotic telomere clustering; P:mismatch repair; P:negative regulation of mitotic recombination; P:nuclear-transcribed mRNA poly(A) tail shortening; P:oogenesis; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of isotype switching to IgG isotypes; P:resolution of meiotic recombination intermediates; P:response to bacterium; P:somatic hypermutation of immunoglobulin genes; P:spermatogenesis; scaffold51 indexed_genome mRNA 8693857 8696354 . + . ID=transcript_9525;Q7L775 O94866 Q9H3L3,EPM2A-interacting protein 1,Laforin-interacting protein;, PF18658;, GO:0098554;GO:0005634;GO:0042802;GO:2000467;GO:0045725;GO:0032868;, C:cytoplasmic side of endoplasmic reticulum membrane; C:nucleus;, F:identical protein binding;, P:positive regulation of glycogen (starch) synthase activity; P:positive regulation of glycogen biosynthetic process; P:response to insulin; scaffold51 indexed_genome mRNA 8726444 8828416 . + . ID=transcript_9526;O15050 Q8N8K0,TPR and ankyrin repeat-containing protein 1,Lupus brain antigen 1 homolog;|O15050 Q8N8K0,TPR and ankyrin repeat-containing protein 1,Lupus brain antigen 1 homolog;|P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|O15050 Q8N8K0,TPR and ankyrin repeat-containing protein 1,Lupus brain antigen 1 homolog;|O15050 Q8N8K0,TPR and ankyrin repeat-containing protein 1,Lupus brain antigen 1 homolog;|O15050 Q8N8K0,TPR and ankyrin repeat-containing protein 1,Lupus brain antigen 1 homolog; scaffold51 indexed_genome mRNA 8887176 8887759 . + . ID=transcript_9527;Q9C098,Serine/threonine-protein kinase DCLK3,Doublecortin domain-containing protein 3C;Doublecortin-like and CAM kinase-like 3;Doublecortin-like kinase 3;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0018105;, C:cytoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:peptidyl-serine phosphorylation; scaffold51 indexed_genome mRNA 8898800 8900296 . + . ID=transcript_9528;Q9C098,Serine/threonine-protein kinase DCLK3,Doublecortin domain-containing protein 3C;Doublecortin-like and CAM kinase-like 3;Doublecortin-like kinase 3;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0018105;, C:cytoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:peptidyl-serine phosphorylation; scaffold51 indexed_genome mRNA 8939278 9028965 . + . ID=transcript_9529;Q13439 F8W8Q7 Q13270 Q13654 Q14436 Q59EW8,Golgin subfamily A member 4,256 kDa golgin;Golgin-245;Protein 72.1;Trans-Golgi p230;, PF01465;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0000139;GO:0005654;GO:0005886;GO:0005802;GO:0051020;GO:0043001;GO:0045773;GO:0016192;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase binding;, P:Golgi to plasma membrane protein transport; P:positive regulation of axon extension; P:vesicle-mediated transport;|Q13439 F8W8Q7 Q13270 Q13654 Q14436 Q59EW8,Golgin subfamily A member 4,256 kDa golgin;Golgin-245;Protein 72.1;Trans-Golgi p230;, PF01465;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0000139;GO:0005654;GO:0005886;GO:0005802;GO:0051020;GO:0043001;GO:0045773;GO:0016192;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase binding;, P:Golgi to plasma membrane protein transport; P:positive regulation of axon extension; P:vesicle-mediated transport;|Q13439 F8W8Q7 Q13270 Q13654 Q14436 Q59EW8,Golgin subfamily A member 4,256 kDa golgin;Golgin-245;Protein 72.1;Trans-Golgi p230;, PF01465;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0000139;GO:0005654;GO:0005886;GO:0005802;GO:0051020;GO:0043001;GO:0045773;GO:0016192;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase binding;, P:Golgi to plasma membrane protein transport; P:positive regulation of axon extension; P:vesicle-mediated transport;|Q13439 F8W8Q7 Q13270 Q13654 Q14436 Q59EW8,Golgin subfamily A member 4,256 kDa golgin;Golgin-245;Protein 72.1;Trans-Golgi p230;, PF01465;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0000139;GO:0005654;GO:0005886;GO:0005802;GO:0051020;GO:0043001;GO:0045773;GO:0016192;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:plasma membrane; C:trans-Golgi network;, F:GTPase binding;, P:Golgi to plasma membrane protein transport; P:positive regulation of axon extension; P:vesicle-mediated transport; scaffold51 indexed_genome mRNA 9074290 9412823 . + . ID=transcript_9530;Q13797 Q14638,Integrin alpha-9,Integrin alpha-RLC;, PF01839;PF08441;, GO:0034679;GO:0008305;GO:0005886;GO:0005518;GO:0043236;GO:0046872;GO:0007155;GO:0030198;GO:0007229;GO:0042060;, C:integrin alpha9-beta1 complex; C:integrin complex; C:plasma membrane;, F:collagen binding; F:laminin binding; F:metal ion binding;, P:cell adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:wound healing; scaffold51 indexed_genome mRNA 9547788 9576141 . + . ID=transcript_9531;O15194 Q3ZTU0 Q70KI4 Q7Z5Q2,CTD small phosphatase-like protein,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3;NIF-like protein;Nuclear LIM interactor-interacting factor 1;Protein YA22;RBSP3;Small C-terminal domain phosphatase 3;, PF03031;, GO:0070062;GO:0005634;GO:0046872;GO:0004721;GO:0106306;GO:0106307;GO:0008420;GO:2000134;GO:0001933;, C:extracellular exosome; C:nucleus;, F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein phosphorylation;|O15194 Q3ZTU0 Q70KI4 Q7Z5Q2,CTD small phosphatase-like protein,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3;NIF-like protein;Nuclear LIM interactor-interacting factor 1;Protein YA22;RBSP3;Small C-terminal domain phosphatase 3;, PF03031;, GO:0070062;GO:0005634;GO:0046872;GO:0004721;GO:0106306;GO:0106307;GO:0008420;GO:2000134;GO:0001933;, C:extracellular exosome; C:nucleus;, F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein phosphorylation;|O15194 Q3ZTU0 Q70KI4 Q7Z5Q2,CTD small phosphatase-like protein,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3;NIF-like protein;Nuclear LIM interactor-interacting factor 1;Protein YA22;RBSP3;Small C-terminal domain phosphatase 3;, PF03031;, GO:0070062;GO:0005634;GO:0046872;GO:0004721;GO:0106306;GO:0106307;GO:0008420;GO:2000134;GO:0001933;, C:extracellular exosome; C:nucleus;, F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein phosphorylation;|O15194 Q3ZTU0 Q70KI4 Q7Z5Q2,CTD small phosphatase-like protein,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3;NIF-like protein;Nuclear LIM interactor-interacting factor 1;Protein YA22;RBSP3;Small C-terminal domain phosphatase 3;, PF03031;, GO:0070062;GO:0005634;GO:0046872;GO:0004721;GO:0106306;GO:0106307;GO:0008420;GO:2000134;GO:0001933;, C:extracellular exosome; C:nucleus;, F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein phosphorylation; scaffold51 indexed_genome mRNA 9603883 9712641 . - . ID=transcript_9532;P51178 B3KR14 Q86VN8,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 {ECO:0000305},Phosphoinositide phospholipase C-delta-1;Phospholipase C-III;Phospholipase C-delta-1;, PF00168;PF09279;PF00388;PF00387;, GO:0005737;GO:0070062;GO:0005886;GO:0005509;GO:0032794;GO:0070300;GO:0004435;GO:0005546;GO:0001786;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0006644;, C:cytoplasm; C:extracellular exosome; C:plasma membrane;, F:calcium ion binding; F:GTPase activating protein binding; F:phosphatidic acid binding; F:phosphatidylinositol phospholipase C activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:phospholipid metabolic process;|P51178 B3KR14 Q86VN8,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 {ECO:0000305},Phosphoinositide phospholipase C-delta-1;Phospholipase C-III;Phospholipase C-delta-1;, PF00168;PF09279;PF00388;PF00387;, GO:0005737;GO:0070062;GO:0005886;GO:0005509;GO:0032794;GO:0070300;GO:0004435;GO:0005546;GO:0001786;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0006644;, C:cytoplasm; C:extracellular exosome; C:plasma membrane;, F:calcium ion binding; F:GTPase activating protein binding; F:phosphatidic acid binding; F:phosphatidylinositol phospholipase C activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:phospholipid metabolic process;|P51178 B3KR14 Q86VN8,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 {ECO:0000305},Phosphoinositide phospholipase C-delta-1;Phospholipase C-III;Phospholipase C-delta-1;, PF00168;PF09279;PF00388;PF00387;, GO:0005737;GO:0070062;GO:0005886;GO:0005509;GO:0032794;GO:0070300;GO:0004435;GO:0005546;GO:0001786;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0006644;, C:cytoplasm; C:extracellular exosome; C:plasma membrane;, F:calcium ion binding; F:GTPase activating protein binding; F:phosphatidic acid binding; F:phosphatidylinositol phospholipase C activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:phospholipid metabolic process;|P51178 B3KR14 Q86VN8,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 {ECO:0000305},Phosphoinositide phospholipase C-delta-1;Phospholipase C-III;Phospholipase C-delta-1;, PF00168;PF09279;PF00388;PF00387;, GO:0005737;GO:0070062;GO:0005886;GO:0005509;GO:0032794;GO:0070300;GO:0004435;GO:0005546;GO:0001786;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0006644;, C:cytoplasm; C:extracellular exosome; C:plasma membrane;, F:calcium ion binding; F:GTPase activating protein binding; F:phosphatidic acid binding; F:phosphatidylinositol phospholipase C activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:phospholipid metabolic process;|P51178 B3KR14 Q86VN8,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 {ECO:0000305},Phosphoinositide phospholipase C-delta-1;Phospholipase C-III;Phospholipase C-delta-1;, PF00168;PF09279;PF00388;PF00387;, GO:0005737;GO:0070062;GO:0005886;GO:0005509;GO:0032794;GO:0070300;GO:0004435;GO:0005546;GO:0001786;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0006644;, C:cytoplasm; C:extracellular exosome; C:plasma membrane;, F:calcium ion binding; F:GTPase activating protein binding; F:phosphatidic acid binding; F:phosphatidylinositol phospholipase C activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:phospholipid metabolic process;|P51178 B3KR14 Q86VN8,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 {ECO:0000305},Phosphoinositide phospholipase C-delta-1;Phospholipase C-III;Phospholipase C-delta-1;, PF00168;PF09279;PF00388;PF00387;, GO:0005737;GO:0070062;GO:0005886;GO:0005509;GO:0032794;GO:0070300;GO:0004435;GO:0005546;GO:0001786;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0006644;, C:cytoplasm; C:extracellular exosome; C:plasma membrane;, F:calcium ion binding; F:GTPase activating protein binding; F:phosphatidic acid binding; F:phosphatidylinositol phospholipase C activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:phospholipid metabolic process;|Q9Y238 Q9NSW0 Q9NTG5,Deleted in lung and esophageal cancer protein 1,Deleted in lung cancer protein 1;, , GO:0005737;GO:0005829;GO:0002357;GO:0008285;, C:cytoplasm; C:cytosol;, , P:defense response to tumor cell; P:negative regulation of cell population proliferation;|Q9Y238 Q9NSW0 Q9NTG5,Deleted in lung and esophageal cancer protein 1,Deleted in lung cancer protein 1;, , GO:0005737;GO:0005829;GO:0002357;GO:0008285;, C:cytoplasm; C:cytosol;, , P:defense response to tumor cell; P:negative regulation of cell population proliferation;|Q9Y238 Q9NSW0 Q9NTG5,Deleted in lung and esophageal cancer protein 1,Deleted in lung cancer protein 1;, , GO:0005737;GO:0005829;GO:0002357;GO:0008285;, C:cytoplasm; C:cytosol;, , P:defense response to tumor cell; P:negative regulation of cell population proliferation; scaffold51 indexed_genome mRNA 9713898 9742575 . + . ID=transcript_9533;Q9Y238 Q9NSW0 Q9NTG5,Deleted in lung and esophageal cancer protein 1,Deleted in lung cancer protein 1;, , GO:0005737;GO:0005829;GO:0002357;GO:0008285;, C:cytoplasm; C:cytosol;, , P:defense response to tumor cell; P:negative regulation of cell population proliferation;|Q9Y238 Q9NSW0 Q9NTG5,Deleted in lung and esophageal cancer protein 1,Deleted in lung cancer protein 1;, , GO:0005737;GO:0005829;GO:0002357;GO:0008285;, C:cytoplasm; C:cytosol;, , P:defense response to tumor cell; P:negative regulation of cell population proliferation;|P09110 G5E935 Q96CA6,3-ketoacyl-CoA thiolase, peroxisomal {ECO:0000305},Acetyl-CoA C-myristoyltransferase;Acetyl-CoA acyltransferase;Beta-ketothiolase;Peroxisomal 3-oxoacyl-CoA thiolase;, PF02803;PF00108;, GO:0005829;GO:0005576;GO:0016020;GO:0005782;GO:0005777;GO:0035580;GO:0008775;GO:0003985;GO:0003988;GO:0050633;GO:0016401;GO:0036109;GO:0008206;GO:0006635;GO:0033540;GO:0043312;GO:0010124;GO:0008104;GO:0000038;, C:cytosol; C:extracellular region; C:membrane; C:peroxisomal matrix; C:peroxisome; C:specific granule lumen;, F:acetate CoA-transferase activity; F:acetyl-CoA C-acetyltransferase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:palmitoyl-CoA oxidase activity;, P:alpha-linolenic acid metabolic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:neutrophil degranulation; P:phenylacetate catabolic process; P:protein localization; P:very long-chain fatty acid metabolic process;|P09110 G5E935 Q96CA6,3-ketoacyl-CoA thiolase, peroxisomal {ECO:0000305},Acetyl-CoA C-myristoyltransferase;Acetyl-CoA acyltransferase;Beta-ketothiolase;Peroxisomal 3-oxoacyl-CoA thiolase;, PF02803;PF00108;, GO:0005829;GO:0005576;GO:0016020;GO:0005782;GO:0005777;GO:0035580;GO:0008775;GO:0003985;GO:0003988;GO:0050633;GO:0016401;GO:0036109;GO:0008206;GO:0006635;GO:0033540;GO:0043312;GO:0010124;GO:0008104;GO:0000038;, C:cytosol; C:extracellular region; C:membrane; C:peroxisomal matrix; C:peroxisome; C:specific granule lumen;, F:acetate CoA-transferase activity; F:acetyl-CoA C-acetyltransferase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:palmitoyl-CoA oxidase activity;, P:alpha-linolenic acid metabolic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:neutrophil degranulation; P:phenylacetate catabolic process; P:protein localization; P:very long-chain fatty acid metabolic process;|P09110 G5E935 Q96CA6,3-ketoacyl-CoA thiolase, peroxisomal {ECO:0000305},Acetyl-CoA C-myristoyltransferase;Acetyl-CoA acyltransferase;Beta-ketothiolase;Peroxisomal 3-oxoacyl-CoA thiolase;, PF02803;PF00108;, GO:0005829;GO:0005576;GO:0016020;GO:0005782;GO:0005777;GO:0035580;GO:0008775;GO:0003985;GO:0003988;GO:0050633;GO:0016401;GO:0036109;GO:0008206;GO:0006635;GO:0033540;GO:0043312;GO:0010124;GO:0008104;GO:0000038;, C:cytosol; C:extracellular region; C:membrane; C:peroxisomal matrix; C:peroxisome; C:specific granule lumen;, F:acetate CoA-transferase activity; F:acetyl-CoA C-acetyltransferase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:palmitoyl-CoA oxidase activity;, P:alpha-linolenic acid metabolic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:neutrophil degranulation; P:phenylacetate catabolic process; P:protein localization; P:very long-chain fatty acid metabolic process;|P09110 G5E935 Q96CA6,3-ketoacyl-CoA thiolase, peroxisomal {ECO:0000305},Acetyl-CoA C-myristoyltransferase;Acetyl-CoA acyltransferase;Beta-ketothiolase;Peroxisomal 3-oxoacyl-CoA thiolase;, PF02803;PF00108;, GO:0005829;GO:0005576;GO:0016020;GO:0005782;GO:0005777;GO:0035580;GO:0008775;GO:0003985;GO:0003988;GO:0050633;GO:0016401;GO:0036109;GO:0008206;GO:0006635;GO:0033540;GO:0043312;GO:0010124;GO:0008104;GO:0000038;, C:cytosol; C:extracellular region; C:membrane; C:peroxisomal matrix; C:peroxisome; C:specific granule lumen;, F:acetate CoA-transferase activity; F:acetyl-CoA C-acetyltransferase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:palmitoyl-CoA oxidase activity;, P:alpha-linolenic acid metabolic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:neutrophil degranulation; P:phenylacetate catabolic process; P:protein localization; P:very long-chain fatty acid metabolic process;|P09110 G5E935 Q96CA6,3-ketoacyl-CoA thiolase, peroxisomal {ECO:0000305},Acetyl-CoA C-myristoyltransferase;Acetyl-CoA acyltransferase;Beta-ketothiolase;Peroxisomal 3-oxoacyl-CoA thiolase;, PF02803;PF00108;, GO:0005829;GO:0005576;GO:0016020;GO:0005782;GO:0005777;GO:0035580;GO:0008775;GO:0003985;GO:0003988;GO:0050633;GO:0016401;GO:0036109;GO:0008206;GO:0006635;GO:0033540;GO:0043312;GO:0010124;GO:0008104;GO:0000038;, C:cytosol; C:extracellular region; C:membrane; C:peroxisomal matrix; C:peroxisome; C:specific granule lumen;, F:acetate CoA-transferase activity; F:acetyl-CoA C-acetyltransferase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:palmitoyl-CoA oxidase activity;, P:alpha-linolenic acid metabolic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:neutrophil degranulation; P:phenylacetate catabolic process; P:protein localization; P:very long-chain fatty acid metabolic process;|P09110 G5E935 Q96CA6,3-ketoacyl-CoA thiolase, peroxisomal {ECO:0000305},Acetyl-CoA C-myristoyltransferase;Acetyl-CoA acyltransferase;Beta-ketothiolase;Peroxisomal 3-oxoacyl-CoA thiolase;, PF02803;PF00108;, GO:0005829;GO:0005576;GO:0016020;GO:0005782;GO:0005777;GO:0035580;GO:0008775;GO:0003985;GO:0003988;GO:0050633;GO:0016401;GO:0036109;GO:0008206;GO:0006635;GO:0033540;GO:0043312;GO:0010124;GO:0008104;GO:0000038;, C:cytosol; C:extracellular region; C:membrane; C:peroxisomal matrix; C:peroxisome; C:specific granule lumen;, F:acetate CoA-transferase activity; F:acetyl-CoA C-acetyltransferase activity; F:acetyl-CoA C-acyltransferase activity; F:acetyl-CoA C-myristoyltransferase activity; F:palmitoyl-CoA oxidase activity;, P:alpha-linolenic acid metabolic process; P:bile acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:neutrophil degranulation; P:phenylacetate catabolic process; P:protein localization; P:very long-chain fatty acid metabolic process;|Q9P2J4,Zinc finger MYM-type protein 6,Transposon-derived Buster2 transposase-like protein;Zinc finger protein 258;, PF14291;PF06467;, GO:0005634;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleus;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis; scaffold51 indexed_genome mRNA 9744997 9749115 . + . ID=transcript_9534;Q53XS7,Myeloid differentiation primary response protein MyD88,, PF00531;PF01582;, GO:0005737;GO:0005829;GO:0010008;GO:0005634;GO:0005886;GO:0014069;GO:0032991;GO:0005123;GO:0042802;GO:0005149;GO:0043621;GO:0070976;GO:0005121;GO:0035325;GO:0070935;GO:0006915;GO:0007166;GO:0071222;GO:0071260;GO:0140052;GO:0042742;GO:0050830;GO:0042832;GO:0090557;GO:0016064;GO:0009682;GO:0045087;GO:0070498;GO:0007254;GO:0002269;GO:0031663;GO:0002755;GO:0043066;GO:0002283;GO:0070944;GO:0006909;GO:0032722;GO:1900017;GO:0010628;GO:0043123;GO:0032740;GO:0032747;GO:0032755;GO:0032757;GO:0046330;GO:0050671;GO:0051092;GO:0048661;GO:0032760;GO:0032481;GO:2000338;GO:2000341;GO:0050727;GO:1902622;GO:0070555;GO:0002238;GO:0032494;GO:0009615;GO:0007165;GO:0008063;GO:0034162;GO:0002224;GO:0060337;, C:cytoplasm; C:cytosol; C:endosome membrane; C:nucleus; C:plasma membrane; C:postsynaptic density; C:protein-containing complex;, F:death receptor binding; F:identical protein binding; F:interleukin-1 receptor binding; F:protein self-association; F:TIR domain binding; F:Toll binding; F:Toll-like receptor binding;, P:3'-UTR-mediated mRNA stabilization; P:apoptotic process; P:cell surface receptor signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:defense response to bacterium; P:defense response to Gram-positive bacterium; P:defense response to protozoan; P:establishment of endothelial intestinal barrier; P:immunoglobulin mediated immune response; P:induced systemic resistance; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:leukocyte activation involved in inflammatory response; P:lipopolysaccharide-mediated signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:neutrophil activation involved in immune response; P:neutrophil-mediated killing of bacterium; P:phagocytosis; P:positive regulation of chemokine production; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-23 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of lymphocyte proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:regulation of chemokine (C-X-C motif) ligand 1 production; P:regulation of chemokine (C-X-C motif) ligand 2 production; P:regulation of inflammatory response; P:regulation of neutrophil migration; P:response to interleukin-1; P:response to molecule of fungal origin; P:response to peptidoglycan; P:response to virus; P:signal transduction; P:Toll signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; P:type I interferon signaling pathway;|Q53XS7,Myeloid differentiation primary response protein MyD88,, PF00531;PF01582;, GO:0005737;GO:0005829;GO:0010008;GO:0005634;GO:0005886;GO:0014069;GO:0032991;GO:0005123;GO:0042802;GO:0005149;GO:0043621;GO:0070976;GO:0005121;GO:0035325;GO:0070935;GO:0006915;GO:0007166;GO:0071222;GO:0071260;GO:0140052;GO:0042742;GO:0050830;GO:0042832;GO:0090557;GO:0016064;GO:0009682;GO:0045087;GO:0070498;GO:0007254;GO:0002269;GO:0031663;GO:0002755;GO:0043066;GO:0002283;GO:0070944;GO:0006909;GO:0032722;GO:1900017;GO:0010628;GO:0043123;GO:0032740;GO:0032747;GO:0032755;GO:0032757;GO:0046330;GO:0050671;GO:0051092;GO:0048661;GO:0032760;GO:0032481;GO:2000338;GO:2000341;GO:0050727;GO:1902622;GO:0070555;GO:0002238;GO:0032494;GO:0009615;GO:0007165;GO:0008063;GO:0034162;GO:0002224;GO:0060337;, C:cytoplasm; C:cytosol; C:endosome membrane; C:nucleus; C:plasma membrane; C:postsynaptic density; C:protein-containing complex;, F:death receptor binding; F:identical protein binding; F:interleukin-1 receptor binding; F:protein self-association; F:TIR domain binding; F:Toll binding; F:Toll-like receptor binding;, P:3'-UTR-mediated mRNA stabilization; P:apoptotic process; P:cell surface receptor signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:defense response to bacterium; P:defense response to Gram-positive bacterium; P:defense response to protozoan; P:establishment of endothelial intestinal barrier; P:immunoglobulin mediated immune response; P:induced systemic resistance; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:leukocyte activation involved in inflammatory response; P:lipopolysaccharide-mediated signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:neutrophil activation involved in immune response; P:neutrophil-mediated killing of bacterium; P:phagocytosis; P:positive regulation of chemokine production; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-23 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of lymphocyte proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon production; P:regulation of chemokine (C-X-C motif) ligand 1 production; P:regulation of chemokine (C-X-C motif) ligand 2 production; P:regulation of inflammatory response; P:regulation of neutrophil migration; P:response to interleukin-1; P:response to molecule of fungal origin; P:response to peptidoglycan; P:response to virus; P:signal transduction; P:Toll signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; P:type I interferon signaling pathway; scaffold51 indexed_genome mRNA 9771668 9798054 . + . ID=transcript_9535;O95747 Q3LR53 Q7Z501 Q9UPQ1,Serine/threonine-protein kinase OSR1,Oxidative stress-responsive 1 protein;, PF12202;PF00069;, GO:0005829;GO:0070062;GO:0005524;GO:0042802;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0071476;GO:1990869;GO:0038116;GO:0038146;GO:0035556;GO:1901017;GO:0007231;GO:0018107;GO:0010820;GO:0046777;GO:0006468;GO:0006979;GO:0007165;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular hypotonic response; P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:chemokine (C-X-C motif) ligand 12 signaling pathway; P:intracellular signal transduction; P:negative regulation of potassium ion transmembrane transporter activity; P:osmosensory signaling pathway; P:peptidyl-threonine phosphorylation; P:positive regulation of T cell chemotaxis; P:protein autophosphorylation; P:protein phosphorylation; P:response to oxidative stress; P:signal transduction; scaffold51 indexed_genome mRNA 9826799 9857808 . + . ID=transcript_9536;O95747 Q3LR53 Q7Z501 Q9UPQ1,Serine/threonine-protein kinase OSR1,Oxidative stress-responsive 1 protein;, PF12202;PF00069;, GO:0005829;GO:0070062;GO:0005524;GO:0042802;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0071476;GO:1990869;GO:0038116;GO:0038146;GO:0035556;GO:1901017;GO:0007231;GO:0018107;GO:0010820;GO:0046777;GO:0006468;GO:0006979;GO:0007165;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular hypotonic response; P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:chemokine (C-X-C motif) ligand 12 signaling pathway; P:intracellular signal transduction; P:negative regulation of potassium ion transmembrane transporter activity; P:osmosensory signaling pathway; P:peptidyl-threonine phosphorylation; P:positive regulation of T cell chemotaxis; P:protein autophosphorylation; P:protein phosphorylation; P:response to oxidative stress; P:signal transduction;|O95747 Q3LR53 Q7Z501 Q9UPQ1,Serine/threonine-protein kinase OSR1,Oxidative stress-responsive 1 protein;, PF12202;PF00069;, GO:0005829;GO:0070062;GO:0005524;GO:0042802;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0071476;GO:1990869;GO:0038116;GO:0038146;GO:0035556;GO:1901017;GO:0007231;GO:0018107;GO:0010820;GO:0046777;GO:0006468;GO:0006979;GO:0007165;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular hypotonic response; P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:chemokine (C-X-C motif) ligand 12 signaling pathway; P:intracellular signal transduction; P:negative regulation of potassium ion transmembrane transporter activity; P:osmosensory signaling pathway; P:peptidyl-threonine phosphorylation; P:positive regulation of T cell chemotaxis; P:protein autophosphorylation; P:protein phosphorylation; P:response to oxidative stress; P:signal transduction;|O95747 Q3LR53 Q7Z501 Q9UPQ1,Serine/threonine-protein kinase OSR1,Oxidative stress-responsive 1 protein;, PF12202;PF00069;, GO:0005829;GO:0070062;GO:0005524;GO:0042802;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0071476;GO:1990869;GO:0038116;GO:0038146;GO:0035556;GO:1901017;GO:0007231;GO:0018107;GO:0010820;GO:0046777;GO:0006468;GO:0006979;GO:0007165;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular hypotonic response; P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:chemokine (C-X-C motif) ligand 12 signaling pathway; P:intracellular signal transduction; P:negative regulation of potassium ion transmembrane transporter activity; P:osmosensory signaling pathway; P:peptidyl-threonine phosphorylation; P:positive regulation of T cell chemotaxis; P:protein autophosphorylation; P:protein phosphorylation; P:response to oxidative stress; P:signal transduction; scaffold51 indexed_genome mRNA 9914139 9957733 . + . ID=transcript_9537;O75191 B2RAW4 B4DDT2 B9EH64,Xylulose kinase,, PF02782;PF00370;, GO:0005829;GO:0005524;GO:0016773;GO:0004856;GO:0005975;GO:0042732;GO:0006091;GO:0019640;GO:0016310;GO:0005998;GO:0005997;, C:cytosol;, F:ATP binding; F:phosphotransferase activity, alcohol group as acceptor; F:xylulokinase activity;, P:carbohydrate metabolic process; P:D-xylose metabolic process; P:generation of precursor metabolites and energy; P:glucuronate catabolic process to xylulose 5-phosphate; P:phosphorylation; P:xylulose catabolic process; P:xylulose metabolic process; scaffold51 indexed_genome mRNA 9960219 9986971 . + . ID=transcript_9538;Q13705 Q4VAV0,Activin receptor type-2B,Activin receptor type IIB;, PF01064;PF00069;, GO:0048179;GO:0005737;GO:0005887;GO:0005886;GO:0032991;GO:0043235;GO:0048185;GO:0017002;GO:0005524;GO:0019838;GO:0046872;GO:0004674;GO:0032924;GO:0009952;GO:0060840;GO:0001974;GO:0030509;GO:0071363;GO:0001946;GO:0060836;GO:0030514;GO:0120163;GO:0000122;GO:0032927;GO:0030513;GO:0030501;GO:0045669;GO:0006468;GO:0006355;GO:0061298;GO:0007165;GO:0007178;GO:0060841;, C:activin receptor complex; C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex; C:receptor complex;, F:activin binding; F:activin-activated receptor activity; F:ATP binding; F:growth factor binding; F:metal ion binding; F:protein serine/threonine kinase activity;, P:activin receptor signaling pathway; P:anterior/posterior pattern specification; P:artery development; P:blood vessel remodeling; P:BMP signaling pathway; P:cellular response to growth factor stimulus; P:lymphangiogenesis; P:lymphatic endothelial cell differentiation; P:negative regulation of BMP signaling pathway; P:negative regulation of cold-induced thermogenesis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of activin receptor signaling pathway; P:positive regulation of BMP signaling pathway; P:positive regulation of bone mineralization; P:positive regulation of osteoblast differentiation; P:protein phosphorylation; P:regulation of transcription, DNA-templated; P:retina vasculature development in camera-type eye; P:signal transduction; P:transmembrane receptor protein serine/threonine kinase signaling pathway; P:venous blood vessel development; scaffold51 indexed_genome mRNA 10032496 10560947 . - . ID=transcript_9539;Q59H93 Q75RX9 Q75RY0 Q86UR3 Q8IZC9 Q96J69,Sodium channel protein type 5 subunit alpha,Sodium channel protein cardiac muscle subunit alpha;Sodium channel protein type V subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.5;hH1 {ECO:0000303|PubMed:1309946};, PF00520;PF06512;PF11933;, GO:0005901;GO:0009986;GO:0005783;GO:0016021;GO:0014704;GO:0016328;GO:0005730;GO:0005654;GO:0048471;GO:0005886;GO:0042383;GO:0030315;GO:0001518;GO:0030018;GO:0030506;GO:0005516;GO:0019899;GO:0017134;GO:0044325;GO:0050998;GO:0019904;GO:0019901;GO:0097110;GO:0031625;GO:0005244;GO:0005248;GO:0086060;GO:0086061;GO:0086006;GO:0086062;GO:0086063;GO:0086014;GO:0086016;GO:0086067;GO:0003360;GO:0086043;GO:0061337;GO:0086002;GO:0060048;GO:0003231;GO:0071277;GO:0021549;GO:0051899;GO:0086010;GO:0098912;GO:0086045;GO:0086048;GO:0086012;GO:0086047;GO:0086046;GO:0019228;GO:0042475;GO:0045760;GO:0050679;GO:0010765;GO:0060371;GO:0060372;GO:0086004;GO:0002027;GO:0086091;GO:1902305;GO:0060373;GO:0060307;GO:0014894;GO:0086015;GO:0035725;GO:0006814;GO:0021537;GO:0086005;, C:caveola; C:cell surface; C:endoplasmic reticulum; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:T-tubule; C:voltage-gated sodium channel complex; C:Z disc;, F:ankyrin binding; F:calmodulin binding; F:enzyme binding; F:fibroblast growth factor binding; F:ion channel binding; F:nitric-oxide synthase binding; F:protein domain specific binding; F:protein kinase binding; F:scaffold protein binding; F:ubiquitin protein ligase binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity; F:voltage-gated sodium channel activity involved in AV node cell action potential; F:voltage-gated sodium channel activity involved in bundle of His cell action potential; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; F:voltage-gated sodium channel activity involved in Purkinje myocyte action potential; F:voltage-gated sodium channel activity involved in SA node cell action potential;, P:atrial cardiac muscle cell action potential; P:AV node cell action potential; P:AV node cell to bundle of His cell communication; P:brainstem development; P:bundle of His cell action potential; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:cardiac ventricle development; P:cellular response to calcium ion; P:cerebellum development; P:membrane depolarization; P:membrane depolarization during action potential; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during bundle of His cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:odontogenesis of dentin-containing tooth; P:positive regulation of action potential; P:positive regulation of epithelial cell proliferation; P:positive regulation of sodium ion transport; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of cardiac muscle cell contraction; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:response to denervation involved in regulation of muscle adaptation; P:SA node cell action potential; P:sodium ion transmembrane transport; P:sodium ion transport; P:telencephalon development; P:ventricular cardiac muscle cell action potential;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q59H93 Q75RX9 Q75RY0 Q86UR3 Q8IZC9 Q96J69,Sodium channel protein type 5 subunit alpha,Sodium channel protein cardiac muscle subunit alpha;Sodium channel protein type V subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.5;hH1 {ECO:0000303|PubMed:1309946};, PF00520;PF06512;PF11933;, GO:0005901;GO:0009986;GO:0005783;GO:0016021;GO:0014704;GO:0016328;GO:0005730;GO:0005654;GO:0048471;GO:0005886;GO:0042383;GO:0030315;GO:0001518;GO:0030018;GO:0030506;GO:0005516;GO:0019899;GO:0017134;GO:0044325;GO:0050998;GO:0019904;GO:0019901;GO:0097110;GO:0031625;GO:0005244;GO:0005248;GO:0086060;GO:0086061;GO:0086006;GO:0086062;GO:0086063;GO:0086014;GO:0086016;GO:0086067;GO:0003360;GO:0086043;GO:0061337;GO:0086002;GO:0060048;GO:0003231;GO:0071277;GO:0021549;GO:0051899;GO:0086010;GO:0098912;GO:0086045;GO:0086048;GO:0086012;GO:0086047;GO:0086046;GO:0019228;GO:0042475;GO:0045760;GO:0050679;GO:0010765;GO:0060371;GO:0060372;GO:0086004;GO:0002027;GO:0086091;GO:1902305;GO:0060373;GO:0060307;GO:0014894;GO:0086015;GO:0035725;GO:0006814;GO:0021537;GO:0086005;, C:caveola; C:cell surface; C:endoplasmic reticulum; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:T-tubule; C:voltage-gated sodium channel complex; C:Z disc;, F:ankyrin binding; F:calmodulin binding; F:enzyme binding; F:fibroblast growth factor binding; F:ion channel binding; F:nitric-oxide synthase binding; F:protein domain specific binding; F:protein kinase binding; F:scaffold protein binding; F:ubiquitin protein ligase binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity; F:voltage-gated sodium channel activity involved in AV node cell action potential; F:voltage-gated sodium channel activity involved in bundle of His cell action potential; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; F:voltage-gated sodium channel activity involved in Purkinje myocyte action potential; F:voltage-gated sodium channel activity involved in SA node cell action potential;, P:atrial cardiac muscle cell action potential; P:AV node cell action potential; P:AV node cell to bundle of His cell communication; P:brainstem development; P:bundle of His cell action potential; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:cardiac ventricle development; P:cellular response to calcium ion; P:cerebellum development; P:membrane depolarization; P:membrane depolarization during action potential; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during bundle of His cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:odontogenesis of dentin-containing tooth; P:positive regulation of action potential; P:positive regulation of epithelial cell proliferation; P:positive regulation of sodium ion transport; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of cardiac muscle cell contraction; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:response to denervation involved in regulation of muscle adaptation; P:SA node cell action potential; P:sodium ion transmembrane transport; P:sodium ion transport; P:telencephalon development; P:ventricular cardiac muscle cell action potential;|Q8TCG7,Xin actin-binding repeat-containing protein 1,Cardiomyopathy-associated protein 1;, PF08043;, GO:0030054;GO:0051015;GO:0003723;GO:0007015;GO:0032091;, C:cell junction;, F:actin filament binding; F:RNA binding;, P:actin filament organization; P:negative regulation of protein binding;|Q9UI33 A6NN05 C9JD48 C9JR31 Q68K15 Q8NDX3 Q9UHE0 Q9UHM0,Sodium channel protein type 11 subunit alpha,Peripheral nerve sodium channel 5;Sensory neuron sodium channel 2;Sodium channel protein type XI subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.9;hNaN;, PF00520;PF06512;, GO:0030424;GO:0044299;GO:0070062;GO:0001518;GO:0005244;GO:0005248;GO:0086010;GO:0019228;GO:0034765;GO:0051930;GO:0042493;GO:0035725;GO:0006814;, C:axon; C:C-fiber; C:extracellular exosome; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:membrane depolarization during action potential; P:neuronal action potential; P:regulation of ion transmembrane transport; P:regulation of sensory perception of pain; P:response to drug; P:sodium ion transmembrane transport; P:sodium ion transport;|Q8TAF3 B4DM86 B4DQI2 B4DY84 Q63HJ2 Q658Y1 Q8N3Z1 Q9NSK8 Q9P279,WD repeat-containing protein 48 {ECO:0000303|PubMed:24145035},USP1-associated factor 1 {ECO:0000303|PubMed:18082604};WD repeat endosomal protein;p80 {ECO:0000303|PubMed:12196293};, PF11816;PF00400;, GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0003697;GO:0043130;GO:0006974;GO:0042769;GO:0000724;GO:0048568;GO:0048872;GO:0036297;GO:0035264;GO:1905168;GO:0050679;GO:1903003;GO:0016579;GO:1902525;GO:0072520;GO:0007338;GO:0048705;GO:0043588;GO:0007283;GO:0016032;, C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:homeostasis of number of cells; P:interstrand cross-link repair; P:multicellular organism growth; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of epithelial cell proliferation; P:positive regulation of protein deubiquitination; P:protein deubiquitination; P:regulation of protein monoubiquitination; P:seminiferous tubule development; P:single fertilization; P:skeletal system morphogenesis; P:skin development; P:spermatogenesis; P:viral process;|Q8TAF3 B4DM86 B4DQI2 B4DY84 Q63HJ2 Q658Y1 Q8N3Z1 Q9NSK8 Q9P279,WD repeat-containing protein 48 {ECO:0000303|PubMed:24145035},USP1-associated factor 1 {ECO:0000303|PubMed:18082604};WD repeat endosomal protein;p80 {ECO:0000303|PubMed:12196293};, PF11816;PF00400;, GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0003697;GO:0043130;GO:0006974;GO:0042769;GO:0000724;GO:0048568;GO:0048872;GO:0036297;GO:0035264;GO:1905168;GO:0050679;GO:1903003;GO:0016579;GO:1902525;GO:0072520;GO:0007338;GO:0048705;GO:0043588;GO:0007283;GO:0016032;, C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:homeostasis of number of cells; P:interstrand cross-link repair; P:multicellular organism growth; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of epithelial cell proliferation; P:positive regulation of protein deubiquitination; P:protein deubiquitination; P:regulation of protein monoubiquitination; P:seminiferous tubule development; P:single fertilization; P:skeletal system morphogenesis; P:skin development; P:spermatogenesis; P:viral process;|Q8TAF3 B4DM86 B4DQI2 B4DY84 Q63HJ2 Q658Y1 Q8N3Z1 Q9NSK8 Q9P279,WD repeat-containing protein 48 {ECO:0000303|PubMed:24145035},USP1-associated factor 1 {ECO:0000303|PubMed:18082604};WD repeat endosomal protein;p80 {ECO:0000303|PubMed:12196293};, PF11816;PF00400;, GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0003697;GO:0043130;GO:0006974;GO:0042769;GO:0000724;GO:0048568;GO:0048872;GO:0036297;GO:0035264;GO:1905168;GO:0050679;GO:1903003;GO:0016579;GO:1902525;GO:0072520;GO:0007338;GO:0048705;GO:0043588;GO:0007283;GO:0016032;, C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:homeostasis of number of cells; P:interstrand cross-link repair; P:multicellular organism growth; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of epithelial cell proliferation; P:positive regulation of protein deubiquitination; P:protein deubiquitination; P:regulation of protein monoubiquitination; P:seminiferous tubule development; P:single fertilization; P:skeletal system morphogenesis; P:skin development; P:spermatogenesis; P:viral process;|Q8TAF3 B4DM86 B4DQI2 B4DY84 Q63HJ2 Q658Y1 Q8N3Z1 Q9NSK8 Q9P279,WD repeat-containing protein 48 {ECO:0000303|PubMed:24145035},USP1-associated factor 1 {ECO:0000303|PubMed:18082604};WD repeat endosomal protein;p80 {ECO:0000303|PubMed:12196293};, PF11816;PF00400;, GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0003697;GO:0043130;GO:0006974;GO:0042769;GO:0000724;GO:0048568;GO:0048872;GO:0036297;GO:0035264;GO:1905168;GO:0050679;GO:1903003;GO:0016579;GO:1902525;GO:0072520;GO:0007338;GO:0048705;GO:0043588;GO:0007283;GO:0016032;, C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:homeostasis of number of cells; P:interstrand cross-link repair; P:multicellular organism growth; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of epithelial cell proliferation; P:positive regulation of protein deubiquitination; P:protein deubiquitination; P:regulation of protein monoubiquitination; P:seminiferous tubule development; P:single fertilization; P:skeletal system morphogenesis; P:skin development; P:spermatogenesis; P:viral process;|Q8TAF3 B4DM86 B4DQI2 B4DY84 Q63HJ2 Q658Y1 Q8N3Z1 Q9NSK8 Q9P279,WD repeat-containing protein 48 {ECO:0000303|PubMed:24145035},USP1-associated factor 1 {ECO:0000303|PubMed:18082604};WD repeat endosomal protein;p80 {ECO:0000303|PubMed:12196293};, PF11816;PF00400;, GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0003697;GO:0043130;GO:0006974;GO:0042769;GO:0000724;GO:0048568;GO:0048872;GO:0036297;GO:0035264;GO:1905168;GO:0050679;GO:1903003;GO:0016579;GO:1902525;GO:0072520;GO:0007338;GO:0048705;GO:0043588;GO:0007283;GO:0016032;, C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:homeostasis of number of cells; P:interstrand cross-link repair; P:multicellular organism growth; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of epithelial cell proliferation; P:positive regulation of protein deubiquitination; P:protein deubiquitination; P:regulation of protein monoubiquitination; P:seminiferous tubule development; P:single fertilization; P:skeletal system morphogenesis; P:skin development; P:spermatogenesis; P:viral process;|Q8TAF3 B4DM86 B4DQI2 B4DY84 Q63HJ2 Q658Y1 Q8N3Z1 Q9NSK8 Q9P279,WD repeat-containing protein 48 {ECO:0000303|PubMed:24145035},USP1-associated factor 1 {ECO:0000303|PubMed:18082604};WD repeat endosomal protein;p80 {ECO:0000303|PubMed:12196293};, PF11816;PF00400;, GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0003697;GO:0043130;GO:0006974;GO:0042769;GO:0000724;GO:0048568;GO:0048872;GO:0036297;GO:0035264;GO:1905168;GO:0050679;GO:1903003;GO:0016579;GO:1902525;GO:0072520;GO:0007338;GO:0048705;GO:0043588;GO:0007283;GO:0016032;, C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:homeostasis of number of cells; P:interstrand cross-link repair; P:multicellular organism growth; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of epithelial cell proliferation; P:positive regulation of protein deubiquitination; P:protein deubiquitination; P:regulation of protein monoubiquitination; P:seminiferous tubule development; P:single fertilization; P:skeletal system morphogenesis; P:skin development; P:spermatogenesis; P:viral process;|Q8TAF3 B4DM86 B4DQI2 B4DY84 Q63HJ2 Q658Y1 Q8N3Z1 Q9NSK8 Q9P279,WD repeat-containing protein 48 {ECO:0000303|PubMed:24145035},USP1-associated factor 1 {ECO:0000303|PubMed:18082604};WD repeat endosomal protein;p80 {ECO:0000303|PubMed:12196293};, PF11816;PF00400;, GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0003697;GO:0043130;GO:0006974;GO:0042769;GO:0000724;GO:0048568;GO:0048872;GO:0036297;GO:0035264;GO:1905168;GO:0050679;GO:1903003;GO:0016579;GO:1902525;GO:0072520;GO:0007338;GO:0048705;GO:0043588;GO:0007283;GO:0016032;, C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:double-strand break repair via homologous recombination; P:embryonic organ development; P:homeostasis of number of cells; P:interstrand cross-link repair; P:multicellular organism growth; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of epithelial cell proliferation; P:positive regulation of protein deubiquitination; P:protein deubiquitination; P:regulation of protein monoubiquitination; P:seminiferous tubule development; P:single fertilization; P:skeletal system morphogenesis; P:skin development; P:spermatogenesis; P:viral process;|Q9BQQ3 B3KWC8 Q3SYG7 Q8N272 Q96H42,Golgi reassembly-stacking protein 1,Golgi peripheral membrane protein p65;Golgi phosphoprotein 5;Golgi reassembly-stacking protein of 65 kDa;, PF04495;, GO:0033116;GO:0005794;GO:0000139;GO:0046872;GO:0048208;GO:0006888;GO:0061951;GO:0007030;GO:0050774;GO:1904668;GO:0006487;GO:0015031;, C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi membrane;, F:metal ion binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization to plasma membrane; P:Golgi organization; P:negative regulation of dendrite morphogenesis; P:positive regulation of ubiquitin protein ligase activity; P:protein N-linked glycosylation; P:protein transport;|Q9BQQ3 B3KWC8 Q3SYG7 Q8N272 Q96H42,Golgi reassembly-stacking protein 1,Golgi peripheral membrane protein p65;Golgi phosphoprotein 5;Golgi reassembly-stacking protein of 65 kDa;, PF04495;, GO:0033116;GO:0005794;GO:0000139;GO:0046872;GO:0048208;GO:0006888;GO:0061951;GO:0007030;GO:0050774;GO:1904668;GO:0006487;GO:0015031;, C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi membrane;, F:metal ion binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of protein localization to plasma membrane; P:Golgi organization; P:negative regulation of dendrite morphogenesis; P:positive regulation of ubiquitin protein ligase activity; P:protein N-linked glycosylation; P:protein transport;|Q8NDW8 A1L388 B4DYF6 B4DYJ3 D3YTE7 D4PHA5 Q6P5W8 Q8N7G5 Q8NA02,Tetratricopeptide repeat protein 21A {ECO:0000303|PubMed:30929735},Stress-inducible protein 2 {ECO:0000303|PubMed:12543795};, PF13181;, GO:0005929;GO:0030991;GO:0030317;GO:0035721;GO:0061512;GO:0007286;, C:cilium; C:intraciliary transport particle A;, , P:flagellated sperm motility; P:intraciliary retrograde transport; P:protein localization to cilium; P:spermatid development;|Q8NDW8 A1L388 B4DYF6 B4DYJ3 D3YTE7 D4PHA5 Q6P5W8 Q8N7G5 Q8NA02,Tetratricopeptide repeat protein 21A {ECO:0000303|PubMed:30929735},Stress-inducible protein 2 {ECO:0000303|PubMed:12543795};, PF13181;, GO:0005929;GO:0030991;GO:0030317;GO:0035721;GO:0061512;GO:0007286;, C:cilium; C:intraciliary transport particle A;, , P:flagellated sperm motility; P:intraciliary retrograde transport; P:protein localization to cilium; P:spermatid development;|Q8NDW8 A1L388 B4DYF6 B4DYJ3 D3YTE7 D4PHA5 Q6P5W8 Q8N7G5 Q8NA02,Tetratricopeptide repeat protein 21A {ECO:0000303|PubMed:30929735},Stress-inducible protein 2 {ECO:0000303|PubMed:12543795};, PF13181;, GO:0005929;GO:0030991;GO:0030317;GO:0035721;GO:0061512;GO:0007286;, C:cilium; C:intraciliary transport particle A;, , P:flagellated sperm motility; P:intraciliary retrograde transport; P:protein localization to cilium; P:spermatid development;|Q96S65 Q69YY5,Cysteine/serine-rich nuclear protein 1,Axin-1 up-regulated gene 1 protein;Protein URAX1;TGF-beta-induced apoptosis protein 3;, PF16019;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0043565;GO:0006915;GO:0060325;GO:0048008;GO:0045944;GO:0009791;GO:0006357;GO:0060021;GO:0048705;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding;, P:apoptotic process; P:face morphogenesis; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; P:skeletal system morphogenesis;|Q96S65 Q69YY5,Cysteine/serine-rich nuclear protein 1,Axin-1 up-regulated gene 1 protein;Protein URAX1;TGF-beta-induced apoptosis protein 3;, PF16019;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0043565;GO:0006915;GO:0060325;GO:0048008;GO:0045944;GO:0009791;GO:0006357;GO:0060021;GO:0048705;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding;, P:apoptotic process; P:face morphogenesis; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; P:skeletal system morphogenesis;|Q8TCG7,Xin actin-binding repeat-containing protein 1,Cardiomyopathy-associated protein 1;, PF08043;, GO:0030054;GO:0051015;GO:0003723;GO:0007015;GO:0032091;, C:cell junction;, F:actin filament binding; F:RNA binding;, P:actin filament organization; P:negative regulation of protein binding; scaffold51 indexed_genome mRNA 10616253 10627489 . - . ID=transcript_9540;P49238 A0N0N6 B2R5Z4 J3KP17,CX3C chemokine receptor 1,Beta chemokine receptor-like 1;CMK-BRL-1;Fractalkine receptor;G-protein coupled receptor 13;V28;, PF00001;, GO:0009986;GO:0097447;GO:0009897;GO:0005887;GO:0043005;GO:0032809;GO:0048471;GO:0005886;GO:0019957;GO:0016493;GO:0019960;GO:0016495;GO:0004950;GO:0008528;GO:0004930;GO:0035425;GO:0019722;GO:0007155;GO:0060326;GO:0007267;GO:0006968;GO:0071222;GO:0071560;GO:0021626;GO:0006935;GO:0007186;GO:0006955;GO:0045087;GO:0050901;GO:0007613;GO:0050804;GO:0150090;GO:2001234;GO:0030336;GO:0110091;GO:0032691;GO:1900272;GO:0007200;GO:0045766;GO:0007204;GO:1903721;GO:1904141;GO:0002052;GO:0050769;GO:0051092;GO:0051897;GO:1904139;GO:0050767;GO:0045428;GO:0048167;GO:0032680;GO:0002931;GO:0009611;GO:0035176;GO:0060074;GO:0098883;GO:0016032;, C:cell surface; C:dendritic tree; C:external side of plasma membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:C-X3-C chemokine binding; F:C-X3-C chemokine receptor activity; F:chemokine receptor activity; F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity;, P:autocrine signaling; P:calcium-mediated signaling; P:cell adhesion; P:cell chemotaxis; P:cell-cell signaling; P:cellular defense response; P:cellular response to lipopolysaccharide; P:cellular response to transforming growth factor beta stimulus; P:central nervous system maturation; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:innate immune response; P:leukocyte tethering or rolling; P:memory; P:modulation of chemical synaptic transmission; P:multiple spine synapse organization, single dendrite; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell migration; P:negative regulation of hippocampal neuron apoptotic process; P:negative regulation of interleukin-1 beta production; P:negative regulation of long-term synaptic potentiation; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of microglial cell migration; P:positive regulation of neuroblast proliferation; P:positive regulation of neurogenesis; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase B signaling; P:regulation of microglial cell migration; P:regulation of neurogenesis; P:regulation of nitric oxide biosynthetic process; P:regulation of synaptic plasticity; P:regulation of tumor necrosis factor production; P:response to ischemia; P:response to wounding; P:social behavior; P:synapse maturation; P:synapse pruning; P:viral process; scaffold51 indexed_genome mRNA 10677674 10678480 . - . ID=transcript_9541;P51685 B2RC64 Q3KNQ8 Q3KNR3 Q9BYX5,C-C chemokine receptor type 8,CC chemokine receptor CHEMR1;CMKBRL2;Chemokine receptor-like 1;GPR-CY6;TER1;, PF00001;, GO:0009897;GO:0005887;GO:0005886;GO:0019957;GO:0016493;GO:0004950;GO:0015026;GO:0019722;GO:0007155;GO:0060326;GO:0006935;GO:0007186;GO:0006955;GO:0007204;, C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:chemokine receptor activity; F:coreceptor activity;, P:calcium-mediated signaling; P:cell adhesion; P:cell chemotaxis; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:positive regulation of cytosolic calcium ion concentration; scaffold51 indexed_genome mRNA 10688005 10701431 . + . ID=transcript_9542;Q96DW6 Q9NWX2,Mitochondrial glycine transporter {ECO:0000255|HAMAP-Rule:MF_03064},Mitochondrial glycine transporter GlyC {ECO:0000303|PubMed:27476175};Solute carrier family 25 member 38 {ECO:0000255|HAMAP-Rule:MF_03064};, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015187;GO:0030218;GO:1904983;GO:0006783;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:glycine transmembrane transporter activity;, P:erythrocyte differentiation; P:glycine import into mitochondrion; P:heme biosynthetic process;|Q96DW6 Q9NWX2,Mitochondrial glycine transporter {ECO:0000255|HAMAP-Rule:MF_03064},Mitochondrial glycine transporter GlyC {ECO:0000303|PubMed:27476175};Solute carrier family 25 member 38 {ECO:0000255|HAMAP-Rule:MF_03064};, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015187;GO:0030218;GO:1904983;GO:0006783;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:glycine transmembrane transporter activity;, P:erythrocyte differentiation; P:glycine import into mitochondrion; P:heme biosynthetic process;|Q96DW6 Q9NWX2,Mitochondrial glycine transporter {ECO:0000255|HAMAP-Rule:MF_03064},Mitochondrial glycine transporter GlyC {ECO:0000303|PubMed:27476175};Solute carrier family 25 member 38 {ECO:0000255|HAMAP-Rule:MF_03064};, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015187;GO:0030218;GO:1904983;GO:0006783;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:glycine transmembrane transporter activity;, P:erythrocyte differentiation; P:glycine import into mitochondrion; P:heme biosynthetic process;|Q96DW6 Q9NWX2,Mitochondrial glycine transporter {ECO:0000255|HAMAP-Rule:MF_03064},Mitochondrial glycine transporter GlyC {ECO:0000303|PubMed:27476175};Solute carrier family 25 member 38 {ECO:0000255|HAMAP-Rule:MF_03064};, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015187;GO:0030218;GO:1904983;GO:0006783;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:glycine transmembrane transporter activity;, P:erythrocyte differentiation; P:glycine import into mitochondrion; P:heme biosynthetic process;|Q96DW6 Q9NWX2,Mitochondrial glycine transporter {ECO:0000255|HAMAP-Rule:MF_03064},Mitochondrial glycine transporter GlyC {ECO:0000303|PubMed:27476175};Solute carrier family 25 member 38 {ECO:0000255|HAMAP-Rule:MF_03064};, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015187;GO:0030218;GO:1904983;GO:0006783;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:glycine transmembrane transporter activity;, P:erythrocyte differentiation; P:glycine import into mitochondrion; P:heme biosynthetic process;|Q96DW6 Q9NWX2,Mitochondrial glycine transporter {ECO:0000255|HAMAP-Rule:MF_03064},Mitochondrial glycine transporter GlyC {ECO:0000303|PubMed:27476175};Solute carrier family 25 member 38 {ECO:0000255|HAMAP-Rule:MF_03064};, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015187;GO:0030218;GO:1904983;GO:0006783;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:glycine transmembrane transporter activity;, P:erythrocyte differentiation; P:glycine import into mitochondrion; P:heme biosynthetic process; scaffold51 indexed_genome mRNA 10703203 10724625 . + . ID=transcript_9543;P31944 O95823 Q3SYC9,Caspase-14,, , GO:0005737;GO:0005829;GO:0045095;GO:0005739;GO:0005654;GO:0005634;GO:0004197;GO:0097200;GO:0070268;GO:0008544;GO:0031424;, C:cytoplasm; C:cytosol; C:keratin filament; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis;, P:cornification; P:epidermis development; P:keratinization; scaffold51 indexed_genome mRNA 10727678 10730084 . + . ID=transcript_9544;P08865 P11085 P12030 Q16471 Q6IPD1 Q6IPD2 Q6NSD1 Q6NXQ8 Q86VC0,40S ribosomal protein SA {ECO:0000255|HAMAP-Rule:MF_03016},37 kDa laminin receptor precursor {ECO:0000255|HAMAP-Rule:MF_03016};37/67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};Colon carcinoma laminin-binding protein;Laminin receptor 1 {ECO:0000255|HAMAP-Rule:MF_03016};Laminin-binding protein precursor p40 {ECO:0000255|HAMAP-Rule:MF_03016};Multidrug resistance-associated protein MGr1-Ag;NEM/1CHD4;Small ribosomal subunit protein uS2 {ECO:0000303|PubMed:24524803};, PF16122;PF00318;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0043236;GO:0005055;GO:0043022;GO:0003723;GO:0003735;GO:0001618;GO:0007155;GO:0002181;GO:0000184;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:laminin binding; F:laminin receptor activity; F:ribosome binding; F:RNA binding; F:structural constituent of ribosome; F:virus receptor activity;, P:cell adhesion; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold51 indexed_genome mRNA 10736827 10740708 . + . ID=transcript_9545;P08865 P11085 P12030 Q16471 Q6IPD1 Q6IPD2 Q6NSD1 Q6NXQ8 Q86VC0,40S ribosomal protein SA {ECO:0000255|HAMAP-Rule:MF_03016},37 kDa laminin receptor precursor {ECO:0000255|HAMAP-Rule:MF_03016};37/67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};Colon carcinoma laminin-binding protein;Laminin receptor 1 {ECO:0000255|HAMAP-Rule:MF_03016};Laminin-binding protein precursor p40 {ECO:0000255|HAMAP-Rule:MF_03016};Multidrug resistance-associated protein MGr1-Ag;NEM/1CHD4;Small ribosomal subunit protein uS2 {ECO:0000303|PubMed:24524803};, PF16122;PF00318;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0043236;GO:0005055;GO:0043022;GO:0003723;GO:0003735;GO:0001618;GO:0007155;GO:0002181;GO:0000184;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:laminin binding; F:laminin receptor activity; F:ribosome binding; F:RNA binding; F:structural constituent of ribosome; F:virus receptor activity;, P:cell adhesion; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P08865 P11085 P12030 Q16471 Q6IPD1 Q6IPD2 Q6NSD1 Q6NXQ8 Q86VC0,40S ribosomal protein SA {ECO:0000255|HAMAP-Rule:MF_03016},37 kDa laminin receptor precursor {ECO:0000255|HAMAP-Rule:MF_03016};37/67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};Colon carcinoma laminin-binding protein;Laminin receptor 1 {ECO:0000255|HAMAP-Rule:MF_03016};Laminin-binding protein precursor p40 {ECO:0000255|HAMAP-Rule:MF_03016};Multidrug resistance-associated protein MGr1-Ag;NEM/1CHD4;Small ribosomal subunit protein uS2 {ECO:0000303|PubMed:24524803};, PF16122;PF00318;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0043236;GO:0005055;GO:0043022;GO:0003723;GO:0003735;GO:0001618;GO:0007155;GO:0002181;GO:0000184;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:laminin binding; F:laminin receptor activity; F:ribosome binding; F:RNA binding; F:structural constituent of ribosome; F:virus receptor activity;, P:cell adhesion; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold51 indexed_genome mRNA 10767799 10791820 . + . ID=transcript_9546;Q13875 A8K2C2 G5E945 Q13874 Q6DHZ6 Q8TBJ1,Myelin-associated oligodendrocyte basic protein,, PF02318;, GO:0030864;GO:0005739;GO:0043209;GO:0048471;GO:0003779;GO:0017022;GO:0019911;GO:0032289;GO:0007399;, C:cortical actin cytoskeleton; C:mitochondrion; C:myelin sheath; C:perinuclear region of cytoplasm;, F:actin binding; F:myosin binding; F:structural constituent of myelin sheath;, P:central nervous system myelin formation; P:nervous system development;|Q13875 A8K2C2 G5E945 Q13874 Q6DHZ6 Q8TBJ1,Myelin-associated oligodendrocyte basic protein,, PF02318;, GO:0030864;GO:0005739;GO:0043209;GO:0048471;GO:0003779;GO:0017022;GO:0019911;GO:0032289;GO:0007399;, C:cortical actin cytoskeleton; C:mitochondrion; C:myelin sheath; C:perinuclear region of cytoplasm;, F:actin binding; F:myosin binding; F:structural constituent of myelin sheath;, P:central nervous system myelin formation; P:nervous system development; scaffold51 indexed_genome mRNA 11101274 11178310 . + . ID=transcript_9547;Q8IUF5 Q9Y3V4,Rab effector MyRIP,Exophilin-8;Myosin-VIIa- and Rab-interacting protein;Synaptotagmin-like protein lacking C2 domains C;, PF02318;PF04698;, GO:0030864;GO:0031045;GO:0000145;GO:0042470;GO:0048471;GO:0001750;GO:0045202;GO:0030133;GO:0003779;GO:0017022;GO:0051018;GO:0031267;GO:0008270;GO:0006886;GO:0032024;, C:cortical actin cytoskeleton; C:dense core granule; C:exocyst; C:melanosome; C:perinuclear region of cytoplasm; C:photoreceptor outer segment; C:synapse; C:transport vesicle;, F:actin binding; F:myosin binding; F:protein kinase A binding; F:small GTPase binding; F:zinc ion binding;, P:intracellular protein transport; P:positive regulation of insulin secretion; scaffold51 indexed_genome mRNA 11202874 11206191 . + . ID=transcript_9548;O60739 Q9UQF8,Eukaryotic translation initiation factor 1b,Protein translation factor SUI1 homolog GC20;, PF01253;, GO:0016282;GO:0043024;GO:0003723;GO:0003743;GO:0006446;, C:eukaryotic 43S preinitiation complex;, F:ribosomal small subunit binding; F:RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation;|O60739 Q9UQF8,Eukaryotic translation initiation factor 1b,Protein translation factor SUI1 homolog GC20;, PF01253;, GO:0016282;GO:0043024;GO:0003723;GO:0003743;GO:0006446;, C:eukaryotic 43S preinitiation complex;, F:ribosomal small subunit binding; F:RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation;|O60739 Q9UQF8,Eukaryotic translation initiation factor 1b,Protein translation factor SUI1 homolog GC20;, PF01253;, GO:0016282;GO:0043024;GO:0003723;GO:0003743;GO:0006446;, C:eukaryotic 43S preinitiation complex;, F:ribosomal small subunit binding; F:RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation; scaffold51 indexed_genome mRNA 11257380 11293777 . + . ID=transcript_9549;O75355 B2R8D0 G5E9N0 O60495 Q8N6K2,Ectonucleoside triphosphate diphosphohydrolase 3,CD39 antigen-like 3;Ecto-ATP diphosphohydrolase 3;Ecto-apyrase 3;HB6;, PF01150;, GO:0016021;GO:0016020;GO:0005886;GO:0102490;GO:0005524;GO:0102485;GO:0102486;GO:0102491;GO:0102488;GO:0102487;GO:0102489;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0009143;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:8-oxo-dGTP phosphohydrolase activity; F:ATP binding; F:dATP phosphohydrolase activity; F:dCTP phosphohydrolase activity; F:dGTP phosphohydrolase activity; F:dTTP phosphohydrolase activity; F:dUTP phosphohydrolase activity; F:GTP phosphohydrolase activity; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:nucleoside triphosphate catabolic process;|O75355 B2R8D0 G5E9N0 O60495 Q8N6K2,Ectonucleoside triphosphate diphosphohydrolase 3,CD39 antigen-like 3;Ecto-ATP diphosphohydrolase 3;Ecto-apyrase 3;HB6;, PF01150;, GO:0016021;GO:0016020;GO:0005886;GO:0102490;GO:0005524;GO:0102485;GO:0102486;GO:0102491;GO:0102488;GO:0102487;GO:0102489;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0009143;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:8-oxo-dGTP phosphohydrolase activity; F:ATP binding; F:dATP phosphohydrolase activity; F:dCTP phosphohydrolase activity; F:dGTP phosphohydrolase activity; F:dTTP phosphohydrolase activity; F:dUTP phosphohydrolase activity; F:GTP phosphohydrolase activity; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:nucleoside triphosphate catabolic process; scaffold51 indexed_genome mRNA 11294280 11301273 . + . ID=transcript_9550;O75355 B2R8D0 G5E9N0 O60495 Q8N6K2,Ectonucleoside triphosphate diphosphohydrolase 3,CD39 antigen-like 3;Ecto-ATP diphosphohydrolase 3;Ecto-apyrase 3;HB6;, PF01150;, GO:0016021;GO:0016020;GO:0005886;GO:0102490;GO:0005524;GO:0102485;GO:0102486;GO:0102491;GO:0102488;GO:0102487;GO:0102489;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0009143;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:8-oxo-dGTP phosphohydrolase activity; F:ATP binding; F:dATP phosphohydrolase activity; F:dCTP phosphohydrolase activity; F:dGTP phosphohydrolase activity; F:dTTP phosphohydrolase activity; F:dUTP phosphohydrolase activity; F:GTP phosphohydrolase activity; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:nucleoside triphosphate catabolic process;|O75355 B2R8D0 G5E9N0 O60495 Q8N6K2,Ectonucleoside triphosphate diphosphohydrolase 3,CD39 antigen-like 3;Ecto-ATP diphosphohydrolase 3;Ecto-apyrase 3;HB6;, PF01150;, GO:0016021;GO:0016020;GO:0005886;GO:0102490;GO:0005524;GO:0102485;GO:0102486;GO:0102491;GO:0102488;GO:0102487;GO:0102489;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009134;GO:0009143;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:8-oxo-dGTP phosphohydrolase activity; F:ATP binding; F:dATP phosphohydrolase activity; F:dCTP phosphohydrolase activity; F:dGTP phosphohydrolase activity; F:dTTP phosphohydrolase activity; F:dUTP phosphohydrolase activity; F:GTP phosphohydrolase activity; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:nucleoside triphosphate catabolic process; scaffold51 indexed_genome mRNA 11329690 11331919 . + . ID=transcript_9551;Q9BYF6,60S ribosomal protein L14,CAG-ISL 7;Large ribosomal subunit protein eL14 {ECO:0000303|PubMed:24524803};, PF01929;, GO:0005829;GO:0022625;GO:0070062;GO:0016020;GO:0014069;GO:0045296;GO:0003723;GO:0003735;GO:0000184;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:membrane; C:postsynaptic density;, F:cadherin binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q9BYF6,60S ribosomal protein L14,CAG-ISL 7;Large ribosomal subunit protein eL14 {ECO:0000303|PubMed:24524803};, PF01929;, GO:0005829;GO:0022625;GO:0070062;GO:0016020;GO:0014069;GO:0045296;GO:0003723;GO:0003735;GO:0000184;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:membrane; C:postsynaptic density;, F:cadherin binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold51 indexed_genome mRNA 11381028 11382068 . - . ID=transcript_9552;Q6ZNG0 Q8N223,Zinc finger protein 620,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 11382075 11384184 . - . ID=transcript_9553;Q6ZSS3 Q14DC7 Q8TE91,Zinc finger protein 621,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 11384891 11386908 . - . ID=transcript_9554;Q6ZSS3 Q14DC7 Q8TE91,Zinc finger protein 621,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 11419087 11419749 . - . ID=transcript_9555;Q6ZSS3 Q14DC7 Q8TE91,Zinc finger protein 621,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 11870180 12372290 . + . ID=transcript_9556;P35222 A8K1L7 Q8NEW9 Q8NI94 Q9H391,Catenin beta-1,Beta-catenin;, PF00514;, GO:0005912;GO:0016323;GO:0030877;GO:1990907;GO:0070369;GO:0016342;GO:0005938;GO:0030054;GO:0071944;GO:0042995;GO:0005911;GO:0005813;GO:0005737;GO:0005829;GO:0000791;GO:0070062;GO:0005925;GO:0016328;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0032993;GO:0000922;GO:0045202;GO:0005667;GO:1990909;GO:0045294;GO:0008013;GO:0045296;GO:0003682;GO:0140297;GO:0019899;GO:0030331;GO:1990226;GO:0070411;GO:0044325;GO:0019900;GO:0035257;GO:0008022;GO:0019903;GO:0001102;GO:0001085;GO:0046332;GO:0003713;GO:0001221;GO:0008134;GO:0034333;GO:1904886;GO:1904837;GO:0001569;GO:0060070;GO:1904954;GO:0044336;GO:0061324;GO:0044334;GO:0007155;GO:0098609;GO:0071363;GO:0071681;GO:0035995;GO:0036023;GO:0061154;GO:0035635;GO:0001837;GO:0035315;GO:1904948;GO:0016525;GO:0043066;GO:0008285;GO:0045976;GO:0033234;GO:0045892;GO:1990138;GO:0043065;GO:0051091;GO:0010718;GO:0010909;GO:0051571;GO:0051149;GO:0002052;GO:0043525;GO:0051973;GO:0032212;GO:0045944;GO:0045893;GO:0032481;GO:0043161;GO:0034394;GO:0000209;GO:0045765;GO:0090279;GO:0060828;GO:0030997;GO:0070602;GO:0048145;GO:0072182;GO:0050767;GO:2000008;GO:0048660;GO:0060260;GO:0042493;GO:0032355;GO:0019827;GO:0061549;GO:0016032;GO:0016055;GO:0007223;, C:adherens junction; C:basolateral plasma membrane; C:beta-catenin destruction complex; C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:catenin complex; C:cell cortex; C:cell junction; C:cell periphery; C:cell projection; C:cell-cell junction; C:centrosome; C:cytoplasm; C:cytosol; C:euchromatin; C:extracellular exosome; C:focal adhesion; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:spindle pole; C:synapse; C:transcription regulator complex; C:Wnt signalosome;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:chromatin binding; F:DNA-binding transcription factor binding; F:enzyme binding; F:estrogen receptor binding; F:histone methyltransferase binding; F:I-SMAD binding; F:ion channel binding; F:kinase binding; F:nuclear hormone receptor binding; F:protein C-terminus binding; F:protein phosphatase binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:SMAD binding; F:transcription coactivator activity; F:transcription coregulator binding; F:transcription factor binding;, P:adherens junction assembly; P:beta-catenin destruction complex disassembly; P:beta-catenin-TCF complex assembly; P:branching involved in blood vessel morphogenesis; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; P:cell adhesion; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cellular response to indole-3-methanol; P:detection of muscle stretch; P:embryonic skeletal limb joint morphogenesis; P:endothelial tube morphogenesis; P:entry of bacterium into host cell; P:epithelial to mesenchymal transition; P:hair cell differentiation; P:midbrain dopaminergic neuron differentiation; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle, embryonic; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:neuron projection extension; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; P:positive regulation of histone H3-K4 methylation; P:positive regulation of muscle cell differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein localization to cell surface; P:protein polyubiquitination; P:regulation of angiogenesis; P:regulation of calcium ion import; P:regulation of canonical Wnt signaling pathway; P:regulation of centriole-centriole cohesion; P:regulation of centromeric sister chromatid cohesion; P:regulation of fibroblast proliferation; P:regulation of nephron tubule epithelial cell differentiation; P:regulation of neurogenesis; P:regulation of protein localization to cell surface; P:regulation of smooth muscle cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to drug; P:response to estradiol; P:stem cell population maintenance; P:sympathetic ganglion development; P:viral process; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|Q96C45 A6NF15 B3KSE5 B4E2M4 Q8IW79 Q9NWV6 Q9UF96,Serine/threonine-protein kinase ULK4,Unc-51-like kinase 4;, PF00069;, GO:0005524;GO:0106310;GO:0106311;GO:0000226;GO:0046328;GO:0043408;GO:2001222;GO:0010975;GO:1900744;GO:0090036;, , F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:microtubule cytoskeleton organization; P:regulation of JNK cascade; P:regulation of MAPK cascade; P:regulation of neuron migration; P:regulation of neuron projection development; P:regulation of p38MAPK cascade; P:regulation of protein kinase C signaling;|P35222 A8K1L7 Q8NEW9 Q8NI94 Q9H391,Catenin beta-1,Beta-catenin;, PF00514;, GO:0005912;GO:0016323;GO:0030877;GO:1990907;GO:0070369;GO:0016342;GO:0005938;GO:0030054;GO:0071944;GO:0042995;GO:0005911;GO:0005813;GO:0005737;GO:0005829;GO:0000791;GO:0070062;GO:0005925;GO:0016328;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0032993;GO:0000922;GO:0045202;GO:0005667;GO:1990909;GO:0045294;GO:0008013;GO:0045296;GO:0003682;GO:0140297;GO:0019899;GO:0030331;GO:1990226;GO:0070411;GO:0044325;GO:0019900;GO:0035257;GO:0008022;GO:0019903;GO:0001102;GO:0001085;GO:0046332;GO:0003713;GO:0001221;GO:0008134;GO:0034333;GO:1904886;GO:1904837;GO:0001569;GO:0060070;GO:1904954;GO:0044336;GO:0061324;GO:0044334;GO:0007155;GO:0098609;GO:0071363;GO:0071681;GO:0035995;GO:0036023;GO:0061154;GO:0035635;GO:0001837;GO:0035315;GO:1904948;GO:0016525;GO:0043066;GO:0008285;GO:0045976;GO:0033234;GO:0045892;GO:1990138;GO:0043065;GO:0051091;GO:0010718;GO:0010909;GO:0051571;GO:0051149;GO:0002052;GO:0043525;GO:0051973;GO:0032212;GO:0045944;GO:0045893;GO:0032481;GO:0043161;GO:0034394;GO:0000209;GO:0045765;GO:0090279;GO:0060828;GO:0030997;GO:0070602;GO:0048145;GO:0072182;GO:0050767;GO:2000008;GO:0048660;GO:0060260;GO:0042493;GO:0032355;GO:0019827;GO:0061549;GO:0016032;GO:0016055;GO:0007223;, C:adherens junction; C:basolateral plasma membrane; C:beta-catenin destruction complex; C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:catenin complex; C:cell cortex; C:cell junction; C:cell periphery; C:cell projection; C:cell-cell junction; C:centrosome; C:cytoplasm; C:cytosol; C:euchromatin; C:extracellular exosome; C:focal adhesion; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:spindle pole; C:synapse; C:transcription regulator complex; C:Wnt signalosome;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:chromatin binding; F:DNA-binding transcription factor binding; F:enzyme binding; F:estrogen receptor binding; F:histone methyltransferase binding; F:I-SMAD binding; F:ion channel binding; F:kinase binding; F:nuclear hormone receptor binding; F:protein C-terminus binding; F:protein phosphatase binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:SMAD binding; F:transcription coactivator activity; F:transcription coregulator binding; F:transcription factor binding;, P:adherens junction assembly; P:beta-catenin destruction complex disassembly; P:beta-catenin-TCF complex assembly; P:branching involved in blood vessel morphogenesis; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; P:cell adhesion; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cellular response to indole-3-methanol; P:detection of muscle stretch; P:embryonic skeletal limb joint morphogenesis; P:endothelial tube morphogenesis; P:entry of bacterium into host cell; P:epithelial to mesenchymal transition; P:hair cell differentiation; P:midbrain dopaminergic neuron differentiation; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle, embryonic; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:neuron projection extension; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; P:positive regulation of histone H3-K4 methylation; P:positive regulation of muscle cell differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein localization to cell surface; P:protein polyubiquitination; P:regulation of angiogenesis; P:regulation of calcium ion import; P:regulation of canonical Wnt signaling pathway; P:regulation of centriole-centriole cohesion; P:regulation of centromeric sister chromatid cohesion; P:regulation of fibroblast proliferation; P:regulation of nephron tubule epithelial cell differentiation; P:regulation of neurogenesis; P:regulation of protein localization to cell surface; P:regulation of smooth muscle cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to drug; P:response to estradiol; P:stem cell population maintenance; P:sympathetic ganglion development; P:viral process; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|P35222 A8K1L7 Q8NEW9 Q8NI94 Q9H391,Catenin beta-1,Beta-catenin;, PF00514;, GO:0005912;GO:0016323;GO:0030877;GO:1990907;GO:0070369;GO:0016342;GO:0005938;GO:0030054;GO:0071944;GO:0042995;GO:0005911;GO:0005813;GO:0005737;GO:0005829;GO:0000791;GO:0070062;GO:0005925;GO:0016328;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0032993;GO:0000922;GO:0045202;GO:0005667;GO:1990909;GO:0045294;GO:0008013;GO:0045296;GO:0003682;GO:0140297;GO:0019899;GO:0030331;GO:1990226;GO:0070411;GO:0044325;GO:0019900;GO:0035257;GO:0008022;GO:0019903;GO:0001102;GO:0001085;GO:0046332;GO:0003713;GO:0001221;GO:0008134;GO:0034333;GO:1904886;GO:1904837;GO:0001569;GO:0060070;GO:1904954;GO:0044336;GO:0061324;GO:0044334;GO:0007155;GO:0098609;GO:0071363;GO:0071681;GO:0035995;GO:0036023;GO:0061154;GO:0035635;GO:0001837;GO:0035315;GO:1904948;GO:0016525;GO:0043066;GO:0008285;GO:0045976;GO:0033234;GO:0045892;GO:1990138;GO:0043065;GO:0051091;GO:0010718;GO:0010909;GO:0051571;GO:0051149;GO:0002052;GO:0043525;GO:0051973;GO:0032212;GO:0045944;GO:0045893;GO:0032481;GO:0043161;GO:0034394;GO:0000209;GO:0045765;GO:0090279;GO:0060828;GO:0030997;GO:0070602;GO:0048145;GO:0072182;GO:0050767;GO:2000008;GO:0048660;GO:0060260;GO:0042493;GO:0032355;GO:0019827;GO:0061549;GO:0016032;GO:0016055;GO:0007223;, C:adherens junction; C:basolateral plasma membrane; C:beta-catenin destruction complex; C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:catenin complex; C:cell cortex; C:cell junction; C:cell periphery; C:cell projection; C:cell-cell junction; C:centrosome; C:cytoplasm; C:cytosol; C:euchromatin; C:extracellular exosome; C:focal adhesion; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:spindle pole; C:synapse; C:transcription regulator complex; C:Wnt signalosome;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:chromatin binding; F:DNA-binding transcription factor binding; F:enzyme binding; F:estrogen receptor binding; F:histone methyltransferase binding; F:I-SMAD binding; F:ion channel binding; F:kinase binding; F:nuclear hormone receptor binding; F:protein C-terminus binding; F:protein phosphatase binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:SMAD binding; F:transcription coactivator activity; F:transcription coregulator binding; F:transcription factor binding;, P:adherens junction assembly; P:beta-catenin destruction complex disassembly; P:beta-catenin-TCF complex assembly; P:branching involved in blood vessel morphogenesis; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; P:cell adhesion; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cellular response to indole-3-methanol; P:detection of muscle stretch; P:embryonic skeletal limb joint morphogenesis; P:endothelial tube morphogenesis; P:entry of bacterium into host cell; P:epithelial to mesenchymal transition; P:hair cell differentiation; P:midbrain dopaminergic neuron differentiation; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle, embryonic; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:neuron projection extension; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; P:positive regulation of histone H3-K4 methylation; P:positive regulation of muscle cell differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein localization to cell surface; P:protein polyubiquitination; P:regulation of angiogenesis; P:regulation of calcium ion import; P:regulation of canonical Wnt signaling pathway; P:regulation of centriole-centriole cohesion; P:regulation of centromeric sister chromatid cohesion; P:regulation of fibroblast proliferation; P:regulation of nephron tubule epithelial cell differentiation; P:regulation of neurogenesis; P:regulation of protein localization to cell surface; P:regulation of smooth muscle cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to drug; P:response to estradiol; P:stem cell population maintenance; P:sympathetic ganglion development; P:viral process; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|P35222 A8K1L7 Q8NEW9 Q8NI94 Q9H391,Catenin beta-1,Beta-catenin;, PF00514;, GO:0005912;GO:0016323;GO:0030877;GO:1990907;GO:0070369;GO:0016342;GO:0005938;GO:0030054;GO:0071944;GO:0042995;GO:0005911;GO:0005813;GO:0005737;GO:0005829;GO:0000791;GO:0070062;GO:0005925;GO:0016328;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0032993;GO:0000922;GO:0045202;GO:0005667;GO:1990909;GO:0045294;GO:0008013;GO:0045296;GO:0003682;GO:0140297;GO:0019899;GO:0030331;GO:1990226;GO:0070411;GO:0044325;GO:0019900;GO:0035257;GO:0008022;GO:0019903;GO:0001102;GO:0001085;GO:0046332;GO:0003713;GO:0001221;GO:0008134;GO:0034333;GO:1904886;GO:1904837;GO:0001569;GO:0060070;GO:1904954;GO:0044336;GO:0061324;GO:0044334;GO:0007155;GO:0098609;GO:0071363;GO:0071681;GO:0035995;GO:0036023;GO:0061154;GO:0035635;GO:0001837;GO:0035315;GO:1904948;GO:0016525;GO:0043066;GO:0008285;GO:0045976;GO:0033234;GO:0045892;GO:1990138;GO:0043065;GO:0051091;GO:0010718;GO:0010909;GO:0051571;GO:0051149;GO:0002052;GO:0043525;GO:0051973;GO:0032212;GO:0045944;GO:0045893;GO:0032481;GO:0043161;GO:0034394;GO:0000209;GO:0045765;GO:0090279;GO:0060828;GO:0030997;GO:0070602;GO:0048145;GO:0072182;GO:0050767;GO:2000008;GO:0048660;GO:0060260;GO:0042493;GO:0032355;GO:0019827;GO:0061549;GO:0016032;GO:0016055;GO:0007223;, C:adherens junction; C:basolateral plasma membrane; C:beta-catenin destruction complex; C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:catenin complex; C:cell cortex; C:cell junction; C:cell periphery; C:cell projection; C:cell-cell junction; C:centrosome; C:cytoplasm; C:cytosol; C:euchromatin; C:extracellular exosome; C:focal adhesion; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:spindle pole; C:synapse; C:transcription regulator complex; C:Wnt signalosome;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:chromatin binding; F:DNA-binding transcription factor binding; F:enzyme binding; F:estrogen receptor binding; F:histone methyltransferase binding; F:I-SMAD binding; F:ion channel binding; F:kinase binding; F:nuclear hormone receptor binding; F:protein C-terminus binding; F:protein phosphatase binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:SMAD binding; F:transcription coactivator activity; F:transcription coregulator binding; F:transcription factor binding;, P:adherens junction assembly; P:beta-catenin destruction complex disassembly; P:beta-catenin-TCF complex assembly; P:branching involved in blood vessel morphogenesis; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; P:cell adhesion; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cellular response to indole-3-methanol; P:detection of muscle stretch; P:embryonic skeletal limb joint morphogenesis; P:endothelial tube morphogenesis; P:entry of bacterium into host cell; P:epithelial to mesenchymal transition; P:hair cell differentiation; P:midbrain dopaminergic neuron differentiation; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle, embryonic; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:neuron projection extension; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; P:positive regulation of histone H3-K4 methylation; P:positive regulation of muscle cell differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein localization to cell surface; P:protein polyubiquitination; P:regulation of angiogenesis; P:regulation of calcium ion import; P:regulation of canonical Wnt signaling pathway; P:regulation of centriole-centriole cohesion; P:regulation of centromeric sister chromatid cohesion; P:regulation of fibroblast proliferation; P:regulation of nephron tubule epithelial cell differentiation; P:regulation of neurogenesis; P:regulation of protein localization to cell surface; P:regulation of smooth muscle cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to drug; P:response to estradiol; P:stem cell population maintenance; P:sympathetic ganglion development; P:viral process; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|P35222 A8K1L7 Q8NEW9 Q8NI94 Q9H391,Catenin beta-1,Beta-catenin;, PF00514;, GO:0005912;GO:0016323;GO:0030877;GO:1990907;GO:0070369;GO:0016342;GO:0005938;GO:0030054;GO:0071944;GO:0042995;GO:0005911;GO:0005813;GO:0005737;GO:0005829;GO:0000791;GO:0070062;GO:0005925;GO:0016328;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0032993;GO:0000922;GO:0045202;GO:0005667;GO:1990909;GO:0045294;GO:0008013;GO:0045296;GO:0003682;GO:0140297;GO:0019899;GO:0030331;GO:1990226;GO:0070411;GO:0044325;GO:0019900;GO:0035257;GO:0008022;GO:0019903;GO:0001102;GO:0001085;GO:0046332;GO:0003713;GO:0001221;GO:0008134;GO:0034333;GO:1904886;GO:1904837;GO:0001569;GO:0060070;GO:1904954;GO:0044336;GO:0061324;GO:0044334;GO:0007155;GO:0098609;GO:0071363;GO:0071681;GO:0035995;GO:0036023;GO:0061154;GO:0035635;GO:0001837;GO:0035315;GO:1904948;GO:0016525;GO:0043066;GO:0008285;GO:0045976;GO:0033234;GO:0045892;GO:1990138;GO:0043065;GO:0051091;GO:0010718;GO:0010909;GO:0051571;GO:0051149;GO:0002052;GO:0043525;GO:0051973;GO:0032212;GO:0045944;GO:0045893;GO:0032481;GO:0043161;GO:0034394;GO:0000209;GO:0045765;GO:0090279;GO:0060828;GO:0030997;GO:0070602;GO:0048145;GO:0072182;GO:0050767;GO:2000008;GO:0048660;GO:0060260;GO:0042493;GO:0032355;GO:0019827;GO:0061549;GO:0016032;GO:0016055;GO:0007223;, C:adherens junction; C:basolateral plasma membrane; C:beta-catenin destruction complex; C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:catenin complex; C:cell cortex; C:cell junction; C:cell periphery; C:cell projection; C:cell-cell junction; C:centrosome; C:cytoplasm; C:cytosol; C:euchromatin; C:extracellular exosome; C:focal adhesion; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:spindle pole; C:synapse; C:transcription regulator complex; C:Wnt signalosome;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:chromatin binding; F:DNA-binding transcription factor binding; F:enzyme binding; F:estrogen receptor binding; F:histone methyltransferase binding; F:I-SMAD binding; F:ion channel binding; F:kinase binding; F:nuclear hormone receptor binding; F:protein C-terminus binding; F:protein phosphatase binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:SMAD binding; F:transcription coactivator activity; F:transcription coregulator binding; F:transcription factor binding;, P:adherens junction assembly; P:beta-catenin destruction complex disassembly; P:beta-catenin-TCF complex assembly; P:branching involved in blood vessel morphogenesis; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; P:cell adhesion; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cellular response to indole-3-methanol; P:detection of muscle stretch; P:embryonic skeletal limb joint morphogenesis; P:endothelial tube morphogenesis; P:entry of bacterium into host cell; P:epithelial to mesenchymal transition; P:hair cell differentiation; P:midbrain dopaminergic neuron differentiation; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle, embryonic; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:neuron projection extension; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; P:positive regulation of histone H3-K4 methylation; P:positive regulation of muscle cell differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein localization to cell surface; P:protein polyubiquitination; P:regulation of angiogenesis; P:regulation of calcium ion import; P:regulation of canonical Wnt signaling pathway; P:regulation of centriole-centriole cohesion; P:regulation of centromeric sister chromatid cohesion; P:regulation of fibroblast proliferation; P:regulation of nephron tubule epithelial cell differentiation; P:regulation of neurogenesis; P:regulation of protein localization to cell surface; P:regulation of smooth muscle cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to drug; P:response to estradiol; P:stem cell population maintenance; P:sympathetic ganglion development; P:viral process; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|P35222 A8K1L7 Q8NEW9 Q8NI94 Q9H391,Catenin beta-1,Beta-catenin;, PF00514;, GO:0005912;GO:0016323;GO:0030877;GO:1990907;GO:0070369;GO:0016342;GO:0005938;GO:0030054;GO:0071944;GO:0042995;GO:0005911;GO:0005813;GO:0005737;GO:0005829;GO:0000791;GO:0070062;GO:0005925;GO:0016328;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0032993;GO:0000922;GO:0045202;GO:0005667;GO:1990909;GO:0045294;GO:0008013;GO:0045296;GO:0003682;GO:0140297;GO:0019899;GO:0030331;GO:1990226;GO:0070411;GO:0044325;GO:0019900;GO:0035257;GO:0008022;GO:0019903;GO:0001102;GO:0001085;GO:0046332;GO:0003713;GO:0001221;GO:0008134;GO:0034333;GO:1904886;GO:1904837;GO:0001569;GO:0060070;GO:1904954;GO:0044336;GO:0061324;GO:0044334;GO:0007155;GO:0098609;GO:0071363;GO:0071681;GO:0035995;GO:0036023;GO:0061154;GO:0035635;GO:0001837;GO:0035315;GO:1904948;GO:0016525;GO:0043066;GO:0008285;GO:0045976;GO:0033234;GO:0045892;GO:1990138;GO:0043065;GO:0051091;GO:0010718;GO:0010909;GO:0051571;GO:0051149;GO:0002052;GO:0043525;GO:0051973;GO:0032212;GO:0045944;GO:0045893;GO:0032481;GO:0043161;GO:0034394;GO:0000209;GO:0045765;GO:0090279;GO:0060828;GO:0030997;GO:0070602;GO:0048145;GO:0072182;GO:0050767;GO:2000008;GO:0048660;GO:0060260;GO:0042493;GO:0032355;GO:0019827;GO:0061549;GO:0016032;GO:0016055;GO:0007223;, C:adherens junction; C:basolateral plasma membrane; C:beta-catenin destruction complex; C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:catenin complex; C:cell cortex; C:cell junction; C:cell periphery; C:cell projection; C:cell-cell junction; C:centrosome; C:cytoplasm; C:cytosol; C:euchromatin; C:extracellular exosome; C:focal adhesion; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:spindle pole; C:synapse; C:transcription regulator complex; C:Wnt signalosome;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:chromatin binding; F:DNA-binding transcription factor binding; F:enzyme binding; F:estrogen receptor binding; F:histone methyltransferase binding; F:I-SMAD binding; F:ion channel binding; F:kinase binding; F:nuclear hormone receptor binding; F:protein C-terminus binding; F:protein phosphatase binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:SMAD binding; F:transcription coactivator activity; F:transcription coregulator binding; F:transcription factor binding;, P:adherens junction assembly; P:beta-catenin destruction complex disassembly; P:beta-catenin-TCF complex assembly; P:branching involved in blood vessel morphogenesis; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; P:cell adhesion; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cellular response to indole-3-methanol; P:detection of muscle stretch; P:embryonic skeletal limb joint morphogenesis; P:endothelial tube morphogenesis; P:entry of bacterium into host cell; P:epithelial to mesenchymal transition; P:hair cell differentiation; P:midbrain dopaminergic neuron differentiation; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle, embryonic; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:neuron projection extension; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; P:positive regulation of histone H3-K4 methylation; P:positive regulation of muscle cell differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein localization to cell surface; P:protein polyubiquitination; P:regulation of angiogenesis; P:regulation of calcium ion import; P:regulation of canonical Wnt signaling pathway; P:regulation of centriole-centriole cohesion; P:regulation of centromeric sister chromatid cohesion; P:regulation of fibroblast proliferation; P:regulation of nephron tubule epithelial cell differentiation; P:regulation of neurogenesis; P:regulation of protein localization to cell surface; P:regulation of smooth muscle cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to drug; P:response to estradiol; P:stem cell population maintenance; P:sympathetic ganglion development; P:viral process; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|P14923 Q15093 Q15151 Q7L3S5 Q86W21 Q9BWC4 Q9HCX9,Junction plakoglobin,Catenin gamma;Desmoplakin III;Desmoplakin-3;, PF00514;, GO:0015629;GO:0005912;GO:0016327;GO:0016342;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0005829;GO:0030057;GO:0070062;GO:0005576;GO:0005916;GO:1904813;GO:0005925;GO:0071665;GO:0014704;GO:0005882;GO:0016328;GO:0005634;GO:0005886;GO:0032993;GO:0035580;GO:0030018;GO:0005915;GO:0045294;GO:0045296;GO:0050839;GO:0086083;GO:0106006;GO:0035257;GO:0042803;GO:0019901;GO:0019903;GO:0044877;GO:0005198;GO:0003713;GO:0034332;GO:0086073;GO:0016477;GO:0098609;GO:0071681;GO:0070268;GO:0002159;GO:0050982;GO:0071603;GO:0031424;GO:0043537;GO:0043312;GO:0045766;GO:0090263;GO:0001954;GO:0051091;GO:0042307;GO:0045944;GO:0072659;GO:0042127;GO:0086091;GO:0098911;, C:actin cytoskeleton; C:adherens junction; C:apicolateral plasma membrane; C:catenin complex; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:desmosome; C:extracellular exosome; C:extracellular region; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:gamma-catenin-TCF7L2 complex; C:intercalated disc; C:intermediate filament; C:lateral plasma membrane; C:nucleus; C:plasma membrane; C:protein-DNA complex; C:specific granule lumen; C:Z disc; C:zonula adherens;, F:alpha-catenin binding; F:cadherin binding; F:cell adhesion molecule binding; F:cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication; F:cytoskeletal protein-membrane anchor activity; F:nuclear hormone receptor binding; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:structural molecule activity; F:transcription coactivator activity;, P:adherens junction organization; P:bundle of His cell-Purkinje myocyte adhesion involved in cell communication; P:cell migration; P:cell-cell adhesion; P:cellular response to indole-3-methanol; P:cornification; P:desmosome assembly; P:detection of mechanical stimulus; P:endothelial cell-cell adhesion; P:keratinization; P:negative regulation of blood vessel endothelial cell migration; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell-matrix adhesion; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of protein import into nucleus; P:positive regulation of transcription by RNA polymerase II; P:protein localization to plasma membrane; P:regulation of cell population proliferation; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell action potential;|P35222 A8K1L7 Q8NEW9 Q8NI94 Q9H391,Catenin beta-1,Beta-catenin;, PF00514;, GO:0005912;GO:0016323;GO:0030877;GO:1990907;GO:0070369;GO:0016342;GO:0005938;GO:0030054;GO:0071944;GO:0042995;GO:0005911;GO:0005813;GO:0005737;GO:0005829;GO:0000791;GO:0070062;GO:0005925;GO:0016328;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0032993;GO:0000922;GO:0045202;GO:0005667;GO:1990909;GO:0045294;GO:0008013;GO:0045296;GO:0003682;GO:0140297;GO:0019899;GO:0030331;GO:1990226;GO:0070411;GO:0044325;GO:0019900;GO:0035257;GO:0008022;GO:0019903;GO:0001102;GO:0001085;GO:0046332;GO:0003713;GO:0001221;GO:0008134;GO:0034333;GO:1904886;GO:1904837;GO:0001569;GO:0060070;GO:1904954;GO:0044336;GO:0061324;GO:0044334;GO:0007155;GO:0098609;GO:0071363;GO:0071681;GO:0035995;GO:0036023;GO:0061154;GO:0035635;GO:0001837;GO:0035315;GO:1904948;GO:0016525;GO:0043066;GO:0008285;GO:0045976;GO:0033234;GO:0045892;GO:1990138;GO:0043065;GO:0051091;GO:0010718;GO:0010909;GO:0051571;GO:0051149;GO:0002052;GO:0043525;GO:0051973;GO:0032212;GO:0045944;GO:0045893;GO:0032481;GO:0043161;GO:0034394;GO:0000209;GO:0045765;GO:0090279;GO:0060828;GO:0030997;GO:0070602;GO:0048145;GO:0072182;GO:0050767;GO:2000008;GO:0048660;GO:0060260;GO:0042493;GO:0032355;GO:0019827;GO:0061549;GO:0016032;GO:0016055;GO:0007223;, C:adherens junction; C:basolateral plasma membrane; C:beta-catenin destruction complex; C:beta-catenin-TCF complex; C:beta-catenin-TCF7L2 complex; C:catenin complex; C:cell cortex; C:cell junction; C:cell periphery; C:cell projection; C:cell-cell junction; C:centrosome; C:cytoplasm; C:cytosol; C:euchromatin; C:extracellular exosome; C:focal adhesion; C:lateral plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:protein-DNA complex; C:spindle pole; C:synapse; C:transcription regulator complex; C:Wnt signalosome;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:chromatin binding; F:DNA-binding transcription factor binding; F:enzyme binding; F:estrogen receptor binding; F:histone methyltransferase binding; F:I-SMAD binding; F:ion channel binding; F:kinase binding; F:nuclear hormone receptor binding; F:protein C-terminus binding; F:protein phosphatase binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:SMAD binding; F:transcription coactivator activity; F:transcription coregulator binding; F:transcription factor binding;, P:adherens junction assembly; P:beta-catenin destruction complex disassembly; P:beta-catenin-TCF complex assembly; P:branching involved in blood vessel morphogenesis; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; P:cell adhesion; P:cell-cell adhesion; P:cellular response to growth factor stimulus; P:cellular response to indole-3-methanol; P:detection of muscle stretch; P:embryonic skeletal limb joint morphogenesis; P:endothelial tube morphogenesis; P:entry of bacterium into host cell; P:epithelial to mesenchymal transition; P:hair cell differentiation; P:midbrain dopaminergic neuron differentiation; P:negative regulation of angiogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle, embryonic; P:negative regulation of protein sumoylation; P:negative regulation of transcription, DNA-templated; P:neuron projection extension; P:positive regulation of apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; P:positive regulation of histone H3-K4 methylation; P:positive regulation of muscle cell differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron apoptotic process; P:positive regulation of telomerase activity; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein localization to cell surface; P:protein polyubiquitination; P:regulation of angiogenesis; P:regulation of calcium ion import; P:regulation of canonical Wnt signaling pathway; P:regulation of centriole-centriole cohesion; P:regulation of centromeric sister chromatid cohesion; P:regulation of fibroblast proliferation; P:regulation of nephron tubule epithelial cell differentiation; P:regulation of neurogenesis; P:regulation of protein localization to cell surface; P:regulation of smooth muscle cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to drug; P:response to estradiol; P:stem cell population maintenance; P:sympathetic ganglion development; P:viral process; P:Wnt signaling pathway; P:Wnt signaling pathway, calcium modulating pathway; scaffold51 indexed_genome mRNA 12401592 12538655 . + . ID=transcript_9557;Q9UPV9 E9PDS2 J3KNT7 Q63HR0 Q659B5 Q96B69,Trafficking kinesin-binding protein 1,106 kDa O-GlcNAc transferase-interacting protein;Protein Milton {ECO:0000303|PubMed:24995978};, PF04849;PF12448;, GO:1904115;GO:0005938;GO:0005737;GO:0031410;GO:0030425;GO:0005769;GO:0031966;GO:0005739;GO:0005634;GO:0050811;GO:0017022;GO:0005102;GO:0098957;GO:0008333;GO:0048311;GO:0022008;GO:0006493;GO:0006605;GO:0006357;GO:0047496;, C:axon cytoplasm; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:early endosome; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:GABA receptor binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport of mitochondrion; P:endosome to lysosome transport; P:mitochondrion distribution; P:neurogenesis; P:protein O-linked glycosylation; P:protein targeting; P:regulation of transcription by RNA polymerase II; P:vesicle transport along microtubule;|Q9UPV9 E9PDS2 J3KNT7 Q63HR0 Q659B5 Q96B69,Trafficking kinesin-binding protein 1,106 kDa O-GlcNAc transferase-interacting protein;Protein Milton {ECO:0000303|PubMed:24995978};, PF04849;PF12448;, GO:1904115;GO:0005938;GO:0005737;GO:0031410;GO:0030425;GO:0005769;GO:0031966;GO:0005739;GO:0005634;GO:0050811;GO:0017022;GO:0005102;GO:0098957;GO:0008333;GO:0048311;GO:0022008;GO:0006493;GO:0006605;GO:0006357;GO:0047496;, C:axon cytoplasm; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:early endosome; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:GABA receptor binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport of mitochondrion; P:endosome to lysosome transport; P:mitochondrion distribution; P:neurogenesis; P:protein O-linked glycosylation; P:protein targeting; P:regulation of transcription by RNA polymerase II; P:vesicle transport along microtubule;|Q9UPV9 E9PDS2 J3KNT7 Q63HR0 Q659B5 Q96B69,Trafficking kinesin-binding protein 1,106 kDa O-GlcNAc transferase-interacting protein;Protein Milton {ECO:0000303|PubMed:24995978};, PF04849;PF12448;, GO:1904115;GO:0005938;GO:0005737;GO:0031410;GO:0030425;GO:0005769;GO:0031966;GO:0005739;GO:0005634;GO:0050811;GO:0017022;GO:0005102;GO:0098957;GO:0008333;GO:0048311;GO:0022008;GO:0006493;GO:0006605;GO:0006357;GO:0047496;, C:axon cytoplasm; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:early endosome; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:GABA receptor binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport of mitochondrion; P:endosome to lysosome transport; P:mitochondrion distribution; P:neurogenesis; P:protein O-linked glycosylation; P:protein targeting; P:regulation of transcription by RNA polymerase II; P:vesicle transport along microtubule;|Q9UPV9 E9PDS2 J3KNT7 Q63HR0 Q659B5 Q96B69,Trafficking kinesin-binding protein 1,106 kDa O-GlcNAc transferase-interacting protein;Protein Milton {ECO:0000303|PubMed:24995978};, PF04849;PF12448;, GO:1904115;GO:0005938;GO:0005737;GO:0031410;GO:0030425;GO:0005769;GO:0031966;GO:0005739;GO:0005634;GO:0050811;GO:0017022;GO:0005102;GO:0098957;GO:0008333;GO:0048311;GO:0022008;GO:0006493;GO:0006605;GO:0006357;GO:0047496;, C:axon cytoplasm; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:early endosome; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:GABA receptor binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport of mitochondrion; P:endosome to lysosome transport; P:mitochondrion distribution; P:neurogenesis; P:protein O-linked glycosylation; P:protein targeting; P:regulation of transcription by RNA polymerase II; P:vesicle transport along microtubule;|Q9UPV9 E9PDS2 J3KNT7 Q63HR0 Q659B5 Q96B69,Trafficking kinesin-binding protein 1,106 kDa O-GlcNAc transferase-interacting protein;Protein Milton {ECO:0000303|PubMed:24995978};, PF04849;PF12448;, GO:1904115;GO:0005938;GO:0005737;GO:0031410;GO:0030425;GO:0005769;GO:0031966;GO:0005739;GO:0005634;GO:0050811;GO:0017022;GO:0005102;GO:0098957;GO:0008333;GO:0048311;GO:0022008;GO:0006493;GO:0006605;GO:0006357;GO:0047496;, C:axon cytoplasm; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:early endosome; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:GABA receptor binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport of mitochondrion; P:endosome to lysosome transport; P:mitochondrion distribution; P:neurogenesis; P:protein O-linked glycosylation; P:protein targeting; P:regulation of transcription by RNA polymerase II; P:vesicle transport along microtubule;|Q9UPV9 E9PDS2 J3KNT7 Q63HR0 Q659B5 Q96B69,Trafficking kinesin-binding protein 1,106 kDa O-GlcNAc transferase-interacting protein;Protein Milton {ECO:0000303|PubMed:24995978};, PF04849;PF12448;, GO:1904115;GO:0005938;GO:0005737;GO:0031410;GO:0030425;GO:0005769;GO:0031966;GO:0005739;GO:0005634;GO:0050811;GO:0017022;GO:0005102;GO:0098957;GO:0008333;GO:0048311;GO:0022008;GO:0006493;GO:0006605;GO:0006357;GO:0047496;, C:axon cytoplasm; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:early endosome; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:GABA receptor binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport of mitochondrion; P:endosome to lysosome transport; P:mitochondrion distribution; P:neurogenesis; P:protein O-linked glycosylation; P:protein targeting; P:regulation of transcription by RNA polymerase II; P:vesicle transport along microtubule; scaffold51 indexed_genome mRNA 12541796 12544778 . + . ID=transcript_9558;Q9UPV9 E9PDS2 J3KNT7 Q63HR0 Q659B5 Q96B69,Trafficking kinesin-binding protein 1,106 kDa O-GlcNAc transferase-interacting protein;Protein Milton {ECO:0000303|PubMed:24995978};, PF04849;PF12448;, GO:1904115;GO:0005938;GO:0005737;GO:0031410;GO:0030425;GO:0005769;GO:0031966;GO:0005739;GO:0005634;GO:0050811;GO:0017022;GO:0005102;GO:0098957;GO:0008333;GO:0048311;GO:0022008;GO:0006493;GO:0006605;GO:0006357;GO:0047496;, C:axon cytoplasm; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:early endosome; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:GABA receptor binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport of mitochondrion; P:endosome to lysosome transport; P:mitochondrion distribution; P:neurogenesis; P:protein O-linked glycosylation; P:protein targeting; P:regulation of transcription by RNA polymerase II; P:vesicle transport along microtubule; scaffold51 indexed_genome mRNA 12547109 12553453 . + . ID=transcript_9559;Q9UPV9 E9PDS2 J3KNT7 Q63HR0 Q659B5 Q96B69,Trafficking kinesin-binding protein 1,106 kDa O-GlcNAc transferase-interacting protein;Protein Milton {ECO:0000303|PubMed:24995978};, PF04849;PF12448;, GO:1904115;GO:0005938;GO:0005737;GO:0031410;GO:0030425;GO:0005769;GO:0031966;GO:0005739;GO:0005634;GO:0050811;GO:0017022;GO:0005102;GO:0098957;GO:0008333;GO:0048311;GO:0022008;GO:0006493;GO:0006605;GO:0006357;GO:0047496;, C:axon cytoplasm; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:early endosome; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:GABA receptor binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport of mitochondrion; P:endosome to lysosome transport; P:mitochondrion distribution; P:neurogenesis; P:protein O-linked glycosylation; P:protein targeting; P:regulation of transcription by RNA polymerase II; P:vesicle transport along microtubule;|Q9UPV9 E9PDS2 J3KNT7 Q63HR0 Q659B5 Q96B69,Trafficking kinesin-binding protein 1,106 kDa O-GlcNAc transferase-interacting protein;Protein Milton {ECO:0000303|PubMed:24995978};, PF04849;PF12448;, GO:1904115;GO:0005938;GO:0005737;GO:0031410;GO:0030425;GO:0005769;GO:0031966;GO:0005739;GO:0005634;GO:0050811;GO:0017022;GO:0005102;GO:0098957;GO:0008333;GO:0048311;GO:0022008;GO:0006493;GO:0006605;GO:0006357;GO:0047496;, C:axon cytoplasm; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:early endosome; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:GABA receptor binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport of mitochondrion; P:endosome to lysosome transport; P:mitochondrion distribution; P:neurogenesis; P:protein O-linked glycosylation; P:protein targeting; P:regulation of transcription by RNA polymerase II; P:vesicle transport along microtubule; scaffold51 indexed_genome mRNA 12553458 12554661 . + . ID=transcript_9560;Q8WCX6 Q9B2U5 Q9B2Z2,ATP synthase subunit a,F-ATPase protein 6;, PF00119;, GO:0016021;GO:0005743;GO:0005753;GO:0045263;GO:0015078;GO:0007568;GO:0006754;GO:0015986;GO:0042407;GO:0042776;GO:0055093;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:proton-transporting ATP synthase complex, coupling factor F(o);, F:proton transmembrane transporter activity;, P:aging; P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:response to hyperoxia; scaffold51 indexed_genome mRNA 12565186 12570784 . - . ID=transcript_9561;P06307,Cholecystokinin,, PF00918;, GO:0030424;GO:0043203;GO:0043194;GO:0030425;GO:0005576;GO:0005615;GO:0043204;GO:0043195;GO:0005179;GO:0005184;GO:0051428;GO:0006919;GO:0007409;GO:0007586;GO:0042755;GO:0007186;GO:0007613;GO:0032099;GO:2000986;GO:1903999;GO:0001764;GO:0043065;GO:2000987;GO:0008284;GO:0014049;GO:0051901;GO:0050731;GO:0031334;GO:1904058;GO:0007205;GO:0001836;GO:0007165;GO:0008542;, C:axon; C:axon hillock; C:axon initial segment; C:dendrite; C:extracellular region; C:extracellular space; C:perikaryon; C:terminal bouton;, F:hormone activity; F:neuropeptide hormone activity; F:peptide hormone receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:axonogenesis; P:digestion; P:eating behavior; P:G protein-coupled receptor signaling pathway; P:memory; P:negative regulation of appetite; P:negative regulation of behavioral fear response; P:negative regulation of eating behavior; P:neuron migration; P:positive regulation of apoptotic process; P:positive regulation of behavioral fear response; P:positive regulation of cell population proliferation; P:positive regulation of glutamate secretion; P:positive regulation of mitochondrial depolarization; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein-containing complex assembly; P:positive regulation of sensory perception of pain; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:release of cytochrome c from mitochondria; P:signal transduction; P:visual learning; scaffold51 indexed_genome mRNA 12651302 12651833 . + . ID=transcript_9562;Q9UHA2 B2R5L1,SS18-like protein 2,SYT homolog 2;, PF05030;, GO:0005634;GO:0003713;GO:0050775;GO:0045944;, C:nucleus;, F:transcription coactivator activity;, P:positive regulation of dendrite morphogenesis; P:positive regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 12655285 12668507 . + . ID=transcript_9563;P30414,NK-tumor recognition protein {ECO:0000305|PubMed:8421688},Natural-killer cells cyclophilin-related protein;Peptidyl-prolyl cis-trans isomerase NKTR {ECO:0000305|PubMed:20676357};Rotamase;, PF00160;, GO:0005737;GO:0043231;GO:0005634;GO:0005886;GO:0016018;GO:0003755;GO:0006457;GO:0000413;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding; P:protein peptidyl-prolyl isomerization;|P30414,NK-tumor recognition protein {ECO:0000305|PubMed:8421688},Natural-killer cells cyclophilin-related protein;Peptidyl-prolyl cis-trans isomerase NKTR {ECO:0000305|PubMed:20676357};Rotamase;, PF00160;, GO:0005737;GO:0043231;GO:0005634;GO:0005886;GO:0016018;GO:0003755;GO:0006457;GO:0000413;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding; P:protein peptidyl-prolyl isomerization;|P30414,NK-tumor recognition protein {ECO:0000305|PubMed:8421688},Natural-killer cells cyclophilin-related protein;Peptidyl-prolyl cis-trans isomerase NKTR {ECO:0000305|PubMed:20676357};Rotamase;, PF00160;, GO:0005737;GO:0043231;GO:0005634;GO:0005886;GO:0016018;GO:0003755;GO:0006457;GO:0000413;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding; P:protein peptidyl-prolyl isomerization;|P30414,NK-tumor recognition protein {ECO:0000305|PubMed:8421688},Natural-killer cells cyclophilin-related protein;Peptidyl-prolyl cis-trans isomerase NKTR {ECO:0000305|PubMed:20676357};Rotamase;, PF00160;, GO:0005737;GO:0043231;GO:0005634;GO:0005886;GO:0016018;GO:0003755;GO:0006457;GO:0000413;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding; P:protein peptidyl-prolyl isomerization; scaffold51 indexed_genome mRNA 12674617 12685446 . + . ID=transcript_9564;P30414,NK-tumor recognition protein {ECO:0000305|PubMed:8421688},Natural-killer cells cyclophilin-related protein;Peptidyl-prolyl cis-trans isomerase NKTR {ECO:0000305|PubMed:20676357};Rotamase;, PF00160;, GO:0005737;GO:0043231;GO:0005634;GO:0005886;GO:0016018;GO:0003755;GO:0006457;GO:0000413;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding; P:protein peptidyl-prolyl isomerization;|P30414,NK-tumor recognition protein {ECO:0000305|PubMed:8421688},Natural-killer cells cyclophilin-related protein;Peptidyl-prolyl cis-trans isomerase NKTR {ECO:0000305|PubMed:20676357};Rotamase;, PF00160;, GO:0005737;GO:0043231;GO:0005634;GO:0005886;GO:0016018;GO:0003755;GO:0006457;GO:0000413;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding; P:protein peptidyl-prolyl isomerization;|P30414,NK-tumor recognition protein {ECO:0000305|PubMed:8421688},Natural-killer cells cyclophilin-related protein;Peptidyl-prolyl cis-trans isomerase NKTR {ECO:0000305|PubMed:20676357};Rotamase;, PF00160;, GO:0005737;GO:0043231;GO:0005634;GO:0005886;GO:0016018;GO:0003755;GO:0006457;GO:0000413;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding; P:protein peptidyl-prolyl isomerization;|P30414,NK-tumor recognition protein {ECO:0000305|PubMed:8421688},Natural-killer cells cyclophilin-related protein;Peptidyl-prolyl cis-trans isomerase NKTR {ECO:0000305|PubMed:20676357};Rotamase;, PF00160;, GO:0005737;GO:0043231;GO:0005634;GO:0005886;GO:0016018;GO:0003755;GO:0006457;GO:0000413;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding; P:protein peptidyl-prolyl isomerization; scaffold51 indexed_genome mRNA 12685476 12690725 . + . ID=transcript_9565;P30414,NK-tumor recognition protein {ECO:0000305|PubMed:8421688},Natural-killer cells cyclophilin-related protein;Peptidyl-prolyl cis-trans isomerase NKTR {ECO:0000305|PubMed:20676357};Rotamase;, PF00160;, GO:0005737;GO:0043231;GO:0005634;GO:0005886;GO:0016018;GO:0003755;GO:0006457;GO:0000413;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:protein folding; P:protein peptidyl-prolyl isomerization; scaffold51 indexed_genome mRNA 12713337 12720452 . + . ID=transcript_9566;Q2TBA0 Q86SI1 Q96MR2,Kelch-like protein 40 {ECO:0000305},Kelch repeat and BTB domain-containing protein 5;Sarcosynapsin {ECO:0000303|Ref.1};, PF07707;PF00651;PF01344;, GO:0031672;GO:0031463;GO:0005737;GO:0031674;GO:0032435;GO:0031397;GO:0032436;GO:0031398;GO:0048741;GO:0098528;, C:A band; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:I band;, , P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:skeletal muscle fiber development; P:skeletal muscle fiber differentiation; scaffold51 indexed_genome mRNA 12720512 12752801 . - . ID=transcript_9567;Q9HCP6 Q8TBG3 Q9ULP7,Protein-cysteine N-palmitoyltransferase HHAT-like protein,Glycerol uptake/transporter homolog;Hedgehog acyltransferase-like protein;, PF03062;, GO:0005783;GO:0005789;GO:0016021;GO:0048471;GO:0016746;GO:0060262;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:transferase activity, transferring acyl groups;, P:negative regulation of N-terminal protein palmitoylation;|Q9HCP6 Q8TBG3 Q9ULP7,Protein-cysteine N-palmitoyltransferase HHAT-like protein,Glycerol uptake/transporter homolog;Hedgehog acyltransferase-like protein;, PF03062;, GO:0005783;GO:0005789;GO:0016021;GO:0048471;GO:0016746;GO:0060262;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:transferase activity, transferring acyl groups;, P:negative regulation of N-terminal protein palmitoylation;|Q9HCP6 Q8TBG3 Q9ULP7,Protein-cysteine N-palmitoyltransferase HHAT-like protein,Glycerol uptake/transporter homolog;Hedgehog acyltransferase-like protein;, PF03062;, GO:0005783;GO:0005789;GO:0016021;GO:0048471;GO:0016746;GO:0060262;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:transferase activity, transferring acyl groups;, P:negative regulation of N-terminal protein palmitoylation;|Q9HCP6 Q8TBG3 Q9ULP7,Protein-cysteine N-palmitoyltransferase HHAT-like protein,Glycerol uptake/transporter homolog;Hedgehog acyltransferase-like protein;, PF03062;, GO:0005783;GO:0005789;GO:0016021;GO:0048471;GO:0016746;GO:0060262;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:transferase activity, transferring acyl groups;, P:negative regulation of N-terminal protein palmitoylation;|Q8IYE1,Coiled-coil domain-containing protein 13 {ECO:0000305},, , GO:0042995;GO:0034451;GO:0005813;GO:0005829;GO:0005654;GO:0006974;GO:0031122;GO:1905515;, C:cell projection; C:centriolar satellite; C:centrosome; C:cytosol; C:nucleoplasm;, , P:cellular response to DNA damage stimulus; P:cytoplasmic microtubule organization; P:non-motile cilium assembly;|Q8IYE1,Coiled-coil domain-containing protein 13 {ECO:0000305},, , GO:0042995;GO:0034451;GO:0005813;GO:0005829;GO:0005654;GO:0006974;GO:0031122;GO:1905515;, C:cell projection; C:centriolar satellite; C:centrosome; C:cytosol; C:nucleoplasm;, , P:cellular response to DNA damage stimulus; P:cytoplasmic microtubule organization; P:non-motile cilium assembly;|Q8IYE1,Coiled-coil domain-containing protein 13 {ECO:0000305},, , GO:0042995;GO:0034451;GO:0005813;GO:0005829;GO:0005654;GO:0006974;GO:0031122;GO:1905515;, C:cell projection; C:centriolar satellite; C:centrosome; C:cytosol; C:nucleoplasm;, , P:cellular response to DNA damage stimulus; P:cytoplasmic microtubule organization; P:non-motile cilium assembly; scaffold51 indexed_genome mRNA 12757994 12768243 . - . ID=transcript_9568;Q8IYE1,Coiled-coil domain-containing protein 13 {ECO:0000305},, , GO:0042995;GO:0034451;GO:0005813;GO:0005829;GO:0005654;GO:0006974;GO:0031122;GO:1905515;, C:cell projection; C:centriolar satellite; C:centrosome; C:cytosol; C:nucleoplasm;, , P:cellular response to DNA damage stimulus; P:cytoplasmic microtubule organization; P:non-motile cilium assembly; scaffold51 indexed_genome mRNA 12776675 12779335 . - . ID=transcript_9569;Q9Y241 Q9UFZ2,HIG1 domain family member 1A, mitochondrial,Hypoxia-inducible gene 1 protein;RCF1 homolog A;, PF04588;, GO:0016021;GO:0005743;GO:0005739;GO:0005654;GO:0032991;GO:0070469;GO:0097250;GO:0043066;GO:0061418;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:protein-containing complex; C:respirasome;, , P:mitochondrial respirasome assembly; P:negative regulation of apoptotic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; scaffold51 indexed_genome mRNA 12833003 12835416 . - . ID=transcript_9570;Q9UNU6 B2RCY3 O75958 Q6NWT2 Q6NWT3,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,7-alpha-hydroxy-4-cholesten-3-one 12-alpha-hydroxylase;CYPVIIIB1;Cytochrome P450 8B1;Sterol 12-alpha-hydroxylase;, PF00067;, GO:0005789;GO:0016021;GO:0020037;GO:0005506;GO:0019825;GO:0008397;GO:0006699;GO:0038183;GO:0045797;GO:0070723;GO:0031667;GO:0016125;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:heme binding; F:iron ion binding; F:oxygen binding; F:sterol 12-alpha-hydroxylase activity;, P:bile acid biosynthetic process; P:bile acid signaling pathway; P:positive regulation of intestinal cholesterol absorption; P:response to cholesterol; P:response to nutrient levels; P:sterol metabolic process; scaffold51 indexed_genome mRNA 12904490 12922941 . + . ID=transcript_9571;Q9UFP1 B3KR48,Golgi-associated kinase 1A {ECO:0000305},Protein FAM198A;, PF15051;, GO:0005901;GO:0005783;GO:0005576;GO:0005794;GO:0043231;, C:caveola; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:intracellular membrane-bounded organelle; scaffold51 indexed_genome mRNA 13124041 13166938 . + . ID=transcript_9572;Q9NRH2 B2RAV6 Q14706 Q68D15 Q6IQ46 Q9NXI7,SNF-related serine/threonine-protein kinase,SNF1-related kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0030099;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:myeloid cell differentiation; P:protein phosphorylation;|Q9NRH2 B2RAV6 Q14706 Q68D15 Q6IQ46 Q9NXI7,SNF-related serine/threonine-protein kinase,SNF1-related kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0030099;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:myeloid cell differentiation; P:protein phosphorylation; scaffold51 indexed_genome mRNA 13168998 13173379 . - . ID=transcript_9573;Q9NRH2 B2RAV6 Q14706 Q68D15 Q6IQ46 Q9NXI7,SNF-related serine/threonine-protein kinase,SNF1-related kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0030099;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:myeloid cell differentiation; P:protein phosphorylation;|Q9NRH2 B2RAV6 Q14706 Q68D15 Q6IQ46 Q9NXI7,SNF-related serine/threonine-protein kinase,SNF1-related kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0030099;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:myeloid cell differentiation; P:protein phosphorylation;|Q9NRH2 B2RAV6 Q14706 Q68D15 Q6IQ46 Q9NXI7,SNF-related serine/threonine-protein kinase,SNF1-related kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0030099;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:myeloid cell differentiation; P:protein phosphorylation; scaffold51 indexed_genome mRNA 13173919 13184994 . + . ID=transcript_9574;Q9NRH2 B2RAV6 Q14706 Q68D15 Q6IQ46 Q9NXI7,SNF-related serine/threonine-protein kinase,SNF1-related kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0030099;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:myeloid cell differentiation; P:protein phosphorylation; scaffold51 indexed_genome mRNA 13185003 13383332 . - . ID=transcript_9575;Q8IXX9,Anoctamin-10,Transmembrane protein 16K;, PF04547;, GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0005227;GO:0005229;GO:0006812;GO:0006821;GO:0034220;GO:0055085;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:intracellular calcium activated chloride channel activity;, P:cation transport; P:chloride transport; P:ion transmembrane transport; P:transmembrane transport; scaffold51 indexed_genome mRNA 13453951 13474318 . + . ID=transcript_9576;Q8WTS1 B2R9K0 Q9Y369,1-acylglycerol-3-phosphate O-acyltransferase ABHD5 {ECO:0000305},Abhydrolase domain-containing protein 5;Lipid droplet-binding protein CGI-58;, PF00561;, GO:0005829;GO:0043231;GO:0005811;GO:0005739;GO:0005654;GO:0003841;GO:0052689;GO:0042171;GO:0030154;GO:0006631;GO:0055088;GO:0010891;GO:0006654;GO:0051006;GO:0010898;, C:cytosol; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion; C:nucleoplasm;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity;, P:cell differentiation; P:fatty acid metabolic process; P:lipid homeostasis; P:negative regulation of sequestering of triglyceride; P:phosphatidic acid biosynthetic process; P:positive regulation of lipoprotein lipase activity; P:positive regulation of triglyceride catabolic process; scaffold51 indexed_genome mRNA 14100812 14117664 . + . ID=transcript_9577;Q8N3R3 A8K9P1 Q0P5T9 Q495R1 Q495R3 Q4G0M4 Q6GMU8,T-cell activation inhibitor, mitochondrial,Tolerance associated gene-1 protein;, PF14687;PF14688;, GO:0005739;, C:mitochondrion; scaffold51 indexed_genome mRNA 14121458 14137334 . + . ID=transcript_9578;Q8N3R3 A8K9P1 Q0P5T9 Q495R1 Q495R3 Q4G0M4 Q6GMU8,T-cell activation inhibitor, mitochondrial,Tolerance associated gene-1 protein;, PF14687;PF14688;, GO:0005739;, C:mitochondrion;|Q8N3R3 A8K9P1 Q0P5T9 Q495R1 Q495R3 Q4G0M4 Q6GMU8,T-cell activation inhibitor, mitochondrial,Tolerance associated gene-1 protein;, PF14687;PF14688;, GO:0005739;, C:mitochondrion;|Q8N3R3 A8K9P1 Q0P5T9 Q495R1 Q495R3 Q4G0M4 Q6GMU8,T-cell activation inhibitor, mitochondrial,Tolerance associated gene-1 protein;, PF14687;PF14688;, GO:0005739;, C:mitochondrion; scaffold51 indexed_genome mRNA 14151622 14152318 . - . ID=transcript_9579;Q96C01 Q96SS3,Protein FAM136A,, PF05811;, GO:0005737;, C:cytoplasm; scaffold51 indexed_genome mRNA 14155792 14169179 . - . ID=transcript_9580;P59923 Q3MJD1,Zinc finger protein 445 {ECO:0000305},Zinc finger protein 168;Zinc finger protein with KRAB and SCAN domains 15;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003682;GO:0001228;GO:0010385;GO:0046872;GO:0000978;GO:0010216;GO:0071517;GO:2000653;GO:0006357;, C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:double-stranded methylated DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:maintenance of DNA methylation; P:maintenance of imprinting at mating-type locus; P:regulation of genetic imprinting; P:regulation of transcription by RNA polymerase II;|P59923 Q3MJD1,Zinc finger protein 445 {ECO:0000305},Zinc finger protein 168;Zinc finger protein with KRAB and SCAN domains 15;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003682;GO:0001228;GO:0010385;GO:0046872;GO:0000978;GO:0010216;GO:0071517;GO:2000653;GO:0006357;, C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:double-stranded methylated DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:maintenance of DNA methylation; P:maintenance of imprinting at mating-type locus; P:regulation of genetic imprinting; P:regulation of transcription by RNA polymerase II;|P59923 Q3MJD1,Zinc finger protein 445 {ECO:0000305},Zinc finger protein 168;Zinc finger protein with KRAB and SCAN domains 15;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003682;GO:0001228;GO:0010385;GO:0046872;GO:0000978;GO:0010216;GO:0071517;GO:2000653;GO:0006357;, C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:double-stranded methylated DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:maintenance of DNA methylation; P:maintenance of imprinting at mating-type locus; P:regulation of genetic imprinting; P:regulation of transcription by RNA polymerase II;|P59923 Q3MJD1,Zinc finger protein 445 {ECO:0000305},Zinc finger protein 168;Zinc finger protein with KRAB and SCAN domains 15;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003682;GO:0001228;GO:0010385;GO:0046872;GO:0000978;GO:0010216;GO:0071517;GO:2000653;GO:0006357;, C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:double-stranded methylated DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:maintenance of DNA methylation; P:maintenance of imprinting at mating-type locus; P:regulation of genetic imprinting; P:regulation of transcription by RNA polymerase II;|P59923 Q3MJD1,Zinc finger protein 445 {ECO:0000305},Zinc finger protein 168;Zinc finger protein with KRAB and SCAN domains 15;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003682;GO:0001228;GO:0010385;GO:0046872;GO:0000978;GO:0010216;GO:0071517;GO:2000653;GO:0006357;, C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:double-stranded methylated DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:maintenance of DNA methylation; P:maintenance of imprinting at mating-type locus; P:regulation of genetic imprinting; P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 14217363 14228995 . - . ID=transcript_9581;Q9P0L1 A0PJV3 A8K5H0 Q6WL09 Q96FQ2,Zinc finger protein with KRAB and SCAN domains 7,Zinc finger protein 167;Zinc finger protein 448;Zinc finger protein 64;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 14231381 14245446 . + . ID=transcript_9582;Q9P0L1 A0PJV3 A8K5H0 Q6WL09 Q96FQ2,Zinc finger protein with KRAB and SCAN domains 7,Zinc finger protein 167;Zinc finger protein 448;Zinc finger protein 64;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 14250935 14262789 . + . ID=transcript_9583;Q6AZW8 Q7Z331 Q8N9M8,Zinc finger protein 660,, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 14269578 14286888 . + . ID=transcript_9584;O14709 B2RAH8 Q86VG0,Zinc finger protein 197,Zinc finger protein with KRAB and SCAN domains 9;ZnF20;pVHL-associated KRAB domain-containing protein;, PF01352;PF02023;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 14290239 14298474 . + . ID=transcript_9585;P13682 B2RBU6 Q53Y54 Q96D01,Zinc finger protein 35,Zinc finger protein HF.10;, PF00096;, GO:0005634;GO:0048471;GO:0003677;GO:0003700;GO:0000981;GO:0046872;GO:0000977;GO:0043565;GO:0071300;GO:0006357;GO:0006355;GO:0007283;, C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:cellular response to retinoic acid; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis; scaffold51 indexed_genome mRNA 14315543 14319699 . + . ID=transcript_9586;Q8TBZ5,Zinc finger protein 502,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0044794;GO:0044791;GO:0006355;GO:0016032;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation by host of viral process; P:positive regulation by host of viral release from host cell; P:regulation of transcription, DNA-templated; P:viral process; scaffold51 indexed_genome mRNA 14329848 14332669 . - . ID=transcript_9587;Q96CX3 B4DLY7 Q96NU9,Zinc finger protein 501,Zinc finger protein 52;, PF00096;, GO:0005730;GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:1990837;GO:0007030;GO:0006357;, C:nucleolus; C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:Golgi organization; P:regulation of transcription by RNA polymerase II; scaffold51 indexed_genome mRNA 14342651 14349950 . - . ID=transcript_9588;Q96AT1 A8K0I4 Q96HJ8 Q9ULS7,Uncharacterized protein KIAA1143,, PF15377;|Q96AT1 A8K0I4 Q96HJ8 Q9ULS7,Uncharacterized protein KIAA1143,, PF15377;|Q96AT1 A8K0I4 Q96HJ8 Q9ULS7,Uncharacterized protein KIAA1143,, PF15377;|Q96AT1 A8K0I4 Q96HJ8 Q9ULS7,Uncharacterized protein KIAA1143,, PF15377; scaffold51 indexed_genome mRNA 14369411 14380264 . + . ID=transcript_9589;Q9NS87 Q17RV9 Q69YL6 Q96JX7 Q9H280,Kinesin-like protein KIF15,Kinesin-like protein 2;Kinesin-like protein 7;Serologically defined breast cancer antigen NY-BR-62;, PF15908;PF00225;, GO:0005813;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0005873;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0007018;GO:0000278;GO:0006890;, C:centrosome; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cell cycle; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NS87 Q17RV9 Q69YL6 Q96JX7 Q9H280,Kinesin-like protein KIF15,Kinesin-like protein 2;Kinesin-like protein 7;Serologically defined breast cancer antigen NY-BR-62;, PF15908;PF00225;, GO:0005813;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0005873;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0007018;GO:0000278;GO:0006890;, C:centrosome; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cell cycle; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold51 indexed_genome mRNA 14380306 14393577 . - . ID=transcript_9590;Q9NS87 Q17RV9 Q69YL6 Q96JX7 Q9H280,Kinesin-like protein KIF15,Kinesin-like protein 2;Kinesin-like protein 7;Serologically defined breast cancer antigen NY-BR-62;, PF15908;PF00225;, GO:0005813;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0005873;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0007018;GO:0000278;GO:0006890;, C:centrosome; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cell cycle; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NS87 Q17RV9 Q69YL6 Q96JX7 Q9H280,Kinesin-like protein KIF15,Kinesin-like protein 2;Kinesin-like protein 7;Serologically defined breast cancer antigen NY-BR-62;, PF15908;PF00225;, GO:0005813;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0005873;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0007018;GO:0000278;GO:0006890;, C:centrosome; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cell cycle; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NS87 Q17RV9 Q69YL6 Q96JX7 Q9H280,Kinesin-like protein KIF15,Kinesin-like protein 2;Kinesin-like protein 7;Serologically defined breast cancer antigen NY-BR-62;, PF15908;PF00225;, GO:0005813;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0005873;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0007018;GO:0000278;GO:0006890;, C:centrosome; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cell cycle; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NS87 Q17RV9 Q69YL6 Q96JX7 Q9H280,Kinesin-like protein KIF15,Kinesin-like protein 2;Kinesin-like protein 7;Serologically defined breast cancer antigen NY-BR-62;, PF15908;PF00225;, GO:0005813;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0005873;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0007018;GO:0000278;GO:0006890;, C:centrosome; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cell cycle; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold51 indexed_genome mRNA 14396065 14403650 . + . ID=transcript_9591;Q9NS87 Q17RV9 Q69YL6 Q96JX7 Q9H280,Kinesin-like protein KIF15,Kinesin-like protein 2;Kinesin-like protein 7;Serologically defined breast cancer antigen NY-BR-62;, PF15908;PF00225;, GO:0005813;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0005873;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0007018;GO:0000278;GO:0006890;, C:centrosome; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cell cycle; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NS87 Q17RV9 Q69YL6 Q96JX7 Q9H280,Kinesin-like protein KIF15,Kinesin-like protein 2;Kinesin-like protein 7;Serologically defined breast cancer antigen NY-BR-62;, PF15908;PF00225;, GO:0005813;GO:0005829;GO:0005871;GO:0016020;GO:0005874;GO:0005873;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0019886;GO:0007018;GO:0000278;GO:0006890;, C:centrosome; C:cytosol; C:kinesin complex; C:membrane; C:microtubule; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cell cycle; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold51 indexed_genome mRNA 14460759 14481031 . - . ID=transcript_9592;Q93075 Q3MIL9 Q5BKU0,Putative deoxyribonuclease TATDN2,, PF01026;, GO:0005654;GO:0016888;GO:0046872;GO:0036498;, C:nucleoplasm;, F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:metal ion binding;, P:IRE1-mediated unfolded protein response; scaffold51 indexed_genome mRNA 14488594 14541610 . - . ID=transcript_9593;O43187 B4DQZ6 Q08AG6 Q5K546,Interleukin-1 receptor-associated kinase-like 2,, PF00531;PF00069;, GO:0005737;GO:0005829;GO:0010008;GO:0005634;GO:0005886;GO:0005524;GO:0046982;GO:0042803;GO:0004672;GO:0000187;GO:0019221;GO:0007249;GO:0006954;GO:0070498;GO:0035556;GO:0007254;GO:0031663;GO:0002755;GO:0032088;GO:0070423;GO:0051092;GO:0006468;GO:0001959;GO:0070555;GO:0034162;GO:0002224;, C:cytoplasm; C:cytosol; C:endosome membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity;, P:activation of MAPK activity; P:cytokine-mediated signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:lipopolysaccharide-mediated signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:protein phosphorylation; P:regulation of cytokine-mediated signaling pathway; P:response to interleukin-1; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|O43187 B4DQZ6 Q08AG6 Q5K546,Interleukin-1 receptor-associated kinase-like 2,, PF00531;PF00069;, GO:0005737;GO:0005829;GO:0010008;GO:0005634;GO:0005886;GO:0005524;GO:0046982;GO:0042803;GO:0004672;GO:0000187;GO:0019221;GO:0007249;GO:0006954;GO:0070498;GO:0035556;GO:0007254;GO:0031663;GO:0002755;GO:0032088;GO:0070423;GO:0051092;GO:0006468;GO:0001959;GO:0070555;GO:0034162;GO:0002224;, C:cytoplasm; C:cytosol; C:endosome membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity;, P:activation of MAPK activity; P:cytokine-mediated signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:lipopolysaccharide-mediated signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:protein phosphorylation; P:regulation of cytokine-mediated signaling pathway; P:response to interleukin-1; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; scaffold51 indexed_genome mRNA 14547935 14554553 . - . ID=transcript_9594;P40337 B2RE45 Q13599 Q6PDA9,von Hippel-Lindau disease tumor suppressor,Protein G7;pVHL;, PF01847;PF17211;, GO:0005829;GO:0005783;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0019899;GO:0008134;GO:1990756;GO:0000902;GO:0043066;GO:0008285;GO:0010629;GO:0046426;GO:0000122;GO:0061428;GO:0045597;GO:0045893;GO:0043687;GO:0050821;GO:0016567;GO:0006508;GO:0061418;GO:0006355;, C:cytosol; C:endoplasmic reticulum; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:transcription factor binding; F:ubiquitin ligase-substrate adaptor activity;, P:cell morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of cell differentiation; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:protein stabilization; P:protein ubiquitination; P:proteolysis; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated;|P40337 B2RE45 Q13599 Q6PDA9,von Hippel-Lindau disease tumor suppressor,Protein G7;pVHL;, PF01847;PF17211;, GO:0005829;GO:0005783;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0019899;GO:0008134;GO:1990756;GO:0000902;GO:0043066;GO:0008285;GO:0010629;GO:0046426;GO:0000122;GO:0061428;GO:0045597;GO:0045893;GO:0043687;GO:0050821;GO:0016567;GO:0006508;GO:0061418;GO:0006355;, C:cytosol; C:endoplasmic reticulum; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:transcription factor binding; F:ubiquitin ligase-substrate adaptor activity;, P:cell morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of cell differentiation; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:protein stabilization; P:protein ubiquitination; P:proteolysis; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; scaffold51 indexed_genome mRNA 14558982 14566733 . - . ID=transcript_9595;Q8WUW1 B2R5E2 Q9P082,Protein BRICK1,, , GO:0005856;GO:0005829;GO:0070062;GO:0030027;GO:0031209;GO:0042802;GO:0044877;GO:0007015;GO:0048870;GO:0038096;GO:0001701;GO:2000601;GO:0008284;GO:0010592;GO:0031334;GO:0016601;GO:0008064;GO:0048010;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:lamellipodium; C:SCAR complex;, F:identical protein binding; F:protein-containing complex binding;, P:actin filament organization; P:cell motility; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:in utero embryonic development; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of cell population proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of protein-containing complex assembly; P:Rac protein signal transduction; P:regulation of actin polymerization or depolymerization; P:vascular endothelial growth factor receptor signaling pathway;|Q8WUW1 B2R5E2 Q9P082,Protein BRICK1,, , GO:0005856;GO:0005829;GO:0070062;GO:0030027;GO:0031209;GO:0042802;GO:0044877;GO:0007015;GO:0048870;GO:0038096;GO:0001701;GO:2000601;GO:0008284;GO:0010592;GO:0031334;GO:0016601;GO:0008064;GO:0048010;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:lamellipodium; C:SCAR complex;, F:identical protein binding; F:protein-containing complex binding;, P:actin filament organization; P:cell motility; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:in utero embryonic development; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of cell population proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of protein-containing complex assembly; P:Rac protein signal transduction; P:regulation of actin polymerization or depolymerization; P:vascular endothelial growth factor receptor signaling pathway; scaffold51 indexed_genome mRNA 14572954 14583534 . - . ID=transcript_9596;Q9BXW9 Q2LA86 Q69YP9 Q6PJN7 Q9BQ06 Q9H9T9,Fanconi anemia group D2 protein,, PF14631;, GO:0000793;GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0070182;GO:0048854;GO:0034599;GO:1990918;GO:0007276;GO:0007129;GO:0036297;GO:0031573;GO:0097150;GO:2000348;GO:0051090;GO:0050727;GO:0045589;GO:0010332;, C:condensed chromosome; C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA polymerase binding;, P:brain morphogenesis; P:cellular response to oxidative stress; P:double-strand break repair involved in meiotic recombination; P:gamete generation; P:homologous chromosome pairing at meiosis; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:neuronal stem cell population maintenance; P:regulation of CD40 signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of inflammatory response; P:regulation of regulatory T cell differentiation; P:response to gamma radiation; scaffold51 indexed_genome mRNA 14591688 14596509 . - . ID=transcript_9597;Q9BXW9 Q2LA86 Q69YP9 Q6PJN7 Q9BQ06 Q9H9T9,Fanconi anemia group D2 protein,, PF14631;, GO:0000793;GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0070182;GO:0048854;GO:0034599;GO:1990918;GO:0007276;GO:0007129;GO:0036297;GO:0031573;GO:0097150;GO:2000348;GO:0051090;GO:0050727;GO:0045589;GO:0010332;, C:condensed chromosome; C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA polymerase binding;, P:brain morphogenesis; P:cellular response to oxidative stress; P:double-strand break repair involved in meiotic recombination; P:gamete generation; P:homologous chromosome pairing at meiosis; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:neuronal stem cell population maintenance; P:regulation of CD40 signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of inflammatory response; P:regulation of regulatory T cell differentiation; P:response to gamma radiation; scaffold51 indexed_genome mRNA 14600048 14604865 . - . ID=transcript_9598;Q9BXW9 Q2LA86 Q69YP9 Q6PJN7 Q9BQ06 Q9H9T9,Fanconi anemia group D2 protein,, PF14631;, GO:0000793;GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0070182;GO:0048854;GO:0034599;GO:1990918;GO:0007276;GO:0007129;GO:0036297;GO:0031573;GO:0097150;GO:2000348;GO:0051090;GO:0050727;GO:0045589;GO:0010332;, C:condensed chromosome; C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA polymerase binding;, P:brain morphogenesis; P:cellular response to oxidative stress; P:double-strand break repair involved in meiotic recombination; P:gamete generation; P:homologous chromosome pairing at meiosis; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:neuronal stem cell population maintenance; P:regulation of CD40 signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of inflammatory response; P:regulation of regulatory T cell differentiation; P:response to gamma radiation; scaffold51 indexed_genome mRNA 14607956 14614450 . - . ID=transcript_9599;Q9BXW9 Q2LA86 Q69YP9 Q6PJN7 Q9BQ06 Q9H9T9,Fanconi anemia group D2 protein,, PF14631;, GO:0000793;GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0070182;GO:0048854;GO:0034599;GO:1990918;GO:0007276;GO:0007129;GO:0036297;GO:0031573;GO:0097150;GO:2000348;GO:0051090;GO:0050727;GO:0045589;GO:0010332;, C:condensed chromosome; C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA polymerase binding;, P:brain morphogenesis; P:cellular response to oxidative stress; P:double-strand break repair involved in meiotic recombination; P:gamete generation; P:homologous chromosome pairing at meiosis; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:neuronal stem cell population maintenance; P:regulation of CD40 signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of inflammatory response; P:regulation of regulatory T cell differentiation; P:response to gamma radiation; scaffold51 indexed_genome mRNA 14623529 14641825 . + . ID=transcript_9600;Q9P0I2 B2R4Z9 Q53GH8 Q6ZMC2,ER membrane protein complex subunit 3,Transmembrane protein 111;, PF01956;, GO:0072546;GO:0030176;GO:0016021;GO:0045050;GO:0071816;, C:EMC complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q9P0I2 B2R4Z9 Q53GH8 Q6ZMC2,ER membrane protein complex subunit 3,Transmembrane protein 111;, PF01956;, GO:0072546;GO:0030176;GO:0016021;GO:0045050;GO:0071816;, C:EMC complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q9P0I2 B2R4Z9 Q53GH8 Q6ZMC2,ER membrane protein complex subunit 3,Transmembrane protein 111;, PF01956;, GO:0072546;GO:0030176;GO:0016021;GO:0045050;GO:0071816;, C:EMC complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q9P0I2 B2R4Z9 Q53GH8 Q6ZMC2,ER membrane protein complex subunit 3,Transmembrane protein 111;, PF01956;, GO:0072546;GO:0030176;GO:0016021;GO:0045050;GO:0071816;, C:EMC complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q9P0I2 B2R4Z9 Q53GH8 Q6ZMC2,ER membrane protein complex subunit 3,Transmembrane protein 111;, PF01956;, GO:0072546;GO:0030176;GO:0016021;GO:0045050;GO:0071816;, C:EMC complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane; scaffold51 indexed_genome mRNA 14650473 14655093 . + . ID=transcript_9601;Q5FWE3 Q49AD0 Q6UXY6 Q8NBC9,Proline-rich transmembrane protein 3,, , GO:0016021;, C:integral component of membrane;|Q5FWE3 Q49AD0 Q6UXY6 Q8NBC9,Proline-rich transmembrane protein 3,, , GO:0016021;, C:integral component of membrane; scaffold51 indexed_genome mRNA 14655104 14664102 . - . ID=transcript_9602;Q96HD1 A8MX90 B2RAA9 Q6I9X5 Q8NFT4 Q9Y409,Protein disulfide isomerase CRELD1 {ECO:0000305},Cysteine-rich with EGF-like domain protein 1 {ECO:0000305};, PF11938;PF07645;, GO:0062023;GO:0016021;GO:0005509;GO:0003756;GO:0003279;GO:0003197;, C:collagen-containing extracellular matrix; C:integral component of membrane;, F:calcium ion binding; F:protein disulfide isomerase activity;, P:cardiac septum development; P:endocardial cushion development;|Q96HD1 A8MX90 B2RAA9 Q6I9X5 Q8NFT4 Q9Y409,Protein disulfide isomerase CRELD1 {ECO:0000305},Cysteine-rich with EGF-like domain protein 1 {ECO:0000305};, PF11938;PF07645;, GO:0062023;GO:0016021;GO:0005509;GO:0003756;GO:0003279;GO:0003197;, C:collagen-containing extracellular matrix; C:integral component of membrane;, F:calcium ion binding; F:protein disulfide isomerase activity;, P:cardiac septum development; P:endocardial cushion development;|Q96HD1 A8MX90 B2RAA9 Q6I9X5 Q8NFT4 Q9Y409,Protein disulfide isomerase CRELD1 {ECO:0000305},Cysteine-rich with EGF-like domain protein 1 {ECO:0000305};, PF11938;PF07645;, GO:0062023;GO:0016021;GO:0005509;GO:0003756;GO:0003279;GO:0003197;, C:collagen-containing extracellular matrix; C:integral component of membrane;, F:calcium ion binding; F:protein disulfide isomerase activity;, P:cardiac septum development; P:endocardial cushion development;|Q96HD1 A8MX90 B2RAA9 Q6I9X5 Q8NFT4 Q9Y409,Protein disulfide isomerase CRELD1 {ECO:0000305},Cysteine-rich with EGF-like domain protein 1 {ECO:0000305};, PF11938;PF07645;, GO:0062023;GO:0016021;GO:0005509;GO:0003756;GO:0003279;GO:0003197;, C:collagen-containing extracellular matrix; C:integral component of membrane;, F:calcium ion binding; F:protein disulfide isomerase activity;, P:cardiac septum development; P:endocardial cushion development; scaffold51 indexed_genome mRNA 14664312 14675553 . - . ID=transcript_9603;Q9BR97,Interleukin-17 receptor C,Interleukin-17 receptor homolog;Interleukin-17 receptor-like protein;ZcytoR14;, PF15037;PF08357;, GO:0009986;GO:0016021;GO:0005886;GO:0030368;GO:0005102;GO:0050832;GO:0071621;GO:0006954;GO:0097400;GO:1900017;GO:0032755;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:interleukin-17 receptor activity; F:signaling receptor binding;, P:defense response to fungus; P:granulocyte chemotaxis; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of interleukin-6 production;|Q9BR97,Interleukin-17 receptor C,Interleukin-17 receptor homolog;Interleukin-17 receptor-like protein;ZcytoR14;, PF15037;PF08357;, GO:0009986;GO:0016021;GO:0005886;GO:0030368;GO:0005102;GO:0050832;GO:0071621;GO:0006954;GO:0097400;GO:1900017;GO:0032755;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:interleukin-17 receptor activity; F:signaling receptor binding;, P:defense response to fungus; P:granulocyte chemotaxis; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of interleukin-6 production;|Q9BR97,Interleukin-17 receptor C,Interleukin-17 receptor homolog;Interleukin-17 receptor-like protein;ZcytoR14;, PF15037;PF08357;, GO:0009986;GO:0016021;GO:0005886;GO:0030368;GO:0005102;GO:0050832;GO:0071621;GO:0006954;GO:0097400;GO:1900017;GO:0032755;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:interleukin-17 receptor activity; F:signaling receptor binding;, P:defense response to fungus; P:granulocyte chemotaxis; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of interleukin-6 production;|Q9BR97,Interleukin-17 receptor C,Interleukin-17 receptor homolog;Interleukin-17 receptor-like protein;ZcytoR14;, PF15037;PF08357;, GO:0009986;GO:0016021;GO:0005886;GO:0030368;GO:0005102;GO:0050832;GO:0071621;GO:0006954;GO:0097400;GO:1900017;GO:0032755;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:interleukin-17 receptor activity; F:signaling receptor binding;, P:defense response to fungus; P:granulocyte chemotaxis; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of interleukin-6 production;|Q9BR97,Interleukin-17 receptor C,Interleukin-17 receptor homolog;Interleukin-17 receptor-like protein;ZcytoR14;, PF15037;PF08357;, GO:0009986;GO:0016021;GO:0005886;GO:0030368;GO:0005102;GO:0050832;GO:0071621;GO:0006954;GO:0097400;GO:1900017;GO:0032755;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:interleukin-17 receptor activity; F:signaling receptor binding;, P:defense response to fungus; P:granulocyte chemotaxis; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of interleukin-6 production;|Q9BR97,Interleukin-17 receptor C,Interleukin-17 receptor homolog;Interleukin-17 receptor-like protein;ZcytoR14;, PF15037;PF08357;, GO:0009986;GO:0016021;GO:0005886;GO:0030368;GO:0005102;GO:0050832;GO:0071621;GO:0006954;GO:0097400;GO:1900017;GO:0032755;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:interleukin-17 receptor activity; F:signaling receptor binding;, P:defense response to fungus; P:granulocyte chemotaxis; P:inflammatory response; P:interleukin-17-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of interleukin-6 production; scaffold51 indexed_genome mRNA 14676681 14696375 . + . ID=transcript_9604;Q8NFR9 B2RB34 B2RNR1 B9EH65 Q6P532 Q8N8H7 Q8N8H8 Q8TEC2,Interleukin-17 receptor E,, PF15037;PF08357;, GO:0005737;GO:0005576;GO:0016021;GO:0005886;GO:0030368;GO:0006954;GO:0097400;, C:cytoplasm; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:interleukin-17 receptor activity;, P:inflammatory response; P:interleukin-17-mediated signaling pathway;|Q8NFR9 B2RB34 B2RNR1 B9EH65 Q6P532 Q8N8H7 Q8N8H8 Q8TEC2,Interleukin-17 receptor E,, PF15037;PF08357;, GO:0005737;GO:0005576;GO:0016021;GO:0005886;GO:0030368;GO:0006954;GO:0097400;, C:cytoplasm; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:interleukin-17 receptor activity;, P:inflammatory response; P:interleukin-17-mediated signaling pathway; scaffold51 indexed_genome mRNA 14698492 14702252 . + . ID=transcript_9605;Q8N5M9 Q8NCF6 Q96SW1,Protein jagunal homolog 1 {ECO:0000305},, PF07086;, GO:0005783;GO:0005789;GO:0016021;GO:1904577;GO:0050832;GO:0007029;GO:0006887;GO:0038158;GO:0061179;GO:0030223;GO:0002446;GO:1990266;GO:0015031;GO:0016192;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:cellular response to tunicamycin; P:defense response to fungus; P:endoplasmic reticulum organization; P:exocytosis; P:granulocyte colony-stimulating factor signaling pathway; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; P:neutrophil differentiation; P:neutrophil mediated immunity; P:neutrophil migration; P:protein transport; P:vesicle-mediated transport; scaffold51 indexed_genome mRNA 14708352 14718537 . + . ID=transcript_9606;Q96AQ7 C9JMN7 Q67DW9 Q9GZY9,Cell death activator CIDE-3,Cell death-inducing DFFA-like effector protein C;Fat-specific protein FSP27 homolog;, PF02017;, GO:0005829;GO:0005783;GO:0005811;GO:0005634;GO:0006915;GO:0097194;GO:0034389;GO:0042981;, C:cytosol; C:endoplasmic reticulum; C:lipid droplet; C:nucleus;, , P:apoptotic process; P:execution phase of apoptosis; P:lipid droplet organization; P:regulation of apoptotic process; scaffold51 indexed_genome mRNA 14723667 14732097 . + . ID=transcript_9607;Q6P087 B4DS39 Q6P6A9 Q8N1B2 Q8NAV3,Mitochondrial mRNA pseudouridine synthase RPUSD3,RNA pseudouridylate synthase domain-containing protein 3;, PF00849;, GO:0005759;GO:0005739;GO:0035770;GO:0009982;GO:0003723;GO:0000455;GO:0006397;GO:0070131;, C:mitochondrial matrix; C:mitochondrion; C:ribonucleoprotein granule;, F:pseudouridine synthase activity; F:RNA binding;, P:enzyme-directed rRNA pseudouridine synthesis; P:mRNA processing; P:positive regulation of mitochondrial translation;|Q6P087 B4DS39 Q6P6A9 Q8N1B2 Q8NAV3,Mitochondrial mRNA pseudouridine synthase RPUSD3,RNA pseudouridylate synthase domain-containing protein 3;, PF00849;, GO:0005759;GO:0005739;GO:0035770;GO:0009982;GO:0003723;GO:0000455;GO:0006397;GO:0070131;, C:mitochondrial matrix; C:mitochondrion; C:ribonucleoprotein granule;, F:pseudouridine synthase activity; F:RNA binding;, P:enzyme-directed rRNA pseudouridine synthesis; P:mRNA processing; P:positive regulation of mitochondrial translation;|Q6P087 B4DS39 Q6P6A9 Q8N1B2 Q8NAV3,Mitochondrial mRNA pseudouridine synthase RPUSD3,RNA pseudouridylate synthase domain-containing protein 3;, PF00849;, GO:0005759;GO:0005739;GO:0035770;GO:0009982;GO:0003723;GO:0000455;GO:0006397;GO:0070131;, C:mitochondrial matrix; C:mitochondrion; C:ribonucleoprotein granule;, F:pseudouridine synthase activity; F:RNA binding;, P:enzyme-directed rRNA pseudouridine synthesis; P:mRNA processing; P:positive regulation of mitochondrial translation;|O60930 B3KQU4 O60523 O60857 Q57Z93 Q5U0C1 Q6FHD4,Ribonuclease H1,Ribonuclease H type II;, PF01693;PF00075;, GO:0005737;GO:0000287;GO:0003676;GO:0004540;GO:0003723;GO:0004523;GO:0043137;GO:0006401;GO:0090502;, C:cytoplasm;, F:magnesium ion binding; F:nucleic acid binding; F:ribonuclease activity; F:RNA binding; F:RNA-DNA hybrid ribonuclease activity;, P:DNA replication, removal of RNA primer; P:RNA catabolic process; P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold51 indexed_genome mRNA 14732249 14756814 . - . ID=transcript_9608;Q9Y4R7 Q4KMS8 Q6AWA3 Q6ZU95 Q8NDN8 Q96GG8 Q9H876 Q9UI99,Tubulin monoglycylase TTLL3,HOTTL;Tubulin--tyrosine ligase-like protein 3;, PF03133;, GO:0005930;GO:0005929;GO:0005829;GO:0005874;GO:0015630;GO:0005524;GO:0070735;GO:0070736;GO:0035082;GO:0060271;GO:0018094;, C:axoneme; C:cilium; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:protein-glycine ligase activity; F:protein-glycine ligase activity, initiating;, P:axoneme assembly; P:cilium assembly; P:protein polyglycylation;|Q9Y4R7 Q4KMS8 Q6AWA3 Q6ZU95 Q8NDN8 Q96GG8 Q9H876 Q9UI99,Tubulin monoglycylase TTLL3,HOTTL;Tubulin--tyrosine ligase-like protein 3;, PF03133;, GO:0005930;GO:0005929;GO:0005829;GO:0005874;GO:0015630;GO:0005524;GO:0070735;GO:0070736;GO:0035082;GO:0060271;GO:0018094;, C:axoneme; C:cilium; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:protein-glycine ligase activity; F:protein-glycine ligase activity, initiating;, P:axoneme assembly; P:cilium assembly; P:protein polyglycylation;|Q9Y4R7 Q4KMS8 Q6AWA3 Q6ZU95 Q8NDN8 Q96GG8 Q9H876 Q9UI99,Tubulin monoglycylase TTLL3,HOTTL;Tubulin--tyrosine ligase-like protein 3;, PF03133;, GO:0005930;GO:0005929;GO:0005829;GO:0005874;GO:0015630;GO:0005524;GO:0070735;GO:0070736;GO:0035082;GO:0060271;GO:0018094;, C:axoneme; C:cilium; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:protein-glycine ligase activity; F:protein-glycine ligase activity, initiating;, P:axoneme assembly; P:cilium assembly; P:protein polyglycylation;|A6PVC2 B5MDV0,Protein monoglycylase TTLL8,Tubulin--tyrosine ligase-like protein 8;, PF03133;, GO:0005930;GO:0005929;GO:0005829;GO:0005874;GO:0015630;GO:0005524;GO:0070735;GO:0070736;GO:0018094;, C:axoneme; C:cilium; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:protein-glycine ligase activity; F:protein-glycine ligase activity, initiating;, P:protein polyglycylation;|Q9Y4R7 Q4KMS8 Q6AWA3 Q6ZU95 Q8NDN8 Q96GG8 Q9H876 Q9UI99,Tubulin monoglycylase TTLL3,HOTTL;Tubulin--tyrosine ligase-like protein 3;, PF03133;, GO:0005930;GO:0005929;GO:0005829;GO:0005874;GO:0015630;GO:0005524;GO:0070735;GO:0070736;GO:0035082;GO:0060271;GO:0018094;, C:axoneme; C:cilium; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:protein-glycine ligase activity; F:protein-glycine ligase activity, initiating;, P:axoneme assembly; P:cilium assembly; P:protein polyglycylation; scaffold51 indexed_genome mRNA 14756966 14768398 . - . ID=transcript_9609;P59998 C9JWM7 E7ETI0 F6TTL5 O15509 Q6P0W5 Q96QJ3,Actin-related protein 2/3 complex subunit 4,Arp2/3 complex 20 kDa subunit;, PF05856;, GO:0005885;GO:0042995;GO:0005829;GO:0070062;GO:0005634;GO:0035861;GO:0003779;GO:0019899;GO:0005200;GO:0030041;GO:0045010;GO:0034314;GO:0048013;GO:0038096;GO:0061024;, C:Arp2/3 protein complex; C:cell projection; C:cytosol; C:extracellular exosome; C:nucleus; C:site of double-strand break;, F:actin binding; F:enzyme binding; F:structural constituent of cytoskeleton;, P:actin filament polymerization; P:actin nucleation; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization;|P59998 C9JWM7 E7ETI0 F6TTL5 O15509 Q6P0W5 Q96QJ3,Actin-related protein 2/3 complex subunit 4,Arp2/3 complex 20 kDa subunit;, PF05856;, GO:0005885;GO:0042995;GO:0005829;GO:0070062;GO:0005634;GO:0035861;GO:0003779;GO:0019899;GO:0005200;GO:0030041;GO:0045010;GO:0034314;GO:0048013;GO:0038096;GO:0061024;, C:Arp2/3 protein complex; C:cell projection; C:cytosol; C:extracellular exosome; C:nucleus; C:site of double-strand break;, F:actin binding; F:enzyme binding; F:structural constituent of cytoskeleton;, P:actin filament polymerization; P:actin nucleation; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; scaffold51 indexed_genome mRNA 14768751 14779178 . + . ID=transcript_9610;O75528 Q6FI83 Q9UFS2,Transcriptional adapter 3,ADA3 homolog;STAF54;Transcriptional adapter 3-like;, PF10198;, GO:0005671;GO:0072686;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0033276;GO:0016922;GO:0030374;GO:0019904;GO:0003713;GO:0043966;GO:0043967;GO:0030520;GO:0000278;GO:0010628;GO:0045893;GO:0016579;GO:0031063;GO:0001932;GO:0031647;GO:0006357;GO:0090043;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex; C:transcription factor TFTC complex;, F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:transcription coactivator activity;, P:histone H3 acetylation; P:histone H4 acetylation; P:intracellular estrogen receptor signaling pathway; P:mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of histone deacetylation; P:regulation of protein phosphorylation; P:regulation of protein stability; P:regulation of transcription by RNA polymerase II; P:regulation of tubulin deacetylation;|O75528 Q6FI83 Q9UFS2,Transcriptional adapter 3,ADA3 homolog;STAF54;Transcriptional adapter 3-like;, PF10198;, GO:0005671;GO:0072686;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0033276;GO:0016922;GO:0030374;GO:0019904;GO:0003713;GO:0043966;GO:0043967;GO:0030520;GO:0000278;GO:0010628;GO:0045893;GO:0016579;GO:0031063;GO:0001932;GO:0031647;GO:0006357;GO:0090043;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex; C:transcription factor TFTC complex;, F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:transcription coactivator activity;, P:histone H3 acetylation; P:histone H4 acetylation; P:intracellular estrogen receptor signaling pathway; P:mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of histone deacetylation; P:regulation of protein phosphorylation; P:regulation of protein stability; P:regulation of transcription by RNA polymerase II; P:regulation of tubulin deacetylation;|O75528 Q6FI83 Q9UFS2,Transcriptional adapter 3,ADA3 homolog;STAF54;Transcriptional adapter 3-like;, PF10198;, GO:0005671;GO:0072686;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0033276;GO:0016922;GO:0030374;GO:0019904;GO:0003713;GO:0043966;GO:0043967;GO:0030520;GO:0000278;GO:0010628;GO:0045893;GO:0016579;GO:0031063;GO:0001932;GO:0031647;GO:0006357;GO:0090043;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex; C:transcription factor TFTC complex;, F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:transcription coactivator activity;, P:histone H3 acetylation; P:histone H4 acetylation; P:intracellular estrogen receptor signaling pathway; P:mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of histone deacetylation; P:regulation of protein phosphorylation; P:regulation of protein stability; P:regulation of transcription by RNA polymerase II; P:regulation of tubulin deacetylation;|O75528 Q6FI83 Q9UFS2,Transcriptional adapter 3,ADA3 homolog;STAF54;Transcriptional adapter 3-like;, PF10198;, GO:0005671;GO:0072686;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0033276;GO:0016922;GO:0030374;GO:0019904;GO:0003713;GO:0043966;GO:0043967;GO:0030520;GO:0000278;GO:0010628;GO:0045893;GO:0016579;GO:0031063;GO:0001932;GO:0031647;GO:0006357;GO:0090043;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex; C:transcription factor TFTC complex;, F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:transcription coactivator activity;, P:histone H3 acetylation; P:histone H4 acetylation; P:intracellular estrogen receptor signaling pathway; P:mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of histone deacetylation; P:regulation of protein phosphorylation; P:regulation of protein stability; P:regulation of transcription by RNA polymerase II; P:regulation of tubulin deacetylation;|O75528 Q6FI83 Q9UFS2,Transcriptional adapter 3,ADA3 homolog;STAF54;Transcriptional adapter 3-like;, PF10198;, GO:0005671;GO:0072686;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0033276;GO:0016922;GO:0030374;GO:0019904;GO:0003713;GO:0043966;GO:0043967;GO:0030520;GO:0000278;GO:0010628;GO:0045893;GO:0016579;GO:0031063;GO:0001932;GO:0031647;GO:0006357;GO:0090043;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex; C:transcription factor TFTC complex;, F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:transcription coactivator activity;, P:histone H3 acetylation; P:histone H4 acetylation; P:intracellular estrogen receptor signaling pathway; P:mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of histone deacetylation; P:regulation of protein phosphorylation; P:regulation of protein stability; P:regulation of transcription by RNA polymerase II; P:regulation of tubulin deacetylation;|O75528 Q6FI83 Q9UFS2,Transcriptional adapter 3,ADA3 homolog;STAF54;Transcriptional adapter 3-like;, PF10198;, GO:0005671;GO:0072686;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0033276;GO:0016922;GO:0030374;GO:0019904;GO:0003713;GO:0043966;GO:0043967;GO:0030520;GO:0000278;GO:0010628;GO:0045893;GO:0016579;GO:0031063;GO:0001932;GO:0031647;GO:0006357;GO:0090043;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex; C:transcription factor TFTC complex;, F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:transcription coactivator activity;, P:histone H3 acetylation; P:histone H4 acetylation; P:intracellular estrogen receptor signaling pathway; P:mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of histone deacetylation; P:regulation of protein phosphorylation; P:regulation of protein stability; P:regulation of transcription by RNA polymerase II; P:regulation of tubulin deacetylation;|O75528 Q6FI83 Q9UFS2,Transcriptional adapter 3,ADA3 homolog;STAF54;Transcriptional adapter 3-like;, PF10198;, GO:0005671;GO:0072686;GO:0005654;GO:0005634;GO:0000124;GO:0030914;GO:0033276;GO:0016922;GO:0030374;GO:0019904;GO:0003713;GO:0043966;GO:0043967;GO:0030520;GO:0000278;GO:0010628;GO:0045893;GO:0016579;GO:0031063;GO:0001932;GO:0031647;GO:0006357;GO:0090043;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:SAGA complex; C:STAGA complex; C:transcription factor TFTC complex;, F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein domain specific binding; F:transcription coactivator activity;, P:histone H3 acetylation; P:histone H4 acetylation; P:intracellular estrogen receptor signaling pathway; P:mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of histone deacetylation; P:regulation of protein phosphorylation; P:regulation of protein stability; P:regulation of transcription by RNA polymerase II; P:regulation of tubulin deacetylation; scaffold51 indexed_genome mRNA 14789166 14811504 . + . ID=transcript_9611;Q14012 Q3KPF6,Calcium/calmodulin-dependent protein kinase type 1,CaM kinase I;CaM kinase I alpha;, PF00069;, GO:0005829;GO:0098978;GO:0005634;GO:0014069;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0007049;GO:0030154;GO:0007268;GO:0032091;GO:0007399;GO:0006913;GO:0018105;GO:0060999;GO:0051149;GO:0010976;GO:0033138;GO:1901985;GO:0046827;GO:0071902;GO:0051835;GO:0060143;GO:0045944;GO:0006468;GO:0051147;GO:0043393;GO:0032880;GO:0007165;, C:cytosol; C:glutamatergic synapse; C:nucleus; C:postsynaptic density;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cell differentiation; P:chemical synaptic transmission; P:negative regulation of protein binding; P:nervous system development; P:nucleocytoplasmic transport; P:peptidyl-serine phosphorylation; P:positive regulation of dendritic spine development; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of synapse structural plasticity; P:positive regulation of syncytium formation by plasma membrane fusion; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of muscle cell differentiation; P:regulation of protein binding; P:regulation of protein localization; P:signal transduction;|Q9UIK0 Q9UIK1 Q9UIK2 Q9UL34 Q9Y2C0 Q9Y2C1 Q9Y6C3 Q9Y6C4,N-glycosylase/DNA lyase,, PF00730;PF07934;, GO:0005829;GO:0005759;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0034039;GO:0140078;GO:0003684;GO:0004519;GO:0008017;GO:0032357;GO:0008534;GO:0002526;GO:0007568;GO:0006284;GO:0006285;GO:0006287;GO:0071276;GO:0006974;GO:0045007;GO:0045008;GO:0043066;GO:1901291;GO:0033683;GO:0006355;GO:0042493;GO:0032355;GO:0045471;GO:0051593;GO:0009416;GO:0006979;GO:0009314;, C:cytosol; C:mitochondrial matrix; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:8-oxo-7,8-dihydroguanine DNA N-glycosylase activity; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:endonuclease activity; F:microtubule binding; F:oxidized purine DNA binding; F:oxidized purine nucleobase lesion DNA N-glycosylase activity;, P:acute inflammatory response; P:aging; P:base-excision repair; P:base-excision repair, AP site formation; P:base-excision repair, gap-filling; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:depurination; P:depyrimidination; P:negative regulation of apoptotic process; P:negative regulation of double-strand break repair via single-strand annealing; P:nucleotide-excision repair, DNA incision; P:regulation of transcription, DNA-templated; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to folic acid; P:response to light stimulus; P:response to oxidative stress; P:response to radiation;|Q14012 Q3KPF6,Calcium/calmodulin-dependent protein kinase type 1,CaM kinase I;CaM kinase I alpha;, PF00069;, GO:0005829;GO:0098978;GO:0005634;GO:0014069;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0007049;GO:0030154;GO:0007268;GO:0032091;GO:0007399;GO:0006913;GO:0018105;GO:0060999;GO:0051149;GO:0010976;GO:0033138;GO:1901985;GO:0046827;GO:0071902;GO:0051835;GO:0060143;GO:0045944;GO:0006468;GO:0051147;GO:0043393;GO:0032880;GO:0007165;, C:cytosol; C:glutamatergic synapse; C:nucleus; C:postsynaptic density;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cell differentiation; P:chemical synaptic transmission; P:negative regulation of protein binding; P:nervous system development; P:nucleocytoplasmic transport; P:peptidyl-serine phosphorylation; P:positive regulation of dendritic spine development; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of synapse structural plasticity; P:positive regulation of syncytium formation by plasma membrane fusion; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of muscle cell differentiation; P:regulation of protein binding; P:regulation of protein localization; P:signal transduction;|Q14012 Q3KPF6,Calcium/calmodulin-dependent protein kinase type 1,CaM kinase I;CaM kinase I alpha;, PF00069;, GO:0005829;GO:0098978;GO:0005634;GO:0014069;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0007049;GO:0030154;GO:0007268;GO:0032091;GO:0007399;GO:0006913;GO:0018105;GO:0060999;GO:0051149;GO:0010976;GO:0033138;GO:1901985;GO:0046827;GO:0071902;GO:0051835;GO:0060143;GO:0045944;GO:0006468;GO:0051147;GO:0043393;GO:0032880;GO:0007165;, C:cytosol; C:glutamatergic synapse; C:nucleus; C:postsynaptic density;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cell differentiation; P:chemical synaptic transmission; P:negative regulation of protein binding; P:nervous system development; P:nucleocytoplasmic transport; P:peptidyl-serine phosphorylation; P:positive regulation of dendritic spine development; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of synapse structural plasticity; P:positive regulation of syncytium formation by plasma membrane fusion; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of muscle cell differentiation; P:regulation of protein binding; P:regulation of protein localization; P:signal transduction;|Q14012 Q3KPF6,Calcium/calmodulin-dependent protein kinase type 1,CaM kinase I;CaM kinase I alpha;, PF00069;, GO:0005829;GO:0098978;GO:0005634;GO:0014069;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0007049;GO:0030154;GO:0007268;GO:0032091;GO:0007399;GO:0006913;GO:0018105;GO:0060999;GO:0051149;GO:0010976;GO:0033138;GO:1901985;GO:0046827;GO:0071902;GO:0051835;GO:0060143;GO:0045944;GO:0006468;GO:0051147;GO:0043393;GO:0032880;GO:0007165;, C:cytosol; C:glutamatergic synapse; C:nucleus; C:postsynaptic density;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cell differentiation; P:chemical synaptic transmission; P:negative regulation of protein binding; P:nervous system development; P:nucleocytoplasmic transport; P:peptidyl-serine phosphorylation; P:positive regulation of dendritic spine development; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron projection development; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:positive regulation of protein export from nucleus; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of synapse structural plasticity; P:positive regulation of syncytium formation by plasma membrane fusion; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of muscle cell differentiation; P:regulation of protein binding; P:regulation of protein localization; P:signal transduction;|Q9UIK0 Q9UIK1 Q9UIK2 Q9UL34 Q9Y2C0 Q9Y2C1 Q9Y6C3 Q9Y6C4,N-glycosylase/DNA lyase,, PF00730;PF07934;, GO:0005829;GO:0005759;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0034039;GO:0140078;GO:0003684;GO:0004519;GO:0008017;GO:0032357;GO:0008534;GO:0002526;GO:0007568;GO:0006284;GO:0006285;GO:0006287;GO:0071276;GO:0006974;GO:0045007;GO:0045008;GO:0043066;GO:1901291;GO:0033683;GO:0006355;GO:0042493;GO:0032355;GO:0045471;GO:0051593;GO:0009416;GO:0006979;GO:0009314;, C:cytosol; C:mitochondrial matrix; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:8-oxo-7,8-dihydroguanine DNA N-glycosylase activity; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:endonuclease activity; F:microtubule binding; F:oxidized purine DNA binding; F:oxidized purine nucleobase lesion DNA N-glycosylase activity;, P:acute inflammatory response; P:aging; P:base-excision repair; P:base-excision repair, AP site formation; P:base-excision repair, gap-filling; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:depurination; P:depyrimidination; P:negative regulation of apoptotic process; P:negative regulation of double-strand break repair via single-strand annealing; P:nucleotide-excision repair, DNA incision; P:regulation of transcription, DNA-templated; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to folic acid; P:response to light stimulus; P:response to oxidative stress; P:response to radiation; scaffold51 indexed_genome mRNA 14813165 14828883 . - . ID=transcript_9612;P55201 B4DEZ6 Q7Z6E0 Q8TCM6 Q9UHI0,Peregrin {ECO:0000305},Bromodomain and PHD finger-containing protein 1 {ECO:0000312|HGNC:HGNC:14255};Protein Br140 {ECO:0000303|PubMed:7906940};, PF00439;PF10513;PF00855;, GO:0005694;GO:0005737;GO:0005829;GO:0000123;GO:0070776;GO:0005654;GO:0005634;GO:0005886;GO:0010698;GO:0003677;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0045893;GO:1901796;, C:chromosome; C:cytoplasm; C:cytosol; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:acetyltransferase activator activity; F:DNA binding; F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator;|P55201 B4DEZ6 Q7Z6E0 Q8TCM6 Q9UHI0,Peregrin {ECO:0000305},Bromodomain and PHD finger-containing protein 1 {ECO:0000312|HGNC:HGNC:14255};Protein Br140 {ECO:0000303|PubMed:7906940};, PF00439;PF10513;PF00855;, GO:0005694;GO:0005737;GO:0005829;GO:0000123;GO:0070776;GO:0005654;GO:0005634;GO:0005886;GO:0010698;GO:0003677;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0045893;GO:1901796;, C:chromosome; C:cytoplasm; C:cytosol; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:acetyltransferase activator activity; F:DNA binding; F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator;|P55201 B4DEZ6 Q7Z6E0 Q8TCM6 Q9UHI0,Peregrin {ECO:0000305},Bromodomain and PHD finger-containing protein 1 {ECO:0000312|HGNC:HGNC:14255};Protein Br140 {ECO:0000303|PubMed:7906940};, PF00439;PF10513;PF00855;, GO:0005694;GO:0005737;GO:0005829;GO:0000123;GO:0070776;GO:0005654;GO:0005634;GO:0005886;GO:0010698;GO:0003677;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0045893;GO:1901796;, C:chromosome; C:cytoplasm; C:cytosol; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:acetyltransferase activator activity; F:DNA binding; F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator;|P55201 B4DEZ6 Q7Z6E0 Q8TCM6 Q9UHI0,Peregrin {ECO:0000305},Bromodomain and PHD finger-containing protein 1 {ECO:0000312|HGNC:HGNC:14255};Protein Br140 {ECO:0000303|PubMed:7906940};, PF00439;PF10513;PF00855;, GO:0005694;GO:0005737;GO:0005829;GO:0000123;GO:0070776;GO:0005654;GO:0005634;GO:0005886;GO:0010698;GO:0003677;GO:0042393;GO:0046872;GO:0043966;GO:0044154;GO:0043972;GO:0045893;GO:1901796;, C:chromosome; C:cytoplasm; C:cytosol; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:acetyltransferase activator activity; F:DNA binding; F:histone binding; F:metal ion binding;, P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; scaffold51 indexed_genome mRNA 14830550 14844701 . - . ID=transcript_9613;Q8IYJ1 A1L430 A6NDX6 A8MSP8,Copine-9 {ECO:0000305},Copine IX {ECO:0000312|HGNC:HGNC:24336};, PF00168;PF07002;, GO:0070062;GO:0005615;GO:0005886;GO:0005544;GO:0046872;GO:0030154;GO:0071277;GO:1903861;, C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension;|Q8IYJ1 A1L430 A6NDX6 A8MSP8,Copine-9 {ECO:0000305},Copine IX {ECO:0000312|HGNC:HGNC:24336};, PF00168;PF07002;, GO:0070062;GO:0005615;GO:0005886;GO:0005544;GO:0046872;GO:0030154;GO:0071277;GO:1903861;, C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension;|Q8IYJ1 A1L430 A6NDX6 A8MSP8,Copine-9 {ECO:0000305},Copine IX {ECO:0000312|HGNC:HGNC:24336};, PF00168;PF07002;, GO:0070062;GO:0005615;GO:0005886;GO:0005544;GO:0046872;GO:0030154;GO:0071277;GO:1903861;, C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension;|Q8IYJ1 A1L430 A6NDX6 A8MSP8,Copine-9 {ECO:0000305},Copine IX {ECO:0000312|HGNC:HGNC:24336};, PF00168;PF07002;, GO:0070062;GO:0005615;GO:0005886;GO:0005544;GO:0046872;GO:0030154;GO:0071277;GO:1903861;, C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension;|Q8IYJ1 A1L430 A6NDX6 A8MSP8,Copine-9 {ECO:0000305},Copine IX {ECO:0000312|HGNC:HGNC:24336};, PF00168;PF07002;, GO:0070062;GO:0005615;GO:0005886;GO:0005544;GO:0046872;GO:0030154;GO:0071277;GO:1903861;, C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension;|Q8IYJ1 A1L430 A6NDX6 A8MSP8,Copine-9 {ECO:0000305},Copine IX {ECO:0000312|HGNC:HGNC:24336};, PF00168;PF07002;, GO:0070062;GO:0005615;GO:0005886;GO:0005544;GO:0046872;GO:0030154;GO:0071277;GO:1903861;, C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension;|Q8IYJ1 A1L430 A6NDX6 A8MSP8,Copine-9 {ECO:0000305},Copine IX {ECO:0000312|HGNC:HGNC:24336};, PF00168;PF07002;, GO:0070062;GO:0005615;GO:0005886;GO:0005544;GO:0046872;GO:0030154;GO:0071277;GO:1903861;, C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension; scaffold51 indexed_genome mRNA 14845114 14851811 . - . ID=transcript_9614;Q8IYJ1 A1L430 A6NDX6 A8MSP8,Copine-9 {ECO:0000305},Copine IX {ECO:0000312|HGNC:HGNC:24336};, PF00168;PF07002;, GO:0070062;GO:0005615;GO:0005886;GO:0005544;GO:0046872;GO:0030154;GO:0071277;GO:1903861;, C:extracellular exosome; C:extracellular space; C:plasma membrane;, F:calcium-dependent phospholipid binding; F:metal ion binding;, P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension; scaffold51 indexed_genome mRNA 14851839 14896680 . + . ID=transcript_9615;Q8NCE2 Q0JTH5 Q0JU83 Q6PIZ4 Q6QE21 Q86VK9 Q8IYK1 Q8TCM7 Q9H6C0,Myotubularin-related protein 14,HCV NS5A-transactivated protein 4 splice variant A-binding protein 1;hJumpy;, , GO:0005829;GO:0048471;GO:0001726;GO:0004438;GO:0004725;GO:0016236;GO:0006661;, C:cytosol; C:perinuclear region of cytoplasm; C:ruffle;, F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:macroautophagy; P:phosphatidylinositol biosynthetic process;|Q8NCE2 Q0JTH5 Q0JU83 Q6PIZ4 Q6QE21 Q86VK9 Q8IYK1 Q8TCM7 Q9H6C0,Myotubularin-related protein 14,HCV NS5A-transactivated protein 4 splice variant A-binding protein 1;hJumpy;, , GO:0005829;GO:0048471;GO:0001726;GO:0004438;GO:0004725;GO:0016236;GO:0006661;, C:cytosol; C:perinuclear region of cytoplasm; C:ruffle;, F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:macroautophagy; P:phosphatidylinositol biosynthetic process;|Q8NCE2 Q0JTH5 Q0JU83 Q6PIZ4 Q6QE21 Q86VK9 Q8IYK1 Q8TCM7 Q9H6C0,Myotubularin-related protein 14,HCV NS5A-transactivated protein 4 splice variant A-binding protein 1;hJumpy;, , GO:0005829;GO:0048471;GO:0001726;GO:0004438;GO:0004725;GO:0016236;GO:0006661;, C:cytosol; C:perinuclear region of cytoplasm; C:ruffle;, F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:macroautophagy; P:phosphatidylinositol biosynthetic process;|Q8NCE2 Q0JTH5 Q0JU83 Q6PIZ4 Q6QE21 Q86VK9 Q8IYK1 Q8TCM7 Q9H6C0,Myotubularin-related protein 14,HCV NS5A-transactivated protein 4 splice variant A-binding protein 1;hJumpy;, , GO:0005829;GO:0048471;GO:0001726;GO:0004438;GO:0004725;GO:0016236;GO:0006661;, C:cytosol; C:perinuclear region of cytoplasm; C:ruffle;, F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:macroautophagy; P:phosphatidylinositol biosynthetic process;|Q8NCE2 Q0JTH5 Q0JU83 Q6PIZ4 Q6QE21 Q86VK9 Q8IYK1 Q8TCM7 Q9H6C0,Myotubularin-related protein 14,HCV NS5A-transactivated protein 4 splice variant A-binding protein 1;hJumpy;, , GO:0005829;GO:0048471;GO:0001726;GO:0004438;GO:0004725;GO:0016236;GO:0006661;, C:cytosol; C:perinuclear region of cytoplasm; C:ruffle;, F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:macroautophagy; P:phosphatidylinositol biosynthetic process;|Q8NCE2 Q0JTH5 Q0JU83 Q6PIZ4 Q6QE21 Q86VK9 Q8IYK1 Q8TCM7 Q9H6C0,Myotubularin-related protein 14,HCV NS5A-transactivated protein 4 splice variant A-binding protein 1;hJumpy;, , GO:0005829;GO:0048471;GO:0001726;GO:0004438;GO:0004725;GO:0016236;GO:0006661;, C:cytosol; C:perinuclear region of cytoplasm; C:ruffle;, F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:macroautophagy; P:phosphatidylinositol biosynthetic process; scaffold51 indexed_genome mRNA 14947211 14975611 . + . ID=transcript_9616;Q7Z7J7 A6NH76 Q29RV7,LHFPL tetraspan subfamily member 4 protein {ECO:0000312|HGNC:HGNC:29568},GABAA receptor regulatory Lhfpl4 {ECO:0000250|UniProtKB:Q5U4E0};Lipoma HMGIC fusion partner-like 4 protein {ECO:0000312|HGNC:HGNC:29568};, PF10242;, GO:0030425;GO:0060077;GO:0016021;GO:0016020;GO:0005886;GO:0045211;GO:0050811;GO:0097112;GO:1905702;GO:0007605;, C:dendrite; C:inhibitory synapse; C:integral component of membrane; C:membrane; C:plasma membrane; C:postsynaptic membrane;, F:GABA receptor binding;, P:gamma-aminobutyric acid receptor clustering; P:regulation of inhibitory synapse assembly; P:sensory perception of sound;|Q7Z7J7 A6NH76 Q29RV7,LHFPL tetraspan subfamily member 4 protein {ECO:0000312|HGNC:HGNC:29568},GABAA receptor regulatory Lhfpl4 {ECO:0000250|UniProtKB:Q5U4E0};Lipoma HMGIC fusion partner-like 4 protein {ECO:0000312|HGNC:HGNC:29568};, PF10242;, GO:0030425;GO:0060077;GO:0016021;GO:0016020;GO:0005886;GO:0045211;GO:0050811;GO:0097112;GO:1905702;GO:0007605;, C:dendrite; C:inhibitory synapse; C:integral component of membrane; C:membrane; C:plasma membrane; C:postsynaptic membrane;, F:GABA receptor binding;, P:gamma-aminobutyric acid receptor clustering; P:regulation of inhibitory synapse assembly; P:sensory perception of sound; scaffold51 indexed_genome mRNA 14982552 14997371 . + . ID=transcript_9617;Q9C0A6 Q6AI17 Q8WUB6 Q9H3X4 Q9H6V7 Q9H7S3 Q9NVI9,Histone-lysine N-methyltransferase SETD5 {ECO:0000305},SET domain-containing protein 5 {ECO:0000305};, PF00856;, GO:0000791;GO:0005654;GO:0005634;GO:0046975;GO:0046974;GO:0050890;GO:0016569;GO:0097198;GO:1902275;GO:0032784;GO:0035065;GO:0051963;, C:euchromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K9 specific);, P:cognition; P:covalent chromatin modification; P:histone H3-K36 trimethylation; P:regulation of chromatin organization; P:regulation of DNA-templated transcription, elongation; P:regulation of histone acetylation; P:regulation of synapse assembly;|Q9C0A6 Q6AI17 Q8WUB6 Q9H3X4 Q9H6V7 Q9H7S3 Q9NVI9,Histone-lysine N-methyltransferase SETD5 {ECO:0000305},SET domain-containing protein 5 {ECO:0000305};, PF00856;, GO:0000791;GO:0005654;GO:0005634;GO:0046975;GO:0046974;GO:0050890;GO:0016569;GO:0097198;GO:1902275;GO:0032784;GO:0035065;GO:0051963;, C:euchromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K9 specific);, P:cognition; P:covalent chromatin modification; P:histone H3-K36 trimethylation; P:regulation of chromatin organization; P:regulation of DNA-templated transcription, elongation; P:regulation of histone acetylation; P:regulation of synapse assembly; scaffold51 indexed_genome mRNA 14997405 15066148 . - . ID=transcript_9618;Q9C0A6 Q6AI17 Q8WUB6 Q9H3X4 Q9H6V7 Q9H7S3 Q9NVI9,Histone-lysine N-methyltransferase SETD5 {ECO:0000305},SET domain-containing protein 5 {ECO:0000305};, PF00856;, GO:0000791;GO:0005654;GO:0005634;GO:0046975;GO:0046974;GO:0050890;GO:0016569;GO:0097198;GO:1902275;GO:0032784;GO:0035065;GO:0051963;, C:euchromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K9 specific);, P:cognition; P:covalent chromatin modification; P:histone H3-K36 trimethylation; P:regulation of chromatin organization; P:regulation of DNA-templated transcription, elongation; P:regulation of histone acetylation; P:regulation of synapse assembly;|Q9C0A6 Q6AI17 Q8WUB6 Q9H3X4 Q9H6V7 Q9H7S3 Q9NVI9,Histone-lysine N-methyltransferase SETD5 {ECO:0000305},SET domain-containing protein 5 {ECO:0000305};, PF00856;, GO:0000791;GO:0005654;GO:0005634;GO:0046975;GO:0046974;GO:0050890;GO:0016569;GO:0097198;GO:1902275;GO:0032784;GO:0035065;GO:0051963;, C:euchromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K9 specific);, P:cognition; P:covalent chromatin modification; P:histone H3-K36 trimethylation; P:regulation of chromatin organization; P:regulation of DNA-templated transcription, elongation; P:regulation of histone acetylation; P:regulation of synapse assembly;|Q9C0A6 Q6AI17 Q8WUB6 Q9H3X4 Q9H6V7 Q9H7S3 Q9NVI9,Histone-lysine N-methyltransferase SETD5 {ECO:0000305},SET domain-containing protein 5 {ECO:0000305};, PF00856;, GO:0000791;GO:0005654;GO:0005634;GO:0046975;GO:0046974;GO:0050890;GO:0016569;GO:0097198;GO:1902275;GO:0032784;GO:0035065;GO:0051963;, C:euchromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K9 specific);, P:cognition; P:covalent chromatin modification; P:histone H3-K36 trimethylation; P:regulation of chromatin organization; P:regulation of DNA-templated transcription, elongation; P:regulation of histone acetylation; P:regulation of synapse assembly;|Q9C0A6 Q6AI17 Q8WUB6 Q9H3X4 Q9H6V7 Q9H7S3 Q9NVI9,Histone-lysine N-methyltransferase SETD5 {ECO:0000305},SET domain-containing protein 5 {ECO:0000305};, PF00856;, GO:0000791;GO:0005654;GO:0005634;GO:0046975;GO:0046974;GO:0050890;GO:0016569;GO:0097198;GO:1902275;GO:0032784;GO:0035065;GO:0051963;, C:euchromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K9 specific);, P:cognition; P:covalent chromatin modification; P:histone H3-K36 trimethylation; P:regulation of chromatin organization; P:regulation of DNA-templated transcription, elongation; P:regulation of histone acetylation; P:regulation of synapse assembly;|Q9C0A6 Q6AI17 Q8WUB6 Q9H3X4 Q9H6V7 Q9H7S3 Q9NVI9,Histone-lysine N-methyltransferase SETD5 {ECO:0000305},SET domain-containing protein 5 {ECO:0000305};, PF00856;, GO:0000791;GO:0005654;GO:0005634;GO:0046975;GO:0046974;GO:0050890;GO:0016569;GO:0097198;GO:1902275;GO:0032784;GO:0035065;GO:0051963;, C:euchromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K9 specific);, P:cognition; P:covalent chromatin modification; P:histone H3-K36 trimethylation; P:regulation of chromatin organization; P:regulation of DNA-templated transcription, elongation; P:regulation of histone acetylation; P:regulation of synapse assembly;|Q9C0A6 Q6AI17 Q8WUB6 Q9H3X4 Q9H6V7 Q9H7S3 Q9NVI9,Histone-lysine N-methyltransferase SETD5 {ECO:0000305},SET domain-containing protein 5 {ECO:0000305};, PF00856;, GO:0000791;GO:0005654;GO:0005634;GO:0046975;GO:0046974;GO:0050890;GO:0016569;GO:0097198;GO:1902275;GO:0032784;GO:0035065;GO:0051963;, C:euchromatin; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K9 specific);, P:cognition; P:covalent chromatin modification; P:histone H3-K36 trimethylation; P:regulation of chromatin organization; P:regulation of DNA-templated transcription, elongation; P:regulation of histone acetylation; P:regulation of synapse assembly; scaffold51 indexed_genome mRNA 15076861 15097680 . - . ID=transcript_9619;Q9BV44 Q9H8V6 Q9NVC1 Q9UFS3,THUMP domain-containing protein 3,, PF02926;PF01170;, GO:0005829;GO:0005730;GO:0003723;GO:0016423;GO:0030488;, C:cytosol; C:nucleolus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q9BV44 Q9H8V6 Q9NVC1 Q9UFS3,THUMP domain-containing protein 3,, PF02926;PF01170;, GO:0005829;GO:0005730;GO:0003723;GO:0016423;GO:0030488;, C:cytosol; C:nucleolus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q9BV44 Q9H8V6 Q9NVC1 Q9UFS3,THUMP domain-containing protein 3,, PF02926;PF01170;, GO:0005829;GO:0005730;GO:0003723;GO:0016423;GO:0030488;, C:cytosol; C:nucleolus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q9BV44 Q9H8V6 Q9NVC1 Q9UFS3,THUMP domain-containing protein 3,, PF02926;PF01170;, GO:0005829;GO:0005730;GO:0003723;GO:0016423;GO:0030488;, C:cytosol; C:nucleolus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q9BV44 Q9H8V6 Q9NVC1 Q9UFS3,THUMP domain-containing protein 3,, PF02926;PF01170;, GO:0005829;GO:0005730;GO:0003723;GO:0016423;GO:0030488;, C:cytosol; C:nucleolus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation; scaffold51 indexed_genome mRNA 15097899 15106426 . - . ID=transcript_9620;Q9BV44 Q9H8V6 Q9NVC1 Q9UFS3,THUMP domain-containing protein 3,, PF02926;PF01170;, GO:0005829;GO:0005730;GO:0003723;GO:0016423;GO:0030488;, C:cytosol; C:nucleolus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation;|Q9BV44 Q9H8V6 Q9NVC1 Q9UFS3,THUMP domain-containing protein 3,, PF02926;PF01170;, GO:0005829;GO:0005730;GO:0003723;GO:0016423;GO:0030488;, C:cytosol; C:nucleolus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:tRNA methylation; scaffold52 indexed_genome mRNA 1 4024 . + . ID=transcript_9621;O95153 O75111 Q8N5W3,Peripheral-type benzodiazepine receptor-associated protein 1,Peripheral benzodiazepine receptor-interacting protein;RIMS-binding protein 1;TSPO-associated protein 1 {ECO:0000312|HGNC:HGNC:16831};, PF07653;PF14604;, GO:0044305;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0030156;GO:0099626;GO:0006700;GO:0006836;, C:calyx of Held; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion;, F:benzodiazepine receptor binding; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:C21-steroid hormone biosynthetic process; P:neurotransmitter transport; scaffold52 indexed_genome mRNA 19636 25601 . - . ID=transcript_9622;P63272 B2R4X8 D3DTZ4 Q16550 Q62387 Q6ZP89,Transcription elongation factor SPT4,DRB sensitivity-inducing factor 14 kDa subunit;DRB sensitivity-inducing factor small subunit;, PF06093;, GO:0032044;GO:0005654;GO:0046982;GO:0000993;GO:0008270;GO:0006325;GO:0006397;GO:0032785;GO:0000122;GO:0034244;GO:0032786;GO:0045944;GO:0050434;GO:0034243;GO:0006355;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm;, F:protein heterodimerization activity; F:RNA polymerase II complex binding; F:zinc ion binding;, P:chromatin organization; P:mRNA processing; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription elongation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P63272 B2R4X8 D3DTZ4 Q16550 Q62387 Q6ZP89,Transcription elongation factor SPT4,DRB sensitivity-inducing factor 14 kDa subunit;DRB sensitivity-inducing factor small subunit;, PF06093;, GO:0032044;GO:0005654;GO:0046982;GO:0000993;GO:0008270;GO:0006325;GO:0006397;GO:0032785;GO:0000122;GO:0034244;GO:0032786;GO:0045944;GO:0050434;GO:0034243;GO:0006355;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm;, F:protein heterodimerization activity; F:RNA polymerase II complex binding; F:zinc ion binding;, P:chromatin organization; P:mRNA processing; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription elongation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P63272 B2R4X8 D3DTZ4 Q16550 Q62387 Q6ZP89,Transcription elongation factor SPT4,DRB sensitivity-inducing factor 14 kDa subunit;DRB sensitivity-inducing factor small subunit;, PF06093;, GO:0032044;GO:0005654;GO:0046982;GO:0000993;GO:0008270;GO:0006325;GO:0006397;GO:0032785;GO:0000122;GO:0034244;GO:0032786;GO:0045944;GO:0050434;GO:0034243;GO:0006355;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm;, F:protein heterodimerization activity; F:RNA polymerase II complex binding; F:zinc ion binding;, P:chromatin organization; P:mRNA processing; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription elongation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold52 indexed_genome mRNA 27775 91997 . - . ID=transcript_9623;Q68DV7 A8K4R2 B7Z443 B7Z5D5 B7Z5J5 Q65ZA4 Q6AI04 Q9NXD0,E3 ubiquitin-protein ligase RNF43,RING finger protein 43;RING-type E3 ubiquitin transferase RNF43 {ECO:0000305};, PF13639;PF18212;, GO:0005789;GO:0005887;GO:0005635;GO:0005886;GO:0005109;GO:0046872;GO:0061630;GO:0004842;GO:0007275;GO:0030178;GO:0016567;GO:0072089;GO:0006511;GO:0038018;GO:0016055;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope; C:plasma membrane;, F:frizzled binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:multicellular organism development; P:negative regulation of Wnt signaling pathway; P:protein ubiquitination; P:stem cell proliferation; P:ubiquitin-dependent protein catabolic process; P:Wnt receptor catabolic process; P:Wnt signaling pathway; scaffold52 indexed_genome mRNA 125526 126122 . - . ID=transcript_9624;Q4G112 Q08EH7 Q8N7V2,Heat shock factor protein 5,Heat shock transcription factor 5;, PF00447;, GO:0005634;GO:0003700;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold52 indexed_genome mRNA 156232 180440 . - . ID=transcript_9625;Q9NYA4 D3DTZ6 Q8IV27 Q9Y4D5,Myotubularin-related protein 4,FYVE domain-containing dual specificity protein phosphatase 2;Zinc finger FYVE domain-containing protein 11;, PF01363;PF06602;, GO:0005829;GO:0031901;GO:0005768;GO:0005615;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0030512;GO:0006661;GO:0046856;GO:0006470;GO:0010506;GO:0060304;GO:0014894;GO:0007179;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular space;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:negative regulation of transforming growth factor beta receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation; P:response to denervation involved in regulation of muscle adaptation; P:transforming growth factor beta receptor signaling pathway;|Q9NYA4 D3DTZ6 Q8IV27 Q9Y4D5,Myotubularin-related protein 4,FYVE domain-containing dual specificity protein phosphatase 2;Zinc finger FYVE domain-containing protein 11;, PF01363;PF06602;, GO:0005829;GO:0031901;GO:0005768;GO:0005615;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0030512;GO:0006661;GO:0046856;GO:0006470;GO:0010506;GO:0060304;GO:0014894;GO:0007179;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular space;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:negative regulation of transforming growth factor beta receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation; P:response to denervation involved in regulation of muscle adaptation; P:transforming growth factor beta receptor signaling pathway;|Q9NYA4 D3DTZ6 Q8IV27 Q9Y4D5,Myotubularin-related protein 4,FYVE domain-containing dual specificity protein phosphatase 2;Zinc finger FYVE domain-containing protein 11;, PF01363;PF06602;, GO:0005829;GO:0031901;GO:0005768;GO:0005615;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0030512;GO:0006661;GO:0046856;GO:0006470;GO:0010506;GO:0060304;GO:0014894;GO:0007179;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular space;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:negative regulation of transforming growth factor beta receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation; P:response to denervation involved in regulation of muscle adaptation; P:transforming growth factor beta receptor signaling pathway;|Q9NYA4 D3DTZ6 Q8IV27 Q9Y4D5,Myotubularin-related protein 4,FYVE domain-containing dual specificity protein phosphatase 2;Zinc finger FYVE domain-containing protein 11;, PF01363;PF06602;, GO:0005829;GO:0031901;GO:0005768;GO:0005615;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0030512;GO:0006661;GO:0046856;GO:0006470;GO:0010506;GO:0060304;GO:0014894;GO:0007179;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular space;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:negative regulation of transforming growth factor beta receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation; P:response to denervation involved in regulation of muscle adaptation; P:transforming growth factor beta receptor signaling pathway;|Q9NYA4 D3DTZ6 Q8IV27 Q9Y4D5,Myotubularin-related protein 4,FYVE domain-containing dual specificity protein phosphatase 2;Zinc finger FYVE domain-containing protein 11;, PF01363;PF06602;, GO:0005829;GO:0031901;GO:0005768;GO:0005615;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0030512;GO:0006661;GO:0046856;GO:0006470;GO:0010506;GO:0060304;GO:0014894;GO:0007179;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular space;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:negative regulation of transforming growth factor beta receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation; P:response to denervation involved in regulation of muscle adaptation; P:transforming growth factor beta receptor signaling pathway;|Q9NYA4 D3DTZ6 Q8IV27 Q9Y4D5,Myotubularin-related protein 4,FYVE domain-containing dual specificity protein phosphatase 2;Zinc finger FYVE domain-containing protein 11;, PF01363;PF06602;, GO:0005829;GO:0031901;GO:0005768;GO:0005615;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0030512;GO:0006661;GO:0046856;GO:0006470;GO:0010506;GO:0060304;GO:0014894;GO:0007179;, C:cytosol; C:early endosome membrane; C:endosome; C:extracellular space;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:negative regulation of transforming growth factor beta receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation; P:response to denervation involved in regulation of muscle adaptation; P:transforming growth factor beta receptor signaling pathway; scaffold52 indexed_genome mRNA 182034 190879 . - . ID=transcript_9626;Q9H315 Q9UM58,Septin-4,Apoptosis-related protein in the TGF-beta signaling pathway;Bradeion beta;Brain protein H5;CE5B3 beta;Cell division control-related protein 2;Cerebral protein 7;Peanut-like protein 2;, PF00735;, GO:0032153;GO:0005829;GO:0015630;GO:0005741;GO:0005739;GO:0005654;GO:0005634;GO:0031105;GO:0005940;GO:0097227;GO:0008021;GO:0005525;GO:0003924;GO:0042802;GO:0000287;GO:0060090;GO:0005198;GO:0006915;GO:0030154;GO:0034613;GO:0061640;GO:0043065;GO:2001244;GO:0031398;GO:0042981;GO:0017157;GO:0007283;, C:cell division site; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:septin complex; C:septin ring; C:sperm annulus; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:magnesium ion binding; F:molecular adaptor activity; F:structural molecule activity;, P:apoptotic process; P:cell differentiation; P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of protein ubiquitination; P:regulation of apoptotic process; P:regulation of exocytosis; P:spermatogenesis;|Q9H315 Q9UM58,Septin-4,Apoptosis-related protein in the TGF-beta signaling pathway;Bradeion beta;Brain protein H5;CE5B3 beta;Cell division control-related protein 2;Cerebral protein 7;Peanut-like protein 2;, PF00735;, GO:0032153;GO:0005829;GO:0015630;GO:0005741;GO:0005739;GO:0005654;GO:0005634;GO:0031105;GO:0005940;GO:0097227;GO:0008021;GO:0005525;GO:0003924;GO:0042802;GO:0000287;GO:0060090;GO:0005198;GO:0006915;GO:0030154;GO:0034613;GO:0061640;GO:0043065;GO:2001244;GO:0031398;GO:0042981;GO:0017157;GO:0007283;, C:cell division site; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:septin complex; C:septin ring; C:sperm annulus; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:magnesium ion binding; F:molecular adaptor activity; F:structural molecule activity;, P:apoptotic process; P:cell differentiation; P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of protein ubiquitination; P:regulation of apoptotic process; P:regulation of exocytosis; P:spermatogenesis;|Q9H315 Q9UM58,Septin-4,Apoptosis-related protein in the TGF-beta signaling pathway;Bradeion beta;Brain protein H5;CE5B3 beta;Cell division control-related protein 2;Cerebral protein 7;Peanut-like protein 2;, PF00735;, GO:0032153;GO:0005829;GO:0015630;GO:0005741;GO:0005739;GO:0005654;GO:0005634;GO:0031105;GO:0005940;GO:0097227;GO:0008021;GO:0005525;GO:0003924;GO:0042802;GO:0000287;GO:0060090;GO:0005198;GO:0006915;GO:0030154;GO:0034613;GO:0061640;GO:0043065;GO:2001244;GO:0031398;GO:0042981;GO:0017157;GO:0007283;, C:cell division site; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:septin complex; C:septin ring; C:sperm annulus; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:magnesium ion binding; F:molecular adaptor activity; F:structural molecule activity;, P:apoptotic process; P:cell differentiation; P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of protein ubiquitination; P:regulation of apoptotic process; P:regulation of exocytosis; P:spermatogenesis;|Q9H315 Q9UM58,Septin-4,Apoptosis-related protein in the TGF-beta signaling pathway;Bradeion beta;Brain protein H5;CE5B3 beta;Cell division control-related protein 2;Cerebral protein 7;Peanut-like protein 2;, PF00735;, GO:0032153;GO:0005829;GO:0015630;GO:0005741;GO:0005739;GO:0005654;GO:0005634;GO:0031105;GO:0005940;GO:0097227;GO:0008021;GO:0005525;GO:0003924;GO:0042802;GO:0000287;GO:0060090;GO:0005198;GO:0006915;GO:0030154;GO:0034613;GO:0061640;GO:0043065;GO:2001244;GO:0031398;GO:0042981;GO:0017157;GO:0007283;, C:cell division site; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:septin complex; C:septin ring; C:sperm annulus; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:magnesium ion binding; F:molecular adaptor activity; F:structural molecule activity;, P:apoptotic process; P:cell differentiation; P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of protein ubiquitination; P:regulation of apoptotic process; P:regulation of exocytosis; P:spermatogenesis;|Q9H315 Q9UM58,Septin-4,Apoptosis-related protein in the TGF-beta signaling pathway;Bradeion beta;Brain protein H5;CE5B3 beta;Cell division control-related protein 2;Cerebral protein 7;Peanut-like protein 2;, PF00735;, GO:0032153;GO:0005829;GO:0015630;GO:0005741;GO:0005739;GO:0005654;GO:0005634;GO:0031105;GO:0005940;GO:0097227;GO:0008021;GO:0005525;GO:0003924;GO:0042802;GO:0000287;GO:0060090;GO:0005198;GO:0006915;GO:0030154;GO:0034613;GO:0061640;GO:0043065;GO:2001244;GO:0031398;GO:0042981;GO:0017157;GO:0007283;, C:cell division site; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:septin complex; C:septin ring; C:sperm annulus; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:magnesium ion binding; F:molecular adaptor activity; F:structural molecule activity;, P:apoptotic process; P:cell differentiation; P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of protein ubiquitination; P:regulation of apoptotic process; P:regulation of exocytosis; P:spermatogenesis;|Q9H315 Q9UM58,Septin-4,Apoptosis-related protein in the TGF-beta signaling pathway;Bradeion beta;Brain protein H5;CE5B3 beta;Cell division control-related protein 2;Cerebral protein 7;Peanut-like protein 2;, PF00735;, GO:0032153;GO:0005829;GO:0015630;GO:0005741;GO:0005739;GO:0005654;GO:0005634;GO:0031105;GO:0005940;GO:0097227;GO:0008021;GO:0005525;GO:0003924;GO:0042802;GO:0000287;GO:0060090;GO:0005198;GO:0006915;GO:0030154;GO:0034613;GO:0061640;GO:0043065;GO:2001244;GO:0031398;GO:0042981;GO:0017157;GO:0007283;, C:cell division site; C:cytosol; C:microtubule cytoskeleton; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:septin complex; C:septin ring; C:sperm annulus; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:magnesium ion binding; F:molecular adaptor activity; F:structural molecule activity;, P:apoptotic process; P:cell differentiation; P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of protein ubiquitination; P:regulation of apoptotic process; P:regulation of exocytosis; P:spermatogenesis; scaffold52 indexed_genome mRNA 213763 247192 . - . ID=transcript_9627;Q8IWB6 A6NH19 Q7RTP3 Q8ND97 Q9BXT9,Inactive serine/threonine-protein kinase TEX14,Protein kinase-like protein SgK307;Sugen kinase 307;Testis-expressed sequence 14;Testis-expressed sequence 14 protein;, PF12796;PF07714;, GO:0000777;GO:0005737;GO:0070062;GO:0045171;GO:0000776;GO:0030496;GO:0005524;GO:0004672;GO:0019901;GO:0008608;GO:0051301;GO:1990830;GO:0043063;GO:0007140;GO:0051306;GO:0007094;GO:0032466;GO:0032091;, C:condensed chromosome kinetochore; C:cytoplasm; C:extracellular exosome; C:intercellular bridge; C:kinetochore; C:midbody;, F:ATP binding; F:protein kinase activity; F:protein kinase binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:cellular response to leukemia inhibitory factor; P:intercellular bridge organization; P:male meiotic nuclear division; P:mitotic sister chromatid separation; P:mitotic spindle assembly checkpoint; P:negative regulation of cytokinesis; P:negative regulation of protein binding;|Q8IWB6 A6NH19 Q7RTP3 Q8ND97 Q9BXT9,Inactive serine/threonine-protein kinase TEX14,Protein kinase-like protein SgK307;Sugen kinase 307;Testis-expressed sequence 14;Testis-expressed sequence 14 protein;, PF12796;PF07714;, GO:0000777;GO:0005737;GO:0070062;GO:0045171;GO:0000776;GO:0030496;GO:0005524;GO:0004672;GO:0019901;GO:0008608;GO:0051301;GO:1990830;GO:0043063;GO:0007140;GO:0051306;GO:0007094;GO:0032466;GO:0032091;, C:condensed chromosome kinetochore; C:cytoplasm; C:extracellular exosome; C:intercellular bridge; C:kinetochore; C:midbody;, F:ATP binding; F:protein kinase activity; F:protein kinase binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:cellular response to leukemia inhibitory factor; P:intercellular bridge organization; P:male meiotic nuclear division; P:mitotic sister chromatid separation; P:mitotic spindle assembly checkpoint; P:negative regulation of cytokinesis; P:negative regulation of protein binding;|Q8IWB6 A6NH19 Q7RTP3 Q8ND97 Q9BXT9,Inactive serine/threonine-protein kinase TEX14,Protein kinase-like protein SgK307;Sugen kinase 307;Testis-expressed sequence 14;Testis-expressed sequence 14 protein;, PF12796;PF07714;, GO:0000777;GO:0005737;GO:0070062;GO:0045171;GO:0000776;GO:0030496;GO:0005524;GO:0004672;GO:0019901;GO:0008608;GO:0051301;GO:1990830;GO:0043063;GO:0007140;GO:0051306;GO:0007094;GO:0032466;GO:0032091;, C:condensed chromosome kinetochore; C:cytoplasm; C:extracellular exosome; C:intercellular bridge; C:kinetochore; C:midbody;, F:ATP binding; F:protein kinase activity; F:protein kinase binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:cellular response to leukemia inhibitory factor; P:intercellular bridge organization; P:male meiotic nuclear division; P:mitotic sister chromatid separation; P:mitotic spindle assembly checkpoint; P:negative regulation of cytokinesis; P:negative regulation of protein binding; scaffold52 indexed_genome mRNA 254038 254659 . + . ID=transcript_9628;Q8IWB6 A6NH19 Q7RTP3 Q8ND97 Q9BXT9,Inactive serine/threonine-protein kinase TEX14,Protein kinase-like protein SgK307;Sugen kinase 307;Testis-expressed sequence 14;Testis-expressed sequence 14 protein;, PF12796;PF07714;, GO:0000777;GO:0005737;GO:0070062;GO:0045171;GO:0000776;GO:0030496;GO:0005524;GO:0004672;GO:0019901;GO:0008608;GO:0051301;GO:1990830;GO:0043063;GO:0007140;GO:0051306;GO:0007094;GO:0032466;GO:0032091;, C:condensed chromosome kinetochore; C:cytoplasm; C:extracellular exosome; C:intercellular bridge; C:kinetochore; C:midbody;, F:ATP binding; F:protein kinase activity; F:protein kinase binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:cellular response to leukemia inhibitory factor; P:intercellular bridge organization; P:male meiotic nuclear division; P:mitotic sister chromatid separation; P:mitotic spindle assembly checkpoint; P:negative regulation of cytokinesis; P:negative regulation of protein binding; scaffold52 indexed_genome mRNA 370769 372959 . + . ID=transcript_9629;O43502 O43503 Q3B783,DNA repair protein RAD51 homolog 3,RAD51 homolog C;RAD51-like protein 2;, PF08423;, GO:0030054;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033063;GO:0033065;GO:0005657;GO:0005524;GO:0008821;GO:0003677;GO:0008094;GO:0007596;GO:0006310;GO:0006281;GO:0000724;GO:0007066;GO:0007141;GO:0000707;GO:0010971;GO:0007131;GO:0007062;GO:0007283;GO:0000722;, C:cell junction; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:crossover junction endodeoxyribonuclease activity; F:DNA binding; F:DNA-dependent ATPase activity;, P:blood coagulation; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:female meiosis sister chromatid cohesion; P:male meiosis I; P:meiotic DNA recombinase assembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:reciprocal meiotic recombination; P:sister chromatid cohesion; P:spermatogenesis; P:telomere maintenance via recombination;|O43502 O43503 Q3B783,DNA repair protein RAD51 homolog 3,RAD51 homolog C;RAD51-like protein 2;, PF08423;, GO:0030054;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033063;GO:0033065;GO:0005657;GO:0005524;GO:0008821;GO:0003677;GO:0008094;GO:0007596;GO:0006310;GO:0006281;GO:0000724;GO:0007066;GO:0007141;GO:0000707;GO:0010971;GO:0007131;GO:0007062;GO:0007283;GO:0000722;, C:cell junction; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:crossover junction endodeoxyribonuclease activity; F:DNA binding; F:DNA-dependent ATPase activity;, P:blood coagulation; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:female meiosis sister chromatid cohesion; P:male meiosis I; P:meiotic DNA recombinase assembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:reciprocal meiotic recombination; P:sister chromatid cohesion; P:spermatogenesis; P:telomere maintenance via recombination; scaffold52 indexed_genome mRNA 373226 411435 . + . ID=transcript_9630;O43502 O43503 Q3B783,DNA repair protein RAD51 homolog 3,RAD51 homolog C;RAD51-like protein 2;, PF08423;, GO:0030054;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033063;GO:0033065;GO:0005657;GO:0005524;GO:0008821;GO:0003677;GO:0008094;GO:0007596;GO:0006310;GO:0006281;GO:0000724;GO:0007066;GO:0007141;GO:0000707;GO:0010971;GO:0007131;GO:0007062;GO:0007283;GO:0000722;, C:cell junction; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:crossover junction endodeoxyribonuclease activity; F:DNA binding; F:DNA-dependent ATPase activity;, P:blood coagulation; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:female meiosis sister chromatid cohesion; P:male meiosis I; P:meiotic DNA recombinase assembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:reciprocal meiotic recombination; P:sister chromatid cohesion; P:spermatogenesis; P:telomere maintenance via recombination;|O43502 O43503 Q3B783,DNA repair protein RAD51 homolog 3,RAD51 homolog C;RAD51-like protein 2;, PF08423;, GO:0030054;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033063;GO:0033065;GO:0005657;GO:0005524;GO:0008821;GO:0003677;GO:0008094;GO:0007596;GO:0006310;GO:0006281;GO:0000724;GO:0007066;GO:0007141;GO:0000707;GO:0010971;GO:0007131;GO:0007062;GO:0007283;GO:0000722;, C:cell junction; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:crossover junction endodeoxyribonuclease activity; F:DNA binding; F:DNA-dependent ATPase activity;, P:blood coagulation; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:female meiosis sister chromatid cohesion; P:male meiosis I; P:meiotic DNA recombinase assembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:reciprocal meiotic recombination; P:sister chromatid cohesion; P:spermatogenesis; P:telomere maintenance via recombination;|O43502 O43503 Q3B783,DNA repair protein RAD51 homolog 3,RAD51 homolog C;RAD51-like protein 2;, PF08423;, GO:0030054;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033063;GO:0033065;GO:0005657;GO:0005524;GO:0008821;GO:0003677;GO:0008094;GO:0007596;GO:0006310;GO:0006281;GO:0000724;GO:0007066;GO:0007141;GO:0000707;GO:0010971;GO:0007131;GO:0007062;GO:0007283;GO:0000722;, C:cell junction; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:crossover junction endodeoxyribonuclease activity; F:DNA binding; F:DNA-dependent ATPase activity;, P:blood coagulation; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:female meiosis sister chromatid cohesion; P:male meiosis I; P:meiotic DNA recombinase assembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:reciprocal meiotic recombination; P:sister chromatid cohesion; P:spermatogenesis; P:telomere maintenance via recombination;|O43502 O43503 Q3B783,DNA repair protein RAD51 homolog 3,RAD51 homolog C;RAD51-like protein 2;, PF08423;, GO:0030054;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033063;GO:0033065;GO:0005657;GO:0005524;GO:0008821;GO:0003677;GO:0008094;GO:0007596;GO:0006310;GO:0006281;GO:0000724;GO:0007066;GO:0007141;GO:0000707;GO:0010971;GO:0007131;GO:0007062;GO:0007283;GO:0000722;, C:cell junction; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:crossover junction endodeoxyribonuclease activity; F:DNA binding; F:DNA-dependent ATPase activity;, P:blood coagulation; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:female meiosis sister chromatid cohesion; P:male meiosis I; P:meiotic DNA recombinase assembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:reciprocal meiotic recombination; P:sister chromatid cohesion; P:spermatogenesis; P:telomere maintenance via recombination;|O43502 O43503 Q3B783,DNA repair protein RAD51 homolog 3,RAD51 homolog C;RAD51-like protein 2;, PF08423;, GO:0030054;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033063;GO:0033065;GO:0005657;GO:0005524;GO:0008821;GO:0003677;GO:0008094;GO:0007596;GO:0006310;GO:0006281;GO:0000724;GO:0007066;GO:0007141;GO:0000707;GO:0010971;GO:0007131;GO:0007062;GO:0007283;GO:0000722;, C:cell junction; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:crossover junction endodeoxyribonuclease activity; F:DNA binding; F:DNA-dependent ATPase activity;, P:blood coagulation; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:female meiosis sister chromatid cohesion; P:male meiosis I; P:meiotic DNA recombinase assembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:reciprocal meiotic recombination; P:sister chromatid cohesion; P:spermatogenesis; P:telomere maintenance via recombination;|O43502 O43503 Q3B783,DNA repair protein RAD51 homolog 3,RAD51 homolog C;RAD51-like protein 2;, PF08423;, GO:0030054;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033063;GO:0033065;GO:0005657;GO:0005524;GO:0008821;GO:0003677;GO:0008094;GO:0007596;GO:0006310;GO:0006281;GO:0000724;GO:0007066;GO:0007141;GO:0000707;GO:0010971;GO:0007131;GO:0007062;GO:0007283;GO:0000722;, C:cell junction; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:crossover junction endodeoxyribonuclease activity; F:DNA binding; F:DNA-dependent ATPase activity;, P:blood coagulation; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:female meiosis sister chromatid cohesion; P:male meiosis I; P:meiotic DNA recombinase assembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:reciprocal meiotic recombination; P:sister chromatid cohesion; P:spermatogenesis; P:telomere maintenance via recombination;|O43502 O43503 Q3B783,DNA repair protein RAD51 homolog 3,RAD51 homolog C;RAD51-like protein 2;, PF08423;, GO:0030054;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033063;GO:0033065;GO:0005657;GO:0005524;GO:0008821;GO:0003677;GO:0008094;GO:0007596;GO:0006310;GO:0006281;GO:0000724;GO:0007066;GO:0007141;GO:0000707;GO:0010971;GO:0007131;GO:0007062;GO:0007283;GO:0000722;, C:cell junction; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:crossover junction endodeoxyribonuclease activity; F:DNA binding; F:DNA-dependent ATPase activity;, P:blood coagulation; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:female meiosis sister chromatid cohesion; P:male meiosis I; P:meiotic DNA recombinase assembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:reciprocal meiotic recombination; P:sister chromatid cohesion; P:spermatogenesis; P:telomere maintenance via recombination;|O43502 O43503 Q3B783,DNA repair protein RAD51 homolog 3,RAD51 homolog C;RAD51-like protein 2;, PF08423;, GO:0030054;GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033063;GO:0033065;GO:0005657;GO:0005524;GO:0008821;GO:0003677;GO:0008094;GO:0007596;GO:0006310;GO:0006281;GO:0000724;GO:0007066;GO:0007141;GO:0000707;GO:0010971;GO:0007131;GO:0007062;GO:0007283;GO:0000722;, C:cell junction; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:crossover junction endodeoxyribonuclease activity; F:DNA binding; F:DNA-dependent ATPase activity;, P:blood coagulation; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:female meiosis sister chromatid cohesion; P:male meiosis I; P:meiotic DNA recombinase assembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:reciprocal meiotic recombination; P:sister chromatid cohesion; P:spermatogenesis; P:telomere maintenance via recombination; scaffold52 indexed_genome mRNA 623151 650581 . + . ID=transcript_9631;Q8WY54 A7E2X1 Q68DW1 Q7LAF3 Q9UPT0,Protein phosphatase 1E,Ca(2+)/calmodulin-dependent protein kinase phosphatase N;CaMKP-nucleus;Partner of PIX 1;Partner of PIX-alpha;, PF00481;, GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0004724;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0035690;GO:0006469;GO:0035970;GO:0051496;GO:0006470;, C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:cellular response to drug; P:negative regulation of protein kinase activity; P:peptidyl-threonine dephosphorylation; P:positive regulation of stress fiber assembly; P:protein dephosphorylation; scaffold52 indexed_genome mRNA 660679 663633 . - . ID=transcript_9632;O94972 A8K0V9 A8K8U4 A8MZ79 B4DGZ3 F8WEE6 Q7Z3E6 Q8IYF7 Q8WYF7,E3 ubiquitin-protein ligase TRIM37 {ECO:0000305},Mulibrey nanism protein {ECO:0000303|PubMed:10888877};RING-type E3 ubiquitin transferase TRIM37 {ECO:0000305};Tripartite motif-containing protein 37 {ECO:0000305};, PF00917;PF00643;, GO:0016235;GO:0005737;GO:0005829;GO:0048471;GO:0005777;GO:0003682;GO:0042803;GO:0003713;GO:0005164;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:0070842;GO:0035518;GO:0036353;GO:0046600;GO:0032088;GO:0000122;GO:0051091;GO:0051092;GO:0051865;, C:aggresome; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm; C:peroxisome;, F:chromatin binding; F:protein homodimerization activity; F:transcription coactivator activity; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:aggresome assembly; P:histone H2A monoubiquitination; P:histone H2A-K119 monoubiquitination; P:negative regulation of centriole replication; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoubiquitination; scaffold52 indexed_genome mRNA 674618 794027 . + . ID=transcript_9633;O94972 A8K0V9 A8K8U4 A8MZ79 B4DGZ3 F8WEE6 Q7Z3E6 Q8IYF7 Q8WYF7,E3 ubiquitin-protein ligase TRIM37 {ECO:0000305},Mulibrey nanism protein {ECO:0000303|PubMed:10888877};RING-type E3 ubiquitin transferase TRIM37 {ECO:0000305};Tripartite motif-containing protein 37 {ECO:0000305};, PF00917;PF00643;, GO:0016235;GO:0005737;GO:0005829;GO:0048471;GO:0005777;GO:0003682;GO:0042803;GO:0003713;GO:0005164;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:0070842;GO:0035518;GO:0036353;GO:0046600;GO:0032088;GO:0000122;GO:0051091;GO:0051092;GO:0051865;, C:aggresome; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm; C:peroxisome;, F:chromatin binding; F:protein homodimerization activity; F:transcription coactivator activity; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:aggresome assembly; P:histone H2A monoubiquitination; P:histone H2A-K119 monoubiquitination; P:negative regulation of centriole replication; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoubiquitination;|O94972 A8K0V9 A8K8U4 A8MZ79 B4DGZ3 F8WEE6 Q7Z3E6 Q8IYF7 Q8WYF7,E3 ubiquitin-protein ligase TRIM37 {ECO:0000305},Mulibrey nanism protein {ECO:0000303|PubMed:10888877};RING-type E3 ubiquitin transferase TRIM37 {ECO:0000305};Tripartite motif-containing protein 37 {ECO:0000305};, PF00917;PF00643;, GO:0016235;GO:0005737;GO:0005829;GO:0048471;GO:0005777;GO:0003682;GO:0042803;GO:0003713;GO:0005164;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:0070842;GO:0035518;GO:0036353;GO:0046600;GO:0032088;GO:0000122;GO:0051091;GO:0051092;GO:0051865;, C:aggresome; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm; C:peroxisome;, F:chromatin binding; F:protein homodimerization activity; F:transcription coactivator activity; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:aggresome assembly; P:histone H2A monoubiquitination; P:histone H2A-K119 monoubiquitination; P:negative regulation of centriole replication; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoubiquitination;|O94972 A8K0V9 A8K8U4 A8MZ79 B4DGZ3 F8WEE6 Q7Z3E6 Q8IYF7 Q8WYF7,E3 ubiquitin-protein ligase TRIM37 {ECO:0000305},Mulibrey nanism protein {ECO:0000303|PubMed:10888877};RING-type E3 ubiquitin transferase TRIM37 {ECO:0000305};Tripartite motif-containing protein 37 {ECO:0000305};, PF00917;PF00643;, GO:0016235;GO:0005737;GO:0005829;GO:0048471;GO:0005777;GO:0003682;GO:0042803;GO:0003713;GO:0005164;GO:0061630;GO:0031625;GO:0004842;GO:0008270;GO:0070842;GO:0035518;GO:0036353;GO:0046600;GO:0032088;GO:0000122;GO:0051091;GO:0051092;GO:0051865;, C:aggresome; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm; C:peroxisome;, F:chromatin binding; F:protein homodimerization activity; F:transcription coactivator activity; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:aggresome assembly; P:histone H2A monoubiquitination; P:histone H2A-K119 monoubiquitination; P:negative regulation of centriole replication; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoubiquitination; scaffold52 indexed_genome mRNA 799555 815464 . - . ID=transcript_9634;Q8WVK7 A6NIL3 B3KPL3 E9PCB8,Spindle and kinetochore-associated protein 2,Protein FAM33A;, PF16740;, GO:0000940;GO:0005829;GO:0005876;GO:0008017;GO:0051301;GO:0007059;GO:0000278;GO:0007052;GO:0031110;, C:condensed chromosome outer kinetochore; C:cytosol; C:spindle microtubule;, F:microtubule binding;, P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:mitotic spindle organization; P:regulation of microtubule polymerization or depolymerization;|Q8WVK7 A6NIL3 B3KPL3 E9PCB8,Spindle and kinetochore-associated protein 2,Protein FAM33A;, PF16740;, GO:0000940;GO:0005829;GO:0005876;GO:0008017;GO:0051301;GO:0007059;GO:0000278;GO:0007052;GO:0031110;, C:condensed chromosome outer kinetochore; C:cytosol; C:spindle microtubule;, F:microtubule binding;, P:cell division; P:chromosome segregation; P:mitotic cell cycle; P:mitotic spindle organization; P:regulation of microtubule polymerization or depolymerization; scaffold52 indexed_genome mRNA 866588 871734 . + . ID=transcript_9635;Q8ND04 Q8N5U5 Q8TDN0 Q9H5P5 Q9NVQ1,Protein SMG8,Amplified in breast cancer gene 2 protein;Protein smg-8 homolog;, PF10220;, GO:0005829;GO:0000184;GO:0045859;, C:cytosol;, , P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of protein kinase activity; scaffold52 indexed_genome mRNA 892940 947366 . + . ID=transcript_9636;Q8N9F7 A8W735 Q56VR1 Q8N4E3,Lysophospholipase D GDPD1 {ECO:0000305},Glycerophosphodiester phosphodiesterase 4 {ECO:0000303|PubMed:18991142};Glycerophosphodiester phosphodiesterase domain-containing protein 1;, PF03009;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0048471;GO:0004622;GO:0046872;GO:0008081;GO:0046475;GO:0070291;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm;, F:lysophospholipase activity; F:metal ion binding; F:phosphoric diester hydrolase activity;, P:glycerophospholipid catabolic process; P:N-acylethanolamine metabolic process;|Q8N9F7 A8W735 Q56VR1 Q8N4E3,Lysophospholipase D GDPD1 {ECO:0000305},Glycerophosphodiester phosphodiesterase 4 {ECO:0000303|PubMed:18991142};Glycerophosphodiester phosphodiesterase domain-containing protein 1;, PF03009;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0048471;GO:0004622;GO:0046872;GO:0008081;GO:0046475;GO:0070291;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm;, F:lysophospholipase activity; F:metal ion binding; F:phosphoric diester hydrolase activity;, P:glycerophospholipid catabolic process; P:N-acylethanolamine metabolic process;|Q8N9F7 A8W735 Q56VR1 Q8N4E3,Lysophospholipase D GDPD1 {ECO:0000305},Glycerophosphodiester phosphodiesterase 4 {ECO:0000303|PubMed:18991142};Glycerophosphodiester phosphodiesterase domain-containing protein 1;, PF03009;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0048471;GO:0004622;GO:0046872;GO:0008081;GO:0046475;GO:0070291;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm;, F:lysophospholipase activity; F:metal ion binding; F:phosphoric diester hydrolase activity;, P:glycerophospholipid catabolic process; P:N-acylethanolamine metabolic process;|Q8N9F7 A8W735 Q56VR1 Q8N4E3,Lysophospholipase D GDPD1 {ECO:0000305},Glycerophosphodiester phosphodiesterase 4 {ECO:0000303|PubMed:18991142};Glycerophosphodiester phosphodiesterase domain-containing protein 1;, PF03009;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0048471;GO:0004622;GO:0046872;GO:0008081;GO:0046475;GO:0070291;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:perinuclear region of cytoplasm;, F:lysophospholipase activity; F:metal ion binding; F:phosphoric diester hydrolase activity;, P:glycerophospholipid catabolic process; P:N-acylethanolamine metabolic process;|P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold52 indexed_genome mRNA 1005684 1076313 . + . ID=transcript_9637;Q96QA6 A0PK16 A2RUG4 Q65ZA0 Q8N3W2,Protein yippee-like 2,, PF03226;, GO:0005730;GO:0046872;, C:nucleolus;, F:metal ion binding;|O60688 Q65ZA1 Q6GLI6,Protein yippee-like 1,, PF03226;, GO:0005634;GO:0046872;, C:nucleus;, F:metal ion binding;|Q96QA6 A0PK16 A2RUG4 Q65ZA0 Q8N3W2,Protein yippee-like 2,, PF03226;, GO:0005730;GO:0046872;, C:nucleolus;, F:metal ion binding;|Q96QA6 A0PK16 A2RUG4 Q65ZA0 Q8N3W2,Protein yippee-like 2,, PF03226;, GO:0005730;GO:0046872;, C:nucleolus;, F:metal ion binding; scaffold52 indexed_genome mRNA 1237742 1283214 . + . ID=transcript_9638;Q8IX18 B3KTJ5 C9JR60 Q5JPH4 Q8TC86 Q8WY53 Q9BXM1 Q9H6M9,Probable ATP-dependent RNA helicase DHX40,DEAH box protein 40;Protein PAD;, PF00270;PF04408;PF00271;PF07717;, GO:0005524;GO:0003723;GO:0003724;, , F:ATP binding; F:RNA binding; F:RNA helicase activity; scaffold52 indexed_genome mRNA 1296543 1489790 . + . ID=transcript_9639;Q00610 D3DU00 Q6N0A0 Q86TF2,Clathrin heavy chain 1 {ECO:0000303|PubMed:26822784, ECO:0000303|PubMed:29100083},Clathrin heavy chain on chromosome 17;, PF00637;PF09268;PF01394;, GO:0030118;GO:0030132;GO:0030130;GO:0071439;GO:0045334;GO:0030669;GO:0030136;GO:0005829;GO:0036020;GO:0005768;GO:0070062;GO:1903561;GO:0005925;GO:0005764;GO:0042470;GO:0016020;GO:0072686;GO:1990498;GO:0005886;GO:0032991;GO:0005819;GO:0032588;GO:0032051;GO:0097718;GO:0003725;GO:0050750;GO:0019901;GO:0003723;GO:0005198;GO:1990381;GO:0150093;GO:0019886;GO:0006914;GO:0051301;GO:0048268;GO:0072583;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0000278;GO:1900126;GO:1903077;GO:0001649;GO:0006892;GO:0031623;GO:0006898;GO:0060236;GO:0042147;GO:0033572;GO:0060071;, C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated vesicle; C:cytosol; C:endolysosome membrane; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:focal adhesion; C:lysosome; C:melanosome; C:membrane; C:mitotic spindle; C:mitotic spindle microtubule; C:plasma membrane; C:protein-containing complex; C:spindle; C:trans-Golgi network membrane;, F:clathrin light chain binding; F:disordered domain specific binding; F:double-stranded RNA binding; F:low-density lipoprotein particle receptor binding; F:protein kinase binding; F:RNA binding; F:structural molecule activity; F:ubiquitin-specific protease binding;, P:amyloid-beta clearance by transcytosis; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:autophagy; P:cell division; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:mitotic cell cycle; P:negative regulation of hyaluronan biosynthetic process; P:negative regulation of protein localization to plasma membrane; P:osteoblast differentiation; P:post-Golgi vesicle-mediated transport; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of mitotic spindle organization; P:retrograde transport, endosome to Golgi; P:transferrin transport; P:Wnt signaling pathway, planar cell polarity pathway;|Q00610 D3DU00 Q6N0A0 Q86TF2,Clathrin heavy chain 1 {ECO:0000303|PubMed:26822784, ECO:0000303|PubMed:29100083},Clathrin heavy chain on chromosome 17;, PF00637;PF09268;PF01394;, GO:0030118;GO:0030132;GO:0030130;GO:0071439;GO:0045334;GO:0030669;GO:0030136;GO:0005829;GO:0036020;GO:0005768;GO:0070062;GO:1903561;GO:0005925;GO:0005764;GO:0042470;GO:0016020;GO:0072686;GO:1990498;GO:0005886;GO:0032991;GO:0005819;GO:0032588;GO:0032051;GO:0097718;GO:0003725;GO:0050750;GO:0019901;GO:0003723;GO:0005198;GO:1990381;GO:0150093;GO:0019886;GO:0006914;GO:0051301;GO:0048268;GO:0072583;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0000278;GO:1900126;GO:1903077;GO:0001649;GO:0006892;GO:0031623;GO:0006898;GO:0060236;GO:0042147;GO:0033572;GO:0060071;, C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated vesicle; C:cytosol; C:endolysosome membrane; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:focal adhesion; C:lysosome; C:melanosome; C:membrane; C:mitotic spindle; C:mitotic spindle microtubule; C:plasma membrane; C:protein-containing complex; C:spindle; C:trans-Golgi network membrane;, F:clathrin light chain binding; F:disordered domain specific binding; F:double-stranded RNA binding; F:low-density lipoprotein particle receptor binding; F:protein kinase binding; F:RNA binding; F:structural molecule activity; F:ubiquitin-specific protease binding;, P:amyloid-beta clearance by transcytosis; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:autophagy; P:cell division; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:mitotic cell cycle; P:negative regulation of hyaluronan biosynthetic process; P:negative regulation of protein localization to plasma membrane; P:osteoblast differentiation; P:post-Golgi vesicle-mediated transport; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of mitotic spindle organization; P:retrograde transport, endosome to Golgi; P:transferrin transport; P:Wnt signaling pathway, planar cell polarity pathway;|Q00610 D3DU00 Q6N0A0 Q86TF2,Clathrin heavy chain 1 {ECO:0000303|PubMed:26822784, ECO:0000303|PubMed:29100083},Clathrin heavy chain on chromosome 17;, PF00637;PF09268;PF01394;, GO:0030118;GO:0030132;GO:0030130;GO:0071439;GO:0045334;GO:0030669;GO:0030136;GO:0005829;GO:0036020;GO:0005768;GO:0070062;GO:1903561;GO:0005925;GO:0005764;GO:0042470;GO:0016020;GO:0072686;GO:1990498;GO:0005886;GO:0032991;GO:0005819;GO:0032588;GO:0032051;GO:0097718;GO:0003725;GO:0050750;GO:0019901;GO:0003723;GO:0005198;GO:1990381;GO:0150093;GO:0019886;GO:0006914;GO:0051301;GO:0048268;GO:0072583;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0000278;GO:1900126;GO:1903077;GO:0001649;GO:0006892;GO:0031623;GO:0006898;GO:0060236;GO:0042147;GO:0033572;GO:0060071;, C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated vesicle; C:cytosol; C:endolysosome membrane; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:focal adhesion; C:lysosome; C:melanosome; C:membrane; C:mitotic spindle; C:mitotic spindle microtubule; C:plasma membrane; C:protein-containing complex; C:spindle; C:trans-Golgi network membrane;, F:clathrin light chain binding; F:disordered domain specific binding; F:double-stranded RNA binding; F:low-density lipoprotein particle receptor binding; F:protein kinase binding; F:RNA binding; F:structural molecule activity; F:ubiquitin-specific protease binding;, P:amyloid-beta clearance by transcytosis; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:autophagy; P:cell division; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:mitotic cell cycle; P:negative regulation of hyaluronan biosynthetic process; P:negative regulation of protein localization to plasma membrane; P:osteoblast differentiation; P:post-Golgi vesicle-mediated transport; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of mitotic spindle organization; P:retrograde transport, endosome to Golgi; P:transferrin transport; P:Wnt signaling pathway, planar cell polarity pathway;|Q96GC9 B4DVV9 Q9H0P4 Q9P089,Vacuole membrane protein 1 {ECO:0000305},Transmembrane protein 49;, PF09335;, GO:0000421;GO:0012505;GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0016020;GO:0005730;GO:0000407;GO:0005886;GO:0000045;GO:0016240;GO:0006914;GO:0034329;GO:0098609;GO:0007566;GO:0007030;GO:0042953;GO:1990456;GO:0140056;GO:1901896;, C:autophagosome membrane; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:membrane; C:nucleolus; C:phagophore assembly site; C:plasma membrane;, , P:autophagosome assembly; P:autophagosome membrane docking; P:autophagy; P:cell junction assembly; P:cell-cell adhesion; P:embryo implantation; P:Golgi organization; P:lipoprotein transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:organelle localization by membrane tethering; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity;|Q96GC9 B4DVV9 Q9H0P4 Q9P089,Vacuole membrane protein 1 {ECO:0000305},Transmembrane protein 49;, PF09335;, GO:0000421;GO:0012505;GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0016020;GO:0005730;GO:0000407;GO:0005886;GO:0000045;GO:0016240;GO:0006914;GO:0034329;GO:0098609;GO:0007566;GO:0007030;GO:0042953;GO:1990456;GO:0140056;GO:1901896;, C:autophagosome membrane; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:membrane; C:nucleolus; C:phagophore assembly site; C:plasma membrane;, , P:autophagosome assembly; P:autophagosome membrane docking; P:autophagy; P:cell junction assembly; P:cell-cell adhesion; P:embryo implantation; P:Golgi organization; P:lipoprotein transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:organelle localization by membrane tethering; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity;|Q96GC9 B4DVV9 Q9H0P4 Q9P089,Vacuole membrane protein 1 {ECO:0000305},Transmembrane protein 49;, PF09335;, GO:0000421;GO:0012505;GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0016020;GO:0005730;GO:0000407;GO:0005886;GO:0000045;GO:0016240;GO:0006914;GO:0034329;GO:0098609;GO:0007566;GO:0007030;GO:0042953;GO:1990456;GO:0140056;GO:1901896;, C:autophagosome membrane; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:membrane; C:nucleolus; C:phagophore assembly site; C:plasma membrane;, , P:autophagosome assembly; P:autophagosome membrane docking; P:autophagy; P:cell junction assembly; P:cell-cell adhesion; P:embryo implantation; P:Golgi organization; P:lipoprotein transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:organelle localization by membrane tethering; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity;|Q96GC9 B4DVV9 Q9H0P4 Q9P089,Vacuole membrane protein 1 {ECO:0000305},Transmembrane protein 49;, PF09335;, GO:0000421;GO:0012505;GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0016020;GO:0005730;GO:0000407;GO:0005886;GO:0000045;GO:0016240;GO:0006914;GO:0034329;GO:0098609;GO:0007566;GO:0007030;GO:0042953;GO:1990456;GO:0140056;GO:1901896;, C:autophagosome membrane; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:membrane; C:nucleolus; C:phagophore assembly site; C:plasma membrane;, , P:autophagosome assembly; P:autophagosome membrane docking; P:autophagy; P:cell junction assembly; P:cell-cell adhesion; P:embryo implantation; P:Golgi organization; P:lipoprotein transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:organelle localization by membrane tethering; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; scaffold52 indexed_genome mRNA 1503957 1526452 . - . ID=transcript_9640;Q9UJT1 B4DPT8 B4DW01 D3DU02 E9PCA7 E9PCQ8 Q5KU36 Q9BWG9 Q9H7Z8,Tubulin delta chain,Delta-tubulin;, PF00091;, GO:0005814;GO:0005929;GO:0005737;GO:0005829;GO:0005874;GO:0005654;GO:0005525;GO:0003924;GO:0005200;GO:0030030;GO:0000226;GO:0000278;GO:0007275;GO:0045880;, C:centriole; C:cilium; C:cytoplasm; C:cytosol; C:microtubule; C:nucleoplasm;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:cell projection organization; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:multicellular organism development; P:positive regulation of smoothened signaling pathway; scaffold52 indexed_genome mRNA 1526648 1569486 . + . ID=transcript_9641;P23443 B2R779 B4DLT4 B4DTG1 E7ESB8 F6UYM1 Q7Z721,Ribosomal protein S6 kinase beta-1,70 kDa ribosomal protein S6 kinase 1;Ribosomal protein S6 kinase I;Serine/threonine-protein kinase 14A;p70 ribosomal S6 kinase alpha;, PF00069;PF00433;, GO:0009986;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0043005;GO:0005654;GO:0005634;GO:0048471;GO:0045202;GO:0005524;GO:0042802;GO:0030165;GO:0042277;GO:0004672;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007568;GO:0006915;GO:0001662;GO:0016477;GO:0071549;GO:0071363;GO:0032869;GO:0071346;GO:0000082;GO:0007281;GO:0044539;GO:0007616;GO:0043066;GO:2001237;GO:0046627;GO:0018105;GO:0048015;GO:0045931;GO:0048633;GO:0014911;GO:0048661;GO:0045727;GO:0045948;GO:0043491;GO:0046324;GO:0042493;GO:0014878;GO:0045471;GO:0033762;GO:0009749;GO:0009408;GO:0043201;GO:0032496;GO:0009612;GO:0007584;GO:0031667;GO:0033574;GO:0009636;GO:0034612;GO:0009611;GO:0007165;GO:0014732;GO:0003009;GO:0031929;, C:cell surface; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:identical protein binding; F:PDZ domain binding; F:peptide binding; F:protein kinase activity; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:aging; P:apoptotic process; P:behavioral fear response; P:cell migration; P:cellular response to dexamethasone stimulus; P:cellular response to growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:G1/S transition of mitotic cell cycle; P:germ cell development; P:long-chain fatty acid import into cell; P:long-term memory; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-serine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of mitotic cell cycle; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of translation; P:positive regulation of translational initiation; P:protein kinase B signaling; P:regulation of glucose import; P:response to drug; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to ethanol; P:response to glucagon; P:response to glucose; P:response to heat; P:response to leucine; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:response to nutrient; P:response to nutrient levels; P:response to testosterone; P:response to toxic substance; P:response to tumor necrosis factor; P:response to wounding; P:signal transduction; P:skeletal muscle atrophy; P:skeletal muscle contraction; P:TOR signaling;|P23443 B2R779 B4DLT4 B4DTG1 E7ESB8 F6UYM1 Q7Z721,Ribosomal protein S6 kinase beta-1,70 kDa ribosomal protein S6 kinase 1;Ribosomal protein S6 kinase I;Serine/threonine-protein kinase 14A;p70 ribosomal S6 kinase alpha;, PF00069;PF00433;, GO:0009986;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0043005;GO:0005654;GO:0005634;GO:0048471;GO:0045202;GO:0005524;GO:0042802;GO:0030165;GO:0042277;GO:0004672;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007568;GO:0006915;GO:0001662;GO:0016477;GO:0071549;GO:0071363;GO:0032869;GO:0071346;GO:0000082;GO:0007281;GO:0044539;GO:0007616;GO:0043066;GO:2001237;GO:0046627;GO:0018105;GO:0048015;GO:0045931;GO:0048633;GO:0014911;GO:0048661;GO:0045727;GO:0045948;GO:0043491;GO:0046324;GO:0042493;GO:0014878;GO:0045471;GO:0033762;GO:0009749;GO:0009408;GO:0043201;GO:0032496;GO:0009612;GO:0007584;GO:0031667;GO:0033574;GO:0009636;GO:0034612;GO:0009611;GO:0007165;GO:0014732;GO:0003009;GO:0031929;, C:cell surface; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:identical protein binding; F:PDZ domain binding; F:peptide binding; F:protein kinase activity; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:aging; P:apoptotic process; P:behavioral fear response; P:cell migration; P:cellular response to dexamethasone stimulus; P:cellular response to growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:G1/S transition of mitotic cell cycle; P:germ cell development; P:long-chain fatty acid import into cell; P:long-term memory; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-serine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of mitotic cell cycle; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of translation; P:positive regulation of translational initiation; P:protein kinase B signaling; P:regulation of glucose import; P:response to drug; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to ethanol; P:response to glucagon; P:response to glucose; P:response to heat; P:response to leucine; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:response to nutrient; P:response to nutrient levels; P:response to testosterone; P:response to toxic substance; P:response to tumor necrosis factor; P:response to wounding; P:signal transduction; P:skeletal muscle atrophy; P:skeletal muscle contraction; P:TOR signaling;|P23443 B2R779 B4DLT4 B4DTG1 E7ESB8 F6UYM1 Q7Z721,Ribosomal protein S6 kinase beta-1,70 kDa ribosomal protein S6 kinase 1;Ribosomal protein S6 kinase I;Serine/threonine-protein kinase 14A;p70 ribosomal S6 kinase alpha;, PF00069;PF00433;, GO:0009986;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0043005;GO:0005654;GO:0005634;GO:0048471;GO:0045202;GO:0005524;GO:0042802;GO:0030165;GO:0042277;GO:0004672;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007568;GO:0006915;GO:0001662;GO:0016477;GO:0071549;GO:0071363;GO:0032869;GO:0071346;GO:0000082;GO:0007281;GO:0044539;GO:0007616;GO:0043066;GO:2001237;GO:0046627;GO:0018105;GO:0048015;GO:0045931;GO:0048633;GO:0014911;GO:0048661;GO:0045727;GO:0045948;GO:0043491;GO:0046324;GO:0042493;GO:0014878;GO:0045471;GO:0033762;GO:0009749;GO:0009408;GO:0043201;GO:0032496;GO:0009612;GO:0007584;GO:0031667;GO:0033574;GO:0009636;GO:0034612;GO:0009611;GO:0007165;GO:0014732;GO:0003009;GO:0031929;, C:cell surface; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:identical protein binding; F:PDZ domain binding; F:peptide binding; F:protein kinase activity; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:aging; P:apoptotic process; P:behavioral fear response; P:cell migration; P:cellular response to dexamethasone stimulus; P:cellular response to growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:G1/S transition of mitotic cell cycle; P:germ cell development; P:long-chain fatty acid import into cell; P:long-term memory; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-serine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of mitotic cell cycle; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of translation; P:positive regulation of translational initiation; P:protein kinase B signaling; P:regulation of glucose import; P:response to drug; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to ethanol; P:response to glucagon; P:response to glucose; P:response to heat; P:response to leucine; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:response to nutrient; P:response to nutrient levels; P:response to testosterone; P:response to toxic substance; P:response to tumor necrosis factor; P:response to wounding; P:signal transduction; P:skeletal muscle atrophy; P:skeletal muscle contraction; P:TOR signaling;|P23443 B2R779 B4DLT4 B4DTG1 E7ESB8 F6UYM1 Q7Z721,Ribosomal protein S6 kinase beta-1,70 kDa ribosomal protein S6 kinase 1;Ribosomal protein S6 kinase I;Serine/threonine-protein kinase 14A;p70 ribosomal S6 kinase alpha;, PF00069;PF00433;, GO:0009986;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0043005;GO:0005654;GO:0005634;GO:0048471;GO:0045202;GO:0005524;GO:0042802;GO:0030165;GO:0042277;GO:0004672;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007568;GO:0006915;GO:0001662;GO:0016477;GO:0071549;GO:0071363;GO:0032869;GO:0071346;GO:0000082;GO:0007281;GO:0044539;GO:0007616;GO:0043066;GO:2001237;GO:0046627;GO:0018105;GO:0048015;GO:0045931;GO:0048633;GO:0014911;GO:0048661;GO:0045727;GO:0045948;GO:0043491;GO:0046324;GO:0042493;GO:0014878;GO:0045471;GO:0033762;GO:0009749;GO:0009408;GO:0043201;GO:0032496;GO:0009612;GO:0007584;GO:0031667;GO:0033574;GO:0009636;GO:0034612;GO:0009611;GO:0007165;GO:0014732;GO:0003009;GO:0031929;, C:cell surface; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:identical protein binding; F:PDZ domain binding; F:peptide binding; F:protein kinase activity; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:aging; P:apoptotic process; P:behavioral fear response; P:cell migration; P:cellular response to dexamethasone stimulus; P:cellular response to growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:G1/S transition of mitotic cell cycle; P:germ cell development; P:long-chain fatty acid import into cell; P:long-term memory; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-serine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of mitotic cell cycle; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of translation; P:positive regulation of translational initiation; P:protein kinase B signaling; P:regulation of glucose import; P:response to drug; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to ethanol; P:response to glucagon; P:response to glucose; P:response to heat; P:response to leucine; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:response to nutrient; P:response to nutrient levels; P:response to testosterone; P:response to toxic substance; P:response to tumor necrosis factor; P:response to wounding; P:signal transduction; P:skeletal muscle atrophy; P:skeletal muscle contraction; P:TOR signaling;|P23443 B2R779 B4DLT4 B4DTG1 E7ESB8 F6UYM1 Q7Z721,Ribosomal protein S6 kinase beta-1,70 kDa ribosomal protein S6 kinase 1;Ribosomal protein S6 kinase I;Serine/threonine-protein kinase 14A;p70 ribosomal S6 kinase alpha;, PF00069;PF00433;, GO:0009986;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0043005;GO:0005654;GO:0005634;GO:0048471;GO:0045202;GO:0005524;GO:0042802;GO:0030165;GO:0042277;GO:0004672;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007568;GO:0006915;GO:0001662;GO:0016477;GO:0071549;GO:0071363;GO:0032869;GO:0071346;GO:0000082;GO:0007281;GO:0044539;GO:0007616;GO:0043066;GO:2001237;GO:0046627;GO:0018105;GO:0048015;GO:0045931;GO:0048633;GO:0014911;GO:0048661;GO:0045727;GO:0045948;GO:0043491;GO:0046324;GO:0042493;GO:0014878;GO:0045471;GO:0033762;GO:0009749;GO:0009408;GO:0043201;GO:0032496;GO:0009612;GO:0007584;GO:0031667;GO:0033574;GO:0009636;GO:0034612;GO:0009611;GO:0007165;GO:0014732;GO:0003009;GO:0031929;, C:cell surface; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:identical protein binding; F:PDZ domain binding; F:peptide binding; F:protein kinase activity; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:aging; P:apoptotic process; P:behavioral fear response; P:cell migration; P:cellular response to dexamethasone stimulus; P:cellular response to growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:G1/S transition of mitotic cell cycle; P:germ cell development; P:long-chain fatty acid import into cell; P:long-term memory; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-serine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of mitotic cell cycle; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of translation; P:positive regulation of translational initiation; P:protein kinase B signaling; P:regulation of glucose import; P:response to drug; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to ethanol; P:response to glucagon; P:response to glucose; P:response to heat; P:response to leucine; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:response to nutrient; P:response to nutrient levels; P:response to testosterone; P:response to toxic substance; P:response to tumor necrosis factor; P:response to wounding; P:signal transduction; P:skeletal muscle atrophy; P:skeletal muscle contraction; P:TOR signaling;|P23443 B2R779 B4DLT4 B4DTG1 E7ESB8 F6UYM1 Q7Z721,Ribosomal protein S6 kinase beta-1,70 kDa ribosomal protein S6 kinase 1;Ribosomal protein S6 kinase I;Serine/threonine-protein kinase 14A;p70 ribosomal S6 kinase alpha;, PF00069;PF00433;, GO:0009986;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0043005;GO:0005654;GO:0005634;GO:0048471;GO:0045202;GO:0005524;GO:0042802;GO:0030165;GO:0042277;GO:0004672;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007568;GO:0006915;GO:0001662;GO:0016477;GO:0071549;GO:0071363;GO:0032869;GO:0071346;GO:0000082;GO:0007281;GO:0044539;GO:0007616;GO:0043066;GO:2001237;GO:0046627;GO:0018105;GO:0048015;GO:0045931;GO:0048633;GO:0014911;GO:0048661;GO:0045727;GO:0045948;GO:0043491;GO:0046324;GO:0042493;GO:0014878;GO:0045471;GO:0033762;GO:0009749;GO:0009408;GO:0043201;GO:0032496;GO:0009612;GO:0007584;GO:0031667;GO:0033574;GO:0009636;GO:0034612;GO:0009611;GO:0007165;GO:0014732;GO:0003009;GO:0031929;, C:cell surface; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:identical protein binding; F:PDZ domain binding; F:peptide binding; F:protein kinase activity; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:aging; P:apoptotic process; P:behavioral fear response; P:cell migration; P:cellular response to dexamethasone stimulus; P:cellular response to growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:G1/S transition of mitotic cell cycle; P:germ cell development; P:long-chain fatty acid import into cell; P:long-term memory; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-serine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of mitotic cell cycle; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of translation; P:positive regulation of translational initiation; P:protein kinase B signaling; P:regulation of glucose import; P:response to drug; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to ethanol; P:response to glucagon; P:response to glucose; P:response to heat; P:response to leucine; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:response to nutrient; P:response to nutrient levels; P:response to testosterone; P:response to toxic substance; P:response to tumor necrosis factor; P:response to wounding; P:signal transduction; P:skeletal muscle atrophy; P:skeletal muscle contraction; P:TOR signaling;|P23443 B2R779 B4DLT4 B4DTG1 E7ESB8 F6UYM1 Q7Z721,Ribosomal protein S6 kinase beta-1,70 kDa ribosomal protein S6 kinase 1;Ribosomal protein S6 kinase I;Serine/threonine-protein kinase 14A;p70 ribosomal S6 kinase alpha;, PF00069;PF00433;, GO:0009986;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0043005;GO:0005654;GO:0005634;GO:0048471;GO:0045202;GO:0005524;GO:0042802;GO:0030165;GO:0042277;GO:0004672;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007568;GO:0006915;GO:0001662;GO:0016477;GO:0071549;GO:0071363;GO:0032869;GO:0071346;GO:0000082;GO:0007281;GO:0044539;GO:0007616;GO:0043066;GO:2001237;GO:0046627;GO:0018105;GO:0048015;GO:0045931;GO:0048633;GO:0014911;GO:0048661;GO:0045727;GO:0045948;GO:0043491;GO:0046324;GO:0042493;GO:0014878;GO:0045471;GO:0033762;GO:0009749;GO:0009408;GO:0043201;GO:0032496;GO:0009612;GO:0007584;GO:0031667;GO:0033574;GO:0009636;GO:0034612;GO:0009611;GO:0007165;GO:0014732;GO:0003009;GO:0031929;, C:cell surface; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:identical protein binding; F:PDZ domain binding; F:peptide binding; F:protein kinase activity; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:aging; P:apoptotic process; P:behavioral fear response; P:cell migration; P:cellular response to dexamethasone stimulus; P:cellular response to growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to interferon-gamma; P:G1/S transition of mitotic cell cycle; P:germ cell development; P:long-chain fatty acid import into cell; P:long-term memory; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-serine phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of mitotic cell cycle; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of translation; P:positive regulation of translational initiation; P:protein kinase B signaling; P:regulation of glucose import; P:response to drug; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to ethanol; P:response to glucagon; P:response to glucose; P:response to heat; P:response to leucine; P:response to lipopolysaccharide; P:response to mechanical stimulus; P:response to nutrient; P:response to nutrient levels; P:response to testosterone; P:response to toxic substance; P:response to tumor necrosis factor; P:response to wounding; P:signal transduction; P:skeletal muscle atrophy; P:skeletal muscle contraction; P:TOR signaling; scaffold52 indexed_genome mRNA 1572680 1582578 . - . ID=transcript_9642;Q5M7Z0 Q8N7D0 Q96IZ9 Q9Y686,E3 ubiquitin-protein ligase RNFT1 {ECO:0000305},Protein PTD016;RING finger and transmembrane domain-containing protein 1;, , GO:0005783;GO:0005789;GO:0016021;GO:0046872;GO:0043130;GO:0061630;GO:1904294;GO:0051865;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase activity;, P:positive regulation of ERAD pathway; P:protein autoubiquitination;|Q5M7Z0 Q8N7D0 Q96IZ9 Q9Y686,E3 ubiquitin-protein ligase RNFT1 {ECO:0000305},Protein PTD016;RING finger and transmembrane domain-containing protein 1;, , GO:0005783;GO:0005789;GO:0016021;GO:0046872;GO:0043130;GO:0061630;GO:1904294;GO:0051865;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase activity;, P:positive regulation of ERAD pathway; P:protein autoubiquitination;|Q5M7Z0 Q8N7D0 Q96IZ9 Q9Y686,E3 ubiquitin-protein ligase RNFT1 {ECO:0000305},Protein PTD016;RING finger and transmembrane domain-containing protein 1;, , GO:0005783;GO:0005789;GO:0016021;GO:0046872;GO:0043130;GO:0061630;GO:1904294;GO:0051865;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase activity;, P:positive regulation of ERAD pathway; P:protein autoubiquitination;|Q5M7Z0 Q8N7D0 Q96IZ9 Q9Y686,E3 ubiquitin-protein ligase RNFT1 {ECO:0000305},Protein PTD016;RING finger and transmembrane domain-containing protein 1;, , GO:0005783;GO:0005789;GO:0016021;GO:0046872;GO:0043130;GO:0061630;GO:1904294;GO:0051865;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase activity;, P:positive regulation of ERAD pathway; P:protein autoubiquitination; scaffold52 indexed_genome mRNA 1758357 1834641 . + . ID=transcript_9643;Q9UHV7 B2RU05 O60334,Mediator of RNA polymerase II transcription subunit 13 {ECO:0000305},Activator-recruited cofactor 250 kDa component;Mediator complex subunit 13;Thyroid hormone receptor-associated protein 1;Thyroid hormone receptor-associated protein complex 240 kDa component;Vitamin D3 receptor-interacting protein complex component DRIP250;, PF06333;PF18296;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0060260;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|Q9UHV7 B2RU05 O60334,Mediator of RNA polymerase II transcription subunit 13 {ECO:0000305},Activator-recruited cofactor 250 kDa component;Mediator complex subunit 13;Thyroid hormone receptor-associated protein 1;Thyroid hormone receptor-associated protein complex 240 kDa component;Vitamin D3 receptor-interacting protein complex component DRIP250;, PF06333;PF18296;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0060260;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; scaffold52 indexed_genome mRNA 1834813 1852727 . - . ID=transcript_9644;Q9UHV7 B2RU05 O60334,Mediator of RNA polymerase II transcription subunit 13 {ECO:0000305},Activator-recruited cofactor 250 kDa component;Mediator complex subunit 13;Thyroid hormone receptor-associated protein 1;Thyroid hormone receptor-associated protein complex 240 kDa component;Vitamin D3 receptor-interacting protein complex component DRIP250;, PF06333;PF18296;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0060260;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|Q9UHV7 B2RU05 O60334,Mediator of RNA polymerase II transcription subunit 13 {ECO:0000305},Activator-recruited cofactor 250 kDa component;Mediator complex subunit 13;Thyroid hormone receptor-associated protein 1;Thyroid hormone receptor-associated protein complex 240 kDa component;Vitamin D3 receptor-interacting protein complex component DRIP250;, PF06333;PF18296;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0060260;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|Q9UHV7 B2RU05 O60334,Mediator of RNA polymerase II transcription subunit 13 {ECO:0000305},Activator-recruited cofactor 250 kDa component;Mediator complex subunit 13;Thyroid hormone receptor-associated protein 1;Thyroid hormone receptor-associated protein complex 240 kDa component;Vitamin D3 receptor-interacting protein complex component DRIP250;, PF06333;PF18296;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0060260;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; scaffold52 indexed_genome mRNA 1873845 1925179 . + . ID=transcript_9645;Q9H0H0 Q9ULD3,Integrator complex subunit 2,, PF14750;, GO:0005737;GO:0016021;GO:0032039;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0034472;GO:0016180;GO:0042795;, C:cytoplasm; C:integral component of membrane; C:integrator complex; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H0H0 Q9ULD3,Integrator complex subunit 2,, PF14750;, GO:0005737;GO:0016021;GO:0032039;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0034472;GO:0016180;GO:0042795;, C:cytoplasm; C:integral component of membrane; C:integrator complex; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H0H0 Q9ULD3,Integrator complex subunit 2,, PF14750;, GO:0005737;GO:0016021;GO:0032039;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0034472;GO:0016180;GO:0042795;, C:cytoplasm; C:integral component of membrane; C:integrator complex; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H0H0 Q9ULD3,Integrator complex subunit 2,, PF14750;, GO:0005737;GO:0016021;GO:0032039;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0034472;GO:0016180;GO:0042795;, C:cytoplasm; C:integral component of membrane; C:integrator complex; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II;|Q9H0H0 Q9ULD3,Integrator complex subunit 2,, PF14750;, GO:0005737;GO:0016021;GO:0032039;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0034472;GO:0016180;GO:0042795;, C:cytoplasm; C:integral component of membrane; C:integrator complex; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold52 indexed_genome mRNA 2020156 2113485 . + . ID=transcript_9646;Q9BX63 A0A024QZ45 Q3MJE2 Q8NCI5,Fanconi anemia group J protein,ATP-dependent RNA helicase BRIP1;BRCA1-associated C-terminal helicase 1;BRCA1-interacting protein C-terminal helicase 1;, PF06733;PF13307;, GO:0005737;GO:0031965;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003682;GO:0003677;GO:0003678;GO:0046872;GO:0003724;GO:1904385;GO:0071456;GO:0071295;GO:0051026;GO:0000077;GO:0006260;GO:0006302;GO:1990918;GO:0010705;GO:0008285;GO:0010629;GO:0006289;GO:1901796;GO:0006357;GO:0009636;GO:0072520;GO:0007286;GO:0007284;, C:cytoplasm; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:metal ion binding; F:RNA helicase activity;, P:cellular response to angiotensin; P:cellular response to hypoxia; P:cellular response to vitamin; P:chiasma assembly; P:DNA damage checkpoint; P:DNA replication; P:double-strand break repair; P:double-strand break repair involved in meiotic recombination; P:meiotic DNA double-strand break processing involved in reciprocal meiotic recombination; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:nucleotide-excision repair; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:response to toxic substance; P:seminiferous tubule development; P:spermatid development; P:spermatogonial cell division; scaffold52 indexed_genome mRNA 2298234 2316097 . + . ID=transcript_9647;P57082 A5PKU7 B2RMT1 B7ZLV3,T-box transcription factor TBX4,, PF00907;, GO:0000785;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:0001525;GO:0001708;GO:0035116;GO:0030326;GO:1990401;GO:0035108;GO:0030324;GO:0002009;GO:0007275;GO:0006357;GO:0006355;GO:0048705;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:cell fate specification; P:embryonic hindlimb morphogenesis; P:embryonic limb morphogenesis; P:embryonic lung development; P:limb morphogenesis; P:lung development; P:morphogenesis of an epithelium; P:multicellular organism development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:skeletal system morphogenesis;|P57082 A5PKU7 B2RMT1 B7ZLV3,T-box transcription factor TBX4,, PF00907;, GO:0000785;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:0001525;GO:0001708;GO:0035116;GO:0030326;GO:1990401;GO:0035108;GO:0030324;GO:0002009;GO:0007275;GO:0006357;GO:0006355;GO:0048705;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:cell fate specification; P:embryonic hindlimb morphogenesis; P:embryonic limb morphogenesis; P:embryonic lung development; P:limb morphogenesis; P:lung development; P:morphogenesis of an epithelium; P:multicellular organism development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:skeletal system morphogenesis; scaffold52 indexed_genome mRNA 2370718 2372913 . - . ID=transcript_9648;Q13207 Q16424 Q7Z647,T-box transcription factor TBX2,, PF00907;PF12598;, GO:0000785;GO:0005634;GO:0005667;GO:0003677;GO:0000981;GO:0001227;GO:0000978;GO:0043565;GO:1990837;GO:0035909;GO:0036302;GO:1905222;GO:1905072;GO:0048738;GO:0007569;GO:0001708;GO:0090398;GO:0060560;GO:0048596;GO:0042733;GO:0035050;GO:0003272;GO:0003203;GO:0001947;GO:0060596;GO:0007521;GO:1901211;GO:1901208;GO:0000122;GO:0045892;GO:0007219;GO:0003151;GO:0003148;GO:0060465;GO:0060045;GO:0008284;GO:0008016;GO:0006357;GO:0003256;GO:0060021;GO:0051145;GO:0072105;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:aorta morphogenesis; P:atrioventricular canal development; P:atrioventricular canal morphogenesis; P:cardiac jelly development; P:cardiac muscle tissue development; P:cell aging; P:cell fate specification; P:cellular senescence; P:developmental growth involved in morphogenesis; P:embryonic camera-type eye morphogenesis; P:embryonic digit morphogenesis; P:embryonic heart tube development; P:endocardial cushion formation; P:endocardial cushion morphogenesis; P:heart looping; P:mammary placode formation; P:muscle cell fate determination; P:negative regulation of cardiac chamber formation; P:negative regulation of heart looping; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:outflow tract morphogenesis; P:outflow tract septum morphogenesis; P:pharynx development; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell population proliferation; P:regulation of heart contraction; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:roof of mouth development; P:smooth muscle cell differentiation; P:ureteric peristalsis; scaffold52 indexed_genome mRNA 2374193 2377037 . - . ID=transcript_9649;Q13207 Q16424 Q7Z647,T-box transcription factor TBX2,, PF00907;PF12598;, GO:0000785;GO:0005634;GO:0005667;GO:0003677;GO:0000981;GO:0001227;GO:0000978;GO:0043565;GO:1990837;GO:0035909;GO:0036302;GO:1905222;GO:1905072;GO:0048738;GO:0007569;GO:0001708;GO:0090398;GO:0060560;GO:0048596;GO:0042733;GO:0035050;GO:0003272;GO:0003203;GO:0001947;GO:0060596;GO:0007521;GO:1901211;GO:1901208;GO:0000122;GO:0045892;GO:0007219;GO:0003151;GO:0003148;GO:0060465;GO:0060045;GO:0008284;GO:0008016;GO:0006357;GO:0003256;GO:0060021;GO:0051145;GO:0072105;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:aorta morphogenesis; P:atrioventricular canal development; P:atrioventricular canal morphogenesis; P:cardiac jelly development; P:cardiac muscle tissue development; P:cell aging; P:cell fate specification; P:cellular senescence; P:developmental growth involved in morphogenesis; P:embryonic camera-type eye morphogenesis; P:embryonic digit morphogenesis; P:embryonic heart tube development; P:endocardial cushion formation; P:endocardial cushion morphogenesis; P:heart looping; P:mammary placode formation; P:muscle cell fate determination; P:negative regulation of cardiac chamber formation; P:negative regulation of heart looping; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:outflow tract morphogenesis; P:outflow tract septum morphogenesis; P:pharynx development; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell population proliferation; P:regulation of heart contraction; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:roof of mouth development; P:smooth muscle cell differentiation; P:ureteric peristalsis;|Q13207 Q16424 Q7Z647,T-box transcription factor TBX2,, PF00907;PF12598;, GO:0000785;GO:0005634;GO:0005667;GO:0003677;GO:0000981;GO:0001227;GO:0000978;GO:0043565;GO:1990837;GO:0035909;GO:0036302;GO:1905222;GO:1905072;GO:0048738;GO:0007569;GO:0001708;GO:0090398;GO:0060560;GO:0048596;GO:0042733;GO:0035050;GO:0003272;GO:0003203;GO:0001947;GO:0060596;GO:0007521;GO:1901211;GO:1901208;GO:0000122;GO:0045892;GO:0007219;GO:0003151;GO:0003148;GO:0060465;GO:0060045;GO:0008284;GO:0008016;GO:0006357;GO:0003256;GO:0060021;GO:0051145;GO:0072105;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:aorta morphogenesis; P:atrioventricular canal development; P:atrioventricular canal morphogenesis; P:cardiac jelly development; P:cardiac muscle tissue development; P:cell aging; P:cell fate specification; P:cellular senescence; P:developmental growth involved in morphogenesis; P:embryonic camera-type eye morphogenesis; P:embryonic digit morphogenesis; P:embryonic heart tube development; P:endocardial cushion formation; P:endocardial cushion morphogenesis; P:heart looping; P:mammary placode formation; P:muscle cell fate determination; P:negative regulation of cardiac chamber formation; P:negative regulation of heart looping; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:outflow tract morphogenesis; P:outflow tract septum morphogenesis; P:pharynx development; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell population proliferation; P:regulation of heart contraction; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:roof of mouth development; P:smooth muscle cell differentiation; P:ureteric peristalsis; scaffold52 indexed_genome mRNA 2385931 2967627 . - . ID=transcript_9650;Q9H957 Q9H9Y9 Q9NXP4,Breast carcinoma-amplified sequence 3 {ECO:0000312|HGNC:HGNC:14347, ECO:0000312|MIM:607470},GAOB1;, PF12490;, GO:0031252;GO:0005737;GO:0005881;GO:0045111;GO:0005634;GO:0035327;GO:0010698;GO:0048487;GO:0003682;GO:0035035;GO:0042393;GO:0035257;GO:0008134;GO:0090630;GO:0001525;GO:0071391;GO:0007030;GO:0031023;GO:0051895;GO:0034260;GO:2000251;GO:0043085;GO:0010595;GO:0051491;GO:0043547;GO:0090316;GO:0045944;GO:2000114;GO:0042594;GO:0035148;, C:cell leading edge; C:cytoplasm; C:cytoplasmic microtubule; C:intermediate filament cytoskeleton; C:nucleus; C:transcriptionally active chromatin;, F:acetyltransferase activator activity; F:beta-tubulin binding; F:chromatin binding; F:histone acetyltransferase binding; F:histone binding; F:nuclear hormone receptor binding; F:transcription factor binding;, P:activation of GTPase activity; P:angiogenesis; P:cellular response to estrogen stimulus; P:Golgi organization; P:microtubule organizing center organization; P:negative regulation of focal adhesion assembly; P:negative regulation of GTPase activity; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of catalytic activity; P:positive regulation of endothelial cell migration; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:positive regulation of intracellular protein transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of establishment of cell polarity; P:response to starvation; P:tube formation; scaffold52 indexed_genome mRNA 2980724 2984451 . - . ID=transcript_9651;O15297 Q53XP4 Q6P991 Q8IVR6,Protein phosphatase 1D,Protein phosphatase 2C isoform delta;Protein phosphatase magnesium-dependent 1 delta;p53-induced protein phosphatase 1;, PF00481;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0051019;GO:0106306;GO:0004722;GO:0106307;GO:0009267;GO:0006342;GO:0030330;GO:0006306;GO:0000086;GO:0008285;GO:0045814;GO:0035970;GO:0006470;GO:0006468;GO:0060260;GO:0009617;GO:0009314;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:mitogen-activated protein kinase binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:cellular response to starvation; P:chromatin silencing; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:G2/M transition of mitotic cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of gene expression, epigenetic; P:peptidyl-threonine dephosphorylation; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to bacterium; P:response to radiation;|O15297 Q53XP4 Q6P991 Q8IVR6,Protein phosphatase 1D,Protein phosphatase 2C isoform delta;Protein phosphatase magnesium-dependent 1 delta;p53-induced protein phosphatase 1;, PF00481;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0051019;GO:0106306;GO:0004722;GO:0106307;GO:0009267;GO:0006342;GO:0030330;GO:0006306;GO:0000086;GO:0008285;GO:0045814;GO:0035970;GO:0006470;GO:0006468;GO:0060260;GO:0009617;GO:0009314;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:mitogen-activated protein kinase binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:cellular response to starvation; P:chromatin silencing; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:G2/M transition of mitotic cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of gene expression, epigenetic; P:peptidyl-threonine dephosphorylation; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to bacterium; P:response to radiation; scaffold52 indexed_genome mRNA 2986976 2988334 . - . ID=transcript_9652;O15297 Q53XP4 Q6P991 Q8IVR6,Protein phosphatase 1D,Protein phosphatase 2C isoform delta;Protein phosphatase magnesium-dependent 1 delta;p53-induced protein phosphatase 1;, PF00481;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0051019;GO:0106306;GO:0004722;GO:0106307;GO:0009267;GO:0006342;GO:0030330;GO:0006306;GO:0000086;GO:0008285;GO:0045814;GO:0035970;GO:0006470;GO:0006468;GO:0060260;GO:0009617;GO:0009314;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:mitogen-activated protein kinase binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:cellular response to starvation; P:chromatin silencing; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:G2/M transition of mitotic cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of gene expression, epigenetic; P:peptidyl-threonine dephosphorylation; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to bacterium; P:response to radiation;|O15297 Q53XP4 Q6P991 Q8IVR6,Protein phosphatase 1D,Protein phosphatase 2C isoform delta;Protein phosphatase magnesium-dependent 1 delta;p53-induced protein phosphatase 1;, PF00481;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0051019;GO:0106306;GO:0004722;GO:0106307;GO:0009267;GO:0006342;GO:0030330;GO:0006306;GO:0000086;GO:0008285;GO:0045814;GO:0035970;GO:0006470;GO:0006468;GO:0060260;GO:0009617;GO:0009314;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:mitogen-activated protein kinase binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:cellular response to starvation; P:chromatin silencing; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:G2/M transition of mitotic cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of gene expression, epigenetic; P:peptidyl-threonine dephosphorylation; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to bacterium; P:response to radiation; scaffold52 indexed_genome mRNA 3131604 3192616 . + . ID=transcript_9653;Q92624 A8K862 O95095 Q8WVC9,Amyloid protein-binding protein 2,Amyloid beta precursor protein-binding protein 2;Protein interacting with APP tail 1;, , GO:0005737;GO:0030659;GO:0005874;GO:0005875;GO:0005654;GO:0005634;GO:0003777;GO:0006886;GO:0046907;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:microtubule; C:microtubule associated complex; C:nucleoplasm; C:nucleus;, F:microtubule motor activity;, P:intracellular protein transport; P:intracellular transport;|Q92624 A8K862 O95095 Q8WVC9,Amyloid protein-binding protein 2,Amyloid beta precursor protein-binding protein 2;Protein interacting with APP tail 1;, , GO:0005737;GO:0030659;GO:0005874;GO:0005875;GO:0005654;GO:0005634;GO:0003777;GO:0006886;GO:0046907;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:microtubule; C:microtubule associated complex; C:nucleoplasm; C:nucleus;, F:microtubule motor activity;, P:intracellular protein transport; P:intracellular transport;|Q92624 A8K862 O95095 Q8WVC9,Amyloid protein-binding protein 2,Amyloid beta precursor protein-binding protein 2;Protein interacting with APP tail 1;, , GO:0005737;GO:0030659;GO:0005874;GO:0005875;GO:0005654;GO:0005634;GO:0003777;GO:0006886;GO:0046907;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:microtubule; C:microtubule associated complex; C:nucleoplasm; C:nucleus;, F:microtubule motor activity;, P:intracellular protein transport; P:intracellular transport;|Q92624 A8K862 O95095 Q8WVC9,Amyloid protein-binding protein 2,Amyloid beta precursor protein-binding protein 2;Protein interacting with APP tail 1;, , GO:0005737;GO:0030659;GO:0005874;GO:0005875;GO:0005654;GO:0005634;GO:0003777;GO:0006886;GO:0046907;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:microtubule; C:microtubule associated complex; C:nucleoplasm; C:nucleus;, F:microtubule motor activity;, P:intracellular protein transport; P:intracellular transport; scaffold52 indexed_genome mRNA 3343692 3345089 . + . ID=transcript_9654;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold52 indexed_genome mRNA 3361752 3455724 . + . ID=transcript_9655;Q8NFA0 Q7Z5T3 Q9BX85 Q9Y591,Ubiquitin carboxyl-terminal hydrolase 32,Deubiquitinating enzyme 32;Renal carcinoma antigen NY-REN-60;Ubiquitin thioesterase 32;Ubiquitin-specific-processing protease 32;, PF06337;PF13202;PF00443;, GO:0005829;GO:0005794;GO:0016020;GO:0005509;GO:0008234;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:Golgi apparatus; C:membrane;, F:calcium ion binding; F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8NFA0 Q7Z5T3 Q9BX85 Q9Y591,Ubiquitin carboxyl-terminal hydrolase 32,Deubiquitinating enzyme 32;Renal carcinoma antigen NY-REN-60;Ubiquitin thioesterase 32;Ubiquitin-specific-processing protease 32;, PF06337;PF13202;PF00443;, GO:0005829;GO:0005794;GO:0016020;GO:0005509;GO:0008234;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:Golgi apparatus; C:membrane;, F:calcium ion binding; F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|P35125 Q15634 Q86WP6 Q8IWT4,Ubiquitin carboxyl-terminal hydrolase 6,Deubiquitinating enzyme 6;Proto-oncogene TRE-2;Ubiquitin thioesterase 6;Ubiquitin-specific-processing protease 6;, PF00566;PF00443;, GO:0005737;GO:0005764;GO:0005886;GO:0055037;GO:0005516;GO:0004197;GO:0005096;GO:0003676;GO:0004843;GO:0090630;GO:0006464;GO:0006886;GO:0016579;GO:0060627;GO:0006511;, C:cytoplasm; C:lysosome; C:plasma membrane; C:recycling endosome;, F:calmodulin binding; F:cysteine-type endopeptidase activity; F:GTPase activator activity; F:nucleic acid binding; F:thiol-dependent ubiquitin-specific protease activity;, P:activation of GTPase activity; P:cellular protein modification process; P:intracellular protein transport; P:protein deubiquitination; P:regulation of vesicle-mediated transport; P:ubiquitin-dependent protein catabolic process;|Q8NFA0 Q7Z5T3 Q9BX85 Q9Y591,Ubiquitin carboxyl-terminal hydrolase 32,Deubiquitinating enzyme 32;Renal carcinoma antigen NY-REN-60;Ubiquitin thioesterase 32;Ubiquitin-specific-processing protease 32;, PF06337;PF13202;PF00443;, GO:0005829;GO:0005794;GO:0016020;GO:0005509;GO:0008234;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:Golgi apparatus; C:membrane;, F:calcium ion binding; F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8NFA0 Q7Z5T3 Q9BX85 Q9Y591,Ubiquitin carboxyl-terminal hydrolase 32,Deubiquitinating enzyme 32;Renal carcinoma antigen NY-REN-60;Ubiquitin thioesterase 32;Ubiquitin-specific-processing protease 32;, PF06337;PF13202;PF00443;, GO:0005829;GO:0005794;GO:0016020;GO:0005509;GO:0008234;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:Golgi apparatus; C:membrane;, F:calcium ion binding; F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8NFA0 Q7Z5T3 Q9BX85 Q9Y591,Ubiquitin carboxyl-terminal hydrolase 32,Deubiquitinating enzyme 32;Renal carcinoma antigen NY-REN-60;Ubiquitin thioesterase 32;Ubiquitin-specific-processing protease 32;, PF06337;PF13202;PF00443;, GO:0005829;GO:0005794;GO:0016020;GO:0005509;GO:0008234;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:Golgi apparatus; C:membrane;, F:calcium ion binding; F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold52 indexed_genome mRNA 3477784 3482104 . - . ID=transcript_9656;P22748 B4DQA4 Q6FHI7,Carbonic anhydrase 4,Carbonate dehydratase IV;Carbonic anhydrase IV;, PF00194;, GO:0031362;GO:0016324;GO:0031526;GO:0009986;GO:0005793;GO:0070062;GO:0005794;GO:0016020;GO:0048471;GO:0005886;GO:0005791;GO:0030667;GO:0005802;GO:0030658;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;, C:anchored component of external side of plasma membrane; C:apical plasma membrane; C:brush border membrane; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:rough endoplasmic reticulum; C:secretory granule membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process;|P22748 B4DQA4 Q6FHI7,Carbonic anhydrase 4,Carbonate dehydratase IV;Carbonic anhydrase IV;, PF00194;, GO:0031362;GO:0016324;GO:0031526;GO:0009986;GO:0005793;GO:0070062;GO:0005794;GO:0016020;GO:0048471;GO:0005886;GO:0005791;GO:0030667;GO:0005802;GO:0030658;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;, C:anchored component of external side of plasma membrane; C:apical plasma membrane; C:brush border membrane; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:rough endoplasmic reticulum; C:secretory granule membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process; scaffold52 indexed_genome mRNA 3524303 3533068 . + . ID=transcript_9657;Q15649 A8K493 K7EQP1 Q8WVJ3,Zinc finger HIT domain-containing protein 3,HNF-4a coactivator;Thyroid hormone receptor interactor 3;Thyroid receptor-interacting protein 3;, PF04438;, GO:0005737;GO:0005634;GO:0070761;GO:0046872;GO:0046966;GO:0000492;GO:0000463;GO:0006355;GO:0048254;, C:cytoplasm; C:nucleus; C:pre-snoRNP complex;, F:metal ion binding; F:thyroid hormone receptor binding;, P:box C/D snoRNP assembly; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of transcription, DNA-templated; P:snoRNA localization;|Q15649 A8K493 K7EQP1 Q8WVJ3,Zinc finger HIT domain-containing protein 3,HNF-4a coactivator;Thyroid hormone receptor interactor 3;Thyroid receptor-interacting protein 3;, PF04438;, GO:0005737;GO:0005634;GO:0070761;GO:0046872;GO:0046966;GO:0000492;GO:0000463;GO:0006355;GO:0048254;, C:cytoplasm; C:nucleus; C:pre-snoRNP complex;, F:metal ion binding; F:thyroid hormone receptor binding;, P:box C/D snoRNP assembly; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of transcription, DNA-templated; P:snoRNA localization;|Q96H55 Q59GS4 Q9H5X2,Unconventional myosin-XIX {ECO:0000303|PubMed:19932026},Myosin head domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26234};, PF00063;, GO:0015629;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0016459;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0000146;GO:0032027;GO:0060002;GO:0007015;GO:0034642;GO:0032465;GO:0090140;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:microfilament motor activity; F:myosin light chain binding; F:plus-end directed microfilament motor activity;, P:actin filament organization; P:mitochondrion migration along actin filament; P:regulation of cytokinesis; P:regulation of mitochondrial fission; P:vesicle transport along actin filament; scaffold52 indexed_genome mRNA 3533078 3539264 . - . ID=transcript_9658;Q96H55 Q59GS4 Q9H5X2,Unconventional myosin-XIX {ECO:0000303|PubMed:19932026},Myosin head domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26234};, PF00063;, GO:0015629;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0016459;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0000146;GO:0032027;GO:0060002;GO:0007015;GO:0034642;GO:0032465;GO:0090140;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:microfilament motor activity; F:myosin light chain binding; F:plus-end directed microfilament motor activity;, P:actin filament organization; P:mitochondrion migration along actin filament; P:regulation of cytokinesis; P:regulation of mitochondrial fission; P:vesicle transport along actin filament;|Q96H55 Q59GS4 Q9H5X2,Unconventional myosin-XIX {ECO:0000303|PubMed:19932026},Myosin head domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26234};, PF00063;, GO:0015629;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0016459;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0000146;GO:0032027;GO:0060002;GO:0007015;GO:0034642;GO:0032465;GO:0090140;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:microfilament motor activity; F:myosin light chain binding; F:plus-end directed microfilament motor activity;, P:actin filament organization; P:mitochondrion migration along actin filament; P:regulation of cytokinesis; P:regulation of mitochondrial fission; P:vesicle transport along actin filament;|Q96H55 Q59GS4 Q9H5X2,Unconventional myosin-XIX {ECO:0000303|PubMed:19932026},Myosin head domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26234};, PF00063;, GO:0015629;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0016459;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0000146;GO:0032027;GO:0060002;GO:0007015;GO:0034642;GO:0032465;GO:0090140;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:microfilament motor activity; F:myosin light chain binding; F:plus-end directed microfilament motor activity;, P:actin filament organization; P:mitochondrion migration along actin filament; P:regulation of cytokinesis; P:regulation of mitochondrial fission; P:vesicle transport along actin filament;|Q96H55 Q59GS4 Q9H5X2,Unconventional myosin-XIX {ECO:0000303|PubMed:19932026},Myosin head domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26234};, PF00063;, GO:0015629;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0016459;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0000146;GO:0032027;GO:0060002;GO:0007015;GO:0034642;GO:0032465;GO:0090140;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:microfilament motor activity; F:myosin light chain binding; F:plus-end directed microfilament motor activity;, P:actin filament organization; P:mitochondrion migration along actin filament; P:regulation of cytokinesis; P:regulation of mitochondrial fission; P:vesicle transport along actin filament; scaffold52 indexed_genome mRNA 3542129 3544490 . + . ID=transcript_9659;Q96H55 Q59GS4 Q9H5X2,Unconventional myosin-XIX {ECO:0000303|PubMed:19932026},Myosin head domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26234};, PF00063;, GO:0015629;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0016459;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0000146;GO:0032027;GO:0060002;GO:0007015;GO:0034642;GO:0032465;GO:0090140;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:microfilament motor activity; F:myosin light chain binding; F:plus-end directed microfilament motor activity;, P:actin filament organization; P:mitochondrion migration along actin filament; P:regulation of cytokinesis; P:regulation of mitochondrial fission; P:vesicle transport along actin filament; scaffold52 indexed_genome mRNA 3544975 3563554 . - . ID=transcript_9660;Q96H55 Q59GS4 Q9H5X2,Unconventional myosin-XIX {ECO:0000303|PubMed:19932026},Myosin head domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26234};, PF00063;, GO:0015629;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0016459;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0000146;GO:0032027;GO:0060002;GO:0007015;GO:0034642;GO:0032465;GO:0090140;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:microfilament motor activity; F:myosin light chain binding; F:plus-end directed microfilament motor activity;, P:actin filament organization; P:mitochondrion migration along actin filament; P:regulation of cytokinesis; P:regulation of mitochondrial fission; P:vesicle transport along actin filament;|Q96H55 Q59GS4 Q9H5X2,Unconventional myosin-XIX {ECO:0000303|PubMed:19932026},Myosin head domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26234};, PF00063;, GO:0015629;GO:0005737;GO:0005829;GO:0005741;GO:0005739;GO:0016459;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0000146;GO:0032027;GO:0060002;GO:0007015;GO:0034642;GO:0032465;GO:0090140;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:microfilament motor activity; F:myosin light chain binding; F:plus-end directed microfilament motor activity;, P:actin filament organization; P:mitochondrion migration along actin filament; P:regulation of cytokinesis; P:regulation of mitochondrial fission; P:vesicle transport along actin filament; scaffold52 indexed_genome mRNA 3565028 3567658 . + . ID=transcript_9661;Q7Z7B1 Q8N9G3,Phosphatidylinositol-glycan biosynthesis class W protein {ECO:0000305},, PF06423;, GO:0005789;GO:0016021;GO:0032216;GO:0006506;GO:0006505;GO:0016254;GO:0072659;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:glucosaminyl-phosphatidylinositol O-acyltransferase activity;, P:GPI anchor biosynthetic process; P:GPI anchor metabolic process; P:preassembly of GPI anchor in ER membrane; P:protein localization to plasma membrane;|Q7Z7B1 Q8N9G3,Phosphatidylinositol-glycan biosynthesis class W protein {ECO:0000305},, PF06423;, GO:0005789;GO:0016021;GO:0032216;GO:0006506;GO:0006505;GO:0016254;GO:0072659;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:glucosaminyl-phosphatidylinositol O-acyltransferase activity;, P:GPI anchor biosynthetic process; P:GPI anchor metabolic process; P:preassembly of GPI anchor in ER membrane; P:protein localization to plasma membrane; scaffold52 indexed_genome mRNA 3569639 3571215 . - . ID=transcript_9662;Q9H3C7 B2RPK7 Q96T90 Q9GZR8 Q9H767,Gametogenetin-binding protein 2,Laryngeal carcinoma-related protein 1;Protein ZNF403;, , GO:0005737;GO:0031410;GO:0005634;GO:0030154;GO:0060716;GO:0008285;GO:0010629;GO:0033140;GO:0061099;GO:0042532;GO:0007283;, C:cytoplasm; C:cytoplasmic vesicle; C:nucleus;, , P:cell differentiation; P:labyrinthine layer blood vessel development; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of tyrosine phosphorylation of STAT protein; P:spermatogenesis; scaffold52 indexed_genome mRNA 3572988 3580700 . + . ID=transcript_9663;Q6UWP2 A0A0U5BLD0 B2RDZ3 Q9BUC7 Q9H674,Dehydrogenase/reductase SDR family member 11,17-beta-hydroxysteroid dehydrogenase {ECO:0000305|PubMed:26920053};3-beta-hydroxysteroid 3-dehydrogenase {ECO:0000305|PubMed:26920053};Estradiol 17-beta-dehydrogenase {ECO:0000305|PubMed:26920053};Short-chain dehydrogenase/reductase family 24C member 1 {ECO:0000303|PubMed:19027726};, PF00106;, GO:0005576;GO:0044594;GO:0072582;GO:0072555;GO:0000253;GO:0004303;GO:0000166;GO:0006703;GO:0006694;, C:extracellular region;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:17-beta-ketosteroid reductase activity; F:3-keto sterol reductase activity; F:estradiol 17-beta-dehydrogenase activity; F:nucleotide binding;, P:estrogen biosynthetic process; P:steroid biosynthetic process;|Q6UWP2 A0A0U5BLD0 B2RDZ3 Q9BUC7 Q9H674,Dehydrogenase/reductase SDR family member 11,17-beta-hydroxysteroid dehydrogenase {ECO:0000305|PubMed:26920053};3-beta-hydroxysteroid 3-dehydrogenase {ECO:0000305|PubMed:26920053};Estradiol 17-beta-dehydrogenase {ECO:0000305|PubMed:26920053};Short-chain dehydrogenase/reductase family 24C member 1 {ECO:0000303|PubMed:19027726};, PF00106;, GO:0005576;GO:0044594;GO:0072582;GO:0072555;GO:0000253;GO:0004303;GO:0000166;GO:0006703;GO:0006694;, C:extracellular region;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:17-beta-ketosteroid reductase activity; F:3-keto sterol reductase activity; F:estradiol 17-beta-dehydrogenase activity; F:nucleotide binding;, P:estrogen biosynthetic process; P:steroid biosynthetic process;|Q6UWP2 A0A0U5BLD0 B2RDZ3 Q9BUC7 Q9H674,Dehydrogenase/reductase SDR family member 11,17-beta-hydroxysteroid dehydrogenase {ECO:0000305|PubMed:26920053};3-beta-hydroxysteroid 3-dehydrogenase {ECO:0000305|PubMed:26920053};Estradiol 17-beta-dehydrogenase {ECO:0000305|PubMed:26920053};Short-chain dehydrogenase/reductase family 24C member 1 {ECO:0000303|PubMed:19027726};, PF00106;, GO:0005576;GO:0044594;GO:0072582;GO:0072555;GO:0000253;GO:0004303;GO:0000166;GO:0006703;GO:0006694;, C:extracellular region;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:17-beta-ketosteroid reductase activity; F:3-keto sterol reductase activity; F:estradiol 17-beta-dehydrogenase activity; F:nucleotide binding;, P:estrogen biosynthetic process; P:steroid biosynthetic process; scaffold52 indexed_genome mRNA 3582254 3589292 . + . ID=transcript_9664;Q6IN84 A8K8E2 Q96GK2 Q9H664,rRNA methyltransferase 1, mitochondrial {ECO:0000303|PubMed:24036117},16S rRNA (guanosine(1145)-2'-O)-methyltransferase {ECO:0000303|PubMed:25074936};16S rRNA [Gm1145] 2'-O-methyltransferase {ECO:0000303|PubMed:25074936};, PF00588;PF08032;, GO:0005759;GO:0005739;GO:0003723;GO:0070039;GO:0000451;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding; F:rRNA (guanosine-2'-O-)-methyltransferase activity;, P:rRNA 2'-O-methylation; scaffold52 indexed_genome mRNA 3923565 3929753 . + . ID=transcript_9665;P48742 Q3MIW0,LIM/homeobox protein Lhx1,Homeobox protein Lim-1;, PF00046;PF00412;, GO:0000785;GO:0005634;GO:0032991;GO:0005667;GO:0000987;GO:0003700;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0048646;GO:0009653;GO:0009887;GO:0009948;GO:0009952;GO:0001658;GO:0007267;GO:0044344;GO:0021702;GO:0021937;GO:0021549;GO:0060067;GO:0072049;GO:0097379;GO:0009953;GO:0001705;GO:0009880;GO:0060059;GO:0048703;GO:0001706;GO:0060429;GO:0021871;GO:0001702;GO:0060322;GO:0035852;GO:0001822;GO:0097477;GO:0048382;GO:0072177;GO:0072278;GO:0072224;GO:0035502;GO:0072283;GO:0072284;GO:0008045;GO:0045892;GO:0035849;GO:0072178;GO:0007399;GO:0030182;GO:0060066;GO:0035846;GO:0061205;GO:0007389;GO:2000744;GO:0090190;GO:0040019;GO:2000543;GO:2000768;GO:0045893;GO:0009791;GO:0090009;GO:0048793;GO:0010468;GO:0006357;GO:0072077;GO:0010842;GO:0072050;GO:0032525;GO:0021527;GO:0021537;GO:0006366;GO:0072197;GO:0001657;GO:0001655;GO:0035847;GO:0060065;GO:0060068;GO:0021517;, C:chromatin; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure formation involved in morphogenesis; P:anatomical structure morphogenesis; P:animal organ morphogenesis; P:anterior/posterior axis specification; P:anterior/posterior pattern specification; P:branching involved in ureteric bud morphogenesis; P:cell-cell signaling; P:cellular response to fibroblast growth factor stimulus; P:cerebellar Purkinje cell differentiation; P:cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation; P:cerebellum development; P:cervix development; P:comma-shaped body morphogenesis; P:dorsal spinal cord interneuron posterior axon guidance; P:dorsal/ventral pattern formation; P:ectoderm formation; P:embryonic pattern specification; P:embryonic retina morphogenesis in camera-type eye; P:embryonic viscerocranium morphogenesis; P:endoderm formation; P:epithelium development; P:forebrain regionalization; P:gastrulation with mouth forming second; P:head development; P:horizontal cell localization; P:kidney development; P:lateral motor column neuron migration; P:mesendoderm development; P:mesonephric duct development; P:metanephric comma-shaped body morphogenesis; P:metanephric glomerulus development; P:metanephric part of ureteric bud development; P:metanephric renal vesicle morphogenesis; P:metanephric S-shaped body morphogenesis; P:motor neuron axon guidance; P:negative regulation of transcription, DNA-templated; P:nephric duct elongation; P:nephric duct morphogenesis; P:nervous system development; P:neuron differentiation; P:oviduct development; P:oviduct epithelium development; P:paramesonephric duct development; P:pattern specification process; P:positive regulation of anterior head development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of embryonic development; P:positive regulation of gastrulation; P:positive regulation of nephron tubule epithelial cell differentiation; P:positive regulation of transcription, DNA-templated; P:post-embryonic development; P:primitive streak formation; P:pronephros development; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:renal vesicle morphogenesis; P:retina layer formation; P:S-shaped body morphogenesis; P:somite rostral/caudal axis specification; P:spinal cord association neuron differentiation; P:telencephalon development; P:transcription by RNA polymerase II; P:ureter morphogenesis; P:ureteric bud development; P:urogenital system development; P:uterine epithelium development; P:uterus development; P:vagina development; P:ventral spinal cord development;|P48742 Q3MIW0,LIM/homeobox protein Lhx1,Homeobox protein Lim-1;, PF00046;PF00412;, GO:0000785;GO:0005634;GO:0032991;GO:0005667;GO:0000987;GO:0003700;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0048646;GO:0009653;GO:0009887;GO:0009948;GO:0009952;GO:0001658;GO:0007267;GO:0044344;GO:0021702;GO:0021937;GO:0021549;GO:0060067;GO:0072049;GO:0097379;GO:0009953;GO:0001705;GO:0009880;GO:0060059;GO:0048703;GO:0001706;GO:0060429;GO:0021871;GO:0001702;GO:0060322;GO:0035852;GO:0001822;GO:0097477;GO:0048382;GO:0072177;GO:0072278;GO:0072224;GO:0035502;GO:0072283;GO:0072284;GO:0008045;GO:0045892;GO:0035849;GO:0072178;GO:0007399;GO:0030182;GO:0060066;GO:0035846;GO:0061205;GO:0007389;GO:2000744;GO:0090190;GO:0040019;GO:2000543;GO:2000768;GO:0045893;GO:0009791;GO:0090009;GO:0048793;GO:0010468;GO:0006357;GO:0072077;GO:0010842;GO:0072050;GO:0032525;GO:0021527;GO:0021537;GO:0006366;GO:0072197;GO:0001657;GO:0001655;GO:0035847;GO:0060065;GO:0060068;GO:0021517;, C:chromatin; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure formation involved in morphogenesis; P:anatomical structure morphogenesis; P:animal organ morphogenesis; P:anterior/posterior axis specification; P:anterior/posterior pattern specification; P:branching involved in ureteric bud morphogenesis; P:cell-cell signaling; P:cellular response to fibroblast growth factor stimulus; P:cerebellar Purkinje cell differentiation; P:cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation; P:cerebellum development; P:cervix development; P:comma-shaped body morphogenesis; P:dorsal spinal cord interneuron posterior axon guidance; P:dorsal/ventral pattern formation; P:ectoderm formation; P:embryonic pattern specification; P:embryonic retina morphogenesis in camera-type eye; P:embryonic viscerocranium morphogenesis; P:endoderm formation; P:epithelium development; P:forebrain regionalization; P:gastrulation with mouth forming second; P:head development; P:horizontal cell localization; P:kidney development; P:lateral motor column neuron migration; P:mesendoderm development; P:mesonephric duct development; P:metanephric comma-shaped body morphogenesis; P:metanephric glomerulus development; P:metanephric part of ureteric bud development; P:metanephric renal vesicle morphogenesis; P:metanephric S-shaped body morphogenesis; P:motor neuron axon guidance; P:negative regulation of transcription, DNA-templated; P:nephric duct elongation; P:nephric duct morphogenesis; P:nervous system development; P:neuron differentiation; P:oviduct development; P:oviduct epithelium development; P:paramesonephric duct development; P:pattern specification process; P:positive regulation of anterior head development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of embryonic development; P:positive regulation of gastrulation; P:positive regulation of nephron tubule epithelial cell differentiation; P:positive regulation of transcription, DNA-templated; P:post-embryonic development; P:primitive streak formation; P:pronephros development; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:renal vesicle morphogenesis; P:retina layer formation; P:S-shaped body morphogenesis; P:somite rostral/caudal axis specification; P:spinal cord association neuron differentiation; P:telencephalon development; P:transcription by RNA polymerase II; P:ureter morphogenesis; P:ureteric bud development; P:urogenital system development; P:uterine epithelium development; P:uterus development; P:vagina development; P:ventral spinal cord development;|P48742 Q3MIW0,LIM/homeobox protein Lhx1,Homeobox protein Lim-1;, PF00046;PF00412;, GO:0000785;GO:0005634;GO:0032991;GO:0005667;GO:0000987;GO:0003700;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0048646;GO:0009653;GO:0009887;GO:0009948;GO:0009952;GO:0001658;GO:0007267;GO:0044344;GO:0021702;GO:0021937;GO:0021549;GO:0060067;GO:0072049;GO:0097379;GO:0009953;GO:0001705;GO:0009880;GO:0060059;GO:0048703;GO:0001706;GO:0060429;GO:0021871;GO:0001702;GO:0060322;GO:0035852;GO:0001822;GO:0097477;GO:0048382;GO:0072177;GO:0072278;GO:0072224;GO:0035502;GO:0072283;GO:0072284;GO:0008045;GO:0045892;GO:0035849;GO:0072178;GO:0007399;GO:0030182;GO:0060066;GO:0035846;GO:0061205;GO:0007389;GO:2000744;GO:0090190;GO:0040019;GO:2000543;GO:2000768;GO:0045893;GO:0009791;GO:0090009;GO:0048793;GO:0010468;GO:0006357;GO:0072077;GO:0010842;GO:0072050;GO:0032525;GO:0021527;GO:0021537;GO:0006366;GO:0072197;GO:0001657;GO:0001655;GO:0035847;GO:0060065;GO:0060068;GO:0021517;, C:chromatin; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure formation involved in morphogenesis; P:anatomical structure morphogenesis; P:animal organ morphogenesis; P:anterior/posterior axis specification; P:anterior/posterior pattern specification; P:branching involved in ureteric bud morphogenesis; P:cell-cell signaling; P:cellular response to fibroblast growth factor stimulus; P:cerebellar Purkinje cell differentiation; P:cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation; P:cerebellum development; P:cervix development; P:comma-shaped body morphogenesis; P:dorsal spinal cord interneuron posterior axon guidance; P:dorsal/ventral pattern formation; P:ectoderm formation; P:embryonic pattern specification; P:embryonic retina morphogenesis in camera-type eye; P:embryonic viscerocranium morphogenesis; P:endoderm formation; P:epithelium development; P:forebrain regionalization; P:gastrulation with mouth forming second; P:head development; P:horizontal cell localization; P:kidney development; P:lateral motor column neuron migration; P:mesendoderm development; P:mesonephric duct development; P:metanephric comma-shaped body morphogenesis; P:metanephric glomerulus development; P:metanephric part of ureteric bud development; P:metanephric renal vesicle morphogenesis; P:metanephric S-shaped body morphogenesis; P:motor neuron axon guidance; P:negative regulation of transcription, DNA-templated; P:nephric duct elongation; P:nephric duct morphogenesis; P:nervous system development; P:neuron differentiation; P:oviduct development; P:oviduct epithelium development; P:paramesonephric duct development; P:pattern specification process; P:positive regulation of anterior head development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of embryonic development; P:positive regulation of gastrulation; P:positive regulation of nephron tubule epithelial cell differentiation; P:positive regulation of transcription, DNA-templated; P:post-embryonic development; P:primitive streak formation; P:pronephros development; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:renal vesicle morphogenesis; P:retina layer formation; P:S-shaped body morphogenesis; P:somite rostral/caudal axis specification; P:spinal cord association neuron differentiation; P:telencephalon development; P:transcription by RNA polymerase II; P:ureter morphogenesis; P:ureteric bud development; P:urogenital system development; P:uterine epithelium development; P:uterus development; P:vagina development; P:ventral spinal cord development;|P48742 Q3MIW0,LIM/homeobox protein Lhx1,Homeobox protein Lim-1;, PF00046;PF00412;, GO:0000785;GO:0005634;GO:0032991;GO:0005667;GO:0000987;GO:0003700;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0048646;GO:0009653;GO:0009887;GO:0009948;GO:0009952;GO:0001658;GO:0007267;GO:0044344;GO:0021702;GO:0021937;GO:0021549;GO:0060067;GO:0072049;GO:0097379;GO:0009953;GO:0001705;GO:0009880;GO:0060059;GO:0048703;GO:0001706;GO:0060429;GO:0021871;GO:0001702;GO:0060322;GO:0035852;GO:0001822;GO:0097477;GO:0048382;GO:0072177;GO:0072278;GO:0072224;GO:0035502;GO:0072283;GO:0072284;GO:0008045;GO:0045892;GO:0035849;GO:0072178;GO:0007399;GO:0030182;GO:0060066;GO:0035846;GO:0061205;GO:0007389;GO:2000744;GO:0090190;GO:0040019;GO:2000543;GO:2000768;GO:0045893;GO:0009791;GO:0090009;GO:0048793;GO:0010468;GO:0006357;GO:0072077;GO:0010842;GO:0072050;GO:0032525;GO:0021527;GO:0021537;GO:0006366;GO:0072197;GO:0001657;GO:0001655;GO:0035847;GO:0060065;GO:0060068;GO:0021517;, C:chromatin; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure formation involved in morphogenesis; P:anatomical structure morphogenesis; P:animal organ morphogenesis; P:anterior/posterior axis specification; P:anterior/posterior pattern specification; P:branching involved in ureteric bud morphogenesis; P:cell-cell signaling; P:cellular response to fibroblast growth factor stimulus; P:cerebellar Purkinje cell differentiation; P:cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation; P:cerebellum development; P:cervix development; P:comma-shaped body morphogenesis; P:dorsal spinal cord interneuron posterior axon guidance; P:dorsal/ventral pattern formation; P:ectoderm formation; P:embryonic pattern specification; P:embryonic retina morphogenesis in camera-type eye; P:embryonic viscerocranium morphogenesis; P:endoderm formation; P:epithelium development; P:forebrain regionalization; P:gastrulation with mouth forming second; P:head development; P:horizontal cell localization; P:kidney development; P:lateral motor column neuron migration; P:mesendoderm development; P:mesonephric duct development; P:metanephric comma-shaped body morphogenesis; P:metanephric glomerulus development; P:metanephric part of ureteric bud development; P:metanephric renal vesicle morphogenesis; P:metanephric S-shaped body morphogenesis; P:motor neuron axon guidance; P:negative regulation of transcription, DNA-templated; P:nephric duct elongation; P:nephric duct morphogenesis; P:nervous system development; P:neuron differentiation; P:oviduct development; P:oviduct epithelium development; P:paramesonephric duct development; P:pattern specification process; P:positive regulation of anterior head development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of embryonic development; P:positive regulation of gastrulation; P:positive regulation of nephron tubule epithelial cell differentiation; P:positive regulation of transcription, DNA-templated; P:post-embryonic development; P:primitive streak formation; P:pronephros development; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:renal vesicle morphogenesis; P:retina layer formation; P:S-shaped body morphogenesis; P:somite rostral/caudal axis specification; P:spinal cord association neuron differentiation; P:telencephalon development; P:transcription by RNA polymerase II; P:ureter morphogenesis; P:ureteric bud development; P:urogenital system development; P:uterine epithelium development; P:uterus development; P:vagina development; P:ventral spinal cord development; scaffold52 indexed_genome mRNA 3935433 4012553 . + . ID=transcript_9666;Q9NY61 A6NCJ6 B3KQ26 Q9P0A4 Q9UNX5,Protein AATF,Apoptosis-antagonizing transcription factor;Rb-binding protein Che-1;, PF13339;PF08164;, GO:0005737;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0043522;GO:0019901;GO:0003723;GO:0048156;GO:0007155;GO:0006974;GO:0040016;GO:0042985;GO:0043066;GO:2001234;GO:2000378;GO:0032929;GO:0045944;GO:0007346;GO:0006357;GO:0042254;, C:cytoplasm; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:leucine zipper domain binding; F:protein kinase binding; F:RNA binding; F:tau protein binding;, P:cell adhesion; P:cellular response to DNA damage stimulus; P:embryonic cleavage; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of superoxide anion generation; P:positive regulation of transcription by RNA polymerase II; P:regulation of mitotic cell cycle; P:regulation of transcription by RNA polymerase II; P:ribosome biogenesis;|Q9NY61 A6NCJ6 B3KQ26 Q9P0A4 Q9UNX5,Protein AATF,Apoptosis-antagonizing transcription factor;Rb-binding protein Che-1;, PF13339;PF08164;, GO:0005737;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0043522;GO:0019901;GO:0003723;GO:0048156;GO:0007155;GO:0006974;GO:0040016;GO:0042985;GO:0043066;GO:2001234;GO:2000378;GO:0032929;GO:0045944;GO:0007346;GO:0006357;GO:0042254;, C:cytoplasm; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:leucine zipper domain binding; F:protein kinase binding; F:RNA binding; F:tau protein binding;, P:cell adhesion; P:cellular response to DNA damage stimulus; P:embryonic cleavage; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of superoxide anion generation; P:positive regulation of transcription by RNA polymerase II; P:regulation of mitotic cell cycle; P:regulation of transcription by RNA polymerase II; P:ribosome biogenesis; scaffold52 indexed_genome mRNA 4037391 4038023 . - . ID=transcript_9667;Q9NY61 A6NCJ6 B3KQ26 Q9P0A4 Q9UNX5,Protein AATF,Apoptosis-antagonizing transcription factor;Rb-binding protein Che-1;, PF13339;PF08164;, GO:0005737;GO:0005794;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0043522;GO:0019901;GO:0003723;GO:0048156;GO:0007155;GO:0006974;GO:0040016;GO:0042985;GO:0043066;GO:2001234;GO:2000378;GO:0032929;GO:0045944;GO:0007346;GO:0006357;GO:0042254;, C:cytoplasm; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:leucine zipper domain binding; F:protein kinase binding; F:RNA binding; F:tau protein binding;, P:cell adhesion; P:cellular response to DNA damage stimulus; P:embryonic cleavage; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of superoxide anion generation; P:positive regulation of transcription by RNA polymerase II; P:regulation of mitotic cell cycle; P:regulation of transcription by RNA polymerase II; P:ribosome biogenesis; scaffold52 indexed_genome mRNA 4056242 4288836 . - . ID=transcript_9668;Q86WB2 Q86WB3,Acetyl-CoA carboxylase 1 {ECO:0000303|PubMed:12810950},Acetyl-Coenzyme A carboxylase alpha;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0015629;GO:0005829;GO:0001650;GO:0003989;GO:0005524;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0071380;GO:0006633;GO:0046949;GO:0055088;GO:2001295;GO:0031325;GO:0051289;GO:0019538;GO:0019216;GO:0001894;, C:actin cytoskeleton; C:cytosol; C:fibrillar center;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:cellular response to prostaglandin E stimulus; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid homeostasis; P:malonyl-CoA biosynthetic process; P:positive regulation of cellular metabolic process; P:protein homotetramerization; P:protein metabolic process; P:regulation of lipid metabolic process; P:tissue homeostasis;|Q86WB2 Q86WB3,Acetyl-CoA carboxylase 1 {ECO:0000303|PubMed:12810950},Acetyl-Coenzyme A carboxylase alpha;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0015629;GO:0005829;GO:0001650;GO:0003989;GO:0005524;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0071380;GO:0006633;GO:0046949;GO:0055088;GO:2001295;GO:0031325;GO:0051289;GO:0019538;GO:0019216;GO:0001894;, C:actin cytoskeleton; C:cytosol; C:fibrillar center;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:cellular response to prostaglandin E stimulus; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid homeostasis; P:malonyl-CoA biosynthetic process; P:positive regulation of cellular metabolic process; P:protein homotetramerization; P:protein metabolic process; P:regulation of lipid metabolic process; P:tissue homeostasis;|Q86WB2 Q86WB3,Acetyl-CoA carboxylase 1 {ECO:0000303|PubMed:12810950},Acetyl-Coenzyme A carboxylase alpha;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0015629;GO:0005829;GO:0001650;GO:0003989;GO:0005524;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0071380;GO:0006633;GO:0046949;GO:0055088;GO:2001295;GO:0031325;GO:0051289;GO:0019538;GO:0019216;GO:0001894;, C:actin cytoskeleton; C:cytosol; C:fibrillar center;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:cellular response to prostaglandin E stimulus; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid homeostasis; P:malonyl-CoA biosynthetic process; P:positive regulation of cellular metabolic process; P:protein homotetramerization; P:protein metabolic process; P:regulation of lipid metabolic process; P:tissue homeostasis;|Q86WB2 Q86WB3,Acetyl-CoA carboxylase 1 {ECO:0000303|PubMed:12810950},Acetyl-Coenzyme A carboxylase alpha;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0015629;GO:0005829;GO:0001650;GO:0003989;GO:0005524;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0071380;GO:0006633;GO:0046949;GO:0055088;GO:2001295;GO:0031325;GO:0051289;GO:0019538;GO:0019216;GO:0001894;, C:actin cytoskeleton; C:cytosol; C:fibrillar center;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:cellular response to prostaglandin E stimulus; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid homeostasis; P:malonyl-CoA biosynthetic process; P:positive regulation of cellular metabolic process; P:protein homotetramerization; P:protein metabolic process; P:regulation of lipid metabolic process; P:tissue homeostasis;|Q86WB2 Q86WB3,Acetyl-CoA carboxylase 1 {ECO:0000303|PubMed:12810950},Acetyl-Coenzyme A carboxylase alpha;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0015629;GO:0005829;GO:0001650;GO:0003989;GO:0005524;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0071380;GO:0006633;GO:0046949;GO:0055088;GO:2001295;GO:0031325;GO:0051289;GO:0019538;GO:0019216;GO:0001894;, C:actin cytoskeleton; C:cytosol; C:fibrillar center;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:cellular response to prostaglandin E stimulus; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid homeostasis; P:malonyl-CoA biosynthetic process; P:positive regulation of cellular metabolic process; P:protein homotetramerization; P:protein metabolic process; P:regulation of lipid metabolic process; P:tissue homeostasis; scaffold52 indexed_genome mRNA 4353752 4395753 . + . ID=transcript_9669;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|O75478 A8MVD0 B3KMU9 Q9BVJ0 Q9UCW2 Q9UP49,Transcriptional adapter 2-alpha,Transcriptional adapter 2-like;, PF00249;PF04433;, GO:0005694;GO:0005634;GO:0000125;GO:0070461;GO:0003682;GO:0003677;GO:0003713;GO:0006338;GO:0043966;GO:0035066;GO:0006357;, C:chromosome; C:nucleus; C:PCAF complex; C:SAGA-type complex;, F:chromatin binding; F:DNA binding; F:transcription coactivator activity;, P:chromatin remodeling; P:histone H3 acetylation; P:positive regulation of histone acetylation; P:regulation of transcription by RNA polymerase II;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|O75478 A8MVD0 B3KMU9 Q9BVJ0 Q9UCW2 Q9UP49,Transcriptional adapter 2-alpha,Transcriptional adapter 2-like;, PF00249;PF04433;, GO:0005694;GO:0005634;GO:0000125;GO:0070461;GO:0003682;GO:0003677;GO:0003713;GO:0006338;GO:0043966;GO:0035066;GO:0006357;, C:chromosome; C:nucleus; C:PCAF complex; C:SAGA-type complex;, F:chromatin binding; F:DNA binding; F:transcription coactivator activity;, P:chromatin remodeling; P:histone H3 acetylation; P:positive regulation of histone acetylation; P:regulation of transcription by RNA polymerase II;|O75478 A8MVD0 B3KMU9 Q9BVJ0 Q9UCW2 Q9UP49,Transcriptional adapter 2-alpha,Transcriptional adapter 2-like;, PF00249;PF04433;, GO:0005694;GO:0005634;GO:0000125;GO:0070461;GO:0003682;GO:0003677;GO:0003713;GO:0006338;GO:0043966;GO:0035066;GO:0006357;, C:chromosome; C:nucleus; C:PCAF complex; C:SAGA-type complex;, F:chromatin binding; F:DNA binding; F:transcription coactivator activity;, P:chromatin remodeling; P:histone H3 acetylation; P:positive regulation of histone acetylation; P:regulation of transcription by RNA polymerase II;|O75478 A8MVD0 B3KMU9 Q9BVJ0 Q9UCW2 Q9UP49,Transcriptional adapter 2-alpha,Transcriptional adapter 2-like;, PF00249;PF04433;, GO:0005694;GO:0005634;GO:0000125;GO:0070461;GO:0003682;GO:0003677;GO:0003713;GO:0006338;GO:0043966;GO:0035066;GO:0006357;, C:chromosome; C:nucleus; C:PCAF complex; C:SAGA-type complex;, F:chromatin binding; F:DNA binding; F:transcription coactivator activity;, P:chromatin remodeling; P:histone H3 acetylation; P:positive regulation of histone acetylation; P:regulation of transcription by RNA polymerase II; scaffold52 indexed_genome mRNA 4437919 4440066 . + . ID=transcript_9670;O95147,Dual specificity protein phosphatase 14,MKP-1-like protein tyrosine phosphatase;Mitogen-activated protein kinase phosphatase 6;, , GO:0017017;GO:0106306;GO:0106307;GO:0004725;GO:0003723;, , F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:RNA binding; scaffold52 indexed_genome mRNA 4442330 4520509 . - . ID=transcript_9671;Q9UMZ2 A8MWU4 B7ZKZ2 B7ZKZ3 Q17RI2 Q5BKU5 Q6ZT17,Synergin gamma,AP1 subunit gamma-binding protein 1;Gamma-synergin;, , GO:0030121;GO:0030130;GO:0005737;GO:0005794;GO:0006897;GO:0006886;, C:AP-1 adaptor complex; C:clathrin coat of trans-Golgi network vesicle; C:cytoplasm; C:Golgi apparatus;, , P:endocytosis; P:intracellular protein transport;|Q9UMZ2 A8MWU4 B7ZKZ2 B7ZKZ3 Q17RI2 Q5BKU5 Q6ZT17,Synergin gamma,AP1 subunit gamma-binding protein 1;Gamma-synergin;, , GO:0030121;GO:0030130;GO:0005737;GO:0005794;GO:0006897;GO:0006886;, C:AP-1 adaptor complex; C:clathrin coat of trans-Golgi network vesicle; C:cytoplasm; C:Golgi apparatus;, , P:endocytosis; P:intracellular protein transport;|Q9UMZ2 A8MWU4 B7ZKZ2 B7ZKZ3 Q17RI2 Q5BKU5 Q6ZT17,Synergin gamma,AP1 subunit gamma-binding protein 1;Gamma-synergin;, , GO:0030121;GO:0030130;GO:0005737;GO:0005794;GO:0006897;GO:0006886;, C:AP-1 adaptor complex; C:clathrin coat of trans-Golgi network vesicle; C:cytoplasm; C:Golgi apparatus;, , P:endocytosis; P:intracellular protein transport; scaffold52 indexed_genome mRNA 4538420 4560388 . - . ID=transcript_9672;Q9Y2R4 Q86YG1 Q8N213 Q9NVE0 Q9Y482,Probable ATP-dependent RNA helicase DDX52,ATP-dependent RNA helicase ROK1-like;DEAD box protein 52;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;GO:0030490;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:maturation of SSU-rRNA; P:rRNA processing;|Q9Y2R4 Q86YG1 Q8N213 Q9NVE0 Q9Y482,Probable ATP-dependent RNA helicase DDX52,ATP-dependent RNA helicase ROK1-like;DEAD box protein 52;, PF00270;PF00271;, GO:0016020;GO:0005730;GO:0005654;GO:0005524;GO:0003723;GO:0003724;GO:0030490;GO:0006364;, C:membrane; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:maturation of SSU-rRNA; P:rRNA processing; scaffold52 indexed_genome mRNA 4602347 4627147 . - . ID=transcript_9673;P35680 B4DKM3 E0YMJ9,Hepatocyte nuclear factor 1-beta,Homeoprotein LFB3;Transcription factor 2;Variant hepatic nuclear factor 1;, PF04814;PF04812;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0042802;GO:0042803;GO:0044877;GO:0000978;GO:0032922;GO:0048598;GO:0031018;GO:0048806;GO:0070365;GO:0030073;GO:0001822;GO:0031016;GO:0060261;GO:0045893;GO:0039020;GO:0048793;GO:0065004;GO:0035565;GO:0006357;GO:0009743;GO:0042493;GO:0014070;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein homodimerization activity; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:embryonic morphogenesis; P:endocrine pancreas development; P:genitalia development; P:hepatocyte differentiation; P:insulin secretion; P:kidney development; P:pancreas development; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:pronephric nephron tubule development; P:pronephros development; P:protein-DNA complex assembly; P:regulation of pronephros size; P:regulation of transcription by RNA polymerase II; P:response to carbohydrate; P:response to drug; P:response to organic cyclic compound; scaffold52 indexed_genome mRNA 4652301 4659714 . - . ID=transcript_9674;P35680 B4DKM3 E0YMJ9,Hepatocyte nuclear factor 1-beta,Homeoprotein LFB3;Transcription factor 2;Variant hepatic nuclear factor 1;, PF04814;PF04812;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0042802;GO:0042803;GO:0044877;GO:0000978;GO:0032922;GO:0048598;GO:0031018;GO:0048806;GO:0070365;GO:0030073;GO:0001822;GO:0031016;GO:0060261;GO:0045893;GO:0039020;GO:0048793;GO:0065004;GO:0035565;GO:0006357;GO:0009743;GO:0042493;GO:0014070;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein homodimerization activity; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:embryonic morphogenesis; P:endocrine pancreas development; P:genitalia development; P:hepatocyte differentiation; P:insulin secretion; P:kidney development; P:pancreas development; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:pronephric nephron tubule development; P:pronephros development; P:protein-DNA complex assembly; P:regulation of pronephros size; P:regulation of transcription by RNA polymerase II; P:response to carbohydrate; P:response to drug; P:response to organic cyclic compound; scaffold52 indexed_genome mRNA 4664250 4664862 . + . ID=transcript_9675;P35680 B4DKM3 E0YMJ9,Hepatocyte nuclear factor 1-beta,Homeoprotein LFB3;Transcription factor 2;Variant hepatic nuclear factor 1;, PF04814;PF04812;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0042802;GO:0042803;GO:0044877;GO:0000978;GO:0032922;GO:0048598;GO:0031018;GO:0048806;GO:0070365;GO:0030073;GO:0001822;GO:0031016;GO:0060261;GO:0045893;GO:0039020;GO:0048793;GO:0065004;GO:0035565;GO:0006357;GO:0009743;GO:0042493;GO:0014070;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein homodimerization activity; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:embryonic morphogenesis; P:endocrine pancreas development; P:genitalia development; P:hepatocyte differentiation; P:insulin secretion; P:kidney development; P:pancreas development; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:pronephric nephron tubule development; P:pronephros development; P:protein-DNA complex assembly; P:regulation of pronephros size; P:regulation of transcription by RNA polymerase II; P:response to carbohydrate; P:response to drug; P:response to organic cyclic compound; scaffold52 indexed_genome mRNA 4765109 4797204 . - . ID=transcript_9676;Q6AI08 B3KXP3 Q6MZX1 Q6MZY2 Q8TDM9 Q9H6B3 Q9H6M7,HEAT repeat-containing protein 6,Amplified in breast cancer protein 1;, PF13251;, GO:0003723;, , F:RNA binding;|Q6AI08 B3KXP3 Q6MZX1 Q6MZY2 Q8TDM9 Q9H6B3 Q9H6M7,HEAT repeat-containing protein 6,Amplified in breast cancer protein 1;, PF13251;, GO:0003723;, , F:RNA binding;|Q6AI08 B3KXP3 Q6MZX1 Q6MZY2 Q8TDM9 Q9H6B3 Q9H6M7,HEAT repeat-containing protein 6,Amplified in breast cancer protein 1;, PF13251;, GO:0003723;, , F:RNA binding; scaffold52 indexed_genome mRNA 4863390 4904791 . + . ID=transcript_9677;Q50EM7 Q50EM8 Q569J2 Q6NSB0,C-C motif chemokine 4-like,Lymphocyte activation gene 1 protein;Macrophage inflammatory protein 1-beta;Monocyte adherence-induced protein 5-alpha;Small-inducible cytokine A4-like;, PF00048;, GO:0005615;GO:0048020;GO:0008009;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0048245;GO:0007186;GO:0006954;GO:0048247;GO:0002548;GO:0030593;GO:0070374;GO:0043547;, C:extracellular space;, F:CCR chemokine receptor binding; F:chemokine activity;, P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:eosinophil chemotaxis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:neutrophil chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; scaffold52 indexed_genome mRNA 4948368 4950069 . - . ID=transcript_9678;P13236 P22617 Q13704 Q3SXL8 Q6FGI8,C-C motif chemokine 4,G-26 T-lymphocyte-secreted protein;HC21;Lymphocyte activation gene 1 protein;MIP-1-beta(1-69);Macrophage inflammatory protein 1-beta;PAT 744;Protein H400;SIS-gamma;Small-inducible cytokine A4;T-cell activation protein 2;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0031726;GO:0031730;GO:0008009;GO:0005125;GO:0042802;GO:0007155;GO:0007267;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0019221;GO:0048245;GO:0007163;GO:0007186;GO:0006955;GO:0006954;GO:0048247;GO:0002548;GO:0043922;GO:0030593;GO:0051928;GO:0050850;GO:0070374;GO:0043547;GO:2000503;GO:0009636;GO:0009615;GO:0007165;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:CCR1 chemokine receptor binding; F:CCR5 chemokine receptor binding; F:chemokine activity; F:cytokine activity; F:identical protein binding;, P:cell adhesion; P:cell-cell signaling; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:eosinophil chemotaxis; P:establishment or maintenance of cell polarity; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:negative regulation by host of viral transcription; P:neutrophil chemotaxis; P:positive regulation of calcium ion transport; P:positive regulation of calcium-mediated signaling; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of natural killer cell chemotaxis; P:response to toxic substance; P:response to virus; P:signal transduction; scaffold52 indexed_genome mRNA 4964234 4966184 . + . ID=transcript_9679;P16619 A6NGK6 B2RUX4 Q3B7A8 Q53YA5 Q96I68,C-C motif chemokine 3-like 1,G0/G1 switch regulatory protein 19-2;LD78-beta(1-70);PAT 464.2;Small-inducible cytokine A3-like 1;Tonsillar lymphocyte LD78 beta protein;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0008009;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0019221;GO:0007186;GO:0006954;GO:0048247;GO:0002548;GO:0008285;GO:0030593;GO:0070374;GO:0043547;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:chemokine activity;, P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:negative regulation of cell population proliferation; P:neutrophil chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; scaffold52 indexed_genome mRNA 5036779 5041175 . + . ID=transcript_9680;Q16663 B2RU34 E1P651 Q9UM74,C-C motif chemokine 15,Chemokine CC-2;Leukotactin-1;MIP-1 delta;Macrophage inflammatory protein 5;Mrp-2b;NCC-3;Small-inducible cytokine A15;, PF00048;, GO:0005615;GO:0048020;GO:0042056;GO:0008009;GO:0008201;GO:0005102;GO:0007267;GO:0006874;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0007186;GO:0006954;GO:0048247;GO:0002548;GO:0030593;GO:0070374;GO:0043547;GO:0007165;, C:extracellular space;, F:CCR chemokine receptor binding; F:chemoattractant activity; F:chemokine activity; F:heparin binding; F:signaling receptor binding;, P:cell-cell signaling; P:cellular calcium ion homeostasis; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:neutrophil chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:signal transduction;|Q16663 B2RU34 E1P651 Q9UM74,C-C motif chemokine 15,Chemokine CC-2;Leukotactin-1;MIP-1 delta;Macrophage inflammatory protein 5;Mrp-2b;NCC-3;Small-inducible cytokine A15;, PF00048;, GO:0005615;GO:0048020;GO:0042056;GO:0008009;GO:0008201;GO:0005102;GO:0007267;GO:0006874;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0007186;GO:0006954;GO:0048247;GO:0002548;GO:0030593;GO:0070374;GO:0043547;GO:0007165;, C:extracellular space;, F:CCR chemokine receptor binding; F:chemoattractant activity; F:chemokine activity; F:heparin binding; F:signaling receptor binding;, P:cell-cell signaling; P:cellular calcium ion homeostasis; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:neutrophil chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:signal transduction; scaffold52 indexed_genome mRNA 5057009 5062294 . + . ID=transcript_9681;Q16627 E1P649 E1P650 Q13954,C-C motif chemokine 14,Chemokine CC-1/CC-3;HCC-1(1-74);NCC-2;Small-inducible cytokine A14;, PF00048;, GO:0005615;GO:0048020;GO:0008009;GO:0006874;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0007186;GO:0006954;GO:0048247;GO:0002548;GO:0030593;GO:0008284;GO:0070374;GO:0043547;, C:extracellular space;, F:CCR chemokine receptor binding; F:chemokine activity;, P:cellular calcium ion homeostasis; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:neutrophil chemotaxis; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; scaffold52 indexed_genome mRNA 5063254 5068618 . - . ID=transcript_9682;O15467 Q4KKU0,C-C motif chemokine 16,Chemokine CC-4;Chemokine LEC;IL-10-inducible chemokine;LCC-1;Liver-expressed chemokine;Lymphocyte and monocyte chemoattractant;Monotactin-1;NCC-4;Small-inducible cytokine A16;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0042056;GO:0008009;GO:0007154;GO:0007267;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0007186;GO:0006954;GO:0048247;GO:0002548;GO:0030593;GO:0070374;GO:0043547;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:chemoattractant activity; F:chemokine activity;, P:cell communication; P:cell-cell signaling; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:neutrophil chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity;|O15467 Q4KKU0,C-C motif chemokine 16,Chemokine CC-4;Chemokine LEC;IL-10-inducible chemokine;LCC-1;Liver-expressed chemokine;Lymphocyte and monocyte chemoattractant;Monotactin-1;NCC-4;Small-inducible cytokine A16;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0042056;GO:0008009;GO:0007154;GO:0007267;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0007186;GO:0006954;GO:0048247;GO:0002548;GO:0030593;GO:0070374;GO:0043547;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:chemoattractant activity; F:chemokine activity;, P:cell communication; P:cell-cell signaling; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:neutrophil chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity;|O15467 Q4KKU0,C-C motif chemokine 16,Chemokine CC-4;Chemokine LEC;IL-10-inducible chemokine;LCC-1;Liver-expressed chemokine;Lymphocyte and monocyte chemoattractant;Monotactin-1;NCC-4;Small-inducible cytokine A16;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0042056;GO:0008009;GO:0007154;GO:0007267;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0007186;GO:0006954;GO:0048247;GO:0002548;GO:0030593;GO:0070374;GO:0043547;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:chemoattractant activity; F:chemokine activity;, P:cell communication; P:cell-cell signaling; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:neutrophil chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; scaffold52 indexed_genome mRNA 5103669 5110387 . + . ID=transcript_9683;P13501 O43646 Q0QVW8 Q4ZGJ1 Q9NYA2 Q9UBG2 Q9UC99,C-C motif chemokine 5,EoCP;Eosinophil chemotactic cytokine;SIS-delta;Small-inducible cytokine A5;T cell-specific protein P228;T-cell-specific protein RANTES;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0031726;GO:0031729;GO:0031730;GO:0042056;GO:0008009;GO:0046817;GO:0042379;GO:0042802;GO:0004435;GO:0016004;GO:0042803;GO:0004672;GO:0043621;GO:0030298;GO:0031584;GO:0006816;GO:0007267;GO:0006874;GO:0044344;GO:0071346;GO:0071347;GO:0071407;GO:0071356;GO:0070098;GO:0006935;GO:0019221;GO:0002407;GO:0048245;GO:0006887;GO:0007186;GO:0006954;GO:0007159;GO:0031663;GO:0048247;GO:0048246;GO:0000165;GO:0002548;GO:0043922;GO:0045744;GO:0070233;GO:0045071;GO:0042119;GO:0030593;GO:0010536;GO:0051928;GO:0045785;GO:0030335;GO:0033634;GO:0031328;GO:0070374;GO:0043547;GO:0034112;GO:0045089;GO:0010759;GO:0090026;GO:2000503;GO:0014068;GO:0042327;GO:0046427;GO:0014911;GO:0048661;GO:0070234;GO:0010820;GO:2000406;GO:0042102;GO:0045948;GO:0042531;GO:0045070;GO:0043491;GO:0002676;GO:0050796;GO:1901214;GO:0050863;GO:0009636;GO:0009615;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:CCR1 chemokine receptor binding; F:CCR4 chemokine receptor binding; F:CCR5 chemokine receptor binding; F:chemoattractant activity; F:chemokine activity; F:chemokine receptor antagonist activity; F:chemokine receptor binding; F:identical protein binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase activator activity; F:protein homodimerization activity; F:protein kinase activity; F:protein self-association; F:receptor signaling protein tyrosine kinase activator activity;, P:activation of phospholipase D activity; P:calcium ion transport; P:cell-cell signaling; P:cellular calcium ion homeostasis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:dendritic cell chemotaxis; P:eosinophil chemotaxis; P:exocytosis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:leukocyte cell-cell adhesion; P:lipopolysaccharide-mediated signaling pathway; P:lymphocyte chemotaxis; P:macrophage chemotaxis; P:MAPK cascade; P:monocyte chemotaxis; P:negative regulation by host of viral transcription; P:negative regulation of G protein-coupled receptor signaling pathway; P:negative regulation of T cell apoptotic process; P:negative regulation of viral genome replication; P:neutrophil activation; P:neutrophil chemotaxis; P:positive regulation of activation of Janus kinase activity; P:positive regulation of calcium ion transport; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of cellular biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of innate immune response; P:positive regulation of macrophage chemotaxis; P:positive regulation of monocyte chemotaxis; P:positive regulation of natural killer cell chemotaxis; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phosphorylation; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of T cell apoptotic process; P:positive regulation of T cell chemotaxis; P:positive regulation of T cell migration; P:positive regulation of T cell proliferation; P:positive regulation of translational initiation; P:positive regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of viral genome replication; P:protein kinase B signaling; P:regulation of chronic inflammatory response; P:regulation of insulin secretion; P:regulation of neuron death; P:regulation of T cell activation; P:response to toxic substance; P:response to virus; scaffold52 indexed_genome mRNA 5123645 5125493 . - . ID=transcript_9684;A2RTY3 B4DX21 B4DXA4 B4DXF0 Q8N4R4 Q96M46,Protein HEATR9,HEAT repeat-containing protein 9; scaffold52 indexed_genome mRNA 5127800 5133383 . - . ID=transcript_9685;A2RTY3 B4DX21 B4DXA4 B4DXF0 Q8N4R4 Q96M46,Protein HEATR9,HEAT repeat-containing protein 9; scaffold52 indexed_genome mRNA 5136070 5166203 . - . ID=transcript_9686;Q92804 B2R837 Q86X94 Q92751,TATA-binding protein-associated factor 2N,68 kDa TATA-binding protein-associated factor;RNA-binding protein 56;, PF00076;PF00641;, GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003723;GO:0003712;GO:0048255;GO:0045893;GO:1901796;GO:0006366;GO:0006367;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:RNA binding; F:transcription coregulator activity;, P:mRNA stabilization; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q92804 B2R837 Q86X94 Q92751,TATA-binding protein-associated factor 2N,68 kDa TATA-binding protein-associated factor;RNA-binding protein 56;, PF00076;PF00641;, GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003723;GO:0003712;GO:0048255;GO:0045893;GO:1901796;GO:0006366;GO:0006367;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:RNA binding; F:transcription coregulator activity;, P:mRNA stabilization; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold52 indexed_genome mRNA 5260631 5265826 . - . ID=transcript_9687;P63010 A6NJP3 P21851 Q7Z451 Q96J19,AP-2 complex subunit beta,AP105B;Adaptor protein complex AP-2 subunit beta;Adaptor-related protein complex 2 subunit beta;Beta-2-adaptin;Beta-adaptin;Clathrin assembly protein complex 2 beta large chain;Plasma membrane adaptor HA2/AP2 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030122;GO:0030131;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0098978;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0030276;GO:0044877;GO:0005048;GO:0019886;GO:0035904;GO:0048268;GO:0072583;GO:0060976;GO:0048013;GO:0006886;GO:0001822;GO:0034383;GO:0032802;GO:0061024;GO:1901215;GO:0045807;GO:1905477;GO:0098884;GO:0050690;GO:0048488;GO:0003281;GO:0016192;GO:0060071;, C:AP-2 adaptor complex; C:clathrin adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse;, F:clathrin binding; F:protein-containing complex binding; F:signal sequence binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:aorta development; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:coronary vasculature development; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:kidney development; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of neuron death; P:positive regulation of endocytosis; P:positive regulation of protein localization to membrane; P:postsynaptic neurotransmitter receptor internalization; P:regulation of defense response to virus by virus; P:synaptic vesicle endocytosis; P:ventricular septum development; P:vesicle-mediated transport; P:Wnt signaling pathway, planar cell polarity pathway; scaffold52 indexed_genome mRNA 5281384 5288558 . - . ID=transcript_9688;O00623 B2R6M2,Peroxisome assembly protein 12,Peroxin-12;Peroxisome assembly factor 3;, PF04757;, GO:0005829;GO:0005779;GO:1990429;GO:0005778;GO:0005777;GO:0008022;GO:0004842;GO:0008270;GO:0007031;GO:0016558;GO:0045046;GO:0008104;GO:0006513;GO:0006625;GO:0016567;, C:cytosol; C:integral component of peroxisomal membrane; C:peroxisomal importomer complex; C:peroxisomal membrane; C:peroxisome;, F:protein C-terminus binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein import into peroxisome membrane; P:protein localization; P:protein monoubiquitination; P:protein targeting to peroxisome; P:protein ubiquitination; scaffold52 indexed_genome mRNA 5423615 5454505 . - . ID=transcript_9689;Q8IWX7 Q495Q8 Q495Q9,Protein unc-45 homolog B,SMUNC45;, PF11701;, GO:0005829;GO:0051879;GO:0030154;GO:0061077;GO:0002088;GO:0007517;, C:cytosol;, F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:lens development in camera-type eye; P:muscle organ development;|Q8IWX7 Q495Q8 Q495Q9,Protein unc-45 homolog B,SMUNC45;, PF11701;, GO:0005829;GO:0051879;GO:0030154;GO:0061077;GO:0002088;GO:0007517;, C:cytosol;, F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:lens development in camera-type eye; P:muscle organ development;|Q8IWX7 Q495Q8 Q495Q9,Protein unc-45 homolog B,SMUNC45;, PF11701;, GO:0005829;GO:0051879;GO:0030154;GO:0061077;GO:0002088;GO:0007517;, C:cytosol;, F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:lens development in camera-type eye; P:muscle organ development;|Q8IWX7 Q495Q8 Q495Q9,Protein unc-45 homolog B,SMUNC45;, PF11701;, GO:0005829;GO:0051879;GO:0030154;GO:0061077;GO:0002088;GO:0007517;, C:cytosol;, F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:lens development in camera-type eye; P:muscle organ development;|Q8IWX7 Q495Q8 Q495Q9,Protein unc-45 homolog B,SMUNC45;, PF11701;, GO:0005829;GO:0051879;GO:0030154;GO:0061077;GO:0002088;GO:0007517;, C:cytosol;, F:Hsp90 protein binding;, P:cell differentiation; P:chaperone-mediated protein folding; P:lens development in camera-type eye; P:muscle organ development; scaffold52 indexed_genome mRNA 5462173 5469955 . + . ID=transcript_9690;Q9NVX2 O60868 Q59GJ8 Q9BU54,Notchless protein homolog 1,, PF08154;PF00400;, GO:0005730;GO:0005654;GO:0061484;GO:0001826;GO:0001822;GO:2001268;GO:0045930;GO:0007219;GO:0090263;GO:0000027;GO:0048705;GO:0001756;, C:nucleolus; C:nucleoplasm;, , P:hematopoietic stem cell homeostasis; P:inner cell mass cell differentiation; P:kidney development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of mitotic cell cycle; P:Notch signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:ribosomal large subunit assembly; P:skeletal system morphogenesis; P:somitogenesis;|Q9NVX2 O60868 Q59GJ8 Q9BU54,Notchless protein homolog 1,, PF08154;PF00400;, GO:0005730;GO:0005654;GO:0061484;GO:0001826;GO:0001822;GO:2001268;GO:0045930;GO:0007219;GO:0090263;GO:0000027;GO:0048705;GO:0001756;, C:nucleolus; C:nucleoplasm;, , P:hematopoietic stem cell homeostasis; P:inner cell mass cell differentiation; P:kidney development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of mitotic cell cycle; P:Notch signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:ribosomal large subunit assembly; P:skeletal system morphogenesis; P:somitogenesis;|Q9NVX2 O60868 Q59GJ8 Q9BU54,Notchless protein homolog 1,, PF08154;PF00400;, GO:0005730;GO:0005654;GO:0061484;GO:0001826;GO:0001822;GO:2001268;GO:0045930;GO:0007219;GO:0090263;GO:0000027;GO:0048705;GO:0001756;, C:nucleolus; C:nucleoplasm;, , P:hematopoietic stem cell homeostasis; P:inner cell mass cell differentiation; P:kidney development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of mitotic cell cycle; P:Notch signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:ribosomal large subunit assembly; P:skeletal system morphogenesis; P:somitogenesis;|Q9NVX2 O60868 Q59GJ8 Q9BU54,Notchless protein homolog 1,, PF08154;PF00400;, GO:0005730;GO:0005654;GO:0061484;GO:0001826;GO:0001822;GO:2001268;GO:0045930;GO:0007219;GO:0090263;GO:0000027;GO:0048705;GO:0001756;, C:nucleolus; C:nucleoplasm;, , P:hematopoietic stem cell homeostasis; P:inner cell mass cell differentiation; P:kidney development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of mitotic cell cycle; P:Notch signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:ribosomal large subunit assembly; P:skeletal system morphogenesis; P:somitogenesis;|Q9NVX2 O60868 Q59GJ8 Q9BU54,Notchless protein homolog 1,, PF08154;PF00400;, GO:0005730;GO:0005654;GO:0061484;GO:0001826;GO:0001822;GO:2001268;GO:0045930;GO:0007219;GO:0090263;GO:0000027;GO:0048705;GO:0001756;, C:nucleolus; C:nucleoplasm;, , P:hematopoietic stem cell homeostasis; P:inner cell mass cell differentiation; P:kidney development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of mitotic cell cycle; P:Notch signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:ribosomal large subunit assembly; P:skeletal system morphogenesis; P:somitogenesis; scaffold52 indexed_genome mRNA 5485801 5495040 . + . ID=transcript_9691;O76085 O94908 Q9UFU5,DNA repair protein RAD51 homolog 4,R51H3;RAD51 homolog D;RAD51-like protein 3;TRAD;, PF08423;, GO:0005813;GO:0000781;GO:0005737;GO:0005654;GO:0005634;GO:0033063;GO:0005657;GO:0005524;GO:0003677;GO:0008094;GO:0043015;GO:0003697;GO:0006281;GO:0000724;GO:0036297;GO:0007131;GO:0051726;GO:0042148;GO:0000723;GO:0000722;, C:centrosome; C:chromosome, telomeric region; C:cytoplasm; C:nucleoplasm; C:nucleus; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:replication fork;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:gamma-tubulin binding; F:single-stranded DNA binding;, P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:reciprocal meiotic recombination; P:regulation of cell cycle; P:strand invasion; P:telomere maintenance; P:telomere maintenance via recombination; scaffold52 indexed_genome mRNA 5575931 5618733 . + . ID=transcript_9692;Q8WZ73 E1P633 Q8NHW0 Q8TBY7 Q96BE6,E3 ubiquitin-protein ligase rififylin {ECO:0000305},Caspase regulator CARP2;Caspases-8 and -10-associated RING finger protein 2;FYVE-RING finger protein Sakura;RING finger and FYVE-like domain-containing protein 1;RING finger protein 189;RING finger protein 34-like;RING-type E3 ubiquitin transferase rififylin {ECO:0000305};, , GO:0005737;GO:0005829;GO:0010008;GO:0016020;GO:0005654;GO:0005886;GO:0055038;GO:0046872;GO:0002039;GO:0002020;GO:0019901;GO:0061630;GO:0031625;GO:0006915;GO:2001271;GO:1902042;GO:1901797;GO:0010804;GO:0043161;GO:0070936;GO:0010762;GO:1901796;GO:0032006;GO:0006511;, C:cytoplasm; C:cytosol; C:endosome membrane; C:membrane; C:nucleoplasm; C:plasma membrane; C:recycling endosome membrane;, F:metal ion binding; F:p53 binding; F:protease binding; F:protein kinase binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:regulation of fibroblast migration; P:regulation of signal transduction by p53 class mediator; P:regulation of TOR signaling; P:ubiquitin-dependent protein catabolic process;|Q8WZ73 E1P633 Q8NHW0 Q8TBY7 Q96BE6,E3 ubiquitin-protein ligase rififylin {ECO:0000305},Caspase regulator CARP2;Caspases-8 and -10-associated RING finger protein 2;FYVE-RING finger protein Sakura;RING finger and FYVE-like domain-containing protein 1;RING finger protein 189;RING finger protein 34-like;RING-type E3 ubiquitin transferase rififylin {ECO:0000305};, , GO:0005737;GO:0005829;GO:0010008;GO:0016020;GO:0005654;GO:0005886;GO:0055038;GO:0046872;GO:0002039;GO:0002020;GO:0019901;GO:0061630;GO:0031625;GO:0006915;GO:2001271;GO:1902042;GO:1901797;GO:0010804;GO:0043161;GO:0070936;GO:0010762;GO:1901796;GO:0032006;GO:0006511;, C:cytoplasm; C:cytosol; C:endosome membrane; C:membrane; C:nucleoplasm; C:plasma membrane; C:recycling endosome membrane;, F:metal ion binding; F:p53 binding; F:protease binding; F:protein kinase binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:regulation of fibroblast migration; P:regulation of signal transduction by p53 class mediator; P:regulation of TOR signaling; P:ubiquitin-dependent protein catabolic process;|Q8WZ73 E1P633 Q8NHW0 Q8TBY7 Q96BE6,E3 ubiquitin-protein ligase rififylin {ECO:0000305},Caspase regulator CARP2;Caspases-8 and -10-associated RING finger protein 2;FYVE-RING finger protein Sakura;RING finger and FYVE-like domain-containing protein 1;RING finger protein 189;RING finger protein 34-like;RING-type E3 ubiquitin transferase rififylin {ECO:0000305};, , GO:0005737;GO:0005829;GO:0010008;GO:0016020;GO:0005654;GO:0005886;GO:0055038;GO:0046872;GO:0002039;GO:0002020;GO:0019901;GO:0061630;GO:0031625;GO:0006915;GO:2001271;GO:1902042;GO:1901797;GO:0010804;GO:0043161;GO:0070936;GO:0010762;GO:1901796;GO:0032006;GO:0006511;, C:cytoplasm; C:cytosol; C:endosome membrane; C:membrane; C:nucleoplasm; C:plasma membrane; C:recycling endosome membrane;, F:metal ion binding; F:p53 binding; F:protease binding; F:protein kinase binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:regulation of fibroblast migration; P:regulation of signal transduction by p53 class mediator; P:regulation of TOR signaling; P:ubiquitin-dependent protein catabolic process;|Q8WZ73 E1P633 Q8NHW0 Q8TBY7 Q96BE6,E3 ubiquitin-protein ligase rififylin {ECO:0000305},Caspase regulator CARP2;Caspases-8 and -10-associated RING finger protein 2;FYVE-RING finger protein Sakura;RING finger and FYVE-like domain-containing protein 1;RING finger protein 189;RING finger protein 34-like;RING-type E3 ubiquitin transferase rififylin {ECO:0000305};, , GO:0005737;GO:0005829;GO:0010008;GO:0016020;GO:0005654;GO:0005886;GO:0055038;GO:0046872;GO:0002039;GO:0002020;GO:0019901;GO:0061630;GO:0031625;GO:0006915;GO:2001271;GO:1902042;GO:1901797;GO:0010804;GO:0043161;GO:0070936;GO:0010762;GO:1901796;GO:0032006;GO:0006511;, C:cytoplasm; C:cytosol; C:endosome membrane; C:membrane; C:nucleoplasm; C:plasma membrane; C:recycling endosome membrane;, F:metal ion binding; F:p53 binding; F:protease binding; F:protein kinase binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:regulation of fibroblast migration; P:regulation of signal transduction by p53 class mediator; P:regulation of TOR signaling; P:ubiquitin-dependent protein catabolic process;|P49916 E5KLB5 E5KLB6 Q16714 Q6NVK3,DNA ligase 3,DNA ligase III;Polydeoxyribonucleotide synthase [ATP] 3;, PF04679;PF01068;PF04675;PF16759;PF00645;, GO:0005737;GO:0070421;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0008270;GO:0006288;GO:0006287;GO:0007049;GO:0051301;GO:0071897;GO:0006266;GO:0006302;GO:0097681;GO:0000724;GO:0006273;GO:0043504;GO:0007005;GO:0090298;GO:0006297;GO:0006283;, C:cytoplasm; C:DNA ligase III-XRCC1 complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:zinc ion binding;, P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cell cycle; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via homologous recombination; P:lagging strand elongation; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of mitochondrial DNA replication; P:nucleotide-excision repair, DNA gap filling; P:transcription-coupled nucleotide-excision repair;|P49916 E5KLB5 E5KLB6 Q16714 Q6NVK3,DNA ligase 3,DNA ligase III;Polydeoxyribonucleotide synthase [ATP] 3;, PF04679;PF01068;PF04675;PF16759;PF00645;, GO:0005737;GO:0070421;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0008270;GO:0006288;GO:0006287;GO:0007049;GO:0051301;GO:0071897;GO:0006266;GO:0006302;GO:0097681;GO:0000724;GO:0006273;GO:0043504;GO:0007005;GO:0090298;GO:0006297;GO:0006283;, C:cytoplasm; C:DNA ligase III-XRCC1 complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:zinc ion binding;, P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cell cycle; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via homologous recombination; P:lagging strand elongation; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of mitochondrial DNA replication; P:nucleotide-excision repair, DNA gap filling; P:transcription-coupled nucleotide-excision repair;|P49916 E5KLB5 E5KLB6 Q16714 Q6NVK3,DNA ligase 3,DNA ligase III;Polydeoxyribonucleotide synthase [ATP] 3;, PF04679;PF01068;PF04675;PF16759;PF00645;, GO:0005737;GO:0070421;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0008270;GO:0006288;GO:0006287;GO:0007049;GO:0051301;GO:0071897;GO:0006266;GO:0006302;GO:0097681;GO:0000724;GO:0006273;GO:0043504;GO:0007005;GO:0090298;GO:0006297;GO:0006283;, C:cytoplasm; C:DNA ligase III-XRCC1 complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:zinc ion binding;, P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cell cycle; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via homologous recombination; P:lagging strand elongation; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of mitochondrial DNA replication; P:nucleotide-excision repair, DNA gap filling; P:transcription-coupled nucleotide-excision repair;|P49916 E5KLB5 E5KLB6 Q16714 Q6NVK3,DNA ligase 3,DNA ligase III;Polydeoxyribonucleotide synthase [ATP] 3;, PF04679;PF01068;PF04675;PF16759;PF00645;, GO:0005737;GO:0070421;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0008270;GO:0006288;GO:0006287;GO:0007049;GO:0051301;GO:0071897;GO:0006266;GO:0006302;GO:0097681;GO:0000724;GO:0006273;GO:0043504;GO:0007005;GO:0090298;GO:0006297;GO:0006283;, C:cytoplasm; C:DNA ligase III-XRCC1 complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:zinc ion binding;, P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cell cycle; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via homologous recombination; P:lagging strand elongation; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of mitochondrial DNA replication; P:nucleotide-excision repair, DNA gap filling; P:transcription-coupled nucleotide-excision repair;|P49916 E5KLB5 E5KLB6 Q16714 Q6NVK3,DNA ligase 3,DNA ligase III;Polydeoxyribonucleotide synthase [ATP] 3;, PF04679;PF01068;PF04675;PF16759;PF00645;, GO:0005737;GO:0070421;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0008270;GO:0006288;GO:0006287;GO:0007049;GO:0051301;GO:0071897;GO:0006266;GO:0006302;GO:0097681;GO:0000724;GO:0006273;GO:0043504;GO:0007005;GO:0090298;GO:0006297;GO:0006283;, C:cytoplasm; C:DNA ligase III-XRCC1 complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:zinc ion binding;, P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cell cycle; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via homologous recombination; P:lagging strand elongation; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of mitochondrial DNA replication; P:nucleotide-excision repair, DNA gap filling; P:transcription-coupled nucleotide-excision repair;|P49916 E5KLB5 E5KLB6 Q16714 Q6NVK3,DNA ligase 3,DNA ligase III;Polydeoxyribonucleotide synthase [ATP] 3;, PF04679;PF01068;PF04675;PF16759;PF00645;, GO:0005737;GO:0070421;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0008270;GO:0006288;GO:0006287;GO:0007049;GO:0051301;GO:0071897;GO:0006266;GO:0006302;GO:0097681;GO:0000724;GO:0006273;GO:0043504;GO:0007005;GO:0090298;GO:0006297;GO:0006283;, C:cytoplasm; C:DNA ligase III-XRCC1 complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:zinc ion binding;, P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cell cycle; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via homologous recombination; P:lagging strand elongation; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of mitochondrial DNA replication; P:nucleotide-excision repair, DNA gap filling; P:transcription-coupled nucleotide-excision repair;|P49916 E5KLB5 E5KLB6 Q16714 Q6NVK3,DNA ligase 3,DNA ligase III;Polydeoxyribonucleotide synthase [ATP] 3;, PF04679;PF01068;PF04675;PF16759;PF00645;, GO:0005737;GO:0070421;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0008270;GO:0006288;GO:0006287;GO:0007049;GO:0051301;GO:0071897;GO:0006266;GO:0006302;GO:0097681;GO:0000724;GO:0006273;GO:0043504;GO:0007005;GO:0090298;GO:0006297;GO:0006283;, C:cytoplasm; C:DNA ligase III-XRCC1 complex; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:zinc ion binding;, P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cell cycle; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via homologous recombination; P:lagging strand elongation; P:mitochondrial DNA repair; P:mitochondrion organization; P:negative regulation of mitochondrial DNA replication; P:nucleotide-excision repair, DNA gap filling; P:transcription-coupled nucleotide-excision repair; scaffold52 indexed_genome mRNA 5646489 5652550 . - . ID=transcript_9693;Q96NB3 Q96F60 Q96GZ5 Q9BU38,Zinc finger protein 830 {ECO:0000312|HGNC:HGNC:28291},Coiled-coil domain-containing protein 16 {ECO:0000305};, , GO:0005694;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003676;GO:0008270;GO:0001832;GO:0051301;GO:0051276;GO:0060729;GO:0044773;GO:0033314;GO:0006397;GO:0043066;GO:0033260;GO:0001541;GO:0001546;GO:0048478;GO:0008380;GO:0006283;, C:chromosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:nucleic acid binding; F:zinc ion binding;, P:blastocyst growth; P:cell division; P:chromosome organization; P:intestinal epithelial structure maintenance; P:mitotic DNA damage checkpoint; P:mitotic DNA replication checkpoint; P:mRNA processing; P:negative regulation of apoptotic process; P:nuclear DNA replication; P:ovarian follicle development; P:preantral ovarian follicle growth; P:replication fork protection; P:RNA splicing; P:transcription-coupled nucleotide-excision repair; scaffold52 indexed_genome mRNA 5654493 5688023 . + . ID=transcript_9694;Q92526 B4DX20 B4DYB0 Q8TC34,T-complex protein 1 subunit zeta-2,CCT-zeta-2;CCT-zeta-like;TCP-1-zeta-like;Testis-specific Tcp20;Testis-specific protein TSA303 {ECO:0000303|PubMed:8812458};, PF00118;, GO:0005832;GO:0005829;GO:0005524;GO:0016887;GO:0044183;GO:0051082;GO:0006457;GO:1901998;, C:chaperonin-containing T-complex; C:cytosol;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:unfolded protein binding;, P:protein folding; P:toxin transport; scaffold52 indexed_genome mRNA 5982385 5985616 . - . ID=transcript_9695;Q6IEE7 A0A0J9YW40 Q8WUF4 Q8WVA5,Transmembrane protein 132E {ECO:0000305},, PF16070;PF15706;PF15705;, GO:0044297;GO:0016021;GO:0035677;, C:cell body; C:integral component of membrane;, , P:posterior lateral line neuromast hair cell development; scaffold52 indexed_genome mRNA 5986755 5993071 . - . ID=transcript_9696;Q6IEE7 A0A0J9YW40 Q8WUF4 Q8WVA5,Transmembrane protein 132E {ECO:0000305},, PF16070;PF15706;PF15705;, GO:0044297;GO:0016021;GO:0035677;, C:cell body; C:integral component of membrane;, , P:posterior lateral line neuromast hair cell development; scaffold52 indexed_genome mRNA 5995586 6039878 . - . ID=transcript_9697;Q6IEE7 A0A0J9YW40 Q8WUF4 Q8WVA5,Transmembrane protein 132E {ECO:0000305},, PF16070;PF15706;PF15705;, GO:0044297;GO:0016021;GO:0035677;, C:cell body; C:integral component of membrane;, , P:posterior lateral line neuromast hair cell development; scaffold52 indexed_genome mRNA 6309954 6311975 . - . ID=transcript_9698;P80075 A0AV77 P78388,C-C motif chemokine 8,HC14;Monocyte chemoattractant protein 2;Monocyte chemotactic protein 2;Small-inducible cytokine A8;, PF00048;, GO:0005615;GO:0048020;GO:0008009;GO:0008201;GO:0016004;GO:0004672;GO:0061844;GO:0006816;GO:0007267;GO:0006874;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0048245;GO:0006887;GO:0007186;GO:0006954;GO:0031640;GO:0048247;GO:0002548;GO:0044828;GO:0070664;GO:0030593;GO:0070374;GO:0043547;GO:0002687;GO:0009615;GO:0007165;, C:extracellular space;, F:CCR chemokine receptor binding; F:chemokine activity; F:heparin binding; F:phospholipase activator activity; F:protein kinase activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:calcium ion transport; P:cell-cell signaling; P:cellular calcium ion homeostasis; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:eosinophil chemotaxis; P:exocytosis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:negative regulation by host of viral genome replication; P:negative regulation of leukocyte proliferation; P:neutrophil chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of leukocyte migration; P:response to virus; P:signal transduction; scaffold52 indexed_genome mRNA 6390573 6392445 . - . ID=transcript_9699;P13500 B2R4V3 Q9UDF3,C-C motif chemokine 2,HC11;Monocyte chemoattractant protein 1;Monocyte chemotactic and activating factor;Monocyte chemotactic protein 1;Monocyte secretory protein JE;Small-inducible cytokine A2;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0031727;GO:0008009;GO:0004672;GO:0005102;GO:0001525;GO:0009887;GO:0043615;GO:0007155;GO:0007166;GO:0019725;GO:0044344;GO:0071346;GO:0071347;GO:0071222;GO:0071407;GO:0071356;GO:0070098;GO:0006935;GO:0019221;GO:0007010;GO:0048245;GO:0007186;GO:0007187;GO:0035684;GO:0006959;GO:0006954;GO:0031663;GO:0048247;GO:0048246;GO:0000165;GO:0002548;GO:2000134;GO:0034351;GO:2000502;GO:0043524;GO:1905563;GO:0030593;GO:0036499;GO:2000427;GO:0090280;GO:2000353;GO:0070374;GO:0043547;GO:0051770;GO:1904783;GO:0051968;GO:0050870;GO:0043491;GO:0006468;GO:0007259;GO:0008360;GO:0009617;GO:0019233;GO:0007165;GO:0019079;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:CCR2 chemokine receptor binding; F:chemokine activity; F:protein kinase activity; F:signaling receptor binding;, P:angiogenesis; P:animal organ morphogenesis; P:astrocyte cell migration; P:cell adhesion; P:cell surface receptor signaling pathway; P:cellular homeostasis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to organic cyclic compound; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:cytoskeleton organization; P:eosinophil chemotaxis; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:helper T cell extravasation; P:humoral immune response; P:inflammatory response; P:lipopolysaccharide-mediated signaling pathway; P:lymphocyte chemotaxis; P:macrophage chemotaxis; P:MAPK cascade; P:monocyte chemotaxis; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of glial cell apoptotic process; P:negative regulation of natural killer cell chemotaxis; P:negative regulation of neuron apoptotic process; P:negative regulation of vascular endothelial cell proliferation; P:neutrophil chemotaxis; P:PERK-mediated unfolded protein response; P:positive regulation of apoptotic cell clearance; P:positive regulation of calcium ion import; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of NMDA glutamate receptor activity; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of T cell activation; P:protein kinase B signaling; P:protein phosphorylation; P:receptor signaling pathway via JAK-STAT; P:regulation of cell shape; P:response to bacterium; P:sensory perception of pain; P:signal transduction; P:viral genome replication;|P13500 B2R4V3 Q9UDF3,C-C motif chemokine 2,HC11;Monocyte chemoattractant protein 1;Monocyte chemotactic and activating factor;Monocyte chemotactic protein 1;Monocyte secretory protein JE;Small-inducible cytokine A2;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0031727;GO:0008009;GO:0004672;GO:0005102;GO:0001525;GO:0009887;GO:0043615;GO:0007155;GO:0007166;GO:0019725;GO:0044344;GO:0071346;GO:0071347;GO:0071222;GO:0071407;GO:0071356;GO:0070098;GO:0006935;GO:0019221;GO:0007010;GO:0048245;GO:0007186;GO:0007187;GO:0035684;GO:0006959;GO:0006954;GO:0031663;GO:0048247;GO:0048246;GO:0000165;GO:0002548;GO:2000134;GO:0034351;GO:2000502;GO:0043524;GO:1905563;GO:0030593;GO:0036499;GO:2000427;GO:0090280;GO:2000353;GO:0070374;GO:0043547;GO:0051770;GO:1904783;GO:0051968;GO:0050870;GO:0043491;GO:0006468;GO:0007259;GO:0008360;GO:0009617;GO:0019233;GO:0007165;GO:0019079;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:CCR2 chemokine receptor binding; F:chemokine activity; F:protein kinase activity; F:signaling receptor binding;, P:angiogenesis; P:animal organ morphogenesis; P:astrocyte cell migration; P:cell adhesion; P:cell surface receptor signaling pathway; P:cellular homeostasis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to organic cyclic compound; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:cytoskeleton organization; P:eosinophil chemotaxis; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:helper T cell extravasation; P:humoral immune response; P:inflammatory response; P:lipopolysaccharide-mediated signaling pathway; P:lymphocyte chemotaxis; P:macrophage chemotaxis; P:MAPK cascade; P:monocyte chemotaxis; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of glial cell apoptotic process; P:negative regulation of natural killer cell chemotaxis; P:negative regulation of neuron apoptotic process; P:negative regulation of vascular endothelial cell proliferation; P:neutrophil chemotaxis; P:PERK-mediated unfolded protein response; P:positive regulation of apoptotic cell clearance; P:positive regulation of calcium ion import; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of NMDA glutamate receptor activity; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of T cell activation; P:protein kinase B signaling; P:protein phosphorylation; P:receptor signaling pathway via JAK-STAT; P:regulation of cell shape; P:response to bacterium; P:sensory perception of pain; P:signal transduction; P:viral genome replication; scaffold52 indexed_genome mRNA 7783607 7794094 . - . ID=transcript_9700;Q9Y2Y6 E1P631 Q9UFK2,Transmembrane protein 98,Protein TADA1;, , GO:0005783;GO:0005789;GO:0070062;GO:0005615;GO:0016021;GO:0005886;GO:0031642;GO:0048715;GO:1900181;GO:0010955;GO:0045063;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of myelination; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of protein localization to nucleus; P:negative regulation of protein processing; P:T-helper 1 cell differentiation;|Q9Y2Y6 E1P631 Q9UFK2,Transmembrane protein 98,Protein TADA1;, , GO:0005783;GO:0005789;GO:0070062;GO:0005615;GO:0016021;GO:0005886;GO:0031642;GO:0048715;GO:1900181;GO:0010955;GO:0045063;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of myelination; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of protein localization to nucleus; P:negative regulation of protein processing; P:T-helper 1 cell differentiation;|Q9Y2Y6 E1P631 Q9UFK2,Transmembrane protein 98,Protein TADA1;, , GO:0005783;GO:0005789;GO:0070062;GO:0005615;GO:0016021;GO:0005886;GO:0031642;GO:0048715;GO:1900181;GO:0010955;GO:0045063;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of myelination; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of protein localization to nucleus; P:negative regulation of protein processing; P:T-helper 1 cell differentiation; scaffold52 indexed_genome mRNA 7832370 8189339 . + . ID=transcript_9701;O94832 A6H8V3 Q8NHP9,Unconventional myosin-Id,, PF00612;PF00063;PF06017;, GO:0015629;GO:0097440;GO:0030673;GO:0030424;GO:0016323;GO:0005903;GO:0005938;GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0005902;GO:0043209;GO:0016459;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0044853;GO:0005790;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0048306;GO:0005516;GO:0000146;GO:0019904;GO:0007015;GO:0051641;GO:0061502;GO:0030900;GO:0010923;GO:0015031;GO:0030050;, C:actin cytoskeleton; C:apical dendrite; C:axolemma; C:axon; C:basolateral plasma membrane; C:brush border; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:microvillus; C:myelin sheath; C:myosin complex; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:plasma membrane raft; C:smooth endoplasmic reticulum; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calcium-dependent protein binding; F:calmodulin binding; F:microfilament motor activity; F:protein domain specific binding;, P:actin filament organization; P:cellular localization; P:early endosome to recycling endosome transport; P:forebrain development; P:negative regulation of phosphatase activity; P:protein transport; P:vesicle transport along actin filament; scaffold52 indexed_genome mRNA 8208556 8235413 . - . ID=transcript_9702;O00231 A8K3I7 E1P663 O00495 Q53FT5,26S proteasome non-ATPase regulatory subunit 11,26S proteasome regulatory subunit RPN6;26S proteasome regulatory subunit S9;26S proteasome regulatory subunit p44.5;, PF01399;PF18503;PF18055;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0048863;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stem cell differentiation; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00231 A8K3I7 E1P663 O00495 Q53FT5,26S proteasome non-ATPase regulatory subunit 11,26S proteasome regulatory subunit RPN6;26S proteasome regulatory subunit S9;26S proteasome regulatory subunit p44.5;, PF01399;PF18503;PF18055;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0048863;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stem cell differentiation; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00231 A8K3I7 E1P663 O00495 Q53FT5,26S proteasome non-ATPase regulatory subunit 11,26S proteasome regulatory subunit RPN6;26S proteasome regulatory subunit S9;26S proteasome regulatory subunit p44.5;, PF01399;PF18503;PF18055;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0048863;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stem cell differentiation; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00231 A8K3I7 E1P663 O00495 Q53FT5,26S proteasome non-ATPase regulatory subunit 11,26S proteasome regulatory subunit RPN6;26S proteasome regulatory subunit S9;26S proteasome regulatory subunit p44.5;, PF01399;PF18503;PF18055;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0048863;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stem cell differentiation; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00231 A8K3I7 E1P663 O00495 Q53FT5,26S proteasome non-ATPase regulatory subunit 11,26S proteasome regulatory subunit RPN6;26S proteasome regulatory subunit S9;26S proteasome regulatory subunit p44.5;, PF01399;PF18503;PF18055;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0048863;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stem cell differentiation; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00231 A8K3I7 E1P663 O00495 Q53FT5,26S proteasome non-ATPase regulatory subunit 11,26S proteasome regulatory subunit RPN6;26S proteasome regulatory subunit S9;26S proteasome regulatory subunit p44.5;, PF01399;PF18503;PF18055;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0048863;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stem cell differentiation; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O00231 A8K3I7 E1P663 O00495 Q53FT5,26S proteasome non-ATPase regulatory subunit 11,26S proteasome regulatory subunit RPN6;26S proteasome regulatory subunit S9;26S proteasome regulatory subunit p44.5;, PF01399;PF18503;PF18055;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0048863;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stem cell differentiation; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold52 indexed_genome mRNA 8280477 8292469 . - . ID=transcript_9703;O43670 A8K6Y6 E1P660 E1P661 E1P662 Q53XS9 Q96HW5 Q9BUQ7,BUB3-interacting and GLEBS motif-containing protein ZNF207 {ECO:0000303|PubMed:24462186, ECO:0000303|PubMed:24462187},Zinc finger protein 207;, , GO:0000777;GO:0005737;GO:0000776;GO:0005874;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:1990047;GO:0003677;GO:0046872;GO:0008017;GO:0003723;GO:0008608;GO:0051301;GO:0001578;GO:0046785;GO:0000070;GO:0090307;GO:0007094;GO:0050821;GO:0051983;, C:condensed chromosome kinetochore; C:cytoplasm; C:kinetochore; C:microtubule; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle; C:spindle matrix;, F:DNA binding; F:metal ion binding; F:microtubule binding; F:RNA binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:microtubule bundle formation; P:microtubule polymerization; P:mitotic sister chromatid segregation; P:mitotic spindle assembly; P:mitotic spindle assembly checkpoint; P:protein stabilization; P:regulation of chromosome segregation; scaffold52 indexed_genome mRNA 8294123 8301594 . - . ID=transcript_9704;O43670 A8K6Y6 E1P660 E1P661 E1P662 Q53XS9 Q96HW5 Q9BUQ7,BUB3-interacting and GLEBS motif-containing protein ZNF207 {ECO:0000303|PubMed:24462186, ECO:0000303|PubMed:24462187},Zinc finger protein 207;, , GO:0000777;GO:0005737;GO:0000776;GO:0005874;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:1990047;GO:0003677;GO:0046872;GO:0008017;GO:0003723;GO:0008608;GO:0051301;GO:0001578;GO:0046785;GO:0000070;GO:0090307;GO:0007094;GO:0050821;GO:0051983;, C:condensed chromosome kinetochore; C:cytoplasm; C:kinetochore; C:microtubule; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle; C:spindle matrix;, F:DNA binding; F:metal ion binding; F:microtubule binding; F:RNA binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:microtubule bundle formation; P:microtubule polymerization; P:mitotic sister chromatid segregation; P:mitotic spindle assembly; P:mitotic spindle assembly checkpoint; P:protein stabilization; P:regulation of chromosome segregation; scaffold52 indexed_genome mRNA 8304276 8316970 . + . ID=transcript_9705;Q9HAS0 Q7Z2H4,Protein Njmu-R1,, PF15053;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi;|Q9HAS0 Q7Z2H4,Protein Njmu-R1,, PF15053;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi;|Q9HAS0 Q7Z2H4,Protein Njmu-R1,, PF15053;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi;|Q9HAS0 Q7Z2H4,Protein Njmu-R1,, PF15053;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi;|Q9HAS0 Q7Z2H4,Protein Njmu-R1,, PF15053;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi;|Q9HAS0 Q7Z2H4,Protein Njmu-R1,, PF15053;, GO:0031410;GO:0005802;GO:0006886;GO:0099041;, C:cytoplasmic vesicle; C:trans-Golgi network;, , P:intracellular protein transport; P:vesicle tethering to Golgi; scaffold52 indexed_genome mRNA 8319221 8353744 . - . ID=transcript_9706;P58872 A6NMH1 Q495Y4 Q495Y5 Q495Y6,Rhomboid-related protein 3,Ventrhoid transmembrane protein;, PF13499;PF01694;, GO:0016021;GO:0005509;GO:0004252;, C:integral component of membrane;, F:calcium ion binding; F:serine-type endopeptidase activity; scaffold52 indexed_genome mRNA 8411717 8415268 . + . ID=transcript_9707;Q86UB0 Q8IW28 Q8IXJ7 Q9H067 Q9H9N8 Q9NUZ2,Mitochondrial Rho GTPase 1,Rac-GTP-binding protein-like protein;Ras homolog gene family member T1;, PF08355;PF08356;PF00071;, GO:0005829;GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0005509;GO:0005525;GO:0003924;GO:0019725;GO:0034640;GO:0097345;GO:0007005;GO:0047497;GO:0016579;GO:0010821;GO:0046928;GO:1902513;GO:0051056;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:cellular homeostasis; P:establishment of mitochondrion localization by microtubule attachment; P:mitochondrial outer membrane permeabilization; P:mitochondrion organization; P:mitochondrion transport along microtubule; P:protein deubiquitination; P:regulation of mitochondrion organization; P:regulation of neurotransmitter secretion; P:regulation of organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction;|Q86UB0 Q8IW28 Q8IXJ7 Q9H067 Q9H9N8 Q9NUZ2,Mitochondrial Rho GTPase 1,Rac-GTP-binding protein-like protein;Ras homolog gene family member T1;, PF08355;PF08356;PF00071;, GO:0005829;GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0005509;GO:0005525;GO:0003924;GO:0019725;GO:0034640;GO:0097345;GO:0007005;GO:0047497;GO:0016579;GO:0010821;GO:0046928;GO:1902513;GO:0051056;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:cellular homeostasis; P:establishment of mitochondrion localization by microtubule attachment; P:mitochondrial outer membrane permeabilization; P:mitochondrion organization; P:mitochondrion transport along microtubule; P:protein deubiquitination; P:regulation of mitochondrion organization; P:regulation of neurotransmitter secretion; P:regulation of organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction; scaffold52 indexed_genome mRNA 8423880 8428721 . - . ID=transcript_9708;Q86UB0 Q8IW28 Q8IXJ7 Q9H067 Q9H9N8 Q9NUZ2,Mitochondrial Rho GTPase 1,Rac-GTP-binding protein-like protein;Ras homolog gene family member T1;, PF08355;PF08356;PF00071;, GO:0005829;GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0005509;GO:0005525;GO:0003924;GO:0019725;GO:0034640;GO:0097345;GO:0007005;GO:0047497;GO:0016579;GO:0010821;GO:0046928;GO:1902513;GO:0051056;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:cellular homeostasis; P:establishment of mitochondrion localization by microtubule attachment; P:mitochondrial outer membrane permeabilization; P:mitochondrion organization; P:mitochondrion transport along microtubule; P:protein deubiquitination; P:regulation of mitochondrion organization; P:regulation of neurotransmitter secretion; P:regulation of organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction; scaffold52 indexed_genome mRNA 8429300 8454079 . - . ID=transcript_9709;Q86UB0 Q8IW28 Q8IXJ7 Q9H067 Q9H9N8 Q9NUZ2,Mitochondrial Rho GTPase 1,Rac-GTP-binding protein-like protein;Ras homolog gene family member T1;, PF08355;PF08356;PF00071;, GO:0005829;GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0005509;GO:0005525;GO:0003924;GO:0019725;GO:0034640;GO:0097345;GO:0007005;GO:0047497;GO:0016579;GO:0010821;GO:0046928;GO:1902513;GO:0051056;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:cellular homeostasis; P:establishment of mitochondrion localization by microtubule attachment; P:mitochondrial outer membrane permeabilization; P:mitochondrion organization; P:mitochondrion transport along microtubule; P:protein deubiquitination; P:regulation of mitochondrion organization; P:regulation of neurotransmitter secretion; P:regulation of organelle transport along microtubule; P:regulation of small GTPase mediated signal transduction; scaffold52 indexed_genome mRNA 8503097 8525409 . - . ID=transcript_9710;Q9NPF8 Q8N4Q6 Q96SD5,Arf-GAP with dual PH domain-containing protein 2,Centaurin-alpha-2;, PF01412;PF00169;, GO:0005737;GO:0043231;GO:0005740;GO:0005886;GO:0005096;GO:0043533;GO:0046872;GO:0005547;GO:0043325;GO:0005546;GO:0030674;GO:0007507;GO:0048017;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrial envelope; C:plasma membrane;, F:GTPase activator activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-macromolecule adaptor activity;, P:heart development; P:inositol lipid-mediated signaling;|Q9NPF8 Q8N4Q6 Q96SD5,Arf-GAP with dual PH domain-containing protein 2,Centaurin-alpha-2;, PF01412;PF00169;, GO:0005737;GO:0043231;GO:0005740;GO:0005886;GO:0005096;GO:0043533;GO:0046872;GO:0005547;GO:0043325;GO:0005546;GO:0030674;GO:0007507;GO:0048017;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrial envelope; C:plasma membrane;, F:GTPase activator activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-macromolecule adaptor activity;, P:heart development; P:inositol lipid-mediated signaling; scaffold52 indexed_genome mRNA 8553516 8581055 . - . ID=transcript_9711;Q96QE3 Q05DH0 Q69YR6 Q9H9I1,ATPase family AAA domain-containing protein 5,Chromosome fragility-associated gene 1 protein;, PF00004;, GO:0031391;GO:0005634;GO:0005524;GO:0003677;GO:0061860;GO:0006974;GO:0090618;GO:1902751;GO:0045740;, C:Elg1 RFC-like complex; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp unloader activity;, P:cellular response to DNA damage stimulus; P:DNA clamp unloading; P:positive regulation of cell cycle G2/M phase transition; P:positive regulation of DNA replication;|Q96QE3 Q05DH0 Q69YR6 Q9H9I1,ATPase family AAA domain-containing protein 5,Chromosome fragility-associated gene 1 protein;, PF00004;, GO:0031391;GO:0005634;GO:0005524;GO:0003677;GO:0061860;GO:0006974;GO:0090618;GO:1902751;GO:0045740;, C:Elg1 RFC-like complex; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp unloader activity;, P:cellular response to DNA damage stimulus; P:DNA clamp unloading; P:positive regulation of cell cycle G2/M phase transition; P:positive regulation of DNA replication;|Q96QE3 Q05DH0 Q69YR6 Q9H9I1,ATPase family AAA domain-containing protein 5,Chromosome fragility-associated gene 1 protein;, PF00004;, GO:0031391;GO:0005634;GO:0005524;GO:0003677;GO:0061860;GO:0006974;GO:0090618;GO:1902751;GO:0045740;, C:Elg1 RFC-like complex; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp unloader activity;, P:cellular response to DNA damage stimulus; P:DNA clamp unloading; P:positive regulation of cell cycle G2/M phase transition; P:positive regulation of DNA replication;|Q96QE3 Q05DH0 Q69YR6 Q9H9I1,ATPase family AAA domain-containing protein 5,Chromosome fragility-associated gene 1 protein;, PF00004;, GO:0031391;GO:0005634;GO:0005524;GO:0003677;GO:0061860;GO:0006974;GO:0090618;GO:1902751;GO:0045740;, C:Elg1 RFC-like complex; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp unloader activity;, P:cellular response to DNA damage stimulus; P:DNA clamp unloading; P:positive regulation of cell cycle G2/M phase transition; P:positive regulation of DNA replication;|Q96QE3 Q05DH0 Q69YR6 Q9H9I1,ATPase family AAA domain-containing protein 5,Chromosome fragility-associated gene 1 protein;, PF00004;, GO:0031391;GO:0005634;GO:0005524;GO:0003677;GO:0061860;GO:0006974;GO:0090618;GO:1902751;GO:0045740;, C:Elg1 RFC-like complex; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA clamp unloader activity;, P:cellular response to DNA damage stimulus; P:DNA clamp unloading; P:positive regulation of cell cycle G2/M phase transition; P:positive regulation of DNA replication; scaffold52 indexed_genome mRNA 8616307 8643080 . + . ID=transcript_9712;Q8IUI8 A6NJF3 B2R8C3 Q2MLY7 Q9UNI3 Q9Y6M8,Cytokine receptor-like factor 3,Cytokine receptor-like molecule 9;Cytokine receptor-related protein 4;Type I cytokine receptor-like factor p48;, , GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0003677;GO:0042802;GO:0000082;GO:0030308;GO:0071158;GO:0046427;GO:0045944;GO:0045893;, C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;, F:DNA binding; F:identical protein binding;, P:G1/S transition of mitotic cell cycle; P:negative regulation of cell growth; P:positive regulation of cell cycle arrest; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated;|Q8IUI8 A6NJF3 B2R8C3 Q2MLY7 Q9UNI3 Q9Y6M8,Cytokine receptor-like factor 3,Cytokine receptor-like molecule 9;Cytokine receptor-related protein 4;Type I cytokine receptor-like factor p48;, , GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0003677;GO:0042802;GO:0000082;GO:0030308;GO:0071158;GO:0046427;GO:0045944;GO:0045893;, C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;, F:DNA binding; F:identical protein binding;, P:G1/S transition of mitotic cell cycle; P:negative regulation of cell growth; P:positive regulation of cell cycle arrest; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated;|Q8IUI8 A6NJF3 B2R8C3 Q2MLY7 Q9UNI3 Q9Y6M8,Cytokine receptor-like factor 3,Cytokine receptor-like molecule 9;Cytokine receptor-related protein 4;Type I cytokine receptor-like factor p48;, , GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0003677;GO:0042802;GO:0000082;GO:0030308;GO:0071158;GO:0046427;GO:0045944;GO:0045893;, C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;, F:DNA binding; F:identical protein binding;, P:G1/S transition of mitotic cell cycle; P:negative regulation of cell growth; P:positive regulation of cell cycle arrest; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; scaffold52 indexed_genome mRNA 8651778 8688194 . - . ID=transcript_9713;Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle;|Q15022 Q96BD9,Polycomb protein SUZ12,Chromatin precipitated E2F target 9 protein;Joined to JAZF1 protein;Suppressor of zeste 12 protein homolog;, PF09733;, GO:0035098;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0031490;GO:0042054;GO:0046872;GO:0035064;GO:0001226;GO:0098532;GO:0045596;GO:0032682;GO:0050680;GO:0070317;GO:0045814;GO:0042532;GO:0032526;GO:0021510;GO:0019058;, C:ESC/E(Z) complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:histone methyltransferase activity; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:histone H3-K27 trimethylation; P:negative regulation of cell differentiation; P:negative regulation of chemokine production; P:negative regulation of epithelial cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of tyrosine phosphorylation of STAT protein; P:response to retinoic acid; P:spinal cord development; P:viral life cycle; scaffold52 indexed_genome mRNA 8717115 8743870 . + . ID=transcript_9714;Q9NYH9 Q8IX96 Q96BL2 Q9NQ91,U3 small nucleolar RNA-associated protein 6 homolog,Hepatocellular carcinoma-associated antigen 66;Multiple hat domains protein;, PF08640;, GO:0005694;GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0030515;GO:0000462;GO:0006364;, C:chromosome; C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9NYH9 Q8IX96 Q96BL2 Q9NQ91,U3 small nucleolar RNA-associated protein 6 homolog,Hepatocellular carcinoma-associated antigen 66;Multiple hat domains protein;, PF08640;, GO:0005694;GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0030515;GO:0000462;GO:0006364;, C:chromosome; C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9NYH9 Q8IX96 Q96BL2 Q9NQ91,U3 small nucleolar RNA-associated protein 6 homolog,Hepatocellular carcinoma-associated antigen 66;Multiple hat domains protein;, PF08640;, GO:0005694;GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0030515;GO:0000462;GO:0006364;, C:chromosome; C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9NYH9 Q8IX96 Q96BL2 Q9NQ91,U3 small nucleolar RNA-associated protein 6 homolog,Hepatocellular carcinoma-associated antigen 66;Multiple hat domains protein;, PF08640;, GO:0005694;GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0030515;GO:0000462;GO:0006364;, C:chromosome; C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9NYH9 Q8IX96 Q96BL2 Q9NQ91,U3 small nucleolar RNA-associated protein 6 homolog,Hepatocellular carcinoma-associated antigen 66;Multiple hat domains protein;, PF08640;, GO:0005694;GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0030515;GO:0000462;GO:0006364;, C:chromosome; C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9NYH9 Q8IX96 Q96BL2 Q9NQ91,U3 small nucleolar RNA-associated protein 6 homolog,Hepatocellular carcinoma-associated antigen 66;Multiple hat domains protein;, PF08640;, GO:0005694;GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0030515;GO:0000462;GO:0006364;, C:chromosome; C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q9NYH9 Q8IX96 Q96BL2 Q9NQ91,U3 small nucleolar RNA-associated protein 6 homolog,Hepatocellular carcinoma-associated antigen 66;Multiple hat domains protein;, PF08640;, GO:0005694;GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0030515;GO:0000462;GO:0006364;, C:chromosome; C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing; scaffold52 indexed_genome mRNA 8745557 8755284 . + . ID=transcript_9715;Q9NQ92 A6NP14 E1P656 Q96EF5 Q96P75,Coordinator of PRMT5 and differentiation stimulator,Cooperator of PRMT5;Protein TTP1;, PF15340;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0042393;GO:0043985;GO:0007517;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:histone binding;, P:histone H4-R3 methylation; P:muscle organ development; scaffold52 indexed_genome mRNA 9001237 9015025 . - . ID=transcript_9716;Q86YS3 Q52LI1 Q8N829 Q8NDT7 Q969D8,Rab11 family-interacting protein 4,Arfophilin-2;, PF09457;, GO:0032154;GO:0030139;GO:0005768;GO:0005615;GO:0005815;GO:0030496;GO:0048471;GO:0055038;GO:0005819;GO:0005509;GO:0042803;GO:0031267;GO:0032456;GO:0003407;GO:1903452;GO:0032465;GO:0016032;, C:cleavage furrow; C:endocytic vesicle; C:endosome; C:extracellular space; C:microtubule organizing center; C:midbody; C:perinuclear region of cytoplasm; C:recycling endosome membrane; C:spindle;, F:calcium ion binding; F:protein homodimerization activity; F:small GTPase binding;, P:endocytic recycling; P:neural retina development; P:positive regulation of G1 to G0 transition; P:regulation of cytokinesis; P:viral process; scaffold52 indexed_genome mRNA 9119840 9274658 . - . ID=transcript_9717;P21359 O00662 Q14284 Q14930 Q14931 Q9UMK3,Neurofibromin,Neurofibromatosis-related protein NF-1;, PF13716;PF00616;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0016020;GO:0005730;GO:0005634;GO:0005096;GO:0031210;GO:0008429;GO:0030036;GO:0030325;GO:0048844;GO:0007420;GO:0048593;GO:0007154;GO:0021987;GO:0050890;GO:0030199;GO:0030198;GO:0021897;GO:0048853;GO:0007507;GO:0001889;GO:0000165;GO:0001656;GO:0022011;GO:0030336;GO:0001937;GO:0048147;GO:0043407;GO:0043409;GO:0007406;GO:0048715;GO:0006469;GO:0001649;GO:0007422;GO:0014065;GO:0043473;GO:0045762;GO:0043065;GO:0043547;GO:0043525;GO:0007265;GO:0045765;GO:0043535;GO:0045124;GO:0001952;GO:0045685;GO:0043087;GO:0001666;GO:0014044;GO:0048745;GO:0021510;GO:0048485;GO:0008542;GO:0042060;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:membrane; C:nucleolus; C:nucleus;, F:GTPase activator activity; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding;, P:actin cytoskeleton organization; P:adrenal gland development; P:artery morphogenesis; P:brain development; P:camera-type eye morphogenesis; P:cell communication; P:cerebral cortex development; P:cognition; P:collagen fibril organization; P:extracellular matrix organization; P:forebrain astrocyte development; P:forebrain morphogenesis; P:heart development; P:liver development; P:MAPK cascade; P:metanephros development; P:myelination in peripheral nervous system; P:negative regulation of cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of MAP kinase activity; P:negative regulation of MAPK cascade; P:negative regulation of neuroblast proliferation; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of protein kinase activity; P:osteoblast differentiation; P:peripheral nervous system development; P:phosphatidylinositol 3-kinase signaling; P:pigmentation; P:positive regulation of adenylate cyclase activity; P:positive regulation of apoptotic process; P:positive regulation of GTPase activity; P:positive regulation of neuron apoptotic process; P:Ras protein signal transduction; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of bone resorption; P:regulation of cell-matrix adhesion; P:regulation of glial cell differentiation; P:regulation of GTPase activity; P:response to hypoxia; P:Schwann cell development; P:smooth muscle tissue development; P:spinal cord development; P:sympathetic nervous system development; P:visual learning; P:wound healing;|P21359 O00662 Q14284 Q14930 Q14931 Q9UMK3,Neurofibromin,Neurofibromatosis-related protein NF-1;, PF13716;PF00616;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0016020;GO:0005730;GO:0005634;GO:0005096;GO:0031210;GO:0008429;GO:0030036;GO:0030325;GO:0048844;GO:0007420;GO:0048593;GO:0007154;GO:0021987;GO:0050890;GO:0030199;GO:0030198;GO:0021897;GO:0048853;GO:0007507;GO:0001889;GO:0000165;GO:0001656;GO:0022011;GO:0030336;GO:0001937;GO:0048147;GO:0043407;GO:0043409;GO:0007406;GO:0048715;GO:0006469;GO:0001649;GO:0007422;GO:0014065;GO:0043473;GO:0045762;GO:0043065;GO:0043547;GO:0043525;GO:0007265;GO:0045765;GO:0043535;GO:0045124;GO:0001952;GO:0045685;GO:0043087;GO:0001666;GO:0014044;GO:0048745;GO:0021510;GO:0048485;GO:0008542;GO:0042060;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:membrane; C:nucleolus; C:nucleus;, F:GTPase activator activity; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding;, P:actin cytoskeleton organization; P:adrenal gland development; P:artery morphogenesis; P:brain development; P:camera-type eye morphogenesis; P:cell communication; P:cerebral cortex development; P:cognition; P:collagen fibril organization; P:extracellular matrix organization; P:forebrain astrocyte development; P:forebrain morphogenesis; P:heart development; P:liver development; P:MAPK cascade; P:metanephros development; P:myelination in peripheral nervous system; P:negative regulation of cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of MAP kinase activity; P:negative regulation of MAPK cascade; P:negative regulation of neuroblast proliferation; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of protein kinase activity; P:osteoblast differentiation; P:peripheral nervous system development; P:phosphatidylinositol 3-kinase signaling; P:pigmentation; P:positive regulation of adenylate cyclase activity; P:positive regulation of apoptotic process; P:positive regulation of GTPase activity; P:positive regulation of neuron apoptotic process; P:Ras protein signal transduction; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of bone resorption; P:regulation of cell-matrix adhesion; P:regulation of glial cell differentiation; P:regulation of GTPase activity; P:response to hypoxia; P:Schwann cell development; P:smooth muscle tissue development; P:spinal cord development; P:sympathetic nervous system development; P:visual learning; P:wound healing;|P22794 B2R5X2 B4DHX8,Protein EVI2A,Ecotropic viral integration site 2A protein homolog;, PF05399;, GO:0016021;GO:0004888;, C:integral component of membrane;, F:transmembrane signaling receptor activity;|P34910 B7Z4A7,Protein EVI2B {ECO:0000305},Ecotropic viral integration site 2B protein homolog;, , GO:0005887;GO:0061515;GO:0043066;GO:0071157;GO:0030854;GO:0045660;GO:2000035;, C:integral component of plasma membrane;, , P:myeloid cell development; P:negative regulation of apoptotic process; P:negative regulation of cell cycle arrest; P:positive regulation of granulocyte differentiation; P:positive regulation of neutrophil differentiation; P:regulation of stem cell division;|P23515 E1P659,Oligodendrocyte-myelin glycoprotein,, PF00560;PF13855;PF01462;, GO:0031225;GO:0005886;GO:0007155;GO:0050771;GO:0031102;, C:anchored component of membrane; C:plasma membrane;, , P:cell adhesion; P:negative regulation of axonogenesis; P:neuron projection regeneration; scaffold52 indexed_genome mRNA 9446120 9462835 . + . ID=transcript_9718;Q9Y6I7 Q9NRB1 Q9UBH9 Q9UG25 Q9UNN6 Q9Y656,WD repeat and SOCS box-containing protein 1,SOCS box-containing WD protein SWiP-1;, PF07525;PF00400;, GO:0005829;GO:0035556;GO:0043687;GO:0000209;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein polyubiquitination;|Q9Y6I7 Q9NRB1 Q9UBH9 Q9UG25 Q9UNN6 Q9Y656,WD repeat and SOCS box-containing protein 1,SOCS box-containing WD protein SWiP-1;, PF07525;PF00400;, GO:0005829;GO:0035556;GO:0043687;GO:0000209;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein polyubiquitination;|Q9Y6I7 Q9NRB1 Q9UBH9 Q9UG25 Q9UNN6 Q9Y656,WD repeat and SOCS box-containing protein 1,SOCS box-containing WD protein SWiP-1;, PF07525;PF00400;, GO:0005829;GO:0035556;GO:0043687;GO:0000209;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein polyubiquitination;|Q9Y6I7 Q9NRB1 Q9UBH9 Q9UG25 Q9UNN6 Q9Y656,WD repeat and SOCS box-containing protein 1,SOCS box-containing WD protein SWiP-1;, PF07525;PF00400;, GO:0005829;GO:0035556;GO:0043687;GO:0000209;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein polyubiquitination; scaffold52 indexed_genome mRNA 9670512 9711880 . + . ID=transcript_9719;Q8IVT5 F8WEA9 H7BYU0 Q13476,Kinase suppressor of Ras 1,, PF07714;PF13543;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0016020;GO:0032991;GO:0032587;GO:0071889;GO:0005524;GO:0005078;GO:0046872;GO:0008022;GO:0004672;GO:0106310;GO:0106311;GO:0000185;GO:0019933;GO:0000165;GO:0043410;GO:0007265;GO:0042127;GO:0043405;GO:0007165;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:protein-containing complex; C:ruffle membrane;, F:14-3-3 protein binding; F:ATP binding; F:MAP-kinase scaffold activity; F:metal ion binding; F:protein C-terminus binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKKK activity; P:cAMP-mediated signaling; P:MAPK cascade; P:positive regulation of MAPK cascade; P:Ras protein signal transduction; P:regulation of cell population proliferation; P:regulation of MAP kinase activity; P:signal transduction; scaffold52 indexed_genome mRNA 9748665 9751891 . + . ID=transcript_9720;Q6DKI2 B0AZM7,Galectin-9C,Galectin-9-like protein B;, PF00337;, GO:0005829;GO:0005634;GO:0030246;GO:0016936;GO:2000562;GO:0032689;GO:0010628;, C:cytosol; C:nucleus;, F:carbohydrate binding; F:galactoside binding;, P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of interferon-gamma production; P:positive regulation of gene expression; scaffold52 indexed_genome mRNA 9861252 9865550 . + . ID=transcript_9721;Q3B8N2 A6NLF8 A8K2J8,Galectin-9B,Galectin-9-like protein A;, PF00337;, GO:0005829;GO:0005634;GO:0030246;GO:0016936;GO:2000562;GO:0032689;GO:0010628;, C:cytosol; C:nucleus;, F:carbohydrate binding; F:galactoside binding;, P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of interferon-gamma production; P:positive regulation of gene expression; scaffold52 indexed_genome mRNA 9865578 9868118 . + . ID=transcript_9722;O00182 A7VJG6 F8W9W4 O14532 O75028 Q3B8N1 Q53FQ0 Q8WYQ7 Q9NQ58,Galectin-9,Ecalectin;Tumor antigen HOM-HD-21;, PF00337;, GO:0062023;GO:0005737;GO:0005829;GO:0005615;GO:0005634;GO:0030246;GO:0048030;GO:0019899;GO:0005534;GO:0016936;GO:0071346;GO:0098586;GO:0006935;GO:0070371;GO:0007565;GO:0006954;GO:0060135;GO:0002519;GO:0046007;GO:2000562;GO:0032682;GO:0010629;GO:0032689;GO:0043305;GO:0045953;GO:0032720;GO:0038066;GO:0070241;GO:2000563;GO:0032834;GO:2001269;GO:2000670;GO:2000510;GO:2001200;GO:0070374;GO:0010628;GO:0043123;GO:0032729;GO:0032731;GO:0032733;GO:0032735;GO:0032736;GO:0032753;GO:0032755;GO:0032757;GO:0071639;GO:0051092;GO:1901224;GO:2001190;GO:0071636;GO:0032760;GO:0046598;GO:0070555;GO:0032496;, C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular space; C:nucleus;, F:carbohydrate binding; F:disaccharide binding; F:enzyme binding; F:galactose binding; F:galactoside binding;, P:cellular response to interferon-gamma; P:cellular response to virus; P:chemotaxis; P:ERK1 and ERK2 cascade; P:female pregnancy; P:inflammatory response; P:maternal process involved in female pregnancy; P:natural killer cell tolerance induction; P:negative regulation of activated T cell proliferation; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of chemokine production; P:negative regulation of gene expression; P:negative regulation of interferon-gamma production; P:negative regulation of mast cell degranulation; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of tumor necrosis factor production; P:p38MAPK cascade; P:positive regulation of activated T cell autonomous cell death; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; P:positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of dendritic cell differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of monocyte chemotactic protein-1 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:positive regulation of transforming growth factor beta production; P:positive regulation of tumor necrosis factor production; P:positive regulation of viral entry into host cell; P:response to interleukin-1; P:response to lipopolysaccharide;|Q6DKI2 B0AZM7,Galectin-9C,Galectin-9-like protein B;, PF00337;, GO:0005829;GO:0005634;GO:0030246;GO:0016936;GO:2000562;GO:0032689;GO:0010628;, C:cytosol; C:nucleus;, F:carbohydrate binding; F:galactoside binding;, P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of interferon-gamma production; P:positive regulation of gene expression; scaffold52 indexed_genome mRNA 9971139 9975717 . + . ID=transcript_9723;A8MSI8 A6NJT7 Q6X7B8,LYR motif-containing protein 9,, PF05347; scaffold52 indexed_genome mRNA 10120617 10244521 . + . ID=transcript_9724;Q9UBE8 B2RCX1 Q2PNI9 Q6P2A3,Serine/threonine-protein kinase NLK,Nemo-like kinase;Protein LAK1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0106311;GO:0042169;GO:0008134;GO:0031625;GO:0035556;GO:0030178;GO:0018107;GO:0046777;GO:0006468;GO:0050821;GO:0010468;GO:0006355;GO:0042501;GO:0007179;GO:0007223;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:SH2 domain binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:intracellular signal transduction; P:negative regulation of Wnt signaling pathway; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of gene expression; P:regulation of transcription, DNA-templated; P:serine phosphorylation of STAT protein; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|Q9UBE8 B2RCX1 Q2PNI9 Q6P2A3,Serine/threonine-protein kinase NLK,Nemo-like kinase;Protein LAK1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0106311;GO:0042169;GO:0008134;GO:0031625;GO:0035556;GO:0030178;GO:0018107;GO:0046777;GO:0006468;GO:0050821;GO:0010468;GO:0006355;GO:0042501;GO:0007179;GO:0007223;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:SH2 domain binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:intracellular signal transduction; P:negative regulation of Wnt signaling pathway; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of gene expression; P:regulation of transcription, DNA-templated; P:serine phosphorylation of STAT protein; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|Q9UBE8 B2RCX1 Q2PNI9 Q6P2A3,Serine/threonine-protein kinase NLK,Nemo-like kinase;Protein LAK1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0106311;GO:0042169;GO:0008134;GO:0031625;GO:0035556;GO:0030178;GO:0018107;GO:0046777;GO:0006468;GO:0050821;GO:0010468;GO:0006355;GO:0042501;GO:0007179;GO:0007223;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:SH2 domain binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:intracellular signal transduction; P:negative regulation of Wnt signaling pathway; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of gene expression; P:regulation of transcription, DNA-templated; P:serine phosphorylation of STAT protein; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|Q9UBE8 B2RCX1 Q2PNI9 Q6P2A3,Serine/threonine-protein kinase NLK,Nemo-like kinase;Protein LAK1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0106311;GO:0042169;GO:0008134;GO:0031625;GO:0035556;GO:0030178;GO:0018107;GO:0046777;GO:0006468;GO:0050821;GO:0010468;GO:0006355;GO:0042501;GO:0007179;GO:0007223;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:SH2 domain binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:intracellular signal transduction; P:negative regulation of Wnt signaling pathway; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of gene expression; P:regulation of transcription, DNA-templated; P:serine phosphorylation of STAT protein; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|Q9UBE8 B2RCX1 Q2PNI9 Q6P2A3,Serine/threonine-protein kinase NLK,Nemo-like kinase;Protein LAK1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0106311;GO:0042169;GO:0008134;GO:0031625;GO:0035556;GO:0030178;GO:0018107;GO:0046777;GO:0006468;GO:0050821;GO:0010468;GO:0006355;GO:0042501;GO:0007179;GO:0007223;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:SH2 domain binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:intracellular signal transduction; P:negative regulation of Wnt signaling pathway; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of gene expression; P:regulation of transcription, DNA-templated; P:serine phosphorylation of STAT protein; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, calcium modulating pathway;|Q9UBE8 B2RCX1 Q2PNI9 Q6P2A3,Serine/threonine-protein kinase NLK,Nemo-like kinase;Protein LAK1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0004672;GO:0106310;GO:0106311;GO:0042169;GO:0008134;GO:0031625;GO:0035556;GO:0030178;GO:0018107;GO:0046777;GO:0006468;GO:0050821;GO:0010468;GO:0006355;GO:0042501;GO:0007179;GO:0007223;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:SH2 domain binding; F:transcription factor binding; F:ubiquitin protein ligase binding;, P:intracellular signal transduction; P:negative regulation of Wnt signaling pathway; P:peptidyl-threonine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of gene expression; P:regulation of transcription, DNA-templated; P:serine phosphorylation of STAT protein; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, calcium modulating pathway; scaffold52 indexed_genome mRNA 10269695 10292574 . - . ID=transcript_9725;Q5BJF2 B4DS02 Q07823,Sigma intracellular receptor 2 {ECO:0000305},Meningioma-associated protein 30 {ECO:0000303|PubMed:7694637};Transmembrane protein 97 {ECO:0000312|HGNC:HGNC:28106};, , GO:0005783;GO:0016021;GO:0005764;GO:0031965;GO:0005886;GO:0005791;GO:0030867;GO:0042632;GO:0001558;, C:endoplasmic reticulum; C:integral component of membrane; C:lysosome; C:nuclear membrane; C:plasma membrane; C:rough endoplasmic reticulum; C:rough endoplasmic reticulum membrane;, , P:cholesterol homeostasis; P:regulation of cell growth;|Q8IY31 J3QL09 Q5GLZ2 Q9BUG5,Intraflagellar transport protein 20 homolog,, PF14931;, GO:0005814;GO:0005813;GO:0097546;GO:0097542;GO:0005929;GO:0005801;GO:0044292;GO:0005794;GO:0000139;GO:0030992;GO:1902636;GO:0005902;GO:0031514;GO:0032391;GO:0001750;GO:0032420;GO:0002046;GO:0031267;GO:0055007;GO:0051642;GO:0060271;GO:0090102;GO:0045198;GO:0001736;GO:0060122;GO:0042073;GO:0035735;GO:0001822;GO:0061351;GO:0036372;GO:0035845;GO:0061512;GO:0034067;GO:0072659;GO:2000785;GO:0060828;GO:1902017;GO:2000583;GO:0007224;GO:0007283;GO:0008542;, C:centriole; C:centrosome; C:ciliary base; C:ciliary tip; C:cilium; C:cis-Golgi network; C:dendrite terminus; C:Golgi apparatus; C:Golgi membrane; C:intraciliary transport particle B; C:kinociliary basal body; C:microvillus; C:motile cilium; C:photoreceptor connecting cilium; C:photoreceptor outer segment; C:stereocilium;, F:opsin binding; F:small GTPase binding;, P:cardiac muscle cell differentiation; P:centrosome localization; P:cilium assembly; P:cochlea development; P:establishment of epithelial cell apical/basal polarity; P:establishment of planar polarity; P:inner ear receptor cell stereocilium organization; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:neural precursor cell proliferation; P:opsin transport; P:photoreceptor cell outer segment organization; P:protein localization to cilium; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:regulation of autophagosome assembly; P:regulation of canonical Wnt signaling pathway; P:regulation of cilium assembly; P:regulation of platelet-derived growth factor receptor-alpha signaling pathway; P:smoothened signaling pathway; P:spermatogenesis; P:visual learning;|Q8IY31 J3QL09 Q5GLZ2 Q9BUG5,Intraflagellar transport protein 20 homolog,, PF14931;, GO:0005814;GO:0005813;GO:0097546;GO:0097542;GO:0005929;GO:0005801;GO:0044292;GO:0005794;GO:0000139;GO:0030992;GO:1902636;GO:0005902;GO:0031514;GO:0032391;GO:0001750;GO:0032420;GO:0002046;GO:0031267;GO:0055007;GO:0051642;GO:0060271;GO:0090102;GO:0045198;GO:0001736;GO:0060122;GO:0042073;GO:0035735;GO:0001822;GO:0061351;GO:0036372;GO:0035845;GO:0061512;GO:0034067;GO:0072659;GO:2000785;GO:0060828;GO:1902017;GO:2000583;GO:0007224;GO:0007283;GO:0008542;, C:centriole; C:centrosome; C:ciliary base; C:ciliary tip; C:cilium; C:cis-Golgi network; C:dendrite terminus; C:Golgi apparatus; C:Golgi membrane; C:intraciliary transport particle B; C:kinociliary basal body; C:microvillus; C:motile cilium; C:photoreceptor connecting cilium; C:photoreceptor outer segment; C:stereocilium;, F:opsin binding; F:small GTPase binding;, P:cardiac muscle cell differentiation; P:centrosome localization; P:cilium assembly; P:cochlea development; P:establishment of epithelial cell apical/basal polarity; P:establishment of planar polarity; P:inner ear receptor cell stereocilium organization; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:neural precursor cell proliferation; P:opsin transport; P:photoreceptor cell outer segment organization; P:protein localization to cilium; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:regulation of autophagosome assembly; P:regulation of canonical Wnt signaling pathway; P:regulation of cilium assembly; P:regulation of platelet-derived growth factor receptor-alpha signaling pathway; P:smoothened signaling pathway; P:spermatogenesis; P:visual learning;|Q13829 B7Z6M4 Q5TZQ1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2,BTB/POZ domain-containing protein TNFAIP1;Protein B12;Tumor necrosis factor, alpha-induced protein 1, endothelial;, PF02214;, GO:0031463;GO:0005737;GO:0005768;GO:0005634;GO:0042802;GO:0031267;GO:0006915;GO:0016477;GO:0006955;GO:0035024;GO:0045740;GO:0043161;GO:0051260;GO:0016567;GO:0043149;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:endosome; C:nucleus;, F:identical protein binding; F:small GTPase binding;, P:apoptotic process; P:cell migration; P:immune response; P:negative regulation of Rho protein signal transduction; P:positive regulation of DNA replication; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; P:stress fiber assembly;|Q13829 B7Z6M4 Q5TZQ1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2,BTB/POZ domain-containing protein TNFAIP1;Protein B12;Tumor necrosis factor, alpha-induced protein 1, endothelial;, PF02214;, GO:0031463;GO:0005737;GO:0005768;GO:0005634;GO:0042802;GO:0031267;GO:0006915;GO:0016477;GO:0006955;GO:0035024;GO:0045740;GO:0043161;GO:0051260;GO:0016567;GO:0043149;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:endosome; C:nucleus;, F:identical protein binding; F:small GTPase binding;, P:apoptotic process; P:cell migration; P:immune response; P:negative regulation of Rho protein signal transduction; P:positive regulation of DNA replication; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; P:stress fiber assembly;|Q13829 B7Z6M4 Q5TZQ1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2,BTB/POZ domain-containing protein TNFAIP1;Protein B12;Tumor necrosis factor, alpha-induced protein 1, endothelial;, PF02214;, GO:0031463;GO:0005737;GO:0005768;GO:0005634;GO:0042802;GO:0031267;GO:0006915;GO:0016477;GO:0006955;GO:0035024;GO:0045740;GO:0043161;GO:0051260;GO:0016567;GO:0043149;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:endosome; C:nucleus;, F:identical protein binding; F:small GTPase binding;, P:apoptotic process; P:cell migration; P:immune response; P:negative regulation of Rho protein signal transduction; P:positive regulation of DNA replication; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; P:stress fiber assembly;|Q13829 B7Z6M4 Q5TZQ1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2,BTB/POZ domain-containing protein TNFAIP1;Protein B12;Tumor necrosis factor, alpha-induced protein 1, endothelial;, PF02214;, GO:0031463;GO:0005737;GO:0005768;GO:0005634;GO:0042802;GO:0031267;GO:0006915;GO:0016477;GO:0006955;GO:0035024;GO:0045740;GO:0043161;GO:0051260;GO:0016567;GO:0043149;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:endosome; C:nucleus;, F:identical protein binding; F:small GTPase binding;, P:apoptotic process; P:cell migration; P:immune response; P:negative regulation of Rho protein signal transduction; P:positive regulation of DNA replication; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; P:stress fiber assembly; scaffold52 indexed_genome mRNA 10292582 10305225 . - . ID=transcript_9726;Q13829 B7Z6M4 Q5TZQ1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2,BTB/POZ domain-containing protein TNFAIP1;Protein B12;Tumor necrosis factor, alpha-induced protein 1, endothelial;, PF02214;, GO:0031463;GO:0005737;GO:0005768;GO:0005634;GO:0042802;GO:0031267;GO:0006915;GO:0016477;GO:0006955;GO:0035024;GO:0045740;GO:0043161;GO:0051260;GO:0016567;GO:0043149;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:endosome; C:nucleus;, F:identical protein binding; F:small GTPase binding;, P:apoptotic process; P:cell migration; P:immune response; P:negative regulation of Rho protein signal transduction; P:positive regulation of DNA replication; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; P:stress fiber assembly;|Q9Y2S7 B2R846 Q96JE4,Polymerase delta-interacting protein 2 {ECO:0000303|PubMed:26984527},38 kDa DNA polymerase delta interaction protein {ECO:0000303|PubMed:12522211};, PF04379;PF08755;, GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0003677;GO:0070987;GO:0070584;GO:0016242;GO:0045931;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:DNA binding;, P:error-free translesion synthesis; P:mitochondrion morphogenesis; P:negative regulation of macroautophagy; P:positive regulation of mitotic cell cycle;|Q9Y2S7 B2R846 Q96JE4,Polymerase delta-interacting protein 2 {ECO:0000303|PubMed:26984527},38 kDa DNA polymerase delta interaction protein {ECO:0000303|PubMed:12522211};, PF04379;PF08755;, GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0003677;GO:0070987;GO:0070584;GO:0016242;GO:0045931;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:DNA binding;, P:error-free translesion synthesis; P:mitochondrion morphogenesis; P:negative regulation of macroautophagy; P:positive regulation of mitotic cell cycle;|Q9Y2S7 B2R846 Q96JE4,Polymerase delta-interacting protein 2 {ECO:0000303|PubMed:26984527},38 kDa DNA polymerase delta interaction protein {ECO:0000303|PubMed:12522211};, PF04379;PF08755;, GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0003677;GO:0070987;GO:0070584;GO:0016242;GO:0045931;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:DNA binding;, P:error-free translesion synthesis; P:mitochondrion morphogenesis; P:negative regulation of macroautophagy; P:positive regulation of mitotic cell cycle; scaffold52 indexed_genome mRNA 10305267 10310209 . + . ID=transcript_9727;Q8N511,Transmembrane protein 199 {ECO:0000303|PubMed:26833330},, PF11712;, GO:0030663;GO:0012505;GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0005764;GO:0016471;GO:0006879;GO:0036295;GO:0007042;GO:1905146;GO:0070072;, C:COPI-coated vesicle membrane; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lysosome; C:vacuolar proton-transporting V-type ATPase complex;, , P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:lysosomal lumen acidification; P:lysosomal protein catabolic process; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q8N511,Transmembrane protein 199 {ECO:0000303|PubMed:26833330},, PF11712;, GO:0030663;GO:0012505;GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0005764;GO:0016471;GO:0006879;GO:0036295;GO:0007042;GO:1905146;GO:0070072;, C:COPI-coated vesicle membrane; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lysosome; C:vacuolar proton-transporting V-type ATPase complex;, , P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:lysosomal lumen acidification; P:lysosomal protein catabolic process; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q8N511,Transmembrane protein 199 {ECO:0000303|PubMed:26833330},, PF11712;, GO:0030663;GO:0012505;GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0005764;GO:0016471;GO:0006879;GO:0036295;GO:0007042;GO:1905146;GO:0070072;, C:COPI-coated vesicle membrane; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lysosome; C:vacuolar proton-transporting V-type ATPase complex;, , P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:lysosomal lumen acidification; P:lysosomal protein catabolic process; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q8N511,Transmembrane protein 199 {ECO:0000303|PubMed:26833330},, PF11712;, GO:0030663;GO:0012505;GO:0005783;GO:0005789;GO:0033116;GO:0016021;GO:0005764;GO:0016471;GO:0006879;GO:0036295;GO:0007042;GO:1905146;GO:0070072;, C:COPI-coated vesicle membrane; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane; C:lysosome; C:vacuolar proton-transporting V-type ATPase complex;, , P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:lysosomal lumen acidification; P:lysosomal protein catabolic process; P:vacuolar proton-transporting V-type ATPase complex assembly; scaffold52 indexed_genome mRNA 10316705 10318991 . - . ID=transcript_9728;Q9HB31 F6T8T6,Homeobox protein SEBOX,Homeobox OG-9;Skin-, embryo-, brain- and oocyte-specific homeobox;, PF00046;, GO:0005634;GO:0003677;GO:0000981;GO:0009792;GO:0048477;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific;, P:embryo development ending in birth or egg hatching; P:oogenesis; P:regulation of transcription by RNA polymerase II; scaffold52 indexed_genome mRNA 10319782 10322753 . + . ID=transcript_9729;P04004 B2R7G0 P01141 Q9BSH7,Vitronectin,S-protein;Serum-spreading factor;V75;, PF00045;PF01033;, GO:0071062;GO:0072562;GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005201;GO:0008201;GO:0005178;GO:0030247;GO:0005044;GO:0007155;GO:0033627;GO:0016477;GO:0007160;GO:0035987;GO:0030198;GO:0006955;GO:0030195;GO:0010951;GO:0050731;GO:0032092;GO:0048260;GO:0014911;GO:0030949;GO:0090303;GO:0030449;GO:0061302;, C:alphav-beta3 integrin-vitronectin complex; C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:extracellular matrix structural constituent; F:heparin binding; F:integrin binding; F:polysaccharide binding; F:scavenger receptor activity;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:endodermal cell differentiation; P:extracellular matrix organization; P:immune response; P:negative regulation of blood coagulation; P:negative regulation of endopeptidase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein binding; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of smooth muscle cell migration; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of wound healing; P:regulation of complement activation; P:smooth muscle cell-matrix adhesion;|P04004 B2R7G0 P01141 Q9BSH7,Vitronectin,S-protein;Serum-spreading factor;V75;, PF00045;PF01033;, GO:0071062;GO:0072562;GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005201;GO:0008201;GO:0005178;GO:0030247;GO:0005044;GO:0007155;GO:0033627;GO:0016477;GO:0007160;GO:0035987;GO:0030198;GO:0006955;GO:0030195;GO:0010951;GO:0050731;GO:0032092;GO:0048260;GO:0014911;GO:0030949;GO:0090303;GO:0030449;GO:0061302;, C:alphav-beta3 integrin-vitronectin complex; C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:extracellular matrix structural constituent; F:heparin binding; F:integrin binding; F:polysaccharide binding; F:scavenger receptor activity;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:endodermal cell differentiation; P:extracellular matrix organization; P:immune response; P:negative regulation of blood coagulation; P:negative regulation of endopeptidase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein binding; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of smooth muscle cell migration; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of wound healing; P:regulation of complement activation; P:smooth muscle cell-matrix adhesion;|P04004 B2R7G0 P01141 Q9BSH7,Vitronectin,S-protein;Serum-spreading factor;V75;, PF00045;PF01033;, GO:0071062;GO:0072562;GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005201;GO:0008201;GO:0005178;GO:0030247;GO:0005044;GO:0007155;GO:0033627;GO:0016477;GO:0007160;GO:0035987;GO:0030198;GO:0006955;GO:0030195;GO:0010951;GO:0050731;GO:0032092;GO:0048260;GO:0014911;GO:0030949;GO:0090303;GO:0030449;GO:0061302;, C:alphav-beta3 integrin-vitronectin complex; C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle;, F:extracellular matrix structural constituent; F:heparin binding; F:integrin binding; F:polysaccharide binding; F:scavenger receptor activity;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:endodermal cell differentiation; P:extracellular matrix organization; P:immune response; P:negative regulation of blood coagulation; P:negative regulation of endopeptidase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein binding; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of smooth muscle cell migration; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of wound healing; P:regulation of complement activation; P:smooth muscle cell-matrix adhesion; scaffold52 indexed_genome mRNA 10324288 10353225 . + . ID=transcript_9730;Q6SZW1 O60277 Q7LGG3 Q9NXY5,NAD(+) hydrolase SARM1 {ECO:0000305},NADP(+) hydrolase SARM1 {ECO:0000305};Sterile alpha and Armadillo repeat protein {ECO:0000303|PubMed:11386760};Sterile alpha and TIR motif-containing protein 1 {ECO:0000303|PubMed:18089857, ECO:0000303|Ref.2};Sterile alpha motif domain-containing protein 2 {ECO:0000303|PubMed:17724133};Tir-1 homolog {ECO:0000303|PubMed:15123841};, PF07647;PF13676;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0031315;GO:0005874;GO:0005739;GO:0045202;GO:0042802;GO:0050135;GO:0003953;GO:0061809;GO:0035591;GO:0030154;GO:0045087;GO:0019677;GO:0034128;GO:0007399;GO:1901216;GO:0042981;GO:0048814;GO:1901214;GO:0048678;GO:0009749;GO:0007165;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of mitochondrial outer membrane; C:microtubule; C:mitochondrion; C:synapse;, F:identical protein binding; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:signaling adaptor activity;, P:cell differentiation; P:innate immune response; P:NAD catabolic process; P:negative regulation of MyD88-independent toll-like receptor signaling pathway; P:nervous system development; P:positive regulation of neuron death; P:regulation of apoptotic process; P:regulation of dendrite morphogenesis; P:regulation of neuron death; P:response to axon injury; P:response to glucose; P:signal transduction;|Q96NT5 Q1HE20 Q86T92 Q8TEG3 Q96FL0,Proton-coupled folate transporter,G21;Heme carrier protein 1;PCFT/HCP1;Solute carrier family 46 member 1;, PF07690;, GO:0016324;GO:0016323;GO:0031526;GO:0009986;GO:0005737;GO:0016021;GO:0005886;GO:0005542;GO:0008517;GO:0015350;GO:0015078;GO:0006879;GO:1904447;GO:0046655;GO:0015884;GO:0015886;GO:0098829;GO:0051958;GO:1902600;, C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:cell surface; C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:folic acid binding; F:folic acid transmembrane transporter activity; F:methotrexate transmembrane transporter activity; F:proton transmembrane transporter activity;, P:cellular iron ion homeostasis; P:folate import across plasma membrane; P:folic acid metabolic process; P:folic acid transport; P:heme transport; P:intestinal folate absorption; P:methotrexate transport; P:proton transmembrane transport;|Q96NT5 Q1HE20 Q86T92 Q8TEG3 Q96FL0,Proton-coupled folate transporter,G21;Heme carrier protein 1;PCFT/HCP1;Solute carrier family 46 member 1;, PF07690;, GO:0016324;GO:0016323;GO:0031526;GO:0009986;GO:0005737;GO:0016021;GO:0005886;GO:0005542;GO:0008517;GO:0015350;GO:0015078;GO:0006879;GO:1904447;GO:0046655;GO:0015884;GO:0015886;GO:0098829;GO:0051958;GO:1902600;, C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:cell surface; C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:folic acid binding; F:folic acid transmembrane transporter activity; F:methotrexate transmembrane transporter activity; F:proton transmembrane transporter activity;, P:cellular iron ion homeostasis; P:folate import across plasma membrane; P:folic acid metabolic process; P:folic acid transport; P:heme transport; P:intestinal folate absorption; P:methotrexate transport; P:proton transmembrane transport;|Q96NT5 Q1HE20 Q86T92 Q8TEG3 Q96FL0,Proton-coupled folate transporter,G21;Heme carrier protein 1;PCFT/HCP1;Solute carrier family 46 member 1;, PF07690;, GO:0016324;GO:0016323;GO:0031526;GO:0009986;GO:0005737;GO:0016021;GO:0005886;GO:0005542;GO:0008517;GO:0015350;GO:0015078;GO:0006879;GO:1904447;GO:0046655;GO:0015884;GO:0015886;GO:0098829;GO:0051958;GO:1902600;, C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:cell surface; C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:folic acid binding; F:folic acid transmembrane transporter activity; F:methotrexate transmembrane transporter activity; F:proton transmembrane transporter activity;, P:cellular iron ion homeostasis; P:folate import across plasma membrane; P:folic acid metabolic process; P:folic acid transport; P:heme transport; P:intestinal folate absorption; P:methotrexate transport; P:proton transmembrane transport; scaffold52 indexed_genome mRNA 10429182 10430472 . + . ID=transcript_9731;Q13183 B2RBI9 B4DPL1 E7ETH5 Q4VAR7,Solute carrier family 13 member 2,Na(+)/dicarboxylate cotransporter 1;Renal sodium/dicarboxylate cotransporter;, PF00939;, GO:0070062;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0015361;GO:0015141;GO:0098656;GO:0071422;, C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:low-affinity sodium:dicarboxylate symporter activity; F:succinate transmembrane transporter activity;, P:anion transmembrane transport; P:succinate transmembrane transport; scaffold52 indexed_genome mRNA 10472655 10475097 . - . ID=transcript_9732;Q13432 A8K8G4 F1T095 O95126,Protein unc-119 homolog A,Retinal protein 4;, PF05351;, GO:0005813;GO:0005829;GO:0045171;GO:0051233;GO:0000922;GO:0045202;GO:0008289;GO:0007268;GO:0006897;GO:0042953;GO:0000281;GO:2001287;GO:1900186;GO:0007399;GO:0007602;GO:0061098;GO:0007601;, C:centrosome; C:cytosol; C:intercellular bridge; C:spindle midzone; C:spindle pole; C:synapse;, F:lipid binding;, P:chemical synaptic transmission; P:endocytosis; P:lipoprotein transport; P:mitotic cytokinesis; P:negative regulation of caveolin-mediated endocytosis; P:negative regulation of clathrin-dependent endocytosis; P:nervous system development; P:phototransduction; P:positive regulation of protein tyrosine kinase activity; P:visual perception;|Q13432 A8K8G4 F1T095 O95126,Protein unc-119 homolog A,Retinal protein 4;, PF05351;, GO:0005813;GO:0005829;GO:0045171;GO:0051233;GO:0000922;GO:0045202;GO:0008289;GO:0007268;GO:0006897;GO:0042953;GO:0000281;GO:2001287;GO:1900186;GO:0007399;GO:0007602;GO:0061098;GO:0007601;, C:centrosome; C:cytosol; C:intercellular bridge; C:spindle midzone; C:spindle pole; C:synapse;, F:lipid binding;, P:chemical synaptic transmission; P:endocytosis; P:lipoprotein transport; P:mitotic cytokinesis; P:negative regulation of caveolin-mediated endocytosis; P:negative regulation of clathrin-dependent endocytosis; P:nervous system development; P:phototransduction; P:positive regulation of protein tyrosine kinase activity; P:visual perception; scaffold52 indexed_genome mRNA 10484022 10495828 . - . ID=transcript_9733;Q96S52 Q6UVX6,GPI transamidase component PIG-S,Phosphatidylinositol-glycan biosynthesis class S protein;, PF10510;, GO:0005789;GO:0042765;GO:0016020;GO:0016255;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane;, , P:attachment of GPI anchor to protein;|Q96S52 Q6UVX6,GPI transamidase component PIG-S,Phosphatidylinositol-glycan biosynthesis class S protein;, PF10510;, GO:0005789;GO:0042765;GO:0016020;GO:0016255;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane;, , P:attachment of GPI anchor to protein;|Q96S52 Q6UVX6,GPI transamidase component PIG-S,Phosphatidylinositol-glycan biosynthesis class S protein;, PF10510;, GO:0005789;GO:0042765;GO:0016020;GO:0016255;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane;, , P:attachment of GPI anchor to protein;|Q96S52 Q6UVX6,GPI transamidase component PIG-S,Phosphatidylinositol-glycan biosynthesis class S protein;, PF10510;, GO:0005789;GO:0042765;GO:0016020;GO:0016255;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane;, , P:attachment of GPI anchor to protein;|Q96S52 Q6UVX6,GPI transamidase component PIG-S,Phosphatidylinositol-glycan biosynthesis class S protein;, PF10510;, GO:0005789;GO:0042765;GO:0016020;GO:0016255;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane;, , P:attachment of GPI anchor to protein;|Q96S52 Q6UVX6,GPI transamidase component PIG-S,Phosphatidylinositol-glycan biosynthesis class S protein;, PF10510;, GO:0005789;GO:0042765;GO:0016020;GO:0016255;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane;, , P:attachment of GPI anchor to protein;|Q96S52 Q6UVX6,GPI transamidase component PIG-S,Phosphatidylinositol-glycan biosynthesis class S protein;, PF10510;, GO:0005789;GO:0042765;GO:0016020;GO:0016255;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane;, , P:attachment of GPI anchor to protein; scaffold52 indexed_genome mRNA 10497844 10501355 . - . ID=transcript_9734;P09972 B2R5R3 Q3SYL3 Q6FH94 Q6P0L5,Fructose-bisphosphate aldolase C,Brain-type aldolase;, PF00274;, GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0034774;GO:1904724;GO:0008092;GO:0004332;GO:0061621;GO:0030855;GO:0030388;GO:0006000;GO:0006094;GO:0006096;GO:0043312;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen; C:tertiary granule lumen;, F:cytoskeletal protein binding; F:fructose-bisphosphate aldolase activity;, P:canonical glycolysis; P:epithelial cell differentiation; P:fructose 1,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:neutrophil degranulation;|P09972 B2R5R3 Q3SYL3 Q6FH94 Q6P0L5,Fructose-bisphosphate aldolase C,Brain-type aldolase;, PF00274;, GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0034774;GO:1904724;GO:0008092;GO:0004332;GO:0061621;GO:0030855;GO:0030388;GO:0006000;GO:0006094;GO:0006096;GO:0043312;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen; C:tertiary granule lumen;, F:cytoskeletal protein binding; F:fructose-bisphosphate aldolase activity;, P:canonical glycolysis; P:epithelial cell differentiation; P:fructose 1,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:neutrophil degranulation;|P09972 B2R5R3 Q3SYL3 Q6FH94 Q6P0L5,Fructose-bisphosphate aldolase C,Brain-type aldolase;, PF00274;, GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0034774;GO:1904724;GO:0008092;GO:0004332;GO:0061621;GO:0030855;GO:0030388;GO:0006000;GO:0006094;GO:0006096;GO:0043312;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen; C:tertiary granule lumen;, F:cytoskeletal protein binding; F:fructose-bisphosphate aldolase activity;, P:canonical glycolysis; P:epithelial cell differentiation; P:fructose 1,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:neutrophil degranulation; scaffold52 indexed_genome mRNA 10502058 10520717 . - . ID=transcript_9735;Q96R06 O95213 Q9BWE8 Q9NT17 Q9UFE6,Sperm-associated antigen 5,Astrin;Deepest;Mitotic spindle-associated protein p126;, , GO:0034451;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0035371;GO:0030496;GO:0072686;GO:0097431;GO:0016604;GO:0008017;GO:0051301;GO:0007059;GO:0000070;GO:0032388;GO:1905832;GO:0071539;GO:0051988;GO:0090235;GO:0007051;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:microtubule plus-end; C:midbody; C:mitotic spindle; C:mitotic spindle pole; C:nuclear body;, F:microtubule binding;, P:cell division; P:chromosome segregation; P:mitotic sister chromatid segregation; P:positive regulation of intracellular transport; P:positive regulation of spindle assembly; P:protein localization to centrosome; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of metaphase plate congression; P:spindle organization;|Q96R06 O95213 Q9BWE8 Q9NT17 Q9UFE6,Sperm-associated antigen 5,Astrin;Deepest;Mitotic spindle-associated protein p126;, , GO:0034451;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0035371;GO:0030496;GO:0072686;GO:0097431;GO:0016604;GO:0008017;GO:0051301;GO:0007059;GO:0000070;GO:0032388;GO:1905832;GO:0071539;GO:0051988;GO:0090235;GO:0007051;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:microtubule plus-end; C:midbody; C:mitotic spindle; C:mitotic spindle pole; C:nuclear body;, F:microtubule binding;, P:cell division; P:chromosome segregation; P:mitotic sister chromatid segregation; P:positive regulation of intracellular transport; P:positive regulation of spindle assembly; P:protein localization to centrosome; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of metaphase plate congression; P:spindle organization;|Q96R06 O95213 Q9BWE8 Q9NT17 Q9UFE6,Sperm-associated antigen 5,Astrin;Deepest;Mitotic spindle-associated protein p126;, , GO:0034451;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0035371;GO:0030496;GO:0072686;GO:0097431;GO:0016604;GO:0008017;GO:0051301;GO:0007059;GO:0000070;GO:0032388;GO:1905832;GO:0071539;GO:0051988;GO:0090235;GO:0007051;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:microtubule plus-end; C:midbody; C:mitotic spindle; C:mitotic spindle pole; C:nuclear body;, F:microtubule binding;, P:cell division; P:chromosome segregation; P:mitotic sister chromatid segregation; P:positive regulation of intracellular transport; P:positive regulation of spindle assembly; P:protein localization to centrosome; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of metaphase plate congression; P:spindle organization;|Q96R06 O95213 Q9BWE8 Q9NT17 Q9UFE6,Sperm-associated antigen 5,Astrin;Deepest;Mitotic spindle-associated protein p126;, , GO:0034451;GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0035371;GO:0030496;GO:0072686;GO:0097431;GO:0016604;GO:0008017;GO:0051301;GO:0007059;GO:0000070;GO:0032388;GO:1905832;GO:0071539;GO:0051988;GO:0090235;GO:0007051;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:microtubule plus-end; C:midbody; C:mitotic spindle; C:mitotic spindle pole; C:nuclear body;, F:microtubule binding;, P:cell division; P:chromosome segregation; P:mitotic sister chromatid segregation; P:positive regulation of intracellular transport; P:positive regulation of spindle assembly; P:protein localization to centrosome; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of metaphase plate congression; P:spindle organization; scaffold52 indexed_genome mRNA 10521653 10527425 . - . ID=transcript_9736;Q96LW2 B4DFP4 L7N484 Q49A48,Ribosomal protein S6 kinase-related protein {ECO:0000305},Sugen kinase 494;, PF00069;, GO:0005524;GO:0106310;GO:0106311;, , F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;|Q96LW2 B4DFP4 L7N484 Q49A48,Ribosomal protein S6 kinase-related protein {ECO:0000305},Sugen kinase 494;, PF00069;, GO:0005524;GO:0106310;GO:0106311;, , F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;|Q96LW2 B4DFP4 L7N484 Q49A48,Ribosomal protein S6 kinase-related protein {ECO:0000305},Sugen kinase 494;, PF00069;, GO:0005524;GO:0106310;GO:0106311;, , F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;|Q96LW2 B4DFP4 L7N484 Q49A48,Ribosomal protein S6 kinase-related protein {ECO:0000305},Sugen kinase 494;, PF00069;, GO:0005524;GO:0106310;GO:0106311;, , F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity; scaffold52 indexed_genome mRNA 10527459 10554300 . - . ID=transcript_9737;Q14667 A6NCX3 Q3SYN5 Q49A07 Q5H9T4 Q6WG74 Q6ZP51 Q96HH8,Protein KIAA0100,Antigen MLAA-22;Breast cancer-overexpressed gene 1 protein;, PF10351;PF10344;PF10347;, GO:0005576;, C:extracellular region;|Q14667 A6NCX3 Q3SYN5 Q49A07 Q5H9T4 Q6WG74 Q6ZP51 Q96HH8,Protein KIAA0100,Antigen MLAA-22;Breast cancer-overexpressed gene 1 protein;, PF10351;PF10344;PF10347;, GO:0005576;, C:extracellular region;|Q14667 A6NCX3 Q3SYN5 Q49A07 Q5H9T4 Q6WG74 Q6ZP51 Q96HH8,Protein KIAA0100,Antigen MLAA-22;Breast cancer-overexpressed gene 1 protein;, PF10351;PF10344;PF10347;, GO:0005576;, C:extracellular region;|Q14667 A6NCX3 Q3SYN5 Q49A07 Q5H9T4 Q6WG74 Q6ZP51 Q96HH8,Protein KIAA0100,Antigen MLAA-22;Breast cancer-overexpressed gene 1 protein;, PF10351;PF10344;PF10347;, GO:0005576;, C:extracellular region;|Q14667 A6NCX3 Q3SYN5 Q49A07 Q5H9T4 Q6WG74 Q6ZP51 Q96HH8,Protein KIAA0100,Antigen MLAA-22;Breast cancer-overexpressed gene 1 protein;, PF10351;PF10344;PF10347;, GO:0005576;, C:extracellular region;|Q14667 A6NCX3 Q3SYN5 Q49A07 Q5H9T4 Q6WG74 Q6ZP51 Q96HH8,Protein KIAA0100,Antigen MLAA-22;Breast cancer-overexpressed gene 1 protein;, PF10351;PF10344;PF10347;, GO:0005576;, C:extracellular region;|Q14667 A6NCX3 Q3SYN5 Q49A07 Q5H9T4 Q6WG74 Q6ZP51 Q96HH8,Protein KIAA0100,Antigen MLAA-22;Breast cancer-overexpressed gene 1 protein;, PF10351;PF10344;PF10347;, GO:0005576;, C:extracellular region; scaffold52 indexed_genome mRNA 10556835 10596534 . + . ID=transcript_9738;Q99470 Q9BQ79,Stromal cell-derived factor 2,, PF02815;, GO:0101031;GO:0005783;GO:0005789;GO:0051787;GO:0051085;, C:chaperone complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:misfolded protein binding;, P:chaperone cofactor-dependent protein refolding;|Q9BTH9 Q9BTI2,Transcription elongation factor SPT6,Histone chaperone suppressor of Ty6;Tat-cotransactivator 2 protein;, PF14635;PF17674;PF14641;PF00575;PF14633;PF14632;PF14639;, GO:0005654;GO:0008023;GO:0035327;GO:0003677;GO:0042393;GO:0031491;GO:0003723;GO:0001825;GO:0070827;GO:0006397;GO:0042789;GO:0051028;GO:0061086;GO:0034728;GO:0032968;GO:0045191;GO:0010793;GO:0050684;GO:0051147;GO:0008380;GO:0006366;GO:0006368;GO:0016032;, C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:DNA binding; F:histone binding; F:nucleosome binding; F:RNA binding;, P:blastocyst formation; P:chromatin maintenance; P:mRNA processing; P:mRNA transcription by RNA polymerase II; P:mRNA transport; P:negative regulation of histone H3-K27 methylation; P:nucleosome organization; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:regulation of isotype switching; P:regulation of mRNA export from nucleus; P:regulation of mRNA processing; P:regulation of muscle cell differentiation; P:RNA splicing; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q9BTH9 Q9BTI2,Transcription elongation factor SPT6,Histone chaperone suppressor of Ty6;Tat-cotransactivator 2 protein;, PF14635;PF17674;PF14641;PF00575;PF14633;PF14632;PF14639;, GO:0005654;GO:0008023;GO:0035327;GO:0003677;GO:0042393;GO:0031491;GO:0003723;GO:0001825;GO:0070827;GO:0006397;GO:0042789;GO:0051028;GO:0061086;GO:0034728;GO:0032968;GO:0045191;GO:0010793;GO:0050684;GO:0051147;GO:0008380;GO:0006366;GO:0006368;GO:0016032;, C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:DNA binding; F:histone binding; F:nucleosome binding; F:RNA binding;, P:blastocyst formation; P:chromatin maintenance; P:mRNA processing; P:mRNA transcription by RNA polymerase II; P:mRNA transport; P:negative regulation of histone H3-K27 methylation; P:nucleosome organization; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:regulation of isotype switching; P:regulation of mRNA export from nucleus; P:regulation of mRNA processing; P:regulation of muscle cell differentiation; P:RNA splicing; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q9BTH9 Q9BTI2,Transcription elongation factor SPT6,Histone chaperone suppressor of Ty6;Tat-cotransactivator 2 protein;, PF14635;PF17674;PF14641;PF00575;PF14633;PF14632;PF14639;, GO:0005654;GO:0008023;GO:0035327;GO:0003677;GO:0042393;GO:0031491;GO:0003723;GO:0001825;GO:0070827;GO:0006397;GO:0042789;GO:0051028;GO:0061086;GO:0034728;GO:0032968;GO:0045191;GO:0010793;GO:0050684;GO:0051147;GO:0008380;GO:0006366;GO:0006368;GO:0016032;, C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:DNA binding; F:histone binding; F:nucleosome binding; F:RNA binding;, P:blastocyst formation; P:chromatin maintenance; P:mRNA processing; P:mRNA transcription by RNA polymerase II; P:mRNA transport; P:negative regulation of histone H3-K27 methylation; P:nucleosome organization; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:regulation of isotype switching; P:regulation of mRNA export from nucleus; P:regulation of mRNA processing; P:regulation of muscle cell differentiation; P:RNA splicing; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process; scaffold52 indexed_genome mRNA 10597771 10605317 . - . ID=transcript_9739;Q8NCQ7 B4DX95 G5E9R8 Q6PKN3,Protein PROCA1 {ECO:0000305},Protein interacting with cyclin A1 {ECO:0000303|PubMed:15159402};, PF05826;, GO:0030332;GO:0004623;GO:0050482;GO:0006644;, , F:cyclin binding; F:phospholipase A2 activity;, P:arachidonic acid secretion; P:phospholipid metabolic process; scaffold52 indexed_genome mRNA 10607122 10612960 . - . ID=transcript_9740;Q9BZG1 B4E3A0 E9PEJ9 Q5BJE6 Q8NCJ8 Q96AR4,Ras-related protein Rab-34,Ras-related protein Rab-39;Ras-related protein Rah;, PF00071;, GO:0005929;GO:0070062;GO:0005794;GO:0031985;GO:0005795;GO:0048471;GO:0045335;GO:0030670;GO:0031982;GO:0005525;GO:0030742;GO:0003924;GO:0031267;GO:0019882;GO:0030030;GO:0006897;GO:0043001;GO:0032418;GO:0090382;GO:0090385;GO:0045880;GO:0072659;, C:cilium; C:extracellular exosome; C:Golgi apparatus; C:Golgi cisterna; C:Golgi stack; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:vesicle;, F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity; F:small GTPase binding;, P:antigen processing and presentation; P:cell projection organization; P:endocytosis; P:Golgi to plasma membrane protein transport; P:lysosome localization; P:phagosome maturation; P:phagosome-lysosome fusion; P:positive regulation of smoothened signaling pathway; P:protein localization to plasma membrane;|Q9BZG1 B4E3A0 E9PEJ9 Q5BJE6 Q8NCJ8 Q96AR4,Ras-related protein Rab-34,Ras-related protein Rab-39;Ras-related protein Rah;, PF00071;, GO:0005929;GO:0070062;GO:0005794;GO:0031985;GO:0005795;GO:0048471;GO:0045335;GO:0030670;GO:0031982;GO:0005525;GO:0030742;GO:0003924;GO:0031267;GO:0019882;GO:0030030;GO:0006897;GO:0043001;GO:0032418;GO:0090382;GO:0090385;GO:0045880;GO:0072659;, C:cilium; C:extracellular exosome; C:Golgi apparatus; C:Golgi cisterna; C:Golgi stack; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:vesicle;, F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity; F:small GTPase binding;, P:antigen processing and presentation; P:cell projection organization; P:endocytosis; P:Golgi to plasma membrane protein transport; P:lysosome localization; P:phagosome maturation; P:phagosome-lysosome fusion; P:positive regulation of smoothened signaling pathway; P:protein localization to plasma membrane;|P0DI83,Ras-related protein Rab-34, isoform NARR,Nine amino-acid residue-repeats;, , GO:0005730;, C:nucleolus; scaffold52 indexed_genome mRNA 10613562 10618043 . - . ID=transcript_9741;P62750 B2R5B2 P29316 P39024 Q92774,60S ribosomal protein L23a,Large ribosomal subunit protein uL23 {ECO:0000303|PubMed:24524803};, PF00276;PF03939;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005730;GO:0005634;GO:0045296;GO:0003723;GO:0019843;GO:0003735;GO:1904841;GO:0000184;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:nucleolus; C:nucleus;, F:cadherin binding; F:RNA binding; F:rRNA binding; F:structural constituent of ribosome; F:TORC2 complex binding;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62750 B2R5B2 P29316 P39024 Q92774,60S ribosomal protein L23a,Large ribosomal subunit protein uL23 {ECO:0000303|PubMed:24524803};, PF00276;PF03939;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005730;GO:0005634;GO:0045296;GO:0003723;GO:0019843;GO:0003735;GO:1904841;GO:0000184;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:nucleolus; C:nucleus;, F:cadherin binding; F:RNA binding; F:rRNA binding; F:structural constituent of ribosome; F:TORC2 complex binding;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q96CP7 A8MYP9,TLC domain-containing protein 1,Calfacilitin;, PF03798;, GO:0016021;GO:0005886;GO:0055088;GO:0071709;GO:0055091;GO:0007009;GO:0097035;, C:integral component of membrane; C:plasma membrane;, , P:lipid homeostasis; P:membrane assembly; P:phospholipid homeostasis; P:plasma membrane organization; P:regulation of membrane lipid distribution; scaffold52 indexed_genome mRNA 10618102 10628331 . + . ID=transcript_9742;Q86SG6 A6NIC5 Q14CL7 Q2M1S6 Q8NDH1,Serine/threonine-protein kinase Nek8,Never in mitosis A-related kinase 8;Nima-related protein kinase 12a;, PF00069;PF00415;, GO:0005813;GO:0097546;GO:0097543;GO:0005929;GO:0005737;GO:0005634;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0009887;GO:0007059;GO:0007368;GO:0007507;GO:0035330;, C:centrosome; C:ciliary base; C:ciliary inversin compartment; C:cilium; C:cytoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:animal organ morphogenesis; P:chromosome segregation; P:determination of left/right symmetry; P:heart development; P:regulation of hippo signaling;|Q86SG6 A6NIC5 Q14CL7 Q2M1S6 Q8NDH1,Serine/threonine-protein kinase Nek8,Never in mitosis A-related kinase 8;Nima-related protein kinase 12a;, PF00069;PF00415;, GO:0005813;GO:0097546;GO:0097543;GO:0005929;GO:0005737;GO:0005634;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0009887;GO:0007059;GO:0007368;GO:0007507;GO:0035330;, C:centrosome; C:ciliary base; C:ciliary inversin compartment; C:cilium; C:cytoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:animal organ morphogenesis; P:chromosome segregation; P:determination of left/right symmetry; P:heart development; P:regulation of hippo signaling;|Q86SG6 A6NIC5 Q14CL7 Q2M1S6 Q8NDH1,Serine/threonine-protein kinase Nek8,Never in mitosis A-related kinase 8;Nima-related protein kinase 12a;, PF00069;PF00415;, GO:0005813;GO:0097546;GO:0097543;GO:0005929;GO:0005737;GO:0005634;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0009887;GO:0007059;GO:0007368;GO:0007507;GO:0035330;, C:centrosome; C:ciliary base; C:ciliary inversin compartment; C:cilium; C:cytoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:animal organ morphogenesis; P:chromosome segregation; P:determination of left/right symmetry; P:heart development; P:regulation of hippo signaling;|Q86SG6 A6NIC5 Q14CL7 Q2M1S6 Q8NDH1,Serine/threonine-protein kinase Nek8,Never in mitosis A-related kinase 8;Nima-related protein kinase 12a;, PF00069;PF00415;, GO:0005813;GO:0097546;GO:0097543;GO:0005929;GO:0005737;GO:0005634;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0009887;GO:0007059;GO:0007368;GO:0007507;GO:0035330;, C:centrosome; C:ciliary base; C:ciliary inversin compartment; C:cilium; C:cytoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:animal organ morphogenesis; P:chromosome segregation; P:determination of left/right symmetry; P:heart development; P:regulation of hippo signaling; scaffold52 indexed_genome mRNA 10634179 10640085 . + . ID=transcript_9743;Q9BUZ4 O75615 Q14848 Q2KJU4 Q2PJN8,TNF receptor-associated factor 4,Cysteine-rich domain associated with RING and Traf domains protein 1;Metastatic lymph node gene 62 protein;RING finger protein 83;, PF00097;PF02176;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0042802;GO:0019901;GO:0031996;GO:0005164;GO:0031625;GO:0050699;GO:0008270;GO:0007250;GO:0006915;GO:0046330;GO:0045860;GO:0070534;GO:0042981;GO:0043122;GO:0007585;GO:0030323;GO:0033209;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding; F:protein kinase binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:WW domain binding; F:zinc ion binding;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of protein kinase activity; P:protein K63-linked ubiquitination; P:regulation of apoptotic process; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:respiratory gaseous exchange by respiratory system; P:respiratory tube development; P:tumor necrosis factor-mediated signaling pathway;|Q9BUZ4 O75615 Q14848 Q2KJU4 Q2PJN8,TNF receptor-associated factor 4,Cysteine-rich domain associated with RING and Traf domains protein 1;Metastatic lymph node gene 62 protein;RING finger protein 83;, PF00097;PF02176;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0042802;GO:0019901;GO:0031996;GO:0005164;GO:0031625;GO:0050699;GO:0008270;GO:0007250;GO:0006915;GO:0046330;GO:0045860;GO:0070534;GO:0042981;GO:0043122;GO:0007585;GO:0030323;GO:0033209;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding; F:protein kinase binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:WW domain binding; F:zinc ion binding;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of protein kinase activity; P:protein K63-linked ubiquitination; P:regulation of apoptotic process; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:respiratory gaseous exchange by respiratory system; P:respiratory tube development; P:tumor necrosis factor-mediated signaling pathway;|Q9BUZ4 O75615 Q14848 Q2KJU4 Q2PJN8,TNF receptor-associated factor 4,Cysteine-rich domain associated with RING and Traf domains protein 1;Metastatic lymph node gene 62 protein;RING finger protein 83;, PF00097;PF02176;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0042802;GO:0019901;GO:0031996;GO:0005164;GO:0031625;GO:0050699;GO:0008270;GO:0007250;GO:0006915;GO:0046330;GO:0045860;GO:0070534;GO:0042981;GO:0043122;GO:0007585;GO:0030323;GO:0033209;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding; F:protein kinase binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:WW domain binding; F:zinc ion binding;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of protein kinase activity; P:protein K63-linked ubiquitination; P:regulation of apoptotic process; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:respiratory gaseous exchange by respiratory system; P:respiratory tube development; P:tumor necrosis factor-mediated signaling pathway;|Q9BUZ4 O75615 Q14848 Q2KJU4 Q2PJN8,TNF receptor-associated factor 4,Cysteine-rich domain associated with RING and Traf domains protein 1;Metastatic lymph node gene 62 protein;RING finger protein 83;, PF00097;PF02176;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0042802;GO:0019901;GO:0031996;GO:0005164;GO:0031625;GO:0050699;GO:0008270;GO:0007250;GO:0006915;GO:0046330;GO:0045860;GO:0070534;GO:0042981;GO:0043122;GO:0007585;GO:0030323;GO:0033209;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding; F:protein kinase binding; F:thioesterase binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:WW domain binding; F:zinc ion binding;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of protein kinase activity; P:protein K63-linked ubiquitination; P:regulation of apoptotic process; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:respiratory gaseous exchange by respiratory system; P:respiratory tube development; P:tumor necrosis factor-mediated signaling pathway; scaffold52 indexed_genome mRNA 10642725 10653440 . - . ID=transcript_9744;Q8WU58 Q9H6F3 Q9NVJ4 Q9NXN6,Protein FAM222B,, PF15258;, GO:0005654;, C:nucleoplasm;|Q8WU58 Q9H6F3 Q9NVJ4 Q9NXN6,Protein FAM222B,, PF15258;, GO:0005654;, C:nucleoplasm; scaffold52 indexed_genome mRNA 10704649 10707396 . + . ID=transcript_9745;O75616 B3KN21 C9JEC6 O75617 Q8WUY4 Q96LE2 Q96TC0,GTPase Era, mitochondrial,Conserved ERA-like GTPase;ERA-W;ERA-like protein 1;, PF01926;, GO:0005829;GO:0005743;GO:0005759;GO:0005739;GO:0005525;GO:0043024;GO:0003723;GO:0019843;GO:0070125;GO:0070126;GO:0000028;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosomal small subunit assembly;|O75616 B3KN21 C9JEC6 O75617 Q8WUY4 Q96LE2 Q96TC0,GTPase Era, mitochondrial,Conserved ERA-like GTPase;ERA-W;ERA-like protein 1;, PF01926;, GO:0005829;GO:0005743;GO:0005759;GO:0005739;GO:0005525;GO:0043024;GO:0003723;GO:0019843;GO:0070125;GO:0070126;GO:0000028;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosomal small subunit assembly;|O75616 B3KN21 C9JEC6 O75617 Q8WUY4 Q96LE2 Q96TC0,GTPase Era, mitochondrial,Conserved ERA-like GTPase;ERA-W;ERA-like protein 1;, PF01926;, GO:0005829;GO:0005743;GO:0005759;GO:0005739;GO:0005525;GO:0043024;GO:0003723;GO:0019843;GO:0070125;GO:0070126;GO:0000028;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:ribosomal small subunit binding; F:RNA binding; F:rRNA binding;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosomal small subunit assembly; scaffold52 indexed_genome mRNA 10720870 10746079 . - . ID=transcript_9746;Q14254,Flotillin-2,Epidermal surface antigen;Membrane component chromosome 17 surface marker 1;, PF01145;PF15975;, GO:0005912;GO:0016323;GO:0005901;GO:0044291;GO:0031410;GO:0030139;GO:0005768;GO:0070062;GO:0016600;GO:0005925;GO:0043231;GO:0030027;GO:0016020;GO:0048471;GO:0005886;GO:0001931;GO:0031982;GO:0007155;GO:0008544;GO:0001765;GO:1902992;GO:0010629;GO:1903905;GO:0051092;GO:0072659;GO:0044860;GO:0050821;GO:0045661;GO:0060544;, C:adherens junction; C:basolateral plasma membrane; C:caveola; C:cell-cell contact zone; C:cytoplasmic vesicle; C:endocytic vesicle; C:endosome; C:extracellular exosome; C:flotillin complex; C:focal adhesion; C:intracellular membrane-bounded organelle; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:uropod; C:vesicle;, , P:cell adhesion; P:epidermis development; P:membrane raft assembly; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of gene expression; P:positive regulation of establishment of T cell polarity; P:positive regulation of NF-kappaB transcription factor activity; P:protein localization to plasma membrane; P:protein localization to plasma membrane raft; P:protein stabilization; P:regulation of myoblast differentiation; P:regulation of necroptotic process;|Q14254,Flotillin-2,Epidermal surface antigen;Membrane component chromosome 17 surface marker 1;, PF01145;PF15975;, GO:0005912;GO:0016323;GO:0005901;GO:0044291;GO:0031410;GO:0030139;GO:0005768;GO:0070062;GO:0016600;GO:0005925;GO:0043231;GO:0030027;GO:0016020;GO:0048471;GO:0005886;GO:0001931;GO:0031982;GO:0007155;GO:0008544;GO:0001765;GO:1902992;GO:0010629;GO:1903905;GO:0051092;GO:0072659;GO:0044860;GO:0050821;GO:0045661;GO:0060544;, C:adherens junction; C:basolateral plasma membrane; C:caveola; C:cell-cell contact zone; C:cytoplasmic vesicle; C:endocytic vesicle; C:endosome; C:extracellular exosome; C:flotillin complex; C:focal adhesion; C:intracellular membrane-bounded organelle; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:uropod; C:vesicle;, , P:cell adhesion; P:epidermis development; P:membrane raft assembly; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of gene expression; P:positive regulation of establishment of T cell polarity; P:positive regulation of NF-kappaB transcription factor activity; P:protein localization to plasma membrane; P:protein localization to plasma membrane raft; P:protein stabilization; P:regulation of myoblast differentiation; P:regulation of necroptotic process;|Q14254,Flotillin-2,Epidermal surface antigen;Membrane component chromosome 17 surface marker 1;, PF01145;PF15975;, GO:0005912;GO:0016323;GO:0005901;GO:0044291;GO:0031410;GO:0030139;GO:0005768;GO:0070062;GO:0016600;GO:0005925;GO:0043231;GO:0030027;GO:0016020;GO:0048471;GO:0005886;GO:0001931;GO:0031982;GO:0007155;GO:0008544;GO:0001765;GO:1902992;GO:0010629;GO:1903905;GO:0051092;GO:0072659;GO:0044860;GO:0050821;GO:0045661;GO:0060544;, C:adherens junction; C:basolateral plasma membrane; C:caveola; C:cell-cell contact zone; C:cytoplasmic vesicle; C:endocytic vesicle; C:endosome; C:extracellular exosome; C:flotillin complex; C:focal adhesion; C:intracellular membrane-bounded organelle; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:uropod; C:vesicle;, , P:cell adhesion; P:epidermis development; P:membrane raft assembly; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of gene expression; P:positive regulation of establishment of T cell polarity; P:positive regulation of NF-kappaB transcription factor activity; P:protein localization to plasma membrane; P:protein localization to plasma membrane raft; P:protein stabilization; P:regulation of myoblast differentiation; P:regulation of necroptotic process;|Q14254,Flotillin-2,Epidermal surface antigen;Membrane component chromosome 17 surface marker 1;, PF01145;PF15975;, GO:0005912;GO:0016323;GO:0005901;GO:0044291;GO:0031410;GO:0030139;GO:0005768;GO:0070062;GO:0016600;GO:0005925;GO:0043231;GO:0030027;GO:0016020;GO:0048471;GO:0005886;GO:0001931;GO:0031982;GO:0007155;GO:0008544;GO:0001765;GO:1902992;GO:0010629;GO:1903905;GO:0051092;GO:0072659;GO:0044860;GO:0050821;GO:0045661;GO:0060544;, C:adherens junction; C:basolateral plasma membrane; C:caveola; C:cell-cell contact zone; C:cytoplasmic vesicle; C:endocytic vesicle; C:endosome; C:extracellular exosome; C:flotillin complex; C:focal adhesion; C:intracellular membrane-bounded organelle; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:uropod; C:vesicle;, , P:cell adhesion; P:epidermis development; P:membrane raft assembly; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of gene expression; P:positive regulation of establishment of T cell polarity; P:positive regulation of NF-kappaB transcription factor activity; P:protein localization to plasma membrane; P:protein localization to plasma membrane raft; P:protein stabilization; P:regulation of myoblast differentiation; P:regulation of necroptotic process;|Q14254,Flotillin-2,Epidermal surface antigen;Membrane component chromosome 17 surface marker 1;, PF01145;PF15975;, GO:0005912;GO:0016323;GO:0005901;GO:0044291;GO:0031410;GO:0030139;GO:0005768;GO:0070062;GO:0016600;GO:0005925;GO:0043231;GO:0030027;GO:0016020;GO:0048471;GO:0005886;GO:0001931;GO:0031982;GO:0007155;GO:0008544;GO:0001765;GO:1902992;GO:0010629;GO:1903905;GO:0051092;GO:0072659;GO:0044860;GO:0050821;GO:0045661;GO:0060544;, C:adherens junction; C:basolateral plasma membrane; C:caveola; C:cell-cell contact zone; C:cytoplasmic vesicle; C:endocytic vesicle; C:endosome; C:extracellular exosome; C:flotillin complex; C:focal adhesion; C:intracellular membrane-bounded organelle; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:uropod; C:vesicle;, , P:cell adhesion; P:epidermis development; P:membrane raft assembly; P:negative regulation of amyloid precursor protein catabolic process; P:negative regulation of gene expression; P:positive regulation of establishment of T cell polarity; P:positive regulation of NF-kappaB transcription factor activity; P:protein localization to plasma membrane; P:protein localization to plasma membrane raft; P:protein stabilization; P:regulation of myoblast differentiation; P:regulation of necroptotic process; scaffold52 indexed_genome mRNA 10748724 10757295 . + . ID=transcript_9747;Q96QT6 Q0VAI5 Q2TAK2 Q6ZML2 Q9BV34 Q9H7U9 Q9P205,PHD finger protein 12,PHD factor 1;, PF00628;PF16737;, GO:0005654;GO:0005634;GO:0016580;GO:0070822;GO:0017053;GO:0046872;GO:0035091;GO:0003712;GO:0003714;GO:0001222;GO:0000122;GO:0045892;GO:0006355;, C:nucleoplasm; C:nucleus; C:Sin3 complex; C:Sin3-type complex; C:transcription repressor complex;, F:metal ion binding; F:phosphatidylinositol binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription corepressor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q96QT6 Q0VAI5 Q2TAK2 Q6ZML2 Q9BV34 Q9H7U9 Q9P205,PHD finger protein 12,PHD factor 1;, PF00628;PF16737;, GO:0005654;GO:0005634;GO:0016580;GO:0070822;GO:0017053;GO:0046872;GO:0035091;GO:0003712;GO:0003714;GO:0001222;GO:0000122;GO:0045892;GO:0006355;, C:nucleoplasm; C:nucleus; C:Sin3 complex; C:Sin3-type complex; C:transcription repressor complex;, F:metal ion binding; F:phosphatidylinositol binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription corepressor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q96QT6 Q0VAI5 Q2TAK2 Q6ZML2 Q9BV34 Q9H7U9 Q9P205,PHD finger protein 12,PHD factor 1;, PF00628;PF16737;, GO:0005654;GO:0005634;GO:0016580;GO:0070822;GO:0017053;GO:0046872;GO:0035091;GO:0003712;GO:0003714;GO:0001222;GO:0000122;GO:0045892;GO:0006355;, C:nucleoplasm; C:nucleus; C:Sin3 complex; C:Sin3-type complex; C:transcription repressor complex;, F:metal ion binding; F:phosphatidylinositol binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription corepressor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q96QT6 Q0VAI5 Q2TAK2 Q6ZML2 Q9BV34 Q9H7U9 Q9P205,PHD finger protein 12,PHD factor 1;, PF00628;PF16737;, GO:0005654;GO:0005634;GO:0016580;GO:0070822;GO:0017053;GO:0046872;GO:0035091;GO:0003712;GO:0003714;GO:0001222;GO:0000122;GO:0045892;GO:0006355;, C:nucleoplasm; C:nucleus; C:Sin3 complex; C:Sin3-type complex; C:transcription repressor complex;, F:metal ion binding; F:phosphatidylinositol binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription corepressor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q96QT6 Q0VAI5 Q2TAK2 Q6ZML2 Q9BV34 Q9H7U9 Q9P205,PHD finger protein 12,PHD factor 1;, PF00628;PF16737;, GO:0005654;GO:0005634;GO:0016580;GO:0070822;GO:0017053;GO:0046872;GO:0035091;GO:0003712;GO:0003714;GO:0001222;GO:0000122;GO:0045892;GO:0006355;, C:nucleoplasm; C:nucleus; C:Sin3 complex; C:Sin3-type complex; C:transcription repressor complex;, F:metal ion binding; F:phosphatidylinositol binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription corepressor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q96QT6 Q0VAI5 Q2TAK2 Q6ZML2 Q9BV34 Q9H7U9 Q9P205,PHD finger protein 12,PHD factor 1;, PF00628;PF16737;, GO:0005654;GO:0005634;GO:0016580;GO:0070822;GO:0017053;GO:0046872;GO:0035091;GO:0003712;GO:0003714;GO:0001222;GO:0000122;GO:0045892;GO:0006355;, C:nucleoplasm; C:nucleus; C:Sin3 complex; C:Sin3-type complex; C:transcription repressor complex;, F:metal ion binding; F:phosphatidylinositol binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription corepressor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q96QT6 Q0VAI5 Q2TAK2 Q6ZML2 Q9BV34 Q9H7U9 Q9P205,PHD finger protein 12,PHD factor 1;, PF00628;PF16737;, GO:0005654;GO:0005634;GO:0016580;GO:0070822;GO:0017053;GO:0046872;GO:0035091;GO:0003712;GO:0003714;GO:0001222;GO:0000122;GO:0045892;GO:0006355;, C:nucleoplasm; C:nucleus; C:Sin3 complex; C:Sin3-type complex; C:transcription repressor complex;, F:metal ion binding; F:phosphatidylinositol binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription corepressor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold52 indexed_genome mRNA 10757311 10759138 . + . ID=transcript_9748;Q96QT6 Q0VAI5 Q2TAK2 Q6ZML2 Q9BV34 Q9H7U9 Q9P205,PHD finger protein 12,PHD factor 1;, PF00628;PF16737;, GO:0005654;GO:0005634;GO:0016580;GO:0070822;GO:0017053;GO:0046872;GO:0035091;GO:0003712;GO:0003714;GO:0001222;GO:0000122;GO:0045892;GO:0006355;, C:nucleoplasm; C:nucleus; C:Sin3 complex; C:Sin3-type complex; C:transcription repressor complex;, F:metal ion binding; F:phosphatidylinositol binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription corepressor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold52 indexed_genome mRNA 10804116 10809499 . - . ID=transcript_9749;Q53EL9 B6ZDN1 Q8N701 Q8NB57 Q8ND50 Q8TD25 Q96NI5 Q96NQ3,Seizure protein 6 homolog,, PF00431;PF00084;, GO:0097440;GO:0043198;GO:0043197;GO:0005783;GO:0016021;GO:0043025;GO:0048471;GO:0005886;GO:0008344;GO:0021680;GO:0060079;GO:0050773;GO:0090036;GO:0060074;, C:apical dendrite; C:dendritic shaft; C:dendritic spine; C:endoplasmic reticulum; C:integral component of membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:adult locomotory behavior; P:cerebellar Purkinje cell layer development; P:excitatory postsynaptic potential; P:regulation of dendrite development; P:regulation of protein kinase C signaling; P:synapse maturation;|Q53EL9 B6ZDN1 Q8N701 Q8NB57 Q8ND50 Q8TD25 Q96NI5 Q96NQ3,Seizure protein 6 homolog,, PF00431;PF00084;, GO:0097440;GO:0043198;GO:0043197;GO:0005783;GO:0016021;GO:0043025;GO:0048471;GO:0005886;GO:0008344;GO:0021680;GO:0060079;GO:0050773;GO:0090036;GO:0060074;, C:apical dendrite; C:dendritic shaft; C:dendritic spine; C:endoplasmic reticulum; C:integral component of membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:adult locomotory behavior; P:cerebellar Purkinje cell layer development; P:excitatory postsynaptic potential; P:regulation of dendrite development; P:regulation of protein kinase C signaling; P:synapse maturation;|Q53EL9 B6ZDN1 Q8N701 Q8NB57 Q8ND50 Q8TD25 Q96NI5 Q96NQ3,Seizure protein 6 homolog,, PF00431;PF00084;, GO:0097440;GO:0043198;GO:0043197;GO:0005783;GO:0016021;GO:0043025;GO:0048471;GO:0005886;GO:0008344;GO:0021680;GO:0060079;GO:0050773;GO:0090036;GO:0060074;, C:apical dendrite; C:dendritic shaft; C:dendritic spine; C:endoplasmic reticulum; C:integral component of membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:adult locomotory behavior; P:cerebellar Purkinje cell layer development; P:excitatory postsynaptic potential; P:regulation of dendrite development; P:regulation of protein kinase C signaling; P:synapse maturation;|Q53EL9 B6ZDN1 Q8N701 Q8NB57 Q8ND50 Q8TD25 Q96NI5 Q96NQ3,Seizure protein 6 homolog,, PF00431;PF00084;, GO:0097440;GO:0043198;GO:0043197;GO:0005783;GO:0016021;GO:0043025;GO:0048471;GO:0005886;GO:0008344;GO:0021680;GO:0060079;GO:0050773;GO:0090036;GO:0060074;, C:apical dendrite; C:dendritic shaft; C:dendritic spine; C:endoplasmic reticulum; C:integral component of membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:adult locomotory behavior; P:cerebellar Purkinje cell layer development; P:excitatory postsynaptic potential; P:regulation of dendrite development; P:regulation of protein kinase C signaling; P:synapse maturation; scaffold52 indexed_genome mRNA 10809674 10817009 . - . ID=transcript_9750;Q53EL9 B6ZDN1 Q8N701 Q8NB57 Q8ND50 Q8TD25 Q96NI5 Q96NQ3,Seizure protein 6 homolog,, PF00431;PF00084;, GO:0097440;GO:0043198;GO:0043197;GO:0005783;GO:0016021;GO:0043025;GO:0048471;GO:0005886;GO:0008344;GO:0021680;GO:0060079;GO:0050773;GO:0090036;GO:0060074;, C:apical dendrite; C:dendritic shaft; C:dendritic spine; C:endoplasmic reticulum; C:integral component of membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:adult locomotory behavior; P:cerebellar Purkinje cell layer development; P:excitatory postsynaptic potential; P:regulation of dendrite development; P:regulation of protein kinase C signaling; P:synapse maturation;|Q53EL9 B6ZDN1 Q8N701 Q8NB57 Q8ND50 Q8TD25 Q96NI5 Q96NQ3,Seizure protein 6 homolog,, PF00431;PF00084;, GO:0097440;GO:0043198;GO:0043197;GO:0005783;GO:0016021;GO:0043025;GO:0048471;GO:0005886;GO:0008344;GO:0021680;GO:0060079;GO:0050773;GO:0090036;GO:0060074;, C:apical dendrite; C:dendritic shaft; C:dendritic spine; C:endoplasmic reticulum; C:integral component of membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:adult locomotory behavior; P:cerebellar Purkinje cell layer development; P:excitatory postsynaptic potential; P:regulation of dendrite development; P:regulation of protein kinase C signaling; P:synapse maturation;|Q53EL9 B6ZDN1 Q8N701 Q8NB57 Q8ND50 Q8TD25 Q96NI5 Q96NQ3,Seizure protein 6 homolog,, PF00431;PF00084;, GO:0097440;GO:0043198;GO:0043197;GO:0005783;GO:0016021;GO:0043025;GO:0048471;GO:0005886;GO:0008344;GO:0021680;GO:0060079;GO:0050773;GO:0090036;GO:0060074;, C:apical dendrite; C:dendritic shaft; C:dendritic spine; C:endoplasmic reticulum; C:integral component of membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, , P:adult locomotory behavior; P:cerebellar Purkinje cell layer development; P:excitatory postsynaptic potential; P:regulation of dendrite development; P:regulation of protein kinase C signaling; P:synapse maturation; scaffold52 indexed_genome mRNA 10890550 10893113 . + . ID=transcript_9751;Q9P0Z9 B3KNH0 Q96H28 Q9C070,Peroxisomal sarcosine oxidase,L-pipecolate oxidase;L-pipecolic acid oxidase;, PF01266;, GO:0005829;GO:0005782;GO:0005777;GO:0050031;GO:0008115;GO:0033514;GO:0006554;GO:0008104;GO:0046653;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:L-pipecolate oxidase activity; F:sarcosine oxidase activity;, P:L-lysine catabolic process to acetyl-CoA via L-pipecolate; P:lysine catabolic process; P:protein localization; P:tetrahydrofolate metabolic process;|Q9P0Z9 B3KNH0 Q96H28 Q9C070,Peroxisomal sarcosine oxidase,L-pipecolate oxidase;L-pipecolic acid oxidase;, PF01266;, GO:0005829;GO:0005782;GO:0005777;GO:0050031;GO:0008115;GO:0033514;GO:0006554;GO:0008104;GO:0046653;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:L-pipecolate oxidase activity; F:sarcosine oxidase activity;, P:L-lysine catabolic process to acetyl-CoA via L-pipecolate; P:lysine catabolic process; P:protein localization; P:tetrahydrofolate metabolic process; scaffold52 indexed_genome mRNA 10897545 10904158 . + . ID=transcript_9752;Q9P0Z9 B3KNH0 Q96H28 Q9C070,Peroxisomal sarcosine oxidase,L-pipecolate oxidase;L-pipecolic acid oxidase;, PF01266;, GO:0005829;GO:0005782;GO:0005777;GO:0050031;GO:0008115;GO:0033514;GO:0006554;GO:0008104;GO:0046653;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:L-pipecolate oxidase activity; F:sarcosine oxidase activity;, P:L-lysine catabolic process to acetyl-CoA via L-pipecolate; P:lysine catabolic process; P:protein localization; P:tetrahydrofolate metabolic process;|Q9P0Z9 B3KNH0 Q96H28 Q9C070,Peroxisomal sarcosine oxidase,L-pipecolate oxidase;L-pipecolic acid oxidase;, PF01266;, GO:0005829;GO:0005782;GO:0005777;GO:0050031;GO:0008115;GO:0033514;GO:0006554;GO:0008104;GO:0046653;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:L-pipecolate oxidase activity; F:sarcosine oxidase activity;, P:L-lysine catabolic process to acetyl-CoA via L-pipecolate; P:lysine catabolic process; P:protein localization; P:tetrahydrofolate metabolic process;|Q9P0Z9 B3KNH0 Q96H28 Q9C070,Peroxisomal sarcosine oxidase,L-pipecolate oxidase;L-pipecolic acid oxidase;, PF01266;, GO:0005829;GO:0005782;GO:0005777;GO:0050031;GO:0008115;GO:0033514;GO:0006554;GO:0008104;GO:0046653;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:L-pipecolate oxidase activity; F:sarcosine oxidase activity;, P:L-lysine catabolic process to acetyl-CoA via L-pipecolate; P:lysine catabolic process; P:protein localization; P:tetrahydrofolate metabolic process; scaffold52 indexed_genome mRNA 10917513 10921218 . - . ID=transcript_9753;Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation; scaffold52 indexed_genome mRNA 10924992 11016527 . - . ID=transcript_9754;Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation;|Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation;|Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation;|Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation;|Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation;|Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation;|Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation;|Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation;|Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation;|Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation;|Q92614 Q5H9U3 Q5QD01 Q5W9F9 Q5W9G1 Q8IXP8,Unconventional myosin-XVIIIa,Molecule associated with JAK3 N-terminus;Myosin containing a PDZ domain;Surfactant protein receptor SP-R210 {ECO:0000303|PubMed:16087679};, PF00063;PF01576;PF17820;, GO:0042641;GO:0009986;GO:0005793;GO:0000139;GO:0016020;GO:0016459;GO:0150051;GO:0005802;GO:0051015;GO:0043531;GO:0005524;GO:0003677;GO:0003723;GO:0031032;GO:0090164;GO:0016477;GO:0006259;GO:0007030;GO:0090161;GO:0048194;GO:0043066;GO:1903028;GO:0050714;GO:0043030;, C:actomyosin; C:cell surface; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:membrane; C:myosin complex; C:postsynaptic Golgi apparatus; C:trans-Golgi network;, F:actin filament binding; F:ADP binding; F:ATP binding; F:DNA binding; F:RNA binding;, P:actomyosin structure organization; P:asymmetric Golgi ribbon formation; P:cell migration; P:DNA metabolic process; P:Golgi organization; P:Golgi ribbon formation; P:Golgi vesicle budding; P:negative regulation of apoptotic process; P:positive regulation of opsonization; P:positive regulation of protein secretion; P:regulation of macrophage activation; scaffold52 indexed_genome mRNA 11189873 11276278 . + . ID=transcript_9755;Q7L7X3 A2RUT8 B7ZLV6 Q96L75 Q9H2K7 Q9H7S5 Q9P2I6,Serine/threonine-protein kinase TAO1,Kinase from chicken homolog B;MARK Kinase;Prostate-derived sterile 20-like kinase 2;Thousand and one amino acid protein kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0070062;GO:0015630;GO:0048471;GO:0043014;GO:0005524;GO:0048487;GO:0016301;GO:0004672;GO:0106310;GO:0043539;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0016740;GO:0007257;GO:0000187;GO:0032147;GO:0006974;GO:0006281;GO:0097194;GO:0000165;GO:0000226;GO:0007095;GO:0007052;GO:0007026;GO:0070050;GO:0048812;GO:0016310;GO:0046330;GO:1901985;GO:0032874;GO:0046777;GO:0006468;GO:0032956;GO:0051493;GO:0070507;GO:0031098;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:perinuclear region of cytoplasm;, F:alpha-tubulin binding; F:ATP binding; F:beta-tubulin binding; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:transferase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:activation of protein kinase activity; P:cellular response to DNA damage stimulus; P:DNA repair; P:execution phase of apoptosis; P:MAPK cascade; P:microtubule cytoskeleton organization; P:mitotic G2 DNA damage checkpoint; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:neuron cellular homeostasis; P:neuron projection morphogenesis; P:phosphorylation; P:positive regulation of JNK cascade; P:positive regulation of protein acetylation; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of cytoskeleton organization; P:regulation of microtubule cytoskeleton organization; P:stress-activated protein kinase signaling cascade; scaffold52 indexed_genome mRNA 11296731 11304104 . - . ID=transcript_9756;Q9Y2X7 B4DGU9 B4DSV3 Q86SS0 Q9BRJ4,ARF GTPase-activating protein GIT1,Cool-associated and tyrosine-phosphorylated protein 1;G protein-coupled receptor kinase-interactor 1;GRK-interacting protein 1;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0044305;GO:0005813;GO:0005829;GO:0005925;GO:0016020;GO:0005739;GO:0097431;GO:0098794;GO:0043015;GO:0005096;GO:0046872;GO:0044877;GO:0007420;GO:0045454;GO:0071222;GO:0048013;GO:0001957;GO:0007626;GO:0061743;GO:0045820;GO:0106015;GO:0032691;GO:0048666;GO:0090063;GO:0099171;GO:0032465;GO:0008277;GO:2000300;, C:calyx of Held; C:centrosome; C:cytosol; C:focal adhesion; C:membrane; C:mitochondrion; C:mitotic spindle pole; C:postsynapse;, F:gamma-tubulin binding; F:GTPase activator activity; F:metal ion binding; F:protein-containing complex binding;, P:brain development; P:cell redox homeostasis; P:cellular response to lipopolysaccharide; P:ephrin receptor signaling pathway; P:intramembranous ossification; P:locomotory behavior; P:motor learning; P:negative regulation of glycolytic process; P:negative regulation of inflammatory response to wounding; P:negative regulation of interleukin-1 beta production; P:neuron development; P:positive regulation of microtubule nucleation; P:presynaptic modulation of chemical synaptic transmission; P:regulation of cytokinesis; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of synaptic vesicle exocytosis;|Q9Y2X7 B4DGU9 B4DSV3 Q86SS0 Q9BRJ4,ARF GTPase-activating protein GIT1,Cool-associated and tyrosine-phosphorylated protein 1;G protein-coupled receptor kinase-interactor 1;GRK-interacting protein 1;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0044305;GO:0005813;GO:0005829;GO:0005925;GO:0016020;GO:0005739;GO:0097431;GO:0098794;GO:0043015;GO:0005096;GO:0046872;GO:0044877;GO:0007420;GO:0045454;GO:0071222;GO:0048013;GO:0001957;GO:0007626;GO:0061743;GO:0045820;GO:0106015;GO:0032691;GO:0048666;GO:0090063;GO:0099171;GO:0032465;GO:0008277;GO:2000300;, C:calyx of Held; C:centrosome; C:cytosol; C:focal adhesion; C:membrane; C:mitochondrion; C:mitotic spindle pole; C:postsynapse;, F:gamma-tubulin binding; F:GTPase activator activity; F:metal ion binding; F:protein-containing complex binding;, P:brain development; P:cell redox homeostasis; P:cellular response to lipopolysaccharide; P:ephrin receptor signaling pathway; P:intramembranous ossification; P:locomotory behavior; P:motor learning; P:negative regulation of glycolytic process; P:negative regulation of inflammatory response to wounding; P:negative regulation of interleukin-1 beta production; P:neuron development; P:positive regulation of microtubule nucleation; P:presynaptic modulation of chemical synaptic transmission; P:regulation of cytokinesis; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of synaptic vesicle exocytosis; scaffold52 indexed_genome mRNA 11304816 11308855 . - . ID=transcript_9757;Q9Y2X7 B4DGU9 B4DSV3 Q86SS0 Q9BRJ4,ARF GTPase-activating protein GIT1,Cool-associated and tyrosine-phosphorylated protein 1;G protein-coupled receptor kinase-interactor 1;GRK-interacting protein 1;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0044305;GO:0005813;GO:0005829;GO:0005925;GO:0016020;GO:0005739;GO:0097431;GO:0098794;GO:0043015;GO:0005096;GO:0046872;GO:0044877;GO:0007420;GO:0045454;GO:0071222;GO:0048013;GO:0001957;GO:0007626;GO:0061743;GO:0045820;GO:0106015;GO:0032691;GO:0048666;GO:0090063;GO:0099171;GO:0032465;GO:0008277;GO:2000300;, C:calyx of Held; C:centrosome; C:cytosol; C:focal adhesion; C:membrane; C:mitochondrion; C:mitotic spindle pole; C:postsynapse;, F:gamma-tubulin binding; F:GTPase activator activity; F:metal ion binding; F:protein-containing complex binding;, P:brain development; P:cell redox homeostasis; P:cellular response to lipopolysaccharide; P:ephrin receptor signaling pathway; P:intramembranous ossification; P:locomotory behavior; P:motor learning; P:negative regulation of glycolytic process; P:negative regulation of inflammatory response to wounding; P:negative regulation of interleukin-1 beta production; P:neuron development; P:positive regulation of microtubule nucleation; P:presynaptic modulation of chemical synaptic transmission; P:regulation of cytokinesis; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of synaptic vesicle exocytosis; scaffold52 indexed_genome mRNA 11310447 11311384 . - . ID=transcript_9758;Q9Y2X7 B4DGU9 B4DSV3 Q86SS0 Q9BRJ4,ARF GTPase-activating protein GIT1,Cool-associated and tyrosine-phosphorylated protein 1;G protein-coupled receptor kinase-interactor 1;GRK-interacting protein 1;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0044305;GO:0005813;GO:0005829;GO:0005925;GO:0016020;GO:0005739;GO:0097431;GO:0098794;GO:0043015;GO:0005096;GO:0046872;GO:0044877;GO:0007420;GO:0045454;GO:0071222;GO:0048013;GO:0001957;GO:0007626;GO:0061743;GO:0045820;GO:0106015;GO:0032691;GO:0048666;GO:0090063;GO:0099171;GO:0032465;GO:0008277;GO:2000300;, C:calyx of Held; C:centrosome; C:cytosol; C:focal adhesion; C:membrane; C:mitochondrion; C:mitotic spindle pole; C:postsynapse;, F:gamma-tubulin binding; F:GTPase activator activity; F:metal ion binding; F:protein-containing complex binding;, P:brain development; P:cell redox homeostasis; P:cellular response to lipopolysaccharide; P:ephrin receptor signaling pathway; P:intramembranous ossification; P:locomotory behavior; P:motor learning; P:negative regulation of glycolytic process; P:negative regulation of inflammatory response to wounding; P:negative regulation of interleukin-1 beta production; P:neuron development; P:positive regulation of microtubule nucleation; P:presynaptic modulation of chemical synaptic transmission; P:regulation of cytokinesis; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of synaptic vesicle exocytosis; scaffold52 indexed_genome mRNA 11328775 11330995 . - . ID=transcript_9759;Q86YJ7 Q8N7S9,Ankyrin repeat domain-containing protein 13B,, PF12796;PF11904;, GO:0005737;GO:0005769;GO:0043231;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:0002091;, C:cytoplasm; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of receptor internalization; scaffold52 indexed_genome mRNA 11331185 11335149 . + . ID=transcript_9760;Q86YJ7 Q8N7S9,Ankyrin repeat domain-containing protein 13B,, PF12796;PF11904;, GO:0005737;GO:0005769;GO:0043231;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:0002091;, C:cytoplasm; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of receptor internalization;|Q86YJ7 Q8N7S9,Ankyrin repeat domain-containing protein 13B,, PF12796;PF11904;, GO:0005737;GO:0005769;GO:0043231;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:0002091;, C:cytoplasm; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of receptor internalization;|Q86YJ7 Q8N7S9,Ankyrin repeat domain-containing protein 13B,, PF12796;PF11904;, GO:0005737;GO:0005769;GO:0043231;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:0002091;, C:cytoplasm; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of receptor internalization;|Q86YJ7 Q8N7S9,Ankyrin repeat domain-containing protein 13B,, PF12796;PF11904;, GO:0005737;GO:0005769;GO:0043231;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:0002091;, C:cytoplasm; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of receptor internalization; scaffold52 indexed_genome mRNA 11342629 11344669 . + . ID=transcript_9761;Q6QEF8 B3KU26 Q71MF3 Q8WYH7 Q96K02,Coronin-6,Coronin-like protein E;, PF12894;PF08953;PF00400;, GO:0051015;GO:0007015;GO:0016477;, , F:actin filament binding;, P:actin filament organization; P:cell migration; scaffold52 indexed_genome mRNA 11354740 11411093 . - . ID=transcript_9762;Q76I76 Q8TDB5 Q8WYL1 Q8WYL2 Q96F40 Q96H36 Q9C0D8,Protein phosphatase Slingshot homolog 2,SSH-like protein 2;, PF08766;, GO:0005737;GO:0005856;GO:0005615;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0030837;GO:0006470;, C:cytoplasm; C:cytoskeleton; C:extracellular space;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization; P:protein dephosphorylation;|Q76I76 Q8TDB5 Q8WYL1 Q8WYL2 Q96F40 Q96H36 Q9C0D8,Protein phosphatase Slingshot homolog 2,SSH-like protein 2;, PF08766;, GO:0005737;GO:0005856;GO:0005615;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0030837;GO:0006470;, C:cytoplasm; C:cytoskeleton; C:extracellular space;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization; P:protein dephosphorylation;|Q76I76 Q8TDB5 Q8WYL1 Q8WYL2 Q96F40 Q96H36 Q9C0D8,Protein phosphatase Slingshot homolog 2,SSH-like protein 2;, PF08766;, GO:0005737;GO:0005856;GO:0005615;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0030837;GO:0006470;, C:cytoplasm; C:cytoskeleton; C:extracellular space;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization; P:protein dephosphorylation;|Q76I76 Q8TDB5 Q8WYL1 Q8WYL2 Q96F40 Q96H36 Q9C0D8,Protein phosphatase Slingshot homolog 2,SSH-like protein 2;, PF08766;, GO:0005737;GO:0005856;GO:0005615;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0030837;GO:0006470;, C:cytoplasm; C:cytoskeleton; C:extracellular space;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization; P:protein dephosphorylation;|Q76I76 Q8TDB5 Q8WYL1 Q8WYL2 Q96F40 Q96H36 Q9C0D8,Protein phosphatase Slingshot homolog 2,SSH-like protein 2;, PF08766;, GO:0005737;GO:0005856;GO:0005615;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0030837;GO:0006470;, C:cytoplasm; C:cytoskeleton; C:extracellular space;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization; P:protein dephosphorylation; scaffold52 indexed_genome mRNA 11618435 11638140 . + . ID=transcript_9763;A4FU69 B2RPN0 B4DS75 B4DZR5 F5GYL2 Q0VD68 Q6ZRM6 Q8NDG9,EF-hand calcium-binding domain-containing protein 5,, , GO:0005509;, , F:calcium ion binding; scaffold52 indexed_genome mRNA 11657300 11657841 . + . ID=transcript_9764;A4FU69 B2RPN0 B4DS75 B4DZR5 F5GYL2 Q0VD68 Q6ZRM6 Q8NDG9,EF-hand calcium-binding domain-containing protein 5,, , GO:0005509;, , F:calcium ion binding; scaffold52 indexed_genome mRNA 11679587 11685091 . + . ID=transcript_9765;A4FU69 B2RPN0 B4DS75 B4DZR5 F5GYL2 Q0VD68 Q6ZRM6 Q8NDG9,EF-hand calcium-binding domain-containing protein 5,, , GO:0005509;, , F:calcium ion binding; scaffold52 indexed_genome mRNA 11706635 11751682 . - . ID=transcript_9766;Q9H0G5 Q6FI71,Nuclear speckle splicing regulatory protein 1,Coiled-coil domain-containing protein 55;Nuclear speckle-related protein 70;, PF09745;, GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0003729;GO:0003723;GO:0032502;GO:0001701;GO:0006397;GO:0000381;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding;, P:developmental process; P:in utero embryonic development; P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;|Q9H0G5 Q6FI71,Nuclear speckle splicing regulatory protein 1,Coiled-coil domain-containing protein 55;Nuclear speckle-related protein 70;, PF09745;, GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0003729;GO:0003723;GO:0032502;GO:0001701;GO:0006397;GO:0000381;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding;, P:developmental process; P:in utero embryonic development; P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;|Q9H0G5 Q6FI71,Nuclear speckle splicing regulatory protein 1,Coiled-coil domain-containing protein 55;Nuclear speckle-related protein 70;, PF09745;, GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0003729;GO:0003723;GO:0032502;GO:0001701;GO:0006397;GO:0000381;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding;, P:developmental process; P:in utero embryonic development; P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;|Q9H0G5 Q6FI71,Nuclear speckle splicing regulatory protein 1,Coiled-coil domain-containing protein 55;Nuclear speckle-related protein 70;, PF09745;, GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0003729;GO:0003723;GO:0032502;GO:0001701;GO:0006397;GO:0000381;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding;, P:developmental process; P:in utero embryonic development; P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;|Q9H0G5 Q6FI71,Nuclear speckle splicing regulatory protein 1,Coiled-coil domain-containing protein 55;Nuclear speckle-related protein 70;, PF09745;, GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0003729;GO:0003723;GO:0032502;GO:0001701;GO:0006397;GO:0000381;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:RNA binding;, P:developmental process; P:in utero embryonic development; P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; scaffold52 indexed_genome mRNA 11757088 11791792 . + . ID=transcript_9767;P31645 Q5EE02,Sodium-dependent serotonin transporter,5HT transporter;Solute carrier family 6 member 4;, PF03491;PF00209;, GO:0012505;GO:0010008;GO:0005925;GO:0005887;GO:0099055;GO:0099056;GO:0045121;GO:0043005;GO:0005886;GO:0099154;GO:0045202;GO:0051015;GO:0019811;GO:0042802;GO:0046872;GO:0008504;GO:0005326;GO:0050998;GO:0051378;GO:0005335;GO:0017075;GO:0048854;GO:0071321;GO:0071300;GO:0007623;GO:0007613;GO:0015844;GO:0021941;GO:0045665;GO:0046621;GO:0032227;GO:0042136;GO:0006836;GO:0045787;GO:0010628;GO:0014064;GO:0090067;GO:0042493;GO:0032355;GO:0001666;GO:0007584;GO:0009636;GO:0051610;GO:0035176;GO:0035725;GO:0042713;GO:0042310;, C:endomembrane system; C:endosome membrane; C:focal adhesion; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:serotonergic synapse; C:synapse;, F:actin filament binding; F:cocaine binding; F:identical protein binding; F:metal ion binding; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:nitric-oxide synthase binding; F:serotonin binding; F:serotonin:sodium symporter activity; F:syntaxin-1 binding;, P:brain morphogenesis; P:cellular response to cGMP; P:cellular response to retinoic acid; P:circadian rhythm; P:memory; P:monoamine transport; P:negative regulation of cerebellar granule cell precursor proliferation; P:negative regulation of neuron differentiation; P:negative regulation of organ growth; P:negative regulation of synaptic transmission, dopaminergic; P:neurotransmitter biosynthetic process; P:neurotransmitter transport; P:positive regulation of cell cycle; P:positive regulation of gene expression; P:positive regulation of serotonin secretion; P:regulation of thalamus size; P:response to drug; P:response to estradiol; P:response to hypoxia; P:response to nutrient; P:response to toxic substance; P:serotonin uptake; P:social behavior; P:sodium ion transmembrane transport; P:sperm ejaculation; P:vasoconstriction;|P31645 Q5EE02,Sodium-dependent serotonin transporter,5HT transporter;Solute carrier family 6 member 4;, PF03491;PF00209;, GO:0012505;GO:0010008;GO:0005925;GO:0005887;GO:0099055;GO:0099056;GO:0045121;GO:0043005;GO:0005886;GO:0099154;GO:0045202;GO:0051015;GO:0019811;GO:0042802;GO:0046872;GO:0008504;GO:0005326;GO:0050998;GO:0051378;GO:0005335;GO:0017075;GO:0048854;GO:0071321;GO:0071300;GO:0007623;GO:0007613;GO:0015844;GO:0021941;GO:0045665;GO:0046621;GO:0032227;GO:0042136;GO:0006836;GO:0045787;GO:0010628;GO:0014064;GO:0090067;GO:0042493;GO:0032355;GO:0001666;GO:0007584;GO:0009636;GO:0051610;GO:0035176;GO:0035725;GO:0042713;GO:0042310;, C:endomembrane system; C:endosome membrane; C:focal adhesion; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:serotonergic synapse; C:synapse;, F:actin filament binding; F:cocaine binding; F:identical protein binding; F:metal ion binding; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:nitric-oxide synthase binding; F:serotonin binding; F:serotonin:sodium symporter activity; F:syntaxin-1 binding;, P:brain morphogenesis; P:cellular response to cGMP; P:cellular response to retinoic acid; P:circadian rhythm; P:memory; P:monoamine transport; P:negative regulation of cerebellar granule cell precursor proliferation; P:negative regulation of neuron differentiation; P:negative regulation of organ growth; P:negative regulation of synaptic transmission, dopaminergic; P:neurotransmitter biosynthetic process; P:neurotransmitter transport; P:positive regulation of cell cycle; P:positive regulation of gene expression; P:positive regulation of serotonin secretion; P:regulation of thalamus size; P:response to drug; P:response to estradiol; P:response to hypoxia; P:response to nutrient; P:response to toxic substance; P:serotonin uptake; P:social behavior; P:sodium ion transmembrane transport; P:sperm ejaculation; P:vasoconstriction; scaffold52 indexed_genome mRNA 11801881 11823694 . - . ID=transcript_9768;Q13867 B2R796 Q53F86 Q9UER9,Bleomycin hydrolase,, PF03051;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0004180;GO:0004197;GO:0008234;GO:0042802;GO:0043418;GO:0000209;GO:0006508;GO:0042493;GO:0009636;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:carboxypeptidase activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:identical protein binding;, P:homocysteine catabolic process; P:protein polyubiquitination; P:proteolysis; P:response to drug; P:response to toxic substance;|Q13867 B2R796 Q53F86 Q9UER9,Bleomycin hydrolase,, PF03051;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0004180;GO:0004197;GO:0008234;GO:0042802;GO:0043418;GO:0000209;GO:0006508;GO:0042493;GO:0009636;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:carboxypeptidase activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:identical protein binding;, P:homocysteine catabolic process; P:protein polyubiquitination; P:proteolysis; P:response to drug; P:response to toxic substance; scaffold52 indexed_genome mRNA 11823895 11843647 . - . ID=transcript_9769;Q13867 B2R796 Q53F86 Q9UER9,Bleomycin hydrolase,, PF03051;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0004180;GO:0004197;GO:0008234;GO:0042802;GO:0043418;GO:0000209;GO:0006508;GO:0042493;GO:0009636;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:carboxypeptidase activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:identical protein binding;, P:homocysteine catabolic process; P:protein polyubiquitination; P:proteolysis; P:response to drug; P:response to toxic substance;|Q13867 B2R796 Q53F86 Q9UER9,Bleomycin hydrolase,, PF03051;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0004180;GO:0004197;GO:0008234;GO:0042802;GO:0043418;GO:0000209;GO:0006508;GO:0042493;GO:0009636;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:carboxypeptidase activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:identical protein binding;, P:homocysteine catabolic process; P:protein polyubiquitination; P:proteolysis; P:response to drug; P:response to toxic substance; scaffold52 indexed_genome mRNA 11931048 11984978 . + . ID=transcript_9770;O75976 B7Z7T9 B7ZAU4 F5GZH6 O15377 Q86SH9 Q86XE6,Carboxypeptidase D,Metallocarboxypeptidase D;gp180;, PF00246;, GO:0070062;GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0004181;GO:0004185;GO:0008270;GO:0006518;GO:0016485;, C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:metallocarboxypeptidase activity; F:serine-type carboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing;|O75976 B7Z7T9 B7ZAU4 F5GZH6 O15377 Q86SH9 Q86XE6,Carboxypeptidase D,Metallocarboxypeptidase D;gp180;, PF00246;, GO:0070062;GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0004181;GO:0004185;GO:0008270;GO:0006518;GO:0016485;, C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:metallocarboxypeptidase activity; F:serine-type carboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing;|O75976 B7Z7T9 B7ZAU4 F5GZH6 O15377 Q86SH9 Q86XE6,Carboxypeptidase D,Metallocarboxypeptidase D;gp180;, PF00246;, GO:0070062;GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0004181;GO:0004185;GO:0008270;GO:0006518;GO:0016485;, C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:metallocarboxypeptidase activity; F:serine-type carboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing; scaffold52 indexed_genome mRNA 11985015 11998389 . + . ID=transcript_9771;O75976 B7Z7T9 B7ZAU4 F5GZH6 O15377 Q86SH9 Q86XE6,Carboxypeptidase D,Metallocarboxypeptidase D;gp180;, PF00246;, GO:0070062;GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0004181;GO:0004185;GO:0008270;GO:0006518;GO:0016485;, C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:metallocarboxypeptidase activity; F:serine-type carboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing; scaffold52 indexed_genome mRNA 12003581 12049107 . + . ID=transcript_9772;O95249 J3KST5 O75392,Golgi SNAP receptor complex member 1,28 kDa Golgi SNARE protein;28 kDa cis-Golgi SNARE p28;, , GO:0005801;GO:0005829;GO:0005794;GO:0005797;GO:0000139;GO:0016021;GO:0016020;GO:0031201;GO:0030133;GO:0005484;GO:0006888;GO:0006891;GO:0015031;GO:0048209;GO:0042147;GO:0006906;, C:cis-Golgi network; C:cytosol; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi membrane; C:integral component of membrane; C:membrane; C:SNARE complex; C:transport vesicle;, F:SNAP receptor activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport; P:regulation of vesicle targeting, to, from or within Golgi; P:retrograde transport, endosome to Golgi; P:vesicle fusion;|O95249 J3KST5 O75392,Golgi SNAP receptor complex member 1,28 kDa Golgi SNARE protein;28 kDa cis-Golgi SNARE p28;, , GO:0005801;GO:0005829;GO:0005794;GO:0005797;GO:0000139;GO:0016021;GO:0016020;GO:0031201;GO:0030133;GO:0005484;GO:0006888;GO:0006891;GO:0015031;GO:0048209;GO:0042147;GO:0006906;, C:cis-Golgi network; C:cytosol; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi membrane; C:integral component of membrane; C:membrane; C:SNARE complex; C:transport vesicle;, F:SNAP receptor activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport; P:regulation of vesicle targeting, to, from or within Golgi; P:retrograde transport, endosome to Golgi; P:vesicle fusion; scaffold52 indexed_genome mRNA 12251378 12341421 . + . ID=transcript_9773;Q12979 B3KW89 B7Z6H7 D3DTH3 D3DTH4 F5H3S2 F5H8B3 Q13693 Q13694,Active breakpoint cluster region-related protein {ECO:0000305},, PF00168;PF00169;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0098978;GO:0016020;GO:0098685;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0050804;GO:0043065;GO:0051056;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:membrane; C:Schaffer collateral - CA1 synapse;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:modulation of chemical synaptic transmission; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction;|Q12979 B3KW89 B7Z6H7 D3DTH3 D3DTH4 F5H3S2 F5H8B3 Q13693 Q13694,Active breakpoint cluster region-related protein {ECO:0000305},, PF00168;PF00169;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0098978;GO:0016020;GO:0098685;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0050804;GO:0043065;GO:0051056;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:membrane; C:Schaffer collateral - CA1 synapse;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:modulation of chemical synaptic transmission; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; scaffold52 indexed_genome mRNA 12343470 12348444 . - . ID=transcript_9774;Q9Y584 Q9NWI8,Mitochondrial import inner membrane translocase subunit Tim22,Testis-expressed protein 4;, , GO:0016021;GO:0005743;GO:0042721;GO:0030943;GO:0008320;GO:0140318;GO:0045039;GO:0006626;, C:integral component of membrane; C:mitochondrial inner membrane; C:TIM22 mitochondrial import inner membrane insertion complex;, F:mitochondrion targeting sequence binding; F:protein transmembrane transporter activity; F:protein transporter activity;, P:protein insertion into mitochondrial inner membrane; P:protein targeting to mitochondrion;|Q9Y584 Q9NWI8,Mitochondrial import inner membrane translocase subunit Tim22,Testis-expressed protein 4;, , GO:0016021;GO:0005743;GO:0042721;GO:0030943;GO:0008320;GO:0140318;GO:0045039;GO:0006626;, C:integral component of membrane; C:mitochondrial inner membrane; C:TIM22 mitochondrial import inner membrane insertion complex;, F:mitochondrion targeting sequence binding; F:protein transmembrane transporter activity; F:protein transporter activity;, P:protein insertion into mitochondrial inner membrane; P:protein targeting to mitochondrion; scaffold52 indexed_genome mRNA 12361695 12520304 . + . ID=transcript_9775;Q6DKJ4 B4DXQ0 D3DTH2 Q3SWW6 Q6P3U6 Q7L4C6 Q9H9Q1,Nucleoredoxin,, PF13905;, GO:0005829;GO:0005634;GO:0047134;GO:0004791;GO:0030154;GO:0072359;GO:0001701;GO:0031397;GO:0030178;GO:0016055;, C:cytosol; C:nucleus;, F:protein-disulfide reductase activity; F:thioredoxin-disulfide reductase activity;, P:cell differentiation; P:circulatory system development; P:in utero embryonic development; P:negative regulation of protein ubiquitination; P:negative regulation of Wnt signaling pathway; P:Wnt signaling pathway;|Q6DKJ4 B4DXQ0 D3DTH2 Q3SWW6 Q6P3U6 Q7L4C6 Q9H9Q1,Nucleoredoxin,, PF13905;, GO:0005829;GO:0005634;GO:0047134;GO:0004791;GO:0030154;GO:0072359;GO:0001701;GO:0031397;GO:0030178;GO:0016055;, C:cytosol; C:nucleus;, F:protein-disulfide reductase activity; F:thioredoxin-disulfide reductase activity;, P:cell differentiation; P:circulatory system development; P:in utero embryonic development; P:negative regulation of protein ubiquitination; P:negative regulation of Wnt signaling pathway; P:Wnt signaling pathway;|Q6DKJ4 B4DXQ0 D3DTH2 Q3SWW6 Q6P3U6 Q7L4C6 Q9H9Q1,Nucleoredoxin,, PF13905;, GO:0005829;GO:0005634;GO:0047134;GO:0004791;GO:0030154;GO:0072359;GO:0001701;GO:0031397;GO:0030178;GO:0016055;, C:cytosol; C:nucleus;, F:protein-disulfide reductase activity; F:thioredoxin-disulfide reductase activity;, P:cell differentiation; P:circulatory system development; P:in utero embryonic development; P:negative regulation of protein ubiquitination; P:negative regulation of Wnt signaling pathway; P:Wnt signaling pathway;|Q6DKJ4 B4DXQ0 D3DTH2 Q3SWW6 Q6P3U6 Q7L4C6 Q9H9Q1,Nucleoredoxin,, PF13905;, GO:0005829;GO:0005634;GO:0047134;GO:0004791;GO:0030154;GO:0072359;GO:0001701;GO:0031397;GO:0030178;GO:0016055;, C:cytosol; C:nucleus;, F:protein-disulfide reductase activity; F:thioredoxin-disulfide reductase activity;, P:cell differentiation; P:circulatory system development; P:in utero embryonic development; P:negative regulation of protein ubiquitination; P:negative regulation of Wnt signaling pathway; P:Wnt signaling pathway;|Q6DKJ4 B4DXQ0 D3DTH2 Q3SWW6 Q6P3U6 Q7L4C6 Q9H9Q1,Nucleoredoxin,, PF13905;, GO:0005829;GO:0005634;GO:0047134;GO:0004791;GO:0030154;GO:0072359;GO:0001701;GO:0031397;GO:0030178;GO:0016055;, C:cytosol; C:nucleus;, F:protein-disulfide reductase activity; F:thioredoxin-disulfide reductase activity;, P:cell differentiation; P:circulatory system development; P:in utero embryonic development; P:negative regulation of protein ubiquitination; P:negative regulation of Wnt signaling pathway; P:Wnt signaling pathway; scaffold52 indexed_genome mRNA 12524904 12530168 . - . ID=transcript_9776;Q9HC36 Q53GN1 Q86VC3 Q96F76 Q9NVQ5,rRNA methyltransferase 3, mitochondrial {ECO:0000303|PubMed:25009282},16S rRNA (guanosine(1370)-2'-O)-methyltransferase {ECO:0000303|PubMed:25074936};16S rRNA [Gm1370] 2'-O-methyltransferase {ECO:0000303|PubMed:25074936};RNA methyltransferase-like protein 1 {ECO:0000303|PubMed:12296377};, PF00588;, GO:0005759;GO:0005739;GO:0042802;GO:0003723;GO:0070039;GO:0000451;, C:mitochondrial matrix; C:mitochondrion;, F:identical protein binding; F:RNA binding; F:rRNA (guanosine-2'-O-)-methyltransferase activity;, P:rRNA 2'-O-methylation;|Q9HC36 Q53GN1 Q86VC3 Q96F76 Q9NVQ5,rRNA methyltransferase 3, mitochondrial {ECO:0000303|PubMed:25009282},16S rRNA (guanosine(1370)-2'-O)-methyltransferase {ECO:0000303|PubMed:25074936};16S rRNA [Gm1370] 2'-O-methyltransferase {ECO:0000303|PubMed:25074936};RNA methyltransferase-like protein 1 {ECO:0000303|PubMed:12296377};, PF00588;, GO:0005759;GO:0005739;GO:0042802;GO:0003723;GO:0070039;GO:0000451;, C:mitochondrial matrix; C:mitochondrion;, F:identical protein binding; F:RNA binding; F:rRNA (guanosine-2'-O-)-methyltransferase activity;, P:rRNA 2'-O-methylation; scaffold52 indexed_genome mRNA 12530241 12553398 . + . ID=transcript_9777;Q9HC38 D3DTG9 D3DTH1 Q96B89 Q9H3J8 Q9HC37 Q9NVN1,Glyoxalase domain-containing protein 4,, , GO:0070062;GO:0005739;GO:0045296;, C:extracellular exosome; C:mitochondrion;, F:cadherin binding;|Q9HC38 D3DTG9 D3DTH1 Q96B89 Q9H3J8 Q9HC37 Q9NVN1,Glyoxalase domain-containing protein 4,, , GO:0070062;GO:0005739;GO:0045296;, C:extracellular exosome; C:mitochondrion;, F:cadherin binding; scaffold52 indexed_genome mRNA 12555856 12562832 . + . ID=transcript_9778;P57678 Q9NZS7 Q9UG32 Q9Y4Q2,Gem-associated protein 4,Component of gems 4;p97;, , GO:0015030;GO:0005737;GO:0005829;GO:0070062;GO:0097504;GO:0016020;GO:0016604;GO:0005730;GO:0005654;GO:0030532;GO:0032797;GO:0034719;GO:0043021;GO:0051170;GO:0006364;GO:0000387;, C:Cajal body; C:cytoplasm; C:cytosol; C:extracellular exosome; C:Gemini of coiled bodies; C:membrane; C:nuclear body; C:nucleolus; C:nucleoplasm; C:small nuclear ribonucleoprotein complex; C:SMN complex; C:SMN-Sm protein complex;, F:ribonucleoprotein complex binding;, P:import into nucleus; P:rRNA processing; P:spliceosomal snRNP assembly; scaffold52 indexed_genome mRNA 12563777 12572014 . - . ID=transcript_9779;Q8TBR7 A8K7Q0 Q7Z464 Q96D97 Q9H6H3,TLC domain-containing protein 3A {ECO:0000305},Protein CT120 {ECO:0000303|PubMed:12270127};Protein FAM57A;, PF03798;, GO:0005783;GO:0016021;GO:0005886;GO:0055088;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane;, , P:lipid homeostasis; scaffold52 indexed_genome mRNA 12595131 12719365 . + . ID=transcript_9780;Q5VIR6 A8K2S8 B3FH42 Q8WYW3 Q9BRR2 Q9BY02 Q9NV25,Vacuolar protein sorting-associated protein 53 homolog,, PF04100;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0032456;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, , P:endocytic recycling; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q5VIR6 A8K2S8 B3FH42 Q8WYW3 Q9BRR2 Q9BY02 Q9NV25,Vacuolar protein sorting-associated protein 53 homolog,, PF04100;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0032456;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, , P:endocytic recycling; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q5VIR6 A8K2S8 B3FH42 Q8WYW3 Q9BRR2 Q9BY02 Q9NV25,Vacuolar protein sorting-associated protein 53 homolog,, PF04100;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0032456;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, , P:endocytic recycling; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q5VIR6 A8K2S8 B3FH42 Q8WYW3 Q9BRR2 Q9BY02 Q9NV25,Vacuolar protein sorting-associated protein 53 homolog,, PF04100;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0032456;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, , P:endocytic recycling; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q5VIR6 A8K2S8 B3FH42 Q8WYW3 Q9BRR2 Q9BY02 Q9NV25,Vacuolar protein sorting-associated protein 53 homolog,, PF04100;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0032456;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, , P:endocytic recycling; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi; scaffold52 indexed_genome mRNA 12827277 12914952 . + . ID=transcript_9781;Q9UNE2 D3DTG7 Q9BSB3,Rab effector Noc2,No C2 domains protein;Rabphilin-3A-like protein;, PF02318;, GO:0005737;GO:0030667;GO:0030658;GO:0008092;GO:0030274;GO:0046872;GO:0031267;GO:0006887;GO:0006886;GO:0050714;GO:0017157;GO:0042493;, C:cytoplasm; C:secretory granule membrane; C:transport vesicle membrane;, F:cytoskeletal protein binding; F:LIM domain binding; F:metal ion binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:positive regulation of protein secretion; P:regulation of exocytosis; P:response to drug; scaffold52 indexed_genome mRNA 12943547 12973156 . + . ID=transcript_9782;Q14184 A0A087WZX8,Double C2-like domain-containing protein beta,, PF00168;, GO:0005737;GO:0005886;GO:0098793;GO:0005509;GO:0005544;GO:0048791;GO:0045956;GO:0032024;GO:0031340;GO:0008104;, C:cytoplasm; C:plasma membrane; C:presynapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of insulin secretion; P:positive regulation of vesicle fusion; P:protein localization; scaffold52 indexed_genome mRNA 12988921 13023708 . - . ID=transcript_9783;P62258 B3KY71 D3DTH5 P29360 P42655 Q4VJB6 Q53XZ5 Q63631 Q7M4R4,14-3-3 protein epsilon,, PF00244;, GO:0090724;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0098978;GO:0005871;GO:0042470;GO:0016020;GO:0005739;GO:0005634;GO:0045296;GO:0005246;GO:0019899;GO:0042826;GO:0042802;GO:0044325;GO:0023026;GO:0051219;GO:0050815;GO:0015459;GO:0046982;GO:0003723;GO:0097110;GO:0031625;GO:0034605;GO:0097711;GO:0000086;GO:0035329;GO:0035556;GO:0000165;GO:0086013;GO:1905913;GO:1901020;GO:0043154;GO:1902309;GO:0046827;GO:1900740;GO:0034504;GO:1900034;GO:0051480;GO:0010389;GO:0086091;GO:0003064;GO:0060306;GO:0099072;GO:1901016;GO:0021762;GO:0016032;, C:central region of growth cone; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:kinesin complex; C:melanosome; C:membrane; C:mitochondrion; C:nucleus;, F:cadherin binding; F:calcium channel regulator activity; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:ion channel binding; F:MHC class II protein complex binding; F:phosphoprotein binding; F:phosphoserine residue binding; F:potassium channel regulator activity; F:protein heterodimerization activity; F:RNA binding; F:scaffold protein binding; F:ubiquitin protein ligase binding;, P:cellular response to heat; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:intracellular signal transduction; P:MAPK cascade; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of calcium ion export across plasma membrane; P:negative regulation of calcium ion transmembrane transporter activity; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of peptidyl-serine dephosphorylation; P:positive regulation of protein export from nucleus; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein localization to nucleus; P:regulation of cellular response to heat; P:regulation of cytosolic calcium ion concentration; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of heart rate by cardiac conduction; P:regulation of heart rate by hormone; P:regulation of membrane repolarization; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:regulation of potassium ion transmembrane transporter activity; P:substantia nigra development; P:viral process;|P62258 B3KY71 D3DTH5 P29360 P42655 Q4VJB6 Q53XZ5 Q63631 Q7M4R4,14-3-3 protein epsilon,, PF00244;, GO:0090724;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0098978;GO:0005871;GO:0042470;GO:0016020;GO:0005739;GO:0005634;GO:0045296;GO:0005246;GO:0019899;GO:0042826;GO:0042802;GO:0044325;GO:0023026;GO:0051219;GO:0050815;GO:0015459;GO:0046982;GO:0003723;GO:0097110;GO:0031625;GO:0034605;GO:0097711;GO:0000086;GO:0035329;GO:0035556;GO:0000165;GO:0086013;GO:1905913;GO:1901020;GO:0043154;GO:1902309;GO:0046827;GO:1900740;GO:0034504;GO:1900034;GO:0051480;GO:0010389;GO:0086091;GO:0003064;GO:0060306;GO:0099072;GO:1901016;GO:0021762;GO:0016032;, C:central region of growth cone; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:kinesin complex; C:melanosome; C:membrane; C:mitochondrion; C:nucleus;, F:cadherin binding; F:calcium channel regulator activity; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:ion channel binding; F:MHC class II protein complex binding; F:phosphoprotein binding; F:phosphoserine residue binding; F:potassium channel regulator activity; F:protein heterodimerization activity; F:RNA binding; F:scaffold protein binding; F:ubiquitin protein ligase binding;, P:cellular response to heat; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:intracellular signal transduction; P:MAPK cascade; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of calcium ion export across plasma membrane; P:negative regulation of calcium ion transmembrane transporter activity; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of peptidyl-serine dephosphorylation; P:positive regulation of protein export from nucleus; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein localization to nucleus; P:regulation of cellular response to heat; P:regulation of cytosolic calcium ion concentration; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of heart rate by cardiac conduction; P:regulation of heart rate by hormone; P:regulation of membrane repolarization; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:regulation of potassium ion transmembrane transporter activity; P:substantia nigra development; P:viral process;|P62258 B3KY71 D3DTH5 P29360 P42655 Q4VJB6 Q53XZ5 Q63631 Q7M4R4,14-3-3 protein epsilon,, PF00244;, GO:0090724;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0098978;GO:0005871;GO:0042470;GO:0016020;GO:0005739;GO:0005634;GO:0045296;GO:0005246;GO:0019899;GO:0042826;GO:0042802;GO:0044325;GO:0023026;GO:0051219;GO:0050815;GO:0015459;GO:0046982;GO:0003723;GO:0097110;GO:0031625;GO:0034605;GO:0097711;GO:0000086;GO:0035329;GO:0035556;GO:0000165;GO:0086013;GO:1905913;GO:1901020;GO:0043154;GO:1902309;GO:0046827;GO:1900740;GO:0034504;GO:1900034;GO:0051480;GO:0010389;GO:0086091;GO:0003064;GO:0060306;GO:0099072;GO:1901016;GO:0021762;GO:0016032;, C:central region of growth cone; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:kinesin complex; C:melanosome; C:membrane; C:mitochondrion; C:nucleus;, F:cadherin binding; F:calcium channel regulator activity; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:ion channel binding; F:MHC class II protein complex binding; F:phosphoprotein binding; F:phosphoserine residue binding; F:potassium channel regulator activity; F:protein heterodimerization activity; F:RNA binding; F:scaffold protein binding; F:ubiquitin protein ligase binding;, P:cellular response to heat; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:hippo signaling; P:intracellular signal transduction; P:MAPK cascade; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of calcium ion export across plasma membrane; P:negative regulation of calcium ion transmembrane transporter activity; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of peptidyl-serine dephosphorylation; P:positive regulation of protein export from nucleus; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein localization to nucleus; P:regulation of cellular response to heat; P:regulation of cytosolic calcium ion concentration; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of heart rate by cardiac conduction; P:regulation of heart rate by hormone; P:regulation of membrane repolarization; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:regulation of potassium ion transmembrane transporter activity; P:substantia nigra development; P:viral process; scaffold52 indexed_genome mRNA 13044537 13045444 . + . ID=transcript_9784;P46108 A8MWE8 B0LPE8 D3DTH6 Q96GA9 Q96HJ0,Adapter molecule crk,Proto-oncogene c-Crk;p38;, PF00017;PF00018;PF07653;, GO:0015629;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0005634;GO:0005886;GO:0032991;GO:0008092;GO:0046875;GO:0005159;GO:0019900;GO:0001784;GO:0045309;GO:0043621;GO:1990782;GO:0097110;GO:0042169;GO:0017124;GO:0035591;GO:0030159;GO:0031625;GO:0030036;GO:0090630;GO:0000186;GO:0060326;GO:1990859;GO:1990314;GO:1990090;GO:0071732;GO:0071560;GO:0098749;GO:0021987;GO:0019221;GO:0016358;GO:0048013;GO:0030010;GO:0038096;GO:0035685;GO:0021766;GO:0006629;GO:2000146;GO:0045953;GO:0061045;GO:0001764;GO:0030307;GO:0014911;GO:1900026;GO:0038026;GO:0032956;GO:0033628;GO:0008360;GO:0050773;GO:0043087;GO:1902531;GO:0043393;GO:0035020;GO:0009966;GO:2000404;GO:0006357;GO:0061847;GO:0035728;GO:0042542;GO:0001878;GO:0048010;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:cytoskeletal protein binding; F:ephrin receptor binding; F:insulin-like growth factor receptor binding; F:kinase binding; F:phosphotyrosine residue binding; F:protein phosphorylated amino acid binding; F:protein self-association; F:protein tyrosine kinase binding; F:scaffold protein binding; F:SH2 domain binding; F:SH3 domain binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity; F:ubiquitin protein ligase binding;, P:actin cytoskeleton organization; P:activation of GTPase activity; P:activation of MAPKK activity; P:cell chemotaxis; P:cellular response to endothelin; P:cellular response to insulin-like growth factor stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to nitric oxide; P:cellular response to transforming growth factor beta stimulus; P:cerebellar neuron development; P:cerebral cortex development; P:cytokine-mediated signaling pathway; P:dendrite development; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:helper T cell diapedesis; P:hippocampus development; P:lipid metabolic process; P:negative regulation of cell motility; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of wound healing; P:neuron migration; P:positive regulation of cell growth; P:positive regulation of smooth muscle cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:reelin-mediated signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of cell adhesion mediated by integrin; P:regulation of cell shape; P:regulation of dendrite development; P:regulation of GTPase activity; P:regulation of intracellular signal transduction; P:regulation of protein binding; P:regulation of Rac protein signal transduction; P:regulation of signal transduction; P:regulation of T cell migration; P:regulation of transcription by RNA polymerase II; P:response to cholecystokinin; P:response to hepatocyte growth factor; P:response to hydrogen peroxide; P:response to yeast; P:vascular endothelial growth factor receptor signaling pathway; scaffold52 indexed_genome mRNA 13075176 13092706 . - . ID=transcript_9785;O00159 Q4LE56 Q6NVJ7 Q86Y95,Unconventional myosin-Ic,Myosin I beta;, PF00612;PF00063;PF06017;, GO:0015629;GO:0009925;GO:0005903;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0031941;GO:0016328;GO:0016020;GO:0045121;GO:0005902;GO:0016604;GO:0005643;GO:0005730;GO:0005654;GO:0045335;GO:0005886;GO:0032587;GO:0060171;GO:0016461;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0008022;GO:0005102;GO:0031267;GO:0007015;GO:0071346;GO:0038096;GO:0051028;GO:0030838;GO:0030335;GO:0038089;GO:1900078;GO:0045815;GO:0090314;GO:1900748;GO:0006605;GO:0006612;GO:2000810;GO:0030050;, C:actin cytoskeleton; C:basal plasma membrane; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:filamentous actin; C:lateral plasma membrane; C:membrane; C:membrane raft; C:microvillus; C:nuclear body; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:ruffle membrane; C:stereocilium membrane; C:unconventional myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:protein C-terminus binding; F:signaling receptor binding; F:small GTPase binding;, P:actin filament organization; P:cellular response to interferon-gamma; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:mRNA transport; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cellular response to insulin stimulus; P:positive regulation of gene expression, epigenetic; P:positive regulation of protein targeting to membrane; P:positive regulation of vascular endothelial growth factor signaling pathway; P:protein targeting; P:protein targeting to membrane; P:regulation of bicellular tight junction assembly; P:vesicle transport along actin filament;|O00159 Q4LE56 Q6NVJ7 Q86Y95,Unconventional myosin-Ic,Myosin I beta;, PF00612;PF00063;PF06017;, GO:0015629;GO:0009925;GO:0005903;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0031941;GO:0016328;GO:0016020;GO:0045121;GO:0005902;GO:0016604;GO:0005643;GO:0005730;GO:0005654;GO:0045335;GO:0005886;GO:0032587;GO:0060171;GO:0016461;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0008022;GO:0005102;GO:0031267;GO:0007015;GO:0071346;GO:0038096;GO:0051028;GO:0030838;GO:0030335;GO:0038089;GO:1900078;GO:0045815;GO:0090314;GO:1900748;GO:0006605;GO:0006612;GO:2000810;GO:0030050;, C:actin cytoskeleton; C:basal plasma membrane; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:filamentous actin; C:lateral plasma membrane; C:membrane; C:membrane raft; C:microvillus; C:nuclear body; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:ruffle membrane; C:stereocilium membrane; C:unconventional myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:protein C-terminus binding; F:signaling receptor binding; F:small GTPase binding;, P:actin filament organization; P:cellular response to interferon-gamma; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:mRNA transport; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cellular response to insulin stimulus; P:positive regulation of gene expression, epigenetic; P:positive regulation of protein targeting to membrane; P:positive regulation of vascular endothelial growth factor signaling pathway; P:protein targeting; P:protein targeting to membrane; P:regulation of bicellular tight junction assembly; P:vesicle transport along actin filament;|O00159 Q4LE56 Q6NVJ7 Q86Y95,Unconventional myosin-Ic,Myosin I beta;, PF00612;PF00063;PF06017;, GO:0015629;GO:0009925;GO:0005903;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0031941;GO:0016328;GO:0016020;GO:0045121;GO:0005902;GO:0016604;GO:0005643;GO:0005730;GO:0005654;GO:0045335;GO:0005886;GO:0032587;GO:0060171;GO:0016461;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0008022;GO:0005102;GO:0031267;GO:0007015;GO:0071346;GO:0038096;GO:0051028;GO:0030838;GO:0030335;GO:0038089;GO:1900078;GO:0045815;GO:0090314;GO:1900748;GO:0006605;GO:0006612;GO:2000810;GO:0030050;, C:actin cytoskeleton; C:basal plasma membrane; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:filamentous actin; C:lateral plasma membrane; C:membrane; C:membrane raft; C:microvillus; C:nuclear body; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:ruffle membrane; C:stereocilium membrane; C:unconventional myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:protein C-terminus binding; F:signaling receptor binding; F:small GTPase binding;, P:actin filament organization; P:cellular response to interferon-gamma; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:mRNA transport; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cellular response to insulin stimulus; P:positive regulation of gene expression, epigenetic; P:positive regulation of protein targeting to membrane; P:positive regulation of vascular endothelial growth factor signaling pathway; P:protein targeting; P:protein targeting to membrane; P:regulation of bicellular tight junction assembly; P:vesicle transport along actin filament;|O00159 Q4LE56 Q6NVJ7 Q86Y95,Unconventional myosin-Ic,Myosin I beta;, PF00612;PF00063;PF06017;, GO:0015629;GO:0009925;GO:0005903;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0031941;GO:0016328;GO:0016020;GO:0045121;GO:0005902;GO:0016604;GO:0005643;GO:0005730;GO:0005654;GO:0045335;GO:0005886;GO:0032587;GO:0060171;GO:0016461;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0008022;GO:0005102;GO:0031267;GO:0007015;GO:0071346;GO:0038096;GO:0051028;GO:0030838;GO:0030335;GO:0038089;GO:1900078;GO:0045815;GO:0090314;GO:1900748;GO:0006605;GO:0006612;GO:2000810;GO:0030050;, C:actin cytoskeleton; C:basal plasma membrane; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:filamentous actin; C:lateral plasma membrane; C:membrane; C:membrane raft; C:microvillus; C:nuclear body; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:ruffle membrane; C:stereocilium membrane; C:unconventional myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:protein C-terminus binding; F:signaling receptor binding; F:small GTPase binding;, P:actin filament organization; P:cellular response to interferon-gamma; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:mRNA transport; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cellular response to insulin stimulus; P:positive regulation of gene expression, epigenetic; P:positive regulation of protein targeting to membrane; P:positive regulation of vascular endothelial growth factor signaling pathway; P:protein targeting; P:protein targeting to membrane; P:regulation of bicellular tight junction assembly; P:vesicle transport along actin filament;|O00159 Q4LE56 Q6NVJ7 Q86Y95,Unconventional myosin-Ic,Myosin I beta;, PF00612;PF00063;PF06017;, GO:0015629;GO:0009925;GO:0005903;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0031941;GO:0016328;GO:0016020;GO:0045121;GO:0005902;GO:0016604;GO:0005643;GO:0005730;GO:0005654;GO:0045335;GO:0005886;GO:0032587;GO:0060171;GO:0016461;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0008022;GO:0005102;GO:0031267;GO:0007015;GO:0071346;GO:0038096;GO:0051028;GO:0030838;GO:0030335;GO:0038089;GO:1900078;GO:0045815;GO:0090314;GO:1900748;GO:0006605;GO:0006612;GO:2000810;GO:0030050;, C:actin cytoskeleton; C:basal plasma membrane; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:filamentous actin; C:lateral plasma membrane; C:membrane; C:membrane raft; C:microvillus; C:nuclear body; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:ruffle membrane; C:stereocilium membrane; C:unconventional myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:protein C-terminus binding; F:signaling receptor binding; F:small GTPase binding;, P:actin filament organization; P:cellular response to interferon-gamma; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:mRNA transport; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cellular response to insulin stimulus; P:positive regulation of gene expression, epigenetic; P:positive regulation of protein targeting to membrane; P:positive regulation of vascular endothelial growth factor signaling pathway; P:protein targeting; P:protein targeting to membrane; P:regulation of bicellular tight junction assembly; P:vesicle transport along actin filament;|O00159 Q4LE56 Q6NVJ7 Q86Y95,Unconventional myosin-Ic,Myosin I beta;, PF00612;PF00063;PF06017;, GO:0015629;GO:0009925;GO:0005903;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0031941;GO:0016328;GO:0016020;GO:0045121;GO:0005902;GO:0016604;GO:0005643;GO:0005730;GO:0005654;GO:0045335;GO:0005886;GO:0032587;GO:0060171;GO:0016461;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0008022;GO:0005102;GO:0031267;GO:0007015;GO:0071346;GO:0038096;GO:0051028;GO:0030838;GO:0030335;GO:0038089;GO:1900078;GO:0045815;GO:0090314;GO:1900748;GO:0006605;GO:0006612;GO:2000810;GO:0030050;, C:actin cytoskeleton; C:basal plasma membrane; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:filamentous actin; C:lateral plasma membrane; C:membrane; C:membrane raft; C:microvillus; C:nuclear body; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:ruffle membrane; C:stereocilium membrane; C:unconventional myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:protein C-terminus binding; F:signaling receptor binding; F:small GTPase binding;, P:actin filament organization; P:cellular response to interferon-gamma; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:mRNA transport; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cellular response to insulin stimulus; P:positive regulation of gene expression, epigenetic; P:positive regulation of protein targeting to membrane; P:positive regulation of vascular endothelial growth factor signaling pathway; P:protein targeting; P:protein targeting to membrane; P:regulation of bicellular tight junction assembly; P:vesicle transport along actin filament;|O00159 Q4LE56 Q6NVJ7 Q86Y95,Unconventional myosin-Ic,Myosin I beta;, PF00612;PF00063;PF06017;, GO:0015629;GO:0009925;GO:0005903;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0031941;GO:0016328;GO:0016020;GO:0045121;GO:0005902;GO:0016604;GO:0005643;GO:0005730;GO:0005654;GO:0045335;GO:0005886;GO:0032587;GO:0060171;GO:0016461;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0008022;GO:0005102;GO:0031267;GO:0007015;GO:0071346;GO:0038096;GO:0051028;GO:0030838;GO:0030335;GO:0038089;GO:1900078;GO:0045815;GO:0090314;GO:1900748;GO:0006605;GO:0006612;GO:2000810;GO:0030050;, C:actin cytoskeleton; C:basal plasma membrane; C:brush border; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:filamentous actin; C:lateral plasma membrane; C:membrane; C:membrane raft; C:microvillus; C:nuclear body; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:phagocytic vesicle; C:plasma membrane; C:ruffle membrane; C:stereocilium membrane; C:unconventional myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity; F:protein C-terminus binding; F:signaling receptor binding; F:small GTPase binding;, P:actin filament organization; P:cellular response to interferon-gamma; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:mRNA transport; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cellular response to insulin stimulus; P:positive regulation of gene expression, epigenetic; P:positive regulation of protein targeting to membrane; P:positive regulation of vascular endothelial growth factor signaling pathway; P:protein targeting; P:protein targeting to membrane; P:regulation of bicellular tight junction assembly; P:vesicle transport along actin filament; scaffold52 indexed_genome mRNA 13101087 13104609 . - . ID=transcript_9786;Q9BT40 B2R6I2 B2R750 D3DTH8 Q15733 Q9NPJ5 Q9P2R5,Inositol polyphosphate 5-phosphatase K {ECO:0000305},Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase;Phosphatidylinositol-4,5-bisphosphate 5-phosphatase;Skeletal muscle and kidney-enriched inositol phosphatase {ECO:0000303|PubMed:10753883};, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0005886;GO:0001726;GO:0032587;GO:0005802;GO:0016312;GO:0046030;GO:0052659;GO:0052658;GO:0004445;GO:0042577;GO:0034595;GO:0034594;GO:0034485;GO:0004439;GO:0005000;GO:0030036;GO:0071320;GO:0071364;GO:0032870;GO:0032869;GO:0071356;GO:0016311;GO:0007186;GO:0042593;GO:0001701;GO:0046855;GO:0043922;GO:0051926;GO:0035305;GO:0010829;GO:2000466;GO:0045719;GO:0046627;GO:0043407;GO:0033137;GO:0010801;GO:0006469;GO:0051898;GO:0001933;GO:0090315;GO:0045869;GO:0051497;GO:0045892;GO:0006661;GO:0046856;GO:2001153;GO:0045893;GO:0035810;GO:0072659;GO:0005979;GO:0097178;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle; C:ruffle membrane; C:trans-Golgi network;, F:inositol bisphosphate phosphatase activity; F:inositol trisphosphate phosphatase activity; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:lipid phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol trisphosphate phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:vasopressin receptor activity;, P:actin cytoskeleton organization; P:cellular response to cAMP; P:cellular response to epidermal growth factor stimulus; P:cellular response to hormone stimulus; P:cellular response to insulin stimulus; P:cellular response to tumor necrosis factor; P:dephosphorylation; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:negative regulation by host of viral transcription; P:negative regulation of calcium ion transport; P:negative regulation of dephosphorylation; P:negative regulation of glucose transmembrane transport; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein targeting to membrane; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of stress fiber assembly; P:negative regulation of transcription, DNA-templated; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of renal water transport; P:positive regulation of transcription, DNA-templated; P:positive regulation of urine volume; P:protein localization to plasma membrane; P:regulation of glycogen biosynthetic process; P:ruffle assembly;|Q9BT40 B2R6I2 B2R750 D3DTH8 Q15733 Q9NPJ5 Q9P2R5,Inositol polyphosphate 5-phosphatase K {ECO:0000305},Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase;Phosphatidylinositol-4,5-bisphosphate 5-phosphatase;Skeletal muscle and kidney-enriched inositol phosphatase {ECO:0000303|PubMed:10753883};, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0005886;GO:0001726;GO:0032587;GO:0005802;GO:0016312;GO:0046030;GO:0052659;GO:0052658;GO:0004445;GO:0042577;GO:0034595;GO:0034594;GO:0034485;GO:0004439;GO:0005000;GO:0030036;GO:0071320;GO:0071364;GO:0032870;GO:0032869;GO:0071356;GO:0016311;GO:0007186;GO:0042593;GO:0001701;GO:0046855;GO:0043922;GO:0051926;GO:0035305;GO:0010829;GO:2000466;GO:0045719;GO:0046627;GO:0043407;GO:0033137;GO:0010801;GO:0006469;GO:0051898;GO:0001933;GO:0090315;GO:0045869;GO:0051497;GO:0045892;GO:0006661;GO:0046856;GO:2001153;GO:0045893;GO:0035810;GO:0072659;GO:0005979;GO:0097178;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle; C:ruffle membrane; C:trans-Golgi network;, F:inositol bisphosphate phosphatase activity; F:inositol trisphosphate phosphatase activity; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:lipid phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol trisphosphate phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:vasopressin receptor activity;, P:actin cytoskeleton organization; P:cellular response to cAMP; P:cellular response to epidermal growth factor stimulus; P:cellular response to hormone stimulus; P:cellular response to insulin stimulus; P:cellular response to tumor necrosis factor; P:dephosphorylation; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:negative regulation by host of viral transcription; P:negative regulation of calcium ion transport; P:negative regulation of dephosphorylation; P:negative regulation of glucose transmembrane transport; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein targeting to membrane; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of stress fiber assembly; P:negative regulation of transcription, DNA-templated; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of renal water transport; P:positive regulation of transcription, DNA-templated; P:positive regulation of urine volume; P:protein localization to plasma membrane; P:regulation of glycogen biosynthetic process; P:ruffle assembly; scaffold52 indexed_genome mRNA 13104612 13120159 . - . ID=transcript_9787;Q9BT40 B2R6I2 B2R750 D3DTH8 Q15733 Q9NPJ5 Q9P2R5,Inositol polyphosphate 5-phosphatase K {ECO:0000305},Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase;Phosphatidylinositol-4,5-bisphosphate 5-phosphatase;Skeletal muscle and kidney-enriched inositol phosphatase {ECO:0000303|PubMed:10753883};, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0005886;GO:0001726;GO:0032587;GO:0005802;GO:0016312;GO:0046030;GO:0052659;GO:0052658;GO:0004445;GO:0042577;GO:0034595;GO:0034594;GO:0034485;GO:0004439;GO:0005000;GO:0030036;GO:0071320;GO:0071364;GO:0032870;GO:0032869;GO:0071356;GO:0016311;GO:0007186;GO:0042593;GO:0001701;GO:0046855;GO:0043922;GO:0051926;GO:0035305;GO:0010829;GO:2000466;GO:0045719;GO:0046627;GO:0043407;GO:0033137;GO:0010801;GO:0006469;GO:0051898;GO:0001933;GO:0090315;GO:0045869;GO:0051497;GO:0045892;GO:0006661;GO:0046856;GO:2001153;GO:0045893;GO:0035810;GO:0072659;GO:0005979;GO:0097178;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle; C:ruffle membrane; C:trans-Golgi network;, F:inositol bisphosphate phosphatase activity; F:inositol trisphosphate phosphatase activity; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:lipid phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol trisphosphate phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:vasopressin receptor activity;, P:actin cytoskeleton organization; P:cellular response to cAMP; P:cellular response to epidermal growth factor stimulus; P:cellular response to hormone stimulus; P:cellular response to insulin stimulus; P:cellular response to tumor necrosis factor; P:dephosphorylation; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:negative regulation by host of viral transcription; P:negative regulation of calcium ion transport; P:negative regulation of dephosphorylation; P:negative regulation of glucose transmembrane transport; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein targeting to membrane; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of stress fiber assembly; P:negative regulation of transcription, DNA-templated; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of renal water transport; P:positive regulation of transcription, DNA-templated; P:positive regulation of urine volume; P:protein localization to plasma membrane; P:regulation of glycogen biosynthetic process; P:ruffle assembly;|Q9BT40 B2R6I2 B2R750 D3DTH8 Q15733 Q9NPJ5 Q9P2R5,Inositol polyphosphate 5-phosphatase K {ECO:0000305},Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase;Phosphatidylinositol-4,5-bisphosphate 5-phosphatase;Skeletal muscle and kidney-enriched inositol phosphatase {ECO:0000303|PubMed:10753883};, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0005886;GO:0001726;GO:0032587;GO:0005802;GO:0016312;GO:0046030;GO:0052659;GO:0052658;GO:0004445;GO:0042577;GO:0034595;GO:0034594;GO:0034485;GO:0004439;GO:0005000;GO:0030036;GO:0071320;GO:0071364;GO:0032870;GO:0032869;GO:0071356;GO:0016311;GO:0007186;GO:0042593;GO:0001701;GO:0046855;GO:0043922;GO:0051926;GO:0035305;GO:0010829;GO:2000466;GO:0045719;GO:0046627;GO:0043407;GO:0033137;GO:0010801;GO:0006469;GO:0051898;GO:0001933;GO:0090315;GO:0045869;GO:0051497;GO:0045892;GO:0006661;GO:0046856;GO:2001153;GO:0045893;GO:0035810;GO:0072659;GO:0005979;GO:0097178;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle; C:ruffle membrane; C:trans-Golgi network;, F:inositol bisphosphate phosphatase activity; F:inositol trisphosphate phosphatase activity; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:lipid phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol trisphosphate phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:vasopressin receptor activity;, P:actin cytoskeleton organization; P:cellular response to cAMP; P:cellular response to epidermal growth factor stimulus; P:cellular response to hormone stimulus; P:cellular response to insulin stimulus; P:cellular response to tumor necrosis factor; P:dephosphorylation; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:negative regulation by host of viral transcription; P:negative regulation of calcium ion transport; P:negative regulation of dephosphorylation; P:negative regulation of glucose transmembrane transport; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein targeting to membrane; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of stress fiber assembly; P:negative regulation of transcription, DNA-templated; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of renal water transport; P:positive regulation of transcription, DNA-templated; P:positive regulation of urine volume; P:protein localization to plasma membrane; P:regulation of glycogen biosynthetic process; P:ruffle assembly;|Q9BT40 B2R6I2 B2R750 D3DTH8 Q15733 Q9NPJ5 Q9P2R5,Inositol polyphosphate 5-phosphatase K {ECO:0000305},Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase;Phosphatidylinositol-4,5-bisphosphate 5-phosphatase;Skeletal muscle and kidney-enriched inositol phosphatase {ECO:0000303|PubMed:10753883};, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0005886;GO:0001726;GO:0032587;GO:0005802;GO:0016312;GO:0046030;GO:0052659;GO:0052658;GO:0004445;GO:0042577;GO:0034595;GO:0034594;GO:0034485;GO:0004439;GO:0005000;GO:0030036;GO:0071320;GO:0071364;GO:0032870;GO:0032869;GO:0071356;GO:0016311;GO:0007186;GO:0042593;GO:0001701;GO:0046855;GO:0043922;GO:0051926;GO:0035305;GO:0010829;GO:2000466;GO:0045719;GO:0046627;GO:0043407;GO:0033137;GO:0010801;GO:0006469;GO:0051898;GO:0001933;GO:0090315;GO:0045869;GO:0051497;GO:0045892;GO:0006661;GO:0046856;GO:2001153;GO:0045893;GO:0035810;GO:0072659;GO:0005979;GO:0097178;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle; C:ruffle membrane; C:trans-Golgi network;, F:inositol bisphosphate phosphatase activity; F:inositol trisphosphate phosphatase activity; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:lipid phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol trisphosphate phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:vasopressin receptor activity;, P:actin cytoskeleton organization; P:cellular response to cAMP; P:cellular response to epidermal growth factor stimulus; P:cellular response to hormone stimulus; P:cellular response to insulin stimulus; P:cellular response to tumor necrosis factor; P:dephosphorylation; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:negative regulation by host of viral transcription; P:negative regulation of calcium ion transport; P:negative regulation of dephosphorylation; P:negative regulation of glucose transmembrane transport; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein targeting to membrane; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of stress fiber assembly; P:negative regulation of transcription, DNA-templated; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of renal water transport; P:positive regulation of transcription, DNA-templated; P:positive regulation of urine volume; P:protein localization to plasma membrane; P:regulation of glycogen biosynthetic process; P:ruffle assembly;|Q9BT40 B2R6I2 B2R750 D3DTH8 Q15733 Q9NPJ5 Q9P2R5,Inositol polyphosphate 5-phosphatase K {ECO:0000305},Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase;Phosphatidylinositol-4,5-bisphosphate 5-phosphatase;Skeletal muscle and kidney-enriched inositol phosphatase {ECO:0000303|PubMed:10753883};, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0005783;GO:0016020;GO:0043005;GO:0005634;GO:0048471;GO:0005886;GO:0001726;GO:0032587;GO:0005802;GO:0016312;GO:0046030;GO:0052659;GO:0052658;GO:0004445;GO:0042577;GO:0034595;GO:0034594;GO:0034485;GO:0004439;GO:0005000;GO:0030036;GO:0071320;GO:0071364;GO:0032870;GO:0032869;GO:0071356;GO:0016311;GO:0007186;GO:0042593;GO:0001701;GO:0046855;GO:0043922;GO:0051926;GO:0035305;GO:0010829;GO:2000466;GO:0045719;GO:0046627;GO:0043407;GO:0033137;GO:0010801;GO:0006469;GO:0051898;GO:0001933;GO:0090315;GO:0045869;GO:0051497;GO:0045892;GO:0006661;GO:0046856;GO:2001153;GO:0045893;GO:0035810;GO:0072659;GO:0005979;GO:0097178;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:membrane; C:neuron projection; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle; C:ruffle membrane; C:trans-Golgi network;, F:inositol bisphosphate phosphatase activity; F:inositol trisphosphate phosphatase activity; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:lipid phosphatase activity; F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol trisphosphate phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:vasopressin receptor activity;, P:actin cytoskeleton organization; P:cellular response to cAMP; P:cellular response to epidermal growth factor stimulus; P:cellular response to hormone stimulus; P:cellular response to insulin stimulus; P:cellular response to tumor necrosis factor; P:dephosphorylation; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:negative regulation by host of viral transcription; P:negative regulation of calcium ion transport; P:negative regulation of dephosphorylation; P:negative regulation of glucose transmembrane transport; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein targeting to membrane; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of stress fiber assembly; P:negative regulation of transcription, DNA-templated; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of renal water transport; P:positive regulation of transcription, DNA-templated; P:positive regulation of urine volume; P:protein localization to plasma membrane; P:regulation of glycogen biosynthetic process; P:ruffle assembly; scaffold52 indexed_genome mRNA 13122273 13157375 . - . ID=transcript_9788;Q00169,Phosphatidylinositol transfer protein alpha isoform,, PF02121;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0031210;GO:0120019;GO:0008525;GO:1901611;GO:0035091;GO:0008526;GO:0035722;GO:0006629;GO:0015914;GO:0007601;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylglycerol binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:interleukin-12-mediated signaling pathway; P:lipid metabolic process; P:phospholipid transport; P:visual perception;|Q00169,Phosphatidylinositol transfer protein alpha isoform,, PF02121;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0031210;GO:0120019;GO:0008525;GO:1901611;GO:0035091;GO:0008526;GO:0035722;GO:0006629;GO:0015914;GO:0007601;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylglycerol binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:interleukin-12-mediated signaling pathway; P:lipid metabolic process; P:phospholipid transport; P:visual perception;|Q00169,Phosphatidylinositol transfer protein alpha isoform,, PF02121;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0031210;GO:0120019;GO:0008525;GO:1901611;GO:0035091;GO:0008526;GO:0035722;GO:0006629;GO:0015914;GO:0007601;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylglycerol binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:interleukin-12-mediated signaling pathway; P:lipid metabolic process; P:phospholipid transport; P:visual perception;|Q00169,Phosphatidylinositol transfer protein alpha isoform,, PF02121;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0031210;GO:0120019;GO:0008525;GO:1901611;GO:0035091;GO:0008526;GO:0035722;GO:0006629;GO:0015914;GO:0007601;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylglycerol binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:interleukin-12-mediated signaling pathway; P:lipid metabolic process; P:phospholipid transport; P:visual perception;|Q00169,Phosphatidylinositol transfer protein alpha isoform,, PF02121;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0031210;GO:0120019;GO:0008525;GO:1901611;GO:0035091;GO:0008526;GO:0035722;GO:0006629;GO:0015914;GO:0007601;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylglycerol binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:interleukin-12-mediated signaling pathway; P:lipid metabolic process; P:phospholipid transport; P:visual perception; scaffold52 indexed_genome mRNA 13165144 13177944 . - . ID=transcript_9789;Q8N370 B7Z6X9 C9JNU8 D3DTH9 Q5CD75 Q6IPM1 Q8NBX1 Q8NC21 Q8WZ00,Large neutral amino acids transporter small subunit 4,L-type amino acid transporter 4;Solute carrier family 43 member 2;, PF07690;, GO:0016021;GO:0005886;GO:0015179;GO:0015175;GO:0006865;GO:0051956;GO:0060358;GO:0015804;, C:integral component of membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:negative regulation of amino acid transport; P:negative regulation of leucine import; P:neutral amino acid transport;|Q8N370 B7Z6X9 C9JNU8 D3DTH9 Q5CD75 Q6IPM1 Q8NBX1 Q8NC21 Q8WZ00,Large neutral amino acids transporter small subunit 4,L-type amino acid transporter 4;Solute carrier family 43 member 2;, PF07690;, GO:0016021;GO:0005886;GO:0015179;GO:0015175;GO:0006865;GO:0051956;GO:0060358;GO:0015804;, C:integral component of membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:negative regulation of amino acid transport; P:negative regulation of leucine import; P:neutral amino acid transport;|Q8N370 B7Z6X9 C9JNU8 D3DTH9 Q5CD75 Q6IPM1 Q8NBX1 Q8NC21 Q8WZ00,Large neutral amino acids transporter small subunit 4,L-type amino acid transporter 4;Solute carrier family 43 member 2;, PF07690;, GO:0016021;GO:0005886;GO:0015179;GO:0015175;GO:0006865;GO:0051956;GO:0060358;GO:0015804;, C:integral component of membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:negative regulation of amino acid transport; P:negative regulation of leucine import; P:neutral amino acid transport;|Q8N370 B7Z6X9 C9JNU8 D3DTH9 Q5CD75 Q6IPM1 Q8NBX1 Q8NC21 Q8WZ00,Large neutral amino acids transporter small subunit 4,L-type amino acid transporter 4;Solute carrier family 43 member 2;, PF07690;, GO:0016021;GO:0005886;GO:0015179;GO:0015175;GO:0006865;GO:0051956;GO:0060358;GO:0015804;, C:integral component of membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:negative regulation of amino acid transport; P:negative regulation of leucine import; P:neutral amino acid transport;|Q8N370 B7Z6X9 C9JNU8 D3DTH9 Q5CD75 Q6IPM1 Q8NBX1 Q8NC21 Q8WZ00,Large neutral amino acids transporter small subunit 4,L-type amino acid transporter 4;Solute carrier family 43 member 2;, PF07690;, GO:0016021;GO:0005886;GO:0015179;GO:0015175;GO:0006865;GO:0051956;GO:0060358;GO:0015804;, C:integral component of membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:negative regulation of amino acid transport; P:negative regulation of leucine import; P:neutral amino acid transport; scaffold52 indexed_genome mRNA 13178157 13181394 . - . ID=transcript_9790;Q8N370 B7Z6X9 C9JNU8 D3DTH9 Q5CD75 Q6IPM1 Q8NBX1 Q8NC21 Q8WZ00,Large neutral amino acids transporter small subunit 4,L-type amino acid transporter 4;Solute carrier family 43 member 2;, PF07690;, GO:0016021;GO:0005886;GO:0015179;GO:0015175;GO:0006865;GO:0051956;GO:0060358;GO:0015804;, C:integral component of membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:negative regulation of amino acid transport; P:negative regulation of leucine import; P:neutral amino acid transport; scaffold52 indexed_genome mRNA 13181618 13182565 . - . ID=transcript_9791;Q8N370 B7Z6X9 C9JNU8 D3DTH9 Q5CD75 Q6IPM1 Q8NBX1 Q8NC21 Q8WZ00,Large neutral amino acids transporter small subunit 4,L-type amino acid transporter 4;Solute carrier family 43 member 2;, PF07690;, GO:0016021;GO:0005886;GO:0015179;GO:0015175;GO:0006865;GO:0051956;GO:0060358;GO:0015804;, C:integral component of membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:negative regulation of amino acid transport; P:negative regulation of leucine import; P:neutral amino acid transport; scaffold52 indexed_genome mRNA 13218095 13229564 . + . ID=transcript_9792;Q14162 A8MQ05 O43701 Q8NHD2 Q8NHD3 Q8NHD4 Q8NHD5,Scavenger receptor class F member 1,Acetyl LDL receptor;Scavenger receptor expressed by endothelial cells 1;, PF00053;, GO:0030666;GO:0016021;GO:0005886;GO:0030169;GO:0005044;GO:0004888;GO:0007155;GO:0006707;GO:0016358;GO:0016322;GO:0048680;GO:0010976;GO:0006898;, C:endocytic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:low-density lipoprotein particle binding; F:scavenger receptor activity; F:transmembrane signaling receptor activity;, P:cell adhesion; P:cholesterol catabolic process; P:dendrite development; P:neuron remodeling; P:positive regulation of axon regeneration; P:positive regulation of neuron projection development; P:receptor-mediated endocytosis;|Q14162 A8MQ05 O43701 Q8NHD2 Q8NHD3 Q8NHD4 Q8NHD5,Scavenger receptor class F member 1,Acetyl LDL receptor;Scavenger receptor expressed by endothelial cells 1;, PF00053;, GO:0030666;GO:0016021;GO:0005886;GO:0030169;GO:0005044;GO:0004888;GO:0007155;GO:0006707;GO:0016358;GO:0016322;GO:0048680;GO:0010976;GO:0006898;, C:endocytic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:low-density lipoprotein particle binding; F:scavenger receptor activity; F:transmembrane signaling receptor activity;, P:cell adhesion; P:cholesterol catabolic process; P:dendrite development; P:neuron remodeling; P:positive regulation of axon regeneration; P:positive regulation of neuron projection development; P:receptor-mediated endocytosis;|Q14162 A8MQ05 O43701 Q8NHD2 Q8NHD3 Q8NHD4 Q8NHD5,Scavenger receptor class F member 1,Acetyl LDL receptor;Scavenger receptor expressed by endothelial cells 1;, PF00053;, GO:0030666;GO:0016021;GO:0005886;GO:0030169;GO:0005044;GO:0004888;GO:0007155;GO:0006707;GO:0016358;GO:0016322;GO:0048680;GO:0010976;GO:0006898;, C:endocytic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:low-density lipoprotein particle binding; F:scavenger receptor activity; F:transmembrane signaling receptor activity;, P:cell adhesion; P:cholesterol catabolic process; P:dendrite development; P:neuron remodeling; P:positive regulation of axon regeneration; P:positive regulation of neuron projection development; P:receptor-mediated endocytosis;|Q14162 A8MQ05 O43701 Q8NHD2 Q8NHD3 Q8NHD4 Q8NHD5,Scavenger receptor class F member 1,Acetyl LDL receptor;Scavenger receptor expressed by endothelial cells 1;, PF00053;, GO:0030666;GO:0016021;GO:0005886;GO:0030169;GO:0005044;GO:0004888;GO:0007155;GO:0006707;GO:0016358;GO:0016322;GO:0048680;GO:0010976;GO:0006898;, C:endocytic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:low-density lipoprotein particle binding; F:scavenger receptor activity; F:transmembrane signaling receptor activity;, P:cell adhesion; P:cholesterol catabolic process; P:dendrite development; P:neuron remodeling; P:positive regulation of axon regeneration; P:positive regulation of neuron projection development; P:receptor-mediated endocytosis;|Q14162 A8MQ05 O43701 Q8NHD2 Q8NHD3 Q8NHD4 Q8NHD5,Scavenger receptor class F member 1,Acetyl LDL receptor;Scavenger receptor expressed by endothelial cells 1;, PF00053;, GO:0030666;GO:0016021;GO:0005886;GO:0030169;GO:0005044;GO:0004888;GO:0007155;GO:0006707;GO:0016358;GO:0016322;GO:0048680;GO:0010976;GO:0006898;, C:endocytic vesicle membrane; C:integral component of membrane; C:plasma membrane;, F:low-density lipoprotein particle binding; F:scavenger receptor activity; F:transmembrane signaling receptor activity;, P:cell adhesion; P:cholesterol catabolic process; P:dendrite development; P:neuron remodeling; P:positive regulation of axon regeneration; P:positive regulation of neuron projection development; P:receptor-mediated endocytosis; scaffold52 indexed_genome mRNA 13230300 13234068 . - . ID=transcript_9793;Q96NA2 B2RBQ8 Q71RE6 Q9BSL3 Q9BYS3,Rab-interacting lysosomal protein,, PF09744;PF11461;, GO:0036064;GO:0005737;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0030670;GO:0032991;GO:0051959;GO:0046983;GO:0031267;GO:0019886;GO:0060271;GO:0045022;GO:0008333;GO:0032509;GO:0070676;GO:0042177;GO:0045732;GO:0015031;GO:0010796;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:phagocytic vesicle membrane; C:protein-containing complex;, F:dynein light intermediate chain binding; F:protein dimerization activity; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium assembly; P:early endosome to late endosome transport; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:intralumenal vesicle formation; P:negative regulation of protein catabolic process; P:positive regulation of protein catabolic process; P:protein transport; P:regulation of multivesicular body size;|Q96NA2 B2RBQ8 Q71RE6 Q9BSL3 Q9BYS3,Rab-interacting lysosomal protein,, PF09744;PF11461;, GO:0036064;GO:0005737;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0030670;GO:0032991;GO:0051959;GO:0046983;GO:0031267;GO:0019886;GO:0060271;GO:0045022;GO:0008333;GO:0032509;GO:0070676;GO:0042177;GO:0045732;GO:0015031;GO:0010796;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:phagocytic vesicle membrane; C:protein-containing complex;, F:dynein light intermediate chain binding; F:protein dimerization activity; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium assembly; P:early endosome to late endosome transport; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:intralumenal vesicle formation; P:negative regulation of protein catabolic process; P:positive regulation of protein catabolic process; P:protein transport; P:regulation of multivesicular body size;|Q96NA2 B2RBQ8 Q71RE6 Q9BSL3 Q9BYS3,Rab-interacting lysosomal protein,, PF09744;PF11461;, GO:0036064;GO:0005737;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0030670;GO:0032991;GO:0051959;GO:0046983;GO:0031267;GO:0019886;GO:0060271;GO:0045022;GO:0008333;GO:0032509;GO:0070676;GO:0042177;GO:0045732;GO:0015031;GO:0010796;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:phagocytic vesicle membrane; C:protein-containing complex;, F:dynein light intermediate chain binding; F:protein dimerization activity; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium assembly; P:early endosome to late endosome transport; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:intralumenal vesicle formation; P:negative regulation of protein catabolic process; P:positive regulation of protein catabolic process; P:protein transport; P:regulation of multivesicular body size;|Q96NA2 B2RBQ8 Q71RE6 Q9BSL3 Q9BYS3,Rab-interacting lysosomal protein,, PF09744;PF11461;, GO:0036064;GO:0005737;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0030670;GO:0032991;GO:0051959;GO:0046983;GO:0031267;GO:0019886;GO:0060271;GO:0045022;GO:0008333;GO:0032509;GO:0070676;GO:0042177;GO:0045732;GO:0015031;GO:0010796;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:phagocytic vesicle membrane; C:protein-containing complex;, F:dynein light intermediate chain binding; F:protein dimerization activity; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium assembly; P:early endosome to late endosome transport; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:intralumenal vesicle formation; P:negative regulation of protein catabolic process; P:positive regulation of protein catabolic process; P:protein transport; P:regulation of multivesicular body size;|Q96NA2 B2RBQ8 Q71RE6 Q9BSL3 Q9BYS3,Rab-interacting lysosomal protein,, PF09744;PF11461;, GO:0036064;GO:0005737;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0030670;GO:0032991;GO:0051959;GO:0046983;GO:0031267;GO:0019886;GO:0060271;GO:0045022;GO:0008333;GO:0032509;GO:0070676;GO:0042177;GO:0045732;GO:0015031;GO:0010796;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:phagocytic vesicle membrane; C:protein-containing complex;, F:dynein light intermediate chain binding; F:protein dimerization activity; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium assembly; P:early endosome to late endosome transport; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:intralumenal vesicle formation; P:negative regulation of protein catabolic process; P:positive regulation of protein catabolic process; P:protein transport; P:regulation of multivesicular body size;|Q96NA2 B2RBQ8 Q71RE6 Q9BSL3 Q9BYS3,Rab-interacting lysosomal protein,, PF09744;PF11461;, GO:0036064;GO:0005737;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0030670;GO:0032991;GO:0051959;GO:0046983;GO:0031267;GO:0019886;GO:0060271;GO:0045022;GO:0008333;GO:0032509;GO:0070676;GO:0042177;GO:0045732;GO:0015031;GO:0010796;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:phagocytic vesicle membrane; C:protein-containing complex;, F:dynein light intermediate chain binding; F:protein dimerization activity; F:small GTPase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium assembly; P:early endosome to late endosome transport; P:endosome to lysosome transport; P:endosome transport via multivesicular body sorting pathway; P:intralumenal vesicle formation; P:negative regulation of protein catabolic process; P:positive regulation of protein catabolic process; P:protein transport; P:regulation of multivesicular body size; scaffold52 indexed_genome mRNA 13234599 13267044 . - . ID=transcript_9794;Q6P2Q9 O14547 O75965,Pre-mRNA-processing-splicing factor 8,220 kDa U5 snRNP-specific protein;PRP8 homolog;Splicing factor Prp8;p220;, PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;, GO:0071013;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0071007;GO:0071005;GO:0046540;GO:0005682;GO:0070122;GO:0070530;GO:0097157;GO:0003723;GO:0030619;GO:0030620;GO:0030623;GO:0017070;GO:0071222;GO:0071356;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:catalytic step 2 spliceosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:isopeptidase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:pre-mRNA intronic binding; F:RNA binding; F:U1 snRNA binding; F:U2 snRNA binding; F:U5 snRNA binding; F:U6 snRNA binding;, P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|Q6P2Q9 O14547 O75965,Pre-mRNA-processing-splicing factor 8,220 kDa U5 snRNP-specific protein;PRP8 homolog;Splicing factor Prp8;p220;, PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;, GO:0071013;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0071007;GO:0071005;GO:0046540;GO:0005682;GO:0070122;GO:0070530;GO:0097157;GO:0003723;GO:0030619;GO:0030620;GO:0030623;GO:0017070;GO:0071222;GO:0071356;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:catalytic step 2 spliceosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:isopeptidase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:pre-mRNA intronic binding; F:RNA binding; F:U1 snRNA binding; F:U2 snRNA binding; F:U5 snRNA binding; F:U6 snRNA binding;, P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|Q6P2Q9 O14547 O75965,Pre-mRNA-processing-splicing factor 8,220 kDa U5 snRNP-specific protein;PRP8 homolog;Splicing factor Prp8;p220;, PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;, GO:0071013;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0071007;GO:0071005;GO:0046540;GO:0005682;GO:0070122;GO:0070530;GO:0097157;GO:0003723;GO:0030619;GO:0030620;GO:0030623;GO:0017070;GO:0071222;GO:0071356;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:catalytic step 2 spliceosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:isopeptidase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:pre-mRNA intronic binding; F:RNA binding; F:U1 snRNA binding; F:U2 snRNA binding; F:U5 snRNA binding; F:U6 snRNA binding;, P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|Q6P2Q9 O14547 O75965,Pre-mRNA-processing-splicing factor 8,220 kDa U5 snRNP-specific protein;PRP8 homolog;Splicing factor Prp8;p220;, PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;, GO:0071013;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0071007;GO:0071005;GO:0046540;GO:0005682;GO:0070122;GO:0070530;GO:0097157;GO:0003723;GO:0030619;GO:0030620;GO:0030623;GO:0017070;GO:0071222;GO:0071356;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:catalytic step 2 spliceosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:isopeptidase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:pre-mRNA intronic binding; F:RNA binding; F:U1 snRNA binding; F:U2 snRNA binding; F:U5 snRNA binding; F:U6 snRNA binding;, P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|Q6P2Q9 O14547 O75965,Pre-mRNA-processing-splicing factor 8,220 kDa U5 snRNP-specific protein;PRP8 homolog;Splicing factor Prp8;p220;, PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;, GO:0071013;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0071007;GO:0071005;GO:0046540;GO:0005682;GO:0070122;GO:0070530;GO:0097157;GO:0003723;GO:0030619;GO:0030620;GO:0030623;GO:0017070;GO:0071222;GO:0071356;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:catalytic step 2 spliceosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:isopeptidase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:pre-mRNA intronic binding; F:RNA binding; F:U1 snRNA binding; F:U2 snRNA binding; F:U5 snRNA binding; F:U6 snRNA binding;, P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|Q6P2Q9 O14547 O75965,Pre-mRNA-processing-splicing factor 8,220 kDa U5 snRNP-specific protein;PRP8 homolog;Splicing factor Prp8;p220;, PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;, GO:0071013;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0071007;GO:0071005;GO:0046540;GO:0005682;GO:0070122;GO:0070530;GO:0097157;GO:0003723;GO:0030619;GO:0030620;GO:0030623;GO:0017070;GO:0071222;GO:0071356;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:catalytic step 2 spliceosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:isopeptidase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:pre-mRNA intronic binding; F:RNA binding; F:U1 snRNA binding; F:U2 snRNA binding; F:U5 snRNA binding; F:U6 snRNA binding;, P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|Q6P2Q9 O14547 O75965,Pre-mRNA-processing-splicing factor 8,220 kDa U5 snRNP-specific protein;PRP8 homolog;Splicing factor Prp8;p220;, PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;, GO:0071013;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0071007;GO:0071005;GO:0046540;GO:0005682;GO:0070122;GO:0070530;GO:0097157;GO:0003723;GO:0030619;GO:0030620;GO:0030623;GO:0017070;GO:0071222;GO:0071356;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:catalytic step 2 spliceosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:isopeptidase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:pre-mRNA intronic binding; F:RNA binding; F:U1 snRNA binding; F:U2 snRNA binding; F:U5 snRNA binding; F:U6 snRNA binding;, P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|Q6P2Q9 O14547 O75965,Pre-mRNA-processing-splicing factor 8,220 kDa U5 snRNP-specific protein;PRP8 homolog;Splicing factor Prp8;p220;, PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;, GO:0071013;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0071007;GO:0071005;GO:0046540;GO:0005682;GO:0070122;GO:0070530;GO:0097157;GO:0003723;GO:0030619;GO:0030620;GO:0030623;GO:0017070;GO:0071222;GO:0071356;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:catalytic step 2 spliceosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:isopeptidase activity; F:K63-linked polyubiquitin modification-dependent protein binding; F:pre-mRNA intronic binding; F:RNA binding; F:U1 snRNA binding; F:U2 snRNA binding; F:U5 snRNA binding; F:U6 snRNA binding;, P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|P62244 P39027 P39031 Q3MHD9 Q8C023 Q9BV24,40S ribosomal protein S15a,Small ribosomal subunit protein uS8 {ECO:0000303|PubMed:24524803};, PF00410;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0003723;GO:0003735;GO:0000184;GO:0045787;GO:0008284;GO:0009615;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:response to virus; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold52 indexed_genome mRNA 13287484 13290826 . + . ID=transcript_9795;A6NGC4,TLC domain-containing protein 2,, PF03798;, GO:0016021;GO:0005886;GO:0055088;GO:0071709;GO:0055091;GO:0007009;GO:0097035;, C:integral component of membrane; C:plasma membrane;, , P:lipid homeostasis; P:membrane assembly; P:phospholipid homeostasis; P:plasma membrane organization; P:regulation of membrane lipid distribution;|A6NGC4,TLC domain-containing protein 2,, PF03798;, GO:0016021;GO:0005886;GO:0055088;GO:0071709;GO:0055091;GO:0007009;GO:0097035;, C:integral component of membrane; C:plasma membrane;, , P:lipid homeostasis; P:membrane assembly; P:phospholipid homeostasis; P:plasma membrane organization; P:regulation of membrane lipid distribution;|A6NGC4,TLC domain-containing protein 2,, PF03798;, GO:0016021;GO:0005886;GO:0055088;GO:0071709;GO:0055091;GO:0007009;GO:0097035;, C:integral component of membrane; C:plasma membrane;, , P:lipid homeostasis; P:membrane assembly; P:phospholipid homeostasis; P:plasma membrane organization; P:regulation of membrane lipid distribution; scaffold52 indexed_genome mRNA 13302184 13314481 . + . ID=transcript_9796;Q562E7 B3KW16 B3KXU1 B7Z579 E9PHG7 Q24JP6 Q8N277 Q8N3F3 Q8TEL1,WD repeat-containing protein 81 {ECO:0000312|HGNC:HGNC:26600},, PF02138;PF00400;, GO:0000421;GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0005765;GO:0005739;GO:0070530;GO:0035014;GO:0035973;GO:0045022;GO:0007005;GO:0010923;GO:0050821;GO:0043551;GO:0006511;, C:autophagosome membrane; C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane; C:lysosomal membrane; C:mitochondrion;, F:K63-linked polyubiquitin modification-dependent protein binding; F:phosphatidylinositol 3-kinase regulator activity;, P:aggrephagy; P:early endosome to late endosome transport; P:mitochondrion organization; P:negative regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol 3-kinase activity; P:ubiquitin-dependent protein catabolic process;|Q562E7 B3KW16 B3KXU1 B7Z579 E9PHG7 Q24JP6 Q8N277 Q8N3F3 Q8TEL1,WD repeat-containing protein 81 {ECO:0000312|HGNC:HGNC:26600},, PF02138;PF00400;, GO:0000421;GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0005765;GO:0005739;GO:0070530;GO:0035014;GO:0035973;GO:0045022;GO:0007005;GO:0010923;GO:0050821;GO:0043551;GO:0006511;, C:autophagosome membrane; C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane; C:lysosomal membrane; C:mitochondrion;, F:K63-linked polyubiquitin modification-dependent protein binding; F:phosphatidylinositol 3-kinase regulator activity;, P:aggrephagy; P:early endosome to late endosome transport; P:mitochondrion organization; P:negative regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol 3-kinase activity; P:ubiquitin-dependent protein catabolic process;|Q562E7 B3KW16 B3KXU1 B7Z579 E9PHG7 Q24JP6 Q8N277 Q8N3F3 Q8TEL1,WD repeat-containing protein 81 {ECO:0000312|HGNC:HGNC:26600},, PF02138;PF00400;, GO:0000421;GO:0005829;GO:0031901;GO:0031313;GO:0031902;GO:0005765;GO:0005739;GO:0070530;GO:0035014;GO:0035973;GO:0045022;GO:0007005;GO:0010923;GO:0050821;GO:0043551;GO:0006511;, C:autophagosome membrane; C:cytosol; C:early endosome membrane; C:extrinsic component of endosome membrane; C:late endosome membrane; C:lysosomal membrane; C:mitochondrion;, F:K63-linked polyubiquitin modification-dependent protein binding; F:phosphatidylinositol 3-kinase regulator activity;, P:aggrephagy; P:early endosome to late endosome transport; P:mitochondrion organization; P:negative regulation of phosphatase activity; P:protein stabilization; P:regulation of phosphatidylinositol 3-kinase activity; P:ubiquitin-dependent protein catabolic process; scaffold52 indexed_genome mRNA 13315295 13323037 . + . ID=transcript_9797;P08697 B4E1B7 Q8N5U7 Q9UCG2 Q9UCG3,Alpha-2-antiplasmin,Alpha-2-plasmin inhibitor;Serpin F2;, PF00079;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005577;GO:0031093;GO:0004866;GO:0002020;GO:0042803;GO:0004867;GO:0006953;GO:0048514;GO:0030199;GO:0042730;GO:0002034;GO:0010951;GO:0051918;GO:0010757;GO:0002576;GO:0045597;GO:2000049;GO:0032967;GO:0070374;GO:0046330;GO:0048661;GO:0051496;GO:0045944;GO:0071636;GO:0010033;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule lumen;, F:endopeptidase inhibitor activity; F:protease binding; F:protein homodimerization activity; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:blood vessel morphogenesis; P:collagen fibril organization; P:fibrinolysis; P:maintenance of blood vessel diameter homeostasis by renin-angiotensin; P:negative regulation of endopeptidase activity; P:negative regulation of fibrinolysis; P:negative regulation of plasminogen activation; P:platelet degranulation; P:positive regulation of cell differentiation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of collagen biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of JNK cascade; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta production; P:response to organic substance;|P08697 B4E1B7 Q8N5U7 Q9UCG2 Q9UCG3,Alpha-2-antiplasmin,Alpha-2-plasmin inhibitor;Serpin F2;, PF00079;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005577;GO:0031093;GO:0004866;GO:0002020;GO:0042803;GO:0004867;GO:0006953;GO:0048514;GO:0030199;GO:0042730;GO:0002034;GO:0010951;GO:0051918;GO:0010757;GO:0002576;GO:0045597;GO:2000049;GO:0032967;GO:0070374;GO:0046330;GO:0048661;GO:0051496;GO:0045944;GO:0071636;GO:0010033;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule lumen;, F:endopeptidase inhibitor activity; F:protease binding; F:protein homodimerization activity; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:blood vessel morphogenesis; P:collagen fibril organization; P:fibrinolysis; P:maintenance of blood vessel diameter homeostasis by renin-angiotensin; P:negative regulation of endopeptidase activity; P:negative regulation of fibrinolysis; P:negative regulation of plasminogen activation; P:platelet degranulation; P:positive regulation of cell differentiation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of collagen biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of JNK cascade; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta production; P:response to organic substance;|P08697 B4E1B7 Q8N5U7 Q9UCG2 Q9UCG3,Alpha-2-antiplasmin,Alpha-2-plasmin inhibitor;Serpin F2;, PF00079;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005577;GO:0031093;GO:0004866;GO:0002020;GO:0042803;GO:0004867;GO:0006953;GO:0048514;GO:0030199;GO:0042730;GO:0002034;GO:0010951;GO:0051918;GO:0010757;GO:0002576;GO:0045597;GO:2000049;GO:0032967;GO:0070374;GO:0046330;GO:0048661;GO:0051496;GO:0045944;GO:0071636;GO:0010033;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule lumen;, F:endopeptidase inhibitor activity; F:protease binding; F:protein homodimerization activity; F:serine-type endopeptidase inhibitor activity;, P:acute-phase response; P:blood vessel morphogenesis; P:collagen fibril organization; P:fibrinolysis; P:maintenance of blood vessel diameter homeostasis by renin-angiotensin; P:negative regulation of endopeptidase activity; P:negative regulation of fibrinolysis; P:negative regulation of plasminogen activation; P:platelet degranulation; P:positive regulation of cell differentiation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of collagen biosynthetic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of JNK cascade; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta production; P:response to organic substance; scaffold52 indexed_genome mRNA 13334289 13343477 . + . ID=transcript_9798;P36955 F1T092 Q13236 Q2TU83 Q96CT1 Q96R01 Q9BWA4,Pigment epithelium-derived factor,Cell proliferation-inducing gene 35 protein;EPC-1;Serpin F1;, PF00079;, GO:0043203;GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0042470;GO:0048471;GO:0004867;GO:0007568;GO:0071279;GO:0071549;GO:0071333;GO:0071300;GO:0001822;GO:0016525;GO:0010951;GO:0010596;GO:0060770;GO:0010629;GO:0050728;GO:1901215;GO:0042698;GO:0050769;GO:0010976;GO:0010447;GO:0046685;GO:1901652;GO:0060041;GO:0007614;, C:axon hillock; C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:melanosome; C:perinuclear region of cytoplasm;, F:serine-type endopeptidase inhibitor activity;, P:aging; P:cellular response to cobalt ion; P:cellular response to dexamethasone stimulus; P:cellular response to glucose stimulus; P:cellular response to retinoic acid; P:kidney development; P:negative regulation of angiogenesis; P:negative regulation of endopeptidase activity; P:negative regulation of endothelial cell migration; P:negative regulation of epithelial cell proliferation involved in prostate gland development; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of neuron death; P:ovulation cycle; P:positive regulation of neurogenesis; P:positive regulation of neuron projection development; P:response to acidic pH; P:response to arsenic-containing substance; P:response to peptide; P:retina development in camera-type eye; P:short-term memory; scaffold52 indexed_genome mRNA 13344781 13383872 . - . ID=transcript_9799;Q8IYR2 Q8N1P2 Q8NAT0 Q96LV4 Q96PV2,SET and MYND domain-containing protein 4,, PF00856;PF01753;, GO:0046872;GO:0008168;GO:0032259;, , F:metal ion binding; F:methyltransferase activity;, P:methylation;|Q8IYR2 Q8N1P2 Q8NAT0 Q96LV4 Q96PV2,SET and MYND domain-containing protein 4,, PF00856;PF01753;, GO:0046872;GO:0008168;GO:0032259;, , F:metal ion binding; F:methyltransferase activity;, P:methylation; scaffold52 indexed_genome mRNA 13385047 13430565 . + . ID=transcript_9800;P27694 A8K0Y9 Q59ES9,Replication protein A 70 kDa DNA-binding subunit,Replication factor A protein 1;Single-stranded DNA-binding protein;, PF04057;PF08646;PF16900;PF01336;, GO:0000781;GO:0005662;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0003684;GO:0098505;GO:0046872;GO:0003697;GO:0043047;GO:0006284;GO:0006287;GO:0006974;GO:0042769;GO:0006310;GO:0006281;GO:0006260;GO:0006270;GO:0006268;GO:0006261;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0051321;GO:0006298;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034502;GO:1900034;GO:1901796;GO:0000723;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:chromosome, telomeric region; C:DNA replication factor A complex; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:damaged DNA binding; F:G-rich strand telomeric DNA binding; F:metal ion binding; F:single-stranded DNA binding; F:single-stranded telomeric DNA binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:meiotic cell cycle; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to chromosome; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P27694 A8K0Y9 Q59ES9,Replication protein A 70 kDa DNA-binding subunit,Replication factor A protein 1;Single-stranded DNA-binding protein;, PF04057;PF08646;PF16900;PF01336;, GO:0000781;GO:0005662;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0003684;GO:0098505;GO:0046872;GO:0003697;GO:0043047;GO:0006284;GO:0006287;GO:0006974;GO:0042769;GO:0006310;GO:0006281;GO:0006260;GO:0006270;GO:0006268;GO:0006261;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0051321;GO:0006298;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034502;GO:1900034;GO:1901796;GO:0000723;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:chromosome, telomeric region; C:DNA replication factor A complex; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:damaged DNA binding; F:G-rich strand telomeric DNA binding; F:metal ion binding; F:single-stranded DNA binding; F:single-stranded telomeric DNA binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:meiotic cell cycle; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to chromosome; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P27694 A8K0Y9 Q59ES9,Replication protein A 70 kDa DNA-binding subunit,Replication factor A protein 1;Single-stranded DNA-binding protein;, PF04057;PF08646;PF16900;PF01336;, GO:0000781;GO:0005662;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0003684;GO:0098505;GO:0046872;GO:0003697;GO:0043047;GO:0006284;GO:0006287;GO:0006974;GO:0042769;GO:0006310;GO:0006281;GO:0006260;GO:0006270;GO:0006268;GO:0006261;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0051321;GO:0006298;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034502;GO:1900034;GO:1901796;GO:0000723;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:chromosome, telomeric region; C:DNA replication factor A complex; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:damaged DNA binding; F:G-rich strand telomeric DNA binding; F:metal ion binding; F:single-stranded DNA binding; F:single-stranded telomeric DNA binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:meiotic cell cycle; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to chromosome; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P27694 A8K0Y9 Q59ES9,Replication protein A 70 kDa DNA-binding subunit,Replication factor A protein 1;Single-stranded DNA-binding protein;, PF04057;PF08646;PF16900;PF01336;, GO:0000781;GO:0005662;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0003684;GO:0098505;GO:0046872;GO:0003697;GO:0043047;GO:0006284;GO:0006287;GO:0006974;GO:0042769;GO:0006310;GO:0006281;GO:0006260;GO:0006270;GO:0006268;GO:0006261;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0051321;GO:0006298;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034502;GO:1900034;GO:1901796;GO:0000723;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:chromosome, telomeric region; C:DNA replication factor A complex; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:damaged DNA binding; F:G-rich strand telomeric DNA binding; F:metal ion binding; F:single-stranded DNA binding; F:single-stranded telomeric DNA binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:meiotic cell cycle; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to chromosome; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P27694 A8K0Y9 Q59ES9,Replication protein A 70 kDa DNA-binding subunit,Replication factor A protein 1;Single-stranded DNA-binding protein;, PF04057;PF08646;PF16900;PF01336;, GO:0000781;GO:0005662;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0003684;GO:0098505;GO:0046872;GO:0003697;GO:0043047;GO:0006284;GO:0006287;GO:0006974;GO:0042769;GO:0006310;GO:0006281;GO:0006260;GO:0006270;GO:0006268;GO:0006261;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0051321;GO:0006298;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034502;GO:1900034;GO:1901796;GO:0000723;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:chromosome, telomeric region; C:DNA replication factor A complex; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:damaged DNA binding; F:G-rich strand telomeric DNA binding; F:metal ion binding; F:single-stranded DNA binding; F:single-stranded telomeric DNA binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:meiotic cell cycle; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to chromosome; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P27694 A8K0Y9 Q59ES9,Replication protein A 70 kDa DNA-binding subunit,Replication factor A protein 1;Single-stranded DNA-binding protein;, PF04057;PF08646;PF16900;PF01336;, GO:0000781;GO:0005662;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0003684;GO:0098505;GO:0046872;GO:0003697;GO:0043047;GO:0006284;GO:0006287;GO:0006974;GO:0042769;GO:0006310;GO:0006281;GO:0006260;GO:0006270;GO:0006268;GO:0006261;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0051321;GO:0006298;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034502;GO:1900034;GO:1901796;GO:0000723;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:chromosome, telomeric region; C:DNA replication factor A complex; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:damaged DNA binding; F:G-rich strand telomeric DNA binding; F:metal ion binding; F:single-stranded DNA binding; F:single-stranded telomeric DNA binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:meiotic cell cycle; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to chromosome; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P27694 A8K0Y9 Q59ES9,Replication protein A 70 kDa DNA-binding subunit,Replication factor A protein 1;Single-stranded DNA-binding protein;, PF04057;PF08646;PF16900;PF01336;, GO:0000781;GO:0005662;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0003684;GO:0098505;GO:0046872;GO:0003697;GO:0043047;GO:0006284;GO:0006287;GO:0006974;GO:0042769;GO:0006310;GO:0006281;GO:0006260;GO:0006270;GO:0006268;GO:0006261;GO:0000724;GO:0070987;GO:0042276;GO:0036297;GO:0051321;GO:0006298;GO:0006289;GO:0006297;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034502;GO:1900034;GO:1901796;GO:0000723;GO:0032201;GO:0007004;GO:0006283;GO:0019985;, C:chromosome, telomeric region; C:DNA replication factor A complex; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:damaged DNA binding; F:G-rich strand telomeric DNA binding; F:metal ion binding; F:single-stranded DNA binding; F:single-stranded telomeric DNA binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:interstrand cross-link repair; P:meiotic cell cycle; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to chromosome; P:regulation of cellular response to heat; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold52 indexed_genome mRNA 13537267 13547577 . + . ID=transcript_9801;Q9BZG8 D3DTI3 Q16439 Q4VBA2 Q9BTW7 Q9UCY0,2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 {ECO:0000305},Diphthamide biosynthesis protein 1;Diphtheria toxin resistance protein 1 {ECO:0000305};Ovarian cancer-associated gene 1 protein;S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1 {ECO:0000305};, PF01866;, GO:0030054;GO:0005829;GO:0005654;GO:0090560;GO:0017183;, C:cell junction; C:cytosol; C:nucleoplasm;, F:2-(3-amino-3-carboxypropyl)histidine synthase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|Q9BZG8 D3DTI3 Q16439 Q4VBA2 Q9BTW7 Q9UCY0,2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 {ECO:0000305},Diphthamide biosynthesis protein 1;Diphtheria toxin resistance protein 1 {ECO:0000305};Ovarian cancer-associated gene 1 protein;S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1 {ECO:0000305};, PF01866;, GO:0030054;GO:0005829;GO:0005654;GO:0090560;GO:0017183;, C:cell junction; C:cytosol; C:nucleoplasm;, F:2-(3-amino-3-carboxypropyl)histidine synthase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|Q9BZG8 D3DTI3 Q16439 Q4VBA2 Q9BTW7 Q9UCY0,2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 {ECO:0000305},Diphthamide biosynthesis protein 1;Diphtheria toxin resistance protein 1 {ECO:0000305};Ovarian cancer-associated gene 1 protein;S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1 {ECO:0000305};, PF01866;, GO:0030054;GO:0005829;GO:0005654;GO:0090560;GO:0017183;, C:cell junction; C:cytosol; C:nucleoplasm;, F:2-(3-amino-3-carboxypropyl)histidine synthase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|Q9BZG8 D3DTI3 Q16439 Q4VBA2 Q9BTW7 Q9UCY0,2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 {ECO:0000305},Diphthamide biosynthesis protein 1;Diphtheria toxin resistance protein 1 {ECO:0000305};Ovarian cancer-associated gene 1 protein;S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1 {ECO:0000305};, PF01866;, GO:0030054;GO:0005829;GO:0005654;GO:0090560;GO:0017183;, C:cell junction; C:cytosol; C:nucleoplasm;, F:2-(3-amino-3-carboxypropyl)histidine synthase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|Q9BZG8 D3DTI3 Q16439 Q4VBA2 Q9BTW7 Q9UCY0,2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 {ECO:0000305},Diphthamide biosynthesis protein 1;Diphtheria toxin resistance protein 1 {ECO:0000305};Ovarian cancer-associated gene 1 protein;S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1 {ECO:0000305};, PF01866;, GO:0030054;GO:0005829;GO:0005654;GO:0090560;GO:0017183;, C:cell junction; C:cytosol; C:nucleoplasm;, F:2-(3-amino-3-carboxypropyl)histidine synthase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; scaffold52 indexed_genome mRNA 13560828 13758241 . - . ID=transcript_9802;Q86US8 B7Z874 O94837 Q86VH6 Q9UF60,Telomerase-binding protein EST1A,EST1-like protein A;Ever shorter telomeres 1A;Smg-6 homolog;Telomerase subunit EST1A;hSmg5/7a;, PF10374;PF10373;PF13638;, GO:0000781;GO:0005737;GO:0005829;GO:0005730;GO:0005634;GO:0005697;GO:0070182;GO:0004521;GO:0046872;GO:0043021;GO:0003723;GO:0070034;GO:0042162;GO:0006406;GO:1904354;GO:0000184;GO:0035303;GO:0051972;GO:0032204;GO:0032210;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleus; C:telomerase holoenzyme complex;, F:DNA polymerase binding; F:endoribonuclease activity; F:metal ion binding; F:ribonucleoprotein complex binding; F:RNA binding; F:telomerase RNA binding; F:telomeric DNA binding;, P:mRNA export from nucleus; P:negative regulation of telomere capping; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of dephosphorylation; P:regulation of telomerase activity; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase;|Q86US8 B7Z874 O94837 Q86VH6 Q9UF60,Telomerase-binding protein EST1A,EST1-like protein A;Ever shorter telomeres 1A;Smg-6 homolog;Telomerase subunit EST1A;hSmg5/7a;, PF10374;PF10373;PF13638;, GO:0000781;GO:0005737;GO:0005829;GO:0005730;GO:0005634;GO:0005697;GO:0070182;GO:0004521;GO:0046872;GO:0043021;GO:0003723;GO:0070034;GO:0042162;GO:0006406;GO:1904354;GO:0000184;GO:0035303;GO:0051972;GO:0032204;GO:0032210;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleus; C:telomerase holoenzyme complex;, F:DNA polymerase binding; F:endoribonuclease activity; F:metal ion binding; F:ribonucleoprotein complex binding; F:RNA binding; F:telomerase RNA binding; F:telomeric DNA binding;, P:mRNA export from nucleus; P:negative regulation of telomere capping; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of dephosphorylation; P:regulation of telomerase activity; P:regulation of telomere maintenance; P:regulation of telomere maintenance via telomerase; scaffold52 indexed_genome mRNA 13765323 13779723 . + . ID=transcript_9803;Q9GZT4 D3DTI5 Q6IA55,Serine racemase {ECO:0000303|PubMed:11054547},D-serine ammonia-lyase;D-serine dehydratase;L-serine ammonia-lyase;L-serine dehydratase;, PF00291;, GO:0045177;GO:0005737;GO:0005829;GO:0043025;GO:0005886;GO:0005524;GO:0005509;GO:0008721;GO:0016594;GO:0042802;GO:0003941;GO:0000287;GO:0030165;GO:0042803;GO:0030170;GO:0030378;GO:0018114;GO:0007568;GO:0007420;GO:0070179;GO:0070178;GO:0006564;GO:0006563;GO:0042866;GO:0042493;GO:0032496;GO:0043278;GO:0009069;, C:apical part of cell; C:cytoplasm; C:cytosol; C:neuronal cell body; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:D-serine ammonia-lyase activity; F:glycine binding; F:identical protein binding; F:L-serine ammonia-lyase activity; F:magnesium ion binding; F:PDZ domain binding; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:serine racemase activity; F:threonine racemase activity;, P:aging; P:brain development; P:D-serine biosynthetic process; P:D-serine metabolic process; P:L-serine biosynthetic process; P:L-serine metabolic process; P:pyruvate biosynthetic process; P:response to drug; P:response to lipopolysaccharide; P:response to morphine; P:serine family amino acid metabolic process;|Q9GZT4 D3DTI5 Q6IA55,Serine racemase {ECO:0000303|PubMed:11054547},D-serine ammonia-lyase;D-serine dehydratase;L-serine ammonia-lyase;L-serine dehydratase;, PF00291;, GO:0045177;GO:0005737;GO:0005829;GO:0043025;GO:0005886;GO:0005524;GO:0005509;GO:0008721;GO:0016594;GO:0042802;GO:0003941;GO:0000287;GO:0030165;GO:0042803;GO:0030170;GO:0030378;GO:0018114;GO:0007568;GO:0007420;GO:0070179;GO:0070178;GO:0006564;GO:0006563;GO:0042866;GO:0042493;GO:0032496;GO:0043278;GO:0009069;, C:apical part of cell; C:cytoplasm; C:cytosol; C:neuronal cell body; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:D-serine ammonia-lyase activity; F:glycine binding; F:identical protein binding; F:L-serine ammonia-lyase activity; F:magnesium ion binding; F:PDZ domain binding; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:serine racemase activity; F:threonine racemase activity;, P:aging; P:brain development; P:D-serine biosynthetic process; P:D-serine metabolic process; P:L-serine biosynthetic process; P:L-serine metabolic process; P:pyruvate biosynthetic process; P:response to drug; P:response to lipopolysaccharide; P:response to morphine; P:serine family amino acid metabolic process;|Q2NL82 Q8WUY5 Q9NVT0 Q9P2E6,Pre-rRNA-processing protein TSR1 homolog,, PF08142;PF04950;, GO:0005829;GO:0005730;GO:0005654;GO:0030688;GO:0005525;GO:0003924;GO:0003723;GO:0034511;GO:0000479;GO:0000462;, C:cytosol; C:nucleolus; C:nucleoplasm; C:preribosome, small subunit precursor;, F:GTP binding; F:GTPase activity; F:RNA binding; F:U3 snoRNA binding;, P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q2NL82 Q8WUY5 Q9NVT0 Q9P2E6,Pre-rRNA-processing protein TSR1 homolog,, PF08142;PF04950;, GO:0005829;GO:0005730;GO:0005654;GO:0030688;GO:0005525;GO:0003924;GO:0003723;GO:0034511;GO:0000479;GO:0000462;, C:cytosol; C:nucleolus; C:nucleoplasm; C:preribosome, small subunit precursor;, F:GTP binding; F:GTPase activity; F:RNA binding; F:U3 snoRNA binding;, P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q2NL82 Q8WUY5 Q9NVT0 Q9P2E6,Pre-rRNA-processing protein TSR1 homolog,, PF08142;PF04950;, GO:0005829;GO:0005730;GO:0005654;GO:0030688;GO:0005525;GO:0003924;GO:0003723;GO:0034511;GO:0000479;GO:0000462;, C:cytosol; C:nucleolus; C:nucleoplasm; C:preribosome, small subunit precursor;, F:GTP binding; F:GTPase activity; F:RNA binding; F:U3 snoRNA binding;, P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q2NL82 Q8WUY5 Q9NVT0 Q9P2E6,Pre-rRNA-processing protein TSR1 homolog,, PF08142;PF04950;, GO:0005829;GO:0005730;GO:0005654;GO:0030688;GO:0005525;GO:0003924;GO:0003723;GO:0034511;GO:0000479;GO:0000462;, C:cytosol; C:nucleolus; C:nucleoplasm; C:preribosome, small subunit precursor;, F:GTP binding; F:GTPase activity; F:RNA binding; F:U3 snoRNA binding;, P:endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); scaffold52 indexed_genome mRNA 13804965 13822371 . + . ID=transcript_9804;O43147 A5LGW2 B4DH69 Q49AC2 Q6ZUY2 Q8IXU4,Small G protein signaling modulator 2,RUN and TBC1 domain-containing protein 1;, PF12068;PF00566;PF02759;, GO:0005737;GO:0042470;GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:0034499;GO:0043547;, C:cytoplasm; C:melanosome;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:late endosome to Golgi transport; P:positive regulation of GTPase activity;|O43147 A5LGW2 B4DH69 Q49AC2 Q6ZUY2 Q8IXU4,Small G protein signaling modulator 2,RUN and TBC1 domain-containing protein 1;, PF12068;PF00566;PF02759;, GO:0005737;GO:0042470;GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:0034499;GO:0043547;, C:cytoplasm; C:melanosome;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:late endosome to Golgi transport; P:positive regulation of GTPase activity;|O43147 A5LGW2 B4DH69 Q49AC2 Q6ZUY2 Q8IXU4,Small G protein signaling modulator 2,RUN and TBC1 domain-containing protein 1;, PF12068;PF00566;PF02759;, GO:0005737;GO:0042470;GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:0034499;GO:0043547;, C:cytoplasm; C:melanosome;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:late endosome to Golgi transport; P:positive regulation of GTPase activity;|O43147 A5LGW2 B4DH69 Q49AC2 Q6ZUY2 Q8IXU4,Small G protein signaling modulator 2,RUN and TBC1 domain-containing protein 1;, PF12068;PF00566;PF02759;, GO:0005737;GO:0042470;GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:0034499;GO:0043547;, C:cytoplasm; C:melanosome;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:late endosome to Golgi transport; P:positive regulation of GTPase activity;|O43147 A5LGW2 B4DH69 Q49AC2 Q6ZUY2 Q8IXU4,Small G protein signaling modulator 2,RUN and TBC1 domain-containing protein 1;, PF12068;PF00566;PF02759;, GO:0005737;GO:0042470;GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:0034499;GO:0043547;, C:cytoplasm; C:melanosome;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:late endosome to Golgi transport; P:positive regulation of GTPase activity;|O43147 A5LGW2 B4DH69 Q49AC2 Q6ZUY2 Q8IXU4,Small G protein signaling modulator 2,RUN and TBC1 domain-containing protein 1;, PF12068;PF00566;PF02759;, GO:0005737;GO:0042470;GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:0034499;GO:0043547;, C:cytoplasm; C:melanosome;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:late endosome to Golgi transport; P:positive regulation of GTPase activity;|O43147 A5LGW2 B4DH69 Q49AC2 Q6ZUY2 Q8IXU4,Small G protein signaling modulator 2,RUN and TBC1 domain-containing protein 1;, PF12068;PF00566;PF02759;, GO:0005737;GO:0042470;GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:0034499;GO:0043547;, C:cytoplasm; C:melanosome;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:late endosome to Golgi transport; P:positive regulation of GTPase activity; scaffold53 indexed_genome mRNA 43564 46981 . - . ID=transcript_9805;Q96C24 Q5H9J3 Q5JPG8 Q8N9P4 Q9H4R0 Q9H4R1,Synaptotagmin-like protein 4,Exophilin-2;Granuphilin;, PF00168;PF02318;, GO:0005768;GO:0070382;GO:0019898;GO:0005886;GO:0031092;GO:0030658;GO:0046872;GO:0042043;GO:0005543;GO:0031267;GO:0006887;GO:0006886;GO:0032418;GO:0071985;GO:0046676;GO:0001778;GO:0002576;GO:0045921;GO:0050714;GO:1905684;, C:endosome; C:exocytic vesicle; C:extrinsic component of membrane; C:plasma membrane; C:platelet alpha granule membrane; C:transport vesicle membrane;, F:metal ion binding; F:neurexin family protein binding; F:phospholipid binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:lysosome localization; P:multivesicular body sorting pathway; P:negative regulation of insulin secretion; P:plasma membrane repair; P:platelet degranulation; P:positive regulation of exocytosis; P:positive regulation of protein secretion; P:regulation of plasma membrane repair; scaffold53 indexed_genome mRNA 48417 77927 . - . ID=transcript_9806;Q96C24 Q5H9J3 Q5JPG8 Q8N9P4 Q9H4R0 Q9H4R1,Synaptotagmin-like protein 4,Exophilin-2;Granuphilin;, PF00168;PF02318;, GO:0005768;GO:0070382;GO:0019898;GO:0005886;GO:0031092;GO:0030658;GO:0046872;GO:0042043;GO:0005543;GO:0031267;GO:0006887;GO:0006886;GO:0032418;GO:0071985;GO:0046676;GO:0001778;GO:0002576;GO:0045921;GO:0050714;GO:1905684;, C:endosome; C:exocytic vesicle; C:extrinsic component of membrane; C:plasma membrane; C:platelet alpha granule membrane; C:transport vesicle membrane;, F:metal ion binding; F:neurexin family protein binding; F:phospholipid binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; P:lysosome localization; P:multivesicular body sorting pathway; P:negative regulation of insulin secretion; P:plasma membrane repair; P:platelet degranulation; P:positive regulation of exocytosis; P:positive regulation of protein secretion; P:regulation of plasma membrane repair; scaffold53 indexed_genome mRNA 206356 218227 . + . ID=transcript_9807;P33240 Q5H951 Q6LA74 Q8N502,Cleavage stimulation factor subunit 2,CF-1 64 kDa subunit;Cleavage stimulation factor 64 kDa subunit;, PF14327;PF14304;PF00076;, GO:0071920;GO:0005847;GO:0016604;GO:0005654;GO:0003729;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0098789;GO:0006369;GO:0006388;, C:cleavage body; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nucleoplasm;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold53 indexed_genome mRNA 218490 238339 . + . ID=transcript_9808;P33240 Q5H951 Q6LA74 Q8N502,Cleavage stimulation factor subunit 2,CF-1 64 kDa subunit;Cleavage stimulation factor 64 kDa subunit;, PF14327;PF14304;PF00076;, GO:0071920;GO:0005847;GO:0016604;GO:0005654;GO:0003729;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0098789;GO:0006369;GO:0006388;, C:cleavage body; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nucleoplasm;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; P:tRNA splicing, via endonucleolytic cleavage and ligation;|P33240 Q5H951 Q6LA74 Q8N502,Cleavage stimulation factor subunit 2,CF-1 64 kDa subunit;Cleavage stimulation factor 64 kDa subunit;, PF14327;PF14304;PF00076;, GO:0071920;GO:0005847;GO:0016604;GO:0005654;GO:0003729;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0098789;GO:0006369;GO:0006388;, C:cleavage body; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nucleoplasm;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold53 indexed_genome mRNA 319519 326014 . - . ID=transcript_9809;Q6PP77 B2RNN6 B4DKU2 Q5H9J6,XK-related protein 2,Membrane protein XPLAC;X Kell blood group-related, X-linked;, PF09815;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold53 indexed_genome mRNA 486580 499339 . + . ID=transcript_9810;Q53FP2 Q9H7Y3,Transmembrane protein 35A,, PF13564;, GO:0031410;GO:0016021;GO:0005778;, C:cytoplasmic vesicle; C:integral component of membrane; C:peroxisomal membrane; scaffold53 indexed_genome mRNA 500948 558146 . + . ID=transcript_9811;Q92674 Q5JWZ9 Q96ED0,Centromere protein I,FSH primary response protein 1;Follicle-stimulating hormone primary response protein;Interphase centromere complex protein 19;Leucine-rich primary response protein 1;, PF07778;, GO:0005829;GO:0000776;GO:0016604;GO:0005654;GO:0034080;GO:0007052;GO:0007548;, C:cytosol; C:kinetochore; C:nuclear body; C:nucleoplasm;, , P:CENP-A containing nucleosome assembly; P:mitotic spindle organization; P:sex differentiation;|Q92674 Q5JWZ9 Q96ED0,Centromere protein I,FSH primary response protein 1;Follicle-stimulating hormone primary response protein;Interphase centromere complex protein 19;Leucine-rich primary response protein 1;, PF07778;, GO:0005829;GO:0000776;GO:0016604;GO:0005654;GO:0034080;GO:0007052;GO:0007548;, C:cytosol; C:kinetochore; C:nuclear body; C:nucleoplasm;, , P:CENP-A containing nucleosome assembly; P:mitotic spindle organization; P:sex differentiation; scaffold53 indexed_genome mRNA 614912 626914 . + . ID=transcript_9812;Q13474 A6ZKI5 A8K1B0 B1B1F3 B4DIZ0,Dystrophin-related protein 2,, PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0030425;GO:0098978;GO:0043204;GO:0005886;GO:0014069;GO:0008270;GO:0007417;GO:0050808;GO:0099536;, C:dendrite; C:glutamatergic synapse; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:zinc ion binding;, P:central nervous system development; P:synapse organization; P:synaptic signaling; scaffold53 indexed_genome mRNA 626954 628626 . - . ID=transcript_9813;Q13474 A6ZKI5 A8K1B0 B1B1F3 B4DIZ0,Dystrophin-related protein 2,, PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0030425;GO:0098978;GO:0043204;GO:0005886;GO:0014069;GO:0008270;GO:0007417;GO:0050808;GO:0099536;, C:dendrite; C:glutamatergic synapse; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:zinc ion binding;, P:central nervous system development; P:synapse organization; P:synaptic signaling; scaffold53 indexed_genome mRNA 628750 634922 . + . ID=transcript_9814;Q13474 A6ZKI5 A8K1B0 B1B1F3 B4DIZ0,Dystrophin-related protein 2,, PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0030425;GO:0098978;GO:0043204;GO:0005886;GO:0014069;GO:0008270;GO:0007417;GO:0050808;GO:0099536;, C:dendrite; C:glutamatergic synapse; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:zinc ion binding;, P:central nervous system development; P:synapse organization; P:synaptic signaling; scaffold53 indexed_genome mRNA 636836 642958 . + . ID=transcript_9815;Q13474 A6ZKI5 A8K1B0 B1B1F3 B4DIZ0,Dystrophin-related protein 2,, PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0030425;GO:0098978;GO:0043204;GO:0005886;GO:0014069;GO:0008270;GO:0007417;GO:0050808;GO:0099536;, C:dendrite; C:glutamatergic synapse; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:zinc ion binding;, P:central nervous system development; P:synapse organization; P:synaptic signaling; scaffold53 indexed_genome mRNA 687073 689824 . - . ID=transcript_9816;O60220 B2R5A6 Q6IRW6,Mitochondrial import inner membrane translocase subunit Tim8 A,Deafness dystonia protein 1;X-linked deafness dystonia protein;, PF02953;, GO:0005743;GO:0005758;GO:0005739;GO:0042802;GO:0046872;GO:0072321;GO:0007399;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:identical protein binding; F:metal ion binding;, P:chaperone-mediated protein transport; P:nervous system development;|O60220 B2R5A6 Q6IRW6,Mitochondrial import inner membrane translocase subunit Tim8 A,Deafness dystonia protein 1;X-linked deafness dystonia protein;, PF02953;, GO:0005743;GO:0005758;GO:0005739;GO:0042802;GO:0046872;GO:0072321;GO:0007399;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion;, F:identical protein binding; F:metal ion binding;, P:chaperone-mediated protein transport; P:nervous system development; scaffold53 indexed_genome mRNA 691038 695472 . - . ID=transcript_9817;Q06187 B2RAW1 Q32ML5,Tyrosine-protein kinase BTK,Agammaglobulinemia tyrosine kinase;B-cell progenitor kinase;Bruton tyrosine kinase;, PF00779;PF00169;PF07714;PF00017;PF00018;, GO:0005737;GO:0031410;GO:0005829;GO:0045121;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0042802;GO:0046872;GO:0004715;GO:0005547;GO:0004713;GO:0004714;GO:0002250;GO:0097190;GO:0042113;GO:0002344;GO:0050853;GO:0019722;GO:0048469;GO:0098761;GO:0071226;GO:0034614;GO:0038095;GO:0007186;GO:0002553;GO:0007249;GO:0045087;GO:0035556;GO:0007498;GO:0002755;GO:0030889;GO:0001818;GO:0018108;GO:0045579;GO:0051092;GO:0001812;GO:0001805;GO:0046777;GO:0006468;GO:0002902;GO:0002721;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:membrane raft; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:apoptotic signaling pathway; P:B cell activation; P:B cell affinity maturation; P:B cell receptor signaling pathway; P:calcium-mediated signaling; P:cell maturation; P:cellular response to interleukin-7; P:cellular response to molecule of fungal origin; P:cellular response to reactive oxygen species; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:histamine secretion by mast cell; P:I-kappaB kinase/NF-kappaB signaling; P:innate immune response; P:intracellular signal transduction; P:mesoderm development; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of B cell proliferation; P:negative regulation of cytokine production; P:peptidyl-tyrosine phosphorylation; P:positive regulation of B cell differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of type I hypersensitivity; P:positive regulation of type III hypersensitivity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of B cell apoptotic process; P:regulation of B cell cytokine production; scaffold53 indexed_genome mRNA 696030 723144 . + . ID=transcript_9818;Q06187 B2RAW1 Q32ML5,Tyrosine-protein kinase BTK,Agammaglobulinemia tyrosine kinase;B-cell progenitor kinase;Bruton tyrosine kinase;, PF00779;PF00169;PF07714;PF00017;PF00018;, GO:0005737;GO:0031410;GO:0005829;GO:0045121;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0042802;GO:0046872;GO:0004715;GO:0005547;GO:0004713;GO:0004714;GO:0002250;GO:0097190;GO:0042113;GO:0002344;GO:0050853;GO:0019722;GO:0048469;GO:0098761;GO:0071226;GO:0034614;GO:0038095;GO:0007186;GO:0002553;GO:0007249;GO:0045087;GO:0035556;GO:0007498;GO:0002755;GO:0030889;GO:0001818;GO:0018108;GO:0045579;GO:0051092;GO:0001812;GO:0001805;GO:0046777;GO:0006468;GO:0002902;GO:0002721;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:membrane raft; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:apoptotic signaling pathway; P:B cell activation; P:B cell affinity maturation; P:B cell receptor signaling pathway; P:calcium-mediated signaling; P:cell maturation; P:cellular response to interleukin-7; P:cellular response to molecule of fungal origin; P:cellular response to reactive oxygen species; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:histamine secretion by mast cell; P:I-kappaB kinase/NF-kappaB signaling; P:innate immune response; P:intracellular signal transduction; P:mesoderm development; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of B cell proliferation; P:negative regulation of cytokine production; P:peptidyl-tyrosine phosphorylation; P:positive regulation of B cell differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of type I hypersensitivity; P:positive regulation of type III hypersensitivity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of B cell apoptotic process; P:regulation of B cell cytokine production;|Q06187 B2RAW1 Q32ML5,Tyrosine-protein kinase BTK,Agammaglobulinemia tyrosine kinase;B-cell progenitor kinase;Bruton tyrosine kinase;, PF00779;PF00169;PF07714;PF00017;PF00018;, GO:0005737;GO:0031410;GO:0005829;GO:0045121;GO:0005634;GO:0048471;GO:0005886;GO:0005524;GO:0042802;GO:0046872;GO:0004715;GO:0005547;GO:0004713;GO:0004714;GO:0002250;GO:0097190;GO:0042113;GO:0002344;GO:0050853;GO:0019722;GO:0048469;GO:0098761;GO:0071226;GO:0034614;GO:0038095;GO:0007186;GO:0002553;GO:0007249;GO:0045087;GO:0035556;GO:0007498;GO:0002755;GO:0030889;GO:0001818;GO:0018108;GO:0045579;GO:0051092;GO:0001812;GO:0001805;GO:0046777;GO:0006468;GO:0002902;GO:0002721;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:membrane raft; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:apoptotic signaling pathway; P:B cell activation; P:B cell affinity maturation; P:B cell receptor signaling pathway; P:calcium-mediated signaling; P:cell maturation; P:cellular response to interleukin-7; P:cellular response to molecule of fungal origin; P:cellular response to reactive oxygen species; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:histamine secretion by mast cell; P:I-kappaB kinase/NF-kappaB signaling; P:innate immune response; P:intracellular signal transduction; P:mesoderm development; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of B cell proliferation; P:negative regulation of cytokine production; P:peptidyl-tyrosine phosphorylation; P:positive regulation of B cell differentiation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of type I hypersensitivity; P:positive regulation of type III hypersensitivity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of B cell apoptotic process; P:regulation of B cell cytokine production; scaffold53 indexed_genome mRNA 727371 728546 . + . ID=transcript_9819;P83881 P09896 P10661 Q08ES5 Q5J9I6,60S ribosomal protein L36a,60S ribosomal protein L44;Cell growth-inhibiting gene 15 protein;Cell migration-inducing gene 6 protein;Large ribosomal subunit protein eL42 {ECO:0000303|PubMed:24524803};, PF00935;, GO:0005829;GO:0022625;GO:0005783;GO:0005886;GO:0042788;GO:0005840;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:plasma membrane; C:polysomal ribosome; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold53 indexed_genome mRNA 730471 734688 . + . ID=transcript_9820;P83881 P09896 P10661 Q08ES5 Q5J9I6,60S ribosomal protein L36a,60S ribosomal protein L44;Cell growth-inhibiting gene 15 protein;Cell migration-inducing gene 6 protein;Large ribosomal subunit protein eL42 {ECO:0000303|PubMed:24524803};, PF00935;, GO:0005829;GO:0022625;GO:0005783;GO:0005886;GO:0042788;GO:0005840;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:plasma membrane; C:polysomal ribosome; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold53 indexed_genome mRNA 734704 746313 . - . ID=transcript_9821;P06280 Q6LER7,Alpha-galactosidase A {ECO:0000305},Alpha-D-galactosidase A;Alpha-D-galactoside galactohydrolase;Galactosylgalactosylglucosylceramidase GLA {ECO:0000305};Melibiase;, PF16499;PF17450;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0005794;GO:0043202;GO:0005764;GO:0004557;GO:0003824;GO:0017041;GO:0016787;GO:0042803;GO:0052692;GO:0005102;GO:0016139;GO:0046479;GO:0006687;GO:0046477;GO:0045019;GO:0051001;GO:0043312;GO:0009311;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:lysosomal lumen; C:lysosome;, F:alpha-galactosidase activity; F:catalytic activity; F:galactosylgalactosylglucosylceramidase activity; F:hydrolase activity; F:protein homodimerization activity; F:raffinose alpha-galactosidase activity; F:signaling receptor binding;, P:glycoside catabolic process; P:glycosphingolipid catabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide catabolic process; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric-oxide synthase activity; P:neutrophil degranulation; P:oligosaccharide metabolic process;|P06280 Q6LER7,Alpha-galactosidase A {ECO:0000305},Alpha-D-galactosidase A;Alpha-D-galactoside galactohydrolase;Galactosylgalactosylglucosylceramidase GLA {ECO:0000305};Melibiase;, PF16499;PF17450;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0005794;GO:0043202;GO:0005764;GO:0004557;GO:0003824;GO:0017041;GO:0016787;GO:0042803;GO:0052692;GO:0005102;GO:0016139;GO:0046479;GO:0006687;GO:0046477;GO:0045019;GO:0051001;GO:0043312;GO:0009311;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:lysosomal lumen; C:lysosome;, F:alpha-galactosidase activity; F:catalytic activity; F:galactosylgalactosylglucosylceramidase activity; F:hydrolase activity; F:protein homodimerization activity; F:raffinose alpha-galactosidase activity; F:signaling receptor binding;, P:glycoside catabolic process; P:glycosphingolipid catabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide catabolic process; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric-oxide synthase activity; P:neutrophil degranulation; P:oligosaccharide metabolic process;|P06280 Q6LER7,Alpha-galactosidase A {ECO:0000305},Alpha-D-galactosidase A;Alpha-D-galactoside galactohydrolase;Galactosylgalactosylglucosylceramidase GLA {ECO:0000305};Melibiase;, PF16499;PF17450;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0005794;GO:0043202;GO:0005764;GO:0004557;GO:0003824;GO:0017041;GO:0016787;GO:0042803;GO:0052692;GO:0005102;GO:0016139;GO:0046479;GO:0006687;GO:0046477;GO:0045019;GO:0051001;GO:0043312;GO:0009311;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:lysosomal lumen; C:lysosome;, F:alpha-galactosidase activity; F:catalytic activity; F:galactosylgalactosylglucosylceramidase activity; F:hydrolase activity; F:protein homodimerization activity; F:raffinose alpha-galactosidase activity; F:signaling receptor binding;, P:glycoside catabolic process; P:glycosphingolipid catabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide catabolic process; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric-oxide synthase activity; P:neutrophil degranulation; P:oligosaccharide metabolic process;|P06280 Q6LER7,Alpha-galactosidase A {ECO:0000305},Alpha-D-galactosidase A;Alpha-D-galactoside galactohydrolase;Galactosylgalactosylglucosylceramidase GLA {ECO:0000305};Melibiase;, PF16499;PF17450;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0005794;GO:0043202;GO:0005764;GO:0004557;GO:0003824;GO:0017041;GO:0016787;GO:0042803;GO:0052692;GO:0005102;GO:0016139;GO:0046479;GO:0006687;GO:0046477;GO:0045019;GO:0051001;GO:0043312;GO:0009311;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:lysosomal lumen; C:lysosome;, F:alpha-galactosidase activity; F:catalytic activity; F:galactosylgalactosylglucosylceramidase activity; F:hydrolase activity; F:protein homodimerization activity; F:raffinose alpha-galactosidase activity; F:signaling receptor binding;, P:glycoside catabolic process; P:glycosphingolipid catabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide catabolic process; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric-oxide synthase activity; P:neutrophil degranulation; P:oligosaccharide metabolic process;|P06280 Q6LER7,Alpha-galactosidase A {ECO:0000305},Alpha-D-galactosidase A;Alpha-D-galactoside galactohydrolase;Galactosylgalactosylglucosylceramidase GLA {ECO:0000305};Melibiase;, PF16499;PF17450;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0005794;GO:0043202;GO:0005764;GO:0004557;GO:0003824;GO:0017041;GO:0016787;GO:0042803;GO:0052692;GO:0005102;GO:0016139;GO:0046479;GO:0006687;GO:0046477;GO:0045019;GO:0051001;GO:0043312;GO:0009311;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:lysosomal lumen; C:lysosome;, F:alpha-galactosidase activity; F:catalytic activity; F:galactosylgalactosylglucosylceramidase activity; F:hydrolase activity; F:protein homodimerization activity; F:raffinose alpha-galactosidase activity; F:signaling receptor binding;, P:glycoside catabolic process; P:glycosphingolipid catabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide catabolic process; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric-oxide synthase activity; P:neutrophil degranulation; P:oligosaccharide metabolic process;|P06280 Q6LER7,Alpha-galactosidase A {ECO:0000305},Alpha-D-galactosidase A;Alpha-D-galactoside galactohydrolase;Galactosylgalactosylglucosylceramidase GLA {ECO:0000305};Melibiase;, PF16499;PF17450;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0005794;GO:0043202;GO:0005764;GO:0004557;GO:0003824;GO:0017041;GO:0016787;GO:0042803;GO:0052692;GO:0005102;GO:0016139;GO:0046479;GO:0006687;GO:0046477;GO:0045019;GO:0051001;GO:0043312;GO:0009311;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:lysosomal lumen; C:lysosome;, F:alpha-galactosidase activity; F:catalytic activity; F:galactosylgalactosylglucosylceramidase activity; F:hydrolase activity; F:protein homodimerization activity; F:raffinose alpha-galactosidase activity; F:signaling receptor binding;, P:glycoside catabolic process; P:glycosphingolipid catabolic process; P:glycosphingolipid metabolic process; P:glycosylceramide catabolic process; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric-oxide synthase activity; P:neutrophil degranulation; P:oligosaccharide metabolic process; scaffold53 indexed_genome mRNA 748482 754391 . + . ID=transcript_9822;P55795 A1L400 Q9HHA7,Heterogeneous nuclear ribonucleoprotein H2,FTP-3;Heterogeneous nuclear ribonucleoprotein H';, PF00076;PF08080;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0014069;GO:1990904;GO:0003723;GO:0000398;GO:0043484;GO:0016070;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:postsynaptic density; C:ribonucleoprotein complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; scaffold53 indexed_genome mRNA 830191 832525 . + . ID=transcript_9823;Q5H9R4 A8K928 B3KXA4 F8W8Y7 Q5H9K8 Q8N8D6,Armadillo repeat-containing X-linked protein 4,, PF04826;, GO:0016021;, C:integral component of membrane; scaffold53 indexed_genome mRNA 832614 833320 . + . ID=transcript_9824;Q5H9R4 A8K928 B3KXA4 F8W8Y7 Q5H9K8 Q8N8D6,Armadillo repeat-containing X-linked protein 4,, PF04826;, GO:0016021;, C:integral component of membrane; scaffold53 indexed_genome mRNA 833364 838333 . - . ID=transcript_9825;Q5H9R4 A8K928 B3KXA4 F8W8Y7 Q5H9K8 Q8N8D6,Armadillo repeat-containing X-linked protein 4,, PF04826;, GO:0016021;, C:integral component of membrane; scaffold53 indexed_genome mRNA 882857 886984 . + . ID=transcript_9826;Q9P291 Q53HK2 Q9H2Q0,Armadillo repeat-containing X-linked protein 1,ARM protein lost in epithelial cancers on chromosome X 1;, PF04826;, GO:0016021;GO:0005741;GO:0005739;GO:0061484;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, , P:hematopoietic stem cell homeostasis; scaffold53 indexed_genome mRNA 943508 952711 . - . ID=transcript_9827;Q9UH62 Q53HC6 Q7LCF5 Q9NPE4,Armadillo repeat-containing X-linked protein 3,ARM protein lost in epithelial cancers on chromosome X 3;, PF04826;, GO:1904115;GO:0005829;GO:0031307;GO:0005739;GO:0005634;GO:0019896;GO:0034613;GO:0007005;GO:0045944;, C:axon cytoplasm; C:cytosol; C:integral component of mitochondrial outer membrane; C:mitochondrion; C:nucleus;, , P:axonal transport of mitochondrion; P:cellular protein localization; P:mitochondrion organization; P:positive regulation of transcription by RNA polymerase II; scaffold53 indexed_genome mRNA 969994 973087 . - . ID=transcript_9828;Q7L311 O60267 Q5H9D9,Armadillo repeat-containing X-linked protein 2,ARM protein lost in epithelial cancers on chromosome X 2;, PF04826;, GO:0016021;GO:0005741;GO:0005739;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; scaffold53 indexed_genome mRNA 1199497 1204232 . + . ID=transcript_9829;Q5H9K5 Q8NDS3 Q96JN6,Zinc finger matrin-type protein 1,, , GO:0005634;GO:0003677;GO:0008270;, C:nucleus;, F:DNA binding; F:zinc ion binding; scaffold53 indexed_genome mRNA 1551966 1556620 . + . ID=transcript_9830;Q6P1M9 B3KU88 D3DX99 Q68DB4 Q9BVZ3 Q9H969,Armadillo repeat-containing X-linked protein 5,, PF04826; scaffold53 indexed_genome mRNA 1635116 1637167 . - . ID=transcript_9831;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold53 indexed_genome mRNA 1644530 1647729 . + . ID=transcript_9832;Q96D09 D3DXA0 Q8NAB4,G-protein coupled receptor-associated sorting protein 2,, PF04826;, GO:0005737;GO:0005634;GO:0001540;GO:0001664;GO:0061484;, C:cytoplasm; C:nucleus;, F:amyloid-beta binding; F:G protein-coupled receptor binding;, P:hematopoietic stem cell homeostasis; scaffold53 indexed_genome mRNA 1663074 1668491 . + . ID=transcript_9833;Q6PI77 Q9C0G2,Protein BHLHb9,Transcription regulator of 60 kDa;, PF04826;, GO:0005829;GO:0070062;GO:0005654;GO:0042803;GO:0007611;GO:0043524;GO:0061003;GO:0050769;GO:0051965;, C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:protein homodimerization activity;, P:learning or memory; P:negative regulation of neuron apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of neurogenesis; P:positive regulation of synapse assembly; scaffold53 indexed_genome mRNA 1682115 1683833 . + . ID=transcript_9834;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold53 indexed_genome mRNA 1915081 1944086 . - . ID=transcript_9835;O60687 B3KQT3 Q8WW85,Sushi repeat-containing protein SRPX2,Sushi-repeat protein upregulated in leukemia;, PF13778;PF02494;PF00084;, GO:0009986;GO:0062023;GO:0005737;GO:0060076;GO:0005615;GO:0097060;GO:0036458;GO:0042802;GO:0005102;GO:0001525;GO:0048870;GO:0098609;GO:0090050;GO:0051965;GO:0042325;GO:0071625;, C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:excitatory synapse; C:extracellular space; C:synaptic membrane;, F:hepatocyte growth factor binding; F:identical protein binding; F:signaling receptor binding;, P:angiogenesis; P:cell motility; P:cell-cell adhesion; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of synapse assembly; P:regulation of phosphorylation; P:vocalization behavior; scaffold53 indexed_genome mRNA 1950864 1956429 . + . ID=transcript_9836;O43657 Q54A42 Q6IAN9,Tetraspanin-6,A15 homolog;Putative NF-kappa-B-activating protein 321;T245 protein;Tetraspanin TM4-D;Transmembrane 4 superfamily member 6;, PF00335;, GO:0070062;GO:0005887;GO:1901223;GO:0039532;GO:0043123;, C:extracellular exosome; C:integral component of plasma membrane;, , P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold53 indexed_genome mRNA 5299180 5740559 . - . ID=transcript_9837;O60879 A6NG19 O60878 Q8WX06 Q8WX48 Q9UJL2,Protein diaphanous homolog 2,Diaphanous-related formin-2;, PF06345;PF06367;PF06371;PF02181;, GO:0005829;GO:0005769;GO:0005783;GO:0043231;GO:0005730;GO:0003779;GO:0005102;GO:0031267;GO:0007015;GO:0007292;GO:0007275;GO:0048477;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:nucleolus;, F:actin binding; F:signaling receptor binding; F:small GTPase binding;, P:actin filament organization; P:female gamete generation; P:multicellular organism development; P:oogenesis; scaffold53 indexed_genome mRNA 5933497 6256835 . - . ID=transcript_9838;O60879 A6NG19 O60878 Q8WX06 Q8WX48 Q9UJL2,Protein diaphanous homolog 2,Diaphanous-related formin-2;, PF06345;PF06367;PF06371;PF02181;, GO:0005829;GO:0005769;GO:0005783;GO:0043231;GO:0005730;GO:0003779;GO:0005102;GO:0031267;GO:0007015;GO:0007292;GO:0007275;GO:0048477;, C:cytosol; C:early endosome; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:nucleolus;, F:actin binding; F:signaling receptor binding; F:small GTPase binding;, P:actin filament organization; P:female gamete generation; P:multicellular organism development; P:oogenesis; scaffold53 indexed_genome mRNA 9270104 9316493 . - . ID=transcript_9839;Q8N9E0,Protein FAM133A scaffold53 indexed_genome mRNA 9316773 9319312 . - . ID=transcript_9840;Q99457 B2RCM0 O60788,Nucleosome assembly protein 1-like 3,, PF00956;, GO:0000785;GO:0005634;GO:0003682;GO:0042393;GO:0006334;, C:chromatin; C:nucleus;, F:chromatin binding; F:histone binding;, P:nucleosome assembly; scaffold53 indexed_genome mRNA 11445797 11508149 . - . ID=transcript_9841;Q9H4E0 Q9P2M0 Q9P2X5,Protocadherin-11 X-linked,Protocadherin on the X chromosome;Protocadherin-S;, PF00028;PF08266;PF08374;, GO:0005887;GO:0005886;GO:0005509;GO:0007155;GO:0007156;GO:0010923;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of phosphatase activity; scaffold53 indexed_genome mRNA 11966973 11971518 . - . ID=transcript_9842;Q96DU9 A8K240 Q5JQF4 Q6P529 Q9UFE5,Polyadenylate-binding protein 5,, PF00076;, GO:0010494;GO:0005829;GO:0005759;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;, C:cytoplasmic stress granule; C:cytosol; C:mitochondrial matrix; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding; scaffold54 indexed_genome mRNA 20444 29267 . - . ID=transcript_9843;Q99741 Q8TB30,Cell division control protein 6 homolog,CDC6-related protein;Cdc18-related protein;p62(cdc6);, PF13401;PF17872;PF09079;, GO:0005737;GO:0005829;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0051233;GO:0000922;GO:0005524;GO:0003688;GO:0019900;GO:0000166;GO:0051301;GO:1904385;GO:1904117;GO:0006260;GO:0000076;GO:0006270;GO:0000278;GO:0033314;GO:0008285;GO:0008156;GO:0051984;GO:0045737;GO:0032467;GO:0048146;GO:0036388;GO:0000079;GO:0030071;GO:0000083;GO:0007089;, C:cytoplasm; C:cytosol; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle midzone; C:spindle pole;, F:ATP binding; F:DNA replication origin binding; F:kinase binding; F:nucleotide binding;, P:cell division; P:cellular response to angiotensin; P:cellular response to vasopressin; P:DNA replication; P:DNA replication checkpoint; P:DNA replication initiation; P:mitotic cell cycle; P:mitotic DNA replication checkpoint; P:negative regulation of cell population proliferation; P:negative regulation of DNA replication; P:positive regulation of chromosome segregation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytokinesis; P:positive regulation of fibroblast proliferation; P:pre-replicative complex assembly; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of mitotic metaphase/anaphase transition; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:traversing start control point of mitotic cell cycle;|Q99741 Q8TB30,Cell division control protein 6 homolog,CDC6-related protein;Cdc18-related protein;p62(cdc6);, PF13401;PF17872;PF09079;, GO:0005737;GO:0005829;GO:0045171;GO:0072686;GO:0005654;GO:0005634;GO:0051233;GO:0000922;GO:0005524;GO:0003688;GO:0019900;GO:0000166;GO:0051301;GO:1904385;GO:1904117;GO:0006260;GO:0000076;GO:0006270;GO:0000278;GO:0033314;GO:0008285;GO:0008156;GO:0051984;GO:0045737;GO:0032467;GO:0048146;GO:0036388;GO:0000079;GO:0030071;GO:0000083;GO:0007089;, C:cytoplasm; C:cytosol; C:intercellular bridge; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle midzone; C:spindle pole;, F:ATP binding; F:DNA replication origin binding; F:kinase binding; F:nucleotide binding;, P:cell division; P:cellular response to angiotensin; P:cellular response to vasopressin; P:DNA replication; P:DNA replication checkpoint; P:DNA replication initiation; P:mitotic cell cycle; P:mitotic DNA replication checkpoint; P:negative regulation of cell population proliferation; P:negative regulation of DNA replication; P:positive regulation of chromosome segregation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytokinesis; P:positive regulation of fibroblast proliferation; P:pre-replicative complex assembly; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of mitotic metaphase/anaphase transition; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:traversing start control point of mitotic cell cycle; scaffold54 indexed_genome mRNA 34673 75586 . - . ID=transcript_9844;Q8TF74 A8K0L3 Q658J8 Q71RE1 Q8TE44,WAS/WASL-interacting protein family member 2,WASP-interacting protein-related protein;WIP- and CR16-homologous protein;WIP-related protein;, PF02205;, GO:0005884;GO:0005829;GO:0005654;GO:0005886;GO:0003779;GO:0030048;GO:0038096;, C:actin filament; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:actin binding;, P:actin filament-based movement; P:Fc-gamma receptor signaling pathway involved in phagocytosis;|Q8TF74 A8K0L3 Q658J8 Q71RE1 Q8TE44,WAS/WASL-interacting protein family member 2,WASP-interacting protein-related protein;WIP- and CR16-homologous protein;WIP-related protein;, PF02205;, GO:0005884;GO:0005829;GO:0005654;GO:0005886;GO:0003779;GO:0030048;GO:0038096;, C:actin filament; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:actin binding;, P:actin filament-based movement; P:Fc-gamma receptor signaling pathway involved in phagocytosis;|Q8TF74 A8K0L3 Q658J8 Q71RE1 Q8TE44,WAS/WASL-interacting protein family member 2,WASP-interacting protein-related protein;WIP- and CR16-homologous protein;WIP-related protein;, PF02205;, GO:0005884;GO:0005829;GO:0005654;GO:0005886;GO:0003779;GO:0030048;GO:0038096;, C:actin filament; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:actin binding;, P:actin filament-based movement; P:Fc-gamma receptor signaling pathway involved in phagocytosis; scaffold54 indexed_genome mRNA 93289 106595 . - . ID=transcript_9845;Q9UHV5,Rap guanine nucleotide exchange factor-like 1,Link guanine nucleotide exchange factor II;, PF00617;, GO:0016020;GO:0005085;GO:0007186;GO:0007399;GO:0007264;, C:membrane;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:nervous system development; P:small GTPase mediated signal transduction;|Q9UHV5,Rap guanine nucleotide exchange factor-like 1,Link guanine nucleotide exchange factor II;, PF00617;, GO:0016020;GO:0005085;GO:0007186;GO:0007399;GO:0007264;, C:membrane;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:nervous system development; P:small GTPase mediated signal transduction;|Q9UHV5,Rap guanine nucleotide exchange factor-like 1,Link guanine nucleotide exchange factor II;, PF00617;, GO:0016020;GO:0005085;GO:0007186;GO:0007399;GO:0007264;, C:membrane;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:nervous system development; P:small GTPase mediated signal transduction;|Q9UHV5,Rap guanine nucleotide exchange factor-like 1,Link guanine nucleotide exchange factor II;, PF00617;, GO:0016020;GO:0005085;GO:0007186;GO:0007399;GO:0007264;, C:membrane;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:nervous system development; P:small GTPase mediated signal transduction; scaffold54 indexed_genome mRNA 110516 132534 . - . ID=transcript_9846;O15234 A8K8R0,Protein CASC3,Cancer susceptibility candidate gene 3 protein;Metastatic lymph node gene 51 protein {ECO:0000303|PubMed:12080473};Protein barentsz;, PF09405;, GO:0010494;GO:0005829;GO:0030425;GO:0035145;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0048471;GO:0071006;GO:0019899;GO:0042802;GO:0003723;GO:0031625;GO:0008298;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0006417;GO:0006405;, C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:exon-exon junction complex; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:U2-type catalytic step 1 spliceosome;, F:enzyme binding; F:identical protein binding; F:RNA binding; F:ubiquitin protein ligase binding;, P:intracellular mRNA localization; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation; P:RNA export from nucleus;|O15234 A8K8R0,Protein CASC3,Cancer susceptibility candidate gene 3 protein;Metastatic lymph node gene 51 protein {ECO:0000303|PubMed:12080473};Protein barentsz;, PF09405;, GO:0010494;GO:0005829;GO:0030425;GO:0035145;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0048471;GO:0071006;GO:0019899;GO:0042802;GO:0003723;GO:0031625;GO:0008298;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0006417;GO:0006405;, C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:exon-exon junction complex; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:U2-type catalytic step 1 spliceosome;, F:enzyme binding; F:identical protein binding; F:RNA binding; F:ubiquitin protein ligase binding;, P:intracellular mRNA localization; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation; P:RNA export from nucleus;|O15234 A8K8R0,Protein CASC3,Cancer susceptibility candidate gene 3 protein;Metastatic lymph node gene 51 protein {ECO:0000303|PubMed:12080473};Protein barentsz;, PF09405;, GO:0010494;GO:0005829;GO:0030425;GO:0035145;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0048471;GO:0071006;GO:0019899;GO:0042802;GO:0003723;GO:0031625;GO:0008298;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0006417;GO:0006405;, C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:exon-exon junction complex; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:U2-type catalytic step 1 spliceosome;, F:enzyme binding; F:identical protein binding; F:RNA binding; F:ubiquitin protein ligase binding;, P:intracellular mRNA localization; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation; P:RNA export from nucleus;|O15234 A8K8R0,Protein CASC3,Cancer susceptibility candidate gene 3 protein;Metastatic lymph node gene 51 protein {ECO:0000303|PubMed:12080473};Protein barentsz;, PF09405;, GO:0010494;GO:0005829;GO:0030425;GO:0035145;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0048471;GO:0071006;GO:0019899;GO:0042802;GO:0003723;GO:0031625;GO:0008298;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0006417;GO:0006405;, C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:exon-exon junction complex; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:U2-type catalytic step 1 spliceosome;, F:enzyme binding; F:identical protein binding; F:RNA binding; F:ubiquitin protein ligase binding;, P:intracellular mRNA localization; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation; P:RNA export from nucleus;|O15234 A8K8R0,Protein CASC3,Cancer susceptibility candidate gene 3 protein;Metastatic lymph node gene 51 protein {ECO:0000303|PubMed:12080473};Protein barentsz;, PF09405;, GO:0010494;GO:0005829;GO:0030425;GO:0035145;GO:0031965;GO:0016607;GO:0005654;GO:0005634;GO:0048471;GO:0071006;GO:0019899;GO:0042802;GO:0003723;GO:0031625;GO:0008298;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0006417;GO:0006405;, C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:exon-exon junction complex; C:nuclear membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:U2-type catalytic step 1 spliceosome;, F:enzyme binding; F:identical protein binding; F:RNA binding; F:ubiquitin protein ligase binding;, P:intracellular mRNA localization; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation; P:RNA export from nucleus; scaffold54 indexed_genome mRNA 134167 141211 . - . ID=transcript_9847;Q68DK7 Q0VF46 Q69Z03,Male-specific lethal 1 homolog,Male-specific lethal 1-like 1;Male-specific lethal-1 homolog 1;, PF16801;PF15275;, GO:0072487;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0043984;, C:MSL complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:histone H4-K16 acetylation;|Q68DK7 Q0VF46 Q69Z03,Male-specific lethal 1 homolog,Male-specific lethal 1-like 1;Male-specific lethal-1 homolog 1;, PF16801;PF15275;, GO:0072487;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0043984;, C:MSL complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:histone H4-K16 acetylation;|Q68DK7 Q0VF46 Q69Z03,Male-specific lethal 1 homolog,Male-specific lethal 1-like 1;Male-specific lethal-1 homolog 1;, PF16801;PF15275;, GO:0072487;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0043984;, C:MSL complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:histone H4-K16 acetylation; scaffold54 indexed_genome mRNA 169329 173836 . - . ID=transcript_9848;P10827 A8K3B5 P21205 Q8N6A1 Q96H73,Thyroid hormone receptor alpha,Nuclear receptor subfamily 1 group A member 1;V-erbA-related protein 7;c-erbA-1;c-erbA-alpha;, PF00104;PF00105;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0003700;GO:0000981;GO:0004879;GO:0019904;GO:0044877;GO:0000978;GO:0017025;GO:0070324;GO:0008134;GO:0000976;GO:0008270;GO:0001502;GO:0030154;GO:0030218;GO:0008050;GO:0009755;GO:0007611;GO:2000143;GO:0017055;GO:0000122;GO:0045892;GO:0001503;GO:0120162;GO:0045925;GO:0045944;GO:0008016;GO:0050994;GO:0033032;GO:0002155;GO:0006357;GO:0009409;GO:0030878;GO:0002154;GO:0006366;GO:0006367;GO:0060509;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein domain specific binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:TBP-class protein binding; F:thyroid hormone binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:erythrocyte differentiation; P:female courtship behavior; P:hormone-mediated signaling pathway; P:learning or memory; P:negative regulation of DNA-templated transcription, initiation; P:negative regulation of RNA polymerase II transcription preinitiation complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:ossification; P:positive regulation of cold-induced thermogenesis; P:positive regulation of female receptivity; P:positive regulation of transcription by RNA polymerase II; P:regulation of heart contraction; P:regulation of lipid catabolic process; P:regulation of myeloid cell apoptotic process; P:regulation of thyroid hormone mediated signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to cold; P:thyroid gland development; P:thyroid hormone mediated signaling pathway; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:type I pneumocyte differentiation;|P20393 Q0P5Z4 Q15304,Nuclear receptor subfamily 1 group D member 1,Rev-erbA-alpha;V-erbA-related protein 1;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0030425;GO:0043197;GO:0016604;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0070888;GO:0020037;GO:0004879;GO:0000978;GO:0000977;GO:1990837;GO:0003707;GO:0001222;GO:0000976;GO:0008270;GO:0030154;GO:0001678;GO:0071347;GO:0071222;GO:0071356;GO:0042632;GO:0032922;GO:0007623;GO:0060086;GO:0005978;GO:0009755;GO:0061889;GO:0120163;GO:0043124;GO:0050728;GO:1903979;GO:0150079;GO:0034144;GO:0000122;GO:0045892;GO:0070859;GO:0045944;GO:0045893;GO:0010498;GO:0031648;GO:0042752;GO:0042749;GO:0045598;GO:0061178;GO:0019216;GO:0061469;GO:0044321;GO:0006367;, C:chromatin; C:cytoplasm; C:dendrite; C:dendritic spine; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:heme binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:cellular glucose homeostasis; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:cholesterol homeostasis; P:circadian regulation of gene expression; P:circadian rhythm; P:circadian temperature homeostasis; P:glycogen biosynthetic process; P:hormone-mediated signaling pathway; P:negative regulation of astrocyte activation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of microglial cell activation; P:negative regulation of neuroinflammatory response; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of bile acid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasomal protein catabolic process; P:protein destabilization; P:regulation of circadian rhythm; P:regulation of circadian sleep/wake cycle; P:regulation of fat cell differentiation; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of lipid metabolic process; P:regulation of type B pancreatic cell proliferation; P:response to leptin; P:transcription initiation from RNA polymerase II promoter;|P20393 Q0P5Z4 Q15304,Nuclear receptor subfamily 1 group D member 1,Rev-erbA-alpha;V-erbA-related protein 1;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0030425;GO:0043197;GO:0016604;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0070888;GO:0020037;GO:0004879;GO:0000978;GO:0000977;GO:1990837;GO:0003707;GO:0001222;GO:0000976;GO:0008270;GO:0030154;GO:0001678;GO:0071347;GO:0071222;GO:0071356;GO:0042632;GO:0032922;GO:0007623;GO:0060086;GO:0005978;GO:0009755;GO:0061889;GO:0120163;GO:0043124;GO:0050728;GO:1903979;GO:0150079;GO:0034144;GO:0000122;GO:0045892;GO:0070859;GO:0045944;GO:0045893;GO:0010498;GO:0031648;GO:0042752;GO:0042749;GO:0045598;GO:0061178;GO:0019216;GO:0061469;GO:0044321;GO:0006367;, C:chromatin; C:cytoplasm; C:dendrite; C:dendritic spine; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:heme binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:cellular glucose homeostasis; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:cholesterol homeostasis; P:circadian regulation of gene expression; P:circadian rhythm; P:circadian temperature homeostasis; P:glycogen biosynthetic process; P:hormone-mediated signaling pathway; P:negative regulation of astrocyte activation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of microglial cell activation; P:negative regulation of neuroinflammatory response; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of bile acid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasomal protein catabolic process; P:protein destabilization; P:regulation of circadian rhythm; P:regulation of circadian sleep/wake cycle; P:regulation of fat cell differentiation; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of lipid metabolic process; P:regulation of type B pancreatic cell proliferation; P:response to leptin; P:transcription initiation from RNA polymerase II promoter;|P20393 Q0P5Z4 Q15304,Nuclear receptor subfamily 1 group D member 1,Rev-erbA-alpha;V-erbA-related protein 1;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0030425;GO:0043197;GO:0016604;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0070888;GO:0020037;GO:0004879;GO:0000978;GO:0000977;GO:1990837;GO:0003707;GO:0001222;GO:0000976;GO:0008270;GO:0030154;GO:0001678;GO:0071347;GO:0071222;GO:0071356;GO:0042632;GO:0032922;GO:0007623;GO:0060086;GO:0005978;GO:0009755;GO:0061889;GO:0120163;GO:0043124;GO:0050728;GO:1903979;GO:0150079;GO:0034144;GO:0000122;GO:0045892;GO:0070859;GO:0045944;GO:0045893;GO:0010498;GO:0031648;GO:0042752;GO:0042749;GO:0045598;GO:0061178;GO:0019216;GO:0061469;GO:0044321;GO:0006367;, C:chromatin; C:cytoplasm; C:dendrite; C:dendritic spine; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:heme binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:cellular glucose homeostasis; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:cholesterol homeostasis; P:circadian regulation of gene expression; P:circadian rhythm; P:circadian temperature homeostasis; P:glycogen biosynthetic process; P:hormone-mediated signaling pathway; P:negative regulation of astrocyte activation; P:negative regulation of cold-induced thermogenesis; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of microglial cell activation; P:negative regulation of neuroinflammatory response; P:negative regulation of toll-like receptor 4 signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of bile acid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasomal protein catabolic process; P:protein destabilization; P:regulation of circadian rhythm; P:regulation of circadian sleep/wake cycle; P:regulation of fat cell differentiation; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of lipid metabolic process; P:regulation of type B pancreatic cell proliferation; P:response to leptin; P:transcription initiation from RNA polymerase II promoter;|P10827 A8K3B5 P21205 Q8N6A1 Q96H73,Thyroid hormone receptor alpha,Nuclear receptor subfamily 1 group A member 1;V-erbA-related protein 7;c-erbA-1;c-erbA-alpha;, PF00104;PF00105;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0003700;GO:0000981;GO:0004879;GO:0019904;GO:0044877;GO:0000978;GO:0017025;GO:0070324;GO:0008134;GO:0000976;GO:0008270;GO:0001502;GO:0030154;GO:0030218;GO:0008050;GO:0009755;GO:0007611;GO:2000143;GO:0017055;GO:0000122;GO:0045892;GO:0001503;GO:0120162;GO:0045925;GO:0045944;GO:0008016;GO:0050994;GO:0033032;GO:0002155;GO:0006357;GO:0009409;GO:0030878;GO:0002154;GO:0006366;GO:0006367;GO:0060509;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein domain specific binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:TBP-class protein binding; F:thyroid hormone binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:erythrocyte differentiation; P:female courtship behavior; P:hormone-mediated signaling pathway; P:learning or memory; P:negative regulation of DNA-templated transcription, initiation; P:negative regulation of RNA polymerase II transcription preinitiation complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:ossification; P:positive regulation of cold-induced thermogenesis; P:positive regulation of female receptivity; P:positive regulation of transcription by RNA polymerase II; P:regulation of heart contraction; P:regulation of lipid catabolic process; P:regulation of myeloid cell apoptotic process; P:regulation of thyroid hormone mediated signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to cold; P:thyroid gland development; P:thyroid hormone mediated signaling pathway; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:type I pneumocyte differentiation; scaffold54 indexed_genome mRNA 175226 185729 . - . ID=transcript_9849;P10827 A8K3B5 P21205 Q8N6A1 Q96H73,Thyroid hormone receptor alpha,Nuclear receptor subfamily 1 group A member 1;V-erbA-related protein 7;c-erbA-1;c-erbA-alpha;, PF00104;PF00105;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0003700;GO:0000981;GO:0004879;GO:0019904;GO:0044877;GO:0000978;GO:0017025;GO:0070324;GO:0008134;GO:0000976;GO:0008270;GO:0001502;GO:0030154;GO:0030218;GO:0008050;GO:0009755;GO:0007611;GO:2000143;GO:0017055;GO:0000122;GO:0045892;GO:0001503;GO:0120162;GO:0045925;GO:0045944;GO:0008016;GO:0050994;GO:0033032;GO:0002155;GO:0006357;GO:0009409;GO:0030878;GO:0002154;GO:0006366;GO:0006367;GO:0060509;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein domain specific binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:TBP-class protein binding; F:thyroid hormone binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:erythrocyte differentiation; P:female courtship behavior; P:hormone-mediated signaling pathway; P:learning or memory; P:negative regulation of DNA-templated transcription, initiation; P:negative regulation of RNA polymerase II transcription preinitiation complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:ossification; P:positive regulation of cold-induced thermogenesis; P:positive regulation of female receptivity; P:positive regulation of transcription by RNA polymerase II; P:regulation of heart contraction; P:regulation of lipid catabolic process; P:regulation of myeloid cell apoptotic process; P:regulation of thyroid hormone mediated signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to cold; P:thyroid gland development; P:thyroid hormone mediated signaling pathway; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:type I pneumocyte differentiation;|P10827 A8K3B5 P21205 Q8N6A1 Q96H73,Thyroid hormone receptor alpha,Nuclear receptor subfamily 1 group A member 1;V-erbA-related protein 7;c-erbA-1;c-erbA-alpha;, PF00104;PF00105;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0003700;GO:0000981;GO:0004879;GO:0019904;GO:0044877;GO:0000978;GO:0017025;GO:0070324;GO:0008134;GO:0000976;GO:0008270;GO:0001502;GO:0030154;GO:0030218;GO:0008050;GO:0009755;GO:0007611;GO:2000143;GO:0017055;GO:0000122;GO:0045892;GO:0001503;GO:0120162;GO:0045925;GO:0045944;GO:0008016;GO:0050994;GO:0033032;GO:0002155;GO:0006357;GO:0009409;GO:0030878;GO:0002154;GO:0006366;GO:0006367;GO:0060509;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein domain specific binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:TBP-class protein binding; F:thyroid hormone binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cartilage condensation; P:cell differentiation; P:erythrocyte differentiation; P:female courtship behavior; P:hormone-mediated signaling pathway; P:learning or memory; P:negative regulation of DNA-templated transcription, initiation; P:negative regulation of RNA polymerase II transcription preinitiation complex assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:ossification; P:positive regulation of cold-induced thermogenesis; P:positive regulation of female receptivity; P:positive regulation of transcription by RNA polymerase II; P:regulation of heart contraction; P:regulation of lipid catabolic process; P:regulation of myeloid cell apoptotic process; P:regulation of thyroid hormone mediated signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to cold; P:thyroid gland development; P:thyroid hormone mediated signaling pathway; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:type I pneumocyte differentiation; scaffold54 indexed_genome mRNA 210060 230270 . + . ID=transcript_9850;O75448 A8K4S5 B3KMR9 Q14143 Q9NNY5,Mediator of RNA polymerase II transcription subunit 24,Activator-recruited cofactor 100 kDa component;Cofactor required for Sp1 transcriptional activation subunit 4;Mediator complex subunit 24;Thyroid hormone receptor-associated protein 4;Thyroid hormone receptor-associated protein complex 100 kDa component;Vitamin D3 receptor-interacting protein complex 100 kDa component;, PF11277;, GO:0016592;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription initiation from RNA polymerase II promoter;|O75448 A8K4S5 B3KMR9 Q14143 Q9NNY5,Mediator of RNA polymerase II transcription subunit 24,Activator-recruited cofactor 100 kDa component;Cofactor required for Sp1 transcriptional activation subunit 4;Mediator complex subunit 24;Thyroid hormone receptor-associated protein 4;Thyroid hormone receptor-associated protein complex 100 kDa component;Vitamin D3 receptor-interacting protein complex 100 kDa component;, PF11277;, GO:0016592;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription initiation from RNA polymerase II promoter;|O75448 A8K4S5 B3KMR9 Q14143 Q9NNY5,Mediator of RNA polymerase II transcription subunit 24,Activator-recruited cofactor 100 kDa component;Cofactor required for Sp1 transcriptional activation subunit 4;Mediator complex subunit 24;Thyroid hormone receptor-associated protein 4;Thyroid hormone receptor-associated protein complex 100 kDa component;Vitamin D3 receptor-interacting protein complex 100 kDa component;, PF11277;, GO:0016592;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription initiation from RNA polymerase II promoter;|O75448 A8K4S5 B3KMR9 Q14143 Q9NNY5,Mediator of RNA polymerase II transcription subunit 24,Activator-recruited cofactor 100 kDa component;Cofactor required for Sp1 transcriptional activation subunit 4;Mediator complex subunit 24;Thyroid hormone receptor-associated protein 4;Thyroid hormone receptor-associated protein complex 100 kDa component;Vitamin D3 receptor-interacting protein complex 100 kDa component;, PF11277;, GO:0016592;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription initiation from RNA polymerase II promoter;|O75448 A8K4S5 B3KMR9 Q14143 Q9NNY5,Mediator of RNA polymerase II transcription subunit 24,Activator-recruited cofactor 100 kDa component;Cofactor required for Sp1 transcriptional activation subunit 4;Mediator complex subunit 24;Thyroid hormone receptor-associated protein 4;Thyroid hormone receptor-associated protein complex 100 kDa component;Vitamin D3 receptor-interacting protein complex 100 kDa component;, PF11277;, GO:0016592;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription initiation from RNA polymerase II promoter;|O75448 A8K4S5 B3KMR9 Q14143 Q9NNY5,Mediator of RNA polymerase II transcription subunit 24,Activator-recruited cofactor 100 kDa component;Cofactor required for Sp1 transcriptional activation subunit 4;Mediator complex subunit 24;Thyroid hormone receptor-associated protein 4;Thyroid hormone receptor-associated protein complex 100 kDa component;Vitamin D3 receptor-interacting protein complex 100 kDa component;, PF11277;, GO:0016592;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription initiation from RNA polymerase II promoter; scaffold54 indexed_genome mRNA 230503 233061 . + . ID=transcript_9851;O75448 A8K4S5 B3KMR9 Q14143 Q9NNY5,Mediator of RNA polymerase II transcription subunit 24,Activator-recruited cofactor 100 kDa component;Cofactor required for Sp1 transcriptional activation subunit 4;Mediator complex subunit 24;Thyroid hormone receptor-associated protein 4;Thyroid hormone receptor-associated protein complex 100 kDa component;Vitamin D3 receptor-interacting protein complex 100 kDa component;, PF11277;, GO:0016592;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription initiation from RNA polymerase II promoter;|O75448 A8K4S5 B3KMR9 Q14143 Q9NNY5,Mediator of RNA polymerase II transcription subunit 24,Activator-recruited cofactor 100 kDa component;Cofactor required for Sp1 transcriptional activation subunit 4;Mediator complex subunit 24;Thyroid hormone receptor-associated protein 4;Thyroid hormone receptor-associated protein complex 100 kDa component;Vitamin D3 receptor-interacting protein complex 100 kDa component;, PF11277;, GO:0016592;GO:0005654;GO:0005634;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0060261;GO:0045893;GO:0060260;, C:mediator complex; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription initiation from RNA polymerase II promoter; scaffold54 indexed_genome mRNA 243576 256638 . + . ID=transcript_9852;O43242 B3KMW9 B4DT72 Q96EI2 Q9BQA4,26S proteasome non-ATPase regulatory subunit 3,26S proteasome regulatory subunit RPN3;26S proteasome regulatory subunit S3;Proteasome subunit p58;, PF01399;PF08375;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O43242 B3KMW9 B4DT72 Q96EI2 Q9BQA4,26S proteasome non-ATPase regulatory subunit 3,26S proteasome regulatory subunit RPN3;26S proteasome regulatory subunit S3;Proteasome subunit p58;, PF01399;PF08375;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O43242 B3KMW9 B4DT72 Q96EI2 Q9BQA4,26S proteasome non-ATPase regulatory subunit 3,26S proteasome regulatory subunit RPN3;26S proteasome regulatory subunit S3;Proteasome subunit p58;, PF01399;PF08375;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|O43242 B3KMW9 B4DT72 Q96EI2 Q9BQA4,26S proteasome non-ATPase regulatory subunit 3,26S proteasome regulatory subunit RPN3;26S proteasome regulatory subunit S3;Proteasome subunit p58;, PF01399;PF08375;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008541;GO:0034774;GO:0030234;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0042176;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:enzyme regulator activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold54 indexed_genome mRNA 262742 272620 . - . ID=transcript_9853;Q96QA5 Q32MC5 Q86VE7 Q8N1M6,Gasdermin-A {ECO:0000305},Gasdermin-1;, PF04598;PF17708;, GO:0005829;GO:0016021;GO:0048471;GO:0005886;GO:0005546;GO:0070273;GO:0001786;GO:0006915;GO:0042742;GO:0070269;, C:cytosol; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding;, P:apoptotic process; P:defense response to bacterium; P:pyroptosis; scaffold54 indexed_genome mRNA 307097 310621 . + . ID=transcript_9854;Q8N138 B3KS83 Q6UY83,ORM1-like protein 3,, PF04061;, GO:0005783;GO:0016021;GO:0005886;GO:0030667;GO:0035579;GO:0035339;GO:0090156;GO:0006672;GO:0061744;GO:0042552;GO:0002903;GO:1900060;GO:1904221;GO:0043312;GO:0010508;GO:1900182;GO:0006940;GO:0006686;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane; C:SPOTS complex;, , P:cellular sphingolipid homeostasis; P:ceramide metabolic process; P:motor behavior; P:myelination; P:negative regulation of B cell apoptotic process; P:negative regulation of ceramide biosynthetic process; P:negative regulation of serine C-palmitoyltransferase activity; P:neutrophil degranulation; P:positive regulation of autophagy; P:positive regulation of protein localization to nucleus; P:regulation of smooth muscle contraction; P:sphingomyelin biosynthetic process;|Q8N138 B3KS83 Q6UY83,ORM1-like protein 3,, PF04061;, GO:0005783;GO:0016021;GO:0005886;GO:0030667;GO:0035579;GO:0035339;GO:0090156;GO:0006672;GO:0061744;GO:0042552;GO:0002903;GO:1900060;GO:1904221;GO:0043312;GO:0010508;GO:1900182;GO:0006940;GO:0006686;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane; C:SPOTS complex;, , P:cellular sphingolipid homeostasis; P:ceramide metabolic process; P:motor behavior; P:myelination; P:negative regulation of B cell apoptotic process; P:negative regulation of ceramide biosynthetic process; P:negative regulation of serine C-palmitoyltransferase activity; P:neutrophil degranulation; P:positive regulation of autophagy; P:positive regulation of protein localization to nucleus; P:regulation of smooth muscle contraction; P:sphingomyelin biosynthetic process; scaffold54 indexed_genome mRNA 337636 346915 . - . ID=transcript_9855;Q6X784 A8K8L8 Q6X783 Q86XL5,Zona pellucida-binding protein 2,ZPBP-like protein;, PF07354;, GO:0001669;GO:0044297;GO:0005576;GO:0005634;GO:0002199;GO:0001675;GO:0007339;GO:0032922;GO:0046466;GO:0002638;GO:0006665;, C:acrosomal vesicle; C:cell body; C:extracellular region; C:nucleus; C:zona pellucida receptor complex;, , P:acrosome assembly; P:binding of sperm to zona pellucida; P:circadian regulation of gene expression; P:membrane lipid catabolic process; P:negative regulation of immunoglobulin production; P:sphingolipid metabolic process;|Q6X784 A8K8L8 Q6X783 Q86XL5,Zona pellucida-binding protein 2,ZPBP-like protein;, PF07354;, GO:0001669;GO:0044297;GO:0005576;GO:0005634;GO:0002199;GO:0001675;GO:0007339;GO:0032922;GO:0046466;GO:0002638;GO:0006665;, C:acrosomal vesicle; C:cell body; C:extracellular region; C:nucleus; C:zona pellucida receptor complex;, , P:acrosome assembly; P:binding of sperm to zona pellucida; P:circadian regulation of gene expression; P:membrane lipid catabolic process; P:negative regulation of immunoglobulin production; P:sphingolipid metabolic process; scaffold54 indexed_genome mRNA 371019 371754 . - . ID=transcript_9856;Q9Y277 Q9UIS0,Voltage-dependent anion-selective channel protein 3,Outer mitochondrial membrane protein porin 3;, PF01459;, GO:0070062;GO:0016020;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0000166;GO:0015288;GO:0008308;GO:0015853;GO:1902017;, C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex;, F:nucleotide binding; F:porin activity; F:voltage-gated anion channel activity;, P:adenine transport; P:regulation of cilium assembly; scaffold54 indexed_genome mRNA 437535 439449 . - . ID=transcript_9857;Q69BM3 Q69BM5 Q8N574 Q8WWQ9 Q8WWR0 Q8WWR1 Q8WWR2 Q8WWR3,Zinc finger protein Aiolos,Ikaros family zinc finger protein 3;, PF00096;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0042826;GO:0042802;GO:0046872;GO:1990841;GO:0042803;GO:0000978;GO:0043565;GO:0042113;GO:0007498;GO:0042981;GO:0045577;GO:0030888;GO:0045619;GO:0006357;GO:0009617;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:promoter-specific chromatin binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:B cell activation; P:mesoderm development; P:regulation of apoptotic process; P:regulation of B cell differentiation; P:regulation of B cell proliferation; P:regulation of lymphocyte differentiation; P:regulation of transcription by RNA polymerase II; P:response to bacterium; scaffold54 indexed_genome mRNA 454096 463372 . - . ID=transcript_9858;Q9Y220,Growth factor receptor-bound protein 7,B47;Epidermal growth factor receptor GRB-7;GRB7 adapter protein;, PF08947;PF00169;PF00788;PF00017;, GO:0042995;GO:0010494;GO:0005829;GO:0005925;GO:0005886;GO:0042802;GO:0035091;GO:0019901;GO:0003723;GO:0007411;GO:0007173;GO:0038128;GO:0050900;GO:0017148;GO:0030335;GO:0034063;, C:cell projection; C:cytoplasmic stress granule; C:cytosol; C:focal adhesion; C:plasma membrane;, F:identical protein binding; F:phosphatidylinositol binding; F:protein kinase binding; F:RNA binding;, P:axon guidance; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:leukocyte migration; P:negative regulation of translation; P:positive regulation of cell migration; P:stress granule assembly; scaffold54 indexed_genome mRNA 468407 469821 . + . ID=transcript_9859;Q9BRT3,Migration and invasion enhancer 1,HBV X-transactivated gene 4 protein;HBV XAg-transactivated protein 4;Protein C35;, PF10262;, GO:0034451;GO:0005829;GO:0031235;GO:0005654;GO:0005886;GO:0006915;GO:0043066;GO:0030335;GO:0051491;GO:0010269;, C:centriolar satellite; C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:nucleoplasm; C:plasma membrane;, , P:apoptotic process; P:negative regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of filopodium assembly; P:response to selenium ion;|Q9BRT3,Migration and invasion enhancer 1,HBV X-transactivated gene 4 protein;HBV XAg-transactivated protein 4;Protein C35;, PF10262;, GO:0034451;GO:0005829;GO:0031235;GO:0005654;GO:0005886;GO:0006915;GO:0043066;GO:0030335;GO:0051491;GO:0010269;, C:centriolar satellite; C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane; C:nucleoplasm; C:plasma membrane;, , P:apoptotic process; P:negative regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of filopodium assembly; P:response to selenium ion; scaffold54 indexed_genome mRNA 470453 479479 . - . ID=transcript_9860;P04626 B2RZG3 B4DHN3 Q14256 Q6LDV1 Q9UMK4 X5D2V5,Receptor tyrosine-protein kinase erbB-2,Metastatic lymph node gene 19 protein;Proto-oncogene Neu;Proto-oncogene c-ErbB-2;Tyrosine kinase-type cell surface receptor HER2;p185erbB2;, PF00757;PF14843;PF07714;PF01030;, GO:0016324;GO:0009925;GO:0016323;GO:0005829;GO:0005769;GO:0010008;GO:0038143;GO:0016021;GO:0005887;GO:0043209;GO:0005634;GO:0048471;GO:0005886;GO:0043235;GO:0005524;GO:0043125;GO:0042802;GO:0008022;GO:0046982;GO:0019903;GO:0004713;GO:0001042;GO:0004714;GO:0004888;GO:0007166;GO:0071364;GO:0071363;GO:0007167;GO:0038128;GO:0007507;GO:0035556;GO:0000165;GO:0008045;GO:0007275;GO:0042552;GO:1901185;GO:0033088;GO:0007528;GO:0030182;GO:0048709;GO:0018108;GO:0007422;GO:0014065;GO:0045785;GO:0030307;GO:0008284;GO:0050679;GO:0043547;GO:0033674;GO:0043406;GO:0043410;GO:0051897;GO:0001934;GO:0090314;GO:0045943;GO:0045727;GO:0046777;GO:0006468;GO:0045765;GO:2000145;GO:0070372;GO:0032886;GO:0006357;GO:0007165;GO:0007169;GO:0042060;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytosol; C:early endosome; C:endosome membrane; C:ERBB3:ERBB2 complex; C:integral component of membrane; C:integral component of plasma membrane; C:myelin sheath; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ErbB-3 class receptor binding; F:identical protein binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:RNA polymerase I core binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cellular response to epidermal growth factor stimulus; P:cellular response to growth factor stimulus; P:enzyme linked receptor protein signaling pathway; P:ERBB2 signaling pathway; P:heart development; P:intracellular signal transduction; P:MAPK cascade; P:motor neuron axon guidance; P:multicellular organism development; P:myelination; P:negative regulation of ERBB signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:neuromuscular junction development; P:neuron differentiation; P:oligodendrocyte differentiation; P:peptidyl-tyrosine phosphorylation; P:peripheral nervous system development; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of cell adhesion; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of GTPase activity; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of translation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of angiogenesis; P:regulation of cell motility; P:regulation of ERK1 and ERK2 cascade; P:regulation of microtubule-based process; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing; scaffold54 indexed_genome mRNA 479779 494307 . - . ID=transcript_9861;P04626 B2RZG3 B4DHN3 Q14256 Q6LDV1 Q9UMK4 X5D2V5,Receptor tyrosine-protein kinase erbB-2,Metastatic lymph node gene 19 protein;Proto-oncogene Neu;Proto-oncogene c-ErbB-2;Tyrosine kinase-type cell surface receptor HER2;p185erbB2;, PF00757;PF14843;PF07714;PF01030;, GO:0016324;GO:0009925;GO:0016323;GO:0005829;GO:0005769;GO:0010008;GO:0038143;GO:0016021;GO:0005887;GO:0043209;GO:0005634;GO:0048471;GO:0005886;GO:0043235;GO:0005524;GO:0043125;GO:0042802;GO:0008022;GO:0046982;GO:0019903;GO:0004713;GO:0001042;GO:0004714;GO:0004888;GO:0007166;GO:0071364;GO:0071363;GO:0007167;GO:0038128;GO:0007507;GO:0035556;GO:0000165;GO:0008045;GO:0007275;GO:0042552;GO:1901185;GO:0033088;GO:0007528;GO:0030182;GO:0048709;GO:0018108;GO:0007422;GO:0014065;GO:0045785;GO:0030307;GO:0008284;GO:0050679;GO:0043547;GO:0033674;GO:0043406;GO:0043410;GO:0051897;GO:0001934;GO:0090314;GO:0045943;GO:0045727;GO:0046777;GO:0006468;GO:0045765;GO:2000145;GO:0070372;GO:0032886;GO:0006357;GO:0007165;GO:0007169;GO:0042060;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytosol; C:early endosome; C:endosome membrane; C:ERBB3:ERBB2 complex; C:integral component of membrane; C:integral component of plasma membrane; C:myelin sheath; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ErbB-3 class receptor binding; F:identical protein binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:RNA polymerase I core binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cellular response to epidermal growth factor stimulus; P:cellular response to growth factor stimulus; P:enzyme linked receptor protein signaling pathway; P:ERBB2 signaling pathway; P:heart development; P:intracellular signal transduction; P:MAPK cascade; P:motor neuron axon guidance; P:multicellular organism development; P:myelination; P:negative regulation of ERBB signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:neuromuscular junction development; P:neuron differentiation; P:oligodendrocyte differentiation; P:peptidyl-tyrosine phosphorylation; P:peripheral nervous system development; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of cell adhesion; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of GTPase activity; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of translation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of angiogenesis; P:regulation of cell motility; P:regulation of ERK1 and ERK2 cascade; P:regulation of microtubule-based process; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing; scaffold54 indexed_genome mRNA 503802 517193 . + . ID=transcript_9862;Q96FM1 B4DGK7 Q86Z03 Q8NBJ8,Post-GPI attachment to proteins factor 3,COS16 homolog;Gene coamplified with ERBB2 protein;PER1-like domain-containing protein 1;, PF04080;, GO:0000139;GO:0016021;GO:0031227;GO:0016788;GO:0006506;GO:0006505;, C:Golgi membrane; C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane;, F:hydrolase activity, acting on ester bonds;, P:GPI anchor biosynthetic process; P:GPI anchor metabolic process;|Q96FM1 B4DGK7 Q86Z03 Q8NBJ8,Post-GPI attachment to proteins factor 3,COS16 homolog;Gene coamplified with ERBB2 protein;PER1-like domain-containing protein 1;, PF04080;, GO:0000139;GO:0016021;GO:0031227;GO:0016788;GO:0006506;GO:0006505;, C:Golgi membrane; C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane;, F:hydrolase activity, acting on ester bonds;, P:GPI anchor biosynthetic process; P:GPI anchor metabolic process; scaffold54 indexed_genome mRNA 517569 518311 . + . ID=transcript_9863;P11086,Phenylethanolamine N-methyltransferase,Noradrenaline N-methyltransferase;, PF01234;, GO:0005829;GO:0008170;GO:0004603;GO:0042423;GO:0042418;GO:0032259;, C:cytosol;, F:N-methyltransferase activity; F:phenylethanolamine N-methyltransferase activity;, P:catecholamine biosynthetic process; P:epinephrine biosynthetic process; P:methylation; scaffold54 indexed_genome mRNA 520994 530135 . - . ID=transcript_9864;Q14849 A8MXA4 B4DUY1 F5H0G2 Q53Y53 Q96HM9,StAR-related lipid transfer protein 3 {ECO:0000305},Metastatic lymph node gene 64 protein {ECO:0000303|PubMed:11053434};Protein CAB1 {ECO:0000303|PubMed:9270027};START domain-containing protein 3 {ECO:0000303|PubMed:21322544};, PF10457;PF01852;, GO:0005737;GO:0005829;GO:0140284;GO:0005768;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005654;GO:0044232;GO:0015485;GO:0120020;GO:0042803;GO:0006700;GO:0008203;GO:0030301;GO:0006629;GO:0006839;GO:0008202;GO:0099044;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum-endosome membrane contact site; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nucleoplasm; C:organelle membrane contact site;, F:cholesterol binding; F:cholesterol transfer activity; F:protein homodimerization activity;, P:C21-steroid hormone biosynthetic process; P:cholesterol metabolic process; P:cholesterol transport; P:lipid metabolic process; P:mitochondrial transport; P:steroid metabolic process; P:vesicle tethering to endoplasmic reticulum;|Q14849 A8MXA4 B4DUY1 F5H0G2 Q53Y53 Q96HM9,StAR-related lipid transfer protein 3 {ECO:0000305},Metastatic lymph node gene 64 protein {ECO:0000303|PubMed:11053434};Protein CAB1 {ECO:0000303|PubMed:9270027};START domain-containing protein 3 {ECO:0000303|PubMed:21322544};, PF10457;PF01852;, GO:0005737;GO:0005829;GO:0140284;GO:0005768;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005654;GO:0044232;GO:0015485;GO:0120020;GO:0042803;GO:0006700;GO:0008203;GO:0030301;GO:0006629;GO:0006839;GO:0008202;GO:0099044;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum-endosome membrane contact site; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nucleoplasm; C:organelle membrane contact site;, F:cholesterol binding; F:cholesterol transfer activity; F:protein homodimerization activity;, P:C21-steroid hormone biosynthetic process; P:cholesterol metabolic process; P:cholesterol transport; P:lipid metabolic process; P:mitochondrial transport; P:steroid metabolic process; P:vesicle tethering to endoplasmic reticulum;|Q14849 A8MXA4 B4DUY1 F5H0G2 Q53Y53 Q96HM9,StAR-related lipid transfer protein 3 {ECO:0000305},Metastatic lymph node gene 64 protein {ECO:0000303|PubMed:11053434};Protein CAB1 {ECO:0000303|PubMed:9270027};START domain-containing protein 3 {ECO:0000303|PubMed:21322544};, PF10457;PF01852;, GO:0005737;GO:0005829;GO:0140284;GO:0005768;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005654;GO:0044232;GO:0015485;GO:0120020;GO:0042803;GO:0006700;GO:0008203;GO:0030301;GO:0006629;GO:0006839;GO:0008202;GO:0099044;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum-endosome membrane contact site; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nucleoplasm; C:organelle membrane contact site;, F:cholesterol binding; F:cholesterol transfer activity; F:protein homodimerization activity;, P:C21-steroid hormone biosynthetic process; P:cholesterol metabolic process; P:cholesterol transport; P:lipid metabolic process; P:mitochondrial transport; P:steroid metabolic process; P:vesicle tethering to endoplasmic reticulum;|Q14849 A8MXA4 B4DUY1 F5H0G2 Q53Y53 Q96HM9,StAR-related lipid transfer protein 3 {ECO:0000305},Metastatic lymph node gene 64 protein {ECO:0000303|PubMed:11053434};Protein CAB1 {ECO:0000303|PubMed:9270027};START domain-containing protein 3 {ECO:0000303|PubMed:21322544};, PF10457;PF01852;, GO:0005737;GO:0005829;GO:0140284;GO:0005768;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005654;GO:0044232;GO:0015485;GO:0120020;GO:0042803;GO:0006700;GO:0008203;GO:0030301;GO:0006629;GO:0006839;GO:0008202;GO:0099044;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum-endosome membrane contact site; C:endosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nucleoplasm; C:organelle membrane contact site;, F:cholesterol binding; F:cholesterol transfer activity; F:protein homodimerization activity;, P:C21-steroid hormone biosynthetic process; P:cholesterol metabolic process; P:cholesterol transport; P:lipid metabolic process; P:mitochondrial transport; P:steroid metabolic process; P:vesicle tethering to endoplasmic reticulum; scaffold54 indexed_genome mRNA 549894 550490 . - . ID=transcript_9865;Q9UD71 Q547V9 Q547W0 Q9H7G1,Protein phosphatase 1 regulatory subunit 1B,DARPP-32;Dopamine- and cAMP-regulated neuronal phosphoprotein;, PF05395;, GO:0005737;GO:0005829;GO:0044327;GO:0044326;GO:0098978;GO:0043025;GO:0005634;GO:0031748;GO:0031749;GO:0031750;GO:0031751;GO:0031752;GO:0004860;GO:0004864;GO:0048148;GO:0035556;GO:0007626;GO:0007613;GO:0007621;GO:0032515;GO:0001975;GO:0043278;GO:0035094;GO:0007165;GO:0006351;GO:0008542;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:dendritic spine neck; C:glutamatergic synapse; C:neuronal cell body; C:nucleus;, F:D1 dopamine receptor binding; F:D2 dopamine receptor binding; F:D3 dopamine receptor binding; F:D4 dopamine receptor binding; F:D5 dopamine receptor binding; F:protein kinase inhibitor activity; F:protein phosphatase inhibitor activity;, P:behavioral response to cocaine; P:intracellular signal transduction; P:locomotory behavior; P:memory; P:negative regulation of female receptivity; P:negative regulation of phosphoprotein phosphatase activity; P:response to amphetamine; P:response to morphine; P:response to nicotine; P:signal transduction; P:transcription, DNA-templated; P:visual learning; scaffold54 indexed_genome mRNA 551660 552743 . + . ID=transcript_9866;Q9UD71 Q547V9 Q547W0 Q9H7G1,Protein phosphatase 1 regulatory subunit 1B,DARPP-32;Dopamine- and cAMP-regulated neuronal phosphoprotein;, PF05395;, GO:0005737;GO:0005829;GO:0044327;GO:0044326;GO:0098978;GO:0043025;GO:0005634;GO:0031748;GO:0031749;GO:0031750;GO:0031751;GO:0031752;GO:0004860;GO:0004864;GO:0048148;GO:0035556;GO:0007626;GO:0007613;GO:0007621;GO:0032515;GO:0001975;GO:0043278;GO:0035094;GO:0007165;GO:0006351;GO:0008542;, C:cytoplasm; C:cytosol; C:dendritic spine head; C:dendritic spine neck; C:glutamatergic synapse; C:neuronal cell body; C:nucleus;, F:D1 dopamine receptor binding; F:D2 dopamine receptor binding; F:D3 dopamine receptor binding; F:D4 dopamine receptor binding; F:D5 dopamine receptor binding; F:protein kinase inhibitor activity; F:protein phosphatase inhibitor activity;, P:behavioral response to cocaine; P:intracellular signal transduction; P:locomotory behavior; P:memory; P:negative regulation of female receptivity; P:negative regulation of phosphoprotein phosphatase activity; P:response to amphetamine; P:response to morphine; P:response to nicotine; P:signal transduction; P:transcription, DNA-templated; P:visual learning; scaffold54 indexed_genome mRNA 580294 582421 . - . ID=transcript_9867;Q15784 Q8TBI7 Q9UQC6,Neurogenic differentiation factor 2,Class A basic helix-loop-helix protein 1;NeuroD-related factor;, PF00010;PF12533;, GO:0000785;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0046982;GO:0000978;GO:1990837;GO:0008306;GO:0001662;GO:0071277;GO:0071257;GO:0021695;GO:2000297;GO:0007399;GO:0048666;GO:0030182;GO:0050850;GO:0051091;GO:0045666;GO:0090129;GO:0031915;GO:0016567;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:associative learning; P:behavioral fear response; P:cellular response to calcium ion; P:cellular response to electrical stimulus; P:cerebellar cortex development; P:negative regulation of synapse maturation; P:nervous system development; P:neuron development; P:neuron differentiation; P:positive regulation of calcium-mediated signaling; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron differentiation; P:positive regulation of synapse maturation; P:positive regulation of synaptic plasticity; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 639812 693695 . - . ID=transcript_9868;Q9NYV4 A7E2B2 B4DYX4 B9EIQ6 O94978,Cyclin-dependent kinase 12,Cdc2-related kinase, arginine/serine-rich;Cell division cycle 2-related protein kinase 7;Cell division protein kinase 12;, PF00069;, GO:0002944;GO:0000307;GO:0008024;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0008353;GO:0006397;GO:2000737;GO:0070816;GO:0032968;GO:0046777;GO:0006468;GO:0043405;GO:0043484;GO:0008380;GO:0006368;, C:cyclin K-CDK12 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:mRNA processing; P:negative regulation of stem cell differentiation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of MAP kinase activity; P:regulation of RNA splicing; P:RNA splicing; P:transcription elongation from RNA polymerase II promoter;|Q9NYV4 A7E2B2 B4DYX4 B9EIQ6 O94978,Cyclin-dependent kinase 12,Cdc2-related kinase, arginine/serine-rich;Cell division cycle 2-related protein kinase 7;Cell division protein kinase 12;, PF00069;, GO:0002944;GO:0000307;GO:0008024;GO:0019908;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0004693;GO:0004672;GO:0019901;GO:0106310;GO:0106311;GO:0008353;GO:0006397;GO:2000737;GO:0070816;GO:0032968;GO:0046777;GO:0006468;GO:0043405;GO:0043484;GO:0008380;GO:0006368;, C:cyclin K-CDK12 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cyclin/CDK positive transcription elongation factor complex; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:mRNA processing; P:negative regulation of stem cell differentiation; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of MAP kinase activity; P:regulation of RNA splicing; P:RNA splicing; P:transcription elongation from RNA polymerase II promoter; scaffold54 indexed_genome mRNA 704278 720873 . + . ID=transcript_9869;Q15648 A2RRQ6 O43810 O75447 Q6P9H7 Q6PK58 Q9HD39,Mediator of RNA polymerase II transcription subunit 1,Activator-recruited cofactor 205 kDa component;Mediator complex subunit 1;Peroxisome proliferator-activated receptor-binding protein;Thyroid hormone receptor-associated protein complex 220 kDa component;Thyroid receptor-interacting protein 2;Vitamin D receptor-interacting protein complex component DRIP205;p53 regulatory protein RB18A;, PF10744;, GO:0000785;GO:0016592;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032993;GO:0000151;GO:0003682;GO:0031490;GO:0030331;GO:0050693;GO:0035257;GO:0016922;GO:0030374;GO:0042975;GO:1990841;GO:0044877;GO:0042974;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0003714;GO:0008134;GO:0061630;GO:0042809;GO:0006702;GO:0001525;GO:0031100;GO:0007420;GO:0000902;GO:0071364;GO:0035729;GO:0071383;GO:0097067;GO:0035050;GO:0035162;GO:0035116;GO:0001892;GO:0048822;GO:0060750;GO:0048821;GO:0045444;GO:0030518;GO:0030216;GO:0007595;GO:0002088;GO:0001889;GO:0060745;GO:0060744;GO:0035855;GO:0030224;GO:0042789;GO:0043066;GO:0010839;GO:0045665;GO:0000122;GO:0035357;GO:0045648;GO:0070318;GO:0010628;GO:2000347;GO:0060335;GO:0033148;GO:0045618;GO:0045944;GO:0060261;GO:0045893;GO:0006606;GO:0019216;GO:2001141;GO:0006357;GO:0060260;GO:0070562;GO:0003406;GO:0006590;GO:0002154;GO:0006367;GO:0003222;, C:chromatin; C:mediator complex; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:ubiquitin ligase complex;, F:chromatin binding; F:chromatin DNA binding; F:estrogen receptor binding; F:LBD domain binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:promoter-specific chromatin binding; F:protein-containing complex binding; F:retinoic acid receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:androgen biosynthetic process; P:angiogenesis; P:animal organ regeneration; P:brain development; P:cell morphogenesis; P:cellular response to epidermal growth factor stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to steroid hormone stimulus; P:cellular response to thyroid hormone stimulus; P:embryonic heart tube development; P:embryonic hemopoiesis; P:embryonic hindlimb morphogenesis; P:embryonic placenta development; P:enucleate erythrocyte development; P:epithelial cell proliferation involved in mammary gland duct elongation; P:erythrocyte development; P:fat cell differentiation; P:intracellular steroid hormone receptor signaling pathway; P:keratinocyte differentiation; P:lactation; P:lens development in camera-type eye; P:liver development; P:mammary gland branching involved in pregnancy; P:mammary gland branching involved in thelarche; P:megakaryocyte development; P:monocyte differentiation; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of keratinocyte proliferation; P:negative regulation of neuron differentiation; P:negative regulation of transcription by RNA polymerase II; P:peroxisome proliferator activated receptor signaling pathway; P:positive regulation of erythrocyte differentiation; P:positive regulation of G0 to G1 transition; P:positive regulation of gene expression; P:positive regulation of hepatocyte proliferation; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of keratinocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:regulation of lipid metabolic process; P:regulation of RNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of vitamin D receptor signaling pathway; P:retinal pigment epithelium development; P:thyroid hormone generation; P:thyroid hormone mediated signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:ventricular trabecula myocardium morphogenesis;|Q15648 A2RRQ6 O43810 O75447 Q6P9H7 Q6PK58 Q9HD39,Mediator of RNA polymerase II transcription subunit 1,Activator-recruited cofactor 205 kDa component;Mediator complex subunit 1;Peroxisome proliferator-activated receptor-binding protein;Thyroid hormone receptor-associated protein complex 220 kDa component;Thyroid receptor-interacting protein 2;Vitamin D receptor-interacting protein complex component DRIP205;p53 regulatory protein RB18A;, PF10744;, GO:0000785;GO:0016592;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032993;GO:0000151;GO:0003682;GO:0031490;GO:0030331;GO:0050693;GO:0035257;GO:0016922;GO:0030374;GO:0042975;GO:1990841;GO:0044877;GO:0042974;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0003714;GO:0008134;GO:0061630;GO:0042809;GO:0006702;GO:0001525;GO:0031100;GO:0007420;GO:0000902;GO:0071364;GO:0035729;GO:0071383;GO:0097067;GO:0035050;GO:0035162;GO:0035116;GO:0001892;GO:0048822;GO:0060750;GO:0048821;GO:0045444;GO:0030518;GO:0030216;GO:0007595;GO:0002088;GO:0001889;GO:0060745;GO:0060744;GO:0035855;GO:0030224;GO:0042789;GO:0043066;GO:0010839;GO:0045665;GO:0000122;GO:0035357;GO:0045648;GO:0070318;GO:0010628;GO:2000347;GO:0060335;GO:0033148;GO:0045618;GO:0045944;GO:0060261;GO:0045893;GO:0006606;GO:0019216;GO:2001141;GO:0006357;GO:0060260;GO:0070562;GO:0003406;GO:0006590;GO:0002154;GO:0006367;GO:0003222;, C:chromatin; C:mediator complex; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:ubiquitin ligase complex;, F:chromatin binding; F:chromatin DNA binding; F:estrogen receptor binding; F:LBD domain binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:promoter-specific chromatin binding; F:protein-containing complex binding; F:retinoic acid receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:androgen biosynthetic process; P:angiogenesis; P:animal organ regeneration; P:brain development; P:cell morphogenesis; P:cellular response to epidermal growth factor stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to steroid hormone stimulus; P:cellular response to thyroid hormone stimulus; P:embryonic heart tube development; P:embryonic hemopoiesis; P:embryonic hindlimb morphogenesis; P:embryonic placenta development; P:enucleate erythrocyte development; P:epithelial cell proliferation involved in mammary gland duct elongation; P:erythrocyte development; P:fat cell differentiation; P:intracellular steroid hormone receptor signaling pathway; P:keratinocyte differentiation; P:lactation; P:lens development in camera-type eye; P:liver development; P:mammary gland branching involved in pregnancy; P:mammary gland branching involved in thelarche; P:megakaryocyte development; P:monocyte differentiation; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of keratinocyte proliferation; P:negative regulation of neuron differentiation; P:negative regulation of transcription by RNA polymerase II; P:peroxisome proliferator activated receptor signaling pathway; P:positive regulation of erythrocyte differentiation; P:positive regulation of G0 to G1 transition; P:positive regulation of gene expression; P:positive regulation of hepatocyte proliferation; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of keratinocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:regulation of lipid metabolic process; P:regulation of RNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of vitamin D receptor signaling pathway; P:retinal pigment epithelium development; P:thyroid hormone generation; P:thyroid hormone mediated signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:ventricular trabecula myocardium morphogenesis;|Q15648 A2RRQ6 O43810 O75447 Q6P9H7 Q6PK58 Q9HD39,Mediator of RNA polymerase II transcription subunit 1,Activator-recruited cofactor 205 kDa component;Mediator complex subunit 1;Peroxisome proliferator-activated receptor-binding protein;Thyroid hormone receptor-associated protein complex 220 kDa component;Thyroid receptor-interacting protein 2;Vitamin D receptor-interacting protein complex component DRIP205;p53 regulatory protein RB18A;, PF10744;, GO:0000785;GO:0016592;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032993;GO:0000151;GO:0003682;GO:0031490;GO:0030331;GO:0050693;GO:0035257;GO:0016922;GO:0030374;GO:0042975;GO:1990841;GO:0044877;GO:0042974;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0003714;GO:0008134;GO:0061630;GO:0042809;GO:0006702;GO:0001525;GO:0031100;GO:0007420;GO:0000902;GO:0071364;GO:0035729;GO:0071383;GO:0097067;GO:0035050;GO:0035162;GO:0035116;GO:0001892;GO:0048822;GO:0060750;GO:0048821;GO:0045444;GO:0030518;GO:0030216;GO:0007595;GO:0002088;GO:0001889;GO:0060745;GO:0060744;GO:0035855;GO:0030224;GO:0042789;GO:0043066;GO:0010839;GO:0045665;GO:0000122;GO:0035357;GO:0045648;GO:0070318;GO:0010628;GO:2000347;GO:0060335;GO:0033148;GO:0045618;GO:0045944;GO:0060261;GO:0045893;GO:0006606;GO:0019216;GO:2001141;GO:0006357;GO:0060260;GO:0070562;GO:0003406;GO:0006590;GO:0002154;GO:0006367;GO:0003222;, C:chromatin; C:mediator complex; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:ubiquitin ligase complex;, F:chromatin binding; F:chromatin DNA binding; F:estrogen receptor binding; F:LBD domain binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:promoter-specific chromatin binding; F:protein-containing complex binding; F:retinoic acid receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:androgen biosynthetic process; P:angiogenesis; P:animal organ regeneration; P:brain development; P:cell morphogenesis; P:cellular response to epidermal growth factor stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to steroid hormone stimulus; P:cellular response to thyroid hormone stimulus; P:embryonic heart tube development; P:embryonic hemopoiesis; P:embryonic hindlimb morphogenesis; P:embryonic placenta development; P:enucleate erythrocyte development; P:epithelial cell proliferation involved in mammary gland duct elongation; P:erythrocyte development; P:fat cell differentiation; P:intracellular steroid hormone receptor signaling pathway; P:keratinocyte differentiation; P:lactation; P:lens development in camera-type eye; P:liver development; P:mammary gland branching involved in pregnancy; P:mammary gland branching involved in thelarche; P:megakaryocyte development; P:monocyte differentiation; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of keratinocyte proliferation; P:negative regulation of neuron differentiation; P:negative regulation of transcription by RNA polymerase II; P:peroxisome proliferator activated receptor signaling pathway; P:positive regulation of erythrocyte differentiation; P:positive regulation of G0 to G1 transition; P:positive regulation of gene expression; P:positive regulation of hepatocyte proliferation; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of keratinocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:regulation of lipid metabolic process; P:regulation of RNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of vitamin D receptor signaling pathway; P:retinal pigment epithelium development; P:thyroid hormone generation; P:thyroid hormone mediated signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:ventricular trabecula myocardium morphogenesis;|Q15648 A2RRQ6 O43810 O75447 Q6P9H7 Q6PK58 Q9HD39,Mediator of RNA polymerase II transcription subunit 1,Activator-recruited cofactor 205 kDa component;Mediator complex subunit 1;Peroxisome proliferator-activated receptor-binding protein;Thyroid hormone receptor-associated protein complex 220 kDa component;Thyroid receptor-interacting protein 2;Vitamin D receptor-interacting protein complex component DRIP205;p53 regulatory protein RB18A;, PF10744;, GO:0000785;GO:0016592;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032993;GO:0000151;GO:0003682;GO:0031490;GO:0030331;GO:0050693;GO:0035257;GO:0016922;GO:0030374;GO:0042975;GO:1990841;GO:0044877;GO:0042974;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0003714;GO:0008134;GO:0061630;GO:0042809;GO:0006702;GO:0001525;GO:0031100;GO:0007420;GO:0000902;GO:0071364;GO:0035729;GO:0071383;GO:0097067;GO:0035050;GO:0035162;GO:0035116;GO:0001892;GO:0048822;GO:0060750;GO:0048821;GO:0045444;GO:0030518;GO:0030216;GO:0007595;GO:0002088;GO:0001889;GO:0060745;GO:0060744;GO:0035855;GO:0030224;GO:0042789;GO:0043066;GO:0010839;GO:0045665;GO:0000122;GO:0035357;GO:0045648;GO:0070318;GO:0010628;GO:2000347;GO:0060335;GO:0033148;GO:0045618;GO:0045944;GO:0060261;GO:0045893;GO:0006606;GO:0019216;GO:2001141;GO:0006357;GO:0060260;GO:0070562;GO:0003406;GO:0006590;GO:0002154;GO:0006367;GO:0003222;, C:chromatin; C:mediator complex; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:ubiquitin ligase complex;, F:chromatin binding; F:chromatin DNA binding; F:estrogen receptor binding; F:LBD domain binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:promoter-specific chromatin binding; F:protein-containing complex binding; F:retinoic acid receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:androgen biosynthetic process; P:angiogenesis; P:animal organ regeneration; P:brain development; P:cell morphogenesis; P:cellular response to epidermal growth factor stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to steroid hormone stimulus; P:cellular response to thyroid hormone stimulus; P:embryonic heart tube development; P:embryonic hemopoiesis; P:embryonic hindlimb morphogenesis; P:embryonic placenta development; P:enucleate erythrocyte development; P:epithelial cell proliferation involved in mammary gland duct elongation; P:erythrocyte development; P:fat cell differentiation; P:intracellular steroid hormone receptor signaling pathway; P:keratinocyte differentiation; P:lactation; P:lens development in camera-type eye; P:liver development; P:mammary gland branching involved in pregnancy; P:mammary gland branching involved in thelarche; P:megakaryocyte development; P:monocyte differentiation; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of keratinocyte proliferation; P:negative regulation of neuron differentiation; P:negative regulation of transcription by RNA polymerase II; P:peroxisome proliferator activated receptor signaling pathway; P:positive regulation of erythrocyte differentiation; P:positive regulation of G0 to G1 transition; P:positive regulation of gene expression; P:positive regulation of hepatocyte proliferation; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of keratinocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:regulation of lipid metabolic process; P:regulation of RNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of vitamin D receptor signaling pathway; P:retinal pigment epithelium development; P:thyroid hormone generation; P:thyroid hormone mediated signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:ventricular trabecula myocardium morphogenesis; scaffold54 indexed_genome mRNA 721654 728513 . - . ID=transcript_9870;Q15648 A2RRQ6 O43810 O75447 Q6P9H7 Q6PK58 Q9HD39,Mediator of RNA polymerase II transcription subunit 1,Activator-recruited cofactor 205 kDa component;Mediator complex subunit 1;Peroxisome proliferator-activated receptor-binding protein;Thyroid hormone receptor-associated protein complex 220 kDa component;Thyroid receptor-interacting protein 2;Vitamin D receptor-interacting protein complex component DRIP205;p53 regulatory protein RB18A;, PF10744;, GO:0000785;GO:0016592;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032993;GO:0000151;GO:0003682;GO:0031490;GO:0030331;GO:0050693;GO:0035257;GO:0016922;GO:0030374;GO:0042975;GO:1990841;GO:0044877;GO:0042974;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0003714;GO:0008134;GO:0061630;GO:0042809;GO:0006702;GO:0001525;GO:0031100;GO:0007420;GO:0000902;GO:0071364;GO:0035729;GO:0071383;GO:0097067;GO:0035050;GO:0035162;GO:0035116;GO:0001892;GO:0048822;GO:0060750;GO:0048821;GO:0045444;GO:0030518;GO:0030216;GO:0007595;GO:0002088;GO:0001889;GO:0060745;GO:0060744;GO:0035855;GO:0030224;GO:0042789;GO:0043066;GO:0010839;GO:0045665;GO:0000122;GO:0035357;GO:0045648;GO:0070318;GO:0010628;GO:2000347;GO:0060335;GO:0033148;GO:0045618;GO:0045944;GO:0060261;GO:0045893;GO:0006606;GO:0019216;GO:2001141;GO:0006357;GO:0060260;GO:0070562;GO:0003406;GO:0006590;GO:0002154;GO:0006367;GO:0003222;, C:chromatin; C:mediator complex; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:ubiquitin ligase complex;, F:chromatin binding; F:chromatin DNA binding; F:estrogen receptor binding; F:LBD domain binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:peroxisome proliferator activated receptor binding; F:promoter-specific chromatin binding; F:protein-containing complex binding; F:retinoic acid receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:androgen biosynthetic process; P:angiogenesis; P:animal organ regeneration; P:brain development; P:cell morphogenesis; P:cellular response to epidermal growth factor stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to steroid hormone stimulus; P:cellular response to thyroid hormone stimulus; P:embryonic heart tube development; P:embryonic hemopoiesis; P:embryonic hindlimb morphogenesis; P:embryonic placenta development; P:enucleate erythrocyte development; P:epithelial cell proliferation involved in mammary gland duct elongation; P:erythrocyte development; P:fat cell differentiation; P:intracellular steroid hormone receptor signaling pathway; P:keratinocyte differentiation; P:lactation; P:lens development in camera-type eye; P:liver development; P:mammary gland branching involved in pregnancy; P:mammary gland branching involved in thelarche; P:megakaryocyte development; P:monocyte differentiation; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of keratinocyte proliferation; P:negative regulation of neuron differentiation; P:negative regulation of transcription by RNA polymerase II; P:peroxisome proliferator activated receptor signaling pathway; P:positive regulation of erythrocyte differentiation; P:positive regulation of G0 to G1 transition; P:positive regulation of gene expression; P:positive regulation of hepatocyte proliferation; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of keratinocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:regulation of lipid metabolic process; P:regulation of RNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of vitamin D receptor signaling pathway; P:retinal pigment epithelium development; P:thyroid hormone generation; P:thyroid hormone mediated signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:ventricular trabecula myocardium morphogenesis; scaffold54 indexed_genome mRNA 794276 826250 . - . ID=transcript_9871;Q96IG2 A8K729 Q38J52,F-box/LRR-repeat protein 20,F-box and leucine-rich repeat protein 20;F-box/LRR-repeat protein 2-like;, PF12937;PF13516;, GO:0005829;GO:0019005;GO:0043687;GO:0000209;GO:0031146;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q96IG2 A8K729 Q38J52,F-box/LRR-repeat protein 20,F-box and leucine-rich repeat protein 20;F-box/LRR-repeat protein 2-like;, PF12937;PF13516;, GO:0005829;GO:0019005;GO:0043687;GO:0000209;GO:0031146;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q96IG2 A8K729 Q38J52,F-box/LRR-repeat protein 20,F-box and leucine-rich repeat protein 20;F-box/LRR-repeat protein 2-like;, PF12937;PF13516;, GO:0005829;GO:0019005;GO:0043687;GO:0000209;GO:0031146;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q96IG2 A8K729 Q38J52,F-box/LRR-repeat protein 20,F-box and leucine-rich repeat protein 20;F-box/LRR-repeat protein 2-like;, PF12937;PF13516;, GO:0005829;GO:0019005;GO:0043687;GO:0000209;GO:0031146;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q96IG2 A8K729 Q38J52,F-box/LRR-repeat protein 20,F-box and leucine-rich repeat protein 20;F-box/LRR-repeat protein 2-like;, PF12937;PF13516;, GO:0005829;GO:0019005;GO:0043687;GO:0000209;GO:0031146;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold54 indexed_genome mRNA 848789 862247 . + . ID=transcript_9872;Q6ZMT1 Q32MA3,SH3 and cysteine-rich domain-containing protein 2,24b2/STAC2 {ECO:0000303|PubMed:14702039};Src homology 3 and cysteine-rich domain-containing protein 2;, PF00130;PF14604;, GO:0005829;GO:0031234;GO:0042383;GO:0046872;GO:0035556;GO:1903078;GO:1901387;GO:0003009;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:sarcolemma;, F:metal ion binding;, P:intracellular signal transduction; P:positive regulation of protein localization to plasma membrane; P:positive regulation of voltage-gated calcium channel activity; P:skeletal muscle contraction;|Q6ZMT1 Q32MA3,SH3 and cysteine-rich domain-containing protein 2,24b2/STAC2 {ECO:0000303|PubMed:14702039};Src homology 3 and cysteine-rich domain-containing protein 2;, PF00130;PF14604;, GO:0005829;GO:0031234;GO:0042383;GO:0046872;GO:0035556;GO:1903078;GO:1901387;GO:0003009;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:sarcolemma;, F:metal ion binding;, P:intracellular signal transduction; P:positive regulation of protein localization to plasma membrane; P:positive regulation of voltage-gated calcium channel activity; P:skeletal muscle contraction; scaffold54 indexed_genome mRNA 869359 870840 . + . ID=transcript_9873;P84098 B2R4K2 P14118 P22908 Q502Y6 Q7Z6E4,60S ribosomal protein L19,Large ribosomal subunit protein eL19 {ECO:0000303|PubMed:24524803};, PF01280;, GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005730;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleolus; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P84098 B2R4K2 P14118 P22908 Q502Y6 Q7Z6E4,60S ribosomal protein L19,Large ribosomal subunit protein eL19 {ECO:0000303|PubMed:24524803};, PF01280;, GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005730;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleolus; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold54 indexed_genome mRNA 873777 891406 . + . ID=transcript_9874;Q02641 A8K114 O15331 Q02639 Q02640 Q8N3X9 Q9C085 Q9UD79,Voltage-dependent L-type calcium channel subunit beta-1,Calcium channel voltage-dependent subunit beta 1;, PF00625;PF12052;, GO:0005886;GO:0042383;GO:0045202;GO:0005891;GO:0008331;GO:0005245;GO:0061337;GO:1904646;GO:0007268;GO:0007528;GO:1902514;GO:1901385;, C:plasma membrane; C:sarcolemma; C:synapse; C:voltage-gated calcium channel complex;, F:high voltage-gated calcium channel activity; F:voltage-gated calcium channel activity;, P:cardiac conduction; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:neuromuscular junction development; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of voltage-gated calcium channel activity;|Q9HD32 Q9Y340 Q9Y341,Voltage-dependent L-type calcium channel subunit beta-2,Calcium channel voltage-dependent subunit beta 2;Lambert-Eaton myasthenic syndrome antigen B;, PF00625;PF12052;, GO:0005887;GO:1990454;GO:0098684;GO:0005886;GO:0098793;GO:0005891;GO:0051015;GO:0005262;GO:0005245;GO:0099635;GO:0070509;GO:0061337;GO:0007268;GO:0098912;GO:0086045;GO:0007528;GO:1904879;GO:0051928;GO:1901843;GO:0072659;GO:0086091;GO:1901385;GO:0007601;, C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynapse; C:voltage-gated calcium channel complex;, F:actin filament binding; F:calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;, P:calcium ion import; P:cardiac conduction; P:chemical synaptic transmission; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:neuromuscular junction development; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:positive regulation of calcium ion transport; P:positive regulation of high voltage-gated calcium channel activity; P:protein localization to plasma membrane; P:regulation of heart rate by cardiac conduction; P:regulation of voltage-gated calcium channel activity; P:visual perception;|Q02641 A8K114 O15331 Q02639 Q02640 Q8N3X9 Q9C085 Q9UD79,Voltage-dependent L-type calcium channel subunit beta-1,Calcium channel voltage-dependent subunit beta 1;, PF00625;PF12052;, GO:0005886;GO:0042383;GO:0045202;GO:0005891;GO:0008331;GO:0005245;GO:0061337;GO:1904646;GO:0007268;GO:0007528;GO:1902514;GO:1901385;, C:plasma membrane; C:sarcolemma; C:synapse; C:voltage-gated calcium channel complex;, F:high voltage-gated calcium channel activity; F:voltage-gated calcium channel activity;, P:cardiac conduction; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:neuromuscular junction development; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of voltage-gated calcium channel activity; scaffold54 indexed_genome mRNA 896704 904164 . + . ID=transcript_9875;A6NH57,Putative ADP-ribosylation factor-like protein 5C,ADP-ribosylation factor-like protein 12;, PF00025;, GO:0005802;GO:0005525;GO:0006886;GO:1903292;GO:0016192;, C:trans-Golgi network;, F:GTP binding;, P:intracellular protein transport; P:protein localization to Golgi membrane; P:vesicle-mediated transport; scaffold54 indexed_genome mRNA 912251 977538 . + . ID=transcript_9876;Q8IUK5 B2R7I8 Q5QCZ7 Q5QCZ8 Q5QCZ9 Q9HCT9,Plexin domain-containing protein 1,Tumor endothelial marker 3;Tumor endothelial marker 7;, PF01437;, GO:0005923;GO:0005737;GO:0030425;GO:0005576;GO:0005615;GO:0016021;GO:0043025;GO:0005886;GO:0043235;GO:0001525;GO:0021510;, C:bicellular tight junction; C:cytoplasm; C:dendrite; C:extracellular region; C:extracellular space; C:integral component of membrane; C:neuronal cell body; C:plasma membrane; C:receptor complex;, , P:angiogenesis; P:spinal cord development; scaffold54 indexed_genome mRNA 1034674 1051733 . + . ID=transcript_9877;Q5MNV8 B2RTZ4,F-box only protein 47,, PF00646; scaffold54 indexed_genome mRNA 1051738 1060801 . + . ID=transcript_9878;Q5MNV8 B2RTZ4,F-box only protein 47,, PF00646; scaffold54 indexed_genome mRNA 1070273 1110090 . - . ID=transcript_9879;Q14847 B4DGQ0 Q96ED2 Q96IG0,LIM and SH3 domain protein 1,Metastatic lymph node gene 50 protein;, PF00412;PF00880;PF14604;, GO:0030864;GO:0005737;GO:0005925;GO:0051015;GO:0045296;GO:0015075;GO:0046872;GO:0006811;, C:cortical actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:actin filament binding; F:cadherin binding; F:ion transmembrane transporter activity; F:metal ion binding;, P:ion transport;|Q14847 B4DGQ0 Q96ED2 Q96IG0,LIM and SH3 domain protein 1,Metastatic lymph node gene 50 protein;, PF00412;PF00880;PF14604;, GO:0030864;GO:0005737;GO:0005925;GO:0051015;GO:0045296;GO:0015075;GO:0046872;GO:0006811;, C:cortical actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:actin filament binding; F:cadherin binding; F:ion transmembrane transporter activity; F:metal ion binding;, P:ion transport; scaffold54 indexed_genome mRNA 1125642 1129677 . + . ID=transcript_9880;P62829 P23131 P24048 Q29246 Q3SWV7 Q6P5S1,60S ribosomal protein L23,60S ribosomal protein L17;Large ribosomal subunit protein uL14 {ECO:0000303|PubMed:24524803};, PF00238;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0014069;GO:0032991;GO:0005840;GO:0070180;GO:0003723;GO:0003735;GO:0001223;GO:1990948;GO:0031625;GO:0072717;GO:0071157;GO:0000122;GO:1904667;GO:2000059;GO:0000184;GO:0071158;GO:0008284;GO:0010628;GO:1901798;GO:0050821;GO:0032986;GO:0006610;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:postsynaptic density; C:protein-containing complex; C:ribosome;, F:large ribosomal subunit rRNA binding; F:RNA binding; F:structural constituent of ribosome; F:transcription coactivator binding; F:ubiquitin ligase inhibitor activity; F:ubiquitin protein ligase binding;, P:cellular response to actinomycin D; P:negative regulation of cell cycle arrest; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin protein ligase activity; P:negative regulation of ubiquitin-dependent protein catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell cycle arrest; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of signal transduction by p53 class mediator; P:protein stabilization; P:protein-DNA complex disassembly; P:ribosomal protein import into nucleus; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62829 P23131 P24048 Q29246 Q3SWV7 Q6P5S1,60S ribosomal protein L23,60S ribosomal protein L17;Large ribosomal subunit protein uL14 {ECO:0000303|PubMed:24524803};, PF00238;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0014069;GO:0032991;GO:0005840;GO:0070180;GO:0003723;GO:0003735;GO:0001223;GO:1990948;GO:0031625;GO:0072717;GO:0071157;GO:0000122;GO:1904667;GO:2000059;GO:0000184;GO:0071158;GO:0008284;GO:0010628;GO:1901798;GO:0050821;GO:0032986;GO:0006610;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:postsynaptic density; C:protein-containing complex; C:ribosome;, F:large ribosomal subunit rRNA binding; F:RNA binding; F:structural constituent of ribosome; F:transcription coactivator binding; F:ubiquitin ligase inhibitor activity; F:ubiquitin protein ligase binding;, P:cellular response to actinomycin D; P:negative regulation of cell cycle arrest; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin protein ligase activity; P:negative regulation of ubiquitin-dependent protein catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell cycle arrest; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of signal transduction by p53 class mediator; P:protein stabilization; P:protein-DNA complex disassembly; P:ribosomal protein import into nucleus; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold54 indexed_genome mRNA 1161045 1173022 . + . ID=transcript_9881;Q9NXE8 A0JLM3 Q68DK5,Pre-mRNA-splicing factor CWC25 homolog,Coiled-coil domain-containing protein 49;Spliceosome-associated protein homolog CWC25;, PF10197;PF12542;, GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0005684;GO:0000398;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type spliceosomal complex;, , P:mRNA splicing, via spliceosome; scaffold54 indexed_genome mRNA 1179062 1181186 . + . ID=transcript_9882;Q9NXE8 A0JLM3 Q68DK5,Pre-mRNA-splicing factor CWC25 homolog,Coiled-coil domain-containing protein 49;Spliceosome-associated protein homolog CWC25;, PF10197;PF12542;, GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0005684;GO:0000398;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type spliceosomal complex;, , P:mRNA splicing, via spliceosome;|Q9NXE8 A0JLM3 Q68DK5,Pre-mRNA-splicing factor CWC25 homolog,Coiled-coil domain-containing protein 49;Spliceosome-associated protein homolog CWC25;, PF10197;PF12542;, GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0005684;GO:0000398;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type spliceosomal complex;, , P:mRNA splicing, via spliceosome; scaffold54 indexed_genome mRNA 1188773 1204638 . + . ID=transcript_9883;P78356 Q5U0E8 Q8TBP2,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta {ECO:0000305},1-phosphatidylinositol 5-phosphate 4-kinase 2-beta;Diphosphoinositide kinase 2-beta;Phosphatidylinositol 5-phosphate 4-kinase type II beta;PtdIns(5)P-4-kinase isoform 2-beta;, PF01504;, GO:0005776;GO:0005829;GO:0005789;GO:0005654;GO:0005634;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0005525;GO:0042803;GO:1902635;GO:0061909;GO:0007166;GO:0090217;GO:0046627;GO:0006661;GO:0006644;GO:2000786;GO:0010506;GO:0014066;GO:1901796;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:GTP binding; F:protein homodimerization activity;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:autophagosome-lysosome fusion; P:cell surface receptor signaling pathway; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phospholipid metabolic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of signal transduction by p53 class mediator;|P78356 Q5U0E8 Q8TBP2,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta {ECO:0000305},1-phosphatidylinositol 5-phosphate 4-kinase 2-beta;Diphosphoinositide kinase 2-beta;Phosphatidylinositol 5-phosphate 4-kinase type II beta;PtdIns(5)P-4-kinase isoform 2-beta;, PF01504;, GO:0005776;GO:0005829;GO:0005789;GO:0005654;GO:0005634;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0005525;GO:0042803;GO:1902635;GO:0061909;GO:0007166;GO:0090217;GO:0046627;GO:0006661;GO:0006644;GO:2000786;GO:0010506;GO:0014066;GO:1901796;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:GTP binding; F:protein homodimerization activity;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:autophagosome-lysosome fusion; P:cell surface receptor signaling pathway; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phospholipid metabolic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of signal transduction by p53 class mediator;|P78356 Q5U0E8 Q8TBP2,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta {ECO:0000305},1-phosphatidylinositol 5-phosphate 4-kinase 2-beta;Diphosphoinositide kinase 2-beta;Phosphatidylinositol 5-phosphate 4-kinase type II beta;PtdIns(5)P-4-kinase isoform 2-beta;, PF01504;, GO:0005776;GO:0005829;GO:0005789;GO:0005654;GO:0005634;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0005525;GO:0042803;GO:1902635;GO:0061909;GO:0007166;GO:0090217;GO:0046627;GO:0006661;GO:0006644;GO:2000786;GO:0010506;GO:0014066;GO:1901796;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:GTP binding; F:protein homodimerization activity;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:autophagosome-lysosome fusion; P:cell surface receptor signaling pathway; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phospholipid metabolic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of signal transduction by p53 class mediator;|P78356 Q5U0E8 Q8TBP2,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta {ECO:0000305},1-phosphatidylinositol 5-phosphate 4-kinase 2-beta;Diphosphoinositide kinase 2-beta;Phosphatidylinositol 5-phosphate 4-kinase type II beta;PtdIns(5)P-4-kinase isoform 2-beta;, PF01504;, GO:0005776;GO:0005829;GO:0005789;GO:0005654;GO:0005634;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0005525;GO:0042803;GO:1902635;GO:0061909;GO:0007166;GO:0090217;GO:0046627;GO:0006661;GO:0006644;GO:2000786;GO:0010506;GO:0014066;GO:1901796;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:GTP binding; F:protein homodimerization activity;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:autophagosome-lysosome fusion; P:cell surface receptor signaling pathway; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phospholipid metabolic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of signal transduction by p53 class mediator; scaffold54 indexed_genome mRNA 1209928 1220939 . - . ID=transcript_9884;P49720 P31147 Q0P6J7 Q96E27,Proteasome subunit beta type-3,Proteasome chain 13;Proteasome component C10-II;Proteasome theta chain;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P49720 P31147 Q0P6J7 Q96E27,Proteasome subunit beta type-3,Proteasome chain 13;Proteasome component C10-II;Proteasome theta chain;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold54 indexed_genome mRNA 1228638 1234941 . + . ID=transcript_9885;P35227 A6NGD8,Polycomb group RING finger protein 2,DNA-binding protein Mel-18;RING finger protein 110;Zinc finger protein 144;, PF16207;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0001739;GO:0003677;GO:0046872;GO:1990841;GO:0009952;GO:0070301;GO:0006342;GO:0048704;GO:0016573;GO:0036353;GO:0001701;GO:2001234;GO:0070317;GO:0000122;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:sex chromatin;, F:DNA binding; F:metal ion binding; F:promoter-specific chromatin binding;, P:anterior/posterior pattern specification; P:cellular response to hydrogen peroxide; P:chromatin silencing; P:embryonic skeletal system morphogenesis; P:histone acetylation; P:histone H2A-K119 monoubiquitination; P:in utero embryonic development; P:negative regulation of apoptotic signaling pathway; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II;|P35227 A6NGD8,Polycomb group RING finger protein 2,DNA-binding protein Mel-18;RING finger protein 110;Zinc finger protein 144;, PF16207;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0001739;GO:0003677;GO:0046872;GO:1990841;GO:0009952;GO:0070301;GO:0006342;GO:0048704;GO:0016573;GO:0036353;GO:0001701;GO:2001234;GO:0070317;GO:0000122;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:sex chromatin;, F:DNA binding; F:metal ion binding; F:promoter-specific chromatin binding;, P:anterior/posterior pattern specification; P:cellular response to hydrogen peroxide; P:chromatin silencing; P:embryonic skeletal system morphogenesis; P:histone acetylation; P:histone H2A-K119 monoubiquitination; P:in utero embryonic development; P:negative regulation of apoptotic signaling pathway; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 1237119 1238290 . - . ID=transcript_9886;P0C7P0,CDGSH iron-sulfur domain-containing protein 3, mitochondrial,MitoNEET-related protein 2;Mitochondrial inner NEET protein {ECO:0000303|PubMed:29259115};, PF09360;, GO:0005739;GO:0051537;GO:0046872;GO:0106034;, C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding;, P:protein maturation by [2Fe-2S] cluster transfer; scaffold54 indexed_genome mRNA 1245855 1265812 . - . ID=transcript_9887;P55198 Q59F28 Q96IU3 Q9H5F6 Q9UF49,Protein AF-17,ALL1-fused gene from chromosome 17 protein;, , GO:0005634;GO:0042393;GO:0046872;GO:0031491;GO:2001161;GO:0035811;GO:0010765;GO:0045944;GO:0006355;GO:0036359;GO:0035812;, C:nucleus;, F:histone binding; F:metal ion binding; F:nucleosome binding;, P:negative regulation of histone H3-K79 methylation; P:negative regulation of urine volume; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal potassium excretion; P:renal sodium excretion;|P55198 Q59F28 Q96IU3 Q9H5F6 Q9UF49,Protein AF-17,ALL1-fused gene from chromosome 17 protein;, , GO:0005634;GO:0042393;GO:0046872;GO:0031491;GO:2001161;GO:0035811;GO:0010765;GO:0045944;GO:0006355;GO:0036359;GO:0035812;, C:nucleus;, F:histone binding; F:metal ion binding; F:nucleosome binding;, P:negative regulation of histone H3-K79 methylation; P:negative regulation of urine volume; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal potassium excretion; P:renal sodium excretion;|P55198 Q59F28 Q96IU3 Q9H5F6 Q9UF49,Protein AF-17,ALL1-fused gene from chromosome 17 protein;, , GO:0005634;GO:0042393;GO:0046872;GO:0031491;GO:2001161;GO:0035811;GO:0010765;GO:0045944;GO:0006355;GO:0036359;GO:0035812;, C:nucleus;, F:histone binding; F:metal ion binding; F:nucleosome binding;, P:negative regulation of histone H3-K79 methylation; P:negative regulation of urine volume; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal potassium excretion; P:renal sodium excretion;|P55198 Q59F28 Q96IU3 Q9H5F6 Q9UF49,Protein AF-17,ALL1-fused gene from chromosome 17 protein;, , GO:0005634;GO:0042393;GO:0046872;GO:0031491;GO:2001161;GO:0035811;GO:0010765;GO:0045944;GO:0006355;GO:0036359;GO:0035812;, C:nucleus;, F:histone binding; F:metal ion binding; F:nucleosome binding;, P:negative regulation of histone H3-K79 methylation; P:negative regulation of urine volume; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal potassium excretion; P:renal sodium excretion;|P55198 Q59F28 Q96IU3 Q9H5F6 Q9UF49,Protein AF-17,ALL1-fused gene from chromosome 17 protein;, , GO:0005634;GO:0042393;GO:0046872;GO:0031491;GO:2001161;GO:0035811;GO:0010765;GO:0045944;GO:0006355;GO:0036359;GO:0035812;, C:nucleus;, F:histone binding; F:metal ion binding; F:nucleosome binding;, P:negative regulation of histone H3-K79 methylation; P:negative regulation of urine volume; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal potassium excretion; P:renal sodium excretion;|P55198 Q59F28 Q96IU3 Q9H5F6 Q9UF49,Protein AF-17,ALL1-fused gene from chromosome 17 protein;, , GO:0005634;GO:0042393;GO:0046872;GO:0031491;GO:2001161;GO:0035811;GO:0010765;GO:0045944;GO:0006355;GO:0036359;GO:0035812;, C:nucleus;, F:histone binding; F:metal ion binding; F:nucleosome binding;, P:negative regulation of histone H3-K79 methylation; P:negative regulation of urine volume; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal potassium excretion; P:renal sodium excretion;|P55198 Q59F28 Q96IU3 Q9H5F6 Q9UF49,Protein AF-17,ALL1-fused gene from chromosome 17 protein;, , GO:0005634;GO:0042393;GO:0046872;GO:0031491;GO:2001161;GO:0035811;GO:0010765;GO:0045944;GO:0006355;GO:0036359;GO:0035812;, C:nucleus;, F:histone binding; F:metal ion binding; F:nucleosome binding;, P:negative regulation of histone H3-K79 methylation; P:negative regulation of urine volume; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal potassium excretion; P:renal sodium excretion;|P55198 Q59F28 Q96IU3 Q9H5F6 Q9UF49,Protein AF-17,ALL1-fused gene from chromosome 17 protein;, , GO:0005634;GO:0042393;GO:0046872;GO:0031491;GO:2001161;GO:0035811;GO:0010765;GO:0045944;GO:0006355;GO:0036359;GO:0035812;, C:nucleus;, F:histone binding; F:metal ion binding; F:nucleosome binding;, P:negative regulation of histone H3-K79 methylation; P:negative regulation of urine volume; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal potassium excretion; P:renal sodium excretion;|P55198 Q59F28 Q96IU3 Q9H5F6 Q9UF49,Protein AF-17,ALL1-fused gene from chromosome 17 protein;, , GO:0005634;GO:0042393;GO:0046872;GO:0031491;GO:2001161;GO:0035811;GO:0010765;GO:0045944;GO:0006355;GO:0036359;GO:0035812;, C:nucleus;, F:histone binding; F:metal ion binding; F:nucleosome binding;, P:negative regulation of histone H3-K79 methylation; P:negative regulation of urine volume; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal potassium excretion; P:renal sodium excretion; scaffold54 indexed_genome mRNA 1290708 1291338 . - . ID=transcript_9888;A6NHQ4,Elongin BC and Polycomb repressive complex 2-associated protein {ECO:0000250|UniProtKB:Q7TNS8},Proline-rich protein 28 {ECO:0000312|HGNC:HGNC:34493};, PF15223;, GO:0005694;GO:0070449;GO:0035098;GO:0003682;GO:0035616;GO:0048663;GO:0006357;GO:0048863;, C:chromosome; C:elongin complex; C:ESC/E(Z) complex;, F:chromatin binding;, P:histone H2B conserved C-terminal lysine deubiquitination; P:neuron fate commitment; P:regulation of transcription by RNA polymerase II; P:stem cell differentiation; scaffold54 indexed_genome mRNA 1391785 1427579 . + . ID=transcript_9889;Q9C0H9 Q75T46 Q8N4W8,SRC kinase signaling inhibitor 1 {ECO:0000305},SNAP-25-interacting protein;p130Cas-associated protein;p140Cap;, PF03915;, GO:0015629;GO:0030424;GO:0005737;GO:0030425;GO:0014069;GO:0098793;GO:0045202;GO:0030234;GO:0019901;GO:0006887;GO:0061099;GO:0061098;GO:0030334;GO:0061001;GO:0034446;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:dendrite; C:postsynaptic density; C:presynapse; C:synapse;, F:enzyme regulator activity; F:protein kinase binding;, P:exocytosis; P:negative regulation of protein tyrosine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:substrate adhesion-dependent cell spreading;|Q9C0H9 Q75T46 Q8N4W8,SRC kinase signaling inhibitor 1 {ECO:0000305},SNAP-25-interacting protein;p130Cas-associated protein;p140Cap;, PF03915;, GO:0015629;GO:0030424;GO:0005737;GO:0030425;GO:0014069;GO:0098793;GO:0045202;GO:0030234;GO:0019901;GO:0006887;GO:0061099;GO:0061098;GO:0030334;GO:0061001;GO:0034446;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:dendrite; C:postsynaptic density; C:presynapse; C:synapse;, F:enzyme regulator activity; F:protein kinase binding;, P:exocytosis; P:negative regulation of protein tyrosine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:substrate adhesion-dependent cell spreading;|Q9C0H9 Q75T46 Q8N4W8,SRC kinase signaling inhibitor 1 {ECO:0000305},SNAP-25-interacting protein;p130Cas-associated protein;p140Cap;, PF03915;, GO:0015629;GO:0030424;GO:0005737;GO:0030425;GO:0014069;GO:0098793;GO:0045202;GO:0030234;GO:0019901;GO:0006887;GO:0061099;GO:0061098;GO:0030334;GO:0061001;GO:0034446;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:dendrite; C:postsynaptic density; C:presynapse; C:synapse;, F:enzyme regulator activity; F:protein kinase binding;, P:exocytosis; P:negative regulation of protein tyrosine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:substrate adhesion-dependent cell spreading;|Q9C0H9 Q75T46 Q8N4W8,SRC kinase signaling inhibitor 1 {ECO:0000305},SNAP-25-interacting protein;p130Cas-associated protein;p140Cap;, PF03915;, GO:0015629;GO:0030424;GO:0005737;GO:0030425;GO:0014069;GO:0098793;GO:0045202;GO:0030234;GO:0019901;GO:0006887;GO:0061099;GO:0061098;GO:0030334;GO:0061001;GO:0034446;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:dendrite; C:postsynaptic density; C:presynapse; C:synapse;, F:enzyme regulator activity; F:protein kinase binding;, P:exocytosis; P:negative regulation of protein tyrosine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:substrate adhesion-dependent cell spreading;|Q9C0H9 Q75T46 Q8N4W8,SRC kinase signaling inhibitor 1 {ECO:0000305},SNAP-25-interacting protein;p130Cas-associated protein;p140Cap;, PF03915;, GO:0015629;GO:0030424;GO:0005737;GO:0030425;GO:0014069;GO:0098793;GO:0045202;GO:0030234;GO:0019901;GO:0006887;GO:0061099;GO:0061098;GO:0030334;GO:0061001;GO:0034446;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:dendrite; C:postsynaptic density; C:presynapse; C:synapse;, F:enzyme regulator activity; F:protein kinase binding;, P:exocytosis; P:negative regulation of protein tyrosine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:substrate adhesion-dependent cell spreading;|Q9C0H9 Q75T46 Q8N4W8,SRC kinase signaling inhibitor 1 {ECO:0000305},SNAP-25-interacting protein;p130Cas-associated protein;p140Cap;, PF03915;, GO:0015629;GO:0030424;GO:0005737;GO:0030425;GO:0014069;GO:0098793;GO:0045202;GO:0030234;GO:0019901;GO:0006887;GO:0061099;GO:0061098;GO:0030334;GO:0061001;GO:0034446;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:dendrite; C:postsynaptic density; C:presynapse; C:synapse;, F:enzyme regulator activity; F:protein kinase binding;, P:exocytosis; P:negative regulation of protein tyrosine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:substrate adhesion-dependent cell spreading;|Q9C0H9 Q75T46 Q8N4W8,SRC kinase signaling inhibitor 1 {ECO:0000305},SNAP-25-interacting protein;p130Cas-associated protein;p140Cap;, PF03915;, GO:0015629;GO:0030424;GO:0005737;GO:0030425;GO:0014069;GO:0098793;GO:0045202;GO:0030234;GO:0019901;GO:0006887;GO:0061099;GO:0061098;GO:0030334;GO:0061001;GO:0034446;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:dendrite; C:postsynaptic density; C:presynapse; C:synapse;, F:enzyme regulator activity; F:protein kinase binding;, P:exocytosis; P:negative regulation of protein tyrosine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:substrate adhesion-dependent cell spreading; scaffold54 indexed_genome mRNA 1448044 1449403 . + . ID=transcript_9890;Q9P227,Rho GTPase-activating protein 23,Rho-type GTPase-activating protein 23;, PF17820;PF15410;PF00620;, GO:0005829;GO:0070062;GO:0005096;GO:0051056;GO:0007165;, C:cytosol; C:extracellular exosome;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold54 indexed_genome mRNA 1470079 1522400 . + . ID=transcript_9891;Q9P227,Rho GTPase-activating protein 23,Rho-type GTPase-activating protein 23;, PF17820;PF15410;PF00620;, GO:0005829;GO:0070062;GO:0005096;GO:0051056;GO:0007165;, C:cytosol; C:extracellular exosome;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9P227,Rho GTPase-activating protein 23,Rho-type GTPase-activating protein 23;, PF17820;PF15410;PF00620;, GO:0005829;GO:0070062;GO:0005096;GO:0051056;GO:0007165;, C:cytosol; C:extracellular exosome;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9P227,Rho GTPase-activating protein 23,Rho-type GTPase-activating protein 23;, PF17820;PF15410;PF00620;, GO:0005829;GO:0070062;GO:0005096;GO:0051056;GO:0007165;, C:cytosol; C:extracellular exosome;, F:GTPase activator activity;, P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold54 indexed_genome mRNA 1543907 1560491 . - . ID=transcript_9892;O14512 A2VCU2 Q0IJ63,Suppressor of cytokine signaling 7,Nck, Ash and phospholipase C gamma-binding protein;Nck-associated protein 4;, PF00017;PF07525;, GO:0005829;GO:0005634;GO:0005942;GO:0005886;GO:0046935;GO:0017124;GO:0035556;GO:0009968;GO:0046854;GO:0016567;GO:0040008;, C:cytosol; C:nucleus; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:SH3 domain binding;, P:intracellular signal transduction; P:negative regulation of signal transduction; P:phosphatidylinositol phosphorylation; P:protein ubiquitination; P:regulation of growth; scaffold54 indexed_genome mRNA 1599615 1617223 . - . ID=transcript_9893;Q9BRJ2 A1L436 Q6ZMJ5,39S ribosomal protein L45, mitochondrial,Mitochondrial large ribosomal subunit protein mL45 {ECO:0000303|PubMed:25278503};, PF04280;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q9BRJ2 A1L436 Q6ZMJ5,39S ribosomal protein L45, mitochondrial,Mitochondrial large ribosomal subunit protein mL45 {ECO:0000303|PubMed:25278503};, PF04280;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold54 indexed_genome mRNA 1725785 1727731 . + . ID=transcript_9894;P55786 B7Z463 Q6P145 Q9NP16 Q9UEM2,Puromycin-sensitive aminopeptidase,Cytosol alanyl aminopeptidase;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0070006;GO:0042277;GO:0008270;GO:0071456;GO:0043171;GO:1903955;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:peptide binding; F:zinc ion binding;, P:cellular response to hypoxia; P:peptide catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein polyubiquitination; P:proteolysis;|P55786 B7Z463 Q6P145 Q9NP16 Q9UEM2,Puromycin-sensitive aminopeptidase,Cytosol alanyl aminopeptidase;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0070006;GO:0042277;GO:0008270;GO:0071456;GO:0043171;GO:1903955;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:peptide binding; F:zinc ion binding;, P:cellular response to hypoxia; P:peptide catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein polyubiquitination; P:proteolysis; scaffold54 indexed_genome mRNA 1737020 1738097 . - . ID=transcript_9895;P55786 B7Z463 Q6P145 Q9NP16 Q9UEM2,Puromycin-sensitive aminopeptidase,Cytosol alanyl aminopeptidase;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0070006;GO:0042277;GO:0008270;GO:0071456;GO:0043171;GO:1903955;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:peptide binding; F:zinc ion binding;, P:cellular response to hypoxia; P:peptide catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein polyubiquitination; P:proteolysis; scaffold54 indexed_genome mRNA 1746780 1754798 . + . ID=transcript_9896;P55786 B7Z463 Q6P145 Q9NP16 Q9UEM2,Puromycin-sensitive aminopeptidase,Cytosol alanyl aminopeptidase;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0070006;GO:0042277;GO:0008270;GO:0071456;GO:0043171;GO:1903955;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:peptide binding; F:zinc ion binding;, P:cellular response to hypoxia; P:peptide catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein polyubiquitination; P:proteolysis;|P55786 B7Z463 Q6P145 Q9NP16 Q9UEM2,Puromycin-sensitive aminopeptidase,Cytosol alanyl aminopeptidase;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0070006;GO:0042277;GO:0008270;GO:0071456;GO:0043171;GO:1903955;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:peptide binding; F:zinc ion binding;, P:cellular response to hypoxia; P:peptide catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein polyubiquitination; P:proteolysis;|P55786 B7Z463 Q6P145 Q9NP16 Q9UEM2,Puromycin-sensitive aminopeptidase,Cytosol alanyl aminopeptidase;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0070006;GO:0042277;GO:0008270;GO:0071456;GO:0043171;GO:1903955;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:peptide binding; F:zinc ion binding;, P:cellular response to hypoxia; P:peptide catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein polyubiquitination; P:proteolysis;|P55786 B7Z463 Q6P145 Q9NP16 Q9UEM2,Puromycin-sensitive aminopeptidase,Cytosol alanyl aminopeptidase;, PF11838;PF01433;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0004177;GO:0070006;GO:0042277;GO:0008270;GO:0071456;GO:0043171;GO:1903955;GO:0000209;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:peptide binding; F:zinc ion binding;, P:cellular response to hypoxia; P:peptide catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein polyubiquitination; P:proteolysis; scaffold54 indexed_genome mRNA 1758035 1758666 . - . ID=transcript_9897;Q9P0U1 O95939,Mitochondrial import receptor subunit TOM7 homolog,Translocase of outer membrane 7 kDa subunit homolog;, PF08038;, GO:0016021;GO:0005741;GO:0005742;GO:0005739;GO:0008320;GO:0016236;GO:0098779;GO:1903955;GO:0030150;GO:0006626;GO:0031647;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:protein transmembrane transporter activity;, P:macroautophagy; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein targeting to mitochondrion; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:regulation of protein stability; scaffold54 indexed_genome mRNA 1783669 1805543 . + . ID=transcript_9898;Q14974 B7ZAV6 D3DTT3 Q14637 Q53XN2 Q96J27,Importin subunit beta-1,Importin-90;Karyopherin subunit beta-1;Nuclear factor p97;Pore targeting complex 97 kDa subunit;, PF03810;, GO:0005737;GO:0010494;GO:0005829;GO:0071782;GO:0070062;GO:0005576;GO:1904813;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0035580;GO:0019899;GO:0061608;GO:0008139;GO:0019904;GO:0003723;GO:0031267;GO:0008270;GO:0006309;GO:0030953;GO:0040001;GO:0045184;GO:0075733;GO:0007079;GO:0007080;GO:0007084;GO:0090307;GO:0019054;GO:0043312;GO:0006607;GO:0006606;GO:0031291;GO:0045540;GO:0006610;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:endoplasmic reticulum tubular network; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:specific granule lumen;, F:enzyme binding; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:protein domain specific binding; F:RNA binding; F:small GTPase binding; F:zinc ion binding;, P:apoptotic DNA fragmentation; P:astral microtubule organization; P:establishment of mitotic spindle localization; P:establishment of protein localization; P:intracellular transport of virus; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:mitotic spindle assembly; P:modulation by virus of host cellular process; P:neutrophil degranulation; P:NLS-bearing protein import into nucleus; P:protein import into nucleus; P:Ran protein signal transduction; P:regulation of cholesterol biosynthetic process; P:ribosomal protein import into nucleus;|Q14974 B7ZAV6 D3DTT3 Q14637 Q53XN2 Q96J27,Importin subunit beta-1,Importin-90;Karyopherin subunit beta-1;Nuclear factor p97;Pore targeting complex 97 kDa subunit;, PF03810;, GO:0005737;GO:0010494;GO:0005829;GO:0071782;GO:0070062;GO:0005576;GO:1904813;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0035580;GO:0019899;GO:0061608;GO:0008139;GO:0019904;GO:0003723;GO:0031267;GO:0008270;GO:0006309;GO:0030953;GO:0040001;GO:0045184;GO:0075733;GO:0007079;GO:0007080;GO:0007084;GO:0090307;GO:0019054;GO:0043312;GO:0006607;GO:0006606;GO:0031291;GO:0045540;GO:0006610;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:endoplasmic reticulum tubular network; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:specific granule lumen;, F:enzyme binding; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:protein domain specific binding; F:RNA binding; F:small GTPase binding; F:zinc ion binding;, P:apoptotic DNA fragmentation; P:astral microtubule organization; P:establishment of mitotic spindle localization; P:establishment of protein localization; P:intracellular transport of virus; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:mitotic spindle assembly; P:modulation by virus of host cellular process; P:neutrophil degranulation; P:NLS-bearing protein import into nucleus; P:protein import into nucleus; P:Ran protein signal transduction; P:regulation of cholesterol biosynthetic process; P:ribosomal protein import into nucleus;|Q14974 B7ZAV6 D3DTT3 Q14637 Q53XN2 Q96J27,Importin subunit beta-1,Importin-90;Karyopherin subunit beta-1;Nuclear factor p97;Pore targeting complex 97 kDa subunit;, PF03810;, GO:0005737;GO:0010494;GO:0005829;GO:0071782;GO:0070062;GO:0005576;GO:1904813;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0035580;GO:0019899;GO:0061608;GO:0008139;GO:0019904;GO:0003723;GO:0031267;GO:0008270;GO:0006309;GO:0030953;GO:0040001;GO:0045184;GO:0075733;GO:0007079;GO:0007080;GO:0007084;GO:0090307;GO:0019054;GO:0043312;GO:0006607;GO:0006606;GO:0031291;GO:0045540;GO:0006610;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:endoplasmic reticulum tubular network; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:specific granule lumen;, F:enzyme binding; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:protein domain specific binding; F:RNA binding; F:small GTPase binding; F:zinc ion binding;, P:apoptotic DNA fragmentation; P:astral microtubule organization; P:establishment of mitotic spindle localization; P:establishment of protein localization; P:intracellular transport of virus; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:mitotic spindle assembly; P:modulation by virus of host cellular process; P:neutrophil degranulation; P:NLS-bearing protein import into nucleus; P:protein import into nucleus; P:Ran protein signal transduction; P:regulation of cholesterol biosynthetic process; P:ribosomal protein import into nucleus; scaffold54 indexed_genome mRNA 1819429 1836667 . + . ID=transcript_9899;A7MCY6 B2RZG6 O94873 Q14DW3,TANK-binding kinase 1-binding protein 1,, PF12845;, GO:0005737;GO:0046872;GO:0007249;GO:0045087;GO:0016032;, C:cytoplasm;, F:metal ion binding;, P:I-kappaB kinase/NF-kappaB signaling; P:innate immune response; P:viral process;|A7MCY6 B2RZG6 O94873 Q14DW3,TANK-binding kinase 1-binding protein 1,, PF12845;, GO:0005737;GO:0046872;GO:0007249;GO:0045087;GO:0016032;, C:cytoplasm;, F:metal ion binding;, P:I-kappaB kinase/NF-kappaB signaling; P:innate immune response; P:viral process;|A7MCY6 B2RZG6 O94873 Q14DW3,TANK-binding kinase 1-binding protein 1,, PF12845;, GO:0005737;GO:0046872;GO:0007249;GO:0045087;GO:0016032;, C:cytoplasm;, F:metal ion binding;, P:I-kappaB kinase/NF-kappaB signaling; P:innate immune response; P:viral process; scaffold54 indexed_genome mRNA 1865839 1866642 . + . ID=transcript_9900;Q9UL17,T-box transcription factor TBX21,T-cell-specific T-box transcription factor T-bet;Transcription factor TBLYM;, PF00907;, GO:0043025;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0001708;GO:0071310;GO:0001947;GO:0072676;GO:0007275;GO:0032703;GO:2000320;GO:2000329;GO:2000552;GO:0000122;GO:0045892;GO:0048304;GO:0045893;GO:0043161;GO:0045580;GO:0006357;GO:0006355;GO:0009615;GO:0030217;, C:neuronal cell body; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell fate specification; P:cellular response to organic substance; P:heart looping; P:lymphocyte migration; P:multicellular organism development; P:negative regulation of interleukin-2 production; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of T-helper 17 cell lineage commitment; P:negative regulation of T-helper 2 cell cytokine production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of T cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to virus; P:T cell differentiation; scaffold54 indexed_genome mRNA 1938706 1947168 . - . ID=transcript_9901;Q9BZF2 D3DTT6 Q6PIV6,Oxysterol-binding protein-related protein 7,, PF01237;PF15409;, GO:0005776;GO:0005829;GO:0005789;GO:0043231;GO:0016020;GO:0005654;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0071397;GO:1901800;GO:0010506;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cellular response to cholesterol; P:positive regulation of proteasomal protein catabolic process; P:regulation of autophagy;|Q9BZF2 D3DTT6 Q6PIV6,Oxysterol-binding protein-related protein 7,, PF01237;PF15409;, GO:0005776;GO:0005829;GO:0005789;GO:0043231;GO:0016020;GO:0005654;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0071397;GO:1901800;GO:0010506;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cellular response to cholesterol; P:positive regulation of proteasomal protein catabolic process; P:regulation of autophagy;|Q9BZF2 D3DTT6 Q6PIV6,Oxysterol-binding protein-related protein 7,, PF01237;PF15409;, GO:0005776;GO:0005829;GO:0005789;GO:0043231;GO:0016020;GO:0005654;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0071397;GO:1901800;GO:0010506;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cellular response to cholesterol; P:positive regulation of proteasomal protein catabolic process; P:regulation of autophagy;|Q9BZF2 D3DTT6 Q6PIV6,Oxysterol-binding protein-related protein 7,, PF01237;PF15409;, GO:0005776;GO:0005829;GO:0005789;GO:0043231;GO:0016020;GO:0005654;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0071397;GO:1901800;GO:0010506;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cellular response to cholesterol; P:positive regulation of proteasomal protein catabolic process; P:regulation of autophagy;|Q9BZF2 D3DTT6 Q6PIV6,Oxysterol-binding protein-related protein 7,, PF01237;PF15409;, GO:0005776;GO:0005829;GO:0005789;GO:0043231;GO:0016020;GO:0005654;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0071397;GO:1901800;GO:0010506;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cellular response to cholesterol; P:positive regulation of proteasomal protein catabolic process; P:regulation of autophagy;|Q9BZF2 D3DTT6 Q6PIV6,Oxysterol-binding protein-related protein 7,, PF01237;PF15409;, GO:0005776;GO:0005829;GO:0005789;GO:0043231;GO:0016020;GO:0005654;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0071397;GO:1901800;GO:0010506;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cellular response to cholesterol; P:positive regulation of proteasomal protein catabolic process; P:regulation of autophagy; scaffold54 indexed_genome mRNA 1947180 1950559 . - . ID=transcript_9902;Q9BZF2 D3DTT6 Q6PIV6,Oxysterol-binding protein-related protein 7,, PF01237;PF15409;, GO:0005776;GO:0005829;GO:0005789;GO:0043231;GO:0016020;GO:0005654;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0071397;GO:1901800;GO:0010506;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cellular response to cholesterol; P:positive regulation of proteasomal protein catabolic process; P:regulation of autophagy;|Q9BZF2 D3DTT6 Q6PIV6,Oxysterol-binding protein-related protein 7,, PF01237;PF15409;, GO:0005776;GO:0005829;GO:0005789;GO:0043231;GO:0016020;GO:0005654;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0071397;GO:1901800;GO:0010506;, C:autophagosome; C:cytosol; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cellular response to cholesterol; P:positive regulation of proteasomal protein catabolic process; P:regulation of autophagy; scaffold54 indexed_genome mRNA 1952196 1957931 . - . ID=transcript_9903;Q7Z7H8 A6NGJ4 Q96B80 Q96Q55,39S ribosomal protein L10, mitochondrial,39S ribosomal protein L8, mitochondrial;Mitochondrial large ribosomal subunit protein uL10m {ECO:0000303|PubMed:25278503};, PF00466;, GO:0015934;GO:0005743;GO:0005762;GO:0005739;GO:0005654;GO:1990904;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0042254;GO:0006412;, C:large ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion; C:nucleoplasm; C:ribonucleoprotein complex;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosome biogenesis; P:translation; scaffold54 indexed_genome mRNA 1958519 1959530 . - . ID=transcript_9904;Q96FV0 A8K9Q0,Leucine-rich repeat-containing protein 46,, PF13855; scaffold54 indexed_genome mRNA 1963037 1964762 . - . ID=transcript_9905;Q96FV2 A8K3N1 B7Z8S7 E9PBV5 Q96AC3 Q9BU04,Secernin-2,, PF03577;, GO:0070062;GO:0070004;GO:0016805;, C:extracellular exosome;, F:cysteine-type exopeptidase activity; F:dipeptidase activity; scaffold54 indexed_genome mRNA 1964907 1966770 . - . ID=transcript_9906;Q96FV2 A8K3N1 B7Z8S7 E9PBV5 Q96AC3 Q9BU04,Secernin-2,, PF03577;, GO:0070062;GO:0070004;GO:0016805;, C:extracellular exosome;, F:cysteine-type exopeptidase activity; F:dipeptidase activity;|Q96FV2 A8K3N1 B7Z8S7 E9PBV5 Q96AC3 Q9BU04,Secernin-2,, PF03577;, GO:0070062;GO:0070004;GO:0016805;, C:extracellular exosome;, F:cysteine-type exopeptidase activity; F:dipeptidase activity; scaffold54 indexed_genome mRNA 1973387 1974014 . + . ID=transcript_9907;Q3SY56 B3KXS4,Transcription factor Sp6,Krueppel-like factor 14;, PF00096;, GO:0000785;GO:0005829;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0042481;GO:0006357;, C:chromatin; C:cytosol; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of odontogenesis; P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 2024368 2049563 . + . ID=transcript_9908;Q02086 A6NK74,Transcription factor Sp2,, PF00096;, GO:0000785;GO:0005654;GO:0000981;GO:0001227;GO:0042826;GO:0046872;GO:0000978;GO:1990837;GO:0006955;GO:0035264;GO:0000122;GO:0006357;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:immune response; P:multicellular organism growth; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 2055935 2062226 . + . ID=transcript_9909;Q9NVS9 B4E0V0 B4E152 B4E1D7 D3DTT9,Pyridoxine-5'-phosphate oxidase,Pyridoxamine-phosphate oxidase;, PF10590;PF01243;, GO:0005829;GO:0010181;GO:0042803;GO:0030170;GO:0004733;GO:0042823;GO:0008615;GO:0042816;, C:cytosol;, F:FMN binding; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:pyridoxamine-phosphate oxidase activity;, P:pyridoxal phosphate biosynthetic process; P:pyridoxine biosynthetic process; P:vitamin B6 metabolic process; scaffold54 indexed_genome mRNA 2066140 2071890 . - . ID=transcript_9910;Q9BU68 D3DTU0,Proline-rich protein 15-like protein,Protein ATAD4;, PF15321; scaffold54 indexed_genome mRNA 2084257 2092894 . + . ID=transcript_9911;Q96JB5 B7Z6N4 D3DTU1 D3DTU2 F5H3I5 Q53FA2 Q9H3F8 Q9H8G0 Q9HBR9,CDK5 regulatory subunit-associated protein 3 {ECO:0000305},CDK5 activator-binding protein C53 {ECO:0000305|PubMed:10721722};LXXLL/leucine-zipper-containing ARF-binding protein {ECO:0000303|PubMed:20164180};Protein HSF-27 {ECO:0000312|EMBL:AAK69655.1};, PF05600;, GO:0005813;GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005730;GO:0005634;GO:0032991;GO:0030332;GO:0097371;GO:0051019;GO:0051059;GO:0019901;GO:0044389;GO:0030262;GO:0007420;GO:0008283;GO:0060318;GO:0030968;GO:0001889;GO:0007095;GO:0044818;GO:1903363;GO:0043407;GO:0032088;GO:0044387;GO:0001933;GO:0071901;GO:1900182;GO:0031398;GO:1901798;GO:0045944;GO:0071569;GO:0000079;GO:0007346;GO:0045664;GO:0010921;GO:0034976;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleus; C:protein-containing complex;, F:cyclin binding; F:MDM2/MDM4 family protein binding; F:mitogen-activated protein kinase binding; F:NF-kappaB binding; F:protein kinase binding; F:ubiquitin-like protein ligase binding;, P:apoptotic nuclear changes; P:brain development; P:cell population proliferation; P:definitive erythrocyte differentiation; P:endoplasmic reticulum unfolded protein response; P:liver development; P:mitotic G2 DNA damage checkpoint; P:mitotic G2/M transition checkpoint; P:negative regulation of cellular protein catabolic process; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:positive regulation of protein localization to nucleus; P:positive regulation of protein ubiquitination; P:positive regulation of signal transduction by p53 class mediator; P:positive regulation of transcription by RNA polymerase II; P:protein ufmylation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of mitotic cell cycle; P:regulation of neuron differentiation; P:regulation of phosphatase activity; P:response to endoplasmic reticulum stress; P:viral process;|Q96JB5 B7Z6N4 D3DTU1 D3DTU2 F5H3I5 Q53FA2 Q9H3F8 Q9H8G0 Q9HBR9,CDK5 regulatory subunit-associated protein 3 {ECO:0000305},CDK5 activator-binding protein C53 {ECO:0000305|PubMed:10721722};LXXLL/leucine-zipper-containing ARF-binding protein {ECO:0000303|PubMed:20164180};Protein HSF-27 {ECO:0000312|EMBL:AAK69655.1};, PF05600;, GO:0005813;GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005730;GO:0005634;GO:0032991;GO:0030332;GO:0097371;GO:0051019;GO:0051059;GO:0019901;GO:0044389;GO:0030262;GO:0007420;GO:0008283;GO:0060318;GO:0030968;GO:0001889;GO:0007095;GO:0044818;GO:1903363;GO:0043407;GO:0032088;GO:0044387;GO:0001933;GO:0071901;GO:1900182;GO:0031398;GO:1901798;GO:0045944;GO:0071569;GO:0000079;GO:0007346;GO:0045664;GO:0010921;GO:0034976;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleus; C:protein-containing complex;, F:cyclin binding; F:MDM2/MDM4 family protein binding; F:mitogen-activated protein kinase binding; F:NF-kappaB binding; F:protein kinase binding; F:ubiquitin-like protein ligase binding;, P:apoptotic nuclear changes; P:brain development; P:cell population proliferation; P:definitive erythrocyte differentiation; P:endoplasmic reticulum unfolded protein response; P:liver development; P:mitotic G2 DNA damage checkpoint; P:mitotic G2/M transition checkpoint; P:negative regulation of cellular protein catabolic process; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:positive regulation of protein localization to nucleus; P:positive regulation of protein ubiquitination; P:positive regulation of signal transduction by p53 class mediator; P:positive regulation of transcription by RNA polymerase II; P:protein ufmylation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of mitotic cell cycle; P:regulation of neuron differentiation; P:regulation of phosphatase activity; P:response to endoplasmic reticulum stress; P:viral process;|Q96JB5 B7Z6N4 D3DTU1 D3DTU2 F5H3I5 Q53FA2 Q9H3F8 Q9H8G0 Q9HBR9,CDK5 regulatory subunit-associated protein 3 {ECO:0000305},CDK5 activator-binding protein C53 {ECO:0000305|PubMed:10721722};LXXLL/leucine-zipper-containing ARF-binding protein {ECO:0000303|PubMed:20164180};Protein HSF-27 {ECO:0000312|EMBL:AAK69655.1};, PF05600;, GO:0005813;GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005730;GO:0005634;GO:0032991;GO:0030332;GO:0097371;GO:0051019;GO:0051059;GO:0019901;GO:0044389;GO:0030262;GO:0007420;GO:0008283;GO:0060318;GO:0030968;GO:0001889;GO:0007095;GO:0044818;GO:1903363;GO:0043407;GO:0032088;GO:0044387;GO:0001933;GO:0071901;GO:1900182;GO:0031398;GO:1901798;GO:0045944;GO:0071569;GO:0000079;GO:0007346;GO:0045664;GO:0010921;GO:0034976;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleus; C:protein-containing complex;, F:cyclin binding; F:MDM2/MDM4 family protein binding; F:mitogen-activated protein kinase binding; F:NF-kappaB binding; F:protein kinase binding; F:ubiquitin-like protein ligase binding;, P:apoptotic nuclear changes; P:brain development; P:cell population proliferation; P:definitive erythrocyte differentiation; P:endoplasmic reticulum unfolded protein response; P:liver development; P:mitotic G2 DNA damage checkpoint; P:mitotic G2/M transition checkpoint; P:negative regulation of cellular protein catabolic process; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:positive regulation of protein localization to nucleus; P:positive regulation of protein ubiquitination; P:positive regulation of signal transduction by p53 class mediator; P:positive regulation of transcription by RNA polymerase II; P:protein ufmylation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of mitotic cell cycle; P:regulation of neuron differentiation; P:regulation of phosphatase activity; P:response to endoplasmic reticulum stress; P:viral process;|Q96JB5 B7Z6N4 D3DTU1 D3DTU2 F5H3I5 Q53FA2 Q9H3F8 Q9H8G0 Q9HBR9,CDK5 regulatory subunit-associated protein 3 {ECO:0000305},CDK5 activator-binding protein C53 {ECO:0000305|PubMed:10721722};LXXLL/leucine-zipper-containing ARF-binding protein {ECO:0000303|PubMed:20164180};Protein HSF-27 {ECO:0000312|EMBL:AAK69655.1};, PF05600;, GO:0005813;GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005730;GO:0005634;GO:0032991;GO:0030332;GO:0097371;GO:0051019;GO:0051059;GO:0019901;GO:0044389;GO:0030262;GO:0007420;GO:0008283;GO:0060318;GO:0030968;GO:0001889;GO:0007095;GO:0044818;GO:1903363;GO:0043407;GO:0032088;GO:0044387;GO:0001933;GO:0071901;GO:1900182;GO:0031398;GO:1901798;GO:0045944;GO:0071569;GO:0000079;GO:0007346;GO:0045664;GO:0010921;GO:0034976;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleus; C:protein-containing complex;, F:cyclin binding; F:MDM2/MDM4 family protein binding; F:mitogen-activated protein kinase binding; F:NF-kappaB binding; F:protein kinase binding; F:ubiquitin-like protein ligase binding;, P:apoptotic nuclear changes; P:brain development; P:cell population proliferation; P:definitive erythrocyte differentiation; P:endoplasmic reticulum unfolded protein response; P:liver development; P:mitotic G2 DNA damage checkpoint; P:mitotic G2/M transition checkpoint; P:negative regulation of cellular protein catabolic process; P:negative regulation of MAP kinase activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:positive regulation of protein localization to nucleus; P:positive regulation of protein ubiquitination; P:positive regulation of signal transduction by p53 class mediator; P:positive regulation of transcription by RNA polymerase II; P:protein ufmylation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of mitotic cell cycle; P:regulation of neuron differentiation; P:regulation of phosphatase activity; P:response to endoplasmic reticulum stress; P:viral process; scaffold54 indexed_genome mRNA 2131145 2135205 . - . ID=transcript_9912;Q9P299,Coatomer subunit zeta-2,Zeta-2-coat protein;, PF01217;, GO:0005801;GO:0030126;GO:0005829;GO:0005789;GO:0033116;GO:0000139;GO:0030133;GO:0006888;GO:0006891;GO:0006886;GO:0006890;, C:cis-Golgi network; C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:transport vesicle;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold54 indexed_genome mRNA 2152144 2158383 . - . ID=transcript_9913;Q14494 D3DTU3 D3DTU5 Q12877 Q96FN6,Endoplasmic reticulum membrane sensor NFE2L1 {ECO:0000305},Locus control region-factor 1 {ECO:0000303|PubMed:8036168};Nuclear factor erythroid 2-related factor 1;Nuclear factor, erythroid derived 2, like 1;Protein NRF1, p120 form {ECO:0000303|PubMed:24448410};Transcription factor 11 {ECO:0000303|PubMed:8001966};, PF03131;, GO:0000785;GO:0005829;GO:0005789;GO:0030176;GO:0016021;GO:0005654;GO:0005634;GO:0015485;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0008289;GO:0046982;GO:0000978;GO:0009653;GO:0045454;GO:0071397;GO:0034599;GO:0042632;GO:0008203;GO:0006783;GO:0055088;GO:0000122;GO:0097201;GO:0036003;GO:1901329;GO:0006357;, C:chromatin; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:cholesterol binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:lipid binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell redox homeostasis; P:cellular response to cholesterol; P:cellular response to oxidative stress; P:cholesterol homeostasis; P:cholesterol metabolic process; P:heme biosynthetic process; P:lipid homeostasis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:regulation of odontoblast differentiation; P:regulation of transcription by RNA polymerase II;|Q14494 D3DTU3 D3DTU5 Q12877 Q96FN6,Endoplasmic reticulum membrane sensor NFE2L1 {ECO:0000305},Locus control region-factor 1 {ECO:0000303|PubMed:8036168};Nuclear factor erythroid 2-related factor 1;Nuclear factor, erythroid derived 2, like 1;Protein NRF1, p120 form {ECO:0000303|PubMed:24448410};Transcription factor 11 {ECO:0000303|PubMed:8001966};, PF03131;, GO:0000785;GO:0005829;GO:0005789;GO:0030176;GO:0016021;GO:0005654;GO:0005634;GO:0015485;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0008289;GO:0046982;GO:0000978;GO:0009653;GO:0045454;GO:0071397;GO:0034599;GO:0042632;GO:0008203;GO:0006783;GO:0055088;GO:0000122;GO:0097201;GO:0036003;GO:1901329;GO:0006357;, C:chromatin; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:cholesterol binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:lipid binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell redox homeostasis; P:cellular response to cholesterol; P:cellular response to oxidative stress; P:cholesterol homeostasis; P:cholesterol metabolic process; P:heme biosynthetic process; P:lipid homeostasis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:regulation of odontoblast differentiation; P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 2159213 2164482 . + . ID=transcript_9914;Q14494 D3DTU3 D3DTU5 Q12877 Q96FN6,Endoplasmic reticulum membrane sensor NFE2L1 {ECO:0000305},Locus control region-factor 1 {ECO:0000303|PubMed:8036168};Nuclear factor erythroid 2-related factor 1;Nuclear factor, erythroid derived 2, like 1;Protein NRF1, p120 form {ECO:0000303|PubMed:24448410};Transcription factor 11 {ECO:0000303|PubMed:8001966};, PF03131;, GO:0000785;GO:0005829;GO:0005789;GO:0030176;GO:0016021;GO:0005654;GO:0005634;GO:0015485;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0008289;GO:0046982;GO:0000978;GO:0009653;GO:0045454;GO:0071397;GO:0034599;GO:0042632;GO:0008203;GO:0006783;GO:0055088;GO:0000122;GO:0097201;GO:0036003;GO:1901329;GO:0006357;, C:chromatin; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:cholesterol binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:lipid binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell redox homeostasis; P:cellular response to cholesterol; P:cellular response to oxidative stress; P:cholesterol homeostasis; P:cholesterol metabolic process; P:heme biosynthetic process; P:lipid homeostasis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:regulation of odontoblast differentiation; P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 2170021 2189085 . - . ID=transcript_9915;P83916 P23197,Chromobox protein homolog 1,HP1Hsbeta;Heterochromatin protein 1 homolog beta;Heterochromatin protein p25;M31;Modifier 1 protein;p25beta;, PF00385;PF01393;, GO:0000785;GO:0010369;GO:0000775;GO:0000781;GO:0001939;GO:0000792;GO:0001940;GO:0005654;GO:0005634;GO:0005721;GO:0090734;GO:0005819;GO:0003682;GO:0019899;GO:1990226;GO:0042802;GO:0006974;GO:0045892;GO:0019058;, C:chromatin; C:chromocenter; C:chromosome, centromeric region; C:chromosome, telomeric region; C:female pronucleus; C:heterochromatin; C:male pronucleus; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:site of DNA damage; C:spindle;, F:chromatin binding; F:enzyme binding; F:histone methyltransferase binding; F:identical protein binding;, P:cellular response to DNA damage stimulus; P:negative regulation of transcription, DNA-templated; P:viral life cycle; scaffold54 indexed_genome mRNA 2200776 2209467 . + . ID=transcript_9916;Q9Y5W9 B3KRL6 B4DPY5 D3DTV0 Q53YC0 Q9H885,Sorting nexin-11,, PF00787;, GO:0005768;GO:0016020;GO:1901981;GO:0006886;GO:0016050;, C:endosome; C:membrane;, F:phosphatidylinositol phosphate binding;, P:intracellular protein transport; P:vesicle organization; scaffold54 indexed_genome mRNA 2219045 2437489 . - . ID=transcript_9917;Q86WV1 D3DTV1 O15268,Src kinase-associated phosphoprotein 1,Src family-associated phosphoprotein 1;Src kinase-associated phosphoprotein of 55 kDa;, PF00169;PF00018;, GO:0005911;GO:0005737;GO:0005829;GO:0001772;GO:0005654;GO:0005886;GO:0044853;GO:0042101;GO:0019901;GO:0019903;GO:0044877;GO:0042169;GO:0017124;GO:0002250;GO:0002821;GO:0033634;GO:0001954;GO:0034116;GO:0033625;GO:1903039;GO:0045944;GO:0045893;GO:0072659;GO:0050852;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:immunological synapse; C:nucleoplasm; C:plasma membrane; C:plasma membrane raft; C:T cell receptor complex;, F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:SH2 domain binding; F:SH3 domain binding;, P:adaptive immune response; P:positive regulation of adaptive immune response; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of cell-matrix adhesion; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of integrin activation; P:positive regulation of leukocyte cell-cell adhesion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:T cell receptor signaling pathway;|Q86WV1 D3DTV1 O15268,Src kinase-associated phosphoprotein 1,Src family-associated phosphoprotein 1;Src kinase-associated phosphoprotein of 55 kDa;, PF00169;PF00018;, GO:0005911;GO:0005737;GO:0005829;GO:0001772;GO:0005654;GO:0005886;GO:0044853;GO:0042101;GO:0019901;GO:0019903;GO:0044877;GO:0042169;GO:0017124;GO:0002250;GO:0002821;GO:0033634;GO:0001954;GO:0034116;GO:0033625;GO:1903039;GO:0045944;GO:0045893;GO:0072659;GO:0050852;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:immunological synapse; C:nucleoplasm; C:plasma membrane; C:plasma membrane raft; C:T cell receptor complex;, F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:SH2 domain binding; F:SH3 domain binding;, P:adaptive immune response; P:positive regulation of adaptive immune response; P:positive regulation of cell-cell adhesion mediated by integrin; P:positive regulation of cell-matrix adhesion; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of integrin activation; P:positive regulation of leukocyte cell-cell adhesion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:T cell receptor signaling pathway; scaffold54 indexed_genome mRNA 2628770 2629515 . - . ID=transcript_9918;P14652 P10913 P17485,Homeobox protein Hox-B2,Homeobox protein Hox-2.8;Homeobox protein Hox-2H;K8;, PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0009952;GO:0008015;GO:0009953;GO:0048704;GO:0021612;GO:0002011;GO:0007275;GO:0048857;GO:0045944;GO:0006357;GO:0021569;GO:0021570;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:blood circulation; P:dorsal/ventral pattern formation; P:embryonic skeletal system morphogenesis; P:facial nerve structural organization; P:morphogenesis of an epithelial sheet; P:multicellular organism development; P:neural nucleus development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:rhombomere 3 development; P:rhombomere 4 development; scaffold54 indexed_genome mRNA 2630614 2638870 . + . ID=transcript_9919;P14651 A8K567 B7Z5N8 B7Z5P8 B7ZAD0 D3DTV3 O95615 P17484,Homeobox protein Hox-B3,Homeobox protein Hox-2.7;Homeobox protein Hox-2G;, PF13293;PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0001525;GO:0009952;GO:0051216;GO:0060216;GO:0048704;GO:0060324;GO:0021615;GO:0002244;GO:0000122;GO:0045944;GO:0050767;GO:0006357;GO:0021546;GO:0030878;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:anterior/posterior pattern specification; P:cartilage development; P:definitive hemopoiesis; P:embryonic skeletal system morphogenesis; P:face development; P:glossopharyngeal nerve morphogenesis; P:hematopoietic progenitor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:rhombomere development; P:thyroid gland development;|P14651 A8K567 B7Z5N8 B7Z5P8 B7ZAD0 D3DTV3 O95615 P17484,Homeobox protein Hox-B3,Homeobox protein Hox-2.7;Homeobox protein Hox-2G;, PF13293;PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0001525;GO:0009952;GO:0051216;GO:0060216;GO:0048704;GO:0060324;GO:0021615;GO:0002244;GO:0000122;GO:0045944;GO:0050767;GO:0006357;GO:0021546;GO:0030878;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:anterior/posterior pattern specification; P:cartilage development; P:definitive hemopoiesis; P:embryonic skeletal system morphogenesis; P:face development; P:glossopharyngeal nerve morphogenesis; P:hematopoietic progenitor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:rhombomere development; P:thyroid gland development;|P14651 A8K567 B7Z5N8 B7Z5P8 B7ZAD0 D3DTV3 O95615 P17484,Homeobox protein Hox-B3,Homeobox protein Hox-2.7;Homeobox protein Hox-2G;, PF13293;PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0001525;GO:0009952;GO:0051216;GO:0060216;GO:0048704;GO:0060324;GO:0021615;GO:0002244;GO:0000122;GO:0045944;GO:0050767;GO:0006357;GO:0021546;GO:0030878;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:anterior/posterior pattern specification; P:cartilage development; P:definitive hemopoiesis; P:embryonic skeletal system morphogenesis; P:face development; P:glossopharyngeal nerve morphogenesis; P:hematopoietic progenitor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:rhombomere development; P:thyroid gland development; scaffold54 indexed_genome mRNA 2677083 2678458 . - . ID=transcript_9920;P09067 B2RC69 P09069 Q17RP4,Homeobox protein Hox-B5,Homeobox protein HHO.C10;Homeobox protein Hox-2A;Homeobox protein Hu-1;, PF00046;, GO:0000785;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0009653;GO:0009952;GO:0048704;GO:0045446;GO:0006357;, C:chromatin; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anatomical structure morphogenesis; P:anterior/posterior pattern specification; P:embryonic skeletal system morphogenesis; P:endothelial cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 2680400 2681256 . - . ID=transcript_9921;P17509 A8K835 D3DTV5 P09068 Q9HB11 Q9UGH2,Homeobox protein Hox-B6,Homeobox protein Hox-2.2;Homeobox protein Hox-2B;Homeobox protein Hu-2;, PF00046;, GO:0000785;GO:0005634;GO:0000981;GO:0003723;GO:0000978;GO:1990837;GO:0009952;GO:0048704;GO:0034101;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:embryonic skeletal system morphogenesis; P:erythrocyte homeostasis; P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 2805455 2807936 . - . ID=transcript_9922;Q0VD86 Q6J273 Q6PKN9,Protein INCA1,Inhibitor of CDK interacting with cyclin A1;, PF15142;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0030332;GO:0004861;GO:0042802;GO:0044877;GO:0008285;GO:0045736;GO:2001235;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:identical protein binding; F:protein-containing complex binding;, P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of apoptotic signaling pathway; scaffold54 indexed_genome mRNA 2808530 2809248 . + . ID=transcript_9923;Q0VD86 Q6J273 Q6PKN9,Protein INCA1,Inhibitor of CDK interacting with cyclin A1;, PF15142;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0030332;GO:0004861;GO:0042802;GO:0044877;GO:0008285;GO:0045736;GO:2001235;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:identical protein binding; F:protein-containing complex binding;, P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of apoptotic signaling pathway; scaffold54 indexed_genome mRNA 2879769 2904091 . + . ID=transcript_9924;Q53FQ5 Q53HB5 Q6IBN9 Q9BTF7,Calcium-binding and coiled-coil domain-containing protein 2,Antigen nuclear dot 52 kDa protein;Nuclear domain 10 protein NDP52 {ECO:0000305};Nuclear dot protein 52 {ECO:0000303|PubMed:9230084};, PF17751;, GO:0005776;GO:0000421;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0048471;GO:0016605;GO:0046872;GO:0042803;GO:1901098;GO:0034341;GO:0016032;GO:0098792;, C:autophagosome; C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:PML body;, F:metal ion binding; F:protein homodimerization activity;, P:positive regulation of autophagosome maturation; P:response to interferon-gamma; P:viral process; P:xenophagy;|Q53FQ5 Q53HB5 Q6IBN9 Q9BTF7,Calcium-binding and coiled-coil domain-containing protein 2,Antigen nuclear dot 52 kDa protein;Nuclear domain 10 protein NDP52 {ECO:0000305};Nuclear dot protein 52 {ECO:0000303|PubMed:9230084};, PF17751;, GO:0005776;GO:0000421;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0048471;GO:0016605;GO:0046872;GO:0042803;GO:1901098;GO:0034341;GO:0016032;GO:0098792;, C:autophagosome; C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:PML body;, F:metal ion binding; F:protein homodimerization activity;, P:positive regulation of autophagosome maturation; P:response to interferon-gamma; P:viral process; P:xenophagy;|Q53FQ5 Q53HB5 Q6IBN9 Q9BTF7,Calcium-binding and coiled-coil domain-containing protein 2,Antigen nuclear dot 52 kDa protein;Nuclear domain 10 protein NDP52 {ECO:0000305};Nuclear dot protein 52 {ECO:0000303|PubMed:9230084};, PF17751;, GO:0005776;GO:0000421;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0048471;GO:0016605;GO:0046872;GO:0042803;GO:1901098;GO:0034341;GO:0016032;GO:0098792;, C:autophagosome; C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:PML body;, F:metal ion binding; F:protein homodimerization activity;, P:positive regulation of autophagosome maturation; P:response to interferon-gamma; P:viral process; P:xenophagy;|Q53FQ5 Q53HB5 Q6IBN9 Q9BTF7,Calcium-binding and coiled-coil domain-containing protein 2,Antigen nuclear dot 52 kDa protein;Nuclear domain 10 protein NDP52 {ECO:0000305};Nuclear dot protein 52 {ECO:0000303|PubMed:9230084};, PF17751;, GO:0005776;GO:0000421;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0048471;GO:0016605;GO:0046872;GO:0042803;GO:1901098;GO:0034341;GO:0016032;GO:0098792;, C:autophagosome; C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:PML body;, F:metal ion binding; F:protein homodimerization activity;, P:positive regulation of autophagosome maturation; P:response to interferon-gamma; P:viral process; P:xenophagy;|Q53FQ5 Q53HB5 Q6IBN9 Q9BTF7,Calcium-binding and coiled-coil domain-containing protein 2,Antigen nuclear dot 52 kDa protein;Nuclear domain 10 protein NDP52 {ECO:0000305};Nuclear dot protein 52 {ECO:0000303|PubMed:9230084};, PF17751;, GO:0005776;GO:0000421;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0048471;GO:0016605;GO:0046872;GO:0042803;GO:1901098;GO:0034341;GO:0016032;GO:0098792;, C:autophagosome; C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:PML body;, F:metal ion binding; F:protein homodimerization activity;, P:positive regulation of autophagosome maturation; P:response to interferon-gamma; P:viral process; P:xenophagy;|Q53FQ5 Q53HB5 Q6IBN9 Q9BTF7,Calcium-binding and coiled-coil domain-containing protein 2,Antigen nuclear dot 52 kDa protein;Nuclear domain 10 protein NDP52 {ECO:0000305};Nuclear dot protein 52 {ECO:0000303|PubMed:9230084};, PF17751;, GO:0005776;GO:0000421;GO:0005737;GO:0031410;GO:0005856;GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0048471;GO:0016605;GO:0046872;GO:0042803;GO:1901098;GO:0034341;GO:0016032;GO:0098792;, C:autophagosome; C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:PML body;, F:metal ion binding; F:protein homodimerization activity;, P:positive regulation of autophagosome maturation; P:response to interferon-gamma; P:viral process; P:xenophagy; scaffold54 indexed_genome mRNA 2958798 2960832 . + . ID=transcript_9925;P05496,ATP synthase F(0) complex subunit C1, mitochondrial {ECO:0000305},ATP synthase lipid-binding protein;ATP synthase membrane subunit c locus 1 {ECO:0000312|HGNC:HGNC:841};ATP synthase proteolipid P1;ATP synthase proton-transporting mitochondrial F(0) complex subunit C1;ATPase protein 9;ATPase subunit c;, PF00137;, GO:0016021;GO:0005743;GO:0005753;GO:0000276;GO:0005739;GO:0045263;GO:0008289;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:mitochondrion; C:proton-transporting ATP synthase complex, coupling factor F(o);, F:lipid binding; F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport;|Q06055 B3KQQ6,ATP synthase F(0) complex subunit C2, mitochondrial {ECO:0000305},ATP synthase lipid-binding protein;ATP synthase membrane subunit c locus 2 {ECO:0000312|HGNC:HGNC:842};ATP synthase proteolipid P2;ATP synthase proton-transporting mitochondrial F(0) complex subunit C2;ATPase protein 9;ATPase subunit c;, PF00137;, GO:0016021;GO:0005741;GO:0000276;GO:0045263;GO:0008289;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:proton-transporting ATP synthase complex, coupling factor F(o);, F:lipid binding; F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; scaffold54 indexed_genome mRNA 2968345 2996428 . + . ID=transcript_9926;Q9H832 A6N8M6 A6NC60 Q7L354 Q8TCM4 Q9H893,Ubiquitin-conjugating enzyme E2 Z,E2 ubiquitin-conjugating enzyme Z;Uba6-specific E2 conjugating enzyme 1;Ubiquitin carrier protein Z;Ubiquitin-protein ligase Z;, PF00179;, GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004869;GO:0061631;GO:0006915;GO:0043066;GO:0043065;GO:0016567;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H832 A6N8M6 A6NC60 Q7L354 Q8TCM4 Q9H893,Ubiquitin-conjugating enzyme E2 Z,E2 ubiquitin-conjugating enzyme Z;Uba6-specific E2 conjugating enzyme 1;Ubiquitin carrier protein Z;Ubiquitin-protein ligase Z;, PF00179;, GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004869;GO:0061631;GO:0006915;GO:0043066;GO:0043065;GO:0016567;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H832 A6N8M6 A6NC60 Q7L354 Q8TCM4 Q9H893,Ubiquitin-conjugating enzyme E2 Z,E2 ubiquitin-conjugating enzyme Z;Uba6-specific E2 conjugating enzyme 1;Ubiquitin carrier protein Z;Ubiquitin-protein ligase Z;, PF00179;, GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004869;GO:0061631;GO:0006915;GO:0043066;GO:0043065;GO:0016567;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H832 A6N8M6 A6NC60 Q7L354 Q8TCM4 Q9H893,Ubiquitin-conjugating enzyme E2 Z,E2 ubiquitin-conjugating enzyme Z;Uba6-specific E2 conjugating enzyme 1;Ubiquitin carrier protein Z;Ubiquitin-protein ligase Z;, PF00179;, GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004869;GO:0061631;GO:0006915;GO:0043066;GO:0043065;GO:0016567;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96H20 Q8IXY3 Q9UN50,Vacuolar-sorting protein SNF8,ELL-associated protein of 30 kDa;ESCRT-II complex subunit VPS22;, PF04157;, GO:0005737;GO:0005829;GO:0010008;GO:0000814;GO:0070062;GO:0031902;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0055037;GO:0005667;GO:0016247;GO:0008022;GO:0042803;GO:0047485;GO:0008134;GO:0045022;GO:0032456;GO:0016197;GO:0016236;GO:0036258;GO:0071985;GO:1903543;GO:0010628;GO:0045732;GO:0043328;GO:0010797;GO:0042176;GO:0061635;GO:0006357;GO:1903772;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT II complex; C:extracellular exosome; C:late endosome membrane; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:transcription regulator complex;, F:channel regulator activity; F:protein C-terminus binding; F:protein homodimerization activity; F:protein N-terminus binding; F:transcription factor binding;, P:early endosome to late endosome transport; P:endocytic recycling; P:endosomal transport; P:macroautophagy; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein catabolic process; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:regulation of multivesicular body size involved in endosome transport; P:regulation of protein catabolic process; P:regulation of protein complex stability; P:regulation of transcription by RNA polymerase II; P:regulation of viral budding via host ESCRT complex;|Q96H20 Q8IXY3 Q9UN50,Vacuolar-sorting protein SNF8,ELL-associated protein of 30 kDa;ESCRT-II complex subunit VPS22;, PF04157;, GO:0005737;GO:0005829;GO:0010008;GO:0000814;GO:0070062;GO:0031902;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0055037;GO:0005667;GO:0016247;GO:0008022;GO:0042803;GO:0047485;GO:0008134;GO:0045022;GO:0032456;GO:0016197;GO:0016236;GO:0036258;GO:0071985;GO:1903543;GO:0010628;GO:0045732;GO:0043328;GO:0010797;GO:0042176;GO:0061635;GO:0006357;GO:1903772;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT II complex; C:extracellular exosome; C:late endosome membrane; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:transcription regulator complex;, F:channel regulator activity; F:protein C-terminus binding; F:protein homodimerization activity; F:protein N-terminus binding; F:transcription factor binding;, P:early endosome to late endosome transport; P:endocytic recycling; P:endosomal transport; P:macroautophagy; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein catabolic process; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:regulation of multivesicular body size involved in endosome transport; P:regulation of protein catabolic process; P:regulation of protein complex stability; P:regulation of transcription by RNA polymerase II; P:regulation of viral budding via host ESCRT complex;|Q96H20 Q8IXY3 Q9UN50,Vacuolar-sorting protein SNF8,ELL-associated protein of 30 kDa;ESCRT-II complex subunit VPS22;, PF04157;, GO:0005737;GO:0005829;GO:0010008;GO:0000814;GO:0070062;GO:0031902;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0055037;GO:0005667;GO:0016247;GO:0008022;GO:0042803;GO:0047485;GO:0008134;GO:0045022;GO:0032456;GO:0016197;GO:0016236;GO:0036258;GO:0071985;GO:1903543;GO:0010628;GO:0045732;GO:0043328;GO:0010797;GO:0042176;GO:0061635;GO:0006357;GO:1903772;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT II complex; C:extracellular exosome; C:late endosome membrane; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:transcription regulator complex;, F:channel regulator activity; F:protein C-terminus binding; F:protein homodimerization activity; F:protein N-terminus binding; F:transcription factor binding;, P:early endosome to late endosome transport; P:endocytic recycling; P:endosomal transport; P:macroautophagy; P:multivesicular body assembly; P:multivesicular body sorting pathway; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein catabolic process; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:regulation of multivesicular body size involved in endosome transport; P:regulation of protein catabolic process; P:regulation of protein complex stability; P:regulation of transcription by RNA polymerase II; P:regulation of viral budding via host ESCRT complex; scaffold54 indexed_genome mRNA 3133432 3197380 . + . ID=transcript_9927;Q8NHY0 B4DZE4 Q14CP1 Q86Y40,Beta-1,4 N-acetylgalactosaminyltransferase 2,Sd(a) beta-1,4-GalNAc transferase;UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase;, PF00535;, GO:0000139;GO:0030173;GO:0016021;GO:0008376;GO:0030259;GO:0022408;GO:0009312;GO:0018279;GO:0019276;GO:0006047;, C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity;, P:lipid glycosylation; P:negative regulation of cell-cell adhesion; P:oligosaccharide biosynthetic process; P:protein N-linked glycosylation via asparagine; P:UDP-N-acetylgalactosamine metabolic process; P:UDP-N-acetylglucosamine metabolic process; scaffold54 indexed_genome mRNA 3222217 3228563 . + . ID=transcript_9928;Q9P2A4 C9IZN8 Q9H0P6,ABI gene family member 3,New molecule including SH3;, PF07815;PF14604;, GO:0005737;GO:0043198;GO:0043197;GO:0030027;GO:0016020;GO:0014069;GO:0031209;GO:0051015;GO:0042802;GO:0017124;GO:0002357;GO:0010593;GO:1903077;GO:1900028;GO:2000774;GO:2000249;GO:0030334;GO:0061001;GO:0099151;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:lamellipodium; C:membrane; C:postsynaptic density; C:SCAR complex;, F:actin filament binding; F:identical protein binding; F:SH3 domain binding;, P:defense response to tumor cell; P:negative regulation of lamellipodium assembly; P:negative regulation of protein localization to plasma membrane; P:negative regulation of ruffle assembly; P:positive regulation of cellular senescence; P:regulation of actin cytoskeleton reorganization; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:regulation of postsynaptic density assembly;|Q9P2A4 C9IZN8 Q9H0P6,ABI gene family member 3,New molecule including SH3;, PF07815;PF14604;, GO:0005737;GO:0043198;GO:0043197;GO:0030027;GO:0016020;GO:0014069;GO:0031209;GO:0051015;GO:0042802;GO:0017124;GO:0002357;GO:0010593;GO:1903077;GO:1900028;GO:2000774;GO:2000249;GO:0030334;GO:0061001;GO:0099151;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:lamellipodium; C:membrane; C:postsynaptic density; C:SCAR complex;, F:actin filament binding; F:identical protein binding; F:SH3 domain binding;, P:defense response to tumor cell; P:negative regulation of lamellipodium assembly; P:negative regulation of protein localization to plasma membrane; P:negative regulation of ruffle assembly; P:positive regulation of cellular senescence; P:regulation of actin cytoskeleton reorganization; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:regulation of postsynaptic density assembly; scaffold54 indexed_genome mRNA 3230114 3231554 . + . ID=transcript_9929;Q9P2A4 C9IZN8 Q9H0P6,ABI gene family member 3,New molecule including SH3;, PF07815;PF14604;, GO:0005737;GO:0043198;GO:0043197;GO:0030027;GO:0016020;GO:0014069;GO:0031209;GO:0051015;GO:0042802;GO:0017124;GO:0002357;GO:0010593;GO:1903077;GO:1900028;GO:2000774;GO:2000249;GO:0030334;GO:0061001;GO:0099151;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:lamellipodium; C:membrane; C:postsynaptic density; C:SCAR complex;, F:actin filament binding; F:identical protein binding; F:SH3 domain binding;, P:defense response to tumor cell; P:negative regulation of lamellipodium assembly; P:negative regulation of protein localization to plasma membrane; P:negative regulation of ruffle assembly; P:positive regulation of cellular senescence; P:regulation of actin cytoskeleton reorganization; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:regulation of postsynaptic density assembly; scaffold54 indexed_genome mRNA 3231820 3238793 . - . ID=transcript_9930;Q8TCT1 E9PAM0 Q17RU6,Phosphoethanolamine/phosphocholine phosphatase,, PF06888;, GO:0005829;GO:0031012;GO:0065010;GO:0046872;GO:0016791;GO:0052731;GO:0052732;GO:0016462;GO:0035630;GO:0001958;GO:0006656;GO:0006646;GO:0030500;, C:cytosol; C:extracellular matrix; C:extracellular membrane-bounded organelle;, F:metal ion binding; F:phosphatase activity; F:phosphocholine phosphatase activity; F:phosphoethanolamine phosphatase activity; F:pyrophosphatase activity;, P:bone mineralization involved in bone maturation; P:endochondral ossification; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:regulation of bone mineralization; scaffold54 indexed_genome mRNA 3279172 3296698 . - . ID=transcript_9931;Q9Y2D9 A4QPD9 Q5H9Q0,Zinc finger protein 652,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9Y2D9 A4QPD9 Q5H9Q0,Zinc finger protein 652,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9Y2D9 A4QPD9 Q5H9Q0,Zinc finger protein 652,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9Y2D9 A4QPD9 Q5H9Q0,Zinc finger protein 652,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 3376584 3387119 . - . ID=transcript_9932;P35232 B4DY47 Q4VBQ0,Prohibitin {ECO:0000305},, PF01145;, GO:0009986;GO:0005737;GO:0005769;GO:0070062;GO:0031315;GO:0098891;GO:0098982;GO:0098978;GO:0005887;GO:0016020;GO:0030061;GO:0005743;GO:0035632;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0001850;GO:0001851;GO:0019899;GO:0042826;GO:0008022;GO:0046982;GO:0031871;GO:0003714;GO:0007202;GO:1990051;GO:0031100;GO:0140374;GO:0042113;GO:0023035;GO:0071354;GO:0071897;GO:0016575;GO:0006851;GO:0007005;GO:0044830;GO:0060766;GO:0043066;GO:0030308;GO:0008285;GO:0070373;GO:2000323;GO:0042177;GO:0010944;GO:0000122;GO:0045892;GO:0001649;GO:0001552;GO:0001541;GO:0010942;GO:0045917;GO:0070374;GO:0045745;GO:0010628;GO:0002639;GO:0032740;GO:1901224;GO:0051897;GO:0048661;GO:0045893;GO:0050847;GO:0050821;GO:0042981;GO:0006355;GO:0042493;GO:0045471;GO:0035902;GO:0043434;GO:0039529;GO:0007165;GO:0072538;GO:0046718;, C:cell surface; C:cytoplasm; C:early endosome; C:extracellular exosome; C:extrinsic component of mitochondrial outer membrane; C:extrinsic component of presynaptic active zone membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:membrane; C:mitochondrial crista; C:mitochondrial inner membrane; C:mitochondrial prohibitin complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:complement component C3a binding; F:complement component C3b binding; F:enzyme binding; F:histone deacetylase binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:proteinase activated receptor binding; F:transcription corepressor activity;, P:activation of phospholipase C activity; P:activation of protein kinase C activity; P:animal organ regeneration; P:antiviral innate immune response; P:B cell activation; P:CD40 signaling pathway; P:cellular response to interleukin-6; P:DNA biosynthetic process; P:histone deacetylation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrion organization; P:modulation by host of viral RNA genome replication; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of protein catabolic process; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoblast differentiation; P:ovarian follicle atresia; P:ovarian follicle development; P:positive regulation of cell death; P:positive regulation of complement activation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-17 production; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription, DNA-templated; P:progesterone receptor signaling pathway; P:protein stabilization; P:regulation of apoptotic process; P:regulation of transcription, DNA-templated; P:response to drug; P:response to ethanol; P:response to immobilization stress; P:response to peptide hormone; P:RIG-I signaling pathway; P:signal transduction; P:T-helper 17 type immune response; P:viral entry into host cell;|P35232 B4DY47 Q4VBQ0,Prohibitin {ECO:0000305},, PF01145;, GO:0009986;GO:0005737;GO:0005769;GO:0070062;GO:0031315;GO:0098891;GO:0098982;GO:0098978;GO:0005887;GO:0016020;GO:0030061;GO:0005743;GO:0035632;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0001850;GO:0001851;GO:0019899;GO:0042826;GO:0008022;GO:0046982;GO:0031871;GO:0003714;GO:0007202;GO:1990051;GO:0031100;GO:0140374;GO:0042113;GO:0023035;GO:0071354;GO:0071897;GO:0016575;GO:0006851;GO:0007005;GO:0044830;GO:0060766;GO:0043066;GO:0030308;GO:0008285;GO:0070373;GO:2000323;GO:0042177;GO:0010944;GO:0000122;GO:0045892;GO:0001649;GO:0001552;GO:0001541;GO:0010942;GO:0045917;GO:0070374;GO:0045745;GO:0010628;GO:0002639;GO:0032740;GO:1901224;GO:0051897;GO:0048661;GO:0045893;GO:0050847;GO:0050821;GO:0042981;GO:0006355;GO:0042493;GO:0045471;GO:0035902;GO:0043434;GO:0039529;GO:0007165;GO:0072538;GO:0046718;, C:cell surface; C:cytoplasm; C:early endosome; C:extracellular exosome; C:extrinsic component of mitochondrial outer membrane; C:extrinsic component of presynaptic active zone membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:membrane; C:mitochondrial crista; C:mitochondrial inner membrane; C:mitochondrial prohibitin complex; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:complement component C3a binding; F:complement component C3b binding; F:enzyme binding; F:histone deacetylase binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:proteinase activated receptor binding; F:transcription corepressor activity;, P:activation of phospholipase C activity; P:activation of protein kinase C activity; P:animal organ regeneration; P:antiviral innate immune response; P:B cell activation; P:CD40 signaling pathway; P:cellular response to interleukin-6; P:DNA biosynthetic process; P:histone deacetylation; P:mitochondrial calcium ion transmembrane transport; P:mitochondrion organization; P:modulation by host of viral RNA genome replication; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of protein catabolic process; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoblast differentiation; P:ovarian follicle atresia; P:ovarian follicle development; P:positive regulation of cell death; P:positive regulation of complement activation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-17 production; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription, DNA-templated; P:progesterone receptor signaling pathway; P:protein stabilization; P:regulation of apoptotic process; P:regulation of transcription, DNA-templated; P:response to drug; P:response to ethanol; P:response to immobilization stress; P:response to peptide hormone; P:RIG-I signaling pathway; P:signal transduction; P:T-helper 17 type immune response; P:viral entry into host cell; scaffold54 indexed_genome mRNA 3467676 3489037 . + . ID=transcript_9933;P08138 B2R961 B4E096,Tumor necrosis factor receptor superfamily member 16,Gp80-LNGFR;Low affinity neurotrophin receptor p75NTR;Low-affinity nerve growth factor receptor;p75 ICD;, PF00531;PF18422;PF00020;, GO:0009986;GO:0005911;GO:0005829;GO:0043197;GO:0005768;GO:0005576;GO:0030426;GO:0016021;GO:0005887;GO:0005654;GO:0043204;GO:0005886;GO:0014069;GO:0001540;GO:0005516;GO:0015026;GO:0005035;GO:0048406;GO:0043121;GO:0038023;GO:0031267;GO:0004888;GO:0031625;GO:0006919;GO:0007411;GO:0001678;GO:1904646;GO:0007417;GO:0032922;GO:0016048;GO:0035907;GO:0042593;GO:0031069;GO:0006886;GO:0031293;GO:0043066;GO:0050771;GO:1903588;GO:0043154;GO:0040037;GO:0051799;GO:0021675;GO:0051402;GO:0048011;GO:0043065;GO:2001235;GO:0050772;GO:0048146;GO:0042488;GO:1902895;GO:1900182;GO:0043281;GO:0007266;, C:cell surface; C:cell-cell junction; C:cytosol; C:dendritic spine; C:endosome; C:extracellular region; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:amyloid-beta binding; F:calmodulin binding; F:coreceptor activity; F:death receptor activity; F:nerve growth factor binding; F:neurotrophin binding; F:signaling receptor activity; F:small GTPase binding; F:transmembrane signaling receptor activity; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:axon guidance; P:cellular glucose homeostasis; P:cellular response to amyloid-beta; P:central nervous system development; P:circadian regulation of gene expression; P:detection of temperature stimulus; P:dorsal aorta development; P:glucose homeostasis; P:hair follicle morphogenesis; P:intracellular protein transport; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of axonogenesis; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of hair follicle development; P:nerve development; P:neuron apoptotic process; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of axonogenesis; P:positive regulation of fibroblast proliferation; P:positive regulation of odontogenesis of dentin-containing tooth; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein localization to nucleus; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:Rho protein signal transduction; scaffold54 indexed_genome mRNA 3542683 3546383 . + . ID=transcript_9934;O95157 Q8NDC3 Q8TBF6 Q9ULR1,Neurexophilin-3,, PF06312;, GO:0005576;GO:0005102;GO:0007218;, C:extracellular region;, F:signaling receptor binding;, P:neuropeptide signaling pathway; scaffold54 indexed_genome mRNA 3566269 3639859 . - . ID=transcript_9935;O43791 B2R6S3 D3DTW7 Q53HJ1,Speckle-type POZ protein {ECO:0000305},HIB homolog 1;Roadkill homolog 1;, PF00651;PF00917;, GO:0031463;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0031625;GO:0043161;GO:0000209;GO:0030162;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin protein ligase binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of proteolysis;|O43791 B2R6S3 D3DTW7 Q53HJ1,Speckle-type POZ protein {ECO:0000305},HIB homolog 1;Roadkill homolog 1;, PF00651;PF00917;, GO:0031463;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0031625;GO:0043161;GO:0000209;GO:0030162;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin protein ligase binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of proteolysis;|O43791 B2R6S3 D3DTW7 Q53HJ1,Speckle-type POZ protein {ECO:0000305},HIB homolog 1;Roadkill homolog 1;, PF00651;PF00917;, GO:0031463;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0031625;GO:0043161;GO:0000209;GO:0030162;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin protein ligase binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of proteolysis;|O43791 B2R6S3 D3DTW7 Q53HJ1,Speckle-type POZ protein {ECO:0000305},HIB homolog 1;Roadkill homolog 1;, PF00651;PF00917;, GO:0031463;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0031625;GO:0043161;GO:0000209;GO:0030162;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin protein ligase binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of proteolysis;|O43791 B2R6S3 D3DTW7 Q53HJ1,Speckle-type POZ protein {ECO:0000305},HIB homolog 1;Roadkill homolog 1;, PF00651;PF00917;, GO:0031463;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0031625;GO:0043161;GO:0000209;GO:0030162;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin protein ligase binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of proteolysis;|O43791 B2R6S3 D3DTW7 Q53HJ1,Speckle-type POZ protein {ECO:0000305},HIB homolog 1;Roadkill homolog 1;, PF00651;PF00917;, GO:0031463;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0031625;GO:0043161;GO:0000209;GO:0030162;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin protein ligase binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of proteolysis;|O43791 B2R6S3 D3DTW7 Q53HJ1,Speckle-type POZ protein {ECO:0000305},HIB homolog 1;Roadkill homolog 1;, PF00651;PF00917;, GO:0031463;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0031625;GO:0043161;GO:0000209;GO:0030162;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin protein ligase binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of proteolysis; scaffold54 indexed_genome mRNA 3661209 3664313 . - . ID=transcript_9936;P78383 B4DEC4 J3KQV4 Q96EW7,Solute carrier family 35 member B1,UDP-galactose transporter-related protein 1;, PF08449;, GO:0030176;GO:0030173;GO:0043231;GO:0022857;GO:0005459;GO:0005460;GO:0008643;GO:0072334;, C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle;, F:transmembrane transporter activity; F:UDP-galactose transmembrane transporter activity; F:UDP-glucose transmembrane transporter activity;, P:carbohydrate transport; P:UDP-galactose transmembrane transport;|P78383 B4DEC4 J3KQV4 Q96EW7,Solute carrier family 35 member B1,UDP-galactose transporter-related protein 1;, PF08449;, GO:0030176;GO:0030173;GO:0043231;GO:0022857;GO:0005459;GO:0005460;GO:0008643;GO:0072334;, C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle;, F:transmembrane transporter activity; F:UDP-galactose transmembrane transporter activity; F:UDP-glucose transmembrane transporter activity;, P:carbohydrate transport; P:UDP-galactose transmembrane transport; scaffold54 indexed_genome mRNA 3666273 3671724 . - . ID=transcript_9937;Q9C073 B7Z7Q3,Protein FAM117A,C/EBP-induced protein;, PF15388;|Q9C073 B7Z7Q3,Protein FAM117A,C/EBP-induced protein;, PF15388;|Q9C073 B7Z7Q3,Protein FAM117A,C/EBP-induced protein;, PF15388; scaffold54 indexed_genome mRNA 3671843 3714429 . - . ID=transcript_9938;Q9C073 B7Z7Q3,Protein FAM117A,C/EBP-induced protein;, PF15388;|Q9C073 B7Z7Q3,Protein FAM117A,C/EBP-induced protein;, PF15388; scaffold54 indexed_genome mRNA 3735128 3767107 . + . ID=transcript_9939;O95251 B3KN74 B4DF85 B4DFB4 B4DFE0 B4DGY4 E7ER15 G5E9K7,Histone acetyltransferase KAT7 {ECO:0000305},Histone acetyltransferase binding to ORC1 {ECO:0000303|PubMed:10438470, ECO:0000303|PubMed:10930412};Lysine acetyltransferase 7 {ECO:0000303|PubMed:31767635};MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2 {ECO:0000303|Ref.4};, PF01853;PF01530;PF17772;, GO:0005694;GO:0000775;GO:0005829;GO:0000123;GO:0036409;GO:0005654;GO:0005634;GO:0090734;GO:0003688;GO:0004402;GO:0042393;GO:0003712;GO:0008270;GO:0006281;GO:0006260;GO:0043966;GO:0044154;GO:0043967;GO:0043983;GO:0043981;GO:0043982;GO:0018393;GO:0001779;GO:0045892;GO:0045740;GO:0032786;GO:0045648;GO:1902035;GO:0090240;GO:1900182;GO:0045944;GO:0030174;GO:2000819;GO:0006355;GO:0072716;GO:0072739;GO:0072720;GO:0072710;GO:0072708;GO:0031098;, C:chromosome; C:chromosome, centromeric region; C:cytosol; C:histone acetyltransferase complex; C:histone H3-K14 acetyltransferase complex; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:DNA replication origin binding; F:histone acetyltransferase activity; F:histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:DNA repair; P:DNA replication; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H4 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:internal peptidyl-lysine acetylation; P:natural killer cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA replication; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of erythrocyte differentiation; P:positive regulation of hematopoietic stem cell proliferation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-dependent DNA replication initiation; P:regulation of nucleotide-excision repair; P:regulation of transcription, DNA-templated; P:response to actinomycin D; P:response to anisomycin; P:response to dithiothreitol; P:response to hydroxyurea; P:response to sorbitol; P:stress-activated protein kinase signaling cascade;|O95251 B3KN74 B4DF85 B4DFB4 B4DFE0 B4DGY4 E7ER15 G5E9K7,Histone acetyltransferase KAT7 {ECO:0000305},Histone acetyltransferase binding to ORC1 {ECO:0000303|PubMed:10438470, ECO:0000303|PubMed:10930412};Lysine acetyltransferase 7 {ECO:0000303|PubMed:31767635};MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2 {ECO:0000303|Ref.4};, PF01853;PF01530;PF17772;, GO:0005694;GO:0000775;GO:0005829;GO:0000123;GO:0036409;GO:0005654;GO:0005634;GO:0090734;GO:0003688;GO:0004402;GO:0042393;GO:0003712;GO:0008270;GO:0006281;GO:0006260;GO:0043966;GO:0044154;GO:0043967;GO:0043983;GO:0043981;GO:0043982;GO:0018393;GO:0001779;GO:0045892;GO:0045740;GO:0032786;GO:0045648;GO:1902035;GO:0090240;GO:1900182;GO:0045944;GO:0030174;GO:2000819;GO:0006355;GO:0072716;GO:0072739;GO:0072720;GO:0072710;GO:0072708;GO:0031098;, C:chromosome; C:chromosome, centromeric region; C:cytosol; C:histone acetyltransferase complex; C:histone H3-K14 acetyltransferase complex; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:DNA replication origin binding; F:histone acetyltransferase activity; F:histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:DNA repair; P:DNA replication; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H4 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:internal peptidyl-lysine acetylation; P:natural killer cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA replication; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of erythrocyte differentiation; P:positive regulation of hematopoietic stem cell proliferation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-dependent DNA replication initiation; P:regulation of nucleotide-excision repair; P:regulation of transcription, DNA-templated; P:response to actinomycin D; P:response to anisomycin; P:response to dithiothreitol; P:response to hydroxyurea; P:response to sorbitol; P:stress-activated protein kinase signaling cascade;|O95251 B3KN74 B4DF85 B4DFB4 B4DFE0 B4DGY4 E7ER15 G5E9K7,Histone acetyltransferase KAT7 {ECO:0000305},Histone acetyltransferase binding to ORC1 {ECO:0000303|PubMed:10438470, ECO:0000303|PubMed:10930412};Lysine acetyltransferase 7 {ECO:0000303|PubMed:31767635};MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2 {ECO:0000303|Ref.4};, PF01853;PF01530;PF17772;, GO:0005694;GO:0000775;GO:0005829;GO:0000123;GO:0036409;GO:0005654;GO:0005634;GO:0090734;GO:0003688;GO:0004402;GO:0042393;GO:0003712;GO:0008270;GO:0006281;GO:0006260;GO:0043966;GO:0044154;GO:0043967;GO:0043983;GO:0043981;GO:0043982;GO:0018393;GO:0001779;GO:0045892;GO:0045740;GO:0032786;GO:0045648;GO:1902035;GO:0090240;GO:1900182;GO:0045944;GO:0030174;GO:2000819;GO:0006355;GO:0072716;GO:0072739;GO:0072720;GO:0072710;GO:0072708;GO:0031098;, C:chromosome; C:chromosome, centromeric region; C:cytosol; C:histone acetyltransferase complex; C:histone H3-K14 acetyltransferase complex; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:DNA replication origin binding; F:histone acetyltransferase activity; F:histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:DNA repair; P:DNA replication; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H4 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:internal peptidyl-lysine acetylation; P:natural killer cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA replication; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of erythrocyte differentiation; P:positive regulation of hematopoietic stem cell proliferation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-dependent DNA replication initiation; P:regulation of nucleotide-excision repair; P:regulation of transcription, DNA-templated; P:response to actinomycin D; P:response to anisomycin; P:response to dithiothreitol; P:response to hydroxyurea; P:response to sorbitol; P:stress-activated protein kinase signaling cascade; scaffold54 indexed_genome mRNA 3767127 3769350 . - . ID=transcript_9940;O95251 B3KN74 B4DF85 B4DFB4 B4DFE0 B4DGY4 E7ER15 G5E9K7,Histone acetyltransferase KAT7 {ECO:0000305},Histone acetyltransferase binding to ORC1 {ECO:0000303|PubMed:10438470, ECO:0000303|PubMed:10930412};Lysine acetyltransferase 7 {ECO:0000303|PubMed:31767635};MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2 {ECO:0000303|Ref.4};, PF01853;PF01530;PF17772;, GO:0005694;GO:0000775;GO:0005829;GO:0000123;GO:0036409;GO:0005654;GO:0005634;GO:0090734;GO:0003688;GO:0004402;GO:0042393;GO:0003712;GO:0008270;GO:0006281;GO:0006260;GO:0043966;GO:0044154;GO:0043967;GO:0043983;GO:0043981;GO:0043982;GO:0018393;GO:0001779;GO:0045892;GO:0045740;GO:0032786;GO:0045648;GO:1902035;GO:0090240;GO:1900182;GO:0045944;GO:0030174;GO:2000819;GO:0006355;GO:0072716;GO:0072739;GO:0072720;GO:0072710;GO:0072708;GO:0031098;, C:chromosome; C:chromosome, centromeric region; C:cytosol; C:histone acetyltransferase complex; C:histone H3-K14 acetyltransferase complex; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:DNA replication origin binding; F:histone acetyltransferase activity; F:histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:DNA repair; P:DNA replication; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H4 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:internal peptidyl-lysine acetylation; P:natural killer cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA replication; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of erythrocyte differentiation; P:positive regulation of hematopoietic stem cell proliferation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-dependent DNA replication initiation; P:regulation of nucleotide-excision repair; P:regulation of transcription, DNA-templated; P:response to actinomycin D; P:response to anisomycin; P:response to dithiothreitol; P:response to hydroxyurea; P:response to sorbitol; P:stress-activated protein kinase signaling cascade; scaffold54 indexed_genome mRNA 3915467 3918433 . - . ID=transcript_9941;O60479 B3KQL6,Homeobox protein DLX-3,, PF12413;PF00046;, GO:0000785;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0001568;GO:0030154;GO:0030855;GO:0071895;GO:0042475;GO:0001890;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:blood vessel development; P:cell differentiation; P:epithelial cell differentiation; P:odontoblast differentiation; P:odontogenesis of dentin-containing tooth; P:placenta development; P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 3984041 4015152 . + . ID=transcript_9942;P26006 A7E246 B7ZM80 B9EGQ1 D3DTX4 D3DTX5,Integrin alpha-3,CD49 antigen-like family member C;FRP-2;Galactoprotein B3;VLA-3 subunit alpha;, PF01839;PF08441;, GO:0016323;GO:0071944;GO:0009986;GO:0060076;GO:0009897;GO:0070062;GO:0031527;GO:0005925;GO:1990812;GO:0034667;GO:0008305;GO:0048471;GO:0005886;GO:0043235;GO:0097060;GO:0005518;GO:0001968;GO:0005178;GO:0043236;GO:0046872;GO:0002020;GO:0019904;GO:0046982;GO:0007160;GO:0097062;GO:0035640;GO:0030198;GO:0007507;GO:0007229;GO:0050900;GO:0030324;GO:0060135;GO:0007613;GO:0048333;GO:0031345;GO:0035024;GO:0072006;GO:0001764;GO:0010811;GO:0010634;GO:0010628;GO:0010976;GO:1903078;GO:0030510;GO:0017015;GO:0030111;GO:0097205;GO:0042493;GO:0034698;GO:0043588;, C:basolateral plasma membrane; C:cell periphery; C:cell surface; C:excitatory synapse; C:external side of plasma membrane; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:growth cone filopodium; C:integrin alpha3-beta1 complex; C:integrin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:synaptic membrane;, F:collagen binding; F:fibronectin binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:protease binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell-matrix adhesion; P:dendritic spine maintenance; P:exploration behavior; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lung development; P:maternal process involved in female pregnancy; P:memory; P:mesodermal cell differentiation; P:negative regulation of cell projection organization; P:negative regulation of Rho protein signal transduction; P:nephron development; P:neuron migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of protein localization to plasma membrane; P:regulation of BMP signaling pathway; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of Wnt signaling pathway; P:renal filtration; P:response to drug; P:response to gonadotropin; P:skin development;|P26006 A7E246 B7ZM80 B9EGQ1 D3DTX4 D3DTX5,Integrin alpha-3,CD49 antigen-like family member C;FRP-2;Galactoprotein B3;VLA-3 subunit alpha;, PF01839;PF08441;, GO:0016323;GO:0071944;GO:0009986;GO:0060076;GO:0009897;GO:0070062;GO:0031527;GO:0005925;GO:1990812;GO:0034667;GO:0008305;GO:0048471;GO:0005886;GO:0043235;GO:0097060;GO:0005518;GO:0001968;GO:0005178;GO:0043236;GO:0046872;GO:0002020;GO:0019904;GO:0046982;GO:0007160;GO:0097062;GO:0035640;GO:0030198;GO:0007507;GO:0007229;GO:0050900;GO:0030324;GO:0060135;GO:0007613;GO:0048333;GO:0031345;GO:0035024;GO:0072006;GO:0001764;GO:0010811;GO:0010634;GO:0010628;GO:0010976;GO:1903078;GO:0030510;GO:0017015;GO:0030111;GO:0097205;GO:0042493;GO:0034698;GO:0043588;, C:basolateral plasma membrane; C:cell periphery; C:cell surface; C:excitatory synapse; C:external side of plasma membrane; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:growth cone filopodium; C:integrin alpha3-beta1 complex; C:integrin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:synaptic membrane;, F:collagen binding; F:fibronectin binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:protease binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell-matrix adhesion; P:dendritic spine maintenance; P:exploration behavior; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lung development; P:maternal process involved in female pregnancy; P:memory; P:mesodermal cell differentiation; P:negative regulation of cell projection organization; P:negative regulation of Rho protein signal transduction; P:nephron development; P:neuron migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of protein localization to plasma membrane; P:regulation of BMP signaling pathway; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of Wnt signaling pathway; P:renal filtration; P:response to drug; P:response to gonadotropin; P:skin development;|P26006 A7E246 B7ZM80 B9EGQ1 D3DTX4 D3DTX5,Integrin alpha-3,CD49 antigen-like family member C;FRP-2;Galactoprotein B3;VLA-3 subunit alpha;, PF01839;PF08441;, GO:0016323;GO:0071944;GO:0009986;GO:0060076;GO:0009897;GO:0070062;GO:0031527;GO:0005925;GO:1990812;GO:0034667;GO:0008305;GO:0048471;GO:0005886;GO:0043235;GO:0097060;GO:0005518;GO:0001968;GO:0005178;GO:0043236;GO:0046872;GO:0002020;GO:0019904;GO:0046982;GO:0007160;GO:0097062;GO:0035640;GO:0030198;GO:0007507;GO:0007229;GO:0050900;GO:0030324;GO:0060135;GO:0007613;GO:0048333;GO:0031345;GO:0035024;GO:0072006;GO:0001764;GO:0010811;GO:0010634;GO:0010628;GO:0010976;GO:1903078;GO:0030510;GO:0017015;GO:0030111;GO:0097205;GO:0042493;GO:0034698;GO:0043588;, C:basolateral plasma membrane; C:cell periphery; C:cell surface; C:excitatory synapse; C:external side of plasma membrane; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:growth cone filopodium; C:integrin alpha3-beta1 complex; C:integrin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:synaptic membrane;, F:collagen binding; F:fibronectin binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:protease binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell-matrix adhesion; P:dendritic spine maintenance; P:exploration behavior; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lung development; P:maternal process involved in female pregnancy; P:memory; P:mesodermal cell differentiation; P:negative regulation of cell projection organization; P:negative regulation of Rho protein signal transduction; P:nephron development; P:neuron migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of protein localization to plasma membrane; P:regulation of BMP signaling pathway; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of Wnt signaling pathway; P:renal filtration; P:response to drug; P:response to gonadotropin; P:skin development;|P26006 A7E246 B7ZM80 B9EGQ1 D3DTX4 D3DTX5,Integrin alpha-3,CD49 antigen-like family member C;FRP-2;Galactoprotein B3;VLA-3 subunit alpha;, PF01839;PF08441;, GO:0016323;GO:0071944;GO:0009986;GO:0060076;GO:0009897;GO:0070062;GO:0031527;GO:0005925;GO:1990812;GO:0034667;GO:0008305;GO:0048471;GO:0005886;GO:0043235;GO:0097060;GO:0005518;GO:0001968;GO:0005178;GO:0043236;GO:0046872;GO:0002020;GO:0019904;GO:0046982;GO:0007160;GO:0097062;GO:0035640;GO:0030198;GO:0007507;GO:0007229;GO:0050900;GO:0030324;GO:0060135;GO:0007613;GO:0048333;GO:0031345;GO:0035024;GO:0072006;GO:0001764;GO:0010811;GO:0010634;GO:0010628;GO:0010976;GO:1903078;GO:0030510;GO:0017015;GO:0030111;GO:0097205;GO:0042493;GO:0034698;GO:0043588;, C:basolateral plasma membrane; C:cell periphery; C:cell surface; C:excitatory synapse; C:external side of plasma membrane; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:growth cone filopodium; C:integrin alpha3-beta1 complex; C:integrin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:synaptic membrane;, F:collagen binding; F:fibronectin binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:protease binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell-matrix adhesion; P:dendritic spine maintenance; P:exploration behavior; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lung development; P:maternal process involved in female pregnancy; P:memory; P:mesodermal cell differentiation; P:negative regulation of cell projection organization; P:negative regulation of Rho protein signal transduction; P:nephron development; P:neuron migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of protein localization to plasma membrane; P:regulation of BMP signaling pathway; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of Wnt signaling pathway; P:renal filtration; P:response to drug; P:response to gonadotropin; P:skin development;|P26006 A7E246 B7ZM80 B9EGQ1 D3DTX4 D3DTX5,Integrin alpha-3,CD49 antigen-like family member C;FRP-2;Galactoprotein B3;VLA-3 subunit alpha;, PF01839;PF08441;, GO:0016323;GO:0071944;GO:0009986;GO:0060076;GO:0009897;GO:0070062;GO:0031527;GO:0005925;GO:1990812;GO:0034667;GO:0008305;GO:0048471;GO:0005886;GO:0043235;GO:0097060;GO:0005518;GO:0001968;GO:0005178;GO:0043236;GO:0046872;GO:0002020;GO:0019904;GO:0046982;GO:0007160;GO:0097062;GO:0035640;GO:0030198;GO:0007507;GO:0007229;GO:0050900;GO:0030324;GO:0060135;GO:0007613;GO:0048333;GO:0031345;GO:0035024;GO:0072006;GO:0001764;GO:0010811;GO:0010634;GO:0010628;GO:0010976;GO:1903078;GO:0030510;GO:0017015;GO:0030111;GO:0097205;GO:0042493;GO:0034698;GO:0043588;, C:basolateral plasma membrane; C:cell periphery; C:cell surface; C:excitatory synapse; C:external side of plasma membrane; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:growth cone filopodium; C:integrin alpha3-beta1 complex; C:integrin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:synaptic membrane;, F:collagen binding; F:fibronectin binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:protease binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell-matrix adhesion; P:dendritic spine maintenance; P:exploration behavior; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lung development; P:maternal process involved in female pregnancy; P:memory; P:mesodermal cell differentiation; P:negative regulation of cell projection organization; P:negative regulation of Rho protein signal transduction; P:nephron development; P:neuron migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of protein localization to plasma membrane; P:regulation of BMP signaling pathway; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of Wnt signaling pathway; P:renal filtration; P:response to drug; P:response to gonadotropin; P:skin development;|P26006 A7E246 B7ZM80 B9EGQ1 D3DTX4 D3DTX5,Integrin alpha-3,CD49 antigen-like family member C;FRP-2;Galactoprotein B3;VLA-3 subunit alpha;, PF01839;PF08441;, GO:0016323;GO:0071944;GO:0009986;GO:0060076;GO:0009897;GO:0070062;GO:0031527;GO:0005925;GO:1990812;GO:0034667;GO:0008305;GO:0048471;GO:0005886;GO:0043235;GO:0097060;GO:0005518;GO:0001968;GO:0005178;GO:0043236;GO:0046872;GO:0002020;GO:0019904;GO:0046982;GO:0007160;GO:0097062;GO:0035640;GO:0030198;GO:0007507;GO:0007229;GO:0050900;GO:0030324;GO:0060135;GO:0007613;GO:0048333;GO:0031345;GO:0035024;GO:0072006;GO:0001764;GO:0010811;GO:0010634;GO:0010628;GO:0010976;GO:1903078;GO:0030510;GO:0017015;GO:0030111;GO:0097205;GO:0042493;GO:0034698;GO:0043588;, C:basolateral plasma membrane; C:cell periphery; C:cell surface; C:excitatory synapse; C:external side of plasma membrane; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:growth cone filopodium; C:integrin alpha3-beta1 complex; C:integrin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:synaptic membrane;, F:collagen binding; F:fibronectin binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:protease binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell-matrix adhesion; P:dendritic spine maintenance; P:exploration behavior; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lung development; P:maternal process involved in female pregnancy; P:memory; P:mesodermal cell differentiation; P:negative regulation of cell projection organization; P:negative regulation of Rho protein signal transduction; P:nephron development; P:neuron migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of protein localization to plasma membrane; P:regulation of BMP signaling pathway; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of Wnt signaling pathway; P:renal filtration; P:response to drug; P:response to gonadotropin; P:skin development;|P26006 A7E246 B7ZM80 B9EGQ1 D3DTX4 D3DTX5,Integrin alpha-3,CD49 antigen-like family member C;FRP-2;Galactoprotein B3;VLA-3 subunit alpha;, PF01839;PF08441;, GO:0016323;GO:0071944;GO:0009986;GO:0060076;GO:0009897;GO:0070062;GO:0031527;GO:0005925;GO:1990812;GO:0034667;GO:0008305;GO:0048471;GO:0005886;GO:0043235;GO:0097060;GO:0005518;GO:0001968;GO:0005178;GO:0043236;GO:0046872;GO:0002020;GO:0019904;GO:0046982;GO:0007160;GO:0097062;GO:0035640;GO:0030198;GO:0007507;GO:0007229;GO:0050900;GO:0030324;GO:0060135;GO:0007613;GO:0048333;GO:0031345;GO:0035024;GO:0072006;GO:0001764;GO:0010811;GO:0010634;GO:0010628;GO:0010976;GO:1903078;GO:0030510;GO:0017015;GO:0030111;GO:0097205;GO:0042493;GO:0034698;GO:0043588;, C:basolateral plasma membrane; C:cell periphery; C:cell surface; C:excitatory synapse; C:external side of plasma membrane; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:growth cone filopodium; C:integrin alpha3-beta1 complex; C:integrin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:synaptic membrane;, F:collagen binding; F:fibronectin binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:protease binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell-matrix adhesion; P:dendritic spine maintenance; P:exploration behavior; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lung development; P:maternal process involved in female pregnancy; P:memory; P:mesodermal cell differentiation; P:negative regulation of cell projection organization; P:negative regulation of Rho protein signal transduction; P:nephron development; P:neuron migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of protein localization to plasma membrane; P:regulation of BMP signaling pathway; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of Wnt signaling pathway; P:renal filtration; P:response to drug; P:response to gonadotropin; P:skin development;|P26006 A7E246 B7ZM80 B9EGQ1 D3DTX4 D3DTX5,Integrin alpha-3,CD49 antigen-like family member C;FRP-2;Galactoprotein B3;VLA-3 subunit alpha;, PF01839;PF08441;, GO:0016323;GO:0071944;GO:0009986;GO:0060076;GO:0009897;GO:0070062;GO:0031527;GO:0005925;GO:1990812;GO:0034667;GO:0008305;GO:0048471;GO:0005886;GO:0043235;GO:0097060;GO:0005518;GO:0001968;GO:0005178;GO:0043236;GO:0046872;GO:0002020;GO:0019904;GO:0046982;GO:0007160;GO:0097062;GO:0035640;GO:0030198;GO:0007507;GO:0007229;GO:0050900;GO:0030324;GO:0060135;GO:0007613;GO:0048333;GO:0031345;GO:0035024;GO:0072006;GO:0001764;GO:0010811;GO:0010634;GO:0010628;GO:0010976;GO:1903078;GO:0030510;GO:0017015;GO:0030111;GO:0097205;GO:0042493;GO:0034698;GO:0043588;, C:basolateral plasma membrane; C:cell periphery; C:cell surface; C:excitatory synapse; C:external side of plasma membrane; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:growth cone filopodium; C:integrin alpha3-beta1 complex; C:integrin complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:receptor complex; C:synaptic membrane;, F:collagen binding; F:fibronectin binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:protease binding; F:protein domain specific binding; F:protein heterodimerization activity;, P:cell-matrix adhesion; P:dendritic spine maintenance; P:exploration behavior; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:leukocyte migration; P:lung development; P:maternal process involved in female pregnancy; P:memory; P:mesodermal cell differentiation; P:negative regulation of cell projection organization; P:negative regulation of Rho protein signal transduction; P:nephron development; P:neuron migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:positive regulation of protein localization to plasma membrane; P:regulation of BMP signaling pathway; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of Wnt signaling pathway; P:renal filtration; P:response to drug; P:response to gonadotropin; P:skin development; scaffold54 indexed_genome mRNA 4016031 4032106 . + . ID=transcript_9943;Q15119 A8K3A7 B3KNW0 Q6P515 Q9BS05,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial,Pyruvate dehydrogenase kinase isoform 2;, PF10436;PF02518;, GO:0005829;GO:0005759;GO:0005967;GO:0005739;GO:0005654;GO:0005524;GO:0042803;GO:0004672;GO:0004740;GO:0031670;GO:0034614;GO:0042593;GO:0006006;GO:0008286;GO:0072332;GO:0006468;GO:0010510;GO:0050848;GO:0010565;GO:0006111;GO:0010906;GO:0006885;, C:cytosol; C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:protein homodimerization activity; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cellular response to nutrient; P:cellular response to reactive oxygen species; P:glucose homeostasis; P:glucose metabolic process; P:insulin receptor signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:protein phosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of calcium-mediated signaling; P:regulation of cellular ketone metabolic process; P:regulation of gluconeogenesis; P:regulation of glucose metabolic process; P:regulation of pH;|Q15119 A8K3A7 B3KNW0 Q6P515 Q9BS05,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial,Pyruvate dehydrogenase kinase isoform 2;, PF10436;PF02518;, GO:0005829;GO:0005759;GO:0005967;GO:0005739;GO:0005654;GO:0005524;GO:0042803;GO:0004672;GO:0004740;GO:0031670;GO:0034614;GO:0042593;GO:0006006;GO:0008286;GO:0072332;GO:0006468;GO:0010510;GO:0050848;GO:0010565;GO:0006111;GO:0010906;GO:0006885;, C:cytosol; C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:protein homodimerization activity; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cellular response to nutrient; P:cellular response to reactive oxygen species; P:glucose homeostasis; P:glucose metabolic process; P:insulin receptor signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:protein phosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of calcium-mediated signaling; P:regulation of cellular ketone metabolic process; P:regulation of gluconeogenesis; P:regulation of glucose metabolic process; P:regulation of pH;|Q15119 A8K3A7 B3KNW0 Q6P515 Q9BS05,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial,Pyruvate dehydrogenase kinase isoform 2;, PF10436;PF02518;, GO:0005829;GO:0005759;GO:0005967;GO:0005739;GO:0005654;GO:0005524;GO:0042803;GO:0004672;GO:0004740;GO:0031670;GO:0034614;GO:0042593;GO:0006006;GO:0008286;GO:0072332;GO:0006468;GO:0010510;GO:0050848;GO:0010565;GO:0006111;GO:0010906;GO:0006885;, C:cytosol; C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:protein homodimerization activity; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cellular response to nutrient; P:cellular response to reactive oxygen species; P:glucose homeostasis; P:glucose metabolic process; P:insulin receptor signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:protein phosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of calcium-mediated signaling; P:regulation of cellular ketone metabolic process; P:regulation of gluconeogenesis; P:regulation of glucose metabolic process; P:regulation of pH;|Q15119 A8K3A7 B3KNW0 Q6P515 Q9BS05,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial,Pyruvate dehydrogenase kinase isoform 2;, PF10436;PF02518;, GO:0005829;GO:0005759;GO:0005967;GO:0005739;GO:0005654;GO:0005524;GO:0042803;GO:0004672;GO:0004740;GO:0031670;GO:0034614;GO:0042593;GO:0006006;GO:0008286;GO:0072332;GO:0006468;GO:0010510;GO:0050848;GO:0010565;GO:0006111;GO:0010906;GO:0006885;, C:cytosol; C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:protein homodimerization activity; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cellular response to nutrient; P:cellular response to reactive oxygen species; P:glucose homeostasis; P:glucose metabolic process; P:insulin receptor signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:protein phosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of calcium-mediated signaling; P:regulation of cellular ketone metabolic process; P:regulation of gluconeogenesis; P:regulation of glucose metabolic process; P:regulation of pH;|Q15119 A8K3A7 B3KNW0 Q6P515 Q9BS05,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial,Pyruvate dehydrogenase kinase isoform 2;, PF10436;PF02518;, GO:0005829;GO:0005759;GO:0005967;GO:0005739;GO:0005654;GO:0005524;GO:0042803;GO:0004672;GO:0004740;GO:0031670;GO:0034614;GO:0042593;GO:0006006;GO:0008286;GO:0072332;GO:0006468;GO:0010510;GO:0050848;GO:0010565;GO:0006111;GO:0010906;GO:0006885;, C:cytosol; C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:protein homodimerization activity; F:protein kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cellular response to nutrient; P:cellular response to reactive oxygen species; P:glucose homeostasis; P:glucose metabolic process; P:insulin receptor signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:protein phosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of calcium-mediated signaling; P:regulation of cellular ketone metabolic process; P:regulation of gluconeogenesis; P:regulation of glucose metabolic process; P:regulation of pH; scaffold54 indexed_genome mRNA 4032209 4049841 . - . ID=transcript_9944;Q8IZD0 A5D8V1 Q8N2X0,Sterile alpha motif domain-containing protein 14,, PF07647;, GO:0015629;GO:0005737;GO:0030425;GO:0014069;GO:0051015;GO:0007015;GO:0019722;GO:0031175;, C:actin cytoskeleton; C:cytoplasm; C:dendrite; C:postsynaptic density;, F:actin filament binding;, P:actin filament organization; P:calcium-mediated signaling; P:neuron projection development;|Q8IZD0 A5D8V1 Q8N2X0,Sterile alpha motif domain-containing protein 14,, PF07647;, GO:0015629;GO:0005737;GO:0030425;GO:0014069;GO:0051015;GO:0007015;GO:0019722;GO:0031175;, C:actin cytoskeleton; C:cytoplasm; C:dendrite; C:postsynaptic density;, F:actin filament binding;, P:actin filament organization; P:calcium-mediated signaling; P:neuron projection development; scaffold54 indexed_genome mRNA 4053252 4068583 . - . ID=transcript_9945;Q96SB3 D3DTX6 Q8TCR9,Neurabin-2,Neurabin-II;Protein phosphatase 1 regulatory subunit 9B;Spinophilin;, PF00595;PF17817;, GO:0015629;GO:0005912;GO:0030864;GO:0005737;GO:1990780;GO:0030425;GO:0044327;GO:0044326;GO:0030175;GO:0030426;GO:0030027;GO:0043025;GO:0005654;GO:0005886;GO:0014069;GO:0000164;GO:0032587;GO:0051015;GO:0031749;GO:0044325;GO:0019900;GO:0008022;GO:0004672;GO:0008157;GO:0004864;GO:0030042;GO:0007015;GO:0007568;GO:0019722;GO:0007050;GO:0016477;GO:0035690;GO:0071364;GO:0071392;GO:0071315;GO:1901653;GO:0021987;GO:0016358;GO:0003006;GO:0046847;GO:0021766;GO:0007612;GO:0060179;GO:0050804;GO:0030308;GO:0031175;GO:1904372;GO:1903078;GO:1903119;GO:1990778;GO:0001560;GO:0042127;GO:0007096;GO:2000474;GO:0001932;GO:0061458;GO:0001975;GO:0097338;GO:0035902;GO:1904373;GO:1904386;GO:0035094;GO:0034695;GO:0048545;GO:0008380;, C:actin cytoskeleton; C:adherens junction; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of dendritic spine plasma membrane; C:dendrite; C:dendritic spine head; C:dendritic spine neck; C:filopodium; C:growth cone; C:lamellipodium; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:protein phosphatase type 1 complex; C:ruffle membrane;, F:actin filament binding; F:D2 dopamine receptor binding; F:ion channel binding; F:kinase binding; F:protein C-terminus binding; F:protein kinase activity; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin filament depolymerization; P:actin filament organization; P:aging; P:calcium-mediated signaling; P:cell cycle arrest; P:cell migration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to morphine; P:cellular response to peptide; P:cerebral cortex development; P:dendrite development; P:developmental process involved in reproduction; P:filopodium assembly; P:hippocampus development; P:learning; P:male mating behavior; P:modulation of chemical synaptic transmission; P:negative regulation of cell growth; P:neuron projection development; P:positive regulation of protein localization to actin cortical patch; P:positive regulation of protein localization to plasma membrane; P:protein localization to actin cytoskeleton; P:protein localization to cell periphery; P:regulation of cell growth by extracellular stimulus; P:regulation of cell population proliferation; P:regulation of exit from mitosis; P:regulation of opioid receptor signaling pathway; P:regulation of protein phosphorylation; P:reproductive system development; P:response to amphetamine; P:response to clozapine; P:response to immobilization stress; P:response to kainic acid; P:response to L-phenylalanine derivative; P:response to nicotine; P:response to prostaglandin E; P:response to steroid hormone; P:RNA splicing;|Q96SB3 D3DTX6 Q8TCR9,Neurabin-2,Neurabin-II;Protein phosphatase 1 regulatory subunit 9B;Spinophilin;, PF00595;PF17817;, GO:0015629;GO:0005912;GO:0030864;GO:0005737;GO:1990780;GO:0030425;GO:0044327;GO:0044326;GO:0030175;GO:0030426;GO:0030027;GO:0043025;GO:0005654;GO:0005886;GO:0014069;GO:0000164;GO:0032587;GO:0051015;GO:0031749;GO:0044325;GO:0019900;GO:0008022;GO:0004672;GO:0008157;GO:0004864;GO:0030042;GO:0007015;GO:0007568;GO:0019722;GO:0007050;GO:0016477;GO:0035690;GO:0071364;GO:0071392;GO:0071315;GO:1901653;GO:0021987;GO:0016358;GO:0003006;GO:0046847;GO:0021766;GO:0007612;GO:0060179;GO:0050804;GO:0030308;GO:0031175;GO:1904372;GO:1903078;GO:1903119;GO:1990778;GO:0001560;GO:0042127;GO:0007096;GO:2000474;GO:0001932;GO:0061458;GO:0001975;GO:0097338;GO:0035902;GO:1904373;GO:1904386;GO:0035094;GO:0034695;GO:0048545;GO:0008380;, C:actin cytoskeleton; C:adherens junction; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of dendritic spine plasma membrane; C:dendrite; C:dendritic spine head; C:dendritic spine neck; C:filopodium; C:growth cone; C:lamellipodium; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:protein phosphatase type 1 complex; C:ruffle membrane;, F:actin filament binding; F:D2 dopamine receptor binding; F:ion channel binding; F:kinase binding; F:protein C-terminus binding; F:protein kinase activity; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin filament depolymerization; P:actin filament organization; P:aging; P:calcium-mediated signaling; P:cell cycle arrest; P:cell migration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to morphine; P:cellular response to peptide; P:cerebral cortex development; P:dendrite development; P:developmental process involved in reproduction; P:filopodium assembly; P:hippocampus development; P:learning; P:male mating behavior; P:modulation of chemical synaptic transmission; P:negative regulation of cell growth; P:neuron projection development; P:positive regulation of protein localization to actin cortical patch; P:positive regulation of protein localization to plasma membrane; P:protein localization to actin cytoskeleton; P:protein localization to cell periphery; P:regulation of cell growth by extracellular stimulus; P:regulation of cell population proliferation; P:regulation of exit from mitosis; P:regulation of opioid receptor signaling pathway; P:regulation of protein phosphorylation; P:reproductive system development; P:response to amphetamine; P:response to clozapine; P:response to immobilization stress; P:response to kainic acid; P:response to L-phenylalanine derivative; P:response to nicotine; P:response to prostaglandin E; P:response to steroid hormone; P:RNA splicing;|Q96SB3 D3DTX6 Q8TCR9,Neurabin-2,Neurabin-II;Protein phosphatase 1 regulatory subunit 9B;Spinophilin;, PF00595;PF17817;, GO:0015629;GO:0005912;GO:0030864;GO:0005737;GO:1990780;GO:0030425;GO:0044327;GO:0044326;GO:0030175;GO:0030426;GO:0030027;GO:0043025;GO:0005654;GO:0005886;GO:0014069;GO:0000164;GO:0032587;GO:0051015;GO:0031749;GO:0044325;GO:0019900;GO:0008022;GO:0004672;GO:0008157;GO:0004864;GO:0030042;GO:0007015;GO:0007568;GO:0019722;GO:0007050;GO:0016477;GO:0035690;GO:0071364;GO:0071392;GO:0071315;GO:1901653;GO:0021987;GO:0016358;GO:0003006;GO:0046847;GO:0021766;GO:0007612;GO:0060179;GO:0050804;GO:0030308;GO:0031175;GO:1904372;GO:1903078;GO:1903119;GO:1990778;GO:0001560;GO:0042127;GO:0007096;GO:2000474;GO:0001932;GO:0061458;GO:0001975;GO:0097338;GO:0035902;GO:1904373;GO:1904386;GO:0035094;GO:0034695;GO:0048545;GO:0008380;, C:actin cytoskeleton; C:adherens junction; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of dendritic spine plasma membrane; C:dendrite; C:dendritic spine head; C:dendritic spine neck; C:filopodium; C:growth cone; C:lamellipodium; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:protein phosphatase type 1 complex; C:ruffle membrane;, F:actin filament binding; F:D2 dopamine receptor binding; F:ion channel binding; F:kinase binding; F:protein C-terminus binding; F:protein kinase activity; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin filament depolymerization; P:actin filament organization; P:aging; P:calcium-mediated signaling; P:cell cycle arrest; P:cell migration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to morphine; P:cellular response to peptide; P:cerebral cortex development; P:dendrite development; P:developmental process involved in reproduction; P:filopodium assembly; P:hippocampus development; P:learning; P:male mating behavior; P:modulation of chemical synaptic transmission; P:negative regulation of cell growth; P:neuron projection development; P:positive regulation of protein localization to actin cortical patch; P:positive regulation of protein localization to plasma membrane; P:protein localization to actin cytoskeleton; P:protein localization to cell periphery; P:regulation of cell growth by extracellular stimulus; P:regulation of cell population proliferation; P:regulation of exit from mitosis; P:regulation of opioid receptor signaling pathway; P:regulation of protein phosphorylation; P:reproductive system development; P:response to amphetamine; P:response to clozapine; P:response to immobilization stress; P:response to kainic acid; P:response to L-phenylalanine derivative; P:response to nicotine; P:response to prostaglandin E; P:response to steroid hormone; P:RNA splicing;|Q96SB3 D3DTX6 Q8TCR9,Neurabin-2,Neurabin-II;Protein phosphatase 1 regulatory subunit 9B;Spinophilin;, PF00595;PF17817;, GO:0015629;GO:0005912;GO:0030864;GO:0005737;GO:1990780;GO:0030425;GO:0044327;GO:0044326;GO:0030175;GO:0030426;GO:0030027;GO:0043025;GO:0005654;GO:0005886;GO:0014069;GO:0000164;GO:0032587;GO:0051015;GO:0031749;GO:0044325;GO:0019900;GO:0008022;GO:0004672;GO:0008157;GO:0004864;GO:0030042;GO:0007015;GO:0007568;GO:0019722;GO:0007050;GO:0016477;GO:0035690;GO:0071364;GO:0071392;GO:0071315;GO:1901653;GO:0021987;GO:0016358;GO:0003006;GO:0046847;GO:0021766;GO:0007612;GO:0060179;GO:0050804;GO:0030308;GO:0031175;GO:1904372;GO:1903078;GO:1903119;GO:1990778;GO:0001560;GO:0042127;GO:0007096;GO:2000474;GO:0001932;GO:0061458;GO:0001975;GO:0097338;GO:0035902;GO:1904373;GO:1904386;GO:0035094;GO:0034695;GO:0048545;GO:0008380;, C:actin cytoskeleton; C:adherens junction; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of dendritic spine plasma membrane; C:dendrite; C:dendritic spine head; C:dendritic spine neck; C:filopodium; C:growth cone; C:lamellipodium; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:protein phosphatase type 1 complex; C:ruffle membrane;, F:actin filament binding; F:D2 dopamine receptor binding; F:ion channel binding; F:kinase binding; F:protein C-terminus binding; F:protein kinase activity; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin filament depolymerization; P:actin filament organization; P:aging; P:calcium-mediated signaling; P:cell cycle arrest; P:cell migration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to morphine; P:cellular response to peptide; P:cerebral cortex development; P:dendrite development; P:developmental process involved in reproduction; P:filopodium assembly; P:hippocampus development; P:learning; P:male mating behavior; P:modulation of chemical synaptic transmission; P:negative regulation of cell growth; P:neuron projection development; P:positive regulation of protein localization to actin cortical patch; P:positive regulation of protein localization to plasma membrane; P:protein localization to actin cytoskeleton; P:protein localization to cell periphery; P:regulation of cell growth by extracellular stimulus; P:regulation of cell population proliferation; P:regulation of exit from mitosis; P:regulation of opioid receptor signaling pathway; P:regulation of protein phosphorylation; P:reproductive system development; P:response to amphetamine; P:response to clozapine; P:response to immobilization stress; P:response to kainic acid; P:response to L-phenylalanine derivative; P:response to nicotine; P:response to prostaglandin E; P:response to steroid hormone; P:RNA splicing;|Q96SB3 D3DTX6 Q8TCR9,Neurabin-2,Neurabin-II;Protein phosphatase 1 regulatory subunit 9B;Spinophilin;, PF00595;PF17817;, GO:0015629;GO:0005912;GO:0030864;GO:0005737;GO:1990780;GO:0030425;GO:0044327;GO:0044326;GO:0030175;GO:0030426;GO:0030027;GO:0043025;GO:0005654;GO:0005886;GO:0014069;GO:0000164;GO:0032587;GO:0051015;GO:0031749;GO:0044325;GO:0019900;GO:0008022;GO:0004672;GO:0008157;GO:0004864;GO:0030042;GO:0007015;GO:0007568;GO:0019722;GO:0007050;GO:0016477;GO:0035690;GO:0071364;GO:0071392;GO:0071315;GO:1901653;GO:0021987;GO:0016358;GO:0003006;GO:0046847;GO:0021766;GO:0007612;GO:0060179;GO:0050804;GO:0030308;GO:0031175;GO:1904372;GO:1903078;GO:1903119;GO:1990778;GO:0001560;GO:0042127;GO:0007096;GO:2000474;GO:0001932;GO:0061458;GO:0001975;GO:0097338;GO:0035902;GO:1904373;GO:1904386;GO:0035094;GO:0034695;GO:0048545;GO:0008380;, C:actin cytoskeleton; C:adherens junction; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of dendritic spine plasma membrane; C:dendrite; C:dendritic spine head; C:dendritic spine neck; C:filopodium; C:growth cone; C:lamellipodium; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:protein phosphatase type 1 complex; C:ruffle membrane;, F:actin filament binding; F:D2 dopamine receptor binding; F:ion channel binding; F:kinase binding; F:protein C-terminus binding; F:protein kinase activity; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin filament depolymerization; P:actin filament organization; P:aging; P:calcium-mediated signaling; P:cell cycle arrest; P:cell migration; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to morphine; P:cellular response to peptide; P:cerebral cortex development; P:dendrite development; P:developmental process involved in reproduction; P:filopodium assembly; P:hippocampus development; P:learning; P:male mating behavior; P:modulation of chemical synaptic transmission; P:negative regulation of cell growth; P:neuron projection development; P:positive regulation of protein localization to actin cortical patch; P:positive regulation of protein localization to plasma membrane; P:protein localization to actin cytoskeleton; P:protein localization to cell periphery; P:regulation of cell growth by extracellular stimulus; P:regulation of cell population proliferation; P:regulation of exit from mitosis; P:regulation of opioid receptor signaling pathway; P:regulation of protein phosphorylation; P:reproductive system development; P:response to amphetamine; P:response to clozapine; P:response to immobilization stress; P:response to kainic acid; P:response to L-phenylalanine derivative; P:response to nicotine; P:response to prostaglandin E; P:response to steroid hormone; P:RNA splicing; scaffold54 indexed_genome mRNA 4095030 4102384 . + . ID=transcript_9946;Q16586 A6NEB8 A8K3K7 Q13710 Q13712,Alpha-sarcoglycan,50 kDa dystrophin-associated glycoprotein;Adhalin;Dystroglycan-2;, PF05510;, GO:0005911;GO:0005737;GO:0005856;GO:0016010;GO:0016021;GO:0045121;GO:0016012;GO:0042383;GO:0005509;GO:0006936;GO:0007517;GO:0014894;GO:0043403;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:integral component of membrane; C:membrane raft; C:sarcoglycan complex; C:sarcolemma;, F:calcium ion binding;, P:muscle contraction; P:muscle organ development; P:response to denervation involved in regulation of muscle adaptation; P:skeletal muscle tissue regeneration;|Q16586 A6NEB8 A8K3K7 Q13710 Q13712,Alpha-sarcoglycan,50 kDa dystrophin-associated glycoprotein;Adhalin;Dystroglycan-2;, PF05510;, GO:0005911;GO:0005737;GO:0005856;GO:0016010;GO:0016021;GO:0045121;GO:0016012;GO:0042383;GO:0005509;GO:0006936;GO:0007517;GO:0014894;GO:0043403;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:integral component of membrane; C:membrane raft; C:sarcoglycan complex; C:sarcolemma;, F:calcium ion binding;, P:muscle contraction; P:muscle organ development; P:response to denervation involved in regulation of muscle adaptation; P:skeletal muscle tissue regeneration;|Q16586 A6NEB8 A8K3K7 Q13710 Q13712,Alpha-sarcoglycan,50 kDa dystrophin-associated glycoprotein;Adhalin;Dystroglycan-2;, PF05510;, GO:0005911;GO:0005737;GO:0005856;GO:0016010;GO:0016021;GO:0045121;GO:0016012;GO:0042383;GO:0005509;GO:0006936;GO:0007517;GO:0014894;GO:0043403;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:integral component of membrane; C:membrane raft; C:sarcoglycan complex; C:sarcolemma;, F:calcium ion binding;, P:muscle contraction; P:muscle organ development; P:response to denervation involved in regulation of muscle adaptation; P:skeletal muscle tissue regeneration;|P60008,Putative spermatid-specific linker histone H1-like protein {ECO:0000305},H1.9 linker histone pseudogene {ECO:0000312|HGNC:HGNC:30616};, PF00538;, GO:0001673;GO:0000786;GO:0005634;GO:0003690;GO:0042393;GO:0003676;GO:0031492;GO:0006338;GO:0006342;GO:0030261;GO:0007281;GO:0007275;GO:0031936;GO:0045910;GO:0006334;GO:0016584;GO:0006355;GO:0007283;, C:male germ cell nucleus; C:nucleosome; C:nucleus;, F:double-stranded DNA binding; F:histone binding; F:nucleic acid binding; F:nucleosomal DNA binding;, P:chromatin remodeling; P:chromatin silencing; P:chromosome condensation; P:germ cell development; P:multicellular organism development; P:negative regulation of chromatin silencing; P:negative regulation of DNA recombination; P:nucleosome assembly; P:nucleosome positioning; P:regulation of transcription, DNA-templated; P:spermatogenesis; scaffold54 indexed_genome mRNA 4110053 4127228 . - . ID=transcript_9947;Q15201 Q16050 Q59F64 Q7KZ30 Q7KZ34 Q8IVI5 Q8N473 Q9UML6 Q9UMM7,Collagen alpha-1(I) chain,Alpha-1 type I collagen;, PF01410;PF01391;PF00093;, GO:0005584;GO:0062023;GO:0005737;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005794;GO:0030141;GO:0005201;GO:0030020;GO:0042802;GO:0046872;GO:0048407;GO:0002020;GO:0007596;GO:0001568;GO:0060346;GO:0060351;GO:0071230;GO:0071364;GO:0044344;GO:1902618;GO:0071260;GO:0071300;GO:0071560;GO:0071356;GO:0071306;GO:0032964;GO:0030199;GO:0038063;GO:0048706;GO:0001958;GO:0030198;GO:0060325;GO:0001957;GO:0050900;GO:0010812;GO:0001503;GO:0001649;GO:0030168;GO:0090263;GO:0030335;GO:0010718;GO:0045893;GO:0034504;GO:0015031;GO:0050776;GO:0051591;GO:0031960;GO:0042493;GO:0032355;GO:0042542;GO:0055093;GO:0009612;GO:0043434;GO:0007605;GO:0001501;GO:0043588;GO:0043589;GO:0044691;GO:0034505;GO:0007601;, C:collagen type I trimer; C:collagen-containing extracellular matrix; C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:secretory granule;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:identical protein binding; F:metal ion binding; F:platelet-derived growth factor binding; F:protease binding;, P:blood coagulation; P:blood vessel development; P:bone trabecula formation; P:cartilage development involved in endochondral bone morphogenesis; P:cellular response to amino acid stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to fluoride; P:cellular response to mechanical stimulus; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:cellular response to vitamin E; P:collagen biosynthetic process; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:embryonic skeletal system development; P:endochondral ossification; P:extracellular matrix organization; P:face morphogenesis; P:intramembranous ossification; P:leukocyte migration; P:negative regulation of cell-substrate adhesion; P:ossification; P:osteoblast differentiation; P:platelet activation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of transcription, DNA-templated; P:protein localization to nucleus; P:protein transport; P:regulation of immune response; P:response to cAMP; P:response to corticosteroid; P:response to drug; P:response to estradiol; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to mechanical stimulus; P:response to peptide hormone; P:sensory perception of sound; P:skeletal system development; P:skin development; P:skin morphogenesis; P:tooth eruption; P:tooth mineralization; P:visual perception; scaffold54 indexed_genome mRNA 4264179 4267443 . + . ID=transcript_9948;Q9H1B5 Q6UY41 Q86V00,Xylosyltransferase 2,Peptide O-xylosyltransferase 1;Xylosyltransferase II {ECO:0000303|PubMed:17189265};, PF02485;PF12529;, GO:0005615;GO:0000139;GO:0016021;GO:0000287;GO:0030145;GO:0030158;GO:0030206;GO:0050650;GO:0006024;GO:0030203;GO:0015012;GO:0030210;, C:extracellular space; C:Golgi membrane; C:integral component of membrane;, F:magnesium ion binding; F:manganese ion binding; F:protein xylosyltransferase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process; scaffold54 indexed_genome mRNA 4267641 4274616 . - . ID=transcript_9949;Q9H1B5 Q6UY41 Q86V00,Xylosyltransferase 2,Peptide O-xylosyltransferase 1;Xylosyltransferase II {ECO:0000303|PubMed:17189265};, PF02485;PF12529;, GO:0005615;GO:0000139;GO:0016021;GO:0000287;GO:0030145;GO:0030158;GO:0030206;GO:0050650;GO:0006024;GO:0030203;GO:0015012;GO:0030210;, C:extracellular space; C:Golgi membrane; C:integral component of membrane;, F:magnesium ion binding; F:manganese ion binding; F:protein xylosyltransferase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process;|Q9H1B5 Q6UY41 Q86V00,Xylosyltransferase 2,Peptide O-xylosyltransferase 1;Xylosyltransferase II {ECO:0000303|PubMed:17189265};, PF02485;PF12529;, GO:0005615;GO:0000139;GO:0016021;GO:0000287;GO:0030145;GO:0030158;GO:0030206;GO:0050650;GO:0006024;GO:0030203;GO:0015012;GO:0030210;, C:extracellular space; C:Golgi membrane; C:integral component of membrane;, F:magnesium ion binding; F:manganese ion binding; F:protein xylosyltransferase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process;|Q9H1B5 Q6UY41 Q86V00,Xylosyltransferase 2,Peptide O-xylosyltransferase 1;Xylosyltransferase II {ECO:0000303|PubMed:17189265};, PF02485;PF12529;, GO:0005615;GO:0000139;GO:0016021;GO:0000287;GO:0030145;GO:0030158;GO:0030206;GO:0050650;GO:0006024;GO:0030203;GO:0015012;GO:0030210;, C:extracellular space; C:Golgi membrane; C:integral component of membrane;, F:magnesium ion binding; F:manganese ion binding; F:protein xylosyltransferase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process;|Q9H1B5 Q6UY41 Q86V00,Xylosyltransferase 2,Peptide O-xylosyltransferase 1;Xylosyltransferase II {ECO:0000303|PubMed:17189265};, PF02485;PF12529;, GO:0005615;GO:0000139;GO:0016021;GO:0000287;GO:0030145;GO:0030158;GO:0030206;GO:0050650;GO:0006024;GO:0030203;GO:0015012;GO:0030210;, C:extracellular space; C:Golgi membrane; C:integral component of membrane;, F:magnesium ion binding; F:manganese ion binding; F:protein xylosyltransferase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process;|Q9H1B5 Q6UY41 Q86V00,Xylosyltransferase 2,Peptide O-xylosyltransferase 1;Xylosyltransferase II {ECO:0000303|PubMed:17189265};, PF02485;PF12529;, GO:0005615;GO:0000139;GO:0016021;GO:0000287;GO:0030145;GO:0030158;GO:0030206;GO:0050650;GO:0006024;GO:0030203;GO:0015012;GO:0030210;, C:extracellular space; C:Golgi membrane; C:integral component of membrane;, F:magnesium ion binding; F:manganese ion binding; F:protein xylosyltransferase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process;|Q9H1B5 Q6UY41 Q86V00,Xylosyltransferase 2,Peptide O-xylosyltransferase 1;Xylosyltransferase II {ECO:0000303|PubMed:17189265};, PF02485;PF12529;, GO:0005615;GO:0000139;GO:0016021;GO:0000287;GO:0030145;GO:0030158;GO:0030206;GO:0050650;GO:0006024;GO:0030203;GO:0015012;GO:0030210;, C:extracellular space; C:Golgi membrane; C:integral component of membrane;, F:magnesium ion binding; F:manganese ion binding; F:protein xylosyltransferase activity;, P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process; scaffold54 indexed_genome mRNA 4280395 4283469 . + . ID=transcript_9950;Q9P0M9 B2RE14,39S ribosomal protein L27, mitochondrial,Mitochondrial large ribosomal subunit protein bL27m {ECO:0000303|PubMed:25278503};, PF01016;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9P0M9 B2RE14,39S ribosomal protein L27, mitochondrial,Mitochondrial large ribosomal subunit protein bL27m {ECO:0000303|PubMed:25278503};, PF01016;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9P0M9 B2RE14,39S ribosomal protein L27, mitochondrial,Mitochondrial large ribosomal subunit protein bL27m {ECO:0000303|PubMed:25278503};, PF01016;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold54 indexed_genome mRNA 4285332 4290018 . + . ID=transcript_9951;Q96AY2 Q96N62,Crossover junction endonuclease EME1,MMS4 homolog;, PF02732;, GO:0000792;GO:0048476;GO:0005730;GO:0005654;GO:0003677;GO:0004519;GO:0046872;GO:0006302;GO:0036297;GO:0031573;GO:0031297;GO:0000712;GO:0072429;, C:heterochromatin; C:Holliday junction resolvase complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:endonuclease activity; F:metal ion binding;, P:double-strand break repair; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:replication fork processing; P:resolution of meiotic recombination intermediates; P:response to intra-S DNA damage checkpoint signaling;|Q96AY2 Q96N62,Crossover junction endonuclease EME1,MMS4 homolog;, PF02732;, GO:0000792;GO:0048476;GO:0005730;GO:0005654;GO:0003677;GO:0004519;GO:0046872;GO:0006302;GO:0036297;GO:0031573;GO:0031297;GO:0000712;GO:0072429;, C:heterochromatin; C:Holliday junction resolvase complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:endonuclease activity; F:metal ion binding;, P:double-strand break repair; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:replication fork processing; P:resolution of meiotic recombination intermediates; P:response to intra-S DNA damage checkpoint signaling; scaffold54 indexed_genome mRNA 4290671 4294285 . + . ID=transcript_9952;Q96AY2 Q96N62,Crossover junction endonuclease EME1,MMS4 homolog;, PF02732;, GO:0000792;GO:0048476;GO:0005730;GO:0005654;GO:0003677;GO:0004519;GO:0046872;GO:0006302;GO:0036297;GO:0031573;GO:0031297;GO:0000712;GO:0072429;, C:heterochromatin; C:Holliday junction resolvase complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:endonuclease activity; F:metal ion binding;, P:double-strand break repair; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:replication fork processing; P:resolution of meiotic recombination intermediates; P:response to intra-S DNA damage checkpoint signaling;|Q96AG4 B2RE83 D3DTX8 Q9P189,Leucine-rich repeat-containing protein 59,Ribosome-binding protein p34;, PF13855;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0042645;GO:0005635;GO:0045296;GO:0003723;GO:0046579;GO:0007165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial nucleoid; C:nuclear envelope;, F:cadherin binding; F:RNA binding;, P:positive regulation of Ras protein signal transduction; P:signal transduction; scaffold54 indexed_genome mRNA 4294566 4304288 . - . ID=transcript_9953;Q96AG4 B2RE83 D3DTX8 Q9P189,Leucine-rich repeat-containing protein 59,Ribosome-binding protein p34;, PF13855;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0042645;GO:0005635;GO:0045296;GO:0003723;GO:0046579;GO:0007165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial nucleoid; C:nuclear envelope;, F:cadherin binding; F:RNA binding;, P:positive regulation of Ras protein signal transduction; P:signal transduction;|Q96AG4 B2RE83 D3DTX8 Q9P189,Leucine-rich repeat-containing protein 59,Ribosome-binding protein p34;, PF13855;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0042645;GO:0005635;GO:0045296;GO:0003723;GO:0046579;GO:0007165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial nucleoid; C:nuclear envelope;, F:cadherin binding; F:RNA binding;, P:positive regulation of Ras protein signal transduction; P:signal transduction;|Q96AG4 B2RE83 D3DTX8 Q9P189,Leucine-rich repeat-containing protein 59,Ribosome-binding protein p34;, PF13855;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0042645;GO:0005635;GO:0045296;GO:0003723;GO:0046579;GO:0007165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial nucleoid; C:nuclear envelope;, F:cadherin binding; F:RNA binding;, P:positive regulation of Ras protein signal transduction; P:signal transduction;|Q96AG4 B2RE83 D3DTX8 Q9P189,Leucine-rich repeat-containing protein 59,Ribosome-binding protein p34;, PF13855;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0042645;GO:0005635;GO:0045296;GO:0003723;GO:0046579;GO:0007165;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondrial nucleoid; C:nuclear envelope;, F:cadherin binding; F:RNA binding;, P:positive regulation of Ras protein signal transduction; P:signal transduction; scaffold54 indexed_genome mRNA 4317403 4347311 . + . ID=transcript_9954;Q96CM8 B4DFQ6 B4DHT5 B4DUF5 Q9H7G2,Medium-chain acyl-CoA ligase ACSF2, mitochondrial {ECO:0000305},, PF00501;PF13193;, GO:0005759;GO:0005524;GO:0047760;GO:0031956;GO:0006637;GO:0006631;, C:mitochondrial matrix;, F:ATP binding; F:butyrate-CoA ligase activity; F:medium-chain fatty acid-CoA ligase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q96CM8 B4DFQ6 B4DHT5 B4DUF5 Q9H7G2,Medium-chain acyl-CoA ligase ACSF2, mitochondrial {ECO:0000305},, PF00501;PF13193;, GO:0005759;GO:0005524;GO:0047760;GO:0031956;GO:0006637;GO:0006631;, C:mitochondrial matrix;, F:ATP binding; F:butyrate-CoA ligase activity; F:medium-chain fatty acid-CoA ligase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q96CM8 B4DFQ6 B4DHT5 B4DUF5 Q9H7G2,Medium-chain acyl-CoA ligase ACSF2, mitochondrial {ECO:0000305},, PF00501;PF13193;, GO:0005759;GO:0005524;GO:0047760;GO:0031956;GO:0006637;GO:0006631;, C:mitochondrial matrix;, F:ATP binding; F:butyrate-CoA ligase activity; F:medium-chain fatty acid-CoA ligase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q96CM8 B4DFQ6 B4DHT5 B4DUF5 Q9H7G2,Medium-chain acyl-CoA ligase ACSF2, mitochondrial {ECO:0000305},, PF00501;PF13193;, GO:0005759;GO:0005524;GO:0047760;GO:0031956;GO:0006637;GO:0006631;, C:mitochondrial matrix;, F:ATP binding; F:butyrate-CoA ligase activity; F:medium-chain fatty acid-CoA ligase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q96CM8 B4DFQ6 B4DHT5 B4DUF5 Q9H7G2,Medium-chain acyl-CoA ligase ACSF2, mitochondrial {ECO:0000305},, PF00501;PF13193;, GO:0005759;GO:0005524;GO:0047760;GO:0031956;GO:0006637;GO:0006631;, C:mitochondrial matrix;, F:ATP binding; F:butyrate-CoA ligase activity; F:medium-chain fatty acid-CoA ligase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q96CM8 B4DFQ6 B4DHT5 B4DUF5 Q9H7G2,Medium-chain acyl-CoA ligase ACSF2, mitochondrial {ECO:0000305},, PF00501;PF13193;, GO:0005759;GO:0005524;GO:0047760;GO:0031956;GO:0006637;GO:0006631;, C:mitochondrial matrix;, F:ATP binding; F:butyrate-CoA ligase activity; F:medium-chain fatty acid-CoA ligase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process;|O15335 A8K812 Q6GTU0 Q96RJ5,Chondroadherin,Cartilage leucine-rich protein;, PF00560;PF13855;PF01462;, GO:0031012;GO:0005615;GO:0060348;GO:1900155;, C:extracellular matrix; C:extracellular space;, , P:bone development; P:negative regulation of bone trabecula formation;|O15335 A8K812 Q6GTU0 Q96RJ5,Chondroadherin,Cartilage leucine-rich protein;, PF00560;PF13855;PF01462;, GO:0031012;GO:0005615;GO:0060348;GO:1900155;, C:extracellular matrix; C:extracellular space;, , P:bone development; P:negative regulation of bone trabecula formation;|O15335 A8K812 Q6GTU0 Q96RJ5,Chondroadherin,Cartilage leucine-rich protein;, PF00560;PF13855;PF01462;, GO:0031012;GO:0005615;GO:0060348;GO:1900155;, C:extracellular matrix; C:extracellular space;, , P:bone development; P:negative regulation of bone trabecula formation;|Q96CM8 B4DFQ6 B4DHT5 B4DUF5 Q9H7G2,Medium-chain acyl-CoA ligase ACSF2, mitochondrial {ECO:0000305},, PF00501;PF13193;, GO:0005759;GO:0005524;GO:0047760;GO:0031956;GO:0006637;GO:0006631;, C:mitochondrial matrix;, F:ATP binding; F:butyrate-CoA ligase activity; F:medium-chain fatty acid-CoA ligase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process;|Q96CM8 B4DFQ6 B4DHT5 B4DUF5 Q9H7G2,Medium-chain acyl-CoA ligase ACSF2, mitochondrial {ECO:0000305},, PF00501;PF13193;, GO:0005759;GO:0005524;GO:0047760;GO:0031956;GO:0006637;GO:0006631;, C:mitochondrial matrix;, F:ATP binding; F:butyrate-CoA ligase activity; F:medium-chain fatty acid-CoA ligase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process; scaffold54 indexed_genome mRNA 4353862 4362615 . + . ID=transcript_9955;Q9HA92 B4DMW0 Q53HV8 Q86VC4 Q9BRY7 Q9NUS7,Radical S-adenosyl methionine domain-containing protein 1, mitochondrial,Putative heme chaperone {ECO:0000303|PubMed:29282292};, PF06969;PF04055;, GO:0005737;GO:0005739;GO:0051539;GO:0004109;GO:0020037;GO:0046872;GO:0006779;, C:cytoplasm; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:coproporphyrinogen oxidase activity; F:heme binding; F:metal ion binding;, P:porphyrin-containing compound biosynthetic process;|Q9HA92 B4DMW0 Q53HV8 Q86VC4 Q9BRY7 Q9NUS7,Radical S-adenosyl methionine domain-containing protein 1, mitochondrial,Putative heme chaperone {ECO:0000303|PubMed:29282292};, PF06969;PF04055;, GO:0005737;GO:0005739;GO:0051539;GO:0004109;GO:0020037;GO:0046872;GO:0006779;, C:cytoplasm; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:coproporphyrinogen oxidase activity; F:heme binding; F:metal ion binding;, P:porphyrin-containing compound biosynthetic process;|Q9HA92 B4DMW0 Q53HV8 Q86VC4 Q9BRY7 Q9NUS7,Radical S-adenosyl methionine domain-containing protein 1, mitochondrial,Putative heme chaperone {ECO:0000303|PubMed:29282292};, PF06969;PF04055;, GO:0005737;GO:0005739;GO:0051539;GO:0004109;GO:0020037;GO:0046872;GO:0006779;, C:cytoplasm; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:coproporphyrinogen oxidase activity; F:heme binding; F:metal ion binding;, P:porphyrin-containing compound biosynthetic process;|Q9HA92 B4DMW0 Q53HV8 Q86VC4 Q9BRY7 Q9NUS7,Radical S-adenosyl methionine domain-containing protein 1, mitochondrial,Putative heme chaperone {ECO:0000303|PubMed:29282292};, PF06969;PF04055;, GO:0005737;GO:0005739;GO:0051539;GO:0004109;GO:0020037;GO:0046872;GO:0006779;, C:cytoplasm; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:coproporphyrinogen oxidase activity; F:heme binding; F:metal ion binding;, P:porphyrin-containing compound biosynthetic process;|Q9HA92 B4DMW0 Q53HV8 Q86VC4 Q9BRY7 Q9NUS7,Radical S-adenosyl methionine domain-containing protein 1, mitochondrial,Putative heme chaperone {ECO:0000303|PubMed:29282292};, PF06969;PF04055;, GO:0005737;GO:0005739;GO:0051539;GO:0004109;GO:0020037;GO:0046872;GO:0006779;, C:cytoplasm; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:coproporphyrinogen oxidase activity; F:heme binding; F:metal ion binding;, P:porphyrin-containing compound biosynthetic process; scaffold54 indexed_genome mRNA 4376349 4397980 . + . ID=transcript_9956;Q8TBZ2 A6NHJ3 Q8TDV8 Q9H0K0,MYCBP-associated protein,AMAM-1;AMY-1-binding protein 1;, PF14646;, GO:0005737;GO:0016020;GO:0045202;GO:0030154;GO:0007268;GO:0007275;GO:0007283;, C:cytoplasm; C:membrane; C:synapse;, , P:cell differentiation; P:chemical synaptic transmission; P:multicellular organism development; P:spermatogenesis;|Q8TBZ2 A6NHJ3 Q8TDV8 Q9H0K0,MYCBP-associated protein,AMAM-1;AMY-1-binding protein 1;, PF14646;, GO:0005737;GO:0016020;GO:0045202;GO:0030154;GO:0007268;GO:0007275;GO:0007283;, C:cytoplasm; C:membrane; C:synapse;, , P:cell differentiation; P:chemical synaptic transmission; P:multicellular organism development; P:spermatogenesis;|Q8TBZ2 A6NHJ3 Q8TDV8 Q9H0K0,MYCBP-associated protein,AMAM-1;AMY-1-binding protein 1;, PF14646;, GO:0005737;GO:0016020;GO:0045202;GO:0030154;GO:0007268;GO:0007275;GO:0007283;, C:cytoplasm; C:membrane; C:synapse;, , P:cell differentiation; P:chemical synaptic transmission; P:multicellular organism development; P:spermatogenesis;|Q8TBZ2 A6NHJ3 Q8TDV8 Q9H0K0,MYCBP-associated protein,AMAM-1;AMY-1-binding protein 1;, PF14646;, GO:0005737;GO:0016020;GO:0045202;GO:0030154;GO:0007268;GO:0007275;GO:0007283;, C:cytoplasm; C:membrane; C:synapse;, , P:cell differentiation; P:chemical synaptic transmission; P:multicellular organism development; P:spermatogenesis;|Q8TBZ2 A6NHJ3 Q8TDV8 Q9H0K0,MYCBP-associated protein,AMAM-1;AMY-1-binding protein 1;, PF14646;, GO:0005737;GO:0016020;GO:0045202;GO:0030154;GO:0007268;GO:0007275;GO:0007283;, C:cytoplasm; C:membrane; C:synapse;, , P:cell differentiation; P:chemical synaptic transmission; P:multicellular organism development; P:spermatogenesis; scaffold54 indexed_genome mRNA 4401023 4409984 . + . ID=transcript_9957;Q9H201 A8K6J3 A8KAB2 Q9BVN6 Q9NWK2,Epsin-3,EPS-15-interacting protein 3;, PF01417;PF02809;, GO:0030125;GO:0005905;GO:0030136;GO:0005768;GO:0070062;GO:0019897;GO:0043231;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0030276;GO:1990175;GO:0005543;GO:0006897;, C:clathrin vesicle coat; C:clathrin-coated pit; C:clathrin-coated vesicle; C:endosome; C:extracellular exosome; C:extrinsic component of plasma membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:clathrin binding; F:EH domain binding; F:phospholipid binding;, P:endocytosis;|Q9H201 A8K6J3 A8KAB2 Q9BVN6 Q9NWK2,Epsin-3,EPS-15-interacting protein 3;, PF01417;PF02809;, GO:0030125;GO:0005905;GO:0030136;GO:0005768;GO:0070062;GO:0019897;GO:0043231;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0030276;GO:1990175;GO:0005543;GO:0006897;, C:clathrin vesicle coat; C:clathrin-coated pit; C:clathrin-coated vesicle; C:endosome; C:extracellular exosome; C:extrinsic component of plasma membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:clathrin binding; F:EH domain binding; F:phospholipid binding;, P:endocytosis; scaffold54 indexed_genome mRNA 4413602 4421838 . + . ID=transcript_9958;Q8TB22 Q2TA99 Q2XUZ6 Q6P0P1 Q8WVW3 Q9H747,Spermatogenesis-associated protein 20,Sperm-specific protein 411;, PF03190;, GO:0005576;GO:0005975;GO:0030154;GO:0007275;GO:0007283;, C:extracellular region;, , P:carbohydrate metabolic process; P:cell differentiation; P:multicellular organism development; P:spermatogenesis;|Q8TB22 Q2TA99 Q2XUZ6 Q6P0P1 Q8WVW3 Q9H747,Spermatogenesis-associated protein 20,Sperm-specific protein 411;, PF03190;, GO:0005576;GO:0005975;GO:0030154;GO:0007275;GO:0007283;, C:extracellular region;, , P:carbohydrate metabolic process; P:cell differentiation; P:multicellular organism development; P:spermatogenesis;|Q8TB22 Q2TA99 Q2XUZ6 Q6P0P1 Q8WVW3 Q9H747,Spermatogenesis-associated protein 20,Sperm-specific protein 411;, PF03190;, GO:0005576;GO:0005975;GO:0030154;GO:0007275;GO:0007283;, C:extracellular region;, , P:carbohydrate metabolic process; P:cell differentiation; P:multicellular organism development; P:spermatogenesis;|Q8TB22 Q2TA99 Q2XUZ6 Q6P0P1 Q8WVW3 Q9H747,Spermatogenesis-associated protein 20,Sperm-specific protein 411;, PF03190;, GO:0005576;GO:0005975;GO:0030154;GO:0007275;GO:0007283;, C:extracellular region;, , P:carbohydrate metabolic process; P:cell differentiation; P:multicellular organism development; P:spermatogenesis; scaffold54 indexed_genome mRNA 4427440 4428054 . - . ID=transcript_9959;Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling; scaffold54 indexed_genome mRNA 4435184 4439126 . + . ID=transcript_9960;Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling; scaffold54 indexed_genome mRNA 4439253 4444340 . + . ID=transcript_9961;Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling; scaffold54 indexed_genome mRNA 4444516 4489880 . + . ID=transcript_9962;Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling;|Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling;|Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling;|Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling;|Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling;|Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling;|Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling;|Q9UHP0 Q9ULU6 Q9UNG7 Q9Y5T2 Q9Y5T3,Voltage-dependent T-type calcium channel subunit alpha-1G,Cav3.1c;NBR13;Voltage-gated calcium channel subunit alpha Cav3.1;, PF00520;, GO:0005737;GO:0043005;GO:0005886;GO:0045202;GO:0005891;GO:0001518;GO:0008332;GO:0097110;GO:0086056;GO:0086059;GO:0005248;GO:0086016;GO:0086027;GO:0070509;GO:0070588;GO:0086002;GO:0007268;GO:0086010;GO:0086045;GO:0086046;GO:0019228;GO:0045956;GO:0060371;GO:0086091;GO:0034765;GO:0042391;GO:0010045;GO:0086015;GO:0086018;, C:cytoplasm; C:neuron projection; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:scaffold protein binding; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential; F:voltage-gated sodium channel activity;, P:AV node cell action potential; P:AV node cell to bundle of His cell signaling; P:calcium ion import; P:calcium ion transmembrane transport; P:cardiac muscle cell action potential involved in contraction; P:chemical synaptic transmission; P:membrane depolarization during action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:response to nickel cation; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell signaling; scaffold54 indexed_genome mRNA 4496528 4545331 . + . ID=transcript_9963;Q86X85 Q9UN52,ATP-binding cassette sub-family C member 3,Canalicular multispecific organic anion transporter 2 {ECO:0000303|PubMed:9813153};Multi-specific organic anion transporter D {ECO:0000303|PubMed:9827529};Multidrug resistance-associated protein 3;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0016020;GO:0005886;GO:0015432;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015164;GO:0071714;GO:0042910;GO:0015721;GO:0015722;GO:0006855;GO:0071716;GO:0055085;GO:0150104;GO:0042908;, C:basolateral plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:glucuronoside transmembrane transporter activity; F:icosanoid transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:canalicular bile acid transport; P:drug transmembrane transport; P:leukotriene transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport;|Q86X85 Q9UN52,ATP-binding cassette sub-family C member 3,Canalicular multispecific organic anion transporter 2 {ECO:0000303|PubMed:9813153};Multi-specific organic anion transporter D {ECO:0000303|PubMed:9827529};Multidrug resistance-associated protein 3;, PF00664;PF00005;, GO:0016323;GO:0016021;GO:0016020;GO:0005886;GO:0015432;GO:0015431;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0015164;GO:0071714;GO:0042910;GO:0015721;GO:0015722;GO:0006855;GO:0071716;GO:0055085;GO:0150104;GO:0042908;, C:basolateral plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:ABC-type bile acid transporter activity; F:ABC-type glutathione S-conjugate transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:glucuronoside transmembrane transporter activity; F:icosanoid transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:bile acid and bile salt transport; P:canalicular bile acid transport; P:drug transmembrane transport; P:leukotriene transport; P:transmembrane transport; P:transport across blood-brain barrier; P:xenobiotic transport; scaffold54 indexed_genome mRNA 4546721 4562778 . - . ID=transcript_9964;Q6AI12 Q96E32,Ankyrin repeat domain-containing protein 40|Q6AI12 Q96E32,Ankyrin repeat domain-containing protein 40|Q6AI12 Q96E32,Ankyrin repeat domain-containing protein 40|Q6AI12 Q96E32,Ankyrin repeat domain-containing protein 40|Q6AI12 Q96E32,Ankyrin repeat domain-containing protein 40|Q6AI12 Q96E32,Ankyrin repeat domain-containing protein 40 scaffold54 indexed_genome mRNA 4580496 4597984 . + . ID=transcript_9965;O95232 B3KN54 D3DTY1 Q6PHR9 Q9NUY0 Q9P2S7,Luc7-like protein 3,Cisplatin resistance-associated-overexpressed protein;Luc7A;Okadaic acid-inducible phosphoprotein OA48-18;cAMP regulatory element-associated protein 1;, PF03194;, GO:0016607;GO:0005654;GO:0005634;GO:0005685;GO:0071004;GO:0003677;GO:0003729;GO:0003723;GO:0006376;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:U1 snRNP; C:U2-type prespliceosome;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:RNA splicing;|O95232 B3KN54 D3DTY1 Q6PHR9 Q9NUY0 Q9P2S7,Luc7-like protein 3,Cisplatin resistance-associated-overexpressed protein;Luc7A;Okadaic acid-inducible phosphoprotein OA48-18;cAMP regulatory element-associated protein 1;, PF03194;, GO:0016607;GO:0005654;GO:0005634;GO:0005685;GO:0071004;GO:0003677;GO:0003729;GO:0003723;GO:0006376;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:U1 snRNP; C:U2-type prespliceosome;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:RNA splicing;|O95232 B3KN54 D3DTY1 Q6PHR9 Q9NUY0 Q9P2S7,Luc7-like protein 3,Cisplatin resistance-associated-overexpressed protein;Luc7A;Okadaic acid-inducible phosphoprotein OA48-18;cAMP regulatory element-associated protein 1;, PF03194;, GO:0016607;GO:0005654;GO:0005634;GO:0005685;GO:0071004;GO:0003677;GO:0003729;GO:0003723;GO:0006376;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:U1 snRNP; C:U2-type prespliceosome;, F:DNA binding; F:mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:RNA splicing; scaffold54 indexed_genome mRNA 4600189 4601314 . + . ID=transcript_9966;Q53H64 Q9NWQ1,Putative ANKRD40 C-terminal-like protein {ECO:0000305} scaffold54 indexed_genome mRNA 4692133 4696756 . + . ID=transcript_9967;P50616 B2R9T0 D3DTY3 Q4KMQ0,Protein Tob1,Transducer of erbB-2 1;, PF07742;, GO:0030014;GO:0005737;GO:0005634;GO:0030971;GO:0046332;GO:0003714;GO:0030514;GO:0008285;GO:0060212;GO:0045668;GO:0017148;GO:1900153;GO:0060213;GO:0010468;GO:0060390;, C:CCR4-NOT complex; C:cytoplasm; C:nucleus;, F:receptor tyrosine kinase binding; F:SMAD binding; F:transcription corepressor activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:negative regulation of osteoblast differentiation; P:negative regulation of translation; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of gene expression; P:regulation of SMAD protein signal transduction; scaffold54 indexed_genome mRNA 4780688 4791697 . - . ID=transcript_9968;Q8IZX7 Q96II0 Q9H811,C-Jun-amino-terminal kinase-interacting protein 4,Cancer/testis antigen 89;Human lung cancer oncogene 6 protein;JNK-associated leucine-zipper protein;Mitogen-activated protein kinase 8-interacting protein 4;Proliferation-inducing protein 6;Protein highly expressed in testis;Sperm surface protein;Sperm-associated antigen 9;Sperm-specific protein;Sunday driver 1;, PF16471;PF09744;, GO:0001669;GO:0034451;GO:0005737;GO:0005829;GO:0070062;GO:0005765;GO:0048471;GO:0042802;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0032418;GO:1903860;GO:0045665;GO:0001933;GO:0030335;GO:0051149;GO:0045666;GO:0042147;GO:0051146;GO:0016192;, C:acrosomal vesicle; C:centriolar satellite; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:perinuclear region of cytoplasm;, F:identical protein binding; F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:lysosome localization; P:negative regulation of dendrite extension; P:negative regulation of neuron differentiation; P:negative regulation of protein phosphorylation; P:positive regulation of cell migration; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:retrograde transport, endosome to Golgi; P:striated muscle cell differentiation; P:vesicle-mediated transport;|Q8IZX7 Q96II0 Q9H811,C-Jun-amino-terminal kinase-interacting protein 4,Cancer/testis antigen 89;Human lung cancer oncogene 6 protein;JNK-associated leucine-zipper protein;Mitogen-activated protein kinase 8-interacting protein 4;Proliferation-inducing protein 6;Protein highly expressed in testis;Sperm surface protein;Sperm-associated antigen 9;Sperm-specific protein;Sunday driver 1;, PF16471;PF09744;, GO:0001669;GO:0034451;GO:0005737;GO:0005829;GO:0070062;GO:0005765;GO:0048471;GO:0042802;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0032418;GO:1903860;GO:0045665;GO:0001933;GO:0030335;GO:0051149;GO:0045666;GO:0042147;GO:0051146;GO:0016192;, C:acrosomal vesicle; C:centriolar satellite; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:perinuclear region of cytoplasm;, F:identical protein binding; F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:lysosome localization; P:negative regulation of dendrite extension; P:negative regulation of neuron differentiation; P:negative regulation of protein phosphorylation; P:positive regulation of cell migration; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:retrograde transport, endosome to Golgi; P:striated muscle cell differentiation; P:vesicle-mediated transport; scaffold54 indexed_genome mRNA 4791737 4862222 . - . ID=transcript_9969;Q8IZX7 Q96II0 Q9H811,C-Jun-amino-terminal kinase-interacting protein 4,Cancer/testis antigen 89;Human lung cancer oncogene 6 protein;JNK-associated leucine-zipper protein;Mitogen-activated protein kinase 8-interacting protein 4;Proliferation-inducing protein 6;Protein highly expressed in testis;Sperm surface protein;Sperm-associated antigen 9;Sperm-specific protein;Sunday driver 1;, PF16471;PF09744;, GO:0001669;GO:0034451;GO:0005737;GO:0005829;GO:0070062;GO:0005765;GO:0048471;GO:0042802;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0032418;GO:1903860;GO:0045665;GO:0001933;GO:0030335;GO:0051149;GO:0045666;GO:0042147;GO:0051146;GO:0016192;, C:acrosomal vesicle; C:centriolar satellite; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:perinuclear region of cytoplasm;, F:identical protein binding; F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:lysosome localization; P:negative regulation of dendrite extension; P:negative regulation of neuron differentiation; P:negative regulation of protein phosphorylation; P:positive regulation of cell migration; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:retrograde transport, endosome to Golgi; P:striated muscle cell differentiation; P:vesicle-mediated transport;|Q8IZX7 Q96II0 Q9H811,C-Jun-amino-terminal kinase-interacting protein 4,Cancer/testis antigen 89;Human lung cancer oncogene 6 protein;JNK-associated leucine-zipper protein;Mitogen-activated protein kinase 8-interacting protein 4;Proliferation-inducing protein 6;Protein highly expressed in testis;Sperm surface protein;Sperm-associated antigen 9;Sperm-specific protein;Sunday driver 1;, PF16471;PF09744;, GO:0001669;GO:0034451;GO:0005737;GO:0005829;GO:0070062;GO:0005765;GO:0048471;GO:0042802;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0032418;GO:1903860;GO:0045665;GO:0001933;GO:0030335;GO:0051149;GO:0045666;GO:0042147;GO:0051146;GO:0016192;, C:acrosomal vesicle; C:centriolar satellite; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:perinuclear region of cytoplasm;, F:identical protein binding; F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:lysosome localization; P:negative regulation of dendrite extension; P:negative regulation of neuron differentiation; P:negative regulation of protein phosphorylation; P:positive regulation of cell migration; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:retrograde transport, endosome to Golgi; P:striated muscle cell differentiation; P:vesicle-mediated transport;|Q8IZX7 Q96II0 Q9H811,C-Jun-amino-terminal kinase-interacting protein 4,Cancer/testis antigen 89;Human lung cancer oncogene 6 protein;JNK-associated leucine-zipper protein;Mitogen-activated protein kinase 8-interacting protein 4;Proliferation-inducing protein 6;Protein highly expressed in testis;Sperm surface protein;Sperm-associated antigen 9;Sperm-specific protein;Sunday driver 1;, PF16471;PF09744;, GO:0001669;GO:0034451;GO:0005737;GO:0005829;GO:0070062;GO:0005765;GO:0048471;GO:0042802;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0032418;GO:1903860;GO:0045665;GO:0001933;GO:0030335;GO:0051149;GO:0045666;GO:0042147;GO:0051146;GO:0016192;, C:acrosomal vesicle; C:centriolar satellite; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:perinuclear region of cytoplasm;, F:identical protein binding; F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:lysosome localization; P:negative regulation of dendrite extension; P:negative regulation of neuron differentiation; P:negative regulation of protein phosphorylation; P:positive regulation of cell migration; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:retrograde transport, endosome to Golgi; P:striated muscle cell differentiation; P:vesicle-mediated transport;|Q8IZX7 Q96II0 Q9H811,C-Jun-amino-terminal kinase-interacting protein 4,Cancer/testis antigen 89;Human lung cancer oncogene 6 protein;JNK-associated leucine-zipper protein;Mitogen-activated protein kinase 8-interacting protein 4;Proliferation-inducing protein 6;Protein highly expressed in testis;Sperm surface protein;Sperm-associated antigen 9;Sperm-specific protein;Sunday driver 1;, PF16471;PF09744;, GO:0001669;GO:0034451;GO:0005737;GO:0005829;GO:0070062;GO:0005765;GO:0048471;GO:0042802;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0032418;GO:1903860;GO:0045665;GO:0001933;GO:0030335;GO:0051149;GO:0045666;GO:0042147;GO:0051146;GO:0016192;, C:acrosomal vesicle; C:centriolar satellite; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:perinuclear region of cytoplasm;, F:identical protein binding; F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:lysosome localization; P:negative regulation of dendrite extension; P:negative regulation of neuron differentiation; P:negative regulation of protein phosphorylation; P:positive regulation of cell migration; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:retrograde transport, endosome to Golgi; P:striated muscle cell differentiation; P:vesicle-mediated transport;|Q8IZX7 Q96II0 Q9H811,C-Jun-amino-terminal kinase-interacting protein 4,Cancer/testis antigen 89;Human lung cancer oncogene 6 protein;JNK-associated leucine-zipper protein;Mitogen-activated protein kinase 8-interacting protein 4;Proliferation-inducing protein 6;Protein highly expressed in testis;Sperm surface protein;Sperm-associated antigen 9;Sperm-specific protein;Sunday driver 1;, PF16471;PF09744;, GO:0001669;GO:0034451;GO:0005737;GO:0005829;GO:0070062;GO:0005765;GO:0048471;GO:0042802;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0032418;GO:1903860;GO:0045665;GO:0001933;GO:0030335;GO:0051149;GO:0045666;GO:0042147;GO:0051146;GO:0016192;, C:acrosomal vesicle; C:centriolar satellite; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lysosomal membrane; C:perinuclear region of cytoplasm;, F:identical protein binding; F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:lysosome localization; P:negative regulation of dendrite extension; P:negative regulation of neuron differentiation; P:negative regulation of protein phosphorylation; P:positive regulation of cell migration; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron differentiation; P:retrograde transport, endosome to Golgi; P:striated muscle cell differentiation; P:vesicle-mediated transport; scaffold54 indexed_genome mRNA 4979873 4991208 . + . ID=transcript_9970;P15531 Q6FGK3 Q86XQ2 Q9UDJ6,Nucleoside diphosphate kinase A,Granzyme A-activated DNase;Metastasis inhibition factor nm23;NM23-H1;Tumor metastatic process-associated protein;, PF00334;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005882;GO:0016020;GO:0005741;GO:0005634;GO:0048471;GO:0032587;GO:0005524;GO:0004536;GO:0019899;GO:0043015;GO:0005525;GO:0042802;GO:0019215;GO:0000287;GO:0004550;GO:0043024;GO:0003723;GO:0000977;GO:0003697;GO:0030154;GO:0035690;GO:0071398;GO:0071333;GO:0006241;GO:0006897;GO:0006183;GO:0021766;GO:0007595;GO:0008285;GO:0010629;GO:0002762;GO:0015949;GO:0043388;GO:0050679;GO:0010976;GO:0042981;GO:0014075;GO:0051591;GO:0033574;GO:0006228;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intermediate filament; C:membrane; C:mitochondrial outer membrane; C:nucleus; C:perinuclear region of cytoplasm; C:ruffle membrane;, F:ATP binding; F:deoxyribonuclease activity; F:enzyme binding; F:gamma-tubulin binding; F:GTP binding; F:identical protein binding; F:intermediate filament binding; F:magnesium ion binding; F:nucleoside diphosphate kinase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:single-stranded DNA binding;, P:cell differentiation; P:cellular response to drug; P:cellular response to fatty acid; P:cellular response to glucose stimulus; P:CTP biosynthetic process; P:endocytosis; P:GTP biosynthetic process; P:hippocampus development; P:lactation; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of myeloid leukocyte differentiation; P:nucleobase-containing small molecule interconversion; P:positive regulation of DNA binding; P:positive regulation of epithelial cell proliferation; P:positive regulation of neuron projection development; P:regulation of apoptotic process; P:response to amine; P:response to cAMP; P:response to testosterone; P:UTP biosynthetic process;|P15531 Q6FGK3 Q86XQ2 Q9UDJ6,Nucleoside diphosphate kinase A,Granzyme A-activated DNase;Metastasis inhibition factor nm23;NM23-H1;Tumor metastatic process-associated protein;, PF00334;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005882;GO:0016020;GO:0005741;GO:0005634;GO:0048471;GO:0032587;GO:0005524;GO:0004536;GO:0019899;GO:0043015;GO:0005525;GO:0042802;GO:0019215;GO:0000287;GO:0004550;GO:0043024;GO:0003723;GO:0000977;GO:0003697;GO:0030154;GO:0035690;GO:0071398;GO:0071333;GO:0006241;GO:0006897;GO:0006183;GO:0021766;GO:0007595;GO:0008285;GO:0010629;GO:0002762;GO:0015949;GO:0043388;GO:0050679;GO:0010976;GO:0042981;GO:0014075;GO:0051591;GO:0033574;GO:0006228;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intermediate filament; C:membrane; C:mitochondrial outer membrane; C:nucleus; C:perinuclear region of cytoplasm; C:ruffle membrane;, F:ATP binding; F:deoxyribonuclease activity; F:enzyme binding; F:gamma-tubulin binding; F:GTP binding; F:identical protein binding; F:intermediate filament binding; F:magnesium ion binding; F:nucleoside diphosphate kinase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:single-stranded DNA binding;, P:cell differentiation; P:cellular response to drug; P:cellular response to fatty acid; P:cellular response to glucose stimulus; P:CTP biosynthetic process; P:endocytosis; P:GTP biosynthetic process; P:hippocampus development; P:lactation; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of myeloid leukocyte differentiation; P:nucleobase-containing small molecule interconversion; P:positive regulation of DNA binding; P:positive regulation of epithelial cell proliferation; P:positive regulation of neuron projection development; P:regulation of apoptotic process; P:response to amine; P:response to cAMP; P:response to testosterone; P:UTP biosynthetic process;|P15531 Q6FGK3 Q86XQ2 Q9UDJ6,Nucleoside diphosphate kinase A,Granzyme A-activated DNase;Metastasis inhibition factor nm23;NM23-H1;Tumor metastatic process-associated protein;, PF00334;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005882;GO:0016020;GO:0005741;GO:0005634;GO:0048471;GO:0032587;GO:0005524;GO:0004536;GO:0019899;GO:0043015;GO:0005525;GO:0042802;GO:0019215;GO:0000287;GO:0004550;GO:0043024;GO:0003723;GO:0000977;GO:0003697;GO:0030154;GO:0035690;GO:0071398;GO:0071333;GO:0006241;GO:0006897;GO:0006183;GO:0021766;GO:0007595;GO:0008285;GO:0010629;GO:0002762;GO:0015949;GO:0043388;GO:0050679;GO:0010976;GO:0042981;GO:0014075;GO:0051591;GO:0033574;GO:0006228;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intermediate filament; C:membrane; C:mitochondrial outer membrane; C:nucleus; C:perinuclear region of cytoplasm; C:ruffle membrane;, F:ATP binding; F:deoxyribonuclease activity; F:enzyme binding; F:gamma-tubulin binding; F:GTP binding; F:identical protein binding; F:intermediate filament binding; F:magnesium ion binding; F:nucleoside diphosphate kinase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:single-stranded DNA binding;, P:cell differentiation; P:cellular response to drug; P:cellular response to fatty acid; P:cellular response to glucose stimulus; P:CTP biosynthetic process; P:endocytosis; P:GTP biosynthetic process; P:hippocampus development; P:lactation; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of myeloid leukocyte differentiation; P:nucleobase-containing small molecule interconversion; P:positive regulation of DNA binding; P:positive regulation of epithelial cell proliferation; P:positive regulation of neuron projection development; P:regulation of apoptotic process; P:response to amine; P:response to cAMP; P:response to testosterone; P:UTP biosynthetic process; scaffold54 indexed_genome mRNA 4995742 5008560 . + . ID=transcript_9971;P22392 A8MWA3 Q1WM23 Q6LCT6,Nucleoside diphosphate kinase B,C-myc purine-binding transcription factor PUF;Histidine protein kinase NDKB;nm23-H2;, PF00334;, GO:0071944;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005882;GO:0030027;GO:0031966;GO:0005634;GO:0048471;GO:0001726;GO:0034774;GO:0005524;GO:0003677;GO:0008144;GO:0019899;GO:0005504;GO:0051880;GO:0019003;GO:0042802;GO:0019215;GO:0046872;GO:0004550;GO:0004673;GO:0004674;GO:0003713;GO:0007189;GO:0007155;GO:0071398;GO:0071333;GO:0034599;GO:0006241;GO:0006183;GO:0007229;GO:0043066;GO:0002762;GO:0043312;GO:0015949;GO:0006165;GO:0009142;GO:0050679;GO:0045618;GO:0010976;GO:0045944;GO:0045893;GO:0046777;GO:0042981;GO:0045682;GO:0060416;GO:0006228;, C:cell periphery; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:intermediate filament; C:lamellipodium; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:ruffle; C:secretory granule lumen;, F:ATP binding; F:DNA binding; F:drug binding; F:enzyme binding; F:fatty acid binding; F:G-quadruplex DNA binding; F:GDP binding; F:identical protein binding; F:intermediate filament binding; F:metal ion binding; F:nucleoside diphosphate kinase activity; F:protein histidine kinase activity; F:protein serine/threonine kinase activity; F:transcription coactivator activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cellular response to fatty acid; P:cellular response to glucose stimulus; P:cellular response to oxidative stress; P:CTP biosynthetic process; P:GTP biosynthetic process; P:integrin-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of myeloid leukocyte differentiation; P:neutrophil degranulation; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:positive regulation of epithelial cell proliferation; P:positive regulation of keratinocyte differentiation; P:positive regulation of neuron projection development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:regulation of apoptotic process; P:regulation of epidermis development; P:response to growth hormone; P:UTP biosynthetic process;|P22392 A8MWA3 Q1WM23 Q6LCT6,Nucleoside diphosphate kinase B,C-myc purine-binding transcription factor PUF;Histidine protein kinase NDKB;nm23-H2;, PF00334;, GO:0071944;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005882;GO:0030027;GO:0031966;GO:0005634;GO:0048471;GO:0001726;GO:0034774;GO:0005524;GO:0003677;GO:0008144;GO:0019899;GO:0005504;GO:0051880;GO:0019003;GO:0042802;GO:0019215;GO:0046872;GO:0004550;GO:0004673;GO:0004674;GO:0003713;GO:0007189;GO:0007155;GO:0071398;GO:0071333;GO:0034599;GO:0006241;GO:0006183;GO:0007229;GO:0043066;GO:0002762;GO:0043312;GO:0015949;GO:0006165;GO:0009142;GO:0050679;GO:0045618;GO:0010976;GO:0045944;GO:0045893;GO:0046777;GO:0042981;GO:0045682;GO:0060416;GO:0006228;, C:cell periphery; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:intermediate filament; C:lamellipodium; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:ruffle; C:secretory granule lumen;, F:ATP binding; F:DNA binding; F:drug binding; F:enzyme binding; F:fatty acid binding; F:G-quadruplex DNA binding; F:GDP binding; F:identical protein binding; F:intermediate filament binding; F:metal ion binding; F:nucleoside diphosphate kinase activity; F:protein histidine kinase activity; F:protein serine/threonine kinase activity; F:transcription coactivator activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cellular response to fatty acid; P:cellular response to glucose stimulus; P:cellular response to oxidative stress; P:CTP biosynthetic process; P:GTP biosynthetic process; P:integrin-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of myeloid leukocyte differentiation; P:neutrophil degranulation; P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:positive regulation of epithelial cell proliferation; P:positive regulation of keratinocyte differentiation; P:positive regulation of neuron projection development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:regulation of apoptotic process; P:regulation of epidermis development; P:response to growth hormone; P:UTP biosynthetic process; scaffold54 indexed_genome mRNA 5010781 5014821 . + . ID=transcript_9972;Q05BQ5 Q6ZVU7 Q9NXU1,MBT domain-containing protein 1,, PF02820;, GO:0005634;GO:0003682;GO:0042393;GO:0035064;GO:0008270;GO:0006325;GO:0048706;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding; F:methylated histone binding; F:zinc ion binding;, P:chromatin organization; P:embryonic skeletal system development; P:negative regulation of transcription, DNA-templated;|Q05BQ5 Q6ZVU7 Q9NXU1,MBT domain-containing protein 1,, PF02820;, GO:0005634;GO:0003682;GO:0042393;GO:0035064;GO:0008270;GO:0006325;GO:0048706;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding; F:methylated histone binding; F:zinc ion binding;, P:chromatin organization; P:embryonic skeletal system development; P:negative regulation of transcription, DNA-templated; scaffold54 indexed_genome mRNA 5064857 5124701 . + . ID=transcript_9973;Q9Y5J1 Q9H4N6,U3 small nucleolar RNA-associated protein 18 homolog,WD repeat-containing protein 50;, , GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0034388;GO:0032040;GO:0003723;GO:0006364;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:rRNA processing;|Q9Y5J1 Q9H4N6,U3 small nucleolar RNA-associated protein 18 homolog,WD repeat-containing protein 50;, , GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0034388;GO:0032040;GO:0003723;GO:0006364;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:rRNA processing;|Q9Y5J1 Q9H4N6,U3 small nucleolar RNA-associated protein 18 homolog,WD repeat-containing protein 50;, , GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0034388;GO:0032040;GO:0003723;GO:0006364;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:rRNA processing;|Q9Y5J1 Q9H4N6,U3 small nucleolar RNA-associated protein 18 homolog,WD repeat-containing protein 50;, , GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0034388;GO:0032040;GO:0003723;GO:0006364;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:rRNA processing;|Q9Y5J1 Q9H4N6,U3 small nucleolar RNA-associated protein 18 homolog,WD repeat-containing protein 50;, , GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0034388;GO:0032040;GO:0003723;GO:0006364;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:rRNA processing; scaffold54 indexed_genome mRNA 5229606 5230167 . - . ID=transcript_9974;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold54 indexed_genome mRNA 5292182 5297858 . - . ID=transcript_9975;P46734 B3KSK7 Q99441 Q9UE71 Q9UE72,Dual specificity mitogen-activated protein kinase kinase 3,MAPK/ERK kinase 3;Stress-activated protein kinase kinase 2;, PF00069;, GO:0005829;GO:0016020;GO:0005654;GO:0005524;GO:0004708;GO:0019901;GO:0106310;GO:0106311;GO:0004714;GO:0000187;GO:0060048;GO:0035924;GO:0006954;GO:0035331;GO:0038066;GO:0043536;GO:0045860;GO:0045893;GO:0001817;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm;, F:ATP binding; F:MAP kinase kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:cardiac muscle contraction; P:cellular response to vascular endothelial growth factor stimulus; P:inflammatory response; P:negative regulation of hippo signaling; P:p38MAPK cascade; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of protein kinase activity; P:positive regulation of transcription, DNA-templated; P:regulation of cytokine production; P:signal transduction;|P46734 B3KSK7 Q99441 Q9UE71 Q9UE72,Dual specificity mitogen-activated protein kinase kinase 3,MAPK/ERK kinase 3;Stress-activated protein kinase kinase 2;, PF00069;, GO:0005829;GO:0016020;GO:0005654;GO:0005524;GO:0004708;GO:0019901;GO:0106310;GO:0106311;GO:0004714;GO:0000187;GO:0060048;GO:0035924;GO:0006954;GO:0035331;GO:0038066;GO:0043536;GO:0045860;GO:0045893;GO:0001817;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm;, F:ATP binding; F:MAP kinase kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:cardiac muscle contraction; P:cellular response to vascular endothelial growth factor stimulus; P:inflammatory response; P:negative regulation of hippo signaling; P:p38MAPK cascade; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of protein kinase activity; P:positive regulation of transcription, DNA-templated; P:regulation of cytokine production; P:signal transduction;|P46734 B3KSK7 Q99441 Q9UE71 Q9UE72,Dual specificity mitogen-activated protein kinase kinase 3,MAPK/ERK kinase 3;Stress-activated protein kinase kinase 2;, PF00069;, GO:0005829;GO:0016020;GO:0005654;GO:0005524;GO:0004708;GO:0019901;GO:0106310;GO:0106311;GO:0004714;GO:0000187;GO:0060048;GO:0035924;GO:0006954;GO:0035331;GO:0038066;GO:0043536;GO:0045860;GO:0045893;GO:0001817;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm;, F:ATP binding; F:MAP kinase kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:cardiac muscle contraction; P:cellular response to vascular endothelial growth factor stimulus; P:inflammatory response; P:negative regulation of hippo signaling; P:p38MAPK cascade; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of protein kinase activity; P:positive regulation of transcription, DNA-templated; P:regulation of cytokine production; P:signal transduction; scaffold54 indexed_genome mRNA 5338427 5345622 . - . ID=transcript_9976;Q8N6N6 A8MWQ7 B3KX70,Protein NATD1,N-acetyltransferase domain-containing protein 1;, PF14542;|Q8N6N6 A8MWQ7 B3KX70,Protein NATD1,N-acetyltransferase domain-containing protein 1;, PF14542; scaffold54 indexed_genome mRNA 5347484 5357052 . + . ID=transcript_9977;P17152 Q53YB2,Transmembrane protein 11, mitochondrial,Protein PM1;Protein PMI;, PF14972;, GO:0031305;GO:0005887;GO:0005739;GO:0007007;GO:0007005;, C:integral component of mitochondrial inner membrane; C:integral component of plasma membrane; C:mitochondrion;, , P:inner mitochondrial membrane organization; P:mitochondrion organization;|P17152 Q53YB2,Transmembrane protein 11, mitochondrial,Protein PM1;Protein PMI;, PF14972;, GO:0031305;GO:0005887;GO:0005739;GO:0007007;GO:0007005;, C:integral component of mitochondrial inner membrane; C:integral component of plasma membrane; C:mitochondrion;, , P:inner mitochondrial membrane organization; P:mitochondrion organization; scaffold54 indexed_genome mRNA 5357059 5401910 . - . ID=transcript_9978;Q6IAN0 B5MEF4 Q6UX59 Q9BTF9 Q9UFM6 Q9Y3A1,Dehydrogenase/reductase SDR family member 7B,Short-chain dehydrogenase/reductase family 32C member 1 {ECO:0000303|PubMed:19027726};, PF00106;, GO:0005789;GO:0016021;GO:0016020;GO:0005778;GO:0016491;GO:0008611;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:peroxisomal membrane;, F:oxidoreductase activity;, P:ether lipid biosynthetic process;|Q6IAN0 B5MEF4 Q6UX59 Q9BTF9 Q9UFM6 Q9Y3A1,Dehydrogenase/reductase SDR family member 7B,Short-chain dehydrogenase/reductase family 32C member 1 {ECO:0000303|PubMed:19027726};, PF00106;, GO:0005789;GO:0016021;GO:0016020;GO:0005778;GO:0016491;GO:0008611;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:peroxisomal membrane;, F:oxidoreductase activity;, P:ether lipid biosynthetic process;|Q6IAN0 B5MEF4 Q6UX59 Q9BTF9 Q9UFM6 Q9Y3A1,Dehydrogenase/reductase SDR family member 7B,Short-chain dehydrogenase/reductase family 32C member 1 {ECO:0000303|PubMed:19027726};, PF00106;, GO:0005789;GO:0016021;GO:0016020;GO:0005778;GO:0016491;GO:0008611;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:peroxisomal membrane;, F:oxidoreductase activity;, P:ether lipid biosynthetic process; scaffold54 indexed_genome mRNA 5422506 5451027 . + . ID=transcript_9979;Q9UPT9 A0JNS3 Q2NLE2 Q6MZY4 Q8TBS8 Q96IW5,Ubiquitin carboxyl-terminal hydrolase 22,Deubiquitinating enzyme 22;Ubiquitin thioesterase 22;Ubiquitin-specific-processing protease 22;, PF00443;PF02148;, GO:0005654;GO:0000124;GO:0008234;GO:0019899;GO:0030374;GO:0004843;GO:0003713;GO:0008270;GO:0007049;GO:0009792;GO:0016578;GO:0043967;GO:0016574;GO:0045931;GO:0045893;GO:0016579;GO:0006511;, C:nucleoplasm; C:SAGA complex;, F:cysteine-type peptidase activity; F:enzyme binding; F:nuclear receptor coactivator activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:zinc ion binding;, P:cell cycle; P:embryo development ending in birth or egg hatching; P:histone deubiquitination; P:histone H4 acetylation; P:histone ubiquitination; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UPT9 A0JNS3 Q2NLE2 Q6MZY4 Q8TBS8 Q96IW5,Ubiquitin carboxyl-terminal hydrolase 22,Deubiquitinating enzyme 22;Ubiquitin thioesterase 22;Ubiquitin-specific-processing protease 22;, PF00443;PF02148;, GO:0005654;GO:0000124;GO:0008234;GO:0019899;GO:0030374;GO:0004843;GO:0003713;GO:0008270;GO:0007049;GO:0009792;GO:0016578;GO:0043967;GO:0016574;GO:0045931;GO:0045893;GO:0016579;GO:0006511;, C:nucleoplasm; C:SAGA complex;, F:cysteine-type peptidase activity; F:enzyme binding; F:nuclear receptor coactivator activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:zinc ion binding;, P:cell cycle; P:embryo development ending in birth or egg hatching; P:histone deubiquitination; P:histone H4 acetylation; P:histone ubiquitination; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UPT9 A0JNS3 Q2NLE2 Q6MZY4 Q8TBS8 Q96IW5,Ubiquitin carboxyl-terminal hydrolase 22,Deubiquitinating enzyme 22;Ubiquitin thioesterase 22;Ubiquitin-specific-processing protease 22;, PF00443;PF02148;, GO:0005654;GO:0000124;GO:0008234;GO:0019899;GO:0030374;GO:0004843;GO:0003713;GO:0008270;GO:0007049;GO:0009792;GO:0016578;GO:0043967;GO:0016574;GO:0045931;GO:0045893;GO:0016579;GO:0006511;, C:nucleoplasm; C:SAGA complex;, F:cysteine-type peptidase activity; F:enzyme binding; F:nuclear receptor coactivator activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:zinc ion binding;, P:cell cycle; P:embryo development ending in birth or egg hatching; P:histone deubiquitination; P:histone H4 acetylation; P:histone ubiquitination; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UPT9 A0JNS3 Q2NLE2 Q6MZY4 Q8TBS8 Q96IW5,Ubiquitin carboxyl-terminal hydrolase 22,Deubiquitinating enzyme 22;Ubiquitin thioesterase 22;Ubiquitin-specific-processing protease 22;, PF00443;PF02148;, GO:0005654;GO:0000124;GO:0008234;GO:0019899;GO:0030374;GO:0004843;GO:0003713;GO:0008270;GO:0007049;GO:0009792;GO:0016578;GO:0043967;GO:0016574;GO:0045931;GO:0045893;GO:0016579;GO:0006511;, C:nucleoplasm; C:SAGA complex;, F:cysteine-type peptidase activity; F:enzyme binding; F:nuclear receptor coactivator activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:zinc ion binding;, P:cell cycle; P:embryo development ending in birth or egg hatching; P:histone deubiquitination; P:histone H4 acetylation; P:histone ubiquitination; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UPT9 A0JNS3 Q2NLE2 Q6MZY4 Q8TBS8 Q96IW5,Ubiquitin carboxyl-terminal hydrolase 22,Deubiquitinating enzyme 22;Ubiquitin thioesterase 22;Ubiquitin-specific-processing protease 22;, PF00443;PF02148;, GO:0005654;GO:0000124;GO:0008234;GO:0019899;GO:0030374;GO:0004843;GO:0003713;GO:0008270;GO:0007049;GO:0009792;GO:0016578;GO:0043967;GO:0016574;GO:0045931;GO:0045893;GO:0016579;GO:0006511;, C:nucleoplasm; C:SAGA complex;, F:cysteine-type peptidase activity; F:enzyme binding; F:nuclear receptor coactivator activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:zinc ion binding;, P:cell cycle; P:embryo development ending in birth or egg hatching; P:histone deubiquitination; P:histone H4 acetylation; P:histone ubiquitination; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UPT9 A0JNS3 Q2NLE2 Q6MZY4 Q8TBS8 Q96IW5,Ubiquitin carboxyl-terminal hydrolase 22,Deubiquitinating enzyme 22;Ubiquitin thioesterase 22;Ubiquitin-specific-processing protease 22;, PF00443;PF02148;, GO:0005654;GO:0000124;GO:0008234;GO:0019899;GO:0030374;GO:0004843;GO:0003713;GO:0008270;GO:0007049;GO:0009792;GO:0016578;GO:0043967;GO:0016574;GO:0045931;GO:0045893;GO:0016579;GO:0006511;, C:nucleoplasm; C:SAGA complex;, F:cysteine-type peptidase activity; F:enzyme binding; F:nuclear receptor coactivator activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:zinc ion binding;, P:cell cycle; P:embryo development ending in birth or egg hatching; P:histone deubiquitination; P:histone H4 acetylation; P:histone ubiquitination; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9UPT9 A0JNS3 Q2NLE2 Q6MZY4 Q8TBS8 Q96IW5,Ubiquitin carboxyl-terminal hydrolase 22,Deubiquitinating enzyme 22;Ubiquitin thioesterase 22;Ubiquitin-specific-processing protease 22;, PF00443;PF02148;, GO:0005654;GO:0000124;GO:0008234;GO:0019899;GO:0030374;GO:0004843;GO:0003713;GO:0008270;GO:0007049;GO:0009792;GO:0016578;GO:0043967;GO:0016574;GO:0045931;GO:0045893;GO:0016579;GO:0006511;, C:nucleoplasm; C:SAGA complex;, F:cysteine-type peptidase activity; F:enzyme binding; F:nuclear receptor coactivator activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:zinc ion binding;, P:cell cycle; P:embryo development ending in birth or egg hatching; P:histone deubiquitination; P:histone H4 acetylation; P:histone ubiquitination; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold54 indexed_genome mRNA 5567593 5639979 . + . ID=transcript_9980;Q6WCQ1 Q3KQZ5 Q5FB94 Q6DHW2 Q7Z5Y2 Q8N390 Q96G40,Myosin phosphatase Rho-interacting protein,Rho-interacting protein 3;p116Rip;, PF00169;, GO:0015629;GO:0005829;GO:0005925;GO:0051015;GO:0045296;GO:0007015;, C:actin cytoskeleton; C:cytosol; C:focal adhesion;, F:actin filament binding; F:cadherin binding;, P:actin filament organization;|Q6WCQ1 Q3KQZ5 Q5FB94 Q6DHW2 Q7Z5Y2 Q8N390 Q96G40,Myosin phosphatase Rho-interacting protein,Rho-interacting protein 3;p116Rip;, PF00169;, GO:0015629;GO:0005829;GO:0005925;GO:0051015;GO:0045296;GO:0007015;, C:actin cytoskeleton; C:cytosol; C:focal adhesion;, F:actin filament binding; F:cadherin binding;, P:actin filament organization;|Q6WCQ1 Q3KQZ5 Q5FB94 Q6DHW2 Q7Z5Y2 Q8N390 Q96G40,Myosin phosphatase Rho-interacting protein,Rho-interacting protein 3;p116Rip;, PF00169;, GO:0015629;GO:0005829;GO:0005925;GO:0051015;GO:0045296;GO:0007015;, C:actin cytoskeleton; C:cytosol; C:focal adhesion;, F:actin filament binding; F:cadherin binding;, P:actin filament organization;|Q6WCQ1 Q3KQZ5 Q5FB94 Q6DHW2 Q7Z5Y2 Q8N390 Q96G40,Myosin phosphatase Rho-interacting protein,Rho-interacting protein 3;p116Rip;, PF00169;, GO:0015629;GO:0005829;GO:0005925;GO:0051015;GO:0045296;GO:0007015;, C:actin cytoskeleton; C:cytosol; C:focal adhesion;, F:actin filament binding; F:cadherin binding;, P:actin filament organization; scaffold54 indexed_genome mRNA 5655206 5668809 . + . ID=transcript_9981;Q8NFG4 A6NJJ8 Q6ZRX1 Q96BD2 Q96BE4,Folliculin {ECO:0000303|PubMed:15657874},BHD skin lesion fibrofolliculoma protein {ECO:0000303|PubMed:12204536};Birt-Hogg-Dube syndrome protein {ECO:0000303|PubMed:12204536};, PF11704;PF16692;, GO:0005813;GO:0005929;GO:0005737;GO:0005829;GO:0005765;GO:0005764;GO:0072686;GO:0005634;GO:0005886;GO:0005096;GO:0005085;GO:0044877;GO:0007043;GO:0034198;GO:0009267;GO:0097009;GO:0030097;GO:0001701;GO:0032418;GO:2001170;GO:1903444;GO:0030308;GO:0030336;GO:1901723;GO:0120163;GO:0070373;GO:0010629;GO:0010823;GO:0051898;GO:1900181;GO:0035024;GO:0032007;GO:0000122;GO:0043065;GO:0010508;GO:0045785;GO:0043547;GO:0001934;GO:0032008;GO:1904263;GO:0045944;GO:0030511;GO:0032465;GO:0035065;GO:2000973;GO:0001932;GO:0046578;GO:0032006;GO:0031929;, C:centrosome; C:cilium; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:lysosome; C:mitotic spindle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding;, P:cell-cell junction assembly; P:cellular response to amino acid starvation; P:cellular response to starvation; P:energy homeostasis; P:hemopoiesis; P:in utero embryonic development; P:lysosome localization; P:negative regulation of ATP biosynthetic process; P:negative regulation of brown fat cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell proliferation involved in kidney development; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of mitochondrion organization; P:negative regulation of protein kinase B signaling; P:negative regulation of protein localization to nucleus; P:negative regulation of Rho protein signal transduction; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cell adhesion; P:positive regulation of GTPase activity; P:positive regulation of protein phosphorylation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cytokinesis; P:regulation of histone acetylation; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:regulation of Ras protein signal transduction; P:regulation of TOR signaling; P:TOR signaling;|Q8NFG4 A6NJJ8 Q6ZRX1 Q96BD2 Q96BE4,Folliculin {ECO:0000303|PubMed:15657874},BHD skin lesion fibrofolliculoma protein {ECO:0000303|PubMed:12204536};Birt-Hogg-Dube syndrome protein {ECO:0000303|PubMed:12204536};, PF11704;PF16692;, GO:0005813;GO:0005929;GO:0005737;GO:0005829;GO:0005765;GO:0005764;GO:0072686;GO:0005634;GO:0005886;GO:0005096;GO:0005085;GO:0044877;GO:0007043;GO:0034198;GO:0009267;GO:0097009;GO:0030097;GO:0001701;GO:0032418;GO:2001170;GO:1903444;GO:0030308;GO:0030336;GO:1901723;GO:0120163;GO:0070373;GO:0010629;GO:0010823;GO:0051898;GO:1900181;GO:0035024;GO:0032007;GO:0000122;GO:0043065;GO:0010508;GO:0045785;GO:0043547;GO:0001934;GO:0032008;GO:1904263;GO:0045944;GO:0030511;GO:0032465;GO:0035065;GO:2000973;GO:0001932;GO:0046578;GO:0032006;GO:0031929;, C:centrosome; C:cilium; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:lysosome; C:mitotic spindle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding;, P:cell-cell junction assembly; P:cellular response to amino acid starvation; P:cellular response to starvation; P:energy homeostasis; P:hemopoiesis; P:in utero embryonic development; P:lysosome localization; P:negative regulation of ATP biosynthetic process; P:negative regulation of brown fat cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell proliferation involved in kidney development; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of mitochondrion organization; P:negative regulation of protein kinase B signaling; P:negative regulation of protein localization to nucleus; P:negative regulation of Rho protein signal transduction; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cell adhesion; P:positive regulation of GTPase activity; P:positive regulation of protein phosphorylation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cytokinesis; P:regulation of histone acetylation; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:regulation of Ras protein signal transduction; P:regulation of TOR signaling; P:TOR signaling;|Q8NFG4 A6NJJ8 Q6ZRX1 Q96BD2 Q96BE4,Folliculin {ECO:0000303|PubMed:15657874},BHD skin lesion fibrofolliculoma protein {ECO:0000303|PubMed:12204536};Birt-Hogg-Dube syndrome protein {ECO:0000303|PubMed:12204536};, PF11704;PF16692;, GO:0005813;GO:0005929;GO:0005737;GO:0005829;GO:0005765;GO:0005764;GO:0072686;GO:0005634;GO:0005886;GO:0005096;GO:0005085;GO:0044877;GO:0007043;GO:0034198;GO:0009267;GO:0097009;GO:0030097;GO:0001701;GO:0032418;GO:2001170;GO:1903444;GO:0030308;GO:0030336;GO:1901723;GO:0120163;GO:0070373;GO:0010629;GO:0010823;GO:0051898;GO:1900181;GO:0035024;GO:0032007;GO:0000122;GO:0043065;GO:0010508;GO:0045785;GO:0043547;GO:0001934;GO:0032008;GO:1904263;GO:0045944;GO:0030511;GO:0032465;GO:0035065;GO:2000973;GO:0001932;GO:0046578;GO:0032006;GO:0031929;, C:centrosome; C:cilium; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:lysosome; C:mitotic spindle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding;, P:cell-cell junction assembly; P:cellular response to amino acid starvation; P:cellular response to starvation; P:energy homeostasis; P:hemopoiesis; P:in utero embryonic development; P:lysosome localization; P:negative regulation of ATP biosynthetic process; P:negative regulation of brown fat cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell proliferation involved in kidney development; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of mitochondrion organization; P:negative regulation of protein kinase B signaling; P:negative regulation of protein localization to nucleus; P:negative regulation of Rho protein signal transduction; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cell adhesion; P:positive regulation of GTPase activity; P:positive regulation of protein phosphorylation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cytokinesis; P:regulation of histone acetylation; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:regulation of Ras protein signal transduction; P:regulation of TOR signaling; P:TOR signaling;|Q8NFG4 A6NJJ8 Q6ZRX1 Q96BD2 Q96BE4,Folliculin {ECO:0000303|PubMed:15657874},BHD skin lesion fibrofolliculoma protein {ECO:0000303|PubMed:12204536};Birt-Hogg-Dube syndrome protein {ECO:0000303|PubMed:12204536};, PF11704;PF16692;, GO:0005813;GO:0005929;GO:0005737;GO:0005829;GO:0005765;GO:0005764;GO:0072686;GO:0005634;GO:0005886;GO:0005096;GO:0005085;GO:0044877;GO:0007043;GO:0034198;GO:0009267;GO:0097009;GO:0030097;GO:0001701;GO:0032418;GO:2001170;GO:1903444;GO:0030308;GO:0030336;GO:1901723;GO:0120163;GO:0070373;GO:0010629;GO:0010823;GO:0051898;GO:1900181;GO:0035024;GO:0032007;GO:0000122;GO:0043065;GO:0010508;GO:0045785;GO:0043547;GO:0001934;GO:0032008;GO:1904263;GO:0045944;GO:0030511;GO:0032465;GO:0035065;GO:2000973;GO:0001932;GO:0046578;GO:0032006;GO:0031929;, C:centrosome; C:cilium; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:lysosome; C:mitotic spindle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding;, P:cell-cell junction assembly; P:cellular response to amino acid starvation; P:cellular response to starvation; P:energy homeostasis; P:hemopoiesis; P:in utero embryonic development; P:lysosome localization; P:negative regulation of ATP biosynthetic process; P:negative regulation of brown fat cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell proliferation involved in kidney development; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of mitochondrion organization; P:negative regulation of protein kinase B signaling; P:negative regulation of protein localization to nucleus; P:negative regulation of Rho protein signal transduction; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cell adhesion; P:positive regulation of GTPase activity; P:positive regulation of protein phosphorylation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cytokinesis; P:regulation of histone acetylation; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:regulation of Ras protein signal transduction; P:regulation of TOR signaling; P:TOR signaling;|Q8NFG4 A6NJJ8 Q6ZRX1 Q96BD2 Q96BE4,Folliculin {ECO:0000303|PubMed:15657874},BHD skin lesion fibrofolliculoma protein {ECO:0000303|PubMed:12204536};Birt-Hogg-Dube syndrome protein {ECO:0000303|PubMed:12204536};, PF11704;PF16692;, GO:0005813;GO:0005929;GO:0005737;GO:0005829;GO:0005765;GO:0005764;GO:0072686;GO:0005634;GO:0005886;GO:0005096;GO:0005085;GO:0044877;GO:0007043;GO:0034198;GO:0009267;GO:0097009;GO:0030097;GO:0001701;GO:0032418;GO:2001170;GO:1903444;GO:0030308;GO:0030336;GO:1901723;GO:0120163;GO:0070373;GO:0010629;GO:0010823;GO:0051898;GO:1900181;GO:0035024;GO:0032007;GO:0000122;GO:0043065;GO:0010508;GO:0045785;GO:0043547;GO:0001934;GO:0032008;GO:1904263;GO:0045944;GO:0030511;GO:0032465;GO:0035065;GO:2000973;GO:0001932;GO:0046578;GO:0032006;GO:0031929;, C:centrosome; C:cilium; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:lysosome; C:mitotic spindle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding;, P:cell-cell junction assembly; P:cellular response to amino acid starvation; P:cellular response to starvation; P:energy homeostasis; P:hemopoiesis; P:in utero embryonic development; P:lysosome localization; P:negative regulation of ATP biosynthetic process; P:negative regulation of brown fat cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell proliferation involved in kidney development; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of mitochondrion organization; P:negative regulation of protein kinase B signaling; P:negative regulation of protein localization to nucleus; P:negative regulation of Rho protein signal transduction; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cell adhesion; P:positive regulation of GTPase activity; P:positive regulation of protein phosphorylation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cytokinesis; P:regulation of histone acetylation; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:regulation of Ras protein signal transduction; P:regulation of TOR signaling; P:TOR signaling;|Q8NFG4 A6NJJ8 Q6ZRX1 Q96BD2 Q96BE4,Folliculin {ECO:0000303|PubMed:15657874},BHD skin lesion fibrofolliculoma protein {ECO:0000303|PubMed:12204536};Birt-Hogg-Dube syndrome protein {ECO:0000303|PubMed:12204536};, PF11704;PF16692;, GO:0005813;GO:0005929;GO:0005737;GO:0005829;GO:0005765;GO:0005764;GO:0072686;GO:0005634;GO:0005886;GO:0005096;GO:0005085;GO:0044877;GO:0007043;GO:0034198;GO:0009267;GO:0097009;GO:0030097;GO:0001701;GO:0032418;GO:2001170;GO:1903444;GO:0030308;GO:0030336;GO:1901723;GO:0120163;GO:0070373;GO:0010629;GO:0010823;GO:0051898;GO:1900181;GO:0035024;GO:0032007;GO:0000122;GO:0043065;GO:0010508;GO:0045785;GO:0043547;GO:0001934;GO:0032008;GO:1904263;GO:0045944;GO:0030511;GO:0032465;GO:0035065;GO:2000973;GO:0001932;GO:0046578;GO:0032006;GO:0031929;, C:centrosome; C:cilium; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:lysosome; C:mitotic spindle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding;, P:cell-cell junction assembly; P:cellular response to amino acid starvation; P:cellular response to starvation; P:energy homeostasis; P:hemopoiesis; P:in utero embryonic development; P:lysosome localization; P:negative regulation of ATP biosynthetic process; P:negative regulation of brown fat cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell proliferation involved in kidney development; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of mitochondrion organization; P:negative regulation of protein kinase B signaling; P:negative regulation of protein localization to nucleus; P:negative regulation of Rho protein signal transduction; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cell adhesion; P:positive regulation of GTPase activity; P:positive regulation of protein phosphorylation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cytokinesis; P:regulation of histone acetylation; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:regulation of Ras protein signal transduction; P:regulation of TOR signaling; P:TOR signaling;|Q8NFG4 A6NJJ8 Q6ZRX1 Q96BD2 Q96BE4,Folliculin {ECO:0000303|PubMed:15657874},BHD skin lesion fibrofolliculoma protein {ECO:0000303|PubMed:12204536};Birt-Hogg-Dube syndrome protein {ECO:0000303|PubMed:12204536};, PF11704;PF16692;, GO:0005813;GO:0005929;GO:0005737;GO:0005829;GO:0005765;GO:0005764;GO:0072686;GO:0005634;GO:0005886;GO:0005096;GO:0005085;GO:0044877;GO:0007043;GO:0034198;GO:0009267;GO:0097009;GO:0030097;GO:0001701;GO:0032418;GO:2001170;GO:1903444;GO:0030308;GO:0030336;GO:1901723;GO:0120163;GO:0070373;GO:0010629;GO:0010823;GO:0051898;GO:1900181;GO:0035024;GO:0032007;GO:0000122;GO:0043065;GO:0010508;GO:0045785;GO:0043547;GO:0001934;GO:0032008;GO:1904263;GO:0045944;GO:0030511;GO:0032465;GO:0035065;GO:2000973;GO:0001932;GO:0046578;GO:0032006;GO:0031929;, C:centrosome; C:cilium; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:lysosome; C:mitotic spindle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding;, P:cell-cell junction assembly; P:cellular response to amino acid starvation; P:cellular response to starvation; P:energy homeostasis; P:hemopoiesis; P:in utero embryonic development; P:lysosome localization; P:negative regulation of ATP biosynthetic process; P:negative regulation of brown fat cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell proliferation involved in kidney development; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of mitochondrion organization; P:negative regulation of protein kinase B signaling; P:negative regulation of protein localization to nucleus; P:negative regulation of Rho protein signal transduction; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cell adhesion; P:positive regulation of GTPase activity; P:positive regulation of protein phosphorylation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cytokinesis; P:regulation of histone acetylation; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:regulation of Ras protein signal transduction; P:regulation of TOR signaling; P:TOR signaling;|Q8NFG4 A6NJJ8 Q6ZRX1 Q96BD2 Q96BE4,Folliculin {ECO:0000303|PubMed:15657874},BHD skin lesion fibrofolliculoma protein {ECO:0000303|PubMed:12204536};Birt-Hogg-Dube syndrome protein {ECO:0000303|PubMed:12204536};, PF11704;PF16692;, GO:0005813;GO:0005929;GO:0005737;GO:0005829;GO:0005765;GO:0005764;GO:0072686;GO:0005634;GO:0005886;GO:0005096;GO:0005085;GO:0044877;GO:0007043;GO:0034198;GO:0009267;GO:0097009;GO:0030097;GO:0001701;GO:0032418;GO:2001170;GO:1903444;GO:0030308;GO:0030336;GO:1901723;GO:0120163;GO:0070373;GO:0010629;GO:0010823;GO:0051898;GO:1900181;GO:0035024;GO:0032007;GO:0000122;GO:0043065;GO:0010508;GO:0045785;GO:0043547;GO:0001934;GO:0032008;GO:1904263;GO:0045944;GO:0030511;GO:0032465;GO:0035065;GO:2000973;GO:0001932;GO:0046578;GO:0032006;GO:0031929;, C:centrosome; C:cilium; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:lysosome; C:mitotic spindle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding;, P:cell-cell junction assembly; P:cellular response to amino acid starvation; P:cellular response to starvation; P:energy homeostasis; P:hemopoiesis; P:in utero embryonic development; P:lysosome localization; P:negative regulation of ATP biosynthetic process; P:negative regulation of brown fat cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell proliferation involved in kidney development; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of mitochondrion organization; P:negative regulation of protein kinase B signaling; P:negative regulation of protein localization to nucleus; P:negative regulation of Rho protein signal transduction; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cell adhesion; P:positive regulation of GTPase activity; P:positive regulation of protein phosphorylation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cytokinesis; P:regulation of histone acetylation; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:regulation of Ras protein signal transduction; P:regulation of TOR signaling; P:TOR signaling;|Q8NFG4 A6NJJ8 Q6ZRX1 Q96BD2 Q96BE4,Folliculin {ECO:0000303|PubMed:15657874},BHD skin lesion fibrofolliculoma protein {ECO:0000303|PubMed:12204536};Birt-Hogg-Dube syndrome protein {ECO:0000303|PubMed:12204536};, PF11704;PF16692;, GO:0005813;GO:0005929;GO:0005737;GO:0005829;GO:0005765;GO:0005764;GO:0072686;GO:0005634;GO:0005886;GO:0005096;GO:0005085;GO:0044877;GO:0007043;GO:0034198;GO:0009267;GO:0097009;GO:0030097;GO:0001701;GO:0032418;GO:2001170;GO:1903444;GO:0030308;GO:0030336;GO:1901723;GO:0120163;GO:0070373;GO:0010629;GO:0010823;GO:0051898;GO:1900181;GO:0035024;GO:0032007;GO:0000122;GO:0043065;GO:0010508;GO:0045785;GO:0043547;GO:0001934;GO:0032008;GO:1904263;GO:0045944;GO:0030511;GO:0032465;GO:0035065;GO:2000973;GO:0001932;GO:0046578;GO:0032006;GO:0031929;, C:centrosome; C:cilium; C:cytoplasm; C:cytosol; C:lysosomal membrane; C:lysosome; C:mitotic spindle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein-containing complex binding;, P:cell-cell junction assembly; P:cellular response to amino acid starvation; P:cellular response to starvation; P:energy homeostasis; P:hemopoiesis; P:in utero embryonic development; P:lysosome localization; P:negative regulation of ATP biosynthetic process; P:negative regulation of brown fat cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell migration; P:negative regulation of cell proliferation involved in kidney development; P:negative regulation of cold-induced thermogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of gene expression; P:negative regulation of mitochondrion organization; P:negative regulation of protein kinase B signaling; P:negative regulation of protein localization to nucleus; P:negative regulation of Rho protein signal transduction; P:negative regulation of TOR signaling; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cell adhesion; P:positive regulation of GTPase activity; P:positive regulation of protein phosphorylation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cytokinesis; P:regulation of histone acetylation; P:regulation of pro-B cell differentiation; P:regulation of protein phosphorylation; P:regulation of Ras protein signal transduction; P:regulation of TOR signaling; P:TOR signaling; scaffold54 indexed_genome mRNA 5680736 5701185 . - . ID=transcript_9982;Q9UNS2 B2R683 B4DY81 O43191 Q7LDR6,COP9 signalosome complex subunit 3,JAB1-containing signalosome subunit 3;, PF01399;, GO:0008180;GO:0005737;GO:0005829;GO:0005654;GO:0001701;GO:0000715;GO:0043687;GO:0000338;GO:0009416;GO:0007165;GO:0006283;GO:0006511;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:nucleoplasm;, , P:in utero embryonic development; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:response to light stimulus; P:signal transduction; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process;|Q9UNS2 B2R683 B4DY81 O43191 Q7LDR6,COP9 signalosome complex subunit 3,JAB1-containing signalosome subunit 3;, PF01399;, GO:0008180;GO:0005737;GO:0005829;GO:0005654;GO:0001701;GO:0000715;GO:0043687;GO:0000338;GO:0009416;GO:0007165;GO:0006283;GO:0006511;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:nucleoplasm;, , P:in utero embryonic development; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:response to light stimulus; P:signal transduction; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process;|Q9UNS2 B2R683 B4DY81 O43191 Q7LDR6,COP9 signalosome complex subunit 3,JAB1-containing signalosome subunit 3;, PF01399;, GO:0008180;GO:0005737;GO:0005829;GO:0005654;GO:0001701;GO:0000715;GO:0043687;GO:0000338;GO:0009416;GO:0007165;GO:0006283;GO:0006511;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:nucleoplasm;, , P:in utero embryonic development; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:response to light stimulus; P:signal transduction; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process;|Q9UNS2 B2R683 B4DY81 O43191 Q7LDR6,COP9 signalosome complex subunit 3,JAB1-containing signalosome subunit 3;, PF01399;, GO:0008180;GO:0005737;GO:0005829;GO:0005654;GO:0001701;GO:0000715;GO:0043687;GO:0000338;GO:0009416;GO:0007165;GO:0006283;GO:0006511;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:nucleoplasm;, , P:in utero embryonic development; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:response to light stimulus; P:signal transduction; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process;|Q9UNS2 B2R683 B4DY81 O43191 Q7LDR6,COP9 signalosome complex subunit 3,JAB1-containing signalosome subunit 3;, PF01399;, GO:0008180;GO:0005737;GO:0005829;GO:0005654;GO:0001701;GO:0000715;GO:0043687;GO:0000338;GO:0009416;GO:0007165;GO:0006283;GO:0006511;, C:COP9 signalosome; C:cytoplasm; C:cytosol; C:nucleoplasm;, , P:in utero embryonic development; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:response to light stimulus; P:signal transduction; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; scaffold54 indexed_genome mRNA 5704771 5715691 . + . ID=transcript_9983;Q9NPB1,5'(3')-deoxyribonucleotidase, mitochondrial,Deoxy-5'-nucleotidase 2;, PF06941;, GO:0005759;GO:0005739;GO:0008253;GO:0046872;GO:0008252;GO:0000166;GO:0006260;GO:0009223;GO:0046135;, C:mitochondrial matrix; C:mitochondrion;, F:5'-nucleotidase activity; F:metal ion binding; F:nucleotidase activity; F:nucleotide binding;, P:DNA replication; P:pyrimidine deoxyribonucleotide catabolic process; P:pyrimidine nucleoside catabolic process; scaffold54 indexed_genome mRNA 5716200 5717532 . + . ID=transcript_9984;Q9NPB1,5'(3')-deoxyribonucleotidase, mitochondrial,Deoxy-5'-nucleotidase 2;, PF06941;, GO:0005759;GO:0005739;GO:0008253;GO:0046872;GO:0008252;GO:0000166;GO:0006260;GO:0009223;GO:0046135;, C:mitochondrial matrix; C:mitochondrion;, F:5'-nucleotidase activity; F:metal ion binding; F:nucleotidase activity; F:nucleotide binding;, P:DNA replication; P:pyrimidine deoxyribonucleotide catabolic process; P:pyrimidine nucleoside catabolic process; scaffold54 indexed_genome mRNA 5758039 5765337 . + . ID=transcript_9985;Q9Y272 B2R709 B4DFF4 Q9NYB4,Dexamethasone-induced Ras-related protein 1,Activator of G-protein signaling 1;, PF00071;, GO:0005634;GO:0048471;GO:0005886;GO:0016529;GO:0005525;GO:0003924;GO:0007186;GO:0045892;GO:0007263;GO:0007165;, C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcoplasmic reticulum;, F:GTP binding; F:GTPase activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of transcription, DNA-templated; P:nitric oxide mediated signal transduction; P:signal transduction; scaffold54 indexed_genome mRNA 5773142 5807810 . - . ID=transcript_9986;Q9UBM1 A8MZ66 B4DY41 D3DXC3 Q6IAQ5 Q86VL3 Q9BW86 Q9UHY6 Q9Y6V9,Phosphatidylethanolamine N-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03216},PEMT2;Phospholipid methyltransferase {ECO:0000255|HAMAP-Rule:MF_03216};, PF04191;, GO:0031526;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0031966;GO:0005739;GO:0042383;GO:0080101;GO:0000773;GO:0008429;GO:0004608;GO:0001835;GO:0032259;GO:0008285;GO:0006656;GO:0120162;GO:0050747;GO:0043200;GO:0042493;GO:0045471;GO:0033273;GO:0046498;GO:0046500;GO:0006686;, C:brush border membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrial membrane; C:mitochondrion; C:sarcolemma;, F:phosphatidyl-N-dimethylethanolamine N-methyltransferase activity; F:phosphatidyl-N-methylethanolamine N-methyltransferase activity; F:phosphatidylethanolamine binding; F:phosphatidylethanolamine N-methyltransferase activity;, P:blastocyst hatching; P:methylation; P:negative regulation of cell population proliferation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of lipoprotein metabolic process; P:response to amino acid; P:response to drug; P:response to ethanol; P:response to vitamin; P:S-adenosylhomocysteine metabolic process; P:S-adenosylmethionine metabolic process; P:sphingomyelin biosynthetic process;|Q9UBM1 A8MZ66 B4DY41 D3DXC3 Q6IAQ5 Q86VL3 Q9BW86 Q9UHY6 Q9Y6V9,Phosphatidylethanolamine N-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03216},PEMT2;Phospholipid methyltransferase {ECO:0000255|HAMAP-Rule:MF_03216};, PF04191;, GO:0031526;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0031966;GO:0005739;GO:0042383;GO:0080101;GO:0000773;GO:0008429;GO:0004608;GO:0001835;GO:0032259;GO:0008285;GO:0006656;GO:0120162;GO:0050747;GO:0043200;GO:0042493;GO:0045471;GO:0033273;GO:0046498;GO:0046500;GO:0006686;, C:brush border membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrial membrane; C:mitochondrion; C:sarcolemma;, F:phosphatidyl-N-dimethylethanolamine N-methyltransferase activity; F:phosphatidyl-N-methylethanolamine N-methyltransferase activity; F:phosphatidylethanolamine binding; F:phosphatidylethanolamine N-methyltransferase activity;, P:blastocyst hatching; P:methylation; P:negative regulation of cell population proliferation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of lipoprotein metabolic process; P:response to amino acid; P:response to drug; P:response to ethanol; P:response to vitamin; P:S-adenosylhomocysteine metabolic process; P:S-adenosylmethionine metabolic process; P:sphingomyelin biosynthetic process;|Q9UBM1 A8MZ66 B4DY41 D3DXC3 Q6IAQ5 Q86VL3 Q9BW86 Q9UHY6 Q9Y6V9,Phosphatidylethanolamine N-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03216},PEMT2;Phospholipid methyltransferase {ECO:0000255|HAMAP-Rule:MF_03216};, PF04191;, GO:0031526;GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0031966;GO:0005739;GO:0042383;GO:0080101;GO:0000773;GO:0008429;GO:0004608;GO:0001835;GO:0032259;GO:0008285;GO:0006656;GO:0120162;GO:0050747;GO:0043200;GO:0042493;GO:0045471;GO:0033273;GO:0046498;GO:0046500;GO:0006686;, C:brush border membrane; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrial membrane; C:mitochondrion; C:sarcolemma;, F:phosphatidyl-N-dimethylethanolamine N-methyltransferase activity; F:phosphatidyl-N-methylethanolamine N-methyltransferase activity; F:phosphatidylethanolamine binding; F:phosphatidylethanolamine N-methyltransferase activity;, P:blastocyst hatching; P:methylation; P:negative regulation of cell population proliferation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of lipoprotein metabolic process; P:response to amino acid; P:response to drug; P:response to ethanol; P:response to vitamin; P:S-adenosylhomocysteine metabolic process; P:S-adenosylmethionine metabolic process; P:sphingomyelin biosynthetic process; scaffold54 indexed_genome mRNA 5924553 5938764 . + . ID=transcript_9987;Q7Z5J4 Q8N3B4 Q8ND08 Q8WU64 Q96JK5 Q9H1C1 Q9H1C2 Q9UF69,Retinoic acid-induced protein 1,, , GO:0005737;GO:0005654;GO:0005634;GO:0046872;GO:0032922;GO:0040015;GO:0045893;GO:0006357;GO:0001501;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:metal ion binding;, P:circadian regulation of gene expression; P:negative regulation of multicellular organism growth; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal system development; scaffold54 indexed_genome mRNA 5944030 5953270 . - . ID=transcript_9988;Q8TAK9,Sterol regulatory element-binding protein 1 {ECO:0000303|PubMed:8402897},Class D basic helix-loop-helix protein 1;Sterol regulatory element-binding transcription factor 1 {ECO:0000303|PubMed:8402897};, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0012507;GO:0000139;GO:0016021;GO:0005635;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0046983;GO:0019901;GO:0044877;GO:0000978;GO:0000977;GO:1990837;GO:0032810;GO:0007568;GO:0071398;GO:0009267;GO:0008203;GO:0007623;GO:0045444;GO:0008286;GO:0030522;GO:0008610;GO:0010876;GO:0006629;GO:0030324;GO:0042789;GO:0046676;GO:0000122;GO:0045542;GO:0031065;GO:1902895;GO:0045944;GO:0010867;GO:1903146;GO:0045540;GO:0019217;GO:0003062;GO:0019216;GO:0010883;GO:0031647;GO:1903214;GO:0006357;GO:0051591;GO:0042493;GO:0045471;GO:0032094;GO:0033762;GO:0009749;GO:0032570;GO:0032526;GO:0032933;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein dimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:sterol response element binding;, P:aging; P:cellular response to fatty acid; P:cellular response to starvation; P:cholesterol metabolic process; P:circadian rhythm; P:fat cell differentiation; P:insulin receptor signaling pathway; P:intracellular receptor signaling pathway; P:lipid biosynthetic process; P:lipid localization; P:lipid metabolic process; P:lung development; P:mRNA transcription by RNA polymerase II; P:negative regulation of insulin secretion; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of histone deacetylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of triglyceride biosynthetic process; P:regulation of autophagy of mitochondrion; P:regulation of cholesterol biosynthetic process; P:regulation of fatty acid metabolic process; P:regulation of heart rate by chemical signal; P:regulation of lipid metabolic process; P:regulation of lipid storage; P:regulation of protein stability; P:regulation of protein targeting to mitochondrion; P:regulation of transcription by RNA polymerase II; P:response to cAMP; P:response to drug; P:response to ethanol; P:response to food; P:response to glucagon; P:response to glucose; P:response to progesterone; P:response to retinoic acid; P:SREBP signaling pathway;|Q8TAK9,Sterol regulatory element-binding protein 1 {ECO:0000303|PubMed:8402897},Class D basic helix-loop-helix protein 1;Sterol regulatory element-binding transcription factor 1 {ECO:0000303|PubMed:8402897};, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0012507;GO:0000139;GO:0016021;GO:0005635;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0046983;GO:0019901;GO:0044877;GO:0000978;GO:0000977;GO:1990837;GO:0032810;GO:0007568;GO:0071398;GO:0009267;GO:0008203;GO:0007623;GO:0045444;GO:0008286;GO:0030522;GO:0008610;GO:0010876;GO:0006629;GO:0030324;GO:0042789;GO:0046676;GO:0000122;GO:0045542;GO:0031065;GO:1902895;GO:0045944;GO:0010867;GO:1903146;GO:0045540;GO:0019217;GO:0003062;GO:0019216;GO:0010883;GO:0031647;GO:1903214;GO:0006357;GO:0051591;GO:0042493;GO:0045471;GO:0032094;GO:0033762;GO:0009749;GO:0032570;GO:0032526;GO:0032933;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein dimerization activity; F:protein kinase binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:sterol response element binding;, P:aging; P:cellular response to fatty acid; P:cellular response to starvation; P:cholesterol metabolic process; P:circadian rhythm; P:fat cell differentiation; P:insulin receptor signaling pathway; P:intracellular receptor signaling pathway; P:lipid biosynthetic process; P:lipid localization; P:lipid metabolic process; P:lung development; P:mRNA transcription by RNA polymerase II; P:negative regulation of insulin secretion; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of histone deacetylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of triglyceride biosynthetic process; P:regulation of autophagy of mitochondrion; P:regulation of cholesterol biosynthetic process; P:regulation of fatty acid metabolic process; P:regulation of heart rate by chemical signal; P:regulation of lipid metabolic process; P:regulation of lipid storage; P:regulation of protein stability; P:regulation of protein targeting to mitochondrion; P:regulation of transcription by RNA polymerase II; P:response to cAMP; P:response to drug; P:response to ethanol; P:response to food; P:response to glucagon; P:response to glucose; P:response to progesterone; P:response to retinoic acid; P:SREBP signaling pathway; scaffold54 indexed_genome mRNA 5967513 5981610 . - . ID=transcript_9989;Q6ZVM7 B7Z2L7 B7Z7F4 Q86V61 Q8TDE7 Q96M88,TOM1-like protein 2,Target of Myb-like protein 2;, PF03127;PF00790;, GO:0005768;GO:0070062;GO:0016020;GO:0030276;GO:0019901;GO:0006886;GO:0045839;GO:0007165;, C:endosome; C:extracellular exosome; C:membrane;, F:clathrin binding; F:protein kinase binding;, P:intracellular protein transport; P:negative regulation of mitotic nuclear division; P:signal transduction; scaffold54 indexed_genome mRNA 5981958 5996805 . - . ID=transcript_9990;Q6ZVM7 B7Z2L7 B7Z7F4 Q86V61 Q8TDE7 Q96M88,TOM1-like protein 2,Target of Myb-like protein 2;, PF03127;PF00790;, GO:0005768;GO:0070062;GO:0016020;GO:0030276;GO:0019901;GO:0006886;GO:0045839;GO:0007165;, C:endosome; C:extracellular exosome; C:membrane;, F:clathrin binding; F:protein kinase binding;, P:intracellular protein transport; P:negative regulation of mitotic nuclear division; P:signal transduction; scaffold54 indexed_genome mRNA 6049543 6068200 . + . ID=transcript_9991;Q9H069 A8KAE6 Q86SF9 Q86W73 Q8IWG0,Dynein regulatory complex subunit 3,Leucine-rich repeat-containing protein 48;, , GO:0005930;GO:0005737;GO:0031514;, C:axoneme; C:cytoplasm; C:motile cilium;|Q9H069 A8KAE6 Q86SF9 Q86W73 Q8IWG0,Dynein regulatory complex subunit 3,Leucine-rich repeat-containing protein 48;, , GO:0005930;GO:0005737;GO:0031514;, C:axoneme; C:cytoplasm; C:motile cilium; scaffold54 indexed_genome mRNA 6069059 6079895 . - . ID=transcript_9992;Q8N5M1 A6NDE5 A8K2J2 Q6XYC7,ATP synthase mitochondrial F1 complex assembly factor 2,ATP12 homolog;, PF07542;, GO:0005829;GO:0005739;GO:0016607;GO:0043461;, C:cytosol; C:mitochondrion; C:nuclear speck;, , P:proton-transporting ATP synthase complex assembly;|Q8N5M1 A6NDE5 A8K2J2 Q6XYC7,ATP synthase mitochondrial F1 complex assembly factor 2,ATP12 homolog;, PF07542;, GO:0005829;GO:0005739;GO:0016607;GO:0043461;, C:cytosol; C:mitochondrion; C:nuclear speck;, , P:proton-transporting ATP synthase complex assembly; scaffold54 indexed_genome mRNA 6091652 6094914 . - . ID=transcript_9993;Q8IVV7 Q8TEB5 Q9BW50,Glucose-induced degradation protein 4 homolog,Vacuolar import and degradation protein 24 homolog;, PF09783;, GO:0000151;GO:0061630;GO:0043161;, C:ubiquitin ligase complex;, F:ubiquitin protein ligase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q8IVV7 Q8TEB5 Q9BW50,Glucose-induced degradation protein 4 homolog,Vacuolar import and degradation protein 24 homolog;, PF09783;, GO:0000151;GO:0061630;GO:0043161;, C:ubiquitin ligase complex;, F:ubiquitin protein ligase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; scaffold54 indexed_genome mRNA 6099481 6107472 . + . ID=transcript_9994;P55039 B2R8G5 Q53Y50 Q9BWB2,Developmentally-regulated GTP-binding protein 2,Translation factor GTPase DRG2;, PF01926;PF16897;PF02824;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0002181;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding;, P:cytoplasmic translation; P:signal transduction;|P55039 B2R8G5 Q53Y50 Q9BWB2,Developmentally-regulated GTP-binding protein 2,Translation factor GTPase DRG2;, PF01926;PF16897;PF02824;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0002181;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding;, P:cytoplasmic translation; P:signal transduction;|P55039 B2R8G5 Q53Y50 Q9BWB2,Developmentally-regulated GTP-binding protein 2,Translation factor GTPase DRG2;, PF01926;PF16897;PF02824;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0002181;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding;, P:cytoplasmic translation; P:signal transduction;|P55039 B2R8G5 Q53Y50 Q9BWB2,Developmentally-regulated GTP-binding protein 2,Translation factor GTPase DRG2;, PF01926;PF16897;PF02824;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0002181;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding;, P:cytoplasmic translation; P:signal transduction;|P55039 B2R8G5 Q53Y50 Q9BWB2,Developmentally-regulated GTP-binding protein 2,Translation factor GTPase DRG2;, PF01926;PF16897;PF02824;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0005525;GO:0003924;GO:0046872;GO:0003723;GO:0002181;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:GTP binding; F:GTPase activity; F:metal ion binding; F:RNA binding;, P:cytoplasmic translation; P:signal transduction; scaffold54 indexed_genome mRNA 6111449 6114025 . - . ID=transcript_9995;Q9UKN7 B4DFC7,Unconventional myosin-XV,Unconventional myosin-15;, PF00612;PF00063;PF00784;PF07653;, GO:0015629;GO:0098858;GO:0005737;GO:0070062;GO:0016459;GO:0032420;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin-based cell projection; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:stereocilium; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:sensory perception of sound; P:vesicle transport along actin filament; scaffold54 indexed_genome mRNA 6114283 6137027 . - . ID=transcript_9996;Q9UKN7 B4DFC7,Unconventional myosin-XV,Unconventional myosin-15;, PF00612;PF00063;PF00784;PF07653;, GO:0015629;GO:0098858;GO:0005737;GO:0070062;GO:0016459;GO:0032420;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin-based cell projection; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:stereocilium; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:sensory perception of sound; P:vesicle transport along actin filament;|Q9UKN7 B4DFC7,Unconventional myosin-XV,Unconventional myosin-15;, PF00612;PF00063;PF00784;PF07653;, GO:0015629;GO:0098858;GO:0005737;GO:0070062;GO:0016459;GO:0032420;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin-based cell projection; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:stereocilium; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:sensory perception of sound; P:vesicle transport along actin filament;|Q9UKN7 B4DFC7,Unconventional myosin-XV,Unconventional myosin-15;, PF00612;PF00063;PF00784;PF07653;, GO:0015629;GO:0098858;GO:0005737;GO:0070062;GO:0016459;GO:0032420;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin-based cell projection; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:stereocilium; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:sensory perception of sound; P:vesicle transport along actin filament;|Q9UKN7 B4DFC7,Unconventional myosin-XV,Unconventional myosin-15;, PF00612;PF00063;PF00784;PF07653;, GO:0015629;GO:0098858;GO:0005737;GO:0070062;GO:0016459;GO:0032420;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin-based cell projection; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:stereocilium; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:sensory perception of sound; P:vesicle transport along actin filament;|Q9UKN7 B4DFC7,Unconventional myosin-XV,Unconventional myosin-15;, PF00612;PF00063;PF00784;PF07653;, GO:0015629;GO:0098858;GO:0005737;GO:0070062;GO:0016459;GO:0032420;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin-based cell projection; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:stereocilium; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:sensory perception of sound; P:vesicle transport along actin filament;|Q9UKN7 B4DFC7,Unconventional myosin-XV,Unconventional myosin-15;, PF00612;PF00063;PF00784;PF07653;, GO:0015629;GO:0098858;GO:0005737;GO:0070062;GO:0016459;GO:0032420;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin-based cell projection; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:stereocilium; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:sensory perception of sound; P:vesicle transport along actin filament;|Q9UKN7 B4DFC7,Unconventional myosin-XV,Unconventional myosin-15;, PF00612;PF00063;PF00784;PF07653;, GO:0015629;GO:0098858;GO:0005737;GO:0070062;GO:0016459;GO:0032420;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin-based cell projection; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:stereocilium; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:sensory perception of sound; P:vesicle transport along actin filament; scaffold54 indexed_genome mRNA 6137262 6160213 . + . ID=transcript_9997;Q9UKN7 B4DFC7,Unconventional myosin-XV,Unconventional myosin-15;, PF00612;PF00063;PF00784;PF07653;, GO:0015629;GO:0098858;GO:0005737;GO:0070062;GO:0016459;GO:0032420;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin-based cell projection; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:stereocilium; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:sensory perception of sound; P:vesicle transport along actin filament;|Q9UKN7 B4DFC7,Unconventional myosin-XV,Unconventional myosin-15;, PF00612;PF00063;PF00784;PF07653;, GO:0015629;GO:0098858;GO:0005737;GO:0070062;GO:0016459;GO:0032420;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:actin-based cell projection; C:cytoplasm; C:extracellular exosome; C:myosin complex; C:stereocilium; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:sensory perception of sound; P:vesicle transport along actin filament; scaffold54 indexed_genome mRNA 6187505 6191682 . + . ID=transcript_9998;Q6P6C2 B4DVJ4 D3DXC6 Q9NXD6,RNA demethylase ALKBH5 {ECO:0000303|PubMed:24616105},Alkylated DNA repair protein alkB homolog 5;Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5;, PF13532;, GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0016706;GO:0046872;GO:0035515;GO:0003723;GO:1990931;GO:0030154;GO:0006307;GO:0006406;GO:0006397;GO:0035553;GO:0043488;GO:0001666;GO:0007283;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:metal ion binding; F:oxidative RNA demethylase activity; F:RNA binding; F:RNA N6-methyladenosine dioxygenase activity;, P:cell differentiation; P:DNA dealkylation involved in DNA repair; P:mRNA export from nucleus; P:mRNA processing; P:oxidative single-stranded RNA demethylation; P:regulation of mRNA stability; P:response to hypoxia; P:spermatogenesis;|Q6P6C2 B4DVJ4 D3DXC6 Q9NXD6,RNA demethylase ALKBH5 {ECO:0000303|PubMed:24616105},Alkylated DNA repair protein alkB homolog 5;Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5;, PF13532;, GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0016706;GO:0046872;GO:0035515;GO:0003723;GO:1990931;GO:0030154;GO:0006307;GO:0006406;GO:0006397;GO:0035553;GO:0043488;GO:0001666;GO:0007283;, C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:metal ion binding; F:oxidative RNA demethylase activity; F:RNA binding; F:RNA N6-methyladenosine dioxygenase activity;, P:cell differentiation; P:DNA dealkylation involved in DNA repair; P:mRNA export from nucleus; P:mRNA processing; P:oxidative single-stranded RNA demethylation; P:regulation of mRNA stability; P:response to hypoxia; P:spermatogenesis; scaffold54 indexed_genome mRNA 6209005 6251760 . + . ID=transcript_9999;Q13045 B4DIL0 F5H407 J3QLG3,Protein flightless-1 homolog,, PF00626;PF13855;, GO:0015629;GO:0005903;GO:0034451;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0003779;GO:0051015;GO:0005546;GO:0051014;GO:0008154;GO:0051016;GO:0007275;GO:0030239;, C:actin cytoskeleton; C:brush border; C:centriolar satellite; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:actin binding; F:actin filament binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:multicellular organism development; P:myofibril assembly;|Q15334 A7MBM7 O00188 Q58F11 Q86UK6,Lethal(2) giant larvae protein homolog 1,DLG4;Hugl-1;Human homolog to the D-lgl gene protein;, PF08366;PF00400;, GO:0030424;GO:0030864;GO:0005737;GO:0005856;GO:0031901;GO:0000137;GO:0005886;GO:0032588;GO:0005096;GO:0045159;GO:0019901;GO:0005198;GO:0007409;GO:0030866;GO:0051294;GO:0006887;GO:0006893;GO:0065003;GO:0032878;GO:0008593;GO:0050708;, C:axon; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:early endosome membrane; C:Golgi cis cisterna; C:plasma membrane; C:trans-Golgi network membrane;, F:GTPase activator activity; F:myosin II binding; F:protein kinase binding; F:structural molecule activity;, P:axonogenesis; P:cortical actin cytoskeleton organization; P:establishment of spindle orientation; P:exocytosis; P:Golgi to plasma membrane transport; P:protein-containing complex assembly; P:regulation of establishment or maintenance of cell polarity; P:regulation of Notch signaling pathway; P:regulation of protein secretion;|Q13045 B4DIL0 F5H407 J3QLG3,Protein flightless-1 homolog,, PF00626;PF13855;, GO:0015629;GO:0005903;GO:0034451;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0003779;GO:0051015;GO:0005546;GO:0051014;GO:0008154;GO:0051016;GO:0007275;GO:0030239;, C:actin cytoskeleton; C:brush border; C:centriolar satellite; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:actin binding; F:actin filament binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:multicellular organism development; P:myofibril assembly;|Q13045 B4DIL0 F5H407 J3QLG3,Protein flightless-1 homolog,, PF00626;PF13855;, GO:0015629;GO:0005903;GO:0034451;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0003779;GO:0051015;GO:0005546;GO:0051014;GO:0008154;GO:0051016;GO:0007275;GO:0030239;, C:actin cytoskeleton; C:brush border; C:centriolar satellite; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:actin binding; F:actin filament binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:multicellular organism development; P:myofibril assembly;|Q13045 B4DIL0 F5H407 J3QLG3,Protein flightless-1 homolog,, PF00626;PF13855;, GO:0015629;GO:0005903;GO:0034451;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0003779;GO:0051015;GO:0005546;GO:0051014;GO:0008154;GO:0051016;GO:0007275;GO:0030239;, C:actin cytoskeleton; C:brush border; C:centriolar satellite; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:actin binding; F:actin filament binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:actin filament severing; P:actin polymerization or depolymerization; P:barbed-end actin filament capping; P:multicellular organism development; P:myofibril assembly;|Q96C03 J3KPT3 Q6ZRD4 Q96N07,Mitochondrial dynamics protein MID49,Mitochondrial dynamics protein of 49 kDa;Mitochondrial elongation factor 2;Smith-Magenis syndrome chromosomal region candidate gene 7 protein;, PF03281;, GO:0016021;GO:0005741;GO:0005739;GO:0003374;GO:0007005;GO:0090141;GO:0090314;GO:0010821;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, , P:dynamin family protein polymerization involved in mitochondrial fission; P:mitochondrion organization; P:positive regulation of mitochondrial fission; P:positive regulation of protein targeting to membrane; P:regulation of mitochondrion organization;|Q96C03 J3KPT3 Q6ZRD4 Q96N07,Mitochondrial dynamics protein MID49,Mitochondrial dynamics protein of 49 kDa;Mitochondrial elongation factor 2;Smith-Magenis syndrome chromosomal region candidate gene 7 protein;, PF03281;, GO:0016021;GO:0005741;GO:0005739;GO:0003374;GO:0007005;GO:0090141;GO:0090314;GO:0010821;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, , P:dynamin family protein polymerization involved in mitochondrial fission; P:mitochondrion organization; P:positive regulation of mitochondrial fission; P:positive regulation of protein targeting to membrane; P:regulation of mitochondrion organization; scaffold54 indexed_genome mRNA 6253865 6273969 . - . ID=transcript_10000;Q13472 A8KA61 B4DK80 D3DXC7 Q13473,DNA topoisomerase 3-alpha,DNA topoisomerase III alpha;, PF01131;PF01751;PF01396;PF06839;, GO:0005694;GO:0005759;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0003916;GO:0003917;GO:0003697;GO:0008270;GO:0051304;GO:0006260;GO:0006265;GO:0051321;GO:0032042;GO:1901796;, C:chromosome; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:DNA topoisomerase activity; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:single-stranded DNA binding; F:zinc ion binding;, P:chromosome separation; P:DNA replication; P:DNA topological change; P:meiotic cell cycle; P:mitochondrial DNA metabolic process; P:regulation of signal transduction by p53 class mediator;|Q13472 A8KA61 B4DK80 D3DXC7 Q13473,DNA topoisomerase 3-alpha,DNA topoisomerase III alpha;, PF01131;PF01751;PF01396;PF06839;, GO:0005694;GO:0005759;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0003916;GO:0003917;GO:0003697;GO:0008270;GO:0051304;GO:0006260;GO:0006265;GO:0051321;GO:0032042;GO:1901796;, C:chromosome; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:DNA topoisomerase activity; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:single-stranded DNA binding; F:zinc ion binding;, P:chromosome separation; P:DNA replication; P:DNA topological change; P:meiotic cell cycle; P:mitochondrial DNA metabolic process; P:regulation of signal transduction by p53 class mediator;|Q13472 A8KA61 B4DK80 D3DXC7 Q13473,DNA topoisomerase 3-alpha,DNA topoisomerase III alpha;, PF01131;PF01751;PF01396;PF06839;, GO:0005694;GO:0005759;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0003916;GO:0003917;GO:0003697;GO:0008270;GO:0051304;GO:0006260;GO:0006265;GO:0051321;GO:0032042;GO:1901796;, C:chromosome; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:DNA topoisomerase activity; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:single-stranded DNA binding; F:zinc ion binding;, P:chromosome separation; P:DNA replication; P:DNA topological change; P:meiotic cell cycle; P:mitochondrial DNA metabolic process; P:regulation of signal transduction by p53 class mediator;|Q13472 A8KA61 B4DK80 D3DXC7 Q13473,DNA topoisomerase 3-alpha,DNA topoisomerase III alpha;, PF01131;PF01751;PF01396;PF06839;, GO:0005694;GO:0005759;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0003916;GO:0003917;GO:0003697;GO:0008270;GO:0051304;GO:0006260;GO:0006265;GO:0051321;GO:0032042;GO:1901796;, C:chromosome; C:mitochondrial matrix; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:DNA topoisomerase activity; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:single-stranded DNA binding; F:zinc ion binding;, P:chromosome separation; P:DNA replication; P:DNA topological change; P:meiotic cell cycle; P:mitochondrial DNA metabolic process; P:regulation of signal transduction by p53 class mediator; scaffold54 indexed_genome mRNA 6274092 6297830 . - . ID=transcript_10001;Q8TEV9 A5PKZ5 Q3ZCN0 Q6PJL3,Guanine nucleotide exchange protein SMCR8 {ECO:0000305},Smith-Magenis syndrome chromosomal region candidate gene 8 protein {ECO:0000312|HGNC:HGNC:17921};, PF11704;, GO:1990316;GO:0000785;GO:0005737;GO:0032045;GO:0005654;GO:0005085;GO:0019901;GO:0004860;GO:0006914;GO:1902902;GO:0010629;GO:0016242;GO:0006469;GO:1901098;GO:0032008;GO:0010506;GO:1903432;, C:Atg1/ULK1 kinase complex; C:chromatin; C:cytoplasm; C:guanyl-nucleotide exchange factor complex; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity; F:protein kinase binding; F:protein kinase inhibitor activity;, P:autophagy; P:negative regulation of autophagosome assembly; P:negative regulation of gene expression; P:negative regulation of macroautophagy; P:negative regulation of protein kinase activity; P:positive regulation of autophagosome maturation; P:positive regulation of TOR signaling; P:regulation of autophagy; P:regulation of TORC1 signaling;|P34896 B4DPM9 D3DXD0 Q96HY0 Q9UMD1 Q9UMD2,Serine hydroxymethyltransferase, cytosolic,Glycine hydroxymethyltransferase;Serine methylase;, PF00464;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0050897;GO:0004372;GO:0042802;GO:0008732;GO:0048027;GO:0042803;GO:0030170;GO:0070905;GO:0036094;GO:0000900;GO:0008270;GO:0045329;GO:1990830;GO:1904482;GO:0046655;GO:0019264;GO:0006544;GO:0006565;GO:0006563;GO:0017148;GO:0006730;GO:0051289;GO:0009113;GO:0035999;GO:0046653;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:cobalt ion binding; F:glycine hydroxymethyltransferase activity; F:identical protein binding; F:L-allo-threonine aldolase activity; F:mRNA 5'-UTR binding; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:serine binding; F:small molecule binding; F:translation repressor activity, mRNA regulatory element binding; F:zinc ion binding;, P:carnitine biosynthetic process; P:cellular response to leukemia inhibitory factor; P:cellular response to tetrahydrofolate; P:folic acid metabolic process; P:glycine biosynthetic process from serine; P:glycine metabolic process; P:L-serine catabolic process; P:L-serine metabolic process; P:negative regulation of translation; P:one-carbon metabolic process; P:protein homotetramerization; P:purine nucleobase biosynthetic process; P:tetrahydrofolate interconversion; P:tetrahydrofolate metabolic process;|P34896 B4DPM9 D3DXD0 Q96HY0 Q9UMD1 Q9UMD2,Serine hydroxymethyltransferase, cytosolic,Glycine hydroxymethyltransferase;Serine methylase;, PF00464;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0050897;GO:0004372;GO:0042802;GO:0008732;GO:0048027;GO:0042803;GO:0030170;GO:0070905;GO:0036094;GO:0000900;GO:0008270;GO:0045329;GO:1990830;GO:1904482;GO:0046655;GO:0019264;GO:0006544;GO:0006565;GO:0006563;GO:0017148;GO:0006730;GO:0051289;GO:0009113;GO:0035999;GO:0046653;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:cobalt ion binding; F:glycine hydroxymethyltransferase activity; F:identical protein binding; F:L-allo-threonine aldolase activity; F:mRNA 5'-UTR binding; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:serine binding; F:small molecule binding; F:translation repressor activity, mRNA regulatory element binding; F:zinc ion binding;, P:carnitine biosynthetic process; P:cellular response to leukemia inhibitory factor; P:cellular response to tetrahydrofolate; P:folic acid metabolic process; P:glycine biosynthetic process from serine; P:glycine metabolic process; P:L-serine catabolic process; P:L-serine metabolic process; P:negative regulation of translation; P:one-carbon metabolic process; P:protein homotetramerization; P:purine nucleobase biosynthetic process; P:tetrahydrofolate interconversion; P:tetrahydrofolate metabolic process; scaffold54 indexed_genome mRNA 6343799 6364633 . + . ID=transcript_10002;O60256 B4E1M8 B4E329 B7ZKZ1 E7EMY2 Q6IAS2,Phosphoribosyl pyrophosphate synthase-associated protein 2,41 kDa phosphoribosypyrophosphate synthetase-associated protein;, PF14572;PF13793;, GO:0005737;GO:0002189;GO:0004857;GO:0042802;GO:0000287;GO:0004749;GO:0006015;GO:0006139;GO:0009116;GO:0006164;, C:cytoplasm; C:ribose phosphate diphosphokinase complex;, F:enzyme inhibitor activity; F:identical protein binding; F:magnesium ion binding; F:ribose phosphate diphosphokinase activity;, P:5-phosphoribose 1-diphosphate biosynthetic process; P:nucleobase-containing compound metabolic process; P:nucleoside metabolic process; P:purine nucleotide biosynthetic process;|O60256 B4E1M8 B4E329 B7ZKZ1 E7EMY2 Q6IAS2,Phosphoribosyl pyrophosphate synthase-associated protein 2,41 kDa phosphoribosypyrophosphate synthetase-associated protein;, PF14572;PF13793;, GO:0005737;GO:0002189;GO:0004857;GO:0042802;GO:0000287;GO:0004749;GO:0006015;GO:0006139;GO:0009116;GO:0006164;, C:cytoplasm; C:ribose phosphate diphosphokinase complex;, F:enzyme inhibitor activity; F:identical protein binding; F:magnesium ion binding; F:ribose phosphate diphosphokinase activity;, P:5-phosphoribose 1-diphosphate biosynthetic process; P:nucleobase-containing compound metabolic process; P:nucleoside metabolic process; P:purine nucleotide biosynthetic process;|O60256 B4E1M8 B4E329 B7ZKZ1 E7EMY2 Q6IAS2,Phosphoribosyl pyrophosphate synthase-associated protein 2,41 kDa phosphoribosypyrophosphate synthetase-associated protein;, PF14572;PF13793;, GO:0005737;GO:0002189;GO:0004857;GO:0042802;GO:0000287;GO:0004749;GO:0006015;GO:0006139;GO:0009116;GO:0006164;, C:cytoplasm; C:ribose phosphate diphosphokinase complex;, F:enzyme inhibitor activity; F:identical protein binding; F:magnesium ion binding; F:ribose phosphate diphosphokinase activity;, P:5-phosphoribose 1-diphosphate biosynthetic process; P:nucleobase-containing compound metabolic process; P:nucleoside metabolic process; P:purine nucleotide biosynthetic process; scaffold54 indexed_genome mRNA 6378556 6407498 . - . ID=transcript_10003;A6ND36 Q3KQZ4 Q6ZW60,Protein FAM83G,Protein associated with SMAD1 {ECO:0000303|PubMed:24554596};, PF07894;, GO:0005829;GO:0005634;GO:0019901;GO:0030509;GO:0007165;, C:cytosol; C:nucleus;, F:protein kinase binding;, P:BMP signaling pathway; P:signal transduction; scaffold54 indexed_genome mRNA 6422209 6442924 . - . ID=transcript_10004;Q13588,GRB2-related adapter protein {ECO:0000305},, PF00017;PF00018;, GO:0005737;GO:0005829;GO:0016020;GO:0098793;GO:0007267;GO:0007265;GO:0007605;, C:cytoplasm; C:cytosol; C:membrane; C:presynapse;, , P:cell-cell signaling; P:Ras protein signal transduction; P:sensory perception of sound;|Q13588,GRB2-related adapter protein {ECO:0000305},, PF00017;PF00018;, GO:0005737;GO:0005829;GO:0016020;GO:0098793;GO:0007267;GO:0007265;GO:0007605;, C:cytoplasm; C:cytosol; C:membrane; C:presynapse;, , P:cell-cell signaling; P:Ras protein signal transduction; P:sensory perception of sound;|Q13588,GRB2-related adapter protein {ECO:0000305},, PF00017;PF00018;, GO:0005737;GO:0005829;GO:0016020;GO:0098793;GO:0007267;GO:0007265;GO:0007605;, C:cytoplasm; C:cytosol; C:membrane; C:presynapse;, , P:cell-cell signaling; P:Ras protein signal transduction; P:sensory perception of sound; scaffold54 indexed_genome mRNA 6493100 6493863 . + . ID=transcript_10005;O95208 A8MTV8 B3KRX8 E9PBC2 O95207 Q52LD0 Q9H7Z2 Q9UPT7,Epsin-2,EPS-15-interacting protein 2;, PF01417;, GO:0030128;GO:0030125;GO:0005829;GO:0005768;GO:0043231;GO:0005886;GO:0045296;GO:0030276;GO:0005543;GO:0006897;GO:0061024;GO:1903671;GO:0030948;GO:0045747;, C:clathrin coat of endocytic vesicle; C:clathrin vesicle coat; C:cytosol; C:endosome; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:cadherin binding; F:clathrin binding; F:phospholipid binding;, P:endocytosis; P:membrane organization; P:negative regulation of sprouting angiogenesis; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of Notch signaling pathway; scaffold54 indexed_genome mRNA 6508190 6527542 . + . ID=transcript_10006;O95208 A8MTV8 B3KRX8 E9PBC2 O95207 Q52LD0 Q9H7Z2 Q9UPT7,Epsin-2,EPS-15-interacting protein 2;, PF01417;, GO:0030128;GO:0030125;GO:0005829;GO:0005768;GO:0043231;GO:0005886;GO:0045296;GO:0030276;GO:0005543;GO:0006897;GO:0061024;GO:1903671;GO:0030948;GO:0045747;, C:clathrin coat of endocytic vesicle; C:clathrin vesicle coat; C:cytosol; C:endosome; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:cadherin binding; F:clathrin binding; F:phospholipid binding;, P:endocytosis; P:membrane organization; P:negative regulation of sprouting angiogenesis; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of Notch signaling pathway;|Q9UPM9 Q9BU22,B9 domain-containing protein 1,MKS1-related protein 1;, PF07162;, GO:0005813;GO:0036064;GO:0035869;GO:0005829;GO:0036038;GO:0008158;GO:0097711;GO:0060271;GO:0007224;, C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cytosol; C:MKS complex;, F:hedgehog receptor activity;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:smoothened signaling pathway;|O95208 A8MTV8 B3KRX8 E9PBC2 O95207 Q52LD0 Q9H7Z2 Q9UPT7,Epsin-2,EPS-15-interacting protein 2;, PF01417;, GO:0030128;GO:0030125;GO:0005829;GO:0005768;GO:0043231;GO:0005886;GO:0045296;GO:0030276;GO:0005543;GO:0006897;GO:0061024;GO:1903671;GO:0030948;GO:0045747;, C:clathrin coat of endocytic vesicle; C:clathrin vesicle coat; C:cytosol; C:endosome; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:cadherin binding; F:clathrin binding; F:phospholipid binding;, P:endocytosis; P:membrane organization; P:negative regulation of sprouting angiogenesis; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of Notch signaling pathway;|Q9UPM9 Q9BU22,B9 domain-containing protein 1,MKS1-related protein 1;, PF07162;, GO:0005813;GO:0036064;GO:0035869;GO:0005829;GO:0036038;GO:0008158;GO:0097711;GO:0060271;GO:0007224;, C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cytosol; C:MKS complex;, F:hedgehog receptor activity;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:smoothened signaling pathway; scaffold54 indexed_genome mRNA 6544009 6551780 . + . ID=transcript_10007;Q13164 Q16634 Q59F50 Q6QLU7 Q7L4P4 Q969G1 Q96G51,Mitogen-activated protein kinase 7,Big MAP kinase 1;Extracellular signal-regulated kinase 5;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0004707;GO:0051019;GO:0106310;GO:0106311;GO:0007411;GO:0019933;GO:0007049;GO:0071363;GO:0070301;GO:0071499;GO:0071560;GO:0035556;GO:0070885;GO:0051344;GO:2000352;GO:2001240;GO:0034115;GO:0050728;GO:1902176;GO:0060761;GO:0018105;GO:0051247;GO:0045944;GO:0036003;GO:0045765;GO:0010468;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:MAP kinase activity; F:mitogen-activated protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:cAMP-mediated signaling; P:cell cycle; P:cellular response to growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to laminar fluid shear stress; P:cellular response to transforming growth factor beta stimulus; P:intracellular signal transduction; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of inflammatory response; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of response to cytokine stimulus; P:peptidyl-serine phosphorylation; P:positive regulation of protein metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:regulation of angiogenesis; P:regulation of gene expression; P:signal transduction;|P55083 A8KAJ1 A8MVM2 B4E317 Q6P680,Microfibril-associated glycoprotein 4,, PF00147;, GO:0062023;GO:0071953;GO:0005576;GO:0005615;GO:0001527;GO:0003823;GO:0097367;GO:0005102;GO:0007155;GO:0071493;GO:0001867;GO:0048251;GO:0010712;GO:0097435;GO:0009650;, C:collagen-containing extracellular matrix; C:elastic fiber; C:extracellular region; C:extracellular space; C:microfibril;, F:antigen binding; F:carbohydrate derivative binding; F:signaling receptor binding;, P:cell adhesion; P:cellular response to UV-B; P:complement activation, lectin pathway; P:elastic fiber assembly; P:regulation of collagen metabolic process; P:supramolecular fiber organization; P:UV protection; scaffold54 indexed_genome mRNA 6563503 6570633 . + . ID=transcript_10008;Q9ULX5 O60633 Q7Z5V9,RING finger protein 112,Brain finger protein;Zinc finger protein 179;, PF02263;PF00097;, GO:0044297;GO:0005737;GO:0005768;GO:0019898;GO:0016021;GO:0043005;GO:0016604;GO:0005654;GO:0005634;GO:0043204;GO:0014069;GO:0008021;GO:0005525;GO:0003924;GO:0043621;GO:0061630;GO:0008270;GO:0007050;GO:0036474;GO:0036473;GO:1990403;GO:0007029;GO:0030182;GO:0071158;GO:0045687;GO:0045666;GO:0051865;GO:0051260;GO:0033194;, C:cell body; C:cytoplasm; C:endosome; C:extrinsic component of membrane; C:integral component of membrane; C:neuron projection; C:nuclear body; C:nucleoplasm; C:nucleus; C:perikaryon; C:postsynaptic density; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:protein self-association; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cell cycle arrest; P:cell death in response to hydrogen peroxide; P:cell death in response to oxidative stress; P:embryonic brain development; P:endoplasmic reticulum organization; P:neuron differentiation; P:positive regulation of cell cycle arrest; P:positive regulation of glial cell differentiation; P:positive regulation of neuron differentiation; P:protein autoubiquitination; P:protein homooligomerization; P:response to hydroperoxide;|Q9ULX5 O60633 Q7Z5V9,RING finger protein 112,Brain finger protein;Zinc finger protein 179;, PF02263;PF00097;, GO:0044297;GO:0005737;GO:0005768;GO:0019898;GO:0016021;GO:0043005;GO:0016604;GO:0005654;GO:0005634;GO:0043204;GO:0014069;GO:0008021;GO:0005525;GO:0003924;GO:0043621;GO:0061630;GO:0008270;GO:0007050;GO:0036474;GO:0036473;GO:1990403;GO:0007029;GO:0030182;GO:0071158;GO:0045687;GO:0045666;GO:0051865;GO:0051260;GO:0033194;, C:cell body; C:cytoplasm; C:endosome; C:extrinsic component of membrane; C:integral component of membrane; C:neuron projection; C:nuclear body; C:nucleoplasm; C:nucleus; C:perikaryon; C:postsynaptic density; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:protein self-association; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cell cycle arrest; P:cell death in response to hydrogen peroxide; P:cell death in response to oxidative stress; P:embryonic brain development; P:endoplasmic reticulum organization; P:neuron differentiation; P:positive regulation of cell cycle arrest; P:positive regulation of glial cell differentiation; P:positive regulation of neuron differentiation; P:protein autoubiquitination; P:protein homooligomerization; P:response to hydroperoxide;|Q9ULX5 O60633 Q7Z5V9,RING finger protein 112,Brain finger protein;Zinc finger protein 179;, PF02263;PF00097;, GO:0044297;GO:0005737;GO:0005768;GO:0019898;GO:0016021;GO:0043005;GO:0016604;GO:0005654;GO:0005634;GO:0043204;GO:0014069;GO:0008021;GO:0005525;GO:0003924;GO:0043621;GO:0061630;GO:0008270;GO:0007050;GO:0036474;GO:0036473;GO:1990403;GO:0007029;GO:0030182;GO:0071158;GO:0045687;GO:0045666;GO:0051865;GO:0051260;GO:0033194;, C:cell body; C:cytoplasm; C:endosome; C:extrinsic component of membrane; C:integral component of membrane; C:neuron projection; C:nuclear body; C:nucleoplasm; C:nucleus; C:perikaryon; C:postsynaptic density; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:protein self-association; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cell cycle arrest; P:cell death in response to hydrogen peroxide; P:cell death in response to oxidative stress; P:embryonic brain development; P:endoplasmic reticulum organization; P:neuron differentiation; P:positive regulation of cell cycle arrest; P:positive regulation of glial cell differentiation; P:positive regulation of neuron differentiation; P:protein autoubiquitination; P:protein homooligomerization; P:response to hydroperoxide; scaffold54 indexed_genome mRNA 6688606 6704521 . + . ID=transcript_10009;P51648 Q6I9T3 Q93011 Q96J37,Aldehyde dehydrogenase family 3 member A2,Aldehyde dehydrogenase 10 {ECO:0000303|PubMed:9070922};Fatty aldehyde dehydrogenase;Microsomal aldehyde dehydrogenase;, PF00171;, GO:0005829;GO:0005789;GO:0016021;GO:0043231;GO:0005778;GO:0005777;GO:0004028;GO:0004029;GO:0043878;GO:0046577;GO:0050061;GO:0052814;GO:0042803;GO:0006081;GO:0007417;GO:0008544;GO:0001561;GO:0046458;GO:0007422;GO:0033306;GO:0045046;GO:0045048;GO:0006714;GO:0030148;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:peroxisomal membrane; C:peroxisome;, F:3-chloroallyl aldehyde dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:long-chain-alcohol oxidase activity; F:long-chain-aldehyde dehydrogenase activity; F:medium-chain-aldehyde dehydrogenase activity; F:protein homodimerization activity;, P:cellular aldehyde metabolic process; P:central nervous system development; P:epidermis development; P:fatty acid alpha-oxidation; P:hexadecanal metabolic process; P:peripheral nervous system development; P:phytol metabolic process; P:protein import into peroxisome membrane; P:protein insertion into ER membrane; P:sesquiterpenoid metabolic process; P:sphingolipid biosynthetic process;|P51648 Q6I9T3 Q93011 Q96J37,Aldehyde dehydrogenase family 3 member A2,Aldehyde dehydrogenase 10 {ECO:0000303|PubMed:9070922};Fatty aldehyde dehydrogenase;Microsomal aldehyde dehydrogenase;, PF00171;, GO:0005829;GO:0005789;GO:0016021;GO:0043231;GO:0005778;GO:0005777;GO:0004028;GO:0004029;GO:0043878;GO:0046577;GO:0050061;GO:0052814;GO:0042803;GO:0006081;GO:0007417;GO:0008544;GO:0001561;GO:0046458;GO:0007422;GO:0033306;GO:0045046;GO:0045048;GO:0006714;GO:0030148;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:peroxisomal membrane; C:peroxisome;, F:3-chloroallyl aldehyde dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:long-chain-alcohol oxidase activity; F:long-chain-aldehyde dehydrogenase activity; F:medium-chain-aldehyde dehydrogenase activity; F:protein homodimerization activity;, P:cellular aldehyde metabolic process; P:central nervous system development; P:epidermis development; P:fatty acid alpha-oxidation; P:hexadecanal metabolic process; P:peripheral nervous system development; P:phytol metabolic process; P:protein import into peroxisome membrane; P:protein insertion into ER membrane; P:sesquiterpenoid metabolic process; P:sphingolipid biosynthetic process;|P51648 Q6I9T3 Q93011 Q96J37,Aldehyde dehydrogenase family 3 member A2,Aldehyde dehydrogenase 10 {ECO:0000303|PubMed:9070922};Fatty aldehyde dehydrogenase;Microsomal aldehyde dehydrogenase;, PF00171;, GO:0005829;GO:0005789;GO:0016021;GO:0043231;GO:0005778;GO:0005777;GO:0004028;GO:0004029;GO:0043878;GO:0046577;GO:0050061;GO:0052814;GO:0042803;GO:0006081;GO:0007417;GO:0008544;GO:0001561;GO:0046458;GO:0007422;GO:0033306;GO:0045046;GO:0045048;GO:0006714;GO:0030148;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:peroxisomal membrane; C:peroxisome;, F:3-chloroallyl aldehyde dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:long-chain-alcohol oxidase activity; F:long-chain-aldehyde dehydrogenase activity; F:medium-chain-aldehyde dehydrogenase activity; F:protein homodimerization activity;, P:cellular aldehyde metabolic process; P:central nervous system development; P:epidermis development; P:fatty acid alpha-oxidation; P:hexadecanal metabolic process; P:peripheral nervous system development; P:phytol metabolic process; P:protein import into peroxisome membrane; P:protein insertion into ER membrane; P:sesquiterpenoid metabolic process; P:sphingolipid biosynthetic process;|P51648 Q6I9T3 Q93011 Q96J37,Aldehyde dehydrogenase family 3 member A2,Aldehyde dehydrogenase 10 {ECO:0000303|PubMed:9070922};Fatty aldehyde dehydrogenase;Microsomal aldehyde dehydrogenase;, PF00171;, GO:0005829;GO:0005789;GO:0016021;GO:0043231;GO:0005778;GO:0005777;GO:0004028;GO:0004029;GO:0043878;GO:0046577;GO:0050061;GO:0052814;GO:0042803;GO:0006081;GO:0007417;GO:0008544;GO:0001561;GO:0046458;GO:0007422;GO:0033306;GO:0045046;GO:0045048;GO:0006714;GO:0030148;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:peroxisomal membrane; C:peroxisome;, F:3-chloroallyl aldehyde dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:long-chain-alcohol oxidase activity; F:long-chain-aldehyde dehydrogenase activity; F:medium-chain-aldehyde dehydrogenase activity; F:protein homodimerization activity;, P:cellular aldehyde metabolic process; P:central nervous system development; P:epidermis development; P:fatty acid alpha-oxidation; P:hexadecanal metabolic process; P:peripheral nervous system development; P:phytol metabolic process; P:protein import into peroxisome membrane; P:protein insertion into ER membrane; P:sesquiterpenoid metabolic process; P:sphingolipid biosynthetic process; scaffold54 indexed_genome mRNA 6706016 6713858 . - . ID=transcript_10010;Q86VL8 A0JBX9 A0P8Z7 Q63HJ9 Q8IV44 Q96NA1,Multidrug and toxin extrusion protein 2,Kidney-specific H(+)/organic cation antiporter;Solute carrier family 47 member 2;, PF01554;, GO:0016021;GO:0016020;GO:0005886;GO:0015297;GO:0022857;GO:0042910;GO:0055085;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:antiporter activity; F:transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:transmembrane transport; scaffold54 indexed_genome mRNA 6738257 6747415 . - . ID=transcript_10011;P30838 A8K828 Q9BT37,Aldehyde dehydrogenase, dimeric NADP-preferring,ALDHIII;Aldehyde dehydrogenase 3;Aldehyde dehydrogenase family 3 member A1;, PF00171;, GO:0005829;GO:0005783;GO:0005615;GO:0005886;GO:0004028;GO:0008106;GO:0004029;GO:0018479;GO:0007568;GO:0006081;GO:0008284;GO:0051591;GO:0042493;GO:0051384;GO:0001666;GO:0007584;GO:0006805;, C:cytosol; C:endoplasmic reticulum; C:extracellular space; C:plasma membrane;, F:3-chloroallyl aldehyde dehydrogenase activity; F:alcohol dehydrogenase (NADP+) activity; F:aldehyde dehydrogenase (NAD+) activity; F:benzaldehyde dehydrogenase (NAD+) activity;, P:aging; P:cellular aldehyde metabolic process; P:positive regulation of cell population proliferation; P:response to cAMP; P:response to drug; P:response to glucocorticoid; P:response to hypoxia; P:response to nutrient; P:xenobiotic metabolic process; scaffold54 indexed_genome mRNA 6764849 6820634 . - . ID=transcript_10012;Q8IYT8 A8MY69 O75119,Serine/threonine-protein kinase ULK2,Unc-51-like kinase 2;, PF12063;PF00069;, GO:0030659;GO:0034045;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0048675;GO:0075044;GO:0046777;GO:0042594;GO:0007165;, C:cytoplasmic vesicle membrane; C:phagophore assembly site membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:axon extension; P:positive regulation by symbiont of host autophagy; P:protein autophosphorylation; P:response to starvation; P:signal transduction;|Q8IYT8 A8MY69 O75119,Serine/threonine-protein kinase ULK2,Unc-51-like kinase 2;, PF12063;PF00069;, GO:0030659;GO:0034045;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0048675;GO:0075044;GO:0046777;GO:0042594;GO:0007165;, C:cytoplasmic vesicle membrane; C:phagophore assembly site membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:axon extension; P:positive regulation by symbiont of host autophagy; P:protein autophosphorylation; P:response to starvation; P:signal transduction;|Q8IYT8 A8MY69 O75119,Serine/threonine-protein kinase ULK2,Unc-51-like kinase 2;, PF12063;PF00069;, GO:0030659;GO:0034045;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0048675;GO:0075044;GO:0046777;GO:0042594;GO:0007165;, C:cytoplasmic vesicle membrane; C:phagophore assembly site membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:axon extension; P:positive regulation by symbiont of host autophagy; P:protein autophosphorylation; P:response to starvation; P:signal transduction;|Q8IYT8 A8MY69 O75119,Serine/threonine-protein kinase ULK2,Unc-51-like kinase 2;, PF12063;PF00069;, GO:0030659;GO:0034045;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0048675;GO:0075044;GO:0046777;GO:0042594;GO:0007165;, C:cytoplasmic vesicle membrane; C:phagophore assembly site membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:axon extension; P:positive regulation by symbiont of host autophagy; P:protein autophosphorylation; P:response to starvation; P:signal transduction;|Q8IYT8 A8MY69 O75119,Serine/threonine-protein kinase ULK2,Unc-51-like kinase 2;, PF12063;PF00069;, GO:0030659;GO:0034045;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0048675;GO:0075044;GO:0046777;GO:0042594;GO:0007165;, C:cytoplasmic vesicle membrane; C:phagophore assembly site membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:axon extension; P:positive regulation by symbiont of host autophagy; P:protein autophosphorylation; P:response to starvation; P:signal transduction;|Q8IYT8 A8MY69 O75119,Serine/threonine-protein kinase ULK2,Unc-51-like kinase 2;, PF12063;PF00069;, GO:0030659;GO:0034045;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0048675;GO:0075044;GO:0046777;GO:0042594;GO:0007165;, C:cytoplasmic vesicle membrane; C:phagophore assembly site membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:axon extension; P:positive regulation by symbiont of host autophagy; P:protein autophosphorylation; P:response to starvation; P:signal transduction; scaffold54 indexed_genome mRNA 6839686 6873115 . - . ID=transcript_10013;O43572 B2R650 Q96AJ7,A-kinase anchor protein 10, mitochondrial,Dual specificity A kinase-anchoring protein 2;Protein kinase A-anchoring protein 10;, PF00615;, GO:0005829;GO:0005739;GO:0005886;GO:0032991;GO:0051018;GO:0007596;GO:0008104;GO:0007165;, C:cytosol; C:mitochondrion; C:plasma membrane; C:protein-containing complex;, F:protein kinase A binding;, P:blood coagulation; P:protein localization; P:signal transduction;|O43572 B2R650 Q96AJ7,A-kinase anchor protein 10, mitochondrial,Dual specificity A kinase-anchoring protein 2;Protein kinase A-anchoring protein 10;, PF00615;, GO:0005829;GO:0005739;GO:0005886;GO:0032991;GO:0051018;GO:0007596;GO:0008104;GO:0007165;, C:cytosol; C:mitochondrion; C:plasma membrane; C:protein-containing complex;, F:protein kinase A binding;, P:blood coagulation; P:protein localization; P:signal transduction;|O43572 B2R650 Q96AJ7,A-kinase anchor protein 10, mitochondrial,Dual specificity A kinase-anchoring protein 2;Protein kinase A-anchoring protein 10;, PF00615;, GO:0005829;GO:0005739;GO:0005886;GO:0032991;GO:0051018;GO:0007596;GO:0008104;GO:0007165;, C:cytosol; C:mitochondrion; C:plasma membrane; C:protein-containing complex;, F:protein kinase A binding;, P:blood coagulation; P:protein localization; P:signal transduction; scaffold54 indexed_genome mRNA 6900634 7052613 . + . ID=transcript_10014;Q5M774 Q86XT8 Q8N4U4 Q8WU84 Q9HCQ3,Cytospin-B,Nuclear structure protein 5;Sperm antigen HCMOGT-1;Sperm antigen with calponin homology and coiled-coil domains 1;, PF00307;, GO:0005829;GO:0001650;GO:0031941;GO:0043231;GO:0016020;GO:0005815;GO:0005654;GO:0030036;, C:cytosol; C:fibrillar center; C:filamentous actin; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule organizing center; C:nucleoplasm;, , P:actin cytoskeleton organization; scaffold54 indexed_genome mRNA 7059150 7105399 . + . ID=transcript_10015;Q5M774 Q86XT8 Q8N4U4 Q8WU84 Q9HCQ3,Cytospin-B,Nuclear structure protein 5;Sperm antigen HCMOGT-1;Sperm antigen with calponin homology and coiled-coil domains 1;, PF00307;, GO:0005829;GO:0001650;GO:0031941;GO:0043231;GO:0016020;GO:0005815;GO:0005654;GO:0030036;, C:cytosol; C:fibrillar center; C:filamentous actin; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule organizing center; C:nucleoplasm;, , P:actin cytoskeleton organization; scaffold54 indexed_genome mRNA 7126485 7157521 . - . ID=transcript_10016;P29275,Adenosine receptor A2b,, PF00001;, GO:0005887;GO:0005886;GO:0001609;GO:0007190;GO:0000187;GO:0006968;GO:0044267;GO:0007588;GO:0007186;GO:0007254;GO:0002862;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled adenosine receptor activity;, P:activation of adenylate cyclase activity; P:activation of MAPK activity; P:cellular defense response; P:cellular protein metabolic process; P:excretion; P:G protein-coupled receptor signaling pathway; P:JNK cascade; P:negative regulation of inflammatory response to antigenic stimulus;|P29275,Adenosine receptor A2b,, PF00001;, GO:0005887;GO:0005886;GO:0001609;GO:0007190;GO:0000187;GO:0006968;GO:0044267;GO:0007588;GO:0007186;GO:0007254;GO:0002862;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled adenosine receptor activity;, P:activation of adenylate cyclase activity; P:activation of MAPK activity; P:cellular defense response; P:cellular protein metabolic process; P:excretion; P:G protein-coupled receptor signaling pathway; P:JNK cascade; P:negative regulation of inflammatory response to antigenic stimulus;|Q19AV6,Zinc finger SWIM domain-containing protein 7,SWIM domain-containing and Srs2-interacting protein 1 homolog;SWIM-type zinc finger domain-containing protein 7;, PF04434;, GO:0005634;GO:0097196;GO:0008270;GO:0000724;GO:0050821;, C:nucleus; C:Shu complex;, F:zinc ion binding;, P:double-strand break repair via homologous recombination; P:protein stabilization;|Q19AV6,Zinc finger SWIM domain-containing protein 7,SWIM domain-containing and Srs2-interacting protein 1 homolog;SWIM-type zinc finger domain-containing protein 7;, PF04434;, GO:0005634;GO:0097196;GO:0008270;GO:0000724;GO:0050821;, C:nucleus; C:Shu complex;, F:zinc ion binding;, P:double-strand break repair via homologous recombination; P:protein stabilization; scaffold54 indexed_genome mRNA 7163867 7298621 . - . ID=transcript_10017;O75376 B3DLF8 E9PGV6 Q86YY0 Q9UPV5 Q9UQ18,Nuclear receptor corepressor 1,, PF15784;PF00249;, GO:0000785;GO:0005829;GO:0000118;GO:0016020;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0042826;GO:0035257;GO:0001102;GO:0046966;GO:0003714;GO:0000976;GO:0006325;GO:0007623;GO:0030522;GO:0045475;GO:0060766;GO:0045922;GO:0045820;GO:0046329;GO:1903799;GO:0000122;GO:0045892;GO:0019216;GO:0051225;GO:0006367;, C:chromatin; C:cytosol; C:histone deacetylase complex; C:membrane; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:histone deacetylase binding; F:nuclear hormone receptor binding; F:RNA polymerase II activating transcription factor binding; F:thyroid hormone receptor binding; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:circadian rhythm; P:intracellular receptor signaling pathway; P:locomotor rhythm; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of fatty acid metabolic process; P:negative regulation of glycolytic process; P:negative regulation of JNK cascade; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:spindle assembly; P:transcription initiation from RNA polymerase II promoter;|Q6DKK2 A8MZ52 B3KP62 B4DN65 Q2M248 Q7L3U8 Q9H6G3 Q9NXB2,Tetratricopeptide repeat protein 19, mitochondrial,, , GO:0005813;GO:0030496;GO:0005743;GO:0005739;GO:0070469;GO:0034551;GO:0000281;, C:centrosome; C:midbody; C:mitochondrial inner membrane; C:mitochondrion; C:respirasome;, , P:mitochondrial respiratory chain complex III assembly; P:mitotic cytokinesis;|Q6DKK2 A8MZ52 B3KP62 B4DN65 Q2M248 Q7L3U8 Q9H6G3 Q9NXB2,Tetratricopeptide repeat protein 19, mitochondrial,, , GO:0005813;GO:0030496;GO:0005743;GO:0005739;GO:0070469;GO:0034551;GO:0000281;, C:centrosome; C:midbody; C:mitochondrial inner membrane; C:mitochondrion; C:respirasome;, , P:mitochondrial respiratory chain complex III assembly; P:mitotic cytokinesis;|Q6DKK2 A8MZ52 B3KP62 B4DN65 Q2M248 Q7L3U8 Q9H6G3 Q9NXB2,Tetratricopeptide repeat protein 19, mitochondrial,, , GO:0005813;GO:0030496;GO:0005743;GO:0005739;GO:0070469;GO:0034551;GO:0000281;, C:centrosome; C:midbody; C:mitochondrial inner membrane; C:mitochondrion; C:respirasome;, , P:mitochondrial respiratory chain complex III assembly; P:mitotic cytokinesis;|O75376 B3DLF8 E9PGV6 Q86YY0 Q9UPV5 Q9UQ18,Nuclear receptor corepressor 1,, PF15784;PF00249;, GO:0000785;GO:0005829;GO:0000118;GO:0016020;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0042826;GO:0035257;GO:0001102;GO:0046966;GO:0003714;GO:0000976;GO:0006325;GO:0007623;GO:0030522;GO:0045475;GO:0060766;GO:0045922;GO:0045820;GO:0046329;GO:1903799;GO:0000122;GO:0045892;GO:0019216;GO:0051225;GO:0006367;, C:chromatin; C:cytosol; C:histone deacetylase complex; C:membrane; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:histone deacetylase binding; F:nuclear hormone receptor binding; F:RNA polymerase II activating transcription factor binding; F:thyroid hormone receptor binding; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:circadian rhythm; P:intracellular receptor signaling pathway; P:locomotor rhythm; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of fatty acid metabolic process; P:negative regulation of glycolytic process; P:negative regulation of JNK cascade; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:spindle assembly; P:transcription initiation from RNA polymerase II promoter;|O75376 B3DLF8 E9PGV6 Q86YY0 Q9UPV5 Q9UQ18,Nuclear receptor corepressor 1,, PF15784;PF00249;, GO:0000785;GO:0005829;GO:0000118;GO:0016020;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0042826;GO:0035257;GO:0001102;GO:0046966;GO:0003714;GO:0000976;GO:0006325;GO:0007623;GO:0030522;GO:0045475;GO:0060766;GO:0045922;GO:0045820;GO:0046329;GO:1903799;GO:0000122;GO:0045892;GO:0019216;GO:0051225;GO:0006367;, C:chromatin; C:cytosol; C:histone deacetylase complex; C:membrane; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:histone deacetylase binding; F:nuclear hormone receptor binding; F:RNA polymerase II activating transcription factor binding; F:thyroid hormone receptor binding; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:circadian rhythm; P:intracellular receptor signaling pathway; P:locomotor rhythm; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of fatty acid metabolic process; P:negative regulation of glycolytic process; P:negative regulation of JNK cascade; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:spindle assembly; P:transcription initiation from RNA polymerase II promoter;|O75376 B3DLF8 E9PGV6 Q86YY0 Q9UPV5 Q9UQ18,Nuclear receptor corepressor 1,, PF15784;PF00249;, GO:0000785;GO:0005829;GO:0000118;GO:0016020;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0042826;GO:0035257;GO:0001102;GO:0046966;GO:0003714;GO:0000976;GO:0006325;GO:0007623;GO:0030522;GO:0045475;GO:0060766;GO:0045922;GO:0045820;GO:0046329;GO:1903799;GO:0000122;GO:0045892;GO:0019216;GO:0051225;GO:0006367;, C:chromatin; C:cytosol; C:histone deacetylase complex; C:membrane; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:histone deacetylase binding; F:nuclear hormone receptor binding; F:RNA polymerase II activating transcription factor binding; F:thyroid hormone receptor binding; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:circadian rhythm; P:intracellular receptor signaling pathway; P:locomotor rhythm; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of fatty acid metabolic process; P:negative regulation of glycolytic process; P:negative regulation of JNK cascade; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:spindle assembly; P:transcription initiation from RNA polymerase II promoter; scaffold54 indexed_genome mRNA 7323664 7372500 . - . ID=transcript_10018;Q9Y2B2 A8KA67 B4DYN4,N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase,Phosphatidylinositol-glycan biosynthesis class L protein;, PF02585;, GO:0005783;GO:0005789;GO:0016021;GO:0016811;GO:0000225;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acetylglucosaminylphosphatidylinositol deacetylase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9Y2B2 A8KA67 B4DYN4,N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase,Phosphatidylinositol-glycan biosynthesis class L protein;, PF02585;, GO:0005783;GO:0005789;GO:0016021;GO:0016811;GO:0000225;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acetylglucosaminylphosphatidylinositol deacetylase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9Y2B2 A8KA67 B4DYN4,N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase,Phosphatidylinositol-glycan biosynthesis class L protein;, PF02585;, GO:0005783;GO:0005789;GO:0016021;GO:0016811;GO:0000225;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acetylglucosaminylphosphatidylinositol deacetylase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9Y2B2 A8KA67 B4DYN4,N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase,Phosphatidylinositol-glycan biosynthesis class L protein;, PF02585;, GO:0005783;GO:0005789;GO:0016021;GO:0016811;GO:0000225;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acetylglucosaminylphosphatidylinositol deacetylase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9Y2B2 A8KA67 B4DYN4,N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase,Phosphatidylinositol-glycan biosynthesis class L protein;, PF02585;, GO:0005783;GO:0005789;GO:0016021;GO:0016811;GO:0000225;GO:0006506;GO:0016254;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:N-acetylglucosaminylphosphatidylinositol deacetylase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q7Z7K6 B2RPK2 Q3L8N5 Q8NFH6,Centromere protein V,Nuclear protein p30;Proline-rich protein 6;, PF04828;, GO:0000777;GO:0005829;GO:0000776;GO:0015630;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0051233;GO:0016846;GO:0046872;GO:0001667;GO:0007049;GO:0051301;GO:0034508;GO:0031508;GO:0032467;GO:0033044;, C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:microtubule cytoskeleton; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:carbon-sulfur lyase activity; F:metal ion binding;, P:ameboidal-type cell migration; P:cell cycle; P:cell division; P:centromere complex assembly; P:pericentric heterochromatin assembly; P:positive regulation of cytokinesis; P:regulation of chromosome organization;|Q7Z7K6 B2RPK2 Q3L8N5 Q8NFH6,Centromere protein V,Nuclear protein p30;Proline-rich protein 6;, PF04828;, GO:0000777;GO:0005829;GO:0000776;GO:0015630;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0051233;GO:0016846;GO:0046872;GO:0001667;GO:0007049;GO:0051301;GO:0034508;GO:0031508;GO:0032467;GO:0033044;, C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:microtubule cytoskeleton; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:carbon-sulfur lyase activity; F:metal ion binding;, P:ameboidal-type cell migration; P:cell cycle; P:cell division; P:centromere complex assembly; P:pericentric heterochromatin assembly; P:positive regulation of cytokinesis; P:regulation of chromosome organization;|Q7Z7K6 B2RPK2 Q3L8N5 Q8NFH6,Centromere protein V,Nuclear protein p30;Proline-rich protein 6;, PF04828;, GO:0000777;GO:0005829;GO:0000776;GO:0015630;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0051233;GO:0016846;GO:0046872;GO:0001667;GO:0007049;GO:0051301;GO:0034508;GO:0031508;GO:0032467;GO:0033044;, C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:microtubule cytoskeleton; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:carbon-sulfur lyase activity; F:metal ion binding;, P:ameboidal-type cell migration; P:cell cycle; P:cell division; P:centromere complex assembly; P:pericentric heterochromatin assembly; P:positive regulation of cytokinesis; P:regulation of chromosome organization; scaffold54 indexed_genome mRNA 7372503 7373465 . - . ID=transcript_10019;Q7Z7K6 B2RPK2 Q3L8N5 Q8NFH6,Centromere protein V,Nuclear protein p30;Proline-rich protein 6;, PF04828;, GO:0000777;GO:0005829;GO:0000776;GO:0015630;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0051233;GO:0016846;GO:0046872;GO:0001667;GO:0007049;GO:0051301;GO:0034508;GO:0031508;GO:0032467;GO:0033044;, C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:microtubule cytoskeleton; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:carbon-sulfur lyase activity; F:metal ion binding;, P:ameboidal-type cell migration; P:cell cycle; P:cell division; P:centromere complex assembly; P:pericentric heterochromatin assembly; P:positive regulation of cytokinesis; P:regulation of chromosome organization; scaffold54 indexed_genome mRNA 7373937 7375584 . - . ID=transcript_10020;Q7Z7K6 B2RPK2 Q3L8N5 Q8NFH6,Centromere protein V,Nuclear protein p30;Proline-rich protein 6;, PF04828;, GO:0000777;GO:0005829;GO:0000776;GO:0015630;GO:0030496;GO:0031965;GO:0005654;GO:0005634;GO:0051233;GO:0016846;GO:0046872;GO:0001667;GO:0007049;GO:0051301;GO:0034508;GO:0031508;GO:0032467;GO:0033044;, C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:microtubule cytoskeleton; C:midbody; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:carbon-sulfur lyase activity; F:metal ion binding;, P:ameboidal-type cell migration; P:cell cycle; P:cell division; P:centromere complex assembly; P:pericentric heterochromatin assembly; P:positive regulation of cytokinesis; P:regulation of chromosome organization; scaffold54 indexed_genome mRNA 7395174 7396616 . + . ID=transcript_10021;Q91887 Q91888 Q9BWD6 Q9BX98 Q9UEF2 Q9UEG1 Q9UEK8 Q9UPK7,Polyubiquitin-B,, PF00240;, GO:0005737;GO:0005829;GO:0030666;GO:0005789;GO:0010008;GO:0070062;GO:0005615;GO:0043657;GO:0005741;GO:0005739;GO:0043005;GO:0043025;GO:0005654;GO:0005634;GO:0005886;GO:0031982;GO:0031386;GO:0031625;GO:0000187;GO:0035973;GO:1990000;GO:0031145;GO:0019221;GO:0002753;GO:0042769;GO:1904380;GO:0016197;GO:0097009;GO:0070987;GO:0042276;GO:0060613;GO:0008585;GO:0007144;GO:0070911;GO:0021888;GO:0007249;GO:0070498;GO:0036297;GO:0075733;GO:0007254;GO:0007141;GO:0061024;GO:0047497;GO:0019941;GO:0052031;GO:0002755;GO:0002756;GO:0043066;GO:0000122;GO:0030512;GO:0048812;GO:0070423;GO:0000715;GO:0000717;GO:0006297;GO:0033683;GO:0006296;GO:0006294;GO:0043065;GO:1902255;GO:0051092;GO:1902527;GO:0031398;GO:0045944;GO:0036388;GO:0016579;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:0051881;GO:0043488;GO:1901214;GO:0061136;GO:0061418;GO:0072520;GO:0051403;GO:0006283;GO:0007179;GO:0019985;GO:0055085;GO:0035666;GO:0019058;GO:0019081;GO:0019068;GO:0016055;, C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:host cell; C:mitochondrial outer membrane; C:mitochondrion; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle;, F:protein tag; F:ubiquitin protein ligase binding;, P:activation of MAPK activity; P:aggrephagy; P:amyloid fibril formation; P:anaphase-promoting complex-dependent catabolic process; P:cytokine-mediated signaling pathway; P:cytoplasmic pattern recognition receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:endoplasmic reticulum mannose trimming; P:endosomal transport; P:energy homeostasis; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:fat pad development; P:female gonad development; P:female meiosis I; P:global genome nucleotide-excision repair; P:hypothalamus gonadotrophin-releasing hormone neuron development; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:interstrand cross-link repair; P:intracellular transport of virus; P:JNK cascade; P:male meiosis I; P:membrane organization; P:mitochondrion transport along microtubule; P:modification-dependent protein catabolic process; P:modulation by symbiont of host defense response; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron projection morphogenesis; P:nucleotide-binding oligomerization domain containing signaling pathway; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein monoubiquitination; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly; P:protein deubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitochondrial membrane potential; P:regulation of mRNA stability; P:regulation of neuron death; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:seminiferous tubule development; P:stress-activated MAPK cascade; P:transcription-coupled nucleotide-excision repair; P:transforming growth factor beta receptor signaling pathway; P:translesion synthesis; P:transmembrane transport; P:TRIF-dependent toll-like receptor signaling pathway; P:viral life cycle; P:viral translation; P:virion assembly; P:Wnt signaling pathway; scaffold54 indexed_genome mRNA 7416262 7430449 . + . ID=transcript_10022;Q9Y5S1 A6NML2 A8K0Z0 Q9Y670,Transient receptor potential cation channel subfamily V member 2,Osm-9-like TRP channel 2;Vanilloid receptor-like protein 1;, PF12796;PF00520;, GO:0044295;GO:0044297;GO:0009986;GO:0032584;GO:0005887;GO:0042470;GO:0005886;GO:0005262;GO:0005261;GO:0005216;GO:0015075;GO:0098703;GO:0070588;GO:0045773;GO:0090280;GO:0120162;GO:0009408;GO:0009266;GO:0007600;, C:axonal growth cone; C:cell body; C:cell surface; C:growth cone membrane; C:integral component of plasma membrane; C:melanosome; C:plasma membrane;, F:calcium channel activity; F:cation channel activity; F:ion channel activity; F:ion transmembrane transporter activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:positive regulation of axon extension; P:positive regulation of calcium ion import; P:positive regulation of cold-induced thermogenesis; P:response to heat; P:response to temperature stimulus; P:sensory perception; scaffold54 indexed_genome mRNA 7430872 7433889 . + . ID=transcript_10023;Q9Y5S1 A6NML2 A8K0Z0 Q9Y670,Transient receptor potential cation channel subfamily V member 2,Osm-9-like TRP channel 2;Vanilloid receptor-like protein 1;, PF12796;PF00520;, GO:0044295;GO:0044297;GO:0009986;GO:0032584;GO:0005887;GO:0042470;GO:0005886;GO:0005262;GO:0005261;GO:0005216;GO:0015075;GO:0098703;GO:0070588;GO:0045773;GO:0090280;GO:0120162;GO:0009408;GO:0009266;GO:0007600;, C:axonal growth cone; C:cell body; C:cell surface; C:growth cone membrane; C:integral component of plasma membrane; C:melanosome; C:plasma membrane;, F:calcium channel activity; F:cation channel activity; F:ion channel activity; F:ion transmembrane transporter activity;, P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:positive regulation of axon extension; P:positive regulation of calcium ion import; P:positive regulation of cold-induced thermogenesis; P:response to heat; P:response to temperature stimulus; P:sensory perception; scaffold54 indexed_genome mRNA 7437493 7448919 . - . ID=transcript_10024;Q8NAA5,Leucine-rich repeat-containing protein 75A,Leucine-rich repeat-containing protein FAM211A;, , GO:0005737;, C:cytoplasm; scaffold54 indexed_genome mRNA 7510204 7522918 . + . ID=transcript_10025;Q9HBT7 Q6IAG1,Zinc finger protein 287 {ECO:0000305},Zinc finger protein with KRAB and SCAN domains 13;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9HBT7 Q6IAG1,Zinc finger protein 287 {ECO:0000305},Zinc finger protein with KRAB and SCAN domains 13;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 7546246 7554801 . - . ID=transcript_10026;Q9P2J8 Q3SY62 Q3SY63 Q6ZN27,Zinc finger protein 624,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 7561087 7575488 . - . ID=transcript_10027;Q9HBT8 B4DKF9 Q96JF3,Zinc finger protein 286A,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P0CG31,Putative zinc finger protein 286B,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9HBT8 B4DKF9 Q96JF3,Zinc finger protein 286A,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9HBT8 B4DKF9 Q96JF3,Zinc finger protein 286A,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 7600270 7618839 . + . ID=transcript_10028;O95361 Q6IAL8 Q7Z6I2 Q96BE8 Q96J43,Tripartite motif-containing protein 16,E3 ubiquitin-protein ligase TRIM16;Estrogen-responsive B box protein;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005886;GO:0016605;GO:0003677;GO:0019966;GO:0032089;GO:0016740;GO:0008270;GO:0043966;GO:0043967;GO:0032731;GO:0045618;GO:0048386;GO:0045893;GO:0060416;GO:0046683;GO:0032526;, C:cytoplasm; C:cytosol; C:plasma membrane; C:PML body;, F:DNA binding; F:interleukin-1 binding; F:NACHT domain binding; F:transferase activity; F:zinc ion binding;, P:histone H3 acetylation; P:histone H4 acetylation; P:positive regulation of interleukin-1 beta production; P:positive regulation of keratinocyte differentiation; P:positive regulation of retinoic acid receptor signaling pathway; P:positive regulation of transcription, DNA-templated; P:response to growth hormone; P:response to organophosphorus; P:response to retinoic acid;|O95361 Q6IAL8 Q7Z6I2 Q96BE8 Q96J43,Tripartite motif-containing protein 16,E3 ubiquitin-protein ligase TRIM16;Estrogen-responsive B box protein;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005886;GO:0016605;GO:0003677;GO:0019966;GO:0032089;GO:0016740;GO:0008270;GO:0043966;GO:0043967;GO:0032731;GO:0045618;GO:0048386;GO:0045893;GO:0060416;GO:0046683;GO:0032526;, C:cytoplasm; C:cytosol; C:plasma membrane; C:PML body;, F:DNA binding; F:interleukin-1 binding; F:NACHT domain binding; F:transferase activity; F:zinc ion binding;, P:histone H3 acetylation; P:histone H4 acetylation; P:positive regulation of interleukin-1 beta production; P:positive regulation of keratinocyte differentiation; P:positive regulation of retinoic acid receptor signaling pathway; P:positive regulation of transcription, DNA-templated; P:response to growth hormone; P:response to organophosphorus; P:response to retinoic acid;|Q309B1 A0PK10 B2RUW6 B4DQK2 B4DWQ8,Tripartite motif-containing protein 16-like protein,Tripartite motif-containing protein 70;, PF13765;PF00622;, GO:0005829;GO:0005886;, C:cytosol; C:plasma membrane;|Q309B1 A0PK10 B2RUW6 B4DQK2 B4DWQ8,Tripartite motif-containing protein 16-like protein,Tripartite motif-containing protein 70;, PF13765;PF00622;, GO:0005829;GO:0005886;, C:cytosol; C:plasma membrane;|O95361 Q6IAL8 Q7Z6I2 Q96BE8 Q96J43,Tripartite motif-containing protein 16,E3 ubiquitin-protein ligase TRIM16;Estrogen-responsive B box protein;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005886;GO:0016605;GO:0003677;GO:0019966;GO:0032089;GO:0016740;GO:0008270;GO:0043966;GO:0043967;GO:0032731;GO:0045618;GO:0048386;GO:0045893;GO:0060416;GO:0046683;GO:0032526;, C:cytoplasm; C:cytosol; C:plasma membrane; C:PML body;, F:DNA binding; F:interleukin-1 binding; F:NACHT domain binding; F:transferase activity; F:zinc ion binding;, P:histone H3 acetylation; P:histone H4 acetylation; P:positive regulation of interleukin-1 beta production; P:positive regulation of keratinocyte differentiation; P:positive regulation of retinoic acid receptor signaling pathway; P:positive regulation of transcription, DNA-templated; P:response to growth hormone; P:response to organophosphorus; P:response to retinoic acid; scaffold54 indexed_genome mRNA 7650272 7653038 . + . ID=transcript_10029;Q5XX13 C9JRY8 C9JZD7 Q8TC00 Q9H0F0,F-box/WD repeat-containing protein 10,F-box and WD-40 domain-containing protein 10;Ubiquitin ligase-specificity factor;, PF00400;, GO:0005829;GO:0043687;GO:0000209;, C:cytosol;, , P:post-translational protein modification; P:protein polyubiquitination; scaffold54 indexed_genome mRNA 7653313 7653830 . + . ID=transcript_10030;Q5XX13 C9JRY8 C9JZD7 Q8TC00 Q9H0F0,F-box/WD repeat-containing protein 10,F-box and WD-40 domain-containing protein 10;Ubiquitin ligase-specificity factor;, PF00400;, GO:0005829;GO:0043687;GO:0000209;, C:cytosol;, , P:post-translational protein modification; P:protein polyubiquitination; scaffold54 indexed_genome mRNA 7656534 7670611 . + . ID=transcript_10031;Q9NYZ1 A8K448 Q96HK5 Q9Y3E6,Golgi apparatus membrane protein TVP23 homolog B,, PF05832;, GO:0030173;GO:0009306;GO:0016192;, C:integral component of Golgi membrane;, , P:protein secretion; P:vesicle-mediated transport;|Q9NYZ1 A8K448 Q96HK5 Q9Y3E6,Golgi apparatus membrane protein TVP23 homolog B,, PF05832;, GO:0030173;GO:0009306;GO:0016192;, C:integral component of Golgi membrane;, , P:protein secretion; P:vesicle-mediated transport;|Q9NYZ1 A8K448 Q96HK5 Q9Y3E6,Golgi apparatus membrane protein TVP23 homolog B,, PF05832;, GO:0030173;GO:0009306;GO:0016192;, C:integral component of Golgi membrane;, , P:protein secretion; P:vesicle-mediated transport;|Q9NYZ1 A8K448 Q96HK5 Q9Y3E6,Golgi apparatus membrane protein TVP23 homolog B,, PF05832;, GO:0030173;GO:0009306;GO:0016192;, C:integral component of Golgi membrane;, , P:protein secretion; P:vesicle-mediated transport; scaffold54 indexed_genome mRNA 7807528 7834177 . + . ID=transcript_10032;Q9BXF9 B2RAS7 D3DTT0 Q8N5R5 Q96M48,Tektin-3,, , GO:0002080;GO:0070062;GO:0015630;GO:0005634;GO:0002081;GO:0036126;GO:0060271;GO:0060294;GO:0030317;GO:0060378;, C:acrosomal membrane; C:extracellular exosome; C:microtubule cytoskeleton; C:nucleus; C:outer acrosomal membrane; C:sperm flagellum;, , P:cilium assembly; P:cilium movement involved in cell motility; P:flagellated sperm motility; P:regulation of brood size;|Q9BXF9 B2RAS7 D3DTT0 Q8N5R5 Q96M48,Tektin-3,, , GO:0002080;GO:0070062;GO:0015630;GO:0005634;GO:0002081;GO:0036126;GO:0060271;GO:0060294;GO:0030317;GO:0060378;, C:acrosomal membrane; C:extracellular exosome; C:microtubule cytoskeleton; C:nucleus; C:outer acrosomal membrane; C:sperm flagellum;, , P:cilium assembly; P:cilium movement involved in cell motility; P:flagellated sperm motility; P:regulation of brood size; scaffold54 indexed_genome mRNA 7867611 7892951 . + . ID=transcript_10033;Q01453 Q8WV01,Peripheral myelin protein 22,Growth arrest-specific protein 3;, PF00822;, GO:0016021;GO:0005886;GO:0045202;GO:0032060;GO:0008219;GO:0007268;GO:0032288;GO:0007399;GO:0007422;, C:integral component of membrane; C:plasma membrane; C:synapse;, , P:bleb assembly; P:cell death; P:chemical synaptic transmission; P:myelin assembly; P:nervous system development; P:peripheral nervous system development; scaffold54 indexed_genome mRNA 8423596 8502991 . - . ID=transcript_10034;Q12887 B2R6U5 B4DJ50 O15334 Q969F7,Protoheme IX farnesyltransferase, mitochondrial,Heme O synthase;, PF01040;, GO:0070069;GO:0005829;GO:0016021;GO:0005743;GO:0005739;GO:0005730;GO:0004311;GO:0008495;GO:0045333;GO:0006784;GO:0006783;GO:0048034;GO:0006123;GO:0000266;GO:1902600;GO:0008535;, C:cytochrome complex; C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleolus;, F:farnesyltranstransferase activity; F:protoheme IX farnesyltransferase activity;, P:cellular respiration; P:heme A biosynthetic process; P:heme biosynthetic process; P:heme O biosynthetic process; P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial fission; P:proton transmembrane transport; P:respiratory chain complex IV assembly;|Q12887 B2R6U5 B4DJ50 O15334 Q969F7,Protoheme IX farnesyltransferase, mitochondrial,Heme O synthase;, PF01040;, GO:0070069;GO:0005829;GO:0016021;GO:0005743;GO:0005739;GO:0005730;GO:0004311;GO:0008495;GO:0045333;GO:0006784;GO:0006783;GO:0048034;GO:0006123;GO:0000266;GO:1902600;GO:0008535;, C:cytochrome complex; C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleolus;, F:farnesyltranstransferase activity; F:protoheme IX farnesyltransferase activity;, P:cellular respiration; P:heme A biosynthetic process; P:heme biosynthetic process; P:heme O biosynthetic process; P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial fission; P:proton transmembrane transport; P:respiratory chain complex IV assembly; scaffold54 indexed_genome mRNA 8507144 8530338 . - . ID=transcript_10035;Q12887 B2R6U5 B4DJ50 O15334 Q969F7,Protoheme IX farnesyltransferase, mitochondrial,Heme O synthase;, PF01040;, GO:0070069;GO:0005829;GO:0016021;GO:0005743;GO:0005739;GO:0005730;GO:0004311;GO:0008495;GO:0045333;GO:0006784;GO:0006783;GO:0048034;GO:0006123;GO:0000266;GO:1902600;GO:0008535;, C:cytochrome complex; C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleolus;, F:farnesyltranstransferase activity; F:protoheme IX farnesyltransferase activity;, P:cellular respiration; P:heme A biosynthetic process; P:heme biosynthetic process; P:heme O biosynthetic process; P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial fission; P:proton transmembrane transport; P:respiratory chain complex IV assembly; scaffold54 indexed_genome mRNA 9203433 9213288 . + . ID=transcript_10036;Q9BQ52 B4DPL9 Q6IA94 Q9HAS8 Q9HAS9 Q9NVT1,Zinc phosphodiesterase ELAC protein 2,ElaC homolog protein 2;Heredity prostate cancer protein 2;Ribonuclease Z 2;tRNA 3 endonuclease 2;tRNase Z 2;, PF12706;PF13691;, GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0005634;GO:0042781;GO:0046872;GO:0003723;GO:0004549;GO:0072684;GO:0090646;GO:0042780;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:3'-tRNA processing endoribonuclease activity; F:metal ion binding; F:RNA binding; F:tRNA-specific ribonuclease activity;, P:mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; P:mitochondrial tRNA processing; P:tRNA 3'-end processing;|Q9BQ52 B4DPL9 Q6IA94 Q9HAS8 Q9HAS9 Q9NVT1,Zinc phosphodiesterase ELAC protein 2,ElaC homolog protein 2;Heredity prostate cancer protein 2;Ribonuclease Z 2;tRNA 3 endonuclease 2;tRNase Z 2;, PF12706;PF13691;, GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0005634;GO:0042781;GO:0046872;GO:0003723;GO:0004549;GO:0072684;GO:0090646;GO:0042780;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:3'-tRNA processing endoribonuclease activity; F:metal ion binding; F:RNA binding; F:tRNA-specific ribonuclease activity;, P:mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; P:mitochondrial tRNA processing; P:tRNA 3'-end processing; scaffold54 indexed_genome mRNA 9213503 9221800 . + . ID=transcript_10037;Q9BQ52 B4DPL9 Q6IA94 Q9HAS8 Q9HAS9 Q9NVT1,Zinc phosphodiesterase ELAC protein 2,ElaC homolog protein 2;Heredity prostate cancer protein 2;Ribonuclease Z 2;tRNA 3 endonuclease 2;tRNase Z 2;, PF12706;PF13691;, GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0005634;GO:0042781;GO:0046872;GO:0003723;GO:0004549;GO:0072684;GO:0090646;GO:0042780;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:3'-tRNA processing endoribonuclease activity; F:metal ion binding; F:RNA binding; F:tRNA-specific ribonuclease activity;, P:mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; P:mitochondrial tRNA processing; P:tRNA 3'-end processing;|Q9BQ52 B4DPL9 Q6IA94 Q9HAS8 Q9HAS9 Q9NVT1,Zinc phosphodiesterase ELAC protein 2,ElaC homolog protein 2;Heredity prostate cancer protein 2;Ribonuclease Z 2;tRNA 3 endonuclease 2;tRNase Z 2;, PF12706;PF13691;, GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0005634;GO:0042781;GO:0046872;GO:0003723;GO:0004549;GO:0072684;GO:0090646;GO:0042780;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:3'-tRNA processing endoribonuclease activity; F:metal ion binding; F:RNA binding; F:tRNA-specific ribonuclease activity;, P:mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; P:mitochondrial tRNA processing; P:tRNA 3'-end processing;|Q9BQ52 B4DPL9 Q6IA94 Q9HAS8 Q9HAS9 Q9NVT1,Zinc phosphodiesterase ELAC protein 2,ElaC homolog protein 2;Heredity prostate cancer protein 2;Ribonuclease Z 2;tRNA 3 endonuclease 2;tRNase Z 2;, PF12706;PF13691;, GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0005634;GO:0042781;GO:0046872;GO:0003723;GO:0004549;GO:0072684;GO:0090646;GO:0042780;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:3'-tRNA processing endoribonuclease activity; F:metal ion binding; F:RNA binding; F:tRNA-specific ribonuclease activity;, P:mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; P:mitochondrial tRNA processing; P:tRNA 3'-end processing;|Q17R89 A6NCP5 A8MQB2 O75160 Q7Z5Z7 Q9Y4Q4,Rho GTPase-activating protein 44 {ECO:0000305},NPC-A-10;Rho-type GTPase-activating protein RICH2;RhoGAP interacting with CIP4 homologs protein 2;, PF03114;PF00620;, GO:0005829;GO:0030425;GO:0043197;GO:0098978;GO:0031256;GO:0014069;GO:0048786;GO:0055037;GO:0005096;GO:0005543;GO:0031267;GO:0006887;GO:0098886;GO:0051490;GO:0035021;GO:0098887;GO:0032956;GO:0061001;GO:0043087;GO:0099152;GO:0035020;GO:0051056;GO:0007165;, C:cytosol; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:leading edge membrane; C:postsynaptic density; C:presynaptic active zone; C:recycling endosome;, F:GTPase activator activity; F:phospholipid binding; F:small GTPase binding;, P:exocytosis; P:modification of dendritic spine; P:negative regulation of filopodium assembly; P:negative regulation of Rac protein signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of actin cytoskeleton organization; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of Rac protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold54 indexed_genome mRNA 9225053 9250409 . - . ID=transcript_10038;Q17R89 A6NCP5 A8MQB2 O75160 Q7Z5Z7 Q9Y4Q4,Rho GTPase-activating protein 44 {ECO:0000305},NPC-A-10;Rho-type GTPase-activating protein RICH2;RhoGAP interacting with CIP4 homologs protein 2;, PF03114;PF00620;, GO:0005829;GO:0030425;GO:0043197;GO:0098978;GO:0031256;GO:0014069;GO:0048786;GO:0055037;GO:0005096;GO:0005543;GO:0031267;GO:0006887;GO:0098886;GO:0051490;GO:0035021;GO:0098887;GO:0032956;GO:0061001;GO:0043087;GO:0099152;GO:0035020;GO:0051056;GO:0007165;, C:cytosol; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:leading edge membrane; C:postsynaptic density; C:presynaptic active zone; C:recycling endosome;, F:GTPase activator activity; F:phospholipid binding; F:small GTPase binding;, P:exocytosis; P:modification of dendritic spine; P:negative regulation of filopodium assembly; P:negative regulation of Rac protein signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of actin cytoskeleton organization; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of Rac protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q17R89 A6NCP5 A8MQB2 O75160 Q7Z5Z7 Q9Y4Q4,Rho GTPase-activating protein 44 {ECO:0000305},NPC-A-10;Rho-type GTPase-activating protein RICH2;RhoGAP interacting with CIP4 homologs protein 2;, PF03114;PF00620;, GO:0005829;GO:0030425;GO:0043197;GO:0098978;GO:0031256;GO:0014069;GO:0048786;GO:0055037;GO:0005096;GO:0005543;GO:0031267;GO:0006887;GO:0098886;GO:0051490;GO:0035021;GO:0098887;GO:0032956;GO:0061001;GO:0043087;GO:0099152;GO:0035020;GO:0051056;GO:0007165;, C:cytosol; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:leading edge membrane; C:postsynaptic density; C:presynaptic active zone; C:recycling endosome;, F:GTPase activator activity; F:phospholipid binding; F:small GTPase binding;, P:exocytosis; P:modification of dendritic spine; P:negative regulation of filopodium assembly; P:negative regulation of Rac protein signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of actin cytoskeleton organization; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of Rac protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q17R89 A6NCP5 A8MQB2 O75160 Q7Z5Z7 Q9Y4Q4,Rho GTPase-activating protein 44 {ECO:0000305},NPC-A-10;Rho-type GTPase-activating protein RICH2;RhoGAP interacting with CIP4 homologs protein 2;, PF03114;PF00620;, GO:0005829;GO:0030425;GO:0043197;GO:0098978;GO:0031256;GO:0014069;GO:0048786;GO:0055037;GO:0005096;GO:0005543;GO:0031267;GO:0006887;GO:0098886;GO:0051490;GO:0035021;GO:0098887;GO:0032956;GO:0061001;GO:0043087;GO:0099152;GO:0035020;GO:0051056;GO:0007165;, C:cytosol; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:leading edge membrane; C:postsynaptic density; C:presynaptic active zone; C:recycling endosome;, F:GTPase activator activity; F:phospholipid binding; F:small GTPase binding;, P:exocytosis; P:modification of dendritic spine; P:negative regulation of filopodium assembly; P:negative regulation of Rac protein signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of actin cytoskeleton organization; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of Rac protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q17R89 A6NCP5 A8MQB2 O75160 Q7Z5Z7 Q9Y4Q4,Rho GTPase-activating protein 44 {ECO:0000305},NPC-A-10;Rho-type GTPase-activating protein RICH2;RhoGAP interacting with CIP4 homologs protein 2;, PF03114;PF00620;, GO:0005829;GO:0030425;GO:0043197;GO:0098978;GO:0031256;GO:0014069;GO:0048786;GO:0055037;GO:0005096;GO:0005543;GO:0031267;GO:0006887;GO:0098886;GO:0051490;GO:0035021;GO:0098887;GO:0032956;GO:0061001;GO:0043087;GO:0099152;GO:0035020;GO:0051056;GO:0007165;, C:cytosol; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:leading edge membrane; C:postsynaptic density; C:presynaptic active zone; C:recycling endosome;, F:GTPase activator activity; F:phospholipid binding; F:small GTPase binding;, P:exocytosis; P:modification of dendritic spine; P:negative regulation of filopodium assembly; P:negative regulation of Rac protein signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of actin cytoskeleton organization; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of Rac protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q17R89 A6NCP5 A8MQB2 O75160 Q7Z5Z7 Q9Y4Q4,Rho GTPase-activating protein 44 {ECO:0000305},NPC-A-10;Rho-type GTPase-activating protein RICH2;RhoGAP interacting with CIP4 homologs protein 2;, PF03114;PF00620;, GO:0005829;GO:0030425;GO:0043197;GO:0098978;GO:0031256;GO:0014069;GO:0048786;GO:0055037;GO:0005096;GO:0005543;GO:0031267;GO:0006887;GO:0098886;GO:0051490;GO:0035021;GO:0098887;GO:0032956;GO:0061001;GO:0043087;GO:0099152;GO:0035020;GO:0051056;GO:0007165;, C:cytosol; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:leading edge membrane; C:postsynaptic density; C:presynaptic active zone; C:recycling endosome;, F:GTPase activator activity; F:phospholipid binding; F:small GTPase binding;, P:exocytosis; P:modification of dendritic spine; P:negative regulation of filopodium assembly; P:negative regulation of Rac protein signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of actin cytoskeleton organization; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of Rac protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold54 indexed_genome mRNA 9268318 9308720 . - . ID=transcript_10039;Q17R89 A6NCP5 A8MQB2 O75160 Q7Z5Z7 Q9Y4Q4,Rho GTPase-activating protein 44 {ECO:0000305},NPC-A-10;Rho-type GTPase-activating protein RICH2;RhoGAP interacting with CIP4 homologs protein 2;, PF03114;PF00620;, GO:0005829;GO:0030425;GO:0043197;GO:0098978;GO:0031256;GO:0014069;GO:0048786;GO:0055037;GO:0005096;GO:0005543;GO:0031267;GO:0006887;GO:0098886;GO:0051490;GO:0035021;GO:0098887;GO:0032956;GO:0061001;GO:0043087;GO:0099152;GO:0035020;GO:0051056;GO:0007165;, C:cytosol; C:dendrite; C:dendritic spine; C:glutamatergic synapse; C:leading edge membrane; C:postsynaptic density; C:presynaptic active zone; C:recycling endosome;, F:GTPase activator activity; F:phospholipid binding; F:small GTPase binding;, P:exocytosis; P:modification of dendritic spine; P:negative regulation of filopodium assembly; P:negative regulation of Rac protein signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of actin cytoskeleton organization; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of Rac protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold54 indexed_genome mRNA 9359581 9444314 . - . ID=transcript_10040;Q8IZQ8 Q5UBU5 Q8N7Q1,Myocardin,, PF02755;PF02037;, GO:0000785;GO:0005634;GO:0035035;GO:0042826;GO:0070412;GO:0061629;GO:0003713;GO:0008134;GO:0055007;GO:0003231;GO:0035051;GO:0043954;GO:0048565;GO:0097070;GO:0048286;GO:1900222;GO:0010667;GO:0060354;GO:0008285;GO:0045736;GO:0010832;GO:2000587;GO:2001015;GO:0000122;GO:1904753;GO:1904706;GO:2000727;GO:2000724;GO:0008284;GO:0043388;GO:0051091;GO:1903800;GO:0051152;GO:0045987;GO:0045944;GO:0003257;GO:2000721;GO:0045893;GO:0030511;GO:0001560;GO:0035065;GO:0045661;GO:1900239;GO:0051150;GO:0001666;GO:0051145;GO:0060157;GO:0060065;GO:0035886;GO:0001570;GO:0055012;, C:chromatin; C:nucleus;, F:histone acetyltransferase binding; F:histone deacetylase binding; F:R-SMAD binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:transcription coactivator activity; F:transcription factor binding;, P:cardiac muscle cell differentiation; P:cardiac ventricle development; P:cardiocyte differentiation; P:cellular component maintenance; P:digestive tract development; P:ductus arteriosus closure; P:lung alveolus development; P:negative regulation of amyloid-beta clearance; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of myotube differentiation; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of skeletal muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cardiac vascular smooth muscle cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of DNA binding; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of smooth muscle contraction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cell growth by extracellular stimulus; P:regulation of histone acetylation; P:regulation of myoblast differentiation; P:regulation of phenotypic switching; P:regulation of smooth muscle cell differentiation; P:response to hypoxia; P:smooth muscle cell differentiation; P:urinary bladder development; P:uterus development; P:vascular associated smooth muscle cell differentiation; P:vasculogenesis; P:ventricular cardiac muscle cell differentiation;|Q8IZQ8 Q5UBU5 Q8N7Q1,Myocardin,, PF02755;PF02037;, GO:0000785;GO:0005634;GO:0035035;GO:0042826;GO:0070412;GO:0061629;GO:0003713;GO:0008134;GO:0055007;GO:0003231;GO:0035051;GO:0043954;GO:0048565;GO:0097070;GO:0048286;GO:1900222;GO:0010667;GO:0060354;GO:0008285;GO:0045736;GO:0010832;GO:2000587;GO:2001015;GO:0000122;GO:1904753;GO:1904706;GO:2000727;GO:2000724;GO:0008284;GO:0043388;GO:0051091;GO:1903800;GO:0051152;GO:0045987;GO:0045944;GO:0003257;GO:2000721;GO:0045893;GO:0030511;GO:0001560;GO:0035065;GO:0045661;GO:1900239;GO:0051150;GO:0001666;GO:0051145;GO:0060157;GO:0060065;GO:0035886;GO:0001570;GO:0055012;, C:chromatin; C:nucleus;, F:histone acetyltransferase binding; F:histone deacetylase binding; F:R-SMAD binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:transcription coactivator activity; F:transcription factor binding;, P:cardiac muscle cell differentiation; P:cardiac ventricle development; P:cardiocyte differentiation; P:cellular component maintenance; P:digestive tract development; P:ductus arteriosus closure; P:lung alveolus development; P:negative regulation of amyloid-beta clearance; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of myotube differentiation; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of skeletal muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cardiac vascular smooth muscle cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of DNA binding; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of smooth muscle contraction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cell growth by extracellular stimulus; P:regulation of histone acetylation; P:regulation of myoblast differentiation; P:regulation of phenotypic switching; P:regulation of smooth muscle cell differentiation; P:response to hypoxia; P:smooth muscle cell differentiation; P:urinary bladder development; P:uterus development; P:vascular associated smooth muscle cell differentiation; P:vasculogenesis; P:ventricular cardiac muscle cell differentiation; scaffold54 indexed_genome mRNA 9794403 9843211 . + . ID=transcript_10041;P45985 B2R7N7 B3KYB2 D3DTS5 Q5U0B8 Q6FHX4 Q6P9H2 Q6PIE6,Dual specificity mitogen-activated protein kinase kinase 4,JNK-activating kinase 1;MAPK/ERK kinase 4;SAPK/ERK kinase 1;Stress-activated protein kinase kinase 1;c-Jun N-terminal kinase kinase 1;, PF00069;, GO:0030424;GO:0005829;GO:0032839;GO:0005634;GO:0043204;GO:0005524;GO:0008545;GO:0004708;GO:0031435;GO:0004672;GO:0106310;GO:0106311;GO:0004714;GO:0007257;GO:0000187;GO:0006915;GO:0061049;GO:0071260;GO:0072709;GO:0038095;GO:0007254;GO:2000672;GO:0045740;GO:0043525;GO:0051770;GO:0034393;GO:0009611;GO:0007165;, C:axon; C:cytosol; C:dendrite cytoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:JUN kinase kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:apoptotic process; P:cell growth involved in cardiac muscle cell development; P:cellular response to mechanical stimulus; P:cellular response to sorbitol; P:Fc-epsilon receptor signaling pathway; P:JNK cascade; P:negative regulation of motor neuron apoptotic process; P:positive regulation of DNA replication; P:positive regulation of neuron apoptotic process; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of smooth muscle cell apoptotic process; P:response to wounding; P:signal transduction;|P45985 B2R7N7 B3KYB2 D3DTS5 Q5U0B8 Q6FHX4 Q6P9H2 Q6PIE6,Dual specificity mitogen-activated protein kinase kinase 4,JNK-activating kinase 1;MAPK/ERK kinase 4;SAPK/ERK kinase 1;Stress-activated protein kinase kinase 1;c-Jun N-terminal kinase kinase 1;, PF00069;, GO:0030424;GO:0005829;GO:0032839;GO:0005634;GO:0043204;GO:0005524;GO:0008545;GO:0004708;GO:0031435;GO:0004672;GO:0106310;GO:0106311;GO:0004714;GO:0007257;GO:0000187;GO:0006915;GO:0061049;GO:0071260;GO:0072709;GO:0038095;GO:0007254;GO:2000672;GO:0045740;GO:0043525;GO:0051770;GO:0034393;GO:0009611;GO:0007165;, C:axon; C:cytosol; C:dendrite cytoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:JUN kinase kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:apoptotic process; P:cell growth involved in cardiac muscle cell development; P:cellular response to mechanical stimulus; P:cellular response to sorbitol; P:Fc-epsilon receptor signaling pathway; P:JNK cascade; P:negative regulation of motor neuron apoptotic process; P:positive regulation of DNA replication; P:positive regulation of neuron apoptotic process; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of smooth muscle cell apoptotic process; P:response to wounding; P:signal transduction;|P45985 B2R7N7 B3KYB2 D3DTS5 Q5U0B8 Q6FHX4 Q6P9H2 Q6PIE6,Dual specificity mitogen-activated protein kinase kinase 4,JNK-activating kinase 1;MAPK/ERK kinase 4;SAPK/ERK kinase 1;Stress-activated protein kinase kinase 1;c-Jun N-terminal kinase kinase 1;, PF00069;, GO:0030424;GO:0005829;GO:0032839;GO:0005634;GO:0043204;GO:0005524;GO:0008545;GO:0004708;GO:0031435;GO:0004672;GO:0106310;GO:0106311;GO:0004714;GO:0007257;GO:0000187;GO:0006915;GO:0061049;GO:0071260;GO:0072709;GO:0038095;GO:0007254;GO:2000672;GO:0045740;GO:0043525;GO:0051770;GO:0034393;GO:0009611;GO:0007165;, C:axon; C:cytosol; C:dendrite cytoplasm; C:nucleus; C:perikaryon;, F:ATP binding; F:JUN kinase kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:apoptotic process; P:cell growth involved in cardiac muscle cell development; P:cellular response to mechanical stimulus; P:cellular response to sorbitol; P:Fc-epsilon receptor signaling pathway; P:JNK cascade; P:negative regulation of motor neuron apoptotic process; P:positive regulation of DNA replication; P:positive regulation of neuron apoptotic process; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of smooth muscle cell apoptotic process; P:response to wounding; P:signal transduction; scaffold54 indexed_genome mRNA 9892675 9904821 . + . ID=transcript_10042;P17022 Q5QHQ3 Q8IYC4 Q8NAH6,Zinc finger protein 18,Heart development-specific gene 1 protein;Zinc finger protein 535;Zinc finger protein KOX11;Zinc finger protein with KRAB and SCAN domains 6;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P17022 Q5QHQ3 Q8IYC4 Q8NAH6,Zinc finger protein 18,Heart development-specific gene 1 protein;Zinc finger protein 535;Zinc finger protein KOX11;Zinc finger protein with KRAB and SCAN domains 6;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P17022 Q5QHQ3 Q8IYC4 Q8NAH6,Zinc finger protein 18,Heart development-specific gene 1 protein;Zinc finger protein 535;Zinc finger protein KOX11;Zinc finger protein with KRAB and SCAN domains 6;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold54 indexed_genome mRNA 9906669 9910109 . - . ID=transcript_10043;Q9NYC9 A2VCQ8 O15064 O95494 Q9NQ28,Dynein heavy chain 9, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 9;Ciliary dynein heavy chain 9;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0097729;GO:0005930;GO:0120135;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0030030;GO:0003341;GO:0007018;, C:9+2 motile cilium; C:axoneme; C:distal portion of axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cell projection organization; P:cilium movement; P:microtubule-based movement; scaffold54 indexed_genome mRNA 9923110 9931620 . - . ID=transcript_10044;Q9NYC9 A2VCQ8 O15064 O95494 Q9NQ28,Dynein heavy chain 9, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 9;Ciliary dynein heavy chain 9;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0097729;GO:0005930;GO:0120135;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0030030;GO:0003341;GO:0007018;, C:9+2 motile cilium; C:axoneme; C:distal portion of axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cell projection organization; P:cilium movement; P:microtubule-based movement; scaffold54 indexed_genome mRNA 9959294 9968165 . - . ID=transcript_10045;Q9NYC9 A2VCQ8 O15064 O95494 Q9NQ28,Dynein heavy chain 9, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 9;Ciliary dynein heavy chain 9;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0097729;GO:0005930;GO:0120135;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0030030;GO:0003341;GO:0007018;, C:9+2 motile cilium; C:axoneme; C:distal portion of axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cell projection organization; P:cilium movement; P:microtubule-based movement; scaffold54 indexed_genome mRNA 10804151 10821384 . - . ID=transcript_10046;Q6QAJ8 A1YRJ4 B2RNE4 B4DJ52 B9EGW3,Transmembrane protein 220,, PF15071;, GO:0016021;, C:integral component of membrane;|Q3LIE5 A8K9B4 D3DTS4 Q9BVD4 Q9NRU8,Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase,ADPRibase-Mn;CDP-choline phosphohydrolase;, PF00149;, GO:0005829;GO:0008663;GO:0047631;GO:0047734;GO:0030145;GO:0034656;, C:cytosol;, F:2',3'-cyclic-nucleotide 2'-phosphodiesterase activity; F:ADP-ribose diphosphatase activity; F:CDP-glycerol diphosphatase activity; F:manganese ion binding;, P:nucleobase-containing small molecule catabolic process; scaffold54 indexed_genome mRNA 10821463 10839452 . + . ID=transcript_10047;O75880 B2RDM0,Protein SCO1 homolog, mitochondrial,, PF02630;, GO:0031305;GO:0005739;GO:0030016;GO:0016531;GO:0006878;GO:0033617;, C:integral component of mitochondrial inner membrane; C:mitochondrion; C:myofibril;, F:copper chaperone activity;, P:cellular copper ion homeostasis; P:mitochondrial cytochrome c oxidase assembly; scaffold54 indexed_genome mRNA 10869086 10870790 . + . ID=transcript_10048;P11055 Q15492,Myosin-3,Muscle embryonic myosin heavy chain;Myosin heavy chain 3;Myosin heavy chain, fast skeletal muscle, embryonic;SMHCE;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0005859;GO:0032982;GO:0030017;GO:0051015;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0030048;GO:0046034;GO:0030326;GO:0060325;GO:0030049;GO:0007517;GO:0006470;GO:0045214;GO:0003009;, C:cytosol; C:extracellular exosome; C:muscle myosin complex; C:myosin filament; C:sarcomere;, F:actin filament binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:actin filament-based movement; P:ATP metabolic process; P:embryonic limb morphogenesis; P:face morphogenesis; P:muscle filament sliding; P:muscle organ development; P:protein dephosphorylation; P:sarcomere organization; P:skeletal muscle contraction;|P12882 Q14CA4 Q9Y622,Myosin-1,Myosin heavy chain 1;Myosin heavy chain 2x;Myosin heavy chain IIx/d;Myosin heavy chain, skeletal muscle, adult 1;, PF00063;PF02736;PF01576;, GO:0031672;GO:0036464;GO:0014704;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0006936;, C:A band; C:cytoplasmic ribonucleoprotein granule; C:intercalated disc; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity;, P:muscle contraction; scaffold54 indexed_genome mRNA 10875015 10876795 . - . ID=transcript_10049;Q9Y623,Myosin-4,Myosin heavy chain 2b;Myosin heavy chain 4;Myosin heavy chain IIb;Myosin heavy chain, skeletal muscle, fetal;, PF00063;PF02736;PF01576;, GO:0005859;GO:0030016;GO:0032982;GO:0030017;GO:0051015;GO:0005524;GO:0016887;GO:0005516;GO:0003725;GO:0000146;GO:0030048;GO:0046034;GO:0006936;GO:0030049;, C:muscle myosin complex; C:myofibril; C:myosin filament; C:sarcomere;, F:actin filament binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:double-stranded RNA binding; F:microfilament motor activity;, P:actin filament-based movement; P:ATP metabolic process; P:muscle contraction; P:muscle filament sliding; scaffold54 indexed_genome mRNA 10877275 10882207 . - . ID=transcript_10050;P11055 Q15492,Myosin-3,Muscle embryonic myosin heavy chain;Myosin heavy chain 3;Myosin heavy chain, fast skeletal muscle, embryonic;SMHCE;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0005859;GO:0032982;GO:0030017;GO:0051015;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0030048;GO:0046034;GO:0030326;GO:0060325;GO:0030049;GO:0007517;GO:0006470;GO:0045214;GO:0003009;, C:cytosol; C:extracellular exosome; C:muscle myosin complex; C:myosin filament; C:sarcomere;, F:actin filament binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:actin filament-based movement; P:ATP metabolic process; P:embryonic limb morphogenesis; P:face morphogenesis; P:muscle filament sliding; P:muscle organ development; P:protein dephosphorylation; P:sarcomere organization; P:skeletal muscle contraction;|P11055 Q15492,Myosin-3,Muscle embryonic myosin heavy chain;Myosin heavy chain 3;Myosin heavy chain, fast skeletal muscle, embryonic;SMHCE;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0005859;GO:0032982;GO:0030017;GO:0051015;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0030048;GO:0046034;GO:0030326;GO:0060325;GO:0030049;GO:0007517;GO:0006470;GO:0045214;GO:0003009;, C:cytosol; C:extracellular exosome; C:muscle myosin complex; C:myosin filament; C:sarcomere;, F:actin filament binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:actin filament-based movement; P:ATP metabolic process; P:embryonic limb morphogenesis; P:face morphogenesis; P:muscle filament sliding; P:muscle organ development; P:protein dephosphorylation; P:sarcomere organization; P:skeletal muscle contraction; scaffold54 indexed_genome mRNA 10882572 10884524 . - . ID=transcript_10051;P11055 Q15492,Myosin-3,Muscle embryonic myosin heavy chain;Myosin heavy chain 3;Myosin heavy chain, fast skeletal muscle, embryonic;SMHCE;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0005859;GO:0032982;GO:0030017;GO:0051015;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0030048;GO:0046034;GO:0030326;GO:0060325;GO:0030049;GO:0007517;GO:0006470;GO:0045214;GO:0003009;, C:cytosol; C:extracellular exosome; C:muscle myosin complex; C:myosin filament; C:sarcomere;, F:actin filament binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:actin filament-based movement; P:ATP metabolic process; P:embryonic limb morphogenesis; P:face morphogenesis; P:muscle filament sliding; P:muscle organ development; P:protein dephosphorylation; P:sarcomere organization; P:skeletal muscle contraction; scaffold54 indexed_genome mRNA 10991309 10993654 . + . ID=transcript_10052;P12882 Q14CA4 Q9Y622,Myosin-1,Myosin heavy chain 1;Myosin heavy chain 2x;Myosin heavy chain IIx/d;Myosin heavy chain, skeletal muscle, adult 1;, PF00063;PF02736;PF01576;, GO:0031672;GO:0036464;GO:0014704;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0006936;, C:A band; C:cytoplasmic ribonucleoprotein granule; C:intercalated disc; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity;, P:muscle contraction;|P13535 Q14910,Myosin-8,Myosin heavy chain 8;Myosin heavy chain, skeletal muscle, perinatal;, PF00063;PF02736;PF01576;, GO:0005737;GO:0005829;GO:0005859;GO:0032982;GO:0030017;GO:0051015;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0032027;GO:0008307;GO:0046034;GO:0006936;GO:0030049;GO:0006470;GO:0003009;, C:cytoplasm; C:cytosol; C:muscle myosin complex; C:myosin filament; C:sarcomere;, F:actin filament binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:myosin light chain binding; F:structural constituent of muscle;, P:ATP metabolic process; P:muscle contraction; P:muscle filament sliding; P:protein dephosphorylation; P:skeletal muscle contraction; scaffold54 indexed_genome mRNA 10993812 10997540 . + . ID=transcript_10053;P12882 Q14CA4 Q9Y622,Myosin-1,Myosin heavy chain 1;Myosin heavy chain 2x;Myosin heavy chain IIx/d;Myosin heavy chain, skeletal muscle, adult 1;, PF00063;PF02736;PF01576;, GO:0031672;GO:0036464;GO:0014704;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0006936;, C:A band; C:cytoplasmic ribonucleoprotein granule; C:intercalated disc; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity;, P:muscle contraction;|P12882 Q14CA4 Q9Y622,Myosin-1,Myosin heavy chain 1;Myosin heavy chain 2x;Myosin heavy chain IIx/d;Myosin heavy chain, skeletal muscle, adult 1;, PF00063;PF02736;PF01576;, GO:0031672;GO:0036464;GO:0014704;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0006936;, C:A band; C:cytoplasmic ribonucleoprotein granule; C:intercalated disc; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity;, P:muscle contraction; scaffold54 indexed_genome mRNA 11381333 11416714 . + . ID=transcript_10054;O60861 A8KAC2 B2RCK9 O43144 Q53Y77 Q7Z571,Growth arrest-specific protein 7,, PF00611;PF14604;PF00397;, GO:0005884;GO:0005737;GO:0005856;GO:0005886;GO:0051015;GO:0042802;GO:0030041;GO:0048812;, C:actin filament; C:cytoplasm; C:cytoskeleton; C:plasma membrane;, F:actin filament binding; F:identical protein binding;, P:actin filament polymerization; P:neuron projection morphogenesis; scaffold54 indexed_genome mRNA 11496961 11528403 . - . ID=transcript_10055;A6NNS2 B7ZW74 B9EJH3,Dehydrogenase/reductase SDR family member 7C,Short-chain dehydrogenase/reductase family 32C member 2 {ECO:0000303|PubMed:19027726};, PF00106;, GO:0005576;GO:0014801;GO:0033017;GO:0004745;GO:0010880;, C:extracellular region; C:longitudinal sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, F:retinol dehydrogenase activity;, P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;|A6NNS2 B7ZW74 B9EJH3,Dehydrogenase/reductase SDR family member 7C,Short-chain dehydrogenase/reductase family 32C member 2 {ECO:0000303|PubMed:19027726};, PF00106;, GO:0005576;GO:0014801;GO:0033017;GO:0004745;GO:0010880;, C:extracellular region; C:longitudinal sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, F:retinol dehydrogenase activity;, P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; scaffold54 indexed_genome mRNA 11533315 11568064 . - . ID=transcript_10056;Q70EL4 A6NDT9 B7ZLT9 B7ZVX5 Q8N2C5 Q96DQ6,Ubiquitin carboxyl-terminal hydrolase 43,Deubiquitinating enzyme 43;Ubiquitin thioesterase 43;Ubiquitin-specific-processing protease 43;, PF00443;, GO:0005654;GO:0008234;GO:0004843;GO:0016579;GO:0019985;GO:0006511;, C:nucleoplasm;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:translesion synthesis; P:ubiquitin-dependent protein catabolic process; scaffold54 indexed_genome mRNA 11574979 11592416 . - . ID=transcript_10057;Q8N1V2 B2RDU7 Q5DX23 Q8TC73 Q8TCI3,Cilia- and flagella-associated protein 52 {ECO:0000312|HGNC:HGNC:16053},WD repeat-containing protein 16 {ECO:0000312|HGNC:HGNC:16053};WD40-repeat protein up-regulated in HCC {ECO:0000303|PubMed:15967112};, PF00400;, GO:0005737;GO:0031514;GO:0060271;, C:cytoplasm; C:motile cilium;, , P:cilium assembly;|Q8N1V2 B2RDU7 Q5DX23 Q8TC73 Q8TCI3,Cilia- and flagella-associated protein 52 {ECO:0000312|HGNC:HGNC:16053},WD repeat-containing protein 16 {ECO:0000312|HGNC:HGNC:16053};WD40-repeat protein up-regulated in HCC {ECO:0000303|PubMed:15967112};, PF00400;, GO:0005737;GO:0031514;GO:0060271;, C:cytoplasm; C:motile cilium;, , P:cilium assembly; scaffold54 indexed_genome mRNA 11600559 11799164 . + . ID=transcript_10058;Q9UNK0 O60712 Q53XT8,Syntaxin-8,, PF05739;, GO:0005829;GO:0005769;GO:0012505;GO:0005783;GO:0005768;GO:0016021;GO:0005887;GO:0005770;GO:0031902;GO:0005765;GO:0048471;GO:0045335;GO:0055037;GO:0031201;GO:0005802;GO:0031982;GO:0019869;GO:0005484;GO:0000149;GO:0019905;GO:0031625;GO:0071346;GO:0045022;GO:0008333;GO:0006886;GO:1903076;GO:0048278;GO:0006906;, C:cytosol; C:early endosome; C:endomembrane system; C:endoplasmic reticulum; C:endosome; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:recycling endosome; C:SNARE complex; C:trans-Golgi network; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding; F:ubiquitin protein ligase binding;, P:cellular response to interferon-gamma; P:early endosome to late endosome transport; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of protein localization to plasma membrane; P:vesicle docking; P:vesicle fusion;|Q9UNK0 O60712 Q53XT8,Syntaxin-8,, PF05739;, GO:0005829;GO:0005769;GO:0012505;GO:0005783;GO:0005768;GO:0016021;GO:0005887;GO:0005770;GO:0031902;GO:0005765;GO:0048471;GO:0045335;GO:0055037;GO:0031201;GO:0005802;GO:0031982;GO:0019869;GO:0005484;GO:0000149;GO:0019905;GO:0031625;GO:0071346;GO:0045022;GO:0008333;GO:0006886;GO:1903076;GO:0048278;GO:0006906;, C:cytosol; C:early endosome; C:endomembrane system; C:endoplasmic reticulum; C:endosome; C:integral component of membrane; C:integral component of plasma membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:recycling endosome; C:SNARE complex; C:trans-Golgi network; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding; F:ubiquitin protein ligase binding;, P:cellular response to interferon-gamma; P:early endosome to late endosome transport; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of protein localization to plasma membrane; P:vesicle docking; P:vesicle fusion; scaffold54 indexed_genome mRNA 11803943 11811612 . - . ID=transcript_10059;O95631 E9KL51,Netrin-1,Epididymis tissue protein Li 131P;, PF00053;PF00055;PF01759;, GO:0005604;GO:0005737;GO:0005576;GO:0009887;GO:0033564;GO:0006915;GO:0032488;GO:0098609;GO:0061643;GO:0016358;GO:0042472;GO:0060603;GO:0008045;GO:0030517;GO:1902842;GO:0001764;GO:0007097;GO:0045773;GO:2000147;GO:0008284;GO:0007265;GO:0030334;GO:0051963;GO:0006930;GO:0009888;, C:basement membrane; C:cytoplasm; C:extracellular region;, , P:animal organ morphogenesis; P:anterior/posterior axon guidance; P:apoptotic process; P:Cdc42 protein signal transduction; P:cell-cell adhesion; P:chemorepulsion of axon; P:dendrite development; P:inner ear morphogenesis; P:mammary gland duct morphogenesis; P:motor neuron axon guidance; P:negative regulation of axon extension; P:negative regulation of netrin-activated signaling pathway; P:neuron migration; P:nuclear migration; P:positive regulation of axon extension; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:Ras protein signal transduction; P:regulation of cell migration; P:regulation of synapse assembly; P:substrate-dependent cell migration, cell extension; P:tissue development;|O95631 E9KL51,Netrin-1,Epididymis tissue protein Li 131P;, PF00053;PF00055;PF01759;, GO:0005604;GO:0005737;GO:0005576;GO:0009887;GO:0033564;GO:0006915;GO:0032488;GO:0098609;GO:0061643;GO:0016358;GO:0042472;GO:0060603;GO:0008045;GO:0030517;GO:1902842;GO:0001764;GO:0007097;GO:0045773;GO:2000147;GO:0008284;GO:0007265;GO:0030334;GO:0051963;GO:0006930;GO:0009888;, C:basement membrane; C:cytoplasm; C:extracellular region;, , P:animal organ morphogenesis; P:anterior/posterior axon guidance; P:apoptotic process; P:Cdc42 protein signal transduction; P:cell-cell adhesion; P:chemorepulsion of axon; P:dendrite development; P:inner ear morphogenesis; P:mammary gland duct morphogenesis; P:motor neuron axon guidance; P:negative regulation of axon extension; P:negative regulation of netrin-activated signaling pathway; P:neuron migration; P:nuclear migration; P:positive regulation of axon extension; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:Ras protein signal transduction; P:regulation of cell migration; P:regulation of synapse assembly; P:substrate-dependent cell migration, cell extension; P:tissue development; scaffold54 indexed_genome mRNA 12039431 12113712 . + . ID=transcript_10060;Q8WYR1 B0LPH4 D3DTS3 Q5G936 Q5G938 Q5G939 Q8IZ23 Q9Y2Y2,Phosphoinositide 3-kinase regulatory subunit 5,PI3-kinase p101 subunit;Phosphatidylinositol 4,5-bisphosphate 3-kinase regulatory subunit;Protein FOAP-2;PtdIns-3-kinase p101;p101-PI3K;, PF10486;, GO:0034451;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005942;GO:0005944;GO:0005886;GO:0046935;GO:0031683;GO:0007186;GO:0014065;GO:0006661;GO:0030168;GO:0043406;GO:0014068;GO:0051897;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:G-protein beta/gamma-subunit complex binding;, P:G protein-coupled receptor signaling pathway; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:platelet activation; P:positive regulation of MAP kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling;|Q8WYR1 B0LPH4 D3DTS3 Q5G936 Q5G938 Q5G939 Q8IZ23 Q9Y2Y2,Phosphoinositide 3-kinase regulatory subunit 5,PI3-kinase p101 subunit;Phosphatidylinositol 4,5-bisphosphate 3-kinase regulatory subunit;Protein FOAP-2;PtdIns-3-kinase p101;p101-PI3K;, PF10486;, GO:0034451;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005942;GO:0005944;GO:0005886;GO:0046935;GO:0031683;GO:0007186;GO:0014065;GO:0006661;GO:0030168;GO:0043406;GO:0014068;GO:0051897;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:G-protein beta/gamma-subunit complex binding;, P:G protein-coupled receptor signaling pathway; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:platelet activation; P:positive regulation of MAP kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling;|Q8WYR1 B0LPH4 D3DTS3 Q5G936 Q5G938 Q5G939 Q8IZ23 Q9Y2Y2,Phosphoinositide 3-kinase regulatory subunit 5,PI3-kinase p101 subunit;Phosphatidylinositol 4,5-bisphosphate 3-kinase regulatory subunit;Protein FOAP-2;PtdIns-3-kinase p101;p101-PI3K;, PF10486;, GO:0034451;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005942;GO:0005944;GO:0005886;GO:0046935;GO:0031683;GO:0007186;GO:0014065;GO:0006661;GO:0030168;GO:0043406;GO:0014068;GO:0051897;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:G-protein beta/gamma-subunit complex binding;, P:G protein-coupled receptor signaling pathway; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:platelet activation; P:positive regulation of MAP kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; scaffold54 indexed_genome mRNA 12157202 12171154 . + . ID=transcript_10061;Q5UE93 Q658R3,Phosphoinositide 3-kinase regulatory subunit 6,Phosphoinositide 3-kinase gamma adapter protein of 87 kDa;p84 PI3K adapter protein;p87 PI3K adapter protein;, PF10486;, GO:0005829;GO:0016020;GO:0005942;GO:0005944;GO:0005886;GO:0046935;GO:0046934;GO:0001525;GO:0007186;GO:0006661;GO:0030168;GO:0045766;GO:0043406;GO:0045582;GO:0042269;, C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:angiogenesis; P:G protein-coupled receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of MAP kinase activity; P:positive regulation of T cell differentiation; P:regulation of natural killer cell mediated cytotoxicity;|Q5UE93 Q658R3,Phosphoinositide 3-kinase regulatory subunit 6,Phosphoinositide 3-kinase gamma adapter protein of 87 kDa;p84 PI3K adapter protein;p87 PI3K adapter protein;, PF10486;, GO:0005829;GO:0016020;GO:0005942;GO:0005944;GO:0005886;GO:0046935;GO:0046934;GO:0001525;GO:0007186;GO:0006661;GO:0030168;GO:0045766;GO:0043406;GO:0045582;GO:0042269;, C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:phosphatidylinositol 3-kinase complex, class IB; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase regulator activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:angiogenesis; P:G protein-coupled receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of MAP kinase activity; P:positive regulation of T cell differentiation; P:regulation of natural killer cell mediated cytotoxicity; scaffold54 indexed_genome mRNA 12305824 12421131 . + . ID=transcript_10062;Q6PK16 Q9BWG0,Myosin-10,Cellular myosin heavy chain, type B;Myosin heavy chain 10;Myosin heavy chain, non-muscle IIb;Non-muscle myosin heavy chain B;Non-muscle myosin heavy chain IIb;, PF00612;PF00063;PF02736;PF01576;, GO:0042641;GO:0005938;GO:0032154;GO:0005737;GO:0005829;GO:0070062;GO:0030027;GO:0030496;GO:0016459;GO:0016460;GO:0097513;GO:0005634;GO:0005844;GO:0001725;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0048027;GO:0035613;GO:0030048;GO:0031032;GO:0007155;GO:0000281;GO:0098885;GO:0050714;GO:0008360;, C:actomyosin; C:cell cortex; C:cleavage furrow; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamellipodium; C:midbody; C:myosin complex; C:myosin II complex; C:myosin II filament; C:nucleus; C:polysome; C:stress fiber;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:mRNA 5'-UTR binding; F:RNA stem-loop binding;, P:actin filament-based movement; P:actomyosin structure organization; P:cell adhesion; P:mitotic cytokinesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of protein secretion; P:regulation of cell shape;|Q6PK16 Q9BWG0,Myosin-10,Cellular myosin heavy chain, type B;Myosin heavy chain 10;Myosin heavy chain, non-muscle IIb;Non-muscle myosin heavy chain B;Non-muscle myosin heavy chain IIb;, PF00612;PF00063;PF02736;PF01576;, GO:0042641;GO:0005938;GO:0032154;GO:0005737;GO:0005829;GO:0070062;GO:0030027;GO:0030496;GO:0016459;GO:0016460;GO:0097513;GO:0005634;GO:0005844;GO:0001725;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0048027;GO:0035613;GO:0030048;GO:0031032;GO:0007155;GO:0000281;GO:0098885;GO:0050714;GO:0008360;, C:actomyosin; C:cell cortex; C:cleavage furrow; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamellipodium; C:midbody; C:myosin complex; C:myosin II complex; C:myosin II filament; C:nucleus; C:polysome; C:stress fiber;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:mRNA 5'-UTR binding; F:RNA stem-loop binding;, P:actin filament-based movement; P:actomyosin structure organization; P:cell adhesion; P:mitotic cytokinesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of protein secretion; P:regulation of cell shape;|Q6PK16 Q9BWG0,Myosin-10,Cellular myosin heavy chain, type B;Myosin heavy chain 10;Myosin heavy chain, non-muscle IIb;Non-muscle myosin heavy chain B;Non-muscle myosin heavy chain IIb;, PF00612;PF00063;PF02736;PF01576;, GO:0042641;GO:0005938;GO:0032154;GO:0005737;GO:0005829;GO:0070062;GO:0030027;GO:0030496;GO:0016459;GO:0016460;GO:0097513;GO:0005634;GO:0005844;GO:0001725;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0048027;GO:0035613;GO:0030048;GO:0031032;GO:0007155;GO:0000281;GO:0098885;GO:0050714;GO:0008360;, C:actomyosin; C:cell cortex; C:cleavage furrow; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamellipodium; C:midbody; C:myosin complex; C:myosin II complex; C:myosin II filament; C:nucleus; C:polysome; C:stress fiber;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:mRNA 5'-UTR binding; F:RNA stem-loop binding;, P:actin filament-based movement; P:actomyosin structure organization; P:cell adhesion; P:mitotic cytokinesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of protein secretion; P:regulation of cell shape;|Q6PK16 Q9BWG0,Myosin-10,Cellular myosin heavy chain, type B;Myosin heavy chain 10;Myosin heavy chain, non-muscle IIb;Non-muscle myosin heavy chain B;Non-muscle myosin heavy chain IIb;, PF00612;PF00063;PF02736;PF01576;, GO:0042641;GO:0005938;GO:0032154;GO:0005737;GO:0005829;GO:0070062;GO:0030027;GO:0030496;GO:0016459;GO:0016460;GO:0097513;GO:0005634;GO:0005844;GO:0001725;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0048027;GO:0035613;GO:0030048;GO:0031032;GO:0007155;GO:0000281;GO:0098885;GO:0050714;GO:0008360;, C:actomyosin; C:cell cortex; C:cleavage furrow; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamellipodium; C:midbody; C:myosin complex; C:myosin II complex; C:myosin II filament; C:nucleus; C:polysome; C:stress fiber;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:mRNA 5'-UTR binding; F:RNA stem-loop binding;, P:actin filament-based movement; P:actomyosin structure organization; P:cell adhesion; P:mitotic cytokinesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of protein secretion; P:regulation of cell shape;|Q6PK16 Q9BWG0,Myosin-10,Cellular myosin heavy chain, type B;Myosin heavy chain 10;Myosin heavy chain, non-muscle IIb;Non-muscle myosin heavy chain B;Non-muscle myosin heavy chain IIb;, PF00612;PF00063;PF02736;PF01576;, GO:0042641;GO:0005938;GO:0032154;GO:0005737;GO:0005829;GO:0070062;GO:0030027;GO:0030496;GO:0016459;GO:0016460;GO:0097513;GO:0005634;GO:0005844;GO:0001725;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0048027;GO:0035613;GO:0030048;GO:0031032;GO:0007155;GO:0000281;GO:0098885;GO:0050714;GO:0008360;, C:actomyosin; C:cell cortex; C:cleavage furrow; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamellipodium; C:midbody; C:myosin complex; C:myosin II complex; C:myosin II filament; C:nucleus; C:polysome; C:stress fiber;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:mRNA 5'-UTR binding; F:RNA stem-loop binding;, P:actin filament-based movement; P:actomyosin structure organization; P:cell adhesion; P:mitotic cytokinesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of protein secretion; P:regulation of cell shape;|Q6PK16 Q9BWG0,Myosin-10,Cellular myosin heavy chain, type B;Myosin heavy chain 10;Myosin heavy chain, non-muscle IIb;Non-muscle myosin heavy chain B;Non-muscle myosin heavy chain IIb;, PF00612;PF00063;PF02736;PF01576;, GO:0042641;GO:0005938;GO:0032154;GO:0005737;GO:0005829;GO:0070062;GO:0030027;GO:0030496;GO:0016459;GO:0016460;GO:0097513;GO:0005634;GO:0005844;GO:0001725;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0048027;GO:0035613;GO:0030048;GO:0031032;GO:0007155;GO:0000281;GO:0098885;GO:0050714;GO:0008360;, C:actomyosin; C:cell cortex; C:cleavage furrow; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamellipodium; C:midbody; C:myosin complex; C:myosin II complex; C:myosin II filament; C:nucleus; C:polysome; C:stress fiber;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:mRNA 5'-UTR binding; F:RNA stem-loop binding;, P:actin filament-based movement; P:actomyosin structure organization; P:cell adhesion; P:mitotic cytokinesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of protein secretion; P:regulation of cell shape;|Q6PK16 Q9BWG0,Myosin-10,Cellular myosin heavy chain, type B;Myosin heavy chain 10;Myosin heavy chain, non-muscle IIb;Non-muscle myosin heavy chain B;Non-muscle myosin heavy chain IIb;, PF00612;PF00063;PF02736;PF01576;, GO:0042641;GO:0005938;GO:0032154;GO:0005737;GO:0005829;GO:0070062;GO:0030027;GO:0030496;GO:0016459;GO:0016460;GO:0097513;GO:0005634;GO:0005844;GO:0001725;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0048027;GO:0035613;GO:0030048;GO:0031032;GO:0007155;GO:0000281;GO:0098885;GO:0050714;GO:0008360;, C:actomyosin; C:cell cortex; C:cleavage furrow; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamellipodium; C:midbody; C:myosin complex; C:myosin II complex; C:myosin II filament; C:nucleus; C:polysome; C:stress fiber;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:mRNA 5'-UTR binding; F:RNA stem-loop binding;, P:actin filament-based movement; P:actomyosin structure organization; P:cell adhesion; P:mitotic cytokinesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of protein secretion; P:regulation of cell shape;|Q6PK16 Q9BWG0,Myosin-10,Cellular myosin heavy chain, type B;Myosin heavy chain 10;Myosin heavy chain, non-muscle IIb;Non-muscle myosin heavy chain B;Non-muscle myosin heavy chain IIb;, PF00612;PF00063;PF02736;PF01576;, GO:0042641;GO:0005938;GO:0032154;GO:0005737;GO:0005829;GO:0070062;GO:0030027;GO:0030496;GO:0016459;GO:0016460;GO:0097513;GO:0005634;GO:0005844;GO:0001725;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0048027;GO:0035613;GO:0030048;GO:0031032;GO:0007155;GO:0000281;GO:0098885;GO:0050714;GO:0008360;, C:actomyosin; C:cell cortex; C:cleavage furrow; C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamellipodium; C:midbody; C:myosin complex; C:myosin II complex; C:myosin II filament; C:nucleus; C:polysome; C:stress fiber;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:mRNA 5'-UTR binding; F:RNA stem-loop binding;, P:actin filament-based movement; P:actomyosin structure organization; P:cell adhesion; P:mitotic cytokinesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of protein secretion; P:regulation of cell shape; scaffold54 indexed_genome mRNA 12433548 12499195 . - . ID=transcript_10063;Q9GZM8 B3KP93 D3DTS0 J3QT32 Q86T80 Q8TAR7 Q9UH50,Nuclear distribution protein nudE-like 1,Mitosin-associated protein 1;, PF04880;, GO:1904115;GO:0043203;GO:0031252;GO:0090724;GO:0005813;GO:0000777;GO:0005829;GO:0005871;GO:0000776;GO:0005874;GO:0060053;GO:0005635;GO:0005819;GO:0008021;GO:0043014;GO:0048487;GO:0042802;GO:0008017;GO:0070012;GO:0044877;GO:0090630;GO:0016477;GO:0021955;GO:0051642;GO:0021799;GO:0007059;GO:0051303;GO:0000132;GO:0001833;GO:0008286;GO:0032418;GO:0007020;GO:0007100;GO:0007052;GO:0060052;GO:0001764;GO:1990138;GO:0051081;GO:0045773;GO:0048680;GO:0043547;GO:1900029;GO:0033157;GO:2000574;GO:0010975;GO:0008090;GO:0047496;, C:axon cytoplasm; C:axon hillock; C:cell leading edge; C:central region of growth cone; C:centrosome; C:condensed chromosome kinetochore; C:cytosol; C:kinesin complex; C:kinetochore; C:microtubule; C:neurofilament cytoskeleton; C:nuclear envelope; C:spindle; C:synaptic vesicle;, F:alpha-tubulin binding; F:beta-tubulin binding; F:identical protein binding; F:microtubule binding; F:oligopeptidase activity; F:protein-containing complex binding;, P:activation of GTPase activity; P:cell migration; P:central nervous system neuron axonogenesis; P:centrosome localization; P:cerebral cortex radially oriented cell migration; P:chromosome segregation; P:establishment of chromosome localization; P:establishment of mitotic spindle orientation; P:inner cell mass cell proliferation; P:insulin receptor signaling pathway; P:lysosome localization; P:microtubule nucleation; P:mitotic centrosome separation; P:mitotic spindle organization; P:neurofilament cytoskeleton organization; P:neuron migration; P:neuron projection extension; P:nuclear envelope disassembly; P:positive regulation of axon extension; P:positive regulation of axon regeneration; P:positive regulation of GTPase activity; P:positive regulation of ruffle assembly; P:regulation of intracellular protein transport; P:regulation of microtubule motor activity; P:regulation of neuron projection development; P:retrograde axonal transport; P:vesicle transport along microtubule;|Q9GZM8 B3KP93 D3DTS0 J3QT32 Q86T80 Q8TAR7 Q9UH50,Nuclear distribution protein nudE-like 1,Mitosin-associated protein 1;, PF04880;, GO:1904115;GO:0043203;GO:0031252;GO:0090724;GO:0005813;GO:0000777;GO:0005829;GO:0005871;GO:0000776;GO:0005874;GO:0060053;GO:0005635;GO:0005819;GO:0008021;GO:0043014;GO:0048487;GO:0042802;GO:0008017;GO:0070012;GO:0044877;GO:0090630;GO:0016477;GO:0021955;GO:0051642;GO:0021799;GO:0007059;GO:0051303;GO:0000132;GO:0001833;GO:0008286;GO:0032418;GO:0007020;GO:0007100;GO:0007052;GO:0060052;GO:0001764;GO:1990138;GO:0051081;GO:0045773;GO:0048680;GO:0043547;GO:1900029;GO:0033157;GO:2000574;GO:0010975;GO:0008090;GO:0047496;, C:axon cytoplasm; C:axon hillock; C:cell leading edge; C:central region of growth cone; C:centrosome; C:condensed chromosome kinetochore; C:cytosol; C:kinesin complex; C:kinetochore; C:microtubule; C:neurofilament cytoskeleton; C:nuclear envelope; C:spindle; C:synaptic vesicle;, F:alpha-tubulin binding; F:beta-tubulin binding; F:identical protein binding; F:microtubule binding; F:oligopeptidase activity; F:protein-containing complex binding;, P:activation of GTPase activity; P:cell migration; P:central nervous system neuron axonogenesis; P:centrosome localization; P:cerebral cortex radially oriented cell migration; P:chromosome segregation; P:establishment of chromosome localization; P:establishment of mitotic spindle orientation; P:inner cell mass cell proliferation; P:insulin receptor signaling pathway; P:lysosome localization; P:microtubule nucleation; P:mitotic centrosome separation; P:mitotic spindle organization; P:neurofilament cytoskeleton organization; P:neuron migration; P:neuron projection extension; P:nuclear envelope disassembly; P:positive regulation of axon extension; P:positive regulation of axon regeneration; P:positive regulation of GTPase activity; P:positive regulation of ruffle assembly; P:regulation of intracellular protein transport; P:regulation of microtubule motor activity; P:regulation of neuron projection development; P:retrograde axonal transport; P:vesicle transport along microtubule; scaffold54 indexed_genome mRNA 12503661 12504388 . - . ID=transcript_10064;P61254 B2R4F0 D3DTR8 Q02877 Q6IPY2,60S ribosomal protein L26,Large ribosomal subunit protein uL24 {ECO:0000303|PubMed:24524803};, PF00467;PF16906;, GO:0005737;GO:0005829;GO:0022625;GO:0022626;GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:1990904;GO:0048027;GO:0003723;GO:0003735;GO:0071480;GO:0034644;GO:0002181;GO:0006977;GO:0000184;GO:1902164;GO:1902167;GO:0045727;GO:1904803;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:cytosolic ribosome; C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:ribonucleoprotein complex;, F:mRNA 5'-UTR binding; F:RNA binding; F:structural constituent of ribosome;, P:cellular response to gamma radiation; P:cellular response to UV; P:cytoplasmic translation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:positive regulation of translation; P:regulation of translation involved in cellular response to UV; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold54 indexed_genome mRNA 12505425 12509880 . + . ID=transcript_10065;Q6ZNG9 Q8IYY0,KRAB-A domain-containing protein 2,, PF01352;, GO:0003676;GO:0015074;GO:0006355;, , F:nucleic acid binding;, P:DNA integration; P:regulation of transcription, DNA-templated; scaffold54 indexed_genome mRNA 12540665 12543191 . + . ID=transcript_10066;O94989 A8K6G1 Q8N449 Q9H8B4,Rho guanine nucleotide exchange factor 15,Ephexin-5;Vsm-RhoGEF;, PF00621;, GO:0005737;GO:0030425;GO:0005096;GO:0005085;GO:0090630;GO:2000297;GO:0051496;GO:0050790;GO:0061299;, C:cytoplasm; C:dendrite;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:negative regulation of synapse maturation; P:positive regulation of stress fiber assembly; P:regulation of catalytic activity; P:retina vasculature morphogenesis in camera-type eye; scaffold54 indexed_genome mRNA 12543827 12550673 . - . ID=transcript_10067;O94989 A8K6G1 Q8N449 Q9H8B4,Rho guanine nucleotide exchange factor 15,Ephexin-5;Vsm-RhoGEF;, PF00621;, GO:0005737;GO:0030425;GO:0005096;GO:0005085;GO:0090630;GO:2000297;GO:0051496;GO:0050790;GO:0061299;, C:cytoplasm; C:dendrite;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:negative regulation of synapse maturation; P:positive regulation of stress fiber assembly; P:regulation of catalytic activity; P:retina vasculature morphogenesis in camera-type eye;|O94989 A8K6G1 Q8N449 Q9H8B4,Rho guanine nucleotide exchange factor 15,Ephexin-5;Vsm-RhoGEF;, PF00621;, GO:0005737;GO:0030425;GO:0005096;GO:0005085;GO:0090630;GO:2000297;GO:0051496;GO:0050790;GO:0061299;, C:cytoplasm; C:dendrite;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:negative regulation of synapse maturation; P:positive regulation of stress fiber assembly; P:regulation of catalytic activity; P:retina vasculature morphogenesis in camera-type eye;|O94989 A8K6G1 Q8N449 Q9H8B4,Rho guanine nucleotide exchange factor 15,Ephexin-5;Vsm-RhoGEF;, PF00621;, GO:0005737;GO:0030425;GO:0005096;GO:0005085;GO:0090630;GO:2000297;GO:0051496;GO:0050790;GO:0061299;, C:cytoplasm; C:dendrite;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:negative regulation of synapse maturation; P:positive regulation of stress fiber assembly; P:regulation of catalytic activity; P:retina vasculature morphogenesis in camera-type eye; scaffold54 indexed_genome mRNA 12565812 12571236 . + . ID=transcript_10068;Q3KQZ1 Q494X5 Q6RGS3 Q8N7Y5,Solute carrier family 25 member 35,, PF00153;, GO:0016021;GO:0005743;, C:integral component of membrane; C:mitochondrial inner membrane;|Q9HD47 D3DTR6 Q68DI3 Q9BR68 Q9HD48 Q9NRU9 Q9P001 Q9P0P2,Ran guanine nucleotide release factor,Ran-binding protein MOG1;, PF04603;, GO:0005901;GO:0005737;GO:0005829;GO:0014704;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005791;GO:0005085;GO:0044325;GO:0031267;GO:0017080;GO:0006888;GO:2000010;GO:1903078;GO:0032527;GO:0098905;GO:0098909;GO:0002027;GO:0003254;GO:1900825;GO:0042391;GO:0090226;GO:1902305;GO:2000649;, C:caveola; C:cytoplasm; C:cytosol; C:intercalated disc; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:rough endoplasmic reticulum;, F:guanyl-nucleotide exchange factor activity; F:ion channel binding; F:small GTPase binding; F:sodium channel regulator activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to plasma membrane; P:protein exit from endoplasmic reticulum; P:regulation of bundle of His cell action potential; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of heart rate; P:regulation of membrane depolarization; P:regulation of membrane depolarization during cardiac muscle cell action potential; P:regulation of membrane potential; P:regulation of microtubule nucleation by Ran protein signal transduction; P:regulation of sodium ion transmembrane transport; P:regulation of sodium ion transmembrane transporter activity; scaffold54 indexed_genome mRNA 12578769 12594477 . - . ID=transcript_10069;O15067 A6H8V8,Phosphoribosylformylglycinamidine synthase,Formylglycinamide ribonucleotide amidotransferase;Formylglycinamide ribotide amidotransferase;, PF02769;PF18072;PF18076;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004642;GO:0006189;GO:0097065;GO:0006541;GO:0009168;GO:0042493;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylformylglycinamidine synthase activity;, P:'de novo' IMP biosynthetic process; P:anterior head development; P:glutamine metabolic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to drug;|O15067 A6H8V8,Phosphoribosylformylglycinamidine synthase,Formylglycinamide ribonucleotide amidotransferase;Formylglycinamide ribotide amidotransferase;, PF02769;PF18072;PF18076;, GO:0005829;GO:0070062;GO:0005524;GO:0046872;GO:0004642;GO:0006189;GO:0097065;GO:0006541;GO:0009168;GO:0042493;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:metal ion binding; F:phosphoribosylformylglycinamidine synthase activity;, P:'de novo' IMP biosynthetic process; P:anterior head development; P:glutamine metabolic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to drug; scaffold54 indexed_genome mRNA 12601396 12621971 . + . ID=transcript_10070;Q2NKJ3 B3KR66 C9JEX5 Q1PCD1 Q2TBE3 Q8N3S6 Q9H6L0,CST complex subunit CTC1,Conserved telomere maintenance component 1;HBV DNAPTP1-transactivated protein B;, PF15489;, GO:0000781;GO:1990879;GO:0005829;GO:0005654;GO:0005634;GO:0098505;GO:0003697;GO:0042162;GO:0048539;GO:0006974;GO:0071425;GO:0035264;GO:0032211;GO:0045740;GO:0048146;GO:0010389;GO:0090399;GO:0048536;GO:0016233;GO:0000723;GO:0032201;GO:0010833;GO:0048538;, C:chromosome, telomeric region; C:CST complex; C:cytosol; C:nucleoplasm; C:nucleus;, F:G-rich strand telomeric DNA binding; F:single-stranded DNA binding; F:telomeric DNA binding;, P:bone marrow development; P:cellular response to DNA damage stimulus; P:hematopoietic stem cell proliferation; P:multicellular organism growth; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA replication; P:positive regulation of fibroblast proliferation; P:regulation of G2/M transition of mitotic cell cycle; P:replicative senescence; P:spleen development; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomere lengthening; P:thymus development;|Q2NKJ3 B3KR66 C9JEX5 Q1PCD1 Q2TBE3 Q8N3S6 Q9H6L0,CST complex subunit CTC1,Conserved telomere maintenance component 1;HBV DNAPTP1-transactivated protein B;, PF15489;, GO:0000781;GO:1990879;GO:0005829;GO:0005654;GO:0005634;GO:0098505;GO:0003697;GO:0042162;GO:0048539;GO:0006974;GO:0071425;GO:0035264;GO:0032211;GO:0045740;GO:0048146;GO:0010389;GO:0090399;GO:0048536;GO:0016233;GO:0000723;GO:0032201;GO:0010833;GO:0048538;, C:chromosome, telomeric region; C:CST complex; C:cytosol; C:nucleoplasm; C:nucleus;, F:G-rich strand telomeric DNA binding; F:single-stranded DNA binding; F:telomeric DNA binding;, P:bone marrow development; P:cellular response to DNA damage stimulus; P:hematopoietic stem cell proliferation; P:multicellular organism growth; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA replication; P:positive regulation of fibroblast proliferation; P:regulation of G2/M transition of mitotic cell cycle; P:replicative senescence; P:spleen development; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomere lengthening; P:thymus development;|Q2NKJ3 B3KR66 C9JEX5 Q1PCD1 Q2TBE3 Q8N3S6 Q9H6L0,CST complex subunit CTC1,Conserved telomere maintenance component 1;HBV DNAPTP1-transactivated protein B;, PF15489;, GO:0000781;GO:1990879;GO:0005829;GO:0005654;GO:0005634;GO:0098505;GO:0003697;GO:0042162;GO:0048539;GO:0006974;GO:0071425;GO:0035264;GO:0032211;GO:0045740;GO:0048146;GO:0010389;GO:0090399;GO:0048536;GO:0016233;GO:0000723;GO:0032201;GO:0010833;GO:0048538;, C:chromosome, telomeric region; C:CST complex; C:cytosol; C:nucleoplasm; C:nucleus;, F:G-rich strand telomeric DNA binding; F:single-stranded DNA binding; F:telomeric DNA binding;, P:bone marrow development; P:cellular response to DNA damage stimulus; P:hematopoietic stem cell proliferation; P:multicellular organism growth; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA replication; P:positive regulation of fibroblast proliferation; P:regulation of G2/M transition of mitotic cell cycle; P:replicative senescence; P:spleen development; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomere lengthening; P:thymus development;|Q2NKJ3 B3KR66 C9JEX5 Q1PCD1 Q2TBE3 Q8N3S6 Q9H6L0,CST complex subunit CTC1,Conserved telomere maintenance component 1;HBV DNAPTP1-transactivated protein B;, PF15489;, GO:0000781;GO:1990879;GO:0005829;GO:0005654;GO:0005634;GO:0098505;GO:0003697;GO:0042162;GO:0048539;GO:0006974;GO:0071425;GO:0035264;GO:0032211;GO:0045740;GO:0048146;GO:0010389;GO:0090399;GO:0048536;GO:0016233;GO:0000723;GO:0032201;GO:0010833;GO:0048538;, C:chromosome, telomeric region; C:CST complex; C:cytosol; C:nucleoplasm; C:nucleus;, F:G-rich strand telomeric DNA binding; F:single-stranded DNA binding; F:telomeric DNA binding;, P:bone marrow development; P:cellular response to DNA damage stimulus; P:hematopoietic stem cell proliferation; P:multicellular organism growth; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA replication; P:positive regulation of fibroblast proliferation; P:regulation of G2/M transition of mitotic cell cycle; P:replicative senescence; P:spleen development; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomere lengthening; P:thymus development;|Q2NKJ3 B3KR66 C9JEX5 Q1PCD1 Q2TBE3 Q8N3S6 Q9H6L0,CST complex subunit CTC1,Conserved telomere maintenance component 1;HBV DNAPTP1-transactivated protein B;, PF15489;, GO:0000781;GO:1990879;GO:0005829;GO:0005654;GO:0005634;GO:0098505;GO:0003697;GO:0042162;GO:0048539;GO:0006974;GO:0071425;GO:0035264;GO:0032211;GO:0045740;GO:0048146;GO:0010389;GO:0090399;GO:0048536;GO:0016233;GO:0000723;GO:0032201;GO:0010833;GO:0048538;, C:chromosome, telomeric region; C:CST complex; C:cytosol; C:nucleoplasm; C:nucleus;, F:G-rich strand telomeric DNA binding; F:single-stranded DNA binding; F:telomeric DNA binding;, P:bone marrow development; P:cellular response to DNA damage stimulus; P:hematopoietic stem cell proliferation; P:multicellular organism growth; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA replication; P:positive regulation of fibroblast proliferation; P:regulation of G2/M transition of mitotic cell cycle; P:replicative senescence; P:spleen development; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomere lengthening; P:thymus development;|Q2NKJ3 B3KR66 C9JEX5 Q1PCD1 Q2TBE3 Q8N3S6 Q9H6L0,CST complex subunit CTC1,Conserved telomere maintenance component 1;HBV DNAPTP1-transactivated protein B;, PF15489;, GO:0000781;GO:1990879;GO:0005829;GO:0005654;GO:0005634;GO:0098505;GO:0003697;GO:0042162;GO:0048539;GO:0006974;GO:0071425;GO:0035264;GO:0032211;GO:0045740;GO:0048146;GO:0010389;GO:0090399;GO:0048536;GO:0016233;GO:0000723;GO:0032201;GO:0010833;GO:0048538;, C:chromosome, telomeric region; C:CST complex; C:cytosol; C:nucleoplasm; C:nucleus;, F:G-rich strand telomeric DNA binding; F:single-stranded DNA binding; F:telomeric DNA binding;, P:bone marrow development; P:cellular response to DNA damage stimulus; P:hematopoietic stem cell proliferation; P:multicellular organism growth; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of DNA replication; P:positive regulation of fibroblast proliferation; P:regulation of G2/M transition of mitotic cell cycle; P:replicative senescence; P:spleen development; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomere lengthening; P:thymus development; scaffold54 indexed_genome mRNA 12632356 12634728 . + . ID=transcript_10071;O95083 Q96DV5 Q9UQ46,Aurora kinase B,Aurora 1;Aurora- and IPL1-like midbody-associated protein 1;Aurora/IPL1-related kinase 2;STK-1;Serine/threonine-protein kinase 12;Serine/threonine-protein kinase 5;Serine/threonine-protein kinase aurora-B;, PF00069;, GO:0010369;GO:0032133;GO:0000779;GO:0005829;GO:0000776;GO:0030496;GO:1990023;GO:0097431;GO:0005654;GO:0005634;GO:0005819;GO:0005876;GO:0051233;GO:0031616;GO:0005524;GO:0035174;GO:0019900;GO:0046872;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0009838;GO:0007568;GO:0031145;GO:0008608;GO:0008283;GO:0034644;GO:0036089;GO:0043988;GO:0016570;GO:0044878;GO:0007094;GO:0051256;GO:0007052;GO:0002903;GO:0032466;GO:0032091;GO:0000122;GO:0032467;GO:1905116;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:0034501;GO:0006468;GO:0051983;GO:0032465;GO:1901796;GO:0007051;GO:0006511;, C:chromocenter; C:chromosome passenger complex; C:condensed chromosome, centromeric region; C:cytosol; C:kinetochore; C:midbody; C:mitotic spindle midzone; C:mitotic spindle pole; C:nucleoplasm; C:nucleus; C:spindle; C:spindle microtubule; C:spindle midzone; C:spindle pole centrosome;, F:ATP binding; F:histone serine kinase activity; F:kinase binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:abscission; P:aging; P:anaphase-promoting complex-dependent catabolic process; P:attachment of spindle microtubules to kinetochore; P:cell population proliferation; P:cellular response to UV; P:cleavage furrow formation; P:histone H3-S28 phosphorylation; P:histone modification; P:mitotic cytokinesis checkpoint; P:mitotic spindle assembly checkpoint; P:mitotic spindle midzone assembly; P:mitotic spindle organization; P:negative regulation of B cell apoptotic process; P:negative regulation of cytokinesis; P:negative regulation of protein binding; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cytokinesis; P:positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to kinetochore; P:protein phosphorylation; P:regulation of chromosome segregation; P:regulation of cytokinesis; P:regulation of signal transduction by p53 class mediator; P:spindle organization; P:ubiquitin-dependent protein catabolic process; scaffold54 indexed_genome mRNA 12639635 12641785 . + . ID=transcript_10072;Q96GS4 Q53HS4 Q9NXW8,BLOC-1-related complex subunit 6 {ECO:0000305},Lysosome-dispersing protein {ECO:0000303|PubMed:25898167};, PF10157;, GO:0099078;GO:0005765;GO:0042802;GO:0032418;, C:BORC complex; C:lysosomal membrane;, F:identical protein binding;, P:lysosome localization; scaffold54 indexed_genome mRNA 12649592 12652607 . + . ID=transcript_10073;Q6UX40 A0PJV7 Q6NSE3 Q6ZRX9 Q96T82,Transmembrane protein 107 {ECO:0000312|HGNC:HGNC:28128},, PF14995;, GO:0035869;GO:0016021;GO:0036038;GO:0060271;GO:0097094;GO:0003127;GO:0042733;GO:0021532;GO:1905515;GO:1904491;GO:0010468;GO:0060021;, C:ciliary transition zone; C:integral component of membrane; C:MKS complex;, , P:cilium assembly; P:craniofacial suture morphogenesis; P:detection of nodal flow; P:embryonic digit morphogenesis; P:neural tube patterning; P:non-motile cilium assembly; P:protein localization to ciliary transition zone; P:regulation of gene expression; P:roof of mouth development; scaffold54 indexed_genome mRNA 12673980 12674715 . - . ID=transcript_10074;Q15836 Q9BRV4,Vesicle-associated membrane protein 3,Cellubrevin;Synaptobrevin-3;, PF00957;, GO:0016324;GO:0009986;GO:0030669;GO:0030136;GO:0005829;GO:0005769;GO:0016021;GO:0030285;GO:0043231;GO:0043005;GO:0048471;GO:0030670;GO:0005886;GO:0055037;GO:0055038;GO:0030141;GO:0031201;GO:0032588;GO:0030133;GO:0005484;GO:0019905;GO:0017075;GO:0002479;GO:0017156;GO:0071346;GO:0006887;GO:0043001;GO:0061025;GO:0061024;GO:1903531;GO:0001921;GO:0065003;GO:0042147;GO:0035493;GO:0034446;GO:0006904;GO:0006906;GO:0016192;, C:apical plasma membrane; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:neuron projection; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:secretory granule; C:SNARE complex; C:trans-Golgi network membrane; C:transport vesicle;, F:SNAP receptor activity; F:syntaxin binding; F:syntaxin-1 binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:calcium-ion regulated exocytosis; P:cellular response to interferon-gamma; P:exocytosis; P:Golgi to plasma membrane protein transport; P:membrane fusion; P:membrane organization; P:negative regulation of secretion by cell; P:positive regulation of receptor recycling; P:protein-containing complex assembly; P:retrograde transport, endosome to Golgi; P:SNARE complex assembly; P:substrate adhesion-dependent cell spreading; P:vesicle docking involved in exocytosis; P:vesicle fusion; P:vesicle-mediated transport; scaffold54 indexed_genome mRNA 12680696 12694379 . + . ID=transcript_10075;O15534 B2RPA8 B4DI49 D3DTR3,Period circadian protein homolog 1,Circadian clock protein PERIOD 1;Circadian pacemaker protein Rigui;, PF08447;PF12114;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0070888;GO:0019900;GO:0000978;GO:0001222;GO:0000976;GO:0031625;GO:0032922;GO:0097167;GO:0007623;GO:0009649;GO:0043153;GO:0043966;GO:0070932;GO:0043967;GO:2000323;GO:0043124;GO:0046329;GO:0000122;GO:0045892;GO:0045944;GO:0010608;GO:0042752;GO:1900015;GO:0042634;GO:1900744;GO:0002028;GO:0051591;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:E-box binding; F:kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:circadian regulation of gene expression; P:circadian regulation of translation; P:circadian rhythm; P:entrainment of circadian clock; P:entrainment of circadian clock by photoperiod; P:histone H3 acetylation; P:histone H3 deacetylation; P:histone H4 acetylation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:posttranscriptional regulation of gene expression; P:regulation of circadian rhythm; P:regulation of cytokine production involved in inflammatory response; P:regulation of hair cycle; P:regulation of p38MAPK cascade; P:regulation of sodium ion transport; P:response to cAMP;|O15534 B2RPA8 B4DI49 D3DTR3,Period circadian protein homolog 1,Circadian clock protein PERIOD 1;Circadian pacemaker protein Rigui;, PF08447;PF12114;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0070888;GO:0019900;GO:0000978;GO:0001222;GO:0000976;GO:0031625;GO:0032922;GO:0097167;GO:0007623;GO:0009649;GO:0043153;GO:0043966;GO:0070932;GO:0043967;GO:2000323;GO:0043124;GO:0046329;GO:0000122;GO:0045892;GO:0045944;GO:0010608;GO:0042752;GO:1900015;GO:0042634;GO:1900744;GO:0002028;GO:0051591;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:E-box binding; F:kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:circadian regulation of gene expression; P:circadian regulation of translation; P:circadian rhythm; P:entrainment of circadian clock; P:entrainment of circadian clock by photoperiod; P:histone H3 acetylation; P:histone H3 deacetylation; P:histone H4 acetylation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:posttranscriptional regulation of gene expression; P:regulation of circadian rhythm; P:regulation of cytokine production involved in inflammatory response; P:regulation of hair cycle; P:regulation of p38MAPK cascade; P:regulation of sodium ion transport; P:response to cAMP;|O15534 B2RPA8 B4DI49 D3DTR3,Period circadian protein homolog 1,Circadian clock protein PERIOD 1;Circadian pacemaker protein Rigui;, PF08447;PF12114;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0070888;GO:0019900;GO:0000978;GO:0001222;GO:0000976;GO:0031625;GO:0032922;GO:0097167;GO:0007623;GO:0009649;GO:0043153;GO:0043966;GO:0070932;GO:0043967;GO:2000323;GO:0043124;GO:0046329;GO:0000122;GO:0045892;GO:0045944;GO:0010608;GO:0042752;GO:1900015;GO:0042634;GO:1900744;GO:0002028;GO:0051591;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:E-box binding; F:kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:circadian regulation of gene expression; P:circadian regulation of translation; P:circadian rhythm; P:entrainment of circadian clock; P:entrainment of circadian clock by photoperiod; P:histone H3 acetylation; P:histone H3 deacetylation; P:histone H4 acetylation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:posttranscriptional regulation of gene expression; P:regulation of circadian rhythm; P:regulation of cytokine production involved in inflammatory response; P:regulation of hair cycle; P:regulation of p38MAPK cascade; P:regulation of sodium ion transport; P:response to cAMP;|O15534 B2RPA8 B4DI49 D3DTR3,Period circadian protein homolog 1,Circadian clock protein PERIOD 1;Circadian pacemaker protein Rigui;, PF08447;PF12114;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0070888;GO:0019900;GO:0000978;GO:0001222;GO:0000976;GO:0031625;GO:0032922;GO:0097167;GO:0007623;GO:0009649;GO:0043153;GO:0043966;GO:0070932;GO:0043967;GO:2000323;GO:0043124;GO:0046329;GO:0000122;GO:0045892;GO:0045944;GO:0010608;GO:0042752;GO:1900015;GO:0042634;GO:1900744;GO:0002028;GO:0051591;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:E-box binding; F:kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:circadian regulation of gene expression; P:circadian regulation of translation; P:circadian rhythm; P:entrainment of circadian clock; P:entrainment of circadian clock by photoperiod; P:histone H3 acetylation; P:histone H3 deacetylation; P:histone H4 acetylation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:posttranscriptional regulation of gene expression; P:regulation of circadian rhythm; P:regulation of cytokine production involved in inflammatory response; P:regulation of hair cycle; P:regulation of p38MAPK cascade; P:regulation of sodium ion transport; P:response to cAMP;|O15534 B2RPA8 B4DI49 D3DTR3,Period circadian protein homolog 1,Circadian clock protein PERIOD 1;Circadian pacemaker protein Rigui;, PF08447;PF12114;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0070888;GO:0019900;GO:0000978;GO:0001222;GO:0000976;GO:0031625;GO:0032922;GO:0097167;GO:0007623;GO:0009649;GO:0043153;GO:0043966;GO:0070932;GO:0043967;GO:2000323;GO:0043124;GO:0046329;GO:0000122;GO:0045892;GO:0045944;GO:0010608;GO:0042752;GO:1900015;GO:0042634;GO:1900744;GO:0002028;GO:0051591;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:E-box binding; F:kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:circadian regulation of gene expression; P:circadian regulation of translation; P:circadian rhythm; P:entrainment of circadian clock; P:entrainment of circadian clock by photoperiod; P:histone H3 acetylation; P:histone H3 deacetylation; P:histone H4 acetylation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:posttranscriptional regulation of gene expression; P:regulation of circadian rhythm; P:regulation of cytokine production involved in inflammatory response; P:regulation of hair cycle; P:regulation of p38MAPK cascade; P:regulation of sodium ion transport; P:response to cAMP;|O15534 B2RPA8 B4DI49 D3DTR3,Period circadian protein homolog 1,Circadian clock protein PERIOD 1;Circadian pacemaker protein Rigui;, PF08447;PF12114;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0070888;GO:0019900;GO:0000978;GO:0001222;GO:0000976;GO:0031625;GO:0032922;GO:0097167;GO:0007623;GO:0009649;GO:0043153;GO:0043966;GO:0070932;GO:0043967;GO:2000323;GO:0043124;GO:0046329;GO:0000122;GO:0045892;GO:0045944;GO:0010608;GO:0042752;GO:1900015;GO:0042634;GO:1900744;GO:0002028;GO:0051591;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:E-box binding; F:kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:circadian regulation of gene expression; P:circadian regulation of translation; P:circadian rhythm; P:entrainment of circadian clock; P:entrainment of circadian clock by photoperiod; P:histone H3 acetylation; P:histone H3 deacetylation; P:histone H4 acetylation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:posttranscriptional regulation of gene expression; P:regulation of circadian rhythm; P:regulation of cytokine production involved in inflammatory response; P:regulation of hair cycle; P:regulation of p38MAPK cascade; P:regulation of sodium ion transport; P:response to cAMP;|O15534 B2RPA8 B4DI49 D3DTR3,Period circadian protein homolog 1,Circadian clock protein PERIOD 1;Circadian pacemaker protein Rigui;, PF08447;PF12114;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031490;GO:0070888;GO:0019900;GO:0000978;GO:0001222;GO:0000976;GO:0031625;GO:0032922;GO:0097167;GO:0007623;GO:0009649;GO:0043153;GO:0043966;GO:0070932;GO:0043967;GO:2000323;GO:0043124;GO:0046329;GO:0000122;GO:0045892;GO:0045944;GO:0010608;GO:0042752;GO:1900015;GO:0042634;GO:1900744;GO:0002028;GO:0051591;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:E-box binding; F:kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:circadian regulation of gene expression; P:circadian regulation of translation; P:circadian rhythm; P:entrainment of circadian clock; P:entrainment of circadian clock by photoperiod; P:histone H3 acetylation; P:histone H3 deacetylation; P:histone H4 acetylation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of JNK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:posttranscriptional regulation of gene expression; P:regulation of circadian rhythm; P:regulation of cytokine production involved in inflammatory response; P:regulation of hair cycle; P:regulation of p38MAPK cascade; P:regulation of sodium ion transport; P:response to cAMP; scaffold54 indexed_genome mRNA 12832908 12850007 . - . ID=transcript_10076;Q8N137 A6NHQ1 Q331K3 Q69YV7 Q8NCB8 Q8WXV3 Q96CQ7 Q9C060,Centrobin,Centrosomal BRCA2-interacting protein;LYST-interacting protein 8;, , GO:0005814;GO:0005813;GO:0005829;GO:0019904;GO:0007099;GO:0051299;GO:1902410;GO:1902017;, C:centriole; C:centrosome; C:cytosol;, F:protein domain specific binding;, P:centriole replication; P:centrosome separation; P:mitotic cytokinetic process; P:regulation of cilium assembly;|Q8N137 A6NHQ1 Q331K3 Q69YV7 Q8NCB8 Q8WXV3 Q96CQ7 Q9C060,Centrobin,Centrosomal BRCA2-interacting protein;LYST-interacting protein 8;, , GO:0005814;GO:0005813;GO:0005829;GO:0019904;GO:0007099;GO:0051299;GO:1902410;GO:1902017;, C:centriole; C:centrosome; C:cytosol;, F:protein domain specific binding;, P:centriole replication; P:centrosome separation; P:mitotic cytokinetic process; P:regulation of cilium assembly;|Q8N137 A6NHQ1 Q331K3 Q69YV7 Q8NCB8 Q8WXV3 Q96CQ7 Q9C060,Centrobin,Centrosomal BRCA2-interacting protein;LYST-interacting protein 8;, , GO:0005814;GO:0005813;GO:0005829;GO:0019904;GO:0007099;GO:0051299;GO:1902410;GO:1902017;, C:centriole; C:centrosome; C:cytosol;, F:protein domain specific binding;, P:centriole replication; P:centrosome separation; P:mitotic cytokinetic process; P:regulation of cilium assembly;|Q8N137 A6NHQ1 Q331K3 Q69YV7 Q8NCB8 Q8WXV3 Q96CQ7 Q9C060,Centrobin,Centrosomal BRCA2-interacting protein;LYST-interacting protein 8;, , GO:0005814;GO:0005813;GO:0005829;GO:0019904;GO:0007099;GO:0051299;GO:1902410;GO:1902017;, C:centriole; C:centrosome; C:cytosol;, F:protein domain specific binding;, P:centriole replication; P:centrosome separation; P:mitotic cytokinetic process; P:regulation of cilium assembly;|Q8N137 A6NHQ1 Q331K3 Q69YV7 Q8NCB8 Q8WXV3 Q96CQ7 Q9C060,Centrobin,Centrosomal BRCA2-interacting protein;LYST-interacting protein 8;, , GO:0005814;GO:0005813;GO:0005829;GO:0019904;GO:0007099;GO:0051299;GO:1902410;GO:1902017;, C:centriole; C:centrosome; C:cytosol;, F:protein domain specific binding;, P:centriole replication; P:centrosome separation; P:mitotic cytokinetic process; P:regulation of cilium assembly;|Q8N137 A6NHQ1 Q331K3 Q69YV7 Q8NCB8 Q8WXV3 Q96CQ7 Q9C060,Centrobin,Centrosomal BRCA2-interacting protein;LYST-interacting protein 8;, , GO:0005814;GO:0005813;GO:0005829;GO:0019904;GO:0007099;GO:0051299;GO:1902410;GO:1902017;, C:centriole; C:centrosome; C:cytosol;, F:protein domain specific binding;, P:centriole replication; P:centrosome separation; P:mitotic cytokinetic process; P:regulation of cilium assembly; scaffold54 indexed_genome mRNA 12850166 12851756 . + . ID=transcript_10077;Q9Y5R8 D3DTR0,Trafficking protein particle complex subunit 1,BET5 homolog;Multiple myeloma protein 2;, PF04099;, GO:0035578;GO:0005829;GO:0005783;GO:0005576;GO:0005794;GO:0030008;GO:0048208;GO:0006888;GO:0043312;, C:azurophil granule lumen; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:neutrophil degranulation;|Q9Y5R8 D3DTR0,Trafficking protein particle complex subunit 1,BET5 homolog;Multiple myeloma protein 2;, PF04099;, GO:0035578;GO:0005829;GO:0005783;GO:0005576;GO:0005794;GO:0030008;GO:0048208;GO:0006888;GO:0043312;, C:azurophil granule lumen; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:neutrophil degranulation; scaffold54 indexed_genome mRNA 12852724 12859617 . + . ID=transcript_10078;O43448 Q4VAW0,Voltage-gated potassium channel subunit beta-3,K(+) channel subunit beta-3;Kv-beta-3;, PF00248;, GO:0005737;GO:0005886;GO:0008076;GO:0004033;GO:0047834;GO:0044325;GO:0015459;GO:0005249;GO:0071805;GO:0006813;GO:1901379;, C:cytoplasm; C:plasma membrane; C:voltage-gated potassium channel complex;, F:aldo-keto reductase (NADP) activity; F:D-threo-aldose 1-dehydrogenase activity; F:ion channel binding; F:potassium channel regulator activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport;|O43448 Q4VAW0,Voltage-gated potassium channel subunit beta-3,K(+) channel subunit beta-3;Kv-beta-3;, PF00248;, GO:0005737;GO:0005886;GO:0008076;GO:0004033;GO:0047834;GO:0044325;GO:0015459;GO:0005249;GO:0071805;GO:0006813;GO:1901379;, C:cytoplasm; C:plasma membrane; C:voltage-gated potassium channel complex;, F:aldo-keto reductase (NADP) activity; F:D-threo-aldose 1-dehydrogenase activity; F:ion channel binding; F:potassium channel regulator activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport;|O43448 Q4VAW0,Voltage-gated potassium channel subunit beta-3,K(+) channel subunit beta-3;Kv-beta-3;, PF00248;, GO:0005737;GO:0005886;GO:0008076;GO:0004033;GO:0047834;GO:0044325;GO:0015459;GO:0005249;GO:0071805;GO:0006813;GO:1901379;, C:cytoplasm; C:plasma membrane; C:voltage-gated potassium channel complex;, F:aldo-keto reductase (NADP) activity; F:D-threo-aldose 1-dehydrogenase activity; F:ion channel binding; F:potassium channel regulator activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport;|O43448 Q4VAW0,Voltage-gated potassium channel subunit beta-3,K(+) channel subunit beta-3;Kv-beta-3;, PF00248;, GO:0005737;GO:0005886;GO:0008076;GO:0004033;GO:0047834;GO:0044325;GO:0015459;GO:0005249;GO:0071805;GO:0006813;GO:1901379;, C:cytoplasm; C:plasma membrane; C:voltage-gated potassium channel complex;, F:aldo-keto reductase (NADP) activity; F:D-threo-aldose 1-dehydrogenase activity; F:ion channel binding; F:potassium channel regulator activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport;|O43448 Q4VAW0,Voltage-gated potassium channel subunit beta-3,K(+) channel subunit beta-3;Kv-beta-3;, PF00248;, GO:0005737;GO:0005886;GO:0008076;GO:0004033;GO:0047834;GO:0044325;GO:0015459;GO:0005249;GO:0071805;GO:0006813;GO:1901379;, C:cytoplasm; C:plasma membrane; C:voltage-gated potassium channel complex;, F:aldo-keto reductase (NADP) activity; F:D-threo-aldose 1-dehydrogenase activity; F:ion channel binding; F:potassium channel regulator activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport;|O43448 Q4VAW0,Voltage-gated potassium channel subunit beta-3,K(+) channel subunit beta-3;Kv-beta-3;, PF00248;, GO:0005737;GO:0005886;GO:0008076;GO:0004033;GO:0047834;GO:0044325;GO:0015459;GO:0005249;GO:0071805;GO:0006813;GO:1901379;, C:cytoplasm; C:plasma membrane; C:voltage-gated potassium channel complex;, F:aldo-keto reductase (NADP) activity; F:D-threo-aldose 1-dehydrogenase activity; F:ion channel binding; F:potassium channel regulator activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of potassium ion transmembrane transport; scaffold54 indexed_genome mRNA 12864867 12866387 . + . ID=transcript_10079;A6NIN4 A0A1B0GVC2,RING finger protein 227 {ECO:0000305},Long intergenic non-protein coding RNA 2581 {ECO:0000312|HGNC:HGNC:27571};, PF15451;PF13445;, GO:0046872;, , F:metal ion binding; scaffold54 indexed_genome mRNA 12867040 12886585 . - . ID=transcript_10080;Q12873 D3DTQ9 E9PG89 Q9Y4I0,Chromodomain-helicase-DNA-binding protein 3,ATP-dependent helicase CHD3;Mi-2 autoantigen 240 kDa protein;Mi2-alpha;Zinc finger helicase;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0034451;GO:0005813;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0016581;GO:0016605;GO:0005524;GO:0016887;GO:0003677;GO:0003678;GO:0036121;GO:0004386;GO:0070615;GO:0003723;GO:0000976;GO:0008270;GO:0043044;GO:0007098;GO:0006333;GO:0000122;GO:1901796;GO:0006357;GO:0006355;GO:0007051;, C:centriolar satellite; C:centrosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:NuRD complex; C:PML body;, F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA helicase activity; F:double-stranded DNA helicase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:centrosome cycle; P:chromatin assembly or disassembly; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spindle organization;|Q12873 D3DTQ9 E9PG89 Q9Y4I0,Chromodomain-helicase-DNA-binding protein 3,ATP-dependent helicase CHD3;Mi-2 autoantigen 240 kDa protein;Mi2-alpha;Zinc finger helicase;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0034451;GO:0005813;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0016581;GO:0016605;GO:0005524;GO:0016887;GO:0003677;GO:0003678;GO:0036121;GO:0004386;GO:0070615;GO:0003723;GO:0000976;GO:0008270;GO:0043044;GO:0007098;GO:0006333;GO:0000122;GO:1901796;GO:0006357;GO:0006355;GO:0007051;, C:centriolar satellite; C:centrosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:NuRD complex; C:PML body;, F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA helicase activity; F:double-stranded DNA helicase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:centrosome cycle; P:chromatin assembly or disassembly; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spindle organization;|Q12873 D3DTQ9 E9PG89 Q9Y4I0,Chromodomain-helicase-DNA-binding protein 3,ATP-dependent helicase CHD3;Mi-2 autoantigen 240 kDa protein;Mi2-alpha;Zinc finger helicase;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0034451;GO:0005813;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0016581;GO:0016605;GO:0005524;GO:0016887;GO:0003677;GO:0003678;GO:0036121;GO:0004386;GO:0070615;GO:0003723;GO:0000976;GO:0008270;GO:0043044;GO:0007098;GO:0006333;GO:0000122;GO:1901796;GO:0006357;GO:0006355;GO:0007051;, C:centriolar satellite; C:centrosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:NuRD complex; C:PML body;, F:ATP binding; F:ATPase activity; F:DNA binding; F:DNA helicase activity; F:double-stranded DNA helicase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:centrosome cycle; P:chromatin assembly or disassembly; P:negative regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spindle organization; scaffold54 indexed_genome mRNA 12902793 12924146 . - . ID=transcript_10081;Q6P9G0 D3DTQ8 Q96DM7,Cytochrome b5 domain-containing protein 1,, PF00173;, GO:0046872;, , F:metal ion binding;|Q6P9G0 D3DTQ8 Q96DM7,Cytochrome b5 domain-containing protein 1,, PF00173;, GO:0046872;, , F:metal ion binding; scaffold54 indexed_genome mRNA 12924772 12925655 . - . ID=transcript_10082;Q6PEY1,Transmembrane protein 88,, , GO:0005829;GO:0016021;GO:0005886;GO:0030165;GO:0007275;GO:0090090;GO:0072659;GO:0050821;GO:0016055;, C:cytosol; C:integral component of membrane; C:plasma membrane;, F:PDZ domain binding;, P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:protein localization to plasma membrane; P:protein stabilization; P:Wnt signaling pathway; scaffold54 indexed_genome mRNA 12946638 12954007 . - . ID=transcript_10083;Q9P225 A8K992 B5MDX5 O15434 Q6PIH3 Q6ZR42,Dynein heavy chain 2, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 2;Ciliary dynein heavy chain 2;Dynein heavy chain domain-containing protein 3;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement; scaffold54 indexed_genome mRNA 12954943 12968871 . - . ID=transcript_10084;Q9P225 A8K992 B5MDX5 O15434 Q6PIH3 Q6ZR42,Dynein heavy chain 2, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 2;Ciliary dynein heavy chain 2;Dynein heavy chain domain-containing protein 3;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement;|Q9P225 A8K992 B5MDX5 O15434 Q6PIH3 Q6ZR42,Dynein heavy chain 2, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 2;Ciliary dynein heavy chain 2;Dynein heavy chain domain-containing protein 3;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0060285;GO:0007018;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium-dependent cell motility; P:microtubule-based movement; scaffold54 indexed_genome mRNA 13060325 13061529 . + . ID=transcript_10085;Q15768 B2RBW2 D3DTQ6 O00680 Q8TBH7 Q92875,Ephrin-B3,EPH-related receptor transmembrane ligand ELK-L3;EPH-related receptor tyrosine kinase ligand 8;, PF00812;, GO:0098978;GO:0098686;GO:0005887;GO:0099061;GO:0099056;GO:0005886;GO:0046875;GO:0005005;GO:0001618;GO:0007628;GO:0016198;GO:0007411;GO:0007267;GO:0048013;GO:0050771;GO:0007399;GO:0031295;GO:0099557;, C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:plasma membrane;, F:ephrin receptor binding; F:transmembrane-ephrin receptor activity; F:virus receptor activity;, P:adult walking behavior; P:axon choice point recognition; P:axon guidance; P:cell-cell signaling; P:ephrin receptor signaling pathway; P:negative regulation of axonogenesis; P:nervous system development; P:T cell costimulation; P:trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission; scaffold54 indexed_genome mRNA 13061593 13065581 . - . ID=transcript_10086;Q15768 B2RBW2 D3DTQ6 O00680 Q8TBH7 Q92875,Ephrin-B3,EPH-related receptor transmembrane ligand ELK-L3;EPH-related receptor tyrosine kinase ligand 8;, PF00812;, GO:0098978;GO:0098686;GO:0005887;GO:0099061;GO:0099056;GO:0005886;GO:0046875;GO:0005005;GO:0001618;GO:0007628;GO:0016198;GO:0007411;GO:0007267;GO:0048013;GO:0050771;GO:0007399;GO:0031295;GO:0099557;, C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:plasma membrane;, F:ephrin receptor binding; F:transmembrane-ephrin receptor activity; F:virus receptor activity;, P:adult walking behavior; P:axon choice point recognition; P:axon guidance; P:cell-cell signaling; P:ephrin receptor signaling pathway; P:negative regulation of axonogenesis; P:nervous system development; P:T cell costimulation; P:trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission; scaffold54 indexed_genome mRNA 13067699 13069597 . - . ID=transcript_10087;Q9BUR4 B3KPR9 D3DTQ4 Q08ET9 Q9NW09,Telomerase Cajal body protein 1 {ECO:0000303|PubMed:19179534},WD repeat-containing protein 79 {ECO:0000303|PubMed:19285445};WD40 repeat-containing protein antisense to TP53 gene {ECO:0000303|PubMed:19250907};, PF00400;, GO:0015030;GO:0000781;GO:0005829;GO:0016604;GO:0005654;GO:0035861;GO:0005697;GO:0051087;GO:0042393;GO:0042802;GO:0044877;GO:0003723;GO:0070034;GO:0031625;GO:0030576;GO:0006281;GO:0045739;GO:2000781;GO:1905168;GO:2001034;GO:1904851;GO:0051973;GO:1904867;GO:0034337;GO:0090666;GO:0090671;GO:0032203;GO:0007004;GO:0016032;, C:Cajal body; C:chromosome, telomeric region; C:cytosol; C:nuclear body; C:nucleoplasm; C:site of double-strand break; C:telomerase holoenzyme complex;, F:chaperone binding; F:histone binding; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:telomerase RNA binding; F:ubiquitin protein ligase binding;, P:Cajal body organization; P:DNA repair; P:positive regulation of DNA repair; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of telomerase activity; P:protein localization to Cajal body; P:RNA folding; P:scaRNA localization to Cajal body; P:telomerase RNA localization to Cajal body; P:telomere formation via telomerase; P:telomere maintenance via telomerase; P:viral process;|Q9BUR4 B3KPR9 D3DTQ4 Q08ET9 Q9NW09,Telomerase Cajal body protein 1 {ECO:0000303|PubMed:19179534},WD repeat-containing protein 79 {ECO:0000303|PubMed:19285445};WD40 repeat-containing protein antisense to TP53 gene {ECO:0000303|PubMed:19250907};, PF00400;, GO:0015030;GO:0000781;GO:0005829;GO:0016604;GO:0005654;GO:0035861;GO:0005697;GO:0051087;GO:0042393;GO:0042802;GO:0044877;GO:0003723;GO:0070034;GO:0031625;GO:0030576;GO:0006281;GO:0045739;GO:2000781;GO:1905168;GO:2001034;GO:1904851;GO:0051973;GO:1904867;GO:0034337;GO:0090666;GO:0090671;GO:0032203;GO:0007004;GO:0016032;, C:Cajal body; C:chromosome, telomeric region; C:cytosol; C:nuclear body; C:nucleoplasm; C:site of double-strand break; C:telomerase holoenzyme complex;, F:chaperone binding; F:histone binding; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:telomerase RNA binding; F:ubiquitin protein ligase binding;, P:Cajal body organization; P:DNA repair; P:positive regulation of DNA repair; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of telomerase activity; P:protein localization to Cajal body; P:RNA folding; P:scaRNA localization to Cajal body; P:telomerase RNA localization to Cajal body; P:telomere formation via telomerase; P:telomere maintenance via telomerase; P:viral process; scaffold54 indexed_genome mRNA 13069800 13078420 . - . ID=transcript_10088;Q9BUR4 B3KPR9 D3DTQ4 Q08ET9 Q9NW09,Telomerase Cajal body protein 1 {ECO:0000303|PubMed:19179534},WD repeat-containing protein 79 {ECO:0000303|PubMed:19285445};WD40 repeat-containing protein antisense to TP53 gene {ECO:0000303|PubMed:19250907};, PF00400;, GO:0015030;GO:0000781;GO:0005829;GO:0016604;GO:0005654;GO:0035861;GO:0005697;GO:0051087;GO:0042393;GO:0042802;GO:0044877;GO:0003723;GO:0070034;GO:0031625;GO:0030576;GO:0006281;GO:0045739;GO:2000781;GO:1905168;GO:2001034;GO:1904851;GO:0051973;GO:1904867;GO:0034337;GO:0090666;GO:0090671;GO:0032203;GO:0007004;GO:0016032;, C:Cajal body; C:chromosome, telomeric region; C:cytosol; C:nuclear body; C:nucleoplasm; C:site of double-strand break; C:telomerase holoenzyme complex;, F:chaperone binding; F:histone binding; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:telomerase RNA binding; F:ubiquitin protein ligase binding;, P:Cajal body organization; P:DNA repair; P:positive regulation of DNA repair; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of telomerase activity; P:protein localization to Cajal body; P:RNA folding; P:scaRNA localization to Cajal body; P:telomerase RNA localization to Cajal body; P:telomere formation via telomerase; P:telomere maintenance via telomerase; P:viral process;|Q9BUR4 B3KPR9 D3DTQ4 Q08ET9 Q9NW09,Telomerase Cajal body protein 1 {ECO:0000303|PubMed:19179534},WD repeat-containing protein 79 {ECO:0000303|PubMed:19285445};WD40 repeat-containing protein antisense to TP53 gene {ECO:0000303|PubMed:19250907};, PF00400;, GO:0015030;GO:0000781;GO:0005829;GO:0016604;GO:0005654;GO:0035861;GO:0005697;GO:0051087;GO:0042393;GO:0042802;GO:0044877;GO:0003723;GO:0070034;GO:0031625;GO:0030576;GO:0006281;GO:0045739;GO:2000781;GO:1905168;GO:2001034;GO:1904851;GO:0051973;GO:1904867;GO:0034337;GO:0090666;GO:0090671;GO:0032203;GO:0007004;GO:0016032;, C:Cajal body; C:chromosome, telomeric region; C:cytosol; C:nuclear body; C:nucleoplasm; C:site of double-strand break; C:telomerase holoenzyme complex;, F:chaperone binding; F:histone binding; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:telomerase RNA binding; F:ubiquitin protein ligase binding;, P:Cajal body organization; P:DNA repair; P:positive regulation of DNA repair; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of telomerase activity; P:protein localization to Cajal body; P:RNA folding; P:scaRNA localization to Cajal body; P:telomerase RNA localization to Cajal body; P:telomere formation via telomerase; P:telomere maintenance via telomerase; P:viral process;|Q9BUR4 B3KPR9 D3DTQ4 Q08ET9 Q9NW09,Telomerase Cajal body protein 1 {ECO:0000303|PubMed:19179534},WD repeat-containing protein 79 {ECO:0000303|PubMed:19285445};WD40 repeat-containing protein antisense to TP53 gene {ECO:0000303|PubMed:19250907};, PF00400;, GO:0015030;GO:0000781;GO:0005829;GO:0016604;GO:0005654;GO:0035861;GO:0005697;GO:0051087;GO:0042393;GO:0042802;GO:0044877;GO:0003723;GO:0070034;GO:0031625;GO:0030576;GO:0006281;GO:0045739;GO:2000781;GO:1905168;GO:2001034;GO:1904851;GO:0051973;GO:1904867;GO:0034337;GO:0090666;GO:0090671;GO:0032203;GO:0007004;GO:0016032;, C:Cajal body; C:chromosome, telomeric region; C:cytosol; C:nuclear body; C:nucleoplasm; C:site of double-strand break; C:telomerase holoenzyme complex;, F:chaperone binding; F:histone binding; F:identical protein binding; F:protein-containing complex binding; F:RNA binding; F:telomerase RNA binding; F:ubiquitin protein ligase binding;, P:Cajal body organization; P:DNA repair; P:positive regulation of DNA repair; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of telomerase activity; P:protein localization to Cajal body; P:RNA folding; P:scaRNA localization to Cajal body; P:telomerase RNA localization to Cajal body; P:telomere formation via telomerase; P:telomere maintenance via telomerase; P:viral process; scaffold54 indexed_genome mRNA 13079359 13092175 . + . ID=transcript_10089;Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61,Cellular tumor antigen p53,Antigen NY-CO-13;Phosphoprotein p53;Tumor suppressor p53;, PF00870;PF08563;PF07710;PF18521;, GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005759;GO:0005739;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0005657;GO:0035861;GO:0005667;GO:0005524;GO:0051087;GO:0003682;GO:0000987;GO:0005507;GO:0001046;GO:0097718;GO:0003677;GO:0001216;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0035035;GO:0042826;GO:0035033;GO:0042802;GO:0097371;GO:0003730;GO:0002039;GO:1990841;GO:0002020;GO:0046982;GO:0019901;GO:0047485;GO:0051721;GO:0019903;GO:0043621;GO:0030971;GO:0000978;GO:0001085;GO:0001094;GO:0008134;GO:0000976;GO:0031625;GO:0008270;GO:0006914;GO:0002326;GO:0048539;GO:0060411;GO:0007569;GO:0007050;GO:0034613;GO:0072717;GO:0006974;GO:0035690;GO:0071480;GO:0042149;GO:0071456;GO:0071479;GO:0034644;GO:0071494;GO:0021549;GO:0031497;GO:0048512;GO:0019221;GO:0008340;GO:0030330;GO:0006977;GO:0006978;GO:0000733;GO:0006302;GO:0048568;GO:0043153;GO:0006983;GO:0007369;GO:0002244;GO:0060218;GO:0001701;GO:0060333;GO:0097193;GO:0072332;GO:0042771;GO:0070059;GO:1990144;GO:0043504;GO:0071850;GO:0031571;GO:0009299;GO:0035264;GO:0070266;GO:0043066;GO:0030308;GO:0008285;GO:0008156;GO:0048147;GO:1904024;GO:0051097;GO:1901525;GO:0007406;GO:1905856;GO:1903799;GO:0045861;GO:2000378;GO:0051974;GO:0000122;GO:0045892;GO:0030512;GO:0051402;GO:0006289;GO:0097252;GO:0090403;GO:0043065;GO:0010666;GO:0090343;GO:0071158;GO:1900119;GO:0010628;GO:0031065;GO:2001244;GO:0035794;GO:0043525;GO:0050731;GO:1902895;GO:1903800;GO:0062100;GO:0046827;GO:1900740;GO:2000379;GO:0090200;GO:0045899;GO:0070245;GO:0045944;GO:1990440;GO:0061419;GO:0036003;GO:0045893;GO:0016579;GO:0006606;GO:0008104;GO:0050821;GO:0051262;GO:0065003;GO:0007265;GO:0042981;GO:1902749;GO:2000772;GO:0043516;GO:2000269;GO:1902253;GO:1902108;GO:1901796;GO:0034103;GO:0006357;GO:1990248;GO:0060260;GO:0006355;GO:0001836;GO:0090399;GO:0046677;GO:0010332;GO:0002931;GO:0009651;GO:0010165;GO:0009303;GO:0072331;GO:0001756;GO:0033077;GO:0002360;GO:0002309;GO:0007179;GO:0033209;GO:0016032;, C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:mitochondrial matrix; C:mitochondrion; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex; C:replication fork; C:site of double-strand break; C:transcription regulator complex;, F:ATP binding; F:chaperone binding; F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:copper ion binding; F:core promoter sequence-specific DNA binding; F:disordered domain specific binding; F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:identical protein binding; F:MDM2/MDM4 family protein binding; F:mRNA 3'-UTR binding; F:p53 binding; F:promoter-specific chromatin binding; F:protease binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein N-terminus binding; F:protein phosphatase 2A binding; F:protein phosphatase binding; F:protein self-association; F:receptor tyrosine kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:TFIID-class transcription factor complex binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:autophagy; P:B cell lineage commitment; P:bone marrow development; P:cardiac septum morphogenesis; P:cell aging; P:cell cycle arrest; P:cellular protein localization; P:cellular response to actinomycin D; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:cellular response to gamma radiation; P:cellular response to glucose starvation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:cellular response to UV; P:cellular response to UV-C; P:cerebellum development; P:chromatin assembly; P:circadian behavior; P:cytokine-mediated signaling pathway; P:determination of adult lifespan; P:DNA damage response, signal transduction by p53 class mediator; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA strand renaturation; P:double-strand break repair; P:embryonic organ development; P:entrainment of circadian clock by photoperiod; P:ER overload response; P:gastrulation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell differentiation; P:in utero embryonic development; P:interferon-gamma-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:intrinsic apoptotic signaling pathway in response to hypoxia; P:mitochondrial DNA repair; P:mitotic cell cycle arrest; P:mitotic G1 DNA damage checkpoint; P:mRNA transcription; P:multicellular organism growth; P:necroptotic process; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of DNA replication; P:negative regulation of fibroblast proliferation; P:negative regulation of glucose catabolic process to lactate via pyruvate; P:negative regulation of helicase activity; P:negative regulation of mitophagy; P:negative regulation of neuroblast proliferation; P:negative regulation of pentose-phosphate shunt; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of proteolysis; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron apoptotic process; P:nucleotide-excision repair; P:oligodendrocyte apoptotic process; P:oxidative stress-induced premature senescence; P:positive regulation of apoptotic process; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cell aging; P:positive regulation of cell cycle arrest; P:positive regulation of execution phase of apoptosis; P:positive regulation of gene expression; P:positive regulation of histone deacetylation; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of neuron apoptotic process; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed necrotic cell death; P:positive regulation of protein export from nucleus; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of thymocyte apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:protein import into nucleus; P:protein localization; P:protein stabilization; P:protein tetramerization; P:protein-containing complex assembly; P:Ras protein signal transduction; P:regulation of apoptotic process; P:regulation of cell cycle G2/M phase transition; P:regulation of cellular senescence; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of fibroblast apoptotic process; P:regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:regulation of mitochondrial membrane permeability involved in apoptotic process; P:regulation of signal transduction by p53 class mediator; P:regulation of tissue remodeling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to DNA damage; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:release of cytochrome c from mitochondria; P:replicative senescence; P:response to antibiotic; P:response to gamma radiation; P:response to ischemia; P:response to salt stress; P:response to X-ray; P:rRNA transcription; P:signal transduction by p53 class mediator; P:somitogenesis; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell proliferation involved in immune response; P:transforming growth factor beta receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61,Cellular tumor antigen p53,Antigen NY-CO-13;Phosphoprotein p53;Tumor suppressor p53;, PF00870;PF08563;PF07710;PF18521;, GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005759;GO:0005739;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0005657;GO:0035861;GO:0005667;GO:0005524;GO:0051087;GO:0003682;GO:0000987;GO:0005507;GO:0001046;GO:0097718;GO:0003677;GO:0001216;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0035035;GO:0042826;GO:0035033;GO:0042802;GO:0097371;GO:0003730;GO:0002039;GO:1990841;GO:0002020;GO:0046982;GO:0019901;GO:0047485;GO:0051721;GO:0019903;GO:0043621;GO:0030971;GO:0000978;GO:0001085;GO:0001094;GO:0008134;GO:0000976;GO:0031625;GO:0008270;GO:0006914;GO:0002326;GO:0048539;GO:0060411;GO:0007569;GO:0007050;GO:0034613;GO:0072717;GO:0006974;GO:0035690;GO:0071480;GO:0042149;GO:0071456;GO:0071479;GO:0034644;GO:0071494;GO:0021549;GO:0031497;GO:0048512;GO:0019221;GO:0008340;GO:0030330;GO:0006977;GO:0006978;GO:0000733;GO:0006302;GO:0048568;GO:0043153;GO:0006983;GO:0007369;GO:0002244;GO:0060218;GO:0001701;GO:0060333;GO:0097193;GO:0072332;GO:0042771;GO:0070059;GO:1990144;GO:0043504;GO:0071850;GO:0031571;GO:0009299;GO:0035264;GO:0070266;GO:0043066;GO:0030308;GO:0008285;GO:0008156;GO:0048147;GO:1904024;GO:0051097;GO:1901525;GO:0007406;GO:1905856;GO:1903799;GO:0045861;GO:2000378;GO:0051974;GO:0000122;GO:0045892;GO:0030512;GO:0051402;GO:0006289;GO:0097252;GO:0090403;GO:0043065;GO:0010666;GO:0090343;GO:0071158;GO:1900119;GO:0010628;GO:0031065;GO:2001244;GO:0035794;GO:0043525;GO:0050731;GO:1902895;GO:1903800;GO:0062100;GO:0046827;GO:1900740;GO:2000379;GO:0090200;GO:0045899;GO:0070245;GO:0045944;GO:1990440;GO:0061419;GO:0036003;GO:0045893;GO:0016579;GO:0006606;GO:0008104;GO:0050821;GO:0051262;GO:0065003;GO:0007265;GO:0042981;GO:1902749;GO:2000772;GO:0043516;GO:2000269;GO:1902253;GO:1902108;GO:1901796;GO:0034103;GO:0006357;GO:1990248;GO:0060260;GO:0006355;GO:0001836;GO:0090399;GO:0046677;GO:0010332;GO:0002931;GO:0009651;GO:0010165;GO:0009303;GO:0072331;GO:0001756;GO:0033077;GO:0002360;GO:0002309;GO:0007179;GO:0033209;GO:0016032;, C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:mitochondrial matrix; C:mitochondrion; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex; C:replication fork; C:site of double-strand break; C:transcription regulator complex;, F:ATP binding; F:chaperone binding; F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:copper ion binding; F:core promoter sequence-specific DNA binding; F:disordered domain specific binding; F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:identical protein binding; F:MDM2/MDM4 family protein binding; F:mRNA 3'-UTR binding; F:p53 binding; F:promoter-specific chromatin binding; F:protease binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein N-terminus binding; F:protein phosphatase 2A binding; F:protein phosphatase binding; F:protein self-association; F:receptor tyrosine kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:TFIID-class transcription factor complex binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:autophagy; P:B cell lineage commitment; P:bone marrow development; P:cardiac septum morphogenesis; P:cell aging; P:cell cycle arrest; P:cellular protein localization; P:cellular response to actinomycin D; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:cellular response to gamma radiation; P:cellular response to glucose starvation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:cellular response to UV; P:cellular response to UV-C; P:cerebellum development; P:chromatin assembly; P:circadian behavior; P:cytokine-mediated signaling pathway; P:determination of adult lifespan; P:DNA damage response, signal transduction by p53 class mediator; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA strand renaturation; P:double-strand break repair; P:embryonic organ development; P:entrainment of circadian clock by photoperiod; P:ER overload response; P:gastrulation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell differentiation; P:in utero embryonic development; P:interferon-gamma-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:intrinsic apoptotic signaling pathway in response to hypoxia; P:mitochondrial DNA repair; P:mitotic cell cycle arrest; P:mitotic G1 DNA damage checkpoint; P:mRNA transcription; P:multicellular organism growth; P:necroptotic process; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of DNA replication; P:negative regulation of fibroblast proliferation; P:negative regulation of glucose catabolic process to lactate via pyruvate; P:negative regulation of helicase activity; P:negative regulation of mitophagy; P:negative regulation of neuroblast proliferation; P:negative regulation of pentose-phosphate shunt; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of proteolysis; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron apoptotic process; P:nucleotide-excision repair; P:oligodendrocyte apoptotic process; P:oxidative stress-induced premature senescence; P:positive regulation of apoptotic process; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cell aging; P:positive regulation of cell cycle arrest; P:positive regulation of execution phase of apoptosis; P:positive regulation of gene expression; P:positive regulation of histone deacetylation; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of neuron apoptotic process; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed necrotic cell death; P:positive regulation of protein export from nucleus; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of thymocyte apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:protein import into nucleus; P:protein localization; P:protein stabilization; P:protein tetramerization; P:protein-containing complex assembly; P:Ras protein signal transduction; P:regulation of apoptotic process; P:regulation of cell cycle G2/M phase transition; P:regulation of cellular senescence; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of fibroblast apoptotic process; P:regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:regulation of mitochondrial membrane permeability involved in apoptotic process; P:regulation of signal transduction by p53 class mediator; P:regulation of tissue remodeling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to DNA damage; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:release of cytochrome c from mitochondria; P:replicative senescence; P:response to antibiotic; P:response to gamma radiation; P:response to ischemia; P:response to salt stress; P:response to X-ray; P:rRNA transcription; P:signal transduction by p53 class mediator; P:somitogenesis; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell proliferation involved in immune response; P:transforming growth factor beta receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61,Cellular tumor antigen p53,Antigen NY-CO-13;Phosphoprotein p53;Tumor suppressor p53;, PF00870;PF08563;PF07710;PF18521;, GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005759;GO:0005739;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0005657;GO:0035861;GO:0005667;GO:0005524;GO:0051087;GO:0003682;GO:0000987;GO:0005507;GO:0001046;GO:0097718;GO:0003677;GO:0001216;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0035035;GO:0042826;GO:0035033;GO:0042802;GO:0097371;GO:0003730;GO:0002039;GO:1990841;GO:0002020;GO:0046982;GO:0019901;GO:0047485;GO:0051721;GO:0019903;GO:0043621;GO:0030971;GO:0000978;GO:0001085;GO:0001094;GO:0008134;GO:0000976;GO:0031625;GO:0008270;GO:0006914;GO:0002326;GO:0048539;GO:0060411;GO:0007569;GO:0007050;GO:0034613;GO:0072717;GO:0006974;GO:0035690;GO:0071480;GO:0042149;GO:0071456;GO:0071479;GO:0034644;GO:0071494;GO:0021549;GO:0031497;GO:0048512;GO:0019221;GO:0008340;GO:0030330;GO:0006977;GO:0006978;GO:0000733;GO:0006302;GO:0048568;GO:0043153;GO:0006983;GO:0007369;GO:0002244;GO:0060218;GO:0001701;GO:0060333;GO:0097193;GO:0072332;GO:0042771;GO:0070059;GO:1990144;GO:0043504;GO:0071850;GO:0031571;GO:0009299;GO:0035264;GO:0070266;GO:0043066;GO:0030308;GO:0008285;GO:0008156;GO:0048147;GO:1904024;GO:0051097;GO:1901525;GO:0007406;GO:1905856;GO:1903799;GO:0045861;GO:2000378;GO:0051974;GO:0000122;GO:0045892;GO:0030512;GO:0051402;GO:0006289;GO:0097252;GO:0090403;GO:0043065;GO:0010666;GO:0090343;GO:0071158;GO:1900119;GO:0010628;GO:0031065;GO:2001244;GO:0035794;GO:0043525;GO:0050731;GO:1902895;GO:1903800;GO:0062100;GO:0046827;GO:1900740;GO:2000379;GO:0090200;GO:0045899;GO:0070245;GO:0045944;GO:1990440;GO:0061419;GO:0036003;GO:0045893;GO:0016579;GO:0006606;GO:0008104;GO:0050821;GO:0051262;GO:0065003;GO:0007265;GO:0042981;GO:1902749;GO:2000772;GO:0043516;GO:2000269;GO:1902253;GO:1902108;GO:1901796;GO:0034103;GO:0006357;GO:1990248;GO:0060260;GO:0006355;GO:0001836;GO:0090399;GO:0046677;GO:0010332;GO:0002931;GO:0009651;GO:0010165;GO:0009303;GO:0072331;GO:0001756;GO:0033077;GO:0002360;GO:0002309;GO:0007179;GO:0033209;GO:0016032;, C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:mitochondrial matrix; C:mitochondrion; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex; C:replication fork; C:site of double-strand break; C:transcription regulator complex;, F:ATP binding; F:chaperone binding; F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:copper ion binding; F:core promoter sequence-specific DNA binding; F:disordered domain specific binding; F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:identical protein binding; F:MDM2/MDM4 family protein binding; F:mRNA 3'-UTR binding; F:p53 binding; F:promoter-specific chromatin binding; F:protease binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein N-terminus binding; F:protein phosphatase 2A binding; F:protein phosphatase binding; F:protein self-association; F:receptor tyrosine kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:TFIID-class transcription factor complex binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:autophagy; P:B cell lineage commitment; P:bone marrow development; P:cardiac septum morphogenesis; P:cell aging; P:cell cycle arrest; P:cellular protein localization; P:cellular response to actinomycin D; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:cellular response to gamma radiation; P:cellular response to glucose starvation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:cellular response to UV; P:cellular response to UV-C; P:cerebellum development; P:chromatin assembly; P:circadian behavior; P:cytokine-mediated signaling pathway; P:determination of adult lifespan; P:DNA damage response, signal transduction by p53 class mediator; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA strand renaturation; P:double-strand break repair; P:embryonic organ development; P:entrainment of circadian clock by photoperiod; P:ER overload response; P:gastrulation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell differentiation; P:in utero embryonic development; P:interferon-gamma-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:intrinsic apoptotic signaling pathway in response to hypoxia; P:mitochondrial DNA repair; P:mitotic cell cycle arrest; P:mitotic G1 DNA damage checkpoint; P:mRNA transcription; P:multicellular organism growth; P:necroptotic process; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of DNA replication; P:negative regulation of fibroblast proliferation; P:negative regulation of glucose catabolic process to lactate via pyruvate; P:negative regulation of helicase activity; P:negative regulation of mitophagy; P:negative regulation of neuroblast proliferation; P:negative regulation of pentose-phosphate shunt; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of proteolysis; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron apoptotic process; P:nucleotide-excision repair; P:oligodendrocyte apoptotic process; P:oxidative stress-induced premature senescence; P:positive regulation of apoptotic process; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cell aging; P:positive regulation of cell cycle arrest; P:positive regulation of execution phase of apoptosis; P:positive regulation of gene expression; P:positive regulation of histone deacetylation; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of neuron apoptotic process; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed necrotic cell death; P:positive regulation of protein export from nucleus; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of thymocyte apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:protein import into nucleus; P:protein localization; P:protein stabilization; P:protein tetramerization; P:protein-containing complex assembly; P:Ras protein signal transduction; P:regulation of apoptotic process; P:regulation of cell cycle G2/M phase transition; P:regulation of cellular senescence; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of fibroblast apoptotic process; P:regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:regulation of mitochondrial membrane permeability involved in apoptotic process; P:regulation of signal transduction by p53 class mediator; P:regulation of tissue remodeling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to DNA damage; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:release of cytochrome c from mitochondria; P:replicative senescence; P:response to antibiotic; P:response to gamma radiation; P:response to ischemia; P:response to salt stress; P:response to X-ray; P:rRNA transcription; P:signal transduction by p53 class mediator; P:somitogenesis; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell proliferation involved in immune response; P:transforming growth factor beta receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61,Cellular tumor antigen p53,Antigen NY-CO-13;Phosphoprotein p53;Tumor suppressor p53;, PF00870;PF08563;PF07710;PF18521;, GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005759;GO:0005739;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0005657;GO:0035861;GO:0005667;GO:0005524;GO:0051087;GO:0003682;GO:0000987;GO:0005507;GO:0001046;GO:0097718;GO:0003677;GO:0001216;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0035035;GO:0042826;GO:0035033;GO:0042802;GO:0097371;GO:0003730;GO:0002039;GO:1990841;GO:0002020;GO:0046982;GO:0019901;GO:0047485;GO:0051721;GO:0019903;GO:0043621;GO:0030971;GO:0000978;GO:0001085;GO:0001094;GO:0008134;GO:0000976;GO:0031625;GO:0008270;GO:0006914;GO:0002326;GO:0048539;GO:0060411;GO:0007569;GO:0007050;GO:0034613;GO:0072717;GO:0006974;GO:0035690;GO:0071480;GO:0042149;GO:0071456;GO:0071479;GO:0034644;GO:0071494;GO:0021549;GO:0031497;GO:0048512;GO:0019221;GO:0008340;GO:0030330;GO:0006977;GO:0006978;GO:0000733;GO:0006302;GO:0048568;GO:0043153;GO:0006983;GO:0007369;GO:0002244;GO:0060218;GO:0001701;GO:0060333;GO:0097193;GO:0072332;GO:0042771;GO:0070059;GO:1990144;GO:0043504;GO:0071850;GO:0031571;GO:0009299;GO:0035264;GO:0070266;GO:0043066;GO:0030308;GO:0008285;GO:0008156;GO:0048147;GO:1904024;GO:0051097;GO:1901525;GO:0007406;GO:1905856;GO:1903799;GO:0045861;GO:2000378;GO:0051974;GO:0000122;GO:0045892;GO:0030512;GO:0051402;GO:0006289;GO:0097252;GO:0090403;GO:0043065;GO:0010666;GO:0090343;GO:0071158;GO:1900119;GO:0010628;GO:0031065;GO:2001244;GO:0035794;GO:0043525;GO:0050731;GO:1902895;GO:1903800;GO:0062100;GO:0046827;GO:1900740;GO:2000379;GO:0090200;GO:0045899;GO:0070245;GO:0045944;GO:1990440;GO:0061419;GO:0036003;GO:0045893;GO:0016579;GO:0006606;GO:0008104;GO:0050821;GO:0051262;GO:0065003;GO:0007265;GO:0042981;GO:1902749;GO:2000772;GO:0043516;GO:2000269;GO:1902253;GO:1902108;GO:1901796;GO:0034103;GO:0006357;GO:1990248;GO:0060260;GO:0006355;GO:0001836;GO:0090399;GO:0046677;GO:0010332;GO:0002931;GO:0009651;GO:0010165;GO:0009303;GO:0072331;GO:0001756;GO:0033077;GO:0002360;GO:0002309;GO:0007179;GO:0033209;GO:0016032;, C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:mitochondrial matrix; C:mitochondrion; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex; C:replication fork; C:site of double-strand break; C:transcription regulator complex;, F:ATP binding; F:chaperone binding; F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:copper ion binding; F:core promoter sequence-specific DNA binding; F:disordered domain specific binding; F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:histone deacetylase regulator activity; F:identical protein binding; F:MDM2/MDM4 family protein binding; F:mRNA 3'-UTR binding; F:p53 binding; F:promoter-specific chromatin binding; F:protease binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein N-terminus binding; F:protein phosphatase 2A binding; F:protein phosphatase binding; F:protein self-association; F:receptor tyrosine kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:TFIID-class transcription factor complex binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:autophagy; P:B cell lineage commitment; P:bone marrow development; P:cardiac septum morphogenesis; P:cell aging; P:cell cycle arrest; P:cellular protein localization; P:cellular response to actinomycin D; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:cellular response to gamma radiation; P:cellular response to glucose starvation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:cellular response to UV; P:cellular response to UV-C; P:cerebellum development; P:chromatin assembly; P:circadian behavior; P:cytokine-mediated signaling pathway; P:determination of adult lifespan; P:DNA damage response, signal transduction by p53 class mediator; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA strand renaturation; P:double-strand break repair; P:embryonic organ development; P:entrainment of circadian clock by photoperiod; P:ER overload response; P:gastrulation; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell differentiation; P:in utero embryonic development; P:interferon-gamma-mediated signaling pathway; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:intrinsic apoptotic signaling pathway in response to hypoxia; P:mitochondrial DNA repair; P:mitotic cell cycle arrest; P:mitotic G1 DNA damage checkpoint; P:mRNA transcription; P:multicellular organism growth; P:necroptotic process; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of DNA replication; P:negative regulation of fibroblast proliferation; P:negative regulation of glucose catabolic process to lactate via pyruvate; P:negative regulation of helicase activity; P:negative regulation of mitophagy; P:negative regulation of neuroblast proliferation; P:negative regulation of pentose-phosphate shunt; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of proteolysis; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron apoptotic process; P:nucleotide-excision repair; P:oligodendrocyte apoptotic process; P:oxidative stress-induced premature senescence; P:positive regulation of apoptotic process; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cell aging; P:positive regulation of cell cycle arrest; P:positive regulation of execution phase of apoptosis; P:positive regulation of gene expression; P:positive regulation of histone deacetylation; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of neuron apoptotic process; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of programmed necrotic cell death; P:positive regulation of protein export from nucleus; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of thymocyte apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:protein import into nucleus; P:protein localization; P:protein stabilization; P:protein tetramerization; P:protein-containing complex assembly; P:Ras protein signal transduction; P:regulation of apoptotic process; P:regulation of cell cycle G2/M phase transition; P:regulation of cellular senescence; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of fibroblast apoptotic process; P:regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:regulation of mitochondrial membrane permeability involved in apoptotic process; P:regulation of signal transduction by p53 class mediator; P:regulation of tissue remodeling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to DNA damage; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:release of cytochrome c from mitochondria; P:replicative senescence; P:response to antibiotic; P:response to gamma radiation; P:response to ischemia; P:response to salt stress; P:response to X-ray; P:rRNA transcription; P:signal transduction by p53 class mediator; P:somitogenesis; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell proliferation involved in immune response; P:transforming growth factor beta receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process; scaffold54 indexed_genome mRNA 13096897 13104023 . - . ID=transcript_10090;P14415 A0AV17 A8K278 D3DTQ2 O60444,Sodium/potassium-transporting ATPase subunit beta-2,Adhesion molecule in glia;Sodium/potassium-dependent ATPase subunit beta-2;, PF00287;, GO:0016324;GO:0097450;GO:0097449;GO:0044298;GO:0071944;GO:0031253;GO:0005737;GO:0009897;GO:0016328;GO:0016020;GO:0098984;GO:0001917;GO:0005886;GO:0005890;GO:0001671;GO:0051117;GO:0046982;GO:0030674;GO:0086064;GO:0031589;GO:0030007;GO:0006883;GO:0034220;GO:0021670;GO:0050900;GO:0086009;GO:0061744;GO:1903976;GO:0021944;GO:0045494;GO:0120036;GO:0032781;GO:0010976;GO:1903288;GO:1901018;GO:1903278;GO:1990573;GO:0050821;GO:1903779;GO:0001895;GO:0036376;GO:0021678;GO:0150104;, C:apical plasma membrane; C:astrocyte end-foot; C:astrocyte projection; C:cell body membrane; C:cell periphery; C:cell projection membrane; C:cytoplasm; C:external side of plasma membrane; C:lateral plasma membrane; C:membrane; C:neuron to neuron synapse; C:photoreceptor inner segment; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex;, F:ATPase activator activity; F:ATPase binding; F:protein heterodimerization activity; F:protein-macromolecule adaptor activity;, P:cell communication by electrical coupling involved in cardiac conduction; P:cell-substrate adhesion; P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:lateral ventricle development; P:leukocyte migration; P:membrane repolarization; P:motor behavior; P:negative regulation of glial cell migration; P:neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration; P:photoreceptor cell maintenance; P:plasma membrane bounded cell projection organization; P:positive regulation of ATPase activity; P:positive regulation of neuron projection development; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of sodium ion export across plasma membrane; P:potassium ion import across plasma membrane; P:protein stabilization; P:regulation of cardiac conduction; P:retina homeostasis; P:sodium ion export across plasma membrane; P:third ventricle development; P:transport across blood-brain barrier;|P14415 A0AV17 A8K278 D3DTQ2 O60444,Sodium/potassium-transporting ATPase subunit beta-2,Adhesion molecule in glia;Sodium/potassium-dependent ATPase subunit beta-2;, PF00287;, GO:0016324;GO:0097450;GO:0097449;GO:0044298;GO:0071944;GO:0031253;GO:0005737;GO:0009897;GO:0016328;GO:0016020;GO:0098984;GO:0001917;GO:0005886;GO:0005890;GO:0001671;GO:0051117;GO:0046982;GO:0030674;GO:0086064;GO:0031589;GO:0030007;GO:0006883;GO:0034220;GO:0021670;GO:0050900;GO:0086009;GO:0061744;GO:1903976;GO:0021944;GO:0045494;GO:0120036;GO:0032781;GO:0010976;GO:1903288;GO:1901018;GO:1903278;GO:1990573;GO:0050821;GO:1903779;GO:0001895;GO:0036376;GO:0021678;GO:0150104;, C:apical plasma membrane; C:astrocyte end-foot; C:astrocyte projection; C:cell body membrane; C:cell periphery; C:cell projection membrane; C:cytoplasm; C:external side of plasma membrane; C:lateral plasma membrane; C:membrane; C:neuron to neuron synapse; C:photoreceptor inner segment; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex;, F:ATPase activator activity; F:ATPase binding; F:protein heterodimerization activity; F:protein-macromolecule adaptor activity;, P:cell communication by electrical coupling involved in cardiac conduction; P:cell-substrate adhesion; P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:lateral ventricle development; P:leukocyte migration; P:membrane repolarization; P:motor behavior; P:negative regulation of glial cell migration; P:neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration; P:photoreceptor cell maintenance; P:plasma membrane bounded cell projection organization; P:positive regulation of ATPase activity; P:positive regulation of neuron projection development; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of sodium ion export across plasma membrane; P:potassium ion import across plasma membrane; P:protein stabilization; P:regulation of cardiac conduction; P:retina homeostasis; P:sodium ion export across plasma membrane; P:third ventricle development; P:transport across blood-brain barrier; scaffold54 indexed_genome mRNA 13119834 13124477 . - . ID=transcript_10091;P04278 B0FWH4 E9PGW1 F5H5Z8 I3L1N7 P14689 Q16616 Q3MIL0 Q6ISD2,Sex hormone-binding globulin,Sex steroid-binding protein;Testis-specific androgen-binding protein;Testosterone-estradiol-binding globulin;Testosterone-estrogen-binding globulin;, PF00054;, GO:0070062;GO:0005576;GO:0005497;GO:0005496;, C:extracellular exosome; C:extracellular region;, F:androgen binding; F:steroid binding; scaffold54 indexed_genome mRNA 13124732 13129726 . + . ID=transcript_10092;Q96F10,Thialysine N-epsilon-acetyltransferase {ECO:0000303|PubMed:15283699},Diamine acetyltransferase 2 {ECO:0000305};Spermidine/spermine N(1)-acetyltransferase 2 {ECO:0000303|PubMed:12803540};, PF00583;, GO:0005737;GO:0070062;GO:0004145;GO:0042802;GO:0008080;GO:0019809;GO:0046204;GO:0032920;GO:0032918;GO:0032919;, C:cytoplasm; C:extracellular exosome;, F:diamine N-acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:spermidine binding;, P:nor-spermidine metabolic process; P:putrescine acetylation; P:spermidine acetylation; P:spermine acetylation;|Q96F10,Thialysine N-epsilon-acetyltransferase {ECO:0000303|PubMed:15283699},Diamine acetyltransferase 2 {ECO:0000305};Spermidine/spermine N(1)-acetyltransferase 2 {ECO:0000303|PubMed:12803540};, PF00583;, GO:0005737;GO:0070062;GO:0004145;GO:0042802;GO:0008080;GO:0019809;GO:0046204;GO:0032920;GO:0032918;GO:0032919;, C:cytoplasm; C:extracellular exosome;, F:diamine N-acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:spermidine binding;, P:nor-spermidine metabolic process; P:putrescine acetylation; P:spermidine acetylation; P:spermine acetylation;|Q96F10,Thialysine N-epsilon-acetyltransferase {ECO:0000303|PubMed:15283699},Diamine acetyltransferase 2 {ECO:0000305};Spermidine/spermine N(1)-acetyltransferase 2 {ECO:0000303|PubMed:12803540};, PF00583;, GO:0005737;GO:0070062;GO:0004145;GO:0042802;GO:0008080;GO:0019809;GO:0046204;GO:0032920;GO:0032918;GO:0032919;, C:cytoplasm; C:extracellular exosome;, F:diamine N-acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:spermidine binding;, P:nor-spermidine metabolic process; P:putrescine acetylation; P:spermidine acetylation; P:spermine acetylation; scaffold54 indexed_genome mRNA 13143862 13157579 . + . ID=transcript_10093;P51116 B2R9M2 D3DTQ1 Q86V09 Q8WUM2,Fragile X mental retardation syndrome-related protein 2,, PF05641;PF12235;PF16096;PF00013;PF17904;PF18336;, GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0022625;GO:1902737;GO:0043197;GO:0044326;GO:0030426;GO:0016020;GO:0043025;GO:0005634;GO:0005844;GO:0014069;GO:0098793;GO:0042802;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0045182;GO:0017148;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;, C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:growth cone; C:membrane; C:neuronal cell body; C:nucleus; C:polysome; C:postsynaptic density; C:presynapse;, F:identical protein binding; F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:translation regulator activity;, P:negative regulation of translation; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability;|P51116 B2R9M2 D3DTQ1 Q86V09 Q8WUM2,Fragile X mental retardation syndrome-related protein 2,, PF05641;PF12235;PF16096;PF00013;PF17904;PF18336;, GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0022625;GO:1902737;GO:0043197;GO:0044326;GO:0030426;GO:0016020;GO:0043025;GO:0005634;GO:0005844;GO:0014069;GO:0098793;GO:0042802;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0045182;GO:0017148;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;, C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:growth cone; C:membrane; C:neuronal cell body; C:nucleus; C:polysome; C:postsynaptic density; C:presynapse;, F:identical protein binding; F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:translation regulator activity;, P:negative regulation of translation; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability;|P51116 B2R9M2 D3DTQ1 Q86V09 Q8WUM2,Fragile X mental retardation syndrome-related protein 2,, PF05641;PF12235;PF16096;PF00013;PF17904;PF18336;, GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0022625;GO:1902737;GO:0043197;GO:0044326;GO:0030426;GO:0016020;GO:0043025;GO:0005634;GO:0005844;GO:0014069;GO:0098793;GO:0042802;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0045182;GO:0017148;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;, C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:growth cone; C:membrane; C:neuronal cell body; C:nucleus; C:polysome; C:postsynaptic density; C:presynapse;, F:identical protein binding; F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:translation regulator activity;, P:negative regulation of translation; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability;|P51116 B2R9M2 D3DTQ1 Q86V09 Q8WUM2,Fragile X mental retardation syndrome-related protein 2,, PF05641;PF12235;PF16096;PF00013;PF17904;PF18336;, GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0022625;GO:1902737;GO:0043197;GO:0044326;GO:0030426;GO:0016020;GO:0043025;GO:0005634;GO:0005844;GO:0014069;GO:0098793;GO:0042802;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0045182;GO:0017148;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;, C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:growth cone; C:membrane; C:neuronal cell body; C:nucleus; C:polysome; C:postsynaptic density; C:presynapse;, F:identical protein binding; F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:translation regulator activity;, P:negative regulation of translation; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability;|P51116 B2R9M2 D3DTQ1 Q86V09 Q8WUM2,Fragile X mental retardation syndrome-related protein 2,, PF05641;PF12235;PF16096;PF00013;PF17904;PF18336;, GO:0030424;GO:0005737;GO:0036464;GO:0005829;GO:0022625;GO:1902737;GO:0043197;GO:0044326;GO:0030426;GO:0016020;GO:0043025;GO:0005634;GO:0005844;GO:0014069;GO:0098793;GO:0042802;GO:0003730;GO:0046982;GO:0042803;GO:0003723;GO:0045182;GO:0017148;GO:0001934;GO:2001022;GO:0045727;GO:0000381;GO:0051489;GO:0043488;, C:axon; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:growth cone; C:membrane; C:neuronal cell body; C:nucleus; C:polysome; C:postsynaptic density; C:presynapse;, F:identical protein binding; F:mRNA 3'-UTR binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:translation regulator activity;, P:negative regulation of translation; P:positive regulation of protein phosphorylation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of filopodium assembly; P:regulation of mRNA stability; scaffold54 indexed_genome mRNA 13158280 13163813 . - . ID=transcript_10094;O60248 B4DWU7 D3DTQ0 P35717 Q9Y6W7,Protein SOX-15,Protein SOX-12;Protein SOX-20;, PF00505;, GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0003682;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:0009653;GO:0030154;GO:0006325;GO:0008584;GO:0048627;GO:0045843;GO:0000122;GO:0070318;GO:2000288;GO:0014718;GO:0045944;GO:0006357;GO:0006355;GO:0043403;GO:0060707;, C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell differentiation; P:chromatin organization; P:male gonad development; P:myoblast development; P:negative regulation of striated muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of G0 to G1 transition; P:positive regulation of myoblast proliferation; P:positive regulation of satellite cell activation involved in skeletal muscle regeneration; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:skeletal muscle tissue regeneration; P:trophoblast giant cell differentiation;|O60248 B4DWU7 D3DTQ0 P35717 Q9Y6W7,Protein SOX-15,Protein SOX-12;Protein SOX-20;, PF00505;, GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0003682;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:0009653;GO:0030154;GO:0006325;GO:0008584;GO:0048627;GO:0045843;GO:0000122;GO:0070318;GO:2000288;GO:0014718;GO:0045944;GO:0006357;GO:0006355;GO:0043403;GO:0060707;, C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell differentiation; P:chromatin organization; P:male gonad development; P:myoblast development; P:negative regulation of striated muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of G0 to G1 transition; P:positive regulation of myoblast proliferation; P:positive regulation of satellite cell activation involved in skeletal muscle regeneration; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:skeletal muscle tissue regeneration; P:trophoblast giant cell differentiation;|O75352 B3KQP1 B4DT74 Q9BUU8,Mannose-P-dolichol utilization defect 1 protein,Suppressor of Lec15 and Lec35 glycosylation mutation homolog;, PF04193;, GO:0005789;GO:0016021;GO:0016020;GO:0006488;GO:0009312;GO:0006457;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide biosynthetic process; P:protein folding;|O75352 B3KQP1 B4DT74 Q9BUU8,Mannose-P-dolichol utilization defect 1 protein,Suppressor of Lec15 and Lec35 glycosylation mutation homolog;, PF04193;, GO:0005789;GO:0016021;GO:0016020;GO:0006488;GO:0009312;GO:0006457;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide biosynthetic process; P:protein folding;|O75352 B3KQP1 B4DT74 Q9BUU8,Mannose-P-dolichol utilization defect 1 protein,Suppressor of Lec15 and Lec35 glycosylation mutation homolog;, PF04193;, GO:0005789;GO:0016021;GO:0016020;GO:0006488;GO:0009312;GO:0006457;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide biosynthetic process; P:protein folding; scaffold55 indexed_genome mRNA 60594 62004 . - . ID=transcript_10095;Q9C0C6 B2RCI1 Q8N389 Q8NDZ1,CLOCK-interacting pacemaker,CLOCK-interacting circadian protein;, PF15800;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0042754;GO:0045892;GO:0048511;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:negative regulation of circadian rhythm; P:negative regulation of transcription, DNA-templated; P:rhythmic process; scaffold55 indexed_genome mRNA 62057 72146 . + . ID=transcript_10096;Q9C0C6 B2RCI1 Q8N389 Q8NDZ1,CLOCK-interacting pacemaker,CLOCK-interacting circadian protein;, PF15800;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0042754;GO:0045892;GO:0048511;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:negative regulation of circadian rhythm; P:negative regulation of transcription, DNA-templated; P:rhythmic process; scaffold55 indexed_genome mRNA 88250 99098 . - . ID=transcript_10097;Q8N966 A6NH02 B7Z2L5 Q149P4,Palmitoyltransferase ZDHHC22 {ECO:0000305|PubMed:22399288},Zinc finger DHHC domain-containing protein 22 {ECO:0000312|HGNC:HGNC:20106};, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0019706;GO:0018230;GO:0072659;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein localization to plasma membrane; P:protein palmitoylation; P:protein targeting to membrane; scaffold55 indexed_genome mRNA 175498 199055 . + . ID=transcript_10098;Q9P1W3 B2RN22 B3KWJ5 Q86TS3 Q86TS4 Q9NSQ4 Q9P1W1,Calcium permeable stress-gated cation channel 1,Transmembrane protein 63C;, PF14703;PF02714;PF13967;, GO:0016021;GO:0005886;GO:0005227;GO:1990760;GO:0006812;GO:0003094;, C:integral component of membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:osmolarity-sensing cation channel activity;, P:cation transport; P:glomerular filtration; scaffold55 indexed_genome mRNA 199148 212545 . + . ID=transcript_10099;Q9P1W3 B2RN22 B3KWJ5 Q86TS3 Q86TS4 Q9NSQ4 Q9P1W1,Calcium permeable stress-gated cation channel 1,Transmembrane protein 63C;, PF14703;PF02714;PF13967;, GO:0016021;GO:0005886;GO:0005227;GO:1990760;GO:0006812;GO:0003094;, C:integral component of membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:osmolarity-sensing cation channel activity;, P:cation transport; P:glomerular filtration; scaffold55 indexed_genome mRNA 219052 227748 . - . ID=transcript_10100;Q9NPG2,Neuroglobin,, PF00042;, GO:0005829;GO:0005739;GO:0043204;GO:0020037;GO:0046872;GO:0019825;GO:0005344;GO:0006915;GO:0015671;, C:cytosol; C:mitochondrion; C:perikaryon;, F:heme binding; F:metal ion binding; F:oxygen binding; F:oxygen carrier activity;, P:apoptotic process; P:oxygen transport; scaffold55 indexed_genome mRNA 231446 235896 . - . ID=transcript_10101;Q9UKY4 Q9NSG6 Q9P1W0 Q9P1W2,Protein O-mannosyl-transferase 2,Dolichyl-phosphate-mannose--protein mannosyltransferase 2;, PF02815;PF02366;PF16192;, GO:0005829;GO:0005789;GO:0016021;GO:0005730;GO:0005654;GO:0004169;GO:0000030;GO:0046872;GO:0071712;GO:1904100;GO:0006493;GO:0035269;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleolus; C:nucleoplasm;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:ER-associated misfolded protein catabolic process; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation; scaffold55 indexed_genome mRNA 236041 300564 . + . ID=transcript_10102;Q9UKY4 Q9NSG6 Q9P1W0 Q9P1W2,Protein O-mannosyl-transferase 2,Dolichyl-phosphate-mannose--protein mannosyltransferase 2;, PF02815;PF02366;PF16192;, GO:0005829;GO:0005789;GO:0016021;GO:0005730;GO:0005654;GO:0004169;GO:0000030;GO:0046872;GO:0071712;GO:1904100;GO:0006493;GO:0035269;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleolus; C:nucleoplasm;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:ER-associated misfolded protein catabolic process; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9UKY4 Q9NSG6 Q9P1W0 Q9P1W2,Protein O-mannosyl-transferase 2,Dolichyl-phosphate-mannose--protein mannosyltransferase 2;, PF02815;PF02366;PF16192;, GO:0005829;GO:0005789;GO:0016021;GO:0005730;GO:0005654;GO:0004169;GO:0000030;GO:0046872;GO:0071712;GO:1904100;GO:0006493;GO:0035269;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleolus; C:nucleoplasm;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:ER-associated misfolded protein catabolic process; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9UKY4 Q9NSG6 Q9P1W0 Q9P1W2,Protein O-mannosyl-transferase 2,Dolichyl-phosphate-mannose--protein mannosyltransferase 2;, PF02815;PF02366;PF16192;, GO:0005829;GO:0005789;GO:0016021;GO:0005730;GO:0005654;GO:0004169;GO:0000030;GO:0046872;GO:0071712;GO:1904100;GO:0006493;GO:0035269;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleolus; C:nucleoplasm;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:ER-associated misfolded protein catabolic process; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9BV63,Maleylacetoacetate isomerase,GSTZ1-1;Glutathione S-transferase zeta 1;, PF14497;PF13417;, GO:0005829;GO:0005759;GO:0005739;GO:0004602;GO:0004364;GO:0042802;GO:0016034;GO:0042803;GO:1901687;GO:0006749;GO:0006559;GO:0010510;GO:0006572;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:glutathione peroxidase activity; F:glutathione transferase activity; F:identical protein binding; F:maleylacetoacetate isomerase activity; F:protein homodimerization activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:L-phenylalanine catabolic process; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:tyrosine catabolic process;|Q9BV63,Maleylacetoacetate isomerase,GSTZ1-1;Glutathione S-transferase zeta 1;, PF14497;PF13417;, GO:0005829;GO:0005759;GO:0005739;GO:0004602;GO:0004364;GO:0042802;GO:0016034;GO:0042803;GO:1901687;GO:0006749;GO:0006559;GO:0010510;GO:0006572;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:glutathione peroxidase activity; F:glutathione transferase activity; F:identical protein binding; F:maleylacetoacetate isomerase activity; F:protein homodimerization activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:L-phenylalanine catabolic process; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:tyrosine catabolic process;|Q9BV63,Maleylacetoacetate isomerase,GSTZ1-1;Glutathione S-transferase zeta 1;, PF14497;PF13417;, GO:0005829;GO:0005759;GO:0005739;GO:0004602;GO:0004364;GO:0042802;GO:0016034;GO:0042803;GO:1901687;GO:0006749;GO:0006559;GO:0010510;GO:0006572;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:glutathione peroxidase activity; F:glutathione transferase activity; F:identical protein binding; F:maleylacetoacetate isomerase activity; F:protein homodimerization activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:L-phenylalanine catabolic process; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:tyrosine catabolic process; scaffold55 indexed_genome mRNA 312940 313964 . - . ID=transcript_10103;Q6PL24 B3KTI6 Q3MJB0 Q9P1V9,Protein TMED8,, PF13897; scaffold55 indexed_genome mRNA 314006 340307 . - . ID=transcript_10104;Q6PL24 B3KTI6 Q3MJB0 Q9P1V9,Protein TMED8,, PF13897; scaffold55 indexed_genome mRNA 340442 358252 . + . ID=transcript_10105;Q9P1V8 Q2M3P3,Sterile alpha motif domain-containing protein 15,, PF07647; scaffold55 indexed_genome mRNA 382012 385024 . - . ID=transcript_10106;Q9H9C1 B4DPI6 O95434 Q9H7E1 Q9H9I9,Spermatogenesis-defective protein 39 homolog,VPS33B-interacting protein in apical-basolateral polarity regulator;VPS33B-interacting protein in polarity and apical restriction;, PF04840;, GO:0005737;GO:0005769;GO:0005794;GO:0005770;GO:0055037;GO:0044877;GO:0030154;GO:0032963;GO:0008333;GO:0006886;GO:0017185;GO:0007283;GO:0007034;, C:cytoplasm; C:early endosome; C:Golgi apparatus; C:late endosome; C:recycling endosome;, F:protein-containing complex binding;, P:cell differentiation; P:collagen metabolic process; P:endosome to lysosome transport; P:intracellular protein transport; P:peptidyl-lysine hydroxylation; P:spermatogenesis; P:vacuolar transport;|Q9H9C1 B4DPI6 O95434 Q9H7E1 Q9H9I9,Spermatogenesis-defective protein 39 homolog,VPS33B-interacting protein in apical-basolateral polarity regulator;VPS33B-interacting protein in polarity and apical restriction;, PF04840;, GO:0005737;GO:0005769;GO:0005794;GO:0005770;GO:0055037;GO:0044877;GO:0030154;GO:0032963;GO:0008333;GO:0006886;GO:0017185;GO:0007283;GO:0007034;, C:cytoplasm; C:early endosome; C:Golgi apparatus; C:late endosome; C:recycling endosome;, F:protein-containing complex binding;, P:cell differentiation; P:collagen metabolic process; P:endosome to lysosome transport; P:intracellular protein transport; P:peptidyl-lysine hydroxylation; P:spermatogenesis; P:vacuolar transport; scaffold55 indexed_genome mRNA 385089 385978 . - . ID=transcript_10107;Q9H9C1 B4DPI6 O95434 Q9H7E1 Q9H9I9,Spermatogenesis-defective protein 39 homolog,VPS33B-interacting protein in apical-basolateral polarity regulator;VPS33B-interacting protein in polarity and apical restriction;, PF04840;, GO:0005737;GO:0005769;GO:0005794;GO:0005770;GO:0055037;GO:0044877;GO:0030154;GO:0032963;GO:0008333;GO:0006886;GO:0017185;GO:0007283;GO:0007034;, C:cytoplasm; C:early endosome; C:Golgi apparatus; C:late endosome; C:recycling endosome;, F:protein-containing complex binding;, P:cell differentiation; P:collagen metabolic process; P:endosome to lysosome transport; P:intracellular protein transport; P:peptidyl-lysine hydroxylation; P:spermatogenesis; P:vacuolar transport; scaffold55 indexed_genome mRNA 386413 407543 . + . ID=transcript_10108;Q9H9C1 B4DPI6 O95434 Q9H7E1 Q9H9I9,Spermatogenesis-defective protein 39 homolog,VPS33B-interacting protein in apical-basolateral polarity regulator;VPS33B-interacting protein in polarity and apical restriction;, PF04840;, GO:0005737;GO:0005769;GO:0005794;GO:0005770;GO:0055037;GO:0044877;GO:0030154;GO:0032963;GO:0008333;GO:0006886;GO:0017185;GO:0007283;GO:0007034;, C:cytoplasm; C:early endosome; C:Golgi apparatus; C:late endosome; C:recycling endosome;, F:protein-containing complex binding;, P:cell differentiation; P:collagen metabolic process; P:endosome to lysosome transport; P:intracellular protein transport; P:peptidyl-lysine hydroxylation; P:spermatogenesis; P:vacuolar transport;|Q9H9C1 B4DPI6 O95434 Q9H7E1 Q9H9I9,Spermatogenesis-defective protein 39 homolog,VPS33B-interacting protein in apical-basolateral polarity regulator;VPS33B-interacting protein in polarity and apical restriction;, PF04840;, GO:0005737;GO:0005769;GO:0005794;GO:0005770;GO:0055037;GO:0044877;GO:0030154;GO:0032963;GO:0008333;GO:0006886;GO:0017185;GO:0007283;GO:0007034;, C:cytoplasm; C:early endosome; C:Golgi apparatus; C:late endosome; C:recycling endosome;, F:protein-containing complex binding;, P:cell differentiation; P:collagen metabolic process; P:endosome to lysosome transport; P:intracellular protein transport; P:peptidyl-lysine hydroxylation; P:spermatogenesis; P:vacuolar transport;|Q9H9C1 B4DPI6 O95434 Q9H7E1 Q9H9I9,Spermatogenesis-defective protein 39 homolog,VPS33B-interacting protein in apical-basolateral polarity regulator;VPS33B-interacting protein in polarity and apical restriction;, PF04840;, GO:0005737;GO:0005769;GO:0005794;GO:0005770;GO:0055037;GO:0044877;GO:0030154;GO:0032963;GO:0008333;GO:0006886;GO:0017185;GO:0007283;GO:0007034;, C:cytoplasm; C:early endosome; C:Golgi apparatus; C:late endosome; C:recycling endosome;, F:protein-containing complex binding;, P:cell differentiation; P:collagen metabolic process; P:endosome to lysosome transport; P:intracellular protein transport; P:peptidyl-lysine hydroxylation; P:spermatogenesis; P:vacuolar transport;|Q9H9C1 B4DPI6 O95434 Q9H7E1 Q9H9I9,Spermatogenesis-defective protein 39 homolog,VPS33B-interacting protein in apical-basolateral polarity regulator;VPS33B-interacting protein in polarity and apical restriction;, PF04840;, GO:0005737;GO:0005769;GO:0005794;GO:0005770;GO:0055037;GO:0044877;GO:0030154;GO:0032963;GO:0008333;GO:0006886;GO:0017185;GO:0007283;GO:0007034;, C:cytoplasm; C:early endosome; C:Golgi apparatus; C:late endosome; C:recycling endosome;, F:protein-containing complex binding;, P:cell differentiation; P:collagen metabolic process; P:endosome to lysosome transport; P:intracellular protein transport; P:peptidyl-lysine hydroxylation; P:spermatogenesis; P:vacuolar transport;|Q9H9C1 B4DPI6 O95434 Q9H7E1 Q9H9I9,Spermatogenesis-defective protein 39 homolog,VPS33B-interacting protein in apical-basolateral polarity regulator;VPS33B-interacting protein in polarity and apical restriction;, PF04840;, GO:0005737;GO:0005769;GO:0005794;GO:0005770;GO:0055037;GO:0044877;GO:0030154;GO:0032963;GO:0008333;GO:0006886;GO:0017185;GO:0007283;GO:0007034;, C:cytoplasm; C:early endosome; C:Golgi apparatus; C:late endosome; C:recycling endosome;, F:protein-containing complex binding;, P:cell differentiation; P:collagen metabolic process; P:endosome to lysosome transport; P:intracellular protein transport; P:peptidyl-lysine hydroxylation; P:spermatogenesis; P:vacuolar transport;|Q9H9C1 B4DPI6 O95434 Q9H7E1 Q9H9I9,Spermatogenesis-defective protein 39 homolog,VPS33B-interacting protein in apical-basolateral polarity regulator;VPS33B-interacting protein in polarity and apical restriction;, PF04840;, GO:0005737;GO:0005769;GO:0005794;GO:0005770;GO:0055037;GO:0044877;GO:0030154;GO:0032963;GO:0008333;GO:0006886;GO:0017185;GO:0007283;GO:0007034;, C:cytoplasm; C:early endosome; C:Golgi apparatus; C:late endosome; C:recycling endosome;, F:protein-containing complex binding;, P:cell differentiation; P:collagen metabolic process; P:endosome to lysosome transport; P:intracellular protein transport; P:peptidyl-lysine hydroxylation; P:spermatogenesis; P:vacuolar transport;|Q9H9C1 B4DPI6 O95434 Q9H7E1 Q9H9I9,Spermatogenesis-defective protein 39 homolog,VPS33B-interacting protein in apical-basolateral polarity regulator;VPS33B-interacting protein in polarity and apical restriction;, PF04840;, GO:0005737;GO:0005769;GO:0005794;GO:0005770;GO:0055037;GO:0044877;GO:0030154;GO:0032963;GO:0008333;GO:0006886;GO:0017185;GO:0007283;GO:0007034;, C:cytoplasm; C:early endosome; C:Golgi apparatus; C:late endosome; C:recycling endosome;, F:protein-containing complex binding;, P:cell differentiation; P:collagen metabolic process; P:endosome to lysosome transport; P:intracellular protein transport; P:peptidyl-lysine hydroxylation; P:spermatogenesis; P:vacuolar transport; scaffold55 indexed_genome mRNA 407747 415471 . + . ID=transcript_10109;O95433 B2R9L2 B4DUR9 Q96IL6 Q9P060,Activator of 90 kDa heat shock protein ATPase homolog 1,p38;, PF09229;PF08327;, GO:0005829;GO:0005783;GO:0070062;GO:0001671;GO:0045296;GO:0051087;GO:0051879;GO:0032781;GO:0006457;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome;, F:ATPase activator activity; F:cadherin binding; F:chaperone binding; F:Hsp90 protein binding;, P:positive regulation of ATPase activity; P:protein folding; P:viral process;|O95433 B2R9L2 B4DUR9 Q96IL6 Q9P060,Activator of 90 kDa heat shock protein ATPase homolog 1,p38;, PF09229;PF08327;, GO:0005829;GO:0005783;GO:0070062;GO:0001671;GO:0045296;GO:0051087;GO:0051879;GO:0032781;GO:0006457;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome;, F:ATPase activator activity; F:cadherin binding; F:chaperone binding; F:Hsp90 protein binding;, P:positive regulation of ATPase activity; P:protein folding; P:viral process;|O95433 B2R9L2 B4DUR9 Q96IL6 Q9P060,Activator of 90 kDa heat shock protein ATPase homolog 1,p38;, PF09229;PF08327;, GO:0005829;GO:0005783;GO:0070062;GO:0001671;GO:0045296;GO:0051087;GO:0051879;GO:0032781;GO:0006457;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome;, F:ATPase activator activity; F:cadherin binding; F:chaperone binding; F:Hsp90 protein binding;, P:positive regulation of ATPase activity; P:protein folding; P:viral process;|O95433 B2R9L2 B4DUR9 Q96IL6 Q9P060,Activator of 90 kDa heat shock protein ATPase homolog 1,p38;, PF09229;PF08327;, GO:0005829;GO:0005783;GO:0070062;GO:0001671;GO:0045296;GO:0051087;GO:0051879;GO:0032781;GO:0006457;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome;, F:ATPase activator activity; F:cadherin binding; F:chaperone binding; F:Hsp90 protein binding;, P:positive regulation of ATPase activity; P:protein folding; P:viral process;|O95433 B2R9L2 B4DUR9 Q96IL6 Q9P060,Activator of 90 kDa heat shock protein ATPase homolog 1,p38;, PF09229;PF08327;, GO:0005829;GO:0005783;GO:0070062;GO:0001671;GO:0045296;GO:0051087;GO:0051879;GO:0032781;GO:0006457;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome;, F:ATPase activator activity; F:cadherin binding; F:chaperone binding; F:Hsp90 protein binding;, P:positive regulation of ATPase activity; P:protein folding; P:viral process; scaffold55 indexed_genome mRNA 450660 518065 . - . ID=transcript_10110;O15270 Q16685,Serine palmitoyltransferase 2 {ECO:0000305},Long chain base biosynthesis protein 2;Long chain base biosynthesis protein 2a;Serine-palmitoyl-CoA transferase 2;, PF00155;, GO:0005789;GO:0016021;GO:0017059;GO:0030170;GO:0004758;GO:0060612;GO:0046513;GO:1904504;GO:0046511;GO:0030148;GO:0006686;GO:0046512;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:serine C-palmitoyltransferase complex;, F:pyridoxal phosphate binding; F:serine C-palmitoyltransferase activity;, P:adipose tissue development; P:ceramide biosynthetic process; P:positive regulation of lipophagy; P:sphinganine biosynthetic process; P:sphingolipid biosynthetic process; P:sphingomyelin biosynthetic process; P:sphingosine biosynthetic process;|O15270 Q16685,Serine palmitoyltransferase 2 {ECO:0000305},Long chain base biosynthesis protein 2;Long chain base biosynthesis protein 2a;Serine-palmitoyl-CoA transferase 2;, PF00155;, GO:0005789;GO:0016021;GO:0017059;GO:0030170;GO:0004758;GO:0060612;GO:0046513;GO:1904504;GO:0046511;GO:0030148;GO:0006686;GO:0046512;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:serine C-palmitoyltransferase complex;, F:pyridoxal phosphate binding; F:serine C-palmitoyltransferase activity;, P:adipose tissue development; P:ceramide biosynthetic process; P:positive regulation of lipophagy; P:sphinganine biosynthetic process; P:sphingolipid biosynthetic process; P:sphingomyelin biosynthetic process; P:sphingosine biosynthetic process;|O15270 Q16685,Serine palmitoyltransferase 2 {ECO:0000305},Long chain base biosynthesis protein 2;Long chain base biosynthesis protein 2a;Serine-palmitoyl-CoA transferase 2;, PF00155;, GO:0005789;GO:0016021;GO:0017059;GO:0030170;GO:0004758;GO:0060612;GO:0046513;GO:1904504;GO:0046511;GO:0030148;GO:0006686;GO:0046512;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:serine C-palmitoyltransferase complex;, F:pyridoxal phosphate binding; F:serine C-palmitoyltransferase activity;, P:adipose tissue development; P:ceramide biosynthetic process; P:positive regulation of lipophagy; P:sphinganine biosynthetic process; P:sphingolipid biosynthetic process; P:sphingomyelin biosynthetic process; P:sphingosine biosynthetic process; scaffold55 indexed_genome mRNA 595843 619164 . - . ID=transcript_10111;Q13686 Q8TAU1 Q9ULA7,Nucleic acid dioxygenase ALKBH1 {ECO:0000305},Alkylated DNA repair protein alkB homolog 1 {ECO:0000303|PubMed:19959401};Alpha-ketoglutarate-dependent dioxygenase ABH1 {ECO:0000303|PubMed:19959401};DNA 6mA demethylase {ECO:0000250|UniProtKB:P0CB42};DNA N6-methyl adenine demethylase ALKBH1 {ECO:0000305};DNA lyase ABH1 {ECO:0000303|PubMed:19959401};DNA oxidative demethylase ALKBH1;mRNA N(3)-methylcytidine demethylase {ECO:0000305};, PF13532;, GO:0005737;GO:0005783;GO:0000791;GO:0005739;GO:0005654;GO:0005634;GO:0103053;GO:0016706;GO:0042056;GO:0140078;GO:0008198;GO:0070579;GO:0035516;GO:0035515;GO:0000049;GO:1990984;GO:0048589;GO:0006307;GO:0080111;GO:0006281;GO:0001701;GO:0043524;GO:0001764;GO:0031175;GO:0070989;GO:0035513;GO:0035552;GO:0001890;GO:0070129;GO:0006448;GO:0006446;GO:0042245;GO:1990983;GO:0002101;, C:cytoplasm; C:endoplasmic reticulum; C:euchromatin; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:1-ethyladenine demethylase activity; F:2-oxoglutarate-dependent dioxygenase activity; F:chemoattractant activity; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:ferrous iron binding; F:methylcytosine dioxygenase activity; F:oxidative DNA demethylase activity; F:oxidative RNA demethylase activity; F:tRNA binding; F:tRNA demethylase activity;, P:developmental growth; P:DNA dealkylation involved in DNA repair; P:DNA demethylation; P:DNA repair; P:in utero embryonic development; P:negative regulation of neuron apoptotic process; P:neuron migration; P:neuron projection development; P:oxidative demethylation; P:oxidative RNA demethylation; P:oxidative single-stranded DNA demethylation; P:placenta development; P:regulation of mitochondrial translation; P:regulation of translational elongation; P:regulation of translational initiation; P:RNA repair; P:tRNA demethylation; P:tRNA wobble cytosine modification;|Q13686 Q8TAU1 Q9ULA7,Nucleic acid dioxygenase ALKBH1 {ECO:0000305},Alkylated DNA repair protein alkB homolog 1 {ECO:0000303|PubMed:19959401};Alpha-ketoglutarate-dependent dioxygenase ABH1 {ECO:0000303|PubMed:19959401};DNA 6mA demethylase {ECO:0000250|UniProtKB:P0CB42};DNA N6-methyl adenine demethylase ALKBH1 {ECO:0000305};DNA lyase ABH1 {ECO:0000303|PubMed:19959401};DNA oxidative demethylase ALKBH1;mRNA N(3)-methylcytidine demethylase {ECO:0000305};, PF13532;, GO:0005737;GO:0005783;GO:0000791;GO:0005739;GO:0005654;GO:0005634;GO:0103053;GO:0016706;GO:0042056;GO:0140078;GO:0008198;GO:0070579;GO:0035516;GO:0035515;GO:0000049;GO:1990984;GO:0048589;GO:0006307;GO:0080111;GO:0006281;GO:0001701;GO:0043524;GO:0001764;GO:0031175;GO:0070989;GO:0035513;GO:0035552;GO:0001890;GO:0070129;GO:0006448;GO:0006446;GO:0042245;GO:1990983;GO:0002101;, C:cytoplasm; C:endoplasmic reticulum; C:euchromatin; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:1-ethyladenine demethylase activity; F:2-oxoglutarate-dependent dioxygenase activity; F:chemoattractant activity; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:ferrous iron binding; F:methylcytosine dioxygenase activity; F:oxidative DNA demethylase activity; F:oxidative RNA demethylase activity; F:tRNA binding; F:tRNA demethylase activity;, P:developmental growth; P:DNA dealkylation involved in DNA repair; P:DNA demethylation; P:DNA repair; P:in utero embryonic development; P:negative regulation of neuron apoptotic process; P:neuron migration; P:neuron projection development; P:oxidative demethylation; P:oxidative RNA demethylation; P:oxidative single-stranded DNA demethylation; P:placenta development; P:regulation of mitochondrial translation; P:regulation of translational elongation; P:regulation of translational initiation; P:RNA repair; P:tRNA demethylation; P:tRNA wobble cytosine modification; scaffold55 indexed_genome mRNA 622111 656089 . + . ID=transcript_10112;Q9GZT3 J3KMY7,SRA stem-loop-interacting RNA-binding protein, mitochondrial,, PF00076;, GO:0005739;GO:0005634;GO:0003723;GO:0070584;GO:0000961;, C:mitochondrion; C:nucleus;, F:RNA binding;, P:mitochondrion morphogenesis; P:negative regulation of mitochondrial RNA catabolic process;|Q9GZT3 J3KMY7,SRA stem-loop-interacting RNA-binding protein, mitochondrial,, PF00076;, GO:0005739;GO:0005634;GO:0003723;GO:0070584;GO:0000961;, C:mitochondrion; C:nucleus;, F:RNA binding;, P:mitochondrion morphogenesis; P:negative regulation of mitochondrial RNA catabolic process;|Q13573 A8K8A9 Q13483 Q32N03 Q5D0D6,SNW domain-containing protein 1,Nuclear protein SkiP;Nuclear receptor coactivator NCoA-62 {ECO:0000303|PubMed:9632709};Ski-interacting protein {ECO:0000303|PubMed:11278756, ECO:0000303|PubMed:9569025};, PF02731;, GO:0071013;GO:0016604;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0050681;GO:0019899;GO:0005112;GO:0035257;GO:0042974;GO:0003723;GO:0046332;GO:0003713;GO:0003714;GO:0042809;GO:0071300;GO:0042771;GO:0000398;GO:0000122;GO:0045892;GO:0007219;GO:0043923;GO:0051571;GO:0048026;GO:0050769;GO:0045747;GO:0045944;GO:0007221;GO:0030511;GO:0070564;GO:0048385;GO:0006357;GO:0070562;GO:0048384;GO:0006367;GO:0016032;, C:catalytic step 2 spliceosome; C:nuclear body; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:androgen receptor binding; F:enzyme binding; F:Notch binding; F:nuclear hormone receptor binding; F:retinoic acid receptor binding; F:RNA binding; F:SMAD binding; F:transcription coactivator activity; F:transcription corepressor activity; F:vitamin D receptor binding;, P:cellular response to retinoic acid; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:positive regulation by host of viral transcription; P:positive regulation of histone H3-K4 methylation; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of neurogenesis; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of vitamin D receptor signaling pathway; P:regulation of retinoic acid receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of vitamin D receptor signaling pathway; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q13573 A8K8A9 Q13483 Q32N03 Q5D0D6,SNW domain-containing protein 1,Nuclear protein SkiP;Nuclear receptor coactivator NCoA-62 {ECO:0000303|PubMed:9632709};Ski-interacting protein {ECO:0000303|PubMed:11278756, ECO:0000303|PubMed:9569025};, PF02731;, GO:0071013;GO:0016604;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0050681;GO:0019899;GO:0005112;GO:0035257;GO:0042974;GO:0003723;GO:0046332;GO:0003713;GO:0003714;GO:0042809;GO:0071300;GO:0042771;GO:0000398;GO:0000122;GO:0045892;GO:0007219;GO:0043923;GO:0051571;GO:0048026;GO:0050769;GO:0045747;GO:0045944;GO:0007221;GO:0030511;GO:0070564;GO:0048385;GO:0006357;GO:0070562;GO:0048384;GO:0006367;GO:0016032;, C:catalytic step 2 spliceosome; C:nuclear body; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:androgen receptor binding; F:enzyme binding; F:Notch binding; F:nuclear hormone receptor binding; F:retinoic acid receptor binding; F:RNA binding; F:SMAD binding; F:transcription coactivator activity; F:transcription corepressor activity; F:vitamin D receptor binding;, P:cellular response to retinoic acid; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:positive regulation by host of viral transcription; P:positive regulation of histone H3-K4 methylation; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of neurogenesis; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of vitamin D receptor signaling pathway; P:regulation of retinoic acid receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of vitamin D receptor signaling pathway; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process; scaffold55 indexed_genome mRNA 713965 815364 . + . ID=transcript_10113;Q86TW2 B3KUD5 Q6PD65 Q9UIE6,AarF domain-containing protein kinase 1 {ECO:0000303|PubMed:31125351},, PF03109;, GO:0005576;GO:0032592;GO:0005743;GO:0005524;GO:0004674;GO:0055088;GO:0007005;GO:0010637;GO:1903852;, C:extracellular region; C:integral component of mitochondrial membrane; C:mitochondrial inner membrane;, F:ATP binding; F:protein serine/threonine kinase activity;, P:lipid homeostasis; P:mitochondrion organization; P:negative regulation of mitochondrial fusion; P:positive regulation of cristae formation;|Q86TW2 B3KUD5 Q6PD65 Q9UIE6,AarF domain-containing protein kinase 1 {ECO:0000303|PubMed:31125351},, PF03109;, GO:0005576;GO:0032592;GO:0005743;GO:0005524;GO:0004674;GO:0055088;GO:0007005;GO:0010637;GO:1903852;, C:extracellular region; C:integral component of mitochondrial membrane; C:mitochondrial inner membrane;, F:ATP binding; F:protein serine/threonine kinase activity;, P:lipid homeostasis; P:mitochondrion organization; P:negative regulation of mitochondrial fusion; P:positive regulation of cristae formation;|Q86TW2 B3KUD5 Q6PD65 Q9UIE6,AarF domain-containing protein kinase 1 {ECO:0000303|PubMed:31125351},, PF03109;, GO:0005576;GO:0032592;GO:0005743;GO:0005524;GO:0004674;GO:0055088;GO:0007005;GO:0010637;GO:1903852;, C:extracellular region; C:integral component of mitochondrial membrane; C:mitochondrial inner membrane;, F:ATP binding; F:protein serine/threonine kinase activity;, P:lipid homeostasis; P:mitochondrion organization; P:negative regulation of mitochondrial fusion; P:positive regulation of cristae formation;|Q86TW2 B3KUD5 Q6PD65 Q9UIE6,AarF domain-containing protein kinase 1 {ECO:0000303|PubMed:31125351},, PF03109;, GO:0005576;GO:0032592;GO:0005743;GO:0005524;GO:0004674;GO:0055088;GO:0007005;GO:0010637;GO:1903852;, C:extracellular region; C:integral component of mitochondrial membrane; C:mitochondrial inner membrane;, F:ATP binding; F:protein serine/threonine kinase activity;, P:lipid homeostasis; P:mitochondrion organization; P:negative regulation of mitochondrial fusion; P:positive regulation of cristae formation;|Q86TW2 B3KUD5 Q6PD65 Q9UIE6,AarF domain-containing protein kinase 1 {ECO:0000303|PubMed:31125351},, PF03109;, GO:0005576;GO:0032592;GO:0005743;GO:0005524;GO:0004674;GO:0055088;GO:0007005;GO:0010637;GO:1903852;, C:extracellular region; C:integral component of mitochondrial membrane; C:mitochondrial inner membrane;, F:ATP binding; F:protein serine/threonine kinase activity;, P:lipid homeostasis; P:mitochondrion organization; P:negative regulation of mitochondrial fusion; P:positive regulation of cristae formation; scaffold55 indexed_genome mRNA 2378836 2778602 . + . ID=transcript_10114;Q9HDB5 A5PKW8 A8MPU5 B3KPM7 Q6NUR0 Q8IUD8,Neurexin-3-beta,Neurexin III-beta;, PF02210;PF01034;, GO:0016021;GO:0005886;GO:0050839;GO:0097109;GO:0004888;GO:0030534;GO:0001525;GO:0007612;GO:0007158;GO:0007165;GO:0035176;GO:0071625;, C:integral component of membrane; C:plasma membrane;, F:cell adhesion molecule binding; F:neuroligin family protein binding; F:transmembrane signaling receptor activity;, P:adult behavior; P:angiogenesis; P:learning; P:neuron cell-cell adhesion; P:signal transduction; P:social behavior; P:vocalization behavior;|Q9B2Z0 Q9B2Z4 Q9T6H6 Q9T9Y0 Q9TEH4,Cytochrome b,Complex III subunit 3;Complex III subunit III;Cytochrome b-c1 complex subunit 3;Ubiquinol-cytochrome-c reductase complex cytochrome b subunit;, PF00032;PF00033;, GO:0031305;GO:0005743;GO:0005750;GO:0005739;GO:0046872;GO:0044877;GO:0008121;GO:0031100;GO:0015990;GO:0042538;GO:0006122;GO:0046686;GO:0051592;GO:0033590;GO:0046688;GO:0042493;GO:0045471;GO:0033762;GO:0009408;GO:0055093;GO:0001666;GO:0046689;GO:0009636;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:metal ion binding; F:protein-containing complex binding; F:ubiquinol-cytochrome-c reductase activity;, P:animal organ regeneration; P:electron transport coupled proton transport; P:hyperosmotic salinity response; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:response to cadmium ion; P:response to calcium ion; P:response to cobalamin; P:response to copper ion; P:response to drug; P:response to ethanol; P:response to glucagon; P:response to heat; P:response to hyperoxia; P:response to hypoxia; P:response to mercury ion; P:response to toxic substance;|P00395 Q34770,Cytochrome c oxidase subunit 1,Cytochrome c oxidase polypeptide I;, PF00115;, GO:0016021;GO:0005743;GO:0005750;GO:0005751;GO:0045277;GO:0004129;GO:0020037;GO:0046872;GO:0009060;GO:0007568;GO:0021549;GO:0015990;GO:0006123;GO:0022904;GO:0046688;GO:0051602;GO:0006979;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:heme binding; F:metal ion binding;, P:aerobic respiration; P:aging; P:cerebellum development; P:electron transport coupled proton transport; P:mitochondrial electron transport, cytochrome c to oxygen; P:respiratory electron transport chain; P:response to copper ion; P:response to electrical stimulus; P:response to oxidative stress;|Q9HDB5 A5PKW8 A8MPU5 B3KPM7 Q6NUR0 Q8IUD8,Neurexin-3-beta,Neurexin III-beta;, PF02210;PF01034;, GO:0016021;GO:0005886;GO:0050839;GO:0097109;GO:0004888;GO:0030534;GO:0001525;GO:0007612;GO:0007158;GO:0007165;GO:0035176;GO:0071625;, C:integral component of membrane; C:plasma membrane;, F:cell adhesion molecule binding; F:neuroligin family protein binding; F:transmembrane signaling receptor activity;, P:adult behavior; P:angiogenesis; P:learning; P:neuron cell-cell adhesion; P:signal transduction; P:social behavior; P:vocalization behavior;|P02792 B2R4B9 Q6IBT7 Q7Z2W1 Q86WI9 Q8WU07 Q96AU9 Q96CU0 Q9BTZ8,Ferritin light chain,, PF00210;, GO:0044754;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0008043;GO:0016020;GO:0008199;GO:0008198;GO:0042802;GO:0005506;GO:0006879;GO:0006880;GO:0055072;GO:0006826;GO:0043312;GO:0006892;, C:autolysosome; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular ferritin complex; C:membrane;, F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:iron ion binding;, P:cellular iron ion homeostasis; P:intracellular sequestering of iron ion; P:iron ion homeostasis; P:iron ion transport; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; scaffold55 indexed_genome mRNA 3327177 3362120 . + . ID=transcript_10115;Q6ZU80 B9EK52 Q86X97 Q96ML4,Centrosomal protein of 128 kDa,, , GO:0120103;GO:0005814;GO:0005737;GO:0000922;GO:0008104;, C:centriolar subdistal appendage; C:centriole; C:cytoplasm; C:spindle pole;, , P:protein localization;|Q6ZU80 B9EK52 Q86X97 Q96ML4,Centrosomal protein of 128 kDa,, , GO:0120103;GO:0005814;GO:0005737;GO:0000922;GO:0008104;, C:centriolar subdistal appendage; C:centriole; C:cytoplasm; C:spindle pole;, , P:protein localization; scaffold55 indexed_genome mRNA 3566785 3603039 . - . ID=transcript_10116;Q6ZU80 B9EK52 Q86X97 Q96ML4,Centrosomal protein of 128 kDa,, , GO:0120103;GO:0005814;GO:0005737;GO:0000922;GO:0008104;, C:centriolar subdistal appendage; C:centriole; C:cytoplasm; C:spindle pole;, , P:protein localization; scaffold55 indexed_genome mRNA 3653775 3715582 . - . ID=transcript_10117;Q6ZU80 B9EK52 Q86X97 Q96ML4,Centrosomal protein of 128 kDa,, , GO:0120103;GO:0005814;GO:0005737;GO:0000922;GO:0008104;, C:centriolar subdistal appendage; C:centriole; C:cytoplasm; C:spindle pole;, , P:protein localization; scaffold55 indexed_genome mRNA 3719750 3762245 . - . ID=transcript_10118;Q6ZU80 B9EK52 Q86X97 Q96ML4,Centrosomal protein of 128 kDa,, , GO:0120103;GO:0005814;GO:0005737;GO:0000922;GO:0008104;, C:centriolar subdistal appendage; C:centriole; C:cytoplasm; C:spindle pole;, , P:protein localization; scaffold55 indexed_genome mRNA 4000202 4031519 . - . ID=transcript_10119;P52655 Q3KNQ9,Transcription initiation factor IIA subunit 1,General transcription factor IIA subunit 1;TFIIAL;Transcription initiation factor TFIIA 42 kDa subunit;, PF03153;, GO:0005829;GO:0005654;GO:0005672;GO:0005669;GO:0097550;GO:0003677;GO:0046982;GO:0000979;GO:0016251;GO:0001103;GO:0017025;GO:0008134;GO:0042795;GO:0006366;GO:0006367;, C:cytosol; C:nucleoplasm; C:transcription factor TFIIA complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II repressing transcription factor binding; F:TBP-class protein binding; F:transcription factor binding;, P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P52655 Q3KNQ9,Transcription initiation factor IIA subunit 1,General transcription factor IIA subunit 1;TFIIAL;Transcription initiation factor TFIIA 42 kDa subunit;, PF03153;, GO:0005829;GO:0005654;GO:0005672;GO:0005669;GO:0097550;GO:0003677;GO:0046982;GO:0000979;GO:0016251;GO:0001103;GO:0017025;GO:0008134;GO:0042795;GO:0006366;GO:0006367;, C:cytosol; C:nucleoplasm; C:transcription factor TFIIA complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II repressing transcription factor binding; F:TBP-class protein binding; F:transcription factor binding;, P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P52655 Q3KNQ9,Transcription initiation factor IIA subunit 1,General transcription factor IIA subunit 1;TFIIAL;Transcription initiation factor TFIIA 42 kDa subunit;, PF03153;, GO:0005829;GO:0005654;GO:0005672;GO:0005669;GO:0097550;GO:0003677;GO:0046982;GO:0000979;GO:0016251;GO:0001103;GO:0017025;GO:0008134;GO:0042795;GO:0006366;GO:0006367;, C:cytosol; C:nucleoplasm; C:transcription factor TFIIA complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II repressing transcription factor binding; F:TBP-class protein binding; F:transcription factor binding;, P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold55 indexed_genome mRNA 4094151 4101759 . - . ID=transcript_10120;Q8WXE9 G3V2T7 Q17R24 Q59H11 Q6NT47 Q96RI7 Q96RU6,Stonin-2,Stoned B;, PF00928;PF12016;, GO:0030136;GO:0031410;GO:0005829;GO:0043231;GO:0016020;GO:0043005;GO:0005730;GO:0008021;GO:0035615;GO:0061024;GO:0030100;GO:0048488;GO:0016192;, C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:neuron projection; C:nucleolus; C:synaptic vesicle;, F:clathrin adaptor activity;, P:membrane organization; P:regulation of endocytosis; P:synaptic vesicle endocytosis; P:vesicle-mediated transport;|Q8WXE9 G3V2T7 Q17R24 Q59H11 Q6NT47 Q96RI7 Q96RU6,Stonin-2,Stoned B;, PF00928;PF12016;, GO:0030136;GO:0031410;GO:0005829;GO:0043231;GO:0016020;GO:0043005;GO:0005730;GO:0008021;GO:0035615;GO:0061024;GO:0030100;GO:0048488;GO:0016192;, C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:neuron projection; C:nucleolus; C:synaptic vesicle;, F:clathrin adaptor activity;, P:membrane organization; P:regulation of endocytosis; P:synaptic vesicle endocytosis; P:vesicle-mediated transport; scaffold55 indexed_genome mRNA 4266794 4275077 . - . ID=transcript_10121;Q9UBV2 Q6UWT6 Q9P1T9 Q9UHK7,Protein sel-1 homolog 1,Suppressor of lin-12-like protein 1;, PF00040;PF08238;, GO:0036513;GO:0005783;GO:0005789;GO:0044322;GO:0000836;GO:0000839;GO:0016021;GO:1904380;GO:0036503;GO:0007219;GO:0009306;GO:0050821;GO:0016567;GO:0030970;GO:0055085;GO:0006641;GO:0030433;, C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of membrane;, , P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:Notch signaling pathway; P:protein secretion; P:protein stabilization; P:protein ubiquitination; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:triglyceride metabolic process; P:ubiquitin-dependent ERAD pathway; scaffold55 indexed_genome mRNA 4276338 4324070 . - . ID=transcript_10122;Q9UBV2 Q6UWT6 Q9P1T9 Q9UHK7,Protein sel-1 homolog 1,Suppressor of lin-12-like protein 1;, PF00040;PF08238;, GO:0036513;GO:0005783;GO:0005789;GO:0044322;GO:0000836;GO:0000839;GO:0016021;GO:1904380;GO:0036503;GO:0007219;GO:0009306;GO:0050821;GO:0016567;GO:0030970;GO:0055085;GO:0006641;GO:0030433;, C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of membrane;, , P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:Notch signaling pathway; P:protein secretion; P:protein stabilization; P:protein ubiquitination; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:triglyceride metabolic process; P:ubiquitin-dependent ERAD pathway; scaffold55 indexed_genome mRNA 8376008 8377105 . + . ID=transcript_10123;O43155 A0AV84 B7ZLP3,Leucine-rich repeat transmembrane protein FLRT2,Fibronectin-like domain-containing leucine-rich transmembrane protein 2;, PF13855;PF01463;, GO:0005911;GO:0005789;GO:0070062;GO:0031012;GO:0005615;GO:0005925;GO:0005887;GO:0043005;GO:0005886;GO:0045202;GO:0045499;GO:0005104;GO:0030674;GO:0007411;GO:0071711;GO:0061343;GO:0008543;GO:0003007;GO:0051965;GO:2001222;, C:cell-cell junction; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular matrix; C:extracellular space; C:focal adhesion; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:synapse;, F:chemorepellent activity; F:fibroblast growth factor receptor binding; F:protein-macromolecule adaptor activity;, P:axon guidance; P:basement membrane organization; P:cell adhesion involved in heart morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:heart morphogenesis; P:positive regulation of synapse assembly; P:regulation of neuron migration; scaffold55 indexed_genome mRNA 10591981 10606985 . - . ID=transcript_10124;P54803 B4DKE8 B4DYN1 B4DZJ8 B7Z7Z2 J3KN25 J3KPP8 Q8J030,Galactocerebrosidase {ECO:0000305},Galactocerebroside beta-galactosidase;Galactosylceramidase {ECO:0000303|PubMed:9272171};Galactosylceramide beta-galactosidase;, PF02057;PF17387;, GO:0043202;GO:0005764;GO:0004336;GO:0006683;GO:0006687;GO:0042552;, C:lysosomal lumen; C:lysosome;, F:galactosylceramidase activity;, P:galactosylceramide catabolic process; P:glycosphingolipid metabolic process; P:myelination;|P54803 B4DKE8 B4DYN1 B4DZJ8 B7Z7Z2 J3KN25 J3KPP8 Q8J030,Galactocerebrosidase {ECO:0000305},Galactocerebroside beta-galactosidase;Galactosylceramidase {ECO:0000303|PubMed:9272171};Galactosylceramide beta-galactosidase;, PF02057;PF17387;, GO:0043202;GO:0005764;GO:0004336;GO:0006683;GO:0006687;GO:0042552;, C:lysosomal lumen; C:lysosome;, F:galactosylceramidase activity;, P:galactosylceramide catabolic process; P:glycosphingolipid metabolic process; P:myelination;|P54803 B4DKE8 B4DYN1 B4DZJ8 B7Z7Z2 J3KN25 J3KPP8 Q8J030,Galactocerebrosidase {ECO:0000305},Galactocerebroside beta-galactosidase;Galactosylceramidase {ECO:0000303|PubMed:9272171};Galactosylceramide beta-galactosidase;, PF02057;PF17387;, GO:0043202;GO:0005764;GO:0004336;GO:0006683;GO:0006687;GO:0042552;, C:lysosomal lumen; C:lysosome;, F:galactosylceramidase activity;, P:galactosylceramide catabolic process; P:glycosphingolipid metabolic process; P:myelination;|P54803 B4DKE8 B4DYN1 B4DZJ8 B7Z7Z2 J3KN25 J3KPP8 Q8J030,Galactocerebrosidase {ECO:0000305},Galactocerebroside beta-galactosidase;Galactosylceramidase {ECO:0000303|PubMed:9272171};Galactosylceramide beta-galactosidase;, PF02057;PF17387;, GO:0043202;GO:0005764;GO:0004336;GO:0006683;GO:0006687;GO:0042552;, C:lysosomal lumen; C:lysosome;, F:galactosylceramidase activity;, P:galactosylceramide catabolic process; P:glycosphingolipid metabolic process; P:myelination; scaffold55 indexed_genome mRNA 10671129 10679714 . + . ID=transcript_10125;Q8IYL9 O75819,Psychosine receptor,G-protein coupled receptor 65;T-cell death-associated gene 8 protein;, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0031532;GO:0090630;GO:0007189;GO:0006915;GO:0007186;GO:0006955;GO:0007275;GO:0051482;GO:0035025;GO:0051496;GO:0010447;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:actin cytoskeleton reorganization; P:activation of GTPase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:multicellular organism development; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of Rho protein signal transduction; P:positive regulation of stress fiber assembly; P:response to acidic pH; scaffold55 indexed_genome mRNA 10827908 10909472 . - . ID=transcript_10126;P57789 B2R8T4 B2RCT3 B5TJL4 Q6B014 Q8TDK7 Q8TDK8 Q9HB59,Potassium channel subfamily K member 10,Outward rectifying potassium channel protein TREK-2;TREK-2 K(+) channel subunit;, PF07885;, GO:0005887;GO:0005886;GO:0005267;GO:0022841;GO:0005244;GO:0007613;GO:0071805;GO:0034765;GO:0007165;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane;, F:potassium channel activity; F:potassium ion leak channel activity; F:voltage-gated ion channel activity;, P:memory; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:signal transduction; P:stabilization of membrane potential; scaffold55 indexed_genome mRNA 11042934 11062652 . + . ID=transcript_10127;Q9P0W8 Q5BKY5 Q8WX30 Q96HF3 Q9H0X0 Q9P0W7,Spermatogenesis-associated protein 7,HSD-3.1;Spermatogenesis-associated protein HSD3;, PF15244;, GO:0005930;GO:0036064;GO:0005829;GO:0015630;GO:0005739;GO:0005654;GO:0032391;GO:0120206;GO:0120200;GO:0000226;GO:0045494;GO:1903621;GO:1903546;GO:0050896;GO:0007601;, C:axoneme; C:ciliary basal body; C:cytosol; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:photoreceptor connecting cilium; C:photoreceptor distal connecting cilium; C:rod photoreceptor outer segment;, , P:microtubule cytoskeleton organization; P:photoreceptor cell maintenance; P:protein localization to photoreceptor connecting cilium; P:protein localization to photoreceptor outer segment; P:response to stimulus; P:visual perception;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9P0W8 Q5BKY5 Q8WX30 Q96HF3 Q9H0X0 Q9P0W7,Spermatogenesis-associated protein 7,HSD-3.1;Spermatogenesis-associated protein HSD3;, PF15244;, GO:0005930;GO:0036064;GO:0005829;GO:0015630;GO:0005739;GO:0005654;GO:0032391;GO:0120206;GO:0120200;GO:0000226;GO:0045494;GO:1903621;GO:1903546;GO:0050896;GO:0007601;, C:axoneme; C:ciliary basal body; C:cytosol; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:photoreceptor connecting cilium; C:photoreceptor distal connecting cilium; C:rod photoreceptor outer segment;, , P:microtubule cytoskeleton organization; P:photoreceptor cell maintenance; P:protein localization to photoreceptor connecting cilium; P:protein localization to photoreceptor outer segment; P:response to stimulus; P:visual perception;|Q9P0W8 Q5BKY5 Q8WX30 Q96HF3 Q9H0X0 Q9P0W7,Spermatogenesis-associated protein 7,HSD-3.1;Spermatogenesis-associated protein HSD3;, PF15244;, GO:0005930;GO:0036064;GO:0005829;GO:0015630;GO:0005739;GO:0005654;GO:0032391;GO:0120206;GO:0120200;GO:0000226;GO:0045494;GO:1903621;GO:1903546;GO:0050896;GO:0007601;, C:axoneme; C:ciliary basal body; C:cytosol; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:photoreceptor connecting cilium; C:photoreceptor distal connecting cilium; C:rod photoreceptor outer segment;, , P:microtubule cytoskeleton organization; P:photoreceptor cell maintenance; P:protein localization to photoreceptor connecting cilium; P:protein localization to photoreceptor outer segment; P:response to stimulus; P:visual perception; scaffold55 indexed_genome mRNA 11074747 11075367 . - . ID=transcript_10128;Q16825,Tyrosine-protein phosphatase non-receptor type 21,Protein-tyrosine phosphatase D1;, PF09380;PF00373;PF09379;PF00102;, GO:0005737;GO:0005856;GO:0004725;GO:0006470;, C:cytoplasm; C:cytoskeleton;, F:protein tyrosine phosphatase activity;, P:protein dephosphorylation; scaffold55 indexed_genome mRNA 11156686 11204846 . + . ID=transcript_10129;Q6PUI8 Q86TQ5 Q86TW0 Q86TW1 Q8NCT6 Q8NCZ3 Q8TDE2 Q9HAC9 Q9Y5A0,Zinc finger CCCH domain-containing protein 14,Mammalian suppressor of tau pathology-2;Renal carcinoma antigen NY-REN-37;, , GO:1904115;GO:0005737;GO:0032839;GO:0016607;GO:0005730;GO:0005634;GO:1990904;GO:0046872;GO:0008143;GO:0003723;GO:1900364;GO:0043488;, C:axon cytoplasm; C:cytoplasm; C:dendrite cytoplasm; C:nuclear speck; C:nucleolus; C:nucleus; C:ribonucleoprotein complex;, F:metal ion binding; F:poly(A) binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:regulation of mRNA stability;|Q6PUI8 Q86TQ5 Q86TW0 Q86TW1 Q8NCT6 Q8NCZ3 Q8TDE2 Q9HAC9 Q9Y5A0,Zinc finger CCCH domain-containing protein 14,Mammalian suppressor of tau pathology-2;Renal carcinoma antigen NY-REN-37;, , GO:1904115;GO:0005737;GO:0032839;GO:0016607;GO:0005730;GO:0005634;GO:1990904;GO:0046872;GO:0008143;GO:0003723;GO:1900364;GO:0043488;, C:axon cytoplasm; C:cytoplasm; C:dendrite cytoplasm; C:nuclear speck; C:nucleolus; C:nucleus; C:ribonucleoprotein complex;, F:metal ion binding; F:poly(A) binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:regulation of mRNA stability;|Q6PUI8 Q86TQ5 Q86TW0 Q86TW1 Q8NCT6 Q8NCZ3 Q8TDE2 Q9HAC9 Q9Y5A0,Zinc finger CCCH domain-containing protein 14,Mammalian suppressor of tau pathology-2;Renal carcinoma antigen NY-REN-37;, , GO:1904115;GO:0005737;GO:0032839;GO:0016607;GO:0005730;GO:0005634;GO:1990904;GO:0046872;GO:0008143;GO:0003723;GO:1900364;GO:0043488;, C:axon cytoplasm; C:cytoplasm; C:dendrite cytoplasm; C:nuclear speck; C:nucleolus; C:nucleus; C:ribonucleoprotein complex;, F:metal ion binding; F:poly(A) binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:regulation of mRNA stability;|Q6PUI8 Q86TQ5 Q86TW0 Q86TW1 Q8NCT6 Q8NCZ3 Q8TDE2 Q9HAC9 Q9Y5A0,Zinc finger CCCH domain-containing protein 14,Mammalian suppressor of tau pathology-2;Renal carcinoma antigen NY-REN-37;, , GO:1904115;GO:0005737;GO:0032839;GO:0016607;GO:0005730;GO:0005634;GO:1990904;GO:0046872;GO:0008143;GO:0003723;GO:1900364;GO:0043488;, C:axon cytoplasm; C:cytoplasm; C:dendrite cytoplasm; C:nuclear speck; C:nucleolus; C:nucleus; C:ribonucleoprotein complex;, F:metal ion binding; F:poly(A) binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:regulation of mRNA stability;|Q6PUI8 Q86TQ5 Q86TW0 Q86TW1 Q8NCT6 Q8NCZ3 Q8TDE2 Q9HAC9 Q9Y5A0,Zinc finger CCCH domain-containing protein 14,Mammalian suppressor of tau pathology-2;Renal carcinoma antigen NY-REN-37;, , GO:1904115;GO:0005737;GO:0032839;GO:0016607;GO:0005730;GO:0005634;GO:1990904;GO:0046872;GO:0008143;GO:0003723;GO:1900364;GO:0043488;, C:axon cytoplasm; C:cytoplasm; C:dendrite cytoplasm; C:nuclear speck; C:nucleolus; C:nucleus; C:ribonucleoprotein complex;, F:metal ion binding; F:poly(A) binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:regulation of mRNA stability;|Q6PUI8 Q86TQ5 Q86TW0 Q86TW1 Q8NCT6 Q8NCZ3 Q8TDE2 Q9HAC9 Q9Y5A0,Zinc finger CCCH domain-containing protein 14,Mammalian suppressor of tau pathology-2;Renal carcinoma antigen NY-REN-37;, , GO:1904115;GO:0005737;GO:0032839;GO:0016607;GO:0005730;GO:0005634;GO:1990904;GO:0046872;GO:0008143;GO:0003723;GO:1900364;GO:0043488;, C:axon cytoplasm; C:cytoplasm; C:dendrite cytoplasm; C:nuclear speck; C:nucleolus; C:nucleus; C:ribonucleoprotein complex;, F:metal ion binding; F:poly(A) binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:regulation of mRNA stability;|Q6PUI8 Q86TQ5 Q86TW0 Q86TW1 Q8NCT6 Q8NCZ3 Q8TDE2 Q9HAC9 Q9Y5A0,Zinc finger CCCH domain-containing protein 14,Mammalian suppressor of tau pathology-2;Renal carcinoma antigen NY-REN-37;, , GO:1904115;GO:0005737;GO:0032839;GO:0016607;GO:0005730;GO:0005634;GO:1990904;GO:0046872;GO:0008143;GO:0003723;GO:1900364;GO:0043488;, C:axon cytoplasm; C:cytoplasm; C:dendrite cytoplasm; C:nuclear speck; C:nucleolus; C:nucleus; C:ribonucleoprotein complex;, F:metal ion binding; F:poly(A) binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:regulation of mRNA stability;|Q6PUI8 Q86TQ5 Q86TW0 Q86TW1 Q8NCT6 Q8NCZ3 Q8TDE2 Q9HAC9 Q9Y5A0,Zinc finger CCCH domain-containing protein 14,Mammalian suppressor of tau pathology-2;Renal carcinoma antigen NY-REN-37;, , GO:1904115;GO:0005737;GO:0032839;GO:0016607;GO:0005730;GO:0005634;GO:1990904;GO:0046872;GO:0008143;GO:0003723;GO:1900364;GO:0043488;, C:axon cytoplasm; C:cytoplasm; C:dendrite cytoplasm; C:nuclear speck; C:nucleolus; C:nucleus; C:ribonucleoprotein complex;, F:metal ion binding; F:poly(A) binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:regulation of mRNA stability;|Q6PUI8 Q86TQ5 Q86TW0 Q86TW1 Q8NCT6 Q8NCZ3 Q8TDE2 Q9HAC9 Q9Y5A0,Zinc finger CCCH domain-containing protein 14,Mammalian suppressor of tau pathology-2;Renal carcinoma antigen NY-REN-37;, , GO:1904115;GO:0005737;GO:0032839;GO:0016607;GO:0005730;GO:0005634;GO:1990904;GO:0046872;GO:0008143;GO:0003723;GO:1900364;GO:0043488;, C:axon cytoplasm; C:cytoplasm; C:dendrite cytoplasm; C:nuclear speck; C:nucleolus; C:nucleus; C:ribonucleoprotein complex;, F:metal ion binding; F:poly(A) binding; F:RNA binding;, P:negative regulation of mRNA polyadenylation; P:regulation of mRNA stability;|Q05BV3 B9EK59 Q5H9N6 Q6UYC9 Q6ZRP3 Q6ZT03,Echinoderm microtubule-associated protein-like 5,, PF12894;PF03451;PF00400;, GO:0005737;GO:0070062;GO:0005874;GO:0003824;GO:0008017;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:catalytic activity; F:microtubule binding;|Q05BV3 B9EK59 Q5H9N6 Q6UYC9 Q6ZRP3 Q6ZT03,Echinoderm microtubule-associated protein-like 5,, PF12894;PF03451;PF00400;, GO:0005737;GO:0070062;GO:0005874;GO:0003824;GO:0008017;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:catalytic activity; F:microtubule binding;|Q05BV3 B9EK59 Q5H9N6 Q6UYC9 Q6ZRP3 Q6ZT03,Echinoderm microtubule-associated protein-like 5,, PF12894;PF03451;PF00400;, GO:0005737;GO:0070062;GO:0005874;GO:0003824;GO:0008017;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:catalytic activity; F:microtubule binding;|Q05BV3 B9EK59 Q5H9N6 Q6UYC9 Q6ZRP3 Q6ZT03,Echinoderm microtubule-associated protein-like 5,, PF12894;PF03451;PF00400;, GO:0005737;GO:0070062;GO:0005874;GO:0003824;GO:0008017;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:catalytic activity; F:microtubule binding;|Q05BV3 B9EK59 Q5H9N6 Q6UYC9 Q6ZRP3 Q6ZT03,Echinoderm microtubule-associated protein-like 5,, PF12894;PF03451;PF00400;, GO:0005737;GO:0070062;GO:0005874;GO:0003824;GO:0008017;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:catalytic activity; F:microtubule binding;|Q05BV3 B9EK59 Q5H9N6 Q6UYC9 Q6ZRP3 Q6ZT03,Echinoderm microtubule-associated protein-like 5,, PF12894;PF03451;PF00400;, GO:0005737;GO:0070062;GO:0005874;GO:0003824;GO:0008017;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:catalytic activity; F:microtubule binding; scaffold55 indexed_genome mRNA 11213294 11350646 . + . ID=transcript_10130;Q05BV3 B9EK59 Q5H9N6 Q6UYC9 Q6ZRP3 Q6ZT03,Echinoderm microtubule-associated protein-like 5,, PF12894;PF03451;PF00400;, GO:0005737;GO:0070062;GO:0005874;GO:0003824;GO:0008017;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:catalytic activity; F:microtubule binding;|Q05BV3 B9EK59 Q5H9N6 Q6UYC9 Q6ZRP3 Q6ZT03,Echinoderm microtubule-associated protein-like 5,, PF12894;PF03451;PF00400;, GO:0005737;GO:0070062;GO:0005874;GO:0003824;GO:0008017;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:catalytic activity; F:microtubule binding;|Q05BV3 B9EK59 Q5H9N6 Q6UYC9 Q6ZRP3 Q6ZT03,Echinoderm microtubule-associated protein-like 5,, PF12894;PF03451;PF00400;, GO:0005737;GO:0070062;GO:0005874;GO:0003824;GO:0008017;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:catalytic activity; F:microtubule binding; scaffold55 indexed_genome mRNA 11392594 11432401 . + . ID=transcript_10131;Q8TAM2 A6NFG2 B3KWA5 Q67B97 Q86SY0 Q86TV9 Q86U26 Q8NDH9 Q96DG8,Tetratricopeptide repeat protein 8,Bardet-Biedl syndrome 8 protein;, PF13176;, GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005929;GO:0005829;GO:0097730;GO:0001103;GO:0060271;GO:0048560;GO:1905515;GO:0015031;GO:0050893;, C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytosol; C:non-motile cilium;, F:RNA polymerase II repressing transcription factor binding;, P:cilium assembly; P:establishment of anatomical structure orientation; P:non-motile cilium assembly; P:protein transport; P:sensory processing;|Q8TAM2 A6NFG2 B3KWA5 Q67B97 Q86SY0 Q86TV9 Q86U26 Q8NDH9 Q96DG8,Tetratricopeptide repeat protein 8,Bardet-Biedl syndrome 8 protein;, PF13176;, GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005929;GO:0005829;GO:0097730;GO:0001103;GO:0060271;GO:0048560;GO:1905515;GO:0015031;GO:0050893;, C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytosol; C:non-motile cilium;, F:RNA polymerase II repressing transcription factor binding;, P:cilium assembly; P:establishment of anatomical structure orientation; P:non-motile cilium assembly; P:protein transport; P:sensory processing;|Q8TAM2 A6NFG2 B3KWA5 Q67B97 Q86SY0 Q86TV9 Q86U26 Q8NDH9 Q96DG8,Tetratricopeptide repeat protein 8,Bardet-Biedl syndrome 8 protein;, PF13176;, GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005929;GO:0005829;GO:0097730;GO:0001103;GO:0060271;GO:0048560;GO:1905515;GO:0015031;GO:0050893;, C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytosol; C:non-motile cilium;, F:RNA polymerase II repressing transcription factor binding;, P:cilium assembly; P:establishment of anatomical structure orientation; P:non-motile cilium assembly; P:protein transport; P:sensory processing;|Q8TAM2 A6NFG2 B3KWA5 Q67B97 Q86SY0 Q86TV9 Q86U26 Q8NDH9 Q96DG8,Tetratricopeptide repeat protein 8,Bardet-Biedl syndrome 8 protein;, PF13176;, GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005929;GO:0005829;GO:0097730;GO:0001103;GO:0060271;GO:0048560;GO:1905515;GO:0015031;GO:0050893;, C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytosol; C:non-motile cilium;, F:RNA polymerase II repressing transcription factor binding;, P:cilium assembly; P:establishment of anatomical structure orientation; P:non-motile cilium assembly; P:protein transport; P:sensory processing; scaffold55 indexed_genome mRNA 11442673 11448938 . + . ID=transcript_10132;Q8TAM2 A6NFG2 B3KWA5 Q67B97 Q86SY0 Q86TV9 Q86U26 Q8NDH9 Q96DG8,Tetratricopeptide repeat protein 8,Bardet-Biedl syndrome 8 protein;, PF13176;, GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005929;GO:0005829;GO:0097730;GO:0001103;GO:0060271;GO:0048560;GO:1905515;GO:0015031;GO:0050893;, C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytosol; C:non-motile cilium;, F:RNA polymerase II repressing transcription factor binding;, P:cilium assembly; P:establishment of anatomical structure orientation; P:non-motile cilium assembly; P:protein transport; P:sensory processing;|Q8TAM2 A6NFG2 B3KWA5 Q67B97 Q86SY0 Q86TV9 Q86U26 Q8NDH9 Q96DG8,Tetratricopeptide repeat protein 8,Bardet-Biedl syndrome 8 protein;, PF13176;, GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005929;GO:0005829;GO:0097730;GO:0001103;GO:0060271;GO:0048560;GO:1905515;GO:0015031;GO:0050893;, C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytosol; C:non-motile cilium;, F:RNA polymerase II repressing transcription factor binding;, P:cilium assembly; P:establishment of anatomical structure orientation; P:non-motile cilium assembly; P:protein transport; P:sensory processing;|Q8TAM2 A6NFG2 B3KWA5 Q67B97 Q86SY0 Q86TV9 Q86U26 Q8NDH9 Q96DG8,Tetratricopeptide repeat protein 8,Bardet-Biedl syndrome 8 protein;, PF13176;, GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005929;GO:0005829;GO:0097730;GO:0001103;GO:0060271;GO:0048560;GO:1905515;GO:0015031;GO:0050893;, C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cilium; C:cytosol; C:non-motile cilium;, F:RNA polymerase II repressing transcription factor binding;, P:cilium assembly; P:establishment of anatomical structure orientation; P:non-motile cilium assembly; P:protein transport; P:sensory processing; scaffold55 indexed_genome mRNA 12298122 12465596 . - . ID=transcript_10133;Q9BUY7 B3KT10 B7Z5G9 G3V5G1 Q86T09 Q86TV7 Q8NDQ1,EF-hand calcium-binding domain-containing protein 11,, PF13499;PF13833;, GO:0005509;, , F:calcium ion binding; scaffold55 indexed_genome mRNA 12490705 12540103 . + . ID=transcript_10134;Q9NUW8 Q2HXX4 Q86TV8 Q96BK7 Q9NZM7 Q9NZM8,Tyrosyl-DNA phosphodiesterase 1,, PF06087;, GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0017005;GO:0003690;GO:0004527;GO:0003697;GO:0006281;GO:0006302;GO:0000012;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:3'-tyrosyl-DNA phosphodiesterase activity; F:double-stranded DNA binding; F:exonuclease activity; F:single-stranded DNA binding;, P:DNA repair; P:double-strand break repair; P:single strand break repair;|Q9NUW8 Q2HXX4 Q86TV8 Q96BK7 Q9NZM7 Q9NZM8,Tyrosyl-DNA phosphodiesterase 1,, PF06087;, GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0017005;GO:0003690;GO:0004527;GO:0003697;GO:0006281;GO:0006302;GO:0000012;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:3'-tyrosyl-DNA phosphodiesterase activity; F:double-stranded DNA binding; F:exonuclease activity; F:single-stranded DNA binding;, P:DNA repair; P:double-strand break repair; P:single strand break repair;|Q9NUW8 Q2HXX4 Q86TV8 Q96BK7 Q9NZM7 Q9NZM8,Tyrosyl-DNA phosphodiesterase 1,, PF06087;, GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0017005;GO:0003690;GO:0004527;GO:0003697;GO:0006281;GO:0006302;GO:0000012;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:3'-tyrosyl-DNA phosphodiesterase activity; F:double-stranded DNA binding; F:exonuclease activity; F:single-stranded DNA binding;, P:DNA repair; P:double-strand break repair; P:single strand break repair;|Q9NUW8 Q2HXX4 Q86TV8 Q96BK7 Q9NZM7 Q9NZM8,Tyrosyl-DNA phosphodiesterase 1,, PF06087;, GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0017005;GO:0003690;GO:0004527;GO:0003697;GO:0006281;GO:0006302;GO:0000012;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:3'-tyrosyl-DNA phosphodiesterase activity; F:double-stranded DNA binding; F:exonuclease activity; F:single-stranded DNA binding;, P:DNA repair; P:double-strand break repair; P:single strand break repair; scaffold55 indexed_genome mRNA 12712066 12744115 . - . ID=transcript_10135;Q9H7Z3 B4DH71 Q4G0A7 Q9NWH6,Nuclear exosome regulator NRDE2 {ECO:0000305|PubMed:30842217},Protein NRDE2 homolog {ECO:0000305};, PF08424;, GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0006974;GO:0031048;GO:0000278;GO:1902369;GO:0046833;GO:0016246;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:cellular response to DNA damage stimulus; P:heterochromatin assembly by small RNA; P:mitotic cell cycle; P:negative regulation of RNA catabolic process; P:positive regulation of RNA export from nucleus; P:RNA interference; P:RNA splicing;|P62191 B4DR63 P49014 Q03527 Q6IAW0 Q6NW36 Q96AZ3,26S proteasome regulatory subunit 4,26S proteasome AAA-ATPase subunit RPT2;Proteasome 26S subunit ATPase 1;, PF00004;PF17862;PF16450;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0036402;GO:0003723;GO:0017025;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:1901215;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0006457;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:RNA binding; F:TBP-class protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of neuron death; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein folding; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q9H7Z3 B4DH71 Q4G0A7 Q9NWH6,Nuclear exosome regulator NRDE2 {ECO:0000305|PubMed:30842217},Protein NRDE2 homolog {ECO:0000305};, PF08424;, GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0006974;GO:0031048;GO:0000278;GO:1902369;GO:0046833;GO:0016246;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:cellular response to DNA damage stimulus; P:heterochromatin assembly by small RNA; P:mitotic cell cycle; P:negative regulation of RNA catabolic process; P:positive regulation of RNA export from nucleus; P:RNA interference; P:RNA splicing;|Q9H7Z3 B4DH71 Q4G0A7 Q9NWH6,Nuclear exosome regulator NRDE2 {ECO:0000305|PubMed:30842217},Protein NRDE2 homolog {ECO:0000305};, PF08424;, GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0006974;GO:0031048;GO:0000278;GO:1902369;GO:0046833;GO:0016246;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:cellular response to DNA damage stimulus; P:heterochromatin assembly by small RNA; P:mitotic cell cycle; P:negative regulation of RNA catabolic process; P:positive regulation of RNA export from nucleus; P:RNA interference; P:RNA splicing;|Q9H7Z3 B4DH71 Q4G0A7 Q9NWH6,Nuclear exosome regulator NRDE2 {ECO:0000305|PubMed:30842217},Protein NRDE2 homolog {ECO:0000305};, PF08424;, GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0006974;GO:0031048;GO:0000278;GO:1902369;GO:0046833;GO:0016246;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:cellular response to DNA damage stimulus; P:heterochromatin assembly by small RNA; P:mitotic cell cycle; P:negative regulation of RNA catabolic process; P:positive regulation of RNA export from nucleus; P:RNA interference; P:RNA splicing; scaffold55 indexed_genome mRNA 12744450 12772488 . - . ID=transcript_10136;Q9H7Z3 B4DH71 Q4G0A7 Q9NWH6,Nuclear exosome regulator NRDE2 {ECO:0000305|PubMed:30842217},Protein NRDE2 homolog {ECO:0000305};, PF08424;, GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0006974;GO:0031048;GO:0000278;GO:1902369;GO:0046833;GO:0016246;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:cellular response to DNA damage stimulus; P:heterochromatin assembly by small RNA; P:mitotic cell cycle; P:negative regulation of RNA catabolic process; P:positive regulation of RNA export from nucleus; P:RNA interference; P:RNA splicing;|Q9H7Z3 B4DH71 Q4G0A7 Q9NWH6,Nuclear exosome regulator NRDE2 {ECO:0000305|PubMed:30842217},Protein NRDE2 homolog {ECO:0000305};, PF08424;, GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0006974;GO:0031048;GO:0000278;GO:1902369;GO:0046833;GO:0016246;GO:0008380;, C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, , P:cellular response to DNA damage stimulus; P:heterochromatin assembly by small RNA; P:mitotic cell cycle; P:negative regulation of RNA catabolic process; P:positive regulation of RNA export from nucleus; P:RNA interference; P:RNA splicing; scaffold55 indexed_genome mRNA 12855259 12863030 . + . ID=transcript_10137;Q96HK3,Calmodulin-1 {ECO:0000312|HGNC:HGNC:1442},, PF13499;, GO:0034704;GO:1902494;GO:0005813;GO:0005737;GO:0005829;GO:0005576;GO:0030426;GO:0031966;GO:0043209;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0030017;GO:0005876;GO:0000922;GO:0030672;GO:0031982;GO:0008076;GO:0010856;GO:0008179;GO:0019855;GO:0005509;GO:0048306;GO:0097718;GO:0030234;GO:0044325;GO:0031997;GO:0050998;GO:0030235;GO:0043548;GO:0019904;GO:0019901;GO:0072542;GO:0043539;GO:0031432;GO:0031800;GO:0007190;GO:0016240;GO:0007268;GO:0005513;GO:0090151;GO:0038095;GO:0007186;GO:0000086;GO:0005980;GO:0043647;GO:0000165;GO:1990456;GO:0006936;GO:1901842;GO:0010801;GO:0060315;GO:0140056;GO:0002576;GO:0051343;GO:0043388;GO:0051000;GO:0010800;GO:0032516;GO:0031954;GO:0035307;GO:0071902;GO:0060316;GO:0098901;GO:0055117;GO:0010881;GO:1901844;GO:0032465;GO:0002027;GO:0050999;GO:0010880;GO:0022400;GO:0060314;GO:1900242;GO:2000300;GO:0001975;GO:0051592;GO:0051412;GO:0021762;GO:0046146;GO:0016032;GO:0007223;, C:calcium channel complex; C:catalytic complex; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular region; C:growth cone; C:mitochondrial membrane; C:myelin sheath; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:sarcomere; C:spindle microtubule; C:spindle pole; C:synaptic vesicle membrane; C:vesicle; C:voltage-gated potassium channel complex;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium-dependent protein binding; F:disordered domain specific binding; F:enzyme regulator activity; F:ion channel binding; F:N-terminal myristoylation domain binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase activator activity; F:protein serine/threonine kinase activator activity; F:titin binding; F:type 3 metabotropic glutamate receptor binding;, P:activation of adenylate cyclase activity; P:autophagosome membrane docking; P:chemical synaptic transmission; P:detection of calcium ion; P:establishment of protein localization to mitochondrial membrane; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:glycogen catabolic process; P:inositol phosphate metabolic process; P:MAPK cascade; P:mitochondrion-endoplasmic reticulum membrane tethering; P:muscle contraction; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:organelle localization by membrane tethering; P:platelet degranulation; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of DNA binding; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytokinesis; P:regulation of heart rate; P:regulation of nitric-oxide synthase activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of rhodopsin mediated signaling pathway; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic vesicle endocytosis; P:regulation of synaptic vesicle exocytosis; P:response to amphetamine; P:response to calcium ion; P:response to corticosterone; P:substantia nigra development; P:tetrahydrobiopterin metabolic process; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q96HK3,Calmodulin-1 {ECO:0000312|HGNC:HGNC:1442},, PF13499;, GO:0034704;GO:1902494;GO:0005813;GO:0005737;GO:0005829;GO:0005576;GO:0030426;GO:0031966;GO:0043209;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0030017;GO:0005876;GO:0000922;GO:0030672;GO:0031982;GO:0008076;GO:0010856;GO:0008179;GO:0019855;GO:0005509;GO:0048306;GO:0097718;GO:0030234;GO:0044325;GO:0031997;GO:0050998;GO:0030235;GO:0043548;GO:0019904;GO:0019901;GO:0072542;GO:0043539;GO:0031432;GO:0031800;GO:0007190;GO:0016240;GO:0007268;GO:0005513;GO:0090151;GO:0038095;GO:0007186;GO:0000086;GO:0005980;GO:0043647;GO:0000165;GO:1990456;GO:0006936;GO:1901842;GO:0010801;GO:0060315;GO:0140056;GO:0002576;GO:0051343;GO:0043388;GO:0051000;GO:0010800;GO:0032516;GO:0031954;GO:0035307;GO:0071902;GO:0060316;GO:0098901;GO:0055117;GO:0010881;GO:1901844;GO:0032465;GO:0002027;GO:0050999;GO:0010880;GO:0022400;GO:0060314;GO:1900242;GO:2000300;GO:0001975;GO:0051592;GO:0051412;GO:0021762;GO:0046146;GO:0016032;GO:0007223;, C:calcium channel complex; C:catalytic complex; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular region; C:growth cone; C:mitochondrial membrane; C:myelin sheath; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:sarcomere; C:spindle microtubule; C:spindle pole; C:synaptic vesicle membrane; C:vesicle; C:voltage-gated potassium channel complex;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium-dependent protein binding; F:disordered domain specific binding; F:enzyme regulator activity; F:ion channel binding; F:N-terminal myristoylation domain binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase activator activity; F:protein serine/threonine kinase activator activity; F:titin binding; F:type 3 metabotropic glutamate receptor binding;, P:activation of adenylate cyclase activity; P:autophagosome membrane docking; P:chemical synaptic transmission; P:detection of calcium ion; P:establishment of protein localization to mitochondrial membrane; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:glycogen catabolic process; P:inositol phosphate metabolic process; P:MAPK cascade; P:mitochondrion-endoplasmic reticulum membrane tethering; P:muscle contraction; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:organelle localization by membrane tethering; P:platelet degranulation; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of DNA binding; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytokinesis; P:regulation of heart rate; P:regulation of nitric-oxide synthase activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of rhodopsin mediated signaling pathway; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic vesicle endocytosis; P:regulation of synaptic vesicle exocytosis; P:response to amphetamine; P:response to calcium ion; P:response to corticosterone; P:substantia nigra development; P:tetrahydrobiopterin metabolic process; P:viral process; P:Wnt signaling pathway, calcium modulating pathway; scaffold56 indexed_genome mRNA 3397 99231 . + . ID=transcript_10138;Q9UQR1 D3DN27 O00389 O43591 Q58EY5 Q6PJ98,Zinc finger protein 148,Transcription factor ZBP-89;Zinc finger DNA-binding protein 89;, PF00096;, GO:0005794;GO:0005654;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0006968;GO:0007276;GO:0010629;GO:0000122;GO:0045892;GO:0045944;GO:0065003;GO:0006357;GO:0021762;, C:Golgi apparatus; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:cellular defense response; P:gamete generation; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of transcription by RNA polymerase II; P:substantia nigra development;|Q9UQR1 D3DN27 O00389 O43591 Q58EY5 Q6PJ98,Zinc finger protein 148,Transcription factor ZBP-89;Zinc finger DNA-binding protein 89;, PF00096;, GO:0005794;GO:0005654;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0006968;GO:0007276;GO:0010629;GO:0000122;GO:0045892;GO:0045944;GO:0065003;GO:0006357;GO:0021762;, C:Golgi apparatus; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:cellular defense response; P:gamete generation; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of transcription by RNA polymerase II; P:substantia nigra development; scaffold56 indexed_genome mRNA 314559 361859 . + . ID=transcript_10139;Q9ULI3 Q6NX66 Q8NC40 Q9BSV0,Protein HEG homolog 1,, PF00008;PF07645;, GO:0005911;GO:0009897;GO:0005576;GO:0016021;GO:0005509;GO:0003209;GO:0055017;GO:0007043;GO:0001886;GO:0007507;GO:0001701;GO:0030324;GO:0003017;GO:0001945;GO:0035264;GO:1905709;GO:0035024;GO:2000299;GO:0060039;GO:0090271;GO:0009791;GO:1902414;GO:0050878;GO:0001570;GO:0048845;GO:0003281;GO:0003222;, C:cell-cell junction; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane;, F:calcium ion binding;, P:cardiac atrium morphogenesis; P:cardiac muscle tissue growth; P:cell-cell junction assembly; P:endothelial cell morphogenesis; P:heart development; P:in utero embryonic development; P:lung development; P:lymph circulation; P:lymph vessel development; P:multicellular organism growth; P:negative regulation of membrane permeability; P:negative regulation of Rho protein signal transduction; P:negative regulation of Rho-dependent protein serine/threonine kinase activity; P:pericardium development; P:positive regulation of fibroblast growth factor production; P:post-embryonic development; P:protein localization to cell junction; P:regulation of body fluid levels; P:vasculogenesis; P:venous blood vessel morphogenesis; P:ventricular septum development; P:ventricular trabecula myocardium morphogenesis; scaffold56 indexed_genome mRNA 417895 437509 . + . ID=transcript_10140;Q9H3R2 Q6UWD9 Q9NXT5,Mucin-13,Down-regulated in colon cancer 1;, PF01390;, GO:0016324;GO:0005829;GO:0005615;GO:0005796;GO:0016021;GO:0005886;GO:0042803;GO:0030277;GO:0016266;GO:0002223;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:Golgi lumen; C:integral component of membrane; C:plasma membrane;, F:protein homodimerization activity;, P:maintenance of gastrointestinal epithelium; P:O-glycan processing; P:stimulatory C-type lectin receptor signaling pathway; scaffold56 indexed_genome mRNA 467083 570624 . + . ID=transcript_10141;P18084 B0LPF8 B2RD70,Integrin beta-5,, PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0070062;GO:0005925;GO:0034684;GO:0045335;GO:0005886;GO:0043235;GO:0005178;GO:0038023;GO:0001618;GO:0002479;GO:0033627;GO:0016477;GO:0007160;GO:0035987;GO:0090136;GO:0030198;GO:0007229;GO:0006936;GO:0043149;GO:0007179;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:integrin alphav-beta5 complex; C:phagocytic vesicle; C:plasma membrane; C:receptor complex;, F:integrin binding; F:signaling receptor activity; F:virus receptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:endodermal cell differentiation; P:epithelial cell-cell adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:muscle contraction; P:stress fiber assembly; P:transforming growth factor beta receptor signaling pathway;|P18084 B0LPF8 B2RD70,Integrin beta-5,, PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0070062;GO:0005925;GO:0034684;GO:0045335;GO:0005886;GO:0043235;GO:0005178;GO:0038023;GO:0001618;GO:0002479;GO:0033627;GO:0016477;GO:0007160;GO:0035987;GO:0090136;GO:0030198;GO:0007229;GO:0006936;GO:0043149;GO:0007179;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:integrin alphav-beta5 complex; C:phagocytic vesicle; C:plasma membrane; C:receptor complex;, F:integrin binding; F:signaling receptor activity; F:virus receptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:endodermal cell differentiation; P:epithelial cell-cell adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:muscle contraction; P:stress fiber assembly; P:transforming growth factor beta receptor signaling pathway; scaffold56 indexed_genome mRNA 570692 578341 . + . ID=transcript_10142;P18084 B0LPF8 B2RD70,Integrin beta-5,, PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0070062;GO:0005925;GO:0034684;GO:0045335;GO:0005886;GO:0043235;GO:0005178;GO:0038023;GO:0001618;GO:0002479;GO:0033627;GO:0016477;GO:0007160;GO:0035987;GO:0090136;GO:0030198;GO:0007229;GO:0006936;GO:0043149;GO:0007179;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:integrin alphav-beta5 complex; C:phagocytic vesicle; C:plasma membrane; C:receptor complex;, F:integrin binding; F:signaling receptor activity; F:virus receptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:endodermal cell differentiation; P:epithelial cell-cell adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:muscle contraction; P:stress fiber assembly; P:transforming growth factor beta receptor signaling pathway;|P18084 B0LPF8 B2RD70,Integrin beta-5,, PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0009986;GO:0070062;GO:0005925;GO:0034684;GO:0045335;GO:0005886;GO:0043235;GO:0005178;GO:0038023;GO:0001618;GO:0002479;GO:0033627;GO:0016477;GO:0007160;GO:0035987;GO:0090136;GO:0030198;GO:0007229;GO:0006936;GO:0043149;GO:0007179;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:integrin alphav-beta5 complex; C:phagocytic vesicle; C:plasma membrane; C:receptor complex;, F:integrin binding; F:signaling receptor activity; F:virus receptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:endodermal cell differentiation; P:epithelial cell-cell adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:muscle contraction; P:stress fiber assembly; P:transforming growth factor beta receptor signaling pathway; scaffold56 indexed_genome mRNA 593923 645814 . - . ID=transcript_10143;P11172 B5LY68 B5LY72 O00758 O00759 O00760 Q16862 Q9H3Q2 Q9UG49,Uridine 5'-monophosphate synthase,, PF00215;PF00156;, GO:0005737;GO:0005829;GO:0005634;GO:0042802;GO:0004588;GO:0004590;GO:0006207;GO:0044205;GO:0035690;GO:0007565;GO:0007595;GO:0019856;GO:0046134;GO:0006222;, C:cytoplasm; C:cytosol; C:nucleus;, F:identical protein binding; F:orotate phosphoribosyltransferase activity; F:orotidine-5'-phosphate decarboxylase activity;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:cellular response to drug; P:female pregnancy; P:lactation; P:pyrimidine nucleobase biosynthetic process; P:pyrimidine nucleoside biosynthetic process; P:UMP biosynthetic process;|P11172 B5LY68 B5LY72 O00758 O00759 O00760 Q16862 Q9H3Q2 Q9UG49,Uridine 5'-monophosphate synthase,, PF00215;PF00156;, GO:0005737;GO:0005829;GO:0005634;GO:0042802;GO:0004588;GO:0004590;GO:0006207;GO:0044205;GO:0035690;GO:0007565;GO:0007595;GO:0019856;GO:0046134;GO:0006222;, C:cytoplasm; C:cytosol; C:nucleus;, F:identical protein binding; F:orotate phosphoribosyltransferase activity; F:orotidine-5'-phosphate decarboxylase activity;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:cellular response to drug; P:female pregnancy; P:lactation; P:pyrimidine nucleobase biosynthetic process; P:pyrimidine nucleoside biosynthetic process; P:UMP biosynthetic process; scaffold56 indexed_genome mRNA 652978 654827 . - . ID=transcript_10144;O60229 A8MSI4 C9JQ37 J3QSW6 Q6ZN45 Q8TBQ5 Q9NSZ4 Q9Y2A5,Kalirin {ECO:0000250|UniProtKB:P97924},Huntingtin-associated protein-interacting protein;Protein Duo;Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain;, PF13716;PF00041;PF07679;PF00169;PF00069;PF00621;PF00435;, GO:0015629;GO:0005829;GO:0070062;GO:0005654;GO:0005524;GO:0005085;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0008344;GO:0007411;GO:0007417;GO:0048013;GO:0007186;GO:0046959;GO:0035556;GO:0007595;GO:0042711;GO:0060137;GO:0007613;GO:0060125;GO:0007399;GO:0007528;GO:0043065;GO:0061003;GO:0043547;GO:0006468;GO:0051056;GO:0007165;GO:0035176;GO:0016192;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adult locomotory behavior; P:axon guidance; P:central nervous system development; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:habituation; P:intracellular signal transduction; P:lactation; P:maternal behavior; P:maternal process involved in parturition; P:memory; P:negative regulation of growth hormone secretion; P:nervous system development; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of GTPase activity; P:protein phosphorylation; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:social behavior; P:vesicle-mediated transport; scaffold56 indexed_genome mRNA 686562 687579 . - . ID=transcript_10145;O60229 A8MSI4 C9JQ37 J3QSW6 Q6ZN45 Q8TBQ5 Q9NSZ4 Q9Y2A5,Kalirin {ECO:0000250|UniProtKB:P97924},Huntingtin-associated protein-interacting protein;Protein Duo;Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain;, PF13716;PF00041;PF07679;PF00169;PF00069;PF00621;PF00435;, GO:0015629;GO:0005829;GO:0070062;GO:0005654;GO:0005524;GO:0005085;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0008344;GO:0007411;GO:0007417;GO:0048013;GO:0007186;GO:0046959;GO:0035556;GO:0007595;GO:0042711;GO:0060137;GO:0007613;GO:0060125;GO:0007399;GO:0007528;GO:0043065;GO:0061003;GO:0043547;GO:0006468;GO:0051056;GO:0007165;GO:0035176;GO:0016192;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adult locomotory behavior; P:axon guidance; P:central nervous system development; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:habituation; P:intracellular signal transduction; P:lactation; P:maternal behavior; P:maternal process involved in parturition; P:memory; P:negative regulation of growth hormone secretion; P:nervous system development; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of GTPase activity; P:protein phosphorylation; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:social behavior; P:vesicle-mediated transport; scaffold56 indexed_genome mRNA 690580 765348 . - . ID=transcript_10146;O60229 A8MSI4 C9JQ37 J3QSW6 Q6ZN45 Q8TBQ5 Q9NSZ4 Q9Y2A5,Kalirin {ECO:0000250|UniProtKB:P97924},Huntingtin-associated protein-interacting protein;Protein Duo;Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain;, PF13716;PF00041;PF07679;PF00169;PF00069;PF00621;PF00435;, GO:0015629;GO:0005829;GO:0070062;GO:0005654;GO:0005524;GO:0005085;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0008344;GO:0007411;GO:0007417;GO:0048013;GO:0007186;GO:0046959;GO:0035556;GO:0007595;GO:0042711;GO:0060137;GO:0007613;GO:0060125;GO:0007399;GO:0007528;GO:0043065;GO:0061003;GO:0043547;GO:0006468;GO:0051056;GO:0007165;GO:0035176;GO:0016192;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adult locomotory behavior; P:axon guidance; P:central nervous system development; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:habituation; P:intracellular signal transduction; P:lactation; P:maternal behavior; P:maternal process involved in parturition; P:memory; P:negative regulation of growth hormone secretion; P:nervous system development; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of GTPase activity; P:protein phosphorylation; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:social behavior; P:vesicle-mediated transport;|O60229 A8MSI4 C9JQ37 J3QSW6 Q6ZN45 Q8TBQ5 Q9NSZ4 Q9Y2A5,Kalirin {ECO:0000250|UniProtKB:P97924},Huntingtin-associated protein-interacting protein;Protein Duo;Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain;, PF13716;PF00041;PF07679;PF00169;PF00069;PF00621;PF00435;, GO:0015629;GO:0005829;GO:0070062;GO:0005654;GO:0005524;GO:0005085;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0008344;GO:0007411;GO:0007417;GO:0048013;GO:0007186;GO:0046959;GO:0035556;GO:0007595;GO:0042711;GO:0060137;GO:0007613;GO:0060125;GO:0007399;GO:0007528;GO:0043065;GO:0061003;GO:0043547;GO:0006468;GO:0051056;GO:0007165;GO:0035176;GO:0016192;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adult locomotory behavior; P:axon guidance; P:central nervous system development; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:habituation; P:intracellular signal transduction; P:lactation; P:maternal behavior; P:maternal process involved in parturition; P:memory; P:negative regulation of growth hormone secretion; P:nervous system development; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of GTPase activity; P:protein phosphorylation; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:social behavior; P:vesicle-mediated transport;|O60229 A8MSI4 C9JQ37 J3QSW6 Q6ZN45 Q8TBQ5 Q9NSZ4 Q9Y2A5,Kalirin {ECO:0000250|UniProtKB:P97924},Huntingtin-associated protein-interacting protein;Protein Duo;Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain;, PF13716;PF00041;PF07679;PF00169;PF00069;PF00621;PF00435;, GO:0015629;GO:0005829;GO:0070062;GO:0005654;GO:0005524;GO:0005085;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0008344;GO:0007411;GO:0007417;GO:0048013;GO:0007186;GO:0046959;GO:0035556;GO:0007595;GO:0042711;GO:0060137;GO:0007613;GO:0060125;GO:0007399;GO:0007528;GO:0043065;GO:0061003;GO:0043547;GO:0006468;GO:0051056;GO:0007165;GO:0035176;GO:0016192;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adult locomotory behavior; P:axon guidance; P:central nervous system development; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:habituation; P:intracellular signal transduction; P:lactation; P:maternal behavior; P:maternal process involved in parturition; P:memory; P:negative regulation of growth hormone secretion; P:nervous system development; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of GTPase activity; P:protein phosphorylation; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:social behavior; P:vesicle-mediated transport; scaffold56 indexed_genome mRNA 850413 955976 . - . ID=transcript_10147;O60229 A8MSI4 C9JQ37 J3QSW6 Q6ZN45 Q8TBQ5 Q9NSZ4 Q9Y2A5,Kalirin {ECO:0000250|UniProtKB:P97924},Huntingtin-associated protein-interacting protein;Protein Duo;Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain;, PF13716;PF00041;PF07679;PF00169;PF00069;PF00621;PF00435;, GO:0015629;GO:0005829;GO:0070062;GO:0005654;GO:0005524;GO:0005085;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0008344;GO:0007411;GO:0007417;GO:0048013;GO:0007186;GO:0046959;GO:0035556;GO:0007595;GO:0042711;GO:0060137;GO:0007613;GO:0060125;GO:0007399;GO:0007528;GO:0043065;GO:0061003;GO:0043547;GO:0006468;GO:0051056;GO:0007165;GO:0035176;GO:0016192;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adult locomotory behavior; P:axon guidance; P:central nervous system development; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:habituation; P:intracellular signal transduction; P:lactation; P:maternal behavior; P:maternal process involved in parturition; P:memory; P:negative regulation of growth hormone secretion; P:nervous system development; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of GTPase activity; P:protein phosphorylation; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:social behavior; P:vesicle-mediated transport; scaffold56 indexed_genome mRNA 1017236 1081478 . - . ID=transcript_10148;O60229 A8MSI4 C9JQ37 J3QSW6 Q6ZN45 Q8TBQ5 Q9NSZ4 Q9Y2A5,Kalirin {ECO:0000250|UniProtKB:P97924},Huntingtin-associated protein-interacting protein;Protein Duo;Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain;, PF13716;PF00041;PF07679;PF00169;PF00069;PF00621;PF00435;, GO:0015629;GO:0005829;GO:0070062;GO:0005654;GO:0005524;GO:0005085;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0008344;GO:0007411;GO:0007417;GO:0048013;GO:0007186;GO:0046959;GO:0035556;GO:0007595;GO:0042711;GO:0060137;GO:0007613;GO:0060125;GO:0007399;GO:0007528;GO:0043065;GO:0061003;GO:0043547;GO:0006468;GO:0051056;GO:0007165;GO:0035176;GO:0016192;, C:actin cytoskeleton; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adult locomotory behavior; P:axon guidance; P:central nervous system development; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:habituation; P:intracellular signal transduction; P:lactation; P:maternal behavior; P:maternal process involved in parturition; P:memory; P:negative regulation of growth hormone secretion; P:nervous system development; P:neuromuscular junction development; P:positive regulation of apoptotic process; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of GTPase activity; P:protein phosphorylation; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:social behavior; P:vesicle-mediated transport; scaffold56 indexed_genome mRNA 1381851 1444771 . + . ID=transcript_10149;Q8WUJ8 Q96K47 Q9H9A3 Q9UFH0,Coiled-coil domain-containing protein 14,, PF15254;, GO:0034451;GO:0005813;GO:0005737;GO:0071539;GO:0021762;, C:centriolar satellite; C:centrosome; C:cytoplasm;, , P:protein localization to centrosome; P:substantia nigra development;|Q9BZX4 D3DNA6 Q96BM7,Ropporin-1B,Rhophilin-associated protein 1B;, , GO:0005737;GO:0031514;GO:0046982;GO:0030159;GO:0007340;GO:0098609;GO:0044782;GO:0061640;GO:0030317;GO:0007342;GO:0061512;GO:0001932;GO:0007266;GO:0048240;GO:0007283;, C:cytoplasm; C:motile cilium;, F:protein heterodimerization activity; F:signaling receptor complex adaptor activity;, P:acrosome reaction; P:cell-cell adhesion; P:cilium organization; P:cytoskeleton-dependent cytokinesis; P:flagellated sperm motility; P:fusion of sperm to egg plasma membrane involved in single fertilization; P:protein localization to cilium; P:regulation of protein phosphorylation; P:Rho protein signal transduction; P:sperm capacitation; P:spermatogenesis;|Q8WUJ8 Q96K47 Q9H9A3 Q9UFH0,Coiled-coil domain-containing protein 14,, PF15254;, GO:0034451;GO:0005813;GO:0005737;GO:0071539;GO:0021762;, C:centriolar satellite; C:centrosome; C:cytoplasm;, , P:protein localization to centrosome; P:substantia nigra development; scaffold56 indexed_genome mRNA 1513821 1516729 . + . ID=transcript_10150;Q8NCC5 Q6PIU7 Q86SS4 Q9BQG7,Sugar phosphate exchanger 3,Solute carrier family 37 member 3;, PF07690;, GO:0030176;GO:0022857;GO:0008643;GO:0015712;, C:integral component of endoplasmic reticulum membrane;, F:transmembrane transporter activity;, P:carbohydrate transport; P:hexose phosphate transport; scaffold56 indexed_genome mRNA 1756032 1761316 . + . ID=transcript_10151;Q9UIT9,Myosin light chain kinase, smooth muscle {ECO:0000305},Kinase-related protein;Telokin;, PF00041;PF07679;PF00069;, GO:0015629;GO:0032154;GO:0005737;GO:0005829;GO:0030027;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005516;GO:0046872;GO:0004687;GO:0004672;GO:0060414;GO:0032060;GO:0071476;GO:0006936;GO:0051928;GO:0030335;GO:0090303;GO:0006468;GO:0006939;GO:0014820;, C:actin cytoskeleton; C:cleavage furrow; C:cytoplasm; C:cytosol; C:lamellipodium; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:calmodulin binding; F:metal ion binding; F:myosin light chain kinase activity; F:protein kinase activity;, P:aorta smooth muscle tissue morphogenesis; P:bleb assembly; P:cellular hypotonic response; P:muscle contraction; P:positive regulation of calcium ion transport; P:positive regulation of cell migration; P:positive regulation of wound healing; P:protein phosphorylation; P:smooth muscle contraction; P:tonic smooth muscle contraction;|Q9UIT9,Myosin light chain kinase, smooth muscle {ECO:0000305},Kinase-related protein;Telokin;, PF00041;PF07679;PF00069;, GO:0015629;GO:0032154;GO:0005737;GO:0005829;GO:0030027;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005516;GO:0046872;GO:0004687;GO:0004672;GO:0060414;GO:0032060;GO:0071476;GO:0006936;GO:0051928;GO:0030335;GO:0090303;GO:0006468;GO:0006939;GO:0014820;, C:actin cytoskeleton; C:cleavage furrow; C:cytoplasm; C:cytosol; C:lamellipodium; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:calmodulin binding; F:metal ion binding; F:myosin light chain kinase activity; F:protein kinase activity;, P:aorta smooth muscle tissue morphogenesis; P:bleb assembly; P:cellular hypotonic response; P:muscle contraction; P:positive regulation of calcium ion transport; P:positive regulation of cell migration; P:positive regulation of wound healing; P:protein phosphorylation; P:smooth muscle contraction; P:tonic smooth muscle contraction; scaffold56 indexed_genome mRNA 1762514 1763299 . - . ID=transcript_10152;Q9UIT9,Myosin light chain kinase, smooth muscle {ECO:0000305},Kinase-related protein;Telokin;, PF00041;PF07679;PF00069;, GO:0015629;GO:0032154;GO:0005737;GO:0005829;GO:0030027;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005516;GO:0046872;GO:0004687;GO:0004672;GO:0060414;GO:0032060;GO:0071476;GO:0006936;GO:0051928;GO:0030335;GO:0090303;GO:0006468;GO:0006939;GO:0014820;, C:actin cytoskeleton; C:cleavage furrow; C:cytoplasm; C:cytosol; C:lamellipodium; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:calmodulin binding; F:metal ion binding; F:myosin light chain kinase activity; F:protein kinase activity;, P:aorta smooth muscle tissue morphogenesis; P:bleb assembly; P:cellular hypotonic response; P:muscle contraction; P:positive regulation of calcium ion transport; P:positive regulation of cell migration; P:positive regulation of wound healing; P:protein phosphorylation; P:smooth muscle contraction; P:tonic smooth muscle contraction; scaffold56 indexed_genome mRNA 1790005 1871460 . + . ID=transcript_10153;Q6Y1H2,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 2 {ECO:0000303|PubMed:18554506};Protein-tyrosine phosphatase-like member B {ECO:0000312|HGNC:HGNC:9640};, PF04387;, GO:0005783;GO:0005789;GO:0030176;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0102158;GO:0030497;GO:0035338;GO:0035335;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:fatty acid elongation; P:long-chain fatty-acyl-CoA biosynthetic process; P:peptidyl-tyrosine dephosphorylation; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q6Y1H2,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 2 {ECO:0000303|PubMed:18554506};Protein-tyrosine phosphatase-like member B {ECO:0000312|HGNC:HGNC:9640};, PF04387;, GO:0005783;GO:0005789;GO:0030176;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0102158;GO:0030497;GO:0035338;GO:0035335;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:fatty acid elongation; P:long-chain fatty-acyl-CoA biosynthetic process; P:peptidyl-tyrosine dephosphorylation; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q6Y1H2,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 {ECO:0000305},3-hydroxyacyl-CoA dehydratase 2 {ECO:0000303|PubMed:18554506};Protein-tyrosine phosphatase-like member B {ECO:0000312|HGNC:HGNC:9640};, PF04387;, GO:0005783;GO:0005789;GO:0030176;GO:0102343;GO:0102344;GO:0102345;GO:0018812;GO:0019899;GO:0102158;GO:0030497;GO:0035338;GO:0035335;GO:0030148;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane;, F:3-hydroxy-arachidoyl-CoA dehydratase activity; F:3-hydroxy-behenoyl-CoA dehydratase activity; F:3-hydroxy-lignoceroyl-CoA dehydratase activity; F:3-hydroxyacyl-CoA dehydratase activity; F:enzyme binding; F:very-long-chain 3-hydroxyacyl-CoA dehydratase activity;, P:fatty acid elongation; P:long-chain fatty-acyl-CoA biosynthetic process; P:peptidyl-tyrosine dephosphorylation; P:sphingolipid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold56 indexed_genome mRNA 2033464 2039255 . + . ID=transcript_10154;O95622 B7Z8A6 Q7RTV7 Q8NFM3,Adenylate cyclase type 5,ATP pyrophosphate-lyase 5;Adenylate cyclase type V;Adenylyl cyclase 5;, PF16214;PF06327;PF00211;, GO:0005929;GO:0016021;GO:0005887;GO:0045111;GO:0005886;GO:0004016;GO:0008179;GO:0005524;GO:0046872;GO:0097110;GO:0007190;GO:0034199;GO:0007191;GO:0007189;GO:0007195;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0001973;GO:0007186;GO:0007626;GO:0002862;GO:0050885;GO:0007204;GO:0061178;GO:0003091;, C:cilium; C:integral component of membrane; C:integral component of plasma membrane; C:intermediate filament cytoskeleton; C:plasma membrane;, F:adenylate cyclase activity; F:adenylate cyclase binding; F:ATP binding; F:metal ion binding; F:scaffold protein binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:G protein-coupled adenosine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:locomotory behavior; P:negative regulation of inflammatory response to antigenic stimulus; P:neuromuscular process controlling balance; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:renal water homeostasis; scaffold56 indexed_genome mRNA 2052958 2054083 . + . ID=transcript_10155;O95622 B7Z8A6 Q7RTV7 Q8NFM3,Adenylate cyclase type 5,ATP pyrophosphate-lyase 5;Adenylate cyclase type V;Adenylyl cyclase 5;, PF16214;PF06327;PF00211;, GO:0005929;GO:0016021;GO:0005887;GO:0045111;GO:0005886;GO:0004016;GO:0008179;GO:0005524;GO:0046872;GO:0097110;GO:0007190;GO:0034199;GO:0007191;GO:0007189;GO:0007195;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0001973;GO:0007186;GO:0007626;GO:0002862;GO:0050885;GO:0007204;GO:0061178;GO:0003091;, C:cilium; C:integral component of membrane; C:integral component of plasma membrane; C:intermediate filament cytoskeleton; C:plasma membrane;, F:adenylate cyclase activity; F:adenylate cyclase binding; F:ATP binding; F:metal ion binding; F:scaffold protein binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:G protein-coupled adenosine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:locomotory behavior; P:negative regulation of inflammatory response to antigenic stimulus; P:neuromuscular process controlling balance; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:renal water homeostasis; scaffold56 indexed_genome mRNA 2062005 2066692 . + . ID=transcript_10156;O43306 Q9NR75 Q9UDB0,Adenylate cyclase type 6,ATP pyrophosphate-lyase 6;Adenylate cyclase type VI;Adenylyl cyclase 6 {ECO:0000303|PubMed:17916776};Ca(2+)-inhibitable adenylyl cyclase;, PF16214;PF06327;PF00211;, GO:0005929;GO:0005887;GO:0031226;GO:0016020;GO:0005886;GO:0032420;GO:0004016;GO:0005524;GO:0046872;GO:0019901;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0097746;GO:0006171;GO:0071870;GO:1904322;GO:0071377;GO:0071380;GO:1904117;GO:0007212;GO:0007186;GO:0002862;GO:0010977;GO:0035811;GO:0003091;, C:cilium; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane; C:stereocilium;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:blood vessel diameter maintenance; P:cAMP biosynthetic process; P:cellular response to catecholamine stimulus; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to vasopressin; P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron projection development; P:negative regulation of urine volume; P:renal water homeostasis; scaffold56 indexed_genome mRNA 2066710 2067345 . - . ID=transcript_10157;O43306 Q9NR75 Q9UDB0,Adenylate cyclase type 6,ATP pyrophosphate-lyase 6;Adenylate cyclase type VI;Adenylyl cyclase 6 {ECO:0000303|PubMed:17916776};Ca(2+)-inhibitable adenylyl cyclase;, PF16214;PF06327;PF00211;, GO:0005929;GO:0005887;GO:0031226;GO:0016020;GO:0005886;GO:0032420;GO:0004016;GO:0005524;GO:0046872;GO:0019901;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0097746;GO:0006171;GO:0071870;GO:1904322;GO:0071377;GO:0071380;GO:1904117;GO:0007212;GO:0007186;GO:0002862;GO:0010977;GO:0035811;GO:0003091;, C:cilium; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane; C:stereocilium;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein kinase C binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:blood vessel diameter maintenance; P:cAMP biosynthetic process; P:cellular response to catecholamine stimulus; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to vasopressin; P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron projection development; P:negative regulation of urine volume; P:renal water homeostasis; scaffold56 indexed_genome mRNA 2067355 2067979 . - . ID=transcript_10158;O95622 B7Z8A6 Q7RTV7 Q8NFM3,Adenylate cyclase type 5,ATP pyrophosphate-lyase 5;Adenylate cyclase type V;Adenylyl cyclase 5;, PF16214;PF06327;PF00211;, GO:0005929;GO:0016021;GO:0005887;GO:0045111;GO:0005886;GO:0004016;GO:0008179;GO:0005524;GO:0046872;GO:0097110;GO:0007190;GO:0034199;GO:0007191;GO:0007189;GO:0007195;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0001973;GO:0007186;GO:0007626;GO:0002862;GO:0050885;GO:0007204;GO:0061178;GO:0003091;, C:cilium; C:integral component of membrane; C:integral component of plasma membrane; C:intermediate filament cytoskeleton; C:plasma membrane;, F:adenylate cyclase activity; F:adenylate cyclase binding; F:ATP binding; F:metal ion binding; F:scaffold protein binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:G protein-coupled adenosine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:locomotory behavior; P:negative regulation of inflammatory response to antigenic stimulus; P:neuromuscular process controlling balance; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:renal water homeostasis; scaffold56 indexed_genome mRNA 2069569 2071585 . - . ID=transcript_10159;O95622 B7Z8A6 Q7RTV7 Q8NFM3,Adenylate cyclase type 5,ATP pyrophosphate-lyase 5;Adenylate cyclase type V;Adenylyl cyclase 5;, PF16214;PF06327;PF00211;, GO:0005929;GO:0016021;GO:0005887;GO:0045111;GO:0005886;GO:0004016;GO:0008179;GO:0005524;GO:0046872;GO:0097110;GO:0007190;GO:0034199;GO:0007191;GO:0007189;GO:0007195;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0001973;GO:0007186;GO:0007626;GO:0002862;GO:0050885;GO:0007204;GO:0061178;GO:0003091;, C:cilium; C:integral component of membrane; C:integral component of plasma membrane; C:intermediate filament cytoskeleton; C:plasma membrane;, F:adenylate cyclase activity; F:adenylate cyclase binding; F:ATP binding; F:metal ion binding; F:scaffold protein binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:G protein-coupled adenosine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:locomotory behavior; P:negative regulation of inflammatory response to antigenic stimulus; P:neuromuscular process controlling balance; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:renal water homeostasis; scaffold56 indexed_genome mRNA 2072020 2072839 . - . ID=transcript_10160;O95622 B7Z8A6 Q7RTV7 Q8NFM3,Adenylate cyclase type 5,ATP pyrophosphate-lyase 5;Adenylate cyclase type V;Adenylyl cyclase 5;, PF16214;PF06327;PF00211;, GO:0005929;GO:0016021;GO:0005887;GO:0045111;GO:0005886;GO:0004016;GO:0008179;GO:0005524;GO:0046872;GO:0097110;GO:0007190;GO:0034199;GO:0007191;GO:0007189;GO:0007195;GO:0007193;GO:0006171;GO:1904322;GO:0071377;GO:0001973;GO:0007186;GO:0007626;GO:0002862;GO:0050885;GO:0007204;GO:0061178;GO:0003091;, C:cilium; C:integral component of membrane; C:integral component of plasma membrane; C:intermediate filament cytoskeleton; C:plasma membrane;, F:adenylate cyclase activity; F:adenylate cyclase binding; F:ATP binding; F:metal ion binding; F:scaffold protein binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:G protein-coupled adenosine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:locomotory behavior; P:negative regulation of inflammatory response to antigenic stimulus; P:neuromuscular process controlling balance; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:renal water homeostasis; scaffold56 indexed_genome mRNA 2097570 2153216 . - . ID=transcript_10161;Q96IW7 B2RE26 Q9Y682,Vesicle-trafficking protein SEC22a,SEC22 vesicle-trafficking protein homolog A;SEC22 vesicle-trafficking protein-like 2;, PF13774;, GO:0005789;GO:0016021;GO:0005215;GO:0006888;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:transporter activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport;|Q96IW7 B2RE26 Q9Y682,Vesicle-trafficking protein SEC22a,SEC22 vesicle-trafficking protein homolog A;SEC22 vesicle-trafficking protein-like 2;, PF13774;, GO:0005789;GO:0016021;GO:0005215;GO:0006888;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:transporter activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; scaffold56 indexed_genome mRNA 2227707 2302941 . - . ID=transcript_10162;Q14554 D3DN95 Q9BV43,Protein disulfide-isomerase A5,Protein disulfide isomerase-related protein;, PF00085;, GO:0005788;GO:0005789;GO:0016491;GO:0015037;GO:0003756;GO:0036498;GO:0006457;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane;, F:oxidoreductase activity; F:peptide disulfide oxidoreductase activity; F:protein disulfide isomerase activity;, P:IRE1-mediated unfolded protein response; P:protein folding;|Q14554 D3DN95 Q9BV43,Protein disulfide-isomerase A5,Protein disulfide isomerase-related protein;, PF00085;, GO:0005788;GO:0005789;GO:0016491;GO:0015037;GO:0003756;GO:0036498;GO:0006457;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane;, F:oxidoreductase activity; F:peptide disulfide oxidoreductase activity; F:protein disulfide isomerase activity;, P:IRE1-mediated unfolded protein response; P:protein folding;|Q14554 D3DN95 Q9BV43,Protein disulfide-isomerase A5,Protein disulfide isomerase-related protein;, PF00085;, GO:0005788;GO:0005789;GO:0016491;GO:0015037;GO:0003756;GO:0036498;GO:0006457;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane;, F:oxidoreductase activity; F:peptide disulfide oxidoreductase activity; F:protein disulfide isomerase activity;, P:IRE1-mediated unfolded protein response; P:protein folding; scaffold56 indexed_genome mRNA 2373061 2489170 . + . ID=transcript_10163;Q9P283 A8K5U2 B7Z393 F8W9U8 Q6DD89 Q6UY12 Q9NW17,Semaphorin-5B,, PF01437;PF01403;PF00090;, GO:0016021;GO:0045499;GO:0030215;GO:0048675;GO:0007411;GO:0050908;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:integral component of membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:detection of light stimulus involved in visual perception; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold56 indexed_genome mRNA 2489182 2500300 . + . ID=transcript_10164;Q9P283 A8K5U2 B7Z393 F8W9U8 Q6DD89 Q6UY12 Q9NW17,Semaphorin-5B,, PF01437;PF01403;PF00090;, GO:0016021;GO:0045499;GO:0030215;GO:0048675;GO:0007411;GO:0050908;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:integral component of membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:detection of light stimulus involved in visual perception; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold56 indexed_genome mRNA 2502484 2503495 . - . ID=transcript_10165;Q9P283 A8K5U2 B7Z393 F8W9U8 Q6DD89 Q6UY12 Q9NW17,Semaphorin-5B,, PF01437;PF01403;PF00090;, GO:0016021;GO:0045499;GO:0030215;GO:0048675;GO:0007411;GO:0050908;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:integral component of membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:detection of light stimulus involved in visual perception; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold56 indexed_genome mRNA 2530841 2616601 . - . ID=transcript_10166;Q96SL1 A8K561 Q8NBX9,Solute carrier family 49 member 4 {ECO:0000305},Disrupted in renal cancer protein 2;Disrupted in renal carcinoma protein 2 {ECO:0000303|PubMed:21692750};, , GO:0016021;GO:0043231;GO:0005765;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;|Q96SL1 A8K561 Q8NBX9,Solute carrier family 49 member 4 {ECO:0000305},Disrupted in renal cancer protein 2;Disrupted in renal carcinoma protein 2 {ECO:0000303|PubMed:21692750};, , GO:0016021;GO:0043231;GO:0005765;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; scaffold56 indexed_genome mRNA 2616845 2670639 . + . ID=transcript_10167;Q96EW2 Q6P476 Q8N8J4 Q8NHH6 Q8WWF0,HSPB1-associated protein 1,27 kDa heat shock protein-associated protein 1;Protein associated with small stress protein 1;, PF13621;, GO:0005737;GO:0016706;, C:cytoplasm;, F:2-oxoglutarate-dependent dioxygenase activity;|Q96EW2 Q6P476 Q8N8J4 Q8NHH6 Q8WWF0,HSPB1-associated protein 1,27 kDa heat shock protein-associated protein 1;Protein associated with small stress protein 1;, PF13621;, GO:0005737;GO:0016706;, C:cytoplasm;, F:2-oxoglutarate-dependent dioxygenase activity; scaffold56 indexed_genome mRNA 2670657 2672741 . + . ID=transcript_10168;Q96EW2 Q6P476 Q8N8J4 Q8NHH6 Q8WWF0,HSPB1-associated protein 1,27 kDa heat shock protein-associated protein 1;Protein associated with small stress protein 1;, PF13621;, GO:0005737;GO:0016706;, C:cytoplasm;, F:2-oxoglutarate-dependent dioxygenase activity; scaffold56 indexed_genome mRNA 2679834 2728558 . - . ID=transcript_10169;Q460N5 B4E2H0 Q460N4 Q8J027 Q9H9X9 Q9NV60 Q9ULF2,Protein mono-ADP-ribosyltransferase PARP14 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 8 {ECO:0000303|PubMed:20106667};B aggressive lymphoma protein 2 {ECO:0000303|PubMed:16061477};Poly [ADP-ribose] polymerase 14 {ECO:0000303|PubMed:20106667};, PF01661;PF00644;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0019899;GO:0003950;GO:0070403;GO:1990404;GO:0003714;GO:0045087;GO:0010629;GO:0060336;GO:0042532;GO:1902216;GO:0042531;GO:0006471;GO:0140289;GO:0070212;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:protein ADP-ribosylase activity; F:transcription corepressor activity;, P:innate immune response; P:negative regulation of gene expression; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of interleukin-4-mediated signaling pathway; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein poly-ADP-ribosylation;|Q460N5 B4E2H0 Q460N4 Q8J027 Q9H9X9 Q9NV60 Q9ULF2,Protein mono-ADP-ribosyltransferase PARP14 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 8 {ECO:0000303|PubMed:20106667};B aggressive lymphoma protein 2 {ECO:0000303|PubMed:16061477};Poly [ADP-ribose] polymerase 14 {ECO:0000303|PubMed:20106667};, PF01661;PF00644;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0019899;GO:0003950;GO:0070403;GO:1990404;GO:0003714;GO:0045087;GO:0010629;GO:0060336;GO:0042532;GO:1902216;GO:0042531;GO:0006471;GO:0140289;GO:0070212;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:protein ADP-ribosylase activity; F:transcription corepressor activity;, P:innate immune response; P:negative regulation of gene expression; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of interleukin-4-mediated signaling pathway; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein poly-ADP-ribosylation;|Q460N5 B4E2H0 Q460N4 Q8J027 Q9H9X9 Q9NV60 Q9ULF2,Protein mono-ADP-ribosyltransferase PARP14 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 8 {ECO:0000303|PubMed:20106667};B aggressive lymphoma protein 2 {ECO:0000303|PubMed:16061477};Poly [ADP-ribose] polymerase 14 {ECO:0000303|PubMed:20106667};, PF01661;PF00644;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0019899;GO:0003950;GO:0070403;GO:1990404;GO:0003714;GO:0045087;GO:0010629;GO:0060336;GO:0042532;GO:1902216;GO:0042531;GO:0006471;GO:0140289;GO:0070212;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:protein ADP-ribosylase activity; F:transcription corepressor activity;, P:innate immune response; P:negative regulation of gene expression; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of interleukin-4-mediated signaling pathway; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein poly-ADP-ribosylation; scaffold56 indexed_genome mRNA 2742431 2751399 . - . ID=transcript_10170;Q8TDB6 B3KWH6 Q53ZZ3 Q5MJP7,E3 ubiquitin-protein ligase DTX3L,B-lymphoma- and BAL-associated protein;Protein deltex-3-like;RING-type E3 ubiquitin transferase DTX3L {ECO:0000305};Rhysin-2;, PF18102;, GO:0005737;GO:0005829;GO:0031901;GO:0005765;GO:0005764;GO:0005654;GO:0005634;GO:0032991;GO:0008047;GO:0019899;GO:0004857;GO:0042393;GO:0046872;GO:0097677;GO:0061630;GO:0044389;GO:0004842;GO:0006974;GO:0051607;GO:0006302;GO:0008333;GO:0033522;GO:0033523;GO:0010390;GO:0045087;GO:0051444;GO:0007219;GO:0035563;GO:0002230;GO:2001034;GO:1901666;GO:0032092;GO:1902966;GO:1900182;GO:2000646;GO:0045893;GO:0051865;GO:0070936;GO:0000209;GO:0015031;GO:0016567;GO:0006511;GO:0016032;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:lysosomal membrane; C:lysosome; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:enzyme activator activity; F:enzyme binding; F:enzyme inhibitor activity; F:histone binding; F:metal ion binding; F:STAT family protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:defense response to virus; P:double-strand break repair; P:endosome to lysosome transport; P:histone H2A ubiquitination; P:histone H2B ubiquitination; P:histone monoubiquitination; P:innate immune response; P:negative regulation of ubiquitin-protein transferase activity; P:Notch signaling pathway; P:positive regulation of chromatin binding; P:positive regulation of defense response to virus by host; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of NAD+ ADP-ribosyltransferase activity; P:positive regulation of protein binding; P:positive regulation of protein localization to early endosome; P:positive regulation of protein localization to nucleus; P:positive regulation of receptor catabolic process; P:positive regulation of transcription, DNA-templated; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein transport; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold56 indexed_genome mRNA 2759619 2781156 . + . ID=transcript_10171;Q8IXQ6 A8KA94 B2R8S9 E9PFM7 Q8TCP3 Q9BZL8 Q9BZL9,Protein mono-ADP-ribosyltransferase PARP9 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 9;B aggressive lymphoma protein {ECO:0000303|PubMed:11110709};Poly [ADP-ribose] polymerase 9;, PF01661;, GO:0005737;GO:0005829;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0090734;GO:0072570;GO:0019899;GO:0004857;GO:0042393;GO:0003950;GO:1990404;GO:0097677;GO:0003714;GO:0044389;GO:0016477;GO:0051607;GO:0006302;GO:0045087;GO:0034356;GO:0043086;GO:0010629;GO:0000122;GO:0035563;GO:0002230;GO:2001034;GO:0060335;GO:1900182;GO:0045893;GO:0042531;GO:0010608;GO:0006471;GO:0140289;GO:0060330;GO:0019082;, C:cytoplasm; C:cytosol; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:site of DNA damage;, F:ADP-D-ribose binding; F:enzyme binding; F:enzyme inhibitor activity; F:histone binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:STAT family protein binding; F:transcription corepressor activity; F:ubiquitin-like protein ligase binding;, P:cell migration; P:defense response to virus; P:double-strand break repair; P:innate immune response; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of catalytic activity; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chromatin binding; P:positive regulation of defense response to virus by host; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription, DNA-templated; P:positive regulation of tyrosine phosphorylation of STAT protein; P:posttranscriptional regulation of gene expression; P:protein ADP-ribosylation; P:protein mono-ADP-ribosylation; P:regulation of response to interferon-gamma; P:viral protein processing; scaffold56 indexed_genome mRNA 2789042 2863719 . + . ID=transcript_10172;P52294 D3DN93 Q6IBQ9 Q9BQ56,Importin subunit alpha-5,Karyopherin subunit alpha-1;Nucleoprotein interactor 1;RAG cohort protein 2;SRP1-beta;, PF00514;PF16186;PF01749;, GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0043657;GO:0005643;GO:0005654;GO:0005634;GO:0014069;GO:0061608;GO:0008139;GO:0006309;GO:0075733;GO:0019054;GO:0006607;GO:0099527;GO:0042981;GO:0060828;GO:0000018;GO:0014901;GO:0014841;, C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:host cell; C:nuclear pore; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:apoptotic DNA fragmentation; P:intracellular transport of virus; P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:postsynapse to nucleus signaling pathway; P:regulation of apoptotic process; P:regulation of canonical Wnt signaling pathway; P:regulation of DNA recombination; P:satellite cell activation involved in skeletal muscle regeneration; P:skeletal muscle satellite cell proliferation;|P52294 D3DN93 Q6IBQ9 Q9BQ56,Importin subunit alpha-5,Karyopherin subunit alpha-1;Nucleoprotein interactor 1;RAG cohort protein 2;SRP1-beta;, PF00514;PF16186;PF01749;, GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0043657;GO:0005643;GO:0005654;GO:0005634;GO:0014069;GO:0061608;GO:0008139;GO:0006309;GO:0075733;GO:0019054;GO:0006607;GO:0099527;GO:0042981;GO:0060828;GO:0000018;GO:0014901;GO:0014841;, C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:host cell; C:nuclear pore; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding;, P:apoptotic DNA fragmentation; P:intracellular transport of virus; P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:postsynapse to nucleus signaling pathway; P:regulation of apoptotic process; P:regulation of canonical Wnt signaling pathway; P:regulation of DNA recombination; P:satellite cell activation involved in skeletal muscle regeneration; P:skeletal muscle satellite cell proliferation; scaffold56 indexed_genome mRNA 2873526 2877605 . + . ID=transcript_10173;P45880 Q5VWK1 Q5VWK3 Q6IB40 Q7L3J5 Q9BWK8 Q9Y5I6,Voltage-dependent anion-selective channel protein 2,Outer mitochondrial membrane protein porin 2;, PF01459;, GO:0001669;GO:0016020;GO:0045121;GO:0031966;GO:0042645;GO:0005741;GO:0005739;GO:0005634;GO:0046930;GO:0008021;GO:0097001;GO:0015485;GO:0000166;GO:0031210;GO:0015288;GO:0008308;GO:0006820;GO:0007339;GO:0097345;GO:2001243;GO:0032272;, C:acrosomal vesicle; C:membrane; C:membrane raft; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:pore complex; C:synaptic vesicle;, F:ceramide binding; F:cholesterol binding; F:nucleotide binding; F:phosphatidylcholine binding; F:porin activity; F:voltage-gated anion channel activity;, P:anion transport; P:binding of sperm to zona pellucida; P:mitochondrial outer membrane permeabilization; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of protein polymerization; scaffold56 indexed_genome mRNA 2913256 2961149 . + . ID=transcript_10174;Q4VC31 Q32LY6,Protein MIX23 {ECO:0000305},Coiled-coil domain-containing protein 58;, PF09774;, GO:0005739;, C:mitochondrion;|Q4VC31 Q32LY6,Protein MIX23 {ECO:0000305},Coiled-coil domain-containing protein 58;, PF09774;, GO:0005739;, C:mitochondrion;|Q4VC31 Q32LY6,Protein MIX23 {ECO:0000305},Coiled-coil domain-containing protein 58;, PF09774;, GO:0005739;, C:mitochondrion; scaffold56 indexed_genome mRNA 2984861 2986021 . - . ID=transcript_10175;P41180 Q13912 Q16108 Q16109 Q16110 Q16379 Q2M1T0 Q4PJ19,Extracellular calcium-sensing receptor {ECO:0000305},Parathyroid cell calcium-sensing receptor 1 {ECO:0000303|PubMed:8698326};, PF00003;PF01094;PF07562;, GO:0016324;GO:0043679;GO:0016323;GO:0009986;GO:0005737;GO:0005887;GO:0043025;GO:0005634;GO:0005886;GO:0016597;GO:0005509;GO:0004930;GO:0005178;GO:0044325;GO:0004435;GO:0042803;GO:0019901;GO:0007193;GO:0009653;GO:0006915;GO:0032782;GO:0048754;GO:0070509;GO:0006874;GO:0071333;GO:0035729;GO:0071456;GO:0071404;GO:1901653;GO:0071305;GO:0007635;GO:1902476;GO:0005513;GO:0060613;GO:0007186;GO:0007254;GO:0001503;GO:0007200;GO:0032781;GO:0090280;GO:0008284;GO:0070374;GO:0010628;GO:0032024;GO:0050927;GO:0045907;GO:0051924;GO:0071774;GO:0002931;GO:0042311;, C:apical plasma membrane; C:axon terminus; C:basolateral plasma membrane; C:cell surface; C:cytoplasm; C:integral component of plasma membrane; C:neuronal cell body; C:nucleus; C:plasma membrane;, F:amino acid binding; F:calcium ion binding; F:G protein-coupled receptor activity; F:integrin binding; F:ion channel binding; F:phosphatidylinositol phospholipase C activity; F:protein homodimerization activity; F:protein kinase binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:anatomical structure morphogenesis; P:apoptotic process; P:bile acid secretion; P:branching morphogenesis of an epithelial tube; P:calcium ion import; P:cellular calcium ion homeostasis; P:cellular response to glucose stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hypoxia; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to peptide; P:cellular response to vitamin D; P:chemosensory behavior; P:chloride transmembrane transport; P:detection of calcium ion; P:fat pad development; P:G protein-coupled receptor signaling pathway; P:JNK cascade; P:ossification; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of ATPase activity; P:positive regulation of calcium ion import; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of insulin secretion; P:positive regulation of positive chemotaxis; P:positive regulation of vasoconstriction; P:regulation of calcium ion transport; P:response to fibroblast growth factor; P:response to ischemia; P:vasodilation; scaffold56 indexed_genome mRNA 3187175 3205680 . + . ID=transcript_10176;Q86SU0 Q6ZP61 Q7Z578,Immunoglobulin-like domain-containing receptor 1,, PF05624;, GO:0005829;GO:0016021;GO:0005886;GO:0032991;GO:0061689;GO:0070506;GO:0042802;GO:1990830;GO:0090277;, C:cytosol; C:integral component of membrane; C:plasma membrane; C:protein-containing complex; C:tricellular tight junction;, F:high-density lipoprotein particle receptor activity; F:identical protein binding;, P:cellular response to leukemia inhibitory factor; P:positive regulation of peptide hormone secretion; scaffold56 indexed_genome mRNA 3205709 3219140 . + . ID=transcript_10177;Q86SU0 Q6ZP61 Q7Z578,Immunoglobulin-like domain-containing receptor 1,, PF05624;, GO:0005829;GO:0016021;GO:0005886;GO:0032991;GO:0061689;GO:0070506;GO:0042802;GO:1990830;GO:0090277;, C:cytosol; C:integral component of membrane; C:plasma membrane; C:protein-containing complex; C:tricellular tight junction;, F:high-density lipoprotein particle receptor activity; F:identical protein binding;, P:cellular response to leukemia inhibitory factor; P:positive regulation of peptide hormone secretion; scaffold56 indexed_genome mRNA 3323305 3362287 . - . ID=transcript_10178;Q16348 A8K1A5 B4E2A7,Solute carrier family 15 member 2 {ECO:0000305},Kidney H(+)/peptide cotransporter {ECO:0000250|UniProtKB:P46029};Oligopeptide transporter, kidney isoform {ECO:0000250|UniProtKB:P46029};Peptide transporter 2 {ECO:0000303|PubMed:7756356};, PF00854;, GO:0016324;GO:0070062;GO:0005887;GO:0005886;GO:0044214;GO:0071916;GO:0015333;GO:0140206;GO:0042938;GO:0045087;GO:0006811;GO:0015835;GO:0015031;GO:0070424;GO:0070293;GO:0150104;GO:1990961;GO:0042908;, C:apical plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:spanning component of plasma membrane;, F:dipeptide transmembrane transporter activity; F:peptide:proton symporter activity;, P:dipeptide import across plasma membrane; P:dipeptide transport; P:innate immune response; P:ion transport; P:peptidoglycan transport; P:protein transport; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:renal absorption; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane; P:xenobiotic transport;|Q16348 A8K1A5 B4E2A7,Solute carrier family 15 member 2 {ECO:0000305},Kidney H(+)/peptide cotransporter {ECO:0000250|UniProtKB:P46029};Oligopeptide transporter, kidney isoform {ECO:0000250|UniProtKB:P46029};Peptide transporter 2 {ECO:0000303|PubMed:7756356};, PF00854;, GO:0016324;GO:0070062;GO:0005887;GO:0005886;GO:0044214;GO:0071916;GO:0015333;GO:0140206;GO:0042938;GO:0045087;GO:0006811;GO:0015835;GO:0015031;GO:0070424;GO:0070293;GO:0150104;GO:1990961;GO:0042908;, C:apical plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:spanning component of plasma membrane;, F:dipeptide transmembrane transporter activity; F:peptide:proton symporter activity;, P:dipeptide import across plasma membrane; P:dipeptide transport; P:innate immune response; P:ion transport; P:peptidoglycan transport; P:protein transport; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:renal absorption; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane; P:xenobiotic transport;|Q16348 A8K1A5 B4E2A7,Solute carrier family 15 member 2 {ECO:0000305},Kidney H(+)/peptide cotransporter {ECO:0000250|UniProtKB:P46029};Oligopeptide transporter, kidney isoform {ECO:0000250|UniProtKB:P46029};Peptide transporter 2 {ECO:0000303|PubMed:7756356};, PF00854;, GO:0016324;GO:0070062;GO:0005887;GO:0005886;GO:0044214;GO:0071916;GO:0015333;GO:0140206;GO:0042938;GO:0045087;GO:0006811;GO:0015835;GO:0015031;GO:0070424;GO:0070293;GO:0150104;GO:1990961;GO:0042908;, C:apical plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:spanning component of plasma membrane;, F:dipeptide transmembrane transporter activity; F:peptide:proton symporter activity;, P:dipeptide import across plasma membrane; P:dipeptide transport; P:innate immune response; P:ion transport; P:peptidoglycan transport; P:protein transport; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:renal absorption; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane; P:xenobiotic transport;|Q16348 A8K1A5 B4E2A7,Solute carrier family 15 member 2 {ECO:0000305},Kidney H(+)/peptide cotransporter {ECO:0000250|UniProtKB:P46029};Oligopeptide transporter, kidney isoform {ECO:0000250|UniProtKB:P46029};Peptide transporter 2 {ECO:0000303|PubMed:7756356};, PF00854;, GO:0016324;GO:0070062;GO:0005887;GO:0005886;GO:0044214;GO:0071916;GO:0015333;GO:0140206;GO:0042938;GO:0045087;GO:0006811;GO:0015835;GO:0015031;GO:0070424;GO:0070293;GO:0150104;GO:1990961;GO:0042908;, C:apical plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:spanning component of plasma membrane;, F:dipeptide transmembrane transporter activity; F:peptide:proton symporter activity;, P:dipeptide import across plasma membrane; P:dipeptide transport; P:innate immune response; P:ion transport; P:peptidoglycan transport; P:protein transport; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:renal absorption; P:transport across blood-brain barrier; P:xenobiotic detoxification by transmembrane export across the plasma membrane; P:xenobiotic transport; scaffold56 indexed_genome mRNA 3370687 3416823 . - . ID=transcript_10179;Q96CJ1 Q9NZ82,ELL-associated factor 2,Testosterone-regulated apoptosis inducer and tumor suppressor protein;, PF09816;, GO:0016607;GO:0005654;GO:0032783;GO:0008023;GO:0003711;GO:0006915;GO:0045944;GO:0034243;GO:0006366;GO:0006368;, C:nuclear speck; C:nucleoplasm; C:super elongation complex; C:transcription elongation factor complex;, F:transcription elongation regulator activity;, P:apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription elongation from RNA polymerase II promoter; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold56 indexed_genome mRNA 3542976 5315501 . + . ID=transcript_10180;Q14789 B2ZZ91 D3DN92 E7EP74 F1T0J2 Q14398,Golgin subfamily B member 1,372 kDa Golgi complex-associated protein;Giantin;Macrogolgin;, , GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0016020;GO:0003723;GO:0043565;GO:0006888;GO:0007030;GO:0006892;GO:1905793;GO:0006355;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane; C:membrane;, F:RNA binding; F:sequence-specific DNA binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:post-Golgi vesicle-mediated transport; P:protein localization to pericentriolar material; P:regulation of transcription, DNA-templated;|Q14789 B2ZZ91 D3DN92 E7EP74 F1T0J2 Q14398,Golgin subfamily B member 1,372 kDa Golgi complex-associated protein;Giantin;Macrogolgin;, , GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0016020;GO:0003723;GO:0043565;GO:0006888;GO:0007030;GO:0006892;GO:1905793;GO:0006355;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane; C:membrane;, F:RNA binding; F:sequence-specific DNA binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:post-Golgi vesicle-mediated transport; P:protein localization to pericentriolar material; P:regulation of transcription, DNA-templated;|Q14789 B2ZZ91 D3DN92 E7EP74 F1T0J2 Q14398,Golgin subfamily B member 1,372 kDa Golgi complex-associated protein;Giantin;Macrogolgin;, , GO:0005801;GO:0005829;GO:0005793;GO:0005794;GO:0000139;GO:0005795;GO:0016021;GO:0016020;GO:0003723;GO:0043565;GO:0006888;GO:0007030;GO:0006892;GO:1905793;GO:0006355;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:integral component of membrane; C:membrane;, F:RNA binding; F:sequence-specific DNA binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:post-Golgi vesicle-mediated transport; P:protein localization to pericentriolar material; P:regulation of transcription, DNA-templated;|Q9UH90 B2RAX7 Q32M70 Q9ULM5,F-box only protein 40,Muscle disease-related protein;, PF15966;PF15965;, GO:0005737;GO:0005829;GO:0061630;GO:0008270;GO:0042692;GO:0043687;GO:0000209;, C:cytoplasm; C:cytosol;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:muscle cell differentiation; P:post-translational protein modification; P:protein polyubiquitination;|P14317 B4DQ69 Q53Y93 Q6IBK9 Q9UDK0,Hematopoietic lineage cell-specific protein,Hematopoietic cell-specific LYN substrate 1;LckBP1;p75;, PF02218;PF00018;, GO:0030864;GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0005886;GO:0030427;GO:0005667;GO:0051015;GO:0019901;GO:0001085;GO:0017124;GO:0030041;GO:0071345;GO:0030218;GO:0035556;GO:2000107;GO:0000122;GO:2000251;GO:0008284;GO:0051091;GO:0030854;GO:0045651;GO:0033138;GO:0050731;GO:0014068;GO:0042307;GO:0051897;GO:0045944;GO:0042531;GO:0030833;GO:0006355;GO:0009725;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:plasma membrane; C:site of polarized growth; C:transcription regulator complex;, F:actin filament binding; F:protein kinase binding; F:RNA polymerase II transcription factor binding; F:SH3 domain binding;, P:actin filament polymerization; P:cellular response to cytokine stimulus; P:erythrocyte differentiation; P:intracellular signal transduction; P:negative regulation of leukocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of granulocyte differentiation; P:positive regulation of macrophage differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of actin filament polymerization; P:regulation of transcription, DNA-templated; P:response to hormone;|O75417 O95160 Q6VMB5,DNA polymerase theta {ECO:0000303|PubMed:10395804, ECO:0000303|PubMed:14576298, ECO:0000312|HGNC:HGNC:9186},DNA polymerase eta {ECO:0000303|Ref.4};, PF00270;PF00476;PF00271;, GO:0005694;GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0008409;GO:0051575;GO:0005524;GO:0003682;GO:0003684;GO:0003887;GO:0042802;GO:0017116;GO:0006284;GO:0006974;GO:0006281;GO:0006261;GO:0006302;GO:0097681;GO:0000724;GO:2000042;GO:0051260;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:5'-3' exonuclease activity; F:5'-deoxyribose-5-phosphate lyase activity; F:ATP binding; F:chromatin binding; F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:identical protein binding; F:single-stranded DNA helicase activity;, P:base-excision repair; P:cellular response to DNA damage stimulus; P:DNA repair; P:DNA-dependent DNA replication; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via homologous recombination; P:negative regulation of double-strand break repair via homologous recombination; P:protein homooligomerization; P:somatic hypermutation of immunoglobulin genes;|O75417 O95160 Q6VMB5,DNA polymerase theta {ECO:0000303|PubMed:10395804, ECO:0000303|PubMed:14576298, ECO:0000312|HGNC:HGNC:9186},DNA polymerase eta {ECO:0000303|Ref.4};, PF00270;PF00476;PF00271;, GO:0005694;GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0008409;GO:0051575;GO:0005524;GO:0003682;GO:0003684;GO:0003887;GO:0042802;GO:0017116;GO:0006284;GO:0006974;GO:0006281;GO:0006261;GO:0006302;GO:0097681;GO:0000724;GO:2000042;GO:0051260;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:5'-3' exonuclease activity; F:5'-deoxyribose-5-phosphate lyase activity; F:ATP binding; F:chromatin binding; F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:identical protein binding; F:single-stranded DNA helicase activity;, P:base-excision repair; P:cellular response to DNA damage stimulus; P:DNA repair; P:DNA-dependent DNA replication; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via homologous recombination; P:negative regulation of double-strand break repair via homologous recombination; P:protein homooligomerization; P:somatic hypermutation of immunoglobulin genes;|O75417 O95160 Q6VMB5,DNA polymerase theta {ECO:0000303|PubMed:10395804, ECO:0000303|PubMed:14576298, ECO:0000312|HGNC:HGNC:9186},DNA polymerase eta {ECO:0000303|Ref.4};, PF00270;PF00476;PF00271;, GO:0005694;GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0008409;GO:0051575;GO:0005524;GO:0003682;GO:0003684;GO:0003887;GO:0042802;GO:0017116;GO:0006284;GO:0006974;GO:0006281;GO:0006261;GO:0006302;GO:0097681;GO:0000724;GO:2000042;GO:0051260;GO:0016446;, C:chromosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:5'-3' exonuclease activity; F:5'-deoxyribose-5-phosphate lyase activity; F:ATP binding; F:chromatin binding; F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:identical protein binding; F:single-stranded DNA helicase activity;, P:base-excision repair; P:cellular response to DNA damage stimulus; P:DNA repair; P:DNA-dependent DNA replication; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via homologous recombination; P:negative regulation of double-strand break repair via homologous recombination; P:protein homooligomerization; P:somatic hypermutation of immunoglobulin genes;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|Q9Y2K9 Q4G1B4 Q6PIC3,Syntaxin-binding protein 5-like,Lethal(2) giant larvae protein homolog 4;Tomosyn-2;, PF08596;PF08366;PF00400;, GO:0005737;GO:0031594;GO:0098992;GO:0005886;GO:0031201;GO:0005096;GO:0045159;GO:0019905;GO:0006887;GO:0042593;GO:0046676;GO:0015031;GO:0017157;GO:0050708;GO:2000300;, C:cytoplasm; C:neuromuscular junction; C:neuronal dense core vesicle; C:plasma membrane; C:SNARE complex;, F:GTPase activator activity; F:myosin II binding; F:syntaxin binding;, P:exocytosis; P:glucose homeostasis; P:negative regulation of insulin secretion; P:protein transport; P:regulation of exocytosis; P:regulation of protein secretion; P:regulation of synaptic vesicle exocytosis;|P29083 Q16103,General transcription factor IIE subunit 1,General transcription factor IIE 56 kDa subunit;Transcription initiation factor IIE subunit alpha;, PF08271;PF11521;PF02002;, GO:0005829;GO:0005654;GO:0005634;GO:0005669;GO:0005673;GO:0097550;GO:0046872;GO:0016251;GO:0042795;GO:0006366;GO:0006367;GO:0001113;GO:0016032;, C:cytosol; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFIIE complex; C:transcription preinitiation complex;, F:metal ion binding; F:RNA polymerase II general transcription initiation factor activity;, P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:transcription open complex formation at RNA polymerase II promoter; P:viral process;|Q5HYI8 Q8WUD3,Rab-like protein 3,, , GO:0012505;GO:0005525;GO:0003924;GO:0042803;GO:0030183;GO:0006886;GO:0001779;GO:0050821;GO:1903059;GO:0046578;GO:0033077;, C:endomembrane system;, F:GTP binding; F:GTPase activity; F:protein homodimerization activity;, P:B cell differentiation; P:intracellular protein transport; P:natural killer cell differentiation; P:protein stabilization; P:regulation of protein lipidation; P:regulation of Ras protein signal transduction; P:T cell differentiation in thymus;|Q5HYI8 Q8WUD3,Rab-like protein 3,, , GO:0012505;GO:0005525;GO:0003924;GO:0042803;GO:0030183;GO:0006886;GO:0001779;GO:0050821;GO:1903059;GO:0046578;GO:0033077;, C:endomembrane system;, F:GTP binding; F:GTPase activity; F:protein homodimerization activity;, P:B cell differentiation; P:intracellular protein transport; P:natural killer cell differentiation; P:protein stabilization; P:regulation of protein lipidation; P:regulation of Ras protein signal transduction; P:T cell differentiation in thymus;|Q5HYI8 Q8WUD3,Rab-like protein 3,, , GO:0012505;GO:0005525;GO:0003924;GO:0042803;GO:0030183;GO:0006886;GO:0001779;GO:0050821;GO:1903059;GO:0046578;GO:0033077;, C:endomembrane system;, F:GTP binding; F:GTPase activity; F:protein homodimerization activity;, P:B cell differentiation; P:intracellular protein transport; P:natural killer cell differentiation; P:protein stabilization; P:regulation of protein lipidation; P:regulation of Ras protein signal transduction; P:T cell differentiation in thymus;|Q5HYI8 Q8WUD3,Rab-like protein 3,, , GO:0012505;GO:0005525;GO:0003924;GO:0042803;GO:0030183;GO:0006886;GO:0001779;GO:0050821;GO:1903059;GO:0046578;GO:0033077;, C:endomembrane system;, F:GTP binding; F:GTPase activity; F:protein homodimerization activity;, P:B cell differentiation; P:intracellular protein transport; P:natural killer cell differentiation; P:protein stabilization; P:regulation of protein lipidation; P:regulation of Ras protein signal transduction; P:T cell differentiation in thymus;|Q5HYI8 Q8WUD3,Rab-like protein 3,, , GO:0012505;GO:0005525;GO:0003924;GO:0042803;GO:0030183;GO:0006886;GO:0001779;GO:0050821;GO:1903059;GO:0046578;GO:0033077;, C:endomembrane system;, F:GTP binding; F:GTPase activity; F:protein homodimerization activity;, P:B cell differentiation; P:intracellular protein transport; P:natural killer cell differentiation; P:protein stabilization; P:regulation of protein lipidation; P:regulation of Ras protein signal transduction; P:T cell differentiation in thymus;|Q5HYI8 Q8WUD3,Rab-like protein 3,, , GO:0012505;GO:0005525;GO:0003924;GO:0042803;GO:0030183;GO:0006886;GO:0001779;GO:0050821;GO:1903059;GO:0046578;GO:0033077;, C:endomembrane system;, F:GTP binding; F:GTPase activity; F:protein homodimerization activity;, P:B cell differentiation; P:intracellular protein transport; P:natural killer cell differentiation; P:protein stabilization; P:regulation of protein lipidation; P:regulation of Ras protein signal transduction; P:T cell differentiation in thymus;|Q5HYI8 Q8WUD3,Rab-like protein 3,, , GO:0012505;GO:0005525;GO:0003924;GO:0042803;GO:0030183;GO:0006886;GO:0001779;GO:0050821;GO:1903059;GO:0046578;GO:0033077;, C:endomembrane system;, F:GTP binding; F:GTPase activity; F:protein homodimerization activity;, P:B cell differentiation; P:intracellular protein transport; P:natural killer cell differentiation; P:protein stabilization; P:regulation of protein lipidation; P:regulation of Ras protein signal transduction; P:T cell differentiation in thymus;|Q93099 A8K417 B2R8Z0,Homogentisate 1,2-dioxygenase,Homogentisate oxygenase;Homogentisic acid oxidase;Homogentisicase;, PF04209;, GO:0005737;GO:0005829;GO:0070062;GO:0004411;GO:0042802;GO:0046872;GO:0006559;GO:0006572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:homogentisate 1,2-dioxygenase activity; F:identical protein binding; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|Q93099 A8K417 B2R8Z0,Homogentisate 1,2-dioxygenase,Homogentisate oxygenase;Homogentisic acid oxidase;Homogentisicase;, PF04209;, GO:0005737;GO:0005829;GO:0070062;GO:0004411;GO:0042802;GO:0046872;GO:0006559;GO:0006572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:homogentisate 1,2-dioxygenase activity; F:identical protein binding; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|Q93099 A8K417 B2R8Z0,Homogentisate 1,2-dioxygenase,Homogentisate oxygenase;Homogentisic acid oxidase;Homogentisicase;, PF04209;, GO:0005737;GO:0005829;GO:0070062;GO:0004411;GO:0042802;GO:0046872;GO:0006559;GO:0006572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:homogentisate 1,2-dioxygenase activity; F:identical protein binding; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|Q93099 A8K417 B2R8Z0,Homogentisate 1,2-dioxygenase,Homogentisate oxygenase;Homogentisic acid oxidase;Homogentisicase;, PF04209;, GO:0005737;GO:0005829;GO:0070062;GO:0004411;GO:0042802;GO:0046872;GO:0006559;GO:0006572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:homogentisate 1,2-dioxygenase activity; F:identical protein binding; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|Q93099 A8K417 B2R8Z0,Homogentisate 1,2-dioxygenase,Homogentisate oxygenase;Homogentisic acid oxidase;Homogentisicase;, PF04209;, GO:0005737;GO:0005829;GO:0070062;GO:0004411;GO:0042802;GO:0046872;GO:0006559;GO:0006572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:homogentisate 1,2-dioxygenase activity; F:identical protein binding; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|Q93099 A8K417 B2R8Z0,Homogentisate 1,2-dioxygenase,Homogentisate oxygenase;Homogentisic acid oxidase;Homogentisicase;, PF04209;, GO:0005737;GO:0005829;GO:0070062;GO:0004411;GO:0042802;GO:0046872;GO:0006559;GO:0006572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:homogentisate 1,2-dioxygenase activity; F:identical protein binding; F:metal ion binding;, P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|O95168 B2RUY3 B9EJC7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,Complex I-B15;NADH-ubiquinone oxidoreductase B15 subunit;, PF07225;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0008137;GO:0006120;GO:0032981;GO:0006979;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to oxidative stress;|O95168 B2RUY3 B9EJC7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,Complex I-B15;NADH-ubiquinone oxidoreductase B15 subunit;, PF07225;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0008137;GO:0006120;GO:0032981;GO:0006979;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to oxidative stress;|O95168 B2RUY3 B9EJC7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,Complex I-B15;NADH-ubiquinone oxidoreductase B15 subunit;, PF07225;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0008137;GO:0006120;GO:0032981;GO:0006979;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to oxidative stress;|Q12841 A8K523 B4DTT5 D3DN90 Q549Z0,Follistatin-related protein 1,Follistatin-like protein 1;, PF09289;PF07648;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0008201;GO:0030154;GO:0044267;GO:0045446;GO:0043542;GO:0061484;GO:0007275;GO:0043066;GO:0043687;GO:0030510;GO:0038098;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:heparin binding;, P:cell differentiation; P:cellular protein metabolic process; P:endothelial cell differentiation; P:endothelial cell migration; P:hematopoietic stem cell homeostasis; P:multicellular organism development; P:negative regulation of apoptotic process; P:post-translational protein modification; P:regulation of BMP signaling pathway; P:sequestering of BMP from receptor via BMP binding;|Q12841 A8K523 B4DTT5 D3DN90 Q549Z0,Follistatin-related protein 1,Follistatin-like protein 1;, PF09289;PF07648;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0008201;GO:0030154;GO:0044267;GO:0045446;GO:0043542;GO:0061484;GO:0007275;GO:0043066;GO:0043687;GO:0030510;GO:0038098;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:heparin binding;, P:cell differentiation; P:cellular protein metabolic process; P:endothelial cell differentiation; P:endothelial cell migration; P:hematopoietic stem cell homeostasis; P:multicellular organism development; P:negative regulation of apoptotic process; P:post-translational protein modification; P:regulation of BMP signaling pathway; P:sequestering of BMP from receptor via BMP binding;|Q12841 A8K523 B4DTT5 D3DN90 Q549Z0,Follistatin-related protein 1,Follistatin-like protein 1;, PF09289;PF07648;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0008201;GO:0030154;GO:0044267;GO:0045446;GO:0043542;GO:0061484;GO:0007275;GO:0043066;GO:0043687;GO:0030510;GO:0038098;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:heparin binding;, P:cell differentiation; P:cellular protein metabolic process; P:endothelial cell differentiation; P:endothelial cell migration; P:hematopoietic stem cell homeostasis; P:multicellular organism development; P:negative regulation of apoptotic process; P:post-translational protein modification; P:regulation of BMP signaling pathway; P:sequestering of BMP from receptor via BMP binding;|Q12841 A8K523 B4DTT5 D3DN90 Q549Z0,Follistatin-related protein 1,Follistatin-like protein 1;, PF09289;PF07648;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0008201;GO:0030154;GO:0044267;GO:0045446;GO:0043542;GO:0061484;GO:0007275;GO:0043066;GO:0043687;GO:0030510;GO:0038098;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:heparin binding;, P:cell differentiation; P:cellular protein metabolic process; P:endothelial cell differentiation; P:endothelial cell migration; P:hematopoietic stem cell homeostasis; P:multicellular organism development; P:negative regulation of apoptotic process; P:post-translational protein modification; P:regulation of BMP signaling pathway; P:sequestering of BMP from receptor via BMP binding;|Q12841 A8K523 B4DTT5 D3DN90 Q549Z0,Follistatin-related protein 1,Follistatin-like protein 1;, PF09289;PF07648;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0008201;GO:0030154;GO:0044267;GO:0045446;GO:0043542;GO:0061484;GO:0007275;GO:0043066;GO:0043687;GO:0030510;GO:0038098;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:heparin binding;, P:cell differentiation; P:cellular protein metabolic process; P:endothelial cell differentiation; P:endothelial cell migration; P:hematopoietic stem cell homeostasis; P:multicellular organism development; P:negative regulation of apoptotic process; P:post-translational protein modification; P:regulation of BMP signaling pathway; P:sequestering of BMP from receptor via BMP binding;|Q96CX6,Leucine-rich repeat-containing protein 58,, PF13855;|Q8NFN8 B7ZL66 E9PFZ4 Q14CM1 Q86SN6,Probable G-protein coupled receptor 156,G-protein coupled receptor PGR28;GABAB-related G-protein coupled receptor;, PF00003;, GO:0038039;GO:0005886;GO:0004965;GO:0004888;GO:0007214;, C:G protein-coupled receptor heterodimeric complex; C:plasma membrane;, F:G protein-coupled GABA receptor activity; F:transmembrane signaling receptor activity;, P:gamma-aminobutyric acid signaling pathway;|Q8NFN8 B7ZL66 E9PFZ4 Q14CM1 Q86SN6,Probable G-protein coupled receptor 156,G-protein coupled receptor PGR28;GABAB-related G-protein coupled receptor;, PF00003;, GO:0038039;GO:0005886;GO:0004965;GO:0004888;GO:0007214;, C:G protein-coupled receptor heterodimeric complex; C:plasma membrane;, F:G protein-coupled GABA receptor activity; F:transmembrane signaling receptor activity;, P:gamma-aminobutyric acid signaling pathway;|Q8NFN8 B7ZL66 E9PFZ4 Q14CM1 Q86SN6,Probable G-protein coupled receptor 156,G-protein coupled receptor PGR28;GABAB-related G-protein coupled receptor;, PF00003;, GO:0038039;GO:0005886;GO:0004965;GO:0004888;GO:0007214;, C:G protein-coupled receptor heterodimeric complex; C:plasma membrane;, F:G protein-coupled GABA receptor activity; F:transmembrane signaling receptor activity;, P:gamma-aminobutyric acid signaling pathway;|Q8NFN8 B7ZL66 E9PFZ4 Q14CM1 Q86SN6,Probable G-protein coupled receptor 156,G-protein coupled receptor PGR28;GABAB-related G-protein coupled receptor;, PF00003;, GO:0038039;GO:0005886;GO:0004965;GO:0004888;GO:0007214;, C:G protein-coupled receptor heterodimeric complex; C:plasma membrane;, F:G protein-coupled GABA receptor activity; F:transmembrane signaling receptor activity;, P:gamma-aminobutyric acid signaling pathway;|P49841 D3DN89 Q9BWH3 Q9UL47,Glycogen synthase kinase-3 beta,Serine/threonine-protein kinase GSK3B;, PF00069;, GO:0030424;GO:0030877;GO:0005813;GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0098794;GO:1990909;GO:0005524;GO:0008013;GO:0034452;GO:0016301;GO:0051059;GO:0002039;GO:0002020;GO:0034236;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0001085;GO:0048156;GO:0050321;GO:0031625;GO:1904885;GO:1904886;GO:1904646;GO:0036016;GO:0007623;GO:0007212;GO:0001837;GO:0006983;GO:0030010;GO:0060079;GO:0097191;GO:0097192;GO:0005977;GO:0021766;GO:0008286;GO:0035556;GO:0030011;GO:0043066;GO:0070885;GO:0090090;GO:1904339;GO:1902042;GO:2000466;GO:0045719;GO:1901215;GO:0032515;GO:1901984;GO:0032091;GO:1900181;GO:0031333;GO:2000077;GO:0031175;GO:0106027;GO:0018105;GO:0018107;GO:0010508;GO:0001954;GO:0010628;GO:0043547;GO:1901030;GO:0010822;GO:1901216;GO:0032436;GO:0032092;GO:0045732;GO:0046827;GO:1904781;GO:0031334;GO:0046777;GO:0006468;GO:0030516;GO:0050770;GO:1900034;GO:0042752;GO:0048814;GO:1900271;GO:0150101;GO:0070507;GO:0032886;GO:0010975;GO:2000300;GO:0007165;GO:0071109;GO:0019082;GO:0016055;, C:axon; C:beta-catenin destruction complex; C:centrosome; C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynapse; C:Wnt signalosome;, F:ATP binding; F:beta-catenin binding; F:dynactin binding; F:kinase activity; F:NF-kappaB binding; F:p53 binding; F:protease binding; F:protein kinase A catalytic subunit binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II transcription factor binding; F:tau protein binding; F:tau-protein kinase activity; F:ubiquitin protein ligase binding;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cellular response to amyloid-beta; P:cellular response to interleukin-3; P:circadian rhythm; P:dopamine receptor signaling pathway; P:epithelial to mesenchymal transition; P:ER overload response; P:establishment of cell polarity; P:excitatory postsynaptic potential; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glycogen metabolic process; P:hippocampus development; P:insulin receptor signaling pathway; P:intracellular signal transduction; P:maintenance of cell polarity; P:negative regulation of apoptotic process; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of dopaminergic neuron differentiation; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of neuron death; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein acetylation; P:negative regulation of protein binding; P:negative regulation of protein localization to nucleus; P:negative regulation of protein-containing complex assembly; P:negative regulation of type B pancreatic cell development; P:neuron projection development; P:neuron projection organization; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell-matrix adhesion; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of mitochondrion organization; P:positive regulation of neuron death; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:positive regulation of protein export from nucleus; P:positive regulation of protein localization to centrosome; P:positive regulation of protein-containing complex assembly; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axon extension; P:regulation of axonogenesis; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of dendrite morphogenesis; P:regulation of long-term synaptic potentiation; P:regulation of microtubule anchoring at centrosome; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule-based process; P:regulation of neuron projection development; P:regulation of synaptic vesicle exocytosis; P:signal transduction; P:superior temporal gyrus development; P:viral protein processing; P:Wnt signaling pathway;|Q9UJ27 Q9UNW4,Nuclear receptor subfamily 1 group I member 2,Orphan nuclear receptor PAR1;Orphan nuclear receptor PXR;Pregnane X receptor;Steroid and xenobiotic receptor;, PF00104;PF00105;, GO:0000785;GO:0045111;GO:0016604;GO:0005654;GO:0001228;GO:0000981;GO:0008144;GO:0004879;GO:0016922;GO:0000978;GO:0000977;GO:1990837;GO:0008270;GO:0030154;GO:0042738;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0006355;GO:0007165;GO:0008202;GO:0006367;GO:0006805;GO:0042908;, C:chromatin; C:intermediate filament cytoskeleton; C:nuclear body; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:drug binding; F:nuclear receptor activity; F:nuclear receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell differentiation; P:exogenous drug catabolic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:signal transduction; P:steroid metabolic process; P:transcription initiation from RNA polymerase II promoter; P:xenobiotic metabolic process; P:xenobiotic transport;|Q9UJ27 Q9UNW4,Nuclear receptor subfamily 1 group I member 2,Orphan nuclear receptor PAR1;Orphan nuclear receptor PXR;Pregnane X receptor;Steroid and xenobiotic receptor;, PF00104;PF00105;, GO:0000785;GO:0045111;GO:0016604;GO:0005654;GO:0001228;GO:0000981;GO:0008144;GO:0004879;GO:0016922;GO:0000978;GO:0000977;GO:1990837;GO:0008270;GO:0030154;GO:0042738;GO:0000122;GO:0045892;GO:0045944;GO:0045893;GO:0006355;GO:0007165;GO:0008202;GO:0006367;GO:0006805;GO:0042908;, C:chromatin; C:intermediate filament cytoskeleton; C:nuclear body; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:drug binding; F:nuclear receptor activity; F:nuclear receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell differentiation; P:exogenous drug catabolic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:signal transduction; P:steroid metabolic process; P:transcription initiation from RNA polymerase II promoter; P:xenobiotic metabolic process; P:xenobiotic transport;|Q96A45 Q96JE8,Cilia- and flagella-associated protein 91 {ECO:0000305},AMY-1-associating protein expressed in testis 1 {ECO:0000303|PubMed:15863901};MYCBP/AMY-1-associated testis-expressed protein 1 {ECO:0000305};Protein MAATS1 {ECO:0000305};, PF14738;, GO:0005930;GO:0005739;GO:0031514;GO:0003341;, C:axoneme; C:mitochondrion; C:motile cilium;, , P:cilium movement;|Q9HBU9 Q86UE7,Popeye domain-containing protein 2,, PF04831;, GO:0016021;GO:0042383;GO:0030552;GO:0007507;GO:0002027;GO:0042391;GO:0007519;GO:0051146;, C:integral component of membrane; C:sarcolemma;, F:cAMP binding;, P:heart development; P:regulation of heart rate; P:regulation of membrane potential; P:skeletal muscle tissue development; P:striated muscle cell differentiation;|Q9HBU9 Q86UE7,Popeye domain-containing protein 2,, PF04831;, GO:0016021;GO:0042383;GO:0030552;GO:0007507;GO:0002027;GO:0042391;GO:0007519;GO:0051146;, C:integral component of membrane; C:sarcolemma;, F:cAMP binding;, P:heart development; P:regulation of heart rate; P:regulation of membrane potential; P:skeletal muscle tissue development; P:striated muscle cell differentiation;|Q53H76 B2R8V2 B4DXA2 O95991 Q86WX6 Q9UPD2,Phospholipase A1 member A {ECO:0000305},Phosphatidylserine-specific phospholipase A1;, PF00151;, GO:0002080;GO:0005576;GO:0005615;GO:0016298;GO:0008970;GO:0004806;GO:0016042;GO:0006629;GO:0036150;GO:0006658;, C:acrosomal membrane; C:extracellular region; C:extracellular space;, F:lipase activity; F:phospholipase A1 activity; F:triglyceride lipase activity;, P:lipid catabolic process; P:lipid metabolic process; P:phosphatidylserine acyl-chain remodeling; P:phosphatidylserine metabolic process;|Q53H76 B2R8V2 B4DXA2 O95991 Q86WX6 Q9UPD2,Phospholipase A1 member A {ECO:0000305},Phosphatidylserine-specific phospholipase A1;, PF00151;, GO:0002080;GO:0005576;GO:0005615;GO:0016298;GO:0008970;GO:0004806;GO:0016042;GO:0006629;GO:0036150;GO:0006658;, C:acrosomal membrane; C:extracellular region; C:extracellular space;, F:lipase activity; F:phospholipase A1 activity; F:triglyceride lipase activity;, P:lipid catabolic process; P:lipid metabolic process; P:phosphatidylserine acyl-chain remodeling; P:phosphatidylserine metabolic process; scaffold56 indexed_genome mRNA 5319617 5329456 . - . ID=transcript_10181;P54922 B2R8H1 D3DN83,[Protein ADP-ribosylarginine] hydrolase,ADP-ribose-L-arginine cleaving enzyme;, PF03747;, GO:0005776;GO:0005829;GO:0005615;GO:0055037;GO:0003875;GO:0005096;GO:0000287;GO:0030955;GO:0090630;GO:0006464;GO:0006886;GO:0051725;GO:2000785;, C:autophagosome; C:cytosol; C:extracellular space; C:recycling endosome;, F:ADP-ribosylarginine hydrolase activity; F:GTPase activator activity; F:magnesium ion binding; F:potassium ion binding;, P:activation of GTPase activity; P:cellular protein modification process; P:intracellular protein transport; P:protein de-ADP-ribosylation; P:regulation of autophagosome assembly; scaffold56 indexed_genome mRNA 5338554 5360139 . + . ID=transcript_10182;P33681 Q5DTA9 Q5DTB0,T-lymphocyte activation antigen CD80,Activation B7-1 antigen;BB1;CTLA-4 counter-receptor B7.1;, PF08205;PF07686;, GO:0009986;GO:0009897;GO:0016021;GO:0005886;GO:0098636;GO:0015026;GO:0001618;GO:0007166;GO:0071222;GO:0019221;GO:0006955;GO:0035556;GO:0042130;GO:0032725;GO:0032743;GO:0050731;GO:0051897;GO:0009967;GO:0042102;GO:0045627;GO:0045893;GO:0031295;, C:cell surface; C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane; C:protein complex involved in cell adhesion;, F:coreceptor activity; F:virus receptor activity;, P:cell surface receptor signaling pathway; P:cellular response to lipopolysaccharide; P:cytokine-mediated signaling pathway; P:immune response; P:intracellular signal transduction; P:negative regulation of T cell proliferation; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of interleukin-2 production; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of signal transduction; P:positive regulation of T cell proliferation; P:positive regulation of T-helper 1 cell differentiation; P:positive regulation of transcription, DNA-templated; P:T cell costimulation; scaffold56 indexed_genome mRNA 5364355 5385950 . - . ID=transcript_10183;Q9NPL8 D3DN81 Q6IAJ7 Q6UWU6 Q9NPR3 Q9NPS5 Q9P0Y6,Complex I assembly factor TIMMDC1, mitochondrial,Protein M5-14;Translocase of inner mitochondrial membrane domain-containing protein 1;, , GO:0016021;GO:0005743;GO:0005739;GO:0005654;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm;, , P:mitochondrial respiratory chain complex I assembly;|Q9NPL8 D3DN81 Q6IAJ7 Q6UWU6 Q9NPR3 Q9NPS5 Q9P0Y6,Complex I assembly factor TIMMDC1, mitochondrial,Protein M5-14;Translocase of inner mitochondrial membrane domain-containing protein 1;, , GO:0016021;GO:0005743;GO:0005739;GO:0005654;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm;, , P:mitochondrial respiratory chain complex I assembly;|Q9NPL8 D3DN81 Q6IAJ7 Q6UWU6 Q9NPR3 Q9NPS5 Q9P0Y6,Complex I assembly factor TIMMDC1, mitochondrial,Protein M5-14;Translocase of inner mitochondrial membrane domain-containing protein 1;, , GO:0016021;GO:0005743;GO:0005739;GO:0005654;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm;, , P:mitochondrial respiratory chain complex I assembly; scaffold56 indexed_genome mRNA 5389274 5413945 . + . ID=transcript_10184;Q8NBL1 B2RD13 Q53GJ4 Q8N2T1,Protein O-glucosyltransferase 1 {ECO:0000305},CAP10-like 46 kDa protein {ECO:0000303|PubMed:16524674};KTEL motif-containing protein 1;Myelodysplastic syndromes relative protein;O-glucosyltransferase Rumi homolog {ECO:0000303|PubMed:21490058};Protein O-xylosyltransferase POGLUT1 {ECO:0000305};, PF05686;, GO:0012505;GO:0005783;GO:0005788;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0048318;GO:0072359;GO:0007369;GO:0060537;GO:0048339;GO:0045747;GO:0006493;GO:0018242;GO:0010470;GO:0001756;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:axial mesoderm development; P:circulatory system development; P:gastrulation; P:muscle tissue development; P:paraxial mesoderm development; P:positive regulation of Notch signaling pathway; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:regulation of gastrulation; P:somitogenesis;|Q8NBL1 B2RD13 Q53GJ4 Q8N2T1,Protein O-glucosyltransferase 1 {ECO:0000305},CAP10-like 46 kDa protein {ECO:0000303|PubMed:16524674};KTEL motif-containing protein 1;Myelodysplastic syndromes relative protein;O-glucosyltransferase Rumi homolog {ECO:0000303|PubMed:21490058};Protein O-xylosyltransferase POGLUT1 {ECO:0000305};, PF05686;, GO:0012505;GO:0005783;GO:0005788;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0048318;GO:0072359;GO:0007369;GO:0060537;GO:0048339;GO:0045747;GO:0006493;GO:0018242;GO:0010470;GO:0001756;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:axial mesoderm development; P:circulatory system development; P:gastrulation; P:muscle tissue development; P:paraxial mesoderm development; P:positive regulation of Notch signaling pathway; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:regulation of gastrulation; P:somitogenesis;|Q8NBL1 B2RD13 Q53GJ4 Q8N2T1,Protein O-glucosyltransferase 1 {ECO:0000305},CAP10-like 46 kDa protein {ECO:0000303|PubMed:16524674};KTEL motif-containing protein 1;Myelodysplastic syndromes relative protein;O-glucosyltransferase Rumi homolog {ECO:0000303|PubMed:21490058};Protein O-xylosyltransferase POGLUT1 {ECO:0000305};, PF05686;, GO:0012505;GO:0005783;GO:0005788;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0048318;GO:0072359;GO:0007369;GO:0060537;GO:0048339;GO:0045747;GO:0006493;GO:0018242;GO:0010470;GO:0001756;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:axial mesoderm development; P:circulatory system development; P:gastrulation; P:muscle tissue development; P:paraxial mesoderm development; P:positive regulation of Notch signaling pathway; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:regulation of gastrulation; P:somitogenesis;|Q8NBL1 B2RD13 Q53GJ4 Q8N2T1,Protein O-glucosyltransferase 1 {ECO:0000305},CAP10-like 46 kDa protein {ECO:0000303|PubMed:16524674};KTEL motif-containing protein 1;Myelodysplastic syndromes relative protein;O-glucosyltransferase Rumi homolog {ECO:0000303|PubMed:21490058};Protein O-xylosyltransferase POGLUT1 {ECO:0000305};, PF05686;, GO:0012505;GO:0005783;GO:0005788;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0048318;GO:0072359;GO:0007369;GO:0060537;GO:0048339;GO:0045747;GO:0006493;GO:0018242;GO:0010470;GO:0001756;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:axial mesoderm development; P:circulatory system development; P:gastrulation; P:muscle tissue development; P:paraxial mesoderm development; P:positive regulation of Notch signaling pathway; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:regulation of gastrulation; P:somitogenesis;|Q8NBL1 B2RD13 Q53GJ4 Q8N2T1,Protein O-glucosyltransferase 1 {ECO:0000305},CAP10-like 46 kDa protein {ECO:0000303|PubMed:16524674};KTEL motif-containing protein 1;Myelodysplastic syndromes relative protein;O-glucosyltransferase Rumi homolog {ECO:0000303|PubMed:21490058};Protein O-xylosyltransferase POGLUT1 {ECO:0000305};, PF05686;, GO:0012505;GO:0005783;GO:0005788;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0048318;GO:0072359;GO:0007369;GO:0060537;GO:0048339;GO:0045747;GO:0006493;GO:0018242;GO:0010470;GO:0001756;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:axial mesoderm development; P:circulatory system development; P:gastrulation; P:muscle tissue development; P:paraxial mesoderm development; P:positive regulation of Notch signaling pathway; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:regulation of gastrulation; P:somitogenesis;|Q8NBL1 B2RD13 Q53GJ4 Q8N2T1,Protein O-glucosyltransferase 1 {ECO:0000305},CAP10-like 46 kDa protein {ECO:0000303|PubMed:16524674};KTEL motif-containing protein 1;Myelodysplastic syndromes relative protein;O-glucosyltransferase Rumi homolog {ECO:0000303|PubMed:21490058};Protein O-xylosyltransferase POGLUT1 {ECO:0000305};, PF05686;, GO:0012505;GO:0005783;GO:0005788;GO:0140561;GO:0140562;GO:0046527;GO:0035251;GO:0035252;GO:0048318;GO:0072359;GO:0007369;GO:0060537;GO:0048339;GO:0045747;GO:0006493;GO:0018242;GO:0010470;GO:0001756;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:EGF-domain serine glucosyltransferase activity; F:EGF-domain serine xylosyltransferase activity; F:glucosyltransferase activity; F:UDP-glucosyltransferase activity; F:UDP-xylosyltransferase activity;, P:axial mesoderm development; P:circulatory system development; P:gastrulation; P:muscle tissue development; P:paraxial mesoderm development; P:positive regulation of Notch signaling pathway; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:regulation of gastrulation; P:somitogenesis; scaffold56 indexed_genome mRNA 5418110 5446291 . + . ID=transcript_10185;Q9NV64 D3DN80 Q53FN4 Q53GI1 Q6PKB5,Transmembrane protein 39A,, PF10271;, GO:0005789;GO:0016021;GO:0016020;GO:0006914;GO:1902902;GO:1901097;GO:0045070;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:autophagy; P:negative regulation of autophagosome assembly; P:negative regulation of autophagosome maturation; P:positive regulation of viral genome replication;|Q9NV64 D3DN80 Q53FN4 Q53GI1 Q6PKB5,Transmembrane protein 39A,, PF10271;, GO:0005789;GO:0016021;GO:0016020;GO:0006914;GO:1902902;GO:1901097;GO:0045070;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:autophagy; P:negative regulation of autophagosome assembly; P:negative regulation of autophagosome maturation; P:positive regulation of viral genome replication;|Q9NV64 D3DN80 Q53FN4 Q53GI1 Q6PKB5,Transmembrane protein 39A,, PF10271;, GO:0005789;GO:0016021;GO:0016020;GO:0006914;GO:1902902;GO:1901097;GO:0045070;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:autophagy; P:negative regulation of autophagosome assembly; P:negative regulation of autophagosome maturation; P:positive regulation of viral genome replication; scaffold56 indexed_genome mRNA 5447179 5447848 . + . ID=transcript_10186;Q9NV64 D3DN80 Q53FN4 Q53GI1 Q6PKB5,Transmembrane protein 39A,, PF10271;, GO:0005789;GO:0016021;GO:0016020;GO:0006914;GO:1902902;GO:1901097;GO:0045070;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:autophagy; P:negative regulation of autophagosome assembly; P:negative regulation of autophagosome maturation; P:positive regulation of viral genome replication; scaffold56 indexed_genome mRNA 5453205 5574923 . - . ID=transcript_10187;Q2M1Z3 Q9ULL6,Rho GTPase-activating protein 31,Cdc42 GTPase-activating protein;, PF00620;, GO:0005829;GO:0005925;GO:0030027;GO:0005096;GO:0017124;GO:0051056;GO:0007264;, C:cytosol; C:focal adhesion; C:lamellipodium;, F:GTPase activator activity; F:SH3 domain binding;, P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; scaffold56 indexed_genome mRNA 5604917 5632675 . + . ID=transcript_10188;O60513 Q68D68 Q9BSW3 Q9C078,Beta-1,4-galactosyltransferase 4 {ECO:0000305},Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;Lactotriaosylceramide beta-1,4-galactosyltransferase;N-acetyllactosamine synthase;Nal synthase;UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4;, PF02709;PF13733;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0008378;GO:0046872;GO:0003945;GO:0005975;GO:0018146;GO:0006643;GO:0006486;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:galactosyltransferase activity; F:metal ion binding; F:N-acetyllactosamine synthase activity;, P:carbohydrate metabolic process; P:keratan sulfate biosynthetic process; P:membrane lipid metabolic process; P:protein glycosylation;|O60513 Q68D68 Q9BSW3 Q9C078,Beta-1,4-galactosyltransferase 4 {ECO:0000305},Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;Lactotriaosylceramide beta-1,4-galactosyltransferase;N-acetyllactosamine synthase;Nal synthase;UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4;, PF02709;PF13733;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0008378;GO:0046872;GO:0003945;GO:0005975;GO:0018146;GO:0006643;GO:0006486;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:galactosyltransferase activity; F:metal ion binding; F:N-acetyllactosamine synthase activity;, P:carbohydrate metabolic process; P:keratan sulfate biosynthetic process; P:membrane lipid metabolic process; P:protein glycosylation;|O60513 Q68D68 Q9BSW3 Q9C078,Beta-1,4-galactosyltransferase 4 {ECO:0000305},Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;Lactotriaosylceramide beta-1,4-galactosyltransferase;N-acetyllactosamine synthase;Nal synthase;UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4;, PF02709;PF13733;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0008378;GO:0046872;GO:0003945;GO:0005975;GO:0018146;GO:0006643;GO:0006486;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:galactosyltransferase activity; F:metal ion binding; F:N-acetyllactosamine synthase activity;, P:carbohydrate metabolic process; P:keratan sulfate biosynthetic process; P:membrane lipid metabolic process; P:protein glycosylation; scaffold56 indexed_genome mRNA 5640801 5672237 . - . ID=transcript_10189;O75841 O60753 Q9UIM2 Q9UNX6,Uroplakin-1b,Tetraspanin-20;Uroplakin Ib;, PF00335;, GO:0120001;GO:0070062;GO:0016021;GO:0005887;GO:0005198;GO:0030855;GO:0009617;, C:apical plasma membrane urothelial plaque; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane;, F:structural molecule activity;, P:epithelial cell differentiation; P:response to bacterium; scaffold56 indexed_genome mRNA 5755456 5893186 . + . ID=transcript_10190;Q5DX21 C9JZN0 Q8N4F1 Q8N7T8 Q8NDD2,Immunoglobulin superfamily member 11,Brain and testis-specific immunoglobulin superfamily protein;V-set and immunoglobulin domain-containing protein 3;, PF07686;, GO:0005911;GO:0060076;GO:0016021;GO:0005886;GO:0014069;GO:0035255;GO:0007156;GO:0045185;GO:1900273;GO:0061885;GO:0040008;, C:cell-cell junction; C:excitatory synapse; C:integral component of membrane; C:plasma membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:maintenance of protein location; P:positive regulation of long-term synaptic potentiation; P:positive regulation of mini excitatory postsynaptic potential; P:regulation of growth;|Q5DX21 C9JZN0 Q8N4F1 Q8N7T8 Q8NDD2,Immunoglobulin superfamily member 11,Brain and testis-specific immunoglobulin superfamily protein;V-set and immunoglobulin domain-containing protein 3;, PF07686;, GO:0005911;GO:0060076;GO:0016021;GO:0005886;GO:0014069;GO:0035255;GO:0007156;GO:0045185;GO:1900273;GO:0061885;GO:0040008;, C:cell-cell junction; C:excitatory synapse; C:integral component of membrane; C:plasma membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:maintenance of protein location; P:positive regulation of long-term synaptic potentiation; P:positive regulation of mini excitatory postsynaptic potential; P:regulation of growth;|Q5DX21 C9JZN0 Q8N4F1 Q8N7T8 Q8NDD2,Immunoglobulin superfamily member 11,Brain and testis-specific immunoglobulin superfamily protein;V-set and immunoglobulin domain-containing protein 3;, PF07686;, GO:0005911;GO:0060076;GO:0016021;GO:0005886;GO:0014069;GO:0035255;GO:0007156;GO:0045185;GO:1900273;GO:0061885;GO:0040008;, C:cell-cell junction; C:excitatory synapse; C:integral component of membrane; C:plasma membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:maintenance of protein location; P:positive regulation of long-term synaptic potentiation; P:positive regulation of mini excitatory postsynaptic potential; P:regulation of growth;|Q5DX21 C9JZN0 Q8N4F1 Q8N7T8 Q8NDD2,Immunoglobulin superfamily member 11,Brain and testis-specific immunoglobulin superfamily protein;V-set and immunoglobulin domain-containing protein 3;, PF07686;, GO:0005911;GO:0060076;GO:0016021;GO:0005886;GO:0014069;GO:0035255;GO:0007156;GO:0045185;GO:1900273;GO:0061885;GO:0040008;, C:cell-cell junction; C:excitatory synapse; C:integral component of membrane; C:plasma membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:maintenance of protein location; P:positive regulation of long-term synaptic potentiation; P:positive regulation of mini excitatory postsynaptic potential; P:regulation of growth; scaffold56 indexed_genome mRNA 6712060 8999161 . + . ID=transcript_10191;Q13449 Q8IV49,Limbic system-associated membrane protein,IgLON family member 3;, PF07679;, GO:0031225;GO:0005829;GO:0005576;GO:0005886;GO:0007155;GO:0007399;, C:anchored component of membrane; C:cytosol; C:extracellular region; C:plasma membrane;, , P:cell adhesion; P:nervous system development;|Q13449 Q8IV49,Limbic system-associated membrane protein,IgLON family member 3;, PF07679;, GO:0031225;GO:0005829;GO:0005576;GO:0005886;GO:0007155;GO:0007399;, C:anchored component of membrane; C:cytosol; C:extracellular region; C:plasma membrane;, , P:cell adhesion; P:nervous system development;|Q13449 Q8IV49,Limbic system-associated membrane protein,IgLON family member 3;, PF07679;, GO:0031225;GO:0005829;GO:0005576;GO:0005886;GO:0007155;GO:0007399;, C:anchored component of membrane; C:cytosol; C:extracellular region; C:plasma membrane;, , P:cell adhesion; P:nervous system development; scaffold56 indexed_genome mRNA 9068615 9166499 . - . ID=transcript_10192;P17677 A8K0Y4,Neuromodulin,Axonal membrane protein GAP-43;Growth-associated protein 43;Neural phosphoprotein B-50;pp46;, PF00612;PF06614;PF10580;, GO:0005737;GO:0030425;GO:0031527;GO:0098982;GO:0032584;GO:0043204;GO:0005886;GO:0014069;GO:0005516;GO:0035727;GO:1901981;GO:0001786;GO:0016198;GO:0031103;GO:0045165;GO:0010001;GO:0007205;GO:0051489;GO:0040008;GO:0099150;GO:0009611;GO:0042246;, C:cytoplasm; C:dendrite; C:filopodium membrane; C:GABA-ergic synapse; C:growth cone membrane; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:calmodulin binding; F:lysophosphatidic acid binding; F:phosphatidylinositol phosphate binding; F:phosphatidylserine binding;, P:axon choice point recognition; P:axon regeneration; P:cell fate commitment; P:glial cell differentiation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of filopodium assembly; P:regulation of growth; P:regulation of postsynaptic specialization assembly; P:response to wounding; P:tissue regeneration; scaffold56 indexed_genome mRNA 10462463 10475484 . + . ID=transcript_10193;Q9HC78 Q63HP6 Q8N6R5 Q9Y410,Zinc finger and BTB domain-containing protein 20,Dendritic-derived BTB/POZ zinc finger protein;Zinc finger protein 288;, PF00651;PF00096;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0000976;GO:0071333;GO:0055088;GO:0045821;GO:0046889;GO:0006357;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to glucose stimulus; P:lipid homeostasis; P:positive regulation of glycolytic process; P:positive regulation of lipid biosynthetic process; P:regulation of transcription by RNA polymerase II; scaffold56 indexed_genome mRNA 10699455 10723232 . - . ID=transcript_10194;Q9H974 A6NGE9 B7Z472 B7Z5R2 J3KR78 Q6IA59,Queuine tRNA-ribosyltransferase accessory subunit 2 {ECO:0000255|HAMAP-Rule:MF_03043},Queuine tRNA-ribosyltransferase domain-containing protein 1 {ECO:0000255|HAMAP-Rule:MF_03043};, PF01702;, GO:0005737;GO:0005741;GO:0005739;GO:0032991;GO:0046872;GO:0046982;GO:0042803;GO:0008479;GO:0006400;GO:0101030;, C:cytoplasm; C:mitochondrial outer membrane; C:mitochondrion; C:protein-containing complex;, F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:queuine tRNA-ribosyltransferase activity;, P:tRNA modification; P:tRNA-guanine transglycosylation; scaffold56 indexed_genome mRNA 10723477 10780462 . + . ID=transcript_10195;Q8NCU4 B4DYL1 Q9P2E0,Coiled-coil domain-containing protein 191 scaffold56 indexed_genome mRNA 10782212 10817769 . + . ID=transcript_10196;Q8NCU4 B4DYL1 Q9P2E0,Coiled-coil domain-containing protein 191|Q8NCU4 B4DYL1 Q9P2E0,Coiled-coil domain-containing protein 191 scaffold56 indexed_genome mRNA 10825933 10828186 . - . ID=transcript_10197;Q8IYP9 D3DN76,Palmitoyltransferase ZDHHC23 {ECO:0000305},Zinc finger DHHC domain-containing protein 23 {ECO:0000312|HGNC:HGNC:28654};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0019706;GO:0018230;GO:0072659;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein localization to plasma membrane; P:protein palmitoylation; P:protein targeting to membrane; scaffold56 indexed_genome mRNA 10836589 10868199 . - . ID=transcript_10198;Q8IYS0 A8K9Y1 A8KA99 Q6AW94 Q6UWN1 Q8N6S0 Q9UF46,Protein Aster-C {ECO:0000250|UniProtKB:Q8CI52},GRAM domain-containing protein 1C;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0015485;GO:0120020;GO:0071397;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:cellular response to cholesterol;|Q8IYS0 A8K9Y1 A8KA99 Q6AW94 Q6UWN1 Q8N6S0 Q9UF46,Protein Aster-C {ECO:0000250|UniProtKB:Q8CI52},GRAM domain-containing protein 1C;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0015485;GO:0120020;GO:0071397;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:cellular response to cholesterol;|Q8IYS0 A8K9Y1 A8KA99 Q6AW94 Q6UWN1 Q8N6S0 Q9UF46,Protein Aster-C {ECO:0000250|UniProtKB:Q8CI52},GRAM domain-containing protein 1C;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0015485;GO:0120020;GO:0071397;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:cellular response to cholesterol;|Q8IYS0 A8K9Y1 A8KA99 Q6AW94 Q6UWN1 Q8N6S0 Q9UF46,Protein Aster-C {ECO:0000250|UniProtKB:Q8CI52},GRAM domain-containing protein 1C;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0015485;GO:0120020;GO:0071397;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:cellular response to cholesterol;|Q8IYS0 A8K9Y1 A8KA99 Q6AW94 Q6UWN1 Q8N6S0 Q9UF46,Protein Aster-C {ECO:0000250|UniProtKB:Q8CI52},GRAM domain-containing protein 1C;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0015485;GO:0120020;GO:0071397;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:cellular response to cholesterol; scaffold56 indexed_genome mRNA 10872943 10949245 . - . ID=transcript_10199;Q8IYS0 A8K9Y1 A8KA99 Q6AW94 Q6UWN1 Q8N6S0 Q9UF46,Protein Aster-C {ECO:0000250|UniProtKB:Q8CI52},GRAM domain-containing protein 1C;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0015485;GO:0120020;GO:0071397;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:cellular response to cholesterol;|Q8IYS0 A8K9Y1 A8KA99 Q6AW94 Q6UWN1 Q8N6S0 Q9UF46,Protein Aster-C {ECO:0000250|UniProtKB:Q8CI52},GRAM domain-containing protein 1C;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0015485;GO:0120020;GO:0071397;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:cellular response to cholesterol;|Q8IYS0 A8K9Y1 A8KA99 Q6AW94 Q6UWN1 Q8N6S0 Q9UF46,Protein Aster-C {ECO:0000250|UniProtKB:Q8CI52},GRAM domain-containing protein 1C;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0015485;GO:0120020;GO:0071397;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:cellular response to cholesterol;|Q5VTE0,Putative elongation factor 1-alpha-like 3,Eukaryotic elongation factor 1 A-like 3;Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5;, PF00009;PF03144;PF03143;, GO:0005737;GO:0070062;GO:0005615;GO:0005634;GO:0005525;GO:0003924;GO:0003746;GO:0006412;GO:0006414;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleus;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:translation; P:translational elongation; scaffold56 indexed_genome mRNA 10979229 11042785 . - . ID=transcript_10200;P38606 B2RBR8 B7Z1R5 D3DN75 Q53YD9 Q96DY6 Q9UHY3,V-type proton ATPase catalytic subunit A,V-ATPase 69 kDa subunit;Vacuolar ATPase isoform VA68;Vacuolar proton pump subunit alpha;, PF00006;PF02874;PF16886;, GO:0016324;GO:0005829;GO:0070062;GO:0043231;GO:0005765;GO:0005902;GO:0005654;GO:0005886;GO:0016469;GO:0033180;GO:0005774;GO:0005524;GO:0046933;GO:0046961;GO:0006879;GO:0034198;GO:0036295;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:microvillus; C:nucleoplasm; C:plasma membrane; C:proton-transporting two-sector ATPase complex; C:proton-transporting V-type ATPase, V1 domain; C:vacuolar membrane;, F:ATP binding; F:proton-transporting ATP synthase activity, rotational mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to amino acid starvation; P:cellular response to increased oxygen levels; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport;|P38606 B2RBR8 B7Z1R5 D3DN75 Q53YD9 Q96DY6 Q9UHY3,V-type proton ATPase catalytic subunit A,V-ATPase 69 kDa subunit;Vacuolar ATPase isoform VA68;Vacuolar proton pump subunit alpha;, PF00006;PF02874;PF16886;, GO:0016324;GO:0005829;GO:0070062;GO:0043231;GO:0005765;GO:0005902;GO:0005654;GO:0005886;GO:0016469;GO:0033180;GO:0005774;GO:0005524;GO:0046933;GO:0046961;GO:0006879;GO:0034198;GO:0036295;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:microvillus; C:nucleoplasm; C:plasma membrane; C:proton-transporting two-sector ATPase complex; C:proton-transporting V-type ATPase, V1 domain; C:vacuolar membrane;, F:ATP binding; F:proton-transporting ATP synthase activity, rotational mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to amino acid starvation; P:cellular response to increased oxygen levels; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport;|P38606 B2RBR8 B7Z1R5 D3DN75 Q53YD9 Q96DY6 Q9UHY3,V-type proton ATPase catalytic subunit A,V-ATPase 69 kDa subunit;Vacuolar ATPase isoform VA68;Vacuolar proton pump subunit alpha;, PF00006;PF02874;PF16886;, GO:0016324;GO:0005829;GO:0070062;GO:0043231;GO:0005765;GO:0005902;GO:0005654;GO:0005886;GO:0016469;GO:0033180;GO:0005774;GO:0005524;GO:0046933;GO:0046961;GO:0006879;GO:0034198;GO:0036295;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:microvillus; C:nucleoplasm; C:plasma membrane; C:proton-transporting two-sector ATPase complex; C:proton-transporting V-type ATPase, V1 domain; C:vacuolar membrane;, F:ATP binding; F:proton-transporting ATP synthase activity, rotational mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to amino acid starvation; P:cellular response to increased oxygen levels; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport;|P38606 B2RBR8 B7Z1R5 D3DN75 Q53YD9 Q96DY6 Q9UHY3,V-type proton ATPase catalytic subunit A,V-ATPase 69 kDa subunit;Vacuolar ATPase isoform VA68;Vacuolar proton pump subunit alpha;, PF00006;PF02874;PF16886;, GO:0016324;GO:0005829;GO:0070062;GO:0043231;GO:0005765;GO:0005902;GO:0005654;GO:0005886;GO:0016469;GO:0033180;GO:0005774;GO:0005524;GO:0046933;GO:0046961;GO:0006879;GO:0034198;GO:0036295;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:microvillus; C:nucleoplasm; C:plasma membrane; C:proton-transporting two-sector ATPase complex; C:proton-transporting V-type ATPase, V1 domain; C:vacuolar membrane;, F:ATP binding; F:proton-transporting ATP synthase activity, rotational mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular iron ion homeostasis; P:cellular response to amino acid starvation; P:cellular response to increased oxygen levels; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport; scaffold56 indexed_genome mRNA 11067714 11068363 . + . ID=transcript_10201;Q9GZZ1 D3DN74 Q68DQ1,N-alpha-acetyltransferase 50 {ECO:0000305},N-acetyltransferase 13;N-acetyltransferase 5 {ECO:0000303|PubMed:16507339};N-acetyltransferase san homolog {ECO:0000303|PubMed:16507339};N-epsilon-acetyltransferase 50 {ECO:0000305};NatE catalytic subunit;, PF00583;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0010485;GO:0008080;GO:0004596;GO:0052858;GO:0034087;GO:0016573;GO:0007064;GO:0071962;GO:0006474;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus;, F:H4 histone acetyltransferase activity; F:N-acetyltransferase activity; F:peptide alpha-N-acetyltransferase activity; F:peptidyl-lysine acetyltransferase activity;, P:establishment of mitotic sister chromatid cohesion; P:histone acetylation; P:mitotic sister chromatid cohesion; P:mitotic sister chromatid cohesion, centromeric; P:N-terminal protein amino acid acetylation; scaffold56 indexed_genome mRNA 11068524 11070070 . + . ID=transcript_10202;Q9GZZ1 D3DN74 Q68DQ1,N-alpha-acetyltransferase 50 {ECO:0000305},N-acetyltransferase 13;N-acetyltransferase 5 {ECO:0000303|PubMed:16507339};N-acetyltransferase san homolog {ECO:0000303|PubMed:16507339};N-epsilon-acetyltransferase 50 {ECO:0000305};NatE catalytic subunit;, PF00583;, GO:0005737;GO:0005829;GO:0070062;GO:0031415;GO:0005634;GO:0010485;GO:0008080;GO:0004596;GO:0052858;GO:0034087;GO:0016573;GO:0007064;GO:0071962;GO:0006474;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:NatA complex; C:nucleus;, F:H4 histone acetyltransferase activity; F:N-acetyltransferase activity; F:peptide alpha-N-acetyltransferase activity; F:peptidyl-lysine acetyltransferase activity;, P:establishment of mitotic sister chromatid cohesion; P:histone acetylation; P:mitotic sister chromatid cohesion; P:mitotic sister chromatid cohesion, centromeric; P:N-terminal protein amino acid acetylation; scaffold56 indexed_genome mRNA 11084910 11148040 . + . ID=transcript_10203;Q68DE3 Q7Z3L9 Q8IVF3 Q9H8T4,Basic helix-loop-helix domain-containing protein USF3 {ECO:0000305},Upstream transcription factor 3;, PF00010;, GO:0005634;GO:0003677;GO:0046983;GO:0010719;, C:nucleus;, F:DNA binding; F:protein dimerization activity;, P:negative regulation of epithelial to mesenchymal transition; scaffold56 indexed_genome mRNA 11163093 11191927 . - . ID=transcript_10204;Q9NXL6 Q17RR4,SID1 transmembrane family member 1,, PF13965;, GO:0016021;GO:0005764;GO:0005886;GO:0015485;GO:0003725;GO:0051033;GO:0050658;, C:integral component of membrane; C:lysosome; C:plasma membrane;, F:cholesterol binding; F:double-stranded RNA binding; F:RNA transmembrane transporter activity;, P:RNA transport;|Q9NXL6 Q17RR4,SID1 transmembrane family member 1,, PF13965;, GO:0016021;GO:0005764;GO:0005886;GO:0015485;GO:0003725;GO:0051033;GO:0050658;, C:integral component of membrane; C:lysosome; C:plasma membrane;, F:cholesterol binding; F:double-stranded RNA binding; F:RNA transmembrane transporter activity;, P:RNA transport; scaffold56 indexed_genome mRNA 11211662 11215108 . - . ID=transcript_10205;Q9NXL6 Q17RR4,SID1 transmembrane family member 1,, PF13965;, GO:0016021;GO:0005764;GO:0005886;GO:0015485;GO:0003725;GO:0051033;GO:0050658;, C:integral component of membrane; C:lysosome; C:plasma membrane;, F:cholesterol binding; F:double-stranded RNA binding; F:RNA transmembrane transporter activity;, P:RNA transport; scaffold56 indexed_genome mRNA 11215705 11232451 . - . ID=transcript_10206;Q9NXL6 Q17RR4,SID1 transmembrane family member 1,, PF13965;, GO:0016021;GO:0005764;GO:0005886;GO:0015485;GO:0003725;GO:0051033;GO:0050658;, C:integral component of membrane; C:lysosome; C:plasma membrane;, F:cholesterol binding; F:double-stranded RNA binding; F:RNA transmembrane transporter activity;, P:RNA transport; scaffold56 indexed_genome mRNA 11287247 11343484 . + . ID=transcript_10207;Q8N0Z3 D3DN72 Q8WUX6,Spindle and centriole-associated protein 1,Coiled-coil domain-containing protein 52;Spindle and centriole-associated protein;, PF15678;, GO:0005814;GO:0005813;GO:0005737;GO:0005819;GO:0051301;GO:0051310;GO:0090307;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:spindle;, , P:cell division; P:metaphase plate congression; P:mitotic spindle assembly; P:regulation of centriole replication;|Q8N0Z3 D3DN72 Q8WUX6,Spindle and centriole-associated protein 1,Coiled-coil domain-containing protein 52;Spindle and centriole-associated protein;, PF15678;, GO:0005814;GO:0005813;GO:0005737;GO:0005819;GO:0051301;GO:0051310;GO:0090307;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:spindle;, , P:cell division; P:metaphase plate congression; P:mitotic spindle assembly; P:regulation of centriole replication;|Q8N0Z3 D3DN72 Q8WUX6,Spindle and centriole-associated protein 1,Coiled-coil domain-containing protein 52;Spindle and centriole-associated protein;, PF15678;, GO:0005814;GO:0005813;GO:0005737;GO:0005819;GO:0051301;GO:0051310;GO:0090307;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:spindle;, , P:cell division; P:metaphase plate congression; P:mitotic spindle assembly; P:regulation of centriole replication;|Q8N0Z3 D3DN72 Q8WUX6,Spindle and centriole-associated protein 1,Coiled-coil domain-containing protein 52;Spindle and centriole-associated protein;, PF15678;, GO:0005814;GO:0005813;GO:0005737;GO:0005819;GO:0051301;GO:0051310;GO:0090307;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:spindle;, , P:cell division; P:metaphase plate congression; P:mitotic spindle assembly; P:regulation of centriole replication;|Q8N0Z3 D3DN72 Q8WUX6,Spindle and centriole-associated protein 1,Coiled-coil domain-containing protein 52;Spindle and centriole-associated protein;, PF15678;, GO:0005814;GO:0005813;GO:0005737;GO:0005819;GO:0051301;GO:0051310;GO:0090307;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:spindle;, , P:cell division; P:metaphase plate congression; P:mitotic spindle assembly; P:regulation of centriole replication; scaffold56 indexed_genome mRNA 11368367 11379024 . + . ID=transcript_10208;Q96MT7,Cilia- and flagella-associated protein 44 {ECO:0000312|HGNC:HGNC:25631},WD repeat-containing protein 52 {ECO:0000312|HGNC:HGNC:25631};, PF00400;, GO:0005737;GO:0005856;GO:0031514;GO:0008233;GO:0060271;GO:0060285;GO:0000226;GO:0007288;, C:cytoplasm; C:cytoskeleton; C:motile cilium;, F:peptidase activity;, P:cilium assembly; P:cilium-dependent cell motility; P:microtubule cytoskeleton organization; P:sperm axoneme assembly; scaffold56 indexed_genome mRNA 11402996 11436572 . + . ID=transcript_10209;Q96MT7,Cilia- and flagella-associated protein 44 {ECO:0000312|HGNC:HGNC:25631},WD repeat-containing protein 52 {ECO:0000312|HGNC:HGNC:25631};, PF00400;, GO:0005737;GO:0005856;GO:0031514;GO:0008233;GO:0060271;GO:0060285;GO:0000226;GO:0007288;, C:cytoplasm; C:cytoskeleton; C:motile cilium;, F:peptidase activity;, P:cilium assembly; P:cilium-dependent cell motility; P:microtubule cytoskeleton organization; P:sperm axoneme assembly; scaffold56 indexed_genome mRNA 11436641 11466672 . + . ID=transcript_10210;Q96MT7,Cilia- and flagella-associated protein 44 {ECO:0000312|HGNC:HGNC:25631},WD repeat-containing protein 52 {ECO:0000312|HGNC:HGNC:25631};, PF00400;, GO:0005737;GO:0005856;GO:0031514;GO:0008233;GO:0060271;GO:0060285;GO:0000226;GO:0007288;, C:cytoplasm; C:cytoskeleton; C:motile cilium;, F:peptidase activity;, P:cilium assembly; P:cilium-dependent cell motility; P:microtubule cytoskeleton organization; P:sperm axoneme assembly;|Q96MT7,Cilia- and flagella-associated protein 44 {ECO:0000312|HGNC:HGNC:25631},WD repeat-containing protein 52 {ECO:0000312|HGNC:HGNC:25631};, PF00400;, GO:0005737;GO:0005856;GO:0031514;GO:0008233;GO:0060271;GO:0060285;GO:0000226;GO:0007288;, C:cytoplasm; C:cytoskeleton; C:motile cilium;, F:peptidase activity;, P:cilium assembly; P:cilium-dependent cell motility; P:microtubule cytoskeleton organization; P:sperm axoneme assembly; scaffold56 indexed_genome mRNA 11471573 11482455 . + . ID=transcript_10211;Q96MT7,Cilia- and flagella-associated protein 44 {ECO:0000312|HGNC:HGNC:25631},WD repeat-containing protein 52 {ECO:0000312|HGNC:HGNC:25631};, PF00400;, GO:0005737;GO:0005856;GO:0031514;GO:0008233;GO:0060271;GO:0060285;GO:0000226;GO:0007288;, C:cytoplasm; C:cytoskeleton; C:motile cilium;, F:peptidase activity;, P:cilium assembly; P:cilium-dependent cell motility; P:microtubule cytoskeleton organization; P:sperm axoneme assembly; scaffold56 indexed_genome mRNA 11484323 11559417 . - . ID=transcript_10212;Q9BWV1 A6NJ30 B2RMS8 D3DN70 Q6UXJ5 Q8N2P7 Q8NF26,Brother of CDO,, PF00041;PF07679;PF00047;, GO:0044295;GO:0005887;GO:0005886;GO:0007411;GO:0007155;GO:0051149;GO:0045663;GO:0007224;, C:axonal growth cone; C:integral component of plasma membrane; C:plasma membrane;, , P:axon guidance; P:cell adhesion; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:smoothened signaling pathway;|Q9BWV1 A6NJ30 B2RMS8 D3DN70 Q6UXJ5 Q8N2P7 Q8NF26,Brother of CDO,, PF00041;PF07679;PF00047;, GO:0044295;GO:0005887;GO:0005886;GO:0007411;GO:0007155;GO:0051149;GO:0045663;GO:0007224;, C:axonal growth cone; C:integral component of plasma membrane; C:plasma membrane;, , P:axon guidance; P:cell adhesion; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:smoothened signaling pathway;|Q9BWV1 A6NJ30 B2RMS8 D3DN70 Q6UXJ5 Q8N2P7 Q8NF26,Brother of CDO,, PF00041;PF07679;PF00047;, GO:0044295;GO:0005887;GO:0005886;GO:0007411;GO:0007155;GO:0051149;GO:0045663;GO:0007224;, C:axonal growth cone; C:integral component of plasma membrane; C:plasma membrane;, , P:axon guidance; P:cell adhesion; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:smoothened signaling pathway;|Q9BWV1 A6NJ30 B2RMS8 D3DN70 Q6UXJ5 Q8N2P7 Q8NF26,Brother of CDO,, PF00041;PF07679;PF00047;, GO:0044295;GO:0005887;GO:0005886;GO:0007411;GO:0007155;GO:0051149;GO:0045663;GO:0007224;, C:axonal growth cone; C:integral component of plasma membrane; C:plasma membrane;, , P:axon guidance; P:cell adhesion; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:smoothened signaling pathway;|Q9BWV1 A6NJ30 B2RMS8 D3DN70 Q6UXJ5 Q8N2P7 Q8NF26,Brother of CDO,, PF00041;PF07679;PF00047;, GO:0044295;GO:0005887;GO:0005886;GO:0007411;GO:0007155;GO:0051149;GO:0045663;GO:0007224;, C:axonal growth cone; C:integral component of plasma membrane; C:plasma membrane;, , P:axon guidance; P:cell adhesion; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:smoothened signaling pathway;|Q9BWV1 A6NJ30 B2RMS8 D3DN70 Q6UXJ5 Q8N2P7 Q8NF26,Brother of CDO,, PF00041;PF07679;PF00047;, GO:0044295;GO:0005887;GO:0005886;GO:0007411;GO:0007155;GO:0051149;GO:0045663;GO:0007224;, C:axonal growth cone; C:integral component of plasma membrane; C:plasma membrane;, , P:axon guidance; P:cell adhesion; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:smoothened signaling pathway; scaffold56 indexed_genome mRNA 11753830 11793430 . + . ID=transcript_10213;Q6NW34 D3DN69 Q68DM6 Q9H7U0 Q9UFM4,Nucleolus and neural progenitor protein {ECO:0000305},, PF14780;, GO:0005730;GO:0005634;GO:0007275;GO:0045665;GO:0045747;, C:nucleolus; C:nucleus;, , P:multicellular organism development; P:negative regulation of neuron differentiation; P:positive regulation of Notch signaling pathway;|Q6NW34 D3DN69 Q68DM6 Q9H7U0 Q9UFM4,Nucleolus and neural progenitor protein {ECO:0000305},, PF14780;, GO:0005730;GO:0005634;GO:0007275;GO:0045665;GO:0045747;, C:nucleolus; C:nucleus;, , P:multicellular organism development; P:negative regulation of neuron differentiation; P:positive regulation of Notch signaling pathway;|Q6NW34 D3DN69 Q68DM6 Q9H7U0 Q9UFM4,Nucleolus and neural progenitor protein {ECO:0000305},, PF14780;, GO:0005730;GO:0005634;GO:0007275;GO:0045665;GO:0045747;, C:nucleolus; C:nucleus;, , P:multicellular organism development; P:negative regulation of neuron differentiation; P:positive regulation of Notch signaling pathway;|Q8N3Z3 A6NE99 A6NN11 A8K0P6 Q5I0Y4,GTP-binding protein 8,, PF01926;, GO:0005739;GO:0005525;GO:0046872;, C:mitochondrion;, F:GTP binding; F:metal ion binding;|Q8N3Z3 A6NE99 A6NN11 A8K0P6 Q5I0Y4,GTP-binding protein 8,, PF01926;, GO:0005739;GO:0005525;GO:0046872;, C:mitochondrion;, F:GTP binding; F:metal ion binding; scaffold56 indexed_genome mRNA 11815230 11861437 . + . ID=transcript_10214;Q8TD52,Cell surface glycoprotein CD200 receptor 1,CD200 cell surface glycoprotein receptor;Cell surface glycoprotein OX2 receptor 1;, PF08205;, GO:0009986;GO:0009897;GO:0005576;GO:0016021;GO:0005886;GO:0043235;GO:0140081;GO:0019763;GO:0038023;GO:0034113;GO:0035556;GO:0032715;GO:1905522;GO:0150079;GO:1901215;GO:2000405;GO:0050776;GO:0150077;GO:0007165;GO:0016032;, C:cell surface; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:glycosylated region protein binding; F:immunoglobulin receptor activity; F:signaling receptor activity;, P:heterotypic cell-cell adhesion; P:intracellular signal transduction; P:negative regulation of interleukin-6 production; P:negative regulation of macrophage migration; P:negative regulation of neuroinflammatory response; P:negative regulation of neuron death; P:negative regulation of T cell migration; P:regulation of immune response; P:regulation of neuroinflammatory response; P:signal transduction; P:viral process;|Q8TD52,Cell surface glycoprotein CD200 receptor 1,CD200 cell surface glycoprotein receptor;Cell surface glycoprotein OX2 receptor 1;, PF08205;, GO:0009986;GO:0009897;GO:0005576;GO:0016021;GO:0005886;GO:0043235;GO:0140081;GO:0019763;GO:0038023;GO:0034113;GO:0035556;GO:0032715;GO:1905522;GO:0150079;GO:1901215;GO:2000405;GO:0050776;GO:0150077;GO:0007165;GO:0016032;, C:cell surface; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:glycosylated region protein binding; F:immunoglobulin receptor activity; F:signaling receptor activity;, P:heterotypic cell-cell adhesion; P:intracellular signal transduction; P:negative regulation of interleukin-6 production; P:negative regulation of macrophage migration; P:negative regulation of neuroinflammatory response; P:negative regulation of neuron death; P:negative regulation of T cell migration; P:regulation of immune response; P:regulation of neuroinflammatory response; P:signal transduction; P:viral process;|Q8TD52,Cell surface glycoprotein CD200 receptor 1,CD200 cell surface glycoprotein receptor;Cell surface glycoprotein OX2 receptor 1;, PF08205;, GO:0009986;GO:0009897;GO:0005576;GO:0016021;GO:0005886;GO:0043235;GO:0140081;GO:0019763;GO:0038023;GO:0034113;GO:0035556;GO:0032715;GO:1905522;GO:0150079;GO:1901215;GO:2000405;GO:0050776;GO:0150077;GO:0007165;GO:0016032;, C:cell surface; C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:glycosylated region protein binding; F:immunoglobulin receptor activity; F:signaling receptor activity;, P:heterotypic cell-cell adhesion; P:intracellular signal transduction; P:negative regulation of interleukin-6 production; P:negative regulation of macrophage migration; P:negative regulation of neuroinflammatory response; P:negative regulation of neuron death; P:negative regulation of T cell migration; P:regulation of immune response; P:regulation of neuroinflammatory response; P:signal transduction; P:viral process; scaffold56 indexed_genome mRNA 12078692 12133675 . + . ID=transcript_10215;Q76M96 D3DN67 Q5PR20 Q6GPG9 Q8IVT6 Q8NBV1 Q8NHY8,Coiled-coil domain-containing protein 80,Down-regulated by oncogenes protein 1;Up-regulated in BRS-3 deficient mouse homolog;, PF13778;, GO:0005604;GO:0005576;GO:0005614;GO:0001968;GO:0008201;GO:0030198;GO:0010811;GO:0009617;, C:basement membrane; C:extracellular region; C:interstitial matrix;, F:fibronectin binding; F:heparin binding;, P:extracellular matrix organization; P:positive regulation of cell-substrate adhesion; P:response to bacterium; scaffold56 indexed_genome mRNA 12142883 12203696 . - . ID=transcript_10216;Q9BS91 D3DN66 Q69YY6 Q6ZMD6 Q9NWM9,Probable UDP-sugar transporter protein SLC35A5,Solute carrier family 35 member A5;, PF04142;, GO:0030173;GO:0015165;GO:0008643;, C:integral component of Golgi membrane;, F:pyrimidine nucleotide-sugar transmembrane transporter activity;, P:carbohydrate transport;|Q9BS91 D3DN66 Q69YY6 Q6ZMD6 Q9NWM9,Probable UDP-sugar transporter protein SLC35A5,Solute carrier family 35 member A5;, PF04142;, GO:0030173;GO:0015165;GO:0008643;, C:integral component of Golgi membrane;, F:pyrimidine nucleotide-sugar transmembrane transporter activity;, P:carbohydrate transport;|Q9NT62 Q6PKC5 Q9H6L9,Ubiquitin-like-conjugating enzyme ATG3,Autophagy-related protein 3;Protein PC3-96;, PF03987;, GO:0000153;GO:0005829;GO:0019777;GO:0019776;GO:0019899;GO:0019787;GO:0000045;GO:0000422;GO:0044804;GO:0006464;GO:0016236;GO:0043653;GO:0050765;GO:0006612;GO:0016567;GO:1902017;, C:cytoplasmic ubiquitin ligase complex; C:cytosol;, F:Atg12 transferase activity; F:Atg8 ligase activity; F:enzyme binding; F:ubiquitin-like protein transferase activity;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular protein modification process; P:macroautophagy; P:mitochondrial fragmentation involved in apoptotic process; P:negative regulation of phagocytosis; P:protein targeting to membrane; P:protein ubiquitination; P:regulation of cilium assembly;|Q9NT62 Q6PKC5 Q9H6L9,Ubiquitin-like-conjugating enzyme ATG3,Autophagy-related protein 3;Protein PC3-96;, PF03987;, GO:0000153;GO:0005829;GO:0019777;GO:0019776;GO:0019899;GO:0019787;GO:0000045;GO:0000422;GO:0044804;GO:0006464;GO:0016236;GO:0043653;GO:0050765;GO:0006612;GO:0016567;GO:1902017;, C:cytoplasmic ubiquitin ligase complex; C:cytosol;, F:Atg12 transferase activity; F:Atg8 ligase activity; F:enzyme binding; F:ubiquitin-like protein transferase activity;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular protein modification process; P:macroautophagy; P:mitochondrial fragmentation involved in apoptotic process; P:negative regulation of phagocytosis; P:protein targeting to membrane; P:protein ubiquitination; P:regulation of cilium assembly;|Q9NT62 Q6PKC5 Q9H6L9,Ubiquitin-like-conjugating enzyme ATG3,Autophagy-related protein 3;Protein PC3-96;, PF03987;, GO:0000153;GO:0005829;GO:0019777;GO:0019776;GO:0019899;GO:0019787;GO:0000045;GO:0000422;GO:0044804;GO:0006464;GO:0016236;GO:0043653;GO:0050765;GO:0006612;GO:0016567;GO:1902017;, C:cytoplasmic ubiquitin ligase complex; C:cytosol;, F:Atg12 transferase activity; F:Atg8 ligase activity; F:enzyme binding; F:ubiquitin-like protein transferase activity;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular protein modification process; P:macroautophagy; P:mitochondrial fragmentation involved in apoptotic process; P:negative regulation of phagocytosis; P:protein targeting to membrane; P:protein ubiquitination; P:regulation of cilium assembly;|Q9NT62 Q6PKC5 Q9H6L9,Ubiquitin-like-conjugating enzyme ATG3,Autophagy-related protein 3;Protein PC3-96;, PF03987;, GO:0000153;GO:0005829;GO:0019777;GO:0019776;GO:0019899;GO:0019787;GO:0000045;GO:0000422;GO:0044804;GO:0006464;GO:0016236;GO:0043653;GO:0050765;GO:0006612;GO:0016567;GO:1902017;, C:cytoplasmic ubiquitin ligase complex; C:cytosol;, F:Atg12 transferase activity; F:Atg8 ligase activity; F:enzyme binding; F:ubiquitin-like protein transferase activity;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular protein modification process; P:macroautophagy; P:mitochondrial fragmentation involved in apoptotic process; P:negative regulation of phagocytosis; P:protein targeting to membrane; P:protein ubiquitination; P:regulation of cilium assembly;|Q9NT62 Q6PKC5 Q9H6L9,Ubiquitin-like-conjugating enzyme ATG3,Autophagy-related protein 3;Protein PC3-96;, PF03987;, GO:0000153;GO:0005829;GO:0019777;GO:0019776;GO:0019899;GO:0019787;GO:0000045;GO:0000422;GO:0044804;GO:0006464;GO:0016236;GO:0043653;GO:0050765;GO:0006612;GO:0016567;GO:1902017;, C:cytoplasmic ubiquitin ligase complex; C:cytosol;, F:Atg12 transferase activity; F:Atg8 ligase activity; F:enzyme binding; F:ubiquitin-like protein transferase activity;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular protein modification process; P:macroautophagy; P:mitochondrial fragmentation involved in apoptotic process; P:negative regulation of phagocytosis; P:protein targeting to membrane; P:protein ubiquitination; P:regulation of cilium assembly;|Q9NT62 Q6PKC5 Q9H6L9,Ubiquitin-like-conjugating enzyme ATG3,Autophagy-related protein 3;Protein PC3-96;, PF03987;, GO:0000153;GO:0005829;GO:0019777;GO:0019776;GO:0019899;GO:0019787;GO:0000045;GO:0000422;GO:0044804;GO:0006464;GO:0016236;GO:0043653;GO:0050765;GO:0006612;GO:0016567;GO:1902017;, C:cytoplasmic ubiquitin ligase complex; C:cytosol;, F:Atg12 transferase activity; F:Atg8 ligase activity; F:enzyme binding; F:ubiquitin-like protein transferase activity;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular protein modification process; P:macroautophagy; P:mitochondrial fragmentation involved in apoptotic process; P:negative regulation of phagocytosis; P:protein targeting to membrane; P:protein ubiquitination; P:regulation of cilium assembly; scaffold57 indexed_genome mRNA 14256 14832 . - . ID=transcript_10217;Q96EY4 Q0P6E4 Q0P6J1 Q9NUR7,Translation machinery-associated protein 16,, PF11176;, GO:0005730;GO:0005654;GO:0005634;, C:nucleolus; C:nucleoplasm; C:nucleus; scaffold57 indexed_genome mRNA 29155 31544 . + . ID=transcript_10218;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold57 indexed_genome mRNA 262979 273799 . - . ID=transcript_10219;Q15761 Q6GTR7 Q92916,Neuropeptide Y receptor type 5,NPY-Y5 receptor;, PF00001;, GO:0005737;GO:0005887;GO:0016020;GO:0043005;GO:0005886;GO:0045202;GO:0004983;GO:0001602;GO:0001601;GO:0007568;GO:0003214;GO:0007268;GO:0042755;GO:0007186;GO:0060112;GO:0002865;GO:0043066;GO:0014050;GO:0032229;GO:0003151;GO:0002675;GO:0070374;GO:0048661;, C:cytoplasm; C:integral component of plasma membrane; C:membrane; C:neuron projection; C:plasma membrane; C:synapse;, F:neuropeptide Y receptor activity; F:pancreatic polypeptide receptor activity; F:peptide YY receptor activity;, P:aging; P:cardiac left ventricle morphogenesis; P:chemical synaptic transmission; P:eating behavior; P:G protein-coupled receptor signaling pathway; P:generation of ovulation cycle rhythm; P:negative regulation of acute inflammatory response to antigenic stimulus; P:negative regulation of apoptotic process; P:negative regulation of glutamate secretion; P:negative regulation of synaptic transmission, GABAergic; P:outflow tract morphogenesis; P:positive regulation of acute inflammatory response; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of smooth muscle cell proliferation; scaffold57 indexed_genome mRNA 287064 296761 . + . ID=transcript_10220;P25929 B2R6H5,Neuropeptide Y receptor type 1,, PF00001;, GO:0005887;GO:0005886;GO:0004983;GO:0001602;GO:0001601;GO:0007193;GO:0007631;GO:0007186;GO:0007187;GO:0006006;GO:0007626;GO:0003151;GO:0008217;GO:0040014;GO:0019233;, C:integral component of plasma membrane; C:plasma membrane;, F:neuropeptide Y receptor activity; F:pancreatic polypeptide receptor activity; F:peptide YY receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:feeding behavior; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:glucose metabolic process; P:locomotory behavior; P:outflow tract morphogenesis; P:regulation of blood pressure; P:regulation of multicellular organism growth; P:sensory perception of pain; scaffold57 indexed_genome mRNA 514587 557047 . + . ID=transcript_10221;Q96HR8 D3DP28 E9PAZ2,H/ACA ribonucleoprotein complex non-core subunit NAF1,, PF04410;, GO:0005737;GO:0005654;GO:0005732;GO:0042802;GO:0003723;GO:0070034;GO:0000493;GO:0051973;GO:1904874;GO:0032212;GO:1904358;GO:0042254;GO:0043489;GO:0000454;GO:1905323;GO:0090669;, C:cytoplasm; C:nucleoplasm; C:sno(s)RNA-containing ribonucleoprotein complex;, F:identical protein binding; F:RNA binding; F:telomerase RNA binding;, P:box H/ACA snoRNP assembly; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:ribosome biogenesis; P:RNA stabilization; P:snoRNA guided rRNA pseudouridine synthesis; P:telomerase holoenzyme complex assembly; P:telomerase RNA stabilization;|Q96HR8 D3DP28 E9PAZ2,H/ACA ribonucleoprotein complex non-core subunit NAF1,, PF04410;, GO:0005737;GO:0005654;GO:0005732;GO:0042802;GO:0003723;GO:0070034;GO:0000493;GO:0051973;GO:1904874;GO:0032212;GO:1904358;GO:0042254;GO:0043489;GO:0000454;GO:1905323;GO:0090669;, C:cytoplasm; C:nucleoplasm; C:sno(s)RNA-containing ribonucleoprotein complex;, F:identical protein binding; F:RNA binding; F:telomerase RNA binding;, P:box H/ACA snoRNP assembly; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:ribosome biogenesis; P:RNA stabilization; P:snoRNA guided rRNA pseudouridine synthesis; P:telomerase holoenzyme complex assembly; P:telomerase RNA stabilization;|Q96HR8 D3DP28 E9PAZ2,H/ACA ribonucleoprotein complex non-core subunit NAF1,, PF04410;, GO:0005737;GO:0005654;GO:0005732;GO:0042802;GO:0003723;GO:0070034;GO:0000493;GO:0051973;GO:1904874;GO:0032212;GO:1904358;GO:0042254;GO:0043489;GO:0000454;GO:1905323;GO:0090669;, C:cytoplasm; C:nucleoplasm; C:sno(s)RNA-containing ribonucleoprotein complex;, F:identical protein binding; F:RNA binding; F:telomerase RNA binding;, P:box H/ACA snoRNP assembly; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:ribosome biogenesis; P:RNA stabilization; P:snoRNA guided rRNA pseudouridine synthesis; P:telomerase holoenzyme complex assembly; P:telomerase RNA stabilization;|Q96HR8 D3DP28 E9PAZ2,H/ACA ribonucleoprotein complex non-core subunit NAF1,, PF04410;, GO:0005737;GO:0005654;GO:0005732;GO:0042802;GO:0003723;GO:0070034;GO:0000493;GO:0051973;GO:1904874;GO:0032212;GO:1904358;GO:0042254;GO:0043489;GO:0000454;GO:1905323;GO:0090669;, C:cytoplasm; C:nucleoplasm; C:sno(s)RNA-containing ribonucleoprotein complex;, F:identical protein binding; F:RNA binding; F:telomerase RNA binding;, P:box H/ACA snoRNP assembly; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of telomere maintenance via telomere lengthening; P:ribosome biogenesis; P:RNA stabilization; P:snoRNA guided rRNA pseudouridine synthesis; P:telomerase holoenzyme complex assembly; P:telomerase RNA stabilization; scaffold57 indexed_genome mRNA 1333377 1360733 . + . ID=transcript_10222;Q8IWZ6 Q4W5P8 Q8N581 Q9NVI4,Bardet-Biedl syndrome 7 protein,BBS2-like protein 1;, , GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0001750;GO:0001103;GO:0007420;GO:0060271;GO:0007368;GO:0048546;GO:0001654;GO:0045444;GO:0001947;GO:0046907;GO:0060173;GO:0032402;GO:1905515;GO:0051877;GO:0032436;GO:1903929;GO:0008104;GO:0015031;GO:0006357;GO:0007224;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:photoreceptor outer segment;, F:RNA polymerase II repressing transcription factor binding;, P:brain development; P:cilium assembly; P:determination of left/right symmetry; P:digestive tract morphogenesis; P:eye development; P:fat cell differentiation; P:heart looping; P:intracellular transport; P:limb development; P:melanosome transport; P:non-motile cilium assembly; P:pigment granule aggregation in cell center; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:primary palate development; P:protein localization; P:protein transport; P:regulation of transcription by RNA polymerase II; P:smoothened signaling pathway; P:visual perception;|Q8IWZ6 Q4W5P8 Q8N581 Q9NVI4,Bardet-Biedl syndrome 7 protein,BBS2-like protein 1;, , GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0001750;GO:0001103;GO:0007420;GO:0060271;GO:0007368;GO:0048546;GO:0001654;GO:0045444;GO:0001947;GO:0046907;GO:0060173;GO:0032402;GO:1905515;GO:0051877;GO:0032436;GO:1903929;GO:0008104;GO:0015031;GO:0006357;GO:0007224;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:photoreceptor outer segment;, F:RNA polymerase II repressing transcription factor binding;, P:brain development; P:cilium assembly; P:determination of left/right symmetry; P:digestive tract morphogenesis; P:eye development; P:fat cell differentiation; P:heart looping; P:intracellular transport; P:limb development; P:melanosome transport; P:non-motile cilium assembly; P:pigment granule aggregation in cell center; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:primary palate development; P:protein localization; P:protein transport; P:regulation of transcription by RNA polymerase II; P:smoothened signaling pathway; P:visual perception;|Q8IWZ6 Q4W5P8 Q8N581 Q9NVI4,Bardet-Biedl syndrome 7 protein,BBS2-like protein 1;, , GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0001750;GO:0001103;GO:0007420;GO:0060271;GO:0007368;GO:0048546;GO:0001654;GO:0045444;GO:0001947;GO:0046907;GO:0060173;GO:0032402;GO:1905515;GO:0051877;GO:0032436;GO:1903929;GO:0008104;GO:0015031;GO:0006357;GO:0007224;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:photoreceptor outer segment;, F:RNA polymerase II repressing transcription factor binding;, P:brain development; P:cilium assembly; P:determination of left/right symmetry; P:digestive tract morphogenesis; P:eye development; P:fat cell differentiation; P:heart looping; P:intracellular transport; P:limb development; P:melanosome transport; P:non-motile cilium assembly; P:pigment granule aggregation in cell center; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:primary palate development; P:protein localization; P:protein transport; P:regulation of transcription by RNA polymerase II; P:smoothened signaling pathway; P:visual perception;|Q8IWZ6 Q4W5P8 Q8N581 Q9NVI4,Bardet-Biedl syndrome 7 protein,BBS2-like protein 1;, , GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0001750;GO:0001103;GO:0007420;GO:0060271;GO:0007368;GO:0048546;GO:0001654;GO:0045444;GO:0001947;GO:0046907;GO:0060173;GO:0032402;GO:1905515;GO:0051877;GO:0032436;GO:1903929;GO:0008104;GO:0015031;GO:0006357;GO:0007224;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:photoreceptor outer segment;, F:RNA polymerase II repressing transcription factor binding;, P:brain development; P:cilium assembly; P:determination of left/right symmetry; P:digestive tract morphogenesis; P:eye development; P:fat cell differentiation; P:heart looping; P:intracellular transport; P:limb development; P:melanosome transport; P:non-motile cilium assembly; P:pigment granule aggregation in cell center; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:primary palate development; P:protein localization; P:protein transport; P:regulation of transcription by RNA polymerase II; P:smoothened signaling pathway; P:visual perception;|Q8IWZ6 Q4W5P8 Q8N581 Q9NVI4,Bardet-Biedl syndrome 7 protein,BBS2-like protein 1;, , GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0001750;GO:0001103;GO:0007420;GO:0060271;GO:0007368;GO:0048546;GO:0001654;GO:0045444;GO:0001947;GO:0046907;GO:0060173;GO:0032402;GO:1905515;GO:0051877;GO:0032436;GO:1903929;GO:0008104;GO:0015031;GO:0006357;GO:0007224;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:photoreceptor outer segment;, F:RNA polymerase II repressing transcription factor binding;, P:brain development; P:cilium assembly; P:determination of left/right symmetry; P:digestive tract morphogenesis; P:eye development; P:fat cell differentiation; P:heart looping; P:intracellular transport; P:limb development; P:melanosome transport; P:non-motile cilium assembly; P:pigment granule aggregation in cell center; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:primary palate development; P:protein localization; P:protein transport; P:regulation of transcription by RNA polymerase II; P:smoothened signaling pathway; P:visual perception;|Q8IWZ6 Q4W5P8 Q8N581 Q9NVI4,Bardet-Biedl syndrome 7 protein,BBS2-like protein 1;, , GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0001750;GO:0001103;GO:0007420;GO:0060271;GO:0007368;GO:0048546;GO:0001654;GO:0045444;GO:0001947;GO:0046907;GO:0060173;GO:0032402;GO:1905515;GO:0051877;GO:0032436;GO:1903929;GO:0008104;GO:0015031;GO:0006357;GO:0007224;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:photoreceptor outer segment;, F:RNA polymerase II repressing transcription factor binding;, P:brain development; P:cilium assembly; P:determination of left/right symmetry; P:digestive tract morphogenesis; P:eye development; P:fat cell differentiation; P:heart looping; P:intracellular transport; P:limb development; P:melanosome transport; P:non-motile cilium assembly; P:pigment granule aggregation in cell center; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:primary palate development; P:protein localization; P:protein transport; P:regulation of transcription by RNA polymerase II; P:smoothened signaling pathway; P:visual perception;|Q8IWZ6 Q4W5P8 Q8N581 Q9NVI4,Bardet-Biedl syndrome 7 protein,BBS2-like protein 1;, , GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0001750;GO:0001103;GO:0007420;GO:0060271;GO:0007368;GO:0048546;GO:0001654;GO:0045444;GO:0001947;GO:0046907;GO:0060173;GO:0032402;GO:1905515;GO:0051877;GO:0032436;GO:1903929;GO:0008104;GO:0015031;GO:0006357;GO:0007224;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:photoreceptor outer segment;, F:RNA polymerase II repressing transcription factor binding;, P:brain development; P:cilium assembly; P:determination of left/right symmetry; P:digestive tract morphogenesis; P:eye development; P:fat cell differentiation; P:heart looping; P:intracellular transport; P:limb development; P:melanosome transport; P:non-motile cilium assembly; P:pigment granule aggregation in cell center; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:primary palate development; P:protein localization; P:protein transport; P:regulation of transcription by RNA polymerase II; P:smoothened signaling pathway; P:visual perception; scaffold57 indexed_genome mRNA 1362065 1367266 . + . ID=transcript_10223;Q8IWZ6 Q4W5P8 Q8N581 Q9NVI4,Bardet-Biedl syndrome 7 protein,BBS2-like protein 1;, , GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0001750;GO:0001103;GO:0007420;GO:0060271;GO:0007368;GO:0048546;GO:0001654;GO:0045444;GO:0001947;GO:0046907;GO:0060173;GO:0032402;GO:1905515;GO:0051877;GO:0032436;GO:1903929;GO:0008104;GO:0015031;GO:0006357;GO:0007224;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:photoreceptor outer segment;, F:RNA polymerase II repressing transcription factor binding;, P:brain development; P:cilium assembly; P:determination of left/right symmetry; P:digestive tract morphogenesis; P:eye development; P:fat cell differentiation; P:heart looping; P:intracellular transport; P:limb development; P:melanosome transport; P:non-motile cilium assembly; P:pigment granule aggregation in cell center; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:primary palate development; P:protein localization; P:protein transport; P:regulation of transcription by RNA polymerase II; P:smoothened signaling pathway; P:visual perception;|Q8IWZ6 Q4W5P8 Q8N581 Q9NVI4,Bardet-Biedl syndrome 7 protein,BBS2-like protein 1;, , GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0016020;GO:0043005;GO:0005634;GO:0001750;GO:0001103;GO:0007420;GO:0060271;GO:0007368;GO:0048546;GO:0001654;GO:0045444;GO:0001947;GO:0046907;GO:0060173;GO:0032402;GO:1905515;GO:0051877;GO:0032436;GO:1903929;GO:0008104;GO:0015031;GO:0006357;GO:0007224;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol; C:membrane; C:neuron projection; C:nucleus; C:photoreceptor outer segment;, F:RNA polymerase II repressing transcription factor binding;, P:brain development; P:cilium assembly; P:determination of left/right symmetry; P:digestive tract morphogenesis; P:eye development; P:fat cell differentiation; P:heart looping; P:intracellular transport; P:limb development; P:melanosome transport; P:non-motile cilium assembly; P:pigment granule aggregation in cell center; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:primary palate development; P:protein localization; P:protein transport; P:regulation of transcription by RNA polymerase II; P:smoothened signaling pathway; P:visual perception; scaffold57 indexed_genome mRNA 1367570 1389525 . - . ID=transcript_10224;P20248 A8K7B6 Q2M3U6 Q4W5P4 Q6LER8,Cyclin-A2 {ECO:0000312|HGNC:HGNC:1578},Cyclin A {ECO:0000303|PubMed:1967822};, PF02984;PF00134;PF16500;, GO:0097124;GO:0000307;GO:0005737;GO:0005829;GO:0001939;GO:0001940;GO:0005654;GO:0005634;GO:0016538;GO:0019904;GO:0019901;GO:0031100;GO:0044843;GO:0051301;GO:0071314;GO:0071392;GO:0071456;GO:1990314;GO:0044320;GO:0071373;GO:0071732;GO:0036120;GO:0090102;GO:0000086;GO:0016572;GO:0044772;GO:0048146;GO:0045893;GO:0016579;GO:0007265;GO:0000079;GO:0006275;GO:0033762;GO:0016032;, C:cyclin A2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:female pronucleus; C:male pronucleus; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein domain specific binding; F:protein kinase binding;, P:animal organ regeneration; P:cell cycle G1/S phase transition; P:cell division; P:cellular response to cocaine; P:cellular response to estradiol stimulus; P:cellular response to hypoxia; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to luteinizing hormone stimulus; P:cellular response to nitric oxide; P:cellular response to platelet-derived growth factor stimulus; P:cochlea development; P:G2/M transition of mitotic cell cycle; P:histone phosphorylation; P:mitotic cell cycle phase transition; P:positive regulation of fibroblast proliferation; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of DNA replication; P:response to glucagon; P:viral process;|P20248 A8K7B6 Q2M3U6 Q4W5P4 Q6LER8,Cyclin-A2 {ECO:0000312|HGNC:HGNC:1578},Cyclin A {ECO:0000303|PubMed:1967822};, PF02984;PF00134;PF16500;, GO:0097124;GO:0000307;GO:0005737;GO:0005829;GO:0001939;GO:0001940;GO:0005654;GO:0005634;GO:0016538;GO:0019904;GO:0019901;GO:0031100;GO:0044843;GO:0051301;GO:0071314;GO:0071392;GO:0071456;GO:1990314;GO:0044320;GO:0071373;GO:0071732;GO:0036120;GO:0090102;GO:0000086;GO:0016572;GO:0044772;GO:0048146;GO:0045893;GO:0016579;GO:0007265;GO:0000079;GO:0006275;GO:0033762;GO:0016032;, C:cyclin A2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:female pronucleus; C:male pronucleus; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein domain specific binding; F:protein kinase binding;, P:animal organ regeneration; P:cell cycle G1/S phase transition; P:cell division; P:cellular response to cocaine; P:cellular response to estradiol stimulus; P:cellular response to hypoxia; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to luteinizing hormone stimulus; P:cellular response to nitric oxide; P:cellular response to platelet-derived growth factor stimulus; P:cochlea development; P:G2/M transition of mitotic cell cycle; P:histone phosphorylation; P:mitotic cell cycle phase transition; P:positive regulation of fibroblast proliferation; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of DNA replication; P:response to glucagon; P:viral process;|P20248 A8K7B6 Q2M3U6 Q4W5P4 Q6LER8,Cyclin-A2 {ECO:0000312|HGNC:HGNC:1578},Cyclin A {ECO:0000303|PubMed:1967822};, PF02984;PF00134;PF16500;, GO:0097124;GO:0000307;GO:0005737;GO:0005829;GO:0001939;GO:0001940;GO:0005654;GO:0005634;GO:0016538;GO:0019904;GO:0019901;GO:0031100;GO:0044843;GO:0051301;GO:0071314;GO:0071392;GO:0071456;GO:1990314;GO:0044320;GO:0071373;GO:0071732;GO:0036120;GO:0090102;GO:0000086;GO:0016572;GO:0044772;GO:0048146;GO:0045893;GO:0016579;GO:0007265;GO:0000079;GO:0006275;GO:0033762;GO:0016032;, C:cyclin A2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:female pronucleus; C:male pronucleus; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein domain specific binding; F:protein kinase binding;, P:animal organ regeneration; P:cell cycle G1/S phase transition; P:cell division; P:cellular response to cocaine; P:cellular response to estradiol stimulus; P:cellular response to hypoxia; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to luteinizing hormone stimulus; P:cellular response to nitric oxide; P:cellular response to platelet-derived growth factor stimulus; P:cochlea development; P:G2/M transition of mitotic cell cycle; P:histone phosphorylation; P:mitotic cell cycle phase transition; P:positive regulation of fibroblast proliferation; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of DNA replication; P:response to glucagon; P:viral process;|P20248 A8K7B6 Q2M3U6 Q4W5P4 Q6LER8,Cyclin-A2 {ECO:0000312|HGNC:HGNC:1578},Cyclin A {ECO:0000303|PubMed:1967822};, PF02984;PF00134;PF16500;, GO:0097124;GO:0000307;GO:0005737;GO:0005829;GO:0001939;GO:0001940;GO:0005654;GO:0005634;GO:0016538;GO:0019904;GO:0019901;GO:0031100;GO:0044843;GO:0051301;GO:0071314;GO:0071392;GO:0071456;GO:1990314;GO:0044320;GO:0071373;GO:0071732;GO:0036120;GO:0090102;GO:0000086;GO:0016572;GO:0044772;GO:0048146;GO:0045893;GO:0016579;GO:0007265;GO:0000079;GO:0006275;GO:0033762;GO:0016032;, C:cyclin A2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:female pronucleus; C:male pronucleus; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein domain specific binding; F:protein kinase binding;, P:animal organ regeneration; P:cell cycle G1/S phase transition; P:cell division; P:cellular response to cocaine; P:cellular response to estradiol stimulus; P:cellular response to hypoxia; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to luteinizing hormone stimulus; P:cellular response to nitric oxide; P:cellular response to platelet-derived growth factor stimulus; P:cochlea development; P:G2/M transition of mitotic cell cycle; P:histone phosphorylation; P:mitotic cell cycle phase transition; P:positive regulation of fibroblast proliferation; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of DNA replication; P:response to glucagon; P:viral process;|P20248 A8K7B6 Q2M3U6 Q4W5P4 Q6LER8,Cyclin-A2 {ECO:0000312|HGNC:HGNC:1578},Cyclin A {ECO:0000303|PubMed:1967822};, PF02984;PF00134;PF16500;, GO:0097124;GO:0000307;GO:0005737;GO:0005829;GO:0001939;GO:0001940;GO:0005654;GO:0005634;GO:0016538;GO:0019904;GO:0019901;GO:0031100;GO:0044843;GO:0051301;GO:0071314;GO:0071392;GO:0071456;GO:1990314;GO:0044320;GO:0071373;GO:0071732;GO:0036120;GO:0090102;GO:0000086;GO:0016572;GO:0044772;GO:0048146;GO:0045893;GO:0016579;GO:0007265;GO:0000079;GO:0006275;GO:0033762;GO:0016032;, C:cyclin A2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:female pronucleus; C:male pronucleus; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein domain specific binding; F:protein kinase binding;, P:animal organ regeneration; P:cell cycle G1/S phase transition; P:cell division; P:cellular response to cocaine; P:cellular response to estradiol stimulus; P:cellular response to hypoxia; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to luteinizing hormone stimulus; P:cellular response to nitric oxide; P:cellular response to platelet-derived growth factor stimulus; P:cochlea development; P:G2/M transition of mitotic cell cycle; P:histone phosphorylation; P:mitotic cell cycle phase transition; P:positive regulation of fibroblast proliferation; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:Ras protein signal transduction; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of DNA replication; P:response to glucagon; P:viral process;|Q06265 Q12883 Q4W5P5 Q86Y41 Q86Y48,Exosome complex component RRP45,Autoantigen PM/Scl 1;Exosome component 9;P75 polymyositis-scleroderma overlap syndrome-associated autoantigen;Polymyositis/scleroderma autoantigen 1;Polymyositis/scleroderma autoantigen 75 kDa;, PF01138;PF03725;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0070062;GO:0000228;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0035925;GO:0003723;GO:0001102;GO:0043928;GO:0000467;GO:0006955;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0000956;GO:0034427;GO:0030307;GO:0045944;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:extracellular exosome; C:nuclear chromosome; C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:immune response; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:positive regulation of cell growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q06265 Q12883 Q4W5P5 Q86Y41 Q86Y48,Exosome complex component RRP45,Autoantigen PM/Scl 1;Exosome component 9;P75 polymyositis-scleroderma overlap syndrome-associated autoantigen;Polymyositis/scleroderma autoantigen 1;Polymyositis/scleroderma autoantigen 75 kDa;, PF01138;PF03725;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0070062;GO:0000228;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0035925;GO:0003723;GO:0001102;GO:0043928;GO:0000467;GO:0006955;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0000956;GO:0034427;GO:0030307;GO:0045944;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:extracellular exosome; C:nuclear chromosome; C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:immune response; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:positive regulation of cell growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q06265 Q12883 Q4W5P5 Q86Y41 Q86Y48,Exosome complex component RRP45,Autoantigen PM/Scl 1;Exosome component 9;P75 polymyositis-scleroderma overlap syndrome-associated autoantigen;Polymyositis/scleroderma autoantigen 1;Polymyositis/scleroderma autoantigen 75 kDa;, PF01138;PF03725;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0070062;GO:0000228;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0035925;GO:0003723;GO:0001102;GO:0043928;GO:0000467;GO:0006955;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0000956;GO:0034427;GO:0030307;GO:0045944;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:extracellular exosome; C:nuclear chromosome; C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:immune response; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:positive regulation of cell growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q06265 Q12883 Q4W5P5 Q86Y41 Q86Y48,Exosome complex component RRP45,Autoantigen PM/Scl 1;Exosome component 9;P75 polymyositis-scleroderma overlap syndrome-associated autoantigen;Polymyositis/scleroderma autoantigen 1;Polymyositis/scleroderma autoantigen 75 kDa;, PF01138;PF03725;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0070062;GO:0000228;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0035925;GO:0003723;GO:0001102;GO:0043928;GO:0000467;GO:0006955;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0000956;GO:0034427;GO:0030307;GO:0045944;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:extracellular exosome; C:nuclear chromosome; C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:immune response; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:positive regulation of cell growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q06265 Q12883 Q4W5P5 Q86Y41 Q86Y48,Exosome complex component RRP45,Autoantigen PM/Scl 1;Exosome component 9;P75 polymyositis-scleroderma overlap syndrome-associated autoantigen;Polymyositis/scleroderma autoantigen 1;Polymyositis/scleroderma autoantigen 75 kDa;, PF01138;PF03725;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0070062;GO:0000228;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0035925;GO:0003723;GO:0001102;GO:0043928;GO:0000467;GO:0006955;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0000956;GO:0034427;GO:0030307;GO:0045944;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:extracellular exosome; C:nuclear chromosome; C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:immune response; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:positive regulation of cell growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q06265 Q12883 Q4W5P5 Q86Y41 Q86Y48,Exosome complex component RRP45,Autoantigen PM/Scl 1;Exosome component 9;P75 polymyositis-scleroderma overlap syndrome-associated autoantigen;Polymyositis/scleroderma autoantigen 1;Polymyositis/scleroderma autoantigen 75 kDa;, PF01138;PF03725;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0070062;GO:0000228;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0035925;GO:0003723;GO:0001102;GO:0043928;GO:0000467;GO:0006955;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0000956;GO:0034427;GO:0030307;GO:0045944;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:extracellular exosome; C:nuclear chromosome; C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:immune response; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:positive regulation of cell growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q06265 Q12883 Q4W5P5 Q86Y41 Q86Y48,Exosome complex component RRP45,Autoantigen PM/Scl 1;Exosome component 9;P75 polymyositis-scleroderma overlap syndrome-associated autoantigen;Polymyositis/scleroderma autoantigen 1;Polymyositis/scleroderma autoantigen 75 kDa;, PF01138;PF03725;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0070062;GO:0000228;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0035925;GO:0003723;GO:0001102;GO:0043928;GO:0000467;GO:0006955;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0000956;GO:0034427;GO:0030307;GO:0045944;GO:0043488;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:extracellular exosome; C:nuclear chromosome; C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:immune response; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:positive regulation of cell growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing; scaffold57 indexed_genome mRNA 1529572 1549365 . + . ID=transcript_10225;P08758 D3DNW7 Q6FHB3 Q6FI16 Q8WV69 Q9UDH9,Annexin A5,Anchorin CII;Annexin V;Annexin-5;Calphobindin I;Endonexin II;Lipocortin V;Placental anticoagulant protein 4;Placental anticoagulant protein I;Thromboplastin inhibitor;Vascular anticoagulant-alpha;, PF00191;, GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0016020;GO:0005509;GO:0005544;GO:0004859;GO:0005543;GO:0007596;GO:0043066;GO:0050819;GO:0002576;GO:0007165;, C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phospholipase inhibitor activity; F:phospholipid binding;, P:blood coagulation; P:negative regulation of apoptotic process; P:negative regulation of coagulation; P:platelet degranulation; P:signal transduction; scaffold57 indexed_genome mRNA 1797993 1799407 . - . ID=transcript_10226;Q14155 B1ALK6 B1ALK8 Q3LIA4 Q5W9H0 Q6P9G3 Q6PII2 Q86W63 Q8N3M1,Rho guanine nucleotide exchange factor 7,Beta-Pix;COOL-1;PAK-interacting exchange factor beta;p85;, PF00307;PF00169;PF00621;PF07653;, GO:0005938;GO:0005813;GO:0005829;GO:0005925;GO:0030027;GO:0097431;GO:0043005;GO:0043025;GO:0098794;GO:0032991;GO:0001726;GO:0043015;GO:0005085;GO:0019901;GO:0048013;GO:0048041;GO:0007186;GO:0007030;GO:0035556;GO:0030032;GO:0042059;GO:1905833;GO:0007399;GO:0043065;GO:0010763;GO:0043547;GO:2000394;GO:1900026;GO:1904424;GO:0051056;GO:0007165;, C:cell cortex; C:centrosome; C:cytosol; C:focal adhesion; C:lamellipodium; C:mitotic spindle pole; C:neuron projection; C:neuronal cell body; C:postsynapse; C:protein-containing complex; C:ruffle;, F:gamma-tubulin binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase binding;, P:ephrin receptor signaling pathway; P:focal adhesion assembly; P:G protein-coupled receptor signaling pathway; P:Golgi organization; P:intracellular signal transduction; P:lamellipodium assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of microtubule nucleation; P:nervous system development; P:positive regulation of apoptotic process; P:positive regulation of fibroblast migration; P:positive regulation of GTPase activity; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of GTP binding; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold57 indexed_genome mRNA 2340450 2392017 . + . ID=transcript_10227;Q8TB73 A8K0Q0 Q6UWE5 Q9H5P7,Protein NDNF,Neuron-derived neurotrophic factor;, PF10179;, GO:0031012;GO:0005576;GO:0005615;GO:0005539;GO:0008201;GO:0001525;GO:0044344;GO:0071456;GO:0030198;GO:0021828;GO:2000352;GO:0043524;GO:0001764;GO:0007263;GO:0019800;GO:0010811;GO:0010976;GO:0002931;GO:0061042;, C:extracellular matrix; C:extracellular region; C:extracellular space;, F:glycosaminoglycan binding; F:heparin binding;, P:angiogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to hypoxia; P:extracellular matrix organization; P:gonadotrophin-releasing hormone neuronal migration to the hypothalamus; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:neuron migration; P:nitric oxide mediated signal transduction; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; P:positive regulation of cell-substrate adhesion; P:positive regulation of neuron projection development; P:response to ischemia; P:vascular wound healing; scaffold57 indexed_genome mRNA 2563380 2616623 . + . ID=transcript_10228;Q9NQX1 Q0VAI9 Q0VAJ0 Q6NXQ7,PR domain zinc finger protein 5,PR domain-containing protein 5;, PF00096;, GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0003700;GO:0001227;GO:0046872;GO:0008168;GO:0070491;GO:0000978;GO:0000977;GO:0043565;GO:0000976;GO:1990830;GO:0016575;GO:0051567;GO:0000278;GO:0000122;GO:0045892;GO:0010468;, C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:methyltransferase activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:histone deacetylation; P:histone H3-K9 methylation; P:mitotic cell cycle; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of gene expression; scaffold57 indexed_genome mRNA 2634457 2717182 . + . ID=transcript_10229;Q9NQX1 Q0VAI9 Q0VAJ0 Q6NXQ7,PR domain zinc finger protein 5,PR domain-containing protein 5;, PF00096;, GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0003700;GO:0001227;GO:0046872;GO:0008168;GO:0070491;GO:0000978;GO:0000977;GO:0043565;GO:0000976;GO:1990830;GO:0016575;GO:0051567;GO:0000278;GO:0000122;GO:0045892;GO:0010468;, C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:methyltransferase activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to leukemia inhibitory factor; P:histone deacetylation; P:histone H3-K9 methylation; P:mitotic cell cycle; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of gene expression; scaffold57 indexed_genome mRNA 3130436 3388831 . + . ID=transcript_10230;Q13257 Q53F56 Q548X9 Q6IRW7 Q8IZX3,Mitotic spindle assembly checkpoint protein MAD2A,Mitotic arrest deficient 2-like protein 1;, PF02301;, GO:0000777;GO:0005737;GO:0005829;GO:0000776;GO:0072686;GO:0044615;GO:0005654;GO:0005634;GO:0048471;GO:0000922;GO:0042802;GO:0008022;GO:0042803;GO:0031145;GO:0051301;GO:0051660;GO:0000132;GO:0007094;GO:0007052;GO:0043066;GO:0045930;GO:0042177;GO:1904667;GO:0090267;GO:0007096;GO:1901990;GO:0006511;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:mitotic spindle; C:nuclear pore nuclear basket; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle pole;, F:identical protein binding; F:protein C-terminus binding; F:protein homodimerization activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:establishment of centrosome localization; P:establishment of mitotic spindle orientation; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:negative regulation of apoptotic process; P:negative regulation of mitotic cell cycle; P:negative regulation of protein catabolic process; P:negative regulation of ubiquitin protein ligase activity; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold57 indexed_genome mRNA 3776936 3892208 . + . ID=transcript_10231;O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6,cGMP-specific 3',5'-cyclic phosphodiesterase,cGMP-binding cGMP-specific phosphodiesterase;, PF01590;PF00233;, GO:0005829;GO:0047555;GO:0004114;GO:0030553;GO:0046872;GO:0046069;GO:0007165;, C:cytosol;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP binding; F:metal ion binding;, P:cGMP catabolic process; P:signal transduction;|O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6,cGMP-specific 3',5'-cyclic phosphodiesterase,cGMP-binding cGMP-specific phosphodiesterase;, PF01590;PF00233;, GO:0005829;GO:0047555;GO:0004114;GO:0030553;GO:0046872;GO:0046069;GO:0007165;, C:cytosol;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP binding; F:metal ion binding;, P:cGMP catabolic process; P:signal transduction; scaffold57 indexed_genome mRNA 3895846 3930195 . + . ID=transcript_10232;O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6,cGMP-specific 3',5'-cyclic phosphodiesterase,cGMP-binding cGMP-specific phosphodiesterase;, PF01590;PF00233;, GO:0005829;GO:0047555;GO:0004114;GO:0030553;GO:0046872;GO:0046069;GO:0007165;, C:cytosol;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP binding; F:metal ion binding;, P:cGMP catabolic process; P:signal transduction;|O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6,cGMP-specific 3',5'-cyclic phosphodiesterase,cGMP-binding cGMP-specific phosphodiesterase;, PF01590;PF00233;, GO:0005829;GO:0047555;GO:0004114;GO:0030553;GO:0046872;GO:0046069;GO:0007165;, C:cytosol;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP binding; F:metal ion binding;, P:cGMP catabolic process; P:signal transduction; scaffold57 indexed_genome mRNA 3992092 4053052 . - . ID=transcript_10233;Q70EK8 Q68DA5 Q8WVQ5 Q9P2J7,Inactive ubiquitin carboxyl-terminal hydrolase 53,Inactive ubiquitin-specific peptidase 53;, PF00443;, GO:0005923;GO:0005911;GO:0001508;GO:0051402;GO:0016579;GO:0018215;GO:0010996;GO:0007605;, C:bicellular tight junction; C:cell-cell junction;, , P:action potential; P:neuron apoptotic process; P:protein deubiquitination; P:protein phosphopantetheinylation; P:response to auditory stimulus; P:sensory perception of sound;|Q70EK8 Q68DA5 Q8WVQ5 Q9P2J7,Inactive ubiquitin carboxyl-terminal hydrolase 53,Inactive ubiquitin-specific peptidase 53;, PF00443;, GO:0005923;GO:0005911;GO:0001508;GO:0051402;GO:0016579;GO:0018215;GO:0010996;GO:0007605;, C:bicellular tight junction; C:cell-cell junction;, , P:action potential; P:neuron apoptotic process; P:protein deubiquitination; P:protein phosphopantetheinylation; P:response to auditory stimulus; P:sensory perception of sound; scaffold57 indexed_genome mRNA 4061039 4110385 . - . ID=transcript_10234;Q9NPC6 O43415 Q9HB92,Myozenin-2,Calsarcin-1;FATZ-related protein 2;, PF05556;, GO:0015629;GO:0030017;GO:0030018;GO:0003779;GO:0051373;GO:0030346;GO:0031433;GO:0070885;GO:0000122;GO:0045214;GO:0043503;GO:0007519;, C:actin cytoskeleton; C:sarcomere; C:Z disc;, F:actin binding; F:FATZ binding; F:protein phosphatase 2B binding; F:telethonin binding;, P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of transcription by RNA polymerase II; P:sarcomere organization; P:skeletal muscle fiber adaptation; P:skeletal muscle tissue development;|Q9NPC6 O43415 Q9HB92,Myozenin-2,Calsarcin-1;FATZ-related protein 2;, PF05556;, GO:0015629;GO:0030017;GO:0030018;GO:0003779;GO:0051373;GO:0030346;GO:0031433;GO:0070885;GO:0000122;GO:0045214;GO:0043503;GO:0007519;, C:actin cytoskeleton; C:sarcomere; C:Z disc;, F:actin binding; F:FATZ binding; F:protein phosphatase 2B binding; F:telethonin binding;, P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of transcription by RNA polymerase II; P:sarcomere organization; P:skeletal muscle fiber adaptation; P:skeletal muscle tissue development;|Q9NPC6 O43415 Q9HB92,Myozenin-2,Calsarcin-1;FATZ-related protein 2;, PF05556;, GO:0015629;GO:0030017;GO:0030018;GO:0003779;GO:0051373;GO:0030346;GO:0031433;GO:0070885;GO:0000122;GO:0045214;GO:0043503;GO:0007519;, C:actin cytoskeleton; C:sarcomere; C:Z disc;, F:actin binding; F:FATZ binding; F:protein phosphatase 2B binding; F:telethonin binding;, P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of transcription by RNA polymerase II; P:sarcomere organization; P:skeletal muscle fiber adaptation; P:skeletal muscle tissue development; scaffold57 indexed_genome mRNA 4229238 4245234 . - . ID=transcript_10235;Q9UMS6 B2RWP6 B2Y8J9 C6H0M7 Q9UK89 S5XAM4,Synaptopodin-2,Genethonin-2;Myopodin;, PF00595;, GO:0015629;GO:0005829;GO:0005925;GO:0043231;GO:0005654;GO:0005634;GO:0001725;GO:0099023;GO:0030018;GO:0071889;GO:0003779;GO:0051393;GO:0031005;GO:0051371;GO:0030674;GO:0000045;GO:0061684;GO:0032233;GO:0030335;GO:2000298;, C:actin cytoskeleton; C:cytosol; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:stress fiber; C:vesicle tethering complex; C:Z disc;, F:14-3-3 protein binding; F:actin binding; F:alpha-actinin binding; F:filamin binding; F:muscle alpha-actinin binding; F:protein-macromolecule adaptor activity;, P:autophagosome assembly; P:chaperone-mediated autophagy; P:positive regulation of actin filament bundle assembly; P:positive regulation of cell migration; P:regulation of Rho-dependent protein serine/threonine kinase activity; scaffold57 indexed_genome mRNA 4473322 4589628 . + . ID=transcript_10236;O94855 Q8IYI7,Protein transport protein Sec24D {ECO:0000305},SEC24-related protein D;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0043231;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0001701;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:intracellular membrane-bounded organelle;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:in utero embryonic development; P:intracellular protein transport;|O94855 Q8IYI7,Protein transport protein Sec24D {ECO:0000305},SEC24-related protein D;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0043231;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0048208;GO:0090110;GO:0006888;GO:0001701;GO:0006886;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:intracellular membrane-bounded organelle;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:in utero embryonic development; P:intracellular protein transport; scaffold57 indexed_genome mRNA 4613179 4653297 . - . ID=transcript_10237;Q9HCE5 A6NIG1 Q969V2,N6-adenosine-methyltransferase non-catalytic subunit {ECO:0000305},Methyltransferase-like protein 14 {ECO:0000312|HGNC:HGNC:29330};, PF05063;, GO:0005654;GO:0005634;GO:0036396;GO:0016422;GO:0003729;GO:0021861;GO:0042063;GO:0006402;GO:0061157;GO:0080009;GO:0000398;GO:1901533;GO:0045727;GO:0016070;GO:0007283;GO:0019827;, C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:mRNA binding;, P:forebrain radial glial cell differentiation; P:gliogenesis; P:mRNA catabolic process; P:mRNA destabilization; P:mRNA methylation; P:mRNA splicing, via spliceosome; P:negative regulation of hematopoietic progenitor cell differentiation; P:positive regulation of translation; P:RNA metabolic process; P:spermatogenesis; P:stem cell population maintenance;|Q9HCE5 A6NIG1 Q969V2,N6-adenosine-methyltransferase non-catalytic subunit {ECO:0000305},Methyltransferase-like protein 14 {ECO:0000312|HGNC:HGNC:29330};, PF05063;, GO:0005654;GO:0005634;GO:0036396;GO:0016422;GO:0003729;GO:0021861;GO:0042063;GO:0006402;GO:0061157;GO:0080009;GO:0000398;GO:1901533;GO:0045727;GO:0016070;GO:0007283;GO:0019827;, C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:mRNA binding;, P:forebrain radial glial cell differentiation; P:gliogenesis; P:mRNA catabolic process; P:mRNA destabilization; P:mRNA methylation; P:mRNA splicing, via spliceosome; P:negative regulation of hematopoietic progenitor cell differentiation; P:positive regulation of translation; P:RNA metabolic process; P:spermatogenesis; P:stem cell population maintenance;|Q9HCE5 A6NIG1 Q969V2,N6-adenosine-methyltransferase non-catalytic subunit {ECO:0000305},Methyltransferase-like protein 14 {ECO:0000312|HGNC:HGNC:29330};, PF05063;, GO:0005654;GO:0005634;GO:0036396;GO:0016422;GO:0003729;GO:0021861;GO:0042063;GO:0006402;GO:0061157;GO:0080009;GO:0000398;GO:1901533;GO:0045727;GO:0016070;GO:0007283;GO:0019827;, C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:mRNA binding;, P:forebrain radial glial cell differentiation; P:gliogenesis; P:mRNA catabolic process; P:mRNA destabilization; P:mRNA methylation; P:mRNA splicing, via spliceosome; P:negative regulation of hematopoietic progenitor cell differentiation; P:positive regulation of translation; P:RNA metabolic process; P:spermatogenesis; P:stem cell population maintenance; scaffold57 indexed_genome mRNA 4800247 4817119 . + . ID=transcript_10238;P56730 Q9UP16,Neurotrypsin,Leydin;Motopsin;Serine protease 12;, PF00051;PF00530;PF00089;, GO:0030424;GO:0031410;GO:0030425;GO:0005886;GO:0043083;GO:0043195;GO:0005044;GO:0004252;GO:0008236;GO:0006887;GO:0031638;, C:axon; C:cytoplasmic vesicle; C:dendrite; C:plasma membrane; C:synaptic cleft; C:terminal bouton;, F:scavenger receptor activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:exocytosis; P:zymogen activation; scaffold57 indexed_genome mRNA 4817741 4818262 . + . ID=transcript_10239;P56730 Q9UP16,Neurotrypsin,Leydin;Motopsin;Serine protease 12;, PF00051;PF00530;PF00089;, GO:0030424;GO:0031410;GO:0030425;GO:0005886;GO:0043083;GO:0043195;GO:0005044;GO:0004252;GO:0008236;GO:0006887;GO:0031638;, C:axon; C:cytoplasmic vesicle; C:dendrite; C:plasma membrane; C:synaptic cleft; C:terminal bouton;, F:scavenger receptor activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:exocytosis; P:zymogen activation; scaffold57 indexed_genome mRNA 4831246 4840573 . - . ID=transcript_10240;P56730 Q9UP16,Neurotrypsin,Leydin;Motopsin;Serine protease 12;, PF00051;PF00530;PF00089;, GO:0030424;GO:0031410;GO:0030425;GO:0005886;GO:0043083;GO:0043195;GO:0005044;GO:0004252;GO:0008236;GO:0006887;GO:0031638;, C:axon; C:cytoplasmic vesicle; C:dendrite; C:plasma membrane; C:synaptic cleft; C:terminal bouton;, F:scavenger receptor activity; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:exocytosis; P:zymogen activation; scaffold57 indexed_genome mRNA 4867122 5028597 . - . ID=transcript_10241;O95803 B4DI67 Q4W5C1 Q4W5D0 Q6UWC5 Q9UP21,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3,Glucosaminyl N-deacetylase/N-sulfotransferase 3;N-heparan sulfate sulfotransferase 3;, PF12062;PF00685;, GO:0005794;GO:0000139;GO:0016021;GO:0015016;GO:0019213;GO:0102140;GO:0015012;GO:0015014;GO:0030210;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:[heparan sulfate]-glucosamine N-sulfotransferase activity; F:deacetylase activity; F:heparan sulfate N-deacetylase activity;, P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process;|O95803 B4DI67 Q4W5C1 Q4W5D0 Q6UWC5 Q9UP21,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3,Glucosaminyl N-deacetylase/N-sulfotransferase 3;N-heparan sulfate sulfotransferase 3;, PF12062;PF00685;, GO:0005794;GO:0000139;GO:0016021;GO:0015016;GO:0019213;GO:0102140;GO:0015012;GO:0015014;GO:0030210;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:[heparan sulfate]-glucosamine N-sulfotransferase activity; F:deacetylase activity; F:heparan sulfate N-deacetylase activity;, P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process;|O95803 B4DI67 Q4W5C1 Q4W5D0 Q6UWC5 Q9UP21,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3,Glucosaminyl N-deacetylase/N-sulfotransferase 3;N-heparan sulfate sulfotransferase 3;, PF12062;PF00685;, GO:0005794;GO:0000139;GO:0016021;GO:0015016;GO:0019213;GO:0102140;GO:0015012;GO:0015014;GO:0030210;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:[heparan sulfate]-glucosamine N-sulfotransferase activity; F:deacetylase activity; F:heparan sulfate N-deacetylase activity;, P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process;|O95803 B4DI67 Q4W5C1 Q4W5D0 Q6UWC5 Q9UP21,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3,Glucosaminyl N-deacetylase/N-sulfotransferase 3;N-heparan sulfate sulfotransferase 3;, PF12062;PF00685;, GO:0005794;GO:0000139;GO:0016021;GO:0015016;GO:0019213;GO:0102140;GO:0015012;GO:0015014;GO:0030210;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:[heparan sulfate]-glucosamine N-sulfotransferase activity; F:deacetylase activity; F:heparan sulfate N-deacetylase activity;, P:heparan sulfate proteoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; scaffold57 indexed_genome mRNA 6065652 6067958 . - . ID=transcript_10242;Q8N609 Q8N2L7,Translocating chain-associated membrane protein 1-like 1,, PF08390;PF03798;, GO:0030176;GO:0045048;GO:0006616;, C:integral component of endoplasmic reticulum membrane;, , P:protein insertion into ER membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; scaffold57 indexed_genome mRNA 8452271 8536697 . - . ID=transcript_10243;Q16880 B3KXU7 O00196,2-hydroxyacylsphingosine 1-beta-galactosyltransferase {ECO:0000305},Ceramide UDP-galactosyltransferase;Cerebroside synthase;UDP-galactose-ceramide galactosyltransferase;, PF00201;, GO:0005783;GO:0016021;GO:0043231;GO:0005886;GO:0003851;GO:0047263;GO:0008489;GO:0007417;GO:0007010;GO:0006682;GO:0006687;GO:0048812;GO:0030913;GO:0007422;GO:0002175;, C:endoplasmic reticulum; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; F:N-acylsphingosine galactosyltransferase activity; F:UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity;, P:central nervous system development; P:cytoskeleton organization; P:galactosylceramide biosynthetic process; P:glycosphingolipid metabolic process; P:neuron projection morphogenesis; P:paranodal junction assembly; P:peripheral nervous system development; P:protein localization to paranode region of axon;|Q16880 B3KXU7 O00196,2-hydroxyacylsphingosine 1-beta-galactosyltransferase {ECO:0000305},Ceramide UDP-galactosyltransferase;Cerebroside synthase;UDP-galactose-ceramide galactosyltransferase;, PF00201;, GO:0005783;GO:0016021;GO:0043231;GO:0005886;GO:0003851;GO:0047263;GO:0008489;GO:0007417;GO:0007010;GO:0006682;GO:0006687;GO:0048812;GO:0030913;GO:0007422;GO:0002175;, C:endoplasmic reticulum; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; F:N-acylsphingosine galactosyltransferase activity; F:UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity;, P:central nervous system development; P:cytoskeleton organization; P:galactosylceramide biosynthetic process; P:glycosphingolipid metabolic process; P:neuron projection morphogenesis; P:paranodal junction assembly; P:peripheral nervous system development; P:protein localization to paranode region of axon;|Q16880 B3KXU7 O00196,2-hydroxyacylsphingosine 1-beta-galactosyltransferase {ECO:0000305},Ceramide UDP-galactosyltransferase;Cerebroside synthase;UDP-galactose-ceramide galactosyltransferase;, PF00201;, GO:0005783;GO:0016021;GO:0043231;GO:0005886;GO:0003851;GO:0047263;GO:0008489;GO:0007417;GO:0007010;GO:0006682;GO:0006687;GO:0048812;GO:0030913;GO:0007422;GO:0002175;, C:endoplasmic reticulum; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; F:N-acylsphingosine galactosyltransferase activity; F:UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity;, P:central nervous system development; P:cytoskeleton organization; P:galactosylceramide biosynthetic process; P:glycosphingolipid metabolic process; P:neuron projection morphogenesis; P:paranodal junction assembly; P:peripheral nervous system development; P:protein localization to paranode region of axon; scaffold57 indexed_genome mRNA 9252273 9555079 . + . ID=transcript_10244;Q13557 A8MVS8 Q52PK4 Q59G21 Q8N553 Q9UGH6 Q9UQE9,Calcium/calmodulin-dependent protein kinase type II subunit delta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0042383;GO:0033017;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0044325;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0019871;GO:0031432;GO:0086003;GO:0071277;GO:0032469;GO:0060333;GO:1902306;GO:2000650;GO:0018105;GO:0018107;GO:0010666;GO:0010613;GO:0046777;GO:0006468;GO:1902514;GO:0098901;GO:0098909;GO:0010881;GO:0010649;GO:1901844;GO:0001558;GO:0060341;GO:1900034;GO:0008016;GO:0086091;GO:1901725;GO:0003254;GO:1901897;GO:0010880;GO:0060314;GO:0002026;GO:0006357;GO:0055119;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:sarcolemma; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:ion channel binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:sodium channel inhibitor activity; F:titin binding;, P:cardiac muscle cell contraction; P:cellular response to calcium ion; P:endoplasmic reticulum calcium ion homeostasis; P:interferon-gamma-mediated signaling pathway; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cardiac muscle hypertrophy; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cell growth; P:regulation of cellular localization; P:regulation of cellular response to heat; P:regulation of heart contraction; P:regulation of heart rate by cardiac conduction; P:regulation of histone deacetylase activity; P:regulation of membrane depolarization; P:regulation of relaxation of cardiac muscle; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of the force of heart contraction; P:regulation of transcription by RNA polymerase II; P:relaxation of cardiac muscle;|Q13557 A8MVS8 Q52PK4 Q59G21 Q8N553 Q9UGH6 Q9UQE9,Calcium/calmodulin-dependent protein kinase type II subunit delta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0042383;GO:0033017;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0044325;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0019871;GO:0031432;GO:0086003;GO:0071277;GO:0032469;GO:0060333;GO:1902306;GO:2000650;GO:0018105;GO:0018107;GO:0010666;GO:0010613;GO:0046777;GO:0006468;GO:1902514;GO:0098901;GO:0098909;GO:0010881;GO:0010649;GO:1901844;GO:0001558;GO:0060341;GO:1900034;GO:0008016;GO:0086091;GO:1901725;GO:0003254;GO:1901897;GO:0010880;GO:0060314;GO:0002026;GO:0006357;GO:0055119;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:sarcolemma; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:ion channel binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:sodium channel inhibitor activity; F:titin binding;, P:cardiac muscle cell contraction; P:cellular response to calcium ion; P:endoplasmic reticulum calcium ion homeostasis; P:interferon-gamma-mediated signaling pathway; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cardiac muscle hypertrophy; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cell growth; P:regulation of cellular localization; P:regulation of cellular response to heat; P:regulation of heart contraction; P:regulation of heart rate by cardiac conduction; P:regulation of histone deacetylase activity; P:regulation of membrane depolarization; P:regulation of relaxation of cardiac muscle; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of the force of heart contraction; P:regulation of transcription by RNA polymerase II; P:relaxation of cardiac muscle;|Q13557 A8MVS8 Q52PK4 Q59G21 Q8N553 Q9UGH6 Q9UQE9,Calcium/calmodulin-dependent protein kinase type II subunit delta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0042383;GO:0033017;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0044325;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0019871;GO:0031432;GO:0086003;GO:0071277;GO:0032469;GO:0060333;GO:1902306;GO:2000650;GO:0018105;GO:0018107;GO:0010666;GO:0010613;GO:0046777;GO:0006468;GO:1902514;GO:0098901;GO:0098909;GO:0010881;GO:0010649;GO:1901844;GO:0001558;GO:0060341;GO:1900034;GO:0008016;GO:0086091;GO:1901725;GO:0003254;GO:1901897;GO:0010880;GO:0060314;GO:0002026;GO:0006357;GO:0055119;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:sarcolemma; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:ion channel binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:sodium channel inhibitor activity; F:titin binding;, P:cardiac muscle cell contraction; P:cellular response to calcium ion; P:endoplasmic reticulum calcium ion homeostasis; P:interferon-gamma-mediated signaling pathway; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cardiac muscle hypertrophy; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cell growth; P:regulation of cellular localization; P:regulation of cellular response to heat; P:regulation of heart contraction; P:regulation of heart rate by cardiac conduction; P:regulation of histone deacetylase activity; P:regulation of membrane depolarization; P:regulation of relaxation of cardiac muscle; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of the force of heart contraction; P:regulation of transcription by RNA polymerase II; P:relaxation of cardiac muscle;|Q13557 A8MVS8 Q52PK4 Q59G21 Q8N553 Q9UGH6 Q9UQE9,Calcium/calmodulin-dependent protein kinase type II subunit delta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0042383;GO:0033017;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0044325;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0019871;GO:0031432;GO:0086003;GO:0071277;GO:0032469;GO:0060333;GO:1902306;GO:2000650;GO:0018105;GO:0018107;GO:0010666;GO:0010613;GO:0046777;GO:0006468;GO:1902514;GO:0098901;GO:0098909;GO:0010881;GO:0010649;GO:1901844;GO:0001558;GO:0060341;GO:1900034;GO:0008016;GO:0086091;GO:1901725;GO:0003254;GO:1901897;GO:0010880;GO:0060314;GO:0002026;GO:0006357;GO:0055119;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:sarcolemma; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:ion channel binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:sodium channel inhibitor activity; F:titin binding;, P:cardiac muscle cell contraction; P:cellular response to calcium ion; P:endoplasmic reticulum calcium ion homeostasis; P:interferon-gamma-mediated signaling pathway; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cardiac muscle hypertrophy; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cell growth; P:regulation of cellular localization; P:regulation of cellular response to heat; P:regulation of heart contraction; P:regulation of heart rate by cardiac conduction; P:regulation of histone deacetylase activity; P:regulation of membrane depolarization; P:regulation of relaxation of cardiac muscle; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of the force of heart contraction; P:regulation of transcription by RNA polymerase II; P:relaxation of cardiac muscle;|Q13557 A8MVS8 Q52PK4 Q59G21 Q8N553 Q9UGH6 Q9UQE9,Calcium/calmodulin-dependent protein kinase type II subunit delta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0042383;GO:0033017;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0044325;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0019871;GO:0031432;GO:0086003;GO:0071277;GO:0032469;GO:0060333;GO:1902306;GO:2000650;GO:0018105;GO:0018107;GO:0010666;GO:0010613;GO:0046777;GO:0006468;GO:1902514;GO:0098901;GO:0098909;GO:0010881;GO:0010649;GO:1901844;GO:0001558;GO:0060341;GO:1900034;GO:0008016;GO:0086091;GO:1901725;GO:0003254;GO:1901897;GO:0010880;GO:0060314;GO:0002026;GO:0006357;GO:0055119;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:sarcolemma; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:ion channel binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:sodium channel inhibitor activity; F:titin binding;, P:cardiac muscle cell contraction; P:cellular response to calcium ion; P:endoplasmic reticulum calcium ion homeostasis; P:interferon-gamma-mediated signaling pathway; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cardiac muscle hypertrophy; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cell growth; P:regulation of cellular localization; P:regulation of cellular response to heat; P:regulation of heart contraction; P:regulation of heart rate by cardiac conduction; P:regulation of histone deacetylase activity; P:regulation of membrane depolarization; P:regulation of relaxation of cardiac muscle; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of the force of heart contraction; P:regulation of transcription by RNA polymerase II; P:relaxation of cardiac muscle;|Q13557 A8MVS8 Q52PK4 Q59G21 Q8N553 Q9UGH6 Q9UQE9,Calcium/calmodulin-dependent protein kinase type II subunit delta,, PF08332;PF00069;, GO:0005954;GO:0005737;GO:0005829;GO:0030666;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0042383;GO:0033017;GO:0005524;GO:0005516;GO:0004683;GO:0042802;GO:0044325;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0019871;GO:0031432;GO:0086003;GO:0071277;GO:0032469;GO:0060333;GO:1902306;GO:2000650;GO:0018105;GO:0018107;GO:0010666;GO:0010613;GO:0046777;GO:0006468;GO:1902514;GO:0098901;GO:0098909;GO:0010881;GO:0010649;GO:1901844;GO:0001558;GO:0060341;GO:1900034;GO:0008016;GO:0086091;GO:1901725;GO:0003254;GO:1901897;GO:0010880;GO:0060314;GO:0002026;GO:0006357;GO:0055119;, C:calcium- and calmodulin-dependent protein kinase complex; C:cytoplasm; C:cytosol; C:endocytic vesicle membrane; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:sarcolemma; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:identical protein binding; F:ion channel binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:sodium channel inhibitor activity; F:titin binding;, P:cardiac muscle cell contraction; P:cellular response to calcium ion; P:endoplasmic reticulum calcium ion homeostasis; P:interferon-gamma-mediated signaling pathway; P:negative regulation of sodium ion transmembrane transport; P:negative regulation of sodium ion transmembrane transporter activity; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cardiac muscle hypertrophy; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cell growth; P:regulation of cellular localization; P:regulation of cellular response to heat; P:regulation of heart contraction; P:regulation of heart rate by cardiac conduction; P:regulation of histone deacetylase activity; P:regulation of membrane depolarization; P:regulation of relaxation of cardiac muscle; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of the force of heart contraction; P:regulation of transcription by RNA polymerase II; P:relaxation of cardiac muscle; scaffold57 indexed_genome mRNA 9665927 9741050 . - . ID=transcript_10245;Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential;|Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential;|Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential;|Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential;|Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential;|Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential; scaffold57 indexed_genome mRNA 9742070 10010910 . - . ID=transcript_10246;Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential;|Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential;|Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential;|Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential;|Q01484 Q01485 Q08AC7 Q08AC8 Q7Z3L5,Ankyrin-2,Ankyrin-B;Brain ankyrin;Non-erythroid ankyrin;, PF00023;PF12796;PF00531;PF17809;PF00791;, GO:0031672;GO:0016324;GO:0016323;GO:0043034;GO:0005856;GO:0005829;GO:0005769;GO:0014704;GO:0005764;GO:0031430;GO:0005739;GO:0043005;GO:0005886;GO:0045211;GO:0055037;GO:0042383;GO:0030315;GO:0030018;GO:0051117;GO:0008093;GO:0019899;GO:0044325;GO:0140031;GO:0019901;GO:0030674;GO:0030507;GO:0086014;GO:0086066;GO:0003283;GO:0006874;GO:0034613;GO:0006897;GO:0006888;GO:0086046;GO:1901021;GO:0051928;GO:2001259;GO:0010628;GO:1901018;GO:0043268;GO:0034394;GO:0070972;GO:0036309;GO:0033365;GO:0072659;GO:0036371;GO:0050821;GO:0015031;GO:0098910;GO:1901019;GO:0051924;GO:0086004;GO:0055117;GO:0010882;GO:0010881;GO:0002027;GO:0086091;GO:0031647;GO:0051279;GO:0098907;GO:0060307;GO:0086015;GO:0086070;GO:0070296;GO:0033292;GO:0086005;, C:A band; C:apical plasma membrane; C:basolateral plasma membrane; C:costamere; C:cytoskeleton; C:cytosol; C:early endosome; C:intercalated disc; C:lysosome; C:M band; C:mitochondrion; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:recycling endosome; C:sarcolemma; C:T-tubule; C:Z disc;, F:ATPase binding; F:cytoskeletal anchor activity; F:enzyme binding; F:ion channel binding; F:phosphorylation-dependent protein binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:spectrin binding;, P:atrial cardiac muscle cell action potential; P:atrial cardiac muscle cell to AV node cell communication; P:atrial septum development; P:cellular calcium ion homeostasis; P:cellular protein localization; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:membrane depolarization during SA node cell action potential; P:positive regulation of calcium ion transmembrane transporter activity; P:positive regulation of calcium ion transport; P:positive regulation of cation channel activity; P:positive regulation of gene expression; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to cell surface; P:protein localization to endoplasmic reticulum; P:protein localization to M-band; P:protein localization to organelle; P:protein localization to plasma membrane; P:protein localization to T-tubule; P:protein stabilization; P:protein transport; P:regulation of atrial cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transporter activity; P:regulation of calcium ion transport; P:regulation of cardiac muscle cell contraction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of protein stability; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell action potential; P:SA node cell to atrial cardiac muscle cell communication; P:sarcoplasmic reticulum calcium ion transport; P:T-tubule organization; P:ventricular cardiac muscle cell action potential;|Q9UC61,Peptidyl-prolyl cis-trans isomerase A,Cyclophilin A;Cyclosporin A-binding protein;Rotamase A;, PF00160;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0043231;GO:0016020;GO:0005634;GO:0032991;GO:0034774;GO:0031982;GO:0016018;GO:1904399;GO:0005178;GO:0003755;GO:0003723;GO:0051082;GO:0046790;GO:0000187;GO:0032148;GO:0006915;GO:0060352;GO:0034599;GO:0042118;GO:0044409;GO:0075713;GO:0019064;GO:0035722;GO:0030595;GO:0050900;GO:0034389;GO:1902176;GO:0061944;GO:0006469;GO:0001933;GO:0032873;GO:1903901;GO:0030593;GO:0043312;GO:0030168;GO:0070527;GO:0051092;GO:0035307;GO:0001934;GO:0050714;GO:0045070;GO:0006457;GO:0000413;GO:2001233;GO:0045069;GO:0006278;GO:0019061;GO:0019058;GO:0019076;GO:0019068;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:protein-containing complex; C:secretory granule lumen; C:vesicle;, F:cyclosporin A binding; F:heparan sulfate binding; F:integrin binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding; F:unfolded protein binding; F:virion binding;, P:activation of MAPK activity; P:activation of protein kinase B activity; P:apoptotic process; P:cell adhesion molecule production; P:cellular response to oxidative stress; P:endothelial cell activation; P:entry into host; P:establishment of integrated proviral latency; P:fusion of virus membrane with host plasma membrane; P:interleukin-12-mediated signaling pathway; P:leukocyte chemotaxis; P:leukocyte migration; P:lipid droplet organization; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein K48-linked ubiquitination; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of viral life cycle; P:neutrophil chemotaxis; P:neutrophil degranulation; P:platelet activation; P:platelet aggregation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein dephosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of protein secretion; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of apoptotic signaling pathway; P:regulation of viral genome replication; P:RNA-dependent DNA biosynthetic process; P:uncoating of virus; P:viral life cycle; P:viral release from host cell; P:virion assembly; scaffold57 indexed_genome mRNA 10397237 10402840 . - . ID=transcript_10247;Q4G0J3 B2ZHN6 Q3B7A9 Q9P1S7 Q9Y3Z8,La-related protein 7 {ECO:0000303|PubMed:18483487},La ribonucleoprotein domain family member 7 {ECO:0000303|PubMed:18483487};P-TEFb-interaction protein for 7SK stability {ECO:0000303|PubMed:18249148};, PF05383;PF00076;PF08777;, GO:0120259;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0097322;GO:0003723;GO:0017070;GO:0000494;GO:0030154;GO:0006397;GO:0000122;GO:0034244;GO:0032897;GO:1904871;GO:1905382;GO:0048024;GO:0008380;GO:0007283;GO:1990438;, C:7SK snRNP; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:RNA binding; F:U6 snRNA binding;, P:box C/D RNA 3'-end processing; P:cell differentiation; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of viral transcription; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; P:U6 2'-O-snRNA methylation;|Q4G0J3 B2ZHN6 Q3B7A9 Q9P1S7 Q9Y3Z8,La-related protein 7 {ECO:0000303|PubMed:18483487},La ribonucleoprotein domain family member 7 {ECO:0000303|PubMed:18483487};P-TEFb-interaction protein for 7SK stability {ECO:0000303|PubMed:18249148};, PF05383;PF00076;PF08777;, GO:0120259;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0097322;GO:0003723;GO:0017070;GO:0000494;GO:0030154;GO:0006397;GO:0000122;GO:0034244;GO:0032897;GO:1904871;GO:1905382;GO:0048024;GO:0008380;GO:0007283;GO:1990438;, C:7SK snRNP; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:RNA binding; F:U6 snRNA binding;, P:box C/D RNA 3'-end processing; P:cell differentiation; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of viral transcription; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; P:U6 2'-O-snRNA methylation;|Q4G0J3 B2ZHN6 Q3B7A9 Q9P1S7 Q9Y3Z8,La-related protein 7 {ECO:0000303|PubMed:18483487},La ribonucleoprotein domain family member 7 {ECO:0000303|PubMed:18483487};P-TEFb-interaction protein for 7SK stability {ECO:0000303|PubMed:18249148};, PF05383;PF00076;PF08777;, GO:0120259;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0097322;GO:0003723;GO:0017070;GO:0000494;GO:0030154;GO:0006397;GO:0000122;GO:0034244;GO:0032897;GO:1904871;GO:1905382;GO:0048024;GO:0008380;GO:0007283;GO:1990438;, C:7SK snRNP; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:RNA binding; F:U6 snRNA binding;, P:box C/D RNA 3'-end processing; P:cell differentiation; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of viral transcription; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; P:U6 2'-O-snRNA methylation; scaffold57 indexed_genome mRNA 10402933 10405013 . - . ID=transcript_10248;Q4G0J3 B2ZHN6 Q3B7A9 Q9P1S7 Q9Y3Z8,La-related protein 7 {ECO:0000303|PubMed:18483487},La ribonucleoprotein domain family member 7 {ECO:0000303|PubMed:18483487};P-TEFb-interaction protein for 7SK stability {ECO:0000303|PubMed:18249148};, PF05383;PF00076;PF08777;, GO:0120259;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0097322;GO:0003723;GO:0017070;GO:0000494;GO:0030154;GO:0006397;GO:0000122;GO:0034244;GO:0032897;GO:1904871;GO:1905382;GO:0048024;GO:0008380;GO:0007283;GO:1990438;, C:7SK snRNP; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:RNA binding; F:U6 snRNA binding;, P:box C/D RNA 3'-end processing; P:cell differentiation; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of viral transcription; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; P:U6 2'-O-snRNA methylation; scaffold57 indexed_genome mRNA 10405325 10414963 . - . ID=transcript_10249;Q4G0J3 B2ZHN6 Q3B7A9 Q9P1S7 Q9Y3Z8,La-related protein 7 {ECO:0000303|PubMed:18483487},La ribonucleoprotein domain family member 7 {ECO:0000303|PubMed:18483487};P-TEFb-interaction protein for 7SK stability {ECO:0000303|PubMed:18249148};, PF05383;PF00076;PF08777;, GO:0120259;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0097322;GO:0003723;GO:0017070;GO:0000494;GO:0030154;GO:0006397;GO:0000122;GO:0034244;GO:0032897;GO:1904871;GO:1905382;GO:0048024;GO:0008380;GO:0007283;GO:1990438;, C:7SK snRNP; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:RNA binding; F:U6 snRNA binding;, P:box C/D RNA 3'-end processing; P:cell differentiation; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of viral transcription; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; P:U6 2'-O-snRNA methylation;|Q4G0J3 B2ZHN6 Q3B7A9 Q9P1S7 Q9Y3Z8,La-related protein 7 {ECO:0000303|PubMed:18483487},La ribonucleoprotein domain family member 7 {ECO:0000303|PubMed:18483487};P-TEFb-interaction protein for 7SK stability {ECO:0000303|PubMed:18249148};, PF05383;PF00076;PF08777;, GO:0120259;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0097322;GO:0003723;GO:0017070;GO:0000494;GO:0030154;GO:0006397;GO:0000122;GO:0034244;GO:0032897;GO:1904871;GO:1905382;GO:0048024;GO:0008380;GO:0007283;GO:1990438;, C:7SK snRNP; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:RNA binding; F:U6 snRNA binding;, P:box C/D RNA 3'-end processing; P:cell differentiation; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of viral transcription; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; P:U6 2'-O-snRNA methylation;|Q4G0J3 B2ZHN6 Q3B7A9 Q9P1S7 Q9Y3Z8,La-related protein 7 {ECO:0000303|PubMed:18483487},La ribonucleoprotein domain family member 7 {ECO:0000303|PubMed:18483487};P-TEFb-interaction protein for 7SK stability {ECO:0000303|PubMed:18249148};, PF05383;PF00076;PF08777;, GO:0120259;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0097322;GO:0003723;GO:0017070;GO:0000494;GO:0030154;GO:0006397;GO:0000122;GO:0034244;GO:0032897;GO:1904871;GO:1905382;GO:0048024;GO:0008380;GO:0007283;GO:1990438;, C:7SK snRNP; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:RNA binding; F:U6 snRNA binding;, P:box C/D RNA 3'-end processing; P:cell differentiation; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of viral transcription; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; P:U6 2'-O-snRNA methylation;|Q4G0J3 B2ZHN6 Q3B7A9 Q9P1S7 Q9Y3Z8,La-related protein 7 {ECO:0000303|PubMed:18483487},La ribonucleoprotein domain family member 7 {ECO:0000303|PubMed:18483487};P-TEFb-interaction protein for 7SK stability {ECO:0000303|PubMed:18249148};, PF05383;PF00076;PF08777;, GO:0120259;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0097322;GO:0003723;GO:0017070;GO:0000494;GO:0030154;GO:0006397;GO:0000122;GO:0034244;GO:0032897;GO:1904871;GO:1905382;GO:0048024;GO:0008380;GO:0007283;GO:1990438;, C:7SK snRNP; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:RNA binding; F:U6 snRNA binding;, P:box C/D RNA 3'-end processing; P:cell differentiation; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of viral transcription; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; P:U6 2'-O-snRNA methylation;|Q4G0J3 B2ZHN6 Q3B7A9 Q9P1S7 Q9Y3Z8,La-related protein 7 {ECO:0000303|PubMed:18483487},La ribonucleoprotein domain family member 7 {ECO:0000303|PubMed:18483487};P-TEFb-interaction protein for 7SK stability {ECO:0000303|PubMed:18249148};, PF05383;PF00076;PF08777;, GO:0120259;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0097322;GO:0003723;GO:0017070;GO:0000494;GO:0030154;GO:0006397;GO:0000122;GO:0034244;GO:0032897;GO:1904871;GO:1905382;GO:0048024;GO:0008380;GO:0007283;GO:1990438;, C:7SK snRNP; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:RNA binding; F:U6 snRNA binding;, P:box C/D RNA 3'-end processing; P:cell differentiation; P:mRNA processing; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of viral transcription; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; P:U6 2'-O-snRNA methylation; scaffold57 indexed_genome mRNA 10418457 10426356 . + . ID=transcript_10250;Q86YA3 B3KQX2 B4DSN6 B4DYU8 E9PDE1 G5EA02 Q6ZU11 Q9NSW3 Q9NUJ4,Protein ZGRF1,GRF-type zinc finger domain-containing protein 1;, PF13086;PF13087;PF10382;PF06839;, GO:0005737;GO:0016021;GO:0017108;GO:0004386;GO:0003723;GO:0008270;GO:0071932;, C:cytoplasm; C:integral component of membrane;, F:5'-flap endonuclease activity; F:helicase activity; F:RNA binding; F:zinc ion binding;, P:replication fork reversal; scaffold57 indexed_genome mRNA 10426437 10427143 . - . ID=transcript_10251;Q86YA3 B3KQX2 B4DSN6 B4DYU8 E9PDE1 G5EA02 Q6ZU11 Q9NSW3 Q9NUJ4,Protein ZGRF1,GRF-type zinc finger domain-containing protein 1;, PF13086;PF13087;PF10382;PF06839;, GO:0005737;GO:0016021;GO:0017108;GO:0004386;GO:0003723;GO:0008270;GO:0071932;, C:cytoplasm; C:integral component of membrane;, F:5'-flap endonuclease activity; F:helicase activity; F:RNA binding; F:zinc ion binding;, P:replication fork reversal; scaffold57 indexed_genome mRNA 10435026 10468959 . + . ID=transcript_10252;Q86YA3 B3KQX2 B4DSN6 B4DYU8 E9PDE1 G5EA02 Q6ZU11 Q9NSW3 Q9NUJ4,Protein ZGRF1,GRF-type zinc finger domain-containing protein 1;, PF13086;PF13087;PF10382;PF06839;, GO:0005737;GO:0016021;GO:0017108;GO:0004386;GO:0003723;GO:0008270;GO:0071932;, C:cytoplasm; C:integral component of membrane;, F:5'-flap endonuclease activity; F:helicase activity; F:RNA binding; F:zinc ion binding;, P:replication fork reversal; scaffold57 indexed_genome mRNA 10517620 10520379 . - . ID=transcript_10253;Q96QP1 B4E3G1 F5H138 Q68CI9 Q6P9F9 Q6ZNK4 Q9P201,Alpha-protein kinase 1 {ECO:0000303|PubMed:30111836},Chromosome 4 kinase {ECO:0000303|PubMed:10021370};Lymphocyte alpha-protein kinase {ECO:0000312|HGNC:HGNC:20917};, PF02816;, GO:0005829;GO:0005524;GO:0048029;GO:0106310;GO:0004674;GO:0106311;GO:0002753;GO:0045087;GO:0043123;, C:cytosol;, F:ATP binding; F:monosaccharide binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoplasmic pattern recognition receptor signaling pathway; P:innate immune response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold57 indexed_genome mRNA 10520381 10572895 . - . ID=transcript_10254;Q96QP1 B4E3G1 F5H138 Q68CI9 Q6P9F9 Q6ZNK4 Q9P201,Alpha-protein kinase 1 {ECO:0000303|PubMed:30111836},Chromosome 4 kinase {ECO:0000303|PubMed:10021370};Lymphocyte alpha-protein kinase {ECO:0000312|HGNC:HGNC:20917};, PF02816;, GO:0005829;GO:0005524;GO:0048029;GO:0106310;GO:0004674;GO:0106311;GO:0002753;GO:0045087;GO:0043123;, C:cytosol;, F:ATP binding; F:monosaccharide binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoplasmic pattern recognition receptor signaling pathway; P:innate immune response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold57 indexed_genome mRNA 10637635 10644952 . + . ID=transcript_10255;Q96CG3,TRAF-interacting protein with FHA domain-containing protein A {ECO:0000303|PubMed:12566447},Putative MAPK-activating protein PM14;Putative NF-kappa-B-activating protein 20 {ECO:0000303|PubMed:12761501};TRAF2-binding protein {ECO:0000250|UniProtKB:Q793I8};, PF00498;, GO:0005737;GO:0005829;GO:0002753;GO:0007249;GO:0045087;GO:0043123;GO:0051260;, C:cytoplasm; C:cytosol;, , P:cytoplasmic pattern recognition receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:innate immune response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein homooligomerization; scaffold57 indexed_genome mRNA 10651183 10678202 . - . ID=transcript_10256;Q63HQ0 B2RCV7 Q96GG6 Q9H0V0 Q9P1L4,AP-1 complex-associated regulatory protein,2c18;Adaptor-related protein complex 1-associated regulatory protein;Gamma-1-adaptin brefeldin A resistance protein;Gamma-A1-adaptin and kinesin interactor;, PF15745;, GO:0005829;GO:0005769;GO:0005768;GO:0005794;GO:0005770;GO:0030133;GO:0035650;GO:0019894;GO:0034613;GO:2000146;GO:0001920;GO:1900025;GO:0015031;GO:0034315;GO:0048203;, C:cytosol; C:early endosome; C:endosome; C:Golgi apparatus; C:late endosome; C:transport vesicle;, F:AP-1 adaptor complex binding; F:kinesin binding;, P:cellular protein localization; P:negative regulation of cell motility; P:negative regulation of receptor recycling; P:negative regulation of substrate adhesion-dependent cell spreading; P:protein transport; P:regulation of Arp2/3 complex-mediated actin nucleation; P:vesicle targeting, trans-Golgi to endosome;|Q63HQ0 B2RCV7 Q96GG6 Q9H0V0 Q9P1L4,AP-1 complex-associated regulatory protein,2c18;Adaptor-related protein complex 1-associated regulatory protein;Gamma-1-adaptin brefeldin A resistance protein;Gamma-A1-adaptin and kinesin interactor;, PF15745;, GO:0005829;GO:0005769;GO:0005768;GO:0005794;GO:0005770;GO:0030133;GO:0035650;GO:0019894;GO:0034613;GO:2000146;GO:0001920;GO:1900025;GO:0015031;GO:0034315;GO:0048203;, C:cytosol; C:early endosome; C:endosome; C:Golgi apparatus; C:late endosome; C:transport vesicle;, F:AP-1 adaptor complex binding; F:kinesin binding;, P:cellular protein localization; P:negative regulation of cell motility; P:negative regulation of receptor recycling; P:negative regulation of substrate adhesion-dependent cell spreading; P:protein transport; P:regulation of Arp2/3 complex-mediated actin nucleation; P:vesicle targeting, trans-Golgi to endosome;|Q63HQ0 B2RCV7 Q96GG6 Q9H0V0 Q9P1L4,AP-1 complex-associated regulatory protein,2c18;Adaptor-related protein complex 1-associated regulatory protein;Gamma-1-adaptin brefeldin A resistance protein;Gamma-A1-adaptin and kinesin interactor;, PF15745;, GO:0005829;GO:0005769;GO:0005768;GO:0005794;GO:0005770;GO:0030133;GO:0035650;GO:0019894;GO:0034613;GO:2000146;GO:0001920;GO:1900025;GO:0015031;GO:0034315;GO:0048203;, C:cytosol; C:early endosome; C:endosome; C:Golgi apparatus; C:late endosome; C:transport vesicle;, F:AP-1 adaptor complex binding; F:kinesin binding;, P:cellular protein localization; P:negative regulation of cell motility; P:negative regulation of receptor recycling; P:negative regulation of substrate adhesion-dependent cell spreading; P:protein transport; P:regulation of Arp2/3 complex-mediated actin nucleation; P:vesicle targeting, trans-Golgi to endosome;|Q63HQ0 B2RCV7 Q96GG6 Q9H0V0 Q9P1L4,AP-1 complex-associated regulatory protein,2c18;Adaptor-related protein complex 1-associated regulatory protein;Gamma-1-adaptin brefeldin A resistance protein;Gamma-A1-adaptin and kinesin interactor;, PF15745;, GO:0005829;GO:0005769;GO:0005768;GO:0005794;GO:0005770;GO:0030133;GO:0035650;GO:0019894;GO:0034613;GO:2000146;GO:0001920;GO:1900025;GO:0015031;GO:0034315;GO:0048203;, C:cytosol; C:early endosome; C:endosome; C:Golgi apparatus; C:late endosome; C:transport vesicle;, F:AP-1 adaptor complex binding; F:kinesin binding;, P:cellular protein localization; P:negative regulation of cell motility; P:negative regulation of receptor recycling; P:negative regulation of substrate adhesion-dependent cell spreading; P:protein transport; P:regulation of Arp2/3 complex-mediated actin nucleation; P:vesicle targeting, trans-Golgi to endosome; scaffold57 indexed_genome mRNA 12112745 12128426 . + . ID=transcript_10257;Q99697 A8K6C6 B2RA02 B3KXS0 O60578 O60579 O60580 Q3KQX9 Q9BY17,Pituitary homeobox 2 {ECO:0000305},ALL1-responsive protein ARP1;Homeobox protein PITX2;Paired-like homeodomain transcription factor 2;RIEG bicoid-related homeobox transcription factor;Solurshin;, PF00046;PF03826;, GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0003700;GO:0000981;GO:0001227;GO:0042802;GO:0051219;GO:0042803;GO:0043021;GO:0001102;GO:0000978;GO:0001085;GO:1990837;GO:0008134;GO:0000976;GO:0009653;GO:0043010;GO:0003253;GO:0061325;GO:0035993;GO:0007368;GO:0060971;GO:0035315;GO:0061072;GO:0070986;GO:0000122;GO:0042476;GO:0045944;GO:0060127;GO:0006357;GO:0006355;GO:0060126;GO:0048536;, C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:phosphoprotein binding; F:protein homodimerization activity; F:ribonucleoprotein complex binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:camera-type eye development; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; P:cell proliferation involved in outflow tract morphogenesis; P:deltoid tuberosity development; P:determination of left/right symmetry; P:embryonic heart tube left/right pattern formation; P:hair cell differentiation; P:iris morphogenesis; P:left/right axis specification; P:negative regulation of transcription by RNA polymerase II; P:odontogenesis; P:positive regulation of transcription by RNA polymerase II; P:prolactin secreting cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:somatotropin secreting cell differentiation; P:spleen development; scaffold57 indexed_genome mRNA 12184968 12264528 . - . ID=transcript_10258;Q07075 Q504U2,Glutamyl aminopeptidase,Aminopeptidase A;Differentiation antigen gp160;, PF11838;PF01433;, GO:0045177;GO:0016324;GO:0005903;GO:0005737;GO:0031410;GO:0009897;GO:0070062;GO:0005887;GO:0005765;GO:0005886;GO:0004177;GO:0070006;GO:0042277;GO:0008270;GO:0001525;GO:0002003;GO:0016477;GO:0008283;GO:0007267;GO:0032835;GO:0043171;GO:0006508;GO:0008217;GO:0003081;GO:0007165;, C:apical part of cell; C:apical plasma membrane; C:brush border; C:cytoplasm; C:cytoplasmic vesicle; C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane;, F:aminopeptidase activity; F:metalloaminopeptidase activity; F:peptide binding; F:zinc ion binding;, P:angiogenesis; P:angiotensin maturation; P:cell migration; P:cell population proliferation; P:cell-cell signaling; P:glomerulus development; P:peptide catabolic process; P:proteolysis; P:regulation of blood pressure; P:regulation of systemic arterial blood pressure by renin-angiotensin; P:signal transduction; scaffold58 indexed_genome mRNA 34167 35157 . + . ID=transcript_10259;O43581 F5GZC2 F5GZU9 F5H126 F5H1N2 F5H6C1 Q08AH6,Synaptotagmin-7 {ECO:0000305},IPCA-7;Prostate cancer-associated protein 7;Synaptotagmin VII;, PF00168;, GO:0042995;GO:0005829;GO:0031045;GO:0032009;GO:0070382;GO:0070062;GO:0098686;GO:0099056;GO:0005765;GO:0005764;GO:0005778;GO:0005777;GO:0030670;GO:0005886;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0005516;GO:0030276;GO:0005546;GO:0001786;GO:0000149;GO:0019905;GO:1990927;GO:0048791;GO:0017156;GO:0071277;GO:0006909;GO:0090385;GO:0001778;GO:0045956;GO:0046850;GO:0017158;GO:0014059;GO:0070092;GO:0050796;GO:0050764;GO:1990926;GO:0036465;GO:0090119;GO:0016192;, C:cell projection; C:cytosol; C:dense core granule; C:early phagosome; C:exocytic vesicle; C:extracellular exosome; C:hippocampal mossy fiber to CA3 synapse; C:integral component of presynaptic membrane; C:lysosomal membrane; C:lysosome; C:peroxisomal membrane; C:peroxisome; C:phagocytic vesicle membrane; C:plasma membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calmodulin binding; F:clathrin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium ion regulated lysosome exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:phagocytosis; P:phagosome-lysosome fusion; P:plasma membrane repair; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of bone remodeling; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of glucagon secretion; P:regulation of insulin secretion; P:regulation of phagocytosis; P:short-term synaptic potentiation; P:synaptic vesicle recycling; P:vesicle-mediated cholesterol transport; P:vesicle-mediated transport; scaffold58 indexed_genome mRNA 41144 68511 . + . ID=transcript_10260;O43581 F5GZC2 F5GZU9 F5H126 F5H1N2 F5H6C1 Q08AH6,Synaptotagmin-7 {ECO:0000305},IPCA-7;Prostate cancer-associated protein 7;Synaptotagmin VII;, PF00168;, GO:0042995;GO:0005829;GO:0031045;GO:0032009;GO:0070382;GO:0070062;GO:0098686;GO:0099056;GO:0005765;GO:0005764;GO:0005778;GO:0005777;GO:0030670;GO:0005886;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0005516;GO:0030276;GO:0005546;GO:0001786;GO:0000149;GO:0019905;GO:1990927;GO:0048791;GO:0017156;GO:0071277;GO:0006909;GO:0090385;GO:0001778;GO:0045956;GO:0046850;GO:0017158;GO:0014059;GO:0070092;GO:0050796;GO:0050764;GO:1990926;GO:0036465;GO:0090119;GO:0016192;, C:cell projection; C:cytosol; C:dense core granule; C:early phagosome; C:exocytic vesicle; C:extracellular exosome; C:hippocampal mossy fiber to CA3 synapse; C:integral component of presynaptic membrane; C:lysosomal membrane; C:lysosome; C:peroxisomal membrane; C:peroxisome; C:phagocytic vesicle membrane; C:plasma membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calmodulin binding; F:clathrin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium ion regulated lysosome exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:phagocytosis; P:phagosome-lysosome fusion; P:plasma membrane repair; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of bone remodeling; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of glucagon secretion; P:regulation of insulin secretion; P:regulation of phagocytosis; P:short-term synaptic potentiation; P:synaptic vesicle recycling; P:vesicle-mediated cholesterol transport; P:vesicle-mediated transport;|O43581 F5GZC2 F5GZU9 F5H126 F5H1N2 F5H6C1 Q08AH6,Synaptotagmin-7 {ECO:0000305},IPCA-7;Prostate cancer-associated protein 7;Synaptotagmin VII;, PF00168;, GO:0042995;GO:0005829;GO:0031045;GO:0032009;GO:0070382;GO:0070062;GO:0098686;GO:0099056;GO:0005765;GO:0005764;GO:0005778;GO:0005777;GO:0030670;GO:0005886;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0005516;GO:0030276;GO:0005546;GO:0001786;GO:0000149;GO:0019905;GO:1990927;GO:0048791;GO:0017156;GO:0071277;GO:0006909;GO:0090385;GO:0001778;GO:0045956;GO:0046850;GO:0017158;GO:0014059;GO:0070092;GO:0050796;GO:0050764;GO:1990926;GO:0036465;GO:0090119;GO:0016192;, C:cell projection; C:cytosol; C:dense core granule; C:early phagosome; C:exocytic vesicle; C:extracellular exosome; C:hippocampal mossy fiber to CA3 synapse; C:integral component of presynaptic membrane; C:lysosomal membrane; C:lysosome; C:peroxisomal membrane; C:peroxisome; C:phagocytic vesicle membrane; C:plasma membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:calmodulin binding; F:clathrin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium ion regulated lysosome exocytosis; P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:phagocytosis; P:phagosome-lysosome fusion; P:plasma membrane repair; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of bone remodeling; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of glucagon secretion; P:regulation of insulin secretion; P:regulation of phagocytosis; P:short-term synaptic potentiation; P:synaptic vesicle recycling; P:vesicle-mediated cholesterol transport; P:vesicle-mediated transport; scaffold58 indexed_genome mRNA 70595 72060 . + . ID=transcript_10261;A6NIK2,Leucine-rich repeat-containing protein 10B,, PF13855; scaffold58 indexed_genome mRNA 89536 94704 . - . ID=transcript_10262;Q7Z5V6 Q4G0P4 Q96M77,Protein phosphatase 1 regulatory subunit 32,, PF15691;, GO:0036064;GO:0019902;, C:ciliary basal body;, F:phosphatase binding; scaffold58 indexed_genome mRNA 118972 130631 . + . ID=transcript_10263;Q9NX18,Succinate dehydrogenase assembly factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03057},, PF03937;, GO:0005829;GO:0005759;GO:0005739;GO:0005730;GO:0006121;GO:0034553;GO:0090090;GO:0010719;GO:0006470;GO:0018293;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, , P:mitochondrial electron transport, succinate to ubiquinone; P:mitochondrial respiratory chain complex II assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of epithelial to mesenchymal transition; P:protein dephosphorylation; P:protein-FAD linkage; P:tricarboxylic acid cycle;|Q9NX18,Succinate dehydrogenase assembly factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03057},, PF03937;, GO:0005829;GO:0005759;GO:0005739;GO:0005730;GO:0006121;GO:0034553;GO:0090090;GO:0010719;GO:0006470;GO:0018293;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, , P:mitochondrial electron transport, succinate to ubiquinone; P:mitochondrial respiratory chain complex II assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of epithelial to mesenchymal transition; P:protein dephosphorylation; P:protein-FAD linkage; P:tricarboxylic acid cycle;|Q9NX18,Succinate dehydrogenase assembly factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03057},, PF03937;, GO:0005829;GO:0005759;GO:0005739;GO:0005730;GO:0006121;GO:0034553;GO:0090090;GO:0010719;GO:0006470;GO:0018293;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, , P:mitochondrial electron transport, succinate to ubiquinone; P:mitochondrial respiratory chain complex II assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of epithelial to mesenchymal transition; P:protein dephosphorylation; P:protein-FAD linkage; P:tricarboxylic acid cycle; scaffold58 indexed_genome mRNA 130923 152434 . + . ID=transcript_10264;Q8N684 B3KU04 C9K0Q4 Q7Z3H9 Q9H025 Q9H9V1,Cleavage and polyadenylation specificity factor subunit 7 {ECO:0000305},Cleavage and polyadenylation specificity factor 59 kDa subunit;Cleavage factor Im complex 59 kDa subunit {ECO:0000303|PubMed:8626397};Pre-mRNA cleavage factor Im 59 kDa subunit;, PF00076;, GO:0005737;GO:0016020;GO:0005847;GO:0005849;GO:0005654;GO:0005634;GO:0003723;GO:1990120;GO:0031124;GO:0110104;GO:0000398;GO:0098789;GO:0051290;GO:0051262;GO:0006369;, C:cytoplasm; C:membrane; C:mRNA cleavage and polyadenylation specificity factor complex; C:mRNA cleavage factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:messenger ribonucleoprotein complex assembly; P:mRNA 3'-end processing; P:mRNA alternative polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:protein heterotetramerization; P:protein tetramerization; P:termination of RNA polymerase II transcription;|Q8N684 B3KU04 C9K0Q4 Q7Z3H9 Q9H025 Q9H9V1,Cleavage and polyadenylation specificity factor subunit 7 {ECO:0000305},Cleavage and polyadenylation specificity factor 59 kDa subunit;Cleavage factor Im complex 59 kDa subunit {ECO:0000303|PubMed:8626397};Pre-mRNA cleavage factor Im 59 kDa subunit;, PF00076;, GO:0005737;GO:0016020;GO:0005847;GO:0005849;GO:0005654;GO:0005634;GO:0003723;GO:1990120;GO:0031124;GO:0110104;GO:0000398;GO:0098789;GO:0051290;GO:0051262;GO:0006369;, C:cytoplasm; C:membrane; C:mRNA cleavage and polyadenylation specificity factor complex; C:mRNA cleavage factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:messenger ribonucleoprotein complex assembly; P:mRNA 3'-end processing; P:mRNA alternative polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:protein heterotetramerization; P:protein tetramerization; P:termination of RNA polymerase II transcription;|Q8N684 B3KU04 C9K0Q4 Q7Z3H9 Q9H025 Q9H9V1,Cleavage and polyadenylation specificity factor subunit 7 {ECO:0000305},Cleavage and polyadenylation specificity factor 59 kDa subunit;Cleavage factor Im complex 59 kDa subunit {ECO:0000303|PubMed:8626397};Pre-mRNA cleavage factor Im 59 kDa subunit;, PF00076;, GO:0005737;GO:0016020;GO:0005847;GO:0005849;GO:0005654;GO:0005634;GO:0003723;GO:1990120;GO:0031124;GO:0110104;GO:0000398;GO:0098789;GO:0051290;GO:0051262;GO:0006369;, C:cytoplasm; C:membrane; C:mRNA cleavage and polyadenylation specificity factor complex; C:mRNA cleavage factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:messenger ribonucleoprotein complex assembly; P:mRNA 3'-end processing; P:mRNA alternative polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:protein heterotetramerization; P:protein tetramerization; P:termination of RNA polymerase II transcription;|Q8N684 B3KU04 C9K0Q4 Q7Z3H9 Q9H025 Q9H9V1,Cleavage and polyadenylation specificity factor subunit 7 {ECO:0000305},Cleavage and polyadenylation specificity factor 59 kDa subunit;Cleavage factor Im complex 59 kDa subunit {ECO:0000303|PubMed:8626397};Pre-mRNA cleavage factor Im 59 kDa subunit;, PF00076;, GO:0005737;GO:0016020;GO:0005847;GO:0005849;GO:0005654;GO:0005634;GO:0003723;GO:1990120;GO:0031124;GO:0110104;GO:0000398;GO:0098789;GO:0051290;GO:0051262;GO:0006369;, C:cytoplasm; C:membrane; C:mRNA cleavage and polyadenylation specificity factor complex; C:mRNA cleavage factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:messenger ribonucleoprotein complex assembly; P:mRNA 3'-end processing; P:mRNA alternative polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:protein heterotetramerization; P:protein tetramerization; P:termination of RNA polymerase II transcription;|Q8N684 B3KU04 C9K0Q4 Q7Z3H9 Q9H025 Q9H9V1,Cleavage and polyadenylation specificity factor subunit 7 {ECO:0000305},Cleavage and polyadenylation specificity factor 59 kDa subunit;Cleavage factor Im complex 59 kDa subunit {ECO:0000303|PubMed:8626397};Pre-mRNA cleavage factor Im 59 kDa subunit;, PF00076;, GO:0005737;GO:0016020;GO:0005847;GO:0005849;GO:0005654;GO:0005634;GO:0003723;GO:1990120;GO:0031124;GO:0110104;GO:0000398;GO:0098789;GO:0051290;GO:0051262;GO:0006369;, C:cytoplasm; C:membrane; C:mRNA cleavage and polyadenylation specificity factor complex; C:mRNA cleavage factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:messenger ribonucleoprotein complex assembly; P:mRNA 3'-end processing; P:mRNA alternative polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:protein heterotetramerization; P:protein tetramerization; P:termination of RNA polymerase II transcription;|Q8N684 B3KU04 C9K0Q4 Q7Z3H9 Q9H025 Q9H9V1,Cleavage and polyadenylation specificity factor subunit 7 {ECO:0000305},Cleavage and polyadenylation specificity factor 59 kDa subunit;Cleavage factor Im complex 59 kDa subunit {ECO:0000303|PubMed:8626397};Pre-mRNA cleavage factor Im 59 kDa subunit;, PF00076;, GO:0005737;GO:0016020;GO:0005847;GO:0005849;GO:0005654;GO:0005634;GO:0003723;GO:1990120;GO:0031124;GO:0110104;GO:0000398;GO:0098789;GO:0051290;GO:0051262;GO:0006369;, C:cytoplasm; C:membrane; C:mRNA cleavage and polyadenylation specificity factor complex; C:mRNA cleavage factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:messenger ribonucleoprotein complex assembly; P:mRNA 3'-end processing; P:mRNA alternative polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:protein heterotetramerization; P:protein tetramerization; P:termination of RNA polymerase II transcription; scaffold58 indexed_genome mRNA 157397 161113 . - . ID=transcript_10265;Q9P0N5 A8MZ23 B7Z8N1,Transmembrane protein 216,, PF09799;, GO:0035869;GO:0005929;GO:0005856;GO:0005829;GO:0016021;GO:0036038;GO:0097711;GO:0060271;GO:1905515;, C:ciliary transition zone; C:cilium; C:cytoskeleton; C:cytosol; C:integral component of membrane; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:non-motile cilium assembly;|Q9P0N5 A8MZ23 B7Z8N1,Transmembrane protein 216,, PF09799;, GO:0035869;GO:0005929;GO:0005856;GO:0005829;GO:0016021;GO:0036038;GO:0097711;GO:0060271;GO:1905515;, C:ciliary transition zone; C:cilium; C:cytoskeleton; C:cytosol; C:integral component of membrane; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:non-motile cilium assembly; scaffold58 indexed_genome mRNA 173880 193105 . - . ID=transcript_10266;Q9NPI0 A6NGA7 B4E044 Q5JPE1,Transmembrane protein 138,, PF14935;, GO:0005929;GO:0016021;GO:0005774;GO:0060271;, C:cilium; C:integral component of membrane; C:vacuolar membrane;, , P:cilium assembly;|Q9NPI0 A6NGA7 B4E044 Q5JPE1,Transmembrane protein 138,, PF14935;, GO:0005929;GO:0016021;GO:0005774;GO:0060271;, C:cilium; C:integral component of membrane; C:vacuolar membrane;, , P:cilium assembly;|Q9NPI0 A6NGA7 B4E044 Q5JPE1,Transmembrane protein 138,, PF14935;, GO:0005929;GO:0016021;GO:0005774;GO:0060271;, C:cilium; C:integral component of membrane; C:vacuolar membrane;, , P:cilium assembly;|Q8NBI2 B3KPU2 B4DLN9 J3KQH4 Q6PK96,Cytochrome b ascorbate-dependent protein 3,Cytochrome b561 family member A3;Lysosomal cytochrome b;, PF03188;, GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005730;GO:0046872;GO:0016491;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nucleolus;, F:metal ion binding; F:oxidoreductase activity;|Q8NBI2 B3KPU2 B4DLN9 J3KQH4 Q6PK96,Cytochrome b ascorbate-dependent protein 3,Cytochrome b561 family member A3;Lysosomal cytochrome b;, PF03188;, GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005730;GO:0046872;GO:0016491;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nucleolus;, F:metal ion binding; F:oxidoreductase activity;|Q8NBI2 B3KPU2 B4DLN9 J3KQH4 Q6PK96,Cytochrome b ascorbate-dependent protein 3,Cytochrome b561 family member A3;Lysosomal cytochrome b;, PF03188;, GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005730;GO:0046872;GO:0016491;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nucleolus;, F:metal ion binding; F:oxidoreductase activity;|Q8NBI2 B3KPU2 B4DLN9 J3KQH4 Q6PK96,Cytochrome b ascorbate-dependent protein 3,Cytochrome b561 family member A3;Lysosomal cytochrome b;, PF03188;, GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005730;GO:0046872;GO:0016491;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nucleolus;, F:metal ion binding; F:oxidoreductase activity;|Q8NBI2 B3KPU2 B4DLN9 J3KQH4 Q6PK96,Cytochrome b ascorbate-dependent protein 3,Cytochrome b561 family member A3;Lysosomal cytochrome b;, PF03188;, GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0005730;GO:0046872;GO:0016491;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:nucleolus;, F:metal ion binding; F:oxidoreductase activity; scaffold58 indexed_genome mRNA 193711 206058 . - . ID=transcript_10267;Q3LXA3 Q2L9C1 Q53EQ9 Q9BVA7 Q9H895,Triokinase/FMN cyclase {ECO:0000312|HGNC:HGNC:24552},Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing);, PF02733;PF02734;, GO:0005829;GO:0070062;GO:0005634;GO:0005524;GO:0034012;GO:0004371;GO:0046872;GO:0050354;GO:0046835;GO:0044262;GO:0061624;GO:0019563;GO:0045087;GO:0039534;GO:0045088;, C:cytosol; C:extracellular exosome; C:nucleus;, F:ATP binding; F:FAD-AMP lyase (cyclizing) activity; F:glycerone kinase activity; F:metal ion binding; F:triokinase activity;, P:carbohydrate phosphorylation; P:cellular carbohydrate metabolic process; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:glycerol catabolic process; P:innate immune response; P:negative regulation of MDA-5 signaling pathway; P:regulation of innate immune response;|Q3LXA3 Q2L9C1 Q53EQ9 Q9BVA7 Q9H895,Triokinase/FMN cyclase {ECO:0000312|HGNC:HGNC:24552},Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing);, PF02733;PF02734;, GO:0005829;GO:0070062;GO:0005634;GO:0005524;GO:0034012;GO:0004371;GO:0046872;GO:0050354;GO:0046835;GO:0044262;GO:0061624;GO:0019563;GO:0045087;GO:0039534;GO:0045088;, C:cytosol; C:extracellular exosome; C:nucleus;, F:ATP binding; F:FAD-AMP lyase (cyclizing) activity; F:glycerone kinase activity; F:metal ion binding; F:triokinase activity;, P:carbohydrate phosphorylation; P:cellular carbohydrate metabolic process; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:glycerol catabolic process; P:innate immune response; P:negative regulation of MDA-5 signaling pathway; P:regulation of innate immune response;|Q3LXA3 Q2L9C1 Q53EQ9 Q9BVA7 Q9H895,Triokinase/FMN cyclase {ECO:0000312|HGNC:HGNC:24552},Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing);, PF02733;PF02734;, GO:0005829;GO:0070062;GO:0005634;GO:0005524;GO:0034012;GO:0004371;GO:0046872;GO:0050354;GO:0046835;GO:0044262;GO:0061624;GO:0019563;GO:0045087;GO:0039534;GO:0045088;, C:cytosol; C:extracellular exosome; C:nucleus;, F:ATP binding; F:FAD-AMP lyase (cyclizing) activity; F:glycerone kinase activity; F:metal ion binding; F:triokinase activity;, P:carbohydrate phosphorylation; P:cellular carbohydrate metabolic process; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:glycerol catabolic process; P:innate immune response; P:negative regulation of MDA-5 signaling pathway; P:regulation of innate immune response;|Q3LXA3 Q2L9C1 Q53EQ9 Q9BVA7 Q9H895,Triokinase/FMN cyclase {ECO:0000312|HGNC:HGNC:24552},Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing);, PF02733;PF02734;, GO:0005829;GO:0070062;GO:0005634;GO:0005524;GO:0034012;GO:0004371;GO:0046872;GO:0050354;GO:0046835;GO:0044262;GO:0061624;GO:0019563;GO:0045087;GO:0039534;GO:0045088;, C:cytosol; C:extracellular exosome; C:nucleus;, F:ATP binding; F:FAD-AMP lyase (cyclizing) activity; F:glycerone kinase activity; F:metal ion binding; F:triokinase activity;, P:carbohydrate phosphorylation; P:cellular carbohydrate metabolic process; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:glycerol catabolic process; P:innate immune response; P:negative regulation of MDA-5 signaling pathway; P:regulation of innate immune response; scaffold58 indexed_genome mRNA 206180 232271 . + . ID=transcript_10268;Q16531 A6NG77 B2R648 B4DG00 O15176 Q13289 Q58F96,DNA damage-binding protein 1,DDB p127 subunit;DNA damage-binding protein a;Damage-specific DNA-binding protein 1;HBV X-associated protein 1;UV-damaged DNA-binding factor;UV-damaged DNA-binding protein 1;XPE-binding factor;Xeroderma pigmentosum group E-complementing protein;, PF03178;PF10433;, GO:0000781;GO:0080008;GO:0031464;GO:0031465;GO:0031461;GO:0005737;GO:0070062;GO:0005615;GO:0005654;GO:0005634;GO:0032991;GO:0097602;GO:0003684;GO:0003677;GO:0044877;GO:0030674;GO:0071987;GO:0051702;GO:0006974;GO:0042769;GO:0006281;GO:0070911;GO:0035518;GO:0006289;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0046726;GO:0045722;GO:0045732;GO:0045070;GO:1902188;GO:0043687;GO:0010498;GO:0043161;GO:0016567;GO:1901990;GO:0048511;GO:0006283;GO:0006511;GO:0070914;GO:0016032;, C:chromosome, telomeric region; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cullin family protein binding; F:damaged DNA binding; F:DNA binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:WD40-repeat domain binding;, P:biological process involved in interaction with symbiont; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of gluconeogenesis; P:positive regulation of protein catabolic process; P:positive regulation of viral genome replication; P:positive regulation of viral release from host cell; P:post-translational protein modification; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:UV-damage excision repair; P:viral process;|Q16531 A6NG77 B2R648 B4DG00 O15176 Q13289 Q58F96,DNA damage-binding protein 1,DDB p127 subunit;DNA damage-binding protein a;Damage-specific DNA-binding protein 1;HBV X-associated protein 1;UV-damaged DNA-binding factor;UV-damaged DNA-binding protein 1;XPE-binding factor;Xeroderma pigmentosum group E-complementing protein;, PF03178;PF10433;, GO:0000781;GO:0080008;GO:0031464;GO:0031465;GO:0031461;GO:0005737;GO:0070062;GO:0005615;GO:0005654;GO:0005634;GO:0032991;GO:0097602;GO:0003684;GO:0003677;GO:0044877;GO:0030674;GO:0071987;GO:0051702;GO:0006974;GO:0042769;GO:0006281;GO:0070911;GO:0035518;GO:0006289;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0046726;GO:0045722;GO:0045732;GO:0045070;GO:1902188;GO:0043687;GO:0010498;GO:0043161;GO:0016567;GO:1901990;GO:0048511;GO:0006283;GO:0006511;GO:0070914;GO:0016032;, C:chromosome, telomeric region; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cullin family protein binding; F:damaged DNA binding; F:DNA binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:WD40-repeat domain binding;, P:biological process involved in interaction with symbiont; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of gluconeogenesis; P:positive regulation of protein catabolic process; P:positive regulation of viral genome replication; P:positive regulation of viral release from host cell; P:post-translational protein modification; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:UV-damage excision repair; P:viral process;|Q16531 A6NG77 B2R648 B4DG00 O15176 Q13289 Q58F96,DNA damage-binding protein 1,DDB p127 subunit;DNA damage-binding protein a;Damage-specific DNA-binding protein 1;HBV X-associated protein 1;UV-damaged DNA-binding factor;UV-damaged DNA-binding protein 1;XPE-binding factor;Xeroderma pigmentosum group E-complementing protein;, PF03178;PF10433;, GO:0000781;GO:0080008;GO:0031464;GO:0031465;GO:0031461;GO:0005737;GO:0070062;GO:0005615;GO:0005654;GO:0005634;GO:0032991;GO:0097602;GO:0003684;GO:0003677;GO:0044877;GO:0030674;GO:0071987;GO:0051702;GO:0006974;GO:0042769;GO:0006281;GO:0070911;GO:0035518;GO:0006289;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0046726;GO:0045722;GO:0045732;GO:0045070;GO:1902188;GO:0043687;GO:0010498;GO:0043161;GO:0016567;GO:1901990;GO:0048511;GO:0006283;GO:0006511;GO:0070914;GO:0016032;, C:chromosome, telomeric region; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cullin family protein binding; F:damaged DNA binding; F:DNA binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:WD40-repeat domain binding;, P:biological process involved in interaction with symbiont; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of gluconeogenesis; P:positive regulation of protein catabolic process; P:positive regulation of viral genome replication; P:positive regulation of viral release from host cell; P:post-translational protein modification; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:UV-damage excision repair; P:viral process;|Q16531 A6NG77 B2R648 B4DG00 O15176 Q13289 Q58F96,DNA damage-binding protein 1,DDB p127 subunit;DNA damage-binding protein a;Damage-specific DNA-binding protein 1;HBV X-associated protein 1;UV-damaged DNA-binding factor;UV-damaged DNA-binding protein 1;XPE-binding factor;Xeroderma pigmentosum group E-complementing protein;, PF03178;PF10433;, GO:0000781;GO:0080008;GO:0031464;GO:0031465;GO:0031461;GO:0005737;GO:0070062;GO:0005615;GO:0005654;GO:0005634;GO:0032991;GO:0097602;GO:0003684;GO:0003677;GO:0044877;GO:0030674;GO:0071987;GO:0051702;GO:0006974;GO:0042769;GO:0006281;GO:0070911;GO:0035518;GO:0006289;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0046726;GO:0045722;GO:0045732;GO:0045070;GO:1902188;GO:0043687;GO:0010498;GO:0043161;GO:0016567;GO:1901990;GO:0048511;GO:0006283;GO:0006511;GO:0070914;GO:0016032;, C:chromosome, telomeric region; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cullin family protein binding; F:damaged DNA binding; F:DNA binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:WD40-repeat domain binding;, P:biological process involved in interaction with symbiont; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of gluconeogenesis; P:positive regulation of protein catabolic process; P:positive regulation of viral genome replication; P:positive regulation of viral release from host cell; P:post-translational protein modification; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:UV-damage excision repair; P:viral process;|Q16531 A6NG77 B2R648 B4DG00 O15176 Q13289 Q58F96,DNA damage-binding protein 1,DDB p127 subunit;DNA damage-binding protein a;Damage-specific DNA-binding protein 1;HBV X-associated protein 1;UV-damaged DNA-binding factor;UV-damaged DNA-binding protein 1;XPE-binding factor;Xeroderma pigmentosum group E-complementing protein;, PF03178;PF10433;, GO:0000781;GO:0080008;GO:0031464;GO:0031465;GO:0031461;GO:0005737;GO:0070062;GO:0005615;GO:0005654;GO:0005634;GO:0032991;GO:0097602;GO:0003684;GO:0003677;GO:0044877;GO:0030674;GO:0071987;GO:0051702;GO:0006974;GO:0042769;GO:0006281;GO:0070911;GO:0035518;GO:0006289;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0046726;GO:0045722;GO:0045732;GO:0045070;GO:1902188;GO:0043687;GO:0010498;GO:0043161;GO:0016567;GO:1901990;GO:0048511;GO:0006283;GO:0006511;GO:0070914;GO:0016032;, C:chromosome, telomeric region; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cullin family protein binding; F:damaged DNA binding; F:DNA binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:WD40-repeat domain binding;, P:biological process involved in interaction with symbiont; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of gluconeogenesis; P:positive regulation of protein catabolic process; P:positive regulation of viral genome replication; P:positive regulation of viral release from host cell; P:post-translational protein modification; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:UV-damage excision repair; P:viral process;|Q16531 A6NG77 B2R648 B4DG00 O15176 Q13289 Q58F96,DNA damage-binding protein 1,DDB p127 subunit;DNA damage-binding protein a;Damage-specific DNA-binding protein 1;HBV X-associated protein 1;UV-damaged DNA-binding factor;UV-damaged DNA-binding protein 1;XPE-binding factor;Xeroderma pigmentosum group E-complementing protein;, PF03178;PF10433;, GO:0000781;GO:0080008;GO:0031464;GO:0031465;GO:0031461;GO:0005737;GO:0070062;GO:0005615;GO:0005654;GO:0005634;GO:0032991;GO:0097602;GO:0003684;GO:0003677;GO:0044877;GO:0030674;GO:0071987;GO:0051702;GO:0006974;GO:0042769;GO:0006281;GO:0070911;GO:0035518;GO:0006289;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0046726;GO:0045722;GO:0045732;GO:0045070;GO:1902188;GO:0043687;GO:0010498;GO:0043161;GO:0016567;GO:1901990;GO:0048511;GO:0006283;GO:0006511;GO:0070914;GO:0016032;, C:chromosome, telomeric region; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cullin family protein binding; F:damaged DNA binding; F:DNA binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:WD40-repeat domain binding;, P:biological process involved in interaction with symbiont; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of gluconeogenesis; P:positive regulation of protein catabolic process; P:positive regulation of viral genome replication; P:positive regulation of viral release from host cell; P:post-translational protein modification; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:UV-damage excision repair; P:viral process;|Q16531 A6NG77 B2R648 B4DG00 O15176 Q13289 Q58F96,DNA damage-binding protein 1,DDB p127 subunit;DNA damage-binding protein a;Damage-specific DNA-binding protein 1;HBV X-associated protein 1;UV-damaged DNA-binding factor;UV-damaged DNA-binding protein 1;XPE-binding factor;Xeroderma pigmentosum group E-complementing protein;, PF03178;PF10433;, GO:0000781;GO:0080008;GO:0031464;GO:0031465;GO:0031461;GO:0005737;GO:0070062;GO:0005615;GO:0005654;GO:0005634;GO:0032991;GO:0097602;GO:0003684;GO:0003677;GO:0044877;GO:0030674;GO:0071987;GO:0051702;GO:0006974;GO:0042769;GO:0006281;GO:0070911;GO:0035518;GO:0006289;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0046726;GO:0045722;GO:0045732;GO:0045070;GO:1902188;GO:0043687;GO:0010498;GO:0043161;GO:0016567;GO:1901990;GO:0048511;GO:0006283;GO:0006511;GO:0070914;GO:0016032;, C:chromosome, telomeric region; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cullin family protein binding; F:damaged DNA binding; F:DNA binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:WD40-repeat domain binding;, P:biological process involved in interaction with symbiont; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of gluconeogenesis; P:positive regulation of protein catabolic process; P:positive regulation of viral genome replication; P:positive regulation of viral release from host cell; P:post-translational protein modification; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:UV-damage excision repair; P:viral process;|Q16531 A6NG77 B2R648 B4DG00 O15176 Q13289 Q58F96,DNA damage-binding protein 1,DDB p127 subunit;DNA damage-binding protein a;Damage-specific DNA-binding protein 1;HBV X-associated protein 1;UV-damaged DNA-binding factor;UV-damaged DNA-binding protein 1;XPE-binding factor;Xeroderma pigmentosum group E-complementing protein;, PF03178;PF10433;, GO:0000781;GO:0080008;GO:0031464;GO:0031465;GO:0031461;GO:0005737;GO:0070062;GO:0005615;GO:0005654;GO:0005634;GO:0032991;GO:0097602;GO:0003684;GO:0003677;GO:0044877;GO:0030674;GO:0071987;GO:0051702;GO:0006974;GO:0042769;GO:0006281;GO:0070911;GO:0035518;GO:0006289;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0046726;GO:0045722;GO:0045732;GO:0045070;GO:1902188;GO:0043687;GO:0010498;GO:0043161;GO:0016567;GO:1901990;GO:0048511;GO:0006283;GO:0006511;GO:0070914;GO:0016032;, C:chromosome, telomeric region; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cullin family protein binding; F:damaged DNA binding; F:DNA binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:WD40-repeat domain binding;, P:biological process involved in interaction with symbiont; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of gluconeogenesis; P:positive regulation of protein catabolic process; P:positive regulation of viral genome replication; P:positive regulation of viral release from host cell; P:post-translational protein modification; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:UV-damage excision repair; P:viral process;|Q16531 A6NG77 B2R648 B4DG00 O15176 Q13289 Q58F96,DNA damage-binding protein 1,DDB p127 subunit;DNA damage-binding protein a;Damage-specific DNA-binding protein 1;HBV X-associated protein 1;UV-damaged DNA-binding factor;UV-damaged DNA-binding protein 1;XPE-binding factor;Xeroderma pigmentosum group E-complementing protein;, PF03178;PF10433;, GO:0000781;GO:0080008;GO:0031464;GO:0031465;GO:0031461;GO:0005737;GO:0070062;GO:0005615;GO:0005654;GO:0005634;GO:0032991;GO:0097602;GO:0003684;GO:0003677;GO:0044877;GO:0030674;GO:0071987;GO:0051702;GO:0006974;GO:0042769;GO:0006281;GO:0070911;GO:0035518;GO:0006289;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0046726;GO:0045722;GO:0045732;GO:0045070;GO:1902188;GO:0043687;GO:0010498;GO:0043161;GO:0016567;GO:1901990;GO:0048511;GO:0006283;GO:0006511;GO:0070914;GO:0016032;, C:chromosome, telomeric region; C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cullin family protein binding; F:damaged DNA binding; F:DNA binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:WD40-repeat domain binding;, P:biological process involved in interaction with symbiont; P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of gluconeogenesis; P:positive regulation of protein catabolic process; P:positive regulation of viral genome replication; P:positive regulation of viral release from host cell; P:post-translational protein modification; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of mitotic cell cycle phase transition; P:rhythmic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:UV-damage excision repair; P:viral process; scaffold58 indexed_genome mRNA 245640 253621 . + . ID=transcript_10269;Q96DN2 A5PKV0 Q7Z7L6 Q86WK8,von Willebrand factor C and EGF domain-containing protein,HBV X protein up-regulated gene 11 protein;HBxAg up-regulated gene 11 protein;, PF07645;PF00093;, GO:0005737;GO:0005576;GO:0005509;GO:0098586;, C:cytoplasm; C:extracellular region;, F:calcium ion binding;, P:cellular response to virus;|Q96DN2 A5PKV0 Q7Z7L6 Q86WK8,von Willebrand factor C and EGF domain-containing protein,HBV X protein up-regulated gene 11 protein;HBxAg up-regulated gene 11 protein;, PF07645;PF00093;, GO:0005737;GO:0005576;GO:0005509;GO:0098586;, C:cytoplasm; C:extracellular region;, F:calcium ion binding;, P:cellular response to virus;|Q96DN2 A5PKV0 Q7Z7L6 Q86WK8,von Willebrand factor C and EGF domain-containing protein,HBV X protein up-regulated gene 11 protein;HBxAg up-regulated gene 11 protein;, PF07645;PF00093;, GO:0005737;GO:0005576;GO:0005509;GO:0098586;, C:cytoplasm; C:extracellular region;, F:calcium ion binding;, P:cellular response to virus; scaffold58 indexed_genome mRNA 257979 259231 . - . ID=transcript_10270;Q96DN2 A5PKV0 Q7Z7L6 Q86WK8,von Willebrand factor C and EGF domain-containing protein,HBV X protein up-regulated gene 11 protein;HBxAg up-regulated gene 11 protein;, PF07645;PF00093;, GO:0005737;GO:0005576;GO:0005509;GO:0098586;, C:cytoplasm; C:extracellular region;, F:calcium ion binding;, P:cellular response to virus; scaffold58 indexed_genome mRNA 259245 267067 . + . ID=transcript_10271;Q96DN2 A5PKV0 Q7Z7L6 Q86WK8,von Willebrand factor C and EGF domain-containing protein,HBV X protein up-regulated gene 11 protein;HBxAg up-regulated gene 11 protein;, PF07645;PF00093;, GO:0005737;GO:0005576;GO:0005509;GO:0098586;, C:cytoplasm; C:extracellular region;, F:calcium ion binding;, P:cellular response to virus; scaffold58 indexed_genome mRNA 2721279 2725977 . + . ID=transcript_10272;A5D8V6 Q8N3K4,Vacuolar protein sorting-associated protein 37C,ESCRT-I complex subunit VPS37C;, PF07200;, GO:0010008;GO:0000813;GO:0070062;GO:0043657;GO:0043231;GO:0031902;GO:0048306;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;, C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane;, F:calcium-dependent protein binding;, P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold58 indexed_genome mRNA 2732090 2739742 . - . ID=transcript_10273;P06127 A0N0P4 A8K9I3,T-cell surface glycoprotein CD5,Lymphocyte antigen T1/Leu-1;, PF00530;, GO:0009897;GO:0005887;GO:0005886;GO:0005044;GO:0038023;GO:0097190;GO:0008037;GO:0031295;, C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:scavenger receptor activity; F:signaling receptor activity;, P:apoptotic signaling pathway; P:cell recognition; P:T cell costimulation;|P06127 A0N0P4 A8K9I3,T-cell surface glycoprotein CD5,Lymphocyte antigen T1/Leu-1;, PF00530;, GO:0009897;GO:0005887;GO:0005886;GO:0005044;GO:0038023;GO:0097190;GO:0008037;GO:0031295;, C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:scavenger receptor activity; F:signaling receptor activity;, P:apoptotic signaling pathway; P:cell recognition; P:T cell costimulation; scaffold58 indexed_genome mRNA 2739926 2753765 . - . ID=transcript_10274;P06127 A0N0P4 A8K9I3,T-cell surface glycoprotein CD5,Lymphocyte antigen T1/Leu-1;, PF00530;, GO:0009897;GO:0005887;GO:0005886;GO:0005044;GO:0038023;GO:0097190;GO:0008037;GO:0031295;, C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:scavenger receptor activity; F:signaling receptor activity;, P:apoptotic signaling pathway; P:cell recognition; P:T cell costimulation; scaffold58 indexed_genome mRNA 2821597 2831879 . - . ID=transcript_10275;P30203 A4KAD4 A4KAD5 Q9UMF2 Q9Y4K7 Q9Y4K8 Q9Y4K9 Q9Y4L0,T-cell differentiation antigen CD6,T12;TP120;, PF00530;, GO:0009897;GO:0005576;GO:0001772;GO:0005887;GO:0031226;GO:0042802;GO:0001530;GO:0070891;GO:0005044;GO:0002438;GO:0002250;GO:0007157;GO:0001771;GO:0045087;GO:0031663;GO:1900017;GO:0042102;GO:0032496;, C:external side of plasma membrane; C:extracellular region; C:immunological synapse; C:integral component of plasma membrane; C:intrinsic component of plasma membrane;, F:identical protein binding; F:lipopolysaccharide binding; F:lipoteichoic acid binding; F:scavenger receptor activity;, P:acute inflammatory response to antigenic stimulus; P:adaptive immune response; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:immunological synapse formation; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of T cell proliferation; P:response to lipopolysaccharide; scaffold58 indexed_genome mRNA 2886244 2919244 . + . ID=transcript_10276;Q24JP5 Q69YU7 Q86VZ8 Q86W97 Q9H8K3 Q9HCI9 Q9NWY0,Transmembrane protein 132A,HSPA5-binding protein 1;, PF16070;PF15706;PF15705;, GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0044267;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:cellular protein metabolic process; P:post-translational protein modification;|Q24JP5 Q69YU7 Q86VZ8 Q86W97 Q9H8K3 Q9HCI9 Q9NWY0,Transmembrane protein 132A,HSPA5-binding protein 1;, PF16070;PF15706;PF15705;, GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0044267;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:cellular protein metabolic process; P:post-translational protein modification;|Q24JP5 Q69YU7 Q86VZ8 Q86W97 Q9H8K3 Q9HCI9 Q9NWY0,Transmembrane protein 132A,HSPA5-binding protein 1;, PF16070;PF15706;PF15705;, GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0044267;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:cellular protein metabolic process; P:post-translational protein modification;|Q24JP5 Q69YU7 Q86VZ8 Q86W97 Q9H8K3 Q9HCI9 Q9NWY0,Transmembrane protein 132A,HSPA5-binding protein 1;, PF16070;PF15706;PF15705;, GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0044267;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:cellular protein metabolic process; P:post-translational protein modification;|Q9BVC6,Transmembrane protein 109,Mitsugumin-23;, , GO:0070062;GO:0016021;GO:0005640;GO:0033017;GO:0005244;GO:0071480;GO:0042771;GO:0060548;GO:0034765;, C:extracellular exosome; C:integral component of membrane; C:nuclear outer membrane; C:sarcoplasmic reticulum membrane;, F:voltage-gated ion channel activity;, P:cellular response to gamma radiation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of cell death; P:regulation of ion transmembrane transport; scaffold58 indexed_genome mRNA 2938919 2948322 . + . ID=transcript_10277;Q9UMS4,Pre-mRNA-processing factor 19 {ECO:0000305},Nuclear matrix protein 200 {ECO:0000303|PubMed:11082287};PRP19/PSO4 homolog {ECO:0000303|PubMed:12960389};RING-type E3 ubiquitin transferase PRP19 {ECO:0000305};Senescence evasion factor {ECO:0000303|PubMed:16332694};, PF08606;PF04564;PF00400;, GO:0071013;GO:0005737;GO:0005811;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0000974;GO:0035861;GO:0005819;GO:0071006;GO:0071007;GO:0042802;GO:0061630;GO:0004842;GO:0034450;GO:0034613;GO:0006303;GO:0000349;GO:0001833;GO:0008610;GO:0000398;GO:0048711;GO:0048026;GO:0045666;GO:0010498;GO:0070534;GO:0000209;GO:0072422;GO:0000245;GO:0000244;GO:0006283;, C:catalytic step 2 spliceosome; C:cytoplasm; C:lipid droplet; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:site of double-strand break; C:spindle; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome;, F:identical protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-ubiquitin ligase activity;, P:cellular protein localization; P:double-strand break repair via nonhomologous end joining; P:generation of catalytic spliceosome for first transesterification step; P:inner cell mass cell proliferation; P:lipid biosynthetic process; P:mRNA splicing, via spliceosome; P:positive regulation of astrocyte differentiation; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of neuron differentiation; P:proteasomal protein catabolic process; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:signal transduction involved in DNA damage checkpoint; P:spliceosomal complex assembly; P:spliceosomal tri-snRNP complex assembly; P:transcription-coupled nucleotide-excision repair;|Q9UMS4,Pre-mRNA-processing factor 19 {ECO:0000305},Nuclear matrix protein 200 {ECO:0000303|PubMed:11082287};PRP19/PSO4 homolog {ECO:0000303|PubMed:12960389};RING-type E3 ubiquitin transferase PRP19 {ECO:0000305};Senescence evasion factor {ECO:0000303|PubMed:16332694};, PF08606;PF04564;PF00400;, GO:0071013;GO:0005737;GO:0005811;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0000974;GO:0035861;GO:0005819;GO:0071006;GO:0071007;GO:0042802;GO:0061630;GO:0004842;GO:0034450;GO:0034613;GO:0006303;GO:0000349;GO:0001833;GO:0008610;GO:0000398;GO:0048711;GO:0048026;GO:0045666;GO:0010498;GO:0070534;GO:0000209;GO:0072422;GO:0000245;GO:0000244;GO:0006283;, C:catalytic step 2 spliceosome; C:cytoplasm; C:lipid droplet; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:site of double-strand break; C:spindle; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome;, F:identical protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-ubiquitin ligase activity;, P:cellular protein localization; P:double-strand break repair via nonhomologous end joining; P:generation of catalytic spliceosome for first transesterification step; P:inner cell mass cell proliferation; P:lipid biosynthetic process; P:mRNA splicing, via spliceosome; P:positive regulation of astrocyte differentiation; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of neuron differentiation; P:proteasomal protein catabolic process; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:signal transduction involved in DNA damage checkpoint; P:spliceosomal complex assembly; P:spliceosomal tri-snRNP complex assembly; P:transcription-coupled nucleotide-excision repair;|Q9UMS4,Pre-mRNA-processing factor 19 {ECO:0000305},Nuclear matrix protein 200 {ECO:0000303|PubMed:11082287};PRP19/PSO4 homolog {ECO:0000303|PubMed:12960389};RING-type E3 ubiquitin transferase PRP19 {ECO:0000305};Senescence evasion factor {ECO:0000303|PubMed:16332694};, PF08606;PF04564;PF00400;, GO:0071013;GO:0005737;GO:0005811;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0000974;GO:0035861;GO:0005819;GO:0071006;GO:0071007;GO:0042802;GO:0061630;GO:0004842;GO:0034450;GO:0034613;GO:0006303;GO:0000349;GO:0001833;GO:0008610;GO:0000398;GO:0048711;GO:0048026;GO:0045666;GO:0010498;GO:0070534;GO:0000209;GO:0072422;GO:0000245;GO:0000244;GO:0006283;, C:catalytic step 2 spliceosome; C:cytoplasm; C:lipid droplet; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:site of double-strand break; C:spindle; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome;, F:identical protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:ubiquitin-ubiquitin ligase activity;, P:cellular protein localization; P:double-strand break repair via nonhomologous end joining; P:generation of catalytic spliceosome for first transesterification step; P:inner cell mass cell proliferation; P:lipid biosynthetic process; P:mRNA splicing, via spliceosome; P:positive regulation of astrocyte differentiation; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of neuron differentiation; P:proteasomal protein catabolic process; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:signal transduction involved in DNA damage checkpoint; P:spliceosomal complex assembly; P:spliceosomal tri-snRNP complex assembly; P:transcription-coupled nucleotide-excision repair; scaffold58 indexed_genome mRNA 2985808 2999175 . + . ID=transcript_10278;Q9Y5Y4 O94765 Q4QRI6,Prostaglandin D2 receptor 2,Chemoattractant receptor-homologous molecule expressed on Th2 cells;G-protein coupled receptor 44;, PF00001;, GO:0005887;GO:0043005;GO:0005886;GO:0004930;GO:0042923;GO:0042277;GO:0004956;GO:0004958;GO:0001785;GO:0007193;GO:0019722;GO:0006935;GO:0007186;GO:0006955;GO:2000255;GO:0007218;GO:0045745;, C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:G protein-coupled receptor activity; F:neuropeptide binding; F:peptide binding; F:prostaglandin D receptor activity; F:prostaglandin F receptor activity; F:prostaglandin J receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:calcium-mediated signaling; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:negative regulation of male germ cell proliferation; P:neuropeptide signaling pathway; P:positive regulation of G protein-coupled receptor signaling pathway;|Q9H6F5 B4DY99,Coiled-coil domain-containing protein 86,Cytokine-induced protein with coiled-coil domain;, PF03879;, GO:0005694;GO:0005730;GO:0005654;GO:0005634;GO:0003723;GO:0016032;, C:chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:viral process; scaffold58 indexed_genome mRNA 3093077 3108269 . - . ID=transcript_10279;Q9BY19 Q8TCA5,Membrane-spanning 4-domains subfamily A member 8,Four-span transmembrane protein 4;Membrane-spanning 4-domains subfamily A member 8B;, PF04103;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold58 indexed_genome mRNA 3148649 3187756 . + . ID=transcript_10280;Q92543 E9PKB9 Q8IV55,Sorting nexin-19,, PF08628;PF00787;PF02194;, GO:0005737;GO:0030659;GO:0031901;GO:0032266;GO:0002062;GO:1990502;GO:0006887;GO:0030073;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:early endosome membrane;, F:phosphatidylinositol-3-phosphate binding;, P:chondrocyte differentiation; P:dense core granule maturation; P:exocytosis; P:insulin secretion;|Q92543 E9PKB9 Q8IV55,Sorting nexin-19,, PF08628;PF00787;PF02194;, GO:0005737;GO:0030659;GO:0031901;GO:0032266;GO:0002062;GO:1990502;GO:0006887;GO:0030073;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:early endosome membrane;, F:phosphatidylinositol-3-phosphate binding;, P:chondrocyte differentiation; P:dense core granule maturation; P:exocytosis; P:insulin secretion; scaffold58 indexed_genome mRNA 3535095 3544055 . - . ID=transcript_10281;Q8TE58 Q32MI6,A disintegrin and metalloproteinase with thrombospondin motifs 15,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0009986;GO:0062023;GO:0031012;GO:0005615;GO:0004175;GO:0050840;GO:0008201;GO:0004222;GO:0008270;GO:0022617;GO:0030198;GO:0007520;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:endopeptidase activity; F:extracellular matrix binding; F:heparin binding; F:metalloendopeptidase activity; F:zinc ion binding;, P:extracellular matrix disassembly; P:extracellular matrix organization; P:myoblast fusion; scaffold58 indexed_genome mRNA 3554655 3555505 . - . ID=transcript_10282;Q8TE58 Q32MI6,A disintegrin and metalloproteinase with thrombospondin motifs 15,, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0009986;GO:0062023;GO:0031012;GO:0005615;GO:0004175;GO:0050840;GO:0008201;GO:0004222;GO:0008270;GO:0022617;GO:0030198;GO:0007520;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:endopeptidase activity; F:extracellular matrix binding; F:heparin binding; F:metalloendopeptidase activity; F:zinc ion binding;, P:extracellular matrix disassembly; P:extracellular matrix organization; P:myoblast fusion; scaffold58 indexed_genome mRNA 3581006 3582050 . - . ID=transcript_10283;Q9UP79 Q9NZS0,A disintegrin and metalloproteinase with thrombospondin motifs 8,METH-2;METH-8;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0008201;GO:0005178;GO:0009673;GO:0004222;GO:0008237;GO:0008270;GO:0030198;GO:0008285;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:heparin binding; F:integrin binding; F:low-affinity phosphate transmembrane transporter activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:extracellular matrix organization; P:negative regulation of cell population proliferation; scaffold58 indexed_genome mRNA 3589740 3598504 . + . ID=transcript_10284;Q9UP79 Q9NZS0,A disintegrin and metalloproteinase with thrombospondin motifs 8,METH-2;METH-8;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0008201;GO:0005178;GO:0009673;GO:0004222;GO:0008237;GO:0008270;GO:0030198;GO:0008285;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:heparin binding; F:integrin binding; F:low-affinity phosphate transmembrane transporter activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:extracellular matrix organization; P:negative regulation of cell population proliferation; scaffold58 indexed_genome mRNA 3598522 3599340 . - . ID=transcript_10285;Q9UP79 Q9NZS0,A disintegrin and metalloproteinase with thrombospondin motifs 8,METH-2;METH-8;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0008201;GO:0005178;GO:0009673;GO:0004222;GO:0008237;GO:0008270;GO:0030198;GO:0008285;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:heparin binding; F:integrin binding; F:low-affinity phosphate transmembrane transporter activity; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:extracellular matrix organization; P:negative regulation of cell population proliferation; scaffold58 indexed_genome mRNA 3647891 3711524 . + . ID=transcript_10286;Q8NCP5 Q6IPT8 Q86VJ7 Q86XX5,Zinc finger and BTB domain-containing protein 44,BTB/POZ domain-containing protein 15;Zinc finger protein 851;, PF00651;PF00096;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q8NCP5 Q6IPT8 Q86VJ7 Q86XX5,Zinc finger and BTB domain-containing protein 44,BTB/POZ domain-containing protein 15;Zinc finger protein 851;, PF00651;PF00096;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q8NCP5 Q6IPT8 Q86VJ7 Q86XX5,Zinc finger and BTB domain-containing protein 44,BTB/POZ domain-containing protein 15;Zinc finger protein 851;, PF00651;PF00096;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q8NCP5 Q6IPT8 Q86VJ7 Q86XX5,Zinc finger and BTB domain-containing protein 44,BTB/POZ domain-containing protein 15;Zinc finger protein 851;, PF00651;PF00096;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding; scaffold58 indexed_genome mRNA 3727454 3743570 . - . ID=transcript_10287;Q9Y5Y6 Q9BS01 Q9H3S0 Q9HB36 Q9HCA3,Suppressor of tumorigenicity 14 protein,Matriptase;Membrane-type serine protease 1;Prostamin;Serine protease 14;Serine protease TADG-15;Tumor-associated differentially-expressed gene 15 protein;, PF00431;PF00057;PF01390;PF00089;, GO:0016323;GO:0005615;GO:0019897;GO:0005887;GO:0005886;GO:0004252;GO:0008236;GO:0070268;GO:0060672;GO:0030216;GO:0001843;GO:0006508;, C:basolateral plasma membrane; C:extracellular space; C:extrinsic component of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:cornification; P:epithelial cell morphogenesis involved in placental branching; P:keratinocyte differentiation; P:neural tube closure; P:proteolysis; scaffold58 indexed_genome mRNA 3785478 3787716 . - . ID=transcript_10288;Q06481 B3KXX9 H7BXI4 Q13861 Q14594 Q14662 Q71U10 Q7M4L3 Q9BT36,Amyloid-like protein 2,APPH;Amyloid protein homolog;CDEI box-binding protein;, PF10515;PF12924;PF12925;PF02177;PF00014;, GO:0005788;GO:0070062;GO:0016021;GO:0016020;GO:0005634;GO:0005886;GO:0031092;GO:0003677;GO:0008201;GO:0042802;GO:0004867;GO:0046914;GO:0044267;GO:0007186;GO:0002576;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleus; C:plasma membrane; C:platelet alpha granule membrane;, F:DNA binding; F:heparin binding; F:identical protein binding; F:serine-type endopeptidase inhibitor activity; F:transition metal ion binding;, P:cellular protein metabolic process; P:G protein-coupled receptor signaling pathway; P:platelet degranulation; P:post-translational protein modification; scaffold58 indexed_genome mRNA 3787735 3794437 . - . ID=transcript_10289;Q06481 B3KXX9 H7BXI4 Q13861 Q14594 Q14662 Q71U10 Q7M4L3 Q9BT36,Amyloid-like protein 2,APPH;Amyloid protein homolog;CDEI box-binding protein;, PF10515;PF12924;PF12925;PF02177;PF00014;, GO:0005788;GO:0070062;GO:0016021;GO:0016020;GO:0005634;GO:0005886;GO:0031092;GO:0003677;GO:0008201;GO:0042802;GO:0004867;GO:0046914;GO:0044267;GO:0007186;GO:0002576;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleus; C:plasma membrane; C:platelet alpha granule membrane;, F:DNA binding; F:heparin binding; F:identical protein binding; F:serine-type endopeptidase inhibitor activity; F:transition metal ion binding;, P:cellular protein metabolic process; P:G protein-coupled receptor signaling pathway; P:platelet degranulation; P:post-translational protein modification; scaffold58 indexed_genome mRNA 3800922 3804832 . - . ID=transcript_10290;Q06481 B3KXX9 H7BXI4 Q13861 Q14594 Q14662 Q71U10 Q7M4L3 Q9BT36,Amyloid-like protein 2,APPH;Amyloid protein homolog;CDEI box-binding protein;, PF10515;PF12924;PF12925;PF02177;PF00014;, GO:0005788;GO:0070062;GO:0016021;GO:0016020;GO:0005634;GO:0005886;GO:0031092;GO:0003677;GO:0008201;GO:0042802;GO:0004867;GO:0046914;GO:0044267;GO:0007186;GO:0002576;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleus; C:plasma membrane; C:platelet alpha granule membrane;, F:DNA binding; F:heparin binding; F:identical protein binding; F:serine-type endopeptidase inhibitor activity; F:transition metal ion binding;, P:cellular protein metabolic process; P:G protein-coupled receptor signaling pathway; P:platelet degranulation; P:post-translational protein modification; scaffold58 indexed_genome mRNA 3805256 3813890 . - . ID=transcript_10291;Q06481 B3KXX9 H7BXI4 Q13861 Q14594 Q14662 Q71U10 Q7M4L3 Q9BT36,Amyloid-like protein 2,APPH;Amyloid protein homolog;CDEI box-binding protein;, PF10515;PF12924;PF12925;PF02177;PF00014;, GO:0005788;GO:0070062;GO:0016021;GO:0016020;GO:0005634;GO:0005886;GO:0031092;GO:0003677;GO:0008201;GO:0042802;GO:0004867;GO:0046914;GO:0044267;GO:0007186;GO:0002576;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleus; C:plasma membrane; C:platelet alpha granule membrane;, F:DNA binding; F:heparin binding; F:identical protein binding; F:serine-type endopeptidase inhibitor activity; F:transition metal ion binding;, P:cellular protein metabolic process; P:G protein-coupled receptor signaling pathway; P:platelet degranulation; P:post-translational protein modification; scaffold58 indexed_genome mRNA 3951901 3992305 . + . ID=transcript_10292;Q9NQV6 B7ZL71 G3XAE5 J3KP23 Q17R90 Q2KHR4 Q863Z2 Q9NXI4 Q9ULI9,PR domain zinc finger protein 10,PR domain-containing protein 10;Tristanin;, PF00096;PF12171;, GO:0000785;GO:0005634;GO:0017053;GO:0003677;GO:0046872;GO:0008168;GO:0032259;GO:0045944;GO:0010468;, C:chromatin; C:nucleus; C:transcription repressor complex;, F:DNA binding; F:metal ion binding; F:methyltransferase activity;, P:methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression;|Q9NQV6 B7ZL71 G3XAE5 J3KP23 Q17R90 Q2KHR4 Q863Z2 Q9NXI4 Q9ULI9,PR domain zinc finger protein 10,PR domain-containing protein 10;Tristanin;, PF00096;PF12171;, GO:0000785;GO:0005634;GO:0017053;GO:0003677;GO:0046872;GO:0008168;GO:0032259;GO:0045944;GO:0010468;, C:chromatin; C:nucleus; C:transcription repressor complex;, F:DNA binding; F:metal ion binding; F:methyltransferase activity;, P:methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression;|Q9NQV6 B7ZL71 G3XAE5 J3KP23 Q17R90 Q2KHR4 Q863Z2 Q9NXI4 Q9ULI9,PR domain zinc finger protein 10,PR domain-containing protein 10;Tristanin;, PF00096;PF12171;, GO:0000785;GO:0005634;GO:0017053;GO:0003677;GO:0046872;GO:0008168;GO:0032259;GO:0045944;GO:0010468;, C:chromatin; C:nucleus; C:transcription repressor complex;, F:DNA binding; F:metal ion binding; F:methyltransferase activity;, P:methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold58 indexed_genome mRNA 4008689 4010214 . + . ID=transcript_10293;Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination; scaffold58 indexed_genome mRNA 4010839 4012828 . + . ID=transcript_10294;Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination; scaffold58 indexed_genome mRNA 4015893 4016642 . + . ID=transcript_10295;Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination; scaffold58 indexed_genome mRNA 4017373 4030471 . + . ID=transcript_10296;Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q6P4R8 Q12869 Q15312 Q9H048,Nuclear factor related to kappa-B-binding protein,DNA-binding protein R kappa-B;INO80 complex subunit G;, PF14465;, GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0002020;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:protease binding;, P:DNA recombination; P:DNA repair; P:protein deubiquitination; scaffold58 indexed_genome mRNA 4033427 4034127 . + . ID=transcript_10297;Q96B21 A8K2L8,Transmembrane protein 45B,, PF04819;, GO:0016021;, C:integral component of membrane; scaffold58 indexed_genome mRNA 4034328 4035329 . - . ID=transcript_10298;Q96B21 A8K2L8,Transmembrane protein 45B,, PF04819;, GO:0016021;, C:integral component of membrane; scaffold58 indexed_genome mRNA 4036752 4037403 . + . ID=transcript_10299;Q96B21 A8K2L8,Transmembrane protein 45B,, PF04819;, GO:0016021;, C:integral component of membrane; scaffold58 indexed_genome mRNA 5044245 5447105 . + . ID=transcript_10300;Q9P121 A0MTT2 Q6UXJ3 Q86VJ9,Neurotrimin,IgLON family member 2;, PF07679;, GO:0031225;GO:0005576;GO:0005886;GO:0007155;GO:0008038;, C:anchored component of membrane; C:extracellular region; C:plasma membrane;, , P:cell adhesion; P:neuron recognition;|Q9P121 A0MTT2 Q6UXJ3 Q86VJ9,Neurotrimin,IgLON family member 2;, PF07679;, GO:0031225;GO:0005576;GO:0005886;GO:0007155;GO:0008038;, C:anchored component of membrane; C:extracellular region; C:plasma membrane;, , P:cell adhesion; P:neuron recognition;|P18847 Q5VTZ2 Q6ICQ9 Q7Z566 Q8WYM6,Cyclic AMP-dependent transcription factor ATF-3,Activating transcription factor 3;, PF00170;, GO:1990622;GO:0000785;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0042802;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0034198;GO:0030968;GO:0006094;GO:0070373;GO:0000122;GO:0008284;GO:1903984;GO:0045944;GO:1990440;GO:0010999;GO:0006357;GO:0061394;GO:0035914;, C:CHOP-ATF3 complex; C:chromatin; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to amino acid starvation; P:endoplasmic reticulum unfolded protein response; P:gluconeogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of eIF2 alpha phosphorylation by heme; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance; P:skeletal muscle cell differentiation;|Q9P121 A0MTT2 Q6UXJ3 Q86VJ9,Neurotrimin,IgLON family member 2;, PF07679;, GO:0031225;GO:0005576;GO:0005886;GO:0007155;GO:0008038;, C:anchored component of membrane; C:extracellular region; C:plasma membrane;, , P:cell adhesion; P:neuron recognition;|Q9P121 A0MTT2 Q6UXJ3 Q86VJ9,Neurotrimin,IgLON family member 2;, PF07679;, GO:0031225;GO:0005576;GO:0005886;GO:0007155;GO:0008038;, C:anchored component of membrane; C:extracellular region; C:plasma membrane;, , P:cell adhesion; P:neuron recognition; scaffold58 indexed_genome mRNA 5515454 6005169 . - . ID=transcript_10301;Q14982 B2CZX2 B7ZLQ1 Q17RN7 Q7Z3W6,Opioid-binding protein/cell adhesion molecule,IgLON family member 1;, PF07679;, GO:0031225;GO:0005576;GO:0005886;GO:0007155;GO:0008038;, C:anchored component of membrane; C:extracellular region; C:plasma membrane;, , P:cell adhesion; P:neuron recognition; scaffold58 indexed_genome mRNA 6782065 6788628 . - . ID=transcript_10302;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold58 indexed_genome mRNA 6792766 6835771 . - . ID=transcript_10303;Q9UPX0 G5EA26,Protein turtle homolog B,Immunoglobulin superfamily member 9B;, PF13895;, GO:0098982;GO:0016021;GO:0043005;GO:0014069;GO:0045211;GO:0099629;GO:0007155;GO:0007399;, C:GABA-ergic synapse; C:integral component of membrane; C:neuron projection; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization of symmetric synapse;, , P:cell adhesion; P:nervous system development;|Q9UPX0 G5EA26,Protein turtle homolog B,Immunoglobulin superfamily member 9B;, PF13895;, GO:0098982;GO:0016021;GO:0043005;GO:0014069;GO:0045211;GO:0099629;GO:0007155;GO:0007399;, C:GABA-ergic synapse; C:integral component of membrane; C:neuron projection; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization of symmetric synapse;, , P:cell adhesion; P:nervous system development;|Q9UPX0 G5EA26,Protein turtle homolog B,Immunoglobulin superfamily member 9B;, PF13895;, GO:0098982;GO:0016021;GO:0043005;GO:0014069;GO:0045211;GO:0099629;GO:0007155;GO:0007399;, C:GABA-ergic synapse; C:integral component of membrane; C:neuron projection; C:postsynaptic density; C:postsynaptic membrane; C:postsynaptic specialization of symmetric synapse;, , P:cell adhesion; P:nervous system development; scaffold58 indexed_genome mRNA 6962655 6967085 . + . ID=transcript_10304;Q9BX67 B3KWG9 Q8WWL8 Q96FL1,Junctional adhesion molecule C,JAM-2;Junctional adhesion molecule 3;, PF07686;, GO:0005923;GO:0044291;GO:0005911;GO:0030057;GO:0005615;GO:0031941;GO:0005794;GO:0005887;GO:0005902;GO:0033010;GO:0005886;GO:0098636;GO:0043220;GO:0070160;GO:0098632;GO:0005178;GO:0046982;GO:0042803;GO:0002250;GO:0034333;GO:0001525;GO:0045176;GO:0031103;GO:0098609;GO:0007160;GO:0030010;GO:0030198;GO:0097530;GO:0097241;GO:0034113;GO:0050900;GO:0002523;GO:0035633;GO:0042552;GO:0002318;GO:0033629;GO:0033624;GO:0001780;GO:0002693;GO:1905710;GO:1902414;GO:0034394;GO:0090138;GO:0090022;GO:0007286;GO:0019226;, C:bicellular tight junction; C:cell-cell contact zone; C:cell-cell junction; C:desmosome; C:extracellular space; C:filamentous actin; C:Golgi apparatus; C:integral component of plasma membrane; C:microvillus; C:paranodal junction; C:plasma membrane; C:protein complex involved in cell adhesion; C:Schmidt-Lanterman incisure; C:tight junction;, F:cell-cell adhesion mediator activity; F:integrin binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:adaptive immune response; P:adherens junction assembly; P:angiogenesis; P:apical protein localization; P:axon regeneration; P:cell-cell adhesion; P:cell-matrix adhesion; P:establishment of cell polarity; P:extracellular matrix organization; P:granulocyte migration; P:hematopoietic stem cell migration to bone marrow; P:heterotypic cell-cell adhesion; P:leukocyte migration; P:leukocyte migration involved in inflammatory response; P:maintenance of blood-brain barrier; P:myelination; P:myeloid progenitor cell differentiation; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of integrin activation; P:neutrophil homeostasis; P:positive regulation of cellular extravasation; P:positive regulation of membrane permeability; P:protein localization to cell junction; P:protein localization to cell surface; P:regulation of actin cytoskeleton organization by cell-cell adhesion; P:regulation of neutrophil chemotaxis; P:spermatid development; P:transmission of nerve impulse;|Q9BX67 B3KWG9 Q8WWL8 Q96FL1,Junctional adhesion molecule C,JAM-2;Junctional adhesion molecule 3;, PF07686;, GO:0005923;GO:0044291;GO:0005911;GO:0030057;GO:0005615;GO:0031941;GO:0005794;GO:0005887;GO:0005902;GO:0033010;GO:0005886;GO:0098636;GO:0043220;GO:0070160;GO:0098632;GO:0005178;GO:0046982;GO:0042803;GO:0002250;GO:0034333;GO:0001525;GO:0045176;GO:0031103;GO:0098609;GO:0007160;GO:0030010;GO:0030198;GO:0097530;GO:0097241;GO:0034113;GO:0050900;GO:0002523;GO:0035633;GO:0042552;GO:0002318;GO:0033629;GO:0033624;GO:0001780;GO:0002693;GO:1905710;GO:1902414;GO:0034394;GO:0090138;GO:0090022;GO:0007286;GO:0019226;, C:bicellular tight junction; C:cell-cell contact zone; C:cell-cell junction; C:desmosome; C:extracellular space; C:filamentous actin; C:Golgi apparatus; C:integral component of plasma membrane; C:microvillus; C:paranodal junction; C:plasma membrane; C:protein complex involved in cell adhesion; C:Schmidt-Lanterman incisure; C:tight junction;, F:cell-cell adhesion mediator activity; F:integrin binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:adaptive immune response; P:adherens junction assembly; P:angiogenesis; P:apical protein localization; P:axon regeneration; P:cell-cell adhesion; P:cell-matrix adhesion; P:establishment of cell polarity; P:extracellular matrix organization; P:granulocyte migration; P:hematopoietic stem cell migration to bone marrow; P:heterotypic cell-cell adhesion; P:leukocyte migration; P:leukocyte migration involved in inflammatory response; P:maintenance of blood-brain barrier; P:myelination; P:myeloid progenitor cell differentiation; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of integrin activation; P:neutrophil homeostasis; P:positive regulation of cellular extravasation; P:positive regulation of membrane permeability; P:protein localization to cell junction; P:protein localization to cell surface; P:regulation of actin cytoskeleton organization by cell-cell adhesion; P:regulation of neutrophil chemotaxis; P:spermatid development; P:transmission of nerve impulse;|Q9BX67 B3KWG9 Q8WWL8 Q96FL1,Junctional adhesion molecule C,JAM-2;Junctional adhesion molecule 3;, PF07686;, GO:0005923;GO:0044291;GO:0005911;GO:0030057;GO:0005615;GO:0031941;GO:0005794;GO:0005887;GO:0005902;GO:0033010;GO:0005886;GO:0098636;GO:0043220;GO:0070160;GO:0098632;GO:0005178;GO:0046982;GO:0042803;GO:0002250;GO:0034333;GO:0001525;GO:0045176;GO:0031103;GO:0098609;GO:0007160;GO:0030010;GO:0030198;GO:0097530;GO:0097241;GO:0034113;GO:0050900;GO:0002523;GO:0035633;GO:0042552;GO:0002318;GO:0033629;GO:0033624;GO:0001780;GO:0002693;GO:1905710;GO:1902414;GO:0034394;GO:0090138;GO:0090022;GO:0007286;GO:0019226;, C:bicellular tight junction; C:cell-cell contact zone; C:cell-cell junction; C:desmosome; C:extracellular space; C:filamentous actin; C:Golgi apparatus; C:integral component of plasma membrane; C:microvillus; C:paranodal junction; C:plasma membrane; C:protein complex involved in cell adhesion; C:Schmidt-Lanterman incisure; C:tight junction;, F:cell-cell adhesion mediator activity; F:integrin binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:adaptive immune response; P:adherens junction assembly; P:angiogenesis; P:apical protein localization; P:axon regeneration; P:cell-cell adhesion; P:cell-matrix adhesion; P:establishment of cell polarity; P:extracellular matrix organization; P:granulocyte migration; P:hematopoietic stem cell migration to bone marrow; P:heterotypic cell-cell adhesion; P:leukocyte migration; P:leukocyte migration involved in inflammatory response; P:maintenance of blood-brain barrier; P:myelination; P:myeloid progenitor cell differentiation; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of integrin activation; P:neutrophil homeostasis; P:positive regulation of cellular extravasation; P:positive regulation of membrane permeability; P:protein localization to cell junction; P:protein localization to cell surface; P:regulation of actin cytoskeleton organization by cell-cell adhesion; P:regulation of neutrophil chemotaxis; P:spermatid development; P:transmission of nerve impulse; scaffold58 indexed_genome mRNA 7587053 7595893 . + . ID=transcript_10305;A7KAX9 I7H0B0 O94820 Q86YL6 Q8IUG4 Q9BWG3,Rho GTPase-activating protein 32,Brain-specific Rho GTPase-activating protein;GAB-associated Cdc42/Rac GTPase-activating protein;GC-GAP;GTPase regulator interacting with TrkA;Rho-type GTPase-activating protein 32;Rho/Cdc42/Rac GTPase-activating protein RICS;RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling;p200RhoGAP;p250GAP;, PF00620;PF14604;, GO:0015629;GO:0005938;GO:0005829;GO:0043197;GO:0005789;GO:0010008;GO:0001650;GO:0005794;GO:0000139;GO:0005654;GO:0014069;GO:0005096;GO:1901981;GO:0051056;GO:0007264;, C:actin cytoskeleton; C:cell cortex; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:endosome membrane; C:fibrillar center; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:postsynaptic density;, F:GTPase activator activity; F:phosphatidylinositol phosphate binding;, P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; scaffold58 indexed_genome mRNA 7636869 7661377 . - . ID=transcript_10306;P48544 B2R744 Q6DK13 Q6DK14 Q92807,G protein-activated inward rectifier potassium channel 4,Cardiac inward rectifier;Heart KATP channel;Inward rectifier K(+) channel Kir3.4;KATP-1;Potassium channel, inwardly rectifying subfamily J member 5;, PF01007;PF17655;, GO:0009897;GO:0005886;GO:0030315;GO:0008076;GO:0015467;GO:0086089;GO:1902282;GO:0098914;GO:1901381;GO:1990573;GO:0006813;GO:0086091;GO:0034765;GO:0099625;, C:external side of plasma membrane; C:plasma membrane; C:T-tubule; C:voltage-gated potassium channel complex;, F:G-protein activated inward rectifier potassium channel activity; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:membrane repolarization during atrial cardiac muscle cell action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transport; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:ventricular cardiac muscle cell membrane repolarization; scaffold58 indexed_genome mRNA 7739133 7879532 . - . ID=transcript_10307;Q01543 B2R8H2 B4DFV4 B4DTC6 G3V183 Q14319 Q92480 Q9UE07,Friend leukemia integration 1 transcription factor,Proto-oncogene Fli-1;Transcription factor ERGB;, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0009887;GO:0008015;GO:0030154;GO:0007599;GO:0035855;GO:0045893;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:animal organ morphogenesis; P:blood circulation; P:cell differentiation; P:hemostasis; P:megakaryocyte development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q01543 B2R8H2 B4DFV4 B4DTC6 G3V183 Q14319 Q92480 Q9UE07,Friend leukemia integration 1 transcription factor,Proto-oncogene Fli-1;Transcription factor ERGB;, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0009887;GO:0008015;GO:0030154;GO:0007599;GO:0035855;GO:0045893;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:animal organ morphogenesis; P:blood circulation; P:cell differentiation; P:hemostasis; P:megakaryocyte development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q01543 B2R8H2 B4DFV4 B4DTC6 G3V183 Q14319 Q92480 Q9UE07,Friend leukemia integration 1 transcription factor,Proto-oncogene Fli-1;Transcription factor ERGB;, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0009887;GO:0008015;GO:0030154;GO:0007599;GO:0035855;GO:0045893;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:animal organ morphogenesis; P:blood circulation; P:cell differentiation; P:hemostasis; P:megakaryocyte development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q01543 B2R8H2 B4DFV4 B4DTC6 G3V183 Q14319 Q92480 Q9UE07,Friend leukemia integration 1 transcription factor,Proto-oncogene Fli-1;Transcription factor ERGB;, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0009887;GO:0008015;GO:0030154;GO:0007599;GO:0035855;GO:0045893;GO:0006357;, C:chromatin; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:animal organ morphogenesis; P:blood circulation; P:cell differentiation; P:hemostasis; P:megakaryocyte development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold58 indexed_genome mRNA 8047031 8116544 . + . ID=transcript_10308;P14921 A9UL17 F5GYX9 Q14278 Q16080 Q6N087 Q96AC5,Protein C-ets-1,p54;, PF00178;PF02198;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0042802;GO:0030374;GO:0000978;GO:0008134;GO:0000976;GO:0060055;GO:0030154;GO:0048870;GO:0070301;GO:0044849;GO:0007565;GO:0021854;GO:0006955;GO:0045786;GO:0008285;GO:0021983;GO:0030578;GO:0045766;GO:0043536;GO:0008284;GO:0051272;GO:0010595;GO:0045648;GO:0010628;GO:0050729;GO:1904996;GO:1902895;GO:0045944;GO:0045893;GO:0045765;GO:0042981;GO:0010715;GO:0006357;GO:0046677;GO:0032355;GO:0001666;GO:0070555;GO:0034616;GO:0009612;GO:0006366;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:identical protein binding; F:nuclear receptor coactivator activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:angiogenesis involved in wound healing; P:cell differentiation; P:cell motility; P:cellular response to hydrogen peroxide; P:estrous cycle; P:female pregnancy; P:hypothalamus development; P:immune response; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:pituitary gland development; P:PML body organization; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of endothelial cell migration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of inflammatory response; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of angiogenesis; P:regulation of apoptotic process; P:regulation of extracellular matrix disassembly; P:regulation of transcription by RNA polymerase II; P:response to antibiotic; P:response to estradiol; P:response to hypoxia; P:response to interleukin-1; P:response to laminar fluid shear stress; P:response to mechanical stimulus; P:transcription by RNA polymerase II;|P14921 A9UL17 F5GYX9 Q14278 Q16080 Q6N087 Q96AC5,Protein C-ets-1,p54;, PF00178;PF02198;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0042802;GO:0030374;GO:0000978;GO:0008134;GO:0000976;GO:0060055;GO:0030154;GO:0048870;GO:0070301;GO:0044849;GO:0007565;GO:0021854;GO:0006955;GO:0045786;GO:0008285;GO:0021983;GO:0030578;GO:0045766;GO:0043536;GO:0008284;GO:0051272;GO:0010595;GO:0045648;GO:0010628;GO:0050729;GO:1904996;GO:1902895;GO:0045944;GO:0045893;GO:0045765;GO:0042981;GO:0010715;GO:0006357;GO:0046677;GO:0032355;GO:0001666;GO:0070555;GO:0034616;GO:0009612;GO:0006366;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:identical protein binding; F:nuclear receptor coactivator activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:angiogenesis involved in wound healing; P:cell differentiation; P:cell motility; P:cellular response to hydrogen peroxide; P:estrous cycle; P:female pregnancy; P:hypothalamus development; P:immune response; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:pituitary gland development; P:PML body organization; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of endothelial cell migration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of inflammatory response; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of angiogenesis; P:regulation of apoptotic process; P:regulation of extracellular matrix disassembly; P:regulation of transcription by RNA polymerase II; P:response to antibiotic; P:response to estradiol; P:response to hypoxia; P:response to interleukin-1; P:response to laminar fluid shear stress; P:response to mechanical stimulus; P:transcription by RNA polymerase II; scaffold58 indexed_genome mRNA 10074407 10075170 . + . ID=transcript_10309;Q8IZU9 Q3MIJ7 Q6UWJ9 Q6UWL5 Q96JG0,Kin of IRRE-like protein 3,Kin of irregular chiasm-like protein 3;Nephrin-like protein 2 {ECO:0000303|PubMed:12424224};, PF07679;PF13895;, GO:0030424;GO:0005911;GO:0030425;GO:0043198;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0008021;GO:0050839;GO:0098609;GO:0072102;GO:0030097;GO:0021766;GO:0007156;GO:0002121;GO:0001764;GO:0048812;GO:0021740;GO:0007416;, C:axon; C:cell-cell junction; C:dendrite; C:dendritic shaft; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:synaptic vesicle;, F:cell adhesion molecule binding;, P:cell-cell adhesion; P:glomerulus morphogenesis; P:hemopoiesis; P:hippocampus development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inter-male aggressive behavior; P:neuron migration; P:neuron projection morphogenesis; P:principal sensory nucleus of trigeminal nerve development; P:synapse assembly; scaffold58 indexed_genome mRNA 10086575 10088503 . + . ID=transcript_10310;Q8IZU9 Q3MIJ7 Q6UWJ9 Q6UWL5 Q96JG0,Kin of IRRE-like protein 3,Kin of irregular chiasm-like protein 3;Nephrin-like protein 2 {ECO:0000303|PubMed:12424224};, PF07679;PF13895;, GO:0030424;GO:0005911;GO:0030425;GO:0043198;GO:0005576;GO:0016021;GO:0005887;GO:0005886;GO:0008021;GO:0050839;GO:0098609;GO:0072102;GO:0030097;GO:0021766;GO:0007156;GO:0002121;GO:0001764;GO:0048812;GO:0021740;GO:0007416;, C:axon; C:cell-cell junction; C:dendrite; C:dendritic shaft; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:synaptic vesicle;, F:cell adhesion molecule binding;, P:cell-cell adhesion; P:glomerulus morphogenesis; P:hemopoiesis; P:hippocampus development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:inter-male aggressive behavior; P:neuron migration; P:neuron projection morphogenesis; P:principal sensory nucleus of trigeminal nerve development; P:synapse assembly; scaffold58 indexed_genome mRNA 10091655 10134911 . - . ID=transcript_10311;Q11206 A8K6B2 O60497 Q8N6A6 Q8NFG7 Q96QQ9,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4,Alpha 2,3-sialyltransferase IV;Gal-NAc6S;Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase {ECO:0000303|PubMed:8288606};Gal-beta-1,4-GlcNAc-alpha-2,3-sialyltransferase {ECO:0000303|PubMed:8288606};N-acetyllactosaminide alpha-2,3-sialyltransferase;SAT-3 {ECO:0000303|PubMed:8611500};ST-4;ST3Gal IV;ST3GalA.2;STZ {ECO:0000303|PubMed:8288606};Sialyltransferase 4C;, PF00777;, GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0003836;GO:0047288;GO:0008118;GO:0004513;GO:0008373;GO:0050890;GO:0009247;GO:0009101;GO:0018146;GO:0030259;GO:0016266;GO:0009312;GO:0030194;GO:1903238;GO:0006486;GO:1990743;GO:0097503;GO:0019082;, C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; F:monosialoganglioside sialyltransferase activity; F:N-acetyllactosaminide alpha-2,3-sialyltransferase activity; F:neolactotetraosylceramide alpha-2,3-sialyltransferase activity; F:sialyltransferase activity;, P:cognition; P:glycolipid biosynthetic process; P:glycoprotein biosynthetic process; P:keratan sulfate biosynthetic process; P:lipid glycosylation; P:O-glycan processing; P:oligosaccharide biosynthetic process; P:positive regulation of blood coagulation; P:positive regulation of leukocyte tethering or rolling; P:protein glycosylation; P:protein sialylation; P:sialylation; P:viral protein processing;|Q11206 A8K6B2 O60497 Q8N6A6 Q8NFG7 Q96QQ9,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4,Alpha 2,3-sialyltransferase IV;Gal-NAc6S;Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase {ECO:0000303|PubMed:8288606};Gal-beta-1,4-GlcNAc-alpha-2,3-sialyltransferase {ECO:0000303|PubMed:8288606};N-acetyllactosaminide alpha-2,3-sialyltransferase;SAT-3 {ECO:0000303|PubMed:8611500};ST-4;ST3Gal IV;ST3GalA.2;STZ {ECO:0000303|PubMed:8288606};Sialyltransferase 4C;, PF00777;, GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0003836;GO:0047288;GO:0008118;GO:0004513;GO:0008373;GO:0050890;GO:0009247;GO:0009101;GO:0018146;GO:0030259;GO:0016266;GO:0009312;GO:0030194;GO:1903238;GO:0006486;GO:1990743;GO:0097503;GO:0019082;, C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; F:monosialoganglioside sialyltransferase activity; F:N-acetyllactosaminide alpha-2,3-sialyltransferase activity; F:neolactotetraosylceramide alpha-2,3-sialyltransferase activity; F:sialyltransferase activity;, P:cognition; P:glycolipid biosynthetic process; P:glycoprotein biosynthetic process; P:keratan sulfate biosynthetic process; P:lipid glycosylation; P:O-glycan processing; P:oligosaccharide biosynthetic process; P:positive regulation of blood coagulation; P:positive regulation of leukocyte tethering or rolling; P:protein glycosylation; P:protein sialylation; P:sialylation; P:viral protein processing; scaffold58 indexed_genome mRNA 10143143 10186641 . - . ID=transcript_10312;Q96C86 Q8NHL8 Q9Y2S5,m7GpppX diphosphatase,DCS-1;Decapping scavenger enzyme;Hint-related 7meGMP-directed hydrolase;Histidine triad nucleotide-binding protein 5;Histidine triad protein member 5;Scavenger mRNA-decapping enzyme DcpS;, PF05652;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000932;GO:0042802;GO:0050072;GO:0000340;GO:0036245;GO:0000290;GO:0043928;GO:0045292;GO:0043069;GO:0000288;GO:0090503;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:P-body;, F:identical protein binding; F:m7G(5')pppN diphosphatase activity; F:RNA 7-methylguanosine cap binding;, P:cellular response to menadione; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA cis splicing, via spliceosome; P:negative regulation of programmed cell death; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:RNA phosphodiester bond hydrolysis, exonucleolytic;|Q96C86 Q8NHL8 Q9Y2S5,m7GpppX diphosphatase,DCS-1;Decapping scavenger enzyme;Hint-related 7meGMP-directed hydrolase;Histidine triad nucleotide-binding protein 5;Histidine triad protein member 5;Scavenger mRNA-decapping enzyme DcpS;, PF05652;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000932;GO:0042802;GO:0050072;GO:0000340;GO:0036245;GO:0000290;GO:0043928;GO:0045292;GO:0043069;GO:0000288;GO:0090503;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:P-body;, F:identical protein binding; F:m7G(5')pppN diphosphatase activity; F:RNA 7-methylguanosine cap binding;, P:cellular response to menadione; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA cis splicing, via spliceosome; P:negative regulation of programmed cell death; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:RNA phosphodiester bond hydrolysis, exonucleolytic;|Q96C86 Q8NHL8 Q9Y2S5,m7GpppX diphosphatase,DCS-1;Decapping scavenger enzyme;Hint-related 7meGMP-directed hydrolase;Histidine triad nucleotide-binding protein 5;Histidine triad protein member 5;Scavenger mRNA-decapping enzyme DcpS;, PF05652;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000932;GO:0042802;GO:0050072;GO:0000340;GO:0036245;GO:0000290;GO:0043928;GO:0045292;GO:0043069;GO:0000288;GO:0090503;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:P-body;, F:identical protein binding; F:m7G(5')pppN diphosphatase activity; F:RNA 7-methylguanosine cap binding;, P:cellular response to menadione; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA cis splicing, via spliceosome; P:negative regulation of programmed cell death; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:RNA phosphodiester bond hydrolysis, exonucleolytic;|Q96C86 Q8NHL8 Q9Y2S5,m7GpppX diphosphatase,DCS-1;Decapping scavenger enzyme;Hint-related 7meGMP-directed hydrolase;Histidine triad nucleotide-binding protein 5;Histidine triad protein member 5;Scavenger mRNA-decapping enzyme DcpS;, PF05652;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000932;GO:0042802;GO:0050072;GO:0000340;GO:0036245;GO:0000290;GO:0043928;GO:0045292;GO:0043069;GO:0000288;GO:0090503;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:P-body;, F:identical protein binding; F:m7G(5')pppN diphosphatase activity; F:RNA 7-methylguanosine cap binding;, P:cellular response to menadione; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA cis splicing, via spliceosome; P:negative regulation of programmed cell death; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:RNA phosphodiester bond hydrolysis, exonucleolytic; scaffold58 indexed_genome mRNA 10187221 10189843 . - . ID=transcript_10313;P02792 B2R4B9 Q6IBT7 Q7Z2W1 Q86WI9 Q8WU07 Q96AU9 Q96CU0 Q9BTZ8,Ferritin light chain,, PF00210;, GO:0044754;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0008043;GO:0016020;GO:0008199;GO:0008198;GO:0042802;GO:0005506;GO:0006879;GO:0006880;GO:0055072;GO:0006826;GO:0043312;GO:0006892;, C:autolysosome; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular ferritin complex; C:membrane;, F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:iron ion binding;, P:cellular iron ion homeostasis; P:intracellular sequestering of iron ion; P:iron ion homeostasis; P:iron ion transport; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; scaffold58 indexed_genome mRNA 10189863 10211785 . - . ID=transcript_10314;P58753 B3KW65 Q56UH9 Q56UI0 Q8N5E5,Toll/interleukin-1 receptor domain-containing adapter protein,Adaptor protein Wyatt;MyD88 adapter-like protein;, PF13676;, GO:0005737;GO:0005829;GO:0030139;GO:0005886;GO:0032587;GO:0042802;GO:0005546;GO:0005080;GO:0030674;GO:0035663;GO:0035662;GO:0070935;GO:0007250;GO:0007166;GO:0071221;GO:0071223;GO:0050830;GO:0006954;GO:0045087;GO:0002755;GO:0030099;GO:0030890;GO:2000340;GO:2000343;GO:0070374;GO:0043123;GO:0032735;GO:0032738;GO:0032755;GO:0032757;GO:0046330;GO:0090023;GO:0051092;GO:0031334;GO:0034137;GO:0034141;GO:0034145;GO:0032760;GO:0045088;GO:0032648;GO:0032496;GO:0035665;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:plasma membrane; C:ruffle membrane;, F:identical protein binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase C binding; F:protein-macromolecule adaptor activity; F:Toll-like receptor 2 binding; F:Toll-like receptor 4 binding;, P:3'-UTR-mediated mRNA stabilization; P:activation of NF-kappaB-inducing kinase activity; P:cell surface receptor signaling pathway; P:cellular response to bacterial lipopeptide; P:cellular response to lipoteichoic acid; P:defense response to Gram-positive bacterium; P:inflammatory response; P:innate immune response; P:MyD88-dependent toll-like receptor signaling pathway; P:myeloid cell differentiation; P:positive regulation of B cell proliferation; P:positive regulation of chemokine (C-X-C motif) ligand 1 production; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-15 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of neutrophil chemotaxis; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of toll-like receptor 2 signaling pathway; P:positive regulation of toll-like receptor 3 signaling pathway; P:positive regulation of toll-like receptor 4 signaling pathway; P:positive regulation of tumor necrosis factor production; P:regulation of innate immune response; P:regulation of interferon-beta production; P:response to lipopolysaccharide; P:TIRAP-dependent toll-like receptor 4 signaling pathway; scaffold58 indexed_genome mRNA 10213241 10220895 . - . ID=transcript_10315;Q96CU9 B3KN84 B4DHU2 Q71MG0 Q9BU39 Q9UKY9,FAD-dependent oxidoreductase domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26927},, PF01266;, GO:0005737;GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0016491;GO:0032981;, C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:oxidoreductase activity;, P:mitochondrial respiratory chain complex I assembly;|Q96CU9 B3KN84 B4DHU2 Q71MG0 Q9BU39 Q9UKY9,FAD-dependent oxidoreductase domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26927},, PF01266;, GO:0005737;GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0016491;GO:0032981;, C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:oxidoreductase activity;, P:mitochondrial respiratory chain complex I assembly;|Q96CU9 B3KN84 B4DHU2 Q71MG0 Q9BU39 Q9UKY9,FAD-dependent oxidoreductase domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26927},, PF01266;, GO:0005737;GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0016491;GO:0032981;, C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:oxidoreductase activity;, P:mitochondrial respiratory chain complex I assembly;|Q96CU9 B3KN84 B4DHU2 Q71MG0 Q9BU39 Q9UKY9,FAD-dependent oxidoreductase domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26927},, PF01266;, GO:0005737;GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0016491;GO:0032981;, C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:oxidoreductase activity;, P:mitochondrial respiratory chain complex I assembly;|Q96CU9 B3KN84 B4DHU2 Q71MG0 Q9BU39 Q9UKY9,FAD-dependent oxidoreductase domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26927},, PF01266;, GO:0005737;GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0016491;GO:0032981;, C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:oxidoreductase activity;, P:mitochondrial respiratory chain complex I assembly; scaffold58 indexed_genome mRNA 10221069 10261420 . + . ID=transcript_10316;Q9BPY3 Q9H7B0,Protein FAM118B,, PF13289;, GO:0015030;GO:0042802;GO:0030576;, C:Cajal body;, F:identical protein binding;, P:Cajal body organization;|Q9BPY3 Q9H7B0,Protein FAM118B,, PF13289;, GO:0015030;GO:0042802;GO:0030576;, C:Cajal body;, F:identical protein binding;, P:Cajal body organization; scaffold58 indexed_genome mRNA 10414893 10450290 . + . ID=transcript_10317;Q4KMG0 O14631,Cell adhesion molecule-related/down-regulated by oncogenes,, PF00041;PF07679;, GO:0005887;GO:0005886;GO:0009952;GO:0007155;GO:0001708;GO:0021987;GO:0010172;GO:0060059;GO:0002088;GO:0007520;GO:0043410;GO:0051149;GO:0045663;GO:2000179;GO:0045666;GO:0001934;GO:0048643;GO:0051057;GO:0045944;GO:0043393;GO:0014816;GO:0007224;, C:integral component of plasma membrane; C:plasma membrane;, , P:anterior/posterior pattern specification; P:cell adhesion; P:cell fate specification; P:cerebral cortex development; P:embryonic body morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:lens development in camera-type eye; P:myoblast fusion; P:positive regulation of MAPK cascade; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron differentiation; P:positive regulation of protein phosphorylation; P:positive regulation of skeletal muscle tissue development; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of transcription by RNA polymerase II; P:regulation of protein binding; P:skeletal muscle satellite cell differentiation; P:smoothened signaling pathway; scaffold58 indexed_genome mRNA 10450714 10494516 . + . ID=transcript_10318;Q4KMG0 O14631,Cell adhesion molecule-related/down-regulated by oncogenes,, PF00041;PF07679;, GO:0005887;GO:0005886;GO:0009952;GO:0007155;GO:0001708;GO:0021987;GO:0010172;GO:0060059;GO:0002088;GO:0007520;GO:0043410;GO:0051149;GO:0045663;GO:2000179;GO:0045666;GO:0001934;GO:0048643;GO:0051057;GO:0045944;GO:0043393;GO:0014816;GO:0007224;, C:integral component of plasma membrane; C:plasma membrane;, , P:anterior/posterior pattern specification; P:cell adhesion; P:cell fate specification; P:cerebral cortex development; P:embryonic body morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:lens development in camera-type eye; P:myoblast fusion; P:positive regulation of MAPK cascade; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron differentiation; P:positive regulation of protein phosphorylation; P:positive regulation of skeletal muscle tissue development; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of transcription by RNA polymerase II; P:regulation of protein binding; P:skeletal muscle satellite cell differentiation; P:smoothened signaling pathway;|Q4KMG0 O14631,Cell adhesion molecule-related/down-regulated by oncogenes,, PF00041;PF07679;, GO:0005887;GO:0005886;GO:0009952;GO:0007155;GO:0001708;GO:0021987;GO:0010172;GO:0060059;GO:0002088;GO:0007520;GO:0043410;GO:0051149;GO:0045663;GO:2000179;GO:0045666;GO:0001934;GO:0048643;GO:0051057;GO:0045944;GO:0043393;GO:0014816;GO:0007224;, C:integral component of plasma membrane; C:plasma membrane;, , P:anterior/posterior pattern specification; P:cell adhesion; P:cell fate specification; P:cerebral cortex development; P:embryonic body morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:lens development in camera-type eye; P:myoblast fusion; P:positive regulation of MAPK cascade; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron differentiation; P:positive regulation of protein phosphorylation; P:positive regulation of skeletal muscle tissue development; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of transcription by RNA polymerase II; P:regulation of protein binding; P:skeletal muscle satellite cell differentiation; P:smoothened signaling pathway; scaffold58 indexed_genome mRNA 10507019 10514114 . - . ID=transcript_10319;Q4KMG0 O14631,Cell adhesion molecule-related/down-regulated by oncogenes,, PF00041;PF07679;, GO:0005887;GO:0005886;GO:0009952;GO:0007155;GO:0001708;GO:0021987;GO:0010172;GO:0060059;GO:0002088;GO:0007520;GO:0043410;GO:0051149;GO:0045663;GO:2000179;GO:0045666;GO:0001934;GO:0048643;GO:0051057;GO:0045944;GO:0043393;GO:0014816;GO:0007224;, C:integral component of plasma membrane; C:plasma membrane;, , P:anterior/posterior pattern specification; P:cell adhesion; P:cell fate specification; P:cerebral cortex development; P:embryonic body morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:lens development in camera-type eye; P:myoblast fusion; P:positive regulation of MAPK cascade; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron differentiation; P:positive regulation of protein phosphorylation; P:positive regulation of skeletal muscle tissue development; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of transcription by RNA polymerase II; P:regulation of protein binding; P:skeletal muscle satellite cell differentiation; P:smoothened signaling pathway;|Q4KMG0 O14631,Cell adhesion molecule-related/down-regulated by oncogenes,, PF00041;PF07679;, GO:0005887;GO:0005886;GO:0009952;GO:0007155;GO:0001708;GO:0021987;GO:0010172;GO:0060059;GO:0002088;GO:0007520;GO:0043410;GO:0051149;GO:0045663;GO:2000179;GO:0045666;GO:0001934;GO:0048643;GO:0051057;GO:0045944;GO:0043393;GO:0014816;GO:0007224;, C:integral component of plasma membrane; C:plasma membrane;, , P:anterior/posterior pattern specification; P:cell adhesion; P:cell fate specification; P:cerebral cortex development; P:embryonic body morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:lens development in camera-type eye; P:myoblast fusion; P:positive regulation of MAPK cascade; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron differentiation; P:positive regulation of protein phosphorylation; P:positive regulation of skeletal muscle tissue development; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of transcription by RNA polymerase II; P:regulation of protein binding; P:skeletal muscle satellite cell differentiation; P:smoothened signaling pathway;|Q4KMG0 O14631,Cell adhesion molecule-related/down-regulated by oncogenes,, PF00041;PF07679;, GO:0005887;GO:0005886;GO:0009952;GO:0007155;GO:0001708;GO:0021987;GO:0010172;GO:0060059;GO:0002088;GO:0007520;GO:0043410;GO:0051149;GO:0045663;GO:2000179;GO:0045666;GO:0001934;GO:0048643;GO:0051057;GO:0045944;GO:0043393;GO:0014816;GO:0007224;, C:integral component of plasma membrane; C:plasma membrane;, , P:anterior/posterior pattern specification; P:cell adhesion; P:cell fate specification; P:cerebral cortex development; P:embryonic body morphogenesis; P:embryonic retina morphogenesis in camera-type eye; P:lens development in camera-type eye; P:myoblast fusion; P:positive regulation of MAPK cascade; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron differentiation; P:positive regulation of protein phosphorylation; P:positive regulation of skeletal muscle tissue development; P:positive regulation of small GTPase mediated signal transduction; P:positive regulation of transcription by RNA polymerase II; P:regulation of protein binding; P:skeletal muscle satellite cell differentiation; P:smoothened signaling pathway; scaffold58 indexed_genome mRNA 10550777 10572319 . - . ID=transcript_10320;Q9UHL0 B2R6Z0 Q5XVN2 Q86W81 Q8IYP1,ATP-dependent RNA helicase DDX25,DEAD box protein 25;Gonadotropin-regulated testicular RNA helicase;, PF00270;PF00271;, GO:0033391;GO:0005737;GO:0010494;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0006406;GO:0007275;GO:0016973;GO:0006417;GO:0007286;, C:chromatoid body; C:cytoplasm; C:cytoplasmic stress granule; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA export from nucleus; P:multicellular organism development; P:poly(A)+ mRNA export from nucleus; P:regulation of translation; P:spermatid development;|Q9UHL0 B2R6Z0 Q5XVN2 Q86W81 Q8IYP1,ATP-dependent RNA helicase DDX25,DEAD box protein 25;Gonadotropin-regulated testicular RNA helicase;, PF00270;PF00271;, GO:0033391;GO:0005737;GO:0010494;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0006406;GO:0007275;GO:0016973;GO:0006417;GO:0007286;, C:chromatoid body; C:cytoplasm; C:cytoplasmic stress granule; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA export from nucleus; P:multicellular organism development; P:poly(A)+ mRNA export from nucleus; P:regulation of translation; P:spermatid development;|Q9UHL0 B2R6Z0 Q5XVN2 Q86W81 Q8IYP1,ATP-dependent RNA helicase DDX25,DEAD box protein 25;Gonadotropin-regulated testicular RNA helicase;, PF00270;PF00271;, GO:0033391;GO:0005737;GO:0010494;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0006406;GO:0007275;GO:0016973;GO:0006417;GO:0007286;, C:chromatoid body; C:cytoplasm; C:cytoplasmic stress granule; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA export from nucleus; P:multicellular organism development; P:poly(A)+ mRNA export from nucleus; P:regulation of translation; P:spermatid development; scaffold58 indexed_genome mRNA 10573778 10580106 . + . ID=transcript_10321;Q9BZE2 B2RAM0 Q96D17 Q96J23 Q96NB4,tRNA pseudouridine(38/39) synthase,tRNA pseudouridine synthase 3;tRNA pseudouridylate synthase 3;tRNA-uridine isomerase 3;, PF01416;, GO:0005737;GO:0005829;GO:0005634;GO:0009982;GO:0003723;GO:0106029;GO:1990481;GO:0006400;GO:0031119;, C:cytoplasm; C:cytosol; C:nucleus;, F:pseudouridine synthase activity; F:RNA binding; F:tRNA pseudouridine synthase activity;, P:mRNA pseudouridine synthesis; P:tRNA modification; P:tRNA pseudouridine synthesis;|Q96M11 B3KXI8 Q96BX9,Hydrolethalus syndrome protein 1,, PF15311;, GO:0005814;GO:0005813;GO:0005929;GO:0005737;GO:0005829;GO:0097730;GO:0005634;GO:0005886;GO:0060271;, C:centriole; C:centrosome; C:cilium; C:cytoplasm; C:cytosol; C:non-motile cilium; C:nucleus; C:plasma membrane;, , P:cilium assembly; scaffold58 indexed_genome mRNA 10580236 10583762 . - . ID=transcript_10322;Q9BZE2 B2RAM0 Q96D17 Q96J23 Q96NB4,tRNA pseudouridine(38/39) synthase,tRNA pseudouridine synthase 3;tRNA pseudouridylate synthase 3;tRNA-uridine isomerase 3;, PF01416;, GO:0005737;GO:0005829;GO:0005634;GO:0009982;GO:0003723;GO:0106029;GO:1990481;GO:0006400;GO:0031119;, C:cytoplasm; C:cytosol; C:nucleus;, F:pseudouridine synthase activity; F:RNA binding; F:tRNA pseudouridine synthase activity;, P:mRNA pseudouridine synthesis; P:tRNA modification; P:tRNA pseudouridine synthesis;|Q9BZE2 B2RAM0 Q96D17 Q96J23 Q96NB4,tRNA pseudouridine(38/39) synthase,tRNA pseudouridine synthase 3;tRNA pseudouridylate synthase 3;tRNA-uridine isomerase 3;, PF01416;, GO:0005737;GO:0005829;GO:0005634;GO:0009982;GO:0003723;GO:0106029;GO:1990481;GO:0006400;GO:0031119;, C:cytoplasm; C:cytosol; C:nucleus;, F:pseudouridine synthase activity; F:RNA binding; F:tRNA pseudouridine synthase activity;, P:mRNA pseudouridine synthesis; P:tRNA modification; P:tRNA pseudouridine synthesis;|Q9NW64 A6NDM5 B4DLI9 O95607,Pre-mRNA-splicing factor RBM22,RNA-binding motif protein 22;Zinc finger CCCH domain-containing protein 16;, PF00076;, GO:0071013;GO:0005737;GO:0005654;GO:0005634;GO:0000974;GO:0071006;GO:0071007;GO:0048306;GO:0046872;GO:0036002;GO:0003723;GO:0017070;GO:0035690;GO:0045292;GO:0000398;GO:0046827;GO:0042307;GO:0033120;, C:catalytic step 2 spliceosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:Prp19 complex; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome;, F:calcium-dependent protein binding; F:metal ion binding; F:pre-mRNA binding; F:RNA binding; F:U6 snRNA binding;, P:cellular response to drug; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:positive regulation of protein export from nucleus; P:positive regulation of protein import into nucleus; P:positive regulation of RNA splicing; scaffold58 indexed_genome mRNA 10730431 10733074 . - . ID=transcript_10323;P26436 Q53FF4,Acrosomal protein SP-10,Acrosomal vesicle protein 1;, , GO:0001669;GO:0007275;, C:acrosomal vesicle;, , P:multicellular organism development; scaffold58 indexed_genome mRNA 10782867 10799924 . - . ID=transcript_10324;O14757 A8K934 B4DDD0 B4DSK3 B5BTY6 F5H7S4 H2BI51,Serine/threonine-protein kinase Chk1,CHK1 checkpoint homolog;Cell cycle checkpoint kinase;Checkpoint kinase-1;, PF00069;, GO:0005813;GO:0000785;GO:0000794;GO:0005737;GO:0005829;GO:0005615;GO:0043231;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0035402;GO:0019904;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0006974;GO:0071260;GO:0048096;GO:0000077;GO:0006975;GO:0006281;GO:0006260;GO:0035556;GO:0044818;GO:0070317;GO:0045839;GO:0018107;GO:0045787;GO:0006468;GO:0010569;GO:2000615;GO:0046602;GO:1901796;GO:0010767;GO:0090399;GO:0072425;, C:centrosome; C:chromatin; C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:extracellular space; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:histone kinase activity (H3-T11 specific); F:protein domain specific binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to mechanical stimulus; P:chromatin-mediated maintenance of transcription; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA repair; P:DNA replication; P:intracellular signal transduction; P:mitotic G2/M transition checkpoint; P:negative regulation of G0 to G1 transition; P:negative regulation of mitotic nuclear division; P:peptidyl-threonine phosphorylation; P:positive regulation of cell cycle; P:protein phosphorylation; P:regulation of double-strand break repair via homologous recombination; P:regulation of histone H3-K9 acetylation; P:regulation of mitotic centrosome separation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage; P:replicative senescence; P:signal transduction involved in G2 DNA damage checkpoint;|O14757 A8K934 B4DDD0 B4DSK3 B5BTY6 F5H7S4 H2BI51,Serine/threonine-protein kinase Chk1,CHK1 checkpoint homolog;Cell cycle checkpoint kinase;Checkpoint kinase-1;, PF00069;, GO:0005813;GO:0000785;GO:0000794;GO:0005737;GO:0005829;GO:0005615;GO:0043231;GO:0005654;GO:0005634;GO:0032991;GO:0005524;GO:0035402;GO:0019904;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0006974;GO:0071260;GO:0048096;GO:0000077;GO:0006975;GO:0006281;GO:0006260;GO:0035556;GO:0044818;GO:0070317;GO:0045839;GO:0018107;GO:0045787;GO:0006468;GO:0010569;GO:2000615;GO:0046602;GO:1901796;GO:0010767;GO:0090399;GO:0072425;, C:centrosome; C:chromatin; C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:extracellular space; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:ATP binding; F:histone kinase activity (H3-T11 specific); F:protein domain specific binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to mechanical stimulus; P:chromatin-mediated maintenance of transcription; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA repair; P:DNA replication; P:intracellular signal transduction; P:mitotic G2/M transition checkpoint; P:negative regulation of G0 to G1 transition; P:negative regulation of mitotic nuclear division; P:peptidyl-threonine phosphorylation; P:positive regulation of cell cycle; P:protein phosphorylation; P:regulation of double-strand break repair via homologous recombination; P:regulation of histone H3-K9 acetylation; P:regulation of mitotic centrosome separation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage; P:replicative senescence; P:signal transduction involved in G2 DNA damage checkpoint; scaffold58 indexed_genome mRNA 10805549 10827723 . - . ID=transcript_10325;P46977 B4DJ24 E9PNQ1 Q86XU9 Q8TE35 Q8WUB4,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A,B5;Integral membrane protein 1;Transmembrane protein TMC;, PF02516;, GO:0005789;GO:0016021;GO:0016020;GO:0008250;GO:0035000;GO:0004579;GO:0046872;GO:0043686;GO:0043687;GO:0006487;GO:0018279;GO:0019082;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:oligosaccharyltransferase complex; C:oligosaccharyltransferase III complex;, F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; F:metal ion binding;, P:co-translational protein modification; P:post-translational protein modification; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing;|P46977 B4DJ24 E9PNQ1 Q86XU9 Q8TE35 Q8WUB4,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A,B5;Integral membrane protein 1;Transmembrane protein TMC;, PF02516;, GO:0005789;GO:0016021;GO:0016020;GO:0008250;GO:0035000;GO:0004579;GO:0046872;GO:0043686;GO:0043687;GO:0006487;GO:0018279;GO:0019082;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:oligosaccharyltransferase complex; C:oligosaccharyltransferase III complex;, F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; F:metal ion binding;, P:co-translational protein modification; P:post-translational protein modification; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing;|P46977 B4DJ24 E9PNQ1 Q86XU9 Q8TE35 Q8WUB4,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A,B5;Integral membrane protein 1;Transmembrane protein TMC;, PF02516;, GO:0005789;GO:0016021;GO:0016020;GO:0008250;GO:0035000;GO:0004579;GO:0046872;GO:0043686;GO:0043687;GO:0006487;GO:0018279;GO:0019082;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:oligosaccharyltransferase complex; C:oligosaccharyltransferase III complex;, F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; F:metal ion binding;, P:co-translational protein modification; P:post-translational protein modification; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing; scaffold58 indexed_genome mRNA 10831739 10845510 . - . ID=transcript_10326;O14681 A8K7D6 B4DKL6 Q9BUQ1,Etoposide-induced protein 2.4 homolog,p53-induced gene 8 protein;, , GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0016020;GO:0031965;GO:0061676;GO:0006915;GO:0016236;GO:0030308;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:nuclear membrane;, F:importin-alpha family protein binding;, P:apoptotic process; P:macroautophagy; P:negative regulation of cell growth;|O14681 A8K7D6 B4DKL6 Q9BUQ1,Etoposide-induced protein 2.4 homolog,p53-induced gene 8 protein;, , GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0016020;GO:0031965;GO:0061676;GO:0006915;GO:0016236;GO:0030308;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:nuclear membrane;, F:importin-alpha family protein binding;, P:apoptotic process; P:macroautophagy; P:negative regulation of cell growth; scaffold58 indexed_genome mRNA 10893911 10930343 . + . ID=transcript_10327;Q99689 O00679 O00728 Q6IBI7,Fasciculation and elongation protein zeta-1,Zygin I;Zygin-1;, PF07763;, GO:0030424;GO:0005813;GO:0005737;GO:0030425;GO:0005794;GO:0030426;GO:0005874;GO:0005739;GO:0043025;GO:0005886;GO:0043015;GO:0005080;GO:0047485;GO:0007411;GO:0007155;GO:0071363;GO:0030010;GO:0051654;GO:0021766;GO:0070584;GO:1902902;GO:0007399;GO:0061881;GO:0045666;GO:0010976;, C:axon; C:centrosome; C:cytoplasm; C:dendrite; C:Golgi apparatus; C:growth cone; C:microtubule; C:mitochondrion; C:neuronal cell body; C:plasma membrane;, F:gamma-tubulin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:axon guidance; P:cell adhesion; P:cellular response to growth factor stimulus; P:establishment of cell polarity; P:establishment of mitochondrion localization; P:hippocampus development; P:mitochondrion morphogenesis; P:negative regulation of autophagosome assembly; P:nervous system development; P:positive regulation of anterograde axonal transport of mitochondrion; P:positive regulation of neuron differentiation; P:positive regulation of neuron projection development;|Q99689 O00679 O00728 Q6IBI7,Fasciculation and elongation protein zeta-1,Zygin I;Zygin-1;, PF07763;, GO:0030424;GO:0005813;GO:0005737;GO:0030425;GO:0005794;GO:0030426;GO:0005874;GO:0005739;GO:0043025;GO:0005886;GO:0043015;GO:0005080;GO:0047485;GO:0007411;GO:0007155;GO:0071363;GO:0030010;GO:0051654;GO:0021766;GO:0070584;GO:1902902;GO:0007399;GO:0061881;GO:0045666;GO:0010976;, C:axon; C:centrosome; C:cytoplasm; C:dendrite; C:Golgi apparatus; C:growth cone; C:microtubule; C:mitochondrion; C:neuronal cell body; C:plasma membrane;, F:gamma-tubulin binding; F:protein kinase C binding; F:protein N-terminus binding;, P:axon guidance; P:cell adhesion; P:cellular response to growth factor stimulus; P:establishment of cell polarity; P:establishment of mitochondrion localization; P:hippocampus development; P:mitochondrion morphogenesis; P:negative regulation of autophagosome assembly; P:nervous system development; P:positive regulation of anterograde axonal transport of mitochondrion; P:positive regulation of neuron differentiation; P:positive regulation of neuron projection development; scaffold58 indexed_genome mRNA 10964178 10967692 . - . ID=transcript_10328;Q96KN3 B7Z5I5 F5GZ15 Q63HL6 Q86XD1,Homeobox protein PKNOX2,Homeobox protein PREP-2;PBX/knotted homeobox 2;, PF05920;PF16493;, GO:0015629;GO:0005737;GO:0045171;GO:0015630;GO:0005654;GO:0051015;GO:0003785;GO:0000981;GO:0000978;GO:1990837;GO:0006357;, C:actin cytoskeleton; C:cytoplasm; C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm;, F:actin filament binding; F:actin monomer binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold58 indexed_genome mRNA 11311527 11324027 . - . ID=transcript_10329;Q8TED4 A8K2P9 Q6P599 Q7Z7P8 Q8TEM2,Glucose-6-phosphate exchanger SLC37A2 {ECO:0000305|PubMed:21949678},Solute carrier family 37 member 2 {ECO:0000312|HGNC:HGNC:20644};, PF07690;, GO:0005789;GO:0070062;GO:0030176;GO:0061513;GO:0008643;GO:0015760;GO:0035435;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of endoplasmic reticulum membrane;, F:glucose 6-phosphate:inorganic phosphate antiporter activity;, P:carbohydrate transport; P:glucose-6-phosphate transport; P:phosphate ion transmembrane transport; scaffold58 indexed_genome mRNA 11365641 11371669 . - . ID=transcript_10330;Q0P6D6 Q9H8U7,Coiled-coil domain-containing protein 15,, , GO:0005813;, C:centrosome; scaffold58 indexed_genome mRNA 11386480 11412983 . - . ID=transcript_10331;Q0P6D6 Q9H8U7,Coiled-coil domain-containing protein 15,, , GO:0005813;, C:centrosome; scaffold58 indexed_genome mRNA 11433717 11450861 . + . ID=transcript_10332;Q14CZ8 Q67IP8 Q6ZWL4 Q8N7I3 Q8ND35,Hepatocyte cell adhesion molecule,, PF07686;, GO:0030424;GO:0005911;GO:0005737;GO:0016021;GO:0007155;GO:0007050;GO:0034613;GO:0040008;, C:axon; C:cell-cell junction; C:cytoplasm; C:integral component of membrane;, , P:cell adhesion; P:cell cycle arrest; P:cellular protein localization; P:regulation of growth;|Q14CZ8 Q67IP8 Q6ZWL4 Q8N7I3 Q8ND35,Hepatocyte cell adhesion molecule,, PF07686;, GO:0030424;GO:0005911;GO:0005737;GO:0016021;GO:0007155;GO:0007050;GO:0034613;GO:0040008;, C:axon; C:cell-cell junction; C:cytoplasm; C:integral component of membrane;, , P:cell adhesion; P:cell cycle arrest; P:cellular protein localization; P:regulation of growth; scaffold58 indexed_genome mRNA 11467237 11481479 . + . ID=transcript_10333;Q8WZ75 A8K154 Q14DU7 Q8TEG1 Q96JV6 Q9H718 Q9NWJ8,Roundabout homolog 4,Magic roundabout;, PF00041;PF07679;, GO:0030424;GO:0070062;GO:0016021;GO:0005886;GO:0098632;GO:0038023;GO:0001525;GO:0007411;GO:0070593;GO:0061028;GO:0007156;GO:0030334;, C:axon; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:cell-cell adhesion mediator activity; F:signaling receptor activity;, P:angiogenesis; P:axon guidance; P:dendrite self-avoidance; P:establishment of endothelial barrier; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:regulation of cell migration;|Q8WZ75 A8K154 Q14DU7 Q8TEG1 Q96JV6 Q9H718 Q9NWJ8,Roundabout homolog 4,Magic roundabout;, PF00041;PF07679;, GO:0030424;GO:0070062;GO:0016021;GO:0005886;GO:0098632;GO:0038023;GO:0001525;GO:0007411;GO:0070593;GO:0061028;GO:0007156;GO:0030334;, C:axon; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:cell-cell adhesion mediator activity; F:signaling receptor activity;, P:angiogenesis; P:axon guidance; P:dendrite self-avoidance; P:establishment of endothelial barrier; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:regulation of cell migration;|Q8WZ75 A8K154 Q14DU7 Q8TEG1 Q96JV6 Q9H718 Q9NWJ8,Roundabout homolog 4,Magic roundabout;, PF00041;PF07679;, GO:0030424;GO:0070062;GO:0016021;GO:0005886;GO:0098632;GO:0038023;GO:0001525;GO:0007411;GO:0070593;GO:0061028;GO:0007156;GO:0030334;, C:axon; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:cell-cell adhesion mediator activity; F:signaling receptor activity;, P:angiogenesis; P:axon guidance; P:dendrite self-avoidance; P:establishment of endothelial barrier; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:regulation of cell migration; scaffold58 indexed_genome mRNA 11562593 11571994 . + . ID=transcript_10334;Q6P1R3 B3KRY6 Q9H042 Q9H5K8,Myb/SANT-like DNA-binding domain-containing protein 2 scaffold58 indexed_genome mRNA 11573069 11579438 . + . ID=transcript_10335;Q6P1R3 B3KRY6 Q9H042 Q9H5K8,Myb/SANT-like DNA-binding domain-containing protein 2|Q6P1R3 B3KRY6 Q9H042 Q9H5K8,Myb/SANT-like DNA-binding domain-containing protein 2|Q6P1R3 B3KRY6 Q9H042 Q9H5K8,Myb/SANT-like DNA-binding domain-containing protein 2 scaffold58 indexed_genome mRNA 11583855 11593680 . + . ID=transcript_10336;Q96AP7 B4DVN8 Q96T50,Endothelial cell-selective adhesion molecule,, PF07686;, GO:0005912;GO:0005923;GO:0005911;GO:0016021;GO:0005886;GO:0032991;GO:0098632;GO:0070830;GO:0098609;GO:0034613;GO:0007156;GO:0050900;GO:0035633;GO:2000249;GO:0030833;, C:adherens junction; C:bicellular tight junction; C:cell-cell junction; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, F:cell-cell adhesion mediator activity;, P:bicellular tight junction assembly; P:cell-cell adhesion; P:cellular protein localization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte migration; P:maintenance of blood-brain barrier; P:regulation of actin cytoskeleton reorganization; P:regulation of actin filament polymerization; scaffold58 indexed_genome mRNA 11593701 11598903 . + . ID=transcript_10337;Q96IQ7 O95791 Q9NX42,V-set and immunoglobulin domain-containing protein 2,Cortical thymocyte-like protein;, PF07686;, GO:0005887;GO:0016020;, C:integral component of plasma membrane; C:membrane;|Q96IQ7 O95791 Q9NX42,V-set and immunoglobulin domain-containing protein 2,Cortical thymocyte-like protein;, PF07686;, GO:0005887;GO:0016020;, C:integral component of plasma membrane; C:membrane;|Q96IQ7 O95791 Q9NX42,V-set and immunoglobulin domain-containing protein 2,Cortical thymocyte-like protein;, PF07686;, GO:0005887;GO:0016020;, C:integral component of plasma membrane; C:membrane;|Q96IQ7 O95791 Q9NX42,V-set and immunoglobulin domain-containing protein 2,Cortical thymocyte-like protein;, PF07686;, GO:0005887;GO:0016020;, C:integral component of plasma membrane; C:membrane;|Q96IQ7 O95791 Q9NX42,V-set and immunoglobulin domain-containing protein 2,Cortical thymocyte-like protein;, PF07686;, GO:0005887;GO:0016020;, C:integral component of plasma membrane; C:membrane; scaffold58 indexed_genome mRNA 11599630 11606442 . - . ID=transcript_10338;Q92686,Neurogranin,RC3;, PF00612;, GO:0030424;GO:0005829;GO:0044327;GO:0098978;GO:0031966;GO:0043025;GO:0005634;GO:0014069;GO:0045211;GO:0012510;GO:0005516;GO:0070300;GO:0005547;GO:0008306;GO:0007268;GO:0007399;GO:1900273;GO:0099170;GO:0007165;GO:0021537;, C:axon; C:cytosol; C:dendritic spine head; C:glutamatergic synapse; C:mitochondrial membrane; C:neuronal cell body; C:nucleus; C:postsynaptic density; C:postsynaptic membrane; C:trans-Golgi network transport vesicle membrane;, F:calmodulin binding; F:phosphatidic acid binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:associative learning; P:chemical synaptic transmission; P:nervous system development; P:positive regulation of long-term synaptic potentiation; P:postsynaptic modulation of chemical synaptic transmission; P:signal transduction; P:telencephalon development; scaffold58 indexed_genome mRNA 11653146 11665813 . - . ID=transcript_10339;Q15506 B2R4F2 Q9BXF7,Sperm surface protein Sp17,Cancer/testis antigen 22;Sp17-1;Sperm autoantigenic protein 17;, PF00612;PF02197;, GO:0005929;GO:0005737;GO:0009897;GO:0005576;GO:0031514;GO:0035686;GO:0097228;GO:0005516;GO:0007339;GO:0003351;GO:0007338;GO:0007283;, C:cilium; C:cytoplasm; C:external side of plasma membrane; C:extracellular region; C:motile cilium; C:sperm fibrous sheath; C:sperm principal piece;, F:calmodulin binding;, P:binding of sperm to zona pellucida; P:epithelial cilium movement involved in extracellular fluid movement; P:single fertilization; P:spermatogenesis; scaffold58 indexed_genome mRNA 11679362 11702641 . - . ID=transcript_10340;Q9HAT2 B3KPB0 Q8IUT9 Q9HAU7 Q9NT71,Sialate O-acetylesterase,H-Lse;Sialic acid-specific 9-O-acetylesterase;, PF03629;, GO:0070062;GO:0005615;GO:0005764;GO:0106331;GO:0106330;GO:0001681;GO:0005975;GO:0002682;, C:extracellular exosome; C:extracellular space; C:lysosome;, F:sialate 4-O-acetylesterase activity; F:sialate 9-O-acetylesterase activity; F:sialate O-acetylesterase activity;, P:carbohydrate metabolic process; P:regulation of immune system process;|Q9HAT2 B3KPB0 Q8IUT9 Q9HAU7 Q9NT71,Sialate O-acetylesterase,H-Lse;Sialic acid-specific 9-O-acetylesterase;, PF03629;, GO:0070062;GO:0005615;GO:0005764;GO:0106331;GO:0106330;GO:0001681;GO:0005975;GO:0002682;, C:extracellular exosome; C:extracellular space; C:lysosome;, F:sialate 4-O-acetylesterase activity; F:sialate 9-O-acetylesterase activity; F:sialate O-acetylesterase activity;, P:carbohydrate metabolic process; P:regulation of immune system process;|Q9HAT2 B3KPB0 Q8IUT9 Q9HAU7 Q9NT71,Sialate O-acetylesterase,H-Lse;Sialic acid-specific 9-O-acetylesterase;, PF03629;, GO:0070062;GO:0005615;GO:0005764;GO:0106331;GO:0106330;GO:0001681;GO:0005975;GO:0002682;, C:extracellular exosome; C:extracellular space; C:lysosome;, F:sialate 4-O-acetylesterase activity; F:sialate 9-O-acetylesterase activity; F:sialate O-acetylesterase activity;, P:carbohydrate metabolic process; P:regulation of immune system process;|Q9HAT2 B3KPB0 Q8IUT9 Q9HAU7 Q9NT71,Sialate O-acetylesterase,H-Lse;Sialic acid-specific 9-O-acetylesterase;, PF03629;, GO:0070062;GO:0005615;GO:0005764;GO:0106331;GO:0106330;GO:0001681;GO:0005975;GO:0002682;, C:extracellular exosome; C:extracellular space; C:lysosome;, F:sialate 4-O-acetylesterase activity; F:sialate 9-O-acetylesterase activity; F:sialate O-acetylesterase activity;, P:carbohydrate metabolic process; P:regulation of immune system process; scaffold58 indexed_genome mRNA 11707732 11716087 . - . ID=transcript_10341;Q3YBR2 Q53GJ5 Q66ZJ6 Q69YS7 Q8TCS4 Q8TEI4 Q96SV0,Transforming growth factor beta regulator 1,Nuclear interactor of ARF and Mdm2;, PF05965;PF05964;, GO:0005654;GO:0005634;GO:0007050;GO:0006260;GO:0008285;GO:1990173;GO:0050821;, C:nucleoplasm; C:nucleus;, , P:cell cycle arrest; P:DNA replication; P:negative regulation of cell population proliferation; P:protein localization to nucleoplasm; P:protein stabilization;|Q3YBR2 Q53GJ5 Q66ZJ6 Q69YS7 Q8TCS4 Q8TEI4 Q96SV0,Transforming growth factor beta regulator 1,Nuclear interactor of ARF and Mdm2;, PF05965;PF05964;, GO:0005654;GO:0005634;GO:0007050;GO:0006260;GO:0008285;GO:1990173;GO:0050821;, C:nucleoplasm; C:nucleus;, , P:cell cycle arrest; P:DNA replication; P:negative regulation of cell population proliferation; P:protein localization to nucleoplasm; P:protein stabilization;|Q3YBR2 Q53GJ5 Q66ZJ6 Q69YS7 Q8TCS4 Q8TEI4 Q96SV0,Transforming growth factor beta regulator 1,Nuclear interactor of ARF and Mdm2;, PF05965;PF05964;, GO:0005654;GO:0005634;GO:0007050;GO:0006260;GO:0008285;GO:1990173;GO:0050821;, C:nucleoplasm; C:nucleus;, , P:cell cycle arrest; P:DNA replication; P:negative regulation of cell population proliferation; P:protein localization to nucleoplasm; P:protein stabilization;|Q3YBR2 Q53GJ5 Q66ZJ6 Q69YS7 Q8TCS4 Q8TEI4 Q96SV0,Transforming growth factor beta regulator 1,Nuclear interactor of ARF and Mdm2;, PF05965;PF05964;, GO:0005654;GO:0005634;GO:0007050;GO:0006260;GO:0008285;GO:1990173;GO:0050821;, C:nucleoplasm; C:nucleus;, , P:cell cycle arrest; P:DNA replication; P:negative regulation of cell population proliferation; P:protein localization to nucleoplasm; P:protein stabilization; scaffold59 indexed_genome mRNA 37629 55520 . + . ID=transcript_10342;Q96PZ7 A0A0U1RQY1 Q0H0J5 Q96QU9 Q96RM4,CUB and sushi domain-containing protein 1,CUB and sushi multiple domains protein 1;, PF00431;PF00084;, GO:0016021;, C:integral component of membrane; scaffold59 indexed_genome mRNA 72905 143682 . - . ID=transcript_10343;Q96PZ7 A0A0U1RQY1 Q0H0J5 Q96QU9 Q96RM4,CUB and sushi domain-containing protein 1,CUB and sushi multiple domains protein 1;, PF00431;PF00084;, GO:0016021;, C:integral component of membrane; scaffold59 indexed_genome mRNA 143684 171713 . - . ID=transcript_10344;Q96PZ7 A0A0U1RQY1 Q0H0J5 Q96QU9 Q96RM4,CUB and sushi domain-containing protein 1,CUB and sushi multiple domains protein 1;, PF00431;PF00084;, GO:0016021;, C:integral component of membrane; scaffold59 indexed_genome mRNA 210958 230562 . - . ID=transcript_10345;Q96PZ7 A0A0U1RQY1 Q0H0J5 Q96QU9 Q96RM4,CUB and sushi domain-containing protein 1,CUB and sushi multiple domains protein 1;, PF00431;PF00084;, GO:0016021;, C:integral component of membrane; scaffold59 indexed_genome mRNA 341766 348228 . - . ID=transcript_10346;Q96PZ7 A0A0U1RQY1 Q0H0J5 Q96QU9 Q96RM4,CUB and sushi domain-containing protein 1,CUB and sushi multiple domains protein 1;, PF00431;PF00084;, GO:0016021;, C:integral component of membrane; scaffold59 indexed_genome mRNA 376298 385018 . - . ID=transcript_10347;Q96PZ7 A0A0U1RQY1 Q0H0J5 Q96QU9 Q96RM4,CUB and sushi domain-containing protein 1,CUB and sushi multiple domains protein 1;, PF00431;PF00084;, GO:0016021;, C:integral component of membrane; scaffold59 indexed_genome mRNA 3218506 3219422 . - . ID=transcript_10348;Q8NEM0 A0A075B6F8 B4DWW2 E9PGU5 E9PH63 Q66GU1 Q9H9C7,Microcephalin {ECO:0000303|PubMed:12046007},, PF16589;PF12258;PF12738;, GO:0005737;GO:0005815;GO:0005654;GO:0042802;GO:0060348;GO:0021987;GO:0000132;GO:0000278;GO:0071850;GO:0007076;GO:0000122;GO:0097150;GO:0071539;GO:0046605;GO:0060623;GO:0050727;GO:0043549;, C:cytoplasm; C:microtubule organizing center; C:nucleoplasm;, F:identical protein binding;, P:bone development; P:cerebral cortex development; P:establishment of mitotic spindle orientation; P:mitotic cell cycle; P:mitotic cell cycle arrest; P:mitotic chromosome condensation; P:negative regulation of transcription by RNA polymerase II; P:neuronal stem cell population maintenance; P:protein localization to centrosome; P:regulation of centrosome cycle; P:regulation of chromosome condensation; P:regulation of inflammatory response; P:regulation of kinase activity; scaffold59 indexed_genome mRNA 3221159 3278044 . - . ID=transcript_10349;O15123 A0AV38 A8K205 B7ZLM7 Q9NRR7 Q9P2Y7,Angiopoietin-2,, PF00147;, GO:0042995;GO:0062023;GO:0005576;GO:0005615;GO:0005634;GO:0005886;GO:0046872;GO:0030971;GO:0005102;GO:0001525;GO:0031100;GO:0071363;GO:0010467;GO:0007281;GO:0072012;GO:0050900;GO:0060135;GO:0016525;GO:0043537;GO:0010812;GO:0050928;GO:0045766;GO:0014823;GO:0009749;GO:0001666;GO:0009612;GO:0014070;GO:0009314;GO:0007165;GO:0048014;, C:cell projection; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:nucleus; C:plasma membrane;, F:metal ion binding; F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:angiogenesis; P:animal organ regeneration; P:cellular response to growth factor stimulus; P:gene expression; P:germ cell development; P:glomerulus vasculature development; P:leukocyte migration; P:maternal process involved in female pregnancy; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell-substrate adhesion; P:negative regulation of positive chemotaxis; P:positive regulation of angiogenesis; P:response to activity; P:response to glucose; P:response to hypoxia; P:response to mechanical stimulus; P:response to organic cyclic compound; P:response to radiation; P:signal transduction; P:Tie signaling pathway;|O15123 A0AV38 A8K205 B7ZLM7 Q9NRR7 Q9P2Y7,Angiopoietin-2,, PF00147;, GO:0042995;GO:0062023;GO:0005576;GO:0005615;GO:0005634;GO:0005886;GO:0046872;GO:0030971;GO:0005102;GO:0001525;GO:0031100;GO:0071363;GO:0010467;GO:0007281;GO:0072012;GO:0050900;GO:0060135;GO:0016525;GO:0043537;GO:0010812;GO:0050928;GO:0045766;GO:0014823;GO:0009749;GO:0001666;GO:0009612;GO:0014070;GO:0009314;GO:0007165;GO:0048014;, C:cell projection; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:nucleus; C:plasma membrane;, F:metal ion binding; F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:angiogenesis; P:animal organ regeneration; P:cellular response to growth factor stimulus; P:gene expression; P:germ cell development; P:glomerulus vasculature development; P:leukocyte migration; P:maternal process involved in female pregnancy; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell-substrate adhesion; P:negative regulation of positive chemotaxis; P:positive regulation of angiogenesis; P:response to activity; P:response to glucose; P:response to hypoxia; P:response to mechanical stimulus; P:response to organic cyclic compound; P:response to radiation; P:signal transduction; P:Tie signaling pathway; scaffold59 indexed_genome mRNA 3462658 3514146 . + . ID=transcript_10350;Q9NUQ2 Q8IZ47 Q9BQG4,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon,1-acylglycerol-3-phosphate O-acyltransferase 5;Lysophosphatidic acid acyltransferase epsilon;, PF16076;PF01553;, GO:0012505;GO:0005789;GO:0016021;GO:0005741;GO:0005739;GO:0005635;GO:0003841;GO:0016746;GO:0006639;GO:0016024;GO:0002244;GO:0006654;GO:0008654;, C:endomembrane system; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acylglycerol metabolic process; P:CDP-diacylglycerol biosynthetic process; P:hematopoietic progenitor cell differentiation; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process;|Q9NUQ2 Q8IZ47 Q9BQG4,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon,1-acylglycerol-3-phosphate O-acyltransferase 5;Lysophosphatidic acid acyltransferase epsilon;, PF16076;PF01553;, GO:0012505;GO:0005789;GO:0016021;GO:0005741;GO:0005739;GO:0005635;GO:0003841;GO:0016746;GO:0006639;GO:0016024;GO:0002244;GO:0006654;GO:0008654;, C:endomembrane system; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acylglycerol metabolic process; P:CDP-diacylglycerol biosynthetic process; P:hematopoietic progenitor cell differentiation; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process;|Q9NUQ2 Q8IZ47 Q9BQG4,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon,1-acylglycerol-3-phosphate O-acyltransferase 5;Lysophosphatidic acid acyltransferase epsilon;, PF16076;PF01553;, GO:0012505;GO:0005789;GO:0016021;GO:0005741;GO:0005739;GO:0005635;GO:0003841;GO:0016746;GO:0006639;GO:0016024;GO:0002244;GO:0006654;GO:0008654;, C:endomembrane system; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acylglycerol metabolic process; P:CDP-diacylglycerol biosynthetic process; P:hematopoietic progenitor cell differentiation; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; scaffold59 indexed_genome mRNA 3788783 3808448 . - . ID=transcript_10351;Q8TC21 B2R8P4 O95015 Q8N9X0,Zinc finger protein 596,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9UL59 B2R8Q1,Zinc finger protein 214,BWSCR2-associated zinc finger protein 1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II;|Q6ZN79,Zinc finger protein 705A,, PF01352;PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q6ZN79,Zinc finger protein 705A,, PF01352;PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q6ZN79,Zinc finger protein 705A,, PF01352;PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold59 indexed_genome mRNA 3978963 3979690 . - . ID=transcript_10352;A8MXU0,Putative beta-defensin 108A,Defensin, beta 108A {ECO:0000312|HGNC:HGNC:18089};Defensin, beta 108C {ECO:0000312|HGNC:HGNC:30847};Putative beta-defensin 108B pseudogene 1/2;, PF13841;, GO:0005576;GO:0042742;GO:0045087;, C:extracellular region;, , P:defense response to bacterium; P:innate immune response; scaffold59 indexed_genome mRNA 4032804 4164650 . - . ID=transcript_10353;P51674 B7Z642 E9PHI5 Q92602,Neuronal membrane glycoprotein M6-a,, PF01275;, GO:0044295;GO:0043197;GO:0070062;GO:1903561;GO:0030175;GO:0098978;GO:0099059;GO:0043005;GO:0043025;GO:0005886;GO:0005262;GO:0003407;GO:0001764;GO:0031175;GO:0048812;GO:0051491;GO:0050807;GO:0009617;GO:0048863;GO:0007416;, C:axonal growth cone; C:dendritic spine; C:extracellular exosome; C:extracellular vesicle; C:filopodium; C:glutamatergic synapse; C:integral component of presynaptic active zone membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:calcium channel activity;, P:neural retina development; P:neuron migration; P:neuron projection development; P:neuron projection morphogenesis; P:positive regulation of filopodium assembly; P:regulation of synapse organization; P:response to bacterium; P:stem cell differentiation; P:synapse assembly;|P51674 B7Z642 E9PHI5 Q92602,Neuronal membrane glycoprotein M6-a,, PF01275;, GO:0044295;GO:0043197;GO:0070062;GO:1903561;GO:0030175;GO:0098978;GO:0099059;GO:0043005;GO:0043025;GO:0005886;GO:0005262;GO:0003407;GO:0001764;GO:0031175;GO:0048812;GO:0051491;GO:0050807;GO:0009617;GO:0048863;GO:0007416;, C:axonal growth cone; C:dendritic spine; C:extracellular exosome; C:extracellular vesicle; C:filopodium; C:glutamatergic synapse; C:integral component of presynaptic active zone membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:calcium channel activity;, P:neural retina development; P:neuron migration; P:neuron projection development; P:neuron projection morphogenesis; P:positive regulation of filopodium assembly; P:regulation of synapse organization; P:response to bacterium; P:stem cell differentiation; P:synapse assembly; scaffold59 indexed_genome mRNA 4305045 4323488 . + . ID=transcript_10354;Q8IZU2 E7EQX0 Q0QD35,WD repeat-containing protein 17,, PF12894;PF00400; scaffold59 indexed_genome mRNA 4324474 4346468 . + . ID=transcript_10355;Q8IZU2 E7EQX0 Q0QD35,WD repeat-containing protein 17,, PF12894;PF00400;|Q8IZU2 E7EQX0 Q0QD35,WD repeat-containing protein 17,, PF12894;PF00400; scaffold59 indexed_genome mRNA 4348207 4359085 . + . ID=transcript_10356;Q8IZU2 E7EQX0 Q0QD35,WD repeat-containing protein 17,, PF12894;PF00400;|Q8IZU2 E7EQX0 Q0QD35,WD repeat-containing protein 17,, PF12894;PF00400; scaffold59 indexed_genome mRNA 4366185 4367206 . + . ID=transcript_10357;Q8NEY3 Q8NCS5 Q8WW15,Spermatogenesis-associated protein 4,Testis and spermatogenesis cell-related protein 2;Testis spermatocyte apoptosis-related gene 2 protein;, PF06294;, GO:0005930;GO:0005634;GO:0008017;GO:0051493;, C:axoneme; C:nucleus;, F:microtubule binding;, P:regulation of cytoskeleton organization; scaffold59 indexed_genome mRNA 4379555 4419890 . - . ID=transcript_10358;Q8WWX0 Q8N7B5,Ankyrin repeat and SOCS box protein 5,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0045732;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:positive regulation of protein catabolic process; P:post-translational protein modification; P:protein ubiquitination;|Q8WWX0 Q8N7B5,Ankyrin repeat and SOCS box protein 5,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0045732;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:positive regulation of protein catabolic process; P:post-translational protein modification; P:protein ubiquitination;|Q8WWX0 Q8N7B5,Ankyrin repeat and SOCS box protein 5,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0045732;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:positive regulation of protein catabolic process; P:post-translational protein modification; P:protein ubiquitination;|Q8WWX0 Q8N7B5,Ankyrin repeat and SOCS box protein 5,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0045732;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:positive regulation of protein catabolic process; P:post-translational protein modification; P:protein ubiquitination; scaffold59 indexed_genome mRNA 4431582 4432083 . - . ID=transcript_10359;O14730 Q8IXN9,Serine/threonine-protein kinase RIO3,RIO kinase 3;sudD homolog;, , GO:0005829;GO:0030688;GO:0005524;GO:0089720;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:1990786;GO:0071359;GO:0098586;GO:0007059;GO:0051607;GO:0045087;GO:0030490;GO:0043124;GO:0039534;GO:0031333;GO:0045089;GO:0032728;, C:cytosol; C:preribosome, small subunit precursor;, F:ATP binding; F:caspase binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to dsDNA; P:cellular response to dsRNA; P:cellular response to virus; P:chromosome segregation; P:defense response to virus; P:innate immune response; P:maturation of SSU-rRNA; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of MDA-5 signaling pathway; P:negative regulation of protein-containing complex assembly; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; scaffold59 indexed_genome mRNA 4436315 4445445 . + . ID=transcript_10360;P61009 P12280 Q9H0S7,Signal peptidase complex subunit 3,Microsomal signal peptidase 22/23 kDa subunit;, PF04573;, GO:0005783;GO:0005789;GO:0016021;GO:0005787;GO:0008233;GO:0045047;GO:0006508;GO:0006465;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:signal peptidase complex;, F:peptidase activity;, P:protein targeting to ER; P:proteolysis; P:signal peptide processing; P:viral protein processing;|P61009 P12280 Q9H0S7,Signal peptidase complex subunit 3,Microsomal signal peptidase 22/23 kDa subunit;, PF04573;, GO:0005783;GO:0005789;GO:0016021;GO:0005787;GO:0008233;GO:0045047;GO:0006508;GO:0006465;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:signal peptidase complex;, F:peptidase activity;, P:protein targeting to ER; P:proteolysis; P:signal peptide processing; P:viral protein processing; scaffold59 indexed_genome mRNA 5212196 5225206 . + . ID=transcript_10361;Q8TAT5 Q2PPJ3 Q8NG51 Q9NV95,Endonuclease 8-like 3,DNA glycosylase FPG2;DNA glycosylase/AP lyase Neil3;Endonuclease VIII-like 3;Nei-like protein 3;, PF06831;PF06839;PF00641;, GO:0005694;GO:0005654;GO:0005634;GO:0000405;GO:0140078;GO:0003684;GO:0019104;GO:0003906;GO:0003690;GO:1904931;GO:0003697;GO:0008270;GO:0006284;GO:0006285;GO:0045007;GO:0036297;, C:chromosome; C:nucleoplasm; C:nucleus;, F:bubble DNA binding; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA N-glycosylase activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA binding; F:MCM complex binding; F:single-stranded DNA binding; F:zinc ion binding;, P:base-excision repair; P:base-excision repair, AP site formation; P:depurination; P:interstrand cross-link repair; scaffold59 indexed_genome mRNA 5226871 5234284 . + . ID=transcript_10362;Q8TAT5 Q2PPJ3 Q8NG51 Q9NV95,Endonuclease 8-like 3,DNA glycosylase FPG2;DNA glycosylase/AP lyase Neil3;Endonuclease VIII-like 3;Nei-like protein 3;, PF06831;PF06839;PF00641;, GO:0005694;GO:0005654;GO:0005634;GO:0000405;GO:0140078;GO:0003684;GO:0019104;GO:0003906;GO:0003690;GO:1904931;GO:0003697;GO:0008270;GO:0006284;GO:0006285;GO:0045007;GO:0036297;, C:chromosome; C:nucleoplasm; C:nucleus;, F:bubble DNA binding; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA N-glycosylase activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA binding; F:MCM complex binding; F:single-stranded DNA binding; F:zinc ion binding;, P:base-excision repair; P:base-excision repair, AP site formation; P:depurination; P:interstrand cross-link repair; scaffold59 indexed_genome mRNA 5297559 5313671 . + . ID=transcript_10363;P20933 B2R7H2 D3DP47 Q4W5Q2 Q6FHN6 Q9UCK6 Q9UCK7 Q9UCK8,N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase,Aspartylglucosaminidase;Glycosylasparaginase;N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase;, PF01112;, GO:0035578;GO:0005737;GO:0005783;GO:0005576;GO:0005615;GO:0005764;GO:0003948;GO:0008233;GO:0043621;GO:0043312;GO:0006517;, C:azurophil granule lumen; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:lysosome;, F:N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; F:peptidase activity; F:protein self-association;, P:neutrophil degranulation; P:protein deglycosylation;|P20933 B2R7H2 D3DP47 Q4W5Q2 Q6FHN6 Q9UCK6 Q9UCK7 Q9UCK8,N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase,Aspartylglucosaminidase;Glycosylasparaginase;N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase;, PF01112;, GO:0035578;GO:0005737;GO:0005783;GO:0005576;GO:0005615;GO:0005764;GO:0003948;GO:0008233;GO:0043621;GO:0043312;GO:0006517;, C:azurophil granule lumen; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:lysosome;, F:N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; F:peptidase activity; F:protein self-association;, P:neutrophil degranulation; P:protein deglycosylation;|P20933 B2R7H2 D3DP47 Q4W5Q2 Q6FHN6 Q9UCK6 Q9UCK7 Q9UCK8,N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase,Aspartylglucosaminidase;Glycosylasparaginase;N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase;, PF01112;, GO:0035578;GO:0005737;GO:0005783;GO:0005576;GO:0005615;GO:0005764;GO:0003948;GO:0008233;GO:0043621;GO:0043312;GO:0006517;, C:azurophil granule lumen; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:lysosome;, F:N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; F:peptidase activity; F:protein self-association;, P:neutrophil degranulation; P:protein deglycosylation;|P20933 B2R7H2 D3DP47 Q4W5Q2 Q6FHN6 Q9UCK6 Q9UCK7 Q9UCK8,N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase,Aspartylglucosaminidase;Glycosylasparaginase;N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase;, PF01112;, GO:0035578;GO:0005737;GO:0005783;GO:0005576;GO:0005615;GO:0005764;GO:0003948;GO:0008233;GO:0043621;GO:0043312;GO:0006517;, C:azurophil granule lumen; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:lysosome;, F:N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; F:peptidase activity; F:protein self-association;, P:neutrophil degranulation; P:protein deglycosylation;|P20933 B2R7H2 D3DP47 Q4W5Q2 Q6FHN6 Q9UCK6 Q9UCK7 Q9UCK8,N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase,Aspartylglucosaminidase;Glycosylasparaginase;N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase;, PF01112;, GO:0035578;GO:0005737;GO:0005783;GO:0005576;GO:0005615;GO:0005764;GO:0003948;GO:0008233;GO:0043621;GO:0043312;GO:0006517;, C:azurophil granule lumen; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:lysosome;, F:N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; F:peptidase activity; F:protein self-association;, P:neutrophil degranulation; P:protein deglycosylation; scaffold59 indexed_genome mRNA 10032647 10058519 . + . ID=transcript_10364;Q9P273 Q5XUL9 Q96SY2 Q9NV77 Q9NVW1 Q9NZJ2,Teneurin-3 {ECO:0000305},Protein Odd Oz/ten-m homolog 3 {ECO:0000303|Ref.5};Tenascin-M3 {ECO:0000250|UniProtKB:Q9WTS6};Teneurin transmembrane protein 3 {ECO:0000250|UniProtKB:Q9WTS6};, PF06484;PF15636;, GO:0030424;GO:0005887;GO:0016020;GO:0043005;GO:0050839;GO:0046982;GO:0042803;GO:0048593;GO:0007157;GO:0007156;GO:0048666;GO:0010976;GO:1903385;GO:0007165;, C:axon; C:integral component of plasma membrane; C:membrane; C:neuron projection;, F:cell adhesion molecule binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:camera-type eye morphogenesis; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neuron development; P:positive regulation of neuron projection development; P:regulation of homophilic cell adhesion; P:signal transduction; scaffold59 indexed_genome mRNA 10058551 10095038 . + . ID=transcript_10365;Q9P273 Q5XUL9 Q96SY2 Q9NV77 Q9NVW1 Q9NZJ2,Teneurin-3 {ECO:0000305},Protein Odd Oz/ten-m homolog 3 {ECO:0000303|Ref.5};Tenascin-M3 {ECO:0000250|UniProtKB:Q9WTS6};Teneurin transmembrane protein 3 {ECO:0000250|UniProtKB:Q9WTS6};, PF06484;PF15636;, GO:0030424;GO:0005887;GO:0016020;GO:0043005;GO:0050839;GO:0046982;GO:0042803;GO:0048593;GO:0007157;GO:0007156;GO:0048666;GO:0010976;GO:1903385;GO:0007165;, C:axon; C:integral component of plasma membrane; C:membrane; C:neuron projection;, F:cell adhesion molecule binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:camera-type eye morphogenesis; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neuron development; P:positive regulation of neuron projection development; P:regulation of homophilic cell adhesion; P:signal transduction; scaffold59 indexed_genome mRNA 10408691 10477044 . + . ID=transcript_10366;Q6AWC2 Q32Q84 Q69YQ1 Q6AWB8 Q6ZSY9 Q6ZU09 Q7Z620 Q8TEB8 Q9H6P0,Protein WWC2,BH-3-only member B;WW domain-containing protein 2;, PF00397;, GO:0005829;GO:0019900;GO:0060090;GO:0035331;GO:0046621;GO:0000122;, C:cytosol;, F:kinase binding; F:molecular adaptor activity;, P:negative regulation of hippo signaling; P:negative regulation of organ growth; P:negative regulation of transcription by RNA polymerase II; scaffold59 indexed_genome mRNA 10554023 10609913 . + . ID=transcript_10367;Q9NXV6 Q8TBM5 Q9NYH0,CDKN2A-interacting protein,Collaborator of ARF;, PF11952;, GO:0001652;GO:0005730;GO:0005654;GO:0002039;GO:0003723;GO:0006974;GO:0030308;GO:0030307;GO:0009967;GO:0031647;, C:granular component; C:nucleolus; C:nucleoplasm;, F:p53 binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:negative regulation of cell growth; P:positive regulation of cell growth; P:positive regulation of signal transduction; P:regulation of protein stability;|Q9H160 B6ZDS1 O95698,Inhibitor of growth protein 2,Inhibitor of growth 1-like protein;p32;p33ING2;, PF12998;, GO:0016602;GO:0005654;GO:0005634;GO:0005886;GO:0016580;GO:0003682;GO:0003677;GO:0046872;GO:0035064;GO:0035091;GO:0044877;GO:0006325;GO:0030317;GO:0048133;GO:0007141;GO:0008285;GO:1902166;GO:0031065;GO:0045893;GO:0030511;GO:2000772;GO:0040008;GO:2001020;GO:1901796;GO:0006355;GO:0072520;GO:0007165;GO:0007286;GO:0007283;, C:CCAAT-binding factor complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:Sin3 complex;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:methylated histone binding; F:phosphatidylinositol binding; F:protein-containing complex binding;, P:chromatin organization; P:flagellated sperm motility; P:male germ-line stem cell asymmetric division; P:male meiosis I; P:negative regulation of cell population proliferation; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:positive regulation of histone deacetylation; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cellular senescence; P:regulation of growth; P:regulation of response to DNA damage stimulus; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:seminiferous tubule development; P:signal transduction; P:spermatid development; P:spermatogenesis;|Q9NXV6 Q8TBM5 Q9NYH0,CDKN2A-interacting protein,Collaborator of ARF;, PF11952;, GO:0001652;GO:0005730;GO:0005654;GO:0002039;GO:0003723;GO:0006974;GO:0030308;GO:0030307;GO:0009967;GO:0031647;, C:granular component; C:nucleolus; C:nucleoplasm;, F:p53 binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:negative regulation of cell growth; P:positive regulation of cell growth; P:positive regulation of signal transduction; P:regulation of protein stability;|Q9NXV6 Q8TBM5 Q9NYH0,CDKN2A-interacting protein,Collaborator of ARF;, PF11952;, GO:0001652;GO:0005730;GO:0005654;GO:0002039;GO:0003723;GO:0006974;GO:0030308;GO:0030307;GO:0009967;GO:0031647;, C:granular component; C:nucleolus; C:nucleoplasm;, F:p53 binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:negative regulation of cell growth; P:positive regulation of cell growth; P:positive regulation of signal transduction; P:regulation of protein stability; scaffold59 indexed_genome mRNA 10666141 10674088 . - . ID=transcript_10368;Q6NW29 B2RDE9 B4DDP2 Q75LA9 Q8WVW2,RWD domain-containing protein 4,Protein FAM28A;, PF05773;|Q6NW29 B2RDE9 B4DDP2 Q75LA9 Q8WVW2,RWD domain-containing protein 4,Protein FAM28A;, PF05773; scaffold59 indexed_genome mRNA 10684157 10720192 . + . ID=transcript_10369;Q9H9I7,Trafficking protein particle complex subunit 11,, PF11817;PF12742;, GO:0005829;GO:0005794;GO:0030008;GO:0045054;GO:0006888;GO:0007030;GO:0061635;, C:cytosol; C:Golgi apparatus; C:TRAPP complex;, , P:constitutive secretory pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:regulation of protein complex stability;|Q9H9I7,Trafficking protein particle complex subunit 11,, PF11817;PF12742;, GO:0005829;GO:0005794;GO:0030008;GO:0045054;GO:0006888;GO:0007030;GO:0061635;, C:cytosol; C:Golgi apparatus; C:TRAPP complex;, , P:constitutive secretory pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:regulation of protein complex stability;|Q9H9I7,Trafficking protein particle complex subunit 11,, PF11817;PF12742;, GO:0005829;GO:0005794;GO:0030008;GO:0045054;GO:0006888;GO:0007030;GO:0061635;, C:cytosol; C:Golgi apparatus; C:TRAPP complex;, , P:constitutive secretory pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:regulation of protein complex stability;|Q9H9I7,Trafficking protein particle complex subunit 11,, PF11817;PF12742;, GO:0005829;GO:0005794;GO:0030008;GO:0045054;GO:0006888;GO:0007030;GO:0061635;, C:cytosol; C:Golgi apparatus; C:TRAPP complex;, , P:constitutive secretory pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:regulation of protein complex stability;|Q9H9I7,Trafficking protein particle complex subunit 11,, PF11817;PF12742;, GO:0005829;GO:0005794;GO:0030008;GO:0045054;GO:0006888;GO:0007030;GO:0061635;, C:cytosol; C:Golgi apparatus; C:TRAPP complex;, , P:constitutive secretory pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:regulation of protein complex stability;|Q9H9I7,Trafficking protein particle complex subunit 11,, PF11817;PF12742;, GO:0005829;GO:0005794;GO:0030008;GO:0045054;GO:0006888;GO:0007030;GO:0061635;, C:cytosol; C:Golgi apparatus; C:TRAPP complex;, , P:constitutive secretory pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:regulation of protein complex stability; scaffold59 indexed_genome mRNA 10736035 10736713 . + . ID=transcript_10370;Q4VC31 Q32LY6,Protein MIX23 {ECO:0000305},Coiled-coil domain-containing protein 58;, PF09774;, GO:0005739;, C:mitochondrion; scaffold59 indexed_genome mRNA 10853280 10956081 . + . ID=transcript_10371;Q9P2F5 A6H8U4 Q9NPS8,Storkhead-box protein 2,, PF10264;, GO:0009792;GO:0001893;GO:0006357;, , , P:embryo development ending in birth or egg hatching; P:maternal placenta development; P:regulation of transcription by RNA polymerase II;|Q9P2F5 A6H8U4 Q9NPS8,Storkhead-box protein 2,, PF10264;, GO:0009792;GO:0001893;GO:0006357;, , , P:embryo development ending in birth or egg hatching; P:maternal placenta development; P:regulation of transcription by RNA polymerase II;|Q9P2F5 A6H8U4 Q9NPS8,Storkhead-box protein 2,, PF10264;, GO:0009792;GO:0001893;GO:0006357;, , , P:embryo development ending in birth or egg hatching; P:maternal placenta development; P:regulation of transcription by RNA polymerase II; scaffold59 indexed_genome mRNA 11007593 11084576 . - . ID=transcript_10372;Q6UWR7 Q4W5Q1 Q96M57,Glycerophosphocholine cholinephosphodiesterase ENPP6 {ECO:0000305},Choline-specific glycerophosphodiester phosphodiesterase {ECO:0000303|PubMed:15788404};Ectonucleotide pyrophosphatase/phosphodiesterase family member 6;, PF01663;, GO:0031225;GO:0070062;GO:0005576;GO:0005886;GO:0047390;GO:0008889;GO:0046872;GO:0008081;GO:0019695;GO:0046475;GO:0006629;, C:anchored component of membrane; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:glycerophosphocholine cholinephosphodiesterase activity; F:glycerophosphodiester phosphodiesterase activity; F:metal ion binding; F:phosphoric diester hydrolase activity;, P:choline metabolic process; P:glycerophospholipid catabolic process; P:lipid metabolic process; scaffold59 indexed_genome mRNA 11166939 11208236 . - . ID=transcript_10373;P14316 D6RCK5 H0Y8S3 Q6IAS7 Q96B99,Interferon regulatory factor 2,, PF00605;, GO:0000785;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000977;GO:1990837;GO:0007596;GO:0008283;GO:0051607;GO:0002376;GO:0060333;GO:0000122;GO:0045944;GO:0006357;GO:0006355;GO:0060337;, C:chromatin; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:blood coagulation; P:cell population proliferation; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:type I interferon signaling pathway; scaffold59 indexed_genome mRNA 11351598 11356659 . - . ID=transcript_10374;P42574 A8K5M2 D3DP53 Q96AN1 Q96KP2,Caspase-3,Apopain;Cysteine protease CPP32;Protein Yama;SREBP cleavage activity 1;, , GO:0005737;GO:0005829;GO:0031264;GO:0045121;GO:0043025;GO:0005654;GO:0005634;GO:0004190;GO:0004861;GO:0004197;GO:0097153;GO:0097199;GO:0097200;GO:0005123;GO:0008233;GO:0016005;GO:0002020;GO:0044877;GO:0061713;GO:0006309;GO:0006915;GO:0097190;GO:0007413;GO:0001782;GO:0045165;GO:0006974;GO:0072734;GO:0019221;GO:0030218;GO:0097194;GO:0097192;GO:0034349;GO:0007507;GO:0035329;GO:0021766;GO:0008627;GO:0030216;GO:0007611;GO:0071887;GO:0001554;GO:0046007;GO:0043066;GO:0030889;GO:0051402;GO:0030182;GO:0048011;GO:0030220;GO:1902004;GO:0043065;GO:0043525;GO:0016485;GO:0006508;GO:0016241;GO:0031647;GO:0043200;GO:0046677;GO:0032025;GO:0042493;GO:0032355;GO:0051384;GO:0009749;GO:0042542;GO:0001666;GO:0032496;GO:0035094;GO:0034612;GO:0009411;GO:0010165;GO:0007605;GO:0051146;GO:0043029;GO:0042060;, C:cytoplasm; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:neuronal cell body; C:nucleoplasm; C:nucleus;, F:aspartic-type endopeptidase activity; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:death receptor binding; F:peptidase activity; F:phospholipase A2 activator activity; F:protease binding; F:protein-containing complex binding;, P:anterior neural tube closure; P:apoptotic DNA fragmentation; P:apoptotic process; P:apoptotic signaling pathway; P:axonal fasciculation; P:B cell homeostasis; P:cell fate commitment; P:cellular response to DNA damage stimulus; P:cellular response to staurosporine; P:cytokine-mediated signaling pathway; P:erythrocyte differentiation; P:execution phase of apoptosis; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glial cell apoptotic process; P:heart development; P:hippo signaling; P:hippocampus development; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:keratinocyte differentiation; P:learning or memory; P:leukocyte apoptotic process; P:luteolysis; P:negative regulation of activated T cell proliferation; P:negative regulation of apoptotic process; P:negative regulation of B cell proliferation; P:neuron apoptotic process; P:neuron differentiation; P:neurotrophin TRK receptor signaling pathway; P:platelet formation; P:positive regulation of amyloid-beta formation; P:positive regulation of apoptotic process; P:positive regulation of neuron apoptotic process; P:protein processing; P:proteolysis; P:regulation of macroautophagy; P:regulation of protein stability; P:response to amino acid; P:response to antibiotic; P:response to cobalt ion; P:response to drug; P:response to estradiol; P:response to glucocorticoid; P:response to glucose; P:response to hydrogen peroxide; P:response to hypoxia; P:response to lipopolysaccharide; P:response to nicotine; P:response to tumor necrosis factor; P:response to UV; P:response to X-ray; P:sensory perception of sound; P:striated muscle cell differentiation; P:T cell homeostasis; P:wound healing;|P42574 A8K5M2 D3DP53 Q96AN1 Q96KP2,Caspase-3,Apopain;Cysteine protease CPP32;Protein Yama;SREBP cleavage activity 1;, , GO:0005737;GO:0005829;GO:0031264;GO:0045121;GO:0043025;GO:0005654;GO:0005634;GO:0004190;GO:0004861;GO:0004197;GO:0097153;GO:0097199;GO:0097200;GO:0005123;GO:0008233;GO:0016005;GO:0002020;GO:0044877;GO:0061713;GO:0006309;GO:0006915;GO:0097190;GO:0007413;GO:0001782;GO:0045165;GO:0006974;GO:0072734;GO:0019221;GO:0030218;GO:0097194;GO:0097192;GO:0034349;GO:0007507;GO:0035329;GO:0021766;GO:0008627;GO:0030216;GO:0007611;GO:0071887;GO:0001554;GO:0046007;GO:0043066;GO:0030889;GO:0051402;GO:0030182;GO:0048011;GO:0030220;GO:1902004;GO:0043065;GO:0043525;GO:0016485;GO:0006508;GO:0016241;GO:0031647;GO:0043200;GO:0046677;GO:0032025;GO:0042493;GO:0032355;GO:0051384;GO:0009749;GO:0042542;GO:0001666;GO:0032496;GO:0035094;GO:0034612;GO:0009411;GO:0010165;GO:0007605;GO:0051146;GO:0043029;GO:0042060;, C:cytoplasm; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:neuronal cell body; C:nucleoplasm; C:nucleus;, F:aspartic-type endopeptidase activity; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:death receptor binding; F:peptidase activity; F:phospholipase A2 activator activity; F:protease binding; F:protein-containing complex binding;, P:anterior neural tube closure; P:apoptotic DNA fragmentation; P:apoptotic process; P:apoptotic signaling pathway; P:axonal fasciculation; P:B cell homeostasis; P:cell fate commitment; P:cellular response to DNA damage stimulus; P:cellular response to staurosporine; P:cytokine-mediated signaling pathway; P:erythrocyte differentiation; P:execution phase of apoptosis; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glial cell apoptotic process; P:heart development; P:hippo signaling; P:hippocampus development; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:keratinocyte differentiation; P:learning or memory; P:leukocyte apoptotic process; P:luteolysis; P:negative regulation of activated T cell proliferation; P:negative regulation of apoptotic process; P:negative regulation of B cell proliferation; P:neuron apoptotic process; P:neuron differentiation; P:neurotrophin TRK receptor signaling pathway; P:platelet formation; P:positive regulation of amyloid-beta formation; P:positive regulation of apoptotic process; P:positive regulation of neuron apoptotic process; P:protein processing; P:proteolysis; P:regulation of macroautophagy; P:regulation of protein stability; P:response to amino acid; P:response to antibiotic; P:response to cobalt ion; P:response to drug; P:response to estradiol; P:response to glucocorticoid; P:response to glucose; P:response to hydrogen peroxide; P:response to hypoxia; P:response to lipopolysaccharide; P:response to nicotine; P:response to tumor necrosis factor; P:response to UV; P:response to X-ray; P:sensory perception of sound; P:striated muscle cell differentiation; P:T cell homeostasis; P:wound healing;|P42574 A8K5M2 D3DP53 Q96AN1 Q96KP2,Caspase-3,Apopain;Cysteine protease CPP32;Protein Yama;SREBP cleavage activity 1;, , GO:0005737;GO:0005829;GO:0031264;GO:0045121;GO:0043025;GO:0005654;GO:0005634;GO:0004190;GO:0004861;GO:0004197;GO:0097153;GO:0097199;GO:0097200;GO:0005123;GO:0008233;GO:0016005;GO:0002020;GO:0044877;GO:0061713;GO:0006309;GO:0006915;GO:0097190;GO:0007413;GO:0001782;GO:0045165;GO:0006974;GO:0072734;GO:0019221;GO:0030218;GO:0097194;GO:0097192;GO:0034349;GO:0007507;GO:0035329;GO:0021766;GO:0008627;GO:0030216;GO:0007611;GO:0071887;GO:0001554;GO:0046007;GO:0043066;GO:0030889;GO:0051402;GO:0030182;GO:0048011;GO:0030220;GO:1902004;GO:0043065;GO:0043525;GO:0016485;GO:0006508;GO:0016241;GO:0031647;GO:0043200;GO:0046677;GO:0032025;GO:0042493;GO:0032355;GO:0051384;GO:0009749;GO:0042542;GO:0001666;GO:0032496;GO:0035094;GO:0034612;GO:0009411;GO:0010165;GO:0007605;GO:0051146;GO:0043029;GO:0042060;, C:cytoplasm; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:neuronal cell body; C:nucleoplasm; C:nucleus;, F:aspartic-type endopeptidase activity; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:death receptor binding; F:peptidase activity; F:phospholipase A2 activator activity; F:protease binding; F:protein-containing complex binding;, P:anterior neural tube closure; P:apoptotic DNA fragmentation; P:apoptotic process; P:apoptotic signaling pathway; P:axonal fasciculation; P:B cell homeostasis; P:cell fate commitment; P:cellular response to DNA damage stimulus; P:cellular response to staurosporine; P:cytokine-mediated signaling pathway; P:erythrocyte differentiation; P:execution phase of apoptosis; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glial cell apoptotic process; P:heart development; P:hippo signaling; P:hippocampus development; P:intrinsic apoptotic signaling pathway in response to osmotic stress; P:keratinocyte differentiation; P:learning or memory; P:leukocyte apoptotic process; P:luteolysis; P:negative regulation of activated T cell proliferation; P:negative regulation of apoptotic process; P:negative regulation of B cell proliferation; P:neuron apoptotic process; P:neuron differentiation; P:neurotrophin TRK receptor signaling pathway; P:platelet formation; P:positive regulation of amyloid-beta formation; P:positive regulation of apoptotic process; P:positive regulation of neuron apoptotic process; P:protein processing; P:proteolysis; P:regulation of macroautophagy; P:regulation of protein stability; P:response to amino acid; P:response to antibiotic; P:response to cobalt ion; P:response to drug; P:response to estradiol; P:response to glucocorticoid; P:response to glucose; P:response to hydrogen peroxide; P:response to hypoxia; P:response to lipopolysaccharide; P:response to nicotine; P:response to tumor necrosis factor; P:response to UV; P:response to X-ray; P:sensory perception of sound; P:striated muscle cell differentiation; P:T cell homeostasis; P:wound healing; scaffold59 indexed_genome mRNA 11373646 11430672 . + . ID=transcript_10375;Q96LW4 A0A0A0MTC0 D3DP55 D6RDM1 Q5HYJ9,DNA-directed primase/polymerase protein {ECO:0000303|PubMed:24126761},Coiled-coil domain-containing protein 111 {ECO:0000303|PubMed:23579484};, PF01896;, GO:0005759;GO:0005634;GO:0005657;GO:0003682;GO:0003896;GO:0003887;GO:0030145;GO:0008270;GO:0042276;GO:0043504;GO:0006264;GO:0062176;GO:0031297;GO:0009411;GO:0019985;, C:mitochondrial matrix; C:nucleus; C:replication fork;, F:chromatin binding; F:DNA primase activity; F:DNA-directed DNA polymerase activity; F:manganese ion binding; F:zinc ion binding;, P:error-prone translesion synthesis; P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:R-loop disassembly; P:replication fork processing; P:response to UV; P:translesion synthesis;|Q96LW4 A0A0A0MTC0 D3DP55 D6RDM1 Q5HYJ9,DNA-directed primase/polymerase protein {ECO:0000303|PubMed:24126761},Coiled-coil domain-containing protein 111 {ECO:0000303|PubMed:23579484};, PF01896;, GO:0005759;GO:0005634;GO:0005657;GO:0003682;GO:0003896;GO:0003887;GO:0030145;GO:0008270;GO:0042276;GO:0043504;GO:0006264;GO:0062176;GO:0031297;GO:0009411;GO:0019985;, C:mitochondrial matrix; C:nucleus; C:replication fork;, F:chromatin binding; F:DNA primase activity; F:DNA-directed DNA polymerase activity; F:manganese ion binding; F:zinc ion binding;, P:error-prone translesion synthesis; P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:R-loop disassembly; P:replication fork processing; P:response to UV; P:translesion synthesis;|Q96LW4 A0A0A0MTC0 D3DP55 D6RDM1 Q5HYJ9,DNA-directed primase/polymerase protein {ECO:0000303|PubMed:24126761},Coiled-coil domain-containing protein 111 {ECO:0000303|PubMed:23579484};, PF01896;, GO:0005759;GO:0005634;GO:0005657;GO:0003682;GO:0003896;GO:0003887;GO:0030145;GO:0008270;GO:0042276;GO:0043504;GO:0006264;GO:0062176;GO:0031297;GO:0009411;GO:0019985;, C:mitochondrial matrix; C:nucleus; C:replication fork;, F:chromatin binding; F:DNA primase activity; F:DNA-directed DNA polymerase activity; F:manganese ion binding; F:zinc ion binding;, P:error-prone translesion synthesis; P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:R-loop disassembly; P:replication fork processing; P:response to UV; P:translesion synthesis;|Q96LW4 A0A0A0MTC0 D3DP55 D6RDM1 Q5HYJ9,DNA-directed primase/polymerase protein {ECO:0000303|PubMed:24126761},Coiled-coil domain-containing protein 111 {ECO:0000303|PubMed:23579484};, PF01896;, GO:0005759;GO:0005634;GO:0005657;GO:0003682;GO:0003896;GO:0003887;GO:0030145;GO:0008270;GO:0042276;GO:0043504;GO:0006264;GO:0062176;GO:0031297;GO:0009411;GO:0019985;, C:mitochondrial matrix; C:nucleus; C:replication fork;, F:chromatin binding; F:DNA primase activity; F:DNA-directed DNA polymerase activity; F:manganese ion binding; F:zinc ion binding;, P:error-prone translesion synthesis; P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:R-loop disassembly; P:replication fork processing; P:response to UV; P:translesion synthesis;|Q96LW4 A0A0A0MTC0 D3DP55 D6RDM1 Q5HYJ9,DNA-directed primase/polymerase protein {ECO:0000303|PubMed:24126761},Coiled-coil domain-containing protein 111 {ECO:0000303|PubMed:23579484};, PF01896;, GO:0005759;GO:0005634;GO:0005657;GO:0003682;GO:0003896;GO:0003887;GO:0030145;GO:0008270;GO:0042276;GO:0043504;GO:0006264;GO:0062176;GO:0031297;GO:0009411;GO:0019985;, C:mitochondrial matrix; C:nucleus; C:replication fork;, F:chromatin binding; F:DNA primase activity; F:DNA-directed DNA polymerase activity; F:manganese ion binding; F:zinc ion binding;, P:error-prone translesion synthesis; P:mitochondrial DNA repair; P:mitochondrial DNA replication; P:R-loop disassembly; P:replication fork processing; P:response to UV; P:translesion synthesis;|Q71F23 A2RRD9 Q09GN2 Q32Q71 Q9H5G1,Centromere protein U,Centromere protein of 50 kDa;Interphase centromere complex protein 24;KSHV latent nuclear antigen-interacting protein 1;MLF1-interacting protein;Polo-box-interacting protein 1;, PF13097;, GO:0034451;GO:0000777;GO:0005829;GO:0005654;GO:0005634;GO:0034080;GO:0043009;GO:0007052;GO:0016032;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytosol; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:chordate embryonic development; P:mitotic spindle organization; P:viral process;|Q71F23 A2RRD9 Q09GN2 Q32Q71 Q9H5G1,Centromere protein U,Centromere protein of 50 kDa;Interphase centromere complex protein 24;KSHV latent nuclear antigen-interacting protein 1;MLF1-interacting protein;Polo-box-interacting protein 1;, PF13097;, GO:0034451;GO:0000777;GO:0005829;GO:0005654;GO:0005634;GO:0034080;GO:0043009;GO:0007052;GO:0016032;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytosol; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:chordate embryonic development; P:mitotic spindle organization; P:viral process; scaffold59 indexed_genome mRNA 11430731 11460928 . - . ID=transcript_10376;Q71F23 A2RRD9 Q09GN2 Q32Q71 Q9H5G1,Centromere protein U,Centromere protein of 50 kDa;Interphase centromere complex protein 24;KSHV latent nuclear antigen-interacting protein 1;MLF1-interacting protein;Polo-box-interacting protein 1;, PF13097;, GO:0034451;GO:0000777;GO:0005829;GO:0005654;GO:0005634;GO:0034080;GO:0043009;GO:0007052;GO:0016032;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytosol; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:chordate embryonic development; P:mitotic spindle organization; P:viral process;|Q71F23 A2RRD9 Q09GN2 Q32Q71 Q9H5G1,Centromere protein U,Centromere protein of 50 kDa;Interphase centromere complex protein 24;KSHV latent nuclear antigen-interacting protein 1;MLF1-interacting protein;Polo-box-interacting protein 1;, PF13097;, GO:0034451;GO:0000777;GO:0005829;GO:0005654;GO:0005634;GO:0034080;GO:0043009;GO:0007052;GO:0016032;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytosol; C:nucleoplasm; C:nucleus;, , P:CENP-A containing nucleosome assembly; P:chordate embryonic development; P:mitotic spindle organization; P:viral process; scaffold60 indexed_genome mRNA 93172 230383 . + . ID=transcript_10377;Q71F56 A1L469 Q68DN4 Q9H8C0 Q9NSY9 Q9UFD8 Q9UPX5,Mediator of RNA polymerase II transcription subunit 13-like,Mediator complex subunit 13-like;Thyroid hormone receptor-associated protein 2;Thyroid hormone receptor-associated protein complex 240 kDa component-like;, PF06333;PF11597;PF18296;, GO:0016592;GO:0003712;GO:0006357;, C:mediator complex;, F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II;|Q9P287 B3KP45 Q8ND15 Q96GC4 Q9P288,BRCA2 and CDKN1A-interacting protein,P21- and CDK-associated protein 1;Protein TOK-1;, PF13862;, GO:0005814;GO:0005813;GO:0005829;GO:0097431;GO:0019908;GO:0005654;GO:0005634;GO:0019207;GO:0003723;GO:0015631;GO:0006281;GO:0000132;GO:0034453;GO:0000226;GO:0090307;GO:0007052;GO:0061101;GO:0000079;, C:centriole; C:centrosome; C:cytosol; C:mitotic spindle pole; C:nuclear cyclin-dependent protein kinase holoenzyme complex; C:nucleoplasm; C:nucleus;, F:kinase regulator activity; F:RNA binding; F:tubulin binding;, P:DNA repair; P:establishment of mitotic spindle orientation; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:mitotic spindle assembly; P:mitotic spindle organization; P:neuroendocrine cell differentiation; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q71F56 A1L469 Q68DN4 Q9H8C0 Q9NSY9 Q9UFD8 Q9UPX5,Mediator of RNA polymerase II transcription subunit 13-like,Mediator complex subunit 13-like;Thyroid hormone receptor-associated protein 2;Thyroid hormone receptor-associated protein complex 240 kDa component-like;, PF06333;PF11597;PF18296;, GO:0016592;GO:0003712;GO:0006357;, C:mediator complex;, F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II; scaffold60 indexed_genome mRNA 1385254 1398733 . + . ID=transcript_10378;O15119 Q8TB20 Q9UKF8,T-box transcription factor TBX3,, PF00907;PF12598;, GO:0000785;GO:0005634;GO:0001216;GO:0000981;GO:0001227;GO:0001102;GO:0000978;GO:0001085;GO:0043565;GO:1990837;GO:0009887;GO:0008595;GO:0003167;GO:0036302;GO:1905222;GO:0001568;GO:0060444;GO:0003205;GO:0060317;GO:1905072;GO:0060923;GO:0007569;GO:0001708;GO:0090398;GO:0007417;GO:0042733;GO:0035115;GO:0035116;GO:0003272;GO:0030540;GO:0046884;GO:0035136;GO:0001947;GO:0001701;GO:0021761;GO:0032275;GO:0030539;GO:0030879;GO:0060596;GO:0048332;GO:0043066;GO:2000137;GO:0030857;GO:0045662;GO:0000122;GO:0045892;GO:0003151;GO:0045787;GO:0008284;GO:2000648;GO:0045944;GO:0006357;GO:0060021;GO:0060931;GO:0001501;GO:0051145;GO:0010159;GO:0019827;GO:0072105;GO:0060412;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ morphogenesis; P:anterior/posterior axis specification, embryo; P:atrioventricular bundle cell differentiation; P:atrioventricular canal development; P:atrioventricular canal morphogenesis; P:blood vessel development; P:branching involved in mammary gland duct morphogenesis; P:cardiac chamber development; P:cardiac epithelial to mesenchymal transition; P:cardiac jelly development; P:cardiac muscle cell fate commitment; P:cell aging; P:cell fate specification; P:cellular senescence; P:central nervous system development; P:embryonic digit morphogenesis; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:endocardial cushion formation; P:female genitalia development; P:follicle-stimulating hormone secretion; P:forelimb morphogenesis; P:heart looping; P:in utero embryonic development; P:limbic system development; P:luteinizing hormone secretion; P:male genitalia development; P:mammary gland development; P:mammary placode formation; P:mesoderm morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell proliferation involved in heart morphogenesis; P:negative regulation of epithelial cell differentiation; P:negative regulation of myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:outflow tract morphogenesis; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; P:sinoatrial node cell development; P:skeletal system development; P:smooth muscle cell differentiation; P:specification of animal organ position; P:stem cell population maintenance; P:ureteric peristalsis; P:ventricular septum morphogenesis;|O15119 Q8TB20 Q9UKF8,T-box transcription factor TBX3,, PF00907;PF12598;, GO:0000785;GO:0005634;GO:0001216;GO:0000981;GO:0001227;GO:0001102;GO:0000978;GO:0001085;GO:0043565;GO:1990837;GO:0009887;GO:0008595;GO:0003167;GO:0036302;GO:1905222;GO:0001568;GO:0060444;GO:0003205;GO:0060317;GO:1905072;GO:0060923;GO:0007569;GO:0001708;GO:0090398;GO:0007417;GO:0042733;GO:0035115;GO:0035116;GO:0003272;GO:0030540;GO:0046884;GO:0035136;GO:0001947;GO:0001701;GO:0021761;GO:0032275;GO:0030539;GO:0030879;GO:0060596;GO:0048332;GO:0043066;GO:2000137;GO:0030857;GO:0045662;GO:0000122;GO:0045892;GO:0003151;GO:0045787;GO:0008284;GO:2000648;GO:0045944;GO:0006357;GO:0060021;GO:0060931;GO:0001501;GO:0051145;GO:0010159;GO:0019827;GO:0072105;GO:0060412;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ morphogenesis; P:anterior/posterior axis specification, embryo; P:atrioventricular bundle cell differentiation; P:atrioventricular canal development; P:atrioventricular canal morphogenesis; P:blood vessel development; P:branching involved in mammary gland duct morphogenesis; P:cardiac chamber development; P:cardiac epithelial to mesenchymal transition; P:cardiac jelly development; P:cardiac muscle cell fate commitment; P:cell aging; P:cell fate specification; P:cellular senescence; P:central nervous system development; P:embryonic digit morphogenesis; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:endocardial cushion formation; P:female genitalia development; P:follicle-stimulating hormone secretion; P:forelimb morphogenesis; P:heart looping; P:in utero embryonic development; P:limbic system development; P:luteinizing hormone secretion; P:male genitalia development; P:mammary gland development; P:mammary placode formation; P:mesoderm morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of cell proliferation involved in heart morphogenesis; P:negative regulation of epithelial cell differentiation; P:negative regulation of myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:outflow tract morphogenesis; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; P:sinoatrial node cell development; P:skeletal system development; P:smooth muscle cell differentiation; P:specification of animal organ position; P:stem cell population maintenance; P:ureteric peristalsis; P:ventricular septum morphogenesis; scaffold60 indexed_genome mRNA 1563143 1611990 . + . ID=transcript_10379;Q99593 A6ND77 O15301 Q96TB0 Q9Y4I2,T-box transcription factor TBX5,, PF00907;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0043565;GO:0008134;GO:0060413;GO:0003167;GO:0060928;GO:0060929;GO:0003181;GO:0003218;GO:0001708;GO:0060980;GO:0007267;GO:0035115;GO:0030326;GO:0003197;GO:0035136;GO:0007507;GO:0030324;GO:0002009;GO:0060044;GO:0030336;GO:0008285;GO:0010719;GO:0007389;GO:0060039;GO:0060045;GO:0051891;GO:1901846;GO:0072513;GO:0045944;GO:0045893;GO:0006357;GO:0006367;GO:0003281;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:atrial septum morphogenesis; P:atrioventricular bundle cell differentiation; P:atrioventricular node cell development; P:atrioventricular node cell fate commitment; P:atrioventricular valve morphogenesis; P:cardiac left ventricle formation; P:cell fate specification; P:cell migration involved in coronary vasculogenesis; P:cell-cell signaling; P:embryonic forelimb morphogenesis; P:embryonic limb morphogenesis; P:endocardial cushion development; P:forelimb morphogenesis; P:heart development; P:lung development; P:morphogenesis of an epithelium; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of epithelial to mesenchymal transition; P:pattern specification process; P:pericardium development; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cardioblast differentiation; P:positive regulation of cell communication by electrical coupling involved in cardiac conduction; P:positive regulation of secondary heart field cardioblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:ventricular septum development; scaffold60 indexed_genome mRNA 1847559 1862076 . + . ID=transcript_10380;Q9Y4C8 A8K5X9 Q9BPY6 Q9UFN5,Probable RNA-binding protein 19,RNA-binding motif protein 19;, PF00076;, GO:0005694;GO:0005737;GO:0016020;GO:0016607;GO:0005730;GO:0005654;GO:0003723;GO:0000398;GO:0007275;GO:0040019;, C:chromosome; C:cytoplasm; C:membrane; C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:multicellular organism development; P:positive regulation of embryonic development; scaffold60 indexed_genome mRNA 1862591 1875164 . + . ID=transcript_10381;Q9Y4C8 A8K5X9 Q9BPY6 Q9UFN5,Probable RNA-binding protein 19,RNA-binding motif protein 19;, PF00076;, GO:0005694;GO:0005737;GO:0016020;GO:0016607;GO:0005730;GO:0005654;GO:0003723;GO:0000398;GO:0007275;GO:0040019;, C:chromosome; C:cytoplasm; C:membrane; C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:multicellular organism development; P:positive regulation of embryonic development; scaffold60 indexed_genome mRNA 1875185 1968561 . + . ID=transcript_10382;Q9Y4C8 A8K5X9 Q9BPY6 Q9UFN5,Probable RNA-binding protein 19,RNA-binding motif protein 19;, PF00076;, GO:0005694;GO:0005737;GO:0016020;GO:0016607;GO:0005730;GO:0005654;GO:0003723;GO:0000398;GO:0007275;GO:0040019;, C:chromosome; C:cytoplasm; C:membrane; C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:multicellular organism development; P:positive regulation of embryonic development; scaffold60 indexed_genome mRNA 2223818 2235640 . - . ID=transcript_10383;Q96GA7,Serine dehydratase-like,L-serine deaminase;L-serine dehydratase/L-threonine deaminase;L-threonine dehydratase;Serine dehydratase 2;, PF00291;, GO:0005829;GO:0042802;GO:0003941;GO:0004794;GO:0030170;GO:0009097;GO:0019518;GO:0006567;, C:cytosol;, F:identical protein binding; F:L-serine ammonia-lyase activity; F:L-threonine ammonia-lyase activity; F:pyridoxal phosphate binding;, P:isoleucine biosynthetic process; P:L-threonine catabolic process to glycine; P:threonine catabolic process;|Q96GA7,Serine dehydratase-like,L-serine deaminase;L-serine dehydratase/L-threonine deaminase;L-threonine dehydratase;Serine dehydratase 2;, PF00291;, GO:0005829;GO:0042802;GO:0003941;GO:0004794;GO:0030170;GO:0009097;GO:0019518;GO:0006567;, C:cytosol;, F:identical protein binding; F:L-serine ammonia-lyase activity; F:L-threonine ammonia-lyase activity; F:pyridoxal phosphate binding;, P:isoleucine biosynthetic process; P:L-threonine catabolic process to glycine; P:threonine catabolic process; scaffold60 indexed_genome mRNA 2254140 2263185 . - . ID=transcript_10384;Q8NHP8 F5H5E2,Putative phospholipase B-like 2,76 kDa protein;LAMA-like protein 2;Lamina ancestor homolog 2;Phospholipase B domain-containing protein 2;, PF04916;, GO:0070062;GO:0005576;GO:0043202;GO:0004620;GO:0009395;, C:extracellular exosome; C:extracellular region; C:lysosomal lumen;, F:phospholipase activity;, P:phospholipid catabolic process; scaffold60 indexed_genome mRNA 2300888 2303661 . - . ID=transcript_10385;P62244 P39027 P39031 Q3MHD9 Q8C023 Q9BV24,40S ribosomal protein S15a,Small ribosomal subunit protein uS8 {ECO:0000303|PubMed:24524803};, PF00410;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0003723;GO:0003735;GO:0000184;GO:0045787;GO:0008284;GO:0009615;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:response to virus; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold60 indexed_genome mRNA 2305122 2342979 . + . ID=transcript_10386;Q86Y01 O60630 Q9BS04,E3 ubiquitin-protein ligase DTX1,Protein deltex-1;RING-type E3 ubiquitin transferase DTX1 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005112;GO:0017124;GO:0003713;GO:0061630;GO:0031625;GO:0008270;GO:0007166;GO:1990830;GO:0010001;GO:0045665;GO:0045581;GO:0007219;GO:0016567;GO:0008593;GO:0006366;GO:0006351;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:Notch binding; F:SH3 domain binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:cellular response to leukemia inhibitory factor; P:glial cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of T cell differentiation; P:Notch signaling pathway; P:protein ubiquitination; P:regulation of Notch signaling pathway; P:transcription by RNA polymerase II; P:transcription, DNA-templated;|Q86Y01 O60630 Q9BS04,E3 ubiquitin-protein ligase DTX1,Protein deltex-1;RING-type E3 ubiquitin transferase DTX1 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005112;GO:0017124;GO:0003713;GO:0061630;GO:0031625;GO:0008270;GO:0007166;GO:1990830;GO:0010001;GO:0045665;GO:0045581;GO:0007219;GO:0016567;GO:0008593;GO:0006366;GO:0006351;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:Notch binding; F:SH3 domain binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:cellular response to leukemia inhibitory factor; P:glial cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of T cell differentiation; P:Notch signaling pathway; P:protein ubiquitination; P:regulation of Notch signaling pathway; P:transcription by RNA polymerase II; P:transcription, DNA-templated;|Q86Y01 O60630 Q9BS04,E3 ubiquitin-protein ligase DTX1,Protein deltex-1;RING-type E3 ubiquitin transferase DTX1 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005112;GO:0017124;GO:0003713;GO:0061630;GO:0031625;GO:0008270;GO:0007166;GO:1990830;GO:0010001;GO:0045665;GO:0045581;GO:0007219;GO:0016567;GO:0008593;GO:0006366;GO:0006351;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:Notch binding; F:SH3 domain binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:cellular response to leukemia inhibitory factor; P:glial cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of T cell differentiation; P:Notch signaling pathway; P:protein ubiquitination; P:regulation of Notch signaling pathway; P:transcription by RNA polymerase II; P:transcription, DNA-templated;|Q86Y01 O60630 Q9BS04,E3 ubiquitin-protein ligase DTX1,Protein deltex-1;RING-type E3 ubiquitin transferase DTX1 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005112;GO:0017124;GO:0003713;GO:0061630;GO:0031625;GO:0008270;GO:0007166;GO:1990830;GO:0010001;GO:0045665;GO:0045581;GO:0007219;GO:0016567;GO:0008593;GO:0006366;GO:0006351;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:Notch binding; F:SH3 domain binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:cellular response to leukemia inhibitory factor; P:glial cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of T cell differentiation; P:Notch signaling pathway; P:protein ubiquitination; P:regulation of Notch signaling pathway; P:transcription by RNA polymerase II; P:transcription, DNA-templated;|Q86Y01 O60630 Q9BS04,E3 ubiquitin-protein ligase DTX1,Protein deltex-1;RING-type E3 ubiquitin transferase DTX1 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005112;GO:0017124;GO:0003713;GO:0061630;GO:0031625;GO:0008270;GO:0007166;GO:1990830;GO:0010001;GO:0045665;GO:0045581;GO:0007219;GO:0016567;GO:0008593;GO:0006366;GO:0006351;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm;, F:Notch binding; F:SH3 domain binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:cellular response to leukemia inhibitory factor; P:glial cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of T cell differentiation; P:Notch signaling pathway; P:protein ubiquitination; P:regulation of Notch signaling pathway; P:transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold60 indexed_genome mRNA 2343753 2353546 . - . ID=transcript_10387;O95294 B7ZKM4 C9JFK5 F8VQX1 Q52M03 Q59H24 Q96CC7,RasGAP-activating-like protein 1 {ECO:0000305},RAS protein activator like 1 {ECO:0000312|HGNC:HGNC:9873};Ras GTPase-activating-like protein {ECO:0000303|PubMed:9751798};, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0005096;GO:0046872;GO:0005543;GO:0030154;GO:0071277;GO:0000165;GO:0046580;GO:1903861;GO:0007165;, C:cytosol;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:cell differentiation; P:cellular response to calcium ion; P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:positive regulation of dendrite extension; P:signal transduction;|O95294 B7ZKM4 C9JFK5 F8VQX1 Q52M03 Q59H24 Q96CC7,RasGAP-activating-like protein 1 {ECO:0000305},RAS protein activator like 1 {ECO:0000312|HGNC:HGNC:9873};Ras GTPase-activating-like protein {ECO:0000303|PubMed:9751798};, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0005096;GO:0046872;GO:0005543;GO:0030154;GO:0071277;GO:0000165;GO:0046580;GO:1903861;GO:0007165;, C:cytosol;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:cell differentiation; P:cellular response to calcium ion; P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:positive regulation of dendrite extension; P:signal transduction; scaffold60 indexed_genome mRNA 2386059 2391183 . + . ID=transcript_10388;A6NFT4,Cilia- and flagella-associated protein 73 {ECO:0000305},Coiled-coil domain-containing protein 42B {ECO:0000312|HGNC:HGNC:37100};, PF13863;, GO:0097545;GO:0031514;GO:0070840;GO:0003341;GO:0036159;GO:2000574;, C:axonemal outer doublet; C:motile cilium;, F:dynein complex binding;, P:cilium movement; P:inner dynein arm assembly; P:regulation of microtubule motor activity; scaffold60 indexed_genome mRNA 2391199 2412384 . + . ID=transcript_10389;A6NFT4,Cilia- and flagella-associated protein 73 {ECO:0000305},Coiled-coil domain-containing protein 42B {ECO:0000312|HGNC:HGNC:37100};, PF13863;, GO:0097545;GO:0031514;GO:0070840;GO:0003341;GO:0036159;GO:2000574;, C:axonemal outer doublet; C:motile cilium;, F:dynein complex binding;, P:cilium movement; P:inner dynein arm assembly; P:regulation of microtubule motor activity;|Q8TDD1 Q86YT8 Q9BRZ1,ATP-dependent RNA helicase DDX54,ATP-dependent RNA helicase DP97;DEAD box RNA helicase 97 kDa;DEAD box protein 54;, PF08147;PF00270;PF00271;, GO:0005794;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0030331;GO:0003723;GO:0003724;GO:0005102;GO:0003714;GO:0030520;GO:0016070;GO:0006396;GO:0006364;, C:Golgi apparatus; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:estrogen receptor binding; F:RNA binding; F:RNA helicase activity; F:signaling receptor binding; F:transcription corepressor activity;, P:intracellular estrogen receptor signaling pathway; P:RNA metabolic process; P:RNA processing; P:rRNA processing;|Q8TDD1 Q86YT8 Q9BRZ1,ATP-dependent RNA helicase DDX54,ATP-dependent RNA helicase DP97;DEAD box RNA helicase 97 kDa;DEAD box protein 54;, PF08147;PF00270;PF00271;, GO:0005794;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0030331;GO:0003723;GO:0003724;GO:0005102;GO:0003714;GO:0030520;GO:0016070;GO:0006396;GO:0006364;, C:Golgi apparatus; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:estrogen receptor binding; F:RNA binding; F:RNA helicase activity; F:signaling receptor binding; F:transcription corepressor activity;, P:intracellular estrogen receptor signaling pathway; P:RNA metabolic process; P:RNA processing; P:rRNA processing;|Q8TDD1 Q86YT8 Q9BRZ1,ATP-dependent RNA helicase DDX54,ATP-dependent RNA helicase DP97;DEAD box RNA helicase 97 kDa;DEAD box protein 54;, PF08147;PF00270;PF00271;, GO:0005794;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0030331;GO:0003723;GO:0003724;GO:0005102;GO:0003714;GO:0030520;GO:0016070;GO:0006396;GO:0006364;, C:Golgi apparatus; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:estrogen receptor binding; F:RNA binding; F:RNA helicase activity; F:signaling receptor binding; F:transcription corepressor activity;, P:intracellular estrogen receptor signaling pathway; P:RNA metabolic process; P:RNA processing; P:rRNA processing;|Q8TDD1 Q86YT8 Q9BRZ1,ATP-dependent RNA helicase DDX54,ATP-dependent RNA helicase DP97;DEAD box RNA helicase 97 kDa;DEAD box protein 54;, PF08147;PF00270;PF00271;, GO:0005794;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0030331;GO:0003723;GO:0003724;GO:0005102;GO:0003714;GO:0030520;GO:0016070;GO:0006396;GO:0006364;, C:Golgi apparatus; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:estrogen receptor binding; F:RNA binding; F:RNA helicase activity; F:signaling receptor binding; F:transcription corepressor activity;, P:intracellular estrogen receptor signaling pathway; P:RNA metabolic process; P:RNA processing; P:rRNA processing; scaffold60 indexed_genome mRNA 2412589 2420257 . + . ID=transcript_10390;Q96K30 B3KVZ4 C9JIN1 F8VRG5 Q53GM3 Q96K25,RBPJ-interacting and tubulin-associated protein 1,RBPJ-interacting and tubulin-associated protein;, PF17066;, GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0015631;GO:0045746;GO:0000122;GO:0022008;GO:0007219;GO:0051168;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:tubulin binding;, P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neurogenesis; P:Notch signaling pathway; P:nuclear export;|Q96K30 B3KVZ4 C9JIN1 F8VRG5 Q53GM3 Q96K25,RBPJ-interacting and tubulin-associated protein 1,RBPJ-interacting and tubulin-associated protein;, PF17066;, GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0015631;GO:0045746;GO:0000122;GO:0022008;GO:0007219;GO:0051168;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:tubulin binding;, P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neurogenesis; P:Notch signaling pathway; P:nuclear export;|Q96K30 B3KVZ4 C9JIN1 F8VRG5 Q53GM3 Q96K25,RBPJ-interacting and tubulin-associated protein 1,RBPJ-interacting and tubulin-associated protein;, PF17066;, GO:0005813;GO:0005737;GO:0005654;GO:0005634;GO:0015631;GO:0045746;GO:0000122;GO:0022008;GO:0007219;GO:0051168;, C:centrosome; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:tubulin binding;, P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neurogenesis; P:Notch signaling pathway; P:nuclear export; scaffold60 indexed_genome mRNA 2494970 2513101 . + . ID=transcript_10391;Q9ULQ1 A7E258 Q86XS9 Q8NC20,Two pore calcium channel protein 1,Voltage-dependent calcium channel protein TPC1;, PF00520;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0015280;GO:0072345;GO:0080025;GO:0042803;GO:0005245;GO:0005248;GO:0034220;GO:0010508;GO:0034765;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:ligand-gated sodium channel activity; F:NAADP-sensitive calcium-release channel activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:protein homodimerization activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:ion transmembrane transport; P:positive regulation of autophagy; P:regulation of ion transmembrane transport;|Q9ULQ1 A7E258 Q86XS9 Q8NC20,Two pore calcium channel protein 1,Voltage-dependent calcium channel protein TPC1;, PF00520;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0015280;GO:0072345;GO:0080025;GO:0042803;GO:0005245;GO:0005248;GO:0034220;GO:0010508;GO:0034765;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:ligand-gated sodium channel activity; F:NAADP-sensitive calcium-release channel activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:protein homodimerization activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:ion transmembrane transport; P:positive regulation of autophagy; P:regulation of ion transmembrane transport; scaffold60 indexed_genome mRNA 2513107 2526768 . + . ID=transcript_10392;Q9ULQ1 A7E258 Q86XS9 Q8NC20,Two pore calcium channel protein 1,Voltage-dependent calcium channel protein TPC1;, PF00520;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0015280;GO:0072345;GO:0080025;GO:0042803;GO:0005245;GO:0005248;GO:0034220;GO:0010508;GO:0034765;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:ligand-gated sodium channel activity; F:NAADP-sensitive calcium-release channel activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:protein homodimerization activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:ion transmembrane transport; P:positive regulation of autophagy; P:regulation of ion transmembrane transport;|Q9ULQ1 A7E258 Q86XS9 Q8NC20,Two pore calcium channel protein 1,Voltage-dependent calcium channel protein TPC1;, PF00520;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0015280;GO:0072345;GO:0080025;GO:0042803;GO:0005245;GO:0005248;GO:0034220;GO:0010508;GO:0034765;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:ligand-gated sodium channel activity; F:NAADP-sensitive calcium-release channel activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:protein homodimerization activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:ion transmembrane transport; P:positive regulation of autophagy; P:regulation of ion transmembrane transport;|Q9ULQ1 A7E258 Q86XS9 Q8NC20,Two pore calcium channel protein 1,Voltage-dependent calcium channel protein TPC1;, PF00520;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0015280;GO:0072345;GO:0080025;GO:0042803;GO:0005245;GO:0005248;GO:0034220;GO:0010508;GO:0034765;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:ligand-gated sodium channel activity; F:NAADP-sensitive calcium-release channel activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:protein homodimerization activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:ion transmembrane transport; P:positive regulation of autophagy; P:regulation of ion transmembrane transport;|Q9ULQ1 A7E258 Q86XS9 Q8NC20,Two pore calcium channel protein 1,Voltage-dependent calcium channel protein TPC1;, PF00520;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0015280;GO:0072345;GO:0080025;GO:0042803;GO:0005245;GO:0005248;GO:0034220;GO:0010508;GO:0034765;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:ligand-gated sodium channel activity; F:NAADP-sensitive calcium-release channel activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:protein homodimerization activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:ion transmembrane transport; P:positive regulation of autophagy; P:regulation of ion transmembrane transport;|Q9ULQ1 A7E258 Q86XS9 Q8NC20,Two pore calcium channel protein 1,Voltage-dependent calcium channel protein TPC1;, PF00520;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0015280;GO:0072345;GO:0080025;GO:0042803;GO:0005245;GO:0005248;GO:0034220;GO:0010508;GO:0034765;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:ligand-gated sodium channel activity; F:NAADP-sensitive calcium-release channel activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:protein homodimerization activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:ion transmembrane transport; P:positive regulation of autophagy; P:regulation of ion transmembrane transport; scaffold60 indexed_genome mRNA 2583553 2585263 . - . ID=transcript_10393;P29728 A8K9T1 Q6PJ33 Q86XX8,2'-5'-oligoadenylate synthase 2,p69 OAS / p71 OAS {ECO:0000303|PubMed:1577824};, PF01909;PF10421;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005654;GO:0048471;GO:0001730;GO:0005524;GO:0003725;GO:0046872;GO:0051607;GO:0060333;GO:0045071;GO:0006139;GO:1903487;GO:0060700;GO:0009617;GO:0009615;GO:0006401;GO:0060337;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:2'-5'-oligoadenylate synthetase activity; F:ATP binding; F:double-stranded RNA binding; F:metal ion binding;, P:defense response to virus; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral genome replication; P:nucleobase-containing compound metabolic process; P:regulation of lactation; P:regulation of ribonuclease activity; P:response to bacterium; P:response to virus; P:RNA catabolic process; P:type I interferon signaling pathway; scaffold60 indexed_genome mRNA 2586863 2590194 . - . ID=transcript_10394;P29728 A8K9T1 Q6PJ33 Q86XX8,2'-5'-oligoadenylate synthase 2,p69 OAS / p71 OAS {ECO:0000303|PubMed:1577824};, PF01909;PF10421;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0005654;GO:0048471;GO:0001730;GO:0005524;GO:0003725;GO:0046872;GO:0051607;GO:0060333;GO:0045071;GO:0006139;GO:1903487;GO:0060700;GO:0009617;GO:0009615;GO:0006401;GO:0060337;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:2'-5'-oligoadenylate synthetase activity; F:ATP binding; F:double-stranded RNA binding; F:metal ion binding;, P:defense response to virus; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral genome replication; P:nucleobase-containing compound metabolic process; P:regulation of lactation; P:regulation of ribonuclease activity; P:response to bacterium; P:response to virus; P:RNA catabolic process; P:type I interferon signaling pathway; scaffold60 indexed_genome mRNA 2600982 2608704 . - . ID=transcript_10395;Q16701 Q1PG42 Q3ZM01 Q53GC5 Q53YA4 Q6A1Z3 Q6IPC6 Q6P7N9 Q96J61,2'-5'-oligoadenylate synthase 1,E18/E16;p46/p42 OAS;, PF01909;PF10421;, GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0001730;GO:0005524;GO:0003725;GO:0046872;GO:0035457;GO:0051607;GO:0042593;GO:0006006;GO:0060333;GO:0045071;GO:0051259;GO:0006164;GO:0060700;GO:0009615;GO:0060337;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:2'-5'-oligoadenylate synthetase activity; F:ATP binding; F:double-stranded RNA binding; F:metal ion binding;, P:cellular response to interferon-alpha; P:defense response to virus; P:glucose homeostasis; P:glucose metabolic process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral genome replication; P:protein complex oligomerization; P:purine nucleotide biosynthetic process; P:regulation of ribonuclease activity; P:response to virus; P:type I interferon signaling pathway;|Q16701 Q1PG42 Q3ZM01 Q53GC5 Q53YA4 Q6A1Z3 Q6IPC6 Q6P7N9 Q96J61,2'-5'-oligoadenylate synthase 1,E18/E16;p46/p42 OAS;, PF01909;PF10421;, GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0001730;GO:0005524;GO:0003725;GO:0046872;GO:0035457;GO:0051607;GO:0042593;GO:0006006;GO:0060333;GO:0045071;GO:0051259;GO:0006164;GO:0060700;GO:0009615;GO:0060337;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:2'-5'-oligoadenylate synthetase activity; F:ATP binding; F:double-stranded RNA binding; F:metal ion binding;, P:cellular response to interferon-alpha; P:defense response to virus; P:glucose homeostasis; P:glucose metabolic process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral genome replication; P:protein complex oligomerization; P:purine nucleotide biosynthetic process; P:regulation of ribonuclease activity; P:response to virus; P:type I interferon signaling pathway;|Q16701 Q1PG42 Q3ZM01 Q53GC5 Q53YA4 Q6A1Z3 Q6IPC6 Q6P7N9 Q96J61,2'-5'-oligoadenylate synthase 1,E18/E16;p46/p42 OAS;, PF01909;PF10421;, GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0001730;GO:0005524;GO:0003725;GO:0046872;GO:0035457;GO:0051607;GO:0042593;GO:0006006;GO:0060333;GO:0045071;GO:0051259;GO:0006164;GO:0060700;GO:0009615;GO:0060337;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:2'-5'-oligoadenylate synthetase activity; F:ATP binding; F:double-stranded RNA binding; F:metal ion binding;, P:cellular response to interferon-alpha; P:defense response to virus; P:glucose homeostasis; P:glucose metabolic process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral genome replication; P:protein complex oligomerization; P:purine nucleotide biosynthetic process; P:regulation of ribonuclease activity; P:response to virus; P:type I interferon signaling pathway; scaffold60 indexed_genome mRNA 2614886 2619176 . - . ID=transcript_10396;Q16701 Q1PG42 Q3ZM01 Q53GC5 Q53YA4 Q6A1Z3 Q6IPC6 Q6P7N9 Q96J61,2'-5'-oligoadenylate synthase 1,E18/E16;p46/p42 OAS;, PF01909;PF10421;, GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0016020;GO:0005739;GO:0005654;GO:0005634;GO:0001730;GO:0005524;GO:0003725;GO:0046872;GO:0035457;GO:0051607;GO:0042593;GO:0006006;GO:0060333;GO:0045071;GO:0051259;GO:0006164;GO:0060700;GO:0009615;GO:0060337;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:2'-5'-oligoadenylate synthetase activity; F:ATP binding; F:double-stranded RNA binding; F:metal ion binding;, P:cellular response to interferon-alpha; P:defense response to virus; P:glucose homeostasis; P:glucose metabolic process; P:interferon-gamma-mediated signaling pathway; P:negative regulation of viral genome replication; P:protein complex oligomerization; P:purine nucleotide biosynthetic process; P:regulation of ribonuclease activity; P:response to virus; P:type I interferon signaling pathway; scaffold60 indexed_genome mRNA 2631586 2728168 . - . ID=transcript_10397;Q9Y2J0 B7Z3C3 Q96AE0,Rabphilin-3A,Exophilin-1;, PF00168;PF02318;, GO:0005829;GO:0043197;GO:0019898;GO:0043005;GO:0045211;GO:0032991;GO:0030141;GO:0045202;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0070679;GO:0042301;GO:1901981;GO:0005546;GO:0044877;GO:0008430;GO:0031267;GO:0008270;GO:0006886;GO:0061669;, C:cytosol; C:dendritic spine; C:extrinsic component of membrane; C:neuron projection; C:postsynaptic membrane; C:protein-containing complex; C:secretory granule; C:synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:inositol 1,4,5 trisphosphate binding; F:phosphate ion binding; F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-containing complex binding; F:selenium binding; F:small GTPase binding; F:zinc ion binding;, P:intracellular protein transport; P:spontaneous neurotransmitter secretion;|Q9Y2J0 B7Z3C3 Q96AE0,Rabphilin-3A,Exophilin-1;, PF00168;PF02318;, GO:0005829;GO:0043197;GO:0019898;GO:0043005;GO:0045211;GO:0032991;GO:0030141;GO:0045202;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0070679;GO:0042301;GO:1901981;GO:0005546;GO:0044877;GO:0008430;GO:0031267;GO:0008270;GO:0006886;GO:0061669;, C:cytosol; C:dendritic spine; C:extrinsic component of membrane; C:neuron projection; C:postsynaptic membrane; C:protein-containing complex; C:secretory granule; C:synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:inositol 1,4,5 trisphosphate binding; F:phosphate ion binding; F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-containing complex binding; F:selenium binding; F:small GTPase binding; F:zinc ion binding;, P:intracellular protein transport; P:spontaneous neurotransmitter secretion;|Q9Y2J0 B7Z3C3 Q96AE0,Rabphilin-3A,Exophilin-1;, PF00168;PF02318;, GO:0005829;GO:0043197;GO:0019898;GO:0043005;GO:0045211;GO:0032991;GO:0030141;GO:0045202;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0070679;GO:0042301;GO:1901981;GO:0005546;GO:0044877;GO:0008430;GO:0031267;GO:0008270;GO:0006886;GO:0061669;, C:cytosol; C:dendritic spine; C:extrinsic component of membrane; C:neuron projection; C:postsynaptic membrane; C:protein-containing complex; C:secretory granule; C:synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:inositol 1,4,5 trisphosphate binding; F:phosphate ion binding; F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-containing complex binding; F:selenium binding; F:small GTPase binding; F:zinc ion binding;, P:intracellular protein transport; P:spontaneous neurotransmitter secretion;|Q9Y2J0 B7Z3C3 Q96AE0,Rabphilin-3A,Exophilin-1;, PF00168;PF02318;, GO:0005829;GO:0043197;GO:0019898;GO:0043005;GO:0045211;GO:0032991;GO:0030141;GO:0045202;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0070679;GO:0042301;GO:1901981;GO:0005546;GO:0044877;GO:0008430;GO:0031267;GO:0008270;GO:0006886;GO:0061669;, C:cytosol; C:dendritic spine; C:extrinsic component of membrane; C:neuron projection; C:postsynaptic membrane; C:protein-containing complex; C:secretory granule; C:synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:inositol 1,4,5 trisphosphate binding; F:phosphate ion binding; F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-containing complex binding; F:selenium binding; F:small GTPase binding; F:zinc ion binding;, P:intracellular protein transport; P:spontaneous neurotransmitter secretion;|Q9Y2J0 B7Z3C3 Q96AE0,Rabphilin-3A,Exophilin-1;, PF00168;PF02318;, GO:0005829;GO:0043197;GO:0019898;GO:0043005;GO:0045211;GO:0032991;GO:0030141;GO:0045202;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0070679;GO:0042301;GO:1901981;GO:0005546;GO:0044877;GO:0008430;GO:0031267;GO:0008270;GO:0006886;GO:0061669;, C:cytosol; C:dendritic spine; C:extrinsic component of membrane; C:neuron projection; C:postsynaptic membrane; C:protein-containing complex; C:secretory granule; C:synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:inositol 1,4,5 trisphosphate binding; F:phosphate ion binding; F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-containing complex binding; F:selenium binding; F:small GTPase binding; F:zinc ion binding;, P:intracellular protein transport; P:spontaneous neurotransmitter secretion;|Q9Y2J0 B7Z3C3 Q96AE0,Rabphilin-3A,Exophilin-1;, PF00168;PF02318;, GO:0005829;GO:0043197;GO:0019898;GO:0043005;GO:0045211;GO:0032991;GO:0030141;GO:0045202;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0070679;GO:0042301;GO:1901981;GO:0005546;GO:0044877;GO:0008430;GO:0031267;GO:0008270;GO:0006886;GO:0061669;, C:cytosol; C:dendritic spine; C:extrinsic component of membrane; C:neuron projection; C:postsynaptic membrane; C:protein-containing complex; C:secretory granule; C:synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:inositol 1,4,5 trisphosphate binding; F:phosphate ion binding; F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-containing complex binding; F:selenium binding; F:small GTPase binding; F:zinc ion binding;, P:intracellular protein transport; P:spontaneous neurotransmitter secretion; scaffold60 indexed_genome mRNA 2933467 2949179 . - . ID=transcript_10398;Q06124 A8K1D9 Q96HD7,Tyrosine-protein phosphatase non-receptor type 11,Protein-tyrosine phosphatase 1D;Protein-tyrosine phosphatase 2C;SH-PTP2;SH-PTP3;, PF00017;PF00102;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0045296;GO:0050839;GO:0031748;GO:0005158;GO:0043560;GO:0004726;GO:0051428;GO:0043274;GO:0004721;GO:0001784;GO:0019904;GO:0019901;GO:1990782;GO:0004725;GO:0030971;GO:0030159;GO:0033277;GO:0000187;GO:0036302;GO:0007411;GO:0060020;GO:0007420;GO:0071345;GO:0071364;GO:0071260;GO:0021697;GO:0019221;GO:0000077;GO:0048013;GO:0007173;GO:0038127;GO:0060325;GO:0008543;GO:0048806;GO:0042593;GO:0007507;GO:0048873;GO:0042445;GO:0009755;GO:0048839;GO:0007229;GO:0070102;GO:0061582;GO:0050900;GO:0035855;GO:0032528;GO:0035264;GO:0048609;GO:0033629;GO:0032331;GO:0051463;GO:0060125;GO:0046676;GO:0048011;GO:0035265;GO:0035335;GO:0030168;GO:0030220;GO:0048008;GO:0070374;GO:0046326;GO:0046887;GO:0046628;GO:0032728;GO:0032755;GO:0045931;GO:0045778;GO:0050731;GO:0051897;GO:0032760;GO:0033628;GO:0046825;GO:0043254;GO:0060338;GO:0031295;GO:0006641;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cadherin binding; F:cell adhesion molecule binding; F:D1 dopamine receptor binding; F:insulin receptor binding; F:insulin receptor substrate binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:peptide hormone receptor binding; F:phospholipase binding; F:phosphoprotein phosphatase activity; F:phosphotyrosine residue binding; F:protein domain specific binding; F:protein kinase binding; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:signaling receptor complex adaptor activity;, P:abortive mitotic cell cycle; P:activation of MAPK activity; P:atrioventricular canal development; P:axon guidance; P:Bergmann glial cell differentiation; P:brain development; P:cellular response to cytokine stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to mechanical stimulus; P:cerebellar cortex formation; P:cytokine-mediated signaling pathway; P:DNA damage checkpoint; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB signaling pathway; P:face morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:genitalia development; P:glucose homeostasis; P:heart development; P:homeostasis of number of cells within a tissue; P:hormone metabolic process; P:hormone-mediated signaling pathway; P:inner ear development; P:integrin-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell migration; P:leukocyte migration; P:megakaryocyte development; P:microvillus organization; P:multicellular organism growth; P:multicellular organismal reproductive process; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of chondrocyte differentiation; P:negative regulation of cortisol secretion; P:negative regulation of growth hormone secretion; P:negative regulation of insulin secretion; P:neurotrophin TRK receptor signaling pathway; P:organ growth; P:peptidyl-tyrosine dephosphorylation; P:platelet activation; P:platelet formation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glucose import; P:positive regulation of hormone secretion; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of mitotic cell cycle; P:positive regulation of ossification; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor production; P:regulation of cell adhesion mediated by integrin; P:regulation of protein export from nucleus; P:regulation of protein-containing complex assembly; P:regulation of type I interferon-mediated signaling pathway; P:T cell costimulation; P:triglyceride metabolic process;|Q06124 A8K1D9 Q96HD7,Tyrosine-protein phosphatase non-receptor type 11,Protein-tyrosine phosphatase 1D;Protein-tyrosine phosphatase 2C;SH-PTP2;SH-PTP3;, PF00017;PF00102;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0045296;GO:0050839;GO:0031748;GO:0005158;GO:0043560;GO:0004726;GO:0051428;GO:0043274;GO:0004721;GO:0001784;GO:0019904;GO:0019901;GO:1990782;GO:0004725;GO:0030971;GO:0030159;GO:0033277;GO:0000187;GO:0036302;GO:0007411;GO:0060020;GO:0007420;GO:0071345;GO:0071364;GO:0071260;GO:0021697;GO:0019221;GO:0000077;GO:0048013;GO:0007173;GO:0038127;GO:0060325;GO:0008543;GO:0048806;GO:0042593;GO:0007507;GO:0048873;GO:0042445;GO:0009755;GO:0048839;GO:0007229;GO:0070102;GO:0061582;GO:0050900;GO:0035855;GO:0032528;GO:0035264;GO:0048609;GO:0033629;GO:0032331;GO:0051463;GO:0060125;GO:0046676;GO:0048011;GO:0035265;GO:0035335;GO:0030168;GO:0030220;GO:0048008;GO:0070374;GO:0046326;GO:0046887;GO:0046628;GO:0032728;GO:0032755;GO:0045931;GO:0045778;GO:0050731;GO:0051897;GO:0032760;GO:0033628;GO:0046825;GO:0043254;GO:0060338;GO:0031295;GO:0006641;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cadherin binding; F:cell adhesion molecule binding; F:D1 dopamine receptor binding; F:insulin receptor binding; F:insulin receptor substrate binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:peptide hormone receptor binding; F:phospholipase binding; F:phosphoprotein phosphatase activity; F:phosphotyrosine residue binding; F:protein domain specific binding; F:protein kinase binding; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:signaling receptor complex adaptor activity;, P:abortive mitotic cell cycle; P:activation of MAPK activity; P:atrioventricular canal development; P:axon guidance; P:Bergmann glial cell differentiation; P:brain development; P:cellular response to cytokine stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to mechanical stimulus; P:cerebellar cortex formation; P:cytokine-mediated signaling pathway; P:DNA damage checkpoint; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB signaling pathway; P:face morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:genitalia development; P:glucose homeostasis; P:heart development; P:homeostasis of number of cells within a tissue; P:hormone metabolic process; P:hormone-mediated signaling pathway; P:inner ear development; P:integrin-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell migration; P:leukocyte migration; P:megakaryocyte development; P:microvillus organization; P:multicellular organism growth; P:multicellular organismal reproductive process; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of chondrocyte differentiation; P:negative regulation of cortisol secretion; P:negative regulation of growth hormone secretion; P:negative regulation of insulin secretion; P:neurotrophin TRK receptor signaling pathway; P:organ growth; P:peptidyl-tyrosine dephosphorylation; P:platelet activation; P:platelet formation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glucose import; P:positive regulation of hormone secretion; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of mitotic cell cycle; P:positive regulation of ossification; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor production; P:regulation of cell adhesion mediated by integrin; P:regulation of protein export from nucleus; P:regulation of protein-containing complex assembly; P:regulation of type I interferon-mediated signaling pathway; P:T cell costimulation; P:triglyceride metabolic process;|Q06124 A8K1D9 Q96HD7,Tyrosine-protein phosphatase non-receptor type 11,Protein-tyrosine phosphatase 1D;Protein-tyrosine phosphatase 2C;SH-PTP2;SH-PTP3;, PF00017;PF00102;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0045296;GO:0050839;GO:0031748;GO:0005158;GO:0043560;GO:0004726;GO:0051428;GO:0043274;GO:0004721;GO:0001784;GO:0019904;GO:0019901;GO:1990782;GO:0004725;GO:0030971;GO:0030159;GO:0033277;GO:0000187;GO:0036302;GO:0007411;GO:0060020;GO:0007420;GO:0071345;GO:0071364;GO:0071260;GO:0021697;GO:0019221;GO:0000077;GO:0048013;GO:0007173;GO:0038127;GO:0060325;GO:0008543;GO:0048806;GO:0042593;GO:0007507;GO:0048873;GO:0042445;GO:0009755;GO:0048839;GO:0007229;GO:0070102;GO:0061582;GO:0050900;GO:0035855;GO:0032528;GO:0035264;GO:0048609;GO:0033629;GO:0032331;GO:0051463;GO:0060125;GO:0046676;GO:0048011;GO:0035265;GO:0035335;GO:0030168;GO:0030220;GO:0048008;GO:0070374;GO:0046326;GO:0046887;GO:0046628;GO:0032728;GO:0032755;GO:0045931;GO:0045778;GO:0050731;GO:0051897;GO:0032760;GO:0033628;GO:0046825;GO:0043254;GO:0060338;GO:0031295;GO:0006641;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cadherin binding; F:cell adhesion molecule binding; F:D1 dopamine receptor binding; F:insulin receptor binding; F:insulin receptor substrate binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:peptide hormone receptor binding; F:phospholipase binding; F:phosphoprotein phosphatase activity; F:phosphotyrosine residue binding; F:protein domain specific binding; F:protein kinase binding; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:signaling receptor complex adaptor activity;, P:abortive mitotic cell cycle; P:activation of MAPK activity; P:atrioventricular canal development; P:axon guidance; P:Bergmann glial cell differentiation; P:brain development; P:cellular response to cytokine stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to mechanical stimulus; P:cerebellar cortex formation; P:cytokine-mediated signaling pathway; P:DNA damage checkpoint; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB signaling pathway; P:face morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:genitalia development; P:glucose homeostasis; P:heart development; P:homeostasis of number of cells within a tissue; P:hormone metabolic process; P:hormone-mediated signaling pathway; P:inner ear development; P:integrin-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell migration; P:leukocyte migration; P:megakaryocyte development; P:microvillus organization; P:multicellular organism growth; P:multicellular organismal reproductive process; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of chondrocyte differentiation; P:negative regulation of cortisol secretion; P:negative regulation of growth hormone secretion; P:negative regulation of insulin secretion; P:neurotrophin TRK receptor signaling pathway; P:organ growth; P:peptidyl-tyrosine dephosphorylation; P:platelet activation; P:platelet formation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glucose import; P:positive regulation of hormone secretion; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of mitotic cell cycle; P:positive regulation of ossification; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor production; P:regulation of cell adhesion mediated by integrin; P:regulation of protein export from nucleus; P:regulation of protein-containing complex assembly; P:regulation of type I interferon-mediated signaling pathway; P:T cell costimulation; P:triglyceride metabolic process; scaffold60 indexed_genome mRNA 2950187 2999684 . - . ID=transcript_10399;Q06124 A8K1D9 Q96HD7,Tyrosine-protein phosphatase non-receptor type 11,Protein-tyrosine phosphatase 1D;Protein-tyrosine phosphatase 2C;SH-PTP2;SH-PTP3;, PF00017;PF00102;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0045296;GO:0050839;GO:0031748;GO:0005158;GO:0043560;GO:0004726;GO:0051428;GO:0043274;GO:0004721;GO:0001784;GO:0019904;GO:0019901;GO:1990782;GO:0004725;GO:0030971;GO:0030159;GO:0033277;GO:0000187;GO:0036302;GO:0007411;GO:0060020;GO:0007420;GO:0071345;GO:0071364;GO:0071260;GO:0021697;GO:0019221;GO:0000077;GO:0048013;GO:0007173;GO:0038127;GO:0060325;GO:0008543;GO:0048806;GO:0042593;GO:0007507;GO:0048873;GO:0042445;GO:0009755;GO:0048839;GO:0007229;GO:0070102;GO:0061582;GO:0050900;GO:0035855;GO:0032528;GO:0035264;GO:0048609;GO:0033629;GO:0032331;GO:0051463;GO:0060125;GO:0046676;GO:0048011;GO:0035265;GO:0035335;GO:0030168;GO:0030220;GO:0048008;GO:0070374;GO:0046326;GO:0046887;GO:0046628;GO:0032728;GO:0032755;GO:0045931;GO:0045778;GO:0050731;GO:0051897;GO:0032760;GO:0033628;GO:0046825;GO:0043254;GO:0060338;GO:0031295;GO:0006641;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:cadherin binding; F:cell adhesion molecule binding; F:D1 dopamine receptor binding; F:insulin receptor binding; F:insulin receptor substrate binding; F:non-membrane spanning protein tyrosine phosphatase activity; F:peptide hormone receptor binding; F:phospholipase binding; F:phosphoprotein phosphatase activity; F:phosphotyrosine residue binding; F:protein domain specific binding; F:protein kinase binding; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:signaling receptor complex adaptor activity;, P:abortive mitotic cell cycle; P:activation of MAPK activity; P:atrioventricular canal development; P:axon guidance; P:Bergmann glial cell differentiation; P:brain development; P:cellular response to cytokine stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to mechanical stimulus; P:cerebellar cortex formation; P:cytokine-mediated signaling pathway; P:DNA damage checkpoint; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:ERBB signaling pathway; P:face morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:genitalia development; P:glucose homeostasis; P:heart development; P:homeostasis of number of cells within a tissue; P:hormone metabolic process; P:hormone-mediated signaling pathway; P:inner ear development; P:integrin-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:intestinal epithelial cell migration; P:leukocyte migration; P:megakaryocyte development; P:microvillus organization; P:multicellular organism growth; P:multicellular organismal reproductive process; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of chondrocyte differentiation; P:negative regulation of cortisol secretion; P:negative regulation of growth hormone secretion; P:negative regulation of insulin secretion; P:neurotrophin TRK receptor signaling pathway; P:organ growth; P:peptidyl-tyrosine dephosphorylation; P:platelet activation; P:platelet formation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glucose import; P:positive regulation of hormone secretion; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of mitotic cell cycle; P:positive regulation of ossification; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor production; P:regulation of cell adhesion mediated by integrin; P:regulation of protein export from nucleus; P:regulation of protein-containing complex assembly; P:regulation of type I interferon-mediated signaling pathway; P:T cell costimulation; P:triglyceride metabolic process; scaffold60 indexed_genome mRNA 3010798 3015531 . + . ID=transcript_10400;Q02878 Q2M3Q3 Q8WW97,60S ribosomal protein L6,Large ribosomal subunit protein eL6 {ECO:0000303|PubMed:24524803};Neoplasm-related protein C140;Tax-responsive enhancer element-binding protein 107;, PF01159;PF03868;, GO:0036464;GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0014069;GO:0005791;GO:0045296;GO:0003677;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006355;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome; C:postsynaptic density; C:rough endoplasmic reticulum;, F:cadherin binding; F:DNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of transcription, DNA-templated; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q02878 Q2M3Q3 Q8WW97,60S ribosomal protein L6,Large ribosomal subunit protein eL6 {ECO:0000303|PubMed:24524803};Neoplasm-related protein C140;Tax-responsive enhancer element-binding protein 107;, PF01159;PF03868;, GO:0036464;GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0014069;GO:0005791;GO:0045296;GO:0003677;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006355;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome; C:postsynaptic density; C:rough endoplasmic reticulum;, F:cadherin binding; F:DNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of transcription, DNA-templated; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q02878 Q2M3Q3 Q8WW97,60S ribosomal protein L6,Large ribosomal subunit protein eL6 {ECO:0000303|PubMed:24524803};Neoplasm-related protein C140;Tax-responsive enhancer element-binding protein 107;, PF01159;PF03868;, GO:0036464;GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0014069;GO:0005791;GO:0045296;GO:0003677;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006355;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome; C:postsynaptic density; C:rough endoplasmic reticulum;, F:cadherin binding; F:DNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of transcription, DNA-templated; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold60 indexed_genome mRNA 3031670 3152184 . + . ID=transcript_10401;Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process;|Q9Y3U8 B2R4Y1 D6W634 Q6FIG1 Q9UQF6,60S ribosomal protein L36,Large ribosomal subunit protein eL36 {ECO:0000303|PubMed:24524803};, PF01158;, GO:0005737;GO:0005829;GO:0022625;GO:0016020;GO:0005730;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:membrane; C:nucleolus; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process;|Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process;|Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process; scaffold60 indexed_genome mRNA 3152779 3197710 . + . ID=transcript_10402;Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process;|Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process;|Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process;|Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process;|Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process;|Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process;|Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process;|Q9UFT6,Probable E3 ubiquitin-protein ligase HECTD4,HECT domain-containing protein 4;HECT-type E3 ubiquitin transferase HECTD4;, PF00632;, GO:0016021;GO:0004842;GO:0042593;GO:0006006;, C:integral component of membrane;, F:ubiquitin-protein transferase activity;, P:glucose homeostasis; P:glucose metabolic process; scaffold60 indexed_genome mRNA 3200665 3219662 . - . ID=transcript_10403;O14545 A8K5L6 B4DI89,TRAF-type zinc finger domain-containing protein 1,Protein FLN29;, , GO:0046872;GO:0045824;, , F:metal ion binding;, P:negative regulation of innate immune response;|O14545 A8K5L6 B4DI89,TRAF-type zinc finger domain-containing protein 1,Protein FLN29;, , GO:0046872;GO:0045824;, , F:metal ion binding;, P:negative regulation of innate immune response;|O14545 A8K5L6 B4DI89,TRAF-type zinc finger domain-containing protein 1,Protein FLN29;, , GO:0046872;GO:0045824;, , F:metal ion binding;, P:negative regulation of innate immune response;|O14545 A8K5L6 B4DI89,TRAF-type zinc finger domain-containing protein 1,Protein FLN29;, , GO:0046872;GO:0045824;, , F:metal ion binding;, P:negative regulation of innate immune response;|O14545 A8K5L6 B4DI89,TRAF-type zinc finger domain-containing protein 1,Protein FLN29;, , GO:0046872;GO:0045824;, , F:metal ion binding;, P:negative regulation of innate immune response; scaffold60 indexed_genome mRNA 3249602 3352522 . + . ID=transcript_10404;Q14CX7 A0JLU7 Q6MZH1 Q7Z4N6 Q9H911,N-alpha-acetyltransferase 25, NatB auxiliary subunit,Mitochondrial distribution and morphology protein 20;N-terminal acetyltransferase B complex subunit MDM20;N-terminal acetyltransferase B complex subunit NAA25;p120;, PF09797;, GO:0005737;GO:0005829;GO:0005794;GO:0031416;GO:0017196;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:NatB complex;, , P:N-terminal peptidyl-methionine acetylation;|Q14CX7 A0JLU7 Q6MZH1 Q7Z4N6 Q9H911,N-alpha-acetyltransferase 25, NatB auxiliary subunit,Mitochondrial distribution and morphology protein 20;N-terminal acetyltransferase B complex subunit MDM20;N-terminal acetyltransferase B complex subunit NAA25;p120;, PF09797;, GO:0005737;GO:0005829;GO:0005794;GO:0031416;GO:0017196;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:NatB complex;, , P:N-terminal peptidyl-methionine acetylation;|Q14CX7 A0JLU7 Q6MZH1 Q7Z4N6 Q9H911,N-alpha-acetyltransferase 25, NatB auxiliary subunit,Mitochondrial distribution and morphology protein 20;N-terminal acetyltransferase B complex subunit MDM20;N-terminal acetyltransferase B complex subunit NAA25;p120;, PF09797;, GO:0005737;GO:0005829;GO:0005794;GO:0031416;GO:0017196;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:NatB complex;, , P:N-terminal peptidyl-methionine acetylation;|Q14CX7 A0JLU7 Q6MZH1 Q7Z4N6 Q9H911,N-alpha-acetyltransferase 25, NatB auxiliary subunit,Mitochondrial distribution and morphology protein 20;N-terminal acetyltransferase B complex subunit MDM20;N-terminal acetyltransferase B complex subunit NAA25;p120;, PF09797;, GO:0005737;GO:0005829;GO:0005794;GO:0031416;GO:0017196;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:NatB complex;, , P:N-terminal peptidyl-methionine acetylation;|Q14CX7 A0JLU7 Q6MZH1 Q7Z4N6 Q9H911,N-alpha-acetyltransferase 25, NatB auxiliary subunit,Mitochondrial distribution and morphology protein 20;N-terminal acetyltransferase B complex subunit MDM20;N-terminal acetyltransferase B complex subunit NAA25;p120;, PF09797;, GO:0005737;GO:0005829;GO:0005794;GO:0031416;GO:0017196;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:NatB complex;, , P:N-terminal peptidyl-methionine acetylation;|Q8WCX6 Q9B2U5 Q9B2Z2,ATP synthase subunit a,F-ATPase protein 6;, PF00119;, GO:0016021;GO:0005743;GO:0005753;GO:0045263;GO:0015078;GO:0007568;GO:0006754;GO:0015986;GO:0042407;GO:0042776;GO:0055093;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:proton-transporting ATP synthase complex, coupling factor F(o);, F:proton transmembrane transporter activity;, P:aging; P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:response to hyperoxia;|Q14CX7 A0JLU7 Q6MZH1 Q7Z4N6 Q9H911,N-alpha-acetyltransferase 25, NatB auxiliary subunit,Mitochondrial distribution and morphology protein 20;N-terminal acetyltransferase B complex subunit MDM20;N-terminal acetyltransferase B complex subunit NAA25;p120;, PF09797;, GO:0005737;GO:0005829;GO:0005794;GO:0031416;GO:0017196;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:NatB complex;, , P:N-terminal peptidyl-methionine acetylation;|P30040 C9J183 Q3MJC3 Q6FHT4,Endoplasmic reticulum resident protein 29,Endoplasmic reticulum resident protein 28;Endoplasmic reticulum resident protein 31;, PF07749;PF07912;, GO:0009986;GO:0005783;GO:0005788;GO:0042470;GO:0016020;GO:0005790;GO:0030133;GO:0051087;GO:0042803;GO:0000187;GO:0006886;GO:0010629;GO:0050709;GO:0010628;GO:0001934;GO:0006457;GO:0018215;GO:0009306;GO:0043335;GO:1902235;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:melanosome; C:membrane; C:smooth endoplasmic reticulum; C:transport vesicle;, F:chaperone binding; F:protein homodimerization activity;, P:activation of MAPK activity; P:intracellular protein transport; P:negative regulation of gene expression; P:negative regulation of protein secretion; P:positive regulation of gene expression; P:positive regulation of protein phosphorylation; P:protein folding; P:protein phosphopantetheinylation; P:protein secretion; P:protein unfolding; P:regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;|P30040 C9J183 Q3MJC3 Q6FHT4,Endoplasmic reticulum resident protein 29,Endoplasmic reticulum resident protein 28;Endoplasmic reticulum resident protein 31;, PF07749;PF07912;, GO:0009986;GO:0005783;GO:0005788;GO:0042470;GO:0016020;GO:0005790;GO:0030133;GO:0051087;GO:0042803;GO:0000187;GO:0006886;GO:0010629;GO:0050709;GO:0010628;GO:0001934;GO:0006457;GO:0018215;GO:0009306;GO:0043335;GO:1902235;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:melanosome; C:membrane; C:smooth endoplasmic reticulum; C:transport vesicle;, F:chaperone binding; F:protein homodimerization activity;, P:activation of MAPK activity; P:intracellular protein transport; P:negative regulation of gene expression; P:negative regulation of protein secretion; P:positive regulation of gene expression; P:positive regulation of protein phosphorylation; P:protein folding; P:protein phosphopantetheinylation; P:protein secretion; P:protein unfolding; P:regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;|P30040 C9J183 Q3MJC3 Q6FHT4,Endoplasmic reticulum resident protein 29,Endoplasmic reticulum resident protein 28;Endoplasmic reticulum resident protein 31;, PF07749;PF07912;, GO:0009986;GO:0005783;GO:0005788;GO:0042470;GO:0016020;GO:0005790;GO:0030133;GO:0051087;GO:0042803;GO:0000187;GO:0006886;GO:0010629;GO:0050709;GO:0010628;GO:0001934;GO:0006457;GO:0018215;GO:0009306;GO:0043335;GO:1902235;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:melanosome; C:membrane; C:smooth endoplasmic reticulum; C:transport vesicle;, F:chaperone binding; F:protein homodimerization activity;, P:activation of MAPK activity; P:intracellular protein transport; P:negative regulation of gene expression; P:negative regulation of protein secretion; P:positive regulation of gene expression; P:positive regulation of protein phosphorylation; P:protein folding; P:protein phosphopantetheinylation; P:protein secretion; P:protein unfolding; P:regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;|P30040 C9J183 Q3MJC3 Q6FHT4,Endoplasmic reticulum resident protein 29,Endoplasmic reticulum resident protein 28;Endoplasmic reticulum resident protein 31;, PF07749;PF07912;, GO:0009986;GO:0005783;GO:0005788;GO:0042470;GO:0016020;GO:0005790;GO:0030133;GO:0051087;GO:0042803;GO:0000187;GO:0006886;GO:0010629;GO:0050709;GO:0010628;GO:0001934;GO:0006457;GO:0018215;GO:0009306;GO:0043335;GO:1902235;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:melanosome; C:membrane; C:smooth endoplasmic reticulum; C:transport vesicle;, F:chaperone binding; F:protein homodimerization activity;, P:activation of MAPK activity; P:intracellular protein transport; P:negative regulation of gene expression; P:negative regulation of protein secretion; P:positive regulation of gene expression; P:positive regulation of protein phosphorylation; P:protein folding; P:protein phosphopantetheinylation; P:protein secretion; P:protein unfolding; P:regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;|Q8NCL8 G3V1W7 G5E985 Q6NSH5 Q8IZ66,Transmembrane protein 116,, , GO:0016021;, C:integral component of membrane;|Q8NCL8 G3V1W7 G5E985 Q6NSH5 Q8IZ66,Transmembrane protein 116,, , GO:0016021;, C:integral component of membrane;|Q9UKJ8 O43507 Q2VPC6 Q32MR0,Disintegrin and metalloproteinase domain-containing protein 21,, PF08516;PF00200;PF01562;PF01421;, GO:0009897;GO:0016021;GO:0005886;GO:1990913;GO:0046872;GO:0004222;GO:0008237;GO:0007339;GO:0008584;GO:0007338;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane; C:sperm head plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:binding of sperm to zona pellucida; P:male gonad development; P:single fertilization; scaffold60 indexed_genome mRNA 3409668 3441115 . - . ID=transcript_10405;Q8IW41 B3KVA5 O60491 Q86X46 Q9BVX9 Q9UG86,MAP kinase-activated protein kinase 5,p38-regulated/activated protein kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0032007;GO:0018105;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:0007265;GO:1901796;GO:0006417;GO:0007165;GO:0090400;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:negative regulation of TOR signaling; P:peptidyl-serine phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:Ras protein signal transduction; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:signal transduction; P:stress-induced premature senescence;|Q8IW41 B3KVA5 O60491 Q86X46 Q9BVX9 Q9UG86,MAP kinase-activated protein kinase 5,p38-regulated/activated protein kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0032007;GO:0018105;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:0007265;GO:1901796;GO:0006417;GO:0007165;GO:0090400;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:negative regulation of TOR signaling; P:peptidyl-serine phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:Ras protein signal transduction; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:signal transduction; P:stress-induced premature senescence;|Q8IW41 B3KVA5 O60491 Q86X46 Q9BVX9 Q9UG86,MAP kinase-activated protein kinase 5,p38-regulated/activated protein kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0032007;GO:0018105;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:0007265;GO:1901796;GO:0006417;GO:0007165;GO:0090400;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:negative regulation of TOR signaling; P:peptidyl-serine phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:Ras protein signal transduction; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:signal transduction; P:stress-induced premature senescence;|Q8IW41 B3KVA5 O60491 Q86X46 Q9BVX9 Q9UG86,MAP kinase-activated protein kinase 5,p38-regulated/activated protein kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0032007;GO:0018105;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:0007265;GO:1901796;GO:0006417;GO:0007165;GO:0090400;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:negative regulation of TOR signaling; P:peptidyl-serine phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:Ras protein signal transduction; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:signal transduction; P:stress-induced premature senescence;|Q8IW41 B3KVA5 O60491 Q86X46 Q9BVX9 Q9UG86,MAP kinase-activated protein kinase 5,p38-regulated/activated protein kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0032007;GO:0018105;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:0007265;GO:1901796;GO:0006417;GO:0007165;GO:0090400;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:negative regulation of TOR signaling; P:peptidyl-serine phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:Ras protein signal transduction; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:signal transduction; P:stress-induced premature senescence;|Q8IW41 B3KVA5 O60491 Q86X46 Q9BVX9 Q9UG86,MAP kinase-activated protein kinase 5,p38-regulated/activated protein kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0032007;GO:0018105;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:0007265;GO:1901796;GO:0006417;GO:0007165;GO:0090400;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:negative regulation of TOR signaling; P:peptidyl-serine phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:Ras protein signal transduction; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:signal transduction; P:stress-induced premature senescence;|Q8IW41 B3KVA5 O60491 Q86X46 Q9BVX9 Q9UG86,MAP kinase-activated protein kinase 5,p38-regulated/activated protein kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0032007;GO:0018105;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:0007265;GO:1901796;GO:0006417;GO:0007165;GO:0090400;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:negative regulation of TOR signaling; P:peptidyl-serine phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:Ras protein signal transduction; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:signal transduction; P:stress-induced premature senescence;|Q8IW41 B3KVA5 O60491 Q86X46 Q9BVX9 Q9UG86,MAP kinase-activated protein kinase 5,p38-regulated/activated protein kinase;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0004708;GO:0051019;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0032007;GO:0018105;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:0007265;GO:1901796;GO:0006417;GO:0007165;GO:0090400;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:negative regulation of TOR signaling; P:peptidyl-serine phosphorylation; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:Ras protein signal transduction; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:signal transduction; P:stress-induced premature senescence;|Q8N8E1,Putative uncharacterized protein encoded by MAPKAPK5-AS1,MAPKAPK5 antisense RNA 1;MAPKAPK5 antisense gene protein 1; scaffold60 indexed_genome mRNA 3451260 3475726 . - . ID=transcript_10406;P05091 B4DW54 E7EUE5 Q03639 Q6IB13 Q6IV71,Aldehyde dehydrogenase, mitochondrial,ALDH class 2;ALDH-E2;ALDHI;, PF00171;, GO:0070062;GO:0005759;GO:0004029;GO:0004030;GO:0009055;GO:0043878;GO:0051287;GO:0006066;GO:0005975;GO:0006068;GO:0006069;, C:extracellular exosome; C:mitochondrial matrix;, F:aldehyde dehydrogenase (NAD+) activity; F:aldehyde dehydrogenase [NAD(P)+] activity; F:electron transfer activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:NAD binding;, P:alcohol metabolic process; P:carbohydrate metabolic process; P:ethanol catabolic process; P:ethanol oxidation;|P05091 B4DW54 E7EUE5 Q03639 Q6IB13 Q6IV71,Aldehyde dehydrogenase, mitochondrial,ALDH class 2;ALDH-E2;ALDHI;, PF00171;, GO:0070062;GO:0005759;GO:0004029;GO:0004030;GO:0009055;GO:0043878;GO:0051287;GO:0006066;GO:0005975;GO:0006068;GO:0006069;, C:extracellular exosome; C:mitochondrial matrix;, F:aldehyde dehydrogenase (NAD+) activity; F:aldehyde dehydrogenase [NAD(P)+] activity; F:electron transfer activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:NAD binding;, P:alcohol metabolic process; P:carbohydrate metabolic process; P:ethanol catabolic process; P:ethanol oxidation;|P05091 B4DW54 E7EUE5 Q03639 Q6IB13 Q6IV71,Aldehyde dehydrogenase, mitochondrial,ALDH class 2;ALDH-E2;ALDHI;, PF00171;, GO:0070062;GO:0005759;GO:0004029;GO:0004030;GO:0009055;GO:0043878;GO:0051287;GO:0006066;GO:0005975;GO:0006068;GO:0006069;, C:extracellular exosome; C:mitochondrial matrix;, F:aldehyde dehydrogenase (NAD+) activity; F:aldehyde dehydrogenase [NAD(P)+] activity; F:electron transfer activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:NAD binding;, P:alcohol metabolic process; P:carbohydrate metabolic process; P:ethanol catabolic process; P:ethanol oxidation;|P05091 B4DW54 E7EUE5 Q03639 Q6IB13 Q6IV71,Aldehyde dehydrogenase, mitochondrial,ALDH class 2;ALDH-E2;ALDHI;, PF00171;, GO:0070062;GO:0005759;GO:0004029;GO:0004030;GO:0009055;GO:0043878;GO:0051287;GO:0006066;GO:0005975;GO:0006068;GO:0006069;, C:extracellular exosome; C:mitochondrial matrix;, F:aldehyde dehydrogenase (NAD+) activity; F:aldehyde dehydrogenase [NAD(P)+] activity; F:electron transfer activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:NAD binding;, P:alcohol metabolic process; P:carbohydrate metabolic process; P:ethanol catabolic process; P:ethanol oxidation;|P05091 B4DW54 E7EUE5 Q03639 Q6IB13 Q6IV71,Aldehyde dehydrogenase, mitochondrial,ALDH class 2;ALDH-E2;ALDHI;, PF00171;, GO:0070062;GO:0005759;GO:0004029;GO:0004030;GO:0009055;GO:0043878;GO:0051287;GO:0006066;GO:0005975;GO:0006068;GO:0006069;, C:extracellular exosome; C:mitochondrial matrix;, F:aldehyde dehydrogenase (NAD+) activity; F:aldehyde dehydrogenase [NAD(P)+] activity; F:electron transfer activity; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; F:NAD binding;, P:alcohol metabolic process; P:carbohydrate metabolic process; P:ethanol catabolic process; P:ethanol oxidation; scaffold60 indexed_genome mRNA 3593101 3593862 . + . ID=transcript_10407;Q6ZP65 A8MUC8 B4DWL0 B5MDJ0 O95000,BICD family-like cargo adapter 1,Bicaudal D-related protein 1;Coiled-coil domain-containing protein 64A;, , GO:0005813;GO:0005737;GO:0034452;GO:0031267;GO:0055107;GO:0031175;GO:0047496;, C:centrosome; C:cytoplasm;, F:dynactin binding; F:small GTPase binding;, P:Golgi to secretory granule transport; P:neuron projection development; P:vesicle transport along microtubule; scaffold60 indexed_genome mRNA 3596162 3617656 . + . ID=transcript_10408;Q6ZP65 A8MUC8 B4DWL0 B5MDJ0 O95000,BICD family-like cargo adapter 1,Bicaudal D-related protein 1;Coiled-coil domain-containing protein 64A;, , GO:0005813;GO:0005737;GO:0034452;GO:0031267;GO:0055107;GO:0031175;GO:0047496;, C:centrosome; C:cytoplasm;, F:dynactin binding; F:small GTPase binding;, P:Golgi to secretory granule transport; P:neuron projection development; P:vesicle transport along microtubule;|Q6ZP65 A8MUC8 B4DWL0 B5MDJ0 O95000,BICD family-like cargo adapter 1,Bicaudal D-related protein 1;Coiled-coil domain-containing protein 64A;, , GO:0005813;GO:0005737;GO:0034452;GO:0031267;GO:0055107;GO:0031175;GO:0047496;, C:centrosome; C:cytoplasm;, F:dynactin binding; F:small GTPase binding;, P:Golgi to secretory granule transport; P:neuron projection development; P:vesicle transport along microtubule;|Q6ZP65 A8MUC8 B4DWL0 B5MDJ0 O95000,BICD family-like cargo adapter 1,Bicaudal D-related protein 1;Coiled-coil domain-containing protein 64A;, , GO:0005813;GO:0005737;GO:0034452;GO:0031267;GO:0055107;GO:0031175;GO:0047496;, C:centrosome; C:cytoplasm;, F:dynactin binding; F:small GTPase binding;, P:Golgi to secretory granule transport; P:neuron projection development; P:vesicle transport along microtubule;|Q6ZP65 A8MUC8 B4DWL0 B5MDJ0 O95000,BICD family-like cargo adapter 1,Bicaudal D-related protein 1;Coiled-coil domain-containing protein 64A;, , GO:0005813;GO:0005737;GO:0034452;GO:0031267;GO:0055107;GO:0031175;GO:0047496;, C:centrosome; C:cytoplasm;, F:dynactin binding; F:small GTPase binding;, P:Golgi to secretory granule transport; P:neuron projection development; P:vesicle transport along microtubule;|Q6ZP65 A8MUC8 B4DWL0 B5MDJ0 O95000,BICD family-like cargo adapter 1,Bicaudal D-related protein 1;Coiled-coil domain-containing protein 64A;, , GO:0005813;GO:0005737;GO:0034452;GO:0031267;GO:0055107;GO:0031175;GO:0047496;, C:centrosome; C:cytoplasm;, F:dynactin binding; F:small GTPase binding;, P:Golgi to secretory granule transport; P:neuron projection development; P:vesicle transport along microtubule;|Q6ZP65 A8MUC8 B4DWL0 B5MDJ0 O95000,BICD family-like cargo adapter 1,Bicaudal D-related protein 1;Coiled-coil domain-containing protein 64A;, , GO:0005813;GO:0005737;GO:0034452;GO:0031267;GO:0055107;GO:0031175;GO:0047496;, C:centrosome; C:cytoplasm;, F:dynactin binding; F:small GTPase binding;, P:Golgi to secretory granule transport; P:neuron projection development; P:vesicle transport along microtubule;|Q6ZP65 A8MUC8 B4DWL0 B5MDJ0 O95000,BICD family-like cargo adapter 1,Bicaudal D-related protein 1;Coiled-coil domain-containing protein 64A;, , GO:0005813;GO:0005737;GO:0034452;GO:0031267;GO:0055107;GO:0031175;GO:0047496;, C:centrosome; C:cytoplasm;, F:dynactin binding; F:small GTPase binding;, P:Golgi to secretory granule transport; P:neuron projection development; P:vesicle transport along microtubule; scaffold60 indexed_genome mRNA 3618280 3630003 . - . ID=transcript_10409;Q15286 B2R6E0 B4E390,Ras-related protein Rab-35,GTP-binding protein RAY;Ras-related protein Rab-1C;, PF00071;, GO:0098993;GO:0031253;GO:0045334;GO:0030669;GO:0005905;GO:0005829;GO:0010008;GO:0070062;GO:0045171;GO:0042470;GO:0005886;GO:0055038;GO:0019003;GO:0005525;GO:0003924;GO:0005546;GO:0019882;GO:1990090;GO:0032456;GO:0016197;GO:0000281;GO:0031175;GO:0048227;GO:0008104;GO:0036010;GO:0015031;GO:0032482;, C:anchored component of synaptic vesicle membrane; C:cell projection membrane; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytosol; C:endosome membrane; C:extracellular exosome; C:intercellular bridge; C:melanosome; C:plasma membrane; C:recycling endosome membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:phosphatidylinositol-4,5-bisphosphate binding;, P:antigen processing and presentation; P:cellular response to nerve growth factor stimulus; P:endocytic recycling; P:endosomal transport; P:mitotic cytokinesis; P:neuron projection development; P:plasma membrane to endosome transport; P:protein localization; P:protein localization to endosome; P:protein transport; P:Rab protein signal transduction;|Q15286 B2R6E0 B4E390,Ras-related protein Rab-35,GTP-binding protein RAY;Ras-related protein Rab-1C;, PF00071;, GO:0098993;GO:0031253;GO:0045334;GO:0030669;GO:0005905;GO:0005829;GO:0010008;GO:0070062;GO:0045171;GO:0042470;GO:0005886;GO:0055038;GO:0019003;GO:0005525;GO:0003924;GO:0005546;GO:0019882;GO:1990090;GO:0032456;GO:0016197;GO:0000281;GO:0031175;GO:0048227;GO:0008104;GO:0036010;GO:0015031;GO:0032482;, C:anchored component of synaptic vesicle membrane; C:cell projection membrane; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytosol; C:endosome membrane; C:extracellular exosome; C:intercellular bridge; C:melanosome; C:plasma membrane; C:recycling endosome membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:phosphatidylinositol-4,5-bisphosphate binding;, P:antigen processing and presentation; P:cellular response to nerve growth factor stimulus; P:endocytic recycling; P:endosomal transport; P:mitotic cytokinesis; P:neuron projection development; P:plasma membrane to endosome transport; P:protein localization; P:protein localization to endosome; P:protein transport; P:Rab protein signal transduction;|Q15286 B2R6E0 B4E390,Ras-related protein Rab-35,GTP-binding protein RAY;Ras-related protein Rab-1C;, PF00071;, GO:0098993;GO:0031253;GO:0045334;GO:0030669;GO:0005905;GO:0005829;GO:0010008;GO:0070062;GO:0045171;GO:0042470;GO:0005886;GO:0055038;GO:0019003;GO:0005525;GO:0003924;GO:0005546;GO:0019882;GO:1990090;GO:0032456;GO:0016197;GO:0000281;GO:0031175;GO:0048227;GO:0008104;GO:0036010;GO:0015031;GO:0032482;, C:anchored component of synaptic vesicle membrane; C:cell projection membrane; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:cytosol; C:endosome membrane; C:extracellular exosome; C:intercellular bridge; C:melanosome; C:plasma membrane; C:recycling endosome membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:phosphatidylinositol-4,5-bisphosphate binding;, P:antigen processing and presentation; P:cellular response to nerve growth factor stimulus; P:endocytic recycling; P:endosomal transport; P:mitotic cytokinesis; P:neuron projection development; P:plasma membrane to endosome transport; P:protein localization; P:protein localization to endosome; P:protein transport; P:Rab protein signal transduction; scaffold60 indexed_genome mRNA 3644409 3702678 . + . ID=transcript_10410;Q9UE60,eIF-2-alpha kinase activator GCN1 {ECO:0000250|UniProtKB:E9PVA8},GCN1 eIF-2-alpha kinase activator homolog {ECO:0000312|HGNC:HGNC:4199};GCN1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};General control of amino-acid synthesis 1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};Translational activator GCN1 {ECO:0000250|UniProtKB:E9PVA8};, , GO:0005737;GO:0005829;GO:0016020;GO:0005844;GO:0005840;GO:0045296;GO:0019901;GO:0019887;GO:0043022;GO:0003723;GO:0008135;GO:0034198;GO:1990253;GO:0033674;GO:0036003;, C:cytoplasm; C:cytosol; C:membrane; C:polysome; C:ribosome;, F:cadherin binding; F:protein kinase binding; F:protein kinase regulator activity; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding;, P:cellular response to amino acid starvation; P:cellular response to leucine starvation; P:positive regulation of kinase activity; P:positive regulation of transcription from RNA polymerase II promoter in response to stress;|Q9UE60,eIF-2-alpha kinase activator GCN1 {ECO:0000250|UniProtKB:E9PVA8},GCN1 eIF-2-alpha kinase activator homolog {ECO:0000312|HGNC:HGNC:4199};GCN1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};General control of amino-acid synthesis 1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};Translational activator GCN1 {ECO:0000250|UniProtKB:E9PVA8};, , GO:0005737;GO:0005829;GO:0016020;GO:0005844;GO:0005840;GO:0045296;GO:0019901;GO:0019887;GO:0043022;GO:0003723;GO:0008135;GO:0034198;GO:1990253;GO:0033674;GO:0036003;, C:cytoplasm; C:cytosol; C:membrane; C:polysome; C:ribosome;, F:cadherin binding; F:protein kinase binding; F:protein kinase regulator activity; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding;, P:cellular response to amino acid starvation; P:cellular response to leucine starvation; P:positive regulation of kinase activity; P:positive regulation of transcription from RNA polymerase II promoter in response to stress;|Q9UE60,eIF-2-alpha kinase activator GCN1 {ECO:0000250|UniProtKB:E9PVA8},GCN1 eIF-2-alpha kinase activator homolog {ECO:0000312|HGNC:HGNC:4199};GCN1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};General control of amino-acid synthesis 1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};Translational activator GCN1 {ECO:0000250|UniProtKB:E9PVA8};, , GO:0005737;GO:0005829;GO:0016020;GO:0005844;GO:0005840;GO:0045296;GO:0019901;GO:0019887;GO:0043022;GO:0003723;GO:0008135;GO:0034198;GO:1990253;GO:0033674;GO:0036003;, C:cytoplasm; C:cytosol; C:membrane; C:polysome; C:ribosome;, F:cadherin binding; F:protein kinase binding; F:protein kinase regulator activity; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding;, P:cellular response to amino acid starvation; P:cellular response to leucine starvation; P:positive regulation of kinase activity; P:positive regulation of transcription from RNA polymerase II promoter in response to stress;|Q9UE60,eIF-2-alpha kinase activator GCN1 {ECO:0000250|UniProtKB:E9PVA8},GCN1 eIF-2-alpha kinase activator homolog {ECO:0000312|HGNC:HGNC:4199};GCN1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};General control of amino-acid synthesis 1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};Translational activator GCN1 {ECO:0000250|UniProtKB:E9PVA8};, , GO:0005737;GO:0005829;GO:0016020;GO:0005844;GO:0005840;GO:0045296;GO:0019901;GO:0019887;GO:0043022;GO:0003723;GO:0008135;GO:0034198;GO:1990253;GO:0033674;GO:0036003;, C:cytoplasm; C:cytosol; C:membrane; C:polysome; C:ribosome;, F:cadherin binding; F:protein kinase binding; F:protein kinase regulator activity; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding;, P:cellular response to amino acid starvation; P:cellular response to leucine starvation; P:positive regulation of kinase activity; P:positive regulation of transcription from RNA polymerase II promoter in response to stress;|Q9UE60,eIF-2-alpha kinase activator GCN1 {ECO:0000250|UniProtKB:E9PVA8},GCN1 eIF-2-alpha kinase activator homolog {ECO:0000312|HGNC:HGNC:4199};GCN1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};General control of amino-acid synthesis 1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};Translational activator GCN1 {ECO:0000250|UniProtKB:E9PVA8};, , GO:0005737;GO:0005829;GO:0016020;GO:0005844;GO:0005840;GO:0045296;GO:0019901;GO:0019887;GO:0043022;GO:0003723;GO:0008135;GO:0034198;GO:1990253;GO:0033674;GO:0036003;, C:cytoplasm; C:cytosol; C:membrane; C:polysome; C:ribosome;, F:cadherin binding; F:protein kinase binding; F:protein kinase regulator activity; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding;, P:cellular response to amino acid starvation; P:cellular response to leucine starvation; P:positive regulation of kinase activity; P:positive regulation of transcription from RNA polymerase II promoter in response to stress;|Q9UE60,eIF-2-alpha kinase activator GCN1 {ECO:0000250|UniProtKB:E9PVA8},GCN1 eIF-2-alpha kinase activator homolog {ECO:0000312|HGNC:HGNC:4199};GCN1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};General control of amino-acid synthesis 1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};Translational activator GCN1 {ECO:0000250|UniProtKB:E9PVA8};, , GO:0005737;GO:0005829;GO:0016020;GO:0005844;GO:0005840;GO:0045296;GO:0019901;GO:0019887;GO:0043022;GO:0003723;GO:0008135;GO:0034198;GO:1990253;GO:0033674;GO:0036003;, C:cytoplasm; C:cytosol; C:membrane; C:polysome; C:ribosome;, F:cadherin binding; F:protein kinase binding; F:protein kinase regulator activity; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding;, P:cellular response to amino acid starvation; P:cellular response to leucine starvation; P:positive regulation of kinase activity; P:positive regulation of transcription from RNA polymerase II promoter in response to stress;|Q9UE60,eIF-2-alpha kinase activator GCN1 {ECO:0000250|UniProtKB:E9PVA8},GCN1 eIF-2-alpha kinase activator homolog {ECO:0000312|HGNC:HGNC:4199};GCN1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};General control of amino-acid synthesis 1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};Translational activator GCN1 {ECO:0000250|UniProtKB:E9PVA8};, , GO:0005737;GO:0005829;GO:0016020;GO:0005844;GO:0005840;GO:0045296;GO:0019901;GO:0019887;GO:0043022;GO:0003723;GO:0008135;GO:0034198;GO:1990253;GO:0033674;GO:0036003;, C:cytoplasm; C:cytosol; C:membrane; C:polysome; C:ribosome;, F:cadherin binding; F:protein kinase binding; F:protein kinase regulator activity; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding;, P:cellular response to amino acid starvation; P:cellular response to leucine starvation; P:positive regulation of kinase activity; P:positive regulation of transcription from RNA polymerase II promoter in response to stress;|Q9UE60,eIF-2-alpha kinase activator GCN1 {ECO:0000250|UniProtKB:E9PVA8},GCN1 eIF-2-alpha kinase activator homolog {ECO:0000312|HGNC:HGNC:4199};GCN1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};General control of amino-acid synthesis 1-like protein 1 {ECO:0000250|UniProtKB:E9PVA8};Translational activator GCN1 {ECO:0000250|UniProtKB:E9PVA8};, , GO:0005737;GO:0005829;GO:0016020;GO:0005844;GO:0005840;GO:0045296;GO:0019901;GO:0019887;GO:0043022;GO:0003723;GO:0008135;GO:0034198;GO:1990253;GO:0033674;GO:0036003;, C:cytoplasm; C:cytosol; C:membrane; C:polysome; C:ribosome;, F:cadherin binding; F:protein kinase binding; F:protein kinase regulator activity; F:ribosome binding; F:RNA binding; F:translation factor activity, RNA binding;, P:cellular response to amino acid starvation; P:cellular response to leucine starvation; P:positive regulation of kinase activity; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; scaffold60 indexed_genome mRNA 3705307 3706190 . + . ID=transcript_10411;P05388 Q3B7A4 Q9BVK4,60S acidic ribosomal protein P0,60S ribosomal protein L10E;Large ribosomal subunit protein uL10 {ECO:0000303|PubMed:24524803};, PF00466;PF17777;, GO:0005737;GO:0036464;GO:0005829;GO:0022625;GO:0030425;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0098794;GO:0014069;GO:1990904;GO:0070180;GO:0003723;GO:0003735;GO:0071353;GO:0002181;GO:0035722;GO:0000184;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus; C:postsynapse; C:postsynaptic density; C:ribonucleoprotein complex;, F:large ribosomal subunit rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cellular response to interleukin-4; P:cytoplasmic translation; P:interleukin-12-mediated signaling pathway; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold60 indexed_genome mRNA 3706965 3708271 . - . ID=transcript_10412;P05388 Q3B7A4 Q9BVK4,60S acidic ribosomal protein P0,60S ribosomal protein L10E;Large ribosomal subunit protein uL10 {ECO:0000303|PubMed:24524803};, PF00466;PF17777;, GO:0005737;GO:0036464;GO:0005829;GO:0022625;GO:0030425;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0098794;GO:0014069;GO:1990904;GO:0070180;GO:0003723;GO:0003735;GO:0071353;GO:0002181;GO:0035722;GO:0000184;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus; C:postsynapse; C:postsynaptic density; C:ribonucleoprotein complex;, F:large ribosomal subunit rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cellular response to interleukin-4; P:cytoplasmic translation; P:interleukin-12-mediated signaling pathway; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold60 indexed_genome mRNA 3710092 3719816 . - . ID=transcript_10413;P49023 B2RAI3 B7ZMB4 O14970 O14971 O60360 Q5HYA4,Paxillin,, PF00412;, GO:0005938;GO:0005911;GO:0005829;GO:0005925;GO:0030027;GO:0005875;GO:0005886;GO:0001725;GO:0008013;GO:0046872;GO:0038191;GO:0019903;GO:0003712;GO:0017166;GO:0007155;GO:0007160;GO:0034614;GO:0043542;GO:0060396;GO:0006936;GO:0051496;GO:0007172;GO:0007165;GO:0034446;GO:0007179;GO:0048010;, C:cell cortex; C:cell-cell junction; C:cytosol; C:focal adhesion; C:lamellipodium; C:microtubule associated complex; C:plasma membrane; C:stress fiber;, F:beta-catenin binding; F:metal ion binding; F:neuropilin binding; F:protein phosphatase binding; F:transcription coregulator activity; F:vinculin binding;, P:cell adhesion; P:cell-matrix adhesion; P:cellular response to reactive oxygen species; P:endothelial cell migration; P:growth hormone receptor signaling pathway; P:muscle contraction; P:positive regulation of stress fiber assembly; P:signal complex assembly; P:signal transduction; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P49023 B2RAI3 B7ZMB4 O14970 O14971 O60360 Q5HYA4,Paxillin,, PF00412;, GO:0005938;GO:0005911;GO:0005829;GO:0005925;GO:0030027;GO:0005875;GO:0005886;GO:0001725;GO:0008013;GO:0046872;GO:0038191;GO:0019903;GO:0003712;GO:0017166;GO:0007155;GO:0007160;GO:0034614;GO:0043542;GO:0060396;GO:0006936;GO:0051496;GO:0007172;GO:0007165;GO:0034446;GO:0007179;GO:0048010;, C:cell cortex; C:cell-cell junction; C:cytosol; C:focal adhesion; C:lamellipodium; C:microtubule associated complex; C:plasma membrane; C:stress fiber;, F:beta-catenin binding; F:metal ion binding; F:neuropilin binding; F:protein phosphatase binding; F:transcription coregulator activity; F:vinculin binding;, P:cell adhesion; P:cell-matrix adhesion; P:cellular response to reactive oxygen species; P:endothelial cell migration; P:growth hormone receptor signaling pathway; P:muscle contraction; P:positive regulation of stress fiber assembly; P:signal complex assembly; P:signal transduction; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold60 indexed_genome mRNA 3719819 3728768 . - . ID=transcript_10414;P49023 B2RAI3 B7ZMB4 O14970 O14971 O60360 Q5HYA4,Paxillin,, PF00412;, GO:0005938;GO:0005911;GO:0005829;GO:0005925;GO:0030027;GO:0005875;GO:0005886;GO:0001725;GO:0008013;GO:0046872;GO:0038191;GO:0019903;GO:0003712;GO:0017166;GO:0007155;GO:0007160;GO:0034614;GO:0043542;GO:0060396;GO:0006936;GO:0051496;GO:0007172;GO:0007165;GO:0034446;GO:0007179;GO:0048010;, C:cell cortex; C:cell-cell junction; C:cytosol; C:focal adhesion; C:lamellipodium; C:microtubule associated complex; C:plasma membrane; C:stress fiber;, F:beta-catenin binding; F:metal ion binding; F:neuropilin binding; F:protein phosphatase binding; F:transcription coregulator activity; F:vinculin binding;, P:cell adhesion; P:cell-matrix adhesion; P:cellular response to reactive oxygen species; P:endothelial cell migration; P:growth hormone receptor signaling pathway; P:muscle contraction; P:positive regulation of stress fiber assembly; P:signal complex assembly; P:signal transduction; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P49023 B2RAI3 B7ZMB4 O14970 O14971 O60360 Q5HYA4,Paxillin,, PF00412;, GO:0005938;GO:0005911;GO:0005829;GO:0005925;GO:0030027;GO:0005875;GO:0005886;GO:0001725;GO:0008013;GO:0046872;GO:0038191;GO:0019903;GO:0003712;GO:0017166;GO:0007155;GO:0007160;GO:0034614;GO:0043542;GO:0060396;GO:0006936;GO:0051496;GO:0007172;GO:0007165;GO:0034446;GO:0007179;GO:0048010;, C:cell cortex; C:cell-cell junction; C:cytosol; C:focal adhesion; C:lamellipodium; C:microtubule associated complex; C:plasma membrane; C:stress fiber;, F:beta-catenin binding; F:metal ion binding; F:neuropilin binding; F:protein phosphatase binding; F:transcription coregulator activity; F:vinculin binding;, P:cell adhesion; P:cell-matrix adhesion; P:cellular response to reactive oxygen species; P:endothelial cell migration; P:growth hormone receptor signaling pathway; P:muscle contraction; P:positive regulation of stress fiber assembly; P:signal complex assembly; P:signal transduction; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P49023 B2RAI3 B7ZMB4 O14970 O14971 O60360 Q5HYA4,Paxillin,, PF00412;, GO:0005938;GO:0005911;GO:0005829;GO:0005925;GO:0030027;GO:0005875;GO:0005886;GO:0001725;GO:0008013;GO:0046872;GO:0038191;GO:0019903;GO:0003712;GO:0017166;GO:0007155;GO:0007160;GO:0034614;GO:0043542;GO:0060396;GO:0006936;GO:0051496;GO:0007172;GO:0007165;GO:0034446;GO:0007179;GO:0048010;, C:cell cortex; C:cell-cell junction; C:cytosol; C:focal adhesion; C:lamellipodium; C:microtubule associated complex; C:plasma membrane; C:stress fiber;, F:beta-catenin binding; F:metal ion binding; F:neuropilin binding; F:protein phosphatase binding; F:transcription coregulator activity; F:vinculin binding;, P:cell adhesion; P:cell-matrix adhesion; P:cellular response to reactive oxygen species; P:endothelial cell migration; P:growth hormone receptor signaling pathway; P:muscle contraction; P:positive regulation of stress fiber assembly; P:signal complex assembly; P:signal transduction; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P49023 B2RAI3 B7ZMB4 O14970 O14971 O60360 Q5HYA4,Paxillin,, PF00412;, GO:0005938;GO:0005911;GO:0005829;GO:0005925;GO:0030027;GO:0005875;GO:0005886;GO:0001725;GO:0008013;GO:0046872;GO:0038191;GO:0019903;GO:0003712;GO:0017166;GO:0007155;GO:0007160;GO:0034614;GO:0043542;GO:0060396;GO:0006936;GO:0051496;GO:0007172;GO:0007165;GO:0034446;GO:0007179;GO:0048010;, C:cell cortex; C:cell-cell junction; C:cytosol; C:focal adhesion; C:lamellipodium; C:microtubule associated complex; C:plasma membrane; C:stress fiber;, F:beta-catenin binding; F:metal ion binding; F:neuropilin binding; F:protein phosphatase binding; F:transcription coregulator activity; F:vinculin binding;, P:cell adhesion; P:cell-matrix adhesion; P:cellular response to reactive oxygen species; P:endothelial cell migration; P:growth hormone receptor signaling pathway; P:muscle contraction; P:positive regulation of stress fiber assembly; P:signal complex assembly; P:signal transduction; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold60 indexed_genome mRNA 3781982 3789647 . + . ID=transcript_10415;Q9Y6E7 O43346 Q32M33,NAD-dependent protein lipoamidase sirtuin-4, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03161, ECO:0000303|PubMed:25525879},NAD-dependent ADP-ribosyltransferase sirtuin-4 {ECO:0000255|HAMAP-Rule:MF_03161};NAD-dependent protein deacetylase sirtuin-4 {ECO:0000255|HAMAP-Rule:MF_03161};Regulatory protein SIR2 homolog 4 {ECO:0000255|HAMAP-Rule:MF_03161};SIR2-like protein 4 {ECO:0000255|HAMAP-Rule:MF_03161};, PF02146;, GO:0005743;GO:0005759;GO:0005739;GO:0047708;GO:0061690;GO:0003950;GO:0070403;GO:0008270;GO:0006974;GO:0071456;GO:0006541;GO:0007005;GO:0010667;GO:0046322;GO:0046676;GO:1903217;GO:0034983;GO:0046889;GO:0006471;GO:0000820;GO:1904182;GO:0072350;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:biotinidase activity; F:lipoamidase activity; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:glutamine metabolic process; P:mitochondrion organization; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of fatty acid oxidation; P:negative regulation of insulin secretion; P:negative regulation of protein processing involved in protein targeting to mitochondrion; P:peptidyl-lysine deacetylation; P:positive regulation of lipid biosynthetic process; P:protein ADP-ribosylation; P:regulation of glutamine family amino acid metabolic process; P:regulation of pyruvate dehydrogenase activity; P:tricarboxylic acid metabolic process; scaffold60 indexed_genome mRNA 3816135 3840987 . - . ID=transcript_10416;O43347 Q96PU0 Q96PU1 Q96PU2 Q96PU3,RNA-binding protein Musashi homolog 1,, PF00076;, GO:0005737;GO:0005634;GO:0005844;GO:0042802;GO:0008266;GO:0003723;GO:0007399;, C:cytoplasm; C:nucleus; C:polysome;, F:identical protein binding; F:poly(U) RNA binding; F:RNA binding;, P:nervous system development;|O43347 Q96PU0 Q96PU1 Q96PU2 Q96PU3,RNA-binding protein Musashi homolog 1,, PF00076;, GO:0005737;GO:0005634;GO:0005844;GO:0042802;GO:0008266;GO:0003723;GO:0007399;, C:cytoplasm; C:nucleus; C:polysome;, F:identical protein binding; F:poly(U) RNA binding; F:RNA binding;, P:nervous system development;|O43347 Q96PU0 Q96PU1 Q96PU2 Q96PU3,RNA-binding protein Musashi homolog 1,, PF00076;, GO:0005737;GO:0005634;GO:0005844;GO:0042802;GO:0008266;GO:0003723;GO:0007399;, C:cytoplasm; C:nucleus; C:polysome;, F:identical protein binding; F:poly(U) RNA binding; F:RNA binding;, P:nervous system development;|O43347 Q96PU0 Q96PU1 Q96PU2 Q96PU3,RNA-binding protein Musashi homolog 1,, PF00076;, GO:0005737;GO:0005634;GO:0005844;GO:0042802;GO:0008266;GO:0003723;GO:0007399;, C:cytoplasm; C:nucleus; C:polysome;, F:identical protein binding; F:poly(U) RNA binding; F:RNA binding;, P:nervous system development; scaffold60 indexed_genome mRNA 3895008 3906908 . - . ID=transcript_10417;O43715 B2R4Z7 Q5RKS5 Q6LCA7,TP53-regulated inhibitor of apoptosis 1,Protein 15E1.1;WF-1;p53-inducible cell-survival factor;, PF05254;, GO:0005758;GO:0005739;GO:0005654;GO:0032991;GO:0002039;GO:0006915;GO:0034644;GO:0030330;GO:0006977;GO:0120009;GO:0043066;GO:0043154;GO:1902166;GO:0090201;GO:0015914;GO:2001140;GO:0045944;GO:0042981;GO:0097035;, C:mitochondrial intermembrane space; C:mitochondrion; C:nucleoplasm; C:protein-containing complex;, F:p53 binding;, P:apoptotic process; P:cellular response to UV; P:DNA damage response, signal transduction by p53 class mediator; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:intermembrane lipid transfer; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of release of cytochrome c from mitochondria; P:phospholipid transport; P:positive regulation of phospholipid transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of apoptotic process; P:regulation of membrane lipid distribution;|P12074 B2R500 O43714 Q32Q37,Cytochrome c oxidase subunit 6A1, mitochondrial,Cytochrome c oxidase polypeptide VIa-liver;Cytochrome c oxidase subunit VIA-liver;, PF02046;, GO:0016021;GO:0005743;GO:0005751;GO:0005739;GO:0004129;GO:0030234;GO:0006091;GO:0006123;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV; C:mitochondrion;, F:cytochrome-c oxidase activity; F:enzyme regulator activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen;|O43715 B2R4Z7 Q5RKS5 Q6LCA7,TP53-regulated inhibitor of apoptosis 1,Protein 15E1.1;WF-1;p53-inducible cell-survival factor;, PF05254;, GO:0005758;GO:0005739;GO:0005654;GO:0032991;GO:0002039;GO:0006915;GO:0034644;GO:0030330;GO:0006977;GO:0120009;GO:0043066;GO:0043154;GO:1902166;GO:0090201;GO:0015914;GO:2001140;GO:0045944;GO:0042981;GO:0097035;, C:mitochondrial intermembrane space; C:mitochondrion; C:nucleoplasm; C:protein-containing complex;, F:p53 binding;, P:apoptotic process; P:cellular response to UV; P:DNA damage response, signal transduction by p53 class mediator; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:intermembrane lipid transfer; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of release of cytochrome c from mitochondria; P:phospholipid transport; P:positive regulation of phospholipid transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of apoptotic process; P:regulation of membrane lipid distribution;|O43716 B3KSU7 Q3B824 Q3KNR8,Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03149},Protein 15E1.2;, PF02686;, GO:0030956;GO:0005739;GO:0005524;GO:0050567;GO:0070681;GO:0032543;GO:0006450;, C:glutamyl-tRNA(Gln) amidotransferase complex; C:mitochondrion;, F:ATP binding; F:glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity;, P:glutaminyl-tRNAGln biosynthesis via transamidation; P:mitochondrial translation; P:regulation of translational fidelity;|O43716 B3KSU7 Q3B824 Q3KNR8,Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03149},Protein 15E1.2;, PF02686;, GO:0030956;GO:0005739;GO:0005524;GO:0050567;GO:0070681;GO:0032543;GO:0006450;, C:glutamyl-tRNA(Gln) amidotransferase complex; C:mitochondrion;, F:ATP binding; F:glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity;, P:glutaminyl-tRNAGln biosynthesis via transamidation; P:mitochondrial translation; P:regulation of translational fidelity; scaffold60 indexed_genome mRNA 3907352 3913821 . - . ID=transcript_10418;Q13242 Q52LD1,Serine/arginine-rich splicing factor 9,Pre-mRNA-splicing factor SRp30C;Splicing factor, arginine/serine-rich 9;, PF00076;, GO:0016607;GO:0005730;GO:0005654;GO:0019904;GO:0003723;GO:0000380;GO:0031124;GO:0006406;GO:0006397;GO:0006376;GO:0000398;GO:0048025;GO:0043279;GO:0009636;GO:0006405;, C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:response to alkaloid; P:response to toxic substance; P:RNA export from nucleus;|Q13242 Q52LD1,Serine/arginine-rich splicing factor 9,Pre-mRNA-splicing factor SRp30C;Splicing factor, arginine/serine-rich 9;, PF00076;, GO:0016607;GO:0005730;GO:0005654;GO:0019904;GO:0003723;GO:0000380;GO:0031124;GO:0006406;GO:0006397;GO:0006376;GO:0000398;GO:0048025;GO:0043279;GO:0009636;GO:0006405;, C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:response to alkaloid; P:response to toxic substance; P:RNA export from nucleus;|Q13242 Q52LD1,Serine/arginine-rich splicing factor 9,Pre-mRNA-splicing factor SRp30C;Splicing factor, arginine/serine-rich 9;, PF00076;, GO:0016607;GO:0005730;GO:0005654;GO:0019904;GO:0003723;GO:0000380;GO:0031124;GO:0006406;GO:0006397;GO:0006376;GO:0000398;GO:0048025;GO:0043279;GO:0009636;GO:0006405;, C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:response to alkaloid; P:response to toxic substance; P:RNA export from nucleus;|Q13242 Q52LD1,Serine/arginine-rich splicing factor 9,Pre-mRNA-splicing factor SRp30C;Splicing factor, arginine/serine-rich 9;, PF00076;, GO:0016607;GO:0005730;GO:0005654;GO:0019904;GO:0003723;GO:0000380;GO:0031124;GO:0006406;GO:0006397;GO:0006376;GO:0000398;GO:0048025;GO:0043279;GO:0009636;GO:0006405;, C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:response to alkaloid; P:response to toxic substance; P:RNA export from nucleus; scaffold60 indexed_genome mRNA 3941121 3944433 . - . ID=transcript_10419;Q96FJ2 B2R5B4,Dynein light chain 2, cytoplasmic,8 kDa dynein light chain b;Dynein light chain LC8-type 2;, PF01221;, GO:0097731;GO:0005813;GO:0097542;GO:0005929;GO:0005868;GO:0005829;GO:0030286;GO:0098978;GO:0016020;GO:0005874;GO:0031475;GO:0005634;GO:0005886;GO:0098794;GO:0014069;GO:0045505;GO:0051959;GO:0042802;GO:0044877;GO:0097110;GO:0035973;GO:0019886;GO:0060271;GO:0006888;GO:0035735;GO:0016236;GO:0007052;GO:2000582;GO:0019058;, C:9+0 non-motile cilium; C:centrosome; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:cytosol; C:dynein complex; C:glutamatergic synapse; C:membrane; C:microtubule; C:myosin V complex; C:nucleus; C:plasma membrane; C:postsynapse; C:postsynaptic density;, F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:identical protein binding; F:protein-containing complex binding; F:scaffold protein binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intraciliary transport involved in cilium assembly; P:macroautophagy; P:mitotic spindle organization; P:positive regulation of ATP-dependent microtubule motor activity, plus-end-directed; P:viral life cycle; scaffold60 indexed_genome mRNA 3944898 3958540 . - . ID=transcript_10420;Q5HYK3 B2RDU9 B3GK62 B4DEJ4 Q32Q28 Q53HH0 Q96LV1 Q9BSP8,2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03191},Ubiquinone biosynthesis methyltransferase COQ5 {ECO:0000255|HAMAP-Rule:MF_03191};, PF01209;, GO:0031314;GO:0005759;GO:0032991;GO:0043430;GO:0043333;GO:0008168;GO:0032259;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:protein-containing complex;, F:2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; F:2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity; F:methyltransferase activity;, P:methylation; P:ubiquinone biosynthetic process;|Q5HYK3 B2RDU9 B3GK62 B4DEJ4 Q32Q28 Q53HH0 Q96LV1 Q9BSP8,2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03191},Ubiquinone biosynthesis methyltransferase COQ5 {ECO:0000255|HAMAP-Rule:MF_03191};, PF01209;, GO:0031314;GO:0005759;GO:0032991;GO:0043430;GO:0043333;GO:0008168;GO:0032259;GO:0006744;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:protein-containing complex;, F:2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; F:2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity; F:methyltransferase activity;, P:methylation; P:ubiquinone biosynthetic process; scaffold60 indexed_genome mRNA 3962065 3996546 . + . ID=transcript_10421;Q8N5U6 Q92550 Q9NPP8 Q9ULW4,RING finger protein 10,, PF13639;, GO:0005737;GO:0005634;GO:0046872;GO:0000976;GO:0061630;GO:0010626;GO:0031643;GO:0045944;GO:0045893;GO:0051865;, C:cytoplasm; C:nucleus;, F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase activity;, P:negative regulation of Schwann cell proliferation; P:positive regulation of myelination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein autoubiquitination;|Q8N5U6 Q92550 Q9NPP8 Q9ULW4,RING finger protein 10,, PF13639;, GO:0005737;GO:0005634;GO:0046872;GO:0000976;GO:0061630;GO:0010626;GO:0031643;GO:0045944;GO:0045893;GO:0051865;, C:cytoplasm; C:nucleus;, F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase activity;, P:negative regulation of Schwann cell proliferation; P:positive regulation of myelination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein autoubiquitination;|Q8N5U6 Q92550 Q9NPP8 Q9ULW4,RING finger protein 10,, PF13639;, GO:0005737;GO:0005634;GO:0046872;GO:0000976;GO:0061630;GO:0010626;GO:0031643;GO:0045944;GO:0045893;GO:0051865;, C:cytoplasm; C:nucleus;, F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase activity;, P:negative regulation of Schwann cell proliferation; P:positive regulation of myelination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein autoubiquitination;|Q8N5U6 Q92550 Q9NPP8 Q9ULW4,RING finger protein 10,, PF13639;, GO:0005737;GO:0005634;GO:0046872;GO:0000976;GO:0061630;GO:0010626;GO:0031643;GO:0045944;GO:0045893;GO:0051865;, C:cytoplasm; C:nucleus;, F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase activity;, P:negative regulation of Schwann cell proliferation; P:positive regulation of myelination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein autoubiquitination;|Q8N5U6 Q92550 Q9NPP8 Q9ULW4,RING finger protein 10,, PF13639;, GO:0005737;GO:0005634;GO:0046872;GO:0000976;GO:0061630;GO:0010626;GO:0031643;GO:0045944;GO:0045893;GO:0051865;, C:cytoplasm; C:nucleus;, F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase activity;, P:negative regulation of Schwann cell proliferation; P:positive regulation of myelination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein autoubiquitination; scaffold60 indexed_genome mRNA 3997060 3998969 . + . ID=transcript_10422;Q969H6 A6NL80 Q53FS5 Q9Y2Q6,Ribonuclease P/MRP protein subunit POP5,, PF01900;, GO:0030681;GO:0005655;GO:0005730;GO:0005654;GO:0000172;GO:0004526;GO:0033204;GO:0006364;GO:0001682;GO:0008033;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleolus; C:nucleoplasm; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding;, P:rRNA processing; P:tRNA 5'-leader removal; P:tRNA processing;|Q969H6 A6NL80 Q53FS5 Q9Y2Q6,Ribonuclease P/MRP protein subunit POP5,, PF01900;, GO:0030681;GO:0005655;GO:0005730;GO:0005654;GO:0000172;GO:0004526;GO:0033204;GO:0006364;GO:0001682;GO:0008033;, C:multimeric ribonuclease P complex; C:nucleolar ribonuclease P complex; C:nucleolus; C:nucleoplasm; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding;, P:rRNA processing; P:tRNA 5'-leader removal; P:tRNA processing; scaffold60 indexed_genome mRNA 4040100 4056959 . + . ID=transcript_10423;Q9NZU7 O95663 Q8N6H5 Q9NZU8,Calcium-binding protein 1,Calbrain;Caldendrin;, PF13499;, GO:0005938;GO:0005856;GO:0005615;GO:0000139;GO:0048471;GO:0005886;GO:0014069;GO:0005509;GO:0048306;GO:0004857;GO:0008139;GO:0042308;GO:0050896;GO:0007601;, C:cell cortex; C:cytoskeleton; C:extracellular space; C:Golgi membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:calcium ion binding; F:calcium-dependent protein binding; F:enzyme inhibitor activity; F:nuclear localization sequence binding;, P:negative regulation of protein import into nucleus; P:response to stimulus; P:visual perception;|Q9NZU7 O95663 Q8N6H5 Q9NZU8,Calcium-binding protein 1,Calbrain;Caldendrin;, PF13499;, GO:0005938;GO:0005856;GO:0005615;GO:0000139;GO:0048471;GO:0005886;GO:0014069;GO:0005509;GO:0048306;GO:0004857;GO:0008139;GO:0042308;GO:0050896;GO:0007601;, C:cell cortex; C:cytoskeleton; C:extracellular space; C:Golgi membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:calcium ion binding; F:calcium-dependent protein binding; F:enzyme inhibitor activity; F:nuclear localization sequence binding;, P:negative regulation of protein import into nucleus; P:response to stimulus; P:visual perception;|Q9NZU7 O95663 Q8N6H5 Q9NZU8,Calcium-binding protein 1,Calbrain;Caldendrin;, PF13499;, GO:0005938;GO:0005856;GO:0005615;GO:0000139;GO:0048471;GO:0005886;GO:0014069;GO:0005509;GO:0048306;GO:0004857;GO:0008139;GO:0042308;GO:0050896;GO:0007601;, C:cell cortex; C:cytoskeleton; C:extracellular space; C:Golgi membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:calcium ion binding; F:calcium-dependent protein binding; F:enzyme inhibitor activity; F:nuclear localization sequence binding;, P:negative regulation of protein import into nucleus; P:response to stimulus; P:visual perception; scaffold60 indexed_genome mRNA 4058300 4064525 . - . ID=transcript_10424;Q9NZU7 O95663 Q8N6H5 Q9NZU8,Calcium-binding protein 1,Calbrain;Caldendrin;, PF13499;, GO:0005938;GO:0005856;GO:0005615;GO:0000139;GO:0048471;GO:0005886;GO:0014069;GO:0005509;GO:0048306;GO:0004857;GO:0008139;GO:0042308;GO:0050896;GO:0007601;, C:cell cortex; C:cytoskeleton; C:extracellular space; C:Golgi membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:calcium ion binding; F:calcium-dependent protein binding; F:enzyme inhibitor activity; F:nuclear localization sequence binding;, P:negative regulation of protein import into nucleus; P:response to stimulus; P:visual perception;|Q9NZU7 O95663 Q8N6H5 Q9NZU8,Calcium-binding protein 1,Calbrain;Caldendrin;, PF13499;, GO:0005938;GO:0005856;GO:0005615;GO:0000139;GO:0048471;GO:0005886;GO:0014069;GO:0005509;GO:0048306;GO:0004857;GO:0008139;GO:0042308;GO:0050896;GO:0007601;, C:cell cortex; C:cytoskeleton; C:extracellular space; C:Golgi membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density;, F:calcium ion binding; F:calcium-dependent protein binding; F:enzyme inhibitor activity; F:nuclear localization sequence binding;, P:negative regulation of protein import into nucleus; P:response to stimulus; P:visual perception; scaffold60 indexed_genome mRNA 4078138 4090501 . + . ID=transcript_10425;Q14165,Malectin,, PF11721;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0035579;GO:0030246;GO:0019899;GO:0005975;GO:0043312;GO:0006457;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:specific granule membrane;, F:carbohydrate binding; F:enzyme binding;, P:carbohydrate metabolic process; P:neutrophil degranulation; P:protein folding; scaffold60 indexed_genome mRNA 4099875 4111959 . + . ID=transcript_10426;A6NIH7,Protein unc-119 homolog B,, PF05351;, GO:0035869;GO:0005929;GO:0005829;GO:0008289;GO:0060271;GO:0042953;GO:0007399;, C:ciliary transition zone; C:cilium; C:cytosol;, F:lipid binding;, P:cilium assembly; P:lipoprotein transport; P:nervous system development; scaffold60 indexed_genome mRNA 4113724 4129924 . + . ID=transcript_10427;P16219 P78331,Short-chain specific acyl-CoA dehydrogenase, mitochondrial,Butyryl-CoA dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005813;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0003995;GO:0004085;GO:0050660;GO:0046359;GO:0006635;GO:0033539;, C:centrosome; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:acyl-CoA dehydrogenase activity; F:butyryl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding;, P:butyrate catabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase;|P16219 P78331,Short-chain specific acyl-CoA dehydrogenase, mitochondrial,Butyryl-CoA dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005813;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0003995;GO:0004085;GO:0050660;GO:0046359;GO:0006635;GO:0033539;, C:centrosome; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:acyl-CoA dehydrogenase activity; F:butyryl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding;, P:butyrate catabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase;|P16219 P78331,Short-chain specific acyl-CoA dehydrogenase, mitochondrial,Butyryl-CoA dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005813;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0003995;GO:0004085;GO:0050660;GO:0046359;GO:0006635;GO:0033539;, C:centrosome; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:acyl-CoA dehydrogenase activity; F:butyryl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding;, P:butyrate catabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; scaffold60 indexed_genome mRNA 4166532 4264079 . - . ID=transcript_10428;Q8TCT6 Q3MJ04 Q8TAU4 Q96DD9,Signal peptide peptidase-like 3 {ECO:0000303|PubMed:12077416, ECO:0000312|HGNC:HGNC:30424},Intramembrane protease 2 {ECO:0000303|PubMed:12139484};Presenilin homologous protein 1 {ECO:0000303|PubMed:11978763};Presenilin-like protein 4 {ECO:0000303|Ref.1};, PF04258;, GO:0033116;GO:0005794;GO:0030660;GO:0071458;GO:0071556;GO:0043231;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0042803;GO:0033619;GO:0070886;GO:0007204;GO:0032092;GO:0035307;GO:0006465;GO:0050852;, C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein proteolysis; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of protein dephosphorylation; P:signal peptide processing; P:T cell receptor signaling pathway;|Q8TCT6 Q3MJ04 Q8TAU4 Q96DD9,Signal peptide peptidase-like 3 {ECO:0000303|PubMed:12077416, ECO:0000312|HGNC:HGNC:30424},Intramembrane protease 2 {ECO:0000303|PubMed:12139484};Presenilin homologous protein 1 {ECO:0000303|PubMed:11978763};Presenilin-like protein 4 {ECO:0000303|Ref.1};, PF04258;, GO:0033116;GO:0005794;GO:0030660;GO:0071458;GO:0071556;GO:0043231;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0042803;GO:0033619;GO:0070886;GO:0007204;GO:0032092;GO:0035307;GO:0006465;GO:0050852;, C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein proteolysis; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of protein dephosphorylation; P:signal peptide processing; P:T cell receptor signaling pathway;|Q8TCT6 Q3MJ04 Q8TAU4 Q96DD9,Signal peptide peptidase-like 3 {ECO:0000303|PubMed:12077416, ECO:0000312|HGNC:HGNC:30424},Intramembrane protease 2 {ECO:0000303|PubMed:12139484};Presenilin homologous protein 1 {ECO:0000303|PubMed:11978763};Presenilin-like protein 4 {ECO:0000303|Ref.1};, PF04258;, GO:0033116;GO:0005794;GO:0030660;GO:0071458;GO:0071556;GO:0043231;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0042803;GO:0033619;GO:0070886;GO:0007204;GO:0032092;GO:0035307;GO:0006465;GO:0050852;, C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein proteolysis; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of protein dephosphorylation; P:signal peptide processing; P:T cell receptor signaling pathway;|Q8TCT6 Q3MJ04 Q8TAU4 Q96DD9,Signal peptide peptidase-like 3 {ECO:0000303|PubMed:12077416, ECO:0000312|HGNC:HGNC:30424},Intramembrane protease 2 {ECO:0000303|PubMed:12139484};Presenilin homologous protein 1 {ECO:0000303|PubMed:11978763};Presenilin-like protein 4 {ECO:0000303|Ref.1};, PF04258;, GO:0033116;GO:0005794;GO:0030660;GO:0071458;GO:0071556;GO:0043231;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0042803;GO:0033619;GO:0070886;GO:0007204;GO:0032092;GO:0035307;GO:0006465;GO:0050852;, C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein proteolysis; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of protein dephosphorylation; P:signal peptide processing; P:T cell receptor signaling pathway;|Q8TCT6 Q3MJ04 Q8TAU4 Q96DD9,Signal peptide peptidase-like 3 {ECO:0000303|PubMed:12077416, ECO:0000312|HGNC:HGNC:30424},Intramembrane protease 2 {ECO:0000303|PubMed:12139484};Presenilin homologous protein 1 {ECO:0000303|PubMed:11978763};Presenilin-like protein 4 {ECO:0000303|Ref.1};, PF04258;, GO:0033116;GO:0005794;GO:0030660;GO:0071458;GO:0071556;GO:0043231;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0042803;GO:0033619;GO:0070886;GO:0007204;GO:0032092;GO:0035307;GO:0006465;GO:0050852;, C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein proteolysis; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of protein dephosphorylation; P:signal peptide processing; P:T cell receptor signaling pathway; scaffold60 indexed_genome mRNA 4315845 4329997 . + . ID=transcript_10429;Q99861,Hepatocyte nuclear factor 1-alpha,Liver-specific transcription factor LF-B1;Transcription factor 1;, PF04814;PF04813;PF04812;, GO:0000785;GO:0005737;GO:0005634;GO:0032991;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046983;GO:0046982;GO:0042803;GO:0000978;GO:0000976;GO:0042593;GO:0046323;GO:0030073;GO:0001889;GO:0031016;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0035623;, C:chromatin; C:cytoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:glucose homeostasis; P:glucose import; P:insulin secretion; P:liver development; P:pancreas development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:renal glucose absorption; scaffold60 indexed_genome mRNA 4388417 4391053 . - . ID=transcript_10430;Q8N812,Uncharacterized protein C12orf76,, PF17695; scaffold60 indexed_genome mRNA 4397152 4404448 . - . ID=transcript_10431;Q8IZ07 O60736,Ankyrin repeat domain-containing protein 13A,Protein KE03;, PF11904;, GO:0005737;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:1905667;GO:0002091;, C:cytoplasm; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of protein localization to endosome; P:negative regulation of receptor internalization;|Q8IZ07 O60736,Ankyrin repeat domain-containing protein 13A,Protein KE03;, PF11904;, GO:0005737;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:1905667;GO:0002091;, C:cytoplasm; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of protein localization to endosome; P:negative regulation of receptor internalization;|Q8IZ07 O60736,Ankyrin repeat domain-containing protein 13A,Protein KE03;, PF11904;, GO:0005737;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:1905667;GO:0002091;, C:cytoplasm; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of protein localization to endosome; P:negative regulation of receptor internalization; scaffold60 indexed_genome mRNA 4404546 4405110 . + . ID=transcript_10432;Q8IZ07 O60736,Ankyrin repeat domain-containing protein 13A,Protein KE03;, PF11904;, GO:0005737;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:1905667;GO:0002091;, C:cytoplasm; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of protein localization to endosome; P:negative regulation of receptor internalization; scaffold60 indexed_genome mRNA 4405386 4436112 . - . ID=transcript_10433;Q8IZ07 O60736,Ankyrin repeat domain-containing protein 13A,Protein KE03;, PF11904;, GO:0005737;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:1905667;GO:0002091;, C:cytoplasm; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of protein localization to endosome; P:negative regulation of receptor internalization;|Q8IZ07 O60736,Ankyrin repeat domain-containing protein 13A,Protein KE03;, PF11904;, GO:0005737;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:1905667;GO:0002091;, C:cytoplasm; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of protein localization to endosome; P:negative regulation of receptor internalization; scaffold60 indexed_genome mRNA 4439768 4467333 . + . ID=transcript_10434;Q14161 Q86U59 Q96CI2 Q9BV91 Q9Y5V2,ARF GTPase-activating protein GIT2,Cool-interacting tyrosine-phosphorylated protein 2;G protein-coupled receptor kinase-interactor 2;GRK-interacting protein 2;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0005925;GO:0005654;GO:0005096;GO:0046872;GO:0008277;, C:focal adhesion; C:nucleoplasm;, F:GTPase activator activity; F:metal ion binding;, P:regulation of G protein-coupled receptor signaling pathway;|Q14161 Q86U59 Q96CI2 Q9BV91 Q9Y5V2,ARF GTPase-activating protein GIT2,Cool-interacting tyrosine-phosphorylated protein 2;G protein-coupled receptor kinase-interactor 2;GRK-interacting protein 2;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0005925;GO:0005654;GO:0005096;GO:0046872;GO:0008277;, C:focal adhesion; C:nucleoplasm;, F:GTPase activator activity; F:metal ion binding;, P:regulation of G protein-coupled receptor signaling pathway;|Q14161 Q86U59 Q96CI2 Q9BV91 Q9Y5V2,ARF GTPase-activating protein GIT2,Cool-interacting tyrosine-phosphorylated protein 2;G protein-coupled receptor kinase-interactor 2;GRK-interacting protein 2;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0005925;GO:0005654;GO:0005096;GO:0046872;GO:0008277;, C:focal adhesion; C:nucleoplasm;, F:GTPase activator activity; F:metal ion binding;, P:regulation of G protein-coupled receptor signaling pathway;|Q14161 Q86U59 Q96CI2 Q9BV91 Q9Y5V2,ARF GTPase-activating protein GIT2,Cool-interacting tyrosine-phosphorylated protein 2;G protein-coupled receptor kinase-interactor 2;GRK-interacting protein 2;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0005925;GO:0005654;GO:0005096;GO:0046872;GO:0008277;, C:focal adhesion; C:nucleoplasm;, F:GTPase activator activity; F:metal ion binding;, P:regulation of G protein-coupled receptor signaling pathway; scaffold60 indexed_genome mRNA 4467374 4467971 . - . ID=transcript_10435;Q14161 Q86U59 Q96CI2 Q9BV91 Q9Y5V2,ARF GTPase-activating protein GIT2,Cool-interacting tyrosine-phosphorylated protein 2;G protein-coupled receptor kinase-interactor 2;GRK-interacting protein 2;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0005925;GO:0005654;GO:0005096;GO:0046872;GO:0008277;, C:focal adhesion; C:nucleoplasm;, F:GTPase activator activity; F:metal ion binding;, P:regulation of G protein-coupled receptor signaling pathway; scaffold60 indexed_genome mRNA 4467974 4471588 . + . ID=transcript_10436;Q14161 Q86U59 Q96CI2 Q9BV91 Q9Y5V2,ARF GTPase-activating protein GIT2,Cool-interacting tyrosine-phosphorylated protein 2;G protein-coupled receptor kinase-interactor 2;GRK-interacting protein 2;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0005925;GO:0005654;GO:0005096;GO:0046872;GO:0008277;, C:focal adhesion; C:nucleoplasm;, F:GTPase activator activity; F:metal ion binding;, P:regulation of G protein-coupled receptor signaling pathway; scaffold60 indexed_genome mRNA 4471892 4480957 . - . ID=transcript_10437;Q14161 Q86U59 Q96CI2 Q9BV91 Q9Y5V2,ARF GTPase-activating protein GIT2,Cool-interacting tyrosine-phosphorylated protein 2;G protein-coupled receptor kinase-interactor 2;GRK-interacting protein 2;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0005925;GO:0005654;GO:0005096;GO:0046872;GO:0008277;, C:focal adhesion; C:nucleoplasm;, F:GTPase activator activity; F:metal ion binding;, P:regulation of G protein-coupled receptor signaling pathway;|Q14161 Q86U59 Q96CI2 Q9BV91 Q9Y5V2,ARF GTPase-activating protein GIT2,Cool-interacting tyrosine-phosphorylated protein 2;G protein-coupled receptor kinase-interactor 2;GRK-interacting protein 2;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0005925;GO:0005654;GO:0005096;GO:0046872;GO:0008277;, C:focal adhesion; C:nucleoplasm;, F:GTPase activator activity; F:metal ion binding;, P:regulation of G protein-coupled receptor signaling pathway;|Q14161 Q86U59 Q96CI2 Q9BV91 Q9Y5V2,ARF GTPase-activating protein GIT2,Cool-interacting tyrosine-phosphorylated protein 2;G protein-coupled receptor kinase-interactor 2;GRK-interacting protein 2;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0005925;GO:0005654;GO:0005096;GO:0046872;GO:0008277;, C:focal adhesion; C:nucleoplasm;, F:GTPase activator activity; F:metal ion binding;, P:regulation of G protein-coupled receptor signaling pathway;|Q14161 Q86U59 Q96CI2 Q9BV91 Q9Y5V2,ARF GTPase-activating protein GIT2,Cool-interacting tyrosine-phosphorylated protein 2;G protein-coupled receptor kinase-interactor 2;GRK-interacting protein 2;, PF12796;PF01412;PF12205;PF16559;PF08518;, GO:0005925;GO:0005654;GO:0005096;GO:0046872;GO:0008277;, C:focal adhesion; C:nucleoplasm;, F:GTPase activator activity; F:metal ion binding;, P:regulation of G protein-coupled receptor signaling pathway; scaffold60 indexed_genome mRNA 4485153 4498911 . - . ID=transcript_10438;Q9BT92 Q8NAG0,Trichoplein keratin filament-binding protein,Mitochondrial protein with oncostatic activity;Tumor suppressor protein;, PF13868;, GO:0045179;GO:0005813;GO:0005737;GO:0005829;GO:0030057;GO:0045095;GO:0005739;GO:0005886;GO:0006915;GO:0030030;GO:0030308;GO:1902018;, C:apical cortex; C:centrosome; C:cytoplasm; C:cytosol; C:desmosome; C:keratin filament; C:mitochondrion; C:plasma membrane;, , P:apoptotic process; P:cell projection organization; P:negative regulation of cell growth; P:negative regulation of cilium assembly; scaffold60 indexed_genome mRNA 4525929 4535676 . + . ID=transcript_10439;Q9NZD2 Q53Z13 Q96J68,Glycolipid transfer protein,, PF08718;, GO:0005829;GO:0016020;GO:1902387;GO:1902388;GO:0051861;GO:0042802;GO:0008289;GO:0120013;GO:0035627;GO:0046836;GO:0006687;GO:0120009;, C:cytosol; C:membrane;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:glycolipid binding; F:identical protein binding; F:lipid binding; F:lipid transfer activity;, P:ceramide transport; P:glycolipid transport; P:glycosphingolipid metabolic process; P:intermembrane lipid transfer;|Q9NZD2 Q53Z13 Q96J68,Glycolipid transfer protein,, PF08718;, GO:0005829;GO:0016020;GO:1902387;GO:1902388;GO:0051861;GO:0042802;GO:0008289;GO:0120013;GO:0035627;GO:0046836;GO:0006687;GO:0120009;, C:cytosol; C:membrane;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:glycolipid binding; F:identical protein binding; F:lipid binding; F:lipid transfer activity;, P:ceramide transport; P:glycolipid transport; P:glycosphingolipid metabolic process; P:intermembrane lipid transfer;|Q9NZD2 Q53Z13 Q96J68,Glycolipid transfer protein,, PF08718;, GO:0005829;GO:0016020;GO:1902387;GO:1902388;GO:0051861;GO:0042802;GO:0008289;GO:0120013;GO:0035627;GO:0046836;GO:0006687;GO:0120009;, C:cytosol; C:membrane;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:glycolipid binding; F:identical protein binding; F:lipid binding; F:lipid transfer activity;, P:ceramide transport; P:glycolipid transport; P:glycosphingolipid metabolic process; P:intermembrane lipid transfer; scaffold60 indexed_genome mRNA 4536306 4538057 . + . ID=transcript_10440;Q9NZD2 Q53Z13 Q96J68,Glycolipid transfer protein,, PF08718;, GO:0005829;GO:0016020;GO:1902387;GO:1902388;GO:0051861;GO:0042802;GO:0008289;GO:0120013;GO:0035627;GO:0046836;GO:0006687;GO:0120009;, C:cytosol; C:membrane;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:glycolipid binding; F:identical protein binding; F:lipid binding; F:lipid transfer activity;, P:ceramide transport; P:glycolipid transport; P:glycosphingolipid metabolic process; P:intermembrane lipid transfer;|Q9NZD2 Q53Z13 Q96J68,Glycolipid transfer protein,, PF08718;, GO:0005829;GO:0016020;GO:1902387;GO:1902388;GO:0051861;GO:0042802;GO:0008289;GO:0120013;GO:0035627;GO:0046836;GO:0006687;GO:0120009;, C:cytosol; C:membrane;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:glycolipid binding; F:identical protein binding; F:lipid binding; F:lipid transfer activity;, P:ceramide transport; P:glycolipid transport; P:glycosphingolipid metabolic process; P:intermembrane lipid transfer; scaffold60 indexed_genome mRNA 4576899 4590374 . + . ID=transcript_10441;Q96Q92 Q96RS7 Q9HBC0,Transient receptor potential cation channel subfamily V member 4,Osm-9-like TRP channel 4;Transient receptor potential protein 12;Vanilloid receptor-like channel 2;Vanilloid receptor-like protein 2;Vanilloid receptor-related osmotically-activated channel {ECO:0000303|PubMed:11081638};, PF00023;PF00520;, GO:0005912;GO:0016324;GO:0005929;GO:0030864;GO:0005783;GO:0030175;GO:0005925;GO:0030426;GO:0016021;GO:0005887;GO:0030027;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0043014;GO:0005524;GO:0048487;GO:0005262;GO:0005516;GO:0005261;GO:0042802;GO:0005216;GO:0008289;GO:0046872;GO:0008017;GO:0019901;GO:0005080;GO:0042169;GO:0015275;GO:0031532;GO:0007015;GO:0097497;GO:0070509;GO:0098703;GO:1902656;GO:0070588;GO:0006816;GO:0060351;GO:0006884;GO:0007043;GO:0006874;GO:0071476;GO:0034605;GO:0071470;GO:0043622;GO:0046785;GO:0050891;GO:0010977;GO:0007231;GO:0007204;GO:0031117;GO:0043117;GO:0009612;, C:adherens junction; C:apical plasma membrane; C:cilium; C:cortical actin cytoskeleton; C:endoplasmic reticulum; C:filopodium; C:focal adhesion; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:lamellipodium; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:alpha-tubulin binding; F:ATP binding; F:beta-tubulin binding; F:calcium channel activity; F:calmodulin binding; F:cation channel activity; F:identical protein binding; F:ion channel activity; F:lipid binding; F:metal ion binding; F:microtubule binding; F:protein kinase binding; F:protein kinase C binding; F:SH2 domain binding; F:stretch-activated, cation-selective, calcium channel activity;, P:actin cytoskeleton reorganization; P:actin filament organization; P:blood vessel endothelial cell delamination; P:calcium ion import; P:calcium ion import across plasma membrane; P:calcium ion import into cytosol; P:calcium ion transmembrane transport; P:calcium ion transport; P:cartilage development involved in endochondral bone morphogenesis; P:cell volume homeostasis; P:cell-cell junction assembly; P:cellular calcium ion homeostasis; P:cellular hypotonic response; P:cellular response to heat; P:cellular response to osmotic stress; P:cortical microtubule organization; P:microtubule polymerization; P:multicellular organismal water homeostasis; P:negative regulation of neuron projection development; P:osmosensory signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of microtubule depolymerization; P:positive regulation of vascular permeability; P:response to mechanical stimulus; scaffold60 indexed_genome mRNA 4762502 4789081 . + . ID=transcript_10442;Q03426,Mevalonate kinase {ECO:0000305},, PF08544;PF00288;, GO:0005829;GO:0043231;GO:0005777;GO:0005524;GO:0042802;GO:0000287;GO:0004496;GO:0006695;GO:0019287;GO:0008299;GO:0050728;GO:0019216;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisome;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:mevalonate kinase activity;, P:cholesterol biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:isoprenoid biosynthetic process; P:negative regulation of inflammatory response; P:regulation of lipid metabolic process;|Q03426,Mevalonate kinase {ECO:0000305},, PF08544;PF00288;, GO:0005829;GO:0043231;GO:0005777;GO:0005524;GO:0042802;GO:0000287;GO:0004496;GO:0006695;GO:0019287;GO:0008299;GO:0050728;GO:0019216;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisome;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:mevalonate kinase activity;, P:cholesterol biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:isoprenoid biosynthetic process; P:negative regulation of inflammatory response; P:regulation of lipid metabolic process;|Q03426,Mevalonate kinase {ECO:0000305},, PF08544;PF00288;, GO:0005829;GO:0043231;GO:0005777;GO:0005524;GO:0042802;GO:0000287;GO:0004496;GO:0006695;GO:0019287;GO:0008299;GO:0050728;GO:0019216;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisome;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:mevalonate kinase activity;, P:cholesterol biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:isoprenoid biosynthetic process; P:negative regulation of inflammatory response; P:regulation of lipid metabolic process;|Q03426,Mevalonate kinase {ECO:0000305},, PF08544;PF00288;, GO:0005829;GO:0043231;GO:0005777;GO:0005524;GO:0042802;GO:0000287;GO:0004496;GO:0006695;GO:0019287;GO:0008299;GO:0050728;GO:0019216;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisome;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:mevalonate kinase activity;, P:cholesterol biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:isoprenoid biosynthetic process; P:negative regulation of inflammatory response; P:regulation of lipid metabolic process;|Q03426,Mevalonate kinase {ECO:0000305},, PF08544;PF00288;, GO:0005829;GO:0043231;GO:0005777;GO:0005524;GO:0042802;GO:0000287;GO:0004496;GO:0006695;GO:0019287;GO:0008299;GO:0050728;GO:0019216;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisome;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:mevalonate kinase activity;, P:cholesterol biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:isoprenoid biosynthetic process; P:negative regulation of inflammatory response; P:regulation of lipid metabolic process;|Q03426,Mevalonate kinase {ECO:0000305},, PF08544;PF00288;, GO:0005829;GO:0043231;GO:0005777;GO:0005524;GO:0042802;GO:0000287;GO:0004496;GO:0006695;GO:0019287;GO:0008299;GO:0050728;GO:0019216;, C:cytosol; C:intracellular membrane-bounded organelle; C:peroxisome;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:mevalonate kinase activity;, P:cholesterol biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; P:isoprenoid biosynthetic process; P:negative regulation of inflammatory response; P:regulation of lipid metabolic process; scaffold60 indexed_genome mRNA 4791890 4802996 . + . ID=transcript_10443;Q96EY8 C5HU05 Q9BSH0,Corrinoid adenosyltransferase,Cob(II)alamin adenosyltransferase;Cob(II)yrinic acid a,c-diamide adenosyltransferase;Cobinamide/cobalamin adenosyltransferase;Methylmalonic aciduria type B protein;, PF01923;, GO:0005759;GO:0005524;GO:0008817;GO:0031419;GO:0009235;, C:mitochondrial matrix;, F:ATP binding; F:cob(I)yrinic acid a,c-diamide adenosyltransferase activity; F:cobalamin binding;, P:cobalamin metabolic process;|Q96EY8 C5HU05 Q9BSH0,Corrinoid adenosyltransferase,Cob(II)alamin adenosyltransferase;Cob(II)yrinic acid a,c-diamide adenosyltransferase;Cobinamide/cobalamin adenosyltransferase;Methylmalonic aciduria type B protein;, PF01923;, GO:0005759;GO:0005524;GO:0008817;GO:0031419;GO:0009235;, C:mitochondrial matrix;, F:ATP binding; F:cob(I)yrinic acid a,c-diamide adenosyltransferase activity; F:cobalamin binding;, P:cobalamin metabolic process;|Q96EY8 C5HU05 Q9BSH0,Corrinoid adenosyltransferase,Cob(II)alamin adenosyltransferase;Cob(II)yrinic acid a,c-diamide adenosyltransferase;Cobinamide/cobalamin adenosyltransferase;Methylmalonic aciduria type B protein;, PF01923;, GO:0005759;GO:0005524;GO:0008817;GO:0031419;GO:0009235;, C:mitochondrial matrix;, F:ATP binding; F:cob(I)yrinic acid a,c-diamide adenosyltransferase activity; F:cobalamin binding;, P:cobalamin metabolic process;|Q96EY8 C5HU05 Q9BSH0,Corrinoid adenosyltransferase,Cob(II)alamin adenosyltransferase;Cob(II)yrinic acid a,c-diamide adenosyltransferase;Cobinamide/cobalamin adenosyltransferase;Methylmalonic aciduria type B protein;, PF01923;, GO:0005759;GO:0005524;GO:0008817;GO:0031419;GO:0009235;, C:mitochondrial matrix;, F:ATP binding; F:cob(I)yrinic acid a,c-diamide adenosyltransferase activity; F:cobalamin binding;, P:cobalamin metabolic process; scaffold60 indexed_genome mRNA 4813538 4861272 . - . ID=transcript_10444;Q7Z3V4 A5D8Z3 Q05BX9 Q659F7 Q7Z7Q1 Q9BXZ4,Ubiquitin-protein ligase E3B,HECT-type ubiquitin transferase E3B;, PF00632;, GO:0061630;GO:0000209;GO:0006511;, , F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q7Z3V4 A5D8Z3 Q05BX9 Q659F7 Q7Z7Q1 Q9BXZ4,Ubiquitin-protein ligase E3B,HECT-type ubiquitin transferase E3B;, PF00632;, GO:0061630;GO:0000209;GO:0006511;, , F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q7Z3V4 A5D8Z3 Q05BX9 Q659F7 Q7Z7Q1 Q9BXZ4,Ubiquitin-protein ligase E3B,HECT-type ubiquitin transferase E3B;, PF00632;, GO:0061630;GO:0000209;GO:0006511;, , F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q7Z3V4 A5D8Z3 Q05BX9 Q659F7 Q7Z7Q1 Q9BXZ4,Ubiquitin-protein ligase E3B,HECT-type ubiquitin transferase E3B;, PF00632;, GO:0061630;GO:0000209;GO:0006511;, , F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q7Z3V4 A5D8Z3 Q05BX9 Q659F7 Q7Z7Q1 Q9BXZ4,Ubiquitin-protein ligase E3B,HECT-type ubiquitin transferase E3B;, PF00632;, GO:0061630;GO:0000209;GO:0006511;, , F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q7Z3V4 A5D8Z3 Q05BX9 Q659F7 Q7Z7Q1 Q9BXZ4,Ubiquitin-protein ligase E3B,HECT-type ubiquitin transferase E3B;, PF00632;, GO:0061630;GO:0000209;GO:0006511;, , F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q7Z3V4 A5D8Z3 Q05BX9 Q659F7 Q7Z7Q1 Q9BXZ4,Ubiquitin-protein ligase E3B,HECT-type ubiquitin transferase E3B;, PF00632;, GO:0061630;GO:0000209;GO:0006511;, , F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q7Z3V4 A5D8Z3 Q05BX9 Q659F7 Q7Z7Q1 Q9BXZ4,Ubiquitin-protein ligase E3B,HECT-type ubiquitin transferase E3B;, PF00632;, GO:0061630;GO:0000209;GO:0006511;, , F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold60 indexed_genome mRNA 5019398 5047795 . - . ID=transcript_10445;O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|Q86WB2 Q86WB3,Acetyl-CoA carboxylase 1 {ECO:0000303|PubMed:12810950},Acetyl-Coenzyme A carboxylase alpha;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0015629;GO:0005829;GO:0001650;GO:0003989;GO:0005524;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0071380;GO:0006633;GO:0046949;GO:0055088;GO:2001295;GO:0031325;GO:0051289;GO:0019538;GO:0019216;GO:0001894;, C:actin cytoskeleton; C:cytosol; C:fibrillar center;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:cellular response to prostaglandin E stimulus; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid homeostasis; P:malonyl-CoA biosynthetic process; P:positive regulation of cellular metabolic process; P:protein homotetramerization; P:protein metabolic process; P:regulation of lipid metabolic process; P:tissue homeostasis;|O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound;|Q86WB2 Q86WB3,Acetyl-CoA carboxylase 1 {ECO:0000303|PubMed:12810950},Acetyl-Coenzyme A carboxylase alpha;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0015629;GO:0005829;GO:0001650;GO:0003989;GO:0005524;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0071380;GO:0006633;GO:0046949;GO:0055088;GO:2001295;GO:0031325;GO:0051289;GO:0019538;GO:0019216;GO:0001894;, C:actin cytoskeleton; C:cytosol; C:fibrillar center;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:cellular response to prostaglandin E stimulus; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid homeostasis; P:malonyl-CoA biosynthetic process; P:positive regulation of cellular metabolic process; P:protein homotetramerization; P:protein metabolic process; P:regulation of lipid metabolic process; P:tissue homeostasis;|Q86WB2 Q86WB3,Acetyl-CoA carboxylase 1 {ECO:0000303|PubMed:12810950},Acetyl-Coenzyme A carboxylase alpha;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0015629;GO:0005829;GO:0001650;GO:0003989;GO:0005524;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0071380;GO:0006633;GO:0046949;GO:0055088;GO:2001295;GO:0031325;GO:0051289;GO:0019538;GO:0019216;GO:0001894;, C:actin cytoskeleton; C:cytosol; C:fibrillar center;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:cellular response to prostaglandin E stimulus; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid homeostasis; P:malonyl-CoA biosynthetic process; P:positive regulation of cellular metabolic process; P:protein homotetramerization; P:protein metabolic process; P:regulation of lipid metabolic process; P:tissue homeostasis; scaffold60 indexed_genome mRNA 5056421 5057044 . + . ID=transcript_10446;O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound; scaffold60 indexed_genome mRNA 5068469 5068973 . - . ID=transcript_10447;O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound; scaffold60 indexed_genome mRNA 5072739 5073353 . + . ID=transcript_10448;O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound; scaffold60 indexed_genome mRNA 5081318 5083362 . - . ID=transcript_10449;O00763 A6NK36 Q16852 Q1HEC1 Q6KE87 Q6KE89 Q6TY48,Acetyl-CoA carboxylase 2 {ECO:0000305},ACC-beta;, PF08326;PF02785;PF00289;PF00364;PF01039;PF02786;, GO:0005829;GO:0005741;GO:0005739;GO:0005634;GO:0003989;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0006084;GO:0006853;GO:0097009;GO:0006633;GO:2001295;GO:0043086;GO:0031999;GO:0010629;GO:0031325;GO:0060421;GO:0010884;GO:0051289;GO:0010906;GO:0019216;GO:0042493;GO:0031667;GO:0014070;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus;, F:acetyl-CoA carboxylase activity; F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding;, P:acetyl-CoA metabolic process; P:carnitine shuttle; P:energy homeostasis; P:fatty acid biosynthetic process; P:malonyl-CoA biosynthetic process; P:negative regulation of catalytic activity; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:positive regulation of cellular metabolic process; P:positive regulation of heart growth; P:positive regulation of lipid storage; P:protein homotetramerization; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; P:response to drug; P:response to nutrient levels; P:response to organic cyclic compound; scaffold60 indexed_genome mRNA 5109937 5177511 . + . ID=transcript_10450;Q8N4V2 Q9NPW5,Synaptic vesicle 2-related protein,, PF07690;PF00083;, GO:0016021;GO:0008021;GO:0030672;GO:0022857;, C:integral component of membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:transmembrane transporter activity;|Q8N4V2 Q9NPW5,Synaptic vesicle 2-related protein,, PF07690;PF00083;, GO:0016021;GO:0008021;GO:0030672;GO:0022857;, C:integral component of membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:transmembrane transporter activity;|Q8N4V2 Q9NPW5,Synaptic vesicle 2-related protein,, PF07690;PF00083;, GO:0016021;GO:0008021;GO:0030672;GO:0022857;, C:integral component of membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:transmembrane transporter activity;|Q8N4V2 Q9NPW5,Synaptic vesicle 2-related protein,, PF07690;PF00083;, GO:0016021;GO:0008021;GO:0030672;GO:0022857;, C:integral component of membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:transmembrane transporter activity;|Q8N4V2 Q9NPW5,Synaptic vesicle 2-related protein,, PF07690;PF00083;, GO:0016021;GO:0008021;GO:0030672;GO:0022857;, C:integral component of membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:transmembrane transporter activity;|Q8N4V2 Q9NPW5,Synaptic vesicle 2-related protein,, PF07690;PF00083;, GO:0016021;GO:0008021;GO:0030672;GO:0022857;, C:integral component of membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:transmembrane transporter activity;|Q8N4V2 Q9NPW5,Synaptic vesicle 2-related protein,, PF07690;PF00083;, GO:0016021;GO:0008021;GO:0030672;GO:0022857;, C:integral component of membrane; C:synaptic vesicle; C:synaptic vesicle membrane;, F:transmembrane transporter activity; scaffold60 indexed_genome mRNA 5185174 5198254 . - . ID=transcript_10451;P14920 B2R7I5 Q16758 Q8N6R2,D-amino-acid oxidase,, PF01266;, GO:0005737;GO:0005829;GO:0005782;GO:0005778;GO:0005777;GO:0003884;GO:0071949;GO:0042802;GO:0019752;GO:0055130;GO:0019478;GO:0036088;GO:0070178;GO:0042416;GO:0006562;GO:0008104;, C:cytoplasm; C:cytosol; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:D-amino-acid oxidase activity; F:FAD binding; F:identical protein binding;, P:carboxylic acid metabolic process; P:D-alanine catabolic process; P:D-amino acid catabolic process; P:D-serine catabolic process; P:D-serine metabolic process; P:dopamine biosynthetic process; P:proline catabolic process; P:protein localization;|P14920 B2R7I5 Q16758 Q8N6R2,D-amino-acid oxidase,, PF01266;, GO:0005737;GO:0005829;GO:0005782;GO:0005778;GO:0005777;GO:0003884;GO:0071949;GO:0042802;GO:0019752;GO:0055130;GO:0019478;GO:0036088;GO:0070178;GO:0042416;GO:0006562;GO:0008104;, C:cytoplasm; C:cytosol; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:D-amino-acid oxidase activity; F:FAD binding; F:identical protein binding;, P:carboxylic acid metabolic process; P:D-alanine catabolic process; P:D-amino acid catabolic process; P:D-serine catabolic process; P:D-serine metabolic process; P:dopamine biosynthetic process; P:proline catabolic process; P:protein localization; scaffold60 indexed_genome mRNA 5238776 5267902 . + . ID=transcript_10452;Q8WYL5 Q6P6C0 Q8N9A7 Q8WYL3 Q8WYL4 Q9P2P8,Protein phosphatase Slingshot homolog 1,SSH-like protein 1;, PF08766;, GO:0032154;GO:0005737;GO:0005856;GO:0005829;GO:0030426;GO:0030027;GO:0030496;GO:0005886;GO:0045202;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0000902;GO:0071318;GO:0098976;GO:0030837;GO:1904719;GO:2000463;GO:1901216;GO:0031915;GO:1904754;GO:0006470;GO:0032268;, C:cleavage furrow; C:cytoplasm; C:cytoskeleton; C:cytosol; C:growth cone; C:lamellipodium; C:midbody; C:plasma membrane; C:synapse;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:cell morphogenesis; P:cellular response to ATP; P:excitatory chemical synaptic transmission; P:negative regulation of actin filament polymerization; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron death; P:positive regulation of synaptic plasticity; P:positive regulation of vascular associated smooth muscle cell migration; P:protein dephosphorylation; P:regulation of cellular protein metabolic process;|Q8WYL5 Q6P6C0 Q8N9A7 Q8WYL3 Q8WYL4 Q9P2P8,Protein phosphatase Slingshot homolog 1,SSH-like protein 1;, PF08766;, GO:0032154;GO:0005737;GO:0005856;GO:0005829;GO:0030426;GO:0030027;GO:0030496;GO:0005886;GO:0045202;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0000902;GO:0071318;GO:0098976;GO:0030837;GO:1904719;GO:2000463;GO:1901216;GO:0031915;GO:1904754;GO:0006470;GO:0032268;, C:cleavage furrow; C:cytoplasm; C:cytoskeleton; C:cytosol; C:growth cone; C:lamellipodium; C:midbody; C:plasma membrane; C:synapse;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:cell morphogenesis; P:cellular response to ATP; P:excitatory chemical synaptic transmission; P:negative regulation of actin filament polymerization; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron death; P:positive regulation of synaptic plasticity; P:positive regulation of vascular associated smooth muscle cell migration; P:protein dephosphorylation; P:regulation of cellular protein metabolic process;|Q8WYL5 Q6P6C0 Q8N9A7 Q8WYL3 Q8WYL4 Q9P2P8,Protein phosphatase Slingshot homolog 1,SSH-like protein 1;, PF08766;, GO:0032154;GO:0005737;GO:0005856;GO:0005829;GO:0030426;GO:0030027;GO:0030496;GO:0005886;GO:0045202;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0000902;GO:0071318;GO:0098976;GO:0030837;GO:1904719;GO:2000463;GO:1901216;GO:0031915;GO:1904754;GO:0006470;GO:0032268;, C:cleavage furrow; C:cytoplasm; C:cytoskeleton; C:cytosol; C:growth cone; C:lamellipodium; C:midbody; C:plasma membrane; C:synapse;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:cell morphogenesis; P:cellular response to ATP; P:excitatory chemical synaptic transmission; P:negative regulation of actin filament polymerization; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron death; P:positive regulation of synaptic plasticity; P:positive regulation of vascular associated smooth muscle cell migration; P:protein dephosphorylation; P:regulation of cellular protein metabolic process;|Q8WYL5 Q6P6C0 Q8N9A7 Q8WYL3 Q8WYL4 Q9P2P8,Protein phosphatase Slingshot homolog 1,SSH-like protein 1;, PF08766;, GO:0032154;GO:0005737;GO:0005856;GO:0005829;GO:0030426;GO:0030027;GO:0030496;GO:0005886;GO:0045202;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0000902;GO:0071318;GO:0098976;GO:0030837;GO:1904719;GO:2000463;GO:1901216;GO:0031915;GO:1904754;GO:0006470;GO:0032268;, C:cleavage furrow; C:cytoplasm; C:cytoskeleton; C:cytosol; C:growth cone; C:lamellipodium; C:midbody; C:plasma membrane; C:synapse;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:cell morphogenesis; P:cellular response to ATP; P:excitatory chemical synaptic transmission; P:negative regulation of actin filament polymerization; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron death; P:positive regulation of synaptic plasticity; P:positive regulation of vascular associated smooth muscle cell migration; P:protein dephosphorylation; P:regulation of cellular protein metabolic process;|Q8WYL5 Q6P6C0 Q8N9A7 Q8WYL3 Q8WYL4 Q9P2P8,Protein phosphatase Slingshot homolog 1,SSH-like protein 1;, PF08766;, GO:0032154;GO:0005737;GO:0005856;GO:0005829;GO:0030426;GO:0030027;GO:0030496;GO:0005886;GO:0045202;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0000902;GO:0071318;GO:0098976;GO:0030837;GO:1904719;GO:2000463;GO:1901216;GO:0031915;GO:1904754;GO:0006470;GO:0032268;, C:cleavage furrow; C:cytoplasm; C:cytoskeleton; C:cytosol; C:growth cone; C:lamellipodium; C:midbody; C:plasma membrane; C:synapse;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:cell morphogenesis; P:cellular response to ATP; P:excitatory chemical synaptic transmission; P:negative regulation of actin filament polymerization; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron death; P:positive regulation of synaptic plasticity; P:positive regulation of vascular associated smooth muscle cell migration; P:protein dephosphorylation; P:regulation of cellular protein metabolic process; scaffold60 indexed_genome mRNA 5329983 5375628 . + . ID=transcript_10453;Q9ULV4 A7MAP0 A7MAP1 B3KU12 Q9NSK5,Coronin-1C,Coronin-3 {ECO:0000303|PubMed:12377779};hCRNN4;, PF08953;PF00400;, GO:0015629;GO:0005938;GO:0010008;GO:0016600;GO:0005925;GO:0030027;GO:0016328;GO:0032587;GO:0042383;GO:0030017;GO:0045202;GO:0051015;GO:0031267;GO:0007015;GO:0090630;GO:0016477;GO:0016197;GO:0140285;GO:0097750;GO:0045184;GO:0090148;GO:0010633;GO:0051895;GO:0044387;GO:0001933;GO:1900025;GO:0001755;GO:0006909;GO:2000394;GO:0010632;GO:0010762;GO:0051893;GO:0001932;GO:1900027;GO:1900024;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:endosome membrane; C:flotillin complex; C:focal adhesion; C:lamellipodium; C:lateral plasma membrane; C:ruffle membrane; C:sarcolemma; C:sarcomere; C:synapse;, F:actin filament binding; F:small GTPase binding;, P:actin filament organization; P:activation of GTPase activity; P:cell migration; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:establishment of protein localization; P:membrane fission; P:negative regulation of epithelial cell migration; P:negative regulation of focal adhesion assembly; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of substrate adhesion-dependent cell spreading; P:neural crest cell migration; P:phagocytosis; P:positive regulation of lamellipodium morphogenesis; P:regulation of epithelial cell migration; P:regulation of fibroblast migration; P:regulation of focal adhesion assembly; P:regulation of protein phosphorylation; P:regulation of ruffle assembly; P:regulation of substrate adhesion-dependent cell spreading; P:signal transduction;|Q9ULV4 A7MAP0 A7MAP1 B3KU12 Q9NSK5,Coronin-1C,Coronin-3 {ECO:0000303|PubMed:12377779};hCRNN4;, PF08953;PF00400;, GO:0015629;GO:0005938;GO:0010008;GO:0016600;GO:0005925;GO:0030027;GO:0016328;GO:0032587;GO:0042383;GO:0030017;GO:0045202;GO:0051015;GO:0031267;GO:0007015;GO:0090630;GO:0016477;GO:0016197;GO:0140285;GO:0097750;GO:0045184;GO:0090148;GO:0010633;GO:0051895;GO:0044387;GO:0001933;GO:1900025;GO:0001755;GO:0006909;GO:2000394;GO:0010632;GO:0010762;GO:0051893;GO:0001932;GO:1900027;GO:1900024;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:endosome membrane; C:flotillin complex; C:focal adhesion; C:lamellipodium; C:lateral plasma membrane; C:ruffle membrane; C:sarcolemma; C:sarcomere; C:synapse;, F:actin filament binding; F:small GTPase binding;, P:actin filament organization; P:activation of GTPase activity; P:cell migration; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:establishment of protein localization; P:membrane fission; P:negative regulation of epithelial cell migration; P:negative regulation of focal adhesion assembly; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of substrate adhesion-dependent cell spreading; P:neural crest cell migration; P:phagocytosis; P:positive regulation of lamellipodium morphogenesis; P:regulation of epithelial cell migration; P:regulation of fibroblast migration; P:regulation of focal adhesion assembly; P:regulation of protein phosphorylation; P:regulation of ruffle assembly; P:regulation of substrate adhesion-dependent cell spreading; P:signal transduction;|Q9ULV4 A7MAP0 A7MAP1 B3KU12 Q9NSK5,Coronin-1C,Coronin-3 {ECO:0000303|PubMed:12377779};hCRNN4;, PF08953;PF00400;, GO:0015629;GO:0005938;GO:0010008;GO:0016600;GO:0005925;GO:0030027;GO:0016328;GO:0032587;GO:0042383;GO:0030017;GO:0045202;GO:0051015;GO:0031267;GO:0007015;GO:0090630;GO:0016477;GO:0016197;GO:0140285;GO:0097750;GO:0045184;GO:0090148;GO:0010633;GO:0051895;GO:0044387;GO:0001933;GO:1900025;GO:0001755;GO:0006909;GO:2000394;GO:0010632;GO:0010762;GO:0051893;GO:0001932;GO:1900027;GO:1900024;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:endosome membrane; C:flotillin complex; C:focal adhesion; C:lamellipodium; C:lateral plasma membrane; C:ruffle membrane; C:sarcolemma; C:sarcomere; C:synapse;, F:actin filament binding; F:small GTPase binding;, P:actin filament organization; P:activation of GTPase activity; P:cell migration; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:establishment of protein localization; P:membrane fission; P:negative regulation of epithelial cell migration; P:negative regulation of focal adhesion assembly; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of substrate adhesion-dependent cell spreading; P:neural crest cell migration; P:phagocytosis; P:positive regulation of lamellipodium morphogenesis; P:regulation of epithelial cell migration; P:regulation of fibroblast migration; P:regulation of focal adhesion assembly; P:regulation of protein phosphorylation; P:regulation of ruffle assembly; P:regulation of substrate adhesion-dependent cell spreading; P:signal transduction;|Q9ULV4 A7MAP0 A7MAP1 B3KU12 Q9NSK5,Coronin-1C,Coronin-3 {ECO:0000303|PubMed:12377779};hCRNN4;, PF08953;PF00400;, GO:0015629;GO:0005938;GO:0010008;GO:0016600;GO:0005925;GO:0030027;GO:0016328;GO:0032587;GO:0042383;GO:0030017;GO:0045202;GO:0051015;GO:0031267;GO:0007015;GO:0090630;GO:0016477;GO:0016197;GO:0140285;GO:0097750;GO:0045184;GO:0090148;GO:0010633;GO:0051895;GO:0044387;GO:0001933;GO:1900025;GO:0001755;GO:0006909;GO:2000394;GO:0010632;GO:0010762;GO:0051893;GO:0001932;GO:1900027;GO:1900024;GO:0007165;, C:actin cytoskeleton; C:cell cortex; C:endosome membrane; C:flotillin complex; C:focal adhesion; C:lamellipodium; C:lateral plasma membrane; C:ruffle membrane; C:sarcolemma; C:sarcomere; C:synapse;, F:actin filament binding; F:small GTPase binding;, P:actin filament organization; P:activation of GTPase activity; P:cell migration; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:establishment of protein localization; P:membrane fission; P:negative regulation of epithelial cell migration; P:negative regulation of focal adhesion assembly; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of substrate adhesion-dependent cell spreading; P:neural crest cell migration; P:phagocytosis; P:positive regulation of lamellipodium morphogenesis; P:regulation of epithelial cell migration; P:regulation of fibroblast migration; P:regulation of focal adhesion assembly; P:regulation of protein phosphorylation; P:regulation of ruffle assembly; P:regulation of substrate adhesion-dependent cell spreading; P:signal transduction; scaffold60 indexed_genome mRNA 5417292 5423203 . + . ID=transcript_10454;Q4V9L6 Q6UXE5 Q8N2F5,Transmembrane protein 119,Osteoblast induction factor;, PF15724;, GO:0005789;GO:0016021;GO:0005886;GO:0031214;GO:0001958;GO:0045779;GO:0010832;GO:0001649;GO:1903012;GO:0030501;GO:0010628;GO:0045669;GO:0033690;GO:0001934;GO:0048515;GO:0007283;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, , P:biomineral tissue development; P:endochondral ossification; P:negative regulation of bone resorption; P:negative regulation of myotube differentiation; P:osteoblast differentiation; P:positive regulation of bone development; P:positive regulation of bone mineralization; P:positive regulation of gene expression; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of protein phosphorylation; P:spermatid differentiation; P:spermatogenesis; scaffold60 indexed_genome mRNA 5442731 5449708 . - . ID=transcript_10455;Q9H1K1 Q6P713 Q99617 Q9H1K2,Iron-sulfur cluster assembly enzyme ISCU, mitochondrial,NifU-like N-terminal domain-containing protein;NifU-like protein;, PF01592;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005634;GO:0051537;GO:0051539;GO:0008198;GO:0005506;GO:0060090;GO:0006879;GO:0016226;GO:1904439;GO:1904234;GO:1902958;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:ferrous iron binding; F:iron ion binding; F:molecular adaptor activity;, P:cellular iron ion homeostasis; P:iron-sulfur cluster assembly; P:negative regulation of iron ion import across plasma membrane; P:positive regulation of aconitate hydratase activity; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone;|Q9H1K1 Q6P713 Q99617 Q9H1K2,Iron-sulfur cluster assembly enzyme ISCU, mitochondrial,NifU-like N-terminal domain-containing protein;NifU-like protein;, PF01592;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005634;GO:0051537;GO:0051539;GO:0008198;GO:0005506;GO:0060090;GO:0006879;GO:0016226;GO:1904439;GO:1904234;GO:1902958;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:ferrous iron binding; F:iron ion binding; F:molecular adaptor activity;, P:cellular iron ion homeostasis; P:iron-sulfur cluster assembly; P:negative regulation of iron ion import across plasma membrane; P:positive regulation of aconitate hydratase activity; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; scaffold60 indexed_genome mRNA 5464593 5467334 . + . ID=transcript_10456;Q15020 A8K2E4 B7ZKM0 Q2M2H0 Q58F06 Q8IUS1 Q96J95,Squamous cell carcinoma antigen recognized by T-cells 3 {ECO:0000305},Tat-interacting protein of 110 kDa {ECO:0000303|PubMed:11959860};p110 nuclear RNA-binding protein {ECO:0000303|PubMed:12032085};, PF05391;PF00076;, GO:0061574;GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0042393;GO:0003723;GO:0030621;GO:0017070;GO:0030624;GO:1990381;GO:0000398;GO:0006334;GO:1903586;GO:0010468;GO:0000387;GO:0000244;, C:ASAP complex; C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:histone binding; F:RNA binding; F:U4 snRNA binding; F:U6 snRNA binding; F:U6atac snRNA binding; F:ubiquitin-specific protease binding;, P:mRNA splicing, via spliceosome; P:nucleosome assembly; P:positive regulation of histone deubiquitination; P:regulation of gene expression; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly; scaffold60 indexed_genome mRNA 5473081 5474193 . - . ID=transcript_10457;Q15020 A8K2E4 B7ZKM0 Q2M2H0 Q58F06 Q8IUS1 Q96J95,Squamous cell carcinoma antigen recognized by T-cells 3 {ECO:0000305},Tat-interacting protein of 110 kDa {ECO:0000303|PubMed:11959860};p110 nuclear RNA-binding protein {ECO:0000303|PubMed:12032085};, PF05391;PF00076;, GO:0061574;GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0042393;GO:0003723;GO:0030621;GO:0017070;GO:0030624;GO:1990381;GO:0000398;GO:0006334;GO:1903586;GO:0010468;GO:0000387;GO:0000244;, C:ASAP complex; C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:histone binding; F:RNA binding; F:U4 snRNA binding; F:U6 snRNA binding; F:U6atac snRNA binding; F:ubiquitin-specific protease binding;, P:mRNA splicing, via spliceosome; P:nucleosome assembly; P:positive regulation of histone deubiquitination; P:regulation of gene expression; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly; scaffold60 indexed_genome mRNA 5483750 5491607 . + . ID=transcript_10458;Q15020 A8K2E4 B7ZKM0 Q2M2H0 Q58F06 Q8IUS1 Q96J95,Squamous cell carcinoma antigen recognized by T-cells 3 {ECO:0000305},Tat-interacting protein of 110 kDa {ECO:0000303|PubMed:11959860};p110 nuclear RNA-binding protein {ECO:0000303|PubMed:12032085};, PF05391;PF00076;, GO:0061574;GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0042393;GO:0003723;GO:0030621;GO:0017070;GO:0030624;GO:1990381;GO:0000398;GO:0006334;GO:1903586;GO:0010468;GO:0000387;GO:0000244;, C:ASAP complex; C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:histone binding; F:RNA binding; F:U4 snRNA binding; F:U6 snRNA binding; F:U6atac snRNA binding; F:ubiquitin-specific protease binding;, P:mRNA splicing, via spliceosome; P:nucleosome assembly; P:positive regulation of histone deubiquitination; P:regulation of gene expression; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly;|Q15020 A8K2E4 B7ZKM0 Q2M2H0 Q58F06 Q8IUS1 Q96J95,Squamous cell carcinoma antigen recognized by T-cells 3 {ECO:0000305},Tat-interacting protein of 110 kDa {ECO:0000303|PubMed:11959860};p110 nuclear RNA-binding protein {ECO:0000303|PubMed:12032085};, PF05391;PF00076;, GO:0061574;GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0042393;GO:0003723;GO:0030621;GO:0017070;GO:0030624;GO:1990381;GO:0000398;GO:0006334;GO:1903586;GO:0010468;GO:0000387;GO:0000244;, C:ASAP complex; C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:histone binding; F:RNA binding; F:U4 snRNA binding; F:U6 snRNA binding; F:U6atac snRNA binding; F:ubiquitin-specific protease binding;, P:mRNA splicing, via spliceosome; P:nucleosome assembly; P:positive regulation of histone deubiquitination; P:regulation of gene expression; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly;|Q15020 A8K2E4 B7ZKM0 Q2M2H0 Q58F06 Q8IUS1 Q96J95,Squamous cell carcinoma antigen recognized by T-cells 3 {ECO:0000305},Tat-interacting protein of 110 kDa {ECO:0000303|PubMed:11959860};p110 nuclear RNA-binding protein {ECO:0000303|PubMed:12032085};, PF05391;PF00076;, GO:0061574;GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0042393;GO:0003723;GO:0030621;GO:0017070;GO:0030624;GO:1990381;GO:0000398;GO:0006334;GO:1903586;GO:0010468;GO:0000387;GO:0000244;, C:ASAP complex; C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:histone binding; F:RNA binding; F:U4 snRNA binding; F:U6 snRNA binding; F:U6atac snRNA binding; F:ubiquitin-specific protease binding;, P:mRNA splicing, via spliceosome; P:nucleosome assembly; P:positive regulation of histone deubiquitination; P:regulation of gene expression; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly;|Q15020 A8K2E4 B7ZKM0 Q2M2H0 Q58F06 Q8IUS1 Q96J95,Squamous cell carcinoma antigen recognized by T-cells 3 {ECO:0000305},Tat-interacting protein of 110 kDa {ECO:0000303|PubMed:11959860};p110 nuclear RNA-binding protein {ECO:0000303|PubMed:12032085};, PF05391;PF00076;, GO:0061574;GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0042393;GO:0003723;GO:0030621;GO:0017070;GO:0030624;GO:1990381;GO:0000398;GO:0006334;GO:1903586;GO:0010468;GO:0000387;GO:0000244;, C:ASAP complex; C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:histone binding; F:RNA binding; F:U4 snRNA binding; F:U6 snRNA binding; F:U6atac snRNA binding; F:ubiquitin-specific protease binding;, P:mRNA splicing, via spliceosome; P:nucleosome assembly; P:positive regulation of histone deubiquitination; P:regulation of gene expression; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly;|Q15020 A8K2E4 B7ZKM0 Q2M2H0 Q58F06 Q8IUS1 Q96J95,Squamous cell carcinoma antigen recognized by T-cells 3 {ECO:0000305},Tat-interacting protein of 110 kDa {ECO:0000303|PubMed:11959860};p110 nuclear RNA-binding protein {ECO:0000303|PubMed:12032085};, PF05391;PF00076;, GO:0061574;GO:0015030;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0042393;GO:0003723;GO:0030621;GO:0017070;GO:0030624;GO:1990381;GO:0000398;GO:0006334;GO:1903586;GO:0010468;GO:0000387;GO:0000244;, C:ASAP complex; C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:histone binding; F:RNA binding; F:U4 snRNA binding; F:U6 snRNA binding; F:U6atac snRNA binding; F:ubiquitin-specific protease binding;, P:mRNA splicing, via spliceosome; P:nucleosome assembly; P:positive regulation of histone deubiquitination; P:regulation of gene expression; P:spliceosomal snRNP assembly; P:spliceosomal tri-snRNP complex assembly; scaffold60 indexed_genome mRNA 5492947 5497835 . - . ID=transcript_10459;Q9BVA6 O75406,Protein adenylyltransferase FICD {ECO:0000305},AMPylator FICD {ECO:0000305};De-AMPylase FICD {ECO:0000250|UniProtKB:A0A061I403};FIC domain-containing protein {ECO:0000303|PubMed:25435325};Huntingtin yeast partner E {ECO:0000303|PubMed:25435325, ECO:0000303|PubMed:9700202};Huntingtin-interacting protein 13;Huntingtin-interacting protein E {ECO:0000303|PubMed:25435325, ECO:0000303|PubMed:9700202};, PF02661;, GO:0030176;GO:0005524;GO:0051087;GO:0030544;GO:0042802;GO:0044603;GO:0070733;GO:0042803;GO:0034260;GO:0018117;GO:0044602;GO:1903894;GO:0034976;GO:0006986;, C:integral component of endoplasmic reticulum membrane;, F:ATP binding; F:chaperone binding; F:Hsp70 protein binding; F:identical protein binding; F:protein adenylylhydrolase activity; F:protein adenylyltransferase activity; F:protein homodimerization activity;, P:negative regulation of GTPase activity; P:protein adenylylation; P:protein deadenylylation; P:regulation of IRE1-mediated unfolded protein response; P:response to endoplasmic reticulum stress; P:response to unfolded protein; scaffold60 indexed_genome mRNA 5619532 5660156 . + . ID=transcript_10460;Q99788 A8K6Y5 O75748 Q3KP37 Q5U0H0 Q99789,Chemokine-like receptor 1,G-protein coupled receptor ChemR23;G-protein coupled receptor DEZ;, PF00001;, GO:0016021;GO:0005887;GO:0005886;GO:0004950;GO:0004875;GO:0004930;GO:0038023;GO:0006935;GO:0002430;GO:0007186;GO:0006955;GO:0006954;GO:0032695;GO:0032088;GO:0007200;GO:0120162;GO:0007204;GO:0045600;GO:0010759;GO:0050848;GO:0001501;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:chemokine receptor activity; F:complement receptor activity; F:G protein-coupled receptor activity; F:signaling receptor activity;, P:chemotaxis; P:complement receptor mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:negative regulation of interleukin-12 production; P:negative regulation of NF-kappaB transcription factor activity; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of fat cell differentiation; P:positive regulation of macrophage chemotaxis; P:regulation of calcium-mediated signaling; P:skeletal system development; scaffold60 indexed_genome mRNA 5682212 5736236 . - . ID=transcript_10461;Q2TBF2 B2RN48 B4DES1 Q8IY35 Q9Y4B7,WSC domain-containing protein 2,, PF01822;, GO:0016021;, C:integral component of membrane;|Q2TBF2 B2RN48 B4DES1 Q8IY35 Q9Y4B7,WSC domain-containing protein 2,, PF01822;, GO:0016021;, C:integral component of membrane; scaffold60 indexed_genome mRNA 6038750 6079054 . - . ID=transcript_10462;Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport;|Q2NKQ1 A5LGW1 A8MUT4 B0QYW0 B0QYW1 B5MEG1 B9A6J4 Q5TFL3 Q8TF60,Small G protein signaling modulator 1,RUN and TBC1 domain-containing protein 2;, PF12068;PF00566;PF02759;, GO:0005737;GO:0030659;GO:0005829;GO:0005794;GO:0005096;GO:0031267;GO:0090630;GO:0006886;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; scaffold60 indexed_genome mRNA 6403312 6490983 . + . ID=transcript_10463;P35626 Q9UGW9,Beta-adrenergic receptor kinase 2,G-protein-coupled receptor kinase 3 {ECO:0000312|MIM:109636};, PF00169;PF00069;PF00615;, GO:0005829;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0004672;GO:0007186;GO:0031623;GO:0007165;, C:cytosol; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:G protein-coupled receptor signaling pathway; P:receptor internalization; P:signal transduction;|P35626 Q9UGW9,Beta-adrenergic receptor kinase 2,G-protein-coupled receptor kinase 3 {ECO:0000312|MIM:109636};, PF00169;PF00069;PF00615;, GO:0005829;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0004672;GO:0007186;GO:0031623;GO:0007165;, C:cytosol; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:G protein-coupled receptor signaling pathway; P:receptor internalization; P:signal transduction;|P35626 Q9UGW9,Beta-adrenergic receptor kinase 2,G-protein-coupled receptor kinase 3 {ECO:0000312|MIM:109636};, PF00169;PF00069;PF00615;, GO:0005829;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0004672;GO:0007186;GO:0031623;GO:0007165;, C:cytosol; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:G protein-coupled receptor signaling pathway; P:receptor internalization; P:signal transduction;|P35626 Q9UGW9,Beta-adrenergic receptor kinase 2,G-protein-coupled receptor kinase 3 {ECO:0000312|MIM:109636};, PF00169;PF00069;PF00615;, GO:0005829;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0004672;GO:0007186;GO:0031623;GO:0007165;, C:cytosol; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:G protein-coupled receptor signaling pathway; P:receptor internalization; P:signal transduction;|P35626 Q9UGW9,Beta-adrenergic receptor kinase 2,G-protein-coupled receptor kinase 3 {ECO:0000312|MIM:109636};, PF00169;PF00069;PF00615;, GO:0005829;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0004672;GO:0007186;GO:0031623;GO:0007165;, C:cytosol; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:G protein-coupled receptor signaling pathway; P:receptor internalization; P:signal transduction;|P35626 Q9UGW9,Beta-adrenergic receptor kinase 2,G-protein-coupled receptor kinase 3 {ECO:0000312|MIM:109636};, PF00169;PF00069;PF00615;, GO:0005829;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0004672;GO:0007186;GO:0031623;GO:0007165;, C:cytosol; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:G protein-coupled receptor signaling pathway; P:receptor internalization; P:signal transduction;|P35626 Q9UGW9,Beta-adrenergic receptor kinase 2,G-protein-coupled receptor kinase 3 {ECO:0000312|MIM:109636};, PF00169;PF00069;PF00615;, GO:0005829;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0004672;GO:0007186;GO:0031623;GO:0007165;, C:cytosol; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:G protein-coupled receptor signaling pathway; P:receptor internalization; P:signal transduction;|P35626 Q9UGW9,Beta-adrenergic receptor kinase 2,G-protein-coupled receptor kinase 3 {ECO:0000312|MIM:109636};, PF00169;PF00069;PF00615;, GO:0005829;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0004672;GO:0007186;GO:0031623;GO:0007165;, C:cytosol; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:G protein-coupled receptor signaling pathway; P:receptor internalization; P:signal transduction;|P35626 Q9UGW9,Beta-adrenergic receptor kinase 2,G-protein-coupled receptor kinase 3 {ECO:0000312|MIM:109636};, PF00169;PF00069;PF00615;, GO:0005829;GO:0005886;GO:0005524;GO:0047696;GO:0004703;GO:0004672;GO:0007186;GO:0031623;GO:0007165;, C:cytosol; C:plasma membrane;, F:ATP binding; F:beta-adrenergic receptor kinase activity; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:G protein-coupled receptor signaling pathway; P:receptor internalization; P:signal transduction; scaffold60 indexed_genome mRNA 6497696 6517451 . + . ID=transcript_10464;Q96KR8 Q96KR9,Unconventional myosin-XVIIIb,, PF00063;, GO:0031941;GO:0005634;GO:0016461;GO:0030018;GO:0003779;GO:0005524;GO:0003774;GO:0048739;GO:0001701;GO:0001570;, C:filamentous actin; C:nucleus; C:unconventional myosin complex; C:Z disc;, F:actin binding; F:ATP binding; F:motor activity;, P:cardiac muscle fiber development; P:in utero embryonic development; P:vasculogenesis; scaffold60 indexed_genome mRNA 6517468 6726808 . + . ID=transcript_10465;Q96KR8 Q96KR9,Unconventional myosin-XVIIIb,, PF00063;, GO:0031941;GO:0005634;GO:0016461;GO:0030018;GO:0003779;GO:0005524;GO:0003774;GO:0048739;GO:0001701;GO:0001570;, C:filamentous actin; C:nucleus; C:unconventional myosin complex; C:Z disc;, F:actin binding; F:ATP binding; F:motor activity;, P:cardiac muscle fiber development; P:in utero embryonic development; P:vasculogenesis; scaffold60 indexed_genome mRNA 6959195 7031447 . + . ID=transcript_10466;Q6UXD4 Q9NUI3 Q9NUI4 Q9NUI5 Q9Y2E1 Q9Y3J6,Seizure 6-like protein,, PF00431;PF00084;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane; scaffold60 indexed_genome mRNA 7066716 7075440 . + . ID=transcript_10467;Q6ICH7 B2RCH3 Q7L0W3 Q9NSN3,Aspartate beta-hydroxylase domain-containing protein 2,, PF05118;, GO:0016021;GO:0016020;GO:0051213;GO:0046872;GO:0018193;, C:integral component of membrane; C:membrane;, F:dioxygenase activity; F:metal ion binding;, P:peptidyl-amino acid modification;|Q6ICH7 B2RCH3 Q7L0W3 Q9NSN3,Aspartate beta-hydroxylase domain-containing protein 2,, PF05118;, GO:0016021;GO:0016020;GO:0051213;GO:0046872;GO:0018193;, C:integral component of membrane; C:membrane;, F:dioxygenase activity; F:metal ion binding;, P:peptidyl-amino acid modification; scaffold60 indexed_genome mRNA 7080537 7095393 . - . ID=transcript_10468;Q9NQG7 B1AHQ4 Q5H8V6 Q96LX6 Q9BY93 Q9UH37 Q9UH38,Hermansky-Pudlak syndrome 4 protein,Light-ear protein homolog;, PF19031;PF19033;, GO:0031085;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0005764;GO:0042470;GO:0016020;GO:0042827;GO:0005085;GO:0046983;GO:0042803;GO:0031267;GO:0007596;GO:0007599;GO:0007040;GO:0030318;GO:1903232;GO:0048075;GO:1903955;GO:0050821;GO:0006605;GO:0016192;, C:BLOC-3 complex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane; C:platelet dense granule;, F:guanyl-nucleotide exchange factor activity; F:protein dimerization activity; F:protein homodimerization activity; F:small GTPase binding;, P:blood coagulation; P:hemostasis; P:lysosome organization; P:melanocyte differentiation; P:melanosome assembly; P:positive regulation of eye pigmentation; P:positive regulation of protein targeting to mitochondrion; P:protein stabilization; P:protein targeting; P:vesicle-mediated transport;|Q9NQG7 B1AHQ4 Q5H8V6 Q96LX6 Q9BY93 Q9UH37 Q9UH38,Hermansky-Pudlak syndrome 4 protein,Light-ear protein homolog;, PF19031;PF19033;, GO:0031085;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0005764;GO:0042470;GO:0016020;GO:0042827;GO:0005085;GO:0046983;GO:0042803;GO:0031267;GO:0007596;GO:0007599;GO:0007040;GO:0030318;GO:1903232;GO:0048075;GO:1903955;GO:0050821;GO:0006605;GO:0016192;, C:BLOC-3 complex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane; C:platelet dense granule;, F:guanyl-nucleotide exchange factor activity; F:protein dimerization activity; F:protein homodimerization activity; F:small GTPase binding;, P:blood coagulation; P:hemostasis; P:lysosome organization; P:melanocyte differentiation; P:melanosome assembly; P:positive regulation of eye pigmentation; P:positive regulation of protein targeting to mitochondrion; P:protein stabilization; P:protein targeting; P:vesicle-mediated transport;|Q9NQG7 B1AHQ4 Q5H8V6 Q96LX6 Q9BY93 Q9UH37 Q9UH38,Hermansky-Pudlak syndrome 4 protein,Light-ear protein homolog;, PF19031;PF19033;, GO:0031085;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0005764;GO:0042470;GO:0016020;GO:0042827;GO:0005085;GO:0046983;GO:0042803;GO:0031267;GO:0007596;GO:0007599;GO:0007040;GO:0030318;GO:1903232;GO:0048075;GO:1903955;GO:0050821;GO:0006605;GO:0016192;, C:BLOC-3 complex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane; C:platelet dense granule;, F:guanyl-nucleotide exchange factor activity; F:protein dimerization activity; F:protein homodimerization activity; F:small GTPase binding;, P:blood coagulation; P:hemostasis; P:lysosome organization; P:melanocyte differentiation; P:melanosome assembly; P:positive regulation of eye pigmentation; P:positive regulation of protein targeting to mitochondrion; P:protein stabilization; P:protein targeting; P:vesicle-mediated transport;|Q9NQG7 B1AHQ4 Q5H8V6 Q96LX6 Q9BY93 Q9UH37 Q9UH38,Hermansky-Pudlak syndrome 4 protein,Light-ear protein homolog;, PF19031;PF19033;, GO:0031085;GO:0005737;GO:0031410;GO:0005829;GO:0005765;GO:0005764;GO:0042470;GO:0016020;GO:0042827;GO:0005085;GO:0046983;GO:0042803;GO:0031267;GO:0007596;GO:0007599;GO:0007040;GO:0030318;GO:1903232;GO:0048075;GO:1903955;GO:0050821;GO:0006605;GO:0016192;, C:BLOC-3 complex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane; C:platelet dense granule;, F:guanyl-nucleotide exchange factor activity; F:protein dimerization activity; F:protein homodimerization activity; F:small GTPase binding;, P:blood coagulation; P:hemostasis; P:lysosome organization; P:melanocyte differentiation; P:melanosome assembly; P:positive regulation of eye pigmentation; P:positive regulation of protein targeting to mitochondrion; P:protein stabilization; P:protein targeting; P:vesicle-mediated transport; scaffold60 indexed_genome mRNA 7096568 7127902 . - . ID=transcript_10469;Q9UH36 Q6NXP8,SRR1-like protein,SRR1 domain-containing protein;, PF07985;, GO:0005737;GO:0005634;GO:0007623;GO:0006783;GO:0007017;GO:0042752;GO:0070453;, C:cytoplasm; C:nucleus;, , P:circadian rhythm; P:heme biosynthetic process; P:microtubule-based process; P:regulation of circadian rhythm; P:regulation of heme biosynthetic process; scaffold60 indexed_genome mRNA 7128553 7133908 . + . ID=transcript_10470;Q9UBB9 O95908 Q20WL0 Q5H8V8 Q9UGV7 Q9Y2Q8,Tuftelin-interacting protein 11,Septin and tuftelin-interacting protein 1;, PF01585;PF07842;PF12457;, GO:0071013;GO:0000781;GO:0005737;GO:0031012;GO:0016607;GO:0005730;GO:0005654;GO:0005681;GO:0071008;GO:0003676;GO:0031214;GO:0000398;GO:1904876;GO:2001033;GO:0032091;GO:0031333;GO:0031848;GO:0006396;GO:0000390;, C:catalytic step 2 spliceosome; C:chromosome, telomeric region; C:cytoplasm; C:extracellular matrix; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:spliceosomal complex; C:U2-type post-mRNA release spliceosomal complex;, F:nucleic acid binding;, P:biomineral tissue development; P:mRNA splicing, via spliceosome; P:negative regulation of DNA ligase activity; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:protection from non-homologous end joining at telomere; P:RNA processing; P:spliceosomal complex disassembly;|Q9UBB9 O95908 Q20WL0 Q5H8V8 Q9UGV7 Q9Y2Q8,Tuftelin-interacting protein 11,Septin and tuftelin-interacting protein 1;, PF01585;PF07842;PF12457;, GO:0071013;GO:0000781;GO:0005737;GO:0031012;GO:0016607;GO:0005730;GO:0005654;GO:0005681;GO:0071008;GO:0003676;GO:0031214;GO:0000398;GO:1904876;GO:2001033;GO:0032091;GO:0031333;GO:0031848;GO:0006396;GO:0000390;, C:catalytic step 2 spliceosome; C:chromosome, telomeric region; C:cytoplasm; C:extracellular matrix; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:spliceosomal complex; C:U2-type post-mRNA release spliceosomal complex;, F:nucleic acid binding;, P:biomineral tissue development; P:mRNA splicing, via spliceosome; P:negative regulation of DNA ligase activity; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:protection from non-homologous end joining at telomere; P:RNA processing; P:spliceosomal complex disassembly;|Q9UBB9 O95908 Q20WL0 Q5H8V8 Q9UGV7 Q9Y2Q8,Tuftelin-interacting protein 11,Septin and tuftelin-interacting protein 1;, PF01585;PF07842;PF12457;, GO:0071013;GO:0000781;GO:0005737;GO:0031012;GO:0016607;GO:0005730;GO:0005654;GO:0005681;GO:0071008;GO:0003676;GO:0031214;GO:0000398;GO:1904876;GO:2001033;GO:0032091;GO:0031333;GO:0031848;GO:0006396;GO:0000390;, C:catalytic step 2 spliceosome; C:chromosome, telomeric region; C:cytoplasm; C:extracellular matrix; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:spliceosomal complex; C:U2-type post-mRNA release spliceosomal complex;, F:nucleic acid binding;, P:biomineral tissue development; P:mRNA splicing, via spliceosome; P:negative regulation of DNA ligase activity; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:protection from non-homologous end joining at telomere; P:RNA processing; P:spliceosomal complex disassembly; scaffold60 indexed_genome mRNA 7135635 7138116 . - . ID=transcript_10471;Q9UBB9 O95908 Q20WL0 Q5H8V8 Q9UGV7 Q9Y2Q8,Tuftelin-interacting protein 11,Septin and tuftelin-interacting protein 1;, PF01585;PF07842;PF12457;, GO:0071013;GO:0000781;GO:0005737;GO:0031012;GO:0016607;GO:0005730;GO:0005654;GO:0005681;GO:0071008;GO:0003676;GO:0031214;GO:0000398;GO:1904876;GO:2001033;GO:0032091;GO:0031333;GO:0031848;GO:0006396;GO:0000390;, C:catalytic step 2 spliceosome; C:chromosome, telomeric region; C:cytoplasm; C:extracellular matrix; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:spliceosomal complex; C:U2-type post-mRNA release spliceosomal complex;, F:nucleic acid binding;, P:biomineral tissue development; P:mRNA splicing, via spliceosome; P:negative regulation of DNA ligase activity; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:protection from non-homologous end joining at telomere; P:RNA processing; P:spliceosomal complex disassembly;|Q9UBB9 O95908 Q20WL0 Q5H8V8 Q9UGV7 Q9Y2Q8,Tuftelin-interacting protein 11,Septin and tuftelin-interacting protein 1;, PF01585;PF07842;PF12457;, GO:0071013;GO:0000781;GO:0005737;GO:0031012;GO:0016607;GO:0005730;GO:0005654;GO:0005681;GO:0071008;GO:0003676;GO:0031214;GO:0000398;GO:1904876;GO:2001033;GO:0032091;GO:0031333;GO:0031848;GO:0006396;GO:0000390;, C:catalytic step 2 spliceosome; C:chromosome, telomeric region; C:cytoplasm; C:extracellular matrix; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:spliceosomal complex; C:U2-type post-mRNA release spliceosomal complex;, F:nucleic acid binding;, P:biomineral tissue development; P:mRNA splicing, via spliceosome; P:negative regulation of DNA ligase activity; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:protection from non-homologous end joining at telomere; P:RNA processing; P:spliceosomal complex disassembly; scaffold60 indexed_genome mRNA 7216515 7225727 . - . ID=transcript_10472;P53674,Beta-crystallin B1,Beta-B1 crystallin;, PF00030;, GO:0005212;GO:0002088;GO:0007601;, , F:structural constituent of eye lens;, P:lens development in camera-type eye; P:visual perception; scaffold60 indexed_genome mRNA 8216142 8267413 . - . ID=transcript_10473;P48739 B3KYB8 B7Z7Q0 Q8N5W1,Phosphatidylinositol transfer protein beta isoform,, PF02121;, GO:0005737;GO:0005789;GO:0005794;GO:0000139;GO:0031210;GO:0120019;GO:0008525;GO:0035091;GO:0008526;GO:0140338;GO:0006629;GO:0006997;GO:0015914;GO:0006890;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane;, F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:sphingomyelin transfer activity;, P:lipid metabolic process; P:nucleus organization; P:phospholipid transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P48739 B3KYB8 B7Z7Q0 Q8N5W1,Phosphatidylinositol transfer protein beta isoform,, PF02121;, GO:0005737;GO:0005789;GO:0005794;GO:0000139;GO:0031210;GO:0120019;GO:0008525;GO:0035091;GO:0008526;GO:0140338;GO:0006629;GO:0006997;GO:0015914;GO:0006890;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane;, F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:sphingomyelin transfer activity;, P:lipid metabolic process; P:nucleus organization; P:phospholipid transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P48739 B3KYB8 B7Z7Q0 Q8N5W1,Phosphatidylinositol transfer protein beta isoform,, PF02121;, GO:0005737;GO:0005789;GO:0005794;GO:0000139;GO:0031210;GO:0120019;GO:0008525;GO:0035091;GO:0008526;GO:0140338;GO:0006629;GO:0006997;GO:0015914;GO:0006890;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane;, F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:sphingomyelin transfer activity;, P:lipid metabolic process; P:nucleus organization; P:phospholipid transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold60 indexed_genome mRNA 8333272 8353706 . - . ID=transcript_10474;Q9Y3S5,Tetratricopeptide repeat protein 28,TPR repeat-containing big gene cloned at Keio;, PF12770;PF13176;, GO:0005737;GO:0005815;GO:0030496;GO:0000922;GO:0019900;GO:0007049;GO:0051301;GO:0007346;, C:cytoplasm; C:microtubule organizing center; C:midbody; C:spindle pole;, F:kinase binding;, P:cell cycle; P:cell division; P:regulation of mitotic cell cycle;|Q9Y3S5,Tetratricopeptide repeat protein 28,TPR repeat-containing big gene cloned at Keio;, PF12770;PF13176;, GO:0005737;GO:0005815;GO:0030496;GO:0000922;GO:0019900;GO:0007049;GO:0051301;GO:0007346;, C:cytoplasm; C:microtubule organizing center; C:midbody; C:spindle pole;, F:kinase binding;, P:cell cycle; P:cell division; P:regulation of mitotic cell cycle;|Q9Y3S5,Tetratricopeptide repeat protein 28,TPR repeat-containing big gene cloned at Keio;, PF12770;PF13176;, GO:0005737;GO:0005815;GO:0030496;GO:0000922;GO:0019900;GO:0007049;GO:0051301;GO:0007346;, C:cytoplasm; C:microtubule organizing center; C:midbody; C:spindle pole;, F:kinase binding;, P:cell cycle; P:cell division; P:regulation of mitotic cell cycle; scaffold60 indexed_genome mRNA 8412973 8489993 . - . ID=transcript_10475;Q9Y3S5,Tetratricopeptide repeat protein 28,TPR repeat-containing big gene cloned at Keio;, PF12770;PF13176;, GO:0005737;GO:0005815;GO:0030496;GO:0000922;GO:0019900;GO:0007049;GO:0051301;GO:0007346;, C:cytoplasm; C:microtubule organizing center; C:midbody; C:spindle pole;, F:kinase binding;, P:cell cycle; P:cell division; P:regulation of mitotic cell cycle; scaffold60 indexed_genome mRNA 8605653 8918161 . - . ID=transcript_10476;Q9Y3S5,Tetratricopeptide repeat protein 28,TPR repeat-containing big gene cloned at Keio;, PF12770;PF13176;, GO:0005737;GO:0005815;GO:0030496;GO:0000922;GO:0019900;GO:0007049;GO:0051301;GO:0007346;, C:cytoplasm; C:microtubule organizing center; C:midbody; C:spindle pole;, F:kinase binding;, P:cell cycle; P:cell division; P:regulation of mitotic cell cycle; scaffold60 indexed_genome mRNA 8919394 9008739 . - . ID=transcript_10477;Q9UGF1,Serine/threonine-protein kinase Chk2,CHK2 checkpoint homolog;Cds1 homolog;Checkpoint kinase 2;, PF00498;PF00069;, GO:0005737;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0042802;GO:0046872;GO:0042803;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0031625;GO:0051301;GO:0044257;GO:1903926;GO:0006974;GO:0035690;GO:0071480;GO:0000077;GO:0006975;GO:0006977;GO:0006978;GO:0006302;GO:0000086;GO:0008630;GO:0042771;GO:0044773;GO:0090307;GO:0071157;GO:2000002;GO:0018105;GO:2000210;GO:0001934;GO:0045893;GO:0046777;GO:0006468;GO:0050821;GO:0042176;GO:1901796;GO:0006355;GO:0090399;GO:1903416;GO:0042770;GO:0072428;, C:cytoplasm; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ubiquitin protein ligase binding;, P:cell division; P:cellular protein catabolic process; P:cellular response to bisphenol A; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:cellular response to gamma radiation; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:double-strand break repair; P:G2/M transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic DNA damage checkpoint; P:mitotic spindle assembly; P:negative regulation of cell cycle arrest; P:negative regulation of DNA damage checkpoint; P:peptidyl-serine phosphorylation; P:positive regulation of anoikis; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of protein catabolic process; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:replicative senescence; P:response to glycoside; P:signal transduction in response to DNA damage; P:signal transduction involved in intra-S DNA damage checkpoint;|Q9UGF1,Serine/threonine-protein kinase Chk2,CHK2 checkpoint homolog;Cds1 homolog;Checkpoint kinase 2;, PF00498;PF00069;, GO:0005737;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0042802;GO:0046872;GO:0042803;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0031625;GO:0051301;GO:0044257;GO:1903926;GO:0006974;GO:0035690;GO:0071480;GO:0000077;GO:0006975;GO:0006977;GO:0006978;GO:0006302;GO:0000086;GO:0008630;GO:0042771;GO:0044773;GO:0090307;GO:0071157;GO:2000002;GO:0018105;GO:2000210;GO:0001934;GO:0045893;GO:0046777;GO:0006468;GO:0050821;GO:0042176;GO:1901796;GO:0006355;GO:0090399;GO:1903416;GO:0042770;GO:0072428;, C:cytoplasm; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ubiquitin protein ligase binding;, P:cell division; P:cellular protein catabolic process; P:cellular response to bisphenol A; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:cellular response to gamma radiation; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:double-strand break repair; P:G2/M transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic DNA damage checkpoint; P:mitotic spindle assembly; P:negative regulation of cell cycle arrest; P:negative regulation of DNA damage checkpoint; P:peptidyl-serine phosphorylation; P:positive regulation of anoikis; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of protein catabolic process; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:replicative senescence; P:response to glycoside; P:signal transduction in response to DNA damage; P:signal transduction involved in intra-S DNA damage checkpoint;|Q9UGF1,Serine/threonine-protein kinase Chk2,CHK2 checkpoint homolog;Cds1 homolog;Checkpoint kinase 2;, PF00498;PF00069;, GO:0005737;GO:0005794;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0042802;GO:0046872;GO:0042803;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0031625;GO:0051301;GO:0044257;GO:1903926;GO:0006974;GO:0035690;GO:0071480;GO:0000077;GO:0006975;GO:0006977;GO:0006978;GO:0006302;GO:0000086;GO:0008630;GO:0042771;GO:0044773;GO:0090307;GO:0071157;GO:2000002;GO:0018105;GO:2000210;GO:0001934;GO:0045893;GO:0046777;GO:0006468;GO:0050821;GO:0042176;GO:1901796;GO:0006355;GO:0090399;GO:1903416;GO:0042770;GO:0072428;, C:cytoplasm; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ubiquitin protein ligase binding;, P:cell division; P:cellular protein catabolic process; P:cellular response to bisphenol A; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:cellular response to gamma radiation; P:DNA damage checkpoint; P:DNA damage induced protein phosphorylation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:double-strand break repair; P:G2/M transition of mitotic cell cycle; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic DNA damage checkpoint; P:mitotic spindle assembly; P:negative regulation of cell cycle arrest; P:negative regulation of DNA damage checkpoint; P:peptidyl-serine phosphorylation; P:positive regulation of anoikis; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of protein catabolic process; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:replicative senescence; P:response to glycoside; P:signal transduction in response to DNA damage; P:signal transduction involved in intra-S DNA damage checkpoint;|P17861 Q8WYK6 Q969P1 Q96BD7,X-box-binding protein 1 {ECO:0000303|PubMed:2321018, ECO:0000312|HGNC:HGNC:12801},Tax-responsive element-binding protein 5 {ECO:0000303|PubMed:2196176};, PF07716;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0005654;GO:0005634;GO:0031490;GO:0000987;GO:0003677;GO:0003700;GO:0000981;GO:0030331;GO:0002020;GO:0046982;GO:0042803;GO:0019901;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0031625;GO:0060612;GO:0001525;GO:0006915;GO:0036500;GO:0006914;GO:0071230;GO:0071498;GO:0071332;GO:0042149;GO:0071333;GO:0032869;GO:0071353;GO:0071499;GO:0071222;GO:0031670;GO:0034599;GO:0071375;GO:0035924;GO:0035356;GO:0042632;GO:0030968;GO:0001935;GO:0006633;GO:0055089;GO:0006955;GO:0036498;GO:0001889;GO:0007517;GO:0043066;GO:1902236;GO:1900102;GO:0070373;GO:0010832;GO:0060394;GO:0000122;GO:0030512;GO:0048666;GO:0006996;GO:0014065;GO:0045766;GO:0010508;GO:0045579;GO:0030335;GO:0008284;GO:1900103;GO:2000353;GO:1903071;GO:0045600;GO:2000347;GO:0031062;GO:0002639;GO:0032755;GO:1903489;GO:0045348;GO:0071073;GO:1900100;GO:1901985;GO:0042307;GO:0051897;GO:0001934;GO:0045582;GO:0032008;GO:0045944;GO:1990440;GO:0006990;GO:1904754;GO:1904707;GO:0035470;GO:0031648;GO:0015031;GO:0001558;GO:0031647;GO:0034976;GO:1990418;GO:0055092;GO:0006366;GO:0006511;GO:0048010;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:estrogen receptor binding; F:protease binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:adipose tissue development; P:angiogenesis; P:apoptotic process; P:ATF6-mediated unfolded protein response; P:autophagy; P:cellular response to amino acid stimulus; P:cellular response to fluid shear stress; P:cellular response to fructose stimulus; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:cellular response to interleukin-4; P:cellular response to laminar fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to nutrient; P:cellular response to oxidative stress; P:cellular response to peptide hormone stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:endoplasmic reticulum unfolded protein response; P:endothelial cell proliferation; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:immune response; P:IRE1-mediated unfolded protein response; P:liver development; P:muscle organ development; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of endoplasmic reticulum unfolded protein response; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of myotube differentiation; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron development; P:organelle organization; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of B cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of fat cell differentiation; P:positive regulation of hepatocyte proliferation; P:positive regulation of histone methylation; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-6 production; P:positive regulation of lactation; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of phospholipid biosynthetic process; P:positive regulation of plasma cell differentiation; P:positive regulation of protein acetylation; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of T cell differentiation; P:positive regulation of TOR signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of vascular wound healing; P:protein destabilization; P:protein transport; P:regulation of cell growth; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:response to insulin-like growth factor stimulus; P:sterol homeostasis; P:transcription by RNA polymerase II; P:ubiquitin-dependent protein catabolic process; P:vascular endothelial growth factor receptor signaling pathway;|Q8IWL3 Q9BWS7,Iron-sulfur cluster co-chaperone protein HscB,DnaJ homolog subfamily C member 20;, PF18256;PF07743;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0001671;GO:0051087;GO:0042802;GO:0046872;GO:0044571;GO:0016226;GO:0051259;GO:0097428;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm;, F:ATPase activator activity; F:chaperone binding; F:identical protein binding; F:metal ion binding;, P:[2Fe-2S] cluster assembly; P:iron-sulfur cluster assembly; P:protein complex oligomerization; P:protein maturation by iron-sulfur cluster transfer;|Q8IWL3 Q9BWS7,Iron-sulfur cluster co-chaperone protein HscB,DnaJ homolog subfamily C member 20;, PF18256;PF07743;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0001671;GO:0051087;GO:0042802;GO:0046872;GO:0044571;GO:0016226;GO:0051259;GO:0097428;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm;, F:ATPase activator activity; F:chaperone binding; F:identical protein binding; F:metal ion binding;, P:[2Fe-2S] cluster assembly; P:iron-sulfur cluster assembly; P:protein complex oligomerization; P:protein maturation by iron-sulfur cluster transfer;|Q8IWD4 A8K0F1 B7Z2V1 B7Z860 Q6ICA7 Q8N278,Coiled-coil domain-containing protein 117,, PF15810;|Q8IWD4 A8K0F1 B7Z2V1 B7Z860 Q6ICA7 Q8N278,Coiled-coil domain-containing protein 117,, PF15810;|P17861 Q8WYK6 Q969P1 Q96BD7,X-box-binding protein 1 {ECO:0000303|PubMed:2321018, ECO:0000312|HGNC:HGNC:12801},Tax-responsive element-binding protein 5 {ECO:0000303|PubMed:2196176};, PF07716;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0005654;GO:0005634;GO:0031490;GO:0000987;GO:0003677;GO:0003700;GO:0000981;GO:0030331;GO:0002020;GO:0046982;GO:0042803;GO:0019901;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0031625;GO:0060612;GO:0001525;GO:0006915;GO:0036500;GO:0006914;GO:0071230;GO:0071498;GO:0071332;GO:0042149;GO:0071333;GO:0032869;GO:0071353;GO:0071499;GO:0071222;GO:0031670;GO:0034599;GO:0071375;GO:0035924;GO:0035356;GO:0042632;GO:0030968;GO:0001935;GO:0006633;GO:0055089;GO:0006955;GO:0036498;GO:0001889;GO:0007517;GO:0043066;GO:1902236;GO:1900102;GO:0070373;GO:0010832;GO:0060394;GO:0000122;GO:0030512;GO:0048666;GO:0006996;GO:0014065;GO:0045766;GO:0010508;GO:0045579;GO:0030335;GO:0008284;GO:1900103;GO:2000353;GO:1903071;GO:0045600;GO:2000347;GO:0031062;GO:0002639;GO:0032755;GO:1903489;GO:0045348;GO:0071073;GO:1900100;GO:1901985;GO:0042307;GO:0051897;GO:0001934;GO:0045582;GO:0032008;GO:0045944;GO:1990440;GO:0006990;GO:1904754;GO:1904707;GO:0035470;GO:0031648;GO:0015031;GO:0001558;GO:0031647;GO:0034976;GO:1990418;GO:0055092;GO:0006366;GO:0006511;GO:0048010;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:estrogen receptor binding; F:protease binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:adipose tissue development; P:angiogenesis; P:apoptotic process; P:ATF6-mediated unfolded protein response; P:autophagy; P:cellular response to amino acid stimulus; P:cellular response to fluid shear stress; P:cellular response to fructose stimulus; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:cellular response to interleukin-4; P:cellular response to laminar fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to nutrient; P:cellular response to oxidative stress; P:cellular response to peptide hormone stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:endoplasmic reticulum unfolded protein response; P:endothelial cell proliferation; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:immune response; P:IRE1-mediated unfolded protein response; P:liver development; P:muscle organ development; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of endoplasmic reticulum unfolded protein response; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of myotube differentiation; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron development; P:organelle organization; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of B cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of fat cell differentiation; P:positive regulation of hepatocyte proliferation; P:positive regulation of histone methylation; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-6 production; P:positive regulation of lactation; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of phospholipid biosynthetic process; P:positive regulation of plasma cell differentiation; P:positive regulation of protein acetylation; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of T cell differentiation; P:positive regulation of TOR signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of vascular wound healing; P:protein destabilization; P:protein transport; P:regulation of cell growth; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:response to insulin-like growth factor stimulus; P:sterol homeostasis; P:transcription by RNA polymerase II; P:ubiquitin-dependent protein catabolic process; P:vascular endothelial growth factor receptor signaling pathway;|P17861 Q8WYK6 Q969P1 Q96BD7,X-box-binding protein 1 {ECO:0000303|PubMed:2321018, ECO:0000312|HGNC:HGNC:12801},Tax-responsive element-binding protein 5 {ECO:0000303|PubMed:2196176};, PF07716;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0005654;GO:0005634;GO:0031490;GO:0000987;GO:0003677;GO:0003700;GO:0000981;GO:0030331;GO:0002020;GO:0046982;GO:0042803;GO:0019901;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0031625;GO:0060612;GO:0001525;GO:0006915;GO:0036500;GO:0006914;GO:0071230;GO:0071498;GO:0071332;GO:0042149;GO:0071333;GO:0032869;GO:0071353;GO:0071499;GO:0071222;GO:0031670;GO:0034599;GO:0071375;GO:0035924;GO:0035356;GO:0042632;GO:0030968;GO:0001935;GO:0006633;GO:0055089;GO:0006955;GO:0036498;GO:0001889;GO:0007517;GO:0043066;GO:1902236;GO:1900102;GO:0070373;GO:0010832;GO:0060394;GO:0000122;GO:0030512;GO:0048666;GO:0006996;GO:0014065;GO:0045766;GO:0010508;GO:0045579;GO:0030335;GO:0008284;GO:1900103;GO:2000353;GO:1903071;GO:0045600;GO:2000347;GO:0031062;GO:0002639;GO:0032755;GO:1903489;GO:0045348;GO:0071073;GO:1900100;GO:1901985;GO:0042307;GO:0051897;GO:0001934;GO:0045582;GO:0032008;GO:0045944;GO:1990440;GO:0006990;GO:1904754;GO:1904707;GO:0035470;GO:0031648;GO:0015031;GO:0001558;GO:0031647;GO:0034976;GO:1990418;GO:0055092;GO:0006366;GO:0006511;GO:0048010;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:estrogen receptor binding; F:protease binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:adipose tissue development; P:angiogenesis; P:apoptotic process; P:ATF6-mediated unfolded protein response; P:autophagy; P:cellular response to amino acid stimulus; P:cellular response to fluid shear stress; P:cellular response to fructose stimulus; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:cellular response to interleukin-4; P:cellular response to laminar fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to nutrient; P:cellular response to oxidative stress; P:cellular response to peptide hormone stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:endoplasmic reticulum unfolded protein response; P:endothelial cell proliferation; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:immune response; P:IRE1-mediated unfolded protein response; P:liver development; P:muscle organ development; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of endoplasmic reticulum unfolded protein response; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of myotube differentiation; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron development; P:organelle organization; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of B cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of fat cell differentiation; P:positive regulation of hepatocyte proliferation; P:positive regulation of histone methylation; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-6 production; P:positive regulation of lactation; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of phospholipid biosynthetic process; P:positive regulation of plasma cell differentiation; P:positive regulation of protein acetylation; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of T cell differentiation; P:positive regulation of TOR signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of vascular wound healing; P:protein destabilization; P:protein transport; P:regulation of cell growth; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:response to insulin-like growth factor stimulus; P:sterol homeostasis; P:transcription by RNA polymerase II; P:ubiquitin-dependent protein catabolic process; P:vascular endothelial growth factor receptor signaling pathway;|P17861 Q8WYK6 Q969P1 Q96BD7,X-box-binding protein 1 {ECO:0000303|PubMed:2321018, ECO:0000312|HGNC:HGNC:12801},Tax-responsive element-binding protein 5 {ECO:0000303|PubMed:2196176};, PF07716;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0005654;GO:0005634;GO:0031490;GO:0000987;GO:0003677;GO:0003700;GO:0000981;GO:0030331;GO:0002020;GO:0046982;GO:0042803;GO:0019901;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0031625;GO:0060612;GO:0001525;GO:0006915;GO:0036500;GO:0006914;GO:0071230;GO:0071498;GO:0071332;GO:0042149;GO:0071333;GO:0032869;GO:0071353;GO:0071499;GO:0071222;GO:0031670;GO:0034599;GO:0071375;GO:0035924;GO:0035356;GO:0042632;GO:0030968;GO:0001935;GO:0006633;GO:0055089;GO:0006955;GO:0036498;GO:0001889;GO:0007517;GO:0043066;GO:1902236;GO:1900102;GO:0070373;GO:0010832;GO:0060394;GO:0000122;GO:0030512;GO:0048666;GO:0006996;GO:0014065;GO:0045766;GO:0010508;GO:0045579;GO:0030335;GO:0008284;GO:1900103;GO:2000353;GO:1903071;GO:0045600;GO:2000347;GO:0031062;GO:0002639;GO:0032755;GO:1903489;GO:0045348;GO:0071073;GO:1900100;GO:1901985;GO:0042307;GO:0051897;GO:0001934;GO:0045582;GO:0032008;GO:0045944;GO:1990440;GO:0006990;GO:1904754;GO:1904707;GO:0035470;GO:0031648;GO:0015031;GO:0001558;GO:0031647;GO:0034976;GO:1990418;GO:0055092;GO:0006366;GO:0006511;GO:0048010;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:estrogen receptor binding; F:protease binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:adipose tissue development; P:angiogenesis; P:apoptotic process; P:ATF6-mediated unfolded protein response; P:autophagy; P:cellular response to amino acid stimulus; P:cellular response to fluid shear stress; P:cellular response to fructose stimulus; P:cellular response to glucose starvation; P:cellular response to glucose stimulus; P:cellular response to insulin stimulus; P:cellular response to interleukin-4; P:cellular response to laminar fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to nutrient; P:cellular response to oxidative stress; P:cellular response to peptide hormone stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:endoplasmic reticulum unfolded protein response; P:endothelial cell proliferation; P:fatty acid biosynthetic process; P:fatty acid homeostasis; P:immune response; P:IRE1-mediated unfolded protein response; P:liver development; P:muscle organ development; P:negative regulation of apoptotic process; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of endoplasmic reticulum unfolded protein response; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of myotube differentiation; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron development; P:organelle organization; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of B cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of fat cell differentiation; P:positive regulation of hepatocyte proliferation; P:positive regulation of histone methylation; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-6 production; P:positive regulation of lactation; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of phospholipid biosynthetic process; P:positive regulation of plasma cell differentiation; P:positive regulation of protein acetylation; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of T cell differentiation; P:positive regulation of TOR signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of vascular wound healing; P:protein destabilization; P:protein transport; P:regulation of cell growth; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:response to insulin-like growth factor stimulus; P:sterol homeostasis; P:transcription by RNA polymerase II; P:ubiquitin-dependent protein catabolic process; P:vascular endothelial growth factor receptor signaling pathway; scaffold60 indexed_genome mRNA 9182672 9191327 . + . ID=transcript_10478;Q9ULT6 B3KU18 Q6ICH1 Q6NTF8 Q8WU18,E3 ubiquitin-protein ligase ZNRF3,RING finger protein 203;RING-type E3 ubiquitin transferase ZNRF3;Zinc/RING finger protein 3;, PF13639;PF18212;, GO:0005887;GO:0005886;GO:0005109;GO:0046872;GO:0061630;GO:0004842;GO:0060173;GO:0090090;GO:2000051;GO:0016567;GO:2000095;GO:0072089;GO:0006511;GO:0038018;GO:0016055;, C:integral component of plasma membrane; C:plasma membrane;, F:frizzled binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:limb development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of non-canonical Wnt signaling pathway; P:protein ubiquitination; P:regulation of Wnt signaling pathway, planar cell polarity pathway; P:stem cell proliferation; P:ubiquitin-dependent protein catabolic process; P:Wnt receptor catabolic process; P:Wnt signaling pathway; scaffold60 indexed_genome mRNA 9223198 9259764 . + . ID=transcript_10479;Q96MU8 B0QY46 B0QY47 B1AJR5 Q5TIB9 Q6P3X6 Q9BY70 Q9UGS5 Q9UGU1,Kremen protein 1,Dickkopf receptor;Kringle domain-containing transmembrane protein 1;Kringle-containing protein marking the eye and the nose;, PF00431;PF00051;PF01822;, GO:0016021;GO:0016020;GO:0043025;GO:0005886;GO:0006915;GO:0007154;GO:0060173;GO:0048681;GO:0090090;GO:0030279;GO:0060828;GO:0016055;, C:integral component of membrane; C:membrane; C:neuronal cell body; C:plasma membrane;, , P:apoptotic process; P:cell communication; P:limb development; P:negative regulation of axon regeneration; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ossification; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold60 indexed_genome mRNA 9296861 9336063 . + . ID=transcript_10480;Q96A84 B0QYK6 Q6ICG1 Q86SS7,EMI domain-containing protein 1,Emilin and multimerin domain-containing protein 1;, PF01391;PF07546;, GO:0005581;GO:0005576;, C:collagen trimer; C:extracellular region;|Q96A84 B0QYK6 Q6ICG1 Q86SS7,EMI domain-containing protein 1,Emilin and multimerin domain-containing protein 1;, PF01391;PF07546;, GO:0005581;GO:0005576;, C:collagen trimer; C:extracellular region;|Q96A84 B0QYK6 Q6ICG1 Q86SS7,EMI domain-containing protein 1,Emilin and multimerin domain-containing protein 1;, PF01391;PF07546;, GO:0005581;GO:0005576;, C:collagen trimer; C:extracellular region; scaffold60 indexed_genome mRNA 9336360 9376818 . - . ID=transcript_10481;Q9Y3P4 Q6I9X3 Q9UGQ7,Rhomboid domain-containing protein 3,, PF01694;PF00627;, GO:0016021;GO:0004252;GO:0001889;GO:0000165;GO:0032815;GO:0045732;GO:0002673;GO:0050708;GO:0009410;, C:integral component of membrane;, F:serine-type endopeptidase activity;, P:liver development; P:MAPK cascade; P:negative regulation of natural killer cell activation; P:positive regulation of protein catabolic process; P:regulation of acute inflammatory response; P:regulation of protein secretion; P:response to xenobiotic stimulus;|Q9Y3P4 Q6I9X3 Q9UGQ7,Rhomboid domain-containing protein 3,, PF01694;PF00627;, GO:0016021;GO:0004252;GO:0001889;GO:0000165;GO:0032815;GO:0045732;GO:0002673;GO:0050708;GO:0009410;, C:integral component of membrane;, F:serine-type endopeptidase activity;, P:liver development; P:MAPK cascade; P:negative regulation of natural killer cell activation; P:positive regulation of protein catabolic process; P:regulation of acute inflammatory response; P:regulation of protein secretion; P:response to xenobiotic stimulus;|Q01844 B0QYK1 Q5THL0 Q92635 Q96FE8 Q96MN4 Q96MX4 Q9BWA2,RNA-binding protein EWS,EWS oncogene;Ewing sarcoma breakpoint region 1 protein;, PF00076;PF00641;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005516;GO:0042802;GO:0046872;GO:0003723;GO:0003712;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calmodulin binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription coregulator activity;|Q01844 B0QYK1 Q5THL0 Q92635 Q96FE8 Q96MN4 Q96MX4 Q9BWA2,RNA-binding protein EWS,EWS oncogene;Ewing sarcoma breakpoint region 1 protein;, PF00076;PF00641;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005516;GO:0042802;GO:0046872;GO:0003723;GO:0003712;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calmodulin binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription coregulator activity;|Q01844 B0QYK1 Q5THL0 Q92635 Q96FE8 Q96MN4 Q96MX4 Q9BWA2,RNA-binding protein EWS,EWS oncogene;Ewing sarcoma breakpoint region 1 protein;, PF00076;PF00641;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005516;GO:0042802;GO:0046872;GO:0003723;GO:0003712;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calmodulin binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription coregulator activity;|Q01844 B0QYK1 Q5THL0 Q92635 Q96FE8 Q96MN4 Q96MX4 Q9BWA2,RNA-binding protein EWS,EWS oncogene;Ewing sarcoma breakpoint region 1 protein;, PF00076;PF00641;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005516;GO:0042802;GO:0046872;GO:0003723;GO:0003712;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calmodulin binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription coregulator activity;|Q01844 B0QYK1 Q5THL0 Q92635 Q96FE8 Q96MN4 Q96MX4 Q9BWA2,RNA-binding protein EWS,EWS oncogene;Ewing sarcoma breakpoint region 1 protein;, PF00076;PF00641;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005516;GO:0042802;GO:0046872;GO:0003723;GO:0003712;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calmodulin binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription coregulator activity;|Q01844 B0QYK1 Q5THL0 Q92635 Q96FE8 Q96MN4 Q96MX4 Q9BWA2,RNA-binding protein EWS,EWS oncogene;Ewing sarcoma breakpoint region 1 protein;, PF00076;PF00641;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0005516;GO:0042802;GO:0046872;GO:0003723;GO:0003712;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calmodulin binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription coregulator activity; scaffold60 indexed_genome mRNA 9385115 9390301 . - . ID=transcript_10482;Q99501 B5MCR7 Q53EN7 Q92640 Q9BUY9,GAS2-like protein 1,GAS2-related protein on chromosome 22;Growth arrest-specific protein 2-like 1;, PF00307;PF02187;, GO:0005737;GO:0005856;GO:0051015;GO:0008093;GO:0008017;GO:0046966;GO:0051764;GO:0007050;GO:0009267;GO:0097067;GO:0001578;GO:0000226;GO:0030308;GO:0045647;GO:0010629;GO:0007026;GO:1904825;GO:0051726;GO:0031110;, C:cytoplasm; C:cytoskeleton;, F:actin filament binding; F:cytoskeletal anchor activity; F:microtubule binding; F:thyroid hormone receptor binding;, P:actin crosslink formation; P:cell cycle arrest; P:cellular response to starvation; P:cellular response to thyroid hormone stimulus; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of cell growth; P:negative regulation of erythrocyte differentiation; P:negative regulation of gene expression; P:negative regulation of microtubule depolymerization; P:protein localization to microtubule plus-end; P:regulation of cell cycle; P:regulation of microtubule polymerization or depolymerization;|Q99501 B5MCR7 Q53EN7 Q92640 Q9BUY9,GAS2-like protein 1,GAS2-related protein on chromosome 22;Growth arrest-specific protein 2-like 1;, PF00307;PF02187;, GO:0005737;GO:0005856;GO:0051015;GO:0008093;GO:0008017;GO:0046966;GO:0051764;GO:0007050;GO:0009267;GO:0097067;GO:0001578;GO:0000226;GO:0030308;GO:0045647;GO:0010629;GO:0007026;GO:1904825;GO:0051726;GO:0031110;, C:cytoplasm; C:cytoskeleton;, F:actin filament binding; F:cytoskeletal anchor activity; F:microtubule binding; F:thyroid hormone receptor binding;, P:actin crosslink formation; P:cell cycle arrest; P:cellular response to starvation; P:cellular response to thyroid hormone stimulus; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of cell growth; P:negative regulation of erythrocyte differentiation; P:negative regulation of gene expression; P:negative regulation of microtubule depolymerization; P:protein localization to microtubule plus-end; P:regulation of cell cycle; P:regulation of microtubule polymerization or depolymerization;|Q99501 B5MCR7 Q53EN7 Q92640 Q9BUY9,GAS2-like protein 1,GAS2-related protein on chromosome 22;Growth arrest-specific protein 2-like 1;, PF00307;PF02187;, GO:0005737;GO:0005856;GO:0051015;GO:0008093;GO:0008017;GO:0046966;GO:0051764;GO:0007050;GO:0009267;GO:0097067;GO:0001578;GO:0000226;GO:0030308;GO:0045647;GO:0010629;GO:0007026;GO:1904825;GO:0051726;GO:0031110;, C:cytoplasm; C:cytoskeleton;, F:actin filament binding; F:cytoskeletal anchor activity; F:microtubule binding; F:thyroid hormone receptor binding;, P:actin crosslink formation; P:cell cycle arrest; P:cellular response to starvation; P:cellular response to thyroid hormone stimulus; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of cell growth; P:negative regulation of erythrocyte differentiation; P:negative regulation of gene expression; P:negative regulation of microtubule depolymerization; P:protein localization to microtubule plus-end; P:regulation of cell cycle; P:regulation of microtubule polymerization or depolymerization; scaffold60 indexed_genome mRNA 9390537 9391424 . + . ID=transcript_10483;Q92737 Q49AU5 Q6PI03,Ras-like protein family member 10A,Ras-like protein RRP22;Ras-related protein on chromosome 22;, PF00071;, GO:0005730;GO:0005886;GO:0005525;GO:0003924;GO:0007264;, C:nucleolus; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:small GTPase mediated signal transduction; scaffold60 indexed_genome mRNA 9391558 9392154 . + . ID=transcript_10484;Q92737 Q49AU5 Q6PI03,Ras-like protein family member 10A,Ras-like protein RRP22;Ras-related protein on chromosome 22;, PF00071;, GO:0005730;GO:0005886;GO:0005525;GO:0003924;GO:0007264;, C:nucleolus; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:small GTPase mediated signal transduction; scaffold60 indexed_genome mRNA 9403554 9448219 . - . ID=transcript_10485;Q10567 C9JRD1 F8WDL0 P78436 Q20WL3 Q86X54,AP-1 complex subunit beta-1,Adaptor protein complex AP-1 subunit beta-1;Adaptor-related protein complex 1 subunit beta-1;Beta-1-adaptin;Beta-adaptin 1;Clathrin assembly protein complex 1 beta large chain;Golgi adaptor HA1/AP1 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030131;GO:0030665;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0032588;GO:0030276;GO:0019901;GO:0019886;GO:0007368;GO:0007507;GO:0006886;GO:0001822;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:trans-Golgi network membrane;, F:clathrin binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:heart development; P:intracellular protein transport; P:kidney development; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q10567 C9JRD1 F8WDL0 P78436 Q20WL3 Q86X54,AP-1 complex subunit beta-1,Adaptor protein complex AP-1 subunit beta-1;Adaptor-related protein complex 1 subunit beta-1;Beta-1-adaptin;Beta-adaptin 1;Clathrin assembly protein complex 1 beta large chain;Golgi adaptor HA1/AP1 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030131;GO:0030665;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0032588;GO:0030276;GO:0019901;GO:0019886;GO:0007368;GO:0007507;GO:0006886;GO:0001822;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:trans-Golgi network membrane;, F:clathrin binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:heart development; P:intracellular protein transport; P:kidney development; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q10567 C9JRD1 F8WDL0 P78436 Q20WL3 Q86X54,AP-1 complex subunit beta-1,Adaptor protein complex AP-1 subunit beta-1;Adaptor-related protein complex 1 subunit beta-1;Beta-1-adaptin;Beta-adaptin 1;Clathrin assembly protein complex 1 beta large chain;Golgi adaptor HA1/AP1 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030131;GO:0030665;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0032588;GO:0030276;GO:0019901;GO:0019886;GO:0007368;GO:0007507;GO:0006886;GO:0001822;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:trans-Golgi network membrane;, F:clathrin binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:heart development; P:intracellular protein transport; P:kidney development; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q10567 C9JRD1 F8WDL0 P78436 Q20WL3 Q86X54,AP-1 complex subunit beta-1,Adaptor protein complex AP-1 subunit beta-1;Adaptor-related protein complex 1 subunit beta-1;Beta-1-adaptin;Beta-adaptin 1;Clathrin assembly protein complex 1 beta large chain;Golgi adaptor HA1/AP1 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030131;GO:0030665;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0032588;GO:0030276;GO:0019901;GO:0019886;GO:0007368;GO:0007507;GO:0006886;GO:0001822;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:trans-Golgi network membrane;, F:clathrin binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:heart development; P:intracellular protein transport; P:kidney development; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q10567 C9JRD1 F8WDL0 P78436 Q20WL3 Q86X54,AP-1 complex subunit beta-1,Adaptor protein complex AP-1 subunit beta-1;Adaptor-related protein complex 1 subunit beta-1;Beta-1-adaptin;Beta-adaptin 1;Clathrin assembly protein complex 1 beta large chain;Golgi adaptor HA1/AP1 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030131;GO:0030665;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0032588;GO:0030276;GO:0019901;GO:0019886;GO:0007368;GO:0007507;GO:0006886;GO:0001822;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:trans-Golgi network membrane;, F:clathrin binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:heart development; P:intracellular protein transport; P:kidney development; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q10567 C9JRD1 F8WDL0 P78436 Q20WL3 Q86X54,AP-1 complex subunit beta-1,Adaptor protein complex AP-1 subunit beta-1;Adaptor-related protein complex 1 subunit beta-1;Beta-1-adaptin;Beta-adaptin 1;Clathrin assembly protein complex 1 beta large chain;Golgi adaptor HA1/AP1 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030131;GO:0030665;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0032588;GO:0030276;GO:0019901;GO:0019886;GO:0007368;GO:0007507;GO:0006886;GO:0001822;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:trans-Golgi network membrane;, F:clathrin binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:heart development; P:intracellular protein transport; P:kidney development; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q10567 C9JRD1 F8WDL0 P78436 Q20WL3 Q86X54,AP-1 complex subunit beta-1,Adaptor protein complex AP-1 subunit beta-1;Adaptor-related protein complex 1 subunit beta-1;Beta-1-adaptin;Beta-adaptin 1;Clathrin assembly protein complex 1 beta large chain;Golgi adaptor HA1/AP1 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030131;GO:0030665;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0032588;GO:0030276;GO:0019901;GO:0019886;GO:0007368;GO:0007507;GO:0006886;GO:0001822;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:trans-Golgi network membrane;, F:clathrin binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:heart development; P:intracellular protein transport; P:kidney development; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport; scaffold60 indexed_genome mRNA 9484537 9490651 . - . ID=transcript_10486;P12036 B4DYY4 Q96HF8 Q9UJS7 Q9UQ14,Neurofilament heavy polypeptide,200 kDa neurofilament protein;Neurofilament triplet H protein;, PF07142;PF00038;, GO:0030424;GO:0005737;GO:0005856;GO:0097418;GO:0005883;GO:0014069;GO:0099160;GO:0098685;GO:0070840;GO:0019894;GO:0008017;GO:0019901;GO:0030674;GO:0005200;GO:0099184;GO:0061564;GO:0007409;GO:0030031;GO:1990830;GO:0000226;GO:0033693;GO:0060052;GO:0048936;GO:1902513;, C:axon; C:cytoplasm; C:cytoskeleton; C:neurofibrillary tangle; C:neurofilament; C:postsynaptic density; C:postsynaptic intermediate filament cytoskeleton; C:Schaffer collateral - CA1 synapse;, F:dynein complex binding; F:kinesin binding; F:microtubule binding; F:protein kinase binding; F:protein-macromolecule adaptor activity; F:structural constituent of cytoskeleton; F:structural constituent of postsynaptic intermediate filament cytoskeleton;, P:axon development; P:axonogenesis; P:cell projection assembly; P:cellular response to leukemia inhibitory factor; P:microtubule cytoskeleton organization; P:neurofilament bundle assembly; P:neurofilament cytoskeleton organization; P:peripheral nervous system neuron axonogenesis; P:regulation of organelle transport along microtubule; scaffold60 indexed_genome mRNA 9500262 9506144 . - . ID=transcript_10487;Q13769 O60839 Q9UPZ5,THO complex subunit 5 homolog,Functional spliceosome-associated protein 79;NF2/meningioma region protein pK1.3;Placental protein 39.2;hTREX90;, PF09766;, GO:0005737;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0030224;GO:0031124;GO:0006406;GO:2000002;GO:0032786;GO:0060215;GO:0006405;GO:0008380;GO:0046784;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:monocyte differentiation; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:positive regulation of DNA-templated transcription, elongation; P:primitive hemopoiesis; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q13769 O60839 Q9UPZ5,THO complex subunit 5 homolog,Functional spliceosome-associated protein 79;NF2/meningioma region protein pK1.3;Placental protein 39.2;hTREX90;, PF09766;, GO:0005737;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0030224;GO:0031124;GO:0006406;GO:2000002;GO:0032786;GO:0060215;GO:0006405;GO:0008380;GO:0046784;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:monocyte differentiation; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:positive regulation of DNA-templated transcription, elongation; P:primitive hemopoiesis; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q13769 O60839 Q9UPZ5,THO complex subunit 5 homolog,Functional spliceosome-associated protein 79;NF2/meningioma region protein pK1.3;Placental protein 39.2;hTREX90;, PF09766;, GO:0005737;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0030224;GO:0031124;GO:0006406;GO:2000002;GO:0032786;GO:0060215;GO:0006405;GO:0008380;GO:0046784;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:monocyte differentiation; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:positive regulation of DNA-templated transcription, elongation; P:primitive hemopoiesis; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus; scaffold60 indexed_genome mRNA 9506215 9506861 . - . ID=transcript_10488;Q13769 O60839 Q9UPZ5,THO complex subunit 5 homolog,Functional spliceosome-associated protein 79;NF2/meningioma region protein pK1.3;Placental protein 39.2;hTREX90;, PF09766;, GO:0005737;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0030224;GO:0031124;GO:0006406;GO:2000002;GO:0032786;GO:0060215;GO:0006405;GO:0008380;GO:0046784;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:monocyte differentiation; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:positive regulation of DNA-templated transcription, elongation; P:primitive hemopoiesis; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus; scaffold60 indexed_genome mRNA 9508604 9539122 . - . ID=transcript_10489;Q13769 O60839 Q9UPZ5,THO complex subunit 5 homolog,Functional spliceosome-associated protein 79;NF2/meningioma region protein pK1.3;Placental protein 39.2;hTREX90;, PF09766;, GO:0005737;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0030224;GO:0031124;GO:0006406;GO:2000002;GO:0032786;GO:0060215;GO:0006405;GO:0008380;GO:0046784;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:monocyte differentiation; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:positive regulation of DNA-templated transcription, elongation; P:primitive hemopoiesis; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q13769 O60839 Q9UPZ5,THO complex subunit 5 homolog,Functional spliceosome-associated protein 79;NF2/meningioma region protein pK1.3;Placental protein 39.2;hTREX90;, PF09766;, GO:0005737;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0030224;GO:0031124;GO:0006406;GO:2000002;GO:0032786;GO:0060215;GO:0006405;GO:0008380;GO:0046784;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:monocyte differentiation; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of DNA damage checkpoint; P:positive regulation of DNA-templated transcription, elongation; P:primitive hemopoiesis; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q9BPW8 B2RAY3 O43800,Protein NipSnap homolog 1,, PF07978;, GO:0005739;GO:0097060;GO:0042165;GO:0019233;, C:mitochondrion; C:synaptic membrane;, F:neurotransmitter binding;, P:sensory perception of pain;|Q9BPW8 B2RAY3 O43800,Protein NipSnap homolog 1,, PF07978;, GO:0005739;GO:0097060;GO:0042165;GO:0019233;, C:mitochondrion; C:synaptic membrane;, F:neurotransmitter binding;, P:sensory perception of pain;|Q9BPW8 B2RAY3 O43800,Protein NipSnap homolog 1,, PF07978;, GO:0005739;GO:0097060;GO:0042165;GO:0019233;, C:mitochondrion; C:synaptic membrane;, F:neurotransmitter binding;, P:sensory perception of pain; scaffold60 indexed_genome mRNA 9565366 9628497 . + . ID=transcript_10490;Q9BTW3 Q9UNG9 Q9UNH3 Q9UNH4,Merlin,Moesin-ezrin-radixin-like protein;Neurofibromin-2;Schwannomerlin;Schwannomin;, PF00769;PF09380;PF00373;PF09379;, GO:0005912;GO:0045177;GO:0044297;GO:0032154;GO:0030864;GO:0005737;GO:0005856;GO:0005829;GO:0005769;GO:0031527;GO:0030027;GO:0016020;GO:0043005;GO:0005730;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0003779;GO:0030036;GO:0045216;GO:0007398;GO:0021766;GO:0070306;GO:0001707;GO:0030336;GO:0008285;GO:0022408;GO:0001953;GO:0043409;GO:0006469;GO:0046426;GO:0042532;GO:0042475;GO:0045597;GO:0051496;GO:0042981;GO:0051726;GO:0014013;GO:0035330;GO:2000177;GO:1900180;GO:0031647;GO:0072091;GO:0014010;, C:adherens junction; C:apical part of cell; C:cell body; C:cleavage furrow; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome; C:filopodium membrane; C:lamellipodium; C:membrane; C:neuron projection; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:actin binding;, P:actin cytoskeleton organization; P:cell-cell junction organization; P:ectoderm development; P:hippocampus development; P:lens fiber cell differentiation; P:mesoderm formation; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of MAPK cascade; P:negative regulation of protein kinase activity; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of tyrosine phosphorylation of STAT protein; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell differentiation; P:positive regulation of stress fiber assembly; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of gliogenesis; P:regulation of hippo signaling; P:regulation of neural precursor cell proliferation; P:regulation of protein localization to nucleus; P:regulation of protein stability; P:regulation of stem cell proliferation; P:Schwann cell proliferation;|Q9BTW3 Q9UNG9 Q9UNH3 Q9UNH4,Merlin,Moesin-ezrin-radixin-like protein;Neurofibromin-2;Schwannomerlin;Schwannomin;, PF00769;PF09380;PF00373;PF09379;, GO:0005912;GO:0045177;GO:0044297;GO:0032154;GO:0030864;GO:0005737;GO:0005856;GO:0005829;GO:0005769;GO:0031527;GO:0030027;GO:0016020;GO:0043005;GO:0005730;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0003779;GO:0030036;GO:0045216;GO:0007398;GO:0021766;GO:0070306;GO:0001707;GO:0030336;GO:0008285;GO:0022408;GO:0001953;GO:0043409;GO:0006469;GO:0046426;GO:0042532;GO:0042475;GO:0045597;GO:0051496;GO:0042981;GO:0051726;GO:0014013;GO:0035330;GO:2000177;GO:1900180;GO:0031647;GO:0072091;GO:0014010;, C:adherens junction; C:apical part of cell; C:cell body; C:cleavage furrow; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome; C:filopodium membrane; C:lamellipodium; C:membrane; C:neuron projection; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:actin binding;, P:actin cytoskeleton organization; P:cell-cell junction organization; P:ectoderm development; P:hippocampus development; P:lens fiber cell differentiation; P:mesoderm formation; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of MAPK cascade; P:negative regulation of protein kinase activity; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of tyrosine phosphorylation of STAT protein; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell differentiation; P:positive regulation of stress fiber assembly; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of gliogenesis; P:regulation of hippo signaling; P:regulation of neural precursor cell proliferation; P:regulation of protein localization to nucleus; P:regulation of protein stability; P:regulation of stem cell proliferation; P:Schwann cell proliferation;|Q9BTW3 Q9UNG9 Q9UNH3 Q9UNH4,Merlin,Moesin-ezrin-radixin-like protein;Neurofibromin-2;Schwannomerlin;Schwannomin;, PF00769;PF09380;PF00373;PF09379;, GO:0005912;GO:0045177;GO:0044297;GO:0032154;GO:0030864;GO:0005737;GO:0005856;GO:0005829;GO:0005769;GO:0031527;GO:0030027;GO:0016020;GO:0043005;GO:0005730;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0003779;GO:0030036;GO:0045216;GO:0007398;GO:0021766;GO:0070306;GO:0001707;GO:0030336;GO:0008285;GO:0022408;GO:0001953;GO:0043409;GO:0006469;GO:0046426;GO:0042532;GO:0042475;GO:0045597;GO:0051496;GO:0042981;GO:0051726;GO:0014013;GO:0035330;GO:2000177;GO:1900180;GO:0031647;GO:0072091;GO:0014010;, C:adherens junction; C:apical part of cell; C:cell body; C:cleavage furrow; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome; C:filopodium membrane; C:lamellipodium; C:membrane; C:neuron projection; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:actin binding;, P:actin cytoskeleton organization; P:cell-cell junction organization; P:ectoderm development; P:hippocampus development; P:lens fiber cell differentiation; P:mesoderm formation; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of MAPK cascade; P:negative regulation of protein kinase activity; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of tyrosine phosphorylation of STAT protein; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell differentiation; P:positive regulation of stress fiber assembly; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of gliogenesis; P:regulation of hippo signaling; P:regulation of neural precursor cell proliferation; P:regulation of protein localization to nucleus; P:regulation of protein stability; P:regulation of stem cell proliferation; P:Schwann cell proliferation;|Q9BTW3 Q9UNG9 Q9UNH3 Q9UNH4,Merlin,Moesin-ezrin-radixin-like protein;Neurofibromin-2;Schwannomerlin;Schwannomin;, PF00769;PF09380;PF00373;PF09379;, GO:0005912;GO:0045177;GO:0044297;GO:0032154;GO:0030864;GO:0005737;GO:0005856;GO:0005829;GO:0005769;GO:0031527;GO:0030027;GO:0016020;GO:0043005;GO:0005730;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0003779;GO:0030036;GO:0045216;GO:0007398;GO:0021766;GO:0070306;GO:0001707;GO:0030336;GO:0008285;GO:0022408;GO:0001953;GO:0043409;GO:0006469;GO:0046426;GO:0042532;GO:0042475;GO:0045597;GO:0051496;GO:0042981;GO:0051726;GO:0014013;GO:0035330;GO:2000177;GO:1900180;GO:0031647;GO:0072091;GO:0014010;, C:adherens junction; C:apical part of cell; C:cell body; C:cleavage furrow; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:early endosome; C:filopodium membrane; C:lamellipodium; C:membrane; C:neuron projection; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:actin binding;, P:actin cytoskeleton organization; P:cell-cell junction organization; P:ectoderm development; P:hippocampus development; P:lens fiber cell differentiation; P:mesoderm formation; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of MAPK cascade; P:negative regulation of protein kinase activity; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of tyrosine phosphorylation of STAT protein; P:odontogenesis of dentin-containing tooth; P:positive regulation of cell differentiation; P:positive regulation of stress fiber assembly; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of gliogenesis; P:regulation of hippo signaling; P:regulation of neural precursor cell proliferation; P:regulation of protein localization to nucleus; P:regulation of protein stability; P:regulation of stem cell proliferation; P:Schwann cell proliferation; scaffold60 indexed_genome mRNA 9658995 9662352 . + . ID=transcript_10491;Q86V35,Calcium-binding protein 7,Calneuron II;Calneuron-2;, PF13499;, GO:0016021;GO:0048471;GO:0005886;GO:0032588;GO:0005509;, C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network membrane;, F:calcium ion binding; scaffold60 indexed_genome mRNA 9664740 9683694 . - . ID=transcript_10492;Q9UDW3 A8K9F6,Zinc finger matrin-type protein 5,U11/U12 small nuclear ribonucleoprotein 20 kDa protein;, PF00642;PF06220;, GO:0005654;GO:0005689;GO:0008270;GO:0000398;GO:0008380;, C:nucleoplasm; C:U12-type spliceosomal complex;, F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; scaffold60 indexed_genome mRNA 9684040 9686826 . + . ID=transcript_10493;Q9UDW1 B5MCM5 Q9T2V6,Cytochrome b-c1 complex subunit 9,Complex III subunit 9;Complex III subunit X;Cytochrome c1 non-heme 7 kDa protein;Ubiquinol-cytochrome c reductase complex 7.2 kDa protein;, PF05365;, GO:0016021;GO:0005743;GO:0005750;GO:0008121;GO:0009060;GO:0006122;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III;, F:ubiquinol-cytochrome-c reductase activity;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c;|Q9UDW1 B5MCM5 Q9T2V6,Cytochrome b-c1 complex subunit 9,Complex III subunit 9;Complex III subunit X;Cytochrome c1 non-heme 7 kDa protein;Ubiquinol-cytochrome c reductase complex 7.2 kDa protein;, PF05365;, GO:0016021;GO:0005743;GO:0005750;GO:0008121;GO:0009060;GO:0006122;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III;, F:ubiquinol-cytochrome-c reductase activity;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; scaffold60 indexed_genome mRNA 9701897 9714662 . - . ID=transcript_10494;Q9H1I8 B7Z8E0 F5H6J9 Q4TT54 Q8TAZ0 Q9H711 Q9H9D6,Activating signal cointegrator 1 complex subunit 2,ASC-1 complex subunit p100 {ECO:0000303|PubMed:12077347};Trip4 complex subunit p100 {ECO:0000303|PubMed:12077347};, PF02845;, GO:0099053;GO:0016607;GO:0005654;GO:0005634;GO:0043130;GO:0006307;GO:0006355;, C:activating signal cointegrator 1 complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin binding;, P:DNA dealkylation involved in DNA repair; P:regulation of transcription, DNA-templated;|Q9H1I8 B7Z8E0 F5H6J9 Q4TT54 Q8TAZ0 Q9H711 Q9H9D6,Activating signal cointegrator 1 complex subunit 2,ASC-1 complex subunit p100 {ECO:0000303|PubMed:12077347};Trip4 complex subunit p100 {ECO:0000303|PubMed:12077347};, PF02845;, GO:0099053;GO:0016607;GO:0005654;GO:0005634;GO:0043130;GO:0006307;GO:0006355;, C:activating signal cointegrator 1 complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin binding;, P:DNA dealkylation involved in DNA repair; P:regulation of transcription, DNA-templated; scaffold60 indexed_genome mRNA 9719749 9742473 . - . ID=transcript_10495;Q9H1I8 B7Z8E0 F5H6J9 Q4TT54 Q8TAZ0 Q9H711 Q9H9D6,Activating signal cointegrator 1 complex subunit 2,ASC-1 complex subunit p100 {ECO:0000303|PubMed:12077347};Trip4 complex subunit p100 {ECO:0000303|PubMed:12077347};, PF02845;, GO:0099053;GO:0016607;GO:0005654;GO:0005634;GO:0043130;GO:0006307;GO:0006355;, C:activating signal cointegrator 1 complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin binding;, P:DNA dealkylation involved in DNA repair; P:regulation of transcription, DNA-templated;|Q9H1I8 B7Z8E0 F5H6J9 Q4TT54 Q8TAZ0 Q9H711 Q9H9D6,Activating signal cointegrator 1 complex subunit 2,ASC-1 complex subunit p100 {ECO:0000303|PubMed:12077347};Trip4 complex subunit p100 {ECO:0000303|PubMed:12077347};, PF02845;, GO:0099053;GO:0016607;GO:0005654;GO:0005634;GO:0043130;GO:0006307;GO:0006355;, C:activating signal cointegrator 1 complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin binding;, P:DNA dealkylation involved in DNA repair; P:regulation of transcription, DNA-templated;|Q9H1I8 B7Z8E0 F5H6J9 Q4TT54 Q8TAZ0 Q9H711 Q9H9D6,Activating signal cointegrator 1 complex subunit 2,ASC-1 complex subunit p100 {ECO:0000303|PubMed:12077347};Trip4 complex subunit p100 {ECO:0000303|PubMed:12077347};, PF02845;, GO:0099053;GO:0016607;GO:0005654;GO:0005634;GO:0043130;GO:0006307;GO:0006355;, C:activating signal cointegrator 1 complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin binding;, P:DNA dealkylation involved in DNA repair; P:regulation of transcription, DNA-templated;|Q9H1I8 B7Z8E0 F5H6J9 Q4TT54 Q8TAZ0 Q9H711 Q9H9D6,Activating signal cointegrator 1 complex subunit 2,ASC-1 complex subunit p100 {ECO:0000303|PubMed:12077347};Trip4 complex subunit p100 {ECO:0000303|PubMed:12077347};, PF02845;, GO:0099053;GO:0016607;GO:0005654;GO:0005634;GO:0043130;GO:0006307;GO:0006355;, C:activating signal cointegrator 1 complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ubiquitin binding;, P:DNA dealkylation involved in DNA repair; P:regulation of transcription, DNA-templated; scaffold60 indexed_genome mRNA 9767608 9891962 . + . ID=transcript_10496;Q13615 A5PL26 A7MD32 Q9NYN5 Q9NYN6 Q9UDX6 Q9UEG3,Myotubularin-related protein 3 {ECO:0000305},FYVE domain-containing dual specificity protein phosphatase 1;Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;Zinc finger FYVE domain-containing protein 10;, PF01363;PF06602;, GO:0005737;GO:0005829;GO:0019898;GO:0016020;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0042149;GO:0016236;GO:1904562;GO:0006661;GO:0046856;GO:0006470;GO:2000785;GO:0010506;GO:0060304;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:membrane;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to glucose starvation; P:macroautophagy; P:phosphatidylinositol 5-phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation;|Q13615 A5PL26 A7MD32 Q9NYN5 Q9NYN6 Q9UDX6 Q9UEG3,Myotubularin-related protein 3 {ECO:0000305},FYVE domain-containing dual specificity protein phosphatase 1;Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;Zinc finger FYVE domain-containing protein 10;, PF01363;PF06602;, GO:0005737;GO:0005829;GO:0019898;GO:0016020;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0042149;GO:0016236;GO:1904562;GO:0006661;GO:0046856;GO:0006470;GO:2000785;GO:0010506;GO:0060304;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:membrane;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to glucose starvation; P:macroautophagy; P:phosphatidylinositol 5-phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation;|Q13615 A5PL26 A7MD32 Q9NYN5 Q9NYN6 Q9UDX6 Q9UEG3,Myotubularin-related protein 3 {ECO:0000305},FYVE domain-containing dual specificity protein phosphatase 1;Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;Zinc finger FYVE domain-containing protein 10;, PF01363;PF06602;, GO:0005737;GO:0005829;GO:0019898;GO:0016020;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0042149;GO:0016236;GO:1904562;GO:0006661;GO:0046856;GO:0006470;GO:2000785;GO:0010506;GO:0060304;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:membrane;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to glucose starvation; P:macroautophagy; P:phosphatidylinositol 5-phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation;|Q13615 A5PL26 A7MD32 Q9NYN5 Q9NYN6 Q9UDX6 Q9UEG3,Myotubularin-related protein 3 {ECO:0000305},FYVE domain-containing dual specificity protein phosphatase 1;Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;Zinc finger FYVE domain-containing protein 10;, PF01363;PF06602;, GO:0005737;GO:0005829;GO:0019898;GO:0016020;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0042149;GO:0016236;GO:1904562;GO:0006661;GO:0046856;GO:0006470;GO:2000785;GO:0010506;GO:0060304;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:membrane;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to glucose starvation; P:macroautophagy; P:phosphatidylinositol 5-phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation;|Q13615 A5PL26 A7MD32 Q9NYN5 Q9NYN6 Q9UDX6 Q9UEG3,Myotubularin-related protein 3 {ECO:0000305},FYVE domain-containing dual specificity protein phosphatase 1;Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;Zinc finger FYVE domain-containing protein 10;, PF01363;PF06602;, GO:0005737;GO:0005829;GO:0019898;GO:0016020;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0042149;GO:0016236;GO:1904562;GO:0006661;GO:0046856;GO:0006470;GO:2000785;GO:0010506;GO:0060304;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:membrane;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to glucose starvation; P:macroautophagy; P:phosphatidylinositol 5-phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation;|Q13615 A5PL26 A7MD32 Q9NYN5 Q9NYN6 Q9UDX6 Q9UEG3,Myotubularin-related protein 3 {ECO:0000305},FYVE domain-containing dual specificity protein phosphatase 1;Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;Zinc finger FYVE domain-containing protein 10;, PF01363;PF06602;, GO:0005737;GO:0005829;GO:0019898;GO:0016020;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0042149;GO:0016236;GO:1904562;GO:0006661;GO:0046856;GO:0006470;GO:2000785;GO:0010506;GO:0060304;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:membrane;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to glucose starvation; P:macroautophagy; P:phosphatidylinositol 5-phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation;|Q13615 A5PL26 A7MD32 Q9NYN5 Q9NYN6 Q9UDX6 Q9UEG3,Myotubularin-related protein 3 {ECO:0000305},FYVE domain-containing dual specificity protein phosphatase 1;Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;Zinc finger FYVE domain-containing protein 10;, PF01363;PF06602;, GO:0005737;GO:0005829;GO:0019898;GO:0016020;GO:0046872;GO:0052629;GO:0004438;GO:0019903;GO:0004722;GO:0004725;GO:0042149;GO:0016236;GO:1904562;GO:0006661;GO:0046856;GO:0006470;GO:2000785;GO:0010506;GO:0060304;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:membrane;, F:metal ion binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein phosphatase binding; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to glucose starvation; P:macroautophagy; P:phosphatidylinositol 5-phosphate metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:protein dephosphorylation; P:regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol dephosphorylation; scaffold60 indexed_genome mRNA 10045579 10046594 . + . ID=transcript_10497;P15018 B2RCW7 B5MC23 Q52LZ2,Leukemia inhibitory factor,Differentiation-stimulating factor;Melanoma-derived LPL inhibitor;, PF01291;, GO:0005829;GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005146;GO:0005102;GO:0001974;GO:0019221;GO:0046697;GO:0007566;GO:0006955;GO:0048861;GO:0048286;GO:0060463;GO:0060426;GO:0007275;GO:0048644;GO:0008285;GO:0070373;GO:0046888;GO:0045835;GO:0048666;GO:0048711;GO:0033630;GO:0008284;GO:1901676;GO:0045651;GO:0043410;GO:0072108;GO:0033138;GO:0033141;GO:0050731;GO:1900182;GO:0045944;GO:0042531;GO:0045595;GO:0072307;GO:1903025;GO:0060708;GO:0048863;GO:0019827;GO:0060707;GO:0007260;, C:cytosol; C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:leukemia inhibitory factor receptor binding; F:signaling receptor binding;, P:blood vessel remodeling; P:cytokine-mediated signaling pathway; P:decidualization; P:embryo implantation; P:immune response; P:leukemia inhibitory factor signaling pathway; P:lung alveolus development; P:lung lobe morphogenesis; P:lung vasculature development; P:multicellular organism development; P:muscle organ morphogenesis; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of hormone secretion; P:negative regulation of meiotic nuclear division; P:neuron development; P:positive regulation of astrocyte differentiation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell population proliferation; P:positive regulation of histone H3-K27 acetylation; P:positive regulation of macrophage differentiation; P:positive regulation of MAPK cascade; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of cell differentiation; P:regulation of metanephric nephron tubule epithelial cell differentiation; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:spongiotrophoblast differentiation; P:stem cell differentiation; P:stem cell population maintenance; P:trophoblast giant cell differentiation; P:tyrosine phosphorylation of STAT protein; scaffold60 indexed_genome mRNA 10065465 10068736 . - . ID=transcript_10498;P13725 Q6FHP8 Q9UCP6,Oncostatin-M,, PF01291;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005147;GO:0019221;GO:0006955;GO:0007275;GO:0008285;GO:0046888;GO:0038165;GO:0002675;GO:0051781;GO:0008284;GO:0050729;GO:0032740;GO:0043410;GO:0033138;GO:0050731;GO:0014068;GO:0051897;GO:0045944;GO:0042531;GO:0040008;GO:1902036;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:oncostatin-M receptor binding;, P:cytokine-mediated signaling pathway; P:immune response; P:multicellular organism development; P:negative regulation of cell population proliferation; P:negative regulation of hormone secretion; P:oncostatin-M-mediated signaling pathway; P:positive regulation of acute inflammatory response; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-17 production; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of growth; P:regulation of hematopoietic stem cell differentiation; scaffold60 indexed_genome mRNA 10082516 10087131 . - . ID=transcript_10499;Q8WTX7 O76052 Q96ND9 Q9UIE8,Cytosolic arginine sensor for mTORC1 subunit 1 {ECO:0000312|HGNC:HGNC:34423},Cellular arginine sensor for mTORC1 protein 1 {ECO:0000305|PubMed:26972053};GATS-like protein 3 {ECO:0000305};, PF13840;PF18700;, GO:0005829;GO:0034618;GO:0042802;GO:0034198;GO:1903577;GO:1904262;GO:1902531;, C:cytosol;, F:arginine binding; F:identical protein binding;, P:cellular response to amino acid starvation; P:cellular response to L-arginine; P:negative regulation of TORC1 signaling; P:regulation of intracellular signal transduction;|Q8WTX7 O76052 Q96ND9 Q9UIE8,Cytosolic arginine sensor for mTORC1 subunit 1 {ECO:0000312|HGNC:HGNC:34423},Cellular arginine sensor for mTORC1 protein 1 {ECO:0000305|PubMed:26972053};GATS-like protein 3 {ECO:0000305};, PF13840;PF18700;, GO:0005829;GO:0034618;GO:0042802;GO:0034198;GO:1903577;GO:1904262;GO:1902531;, C:cytosol;, F:arginine binding; F:identical protein binding;, P:cellular response to amino acid starvation; P:cellular response to L-arginine; P:negative regulation of TORC1 signaling; P:regulation of intracellular signal transduction;|Q8WTX7 O76052 Q96ND9 Q9UIE8,Cytosolic arginine sensor for mTORC1 subunit 1 {ECO:0000312|HGNC:HGNC:34423},Cellular arginine sensor for mTORC1 protein 1 {ECO:0000305|PubMed:26972053};GATS-like protein 3 {ECO:0000305};, PF13840;PF18700;, GO:0005829;GO:0034618;GO:0042802;GO:0034198;GO:1903577;GO:1904262;GO:1902531;, C:cytosol;, F:arginine binding; F:identical protein binding;, P:cellular response to amino acid starvation; P:cellular response to L-arginine; P:negative regulation of TORC1 signaling; P:regulation of intracellular signal transduction; scaffold60 indexed_genome mRNA 10089328 10118019 . + . ID=transcript_10500;Q9BXI6 B3KXT8 O76053 Q20WK7 Q543A2,TBC1 domain family member 10A,EBP50-PDX interactor of 64 kDa;Rab27A-GAP-alpha;, PF00566;, GO:0005829;GO:0070062;GO:0005902;GO:0005886;GO:0045296;GO:0005096;GO:0005085;GO:0030165;GO:0097202;GO:0090630;GO:0006886;GO:0045862;GO:0042147;, C:cytosol; C:extracellular exosome; C:microvillus; C:plasma membrane;, F:cadherin binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding;, P:activation of cysteine-type endopeptidase activity; P:activation of GTPase activity; P:intracellular protein transport; P:positive regulation of proteolysis; P:retrograde transport, endosome to Golgi;|Q9BXI6 B3KXT8 O76053 Q20WK7 Q543A2,TBC1 domain family member 10A,EBP50-PDX interactor of 64 kDa;Rab27A-GAP-alpha;, PF00566;, GO:0005829;GO:0070062;GO:0005902;GO:0005886;GO:0045296;GO:0005096;GO:0005085;GO:0030165;GO:0097202;GO:0090630;GO:0006886;GO:0045862;GO:0042147;, C:cytosol; C:extracellular exosome; C:microvillus; C:plasma membrane;, F:cadherin binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding;, P:activation of cysteine-type endopeptidase activity; P:activation of GTPase activity; P:intracellular protein transport; P:positive regulation of proteolysis; P:retrograde transport, endosome to Golgi;|Q9BXI6 B3KXT8 O76053 Q20WK7 Q543A2,TBC1 domain family member 10A,EBP50-PDX interactor of 64 kDa;Rab27A-GAP-alpha;, PF00566;, GO:0005829;GO:0070062;GO:0005902;GO:0005886;GO:0045296;GO:0005096;GO:0005085;GO:0030165;GO:0097202;GO:0090630;GO:0006886;GO:0045862;GO:0042147;, C:cytosol; C:extracellular exosome; C:microvillus; C:plasma membrane;, F:cadherin binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding;, P:activation of cysteine-type endopeptidase activity; P:activation of GTPase activity; P:intracellular protein transport; P:positive regulation of proteolysis; P:retrograde transport, endosome to Golgi;|Q9BXI6 B3KXT8 O76053 Q20WK7 Q543A2,TBC1 domain family member 10A,EBP50-PDX interactor of 64 kDa;Rab27A-GAP-alpha;, PF00566;, GO:0005829;GO:0070062;GO:0005902;GO:0005886;GO:0045296;GO:0005096;GO:0005085;GO:0030165;GO:0097202;GO:0090630;GO:0006886;GO:0045862;GO:0042147;, C:cytosol; C:extracellular exosome; C:microvillus; C:plasma membrane;, F:cadherin binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding;, P:activation of cysteine-type endopeptidase activity; P:activation of GTPase activity; P:intracellular protein transport; P:positive regulation of proteolysis; P:retrograde transport, endosome to Golgi;|Q9BXI6 B3KXT8 O76053 Q20WK7 Q543A2,TBC1 domain family member 10A,EBP50-PDX interactor of 64 kDa;Rab27A-GAP-alpha;, PF00566;, GO:0005829;GO:0070062;GO:0005902;GO:0005886;GO:0045296;GO:0005096;GO:0005085;GO:0030165;GO:0097202;GO:0090630;GO:0006886;GO:0045862;GO:0042147;, C:cytosol; C:extracellular exosome; C:microvillus; C:plasma membrane;, F:cadherin binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding;, P:activation of cysteine-type endopeptidase activity; P:activation of GTPase activity; P:intracellular protein transport; P:positive regulation of proteolysis; P:retrograde transport, endosome to Golgi;|Q9BXI6 B3KXT8 O76053 Q20WK7 Q543A2,TBC1 domain family member 10A,EBP50-PDX interactor of 64 kDa;Rab27A-GAP-alpha;, PF00566;, GO:0005829;GO:0070062;GO:0005902;GO:0005886;GO:0045296;GO:0005096;GO:0005085;GO:0030165;GO:0097202;GO:0090630;GO:0006886;GO:0045862;GO:0042147;, C:cytosol; C:extracellular exosome; C:microvillus; C:plasma membrane;, F:cadherin binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding;, P:activation of cysteine-type endopeptidase activity; P:activation of GTPase activity; P:intracellular protein transport; P:positive regulation of proteolysis; P:retrograde transport, endosome to Golgi; scaffold60 indexed_genome mRNA 10130713 10156671 . - . ID=transcript_10501;Q15459 E9PAW1,Splicing factor 3A subunit 1,SF3a120 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847, ECO:0000303|PubMed:7489498};Spliceosome-associated protein 114;, PF12230;PF01805;PF00240;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0071004;GO:0005684;GO:0003723;GO:0000389;GO:0006397;GO:0000398;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:U2-type prespliceosome assembly;|Q15459 E9PAW1,Splicing factor 3A subunit 1,SF3a120 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847, ECO:0000303|PubMed:7489498};Spliceosome-associated protein 114;, PF12230;PF01805;PF00240;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0071004;GO:0005684;GO:0003723;GO:0000389;GO:0006397;GO:0000398;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:U2-type prespliceosome assembly;|Q15459 E9PAW1,Splicing factor 3A subunit 1,SF3a120 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847, ECO:0000303|PubMed:7489498};Spliceosome-associated protein 114;, PF12230;PF01805;PF00240;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0071004;GO:0005684;GO:0003723;GO:0000389;GO:0006397;GO:0000398;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:U2-type prespliceosome assembly;|P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q15459 E9PAW1,Splicing factor 3A subunit 1,SF3a120 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847, ECO:0000303|PubMed:7489498};Spliceosome-associated protein 114;, PF12230;PF01805;PF00240;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0071004;GO:0005684;GO:0003723;GO:0000389;GO:0006397;GO:0000398;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:U2-type prespliceosome assembly;|Q569K6 Q0VD76 Q9BYA4,Coiled-coil domain-containing protein 157|Q569K6 Q0VD76 Q9BYA4,Coiled-coil domain-containing protein 157 scaffold60 indexed_genome mRNA 10157204 10168430 . - . ID=transcript_10502;Q569K6 Q0VD76 Q9BYA4,Coiled-coil domain-containing protein 157|Q569K6 Q0VD76 Q9BYA4,Coiled-coil domain-containing protein 157|Q569K6 Q0VD76 Q9BYA4,Coiled-coil domain-containing protein 157|Q9Y6U7 A6NEL1,RING finger protein 215,, PF13639;, GO:0005768;GO:0017119;GO:0016021;GO:0016020;GO:0005802;GO:0046872;GO:0061630;GO:0006896;GO:0006623;GO:0006511;, C:endosome; C:Golgi transport complex; C:integral component of membrane; C:membrane; C:trans-Golgi network;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:Golgi to vacuole transport; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process;|Q9Y6U7 A6NEL1,RING finger protein 215,, PF13639;, GO:0005768;GO:0017119;GO:0016021;GO:0016020;GO:0005802;GO:0046872;GO:0061630;GO:0006896;GO:0006623;GO:0006511;, C:endosome; C:Golgi transport complex; C:integral component of membrane; C:membrane; C:trans-Golgi network;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:Golgi to vacuole transport; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process; scaffold60 indexed_genome mRNA 10193459 10215754 . + . ID=transcript_10503;O76054 B7Z8Q1 F5H3U4 Q53EQ2 Q6PD61 Q9ULN4,SEC14-like protein 2,Alpha-tocopherol-associated protein;Squalene transfer protein;Supernatant protein factor;, PF00650;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005543;GO:0008431;GO:0045893;GO:0045540;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:phospholipid binding; F:vitamin E binding;, P:positive regulation of transcription, DNA-templated; P:regulation of cholesterol biosynthetic process;|O76054 B7Z8Q1 F5H3U4 Q53EQ2 Q6PD61 Q9ULN4,SEC14-like protein 2,Alpha-tocopherol-associated protein;Squalene transfer protein;Supernatant protein factor;, PF00650;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005543;GO:0008431;GO:0045893;GO:0045540;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:phospholipid binding; F:vitamin E binding;, P:positive regulation of transcription, DNA-templated; P:regulation of cholesterol biosynthetic process;|O76054 B7Z8Q1 F5H3U4 Q53EQ2 Q6PD61 Q9ULN4,SEC14-like protein 2,Alpha-tocopherol-associated protein;Squalene transfer protein;Supernatant protein factor;, PF00650;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005543;GO:0008431;GO:0045893;GO:0045540;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:phospholipid binding; F:vitamin E binding;, P:positive regulation of transcription, DNA-templated; P:regulation of cholesterol biosynthetic process;|O76054 B7Z8Q1 F5H3U4 Q53EQ2 Q6PD61 Q9ULN4,SEC14-like protein 2,Alpha-tocopherol-associated protein;Squalene transfer protein;Supernatant protein factor;, PF00650;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005543;GO:0008431;GO:0045893;GO:0045540;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:phospholipid binding; F:vitamin E binding;, P:positive regulation of transcription, DNA-templated; P:regulation of cholesterol biosynthetic process; scaffold60 indexed_genome mRNA 10217555 10220779 . + . ID=transcript_10504;Q9UDX5 A6NFQ5 Q9H3K1 Q9P0N6,Mitochondrial fission process protein 1,Mitochondrial 18 kDa protein;, PF10558;, GO:0016021;GO:0005743;GO:0005739;GO:0006915;GO:0000266;GO:0014850;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:apoptotic process; P:mitochondrial fission; P:response to muscle activity;|Q9UDX5 A6NFQ5 Q9H3K1 Q9P0N6,Mitochondrial fission process protein 1,Mitochondrial 18 kDa protein;, PF10558;, GO:0016021;GO:0005743;GO:0005739;GO:0006915;GO:0000266;GO:0014850;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:apoptotic process; P:mitochondrial fission; P:response to muscle activity;|Q9UDX5 A6NFQ5 Q9H3K1 Q9P0N6,Mitochondrial fission process protein 1,Mitochondrial 18 kDa protein;, PF10558;, GO:0016021;GO:0005743;GO:0005739;GO:0006915;GO:0000266;GO:0014850;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, , P:apoptotic process; P:mitochondrial fission; P:response to muscle activity; scaffold60 indexed_genome mRNA 10225173 10227238 . - . ID=transcript_10505;Q9UDX4 E7EN74 E9PE57 Q495V8 Q495W0 Q495W1,SEC14-like protein 3,Tocopherol-associated protein 2;, PF00650;, GO:0070062;GO:0008289;, C:extracellular exosome;, F:lipid binding; scaffold60 indexed_genome mRNA 10227949 10231024 . - . ID=transcript_10506;Q9UDX4 E7EN74 E9PE57 Q495V8 Q495W0 Q495W1,SEC14-like protein 3,Tocopherol-associated protein 2;, PF00650;, GO:0070062;GO:0008289;, C:extracellular exosome;, F:lipid binding;|Q9UDX4 E7EN74 E9PE57 Q495V8 Q495W0 Q495W1,SEC14-like protein 3,Tocopherol-associated protein 2;, PF00650;, GO:0070062;GO:0008289;, C:extracellular exosome;, F:lipid binding; scaffold60 indexed_genome mRNA 10232231 10234750 . - . ID=transcript_10507;Q9UDX4 E7EN74 E9PE57 Q495V8 Q495W0 Q495W1,SEC14-like protein 3,Tocopherol-associated protein 2;, PF00650;, GO:0070062;GO:0008289;, C:extracellular exosome;, F:lipid binding; scaffold60 indexed_genome mRNA 10245632 10259263 . - . ID=transcript_10508;Q9UDX3 A5D6W7 A6NCV4,SEC14-like protein 4,Tocopherol-associated protein 3;, PF00650;, GO:0008289;, , F:lipid binding;|Q9UDX4 E7EN74 E9PE57 Q495V8 Q495W0 Q495W1,SEC14-like protein 3,Tocopherol-associated protein 2;, PF00650;, GO:0070062;GO:0008289;, C:extracellular exosome;, F:lipid binding;|Q9UDX3 A5D6W7 A6NCV4,SEC14-like protein 4,Tocopherol-associated protein 3;, PF00650;, GO:0008289;, , F:lipid binding;|Q9UDX3 A5D6W7 A6NCV4,SEC14-like protein 4,Tocopherol-associated protein 3;, PF00650;, GO:0008289;, , F:lipid binding;|Q9UDX3 A5D6W7 A6NCV4,SEC14-like protein 4,Tocopherol-associated protein 3;, PF00650;, GO:0008289;, , F:lipid binding;|Q9UDX3 A5D6W7 A6NCV4,SEC14-like protein 4,Tocopherol-associated protein 3;, PF00650;, GO:0008289;, , F:lipid binding; scaffold60 indexed_genome mRNA 10269873 10275884 . - . ID=transcript_10509;B5MCN3,Putative SEC14-like protein 6,, PF00650;|Q9UDX3 A5D6W7 A6NCV4,SEC14-like protein 4,Tocopherol-associated protein 3;, PF00650;, GO:0008289;, , F:lipid binding; scaffold60 indexed_genome mRNA 10282562 10283873 . - . ID=transcript_10510;Q99999 Q96C63,Galactosylceramide sulfotransferase {ECO:0000305},3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase {ECO:0000303|PubMed:8830034};3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase {ECO:0000303|PubMed:9030544};Cerebroside sulfotransferase {ECO:0000250|UniProtKB:Q9JHE4};, PF06990;, GO:0000139;GO:0005887;GO:0016020;GO:0050694;GO:0001733;GO:0008146;GO:0006682;GO:0006681;GO:0046486;GO:0042552;GO:0006487;GO:0007283;GO:0006665;, C:Golgi membrane; C:integral component of plasma membrane; C:membrane;, F:galactose 3-O-sulfotransferase activity; F:galactosylceramide sulfotransferase activity; F:sulfotransferase activity;, P:galactosylceramide biosynthetic process; P:galactosylceramide metabolic process; P:glycerolipid metabolic process; P:myelination; P:protein N-linked glycosylation; P:spermatogenesis; P:sphingolipid metabolic process; scaffold60 indexed_genome mRNA 10308553 10313623 . - . ID=transcript_10511;O00541 Q6IC29,Pescadillo homolog {ECO:0000255|HAMAP-Rule:MF_03028},, PF16589;PF06732;, GO:0005694;GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0070545;GO:0030687;GO:0043021;GO:0003723;GO:0008283;GO:0000466;GO:0000463;GO:0051726;GO:0042273;GO:0006364;, C:chromosome; C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm; C:PeBoW complex; C:preribosome, large subunit precursor;, F:ribonucleoprotein complex binding; F:RNA binding;, P:cell population proliferation; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of cell cycle; P:ribosomal large subunit biogenesis; P:rRNA processing;|O00541 Q6IC29,Pescadillo homolog {ECO:0000255|HAMAP-Rule:MF_03028},, PF16589;PF06732;, GO:0005694;GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0070545;GO:0030687;GO:0043021;GO:0003723;GO:0008283;GO:0000466;GO:0000463;GO:0051726;GO:0042273;GO:0006364;, C:chromosome; C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm; C:PeBoW complex; C:preribosome, large subunit precursor;, F:ribonucleoprotein complex binding; F:RNA binding;, P:cell population proliferation; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of cell cycle; P:ribosomal large subunit biogenesis; P:rRNA processing;|O00541 Q6IC29,Pescadillo homolog {ECO:0000255|HAMAP-Rule:MF_03028},, PF16589;PF06732;, GO:0005694;GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0070545;GO:0030687;GO:0043021;GO:0003723;GO:0008283;GO:0000466;GO:0000463;GO:0051726;GO:0042273;GO:0006364;, C:chromosome; C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm; C:PeBoW complex; C:preribosome, large subunit precursor;, F:ribonucleoprotein complex binding; F:RNA binding;, P:cell population proliferation; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of cell cycle; P:ribosomal large subunit biogenesis; P:rRNA processing; scaffold60 indexed_genome mRNA 10330354 10346020 . + . ID=transcript_10512;P20062 Q96FD4 Q9BVI8 Q9UCI5 Q9UCI6 Q9UDM0,Transcobalamin-2,Transcobalamin II;, PF01122;PF14478;, GO:0005768;GO:0005576;GO:0005615;GO:0043202;GO:0031419;GO:0046872;GO:0009235;GO:0015889;GO:0006824;, C:endosome; C:extracellular region; C:extracellular space; C:lysosomal lumen;, F:cobalamin binding; F:metal ion binding;, P:cobalamin metabolic process; P:cobalamin transport; P:cobalt ion transport;|P20062 Q96FD4 Q9BVI8 Q9UCI5 Q9UCI6 Q9UDM0,Transcobalamin-2,Transcobalamin II;, PF01122;PF14478;, GO:0005768;GO:0005576;GO:0005615;GO:0043202;GO:0031419;GO:0046872;GO:0009235;GO:0015889;GO:0006824;, C:endosome; C:extracellular region; C:extracellular space; C:lysosomal lumen;, F:cobalamin binding; F:metal ion binding;, P:cobalamin metabolic process; P:cobalamin transport; P:cobalt ion transport;|P20062 Q96FD4 Q9BVI8 Q9UCI5 Q9UCI6 Q9UDM0,Transcobalamin-2,Transcobalamin II;, PF01122;PF14478;, GO:0005768;GO:0005576;GO:0005615;GO:0043202;GO:0031419;GO:0046872;GO:0009235;GO:0015889;GO:0006824;, C:endosome; C:extracellular region; C:extracellular space; C:lysosomal lumen;, F:cobalamin binding; F:metal ion binding;, P:cobalamin metabolic process; P:cobalamin transport; P:cobalt ion transport; scaffold60 indexed_genome mRNA 10362246 10366403 . + . ID=transcript_10513;Q6ICL7 Q567P0,Solute carrier family 35 member E4,, PF03151;, GO:0005794;GO:0016021;GO:0015297;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity;|Q6ICL7 Q567P0,Solute carrier family 35 member E4,, PF03151;, GO:0005794;GO:0016021;GO:0015297;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity;|Q6ICL7 Q567P0,Solute carrier family 35 member E4,, PF03151;, GO:0005794;GO:0016021;GO:0015297;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity; scaffold60 indexed_genome mRNA 10378233 10383238 . - . ID=transcript_10514;Q8NEJ0 B3KPA4,Dual specificity protein phosphatase 18,Low molecular weight dual specificity phosphatase 20 {ECO:0000303|PubMed:12408986};, , GO:0005737;GO:0005743;GO:0005654;GO:0005634;GO:0017017;GO:0016791;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0016311;GO:0035970;GO:0035335;, C:cytoplasm; C:mitochondrial inner membrane; C:nucleoplasm; C:nucleus;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dephosphorylation; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; scaffold60 indexed_genome mRNA 10384829 10386230 . - . ID=transcript_10515;A6NGY3,Uncharacterized protein C5orf52,, PF17666; scaffold60 indexed_genome mRNA 10386400 10387158 . - . ID=transcript_10516;A6NGY3,Uncharacterized protein C5orf52,, PF17666; scaffold60 indexed_genome mRNA 10396900 10515642 . + . ID=transcript_10517;Q9BY96 Q9BZF0,Oxysterol-binding protein 2,Oxysterol-binding protein-related protein 4;, PF01237;PF00169;, GO:0097440;GO:0005829;GO:0043231;GO:0016020;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0007286;, C:apical dendrite; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:spermatid development;|Q9BY96 Q9BZF0,Oxysterol-binding protein 2,Oxysterol-binding protein-related protein 4;, PF01237;PF00169;, GO:0097440;GO:0005829;GO:0043231;GO:0016020;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0007286;, C:apical dendrite; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:spermatid development;|Q9BY96 Q9BZF0,Oxysterol-binding protein 2,Oxysterol-binding protein-related protein 4;, PF01237;PF00169;, GO:0097440;GO:0005829;GO:0043231;GO:0016020;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0007286;, C:apical dendrite; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:spermatid development;|Q9BY96 Q9BZF0,Oxysterol-binding protein 2,Oxysterol-binding protein-related protein 4;, PF01237;PF00169;, GO:0097440;GO:0005829;GO:0043231;GO:0016020;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0007286;, C:apical dendrite; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:spermatid development;|Q9BY96 Q9BZF0,Oxysterol-binding protein 2,Oxysterol-binding protein-related protein 4;, PF01237;PF00169;, GO:0097440;GO:0005829;GO:0043231;GO:0016020;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0007286;, C:apical dendrite; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:spermatid development;|Q9BY96 Q9BZF0,Oxysterol-binding protein 2,Oxysterol-binding protein-related protein 4;, PF01237;PF00169;, GO:0097440;GO:0005829;GO:0043231;GO:0016020;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0007286;, C:apical dendrite; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:spermatid development;|Q9BY96 Q9BZF0,Oxysterol-binding protein 2,Oxysterol-binding protein-related protein 4;, PF01237;PF00169;, GO:0097440;GO:0005829;GO:0043231;GO:0016020;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0007286;, C:apical dendrite; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:spermatid development; scaffold60 indexed_genome mRNA 10530238 10536354 . + . ID=transcript_10518;Q9Y6X9 B2RNB1 Q9UF28 Q9Y6V2,ATPase MORC2 {ECO:0000305},MORC family CW-type zinc finger protein 2 {ECO:0000305};Zinc finger CW-type coiled-coil domain protein 1;, PF17942;PF07496;, GO:0005737;GO:0005829;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0000287;GO:0042803;GO:0008270;GO:0006974;GO:0006338;GO:0006631;GO:0045814;GO:0045869;GO:0090309;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:magnesium ion binding; F:protein homodimerization activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:fatty acid metabolic process; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; scaffold60 indexed_genome mRNA 10536376 10574288 . - . ID=transcript_10519;Q9Y6X9 B2RNB1 Q9UF28 Q9Y6V2,ATPase MORC2 {ECO:0000305},MORC family CW-type zinc finger protein 2 {ECO:0000305};Zinc finger CW-type coiled-coil domain protein 1;, PF17942;PF07496;, GO:0005737;GO:0005829;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0000287;GO:0042803;GO:0008270;GO:0006974;GO:0006338;GO:0006631;GO:0045814;GO:0045869;GO:0090309;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:magnesium ion binding; F:protein homodimerization activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:fatty acid metabolic process; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly;|Q9Y6X9 B2RNB1 Q9UF28 Q9Y6V2,ATPase MORC2 {ECO:0000305},MORC family CW-type zinc finger protein 2 {ECO:0000305};Zinc finger CW-type coiled-coil domain protein 1;, PF17942;PF07496;, GO:0005737;GO:0005829;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0000287;GO:0042803;GO:0008270;GO:0006974;GO:0006338;GO:0006631;GO:0045814;GO:0045869;GO:0090309;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:magnesium ion binding; F:protein homodimerization activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:fatty acid metabolic process; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly;|Q9Y6X9 B2RNB1 Q9UF28 Q9Y6V2,ATPase MORC2 {ECO:0000305},MORC family CW-type zinc finger protein 2 {ECO:0000305};Zinc finger CW-type coiled-coil domain protein 1;, PF17942;PF07496;, GO:0005737;GO:0005829;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0000287;GO:0042803;GO:0008270;GO:0006974;GO:0006338;GO:0006631;GO:0045814;GO:0045869;GO:0090309;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:magnesium ion binding; F:protein homodimerization activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:fatty acid metabolic process; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly;|Q9Y6X9 B2RNB1 Q9UF28 Q9Y6V2,ATPase MORC2 {ECO:0000305},MORC family CW-type zinc finger protein 2 {ECO:0000305};Zinc finger CW-type coiled-coil domain protein 1;, PF17942;PF07496;, GO:0005737;GO:0005829;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0000287;GO:0042803;GO:0008270;GO:0006974;GO:0006338;GO:0006631;GO:0045814;GO:0045869;GO:0090309;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:magnesium ion binding; F:protein homodimerization activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:fatty acid metabolic process; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly;|Q9Y6X9 B2RNB1 Q9UF28 Q9Y6V2,ATPase MORC2 {ECO:0000305},MORC family CW-type zinc finger protein 2 {ECO:0000305};Zinc finger CW-type coiled-coil domain protein 1;, PF17942;PF07496;, GO:0005737;GO:0005829;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0000287;GO:0042803;GO:0008270;GO:0006974;GO:0006338;GO:0006631;GO:0045814;GO:0045869;GO:0090309;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:magnesium ion binding; F:protein homodimerization activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:fatty acid metabolic process; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly;|Q9Y6X9 B2RNB1 Q9UF28 Q9Y6V2,ATPase MORC2 {ECO:0000305},MORC family CW-type zinc finger protein 2 {ECO:0000305};Zinc finger CW-type coiled-coil domain protein 1;, PF17942;PF07496;, GO:0005737;GO:0005829;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0000287;GO:0042803;GO:0008270;GO:0006974;GO:0006338;GO:0006631;GO:0045814;GO:0045869;GO:0090309;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:magnesium ion binding; F:protein homodimerization activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:fatty acid metabolic process; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly;|Q9Y6X9 B2RNB1 Q9UF28 Q9Y6V2,ATPase MORC2 {ECO:0000305},MORC family CW-type zinc finger protein 2 {ECO:0000305};Zinc finger CW-type coiled-coil domain protein 1;, PF17942;PF07496;, GO:0005737;GO:0005829;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0000287;GO:0042803;GO:0008270;GO:0006974;GO:0006338;GO:0006631;GO:0045814;GO:0045869;GO:0090309;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:magnesium ion binding; F:protein homodimerization activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:fatty acid metabolic process; P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; scaffold60 indexed_genome mRNA 10661654 10679674 . + . ID=transcript_10520;Q9UIT2,Smoothelin,, PF00307;PF12510;, GO:0015629;GO:0005737;GO:0005856;GO:0031941;GO:0005815;GO:0003779;GO:0008307;GO:0030036;GO:0007517;GO:0006939;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:filamentous actin; C:microtubule organizing center;, F:actin binding; F:structural constituent of muscle;, P:actin cytoskeleton organization; P:muscle organ development; P:smooth muscle contraction;|Q9UIT2,Smoothelin,, PF00307;PF12510;, GO:0015629;GO:0005737;GO:0005856;GO:0031941;GO:0005815;GO:0003779;GO:0008307;GO:0030036;GO:0007517;GO:0006939;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:filamentous actin; C:microtubule organizing center;, F:actin binding; F:structural constituent of muscle;, P:actin cytoskeleton organization; P:muscle organ development; P:smooth muscle contraction; scaffold60 indexed_genome mRNA 10679721 10689279 . - . ID=transcript_10521;Q9UIT2,Smoothelin,, PF00307;PF12510;, GO:0015629;GO:0005737;GO:0005856;GO:0031941;GO:0005815;GO:0003779;GO:0008307;GO:0030036;GO:0007517;GO:0006939;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:filamentous actin; C:microtubule organizing center;, F:actin binding; F:structural constituent of muscle;, P:actin cytoskeleton organization; P:muscle organ development; P:smooth muscle contraction; scaffold60 indexed_genome mRNA 10689283 10692476 . - . ID=transcript_10522;Q8WWX9 A8MPZ2,Selenoprotein M {ECO:0000303|PubMed:27645994},, PF08806;, GO:0005788;GO:0005794;GO:0048471;GO:0016491;GO:0060612;GO:0035934;GO:0042445;GO:0035264;GO:0010269;, C:endoplasmic reticulum lumen; C:Golgi apparatus; C:perinuclear region of cytoplasm;, F:oxidoreductase activity;, P:adipose tissue development; P:corticosterone secretion; P:hormone metabolic process; P:multicellular organism growth; P:response to selenium ion; scaffold60 indexed_genome mRNA 10692787 10710120 . + . ID=transcript_10523;Q15735 B3KS54 Q32M61 Q6ZTH6 Q8N902 Q9UDT9,Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A,Inositol polyphosphate 5-phosphatase J;, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0043198;GO:0019898;GO:0030426;GO:0005886;GO:0001726;GO:0052659;GO:0052658;GO:0004445;GO:0034485;GO:0004439;GO:0017124;GO:0046855;GO:0043647;GO:0031115;GO:0010977;GO:0033137;GO:0006661;GO:0046856;, C:cytoplasm; C:cytosol; C:dendritic shaft; C:extrinsic component of membrane; C:growth cone; C:plasma membrane; C:ruffle;, F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:SH3 domain binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:negative regulation of microtubule polymerization; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-serine phosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q15735 B3KS54 Q32M61 Q6ZTH6 Q8N902 Q9UDT9,Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A,Inositol polyphosphate 5-phosphatase J;, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0043198;GO:0019898;GO:0030426;GO:0005886;GO:0001726;GO:0052659;GO:0052658;GO:0004445;GO:0034485;GO:0004439;GO:0017124;GO:0046855;GO:0043647;GO:0031115;GO:0010977;GO:0033137;GO:0006661;GO:0046856;, C:cytoplasm; C:cytosol; C:dendritic shaft; C:extrinsic component of membrane; C:growth cone; C:plasma membrane; C:ruffle;, F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:SH3 domain binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:negative regulation of microtubule polymerization; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-serine phosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q15735 B3KS54 Q32M61 Q6ZTH6 Q8N902 Q9UDT9,Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A,Inositol polyphosphate 5-phosphatase J;, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0043198;GO:0019898;GO:0030426;GO:0005886;GO:0001726;GO:0052659;GO:0052658;GO:0004445;GO:0034485;GO:0004439;GO:0017124;GO:0046855;GO:0043647;GO:0031115;GO:0010977;GO:0033137;GO:0006661;GO:0046856;, C:cytoplasm; C:cytosol; C:dendritic shaft; C:extrinsic component of membrane; C:growth cone; C:plasma membrane; C:ruffle;, F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:SH3 domain binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:negative regulation of microtubule polymerization; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-serine phosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q15735 B3KS54 Q32M61 Q6ZTH6 Q8N902 Q9UDT9,Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A,Inositol polyphosphate 5-phosphatase J;, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0043198;GO:0019898;GO:0030426;GO:0005886;GO:0001726;GO:0052659;GO:0052658;GO:0004445;GO:0034485;GO:0004439;GO:0017124;GO:0046855;GO:0043647;GO:0031115;GO:0010977;GO:0033137;GO:0006661;GO:0046856;, C:cytoplasm; C:cytosol; C:dendritic shaft; C:extrinsic component of membrane; C:growth cone; C:plasma membrane; C:ruffle;, F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:SH3 domain binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:negative regulation of microtubule polymerization; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-serine phosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q15735 B3KS54 Q32M61 Q6ZTH6 Q8N902 Q9UDT9,Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A,Inositol polyphosphate 5-phosphatase J;, PF03372;PF17751;, GO:0005737;GO:0005829;GO:0043198;GO:0019898;GO:0030426;GO:0005886;GO:0001726;GO:0052659;GO:0052658;GO:0004445;GO:0034485;GO:0004439;GO:0017124;GO:0046855;GO:0043647;GO:0031115;GO:0010977;GO:0033137;GO:0006661;GO:0046856;, C:cytoplasm; C:cytosol; C:dendritic shaft; C:extrinsic component of membrane; C:growth cone; C:plasma membrane; C:ruffle;, F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:SH3 domain binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:negative regulation of microtubule polymerization; P:negative regulation of neuron projection development; P:negative regulation of peptidyl-serine phosphorylation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; scaffold60 indexed_genome mRNA 10740563 10756590 . + . ID=transcript_10524;Q96GF1 A8K5C1 A9X3T8 Q8N900,E3 ubiquitin-protein ligase RNF185,RING finger protein 185;RING-type E3 ubiquitin transferase RNF185 {ECO:0000305};, , GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0005741;GO:0046872;GO:0044877;GO:0043130;GO:0061630;GO:0044390;GO:0006914;GO:1904380;GO:0071712;GO:0036503;GO:1904294;GO:0051865;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:mitochondrial outer membrane;, F:metal ion binding; F:protein-containing complex binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:autophagy; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:positive regulation of ERAD pathway; P:protein autoubiquitination; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q96GF1 A8K5C1 A9X3T8 Q8N900,E3 ubiquitin-protein ligase RNF185,RING finger protein 185;RING-type E3 ubiquitin transferase RNF185 {ECO:0000305};, , GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0005741;GO:0046872;GO:0044877;GO:0043130;GO:0061630;GO:0044390;GO:0006914;GO:1904380;GO:0071712;GO:0036503;GO:1904294;GO:0051865;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:mitochondrial outer membrane;, F:metal ion binding; F:protein-containing complex binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:autophagy; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:positive regulation of ERAD pathway; P:protein autoubiquitination; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q96GF1 A8K5C1 A9X3T8 Q8N900,E3 ubiquitin-protein ligase RNF185,RING finger protein 185;RING-type E3 ubiquitin transferase RNF185 {ECO:0000305};, , GO:0005783;GO:0005789;GO:0044322;GO:0016021;GO:0005741;GO:0046872;GO:0044877;GO:0043130;GO:0061630;GO:0044390;GO:0006914;GO:1904380;GO:0071712;GO:0036503;GO:1904294;GO:0051865;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:mitochondrial outer membrane;, F:metal ion binding; F:protein-containing complex binding; F:ubiquitin binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:autophagy; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:positive regulation of ERAD pathway; P:protein autoubiquitination; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold60 indexed_genome mRNA 10795861 10804678 . + . ID=transcript_10525;P53671 A8K6H5 Q7KZ80 Q7L3H5 Q96E10 Q99464 Q9UFU0,LIM domain kinase 2,, PF00412;PF00595;PF07714;, GO:0005813;GO:0005801;GO:0005737;GO:0072686;GO:0005634;GO:0048471;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0030953;GO:0061303;GO:0051650;GO:0060322;GO:1902018;GO:0016310;GO:1900182;GO:0001934;GO:0006468;GO:0007283;, C:centrosome; C:cis-Golgi network; C:cytoplasm; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:astral microtubule organization; P:cornea development in camera-type eye; P:establishment of vesicle localization; P:head development; P:negative regulation of cilium assembly; P:phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:spermatogenesis; scaffold60 indexed_genome mRNA 10806050 10817815 . + . ID=transcript_10526;P53671 A8K6H5 Q7KZ80 Q7L3H5 Q96E10 Q99464 Q9UFU0,LIM domain kinase 2,, PF00412;PF00595;PF07714;, GO:0005813;GO:0005801;GO:0005737;GO:0072686;GO:0005634;GO:0048471;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0030953;GO:0061303;GO:0051650;GO:0060322;GO:1902018;GO:0016310;GO:1900182;GO:0001934;GO:0006468;GO:0007283;, C:centrosome; C:cis-Golgi network; C:cytoplasm; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:astral microtubule organization; P:cornea development in camera-type eye; P:establishment of vesicle localization; P:head development; P:negative regulation of cilium assembly; P:phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:spermatogenesis;|P53671 A8K6H5 Q7KZ80 Q7L3H5 Q96E10 Q99464 Q9UFU0,LIM domain kinase 2,, PF00412;PF00595;PF07714;, GO:0005813;GO:0005801;GO:0005737;GO:0072686;GO:0005634;GO:0048471;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0030953;GO:0061303;GO:0051650;GO:0060322;GO:1902018;GO:0016310;GO:1900182;GO:0001934;GO:0006468;GO:0007283;, C:centrosome; C:cis-Golgi network; C:cytoplasm; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:astral microtubule organization; P:cornea development in camera-type eye; P:establishment of vesicle localization; P:head development; P:negative regulation of cilium assembly; P:phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:spermatogenesis;|P53671 A8K6H5 Q7KZ80 Q7L3H5 Q96E10 Q99464 Q9UFU0,LIM domain kinase 2,, PF00412;PF00595;PF07714;, GO:0005813;GO:0005801;GO:0005737;GO:0072686;GO:0005634;GO:0048471;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0030953;GO:0061303;GO:0051650;GO:0060322;GO:1902018;GO:0016310;GO:1900182;GO:0001934;GO:0006468;GO:0007283;, C:centrosome; C:cis-Golgi network; C:cytoplasm; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:astral microtubule organization; P:cornea development in camera-type eye; P:establishment of vesicle localization; P:head development; P:negative regulation of cilium assembly; P:phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:spermatogenesis;|P53671 A8K6H5 Q7KZ80 Q7L3H5 Q96E10 Q99464 Q9UFU0,LIM domain kinase 2,, PF00412;PF00595;PF07714;, GO:0005813;GO:0005801;GO:0005737;GO:0072686;GO:0005634;GO:0048471;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0030953;GO:0061303;GO:0051650;GO:0060322;GO:1902018;GO:0016310;GO:1900182;GO:0001934;GO:0006468;GO:0007283;, C:centrosome; C:cis-Golgi network; C:cytoplasm; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:astral microtubule organization; P:cornea development in camera-type eye; P:establishment of vesicle localization; P:head development; P:negative regulation of cilium assembly; P:phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:spermatogenesis;|P53671 A8K6H5 Q7KZ80 Q7L3H5 Q96E10 Q99464 Q9UFU0,LIM domain kinase 2,, PF00412;PF00595;PF07714;, GO:0005813;GO:0005801;GO:0005737;GO:0072686;GO:0005634;GO:0048471;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0030953;GO:0061303;GO:0051650;GO:0060322;GO:1902018;GO:0016310;GO:1900182;GO:0001934;GO:0006468;GO:0007283;, C:centrosome; C:cis-Golgi network; C:cytoplasm; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:astral microtubule organization; P:cornea development in camera-type eye; P:establishment of vesicle localization; P:head development; P:negative regulation of cilium assembly; P:phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:spermatogenesis;|P53671 A8K6H5 Q7KZ80 Q7L3H5 Q96E10 Q99464 Q9UFU0,LIM domain kinase 2,, PF00412;PF00595;PF07714;, GO:0005813;GO:0005801;GO:0005737;GO:0072686;GO:0005634;GO:0048471;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0030953;GO:0061303;GO:0051650;GO:0060322;GO:1902018;GO:0016310;GO:1900182;GO:0001934;GO:0006468;GO:0007283;, C:centrosome; C:cis-Golgi network; C:cytoplasm; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:astral microtubule organization; P:cornea development in camera-type eye; P:establishment of vesicle localization; P:head development; P:negative regulation of cilium assembly; P:phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:spermatogenesis;|P53671 A8K6H5 Q7KZ80 Q7L3H5 Q96E10 Q99464 Q9UFU0,LIM domain kinase 2,, PF00412;PF00595;PF07714;, GO:0005813;GO:0005801;GO:0005737;GO:0072686;GO:0005634;GO:0048471;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0030953;GO:0061303;GO:0051650;GO:0060322;GO:1902018;GO:0016310;GO:1900182;GO:0001934;GO:0006468;GO:0007283;, C:centrosome; C:cis-Golgi network; C:cytoplasm; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:astral microtubule organization; P:cornea development in camera-type eye; P:establishment of vesicle localization; P:head development; P:negative regulation of cilium assembly; P:phosphorylation; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:spermatogenesis; scaffold60 indexed_genome mRNA 10818821 10839221 . - . ID=transcript_10527;Q96FE7 B4DRR9 D1MEI0 O00318 Q49A94 Q86YW2 Q8NCJ9,Phosphoinositide-3-kinase-interacting protein 1,Kringle domain-containing protein HGFL;, PF00051;, GO:0016021;GO:0005886;GO:0036313;GO:0004252;GO:0043553;GO:0014067;, C:integral component of membrane; C:plasma membrane;, F:phosphatidylinositol 3-kinase catalytic subunit binding; F:serine-type endopeptidase activity;, P:negative regulation of phosphatidylinositol 3-kinase activity; P:negative regulation of phosphatidylinositol 3-kinase signaling;|Q96FE7 B4DRR9 D1MEI0 O00318 Q49A94 Q86YW2 Q8NCJ9,Phosphoinositide-3-kinase-interacting protein 1,Kringle domain-containing protein HGFL;, PF00051;, GO:0016021;GO:0005886;GO:0036313;GO:0004252;GO:0043553;GO:0014067;, C:integral component of membrane; C:plasma membrane;, F:phosphatidylinositol 3-kinase catalytic subunit binding; F:serine-type endopeptidase activity;, P:negative regulation of phosphatidylinositol 3-kinase activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; scaffold60 indexed_genome mRNA 10857371 10875431 . - . ID=transcript_10528;Q9HBE1 Q9HBE2 Q9HBE3 Q9P1A9 Q9UDU0 Q9Y529,POZ-, AT hook-, and zinc finger-containing protein 1,BTB/POZ domain zinc finger transcription factor;Protein kinase A RI subunit alpha-associated protein;Zinc finger and BTB domain-containing protein 19;Zinc finger protein 278;Zinc finger sarcoma gene protein;, PF00651;PF00096;, GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001227;GO:0046872;GO:0000978;GO:0031625;GO:0008584;GO:0010596;GO:0045892;GO:0045893;GO:0006357;GO:0006355;GO:0007283;GO:0030217;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:male gonad development; P:negative regulation of endothelial cell migration; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:T cell differentiation;|Q9HBE1 Q9HBE2 Q9HBE3 Q9P1A9 Q9UDU0 Q9Y529,POZ-, AT hook-, and zinc finger-containing protein 1,BTB/POZ domain zinc finger transcription factor;Protein kinase A RI subunit alpha-associated protein;Zinc finger and BTB domain-containing protein 19;Zinc finger protein 278;Zinc finger sarcoma gene protein;, PF00651;PF00096;, GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001227;GO:0046872;GO:0000978;GO:0031625;GO:0008584;GO:0010596;GO:0045892;GO:0045893;GO:0006357;GO:0006355;GO:0007283;GO:0030217;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:male gonad development; P:negative regulation of endothelial cell migration; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:T cell differentiation; scaffold60 indexed_genome mRNA 10900695 10916960 . + . ID=transcript_10529;Q9Y295 B2RDS8 Q6FGP8 Q8WW69 Q9UGF2,Developmentally-regulated GTP-binding protein 1,Neural precursor cell expressed developmentally down-regulated protein 3;Translation factor GTPase DRG1;, PF01926;PF16897;PF02824;, GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0005634;GO:0005844;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0030955;GO:0008134;GO:0002181;GO:0007275;GO:0031116;GO:1901673;GO:0006351;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nucleus; C:polysome;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding; F:potassium ion binding; F:transcription factor binding;, P:cytoplasmic translation; P:multicellular organism development; P:positive regulation of microtubule polymerization; P:regulation of mitotic spindle assembly; P:transcription, DNA-templated; scaffold60 indexed_genome mRNA 10918641 10958080 . - . ID=transcript_10530;Q9NRA8 B1AKL2 B1AKL3 B2RBF1 Q8NCF2 Q9H708,Eukaryotic translation initiation factor 4E transporter {ECO:0000303|PubMed:10856257},Eukaryotic translation initiation factor 4E nuclear import factor 1;, PF10477;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005634;GO:0000932;GO:0016605;GO:0019900;GO:0003729;GO:0005049;GO:0003723;GO:0031047;GO:0048255;GO:0106289;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0060213;GO:0006606;GO:0019827;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleus; C:P-body; C:PML body;, F:kinase binding; F:mRNA binding; F:nuclear export signal receptor activity; F:RNA binding;, P:gene silencing by RNA; P:mRNA stabilization; P:negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:protein import into nucleus; P:stem cell population maintenance;|Q9NRA8 B1AKL2 B1AKL3 B2RBF1 Q8NCF2 Q9H708,Eukaryotic translation initiation factor 4E transporter {ECO:0000303|PubMed:10856257},Eukaryotic translation initiation factor 4E nuclear import factor 1;, PF10477;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005634;GO:0000932;GO:0016605;GO:0019900;GO:0003729;GO:0005049;GO:0003723;GO:0031047;GO:0048255;GO:0106289;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0060213;GO:0006606;GO:0019827;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleus; C:P-body; C:PML body;, F:kinase binding; F:mRNA binding; F:nuclear export signal receptor activity; F:RNA binding;, P:gene silencing by RNA; P:mRNA stabilization; P:negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:protein import into nucleus; P:stem cell population maintenance;|Q9NRA8 B1AKL2 B1AKL3 B2RBF1 Q8NCF2 Q9H708,Eukaryotic translation initiation factor 4E transporter {ECO:0000303|PubMed:10856257},Eukaryotic translation initiation factor 4E nuclear import factor 1;, PF10477;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005634;GO:0000932;GO:0016605;GO:0019900;GO:0003729;GO:0005049;GO:0003723;GO:0031047;GO:0048255;GO:0106289;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0060213;GO:0006606;GO:0019827;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleus; C:P-body; C:PML body;, F:kinase binding; F:mRNA binding; F:nuclear export signal receptor activity; F:RNA binding;, P:gene silencing by RNA; P:mRNA stabilization; P:negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:protein import into nucleus; P:stem cell population maintenance;|Q9NRA8 B1AKL2 B1AKL3 B2RBF1 Q8NCF2 Q9H708,Eukaryotic translation initiation factor 4E transporter {ECO:0000303|PubMed:10856257},Eukaryotic translation initiation factor 4E nuclear import factor 1;, PF10477;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005634;GO:0000932;GO:0016605;GO:0019900;GO:0003729;GO:0005049;GO:0003723;GO:0031047;GO:0048255;GO:0106289;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0060213;GO:0006606;GO:0019827;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleus; C:P-body; C:PML body;, F:kinase binding; F:mRNA binding; F:nuclear export signal receptor activity; F:RNA binding;, P:gene silencing by RNA; P:mRNA stabilization; P:negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:protein import into nucleus; P:stem cell population maintenance;|Q9NRA8 B1AKL2 B1AKL3 B2RBF1 Q8NCF2 Q9H708,Eukaryotic translation initiation factor 4E transporter {ECO:0000303|PubMed:10856257},Eukaryotic translation initiation factor 4E nuclear import factor 1;, PF10477;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005634;GO:0000932;GO:0016605;GO:0019900;GO:0003729;GO:0005049;GO:0003723;GO:0031047;GO:0048255;GO:0106289;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0060213;GO:0006606;GO:0019827;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleus; C:P-body; C:PML body;, F:kinase binding; F:mRNA binding; F:nuclear export signal receptor activity; F:RNA binding;, P:gene silencing by RNA; P:mRNA stabilization; P:negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:protein import into nucleus; P:stem cell population maintenance;|Q9NRA8 B1AKL2 B1AKL3 B2RBF1 Q8NCF2 Q9H708,Eukaryotic translation initiation factor 4E transporter {ECO:0000303|PubMed:10856257},Eukaryotic translation initiation factor 4E nuclear import factor 1;, PF10477;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005634;GO:0000932;GO:0016605;GO:0019900;GO:0003729;GO:0005049;GO:0003723;GO:0031047;GO:0048255;GO:0106289;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0060213;GO:0006606;GO:0019827;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleus; C:P-body; C:PML body;, F:kinase binding; F:mRNA binding; F:nuclear export signal receptor activity; F:RNA binding;, P:gene silencing by RNA; P:mRNA stabilization; P:negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:protein import into nucleus; P:stem cell population maintenance;|Q9NRA8 B1AKL2 B1AKL3 B2RBF1 Q8NCF2 Q9H708,Eukaryotic translation initiation factor 4E transporter {ECO:0000303|PubMed:10856257},Eukaryotic translation initiation factor 4E nuclear import factor 1;, PF10477;, GO:0005737;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005634;GO:0000932;GO:0016605;GO:0019900;GO:0003729;GO:0005049;GO:0003723;GO:0031047;GO:0048255;GO:0106289;GO:0045665;GO:0017148;GO:0033962;GO:1905618;GO:0060213;GO:0006606;GO:0019827;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleus; C:P-body; C:PML body;, F:kinase binding; F:mRNA binding; F:nuclear export signal receptor activity; F:RNA binding;, P:gene silencing by RNA; P:mRNA stabilization; P:negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of neuron differentiation; P:negative regulation of translation; P:P-body assembly; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:protein import into nucleus; P:stem cell population maintenance; scaffold60 indexed_genome mRNA 10973493 11051427 . + . ID=transcript_10531;B7ZBE3 O60289 Q2TAN8 Q5W1B5 Q86TK0 Q8N4U8 Q8N8C1 Q8WU14,Protein SFI1 homolog,, , GO:0005814;GO:0005829;GO:0019902;GO:0097711;GO:0000086;GO:0010923;GO:0010389;, C:centriole; C:cytosol;, F:phosphatase binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of phosphatase activity; P:regulation of G2/M transition of mitotic cell cycle;|B7ZBE3 O60289 Q2TAN8 Q5W1B5 Q86TK0 Q8N4U8 Q8N8C1 Q8WU14,Protein SFI1 homolog,, , GO:0005814;GO:0005829;GO:0019902;GO:0097711;GO:0000086;GO:0010923;GO:0010389;, C:centriole; C:cytosol;, F:phosphatase binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of phosphatase activity; P:regulation of G2/M transition of mitotic cell cycle;|B7ZBE3 O60289 Q2TAN8 Q5W1B5 Q86TK0 Q8N4U8 Q8N8C1 Q8WU14,Protein SFI1 homolog,, , GO:0005814;GO:0005829;GO:0019902;GO:0097711;GO:0000086;GO:0010923;GO:0010389;, C:centriole; C:cytosol;, F:phosphatase binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of phosphatase activity; P:regulation of G2/M transition of mitotic cell cycle;|B7ZBE3 O60289 Q2TAN8 Q5W1B5 Q86TK0 Q8N4U8 Q8N8C1 Q8WU14,Protein SFI1 homolog,, , GO:0005814;GO:0005829;GO:0019902;GO:0097711;GO:0000086;GO:0010923;GO:0010389;, C:centriole; C:cytosol;, F:phosphatase binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of phosphatase activity; P:regulation of G2/M transition of mitotic cell cycle;|B7ZBE3 O60289 Q2TAN8 Q5W1B5 Q86TK0 Q8N4U8 Q8N8C1 Q8WU14,Protein SFI1 homolog,, , GO:0005814;GO:0005829;GO:0019902;GO:0097711;GO:0000086;GO:0010923;GO:0010389;, C:centriole; C:cytosol;, F:phosphatase binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of phosphatase activity; P:regulation of G2/M transition of mitotic cell cycle; scaffold60 indexed_genome mRNA 11054107 11093466 . - . ID=transcript_10532;B7ZBE3 O60289 Q2TAN8 Q5W1B5 Q86TK0 Q8N4U8 Q8N8C1 Q8WU14,Protein SFI1 homolog,, , GO:0005814;GO:0005829;GO:0019902;GO:0097711;GO:0000086;GO:0010923;GO:0010389;, C:centriole; C:cytosol;, F:phosphatase binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of phosphatase activity; P:regulation of G2/M transition of mitotic cell cycle;|B7ZBE3 O60289 Q2TAN8 Q5W1B5 Q86TK0 Q8N4U8 Q8N8C1 Q8WU14,Protein SFI1 homolog,, , GO:0005814;GO:0005829;GO:0019902;GO:0097711;GO:0000086;GO:0010923;GO:0010389;, C:centriole; C:cytosol;, F:phosphatase binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of phosphatase activity; P:regulation of G2/M transition of mitotic cell cycle;|Q9UG56 B1AKM7 O43207 O95535 Q6IC28 Q96GQ2 Q9UGA9,Phosphatidylserine decarboxylase proenzyme, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03208},, PF02666;, GO:0031305;GO:0005739;GO:0005634;GO:0004609;GO:0006646;GO:0016540;, C:integral component of mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:phosphatidylserine decarboxylase activity;, P:phosphatidylethanolamine biosynthetic process; P:protein autoprocessing;|Q9UG56 B1AKM7 O43207 O95535 Q6IC28 Q96GQ2 Q9UGA9,Phosphatidylserine decarboxylase proenzyme, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03208},, PF02666;, GO:0031305;GO:0005739;GO:0005634;GO:0004609;GO:0006646;GO:0016540;, C:integral component of mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:phosphatidylserine decarboxylase activity;, P:phosphatidylethanolamine biosynthetic process; P:protein autoprocessing; scaffold60 indexed_genome mRNA 11106477 11134560 . - . ID=transcript_10533;Q5THK1 Q5THK4 Q6ZNN1 Q6ZWH0 Q8IW74 Q9H5T4,Protein PRR14L,Proline rich 14-like protein;, PF15386; scaffold60 indexed_genome mRNA 11146943 11218471 . + . ID=transcript_10534;Q5THZ3 Q68DR1 Q6MZX3 Q6PEZ1 Q9UGV8 Q9UH13,GATOR complex protein DEPDC5 {ECO:0000305},DEP domain-containing protein 5 {ECO:0000312|HGNC:HGNC:18423};, PF00610;PF12257;, GO:0005829;GO:1990130;GO:0005765;GO:0005764;GO:0048471;GO:0005096;GO:0044877;GO:0034198;GO:0035556;GO:0032007;GO:1904262;GO:0010506;, C:cytosol; C:GATOR1 complex; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:protein-containing complex binding;, P:cellular response to amino acid starvation; P:intracellular signal transduction; P:negative regulation of TOR signaling; P:negative regulation of TORC1 signaling; P:regulation of autophagy;|Q5THZ3 Q68DR1 Q6MZX3 Q6PEZ1 Q9UGV8 Q9UH13,GATOR complex protein DEPDC5 {ECO:0000305},DEP domain-containing protein 5 {ECO:0000312|HGNC:HGNC:18423};, PF00610;PF12257;, GO:0005829;GO:1990130;GO:0005765;GO:0005764;GO:0048471;GO:0005096;GO:0044877;GO:0034198;GO:0035556;GO:0032007;GO:1904262;GO:0010506;, C:cytosol; C:GATOR1 complex; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:protein-containing complex binding;, P:cellular response to amino acid starvation; P:intracellular signal transduction; P:negative regulation of TOR signaling; P:negative regulation of TORC1 signaling; P:regulation of autophagy;|Q5THZ3 Q68DR1 Q6MZX3 Q6PEZ1 Q9UGV8 Q9UH13,GATOR complex protein DEPDC5 {ECO:0000305},DEP domain-containing protein 5 {ECO:0000312|HGNC:HGNC:18423};, PF00610;PF12257;, GO:0005829;GO:1990130;GO:0005765;GO:0005764;GO:0048471;GO:0005096;GO:0044877;GO:0034198;GO:0035556;GO:0032007;GO:1904262;GO:0010506;, C:cytosol; C:GATOR1 complex; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:protein-containing complex binding;, P:cellular response to amino acid starvation; P:intracellular signal transduction; P:negative regulation of TOR signaling; P:negative regulation of TORC1 signaling; P:regulation of autophagy;|Q5THZ3 Q68DR1 Q6MZX3 Q6PEZ1 Q9UGV8 Q9UH13,GATOR complex protein DEPDC5 {ECO:0000305},DEP domain-containing protein 5 {ECO:0000312|HGNC:HGNC:18423};, PF00610;PF12257;, GO:0005829;GO:1990130;GO:0005765;GO:0005764;GO:0048471;GO:0005096;GO:0044877;GO:0034198;GO:0035556;GO:0032007;GO:1904262;GO:0010506;, C:cytosol; C:GATOR1 complex; C:lysosomal membrane; C:lysosome; C:perinuclear region of cytoplasm;, F:GTPase activator activity; F:protein-containing complex binding;, P:cellular response to amino acid starvation; P:intracellular signal transduction; P:negative regulation of TOR signaling; P:negative regulation of TORC1 signaling; P:regulation of autophagy; scaffold60 indexed_genome mRNA 11253624 11258121 . + . ID=transcript_10535;Q04917,14-3-3 protein eta,Protein AS1;, PF00244;, GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0005739;GO:0005886;GO:0003779;GO:0019899;GO:0035259;GO:0042802;GO:0005159;GO:0044325;GO:0019904;GO:0046982;GO:0017080;GO:0006713;GO:0042921;GO:0006886;GO:0086010;GO:0050774;GO:1900740;GO:0045893;GO:0045664;GO:2000649;GO:0002028;GO:0048167;GO:0021762;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:mitochondrion; C:plasma membrane;, F:actin binding; F:enzyme binding; F:glucocorticoid receptor binding; F:identical protein binding; F:insulin-like growth factor receptor binding; F:ion channel binding; F:protein domain specific binding; F:protein heterodimerization activity; F:sodium channel regulator activity;, P:glucocorticoid catabolic process; P:glucocorticoid receptor signaling pathway; P:intracellular protein transport; P:membrane depolarization during action potential; P:negative regulation of dendrite morphogenesis; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription, DNA-templated; P:regulation of neuron differentiation; P:regulation of sodium ion transmembrane transporter activity; P:regulation of sodium ion transport; P:regulation of synaptic plasticity; P:substantia nigra development; scaffold60 indexed_genome mRNA 11259177 11263443 . - . ID=transcript_10536;Q04917,14-3-3 protein eta,Protein AS1;, PF00244;, GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0005739;GO:0005886;GO:0003779;GO:0019899;GO:0035259;GO:0042802;GO:0005159;GO:0044325;GO:0019904;GO:0046982;GO:0017080;GO:0006713;GO:0042921;GO:0006886;GO:0086010;GO:0050774;GO:1900740;GO:0045893;GO:0045664;GO:2000649;GO:0002028;GO:0048167;GO:0021762;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:mitochondrion; C:plasma membrane;, F:actin binding; F:enzyme binding; F:glucocorticoid receptor binding; F:identical protein binding; F:insulin-like growth factor receptor binding; F:ion channel binding; F:protein domain specific binding; F:protein heterodimerization activity; F:sodium channel regulator activity;, P:glucocorticoid catabolic process; P:glucocorticoid receptor signaling pathway; P:intracellular protein transport; P:membrane depolarization during action potential; P:negative regulation of dendrite morphogenesis; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription, DNA-templated; P:regulation of neuron differentiation; P:regulation of sodium ion transmembrane transporter activity; P:regulation of sodium ion transport; P:regulation of synaptic plasticity; P:substantia nigra development; scaffold60 indexed_genome mRNA 11317391 11363919 . + . ID=transcript_10537;P13866 B2R7E2 B7Z4Q9 B7ZA69,Sodium/glucose cotransporter 1,High affinity sodium-glucose cotransporter;Solute carrier family 5 member 1;, PF00474;, GO:0016324;GO:0031526;GO:0005911;GO:0005769;GO:0070062;GO:0016021;GO:0005887;GO:0043229;GO:0097708;GO:0048471;GO:0005886;GO:0015151;GO:0055056;GO:0015150;GO:0005354;GO:0005355;GO:0005412;GO:0005367;GO:0015146;GO:0005372;GO:0000017;GO:0015756;GO:0015757;GO:0098708;GO:1904659;GO:0106001;GO:0015798;GO:0015750;GO:0010035;GO:0098719;GO:0006814;GO:0035377;GO:0150104;, C:apical plasma membrane; C:brush border membrane; C:cell-cell junction; C:early endosome; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular organelle; C:intracellular vesicle; C:perinuclear region of cytoplasm; C:plasma membrane;, F:alpha-glucoside transmembrane transporter activity; F:D-glucose transmembrane transporter activity; F:fucose transmembrane transporter activity; F:galactose transmembrane transporter activity; F:glucose transmembrane transporter activity; F:glucose:sodium symporter activity; F:myo-inositol:sodium symporter activity; F:pentose transmembrane transporter activity; F:water transmembrane transporter activity;, P:alpha-glucoside transport; P:fucose transmembrane transport; P:galactose transmembrane transport; P:glucose import across plasma membrane; P:glucose transmembrane transport; P:intestinal hexose absorption; P:myo-inositol transport; P:pentose transmembrane transport; P:response to inorganic substance; P:sodium ion import across plasma membrane; P:sodium ion transport; P:transepithelial water transport; P:transport across blood-brain barrier;|P13866 B2R7E2 B7Z4Q9 B7ZA69,Sodium/glucose cotransporter 1,High affinity sodium-glucose cotransporter;Solute carrier family 5 member 1;, PF00474;, GO:0016324;GO:0031526;GO:0005911;GO:0005769;GO:0070062;GO:0016021;GO:0005887;GO:0043229;GO:0097708;GO:0048471;GO:0005886;GO:0015151;GO:0055056;GO:0015150;GO:0005354;GO:0005355;GO:0005412;GO:0005367;GO:0015146;GO:0005372;GO:0000017;GO:0015756;GO:0015757;GO:0098708;GO:1904659;GO:0106001;GO:0015798;GO:0015750;GO:0010035;GO:0098719;GO:0006814;GO:0035377;GO:0150104;, C:apical plasma membrane; C:brush border membrane; C:cell-cell junction; C:early endosome; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular organelle; C:intracellular vesicle; C:perinuclear region of cytoplasm; C:plasma membrane;, F:alpha-glucoside transmembrane transporter activity; F:D-glucose transmembrane transporter activity; F:fucose transmembrane transporter activity; F:galactose transmembrane transporter activity; F:glucose transmembrane transporter activity; F:glucose:sodium symporter activity; F:myo-inositol:sodium symporter activity; F:pentose transmembrane transporter activity; F:water transmembrane transporter activity;, P:alpha-glucoside transport; P:fucose transmembrane transport; P:galactose transmembrane transport; P:glucose import across plasma membrane; P:glucose transmembrane transport; P:intestinal hexose absorption; P:myo-inositol transport; P:pentose transmembrane transport; P:response to inorganic substance; P:sodium ion import across plasma membrane; P:sodium ion transport; P:transepithelial water transport; P:transport across blood-brain barrier; scaffold61 indexed_genome mRNA 71962 136679 . - . ID=transcript_10538;Q8TBP0 B9A6L7 I3L1E0 I3L4U2 Q8N3Z4 Q96DH7,TBC1 domain family member 16,, PF00566;, GO:0005829;GO:0005769;GO:0005096;GO:0090630;GO:0006886;GO:0001919;, C:cytosol; C:early endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of receptor recycling;|Q8TBP0 B9A6L7 I3L1E0 I3L4U2 Q8N3Z4 Q96DH7,TBC1 domain family member 16,, PF00566;, GO:0005829;GO:0005769;GO:0005096;GO:0090630;GO:0006886;GO:0001919;, C:cytosol; C:early endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of receptor recycling; scaffold61 indexed_genome mRNA 156980 197962 . + . ID=transcript_10539;Q4G0X9 A8MTD2 C9JTI9 C9JTJ0 C9JXW1 J3QSY2 Q6PE47 Q9HCD2 Q9NWL5,Coiled-coil domain-containing protein 40 {ECO:0000305},, , GO:0005930;GO:0005929;GO:0005737;GO:0005576;GO:0070286;GO:0035082;GO:0003341;GO:0071907;GO:0071910;GO:0035469;GO:0060287;GO:0003351;GO:0030317;GO:0001947;GO:0036159;GO:0030324;GO:0044458;GO:0003356;, C:axoneme; C:cilium; C:cytoplasm; C:extracellular region;, , P:axonemal dynein complex assembly; P:axoneme assembly; P:cilium movement; P:determination of digestive tract left/right asymmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:epithelial cilium movement involved in extracellular fluid movement; P:flagellated sperm motility; P:heart looping; P:inner dynein arm assembly; P:lung development; P:motile cilium assembly; P:regulation of cilium beat frequency;|Q4G0X9 A8MTD2 C9JTI9 C9JTJ0 C9JXW1 J3QSY2 Q6PE47 Q9HCD2 Q9NWL5,Coiled-coil domain-containing protein 40 {ECO:0000305},, , GO:0005930;GO:0005929;GO:0005737;GO:0005576;GO:0070286;GO:0035082;GO:0003341;GO:0071907;GO:0071910;GO:0035469;GO:0060287;GO:0003351;GO:0030317;GO:0001947;GO:0036159;GO:0030324;GO:0044458;GO:0003356;, C:axoneme; C:cilium; C:cytoplasm; C:extracellular region;, , P:axonemal dynein complex assembly; P:axoneme assembly; P:cilium movement; P:determination of digestive tract left/right asymmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:epithelial cilium movement involved in extracellular fluid movement; P:flagellated sperm motility; P:heart looping; P:inner dynein arm assembly; P:lung development; P:motile cilium assembly; P:regulation of cilium beat frequency; scaffold61 indexed_genome mRNA 199543 201416 . + . ID=transcript_10540;Q4G0X9 A8MTD2 C9JTI9 C9JTJ0 C9JXW1 J3QSY2 Q6PE47 Q9HCD2 Q9NWL5,Coiled-coil domain-containing protein 40 {ECO:0000305},, , GO:0005930;GO:0005929;GO:0005737;GO:0005576;GO:0070286;GO:0035082;GO:0003341;GO:0071907;GO:0071910;GO:0035469;GO:0060287;GO:0003351;GO:0030317;GO:0001947;GO:0036159;GO:0030324;GO:0044458;GO:0003356;, C:axoneme; C:cilium; C:cytoplasm; C:extracellular region;, , P:axonemal dynein complex assembly; P:axoneme assembly; P:cilium movement; P:determination of digestive tract left/right asymmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:epithelial cilium movement involved in determination of left/right asymmetry; P:epithelial cilium movement involved in extracellular fluid movement; P:flagellated sperm motility; P:heart looping; P:inner dynein arm assembly; P:lung development; P:motile cilium assembly; P:regulation of cilium beat frequency; scaffold61 indexed_genome mRNA 205595 217584 . + . ID=transcript_10541;P10253 Q09GN4 Q14351 Q16302 Q8IWE7,Lysosomal alpha-glucosidase,Acid maltase;Aglucosidase alfa;, PF13802;PF01055;PF16863;PF00088;, GO:0035577;GO:0070062;GO:0101003;GO:0043231;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0070821;GO:0004558;GO:0030246;GO:0004553;GO:0032450;GO:0060048;GO:0002086;GO:0006006;GO:0005980;GO:0003007;GO:0007626;GO:0007040;GO:0000023;GO:0046716;GO:0050885;GO:0050884;GO:0043312;GO:0002026;GO:0005985;GO:0009888;GO:0043181;, C:azurophil granule membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:alpha-1,4-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:cardiac muscle contraction; P:diaphragm contraction; P:glucose metabolic process; P:glycogen catabolic process; P:heart morphogenesis; P:locomotory behavior; P:lysosome organization; P:maltose metabolic process; P:muscle cell cellular homeostasis; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neutrophil degranulation; P:regulation of the force of heart contraction; P:sucrose metabolic process; P:tissue development; P:vacuolar sequestering;|P10253 Q09GN4 Q14351 Q16302 Q8IWE7,Lysosomal alpha-glucosidase,Acid maltase;Aglucosidase alfa;, PF13802;PF01055;PF16863;PF00088;, GO:0035577;GO:0070062;GO:0101003;GO:0043231;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0070821;GO:0004558;GO:0030246;GO:0004553;GO:0032450;GO:0060048;GO:0002086;GO:0006006;GO:0005980;GO:0003007;GO:0007626;GO:0007040;GO:0000023;GO:0046716;GO:0050885;GO:0050884;GO:0043312;GO:0002026;GO:0005985;GO:0009888;GO:0043181;, C:azurophil granule membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:alpha-1,4-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:cardiac muscle contraction; P:diaphragm contraction; P:glucose metabolic process; P:glycogen catabolic process; P:heart morphogenesis; P:locomotory behavior; P:lysosome organization; P:maltose metabolic process; P:muscle cell cellular homeostasis; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neutrophil degranulation; P:regulation of the force of heart contraction; P:sucrose metabolic process; P:tissue development; P:vacuolar sequestering;|P10253 Q09GN4 Q14351 Q16302 Q8IWE7,Lysosomal alpha-glucosidase,Acid maltase;Aglucosidase alfa;, PF13802;PF01055;PF16863;PF00088;, GO:0035577;GO:0070062;GO:0101003;GO:0043231;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0070821;GO:0004558;GO:0030246;GO:0004553;GO:0032450;GO:0060048;GO:0002086;GO:0006006;GO:0005980;GO:0003007;GO:0007626;GO:0007040;GO:0000023;GO:0046716;GO:0050885;GO:0050884;GO:0043312;GO:0002026;GO:0005985;GO:0009888;GO:0043181;, C:azurophil granule membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:alpha-1,4-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:cardiac muscle contraction; P:diaphragm contraction; P:glucose metabolic process; P:glycogen catabolic process; P:heart morphogenesis; P:locomotory behavior; P:lysosome organization; P:maltose metabolic process; P:muscle cell cellular homeostasis; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neutrophil degranulation; P:regulation of the force of heart contraction; P:sucrose metabolic process; P:tissue development; P:vacuolar sequestering;|P10253 Q09GN4 Q14351 Q16302 Q8IWE7,Lysosomal alpha-glucosidase,Acid maltase;Aglucosidase alfa;, PF13802;PF01055;PF16863;PF00088;, GO:0035577;GO:0070062;GO:0101003;GO:0043231;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0070821;GO:0004558;GO:0030246;GO:0004553;GO:0032450;GO:0060048;GO:0002086;GO:0006006;GO:0005980;GO:0003007;GO:0007626;GO:0007040;GO:0000023;GO:0046716;GO:0050885;GO:0050884;GO:0043312;GO:0002026;GO:0005985;GO:0009888;GO:0043181;, C:azurophil granule membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:alpha-1,4-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:cardiac muscle contraction; P:diaphragm contraction; P:glucose metabolic process; P:glycogen catabolic process; P:heart morphogenesis; P:locomotory behavior; P:lysosome organization; P:maltose metabolic process; P:muscle cell cellular homeostasis; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neutrophil degranulation; P:regulation of the force of heart contraction; P:sucrose metabolic process; P:tissue development; P:vacuolar sequestering;|P10253 Q09GN4 Q14351 Q16302 Q8IWE7,Lysosomal alpha-glucosidase,Acid maltase;Aglucosidase alfa;, PF13802;PF01055;PF16863;PF00088;, GO:0035577;GO:0070062;GO:0101003;GO:0043231;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0070821;GO:0004558;GO:0030246;GO:0004553;GO:0032450;GO:0060048;GO:0002086;GO:0006006;GO:0005980;GO:0003007;GO:0007626;GO:0007040;GO:0000023;GO:0046716;GO:0050885;GO:0050884;GO:0043312;GO:0002026;GO:0005985;GO:0009888;GO:0043181;, C:azurophil granule membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:alpha-1,4-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:cardiac muscle contraction; P:diaphragm contraction; P:glucose metabolic process; P:glycogen catabolic process; P:heart morphogenesis; P:locomotory behavior; P:lysosome organization; P:maltose metabolic process; P:muscle cell cellular homeostasis; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neutrophil degranulation; P:regulation of the force of heart contraction; P:sucrose metabolic process; P:tissue development; P:vacuolar sequestering;|P10253 Q09GN4 Q14351 Q16302 Q8IWE7,Lysosomal alpha-glucosidase,Acid maltase;Aglucosidase alfa;, PF13802;PF01055;PF16863;PF00088;, GO:0035577;GO:0070062;GO:0101003;GO:0043231;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0070821;GO:0004558;GO:0030246;GO:0004553;GO:0032450;GO:0060048;GO:0002086;GO:0006006;GO:0005980;GO:0003007;GO:0007626;GO:0007040;GO:0000023;GO:0046716;GO:0050885;GO:0050884;GO:0043312;GO:0002026;GO:0005985;GO:0009888;GO:0043181;, C:azurophil granule membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:alpha-1,4-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:cardiac muscle contraction; P:diaphragm contraction; P:glucose metabolic process; P:glycogen catabolic process; P:heart morphogenesis; P:locomotory behavior; P:lysosome organization; P:maltose metabolic process; P:muscle cell cellular homeostasis; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neutrophil degranulation; P:regulation of the force of heart contraction; P:sucrose metabolic process; P:tissue development; P:vacuolar sequestering;|P10253 Q09GN4 Q14351 Q16302 Q8IWE7,Lysosomal alpha-glucosidase,Acid maltase;Aglucosidase alfa;, PF13802;PF01055;PF16863;PF00088;, GO:0035577;GO:0070062;GO:0101003;GO:0043231;GO:0043202;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0070821;GO:0004558;GO:0030246;GO:0004553;GO:0032450;GO:0060048;GO:0002086;GO:0006006;GO:0005980;GO:0003007;GO:0007626;GO:0007040;GO:0000023;GO:0046716;GO:0050885;GO:0050884;GO:0043312;GO:0002026;GO:0005985;GO:0009888;GO:0043181;, C:azurophil granule membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:alpha-1,4-glucosidase activity; F:carbohydrate binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:maltose alpha-glucosidase activity;, P:cardiac muscle contraction; P:diaphragm contraction; P:glucose metabolic process; P:glycogen catabolic process; P:heart morphogenesis; P:locomotory behavior; P:lysosome organization; P:maltose metabolic process; P:muscle cell cellular homeostasis; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neutrophil degranulation; P:regulation of the force of heart contraction; P:sucrose metabolic process; P:tissue development; P:vacuolar sequestering; scaffold61 indexed_genome mRNA 221294 233324 . - . ID=transcript_10542;P38919 Q15033 Q6IBQ2 Q96A18,Eukaryotic initiation factor 4A-III,ATP-dependent RNA helicase DDX48;ATP-dependent RNA helicase eIF4A-3;DEAD box protein 48;Eukaryotic initiation factor 4A-like NUK-34;Eukaryotic translation initiation factor 4A isoform 3;Nuclear matrix protein 265;, PF00270;PF00271;, GO:0071013;GO:0005737;GO:0005829;GO:0030425;GO:0035145;GO:0098978;GO:0016020;GO:0043025;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0099524;GO:0071006;GO:0005524;GO:0003729;GO:0008143;GO:0043021;GO:0003723;GO:0003724;GO:0035613;GO:0035368;GO:0045182;GO:0008306;GO:1990416;GO:0072715;GO:0048701;GO:0035640;GO:0031124;GO:0006406;GO:0000398;GO:0090394;GO:1904570;GO:1904574;GO:0017148;GO:0000184;GO:0045727;GO:0099578;GO:0014070;GO:0006405;GO:0006364;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:dendrite; C:exon-exon junction complex; C:glutamatergic synapse; C:membrane; C:neuronal cell body; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic cytosol; C:U2-type catalytic step 1 spliceosome;, F:ATP binding; F:mRNA binding; F:poly(A) binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:selenocysteine insertion sequence binding; F:translation regulator activity;, P:associative learning; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to selenite ion; P:embryonic cranial skeleton morphogenesis; P:exploration behavior; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of selenocysteine incorporation; P:negative regulation of selenocysteine insertion sequence binding; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:response to organic cyclic compound; P:RNA export from nucleus; P:rRNA processing;|P38919 Q15033 Q6IBQ2 Q96A18,Eukaryotic initiation factor 4A-III,ATP-dependent RNA helicase DDX48;ATP-dependent RNA helicase eIF4A-3;DEAD box protein 48;Eukaryotic initiation factor 4A-like NUK-34;Eukaryotic translation initiation factor 4A isoform 3;Nuclear matrix protein 265;, PF00270;PF00271;, GO:0071013;GO:0005737;GO:0005829;GO:0030425;GO:0035145;GO:0098978;GO:0016020;GO:0043025;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0099524;GO:0071006;GO:0005524;GO:0003729;GO:0008143;GO:0043021;GO:0003723;GO:0003724;GO:0035613;GO:0035368;GO:0045182;GO:0008306;GO:1990416;GO:0072715;GO:0048701;GO:0035640;GO:0031124;GO:0006406;GO:0000398;GO:0090394;GO:1904570;GO:1904574;GO:0017148;GO:0000184;GO:0045727;GO:0099578;GO:0014070;GO:0006405;GO:0006364;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:dendrite; C:exon-exon junction complex; C:glutamatergic synapse; C:membrane; C:neuronal cell body; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic cytosol; C:U2-type catalytic step 1 spliceosome;, F:ATP binding; F:mRNA binding; F:poly(A) binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:selenocysteine insertion sequence binding; F:translation regulator activity;, P:associative learning; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to selenite ion; P:embryonic cranial skeleton morphogenesis; P:exploration behavior; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of selenocysteine incorporation; P:negative regulation of selenocysteine insertion sequence binding; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:response to organic cyclic compound; P:RNA export from nucleus; P:rRNA processing;|P38919 Q15033 Q6IBQ2 Q96A18,Eukaryotic initiation factor 4A-III,ATP-dependent RNA helicase DDX48;ATP-dependent RNA helicase eIF4A-3;DEAD box protein 48;Eukaryotic initiation factor 4A-like NUK-34;Eukaryotic translation initiation factor 4A isoform 3;Nuclear matrix protein 265;, PF00270;PF00271;, GO:0071013;GO:0005737;GO:0005829;GO:0030425;GO:0035145;GO:0098978;GO:0016020;GO:0043025;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0099524;GO:0071006;GO:0005524;GO:0003729;GO:0008143;GO:0043021;GO:0003723;GO:0003724;GO:0035613;GO:0035368;GO:0045182;GO:0008306;GO:1990416;GO:0072715;GO:0048701;GO:0035640;GO:0031124;GO:0006406;GO:0000398;GO:0090394;GO:1904570;GO:1904574;GO:0017148;GO:0000184;GO:0045727;GO:0099578;GO:0014070;GO:0006405;GO:0006364;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:dendrite; C:exon-exon junction complex; C:glutamatergic synapse; C:membrane; C:neuronal cell body; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic cytosol; C:U2-type catalytic step 1 spliceosome;, F:ATP binding; F:mRNA binding; F:poly(A) binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:selenocysteine insertion sequence binding; F:translation regulator activity;, P:associative learning; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to selenite ion; P:embryonic cranial skeleton morphogenesis; P:exploration behavior; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of selenocysteine incorporation; P:negative regulation of selenocysteine insertion sequence binding; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:response to organic cyclic compound; P:RNA export from nucleus; P:rRNA processing;|P38919 Q15033 Q6IBQ2 Q96A18,Eukaryotic initiation factor 4A-III,ATP-dependent RNA helicase DDX48;ATP-dependent RNA helicase eIF4A-3;DEAD box protein 48;Eukaryotic initiation factor 4A-like NUK-34;Eukaryotic translation initiation factor 4A isoform 3;Nuclear matrix protein 265;, PF00270;PF00271;, GO:0071013;GO:0005737;GO:0005829;GO:0030425;GO:0035145;GO:0098978;GO:0016020;GO:0043025;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0099524;GO:0071006;GO:0005524;GO:0003729;GO:0008143;GO:0043021;GO:0003723;GO:0003724;GO:0035613;GO:0035368;GO:0045182;GO:0008306;GO:1990416;GO:0072715;GO:0048701;GO:0035640;GO:0031124;GO:0006406;GO:0000398;GO:0090394;GO:1904570;GO:1904574;GO:0017148;GO:0000184;GO:0045727;GO:0099578;GO:0014070;GO:0006405;GO:0006364;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:dendrite; C:exon-exon junction complex; C:glutamatergic synapse; C:membrane; C:neuronal cell body; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic cytosol; C:U2-type catalytic step 1 spliceosome;, F:ATP binding; F:mRNA binding; F:poly(A) binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:selenocysteine insertion sequence binding; F:translation regulator activity;, P:associative learning; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to selenite ion; P:embryonic cranial skeleton morphogenesis; P:exploration behavior; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of selenocysteine incorporation; P:negative regulation of selenocysteine insertion sequence binding; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:response to organic cyclic compound; P:RNA export from nucleus; P:rRNA processing;|P38919 Q15033 Q6IBQ2 Q96A18,Eukaryotic initiation factor 4A-III,ATP-dependent RNA helicase DDX48;ATP-dependent RNA helicase eIF4A-3;DEAD box protein 48;Eukaryotic initiation factor 4A-like NUK-34;Eukaryotic translation initiation factor 4A isoform 3;Nuclear matrix protein 265;, PF00270;PF00271;, GO:0071013;GO:0005737;GO:0005829;GO:0030425;GO:0035145;GO:0098978;GO:0016020;GO:0043025;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0099524;GO:0071006;GO:0005524;GO:0003729;GO:0008143;GO:0043021;GO:0003723;GO:0003724;GO:0035613;GO:0035368;GO:0045182;GO:0008306;GO:1990416;GO:0072715;GO:0048701;GO:0035640;GO:0031124;GO:0006406;GO:0000398;GO:0090394;GO:1904570;GO:1904574;GO:0017148;GO:0000184;GO:0045727;GO:0099578;GO:0014070;GO:0006405;GO:0006364;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:dendrite; C:exon-exon junction complex; C:glutamatergic synapse; C:membrane; C:neuronal cell body; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic cytosol; C:U2-type catalytic step 1 spliceosome;, F:ATP binding; F:mRNA binding; F:poly(A) binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:selenocysteine insertion sequence binding; F:translation regulator activity;, P:associative learning; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to selenite ion; P:embryonic cranial skeleton morphogenesis; P:exploration behavior; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of selenocysteine incorporation; P:negative regulation of selenocysteine insertion sequence binding; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:response to organic cyclic compound; P:RNA export from nucleus; P:rRNA processing;|P38919 Q15033 Q6IBQ2 Q96A18,Eukaryotic initiation factor 4A-III,ATP-dependent RNA helicase DDX48;ATP-dependent RNA helicase eIF4A-3;DEAD box protein 48;Eukaryotic initiation factor 4A-like NUK-34;Eukaryotic translation initiation factor 4A isoform 3;Nuclear matrix protein 265;, PF00270;PF00271;, GO:0071013;GO:0005737;GO:0005829;GO:0030425;GO:0035145;GO:0098978;GO:0016020;GO:0043025;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0099524;GO:0071006;GO:0005524;GO:0003729;GO:0008143;GO:0043021;GO:0003723;GO:0003724;GO:0035613;GO:0035368;GO:0045182;GO:0008306;GO:1990416;GO:0072715;GO:0048701;GO:0035640;GO:0031124;GO:0006406;GO:0000398;GO:0090394;GO:1904570;GO:1904574;GO:0017148;GO:0000184;GO:0045727;GO:0099578;GO:0014070;GO:0006405;GO:0006364;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:dendrite; C:exon-exon junction complex; C:glutamatergic synapse; C:membrane; C:neuronal cell body; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic cytosol; C:U2-type catalytic step 1 spliceosome;, F:ATP binding; F:mRNA binding; F:poly(A) binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:selenocysteine insertion sequence binding; F:translation regulator activity;, P:associative learning; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to selenite ion; P:embryonic cranial skeleton morphogenesis; P:exploration behavior; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of selenocysteine incorporation; P:negative regulation of selenocysteine insertion sequence binding; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:response to organic cyclic compound; P:RNA export from nucleus; P:rRNA processing;|P38919 Q15033 Q6IBQ2 Q96A18,Eukaryotic initiation factor 4A-III,ATP-dependent RNA helicase DDX48;ATP-dependent RNA helicase eIF4A-3;DEAD box protein 48;Eukaryotic initiation factor 4A-like NUK-34;Eukaryotic translation initiation factor 4A isoform 3;Nuclear matrix protein 265;, PF00270;PF00271;, GO:0071013;GO:0005737;GO:0005829;GO:0030425;GO:0035145;GO:0098978;GO:0016020;GO:0043025;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0099524;GO:0071006;GO:0005524;GO:0003729;GO:0008143;GO:0043021;GO:0003723;GO:0003724;GO:0035613;GO:0035368;GO:0045182;GO:0008306;GO:1990416;GO:0072715;GO:0048701;GO:0035640;GO:0031124;GO:0006406;GO:0000398;GO:0090394;GO:1904570;GO:1904574;GO:0017148;GO:0000184;GO:0045727;GO:0099578;GO:0014070;GO:0006405;GO:0006364;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:dendrite; C:exon-exon junction complex; C:glutamatergic synapse; C:membrane; C:neuronal cell body; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic cytosol; C:U2-type catalytic step 1 spliceosome;, F:ATP binding; F:mRNA binding; F:poly(A) binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:selenocysteine insertion sequence binding; F:translation regulator activity;, P:associative learning; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to selenite ion; P:embryonic cranial skeleton morphogenesis; P:exploration behavior; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of selenocysteine incorporation; P:negative regulation of selenocysteine insertion sequence binding; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:response to organic cyclic compound; P:RNA export from nucleus; P:rRNA processing; scaffold61 indexed_genome mRNA 270910 279260 . - . ID=transcript_10543;P51688 A8K5E2,N-sulphoglucosamine sulphohydrolase,Sulfoglucosamine sulfamidase;Sulphamidase;, PF16347;PF00884;, GO:0070062;GO:0043202;GO:0005764;GO:0005539;GO:0046872;GO:0008449;GO:0016250;GO:0006027;GO:0030200;, C:extracellular exosome; C:lysosomal lumen; C:lysosome;, F:glycosaminoglycan binding; F:metal ion binding; F:N-acetylglucosamine-6-sulfatase activity; F:N-sulfoglucosamine sulfohydrolase activity;, P:glycosaminoglycan catabolic process; P:heparan sulfate proteoglycan catabolic process; scaffold61 indexed_genome mRNA 279373 297161 . + . ID=transcript_10544;Q86WA9 B2RCI7 Q86VX1 Q86YX7 Q8IV11 Q8N2I1 Q8NG03,Sodium-independent sulfate anion transporter,Solute carrier family 26 member 11;, PF01740;PF00916;, GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0008509;GO:0015301;GO:0008271;GO:0015116;GO:0006811;GO:0008272;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:ion transport; P:sulfate transport;|Q86WA9 B2RCI7 Q86VX1 Q86YX7 Q8IV11 Q8N2I1 Q8NG03,Sodium-independent sulfate anion transporter,Solute carrier family 26 member 11;, PF01740;PF00916;, GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0008509;GO:0015301;GO:0008271;GO:0015116;GO:0006811;GO:0008272;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:ion transport; P:sulfate transport;|Q86WA9 B2RCI7 Q86VX1 Q86YX7 Q8IV11 Q8N2I1 Q8NG03,Sodium-independent sulfate anion transporter,Solute carrier family 26 member 11;, PF01740;PF00916;, GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0008509;GO:0015301;GO:0008271;GO:0015116;GO:0006811;GO:0008272;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:ion transport; P:sulfate transport;|Q86WA9 B2RCI7 Q86VX1 Q86YX7 Q8IV11 Q8N2I1 Q8NG03,Sodium-independent sulfate anion transporter,Solute carrier family 26 member 11;, PF01740;PF00916;, GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0008509;GO:0015301;GO:0008271;GO:0015116;GO:0006811;GO:0008272;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:ion transport; P:sulfate transport;|Q86WA9 B2RCI7 Q86VX1 Q86YX7 Q8IV11 Q8N2I1 Q8NG03,Sodium-independent sulfate anion transporter,Solute carrier family 26 member 11;, PF01740;PF00916;, GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0008509;GO:0015301;GO:0008271;GO:0015116;GO:0006811;GO:0008272;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:ion transport; P:sulfate transport;|Q86WA9 B2RCI7 Q86VX1 Q86YX7 Q8IV11 Q8N2I1 Q8NG03,Sodium-independent sulfate anion transporter,Solute carrier family 26 member 11;, PF01740;PF00916;, GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0008509;GO:0015301;GO:0008271;GO:0015116;GO:0006811;GO:0008272;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:ion transport; P:sulfate transport;|Q86WA9 B2RCI7 Q86VX1 Q86YX7 Q8IV11 Q8N2I1 Q8NG03,Sodium-independent sulfate anion transporter,Solute carrier family 26 member 11;, PF01740;PF00916;, GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0008509;GO:0015301;GO:0008271;GO:0015116;GO:0006811;GO:0008272;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:ion transport; P:sulfate transport;|Q86WA9 B2RCI7 Q86VX1 Q86YX7 Q8IV11 Q8N2I1 Q8NG03,Sodium-independent sulfate anion transporter,Solute carrier family 26 member 11;, PF01740;PF00916;, GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0008509;GO:0015301;GO:0008271;GO:0015116;GO:0006811;GO:0008272;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:ion transport; P:sulfate transport; scaffold61 indexed_genome mRNA 406644 409072 . + . ID=transcript_10545;Q8IZX2 Q8N406 Q8TEU0 Q9H6C9 Q9H6H9 Q9H6P3 Q9H8A9 Q9HCF4 Q9HCL8,E3 ubiquitin-protein ligase RNF213 {ECO:0000305},ALK lymphoma oligomerization partner on chromosome 17 {ECO:0000303|PubMed:12112524};Mysterin {ECO:0000303|PubMed:26126547};RING finger protein 213 {ECO:0000305};RING-type E3 ubiquitin transferase RNF213 {ECO:0000305};, PF00097;, GO:0005737;GO:0005829;GO:0016020;GO:0005730;GO:0016887;GO:0046872;GO:0004842;GO:0001525;GO:0033668;GO:2000051;GO:0051865;GO:0051260;GO:0000209;GO:0016567;GO:0002040;GO:0006511;, C:cytoplasm; C:cytosol; C:membrane; C:nucleolus;, F:ATPase activity; F:metal ion binding; F:ubiquitin-protein transferase activity;, P:angiogenesis; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of non-canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein homooligomerization; P:protein polyubiquitination; P:protein ubiquitination; P:sprouting angiogenesis; P:ubiquitin-dependent protein catabolic process; scaffold61 indexed_genome mRNA 417648 429968 . - . ID=transcript_10546;Q8N8Q3 I3L3S4 Q6P2G2 Q86X99 Q8NAK0,Endonuclease V,Inosine-specific endoribonuclease;, PF04493;, GO:0005737;GO:0010494;GO:0005730;GO:0003677;GO:0016888;GO:0016891;GO:0000287;GO:0003727;GO:0006281;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleolus;, F:DNA binding; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:endoribonuclease activity, producing 5'-phosphomonoesters; F:magnesium ion binding; F:single-stranded RNA binding;, P:DNA repair;|Q8N8Q3 I3L3S4 Q6P2G2 Q86X99 Q8NAK0,Endonuclease V,Inosine-specific endoribonuclease;, PF04493;, GO:0005737;GO:0010494;GO:0005730;GO:0003677;GO:0016888;GO:0016891;GO:0000287;GO:0003727;GO:0006281;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleolus;, F:DNA binding; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:endoribonuclease activity, producing 5'-phosphomonoesters; F:magnesium ion binding; F:single-stranded RNA binding;, P:DNA repair;|Q8N8Q3 I3L3S4 Q6P2G2 Q86X99 Q8NAK0,Endonuclease V,Inosine-specific endoribonuclease;, PF04493;, GO:0005737;GO:0010494;GO:0005730;GO:0003677;GO:0016888;GO:0016891;GO:0000287;GO:0003727;GO:0006281;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleolus;, F:DNA binding; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:endoribonuclease activity, producing 5'-phosphomonoesters; F:magnesium ion binding; F:single-stranded RNA binding;, P:DNA repair;|Q8N8Q3 I3L3S4 Q6P2G2 Q86X99 Q8NAK0,Endonuclease V,Inosine-specific endoribonuclease;, PF04493;, GO:0005737;GO:0010494;GO:0005730;GO:0003677;GO:0016888;GO:0016891;GO:0000287;GO:0003727;GO:0006281;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleolus;, F:DNA binding; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; F:endoribonuclease activity, producing 5'-phosphomonoesters; F:magnesium ion binding; F:single-stranded RNA binding;, P:DNA repair; scaffold61 indexed_genome mRNA 461501 472790 . - . ID=transcript_10547;Q15818 B3KXH3 Q5FWE6,Neuronal pentraxin-1,Neuronal pentraxin I;, PF00354;, GO:0098978;GO:0043005;GO:0005886;GO:0030133;GO:0046872;GO:0060385;GO:0007417;GO:0007268;GO:0098962;, C:glutamatergic synapse; C:neuron projection; C:plasma membrane; C:transport vesicle;, F:metal ion binding;, P:axonogenesis involved in innervation; P:central nervous system development; P:chemical synaptic transmission; P:regulation of postsynaptic neurotransmitter receptor activity;|Q15818 B3KXH3 Q5FWE6,Neuronal pentraxin-1,Neuronal pentraxin I;, PF00354;, GO:0098978;GO:0043005;GO:0005886;GO:0030133;GO:0046872;GO:0060385;GO:0007417;GO:0007268;GO:0098962;, C:glutamatergic synapse; C:neuron projection; C:plasma membrane; C:transport vesicle;, F:metal ion binding;, P:axonogenesis involved in innervation; P:central nervous system development; P:chemical synaptic transmission; P:regulation of postsynaptic neurotransmitter receptor activity; scaffold61 indexed_genome mRNA 524575 854238 . + . ID=transcript_10548;Q8N122 B2RN36 C6KEF2 F5H7J5 Q8N4V9 Q8TB32 Q9P2P3,Regulatory-associated protein of mTOR,p150 target of rapamycin (TOR)-scaffold protein;, PF02985;PF14538;PF00400;, GO:0005737;GO:0010494;GO:0005829;GO:0030425;GO:0005765;GO:0005764;GO:0043025;GO:0005654;GO:0031931;GO:0071889;GO:0030295;GO:0019901;GO:0030291;GO:0044877;GO:0030674;GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0007050;GO:0034198;GO:0071230;GO:0071233;GO:0031669;GO:0009267;GO:0030307;GO:0001938;GO:1900087;GO:0033138;GO:0010800;GO:0071902;GO:0032008;GO:0045945;GO:0010506;GO:0001558;GO:0008361;GO:1900034;GO:0016241;GO:0031929;GO:0038202;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:nucleoplasm; C:TORC1 complex;, F:14-3-3 protein binding; F:protein kinase activator activity; F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:RNA polymerase III type 1 promoter sequence-specific DNA binding; F:RNA polymerase III type 2 promoter sequence-specific DNA binding; F:RNA polymerase III type 3 promoter sequence-specific DNA binding; F:TFIIIC-class transcription factor complex binding;, P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to leucine; P:cellular response to nutrient levels; P:cellular response to starvation; P:positive regulation of cell growth; P:positive regulation of endothelial cell proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of TOR signaling; P:positive regulation of transcription by RNA polymerase III; P:regulation of autophagy; P:regulation of cell growth; P:regulation of cell size; P:regulation of cellular response to heat; P:regulation of macroautophagy; P:TOR signaling; P:TORC1 signaling; P:viral process; scaffold61 indexed_genome mRNA 863624 872813 . + . ID=transcript_10549;Q96FZ7 A8K7U0 Q53FU4 Q9HAE8,Charged multivesicular body protein 6,Chromatin-modifying protein 6;Vacuolar protein sorting-associated protein 20;, PF03357;, GO:0005829;GO:0010008;GO:0000815;GO:0070062;GO:0031902;GO:0016020;GO:0005771;GO:0047485;GO:0044877;GO:0016197;GO:1904902;GO:0032511;GO:0016236;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0007175;GO:0006997;GO:0015031;GO:0042176;GO:0006900;GO:0039702;GO:0019058;, C:cytosol; C:endosome membrane; C:ESCRT III complex; C:extracellular exosome; C:late endosome membrane; C:membrane; C:multivesicular body;, F:protein N-terminus binding; F:protein-containing complex binding;, P:endosomal transport; P:ESCRT III complex assembly; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:macroautophagy; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of epidermal growth factor-activated receptor activity; P:nucleus organization; P:protein transport; P:regulation of protein catabolic process; P:vesicle budding from membrane; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold61 indexed_genome mRNA 898171 954975 . - . ID=transcript_10550;Q9UQB8 O43858 Q53HB1 Q86WC1 Q8N5C0 Q96CR7 Q9UBR3 Q9UQ43,Brain-specific angiogenesis inhibitor 1-associated protein 2,Fas ligand-associated factor 3;Insulin receptor substrate p53/p58;Insulin receptor substrate protein of 53 kDa;, PF08397;PF07653;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0030175;GO:0005654;GO:0005886;GO:0001726;GO:0098641;GO:0008093;GO:0042802;GO:0070064;GO:0008022;GO:0051764;GO:0051017;GO:0007409;GO:0038096;GO:0008286;GO:0007009;GO:2000251;GO:0030838;GO:0032956;GO:0008360;GO:0009617;GO:0048010;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:filopodium; C:nucleoplasm; C:plasma membrane; C:ruffle;, F:cadherin binding involved in cell-cell adhesion; F:cytoskeletal anchor activity; F:identical protein binding; F:proline-rich region binding; F:protein C-terminus binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:axonogenesis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:insulin receptor signaling pathway; P:plasma membrane organization; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:response to bacterium; P:vascular endothelial growth factor receptor signaling pathway;|Q9UQB8 O43858 Q53HB1 Q86WC1 Q8N5C0 Q96CR7 Q9UBR3 Q9UQ43,Brain-specific angiogenesis inhibitor 1-associated protein 2,Fas ligand-associated factor 3;Insulin receptor substrate p53/p58;Insulin receptor substrate protein of 53 kDa;, PF08397;PF07653;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0030175;GO:0005654;GO:0005886;GO:0001726;GO:0098641;GO:0008093;GO:0042802;GO:0070064;GO:0008022;GO:0051764;GO:0051017;GO:0007409;GO:0038096;GO:0008286;GO:0007009;GO:2000251;GO:0030838;GO:0032956;GO:0008360;GO:0009617;GO:0048010;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:filopodium; C:nucleoplasm; C:plasma membrane; C:ruffle;, F:cadherin binding involved in cell-cell adhesion; F:cytoskeletal anchor activity; F:identical protein binding; F:proline-rich region binding; F:protein C-terminus binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:axonogenesis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:insulin receptor signaling pathway; P:plasma membrane organization; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:response to bacterium; P:vascular endothelial growth factor receptor signaling pathway;|Q9UQB8 O43858 Q53HB1 Q86WC1 Q8N5C0 Q96CR7 Q9UBR3 Q9UQ43,Brain-specific angiogenesis inhibitor 1-associated protein 2,Fas ligand-associated factor 3;Insulin receptor substrate p53/p58;Insulin receptor substrate protein of 53 kDa;, PF08397;PF07653;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0030175;GO:0005654;GO:0005886;GO:0001726;GO:0098641;GO:0008093;GO:0042802;GO:0070064;GO:0008022;GO:0051764;GO:0051017;GO:0007409;GO:0038096;GO:0008286;GO:0007009;GO:2000251;GO:0030838;GO:0032956;GO:0008360;GO:0009617;GO:0048010;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:filopodium; C:nucleoplasm; C:plasma membrane; C:ruffle;, F:cadherin binding involved in cell-cell adhesion; F:cytoskeletal anchor activity; F:identical protein binding; F:proline-rich region binding; F:protein C-terminus binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:axonogenesis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:insulin receptor signaling pathway; P:plasma membrane organization; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:response to bacterium; P:vascular endothelial growth factor receptor signaling pathway;|Q9UQB8 O43858 Q53HB1 Q86WC1 Q8N5C0 Q96CR7 Q9UBR3 Q9UQ43,Brain-specific angiogenesis inhibitor 1-associated protein 2,Fas ligand-associated factor 3;Insulin receptor substrate p53/p58;Insulin receptor substrate protein of 53 kDa;, PF08397;PF07653;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0030175;GO:0005654;GO:0005886;GO:0001726;GO:0098641;GO:0008093;GO:0042802;GO:0070064;GO:0008022;GO:0051764;GO:0051017;GO:0007409;GO:0038096;GO:0008286;GO:0007009;GO:2000251;GO:0030838;GO:0032956;GO:0008360;GO:0009617;GO:0048010;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:filopodium; C:nucleoplasm; C:plasma membrane; C:ruffle;, F:cadherin binding involved in cell-cell adhesion; F:cytoskeletal anchor activity; F:identical protein binding; F:proline-rich region binding; F:protein C-terminus binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:axonogenesis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:insulin receptor signaling pathway; P:plasma membrane organization; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:response to bacterium; P:vascular endothelial growth factor receptor signaling pathway;|Q9UQB8 O43858 Q53HB1 Q86WC1 Q8N5C0 Q96CR7 Q9UBR3 Q9UQ43,Brain-specific angiogenesis inhibitor 1-associated protein 2,Fas ligand-associated factor 3;Insulin receptor substrate p53/p58;Insulin receptor substrate protein of 53 kDa;, PF08397;PF07653;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0030175;GO:0005654;GO:0005886;GO:0001726;GO:0098641;GO:0008093;GO:0042802;GO:0070064;GO:0008022;GO:0051764;GO:0051017;GO:0007409;GO:0038096;GO:0008286;GO:0007009;GO:2000251;GO:0030838;GO:0032956;GO:0008360;GO:0009617;GO:0048010;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:filopodium; C:nucleoplasm; C:plasma membrane; C:ruffle;, F:cadherin binding involved in cell-cell adhesion; F:cytoskeletal anchor activity; F:identical protein binding; F:proline-rich region binding; F:protein C-terminus binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:axonogenesis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:insulin receptor signaling pathway; P:plasma membrane organization; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:response to bacterium; P:vascular endothelial growth factor receptor signaling pathway;|Q9UQB8 O43858 Q53HB1 Q86WC1 Q8N5C0 Q96CR7 Q9UBR3 Q9UQ43,Brain-specific angiogenesis inhibitor 1-associated protein 2,Fas ligand-associated factor 3;Insulin receptor substrate p53/p58;Insulin receptor substrate protein of 53 kDa;, PF08397;PF07653;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0030175;GO:0005654;GO:0005886;GO:0001726;GO:0098641;GO:0008093;GO:0042802;GO:0070064;GO:0008022;GO:0051764;GO:0051017;GO:0007409;GO:0038096;GO:0008286;GO:0007009;GO:2000251;GO:0030838;GO:0032956;GO:0008360;GO:0009617;GO:0048010;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:filopodium; C:nucleoplasm; C:plasma membrane; C:ruffle;, F:cadherin binding involved in cell-cell adhesion; F:cytoskeletal anchor activity; F:identical protein binding; F:proline-rich region binding; F:protein C-terminus binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:axonogenesis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:insulin receptor signaling pathway; P:plasma membrane organization; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:response to bacterium; P:vascular endothelial growth factor receptor signaling pathway; scaffold61 indexed_genome mRNA 964254 968101 . - . ID=transcript_10551;Q6ZMQ8 O75136 Q6ZN31 Q86X28,Serine/threonine-protein kinase LMTK1,Apoptosis-associated tyrosine kinase;Brain apoptosis-associated tyrosine kinase;CDK5-binding protein;Lemur tyrosine kinase 1;p35-binding protein;, PF07714;, GO:0016021;GO:0048471;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0004713;GO:0007420;GO:0038083;GO:0006468;, C:integral component of membrane; C:perinuclear region of cytoplasm;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:brain development; P:peptidyl-tyrosine autophosphorylation; P:protein phosphorylation;|Q6ZMQ8 O75136 Q6ZN31 Q86X28,Serine/threonine-protein kinase LMTK1,Apoptosis-associated tyrosine kinase;Brain apoptosis-associated tyrosine kinase;CDK5-binding protein;Lemur tyrosine kinase 1;p35-binding protein;, PF07714;, GO:0016021;GO:0048471;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0004713;GO:0007420;GO:0038083;GO:0006468;, C:integral component of membrane; C:perinuclear region of cytoplasm;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:brain development; P:peptidyl-tyrosine autophosphorylation; P:protein phosphorylation; scaffold61 indexed_genome mRNA 969740 971873 . - . ID=transcript_10552;Q6ZMQ8 O75136 Q6ZN31 Q86X28,Serine/threonine-protein kinase LMTK1,Apoptosis-associated tyrosine kinase;Brain apoptosis-associated tyrosine kinase;CDK5-binding protein;Lemur tyrosine kinase 1;p35-binding protein;, PF07714;, GO:0016021;GO:0048471;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0004713;GO:0007420;GO:0038083;GO:0006468;, C:integral component of membrane; C:perinuclear region of cytoplasm;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:brain development; P:peptidyl-tyrosine autophosphorylation; P:protein phosphorylation; scaffold61 indexed_genome mRNA 972217 975699 . - . ID=transcript_10553;Q6ZMQ8 O75136 Q6ZN31 Q86X28,Serine/threonine-protein kinase LMTK1,Apoptosis-associated tyrosine kinase;Brain apoptosis-associated tyrosine kinase;CDK5-binding protein;Lemur tyrosine kinase 1;p35-binding protein;, PF07714;, GO:0016021;GO:0048471;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0004713;GO:0007420;GO:0038083;GO:0006468;, C:integral component of membrane; C:perinuclear region of cytoplasm;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:brain development; P:peptidyl-tyrosine autophosphorylation; P:protein phosphorylation;|Q6ZMQ8 O75136 Q6ZN31 Q86X28,Serine/threonine-protein kinase LMTK1,Apoptosis-associated tyrosine kinase;Brain apoptosis-associated tyrosine kinase;CDK5-binding protein;Lemur tyrosine kinase 1;p35-binding protein;, PF07714;, GO:0016021;GO:0048471;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0004713;GO:0007420;GO:0038083;GO:0006468;, C:integral component of membrane; C:perinuclear region of cytoplasm;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:brain development; P:peptidyl-tyrosine autophosphorylation; P:protein phosphorylation; scaffold61 indexed_genome mRNA 977514 978920 . + . ID=transcript_10554;Q6ZMQ8 O75136 Q6ZN31 Q86X28,Serine/threonine-protein kinase LMTK1,Apoptosis-associated tyrosine kinase;Brain apoptosis-associated tyrosine kinase;CDK5-binding protein;Lemur tyrosine kinase 1;p35-binding protein;, PF07714;, GO:0016021;GO:0048471;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0004713;GO:0007420;GO:0038083;GO:0006468;, C:integral component of membrane; C:perinuclear region of cytoplasm;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:brain development; P:peptidyl-tyrosine autophosphorylation; P:protein phosphorylation; scaffold61 indexed_genome mRNA 1020890 1037178 . - . ID=transcript_10555;Q9UPN4 A6NHI8 B2RN11 Q96F50,Centrosomal protein of 131 kDa,5-azacytidine-induced protein 1;Pre-acrosome localization protein 1;, , GO:0001669;GO:0034451;GO:0005813;GO:0036064;GO:0035869;GO:0005829;GO:0045171;GO:0043231;GO:0002177;GO:0015630;GO:0120212;GO:0042803;GO:0044877;GO:0097711;GO:0060271;GO:0000086;GO:0035735;GO:1990953;GO:1905198;GO:0007275;GO:1905515;GO:0008284;GO:0090316;GO:0071539;GO:0010824;GO:0010389;GO:0007288;, C:acrosomal vesicle; C:centriolar satellite; C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:manchette; C:microtubule cytoskeleton; C:sperm head-tail coupling apparatus;, F:protein homodimerization activity; F:protein-containing complex binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:intraciliary transport involved in cilium assembly; P:intramanchette transport; P:manchette assembly; P:multicellular organism development; P:non-motile cilium assembly; P:positive regulation of cell population proliferation; P:positive regulation of intracellular protein transport; P:protein localization to centrosome; P:regulation of centrosome duplication; P:regulation of G2/M transition of mitotic cell cycle; P:sperm axoneme assembly;|Q9UPN4 A6NHI8 B2RN11 Q96F50,Centrosomal protein of 131 kDa,5-azacytidine-induced protein 1;Pre-acrosome localization protein 1;, , GO:0001669;GO:0034451;GO:0005813;GO:0036064;GO:0035869;GO:0005829;GO:0045171;GO:0043231;GO:0002177;GO:0015630;GO:0120212;GO:0042803;GO:0044877;GO:0097711;GO:0060271;GO:0000086;GO:0035735;GO:1990953;GO:1905198;GO:0007275;GO:1905515;GO:0008284;GO:0090316;GO:0071539;GO:0010824;GO:0010389;GO:0007288;, C:acrosomal vesicle; C:centriolar satellite; C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:manchette; C:microtubule cytoskeleton; C:sperm head-tail coupling apparatus;, F:protein homodimerization activity; F:protein-containing complex binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:intraciliary transport involved in cilium assembly; P:intramanchette transport; P:manchette assembly; P:multicellular organism development; P:non-motile cilium assembly; P:positive regulation of cell population proliferation; P:positive regulation of intracellular protein transport; P:protein localization to centrosome; P:regulation of centrosome duplication; P:regulation of G2/M transition of mitotic cell cycle; P:sperm axoneme assembly;|Q9UPN4 A6NHI8 B2RN11 Q96F50,Centrosomal protein of 131 kDa,5-azacytidine-induced protein 1;Pre-acrosome localization protein 1;, , GO:0001669;GO:0034451;GO:0005813;GO:0036064;GO:0035869;GO:0005829;GO:0045171;GO:0043231;GO:0002177;GO:0015630;GO:0120212;GO:0042803;GO:0044877;GO:0097711;GO:0060271;GO:0000086;GO:0035735;GO:1990953;GO:1905198;GO:0007275;GO:1905515;GO:0008284;GO:0090316;GO:0071539;GO:0010824;GO:0010389;GO:0007288;, C:acrosomal vesicle; C:centriolar satellite; C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:manchette; C:microtubule cytoskeleton; C:sperm head-tail coupling apparatus;, F:protein homodimerization activity; F:protein-containing complex binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:intraciliary transport involved in cilium assembly; P:intramanchette transport; P:manchette assembly; P:multicellular organism development; P:non-motile cilium assembly; P:positive regulation of cell population proliferation; P:positive regulation of intracellular protein transport; P:protein localization to centrosome; P:regulation of centrosome duplication; P:regulation of G2/M transition of mitotic cell cycle; P:sperm axoneme assembly; scaffold61 indexed_genome mRNA 1042163 1060376 . - . ID=transcript_10556;Q96N21 Q6ZQU0 Q6ZSQ9,AP-4 complex accessory subunit Tepsin {ECO:0000305},ENTH domain-containing protein 2 {ECO:0000312|HGNC:HGNC:26458};Epsin for AP-4;Tetra-epsin {ECO:0000303|PubMed:22472443};, PF01417;, GO:0030662;GO:0005737;GO:0005829;GO:0031312;GO:0005794;GO:0031965;GO:0016607;GO:0032588;, C:coated vesicle membrane; C:cytoplasm; C:cytosol; C:extrinsic component of organelle membrane; C:Golgi apparatus; C:nuclear membrane; C:nuclear speck; C:trans-Golgi network membrane;|Q96N21 Q6ZQU0 Q6ZSQ9,AP-4 complex accessory subunit Tepsin {ECO:0000305},ENTH domain-containing protein 2 {ECO:0000312|HGNC:HGNC:26458};Epsin for AP-4;Tetra-epsin {ECO:0000303|PubMed:22472443};, PF01417;, GO:0030662;GO:0005737;GO:0005829;GO:0031312;GO:0005794;GO:0031965;GO:0016607;GO:0032588;, C:coated vesicle membrane; C:cytoplasm; C:cytosol; C:extrinsic component of organelle membrane; C:Golgi apparatus; C:nuclear membrane; C:nuclear speck; C:trans-Golgi network membrane;|Q96N21 Q6ZQU0 Q6ZSQ9,AP-4 complex accessory subunit Tepsin {ECO:0000305},ENTH domain-containing protein 2 {ECO:0000312|HGNC:HGNC:26458};Epsin for AP-4;Tetra-epsin {ECO:0000303|PubMed:22472443};, PF01417;, GO:0030662;GO:0005737;GO:0005829;GO:0031312;GO:0005794;GO:0031965;GO:0016607;GO:0032588;, C:coated vesicle membrane; C:cytoplasm; C:cytosol; C:extrinsic component of organelle membrane; C:Golgi apparatus; C:nuclear membrane; C:nuclear speck; C:trans-Golgi network membrane;|Q96N21 Q6ZQU0 Q6ZSQ9,AP-4 complex accessory subunit Tepsin {ECO:0000305},ENTH domain-containing protein 2 {ECO:0000312|HGNC:HGNC:26458};Epsin for AP-4;Tetra-epsin {ECO:0000303|PubMed:22472443};, PF01417;, GO:0030662;GO:0005737;GO:0005829;GO:0031312;GO:0005794;GO:0031965;GO:0016607;GO:0032588;, C:coated vesicle membrane; C:cytoplasm; C:cytosol; C:extrinsic component of organelle membrane; C:Golgi apparatus; C:nuclear membrane; C:nuclear speck; C:trans-Golgi network membrane; scaffold61 indexed_genome mRNA 1062614 1103491 . + . ID=transcript_10557;Q9HBR0 Q6ZRC5 Q8NA99 Q96C66,Putative sodium-coupled neutral amino acid transporter 10,Solute carrier family 38 member 10;, PF01490;, GO:0005794;GO:0016021;GO:0015171;GO:0003333;GO:0060348;GO:0006814;, C:Golgi apparatus; C:integral component of membrane;, F:amino acid transmembrane transporter activity;, P:amino acid transmembrane transport; P:bone development; P:sodium ion transport;|Q9HBR0 Q6ZRC5 Q8NA99 Q96C66,Putative sodium-coupled neutral amino acid transporter 10,Solute carrier family 38 member 10;, PF01490;, GO:0005794;GO:0016021;GO:0015171;GO:0003333;GO:0060348;GO:0006814;, C:Golgi apparatus; C:integral component of membrane;, F:amino acid transmembrane transporter activity;, P:amino acid transmembrane transport; P:bone development; P:sodium ion transport;|Q9HBR0 Q6ZRC5 Q8NA99 Q96C66,Putative sodium-coupled neutral amino acid transporter 10,Solute carrier family 38 member 10;, PF01490;, GO:0005794;GO:0016021;GO:0015171;GO:0003333;GO:0060348;GO:0006814;, C:Golgi apparatus; C:integral component of membrane;, F:amino acid transmembrane transporter activity;, P:amino acid transmembrane transport; P:bone development; P:sodium ion transport; scaffold61 indexed_genome mRNA 1227052 1233262 . + . ID=transcript_10558;Q9P281 A0A075B747 Q5U629,BAH and coiled-coil domain-containing protein 1 {ECO:0000305},Bromo adjacent homology domain-containing protein 2;, PF01426;, GO:0003682;, , F:chromatin binding; scaffold61 indexed_genome mRNA 1233287 1246093 . + . ID=transcript_10559;Q9P281 A0A075B747 Q5U629,BAH and coiled-coil domain-containing protein 1 {ECO:0000305},Bromo adjacent homology domain-containing protein 2;, PF01426;, GO:0003682;, , F:chromatin binding;|Q9P281 A0A075B747 Q5U629,BAH and coiled-coil domain-containing protein 1 {ECO:0000305},Bromo adjacent homology domain-containing protein 2;, PF01426;, GO:0003682;, , F:chromatin binding; scaffold61 indexed_genome mRNA 1312959 1323896 . - . ID=transcript_10560;Q0VG06 A6NNM1 Q8N3F7 Q9BV13 Q9H6K7 Q9H7E8,Fanconi anemia core complex-associated protein 100 {ECO:0000303|PubMed:17396147, ECO:0000312|HGNC:HGNC:26171},Fanconi anemia-associated protein of 100 kDa;, PF15146;, GO:0005829;GO:0043240;GO:0005654;GO:0003677;GO:0036297;, C:cytosol; C:Fanconi anaemia nuclear complex; C:nucleoplasm;, F:DNA binding;, P:interstrand cross-link repair;|Q0VG06 A6NNM1 Q8N3F7 Q9BV13 Q9H6K7 Q9H7E8,Fanconi anemia core complex-associated protein 100 {ECO:0000303|PubMed:17396147, ECO:0000312|HGNC:HGNC:26171},Fanconi anemia-associated protein of 100 kDa;, PF15146;, GO:0005829;GO:0043240;GO:0005654;GO:0003677;GO:0036297;, C:cytosol; C:Fanconi anaemia nuclear complex; C:nucleoplasm;, F:DNA binding;, P:interstrand cross-link repair;|Q0VG06 A6NNM1 Q8N3F7 Q9BV13 Q9H6K7 Q9H7E8,Fanconi anemia core complex-associated protein 100 {ECO:0000303|PubMed:17396147, ECO:0000312|HGNC:HGNC:26171},Fanconi anemia-associated protein of 100 kDa;, PF15146;, GO:0005829;GO:0043240;GO:0005654;GO:0003677;GO:0036297;, C:cytosol; C:Fanconi anaemia nuclear complex; C:nucleoplasm;, F:DNA binding;, P:interstrand cross-link repair; scaffold61 indexed_genome mRNA 1325235 1378212 . - . ID=transcript_10561;Q8TAT6 Q8N3J1 Q9H8V2 Q9H964 Q9NWR5 Q9P229,Nuclear protein localization protein 4 homolog,, PF05021;PF11543;PF05020;, GO:0005829;GO:0005783;GO:0042175;GO:0005654;GO:0005634;GO:0036501;GO:0034098;GO:0046872;GO:0043130;GO:0031625;GO:0070987;GO:0007030;GO:0039536;GO:0032480;GO:0030970;GO:0030433;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:nucleoplasm; C:nucleus; C:UFD1-NPL4 complex; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:error-free translesion synthesis; P:Golgi organization; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q8TAT6 Q8N3J1 Q9H8V2 Q9H964 Q9NWR5 Q9P229,Nuclear protein localization protein 4 homolog,, PF05021;PF11543;PF05020;, GO:0005829;GO:0005783;GO:0042175;GO:0005654;GO:0005634;GO:0036501;GO:0034098;GO:0046872;GO:0043130;GO:0031625;GO:0070987;GO:0007030;GO:0039536;GO:0032480;GO:0030970;GO:0030433;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:nucleoplasm; C:nucleus; C:UFD1-NPL4 complex; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:error-free translesion synthesis; P:Golgi organization; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q8TAT6 Q8N3J1 Q9H8V2 Q9H964 Q9NWR5 Q9P229,Nuclear protein localization protein 4 homolog,, PF05021;PF11543;PF05020;, GO:0005829;GO:0005783;GO:0042175;GO:0005654;GO:0005634;GO:0036501;GO:0034098;GO:0046872;GO:0043130;GO:0031625;GO:0070987;GO:0007030;GO:0039536;GO:0032480;GO:0030970;GO:0030433;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:nucleoplasm; C:nucleus; C:UFD1-NPL4 complex; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:error-free translesion synthesis; P:Golgi organization; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q8TAT6 Q8N3J1 Q9H8V2 Q9H964 Q9NWR5 Q9P229,Nuclear protein localization protein 4 homolog,, PF05021;PF11543;PF05020;, GO:0005829;GO:0005783;GO:0042175;GO:0005654;GO:0005634;GO:0036501;GO:0034098;GO:0046872;GO:0043130;GO:0031625;GO:0070987;GO:0007030;GO:0039536;GO:0032480;GO:0030970;GO:0030433;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:nucleoplasm; C:nucleus; C:UFD1-NPL4 complex; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:error-free translesion synthesis; P:Golgi organization; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q8TAT6 Q8N3J1 Q9H8V2 Q9H964 Q9NWR5 Q9P229,Nuclear protein localization protein 4 homolog,, PF05021;PF11543;PF05020;, GO:0005829;GO:0005783;GO:0042175;GO:0005654;GO:0005634;GO:0036501;GO:0034098;GO:0046872;GO:0043130;GO:0031625;GO:0070987;GO:0007030;GO:0039536;GO:0032480;GO:0030970;GO:0030433;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:nucleoplasm; C:nucleus; C:UFD1-NPL4 complex; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:error-free translesion synthesis; P:Golgi organization; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q8TAT6 Q8N3J1 Q9H8V2 Q9H964 Q9NWR5 Q9P229,Nuclear protein localization protein 4 homolog,, PF05021;PF11543;PF05020;, GO:0005829;GO:0005783;GO:0042175;GO:0005654;GO:0005634;GO:0036501;GO:0034098;GO:0046872;GO:0043130;GO:0031625;GO:0070987;GO:0007030;GO:0039536;GO:0032480;GO:0030970;GO:0030433;GO:0006511;, C:cytosol; C:endoplasmic reticulum; C:nuclear outer membrane-endoplasmic reticulum membrane network; C:nucleoplasm; C:nucleus; C:UFD1-NPL4 complex; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:metal ion binding; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:error-free translesion synthesis; P:Golgi organization; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold61 indexed_genome mRNA 1389214 1395593 . - . ID=transcript_10562;P18545 Q3KP63 Q7Z3U8,Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma,, PF04868;, GO:0097381;GO:0042622;GO:0005886;GO:0047555;GO:0030553;GO:0004857;GO:0030507;GO:0000187;GO:0045742;GO:0045745;GO:0022400;GO:0016056;GO:0007601;GO:0007223;, C:photoreceptor disc membrane; C:photoreceptor outer segment membrane; C:plasma membrane;, F:3',5'-cyclic-GMP phosphodiesterase activity; F:cGMP binding; F:enzyme inhibitor activity; F:spectrin binding;, P:activation of MAPK activity; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of G protein-coupled receptor signaling pathway; P:regulation of rhodopsin mediated signaling pathway; P:rhodopsin mediated signaling pathway; P:visual perception; P:Wnt signaling pathway, calcium modulating pathway;|Q5BKU9 A6ND24,Oxidoreductase-like domain-containing protein 1,, PF09791; scaffold61 indexed_genome mRNA 1395680 1401332 . + . ID=transcript_10563;Q6PK04,Coiled-coil domain-containing protein 137,, , GO:0005694;GO:0001650;GO:0005730;GO:0003723;, C:chromosome; C:fibrillar center; C:nucleolus;, F:RNA binding; scaffold61 indexed_genome mRNA 1403664 1404322 . + . ID=transcript_10564;Q03701 Q8NE75,CCAAT/enhancer-binding protein zeta,CCAAT-box-binding transcription factor;, PF03914;, GO:0005634;GO:0003723;GO:0003713;GO:0045944;, C:nucleus;, F:RNA binding; F:transcription coactivator activity;, P:positive regulation of transcription by RNA polymerase II; scaffold61 indexed_genome mRNA 1407903 1412483 . - . ID=transcript_10565;Q0P5N6,ADP-ribosylation factor-like protein 16,, PF00025;, GO:0005525;, , F:GTP binding;|Q0P5N6,ADP-ribosylation factor-like protein 16,, PF00025;, GO:0005525;, , F:GTP binding;|Q0P5N6,ADP-ribosylation factor-like protein 16,, PF00025;, GO:0005525;, , F:GTP binding; scaffold61 indexed_genome mRNA 1412695 1426450 . + . ID=transcript_10566;O14964 Q9NR36,Hepatocyte growth factor-regulated tyrosine kinase substrate,Hrs {ECO:0000303|PubMed:9407053};Protein pp110;, PF01363;PF12210;PF00790;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0033565;GO:0070062;GO:0043231;GO:0005764;GO:0032585;GO:0097013;GO:0046872;GO:0019904;GO:0044389;GO:0016197;GO:0016236;GO:0010324;GO:0061024;GO:0044003;GO:0036258;GO:0016525;GO:0008285;GO:0042059;GO:0010642;GO:0046426;GO:0030948;GO:1903543;GO:0010628;GO:0006892;GO:0016579;GO:0072657;GO:0006622;GO:0043405;GO:0042176;GO:0007165;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:ESCRT-0 complex; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosome; C:multivesicular body membrane; C:phagocytic vesicle lumen;, F:metal ion binding; F:protein domain specific binding; F:ubiquitin-like protein ligase binding;, P:endosomal transport; P:macroautophagy; P:membrane invagination; P:membrane organization; P:modulation by symbiont of host process; P:multivesicular body assembly; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:post-Golgi vesicle-mediated transport; P:protein deubiquitination; P:protein localization to membrane; P:protein targeting to lysosome; P:regulation of MAP kinase activity; P:regulation of protein catabolic process; P:signal transduction;|O14964 Q9NR36,Hepatocyte growth factor-regulated tyrosine kinase substrate,Hrs {ECO:0000303|PubMed:9407053};Protein pp110;, PF01363;PF12210;PF00790;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0033565;GO:0070062;GO:0043231;GO:0005764;GO:0032585;GO:0097013;GO:0046872;GO:0019904;GO:0044389;GO:0016197;GO:0016236;GO:0010324;GO:0061024;GO:0044003;GO:0036258;GO:0016525;GO:0008285;GO:0042059;GO:0010642;GO:0046426;GO:0030948;GO:1903543;GO:0010628;GO:0006892;GO:0016579;GO:0072657;GO:0006622;GO:0043405;GO:0042176;GO:0007165;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:ESCRT-0 complex; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosome; C:multivesicular body membrane; C:phagocytic vesicle lumen;, F:metal ion binding; F:protein domain specific binding; F:ubiquitin-like protein ligase binding;, P:endosomal transport; P:macroautophagy; P:membrane invagination; P:membrane organization; P:modulation by symbiont of host process; P:multivesicular body assembly; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:post-Golgi vesicle-mediated transport; P:protein deubiquitination; P:protein localization to membrane; P:protein targeting to lysosome; P:regulation of MAP kinase activity; P:regulation of protein catabolic process; P:signal transduction;|O14964 Q9NR36,Hepatocyte growth factor-regulated tyrosine kinase substrate,Hrs {ECO:0000303|PubMed:9407053};Protein pp110;, PF01363;PF12210;PF00790;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0033565;GO:0070062;GO:0043231;GO:0005764;GO:0032585;GO:0097013;GO:0046872;GO:0019904;GO:0044389;GO:0016197;GO:0016236;GO:0010324;GO:0061024;GO:0044003;GO:0036258;GO:0016525;GO:0008285;GO:0042059;GO:0010642;GO:0046426;GO:0030948;GO:1903543;GO:0010628;GO:0006892;GO:0016579;GO:0072657;GO:0006622;GO:0043405;GO:0042176;GO:0007165;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:ESCRT-0 complex; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosome; C:multivesicular body membrane; C:phagocytic vesicle lumen;, F:metal ion binding; F:protein domain specific binding; F:ubiquitin-like protein ligase binding;, P:endosomal transport; P:macroautophagy; P:membrane invagination; P:membrane organization; P:modulation by symbiont of host process; P:multivesicular body assembly; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:post-Golgi vesicle-mediated transport; P:protein deubiquitination; P:protein localization to membrane; P:protein targeting to lysosome; P:regulation of MAP kinase activity; P:regulation of protein catabolic process; P:signal transduction;|O14964 Q9NR36,Hepatocyte growth factor-regulated tyrosine kinase substrate,Hrs {ECO:0000303|PubMed:9407053};Protein pp110;, PF01363;PF12210;PF00790;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0033565;GO:0070062;GO:0043231;GO:0005764;GO:0032585;GO:0097013;GO:0046872;GO:0019904;GO:0044389;GO:0016197;GO:0016236;GO:0010324;GO:0061024;GO:0044003;GO:0036258;GO:0016525;GO:0008285;GO:0042059;GO:0010642;GO:0046426;GO:0030948;GO:1903543;GO:0010628;GO:0006892;GO:0016579;GO:0072657;GO:0006622;GO:0043405;GO:0042176;GO:0007165;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:ESCRT-0 complex; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosome; C:multivesicular body membrane; C:phagocytic vesicle lumen;, F:metal ion binding; F:protein domain specific binding; F:ubiquitin-like protein ligase binding;, P:endosomal transport; P:macroautophagy; P:membrane invagination; P:membrane organization; P:modulation by symbiont of host process; P:multivesicular body assembly; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:post-Golgi vesicle-mediated transport; P:protein deubiquitination; P:protein localization to membrane; P:protein targeting to lysosome; P:regulation of MAP kinase activity; P:regulation of protein catabolic process; P:signal transduction;|O14964 Q9NR36,Hepatocyte growth factor-regulated tyrosine kinase substrate,Hrs {ECO:0000303|PubMed:9407053};Protein pp110;, PF01363;PF12210;PF00790;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0033565;GO:0070062;GO:0043231;GO:0005764;GO:0032585;GO:0097013;GO:0046872;GO:0019904;GO:0044389;GO:0016197;GO:0016236;GO:0010324;GO:0061024;GO:0044003;GO:0036258;GO:0016525;GO:0008285;GO:0042059;GO:0010642;GO:0046426;GO:0030948;GO:1903543;GO:0010628;GO:0006892;GO:0016579;GO:0072657;GO:0006622;GO:0043405;GO:0042176;GO:0007165;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:ESCRT-0 complex; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosome; C:multivesicular body membrane; C:phagocytic vesicle lumen;, F:metal ion binding; F:protein domain specific binding; F:ubiquitin-like protein ligase binding;, P:endosomal transport; P:macroautophagy; P:membrane invagination; P:membrane organization; P:modulation by symbiont of host process; P:multivesicular body assembly; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:post-Golgi vesicle-mediated transport; P:protein deubiquitination; P:protein localization to membrane; P:protein targeting to lysosome; P:regulation of MAP kinase activity; P:regulation of protein catabolic process; P:signal transduction; scaffold61 indexed_genome mRNA 1427076 1431458 . + . ID=transcript_10567;P52815 Q969U0 Q9HCA2 Q9UQJ3,39S ribosomal protein L12, mitochondrial,5c5-2;Mitochondrial large ribosomal subunit protein bL12m {ECO:0000303|PubMed:25278503};, PF00542;PF16320;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0006390;GO:0070125;GO:0070126;GO:0045893;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial transcription; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:positive regulation of transcription, DNA-templated; scaffold61 indexed_genome mRNA 1433020 1441785 . + . ID=transcript_10568;Q9UBX3 Q542Z3 Q96BA1 Q96IP1,Mitochondrial dicarboxylate carrier,Solute carrier family 25 member 10;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005654;GO:0005634;GO:0015297;GO:0005310;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0006835;GO:0006094;GO:0006811;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:0071422;GO:0008272;GO:0070221;GO:0015709;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:antiporter activity; F:dicarboxylic acid transmembrane transporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:dicarboxylic acid transport; P:gluconeogenesis; P:ion transport; P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:sulfide oxidation, using sulfide:quinone oxidoreductase; P:thiosulfate transport;|Q9UBX3 Q542Z3 Q96BA1 Q96IP1,Mitochondrial dicarboxylate carrier,Solute carrier family 25 member 10;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005654;GO:0005634;GO:0015297;GO:0005310;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0006835;GO:0006094;GO:0006811;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:0071422;GO:0008272;GO:0070221;GO:0015709;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:antiporter activity; F:dicarboxylic acid transmembrane transporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:dicarboxylic acid transport; P:gluconeogenesis; P:ion transport; P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:sulfide oxidation, using sulfide:quinone oxidoreductase; P:thiosulfate transport;|Q9UBX3 Q542Z3 Q96BA1 Q96IP1,Mitochondrial dicarboxylate carrier,Solute carrier family 25 member 10;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005654;GO:0005634;GO:0015297;GO:0005310;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0006835;GO:0006094;GO:0006811;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:0071422;GO:0008272;GO:0070221;GO:0015709;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:antiporter activity; F:dicarboxylic acid transmembrane transporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:dicarboxylic acid transport; P:gluconeogenesis; P:ion transport; P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:sulfide oxidation, using sulfide:quinone oxidoreductase; P:thiosulfate transport;|Q9UBX3 Q542Z3 Q96BA1 Q96IP1,Mitochondrial dicarboxylate carrier,Solute carrier family 25 member 10;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005654;GO:0005634;GO:0015297;GO:0005310;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0006835;GO:0006094;GO:0006811;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:0071422;GO:0008272;GO:0070221;GO:0015709;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:antiporter activity; F:dicarboxylic acid transmembrane transporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:dicarboxylic acid transport; P:gluconeogenesis; P:ion transport; P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:sulfide oxidation, using sulfide:quinone oxidoreductase; P:thiosulfate transport; scaffold61 indexed_genome mRNA 1472579 1483615 . + . ID=transcript_10569;P47871 Q2M3M5,Glucagon receptor,, PF00002;PF02793;, GO:0016021;GO:0005887;GO:0005886;GO:0008528;GO:0004967;GO:0017046;GO:0007189;GO:0007188;GO:0007166;GO:0071377;GO:0009267;GO:0006091;GO:0042593;GO:0010628;GO:0008217;GO:0050790;GO:0070873;GO:0007584;GO:0042594;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:glucagon receptor activity; F:peptide hormone binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:cellular response to glucagon stimulus; P:cellular response to starvation; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:positive regulation of gene expression; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of glycogen metabolic process; P:response to nutrient; P:response to starvation;|P47871 Q2M3M5,Glucagon receptor,, PF00002;PF02793;, GO:0016021;GO:0005887;GO:0005886;GO:0008528;GO:0004967;GO:0017046;GO:0007189;GO:0007188;GO:0007166;GO:0071377;GO:0009267;GO:0006091;GO:0042593;GO:0010628;GO:0008217;GO:0050790;GO:0070873;GO:0007584;GO:0042594;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:glucagon receptor activity; F:peptide hormone binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:cellular response to glucagon stimulus; P:cellular response to starvation; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:positive regulation of gene expression; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of glycogen metabolic process; P:response to nutrient; P:response to starvation;|P47871 Q2M3M5,Glucagon receptor,, PF00002;PF02793;, GO:0016021;GO:0005887;GO:0005886;GO:0008528;GO:0004967;GO:0017046;GO:0007189;GO:0007188;GO:0007166;GO:0071377;GO:0009267;GO:0006091;GO:0042593;GO:0010628;GO:0008217;GO:0050790;GO:0070873;GO:0007584;GO:0042594;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:glucagon receptor activity; F:peptide hormone binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:cellular response to glucagon stimulus; P:cellular response to starvation; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:positive regulation of gene expression; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of glycogen metabolic process; P:response to nutrient; P:response to starvation;|P47871 Q2M3M5,Glucagon receptor,, PF00002;PF02793;, GO:0016021;GO:0005887;GO:0005886;GO:0008528;GO:0004967;GO:0017046;GO:0007189;GO:0007188;GO:0007166;GO:0071377;GO:0009267;GO:0006091;GO:0042593;GO:0010628;GO:0008217;GO:0050790;GO:0070873;GO:0007584;GO:0042594;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:glucagon receptor activity; F:peptide hormone binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:cellular response to glucagon stimulus; P:cellular response to starvation; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:positive regulation of gene expression; P:regulation of blood pressure; P:regulation of catalytic activity; P:regulation of glycogen metabolic process; P:response to nutrient; P:response to starvation; scaffold61 indexed_genome mRNA 1488908 1494477 . - . ID=transcript_10570;C9JLW8 Q6ZUL0,Mapk-regulated corepressor-interacting protein 1 {ECO:0000303|PubMed:25728771},Granulin-2 {ECO:0000303|PubMed:26184334};Protein FAM195B;, PF14799;, GO:0005737;GO:0010494;GO:0005634;GO:0010717;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleus;, , P:regulation of epithelial to mesenchymal transition; scaffold61 indexed_genome mRNA 1501750 1502968 . - . ID=transcript_10571;Q86WC6,Protein phosphatase 1 regulatory subunit 27,Dysferlin-interacting protein 1;Toonin;, , GO:0019902;GO:0004864;GO:0010923;, , F:phosphatase binding; F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity;|Q86WC6,Protein phosphatase 1 regulatory subunit 27,Dysferlin-interacting protein 1;Toonin;, , GO:0019902;GO:0004864;GO:0010923;, , F:phosphatase binding; F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity; scaffold61 indexed_genome mRNA 1507394 1517763 . - . ID=transcript_10572;P07237 B2RDQ2 P30037 P32079 Q15205 Q6LDE5,Protein disulfide-isomerase,Cellular thyroid hormone-binding protein;Prolyl 4-hydroxylase subunit beta;p55;, PF00085;, GO:0005856;GO:0005829;GO:0005783;GO:0005788;GO:0005793;GO:0009897;GO:0070062;GO:0005576;GO:0005925;GO:0030027;GO:0042470;GO:0016222;GO:0032991;GO:0003779;GO:0005178;GO:0015037;GO:0004656;GO:0003756;GO:0046982;GO:0003723;GO:0016972;GO:0044267;GO:0071456;GO:0034378;GO:0030199;GO:0035722;GO:0038155;GO:0018401;GO:0045785;GO:1900026;GO:0046598;GO:0043687;GO:0006457;GO:0034975;GO:1902175;GO:0034976;GO:0034379;, C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:lamellipodium; C:melanosome; C:procollagen-proline 4-dioxygenase complex; C:protein-containing complex;, F:actin binding; F:integrin binding; F:peptide disulfide oxidoreductase activity; F:procollagen-proline 4-dioxygenase activity; F:protein disulfide isomerase activity; F:protein heterodimerization activity; F:RNA binding; F:thiol oxidase activity;, P:cellular protein metabolic process; P:cellular response to hypoxia; P:chylomicron assembly; P:collagen fibril organization; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:positive regulation of cell adhesion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of viral entry into host cell; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:response to endoplasmic reticulum stress; P:very-low-density lipoprotein particle assembly;|P07237 B2RDQ2 P30037 P32079 Q15205 Q6LDE5,Protein disulfide-isomerase,Cellular thyroid hormone-binding protein;Prolyl 4-hydroxylase subunit beta;p55;, PF00085;, GO:0005856;GO:0005829;GO:0005783;GO:0005788;GO:0005793;GO:0009897;GO:0070062;GO:0005576;GO:0005925;GO:0030027;GO:0042470;GO:0016222;GO:0032991;GO:0003779;GO:0005178;GO:0015037;GO:0004656;GO:0003756;GO:0046982;GO:0003723;GO:0016972;GO:0044267;GO:0071456;GO:0034378;GO:0030199;GO:0035722;GO:0038155;GO:0018401;GO:0045785;GO:1900026;GO:0046598;GO:0043687;GO:0006457;GO:0034975;GO:1902175;GO:0034976;GO:0034379;, C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:lamellipodium; C:melanosome; C:procollagen-proline 4-dioxygenase complex; C:protein-containing complex;, F:actin binding; F:integrin binding; F:peptide disulfide oxidoreductase activity; F:procollagen-proline 4-dioxygenase activity; F:protein disulfide isomerase activity; F:protein heterodimerization activity; F:RNA binding; F:thiol oxidase activity;, P:cellular protein metabolic process; P:cellular response to hypoxia; P:chylomicron assembly; P:collagen fibril organization; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:positive regulation of cell adhesion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of viral entry into host cell; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:response to endoplasmic reticulum stress; P:very-low-density lipoprotein particle assembly;|P07237 B2RDQ2 P30037 P32079 Q15205 Q6LDE5,Protein disulfide-isomerase,Cellular thyroid hormone-binding protein;Prolyl 4-hydroxylase subunit beta;p55;, PF00085;, GO:0005856;GO:0005829;GO:0005783;GO:0005788;GO:0005793;GO:0009897;GO:0070062;GO:0005576;GO:0005925;GO:0030027;GO:0042470;GO:0016222;GO:0032991;GO:0003779;GO:0005178;GO:0015037;GO:0004656;GO:0003756;GO:0046982;GO:0003723;GO:0016972;GO:0044267;GO:0071456;GO:0034378;GO:0030199;GO:0035722;GO:0038155;GO:0018401;GO:0045785;GO:1900026;GO:0046598;GO:0043687;GO:0006457;GO:0034975;GO:1902175;GO:0034976;GO:0034379;, C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:lamellipodium; C:melanosome; C:procollagen-proline 4-dioxygenase complex; C:protein-containing complex;, F:actin binding; F:integrin binding; F:peptide disulfide oxidoreductase activity; F:procollagen-proline 4-dioxygenase activity; F:protein disulfide isomerase activity; F:protein heterodimerization activity; F:RNA binding; F:thiol oxidase activity;, P:cellular protein metabolic process; P:cellular response to hypoxia; P:chylomicron assembly; P:collagen fibril organization; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:positive regulation of cell adhesion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of viral entry into host cell; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:response to endoplasmic reticulum stress; P:very-low-density lipoprotein particle assembly;|P07237 B2RDQ2 P30037 P32079 Q15205 Q6LDE5,Protein disulfide-isomerase,Cellular thyroid hormone-binding protein;Prolyl 4-hydroxylase subunit beta;p55;, PF00085;, GO:0005856;GO:0005829;GO:0005783;GO:0005788;GO:0005793;GO:0009897;GO:0070062;GO:0005576;GO:0005925;GO:0030027;GO:0042470;GO:0016222;GO:0032991;GO:0003779;GO:0005178;GO:0015037;GO:0004656;GO:0003756;GO:0046982;GO:0003723;GO:0016972;GO:0044267;GO:0071456;GO:0034378;GO:0030199;GO:0035722;GO:0038155;GO:0018401;GO:0045785;GO:1900026;GO:0046598;GO:0043687;GO:0006457;GO:0034975;GO:1902175;GO:0034976;GO:0034379;, C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:lamellipodium; C:melanosome; C:procollagen-proline 4-dioxygenase complex; C:protein-containing complex;, F:actin binding; F:integrin binding; F:peptide disulfide oxidoreductase activity; F:procollagen-proline 4-dioxygenase activity; F:protein disulfide isomerase activity; F:protein heterodimerization activity; F:RNA binding; F:thiol oxidase activity;, P:cellular protein metabolic process; P:cellular response to hypoxia; P:chylomicron assembly; P:collagen fibril organization; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:positive regulation of cell adhesion; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of viral entry into host cell; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:response to endoplasmic reticulum stress; P:very-low-density lipoprotein particle assembly; scaffold61 indexed_genome mRNA 1525723 1527170 . + . ID=transcript_10573;P52565 A8MXW0 B2R5X1 B4DDD3 B4DUV9 Q6IBM5,Rho GDP-dissociation inhibitor 1,Rho-GDI alpha;, PF02115;, GO:0005856;GO:0005829;GO:0070062;GO:0016020;GO:0005096;GO:0005094;GO:0043066;GO:0050771;GO:0007162;GO:0050772;GO:2000249;GO:0035023;GO:0051056;GO:0007266;GO:0071526;, C:cytoskeleton; C:cytosol; C:extracellular exosome; C:membrane;, F:GTPase activator activity; F:Rho GDP-dissociation inhibitor activity;, P:negative regulation of apoptotic process; P:negative regulation of axonogenesis; P:negative regulation of cell adhesion; P:positive regulation of axonogenesis; P:regulation of actin cytoskeleton reorganization; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:semaphorin-plexin signaling pathway; scaffold61 indexed_genome mRNA 1546256 1549249 . - . ID=transcript_10574;Q86V81 O43672,THO complex subunit 4,Ally of AML-1 and LEF-1;Aly/REF export factor;Transcriptional coactivator Aly/REF;bZIP-enhancing factor BEF;, PF13865;PF00076;, GO:0071013;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0000346;GO:0062153;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0001649;GO:0032786;GO:0000018;GO:0031297;GO:0006405;GO:0046784;GO:0016032;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:transcription export complex;, F:C5-methylcytidine-containing RNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:osteoblast differentiation; P:positive regulation of DNA-templated transcription, elongation; P:regulation of DNA recombination; P:replication fork processing; P:RNA export from nucleus; P:viral mRNA export from host cell nucleus; P:viral process; scaffold61 indexed_genome mRNA 1554725 1560131 . + . ID=transcript_10575;Q9NYG5 A8MTT2 B7ZW64 Q502X9 Q9BW64 Q9P0R2,Anaphase-promoting complex subunit 11,Cyclosome subunit 11;Hepatocellular carcinoma-associated RING finger protein;, PF12861;, GO:0005680;GO:0031461;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0097602;GO:0061630;GO:0034450;GO:0008270;GO:0031145;GO:0051301;GO:0000278;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cullin family protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9NYG5 A8MTT2 B7ZW64 Q502X9 Q9BW64 Q9P0R2,Anaphase-promoting complex subunit 11,Cyclosome subunit 11;Hepatocellular carcinoma-associated RING finger protein;, PF12861;, GO:0005680;GO:0031461;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0097602;GO:0061630;GO:0034450;GO:0008270;GO:0031145;GO:0051301;GO:0000278;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cullin family protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9NYG5 A8MTT2 B7ZW64 Q502X9 Q9BW64 Q9P0R2,Anaphase-promoting complex subunit 11,Cyclosome subunit 11;Hepatocellular carcinoma-associated RING finger protein;, PF12861;, GO:0005680;GO:0031461;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0097602;GO:0061630;GO:0034450;GO:0008270;GO:0031145;GO:0051301;GO:0000278;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cullin family protein binding; F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold61 indexed_genome mRNA 1565020 1572368 . - . ID=transcript_10576;Q99447 B7Z7A5 B7ZAS0 F5H8B1 Q6IBM3 Q96G08,Ethanolamine-phosphate cytidylyltransferase,CTP:phosphoethanolamine cytidylyltransferase;Phosphorylethanolamine transferase;, PF01467;, GO:0005789;GO:0004306;GO:0006646;GO:0008654;, C:endoplasmic reticulum membrane;, F:ethanolamine-phosphate cytidylyltransferase activity;, P:phosphatidylethanolamine biosynthetic process; P:phospholipid biosynthetic process; scaffold61 indexed_genome mRNA 1572614 1578762 . - . ID=transcript_10577;Q9NRC8 A8K2K0 B3KSU8 Q3MIK4 Q9NSZ6 Q9NUS6,NAD-dependent protein deacetylase sirtuin-7,NAD-dependent protein deacylase sirtuin-7;Regulatory protein SIR2 homolog 7;SIR2-like protein 7;, PF02146;, GO:0000785;GO:0005737;GO:0016607;GO:0005730;GO:0005731;GO:0005654;GO:0005634;GO:0035861;GO:0003682;GO:0019213;GO:0004407;GO:0046872;GO:0070403;GO:0097372;GO:0034979;GO:0061697;GO:0106231;GO:0036055;GO:0003714;GO:0006974;GO:0006281;GO:1990258;GO:0070932;GO:0016570;GO:0007129;GO:0031397;GO:0000122;GO:0010529;GO:0001649;GO:0036049;GO:2000234;GO:0045944;GO:0007072;GO:0006476;GO:0061698;GO:0106230;GO:0062176;GO:0006282;GO:2001032;GO:0006111;GO:0010821;GO:0046825;GO:1901836;GO:0009303;, C:chromatin; C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleolus organizer region; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:chromatin binding; F:deacetylase activity; F:histone deacetylase activity; F:metal ion binding; F:NAD+ binding; F:NAD-dependent histone deacetylase activity (H3-K18 specific); F:NAD-dependent protein deacetylase activity; F:protein-glutaryllysine deglutarylase activity; F:protein-propionyllysine depropionylase activity; F:protein-succinyllysine desuccinylase activity; F:transcription corepressor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:histone glutamine methylation; P:histone H3 deacetylation; P:histone modification; P:homologous chromosome pairing at meiosis; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transposition; P:osteoblast differentiation; P:peptidyl-lysine desuccinylation; P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription involved in exit from mitosis; P:protein deacetylation; P:protein deglutarylation; P:protein depropionylation; P:R-loop disassembly; P:regulation of DNA repair; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of gluconeogenesis; P:regulation of mitochondrion organization; P:regulation of protein export from nucleus; P:regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription;|Q9NRC8 A8K2K0 B3KSU8 Q3MIK4 Q9NSZ6 Q9NUS6,NAD-dependent protein deacetylase sirtuin-7,NAD-dependent protein deacylase sirtuin-7;Regulatory protein SIR2 homolog 7;SIR2-like protein 7;, PF02146;, GO:0000785;GO:0005737;GO:0016607;GO:0005730;GO:0005731;GO:0005654;GO:0005634;GO:0035861;GO:0003682;GO:0019213;GO:0004407;GO:0046872;GO:0070403;GO:0097372;GO:0034979;GO:0061697;GO:0106231;GO:0036055;GO:0003714;GO:0006974;GO:0006281;GO:1990258;GO:0070932;GO:0016570;GO:0007129;GO:0031397;GO:0000122;GO:0010529;GO:0001649;GO:0036049;GO:2000234;GO:0045944;GO:0007072;GO:0006476;GO:0061698;GO:0106230;GO:0062176;GO:0006282;GO:2001032;GO:0006111;GO:0010821;GO:0046825;GO:1901836;GO:0009303;, C:chromatin; C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleolus organizer region; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:chromatin binding; F:deacetylase activity; F:histone deacetylase activity; F:metal ion binding; F:NAD+ binding; F:NAD-dependent histone deacetylase activity (H3-K18 specific); F:NAD-dependent protein deacetylase activity; F:protein-glutaryllysine deglutarylase activity; F:protein-propionyllysine depropionylase activity; F:protein-succinyllysine desuccinylase activity; F:transcription corepressor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:histone glutamine methylation; P:histone H3 deacetylation; P:histone modification; P:homologous chromosome pairing at meiosis; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transposition; P:osteoblast differentiation; P:peptidyl-lysine desuccinylation; P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription involved in exit from mitosis; P:protein deacetylation; P:protein deglutarylation; P:protein depropionylation; P:R-loop disassembly; P:regulation of DNA repair; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of gluconeogenesis; P:regulation of mitochondrion organization; P:regulation of protein export from nucleus; P:regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription;|Q9NRC8 A8K2K0 B3KSU8 Q3MIK4 Q9NSZ6 Q9NUS6,NAD-dependent protein deacetylase sirtuin-7,NAD-dependent protein deacylase sirtuin-7;Regulatory protein SIR2 homolog 7;SIR2-like protein 7;, PF02146;, GO:0000785;GO:0005737;GO:0016607;GO:0005730;GO:0005731;GO:0005654;GO:0005634;GO:0035861;GO:0003682;GO:0019213;GO:0004407;GO:0046872;GO:0070403;GO:0097372;GO:0034979;GO:0061697;GO:0106231;GO:0036055;GO:0003714;GO:0006974;GO:0006281;GO:1990258;GO:0070932;GO:0016570;GO:0007129;GO:0031397;GO:0000122;GO:0010529;GO:0001649;GO:0036049;GO:2000234;GO:0045944;GO:0007072;GO:0006476;GO:0061698;GO:0106230;GO:0062176;GO:0006282;GO:2001032;GO:0006111;GO:0010821;GO:0046825;GO:1901836;GO:0009303;, C:chromatin; C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleolus organizer region; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:chromatin binding; F:deacetylase activity; F:histone deacetylase activity; F:metal ion binding; F:NAD+ binding; F:NAD-dependent histone deacetylase activity (H3-K18 specific); F:NAD-dependent protein deacetylase activity; F:protein-glutaryllysine deglutarylase activity; F:protein-propionyllysine depropionylase activity; F:protein-succinyllysine desuccinylase activity; F:transcription corepressor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:histone glutamine methylation; P:histone H3 deacetylation; P:histone modification; P:homologous chromosome pairing at meiosis; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transposition; P:osteoblast differentiation; P:peptidyl-lysine desuccinylation; P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription involved in exit from mitosis; P:protein deacetylation; P:protein deglutarylation; P:protein depropionylation; P:R-loop disassembly; P:regulation of DNA repair; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of gluconeogenesis; P:regulation of mitochondrion organization; P:regulation of protein export from nucleus; P:regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription;|Q9NRC8 A8K2K0 B3KSU8 Q3MIK4 Q9NSZ6 Q9NUS6,NAD-dependent protein deacetylase sirtuin-7,NAD-dependent protein deacylase sirtuin-7;Regulatory protein SIR2 homolog 7;SIR2-like protein 7;, PF02146;, GO:0000785;GO:0005737;GO:0016607;GO:0005730;GO:0005731;GO:0005654;GO:0005634;GO:0035861;GO:0003682;GO:0019213;GO:0004407;GO:0046872;GO:0070403;GO:0097372;GO:0034979;GO:0061697;GO:0106231;GO:0036055;GO:0003714;GO:0006974;GO:0006281;GO:1990258;GO:0070932;GO:0016570;GO:0007129;GO:0031397;GO:0000122;GO:0010529;GO:0001649;GO:0036049;GO:2000234;GO:0045944;GO:0007072;GO:0006476;GO:0061698;GO:0106230;GO:0062176;GO:0006282;GO:2001032;GO:0006111;GO:0010821;GO:0046825;GO:1901836;GO:0009303;, C:chromatin; C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleolus organizer region; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:chromatin binding; F:deacetylase activity; F:histone deacetylase activity; F:metal ion binding; F:NAD+ binding; F:NAD-dependent histone deacetylase activity (H3-K18 specific); F:NAD-dependent protein deacetylase activity; F:protein-glutaryllysine deglutarylase activity; F:protein-propionyllysine depropionylase activity; F:protein-succinyllysine desuccinylase activity; F:transcription corepressor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:histone glutamine methylation; P:histone H3 deacetylation; P:histone modification; P:homologous chromosome pairing at meiosis; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transposition; P:osteoblast differentiation; P:peptidyl-lysine desuccinylation; P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription involved in exit from mitosis; P:protein deacetylation; P:protein deglutarylation; P:protein depropionylation; P:R-loop disassembly; P:regulation of DNA repair; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of gluconeogenesis; P:regulation of mitochondrion organization; P:regulation of protein export from nucleus; P:regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription;|Q9NRC8 A8K2K0 B3KSU8 Q3MIK4 Q9NSZ6 Q9NUS6,NAD-dependent protein deacetylase sirtuin-7,NAD-dependent protein deacylase sirtuin-7;Regulatory protein SIR2 homolog 7;SIR2-like protein 7;, PF02146;, GO:0000785;GO:0005737;GO:0016607;GO:0005730;GO:0005731;GO:0005654;GO:0005634;GO:0035861;GO:0003682;GO:0019213;GO:0004407;GO:0046872;GO:0070403;GO:0097372;GO:0034979;GO:0061697;GO:0106231;GO:0036055;GO:0003714;GO:0006974;GO:0006281;GO:1990258;GO:0070932;GO:0016570;GO:0007129;GO:0031397;GO:0000122;GO:0010529;GO:0001649;GO:0036049;GO:2000234;GO:0045944;GO:0007072;GO:0006476;GO:0061698;GO:0106230;GO:0062176;GO:0006282;GO:2001032;GO:0006111;GO:0010821;GO:0046825;GO:1901836;GO:0009303;, C:chromatin; C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleolus organizer region; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:chromatin binding; F:deacetylase activity; F:histone deacetylase activity; F:metal ion binding; F:NAD+ binding; F:NAD-dependent histone deacetylase activity (H3-K18 specific); F:NAD-dependent protein deacetylase activity; F:protein-glutaryllysine deglutarylase activity; F:protein-propionyllysine depropionylase activity; F:protein-succinyllysine desuccinylase activity; F:transcription corepressor activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:histone glutamine methylation; P:histone H3 deacetylation; P:histone modification; P:homologous chromosome pairing at meiosis; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transposition; P:osteoblast differentiation; P:peptidyl-lysine desuccinylation; P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription involved in exit from mitosis; P:protein deacetylation; P:protein deglutarylation; P:protein depropionylation; P:R-loop disassembly; P:regulation of DNA repair; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of gluconeogenesis; P:regulation of mitochondrion organization; P:regulation of protein export from nucleus; P:regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription; scaffold61 indexed_genome mRNA 1582362 1584725 . - . ID=transcript_10578;O15525,Transcription factor MafG,V-maf musculoaponeurotic fibrosarcoma oncogene homolog G;hMAF;, PF03131;, GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0000978;GO:1990837;GO:0030534;GO:0007596;GO:0001701;GO:0042127;GO:0030641;GO:0045604;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adult behavior; P:blood coagulation; P:in utero embryonic development; P:regulation of cell population proliferation; P:regulation of cellular pH; P:regulation of epidermal cell differentiation; P:regulation of transcription by RNA polymerase II;|O15525,Transcription factor MafG,V-maf musculoaponeurotic fibrosarcoma oncogene homolog G;hMAF;, PF03131;, GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0000978;GO:1990837;GO:0030534;GO:0007596;GO:0001701;GO:0042127;GO:0030641;GO:0045604;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:adult behavior; P:blood coagulation; P:in utero embryonic development; P:regulation of cell population proliferation; P:regulation of cellular pH; P:regulation of epidermal cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold61 indexed_genome mRNA 1591530 1595374 . - . ID=transcript_10579;P32322 A6NFM2 B4DMU0 Q6FHI4 Q96DI6 Q9HBQ4,Pyrroline-5-carboxylate reductase 1, mitochondrial,, PF03807;PF14748;, GO:0005759;GO:0005739;GO:0042802;GO:0004735;GO:0034599;GO:0009064;GO:0055129;GO:1903206;GO:0006561;GO:0051881;, C:mitochondrial matrix; C:mitochondrion;, F:identical protein binding; F:pyrroline-5-carboxylate reductase activity;, P:cellular response to oxidative stress; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:negative regulation of hydrogen peroxide-induced cell death; P:proline biosynthetic process; P:regulation of mitochondrial membrane potential;|P32322 A6NFM2 B4DMU0 Q6FHI4 Q96DI6 Q9HBQ4,Pyrroline-5-carboxylate reductase 1, mitochondrial,, PF03807;PF14748;, GO:0005759;GO:0005739;GO:0042802;GO:0004735;GO:0034599;GO:0009064;GO:0055129;GO:1903206;GO:0006561;GO:0051881;, C:mitochondrial matrix; C:mitochondrion;, F:identical protein binding; F:pyrroline-5-carboxylate reductase activity;, P:cellular response to oxidative stress; P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; P:negative regulation of hydrogen peroxide-induced cell death; P:proline biosynthetic process; P:regulation of mitochondrial membrane potential; scaffold61 indexed_genome mRNA 1598316 1600850 . + . ID=transcript_10580;A6NDP7,Myeloid-associated differentiation marker-like protein 2,, PF01284;, GO:0005737;GO:0016021;, C:cytoplasm; C:integral component of membrane; scaffold61 indexed_genome mRNA 1612723 1618884 . - . ID=transcript_10581;Q6P988 Q8N410 Q8NI82,Palmitoleoyl-protein carboxylesterase NOTUM {ECO:0000305},hNOTUM {ECO:0000303|PubMed:25731175};, PF03283;, GO:0005788;GO:0005576;GO:1990699;GO:0044267;GO:0090090;GO:0030178;GO:0043687;GO:1990697;GO:0016055;, C:endoplasmic reticulum lumen; C:extracellular region;, F:palmitoleyl hydrolase activity;, P:cellular protein metabolic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of Wnt signaling pathway; P:post-translational protein modification; P:protein depalmitoleylation; P:Wnt signaling pathway;|Q6P988 Q8N410 Q8NI82,Palmitoleoyl-protein carboxylesterase NOTUM {ECO:0000305},hNOTUM {ECO:0000303|PubMed:25731175};, PF03283;, GO:0005788;GO:0005576;GO:1990699;GO:0044267;GO:0090090;GO:0030178;GO:0043687;GO:1990697;GO:0016055;, C:endoplasmic reticulum lumen; C:extracellular region;, F:palmitoleyl hydrolase activity;, P:cellular protein metabolic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of Wnt signaling pathway; P:post-translational protein modification; P:protein depalmitoleylation; P:Wnt signaling pathway;|Q6P988 Q8N410 Q8NI82,Palmitoleoyl-protein carboxylesterase NOTUM {ECO:0000305},hNOTUM {ECO:0000303|PubMed:25731175};, PF03283;, GO:0005788;GO:0005576;GO:1990699;GO:0044267;GO:0090090;GO:0030178;GO:0043687;GO:1990697;GO:0016055;, C:endoplasmic reticulum lumen; C:extracellular region;, F:palmitoleyl hydrolase activity;, P:cellular protein metabolic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of Wnt signaling pathway; P:post-translational protein modification; P:protein depalmitoleylation; P:Wnt signaling pathway; scaffold61 indexed_genome mRNA 1643268 1670391 . + . ID=transcript_10582;Q9BZE9 A8K3K9 Q7Z6N7 Q8WV59 Q96LS5 Q96M40,Tether containing UBX domain for GLUT4,Alveolar soft part sarcoma chromosomal region candidate gene 1 protein;Alveolar soft part sarcoma locus;Renal papillary cell carcinoma protein 17;UBX domain-containing protein 9;, PF11470;PF00789;, GO:0009898;GO:0005829;GO:0012505;GO:0033116;GO:0019898;GO:0043231;GO:0005654;GO:0048471;GO:0005886;GO:0012506;GO:0042593;GO:0006886;GO:0031401;GO:0046324;, C:cytoplasmic side of plasma membrane; C:cytosol; C:endomembrane system; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extrinsic component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle membrane;, , P:glucose homeostasis; P:intracellular protein transport; P:positive regulation of protein modification process; P:regulation of glucose import;|Q9BZE9 A8K3K9 Q7Z6N7 Q8WV59 Q96LS5 Q96M40,Tether containing UBX domain for GLUT4,Alveolar soft part sarcoma chromosomal region candidate gene 1 protein;Alveolar soft part sarcoma locus;Renal papillary cell carcinoma protein 17;UBX domain-containing protein 9;, PF11470;PF00789;, GO:0009898;GO:0005829;GO:0012505;GO:0033116;GO:0019898;GO:0043231;GO:0005654;GO:0048471;GO:0005886;GO:0012506;GO:0042593;GO:0006886;GO:0031401;GO:0046324;, C:cytoplasmic side of plasma membrane; C:cytosol; C:endomembrane system; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extrinsic component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle membrane;, , P:glucose homeostasis; P:intracellular protein transport; P:positive regulation of protein modification process; P:regulation of glucose import;|Q9BZE9 A8K3K9 Q7Z6N7 Q8WV59 Q96LS5 Q96M40,Tether containing UBX domain for GLUT4,Alveolar soft part sarcoma chromosomal region candidate gene 1 protein;Alveolar soft part sarcoma locus;Renal papillary cell carcinoma protein 17;UBX domain-containing protein 9;, PF11470;PF00789;, GO:0009898;GO:0005829;GO:0012505;GO:0033116;GO:0019898;GO:0043231;GO:0005654;GO:0048471;GO:0005886;GO:0012506;GO:0042593;GO:0006886;GO:0031401;GO:0046324;, C:cytoplasmic side of plasma membrane; C:cytosol; C:endomembrane system; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extrinsic component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle membrane;, , P:glucose homeostasis; P:intracellular protein transport; P:positive regulation of protein modification process; P:regulation of glucose import;|Q9BZE9 A8K3K9 Q7Z6N7 Q8WV59 Q96LS5 Q96M40,Tether containing UBX domain for GLUT4,Alveolar soft part sarcoma chromosomal region candidate gene 1 protein;Alveolar soft part sarcoma locus;Renal papillary cell carcinoma protein 17;UBX domain-containing protein 9;, PF11470;PF00789;, GO:0009898;GO:0005829;GO:0012505;GO:0033116;GO:0019898;GO:0043231;GO:0005654;GO:0048471;GO:0005886;GO:0012506;GO:0042593;GO:0006886;GO:0031401;GO:0046324;, C:cytoplasmic side of plasma membrane; C:cytosol; C:endomembrane system; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extrinsic component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle membrane;, , P:glucose homeostasis; P:intracellular protein transport; P:positive regulation of protein modification process; P:regulation of glucose import; scaffold61 indexed_genome mRNA 1671236 1674856 . - . ID=transcript_10583;A8MT69 O00281 O00282 Q96DD4 Q96F51,Centromere protein X,FANCM-associated histone fold protein 2 {ECO:0000303|PubMed:20347428};FANCM-interacting histone fold protein 2 {ECO:0000303|PubMed:20347429};Fanconi anemia-associated polypeptide of 10 kDa;Retinoic acid-inducible gene D9 protein homolog;Stimulated by retinoic acid gene 13 protein homolog;, PF09415;, GO:0000777;GO:0071821;GO:0043240;GO:0005654;GO:0003677;GO:0051301;GO:0034080;GO:0036297;GO:0051382;GO:0031398;GO:0031297;GO:0000712;, C:condensed chromosome kinetochore; C:FANCM-MHF complex; C:Fanconi anaemia nuclear complex; C:nucleoplasm;, F:DNA binding;, P:cell division; P:CENP-A containing nucleosome assembly; P:interstrand cross-link repair; P:kinetochore assembly; P:positive regulation of protein ubiquitination; P:replication fork processing; P:resolution of meiotic recombination intermediates; scaffold61 indexed_genome mRNA 1675103 1682116 . + . ID=transcript_10584;Q96CN5,Leucine-rich repeat-containing protein 45,, PF13516;, GO:0005813;GO:0005829;GO:0005654;GO:0005886;, C:centrosome; C:cytosol; C:nucleoplasm; C:plasma membrane;|Q96CN5,Leucine-rich repeat-containing protein 45,, PF13516;, GO:0005813;GO:0005829;GO:0005654;GO:0005886;, C:centrosome; C:cytosol; C:nucleoplasm; C:plasma membrane;|Q96CN5,Leucine-rich repeat-containing protein 45,, PF13516;, GO:0005813;GO:0005829;GO:0005654;GO:0005886;, C:centrosome; C:cytosol; C:nucleoplasm; C:plasma membrane;|Q96CN5,Leucine-rich repeat-containing protein 45,, PF13516;, GO:0005813;GO:0005829;GO:0005654;GO:0005886;, C:centrosome; C:cytosol; C:nucleoplasm; C:plasma membrane;|Q96CN5,Leucine-rich repeat-containing protein 45,, PF13516;, GO:0005813;GO:0005829;GO:0005654;GO:0005886;, C:centrosome; C:cytosol; C:nucleoplasm; C:plasma membrane; scaffold61 indexed_genome mRNA 1683886 1686226 . - . ID=transcript_10585;P60763 O14658 Q5U0M8,Ras-related C3 botulinum toxin substrate 3 {ECO:0000305},p21-Rac3;, PF00071;, GO:0005938;GO:0071944;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0012505;GO:0070062;GO:0031941;GO:0030426;GO:0043231;GO:0030027;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0045202;GO:0048306;GO:0005525;GO:0003924;GO:0019901;GO:0030036;GO:0007015;GO:0030031;GO:0021894;GO:0030865;GO:0007163;GO:0048873;GO:0035556;GO:0050885;GO:0031175;GO:0033630;GO:1900026;GO:0032956;GO:0008360;GO:0014041;GO:0051056;GO:0007264;GO:0051932;GO:0016055;, C:cell cortex; C:cell periphery; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:endomembrane system; C:extracellular exosome; C:filamentous actin; C:growth cone; C:intracellular membrane-bounded organelle; C:lamellipodium; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse;, F:calcium-dependent protein binding; F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:cell projection assembly; P:cerebral cortex GABAergic interneuron development; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:homeostasis of number of cells within a tissue; P:intracellular signal transduction; P:neuromuscular process controlling balance; P:neuron projection development; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of neuron maturation; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; P:synaptic transmission, GABAergic; P:Wnt signaling pathway;|P60763 O14658 Q5U0M8,Ras-related C3 botulinum toxin substrate 3 {ECO:0000305},p21-Rac3;, PF00071;, GO:0005938;GO:0071944;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0012505;GO:0070062;GO:0031941;GO:0030426;GO:0043231;GO:0030027;GO:0043005;GO:0043025;GO:0048471;GO:0005886;GO:0045202;GO:0048306;GO:0005525;GO:0003924;GO:0019901;GO:0030036;GO:0007015;GO:0030031;GO:0021894;GO:0030865;GO:0007163;GO:0048873;GO:0035556;GO:0050885;GO:0031175;GO:0033630;GO:1900026;GO:0032956;GO:0008360;GO:0014041;GO:0051056;GO:0007264;GO:0051932;GO:0016055;, C:cell cortex; C:cell periphery; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:endomembrane system; C:extracellular exosome; C:filamentous actin; C:growth cone; C:intracellular membrane-bounded organelle; C:lamellipodium; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse;, F:calcium-dependent protein binding; F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:cell projection assembly; P:cerebral cortex GABAergic interneuron development; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:homeostasis of number of cells within a tissue; P:intracellular signal transduction; P:neuromuscular process controlling balance; P:neuron projection development; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of neuron maturation; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; P:synaptic transmission, GABAergic; P:Wnt signaling pathway; scaffold61 indexed_genome mRNA 1686524 1689360 . + . ID=transcript_10586;Q7Z4W1 Q9BTZ3 Q9UHY9,L-xylulose reductase,Carbonyl reductase II;Dicarbonyl/L-xylulose reductase;Kidney dicarbonyl reductase;Short chain dehydrogenase/reductase family 20C member 1;Sperm surface protein P34H;, , GO:0005903;GO:0005881;GO:0070062;GO:0005902;GO:0005634;GO:0005886;GO:0004090;GO:0042802;GO:0044105;GO:0050038;GO:0016655;GO:0042732;GO:0006006;GO:0019640;GO:0006739;GO:0005997;, C:brush border; C:cytoplasmic microtubule; C:extracellular exosome; C:microvillus; C:nucleus; C:plasma membrane;, F:carbonyl reductase (NADPH) activity; F:identical protein binding; F:L-xylulose reductase (NAD+) activity; F:L-xylulose reductase (NADP+) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;, P:D-xylose metabolic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:NADP metabolic process; P:xylulose metabolic process;|Q7Z4W1 Q9BTZ3 Q9UHY9,L-xylulose reductase,Carbonyl reductase II;Dicarbonyl/L-xylulose reductase;Kidney dicarbonyl reductase;Short chain dehydrogenase/reductase family 20C member 1;Sperm surface protein P34H;, , GO:0005903;GO:0005881;GO:0070062;GO:0005902;GO:0005634;GO:0005886;GO:0004090;GO:0042802;GO:0044105;GO:0050038;GO:0016655;GO:0042732;GO:0006006;GO:0019640;GO:0006739;GO:0005997;, C:brush border; C:cytoplasmic microtubule; C:extracellular exosome; C:microvillus; C:nucleus; C:plasma membrane;, F:carbonyl reductase (NADPH) activity; F:identical protein binding; F:L-xylulose reductase (NAD+) activity; F:L-xylulose reductase (NADP+) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;, P:D-xylose metabolic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:NADP metabolic process; P:xylulose metabolic process;|Q7Z4W1 Q9BTZ3 Q9UHY9,L-xylulose reductase,Carbonyl reductase II;Dicarbonyl/L-xylulose reductase;Kidney dicarbonyl reductase;Short chain dehydrogenase/reductase family 20C member 1;Sperm surface protein P34H;, , GO:0005903;GO:0005881;GO:0070062;GO:0005902;GO:0005634;GO:0005886;GO:0004090;GO:0042802;GO:0044105;GO:0050038;GO:0016655;GO:0042732;GO:0006006;GO:0019640;GO:0006739;GO:0005997;, C:brush border; C:cytoplasmic microtubule; C:extracellular exosome; C:microvillus; C:nucleus; C:plasma membrane;, F:carbonyl reductase (NADPH) activity; F:identical protein binding; F:L-xylulose reductase (NAD+) activity; F:L-xylulose reductase (NADP+) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;, P:D-xylose metabolic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:NADP metabolic process; P:xylulose metabolic process;|Q7Z4W1 Q9BTZ3 Q9UHY9,L-xylulose reductase,Carbonyl reductase II;Dicarbonyl/L-xylulose reductase;Kidney dicarbonyl reductase;Short chain dehydrogenase/reductase family 20C member 1;Sperm surface protein P34H;, , GO:0005903;GO:0005881;GO:0070062;GO:0005902;GO:0005634;GO:0005886;GO:0004090;GO:0042802;GO:0044105;GO:0050038;GO:0016655;GO:0042732;GO:0006006;GO:0019640;GO:0006739;GO:0005997;, C:brush border; C:cytoplasmic microtubule; C:extracellular exosome; C:microvillus; C:nucleus; C:plasma membrane;, F:carbonyl reductase (NADPH) activity; F:identical protein binding; F:L-xylulose reductase (NAD+) activity; F:L-xylulose reductase (NADP+) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;, P:D-xylose metabolic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:NADP metabolic process; P:xylulose metabolic process; scaffold61 indexed_genome mRNA 1698023 1702873 . - . ID=transcript_10587;Q7Z4W1 Q9BTZ3 Q9UHY9,L-xylulose reductase,Carbonyl reductase II;Dicarbonyl/L-xylulose reductase;Kidney dicarbonyl reductase;Short chain dehydrogenase/reductase family 20C member 1;Sperm surface protein P34H;, , GO:0005903;GO:0005881;GO:0070062;GO:0005902;GO:0005634;GO:0005886;GO:0004090;GO:0042802;GO:0044105;GO:0050038;GO:0016655;GO:0042732;GO:0006006;GO:0019640;GO:0006739;GO:0005997;, C:brush border; C:cytoplasmic microtubule; C:extracellular exosome; C:microvillus; C:nucleus; C:plasma membrane;, F:carbonyl reductase (NADPH) activity; F:identical protein binding; F:L-xylulose reductase (NAD+) activity; F:L-xylulose reductase (NADP+) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;, P:D-xylose metabolic process; P:glucose metabolic process; P:glucuronate catabolic process to xylulose 5-phosphate; P:NADP metabolic process; P:xylulose metabolic process; scaffold61 indexed_genome mRNA 1723447 1739459 . - . ID=transcript_10588;Q13098 Q8NA10 Q9BWL1,COP9 signalosome complex subunit 1,G protein pathway suppressor 1;JAB1-containing signalosome subunit 1;Protein MFH;, PF01399;PF10602;, GO:0008180;GO:0005829;GO:0005654;GO:0005095;GO:0000188;GO:0007254;GO:0000715;GO:0043687;GO:0000338;GO:0006283;, C:COP9 signalosome; C:cytosol; C:nucleoplasm;, F:GTPase inhibitor activity;, P:inactivation of MAPK activity; P:JNK cascade; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair;|Q9Y644 O00588,Beta-1,3-N-acetylglucosaminyltransferase radical fringe,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase;, PF02434;, GO:0005576;GO:0030173;GO:0008375;GO:0046872;GO:0033829;GO:0009887;GO:0030154;GO:0007399;GO:0007389;GO:0045747;GO:0032092;GO:0008593;, C:extracellular region; C:integral component of Golgi membrane;, F:acetylglucosaminyltransferase activity; F:metal ion binding; F:O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity;, P:animal organ morphogenesis; P:cell differentiation; P:nervous system development; P:pattern specification process; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:regulation of Notch signaling pathway;|Q9Y644 O00588,Beta-1,3-N-acetylglucosaminyltransferase radical fringe,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase;, PF02434;, GO:0005576;GO:0030173;GO:0008375;GO:0046872;GO:0033829;GO:0009887;GO:0030154;GO:0007399;GO:0007389;GO:0045747;GO:0032092;GO:0008593;, C:extracellular region; C:integral component of Golgi membrane;, F:acetylglucosaminyltransferase activity; F:metal ion binding; F:O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity;, P:animal organ morphogenesis; P:cell differentiation; P:nervous system development; P:pattern specification process; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:regulation of Notch signaling pathway;|Q13098 Q8NA10 Q9BWL1,COP9 signalosome complex subunit 1,G protein pathway suppressor 1;JAB1-containing signalosome subunit 1;Protein MFH;, PF01399;PF10602;, GO:0008180;GO:0005829;GO:0005654;GO:0005095;GO:0000188;GO:0007254;GO:0000715;GO:0043687;GO:0000338;GO:0006283;, C:COP9 signalosome; C:cytosol; C:nucleoplasm;, F:GTPase inhibitor activity;, P:inactivation of MAPK activity; P:JNK cascade; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair;|Q6P1R4 A6NHV4 Q96AI3,tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like,tRNA-dihydrouridine synthase 1-like;, PF01207;, GO:0050660;GO:0017150;, , F:flavin adenine dinucleotide binding; F:tRNA dihydrouridine synthase activity;|Q6P1R4 A6NHV4 Q96AI3,tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like,tRNA-dihydrouridine synthase 1-like;, PF01207;, GO:0050660;GO:0017150;, , F:flavin adenine dinucleotide binding; F:tRNA dihydrouridine synthase activity;|Q6P1R4 A6NHV4 Q96AI3,tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like,tRNA-dihydrouridine synthase 1-like;, PF01207;, GO:0050660;GO:0017150;, , F:flavin adenine dinucleotide binding; F:tRNA dihydrouridine synthase activity; scaffold61 indexed_genome mRNA 1739700 1743312 . - . ID=transcript_10589;Q6P1R4 A6NHV4 Q96AI3,tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like,tRNA-dihydrouridine synthase 1-like;, PF01207;, GO:0050660;GO:0017150;, , F:flavin adenine dinucleotide binding; F:tRNA dihydrouridine synthase activity; scaffold61 indexed_genome mRNA 1756779 1775491 . - . ID=transcript_10590;P49327 Q13479 Q16702 Q4LE83 Q6P4U5 Q6SS02 Q969R1 Q96C68 Q96IT0,Fatty acid synthase,Type I fatty acid synthase;, PF00698;PF00107;PF16197;PF00109;PF02801;PF08659;PF08242;PF00550;PF14765;PF00975;, GO:0005829;GO:0070062;GO:0042587;GO:0005794;GO:0042470;GO:0016020;GO:0005886;GO:0008659;GO:0008693;GO:0047451;GO:0004317;GO:0102131;GO:0102132;GO:0004316;GO:0004315;GO:0004313;GO:0004314;GO:0045296;GO:0047117;GO:0042802;GO:0016295;GO:0004320;GO:0016296;GO:0031177;GO:0003723;GO:0006084;GO:0071353;GO:0090557;GO:0008611;GO:0006633;GO:0006631;GO:0046949;GO:0002068;GO:0030522;GO:0030879;GO:0030224;GO:0030223;GO:0001649;GO:0031325;GO:0019216;, C:cytosol; C:extracellular exosome; C:glycogen granule; C:Golgi apparatus; C:melanosome; C:membrane; C:plasma membrane;, F:(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity; F:3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity; F:3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity; F:3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity; F:3-oxo-glutaryl-[acp] methyl ester reductase activity; F:3-oxo-pimeloyl-[acp] methyl ester reductase activity; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; F:[acyl-carrier-protein] S-acetyltransferase activity; F:[acyl-carrier-protein] S-malonyltransferase activity; F:cadherin binding; F:enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity; F:identical protein binding; F:myristoyl-[acyl-carrier-protein] hydrolase activity; F:oleoyl-[acyl-carrier-protein] hydrolase activity; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; F:phosphopantetheine binding; F:RNA binding;, P:acetyl-CoA metabolic process; P:cellular response to interleukin-4; P:establishment of endothelial intestinal barrier; P:ether lipid biosynthetic process; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:fatty-acyl-CoA biosynthetic process; P:glandular epithelial cell development; P:intracellular receptor signaling pathway; P:mammary gland development; P:monocyte differentiation; P:neutrophil differentiation; P:osteoblast differentiation; P:positive regulation of cellular metabolic process; P:regulation of lipid metabolic process; scaffold61 indexed_genome mRNA 1817515 1859086 . - . ID=transcript_10591;Q2TAC2 A6NP51 A8MQC7 Q8IWG2 Q8TER3,Coiled-coil domain-containing protein 57 {ECO:0000305},, , GO:0034451;GO:0005814;GO:0005813;GO:0005737;GO:0005876;GO:0007099;GO:0060271;GO:0000086;GO:0007020;GO:0045931;, C:centriolar satellite; C:centriole; C:centrosome; C:cytoplasm; C:spindle microtubule;, , P:centriole replication; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule nucleation; P:positive regulation of mitotic cell cycle; scaffold61 indexed_genome mRNA 1863350 1882633 . - . ID=transcript_10592;Q2TAC2 A6NP51 A8MQC7 Q8IWG2 Q8TER3,Coiled-coil domain-containing protein 57 {ECO:0000305},, , GO:0034451;GO:0005814;GO:0005813;GO:0005737;GO:0005876;GO:0007099;GO:0060271;GO:0000086;GO:0007020;GO:0045931;, C:centriolar satellite; C:centriole; C:centrosome; C:cytoplasm; C:spindle microtubule;, , P:centriole replication; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule nucleation; P:positive regulation of mitotic cell cycle; scaffold61 indexed_genome mRNA 1886951 1901722 . - . ID=transcript_10593;Q2TAC2 A6NP51 A8MQC7 Q8IWG2 Q8TER3,Coiled-coil domain-containing protein 57 {ECO:0000305},, , GO:0034451;GO:0005814;GO:0005813;GO:0005737;GO:0005876;GO:0007099;GO:0060271;GO:0000086;GO:0007020;GO:0045931;, C:centriolar satellite; C:centriole; C:centrosome; C:cytoplasm; C:spindle microtubule;, , P:centriole replication; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:microtubule nucleation; P:positive regulation of mitotic cell cycle; scaffold61 indexed_genome mRNA 1922880 1963801 . - . ID=transcript_10594;O15427 B3KXG8 Q2M1P8,Monocarboxylate transporter 4,Solute carrier family 16 member 3;, PF07690;, GO:0016324;GO:0016323;GO:0016021;GO:0005887;GO:0099061;GO:0016328;GO:0016020;GO:0031965;GO:0098688;GO:0005886;GO:0015129;GO:0008028;GO:0003723;GO:0015293;GO:0050900;GO:0015718;GO:0035879;GO:0006090;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:lateral plasma membrane; C:membrane; C:nuclear membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane;, F:lactate transmembrane transporter activity; F:monocarboxylic acid transmembrane transporter activity; F:RNA binding; F:symporter activity;, P:leukocyte migration; P:monocarboxylic acid transport; P:plasma membrane lactate transport; P:pyruvate metabolic process;|P48730 A2I2P2 Q96KZ6 Q9BTN5,Casein kinase I isoform delta,Tau-protein kinase CSNK1D;, PF00069;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0033116;GO:0005794;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005819;GO:0005876;GO:0005524;GO:0045296;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0050321;GO:0097711;GO:0032922;GO:0048208;GO:0000086;GO:0007030;GO:0007020;GO:1905515;GO:0018105;GO:0090263;GO:2000052;GO:0032436;GO:0001934;GO:1905426;GO:0071539;GO:0061512;GO:0034067;GO:0006468;GO:0042752;GO:0010389;GO:0051225;GO:0016055;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle; C:spindle microtubule;, F:ATP binding; F:cadherin binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:ciliary basal body-plasma membrane docking; P:circadian regulation of gene expression; P:COPII vesicle coating; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule nucleation; P:non-motile cilium assembly; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation; P:protein localization to centrosome; P:protein localization to cilium; P:protein localization to Golgi apparatus; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; P:Wnt signaling pathway;|P48730 A2I2P2 Q96KZ6 Q9BTN5,Casein kinase I isoform delta,Tau-protein kinase CSNK1D;, PF00069;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0033116;GO:0005794;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005819;GO:0005876;GO:0005524;GO:0045296;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0050321;GO:0097711;GO:0032922;GO:0048208;GO:0000086;GO:0007030;GO:0007020;GO:1905515;GO:0018105;GO:0090263;GO:2000052;GO:0032436;GO:0001934;GO:1905426;GO:0071539;GO:0061512;GO:0034067;GO:0006468;GO:0042752;GO:0010389;GO:0051225;GO:0016055;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle; C:spindle microtubule;, F:ATP binding; F:cadherin binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:ciliary basal body-plasma membrane docking; P:circadian regulation of gene expression; P:COPII vesicle coating; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule nucleation; P:non-motile cilium assembly; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation; P:protein localization to centrosome; P:protein localization to cilium; P:protein localization to Golgi apparatus; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; P:Wnt signaling pathway;|P48730 A2I2P2 Q96KZ6 Q9BTN5,Casein kinase I isoform delta,Tau-protein kinase CSNK1D;, PF00069;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0033116;GO:0005794;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005819;GO:0005876;GO:0005524;GO:0045296;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0050321;GO:0097711;GO:0032922;GO:0048208;GO:0000086;GO:0007030;GO:0007020;GO:1905515;GO:0018105;GO:0090263;GO:2000052;GO:0032436;GO:0001934;GO:1905426;GO:0071539;GO:0061512;GO:0034067;GO:0006468;GO:0042752;GO:0010389;GO:0051225;GO:0016055;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle; C:spindle microtubule;, F:ATP binding; F:cadherin binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:ciliary basal body-plasma membrane docking; P:circadian regulation of gene expression; P:COPII vesicle coating; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule nucleation; P:non-motile cilium assembly; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation; P:protein localization to centrosome; P:protein localization to cilium; P:protein localization to Golgi apparatus; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; P:Wnt signaling pathway;|P48730 A2I2P2 Q96KZ6 Q9BTN5,Casein kinase I isoform delta,Tau-protein kinase CSNK1D;, PF00069;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0033116;GO:0005794;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0005819;GO:0005876;GO:0005524;GO:0045296;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0050321;GO:0097711;GO:0032922;GO:0048208;GO:0000086;GO:0007030;GO:0007020;GO:1905515;GO:0018105;GO:0090263;GO:2000052;GO:0032436;GO:0001934;GO:1905426;GO:0071539;GO:0061512;GO:0034067;GO:0006468;GO:0042752;GO:0010389;GO:0051225;GO:0016055;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle; C:spindle microtubule;, F:ATP binding; F:cadherin binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:ciliary basal body-plasma membrane docking; P:circadian regulation of gene expression; P:COPII vesicle coating; P:G2/M transition of mitotic cell cycle; P:Golgi organization; P:microtubule nucleation; P:non-motile cilium assembly; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation; P:protein localization to centrosome; P:protein localization to cilium; P:protein localization to Golgi apparatus; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; P:Wnt signaling pathway; scaffold61 indexed_genome mRNA 2005832 2009136 . - . ID=transcript_10595;P09564,T-cell antigen CD7,GP40;T-cell leukemia antigen;T-cell surface antigen Leu-9;TP41;, PF07686;, GO:0016021;GO:0016020;GO:0005886;GO:0038023;GO:0002250;GO:0006955;GO:0042110;GO:0007169;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:signaling receptor activity;, P:adaptive immune response; P:immune response; P:T cell activation; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold61 indexed_genome mRNA 2132140 2170085 . - . ID=transcript_10596;Q6PK18 C9JDC8 Q8IZ37 Q9H6J2,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3,, PF13640;, GO:0016021;GO:0016020;GO:0051213;GO:0005506;GO:0031418;GO:0016705;, C:integral component of membrane; C:membrane;, F:dioxygenase activity; F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;|Q6PK18 C9JDC8 Q8IZ37 Q9H6J2,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3,, PF13640;, GO:0016021;GO:0016020;GO:0051213;GO:0005506;GO:0031418;GO:0016705;, C:integral component of membrane; C:membrane;, F:dioxygenase activity; F:iron ion binding; F:L-ascorbic acid binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;|Q8WVB3 B7UUP6 Q8IYN4 Q8TE81,Hexosaminidase D {ECO:0000305},Beta-N-acetylhexosaminidase;Beta-hexosaminidase D;Hexosaminidase domain-containing protein;N-acetyl-beta-galactosaminidase;, PF00728;, GO:0005737;GO:1903561;GO:0005634;GO:0004563;GO:0015929;GO:0102148;GO:0005975;, C:cytoplasm; C:extracellular vesicle; C:nucleus;, F:beta-N-acetylhexosaminidase activity; F:hexosaminidase activity; F:N-acetyl-beta-D-galactosaminidase activity;, P:carbohydrate metabolic process;|Q8WVB3 B7UUP6 Q8IYN4 Q8TE81,Hexosaminidase D {ECO:0000305},Beta-N-acetylhexosaminidase;Beta-hexosaminidase D;Hexosaminidase domain-containing protein;N-acetyl-beta-galactosaminidase;, PF00728;, GO:0005737;GO:1903561;GO:0005634;GO:0004563;GO:0015929;GO:0102148;GO:0005975;, C:cytoplasm; C:extracellular vesicle; C:nucleus;, F:beta-N-acetylhexosaminidase activity; F:hexosaminidase activity; F:N-acetyl-beta-D-galactosaminidase activity;, P:carbohydrate metabolic process;|Q8WVB3 B7UUP6 Q8IYN4 Q8TE81,Hexosaminidase D {ECO:0000305},Beta-N-acetylhexosaminidase;Beta-hexosaminidase D;Hexosaminidase domain-containing protein;N-acetyl-beta-galactosaminidase;, PF00728;, GO:0005737;GO:1903561;GO:0005634;GO:0004563;GO:0015929;GO:0102148;GO:0005975;, C:cytoplasm; C:extracellular vesicle; C:nucleus;, F:beta-N-acetylhexosaminidase activity; F:hexosaminidase activity; F:N-acetyl-beta-D-galactosaminidase activity;, P:carbohydrate metabolic process;|Q9BQA9 E1B6X3 Q96NR1,Cytochrome b-245 chaperone 1 {ECO:0000305},Essential for reactive oxygen species protein {ECO:0000250|UniProtKB:Q3TYS2};, PF15169;, GO:0005783;GO:0005789;GO:0016021;GO:0045087;GO:0045728;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:innate immune response; P:respiratory burst after phagocytosis;|Q9BQA9 E1B6X3 Q96NR1,Cytochrome b-245 chaperone 1 {ECO:0000305},Essential for reactive oxygen species protein {ECO:0000250|UniProtKB:Q3TYS2};, PF15169;, GO:0005783;GO:0005789;GO:0016021;GO:0045087;GO:0045728;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:innate immune response; P:respiratory burst after phagocytosis;|Q9BQA9 E1B6X3 Q96NR1,Cytochrome b-245 chaperone 1 {ECO:0000305},Essential for reactive oxygen species protein {ECO:0000250|UniProtKB:Q3TYS2};, PF15169;, GO:0005783;GO:0005789;GO:0016021;GO:0045087;GO:0045728;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:innate immune response; P:respiratory burst after phagocytosis;|Q9BQA9 E1B6X3 Q96NR1,Cytochrome b-245 chaperone 1 {ECO:0000305},Essential for reactive oxygen species protein {ECO:0000250|UniProtKB:Q3TYS2};, PF15169;, GO:0005783;GO:0005789;GO:0016021;GO:0045087;GO:0045728;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:innate immune response; P:respiratory burst after phagocytosis;|Q9BQA9 E1B6X3 Q96NR1,Cytochrome b-245 chaperone 1 {ECO:0000305},Essential for reactive oxygen species protein {ECO:0000250|UniProtKB:Q3TYS2};, PF15169;, GO:0005783;GO:0005789;GO:0016021;GO:0045087;GO:0045728;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:innate immune response; P:respiratory burst after phagocytosis; scaffold61 indexed_genome mRNA 2174449 2193016 . + . ID=transcript_10597;Q9UHQ1 A6NCJ3 B3KPX2 K4DI98 Q96AY9 Q9BWC6,Nuclear prelamin A recognition factor,Iron-only hydrogenase-like protein 2;, PF02906;PF02256;, GO:0005638;GO:0005652;GO:0031981;GO:0005730;GO:0005654;GO:0005521;, C:lamin filament; C:nuclear lamina; C:nuclear lumen; C:nucleolus; C:nucleoplasm;, F:lamin binding;|Q9BZL1 Q2NL89,Ubiquitin-like protein 5,, PF00240;, GO:0005737;GO:0005634;GO:0031386;GO:0006464;GO:0000398;GO:1903955;, C:cytoplasm; C:nucleus;, F:protein tag;, P:cellular protein modification process; P:mRNA splicing, via spliceosome; P:positive regulation of protein targeting to mitochondrion;|Q9UHQ1 A6NCJ3 B3KPX2 K4DI98 Q96AY9 Q9BWC6,Nuclear prelamin A recognition factor,Iron-only hydrogenase-like protein 2;, PF02906;PF02256;, GO:0005638;GO:0005652;GO:0031981;GO:0005730;GO:0005654;GO:0005521;, C:lamin filament; C:nuclear lamina; C:nuclear lumen; C:nucleolus; C:nucleoplasm;, F:lamin binding;|Q9UHQ1 A6NCJ3 B3KPX2 K4DI98 Q96AY9 Q9BWC6,Nuclear prelamin A recognition factor,Iron-only hydrogenase-like protein 2;, PF02906;PF02256;, GO:0005638;GO:0005652;GO:0031981;GO:0005730;GO:0005654;GO:0005521;, C:lamin filament; C:nuclear lamina; C:nuclear lumen; C:nucleolus; C:nucleoplasm;, F:lamin binding; scaffold61 indexed_genome mRNA 2233870 2262873 . + . ID=transcript_10598;Q01167 A6NEP5 Q13622 Q13623 Q13624,Forkhead box protein K2 {ECO:0000305},G/T-mismatch specific binding protein {ECO:0000303|PubMed:20097901};Interleukin enhancer-binding factor 1 {ECO:0000303|PubMed:12402362, ECO:0000303|PubMed:1909027};, PF00498;PF00250;, GO:0000785;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0000287;GO:0000978;GO:0043565;GO:0000976;GO:0061621;GO:0001678;GO:0010507;GO:0045892;GO:0045944;GO:0045893;GO:0016579;GO:0010906;GO:0006357;GO:0006355;GO:0042594;, C:chromatin; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:magnesium ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:canonical glycolysis; P:cellular glucose homeostasis; P:negative regulation of autophagy; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of glucose metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to starvation;|Q01167 A6NEP5 Q13622 Q13623 Q13624,Forkhead box protein K2 {ECO:0000305},G/T-mismatch specific binding protein {ECO:0000303|PubMed:20097901};Interleukin enhancer-binding factor 1 {ECO:0000303|PubMed:12402362, ECO:0000303|PubMed:1909027};, PF00498;PF00250;, GO:0000785;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0000287;GO:0000978;GO:0043565;GO:0000976;GO:0061621;GO:0001678;GO:0010507;GO:0045892;GO:0045944;GO:0045893;GO:0016579;GO:0010906;GO:0006357;GO:0006355;GO:0042594;, C:chromatin; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:magnesium ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:canonical glycolysis; P:cellular glucose homeostasis; P:negative regulation of autophagy; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of glucose metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to starvation;|Q01167 A6NEP5 Q13622 Q13623 Q13624,Forkhead box protein K2 {ECO:0000305},G/T-mismatch specific binding protein {ECO:0000303|PubMed:20097901};Interleukin enhancer-binding factor 1 {ECO:0000303|PubMed:12402362, ECO:0000303|PubMed:1909027};, PF00498;PF00250;, GO:0000785;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0000287;GO:0000978;GO:0043565;GO:0000976;GO:0061621;GO:0001678;GO:0010507;GO:0045892;GO:0045944;GO:0045893;GO:0016579;GO:0010906;GO:0006357;GO:0006355;GO:0042594;, C:chromatin; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:magnesium ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:canonical glycolysis; P:cellular glucose homeostasis; P:negative regulation of autophagy; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of glucose metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to starvation; scaffold61 indexed_genome mRNA 2272213 2284124 . - . ID=transcript_10599;Q5MNZ6 A0A024R8U4 A0A218N098 O95328 Q2MCP6 Q6IBN2,WD repeat domain phosphoinositide-interacting protein 3,WD repeat-containing protein 45-like;WD repeat-containing protein 45B;WIPI49-like protein;, , GO:0005829;GO:0019898;GO:0005764;GO:0000407;GO:0034045;GO:0080025;GO:0032266;GO:0062078;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0006497;GO:0034497;, C:cytosol; C:extrinsic component of membrane; C:lysosome; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:TSC1-TSC2 complex binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:protein lipidation; P:protein localization to phagophore assembly site;|Q5MNZ6 A0A024R8U4 A0A218N098 O95328 Q2MCP6 Q6IBN2,WD repeat domain phosphoinositide-interacting protein 3,WD repeat-containing protein 45-like;WD repeat-containing protein 45B;WIPI49-like protein;, , GO:0005829;GO:0019898;GO:0005764;GO:0000407;GO:0034045;GO:0080025;GO:0032266;GO:0062078;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0006497;GO:0034497;, C:cytosol; C:extrinsic component of membrane; C:lysosome; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:TSC1-TSC2 complex binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:protein lipidation; P:protein localization to phagophore assembly site;|Q5MNZ6 A0A024R8U4 A0A218N098 O95328 Q2MCP6 Q6IBN2,WD repeat domain phosphoinositide-interacting protein 3,WD repeat-containing protein 45-like;WD repeat-containing protein 45B;WIPI49-like protein;, , GO:0005829;GO:0019898;GO:0005764;GO:0000407;GO:0034045;GO:0080025;GO:0032266;GO:0062078;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0006497;GO:0034497;, C:cytosol; C:extrinsic component of membrane; C:lysosome; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:TSC1-TSC2 complex binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:protein lipidation; P:protein localization to phagophore assembly site;|Q5MNZ6 A0A024R8U4 A0A218N098 O95328 Q2MCP6 Q6IBN2,WD repeat domain phosphoinositide-interacting protein 3,WD repeat-containing protein 45-like;WD repeat-containing protein 45B;WIPI49-like protein;, , GO:0005829;GO:0019898;GO:0005764;GO:0000407;GO:0034045;GO:0080025;GO:0032266;GO:0062078;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0006497;GO:0034497;, C:cytosol; C:extrinsic component of membrane; C:lysosome; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:TSC1-TSC2 complex binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:protein lipidation; P:protein localization to phagophore assembly site; scaffold61 indexed_genome mRNA 2293289 2297934 . - . ID=transcript_10600;Q5MNZ6 A0A024R8U4 A0A218N098 O95328 Q2MCP6 Q6IBN2,WD repeat domain phosphoinositide-interacting protein 3,WD repeat-containing protein 45-like;WD repeat-containing protein 45B;WIPI49-like protein;, , GO:0005829;GO:0019898;GO:0005764;GO:0000407;GO:0034045;GO:0080025;GO:0032266;GO:0062078;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0006497;GO:0034497;, C:cytosol; C:extrinsic component of membrane; C:lysosome; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:TSC1-TSC2 complex binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:protein lipidation; P:protein localization to phagophore assembly site; scaffold61 indexed_genome mRNA 2298225 2332497 . + . ID=transcript_10601;Q12829 Q8WVG3,Ras-related protein Rab-40B,SOCS box-containing protein RAR;, PF00071;PF07525;, GO:0005768;GO:0005635;GO:0048471;GO:0005886;GO:0008021;GO:0005525;GO:0003924;GO:0035556;GO:0072659;GO:0016567;GO:1901998;, C:endosome; C:nuclear envelope; C:perinuclear region of cytoplasm; C:plasma membrane; C:synaptic vesicle;, F:GTP binding; F:GTPase activity;, P:intracellular signal transduction; P:protein localization to plasma membrane; P:protein ubiquitination; P:toxin transport;|Q12829 Q8WVG3,Ras-related protein Rab-40B,SOCS box-containing protein RAR;, PF00071;PF07525;, GO:0005768;GO:0005635;GO:0048471;GO:0005886;GO:0008021;GO:0005525;GO:0003924;GO:0035556;GO:0072659;GO:0016567;GO:1901998;, C:endosome; C:nuclear envelope; C:perinuclear region of cytoplasm; C:plasma membrane; C:synaptic vesicle;, F:GTP binding; F:GTPase activity;, P:intracellular signal transduction; P:protein localization to plasma membrane; P:protein ubiquitination; P:toxin transport;|Q12829 Q8WVG3,Ras-related protein Rab-40B,SOCS box-containing protein RAR;, PF00071;PF07525;, GO:0005768;GO:0005635;GO:0048471;GO:0005886;GO:0008021;GO:0005525;GO:0003924;GO:0035556;GO:0072659;GO:0016567;GO:1901998;, C:endosome; C:nuclear envelope; C:perinuclear region of cytoplasm; C:plasma membrane; C:synaptic vesicle;, F:GTP binding; F:GTPase activity;, P:intracellular signal transduction; P:protein localization to plasma membrane; P:protein ubiquitination; P:toxin transport;|Q12829 Q8WVG3,Ras-related protein Rab-40B,SOCS box-containing protein RAR;, PF00071;PF07525;, GO:0005768;GO:0005635;GO:0048471;GO:0005886;GO:0008021;GO:0005525;GO:0003924;GO:0035556;GO:0072659;GO:0016567;GO:1901998;, C:endosome; C:nuclear envelope; C:perinuclear region of cytoplasm; C:plasma membrane; C:synaptic vesicle;, F:GTP binding; F:GTPase activity;, P:intracellular signal transduction; P:protein localization to plasma membrane; P:protein ubiquitination; P:toxin transport; scaffold61 indexed_genome mRNA 2347274 2355133 . + . ID=transcript_10602;Q9HA64 Q969F4 Q9H0U7,Ketosamine-3-kinase {ECO:0000303|PubMed:14633848},Fructosamine-3-kinase-related protein {ECO:0000303|PubMed:15137908};Protein-psicosamine 3-kinase FN3KRP {ECO:0000305};, PF03881;, GO:0005829;GO:0005524;GO:0016301;GO:0102193;GO:0043687;, C:cytosol;, F:ATP binding; F:kinase activity; F:protein-ribulosamine 3-kinase activity;, P:post-translational protein modification;|Q9HA64 Q969F4 Q9H0U7,Ketosamine-3-kinase {ECO:0000303|PubMed:14633848},Fructosamine-3-kinase-related protein {ECO:0000303|PubMed:15137908};Protein-psicosamine 3-kinase FN3KRP {ECO:0000305};, PF03881;, GO:0005829;GO:0005524;GO:0016301;GO:0102193;GO:0043687;, C:cytosol;, F:ATP binding; F:kinase activity; F:protein-ribulosamine 3-kinase activity;, P:post-translational protein modification;|Q9HA64 Q969F4 Q9H0U7,Ketosamine-3-kinase {ECO:0000303|PubMed:14633848},Fructosamine-3-kinase-related protein {ECO:0000303|PubMed:15137908};Protein-psicosamine 3-kinase FN3KRP {ECO:0000305};, PF03881;, GO:0005829;GO:0005524;GO:0016301;GO:0102193;GO:0043687;, C:cytosol;, F:ATP binding; F:kinase activity; F:protein-ribulosamine 3-kinase activity;, P:post-translational protein modification;|Q9HA64 Q969F4 Q9H0U7,Ketosamine-3-kinase {ECO:0000303|PubMed:14633848},Fructosamine-3-kinase-related protein {ECO:0000303|PubMed:15137908};Protein-psicosamine 3-kinase FN3KRP {ECO:0000305};, PF03881;, GO:0005829;GO:0005524;GO:0016301;GO:0102193;GO:0043687;, C:cytosol;, F:ATP binding; F:kinase activity; F:protein-ribulosamine 3-kinase activity;, P:post-translational protein modification; scaffold61 indexed_genome mRNA 2362451 2372099 . + . ID=transcript_10603;Q9H479,Fructosamine-3-kinase {ECO:0000303|PubMed:11016445},Protein-psicosamine 3-kinase FN3K {ECO:0000305};Protein-ribulosamine 3-kinase FN3K {ECO:0000305};, PF03881;, GO:0005829;GO:0005524;GO:0030387;GO:0016301;GO:0102194;GO:0102193;GO:0030855;GO:0030389;GO:0030393;GO:0043687;GO:0036525;, C:cytosol;, F:ATP binding; F:fructosamine-3-kinase activity; F:kinase activity; F:protein-fructosamine 3-kinase activity; F:protein-ribulosamine 3-kinase activity;, P:epithelial cell differentiation; P:fructosamine metabolic process; P:fructoselysine metabolic process; P:post-translational protein modification; P:protein deglycation;|Q9H479,Fructosamine-3-kinase {ECO:0000303|PubMed:11016445},Protein-psicosamine 3-kinase FN3K {ECO:0000305};Protein-ribulosamine 3-kinase FN3K {ECO:0000305};, PF03881;, GO:0005829;GO:0005524;GO:0030387;GO:0016301;GO:0102194;GO:0102193;GO:0030855;GO:0030389;GO:0030393;GO:0043687;GO:0036525;, C:cytosol;, F:ATP binding; F:fructosamine-3-kinase activity; F:kinase activity; F:protein-fructosamine 3-kinase activity; F:protein-ribulosamine 3-kinase activity;, P:epithelial cell differentiation; P:fructosamine metabolic process; P:fructoselysine metabolic process; P:post-translational protein modification; P:protein deglycation;|Q9H479,Fructosamine-3-kinase {ECO:0000303|PubMed:11016445},Protein-psicosamine 3-kinase FN3K {ECO:0000305};Protein-ribulosamine 3-kinase FN3K {ECO:0000305};, PF03881;, GO:0005829;GO:0005524;GO:0030387;GO:0016301;GO:0102194;GO:0102193;GO:0030855;GO:0030389;GO:0030393;GO:0043687;GO:0036525;, C:cytosol;, F:ATP binding; F:fructosamine-3-kinase activity; F:kinase activity; F:protein-fructosamine 3-kinase activity; F:protein-ribulosamine 3-kinase activity;, P:epithelial cell differentiation; P:fructosamine metabolic process; P:fructoselysine metabolic process; P:post-translational protein modification; P:protein deglycation;|Q9H479,Fructosamine-3-kinase {ECO:0000303|PubMed:11016445},Protein-psicosamine 3-kinase FN3K {ECO:0000305};Protein-ribulosamine 3-kinase FN3K {ECO:0000305};, PF03881;, GO:0005829;GO:0005524;GO:0030387;GO:0016301;GO:0102194;GO:0102193;GO:0030855;GO:0030389;GO:0030393;GO:0043687;GO:0036525;, C:cytosol;, F:ATP binding; F:fructosamine-3-kinase activity; F:kinase activity; F:protein-fructosamine 3-kinase activity; F:protein-ribulosamine 3-kinase activity;, P:epithelial cell differentiation; P:fructosamine metabolic process; P:fructoselysine metabolic process; P:post-translational protein modification; P:protein deglycation; scaffold61 indexed_genome mRNA 2372998 2518849 . + . ID=transcript_10604;Q9Y2J3,Tubulin-specific chaperone D,Beta-tubulin cofactor D;SSD-1;Tubulin-folding cofactor D;, PF12612;, GO:0005912;GO:0005923;GO:0005813;GO:0005737;GO:0016328;GO:0005874;GO:0048487;GO:0051087;GO:0005096;GO:0034333;GO:0070830;GO:0048667;GO:0000226;GO:0000278;GO:0010812;GO:0031115;GO:0007023;GO:0006457;GO:0007021;, C:adherens junction; C:bicellular tight junction; C:centrosome; C:cytoplasm; C:lateral plasma membrane; C:microtubule;, F:beta-tubulin binding; F:chaperone binding; F:GTPase activator activity;, P:adherens junction assembly; P:bicellular tight junction assembly; P:cell morphogenesis involved in neuron differentiation; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of cell-substrate adhesion; P:negative regulation of microtubule polymerization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q9Y2J3,Tubulin-specific chaperone D,Beta-tubulin cofactor D;SSD-1;Tubulin-folding cofactor D;, PF12612;, GO:0005912;GO:0005923;GO:0005813;GO:0005737;GO:0016328;GO:0005874;GO:0048487;GO:0051087;GO:0005096;GO:0034333;GO:0070830;GO:0048667;GO:0000226;GO:0000278;GO:0010812;GO:0031115;GO:0007023;GO:0006457;GO:0007021;, C:adherens junction; C:bicellular tight junction; C:centrosome; C:cytoplasm; C:lateral plasma membrane; C:microtubule;, F:beta-tubulin binding; F:chaperone binding; F:GTPase activator activity;, P:adherens junction assembly; P:bicellular tight junction assembly; P:cell morphogenesis involved in neuron differentiation; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of cell-substrate adhesion; P:negative regulation of microtubule polymerization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q9Y2J3,Tubulin-specific chaperone D,Beta-tubulin cofactor D;SSD-1;Tubulin-folding cofactor D;, PF12612;, GO:0005912;GO:0005923;GO:0005813;GO:0005737;GO:0016328;GO:0005874;GO:0048487;GO:0051087;GO:0005096;GO:0034333;GO:0070830;GO:0048667;GO:0000226;GO:0000278;GO:0010812;GO:0031115;GO:0007023;GO:0006457;GO:0007021;, C:adherens junction; C:bicellular tight junction; C:centrosome; C:cytoplasm; C:lateral plasma membrane; C:microtubule;, F:beta-tubulin binding; F:chaperone binding; F:GTPase activator activity;, P:adherens junction assembly; P:bicellular tight junction assembly; P:cell morphogenesis involved in neuron differentiation; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of cell-substrate adhesion; P:negative regulation of microtubule polymerization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q9Y2J3,Tubulin-specific chaperone D,Beta-tubulin cofactor D;SSD-1;Tubulin-folding cofactor D;, PF12612;, GO:0005912;GO:0005923;GO:0005813;GO:0005737;GO:0016328;GO:0005874;GO:0048487;GO:0051087;GO:0005096;GO:0034333;GO:0070830;GO:0048667;GO:0000226;GO:0000278;GO:0010812;GO:0031115;GO:0007023;GO:0006457;GO:0007021;, C:adherens junction; C:bicellular tight junction; C:centrosome; C:cytoplasm; C:lateral plasma membrane; C:microtubule;, F:beta-tubulin binding; F:chaperone binding; F:GTPase activator activity;, P:adherens junction assembly; P:bicellular tight junction assembly; P:cell morphogenesis involved in neuron differentiation; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of cell-substrate adhesion; P:negative regulation of microtubule polymerization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q9Y2J3,Tubulin-specific chaperone D,Beta-tubulin cofactor D;SSD-1;Tubulin-folding cofactor D;, PF12612;, GO:0005912;GO:0005923;GO:0005813;GO:0005737;GO:0016328;GO:0005874;GO:0048487;GO:0051087;GO:0005096;GO:0034333;GO:0070830;GO:0048667;GO:0000226;GO:0000278;GO:0010812;GO:0031115;GO:0007023;GO:0006457;GO:0007021;, C:adherens junction; C:bicellular tight junction; C:centrosome; C:cytoplasm; C:lateral plasma membrane; C:microtubule;, F:beta-tubulin binding; F:chaperone binding; F:GTPase activator activity;, P:adherens junction assembly; P:bicellular tight junction assembly; P:cell morphogenesis involved in neuron differentiation; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of cell-substrate adhesion; P:negative regulation of microtubule polymerization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q9Y2J3,Tubulin-specific chaperone D,Beta-tubulin cofactor D;SSD-1;Tubulin-folding cofactor D;, PF12612;, GO:0005912;GO:0005923;GO:0005813;GO:0005737;GO:0016328;GO:0005874;GO:0048487;GO:0051087;GO:0005096;GO:0034333;GO:0070830;GO:0048667;GO:0000226;GO:0000278;GO:0010812;GO:0031115;GO:0007023;GO:0006457;GO:0007021;, C:adherens junction; C:bicellular tight junction; C:centrosome; C:cytoplasm; C:lateral plasma membrane; C:microtubule;, F:beta-tubulin binding; F:chaperone binding; F:GTPase activator activity;, P:adherens junction assembly; P:bicellular tight junction assembly; P:cell morphogenesis involved in neuron differentiation; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of cell-substrate adhesion; P:negative regulation of microtubule polymerization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q9Y2J3,Tubulin-specific chaperone D,Beta-tubulin cofactor D;SSD-1;Tubulin-folding cofactor D;, PF12612;, GO:0005912;GO:0005923;GO:0005813;GO:0005737;GO:0016328;GO:0005874;GO:0048487;GO:0051087;GO:0005096;GO:0034333;GO:0070830;GO:0048667;GO:0000226;GO:0000278;GO:0010812;GO:0031115;GO:0007023;GO:0006457;GO:0007021;, C:adherens junction; C:bicellular tight junction; C:centrosome; C:cytoplasm; C:lateral plasma membrane; C:microtubule;, F:beta-tubulin binding; F:chaperone binding; F:GTPase activator activity;, P:adherens junction assembly; P:bicellular tight junction assembly; P:cell morphogenesis involved in neuron differentiation; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of cell-substrate adhesion; P:negative regulation of microtubule polymerization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q9Y2J3,Tubulin-specific chaperone D,Beta-tubulin cofactor D;SSD-1;Tubulin-folding cofactor D;, PF12612;, GO:0005912;GO:0005923;GO:0005813;GO:0005737;GO:0016328;GO:0005874;GO:0048487;GO:0051087;GO:0005096;GO:0034333;GO:0070830;GO:0048667;GO:0000226;GO:0000278;GO:0010812;GO:0031115;GO:0007023;GO:0006457;GO:0007021;, C:adherens junction; C:bicellular tight junction; C:centrosome; C:cytoplasm; C:lateral plasma membrane; C:microtubule;, F:beta-tubulin binding; F:chaperone binding; F:GTPase activator activity;, P:adherens junction assembly; P:bicellular tight junction assembly; P:cell morphogenesis involved in neuron differentiation; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of cell-substrate adhesion; P:negative regulation of microtubule polymerization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly; scaffold61 indexed_genome mRNA 2763887 2764964 . - . ID=transcript_10605;Q15937 Q5VVW1 Q96NV1,Zinc finger protein 79,ZNFpT7;, PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold61 indexed_genome mRNA 2767904 2788840 . - . ID=transcript_10606;O00232 A6NP15 Q53HA2 Q6P053,26S proteasome non-ATPase regulatory subunit 12,26S proteasome regulatory subunit RPN5;26S proteasome regulatory subunit p55;, PF01399;PF18098;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0031595;GO:0005654;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear proteasome complex; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|O00232 A6NP15 Q53HA2 Q6P053,26S proteasome non-ATPase regulatory subunit 12,26S proteasome regulatory subunit RPN5;26S proteasome regulatory subunit p55;, PF01399;PF18098;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0031595;GO:0005654;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear proteasome complex; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|O00232 A6NP15 Q53HA2 Q6P053,26S proteasome non-ATPase regulatory subunit 12,26S proteasome regulatory subunit RPN5;26S proteasome regulatory subunit p55;, PF01399;PF18098;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0031595;GO:0005654;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear proteasome complex; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|O00232 A6NP15 Q53HA2 Q6P053,26S proteasome non-ATPase regulatory subunit 12,26S proteasome regulatory subunit RPN5;26S proteasome regulatory subunit p55;, PF01399;PF18098;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0031595;GO:0005654;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear proteasome complex; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|O00232 A6NP15 Q53HA2 Q6P053,26S proteasome non-ATPase regulatory subunit 12,26S proteasome regulatory subunit RPN5;26S proteasome regulatory subunit p55;, PF01399;PF18098;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0031595;GO:0005654;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear proteasome complex; C:nucleoplasm; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold61 indexed_genome mRNA 2801391 3060637 . + . ID=transcript_10607;Q9UKF7 A8K473 J3QR20 Q96I07,Cytoplasmic phosphatidylinositol transfer protein 1,Mammalian rdgB homolog beta;Retinal degeneration B homolog beta;, PF02121;, GO:0005737;GO:0005829;GO:0005654;GO:0070300;GO:1990050;GO:1901611;GO:0035091;GO:0008526;GO:0015914;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:phosphatidic acid binding; F:phosphatidic acid transfer activity; F:phosphatidylglycerol binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:phospholipid transport; P:signal transduction;|Q9UKF7 A8K473 J3QR20 Q96I07,Cytoplasmic phosphatidylinositol transfer protein 1,Mammalian rdgB homolog beta;Retinal degeneration B homolog beta;, PF02121;, GO:0005737;GO:0005829;GO:0005654;GO:0070300;GO:1990050;GO:1901611;GO:0035091;GO:0008526;GO:0015914;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:phosphatidic acid binding; F:phosphatidic acid transfer activity; F:phosphatidylglycerol binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:phospholipid transport; P:signal transduction;|Q9UKF7 A8K473 J3QR20 Q96I07,Cytoplasmic phosphatidylinositol transfer protein 1,Mammalian rdgB homolog beta;Retinal degeneration B homolog beta;, PF02121;, GO:0005737;GO:0005829;GO:0005654;GO:0070300;GO:1990050;GO:1901611;GO:0035091;GO:0008526;GO:0015914;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:phosphatidic acid binding; F:phosphatidic acid transfer activity; F:phosphatidylglycerol binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:phospholipid transport; P:signal transduction;|Q9UKF7 A8K473 J3QR20 Q96I07,Cytoplasmic phosphatidylinositol transfer protein 1,Mammalian rdgB homolog beta;Retinal degeneration B homolog beta;, PF02121;, GO:0005737;GO:0005829;GO:0005654;GO:0070300;GO:1990050;GO:1901611;GO:0035091;GO:0008526;GO:0015914;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:phosphatidic acid binding; F:phosphatidic acid transfer activity; F:phosphatidylglycerol binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:phospholipid transport; P:signal transduction; scaffold61 indexed_genome mRNA 3082957 3102482 . + . ID=transcript_10608;Q9H8H0 B7Z5V9 Q7L5S1 Q9UG18,Nucleolar protein 11,, PF08168;, GO:0005730;GO:0005654;GO:0034455;GO:0003723;GO:0030490;GO:1901838;GO:0006364;, C:nucleolus; C:nucleoplasm; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing;|Q9H8H0 B7Z5V9 Q7L5S1 Q9UG18,Nucleolar protein 11,, PF08168;, GO:0005730;GO:0005654;GO:0034455;GO:0003723;GO:0030490;GO:1901838;GO:0006364;, C:nucleolus; C:nucleoplasm; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing;|Q9H8H0 B7Z5V9 Q7L5S1 Q9UG18,Nucleolar protein 11,, PF08168;, GO:0005730;GO:0005654;GO:0034455;GO:0003723;GO:0030490;GO:1901838;GO:0006364;, C:nucleolus; C:nucleoplasm; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing;|Q9H8H0 B7Z5V9 Q7L5S1 Q9UG18,Nucleolar protein 11,, PF08168;, GO:0005730;GO:0005654;GO:0034455;GO:0003723;GO:0030490;GO:1901838;GO:0006364;, C:nucleolus; C:nucleoplasm; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing;|Q9H8H0 B7Z5V9 Q7L5S1 Q9UG18,Nucleolar protein 11,, PF08168;, GO:0005730;GO:0005654;GO:0034455;GO:0003723;GO:0030490;GO:1901838;GO:0006364;, C:nucleolus; C:nucleoplasm; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing;|Q9H8H0 B7Z5V9 Q7L5S1 Q9UG18,Nucleolar protein 11,, PF08168;, GO:0005730;GO:0005654;GO:0034455;GO:0003723;GO:0030490;GO:1901838;GO:0006364;, C:nucleolus; C:nucleoplasm; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing;|Q9H8H0 B7Z5V9 Q7L5S1 Q9UG18,Nucleolar protein 11,, PF08168;, GO:0005730;GO:0005654;GO:0034455;GO:0003723;GO:0030490;GO:1901838;GO:0006364;, C:nucleolus; C:nucleoplasm; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing;|Q9H8H0 B7Z5V9 Q7L5S1 Q9UG18,Nucleolar protein 11,, PF08168;, GO:0005730;GO:0005654;GO:0034455;GO:0003723;GO:0030490;GO:1901838;GO:0006364;, C:nucleolus; C:nucleoplasm; C:t-UTP complex;, F:RNA binding;, P:maturation of SSU-rRNA; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA processing; scaffold61 indexed_genome mRNA 3161246 3214541 . + . ID=transcript_10609;Q12830 Q6NX67 Q7Z7D6 Q9UIG2,Nucleosome-remodeling factor subunit BPTF,Bromodomain and PHD finger-containing transcription factor;Fetal Alz-50 clone 1 protein;Fetal Alzheimer antigen;, PF00439;PF02791;PF00628;PF15613;, GO:0044297;GO:0000785;GO:0005737;GO:0030425;GO:0070062;GO:0005654;GO:0005634;GO:0016589;GO:0048471;GO:0046872;GO:0035064;GO:0000978;GO:0043565;GO:0008134;GO:0009952;GO:0007420;GO:1990090;GO:0006338;GO:0001892;GO:0007492;GO:0000122;GO:0042766;GO:0045944;GO:0006357;GO:0009611;, C:cell body; C:chromatin; C:cytoplasm; C:dendrite; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:NURF complex; C:perinuclear region of cytoplasm;, F:metal ion binding; F:methylated histone binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:brain development; P:cellular response to nerve growth factor stimulus; P:chromatin remodeling; P:embryonic placenta development; P:endoderm development; P:negative regulation of transcription by RNA polymerase II; P:nucleosome mobilization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to wounding;|Q12830 Q6NX67 Q7Z7D6 Q9UIG2,Nucleosome-remodeling factor subunit BPTF,Bromodomain and PHD finger-containing transcription factor;Fetal Alz-50 clone 1 protein;Fetal Alzheimer antigen;, PF00439;PF02791;PF00628;PF15613;, GO:0044297;GO:0000785;GO:0005737;GO:0030425;GO:0070062;GO:0005654;GO:0005634;GO:0016589;GO:0048471;GO:0046872;GO:0035064;GO:0000978;GO:0043565;GO:0008134;GO:0009952;GO:0007420;GO:1990090;GO:0006338;GO:0001892;GO:0007492;GO:0000122;GO:0042766;GO:0045944;GO:0006357;GO:0009611;, C:cell body; C:chromatin; C:cytoplasm; C:dendrite; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:NURF complex; C:perinuclear region of cytoplasm;, F:metal ion binding; F:methylated histone binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:brain development; P:cellular response to nerve growth factor stimulus; P:chromatin remodeling; P:embryonic placenta development; P:endoderm development; P:negative regulation of transcription by RNA polymerase II; P:nucleosome mobilization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to wounding;|Q12830 Q6NX67 Q7Z7D6 Q9UIG2,Nucleosome-remodeling factor subunit BPTF,Bromodomain and PHD finger-containing transcription factor;Fetal Alz-50 clone 1 protein;Fetal Alzheimer antigen;, PF00439;PF02791;PF00628;PF15613;, GO:0044297;GO:0000785;GO:0005737;GO:0030425;GO:0070062;GO:0005654;GO:0005634;GO:0016589;GO:0048471;GO:0046872;GO:0035064;GO:0000978;GO:0043565;GO:0008134;GO:0009952;GO:0007420;GO:1990090;GO:0006338;GO:0001892;GO:0007492;GO:0000122;GO:0042766;GO:0045944;GO:0006357;GO:0009611;, C:cell body; C:chromatin; C:cytoplasm; C:dendrite; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:NURF complex; C:perinuclear region of cytoplasm;, F:metal ion binding; F:methylated histone binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:brain development; P:cellular response to nerve growth factor stimulus; P:chromatin remodeling; P:embryonic placenta development; P:endoderm development; P:negative regulation of transcription by RNA polymerase II; P:nucleosome mobilization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to wounding;|Q12830 Q6NX67 Q7Z7D6 Q9UIG2,Nucleosome-remodeling factor subunit BPTF,Bromodomain and PHD finger-containing transcription factor;Fetal Alz-50 clone 1 protein;Fetal Alzheimer antigen;, PF00439;PF02791;PF00628;PF15613;, GO:0044297;GO:0000785;GO:0005737;GO:0030425;GO:0070062;GO:0005654;GO:0005634;GO:0016589;GO:0048471;GO:0046872;GO:0035064;GO:0000978;GO:0043565;GO:0008134;GO:0009952;GO:0007420;GO:1990090;GO:0006338;GO:0001892;GO:0007492;GO:0000122;GO:0042766;GO:0045944;GO:0006357;GO:0009611;, C:cell body; C:chromatin; C:cytoplasm; C:dendrite; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:NURF complex; C:perinuclear region of cytoplasm;, F:metal ion binding; F:methylated histone binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:brain development; P:cellular response to nerve growth factor stimulus; P:chromatin remodeling; P:embryonic placenta development; P:endoderm development; P:negative regulation of transcription by RNA polymerase II; P:nucleosome mobilization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to wounding; scaffold61 indexed_genome mRNA 3215219 3248639 . + . ID=transcript_10610;Q12830 Q6NX67 Q7Z7D6 Q9UIG2,Nucleosome-remodeling factor subunit BPTF,Bromodomain and PHD finger-containing transcription factor;Fetal Alz-50 clone 1 protein;Fetal Alzheimer antigen;, PF00439;PF02791;PF00628;PF15613;, GO:0044297;GO:0000785;GO:0005737;GO:0030425;GO:0070062;GO:0005654;GO:0005634;GO:0016589;GO:0048471;GO:0046872;GO:0035064;GO:0000978;GO:0043565;GO:0008134;GO:0009952;GO:0007420;GO:1990090;GO:0006338;GO:0001892;GO:0007492;GO:0000122;GO:0042766;GO:0045944;GO:0006357;GO:0009611;, C:cell body; C:chromatin; C:cytoplasm; C:dendrite; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:NURF complex; C:perinuclear region of cytoplasm;, F:metal ion binding; F:methylated histone binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:brain development; P:cellular response to nerve growth factor stimulus; P:chromatin remodeling; P:embryonic placenta development; P:endoderm development; P:negative regulation of transcription by RNA polymerase II; P:nucleosome mobilization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to wounding;|Q12830 Q6NX67 Q7Z7D6 Q9UIG2,Nucleosome-remodeling factor subunit BPTF,Bromodomain and PHD finger-containing transcription factor;Fetal Alz-50 clone 1 protein;Fetal Alzheimer antigen;, PF00439;PF02791;PF00628;PF15613;, GO:0044297;GO:0000785;GO:0005737;GO:0030425;GO:0070062;GO:0005654;GO:0005634;GO:0016589;GO:0048471;GO:0046872;GO:0035064;GO:0000978;GO:0043565;GO:0008134;GO:0009952;GO:0007420;GO:1990090;GO:0006338;GO:0001892;GO:0007492;GO:0000122;GO:0042766;GO:0045944;GO:0006357;GO:0009611;, C:cell body; C:chromatin; C:cytoplasm; C:dendrite; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:NURF complex; C:perinuclear region of cytoplasm;, F:metal ion binding; F:methylated histone binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:brain development; P:cellular response to nerve growth factor stimulus; P:chromatin remodeling; P:embryonic placenta development; P:endoderm development; P:negative regulation of transcription by RNA polymerase II; P:nucleosome mobilization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to wounding;|Q12830 Q6NX67 Q7Z7D6 Q9UIG2,Nucleosome-remodeling factor subunit BPTF,Bromodomain and PHD finger-containing transcription factor;Fetal Alz-50 clone 1 protein;Fetal Alzheimer antigen;, PF00439;PF02791;PF00628;PF15613;, GO:0044297;GO:0000785;GO:0005737;GO:0030425;GO:0070062;GO:0005654;GO:0005634;GO:0016589;GO:0048471;GO:0046872;GO:0035064;GO:0000978;GO:0043565;GO:0008134;GO:0009952;GO:0007420;GO:1990090;GO:0006338;GO:0001892;GO:0007492;GO:0000122;GO:0042766;GO:0045944;GO:0006357;GO:0009611;, C:cell body; C:chromatin; C:cytoplasm; C:dendrite; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:NURF complex; C:perinuclear region of cytoplasm;, F:metal ion binding; F:methylated histone binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:brain development; P:cellular response to nerve growth factor stimulus; P:chromatin remodeling; P:embryonic placenta development; P:endoderm development; P:negative regulation of transcription by RNA polymerase II; P:nucleosome mobilization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to wounding; scaffold61 indexed_genome mRNA 3271563 3280743 . + . ID=transcript_10611;P52292 B9EJD6 Q53YE3 Q6NVW7 Q9BRU5,Importin subunit alpha-1 {ECO:0000305},Karyopherin subunit alpha-2;RAG cohort protein 1;SRP1-alpha;, PF00514;PF16186;PF01749;, GO:0005737;GO:0005829;GO:0005789;GO:0098892;GO:0098978;GO:0000139;GO:0043657;GO:0016020;GO:0005654;GO:0005634;GO:0042826;GO:0061608;GO:0008139;GO:0003723;GO:0006259;GO:0006302;GO:0075506;GO:0019054;GO:0006607;GO:1903902;GO:0099527;GO:0000018;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of postsynaptic specialization membrane; C:glutamatergic synapse; C:Golgi membrane; C:host cell; C:membrane; C:nucleoplasm; C:nucleus;, F:histone deacetylase binding; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:RNA binding;, P:DNA metabolic process; P:double-strand break repair; P:entry of viral genome into host nucleus through nuclear pore complex via importin; P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:positive regulation of viral life cycle; P:postsynapse to nucleus signaling pathway; P:regulation of DNA recombination;|P52292 B9EJD6 Q53YE3 Q6NVW7 Q9BRU5,Importin subunit alpha-1 {ECO:0000305},Karyopherin subunit alpha-2;RAG cohort protein 1;SRP1-alpha;, PF00514;PF16186;PF01749;, GO:0005737;GO:0005829;GO:0005789;GO:0098892;GO:0098978;GO:0000139;GO:0043657;GO:0016020;GO:0005654;GO:0005634;GO:0042826;GO:0061608;GO:0008139;GO:0003723;GO:0006259;GO:0006302;GO:0075506;GO:0019054;GO:0006607;GO:1903902;GO:0099527;GO:0000018;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of postsynaptic specialization membrane; C:glutamatergic synapse; C:Golgi membrane; C:host cell; C:membrane; C:nucleoplasm; C:nucleus;, F:histone deacetylase binding; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:RNA binding;, P:DNA metabolic process; P:double-strand break repair; P:entry of viral genome into host nucleus through nuclear pore complex via importin; P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:positive regulation of viral life cycle; P:postsynapse to nucleus signaling pathway; P:regulation of DNA recombination;|P52292 B9EJD6 Q53YE3 Q6NVW7 Q9BRU5,Importin subunit alpha-1 {ECO:0000305},Karyopherin subunit alpha-2;RAG cohort protein 1;SRP1-alpha;, PF00514;PF16186;PF01749;, GO:0005737;GO:0005829;GO:0005789;GO:0098892;GO:0098978;GO:0000139;GO:0043657;GO:0016020;GO:0005654;GO:0005634;GO:0042826;GO:0061608;GO:0008139;GO:0003723;GO:0006259;GO:0006302;GO:0075506;GO:0019054;GO:0006607;GO:1903902;GO:0099527;GO:0000018;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of postsynaptic specialization membrane; C:glutamatergic synapse; C:Golgi membrane; C:host cell; C:membrane; C:nucleoplasm; C:nucleus;, F:histone deacetylase binding; F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:RNA binding;, P:DNA metabolic process; P:double-strand break repair; P:entry of viral genome into host nucleus through nuclear pore complex via importin; P:modulation by virus of host cellular process; P:NLS-bearing protein import into nucleus; P:positive regulation of viral life cycle; P:postsynapse to nucleus signaling pathway; P:regulation of DNA recombination; scaffold61 indexed_genome mRNA 3446433 3480855 . + . ID=transcript_10612;Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HAU4 Q52LL1 Q9H260,E3 ubiquitin-protein ligase SMURF2,HECT-type E3 ubiquitin transferase SMURF2;SMAD ubiquitination regulatory factor 2;SMAD-specific E3 ubiquitin-protein ligase 2;, PF00168;PF00632;PF00397;, GO:0005737;GO:0005829;GO:0045121;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0042802;GO:0046332;GO:0005160;GO:0061630;GO:0004842;GO:0030514;GO:0000122;GO:0045892;GO:0030512;GO:0090263;GO:0045732;GO:1901165;GO:0043161;GO:0016579;GO:0000209;GO:0016567;GO:0017015;GO:0006511;GO:0030579;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane raft; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:identical protein binding; F:SMAD binding; F:transforming growth factor beta receptor binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of trophoblast cell migration; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold61 indexed_genome mRNA 3488853 3489738 . - . ID=transcript_10613;Q96GE4 B4DMD2 Q96M81,Centrosomal protein of 95 kDa,Coiled-coil domain-containing protein 45;, PF19016;, GO:0005813;GO:0005737;GO:0000922;, C:centrosome; C:cytoplasm; C:spindle pole; scaffold61 indexed_genome mRNA 3491651 3497332 . - . ID=transcript_10614;Q96GE4 B4DMD2 Q96M81,Centrosomal protein of 95 kDa,Coiled-coil domain-containing protein 45;, PF19016;, GO:0005813;GO:0005737;GO:0000922;, C:centrosome; C:cytoplasm; C:spindle pole;|Q96GE4 B4DMD2 Q96M81,Centrosomal protein of 95 kDa,Coiled-coil domain-containing protein 45;, PF19016;, GO:0005813;GO:0005737;GO:0000922;, C:centrosome; C:cytoplasm; C:spindle pole;|Q96GE4 B4DMD2 Q96M81,Centrosomal protein of 95 kDa,Coiled-coil domain-containing protein 45;, PF19016;, GO:0005813;GO:0005737;GO:0000922;, C:centrosome; C:cytoplasm; C:spindle pole;|Q96GE4 B4DMD2 Q96M81,Centrosomal protein of 95 kDa,Coiled-coil domain-containing protein 45;, PF19016;, GO:0005813;GO:0005737;GO:0000922;, C:centrosome; C:cytoplasm; C:spindle pole;|Q96GE4 B4DMD2 Q96M81,Centrosomal protein of 95 kDa,Coiled-coil domain-containing protein 45;, PF19016;, GO:0005813;GO:0005737;GO:0000922;, C:centrosome; C:cytoplasm; C:spindle pole; scaffold61 indexed_genome mRNA 3498967 3524523 . - . ID=transcript_10615;Q96GE4 B4DMD2 Q96M81,Centrosomal protein of 95 kDa,Coiled-coil domain-containing protein 45;, PF19016;, GO:0005813;GO:0005737;GO:0000922;, C:centrosome; C:cytoplasm; C:spindle pole;|Q96GE4 B4DMD2 Q96M81,Centrosomal protein of 95 kDa,Coiled-coil domain-containing protein 45;, PF19016;, GO:0005813;GO:0005737;GO:0000922;, C:centrosome; C:cytoplasm; C:spindle pole;|Q96GE4 B4DMD2 Q96M81,Centrosomal protein of 95 kDa,Coiled-coil domain-containing protein 45;, PF19016;, GO:0005813;GO:0005737;GO:0000922;, C:centrosome; C:cytoplasm; C:spindle pole;|Q96GE4 B4DMD2 Q96M81,Centrosomal protein of 95 kDa,Coiled-coil domain-containing protein 45;, PF19016;, GO:0005813;GO:0005737;GO:0000922;, C:centrosome; C:cytoplasm; C:spindle pole; scaffold61 indexed_genome mRNA 3524711 3532847 . + . ID=transcript_10616;P17844 B4DLW8 B5BU21 D3DU32 E7ETL9 O75681 Q53Y61,Probable ATP-dependent RNA helicase DDX5,DEAD box protein 5;RNA helicase p68;, PF00270;PF00271;PF08061;, GO:0071013;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0050681;GO:0005524;GO:0035500;GO:0003730;GO:0036002;GO:0070878;GO:1990841;GO:0070412;GO:0043021;GO:0003723;GO:0003724;GO:0046332;GO:0000380;GO:0030521;GO:0030509;GO:0001837;GO:0030520;GO:0072332;GO:0000398;GO:0009299;GO:0045445;GO:0000122;GO:0000956;GO:0043517;GO:1903800;GO:0061614;GO:0000381;GO:0060765;GO:0045667;GO:2001014;GO:0006357;GO:0048511;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:androgen receptor binding; F:ATP binding; F:MH2 domain binding; F:mRNA 3'-UTR binding; F:pre-mRNA binding; F:primary miRNA binding; F:promoter-specific chromatin binding; F:R-SMAD binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:SMAD binding;, P:alternative mRNA splicing, via spliceosome; P:androgen receptor signaling pathway; P:BMP signaling pathway; P:epithelial to mesenchymal transition; P:intracellular estrogen receptor signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:mRNA splicing, via spliceosome; P:mRNA transcription; P:myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:pri-miRNA transcription by RNA polymerase II; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of androgen receptor signaling pathway; P:regulation of osteoblast differentiation; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:rhythmic process;|P17844 B4DLW8 B5BU21 D3DU32 E7ETL9 O75681 Q53Y61,Probable ATP-dependent RNA helicase DDX5,DEAD box protein 5;RNA helicase p68;, PF00270;PF00271;PF08061;, GO:0071013;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0050681;GO:0005524;GO:0035500;GO:0003730;GO:0036002;GO:0070878;GO:1990841;GO:0070412;GO:0043021;GO:0003723;GO:0003724;GO:0046332;GO:0000380;GO:0030521;GO:0030509;GO:0001837;GO:0030520;GO:0072332;GO:0000398;GO:0009299;GO:0045445;GO:0000122;GO:0000956;GO:0043517;GO:1903800;GO:0061614;GO:0000381;GO:0060765;GO:0045667;GO:2001014;GO:0006357;GO:0048511;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:androgen receptor binding; F:ATP binding; F:MH2 domain binding; F:mRNA 3'-UTR binding; F:pre-mRNA binding; F:primary miRNA binding; F:promoter-specific chromatin binding; F:R-SMAD binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:SMAD binding;, P:alternative mRNA splicing, via spliceosome; P:androgen receptor signaling pathway; P:BMP signaling pathway; P:epithelial to mesenchymal transition; P:intracellular estrogen receptor signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:mRNA splicing, via spliceosome; P:mRNA transcription; P:myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:pri-miRNA transcription by RNA polymerase II; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of androgen receptor signaling pathway; P:regulation of osteoblast differentiation; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:rhythmic process;|P17844 B4DLW8 B5BU21 D3DU32 E7ETL9 O75681 Q53Y61,Probable ATP-dependent RNA helicase DDX5,DEAD box protein 5;RNA helicase p68;, PF00270;PF00271;PF08061;, GO:0071013;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0050681;GO:0005524;GO:0035500;GO:0003730;GO:0036002;GO:0070878;GO:1990841;GO:0070412;GO:0043021;GO:0003723;GO:0003724;GO:0046332;GO:0000380;GO:0030521;GO:0030509;GO:0001837;GO:0030520;GO:0072332;GO:0000398;GO:0009299;GO:0045445;GO:0000122;GO:0000956;GO:0043517;GO:1903800;GO:0061614;GO:0000381;GO:0060765;GO:0045667;GO:2001014;GO:0006357;GO:0048511;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:androgen receptor binding; F:ATP binding; F:MH2 domain binding; F:mRNA 3'-UTR binding; F:pre-mRNA binding; F:primary miRNA binding; F:promoter-specific chromatin binding; F:R-SMAD binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:SMAD binding;, P:alternative mRNA splicing, via spliceosome; P:androgen receptor signaling pathway; P:BMP signaling pathway; P:epithelial to mesenchymal transition; P:intracellular estrogen receptor signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:mRNA splicing, via spliceosome; P:mRNA transcription; P:myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:pri-miRNA transcription by RNA polymerase II; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of androgen receptor signaling pathway; P:regulation of osteoblast differentiation; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:rhythmic process;|P17844 B4DLW8 B5BU21 D3DU32 E7ETL9 O75681 Q53Y61,Probable ATP-dependent RNA helicase DDX5,DEAD box protein 5;RNA helicase p68;, PF00270;PF00271;PF08061;, GO:0071013;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0050681;GO:0005524;GO:0035500;GO:0003730;GO:0036002;GO:0070878;GO:1990841;GO:0070412;GO:0043021;GO:0003723;GO:0003724;GO:0046332;GO:0000380;GO:0030521;GO:0030509;GO:0001837;GO:0030520;GO:0072332;GO:0000398;GO:0009299;GO:0045445;GO:0000122;GO:0000956;GO:0043517;GO:1903800;GO:0061614;GO:0000381;GO:0060765;GO:0045667;GO:2001014;GO:0006357;GO:0048511;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:androgen receptor binding; F:ATP binding; F:MH2 domain binding; F:mRNA 3'-UTR binding; F:pre-mRNA binding; F:primary miRNA binding; F:promoter-specific chromatin binding; F:R-SMAD binding; F:ribonucleoprotein complex binding; F:RNA binding; F:RNA helicase activity; F:SMAD binding;, P:alternative mRNA splicing, via spliceosome; P:androgen receptor signaling pathway; P:BMP signaling pathway; P:epithelial to mesenchymal transition; P:intracellular estrogen receptor signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:mRNA splicing, via spliceosome; P:mRNA transcription; P:myoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:pri-miRNA transcription by RNA polymerase II; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of androgen receptor signaling pathway; P:regulation of osteoblast differentiation; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:rhythmic process; scaffold61 indexed_genome mRNA 3533657 3535238 . - . ID=transcript_10617;Q9UHN1 O00419 Q0IJ81 Q96GW2 Q9UK35 Q9UK94,DNA polymerase subunit gamma-2, mitochondrial,DNA polymerase gamma accessory 55 kDa subunit;Mitochondrial DNA polymerase accessory subunit;MtPolB;PolG-beta;, PF03129;, GO:0005737;GO:0005760;GO:0005759;GO:0042645;GO:0005739;GO:0070182;GO:0030337;GO:0003887;GO:0003690;GO:0042802;GO:0006281;GO:0006261;GO:0001701;GO:0032042;GO:0006264;GO:0070584;GO:0007005;GO:1900264;GO:0022904;, C:cytoplasm; C:gamma DNA polymerase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:DNA polymerase binding; F:DNA polymerase processivity factor activity; F:DNA-directed DNA polymerase activity; F:double-stranded DNA binding; F:identical protein binding;, P:DNA repair; P:DNA-dependent DNA replication; P:in utero embryonic development; P:mitochondrial DNA metabolic process; P:mitochondrial DNA replication; P:mitochondrion morphogenesis; P:mitochondrion organization; P:positive regulation of DNA-directed DNA polymerase activity; P:respiratory electron transport chain; scaffold61 indexed_genome mRNA 3535571 3550879 . + . ID=transcript_10618;Q9UHN1 O00419 Q0IJ81 Q96GW2 Q9UK35 Q9UK94,DNA polymerase subunit gamma-2, mitochondrial,DNA polymerase gamma accessory 55 kDa subunit;Mitochondrial DNA polymerase accessory subunit;MtPolB;PolG-beta;, PF03129;, GO:0005737;GO:0005760;GO:0005759;GO:0042645;GO:0005739;GO:0070182;GO:0030337;GO:0003887;GO:0003690;GO:0042802;GO:0006281;GO:0006261;GO:0001701;GO:0032042;GO:0006264;GO:0070584;GO:0007005;GO:1900264;GO:0022904;, C:cytoplasm; C:gamma DNA polymerase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:DNA polymerase binding; F:DNA polymerase processivity factor activity; F:DNA-directed DNA polymerase activity; F:double-stranded DNA binding; F:identical protein binding;, P:DNA repair; P:DNA-dependent DNA replication; P:in utero embryonic development; P:mitochondrial DNA metabolic process; P:mitochondrial DNA replication; P:mitochondrion morphogenesis; P:mitochondrion organization; P:positive regulation of DNA-directed DNA polymerase activity; P:respiratory electron transport chain;|Q9UHN1 O00419 Q0IJ81 Q96GW2 Q9UK35 Q9UK94,DNA polymerase subunit gamma-2, mitochondrial,DNA polymerase gamma accessory 55 kDa subunit;Mitochondrial DNA polymerase accessory subunit;MtPolB;PolG-beta;, PF03129;, GO:0005737;GO:0005760;GO:0005759;GO:0042645;GO:0005739;GO:0070182;GO:0030337;GO:0003887;GO:0003690;GO:0042802;GO:0006281;GO:0006261;GO:0001701;GO:0032042;GO:0006264;GO:0070584;GO:0007005;GO:1900264;GO:0022904;, C:cytoplasm; C:gamma DNA polymerase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:DNA polymerase binding; F:DNA polymerase processivity factor activity; F:DNA-directed DNA polymerase activity; F:double-stranded DNA binding; F:identical protein binding;, P:DNA repair; P:DNA-dependent DNA replication; P:in utero embryonic development; P:mitochondrial DNA metabolic process; P:mitochondrial DNA replication; P:mitochondrion morphogenesis; P:mitochondrion organization; P:positive regulation of DNA-directed DNA polymerase activity; P:respiratory electron transport chain;|Q9UHN1 O00419 Q0IJ81 Q96GW2 Q9UK35 Q9UK94,DNA polymerase subunit gamma-2, mitochondrial,DNA polymerase gamma accessory 55 kDa subunit;Mitochondrial DNA polymerase accessory subunit;MtPolB;PolG-beta;, PF03129;, GO:0005737;GO:0005760;GO:0005759;GO:0042645;GO:0005739;GO:0070182;GO:0030337;GO:0003887;GO:0003690;GO:0042802;GO:0006281;GO:0006261;GO:0001701;GO:0032042;GO:0006264;GO:0070584;GO:0007005;GO:1900264;GO:0022904;, C:cytoplasm; C:gamma DNA polymerase complex; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:DNA polymerase binding; F:DNA polymerase processivity factor activity; F:DNA-directed DNA polymerase activity; F:double-stranded DNA binding; F:identical protein binding;, P:DNA repair; P:DNA-dependent DNA replication; P:in utero embryonic development; P:mitochondrial DNA metabolic process; P:mitochondrial DNA replication; P:mitochondrion morphogenesis; P:mitochondrion organization; P:positive regulation of DNA-directed DNA polymerase activity; P:respiratory electron transport chain; scaffold61 indexed_genome mRNA 3577368 3596296 . - . ID=transcript_10619;Q7Z6M3 A1L458 B4DUS1 B7ZM50 B9EGN0 D6RUW6 D6RUW8,Allergin-1,Allergy inhibitory receptor 1;Mast cell antigen 32;Mast cell immunoglobulin-like receptor 1;, PF17736;, GO:0005887;GO:0004888;GO:0007166;GO:0098742;GO:0043303;GO:0033004;, C:integral component of plasma membrane;, F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:mast cell degranulation; P:negative regulation of mast cell activation; scaffold61 indexed_genome mRNA 3609866 3686056 . + . ID=transcript_10620;Q9NPB7 Q9NPG9 Q9NQS9 Q9NQT0 Q9NQT1 Q9NQT2,Platelet endothelial cell adhesion molecule,EndoCAM;GPIIA';PECA1;, PF13895;PF17736;, GO:0005911;GO:0070062;GO:0005615;GO:0005887;GO:0045121;GO:0005886;GO:0031092;GO:0032991;GO:0030667;GO:0042803;GO:0004888;GO:0070830;GO:0008037;GO:0007166;GO:0098609;GO:0098742;GO:0050904;GO:0061028;GO:0030198;GO:0072011;GO:0007156;GO:0007159;GO:0050900;GO:0035633;GO:0035696;GO:0043312;GO:0072672;GO:0006909;GO:0002576;GO:0030335;GO:0050731;GO:0150107;GO:0001934;GO:0007165;, C:cell-cell junction; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane; C:platelet alpha granule membrane; C:protein-containing complex; C:secretory granule membrane;, F:protein homodimerization activity; F:transmembrane signaling receptor activity;, P:bicellular tight junction assembly; P:cell recognition; P:cell surface receptor signaling pathway; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:diapedesis; P:establishment of endothelial barrier; P:extracellular matrix organization; P:glomerular endothelium development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:maintenance of blood-brain barrier; P:monocyte extravasation; P:neutrophil degranulation; P:neutrophil extravasation; P:phagocytosis; P:platelet degranulation; P:positive regulation of cell migration; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein localization to cell-cell junction; P:positive regulation of protein phosphorylation; P:signal transduction;|Q9NPB7 Q9NPG9 Q9NQS9 Q9NQT0 Q9NQT1 Q9NQT2,Platelet endothelial cell adhesion molecule,EndoCAM;GPIIA';PECA1;, PF13895;PF17736;, GO:0005911;GO:0070062;GO:0005615;GO:0005887;GO:0045121;GO:0005886;GO:0031092;GO:0032991;GO:0030667;GO:0042803;GO:0004888;GO:0070830;GO:0008037;GO:0007166;GO:0098609;GO:0098742;GO:0050904;GO:0061028;GO:0030198;GO:0072011;GO:0007156;GO:0007159;GO:0050900;GO:0035633;GO:0035696;GO:0043312;GO:0072672;GO:0006909;GO:0002576;GO:0030335;GO:0050731;GO:0150107;GO:0001934;GO:0007165;, C:cell-cell junction; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane; C:platelet alpha granule membrane; C:protein-containing complex; C:secretory granule membrane;, F:protein homodimerization activity; F:transmembrane signaling receptor activity;, P:bicellular tight junction assembly; P:cell recognition; P:cell surface receptor signaling pathway; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:diapedesis; P:establishment of endothelial barrier; P:extracellular matrix organization; P:glomerular endothelium development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:maintenance of blood-brain barrier; P:monocyte extravasation; P:neutrophil degranulation; P:neutrophil extravasation; P:phagocytosis; P:platelet degranulation; P:positive regulation of cell migration; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein localization to cell-cell junction; P:positive regulation of protein phosphorylation; P:signal transduction;|Q9NPB7 Q9NPG9 Q9NQS9 Q9NQT0 Q9NQT1 Q9NQT2,Platelet endothelial cell adhesion molecule,EndoCAM;GPIIA';PECA1;, PF13895;PF17736;, GO:0005911;GO:0070062;GO:0005615;GO:0005887;GO:0045121;GO:0005886;GO:0031092;GO:0032991;GO:0030667;GO:0042803;GO:0004888;GO:0070830;GO:0008037;GO:0007166;GO:0098609;GO:0098742;GO:0050904;GO:0061028;GO:0030198;GO:0072011;GO:0007156;GO:0007159;GO:0050900;GO:0035633;GO:0035696;GO:0043312;GO:0072672;GO:0006909;GO:0002576;GO:0030335;GO:0050731;GO:0150107;GO:0001934;GO:0007165;, C:cell-cell junction; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane; C:platelet alpha granule membrane; C:protein-containing complex; C:secretory granule membrane;, F:protein homodimerization activity; F:transmembrane signaling receptor activity;, P:bicellular tight junction assembly; P:cell recognition; P:cell surface receptor signaling pathway; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:diapedesis; P:establishment of endothelial barrier; P:extracellular matrix organization; P:glomerular endothelium development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:maintenance of blood-brain barrier; P:monocyte extravasation; P:neutrophil degranulation; P:neutrophil extravasation; P:phagocytosis; P:platelet degranulation; P:positive regulation of cell migration; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein localization to cell-cell junction; P:positive regulation of protein phosphorylation; P:signal transduction; scaffold61 indexed_genome mRNA 3733121 3848914 . + . ID=transcript_10621;Q8IWB9 Q6AHZ5 Q8N3L0 Q9C0C5,Testis-expressed protein 2,Transmembrane protein 96;, , GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0008289;GO:0006869;GO:0007165;GO:0006665;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, F:lipid binding;, P:lipid transport; P:signal transduction; P:sphingolipid metabolic process;|Q8IWB9 Q6AHZ5 Q8N3L0 Q9C0C5,Testis-expressed protein 2,Transmembrane protein 96;, , GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0008289;GO:0006869;GO:0007165;GO:0006665;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, F:lipid binding;, P:lipid transport; P:signal transduction; P:sphingolipid metabolic process;|Q8IWB9 Q6AHZ5 Q8N3L0 Q9C0C5,Testis-expressed protein 2,Transmembrane protein 96;, , GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0008289;GO:0006869;GO:0007165;GO:0006665;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, F:lipid binding;, P:lipid transport; P:signal transduction; P:sphingolipid metabolic process;|Q8IWB9 Q6AHZ5 Q8N3L0 Q9C0C5,Testis-expressed protein 2,Transmembrane protein 96;, , GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0008289;GO:0006869;GO:0007165;GO:0006665;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, F:lipid binding;, P:lipid transport; P:signal transduction; P:sphingolipid metabolic process; scaffold61 indexed_genome mRNA 3865547 3922407 . + . ID=transcript_10622;O75460 A1L457 A8K8N8 A8MXS7 Q59EE2,Serine/threonine-protein kinase/endoribonuclease IRE1 {ECO:0000305},Endoplasmic reticulum-to-nucleus signaling 1 {ECO:0000303|PubMed:9637683};Inositol-requiring protein 1 {ECO:0000303|PubMed:9637683};Ire1-alpha {ECO:0000303|PubMed:11779464};, PF00069;PF06479;, GO:1990597;GO:0005737;GO:0005783;GO:0005789;GO:0030176;GO:1990332;GO:1990630;GO:1990604;GO:0005739;GO:0005637;GO:0043531;GO:0005524;GO:0004521;GO:0019899;GO:0030544;GO:0051879;GO:0042802;GO:0000287;GO:0005161;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0051082;GO:0007257;GO:0007050;GO:0071333;GO:0070301;GO:0034620;GO:0035924;GO:0001935;GO:1901142;GO:0070059;GO:0036498;GO:0006402;GO:0006379;GO:0098787;GO:0070054;GO:0036289;GO:1990579;GO:1900103;GO:0033120;GO:1904707;GO:0046777;GO:0006468;GO:0016241;GO:0034976;, C:AIP1-IRE1 complex; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:Ire1 complex; C:IRE1-RACK1-PP2A complex; C:IRE1-TRAF2-ASK1 complex; C:mitochondrion; C:nuclear inner membrane;, F:ADP binding; F:ATP binding; F:endoribonuclease activity; F:enzyme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:identical protein binding; F:magnesium ion binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:unfolded protein binding;, P:activation of JUN kinase activity; P:cell cycle arrest; P:cellular response to glucose stimulus; P:cellular response to hydrogen peroxide; P:cellular response to unfolded protein; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell proliferation; P:insulin metabolic process; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:IRE1-mediated unfolded protein response; P:mRNA catabolic process; P:mRNA cleavage; P:mRNA cleavage involved in mRNA processing; P:mRNA splicing, via endonucleolytic cleavage and ligation; P:peptidyl-serine autophosphorylation; P:peptidyl-serine trans-autophosphorylation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of RNA splicing; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of macroautophagy; P:response to endoplasmic reticulum stress; scaffold61 indexed_genome mRNA 3923622 3948899 . + . ID=transcript_10623;O75460 A1L457 A8K8N8 A8MXS7 Q59EE2,Serine/threonine-protein kinase/endoribonuclease IRE1 {ECO:0000305},Endoplasmic reticulum-to-nucleus signaling 1 {ECO:0000303|PubMed:9637683};Inositol-requiring protein 1 {ECO:0000303|PubMed:9637683};Ire1-alpha {ECO:0000303|PubMed:11779464};, PF00069;PF06479;, GO:1990597;GO:0005737;GO:0005783;GO:0005789;GO:0030176;GO:1990332;GO:1990630;GO:1990604;GO:0005739;GO:0005637;GO:0043531;GO:0005524;GO:0004521;GO:0019899;GO:0030544;GO:0051879;GO:0042802;GO:0000287;GO:0005161;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0051082;GO:0007257;GO:0007050;GO:0071333;GO:0070301;GO:0034620;GO:0035924;GO:0001935;GO:1901142;GO:0070059;GO:0036498;GO:0006402;GO:0006379;GO:0098787;GO:0070054;GO:0036289;GO:1990579;GO:1900103;GO:0033120;GO:1904707;GO:0046777;GO:0006468;GO:0016241;GO:0034976;, C:AIP1-IRE1 complex; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:Ire1 complex; C:IRE1-RACK1-PP2A complex; C:IRE1-TRAF2-ASK1 complex; C:mitochondrion; C:nuclear inner membrane;, F:ADP binding; F:ATP binding; F:endoribonuclease activity; F:enzyme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:identical protein binding; F:magnesium ion binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:unfolded protein binding;, P:activation of JUN kinase activity; P:cell cycle arrest; P:cellular response to glucose stimulus; P:cellular response to hydrogen peroxide; P:cellular response to unfolded protein; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell proliferation; P:insulin metabolic process; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:IRE1-mediated unfolded protein response; P:mRNA catabolic process; P:mRNA cleavage; P:mRNA cleavage involved in mRNA processing; P:mRNA splicing, via endonucleolytic cleavage and ligation; P:peptidyl-serine autophosphorylation; P:peptidyl-serine trans-autophosphorylation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of RNA splicing; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of macroautophagy; P:response to endoplasmic reticulum stress;|O75460 A1L457 A8K8N8 A8MXS7 Q59EE2,Serine/threonine-protein kinase/endoribonuclease IRE1 {ECO:0000305},Endoplasmic reticulum-to-nucleus signaling 1 {ECO:0000303|PubMed:9637683};Inositol-requiring protein 1 {ECO:0000303|PubMed:9637683};Ire1-alpha {ECO:0000303|PubMed:11779464};, PF00069;PF06479;, GO:1990597;GO:0005737;GO:0005783;GO:0005789;GO:0030176;GO:1990332;GO:1990630;GO:1990604;GO:0005739;GO:0005637;GO:0043531;GO:0005524;GO:0004521;GO:0019899;GO:0030544;GO:0051879;GO:0042802;GO:0000287;GO:0005161;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0051082;GO:0007257;GO:0007050;GO:0071333;GO:0070301;GO:0034620;GO:0035924;GO:0001935;GO:1901142;GO:0070059;GO:0036498;GO:0006402;GO:0006379;GO:0098787;GO:0070054;GO:0036289;GO:1990579;GO:1900103;GO:0033120;GO:1904707;GO:0046777;GO:0006468;GO:0016241;GO:0034976;, C:AIP1-IRE1 complex; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:Ire1 complex; C:IRE1-RACK1-PP2A complex; C:IRE1-TRAF2-ASK1 complex; C:mitochondrion; C:nuclear inner membrane;, F:ADP binding; F:ATP binding; F:endoribonuclease activity; F:enzyme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:identical protein binding; F:magnesium ion binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:unfolded protein binding;, P:activation of JUN kinase activity; P:cell cycle arrest; P:cellular response to glucose stimulus; P:cellular response to hydrogen peroxide; P:cellular response to unfolded protein; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell proliferation; P:insulin metabolic process; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:IRE1-mediated unfolded protein response; P:mRNA catabolic process; P:mRNA cleavage; P:mRNA cleavage involved in mRNA processing; P:mRNA splicing, via endonucleolytic cleavage and ligation; P:peptidyl-serine autophosphorylation; P:peptidyl-serine trans-autophosphorylation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of RNA splicing; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of macroautophagy; P:response to endoplasmic reticulum stress; scaffold61 indexed_genome mRNA 3974057 3975474 . - . ID=transcript_10624;P0C7W0 B3KMP0 B4DZJ9 B4E2F8 E9PGL5 J3QKX4,Proline-rich protein 29,, PF15248; scaffold61 indexed_genome mRNA 3976979 3978048 . - . ID=transcript_10625;P0C7W0 B3KMP0 B4DZJ9 B4E2F8 E9PGL5 J3QKX4,Proline-rich protein 29,, PF15248; scaffold61 indexed_genome mRNA 4004362 4037744 . + . ID=transcript_10626;P35499 Q15478 Q16447 Q7Z6B1,Sodium channel protein type 4 subunit alpha,SkM1 {ECO:0000303|PubMed:1315496};Sodium channel protein skeletal muscle subunit alpha;Sodium channel protein type IV subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.4;, PF00520;PF06512;, GO:0030424;GO:0005887;GO:0001518;GO:0005244;GO:0005248;GO:0086010;GO:0006936;GO:0019228;GO:0034765;GO:0100001;GO:0035725;GO:0006814;, C:axon; C:integral component of plasma membrane; C:voltage-gated sodium channel complex;, F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:membrane depolarization during action potential; P:muscle contraction; P:neuronal action potential; P:regulation of ion transmembrane transport; P:regulation of skeletal muscle contraction by action potential; P:sodium ion transmembrane transport; P:sodium ion transport; scaffold61 indexed_genome mRNA 4042996 4045645 . + . ID=transcript_10627;P40259 Q53FS2 Q9BU06,B-cell antigen receptor complex-associated protein beta chain,B-cell-specific glycoprotein B29;Ig-beta;Immunoglobulin-associated B29 protein;, PF07686;, GO:0019815;GO:0005829;GO:0009897;GO:0070062;GO:0005887;GO:0005654;GO:0005886;GO:0042802;GO:0004888;GO:0002250;GO:0030183;GO:0050853;GO:0006955;GO:0007165;, C:B cell receptor complex; C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:identical protein binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:B cell differentiation; P:B cell receptor signaling pathway; P:immune response; P:signal transduction; scaffold61 indexed_genome mRNA 4087037 4097722 . + . ID=transcript_10628;Q92925 A5PLL5 A6NNQ7 B4DV56 B4E1R6 Q7L2I6 Q9UHZ1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2,60 kDa BRG-1/Brm-associated factor subunit B;BRG1-associated factor 60B;, PF02201;, GO:0000785;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003713;GO:0043044;GO:0006338;GO:0006337;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q92925 A5PLL5 A6NNQ7 B4DV56 B4E1R6 Q7L2I6 Q9UHZ1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2,60 kDa BRG-1/Brm-associated factor subunit B;BRG1-associated factor 60B;, PF02201;, GO:0000785;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003713;GO:0043044;GO:0006338;GO:0006337;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q92925 A5PLL5 A6NNQ7 B4DV56 B4E1R6 Q7L2I6 Q9UHZ1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2,60 kDa BRG-1/Brm-associated factor subunit B;BRG1-associated factor 60B;, PF02201;, GO:0000785;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003713;GO:0043044;GO:0006338;GO:0006337;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P62195 A8K3Z3 A8K763 O35051 O43208 P47210 P52915 P52916,26S proteasome regulatory subunit 8,26S proteasome AAA-ATPase subunit RPT6;Proteasome 26S subunit ATPase 5;Proteasome subunit p45;Thyroid hormone receptor-interacting protein 1;p45/SUG;, PF00004;PF17862;PF16450;, GO:0072562;GO:0005737;GO:0031410;GO:0005829;GO:0031597;GO:0070062;GO:0016234;GO:0016020;GO:0031595;GO:0005654;GO:0005634;GO:0098794;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0036402;GO:0017025;GO:0031531;GO:0008134;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0050804;GO:0090090;GO:0010972;GO:0043069;GO:0045892;GO:0038061;GO:0090263;GO:0090261;GO:0045899;GO:0045893;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0006357;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:blood microparticle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:inclusion body; C:membrane; C:nuclear proteasome complex; C:nucleoplasm; C:nucleus; C:postsynapse; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:TBP-class protein binding; F:thyrotropin-releasing hormone receptor binding; F:transcription factor binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of programmed cell death; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of inclusion body assembly; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P62195 A8K3Z3 A8K763 O35051 O43208 P47210 P52915 P52916,26S proteasome regulatory subunit 8,26S proteasome AAA-ATPase subunit RPT6;Proteasome 26S subunit ATPase 5;Proteasome subunit p45;Thyroid hormone receptor-interacting protein 1;p45/SUG;, PF00004;PF17862;PF16450;, GO:0072562;GO:0005737;GO:0031410;GO:0005829;GO:0031597;GO:0070062;GO:0016234;GO:0016020;GO:0031595;GO:0005654;GO:0005634;GO:0098794;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0036402;GO:0017025;GO:0031531;GO:0008134;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0050804;GO:0090090;GO:0010972;GO:0043069;GO:0045892;GO:0038061;GO:0090263;GO:0090261;GO:0045899;GO:0045893;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0006357;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:blood microparticle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:inclusion body; C:membrane; C:nuclear proteasome complex; C:nucleoplasm; C:nucleus; C:postsynapse; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:TBP-class protein binding; F:thyrotropin-releasing hormone receptor binding; F:transcription factor binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of programmed cell death; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of inclusion body assembly; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P62195 A8K3Z3 A8K763 O35051 O43208 P47210 P52915 P52916,26S proteasome regulatory subunit 8,26S proteasome AAA-ATPase subunit RPT6;Proteasome 26S subunit ATPase 5;Proteasome subunit p45;Thyroid hormone receptor-interacting protein 1;p45/SUG;, PF00004;PF17862;PF16450;, GO:0072562;GO:0005737;GO:0031410;GO:0005829;GO:0031597;GO:0070062;GO:0016234;GO:0016020;GO:0031595;GO:0005654;GO:0005634;GO:0098794;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0036402;GO:0017025;GO:0031531;GO:0008134;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0050804;GO:0090090;GO:0010972;GO:0043069;GO:0045892;GO:0038061;GO:0090263;GO:0090261;GO:0045899;GO:0045893;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0006357;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:blood microparticle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:inclusion body; C:membrane; C:nuclear proteasome complex; C:nucleoplasm; C:nucleus; C:postsynapse; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:TBP-class protein binding; F:thyrotropin-releasing hormone receptor binding; F:transcription factor binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of programmed cell death; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of inclusion body assembly; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P62195 A8K3Z3 A8K763 O35051 O43208 P47210 P52915 P52916,26S proteasome regulatory subunit 8,26S proteasome AAA-ATPase subunit RPT6;Proteasome 26S subunit ATPase 5;Proteasome subunit p45;Thyroid hormone receptor-interacting protein 1;p45/SUG;, PF00004;PF17862;PF16450;, GO:0072562;GO:0005737;GO:0031410;GO:0005829;GO:0031597;GO:0070062;GO:0016234;GO:0016020;GO:0031595;GO:0005654;GO:0005634;GO:0098794;GO:0022624;GO:0000502;GO:0008540;GO:0005524;GO:0016887;GO:0036402;GO:0017025;GO:0031531;GO:0008134;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0050804;GO:0090090;GO:0010972;GO:0043069;GO:0045892;GO:0038061;GO:0090263;GO:0090261;GO:0045899;GO:0045893;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0006357;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:blood microparticle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:cytosolic proteasome complex; C:extracellular exosome; C:inclusion body; C:membrane; C:nuclear proteasome complex; C:nucleoplasm; C:nucleus; C:postsynapse; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity; F:TBP-class protein binding; F:thyrotropin-releasing hormone receptor binding; F:transcription factor binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of programmed cell death; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of inclusion body assembly; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold61 indexed_genome mRNA 4098087 4140725 . + . ID=transcript_10629;Q8IY81 B2RCA5 D3DU22 Q8N3A3 Q8WXX1 Q9BWM4 Q9NXT6,pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 {ECO:0000255|HAMAP-Rule:MF_03163},Protein ftsJ homolog 3 {ECO:0000255|HAMAP-Rule:MF_03163};Putative rRNA methyltransferase 3 {ECO:0000255|HAMAP-Rule:MF_03163};, PF11861;PF01728;PF07780;, GO:0005694;GO:0005730;GO:0005654;GO:0030687;GO:0030688;GO:0062105;GO:0003723;GO:0008173;GO:0016435;GO:0008650;GO:0000453;GO:0000466;GO:0000463;GO:0001510;GO:0031167;, C:chromosome; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor; C:preribosome, small subunit precursor;, F:RNA 2'-O-methyltransferase activity; F:RNA binding; F:RNA methyltransferase activity; F:rRNA (guanine) methyltransferase activity; F:rRNA (uridine-2'-O-)-methyltransferase activity;, P:enzyme-directed rRNA 2'-O-methylation; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:RNA methylation; P:rRNA methylation;|Q8IY81 B2RCA5 D3DU22 Q8N3A3 Q8WXX1 Q9BWM4 Q9NXT6,pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 {ECO:0000255|HAMAP-Rule:MF_03163},Protein ftsJ homolog 3 {ECO:0000255|HAMAP-Rule:MF_03163};Putative rRNA methyltransferase 3 {ECO:0000255|HAMAP-Rule:MF_03163};, PF11861;PF01728;PF07780;, GO:0005694;GO:0005730;GO:0005654;GO:0030687;GO:0030688;GO:0062105;GO:0003723;GO:0008173;GO:0016435;GO:0008650;GO:0000453;GO:0000466;GO:0000463;GO:0001510;GO:0031167;, C:chromosome; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor; C:preribosome, small subunit precursor;, F:RNA 2'-O-methyltransferase activity; F:RNA binding; F:RNA methyltransferase activity; F:rRNA (guanine) methyltransferase activity; F:rRNA (uridine-2'-O-)-methyltransferase activity;, P:enzyme-directed rRNA 2'-O-methylation; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:RNA methylation; P:rRNA methylation;|Q86XP3 A6NML1 A8KA43 O75619 Q68G51 Q96BK1 Q96HR7 Q9Y3V8,ATP-dependent RNA helicase DDX42,DEAD box protein 42;RNA helicase-like protein;RNA helicase-related protein;SF3b DEAD box protein;Splicing factor 3B-associated 125 kDa protein;, PF00270;PF00271;, GO:0015030;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0000398;GO:0008104;GO:0042981;, C:Cajal body; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:protein localization; P:regulation of apoptotic process;|Q86XP3 A6NML1 A8KA43 O75619 Q68G51 Q96BK1 Q96HR7 Q9Y3V8,ATP-dependent RNA helicase DDX42,DEAD box protein 42;RNA helicase-like protein;RNA helicase-related protein;SF3b DEAD box protein;Splicing factor 3B-associated 125 kDa protein;, PF00270;PF00271;, GO:0015030;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0000398;GO:0008104;GO:0042981;, C:Cajal body; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:protein localization; P:regulation of apoptotic process;|Q86XP3 A6NML1 A8KA43 O75619 Q68G51 Q96BK1 Q96HR7 Q9Y3V8,ATP-dependent RNA helicase DDX42,DEAD box protein 42;RNA helicase-like protein;RNA helicase-related protein;SF3b DEAD box protein;Splicing factor 3B-associated 125 kDa protein;, PF00270;PF00271;, GO:0015030;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0000398;GO:0008104;GO:0042981;, C:Cajal body; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:protein localization; P:regulation of apoptotic process;|Q86XP3 A6NML1 A8KA43 O75619 Q68G51 Q96BK1 Q96HR7 Q9Y3V8,ATP-dependent RNA helicase DDX42,DEAD box protein 42;RNA helicase-like protein;RNA helicase-related protein;SF3b DEAD box protein;Splicing factor 3B-associated 125 kDa protein;, PF00270;PF00271;, GO:0015030;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0000398;GO:0008104;GO:0042981;, C:Cajal body; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:protein localization; P:regulation of apoptotic process;|Q86XP3 A6NML1 A8KA43 O75619 Q68G51 Q96BK1 Q96HR7 Q9Y3V8,ATP-dependent RNA helicase DDX42,DEAD box protein 42;RNA helicase-like protein;RNA helicase-related protein;SF3b DEAD box protein;Splicing factor 3B-associated 125 kDa protein;, PF00270;PF00271;, GO:0015030;GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0000398;GO:0008104;GO:0042981;, C:Cajal body; C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:protein localization; P:regulation of apoptotic process; scaffold61 indexed_genome mRNA 4141247 4156237 . + . ID=transcript_10630;Q96A33 B2RAS8 D3DU20 Q96D00 Q96JZ7 Q9H3E4 Q9NRG3,PAT complex subunit CCDC47 {ECO:0000303|PubMed:32814900},Calumin {ECO:0000303|PubMed:25009997, ECO:0000303|PubMed:30401460};Coiled-coil domain-containing protein 47;, PF07946;, GO:0005783;GO:0016021;GO:0016020;GO:0030867;GO:0005509;GO:0003723;GO:0032469;GO:0007029;GO:0006983;GO:0036503;GO:0001649;GO:0009791;GO:0030433;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:rough endoplasmic reticulum membrane;, F:calcium ion binding; F:RNA binding;, P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum organization; P:ER overload response; P:ERAD pathway; P:osteoblast differentiation; P:post-embryonic development; P:ubiquitin-dependent ERAD pathway;|Q96A33 B2RAS8 D3DU20 Q96D00 Q96JZ7 Q9H3E4 Q9NRG3,PAT complex subunit CCDC47 {ECO:0000303|PubMed:32814900},Calumin {ECO:0000303|PubMed:25009997, ECO:0000303|PubMed:30401460};Coiled-coil domain-containing protein 47;, PF07946;, GO:0005783;GO:0016021;GO:0016020;GO:0030867;GO:0005509;GO:0003723;GO:0032469;GO:0007029;GO:0006983;GO:0036503;GO:0001649;GO:0009791;GO:0030433;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:rough endoplasmic reticulum membrane;, F:calcium ion binding; F:RNA binding;, P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum organization; P:ER overload response; P:ERAD pathway; P:osteoblast differentiation; P:post-embryonic development; P:ubiquitin-dependent ERAD pathway;|Q96A33 B2RAS8 D3DU20 Q96D00 Q96JZ7 Q9H3E4 Q9NRG3,PAT complex subunit CCDC47 {ECO:0000303|PubMed:32814900},Calumin {ECO:0000303|PubMed:25009997, ECO:0000303|PubMed:30401460};Coiled-coil domain-containing protein 47;, PF07946;, GO:0005783;GO:0016021;GO:0016020;GO:0030867;GO:0005509;GO:0003723;GO:0032469;GO:0007029;GO:0006983;GO:0036503;GO:0001649;GO:0009791;GO:0030433;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:rough endoplasmic reticulum membrane;, F:calcium ion binding; F:RNA binding;, P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum organization; P:ER overload response; P:ERAD pathway; P:osteoblast differentiation; P:post-embryonic development; P:ubiquitin-dependent ERAD pathway;|Q96A33 B2RAS8 D3DU20 Q96D00 Q96JZ7 Q9H3E4 Q9NRG3,PAT complex subunit CCDC47 {ECO:0000303|PubMed:32814900},Calumin {ECO:0000303|PubMed:25009997, ECO:0000303|PubMed:30401460};Coiled-coil domain-containing protein 47;, PF07946;, GO:0005783;GO:0016021;GO:0016020;GO:0030867;GO:0005509;GO:0003723;GO:0032469;GO:0007029;GO:0006983;GO:0036503;GO:0001649;GO:0009791;GO:0030433;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:rough endoplasmic reticulum membrane;, F:calcium ion binding; F:RNA binding;, P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum organization; P:ER overload response; P:ERAD pathway; P:osteoblast differentiation; P:post-embryonic development; P:ubiquitin-dependent ERAD pathway;|Q96A33 B2RAS8 D3DU20 Q96D00 Q96JZ7 Q9H3E4 Q9NRG3,PAT complex subunit CCDC47 {ECO:0000303|PubMed:32814900},Calumin {ECO:0000303|PubMed:25009997, ECO:0000303|PubMed:30401460};Coiled-coil domain-containing protein 47;, PF07946;, GO:0005783;GO:0016021;GO:0016020;GO:0030867;GO:0005509;GO:0003723;GO:0032469;GO:0007029;GO:0006983;GO:0036503;GO:0001649;GO:0009791;GO:0030433;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:rough endoplasmic reticulum membrane;, F:calcium ion binding; F:RNA binding;, P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum organization; P:ER overload response; P:ERAD pathway; P:osteoblast differentiation; P:post-embryonic development; P:ubiquitin-dependent ERAD pathway;|Q96A33 B2RAS8 D3DU20 Q96D00 Q96JZ7 Q9H3E4 Q9NRG3,PAT complex subunit CCDC47 {ECO:0000303|PubMed:32814900},Calumin {ECO:0000303|PubMed:25009997, ECO:0000303|PubMed:30401460};Coiled-coil domain-containing protein 47;, PF07946;, GO:0005783;GO:0016021;GO:0016020;GO:0030867;GO:0005509;GO:0003723;GO:0032469;GO:0007029;GO:0006983;GO:0036503;GO:0001649;GO:0009791;GO:0030433;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:rough endoplasmic reticulum membrane;, F:calcium ion binding; F:RNA binding;, P:endoplasmic reticulum calcium ion homeostasis; P:endoplasmic reticulum organization; P:ER overload response; P:ERAD pathway; P:osteoblast differentiation; P:post-embryonic development; P:ubiquitin-dependent ERAD pathway; scaffold61 indexed_genome mRNA 4164065 4189094 . + . ID=transcript_10631;Q7RTN6 B4DDE3 B4DW17 J3KTC9 Q5JPI2 Q7Z4K9 Q8NC31 Q8NCF1 Q9H272,STE20-related kinase adapter protein alpha,STE20-related adapter protein;Serologically defined breast cancer antigen NY-BR-96;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0019900;GO:0030295;GO:0043539;GO:0032147;GO:0007050;GO:0006611;GO:0006468;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase binding; F:protein kinase activator activity; F:protein serine/threonine kinase activator activity;, P:activation of protein kinase activity; P:cell cycle arrest; P:protein export from nucleus; P:protein phosphorylation;|Q7RTN6 B4DDE3 B4DW17 J3KTC9 Q5JPI2 Q7Z4K9 Q8NC31 Q8NCF1 Q9H272,STE20-related kinase adapter protein alpha,STE20-related adapter protein;Serologically defined breast cancer antigen NY-BR-96;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0019900;GO:0030295;GO:0043539;GO:0032147;GO:0007050;GO:0006611;GO:0006468;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase binding; F:protein kinase activator activity; F:protein serine/threonine kinase activator activity;, P:activation of protein kinase activity; P:cell cycle arrest; P:protein export from nucleus; P:protein phosphorylation;|Q7RTN6 B4DDE3 B4DW17 J3KTC9 Q5JPI2 Q7Z4K9 Q8NC31 Q8NCF1 Q9H272,STE20-related kinase adapter protein alpha,STE20-related adapter protein;Serologically defined breast cancer antigen NY-BR-96;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0019900;GO:0030295;GO:0043539;GO:0032147;GO:0007050;GO:0006611;GO:0006468;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase binding; F:protein kinase activator activity; F:protein serine/threonine kinase activator activity;, P:activation of protein kinase activity; P:cell cycle arrest; P:protein export from nucleus; P:protein phosphorylation; scaffold61 indexed_genome mRNA 4189139 4192425 . + . ID=transcript_10632;Q7RTN6 B4DDE3 B4DW17 J3KTC9 Q5JPI2 Q7Z4K9 Q8NC31 Q8NCF1 Q9H272,STE20-related kinase adapter protein alpha,STE20-related adapter protein;Serologically defined breast cancer antigen NY-BR-96;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0019900;GO:0030295;GO:0043539;GO:0032147;GO:0007050;GO:0006611;GO:0006468;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase binding; F:protein kinase activator activity; F:protein serine/threonine kinase activator activity;, P:activation of protein kinase activity; P:cell cycle arrest; P:protein export from nucleus; P:protein phosphorylation;|Q7RTN6 B4DDE3 B4DW17 J3KTC9 Q5JPI2 Q7Z4K9 Q8NC31 Q8NCF1 Q9H272,STE20-related kinase adapter protein alpha,STE20-related adapter protein;Serologically defined breast cancer antigen NY-BR-96;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0019900;GO:0030295;GO:0043539;GO:0032147;GO:0007050;GO:0006611;GO:0006468;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:kinase binding; F:protein kinase activator activity; F:protein serine/threonine kinase activator activity;, P:activation of protein kinase activity; P:cell cycle arrest; P:protein export from nucleus; P:protein phosphorylation; scaffold61 indexed_genome mRNA 4198664 4200244 . + . ID=transcript_10633;Q9BT23 D3DU16 Q96S91,LIM domain-containing protein 2 {ECO:0000305},, PF00412;, GO:0005829;GO:0005654;GO:0046872;, C:cytosol; C:nucleoplasm;, F:metal ion binding; scaffold61 indexed_genome mRNA 4201905 4269909 . - . ID=transcript_10634;Q99759 B2RCW2 D3DU15 Q5BKZ6 Q8N3I9,Mitogen-activated protein kinase kinase kinase 3,MAPK/ERK kinase kinase 3;, PF00564;PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0001568;GO:0070498;GO:0035556;GO:0000165;GO:2000773;GO:0090050;GO:0071864;GO:0043123;GO:1900745;GO:0046777;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:blood vessel development; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of cellular senescence; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation;|Q99759 B2RCW2 D3DU15 Q5BKZ6 Q8N3I9,Mitogen-activated protein kinase kinase kinase 3,MAPK/ERK kinase kinase 3;, PF00564;PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0001568;GO:0070498;GO:0035556;GO:0000165;GO:2000773;GO:0090050;GO:0071864;GO:0043123;GO:1900745;GO:0046777;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:blood vessel development; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of cellular senescence; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation;|Q99759 B2RCW2 D3DU15 Q5BKZ6 Q8N3I9,Mitogen-activated protein kinase kinase kinase 3,MAPK/ERK kinase kinase 3;, PF00564;PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0001568;GO:0070498;GO:0035556;GO:0000165;GO:2000773;GO:0090050;GO:0071864;GO:0043123;GO:1900745;GO:0046777;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:blood vessel development; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of cellular senescence; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation;|Q99759 B2RCW2 D3DU15 Q5BKZ6 Q8N3I9,Mitogen-activated protein kinase kinase kinase 3,MAPK/ERK kinase kinase 3;, PF00564;PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0001568;GO:0070498;GO:0035556;GO:0000165;GO:2000773;GO:0090050;GO:0071864;GO:0043123;GO:1900745;GO:0046777;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:blood vessel development; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of cellular senescence; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation;|Q99759 B2RCW2 D3DU15 Q5BKZ6 Q8N3I9,Mitogen-activated protein kinase kinase kinase 3,MAPK/ERK kinase kinase 3;, PF00564;PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0001568;GO:0070498;GO:0035556;GO:0000165;GO:2000773;GO:0090050;GO:0071864;GO:0043123;GO:1900745;GO:0046777;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:blood vessel development; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of cellular senescence; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation;|Q99759 B2RCW2 D3DU15 Q5BKZ6 Q8N3I9,Mitogen-activated protein kinase kinase kinase 3,MAPK/ERK kinase kinase 3;, PF00564;PF00069;, GO:0005829;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0001568;GO:0070498;GO:0035556;GO:0000165;GO:2000773;GO:0090050;GO:0071864;GO:0043123;GO:1900745;GO:0046777;, C:cytosol;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:blood vessel development; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of cellular senescence; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell proliferation in bone marrow; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation; scaffold61 indexed_genome mRNA 4277322 4281845 . - . ID=transcript_10635;Q9BSH4 B2RD21 Q8N3N6 Q9UI60,Translational activator of cytochrome c oxidase 1,Coiled-coil domain-containing protein 44;Translational activator of mitochondrially-encoded cytochrome c oxidase I;, PF01709;, GO:0005739;GO:0097177;GO:0003729;GO:0019843;GO:0033617;GO:0061743;GO:1904959;GO:0070129;, C:mitochondrion;, F:mitochondrial ribosome binding; F:mRNA binding; F:rRNA binding;, P:mitochondrial cytochrome c oxidase assembly; P:motor learning; P:regulation of cytochrome-c oxidase activity; P:regulation of mitochondrial translation; scaffold61 indexed_genome mRNA 4287975 4313196 . - . ID=transcript_10636;P61962 B4E039 D3DU14 O15491 Q9DAE4,DDB1- and CUL4-associated factor 7,WD repeat-containing protein 68;WD repeat-containing protein An11 homolog;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0030674;GO:0007275;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:protein-macromolecule adaptor activity;, P:multicellular organism development; P:post-translational protein modification; P:protein ubiquitination;|P61962 B4E039 D3DU14 O15491 Q9DAE4,DDB1- and CUL4-associated factor 7,WD repeat-containing protein 68;WD repeat-containing protein An11 homolog;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0030674;GO:0007275;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:protein-macromolecule adaptor activity;, P:multicellular organism development; P:post-translational protein modification; P:protein ubiquitination;|P61962 B4E039 D3DU14 O15491 Q9DAE4,DDB1- and CUL4-associated factor 7,WD repeat-containing protein 68;WD repeat-containing protein An11 homolog;, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0030674;GO:0007275;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:protein-macromolecule adaptor activity;, P:multicellular organism development; P:post-translational protein modification; P:protein ubiquitination; scaffold61 indexed_genome mRNA 4362322 4376139 . - . ID=transcript_10637;P12821 B0LPF0 B4DXI3 E7EU16 P22966 Q53YX9 Q59GY8 Q7M4L4,Angiotensin-converting enzyme,Dipeptidyl carboxypeptidase I;Kininase II;, PF01401;, GO:0005768;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0016021;GO:0005764;GO:0005886;GO:0003779;GO:0031711;GO:0004180;GO:0031404;GO:0004175;GO:0008238;GO:0070573;GO:0008237;GO:0051019;GO:0031434;GO:0008241;GO:0008240;GO:0008270;GO:0050435;GO:0002003;GO:0002474;GO:0050482;GO:0097746;GO:0001974;GO:0071838;GO:0060047;GO:0060218;GO:0042447;GO:0001822;GO:0032943;GO:1903597;GO:0010629;GO:0032091;GO:0002446;GO:0043171;GO:2000170;GO:1900086;GO:0032092;GO:0061098;GO:0003084;GO:0010608;GO:0006508;GO:0060177;GO:0008217;GO:1902033;GO:0002019;GO:0014910;GO:0003081;GO:0019229;GO:0007283;, C:endosome; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integral component of membrane; C:lysosome; C:plasma membrane;, F:actin binding; F:bradykinin receptor binding; F:carboxypeptidase activity; F:chloride ion binding; F:endopeptidase activity; F:exopeptidase activity; F:metallodipeptidase activity; F:metallopeptidase activity; F:mitogen-activated protein kinase binding; F:mitogen-activated protein kinase kinase binding; F:peptidyl-dipeptidase activity; F:tripeptidyl-peptidase activity; F:zinc ion binding;, P:amyloid-beta metabolic process; P:angiotensin maturation; P:antigen processing and presentation of peptide antigen via MHC class I; P:arachidonic acid secretion; P:blood vessel diameter maintenance; P:blood vessel remodeling; P:cell proliferation in bone marrow; P:heart contraction; P:hematopoietic stem cell differentiation; P:hormone catabolic process; P:kidney development; P:mononuclear cell proliferation; P:negative regulation of gap junction assembly; P:negative regulation of gene expression; P:negative regulation of protein binding; P:neutrophil mediated immunity; P:peptide catabolic process; P:positive regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of protein binding; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of systemic arterial blood pressure; P:posttranscriptional regulation of gene expression; P:proteolysis; P:regulation of angiotensin metabolic process; P:regulation of blood pressure; P:regulation of hematopoietic stem cell proliferation; P:regulation of renal output by angiotensin; P:regulation of smooth muscle cell migration; P:regulation of systemic arterial blood pressure by renin-angiotensin; P:regulation of vasoconstriction; P:spermatogenesis;|P12821 B0LPF0 B4DXI3 E7EU16 P22966 Q53YX9 Q59GY8 Q7M4L4,Angiotensin-converting enzyme,Dipeptidyl carboxypeptidase I;Kininase II;, PF01401;, GO:0005768;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0016021;GO:0005764;GO:0005886;GO:0003779;GO:0031711;GO:0004180;GO:0031404;GO:0004175;GO:0008238;GO:0070573;GO:0008237;GO:0051019;GO:0031434;GO:0008241;GO:0008240;GO:0008270;GO:0050435;GO:0002003;GO:0002474;GO:0050482;GO:0097746;GO:0001974;GO:0071838;GO:0060047;GO:0060218;GO:0042447;GO:0001822;GO:0032943;GO:1903597;GO:0010629;GO:0032091;GO:0002446;GO:0043171;GO:2000170;GO:1900086;GO:0032092;GO:0061098;GO:0003084;GO:0010608;GO:0006508;GO:0060177;GO:0008217;GO:1902033;GO:0002019;GO:0014910;GO:0003081;GO:0019229;GO:0007283;, C:endosome; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integral component of membrane; C:lysosome; C:plasma membrane;, F:actin binding; F:bradykinin receptor binding; F:carboxypeptidase activity; F:chloride ion binding; F:endopeptidase activity; F:exopeptidase activity; F:metallodipeptidase activity; F:metallopeptidase activity; F:mitogen-activated protein kinase binding; F:mitogen-activated protein kinase kinase binding; F:peptidyl-dipeptidase activity; F:tripeptidyl-peptidase activity; F:zinc ion binding;, P:amyloid-beta metabolic process; P:angiotensin maturation; P:antigen processing and presentation of peptide antigen via MHC class I; P:arachidonic acid secretion; P:blood vessel diameter maintenance; P:blood vessel remodeling; P:cell proliferation in bone marrow; P:heart contraction; P:hematopoietic stem cell differentiation; P:hormone catabolic process; P:kidney development; P:mononuclear cell proliferation; P:negative regulation of gap junction assembly; P:negative regulation of gene expression; P:negative regulation of protein binding; P:neutrophil mediated immunity; P:peptide catabolic process; P:positive regulation of peptidyl-cysteine S-nitrosylation; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of protein binding; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of systemic arterial blood pressure; P:posttranscriptional regulation of gene expression; P:proteolysis; P:regulation of angiotensin metabolic process; P:regulation of blood pressure; P:regulation of hematopoietic stem cell proliferation; P:regulation of renal output by angiotensin; P:regulation of smooth muscle cell migration; P:regulation of systemic arterial blood pressure by renin-angiotensin; P:regulation of vasoconstriction; P:spermatogenesis; scaffold61 indexed_genome mRNA 4393494 4394160 . + . ID=transcript_10638;P46778 Q16699,60S ribosomal protein L21,Large ribosomal subunit protein eL21 {ECO:0000303|PubMed:24524803};, PF01157;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold61 indexed_genome mRNA 4397584 4405936 . - . ID=transcript_10639;P49447 B2RE96 B7Z775 D3DU11 Q5BJG9 Q9BU05 Q9BWR9,Transmembrane ascorbate-dependent reductase CYB561 {ECO:0000305},Cytochrome b-561;Cytochrome b561;, PF03188;, GO:0016021;GO:0005765;GO:0030658;GO:0000293;GO:0046872;GO:0016491;GO:0140571;GO:0006879;GO:0022900;GO:0033215;, C:integral component of membrane; C:lysosomal membrane; C:transport vesicle membrane;, F:ferric-chelate reductase activity; F:metal ion binding; F:oxidoreductase activity; F:transmembrane ascorbate ferrireductase activity;, P:cellular iron ion homeostasis; P:electron transport chain; P:reductive iron assimilation; scaffold61 indexed_genome mRNA 4419051 4422116 . + . ID=transcript_10640;P49447 B2RE96 B7Z775 D3DU11 Q5BJG9 Q9BU05 Q9BWR9,Transmembrane ascorbate-dependent reductase CYB561 {ECO:0000305},Cytochrome b-561;Cytochrome b561;, PF03188;, GO:0016021;GO:0005765;GO:0030658;GO:0000293;GO:0046872;GO:0016491;GO:0140571;GO:0006879;GO:0022900;GO:0033215;, C:integral component of membrane; C:lysosomal membrane; C:transport vesicle membrane;, F:ferric-chelate reductase activity; F:metal ion binding; F:oxidoreductase activity; F:transmembrane ascorbate ferrireductase activity;, P:cellular iron ion homeostasis; P:electron transport chain; P:reductive iron assimilation; scaffold61 indexed_genome mRNA 4430392 4432762 . - . ID=transcript_10641;Q9HCD6 Q9HAC3 Q9NW88 Q9NXY9 Q9ULS2,Protein TANC2,Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2;, PF00023;PF12796;PF13181;, GO:0030424;GO:0043197;GO:0099519;GO:0001701;GO:0060998;GO:0061001;, C:axon; C:dendritic spine;, , P:dense core granule cytoskeletal transport; P:in utero embryonic development; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; scaffold61 indexed_genome mRNA 4432786 4448194 . - . ID=transcript_10642;Q9HCD6 Q9HAC3 Q9NW88 Q9NXY9 Q9ULS2,Protein TANC2,Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2;, PF00023;PF12796;PF13181;, GO:0030424;GO:0043197;GO:0099519;GO:0001701;GO:0060998;GO:0061001;, C:axon; C:dendritic spine;, , P:dense core granule cytoskeletal transport; P:in utero embryonic development; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; scaffold61 indexed_genome mRNA 4455621 4483409 . - . ID=transcript_10643;Q9HCD6 Q9HAC3 Q9NW88 Q9NXY9 Q9ULS2,Protein TANC2,Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2;, PF00023;PF12796;PF13181;, GO:0030424;GO:0043197;GO:0099519;GO:0001701;GO:0060998;GO:0061001;, C:axon; C:dendritic spine;, , P:dense core granule cytoskeletal transport; P:in utero embryonic development; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; scaffold61 indexed_genome mRNA 4517661 4570857 . - . ID=transcript_10644;Q9HCD6 Q9HAC3 Q9NW88 Q9NXY9 Q9ULS2,Protein TANC2,Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2;, PF00023;PF12796;PF13181;, GO:0030424;GO:0043197;GO:0099519;GO:0001701;GO:0060998;GO:0061001;, C:axon; C:dendritic spine;, , P:dense core granule cytoskeletal transport; P:in utero embryonic development; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; scaffold61 indexed_genome mRNA 5036179 5036811 . + . ID=transcript_10645;Q8NA82 D3DU09 Q8IYS7 Q8N7Z7,Probable E3 ubiquitin-protein ligase MARCHF10,Membrane-associated RING finger protein 10;Membrane-associated RING-CH protein X;RING finger protein 190;RING-type E3 ubiquitin transferase MARCHF10 {ECO:0000305};, PF12906;, GO:0016740;GO:0008270;GO:0016567;, , F:transferase activity; F:zinc ion binding;, P:protein ubiquitination; scaffold61 indexed_genome mRNA 5070205 5129597 . - . ID=transcript_10646;Q9UBG0 A6H8K4 D3DU08 Q7LGE7 Q9Y5P9,C-type mannose receptor 2,C-type lectin domain family 13 member E;Endocytic receptor 180;Macrophage mannose receptor 2;Urokinase-type plasminogen activator receptor-associated protein;, PF00040;PF00059;, GO:0005925;GO:0016021;GO:0016020;GO:0030246;GO:0005518;GO:0038023;GO:0030574;GO:0006897;GO:0001649;, C:focal adhesion; C:integral component of membrane; C:membrane;, F:carbohydrate binding; F:collagen binding; F:signaling receptor activity;, P:collagen catabolic process; P:endocytosis; P:osteoblast differentiation;|Q9UBG0 A6H8K4 D3DU08 Q7LGE7 Q9Y5P9,C-type mannose receptor 2,C-type lectin domain family 13 member E;Endocytic receptor 180;Macrophage mannose receptor 2;Urokinase-type plasminogen activator receptor-associated protein;, PF00040;PF00059;, GO:0005925;GO:0016021;GO:0016020;GO:0030246;GO:0005518;GO:0038023;GO:0030574;GO:0006897;GO:0001649;, C:focal adhesion; C:integral component of membrane; C:membrane;, F:carbohydrate binding; F:collagen binding; F:signaling receptor activity;, P:collagen catabolic process; P:endocytosis; P:osteoblast differentiation; scaffold61 indexed_genome mRNA 5138113 5214304 . - . ID=transcript_10647;Q86UE8 D3DU07 Q9UKI7 Q9Y4F7,Serine/threonine-protein kinase tousled-like 2,HsHPK;PKU-alpha;Tousled-like kinase 2;, PF00069;, GO:0005882;GO:0005634;GO:0048471;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0006974;GO:0071480;GO:0006325;GO:0007059;GO:0035556;GO:0010507;GO:0032435;GO:0018105;GO:0006468;GO:0001672;, C:intermediate filament; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:chromatin organization; P:chromosome segregation; P:intracellular signal transduction; P:negative regulation of autophagy; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of chromatin assembly or disassembly; scaffold61 indexed_genome mRNA 5295526 5304037 . - . ID=transcript_10648;Q96IZ6 A6NNC4 Q9H9G9 Q9NUI8 Q9P0B5,tRNA N(3)-methylcytidine methyltransferase METTL2A {ECO:0000305},Methyltransferase-like protein 2A {ECO:0000305};, , GO:0016427;GO:0052735;GO:0030488;, , F:tRNA (cytosine) methyltransferase activity; F:tRNA (cytosine-3-)-methyltransferase activity;, P:tRNA methylation;|Q6P1Q9 B4DZ68 Q0IJ54 Q3B7J1,tRNA N(3)-methylcytidine methyltransferase METTL2B {ECO:0000305},Methyltransferase-like protein 2B {ECO:0000305};, , GO:0016427;GO:0052735;GO:0030488;, , F:tRNA (cytosine) methyltransferase activity; F:tRNA (cytosine-3-)-methyltransferase activity;, P:tRNA methylation;|Q6P1Q9 B4DZ68 Q0IJ54 Q3B7J1,tRNA N(3)-methylcytidine methyltransferase METTL2B {ECO:0000305},Methyltransferase-like protein 2B {ECO:0000305};, , GO:0016427;GO:0052735;GO:0030488;, , F:tRNA (cytosine) methyltransferase activity; F:tRNA (cytosine-3-)-methyltransferase activity;, P:tRNA methylation;|Q96IZ6 A6NNC4 Q9H9G9 Q9NUI8 Q9P0B5,tRNA N(3)-methylcytidine methyltransferase METTL2A {ECO:0000305},Methyltransferase-like protein 2A {ECO:0000305};, , GO:0016427;GO:0052735;GO:0030488;, , F:tRNA (cytosine) methyltransferase activity; F:tRNA (cytosine-3-)-methyltransferase activity;, P:tRNA methylation;|Q6P1Q9 B4DZ68 Q0IJ54 Q3B7J1,tRNA N(3)-methylcytidine methyltransferase METTL2B {ECO:0000305},Methyltransferase-like protein 2B {ECO:0000305};, , GO:0016427;GO:0052735;GO:0030488;, , F:tRNA (cytosine) methyltransferase activity; F:tRNA (cytosine-3-)-methyltransferase activity;, P:tRNA methylation; scaffold61 indexed_genome mRNA 5762508 5785216 . - . ID=transcript_10649;P05106 A0PJW2 D3DXJ8 O15495 Q12806 Q13413 Q14648 Q16499,Integrin beta-3 {ECO:0000305},Platelet membrane glycoprotein IIIa {ECO:0000305};, PF07974;PF18372;PF08725;PF07965;PF00362;PF17205;, GO:0035868;GO:0035867;GO:0035866;GO:0071062;GO:0009986;GO:0005911;GO:0070062;GO:0031527;GO:0005925;GO:0098978;GO:0005887;GO:0034683;GO:0008305;GO:0031258;GO:0042470;GO:0031528;GO:0005654;GO:0005634;GO:0005886;GO:0031092;GO:0045211;GO:0032991;GO:0043235;GO:0032587;GO:0045202;GO:0050839;GO:0015026;GO:0019899;GO:0050840;GO:0001968;GO:0042802;GO:0005178;GO:0005161;GO:0002020;GO:0003756;GO:0043184;GO:0001618;GO:0032147;GO:0060055;GO:0038027;GO:0043277;GO:0007596;GO:0007155;GO:0033627;GO:0016477;GO:0007160;GO:0031589;GO:0030198;GO:0034113;GO:0007229;GO:0050900;GO:0048333;GO:0050919;GO:0010888;GO:0032369;GO:0050748;GO:1905598;GO:0010745;GO:0030168;GO:0070527;GO:0002576;GO:0010595;GO:0001938;GO:0050731;GO:0001934;GO:0030949;GO:0045124;GO:0099149;GO:0032880;GO:0051611;GO:0014909;GO:0034446;GO:0035295;GO:0048010;GO:0046718;GO:0042060;, C:alphav-beta3 integrin-HMGB1 complex; C:alphav-beta3 integrin-IGF-1-IGF1R complex; C:alphav-beta3 integrin-PKCalpha complex; C:alphav-beta3 integrin-vitronectin complex; C:cell surface; C:cell-cell junction; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:glutamatergic synapse; C:integral component of plasma membrane; C:integrin alphav-beta3 complex; C:integrin complex; C:lamellipodium membrane; C:melanosome; C:microvillus membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:platelet alpha granule membrane; C:postsynaptic membrane; C:protein-containing complex; C:receptor complex; C:ruffle membrane; C:synapse;, F:cell adhesion molecule binding; F:coreceptor activity; F:enzyme binding; F:extracellular matrix binding; F:fibronectin binding; F:identical protein binding; F:integrin binding; F:platelet-derived growth factor receptor binding; F:protease binding; F:protein disulfide isomerase activity; F:vascular endothelial growth factor receptor 2 binding; F:virus receptor activity;, P:activation of protein kinase activity; P:angiogenesis involved in wound healing; P:apolipoprotein A-I-mediated signaling pathway; P:apoptotic cell clearance; P:blood coagulation; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:cell-substrate adhesion; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte migration; P:mesodermal cell differentiation; P:negative chemotaxis; P:negative regulation of lipid storage; P:negative regulation of lipid transport; P:negative regulation of lipoprotein metabolic process; P:negative regulation of low-density lipoprotein receptor activity; P:negative regulation of macrophage derived foam cell differentiation; P:platelet activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:regulation of bone resorption; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of protein localization; P:regulation of serotonin uptake; P:smooth muscle cell migration; P:substrate adhesion-dependent cell spreading; P:tube development; P:vascular endothelial growth factor receptor signaling pathway; P:viral entry into host cell; P:wound healing; scaffold61 indexed_genome mRNA 5877543 5917789 . + . ID=transcript_10650;P30260 G3V1C4 Q16349 Q96F35,Cell division cycle protein 27 homolog,Anaphase-promoting complex subunit 3;CDC27 homolog;H-NUC;, PF00515;PF13181;, GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold61 indexed_genome mRNA 5918306 5923518 . + . ID=transcript_10651;P30260 G3V1C4 Q16349 Q96F35,Cell division cycle protein 27 homolog,Anaphase-promoting complex subunit 3;CDC27 homolog;H-NUC;, PF00515;PF13181;, GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|P30260 G3V1C4 Q16349 Q96F35,Cell division cycle protein 27 homolog,Anaphase-promoting complex subunit 3;CDC27 homolog;H-NUC;, PF00515;PF13181;, GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|P30260 G3V1C4 Q16349 Q96F35,Cell division cycle protein 27 homolog,Anaphase-promoting complex subunit 3;CDC27 homolog;H-NUC;, PF00515;PF13181;, GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|P30260 G3V1C4 Q16349 Q96F35,Cell division cycle protein 27 homolog,Anaphase-promoting complex subunit 3;CDC27 homolog;H-NUC;, PF00515;PF13181;, GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold61 indexed_genome mRNA 5924245 5926001 . + . ID=transcript_10652;P30260 G3V1C4 Q16349 Q96F35,Cell division cycle protein 27 homolog,Anaphase-promoting complex subunit 3;CDC27 homolog;H-NUC;, PF00515;PF13181;, GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold61 indexed_genome mRNA 5995389 6122532 . + . ID=transcript_10653;Q9ULF3,KAT8 regulatory NSL complex subunit 1,MLL1/MLL complex subunit KANSL1;MSL1 homolog 1;NSL complex protein NSL1;Non-specific lethal 1 homolog;, PF15275;, GO:0000777;GO:0000123;GO:0071339;GO:0044545;GO:0005654;GO:0005634;GO:0035035;GO:0043984;GO:0043981;GO:0043982;, C:condensed chromosome kinetochore; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9ULF3,KAT8 regulatory NSL complex subunit 1,MLL1/MLL complex subunit KANSL1;MSL1 homolog 1;NSL complex protein NSL1;Non-specific lethal 1 homolog;, PF15275;, GO:0000777;GO:0000123;GO:0071339;GO:0044545;GO:0005654;GO:0005634;GO:0035035;GO:0043984;GO:0043981;GO:0043982;, C:condensed chromosome kinetochore; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9ULF3,KAT8 regulatory NSL complex subunit 1,MLL1/MLL complex subunit KANSL1;MSL1 homolog 1;NSL complex protein NSL1;Non-specific lethal 1 homolog;, PF15275;, GO:0000777;GO:0000123;GO:0071339;GO:0044545;GO:0005654;GO:0005634;GO:0035035;GO:0043984;GO:0043981;GO:0043982;, C:condensed chromosome kinetochore; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9ULF3,KAT8 regulatory NSL complex subunit 1,MLL1/MLL complex subunit KANSL1;MSL1 homolog 1;NSL complex protein NSL1;Non-specific lethal 1 homolog;, PF15275;, GO:0000777;GO:0000123;GO:0071339;GO:0044545;GO:0005654;GO:0005634;GO:0035035;GO:0043984;GO:0043981;GO:0043982;, C:condensed chromosome kinetochore; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9ULF3,KAT8 regulatory NSL complex subunit 1,MLL1/MLL complex subunit KANSL1;MSL1 homolog 1;NSL complex protein NSL1;Non-specific lethal 1 homolog;, PF15275;, GO:0000777;GO:0000123;GO:0071339;GO:0044545;GO:0005654;GO:0005634;GO:0035035;GO:0043984;GO:0043981;GO:0043982;, C:condensed chromosome kinetochore; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9ULF3,KAT8 regulatory NSL complex subunit 1,MLL1/MLL complex subunit KANSL1;MSL1 homolog 1;NSL complex protein NSL1;Non-specific lethal 1 homolog;, PF15275;, GO:0000777;GO:0000123;GO:0071339;GO:0044545;GO:0005654;GO:0005634;GO:0035035;GO:0043984;GO:0043981;GO:0043982;, C:condensed chromosome kinetochore; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9ULF3,KAT8 regulatory NSL complex subunit 1,MLL1/MLL complex subunit KANSL1;MSL1 homolog 1;NSL complex protein NSL1;Non-specific lethal 1 homolog;, PF15275;, GO:0000777;GO:0000123;GO:0071339;GO:0044545;GO:0005654;GO:0005634;GO:0035035;GO:0043984;GO:0043981;GO:0043982;, C:condensed chromosome kinetochore; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;|Q9ULF3,KAT8 regulatory NSL complex subunit 1,MLL1/MLL complex subunit KANSL1;MSL1 homolog 1;NSL complex protein NSL1;Non-specific lethal 1 homolog;, PF15275;, GO:0000777;GO:0000123;GO:0071339;GO:0044545;GO:0005654;GO:0005634;GO:0035035;GO:0043984;GO:0043981;GO:0043982;, C:condensed chromosome kinetochore; C:histone acetyltransferase complex; C:MLL1 complex; C:NSL complex; C:nucleoplasm; C:nucleus;, F:histone acetyltransferase binding;, P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; scaffold61 indexed_genome mRNA 6127786 6139156 . - . ID=transcript_10654;Q5XWF0 Q6QT54 Q9UDJ3 Q9UMH0 Q9UQ96,Microtubule-associated protein tau {ECO:0000305},Neurofibrillary tangle protein;Paired helical filament-tau;, PF00418;, GO:0030673;GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0036464;GO:0005829;GO:0030425;GO:0043197;GO:0005576;GO:0097386;GO:0030426;GO:0044304;GO:0045121;GO:0005874;GO:0015630;GO:0005739;GO:0097418;GO:0043005;GO:0043025;GO:0034399;GO:0016607;GO:0005634;GO:0005886;GO:0036477;GO:0045298;GO:0003779;GO:0034185;GO:0051087;GO:0003677;GO:0003690;GO:0034452;GO:0019899;GO:0099077;GO:0051879;GO:0042802;GO:0071813;GO:0008017;GO:0099609;GO:0003680;GO:0035091;GO:1902936;GO:0019901;GO:0051721;GO:0030674;GO:0003723;GO:0043565;GO:0017124;GO:0003697;GO:0006919;GO:1990000;GO:0048143;GO:0061564;GO:0098930;GO:0019896;GO:0007267;GO:1990416;GO:0034605;GO:1990090;GO:0034614;GO:0021954;GO:0031122;GO:0048699;GO:0006475;GO:0048312;GO:0007611;GO:0007613;GO:0001774;GO:0000226;GO:0046785;GO:1903748;GO:0010629;GO:0033673;GO:0090258;GO:0010917;GO:1904428;GO:1902988;GO:0031175;GO:0072386;GO:0045773;GO:1903829;GO:1905689;GO:0031116;GO:1901216;GO:1902474;GO:0032930;GO:0051260;GO:0051258;GO:0010506;GO:0050848;GO:1900034;GO:0033044;GO:1900452;GO:0070507;GO:0031113;GO:0031110;GO:0090140;GO:2001020;GO:0048167;GO:0010288;GO:0016072;GO:0034063;GO:0097435;GO:0007416;GO:0050808;, C:axolemma; C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendrite; C:dendritic spine; C:extracellular region; C:glial cell projection; C:growth cone; C:main axon; C:membrane raft; C:microtubule; C:microtubule cytoskeleton; C:mitochondrion; C:neurofibrillary tangle; C:neuron projection; C:neuronal cell body; C:nuclear periphery; C:nuclear speck; C:nucleus; C:plasma membrane; C:somatodendritic compartment; C:tubulin complex;, F:actin binding; F:apolipoprotein binding; F:chaperone binding; F:DNA binding; F:double-stranded DNA binding; F:dynactin binding; F:enzyme binding; F:histone-dependent DNA binding; F:Hsp90 protein binding; F:identical protein binding; F:lipoprotein particle binding; F:microtubule binding; F:microtubule lateral binding; F:minor groove of adenine-thymine-rich DNA binding; F:phosphatidylinositol binding; F:phosphatidylinositol bisphosphate binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:sequence-specific DNA binding; F:SH3 domain binding; F:single-stranded DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:amyloid fibril formation; P:astrocyte activation; P:axon development; P:axonal transport; P:axonal transport of mitochondrion; P:cell-cell signaling; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to heat; P:cellular response to nerve growth factor stimulus; P:cellular response to reactive oxygen species; P:central nervous system neuron development; P:cytoplasmic microtubule organization; P:generation of neurons; P:internal protein amino acid acetylation; P:intracellular distribution of mitochondria; P:learning or memory; P:memory; P:microglial cell activation; P:microtubule cytoskeleton organization; P:microtubule polymerization; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of gene expression; P:negative regulation of kinase activity; P:negative regulation of mitochondrial fission; P:negative regulation of mitochondrial membrane potential; P:negative regulation of tubulin deacetylation; P:neurofibrillary tangle assembly; P:neuron projection development; P:plus-end-directed organelle transport along microtubule; P:positive regulation of axon extension; P:positive regulation of cellular protein localization; P:positive regulation of diacylglycerol kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of neuron death; P:positive regulation of protein localization to synapse; P:positive regulation of superoxide anion generation; P:protein homooligomerization; P:protein polymerization; P:regulation of autophagy; P:regulation of calcium-mediated signaling; P:regulation of cellular response to heat; P:regulation of chromosome organization; P:regulation of long-term synaptic depression; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of mitochondrial fission; P:regulation of response to DNA damage stimulus; P:regulation of synaptic plasticity; P:response to lead ion; P:rRNA metabolic process; P:stress granule assembly; P:supramolecular fiber organization; P:synapse assembly; P:synapse organization;|Q5XWF0 Q6QT54 Q9UDJ3 Q9UMH0 Q9UQ96,Microtubule-associated protein tau {ECO:0000305},Neurofibrillary tangle protein;Paired helical filament-tau;, PF00418;, GO:0030673;GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0036464;GO:0005829;GO:0030425;GO:0043197;GO:0005576;GO:0097386;GO:0030426;GO:0044304;GO:0045121;GO:0005874;GO:0015630;GO:0005739;GO:0097418;GO:0043005;GO:0043025;GO:0034399;GO:0016607;GO:0005634;GO:0005886;GO:0036477;GO:0045298;GO:0003779;GO:0034185;GO:0051087;GO:0003677;GO:0003690;GO:0034452;GO:0019899;GO:0099077;GO:0051879;GO:0042802;GO:0071813;GO:0008017;GO:0099609;GO:0003680;GO:0035091;GO:1902936;GO:0019901;GO:0051721;GO:0030674;GO:0003723;GO:0043565;GO:0017124;GO:0003697;GO:0006919;GO:1990000;GO:0048143;GO:0061564;GO:0098930;GO:0019896;GO:0007267;GO:1990416;GO:0034605;GO:1990090;GO:0034614;GO:0021954;GO:0031122;GO:0048699;GO:0006475;GO:0048312;GO:0007611;GO:0007613;GO:0001774;GO:0000226;GO:0046785;GO:1903748;GO:0010629;GO:0033673;GO:0090258;GO:0010917;GO:1904428;GO:1902988;GO:0031175;GO:0072386;GO:0045773;GO:1903829;GO:1905689;GO:0031116;GO:1901216;GO:1902474;GO:0032930;GO:0051260;GO:0051258;GO:0010506;GO:0050848;GO:1900034;GO:0033044;GO:1900452;GO:0070507;GO:0031113;GO:0031110;GO:0090140;GO:2001020;GO:0048167;GO:0010288;GO:0016072;GO:0034063;GO:0097435;GO:0007416;GO:0050808;, C:axolemma; C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendrite; C:dendritic spine; C:extracellular region; C:glial cell projection; C:growth cone; C:main axon; C:membrane raft; C:microtubule; C:microtubule cytoskeleton; C:mitochondrion; C:neurofibrillary tangle; C:neuron projection; C:neuronal cell body; C:nuclear periphery; C:nuclear speck; C:nucleus; C:plasma membrane; C:somatodendritic compartment; C:tubulin complex;, F:actin binding; F:apolipoprotein binding; F:chaperone binding; F:DNA binding; F:double-stranded DNA binding; F:dynactin binding; F:enzyme binding; F:histone-dependent DNA binding; F:Hsp90 protein binding; F:identical protein binding; F:lipoprotein particle binding; F:microtubule binding; F:microtubule lateral binding; F:minor groove of adenine-thymine-rich DNA binding; F:phosphatidylinositol binding; F:phosphatidylinositol bisphosphate binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:sequence-specific DNA binding; F:SH3 domain binding; F:single-stranded DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:amyloid fibril formation; P:astrocyte activation; P:axon development; P:axonal transport; P:axonal transport of mitochondrion; P:cell-cell signaling; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to heat; P:cellular response to nerve growth factor stimulus; P:cellular response to reactive oxygen species; P:central nervous system neuron development; P:cytoplasmic microtubule organization; P:generation of neurons; P:internal protein amino acid acetylation; P:intracellular distribution of mitochondria; P:learning or memory; P:memory; P:microglial cell activation; P:microtubule cytoskeleton organization; P:microtubule polymerization; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of gene expression; P:negative regulation of kinase activity; P:negative regulation of mitochondrial fission; P:negative regulation of mitochondrial membrane potential; P:negative regulation of tubulin deacetylation; P:neurofibrillary tangle assembly; P:neuron projection development; P:plus-end-directed organelle transport along microtubule; P:positive regulation of axon extension; P:positive regulation of cellular protein localization; P:positive regulation of diacylglycerol kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of neuron death; P:positive regulation of protein localization to synapse; P:positive regulation of superoxide anion generation; P:protein homooligomerization; P:protein polymerization; P:regulation of autophagy; P:regulation of calcium-mediated signaling; P:regulation of cellular response to heat; P:regulation of chromosome organization; P:regulation of long-term synaptic depression; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of mitochondrial fission; P:regulation of response to DNA damage stimulus; P:regulation of synaptic plasticity; P:response to lead ion; P:rRNA metabolic process; P:stress granule assembly; P:supramolecular fiber organization; P:synapse assembly; P:synapse organization;|Q5XWF0 Q6QT54 Q9UDJ3 Q9UMH0 Q9UQ96,Microtubule-associated protein tau {ECO:0000305},Neurofibrillary tangle protein;Paired helical filament-tau;, PF00418;, GO:0030673;GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0036464;GO:0005829;GO:0030425;GO:0043197;GO:0005576;GO:0097386;GO:0030426;GO:0044304;GO:0045121;GO:0005874;GO:0015630;GO:0005739;GO:0097418;GO:0043005;GO:0043025;GO:0034399;GO:0016607;GO:0005634;GO:0005886;GO:0036477;GO:0045298;GO:0003779;GO:0034185;GO:0051087;GO:0003677;GO:0003690;GO:0034452;GO:0019899;GO:0099077;GO:0051879;GO:0042802;GO:0071813;GO:0008017;GO:0099609;GO:0003680;GO:0035091;GO:1902936;GO:0019901;GO:0051721;GO:0030674;GO:0003723;GO:0043565;GO:0017124;GO:0003697;GO:0006919;GO:1990000;GO:0048143;GO:0061564;GO:0098930;GO:0019896;GO:0007267;GO:1990416;GO:0034605;GO:1990090;GO:0034614;GO:0021954;GO:0031122;GO:0048699;GO:0006475;GO:0048312;GO:0007611;GO:0007613;GO:0001774;GO:0000226;GO:0046785;GO:1903748;GO:0010629;GO:0033673;GO:0090258;GO:0010917;GO:1904428;GO:1902988;GO:0031175;GO:0072386;GO:0045773;GO:1903829;GO:1905689;GO:0031116;GO:1901216;GO:1902474;GO:0032930;GO:0051260;GO:0051258;GO:0010506;GO:0050848;GO:1900034;GO:0033044;GO:1900452;GO:0070507;GO:0031113;GO:0031110;GO:0090140;GO:2001020;GO:0048167;GO:0010288;GO:0016072;GO:0034063;GO:0097435;GO:0007416;GO:0050808;, C:axolemma; C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendrite; C:dendritic spine; C:extracellular region; C:glial cell projection; C:growth cone; C:main axon; C:membrane raft; C:microtubule; C:microtubule cytoskeleton; C:mitochondrion; C:neurofibrillary tangle; C:neuron projection; C:neuronal cell body; C:nuclear periphery; C:nuclear speck; C:nucleus; C:plasma membrane; C:somatodendritic compartment; C:tubulin complex;, F:actin binding; F:apolipoprotein binding; F:chaperone binding; F:DNA binding; F:double-stranded DNA binding; F:dynactin binding; F:enzyme binding; F:histone-dependent DNA binding; F:Hsp90 protein binding; F:identical protein binding; F:lipoprotein particle binding; F:microtubule binding; F:microtubule lateral binding; F:minor groove of adenine-thymine-rich DNA binding; F:phosphatidylinositol binding; F:phosphatidylinositol bisphosphate binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:sequence-specific DNA binding; F:SH3 domain binding; F:single-stranded DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:amyloid fibril formation; P:astrocyte activation; P:axon development; P:axonal transport; P:axonal transport of mitochondrion; P:cell-cell signaling; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to heat; P:cellular response to nerve growth factor stimulus; P:cellular response to reactive oxygen species; P:central nervous system neuron development; P:cytoplasmic microtubule organization; P:generation of neurons; P:internal protein amino acid acetylation; P:intracellular distribution of mitochondria; P:learning or memory; P:memory; P:microglial cell activation; P:microtubule cytoskeleton organization; P:microtubule polymerization; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of gene expression; P:negative regulation of kinase activity; P:negative regulation of mitochondrial fission; P:negative regulation of mitochondrial membrane potential; P:negative regulation of tubulin deacetylation; P:neurofibrillary tangle assembly; P:neuron projection development; P:plus-end-directed organelle transport along microtubule; P:positive regulation of axon extension; P:positive regulation of cellular protein localization; P:positive regulation of diacylglycerol kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of neuron death; P:positive regulation of protein localization to synapse; P:positive regulation of superoxide anion generation; P:protein homooligomerization; P:protein polymerization; P:regulation of autophagy; P:regulation of calcium-mediated signaling; P:regulation of cellular response to heat; P:regulation of chromosome organization; P:regulation of long-term synaptic depression; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of mitochondrial fission; P:regulation of response to DNA damage stimulus; P:regulation of synaptic plasticity; P:response to lead ion; P:rRNA metabolic process; P:stress granule assembly; P:supramolecular fiber organization; P:synapse assembly; P:synapse organization; scaffold61 indexed_genome mRNA 6153616 6156540 . - . ID=transcript_10655;Q5XWF0 Q6QT54 Q9UDJ3 Q9UMH0 Q9UQ96,Microtubule-associated protein tau {ECO:0000305},Neurofibrillary tangle protein;Paired helical filament-tau;, PF00418;, GO:0030673;GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0036464;GO:0005829;GO:0030425;GO:0043197;GO:0005576;GO:0097386;GO:0030426;GO:0044304;GO:0045121;GO:0005874;GO:0015630;GO:0005739;GO:0097418;GO:0043005;GO:0043025;GO:0034399;GO:0016607;GO:0005634;GO:0005886;GO:0036477;GO:0045298;GO:0003779;GO:0034185;GO:0051087;GO:0003677;GO:0003690;GO:0034452;GO:0019899;GO:0099077;GO:0051879;GO:0042802;GO:0071813;GO:0008017;GO:0099609;GO:0003680;GO:0035091;GO:1902936;GO:0019901;GO:0051721;GO:0030674;GO:0003723;GO:0043565;GO:0017124;GO:0003697;GO:0006919;GO:1990000;GO:0048143;GO:0061564;GO:0098930;GO:0019896;GO:0007267;GO:1990416;GO:0034605;GO:1990090;GO:0034614;GO:0021954;GO:0031122;GO:0048699;GO:0006475;GO:0048312;GO:0007611;GO:0007613;GO:0001774;GO:0000226;GO:0046785;GO:1903748;GO:0010629;GO:0033673;GO:0090258;GO:0010917;GO:1904428;GO:1902988;GO:0031175;GO:0072386;GO:0045773;GO:1903829;GO:1905689;GO:0031116;GO:1901216;GO:1902474;GO:0032930;GO:0051260;GO:0051258;GO:0010506;GO:0050848;GO:1900034;GO:0033044;GO:1900452;GO:0070507;GO:0031113;GO:0031110;GO:0090140;GO:2001020;GO:0048167;GO:0010288;GO:0016072;GO:0034063;GO:0097435;GO:0007416;GO:0050808;, C:axolemma; C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendrite; C:dendritic spine; C:extracellular region; C:glial cell projection; C:growth cone; C:main axon; C:membrane raft; C:microtubule; C:microtubule cytoskeleton; C:mitochondrion; C:neurofibrillary tangle; C:neuron projection; C:neuronal cell body; C:nuclear periphery; C:nuclear speck; C:nucleus; C:plasma membrane; C:somatodendritic compartment; C:tubulin complex;, F:actin binding; F:apolipoprotein binding; F:chaperone binding; F:DNA binding; F:double-stranded DNA binding; F:dynactin binding; F:enzyme binding; F:histone-dependent DNA binding; F:Hsp90 protein binding; F:identical protein binding; F:lipoprotein particle binding; F:microtubule binding; F:microtubule lateral binding; F:minor groove of adenine-thymine-rich DNA binding; F:phosphatidylinositol binding; F:phosphatidylinositol bisphosphate binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:sequence-specific DNA binding; F:SH3 domain binding; F:single-stranded DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:amyloid fibril formation; P:astrocyte activation; P:axon development; P:axonal transport; P:axonal transport of mitochondrion; P:cell-cell signaling; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to heat; P:cellular response to nerve growth factor stimulus; P:cellular response to reactive oxygen species; P:central nervous system neuron development; P:cytoplasmic microtubule organization; P:generation of neurons; P:internal protein amino acid acetylation; P:intracellular distribution of mitochondria; P:learning or memory; P:memory; P:microglial cell activation; P:microtubule cytoskeleton organization; P:microtubule polymerization; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of gene expression; P:negative regulation of kinase activity; P:negative regulation of mitochondrial fission; P:negative regulation of mitochondrial membrane potential; P:negative regulation of tubulin deacetylation; P:neurofibrillary tangle assembly; P:neuron projection development; P:plus-end-directed organelle transport along microtubule; P:positive regulation of axon extension; P:positive regulation of cellular protein localization; P:positive regulation of diacylglycerol kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of neuron death; P:positive regulation of protein localization to synapse; P:positive regulation of superoxide anion generation; P:protein homooligomerization; P:protein polymerization; P:regulation of autophagy; P:regulation of calcium-mediated signaling; P:regulation of cellular response to heat; P:regulation of chromosome organization; P:regulation of long-term synaptic depression; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of mitochondrial fission; P:regulation of response to DNA damage stimulus; P:regulation of synaptic plasticity; P:response to lead ion; P:rRNA metabolic process; P:stress granule assembly; P:supramolecular fiber organization; P:synapse assembly; P:synapse organization;|Q5XWF0 Q6QT54 Q9UDJ3 Q9UMH0 Q9UQ96,Microtubule-associated protein tau {ECO:0000305},Neurofibrillary tangle protein;Paired helical filament-tau;, PF00418;, GO:0030673;GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0036464;GO:0005829;GO:0030425;GO:0043197;GO:0005576;GO:0097386;GO:0030426;GO:0044304;GO:0045121;GO:0005874;GO:0015630;GO:0005739;GO:0097418;GO:0043005;GO:0043025;GO:0034399;GO:0016607;GO:0005634;GO:0005886;GO:0036477;GO:0045298;GO:0003779;GO:0034185;GO:0051087;GO:0003677;GO:0003690;GO:0034452;GO:0019899;GO:0099077;GO:0051879;GO:0042802;GO:0071813;GO:0008017;GO:0099609;GO:0003680;GO:0035091;GO:1902936;GO:0019901;GO:0051721;GO:0030674;GO:0003723;GO:0043565;GO:0017124;GO:0003697;GO:0006919;GO:1990000;GO:0048143;GO:0061564;GO:0098930;GO:0019896;GO:0007267;GO:1990416;GO:0034605;GO:1990090;GO:0034614;GO:0021954;GO:0031122;GO:0048699;GO:0006475;GO:0048312;GO:0007611;GO:0007613;GO:0001774;GO:0000226;GO:0046785;GO:1903748;GO:0010629;GO:0033673;GO:0090258;GO:0010917;GO:1904428;GO:1902988;GO:0031175;GO:0072386;GO:0045773;GO:1903829;GO:1905689;GO:0031116;GO:1901216;GO:1902474;GO:0032930;GO:0051260;GO:0051258;GO:0010506;GO:0050848;GO:1900034;GO:0033044;GO:1900452;GO:0070507;GO:0031113;GO:0031110;GO:0090140;GO:2001020;GO:0048167;GO:0010288;GO:0016072;GO:0034063;GO:0097435;GO:0007416;GO:0050808;, C:axolemma; C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendrite; C:dendritic spine; C:extracellular region; C:glial cell projection; C:growth cone; C:main axon; C:membrane raft; C:microtubule; C:microtubule cytoskeleton; C:mitochondrion; C:neurofibrillary tangle; C:neuron projection; C:neuronal cell body; C:nuclear periphery; C:nuclear speck; C:nucleus; C:plasma membrane; C:somatodendritic compartment; C:tubulin complex;, F:actin binding; F:apolipoprotein binding; F:chaperone binding; F:DNA binding; F:double-stranded DNA binding; F:dynactin binding; F:enzyme binding; F:histone-dependent DNA binding; F:Hsp90 protein binding; F:identical protein binding; F:lipoprotein particle binding; F:microtubule binding; F:microtubule lateral binding; F:minor groove of adenine-thymine-rich DNA binding; F:phosphatidylinositol binding; F:phosphatidylinositol bisphosphate binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:sequence-specific DNA binding; F:SH3 domain binding; F:single-stranded DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:amyloid fibril formation; P:astrocyte activation; P:axon development; P:axonal transport; P:axonal transport of mitochondrion; P:cell-cell signaling; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to heat; P:cellular response to nerve growth factor stimulus; P:cellular response to reactive oxygen species; P:central nervous system neuron development; P:cytoplasmic microtubule organization; P:generation of neurons; P:internal protein amino acid acetylation; P:intracellular distribution of mitochondria; P:learning or memory; P:memory; P:microglial cell activation; P:microtubule cytoskeleton organization; P:microtubule polymerization; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of gene expression; P:negative regulation of kinase activity; P:negative regulation of mitochondrial fission; P:negative regulation of mitochondrial membrane potential; P:negative regulation of tubulin deacetylation; P:neurofibrillary tangle assembly; P:neuron projection development; P:plus-end-directed organelle transport along microtubule; P:positive regulation of axon extension; P:positive regulation of cellular protein localization; P:positive regulation of diacylglycerol kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of neuron death; P:positive regulation of protein localization to synapse; P:positive regulation of superoxide anion generation; P:protein homooligomerization; P:protein polymerization; P:regulation of autophagy; P:regulation of calcium-mediated signaling; P:regulation of cellular response to heat; P:regulation of chromosome organization; P:regulation of long-term synaptic depression; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of mitochondrial fission; P:regulation of response to DNA damage stimulus; P:regulation of synaptic plasticity; P:response to lead ion; P:rRNA metabolic process; P:stress granule assembly; P:supramolecular fiber organization; P:synapse assembly; P:synapse organization; scaffold61 indexed_genome mRNA 6159545 6179251 . - . ID=transcript_10656;Q5XWF0 Q6QT54 Q9UDJ3 Q9UMH0 Q9UQ96,Microtubule-associated protein tau {ECO:0000305},Neurofibrillary tangle protein;Paired helical filament-tau;, PF00418;, GO:0030673;GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0036464;GO:0005829;GO:0030425;GO:0043197;GO:0005576;GO:0097386;GO:0030426;GO:0044304;GO:0045121;GO:0005874;GO:0015630;GO:0005739;GO:0097418;GO:0043005;GO:0043025;GO:0034399;GO:0016607;GO:0005634;GO:0005886;GO:0036477;GO:0045298;GO:0003779;GO:0034185;GO:0051087;GO:0003677;GO:0003690;GO:0034452;GO:0019899;GO:0099077;GO:0051879;GO:0042802;GO:0071813;GO:0008017;GO:0099609;GO:0003680;GO:0035091;GO:1902936;GO:0019901;GO:0051721;GO:0030674;GO:0003723;GO:0043565;GO:0017124;GO:0003697;GO:0006919;GO:1990000;GO:0048143;GO:0061564;GO:0098930;GO:0019896;GO:0007267;GO:1990416;GO:0034605;GO:1990090;GO:0034614;GO:0021954;GO:0031122;GO:0048699;GO:0006475;GO:0048312;GO:0007611;GO:0007613;GO:0001774;GO:0000226;GO:0046785;GO:1903748;GO:0010629;GO:0033673;GO:0090258;GO:0010917;GO:1904428;GO:1902988;GO:0031175;GO:0072386;GO:0045773;GO:1903829;GO:1905689;GO:0031116;GO:1901216;GO:1902474;GO:0032930;GO:0051260;GO:0051258;GO:0010506;GO:0050848;GO:1900034;GO:0033044;GO:1900452;GO:0070507;GO:0031113;GO:0031110;GO:0090140;GO:2001020;GO:0048167;GO:0010288;GO:0016072;GO:0034063;GO:0097435;GO:0007416;GO:0050808;, C:axolemma; C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendrite; C:dendritic spine; C:extracellular region; C:glial cell projection; C:growth cone; C:main axon; C:membrane raft; C:microtubule; C:microtubule cytoskeleton; C:mitochondrion; C:neurofibrillary tangle; C:neuron projection; C:neuronal cell body; C:nuclear periphery; C:nuclear speck; C:nucleus; C:plasma membrane; C:somatodendritic compartment; C:tubulin complex;, F:actin binding; F:apolipoprotein binding; F:chaperone binding; F:DNA binding; F:double-stranded DNA binding; F:dynactin binding; F:enzyme binding; F:histone-dependent DNA binding; F:Hsp90 protein binding; F:identical protein binding; F:lipoprotein particle binding; F:microtubule binding; F:microtubule lateral binding; F:minor groove of adenine-thymine-rich DNA binding; F:phosphatidylinositol binding; F:phosphatidylinositol bisphosphate binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:sequence-specific DNA binding; F:SH3 domain binding; F:single-stranded DNA binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:amyloid fibril formation; P:astrocyte activation; P:axon development; P:axonal transport; P:axonal transport of mitochondrion; P:cell-cell signaling; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to heat; P:cellular response to nerve growth factor stimulus; P:cellular response to reactive oxygen species; P:central nervous system neuron development; P:cytoplasmic microtubule organization; P:generation of neurons; P:internal protein amino acid acetylation; P:intracellular distribution of mitochondria; P:learning or memory; P:memory; P:microglial cell activation; P:microtubule cytoskeleton organization; P:microtubule polymerization; P:negative regulation of establishment of protein localization to mitochondrion; P:negative regulation of gene expression; P:negative regulation of kinase activity; P:negative regulation of mitochondrial fission; P:negative regulation of mitochondrial membrane potential; P:negative regulation of tubulin deacetylation; P:neurofibrillary tangle assembly; P:neuron projection development; P:plus-end-directed organelle transport along microtubule; P:positive regulation of axon extension; P:positive regulation of cellular protein localization; P:positive regulation of diacylglycerol kinase activity; P:positive regulation of microtubule polymerization; P:positive regulation of neuron death; P:positive regulation of protein localization to synapse; P:positive regulation of superoxide anion generation; P:protein homooligomerization; P:protein polymerization; P:regulation of autophagy; P:regulation of calcium-mediated signaling; P:regulation of cellular response to heat; P:regulation of chromosome organization; P:regulation of long-term synaptic depression; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule polymerization; P:regulation of microtubule polymerization or depolymerization; P:regulation of mitochondrial fission; P:regulation of response to DNA damage stimulus; P:regulation of synaptic plasticity; P:response to lead ion; P:rRNA metabolic process; P:stress granule assembly; P:supramolecular fiber organization; P:synapse assembly; P:synapse organization; scaffold61 indexed_genome mRNA 6287015 6337673 . - . ID=transcript_10657;P34998 B4DIE9 Q13008 Q4QRJ1 Q9UK64,Corticotropin-releasing factor receptor 1,Corticotropin-releasing hormone receptor 1;, PF00002;PF02793;, GO:0005768;GO:0016021;GO:0005887;GO:0031226;GO:0043005;GO:0005886;GO:0015056;GO:0051424;GO:0043404;GO:0008528;GO:0017046;GO:0007190;GO:0007189;GO:0007188;GO:0007166;GO:0071376;GO:0051458;GO:0007565;GO:0007186;GO:0006955;GO:0002862;GO:1901386;GO:0007567;GO:0010578;GO:2000852;, C:endosome; C:integral component of membrane; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:neuron projection; C:plasma membrane;, F:corticotrophin-releasing factor receptor activity; F:corticotropin-releasing hormone binding; F:corticotropin-releasing hormone receptor activity; F:G protein-coupled peptide receptor activity; F:peptide hormone binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:cellular response to corticotropin-releasing hormone stimulus; P:corticotropin secretion; P:female pregnancy; P:G protein-coupled receptor signaling pathway; P:immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of voltage-gated calcium channel activity; P:parturition; P:regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway; P:regulation of corticosterone secretion;|P34998 B4DIE9 Q13008 Q4QRJ1 Q9UK64,Corticotropin-releasing factor receptor 1,Corticotropin-releasing hormone receptor 1;, PF00002;PF02793;, GO:0005768;GO:0016021;GO:0005887;GO:0031226;GO:0043005;GO:0005886;GO:0015056;GO:0051424;GO:0043404;GO:0008528;GO:0017046;GO:0007190;GO:0007189;GO:0007188;GO:0007166;GO:0071376;GO:0051458;GO:0007565;GO:0007186;GO:0006955;GO:0002862;GO:1901386;GO:0007567;GO:0010578;GO:2000852;, C:endosome; C:integral component of membrane; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:neuron projection; C:plasma membrane;, F:corticotrophin-releasing factor receptor activity; F:corticotropin-releasing hormone binding; F:corticotropin-releasing hormone receptor activity; F:G protein-coupled peptide receptor activity; F:peptide hormone binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:cellular response to corticotropin-releasing hormone stimulus; P:corticotropin secretion; P:female pregnancy; P:G protein-coupled receptor signaling pathway; P:immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of voltage-gated calcium channel activity; P:parturition; P:regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway; P:regulation of corticosterone secretion;|P34998 B4DIE9 Q13008 Q4QRJ1 Q9UK64,Corticotropin-releasing factor receptor 1,Corticotropin-releasing hormone receptor 1;, PF00002;PF02793;, GO:0005768;GO:0016021;GO:0005887;GO:0031226;GO:0043005;GO:0005886;GO:0015056;GO:0051424;GO:0043404;GO:0008528;GO:0017046;GO:0007190;GO:0007189;GO:0007188;GO:0007166;GO:0071376;GO:0051458;GO:0007565;GO:0007186;GO:0006955;GO:0002862;GO:1901386;GO:0007567;GO:0010578;GO:2000852;, C:endosome; C:integral component of membrane; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:neuron projection; C:plasma membrane;, F:corticotrophin-releasing factor receptor activity; F:corticotropin-releasing hormone binding; F:corticotropin-releasing hormone receptor activity; F:G protein-coupled peptide receptor activity; F:peptide hormone binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:cellular response to corticotropin-releasing hormone stimulus; P:corticotropin secretion; P:female pregnancy; P:G protein-coupled receptor signaling pathway; P:immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of voltage-gated calcium channel activity; P:parturition; P:regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway; P:regulation of corticosterone secretion; scaffold61 indexed_genome mRNA 6494473 6513116 . - . ID=transcript_10658;P84077 P10947 P32889,ADP-ribosylation factor 1,, PF00025;, GO:0031252;GO:0030137;GO:0005829;GO:0070062;GO:0005925;GO:0098978;GO:0000139;GO:0005770;GO:0043005;GO:0048471;GO:0005778;GO:0005886;GO:0014069;GO:0032991;GO:0030017;GO:0005802;GO:0019003;GO:0005525;GO:0000287;GO:1990583;GO:0019904;GO:0003723;GO:0007015;GO:0019886;GO:0006878;GO:0098586;GO:0097061;GO:0055108;GO:0035722;GO:0006886;GO:0060292;GO:0097212;GO:1990386;GO:0006661;GO:0045956;GO:0060999;GO:0045807;GO:1902953;GO:1902824;GO:0050714;GO:1902307;GO:0006892;GO:0098974;GO:0034315;GO:0050690;GO:1903725;GO:0002090;GO:0070142;GO:0034379;GO:0016192;, C:cell leading edge; C:COPI-coated vesicle; C:cytosol; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:Golgi membrane; C:late endosome; C:neuron projection; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcomere; C:trans-Golgi network;, F:GDP binding; F:GTP binding; F:magnesium ion binding; F:phospholipase D activator activity; F:protein domain specific binding; F:RNA binding;, P:actin filament organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular copper ion homeostasis; P:cellular response to virus; P:dendritic spine organization; P:Golgi to transport vesicle transport; P:interleukin-12-mediated signaling pathway; P:intracellular protein transport; P:long-term synaptic depression; P:lysosomal membrane organization; P:mitotic cleavage furrow ingression; P:phosphatidylinositol biosynthetic process; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of dendritic spine development; P:positive regulation of endocytosis; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of late endosome to lysosome transport; P:positive regulation of protein secretion; P:positive regulation of sodium ion transmembrane transport; P:post-Golgi vesicle-mediated transport; P:postsynaptic actin cytoskeleton organization; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of defense response to virus by virus; P:regulation of phospholipid metabolic process; P:regulation of receptor internalization; P:synaptic vesicle budding; P:very-low-density lipoprotein particle assembly; P:vesicle-mediated transport;|P61204 A8K6G8 B7ZB63 P16587,ADP-ribosylation factor 3,, PF00025;, GO:0070062;GO:0000139;GO:0048471;GO:0005886;GO:0005525;GO:0003924;GO:0006886;GO:0006661;GO:0006890;GO:0016192;, C:extracellular exosome; C:Golgi membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:phosphatidylinositol biosynthetic process; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport; scaffold61 indexed_genome mRNA 6551284 6677903 . + . ID=transcript_10659;P46459 A8K2D9 B4DFA2 Q8N6D7 Q9UKZ2,Vesicle-fusing ATPase,N-ethylmaleimide-sensitive fusion protein;Vesicular-fusion protein NSF;, PF00004;PF17862;PF02933;PF02359;, GO:0005829;GO:0043198;GO:0005794;GO:0005795;GO:0005765;GO:0005886;GO:0014069;GO:0005524;GO:0016887;GO:0035255;GO:0046872;GO:0030165;GO:0019901;GO:0044877;GO:0000149;GO:0017075;GO:0048208;GO:0006888;GO:0006887;GO:0043001;GO:0048211;GO:0006891;GO:0006886;GO:0045026;GO:0045732;GO:0001921;GO:0006813;GO:0017157;GO:0006890;GO:0035494;GO:0016192;, C:cytosol; C:dendritic shaft; C:Golgi apparatus; C:Golgi stack; C:lysosomal membrane; C:plasma membrane; C:postsynaptic density;, F:ATP binding; F:ATPase activity; F:ionotropic glutamate receptor binding; F:metal ion binding; F:PDZ domain binding; F:protein kinase binding; F:protein-containing complex binding; F:SNARE binding; F:syntaxin-1 binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:Golgi to plasma membrane protein transport; P:Golgi vesicle docking; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:plasma membrane fusion; P:positive regulation of protein catabolic process; P:positive regulation of receptor recycling; P:potassium ion transport; P:regulation of exocytosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:SNARE complex disassembly; P:vesicle-mediated transport;|P46459 A8K2D9 B4DFA2 Q8N6D7 Q9UKZ2,Vesicle-fusing ATPase,N-ethylmaleimide-sensitive fusion protein;Vesicular-fusion protein NSF;, PF00004;PF17862;PF02933;PF02359;, GO:0005829;GO:0043198;GO:0005794;GO:0005795;GO:0005765;GO:0005886;GO:0014069;GO:0005524;GO:0016887;GO:0035255;GO:0046872;GO:0030165;GO:0019901;GO:0044877;GO:0000149;GO:0017075;GO:0048208;GO:0006888;GO:0006887;GO:0043001;GO:0048211;GO:0006891;GO:0006886;GO:0045026;GO:0045732;GO:0001921;GO:0006813;GO:0017157;GO:0006890;GO:0035494;GO:0016192;, C:cytosol; C:dendritic shaft; C:Golgi apparatus; C:Golgi stack; C:lysosomal membrane; C:plasma membrane; C:postsynaptic density;, F:ATP binding; F:ATPase activity; F:ionotropic glutamate receptor binding; F:metal ion binding; F:PDZ domain binding; F:protein kinase binding; F:protein-containing complex binding; F:SNARE binding; F:syntaxin-1 binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:exocytosis; P:Golgi to plasma membrane protein transport; P:Golgi vesicle docking; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:plasma membrane fusion; P:positive regulation of protein catabolic process; P:positive regulation of receptor recycling; P:potassium ion transport; P:regulation of exocytosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:SNARE complex disassembly; P:vesicle-mediated transport; scaffold61 indexed_genome mRNA 6681278 6687244 . - . ID=transcript_10660;P56703 Q2M237 Q9H1J9,Proto-oncogene Wnt-3,Proto-oncogene Int-4 homolog;, PF00110;, GO:0030666;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:1990909;GO:0005125;GO:0005109;GO:0019904;GO:0048018;GO:0009948;GO:0007411;GO:0060070;GO:0044338;GO:1904954;GO:0044339;GO:1905474;GO:0045165;GO:0000902;GO:0071300;GO:0009950;GO:0035115;GO:0035116;GO:0007276;GO:0060323;GO:0060174;GO:0061180;GO:0001707;GO:0048843;GO:0030182;GO:0048697;GO:0010628;GO:0030177;GO:0050767;GO:0060064;GO:0072089;GO:0016055;, C:endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane; C:Wnt signalosome;, F:cytokine activity; F:frizzled binding; F:protein domain specific binding; F:receptor ligand activity;, P:anterior/posterior axis specification; P:axon guidance; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation; P:canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:canonical Wnt signaling pathway involved in osteoblast differentiation; P:canonical Wnt signaling pathway involved in stem cell proliferation; P:cell fate commitment; P:cell morphogenesis; P:cellular response to retinoic acid; P:dorsal/ventral axis specification; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:gamete generation; P:head morphogenesis; P:limb bud formation; P:mammary gland epithelium development; P:mesoderm formation; P:negative regulation of axon extension involved in axon guidance; P:neuron differentiation; P:positive regulation of collateral sprouting in absence of injury; P:positive regulation of gene expression; P:positive regulation of Wnt signaling pathway; P:regulation of neurogenesis; P:Spemann organizer formation at the anterior end of the primitive streak; P:stem cell proliferation; P:Wnt signaling pathway; scaffold61 indexed_genome mRNA 6687404 6743644 . - . ID=transcript_10661;P56703 Q2M237 Q9H1J9,Proto-oncogene Wnt-3,Proto-oncogene Int-4 homolog;, PF00110;, GO:0030666;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:1990909;GO:0005125;GO:0005109;GO:0019904;GO:0048018;GO:0009948;GO:0007411;GO:0060070;GO:0044338;GO:1904954;GO:0044339;GO:1905474;GO:0045165;GO:0000902;GO:0071300;GO:0009950;GO:0035115;GO:0035116;GO:0007276;GO:0060323;GO:0060174;GO:0061180;GO:0001707;GO:0048843;GO:0030182;GO:0048697;GO:0010628;GO:0030177;GO:0050767;GO:0060064;GO:0072089;GO:0016055;, C:endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane; C:Wnt signalosome;, F:cytokine activity; F:frizzled binding; F:protein domain specific binding; F:receptor ligand activity;, P:anterior/posterior axis specification; P:axon guidance; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation; P:canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:canonical Wnt signaling pathway involved in osteoblast differentiation; P:canonical Wnt signaling pathway involved in stem cell proliferation; P:cell fate commitment; P:cell morphogenesis; P:cellular response to retinoic acid; P:dorsal/ventral axis specification; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:gamete generation; P:head morphogenesis; P:limb bud formation; P:mammary gland epithelium development; P:mesoderm formation; P:negative regulation of axon extension involved in axon guidance; P:neuron differentiation; P:positive regulation of collateral sprouting in absence of injury; P:positive regulation of gene expression; P:positive regulation of Wnt signaling pathway; P:regulation of neurogenesis; P:Spemann organizer formation at the anterior end of the primitive streak; P:stem cell proliferation; P:Wnt signaling pathway; scaffold61 indexed_genome mRNA 6825822 6847826 . + . ID=transcript_10662;O14653 D3DXJ5 D3DXJ6 Q8N4B8 Q96DA5 Q9BZZ4,Golgi SNAP receptor complex member 2,27 kDa Golgi SNARE protein;Membrin;, , GO:0005829;GO:0005789;GO:0033116;GO:0012507;GO:0005794;GO:0000139;GO:0016021;GO:0031902;GO:0016020;GO:0031201;GO:0005484;GO:0000149;GO:0048208;GO:0006888;GO:0006896;GO:0006891;GO:0036498;GO:0006623;GO:0042147;GO:0048280;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:late endosome membrane; C:membrane; C:SNARE complex;, F:SNAP receptor activity; F:SNARE binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to vacuole transport; P:intra-Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein targeting to vacuole; P:retrograde transport, endosome to Golgi; P:vesicle fusion with Golgi apparatus; scaffold61 indexed_genome mRNA 6904729 6905361 . + . ID=transcript_10663;A8RCU3 A8RCU8 A8RCW0 A8RCW5,RAD52 motif-containing protein 1,RAD52 homolog B;, PF00076;, GO:0015030;GO:0005829;GO:0005730;GO:0016605;GO:0003677;GO:0003723;, C:Cajal body; C:cytosol; C:nucleolus; C:PML body;, F:DNA binding; F:RNA binding; scaffold61 indexed_genome mRNA 6986051 7035229 . + . ID=transcript_10664;Q9Y4G2 Q6P2R5 Q8TEL9 Q9NPP5 Q9NYA0,Pleckstrin homology domain-containing family M member 1,162 kDa adapter protein;, PF02759;PF13901;, GO:0010008;GO:0043231;GO:0005765;GO:0005730;GO:0046872;GO:0006914;GO:0035556;GO:0032418;GO:0045780;GO:1900029;GO:0015031;, C:endosome membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleolus;, F:metal ion binding;, P:autophagy; P:intracellular signal transduction; P:lysosome localization; P:positive regulation of bone resorption; P:positive regulation of ruffle assembly; P:protein transport;|Q9Y4G2 Q6P2R5 Q8TEL9 Q9NPP5 Q9NYA0,Pleckstrin homology domain-containing family M member 1,162 kDa adapter protein;, PF02759;PF13901;, GO:0010008;GO:0043231;GO:0005765;GO:0005730;GO:0046872;GO:0006914;GO:0035556;GO:0032418;GO:0045780;GO:1900029;GO:0015031;, C:endosome membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleolus;, F:metal ion binding;, P:autophagy; P:intracellular signal transduction; P:lysosome localization; P:positive regulation of bone resorption; P:positive regulation of ruffle assembly; P:protein transport;|Q9Y4G2 Q6P2R5 Q8TEL9 Q9NPP5 Q9NYA0,Pleckstrin homology domain-containing family M member 1,162 kDa adapter protein;, PF02759;PF13901;, GO:0010008;GO:0043231;GO:0005765;GO:0005730;GO:0046872;GO:0006914;GO:0035556;GO:0032418;GO:0045780;GO:1900029;GO:0015031;, C:endosome membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleolus;, F:metal ion binding;, P:autophagy; P:intracellular signal transduction; P:lysosome localization; P:positive regulation of bone resorption; P:positive regulation of ruffle assembly; P:protein transport;|Q9Y4G2 Q6P2R5 Q8TEL9 Q9NPP5 Q9NYA0,Pleckstrin homology domain-containing family M member 1,162 kDa adapter protein;, PF02759;PF13901;, GO:0010008;GO:0043231;GO:0005765;GO:0005730;GO:0046872;GO:0006914;GO:0035556;GO:0032418;GO:0045780;GO:1900029;GO:0015031;, C:endosome membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleolus;, F:metal ion binding;, P:autophagy; P:intracellular signal transduction; P:lysosome localization; P:positive regulation of bone resorption; P:positive regulation of ruffle assembly; P:protein transport; scaffold61 indexed_genome mRNA 7037713 7039146 . + . ID=transcript_10665;Q9Y4G2 Q6P2R5 Q8TEL9 Q9NPP5 Q9NYA0,Pleckstrin homology domain-containing family M member 1,162 kDa adapter protein;, PF02759;PF13901;, GO:0010008;GO:0043231;GO:0005765;GO:0005730;GO:0046872;GO:0006914;GO:0035556;GO:0032418;GO:0045780;GO:1900029;GO:0015031;, C:endosome membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleolus;, F:metal ion binding;, P:autophagy; P:intracellular signal transduction; P:lysosome localization; P:positive regulation of bone resorption; P:positive regulation of ruffle assembly; P:protein transport; scaffold61 indexed_genome mRNA 7076753 7077429 . + . ID=transcript_10666;Q6ZUM4 A4FU35 A8K3N5 C9JTF3 Q494U0 Q6NWZ8 Q8WY58,Rho GTPase-activating protein 27,CIN85-associated multi-domain-containing Rho GTPase-activating protein 1;Rho-type GTPase-activating protein 27;SH3 domain-containing protein 20;, PF00169;PF00620;PF00397;, GO:0005737;GO:0016020;GO:0005096;GO:0017124;GO:0043547;GO:0006898;GO:0043087;GO:0007165;, C:cytoplasm; C:membrane;, F:GTPase activator activity; F:SH3 domain binding;, P:positive regulation of GTPase activity; P:receptor-mediated endocytosis; P:regulation of GTPase activity; P:signal transduction; scaffold61 indexed_genome mRNA 7211709 7231963 . + . ID=transcript_10667;Q99558 A8K2D8 D3DX67 Q8IYN1,Mitogen-activated protein kinase kinase kinase 14,NF-kappa-beta-inducing kinase;Serine/threonine-protein kinase NIK;, PF00069;, GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005524;GO:0004709;GO:0004704;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0071260;GO:0051607;GO:0007249;GO:0006955;GO:0038061;GO:0043123;GO:0033209;, C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:NF-kappaB-inducing kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to mechanical stimulus; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:immune response; P:NIK/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:tumor necrosis factor-mediated signaling pathway;|Q99558 A8K2D8 D3DX67 Q8IYN1,Mitogen-activated protein kinase kinase kinase 14,NF-kappa-beta-inducing kinase;Serine/threonine-protein kinase NIK;, PF00069;, GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005524;GO:0004709;GO:0004704;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0071260;GO:0051607;GO:0007249;GO:0006955;GO:0038061;GO:0043123;GO:0033209;, C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:NF-kappaB-inducing kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to mechanical stimulus; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:immune response; P:NIK/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:tumor necrosis factor-mediated signaling pathway;|Q6ZVK1,Transmembrane protein 179,Transmembrane protein 179A;, , GO:0016021;, C:integral component of membrane;|Q99558 A8K2D8 D3DX67 Q8IYN1,Mitogen-activated protein kinase kinase kinase 14,NF-kappa-beta-inducing kinase;Serine/threonine-protein kinase NIK;, PF00069;, GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005524;GO:0004709;GO:0004704;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0071260;GO:0051607;GO:0007249;GO:0006955;GO:0038061;GO:0043123;GO:0033209;, C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:NF-kappaB-inducing kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to mechanical stimulus; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:immune response; P:NIK/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:tumor necrosis factor-mediated signaling pathway;|Q99558 A8K2D8 D3DX67 Q8IYN1,Mitogen-activated protein kinase kinase kinase 14,NF-kappa-beta-inducing kinase;Serine/threonine-protein kinase NIK;, PF00069;, GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005524;GO:0004709;GO:0004704;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0071260;GO:0051607;GO:0007249;GO:0006955;GO:0038061;GO:0043123;GO:0033209;, C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:NF-kappaB-inducing kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to mechanical stimulus; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:immune response; P:NIK/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:tumor necrosis factor-mediated signaling pathway; scaffold61 indexed_genome mRNA 7250548 7255917 . - . ID=transcript_10668;O95466 D2DGW2 Q6DKG5 Q6IBP3 Q86UH1 Q8N671 Q8TDH1 Q96H10,Formin-like protein 1,CLL-associated antigen KW-13;Leukocyte formin;, PF06367;PF06371;PF02181;, GO:0032059;GO:0005938;GO:0005829;GO:0070062;GO:0016020;GO:0045335;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0051014;GO:0016477;GO:0030866;GO:0008360;, C:bleb; C:cell cortex; C:cytosol; C:extracellular exosome; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:actin filament severing; P:cell migration; P:cortical actin cytoskeleton organization; P:regulation of cell shape;|O95466 D2DGW2 Q6DKG5 Q6IBP3 Q86UH1 Q8N671 Q8TDH1 Q96H10,Formin-like protein 1,CLL-associated antigen KW-13;Leukocyte formin;, PF06367;PF06371;PF02181;, GO:0032059;GO:0005938;GO:0005829;GO:0070062;GO:0016020;GO:0045335;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0051014;GO:0016477;GO:0030866;GO:0008360;, C:bleb; C:cell cortex; C:cytosol; C:extracellular exosome; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:actin filament severing; P:cell migration; P:cortical actin cytoskeleton organization; P:regulation of cell shape;|O95466 D2DGW2 Q6DKG5 Q6IBP3 Q86UH1 Q8N671 Q8TDH1 Q96H10,Formin-like protein 1,CLL-associated antigen KW-13;Leukocyte formin;, PF06367;PF06371;PF02181;, GO:0032059;GO:0005938;GO:0005829;GO:0070062;GO:0016020;GO:0045335;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0051014;GO:0016477;GO:0030866;GO:0008360;, C:bleb; C:cell cortex; C:cytosol; C:extracellular exosome; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:actin filament severing; P:cell migration; P:cortical actin cytoskeleton organization; P:regulation of cell shape;|O95466 D2DGW2 Q6DKG5 Q6IBP3 Q86UH1 Q8N671 Q8TDH1 Q96H10,Formin-like protein 1,CLL-associated antigen KW-13;Leukocyte formin;, PF06367;PF06371;PF02181;, GO:0032059;GO:0005938;GO:0005829;GO:0070062;GO:0016020;GO:0045335;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0051014;GO:0016477;GO:0030866;GO:0008360;, C:bleb; C:cell cortex; C:cytosol; C:extracellular exosome; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:actin filament severing; P:cell migration; P:cortical actin cytoskeleton organization; P:regulation of cell shape; scaffold61 indexed_genome mRNA 7261053 7281175 . - . ID=transcript_10669;O95466 D2DGW2 Q6DKG5 Q6IBP3 Q86UH1 Q8N671 Q8TDH1 Q96H10,Formin-like protein 1,CLL-associated antigen KW-13;Leukocyte formin;, PF06367;PF06371;PF02181;, GO:0032059;GO:0005938;GO:0005829;GO:0070062;GO:0016020;GO:0045335;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0051014;GO:0016477;GO:0030866;GO:0008360;, C:bleb; C:cell cortex; C:cytosol; C:extracellular exosome; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:actin filament severing; P:cell migration; P:cortical actin cytoskeleton organization; P:regulation of cell shape;|O95466 D2DGW2 Q6DKG5 Q6IBP3 Q86UH1 Q8N671 Q8TDH1 Q96H10,Formin-like protein 1,CLL-associated antigen KW-13;Leukocyte formin;, PF06367;PF06371;PF02181;, GO:0032059;GO:0005938;GO:0005829;GO:0070062;GO:0016020;GO:0045335;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0051014;GO:0016477;GO:0030866;GO:0008360;, C:bleb; C:cell cortex; C:cytosol; C:extracellular exosome; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:actin filament severing; P:cell migration; P:cortical actin cytoskeleton organization; P:regulation of cell shape;|O95466 D2DGW2 Q6DKG5 Q6IBP3 Q86UH1 Q8N671 Q8TDH1 Q96H10,Formin-like protein 1,CLL-associated antigen KW-13;Leukocyte formin;, PF06367;PF06371;PF02181;, GO:0032059;GO:0005938;GO:0005829;GO:0070062;GO:0016020;GO:0045335;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0051014;GO:0016477;GO:0030866;GO:0008360;, C:bleb; C:cell cortex; C:cytosol; C:extracellular exosome; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:actin filament severing; P:cell migration; P:cortical actin cytoskeleton organization; P:regulation of cell shape;|O95466 D2DGW2 Q6DKG5 Q6IBP3 Q86UH1 Q8N671 Q8TDH1 Q96H10,Formin-like protein 1,CLL-associated antigen KW-13;Leukocyte formin;, PF06367;PF06371;PF02181;, GO:0032059;GO:0005938;GO:0005829;GO:0070062;GO:0016020;GO:0045335;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0051014;GO:0016477;GO:0030866;GO:0008360;, C:bleb; C:cell cortex; C:cytosol; C:extracellular exosome; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:actin filament severing; P:cell migration; P:cortical actin cytoskeleton organization; P:regulation of cell shape;|O95466 D2DGW2 Q6DKG5 Q6IBP3 Q86UH1 Q8N671 Q8TDH1 Q96H10,Formin-like protein 1,CLL-associated antigen KW-13;Leukocyte formin;, PF06367;PF06371;PF02181;, GO:0032059;GO:0005938;GO:0005829;GO:0070062;GO:0016020;GO:0045335;GO:0005886;GO:0051015;GO:0032794;GO:0031267;GO:0051014;GO:0016477;GO:0030866;GO:0008360;, C:bleb; C:cell cortex; C:cytosol; C:extracellular exosome; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:actin filament binding; F:GTPase activating protein binding; F:small GTPase binding;, P:actin filament severing; P:cell migration; P:cortical actin cytoskeleton organization; P:regulation of cell shape; scaffold61 indexed_genome mRNA 7313043 7318291 . - . ID=transcript_10670;Q96MH2 D3DX66,Protein HEXIM2,Hexamethylene bis-acetamide-inducible protein 2;, PF15313;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0097322;GO:0004861;GO:0042802;GO:0017069;GO:0045736;GO:0000122;GO:0045892;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:7SK snRNA binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:identical protein binding; F:snRNA binding;, P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated;|Q96MH2 D3DX66,Protein HEXIM2,Hexamethylene bis-acetamide-inducible protein 2;, PF15313;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0097322;GO:0004861;GO:0042802;GO:0017069;GO:0045736;GO:0000122;GO:0045892;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:7SK snRNA binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:identical protein binding; F:snRNA binding;, P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; scaffold61 indexed_genome mRNA 7323905 7327966 . - . ID=transcript_10671;O94992 B2R8Y5,Protein HEXIM1,Cardiac lineage protein 1;Estrogen down-regulated gene 1 protein;Hexamethylene bis-acetamide-inducible protein 1;Menage a quatre protein 1;, PF15313;, GO:0120259;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0097322;GO:0004861;GO:0042802;GO:0106140;GO:0004860;GO:0017069;GO:0002218;GO:0007507;GO:0045087;GO:0045736;GO:0000122;GO:0034244;GO:0045892;GO:0032897;GO:1901798;, C:7SK snRNP; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:7SK snRNA binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:identical protein binding; F:P-TEFb complex binding; F:protein kinase inhibitor activity; F:snRNA binding;, P:activation of innate immune response; P:heart development; P:innate immune response; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral transcription; P:positive regulation of signal transduction by p53 class mediator; scaffold61 indexed_genome mRNA 7335523 7336762 . - . ID=transcript_10672;Q8NC06 D3DX64 Q8IUT1 Q9H8Q4,Acyl-CoA-binding domain-containing protein 4,, PF00887;, GO:0000062;GO:0008289;, , F:fatty-acyl-CoA binding; F:lipid binding; scaffold61 indexed_genome mRNA 7336824 7338953 . - . ID=transcript_10673;Q8NC06 D3DX64 Q8IUT1 Q9H8Q4,Acyl-CoA-binding domain-containing protein 4,, PF00887;, GO:0000062;GO:0008289;, , F:fatty-acyl-CoA binding; F:lipid binding; scaffold61 indexed_genome mRNA 7339432 7358164 . + . ID=transcript_10674;Q8N3E9 Q8TEC1 Q8TF37 Q96FL6,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 {ECO:0000305},Phosphoinositide phospholipase C-delta-3;Phospholipase C-delta-3;, PF00168;PF14788;PF00388;PF00387;, GO:0032154;GO:0005829;GO:0005886;GO:0046872;GO:0004435;GO:0001525;GO:0043647;GO:0060716;GO:0016042;GO:0048015;GO:0042127;, C:cleavage furrow; C:cytosol; C:plasma membrane;, F:metal ion binding; F:phosphatidylinositol phospholipase C activity;, P:angiogenesis; P:inositol phosphate metabolic process; P:labyrinthine layer blood vessel development; P:lipid catabolic process; P:phosphatidylinositol-mediated signaling; P:regulation of cell population proliferation; scaffold61 indexed_genome mRNA 7358475 7359661 . + . ID=transcript_10675;Q8N3E9 Q8TEC1 Q8TF37 Q96FL6,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 {ECO:0000305},Phosphoinositide phospholipase C-delta-3;Phospholipase C-delta-3;, PF00168;PF14788;PF00388;PF00387;, GO:0032154;GO:0005829;GO:0005886;GO:0046872;GO:0004435;GO:0001525;GO:0043647;GO:0060716;GO:0016042;GO:0048015;GO:0042127;, C:cleavage furrow; C:cytosol; C:plasma membrane;, F:metal ion binding; F:phosphatidylinositol phospholipase C activity;, P:angiogenesis; P:inositol phosphate metabolic process; P:labyrinthine layer blood vessel development; P:lipid catabolic process; P:phosphatidylinositol-mediated signaling; P:regulation of cell population proliferation; scaffold61 indexed_genome mRNA 7361758 7384439 . - . ID=transcript_10676;P30419 A8K7C1 Q9UE09,Glycylpeptide N-tetradecanoyltransferase 1,Myristoyl-CoA:protein N-myristoyltransferase 1;Peptide N-myristoyltransferase 1;, PF01233;PF02799;, GO:0005737;GO:0005829;GO:0019898;GO:0005739;GO:0005886;GO:0004379;GO:0019107;GO:0042180;GO:0001701;GO:0018008;GO:0006499;GO:1900740;GO:0022400;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:mitochondrion; C:plasma membrane;, F:glycylpeptide N-tetradecanoyltransferase activity; F:myristoyltransferase activity;, P:cellular ketone metabolic process; P:in utero embryonic development; P:N-terminal peptidyl-glycine N-myristoylation; P:N-terminal protein myristoylation; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of rhodopsin mediated signaling pathway;|O60551 B0YJ49 Q53Y38 Q5VUC8 Q9BRB4,Glycylpeptide N-tetradecanoyltransferase 2,Myristoyl-CoA:protein N-myristoyltransferase 2;Peptide N-myristoyltransferase 2;Type II N-myristoyltransferase;, PF01233;PF02799;, GO:0005737;GO:0005829;GO:0019898;GO:0005794;GO:0043657;GO:0005886;GO:0004379;GO:0075733;GO:0018008;GO:0022400;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:Golgi apparatus; C:host cell; C:plasma membrane;, F:glycylpeptide N-tetradecanoyltransferase activity;, P:intracellular transport of virus; P:N-terminal peptidyl-glycine N-myristoylation; P:regulation of rhodopsin mediated signaling pathway;|P30419 A8K7C1 Q9UE09,Glycylpeptide N-tetradecanoyltransferase 1,Myristoyl-CoA:protein N-myristoyltransferase 1;Peptide N-myristoyltransferase 1;, PF01233;PF02799;, GO:0005737;GO:0005829;GO:0019898;GO:0005739;GO:0005886;GO:0004379;GO:0019107;GO:0042180;GO:0001701;GO:0018008;GO:0006499;GO:1900740;GO:0022400;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:mitochondrion; C:plasma membrane;, F:glycylpeptide N-tetradecanoyltransferase activity; F:myristoyltransferase activity;, P:cellular ketone metabolic process; P:in utero embryonic development; P:N-terminal peptidyl-glycine N-myristoylation; P:N-terminal protein myristoylation; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of rhodopsin mediated signaling pathway;|P30419 A8K7C1 Q9UE09,Glycylpeptide N-tetradecanoyltransferase 1,Myristoyl-CoA:protein N-myristoyltransferase 1;Peptide N-myristoyltransferase 1;, PF01233;PF02799;, GO:0005737;GO:0005829;GO:0019898;GO:0005739;GO:0005886;GO:0004379;GO:0019107;GO:0042180;GO:0001701;GO:0018008;GO:0006499;GO:1900740;GO:0022400;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:mitochondrion; C:plasma membrane;, F:glycylpeptide N-tetradecanoyltransferase activity; F:myristoyltransferase activity;, P:cellular ketone metabolic process; P:in utero embryonic development; P:N-terminal peptidyl-glycine N-myristoylation; P:N-terminal protein myristoylation; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of rhodopsin mediated signaling pathway;|P30419 A8K7C1 Q9UE09,Glycylpeptide N-tetradecanoyltransferase 1,Myristoyl-CoA:protein N-myristoyltransferase 1;Peptide N-myristoyltransferase 1;, PF01233;PF02799;, GO:0005737;GO:0005829;GO:0019898;GO:0005739;GO:0005886;GO:0004379;GO:0019107;GO:0042180;GO:0001701;GO:0018008;GO:0006499;GO:1900740;GO:0022400;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:mitochondrion; C:plasma membrane;, F:glycylpeptide N-tetradecanoyltransferase activity; F:myristoyltransferase activity;, P:cellular ketone metabolic process; P:in utero embryonic development; P:N-terminal peptidyl-glycine N-myristoylation; P:N-terminal protein myristoylation; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of rhodopsin mediated signaling pathway;|P30419 A8K7C1 Q9UE09,Glycylpeptide N-tetradecanoyltransferase 1,Myristoyl-CoA:protein N-myristoyltransferase 1;Peptide N-myristoyltransferase 1;, PF01233;PF02799;, GO:0005737;GO:0005829;GO:0019898;GO:0005739;GO:0005886;GO:0004379;GO:0019107;GO:0042180;GO:0001701;GO:0018008;GO:0006499;GO:1900740;GO:0022400;, C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:mitochondrion; C:plasma membrane;, F:glycylpeptide N-tetradecanoyltransferase activity; F:myristoyltransferase activity;, P:cellular ketone metabolic process; P:in utero embryonic development; P:N-terminal peptidyl-glycine N-myristoylation; P:N-terminal protein myristoylation; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of rhodopsin mediated signaling pathway; scaffold61 indexed_genome mRNA 7402848 7418406 . + . ID=transcript_10677;Q8WVC6 A8K3Z0 D3DX60 D3DX62 Q9BR71 Q9H5W1,Dephospho-CoA kinase domain-containing protein,, PF01121;, GO:0016020;GO:0005524;GO:0004140;GO:0015937;, C:membrane;, F:ATP binding; F:dephospho-CoA kinase activity;, P:coenzyme A biosynthetic process; scaffold61 indexed_genome mRNA 7419209 7423442 . + . ID=transcript_10678;Q8WVC6 A8K3Z0 D3DX60 D3DX62 Q9BR71 Q9H5W1,Dephospho-CoA kinase domain-containing protein,, PF01121;, GO:0016020;GO:0005524;GO:0004140;GO:0015937;, C:membrane;, F:ATP binding; F:dephospho-CoA kinase activity;, P:coenzyme A biosynthetic process; scaffold61 indexed_genome mRNA 7518006 7531160 . + . ID=transcript_10679;Q96KS4 Q96P18 Q9UFD0,Glial fibrillary acidic protein,, PF00038;PF04732;, GO:0005737;GO:0005829;GO:0005882;GO:0045111;GO:0042802;GO:0005200;GO:0045109;GO:1904714;GO:0043254;, C:cytoplasm; C:cytosol; C:intermediate filament; C:intermediate filament cytoskeleton;, F:identical protein binding; F:structural constituent of cytoskeleton;, P:intermediate filament organization; P:regulation of chaperone-mediated autophagy; P:regulation of protein-containing complex assembly;|Q96KS4 Q96P18 Q9UFD0,Glial fibrillary acidic protein,, PF00038;PF04732;, GO:0005737;GO:0005829;GO:0005882;GO:0045111;GO:0042802;GO:0005200;GO:0045109;GO:1904714;GO:0043254;, C:cytoplasm; C:cytosol; C:intermediate filament; C:intermediate filament cytoskeleton;, F:identical protein binding; F:structural constituent of cytoskeleton;, P:intermediate filament organization; P:regulation of chaperone-mediated autophagy; P:regulation of protein-containing complex assembly;|Q96KS4 Q96P18 Q9UFD0,Glial fibrillary acidic protein,, PF00038;PF04732;, GO:0005737;GO:0005829;GO:0005882;GO:0045111;GO:0042802;GO:0005200;GO:0045109;GO:1904714;GO:0043254;, C:cytoplasm; C:cytosol; C:intermediate filament; C:intermediate filament cytoskeleton;, F:identical protein binding; F:structural constituent of cytoskeleton;, P:intermediate filament organization; P:regulation of chaperone-mediated autophagy; P:regulation of protein-containing complex assembly;|Q96KS4 Q96P18 Q9UFD0,Glial fibrillary acidic protein,, PF00038;PF04732;, GO:0005737;GO:0005829;GO:0005882;GO:0045111;GO:0042802;GO:0005200;GO:0045109;GO:1904714;GO:0043254;, C:cytoplasm; C:cytosol; C:intermediate filament; C:intermediate filament cytoskeleton;, F:identical protein binding; F:structural constituent of cytoskeleton;, P:intermediate filament organization; P:regulation of chaperone-mediated autophagy; P:regulation of protein-containing complex assembly;|A6NFU0,Ig-like V-type domain-containing protein FAM187A,, PF07686;, GO:0016021;, C:integral component of membrane;|Q96KS4 Q96P18 Q9UFD0,Glial fibrillary acidic protein,, PF00038;PF04732;, GO:0005737;GO:0005829;GO:0005882;GO:0045111;GO:0042802;GO:0005200;GO:0045109;GO:1904714;GO:0043254;, C:cytoplasm; C:cytosol; C:intermediate filament; C:intermediate filament cytoskeleton;, F:identical protein binding; F:structural constituent of cytoskeleton;, P:intermediate filament organization; P:regulation of chaperone-mediated autophagy; P:regulation of protein-containing complex assembly; scaffold61 indexed_genome mRNA 7534499 7571584 . + . ID=transcript_10680;Q15029 B4DK30 B4DMC0 D3DX58 K7EJ81 Q9BUR0,116 kDa U5 small nuclear ribonucleoprotein component,Elongation factor Tu GTP-binding domain-containing protein 2;SNU114 homolog;U5 snRNP-specific protein, 116 kDa;, PF00679;PF14492;PF03764;PF16004;PF00009;PF03144;, GO:0015030;GO:0071013;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0071007;GO:0071005;GO:0046540;GO:0005525;GO:0003924;GO:0003723;GO:0030623;GO:0035690;GO:0000398;GO:0042220;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:U5 snRNA binding;, P:cellular response to drug; P:mRNA splicing, via spliceosome; P:response to cocaine;|Q15029 B4DK30 B4DMC0 D3DX58 K7EJ81 Q9BUR0,116 kDa U5 small nuclear ribonucleoprotein component,Elongation factor Tu GTP-binding domain-containing protein 2;SNU114 homolog;U5 snRNP-specific protein, 116 kDa;, PF00679;PF14492;PF03764;PF16004;PF00009;PF03144;, GO:0015030;GO:0071013;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0071007;GO:0071005;GO:0046540;GO:0005525;GO:0003924;GO:0003723;GO:0030623;GO:0035690;GO:0000398;GO:0042220;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:U5 snRNA binding;, P:cellular response to drug; P:mRNA splicing, via spliceosome; P:response to cocaine;|Q15029 B4DK30 B4DMC0 D3DX58 K7EJ81 Q9BUR0,116 kDa U5 small nuclear ribonucleoprotein component,Elongation factor Tu GTP-binding domain-containing protein 2;SNU114 homolog;U5 snRNP-specific protein, 116 kDa;, PF00679;PF14492;PF03764;PF16004;PF00009;PF03144;, GO:0015030;GO:0071013;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0071007;GO:0071005;GO:0046540;GO:0005525;GO:0003924;GO:0003723;GO:0030623;GO:0035690;GO:0000398;GO:0042220;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:U5 snRNA binding;, P:cellular response to drug; P:mRNA splicing, via spliceosome; P:response to cocaine;|Q15029 B4DK30 B4DMC0 D3DX58 K7EJ81 Q9BUR0,116 kDa U5 small nuclear ribonucleoprotein component,Elongation factor Tu GTP-binding domain-containing protein 2;SNU114 homolog;U5 snRNP-specific protein, 116 kDa;, PF00679;PF14492;PF03764;PF16004;PF00009;PF03144;, GO:0015030;GO:0071013;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0071007;GO:0071005;GO:0046540;GO:0005525;GO:0003924;GO:0003723;GO:0030623;GO:0035690;GO:0000398;GO:0042220;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:U5 snRNA binding;, P:cellular response to drug; P:mRNA splicing, via spliceosome; P:response to cocaine;|Q15029 B4DK30 B4DMC0 D3DX58 K7EJ81 Q9BUR0,116 kDa U5 small nuclear ribonucleoprotein component,Elongation factor Tu GTP-binding domain-containing protein 2;SNU114 homolog;U5 snRNP-specific protein, 116 kDa;, PF00679;PF14492;PF03764;PF16004;PF00009;PF03144;, GO:0015030;GO:0071013;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0071007;GO:0071005;GO:0046540;GO:0005525;GO:0003924;GO:0003723;GO:0030623;GO:0035690;GO:0000398;GO:0042220;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:U5 snRNA binding;, P:cellular response to drug; P:mRNA splicing, via spliceosome; P:response to cocaine;|Q15029 B4DK30 B4DMC0 D3DX58 K7EJ81 Q9BUR0,116 kDa U5 small nuclear ribonucleoprotein component,Elongation factor Tu GTP-binding domain-containing protein 2;SNU114 homolog;U5 snRNP-specific protein, 116 kDa;, PF00679;PF14492;PF03764;PF16004;PF00009;PF03144;, GO:0015030;GO:0071013;GO:0005829;GO:0043231;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:1990904;GO:0071007;GO:0071005;GO:0046540;GO:0005525;GO:0003924;GO:0003723;GO:0030623;GO:0035690;GO:0000398;GO:0042220;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:U5 snRNA binding;, P:cellular response to drug; P:mRNA splicing, via spliceosome; P:response to cocaine; scaffold61 indexed_genome mRNA 7572715 7573231 . - . ID=transcript_10681;Q9P298 D3DX57 Q9P297,HIG1 domain family member 1B,Protein CLST 11240;, PF04588;, GO:0016021;GO:0005739;GO:0097250;, C:integral component of membrane; C:mitochondrion;, , P:mitochondrial respirasome assembly; scaffold61 indexed_genome mRNA 7609918 7612863 . + . ID=transcript_10682;P36383 B3KW68 Q4VAY0,Gap junction gamma-1 protein,Connexin-45;Gap junction alpha-7 protein;, PF00029;, GO:0005922;GO:0005789;GO:0005921;GO:0016021;GO:0014704;GO:0005886;GO:0045202;GO:0005243;GO:0086077;GO:0086020;GO:0005216;GO:0086014;GO:0086053;GO:0048738;GO:0048468;GO:0007043;GO:0007267;GO:0007268;GO:0016264;GO:0006936;GO:0086021;GO:0001570;GO:0007601;, C:connexin complex; C:endoplasmic reticulum membrane; C:gap junction; C:integral component of membrane; C:intercalated disc; C:plasma membrane; C:synapse;, F:gap junction channel activity; F:gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling; F:gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling; F:ion channel activity;, P:atrial cardiac muscle cell action potential; P:AV node cell to bundle of His cell communication by electrical coupling; P:cardiac muscle tissue development; P:cell development; P:cell-cell junction assembly; P:cell-cell signaling; P:chemical synaptic transmission; P:gap junction assembly; P:muscle contraction; P:SA node cell to atrial cardiac muscle cell communication by electrical coupling; P:vasculogenesis; P:visual perception; scaffold61 indexed_genome mRNA 7630692 7655471 . - . ID=transcript_10683;O75078 Q14808 Q14809 Q14810,Disintegrin and metalloproteinase domain-containing protein 11,Metalloproteinase-like, disintegrin-like, and cysteine-rich protein;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0016021;GO:0005886;GO:0005178;GO:0004222;GO:0008237;GO:0007229;, C:integral component of membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:integrin-mediated signaling pathway;|O75078 Q14808 Q14809 Q14810,Disintegrin and metalloproteinase domain-containing protein 11,Metalloproteinase-like, disintegrin-like, and cysteine-rich protein;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0016021;GO:0005886;GO:0005178;GO:0004222;GO:0008237;GO:0007229;, C:integral component of membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:integrin-mediated signaling pathway;|O75078 Q14808 Q14809 Q14810,Disintegrin and metalloproteinase domain-containing protein 11,Metalloproteinase-like, disintegrin-like, and cysteine-rich protein;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0016021;GO:0005886;GO:0005178;GO:0004222;GO:0008237;GO:0007229;, C:integral component of membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:integrin-mediated signaling pathway;|O75078 Q14808 Q14809 Q14810,Disintegrin and metalloproteinase domain-containing protein 11,Metalloproteinase-like, disintegrin-like, and cysteine-rich protein;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0016021;GO:0005886;GO:0005178;GO:0004222;GO:0008237;GO:0007229;, C:integral component of membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:integrin-mediated signaling pathway;|O75078 Q14808 Q14809 Q14810,Disintegrin and metalloproteinase domain-containing protein 11,Metalloproteinase-like, disintegrin-like, and cysteine-rich protein;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0016021;GO:0005886;GO:0005178;GO:0004222;GO:0008237;GO:0007229;, C:integral component of membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:integrin-mediated signaling pathway;|O75078 Q14808 Q14809 Q14810,Disintegrin and metalloproteinase domain-containing protein 11,Metalloproteinase-like, disintegrin-like, and cysteine-rich protein;, PF08516;PF00200;PF07974;PF01562;PF01421;, GO:0016021;GO:0005886;GO:0005178;GO:0004222;GO:0008237;GO:0007229;, C:integral component of membrane; C:plasma membrane;, F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:integrin-mediated signaling pathway; scaffold61 indexed_genome mRNA 7661971 7689747 . - . ID=transcript_10684;Q8NFT6 D3DX56 Q8TEX0 Q96B19 Q9H912,Protein DBF4 homolog B,Activator of S phase kinase-like protein 1;Chiffon homolog B;Dbf4-related factor 1;, PF07535;, GO:0005737;GO:0031431;GO:0043231;GO:0005654;GO:0005634;GO:0003676;GO:0030295;GO:0019901;GO:0043539;GO:0008270;GO:0007049;GO:0008284;GO:0010971;GO:0010571;GO:1901987;, C:cytoplasm; C:Dbf4-dependent protein kinase complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:nucleic acid binding; F:protein kinase activator activity; F:protein kinase binding; F:protein serine/threonine kinase activator activity; F:zinc ion binding;, P:cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication; P:regulation of cell cycle phase transition;|Q8NFT6 D3DX56 Q8TEX0 Q96B19 Q9H912,Protein DBF4 homolog B,Activator of S phase kinase-like protein 1;Chiffon homolog B;Dbf4-related factor 1;, PF07535;, GO:0005737;GO:0031431;GO:0043231;GO:0005654;GO:0005634;GO:0003676;GO:0030295;GO:0019901;GO:0043539;GO:0008270;GO:0007049;GO:0008284;GO:0010971;GO:0010571;GO:1901987;, C:cytoplasm; C:Dbf4-dependent protein kinase complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:nucleic acid binding; F:protein kinase activator activity; F:protein kinase binding; F:protein serine/threonine kinase activator activity; F:zinc ion binding;, P:cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication; P:regulation of cell cycle phase transition;|Q8NFT6 D3DX56 Q8TEX0 Q96B19 Q9H912,Protein DBF4 homolog B,Activator of S phase kinase-like protein 1;Chiffon homolog B;Dbf4-related factor 1;, PF07535;, GO:0005737;GO:0031431;GO:0043231;GO:0005654;GO:0005634;GO:0003676;GO:0030295;GO:0019901;GO:0043539;GO:0008270;GO:0007049;GO:0008284;GO:0010971;GO:0010571;GO:1901987;, C:cytoplasm; C:Dbf4-dependent protein kinase complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:nucleic acid binding; F:protein kinase activator activity; F:protein kinase binding; F:protein serine/threonine kinase activator activity; F:zinc ion binding;, P:cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication; P:regulation of cell cycle phase transition;|Q8NFT6 D3DX56 Q8TEX0 Q96B19 Q9H912,Protein DBF4 homolog B,Activator of S phase kinase-like protein 1;Chiffon homolog B;Dbf4-related factor 1;, PF07535;, GO:0005737;GO:0031431;GO:0043231;GO:0005654;GO:0005634;GO:0003676;GO:0030295;GO:0019901;GO:0043539;GO:0008270;GO:0007049;GO:0008284;GO:0010971;GO:0010571;GO:1901987;, C:cytoplasm; C:Dbf4-dependent protein kinase complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:nucleic acid binding; F:protein kinase activator activity; F:protein kinase binding; F:protein serine/threonine kinase activator activity; F:zinc ion binding;, P:cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication; P:regulation of cell cycle phase transition;|Q8NFT6 D3DX56 Q8TEX0 Q96B19 Q9H912,Protein DBF4 homolog B,Activator of S phase kinase-like protein 1;Chiffon homolog B;Dbf4-related factor 1;, PF07535;, GO:0005737;GO:0031431;GO:0043231;GO:0005654;GO:0005634;GO:0003676;GO:0030295;GO:0019901;GO:0043539;GO:0008270;GO:0007049;GO:0008284;GO:0010971;GO:0010571;GO:1901987;, C:cytoplasm; C:Dbf4-dependent protein kinase complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:nucleic acid binding; F:protein kinase activator activity; F:protein kinase binding; F:protein serine/threonine kinase activator activity; F:zinc ion binding;, P:cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication; P:regulation of cell cycle phase transition;|Q8NFT6 D3DX56 Q8TEX0 Q96B19 Q9H912,Protein DBF4 homolog B,Activator of S phase kinase-like protein 1;Chiffon homolog B;Dbf4-related factor 1;, PF07535;, GO:0005737;GO:0031431;GO:0043231;GO:0005654;GO:0005634;GO:0003676;GO:0030295;GO:0019901;GO:0043539;GO:0008270;GO:0007049;GO:0008284;GO:0010971;GO:0010571;GO:1901987;, C:cytoplasm; C:Dbf4-dependent protein kinase complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:nucleic acid binding; F:protein kinase activator activity; F:protein kinase binding; F:protein serine/threonine kinase activator activity; F:zinc ion binding;, P:cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of nuclear cell cycle DNA replication; P:regulation of cell cycle phase transition; scaffold61 indexed_genome mRNA 7702171 7709951 . + . ID=transcript_10685;Q96MW1 C9JVK9,Coiled-coil domain-containing protein 43,, , GO:0005829;, C:cytosol;|Q96MW1 C9JVK9,Coiled-coil domain-containing protein 43,, , GO:0005829;, C:cytosol;|Q96MW1 C9JVK9,Coiled-coil domain-containing protein 43,, , GO:0005829;, C:cytosol; scaffold61 indexed_genome mRNA 7712592 7714331 . - . ID=transcript_10686;A2RUB1 B4DXJ2 B5MD93 B9EGQ6 C4AM97 Q4G0Y1 Q8IVZ7 Q8NA45,Meiosis-specific coiled-coil domain-containing protein MEIOC {ECO:0000305},Meiosis-specific with coiled-coil domain protein {ECO:0000303|PubMed:26742488, ECO:0000312|HGNC:HGNC:26670};, PF15189;, GO:0005737;GO:0005634;GO:0070192;GO:0006302;GO:0007144;GO:0051729;GO:0007141;GO:0051310;GO:0048255;GO:0048599;GO:0007286;GO:0007130;, C:cytoplasm; C:nucleus;, , P:chromosome organization involved in meiotic cell cycle; P:double-strand break repair; P:female meiosis I; P:germline cell cycle switching, mitotic to meiotic cell cycle; P:male meiosis I; P:metaphase plate congression; P:mRNA stabilization; P:oocyte development; P:spermatid development; P:synaptonemal complex assembly; scaffold61 indexed_genome mRNA 7714521 7715025 . + . ID=transcript_10687;A2RUB1 B4DXJ2 B5MD93 B9EGQ6 C4AM97 Q4G0Y1 Q8IVZ7 Q8NA45,Meiosis-specific coiled-coil domain-containing protein MEIOC {ECO:0000305},Meiosis-specific with coiled-coil domain protein {ECO:0000303|PubMed:26742488, ECO:0000312|HGNC:HGNC:26670};, PF15189;, GO:0005737;GO:0005634;GO:0070192;GO:0006302;GO:0007144;GO:0051729;GO:0007141;GO:0051310;GO:0048255;GO:0048599;GO:0007286;GO:0007130;, C:cytoplasm; C:nucleus;, , P:chromosome organization involved in meiotic cell cycle; P:double-strand break repair; P:female meiosis I; P:germline cell cycle switching, mitotic to meiotic cell cycle; P:male meiosis I; P:metaphase plate congression; P:mRNA stabilization; P:oocyte development; P:spermatid development; P:synaptonemal complex assembly; scaffold61 indexed_genome mRNA 7718050 7721342 . + . ID=transcript_10688;A2RUB1 B4DXJ2 B5MD93 B9EGQ6 C4AM97 Q4G0Y1 Q8IVZ7 Q8NA45,Meiosis-specific coiled-coil domain-containing protein MEIOC {ECO:0000305},Meiosis-specific with coiled-coil domain protein {ECO:0000303|PubMed:26742488, ECO:0000312|HGNC:HGNC:26670};, PF15189;, GO:0005737;GO:0005634;GO:0070192;GO:0006302;GO:0007144;GO:0051729;GO:0007141;GO:0051310;GO:0048255;GO:0048599;GO:0007286;GO:0007130;, C:cytoplasm; C:nucleus;, , P:chromosome organization involved in meiotic cell cycle; P:double-strand break repair; P:female meiosis I; P:germline cell cycle switching, mitotic to meiotic cell cycle; P:male meiosis I; P:metaphase plate congression; P:mRNA stabilization; P:oocyte development; P:spermatid development; P:synaptonemal complex assembly;|A2RUB1 B4DXJ2 B5MD93 B9EGQ6 C4AM97 Q4G0Y1 Q8IVZ7 Q8NA45,Meiosis-specific coiled-coil domain-containing protein MEIOC {ECO:0000305},Meiosis-specific with coiled-coil domain protein {ECO:0000303|PubMed:26742488, ECO:0000312|HGNC:HGNC:26670};, PF15189;, GO:0005737;GO:0005634;GO:0070192;GO:0006302;GO:0007144;GO:0051729;GO:0007141;GO:0051310;GO:0048255;GO:0048599;GO:0007286;GO:0007130;, C:cytoplasm; C:nucleus;, , P:chromosome organization involved in meiotic cell cycle; P:double-strand break repair; P:female meiosis I; P:germline cell cycle switching, mitotic to meiotic cell cycle; P:male meiosis I; P:metaphase plate congression; P:mRNA stabilization; P:oocyte development; P:spermatid development; P:synaptonemal complex assembly; scaffold61 indexed_genome mRNA 7846340 7927378 . + . ID=transcript_10689;Q9UKJ3 B9EGP9 O60300 Q8TB99,G patch domain-containing protein 8,, PF01585;PF12171;, GO:0005634;GO:0046872;GO:0003723;, C:nucleus;, F:metal ion binding; F:RNA binding;|Q9UKJ3 B9EGP9 O60300 Q8TB99,G patch domain-containing protein 8,, PF01585;PF12171;, GO:0005634;GO:0046872;GO:0003723;, C:nucleus;, F:metal ion binding; F:RNA binding;|Q9UKJ3 B9EGP9 O60300 Q8TB99,G patch domain-containing protein 8,, PF01585;PF12171;, GO:0005634;GO:0046872;GO:0003723;, C:nucleus;, F:metal ion binding; F:RNA binding;|Q9UKJ3 B9EGP9 O60300 Q8TB99,G patch domain-containing protein 8,, PF01585;PF12171;, GO:0005634;GO:0046872;GO:0003723;, C:nucleus;, F:metal ion binding; F:RNA binding;|Q9UKJ3 B9EGP9 O60300 Q8TB99,G patch domain-containing protein 8,, PF01585;PF12171;, GO:0005634;GO:0046872;GO:0003723;, C:nucleus;, F:metal ion binding; F:RNA binding;|Q9UKJ3 B9EGP9 O60300 Q8TB99,G patch domain-containing protein 8,, PF01585;PF12171;, GO:0005634;GO:0046872;GO:0003723;, C:nucleus;, F:metal ion binding; F:RNA binding; scaffold61 indexed_genome mRNA 7928769 7936308 . + . ID=transcript_10690;Q9UKJ3 B9EGP9 O60300 Q8TB99,G patch domain-containing protein 8,, PF01585;PF12171;, GO:0005634;GO:0046872;GO:0003723;, C:nucleus;, F:metal ion binding; F:RNA binding; scaffold61 indexed_genome mRNA 7948572 7951009 . + . ID=transcript_10691;P08514 B2RCY8 O95366 Q14443 Q17R67,Integrin alpha-IIb,GPalpha IIb;Platelet membrane glycoprotein IIb;, PF01839;PF00357;PF08441;, GO:0072562;GO:0009986;GO:0009897;GO:0070062;GO:0005925;GO:0008305;GO:0005886;GO:0031092;GO:0050840;GO:0070051;GO:0042802;GO:0046872;GO:0007160;GO:0030198;GO:0007229;GO:0070527;GO:0002576;GO:0002687;GO:0045652;, C:blood microparticle; C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integrin complex; C:plasma membrane; C:platelet alpha granule membrane;, F:extracellular matrix binding; F:fibrinogen binding; F:identical protein binding; F:metal ion binding;, P:cell-matrix adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:platelet aggregation; P:platelet degranulation; P:positive regulation of leukocyte migration; P:regulation of megakaryocyte differentiation; scaffold61 indexed_genome mRNA 7951155 7953755 . + . ID=transcript_10692;P08514 B2RCY8 O95366 Q14443 Q17R67,Integrin alpha-IIb,GPalpha IIb;Platelet membrane glycoprotein IIb;, PF01839;PF00357;PF08441;, GO:0072562;GO:0009986;GO:0009897;GO:0070062;GO:0005925;GO:0008305;GO:0005886;GO:0031092;GO:0050840;GO:0070051;GO:0042802;GO:0046872;GO:0007160;GO:0030198;GO:0007229;GO:0070527;GO:0002576;GO:0002687;GO:0045652;, C:blood microparticle; C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integrin complex; C:plasma membrane; C:platelet alpha granule membrane;, F:extracellular matrix binding; F:fibrinogen binding; F:identical protein binding; F:metal ion binding;, P:cell-matrix adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:platelet aggregation; P:platelet degranulation; P:positive regulation of leukocyte migration; P:regulation of megakaryocyte differentiation; scaffold61 indexed_genome mRNA 7962110 7964403 . + . ID=transcript_10693;A8MVW0 A8MQB4,Protein FAM171A2,, PF10577;, GO:0016021;, C:integral component of membrane; scaffold61 indexed_genome mRNA 7967903 7972011 . - . ID=transcript_10694;Q9BWE7 Q9H8S1 Q9UCH0,Progranulin {ECO:0000303|PubMed:16862116},Acrogranin {ECO:0000250|UniProtKB:P28798};Epithelin precursor {ECO:0000303|PubMed:1618805};Glycoprotein of 88 Kda {ECO:0000250|UniProtKB:P28798};Granulin precursor {ECO:0000303|PubMed:1542665};PC cell-derived growth factor {ECO:0000250|UniProtKB:P28798};Proepithelin {ECO:0000303|PubMed:12526812, ECO:0000303|PubMed:1618805};, PF00396;, GO:0035578;GO:0005783;GO:0005768;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0005770;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0005802;GO:0051087;GO:0005125;GO:0008083;GO:0003723;GO:0002265;GO:0007042;GO:0007041;GO:0007040;GO:0002282;GO:1903979;GO:0043524;GO:1902564;GO:0060266;GO:0043312;GO:0045766;GO:1905247;GO:0048680;GO:0030335;GO:1900426;GO:0010595;GO:0050679;GO:0106016;GO:1905673;GO:0043525;GO:1903334;GO:0050821;GO:0050727;GO:0007165;, C:azurophil granule lumen; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:late endosome; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:chaperone binding; F:cytokine activity; F:growth factor activity; F:RNA binding;, P:astrocyte activation involved in immune response; P:lysosomal lumen acidification; P:lysosomal transport; P:lysosome organization; P:microglial cell activation involved in immune response; P:negative regulation of microglial cell activation; P:negative regulation of neuron apoptotic process; P:negative regulation of neutrophil activation; P:negative regulation of respiratory burst involved in inflammatory response; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of aspartic-type peptidase activity; P:positive regulation of axon regeneration; P:positive regulation of cell migration; P:positive regulation of defense response to bacterium; P:positive regulation of endothelial cell migration; P:positive regulation of epithelial cell proliferation; P:positive regulation of inflammatory response to wounding; P:positive regulation of lysosome organization; P:positive regulation of neuron apoptotic process; P:positive regulation of protein folding; P:protein stabilization; P:regulation of inflammatory response; P:signal transduction;|Q9BWE7 Q9H8S1 Q9UCH0,Progranulin {ECO:0000303|PubMed:16862116},Acrogranin {ECO:0000250|UniProtKB:P28798};Epithelin precursor {ECO:0000303|PubMed:1618805};Glycoprotein of 88 Kda {ECO:0000250|UniProtKB:P28798};Granulin precursor {ECO:0000303|PubMed:1542665};PC cell-derived growth factor {ECO:0000250|UniProtKB:P28798};Proepithelin {ECO:0000303|PubMed:12526812, ECO:0000303|PubMed:1618805};, PF00396;, GO:0035578;GO:0005783;GO:0005768;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0005770;GO:0005765;GO:0005764;GO:0016020;GO:0005886;GO:0005802;GO:0051087;GO:0005125;GO:0008083;GO:0003723;GO:0002265;GO:0007042;GO:0007041;GO:0007040;GO:0002282;GO:1903979;GO:0043524;GO:1902564;GO:0060266;GO:0043312;GO:0045766;GO:1905247;GO:0048680;GO:0030335;GO:1900426;GO:0010595;GO:0050679;GO:0106016;GO:1905673;GO:0043525;GO:1903334;GO:0050821;GO:0050727;GO:0007165;, C:azurophil granule lumen; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:late endosome; C:lysosomal membrane; C:lysosome; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:chaperone binding; F:cytokine activity; F:growth factor activity; F:RNA binding;, P:astrocyte activation involved in immune response; P:lysosomal lumen acidification; P:lysosomal transport; P:lysosome organization; P:microglial cell activation involved in immune response; P:negative regulation of microglial cell activation; P:negative regulation of neuron apoptotic process; P:negative regulation of neutrophil activation; P:negative regulation of respiratory burst involved in inflammatory response; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of aspartic-type peptidase activity; P:positive regulation of axon regeneration; P:positive regulation of cell migration; P:positive regulation of defense response to bacterium; P:positive regulation of endothelial cell migration; P:positive regulation of epithelial cell proliferation; P:positive regulation of inflammatory response to wounding; P:positive regulation of lysosome organization; P:positive regulation of neuron apoptotic process; P:positive regulation of protein folding; P:protein stabilization; P:regulation of inflammatory response; P:signal transduction; scaffold61 indexed_genome mRNA 7992096 7996616 . + . ID=transcript_10695;Q9BZJ4 A8JZZ2 D3DX51 D3DX54 Q4V9M1 Q9P182 Q9UF66 Q9Y379,Solute carrier family 25 member 39,, PF00153;, GO:0016021;GO:0005743;GO:0006783;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:heme biosynthetic process;|Q9BZJ4 A8JZZ2 D3DX51 D3DX54 Q4V9M1 Q9P182 Q9UF66 Q9Y379,Solute carrier family 25 member 39,, PF00153;, GO:0016021;GO:0005743;GO:0006783;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:heme biosynthetic process;|Q9BZJ4 A8JZZ2 D3DX51 D3DX54 Q4V9M1 Q9P182 Q9UF66 Q9Y379,Solute carrier family 25 member 39,, PF00153;, GO:0016021;GO:0005743;GO:0006783;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:heme biosynthetic process;|Q9BZJ4 A8JZZ2 D3DX51 D3DX54 Q4V9M1 Q9P182 Q9UF66 Q9Y379,Solute carrier family 25 member 39,, PF00153;, GO:0016021;GO:0005743;GO:0006783;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:heme biosynthetic process; scaffold61 indexed_genome mRNA 7996814 8006805 . - . ID=transcript_10696;Q59EK9 B2R974 O15483 O60651 Q7Z3S2 Q9UF50,RUN domain-containing protein 3A,Rap2-interacting protein 8;, PF02759;, GO:0005829;GO:0043231;GO:0005886;GO:0030695;GO:0010753;GO:0007264;, C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase regulator activity;, P:positive regulation of cGMP-mediated signaling; P:small GTPase mediated signal transduction;|Q59EK9 B2R974 O15483 O60651 Q7Z3S2 Q9UF50,RUN domain-containing protein 3A,Rap2-interacting protein 8;, PF02759;, GO:0005829;GO:0043231;GO:0005886;GO:0030695;GO:0010753;GO:0007264;, C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase regulator activity;, P:positive regulation of cGMP-mediated signaling; P:small GTPase mediated signal transduction;|Q59EK9 B2R974 O15483 O60651 Q7Z3S2 Q9UF50,RUN domain-containing protein 3A,Rap2-interacting protein 8;, PF02759;, GO:0005829;GO:0043231;GO:0005886;GO:0030695;GO:0010753;GO:0007264;, C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase regulator activity;, P:positive regulation of cGMP-mediated signaling; P:small GTPase mediated signal transduction;|Q59EK9 B2R974 O15483 O60651 Q7Z3S2 Q9UF50,RUN domain-containing protein 3A,Rap2-interacting protein 8;, PF02759;, GO:0005829;GO:0043231;GO:0005886;GO:0030695;GO:0010753;GO:0007264;, C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase regulator activity;, P:positive regulation of cGMP-mediated signaling; P:small GTPase mediated signal transduction; scaffold61 indexed_genome mRNA 8105973 8115996 . + . ID=transcript_10697;Q14CW9 Q8IY68 Q96N40 Q9NPU5,Ataxin-7-like protein 3 {ECO:0000255|HAMAP-Rule:MF_03047},SAGA-associated factor 11 homolog {ECO:0000255|HAMAP-Rule:MF_03047};, PF08313;PF08209;, GO:0071819;GO:0005634;GO:0000124;GO:0030374;GO:0003713;GO:0008270;GO:0016578;GO:0010390;GO:0045893;GO:0006357;, C:DUBm complex; C:nucleus; C:SAGA complex;, F:nuclear receptor coactivator activity; F:transcription coactivator activity; F:zinc ion binding;, P:histone deubiquitination; P:histone monoubiquitination; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q71RG4 B3KU81 Q8NDI2 Q9BPZ5 Q9HAG3,Transmembrane and ubiquitin-like domain-containing protein 2,, PF00240;, GO:0016021;GO:0030433;, C:integral component of membrane;, , P:ubiquitin-dependent ERAD pathway;|Q71RG4 B3KU81 Q8NDI2 Q9BPZ5 Q9HAG3,Transmembrane and ubiquitin-like domain-containing protein 2,, PF00240;, GO:0016021;GO:0030433;, C:integral component of membrane;, , P:ubiquitin-dependent ERAD pathway; scaffold61 indexed_genome mRNA 8123913 8131752 . - . ID=transcript_10698;Q96NS5 B2RBC0 Q8WXK0,Ankyrin repeat and SOCS box protein 16,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q96NS5 B2RBC0 Q8WXK0,Ankyrin repeat and SOCS box protein 16,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; scaffold61 indexed_genome mRNA 8189001 8189819 . + . ID=transcript_10699;Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter; scaffold61 indexed_genome mRNA 8202821 8215155 . + . ID=transcript_10700;Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter;|Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter;|Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter;|Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter;|Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter;|Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter;|Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter;|Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter;|Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter;|Q9UQL6 C9JFV9 O60340 O60528 Q96DY4,Histone deacetylase 5,Antigen NY-CO-9;, PF12203;PF00850;, GO:0005737;GO:0005829;GO:0005794;GO:0000118;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0004407;GO:0042826;GO:0042802;GO:0046872;GO:0032041;GO:0033558;GO:0005080;GO:0070491;GO:0000978;GO:0001085;GO:0008134;GO:0042113;GO:0030183;GO:0032869;GO:0071222;GO:0006325;GO:0006338;GO:0006342;GO:0016575;GO:0006954;GO:0090051;GO:0010832;GO:0000122;GO:0045892;GO:0030182;GO:0051091;GO:0045944;GO:0006476;GO:0040029;GO:0010830;GO:0043393;GO:0014823;GO:0042220;GO:0042493;GO:0006367;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone deacetylase complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:protein deacetylase activity; F:protein kinase C binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:transcription factor binding;, P:B cell activation; P:B cell differentiation; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:chromatin organization; P:chromatin remodeling; P:chromatin silencing; P:histone deacetylation; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of myotube differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of gene expression, epigenetic; P:regulation of myotube differentiation; P:regulation of protein binding; P:response to activity; P:response to cocaine; P:response to drug; P:transcription initiation from RNA polymerase II promoter; scaffold61 indexed_genome mRNA 8215456 8220306 . - . ID=transcript_10701;Q9BUM1 Q8WU15,Glucose-6-phosphatase 3,Glucose-6-phosphatase beta;Ubiquitous glucose-6-phosphatase catalytic subunit-related protein;, PF01569;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0004346;GO:0006094;GO:0051156;GO:0015760;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glucose-6-phosphatase activity;, P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glucose-6-phosphate transport; scaffold61 indexed_genome mRNA 8223549 8243818 . + . ID=transcript_10702;Q3MHD2 Q86YB1 Q96NL5,Protein LSM12 homolog,, PF09793;|Q3MHD2 Q86YB1 Q96NL5,Protein LSM12 homolog,, PF09793;|Q3MHD2 Q86YB1 Q96NL5,Protein LSM12 homolog,, PF09793; scaffold61 indexed_genome mRNA 8255007 8257466 . - . ID=transcript_10703;Q96IK0 B2R9N6,Transmembrane protein 101,Putative NF-kappa-B-activating protein 130;, PF15111;, GO:0016021;GO:0043123;, C:integral component of membrane;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q96IK0 B2R9N6,Transmembrane protein 101,Putative NF-kappa-B-activating protein 130;, PF15111;, GO:0016021;GO:0043123;, C:integral component of membrane;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q96IK0 B2R9N6,Transmembrane protein 101,Putative NF-kappa-B-activating protein 130;, PF15111;, GO:0016021;GO:0043123;, C:integral component of membrane;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold61 indexed_genome mRNA 8257489 8264336 . + . ID=transcript_10704;Q8N159 B2RAZ9 Q8IWR4,N-acetylglutamate synthase, mitochondrial,Amino-acid acetyltransferase;, PF04768;, GO:0005759;GO:0005739;GO:0004042;GO:0034618;GO:0103045;GO:0006526;GO:0006536;GO:0016310;GO:0000050;, C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA:L-glutamate N-acetyltransferase activity; F:arginine binding; F:methione N-acyltransferase activity;, P:arginine biosynthetic process; P:glutamate metabolic process; P:phosphorylation; P:urea cycle;|Q8N159 B2RAZ9 Q8IWR4,N-acetylglutamate synthase, mitochondrial,Amino-acid acetyltransferase;, PF04768;, GO:0005759;GO:0005739;GO:0004042;GO:0034618;GO:0103045;GO:0006526;GO:0006536;GO:0016310;GO:0000050;, C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA:L-glutamate N-acetyltransferase activity; F:arginine binding; F:methione N-acyltransferase activity;, P:arginine biosynthetic process; P:glutamate metabolic process; P:phosphorylation; P:urea cycle;|Q8N159 B2RAZ9 Q8IWR4,N-acetylglutamate synthase, mitochondrial,Amino-acid acetyltransferase;, PF04768;, GO:0005759;GO:0005739;GO:0004042;GO:0034618;GO:0103045;GO:0006526;GO:0006536;GO:0016310;GO:0000050;, C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA:L-glutamate N-acetyltransferase activity; F:arginine binding; F:methione N-acyltransferase activity;, P:arginine biosynthetic process; P:glutamate metabolic process; P:phosphorylation; P:urea cycle;|Q8N159 B2RAZ9 Q8IWR4,N-acetylglutamate synthase, mitochondrial,Amino-acid acetyltransferase;, PF04768;, GO:0005759;GO:0005739;GO:0004042;GO:0034618;GO:0103045;GO:0006526;GO:0006536;GO:0016310;GO:0000050;, C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA:L-glutamate N-acetyltransferase activity; F:arginine binding; F:methione N-acyltransferase activity;, P:arginine biosynthetic process; P:glutamate metabolic process; P:phosphorylation; P:urea cycle; scaffold61 indexed_genome mRNA 8299175 8342926 . + . ID=transcript_10705;Q9BQJ2,MAGUK p55 subfamily member 2,Discs large homolog 2;Protein MPP2;, PF00625;PF02828;PF00595;PF07653;, GO:0005737;GO:0005856;GO:0032590;GO:0043198;GO:0043197;GO:0014069;GO:0060079;GO:0060291;GO:0051260;, C:cytoplasm; C:cytoskeleton; C:dendrite membrane; C:dendritic shaft; C:dendritic spine; C:postsynaptic density;, , P:excitatory postsynaptic potential; P:long-term synaptic potentiation; P:protein homooligomerization;|Q9BQJ2,MAGUK p55 subfamily member 2,Discs large homolog 2;Protein MPP2;, PF00625;PF02828;PF00595;PF07653;, GO:0005737;GO:0005856;GO:0032590;GO:0043198;GO:0043197;GO:0014069;GO:0060079;GO:0060291;GO:0051260;, C:cytoplasm; C:cytoskeleton; C:dendrite membrane; C:dendritic shaft; C:dendritic spine; C:postsynaptic density;, , P:excitatory postsynaptic potential; P:long-term synaptic potentiation; P:protein homooligomerization;|Q9BQJ2,MAGUK p55 subfamily member 2,Discs large homolog 2;Protein MPP2;, PF00625;PF02828;PF00595;PF07653;, GO:0005737;GO:0005856;GO:0032590;GO:0043198;GO:0043197;GO:0014069;GO:0060079;GO:0060291;GO:0051260;, C:cytoplasm; C:cytoskeleton; C:dendrite membrane; C:dendritic shaft; C:dendritic spine; C:postsynaptic density;, , P:excitatory postsynaptic potential; P:long-term synaptic potentiation; P:protein homooligomerization;|Q9BQJ2,MAGUK p55 subfamily member 2,Discs large homolog 2;Protein MPP2;, PF00625;PF02828;PF00595;PF07653;, GO:0005737;GO:0005856;GO:0032590;GO:0043198;GO:0043197;GO:0014069;GO:0060079;GO:0060291;GO:0051260;, C:cytoplasm; C:cytoskeleton; C:dendrite membrane; C:dendritic shaft; C:dendritic spine; C:postsynaptic density;, , P:excitatory postsynaptic potential; P:long-term synaptic potentiation; P:protein homooligomerization;|Q9BQJ2,MAGUK p55 subfamily member 2,Discs large homolog 2;Protein MPP2;, PF00625;PF02828;PF00595;PF07653;, GO:0005737;GO:0005856;GO:0032590;GO:0043198;GO:0043197;GO:0014069;GO:0060079;GO:0060291;GO:0051260;, C:cytoplasm; C:cytoskeleton; C:dendrite membrane; C:dendritic shaft; C:dendritic spine; C:postsynaptic density;, , P:excitatory postsynaptic potential; P:long-term synaptic potentiation; P:protein homooligomerization; scaffold61 indexed_genome mRNA 8365595 8369079 . - . ID=transcript_10706;Q6UXG3 B4DNY5 F5H7P9 F8W9M3 Q8IX38 Q8IX39 Q8TA95,CMRF35-like molecule 9,CD300 antigen-like family member G;Triggering receptor expressed on myeloid cells 4;, PF07686;, GO:0016324;GO:0016323;GO:0016021;GO:0032585;GO:0005886;GO:0004888;GO:0002376;GO:0050776;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:multivesicular body membrane; C:plasma membrane;, F:transmembrane signaling receptor activity;, P:immune system process; P:regulation of immune response; scaffold61 indexed_genome mRNA 8393966 8422531 . + . ID=transcript_10707;Q13368 B2R7N0 D3DX47 Q4GX05 Q6PGR3 Q86SV1,MAGUK p55 subfamily member 3,Discs large homolog 3;Protein MPP3;, PF00625;PF02828;PF00595;|Q13368 B2R7N0 D3DX47 Q4GX05 Q6PGR3 Q86SV1,MAGUK p55 subfamily member 3,Discs large homolog 3;Protein MPP3;, PF00625;PF02828;PF00595;|Q13368 B2R7N0 D3DX47 Q4GX05 Q6PGR3 Q86SV1,MAGUK p55 subfamily member 3,Discs large homolog 3;Protein MPP3;, PF00625;PF02828;PF00595;|Q13368 B2R7N0 D3DX47 Q4GX05 Q6PGR3 Q86SV1,MAGUK p55 subfamily member 3,Discs large homolog 3;Protein MPP3;, PF00625;PF02828;PF00595; scaffold61 indexed_genome mRNA 8447219 8458389 . + . ID=transcript_10708;P51452 D3DX45 Q5U0J1 Q8IYJ9,Dual specificity protein phosphatase 3,Dual specificity protein phosphatase VHR;Vaccinia H1-related phosphatase;, , GO:0005829;GO:0001772;GO:0005654;GO:0005634;GO:0008092;GO:0033549;GO:0016791;GO:0019901;GO:0106306;GO:0106307;GO:1990782;GO:0004725;GO:0008138;GO:0030971;GO:0071364;GO:0016311;GO:0000188;GO:0030336;GO:0050922;GO:0042059;GO:0070373;GO:0046329;GO:0043409;GO:0050868;GO:0050860;GO:0035335;GO:1990264;GO:0120183;GO:0045931;GO:0051893;, C:cytosol; C:immunological synapse; C:nucleoplasm; C:nucleus;, F:cytoskeletal protein binding; F:MAP kinase phosphatase activity; F:phosphatase activity; F:protein kinase binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:receptor tyrosine kinase binding;, P:cellular response to epidermal growth factor stimulus; P:dephosphorylation; P:inactivation of MAPK activity; P:negative regulation of cell migration; P:negative regulation of chemotaxis; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of JNK cascade; P:negative regulation of MAPK cascade; P:negative regulation of T cell activation; P:negative regulation of T cell receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:positive regulation of focal adhesion disassembly; P:positive regulation of mitotic cell cycle; P:regulation of focal adhesion assembly;|P51452 D3DX45 Q5U0J1 Q8IYJ9,Dual specificity protein phosphatase 3,Dual specificity protein phosphatase VHR;Vaccinia H1-related phosphatase;, , GO:0005829;GO:0001772;GO:0005654;GO:0005634;GO:0008092;GO:0033549;GO:0016791;GO:0019901;GO:0106306;GO:0106307;GO:1990782;GO:0004725;GO:0008138;GO:0030971;GO:0071364;GO:0016311;GO:0000188;GO:0030336;GO:0050922;GO:0042059;GO:0070373;GO:0046329;GO:0043409;GO:0050868;GO:0050860;GO:0035335;GO:1990264;GO:0120183;GO:0045931;GO:0051893;, C:cytosol; C:immunological synapse; C:nucleoplasm; C:nucleus;, F:cytoskeletal protein binding; F:MAP kinase phosphatase activity; F:phosphatase activity; F:protein kinase binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:receptor tyrosine kinase binding;, P:cellular response to epidermal growth factor stimulus; P:dephosphorylation; P:inactivation of MAPK activity; P:negative regulation of cell migration; P:negative regulation of chemotaxis; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of JNK cascade; P:negative regulation of MAPK cascade; P:negative regulation of T cell activation; P:negative regulation of T cell receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:positive regulation of focal adhesion disassembly; P:positive regulation of mitotic cell cycle; P:regulation of focal adhesion assembly;|P51452 D3DX45 Q5U0J1 Q8IYJ9,Dual specificity protein phosphatase 3,Dual specificity protein phosphatase VHR;Vaccinia H1-related phosphatase;, , GO:0005829;GO:0001772;GO:0005654;GO:0005634;GO:0008092;GO:0033549;GO:0016791;GO:0019901;GO:0106306;GO:0106307;GO:1990782;GO:0004725;GO:0008138;GO:0030971;GO:0071364;GO:0016311;GO:0000188;GO:0030336;GO:0050922;GO:0042059;GO:0070373;GO:0046329;GO:0043409;GO:0050868;GO:0050860;GO:0035335;GO:1990264;GO:0120183;GO:0045931;GO:0051893;, C:cytosol; C:immunological synapse; C:nucleoplasm; C:nucleus;, F:cytoskeletal protein binding; F:MAP kinase phosphatase activity; F:phosphatase activity; F:protein kinase binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity; F:receptor tyrosine kinase binding;, P:cellular response to epidermal growth factor stimulus; P:dephosphorylation; P:inactivation of MAPK activity; P:negative regulation of cell migration; P:negative regulation of chemotaxis; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of JNK cascade; P:negative regulation of MAPK cascade; P:negative regulation of T cell activation; P:negative regulation of T cell receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:positive regulation of focal adhesion disassembly; P:positive regulation of mitotic cell cycle; P:regulation of focal adhesion assembly; scaffold61 indexed_genome mRNA 8551019 8570980 . + . ID=transcript_10709;P50221 A8K524 A8MWF9 Q15069,Homeobox protein MOX-1,Mesenchyme homeobox 1;, PF00046;, GO:0000785;GO:0005737;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0071837;GO:0000978;GO:0043565;GO:1990837;GO:0060218;GO:0007275;GO:0006357;GO:0061056;GO:0061053;GO:0001757;, C:chromatin; C:cytoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:HMG box domain binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:hematopoietic stem cell differentiation; P:multicellular organism development; P:regulation of transcription by RNA polymerase II; P:sclerotome development; P:somite development; P:somite specification; scaffold61 indexed_genome mRNA 8625069 8672734 . - . ID=transcript_10710;P43268 A8K314 B7Z5J3 B7Z9J6 Q96AW9,ETS translocation variant 4,Adenovirus E1A enhancer-binding protein;E1A-F;Polyomavirus enhancer activator 3 homolog;, PF00178;PF04621;, GO:0000785;GO:0005694;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0045618;GO:0045944;GO:0006357;, C:chromatin; C:chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:positive regulation of keratinocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P43268 A8K314 B7Z5J3 B7Z9J6 Q96AW9,ETS translocation variant 4,Adenovirus E1A enhancer-binding protein;E1A-F;Polyomavirus enhancer activator 3 homolog;, PF00178;PF04621;, GO:0000785;GO:0005694;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0045618;GO:0045944;GO:0006357;, C:chromatin; C:chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:positive regulation of keratinocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P43268 A8K314 B7Z5J3 B7Z9J6 Q96AW9,ETS translocation variant 4,Adenovirus E1A enhancer-binding protein;E1A-F;Polyomavirus enhancer activator 3 homolog;, PF00178;PF04621;, GO:0000785;GO:0005694;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0045618;GO:0045944;GO:0006357;, C:chromatin; C:chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:positive regulation of keratinocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold61 indexed_genome mRNA 8673479 8703962 . - . ID=transcript_10711;Q14562,ATP-dependent RNA helicase DHX8,DEAH box protein 8;RNA helicase HRH1 {ECO:0000303|PubMed:7935475, ECO:0000303|PubMed:8608946};, PF04408;PF00271;PF07717;PF00575;, GO:0071013;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0005524;GO:0042802;GO:0003723;GO:0003724;GO:0000398;GO:0006396;GO:0008380;GO:0000390;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:ATP binding; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:spliceosomal complex disassembly;|Q14562,ATP-dependent RNA helicase DHX8,DEAH box protein 8;RNA helicase HRH1 {ECO:0000303|PubMed:7935475, ECO:0000303|PubMed:8608946};, PF04408;PF00271;PF07717;PF00575;, GO:0071013;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0005524;GO:0042802;GO:0003723;GO:0003724;GO:0000398;GO:0006396;GO:0008380;GO:0000390;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:ATP binding; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:spliceosomal complex disassembly;|Q14562,ATP-dependent RNA helicase DHX8,DEAH box protein 8;RNA helicase HRH1 {ECO:0000303|PubMed:7935475, ECO:0000303|PubMed:8608946};, PF04408;PF00271;PF07717;PF00575;, GO:0071013;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0005524;GO:0042802;GO:0003723;GO:0003724;GO:0000398;GO:0006396;GO:0008380;GO:0000390;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:ATP binding; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:spliceosomal complex disassembly;|Q14562,ATP-dependent RNA helicase DHX8,DEAH box protein 8;RNA helicase HRH1 {ECO:0000303|PubMed:7935475, ECO:0000303|PubMed:8608946};, PF04408;PF00271;PF07717;PF00575;, GO:0071013;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0005524;GO:0042802;GO:0003723;GO:0003724;GO:0000398;GO:0006396;GO:0008380;GO:0000390;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:ATP binding; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:spliceosomal complex disassembly;|Q14562,ATP-dependent RNA helicase DHX8,DEAH box protein 8;RNA helicase HRH1 {ECO:0000303|PubMed:7935475, ECO:0000303|PubMed:8608946};, PF04408;PF00271;PF07717;PF00575;, GO:0071013;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0005524;GO:0042802;GO:0003723;GO:0003724;GO:0000398;GO:0006396;GO:0008380;GO:0000390;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:ATP binding; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; P:spliceosomal complex disassembly; scaffold61 indexed_genome mRNA 8776470 8778065 . + . ID=transcript_10712;P49703 B2RC59 D3DX43,ADP-ribosylation factor-like protein 4D,ADP-ribosylation factor-like protein 4L;, PF00025;, GO:0005737;GO:0005730;GO:0005886;GO:0005525;GO:0003924;GO:0006886;GO:0009306;GO:0016192;, C:cytoplasm; C:nucleolus; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:protein secretion; P:vesicle-mediated transport; scaffold61 indexed_genome mRNA 8855010 8858635 . - . ID=transcript_10713;Q96A25 A8K2X2 B7Z698,Transmembrane protein 106A,, PF07092;, GO:0016021;GO:0005886;GO:0035780;GO:0035781;GO:0045087;GO:0042116;GO:0043123;GO:0032731;GO:0032755;GO:0043410;GO:0045348;GO:1904407;GO:0032760;, C:integral component of membrane; C:plasma membrane;, , P:CD80 biosynthetic process; P:CD86 biosynthetic process; P:innate immune response; P:macrophage activation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of MAPK cascade; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of nitric oxide metabolic process; P:positive regulation of tumor necrosis factor production; scaffold61 indexed_genome mRNA 8859061 8861840 . - . ID=transcript_10714;Q96A25 A8K2X2 B7Z698,Transmembrane protein 106A,, PF07092;, GO:0016021;GO:0005886;GO:0035780;GO:0035781;GO:0045087;GO:0042116;GO:0043123;GO:0032731;GO:0032755;GO:0043410;GO:0045348;GO:1904407;GO:0032760;, C:integral component of membrane; C:plasma membrane;, , P:CD80 biosynthetic process; P:CD86 biosynthetic process; P:innate immune response; P:macrophage activation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of MAPK cascade; P:positive regulation of MHC class II biosynthetic process; P:positive regulation of nitric oxide metabolic process; P:positive regulation of tumor necrosis factor production; scaffold61 indexed_genome mRNA 8862040 8890081 . - . ID=transcript_10715;Q14596 Q13173 Q15026 Q5J7Q8 Q96GB6 Q9NRF7,Next to BRCA1 gene 1 protein,Cell migration-inducing gene 19 protein;Membrane component chromosome 17 surface marker 2;Neighbor of BRCA1 gene 1 protein;Protein 1A1-3B;, PF16158;PF00564;PF00569;, GO:0005776;GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0031430;GO:0016020;GO:0005758;GO:0016604;GO:0005654;GO:0005778;GO:0000407;GO:0043235;GO:0051019;GO:0043130;GO:0008270;GO:0016236;GO:0045668;GO:0000425;GO:0030500;GO:0032872;, C:autophagosome; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:M band; C:membrane; C:mitochondrial intermembrane space; C:nuclear body; C:nucleoplasm; C:peroxisomal membrane; C:phagophore assembly site; C:receptor complex;, F:mitogen-activated protein kinase binding; F:ubiquitin binding; F:zinc ion binding;, P:macroautophagy; P:negative regulation of osteoblast differentiation; P:pexophagy; P:regulation of bone mineralization; P:regulation of stress-activated MAPK cascade;|Q14596 Q13173 Q15026 Q5J7Q8 Q96GB6 Q9NRF7,Next to BRCA1 gene 1 protein,Cell migration-inducing gene 19 protein;Membrane component chromosome 17 surface marker 2;Neighbor of BRCA1 gene 1 protein;Protein 1A1-3B;, PF16158;PF00564;PF00569;, GO:0005776;GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0031430;GO:0016020;GO:0005758;GO:0016604;GO:0005654;GO:0005778;GO:0000407;GO:0043235;GO:0051019;GO:0043130;GO:0008270;GO:0016236;GO:0045668;GO:0000425;GO:0030500;GO:0032872;, C:autophagosome; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:M band; C:membrane; C:mitochondrial intermembrane space; C:nuclear body; C:nucleoplasm; C:peroxisomal membrane; C:phagophore assembly site; C:receptor complex;, F:mitogen-activated protein kinase binding; F:ubiquitin binding; F:zinc ion binding;, P:macroautophagy; P:negative regulation of osteoblast differentiation; P:pexophagy; P:regulation of bone mineralization; P:regulation of stress-activated MAPK cascade;|Q14596 Q13173 Q15026 Q5J7Q8 Q96GB6 Q9NRF7,Next to BRCA1 gene 1 protein,Cell migration-inducing gene 19 protein;Membrane component chromosome 17 surface marker 2;Neighbor of BRCA1 gene 1 protein;Protein 1A1-3B;, PF16158;PF00564;PF00569;, GO:0005776;GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0031430;GO:0016020;GO:0005758;GO:0016604;GO:0005654;GO:0005778;GO:0000407;GO:0043235;GO:0051019;GO:0043130;GO:0008270;GO:0016236;GO:0045668;GO:0000425;GO:0030500;GO:0032872;, C:autophagosome; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:M band; C:membrane; C:mitochondrial intermembrane space; C:nuclear body; C:nucleoplasm; C:peroxisomal membrane; C:phagophore assembly site; C:receptor complex;, F:mitogen-activated protein kinase binding; F:ubiquitin binding; F:zinc ion binding;, P:macroautophagy; P:negative regulation of osteoblast differentiation; P:pexophagy; P:regulation of bone mineralization; P:regulation of stress-activated MAPK cascade;|Q14596 Q13173 Q15026 Q5J7Q8 Q96GB6 Q9NRF7,Next to BRCA1 gene 1 protein,Cell migration-inducing gene 19 protein;Membrane component chromosome 17 surface marker 2;Neighbor of BRCA1 gene 1 protein;Protein 1A1-3B;, PF16158;PF00564;PF00569;, GO:0005776;GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0031430;GO:0016020;GO:0005758;GO:0016604;GO:0005654;GO:0005778;GO:0000407;GO:0043235;GO:0051019;GO:0043130;GO:0008270;GO:0016236;GO:0045668;GO:0000425;GO:0030500;GO:0032872;, C:autophagosome; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:M band; C:membrane; C:mitochondrial intermembrane space; C:nuclear body; C:nucleoplasm; C:peroxisomal membrane; C:phagophore assembly site; C:receptor complex;, F:mitogen-activated protein kinase binding; F:ubiquitin binding; F:zinc ion binding;, P:macroautophagy; P:negative regulation of osteoblast differentiation; P:pexophagy; P:regulation of bone mineralization; P:regulation of stress-activated MAPK cascade;|Q14596 Q13173 Q15026 Q5J7Q8 Q96GB6 Q9NRF7,Next to BRCA1 gene 1 protein,Cell migration-inducing gene 19 protein;Membrane component chromosome 17 surface marker 2;Neighbor of BRCA1 gene 1 protein;Protein 1A1-3B;, PF16158;PF00564;PF00569;, GO:0005776;GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0031430;GO:0016020;GO:0005758;GO:0016604;GO:0005654;GO:0005778;GO:0000407;GO:0043235;GO:0051019;GO:0043130;GO:0008270;GO:0016236;GO:0045668;GO:0000425;GO:0030500;GO:0032872;, C:autophagosome; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:M band; C:membrane; C:mitochondrial intermembrane space; C:nuclear body; C:nucleoplasm; C:peroxisomal membrane; C:phagophore assembly site; C:receptor complex;, F:mitogen-activated protein kinase binding; F:ubiquitin binding; F:zinc ion binding;, P:macroautophagy; P:negative regulation of osteoblast differentiation; P:pexophagy; P:regulation of bone mineralization; P:regulation of stress-activated MAPK cascade;|Q14596 Q13173 Q15026 Q5J7Q8 Q96GB6 Q9NRF7,Next to BRCA1 gene 1 protein,Cell migration-inducing gene 19 protein;Membrane component chromosome 17 surface marker 2;Neighbor of BRCA1 gene 1 protein;Protein 1A1-3B;, PF16158;PF00564;PF00569;, GO:0005776;GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0031430;GO:0016020;GO:0005758;GO:0016604;GO:0005654;GO:0005778;GO:0000407;GO:0043235;GO:0051019;GO:0043130;GO:0008270;GO:0016236;GO:0045668;GO:0000425;GO:0030500;GO:0032872;, C:autophagosome; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:M band; C:membrane; C:mitochondrial intermembrane space; C:nuclear body; C:nucleoplasm; C:peroxisomal membrane; C:phagophore assembly site; C:receptor complex;, F:mitogen-activated protein kinase binding; F:ubiquitin binding; F:zinc ion binding;, P:macroautophagy; P:negative regulation of osteoblast differentiation; P:pexophagy; P:regulation of bone mineralization; P:regulation of stress-activated MAPK cascade;|Q14596 Q13173 Q15026 Q5J7Q8 Q96GB6 Q9NRF7,Next to BRCA1 gene 1 protein,Cell migration-inducing gene 19 protein;Membrane component chromosome 17 surface marker 2;Neighbor of BRCA1 gene 1 protein;Protein 1A1-3B;, PF16158;PF00564;PF00569;, GO:0005776;GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0031430;GO:0016020;GO:0005758;GO:0016604;GO:0005654;GO:0005778;GO:0000407;GO:0043235;GO:0051019;GO:0043130;GO:0008270;GO:0016236;GO:0045668;GO:0000425;GO:0030500;GO:0032872;, C:autophagosome; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:M band; C:membrane; C:mitochondrial intermembrane space; C:nuclear body; C:nucleoplasm; C:peroxisomal membrane; C:phagophore assembly site; C:receptor complex;, F:mitogen-activated protein kinase binding; F:ubiquitin binding; F:zinc ion binding;, P:macroautophagy; P:negative regulation of osteoblast differentiation; P:pexophagy; P:regulation of bone mineralization; P:regulation of stress-activated MAPK cascade;|Q14596 Q13173 Q15026 Q5J7Q8 Q96GB6 Q9NRF7,Next to BRCA1 gene 1 protein,Cell migration-inducing gene 19 protein;Membrane component chromosome 17 surface marker 2;Neighbor of BRCA1 gene 1 protein;Protein 1A1-3B;, PF16158;PF00564;PF00569;, GO:0005776;GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0031430;GO:0016020;GO:0005758;GO:0016604;GO:0005654;GO:0005778;GO:0000407;GO:0043235;GO:0051019;GO:0043130;GO:0008270;GO:0016236;GO:0045668;GO:0000425;GO:0030500;GO:0032872;, C:autophagosome; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:M band; C:membrane; C:mitochondrial intermembrane space; C:nuclear body; C:nucleoplasm; C:peroxisomal membrane; C:phagophore assembly site; C:receptor complex;, F:mitogen-activated protein kinase binding; F:ubiquitin binding; F:zinc ion binding;, P:macroautophagy; P:negative regulation of osteoblast differentiation; P:pexophagy; P:regulation of bone mineralization; P:regulation of stress-activated MAPK cascade;|Q14596 Q13173 Q15026 Q5J7Q8 Q96GB6 Q9NRF7,Next to BRCA1 gene 1 protein,Cell migration-inducing gene 19 protein;Membrane component chromosome 17 surface marker 2;Neighbor of BRCA1 gene 1 protein;Protein 1A1-3B;, PF16158;PF00564;PF00569;, GO:0005776;GO:0005829;GO:0043231;GO:0005770;GO:0005764;GO:0031430;GO:0016020;GO:0005758;GO:0016604;GO:0005654;GO:0005778;GO:0000407;GO:0043235;GO:0051019;GO:0043130;GO:0008270;GO:0016236;GO:0045668;GO:0000425;GO:0030500;GO:0032872;, C:autophagosome; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:M band; C:membrane; C:mitochondrial intermembrane space; C:nuclear body; C:nucleoplasm; C:peroxisomal membrane; C:phagophore assembly site; C:receptor complex;, F:mitogen-activated protein kinase binding; F:ubiquitin binding; F:zinc ion binding;, P:macroautophagy; P:negative regulation of osteoblast differentiation; P:pexophagy; P:regulation of bone mineralization; P:regulation of stress-activated MAPK cascade; scaffold61 indexed_genome mRNA 8916817 8956671 . + . ID=transcript_10716;P38398 E9PFZ0 O15129 Q1RMC1 Q3LRJ0 Q3LRJ6 Q6IN79 Q7KYU9,Breast cancer type 1 susceptibility protein,RING finger protein 53;RING-type E3 ubiquitin transferase BRCA1 {ECO:0000305};, PF00533;PF12820;PF00097;, GO:0070531;GO:0031436;GO:0005694;GO:0005737;GO:0008274;GO:0000800;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:1990904;GO:0000151;GO:0003684;GO:0003677;GO:0019899;GO:0003723;GO:0070063;GO:0003713;GO:0000976;GO:0015631;GO:0031625;GO:0004842;GO:0008270;GO:0006974;GO:0071681;GO:0071356;GO:0007098;GO:0043009;GO:0007059;GO:0000729;GO:0006260;GO:0009048;GO:0006302;GO:0000724;GO:0006303;GO:0006633;GO:0008630;GO:0044818;GO:0046600;GO:1902042;GO:0045717;GO:0070317;GO:0035067;GO:0051572;GO:0051573;GO:0033147;GO:2000378;GO:0045892;GO:0045766;GO:0071158;GO:0045739;GO:0010628;GO:0035066;GO:0051571;GO:2000617;GO:0051574;GO:2000620;GO:0070512;GO:0031398;GO:0045944;GO:0045893;GO:0010575;GO:0006301;GO:0051865;GO:0016579;GO:0085020;GO:0016567;GO:0044030;GO:0006349;GO:1901796;GO:0006357;GO:0043627;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRCA1-BARD1 complex; C:chromosome; C:cytoplasm; C:gamma-tubulin ring complex; C:lateral element; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ribonucleoprotein complex; C:ubiquitin ligase complex;, F:damaged DNA binding; F:DNA binding; F:enzyme binding; F:RNA binding; F:RNA polymerase binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding; F:tubulin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:cellular response to indole-3-methanol; P:cellular response to tumor necrosis factor; P:centrosome cycle; P:chordate embryonic development; P:chromosome segregation; P:DNA double-strand break processing; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:fatty acid biosynthetic process; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:mitotic G2/M transition checkpoint; P:negative regulation of centriole replication; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of G0 to G1 transition; P:negative regulation of histone acetylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone H3-K9 methylation; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of angiogenesis; P:positive regulation of cell cycle arrest; P:positive regulation of DNA repair; P:positive regulation of gene expression; P:positive regulation of histone acetylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H3-K9 methylation; P:positive regulation of histone H4-K16 acetylation; P:positive regulation of histone H4-K20 methylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:postreplication repair; P:protein autoubiquitination; P:protein deubiquitination; P:protein K6-linked ubiquitination; P:protein ubiquitination; P:regulation of DNA methylation; P:regulation of gene expression by genetic imprinting; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:response to estrogen; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint; scaffold61 indexed_genome mRNA 8957433 8958365 . - . ID=transcript_10717;P38398 E9PFZ0 O15129 Q1RMC1 Q3LRJ0 Q3LRJ6 Q6IN79 Q7KYU9,Breast cancer type 1 susceptibility protein,RING finger protein 53;RING-type E3 ubiquitin transferase BRCA1 {ECO:0000305};, PF00533;PF12820;PF00097;, GO:0070531;GO:0031436;GO:0005694;GO:0005737;GO:0008274;GO:0000800;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:1990904;GO:0000151;GO:0003684;GO:0003677;GO:0019899;GO:0003723;GO:0070063;GO:0003713;GO:0000976;GO:0015631;GO:0031625;GO:0004842;GO:0008270;GO:0006974;GO:0071681;GO:0071356;GO:0007098;GO:0043009;GO:0007059;GO:0000729;GO:0006260;GO:0009048;GO:0006302;GO:0000724;GO:0006303;GO:0006633;GO:0008630;GO:0044818;GO:0046600;GO:1902042;GO:0045717;GO:0070317;GO:0035067;GO:0051572;GO:0051573;GO:0033147;GO:2000378;GO:0045892;GO:0045766;GO:0071158;GO:0045739;GO:0010628;GO:0035066;GO:0051571;GO:2000617;GO:0051574;GO:2000620;GO:0070512;GO:0031398;GO:0045944;GO:0045893;GO:0010575;GO:0006301;GO:0051865;GO:0016579;GO:0085020;GO:0016567;GO:0044030;GO:0006349;GO:1901796;GO:0006357;GO:0043627;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRCA1-BARD1 complex; C:chromosome; C:cytoplasm; C:gamma-tubulin ring complex; C:lateral element; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ribonucleoprotein complex; C:ubiquitin ligase complex;, F:damaged DNA binding; F:DNA binding; F:enzyme binding; F:RNA binding; F:RNA polymerase binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding; F:tubulin binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:cellular response to indole-3-methanol; P:cellular response to tumor necrosis factor; P:centrosome cycle; P:chordate embryonic development; P:chromosome segregation; P:DNA double-strand break processing; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:fatty acid biosynthetic process; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:mitotic G2/M transition checkpoint; P:negative regulation of centriole replication; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of G0 to G1 transition; P:negative regulation of histone acetylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone H3-K9 methylation; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of angiogenesis; P:positive regulation of cell cycle arrest; P:positive regulation of DNA repair; P:positive regulation of gene expression; P:positive regulation of histone acetylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H3-K9 methylation; P:positive regulation of histone H4-K16 acetylation; P:positive regulation of histone H4-K20 methylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:postreplication repair; P:protein autoubiquitination; P:protein deubiquitination; P:protein K6-linked ubiquitination; P:protein ubiquitination; P:regulation of DNA methylation; P:regulation of gene expression by genetic imprinting; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:response to estrogen; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint; scaffold61 indexed_genome mRNA 8971896 8975419 . - . ID=transcript_10718;P52198 A8K2D4 O00690 O00734 Q5U0P6 Q99535,Rho-related GTP-binding protein RhoN,Rho family GTPase 2;Rho-related GTP-binding protein Rho7;Rnd2;, PF00071;, GO:0002080;GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005769;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0047485;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0048672;GO:0032956;GO:0008360;GO:0007165;GO:0007264;, C:acrosomal membrane; C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:early endosome; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding; F:protein N-terminus binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:positive regulation of collateral sprouting; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:signal transduction; P:small GTPase mediated signal transduction; scaffold61 indexed_genome mRNA 8981540 8988378 . + . ID=transcript_10719;Q99536 A8K345 B0AZP7 B4DPX4 Q13035 Q5BKZ7 Q96A39 Q9BUT8,Synaptic vesicle membrane protein VAT-1 homolog,, PF08240;, GO:0035578;GO:0070062;GO:0005576;GO:0016021;GO:0005741;GO:0016491;GO:0008270;GO:0010637;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:integral component of membrane; C:mitochondrial outer membrane;, F:oxidoreductase activity; F:zinc ion binding;, P:negative regulation of mitochondrial fusion; P:neutrophil degranulation;|Q99536 A8K345 B0AZP7 B4DPX4 Q13035 Q5BKZ7 Q96A39 Q9BUT8,Synaptic vesicle membrane protein VAT-1 homolog,, PF08240;, GO:0035578;GO:0070062;GO:0005576;GO:0016021;GO:0005741;GO:0016491;GO:0008270;GO:0010637;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:integral component of membrane; C:mitochondrial outer membrane;, F:oxidoreductase activity; F:zinc ion binding;, P:negative regulation of mitochondrial fusion; P:neutrophil degranulation;|Q99536 A8K345 B0AZP7 B4DPX4 Q13035 Q5BKZ7 Q96A39 Q9BUT8,Synaptic vesicle membrane protein VAT-1 homolog,, PF08240;, GO:0035578;GO:0070062;GO:0005576;GO:0016021;GO:0005741;GO:0016491;GO:0008270;GO:0010637;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:integral component of membrane; C:mitochondrial outer membrane;, F:oxidoreductase activity; F:zinc ion binding;, P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; scaffold61 indexed_genome mRNA 8988726 9002479 . - . ID=transcript_10720;P80217 C9JGX1 Q92984 Q99537 Q9BV98,Interferon-induced 35 kDa protein {ECO:0000303|PubMed:8954125},, PF07334;PF07292;, GO:0005737;GO:0005829;GO:0005615;GO:0016020;GO:0005634;GO:0042802;GO:0002281;GO:0008285;GO:1901223;GO:0050729;GO:0045089;GO:1901224;GO:0034145;GO:0060337;, C:cytoplasm; C:cytosol; C:extracellular space; C:membrane; C:nucleus;, F:identical protein binding;, P:macrophage activation involved in immune response; P:negative regulation of cell population proliferation; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of innate immune response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of toll-like receptor 4 signaling pathway; P:type I interferon signaling pathway; scaffold61 indexed_genome mRNA 9004064 9006316 . - . ID=transcript_10721;P61353 P08526 Q4G0A9,60S ribosomal protein L27,Large ribosomal subunit protein eL27 {ECO:0000303|PubMed:24524803};, PF00467;PF01777;, GO:0098556;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005840;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic side of rough endoplasmic reticulum membrane; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P61353 P08526 Q4G0A9,60S ribosomal protein L27,Large ribosomal subunit protein eL27 {ECO:0000303|PubMed:24524803};, PF00467;PF01777;, GO:0098556;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005840;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic side of rough endoplasmic reticulum membrane; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold61 indexed_genome mRNA 9012421 9017746 . - . ID=transcript_10722;Q96C34 Q6Y2K8 Q8IXT9 Q8N3W1,RUN domain-containing protein 1,, PF02759;, GO:0005096;GO:0090630;GO:0001701;GO:0006886;, , F:GTPase activator activity;, P:activation of GTPase activity; P:in utero embryonic development; P:intracellular protein transport;|Q96C34 Q6Y2K8 Q8IXT9 Q8N3W1,RUN domain-containing protein 1,, PF02759;, GO:0005096;GO:0090630;GO:0001701;GO:0006886;, , F:GTPase activator activity;, P:activation of GTPase activity; P:in utero embryonic development; P:intracellular protein transport; scaffold61 indexed_genome mRNA 9017784 9026952 . + . ID=transcript_10723;E9PB15 B9A003,Putative protein PTGES3L {ECO:0000305},Prostaglandin E synthase 3-like;, , GO:0005829;GO:0005634;GO:0051087;GO:0051879;GO:0051131;GO:0006457;, C:cytosol; C:nucleus;, F:chaperone binding; F:Hsp90 protein binding;, P:chaperone-mediated protein complex assembly; P:protein folding;|E9PB15 B9A003,Putative protein PTGES3L {ECO:0000305},Prostaglandin E synthase 3-like;, , GO:0005829;GO:0005634;GO:0051087;GO:0051879;GO:0051131;GO:0006457;, C:cytosol; C:nucleus;, F:chaperone binding; F:Hsp90 protein binding;, P:chaperone-mediated protein complex assembly; P:protein folding;|E9PB15 B9A003,Putative protein PTGES3L {ECO:0000305},Prostaglandin E synthase 3-like;, , GO:0005829;GO:0005634;GO:0051087;GO:0051879;GO:0051131;GO:0006457;, C:cytosol; C:nucleus;, F:chaperone binding; F:Hsp90 protein binding;, P:chaperone-mediated protein complex assembly; P:protein folding; scaffold61 indexed_genome mRNA 9029783 9039064 . + . ID=transcript_10724;Q9BTE6 B4DI73,Alanyl-tRNA editing protein Aarsd1,Alanyl-tRNA synthetase domain-containing protein 1;, PF07973;, GO:0005737;GO:0005634;GO:0004813;GO:0005524;GO:0046872;GO:0003676;GO:0002196;GO:0006419;GO:0006450;, C:cytoplasm; C:nucleus;, F:alanine-tRNA ligase activity; F:ATP binding; F:metal ion binding; F:nucleic acid binding; F:Ser-tRNA(Ala) hydrolase activity;, P:alanyl-tRNA aminoacylation; P:regulation of translational fidelity;|Q9BTE6 B4DI73,Alanyl-tRNA editing protein Aarsd1,Alanyl-tRNA synthetase domain-containing protein 1;, PF07973;, GO:0005737;GO:0005634;GO:0004813;GO:0005524;GO:0046872;GO:0003676;GO:0002196;GO:0006419;GO:0006450;, C:cytoplasm; C:nucleus;, F:alanine-tRNA ligase activity; F:ATP binding; F:metal ion binding; F:nucleic acid binding; F:Ser-tRNA(Ala) hydrolase activity;, P:alanyl-tRNA aminoacylation; P:regulation of translational fidelity;|Q9BTE6 B4DI73,Alanyl-tRNA editing protein Aarsd1,Alanyl-tRNA synthetase domain-containing protein 1;, PF07973;, GO:0005737;GO:0005634;GO:0004813;GO:0005524;GO:0046872;GO:0003676;GO:0002196;GO:0006419;GO:0006450;, C:cytoplasm; C:nucleus;, F:alanine-tRNA ligase activity; F:ATP binding; F:metal ion binding; F:nucleic acid binding; F:Ser-tRNA(Ala) hydrolase activity;, P:alanyl-tRNA aminoacylation; P:regulation of translational fidelity;|Q9BTE6 B4DI73,Alanyl-tRNA editing protein Aarsd1,Alanyl-tRNA synthetase domain-containing protein 1;, PF07973;, GO:0005737;GO:0005634;GO:0004813;GO:0005524;GO:0046872;GO:0003676;GO:0002196;GO:0006419;GO:0006450;, C:cytoplasm; C:nucleus;, F:alanine-tRNA ligase activity; F:ATP binding; F:metal ion binding; F:nucleic acid binding; F:Ser-tRNA(Ala) hydrolase activity;, P:alanyl-tRNA aminoacylation; P:regulation of translational fidelity; scaffold61 indexed_genome mRNA 9072246 9083043 . - . ID=transcript_10725;P35575 A1L4C0 B4E1C3 K7EL82,Glucose-6-phosphatase catalytic subunit 1 {ECO:0000312|HGNC:HGNC:4056},Glucose-6-phosphatase;Glucose-6-phosphatase alpha;, PF01569;, GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0004346;GO:0042301;GO:0016773;GO:0032869;GO:0042632;GO:0006094;GO:0051156;GO:0042593;GO:0015760;GO:0005980;GO:0005977;GO:0035264;GO:0046838;GO:0010468;GO:0009743;GO:0032094;GO:1904638;GO:0008202;GO:0006641;GO:0046415;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glucose-6-phosphatase activity; F:phosphate ion binding; F:phosphotransferase activity, alcohol group as acceptor;, P:cellular response to insulin stimulus; P:cholesterol homeostasis; P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glucose homeostasis; P:glucose-6-phosphate transport; P:glycogen catabolic process; P:glycogen metabolic process; P:multicellular organism growth; P:phosphorylated carbohydrate dephosphorylation; P:regulation of gene expression; P:response to carbohydrate; P:response to food; P:response to resveratrol; P:steroid metabolic process; P:triglyceride metabolic process; P:urate metabolic process;|P35575 A1L4C0 B4E1C3 K7EL82,Glucose-6-phosphatase catalytic subunit 1 {ECO:0000312|HGNC:HGNC:4056},Glucose-6-phosphatase;Glucose-6-phosphatase alpha;, PF01569;, GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0004346;GO:0042301;GO:0016773;GO:0032869;GO:0042632;GO:0006094;GO:0051156;GO:0042593;GO:0015760;GO:0005980;GO:0005977;GO:0035264;GO:0046838;GO:0010468;GO:0009743;GO:0032094;GO:1904638;GO:0008202;GO:0006641;GO:0046415;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glucose-6-phosphatase activity; F:phosphate ion binding; F:phosphotransferase activity, alcohol group as acceptor;, P:cellular response to insulin stimulus; P:cholesterol homeostasis; P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glucose homeostasis; P:glucose-6-phosphate transport; P:glycogen catabolic process; P:glycogen metabolic process; P:multicellular organism growth; P:phosphorylated carbohydrate dephosphorylation; P:regulation of gene expression; P:response to carbohydrate; P:response to food; P:response to resveratrol; P:steroid metabolic process; P:triglyceride metabolic process; P:urate metabolic process;|P35575 A1L4C0 B4E1C3 K7EL82,Glucose-6-phosphatase catalytic subunit 1 {ECO:0000312|HGNC:HGNC:4056},Glucose-6-phosphatase;Glucose-6-phosphatase alpha;, PF01569;, GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0004346;GO:0042301;GO:0016773;GO:0032869;GO:0042632;GO:0006094;GO:0051156;GO:0042593;GO:0015760;GO:0005980;GO:0005977;GO:0035264;GO:0046838;GO:0010468;GO:0009743;GO:0032094;GO:1904638;GO:0008202;GO:0006641;GO:0046415;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glucose-6-phosphatase activity; F:phosphate ion binding; F:phosphotransferase activity, alcohol group as acceptor;, P:cellular response to insulin stimulus; P:cholesterol homeostasis; P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glucose homeostasis; P:glucose-6-phosphate transport; P:glycogen catabolic process; P:glycogen metabolic process; P:multicellular organism growth; P:phosphorylated carbohydrate dephosphorylation; P:regulation of gene expression; P:response to carbohydrate; P:response to food; P:response to resveratrol; P:steroid metabolic process; P:triglyceride metabolic process; P:urate metabolic process; scaffold61 indexed_genome mRNA 9098343 9110264 . - . ID=transcript_10726;Q16853 B2RCI5 K7ESB3 L0L8N9 Q45F94,Membrane primary amine oxidase,Copper amine oxidase;HPAO;Semicarbazide-sensitive amine oxidase;Vascular adhesion protein 1;, PF01179;PF02727;PF02728;, GO:0009986;GO:0005737;GO:0005769;GO:0005783;GO:0005794;GO:0016021;GO:0005902;GO:0005886;GO:0052595;GO:0052594;GO:0005509;GO:0005507;GO:0042802;GO:0052596;GO:0008131;GO:0046982;GO:0048038;GO:0052593;GO:0009308;GO:0007155;GO:0006954;GO:1902283;GO:0046677;GO:0006805;, C:cell surface; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:microvillus; C:plasma membrane;, F:aliphatic-amine oxidase activity; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; F:calcium ion binding; F:copper ion binding; F:identical protein binding; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; F:primary amine oxidase activity; F:protein heterodimerization activity; F:quinone binding; F:tryptamine:oxygen oxidoreductase (deaminating) activity;, P:amine metabolic process; P:cell adhesion; P:inflammatory response; P:negative regulation of primary amine oxidase activity; P:response to antibiotic; P:xenobiotic metabolic process;|Q16853 B2RCI5 K7ESB3 L0L8N9 Q45F94,Membrane primary amine oxidase,Copper amine oxidase;HPAO;Semicarbazide-sensitive amine oxidase;Vascular adhesion protein 1;, PF01179;PF02727;PF02728;, GO:0009986;GO:0005737;GO:0005769;GO:0005783;GO:0005794;GO:0016021;GO:0005902;GO:0005886;GO:0052595;GO:0052594;GO:0005509;GO:0005507;GO:0042802;GO:0052596;GO:0008131;GO:0046982;GO:0048038;GO:0052593;GO:0009308;GO:0007155;GO:0006954;GO:1902283;GO:0046677;GO:0006805;, C:cell surface; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:microvillus; C:plasma membrane;, F:aliphatic-amine oxidase activity; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; F:calcium ion binding; F:copper ion binding; F:identical protein binding; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; F:primary amine oxidase activity; F:protein heterodimerization activity; F:quinone binding; F:tryptamine:oxygen oxidoreductase (deaminating) activity;, P:amine metabolic process; P:cell adhesion; P:inflammatory response; P:negative regulation of primary amine oxidase activity; P:response to antibiotic; P:xenobiotic metabolic process;|Q16853 B2RCI5 K7ESB3 L0L8N9 Q45F94,Membrane primary amine oxidase,Copper amine oxidase;HPAO;Semicarbazide-sensitive amine oxidase;Vascular adhesion protein 1;, PF01179;PF02727;PF02728;, GO:0009986;GO:0005737;GO:0005769;GO:0005783;GO:0005794;GO:0016021;GO:0005902;GO:0005886;GO:0052595;GO:0052594;GO:0005509;GO:0005507;GO:0042802;GO:0052596;GO:0008131;GO:0046982;GO:0048038;GO:0052593;GO:0009308;GO:0007155;GO:0006954;GO:1902283;GO:0046677;GO:0006805;, C:cell surface; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:microvillus; C:plasma membrane;, F:aliphatic-amine oxidase activity; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; F:calcium ion binding; F:copper ion binding; F:identical protein binding; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; F:primary amine oxidase activity; F:protein heterodimerization activity; F:quinone binding; F:tryptamine:oxygen oxidoreductase (deaminating) activity;, P:amine metabolic process; P:cell adhesion; P:inflammatory response; P:negative regulation of primary amine oxidase activity; P:response to antibiotic; P:xenobiotic metabolic process;|Q16853 B2RCI5 K7ESB3 L0L8N9 Q45F94,Membrane primary amine oxidase,Copper amine oxidase;HPAO;Semicarbazide-sensitive amine oxidase;Vascular adhesion protein 1;, PF01179;PF02727;PF02728;, GO:0009986;GO:0005737;GO:0005769;GO:0005783;GO:0005794;GO:0016021;GO:0005902;GO:0005886;GO:0052595;GO:0052594;GO:0005509;GO:0005507;GO:0042802;GO:0052596;GO:0008131;GO:0046982;GO:0048038;GO:0052593;GO:0009308;GO:0007155;GO:0006954;GO:1902283;GO:0046677;GO:0006805;, C:cell surface; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:microvillus; C:plasma membrane;, F:aliphatic-amine oxidase activity; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; F:calcium ion binding; F:copper ion binding; F:identical protein binding; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; F:primary amine oxidase activity; F:protein heterodimerization activity; F:quinone binding; F:tryptamine:oxygen oxidoreductase (deaminating) activity;, P:amine metabolic process; P:cell adhesion; P:inflammatory response; P:negative regulation of primary amine oxidase activity; P:response to antibiotic; P:xenobiotic metabolic process; scaffold61 indexed_genome mRNA 9112328 9112957 . - . ID=transcript_10727;Q8WU90 B4DMW2 D3DPG7 Q5QTQ4 Q8WZ06 Q9NUZ3 Q9NZ37 Q9P079,Zinc finger CCCH domain-containing protein 15,DRG family-regulatory protein 1;Likely ortholog of mouse immediate early response erythropoietin 4;, PF16543;PF18044;, GO:0005829;GO:0005634;GO:0045296;GO:0046872;GO:0003723;GO:0019221;GO:0002181;GO:0043547;, C:cytosol; C:nucleus;, F:cadherin binding; F:metal ion binding; F:RNA binding;, P:cytokine-mediated signaling pathway; P:cytoplasmic translation; P:positive regulation of GTPase activity; scaffold61 indexed_genome mRNA 9117020 9118900 . + . ID=transcript_10728;Q16853 B2RCI5 K7ESB3 L0L8N9 Q45F94,Membrane primary amine oxidase,Copper amine oxidase;HPAO;Semicarbazide-sensitive amine oxidase;Vascular adhesion protein 1;, PF01179;PF02727;PF02728;, GO:0009986;GO:0005737;GO:0005769;GO:0005783;GO:0005794;GO:0016021;GO:0005902;GO:0005886;GO:0052595;GO:0052594;GO:0005509;GO:0005507;GO:0042802;GO:0052596;GO:0008131;GO:0046982;GO:0048038;GO:0052593;GO:0009308;GO:0007155;GO:0006954;GO:1902283;GO:0046677;GO:0006805;, C:cell surface; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:microvillus; C:plasma membrane;, F:aliphatic-amine oxidase activity; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; F:calcium ion binding; F:copper ion binding; F:identical protein binding; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; F:primary amine oxidase activity; F:protein heterodimerization activity; F:quinone binding; F:tryptamine:oxygen oxidoreductase (deaminating) activity;, P:amine metabolic process; P:cell adhesion; P:inflammatory response; P:negative regulation of primary amine oxidase activity; P:response to antibiotic; P:xenobiotic metabolic process; scaffold61 indexed_genome mRNA 9136518 9137535 . + . ID=transcript_10729;Q16853 B2RCI5 K7ESB3 L0L8N9 Q45F94,Membrane primary amine oxidase,Copper amine oxidase;HPAO;Semicarbazide-sensitive amine oxidase;Vascular adhesion protein 1;, PF01179;PF02727;PF02728;, GO:0009986;GO:0005737;GO:0005769;GO:0005783;GO:0005794;GO:0016021;GO:0005902;GO:0005886;GO:0052595;GO:0052594;GO:0005509;GO:0005507;GO:0042802;GO:0052596;GO:0008131;GO:0046982;GO:0048038;GO:0052593;GO:0009308;GO:0007155;GO:0006954;GO:1902283;GO:0046677;GO:0006805;, C:cell surface; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:microvillus; C:plasma membrane;, F:aliphatic-amine oxidase activity; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; F:calcium ion binding; F:copper ion binding; F:identical protein binding; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; F:primary amine oxidase activity; F:protein heterodimerization activity; F:quinone binding; F:tryptamine:oxygen oxidoreductase (deaminating) activity;, P:amine metabolic process; P:cell adhesion; P:inflammatory response; P:negative regulation of primary amine oxidase activity; P:response to antibiotic; P:xenobiotic metabolic process; scaffold61 indexed_genome mRNA 9137589 9138812 . + . ID=transcript_10730;Q16853 B2RCI5 K7ESB3 L0L8N9 Q45F94,Membrane primary amine oxidase,Copper amine oxidase;HPAO;Semicarbazide-sensitive amine oxidase;Vascular adhesion protein 1;, PF01179;PF02727;PF02728;, GO:0009986;GO:0005737;GO:0005769;GO:0005783;GO:0005794;GO:0016021;GO:0005902;GO:0005886;GO:0052595;GO:0052594;GO:0005509;GO:0005507;GO:0042802;GO:0052596;GO:0008131;GO:0046982;GO:0048038;GO:0052593;GO:0009308;GO:0007155;GO:0006954;GO:1902283;GO:0046677;GO:0006805;, C:cell surface; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:microvillus; C:plasma membrane;, F:aliphatic-amine oxidase activity; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; F:calcium ion binding; F:copper ion binding; F:identical protein binding; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; F:primary amine oxidase activity; F:protein heterodimerization activity; F:quinone binding; F:tryptamine:oxygen oxidoreductase (deaminating) activity;, P:amine metabolic process; P:cell adhesion; P:inflammatory response; P:negative regulation of primary amine oxidase activity; P:response to antibiotic; P:xenobiotic metabolic process; scaffold61 indexed_genome mRNA 9142767 9144163 . + . ID=transcript_10731;Q16853 B2RCI5 K7ESB3 L0L8N9 Q45F94,Membrane primary amine oxidase,Copper amine oxidase;HPAO;Semicarbazide-sensitive amine oxidase;Vascular adhesion protein 1;, PF01179;PF02727;PF02728;, GO:0009986;GO:0005737;GO:0005769;GO:0005783;GO:0005794;GO:0016021;GO:0005902;GO:0005886;GO:0052595;GO:0052594;GO:0005509;GO:0005507;GO:0042802;GO:0052596;GO:0008131;GO:0046982;GO:0048038;GO:0052593;GO:0009308;GO:0007155;GO:0006954;GO:1902283;GO:0046677;GO:0006805;, C:cell surface; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:microvillus; C:plasma membrane;, F:aliphatic-amine oxidase activity; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; F:calcium ion binding; F:copper ion binding; F:identical protein binding; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; F:primary amine oxidase activity; F:protein heterodimerization activity; F:quinone binding; F:tryptamine:oxygen oxidoreductase (deaminating) activity;, P:amine metabolic process; P:cell adhesion; P:inflammatory response; P:negative regulation of primary amine oxidase activity; P:response to antibiotic; P:xenobiotic metabolic process; scaffold61 indexed_genome mRNA 9144626 9178835 . + . ID=transcript_10732;Q14457 B2R6N7 O75595 Q9UNA8,Beclin-1,Coiled-coil myosin-like BCL2-interacting protein;Protein GT197;, PF04111;PF17675;PF15285;, GO:0005776;GO:0005829;GO:0030425;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0019898;GO:0031966;GO:0005634;GO:0045335;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0005802;GO:0051020;GO:0042802;GO:0043548;GO:0019901;GO:0031625;GO:0007568;GO:0050435;GO:0006915;GO:0000045;GO:0006914;GO:0000422;GO:0051301;GO:0006968;GO:0071275;GO:0034198;GO:0071280;GO:0071364;GO:0042149;GO:0070301;GO:0006995;GO:0051607;GO:0045022;GO:0043652;GO:0045324;GO:0007040;GO:0016236;GO:0000423;GO:0007080;GO:0043066;GO:1902902;GO:0060548;GO:0008285;GO:1905672;GO:2000378;GO:0048666;GO:1902425;GO:2000786;GO:0010613;GO:2001244;GO:0014068;GO:0016579;GO:0032801;GO:0050790;GO:0032465;GO:0042493;GO:0001666;GO:0010040;GO:0010288;GO:0098780;GO:0033197;GO:0016032;, C:autophagosome; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extrinsic component of membrane; C:mitochondrial membrane; C:nucleus; C:phagocytic vesicle; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II; C:trans-Golgi network;, F:GTPase binding; F:identical protein binding; F:phosphatidylinositol 3-kinase binding; F:protein kinase binding; F:ubiquitin protein ligase binding;, P:aging; P:amyloid-beta metabolic process; P:apoptotic process; P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:cell division; P:cellular defense response; P:cellular response to aluminum ion; P:cellular response to amino acid starvation; P:cellular response to copper ion; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to nitrogen starvation; P:defense response to virus; P:early endosome to late endosome transport; P:engulfment of apoptotic cell; P:late endosome to vacuole transport; P:lysosome organization; P:macroautophagy; P:mitophagy; P:mitotic metaphase plate congression; P:negative regulation of apoptotic process; P:negative regulation of autophagosome assembly; P:negative regulation of cell death; P:negative regulation of cell population proliferation; P:negative regulation of lysosome organization; P:negative regulation of reactive oxygen species metabolic process; P:neuron development; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; P:positive regulation of autophagosome assembly; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein deubiquitination; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of cytokinesis; P:response to drug; P:response to hypoxia; P:response to iron(II) ion; P:response to lead ion; P:response to mitochondrial depolarisation; P:response to vitamin E; P:viral process;|Q16853 B2RCI5 K7ESB3 L0L8N9 Q45F94,Membrane primary amine oxidase,Copper amine oxidase;HPAO;Semicarbazide-sensitive amine oxidase;Vascular adhesion protein 1;, PF01179;PF02727;PF02728;, GO:0009986;GO:0005737;GO:0005769;GO:0005783;GO:0005794;GO:0016021;GO:0005902;GO:0005886;GO:0052595;GO:0052594;GO:0005509;GO:0005507;GO:0042802;GO:0052596;GO:0008131;GO:0046982;GO:0048038;GO:0052593;GO:0009308;GO:0007155;GO:0006954;GO:1902283;GO:0046677;GO:0006805;, C:cell surface; C:cytoplasm; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:microvillus; C:plasma membrane;, F:aliphatic-amine oxidase activity; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; F:calcium ion binding; F:copper ion binding; F:identical protein binding; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; F:primary amine oxidase activity; F:protein heterodimerization activity; F:quinone binding; F:tryptamine:oxygen oxidoreductase (deaminating) activity;, P:amine metabolic process; P:cell adhesion; P:inflammatory response; P:negative regulation of primary amine oxidase activity; P:response to antibiotic; P:xenobiotic metabolic process;|O75106 A5PKW2 O00120 O75105 Q4TTW5 Q9UNY0,Retina-specific copper amine oxidase,Amine oxidase [copper-containing];Semicarbazide-sensitive amine oxidase;, PF01179;PF02727;PF02728;, GO:0005737;GO:0005886;GO:0052595;GO:0052594;GO:0005507;GO:0009055;GO:0052596;GO:0008131;GO:0048038;GO:0052593;GO:0009308;GO:0006584;GO:0007601;GO:0006805;, C:cytoplasm; C:plasma membrane;, F:aliphatic-amine oxidase activity; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; F:copper ion binding; F:electron transfer activity; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; F:primary amine oxidase activity; F:quinone binding; F:tryptamine:oxygen oxidoreductase (deaminating) activity;, P:amine metabolic process; P:catecholamine metabolic process; P:visual perception; P:xenobiotic metabolic process;|P61289 A8K9A3 O35563 P97373 Q12920 Q13172 Q9BQD9,Proteasome activator complex subunit 3,11S regulator complex subunit gamma;Activator of multicatalytic protease subunit 3;Ki nuclear autoantigen;Proteasome activator 28 subunit gamma;, PF02251;PF02252;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0008537;GO:0000502;GO:0061133;GO:0042802;GO:0097371;GO:0002039;GO:0031145;GO:0002479;GO:0006915;GO:0007049;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:2001237;GO:0010972;GO:0038061;GO:0090263;GO:0010950;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:2000045;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome activator complex; C:proteasome complex;, F:endopeptidase activator activity; F:identical protein binding; F:MDM2/MDM4 family protein binding; F:p53 binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic process; P:cell cycle; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endopeptidase activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P61289 A8K9A3 O35563 P97373 Q12920 Q13172 Q9BQD9,Proteasome activator complex subunit 3,11S regulator complex subunit gamma;Activator of multicatalytic protease subunit 3;Ki nuclear autoantigen;Proteasome activator 28 subunit gamma;, PF02251;PF02252;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0008537;GO:0000502;GO:0061133;GO:0042802;GO:0097371;GO:0002039;GO:0031145;GO:0002479;GO:0006915;GO:0007049;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:2001237;GO:0010972;GO:0038061;GO:0090263;GO:0010950;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:2000045;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome activator complex; C:proteasome complex;, F:endopeptidase activator activity; F:identical protein binding; F:MDM2/MDM4 family protein binding; F:p53 binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic process; P:cell cycle; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endopeptidase activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|Q14457 B2R6N7 O75595 Q9UNA8,Beclin-1,Coiled-coil myosin-like BCL2-interacting protein;Protein GT197;, PF04111;PF17675;PF15285;, GO:0005776;GO:0005829;GO:0030425;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0019898;GO:0031966;GO:0005634;GO:0045335;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0005802;GO:0051020;GO:0042802;GO:0043548;GO:0019901;GO:0031625;GO:0007568;GO:0050435;GO:0006915;GO:0000045;GO:0006914;GO:0000422;GO:0051301;GO:0006968;GO:0071275;GO:0034198;GO:0071280;GO:0071364;GO:0042149;GO:0070301;GO:0006995;GO:0051607;GO:0045022;GO:0043652;GO:0045324;GO:0007040;GO:0016236;GO:0000423;GO:0007080;GO:0043066;GO:1902902;GO:0060548;GO:0008285;GO:1905672;GO:2000378;GO:0048666;GO:1902425;GO:2000786;GO:0010613;GO:2001244;GO:0014068;GO:0016579;GO:0032801;GO:0050790;GO:0032465;GO:0042493;GO:0001666;GO:0010040;GO:0010288;GO:0098780;GO:0033197;GO:0016032;, C:autophagosome; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extrinsic component of membrane; C:mitochondrial membrane; C:nucleus; C:phagocytic vesicle; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II; C:trans-Golgi network;, F:GTPase binding; F:identical protein binding; F:phosphatidylinositol 3-kinase binding; F:protein kinase binding; F:ubiquitin protein ligase binding;, P:aging; P:amyloid-beta metabolic process; P:apoptotic process; P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:cell division; P:cellular defense response; P:cellular response to aluminum ion; P:cellular response to amino acid starvation; P:cellular response to copper ion; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to nitrogen starvation; P:defense response to virus; P:early endosome to late endosome transport; P:engulfment of apoptotic cell; P:late endosome to vacuole transport; P:lysosome organization; P:macroautophagy; P:mitophagy; P:mitotic metaphase plate congression; P:negative regulation of apoptotic process; P:negative regulation of autophagosome assembly; P:negative regulation of cell death; P:negative regulation of cell population proliferation; P:negative regulation of lysosome organization; P:negative regulation of reactive oxygen species metabolic process; P:neuron development; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; P:positive regulation of autophagosome assembly; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein deubiquitination; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of cytokinesis; P:response to drug; P:response to hypoxia; P:response to iron(II) ion; P:response to lead ion; P:response to mitochondrial depolarisation; P:response to vitamin E; P:viral process;|Q14457 B2R6N7 O75595 Q9UNA8,Beclin-1,Coiled-coil myosin-like BCL2-interacting protein;Protein GT197;, PF04111;PF17675;PF15285;, GO:0005776;GO:0005829;GO:0030425;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0019898;GO:0031966;GO:0005634;GO:0045335;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0005802;GO:0051020;GO:0042802;GO:0043548;GO:0019901;GO:0031625;GO:0007568;GO:0050435;GO:0006915;GO:0000045;GO:0006914;GO:0000422;GO:0051301;GO:0006968;GO:0071275;GO:0034198;GO:0071280;GO:0071364;GO:0042149;GO:0070301;GO:0006995;GO:0051607;GO:0045022;GO:0043652;GO:0045324;GO:0007040;GO:0016236;GO:0000423;GO:0007080;GO:0043066;GO:1902902;GO:0060548;GO:0008285;GO:1905672;GO:2000378;GO:0048666;GO:1902425;GO:2000786;GO:0010613;GO:2001244;GO:0014068;GO:0016579;GO:0032801;GO:0050790;GO:0032465;GO:0042493;GO:0001666;GO:0010040;GO:0010288;GO:0098780;GO:0033197;GO:0016032;, C:autophagosome; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extrinsic component of membrane; C:mitochondrial membrane; C:nucleus; C:phagocytic vesicle; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II; C:trans-Golgi network;, F:GTPase binding; F:identical protein binding; F:phosphatidylinositol 3-kinase binding; F:protein kinase binding; F:ubiquitin protein ligase binding;, P:aging; P:amyloid-beta metabolic process; P:apoptotic process; P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:cell division; P:cellular defense response; P:cellular response to aluminum ion; P:cellular response to amino acid starvation; P:cellular response to copper ion; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to nitrogen starvation; P:defense response to virus; P:early endosome to late endosome transport; P:engulfment of apoptotic cell; P:late endosome to vacuole transport; P:lysosome organization; P:macroautophagy; P:mitophagy; P:mitotic metaphase plate congression; P:negative regulation of apoptotic process; P:negative regulation of autophagosome assembly; P:negative regulation of cell death; P:negative regulation of cell population proliferation; P:negative regulation of lysosome organization; P:negative regulation of reactive oxygen species metabolic process; P:neuron development; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; P:positive regulation of autophagosome assembly; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein deubiquitination; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of cytokinesis; P:response to drug; P:response to hypoxia; P:response to iron(II) ion; P:response to lead ion; P:response to mitochondrial depolarisation; P:response to vitamin E; P:viral process;|Q14457 B2R6N7 O75595 Q9UNA8,Beclin-1,Coiled-coil myosin-like BCL2-interacting protein;Protein GT197;, PF04111;PF17675;PF15285;, GO:0005776;GO:0005829;GO:0030425;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0019898;GO:0031966;GO:0005634;GO:0045335;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0005802;GO:0051020;GO:0042802;GO:0043548;GO:0019901;GO:0031625;GO:0007568;GO:0050435;GO:0006915;GO:0000045;GO:0006914;GO:0000422;GO:0051301;GO:0006968;GO:0071275;GO:0034198;GO:0071280;GO:0071364;GO:0042149;GO:0070301;GO:0006995;GO:0051607;GO:0045022;GO:0043652;GO:0045324;GO:0007040;GO:0016236;GO:0000423;GO:0007080;GO:0043066;GO:1902902;GO:0060548;GO:0008285;GO:1905672;GO:2000378;GO:0048666;GO:1902425;GO:2000786;GO:0010613;GO:2001244;GO:0014068;GO:0016579;GO:0032801;GO:0050790;GO:0032465;GO:0042493;GO:0001666;GO:0010040;GO:0010288;GO:0098780;GO:0033197;GO:0016032;, C:autophagosome; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extrinsic component of membrane; C:mitochondrial membrane; C:nucleus; C:phagocytic vesicle; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II; C:trans-Golgi network;, F:GTPase binding; F:identical protein binding; F:phosphatidylinositol 3-kinase binding; F:protein kinase binding; F:ubiquitin protein ligase binding;, P:aging; P:amyloid-beta metabolic process; P:apoptotic process; P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:cell division; P:cellular defense response; P:cellular response to aluminum ion; P:cellular response to amino acid starvation; P:cellular response to copper ion; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to nitrogen starvation; P:defense response to virus; P:early endosome to late endosome transport; P:engulfment of apoptotic cell; P:late endosome to vacuole transport; P:lysosome organization; P:macroautophagy; P:mitophagy; P:mitotic metaphase plate congression; P:negative regulation of apoptotic process; P:negative regulation of autophagosome assembly; P:negative regulation of cell death; P:negative regulation of cell population proliferation; P:negative regulation of lysosome organization; P:negative regulation of reactive oxygen species metabolic process; P:neuron development; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; P:positive regulation of autophagosome assembly; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein deubiquitination; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of cytokinesis; P:response to drug; P:response to hypoxia; P:response to iron(II) ion; P:response to lead ion; P:response to mitochondrial depolarisation; P:response to vitamin E; P:viral process;|Q14457 B2R6N7 O75595 Q9UNA8,Beclin-1,Coiled-coil myosin-like BCL2-interacting protein;Protein GT197;, PF04111;PF17675;PF15285;, GO:0005776;GO:0005829;GO:0030425;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0019898;GO:0031966;GO:0005634;GO:0045335;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0005802;GO:0051020;GO:0042802;GO:0043548;GO:0019901;GO:0031625;GO:0007568;GO:0050435;GO:0006915;GO:0000045;GO:0006914;GO:0000422;GO:0051301;GO:0006968;GO:0071275;GO:0034198;GO:0071280;GO:0071364;GO:0042149;GO:0070301;GO:0006995;GO:0051607;GO:0045022;GO:0043652;GO:0045324;GO:0007040;GO:0016236;GO:0000423;GO:0007080;GO:0043066;GO:1902902;GO:0060548;GO:0008285;GO:1905672;GO:2000378;GO:0048666;GO:1902425;GO:2000786;GO:0010613;GO:2001244;GO:0014068;GO:0016579;GO:0032801;GO:0050790;GO:0032465;GO:0042493;GO:0001666;GO:0010040;GO:0010288;GO:0098780;GO:0033197;GO:0016032;, C:autophagosome; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extrinsic component of membrane; C:mitochondrial membrane; C:nucleus; C:phagocytic vesicle; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II; C:trans-Golgi network;, F:GTPase binding; F:identical protein binding; F:phosphatidylinositol 3-kinase binding; F:protein kinase binding; F:ubiquitin protein ligase binding;, P:aging; P:amyloid-beta metabolic process; P:apoptotic process; P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:cell division; P:cellular defense response; P:cellular response to aluminum ion; P:cellular response to amino acid starvation; P:cellular response to copper ion; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to nitrogen starvation; P:defense response to virus; P:early endosome to late endosome transport; P:engulfment of apoptotic cell; P:late endosome to vacuole transport; P:lysosome organization; P:macroautophagy; P:mitophagy; P:mitotic metaphase plate congression; P:negative regulation of apoptotic process; P:negative regulation of autophagosome assembly; P:negative regulation of cell death; P:negative regulation of cell population proliferation; P:negative regulation of lysosome organization; P:negative regulation of reactive oxygen species metabolic process; P:neuron development; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; P:positive regulation of autophagosome assembly; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein deubiquitination; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of cytokinesis; P:response to drug; P:response to hypoxia; P:response to iron(II) ion; P:response to lead ion; P:response to mitochondrial depolarisation; P:response to vitamin E; P:viral process;|Q14457 B2R6N7 O75595 Q9UNA8,Beclin-1,Coiled-coil myosin-like BCL2-interacting protein;Protein GT197;, PF04111;PF17675;PF15285;, GO:0005776;GO:0005829;GO:0030425;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0019898;GO:0031966;GO:0005634;GO:0045335;GO:0000407;GO:0035032;GO:0034271;GO:0034272;GO:0005802;GO:0051020;GO:0042802;GO:0043548;GO:0019901;GO:0031625;GO:0007568;GO:0050435;GO:0006915;GO:0000045;GO:0006914;GO:0000422;GO:0051301;GO:0006968;GO:0071275;GO:0034198;GO:0071280;GO:0071364;GO:0042149;GO:0070301;GO:0006995;GO:0051607;GO:0045022;GO:0043652;GO:0045324;GO:0007040;GO:0016236;GO:0000423;GO:0007080;GO:0043066;GO:1902902;GO:0060548;GO:0008285;GO:1905672;GO:2000378;GO:0048666;GO:1902425;GO:2000786;GO:0010613;GO:2001244;GO:0014068;GO:0016579;GO:0032801;GO:0050790;GO:0032465;GO:0042493;GO:0001666;GO:0010040;GO:0010288;GO:0098780;GO:0033197;GO:0016032;, C:autophagosome; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extrinsic component of membrane; C:mitochondrial membrane; C:nucleus; C:phagocytic vesicle; C:phagophore assembly site; C:phosphatidylinositol 3-kinase complex, class III; C:phosphatidylinositol 3-kinase complex, class III, type I; C:phosphatidylinositol 3-kinase complex, class III, type II; C:trans-Golgi network;, F:GTPase binding; F:identical protein binding; F:phosphatidylinositol 3-kinase binding; F:protein kinase binding; F:ubiquitin protein ligase binding;, P:aging; P:amyloid-beta metabolic process; P:apoptotic process; P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:cell division; P:cellular defense response; P:cellular response to aluminum ion; P:cellular response to amino acid starvation; P:cellular response to copper ion; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to nitrogen starvation; P:defense response to virus; P:early endosome to late endosome transport; P:engulfment of apoptotic cell; P:late endosome to vacuole transport; P:lysosome organization; P:macroautophagy; P:mitophagy; P:mitotic metaphase plate congression; P:negative regulation of apoptotic process; P:negative regulation of autophagosome assembly; P:negative regulation of cell death; P:negative regulation of cell population proliferation; P:negative regulation of lysosome organization; P:negative regulation of reactive oxygen species metabolic process; P:neuron development; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; P:positive regulation of autophagosome assembly; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein deubiquitination; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of cytokinesis; P:response to drug; P:response to hypoxia; P:response to iron(II) ion; P:response to lead ion; P:response to mitochondrial depolarisation; P:response to vitamin E; P:viral process; scaffold61 indexed_genome mRNA 9188759 9189882 . - . ID=transcript_10733;Q9Y2R0 A8K498,Cytochrome c oxidase assembly factor 3 homolog, mitochondrial,Coiled-coil domain-containing protein 56;Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 12 kDa;, PF09813;, GO:0031305;GO:0005739;GO:0033617;GO:0070131;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial cytochrome c oxidase assembly; P:positive regulation of mitochondrial translation;|Q9Y2R0 A8K498,Cytochrome c oxidase assembly factor 3 homolog, mitochondrial,Coiled-coil domain-containing protein 56;Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 12 kDa;, PF09813;, GO:0031305;GO:0005739;GO:0033617;GO:0070131;, C:integral component of mitochondrial inner membrane; C:mitochondrion;, , P:mitochondrial cytochrome c oxidase assembly; P:positive regulation of mitochondrial translation; scaffold61 indexed_genome mRNA 9190951 9192485 . - . ID=transcript_10734;Q96J92 B0LPI0 Q8N8X3 Q8N8Z2 Q96DT8 Q9BYS5,Serine/threonine-protein kinase WNK4 {ECO:0000305},Protein kinase lysine-deficient 4 {ECO:0000312|HGNC:HGNC:14544};Protein kinase with no lysine 4 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005923;GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0019869;GO:0019870;GO:0106310;GO:0004674;GO:0106311;GO:0006821;GO:0072156;GO:0035556;GO:0050801;GO:0006811;GO:0090188;GO:0010766;GO:1903288;GO:2000651;GO:0008104;GO:0006468;GO:0050794;GO:0070294;, C:bicellular tight junction; C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:chloride transport; P:distal tubule morphogenesis; P:intracellular signal transduction; P:ion homeostasis; P:ion transport; P:negative regulation of pancreatic juice secretion; P:negative regulation of sodium ion transport; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:protein localization; P:protein phosphorylation; P:regulation of cellular process; P:renal sodium ion absorption; scaffold61 indexed_genome mRNA 9192974 9201134 . - . ID=transcript_10735;Q96J92 B0LPI0 Q8N8X3 Q8N8Z2 Q96DT8 Q9BYS5,Serine/threonine-protein kinase WNK4 {ECO:0000305},Protein kinase lysine-deficient 4 {ECO:0000312|HGNC:HGNC:14544};Protein kinase with no lysine 4 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005923;GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0019869;GO:0019870;GO:0106310;GO:0004674;GO:0106311;GO:0006821;GO:0072156;GO:0035556;GO:0050801;GO:0006811;GO:0090188;GO:0010766;GO:1903288;GO:2000651;GO:0008104;GO:0006468;GO:0050794;GO:0070294;, C:bicellular tight junction; C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:chloride transport; P:distal tubule morphogenesis; P:intracellular signal transduction; P:ion homeostasis; P:ion transport; P:negative regulation of pancreatic juice secretion; P:negative regulation of sodium ion transport; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:protein localization; P:protein phosphorylation; P:regulation of cellular process; P:renal sodium ion absorption; scaffold61 indexed_genome mRNA 9206636 9214135 . - . ID=transcript_10736;Q9BRG1 B2R581,Vacuolar protein-sorting-associated protein 25,Dermal papilla-derived protein 9;ELL-associated protein of 20 kDa;ESCRT-II complex subunit VPS25;, PF05871;, GO:0005737;GO:0005829;GO:0010008;GO:0000814;GO:0070062;GO:0005654;GO:0005634;GO:0042803;GO:0047485;GO:0005198;GO:0016197;GO:0016236;GO:0036258;GO:0007175;GO:0043328;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT II complex; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:protein homodimerization activity; F:protein N-terminus binding; F:structural molecule activity;, P:endosomal transport; P:macroautophagy; P:multivesicular body assembly; P:negative regulation of epidermal growth factor-activated receptor activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9BRG1 B2R581,Vacuolar protein-sorting-associated protein 25,Dermal papilla-derived protein 9;ELL-associated protein of 20 kDa;ESCRT-II complex subunit VPS25;, PF05871;, GO:0005737;GO:0005829;GO:0010008;GO:0000814;GO:0070062;GO:0005654;GO:0005634;GO:0042803;GO:0047485;GO:0005198;GO:0016197;GO:0016236;GO:0036258;GO:0007175;GO:0043328;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT II complex; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:protein homodimerization activity; F:protein N-terminus binding; F:structural molecule activity;, P:endosomal transport; P:macroautophagy; P:multivesicular body assembly; P:negative regulation of epidermal growth factor-activated receptor activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9BRG1 B2R581,Vacuolar protein-sorting-associated protein 25,Dermal papilla-derived protein 9;ELL-associated protein of 20 kDa;ESCRT-II complex subunit VPS25;, PF05871;, GO:0005737;GO:0005829;GO:0010008;GO:0000814;GO:0070062;GO:0005654;GO:0005634;GO:0042803;GO:0047485;GO:0005198;GO:0016197;GO:0016236;GO:0036258;GO:0007175;GO:0043328;, C:cytoplasm; C:cytosol; C:endosome membrane; C:ESCRT II complex; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:protein homodimerization activity; F:protein N-terminus binding; F:structural molecule activity;, P:endosomal transport; P:macroautophagy; P:multivesicular body assembly; P:negative regulation of epidermal growth factor-activated receptor activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold61 indexed_genome mRNA 9215285 9224183 . - . ID=transcript_10737;O60895 A7L9S6 K7EMD3 Q8N1F2,Receptor activity-modifying protein 2,Calcitonin-receptor-like receptor activity-modifying protein 2;, PF04901;, GO:1903143;GO:0150057;GO:0009986;GO:0005905;GO:0005737;GO:0005887;GO:0005764;GO:0005886;GO:0043235;GO:1990409;GO:0001605;GO:0015026;GO:0007189;GO:0034333;GO:1990410;GO:0097647;GO:0001525;GO:0070831;GO:0070830;GO:0006816;GO:0032870;GO:0035924;GO:0007565;GO:0007186;GO:0007507;GO:0006886;GO:2000352;GO:0002862;GO:0043116;GO:0045766;GO:0010628;GO:0032092;GO:2001214;GO:0072659;GO:0015031;GO:0031623;GO:0008217;GO:0008277;GO:0032355;GO:0001666;GO:0032570;GO:0002040;GO:0097084;GO:0001570;, C:adrenomedullin receptor complex; C:amylin receptor complex 2; C:cell surface; C:clathrin-coated pit; C:cytoplasm; C:integral component of plasma membrane; C:lysosome; C:plasma membrane; C:receptor complex;, F:adrenomedullin binding; F:adrenomedullin receptor activity; F:coreceptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adherens junction assembly; P:adrenomedullin receptor signaling pathway; P:amylin receptor signaling pathway; P:angiogenesis; P:basement membrane assembly; P:bicellular tight junction assembly; P:calcium ion transport; P:cellular response to hormone stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:female pregnancy; P:G protein-coupled receptor signaling pathway; P:heart development; P:intracellular protein transport; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of vascular permeability; P:positive regulation of angiogenesis; P:positive regulation of gene expression; P:positive regulation of protein binding; P:positive regulation of vasculogenesis; P:protein localization to plasma membrane; P:protein transport; P:receptor internalization; P:regulation of blood pressure; P:regulation of G protein-coupled receptor signaling pathway; P:response to estradiol; P:response to hypoxia; P:response to progesterone; P:sprouting angiogenesis; P:vascular associated smooth muscle cell development; P:vasculogenesis;|O60895 A7L9S6 K7EMD3 Q8N1F2,Receptor activity-modifying protein 2,Calcitonin-receptor-like receptor activity-modifying protein 2;, PF04901;, GO:1903143;GO:0150057;GO:0009986;GO:0005905;GO:0005737;GO:0005887;GO:0005764;GO:0005886;GO:0043235;GO:1990409;GO:0001605;GO:0015026;GO:0007189;GO:0034333;GO:1990410;GO:0097647;GO:0001525;GO:0070831;GO:0070830;GO:0006816;GO:0032870;GO:0035924;GO:0007565;GO:0007186;GO:0007507;GO:0006886;GO:2000352;GO:0002862;GO:0043116;GO:0045766;GO:0010628;GO:0032092;GO:2001214;GO:0072659;GO:0015031;GO:0031623;GO:0008217;GO:0008277;GO:0032355;GO:0001666;GO:0032570;GO:0002040;GO:0097084;GO:0001570;, C:adrenomedullin receptor complex; C:amylin receptor complex 2; C:cell surface; C:clathrin-coated pit; C:cytoplasm; C:integral component of plasma membrane; C:lysosome; C:plasma membrane; C:receptor complex;, F:adrenomedullin binding; F:adrenomedullin receptor activity; F:coreceptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adherens junction assembly; P:adrenomedullin receptor signaling pathway; P:amylin receptor signaling pathway; P:angiogenesis; P:basement membrane assembly; P:bicellular tight junction assembly; P:calcium ion transport; P:cellular response to hormone stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:female pregnancy; P:G protein-coupled receptor signaling pathway; P:heart development; P:intracellular protein transport; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of vascular permeability; P:positive regulation of angiogenesis; P:positive regulation of gene expression; P:positive regulation of protein binding; P:positive regulation of vasculogenesis; P:protein localization to plasma membrane; P:protein transport; P:receptor internalization; P:regulation of blood pressure; P:regulation of G protein-coupled receptor signaling pathway; P:response to estradiol; P:response to hypoxia; P:response to progesterone; P:sprouting angiogenesis; P:vascular associated smooth muscle cell development; P:vasculogenesis; scaffold61 indexed_genome mRNA 9243012 9260391 . + . ID=transcript_10738;Q92800 A6NCH6 B4DIJ1 B4DIZ7 B4DSS2 B4E3R7 O43287 Q14459 Q53XP3,Histone-lysine N-methyltransferase EZH1,ENX-2;Enhancer of zeste homolog 1;, PF11616;PF18118;PF18264;PF00856;, GO:0000781;GO:0035098;GO:0005654;GO:0003682;GO:0018024;GO:0003714;GO:0009653;GO:0006338;GO:0006348;GO:0031507;GO:0021766;GO:0070734;GO:0000122;GO:0045944;, C:chromosome, telomeric region; C:ESC/E(Z) complex; C:nucleoplasm;, F:chromatin binding; F:histone-lysine N-methyltransferase activity; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:chromatin remodeling; P:chromatin silencing at telomere; P:heterochromatin assembly; P:hippocampus development; P:histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II;|Q92800 A6NCH6 B4DIJ1 B4DIZ7 B4DSS2 B4E3R7 O43287 Q14459 Q53XP3,Histone-lysine N-methyltransferase EZH1,ENX-2;Enhancer of zeste homolog 1;, PF11616;PF18118;PF18264;PF00856;, GO:0000781;GO:0035098;GO:0005654;GO:0003682;GO:0018024;GO:0003714;GO:0009653;GO:0006338;GO:0006348;GO:0031507;GO:0021766;GO:0070734;GO:0000122;GO:0045944;, C:chromosome, telomeric region; C:ESC/E(Z) complex; C:nucleoplasm;, F:chromatin binding; F:histone-lysine N-methyltransferase activity; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:chromatin remodeling; P:chromatin silencing at telomere; P:heterochromatin assembly; P:hippocampus development; P:histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II;|Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle;|Q92800 A6NCH6 B4DIJ1 B4DIZ7 B4DSS2 B4E3R7 O43287 Q14459 Q53XP3,Histone-lysine N-methyltransferase EZH1,ENX-2;Enhancer of zeste homolog 1;, PF11616;PF18118;PF18264;PF00856;, GO:0000781;GO:0035098;GO:0005654;GO:0003682;GO:0018024;GO:0003714;GO:0009653;GO:0006338;GO:0006348;GO:0031507;GO:0021766;GO:0070734;GO:0000122;GO:0045944;, C:chromosome, telomeric region; C:ESC/E(Z) complex; C:nucleoplasm;, F:chromatin binding; F:histone-lysine N-methyltransferase activity; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:chromatin remodeling; P:chromatin silencing at telomere; P:heterochromatin assembly; P:hippocampus development; P:histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II;|Q6QNY1 B4DQV2 Q5W040 Q8WUI8,Biogenesis of lysosome-related organelles complex 1 subunit 2,Centrosome-associated protein;, PF10046;, GO:1904115;GO:0031083;GO:0099078;GO:0005813;GO:0000930;GO:0005765;GO:0005739;GO:0005634;GO:0043015;GO:0008022;GO:0008089;GO:0048490;GO:0016197;GO:0008625;GO:0032418;GO:0032438;GO:0007020;GO:0097345;GO:0031175;GO:0060155;GO:0008284;GO:0045893;, C:axon cytoplasm; C:BLOC-1 complex; C:BORC complex; C:centrosome; C:gamma-tubulin complex; C:lysosomal membrane; C:mitochondrion; C:nucleus;, F:gamma-tubulin binding; F:protein C-terminus binding;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endosomal transport; P:extrinsic apoptotic signaling pathway via death domain receptors; P:lysosome localization; P:melanosome organization; P:microtubule nucleation; P:mitochondrial outer membrane permeabilization; P:neuron projection development; P:platelet dense granule organization; P:positive regulation of cell population proliferation; P:positive regulation of transcription, DNA-templated;|Q92800 A6NCH6 B4DIJ1 B4DIZ7 B4DSS2 B4E3R7 O43287 Q14459 Q53XP3,Histone-lysine N-methyltransferase EZH1,ENX-2;Enhancer of zeste homolog 1;, PF11616;PF18118;PF18264;PF00856;, GO:0000781;GO:0035098;GO:0005654;GO:0003682;GO:0018024;GO:0003714;GO:0009653;GO:0006338;GO:0006348;GO:0031507;GO:0021766;GO:0070734;GO:0000122;GO:0045944;, C:chromosome, telomeric region; C:ESC/E(Z) complex; C:nucleoplasm;, F:chromatin binding; F:histone-lysine N-methyltransferase activity; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:chromatin remodeling; P:chromatin silencing at telomere; P:heterochromatin assembly; P:hippocampus development; P:histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II;|Q92800 A6NCH6 B4DIJ1 B4DIZ7 B4DSS2 B4E3R7 O43287 Q14459 Q53XP3,Histone-lysine N-methyltransferase EZH1,ENX-2;Enhancer of zeste homolog 1;, PF11616;PF18118;PF18264;PF00856;, GO:0000781;GO:0035098;GO:0005654;GO:0003682;GO:0018024;GO:0003714;GO:0009653;GO:0006338;GO:0006348;GO:0031507;GO:0021766;GO:0070734;GO:0000122;GO:0045944;, C:chromosome, telomeric region; C:ESC/E(Z) complex; C:nucleoplasm;, F:chromatin binding; F:histone-lysine N-methyltransferase activity; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:chromatin remodeling; P:chromatin silencing at telomere; P:heterochromatin assembly; P:hippocampus development; P:histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II;|Q92800 A6NCH6 B4DIJ1 B4DIZ7 B4DSS2 B4E3R7 O43287 Q14459 Q53XP3,Histone-lysine N-methyltransferase EZH1,ENX-2;Enhancer of zeste homolog 1;, PF11616;PF18118;PF18264;PF00856;, GO:0000781;GO:0035098;GO:0005654;GO:0003682;GO:0018024;GO:0003714;GO:0009653;GO:0006338;GO:0006348;GO:0031507;GO:0021766;GO:0070734;GO:0000122;GO:0045944;, C:chromosome, telomeric region; C:ESC/E(Z) complex; C:nucleoplasm;, F:chromatin binding; F:histone-lysine N-methyltransferase activity; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:chromatin remodeling; P:chromatin silencing at telomere; P:heterochromatin assembly; P:hippocampus development; P:histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; scaffold61 indexed_genome mRNA 9260424 9266127 . + . ID=transcript_10739;Q92800 A6NCH6 B4DIJ1 B4DIZ7 B4DSS2 B4E3R7 O43287 Q14459 Q53XP3,Histone-lysine N-methyltransferase EZH1,ENX-2;Enhancer of zeste homolog 1;, PF11616;PF18118;PF18264;PF00856;, GO:0000781;GO:0035098;GO:0005654;GO:0003682;GO:0018024;GO:0003714;GO:0009653;GO:0006338;GO:0006348;GO:0031507;GO:0021766;GO:0070734;GO:0000122;GO:0045944;, C:chromosome, telomeric region; C:ESC/E(Z) complex; C:nucleoplasm;, F:chromatin binding; F:histone-lysine N-methyltransferase activity; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:chromatin remodeling; P:chromatin silencing at telomere; P:heterochromatin assembly; P:hippocampus development; P:histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II;|Q92800 A6NCH6 B4DIJ1 B4DIZ7 B4DSS2 B4E3R7 O43287 Q14459 Q53XP3,Histone-lysine N-methyltransferase EZH1,ENX-2;Enhancer of zeste homolog 1;, PF11616;PF18118;PF18264;PF00856;, GO:0000781;GO:0035098;GO:0005654;GO:0003682;GO:0018024;GO:0003714;GO:0009653;GO:0006338;GO:0006348;GO:0031507;GO:0021766;GO:0070734;GO:0000122;GO:0045944;, C:chromosome, telomeric region; C:ESC/E(Z) complex; C:nucleoplasm;, F:chromatin binding; F:histone-lysine N-methyltransferase activity; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:chromatin remodeling; P:chromatin silencing at telomere; P:heterochromatin assembly; P:hippocampus development; P:histone H3-K27 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II;|Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6,Histone-lysine N-methyltransferase EZH2 {ECO:0000305},ENX-1;Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};Lysine N-methyltransferase 6;, PF11616;PF18118;PF18264;PF00856;, GO:0000785;GO:0005677;GO:0000781;GO:0005737;GO:0035098;GO:0005654;GO:0005634;GO:0045120;GO:0003682;GO:0031490;GO:0042054;GO:0046976;GO:0018024;GO:0070878;GO:1990841;GO:0043021;GO:0000978;GO:0000979;GO:0001226;GO:0003714;GO:0030183;GO:0014898;GO:0048468;GO:0070301;GO:0035984;GO:0021695;GO:0006325;GO:0006348;GO:0006306;GO:0070314;GO:0036333;GO:0021766;GO:0070734;GO:0098532;GO:0016571;GO:0097421;GO:0043433;GO:0045605;GO:0070317;GO:2000134;GO:0045814;GO:0048387;GO:0051154;GO:0000122;GO:0034244;GO:0045892;GO:1902808;GO:0008284;GO:1900006;GO:0010718;GO:0043547;GO:0043406;GO:0071902;GO:0071168;GO:0042752;GO:0014013;GO:0006355;GO:0032355;GO:1904772;GO:0048511;GO:0014834;GO:0019058;, C:chromatin; C:chromatin silencing complex; C:chromosome, telomeric region; C:cytoplasm; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:pronucleus;, F:chromatin binding; F:chromatin DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K27 specific); F:histone-lysine N-methyltransferase activity; F:primary miRNA binding; F:promoter-specific chromatin binding; F:ribonucleoprotein complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity;, P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cell development; P:cellular response to hydrogen peroxide; P:cellular response to trichostatin A; P:cerebellar cortex development; P:chromatin organization; P:chromatin silencing at telomere; P:DNA methylation; P:G1 to G0 transition; P:hepatocyte homeostasis; P:hippocampus development; P:histone H3-K27 methylation; P:histone H3-K27 trimethylation; P:histone methylation; P:liver regeneration; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of epidermal cell differentiation; P:negative regulation of G0 to G1 transition; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression, epigenetic; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of striated muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of GTPase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein serine/threonine kinase activity; P:protein localization to chromatin; P:regulation of circadian rhythm; P:regulation of gliogenesis; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to tetrachloromethane; P:rhythmic process; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; P:viral life cycle; scaffold61 indexed_genome mRNA 9266305 9280329 . - . ID=transcript_10740;P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction;|P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction;|P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction;|P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction;|P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction;|P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction;|P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction;|P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction;|P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction;|P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction; scaffold61 indexed_genome mRNA 9280338 9281697 . - . ID=transcript_10741;P78357,Contactin-associated protein 1,Neurexin IV;Neurexin-4;p190;, PF00754;PF02210;, GO:0016021;GO:0005887;GO:0033010;GO:0033270;GO:0048787;GO:0017124;GO:0038023;GO:0007155;GO:0022010;GO:0007010;GO:0022011;GO:0050885;GO:0050884;GO:0048812;GO:0019227;GO:0030913;GO:0071205;GO:0002175;GO:0007165;, C:integral component of membrane; C:integral component of plasma membrane; C:paranodal junction; C:paranode region of axon; C:presynaptic active zone membrane;, F:SH3 domain binding; F:signaling receptor activity;, P:cell adhesion; P:central nervous system myelination; P:cytoskeleton organization; P:myelination in peripheral nervous system; P:neuromuscular process controlling balance; P:neuromuscular process controlling posture; P:neuron projection morphogenesis; P:neuronal action potential propagation; P:paranodal junction assembly; P:protein localization to juxtaparanode region of axon; P:protein localization to paranode region of axon; P:signal transduction; scaffold61 indexed_genome mRNA 9281711 9283958 . - . ID=transcript_10742;P46092 Q4V749 Q6T7X2 Q9NZG2,C-C chemokine receptor type 10,G-protein coupled receptor 2;, PF00001;, GO:0009986;GO:0005783;GO:0009897;GO:0005887;GO:0005886;GO:0019957;GO:0016493;GO:0004930;GO:0019722;GO:0060326;GO:0007186;GO:0006955;GO:0007204;, C:cell surface; C:endoplasmic reticulum; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:G protein-coupled receptor activity;, P:calcium-mediated signaling; P:cell chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:positive regulation of cytosolic calcium ion concentration; scaffold61 indexed_genome mRNA 9285645 9300662 . + . ID=transcript_10743;Q7Z736 C9JQ76 Q59H20 Q96B28 Q9H7D6 Q9NT18,Pleckstrin homology domain-containing family H member 3,, PF00373;PF00784;PF00788;, GO:0005856;GO:0005615;GO:0007165;, C:cytoskeleton; C:extracellular space;, , P:signal transduction;|Q7Z736 C9JQ76 Q59H20 Q96B28 Q9H7D6 Q9NT18,Pleckstrin homology domain-containing family H member 3,, PF00373;PF00784;PF00788;, GO:0005856;GO:0005615;GO:0007165;, C:cytoskeleton; C:extracellular space;, , P:signal transduction;|Q7Z736 C9JQ76 Q59H20 Q96B28 Q9H7D6 Q9NT18,Pleckstrin homology domain-containing family H member 3,, PF00373;PF00784;PF00788;, GO:0005856;GO:0005615;GO:0007165;, C:cytoskeleton; C:extracellular space;, , P:signal transduction;|Q9NRH3 A6NDI4 Q32NB2,Tubulin gamma-2 chain,Gamma-2-tubulin;, PF00091;PF03953;, GO:0005813;GO:0005737;GO:0005881;GO:0005829;GO:0000930;GO:0005874;GO:0015630;GO:0005634;GO:0000242;GO:0005819;GO:0005876;GO:0005525;GO:0003924;GO:0005200;GO:0005198;GO:0031122;GO:0000212;GO:0000226;GO:0007020;GO:0000278;GO:0000070;GO:0007052;, C:centrosome; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:gamma-tubulin complex; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:pericentriolar material; C:spindle; C:spindle microtubule;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic spindle organization; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:mitotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle organization;|Q9NRH3 A6NDI4 Q32NB2,Tubulin gamma-2 chain,Gamma-2-tubulin;, PF00091;PF03953;, GO:0005813;GO:0005737;GO:0005881;GO:0005829;GO:0000930;GO:0005874;GO:0015630;GO:0005634;GO:0000242;GO:0005819;GO:0005876;GO:0005525;GO:0003924;GO:0005200;GO:0005198;GO:0031122;GO:0000212;GO:0000226;GO:0007020;GO:0000278;GO:0000070;GO:0007052;, C:centrosome; C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:gamma-tubulin complex; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:pericentriolar material; C:spindle; C:spindle microtubule;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic spindle organization; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:mitotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle organization;|P23258 Q53X79 Q9BW59,Tubulin gamma-1 chain,Gamma-1-tubulin;Gamma-tubulin complex component 1;, PF00091;PF03953;, GO:0005813;GO:0000794;GO:0005737;GO:0005829;GO:0000930;GO:0005874;GO:1990498;GO:0005634;GO:0005827;GO:0055037;GO:0005819;GO:0005525;GO:0003924;GO:0042802;GO:0005200;GO:0097711;GO:0031122;GO:0000086;GO:0000212;GO:0000226;GO:0007020;GO:0000278;GO:0000070;GO:0007052;GO:0010389;, C:centrosome; C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:gamma-tubulin complex; C:microtubule; C:mitotic spindle microtubule; C:nucleus; C:polar microtubule; C:recycling endosome; C:spindle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:structural constituent of cytoskeleton;, P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:G2/M transition of mitotic cell cycle; P:meiotic spindle organization; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:mitotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle; scaffold61 indexed_genome mRNA 9341271 9345426 . - . ID=transcript_10744;P23258 Q53X79 Q9BW59,Tubulin gamma-1 chain,Gamma-1-tubulin;Gamma-tubulin complex component 1;, PF00091;PF03953;, GO:0005813;GO:0000794;GO:0005737;GO:0005829;GO:0000930;GO:0005874;GO:1990498;GO:0005634;GO:0005827;GO:0055037;GO:0005819;GO:0005525;GO:0003924;GO:0042802;GO:0005200;GO:0097711;GO:0031122;GO:0000086;GO:0000212;GO:0000226;GO:0007020;GO:0000278;GO:0000070;GO:0007052;GO:0010389;, C:centrosome; C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:gamma-tubulin complex; C:microtubule; C:mitotic spindle microtubule; C:nucleus; C:polar microtubule; C:recycling endosome; C:spindle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:structural constituent of cytoskeleton;, P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:G2/M transition of mitotic cell cycle; P:meiotic spindle organization; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:mitotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle;|P23258 Q53X79 Q9BW59,Tubulin gamma-1 chain,Gamma-1-tubulin;Gamma-tubulin complex component 1;, PF00091;PF03953;, GO:0005813;GO:0000794;GO:0005737;GO:0005829;GO:0000930;GO:0005874;GO:1990498;GO:0005634;GO:0005827;GO:0055037;GO:0005819;GO:0005525;GO:0003924;GO:0042802;GO:0005200;GO:0097711;GO:0031122;GO:0000086;GO:0000212;GO:0000226;GO:0007020;GO:0000278;GO:0000070;GO:0007052;GO:0010389;, C:centrosome; C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:gamma-tubulin complex; C:microtubule; C:mitotic spindle microtubule; C:nucleus; C:polar microtubule; C:recycling endosome; C:spindle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:structural constituent of cytoskeleton;, P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:G2/M transition of mitotic cell cycle; P:meiotic spindle organization; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:mitotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle;|P23258 Q53X79 Q9BW59,Tubulin gamma-1 chain,Gamma-1-tubulin;Gamma-tubulin complex component 1;, PF00091;PF03953;, GO:0005813;GO:0000794;GO:0005737;GO:0005829;GO:0000930;GO:0005874;GO:1990498;GO:0005634;GO:0005827;GO:0055037;GO:0005819;GO:0005525;GO:0003924;GO:0042802;GO:0005200;GO:0097711;GO:0031122;GO:0000086;GO:0000212;GO:0000226;GO:0007020;GO:0000278;GO:0000070;GO:0007052;GO:0010389;, C:centrosome; C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:gamma-tubulin complex; C:microtubule; C:mitotic spindle microtubule; C:nucleus; C:polar microtubule; C:recycling endosome; C:spindle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:structural constituent of cytoskeleton;, P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:G2/M transition of mitotic cell cycle; P:meiotic spindle organization; P:microtubule cytoskeleton organization; P:microtubule nucleation; P:mitotic cell cycle; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:regulation of G2/M transition of mitotic cell cycle; scaffold61 indexed_genome mRNA 9346186 9365791 . + . ID=transcript_10745;Q86VR2 B3KR75,Reticulophagy regulator 3,, , GO:0016021;GO:0032991;GO:0010976;GO:0061709;, C:integral component of membrane; C:protein-containing complex;, , P:positive regulation of neuron projection development; P:reticulophagy;|Q86VR2 B3KR75,Reticulophagy regulator 3,, , GO:0016021;GO:0032991;GO:0010976;GO:0061709;, C:integral component of membrane; C:protein-containing complex;, , P:positive regulation of neuron projection development; P:reticulophagy;|Q86VR2 B3KR75,Reticulophagy regulator 3,, , GO:0016021;GO:0032991;GO:0010976;GO:0061709;, C:integral component of membrane; C:protein-containing complex;, , P:positive regulation of neuron projection development; P:reticulophagy; scaffold61 indexed_genome mRNA 9366742 9378600 . + . ID=transcript_10746;Q9P2W1 C5ILB7 Q14458 Q8WXG2 Q96HA2,Homologous-pairing protein 2 homolog,Nuclear receptor coactivator GT198;PSMC3-interacting protein;Proteasome 26S ATPase subunit 3-interacting protein;Tat-binding protein 1-interacting protein;, PF18517;PF07106;, GO:0005654;GO:0003677;GO:0030374;GO:0007131;, C:nucleoplasm;, F:DNA binding; F:nuclear receptor coactivator activity;, P:reciprocal meiotic recombination;|Q9P2W1 C5ILB7 Q14458 Q8WXG2 Q96HA2,Homologous-pairing protein 2 homolog,Nuclear receptor coactivator GT198;PSMC3-interacting protein;Proteasome 26S ATPase subunit 3-interacting protein;Tat-binding protein 1-interacting protein;, PF18517;PF07106;, GO:0005654;GO:0003677;GO:0030374;GO:0007131;, C:nucleoplasm;, F:DNA binding; F:nuclear receptor coactivator activity;, P:reciprocal meiotic recombination;|Q9NXN3,Max-like protein X,Class D basic helix-loop-helix protein 13;Max-like bHLHZip protein;Protein BigMax;Transcription factor-like protein 4;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0008134;GO:0000122;GO:0045892;GO:0045944;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9NXN3,Max-like protein X,Class D basic helix-loop-helix protein 13;Max-like bHLHZip protein;Protein BigMax;Transcription factor-like protein 4;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0008134;GO:0000122;GO:0045892;GO:0045944;GO:0006357;GO:0006355;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold61 indexed_genome mRNA 9379282 9383302 . - . ID=transcript_10747;Q13057 B2RA78 B4DLU0 Q6GS23 Q8NBM7 Q8NEW1 Q8WXD4 Q9NRM3,Bifunctional coenzyme A synthase,NBP;POV-2;, PF01121;PF01467;, GO:0070062;GO:0005759;GO:0005741;GO:0005524;GO:0004140;GO:0004595;GO:0015937;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrial outer membrane;, F:ATP binding; F:dephospho-CoA kinase activity; F:pantetheine-phosphate adenylyltransferase activity;, P:coenzyme A biosynthetic process;|Q13057 B2RA78 B4DLU0 Q6GS23 Q8NBM7 Q8NEW1 Q8WXD4 Q9NRM3,Bifunctional coenzyme A synthase,NBP;POV-2;, PF01121;PF01467;, GO:0070062;GO:0005759;GO:0005741;GO:0005524;GO:0004140;GO:0004595;GO:0015937;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrial outer membrane;, F:ATP binding; F:dephospho-CoA kinase activity; F:pantetheine-phosphate adenylyltransferase activity;, P:coenzyme A biosynthetic process;|Q13057 B2RA78 B4DLU0 Q6GS23 Q8NBM7 Q8NEW1 Q8WXD4 Q9NRM3,Bifunctional coenzyme A synthase,NBP;POV-2;, PF01121;PF01467;, GO:0070062;GO:0005759;GO:0005741;GO:0005524;GO:0004140;GO:0004595;GO:0015937;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrial outer membrane;, F:ATP binding; F:dephospho-CoA kinase activity; F:pantetheine-phosphate adenylyltransferase activity;, P:coenzyme A biosynthetic process; scaffold61 indexed_genome mRNA 9390719 9400097 . - . ID=transcript_10748;P14061 B3KXS1 Q2M2L8,17-beta-hydroxysteroid dehydrogenase type 1 {ECO:0000305},20 alpha-hydroxysteroid dehydrogenase;E2DH;Estradiol 17-beta-dehydrogenase 1 {ECO:0000305};Placental 17-beta-hydroxysteroid dehydrogenase;Short chain dehydrogenase/reductase family 28C member 1;, PF00106;, GO:0005737;GO:0005829;GO:0044594;GO:0072582;GO:0003824;GO:0035410;GO:0004303;GO:1903924;GO:0050661;GO:0070401;GO:0042803;GO:0005496;GO:0047045;GO:0030283;GO:0006703;GO:0008210;GO:0006694;GO:0061370;, C:cytoplasm; C:cytosol;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:catalytic activity; F:dihydrotestosterone 17-beta-dehydrogenase activity; F:estradiol 17-beta-dehydrogenase activity; F:estradiol binding; F:NADP binding; F:NADP+ binding; F:protein homodimerization activity; F:steroid binding; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase [NAD(P)] activity;, P:estrogen biosynthetic process; P:estrogen metabolic process; P:steroid biosynthetic process; P:testosterone biosynthetic process;|P54802,Alpha-N-acetylglucosaminidase,N-acetyl-alpha-glucosaminidase;, PF05089;PF12972;PF12971;, GO:0070062;GO:0043202;GO:0005764;GO:0004561;GO:0021680;GO:0006027;GO:0060119;GO:0045475;GO:0007040;GO:0042474;GO:0007399;GO:0046548;, C:extracellular exosome; C:lysosomal lumen; C:lysosome;, F:alpha-N-acetylglucosaminidase activity;, P:cerebellar Purkinje cell layer development; P:glycosaminoglycan catabolic process; P:inner ear receptor cell development; P:locomotor rhythm; P:lysosome organization; P:middle ear morphogenesis; P:nervous system development; P:retinal rod cell development;|P54802,Alpha-N-acetylglucosaminidase,N-acetyl-alpha-glucosaminidase;, PF05089;PF12972;PF12971;, GO:0070062;GO:0043202;GO:0005764;GO:0004561;GO:0021680;GO:0006027;GO:0060119;GO:0045475;GO:0007040;GO:0042474;GO:0007399;GO:0046548;, C:extracellular exosome; C:lysosomal lumen; C:lysosome;, F:alpha-N-acetylglucosaminidase activity;, P:cerebellar Purkinje cell layer development; P:glycosaminoglycan catabolic process; P:inner ear receptor cell development; P:locomotor rhythm; P:lysosome organization; P:middle ear morphogenesis; P:nervous system development; P:retinal rod cell development; scaffold61 indexed_genome mRNA 9400276 9404545 . - . ID=transcript_10749;P54802,Alpha-N-acetylglucosaminidase,N-acetyl-alpha-glucosaminidase;, PF05089;PF12972;PF12971;, GO:0070062;GO:0043202;GO:0005764;GO:0004561;GO:0021680;GO:0006027;GO:0060119;GO:0045475;GO:0007040;GO:0042474;GO:0007399;GO:0046548;, C:extracellular exosome; C:lysosomal lumen; C:lysosome;, F:alpha-N-acetylglucosaminidase activity;, P:cerebellar Purkinje cell layer development; P:glycosaminoglycan catabolic process; P:inner ear receptor cell development; P:locomotor rhythm; P:lysosome organization; P:middle ear morphogenesis; P:nervous system development; P:retinal rod cell development;|P54802,Alpha-N-acetylglucosaminidase,N-acetyl-alpha-glucosaminidase;, PF05089;PF12972;PF12971;, GO:0070062;GO:0043202;GO:0005764;GO:0004561;GO:0021680;GO:0006027;GO:0060119;GO:0045475;GO:0007040;GO:0042474;GO:0007399;GO:0046548;, C:extracellular exosome; C:lysosomal lumen; C:lysosome;, F:alpha-N-acetylglucosaminidase activity;, P:cerebellar Purkinje cell layer development; P:glycosaminoglycan catabolic process; P:inner ear receptor cell development; P:locomotor rhythm; P:lysosome organization; P:middle ear morphogenesis; P:nervous system development; P:retinal rod cell development; scaffold61 indexed_genome mRNA 9411300 9464646 . + . ID=transcript_10750;Q93050 B7Z3B7 Q8N5G7 Q9NSX0,V-type proton ATPase 116 kDa subunit a1,Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit;Vacuolar adenosine triphosphatase subunit Ac116;Vacuolar proton pump subunit 1;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1;, PF01496;, GO:0005829;GO:0010008;GO:0070062;GO:0101003;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0016607;GO:0048471;GO:0030670;GO:0005886;GO:0030667;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0016241;GO:1901998;GO:0033572;GO:0007035;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:nuclear speck; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:regulation of macroautophagy; P:toxin transport; P:transferrin transport; P:vacuolar acidification;|Q93050 B7Z3B7 Q8N5G7 Q9NSX0,V-type proton ATPase 116 kDa subunit a1,Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit;Vacuolar adenosine triphosphatase subunit Ac116;Vacuolar proton pump subunit 1;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1;, PF01496;, GO:0005829;GO:0010008;GO:0070062;GO:0101003;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0016607;GO:0048471;GO:0030670;GO:0005886;GO:0030667;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0016241;GO:1901998;GO:0033572;GO:0007035;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:nuclear speck; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:regulation of macroautophagy; P:toxin transport; P:transferrin transport; P:vacuolar acidification;|Q93050 B7Z3B7 Q8N5G7 Q9NSX0,V-type proton ATPase 116 kDa subunit a1,Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit;Vacuolar adenosine triphosphatase subunit Ac116;Vacuolar proton pump subunit 1;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1;, PF01496;, GO:0005829;GO:0010008;GO:0070062;GO:0101003;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0016607;GO:0048471;GO:0030670;GO:0005886;GO:0030667;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0016241;GO:1901998;GO:0033572;GO:0007035;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:nuclear speck; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:regulation of macroautophagy; P:toxin transport; P:transferrin transport; P:vacuolar acidification;|Q93050 B7Z3B7 Q8N5G7 Q9NSX0,V-type proton ATPase 116 kDa subunit a1,Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit;Vacuolar adenosine triphosphatase subunit Ac116;Vacuolar proton pump subunit 1;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1;, PF01496;, GO:0005829;GO:0010008;GO:0070062;GO:0101003;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0016607;GO:0048471;GO:0030670;GO:0005886;GO:0030667;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0016241;GO:1901998;GO:0033572;GO:0007035;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:nuclear speck; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:regulation of macroautophagy; P:toxin transport; P:transferrin transport; P:vacuolar acidification;|Q93050 B7Z3B7 Q8N5G7 Q9NSX0,V-type proton ATPase 116 kDa subunit a1,Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit;Vacuolar adenosine triphosphatase subunit Ac116;Vacuolar proton pump subunit 1;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1;, PF01496;, GO:0005829;GO:0010008;GO:0070062;GO:0101003;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0016607;GO:0048471;GO:0030670;GO:0005886;GO:0030667;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0016241;GO:1901998;GO:0033572;GO:0007035;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:nuclear speck; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:regulation of macroautophagy; P:toxin transport; P:transferrin transport; P:vacuolar acidification;|Q93050 B7Z3B7 Q8N5G7 Q9NSX0,V-type proton ATPase 116 kDa subunit a1,Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit;Vacuolar adenosine triphosphatase subunit Ac116;Vacuolar proton pump subunit 1;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1;, PF01496;, GO:0005829;GO:0010008;GO:0070062;GO:0101003;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0016607;GO:0048471;GO:0030670;GO:0005886;GO:0030667;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0016241;GO:1901998;GO:0033572;GO:0007035;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:nuclear speck; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:regulation of macroautophagy; P:toxin transport; P:transferrin transport; P:vacuolar acidification;|Q93050 B7Z3B7 Q8N5G7 Q9NSX0,V-type proton ATPase 116 kDa subunit a1,Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit;Vacuolar adenosine triphosphatase subunit Ac116;Vacuolar proton pump subunit 1;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1;, PF01496;, GO:0005829;GO:0010008;GO:0070062;GO:0101003;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0016607;GO:0048471;GO:0030670;GO:0005886;GO:0030667;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0016241;GO:1901998;GO:0033572;GO:0007035;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:nuclear speck; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:regulation of macroautophagy; P:toxin transport; P:transferrin transport; P:vacuolar acidification;|Q93050 B7Z3B7 Q8N5G7 Q9NSX0,V-type proton ATPase 116 kDa subunit a1,Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit;Vacuolar adenosine triphosphatase subunit Ac116;Vacuolar proton pump subunit 1;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1;, PF01496;, GO:0005829;GO:0010008;GO:0070062;GO:0101003;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0016607;GO:0048471;GO:0030670;GO:0005886;GO:0030667;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0016241;GO:1901998;GO:0033572;GO:0007035;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:nuclear speck; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:regulation of macroautophagy; P:toxin transport; P:transferrin transport; P:vacuolar acidification;|Q93050 B7Z3B7 Q8N5G7 Q9NSX0,V-type proton ATPase 116 kDa subunit a1,Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit;Vacuolar adenosine triphosphatase subunit Ac116;Vacuolar proton pump subunit 1;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1;, PF01496;, GO:0005829;GO:0010008;GO:0070062;GO:0101003;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0016607;GO:0048471;GO:0030670;GO:0005886;GO:0030667;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0016241;GO:1901998;GO:0033572;GO:0007035;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:nuclear speck; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:regulation of macroautophagy; P:toxin transport; P:transferrin transport; P:vacuolar acidification;|Q93050 B7Z3B7 Q8N5G7 Q9NSX0,V-type proton ATPase 116 kDa subunit a1,Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit;Vacuolar adenosine triphosphatase subunit Ac116;Vacuolar proton pump subunit 1;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1;, PF01496;, GO:0005829;GO:0010008;GO:0070062;GO:0101003;GO:0005794;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0016607;GO:0048471;GO:0030670;GO:0005886;GO:0030667;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0016241;GO:1901998;GO:0033572;GO:0007035;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:nuclear speck; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism;, P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:regulation of macroautophagy; P:toxin transport; P:transferrin transport; P:vacuolar acidification; scaffold61 indexed_genome mRNA 9497225 9511940 . + . ID=transcript_10751;Q6NZI2 B2RAW7 O00535 Q6GMY1 Q96H74 Q9BT85 Q9HAP4,Caveolae-associated protein 1 {ECO:0000312|HGNC:HGNC:9688},Cavin-1;Polymerase I and transcript release factor;, PF15237;, GO:0005901;GO:0005737;GO:0005829;GO:0005783;GO:0043231;GO:0045121;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0042802;GO:0003723;GO:0042134;GO:2000147;GO:0009306;GO:0009303;GO:0006363;GO:0006361;, C:caveola; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane raft; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:RNA binding; F:rRNA primary transcript binding;, P:positive regulation of cell motility; P:protein secretion; P:rRNA transcription; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter;|Q6NZI2 B2RAW7 O00535 Q6GMY1 Q96H74 Q9BT85 Q9HAP4,Caveolae-associated protein 1 {ECO:0000312|HGNC:HGNC:9688},Cavin-1;Polymerase I and transcript release factor;, PF15237;, GO:0005901;GO:0005737;GO:0005829;GO:0005783;GO:0043231;GO:0045121;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0042802;GO:0003723;GO:0042134;GO:2000147;GO:0009306;GO:0009303;GO:0006363;GO:0006361;, C:caveola; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane raft; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:RNA binding; F:rRNA primary transcript binding;, P:positive regulation of cell motility; P:protein secretion; P:rRNA transcription; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter; scaffold61 indexed_genome mRNA 9528123 9600410 . + . ID=transcript_10752;P40763 A8K7B8 K7ENL3 O14916 Q9BW54,Signal transducer and activator of transcription 3 {ECO:0000312|HGNC:HGNC:11364},Acute-phase response factor;, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0090575;GO:0005667;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0004879;GO:0070878;GO:0046983;GO:0042803;GO:0019901;GO:0019903;GO:0000978;GO:0001103;GO:0008134;GO:0000976;GO:0048708;GO:0071345;GO:0032870;GO:0044320;GO:0019221;GO:0006952;GO:0042755;GO:0097009;GO:0001754;GO:0042593;GO:0060396;GO:0060397;GO:0006954;GO:0035723;GO:0038114;GO:0038155;GO:0070106;GO:0070757;GO:0070102;GO:0038111;GO:0038113;GO:0030522;GO:0033210;GO:0010507;GO:2000635;GO:0000122;GO:0007399;GO:0016310;GO:0030335;GO:1900017;GO:0045648;GO:0010628;GO:2000637;GO:0032731;GO:0032733;GO:0032755;GO:0032757;GO:1904685;GO:1905618;GO:0051092;GO:0045747;GO:1902895;GO:0045944;GO:0045893;GO:0032760;GO:0042531;GO:0006606;GO:0060019;GO:0007259;GO:0051726;GO:0042127;GO:0060259;GO:0006357;GO:0006355;GO:0032355;GO:0044321;GO:0043434;GO:0019953;GO:0007165;GO:0035019;GO:0072540;GO:0072538;GO:0001659;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:nuclear receptor activity; F:primary miRNA binding; F:protein dimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:astrocyte differentiation; P:cellular response to cytokine stimulus; P:cellular response to hormone stimulus; P:cellular response to leptin stimulus; P:cytokine-mediated signaling pathway; P:defense response; P:eating behavior; P:energy homeostasis; P:eye photoreceptor cell differentiation; P:glucose homeostasis; P:growth hormone receptor signaling pathway; P:growth hormone receptor signaling pathway via JAK-STAT; P:inflammatory response; P:interleukin-15-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular receptor signaling pathway; P:leptin-mediated signaling pathway; P:negative regulation of autophagy; P:negative regulation of primary miRNA processing; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:phosphorylation; P:positive regulation of cell migration; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of gene silencing by miRNA; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of metalloendopeptidase activity; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of Notch signaling pathway; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein import into nucleus; P:radial glial cell differentiation; P:receptor signaling pathway via JAK-STAT; P:regulation of cell cycle; P:regulation of cell population proliferation; P:regulation of feeding behavior; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to leptin; P:response to peptide hormone; P:sexual reproduction; P:signal transduction; P:somatic stem cell population maintenance; P:T-helper 17 cell lineage commitment; P:T-helper 17 type immune response; P:temperature homeostasis; P:viral process;|P40763 A8K7B8 K7ENL3 O14916 Q9BW54,Signal transducer and activator of transcription 3 {ECO:0000312|HGNC:HGNC:11364},Acute-phase response factor;, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0090575;GO:0005667;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0004879;GO:0070878;GO:0046983;GO:0042803;GO:0019901;GO:0019903;GO:0000978;GO:0001103;GO:0008134;GO:0000976;GO:0048708;GO:0071345;GO:0032870;GO:0044320;GO:0019221;GO:0006952;GO:0042755;GO:0097009;GO:0001754;GO:0042593;GO:0060396;GO:0060397;GO:0006954;GO:0035723;GO:0038114;GO:0038155;GO:0070106;GO:0070757;GO:0070102;GO:0038111;GO:0038113;GO:0030522;GO:0033210;GO:0010507;GO:2000635;GO:0000122;GO:0007399;GO:0016310;GO:0030335;GO:1900017;GO:0045648;GO:0010628;GO:2000637;GO:0032731;GO:0032733;GO:0032755;GO:0032757;GO:1904685;GO:1905618;GO:0051092;GO:0045747;GO:1902895;GO:0045944;GO:0045893;GO:0032760;GO:0042531;GO:0006606;GO:0060019;GO:0007259;GO:0051726;GO:0042127;GO:0060259;GO:0006357;GO:0006355;GO:0032355;GO:0044321;GO:0043434;GO:0019953;GO:0007165;GO:0035019;GO:0072540;GO:0072538;GO:0001659;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:nuclear receptor activity; F:primary miRNA binding; F:protein dimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:astrocyte differentiation; P:cellular response to cytokine stimulus; P:cellular response to hormone stimulus; P:cellular response to leptin stimulus; P:cytokine-mediated signaling pathway; P:defense response; P:eating behavior; P:energy homeostasis; P:eye photoreceptor cell differentiation; P:glucose homeostasis; P:growth hormone receptor signaling pathway; P:growth hormone receptor signaling pathway via JAK-STAT; P:inflammatory response; P:interleukin-15-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular receptor signaling pathway; P:leptin-mediated signaling pathway; P:negative regulation of autophagy; P:negative regulation of primary miRNA processing; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:phosphorylation; P:positive regulation of cell migration; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of gene silencing by miRNA; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of metalloendopeptidase activity; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of Notch signaling pathway; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein import into nucleus; P:radial glial cell differentiation; P:receptor signaling pathway via JAK-STAT; P:regulation of cell cycle; P:regulation of cell population proliferation; P:regulation of feeding behavior; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to leptin; P:response to peptide hormone; P:sexual reproduction; P:signal transduction; P:somatic stem cell population maintenance; P:T-helper 17 cell lineage commitment; P:T-helper 17 type immune response; P:temperature homeostasis; P:viral process;|P40763 A8K7B8 K7ENL3 O14916 Q9BW54,Signal transducer and activator of transcription 3 {ECO:0000312|HGNC:HGNC:11364},Acute-phase response factor;, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0090575;GO:0005667;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0004879;GO:0070878;GO:0046983;GO:0042803;GO:0019901;GO:0019903;GO:0000978;GO:0001103;GO:0008134;GO:0000976;GO:0048708;GO:0071345;GO:0032870;GO:0044320;GO:0019221;GO:0006952;GO:0042755;GO:0097009;GO:0001754;GO:0042593;GO:0060396;GO:0060397;GO:0006954;GO:0035723;GO:0038114;GO:0038155;GO:0070106;GO:0070757;GO:0070102;GO:0038111;GO:0038113;GO:0030522;GO:0033210;GO:0010507;GO:2000635;GO:0000122;GO:0007399;GO:0016310;GO:0030335;GO:1900017;GO:0045648;GO:0010628;GO:2000637;GO:0032731;GO:0032733;GO:0032755;GO:0032757;GO:1904685;GO:1905618;GO:0051092;GO:0045747;GO:1902895;GO:0045944;GO:0045893;GO:0032760;GO:0042531;GO:0006606;GO:0060019;GO:0007259;GO:0051726;GO:0042127;GO:0060259;GO:0006357;GO:0006355;GO:0032355;GO:0044321;GO:0043434;GO:0019953;GO:0007165;GO:0035019;GO:0072540;GO:0072538;GO:0001659;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:RNA polymerase II transcription regulator complex; C:transcription regulator complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:nuclear receptor activity; F:primary miRNA binding; F:protein dimerization activity; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:astrocyte differentiation; P:cellular response to cytokine stimulus; P:cellular response to hormone stimulus; P:cellular response to leptin stimulus; P:cytokine-mediated signaling pathway; P:defense response; P:eating behavior; P:energy homeostasis; P:eye photoreceptor cell differentiation; P:glucose homeostasis; P:growth hormone receptor signaling pathway; P:growth hormone receptor signaling pathway via JAK-STAT; P:inflammatory response; P:interleukin-15-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:interleukin-6-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular receptor signaling pathway; P:leptin-mediated signaling pathway; P:negative regulation of autophagy; P:negative regulation of primary miRNA processing; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:phosphorylation; P:positive regulation of cell migration; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of gene silencing by miRNA; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of metalloendopeptidase activity; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of Notch signaling pathway; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein import into nucleus; P:radial glial cell differentiation; P:receptor signaling pathway via JAK-STAT; P:regulation of cell cycle; P:regulation of cell population proliferation; P:regulation of feeding behavior; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to leptin; P:response to peptide hormone; P:sexual reproduction; P:signal transduction; P:somatic stem cell population maintenance; P:T-helper 17 cell lineage commitment; P:T-helper 17 type immune response; P:temperature homeostasis; P:viral process; scaffold61 indexed_genome mRNA 9601803 9606949 . - . ID=transcript_10753;P42229 Q1KLZ6,Signal transducer and activator of transcription 5A,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0003700;GO:0000981;GO:0000978;GO:0019221;GO:0006952;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0043536;GO:0001938;GO:0007259;GO:0038026;GO:0042127;GO:0040014;GO:0006357;GO:0043434;GO:0019530;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:receptor signaling pathway via JAK-STAT; P:reelin-mediated signaling pathway; P:regulation of cell population proliferation; P:regulation of multicellular organism growth; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:taurine metabolic process;|P51692 Q8WWS8,Signal transducer and activator of transcription 5B,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035259;GO:0042802;GO:0046983;GO:0000978;GO:0071364;GO:0071363;GO:0032870;GO:0019221;GO:0006952;GO:0046543;GO:0046544;GO:0007565;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0019915;GO:0001553;GO:0097531;GO:0001779;GO:0043066;GO:0045647;GO:0048541;GO:0042104;GO:0045579;GO:0045648;GO:0045588;GO:0050729;GO:0032743;GO:0045931;GO:0040018;GO:0032825;GO:0045954;GO:0032819;GO:0045944;GO:0042448;GO:0007259;GO:0042127;GO:0030856;GO:0040014;GO:0019218;GO:0006357;GO:0032355;GO:0070670;GO:0043434;GO:0033077;GO:0043029;GO:0019530;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to growth factor stimulus; P:cellular response to hormone stimulus; P:cytokine-mediated signaling pathway; P:defense response; P:development of secondary female sexual characteristics; P:development of secondary male sexual characteristics; P:female pregnancy; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:lipid storage; P:luteinization; P:mast cell migration; P:natural killer cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:Peyer's patch development; P:positive regulation of activated T cell proliferation; P:positive regulation of B cell differentiation; P:positive regulation of erythrocyte differentiation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-2 production; P:positive regulation of mitotic cell cycle; P:positive regulation of multicellular organism growth; P:positive regulation of natural killer cell differentiation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:progesterone metabolic process; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of epithelial cell differentiation; P:regulation of multicellular organism growth; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to estradiol; P:response to interleukin-4; P:response to peptide hormone; P:T cell differentiation in thymus; P:T cell homeostasis; P:taurine metabolic process;|P42229 Q1KLZ6,Signal transducer and activator of transcription 5A,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0003700;GO:0000981;GO:0000978;GO:0019221;GO:0006952;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0043536;GO:0001938;GO:0007259;GO:0038026;GO:0042127;GO:0040014;GO:0006357;GO:0043434;GO:0019530;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:receptor signaling pathway via JAK-STAT; P:reelin-mediated signaling pathway; P:regulation of cell population proliferation; P:regulation of multicellular organism growth; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:taurine metabolic process; scaffold61 indexed_genome mRNA 9606970 9610937 . - . ID=transcript_10754;P42229 Q1KLZ6,Signal transducer and activator of transcription 5A,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0003700;GO:0000981;GO:0000978;GO:0019221;GO:0006952;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0043536;GO:0001938;GO:0007259;GO:0038026;GO:0042127;GO:0040014;GO:0006357;GO:0043434;GO:0019530;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:receptor signaling pathway via JAK-STAT; P:reelin-mediated signaling pathway; P:regulation of cell population proliferation; P:regulation of multicellular organism growth; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:taurine metabolic process;|P51692 Q8WWS8,Signal transducer and activator of transcription 5B,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035259;GO:0042802;GO:0046983;GO:0000978;GO:0071364;GO:0071363;GO:0032870;GO:0019221;GO:0006952;GO:0046543;GO:0046544;GO:0007565;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0019915;GO:0001553;GO:0097531;GO:0001779;GO:0043066;GO:0045647;GO:0048541;GO:0042104;GO:0045579;GO:0045648;GO:0045588;GO:0050729;GO:0032743;GO:0045931;GO:0040018;GO:0032825;GO:0045954;GO:0032819;GO:0045944;GO:0042448;GO:0007259;GO:0042127;GO:0030856;GO:0040014;GO:0019218;GO:0006357;GO:0032355;GO:0070670;GO:0043434;GO:0033077;GO:0043029;GO:0019530;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to growth factor stimulus; P:cellular response to hormone stimulus; P:cytokine-mediated signaling pathway; P:defense response; P:development of secondary female sexual characteristics; P:development of secondary male sexual characteristics; P:female pregnancy; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:lipid storage; P:luteinization; P:mast cell migration; P:natural killer cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:Peyer's patch development; P:positive regulation of activated T cell proliferation; P:positive regulation of B cell differentiation; P:positive regulation of erythrocyte differentiation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-2 production; P:positive regulation of mitotic cell cycle; P:positive regulation of multicellular organism growth; P:positive regulation of natural killer cell differentiation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:progesterone metabolic process; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of epithelial cell differentiation; P:regulation of multicellular organism growth; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to estradiol; P:response to interleukin-4; P:response to peptide hormone; P:T cell differentiation in thymus; P:T cell homeostasis; P:taurine metabolic process; scaffold61 indexed_genome mRNA 9611554 9623138 . + . ID=transcript_10755;P42229 Q1KLZ6,Signal transducer and activator of transcription 5A,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0003700;GO:0000981;GO:0000978;GO:0019221;GO:0006952;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0043536;GO:0001938;GO:0007259;GO:0038026;GO:0042127;GO:0040014;GO:0006357;GO:0043434;GO:0019530;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:receptor signaling pathway via JAK-STAT; P:reelin-mediated signaling pathway; P:regulation of cell population proliferation; P:regulation of multicellular organism growth; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:taurine metabolic process;|P42229 Q1KLZ6,Signal transducer and activator of transcription 5A,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0003700;GO:0000981;GO:0000978;GO:0019221;GO:0006952;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0043536;GO:0001938;GO:0007259;GO:0038026;GO:0042127;GO:0040014;GO:0006357;GO:0043434;GO:0019530;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:receptor signaling pathway via JAK-STAT; P:reelin-mediated signaling pathway; P:regulation of cell population proliferation; P:regulation of multicellular organism growth; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:taurine metabolic process; scaffold61 indexed_genome mRNA 9680340 9681698 . + . ID=transcript_10756;P42229 Q1KLZ6,Signal transducer and activator of transcription 5A,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0003700;GO:0000981;GO:0000978;GO:0019221;GO:0006952;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0043536;GO:0001938;GO:0007259;GO:0038026;GO:0042127;GO:0040014;GO:0006357;GO:0043434;GO:0019530;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:receptor signaling pathway via JAK-STAT; P:reelin-mediated signaling pathway; P:regulation of cell population proliferation; P:regulation of multicellular organism growth; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:taurine metabolic process; scaffold61 indexed_genome mRNA 9682300 9698350 . + . ID=transcript_10757;P51692 Q8WWS8,Signal transducer and activator of transcription 5B,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035259;GO:0042802;GO:0046983;GO:0000978;GO:0071364;GO:0071363;GO:0032870;GO:0019221;GO:0006952;GO:0046543;GO:0046544;GO:0007565;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0019915;GO:0001553;GO:0097531;GO:0001779;GO:0043066;GO:0045647;GO:0048541;GO:0042104;GO:0045579;GO:0045648;GO:0045588;GO:0050729;GO:0032743;GO:0045931;GO:0040018;GO:0032825;GO:0045954;GO:0032819;GO:0045944;GO:0042448;GO:0007259;GO:0042127;GO:0030856;GO:0040014;GO:0019218;GO:0006357;GO:0032355;GO:0070670;GO:0043434;GO:0033077;GO:0043029;GO:0019530;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to growth factor stimulus; P:cellular response to hormone stimulus; P:cytokine-mediated signaling pathway; P:defense response; P:development of secondary female sexual characteristics; P:development of secondary male sexual characteristics; P:female pregnancy; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:lipid storage; P:luteinization; P:mast cell migration; P:natural killer cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:Peyer's patch development; P:positive regulation of activated T cell proliferation; P:positive regulation of B cell differentiation; P:positive regulation of erythrocyte differentiation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-2 production; P:positive regulation of mitotic cell cycle; P:positive regulation of multicellular organism growth; P:positive regulation of natural killer cell differentiation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:progesterone metabolic process; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of epithelial cell differentiation; P:regulation of multicellular organism growth; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to estradiol; P:response to interleukin-4; P:response to peptide hormone; P:T cell differentiation in thymus; P:T cell homeostasis; P:taurine metabolic process;|P51692 Q8WWS8,Signal transducer and activator of transcription 5B,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035259;GO:0042802;GO:0046983;GO:0000978;GO:0071364;GO:0071363;GO:0032870;GO:0019221;GO:0006952;GO:0046543;GO:0046544;GO:0007565;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0019915;GO:0001553;GO:0097531;GO:0001779;GO:0043066;GO:0045647;GO:0048541;GO:0042104;GO:0045579;GO:0045648;GO:0045588;GO:0050729;GO:0032743;GO:0045931;GO:0040018;GO:0032825;GO:0045954;GO:0032819;GO:0045944;GO:0042448;GO:0007259;GO:0042127;GO:0030856;GO:0040014;GO:0019218;GO:0006357;GO:0032355;GO:0070670;GO:0043434;GO:0033077;GO:0043029;GO:0019530;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to growth factor stimulus; P:cellular response to hormone stimulus; P:cytokine-mediated signaling pathway; P:defense response; P:development of secondary female sexual characteristics; P:development of secondary male sexual characteristics; P:female pregnancy; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:lipid storage; P:luteinization; P:mast cell migration; P:natural killer cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:Peyer's patch development; P:positive regulation of activated T cell proliferation; P:positive regulation of B cell differentiation; P:positive regulation of erythrocyte differentiation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-2 production; P:positive regulation of mitotic cell cycle; P:positive regulation of multicellular organism growth; P:positive regulation of natural killer cell differentiation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:progesterone metabolic process; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of epithelial cell differentiation; P:regulation of multicellular organism growth; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to estradiol; P:response to interleukin-4; P:response to peptide hormone; P:T cell differentiation in thymus; P:T cell homeostasis; P:taurine metabolic process;|P51692 Q8WWS8,Signal transducer and activator of transcription 5B,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035259;GO:0042802;GO:0046983;GO:0000978;GO:0071364;GO:0071363;GO:0032870;GO:0019221;GO:0006952;GO:0046543;GO:0046544;GO:0007565;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0019915;GO:0001553;GO:0097531;GO:0001779;GO:0043066;GO:0045647;GO:0048541;GO:0042104;GO:0045579;GO:0045648;GO:0045588;GO:0050729;GO:0032743;GO:0045931;GO:0040018;GO:0032825;GO:0045954;GO:0032819;GO:0045944;GO:0042448;GO:0007259;GO:0042127;GO:0030856;GO:0040014;GO:0019218;GO:0006357;GO:0032355;GO:0070670;GO:0043434;GO:0033077;GO:0043029;GO:0019530;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to growth factor stimulus; P:cellular response to hormone stimulus; P:cytokine-mediated signaling pathway; P:defense response; P:development of secondary female sexual characteristics; P:development of secondary male sexual characteristics; P:female pregnancy; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:lipid storage; P:luteinization; P:mast cell migration; P:natural killer cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:Peyer's patch development; P:positive regulation of activated T cell proliferation; P:positive regulation of B cell differentiation; P:positive regulation of erythrocyte differentiation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-2 production; P:positive regulation of mitotic cell cycle; P:positive regulation of multicellular organism growth; P:positive regulation of natural killer cell differentiation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:progesterone metabolic process; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of epithelial cell differentiation; P:regulation of multicellular organism growth; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to estradiol; P:response to interleukin-4; P:response to peptide hormone; P:T cell differentiation in thymus; P:T cell homeostasis; P:taurine metabolic process;|P51692 Q8WWS8,Signal transducer and activator of transcription 5B,, PF00017;PF01017;PF02864;PF02865;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0035259;GO:0042802;GO:0046983;GO:0000978;GO:0071364;GO:0071363;GO:0032870;GO:0019221;GO:0006952;GO:0046543;GO:0046544;GO:0007565;GO:0060397;GO:0035723;GO:0038110;GO:0038111;GO:0038113;GO:0007595;GO:0019915;GO:0001553;GO:0097531;GO:0001779;GO:0043066;GO:0045647;GO:0048541;GO:0042104;GO:0045579;GO:0045648;GO:0045588;GO:0050729;GO:0032743;GO:0045931;GO:0040018;GO:0032825;GO:0045954;GO:0032819;GO:0045944;GO:0042448;GO:0007259;GO:0042127;GO:0030856;GO:0040014;GO:0019218;GO:0006357;GO:0032355;GO:0070670;GO:0043434;GO:0033077;GO:0043029;GO:0019530;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to growth factor stimulus; P:cellular response to hormone stimulus; P:cytokine-mediated signaling pathway; P:defense response; P:development of secondary female sexual characteristics; P:development of secondary male sexual characteristics; P:female pregnancy; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:lactation; P:lipid storage; P:luteinization; P:mast cell migration; P:natural killer cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:Peyer's patch development; P:positive regulation of activated T cell proliferation; P:positive regulation of B cell differentiation; P:positive regulation of erythrocyte differentiation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-2 production; P:positive regulation of mitotic cell cycle; P:positive regulation of multicellular organism growth; P:positive regulation of natural killer cell differentiation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:progesterone metabolic process; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of epithelial cell differentiation; P:regulation of multicellular organism growth; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to estradiol; P:response to interleukin-4; P:response to peptide hormone; P:T cell differentiation in thymus; P:T cell homeostasis; P:taurine metabolic process; scaffold61 indexed_genome mRNA 9707850 9712079 . + . ID=transcript_10758;Q8N2G8 B4DQS4 E9PDB5 Q9BXM6,GH3 domain-containing protein,, PF03321;, GO:0005737;GO:0005783;GO:0005576;GO:0016020;GO:0005635;GO:0034774;GO:0035580;GO:0016881;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:nuclear envelope; C:secretory granule lumen; C:specific granule lumen;, F:acid-amino acid ligase activity;, P:neutrophil degranulation;|Q8N2G8 B4DQS4 E9PDB5 Q9BXM6,GH3 domain-containing protein,, PF03321;, GO:0005737;GO:0005783;GO:0005576;GO:0016020;GO:0005635;GO:0034774;GO:0035580;GO:0016881;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:nuclear envelope; C:secretory granule lumen; C:specific granule lumen;, F:acid-amino acid ligase activity;, P:neutrophil degranulation;|Q8N2G8 B4DQS4 E9PDB5 Q9BXM6,GH3 domain-containing protein,, PF03321;, GO:0005737;GO:0005783;GO:0005576;GO:0016020;GO:0005635;GO:0034774;GO:0035580;GO:0016881;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:nuclear envelope; C:secretory granule lumen; C:specific granule lumen;, F:acid-amino acid ligase activity;, P:neutrophil degranulation;|Q8N2G8 B4DQS4 E9PDB5 Q9BXM6,GH3 domain-containing protein,, PF03321;, GO:0005737;GO:0005783;GO:0005576;GO:0016020;GO:0005635;GO:0034774;GO:0035580;GO:0016881;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:nuclear envelope; C:secretory granule lumen; C:specific granule lumen;, F:acid-amino acid ligase activity;, P:neutrophil degranulation;|Q8N2G8 B4DQS4 E9PDB5 Q9BXM6,GH3 domain-containing protein,, PF03321;, GO:0005737;GO:0005783;GO:0005576;GO:0016020;GO:0005635;GO:0034774;GO:0035580;GO:0016881;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:nuclear envelope; C:secretory granule lumen; C:specific granule lumen;, F:acid-amino acid ligase activity;, P:neutrophil degranulation;|Q8N2G8 B4DQS4 E9PDB5 Q9BXM6,GH3 domain-containing protein,, PF03321;, GO:0005737;GO:0005783;GO:0005576;GO:0016020;GO:0005635;GO:0034774;GO:0035580;GO:0016881;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:membrane; C:nuclear envelope; C:secretory granule lumen; C:specific granule lumen;, F:acid-amino acid ligase activity;, P:neutrophil degranulation; scaffold61 indexed_genome mRNA 9715848 9716784 . - . ID=transcript_10759;O43612,Orexin,Hypocretin;, PF02072;, GO:0005576;GO:0048471;GO:0098794;GO:0005791;GO:0030141;GO:0008021;GO:0005184;GO:0031771;GO:0031772;GO:0007268;GO:0042755;GO:0060079;GO:0007186;GO:0008156;GO:0043267;GO:0051970;GO:0007218;GO:0007200;GO:0051928;GO:0120162;GO:0007204;GO:0051971;GO:0007205;GO:0046928;GO:0042594;GO:0030431;GO:0001659;, C:extracellular region; C:perinuclear region of cytoplasm; C:postsynapse; C:rough endoplasmic reticulum; C:secretory granule; C:synaptic vesicle;, F:neuropeptide hormone activity; F:type 1 hypocretin receptor binding; F:type 2 hypocretin receptor binding;, P:chemical synaptic transmission; P:eating behavior; P:excitatory postsynaptic potential; P:G protein-coupled receptor signaling pathway; P:negative regulation of DNA replication; P:negative regulation of potassium ion transport; P:negative regulation of transmission of nerve impulse; P:neuropeptide signaling pathway; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of calcium ion transport; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of transmission of nerve impulse; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of neurotransmitter secretion; P:response to starvation; P:sleep; P:temperature homeostasis; scaffold61 indexed_genome mRNA 9738777 9760675 . + . ID=transcript_10760;P51148 F8W1H5 Q6FH55 Q9P0Y5,Ras-related protein Rab-5C,L1880;RAB5L;, PF00071;, GO:0035577;GO:0005769;GO:0031901;GO:0030139;GO:0012505;GO:0005768;GO:0070062;GO:0005811;GO:0005765;GO:0042470;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0006897;GO:0006886;GO:0043312;GO:0048227;GO:0030100;, C:azurophil granule membrane; C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endomembrane system; C:endosome; C:extracellular exosome; C:lipid droplet; C:lysosomal membrane; C:melanosome; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:endocytosis; P:intracellular protein transport; P:neutrophil degranulation; P:plasma membrane to endosome transport; P:regulation of endocytosis; scaffold61 indexed_genome mRNA 9763315 9771737 . + . ID=transcript_10761;Q92830 Q8N1A2 Q9UCW1,Histone acetyltransferase KAT2A,General control of amino acid synthesis protein 5-like 2 {ECO:0000250|UniProtKB:Q9JHD2};Histone acetyltransferase GCN5 {ECO:0000303|PubMed:8552087, ECO:0000303|PubMed:9611240};Histone glutaryltransferase KAT2A {ECO:0000305};Histone succinyltransferase KAT2A {ECO:0000305};Lysine acetyltransferase 2A {ECO:0000305};STAF97 {ECO:0000303|PubMed:11564863};, PF00583;PF00439;PF06466;, GO:0005671;GO:0005813;GO:0005694;GO:0005737;GO:0005615;GO:0000123;GO:0072686;GO:0005654;GO:0005634;GO:0030914;GO:0033276;GO:0003682;GO:0010484;GO:0004402;GO:0043997;GO:0042826;GO:0106229;GO:0106078;GO:0061733;GO:0019903;GO:0003713;GO:0008134;GO:0071929;GO:0008283;GO:1990090;GO:0071356;GO:0006338;GO:0007507;GO:0016573;GO:0016578;GO:0043966;GO:0044154;GO:0106077;GO:0001701;GO:0018393;GO:0048312;GO:0060173;GO:0007616;GO:0022037;GO:0030901;GO:0035264;GO:0046600;GO:0001843;GO:0106227;GO:2000727;GO:0031346;GO:0001819;GO:0045815;GO:0045722;GO:0035066;GO:0045944;GO:0045893;GO:0016579;GO:1903010;GO:0061035;GO:0031647;GO:0045589;GO:2000036;GO:0048167;GO:0050863;GO:0006357;GO:0031667;GO:0014070;GO:0001756;GO:0021537;GO:0016032;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:centrosome; C:chromosome; C:cytoplasm; C:extracellular space; C:histone acetyltransferase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone acetyltransferase activity (H4-K12 specific); F:histone deacetylase binding; F:histone glutaryltransferase activity; F:histone succinyltransferase activity; F:peptide-lysine-N-acetyltransferase activity; F:protein phosphatase binding; F:transcription coactivator activity; F:transcription factor binding;, P:alpha-tubulin acetylation; P:cell population proliferation; P:cellular response to nerve growth factor stimulus; P:cellular response to tumor necrosis factor; P:chromatin remodeling; P:heart development; P:histone acetylation; P:histone deubiquitination; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone succinylation; P:in utero embryonic development; P:internal peptidyl-lysine acetylation; P:intracellular distribution of mitochondria; P:limb development; P:long-term memory; P:metencephalon development; P:midbrain development; P:multicellular organism growth; P:negative regulation of centriole replication; P:neural tube closure; P:peptidyl-lysine glutarylation; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cell projection organization; P:positive regulation of cytokine production; P:positive regulation of gene expression, epigenetic; P:positive regulation of gluconeogenesis; P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of bone development; P:regulation of cartilage development; P:regulation of protein stability; P:regulation of regulatory T cell differentiation; P:regulation of stem cell population maintenance; P:regulation of synaptic plasticity; P:regulation of T cell activation; P:regulation of transcription by RNA polymerase II; P:response to nutrient levels; P:response to organic cyclic compound; P:somitogenesis; P:telencephalon development; P:viral process;|Q92830 Q8N1A2 Q9UCW1,Histone acetyltransferase KAT2A,General control of amino acid synthesis protein 5-like 2 {ECO:0000250|UniProtKB:Q9JHD2};Histone acetyltransferase GCN5 {ECO:0000303|PubMed:8552087, ECO:0000303|PubMed:9611240};Histone glutaryltransferase KAT2A {ECO:0000305};Histone succinyltransferase KAT2A {ECO:0000305};Lysine acetyltransferase 2A {ECO:0000305};STAF97 {ECO:0000303|PubMed:11564863};, PF00583;PF00439;PF06466;, GO:0005671;GO:0005813;GO:0005694;GO:0005737;GO:0005615;GO:0000123;GO:0072686;GO:0005654;GO:0005634;GO:0030914;GO:0033276;GO:0003682;GO:0010484;GO:0004402;GO:0043997;GO:0042826;GO:0106229;GO:0106078;GO:0061733;GO:0019903;GO:0003713;GO:0008134;GO:0071929;GO:0008283;GO:1990090;GO:0071356;GO:0006338;GO:0007507;GO:0016573;GO:0016578;GO:0043966;GO:0044154;GO:0106077;GO:0001701;GO:0018393;GO:0048312;GO:0060173;GO:0007616;GO:0022037;GO:0030901;GO:0035264;GO:0046600;GO:0001843;GO:0106227;GO:2000727;GO:0031346;GO:0001819;GO:0045815;GO:0045722;GO:0035066;GO:0045944;GO:0045893;GO:0016579;GO:1903010;GO:0061035;GO:0031647;GO:0045589;GO:2000036;GO:0048167;GO:0050863;GO:0006357;GO:0031667;GO:0014070;GO:0001756;GO:0021537;GO:0016032;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:centrosome; C:chromosome; C:cytoplasm; C:extracellular space; C:histone acetyltransferase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone acetyltransferase activity (H4-K12 specific); F:histone deacetylase binding; F:histone glutaryltransferase activity; F:histone succinyltransferase activity; F:peptide-lysine-N-acetyltransferase activity; F:protein phosphatase binding; F:transcription coactivator activity; F:transcription factor binding;, P:alpha-tubulin acetylation; P:cell population proliferation; P:cellular response to nerve growth factor stimulus; P:cellular response to tumor necrosis factor; P:chromatin remodeling; P:heart development; P:histone acetylation; P:histone deubiquitination; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone succinylation; P:in utero embryonic development; P:internal peptidyl-lysine acetylation; P:intracellular distribution of mitochondria; P:limb development; P:long-term memory; P:metencephalon development; P:midbrain development; P:multicellular organism growth; P:negative regulation of centriole replication; P:neural tube closure; P:peptidyl-lysine glutarylation; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cell projection organization; P:positive regulation of cytokine production; P:positive regulation of gene expression, epigenetic; P:positive regulation of gluconeogenesis; P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of bone development; P:regulation of cartilage development; P:regulation of protein stability; P:regulation of regulatory T cell differentiation; P:regulation of stem cell population maintenance; P:regulation of synaptic plasticity; P:regulation of T cell activation; P:regulation of transcription by RNA polymerase II; P:response to nutrient levels; P:response to organic cyclic compound; P:somitogenesis; P:telencephalon development; P:viral process;|Q92830 Q8N1A2 Q9UCW1,Histone acetyltransferase KAT2A,General control of amino acid synthesis protein 5-like 2 {ECO:0000250|UniProtKB:Q9JHD2};Histone acetyltransferase GCN5 {ECO:0000303|PubMed:8552087, ECO:0000303|PubMed:9611240};Histone glutaryltransferase KAT2A {ECO:0000305};Histone succinyltransferase KAT2A {ECO:0000305};Lysine acetyltransferase 2A {ECO:0000305};STAF97 {ECO:0000303|PubMed:11564863};, PF00583;PF00439;PF06466;, GO:0005671;GO:0005813;GO:0005694;GO:0005737;GO:0005615;GO:0000123;GO:0072686;GO:0005654;GO:0005634;GO:0030914;GO:0033276;GO:0003682;GO:0010484;GO:0004402;GO:0043997;GO:0042826;GO:0106229;GO:0106078;GO:0061733;GO:0019903;GO:0003713;GO:0008134;GO:0071929;GO:0008283;GO:1990090;GO:0071356;GO:0006338;GO:0007507;GO:0016573;GO:0016578;GO:0043966;GO:0044154;GO:0106077;GO:0001701;GO:0018393;GO:0048312;GO:0060173;GO:0007616;GO:0022037;GO:0030901;GO:0035264;GO:0046600;GO:0001843;GO:0106227;GO:2000727;GO:0031346;GO:0001819;GO:0045815;GO:0045722;GO:0035066;GO:0045944;GO:0045893;GO:0016579;GO:1903010;GO:0061035;GO:0031647;GO:0045589;GO:2000036;GO:0048167;GO:0050863;GO:0006357;GO:0031667;GO:0014070;GO:0001756;GO:0021537;GO:0016032;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:centrosome; C:chromosome; C:cytoplasm; C:extracellular space; C:histone acetyltransferase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:chromatin binding; F:H3 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone acetyltransferase activity (H4-K12 specific); F:histone deacetylase binding; F:histone glutaryltransferase activity; F:histone succinyltransferase activity; F:peptide-lysine-N-acetyltransferase activity; F:protein phosphatase binding; F:transcription coactivator activity; F:transcription factor binding;, P:alpha-tubulin acetylation; P:cell population proliferation; P:cellular response to nerve growth factor stimulus; P:cellular response to tumor necrosis factor; P:chromatin remodeling; P:heart development; P:histone acetylation; P:histone deubiquitination; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone succinylation; P:in utero embryonic development; P:internal peptidyl-lysine acetylation; P:intracellular distribution of mitochondria; P:limb development; P:long-term memory; P:metencephalon development; P:midbrain development; P:multicellular organism growth; P:negative regulation of centriole replication; P:neural tube closure; P:peptidyl-lysine glutarylation; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cell projection organization; P:positive regulation of cytokine production; P:positive regulation of gene expression, epigenetic; P:positive regulation of gluconeogenesis; P:positive regulation of histone acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of bone development; P:regulation of cartilage development; P:regulation of protein stability; P:regulation of regulatory T cell differentiation; P:regulation of stem cell population maintenance; P:regulation of synaptic plasticity; P:regulation of T cell activation; P:regulation of transcription by RNA polymerase II; P:response to nutrient levels; P:response to organic cyclic compound; P:somitogenesis; P:telencephalon development; P:viral process; scaffold61 indexed_genome mRNA 9772126 9781719 . + . ID=transcript_10762;Q96C10 Q9HAM6,Probable ATP-dependent RNA helicase DHX58,Probable ATP-dependent helicase LGP2;Protein D11Lgp2 homolog;RIG-I-like receptor 3;RIG-I-like receptor LGP2;, PF00271;PF04851;PF18119;PF11648;, GO:0005737;GO:0005524;GO:0003677;GO:0003725;GO:0003724;GO:0003727;GO:0008270;GO:0051607;GO:0045087;GO:0045824;GO:0039534;GO:0039536;GO:0032480;GO:0032728;GO:1900245;GO:1900246;GO:0032481;GO:0045088;GO:0009617;GO:0009615;GO:0016032;, C:cytoplasm;, F:ATP binding; F:DNA binding; F:double-stranded RNA binding; F:RNA helicase activity; F:single-stranded RNA binding; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:negative regulation of innate immune response; P:negative regulation of MDA-5 signaling pathway; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of interferon-beta production; P:positive regulation of MDA-5 signaling pathway; P:positive regulation of RIG-I signaling pathway; P:positive regulation of type I interferon production; P:regulation of innate immune response; P:response to bacterium; P:response to virus; P:viral process;|Q96C10 Q9HAM6,Probable ATP-dependent RNA helicase DHX58,Probable ATP-dependent helicase LGP2;Protein D11Lgp2 homolog;RIG-I-like receptor 3;RIG-I-like receptor LGP2;, PF00271;PF04851;PF18119;PF11648;, GO:0005737;GO:0005524;GO:0003677;GO:0003725;GO:0003724;GO:0003727;GO:0008270;GO:0051607;GO:0045087;GO:0045824;GO:0039534;GO:0039536;GO:0032480;GO:0032728;GO:1900245;GO:1900246;GO:0032481;GO:0045088;GO:0009617;GO:0009615;GO:0016032;, C:cytoplasm;, F:ATP binding; F:DNA binding; F:double-stranded RNA binding; F:RNA helicase activity; F:single-stranded RNA binding; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:negative regulation of innate immune response; P:negative regulation of MDA-5 signaling pathway; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of interferon-beta production; P:positive regulation of MDA-5 signaling pathway; P:positive regulation of RIG-I signaling pathway; P:positive regulation of type I interferon production; P:regulation of innate immune response; P:response to bacterium; P:response to virus; P:viral process; scaffold61 indexed_genome mRNA 9812227 9847187 . + . ID=transcript_10763;Q66K41 A0A087WX54 Q4G0J1,Zinc finger protein 385C {ECO:0000312|HGNC:HGNC:33722},, , GO:0005634;GO:0003676;GO:0008270;, C:nucleus;, F:nucleic acid binding; F:zinc ion binding;|A0A1B0GUU1,Transmembrane protein C17orf113 {ECO:0000305},, , GO:0016021;, C:integral component of membrane;|Q66K41 A0A087WX54 Q4G0J1,Zinc finger protein 385C {ECO:0000312|HGNC:HGNC:33722},, , GO:0005634;GO:0003676;GO:0008270;, C:nucleus;, F:nucleic acid binding; F:zinc ion binding;|Q66K41 A0A087WX54 Q4G0J1,Zinc finger protein 385C {ECO:0000312|HGNC:HGNC:33722},, , GO:0005634;GO:0003676;GO:0008270;, C:nucleus;, F:nucleic acid binding; F:zinc ion binding; scaffold61 indexed_genome mRNA 9847248 9851993 . - . ID=transcript_10764;Q9NYR9 A6NCZ5 B3KNN0 B4DNM3 Q6PK52 Q96KC7 Q9NSX1,NF-kappa-B inhibitor-interacting Ras-like protein 2,I-kappa-B-interacting Ras-like protein 2;, PF00071;, GO:0005737;GO:0005525;GO:0003924;GO:0007249;, C:cytoplasm;, F:GTP binding; F:GTPase activity;, P:I-kappaB kinase/NF-kappaB signaling; scaffold61 indexed_genome mRNA 9854245 9881467 . + . ID=transcript_10765;Q99615 Q7Z784,DnaJ homolog subfamily C member 7,Tetratricopeptide repeat protein 2;, PF00226;PF13181;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0031072;GO:0051085;GO:0006457;GO:1900034;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:heat shock protein binding;, P:chaperone cofactor-dependent protein refolding; P:protein folding; P:regulation of cellular response to heat;|Q99615 Q7Z784,DnaJ homolog subfamily C member 7,Tetratricopeptide repeat protein 2;, PF00226;PF13181;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0031072;GO:0051085;GO:0006457;GO:1900034;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:heat shock protein binding;, P:chaperone cofactor-dependent protein refolding; P:protein folding; P:regulation of cellular response to heat;|Q99615 Q7Z784,DnaJ homolog subfamily C member 7,Tetratricopeptide repeat protein 2;, PF00226;PF13181;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0031072;GO:0051085;GO:0006457;GO:1900034;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:heat shock protein binding;, P:chaperone cofactor-dependent protein refolding; P:protein folding; P:regulation of cellular response to heat; scaffold61 indexed_genome mRNA 9882698 9887753 . - . ID=transcript_10766;P09543,2',3'-cyclic-nucleotide 3'-phosphodiesterase,, PF05881;, GO:0005737;GO:0070062;GO:0005615;GO:0042470;GO:0016020;GO:0005874;GO:0005902;GO:0005743;GO:0005741;GO:0035748;GO:0035749;GO:0048471;GO:0005886;GO:0031143;GO:0045202;GO:0004113;GO:0030551;GO:0003723;GO:0008344;GO:0007568;GO:0007409;GO:0007268;GO:0009214;GO:0030900;GO:0000226;GO:0048709;GO:0046902;GO:0032496;GO:0009636;GO:0021762;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:melanosome; C:membrane; C:microtubule; C:microvillus; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:myelin sheath abaxonal region; C:myelin sheath adaxonal region; C:perinuclear region of cytoplasm; C:plasma membrane; C:pseudopodium; C:synapse;, F:2',3'-cyclic-nucleotide 3'-phosphodiesterase activity; F:cyclic nucleotide binding; F:RNA binding;, P:adult locomotory behavior; P:aging; P:axonogenesis; P:chemical synaptic transmission; P:cyclic nucleotide catabolic process; P:forebrain development; P:microtubule cytoskeleton organization; P:oligodendrocyte differentiation; P:regulation of mitochondrial membrane permeability; P:response to lipopolysaccharide; P:response to toxic substance; P:substantia nigra development;|P09543,2',3'-cyclic-nucleotide 3'-phosphodiesterase,, PF05881;, GO:0005737;GO:0070062;GO:0005615;GO:0042470;GO:0016020;GO:0005874;GO:0005902;GO:0005743;GO:0005741;GO:0035748;GO:0035749;GO:0048471;GO:0005886;GO:0031143;GO:0045202;GO:0004113;GO:0030551;GO:0003723;GO:0008344;GO:0007568;GO:0007409;GO:0007268;GO:0009214;GO:0030900;GO:0000226;GO:0048709;GO:0046902;GO:0032496;GO:0009636;GO:0021762;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:melanosome; C:membrane; C:microtubule; C:microvillus; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:myelin sheath abaxonal region; C:myelin sheath adaxonal region; C:perinuclear region of cytoplasm; C:plasma membrane; C:pseudopodium; C:synapse;, F:2',3'-cyclic-nucleotide 3'-phosphodiesterase activity; F:cyclic nucleotide binding; F:RNA binding;, P:adult locomotory behavior; P:aging; P:axonogenesis; P:chemical synaptic transmission; P:cyclic nucleotide catabolic process; P:forebrain development; P:microtubule cytoskeleton organization; P:oligodendrocyte differentiation; P:regulation of mitochondrial membrane permeability; P:response to lipopolysaccharide; P:response to toxic substance; P:substantia nigra development;|P09543,2',3'-cyclic-nucleotide 3'-phosphodiesterase,, PF05881;, GO:0005737;GO:0070062;GO:0005615;GO:0042470;GO:0016020;GO:0005874;GO:0005902;GO:0005743;GO:0005741;GO:0035748;GO:0035749;GO:0048471;GO:0005886;GO:0031143;GO:0045202;GO:0004113;GO:0030551;GO:0003723;GO:0008344;GO:0007568;GO:0007409;GO:0007268;GO:0009214;GO:0030900;GO:0000226;GO:0048709;GO:0046902;GO:0032496;GO:0009636;GO:0021762;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:melanosome; C:membrane; C:microtubule; C:microvillus; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:myelin sheath abaxonal region; C:myelin sheath adaxonal region; C:perinuclear region of cytoplasm; C:plasma membrane; C:pseudopodium; C:synapse;, F:2',3'-cyclic-nucleotide 3'-phosphodiesterase activity; F:cyclic nucleotide binding; F:RNA binding;, P:adult locomotory behavior; P:aging; P:axonogenesis; P:chemical synaptic transmission; P:cyclic nucleotide catabolic process; P:forebrain development; P:microtubule cytoskeleton organization; P:oligodendrocyte differentiation; P:regulation of mitochondrial membrane permeability; P:response to lipopolysaccharide; P:response to toxic substance; P:substantia nigra development;|P09543,2',3'-cyclic-nucleotide 3'-phosphodiesterase,, PF05881;, GO:0005737;GO:0070062;GO:0005615;GO:0042470;GO:0016020;GO:0005874;GO:0005902;GO:0005743;GO:0005741;GO:0035748;GO:0035749;GO:0048471;GO:0005886;GO:0031143;GO:0045202;GO:0004113;GO:0030551;GO:0003723;GO:0008344;GO:0007568;GO:0007409;GO:0007268;GO:0009214;GO:0030900;GO:0000226;GO:0048709;GO:0046902;GO:0032496;GO:0009636;GO:0021762;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:melanosome; C:membrane; C:microtubule; C:microvillus; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:myelin sheath abaxonal region; C:myelin sheath adaxonal region; C:perinuclear region of cytoplasm; C:plasma membrane; C:pseudopodium; C:synapse;, F:2',3'-cyclic-nucleotide 3'-phosphodiesterase activity; F:cyclic nucleotide binding; F:RNA binding;, P:adult locomotory behavior; P:aging; P:axonogenesis; P:chemical synaptic transmission; P:cyclic nucleotide catabolic process; P:forebrain development; P:microtubule cytoskeleton organization; P:oligodendrocyte differentiation; P:regulation of mitochondrial membrane permeability; P:response to lipopolysaccharide; P:response to toxic substance; P:substantia nigra development; scaffold61 indexed_genome mRNA 9896299 9899984 . - . ID=transcript_10767;Q96NG3 Q6NX40 Q6PJ04 Q9H0K5,Outer dynein arm-docking complex subunit 4,Tetratricopeptide repeat protein 25;, PF17874;, GO:0097729;GO:0005930;GO:0005737;GO:0005576;GO:0120228;GO:0007420;GO:0090660;GO:0003341;GO:0060287;GO:0007507;GO:0030324;GO:0120197;GO:0036158;GO:0120229;, C:9+2 motile cilium; C:axoneme; C:cytoplasm; C:extracellular region; C:outer dynein arm docking complex;, , P:brain development; P:cerebrospinal fluid circulation; P:cilium movement; P:epithelial cilium movement involved in determination of left/right asymmetry; P:heart development; P:lung development; P:mucociliary clearance; P:outer dynein arm assembly; P:protein localization to motile cilium; scaffold61 indexed_genome mRNA 9913812 9919825 . - . ID=transcript_10768;Q96NG3 Q6NX40 Q6PJ04 Q9H0K5,Outer dynein arm-docking complex subunit 4,Tetratricopeptide repeat protein 25;, PF17874;, GO:0097729;GO:0005930;GO:0005737;GO:0005576;GO:0120228;GO:0007420;GO:0090660;GO:0003341;GO:0060287;GO:0007507;GO:0030324;GO:0120197;GO:0036158;GO:0120229;, C:9+2 motile cilium; C:axoneme; C:cytoplasm; C:extracellular region; C:outer dynein arm docking complex;, , P:brain development; P:cerebrospinal fluid circulation; P:cilium movement; P:epithelial cilium movement involved in determination of left/right asymmetry; P:heart development; P:lung development; P:mucociliary clearance; P:outer dynein arm assembly; P:protein localization to motile cilium; scaffold61 indexed_genome mRNA 9931910 9974865 . + . ID=transcript_10769;P53396 B4DIM0 B4E3P0 Q13037 Q9BRL0,ATP-citrate synthase,ATP-citrate (pro-S-)-lyase;Citrate cleavage enzyme;, PF16114;PF00285;PF02629;PF00549;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0005524;GO:0003878;GO:0046872;GO:0006085;GO:0006695;GO:0006101;GO:0015936;GO:0006633;GO:0046949;GO:0008610;GO:0043312;GO:0006107;GO:0031325;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATP citrate synthase activity; F:metal ion binding;, P:acetyl-CoA biosynthetic process; P:cholesterol biosynthetic process; P:citrate metabolic process; P:coenzyme A metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid biosynthetic process; P:neutrophil degranulation; P:oxaloacetate metabolic process; P:positive regulation of cellular metabolic process;|P53396 B4DIM0 B4E3P0 Q13037 Q9BRL0,ATP-citrate synthase,ATP-citrate (pro-S-)-lyase;Citrate cleavage enzyme;, PF16114;PF00285;PF02629;PF00549;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0005524;GO:0003878;GO:0046872;GO:0006085;GO:0006695;GO:0006101;GO:0015936;GO:0006633;GO:0046949;GO:0008610;GO:0043312;GO:0006107;GO:0031325;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATP citrate synthase activity; F:metal ion binding;, P:acetyl-CoA biosynthetic process; P:cholesterol biosynthetic process; P:citrate metabolic process; P:coenzyme A metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid biosynthetic process; P:neutrophil degranulation; P:oxaloacetate metabolic process; P:positive regulation of cellular metabolic process;|P53396 B4DIM0 B4E3P0 Q13037 Q9BRL0,ATP-citrate synthase,ATP-citrate (pro-S-)-lyase;Citrate cleavage enzyme;, PF16114;PF00285;PF02629;PF00549;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0005524;GO:0003878;GO:0046872;GO:0006085;GO:0006695;GO:0006101;GO:0015936;GO:0006633;GO:0046949;GO:0008610;GO:0043312;GO:0006107;GO:0031325;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATP citrate synthase activity; F:metal ion binding;, P:acetyl-CoA biosynthetic process; P:cholesterol biosynthetic process; P:citrate metabolic process; P:coenzyme A metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid biosynthetic process; P:neutrophil degranulation; P:oxaloacetate metabolic process; P:positive regulation of cellular metabolic process;|P53396 B4DIM0 B4E3P0 Q13037 Q9BRL0,ATP-citrate synthase,ATP-citrate (pro-S-)-lyase;Citrate cleavage enzyme;, PF16114;PF00285;PF02629;PF00549;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0005524;GO:0003878;GO:0046872;GO:0006085;GO:0006695;GO:0006101;GO:0015936;GO:0006633;GO:0046949;GO:0008610;GO:0043312;GO:0006107;GO:0031325;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATP citrate synthase activity; F:metal ion binding;, P:acetyl-CoA biosynthetic process; P:cholesterol biosynthetic process; P:citrate metabolic process; P:coenzyme A metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid biosynthetic process; P:neutrophil degranulation; P:oxaloacetate metabolic process; P:positive regulation of cellular metabolic process;|P53396 B4DIM0 B4E3P0 Q13037 Q9BRL0,ATP-citrate synthase,ATP-citrate (pro-S-)-lyase;Citrate cleavage enzyme;, PF16114;PF00285;PF02629;PF00549;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0005524;GO:0003878;GO:0046872;GO:0006085;GO:0006695;GO:0006101;GO:0015936;GO:0006633;GO:0046949;GO:0008610;GO:0043312;GO:0006107;GO:0031325;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATP citrate synthase activity; F:metal ion binding;, P:acetyl-CoA biosynthetic process; P:cholesterol biosynthetic process; P:citrate metabolic process; P:coenzyme A metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid biosynthetic process; P:neutrophil degranulation; P:oxaloacetate metabolic process; P:positive regulation of cellular metabolic process;|P53396 B4DIM0 B4E3P0 Q13037 Q9BRL0,ATP-citrate synthase,ATP-citrate (pro-S-)-lyase;Citrate cleavage enzyme;, PF16114;PF00285;PF02629;PF00549;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0005524;GO:0003878;GO:0046872;GO:0006085;GO:0006695;GO:0006101;GO:0015936;GO:0006633;GO:0046949;GO:0008610;GO:0043312;GO:0006107;GO:0031325;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATP citrate synthase activity; F:metal ion binding;, P:acetyl-CoA biosynthetic process; P:cholesterol biosynthetic process; P:citrate metabolic process; P:coenzyme A metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid biosynthetic process; P:neutrophil degranulation; P:oxaloacetate metabolic process; P:positive regulation of cellular metabolic process;|P53396 B4DIM0 B4E3P0 Q13037 Q9BRL0,ATP-citrate synthase,ATP-citrate (pro-S-)-lyase;Citrate cleavage enzyme;, PF16114;PF00285;PF02629;PF00549;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0005524;GO:0003878;GO:0046872;GO:0006085;GO:0006695;GO:0006101;GO:0015936;GO:0006633;GO:0046949;GO:0008610;GO:0043312;GO:0006107;GO:0031325;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATP citrate synthase activity; F:metal ion binding;, P:acetyl-CoA biosynthetic process; P:cholesterol biosynthetic process; P:citrate metabolic process; P:coenzyme A metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid biosynthetic process; P:neutrophil degranulation; P:oxaloacetate metabolic process; P:positive regulation of cellular metabolic process;|P53396 B4DIM0 B4E3P0 Q13037 Q9BRL0,ATP-citrate synthase,ATP-citrate (pro-S-)-lyase;Citrate cleavage enzyme;, PF16114;PF00285;PF02629;PF00549;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0005524;GO:0003878;GO:0046872;GO:0006085;GO:0006695;GO:0006101;GO:0015936;GO:0006633;GO:0046949;GO:0008610;GO:0043312;GO:0006107;GO:0031325;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATP citrate synthase activity; F:metal ion binding;, P:acetyl-CoA biosynthetic process; P:cholesterol biosynthetic process; P:citrate metabolic process; P:coenzyme A metabolic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:lipid biosynthetic process; P:neutrophil degranulation; P:oxaloacetate metabolic process; P:positive regulation of cellular metabolic process; scaffold61 indexed_genome mRNA 9976157 9986881 . + . ID=transcript_10770;Q9NVR0,Kelch-like protein 11,, PF07707;PF00651;PF01344;, GO:0005829;GO:0043687;, C:cytosol;, , P:post-translational protein modification;|Q9NVR0,Kelch-like protein 11,, PF07707;PF00651;PF01344;, GO:0005829;GO:0043687;, C:cytosol;, , P:post-translational protein modification; scaffold61 indexed_genome mRNA 10000321 10008477 . + . ID=transcript_10771;Q969T7 A8MWB9 C9JKC4 Q7L3B7,7-methylguanosine phosphate-specific 5'-nucleotidase {ECO:0000305|PubMed:23223233},Cytosolic 5'-nucleotidase 3B;Cytosolic 5'-nucleotidase III-like protein {ECO:0000305|PubMed:23223233};N(7)-methylguanylate 5'-phosphatase;, PF05822;, GO:0005737;GO:0005829;GO:0016787;GO:0000287;GO:0000166;GO:0016311;GO:0043928;GO:0009117;, C:cytoplasm; C:cytosol;, F:hydrolase activity; F:magnesium ion binding; F:nucleotide binding;, P:dephosphorylation; P:exonucleolytic catabolism of deadenylated mRNA; P:nucleotide metabolic process;|Q969T7 A8MWB9 C9JKC4 Q7L3B7,7-methylguanosine phosphate-specific 5'-nucleotidase {ECO:0000305|PubMed:23223233},Cytosolic 5'-nucleotidase 3B;Cytosolic 5'-nucleotidase III-like protein {ECO:0000305|PubMed:23223233};N(7)-methylguanylate 5'-phosphatase;, PF05822;, GO:0005737;GO:0005829;GO:0016787;GO:0000287;GO:0000166;GO:0016311;GO:0043928;GO:0009117;, C:cytoplasm; C:cytosol;, F:hydrolase activity; F:magnesium ion binding; F:nucleotide binding;, P:dephosphorylation; P:exonucleolytic catabolism of deadenylated mRNA; P:nucleotide metabolic process;|Q969T7 A8MWB9 C9JKC4 Q7L3B7,7-methylguanosine phosphate-specific 5'-nucleotidase {ECO:0000305|PubMed:23223233},Cytosolic 5'-nucleotidase 3B;Cytosolic 5'-nucleotidase III-like protein {ECO:0000305|PubMed:23223233};N(7)-methylguanylate 5'-phosphatase;, PF05822;, GO:0005737;GO:0005829;GO:0016787;GO:0000287;GO:0000166;GO:0016311;GO:0043928;GO:0009117;, C:cytoplasm; C:cytosol;, F:hydrolase activity; F:magnesium ion binding; F:nucleotide binding;, P:dephosphorylation; P:exonucleolytic catabolism of deadenylated mRNA; P:nucleotide metabolic process; scaffold61 indexed_genome mRNA 10009843 10015015 . - . ID=transcript_10772;Q96AY3 Q7Z3R4 Q9H3N3 Q9H6J3 Q9H6N5 Q9UF89,Peptidyl-prolyl cis-trans isomerase FKBP10,65 kDa FK506-binding protein;FK506-binding protein 10;Immunophilin FKBP65;Rotamase;, PF13202;PF00254;, GO:0005783;GO:0005788;GO:0016020;GO:0005758;GO:0005509;GO:0005528;GO:0003755;GO:0035909;GO:0030199;GO:0085029;GO:0001701;GO:0017185;GO:0018208;GO:0042060;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:membrane; C:mitochondrial intermembrane space;, F:calcium ion binding; F:FK506 binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:aorta morphogenesis; P:collagen fibril organization; P:extracellular matrix assembly; P:in utero embryonic development; P:peptidyl-lysine hydroxylation; P:peptidyl-proline modification; P:wound healing; scaffold61 indexed_genome mRNA 10041885 10070493 . + . ID=transcript_10773;P14923 Q15093 Q15151 Q7L3S5 Q86W21 Q9BWC4 Q9HCX9,Junction plakoglobin,Catenin gamma;Desmoplakin III;Desmoplakin-3;, PF00514;, GO:0015629;GO:0005912;GO:0016327;GO:0016342;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0005829;GO:0030057;GO:0070062;GO:0005576;GO:0005916;GO:1904813;GO:0005925;GO:0071665;GO:0014704;GO:0005882;GO:0016328;GO:0005634;GO:0005886;GO:0032993;GO:0035580;GO:0030018;GO:0005915;GO:0045294;GO:0045296;GO:0050839;GO:0086083;GO:0106006;GO:0035257;GO:0042803;GO:0019901;GO:0019903;GO:0044877;GO:0005198;GO:0003713;GO:0034332;GO:0086073;GO:0016477;GO:0098609;GO:0071681;GO:0070268;GO:0002159;GO:0050982;GO:0071603;GO:0031424;GO:0043537;GO:0043312;GO:0045766;GO:0090263;GO:0001954;GO:0051091;GO:0042307;GO:0045944;GO:0072659;GO:0042127;GO:0086091;GO:0098911;, C:actin cytoskeleton; C:adherens junction; C:apicolateral plasma membrane; C:catenin complex; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:desmosome; C:extracellular exosome; C:extracellular region; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:gamma-catenin-TCF7L2 complex; C:intercalated disc; C:intermediate filament; C:lateral plasma membrane; C:nucleus; C:plasma membrane; C:protein-DNA complex; C:specific granule lumen; C:Z disc; C:zonula adherens;, F:alpha-catenin binding; F:cadherin binding; F:cell adhesion molecule binding; F:cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication; F:cytoskeletal protein-membrane anchor activity; F:nuclear hormone receptor binding; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:structural molecule activity; F:transcription coactivator activity;, P:adherens junction organization; P:bundle of His cell-Purkinje myocyte adhesion involved in cell communication; P:cell migration; P:cell-cell adhesion; P:cellular response to indole-3-methanol; P:cornification; P:desmosome assembly; P:detection of mechanical stimulus; P:endothelial cell-cell adhesion; P:keratinization; P:negative regulation of blood vessel endothelial cell migration; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell-matrix adhesion; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of protein import into nucleus; P:positive regulation of transcription by RNA polymerase II; P:protein localization to plasma membrane; P:regulation of cell population proliferation; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell action potential;|P14923 Q15093 Q15151 Q7L3S5 Q86W21 Q9BWC4 Q9HCX9,Junction plakoglobin,Catenin gamma;Desmoplakin III;Desmoplakin-3;, PF00514;, GO:0015629;GO:0005912;GO:0016327;GO:0016342;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0005829;GO:0030057;GO:0070062;GO:0005576;GO:0005916;GO:1904813;GO:0005925;GO:0071665;GO:0014704;GO:0005882;GO:0016328;GO:0005634;GO:0005886;GO:0032993;GO:0035580;GO:0030018;GO:0005915;GO:0045294;GO:0045296;GO:0050839;GO:0086083;GO:0106006;GO:0035257;GO:0042803;GO:0019901;GO:0019903;GO:0044877;GO:0005198;GO:0003713;GO:0034332;GO:0086073;GO:0016477;GO:0098609;GO:0071681;GO:0070268;GO:0002159;GO:0050982;GO:0071603;GO:0031424;GO:0043537;GO:0043312;GO:0045766;GO:0090263;GO:0001954;GO:0051091;GO:0042307;GO:0045944;GO:0072659;GO:0042127;GO:0086091;GO:0098911;, C:actin cytoskeleton; C:adherens junction; C:apicolateral plasma membrane; C:catenin complex; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:cytosol; C:desmosome; C:extracellular exosome; C:extracellular region; C:fascia adherens; C:ficolin-1-rich granule lumen; C:focal adhesion; C:gamma-catenin-TCF7L2 complex; C:intercalated disc; C:intermediate filament; C:lateral plasma membrane; C:nucleus; C:plasma membrane; C:protein-DNA complex; C:specific granule lumen; C:Z disc; C:zonula adherens;, F:alpha-catenin binding; F:cadherin binding; F:cell adhesion molecule binding; F:cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication; F:cytoskeletal protein-membrane anchor activity; F:nuclear hormone receptor binding; F:protein homodimerization activity; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:structural molecule activity; F:transcription coactivator activity;, P:adherens junction organization; P:bundle of His cell-Purkinje myocyte adhesion involved in cell communication; P:cell migration; P:cell-cell adhesion; P:cellular response to indole-3-methanol; P:cornification; P:desmosome assembly; P:detection of mechanical stimulus; P:endothelial cell-cell adhesion; P:keratinization; P:negative regulation of blood vessel endothelial cell migration; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell-matrix adhesion; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of protein import into nucleus; P:positive regulation of transcription by RNA polymerase II; P:protein localization to plasma membrane; P:regulation of cell population proliferation; P:regulation of heart rate by cardiac conduction; P:regulation of ventricular cardiac muscle cell action potential; scaffold61 indexed_genome mRNA 10085176 10091634 . + . ID=transcript_10774;P54257 A8MQB5 O75358 Q59GK4 Q9H4G3 Q9HA98 Q9NY90,Huntingtin-associated protein 1,Neuroan 1;, PF04849;, GO:0015629;GO:0005776;GO:1904115;GO:0005814;GO:0005813;GO:0031410;GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0005769;GO:0005783;GO:0030426;GO:0016234;GO:0005764;GO:0005739;GO:0005730;GO:0008021;GO:0048403;GO:0044325;GO:0017022;GO:0005102;GO:0008089;GO:0098957;GO:0006914;GO:0007420;GO:0030030;GO:0021549;GO:0007268;GO:0006887;GO:0021979;GO:0048311;GO:1902430;GO:0022008;GO:0048011;GO:0045742;GO:0031587;GO:0050769;GO:0032901;GO:1902857;GO:0032230;GO:0008104;GO:0006605;GO:0017157;GO:1902513;GO:0008090;GO:0047496;, C:actin cytoskeleton; C:autophagosome; C:axon cytoplasm; C:centriole; C:centrosome; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:early endosome; C:endoplasmic reticulum; C:growth cone; C:inclusion body; C:lysosome; C:mitochondrion; C:nucleolus; C:synaptic vesicle;, F:brain-derived neurotrophic factor binding; F:ion channel binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport; P:anterograde axonal transport of mitochondrion; P:autophagy; P:brain development; P:cell projection organization; P:cerebellum development; P:chemical synaptic transmission; P:exocytosis; P:hypothalamus cell differentiation; P:mitochondrion distribution; P:negative regulation of amyloid-beta formation; P:neurogenesis; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of neurogenesis; P:positive regulation of neurotrophin production; P:positive regulation of non-motile cilium assembly; P:positive regulation of synaptic transmission, GABAergic; P:protein localization; P:protein targeting; P:regulation of exocytosis; P:regulation of organelle transport along microtubule; P:retrograde axonal transport; P:vesicle transport along microtubule; scaffold61 indexed_genome mRNA 10091680 10102577 . + . ID=transcript_10775;P54257 A8MQB5 O75358 Q59GK4 Q9H4G3 Q9HA98 Q9NY90,Huntingtin-associated protein 1,Neuroan 1;, PF04849;, GO:0015629;GO:0005776;GO:1904115;GO:0005814;GO:0005813;GO:0031410;GO:0005856;GO:0005829;GO:0030425;GO:0043197;GO:0005769;GO:0005783;GO:0030426;GO:0016234;GO:0005764;GO:0005739;GO:0005730;GO:0008021;GO:0048403;GO:0044325;GO:0017022;GO:0005102;GO:0008089;GO:0098957;GO:0006914;GO:0007420;GO:0030030;GO:0021549;GO:0007268;GO:0006887;GO:0021979;GO:0048311;GO:1902430;GO:0022008;GO:0048011;GO:0045742;GO:0031587;GO:0050769;GO:0032901;GO:1902857;GO:0032230;GO:0008104;GO:0006605;GO:0017157;GO:1902513;GO:0008090;GO:0047496;, C:actin cytoskeleton; C:autophagosome; C:axon cytoplasm; C:centriole; C:centrosome; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:dendrite; C:dendritic spine; C:early endosome; C:endoplasmic reticulum; C:growth cone; C:inclusion body; C:lysosome; C:mitochondrion; C:nucleolus; C:synaptic vesicle;, F:brain-derived neurotrophic factor binding; F:ion channel binding; F:myosin binding; F:signaling receptor binding;, P:anterograde axonal transport; P:anterograde axonal transport of mitochondrion; P:autophagy; P:brain development; P:cell projection organization; P:cerebellum development; P:chemical synaptic transmission; P:exocytosis; P:hypothalamus cell differentiation; P:mitochondrion distribution; P:negative regulation of amyloid-beta formation; P:neurogenesis; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of neurogenesis; P:positive regulation of neurotrophin production; P:positive regulation of non-motile cilium assembly; P:positive regulation of synaptic transmission, GABAergic; P:protein localization; P:protein targeting; P:regulation of exocytosis; P:regulation of organelle transport along microtubule; P:retrograde axonal transport; P:vesicle transport along microtubule;|P01350 P78463 P78464,Gastrin,, PF00918;, GO:0005576;GO:0005615;GO:0005179;GO:0007186;GO:0032094;GO:0007165;, C:extracellular region; C:extracellular space;, F:hormone activity;, P:G protein-coupled receptor signaling pathway; P:response to food; P:signal transduction; scaffold61 indexed_genome mRNA 10120473 10122460 . - . ID=transcript_10776;P41567 Q9UNQ9,Eukaryotic translation initiation factor 1,A121;Protein translation factor SUI1 homolog;Sui1iso1;, PF01253;, GO:0005737;GO:0016282;GO:0005634;GO:0043024;GO:0003723;GO:0008135;GO:0003743;GO:0006446;, C:cytoplasm; C:eukaryotic 43S preinitiation complex; C:nucleus;, F:ribosomal small subunit binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation;|P41567 Q9UNQ9,Eukaryotic translation initiation factor 1,A121;Protein translation factor SUI1 homolog;Sui1iso1;, PF01253;, GO:0005737;GO:0016282;GO:0005634;GO:0043024;GO:0003723;GO:0008135;GO:0003743;GO:0006446;, C:cytoplasm; C:eukaryotic 43S preinitiation complex; C:nucleus;, F:ribosomal small subunit binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation; scaffold61 indexed_genome mRNA 10287551 10291416 . + . ID=transcript_10777;P08727 B2R874 Q5XG83 Q6NW33 Q7L5M9 Q96A53 Q96FV1 Q9BYF9 Q9P1Y4,Keratin, type I cytoskeletal 19,Cytokeratin-19;Keratin-19;, PF00038;, GO:0016327;GO:0071944;GO:0043034;GO:0005829;GO:0016010;GO:0070062;GO:0005882;GO:0005886;GO:0042383;GO:1990357;GO:0030018;GO:0044877;GO:0005200;GO:0008307;GO:0060706;GO:0070268;GO:0031424;GO:0007219;GO:0043627;GO:0045214;GO:0016032;, C:apicolateral plasma membrane; C:cell periphery; C:costamere; C:cytosol; C:dystrophin-associated glycoprotein complex; C:extracellular exosome; C:intermediate filament; C:plasma membrane; C:sarcolemma; C:terminal web; C:Z disc;, F:protein-containing complex binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle;, P:cell differentiation involved in embryonic placenta development; P:cornification; P:keratinization; P:Notch signaling pathway; P:response to estrogen; P:sarcomere organization; P:viral process; scaffold61 indexed_genome mRNA 10304346 10314224 . + . ID=transcript_10778;P13646 Q53G54 Q6AZK5 Q8N240,Keratin, type I cytoskeletal 13,Cytokeratin-13;Keratin-13;, PF00038;, GO:0005829;GO:0070062;GO:0045111;GO:0045095;GO:0005634;GO:0005198;GO:0070268;GO:0007010;GO:0031424;, C:cytosol; C:extracellular exosome; C:intermediate filament cytoskeleton; C:keratin filament; C:nucleus;, F:structural molecule activity;, P:cornification; P:cytoskeleton organization; P:keratinization; scaffold61 indexed_genome mRNA 10954021 10954571 . + . ID=transcript_10779;Q99456 B2R9E0,Keratin, type I cytoskeletal 12,Cytokeratin-12;Keratin-12;, PF00038;, GO:0005829;GO:0070062;GO:0005882;GO:0005198;GO:0061303;GO:0070268;GO:0031424;GO:0002009;GO:0007601;, C:cytosol; C:extracellular exosome; C:intermediate filament;, F:structural molecule activity;, P:cornea development in camera-type eye; P:cornification; P:keratinization; P:morphogenesis of an epithelium; P:visual perception; scaffold61 indexed_genome mRNA 10954720 10955328 . - . ID=transcript_10780;P19012 B3KQY1 B3KRA2 E0CX14 Q53XV8 Q9BUG4,Keratin, type I cytoskeletal 15,Cytokeratin-15;Keratin-15;, PF00038;, GO:0005829;GO:0070062;GO:0005882;GO:0005634;GO:0097110;GO:0005200;GO:0070268;GO:0008544;GO:0031424;, C:cytosol; C:extracellular exosome; C:intermediate filament; C:nucleus;, F:scaffold protein binding; F:structural constituent of cytoskeleton;, P:cornification; P:epidermis development; P:keratinization; scaffold61 indexed_genome mRNA 10996835 11000508 . + . ID=transcript_10781;P19012 B3KQY1 B3KRA2 E0CX14 Q53XV8 Q9BUG4,Keratin, type I cytoskeletal 15,Cytokeratin-15;Keratin-15;, PF00038;, GO:0005829;GO:0070062;GO:0005882;GO:0005634;GO:0097110;GO:0005200;GO:0070268;GO:0008544;GO:0031424;, C:cytosol; C:extracellular exosome; C:intermediate filament; C:nucleus;, F:scaffold protein binding; F:structural constituent of cytoskeleton;, P:cornification; P:epidermis development; P:keratinization;|P13645 Q14664 Q8N175,Keratin, type I cytoskeletal 10,Cytokeratin-10;Keratin-10;, PF00038;, GO:0009986;GO:0001533;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0005882;GO:0016020;GO:0005634;GO:0046982;GO:0030280;GO:0070268;GO:0031424;GO:0030216;GO:0018149;GO:0045684;GO:0051290;, C:cell surface; C:cornified envelope; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:intermediate filament; C:membrane; C:nucleus;, F:protein heterodimerization activity; F:structural constituent of skin epidermis;, P:cornification; P:keratinization; P:keratinocyte differentiation; P:peptide cross-linking; P:positive regulation of epidermis development; P:protein heterotetramerization; scaffold61 indexed_genome mRNA 11121593 11129580 . + . ID=transcript_10782;Q8N1A0 Q7Z368,Keratin-like protein KRT222,Keratin-222;Keratin-222 pseudogene;, PF00038;, GO:0005882;GO:0005198;, C:intermediate filament;, F:structural molecule activity; scaffold61 indexed_genome mRNA 11134679 11157509 . + . ID=transcript_10783;Q969G3 B3KMC1 B4DFR4 C0IMW4 C0IMW5 C0IMW7 H7C3F6 O43539,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,BRG1-associated factor 57;, PF00505;, GO:0000785;GO:0071565;GO:0071564;GO:0000228;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003682;GO:0003677;GO:0008080;GO:0016922;GO:0047485;GO:0003723;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0022008;GO:0006337;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:DNA binding; F:N-acetyltransferase activity; F:nuclear receptor binding; F:protein N-terminus binding; F:RNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:neurogenesis; P:nucleosome disassembly; P:regulation of transcription by RNA polymerase II;|Q969G3 B3KMC1 B4DFR4 C0IMW4 C0IMW5 C0IMW7 H7C3F6 O43539,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,BRG1-associated factor 57;, PF00505;, GO:0000785;GO:0071565;GO:0071564;GO:0000228;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003682;GO:0003677;GO:0008080;GO:0016922;GO:0047485;GO:0003723;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0022008;GO:0006337;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:DNA binding; F:N-acetyltransferase activity; F:nuclear receptor binding; F:protein N-terminus binding; F:RNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:neurogenesis; P:nucleosome disassembly; P:regulation of transcription by RNA polymerase II;|Q969G3 B3KMC1 B4DFR4 C0IMW4 C0IMW5 C0IMW7 H7C3F6 O43539,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,BRG1-associated factor 57;, PF00505;, GO:0000785;GO:0071565;GO:0071564;GO:0000228;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003682;GO:0003677;GO:0008080;GO:0016922;GO:0047485;GO:0003723;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0022008;GO:0006337;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:DNA binding; F:N-acetyltransferase activity; F:nuclear receptor binding; F:protein N-terminus binding; F:RNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:neurogenesis; P:nucleosome disassembly; P:regulation of transcription by RNA polymerase II;|Q969G3 B3KMC1 B4DFR4 C0IMW4 C0IMW5 C0IMW7 H7C3F6 O43539,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,BRG1-associated factor 57;, PF00505;, GO:0000785;GO:0071565;GO:0071564;GO:0000228;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003682;GO:0003677;GO:0008080;GO:0016922;GO:0047485;GO:0003723;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0022008;GO:0006337;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:DNA binding; F:N-acetyltransferase activity; F:nuclear receptor binding; F:protein N-terminus binding; F:RNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:neurogenesis; P:nucleosome disassembly; P:regulation of transcription by RNA polymerase II;|Q969G3 B3KMC1 B4DFR4 C0IMW4 C0IMW5 C0IMW7 H7C3F6 O43539,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,BRG1-associated factor 57;, PF00505;, GO:0000785;GO:0071565;GO:0071564;GO:0000228;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003682;GO:0003677;GO:0008080;GO:0016922;GO:0047485;GO:0003723;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0022008;GO:0006337;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:DNA binding; F:N-acetyltransferase activity; F:nuclear receptor binding; F:protein N-terminus binding; F:RNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:neurogenesis; P:nucleosome disassembly; P:regulation of transcription by RNA polymerase II;|Q969G3 B3KMC1 B4DFR4 C0IMW4 C0IMW5 C0IMW7 H7C3F6 O43539,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,BRG1-associated factor 57;, PF00505;, GO:0000785;GO:0071565;GO:0071564;GO:0000228;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003682;GO:0003677;GO:0008080;GO:0016922;GO:0047485;GO:0003723;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0022008;GO:0006337;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:DNA binding; F:N-acetyltransferase activity; F:nuclear receptor binding; F:protein N-terminus binding; F:RNA binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:neurogenesis; P:nucleosome disassembly; P:regulation of transcription by RNA polymerase II; scaffold61 indexed_genome mRNA 11305227 11317215 . - . ID=transcript_10784;P22692 A0N9W2 B4E351 Q5U012 Q9UCL6,Insulin-like growth factor-binding protein 4,, PF00219;PF00086;, GO:0005788;GO:0005576;GO:0005615;GO:0031994;GO:0031995;GO:0005102;GO:0044267;GO:0006954;GO:0090090;GO:0043568;GO:0043410;GO:0043687;GO:0001558;GO:0010906;GO:0043567;GO:0007165;GO:0044342;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space;, F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:signaling receptor binding;, P:cellular protein metabolic process; P:inflammatory response; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of MAPK cascade; P:post-translational protein modification; P:regulation of cell growth; P:regulation of glucose metabolic process; P:regulation of insulin-like growth factor receptor signaling pathway; P:signal transduction; P:type B pancreatic cell proliferation;|P22692 A0N9W2 B4E351 Q5U012 Q9UCL6,Insulin-like growth factor-binding protein 4,, PF00219;PF00086;, GO:0005788;GO:0005576;GO:0005615;GO:0031994;GO:0031995;GO:0005102;GO:0044267;GO:0006954;GO:0090090;GO:0043568;GO:0043410;GO:0043687;GO:0001558;GO:0010906;GO:0043567;GO:0007165;GO:0044342;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space;, F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:signaling receptor binding;, P:cellular protein metabolic process; P:inflammatory response; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of MAPK cascade; P:post-translational protein modification; P:regulation of cell growth; P:regulation of glucose metabolic process; P:regulation of insulin-like growth factor receptor signaling pathway; P:signal transduction; P:type B pancreatic cell proliferation;|P22692 A0N9W2 B4E351 Q5U012 Q9UCL6,Insulin-like growth factor-binding protein 4,, PF00219;PF00086;, GO:0005788;GO:0005576;GO:0005615;GO:0031994;GO:0031995;GO:0005102;GO:0044267;GO:0006954;GO:0090090;GO:0043568;GO:0043410;GO:0043687;GO:0001558;GO:0010906;GO:0043567;GO:0007165;GO:0044342;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space;, F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:signaling receptor binding;, P:cellular protein metabolic process; P:inflammatory response; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of MAPK cascade; P:post-translational protein modification; P:regulation of cell growth; P:regulation of glucose metabolic process; P:regulation of insulin-like growth factor receptor signaling pathway; P:signal transduction; P:type B pancreatic cell proliferation;|P22692 A0N9W2 B4E351 Q5U012 Q9UCL6,Insulin-like growth factor-binding protein 4,, PF00219;PF00086;, GO:0005788;GO:0005576;GO:0005615;GO:0031994;GO:0031995;GO:0005102;GO:0044267;GO:0006954;GO:0090090;GO:0043568;GO:0043410;GO:0043687;GO:0001558;GO:0010906;GO:0043567;GO:0007165;GO:0044342;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space;, F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:signaling receptor binding;, P:cellular protein metabolic process; P:inflammatory response; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of MAPK cascade; P:post-translational protein modification; P:regulation of cell growth; P:regulation of glucose metabolic process; P:regulation of insulin-like growth factor receptor signaling pathway; P:signal transduction; P:type B pancreatic cell proliferation; scaffold61 indexed_genome mRNA 11337589 11340789 . + . ID=transcript_10785;P11388 B2RTS1 Q71UN1 Q71UQ5 Q9HB24 Q9HB25 Q9HB26 Q9UP44 Q9UQP9,DNA topoisomerase 2-alpha,DNA topoisomerase II, alpha isozyme;, PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;, GO:0000775;GO:0000793;GO:0005737;GO:0009330;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005524;GO:0003682;GO:0003677;GO:0008301;GO:0003918;GO:0008094;GO:0019899;GO:0042826;GO:0000287;GO:0008022;GO:0046982;GO:0042803;GO:0005080;GO:0003723;GO:0043130;GO:0030263;GO:0006974;GO:0007059;GO:0006266;GO:0006265;GO:0040016;GO:0007143;GO:0002244;GO:1905463;GO:0043065;GO:0045870;GO:0045944;GO:0042752;GO:0000712;GO:0048511;GO:0000819;, C:chromosome, centromeric region; C:condensed chromosome; C:cytoplasm; C:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA binding, bending; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; F:DNA-dependent ATPase activity; F:enzyme binding; F:histone deacetylase binding; F:magnesium ion binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase C binding; F:RNA binding; F:ubiquitin binding;, P:apoptotic chromosome condensation; P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA ligation; P:DNA topological change; P:embryonic cleavage; P:female meiotic nuclear division; P:hematopoietic progenitor cell differentiation; P:negative regulation of DNA duplex unwinding; P:positive regulation of apoptotic process; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:resolution of meiotic recombination intermediates; P:rhythmic process; P:sister chromatid segregation; scaffold61 indexed_genome mRNA 11350721 11362561 . + . ID=transcript_10786;P11388 B2RTS1 Q71UN1 Q71UQ5 Q9HB24 Q9HB25 Q9HB26 Q9UP44 Q9UQP9,DNA topoisomerase 2-alpha,DNA topoisomerase II, alpha isozyme;, PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;, GO:0000775;GO:0000793;GO:0005737;GO:0009330;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005524;GO:0003682;GO:0003677;GO:0008301;GO:0003918;GO:0008094;GO:0019899;GO:0042826;GO:0000287;GO:0008022;GO:0046982;GO:0042803;GO:0005080;GO:0003723;GO:0043130;GO:0030263;GO:0006974;GO:0007059;GO:0006266;GO:0006265;GO:0040016;GO:0007143;GO:0002244;GO:1905463;GO:0043065;GO:0045870;GO:0045944;GO:0042752;GO:0000712;GO:0048511;GO:0000819;, C:chromosome, centromeric region; C:condensed chromosome; C:cytoplasm; C:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex;, F:ATP binding; F:chromatin binding; F:DNA binding; F:DNA binding, bending; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; F:DNA-dependent ATPase activity; F:enzyme binding; F:histone deacetylase binding; F:magnesium ion binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase C binding; F:RNA binding; F:ubiquitin binding;, P:apoptotic chromosome condensation; P:cellular response to DNA damage stimulus; P:chromosome segregation; P:DNA ligation; P:DNA topological change; P:embryonic cleavage; P:female meiotic nuclear division; P:hematopoietic progenitor cell differentiation; P:negative regulation of DNA duplex unwinding; P:positive regulation of apoptotic process; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:resolution of meiotic recombination intermediates; P:rhythmic process; P:sister chromatid segregation; scaffold61 indexed_genome mRNA 11388449 11418104 . - . ID=transcript_10787;P10276 B8Y636 P78456 Q13440 Q13441 Q96S41 Q9NQS0,Retinoic acid receptor alpha,Nuclear receptor subfamily 1 group B member 1;, PF00104;PF00105;, GO:0015629;GO:0009986;GO:0000785;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0051393;GO:0003682;GO:0031490;GO:0003700;GO:0000981;GO:0019899;GO:0004879;GO:0019904;GO:0051018;GO:0043422;GO:0001972;GO:0044323;GO:0000978;GO:0000977;GO:1990837;GO:0005102;GO:0008134;GO:0008270;GO:0043277;GO:0030154;GO:0071391;GO:0030851;GO:0009755;GO:0030853;GO:0032689;GO:0000122;GO:0045892;GO:0032720;GO:0051099;GO:0045787;GO:0008284;GO:0032736;GO:0032753;GO:0032754;GO:0045630;GO:0045944;GO:0045893;GO:0006468;GO:0032526;GO:0048384;GO:0007165;GO:0006367;, C:actin cytoskeleton; C:cell surface; C:chromatin; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:alpha-actinin binding; F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:nuclear receptor activity; F:protein domain specific binding; F:protein kinase A binding; F:protein kinase B binding; F:retinoic acid binding; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor binding; F:transcription factor binding; F:zinc ion binding;, P:apoptotic cell clearance; P:cell differentiation; P:cellular response to estrogen stimulus; P:granulocyte differentiation; P:hormone-mediated signaling pathway; P:negative regulation of granulocyte differentiation; P:negative regulation of interferon-gamma production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:positive regulation of binding; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of T-helper 2 cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:signal transduction; P:transcription initiation from RNA polymerase II promoter;|P10276 B8Y636 P78456 Q13440 Q13441 Q96S41 Q9NQS0,Retinoic acid receptor alpha,Nuclear receptor subfamily 1 group B member 1;, PF00104;PF00105;, GO:0015629;GO:0009986;GO:0000785;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0051393;GO:0003682;GO:0031490;GO:0003700;GO:0000981;GO:0019899;GO:0004879;GO:0019904;GO:0051018;GO:0043422;GO:0001972;GO:0044323;GO:0000978;GO:0000977;GO:1990837;GO:0005102;GO:0008134;GO:0008270;GO:0043277;GO:0030154;GO:0071391;GO:0030851;GO:0009755;GO:0030853;GO:0032689;GO:0000122;GO:0045892;GO:0032720;GO:0051099;GO:0045787;GO:0008284;GO:0032736;GO:0032753;GO:0032754;GO:0045630;GO:0045944;GO:0045893;GO:0006468;GO:0032526;GO:0048384;GO:0007165;GO:0006367;, C:actin cytoskeleton; C:cell surface; C:chromatin; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:alpha-actinin binding; F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:nuclear receptor activity; F:protein domain specific binding; F:protein kinase A binding; F:protein kinase B binding; F:retinoic acid binding; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor binding; F:transcription factor binding; F:zinc ion binding;, P:apoptotic cell clearance; P:cell differentiation; P:cellular response to estrogen stimulus; P:granulocyte differentiation; P:hormone-mediated signaling pathway; P:negative regulation of granulocyte differentiation; P:negative regulation of interferon-gamma production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:positive regulation of binding; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-5 production; P:positive regulation of T-helper 2 cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; scaffold62 indexed_genome mRNA 19610 42726 . - . ID=transcript_10788;P31512 Q53XR0,Dimethylaniline monooxygenase [N-oxide-forming] 4,Dimethylaniline oxidase 4;Hepatic flavin-containing monooxygenase 4;, PF00743;, GO:0005789;GO:0016021;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0042737;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding;, P:drug catabolic process;|P31512 Q53XR0,Dimethylaniline monooxygenase [N-oxide-forming] 4,Dimethylaniline oxidase 4;Hepatic flavin-containing monooxygenase 4;, PF00743;, GO:0005789;GO:0016021;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0042737;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding;, P:drug catabolic process;|P31512 Q53XR0,Dimethylaniline monooxygenase [N-oxide-forming] 4,Dimethylaniline oxidase 4;Hepatic flavin-containing monooxygenase 4;, PF00743;, GO:0005789;GO:0016021;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0042737;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding;, P:drug catabolic process;|P31512 Q53XR0,Dimethylaniline monooxygenase [N-oxide-forming] 4,Dimethylaniline oxidase 4;Hepatic flavin-containing monooxygenase 4;, PF00743;, GO:0005789;GO:0016021;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0042737;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding;, P:drug catabolic process;|P31512 Q53XR0,Dimethylaniline monooxygenase [N-oxide-forming] 4,Dimethylaniline oxidase 4;Hepatic flavin-containing monooxygenase 4;, PF00743;, GO:0005789;GO:0016021;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0042737;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding;, P:drug catabolic process; scaffold62 indexed_genome mRNA 49549 53957 . + . ID=transcript_10789;P31512 Q53XR0,Dimethylaniline monooxygenase [N-oxide-forming] 4,Dimethylaniline oxidase 4;Hepatic flavin-containing monooxygenase 4;, PF00743;, GO:0005789;GO:0016021;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0042737;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding;, P:drug catabolic process; scaffold62 indexed_genome mRNA 135470 229827 . + . ID=transcript_10790;Q9UPQ6,Protein PRRC2C,BAT2 domain-containing protein 1;HBV X-transactivated gene 2 protein;HBV XAg-transactivated protein 2;HLA-B-associated transcript 2-like 2;Proline-rich and coiled-coil-containing protein 2C;, PF07001;, GO:0010494;GO:0005829;GO:0016020;GO:0008022;GO:0003723;GO:0030154;GO:0002244;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane;, F:protein C-terminus binding; F:RNA binding;, P:cell differentiation; P:hematopoietic progenitor cell differentiation; P:stress granule assembly;|Q9UPQ6,Protein PRRC2C,BAT2 domain-containing protein 1;HBV X-transactivated gene 2 protein;HBV XAg-transactivated protein 2;HLA-B-associated transcript 2-like 2;Proline-rich and coiled-coil-containing protein 2C;, PF07001;, GO:0010494;GO:0005829;GO:0016020;GO:0008022;GO:0003723;GO:0030154;GO:0002244;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane;, F:protein C-terminus binding; F:RNA binding;, P:cell differentiation; P:hematopoietic progenitor cell differentiation; P:stress granule assembly;|Q9UPQ6,Protein PRRC2C,BAT2 domain-containing protein 1;HBV X-transactivated gene 2 protein;HBV XAg-transactivated protein 2;HLA-B-associated transcript 2-like 2;Proline-rich and coiled-coil-containing protein 2C;, PF07001;, GO:0010494;GO:0005829;GO:0016020;GO:0008022;GO:0003723;GO:0030154;GO:0002244;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane;, F:protein C-terminus binding; F:RNA binding;, P:cell differentiation; P:hematopoietic progenitor cell differentiation; P:stress granule assembly;|Q9UPQ6,Protein PRRC2C,BAT2 domain-containing protein 1;HBV X-transactivated gene 2 protein;HBV XAg-transactivated protein 2;HLA-B-associated transcript 2-like 2;Proline-rich and coiled-coil-containing protein 2C;, PF07001;, GO:0010494;GO:0005829;GO:0016020;GO:0008022;GO:0003723;GO:0030154;GO:0002244;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane;, F:protein C-terminus binding; F:RNA binding;, P:cell differentiation; P:hematopoietic progenitor cell differentiation; P:stress granule assembly;|Q9UPQ6,Protein PRRC2C,BAT2 domain-containing protein 1;HBV X-transactivated gene 2 protein;HBV XAg-transactivated protein 2;HLA-B-associated transcript 2-like 2;Proline-rich and coiled-coil-containing protein 2C;, PF07001;, GO:0010494;GO:0005829;GO:0016020;GO:0008022;GO:0003723;GO:0030154;GO:0002244;GO:0034063;, C:cytoplasmic stress granule; C:cytosol; C:membrane;, F:protein C-terminus binding; F:RNA binding;, P:cell differentiation; P:hematopoietic progenitor cell differentiation; P:stress granule assembly; scaffold62 indexed_genome mRNA 243880 257988 . - . ID=transcript_10791;Q99972 B2RD84 O00620 Q7Z6Q9,Myocilin {ECO:0000303|PubMed:9169133},Myocilin 55 kDa subunit;Trabecular meshwork-induced glucocorticoid response protein {ECO:0000303|PubMed:9497363};, PF02191;, GO:0005929;GO:0062023;GO:0031410;GO:0005783;GO:0070062;GO:0005615;GO:0005794;GO:0005743;GO:0005758;GO:0005741;GO:0033268;GO:0005791;GO:0001968;GO:0005109;GO:0046872;GO:0032027;GO:0030971;GO:0060348;GO:0045162;GO:0038133;GO:0022011;GO:0001953;GO:0035024;GO:0051497;GO:0031175;GO:0038031;GO:0001649;GO:0030335;GO:0051894;GO:0051901;GO:0014068;GO:0051897;GO:0051496;GO:1900026;GO:0043408;GO:0014734;, C:cilium; C:collagen-containing extracellular matrix; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:node of Ranvier; C:rough endoplasmic reticulum;, F:fibronectin binding; F:frizzled binding; F:metal ion binding; F:myosin light chain binding; F:receptor tyrosine kinase binding;, P:bone development; P:clustering of voltage-gated sodium channels; P:ERBB2-ERBB3 signaling pathway; P:myelination in peripheral nervous system; P:negative regulation of cell-matrix adhesion; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:neuron projection development; P:non-canonical Wnt signaling pathway via JNK cascade; P:osteoblast differentiation; P:positive regulation of cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of mitochondrial depolarization; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of MAPK cascade; P:skeletal muscle hypertrophy; scaffold62 indexed_genome mRNA 296627 317244 . - . ID=transcript_10792;O75379 A2IDD8 Q96IY9 Q96J20 Q9UEL7,Vesicle-associated membrane protein 4,, PF00957;, GO:0009986;GO:0030669;GO:0005768;GO:0005794;GO:0000139;GO:0030285;GO:0005764;GO:0005886;GO:0031201;GO:0008021;GO:0005802;GO:0032588;GO:0030133;GO:0090161;GO:0061024;GO:0000226;GO:1900242;GO:0035493;GO:0016189;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of synaptic vesicle membrane; C:lysosome; C:plasma membrane; C:SNARE complex; C:synaptic vesicle; C:trans-Golgi network; C:trans-Golgi network membrane; C:transport vesicle;, , P:Golgi ribbon formation; P:membrane organization; P:microtubule cytoskeleton organization; P:regulation of synaptic vesicle endocytosis; P:SNARE complex assembly; P:synaptic vesicle to endosome fusion;|O75379 A2IDD8 Q96IY9 Q96J20 Q9UEL7,Vesicle-associated membrane protein 4,, PF00957;, GO:0009986;GO:0030669;GO:0005768;GO:0005794;GO:0000139;GO:0030285;GO:0005764;GO:0005886;GO:0031201;GO:0008021;GO:0005802;GO:0032588;GO:0030133;GO:0090161;GO:0061024;GO:0000226;GO:1900242;GO:0035493;GO:0016189;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of synaptic vesicle membrane; C:lysosome; C:plasma membrane; C:SNARE complex; C:synaptic vesicle; C:trans-Golgi network; C:trans-Golgi network membrane; C:transport vesicle;, , P:Golgi ribbon formation; P:membrane organization; P:microtubule cytoskeleton organization; P:regulation of synaptic vesicle endocytosis; P:SNARE complex assembly; P:synaptic vesicle to endosome fusion;|O75379 A2IDD8 Q96IY9 Q96J20 Q9UEL7,Vesicle-associated membrane protein 4,, PF00957;, GO:0009986;GO:0030669;GO:0005768;GO:0005794;GO:0000139;GO:0030285;GO:0005764;GO:0005886;GO:0031201;GO:0008021;GO:0005802;GO:0032588;GO:0030133;GO:0090161;GO:0061024;GO:0000226;GO:1900242;GO:0035493;GO:0016189;, C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of synaptic vesicle membrane; C:lysosome; C:plasma membrane; C:SNARE complex; C:synaptic vesicle; C:trans-Golgi network; C:trans-Golgi network membrane; C:transport vesicle;, , P:Golgi ribbon formation; P:membrane organization; P:microtubule cytoskeleton organization; P:regulation of synaptic vesicle endocytosis; P:SNARE complex assembly; P:synaptic vesicle to endosome fusion; scaffold62 indexed_genome mRNA 331314 347342 . + . ID=transcript_10793;Q96SQ0 Q9Y2Z1 Q9Y3M6,eEF1A lysine and N-terminal methyltransferase {ECO:0000303|PubMed:30143613},Methyltransferase-like protein 13;, PF08241;, GO:0008168;GO:0032259;, , F:methyltransferase activity;, P:methylation; scaffold62 indexed_genome mRNA 575911 996232 . + . ID=transcript_10794;Q9NQ68 Q9NQN6,Dynamin-3,Dynamin, testicular;T-dynamin;, PF01031;PF00350;PF02212;PF00169;, GO:0061828;GO:0030424;GO:0061829;GO:0005737;GO:0031410;GO:0043197;GO:0044327;GO:0070062;GO:0098978;GO:0005794;GO:0016020;GO:0005874;GO:0015630;GO:0031966;GO:0048471;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0043083;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0050998;GO:0099186;GO:0031798;GO:0031802;GO:0003374;GO:0006897;GO:0046847;GO:0061025;GO:0000266;GO:0061002;GO:0051491;GO:1903423;GO:0098884;GO:0031623;GO:0050803;GO:0007416;GO:0016185;, C:apical tubulobulbar complex; C:axon; C:basal tubulobulbar complex; C:cytoplasm; C:cytoplasmic vesicle; C:dendritic spine; C:dendritic spine head; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:mitochondrial membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse; C:synaptic cleft;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding; F:nitric-oxide synthase binding; F:structural constituent of postsynapse; F:type 1 metabotropic glutamate receptor binding; F:type 5 metabotropic glutamate receptor binding;, P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:filopodium assembly; P:membrane fusion; P:mitochondrial fission; P:negative regulation of dendritic spine morphogenesis; P:positive regulation of filopodium assembly; P:positive regulation of synaptic vesicle recycling; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:regulation of synapse structure or activity; P:synapse assembly; P:synaptic vesicle budding from presynaptic endocytic zone membrane; scaffold62 indexed_genome mRNA 1029655 1032485 . - . ID=transcript_10795;Q92535 O14491,Phosphatidylinositol N-acetylglucosaminyltransferase subunit C {ECO:0000305},Phosphatidylinositol-glycan biosynthesis class C protein;, PF06432;, GO:0005789;GO:0000506;GO:0016021;GO:0003824;GO:0017176;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane;, F:catalytic activity; F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold62 indexed_genome mRNA 1132938 1220382 . + . ID=transcript_10796;Q9UBS9 B2RNU4 Q9BQB9 Q9BXQ2 Q9UL04,SUN domain-containing ossification factor,Membrane protein CH1;Protein osteopotentia homolog;SUN-like protein 1;, PF07738;, GO:0005737;GO:0016021;GO:0016020;GO:0005791;GO:0030867;GO:0007275;GO:0001503;GO:0032967;GO:0045669;GO:0046850;, C:cytoplasm; C:integral component of membrane; C:membrane; C:rough endoplasmic reticulum; C:rough endoplasmic reticulum membrane;, , P:multicellular organism development; P:ossification; P:positive regulation of collagen biosynthetic process; P:positive regulation of osteoblast differentiation; P:regulation of bone remodeling;|Q9UBS9 B2RNU4 Q9BQB9 Q9BXQ2 Q9UL04,SUN domain-containing ossification factor,Membrane protein CH1;Protein osteopotentia homolog;SUN-like protein 1;, PF07738;, GO:0005737;GO:0016021;GO:0016020;GO:0005791;GO:0030867;GO:0007275;GO:0001503;GO:0032967;GO:0045669;GO:0046850;, C:cytoplasm; C:integral component of membrane; C:membrane; C:rough endoplasmic reticulum; C:rough endoplasmic reticulum membrane;, , P:multicellular organism development; P:ossification; P:positive regulation of collagen biosynthetic process; P:positive regulation of osteoblast differentiation; P:regulation of bone remodeling; scaffold62 indexed_genome mRNA 1276806 1283246 . + . ID=transcript_10797;P48023 Q9BZP9,Tumor necrosis factor ligand superfamily member 6,Apoptosis antigen ligand;CD95 ligand;Fas antigen ligand;, PF00229;, GO:0005901;GO:0060205;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005887;GO:0043202;GO:0005634;GO:0048471;GO:0005886;GO:0005125;GO:0005123;GO:0005102;GO:0005164;GO:0006919;GO:0006915;GO:0097190;GO:0007267;GO:0030644;GO:0071346;GO:0019221;GO:0048388;GO:0097191;GO:0008625;GO:0006925;GO:0070266;GO:0097527;GO:0016525;GO:1902042;GO:0000122;GO:0043065;GO:0008284;GO:2000353;GO:0045742;GO:0043123;GO:0043525;GO:1905782;GO:1902041;GO:1903514;GO:0070848;GO:0032496;GO:0046666;GO:0007165;GO:0070231;, C:caveola; C:cytoplasmic vesicle lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:lysosomal lumen; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cytokine activity; F:death receptor binding; F:signaling receptor binding; F:tumor necrosis factor receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:apoptotic signaling pathway; P:cell-cell signaling; P:cellular chloride ion homeostasis; P:cellular response to interferon-gamma; P:cytokine-mediated signaling pathway; P:endosomal lumen acidification; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway via death domain receptors; P:inflammatory cell apoptotic process; P:necroptotic process; P:necroptotic signaling pathway; P:negative regulation of angiogenesis; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron apoptotic process; P:positive regulation of phosphatidylserine exposure on apoptotic cell surface; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:release of sequestered calcium ion into cytosol by endoplasmic reticulum; P:response to growth factor; P:response to lipopolysaccharide; P:retinal cell programmed cell death; P:signal transduction; P:T cell apoptotic process; scaffold62 indexed_genome mRNA 2195865 2244676 . + . ID=transcript_10798;O75911 B2R7F3 Q5VUY3 Q6UY38 Q9BUC8,Short-chain dehydrogenase/reductase 3,DD83.1;Retinal short-chain dehydrogenase/reductase 1;Retinol dehydrogenase 17;Short chain dehydrogenase/reductase family 16C member 1;, PF00106;, GO:0005789;GO:0016021;GO:0005811;GO:0042622;GO:0009055;GO:0052650;GO:0000166;GO:0016616;GO:0004745;GO:0060349;GO:0060411;GO:0048387;GO:0003151;GO:0030278;GO:0048385;GO:0001523;GO:0042572;GO:0060021;GO:0007601;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:photoreceptor outer segment membrane;, F:electron transfer activity; F:NADP-retinol dehydrogenase activity; F:nucleotide binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:retinol dehydrogenase activity;, P:bone morphogenesis; P:cardiac septum morphogenesis; P:negative regulation of retinoic acid receptor signaling pathway; P:outflow tract morphogenesis; P:regulation of ossification; P:regulation of retinoic acid receptor signaling pathway; P:retinoid metabolic process; P:retinol metabolic process; P:roof of mouth development; P:visual perception;|O75911 B2R7F3 Q5VUY3 Q6UY38 Q9BUC8,Short-chain dehydrogenase/reductase 3,DD83.1;Retinal short-chain dehydrogenase/reductase 1;Retinol dehydrogenase 17;Short chain dehydrogenase/reductase family 16C member 1;, PF00106;, GO:0005789;GO:0016021;GO:0005811;GO:0042622;GO:0009055;GO:0052650;GO:0000166;GO:0016616;GO:0004745;GO:0060349;GO:0060411;GO:0048387;GO:0003151;GO:0030278;GO:0048385;GO:0001523;GO:0042572;GO:0060021;GO:0007601;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:photoreceptor outer segment membrane;, F:electron transfer activity; F:NADP-retinol dehydrogenase activity; F:nucleotide binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:retinol dehydrogenase activity;, P:bone morphogenesis; P:cardiac septum morphogenesis; P:negative regulation of retinoic acid receptor signaling pathway; P:outflow tract morphogenesis; P:regulation of ossification; P:regulation of retinoic acid receptor signaling pathway; P:retinoid metabolic process; P:retinol metabolic process; P:roof of mouth development; P:visual perception;|O75911 B2R7F3 Q5VUY3 Q6UY38 Q9BUC8,Short-chain dehydrogenase/reductase 3,DD83.1;Retinal short-chain dehydrogenase/reductase 1;Retinol dehydrogenase 17;Short chain dehydrogenase/reductase family 16C member 1;, PF00106;, GO:0005789;GO:0016021;GO:0005811;GO:0042622;GO:0009055;GO:0052650;GO:0000166;GO:0016616;GO:0004745;GO:0060349;GO:0060411;GO:0048387;GO:0003151;GO:0030278;GO:0048385;GO:0001523;GO:0042572;GO:0060021;GO:0007601;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:photoreceptor outer segment membrane;, F:electron transfer activity; F:NADP-retinol dehydrogenase activity; F:nucleotide binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:retinol dehydrogenase activity;, P:bone morphogenesis; P:cardiac septum morphogenesis; P:negative regulation of retinoic acid receptor signaling pathway; P:outflow tract morphogenesis; P:regulation of ossification; P:regulation of retinoic acid receptor signaling pathway; P:retinoid metabolic process; P:retinol metabolic process; P:roof of mouth development; P:visual perception;|O75911 B2R7F3 Q5VUY3 Q6UY38 Q9BUC8,Short-chain dehydrogenase/reductase 3,DD83.1;Retinal short-chain dehydrogenase/reductase 1;Retinol dehydrogenase 17;Short chain dehydrogenase/reductase family 16C member 1;, PF00106;, GO:0005789;GO:0016021;GO:0005811;GO:0042622;GO:0009055;GO:0052650;GO:0000166;GO:0016616;GO:0004745;GO:0060349;GO:0060411;GO:0048387;GO:0003151;GO:0030278;GO:0048385;GO:0001523;GO:0042572;GO:0060021;GO:0007601;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:photoreceptor outer segment membrane;, F:electron transfer activity; F:NADP-retinol dehydrogenase activity; F:nucleotide binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:retinol dehydrogenase activity;, P:bone morphogenesis; P:cardiac septum morphogenesis; P:negative regulation of retinoic acid receptor signaling pathway; P:outflow tract morphogenesis; P:regulation of ossification; P:regulation of retinoic acid receptor signaling pathway; P:retinoid metabolic process; P:retinol metabolic process; P:roof of mouth development; P:visual perception; scaffold62 indexed_genome mRNA 2287621 2475022 . - . ID=transcript_10799;Q9UIM0,Vacuolar protein sorting-associated protein 13D,, PF12624;PF06650;PF00627;PF16908;PF16909;PF16910;, GO:0070062;GO:0019898;GO:0007005;GO:1901526;GO:0045053;GO:0006623;, C:extracellular exosome; C:extrinsic component of membrane;, , P:mitochondrion organization; P:positive regulation of mitophagy; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; scaffold62 indexed_genome mRNA 2475043 2554564 . - . ID=transcript_10800;Q9UIM0,Vacuolar protein sorting-associated protein 13D,, PF12624;PF06650;PF00627;PF16908;PF16909;PF16910;, GO:0070062;GO:0019898;GO:0007005;GO:1901526;GO:0045053;GO:0006623;, C:extracellular exosome; C:extrinsic component of membrane;, , P:mitochondrion organization; P:positive regulation of mitophagy; P:protein retention in Golgi apparatus; P:protein targeting to vacuole; scaffold62 indexed_genome mRNA 2578674 2616062 . - . ID=transcript_10801;P20333 B1AJZ3 Q16042 Q6YI29 Q9UIH1,Tumor necrosis factor receptor superfamily member 1B,Tumor necrosis factor receptor 2;Tumor necrosis factor receptor type II;p75;p80 TNF-alpha receptor;, PF00020;, GO:0005576;GO:0016021;GO:0016020;GO:0045121;GO:0043025;GO:0005634;GO:0048471;GO:0005886;GO:0035579;GO:0002947;GO:0043196;GO:0043120;GO:0005031;GO:0031625;GO:0007568;GO:0003176;GO:0071363;GO:0071222;GO:0019221;GO:0097191;GO:0150098;GO:0006954;GO:0008630;GO:0010614;GO:0060548;GO:0003332;GO:0150079;GO:1901215;GO:0043312;GO:1902339;GO:0051044;GO:0031643;GO:0048714;GO:0003177;GO:0002718;GO:0031641;GO:0150077;GO:2001141;GO:0002724;GO:0042129;GO:0050779;GO:0033209;, C:extracellular region; C:integral component of membrane; C:membrane; C:membrane raft; C:neuronal cell body; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:specific granule membrane; C:tumor necrosis factor receptor superfamily complex; C:varicosity;, F:tumor necrosis factor binding; F:tumor necrosis factor-activated receptor activity; F:ubiquitin protein ligase binding;, P:aging; P:aortic valve development; P:cellular response to growth factor stimulus; P:cellular response to lipopolysaccharide; P:cytokine-mediated signaling pathway; P:extrinsic apoptotic signaling pathway; P:glial cell-neuron signaling; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cell death; P:negative regulation of extracellular matrix constituent secretion; P:negative regulation of neuroinflammatory response; P:negative regulation of neuron death; P:neutrophil degranulation; P:positive regulation of apoptotic process involved in morphogenesis; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of myelination; P:positive regulation of oligodendrocyte differentiation; P:pulmonary valve development; P:regulation of cytokine production involved in immune response; P:regulation of myelination; P:regulation of neuroinflammatory response; P:regulation of RNA biosynthetic process; P:regulation of T cell cytokine production; P:regulation of T cell proliferation; P:RNA destabilization; P:tumor necrosis factor-mediated signaling pathway; scaffold62 indexed_genome mRNA 2733057 2746453 . - . ID=transcript_10802;Q5JXC2 C0KL22 Q96HU6 Q9H839 Q9HA00,Migration and invasion-inhibitory protein,IGFBP2-binding protein;Invasion-inhibitory protein 45;, PF15734;, GO:0030336;GO:0010972;, , , P:negative regulation of cell migration; P:negative regulation of G2/M transition of mitotic cell cycle; scaffold62 indexed_genome mRNA 2759727 2785875 . - . ID=transcript_10803;O95140 A8K1B3 O95572 Q5JXC3 Q5JXC4 Q9H131 Q9NSX8,Mitofusin-2,Transmembrane GTPase MFN2;, PF00350;PF04799;, GO:0005829;GO:0016021;GO:0031306;GO:0005741;GO:0005739;GO:0005525;GO:0003924;GO:0031625;GO:0006915;GO:0007596;GO:0016236;GO:0008053;GO:0007006;GO:0051646;GO:0046580;GO:0048662;GO:0061734;GO:0120162;GO:1905461;GO:1904707;GO:0034497;GO:0006626;GO:0006986;, C:cytosol; C:integral component of membrane; C:intrinsic component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:blood coagulation; P:macroautophagy; P:mitochondrial fusion; P:mitochondrial membrane organization; P:mitochondrion localization; P:negative regulation of Ras protein signal transduction; P:negative regulation of smooth muscle cell proliferation; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of cold-induced thermogenesis; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein localization to phagophore assembly site; P:protein targeting to mitochondrion; P:response to unfolded protein;|O95140 A8K1B3 O95572 Q5JXC3 Q5JXC4 Q9H131 Q9NSX8,Mitofusin-2,Transmembrane GTPase MFN2;, PF00350;PF04799;, GO:0005829;GO:0016021;GO:0031306;GO:0005741;GO:0005739;GO:0005525;GO:0003924;GO:0031625;GO:0006915;GO:0007596;GO:0016236;GO:0008053;GO:0007006;GO:0051646;GO:0046580;GO:0048662;GO:0061734;GO:0120162;GO:1905461;GO:1904707;GO:0034497;GO:0006626;GO:0006986;, C:cytosol; C:integral component of membrane; C:intrinsic component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:blood coagulation; P:macroautophagy; P:mitochondrial fusion; P:mitochondrial membrane organization; P:mitochondrion localization; P:negative regulation of Ras protein signal transduction; P:negative regulation of smooth muscle cell proliferation; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of cold-induced thermogenesis; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein localization to phagophore assembly site; P:protein targeting to mitochondrion; P:response to unfolded protein;|O95140 A8K1B3 O95572 Q5JXC3 Q5JXC4 Q9H131 Q9NSX8,Mitofusin-2,Transmembrane GTPase MFN2;, PF00350;PF04799;, GO:0005829;GO:0016021;GO:0031306;GO:0005741;GO:0005739;GO:0005525;GO:0003924;GO:0031625;GO:0006915;GO:0007596;GO:0016236;GO:0008053;GO:0007006;GO:0051646;GO:0046580;GO:0048662;GO:0061734;GO:0120162;GO:1905461;GO:1904707;GO:0034497;GO:0006626;GO:0006986;, C:cytosol; C:integral component of membrane; C:intrinsic component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:blood coagulation; P:macroautophagy; P:mitochondrial fusion; P:mitochondrial membrane organization; P:mitochondrion localization; P:negative regulation of Ras protein signal transduction; P:negative regulation of smooth muscle cell proliferation; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of cold-induced thermogenesis; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein localization to phagophore assembly site; P:protein targeting to mitochondrion; P:response to unfolded protein;|O95140 A8K1B3 O95572 Q5JXC3 Q5JXC4 Q9H131 Q9NSX8,Mitofusin-2,Transmembrane GTPase MFN2;, PF00350;PF04799;, GO:0005829;GO:0016021;GO:0031306;GO:0005741;GO:0005739;GO:0005525;GO:0003924;GO:0031625;GO:0006915;GO:0007596;GO:0016236;GO:0008053;GO:0007006;GO:0051646;GO:0046580;GO:0048662;GO:0061734;GO:0120162;GO:1905461;GO:1904707;GO:0034497;GO:0006626;GO:0006986;, C:cytosol; C:integral component of membrane; C:intrinsic component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:blood coagulation; P:macroautophagy; P:mitochondrial fusion; P:mitochondrial membrane organization; P:mitochondrion localization; P:negative regulation of Ras protein signal transduction; P:negative regulation of smooth muscle cell proliferation; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of cold-induced thermogenesis; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein localization to phagophore assembly site; P:protein targeting to mitochondrion; P:response to unfolded protein;|O95140 A8K1B3 O95572 Q5JXC3 Q5JXC4 Q9H131 Q9NSX8,Mitofusin-2,Transmembrane GTPase MFN2;, PF00350;PF04799;, GO:0005829;GO:0016021;GO:0031306;GO:0005741;GO:0005739;GO:0005525;GO:0003924;GO:0031625;GO:0006915;GO:0007596;GO:0016236;GO:0008053;GO:0007006;GO:0051646;GO:0046580;GO:0048662;GO:0061734;GO:0120162;GO:1905461;GO:1904707;GO:0034497;GO:0006626;GO:0006986;, C:cytosol; C:integral component of membrane; C:intrinsic component of mitochondrial outer membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:blood coagulation; P:macroautophagy; P:mitochondrial fusion; P:mitochondrial membrane organization; P:mitochondrion localization; P:negative regulation of Ras protein signal transduction; P:negative regulation of smooth muscle cell proliferation; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of cold-induced thermogenesis; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein localization to phagophore assembly site; P:protein targeting to mitochondrion; P:response to unfolded protein; scaffold62 indexed_genome mRNA 2795433 2797794 . - . ID=transcript_10804;Q02809 B4DR87 Q96AV9 Q9H132,Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1,Lysyl hydroxylase 1;, PF03171;, GO:1902494;GO:0005783;GO:0005789;GO:0070062;GO:0030867;GO:0005506;GO:0031418;GO:0008475;GO:0030199;GO:0008544;GO:0017185;GO:0001666;, C:catalytic complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:rough endoplasmic reticulum membrane;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-lysine 5-dioxygenase activity;, P:collagen fibril organization; P:epidermis development; P:peptidyl-lysine hydroxylation; P:response to hypoxia; scaffold62 indexed_genome mRNA 2803174 2804993 . - . ID=transcript_10805;Q02809 B4DR87 Q96AV9 Q9H132,Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1,Lysyl hydroxylase 1;, PF03171;, GO:1902494;GO:0005783;GO:0005789;GO:0070062;GO:0030867;GO:0005506;GO:0031418;GO:0008475;GO:0030199;GO:0008544;GO:0017185;GO:0001666;, C:catalytic complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:rough endoplasmic reticulum membrane;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-lysine 5-dioxygenase activity;, P:collagen fibril organization; P:epidermis development; P:peptidyl-lysine hydroxylation; P:response to hypoxia;|Q02809 B4DR87 Q96AV9 Q9H132,Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1,Lysyl hydroxylase 1;, PF03171;, GO:1902494;GO:0005783;GO:0005789;GO:0070062;GO:0030867;GO:0005506;GO:0031418;GO:0008475;GO:0030199;GO:0008544;GO:0017185;GO:0001666;, C:catalytic complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:rough endoplasmic reticulum membrane;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-lysine 5-dioxygenase activity;, P:collagen fibril organization; P:epidermis development; P:peptidyl-lysine hydroxylation; P:response to hypoxia; scaffold62 indexed_genome mRNA 2810706 2826810 . - . ID=transcript_10806;Q02809 B4DR87 Q96AV9 Q9H132,Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1,Lysyl hydroxylase 1;, PF03171;, GO:1902494;GO:0005783;GO:0005789;GO:0070062;GO:0030867;GO:0005506;GO:0031418;GO:0008475;GO:0030199;GO:0008544;GO:0017185;GO:0001666;, C:catalytic complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:rough endoplasmic reticulum membrane;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-lysine 5-dioxygenase activity;, P:collagen fibril organization; P:epidermis development; P:peptidyl-lysine hydroxylation; P:response to hypoxia;|Q02809 B4DR87 Q96AV9 Q9H132,Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1,Lysyl hydroxylase 1;, PF03171;, GO:1902494;GO:0005783;GO:0005789;GO:0070062;GO:0030867;GO:0005506;GO:0031418;GO:0008475;GO:0030199;GO:0008544;GO:0017185;GO:0001666;, C:catalytic complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:rough endoplasmic reticulum membrane;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-lysine 5-dioxygenase activity;, P:collagen fibril organization; P:epidermis development; P:peptidyl-lysine hydroxylation; P:response to hypoxia;|Q02809 B4DR87 Q96AV9 Q9H132,Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1,Lysyl hydroxylase 1;, PF03171;, GO:1902494;GO:0005783;GO:0005789;GO:0070062;GO:0030867;GO:0005506;GO:0031418;GO:0008475;GO:0030199;GO:0008544;GO:0017185;GO:0001666;, C:catalytic complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:rough endoplasmic reticulum membrane;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-lysine 5-dioxygenase activity;, P:collagen fibril organization; P:epidermis development; P:peptidyl-lysine hydroxylation; P:response to hypoxia; scaffold62 indexed_genome mRNA 2836432 2841844 . + . ID=transcript_10807;Q8IYS2 Q5JXC1 Q8IVF8 Q8NDI7 Q9BSY1,Uncharacterized protein KIAA2013,, , GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q8IYS2 Q5JXC1 Q8IVF8 Q8NDI7 Q9BSY1,Uncharacterized protein KIAA2013,, , GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane; scaffold62 indexed_genome mRNA 2903438 2904902 . + . ID=transcript_10808;P16860 B0ZBE9 Q6FGY0 Q9P2Q7,Natriuretic peptides B,Brain natriuretic factor prohormone {ECO:0000303|PubMed:2138890};Gamma-brain natriuretic peptide {ECO:0000250|UniProtKB:P07634};Iso-ANP {ECO:0000250|UniProtKB:P13205};, PF00212;, GO:0005737;GO:0005576;GO:0005615;GO:0005634;GO:0032991;GO:0008613;GO:0005179;GO:0051427;GO:0005102;GO:0061844;GO:0097746;GO:0007589;GO:0007166;GO:0006182;GO:0019934;GO:0031640;GO:0016525;GO:0030308;GO:0003085;GO:0007218;GO:0035815;GO:0035810;GO:0006457;GO:0007168;GO:0008217;GO:0043114;GO:0042311;, C:cytoplasm; C:extracellular region; C:extracellular space; C:nucleus; C:protein-containing complex;, F:diuretic hormone activity; F:hormone activity; F:hormone receptor binding; F:signaling receptor binding;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:blood vessel diameter maintenance; P:body fluid secretion; P:cell surface receptor signaling pathway; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:killing of cells of other organism; P:negative regulation of angiogenesis; P:negative regulation of cell growth; P:negative regulation of systemic arterial blood pressure; P:neuropeptide signaling pathway; P:positive regulation of renal sodium excretion; P:positive regulation of urine volume; P:protein folding; P:receptor guanylyl cyclase signaling pathway; P:regulation of blood pressure; P:regulation of vascular permeability; P:vasodilation; scaffold62 indexed_genome mRNA 2921849 2930215 . - . ID=transcript_10809;Q99429,Chloride transport protein 6,Chloride channel protein 6;, PF00571;PF00654;, GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0015297;GO:0005524;GO:0015108;GO:0005247;GO:0006884;GO:0006821;GO:0034220;GO:0009612;GO:0007165;, C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:antiporter activity; F:ATP binding; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:cell volume homeostasis; P:chloride transport; P:ion transmembrane transport; P:response to mechanical stimulus; P:signal transduction;|Q99429,Chloride transport protein 6,Chloride channel protein 6;, PF00571;PF00654;, GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0015297;GO:0005524;GO:0015108;GO:0005247;GO:0006884;GO:0006821;GO:0034220;GO:0009612;GO:0007165;, C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:antiporter activity; F:ATP binding; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:cell volume homeostasis; P:chloride transport; P:ion transmembrane transport; P:response to mechanical stimulus; P:signal transduction; scaffold62 indexed_genome mRNA 2930364 2932988 . - . ID=transcript_10810;Q99429,Chloride transport protein 6,Chloride channel protein 6;, PF00571;PF00654;, GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0015297;GO:0005524;GO:0015108;GO:0005247;GO:0006884;GO:0006821;GO:0034220;GO:0009612;GO:0007165;, C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:antiporter activity; F:ATP binding; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:cell volume homeostasis; P:chloride transport; P:ion transmembrane transport; P:response to mechanical stimulus; P:signal transduction; scaffold62 indexed_genome mRNA 2933368 2936534 . - . ID=transcript_10811;Q99429,Chloride transport protein 6,Chloride channel protein 6;, PF00571;PF00654;, GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0015297;GO:0005524;GO:0015108;GO:0005247;GO:0006884;GO:0006821;GO:0034220;GO:0009612;GO:0007165;, C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:antiporter activity; F:ATP binding; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:cell volume homeostasis; P:chloride transport; P:ion transmembrane transport; P:response to mechanical stimulus; P:signal transduction; scaffold62 indexed_genome mRNA 2936728 2956143 . - . ID=transcript_10812;Q99429,Chloride transport protein 6,Chloride channel protein 6;, PF00571;PF00654;, GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0015297;GO:0005524;GO:0015108;GO:0005247;GO:0006884;GO:0006821;GO:0034220;GO:0009612;GO:0007165;, C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:antiporter activity; F:ATP binding; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:cell volume homeostasis; P:chloride transport; P:ion transmembrane transport; P:response to mechanical stimulus; P:signal transduction;|Q99429,Chloride transport protein 6,Chloride channel protein 6;, PF00571;PF00654;, GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0015297;GO:0005524;GO:0015108;GO:0005247;GO:0006884;GO:0006821;GO:0034220;GO:0009612;GO:0007165;, C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:antiporter activity; F:ATP binding; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:cell volume homeostasis; P:chloride transport; P:ion transmembrane transport; P:response to mechanical stimulus; P:signal transduction;|Q99429,Chloride transport protein 6,Chloride channel protein 6;, PF00571;PF00654;, GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0015297;GO:0005524;GO:0015108;GO:0005247;GO:0006884;GO:0006821;GO:0034220;GO:0009612;GO:0007165;, C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:antiporter activity; F:ATP binding; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:cell volume homeostasis; P:chloride transport; P:ion transmembrane transport; P:response to mechanical stimulus; P:signal transduction;|Q99429,Chloride transport protein 6,Chloride channel protein 6;, PF00571;PF00654;, GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0015297;GO:0005524;GO:0015108;GO:0005247;GO:0006884;GO:0006821;GO:0034220;GO:0009612;GO:0007165;, C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:antiporter activity; F:ATP binding; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:cell volume homeostasis; P:chloride transport; P:ion transmembrane transport; P:response to mechanical stimulus; P:signal transduction;|Q99429,Chloride transport protein 6,Chloride channel protein 6;, PF00571;PF00654;, GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0015297;GO:0005524;GO:0015108;GO:0005247;GO:0006884;GO:0006821;GO:0034220;GO:0009612;GO:0007165;, C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:antiporter activity; F:ATP binding; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:cell volume homeostasis; P:chloride transport; P:ion transmembrane transport; P:response to mechanical stimulus; P:signal transduction; scaffold62 indexed_genome mRNA 2958640 2967474 . + . ID=transcript_10813;P42898 B2R7A6 Q5SNW6 Q5SNW9 Q7Z6M6 Q8IU73 Q9UQR2,Methylenetetrahydrofolate reductase {ECO:0000305},, PF02219;, GO:0005829;GO:0045202;GO:0071949;GO:0050660;GO:0004489;GO:0106312;GO:0106313;GO:0072341;GO:0050661;GO:0044877;GO:0046655;GO:0070829;GO:0050667;GO:0009086;GO:0006555;GO:0001843;GO:0031060;GO:0043200;GO:0042493;GO:0051593;GO:0001666;GO:0070555;GO:0033274;GO:0046500;GO:0035999;, C:cytosol; C:synapse;, F:FAD binding; F:flavin adenine dinucleotide binding; F:methylenetetrahydrofolate reductase (NAD(P)H) activity; F:methylenetetrahydrofolate reductase NADH activity; F:methylenetetrahydrofolate reductase NADPH activity; F:modified amino acid binding; F:NADP binding; F:protein-containing complex binding;, P:folic acid metabolic process; P:heterochromatin maintenance; P:homocysteine metabolic process; P:methionine biosynthetic process; P:methionine metabolic process; P:neural tube closure; P:regulation of histone methylation; P:response to amino acid; P:response to drug; P:response to folic acid; P:response to hypoxia; P:response to interleukin-1; P:response to vitamin B2; P:S-adenosylmethionine metabolic process; P:tetrahydrofolate interconversion;|P42898 B2R7A6 Q5SNW6 Q5SNW9 Q7Z6M6 Q8IU73 Q9UQR2,Methylenetetrahydrofolate reductase {ECO:0000305},, PF02219;, GO:0005829;GO:0045202;GO:0071949;GO:0050660;GO:0004489;GO:0106312;GO:0106313;GO:0072341;GO:0050661;GO:0044877;GO:0046655;GO:0070829;GO:0050667;GO:0009086;GO:0006555;GO:0001843;GO:0031060;GO:0043200;GO:0042493;GO:0051593;GO:0001666;GO:0070555;GO:0033274;GO:0046500;GO:0035999;, C:cytosol; C:synapse;, F:FAD binding; F:flavin adenine dinucleotide binding; F:methylenetetrahydrofolate reductase (NAD(P)H) activity; F:methylenetetrahydrofolate reductase NADH activity; F:methylenetetrahydrofolate reductase NADPH activity; F:modified amino acid binding; F:NADP binding; F:protein-containing complex binding;, P:folic acid metabolic process; P:heterochromatin maintenance; P:homocysteine metabolic process; P:methionine biosynthetic process; P:methionine metabolic process; P:neural tube closure; P:regulation of histone methylation; P:response to amino acid; P:response to drug; P:response to folic acid; P:response to hypoxia; P:response to interleukin-1; P:response to vitamin B2; P:S-adenosylmethionine metabolic process; P:tetrahydrofolate interconversion;|P42898 B2R7A6 Q5SNW6 Q5SNW9 Q7Z6M6 Q8IU73 Q9UQR2,Methylenetetrahydrofolate reductase {ECO:0000305},, PF02219;, GO:0005829;GO:0045202;GO:0071949;GO:0050660;GO:0004489;GO:0106312;GO:0106313;GO:0072341;GO:0050661;GO:0044877;GO:0046655;GO:0070829;GO:0050667;GO:0009086;GO:0006555;GO:0001843;GO:0031060;GO:0043200;GO:0042493;GO:0051593;GO:0001666;GO:0070555;GO:0033274;GO:0046500;GO:0035999;, C:cytosol; C:synapse;, F:FAD binding; F:flavin adenine dinucleotide binding; F:methylenetetrahydrofolate reductase (NAD(P)H) activity; F:methylenetetrahydrofolate reductase NADH activity; F:methylenetetrahydrofolate reductase NADPH activity; F:modified amino acid binding; F:NADP binding; F:protein-containing complex binding;, P:folic acid metabolic process; P:heterochromatin maintenance; P:homocysteine metabolic process; P:methionine biosynthetic process; P:methionine metabolic process; P:neural tube closure; P:regulation of histone methylation; P:response to amino acid; P:response to drug; P:response to folic acid; P:response to hypoxia; P:response to interleukin-1; P:response to vitamin B2; P:S-adenosylmethionine metabolic process; P:tetrahydrofolate interconversion; scaffold62 indexed_genome mRNA 3010444 3029565 . - . ID=transcript_10814;Q6RW13 A8MVQ5 Q5SNV4 Q5SNV5 Q96AC0 Q96PL4 Q9NRW9,Type-1 angiotensin II receptor-associated protein,AT1 receptor-associated protein;, PF06396;, GO:0005938;GO:0030659;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005886;GO:0004945;GO:0042802;GO:0008217;GO:0001666;, C:cell cortex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:angiotensin type II receptor activity; F:identical protein binding;, P:regulation of blood pressure; P:response to hypoxia; scaffold62 indexed_genome mRNA 3095315 3117093 . + . ID=transcript_10815;Q9UI95 B3KNE3 Q5TGW7 Q9UNA7 Q9Y6I6,Mitotic spindle assembly checkpoint protein MAD2B,Mitotic arrest deficient 2-like protein 2;REV7 homolog;, PF02301;, GO:0005694;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0005819;GO:0016035;GO:0008432;GO:0001102;GO:0007015;GO:0051301;GO:0042772;GO:0006302;GO:0042276;GO:0007094;GO:0090090;GO:2000048;GO:0043433;GO:2000042;GO:0010719;GO:0042177;GO:0010944;GO:0000122;GO:2000678;GO:1904667;GO:2001034;GO:0045830;GO:0033138;GO:0045893;GO:0001558;, C:chromosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:spindle; C:zeta DNA polymerase complex;, F:JUN kinase binding; F:RNA polymerase II activating transcription factor binding;, P:actin filament organization; P:cell division; P:DNA damage response, signal transduction resulting in transcription; P:double-strand break repair; P:error-prone translesion synthesis; P:mitotic spindle assembly checkpoint; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of protein catabolic process; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of ubiquitin protein ligase activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth;|Q9UI95 B3KNE3 Q5TGW7 Q9UNA7 Q9Y6I6,Mitotic spindle assembly checkpoint protein MAD2B,Mitotic arrest deficient 2-like protein 2;REV7 homolog;, PF02301;, GO:0005694;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0035861;GO:0005819;GO:0016035;GO:0008432;GO:0001102;GO:0007015;GO:0051301;GO:0042772;GO:0006302;GO:0042276;GO:0007094;GO:0090090;GO:2000048;GO:0043433;GO:2000042;GO:0010719;GO:0042177;GO:0010944;GO:0000122;GO:2000678;GO:1904667;GO:2001034;GO:0045830;GO:0033138;GO:0045893;GO:0001558;, C:chromosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:spindle; C:zeta DNA polymerase complex;, F:JUN kinase binding; F:RNA polymerase II activating transcription factor binding;, P:actin filament organization; P:cell division; P:DNA damage response, signal transduction resulting in transcription; P:double-strand break repair; P:error-prone translesion synthesis; P:mitotic spindle assembly checkpoint; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of protein catabolic process; P:negative regulation of transcription by competitive promoter binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of ubiquitin protein ligase activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription, DNA-templated; P:regulation of cell growth;|Q9NRD1 B1AK42 B2RC88 Q9UKT3,F-box only protein 6,F-box protein that recognizes sugar chains 2;F-box/G-domain protein 2;, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0044322;GO:0019005;GO:0030246;GO:0061630;GO:0000077;GO:0006281;GO:0006516;GO:0043687;GO:0000209;GO:0006508;GO:0006986;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum quality control compartment; C:SCF ubiquitin ligase complex;, F:carbohydrate binding; F:ubiquitin protein ligase activity;, P:DNA damage checkpoint; P:DNA repair; P:glycoprotein catabolic process; P:post-translational protein modification; P:protein polyubiquitination; P:proteolysis; P:response to unfolded protein; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway; scaffold62 indexed_genome mRNA 3117870 3130608 . - . ID=transcript_10816;Q9H4M3 B3KNZ2 B7Z743 Q5TGX2 Q5TGX4 Q5TGX5 Q68DJ9 Q8WWY2,F-box only protein 44,F-box protein FBX30;F-box/G-domain protein 3;, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0019005;GO:0006516;GO:0043687;GO:0010498;GO:0000209;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex;, , P:glycoprotein catabolic process; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway;|Q9H4M3 B3KNZ2 B7Z743 Q5TGX2 Q5TGX4 Q5TGX5 Q68DJ9 Q8WWY2,F-box only protein 44,F-box protein FBX30;F-box/G-domain protein 3;, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0019005;GO:0006516;GO:0043687;GO:0010498;GO:0000209;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex;, , P:glycoprotein catabolic process; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway;|Q9H4M3 B3KNZ2 B7Z743 Q5TGX2 Q5TGX4 Q5TGX5 Q68DJ9 Q8WWY2,F-box only protein 44,F-box protein FBX30;F-box/G-domain protein 3;, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0019005;GO:0006516;GO:0043687;GO:0010498;GO:0000209;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex;, , P:glycoprotein catabolic process; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway;|Q9UK22 B2R7K7 Q5TGY0 Q6FGJ7 Q8TB29 Q9UKC6,F-box only protein 2,, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0043197;GO:0005783;GO:0016020;GO:0019005;GO:0001540;GO:0030246;GO:0004842;GO:0006464;GO:0006516;GO:0008285;GO:0043687;GO:0000209;GO:0016567;GO:0006508;GO:0031396;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:dendritic spine; C:endoplasmic reticulum; C:membrane; C:SCF ubiquitin ligase complex;, F:amyloid-beta binding; F:carbohydrate binding; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:glycoprotein catabolic process; P:negative regulation of cell population proliferation; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:proteolysis; P:regulation of protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway;|Q9H4M3 B3KNZ2 B7Z743 Q5TGX2 Q5TGX4 Q5TGX5 Q68DJ9 Q8WWY2,F-box only protein 44,F-box protein FBX30;F-box/G-domain protein 3;, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0019005;GO:0006516;GO:0043687;GO:0010498;GO:0000209;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex;, , P:glycoprotein catabolic process; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway;|Q9H4M3 B3KNZ2 B7Z743 Q5TGX2 Q5TGX4 Q5TGX5 Q68DJ9 Q8WWY2,F-box only protein 44,F-box protein FBX30;F-box/G-domain protein 3;, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0019005;GO:0006516;GO:0043687;GO:0010498;GO:0000209;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex;, , P:glycoprotein catabolic process; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway;|Q9H4M3 B3KNZ2 B7Z743 Q5TGX2 Q5TGX4 Q5TGX5 Q68DJ9 Q8WWY2,F-box only protein 44,F-box protein FBX30;F-box/G-domain protein 3;, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0019005;GO:0006516;GO:0043687;GO:0010498;GO:0000209;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex;, , P:glycoprotein catabolic process; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway;|Q9UK22 B2R7K7 Q5TGY0 Q6FGJ7 Q8TB29 Q9UKC6,F-box only protein 2,, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0043197;GO:0005783;GO:0016020;GO:0019005;GO:0001540;GO:0030246;GO:0004842;GO:0006464;GO:0006516;GO:0008285;GO:0043687;GO:0000209;GO:0016567;GO:0006508;GO:0031396;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:dendritic spine; C:endoplasmic reticulum; C:membrane; C:SCF ubiquitin ligase complex;, F:amyloid-beta binding; F:carbohydrate binding; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:glycoprotein catabolic process; P:negative regulation of cell population proliferation; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:proteolysis; P:regulation of protein ubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway; scaffold62 indexed_genome mRNA 3233940 3240740 . - . ID=transcript_10817;Q9P2K9 Q5VTU9 Q9UJD6,Protein dispatched homolog 3 {ECO:0000303|PubMed:15645143},Patched domain-containing protein 2 {ECO:0000305};, PF02460;, GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0030154;GO:0042632;GO:0008203;GO:0045665;GO:0045834;GO:2000179;GO:0032368;GO:0007224;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, , P:cell differentiation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:negative regulation of neuron differentiation; P:positive regulation of lipid metabolic process; P:positive regulation of neural precursor cell proliferation; P:regulation of lipid transport; P:smoothened signaling pathway;|Q9P2K9 Q5VTU9 Q9UJD6,Protein dispatched homolog 3 {ECO:0000303|PubMed:15645143},Patched domain-containing protein 2 {ECO:0000305};, PF02460;, GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0030154;GO:0042632;GO:0008203;GO:0045665;GO:0045834;GO:2000179;GO:0032368;GO:0007224;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, , P:cell differentiation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:negative regulation of neuron differentiation; P:positive regulation of lipid metabolic process; P:positive regulation of neural precursor cell proliferation; P:regulation of lipid transport; P:smoothened signaling pathway;|Q9P2K9 Q5VTU9 Q9UJD6,Protein dispatched homolog 3 {ECO:0000303|PubMed:15645143},Patched domain-containing protein 2 {ECO:0000305};, PF02460;, GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0030154;GO:0042632;GO:0008203;GO:0045665;GO:0045834;GO:2000179;GO:0032368;GO:0007224;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, , P:cell differentiation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:negative regulation of neuron differentiation; P:positive regulation of lipid metabolic process; P:positive regulation of neural precursor cell proliferation; P:regulation of lipid transport; P:smoothened signaling pathway; scaffold62 indexed_genome mRNA 3241594 3253791 . - . ID=transcript_10818;Q9P2K9 Q5VTU9 Q9UJD6,Protein dispatched homolog 3 {ECO:0000303|PubMed:15645143},Patched domain-containing protein 2 {ECO:0000305};, PF02460;, GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0030154;GO:0042632;GO:0008203;GO:0045665;GO:0045834;GO:2000179;GO:0032368;GO:0007224;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, , P:cell differentiation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:negative regulation of neuron differentiation; P:positive regulation of lipid metabolic process; P:positive regulation of neural precursor cell proliferation; P:regulation of lipid transport; P:smoothened signaling pathway; scaffold62 indexed_genome mRNA 3254209 3290368 . + . ID=transcript_10819;Q9P2K9 Q5VTU9 Q9UJD6,Protein dispatched homolog 3 {ECO:0000303|PubMed:15645143},Patched domain-containing protein 2 {ECO:0000305};, PF02460;, GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0030154;GO:0042632;GO:0008203;GO:0045665;GO:0045834;GO:2000179;GO:0032368;GO:0007224;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, , P:cell differentiation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:negative regulation of neuron differentiation; P:positive regulation of lipid metabolic process; P:positive regulation of neural precursor cell proliferation; P:regulation of lipid transport; P:smoothened signaling pathway;|Q9P2K9 Q5VTU9 Q9UJD6,Protein dispatched homolog 3 {ECO:0000303|PubMed:15645143},Patched domain-containing protein 2 {ECO:0000305};, PF02460;, GO:0005737;GO:0030659;GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0030154;GO:0042632;GO:0008203;GO:0045665;GO:0045834;GO:2000179;GO:0032368;GO:0007224;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, , P:cell differentiation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:negative regulation of neuron differentiation; P:positive regulation of lipid metabolic process; P:positive regulation of neural precursor cell proliferation; P:regulation of lipid transport; P:smoothened signaling pathway; scaffold62 indexed_genome mRNA 3461456 3473058 . + . ID=transcript_10820;Q9Y5Z9 B3KQG3 Q53GX3 Q5THD4,UbiA prenyltransferase domain-containing protein 1,Transitional epithelial response protein 1;, PF01040;, GO:0005737;GO:0005783;GO:0005789;GO:0030173;GO:0016020;GO:0031966;GO:0005634;GO:0016209;GO:0004659;GO:0009234;GO:0006744;GO:0032194;GO:0042371;GO:0042373;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:membrane; C:mitochondrial membrane; C:nucleus;, F:antioxidant activity; F:prenyltransferase activity;, P:menaquinone biosynthetic process; P:ubiquinone biosynthetic process; P:ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate; P:vitamin K biosynthetic process; P:vitamin K metabolic process;|Q9Y5Z9 B3KQG3 Q53GX3 Q5THD4,UbiA prenyltransferase domain-containing protein 1,Transitional epithelial response protein 1;, PF01040;, GO:0005737;GO:0005783;GO:0005789;GO:0030173;GO:0016020;GO:0031966;GO:0005634;GO:0016209;GO:0004659;GO:0009234;GO:0006744;GO:0032194;GO:0042371;GO:0042373;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:membrane; C:mitochondrial membrane; C:nucleus;, F:antioxidant activity; F:prenyltransferase activity;, P:menaquinone biosynthetic process; P:ubiquinone biosynthetic process; P:ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate; P:vitamin K biosynthetic process; P:vitamin K metabolic process;|Q9Y5Z9 B3KQG3 Q53GX3 Q5THD4,UbiA prenyltransferase domain-containing protein 1,Transitional epithelial response protein 1;, PF01040;, GO:0005737;GO:0005783;GO:0005789;GO:0030173;GO:0016020;GO:0031966;GO:0005634;GO:0016209;GO:0004659;GO:0009234;GO:0006744;GO:0032194;GO:0042371;GO:0042373;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:membrane; C:mitochondrial membrane; C:nucleus;, F:antioxidant activity; F:prenyltransferase activity;, P:menaquinone biosynthetic process; P:ubiquinone biosynthetic process; P:ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate; P:vitamin K biosynthetic process; P:vitamin K metabolic process; scaffold62 indexed_genome mRNA 3481584 3602113 . + . ID=transcript_10821;P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3,Serine/threonine-protein kinase mTOR,FK506-binding protein 12-rapamycin complex-associated protein 1;FKBP12-rapamycin complex-associated protein;Mammalian target of rapamycin;Mechanistic target of rapamycin;Rapamycin and FKBP12 target 1;Rapamycin target protein 1;, PF11865;PF02259;PF02260;PF08771;PF00454;, GO:0005737;GO:0005829;GO:0030425;GO:0012505;GO:0005789;GO:0098978;GO:0000139;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0043025;GO:0005635;GO:0005654;GO:0005634;GO:0045335;GO:0016605;GO:0099524;GO:0031931;GO:0031932;GO:0005524;GO:0042802;GO:0016301;GO:0051219;GO:0019904;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0043022;GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0045182;GO:0006207;GO:0032148;GO:0043276;GO:0007420;GO:0055013;GO:0060048;GO:0007569;GO:0007050;GO:0034198;GO:0071230;GO:0071456;GO:0071233;GO:1990253;GO:0031669;GO:0009267;GO:0006112;GO:0007281;GO:0003007;GO:0003179;GO:0007616;GO:0007040;GO:0060135;GO:0048255;GO:0035264;GO:0010507;GO:0070885;GO:0045792;GO:1904193;GO:1904213;GO:0016242;GO:0014736;GO:0001933;GO:0031397;GO:0051647;GO:0018105;GO:0018107;GO:0016310;GO:0030838;GO:0061051;GO:1904056;GO:1904690;GO:0060999;GO:1904000;GO:0001938;GO:0010718;GO:0010628;GO:0060252;GO:1904197;GO:0051549;GO:0010592;GO:0046889;GO:0010831;GO:1901216;GO:0014042;GO:0010976;GO:0045429;GO:0048714;GO:0050731;GO:0032516;GO:0051897;GO:1904058;GO:1904206;GO:0048661;GO:0051496;GO:0045945;GO:1901838;GO:0045727;GO:1903691;GO:0009791;GO:0046777;GO:0030163;GO:0006468;GO:0032956;GO:0090335;GO:0043610;GO:0001558;GO:0008361;GO:1900034;GO:0042752;GO:0031998;GO:0005979;GO:0043087;GO:1904059;GO:0016241;GO:0090559;GO:0031641;GO:0045670;GO:0032095;GO:1901796;GO:0099547;GO:0014823;GO:0043200;GO:0042220;GO:0032868;GO:0043278;GO:0007584;GO:0031667;GO:0048511;GO:0031529;GO:0035176;GO:0021510;GO:0002296;GO:0031929;GO:0038202;GO:0008542;GO:0050882;GO:0042060;, C:cytoplasm; C:cytosol; C:dendrite; C:endomembrane system; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:Golgi membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:neuronal cell body; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:phagocytic vesicle; C:PML body; C:postsynaptic cytosol; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:identical protein binding; F:kinase activity; F:phosphoprotein binding; F:protein domain specific binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosome binding; F:RNA polymerase III type 1 promoter sequence-specific DNA binding; F:RNA polymerase III type 2 promoter sequence-specific DNA binding; F:RNA polymerase III type 3 promoter sequence-specific DNA binding; F:TFIIIC-class transcription factor complex binding; F:translation regulator activity;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:activation of protein kinase B activity; P:anoikis; P:brain development; P:cardiac muscle cell development; P:cardiac muscle contraction; P:cell aging; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to nutrient levels; P:cellular response to starvation; P:energy reserve metabolic process; P:germ cell development; P:heart morphogenesis; P:heart valve morphogenesis; P:long-term memory; P:lysosome organization; P:maternal process involved in female pregnancy; P:mRNA stabilization; P:multicellular organism growth; P:negative regulation of autophagy; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cell size; P:negative regulation of cholangiocyte apoptotic process; P:negative regulation of iodide transmembrane transport; P:negative regulation of macroautophagy; P:negative regulation of muscle atrophy; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:nucleus localization; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of cholangiocyte proliferation; P:positive regulation of cytoplasmic translational initiation; P:positive regulation of dendritic spine development; P:positive regulation of eating behavior; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:positive regulation of glial cell proliferation; P:positive regulation of granulosa cell proliferation; P:positive regulation of keratinocyte migration; P:positive regulation of lamellipodium assembly; P:positive regulation of lipid biosynthetic process; P:positive regulation of myotube differentiation; P:positive regulation of neuron death; P:positive regulation of neuron maturation; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of sensory perception of pain; P:positive regulation of skeletal muscle hypertrophy; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of translation; P:positive regulation of wound healing, spreading of epidermal cells; P:post-embryonic development; P:protein autophosphorylation; P:protein catabolic process; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of brown fat cell differentiation; P:regulation of carbohydrate utilization; P:regulation of cell growth; P:regulation of cell size; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of fatty acid beta-oxidation; P:regulation of glycogen biosynthetic process; P:regulation of GTPase activity; P:regulation of locomotor rhythm; P:regulation of macroautophagy; P:regulation of membrane permeability; P:regulation of myelination; P:regulation of osteoclast differentiation; P:regulation of response to food; P:regulation of signal transduction by p53 class mediator; P:regulation of translation at synapse, modulating synaptic transmission; P:response to activity; P:response to amino acid; P:response to cocaine; P:response to insulin; P:response to morphine; P:response to nutrient; P:response to nutrient levels; P:rhythmic process; P:ruffle organization; P:social behavior; P:spinal cord development; P:T-helper 1 cell lineage commitment; P:TOR signaling; P:TORC1 signaling; P:visual learning; P:voluntary musculoskeletal movement; P:wound healing;|O43827 B2R9B2 F1T0A6 Q4ZGK4,Angiopoietin-related protein 7,Angiopoietin-like factor;Angiopoietin-like protein 7;Cornea-derived transcript 6 protein;, PF00147;, GO:0062023;GO:0005576;GO:0005615;GO:0042802;GO:0005102;GO:0001525;GO:1901346;GO:1903053;GO:0006979;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:identical protein binding; F:signaling receptor binding;, P:angiogenesis; P:negative regulation of vasculature development involved in avascular cornea development in camera-type eye; P:regulation of extracellular matrix organization; P:response to oxidative stress;|P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3,Serine/threonine-protein kinase mTOR,FK506-binding protein 12-rapamycin complex-associated protein 1;FKBP12-rapamycin complex-associated protein;Mammalian target of rapamycin;Mechanistic target of rapamycin;Rapamycin and FKBP12 target 1;Rapamycin target protein 1;, PF11865;PF02259;PF02260;PF08771;PF00454;, GO:0005737;GO:0005829;GO:0030425;GO:0012505;GO:0005789;GO:0098978;GO:0000139;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0043025;GO:0005635;GO:0005654;GO:0005634;GO:0045335;GO:0016605;GO:0099524;GO:0031931;GO:0031932;GO:0005524;GO:0042802;GO:0016301;GO:0051219;GO:0019904;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0043022;GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0045182;GO:0006207;GO:0032148;GO:0043276;GO:0007420;GO:0055013;GO:0060048;GO:0007569;GO:0007050;GO:0034198;GO:0071230;GO:0071456;GO:0071233;GO:1990253;GO:0031669;GO:0009267;GO:0006112;GO:0007281;GO:0003007;GO:0003179;GO:0007616;GO:0007040;GO:0060135;GO:0048255;GO:0035264;GO:0010507;GO:0070885;GO:0045792;GO:1904193;GO:1904213;GO:0016242;GO:0014736;GO:0001933;GO:0031397;GO:0051647;GO:0018105;GO:0018107;GO:0016310;GO:0030838;GO:0061051;GO:1904056;GO:1904690;GO:0060999;GO:1904000;GO:0001938;GO:0010718;GO:0010628;GO:0060252;GO:1904197;GO:0051549;GO:0010592;GO:0046889;GO:0010831;GO:1901216;GO:0014042;GO:0010976;GO:0045429;GO:0048714;GO:0050731;GO:0032516;GO:0051897;GO:1904058;GO:1904206;GO:0048661;GO:0051496;GO:0045945;GO:1901838;GO:0045727;GO:1903691;GO:0009791;GO:0046777;GO:0030163;GO:0006468;GO:0032956;GO:0090335;GO:0043610;GO:0001558;GO:0008361;GO:1900034;GO:0042752;GO:0031998;GO:0005979;GO:0043087;GO:1904059;GO:0016241;GO:0090559;GO:0031641;GO:0045670;GO:0032095;GO:1901796;GO:0099547;GO:0014823;GO:0043200;GO:0042220;GO:0032868;GO:0043278;GO:0007584;GO:0031667;GO:0048511;GO:0031529;GO:0035176;GO:0021510;GO:0002296;GO:0031929;GO:0038202;GO:0008542;GO:0050882;GO:0042060;, C:cytoplasm; C:cytosol; C:dendrite; C:endomembrane system; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:Golgi membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:neuronal cell body; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:phagocytic vesicle; C:PML body; C:postsynaptic cytosol; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:identical protein binding; F:kinase activity; F:phosphoprotein binding; F:protein domain specific binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosome binding; F:RNA polymerase III type 1 promoter sequence-specific DNA binding; F:RNA polymerase III type 2 promoter sequence-specific DNA binding; F:RNA polymerase III type 3 promoter sequence-specific DNA binding; F:TFIIIC-class transcription factor complex binding; F:translation regulator activity;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:activation of protein kinase B activity; P:anoikis; P:brain development; P:cardiac muscle cell development; P:cardiac muscle contraction; P:cell aging; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to nutrient levels; P:cellular response to starvation; P:energy reserve metabolic process; P:germ cell development; P:heart morphogenesis; P:heart valve morphogenesis; P:long-term memory; P:lysosome organization; P:maternal process involved in female pregnancy; P:mRNA stabilization; P:multicellular organism growth; P:negative regulation of autophagy; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cell size; P:negative regulation of cholangiocyte apoptotic process; P:negative regulation of iodide transmembrane transport; P:negative regulation of macroautophagy; P:negative regulation of muscle atrophy; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:nucleus localization; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of cholangiocyte proliferation; P:positive regulation of cytoplasmic translational initiation; P:positive regulation of dendritic spine development; P:positive regulation of eating behavior; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:positive regulation of glial cell proliferation; P:positive regulation of granulosa cell proliferation; P:positive regulation of keratinocyte migration; P:positive regulation of lamellipodium assembly; P:positive regulation of lipid biosynthetic process; P:positive regulation of myotube differentiation; P:positive regulation of neuron death; P:positive regulation of neuron maturation; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of sensory perception of pain; P:positive regulation of skeletal muscle hypertrophy; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of translation; P:positive regulation of wound healing, spreading of epidermal cells; P:post-embryonic development; P:protein autophosphorylation; P:protein catabolic process; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of brown fat cell differentiation; P:regulation of carbohydrate utilization; P:regulation of cell growth; P:regulation of cell size; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of fatty acid beta-oxidation; P:regulation of glycogen biosynthetic process; P:regulation of GTPase activity; P:regulation of locomotor rhythm; P:regulation of macroautophagy; P:regulation of membrane permeability; P:regulation of myelination; P:regulation of osteoclast differentiation; P:regulation of response to food; P:regulation of signal transduction by p53 class mediator; P:regulation of translation at synapse, modulating synaptic transmission; P:response to activity; P:response to amino acid; P:response to cocaine; P:response to insulin; P:response to morphine; P:response to nutrient; P:response to nutrient levels; P:rhythmic process; P:ruffle organization; P:social behavior; P:spinal cord development; P:T-helper 1 cell lineage commitment; P:TOR signaling; P:TORC1 signaling; P:visual learning; P:voluntary musculoskeletal movement; P:wound healing;|P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3,Serine/threonine-protein kinase mTOR,FK506-binding protein 12-rapamycin complex-associated protein 1;FKBP12-rapamycin complex-associated protein;Mammalian target of rapamycin;Mechanistic target of rapamycin;Rapamycin and FKBP12 target 1;Rapamycin target protein 1;, PF11865;PF02259;PF02260;PF08771;PF00454;, GO:0005737;GO:0005829;GO:0030425;GO:0012505;GO:0005789;GO:0098978;GO:0000139;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0043025;GO:0005635;GO:0005654;GO:0005634;GO:0045335;GO:0016605;GO:0099524;GO:0031931;GO:0031932;GO:0005524;GO:0042802;GO:0016301;GO:0051219;GO:0019904;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0043022;GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0045182;GO:0006207;GO:0032148;GO:0043276;GO:0007420;GO:0055013;GO:0060048;GO:0007569;GO:0007050;GO:0034198;GO:0071230;GO:0071456;GO:0071233;GO:1990253;GO:0031669;GO:0009267;GO:0006112;GO:0007281;GO:0003007;GO:0003179;GO:0007616;GO:0007040;GO:0060135;GO:0048255;GO:0035264;GO:0010507;GO:0070885;GO:0045792;GO:1904193;GO:1904213;GO:0016242;GO:0014736;GO:0001933;GO:0031397;GO:0051647;GO:0018105;GO:0018107;GO:0016310;GO:0030838;GO:0061051;GO:1904056;GO:1904690;GO:0060999;GO:1904000;GO:0001938;GO:0010718;GO:0010628;GO:0060252;GO:1904197;GO:0051549;GO:0010592;GO:0046889;GO:0010831;GO:1901216;GO:0014042;GO:0010976;GO:0045429;GO:0048714;GO:0050731;GO:0032516;GO:0051897;GO:1904058;GO:1904206;GO:0048661;GO:0051496;GO:0045945;GO:1901838;GO:0045727;GO:1903691;GO:0009791;GO:0046777;GO:0030163;GO:0006468;GO:0032956;GO:0090335;GO:0043610;GO:0001558;GO:0008361;GO:1900034;GO:0042752;GO:0031998;GO:0005979;GO:0043087;GO:1904059;GO:0016241;GO:0090559;GO:0031641;GO:0045670;GO:0032095;GO:1901796;GO:0099547;GO:0014823;GO:0043200;GO:0042220;GO:0032868;GO:0043278;GO:0007584;GO:0031667;GO:0048511;GO:0031529;GO:0035176;GO:0021510;GO:0002296;GO:0031929;GO:0038202;GO:0008542;GO:0050882;GO:0042060;, C:cytoplasm; C:cytosol; C:dendrite; C:endomembrane system; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:Golgi membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:neuronal cell body; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:phagocytic vesicle; C:PML body; C:postsynaptic cytosol; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:identical protein binding; F:kinase activity; F:phosphoprotein binding; F:protein domain specific binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosome binding; F:RNA polymerase III type 1 promoter sequence-specific DNA binding; F:RNA polymerase III type 2 promoter sequence-specific DNA binding; F:RNA polymerase III type 3 promoter sequence-specific DNA binding; F:TFIIIC-class transcription factor complex binding; F:translation regulator activity;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:activation of protein kinase B activity; P:anoikis; P:brain development; P:cardiac muscle cell development; P:cardiac muscle contraction; P:cell aging; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to nutrient levels; P:cellular response to starvation; P:energy reserve metabolic process; P:germ cell development; P:heart morphogenesis; P:heart valve morphogenesis; P:long-term memory; P:lysosome organization; P:maternal process involved in female pregnancy; P:mRNA stabilization; P:multicellular organism growth; P:negative regulation of autophagy; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cell size; P:negative regulation of cholangiocyte apoptotic process; P:negative regulation of iodide transmembrane transport; P:negative regulation of macroautophagy; P:negative regulation of muscle atrophy; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:nucleus localization; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of cholangiocyte proliferation; P:positive regulation of cytoplasmic translational initiation; P:positive regulation of dendritic spine development; P:positive regulation of eating behavior; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:positive regulation of glial cell proliferation; P:positive regulation of granulosa cell proliferation; P:positive regulation of keratinocyte migration; P:positive regulation of lamellipodium assembly; P:positive regulation of lipid biosynthetic process; P:positive regulation of myotube differentiation; P:positive regulation of neuron death; P:positive regulation of neuron maturation; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of sensory perception of pain; P:positive regulation of skeletal muscle hypertrophy; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of translation; P:positive regulation of wound healing, spreading of epidermal cells; P:post-embryonic development; P:protein autophosphorylation; P:protein catabolic process; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of brown fat cell differentiation; P:regulation of carbohydrate utilization; P:regulation of cell growth; P:regulation of cell size; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of fatty acid beta-oxidation; P:regulation of glycogen biosynthetic process; P:regulation of GTPase activity; P:regulation of locomotor rhythm; P:regulation of macroautophagy; P:regulation of membrane permeability; P:regulation of myelination; P:regulation of osteoclast differentiation; P:regulation of response to food; P:regulation of signal transduction by p53 class mediator; P:regulation of translation at synapse, modulating synaptic transmission; P:response to activity; P:response to amino acid; P:response to cocaine; P:response to insulin; P:response to morphine; P:response to nutrient; P:response to nutrient levels; P:rhythmic process; P:ruffle organization; P:social behavior; P:spinal cord development; P:T-helper 1 cell lineage commitment; P:TOR signaling; P:TORC1 signaling; P:visual learning; P:voluntary musculoskeletal movement; P:wound healing;|P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3,Serine/threonine-protein kinase mTOR,FK506-binding protein 12-rapamycin complex-associated protein 1;FKBP12-rapamycin complex-associated protein;Mammalian target of rapamycin;Mechanistic target of rapamycin;Rapamycin and FKBP12 target 1;Rapamycin target protein 1;, PF11865;PF02259;PF02260;PF08771;PF00454;, GO:0005737;GO:0005829;GO:0030425;GO:0012505;GO:0005789;GO:0098978;GO:0000139;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0043025;GO:0005635;GO:0005654;GO:0005634;GO:0045335;GO:0016605;GO:0099524;GO:0031931;GO:0031932;GO:0005524;GO:0042802;GO:0016301;GO:0051219;GO:0019904;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0043022;GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0045182;GO:0006207;GO:0032148;GO:0043276;GO:0007420;GO:0055013;GO:0060048;GO:0007569;GO:0007050;GO:0034198;GO:0071230;GO:0071456;GO:0071233;GO:1990253;GO:0031669;GO:0009267;GO:0006112;GO:0007281;GO:0003007;GO:0003179;GO:0007616;GO:0007040;GO:0060135;GO:0048255;GO:0035264;GO:0010507;GO:0070885;GO:0045792;GO:1904193;GO:1904213;GO:0016242;GO:0014736;GO:0001933;GO:0031397;GO:0051647;GO:0018105;GO:0018107;GO:0016310;GO:0030838;GO:0061051;GO:1904056;GO:1904690;GO:0060999;GO:1904000;GO:0001938;GO:0010718;GO:0010628;GO:0060252;GO:1904197;GO:0051549;GO:0010592;GO:0046889;GO:0010831;GO:1901216;GO:0014042;GO:0010976;GO:0045429;GO:0048714;GO:0050731;GO:0032516;GO:0051897;GO:1904058;GO:1904206;GO:0048661;GO:0051496;GO:0045945;GO:1901838;GO:0045727;GO:1903691;GO:0009791;GO:0046777;GO:0030163;GO:0006468;GO:0032956;GO:0090335;GO:0043610;GO:0001558;GO:0008361;GO:1900034;GO:0042752;GO:0031998;GO:0005979;GO:0043087;GO:1904059;GO:0016241;GO:0090559;GO:0031641;GO:0045670;GO:0032095;GO:1901796;GO:0099547;GO:0014823;GO:0043200;GO:0042220;GO:0032868;GO:0043278;GO:0007584;GO:0031667;GO:0048511;GO:0031529;GO:0035176;GO:0021510;GO:0002296;GO:0031929;GO:0038202;GO:0008542;GO:0050882;GO:0042060;, C:cytoplasm; C:cytosol; C:dendrite; C:endomembrane system; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:Golgi membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:neuronal cell body; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:phagocytic vesicle; C:PML body; C:postsynaptic cytosol; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:identical protein binding; F:kinase activity; F:phosphoprotein binding; F:protein domain specific binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosome binding; F:RNA polymerase III type 1 promoter sequence-specific DNA binding; F:RNA polymerase III type 2 promoter sequence-specific DNA binding; F:RNA polymerase III type 3 promoter sequence-specific DNA binding; F:TFIIIC-class transcription factor complex binding; F:translation regulator activity;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:activation of protein kinase B activity; P:anoikis; P:brain development; P:cardiac muscle cell development; P:cardiac muscle contraction; P:cell aging; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to nutrient levels; P:cellular response to starvation; P:energy reserve metabolic process; P:germ cell development; P:heart morphogenesis; P:heart valve morphogenesis; P:long-term memory; P:lysosome organization; P:maternal process involved in female pregnancy; P:mRNA stabilization; P:multicellular organism growth; P:negative regulation of autophagy; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cell size; P:negative regulation of cholangiocyte apoptotic process; P:negative regulation of iodide transmembrane transport; P:negative regulation of macroautophagy; P:negative regulation of muscle atrophy; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:nucleus localization; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of cholangiocyte proliferation; P:positive regulation of cytoplasmic translational initiation; P:positive regulation of dendritic spine development; P:positive regulation of eating behavior; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:positive regulation of glial cell proliferation; P:positive regulation of granulosa cell proliferation; P:positive regulation of keratinocyte migration; P:positive regulation of lamellipodium assembly; P:positive regulation of lipid biosynthetic process; P:positive regulation of myotube differentiation; P:positive regulation of neuron death; P:positive regulation of neuron maturation; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of sensory perception of pain; P:positive regulation of skeletal muscle hypertrophy; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of translation; P:positive regulation of wound healing, spreading of epidermal cells; P:post-embryonic development; P:protein autophosphorylation; P:protein catabolic process; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of brown fat cell differentiation; P:regulation of carbohydrate utilization; P:regulation of cell growth; P:regulation of cell size; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of fatty acid beta-oxidation; P:regulation of glycogen biosynthetic process; P:regulation of GTPase activity; P:regulation of locomotor rhythm; P:regulation of macroautophagy; P:regulation of membrane permeability; P:regulation of myelination; P:regulation of osteoclast differentiation; P:regulation of response to food; P:regulation of signal transduction by p53 class mediator; P:regulation of translation at synapse, modulating synaptic transmission; P:response to activity; P:response to amino acid; P:response to cocaine; P:response to insulin; P:response to morphine; P:response to nutrient; P:response to nutrient levels; P:rhythmic process; P:ruffle organization; P:social behavior; P:spinal cord development; P:T-helper 1 cell lineage commitment; P:TOR signaling; P:TORC1 signaling; P:visual learning; P:voluntary musculoskeletal movement; P:wound healing;|P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3,Serine/threonine-protein kinase mTOR,FK506-binding protein 12-rapamycin complex-associated protein 1;FKBP12-rapamycin complex-associated protein;Mammalian target of rapamycin;Mechanistic target of rapamycin;Rapamycin and FKBP12 target 1;Rapamycin target protein 1;, PF11865;PF02259;PF02260;PF08771;PF00454;, GO:0005737;GO:0005829;GO:0030425;GO:0012505;GO:0005789;GO:0098978;GO:0000139;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0043025;GO:0005635;GO:0005654;GO:0005634;GO:0045335;GO:0016605;GO:0099524;GO:0031931;GO:0031932;GO:0005524;GO:0042802;GO:0016301;GO:0051219;GO:0019904;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0043022;GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0045182;GO:0006207;GO:0032148;GO:0043276;GO:0007420;GO:0055013;GO:0060048;GO:0007569;GO:0007050;GO:0034198;GO:0071230;GO:0071456;GO:0071233;GO:1990253;GO:0031669;GO:0009267;GO:0006112;GO:0007281;GO:0003007;GO:0003179;GO:0007616;GO:0007040;GO:0060135;GO:0048255;GO:0035264;GO:0010507;GO:0070885;GO:0045792;GO:1904193;GO:1904213;GO:0016242;GO:0014736;GO:0001933;GO:0031397;GO:0051647;GO:0018105;GO:0018107;GO:0016310;GO:0030838;GO:0061051;GO:1904056;GO:1904690;GO:0060999;GO:1904000;GO:0001938;GO:0010718;GO:0010628;GO:0060252;GO:1904197;GO:0051549;GO:0010592;GO:0046889;GO:0010831;GO:1901216;GO:0014042;GO:0010976;GO:0045429;GO:0048714;GO:0050731;GO:0032516;GO:0051897;GO:1904058;GO:1904206;GO:0048661;GO:0051496;GO:0045945;GO:1901838;GO:0045727;GO:1903691;GO:0009791;GO:0046777;GO:0030163;GO:0006468;GO:0032956;GO:0090335;GO:0043610;GO:0001558;GO:0008361;GO:1900034;GO:0042752;GO:0031998;GO:0005979;GO:0043087;GO:1904059;GO:0016241;GO:0090559;GO:0031641;GO:0045670;GO:0032095;GO:1901796;GO:0099547;GO:0014823;GO:0043200;GO:0042220;GO:0032868;GO:0043278;GO:0007584;GO:0031667;GO:0048511;GO:0031529;GO:0035176;GO:0021510;GO:0002296;GO:0031929;GO:0038202;GO:0008542;GO:0050882;GO:0042060;, C:cytoplasm; C:cytosol; C:dendrite; C:endomembrane system; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:Golgi membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:neuronal cell body; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:phagocytic vesicle; C:PML body; C:postsynaptic cytosol; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:identical protein binding; F:kinase activity; F:phosphoprotein binding; F:protein domain specific binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosome binding; F:RNA polymerase III type 1 promoter sequence-specific DNA binding; F:RNA polymerase III type 2 promoter sequence-specific DNA binding; F:RNA polymerase III type 3 promoter sequence-specific DNA binding; F:TFIIIC-class transcription factor complex binding; F:translation regulator activity;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:activation of protein kinase B activity; P:anoikis; P:brain development; P:cardiac muscle cell development; P:cardiac muscle contraction; P:cell aging; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to nutrient levels; P:cellular response to starvation; P:energy reserve metabolic process; P:germ cell development; P:heart morphogenesis; P:heart valve morphogenesis; P:long-term memory; P:lysosome organization; P:maternal process involved in female pregnancy; P:mRNA stabilization; P:multicellular organism growth; P:negative regulation of autophagy; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cell size; P:negative regulation of cholangiocyte apoptotic process; P:negative regulation of iodide transmembrane transport; P:negative regulation of macroautophagy; P:negative regulation of muscle atrophy; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:nucleus localization; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of cholangiocyte proliferation; P:positive regulation of cytoplasmic translational initiation; P:positive regulation of dendritic spine development; P:positive regulation of eating behavior; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:positive regulation of glial cell proliferation; P:positive regulation of granulosa cell proliferation; P:positive regulation of keratinocyte migration; P:positive regulation of lamellipodium assembly; P:positive regulation of lipid biosynthetic process; P:positive regulation of myotube differentiation; P:positive regulation of neuron death; P:positive regulation of neuron maturation; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of sensory perception of pain; P:positive regulation of skeletal muscle hypertrophy; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of translation; P:positive regulation of wound healing, spreading of epidermal cells; P:post-embryonic development; P:protein autophosphorylation; P:protein catabolic process; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of brown fat cell differentiation; P:regulation of carbohydrate utilization; P:regulation of cell growth; P:regulation of cell size; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of fatty acid beta-oxidation; P:regulation of glycogen biosynthetic process; P:regulation of GTPase activity; P:regulation of locomotor rhythm; P:regulation of macroautophagy; P:regulation of membrane permeability; P:regulation of myelination; P:regulation of osteoclast differentiation; P:regulation of response to food; P:regulation of signal transduction by p53 class mediator; P:regulation of translation at synapse, modulating synaptic transmission; P:response to activity; P:response to amino acid; P:response to cocaine; P:response to insulin; P:response to morphine; P:response to nutrient; P:response to nutrient levels; P:rhythmic process; P:ruffle organization; P:social behavior; P:spinal cord development; P:T-helper 1 cell lineage commitment; P:TOR signaling; P:TORC1 signaling; P:visual learning; P:voluntary musculoskeletal movement; P:wound healing;|P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3,Serine/threonine-protein kinase mTOR,FK506-binding protein 12-rapamycin complex-associated protein 1;FKBP12-rapamycin complex-associated protein;Mammalian target of rapamycin;Mechanistic target of rapamycin;Rapamycin and FKBP12 target 1;Rapamycin target protein 1;, PF11865;PF02259;PF02260;PF08771;PF00454;, GO:0005737;GO:0005829;GO:0030425;GO:0012505;GO:0005789;GO:0098978;GO:0000139;GO:0005765;GO:0005764;GO:0016020;GO:0005741;GO:0043025;GO:0005635;GO:0005654;GO:0005634;GO:0045335;GO:0016605;GO:0099524;GO:0031931;GO:0031932;GO:0005524;GO:0042802;GO:0016301;GO:0051219;GO:0019904;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0043022;GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0045182;GO:0006207;GO:0032148;GO:0043276;GO:0007420;GO:0055013;GO:0060048;GO:0007569;GO:0007050;GO:0034198;GO:0071230;GO:0071456;GO:0071233;GO:1990253;GO:0031669;GO:0009267;GO:0006112;GO:0007281;GO:0003007;GO:0003179;GO:0007616;GO:0007040;GO:0060135;GO:0048255;GO:0035264;GO:0010507;GO:0070885;GO:0045792;GO:1904193;GO:1904213;GO:0016242;GO:0014736;GO:0001933;GO:0031397;GO:0051647;GO:0018105;GO:0018107;GO:0016310;GO:0030838;GO:0061051;GO:1904056;GO:1904690;GO:0060999;GO:1904000;GO:0001938;GO:0010718;GO:0010628;GO:0060252;GO:1904197;GO:0051549;GO:0010592;GO:0046889;GO:0010831;GO:1901216;GO:0014042;GO:0010976;GO:0045429;GO:0048714;GO:0050731;GO:0032516;GO:0051897;GO:1904058;GO:1904206;GO:0048661;GO:0051496;GO:0045945;GO:1901838;GO:0045727;GO:1903691;GO:0009791;GO:0046777;GO:0030163;GO:0006468;GO:0032956;GO:0090335;GO:0043610;GO:0001558;GO:0008361;GO:1900034;GO:0042752;GO:0031998;GO:0005979;GO:0043087;GO:1904059;GO:0016241;GO:0090559;GO:0031641;GO:0045670;GO:0032095;GO:1901796;GO:0099547;GO:0014823;GO:0043200;GO:0042220;GO:0032868;GO:0043278;GO:0007584;GO:0031667;GO:0048511;GO:0031529;GO:0035176;GO:0021510;GO:0002296;GO:0031929;GO:0038202;GO:0008542;GO:0050882;GO:0042060;, C:cytoplasm; C:cytosol; C:dendrite; C:endomembrane system; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:Golgi membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:mitochondrial outer membrane; C:neuronal cell body; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:phagocytic vesicle; C:PML body; C:postsynaptic cytosol; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:identical protein binding; F:kinase activity; F:phosphoprotein binding; F:protein domain specific binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosome binding; F:RNA polymerase III type 1 promoter sequence-specific DNA binding; F:RNA polymerase III type 2 promoter sequence-specific DNA binding; F:RNA polymerase III type 3 promoter sequence-specific DNA binding; F:TFIIIC-class transcription factor complex binding; F:translation regulator activity;, P:'de novo' pyrimidine nucleobase biosynthetic process; P:activation of protein kinase B activity; P:anoikis; P:brain development; P:cardiac muscle cell development; P:cardiac muscle contraction; P:cell aging; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:cellular response to leucine; P:cellular response to leucine starvation; P:cellular response to nutrient levels; P:cellular response to starvation; P:energy reserve metabolic process; P:germ cell development; P:heart morphogenesis; P:heart valve morphogenesis; P:long-term memory; P:lysosome organization; P:maternal process involved in female pregnancy; P:mRNA stabilization; P:multicellular organism growth; P:negative regulation of autophagy; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cell size; P:negative regulation of cholangiocyte apoptotic process; P:negative regulation of iodide transmembrane transport; P:negative regulation of macroautophagy; P:negative regulation of muscle atrophy; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:nucleus localization; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of cholangiocyte proliferation; P:positive regulation of cytoplasmic translational initiation; P:positive regulation of dendritic spine development; P:positive regulation of eating behavior; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:positive regulation of glial cell proliferation; P:positive regulation of granulosa cell proliferation; P:positive regulation of keratinocyte migration; P:positive regulation of lamellipodium assembly; P:positive regulation of lipid biosynthetic process; P:positive regulation of myotube differentiation; P:positive regulation of neuron death; P:positive regulation of neuron maturation; P:positive regulation of neuron projection development; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of sensory perception of pain; P:positive regulation of skeletal muscle hypertrophy; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of translation; P:positive regulation of wound healing, spreading of epidermal cells; P:post-embryonic development; P:protein autophosphorylation; P:protein catabolic process; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of brown fat cell differentiation; P:regulation of carbohydrate utilization; P:regulation of cell growth; P:regulation of cell size; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of fatty acid beta-oxidation; P:regulation of glycogen biosynthetic process; P:regulation of GTPase activity; P:regulation of locomotor rhythm; P:regulation of macroautophagy; P:regulation of membrane permeability; P:regulation of myelination; P:regulation of osteoclast differentiation; P:regulation of response to food; P:regulation of signal transduction by p53 class mediator; P:regulation of translation at synapse, modulating synaptic transmission; P:response to activity; P:response to amino acid; P:response to cocaine; P:response to insulin; P:response to morphine; P:response to nutrient; P:response to nutrient levels; P:rhythmic process; P:ruffle organization; P:social behavior; P:spinal cord development; P:T-helper 1 cell lineage commitment; P:TOR signaling; P:TORC1 signaling; P:visual learning; P:voluntary musculoskeletal movement; P:wound healing; scaffold62 indexed_genome mRNA 3608890 3631583 . + . ID=transcript_10822;Q01780 B1AKQ0 B1AKQ1 Q15158,Exosome component 10 {ECO:0000305},Autoantigen PM/Scl 2;P100 polymyositis-scleroderma overlap syndrome-associated autoantigen;Polymyositis/scleroderma autoantigen 100 kDa;Polymyositis/scleroderma autoantigen 2;, PF01612;PF00570;PF08066;, GO:0005737;GO:0005829;GO:0000178;GO:0016020;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0035327;GO:0000175;GO:0004532;GO:0000166;GO:0003723;GO:0003727;GO:0070034;GO:0071034;GO:0009048;GO:0000467;GO:0071044;GO:0000460;GO:0032211;GO:0071028;GO:0071040;GO:0071039;GO:0071035;GO:0071036;GO:0071037;GO:0071038;GO:0071048;GO:0000956;GO:0000184;GO:0071051;GO:1904872;GO:0006364;, C:cytoplasm; C:cytosol; C:exosome (RNase complex); C:membrane; C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:3'-5'-exoribonuclease activity; F:exoribonuclease activity; F:nucleotide binding; F:RNA binding; F:single-stranded RNA binding; F:telomerase RNA binding;, P:CUT catabolic process; P:dosage compensation by inactivation of X chromosome; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:histone mRNA catabolic process; P:maturation of 5.8S rRNA; P:negative regulation of telomere maintenance via telomerase; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent antisense transcript catabolic process; P:nuclear polyadenylation-dependent CUT catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent snoRNA catabolic process; P:nuclear polyadenylation-dependent snRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:polyadenylation-dependent snoRNA 3'-end processing; P:regulation of telomerase RNA localization to Cajal body; P:rRNA processing;|Q01780 B1AKQ0 B1AKQ1 Q15158,Exosome component 10 {ECO:0000305},Autoantigen PM/Scl 2;P100 polymyositis-scleroderma overlap syndrome-associated autoantigen;Polymyositis/scleroderma autoantigen 100 kDa;Polymyositis/scleroderma autoantigen 2;, PF01612;PF00570;PF08066;, GO:0005737;GO:0005829;GO:0000178;GO:0016020;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0035327;GO:0000175;GO:0004532;GO:0000166;GO:0003723;GO:0003727;GO:0070034;GO:0071034;GO:0009048;GO:0000467;GO:0071044;GO:0000460;GO:0032211;GO:0071028;GO:0071040;GO:0071039;GO:0071035;GO:0071036;GO:0071037;GO:0071038;GO:0071048;GO:0000956;GO:0000184;GO:0071051;GO:1904872;GO:0006364;, C:cytoplasm; C:cytosol; C:exosome (RNase complex); C:membrane; C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:3'-5'-exoribonuclease activity; F:exoribonuclease activity; F:nucleotide binding; F:RNA binding; F:single-stranded RNA binding; F:telomerase RNA binding;, P:CUT catabolic process; P:dosage compensation by inactivation of X chromosome; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:histone mRNA catabolic process; P:maturation of 5.8S rRNA; P:negative regulation of telomere maintenance via telomerase; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent antisense transcript catabolic process; P:nuclear polyadenylation-dependent CUT catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent snoRNA catabolic process; P:nuclear polyadenylation-dependent snRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:polyadenylation-dependent snoRNA 3'-end processing; P:regulation of telomerase RNA localization to Cajal body; P:rRNA processing;|Q01780 B1AKQ0 B1AKQ1 Q15158,Exosome component 10 {ECO:0000305},Autoantigen PM/Scl 2;P100 polymyositis-scleroderma overlap syndrome-associated autoantigen;Polymyositis/scleroderma autoantigen 100 kDa;Polymyositis/scleroderma autoantigen 2;, PF01612;PF00570;PF08066;, GO:0005737;GO:0005829;GO:0000178;GO:0016020;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0035327;GO:0000175;GO:0004532;GO:0000166;GO:0003723;GO:0003727;GO:0070034;GO:0071034;GO:0009048;GO:0000467;GO:0071044;GO:0000460;GO:0032211;GO:0071028;GO:0071040;GO:0071039;GO:0071035;GO:0071036;GO:0071037;GO:0071038;GO:0071048;GO:0000956;GO:0000184;GO:0071051;GO:1904872;GO:0006364;, C:cytoplasm; C:cytosol; C:exosome (RNase complex); C:membrane; C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:3'-5'-exoribonuclease activity; F:exoribonuclease activity; F:nucleotide binding; F:RNA binding; F:single-stranded RNA binding; F:telomerase RNA binding;, P:CUT catabolic process; P:dosage compensation by inactivation of X chromosome; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:histone mRNA catabolic process; P:maturation of 5.8S rRNA; P:negative regulation of telomere maintenance via telomerase; P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent antisense transcript catabolic process; P:nuclear polyadenylation-dependent CUT catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent snoRNA catabolic process; P:nuclear polyadenylation-dependent snRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:polyadenylation-dependent snoRNA 3'-end processing; P:regulation of telomerase RNA localization to Cajal body; P:rRNA processing; scaffold62 indexed_genome mRNA 3657510 3661405 . + . ID=transcript_10823;P19623 B1AKP9 Q15511,Spermidine synthase,Putrescine aminopropyltransferase;, PF17284;, GO:0005829;GO:0042802;GO:0042803;GO:0004766;GO:1990830;GO:0006596;GO:0006595;GO:0008295;, C:cytosol;, F:identical protein binding; F:protein homodimerization activity; F:spermidine synthase activity;, P:cellular response to leukemia inhibitory factor; P:polyamine biosynthetic process; P:polyamine metabolic process; P:spermidine biosynthetic process;|P19623 B1AKP9 Q15511,Spermidine synthase,Putrescine aminopropyltransferase;, PF17284;, GO:0005829;GO:0042802;GO:0042803;GO:0004766;GO:1990830;GO:0006596;GO:0006595;GO:0008295;, C:cytosol;, F:identical protein binding; F:protein homodimerization activity; F:spermidine synthase activity;, P:cellular response to leukemia inhibitory factor; P:polyamine biosynthetic process; P:polyamine metabolic process; P:spermidine biosynthetic process;|P19623 B1AKP9 Q15511,Spermidine synthase,Putrescine aminopropyltransferase;, PF17284;, GO:0005829;GO:0042802;GO:0042803;GO:0004766;GO:1990830;GO:0006596;GO:0006595;GO:0008295;, C:cytosol;, F:identical protein binding; F:protein homodimerization activity; F:spermidine synthase activity;, P:cellular response to leukemia inhibitory factor; P:polyamine biosynthetic process; P:polyamine metabolic process; P:spermidine biosynthetic process; scaffold62 indexed_genome mRNA 3667254 3670360 . + . ID=transcript_10824;Q9H499 Q9UBP3 Q9UC48 Q9ULC7 Q9UMV3 Q9Y270,Mannan-binding lectin serine protease 2,MBL-associated serine protease 2;Mannose-binding protein-associated serine protease 2;, PF00431;PF07645;PF00084;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0048306;GO:0001855;GO:0042802;GO:0008233;GO:0004252;GO:0006956;GO:0006958;GO:0001867;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:calcium-dependent protein binding; F:complement component C4b binding; F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:complement activation, lectin pathway;|Q9H499 Q9UBP3 Q9UC48 Q9ULC7 Q9UMV3 Q9Y270,Mannan-binding lectin serine protease 2,MBL-associated serine protease 2;Mannose-binding protein-associated serine protease 2;, PF00431;PF07645;PF00084;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0048306;GO:0001855;GO:0042802;GO:0008233;GO:0004252;GO:0006956;GO:0006958;GO:0001867;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:calcium-dependent protein binding; F:complement component C4b binding; F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:complement activation, lectin pathway; scaffold62 indexed_genome mRNA 3670387 3690972 . + . ID=transcript_10825;Q9H499 Q9UBP3 Q9UC48 Q9ULC7 Q9UMV3 Q9Y270,Mannan-binding lectin serine protease 2,MBL-associated serine protease 2;Mannose-binding protein-associated serine protease 2;, PF00431;PF07645;PF00084;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0048306;GO:0001855;GO:0042802;GO:0008233;GO:0004252;GO:0006956;GO:0006958;GO:0001867;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:calcium-dependent protein binding; F:complement component C4b binding; F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:complement activation, lectin pathway;|Q9H499 Q9UBP3 Q9UC48 Q9ULC7 Q9UMV3 Q9Y270,Mannan-binding lectin serine protease 2,MBL-associated serine protease 2;Mannose-binding protein-associated serine protease 2;, PF00431;PF07645;PF00084;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0048306;GO:0001855;GO:0042802;GO:0008233;GO:0004252;GO:0006956;GO:0006958;GO:0001867;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:calcium-dependent protein binding; F:complement component C4b binding; F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:complement activation, lectin pathway;|Q9H499 Q9UBP3 Q9UC48 Q9ULC7 Q9UMV3 Q9Y270,Mannan-binding lectin serine protease 2,MBL-associated serine protease 2;Mannose-binding protein-associated serine protease 2;, PF00431;PF07645;PF00084;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0048306;GO:0001855;GO:0042802;GO:0008233;GO:0004252;GO:0006956;GO:0006958;GO:0001867;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:calcium-dependent protein binding; F:complement component C4b binding; F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:complement activation, lectin pathway;|Q9H499 Q9UBP3 Q9UC48 Q9ULC7 Q9UMV3 Q9Y270,Mannan-binding lectin serine protease 2,MBL-associated serine protease 2;Mannose-binding protein-associated serine protease 2;, PF00431;PF07645;PF00084;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0048306;GO:0001855;GO:0042802;GO:0008233;GO:0004252;GO:0006956;GO:0006958;GO:0001867;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:calcium-dependent protein binding; F:complement component C4b binding; F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:complement activation, lectin pathway;|Q96DJ0,TAR DNA-binding protein 43,, PF00076;PF18694;, GO:0010494;GO:0035061;GO:0016607;GO:0005654;GO:0005634;GO:0005726;GO:0003690;GO:0042802;GO:0003730;GO:0097157;GO:0003723;GO:0000978;GO:0061158;GO:0070935;GO:0006397;GO:0043922;GO:0010629;GO:0001933;GO:0071765;GO:0032024;GO:0042307;GO:0042981;GO:0051726;GO:0042752;GO:0010468;GO:0031647;GO:0034976;GO:0048511;GO:0008380;, C:cytoplasmic stress granule; C:interchromatin granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perichromatin fibrils;, F:double-stranded DNA binding; F:identical protein binding; F:mRNA 3'-UTR binding; F:pre-mRNA intronic binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:3'-UTR-mediated mRNA stabilization; P:mRNA processing; P:negative regulation by host of viral transcription; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:nuclear inner membrane organization; P:positive regulation of insulin secretion; P:positive regulation of protein import into nucleus; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:rhythmic process; P:RNA splicing;|Q96DJ0,TAR DNA-binding protein 43,, PF00076;PF18694;, GO:0010494;GO:0035061;GO:0016607;GO:0005654;GO:0005634;GO:0005726;GO:0003690;GO:0042802;GO:0003730;GO:0097157;GO:0003723;GO:0000978;GO:0061158;GO:0070935;GO:0006397;GO:0043922;GO:0010629;GO:0001933;GO:0071765;GO:0032024;GO:0042307;GO:0042981;GO:0051726;GO:0042752;GO:0010468;GO:0031647;GO:0034976;GO:0048511;GO:0008380;, C:cytoplasmic stress granule; C:interchromatin granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perichromatin fibrils;, F:double-stranded DNA binding; F:identical protein binding; F:mRNA 3'-UTR binding; F:pre-mRNA intronic binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:3'-UTR-mediated mRNA stabilization; P:mRNA processing; P:negative regulation by host of viral transcription; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:nuclear inner membrane organization; P:positive regulation of insulin secretion; P:positive regulation of protein import into nucleus; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:rhythmic process; P:RNA splicing;|Q96DJ0,TAR DNA-binding protein 43,, PF00076;PF18694;, GO:0010494;GO:0035061;GO:0016607;GO:0005654;GO:0005634;GO:0005726;GO:0003690;GO:0042802;GO:0003730;GO:0097157;GO:0003723;GO:0000978;GO:0061158;GO:0070935;GO:0006397;GO:0043922;GO:0010629;GO:0001933;GO:0071765;GO:0032024;GO:0042307;GO:0042981;GO:0051726;GO:0042752;GO:0010468;GO:0031647;GO:0034976;GO:0048511;GO:0008380;, C:cytoplasmic stress granule; C:interchromatin granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:perichromatin fibrils;, F:double-stranded DNA binding; F:identical protein binding; F:mRNA 3'-UTR binding; F:pre-mRNA intronic binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:3'-UTR-mediated mRNA destabilization; P:3'-UTR-mediated mRNA stabilization; P:mRNA processing; P:negative regulation by host of viral transcription; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:nuclear inner membrane organization; P:positive regulation of insulin secretion; P:positive regulation of protein import into nucleus; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of circadian rhythm; P:regulation of gene expression; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:rhythmic process; P:RNA splicing; scaffold62 indexed_genome mRNA 3989158 4042075 . + . ID=transcript_10826;Q86V15 Q078S9 Q2EN02 Q5T9S1 Q6ZNM8 Q8WX49 Q8WX50 Q9BT16 Q9NXC6,Zinc finger protein castor homolog 1,Castor-related protein;Putative survival-related protein;Zinc finger protein 693;, , GO:0000785;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000977;GO:0007275;GO:0045944;GO:0045893;GO:0045664;GO:0006355;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of neuron differentiation; P:regulation of transcription, DNA-templated;|Q86V15 Q078S9 Q2EN02 Q5T9S1 Q6ZNM8 Q8WX49 Q8WX50 Q9BT16 Q9NXC6,Zinc finger protein castor homolog 1,Castor-related protein;Putative survival-related protein;Zinc finger protein 693;, , GO:0000785;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000977;GO:0007275;GO:0045944;GO:0045893;GO:0045664;GO:0006355;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of neuron differentiation; P:regulation of transcription, DNA-templated;|Q86V15 Q078S9 Q2EN02 Q5T9S1 Q6ZNM8 Q8WX49 Q8WX50 Q9BT16 Q9NXC6,Zinc finger protein castor homolog 1,Castor-related protein;Putative survival-related protein;Zinc finger protein 693;, , GO:0000785;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000977;GO:0007275;GO:0045944;GO:0045893;GO:0045664;GO:0006355;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of neuron differentiation; P:regulation of transcription, DNA-templated; scaffold62 indexed_genome mRNA 4048803 4079841 . - . ID=transcript_10827;O75381 B2R7N1 B3KML6 B7Z1N2 Q8WX51,Peroxisomal membrane protein PEX14,PTS1 receptor-docking protein;Peroxin-14;Peroxisomal membrane anchor protein PEX14;, PF04695;, GO:0005829;GO:0001650;GO:0016021;GO:0016020;GO:0005634;GO:1990429;GO:0005778;GO:0005777;GO:0032991;GO:0048487;GO:0042802;GO:0008017;GO:0047485;GO:0005102;GO:0003714;GO:0034453;GO:0043433;GO:0032091;GO:0045892;GO:0007031;GO:0036250;GO:0016558;GO:0016560;GO:0044721;GO:0016561;GO:0045046;GO:0008104;GO:0016567;GO:0065003;, C:cytosol; C:fibrillar center; C:integral component of membrane; C:membrane; C:nucleus; C:peroxisomal importomer complex; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:beta-tubulin binding; F:identical protein binding; F:microtubule binding; F:protein N-terminus binding; F:signaling receptor binding; F:transcription corepressor activity;, P:microtubule anchoring; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of protein binding; P:negative regulation of transcription, DNA-templated; P:peroxisome organization; P:peroxisome transport along microtubule; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome matrix, substrate release; P:protein import into peroxisome matrix, translocation; P:protein import into peroxisome membrane; P:protein localization; P:protein ubiquitination; P:protein-containing complex assembly;|O75381 B2R7N1 B3KML6 B7Z1N2 Q8WX51,Peroxisomal membrane protein PEX14,PTS1 receptor-docking protein;Peroxin-14;Peroxisomal membrane anchor protein PEX14;, PF04695;, GO:0005829;GO:0001650;GO:0016021;GO:0016020;GO:0005634;GO:1990429;GO:0005778;GO:0005777;GO:0032991;GO:0048487;GO:0042802;GO:0008017;GO:0047485;GO:0005102;GO:0003714;GO:0034453;GO:0043433;GO:0032091;GO:0045892;GO:0007031;GO:0036250;GO:0016558;GO:0016560;GO:0044721;GO:0016561;GO:0045046;GO:0008104;GO:0016567;GO:0065003;, C:cytosol; C:fibrillar center; C:integral component of membrane; C:membrane; C:nucleus; C:peroxisomal importomer complex; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:beta-tubulin binding; F:identical protein binding; F:microtubule binding; F:protein N-terminus binding; F:signaling receptor binding; F:transcription corepressor activity;, P:microtubule anchoring; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of protein binding; P:negative regulation of transcription, DNA-templated; P:peroxisome organization; P:peroxisome transport along microtubule; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome matrix, substrate release; P:protein import into peroxisome matrix, translocation; P:protein import into peroxisome membrane; P:protein localization; P:protein ubiquitination; P:protein-containing complex assembly;|O75381 B2R7N1 B3KML6 B7Z1N2 Q8WX51,Peroxisomal membrane protein PEX14,PTS1 receptor-docking protein;Peroxin-14;Peroxisomal membrane anchor protein PEX14;, PF04695;, GO:0005829;GO:0001650;GO:0016021;GO:0016020;GO:0005634;GO:1990429;GO:0005778;GO:0005777;GO:0032991;GO:0048487;GO:0042802;GO:0008017;GO:0047485;GO:0005102;GO:0003714;GO:0034453;GO:0043433;GO:0032091;GO:0045892;GO:0007031;GO:0036250;GO:0016558;GO:0016560;GO:0044721;GO:0016561;GO:0045046;GO:0008104;GO:0016567;GO:0065003;, C:cytosol; C:fibrillar center; C:integral component of membrane; C:membrane; C:nucleus; C:peroxisomal importomer complex; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:beta-tubulin binding; F:identical protein binding; F:microtubule binding; F:protein N-terminus binding; F:signaling receptor binding; F:transcription corepressor activity;, P:microtubule anchoring; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of protein binding; P:negative regulation of transcription, DNA-templated; P:peroxisome organization; P:peroxisome transport along microtubule; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome matrix, substrate release; P:protein import into peroxisome matrix, translocation; P:protein import into peroxisome membrane; P:protein localization; P:protein ubiquitination; P:protein-containing complex assembly;|O75381 B2R7N1 B3KML6 B7Z1N2 Q8WX51,Peroxisomal membrane protein PEX14,PTS1 receptor-docking protein;Peroxin-14;Peroxisomal membrane anchor protein PEX14;, PF04695;, GO:0005829;GO:0001650;GO:0016021;GO:0016020;GO:0005634;GO:1990429;GO:0005778;GO:0005777;GO:0032991;GO:0048487;GO:0042802;GO:0008017;GO:0047485;GO:0005102;GO:0003714;GO:0034453;GO:0043433;GO:0032091;GO:0045892;GO:0007031;GO:0036250;GO:0016558;GO:0016560;GO:0044721;GO:0016561;GO:0045046;GO:0008104;GO:0016567;GO:0065003;, C:cytosol; C:fibrillar center; C:integral component of membrane; C:membrane; C:nucleus; C:peroxisomal importomer complex; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:beta-tubulin binding; F:identical protein binding; F:microtubule binding; F:protein N-terminus binding; F:signaling receptor binding; F:transcription corepressor activity;, P:microtubule anchoring; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of protein binding; P:negative regulation of transcription, DNA-templated; P:peroxisome organization; P:peroxisome transport along microtubule; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome matrix, substrate release; P:protein import into peroxisome matrix, translocation; P:protein import into peroxisome membrane; P:protein localization; P:protein ubiquitination; P:protein-containing complex assembly;|O75381 B2R7N1 B3KML6 B7Z1N2 Q8WX51,Peroxisomal membrane protein PEX14,PTS1 receptor-docking protein;Peroxin-14;Peroxisomal membrane anchor protein PEX14;, PF04695;, GO:0005829;GO:0001650;GO:0016021;GO:0016020;GO:0005634;GO:1990429;GO:0005778;GO:0005777;GO:0032991;GO:0048487;GO:0042802;GO:0008017;GO:0047485;GO:0005102;GO:0003714;GO:0034453;GO:0043433;GO:0032091;GO:0045892;GO:0007031;GO:0036250;GO:0016558;GO:0016560;GO:0044721;GO:0016561;GO:0045046;GO:0008104;GO:0016567;GO:0065003;, C:cytosol; C:fibrillar center; C:integral component of membrane; C:membrane; C:nucleus; C:peroxisomal importomer complex; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:beta-tubulin binding; F:identical protein binding; F:microtubule binding; F:protein N-terminus binding; F:signaling receptor binding; F:transcription corepressor activity;, P:microtubule anchoring; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of protein binding; P:negative regulation of transcription, DNA-templated; P:peroxisome organization; P:peroxisome transport along microtubule; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome matrix, substrate release; P:protein import into peroxisome matrix, translocation; P:protein import into peroxisome membrane; P:protein localization; P:protein ubiquitination; P:protein-containing complex assembly; scaffold62 indexed_genome mRNA 4189598 4199552 . + . ID=transcript_10828;O00273 Q5T6G5 Q5T6G6 Q96I97 Q9Y6C6,DNA fragmentation factor subunit alpha,DNA fragmentation factor 45 kDa subunit;Inhibitor of CAD;, PF02017;PF09033;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0060703;GO:0019904;GO:0044183;GO:0006309;GO:0061077;GO:1902511;GO:0032076;GO:1900118;GO:0043065;GO:0042981;GO:0070242;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:deoxyribonuclease inhibitor activity; F:protein domain specific binding; F:protein folding chaperone;, P:apoptotic DNA fragmentation; P:chaperone-mediated protein folding; P:negative regulation of apoptotic DNA fragmentation; P:negative regulation of deoxyribonuclease activity; P:negative regulation of execution phase of apoptosis; P:positive regulation of apoptotic process; P:regulation of apoptotic process; P:thymocyte apoptotic process;|O00273 Q5T6G5 Q5T6G6 Q96I97 Q9Y6C6,DNA fragmentation factor subunit alpha,DNA fragmentation factor 45 kDa subunit;Inhibitor of CAD;, PF02017;PF09033;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0060703;GO:0019904;GO:0044183;GO:0006309;GO:0061077;GO:1902511;GO:0032076;GO:1900118;GO:0043065;GO:0042981;GO:0070242;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:deoxyribonuclease inhibitor activity; F:protein domain specific binding; F:protein folding chaperone;, P:apoptotic DNA fragmentation; P:chaperone-mediated protein folding; P:negative regulation of apoptotic DNA fragmentation; P:negative regulation of deoxyribonuclease activity; P:negative regulation of execution phase of apoptosis; P:positive regulation of apoptotic process; P:regulation of apoptotic process; P:thymocyte apoptotic process; scaffold62 indexed_genome mRNA 4213120 4225457 . - . ID=transcript_10829;Q8N2Z9 Q8NFE5 Q8NFG5,Centromere protein S,Apoptosis-inducing TAF9-like domain-containing protein 1;FANCM-associated histone fold protein 1 {ECO:0000303|PubMed:20347428};FANCM-interacting histone fold protein 1 {ECO:0000303|PubMed:20347429};Fanconi anemia-associated polypeptide of 16 kDa;, PF15630;, GO:0000777;GO:0005829;GO:0071821;GO:0043240;GO:0005654;GO:0003682;GO:0003677;GO:0046982;GO:0051301;GO:0006974;GO:0034080;GO:0006281;GO:0036297;GO:0051382;GO:0007052;GO:0031398;GO:0031297;GO:0000712;, C:condensed chromosome kinetochore; C:cytosol; C:FANCM-MHF complex; C:Fanconi anaemia nuclear complex; C:nucleoplasm;, F:chromatin binding; F:DNA binding; F:protein heterodimerization activity;, P:cell division; P:cellular response to DNA damage stimulus; P:CENP-A containing nucleosome assembly; P:DNA repair; P:interstrand cross-link repair; P:kinetochore assembly; P:mitotic spindle organization; P:positive regulation of protein ubiquitination; P:replication fork processing; P:resolution of meiotic recombination intermediates; scaffold62 indexed_genome mRNA 4239110 4254203 . - . ID=transcript_10830;P52209 A8K2Y9 B4DQJ8 Q9BWD8,6-phosphogluconate dehydrogenase, decarboxylating,, PF00393;PF03446;, GO:0005829;GO:0070062;GO:0005634;GO:0050661;GO:0004616;GO:0046177;GO:0019322;GO:0006098;GO:0009051;, C:cytosol; C:extracellular exosome; C:nucleus;, F:NADP binding; F:phosphogluconate dehydrogenase (decarboxylating) activity;, P:D-gluconate catabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch;|P52209 A8K2Y9 B4DQJ8 Q9BWD8,6-phosphogluconate dehydrogenase, decarboxylating,, PF00393;PF03446;, GO:0005829;GO:0070062;GO:0005634;GO:0050661;GO:0004616;GO:0046177;GO:0019322;GO:0006098;GO:0009051;, C:cytosol; C:extracellular exosome; C:nucleus;, F:NADP binding; F:phosphogluconate dehydrogenase (decarboxylating) activity;, P:D-gluconate catabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch;|P52209 A8K2Y9 B4DQJ8 Q9BWD8,6-phosphogluconate dehydrogenase, decarboxylating,, PF00393;PF03446;, GO:0005829;GO:0070062;GO:0005634;GO:0050661;GO:0004616;GO:0046177;GO:0019322;GO:0006098;GO:0009051;, C:cytosol; C:extracellular exosome; C:nucleus;, F:NADP binding; F:phosphogluconate dehydrogenase (decarboxylating) activity;, P:D-gluconate catabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch;|P52209 A8K2Y9 B4DQJ8 Q9BWD8,6-phosphogluconate dehydrogenase, decarboxylating,, PF00393;PF03446;, GO:0005829;GO:0070062;GO:0005634;GO:0050661;GO:0004616;GO:0046177;GO:0019322;GO:0006098;GO:0009051;, C:cytosol; C:extracellular exosome; C:nucleus;, F:NADP binding; F:phosphogluconate dehydrogenase (decarboxylating) activity;, P:D-gluconate catabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch;|P52209 A8K2Y9 B4DQJ8 Q9BWD8,6-phosphogluconate dehydrogenase, decarboxylating,, PF00393;PF03446;, GO:0005829;GO:0070062;GO:0005634;GO:0050661;GO:0004616;GO:0046177;GO:0019322;GO:0006098;GO:0009051;, C:cytosol; C:extracellular exosome; C:nucleus;, F:NADP binding; F:phosphogluconate dehydrogenase (decarboxylating) activity;, P:D-gluconate catabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch; scaffold62 indexed_genome mRNA 4268317 4443384 . - . ID=transcript_10831;Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|O43896 D3DTL6 O75186 Q5U618,Kinesin-like protein KIF1C,, PF00498;PF00225;PF16183;, GO:0030424;GO:1904115;GO:0030425;GO:0005783;GO:0005794;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0003723;GO:1990048;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0016192;, C:axon; C:axon cytoplasm; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity; F:RNA binding;, P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport;|Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport; scaffold62 indexed_genome mRNA 4475545 4603529 . - . ID=transcript_10832;O95155 A8K8S9 G0ZJH6 O75169 O95338 Q5SZ12 Q5SZ16 Q96QD4 Q9BYI7,Ubiquitin conjugation factor E4 B {ECO:0000305},Homozygously deleted in neuroblastoma 1 {ECO:0000312|EMBL:BAB40446.1};RING-type E3 ubiquitin transferase E4 B;Ubiquitin fusion degradation protein 2 {ECO:0000312|EMBL:AAD02233.1};, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0051117;GO:0019899;GO:0034450;GO:0008626;GO:0043161;GO:0000209;GO:0009411;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATPase binding; F:enzyme binding; F:ubiquitin-ubiquitin ligase activity;, P:granzyme-mediated apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:response to UV; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|O95155 A8K8S9 G0ZJH6 O75169 O95338 Q5SZ12 Q5SZ16 Q96QD4 Q9BYI7,Ubiquitin conjugation factor E4 B {ECO:0000305},Homozygously deleted in neuroblastoma 1 {ECO:0000312|EMBL:BAB40446.1};RING-type E3 ubiquitin transferase E4 B;Ubiquitin fusion degradation protein 2 {ECO:0000312|EMBL:AAD02233.1};, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0051117;GO:0019899;GO:0034450;GO:0008626;GO:0043161;GO:0000209;GO:0009411;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATPase binding; F:enzyme binding; F:ubiquitin-ubiquitin ligase activity;, P:granzyme-mediated apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:response to UV; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|O95155 A8K8S9 G0ZJH6 O75169 O95338 Q5SZ12 Q5SZ16 Q96QD4 Q9BYI7,Ubiquitin conjugation factor E4 B {ECO:0000305},Homozygously deleted in neuroblastoma 1 {ECO:0000312|EMBL:BAB40446.1};RING-type E3 ubiquitin transferase E4 B;Ubiquitin fusion degradation protein 2 {ECO:0000312|EMBL:AAD02233.1};, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0051117;GO:0019899;GO:0034450;GO:0008626;GO:0043161;GO:0000209;GO:0009411;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATPase binding; F:enzyme binding; F:ubiquitin-ubiquitin ligase activity;, P:granzyme-mediated apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:response to UV; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|O95155 A8K8S9 G0ZJH6 O75169 O95338 Q5SZ12 Q5SZ16 Q96QD4 Q9BYI7,Ubiquitin conjugation factor E4 B {ECO:0000305},Homozygously deleted in neuroblastoma 1 {ECO:0000312|EMBL:BAB40446.1};RING-type E3 ubiquitin transferase E4 B;Ubiquitin fusion degradation protein 2 {ECO:0000312|EMBL:AAD02233.1};, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0051117;GO:0019899;GO:0034450;GO:0008626;GO:0043161;GO:0000209;GO:0009411;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATPase binding; F:enzyme binding; F:ubiquitin-ubiquitin ligase activity;, P:granzyme-mediated apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:response to UV; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|O95155 A8K8S9 G0ZJH6 O75169 O95338 Q5SZ12 Q5SZ16 Q96QD4 Q9BYI7,Ubiquitin conjugation factor E4 B {ECO:0000305},Homozygously deleted in neuroblastoma 1 {ECO:0000312|EMBL:BAB40446.1};RING-type E3 ubiquitin transferase E4 B;Ubiquitin fusion degradation protein 2 {ECO:0000312|EMBL:AAD02233.1};, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0051117;GO:0019899;GO:0034450;GO:0008626;GO:0043161;GO:0000209;GO:0009411;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATPase binding; F:enzyme binding; F:ubiquitin-ubiquitin ligase activity;, P:granzyme-mediated apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:response to UV; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|O95155 A8K8S9 G0ZJH6 O75169 O95338 Q5SZ12 Q5SZ16 Q96QD4 Q9BYI7,Ubiquitin conjugation factor E4 B {ECO:0000305},Homozygously deleted in neuroblastoma 1 {ECO:0000312|EMBL:BAB40446.1};RING-type E3 ubiquitin transferase E4 B;Ubiquitin fusion degradation protein 2 {ECO:0000312|EMBL:AAD02233.1};, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0051117;GO:0019899;GO:0034450;GO:0008626;GO:0043161;GO:0000209;GO:0009411;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATPase binding; F:enzyme binding; F:ubiquitin-ubiquitin ligase activity;, P:granzyme-mediated apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:response to UV; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|O95155 A8K8S9 G0ZJH6 O75169 O95338 Q5SZ12 Q5SZ16 Q96QD4 Q9BYI7,Ubiquitin conjugation factor E4 B {ECO:0000305},Homozygously deleted in neuroblastoma 1 {ECO:0000312|EMBL:BAB40446.1};RING-type E3 ubiquitin transferase E4 B;Ubiquitin fusion degradation protein 2 {ECO:0000312|EMBL:AAD02233.1};, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0051117;GO:0019899;GO:0034450;GO:0008626;GO:0043161;GO:0000209;GO:0009411;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATPase binding; F:enzyme binding; F:ubiquitin-ubiquitin ligase activity;, P:granzyme-mediated apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:response to UV; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|O95155 A8K8S9 G0ZJH6 O75169 O95338 Q5SZ12 Q5SZ16 Q96QD4 Q9BYI7,Ubiquitin conjugation factor E4 B {ECO:0000305},Homozygously deleted in neuroblastoma 1 {ECO:0000312|EMBL:BAB40446.1};RING-type E3 ubiquitin transferase E4 B;Ubiquitin fusion degradation protein 2 {ECO:0000312|EMBL:AAD02233.1};, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0051117;GO:0019899;GO:0034450;GO:0008626;GO:0043161;GO:0000209;GO:0009411;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATPase binding; F:enzyme binding; F:ubiquitin-ubiquitin ligase activity;, P:granzyme-mediated apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:response to UV; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|O95155 A8K8S9 G0ZJH6 O75169 O95338 Q5SZ12 Q5SZ16 Q96QD4 Q9BYI7,Ubiquitin conjugation factor E4 B {ECO:0000305},Homozygously deleted in neuroblastoma 1 {ECO:0000312|EMBL:BAB40446.1};RING-type E3 ubiquitin transferase E4 B;Ubiquitin fusion degradation protein 2 {ECO:0000312|EMBL:AAD02233.1};, PF04564;PF10408;, GO:0005737;GO:0005634;GO:0000151;GO:0051117;GO:0019899;GO:0034450;GO:0008626;GO:0043161;GO:0000209;GO:0009411;GO:0030433;GO:0006511;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATPase binding; F:enzyme binding; F:ubiquitin-ubiquitin ligase activity;, P:granzyme-mediated apoptotic signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:response to UV; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold62 indexed_genome mRNA 4676444 4704646 . - . ID=transcript_10833;Q9HAN9 B1AN63 Q8TAE9 Q9H247 Q9H6B6,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 {ECO:0000305},Nicotinamide-nucleotide adenylyltransferase 1;Nicotinate-nucleotide adenylyltransferase 1;, PF01467;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0000309;GO:0004515;GO:1990966;GO:0009435;GO:0019674;GO:1902511;GO:0043524;GO:0009165;GO:0043410;GO:0009611;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:nicotinamide-nucleotide adenylyltransferase activity; F:nicotinate-nucleotide adenylyltransferase activity;, P:ATP generation from poly-ADP-D-ribose; P:NAD biosynthetic process; P:NAD metabolic process; P:negative regulation of apoptotic DNA fragmentation; P:negative regulation of neuron apoptotic process; P:nucleotide biosynthetic process; P:positive regulation of MAPK cascade; P:response to wounding; scaffold62 indexed_genome mRNA 4704693 4715318 . + . ID=transcript_10834;Q8WZA0 B2R6F0 B4E2N0 Q96IU1,Protein LZIC,Leucine zipper and CTNNBIP1 domain-containing protein;Leucine zipper and ICAT homologous domain-containing protein;, PF06384;, GO:0008013;GO:0010212;, , F:beta-catenin binding;, P:response to ionizing radiation; scaffold62 indexed_genome mRNA 4730609 4760823 . + . ID=transcript_10835;Q9NSA3 Q5T4V2,Beta-catenin-interacting protein 1,Inhibitor of beta-catenin and Tcf-4;, PF06384;, GO:0030877;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0070016;GO:0008013;GO:0009952;GO:0001658;GO:0043392;GO:0043433;GO:0072201;GO:0032091;GO:0031333;GO:0048662;GO:0060633;GO:0030178;GO:0045657;GO:0045669;GO:0002528;GO:0016055;, C:beta-catenin destruction complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:armadillo repeat domain binding; F:beta-catenin binding;, P:anterior/posterior pattern specification; P:branching involved in ureteric bud morphogenesis; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of mesenchymal cell proliferation; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of transcription initiation from RNA polymerase II promoter; P:negative regulation of Wnt signaling pathway; P:positive regulation of monocyte differentiation; P:positive regulation of osteoblast differentiation; P:regulation of vascular permeability involved in acute inflammatory response; P:Wnt signaling pathway; scaffold62 indexed_genome mRNA 4776174 4779627 . - . ID=transcript_10836;Q9NSA3 Q5T4V2,Beta-catenin-interacting protein 1,Inhibitor of beta-catenin and Tcf-4;, PF06384;, GO:0030877;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0070016;GO:0008013;GO:0009952;GO:0001658;GO:0043392;GO:0043433;GO:0072201;GO:0032091;GO:0031333;GO:0048662;GO:0060633;GO:0030178;GO:0045657;GO:0045669;GO:0002528;GO:0016055;, C:beta-catenin destruction complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:armadillo repeat domain binding; F:beta-catenin binding;, P:anterior/posterior pattern specification; P:branching involved in ureteric bud morphogenesis; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of mesenchymal cell proliferation; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of transcription initiation from RNA polymerase II promoter; P:negative regulation of Wnt signaling pathway; P:positive regulation of monocyte differentiation; P:positive regulation of osteoblast differentiation; P:regulation of vascular permeability involved in acute inflammatory response; P:Wnt signaling pathway;|Q9NSA3 Q5T4V2,Beta-catenin-interacting protein 1,Inhibitor of beta-catenin and Tcf-4;, PF06384;, GO:0030877;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0070016;GO:0008013;GO:0009952;GO:0001658;GO:0043392;GO:0043433;GO:0072201;GO:0032091;GO:0031333;GO:0048662;GO:0060633;GO:0030178;GO:0045657;GO:0045669;GO:0002528;GO:0016055;, C:beta-catenin destruction complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:armadillo repeat domain binding; F:beta-catenin binding;, P:anterior/posterior pattern specification; P:branching involved in ureteric bud morphogenesis; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of mesenchymal cell proliferation; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of transcription initiation from RNA polymerase II promoter; P:negative regulation of Wnt signaling pathway; P:positive regulation of monocyte differentiation; P:positive regulation of osteoblast differentiation; P:regulation of vascular permeability involved in acute inflammatory response; P:Wnt signaling pathway; scaffold62 indexed_genome mRNA 4854065 4888659 . - . ID=transcript_10837;O94985 A8K183 Q5SR52 Q5UE58 Q71MN0 Q8N4K9,Calsyntenin-1,Alcadein-alpha;Alzheimer-related cadherin-like protein;Non-classical cadherin XB31alpha;, PF00028;, GO:0009986;GO:0005789;GO:0005576;GO:0098982;GO:0098978;GO:0000139;GO:0099061;GO:0099065;GO:0005634;GO:0098845;GO:0045211;GO:0001540;GO:0005509;GO:0019894;GO:0042988;GO:0007155;GO:0007156;GO:0098969;GO:0051965;GO:0050806;GO:0001558;GO:0090128;GO:0099003;, C:cell surface; C:endoplasmic reticulum membrane; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi membrane; C:integral component of postsynaptic density membrane; C:integral component of spine apparatus membrane; C:nucleus; C:postsynaptic endosome; C:postsynaptic membrane;, F:amyloid-beta binding; F:calcium ion binding; F:kinesin binding; F:X11-like protein binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neurotransmitter receptor transport to postsynaptic membrane; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission; P:regulation of cell growth; P:regulation of synapse maturation; P:vesicle-mediated transport in synapse;|O94985 A8K183 Q5SR52 Q5UE58 Q71MN0 Q8N4K9,Calsyntenin-1,Alcadein-alpha;Alzheimer-related cadherin-like protein;Non-classical cadherin XB31alpha;, PF00028;, GO:0009986;GO:0005789;GO:0005576;GO:0098982;GO:0098978;GO:0000139;GO:0099061;GO:0099065;GO:0005634;GO:0098845;GO:0045211;GO:0001540;GO:0005509;GO:0019894;GO:0042988;GO:0007155;GO:0007156;GO:0098969;GO:0051965;GO:0050806;GO:0001558;GO:0090128;GO:0099003;, C:cell surface; C:endoplasmic reticulum membrane; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi membrane; C:integral component of postsynaptic density membrane; C:integral component of spine apparatus membrane; C:nucleus; C:postsynaptic endosome; C:postsynaptic membrane;, F:amyloid-beta binding; F:calcium ion binding; F:kinesin binding; F:X11-like protein binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neurotransmitter receptor transport to postsynaptic membrane; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission; P:regulation of cell growth; P:regulation of synapse maturation; P:vesicle-mediated transport in synapse;|O94985 A8K183 Q5SR52 Q5UE58 Q71MN0 Q8N4K9,Calsyntenin-1,Alcadein-alpha;Alzheimer-related cadherin-like protein;Non-classical cadherin XB31alpha;, PF00028;, GO:0009986;GO:0005789;GO:0005576;GO:0098982;GO:0098978;GO:0000139;GO:0099061;GO:0099065;GO:0005634;GO:0098845;GO:0045211;GO:0001540;GO:0005509;GO:0019894;GO:0042988;GO:0007155;GO:0007156;GO:0098969;GO:0051965;GO:0050806;GO:0001558;GO:0090128;GO:0099003;, C:cell surface; C:endoplasmic reticulum membrane; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi membrane; C:integral component of postsynaptic density membrane; C:integral component of spine apparatus membrane; C:nucleus; C:postsynaptic endosome; C:postsynaptic membrane;, F:amyloid-beta binding; F:calcium ion binding; F:kinesin binding; F:X11-like protein binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neurotransmitter receptor transport to postsynaptic membrane; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission; P:regulation of cell growth; P:regulation of synapse maturation; P:vesicle-mediated transport in synapse;|O94985 A8K183 Q5SR52 Q5UE58 Q71MN0 Q8N4K9,Calsyntenin-1,Alcadein-alpha;Alzheimer-related cadherin-like protein;Non-classical cadherin XB31alpha;, PF00028;, GO:0009986;GO:0005789;GO:0005576;GO:0098982;GO:0098978;GO:0000139;GO:0099061;GO:0099065;GO:0005634;GO:0098845;GO:0045211;GO:0001540;GO:0005509;GO:0019894;GO:0042988;GO:0007155;GO:0007156;GO:0098969;GO:0051965;GO:0050806;GO:0001558;GO:0090128;GO:0099003;, C:cell surface; C:endoplasmic reticulum membrane; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi membrane; C:integral component of postsynaptic density membrane; C:integral component of spine apparatus membrane; C:nucleus; C:postsynaptic endosome; C:postsynaptic membrane;, F:amyloid-beta binding; F:calcium ion binding; F:kinesin binding; F:X11-like protein binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neurotransmitter receptor transport to postsynaptic membrane; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission; P:regulation of cell growth; P:regulation of synapse maturation; P:vesicle-mediated transport in synapse;|O94985 A8K183 Q5SR52 Q5UE58 Q71MN0 Q8N4K9,Calsyntenin-1,Alcadein-alpha;Alzheimer-related cadherin-like protein;Non-classical cadherin XB31alpha;, PF00028;, GO:0009986;GO:0005789;GO:0005576;GO:0098982;GO:0098978;GO:0000139;GO:0099061;GO:0099065;GO:0005634;GO:0098845;GO:0045211;GO:0001540;GO:0005509;GO:0019894;GO:0042988;GO:0007155;GO:0007156;GO:0098969;GO:0051965;GO:0050806;GO:0001558;GO:0090128;GO:0099003;, C:cell surface; C:endoplasmic reticulum membrane; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi membrane; C:integral component of postsynaptic density membrane; C:integral component of spine apparatus membrane; C:nucleus; C:postsynaptic endosome; C:postsynaptic membrane;, F:amyloid-beta binding; F:calcium ion binding; F:kinesin binding; F:X11-like protein binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neurotransmitter receptor transport to postsynaptic membrane; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission; P:regulation of cell growth; P:regulation of synapse maturation; P:vesicle-mediated transport in synapse;|O94985 A8K183 Q5SR52 Q5UE58 Q71MN0 Q8N4K9,Calsyntenin-1,Alcadein-alpha;Alzheimer-related cadherin-like protein;Non-classical cadherin XB31alpha;, PF00028;, GO:0009986;GO:0005789;GO:0005576;GO:0098982;GO:0098978;GO:0000139;GO:0099061;GO:0099065;GO:0005634;GO:0098845;GO:0045211;GO:0001540;GO:0005509;GO:0019894;GO:0042988;GO:0007155;GO:0007156;GO:0098969;GO:0051965;GO:0050806;GO:0001558;GO:0090128;GO:0099003;, C:cell surface; C:endoplasmic reticulum membrane; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi membrane; C:integral component of postsynaptic density membrane; C:integral component of spine apparatus membrane; C:nucleus; C:postsynaptic endosome; C:postsynaptic membrane;, F:amyloid-beta binding; F:calcium ion binding; F:kinesin binding; F:X11-like protein binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:neurotransmitter receptor transport to postsynaptic membrane; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission; P:regulation of cell growth; P:regulation of synapse maturation; P:vesicle-mediated transport in synapse;|O00329 A6NCG0 G1FFP1 O15445 Q5SR49,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta;, PF00454;PF00792;PF02192;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0016020;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0002250;GO:0007411;GO:0042113;GO:0035754;GO:0050853;GO:0016477;GO:0019221;GO:0006954;GO:0045087;GO:0002551;GO:0043303;GO:0060374;GO:0030101;GO:0035747;GO:0001779;GO:0030593;GO:0072672;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0045766;GO:0030335;GO:0038089;GO:0001819;GO:0010595;GO:0001938;GO:1905278;GO:0010628;GO:0033031;GO:0014068;GO:0051897;GO:0006468;GO:0002679;GO:0007165;GO:0042110;GO:0010818;GO:0030217;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:adaptive immune response; P:axon guidance; P:B cell activation; P:B cell chemotaxis; P:B cell receptor signaling pathway; P:cell migration; P:cytokine-mediated signaling pathway; P:inflammatory response; P:innate immune response; P:mast cell chemotaxis; P:mast cell degranulation; P:mast cell differentiation; P:natural killer cell activation; P:natural killer cell chemotaxis; P:natural killer cell differentiation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cytokine production; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of gene expression; P:positive regulation of neutrophil apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:protein phosphorylation; P:respiratory burst involved in defense response; P:signal transduction; P:T cell activation; P:T cell chemotaxis; P:T cell differentiation; P:T cell receptor signaling pathway;|O00329 A6NCG0 G1FFP1 O15445 Q5SR49,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta;, PF00454;PF00792;PF02192;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0016020;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0002250;GO:0007411;GO:0042113;GO:0035754;GO:0050853;GO:0016477;GO:0019221;GO:0006954;GO:0045087;GO:0002551;GO:0043303;GO:0060374;GO:0030101;GO:0035747;GO:0001779;GO:0030593;GO:0072672;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0045766;GO:0030335;GO:0038089;GO:0001819;GO:0010595;GO:0001938;GO:1905278;GO:0010628;GO:0033031;GO:0014068;GO:0051897;GO:0006468;GO:0002679;GO:0007165;GO:0042110;GO:0010818;GO:0030217;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:adaptive immune response; P:axon guidance; P:B cell activation; P:B cell chemotaxis; P:B cell receptor signaling pathway; P:cell migration; P:cytokine-mediated signaling pathway; P:inflammatory response; P:innate immune response; P:mast cell chemotaxis; P:mast cell degranulation; P:mast cell differentiation; P:natural killer cell activation; P:natural killer cell chemotaxis; P:natural killer cell differentiation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cytokine production; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of gene expression; P:positive regulation of neutrophil apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:protein phosphorylation; P:respiratory burst involved in defense response; P:signal transduction; P:T cell activation; P:T cell chemotaxis; P:T cell differentiation; P:T cell receptor signaling pathway; scaffold62 indexed_genome mRNA 4889339 4917768 . - . ID=transcript_10838;O00329 A6NCG0 G1FFP1 O15445 Q5SR49,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta;, PF00454;PF00792;PF02192;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0016020;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0002250;GO:0007411;GO:0042113;GO:0035754;GO:0050853;GO:0016477;GO:0019221;GO:0006954;GO:0045087;GO:0002551;GO:0043303;GO:0060374;GO:0030101;GO:0035747;GO:0001779;GO:0030593;GO:0072672;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0045766;GO:0030335;GO:0038089;GO:0001819;GO:0010595;GO:0001938;GO:1905278;GO:0010628;GO:0033031;GO:0014068;GO:0051897;GO:0006468;GO:0002679;GO:0007165;GO:0042110;GO:0010818;GO:0030217;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:adaptive immune response; P:axon guidance; P:B cell activation; P:B cell chemotaxis; P:B cell receptor signaling pathway; P:cell migration; P:cytokine-mediated signaling pathway; P:inflammatory response; P:innate immune response; P:mast cell chemotaxis; P:mast cell degranulation; P:mast cell differentiation; P:natural killer cell activation; P:natural killer cell chemotaxis; P:natural killer cell differentiation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cytokine production; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of gene expression; P:positive regulation of neutrophil apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:protein phosphorylation; P:respiratory burst involved in defense response; P:signal transduction; P:T cell activation; P:T cell chemotaxis; P:T cell differentiation; P:T cell receptor signaling pathway;|O00329 A6NCG0 G1FFP1 O15445 Q5SR49,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta;, PF00454;PF00792;PF02192;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0016020;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0002250;GO:0007411;GO:0042113;GO:0035754;GO:0050853;GO:0016477;GO:0019221;GO:0006954;GO:0045087;GO:0002551;GO:0043303;GO:0060374;GO:0030101;GO:0035747;GO:0001779;GO:0030593;GO:0072672;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0045766;GO:0030335;GO:0038089;GO:0001819;GO:0010595;GO:0001938;GO:1905278;GO:0010628;GO:0033031;GO:0014068;GO:0051897;GO:0006468;GO:0002679;GO:0007165;GO:0042110;GO:0010818;GO:0030217;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:adaptive immune response; P:axon guidance; P:B cell activation; P:B cell chemotaxis; P:B cell receptor signaling pathway; P:cell migration; P:cytokine-mediated signaling pathway; P:inflammatory response; P:innate immune response; P:mast cell chemotaxis; P:mast cell degranulation; P:mast cell differentiation; P:natural killer cell activation; P:natural killer cell chemotaxis; P:natural killer cell differentiation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cytokine production; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of gene expression; P:positive regulation of neutrophil apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:protein phosphorylation; P:respiratory burst involved in defense response; P:signal transduction; P:T cell activation; P:T cell chemotaxis; P:T cell differentiation; P:T cell receptor signaling pathway;|O00329 A6NCG0 G1FFP1 O15445 Q5SR49,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform,Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta;, PF00454;PF00792;PF02192;PF00794;PF00613;, GO:0005737;GO:0005829;GO:0016020;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0016301;GO:0035004;GO:0052742;GO:0052812;GO:0046934;GO:0002250;GO:0007411;GO:0042113;GO:0035754;GO:0050853;GO:0016477;GO:0019221;GO:0006954;GO:0045087;GO:0002551;GO:0043303;GO:0060374;GO:0030101;GO:0035747;GO:0001779;GO:0030593;GO:0072672;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0016310;GO:0045766;GO:0030335;GO:0038089;GO:0001819;GO:0010595;GO:0001938;GO:1905278;GO:0010628;GO:0033031;GO:0014068;GO:0051897;GO:0006468;GO:0002679;GO:0007165;GO:0042110;GO:0010818;GO:0030217;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:kinase activity; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:adaptive immune response; P:axon guidance; P:B cell activation; P:B cell chemotaxis; P:B cell receptor signaling pathway; P:cell migration; P:cytokine-mediated signaling pathway; P:inflammatory response; P:innate immune response; P:mast cell chemotaxis; P:mast cell degranulation; P:mast cell differentiation; P:natural killer cell activation; P:natural killer cell chemotaxis; P:natural killer cell differentiation; P:neutrophil chemotaxis; P:neutrophil extravasation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; P:positive regulation of cytokine production; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial tube formation; P:positive regulation of gene expression; P:positive regulation of neutrophil apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:protein phosphorylation; P:respiratory burst involved in defense response; P:signal transduction; P:T cell activation; P:T cell chemotaxis; P:T cell differentiation; P:T cell receptor signaling pathway; scaffold62 indexed_genome mRNA 4981334 4993303 . - . ID=transcript_10839;Q5SNT2 B9EH90 Q5SNT3,Transmembrane protein 201,Spindle-associated membrane protein 1;, PF10476;PF09779;, GO:0005737;GO:0005639;GO:0005635;GO:0031965;GO:0000922;GO:0051015;GO:0005521;GO:0051642;GO:0010761;GO:0006998;GO:0030473;GO:0090435;, C:cytoplasm; C:integral component of nuclear inner membrane; C:nuclear envelope; C:nuclear membrane; C:spindle pole;, F:actin filament binding; F:lamin binding;, P:centrosome localization; P:fibroblast migration; P:nuclear envelope organization; P:nuclear migration along microtubule; P:protein localization to nuclear envelope;|Q5SNT2 B9EH90 Q5SNT3,Transmembrane protein 201,Spindle-associated membrane protein 1;, PF10476;PF09779;, GO:0005737;GO:0005639;GO:0005635;GO:0031965;GO:0000922;GO:0051015;GO:0005521;GO:0051642;GO:0010761;GO:0006998;GO:0030473;GO:0090435;, C:cytoplasm; C:integral component of nuclear inner membrane; C:nuclear envelope; C:nuclear membrane; C:spindle pole;, F:actin filament binding; F:lamin binding;, P:centrosome localization; P:fibroblast migration; P:nuclear envelope organization; P:nuclear migration along microtubule; P:protein localization to nuclear envelope;|Q5SNT2 B9EH90 Q5SNT3,Transmembrane protein 201,Spindle-associated membrane protein 1;, PF10476;PF09779;, GO:0005737;GO:0005639;GO:0005635;GO:0031965;GO:0000922;GO:0051015;GO:0005521;GO:0051642;GO:0010761;GO:0006998;GO:0030473;GO:0090435;, C:cytoplasm; C:integral component of nuclear inner membrane; C:nuclear envelope; C:nuclear membrane; C:spindle pole;, F:actin filament binding; F:lamin binding;, P:centrosome localization; P:fibroblast migration; P:nuclear envelope organization; P:nuclear migration along microtubule; P:protein localization to nuclear envelope; scaffold62 indexed_genome mRNA 5012909 5044945 . - . ID=transcript_10840;Q9BSK2,Solute carrier family 25 member 33,Bone marrow stromal cell mitochondrial carrier protein;Protein PNC1;, PF00153;, GO:0016021;GO:0005743;GO:0031966;GO:0015218;GO:0032869;GO:1990314;GO:0031930;GO:0000002;GO:0034551;GO:0006390;GO:0007005;GO:0030307;GO:0008284;GO:1990519;GO:0006864;GO:0071156;GO:0051881;GO:0002082;GO:1903426;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane;, F:pyrimidine nucleotide transmembrane transporter activity;, P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:mitochondria-nucleus signaling pathway; P:mitochondrial genome maintenance; P:mitochondrial respiratory chain complex III assembly; P:mitochondrial transcription; P:mitochondrion organization; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:pyrimidine nucleotide import into mitochondrion; P:pyrimidine nucleotide transport; P:regulation of cell cycle arrest; P:regulation of mitochondrial membrane potential; P:regulation of oxidative phosphorylation; P:regulation of reactive oxygen species biosynthetic process;|Q9BSK2,Solute carrier family 25 member 33,Bone marrow stromal cell mitochondrial carrier protein;Protein PNC1;, PF00153;, GO:0016021;GO:0005743;GO:0031966;GO:0015218;GO:0032869;GO:1990314;GO:0031930;GO:0000002;GO:0034551;GO:0006390;GO:0007005;GO:0030307;GO:0008284;GO:1990519;GO:0006864;GO:0071156;GO:0051881;GO:0002082;GO:1903426;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane;, F:pyrimidine nucleotide transmembrane transporter activity;, P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:mitochondria-nucleus signaling pathway; P:mitochondrial genome maintenance; P:mitochondrial respiratory chain complex III assembly; P:mitochondrial transcription; P:mitochondrion organization; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:pyrimidine nucleotide import into mitochondrion; P:pyrimidine nucleotide transport; P:regulation of cell cycle arrest; P:regulation of mitochondrial membrane potential; P:regulation of oxidative phosphorylation; P:regulation of reactive oxygen species biosynthetic process;|Q9BSK2,Solute carrier family 25 member 33,Bone marrow stromal cell mitochondrial carrier protein;Protein PNC1;, PF00153;, GO:0016021;GO:0005743;GO:0031966;GO:0015218;GO:0032869;GO:1990314;GO:0031930;GO:0000002;GO:0034551;GO:0006390;GO:0007005;GO:0030307;GO:0008284;GO:1990519;GO:0006864;GO:0071156;GO:0051881;GO:0002082;GO:1903426;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane;, F:pyrimidine nucleotide transmembrane transporter activity;, P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:mitochondria-nucleus signaling pathway; P:mitochondrial genome maintenance; P:mitochondrial respiratory chain complex III assembly; P:mitochondrial transcription; P:mitochondrion organization; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:pyrimidine nucleotide import into mitochondrion; P:pyrimidine nucleotide transport; P:regulation of cell cycle arrest; P:regulation of mitochondrial membrane potential; P:regulation of oxidative phosphorylation; P:regulation of reactive oxygen species biosynthetic process; scaffold62 indexed_genome mRNA 5210353 5220513 . - . ID=transcript_10841;Q96BD6 A2A275 Q59FA1 Q5TIH9 Q9BRY9 Q9H6C5,SPRY domain-containing SOCS box protein 1,, PF07525;PF00622;, GO:0005829;GO:0019005;GO:1990756;GO:0043687;GO:0043161;GO:0000209;GO:0016567;GO:0006511;, C:cytosol; C:SCF ubiquitin ligase complex;, F:ubiquitin ligase-substrate adaptor activity;, P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96BD6 A2A275 Q59FA1 Q5TIH9 Q9BRY9 Q9H6C5,SPRY domain-containing SOCS box protein 1,, PF07525;PF00622;, GO:0005829;GO:0019005;GO:1990756;GO:0043687;GO:0043161;GO:0000209;GO:0016567;GO:0006511;, C:cytosol; C:SCF ubiquitin ligase complex;, F:ubiquitin ligase-substrate adaptor activity;, P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold62 indexed_genome mRNA 5307965 5348147 . + . ID=transcript_10842;O95479 Q4TT33 Q66I35 Q68DT3 R4GMU1,GDH/6PGL endoplasmic bifunctional protein {ECO:0000250|UniProtKB:Q8CFX1},, PF02781;PF00479;PF01182;, GO:0005788;GO:0005739;GO:0017057;GO:0030246;GO:0047934;GO:0047935;GO:0004345;GO:0050661;GO:0006006;GO:0009051;GO:2000064;GO:0097305;, C:endoplasmic reticulum lumen; C:mitochondrion;, F:6-phosphogluconolactonase activity; F:carbohydrate binding; F:glucose 1-dehydrogenase (NAD+) activity; F:glucose 1-dehydrogenase (NADP+) activity; F:glucose-6-phosphate dehydrogenase activity; F:NADP binding;, P:glucose metabolic process; P:pentose-phosphate shunt, oxidative branch; P:regulation of cortisol biosynthetic process; P:response to alcohol;|O95479 Q4TT33 Q66I35 Q68DT3 R4GMU1,GDH/6PGL endoplasmic bifunctional protein {ECO:0000250|UniProtKB:Q8CFX1},, PF02781;PF00479;PF01182;, GO:0005788;GO:0005739;GO:0017057;GO:0030246;GO:0047934;GO:0047935;GO:0004345;GO:0050661;GO:0006006;GO:0009051;GO:2000064;GO:0097305;, C:endoplasmic reticulum lumen; C:mitochondrion;, F:6-phosphogluconolactonase activity; F:carbohydrate binding; F:glucose 1-dehydrogenase (NAD+) activity; F:glucose 1-dehydrogenase (NADP+) activity; F:glucose-6-phosphate dehydrogenase activity; F:NADP binding;, P:glucose metabolic process; P:pentose-phosphate shunt, oxidative branch; P:regulation of cortisol biosynthetic process; P:response to alcohol; scaffold62 indexed_genome mRNA 5422164 5424917 . - . ID=transcript_10843;P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription; scaffold62 indexed_genome mRNA 5438194 5460328 . - . ID=transcript_10844;Q5UAW9 A2A334 Q8WWB8 Q9HA73,G-protein coupled receptor 157,, PF00002;, GO:0060170;GO:0016021;GO:0004930;GO:0007166;GO:0048512;GO:0007186;GO:0051482;GO:0060019;, C:ciliary membrane; C:integral component of membrane;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:circadian behavior; P:G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:radial glial cell differentiation;|Q5UAW9 A2A334 Q8WWB8 Q9HA73,G-protein coupled receptor 157,, PF00002;, GO:0060170;GO:0016021;GO:0004930;GO:0007166;GO:0048512;GO:0007186;GO:0051482;GO:0060019;, C:ciliary membrane; C:integral component of membrane;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:circadian behavior; P:G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:radial glial cell differentiation;|Q5UAW9 A2A334 Q8WWB8 Q9HA73,G-protein coupled receptor 157,, PF00002;, GO:0060170;GO:0016021;GO:0004930;GO:0007166;GO:0048512;GO:0007186;GO:0051482;GO:0060019;, C:ciliary membrane; C:integral component of membrane;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:circadian behavior; P:G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:radial glial cell differentiation; scaffold62 indexed_genome mRNA 5484530 5512380 . + . ID=transcript_10845;P22732 Q14770 Q5T977 Q8IVB3,Solute carrier family 2, facilitated glucose transporter member 5 {ECO:0000305},Fructose transporter {ECO:0000305};Glucose transporter type 5, small intestine {ECO:0000303|PubMed:1695905};, PF00083;, GO:0016324;GO:0070062;GO:0005887;GO:0005886;GO:0042383;GO:0035579;GO:0070061;GO:0005353;GO:0005355;GO:0005975;GO:0071332;GO:1990539;GO:0015755;GO:1904659;GO:0106001;GO:0043312;GO:0003044;GO:0009750;, C:apical plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:sarcolemma; C:specific granule membrane;, F:fructose binding; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:cellular response to fructose stimulus; P:fructose import across plasma membrane; P:fructose transmembrane transport; P:glucose transmembrane transport; P:intestinal hexose absorption; P:neutrophil degranulation; P:regulation of systemic arterial blood pressure mediated by a chemical signal; P:response to fructose;|P22732 Q14770 Q5T977 Q8IVB3,Solute carrier family 2, facilitated glucose transporter member 5 {ECO:0000305},Fructose transporter {ECO:0000305};Glucose transporter type 5, small intestine {ECO:0000303|PubMed:1695905};, PF00083;, GO:0016324;GO:0070062;GO:0005887;GO:0005886;GO:0042383;GO:0035579;GO:0070061;GO:0005353;GO:0005355;GO:0005975;GO:0071332;GO:1990539;GO:0015755;GO:1904659;GO:0106001;GO:0043312;GO:0003044;GO:0009750;, C:apical plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane; C:sarcolemma; C:specific granule membrane;, F:fructose binding; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:cellular response to fructose stimulus; P:fructose import across plasma membrane; P:fructose transmembrane transport; P:glucose transmembrane transport; P:intestinal hexose absorption; P:neutrophil degranulation; P:regulation of systemic arterial blood pressure mediated by a chemical signal; P:response to fructose; scaffold62 indexed_genome mRNA 5646967 5660900 . + . ID=transcript_10846;Q71V37 Q7Z3V6 Q8WU71 Q96GV1 Q9BT62 Q9UCH6 Q9UM55,Alpha-enolase,2-phospho-D-glycerate hydro-lyase;C-myc promoter-binding protein;Enolase 1;MBP-1;MPB-1;Non-neural enolase;Phosphopyruvate hydratase;Plasminogen-binding protein;, PF00113;PF03952;, GO:0099738;GO:0009986;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0031430;GO:0016020;GO:0005634;GO:0000015;GO:0005886;GO:0045296;GO:0001227;GO:0051020;GO:0000287;GO:0004634;GO:0042803;GO:0003723;GO:0000977;GO:0061621;GO:0006094;GO:0006096;GO:0044003;GO:0030308;GO:1903298;GO:0000122;GO:0045892;GO:2001171;GO:0045933;GO:0010756;GO:0032889;GO:0009615;, C:cell cortex region; C:cell surface; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:M band; C:membrane; C:nucleus; C:phosphopyruvate hydratase complex; C:plasma membrane;, F:cadherin binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:GTPase binding; F:magnesium ion binding; F:phosphopyruvate hydratase activity; F:protein homodimerization activity; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:modulation by symbiont of host process; P:negative regulation of cell growth; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of ATP biosynthetic process; P:positive regulation of muscle contraction; P:positive regulation of plasminogen activation; P:regulation of vacuole fusion, non-autophagic; P:response to virus;|Q71V37 Q7Z3V6 Q8WU71 Q96GV1 Q9BT62 Q9UCH6 Q9UM55,Alpha-enolase,2-phospho-D-glycerate hydro-lyase;C-myc promoter-binding protein;Enolase 1;MBP-1;MPB-1;Non-neural enolase;Phosphopyruvate hydratase;Plasminogen-binding protein;, PF00113;PF03952;, GO:0099738;GO:0009986;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0031430;GO:0016020;GO:0005634;GO:0000015;GO:0005886;GO:0045296;GO:0001227;GO:0051020;GO:0000287;GO:0004634;GO:0042803;GO:0003723;GO:0000977;GO:0061621;GO:0006094;GO:0006096;GO:0044003;GO:0030308;GO:1903298;GO:0000122;GO:0045892;GO:2001171;GO:0045933;GO:0010756;GO:0032889;GO:0009615;, C:cell cortex region; C:cell surface; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:M band; C:membrane; C:nucleus; C:phosphopyruvate hydratase complex; C:plasma membrane;, F:cadherin binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:GTPase binding; F:magnesium ion binding; F:phosphopyruvate hydratase activity; F:protein homodimerization activity; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:modulation by symbiont of host process; P:negative regulation of cell growth; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of ATP biosynthetic process; P:positive regulation of muscle contraction; P:positive regulation of plasminogen activation; P:regulation of vacuole fusion, non-autophagic; P:response to virus;|Q71V37 Q7Z3V6 Q8WU71 Q96GV1 Q9BT62 Q9UCH6 Q9UM55,Alpha-enolase,2-phospho-D-glycerate hydro-lyase;C-myc promoter-binding protein;Enolase 1;MBP-1;MPB-1;Non-neural enolase;Phosphopyruvate hydratase;Plasminogen-binding protein;, PF00113;PF03952;, GO:0099738;GO:0009986;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0031430;GO:0016020;GO:0005634;GO:0000015;GO:0005886;GO:0045296;GO:0001227;GO:0051020;GO:0000287;GO:0004634;GO:0042803;GO:0003723;GO:0000977;GO:0061621;GO:0006094;GO:0006096;GO:0044003;GO:0030308;GO:1903298;GO:0000122;GO:0045892;GO:2001171;GO:0045933;GO:0010756;GO:0032889;GO:0009615;, C:cell cortex region; C:cell surface; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:M band; C:membrane; C:nucleus; C:phosphopyruvate hydratase complex; C:plasma membrane;, F:cadherin binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:GTPase binding; F:magnesium ion binding; F:phosphopyruvate hydratase activity; F:protein homodimerization activity; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:modulation by symbiont of host process; P:negative regulation of cell growth; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of ATP biosynthetic process; P:positive regulation of muscle contraction; P:positive regulation of plasminogen activation; P:regulation of vacuole fusion, non-autophagic; P:response to virus;|Q71V37 Q7Z3V6 Q8WU71 Q96GV1 Q9BT62 Q9UCH6 Q9UM55,Alpha-enolase,2-phospho-D-glycerate hydro-lyase;C-myc promoter-binding protein;Enolase 1;MBP-1;MPB-1;Non-neural enolase;Phosphopyruvate hydratase;Plasminogen-binding protein;, PF00113;PF03952;, GO:0099738;GO:0009986;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0031430;GO:0016020;GO:0005634;GO:0000015;GO:0005886;GO:0045296;GO:0001227;GO:0051020;GO:0000287;GO:0004634;GO:0042803;GO:0003723;GO:0000977;GO:0061621;GO:0006094;GO:0006096;GO:0044003;GO:0030308;GO:1903298;GO:0000122;GO:0045892;GO:2001171;GO:0045933;GO:0010756;GO:0032889;GO:0009615;, C:cell cortex region; C:cell surface; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:M band; C:membrane; C:nucleus; C:phosphopyruvate hydratase complex; C:plasma membrane;, F:cadherin binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:GTPase binding; F:magnesium ion binding; F:phosphopyruvate hydratase activity; F:protein homodimerization activity; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:modulation by symbiont of host process; P:negative regulation of cell growth; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of ATP biosynthetic process; P:positive regulation of muscle contraction; P:positive regulation of plasminogen activation; P:regulation of vacuole fusion, non-autophagic; P:response to virus;|Q71V37 Q7Z3V6 Q8WU71 Q96GV1 Q9BT62 Q9UCH6 Q9UM55,Alpha-enolase,2-phospho-D-glycerate hydro-lyase;C-myc promoter-binding protein;Enolase 1;MBP-1;MPB-1;Non-neural enolase;Phosphopyruvate hydratase;Plasminogen-binding protein;, PF00113;PF03952;, GO:0099738;GO:0009986;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0031430;GO:0016020;GO:0005634;GO:0000015;GO:0005886;GO:0045296;GO:0001227;GO:0051020;GO:0000287;GO:0004634;GO:0042803;GO:0003723;GO:0000977;GO:0061621;GO:0006094;GO:0006096;GO:0044003;GO:0030308;GO:1903298;GO:0000122;GO:0045892;GO:2001171;GO:0045933;GO:0010756;GO:0032889;GO:0009615;, C:cell cortex region; C:cell surface; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:M band; C:membrane; C:nucleus; C:phosphopyruvate hydratase complex; C:plasma membrane;, F:cadherin binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:GTPase binding; F:magnesium ion binding; F:phosphopyruvate hydratase activity; F:protein homodimerization activity; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:modulation by symbiont of host process; P:negative regulation of cell growth; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of ATP biosynthetic process; P:positive regulation of muscle contraction; P:positive regulation of plasminogen activation; P:regulation of vacuole fusion, non-autophagic; P:response to virus; scaffold62 indexed_genome mRNA 5720429 6140371 . + . ID=transcript_10847;Q9P2R6 O43393 O75046 O75359 Q5VXL9 Q6P6B9 Q9Y2W4,Arginine-glutamic acid dipeptide repeats protein,Atrophin-1-like protein;Atrophin-1-related protein;, PF03154;PF01426;PF01448;PF00320;, GO:0000118;GO:0005634;GO:0003682;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0048755;GO:0021930;GO:0021691;GO:0006338;GO:0048813;GO:0021942;, C:histone deacetylase complex; C:nucleus;, F:chromatin binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:branching morphogenesis of a nerve; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell layer maturation; P:chromatin remodeling; P:dendrite morphogenesis; P:radial glia guided migration of Purkinje cell;|Q9P2R6 O43393 O75046 O75359 Q5VXL9 Q6P6B9 Q9Y2W4,Arginine-glutamic acid dipeptide repeats protein,Atrophin-1-like protein;Atrophin-1-related protein;, PF03154;PF01426;PF01448;PF00320;, GO:0000118;GO:0005634;GO:0003682;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0048755;GO:0021930;GO:0021691;GO:0006338;GO:0048813;GO:0021942;, C:histone deacetylase complex; C:nucleus;, F:chromatin binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:branching morphogenesis of a nerve; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell layer maturation; P:chromatin remodeling; P:dendrite morphogenesis; P:radial glia guided migration of Purkinje cell;|Q9P2R6 O43393 O75046 O75359 Q5VXL9 Q6P6B9 Q9Y2W4,Arginine-glutamic acid dipeptide repeats protein,Atrophin-1-like protein;Atrophin-1-related protein;, PF03154;PF01426;PF01448;PF00320;, GO:0000118;GO:0005634;GO:0003682;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0048755;GO:0021930;GO:0021691;GO:0006338;GO:0048813;GO:0021942;, C:histone deacetylase complex; C:nucleus;, F:chromatin binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:branching morphogenesis of a nerve; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell layer maturation; P:chromatin remodeling; P:dendrite morphogenesis; P:radial glia guided migration of Purkinje cell;|Q9P2R6 O43393 O75046 O75359 Q5VXL9 Q6P6B9 Q9Y2W4,Arginine-glutamic acid dipeptide repeats protein,Atrophin-1-like protein;Atrophin-1-related protein;, PF03154;PF01426;PF01448;PF00320;, GO:0000118;GO:0005634;GO:0003682;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0048755;GO:0021930;GO:0021691;GO:0006338;GO:0048813;GO:0021942;, C:histone deacetylase complex; C:nucleus;, F:chromatin binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:branching morphogenesis of a nerve; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell layer maturation; P:chromatin remodeling; P:dendrite morphogenesis; P:radial glia guided migration of Purkinje cell;|Q9P2R6 O43393 O75046 O75359 Q5VXL9 Q6P6B9 Q9Y2W4,Arginine-glutamic acid dipeptide repeats protein,Atrophin-1-like protein;Atrophin-1-related protein;, PF03154;PF01426;PF01448;PF00320;, GO:0000118;GO:0005634;GO:0003682;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0048755;GO:0021930;GO:0021691;GO:0006338;GO:0048813;GO:0021942;, C:histone deacetylase complex; C:nucleus;, F:chromatin binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:branching morphogenesis of a nerve; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell layer maturation; P:chromatin remodeling; P:dendrite morphogenesis; P:radial glia guided migration of Purkinje cell;|Q9P2R6 O43393 O75046 O75359 Q5VXL9 Q6P6B9 Q9Y2W4,Arginine-glutamic acid dipeptide repeats protein,Atrophin-1-like protein;Atrophin-1-related protein;, PF03154;PF01426;PF01448;PF00320;, GO:0000118;GO:0005634;GO:0003682;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0048755;GO:0021930;GO:0021691;GO:0006338;GO:0048813;GO:0021942;, C:histone deacetylase complex; C:nucleus;, F:chromatin binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:branching morphogenesis of a nerve; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell layer maturation; P:chromatin remodeling; P:dendrite morphogenesis; P:radial glia guided migration of Purkinje cell;|Q9P2R6 O43393 O75046 O75359 Q5VXL9 Q6P6B9 Q9Y2W4,Arginine-glutamic acid dipeptide repeats protein,Atrophin-1-like protein;Atrophin-1-related protein;, PF03154;PF01426;PF01448;PF00320;, GO:0000118;GO:0005634;GO:0003682;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0048755;GO:0021930;GO:0021691;GO:0006338;GO:0048813;GO:0021942;, C:histone deacetylase complex; C:nucleus;, F:chromatin binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:branching morphogenesis of a nerve; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell layer maturation; P:chromatin remodeling; P:dendrite morphogenesis; P:radial glia guided migration of Purkinje cell;|Q9P2R6 O43393 O75046 O75359 Q5VXL9 Q6P6B9 Q9Y2W4,Arginine-glutamic acid dipeptide repeats protein,Atrophin-1-like protein;Atrophin-1-related protein;, PF03154;PF01426;PF01448;PF00320;, GO:0000118;GO:0005634;GO:0003682;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0048755;GO:0021930;GO:0021691;GO:0006338;GO:0048813;GO:0021942;, C:histone deacetylase complex; C:nucleus;, F:chromatin binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:branching morphogenesis of a nerve; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell layer maturation; P:chromatin remodeling; P:dendrite morphogenesis; P:radial glia guided migration of Purkinje cell;|Q9P2R6 O43393 O75046 O75359 Q5VXL9 Q6P6B9 Q9Y2W4,Arginine-glutamic acid dipeptide repeats protein,Atrophin-1-like protein;Atrophin-1-related protein;, PF03154;PF01426;PF01448;PF00320;, GO:0000118;GO:0005634;GO:0003682;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0048755;GO:0021930;GO:0021691;GO:0006338;GO:0048813;GO:0021942;, C:histone deacetylase complex; C:nucleus;, F:chromatin binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:branching morphogenesis of a nerve; P:cerebellar granule cell precursor proliferation; P:cerebellar Purkinje cell layer maturation; P:chromatin remodeling; P:dendrite morphogenesis; P:radial glia guided migration of Purkinje cell; scaffold62 indexed_genome mRNA 6142581 6204292 . - . ID=transcript_10848;Q9Y2W3 A0A0A0MT80 Q5VY46 Q5VY49,Proton-associated sugar transporter A,Deleted in neuroblastoma 5 protein;Solute carrier family 45 member 1;, PF07690;, GO:0016021;GO:0016020;GO:0008506;GO:1904659;, C:integral component of membrane; C:membrane;, F:sucrose:proton symporter activity;, P:glucose transmembrane transport;|Q9Y2W3 A0A0A0MT80 Q5VY46 Q5VY49,Proton-associated sugar transporter A,Deleted in neuroblastoma 5 protein;Solute carrier family 45 member 1;, PF07690;, GO:0016021;GO:0016020;GO:0008506;GO:1904659;, C:integral component of membrane; C:membrane;, F:sucrose:proton symporter activity;, P:glucose transmembrane transport;|Q9Y2W3 A0A0A0MT80 Q5VY46 Q5VY49,Proton-associated sugar transporter A,Deleted in neuroblastoma 5 protein;Solute carrier family 45 member 1;, PF07690;, GO:0016021;GO:0016020;GO:0008506;GO:1904659;, C:integral component of membrane; C:membrane;, F:sucrose:proton symporter activity;, P:glucose transmembrane transport;|Q9Y2W3 A0A0A0MT80 Q5VY46 Q5VY49,Proton-associated sugar transporter A,Deleted in neuroblastoma 5 protein;Solute carrier family 45 member 1;, PF07690;, GO:0016021;GO:0016020;GO:0008506;GO:1904659;, C:integral component of membrane; C:membrane;, F:sucrose:proton symporter activity;, P:glucose transmembrane transport;|Q9Y2W3 A0A0A0MT80 Q5VY46 Q5VY49,Proton-associated sugar transporter A,Deleted in neuroblastoma 5 protein;Solute carrier family 45 member 1;, PF07690;, GO:0016021;GO:0016020;GO:0008506;GO:1904659;, C:integral component of membrane; C:membrane;, F:sucrose:proton symporter activity;, P:glucose transmembrane transport; scaffold62 indexed_genome mRNA 6450282 6455139 . + . ID=transcript_10849;Q9UJM3 B2RDX9 Q9NTG9 Q9UD05,ERBB receptor feedback inhibitor 1,Mitogen-inducible gene 6 protein;, PF09027;PF11555;, GO:0005737;GO:0005829;GO:0031234;GO:0005634;GO:0005096;GO:0019901;GO:0017124;GO:0031267;GO:0071474;GO:0071549;GO:0071364;GO:0032869;GO:0036120;GO:0048286;GO:0060428;GO:0060426;GO:1903243;GO:0032966;GO:0042059;GO:0007175;GO:0070373;GO:0032691;GO:0031953;GO:0045616;GO:0061469;GO:0043589;, C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleus;, F:GTPase activator activity; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:cellular hyperosmotic response; P:cellular response to dexamethasone stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:lung alveolus development; P:lung epithelium development; P:lung vasculature development; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of collagen biosynthetic process; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-1 beta production; P:negative regulation of protein autophosphorylation; P:regulation of keratinocyte differentiation; P:regulation of type B pancreatic cell proliferation; P:skin morphogenesis;|Q9UJM3 B2RDX9 Q9NTG9 Q9UD05,ERBB receptor feedback inhibitor 1,Mitogen-inducible gene 6 protein;, PF09027;PF11555;, GO:0005737;GO:0005829;GO:0031234;GO:0005634;GO:0005096;GO:0019901;GO:0017124;GO:0031267;GO:0071474;GO:0071549;GO:0071364;GO:0032869;GO:0036120;GO:0048286;GO:0060428;GO:0060426;GO:1903243;GO:0032966;GO:0042059;GO:0007175;GO:0070373;GO:0032691;GO:0031953;GO:0045616;GO:0061469;GO:0043589;, C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleus;, F:GTPase activator activity; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:cellular hyperosmotic response; P:cellular response to dexamethasone stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:lung alveolus development; P:lung epithelium development; P:lung vasculature development; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of collagen biosynthetic process; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-1 beta production; P:negative regulation of protein autophosphorylation; P:regulation of keratinocyte differentiation; P:regulation of type B pancreatic cell proliferation; P:skin morphogenesis; scaffold62 indexed_genome mRNA 6491599 6506423 . - . ID=transcript_10850;Q99497 B2R4Z1 O14805 Q6DR95 Q7LFU2,Parkinson disease protein 7 {ECO:0000305},Maillard deglycase {ECO:0000303|PubMed:28596309};Oncogene DJ1 {ECO:0000305};Parkinsonism-associated deglycase {ECO:0000312|HGNC:HGNC:16369};Protein DJ-1 {ECO:0000305};Protein/nucleic acid deglycase DJ-1 {ECO:0000305|PubMed:25416785, ECO:0000305|PubMed:28596309};, PF01965;, GO:0005912;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0045121;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0016605;GO:0098793;GO:0050681;GO:0045296;GO:0005507;GO:1903135;GO:1903136;GO:0019955;GO:0019899;GO:1990422;GO:0042802;GO:0019900;GO:0036478;GO:0045340;GO:0003729;GO:0016684;GO:0019826;GO:0008233;GO:0051920;GO:0036524;GO:0042803;GO:0044877;GO:0070491;GO:0097110;GO:0005102;GO:0044388;GO:0016532;GO:0003713;GO:0008134;GO:0036470;GO:0044390;GO:1990381;GO:0032148;GO:0008344;GO:0035973;GO:0110095;GO:0140041;GO:0036471;GO:0070301;GO:0034599;GO:0070994;GO:0010273;GO:0050787;GO:0006281;GO:0051583;GO:0042593;GO:0036531;GO:0046295;GO:1903189;GO:0106044;GO:0106046;GO:0106045;GO:0016570;GO:0042743;GO:0006954;GO:0030073;GO:0019249;GO:0051899;GO:0060081;GO:0061727;GO:0009438;GO:0007005;GO:0043066;GO:0060548;GO:2001268;GO:1903073;GO:1902236;GO:2001237;GO:0010629;GO:1903206;GO:1903208;GO:1903384;GO:0043524;GO:1901215;GO:1905259;GO:1903202;GO:1903377;GO:0032435;GO:1901984;GO:0032091;GO:0046826;GO:1903094;GO:0006469;GO:0001933;GO:0033234;GO:0031397;GO:1903427;GO:1903122;GO:0051444;GO:2000157;GO:0036527;GO:0036526;GO:0036528;GO:0002866;GO:2000825;GO:1903599;GO:0051091;GO:1903181;GO:0010628;GO:0032757;GO:1903197;GO:1903200;GO:1902958;GO:0033864;GO:2000277;GO:1902177;GO:0033138;GO:0051897;GO:1900182;GO:0031334;GO:1903168;GO:1903428;GO:1901671;GO:0045944;GO:2000679;GO:1903178;GO:0036529;GO:0036530;GO:0006517;GO:0050821;GO:0007265;GO:0060765;GO:0035065;GO:0033182;GO:0050727;GO:0051881;GO:0043523;GO:1902903;GO:0007338;, C:adherens junction; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:membrane raft; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:PML body; C:presynapse;, F:androgen receptor binding; F:cadherin binding; F:copper ion binding; F:cupric ion binding; F:cuprous ion binding; F:cytokine binding; F:enzyme binding; F:glyoxalase (glycolic acid-forming) activity; F:identical protein binding; F:kinase binding; F:L-dopa decarboxylase activator activity; F:mercury ion binding; F:mRNA binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:oxygen sensor activity; F:peptidase activity; F:peroxiredoxin activity; F:protein deglycase activity; F:protein homodimerization activity; F:protein-containing complex binding; F:repressing transcription factor binding; F:scaffold protein binding; F:signaling receptor binding; F:small protein activating enzyme binding; F:superoxide dismutase copper chaperone activity; F:transcription coactivator activity; F:transcription factor binding; F:tyrosine 3-monooxygenase activator activity; F:ubiquitin-like protein conjugating enzyme binding; F:ubiquitin-specific protease binding;, P:activation of protein kinase B activity; P:adult locomotory behavior; P:aggrephagy; P:cellular detoxification of aldehyde; P:cellular detoxification of methylglyoxal; P:cellular response to glyoxal; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:detection of oxidative stress; P:detoxification of copper ion; P:detoxification of mercury ion; P:DNA repair; P:dopamine uptake involved in synaptic transmission; P:glucose homeostasis; P:glutathione deglycation; P:glycolate biosynthetic process; P:glyoxal metabolic process; P:guanine deglycation; P:guanine deglycation, glyoxal removal; P:guanine deglycation, methylglyoxal removal; P:histone modification; P:hydrogen peroxide metabolic process; P:inflammatory response; P:insulin secretion; P:lactate biosynthetic process; P:membrane depolarization; P:membrane hyperpolarization; P:methylglyoxal catabolic process to lactate; P:methylglyoxal metabolic process; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of death-inducing signaling complex assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein acetylation; P:negative regulation of protein binding; P:negative regulation of protein export from nucleus; P:negative regulation of protein K48-linked deubiquitination; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of reactive oxygen species biosynthetic process; P:negative regulation of TRAIL-activated apoptotic signaling pathway; P:negative regulation of ubiquitin-protein transferase activity; P:negative regulation of ubiquitin-specific protease activity; P:peptidyl-arginine deglycation; P:peptidyl-cysteine deglycation; P:peptidyl-lysine deglycation; P:positive regulation of acute inflammatory response to antigenic stimulus; P:positive regulation of androgen receptor activity; P:positive regulation of autophagy of mitochondrion; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine biosynthetic process; P:positive regulation of gene expression; P:positive regulation of interleukin-8 production; P:positive regulation of L-dopa biosynthetic process; P:positive regulation of L-dopa decarboxylase activity; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of oxidative phosphorylation uncoupler activity; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein-containing complex assembly; P:positive regulation of pyrroline-5-carboxylate reductase activity; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of superoxide dismutase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of tyrosine 3-monooxygenase activity; P:protein deglycation, glyoxal removal; P:protein deglycation, methylglyoxal removal; P:protein deglycosylation; P:protein stabilization; P:Ras protein signal transduction; P:regulation of androgen receptor signaling pathway; P:regulation of histone acetylation; P:regulation of histone ubiquitination; P:regulation of inflammatory response; P:regulation of mitochondrial membrane potential; P:regulation of neuron apoptotic process; P:regulation of supramolecular fiber organization; P:single fertilization;|Q99497 B2R4Z1 O14805 Q6DR95 Q7LFU2,Parkinson disease protein 7 {ECO:0000305},Maillard deglycase {ECO:0000303|PubMed:28596309};Oncogene DJ1 {ECO:0000305};Parkinsonism-associated deglycase {ECO:0000312|HGNC:HGNC:16369};Protein DJ-1 {ECO:0000305};Protein/nucleic acid deglycase DJ-1 {ECO:0000305|PubMed:25416785, ECO:0000305|PubMed:28596309};, PF01965;, GO:0005912;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0045121;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0016605;GO:0098793;GO:0050681;GO:0045296;GO:0005507;GO:1903135;GO:1903136;GO:0019955;GO:0019899;GO:1990422;GO:0042802;GO:0019900;GO:0036478;GO:0045340;GO:0003729;GO:0016684;GO:0019826;GO:0008233;GO:0051920;GO:0036524;GO:0042803;GO:0044877;GO:0070491;GO:0097110;GO:0005102;GO:0044388;GO:0016532;GO:0003713;GO:0008134;GO:0036470;GO:0044390;GO:1990381;GO:0032148;GO:0008344;GO:0035973;GO:0110095;GO:0140041;GO:0036471;GO:0070301;GO:0034599;GO:0070994;GO:0010273;GO:0050787;GO:0006281;GO:0051583;GO:0042593;GO:0036531;GO:0046295;GO:1903189;GO:0106044;GO:0106046;GO:0106045;GO:0016570;GO:0042743;GO:0006954;GO:0030073;GO:0019249;GO:0051899;GO:0060081;GO:0061727;GO:0009438;GO:0007005;GO:0043066;GO:0060548;GO:2001268;GO:1903073;GO:1902236;GO:2001237;GO:0010629;GO:1903206;GO:1903208;GO:1903384;GO:0043524;GO:1901215;GO:1905259;GO:1903202;GO:1903377;GO:0032435;GO:1901984;GO:0032091;GO:0046826;GO:1903094;GO:0006469;GO:0001933;GO:0033234;GO:0031397;GO:1903427;GO:1903122;GO:0051444;GO:2000157;GO:0036527;GO:0036526;GO:0036528;GO:0002866;GO:2000825;GO:1903599;GO:0051091;GO:1903181;GO:0010628;GO:0032757;GO:1903197;GO:1903200;GO:1902958;GO:0033864;GO:2000277;GO:1902177;GO:0033138;GO:0051897;GO:1900182;GO:0031334;GO:1903168;GO:1903428;GO:1901671;GO:0045944;GO:2000679;GO:1903178;GO:0036529;GO:0036530;GO:0006517;GO:0050821;GO:0007265;GO:0060765;GO:0035065;GO:0033182;GO:0050727;GO:0051881;GO:0043523;GO:1902903;GO:0007338;, C:adherens junction; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:membrane raft; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:PML body; C:presynapse;, F:androgen receptor binding; F:cadherin binding; F:copper ion binding; F:cupric ion binding; F:cuprous ion binding; F:cytokine binding; F:enzyme binding; F:glyoxalase (glycolic acid-forming) activity; F:identical protein binding; F:kinase binding; F:L-dopa decarboxylase activator activity; F:mercury ion binding; F:mRNA binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:oxygen sensor activity; F:peptidase activity; F:peroxiredoxin activity; F:protein deglycase activity; F:protein homodimerization activity; F:protein-containing complex binding; F:repressing transcription factor binding; F:scaffold protein binding; F:signaling receptor binding; F:small protein activating enzyme binding; F:superoxide dismutase copper chaperone activity; F:transcription coactivator activity; F:transcription factor binding; F:tyrosine 3-monooxygenase activator activity; F:ubiquitin-like protein conjugating enzyme binding; F:ubiquitin-specific protease binding;, P:activation of protein kinase B activity; P:adult locomotory behavior; P:aggrephagy; P:cellular detoxification of aldehyde; P:cellular detoxification of methylglyoxal; P:cellular response to glyoxal; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:detection of oxidative stress; P:detoxification of copper ion; P:detoxification of mercury ion; P:DNA repair; P:dopamine uptake involved in synaptic transmission; P:glucose homeostasis; P:glutathione deglycation; P:glycolate biosynthetic process; P:glyoxal metabolic process; P:guanine deglycation; P:guanine deglycation, glyoxal removal; P:guanine deglycation, methylglyoxal removal; P:histone modification; P:hydrogen peroxide metabolic process; P:inflammatory response; P:insulin secretion; P:lactate biosynthetic process; P:membrane depolarization; P:membrane hyperpolarization; P:methylglyoxal catabolic process to lactate; P:methylglyoxal metabolic process; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of death-inducing signaling complex assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein acetylation; P:negative regulation of protein binding; P:negative regulation of protein export from nucleus; P:negative regulation of protein K48-linked deubiquitination; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of reactive oxygen species biosynthetic process; P:negative regulation of TRAIL-activated apoptotic signaling pathway; P:negative regulation of ubiquitin-protein transferase activity; P:negative regulation of ubiquitin-specific protease activity; P:peptidyl-arginine deglycation; P:peptidyl-cysteine deglycation; P:peptidyl-lysine deglycation; P:positive regulation of acute inflammatory response to antigenic stimulus; P:positive regulation of androgen receptor activity; P:positive regulation of autophagy of mitochondrion; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine biosynthetic process; P:positive regulation of gene expression; P:positive regulation of interleukin-8 production; P:positive regulation of L-dopa biosynthetic process; P:positive regulation of L-dopa decarboxylase activity; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of oxidative phosphorylation uncoupler activity; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein-containing complex assembly; P:positive regulation of pyrroline-5-carboxylate reductase activity; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of superoxide dismutase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of tyrosine 3-monooxygenase activity; P:protein deglycation, glyoxal removal; P:protein deglycation, methylglyoxal removal; P:protein deglycosylation; P:protein stabilization; P:Ras protein signal transduction; P:regulation of androgen receptor signaling pathway; P:regulation of histone acetylation; P:regulation of histone ubiquitination; P:regulation of inflammatory response; P:regulation of mitochondrial membrane potential; P:regulation of neuron apoptotic process; P:regulation of supramolecular fiber organization; P:single fertilization;|Q99497 B2R4Z1 O14805 Q6DR95 Q7LFU2,Parkinson disease protein 7 {ECO:0000305},Maillard deglycase {ECO:0000303|PubMed:28596309};Oncogene DJ1 {ECO:0000305};Parkinsonism-associated deglycase {ECO:0000312|HGNC:HGNC:16369};Protein DJ-1 {ECO:0000305};Protein/nucleic acid deglycase DJ-1 {ECO:0000305|PubMed:25416785, ECO:0000305|PubMed:28596309};, PF01965;, GO:0005912;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0045121;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0016605;GO:0098793;GO:0050681;GO:0045296;GO:0005507;GO:1903135;GO:1903136;GO:0019955;GO:0019899;GO:1990422;GO:0042802;GO:0019900;GO:0036478;GO:0045340;GO:0003729;GO:0016684;GO:0019826;GO:0008233;GO:0051920;GO:0036524;GO:0042803;GO:0044877;GO:0070491;GO:0097110;GO:0005102;GO:0044388;GO:0016532;GO:0003713;GO:0008134;GO:0036470;GO:0044390;GO:1990381;GO:0032148;GO:0008344;GO:0035973;GO:0110095;GO:0140041;GO:0036471;GO:0070301;GO:0034599;GO:0070994;GO:0010273;GO:0050787;GO:0006281;GO:0051583;GO:0042593;GO:0036531;GO:0046295;GO:1903189;GO:0106044;GO:0106046;GO:0106045;GO:0016570;GO:0042743;GO:0006954;GO:0030073;GO:0019249;GO:0051899;GO:0060081;GO:0061727;GO:0009438;GO:0007005;GO:0043066;GO:0060548;GO:2001268;GO:1903073;GO:1902236;GO:2001237;GO:0010629;GO:1903206;GO:1903208;GO:1903384;GO:0043524;GO:1901215;GO:1905259;GO:1903202;GO:1903377;GO:0032435;GO:1901984;GO:0032091;GO:0046826;GO:1903094;GO:0006469;GO:0001933;GO:0033234;GO:0031397;GO:1903427;GO:1903122;GO:0051444;GO:2000157;GO:0036527;GO:0036526;GO:0036528;GO:0002866;GO:2000825;GO:1903599;GO:0051091;GO:1903181;GO:0010628;GO:0032757;GO:1903197;GO:1903200;GO:1902958;GO:0033864;GO:2000277;GO:1902177;GO:0033138;GO:0051897;GO:1900182;GO:0031334;GO:1903168;GO:1903428;GO:1901671;GO:0045944;GO:2000679;GO:1903178;GO:0036529;GO:0036530;GO:0006517;GO:0050821;GO:0007265;GO:0060765;GO:0035065;GO:0033182;GO:0050727;GO:0051881;GO:0043523;GO:1902903;GO:0007338;, C:adherens junction; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:membrane raft; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:PML body; C:presynapse;, F:androgen receptor binding; F:cadherin binding; F:copper ion binding; F:cupric ion binding; F:cuprous ion binding; F:cytokine binding; F:enzyme binding; F:glyoxalase (glycolic acid-forming) activity; F:identical protein binding; F:kinase binding; F:L-dopa decarboxylase activator activity; F:mercury ion binding; F:mRNA binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:oxygen sensor activity; F:peptidase activity; F:peroxiredoxin activity; F:protein deglycase activity; F:protein homodimerization activity; F:protein-containing complex binding; F:repressing transcription factor binding; F:scaffold protein binding; F:signaling receptor binding; F:small protein activating enzyme binding; F:superoxide dismutase copper chaperone activity; F:transcription coactivator activity; F:transcription factor binding; F:tyrosine 3-monooxygenase activator activity; F:ubiquitin-like protein conjugating enzyme binding; F:ubiquitin-specific protease binding;, P:activation of protein kinase B activity; P:adult locomotory behavior; P:aggrephagy; P:cellular detoxification of aldehyde; P:cellular detoxification of methylglyoxal; P:cellular response to glyoxal; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:detection of oxidative stress; P:detoxification of copper ion; P:detoxification of mercury ion; P:DNA repair; P:dopamine uptake involved in synaptic transmission; P:glucose homeostasis; P:glutathione deglycation; P:glycolate biosynthetic process; P:glyoxal metabolic process; P:guanine deglycation; P:guanine deglycation, glyoxal removal; P:guanine deglycation, methylglyoxal removal; P:histone modification; P:hydrogen peroxide metabolic process; P:inflammatory response; P:insulin secretion; P:lactate biosynthetic process; P:membrane depolarization; P:membrane hyperpolarization; P:methylglyoxal catabolic process to lactate; P:methylglyoxal metabolic process; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of death-inducing signaling complex assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein acetylation; P:negative regulation of protein binding; P:negative regulation of protein export from nucleus; P:negative regulation of protein K48-linked deubiquitination; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of reactive oxygen species biosynthetic process; P:negative regulation of TRAIL-activated apoptotic signaling pathway; P:negative regulation of ubiquitin-protein transferase activity; P:negative regulation of ubiquitin-specific protease activity; P:peptidyl-arginine deglycation; P:peptidyl-cysteine deglycation; P:peptidyl-lysine deglycation; P:positive regulation of acute inflammatory response to antigenic stimulus; P:positive regulation of androgen receptor activity; P:positive regulation of autophagy of mitochondrion; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine biosynthetic process; P:positive regulation of gene expression; P:positive regulation of interleukin-8 production; P:positive regulation of L-dopa biosynthetic process; P:positive regulation of L-dopa decarboxylase activity; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of oxidative phosphorylation uncoupler activity; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein-containing complex assembly; P:positive regulation of pyrroline-5-carboxylate reductase activity; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of superoxide dismutase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of tyrosine 3-monooxygenase activity; P:protein deglycation, glyoxal removal; P:protein deglycation, methylglyoxal removal; P:protein deglycosylation; P:protein stabilization; P:Ras protein signal transduction; P:regulation of androgen receptor signaling pathway; P:regulation of histone acetylation; P:regulation of histone ubiquitination; P:regulation of inflammatory response; P:regulation of mitochondrial membrane potential; P:regulation of neuron apoptotic process; P:regulation of supramolecular fiber organization; P:single fertilization;|Q99497 B2R4Z1 O14805 Q6DR95 Q7LFU2,Parkinson disease protein 7 {ECO:0000305},Maillard deglycase {ECO:0000303|PubMed:28596309};Oncogene DJ1 {ECO:0000305};Parkinsonism-associated deglycase {ECO:0000312|HGNC:HGNC:16369};Protein DJ-1 {ECO:0000305};Protein/nucleic acid deglycase DJ-1 {ECO:0000305|PubMed:25416785, ECO:0000305|PubMed:28596309};, PF01965;, GO:0005912;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0045121;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0016605;GO:0098793;GO:0050681;GO:0045296;GO:0005507;GO:1903135;GO:1903136;GO:0019955;GO:0019899;GO:1990422;GO:0042802;GO:0019900;GO:0036478;GO:0045340;GO:0003729;GO:0016684;GO:0019826;GO:0008233;GO:0051920;GO:0036524;GO:0042803;GO:0044877;GO:0070491;GO:0097110;GO:0005102;GO:0044388;GO:0016532;GO:0003713;GO:0008134;GO:0036470;GO:0044390;GO:1990381;GO:0032148;GO:0008344;GO:0035973;GO:0110095;GO:0140041;GO:0036471;GO:0070301;GO:0034599;GO:0070994;GO:0010273;GO:0050787;GO:0006281;GO:0051583;GO:0042593;GO:0036531;GO:0046295;GO:1903189;GO:0106044;GO:0106046;GO:0106045;GO:0016570;GO:0042743;GO:0006954;GO:0030073;GO:0019249;GO:0051899;GO:0060081;GO:0061727;GO:0009438;GO:0007005;GO:0043066;GO:0060548;GO:2001268;GO:1903073;GO:1902236;GO:2001237;GO:0010629;GO:1903206;GO:1903208;GO:1903384;GO:0043524;GO:1901215;GO:1905259;GO:1903202;GO:1903377;GO:0032435;GO:1901984;GO:0032091;GO:0046826;GO:1903094;GO:0006469;GO:0001933;GO:0033234;GO:0031397;GO:1903427;GO:1903122;GO:0051444;GO:2000157;GO:0036527;GO:0036526;GO:0036528;GO:0002866;GO:2000825;GO:1903599;GO:0051091;GO:1903181;GO:0010628;GO:0032757;GO:1903197;GO:1903200;GO:1902958;GO:0033864;GO:2000277;GO:1902177;GO:0033138;GO:0051897;GO:1900182;GO:0031334;GO:1903168;GO:1903428;GO:1901671;GO:0045944;GO:2000679;GO:1903178;GO:0036529;GO:0036530;GO:0006517;GO:0050821;GO:0007265;GO:0060765;GO:0035065;GO:0033182;GO:0050727;GO:0051881;GO:0043523;GO:1902903;GO:0007338;, C:adherens junction; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:membrane raft; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:PML body; C:presynapse;, F:androgen receptor binding; F:cadherin binding; F:copper ion binding; F:cupric ion binding; F:cuprous ion binding; F:cytokine binding; F:enzyme binding; F:glyoxalase (glycolic acid-forming) activity; F:identical protein binding; F:kinase binding; F:L-dopa decarboxylase activator activity; F:mercury ion binding; F:mRNA binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:oxygen sensor activity; F:peptidase activity; F:peroxiredoxin activity; F:protein deglycase activity; F:protein homodimerization activity; F:protein-containing complex binding; F:repressing transcription factor binding; F:scaffold protein binding; F:signaling receptor binding; F:small protein activating enzyme binding; F:superoxide dismutase copper chaperone activity; F:transcription coactivator activity; F:transcription factor binding; F:tyrosine 3-monooxygenase activator activity; F:ubiquitin-like protein conjugating enzyme binding; F:ubiquitin-specific protease binding;, P:activation of protein kinase B activity; P:adult locomotory behavior; P:aggrephagy; P:cellular detoxification of aldehyde; P:cellular detoxification of methylglyoxal; P:cellular response to glyoxal; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:detection of oxidative stress; P:detoxification of copper ion; P:detoxification of mercury ion; P:DNA repair; P:dopamine uptake involved in synaptic transmission; P:glucose homeostasis; P:glutathione deglycation; P:glycolate biosynthetic process; P:glyoxal metabolic process; P:guanine deglycation; P:guanine deglycation, glyoxal removal; P:guanine deglycation, methylglyoxal removal; P:histone modification; P:hydrogen peroxide metabolic process; P:inflammatory response; P:insulin secretion; P:lactate biosynthetic process; P:membrane depolarization; P:membrane hyperpolarization; P:methylglyoxal catabolic process to lactate; P:methylglyoxal metabolic process; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of death-inducing signaling complex assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein acetylation; P:negative regulation of protein binding; P:negative regulation of protein export from nucleus; P:negative regulation of protein K48-linked deubiquitination; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of reactive oxygen species biosynthetic process; P:negative regulation of TRAIL-activated apoptotic signaling pathway; P:negative regulation of ubiquitin-protein transferase activity; P:negative regulation of ubiquitin-specific protease activity; P:peptidyl-arginine deglycation; P:peptidyl-cysteine deglycation; P:peptidyl-lysine deglycation; P:positive regulation of acute inflammatory response to antigenic stimulus; P:positive regulation of androgen receptor activity; P:positive regulation of autophagy of mitochondrion; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine biosynthetic process; P:positive regulation of gene expression; P:positive regulation of interleukin-8 production; P:positive regulation of L-dopa biosynthetic process; P:positive regulation of L-dopa decarboxylase activity; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of oxidative phosphorylation uncoupler activity; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein-containing complex assembly; P:positive regulation of pyrroline-5-carboxylate reductase activity; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of superoxide dismutase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of tyrosine 3-monooxygenase activity; P:protein deglycation, glyoxal removal; P:protein deglycation, methylglyoxal removal; P:protein deglycosylation; P:protein stabilization; P:Ras protein signal transduction; P:regulation of androgen receptor signaling pathway; P:regulation of histone acetylation; P:regulation of histone ubiquitination; P:regulation of inflammatory response; P:regulation of mitochondrial membrane potential; P:regulation of neuron apoptotic process; P:regulation of supramolecular fiber organization; P:single fertilization;|Q99497 B2R4Z1 O14805 Q6DR95 Q7LFU2,Parkinson disease protein 7 {ECO:0000305},Maillard deglycase {ECO:0000303|PubMed:28596309};Oncogene DJ1 {ECO:0000305};Parkinsonism-associated deglycase {ECO:0000312|HGNC:HGNC:16369};Protein DJ-1 {ECO:0000305};Protein/nucleic acid deglycase DJ-1 {ECO:0000305|PubMed:25416785, ECO:0000305|PubMed:28596309};, PF01965;, GO:0005912;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0045121;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0016605;GO:0098793;GO:0050681;GO:0045296;GO:0005507;GO:1903135;GO:1903136;GO:0019955;GO:0019899;GO:1990422;GO:0042802;GO:0019900;GO:0036478;GO:0045340;GO:0003729;GO:0016684;GO:0019826;GO:0008233;GO:0051920;GO:0036524;GO:0042803;GO:0044877;GO:0070491;GO:0097110;GO:0005102;GO:0044388;GO:0016532;GO:0003713;GO:0008134;GO:0036470;GO:0044390;GO:1990381;GO:0032148;GO:0008344;GO:0035973;GO:0110095;GO:0140041;GO:0036471;GO:0070301;GO:0034599;GO:0070994;GO:0010273;GO:0050787;GO:0006281;GO:0051583;GO:0042593;GO:0036531;GO:0046295;GO:1903189;GO:0106044;GO:0106046;GO:0106045;GO:0016570;GO:0042743;GO:0006954;GO:0030073;GO:0019249;GO:0051899;GO:0060081;GO:0061727;GO:0009438;GO:0007005;GO:0043066;GO:0060548;GO:2001268;GO:1903073;GO:1902236;GO:2001237;GO:0010629;GO:1903206;GO:1903208;GO:1903384;GO:0043524;GO:1901215;GO:1905259;GO:1903202;GO:1903377;GO:0032435;GO:1901984;GO:0032091;GO:0046826;GO:1903094;GO:0006469;GO:0001933;GO:0033234;GO:0031397;GO:1903427;GO:1903122;GO:0051444;GO:2000157;GO:0036527;GO:0036526;GO:0036528;GO:0002866;GO:2000825;GO:1903599;GO:0051091;GO:1903181;GO:0010628;GO:0032757;GO:1903197;GO:1903200;GO:1902958;GO:0033864;GO:2000277;GO:1902177;GO:0033138;GO:0051897;GO:1900182;GO:0031334;GO:1903168;GO:1903428;GO:1901671;GO:0045944;GO:2000679;GO:1903178;GO:0036529;GO:0036530;GO:0006517;GO:0050821;GO:0007265;GO:0060765;GO:0035065;GO:0033182;GO:0050727;GO:0051881;GO:0043523;GO:1902903;GO:0007338;, C:adherens junction; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:membrane raft; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:PML body; C:presynapse;, F:androgen receptor binding; F:cadherin binding; F:copper ion binding; F:cupric ion binding; F:cuprous ion binding; F:cytokine binding; F:enzyme binding; F:glyoxalase (glycolic acid-forming) activity; F:identical protein binding; F:kinase binding; F:L-dopa decarboxylase activator activity; F:mercury ion binding; F:mRNA binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:oxygen sensor activity; F:peptidase activity; F:peroxiredoxin activity; F:protein deglycase activity; F:protein homodimerization activity; F:protein-containing complex binding; F:repressing transcription factor binding; F:scaffold protein binding; F:signaling receptor binding; F:small protein activating enzyme binding; F:superoxide dismutase copper chaperone activity; F:transcription coactivator activity; F:transcription factor binding; F:tyrosine 3-monooxygenase activator activity; F:ubiquitin-like protein conjugating enzyme binding; F:ubiquitin-specific protease binding;, P:activation of protein kinase B activity; P:adult locomotory behavior; P:aggrephagy; P:cellular detoxification of aldehyde; P:cellular detoxification of methylglyoxal; P:cellular response to glyoxal; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:detection of oxidative stress; P:detoxification of copper ion; P:detoxification of mercury ion; P:DNA repair; P:dopamine uptake involved in synaptic transmission; P:glucose homeostasis; P:glutathione deglycation; P:glycolate biosynthetic process; P:glyoxal metabolic process; P:guanine deglycation; P:guanine deglycation, glyoxal removal; P:guanine deglycation, methylglyoxal removal; P:histone modification; P:hydrogen peroxide metabolic process; P:inflammatory response; P:insulin secretion; P:lactate biosynthetic process; P:membrane depolarization; P:membrane hyperpolarization; P:methylglyoxal catabolic process to lactate; P:methylglyoxal metabolic process; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of death-inducing signaling complex assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein acetylation; P:negative regulation of protein binding; P:negative regulation of protein export from nucleus; P:negative regulation of protein K48-linked deubiquitination; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of reactive oxygen species biosynthetic process; P:negative regulation of TRAIL-activated apoptotic signaling pathway; P:negative regulation of ubiquitin-protein transferase activity; P:negative regulation of ubiquitin-specific protease activity; P:peptidyl-arginine deglycation; P:peptidyl-cysteine deglycation; P:peptidyl-lysine deglycation; P:positive regulation of acute inflammatory response to antigenic stimulus; P:positive regulation of androgen receptor activity; P:positive regulation of autophagy of mitochondrion; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine biosynthetic process; P:positive regulation of gene expression; P:positive regulation of interleukin-8 production; P:positive regulation of L-dopa biosynthetic process; P:positive regulation of L-dopa decarboxylase activity; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of oxidative phosphorylation uncoupler activity; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein-containing complex assembly; P:positive regulation of pyrroline-5-carboxylate reductase activity; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of superoxide dismutase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of tyrosine 3-monooxygenase activity; P:protein deglycation, glyoxal removal; P:protein deglycation, methylglyoxal removal; P:protein deglycosylation; P:protein stabilization; P:Ras protein signal transduction; P:regulation of androgen receptor signaling pathway; P:regulation of histone acetylation; P:regulation of histone ubiquitination; P:regulation of inflammatory response; P:regulation of mitochondrial membrane potential; P:regulation of neuron apoptotic process; P:regulation of supramolecular fiber organization; P:single fertilization;|Q99497 B2R4Z1 O14805 Q6DR95 Q7LFU2,Parkinson disease protein 7 {ECO:0000305},Maillard deglycase {ECO:0000303|PubMed:28596309};Oncogene DJ1 {ECO:0000305};Parkinsonism-associated deglycase {ECO:0000312|HGNC:HGNC:16369};Protein DJ-1 {ECO:0000305};Protein/nucleic acid deglycase DJ-1 {ECO:0000305|PubMed:25416785, ECO:0000305|PubMed:28596309};, PF01965;, GO:0005912;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0045121;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0016605;GO:0098793;GO:0050681;GO:0045296;GO:0005507;GO:1903135;GO:1903136;GO:0019955;GO:0019899;GO:1990422;GO:0042802;GO:0019900;GO:0036478;GO:0045340;GO:0003729;GO:0016684;GO:0019826;GO:0008233;GO:0051920;GO:0036524;GO:0042803;GO:0044877;GO:0070491;GO:0097110;GO:0005102;GO:0044388;GO:0016532;GO:0003713;GO:0008134;GO:0036470;GO:0044390;GO:1990381;GO:0032148;GO:0008344;GO:0035973;GO:0110095;GO:0140041;GO:0036471;GO:0070301;GO:0034599;GO:0070994;GO:0010273;GO:0050787;GO:0006281;GO:0051583;GO:0042593;GO:0036531;GO:0046295;GO:1903189;GO:0106044;GO:0106046;GO:0106045;GO:0016570;GO:0042743;GO:0006954;GO:0030073;GO:0019249;GO:0051899;GO:0060081;GO:0061727;GO:0009438;GO:0007005;GO:0043066;GO:0060548;GO:2001268;GO:1903073;GO:1902236;GO:2001237;GO:0010629;GO:1903206;GO:1903208;GO:1903384;GO:0043524;GO:1901215;GO:1905259;GO:1903202;GO:1903377;GO:0032435;GO:1901984;GO:0032091;GO:0046826;GO:1903094;GO:0006469;GO:0001933;GO:0033234;GO:0031397;GO:1903427;GO:1903122;GO:0051444;GO:2000157;GO:0036527;GO:0036526;GO:0036528;GO:0002866;GO:2000825;GO:1903599;GO:0051091;GO:1903181;GO:0010628;GO:0032757;GO:1903197;GO:1903200;GO:1902958;GO:0033864;GO:2000277;GO:1902177;GO:0033138;GO:0051897;GO:1900182;GO:0031334;GO:1903168;GO:1903428;GO:1901671;GO:0045944;GO:2000679;GO:1903178;GO:0036529;GO:0036530;GO:0006517;GO:0050821;GO:0007265;GO:0060765;GO:0035065;GO:0033182;GO:0050727;GO:0051881;GO:0043523;GO:1902903;GO:0007338;, C:adherens junction; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:membrane raft; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:PML body; C:presynapse;, F:androgen receptor binding; F:cadherin binding; F:copper ion binding; F:cupric ion binding; F:cuprous ion binding; F:cytokine binding; F:enzyme binding; F:glyoxalase (glycolic acid-forming) activity; F:identical protein binding; F:kinase binding; F:L-dopa decarboxylase activator activity; F:mercury ion binding; F:mRNA binding; F:oxidoreductase activity, acting on peroxide as acceptor; F:oxygen sensor activity; F:peptidase activity; F:peroxiredoxin activity; F:protein deglycase activity; F:protein homodimerization activity; F:protein-containing complex binding; F:repressing transcription factor binding; F:scaffold protein binding; F:signaling receptor binding; F:small protein activating enzyme binding; F:superoxide dismutase copper chaperone activity; F:transcription coactivator activity; F:transcription factor binding; F:tyrosine 3-monooxygenase activator activity; F:ubiquitin-like protein conjugating enzyme binding; F:ubiquitin-specific protease binding;, P:activation of protein kinase B activity; P:adult locomotory behavior; P:aggrephagy; P:cellular detoxification of aldehyde; P:cellular detoxification of methylglyoxal; P:cellular response to glyoxal; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:detection of oxidative stress; P:detoxification of copper ion; P:detoxification of mercury ion; P:DNA repair; P:dopamine uptake involved in synaptic transmission; P:glucose homeostasis; P:glutathione deglycation; P:glycolate biosynthetic process; P:glyoxal metabolic process; P:guanine deglycation; P:guanine deglycation, glyoxal removal; P:guanine deglycation, methylglyoxal removal; P:histone modification; P:hydrogen peroxide metabolic process; P:inflammatory response; P:insulin secretion; P:lactate biosynthetic process; P:membrane depolarization; P:membrane hyperpolarization; P:methylglyoxal catabolic process to lactate; P:methylglyoxal metabolic process; P:mitochondrion organization; P:negative regulation of apoptotic process; P:negative regulation of cell death; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of death-inducing signaling complex assembly; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of hydrogen peroxide-induced neuron death; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein acetylation; P:negative regulation of protein binding; P:negative regulation of protein export from nucleus; P:negative regulation of protein K48-linked deubiquitination; P:negative regulation of protein kinase activity; P:negative regulation of protein phosphorylation; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of reactive oxygen species biosynthetic process; P:negative regulation of TRAIL-activated apoptotic signaling pathway; P:negative regulation of ubiquitin-protein transferase activity; P:negative regulation of ubiquitin-specific protease activity; P:peptidyl-arginine deglycation; P:peptidyl-cysteine deglycation; P:peptidyl-lysine deglycation; P:positive regulation of acute inflammatory response to antigenic stimulus; P:positive regulation of androgen receptor activity; P:positive regulation of autophagy of mitochondrion; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine biosynthetic process; P:positive regulation of gene expression; P:positive regulation of interleukin-8 production; P:positive regulation of L-dopa biosynthetic process; P:positive regulation of L-dopa decarboxylase activity; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of oxidative phosphorylation uncoupler activity; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein-containing complex assembly; P:positive regulation of pyrroline-5-carboxylate reductase activity; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of superoxide dismutase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of tyrosine 3-monooxygenase activity; P:protein deglycation, glyoxal removal; P:protein deglycation, methylglyoxal removal; P:protein deglycosylation; P:protein stabilization; P:Ras protein signal transduction; P:regulation of androgen receptor signaling pathway; P:regulation of histone acetylation; P:regulation of histone ubiquitination; P:regulation of inflammatory response; P:regulation of mitochondrial membrane potential; P:regulation of neuron apoptotic process; P:regulation of supramolecular fiber organization; P:single fertilization; scaffold62 indexed_genome mRNA 6632433 6635624 . - . ID=transcript_10851;P56645 Q5H8X4 Q5H8X5 Q969K6 Q96S77 Q96S78 Q9C0J3 Q9NSP9 Q9UGU8,Period circadian protein homolog 3,Cell growth-inhibiting gene 13 protein;Circadian clock protein PERIOD 3;, PF08447;PF12114;, GO:0005737;GO:0005634;GO:0001222;GO:0000976;GO:0032922;GO:0043153;GO:0000122;GO:0050821;GO:0045187;, C:cytoplasm; C:nucleus;, F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:negative regulation of transcription by RNA polymerase II; P:protein stabilization; P:regulation of circadian sleep/wake cycle, sleep;|P56645 Q5H8X4 Q5H8X5 Q969K6 Q96S77 Q96S78 Q9C0J3 Q9NSP9 Q9UGU8,Period circadian protein homolog 3,Cell growth-inhibiting gene 13 protein;Circadian clock protein PERIOD 3;, PF08447;PF12114;, GO:0005737;GO:0005634;GO:0001222;GO:0000976;GO:0032922;GO:0043153;GO:0000122;GO:0050821;GO:0045187;, C:cytoplasm; C:nucleus;, F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:negative regulation of transcription by RNA polymerase II; P:protein stabilization; P:regulation of circadian sleep/wake cycle, sleep; scaffold62 indexed_genome mRNA 6664671 6680582 . + . ID=transcript_10852;P56645 Q5H8X4 Q5H8X5 Q969K6 Q96S77 Q96S78 Q9C0J3 Q9NSP9 Q9UGU8,Period circadian protein homolog 3,Cell growth-inhibiting gene 13 protein;Circadian clock protein PERIOD 3;, PF08447;PF12114;, GO:0005737;GO:0005634;GO:0001222;GO:0000976;GO:0032922;GO:0043153;GO:0000122;GO:0050821;GO:0045187;, C:cytoplasm; C:nucleus;, F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:negative regulation of transcription by RNA polymerase II; P:protein stabilization; P:regulation of circadian sleep/wake cycle, sleep;|P56645 Q5H8X4 Q5H8X5 Q969K6 Q96S77 Q96S78 Q9C0J3 Q9NSP9 Q9UGU8,Period circadian protein homolog 3,Cell growth-inhibiting gene 13 protein;Circadian clock protein PERIOD 3;, PF08447;PF12114;, GO:0005737;GO:0005634;GO:0001222;GO:0000976;GO:0032922;GO:0043153;GO:0000122;GO:0050821;GO:0045187;, C:cytoplasm; C:nucleus;, F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:negative regulation of transcription by RNA polymerase II; P:protein stabilization; P:regulation of circadian sleep/wake cycle, sleep; scaffold62 indexed_genome mRNA 6683118 6692256 . - . ID=transcript_10853;Q15836 Q9BRV4,Vesicle-associated membrane protein 3,Cellubrevin;Synaptobrevin-3;, PF00957;, GO:0016324;GO:0009986;GO:0030669;GO:0030136;GO:0005829;GO:0005769;GO:0016021;GO:0030285;GO:0043231;GO:0043005;GO:0048471;GO:0030670;GO:0005886;GO:0055037;GO:0055038;GO:0030141;GO:0031201;GO:0032588;GO:0030133;GO:0005484;GO:0019905;GO:0017075;GO:0002479;GO:0017156;GO:0071346;GO:0006887;GO:0043001;GO:0061025;GO:0061024;GO:1903531;GO:0001921;GO:0065003;GO:0042147;GO:0035493;GO:0034446;GO:0006904;GO:0006906;GO:0016192;, C:apical plasma membrane; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:neuron projection; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:secretory granule; C:SNARE complex; C:trans-Golgi network membrane; C:transport vesicle;, F:SNAP receptor activity; F:syntaxin binding; F:syntaxin-1 binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:calcium-ion regulated exocytosis; P:cellular response to interferon-gamma; P:exocytosis; P:Golgi to plasma membrane protein transport; P:membrane fusion; P:membrane organization; P:negative regulation of secretion by cell; P:positive regulation of receptor recycling; P:protein-containing complex assembly; P:retrograde transport, endosome to Golgi; P:SNARE complex assembly; P:substrate adhesion-dependent cell spreading; P:vesicle docking involved in exocytosis; P:vesicle fusion; P:vesicle-mediated transport;|Q15836 Q9BRV4,Vesicle-associated membrane protein 3,Cellubrevin;Synaptobrevin-3;, PF00957;, GO:0016324;GO:0009986;GO:0030669;GO:0030136;GO:0005829;GO:0005769;GO:0016021;GO:0030285;GO:0043231;GO:0043005;GO:0048471;GO:0030670;GO:0005886;GO:0055037;GO:0055038;GO:0030141;GO:0031201;GO:0032588;GO:0030133;GO:0005484;GO:0019905;GO:0017075;GO:0002479;GO:0017156;GO:0071346;GO:0006887;GO:0043001;GO:0061025;GO:0061024;GO:1903531;GO:0001921;GO:0065003;GO:0042147;GO:0035493;GO:0034446;GO:0006904;GO:0006906;GO:0016192;, C:apical plasma membrane; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:neuron projection; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:secretory granule; C:SNARE complex; C:trans-Golgi network membrane; C:transport vesicle;, F:SNAP receptor activity; F:syntaxin binding; F:syntaxin-1 binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:calcium-ion regulated exocytosis; P:cellular response to interferon-gamma; P:exocytosis; P:Golgi to plasma membrane protein transport; P:membrane fusion; P:membrane organization; P:negative regulation of secretion by cell; P:positive regulation of receptor recycling; P:protein-containing complex assembly; P:retrograde transport, endosome to Golgi; P:SNARE complex assembly; P:substrate adhesion-dependent cell spreading; P:vesicle docking involved in exocytosis; P:vesicle fusion; P:vesicle-mediated transport; scaffold62 indexed_genome mRNA 6698723 6799739 . - . ID=transcript_10854;Q9Y6Y1 A7MBM4 G3V3Z7 Q5VUE1 Q6V701 Q8WYI3 Q96S92,Calmodulin-binding transcription activator 1,, PF03859;PF00612;PF01833;, GO:0005829;GO:0005730;GO:0005634;GO:0003690;GO:0003712;GO:0070886;GO:0035307;GO:0006357;, C:cytosol; C:nucleolus; C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of protein dephosphorylation; P:regulation of transcription by RNA polymerase II;|Q9Y6Y1 A7MBM4 G3V3Z7 Q5VUE1 Q6V701 Q8WYI3 Q96S92,Calmodulin-binding transcription activator 1,, PF03859;PF00612;PF01833;, GO:0005829;GO:0005730;GO:0005634;GO:0003690;GO:0003712;GO:0070886;GO:0035307;GO:0006357;, C:cytosol; C:nucleolus; C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of protein dephosphorylation; P:regulation of transcription by RNA polymerase II;|Q9Y6Y1 A7MBM4 G3V3Z7 Q5VUE1 Q6V701 Q8WYI3 Q96S92,Calmodulin-binding transcription activator 1,, PF03859;PF00612;PF01833;, GO:0005829;GO:0005730;GO:0005634;GO:0003690;GO:0003712;GO:0070886;GO:0035307;GO:0006357;, C:cytosol; C:nucleolus; C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of protein dephosphorylation; P:regulation of transcription by RNA polymerase II;|Q9Y6Y1 A7MBM4 G3V3Z7 Q5VUE1 Q6V701 Q8WYI3 Q96S92,Calmodulin-binding transcription activator 1,, PF03859;PF00612;PF01833;, GO:0005829;GO:0005730;GO:0005634;GO:0003690;GO:0003712;GO:0070886;GO:0035307;GO:0006357;, C:cytosol; C:nucleolus; C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of protein dephosphorylation; P:regulation of transcription by RNA polymerase II; scaffold62 indexed_genome mRNA 6800710 7626903 . - . ID=transcript_10855;Q9Y6Y1 A7MBM4 G3V3Z7 Q5VUE1 Q6V701 Q8WYI3 Q96S92,Calmodulin-binding transcription activator 1,, PF03859;PF00612;PF01833;, GO:0005829;GO:0005730;GO:0005634;GO:0003690;GO:0003712;GO:0070886;GO:0035307;GO:0006357;, C:cytosol; C:nucleolus; C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of protein dephosphorylation; P:regulation of transcription by RNA polymerase II; scaffold62 indexed_genome mRNA 7691858 7753382 . + . ID=transcript_10856;Q9NVH1 Q4VWF5 Q5VZN0 Q6PK20 Q6PK70 Q8NDM2 Q96CL7,DnaJ homolog subfamily C member 11,, PF00226;PF11875;, GO:0140275;GO:0005741;GO:0005739;GO:0016607;GO:0005654;GO:0001401;GO:0042407;GO:0007007;, C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:SAM complex;, , P:cristae formation; P:inner mitochondrial membrane organization;|Q9NVH1 Q4VWF5 Q5VZN0 Q6PK20 Q6PK70 Q8NDM2 Q96CL7,DnaJ homolog subfamily C member 11,, PF00226;PF11875;, GO:0140275;GO:0005741;GO:0005739;GO:0016607;GO:0005654;GO:0001401;GO:0042407;GO:0007007;, C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:SAM complex;, , P:cristae formation; P:inner mitochondrial membrane organization;|Q9NVH1 Q4VWF5 Q5VZN0 Q6PK20 Q6PK70 Q8NDM2 Q96CL7,DnaJ homolog subfamily C member 11,, PF00226;PF11875;, GO:0140275;GO:0005741;GO:0005739;GO:0016607;GO:0005654;GO:0001401;GO:0042407;GO:0007007;, C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:SAM complex;, , P:cristae formation; P:inner mitochondrial membrane organization;|Q9NVH1 Q4VWF5 Q5VZN0 Q6PK20 Q6PK70 Q8NDM2 Q96CL7,DnaJ homolog subfamily C member 11,, PF00226;PF11875;, GO:0140275;GO:0005741;GO:0005739;GO:0016607;GO:0005654;GO:0001401;GO:0042407;GO:0007007;, C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:SAM complex;, , P:cristae formation; P:inner mitochondrial membrane organization; scaffold62 indexed_genome mRNA 7753481 7759629 . - . ID=transcript_10857;Q8WTV1 Q569K1 Q5TH66 Q5TH67 Q8N8T6 Q9BSC7 Q9Y3H2 Q9Y3H3,THAP domain-containing protein 3,, PF05485;, GO:0003677;GO:0046872;GO:0045944;, , F:DNA binding; F:metal ion binding;, P:positive regulation of transcription by RNA polymerase II; scaffold62 indexed_genome mRNA 7761620 7769032 . - . ID=transcript_10858;Q86YI8 B3KUQ7 Q59FB6 Q5TH65 Q8N551 Q9UJP2,PHD finger protein 13,Survival time-associated PHD finger protein in ovarian cancer 1;, PF00628;, GO:0005654;GO:0005634;GO:0003682;GO:0046872;GO:0035064;GO:0051301;GO:0006325;GO:0007059;GO:0000278;GO:0007076;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:metal ion binding; F:methylated histone binding;, P:cell division; P:chromatin organization; P:chromosome segregation; P:mitotic cell cycle; P:mitotic chromosome condensation; scaffold62 indexed_genome mRNA 7783580 7789257 . + . ID=transcript_10859;Q9UJP4 B3KQP2 O75057 Q5SY26 Q5SY28 Q8N4I6 Q8NF10,Kelch-like protein 21,, PF07707;PF00651;PF01344;, GO:0031463;GO:0005829;GO:0005827;GO:0097602;GO:0007049;GO:0051301;GO:0035853;GO:0043687;GO:0016567;GO:0032465;, C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:polar microtubule;, F:cullin family protein binding;, P:cell cycle; P:cell division; P:chromosome passenger complex localization to spindle midzone; P:post-translational protein modification; P:protein ubiquitination; P:regulation of cytokinesis;|Q9UJP4 B3KQP2 O75057 Q5SY26 Q5SY28 Q8N4I6 Q8NF10,Kelch-like protein 21,, PF07707;PF00651;PF01344;, GO:0031463;GO:0005829;GO:0005827;GO:0097602;GO:0007049;GO:0051301;GO:0035853;GO:0043687;GO:0016567;GO:0032465;, C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:polar microtubule;, F:cullin family protein binding;, P:cell cycle; P:cell division; P:chromosome passenger complex localization to spindle midzone; P:post-translational protein modification; P:protein ubiquitination; P:regulation of cytokinesis; scaffold62 indexed_genome mRNA 7790351 7799156 . - . ID=transcript_10860;P10074 Q5SY19,Telomere zinc finger-associated protein {ECO:0000303|PubMed:28082411},Krueppel-related zinc finger protein 3 {ECO:0000303|PubMed:9516840};Zinc finger and BTB domain-containing protein 48 {ECO:0000312|HGNC:HGNC:4930};Zinc finger protein 855 {ECO:0000312|HGNC:HGNC:4930};, PF00651;PF00096;, GO:0000781;GO:0005634;GO:0003700;GO:0003691;GO:0042802;GO:0046872;GO:0000978;GO:0000976;GO:0045893;GO:0006357;GO:0010833;, C:chromosome, telomeric region; C:nucleus;, F:DNA-binding transcription factor activity; F:double-stranded telomeric DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:telomere maintenance via telomere lengthening;|P10074 Q5SY19,Telomere zinc finger-associated protein {ECO:0000303|PubMed:28082411},Krueppel-related zinc finger protein 3 {ECO:0000303|PubMed:9516840};Zinc finger and BTB domain-containing protein 48 {ECO:0000312|HGNC:HGNC:4930};Zinc finger protein 855 {ECO:0000312|HGNC:HGNC:4930};, PF00651;PF00096;, GO:0000781;GO:0005634;GO:0003700;GO:0003691;GO:0042802;GO:0046872;GO:0000978;GO:0000976;GO:0045893;GO:0006357;GO:0010833;, C:chromosome, telomeric region; C:nucleus;, F:DNA-binding transcription factor activity; F:double-stranded telomeric DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:telomere maintenance via telomere lengthening;|P10074 Q5SY19,Telomere zinc finger-associated protein {ECO:0000303|PubMed:28082411},Krueppel-related zinc finger protein 3 {ECO:0000303|PubMed:9516840};Zinc finger and BTB domain-containing protein 48 {ECO:0000312|HGNC:HGNC:4930};Zinc finger protein 855 {ECO:0000312|HGNC:HGNC:4930};, PF00651;PF00096;, GO:0000781;GO:0005634;GO:0003700;GO:0003691;GO:0042802;GO:0046872;GO:0000978;GO:0000976;GO:0045893;GO:0006357;GO:0010833;, C:chromosome, telomeric region; C:nucleus;, F:DNA-binding transcription factor activity; F:double-stranded telomeric DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:telomere maintenance via telomere lengthening;|P10074 Q5SY19,Telomere zinc finger-associated protein {ECO:0000303|PubMed:28082411},Krueppel-related zinc finger protein 3 {ECO:0000303|PubMed:9516840};Zinc finger and BTB domain-containing protein 48 {ECO:0000312|HGNC:HGNC:4930};Zinc finger protein 855 {ECO:0000312|HGNC:HGNC:4930};, PF00651;PF00096;, GO:0000781;GO:0005634;GO:0003700;GO:0003691;GO:0042802;GO:0046872;GO:0000978;GO:0000976;GO:0045893;GO:0006357;GO:0010833;, C:chromosome, telomeric region; C:nucleus;, F:DNA-binding transcription factor activity; F:double-stranded telomeric DNA binding; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:telomere maintenance via telomere lengthening; scaffold62 indexed_genome mRNA 7808393 7826951 . + . ID=transcript_10861;Q5SY16 Q2NL84 Q4VBY3 Q6P472 Q7L4D6 Q96EE0 Q9H5L4,Polynucleotide 5'-hydroxyl-kinase NOL9,Nucleolar protein 9;, PF16575;, GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0051731;GO:0003723;GO:0000448;GO:0000460;GO:0006396;GO:0006364;, C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:polynucleotide 5'-hydroxyl-kinase activity; F:RNA binding;, P:cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of 5.8S rRNA; P:RNA processing; P:rRNA processing;|Q5SY16 Q2NL84 Q4VBY3 Q6P472 Q7L4D6 Q96EE0 Q9H5L4,Polynucleotide 5'-hydroxyl-kinase NOL9,Nucleolar protein 9;, PF16575;, GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0051731;GO:0003723;GO:0000448;GO:0000460;GO:0006396;GO:0006364;, C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:polynucleotide 5'-hydroxyl-kinase activity; F:RNA binding;, P:cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of 5.8S rRNA; P:RNA processing; P:rRNA processing;|Q5SY16 Q2NL84 Q4VBY3 Q6P472 Q7L4D6 Q96EE0 Q9H5L4,Polynucleotide 5'-hydroxyl-kinase NOL9,Nucleolar protein 9;, PF16575;, GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0051731;GO:0003723;GO:0000448;GO:0000460;GO:0006396;GO:0006364;, C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:polynucleotide 5'-hydroxyl-kinase activity; F:RNA binding;, P:cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of 5.8S rRNA; P:RNA processing; P:rRNA processing;|Q5SY16 Q2NL84 Q4VBY3 Q6P472 Q7L4D6 Q96EE0 Q9H5L4,Polynucleotide 5'-hydroxyl-kinase NOL9,Nucleolar protein 9;, PF16575;, GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0051731;GO:0003723;GO:0000448;GO:0000460;GO:0006396;GO:0006364;, C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:polynucleotide 5'-hydroxyl-kinase activity; F:RNA binding;, P:cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of 5.8S rRNA; P:RNA processing; P:rRNA processing;|Q5SY16 Q2NL84 Q4VBY3 Q6P472 Q7L4D6 Q96EE0 Q9H5L4,Polynucleotide 5'-hydroxyl-kinase NOL9,Nucleolar protein 9;, PF16575;, GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0051731;GO:0003723;GO:0000448;GO:0000460;GO:0006396;GO:0006364;, C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:polynucleotide 5'-hydroxyl-kinase activity; F:RNA binding;, P:cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of 5.8S rRNA; P:RNA processing; P:rRNA processing;|Q5SY16 Q2NL84 Q4VBY3 Q6P472 Q7L4D6 Q96EE0 Q9H5L4,Polynucleotide 5'-hydroxyl-kinase NOL9,Nucleolar protein 9;, PF16575;, GO:0045111;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0051731;GO:0003723;GO:0000448;GO:0000460;GO:0006396;GO:0006364;, C:intermediate filament cytoskeleton; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:polynucleotide 5'-hydroxyl-kinase activity; F:RNA binding;, P:cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of 5.8S rRNA; P:RNA processing; P:rRNA processing; scaffold62 indexed_genome mRNA 7857979 7878785 . + . ID=transcript_10862;Q6ZNM0 Q7Z436 Q86YD8 Q96BS1,Pleckstrin homology domain-containing family G member 5,Guanine nucleotide exchange factor 720;, PF00621;, GO:0030424;GO:0005911;GO:0005737;GO:0005829;GO:0030139;GO:0030027;GO:0048471;GO:0005886;GO:0005085;GO:0035767;GO:0043542;GO:0007186;GO:0043065;GO:0043123;GO:0051056;GO:0007266;, C:axon; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endocytic vesicle; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:endothelial cell chemotaxis; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q6ZNM0 Q7Z436 Q86YD8 Q96BS1,Pleckstrin homology domain-containing family G member 5,Guanine nucleotide exchange factor 720;, PF00621;, GO:0030424;GO:0005911;GO:0005737;GO:0005829;GO:0030139;GO:0030027;GO:0048471;GO:0005886;GO:0005085;GO:0035767;GO:0043542;GO:0007186;GO:0043065;GO:0043123;GO:0051056;GO:0007266;, C:axon; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endocytic vesicle; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:endothelial cell chemotaxis; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q6ZNM0 Q7Z436 Q86YD8 Q96BS1,Pleckstrin homology domain-containing family G member 5,Guanine nucleotide exchange factor 720;, PF00621;, GO:0030424;GO:0005911;GO:0005737;GO:0005829;GO:0030139;GO:0030027;GO:0048471;GO:0005886;GO:0005085;GO:0035767;GO:0043542;GO:0007186;GO:0043065;GO:0043123;GO:0051056;GO:0007266;, C:axon; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endocytic vesicle; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:endothelial cell chemotaxis; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold62 indexed_genome mRNA 7879655 7906868 . - . ID=transcript_10863;Q6ZNM0 Q7Z436 Q86YD8 Q96BS1,Pleckstrin homology domain-containing family G member 5,Guanine nucleotide exchange factor 720;, PF00621;, GO:0030424;GO:0005911;GO:0005737;GO:0005829;GO:0030139;GO:0030027;GO:0048471;GO:0005886;GO:0005085;GO:0035767;GO:0043542;GO:0007186;GO:0043065;GO:0043123;GO:0051056;GO:0007266;, C:axon; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endocytic vesicle; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:endothelial cell chemotaxis; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q6ZNM0 Q7Z436 Q86YD8 Q96BS1,Pleckstrin homology domain-containing family G member 5,Guanine nucleotide exchange factor 720;, PF00621;, GO:0030424;GO:0005911;GO:0005737;GO:0005829;GO:0030139;GO:0030027;GO:0048471;GO:0005886;GO:0005085;GO:0035767;GO:0043542;GO:0007186;GO:0043065;GO:0043123;GO:0051056;GO:0007266;, C:axon; C:cell-cell junction; C:cytoplasm; C:cytosol; C:endocytic vesicle; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:endothelial cell chemotaxis; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q99722 Q99830 Q99831 Q9BY86 Q9UME0 Q9UME1 Q9UME5,Tumor necrosis factor receptor superfamily member 25,Apo-3;Apoptosis-inducing receptor AIR;Apoptosis-mediating receptor DR3;Apoptosis-mediating receptor TRAMP;Death receptor 3;Lymphocyte-associated receptor of death;Protein WSL;Protein WSL-1;, PF00531;PF00020;, GO:0005829;GO:0005576;GO:0005887;GO:0005886;GO:0038023;GO:0005031;GO:0006915;GO:0097190;GO:0007166;GO:0042981;GO:0007165;GO:0033209;, C:cytosol; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:signaling receptor activity; F:tumor necrosis factor-activated receptor activity;, P:apoptotic process; P:apoptotic signaling pathway; P:cell surface receptor signaling pathway; P:regulation of apoptotic process; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway;|Q99722 Q99830 Q99831 Q9BY86 Q9UME0 Q9UME1 Q9UME5,Tumor necrosis factor receptor superfamily member 25,Apo-3;Apoptosis-inducing receptor AIR;Apoptosis-mediating receptor DR3;Apoptosis-mediating receptor TRAMP;Death receptor 3;Lymphocyte-associated receptor of death;Protein WSL;Protein WSL-1;, PF00531;PF00020;, GO:0005829;GO:0005576;GO:0005887;GO:0005886;GO:0038023;GO:0005031;GO:0006915;GO:0097190;GO:0007166;GO:0042981;GO:0007165;GO:0033209;, C:cytosol; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:signaling receptor activity; F:tumor necrosis factor-activated receptor activity;, P:apoptotic process; P:apoptotic signaling pathway; P:cell surface receptor signaling pathway; P:regulation of apoptotic process; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway;|Q99722 Q99830 Q99831 Q9BY86 Q9UME0 Q9UME1 Q9UME5,Tumor necrosis factor receptor superfamily member 25,Apo-3;Apoptosis-inducing receptor AIR;Apoptosis-mediating receptor DR3;Apoptosis-mediating receptor TRAMP;Death receptor 3;Lymphocyte-associated receptor of death;Protein WSL;Protein WSL-1;, PF00531;PF00020;, GO:0005829;GO:0005576;GO:0005887;GO:0005886;GO:0038023;GO:0005031;GO:0006915;GO:0097190;GO:0007166;GO:0042981;GO:0007165;GO:0033209;, C:cytosol; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:signaling receptor activity; F:tumor necrosis factor-activated receptor activity;, P:apoptotic process; P:apoptotic signaling pathway; P:cell surface receptor signaling pathway; P:regulation of apoptotic process; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway;|Q6ZVH7 Q66K27 Q6ZVG1 Q8IVU2,Espin-like protein,, PF12796;, GO:0005737;GO:0032426;GO:0051015;GO:0051017;GO:0007605;, C:cytoplasm; C:stereocilium tip;, F:actin filament binding;, P:actin filament bundle assembly; P:sensory perception of sound; scaffold62 indexed_genome mRNA 7939915 7941420 . + . ID=transcript_10864;Q9Y543 A2RTZ9 Q96EN4 Q9Y542,Transcription factor HES-2,Class B basic helix-loop-helix protein 40;Hairy and enhancer of split 2;, PF07527;PF00010;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:1990837;GO:0008134;GO:0009952;GO:0050767;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; scaffold62 indexed_genome mRNA 8009991 8067064 . + . ID=transcript_10865;Q5JYL3 Q5JYL4 Q5JYL5 Q5JYL6 Q5TGR4 Q9UJM9 Q9Y539 Q9Y540,Cytosolic acyl coenzyme A thioester hydrolase,Acyl-CoA thioesterase 7;Brain acyl-CoA hydrolase;CTE-IIa;Long chain acyl-CoA thioester hydrolase;, PF03061;, GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0047617;GO:0052689;GO:0000062;GO:0036042;GO:0102991;GO:0016290;GO:0042803;GO:0006637;GO:0015937;GO:0006631;GO:0036116;GO:0051792;GO:0036114;GO:1900535;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:fatty-acyl-CoA binding; F:long-chain fatty acyl-CoA binding; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:protein homodimerization activity;, P:acyl-CoA metabolic process; P:coenzyme A biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty-acyl-CoA catabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty-acyl-CoA catabolic process; P:palmitic acid biosynthetic process;|Q5JYL3 Q5JYL4 Q5JYL5 Q5JYL6 Q5TGR4 Q9UJM9 Q9Y539 Q9Y540,Cytosolic acyl coenzyme A thioester hydrolase,Acyl-CoA thioesterase 7;Brain acyl-CoA hydrolase;CTE-IIa;Long chain acyl-CoA thioester hydrolase;, PF03061;, GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0047617;GO:0052689;GO:0000062;GO:0036042;GO:0102991;GO:0016290;GO:0042803;GO:0006637;GO:0015937;GO:0006631;GO:0036116;GO:0051792;GO:0036114;GO:1900535;, C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:fatty-acyl-CoA binding; F:long-chain fatty acyl-CoA binding; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:protein homodimerization activity;, P:acyl-CoA metabolic process; P:coenzyme A biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty-acyl-CoA catabolic process; P:medium-chain fatty acid biosynthetic process; P:medium-chain fatty-acyl-CoA catabolic process; P:palmitic acid biosynthetic process; scaffold62 indexed_genome mRNA 8092948 8099415 . + . ID=transcript_10866;O60725 Q6FHT0,Protein-S-isoprenylcysteine O-methyltransferase,Isoprenylcysteine carboxylmethyltransferase;Prenylated protein carboxyl methyltransferase;Prenylcysteine carboxyl methyltransferase;, PF04140;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003880;GO:0004671;GO:0006481;GO:0006464;GO:0000165;GO:0043687;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:protein C-terminal carboxyl O-methyltransferase activity; F:protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity;, P:C-terminal protein methylation; P:cellular protein modification process; P:MAPK cascade; P:post-translational protein modification; P:protein targeting to membrane;|O60725 Q6FHT0,Protein-S-isoprenylcysteine O-methyltransferase,Isoprenylcysteine carboxylmethyltransferase;Prenylated protein carboxyl methyltransferase;Prenylcysteine carboxyl methyltransferase;, PF04140;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003880;GO:0004671;GO:0006481;GO:0006464;GO:0000165;GO:0043687;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:protein C-terminal carboxyl O-methyltransferase activity; F:protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity;, P:C-terminal protein methylation; P:cellular protein modification process; P:MAPK cascade; P:post-translational protein modification; P:protein targeting to membrane;|O60725 Q6FHT0,Protein-S-isoprenylcysteine O-methyltransferase,Isoprenylcysteine carboxylmethyltransferase;Prenylated protein carboxyl methyltransferase;Prenylcysteine carboxyl methyltransferase;, PF04140;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003880;GO:0004671;GO:0006481;GO:0006464;GO:0000165;GO:0043687;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:protein C-terminal carboxyl O-methyltransferase activity; F:protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity;, P:C-terminal protein methylation; P:cellular protein modification process; P:MAPK cascade; P:post-translational protein modification; P:protein targeting to membrane; scaffold62 indexed_genome mRNA 8099432 8110110 . - . ID=transcript_10867;Q6ZRF8 A2VCM8 B4DFR6 Q5TGS6 Q6ZS63 Q96MP2,RING finger protein 207,, PF00643;PF00097;, GO:0048471;GO:0051087;GO:0030544;GO:0044325;GO:0008270;GO:0086019;GO:1902261;GO:0010628;GO:1903954;GO:1903762;GO:0055117;GO:1901207;, C:perinuclear region of cytoplasm;, F:chaperone binding; F:Hsp70 protein binding; F:ion channel binding; F:zinc ion binding;, P:cell-cell signaling involved in cardiac conduction; P:positive regulation of delayed rectifier potassium channel activity; P:positive regulation of gene expression; P:positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; P:positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:regulation of cardiac muscle contraction; P:regulation of heart looping;|Q6ZRF8 A2VCM8 B4DFR6 Q5TGS6 Q6ZS63 Q96MP2,RING finger protein 207,, PF00643;PF00097;, GO:0048471;GO:0051087;GO:0030544;GO:0044325;GO:0008270;GO:0086019;GO:1902261;GO:0010628;GO:1903954;GO:1903762;GO:0055117;GO:1901207;, C:perinuclear region of cytoplasm;, F:chaperone binding; F:Hsp70 protein binding; F:ion channel binding; F:zinc ion binding;, P:cell-cell signaling involved in cardiac conduction; P:positive regulation of delayed rectifier potassium channel activity; P:positive regulation of gene expression; P:positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; P:positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:regulation of cardiac muscle contraction; P:regulation of heart looping;|Q6ZRF8 A2VCM8 B4DFR6 Q5TGS6 Q6ZS63 Q96MP2,RING finger protein 207,, PF00643;PF00097;, GO:0048471;GO:0051087;GO:0030544;GO:0044325;GO:0008270;GO:0086019;GO:1902261;GO:0010628;GO:1903954;GO:1903762;GO:0055117;GO:1901207;, C:perinuclear region of cytoplasm;, F:chaperone binding; F:Hsp70 protein binding; F:ion channel binding; F:zinc ion binding;, P:cell-cell signaling involved in cardiac conduction; P:positive regulation of delayed rectifier potassium channel activity; P:positive regulation of gene expression; P:positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; P:positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:regulation of cardiac muscle contraction; P:regulation of heart looping; scaffold62 indexed_genome mRNA 8116529 8119560 . - . ID=transcript_10868;Q6ZRF8 A2VCM8 B4DFR6 Q5TGS6 Q6ZS63 Q96MP2,RING finger protein 207,, PF00643;PF00097;, GO:0048471;GO:0051087;GO:0030544;GO:0044325;GO:0008270;GO:0086019;GO:1902261;GO:0010628;GO:1903954;GO:1903762;GO:0055117;GO:1901207;, C:perinuclear region of cytoplasm;, F:chaperone binding; F:Hsp70 protein binding; F:ion channel binding; F:zinc ion binding;, P:cell-cell signaling involved in cardiac conduction; P:positive regulation of delayed rectifier potassium channel activity; P:positive regulation of gene expression; P:positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; P:positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:regulation of cardiac muscle contraction; P:regulation of heart looping;|Q6ZRF8 A2VCM8 B4DFR6 Q5TGS6 Q6ZS63 Q96MP2,RING finger protein 207,, PF00643;PF00097;, GO:0048471;GO:0051087;GO:0030544;GO:0044325;GO:0008270;GO:0086019;GO:1902261;GO:0010628;GO:1903954;GO:1903762;GO:0055117;GO:1901207;, C:perinuclear region of cytoplasm;, F:chaperone binding; F:Hsp70 protein binding; F:ion channel binding; F:zinc ion binding;, P:cell-cell signaling involved in cardiac conduction; P:positive regulation of delayed rectifier potassium channel activity; P:positive regulation of gene expression; P:positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; P:positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:regulation of cardiac muscle contraction; P:regulation of heart looping; scaffold62 indexed_genome mRNA 8128277 8136874 . + . ID=transcript_10869;P35268 B2R495 Q6IBD1,60S ribosomal protein L22,EBER-associated protein;Epstein-Barr virus small RNA-associated protein;Heparin-binding protein HBp15;Large ribosomal subunit protein eL22 {ECO:0000303|PubMed:24524803};, PF01776;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0098978;GO:0005634;GO:0098793;GO:1990904;GO:0008201;GO:0042802;GO:0003723;GO:0003735;GO:0045182;GO:0046632;GO:0002181;GO:0000184;GO:0099577;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:presynapse; C:ribonucleoprotein complex;, F:heparin binding; F:identical protein binding; F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:alpha-beta T cell differentiation; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation at presynapse, modulating synaptic transmission; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P35268 B2R495 Q6IBD1,60S ribosomal protein L22,EBER-associated protein;Epstein-Barr virus small RNA-associated protein;Heparin-binding protein HBp15;Large ribosomal subunit protein eL22 {ECO:0000303|PubMed:24524803};, PF01776;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0098978;GO:0005634;GO:0098793;GO:1990904;GO:0008201;GO:0042802;GO:0003723;GO:0003735;GO:0045182;GO:0046632;GO:0002181;GO:0000184;GO:0099577;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:presynapse; C:ribonucleoprotein complex;, F:heparin binding; F:identical protein binding; F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:alpha-beta T cell differentiation; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation at presynapse, modulating synaptic transmission; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P35268 B2R495 Q6IBD1,60S ribosomal protein L22,EBER-associated protein;Epstein-Barr virus small RNA-associated protein;Heparin-binding protein HBp15;Large ribosomal subunit protein eL22 {ECO:0000303|PubMed:24524803};, PF01776;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0098978;GO:0005634;GO:0098793;GO:1990904;GO:0008201;GO:0042802;GO:0003723;GO:0003735;GO:0045182;GO:0046632;GO:0002181;GO:0000184;GO:0099577;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:presynapse; C:ribonucleoprotein complex;, F:heparin binding; F:identical protein binding; F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:alpha-beta T cell differentiation; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation at presynapse, modulating synaptic transmission; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P35268 B2R495 Q6IBD1,60S ribosomal protein L22,EBER-associated protein;Epstein-Barr virus small RNA-associated protein;Heparin-binding protein HBp15;Large ribosomal subunit protein eL22 {ECO:0000303|PubMed:24524803};, PF01776;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0098978;GO:0005634;GO:0098793;GO:1990904;GO:0008201;GO:0042802;GO:0003723;GO:0003735;GO:0045182;GO:0046632;GO:0002181;GO:0000184;GO:0099577;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:presynapse; C:ribonucleoprotein complex;, F:heparin binding; F:identical protein binding; F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:alpha-beta T cell differentiation; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation at presynapse, modulating synaptic transmission; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P35268 B2R495 Q6IBD1,60S ribosomal protein L22,EBER-associated protein;Epstein-Barr virus small RNA-associated protein;Heparin-binding protein HBp15;Large ribosomal subunit protein eL22 {ECO:0000303|PubMed:24524803};, PF01776;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0098978;GO:0005634;GO:0098793;GO:1990904;GO:0008201;GO:0042802;GO:0003723;GO:0003735;GO:0045182;GO:0046632;GO:0002181;GO:0000184;GO:0099577;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:presynapse; C:ribonucleoprotein complex;, F:heparin binding; F:identical protein binding; F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:alpha-beta T cell differentiation; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation at presynapse, modulating synaptic transmission; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P35268 B2R495 Q6IBD1,60S ribosomal protein L22,EBER-associated protein;Epstein-Barr virus small RNA-associated protein;Heparin-binding protein HBp15;Large ribosomal subunit protein eL22 {ECO:0000303|PubMed:24524803};, PF01776;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0098978;GO:0005634;GO:0098793;GO:1990904;GO:0008201;GO:0042802;GO:0003723;GO:0003735;GO:0045182;GO:0046632;GO:0002181;GO:0000184;GO:0099577;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:presynapse; C:ribonucleoprotein complex;, F:heparin binding; F:identical protein binding; F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:alpha-beta T cell differentiation; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation at presynapse, modulating synaptic transmission; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold62 indexed_genome mRNA 8150530 8172068 . + . ID=transcript_10870;Q8TDI0 O75032 Q5TG89 Q7LGH2 Q9UFR9,Chromodomain-helicase-DNA-binding protein 5,ATP-dependent helicase CHD5;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005829;GO:0000792;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0005524;GO:0003677;GO:0003678;GO:0061628;GO:0046872;GO:0070615;GO:0021895;GO:0098532;GO:0043967;GO:0008285;GO:1901798;GO:0006357;GO:0035093;, C:cytosol; C:heterochromatin; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:H3K27me3 modified histone binding; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:cerebral cortex neuron differentiation; P:histone H3-K27 trimethylation; P:histone H4 acetylation; P:negative regulation of cell population proliferation; P:positive regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:spermatogenesis, exchange of chromosomal proteins; scaffold62 indexed_genome mRNA 8172434 8204660 . + . ID=transcript_10871;Q8TDI0 O75032 Q5TG89 Q7LGH2 Q9UFR9,Chromodomain-helicase-DNA-binding protein 5,ATP-dependent helicase CHD5;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005829;GO:0000792;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0005524;GO:0003677;GO:0003678;GO:0061628;GO:0046872;GO:0070615;GO:0021895;GO:0098532;GO:0043967;GO:0008285;GO:1901798;GO:0006357;GO:0035093;, C:cytosol; C:heterochromatin; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:H3K27me3 modified histone binding; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:cerebral cortex neuron differentiation; P:histone H3-K27 trimethylation; P:histone H4 acetylation; P:negative regulation of cell population proliferation; P:positive regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:spermatogenesis, exchange of chromosomal proteins;|Q8TDI0 O75032 Q5TG89 Q7LGH2 Q9UFR9,Chromodomain-helicase-DNA-binding protein 5,ATP-dependent helicase CHD5;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005829;GO:0000792;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0005524;GO:0003677;GO:0003678;GO:0061628;GO:0046872;GO:0070615;GO:0021895;GO:0098532;GO:0043967;GO:0008285;GO:1901798;GO:0006357;GO:0035093;, C:cytosol; C:heterochromatin; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:H3K27me3 modified histone binding; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:cerebral cortex neuron differentiation; P:histone H3-K27 trimethylation; P:histone H4 acetylation; P:negative regulation of cell population proliferation; P:positive regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:spermatogenesis, exchange of chromosomal proteins;|Q8TDI0 O75032 Q5TG89 Q7LGH2 Q9UFR9,Chromodomain-helicase-DNA-binding protein 5,ATP-dependent helicase CHD5;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005829;GO:0000792;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0005524;GO:0003677;GO:0003678;GO:0061628;GO:0046872;GO:0070615;GO:0021895;GO:0098532;GO:0043967;GO:0008285;GO:1901798;GO:0006357;GO:0035093;, C:cytosol; C:heterochromatin; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:H3K27me3 modified histone binding; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:cerebral cortex neuron differentiation; P:histone H3-K27 trimethylation; P:histone H4 acetylation; P:negative regulation of cell population proliferation; P:positive regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:spermatogenesis, exchange of chromosomal proteins;|Q8TDI0 O75032 Q5TG89 Q7LGH2 Q9UFR9,Chromodomain-helicase-DNA-binding protein 5,ATP-dependent helicase CHD5;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005829;GO:0000792;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0005524;GO:0003677;GO:0003678;GO:0061628;GO:0046872;GO:0070615;GO:0021895;GO:0098532;GO:0043967;GO:0008285;GO:1901798;GO:0006357;GO:0035093;, C:cytosol; C:heterochromatin; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:H3K27me3 modified histone binding; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:cerebral cortex neuron differentiation; P:histone H3-K27 trimethylation; P:histone H4 acetylation; P:negative regulation of cell population proliferation; P:positive regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:spermatogenesis, exchange of chromosomal proteins; scaffold62 indexed_genome mRNA 8208547 8304455 . - . ID=transcript_10872;Q99411,Voltage-gated potassium channel subunit beta-2,K(+) channel subunit beta-2;Kv-beta-2;, PF00248;, GO:0005856;GO:0005829;GO:0031234;GO:0044224;GO:0016020;GO:1990031;GO:0005886;GO:0035579;GO:0045202;GO:0070821;GO:0008076;GO:0004033;GO:0047834;GO:0044325;GO:0015459;GO:0005249;GO:0070995;GO:0043312;GO:0071805;GO:0098900;GO:1901379;GO:2000008;, C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:juxtaparanode region of axon; C:membrane; C:pinceau fiber; C:plasma membrane; C:specific granule membrane; C:synapse; C:tertiary granule membrane; C:voltage-gated potassium channel complex;, F:aldo-keto reductase (NADP) activity; F:D-threo-aldose 1-dehydrogenase activity; F:ion channel binding; F:potassium channel regulator activity; F:voltage-gated potassium channel activity;, P:NADPH oxidation; P:neutrophil degranulation; P:potassium ion transmembrane transport; P:regulation of action potential; P:regulation of potassium ion transmembrane transport; P:regulation of protein localization to cell surface; scaffold62 indexed_genome mRNA 8385823 8426988 . + . ID=transcript_10873;O75161 Q8IWC0,Nephrocystin-4,Nephroretinin;, , GO:0005923;GO:0005911;GO:0005813;GO:0036064;GO:0097546;GO:0035869;GO:0005829;GO:0043231;GO:0097730;GO:0016604;GO:0005654;GO:0120206;GO:0097470;GO:0005198;GO:0030036;GO:0098609;GO:0097711;GO:0030317;GO:0035329;GO:0090090;GO:0045494;GO:0035845;GO:1903348;GO:1904491;GO:0060041;GO:0007165;GO:0007632;, C:bicellular tight junction; C:cell-cell junction; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary transition zone; C:cytosol; C:intracellular membrane-bounded organelle; C:non-motile cilium; C:nuclear body; C:nucleoplasm; C:photoreceptor distal connecting cilium; C:ribbon synapse;, F:structural molecule activity;, P:actin cytoskeleton organization; P:cell-cell adhesion; P:ciliary basal body-plasma membrane docking; P:flagellated sperm motility; P:hippo signaling; P:negative regulation of canonical Wnt signaling pathway; P:photoreceptor cell maintenance; P:photoreceptor cell outer segment organization; P:positive regulation of bicellular tight junction assembly; P:protein localization to ciliary transition zone; P:retina development in camera-type eye; P:signal transduction; P:visual behavior; scaffold62 indexed_genome mRNA 8431328 8435030 . + . ID=transcript_10874;O75161 Q8IWC0,Nephrocystin-4,Nephroretinin;, , GO:0005923;GO:0005911;GO:0005813;GO:0036064;GO:0097546;GO:0035869;GO:0005829;GO:0043231;GO:0097730;GO:0016604;GO:0005654;GO:0120206;GO:0097470;GO:0005198;GO:0030036;GO:0098609;GO:0097711;GO:0030317;GO:0035329;GO:0090090;GO:0045494;GO:0035845;GO:1903348;GO:1904491;GO:0060041;GO:0007165;GO:0007632;, C:bicellular tight junction; C:cell-cell junction; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary transition zone; C:cytosol; C:intracellular membrane-bounded organelle; C:non-motile cilium; C:nuclear body; C:nucleoplasm; C:photoreceptor distal connecting cilium; C:ribbon synapse;, F:structural molecule activity;, P:actin cytoskeleton organization; P:cell-cell adhesion; P:ciliary basal body-plasma membrane docking; P:flagellated sperm motility; P:hippo signaling; P:negative regulation of canonical Wnt signaling pathway; P:photoreceptor cell maintenance; P:photoreceptor cell outer segment organization; P:positive regulation of bicellular tight junction assembly; P:protein localization to ciliary transition zone; P:retina development in camera-type eye; P:signal transduction; P:visual behavior; scaffold62 indexed_genome mRNA 8444903 8446000 . + . ID=transcript_10875;O75161 Q8IWC0,Nephrocystin-4,Nephroretinin;, , GO:0005923;GO:0005911;GO:0005813;GO:0036064;GO:0097546;GO:0035869;GO:0005829;GO:0043231;GO:0097730;GO:0016604;GO:0005654;GO:0120206;GO:0097470;GO:0005198;GO:0030036;GO:0098609;GO:0097711;GO:0030317;GO:0035329;GO:0090090;GO:0045494;GO:0035845;GO:1903348;GO:1904491;GO:0060041;GO:0007165;GO:0007632;, C:bicellular tight junction; C:cell-cell junction; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary transition zone; C:cytosol; C:intracellular membrane-bounded organelle; C:non-motile cilium; C:nuclear body; C:nucleoplasm; C:photoreceptor distal connecting cilium; C:ribbon synapse;, F:structural molecule activity;, P:actin cytoskeleton organization; P:cell-cell adhesion; P:ciliary basal body-plasma membrane docking; P:flagellated sperm motility; P:hippo signaling; P:negative regulation of canonical Wnt signaling pathway; P:photoreceptor cell maintenance; P:photoreceptor cell outer segment organization; P:positive regulation of bicellular tight junction assembly; P:protein localization to ciliary transition zone; P:retina development in camera-type eye; P:signal transduction; P:visual behavior; scaffold62 indexed_genome mRNA 9453285 9518082 . - . ID=transcript_10876;Q9UKB5 Q9Y229,Adherens junction-associated protein 1,Membrane protein shrew-1;, PF15298;, GO:0005912;GO:0016324;GO:0016323;GO:0009986;GO:0044291;GO:0009898;GO:0044214;GO:0008013;GO:0044877;GO:0007155;GO:0001953;GO:0061045;GO:0030860;, C:adherens junction; C:apical plasma membrane; C:basolateral plasma membrane; C:cell surface; C:cell-cell contact zone; C:cytoplasmic side of plasma membrane; C:spanning component of plasma membrane;, F:beta-catenin binding; F:protein-containing complex binding;, P:cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of wound healing; P:regulation of polarized epithelial cell differentiation; scaffold62 indexed_genome mRNA 10183004 10188806 . + . ID=transcript_10877;Q8IYL3 A8K0C8 A8MUG9 Q5SR20 Q6NX36,UPF0688 protein C1orf174,, PF15772;, GO:0005654;, C:nucleoplasm;|Q8IYL3 A8K0C8 A8MUG9 Q5SR20 Q6NX36,UPF0688 protein C1orf174,, PF15772;, GO:0005654;, C:nucleoplasm;|Q8IYL3 A8K0C8 A8MUG9 Q5SR20 Q6NX36,UPF0688 protein C1orf174,, PF15772;, GO:0005654;, C:nucleoplasm; scaffold62 indexed_genome mRNA 10190889 10201168 . + . ID=transcript_10878;O76075 O60521 Q5SR22 Q9BYI4 Q9BYI5 Q9BYI6,DNA fragmentation factor subunit beta,Caspase-activated deoxyribonuclease;Caspase-activated nuclease;DNA fragmentation factor 40 kDa subunit;, PF02017;PF09230;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0004536;GO:0097718;GO:0019899;GO:0042802;GO:0019904;GO:0030263;GO:0006309;GO:0006308;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:deoxyribonuclease activity; F:disordered domain specific binding; F:enzyme binding; F:identical protein binding; F:protein domain specific binding;, P:apoptotic chromosome condensation; P:apoptotic DNA fragmentation; P:DNA catabolic process;|O76075 O60521 Q5SR22 Q9BYI4 Q9BYI5 Q9BYI6,DNA fragmentation factor subunit beta,Caspase-activated deoxyribonuclease;Caspase-activated nuclease;DNA fragmentation factor 40 kDa subunit;, PF02017;PF09230;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0004536;GO:0097718;GO:0019899;GO:0042802;GO:0019904;GO:0030263;GO:0006309;GO:0006308;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:deoxyribonuclease activity; F:disordered domain specific binding; F:enzyme binding; F:identical protein binding; F:protein domain specific binding;, P:apoptotic chromosome condensation; P:apoptotic DNA fragmentation; P:DNA catabolic process; scaffold62 indexed_genome mRNA 10202742 10205709 . - . ID=transcript_10879;O76075 O60521 Q5SR22 Q9BYI4 Q9BYI5 Q9BYI6,DNA fragmentation factor subunit beta,Caspase-activated deoxyribonuclease;Caspase-activated nuclease;DNA fragmentation factor 40 kDa subunit;, PF02017;PF09230;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0004536;GO:0097718;GO:0019899;GO:0042802;GO:0019904;GO:0030263;GO:0006309;GO:0006308;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:deoxyribonuclease activity; F:disordered domain specific binding; F:enzyme binding; F:identical protein binding; F:protein domain specific binding;, P:apoptotic chromosome condensation; P:apoptotic DNA fragmentation; P:DNA catabolic process; scaffold62 indexed_genome mRNA 10205797 10246074 . + . ID=transcript_10880;O60308 A0A024R4G3 Q5JSQ3 Q5SR24 Q5SR25 Q6PKF5 Q86W32 Q86X14,Centrosomal protein of 104 kDa,, , GO:0005814;GO:0005929;GO:0005737;GO:0000922;, C:centriole; C:cilium; C:cytoplasm; C:spindle pole;|O60308 A0A024R4G3 Q5JSQ3 Q5SR24 Q5SR25 Q6PKF5 Q86W32 Q86X14,Centrosomal protein of 104 kDa,, , GO:0005814;GO:0005929;GO:0005737;GO:0000922;, C:centriole; C:cilium; C:cytoplasm; C:spindle pole;|O60308 A0A024R4G3 Q5JSQ3 Q5SR24 Q5SR25 Q6PKF5 Q86W32 Q86X14,Centrosomal protein of 104 kDa,, , GO:0005814;GO:0005929;GO:0005737;GO:0000922;, C:centriole; C:cilium; C:cytoplasm; C:spindle pole;|O60308 A0A024R4G3 Q5JSQ3 Q5SR24 Q5SR25 Q6PKF5 Q86W32 Q86X14,Centrosomal protein of 104 kDa,, , GO:0005814;GO:0005929;GO:0005737;GO:0000922;, C:centriole; C:cilium; C:cytoplasm; C:spindle pole; scaffold62 indexed_genome mRNA 10249482 10251150 . - . ID=transcript_10881;O60308 A0A024R4G3 Q5JSQ3 Q5SR24 Q5SR25 Q6PKF5 Q86W32 Q86X14,Centrosomal protein of 104 kDa,, , GO:0005814;GO:0005929;GO:0005737;GO:0000922;, C:centriole; C:cilium; C:cytoplasm; C:spindle pole; scaffold62 indexed_genome mRNA 10265753 10268507 . - . ID=transcript_10882;Q8N1G4 Q9ULN5,Leucine-rich repeat-containing protein 47,, PF03483;PF00560;PF12799;PF13855;, GO:0004826;GO:0003723;, , F:phenylalanine-tRNA ligase activity; F:RNA binding; scaffold62 indexed_genome mRNA 10270231 10271251 . + . ID=transcript_10883;Q8N1G4 Q9ULN5,Leucine-rich repeat-containing protein 47,, PF03483;PF00560;PF12799;PF13855;, GO:0004826;GO:0003723;, , F:phenylalanine-tRNA ligase activity; F:RNA binding; scaffold62 indexed_genome mRNA 10274800 10278664 . - . ID=transcript_10884;B2RUZ4,Small integral membrane protein 1 {ECO:0000303|PubMed:23505126, ECO:0000312|HGNC:HGNC:44204},Vel blood group antigen {ECO:0000303|PubMed:23505126};, PF15875;, GO:0009986;GO:0016021;GO:0005886;GO:0042803;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:protein homodimerization activity; scaffold62 indexed_genome mRNA 10311386 10314827 . - . ID=transcript_10885;Q8NHW9 Q8TDY5 Q8TDY6 Q9NTK8,Tumor protein p73,p53-like transcription factor;p53-related protein;, PF00870;PF07710;PF07647;, GO:0030054;GO:0000785;GO:0005829;GO:0005794;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0097371;GO:0046872;GO:0002039;GO:0019901;GO:0000978;GO:0008134;GO:0000976;GO:0000187;GO:0007050;GO:0006974;GO:0008630;GO:0042771;GO:0001822;GO:0006298;GO:0060044;GO:0008285;GO:0045665;GO:0043065;GO:0071158;GO:0048714;GO:1900740;GO:0045944;GO:0045893;GO:0051262;GO:0042981;GO:0010468;GO:1902036;GO:0007346;GO:1901796;GO:0006357;GO:0042493;GO:0010243;GO:0016032;, C:cell junction; C:chromatin; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:MDM2/MDM4 family protein binding; F:metal ion binding; F:p53 binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of MAPK activity; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:kidney development; P:mismatch repair; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell population proliferation; P:negative regulation of neuron differentiation; P:positive regulation of apoptotic process; P:positive regulation of cell cycle arrest; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein tetramerization; P:regulation of apoptotic process; P:regulation of gene expression; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:response to drug; P:response to organonitrogen compound; P:viral process; scaffold62 indexed_genome mRNA 10397850 10409561 . - . ID=transcript_10886;Q9HAZ2 A6NHQ8 B1AJP7 B1AJP8 B1AJP9 B1WB48 Q8WYJ9 Q9C0I8,Histone-lysine N-methyltransferase PRDM16 {ECO:0000305},PR domain zinc finger protein 16 {ECO:0000305};PR domain-containing protein 16 {ECO:0000305};Transcription factor MEL1 {ECO:0000305};, PF00096;, GO:0016235;GO:0005829;GO:0005654;GO:0005634;GO:0017053;GO:0033613;GO:0001228;GO:0001227;GO:0046974;GO:0046872;GO:0000978;GO:0043565;GO:0003713;GO:0003712;GO:0000976;GO:0050873;GO:0070828;GO:0030853;GO:0000122;GO:0045892;GO:0030512;GO:0120162;GO:0045893;GO:0043457;GO:0006357;, C:aggresome; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription regulatory region sequence-specific DNA binding;, P:brown fat cell differentiation; P:heterochromatin organization; P:negative regulation of granulocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription, DNA-templated; P:regulation of cellular respiration; P:regulation of transcription by RNA polymerase II; scaffold62 indexed_genome mRNA 10415334 10423929 . - . ID=transcript_10887;Q9HAZ2 A6NHQ8 B1AJP7 B1AJP8 B1AJP9 B1WB48 Q8WYJ9 Q9C0I8,Histone-lysine N-methyltransferase PRDM16 {ECO:0000305},PR domain zinc finger protein 16 {ECO:0000305};PR domain-containing protein 16 {ECO:0000305};Transcription factor MEL1 {ECO:0000305};, PF00096;, GO:0016235;GO:0005829;GO:0005654;GO:0005634;GO:0017053;GO:0033613;GO:0001228;GO:0001227;GO:0046974;GO:0046872;GO:0000978;GO:0043565;GO:0003713;GO:0003712;GO:0000976;GO:0050873;GO:0070828;GO:0030853;GO:0000122;GO:0045892;GO:0030512;GO:0120162;GO:0045893;GO:0043457;GO:0006357;, C:aggresome; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:activating transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone methyltransferase activity (H3-K9 specific); F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription regulatory region sequence-specific DNA binding;, P:brown fat cell differentiation; P:heterochromatin organization; P:negative regulation of granulocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription, DNA-templated; P:regulation of cellular respiration; P:regulation of transcription by RNA polymerase II; scaffold62 indexed_genome mRNA 11001423 11002082 . - . ID=transcript_10888;A8MYJ7 A8MXL8,Tetratricopeptide repeat protein 34 scaffold62 indexed_genome mRNA 11010165 11036037 . - . ID=transcript_10889;Q495T6 B9DI79 Q495T7 Q495T8 Q5SZS6 Q96PH9,Membrane metallo-endopeptidase-like 1,Membrane metallo-endopeptidase-like 2;NEP2(m);Neprilysin II;Neprilysin-2;, PF01431;PF05649;, GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0004175;GO:0046872;GO:0004222;GO:0016485;GO:0006508;, C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:endopeptidase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:protein processing; P:proteolysis; scaffold62 indexed_genome mRNA 11039286 11046390 . + . ID=transcript_10890;Q495T6 B9DI79 Q495T7 Q495T8 Q5SZS6 Q96PH9,Membrane metallo-endopeptidase-like 1,Membrane metallo-endopeptidase-like 2;NEP2(m);Neprilysin II;Neprilysin-2;, PF01431;PF05649;, GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0004175;GO:0046872;GO:0004222;GO:0016485;GO:0006508;, C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:endopeptidase activity; F:metal ion binding; F:metalloendopeptidase activity;, P:protein processing; P:proteolysis; scaffold62 indexed_genome mRNA 11046938 11050320 . - . ID=transcript_10891;Q8N2H0,Prostamide/prostaglandin F synthase {ECO:0000305},Peroxiredoxin-like 2B {ECO:0000305};Protein FAM213B;, PF13911;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0043209;GO:0016209;GO:0016616;GO:0047017;GO:0001516;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:myelin sheath;, F:antioxidant activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:prostaglandin-F synthase activity;, P:prostaglandin biosynthetic process;|Q8N2H0,Prostamide/prostaglandin F synthase {ECO:0000305},Peroxiredoxin-like 2B {ECO:0000305};Protein FAM213B;, PF13911;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0043209;GO:0016209;GO:0016616;GO:0047017;GO:0001516;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:myelin sheath;, F:antioxidant activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:prostaglandin-F synthase activity;, P:prostaglandin biosynthetic process; scaffold62 indexed_genome mRNA 11083961 11085141 . + . ID=transcript_10892;Q9NVE7 B9DI84 Q53EU3 Q5TA84 Q7RTX3 Q9H3X5,4'-phosphopantetheine phosphatase {ECO:0000303|PubMed:27322068},Inactive pantothenic acid kinase 4 {ECO:0000303|PubMed:30927326};, PF01937;PF03630;, GO:0005829;GO:0005634;GO:0005524;GO:0016787;GO:0046872;GO:0015937;GO:0016310;, C:cytosol; C:nucleus;, F:ATP binding; F:hydrolase activity; F:metal ion binding;, P:coenzyme A biosynthetic process; P:phosphorylation; scaffold62 indexed_genome mRNA 11085291 11099685 . + . ID=transcript_10893;Q9NVE7 B9DI84 Q53EU3 Q5TA84 Q7RTX3 Q9H3X5,4'-phosphopantetheine phosphatase {ECO:0000303|PubMed:27322068},Inactive pantothenic acid kinase 4 {ECO:0000303|PubMed:30927326};, PF01937;PF03630;, GO:0005829;GO:0005634;GO:0005524;GO:0016787;GO:0046872;GO:0015937;GO:0016310;, C:cytosol; C:nucleus;, F:ATP binding; F:hydrolase activity; F:metal ion binding;, P:coenzyme A biosynthetic process; P:phosphorylation;|Q9NVE7 B9DI84 Q53EU3 Q5TA84 Q7RTX3 Q9H3X5,4'-phosphopantetheine phosphatase {ECO:0000303|PubMed:27322068},Inactive pantothenic acid kinase 4 {ECO:0000303|PubMed:30927326};, PF01937;PF03630;, GO:0005829;GO:0005634;GO:0005524;GO:0016787;GO:0046872;GO:0015937;GO:0016310;, C:cytosol; C:nucleus;, F:ATP binding; F:hydrolase activity; F:metal ion binding;, P:coenzyme A biosynthetic process; P:phosphorylation;|Q9NVE7 B9DI84 Q53EU3 Q5TA84 Q7RTX3 Q9H3X5,4'-phosphopantetheine phosphatase {ECO:0000303|PubMed:27322068},Inactive pantothenic acid kinase 4 {ECO:0000303|PubMed:30927326};, PF01937;PF03630;, GO:0005829;GO:0005634;GO:0005524;GO:0016787;GO:0046872;GO:0015937;GO:0016310;, C:cytosol; C:nucleus;, F:ATP binding; F:hydrolase activity; F:metal ion binding;, P:coenzyme A biosynthetic process; P:phosphorylation;|Q9NVE7 B9DI84 Q53EU3 Q5TA84 Q7RTX3 Q9H3X5,4'-phosphopantetheine phosphatase {ECO:0000303|PubMed:27322068},Inactive pantothenic acid kinase 4 {ECO:0000303|PubMed:30927326};, PF01937;PF03630;, GO:0005829;GO:0005634;GO:0005524;GO:0016787;GO:0046872;GO:0015937;GO:0016310;, C:cytosol; C:nucleus;, F:ATP binding; F:hydrolase activity; F:metal ion binding;, P:coenzyme A biosynthetic process; P:phosphorylation;|Q9NVE7 B9DI84 Q53EU3 Q5TA84 Q7RTX3 Q9H3X5,4'-phosphopantetheine phosphatase {ECO:0000303|PubMed:27322068},Inactive pantothenic acid kinase 4 {ECO:0000303|PubMed:30927326};, PF01937;PF03630;, GO:0005829;GO:0005634;GO:0005524;GO:0016787;GO:0046872;GO:0015937;GO:0016310;, C:cytosol; C:nucleus;, F:ATP binding; F:hydrolase activity; F:metal ion binding;, P:coenzyme A biosynthetic process; P:phosphorylation; scaffold62 indexed_genome mRNA 11101858 11104330 . - . ID=transcript_10894;O75038 A2VCM3 B9DI80 Q3LUA8 Q86XJ2 Q86XU1 Q86YU7 Q8TEH5 Q8WUS6,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 {ECO:0000305},Phosphoinositide phospholipase C-eta-2;Phosphoinositide phospholipase C-like 4;Phospholipase C-eta-2;, PF00168;PF09279;PF16457;PF00388;PF00387;, GO:0005737;GO:0005886;GO:0005509;GO:0004435;GO:0043647;GO:0016042;GO:0046488;GO:0048015;, C:cytoplasm; C:plasma membrane;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; scaffold62 indexed_genome mRNA 11104425 11114274 . - . ID=transcript_10895;O75038 A2VCM3 B9DI80 Q3LUA8 Q86XJ2 Q86XU1 Q86YU7 Q8TEH5 Q8WUS6,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 {ECO:0000305},Phosphoinositide phospholipase C-eta-2;Phosphoinositide phospholipase C-like 4;Phospholipase C-eta-2;, PF00168;PF09279;PF16457;PF00388;PF00387;, GO:0005737;GO:0005886;GO:0005509;GO:0004435;GO:0043647;GO:0016042;GO:0046488;GO:0048015;, C:cytoplasm; C:plasma membrane;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; scaffold62 indexed_genome mRNA 11114294 11135796 . - . ID=transcript_10896;O75038 A2VCM3 B9DI80 Q3LUA8 Q86XJ2 Q86XU1 Q86YU7 Q8TEH5 Q8WUS6,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 {ECO:0000305},Phosphoinositide phospholipase C-eta-2;Phosphoinositide phospholipase C-like 4;Phospholipase C-eta-2;, PF00168;PF09279;PF16457;PF00388;PF00387;, GO:0005737;GO:0005886;GO:0005509;GO:0004435;GO:0043647;GO:0016042;GO:0046488;GO:0048015;, C:cytoplasm; C:plasma membrane;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity;, P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; scaffold62 indexed_genome mRNA 11182094 11198230 . + . ID=transcript_10897;O60683 B3KWD8 Q5T095 Q9BW90,Peroxisome biogenesis factor 10,Peroxin-10;Peroxisomal biogenesis factor 10;Peroxisome assembly protein 10;RING finger protein 69;, PF04757;, GO:0005779;GO:0005778;GO:0005777;GO:0046872;GO:0008022;GO:0008270;GO:0007031;GO:0016558;GO:0008104;GO:0016567;, C:integral component of peroxisomal membrane; C:peroxisomal membrane; C:peroxisome;, F:metal ion binding; F:protein C-terminus binding; F:zinc ion binding;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization; P:protein ubiquitination;|O15258 O95322,Protein RER1,, PF03248;, GO:0009986;GO:0005783;GO:0005793;GO:0005794;GO:0030173;GO:0005886;GO:0033130;GO:1903078;GO:0006621;GO:0006890;GO:0071340;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of Golgi membrane; C:plasma membrane;, F:acetylcholine receptor binding;, P:positive regulation of protein localization to plasma membrane; P:protein retention in ER lumen; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:skeletal muscle acetylcholine-gated channel clustering;|O60683 B3KWD8 Q5T095 Q9BW90,Peroxisome biogenesis factor 10,Peroxin-10;Peroxisomal biogenesis factor 10;Peroxisome assembly protein 10;RING finger protein 69;, PF04757;, GO:0005779;GO:0005778;GO:0005777;GO:0046872;GO:0008022;GO:0008270;GO:0007031;GO:0016558;GO:0008104;GO:0016567;, C:integral component of peroxisomal membrane; C:peroxisomal membrane; C:peroxisome;, F:metal ion binding; F:protein C-terminus binding; F:zinc ion binding;, P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization; P:protein ubiquitination;|O15258 O95322,Protein RER1,, PF03248;, GO:0009986;GO:0005783;GO:0005793;GO:0005794;GO:0030173;GO:0005886;GO:0033130;GO:1903078;GO:0006621;GO:0006890;GO:0071340;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of Golgi membrane; C:plasma membrane;, F:acetylcholine receptor binding;, P:positive regulation of protein localization to plasma membrane; P:protein retention in ER lumen; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:skeletal muscle acetylcholine-gated channel clustering;|O15258 O95322,Protein RER1,, PF03248;, GO:0009986;GO:0005783;GO:0005793;GO:0005794;GO:0030173;GO:0005886;GO:0033130;GO:1903078;GO:0006621;GO:0006890;GO:0071340;, C:cell surface; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of Golgi membrane; C:plasma membrane;, F:acetylcholine receptor binding;, P:positive regulation of protein localization to plasma membrane; P:protein retention in ER lumen; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:skeletal muscle acetylcholine-gated channel clustering; scaffold62 indexed_genome mRNA 11198504 11212978 . + . ID=transcript_10898;Q5T089 A6NKZ6 Q8WW30 Q9H852,MORN repeat-containing protein 1,, PF02493; scaffold62 indexed_genome mRNA 11220257 11239739 . + . ID=transcript_10899;Q5T089 A6NKZ6 Q8WW30 Q9H852,MORN repeat-containing protein 1,, PF02493;|Q5T089 A6NKZ6 Q8WW30 Q9H852,MORN repeat-containing protein 1,, PF02493; scaffold62 indexed_genome mRNA 11246188 11248685 . + . ID=transcript_10900;Q5T089 A6NKZ6 Q8WW30 Q9H852,MORN repeat-containing protein 1,, PF02493; scaffold63 indexed_genome mRNA 106648 107518 . - . ID=transcript_10901;Q99678 Q17R96,G-protein coupled receptor 20,, PF00001;, GO:0005829;GO:0005887;GO:0005886;GO:0043235;GO:0004930;GO:0007186;GO:0002862;GO:0051482;GO:0035025;, C:cytosol; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of Rho protein signal transduction; scaffold63 indexed_genome mRNA 143493 256885 . + . ID=transcript_10902;Q5BKX6 Q6ZRI2 Q9ULU3,Solute carrier family 45 member 4,, , GO:0016021;GO:0016020;GO:0008506;GO:0015770;, C:integral component of membrane; C:membrane;, F:sucrose:proton symporter activity;, P:sucrose transport;|Q5BKX6 Q6ZRI2 Q9ULU3,Solute carrier family 45 member 4,, , GO:0016021;GO:0016020;GO:0008506;GO:0015770;, C:integral component of membrane; C:membrane;, F:sucrose:proton symporter activity;, P:sucrose transport;|Q5BKX6 Q6ZRI2 Q9ULU3,Solute carrier family 45 member 4,, , GO:0016021;GO:0016020;GO:0008506;GO:0015770;, C:integral component of membrane; C:membrane;, F:sucrose:proton symporter activity;, P:sucrose transport;|A2RUS2 B7ZM28 O94947 Q2TAM7 Q6ZMS6 Q96DK3,DENN domain-containing protein 3,, PF02141;, GO:0031410;GO:0005829;GO:0005085;GO:0044257;GO:0008333;GO:0032483;, C:cytoplasmic vesicle; C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:cellular protein catabolic process; P:endosome to lysosome transport; P:regulation of Rab protein signal transduction; scaffold63 indexed_genome mRNA 293461 483202 . + . ID=transcript_10903;Q05397 B4E2N6 F5H4S4 J3QT16 Q14291 Q8IYN9 Q9UD85,Focal adhesion kinase 1 {ECO:0000305},Focal adhesion kinase-related nonkinase;Protein phosphatase 1 regulatory subunit 71;Protein-tyrosine kinase 2;p125FAK;pp125FAK;, PF00373;PF18038;PF03623;PF07714;, GO:0005938;GO:0036064;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0031234;GO:0005925;GO:0043231;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005178;GO:0008432;GO:0004715;GO:0019901;GO:0019903;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0001525;GO:0007411;GO:0030154;GO:0048870;GO:0035995;GO:0048013;GO:0007173;GO:0030010;GO:0038096;GO:0060396;GO:0003007;GO:0045087;GO:0007229;GO:0000165;GO:2000811;GO:0043066;GO:0022408;GO:0038007;GO:0018108;GO:0001890;GO:0030335;GO:0008284;GO:0010763;GO:0010759;GO:0120041;GO:0043552;GO:0014068;GO:0045860;GO:0051897;GO:0001934;GO:2000060;GO:0090303;GO:0046777;GO:0030155;GO:0033628;GO:0042127;GO:0008360;GO:0051493;GO:0010594;GO:0010632;GO:0051893;GO:0043087;GO:0045667;GO:0001932;GO:1900024;GO:0007172;GO:0007179;GO:0007169;GO:0048010;, C:cell cortex; C:ciliary basal body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:integrin binding; F:JUN kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:axon guidance; P:cell differentiation; P:cell motility; P:detection of muscle stretch; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway; P:heart morphogenesis; P:innate immune response; P:integrin-mediated signaling pathway; P:MAPK cascade; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cell-cell adhesion; P:netrin-activated signaling pathway; P:peptidyl-tyrosine phosphorylation; P:placenta development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of wound healing; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of endothelial cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of GTPase activity; P:regulation of osteoblast differentiation; P:regulation of protein phosphorylation; P:regulation of substrate adhesion-dependent cell spreading; P:signal complex assembly; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q05397 B4E2N6 F5H4S4 J3QT16 Q14291 Q8IYN9 Q9UD85,Focal adhesion kinase 1 {ECO:0000305},Focal adhesion kinase-related nonkinase;Protein phosphatase 1 regulatory subunit 71;Protein-tyrosine kinase 2;p125FAK;pp125FAK;, PF00373;PF18038;PF03623;PF07714;, GO:0005938;GO:0036064;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0031234;GO:0005925;GO:0043231;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005178;GO:0008432;GO:0004715;GO:0019901;GO:0019903;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0001525;GO:0007411;GO:0030154;GO:0048870;GO:0035995;GO:0048013;GO:0007173;GO:0030010;GO:0038096;GO:0060396;GO:0003007;GO:0045087;GO:0007229;GO:0000165;GO:2000811;GO:0043066;GO:0022408;GO:0038007;GO:0018108;GO:0001890;GO:0030335;GO:0008284;GO:0010763;GO:0010759;GO:0120041;GO:0043552;GO:0014068;GO:0045860;GO:0051897;GO:0001934;GO:2000060;GO:0090303;GO:0046777;GO:0030155;GO:0033628;GO:0042127;GO:0008360;GO:0051493;GO:0010594;GO:0010632;GO:0051893;GO:0043087;GO:0045667;GO:0001932;GO:1900024;GO:0007172;GO:0007179;GO:0007169;GO:0048010;, C:cell cortex; C:ciliary basal body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:integrin binding; F:JUN kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:axon guidance; P:cell differentiation; P:cell motility; P:detection of muscle stretch; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway; P:heart morphogenesis; P:innate immune response; P:integrin-mediated signaling pathway; P:MAPK cascade; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cell-cell adhesion; P:netrin-activated signaling pathway; P:peptidyl-tyrosine phosphorylation; P:placenta development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of wound healing; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of endothelial cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of GTPase activity; P:regulation of osteoblast differentiation; P:regulation of protein phosphorylation; P:regulation of substrate adhesion-dependent cell spreading; P:signal complex assembly; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q05397 B4E2N6 F5H4S4 J3QT16 Q14291 Q8IYN9 Q9UD85,Focal adhesion kinase 1 {ECO:0000305},Focal adhesion kinase-related nonkinase;Protein phosphatase 1 regulatory subunit 71;Protein-tyrosine kinase 2;p125FAK;pp125FAK;, PF00373;PF18038;PF03623;PF07714;, GO:0005938;GO:0036064;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0031234;GO:0005925;GO:0043231;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005178;GO:0008432;GO:0004715;GO:0019901;GO:0019903;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0001525;GO:0007411;GO:0030154;GO:0048870;GO:0035995;GO:0048013;GO:0007173;GO:0030010;GO:0038096;GO:0060396;GO:0003007;GO:0045087;GO:0007229;GO:0000165;GO:2000811;GO:0043066;GO:0022408;GO:0038007;GO:0018108;GO:0001890;GO:0030335;GO:0008284;GO:0010763;GO:0010759;GO:0120041;GO:0043552;GO:0014068;GO:0045860;GO:0051897;GO:0001934;GO:2000060;GO:0090303;GO:0046777;GO:0030155;GO:0033628;GO:0042127;GO:0008360;GO:0051493;GO:0010594;GO:0010632;GO:0051893;GO:0043087;GO:0045667;GO:0001932;GO:1900024;GO:0007172;GO:0007179;GO:0007169;GO:0048010;, C:cell cortex; C:ciliary basal body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:integrin binding; F:JUN kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:axon guidance; P:cell differentiation; P:cell motility; P:detection of muscle stretch; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway; P:heart morphogenesis; P:innate immune response; P:integrin-mediated signaling pathway; P:MAPK cascade; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cell-cell adhesion; P:netrin-activated signaling pathway; P:peptidyl-tyrosine phosphorylation; P:placenta development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of wound healing; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of endothelial cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of GTPase activity; P:regulation of osteoblast differentiation; P:regulation of protein phosphorylation; P:regulation of substrate adhesion-dependent cell spreading; P:signal complex assembly; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q05397 B4E2N6 F5H4S4 J3QT16 Q14291 Q8IYN9 Q9UD85,Focal adhesion kinase 1 {ECO:0000305},Focal adhesion kinase-related nonkinase;Protein phosphatase 1 regulatory subunit 71;Protein-tyrosine kinase 2;p125FAK;pp125FAK;, PF00373;PF18038;PF03623;PF07714;, GO:0005938;GO:0036064;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0031234;GO:0005925;GO:0043231;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005178;GO:0008432;GO:0004715;GO:0019901;GO:0019903;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0001525;GO:0007411;GO:0030154;GO:0048870;GO:0035995;GO:0048013;GO:0007173;GO:0030010;GO:0038096;GO:0060396;GO:0003007;GO:0045087;GO:0007229;GO:0000165;GO:2000811;GO:0043066;GO:0022408;GO:0038007;GO:0018108;GO:0001890;GO:0030335;GO:0008284;GO:0010763;GO:0010759;GO:0120041;GO:0043552;GO:0014068;GO:0045860;GO:0051897;GO:0001934;GO:2000060;GO:0090303;GO:0046777;GO:0030155;GO:0033628;GO:0042127;GO:0008360;GO:0051493;GO:0010594;GO:0010632;GO:0051893;GO:0043087;GO:0045667;GO:0001932;GO:1900024;GO:0007172;GO:0007179;GO:0007169;GO:0048010;, C:cell cortex; C:ciliary basal body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:integrin binding; F:JUN kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:axon guidance; P:cell differentiation; P:cell motility; P:detection of muscle stretch; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway; P:heart morphogenesis; P:innate immune response; P:integrin-mediated signaling pathway; P:MAPK cascade; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cell-cell adhesion; P:netrin-activated signaling pathway; P:peptidyl-tyrosine phosphorylation; P:placenta development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of wound healing; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of endothelial cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of GTPase activity; P:regulation of osteoblast differentiation; P:regulation of protein phosphorylation; P:regulation of substrate adhesion-dependent cell spreading; P:signal complex assembly; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q05397 B4E2N6 F5H4S4 J3QT16 Q14291 Q8IYN9 Q9UD85,Focal adhesion kinase 1 {ECO:0000305},Focal adhesion kinase-related nonkinase;Protein phosphatase 1 regulatory subunit 71;Protein-tyrosine kinase 2;p125FAK;pp125FAK;, PF00373;PF18038;PF03623;PF07714;, GO:0005938;GO:0036064;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0031234;GO:0005925;GO:0043231;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005178;GO:0008432;GO:0004715;GO:0019901;GO:0019903;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0001525;GO:0007411;GO:0030154;GO:0048870;GO:0035995;GO:0048013;GO:0007173;GO:0030010;GO:0038096;GO:0060396;GO:0003007;GO:0045087;GO:0007229;GO:0000165;GO:2000811;GO:0043066;GO:0022408;GO:0038007;GO:0018108;GO:0001890;GO:0030335;GO:0008284;GO:0010763;GO:0010759;GO:0120041;GO:0043552;GO:0014068;GO:0045860;GO:0051897;GO:0001934;GO:2000060;GO:0090303;GO:0046777;GO:0030155;GO:0033628;GO:0042127;GO:0008360;GO:0051493;GO:0010594;GO:0010632;GO:0051893;GO:0043087;GO:0045667;GO:0001932;GO:1900024;GO:0007172;GO:0007179;GO:0007169;GO:0048010;, C:cell cortex; C:ciliary basal body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:integrin binding; F:JUN kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:axon guidance; P:cell differentiation; P:cell motility; P:detection of muscle stretch; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway; P:heart morphogenesis; P:innate immune response; P:integrin-mediated signaling pathway; P:MAPK cascade; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cell-cell adhesion; P:netrin-activated signaling pathway; P:peptidyl-tyrosine phosphorylation; P:placenta development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of wound healing; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of endothelial cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of GTPase activity; P:regulation of osteoblast differentiation; P:regulation of protein phosphorylation; P:regulation of substrate adhesion-dependent cell spreading; P:signal complex assembly; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q05397 B4E2N6 F5H4S4 J3QT16 Q14291 Q8IYN9 Q9UD85,Focal adhesion kinase 1 {ECO:0000305},Focal adhesion kinase-related nonkinase;Protein phosphatase 1 regulatory subunit 71;Protein-tyrosine kinase 2;p125FAK;pp125FAK;, PF00373;PF18038;PF03623;PF07714;, GO:0005938;GO:0036064;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0031234;GO:0005925;GO:0043231;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005178;GO:0008432;GO:0004715;GO:0019901;GO:0019903;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0001525;GO:0007411;GO:0030154;GO:0048870;GO:0035995;GO:0048013;GO:0007173;GO:0030010;GO:0038096;GO:0060396;GO:0003007;GO:0045087;GO:0007229;GO:0000165;GO:2000811;GO:0043066;GO:0022408;GO:0038007;GO:0018108;GO:0001890;GO:0030335;GO:0008284;GO:0010763;GO:0010759;GO:0120041;GO:0043552;GO:0014068;GO:0045860;GO:0051897;GO:0001934;GO:2000060;GO:0090303;GO:0046777;GO:0030155;GO:0033628;GO:0042127;GO:0008360;GO:0051493;GO:0010594;GO:0010632;GO:0051893;GO:0043087;GO:0045667;GO:0001932;GO:1900024;GO:0007172;GO:0007179;GO:0007169;GO:0048010;, C:cell cortex; C:ciliary basal body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:integrin binding; F:JUN kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:axon guidance; P:cell differentiation; P:cell motility; P:detection of muscle stretch; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway; P:heart morphogenesis; P:innate immune response; P:integrin-mediated signaling pathway; P:MAPK cascade; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cell-cell adhesion; P:netrin-activated signaling pathway; P:peptidyl-tyrosine phosphorylation; P:placenta development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of wound healing; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of endothelial cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of GTPase activity; P:regulation of osteoblast differentiation; P:regulation of protein phosphorylation; P:regulation of substrate adhesion-dependent cell spreading; P:signal complex assembly; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q05397 B4E2N6 F5H4S4 J3QT16 Q14291 Q8IYN9 Q9UD85,Focal adhesion kinase 1 {ECO:0000305},Focal adhesion kinase-related nonkinase;Protein phosphatase 1 regulatory subunit 71;Protein-tyrosine kinase 2;p125FAK;pp125FAK;, PF00373;PF18038;PF03623;PF07714;, GO:0005938;GO:0036064;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0031234;GO:0005925;GO:0043231;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005178;GO:0008432;GO:0004715;GO:0019901;GO:0019903;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0001525;GO:0007411;GO:0030154;GO:0048870;GO:0035995;GO:0048013;GO:0007173;GO:0030010;GO:0038096;GO:0060396;GO:0003007;GO:0045087;GO:0007229;GO:0000165;GO:2000811;GO:0043066;GO:0022408;GO:0038007;GO:0018108;GO:0001890;GO:0030335;GO:0008284;GO:0010763;GO:0010759;GO:0120041;GO:0043552;GO:0014068;GO:0045860;GO:0051897;GO:0001934;GO:2000060;GO:0090303;GO:0046777;GO:0030155;GO:0033628;GO:0042127;GO:0008360;GO:0051493;GO:0010594;GO:0010632;GO:0051893;GO:0043087;GO:0045667;GO:0001932;GO:1900024;GO:0007172;GO:0007179;GO:0007169;GO:0048010;, C:cell cortex; C:ciliary basal body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:integrin binding; F:JUN kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:axon guidance; P:cell differentiation; P:cell motility; P:detection of muscle stretch; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway; P:heart morphogenesis; P:innate immune response; P:integrin-mediated signaling pathway; P:MAPK cascade; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cell-cell adhesion; P:netrin-activated signaling pathway; P:peptidyl-tyrosine phosphorylation; P:placenta development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of wound healing; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of endothelial cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of GTPase activity; P:regulation of osteoblast differentiation; P:regulation of protein phosphorylation; P:regulation of substrate adhesion-dependent cell spreading; P:signal complex assembly; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q05397 B4E2N6 F5H4S4 J3QT16 Q14291 Q8IYN9 Q9UD85,Focal adhesion kinase 1 {ECO:0000305},Focal adhesion kinase-related nonkinase;Protein phosphatase 1 regulatory subunit 71;Protein-tyrosine kinase 2;p125FAK;pp125FAK;, PF00373;PF18038;PF03623;PF07714;, GO:0005938;GO:0036064;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0031234;GO:0005925;GO:0043231;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005178;GO:0008432;GO:0004715;GO:0019901;GO:0019903;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0001525;GO:0007411;GO:0030154;GO:0048870;GO:0035995;GO:0048013;GO:0007173;GO:0030010;GO:0038096;GO:0060396;GO:0003007;GO:0045087;GO:0007229;GO:0000165;GO:2000811;GO:0043066;GO:0022408;GO:0038007;GO:0018108;GO:0001890;GO:0030335;GO:0008284;GO:0010763;GO:0010759;GO:0120041;GO:0043552;GO:0014068;GO:0045860;GO:0051897;GO:0001934;GO:2000060;GO:0090303;GO:0046777;GO:0030155;GO:0033628;GO:0042127;GO:0008360;GO:0051493;GO:0010594;GO:0010632;GO:0051893;GO:0043087;GO:0045667;GO:0001932;GO:1900024;GO:0007172;GO:0007179;GO:0007169;GO:0048010;, C:cell cortex; C:ciliary basal body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:integrin binding; F:JUN kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:axon guidance; P:cell differentiation; P:cell motility; P:detection of muscle stretch; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway; P:heart morphogenesis; P:innate immune response; P:integrin-mediated signaling pathway; P:MAPK cascade; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cell-cell adhesion; P:netrin-activated signaling pathway; P:peptidyl-tyrosine phosphorylation; P:placenta development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of wound healing; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of endothelial cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of GTPase activity; P:regulation of osteoblast differentiation; P:regulation of protein phosphorylation; P:regulation of substrate adhesion-dependent cell spreading; P:signal complex assembly; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q05397 B4E2N6 F5H4S4 J3QT16 Q14291 Q8IYN9 Q9UD85,Focal adhesion kinase 1 {ECO:0000305},Focal adhesion kinase-related nonkinase;Protein phosphatase 1 regulatory subunit 71;Protein-tyrosine kinase 2;p125FAK;pp125FAK;, PF00373;PF18038;PF03623;PF07714;, GO:0005938;GO:0036064;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0031234;GO:0005925;GO:0043231;GO:0005634;GO:0005886;GO:0001725;GO:0003779;GO:0005524;GO:0005178;GO:0008432;GO:0004715;GO:0019901;GO:0019903;GO:0004713;GO:0042169;GO:0005102;GO:0004714;GO:0001525;GO:0007411;GO:0030154;GO:0048870;GO:0035995;GO:0048013;GO:0007173;GO:0030010;GO:0038096;GO:0060396;GO:0003007;GO:0045087;GO:0007229;GO:0000165;GO:2000811;GO:0043066;GO:0022408;GO:0038007;GO:0018108;GO:0001890;GO:0030335;GO:0008284;GO:0010763;GO:0010759;GO:0120041;GO:0043552;GO:0014068;GO:0045860;GO:0051897;GO:0001934;GO:2000060;GO:0090303;GO:0046777;GO:0030155;GO:0033628;GO:0042127;GO:0008360;GO:0051493;GO:0010594;GO:0010632;GO:0051893;GO:0043087;GO:0045667;GO:0001932;GO:1900024;GO:0007172;GO:0007179;GO:0007169;GO:0048010;, C:cell cortex; C:ciliary basal body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane; C:stress fiber;, F:actin binding; F:ATP binding; F:integrin binding; F:JUN kinase binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:axon guidance; P:cell differentiation; P:cell motility; P:detection of muscle stretch; P:ephrin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:growth hormone receptor signaling pathway; P:heart morphogenesis; P:innate immune response; P:integrin-mediated signaling pathway; P:MAPK cascade; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of cell-cell adhesion; P:netrin-activated signaling pathway; P:peptidyl-tyrosine phosphorylation; P:placenta development; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of fibroblast migration; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of wound healing; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of endothelial cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of GTPase activity; P:regulation of osteoblast differentiation; P:regulation of protein phosphorylation; P:regulation of substrate adhesion-dependent cell spreading; P:signal complex assembly; P:transforming growth factor beta receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold63 indexed_genome mRNA 544526 583867 . + . ID=transcript_10904;Q9UKV8 Q8TCZ5 Q8WV58 Q96ID1,Protein argonaute-2 {ECO:0000255|HAMAP-Rule:MF_03031},Argonaute RISC catalytic component 2;Eukaryotic translation initiation factor 2C 2 {ECO:0000255|HAMAP-Rule:MF_03031};PAZ Piwi domain protein;Protein slicer {ECO:0000255|HAMAP-Rule:MF_03031};, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0005737;GO:0036464;GO:0005829;GO:0030425;GO:0070062;GO:0016020;GO:0005845;GO:0005654;GO:0005634;GO:0000932;GO:0005844;GO:1990904;GO:0016442;GO:0070578;GO:0001046;GO:0003725;GO:0004521;GO:0090624;GO:0070551;GO:0046872;GO:0035198;GO:0098808;GO:0008022;GO:0000340;GO:0003723;GO:0000993;GO:0003727;GO:0035197;GO:0003743;GO:0031047;GO:0030522;GO:0035280;GO:0035278;GO:0010586;GO:0035279;GO:0090625;GO:0042985;GO:0010629;GO:0045947;GO:0045766;GO:0010628;GO:1905618;GO:1900153;GO:0060213;GO:0045944;GO:0045975;GO:1901165;GO:0009791;GO:0035194;GO:0031054;GO:0035196;GO:0030422;GO:0060964;GO:0010501;GO:0035087;GO:0006412;GO:0007223;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendrite; C:extracellular exosome; C:membrane; C:mRNA cap binding complex; C:nucleoplasm; C:nucleus; C:P-body; C:polysome; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:core promoter sequence-specific DNA binding; F:double-stranded RNA binding; F:endoribonuclease activity; F:endoribonuclease activity, cleaving miRNA-paired mRNA; F:endoribonuclease activity, cleaving siRNA-paired mRNA; F:metal ion binding; F:miRNA binding; F:mRNA cap binding; F:protein C-terminus binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA polymerase II complex binding; F:single-stranded RNA binding; F:siRNA binding; F:translation initiation factor activity;, P:gene silencing by RNA; P:intracellular receptor signaling pathway; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:miRNA metabolic process; P:mRNA cleavage involved in gene silencing by miRNA; P:mRNA cleavage involved in gene silencing by siRNA; P:negative regulation of amyloid precursor protein biosynthetic process; P:negative regulation of gene expression; P:negative regulation of translational initiation; P:positive regulation of angiogenesis; P:positive regulation of gene expression; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation, ncRNA-mediated; P:positive regulation of trophoblast cell migration; P:post-embryonic development; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:regulation of gene silencing by miRNA; P:RNA secondary structure unwinding; P:siRNA loading onto RISC involved in RNA interference; P:translation; P:Wnt signaling pathway, calcium modulating pathway; scaffold63 indexed_genome mRNA 597644 600529 . - . ID=transcript_10905;Q9NRG0,Chromatin accessibility complex protein 1,Chromatin accessibility complex 15 kDa protein;DNA polymerase epsilon subunit p15;, PF00808;, GO:0008623;GO:0008622;GO:0005634;GO:0003677;GO:0003887;GO:0046982;GO:0006338;, C:CHRAC; C:epsilon DNA polymerase complex; C:nucleus;, F:DNA binding; F:DNA-directed DNA polymerase activity; F:protein heterodimerization activity;, P:chromatin remodeling;|Q9NRG0,Chromatin accessibility complex protein 1,Chromatin accessibility complex 15 kDa protein;DNA polymerase epsilon subunit p15;, PF00808;, GO:0008623;GO:0008622;GO:0005634;GO:0003677;GO:0003887;GO:0046982;GO:0006338;, C:CHRAC; C:epsilon DNA polymerase complex; C:nucleus;, F:DNA binding; F:DNA-directed DNA polymerase activity; F:protein heterodimerization activity;, P:chromatin remodeling;|Q9NRG0,Chromatin accessibility complex protein 1,Chromatin accessibility complex 15 kDa protein;DNA polymerase epsilon subunit p15;, PF00808;, GO:0008623;GO:0008622;GO:0005634;GO:0003677;GO:0003887;GO:0046982;GO:0006338;, C:CHRAC; C:epsilon DNA polymerase complex; C:nucleus;, F:DNA binding; F:DNA-directed DNA polymerase activity; F:protein heterodimerization activity;, P:chromatin remodeling; scaffold63 indexed_genome mRNA 645964 1046247 . + . ID=transcript_10906;Q96Q05 Q4VTT3 Q658K7 Q6P149 Q6ZQT3 Q7L5C4 Q86Y21 Q96SL2 Q9BQA2,Trafficking protein particle complex subunit 9,NIK- and IKBKB-binding protein;Tularik gene 1 protein;, PF08626;, GO:0005829;GO:0005783;GO:0005802;GO:0030008;GO:0021987;GO:0048208;GO:0030182;GO:0051092;, C:cytosol; C:endoplasmic reticulum; C:trans-Golgi network; C:TRAPP complex;, , P:cerebral cortex development; P:COPII vesicle coating; P:neuron differentiation; P:positive regulation of NF-kappaB transcription factor activity;|Q96Q05 Q4VTT3 Q658K7 Q6P149 Q6ZQT3 Q7L5C4 Q86Y21 Q96SL2 Q9BQA2,Trafficking protein particle complex subunit 9,NIK- and IKBKB-binding protein;Tularik gene 1 protein;, PF08626;, GO:0005829;GO:0005783;GO:0005802;GO:0030008;GO:0021987;GO:0048208;GO:0030182;GO:0051092;, C:cytosol; C:endoplasmic reticulum; C:trans-Golgi network; C:TRAPP complex;, , P:cerebral cortex development; P:COPII vesicle coating; P:neuron differentiation; P:positive regulation of NF-kappaB transcription factor activity;|Q96Q05 Q4VTT3 Q658K7 Q6P149 Q6ZQT3 Q7L5C4 Q86Y21 Q96SL2 Q9BQA2,Trafficking protein particle complex subunit 9,NIK- and IKBKB-binding protein;Tularik gene 1 protein;, PF08626;, GO:0005829;GO:0005783;GO:0005802;GO:0030008;GO:0021987;GO:0048208;GO:0030182;GO:0051092;, C:cytosol; C:endoplasmic reticulum; C:trans-Golgi network; C:TRAPP complex;, , P:cerebral cortex development; P:COPII vesicle coating; P:neuron differentiation; P:positive regulation of NF-kappaB transcription factor activity; scaffold63 indexed_genome mRNA 1068129 1079904 . - . ID=transcript_10907;Q9NPC2 Q2M290 Q540F2,Potassium channel subfamily K member 9,Acid-sensitive potassium channel protein TASK-3;TWIK-related acid-sensitive K(+) channel 3;Two pore potassium channel KT3.2;, PF07885;, GO:0005887;GO:0005886;GO:0008021;GO:0005267;GO:0022841;GO:0005249;GO:1990573;GO:0071805;GO:0006813;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane; C:synaptic vesicle;, F:potassium channel activity; F:potassium ion leak channel activity; F:voltage-gated potassium channel activity;, P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:stabilization of membrane potential; scaffold63 indexed_genome mRNA 1168946 1170375 . + . ID=transcript_10908;Q9NPC2 Q2M290 Q540F2,Potassium channel subfamily K member 9,Acid-sensitive potassium channel protein TASK-3;TWIK-related acid-sensitive K(+) channel 3;Two pore potassium channel KT3.2;, PF07885;, GO:0005887;GO:0005886;GO:0008021;GO:0005267;GO:0022841;GO:0005249;GO:1990573;GO:0071805;GO:0006813;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane; C:synaptic vesicle;, F:potassium channel activity; F:potassium ion leak channel activity; F:voltage-gated potassium channel activity;, P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:stabilization of membrane potential; scaffold63 indexed_genome mRNA 1536781 1563432 . + . ID=transcript_10909;Q8NFW1 B7ZMH0 C9K0G4 Q8IVT9,Collagen alpha-1(XXII) chain,, PF01391;PF00092;, GO:0005581;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0001525;GO:0030199;GO:0001886;GO:0030198;, C:collagen trimer; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:angiogenesis; P:collagen fibril organization; P:endothelial cell morphogenesis; P:extracellular matrix organization; scaffold63 indexed_genome mRNA 1731109 1746078 . + . ID=transcript_10910;Q8NFW1 B7ZMH0 C9K0G4 Q8IVT9,Collagen alpha-1(XXII) chain,, PF01391;PF00092;, GO:0005581;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0001525;GO:0030199;GO:0001886;GO:0030198;, C:collagen trimer; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:angiogenesis; P:collagen fibril organization; P:endothelial cell morphogenesis; P:extracellular matrix organization;|Q8NFW1 B7ZMH0 C9K0G4 Q8IVT9,Collagen alpha-1(XXII) chain,, PF01391;PF00092;, GO:0005581;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0001525;GO:0030199;GO:0001886;GO:0030198;, C:collagen trimer; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent;, P:angiogenesis; P:collagen fibril organization; P:endothelial cell morphogenesis; P:extracellular matrix organization; scaffold63 indexed_genome mRNA 1816838 1994525 . + . ID=transcript_10911;Q49AJ0 B5MDB3 O95879 Q2WGJ7 Q3KP46,Protein FAM135B,, PF12394;PF05057;, GO:0044255;, , , P:cellular lipid metabolic process; scaffold63 indexed_genome mRNA 2033124 2050123 . + . ID=transcript_10912;Q49AJ0 B5MDB3 O95879 Q2WGJ7 Q3KP46,Protein FAM135B,, PF12394;PF05057;, GO:0044255;, , , P:cellular lipid metabolic process; scaffold63 indexed_genome mRNA 2050351 2068295 . + . ID=transcript_10913;Q49AJ0 B5MDB3 O95879 Q2WGJ7 Q3KP46,Protein FAM135B,, PF12394;PF05057;, GO:0044255;, , , P:cellular lipid metabolic process; scaffold63 indexed_genome mRNA 4441186 4461528 . + . ID=transcript_10914;Q9P243 B7ZL15 E9PER3 Q3MIM5 Q6PJ01 Q75PJ6 Q75PJ7 Q75PJ9 Q86X64,Zinc finger protein ZFAT,Zinc finger gene in AITD susceptibility region;Zinc finger protein 406;, PF00096;, GO:0005829;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0002244;GO:0006355;GO:0060712;, C:cytosol; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:hematopoietic progenitor cell differentiation; P:regulation of transcription, DNA-templated; P:spongiotrophoblast layer development; scaffold63 indexed_genome mRNA 4480272 4503328 . + . ID=transcript_10915;Q9P243 B7ZL15 E9PER3 Q3MIM5 Q6PJ01 Q75PJ6 Q75PJ7 Q75PJ9 Q86X64,Zinc finger protein ZFAT,Zinc finger gene in AITD susceptibility region;Zinc finger protein 406;, PF00096;, GO:0005829;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0002244;GO:0006355;GO:0060712;, C:cytosol; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:hematopoietic progenitor cell differentiation; P:regulation of transcription, DNA-templated; P:spongiotrophoblast layer development; scaffold63 indexed_genome mRNA 4503450 4584823 . + . ID=transcript_10916;Q9P243 B7ZL15 E9PER3 Q3MIM5 Q6PJ01 Q75PJ6 Q75PJ7 Q75PJ9 Q86X64,Zinc finger protein ZFAT,Zinc finger gene in AITD susceptibility region;Zinc finger protein 406;, PF00096;, GO:0005829;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0002244;GO:0006355;GO:0060712;, C:cytosol; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:hematopoietic progenitor cell differentiation; P:regulation of transcription, DNA-templated; P:spongiotrophoblast layer development; scaffold63 indexed_genome mRNA 5254047 5273404 . + . ID=transcript_10917;Q11201 O60677 Q9UN51,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1,Gal-NAc6S;Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase;Monosialoganglioside sialyltransferase;SIATFL;ST3Gal I;ST3GalA.1;ST3O;Sialyltransferase 4A;, PF00777;, GO:0070062;GO:1990675;GO:0000139;GO:1990676;GO:0016021;GO:0016020;GO:0032588;GO:0003836;GO:0047288;GO:0006464;GO:0010706;GO:0018146;GO:0002319;GO:0006054;GO:1905403;GO:0016266;GO:0006487;GO:0006468;GO:1990743;GO:0097503;GO:0019082;, C:extracellular exosome; C:Golgi medial cisterna membrane; C:Golgi membrane; C:Golgi trans cisterna membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network membrane;, F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; F:monosialoganglioside sialyltransferase activity;, P:cellular protein modification process; P:ganglioside biosynthetic process via lactosylceramide; P:keratan sulfate biosynthetic process; P:memory B cell differentiation; P:N-acetylneuraminate metabolic process; P:negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process; P:O-glycan processing; P:protein N-linked glycosylation; P:protein phosphorylation; P:protein sialylation; P:sialylation; P:viral protein processing;|Q11201 O60677 Q9UN51,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1,Gal-NAc6S;Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase;Monosialoganglioside sialyltransferase;SIATFL;ST3Gal I;ST3GalA.1;ST3O;Sialyltransferase 4A;, PF00777;, GO:0070062;GO:1990675;GO:0000139;GO:1990676;GO:0016021;GO:0016020;GO:0032588;GO:0003836;GO:0047288;GO:0006464;GO:0010706;GO:0018146;GO:0002319;GO:0006054;GO:1905403;GO:0016266;GO:0006487;GO:0006468;GO:1990743;GO:0097503;GO:0019082;, C:extracellular exosome; C:Golgi medial cisterna membrane; C:Golgi membrane; C:Golgi trans cisterna membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network membrane;, F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; F:monosialoganglioside sialyltransferase activity;, P:cellular protein modification process; P:ganglioside biosynthetic process via lactosylceramide; P:keratan sulfate biosynthetic process; P:memory B cell differentiation; P:N-acetylneuraminate metabolic process; P:negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process; P:O-glycan processing; P:protein N-linked glycosylation; P:protein phosphorylation; P:protein sialylation; P:sialylation; P:viral protein processing;|Q11201 O60677 Q9UN51,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1,Gal-NAc6S;Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase;Monosialoganglioside sialyltransferase;SIATFL;ST3Gal I;ST3GalA.1;ST3O;Sialyltransferase 4A;, PF00777;, GO:0070062;GO:1990675;GO:0000139;GO:1990676;GO:0016021;GO:0016020;GO:0032588;GO:0003836;GO:0047288;GO:0006464;GO:0010706;GO:0018146;GO:0002319;GO:0006054;GO:1905403;GO:0016266;GO:0006487;GO:0006468;GO:1990743;GO:0097503;GO:0019082;, C:extracellular exosome; C:Golgi medial cisterna membrane; C:Golgi membrane; C:Golgi trans cisterna membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network membrane;, F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; F:monosialoganglioside sialyltransferase activity;, P:cellular protein modification process; P:ganglioside biosynthetic process via lactosylceramide; P:keratan sulfate biosynthetic process; P:memory B cell differentiation; P:N-acetylneuraminate metabolic process; P:negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process; P:O-glycan processing; P:protein N-linked glycosylation; P:protein phosphorylation; P:protein sialylation; P:sialylation; P:viral protein processing;|Q11201 O60677 Q9UN51,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1,Gal-NAc6S;Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase;Monosialoganglioside sialyltransferase;SIATFL;ST3Gal I;ST3GalA.1;ST3O;Sialyltransferase 4A;, PF00777;, GO:0070062;GO:1990675;GO:0000139;GO:1990676;GO:0016021;GO:0016020;GO:0032588;GO:0003836;GO:0047288;GO:0006464;GO:0010706;GO:0018146;GO:0002319;GO:0006054;GO:1905403;GO:0016266;GO:0006487;GO:0006468;GO:1990743;GO:0097503;GO:0019082;, C:extracellular exosome; C:Golgi medial cisterna membrane; C:Golgi membrane; C:Golgi trans cisterna membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network membrane;, F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; F:monosialoganglioside sialyltransferase activity;, P:cellular protein modification process; P:ganglioside biosynthetic process via lactosylceramide; P:keratan sulfate biosynthetic process; P:memory B cell differentiation; P:N-acetylneuraminate metabolic process; P:negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process; P:O-glycan processing; P:protein N-linked glycosylation; P:protein phosphorylation; P:protein sialylation; P:sialylation; P:viral protein processing;|Q11201 O60677 Q9UN51,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1,Gal-NAc6S;Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase;Monosialoganglioside sialyltransferase;SIATFL;ST3Gal I;ST3GalA.1;ST3O;Sialyltransferase 4A;, PF00777;, GO:0070062;GO:1990675;GO:0000139;GO:1990676;GO:0016021;GO:0016020;GO:0032588;GO:0003836;GO:0047288;GO:0006464;GO:0010706;GO:0018146;GO:0002319;GO:0006054;GO:1905403;GO:0016266;GO:0006487;GO:0006468;GO:1990743;GO:0097503;GO:0019082;, C:extracellular exosome; C:Golgi medial cisterna membrane; C:Golgi membrane; C:Golgi trans cisterna membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network membrane;, F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; F:monosialoganglioside sialyltransferase activity;, P:cellular protein modification process; P:ganglioside biosynthetic process via lactosylceramide; P:keratan sulfate biosynthetic process; P:memory B cell differentiation; P:N-acetylneuraminate metabolic process; P:negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process; P:O-glycan processing; P:protein N-linked glycosylation; P:protein phosphorylation; P:protein sialylation; P:sialylation; P:viral protein processing; scaffold63 indexed_genome mRNA 5394259 5450692 . + . ID=transcript_10918;Q92597 B3KR80 B7Z446 O15207 Q6IBG2 Q9NYR6 Q9UK29,Protein NDRG1,Differentiation-related gene 1 protein;N-myc downstream-regulated gene 1 protein;Nickel-specific induction protein Cap43;Reducing agents and tunicamycin-responsive protein;Rit42;, PF03096;, GO:0005912;GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0098978;GO:0005874;GO:0015630;GO:0005634;GO:0048471;GO:0005886;GO:0055038;GO:0045296;GO:0043015;GO:0008017;GO:0031267;GO:0071456;GO:0030330;GO:0045576;GO:0008285;GO:0032287;GO:0099173;GO:0042981;GO:0010038;GO:0007165;, C:adherens junction; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome membrane;, F:cadherin binding; F:gamma-tubulin binding; F:microtubule binding; F:small GTPase binding;, P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator; P:mast cell activation; P:negative regulation of cell population proliferation; P:peripheral nervous system myelin maintenance; P:postsynapse organization; P:regulation of apoptotic process; P:response to metal ion; P:signal transduction;|Q92597 B3KR80 B7Z446 O15207 Q6IBG2 Q9NYR6 Q9UK29,Protein NDRG1,Differentiation-related gene 1 protein;N-myc downstream-regulated gene 1 protein;Nickel-specific induction protein Cap43;Reducing agents and tunicamycin-responsive protein;Rit42;, PF03096;, GO:0005912;GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0098978;GO:0005874;GO:0015630;GO:0005634;GO:0048471;GO:0005886;GO:0055038;GO:0045296;GO:0043015;GO:0008017;GO:0031267;GO:0071456;GO:0030330;GO:0045576;GO:0008285;GO:0032287;GO:0099173;GO:0042981;GO:0010038;GO:0007165;, C:adherens junction; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome membrane;, F:cadherin binding; F:gamma-tubulin binding; F:microtubule binding; F:small GTPase binding;, P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator; P:mast cell activation; P:negative regulation of cell population proliferation; P:peripheral nervous system myelin maintenance; P:postsynapse organization; P:regulation of apoptotic process; P:response to metal ion; P:signal transduction;|Q92597 B3KR80 B7Z446 O15207 Q6IBG2 Q9NYR6 Q9UK29,Protein NDRG1,Differentiation-related gene 1 protein;N-myc downstream-regulated gene 1 protein;Nickel-specific induction protein Cap43;Reducing agents and tunicamycin-responsive protein;Rit42;, PF03096;, GO:0005912;GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0098978;GO:0005874;GO:0015630;GO:0005634;GO:0048471;GO:0005886;GO:0055038;GO:0045296;GO:0043015;GO:0008017;GO:0031267;GO:0071456;GO:0030330;GO:0045576;GO:0008285;GO:0032287;GO:0099173;GO:0042981;GO:0010038;GO:0007165;, C:adherens junction; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome membrane;, F:cadherin binding; F:gamma-tubulin binding; F:microtubule binding; F:small GTPase binding;, P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator; P:mast cell activation; P:negative regulation of cell population proliferation; P:peripheral nervous system myelin maintenance; P:postsynapse organization; P:regulation of apoptotic process; P:response to metal ion; P:signal transduction;|Q92597 B3KR80 B7Z446 O15207 Q6IBG2 Q9NYR6 Q9UK29,Protein NDRG1,Differentiation-related gene 1 protein;N-myc downstream-regulated gene 1 protein;Nickel-specific induction protein Cap43;Reducing agents and tunicamycin-responsive protein;Rit42;, PF03096;, GO:0005912;GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0098978;GO:0005874;GO:0015630;GO:0005634;GO:0048471;GO:0005886;GO:0055038;GO:0045296;GO:0043015;GO:0008017;GO:0031267;GO:0071456;GO:0030330;GO:0045576;GO:0008285;GO:0032287;GO:0099173;GO:0042981;GO:0010038;GO:0007165;, C:adherens junction; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome membrane;, F:cadherin binding; F:gamma-tubulin binding; F:microtubule binding; F:small GTPase binding;, P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator; P:mast cell activation; P:negative regulation of cell population proliferation; P:peripheral nervous system myelin maintenance; P:postsynapse organization; P:regulation of apoptotic process; P:response to metal ion; P:signal transduction; scaffold63 indexed_genome mRNA 5458776 5464354 . - . ID=transcript_10919;O95388 A8KAG6 E7EMM5 Q5JBS6 Q5JBS7 Q5JBS8 Q9HCS3,CCN family member 4 {ECO:0000305},WNT1-inducible-signaling pathway protein 1;Wnt-1-induced secreted protein;, PF00007;PF00219;PF19035;PF00093;, GO:0005829;GO:0031012;GO:0005615;GO:0008201;GO:0005520;GO:0005178;GO:0060348;GO:0007155;GO:0007267;GO:0042593;GO:0060548;GO:0032331;GO:0045599;GO:0001649;GO:0030316;GO:0050729;GO:0045669;GO:0014911;GO:0048661;GO:0030177;GO:0090303;GO:0001817;GO:0007165;GO:0016055;, C:cytosol; C:extracellular matrix; C:extracellular space;, F:heparin binding; F:insulin-like growth factor binding; F:integrin binding;, P:bone development; P:cell adhesion; P:cell-cell signaling; P:glucose homeostasis; P:negative regulation of cell death; P:negative regulation of chondrocyte differentiation; P:negative regulation of fat cell differentiation; P:osteoblast differentiation; P:osteoclast differentiation; P:positive regulation of inflammatory response; P:positive regulation of osteoblast differentiation; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of Wnt signaling pathway; P:positive regulation of wound healing; P:regulation of cytokine production; P:signal transduction; P:Wnt signaling pathway; scaffold63 indexed_genome mRNA 5618217 5632682 . + . ID=transcript_10920;Q13239 B7Z4J2 B7Z4L6 Q6FI01 Q9UMQ8,Src-like-adapter,Src-like-adapter protein 1;, PF00017;PF00018;, GO:0005829;GO:0043197;GO:0005768;GO:0031234;GO:0005925;GO:0004715;GO:0004713;GO:0005102;GO:0030154;GO:0019221;GO:0045087;GO:0009966;GO:0007169;, C:cytosol; C:dendritic spine; C:endosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion;, F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding;, P:cell differentiation; P:cytokine-mediated signaling pathway; P:innate immune response; P:regulation of signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold63 indexed_genome mRNA 5795176 5828037 . - . ID=transcript_10921;A8MW92 A8MZC9 Q86U89 Q86W43 Q96BT0 Q9H702 Q9HBK3 Q9NYR3 Q9Y381,PHD finger protein 20-like protein 1,, PF12618;PF02820;PF18104;, GO:0044545;GO:0046872;GO:0016573;GO:0006357;, C:NSL complex;, F:metal ion binding;, P:histone acetylation; P:regulation of transcription by RNA polymerase II;|A8MW92 A8MZC9 Q86U89 Q86W43 Q96BT0 Q9H702 Q9HBK3 Q9NYR3 Q9Y381,PHD finger protein 20-like protein 1,, PF12618;PF02820;PF18104;, GO:0044545;GO:0046872;GO:0016573;GO:0006357;, C:NSL complex;, F:metal ion binding;, P:histone acetylation; P:regulation of transcription by RNA polymerase II;|A8MW92 A8MZC9 Q86U89 Q86W43 Q96BT0 Q9H702 Q9HBK3 Q9NYR3 Q9Y381,PHD finger protein 20-like protein 1,, PF12618;PF02820;PF18104;, GO:0044545;GO:0046872;GO:0016573;GO:0006357;, C:NSL complex;, F:metal ion binding;, P:histone acetylation; P:regulation of transcription by RNA polymerase II;|A8MW92 A8MZC9 Q86U89 Q86W43 Q96BT0 Q9H702 Q9HBK3 Q9NYR3 Q9Y381,PHD finger protein 20-like protein 1,, PF12618;PF02820;PF18104;, GO:0044545;GO:0046872;GO:0016573;GO:0006357;, C:NSL complex;, F:metal ion binding;, P:histone acetylation; P:regulation of transcription by RNA polymerase II; scaffold63 indexed_genome mRNA 5829497 5866825 . - . ID=transcript_10922;A8MW92 A8MZC9 Q86U89 Q86W43 Q96BT0 Q9H702 Q9HBK3 Q9NYR3 Q9Y381,PHD finger protein 20-like protein 1,, PF12618;PF02820;PF18104;, GO:0044545;GO:0046872;GO:0016573;GO:0006357;, C:NSL complex;, F:metal ion binding;, P:histone acetylation; P:regulation of transcription by RNA polymerase II;|A8MW92 A8MZC9 Q86U89 Q86W43 Q96BT0 Q9H702 Q9HBK3 Q9NYR3 Q9Y381,PHD finger protein 20-like protein 1,, PF12618;PF02820;PF18104;, GO:0044545;GO:0046872;GO:0016573;GO:0006357;, C:NSL complex;, F:metal ion binding;, P:histone acetylation; P:regulation of transcription by RNA polymerase II;|A8MW92 A8MZC9 Q86U89 Q86W43 Q96BT0 Q9H702 Q9HBK3 Q9NYR3 Q9Y381,PHD finger protein 20-like protein 1,, PF12618;PF02820;PF18104;, GO:0044545;GO:0046872;GO:0016573;GO:0006357;, C:NSL complex;, F:metal ion binding;, P:histone acetylation; P:regulation of transcription by RNA polymerase II; scaffold63 indexed_genome mRNA 5912999 5917256 . + . ID=transcript_10923;Q6P5X7 Q3KRC2 Q8WVZ4 Q96LX9,Transmembrane protein 71,, PF15121;, GO:0016021;GO:0005739;, C:integral component of membrane; C:mitochondrion; scaffold63 indexed_genome mRNA 5935227 6004921 . + . ID=transcript_10924;Q86X45 Q13648 Q4G183,Protein tilB homolog,Leucine-rich repeat-containing protein 6;Leucine-rich testis-specific protein;Testis-specific leucine-rich repeat protein;, , GO:0090651;GO:0005929;GO:0005737;GO:0005829;GO:0005576;GO:0090660;GO:0003341;GO:0060287;GO:0051649;GO:0030317;GO:0036159;GO:0008584;GO:0044458;GO:0036158;GO:0061512;GO:0043393;GO:0061458;, C:apical cytoplasm; C:cilium; C:cytoplasm; C:cytosol; C:extracellular region;, , P:cerebrospinal fluid circulation; P:cilium movement; P:epithelial cilium movement involved in determination of left/right asymmetry; P:establishment of localization in cell; P:flagellated sperm motility; P:inner dynein arm assembly; P:male gonad development; P:motile cilium assembly; P:outer dynein arm assembly; P:protein localization to cilium; P:regulation of protein binding; P:reproductive system development; scaffold63 indexed_genome mRNA 6341655 6378127 . + . ID=transcript_10925;O43525 A2VCT8 B4DJY4 E7EQ89,Potassium voltage-gated channel subfamily KQT member 3 {ECO:0000305},KQT-like 3;Potassium channel subunit alpha KvLQT3;Voltage-gated potassium channel subunit Kv7.3;, PF00520;PF03520;PF11956;, GO:0043194;GO:0009986;GO:0016021;GO:0005887;GO:0033268;GO:0005886;GO:0045202;GO:0008076;GO:0005516;GO:0005251;GO:0005249;GO:0007268;GO:0060081;GO:0071805;GO:0034765;, C:axon initial segment; C:cell surface; C:integral component of membrane; C:integral component of plasma membrane; C:node of Ranvier; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:calmodulin binding; F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:chemical synaptic transmission; P:membrane hyperpolarization; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; scaffold63 indexed_genome mRNA 6449589 6450143 . + . ID=transcript_10926;Q02509 B4DNG8,Otoconin-90,Phospholipase A2 homolog;, PF00068;, GO:0031012;GO:0005576;GO:0005509;GO:0004623;GO:0050482;GO:0016042;GO:0045299;GO:0006644;, C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:phospholipase A2 activity;, P:arachidonic acid secretion; P:lipid catabolic process; P:otolith mineralization; P:phospholipid metabolic process; scaffold63 indexed_genome mRNA 6451941 6502675 . - . ID=transcript_10927;Q14156 A7MD19 Q2VPK2 Q63HL7 Q68DX1 Q6IQ18,Protein EFR3 homolog A {ECO:0000305},Protein EFR3-like;, , GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q14156 A7MD19 Q2VPK2 Q63HL7 Q68DX1 Q6IQ18,Protein EFR3 homolog A {ECO:0000305},Protein EFR3-like;, , GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q14156 A7MD19 Q2VPK2 Q63HL7 Q68DX1 Q6IQ18,Protein EFR3 homolog A {ECO:0000305},Protein EFR3-like;, , GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q14156 A7MD19 Q2VPK2 Q63HL7 Q68DX1 Q6IQ18,Protein EFR3 homolog A {ECO:0000305},Protein EFR3-like;, , GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane; scaffold63 indexed_genome mRNA 7062923 7292012 . + . ID=transcript_10928;P40145,Adenylate cyclase type 8 {ECO:0000305},ATP pyrophosphate-lyase 8;Adenylate cyclase type VIII {ECO:0000303|PubMed:8076676};Adenylyl cyclase 8 {ECO:0000303|PubMed:25403481};Ca(2+)/calmodulin-activated adenylyl cyclase;, PF16214;PF06327;PF00211;, GO:0016324;GO:0030424;GO:0016323;GO:0005901;GO:0005905;GO:0030665;GO:0030425;GO:0060076;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0016020;GO:0045121;GO:0032809;GO:0005886;GO:0044853;GO:0014069;GO:0048786;GO:0098685;GO:0003779;GO:0004016;GO:0005524;GO:0008294;GO:0005516;GO:0046872;GO:0046983;GO:0046982;GO:0042803;GO:0051721;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:0071277;GO:1904322;GO:0071377;GO:0071333;GO:0071315;GO:0007186;GO:0042593;GO:0010255;GO:0007611;GO:0007626;GO:0007616;GO:0007613;GO:0002862;GO:0150076;GO:0038003;GO:0032793;GO:0007204;GO:0035774;GO:1900454;GO:1900273;GO:0031915;GO:0051259;GO:0051260;GO:0080135;GO:0051480;GO:0003091;GO:0007165;, C:apical plasma membrane; C:axon; C:basolateral plasma membrane; C:caveola; C:clathrin-coated pit; C:clathrin-coated vesicle membrane; C:dendrite; C:excitatory synapse; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse;, F:actin binding; F:adenylate cyclase activity; F:ATP binding; F:calcium- and calmodulin-responsive adenylate cyclase activity; F:calmodulin binding; F:metal ion binding; F:protein dimerization activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein phosphatase 2A binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to calcium ion; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to glucose stimulus; P:cellular response to morphine; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:glucose mediated signaling pathway; P:learning or memory; P:locomotory behavior; P:long-term memory; P:memory; P:negative regulation of inflammatory response to antigenic stimulus; P:neuroinflammatory response; P:opioid receptor signaling pathway; P:positive regulation of CREB transcription factor activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of long-term synaptic depression; P:positive regulation of long-term synaptic potentiation; P:positive regulation of synaptic plasticity; P:protein complex oligomerization; P:protein homooligomerization; P:regulation of cellular response to stress; P:regulation of cytosolic calcium ion concentration; P:renal water homeostasis; P:signal transduction;|P40145,Adenylate cyclase type 8 {ECO:0000305},ATP pyrophosphate-lyase 8;Adenylate cyclase type VIII {ECO:0000303|PubMed:8076676};Adenylyl cyclase 8 {ECO:0000303|PubMed:25403481};Ca(2+)/calmodulin-activated adenylyl cyclase;, PF16214;PF06327;PF00211;, GO:0016324;GO:0030424;GO:0016323;GO:0005901;GO:0005905;GO:0030665;GO:0030425;GO:0060076;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0016020;GO:0045121;GO:0032809;GO:0005886;GO:0044853;GO:0014069;GO:0048786;GO:0098685;GO:0003779;GO:0004016;GO:0005524;GO:0008294;GO:0005516;GO:0046872;GO:0046983;GO:0046982;GO:0042803;GO:0051721;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:0071277;GO:1904322;GO:0071377;GO:0071333;GO:0071315;GO:0007186;GO:0042593;GO:0010255;GO:0007611;GO:0007626;GO:0007616;GO:0007613;GO:0002862;GO:0150076;GO:0038003;GO:0032793;GO:0007204;GO:0035774;GO:1900454;GO:1900273;GO:0031915;GO:0051259;GO:0051260;GO:0080135;GO:0051480;GO:0003091;GO:0007165;, C:apical plasma membrane; C:axon; C:basolateral plasma membrane; C:caveola; C:clathrin-coated pit; C:clathrin-coated vesicle membrane; C:dendrite; C:excitatory synapse; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse;, F:actin binding; F:adenylate cyclase activity; F:ATP binding; F:calcium- and calmodulin-responsive adenylate cyclase activity; F:calmodulin binding; F:metal ion binding; F:protein dimerization activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein phosphatase 2A binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to calcium ion; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to glucose stimulus; P:cellular response to morphine; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:glucose mediated signaling pathway; P:learning or memory; P:locomotory behavior; P:long-term memory; P:memory; P:negative regulation of inflammatory response to antigenic stimulus; P:neuroinflammatory response; P:opioid receptor signaling pathway; P:positive regulation of CREB transcription factor activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of long-term synaptic depression; P:positive regulation of long-term synaptic potentiation; P:positive regulation of synaptic plasticity; P:protein complex oligomerization; P:protein homooligomerization; P:regulation of cellular response to stress; P:regulation of cytosolic calcium ion concentration; P:renal water homeostasis; P:signal transduction;|P40145,Adenylate cyclase type 8 {ECO:0000305},ATP pyrophosphate-lyase 8;Adenylate cyclase type VIII {ECO:0000303|PubMed:8076676};Adenylyl cyclase 8 {ECO:0000303|PubMed:25403481};Ca(2+)/calmodulin-activated adenylyl cyclase;, PF16214;PF06327;PF00211;, GO:0016324;GO:0030424;GO:0016323;GO:0005901;GO:0005905;GO:0030665;GO:0030425;GO:0060076;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0016020;GO:0045121;GO:0032809;GO:0005886;GO:0044853;GO:0014069;GO:0048786;GO:0098685;GO:0003779;GO:0004016;GO:0005524;GO:0008294;GO:0005516;GO:0046872;GO:0046983;GO:0046982;GO:0042803;GO:0051721;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:0071277;GO:1904322;GO:0071377;GO:0071333;GO:0071315;GO:0007186;GO:0042593;GO:0010255;GO:0007611;GO:0007626;GO:0007616;GO:0007613;GO:0002862;GO:0150076;GO:0038003;GO:0032793;GO:0007204;GO:0035774;GO:1900454;GO:1900273;GO:0031915;GO:0051259;GO:0051260;GO:0080135;GO:0051480;GO:0003091;GO:0007165;, C:apical plasma membrane; C:axon; C:basolateral plasma membrane; C:caveola; C:clathrin-coated pit; C:clathrin-coated vesicle membrane; C:dendrite; C:excitatory synapse; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse;, F:actin binding; F:adenylate cyclase activity; F:ATP binding; F:calcium- and calmodulin-responsive adenylate cyclase activity; F:calmodulin binding; F:metal ion binding; F:protein dimerization activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein phosphatase 2A binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to calcium ion; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to glucose stimulus; P:cellular response to morphine; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:glucose mediated signaling pathway; P:learning or memory; P:locomotory behavior; P:long-term memory; P:memory; P:negative regulation of inflammatory response to antigenic stimulus; P:neuroinflammatory response; P:opioid receptor signaling pathway; P:positive regulation of CREB transcription factor activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of long-term synaptic depression; P:positive regulation of long-term synaptic potentiation; P:positive regulation of synaptic plasticity; P:protein complex oligomerization; P:protein homooligomerization; P:regulation of cellular response to stress; P:regulation of cytosolic calcium ion concentration; P:renal water homeostasis; P:signal transduction;|P40145,Adenylate cyclase type 8 {ECO:0000305},ATP pyrophosphate-lyase 8;Adenylate cyclase type VIII {ECO:0000303|PubMed:8076676};Adenylyl cyclase 8 {ECO:0000303|PubMed:25403481};Ca(2+)/calmodulin-activated adenylyl cyclase;, PF16214;PF06327;PF00211;, GO:0016324;GO:0030424;GO:0016323;GO:0005901;GO:0005905;GO:0030665;GO:0030425;GO:0060076;GO:0098978;GO:0098686;GO:0005887;GO:0099056;GO:0016020;GO:0045121;GO:0032809;GO:0005886;GO:0044853;GO:0014069;GO:0048786;GO:0098685;GO:0003779;GO:0004016;GO:0005524;GO:0008294;GO:0005516;GO:0046872;GO:0046983;GO:0046982;GO:0042803;GO:0051721;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0006171;GO:0071277;GO:1904322;GO:0071377;GO:0071333;GO:0071315;GO:0007186;GO:0042593;GO:0010255;GO:0007611;GO:0007626;GO:0007616;GO:0007613;GO:0002862;GO:0150076;GO:0038003;GO:0032793;GO:0007204;GO:0035774;GO:1900454;GO:1900273;GO:0031915;GO:0051259;GO:0051260;GO:0080135;GO:0051480;GO:0003091;GO:0007165;, C:apical plasma membrane; C:axon; C:basolateral plasma membrane; C:caveola; C:clathrin-coated pit; C:clathrin-coated vesicle membrane; C:dendrite; C:excitatory synapse; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:membrane; C:membrane raft; C:neuronal cell body membrane; C:plasma membrane; C:plasma membrane raft; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse;, F:actin binding; F:adenylate cyclase activity; F:ATP binding; F:calcium- and calmodulin-responsive adenylate cyclase activity; F:calmodulin binding; F:metal ion binding; F:protein dimerization activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein phosphatase 2A binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to calcium ion; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to glucose stimulus; P:cellular response to morphine; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:glucose mediated signaling pathway; P:learning or memory; P:locomotory behavior; P:long-term memory; P:memory; P:negative regulation of inflammatory response to antigenic stimulus; P:neuroinflammatory response; P:opioid receptor signaling pathway; P:positive regulation of CREB transcription factor activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of long-term synaptic depression; P:positive regulation of long-term synaptic potentiation; P:positive regulation of synaptic plasticity; P:protein complex oligomerization; P:protein homooligomerization; P:regulation of cellular response to stress; P:regulation of cytosolic calcium ion concentration; P:renal water homeostasis; P:signal transduction; scaffold63 indexed_genome mRNA 8663689 8667040 . + . ID=transcript_10929;P01106 A8WFE7 P01107 Q14026,Myc proto-oncogene protein,Class E basic helix-loop-helix protein 39;Proto-oncogene c-Myc;Transcription factor p64;, PF00010;PF02344;PF01056;, GO:0000785;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0033613;GO:0001046;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0046983;GO:0044877;GO:0070491;GO:0000978;GO:0008134;GO:1904837;GO:0001658;GO:0007050;GO:0006879;GO:0006974;GO:0035690;GO:0071456;GO:0034644;GO:0006338;GO:0051276;GO:0019221;GO:0006112;GO:0070371;GO:0044346;GO:0000082;GO:0000165;GO:0043066;GO:0051782;GO:0048147;GO:0045656;GO:0032873;GO:0000122;GO:0007219;GO:0015671;GO:0008284;GO:0043280;GO:2000573;GO:1905643;GO:0050679;GO:0048146;GO:0010628;GO:0002053;GO:0090096;GO:2001022;GO:0051973;GO:0045944;GO:0045893;GO:0016579;GO:0032986;GO:0010468;GO:1904672;GO:0032204;GO:0006357;GO:0042493;GO:0010332;GO:0070848;, C:chromatin; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:activating transcription factor binding; F:core promoter sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein dimerization activity; F:protein-containing complex binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:beta-catenin-TCF complex assembly; P:branching involved in ureteric bud morphogenesis; P:cell cycle arrest; P:cellular iron ion homeostasis; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:cellular response to hypoxia; P:cellular response to UV; P:chromatin remodeling; P:chromosome organization; P:cytokine-mediated signaling pathway; P:energy reserve metabolic process; P:ERK1 and ERK2 cascade; P:fibroblast apoptotic process; P:G1/S transition of mitotic cell cycle; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell division; P:negative regulation of fibroblast proliferation; P:negative regulation of monocyte differentiation; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:oxygen transport; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA methylation; P:positive regulation of epithelial cell proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of metanephric cap mesenchymal cell proliferation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of telomerase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:protein-DNA complex disassembly; P:regulation of gene expression; P:regulation of somatic stem cell population maintenance; P:regulation of telomere maintenance; P:regulation of transcription by RNA polymerase II; P:response to drug; P:response to gamma radiation; P:response to growth factor;|P01106 A8WFE7 P01107 Q14026,Myc proto-oncogene protein,Class E basic helix-loop-helix protein 39;Proto-oncogene c-Myc;Transcription factor p64;, PF00010;PF02344;PF01056;, GO:0000785;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0033613;GO:0001046;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0070888;GO:0046983;GO:0044877;GO:0070491;GO:0000978;GO:0008134;GO:1904837;GO:0001658;GO:0007050;GO:0006879;GO:0006974;GO:0035690;GO:0071456;GO:0034644;GO:0006338;GO:0051276;GO:0019221;GO:0006112;GO:0070371;GO:0044346;GO:0000082;GO:0000165;GO:0043066;GO:0051782;GO:0048147;GO:0045656;GO:0032873;GO:0000122;GO:0007219;GO:0015671;GO:0008284;GO:0043280;GO:2000573;GO:1905643;GO:0050679;GO:0048146;GO:0010628;GO:0002053;GO:0090096;GO:2001022;GO:0051973;GO:0045944;GO:0045893;GO:0016579;GO:0032986;GO:0010468;GO:1904672;GO:0032204;GO:0006357;GO:0042493;GO:0010332;GO:0070848;, C:chromatin; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:activating transcription factor binding; F:core promoter sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein dimerization activity; F:protein-containing complex binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:beta-catenin-TCF complex assembly; P:branching involved in ureteric bud morphogenesis; P:cell cycle arrest; P:cellular iron ion homeostasis; P:cellular response to DNA damage stimulus; P:cellular response to drug; P:cellular response to hypoxia; P:cellular response to UV; P:chromatin remodeling; P:chromosome organization; P:cytokine-mediated signaling pathway; P:energy reserve metabolic process; P:ERK1 and ERK2 cascade; P:fibroblast apoptotic process; P:G1/S transition of mitotic cell cycle; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell division; P:negative regulation of fibroblast proliferation; P:negative regulation of monocyte differentiation; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:oxygen transport; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA methylation; P:positive regulation of epithelial cell proliferation; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of metanephric cap mesenchymal cell proliferation; P:positive regulation of response to DNA damage stimulus; P:positive regulation of telomerase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:protein-DNA complex disassembly; P:regulation of gene expression; P:regulation of somatic stem cell population maintenance; P:regulation of telomere maintenance; P:regulation of transcription by RNA polymerase II; P:response to drug; P:response to gamma radiation; P:response to growth factor; scaffold63 indexed_genome mRNA 10512029 10561697 . - . ID=transcript_10930;Q9NUQ9 Q96AZ5 Q9NW21 Q9NZE7,CYFIP-related Rac1 interactor B {ECO:0000305},L1;, PF07159;, GO:0005929;GO:0070062;GO:0005576;GO:0016020;GO:0005739;GO:0031093;GO:0023030;GO:0031267;GO:0071219;GO:0030837;GO:0051058;GO:0002576;GO:0032729;GO:2000568;GO:0050870;GO:0001916;GO:0030334;GO:0050920;GO:2000114;GO:0090140;, C:cilium; C:extracellular exosome; C:extracellular region; C:membrane; C:mitochondrion; C:platelet alpha granule lumen;, F:MHC class Ib protein binding, via antigen binding groove; F:small GTPase binding;, P:cellular response to molecule of bacterial origin; P:negative regulation of actin filament polymerization; P:negative regulation of small GTPase mediated signal transduction; P:platelet degranulation; P:positive regulation of interferon-gamma production; P:positive regulation of memory T cell activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated cytotoxicity; P:regulation of cell migration; P:regulation of chemotaxis; P:regulation of establishment of cell polarity; P:regulation of mitochondrial fission;|Q9NUQ9 Q96AZ5 Q9NW21 Q9NZE7,CYFIP-related Rac1 interactor B {ECO:0000305},L1;, PF07159;, GO:0005929;GO:0070062;GO:0005576;GO:0016020;GO:0005739;GO:0031093;GO:0023030;GO:0031267;GO:0071219;GO:0030837;GO:0051058;GO:0002576;GO:0032729;GO:2000568;GO:0050870;GO:0001916;GO:0030334;GO:0050920;GO:2000114;GO:0090140;, C:cilium; C:extracellular exosome; C:extracellular region; C:membrane; C:mitochondrion; C:platelet alpha granule lumen;, F:MHC class Ib protein binding, via antigen binding groove; F:small GTPase binding;, P:cellular response to molecule of bacterial origin; P:negative regulation of actin filament polymerization; P:negative regulation of small GTPase mediated signal transduction; P:platelet degranulation; P:positive regulation of interferon-gamma production; P:positive regulation of memory T cell activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated cytotoxicity; P:regulation of cell migration; P:regulation of chemotaxis; P:regulation of establishment of cell polarity; P:regulation of mitochondrial fission;|Q9NUQ9 Q96AZ5 Q9NW21 Q9NZE7,CYFIP-related Rac1 interactor B {ECO:0000305},L1;, PF07159;, GO:0005929;GO:0070062;GO:0005576;GO:0016020;GO:0005739;GO:0031093;GO:0023030;GO:0031267;GO:0071219;GO:0030837;GO:0051058;GO:0002576;GO:0032729;GO:2000568;GO:0050870;GO:0001916;GO:0030334;GO:0050920;GO:2000114;GO:0090140;, C:cilium; C:extracellular exosome; C:extracellular region; C:membrane; C:mitochondrion; C:platelet alpha granule lumen;, F:MHC class Ib protein binding, via antigen binding groove; F:small GTPase binding;, P:cellular response to molecule of bacterial origin; P:negative regulation of actin filament polymerization; P:negative regulation of small GTPase mediated signal transduction; P:platelet degranulation; P:positive regulation of interferon-gamma production; P:positive regulation of memory T cell activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated cytotoxicity; P:regulation of cell migration; P:regulation of chemotaxis; P:regulation of establishment of cell polarity; P:regulation of mitochondrial fission;|Q9NUQ9 Q96AZ5 Q9NW21 Q9NZE7,CYFIP-related Rac1 interactor B {ECO:0000305},L1;, PF07159;, GO:0005929;GO:0070062;GO:0005576;GO:0016020;GO:0005739;GO:0031093;GO:0023030;GO:0031267;GO:0071219;GO:0030837;GO:0051058;GO:0002576;GO:0032729;GO:2000568;GO:0050870;GO:0001916;GO:0030334;GO:0050920;GO:2000114;GO:0090140;, C:cilium; C:extracellular exosome; C:extracellular region; C:membrane; C:mitochondrion; C:platelet alpha granule lumen;, F:MHC class Ib protein binding, via antigen binding groove; F:small GTPase binding;, P:cellular response to molecule of bacterial origin; P:negative regulation of actin filament polymerization; P:negative regulation of small GTPase mediated signal transduction; P:platelet degranulation; P:positive regulation of interferon-gamma production; P:positive regulation of memory T cell activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated cytotoxicity; P:regulation of cell migration; P:regulation of chemotaxis; P:regulation of establishment of cell polarity; P:regulation of mitochondrial fission;|Q9NUQ9 Q96AZ5 Q9NW21 Q9NZE7,CYFIP-related Rac1 interactor B {ECO:0000305},L1;, PF07159;, GO:0005929;GO:0070062;GO:0005576;GO:0016020;GO:0005739;GO:0031093;GO:0023030;GO:0031267;GO:0071219;GO:0030837;GO:0051058;GO:0002576;GO:0032729;GO:2000568;GO:0050870;GO:0001916;GO:0030334;GO:0050920;GO:2000114;GO:0090140;, C:cilium; C:extracellular exosome; C:extracellular region; C:membrane; C:mitochondrion; C:platelet alpha granule lumen;, F:MHC class Ib protein binding, via antigen binding groove; F:small GTPase binding;, P:cellular response to molecule of bacterial origin; P:negative regulation of actin filament polymerization; P:negative regulation of small GTPase mediated signal transduction; P:platelet degranulation; P:positive regulation of interferon-gamma production; P:positive regulation of memory T cell activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated cytotoxicity; P:regulation of cell migration; P:regulation of chemotaxis; P:regulation of establishment of cell polarity; P:regulation of mitochondrial fission;|Q9NUQ9 Q96AZ5 Q9NW21 Q9NZE7,CYFIP-related Rac1 interactor B {ECO:0000305},L1;, PF07159;, GO:0005929;GO:0070062;GO:0005576;GO:0016020;GO:0005739;GO:0031093;GO:0023030;GO:0031267;GO:0071219;GO:0030837;GO:0051058;GO:0002576;GO:0032729;GO:2000568;GO:0050870;GO:0001916;GO:0030334;GO:0050920;GO:2000114;GO:0090140;, C:cilium; C:extracellular exosome; C:extracellular region; C:membrane; C:mitochondrion; C:platelet alpha granule lumen;, F:MHC class Ib protein binding, via antigen binding groove; F:small GTPase binding;, P:cellular response to molecule of bacterial origin; P:negative regulation of actin filament polymerization; P:negative regulation of small GTPase mediated signal transduction; P:platelet degranulation; P:positive regulation of interferon-gamma production; P:positive regulation of memory T cell activation; P:positive regulation of T cell activation; P:positive regulation of T cell mediated cytotoxicity; P:regulation of cell migration; P:regulation of chemotaxis; P:regulation of establishment of cell polarity; P:regulation of mitochondrial fission; scaffold63 indexed_genome mRNA 10672706 10804185 . - . ID=transcript_10931;Q9ULH1 B2RNV3,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1,130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein;ADP-ribosylation factor-directed GTPase-activating protein 1;Development and differentiation-enhancing factor 1;PIP2-dependent ARF1 GAP;, PF12796;PF01412;PF00169;PF00018;, GO:0031253;GO:0005829;GO:0043197;GO:0002102;GO:0045296;GO:0005096;GO:0046872;GO:0005547;GO:0005546;GO:0001786;GO:0060271;GO:0061000;GO:1903527;GO:0071803;, C:cell projection membrane; C:cytosol; C:dendritic spine; C:podosome;, F:cadherin binding; F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:cilium assembly; P:negative regulation of dendritic spine development; P:positive regulation of membrane tubulation; P:positive regulation of podosome assembly;|Q9ULH1 B2RNV3,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1,130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein;ADP-ribosylation factor-directed GTPase-activating protein 1;Development and differentiation-enhancing factor 1;PIP2-dependent ARF1 GAP;, PF12796;PF01412;PF00169;PF00018;, GO:0031253;GO:0005829;GO:0043197;GO:0002102;GO:0045296;GO:0005096;GO:0046872;GO:0005547;GO:0005546;GO:0001786;GO:0060271;GO:0061000;GO:1903527;GO:0071803;, C:cell projection membrane; C:cytosol; C:dendritic spine; C:podosome;, F:cadherin binding; F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:cilium assembly; P:negative regulation of dendritic spine development; P:positive regulation of membrane tubulation; P:positive regulation of podosome assembly;|Q9ULH1 B2RNV3,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1,130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein;ADP-ribosylation factor-directed GTPase-activating protein 1;Development and differentiation-enhancing factor 1;PIP2-dependent ARF1 GAP;, PF12796;PF01412;PF00169;PF00018;, GO:0031253;GO:0005829;GO:0043197;GO:0002102;GO:0045296;GO:0005096;GO:0046872;GO:0005547;GO:0005546;GO:0001786;GO:0060271;GO:0061000;GO:1903527;GO:0071803;, C:cell projection membrane; C:cytosol; C:dendritic spine; C:podosome;, F:cadherin binding; F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:cilium assembly; P:negative regulation of dendritic spine development; P:positive regulation of membrane tubulation; P:positive regulation of podosome assembly;|Q9ULH1 B2RNV3,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1,130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein;ADP-ribosylation factor-directed GTPase-activating protein 1;Development and differentiation-enhancing factor 1;PIP2-dependent ARF1 GAP;, PF12796;PF01412;PF00169;PF00018;, GO:0031253;GO:0005829;GO:0043197;GO:0002102;GO:0045296;GO:0005096;GO:0046872;GO:0005547;GO:0005546;GO:0001786;GO:0060271;GO:0061000;GO:1903527;GO:0071803;, C:cell projection membrane; C:cytosol; C:dendritic spine; C:podosome;, F:cadherin binding; F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:cilium assembly; P:negative regulation of dendritic spine development; P:positive regulation of membrane tubulation; P:positive regulation of podosome assembly;|Q9ULH1 B2RNV3,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1,130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein;ADP-ribosylation factor-directed GTPase-activating protein 1;Development and differentiation-enhancing factor 1;PIP2-dependent ARF1 GAP;, PF12796;PF01412;PF00169;PF00018;, GO:0031253;GO:0005829;GO:0043197;GO:0002102;GO:0045296;GO:0005096;GO:0046872;GO:0005547;GO:0005546;GO:0001786;GO:0060271;GO:0061000;GO:1903527;GO:0071803;, C:cell projection membrane; C:cytosol; C:dendritic spine; C:podosome;, F:cadherin binding; F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:cilium assembly; P:negative regulation of dendritic spine development; P:positive regulation of membrane tubulation; P:positive regulation of podosome assembly;|Q9ULH1 B2RNV3,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1,130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein;ADP-ribosylation factor-directed GTPase-activating protein 1;Development and differentiation-enhancing factor 1;PIP2-dependent ARF1 GAP;, PF12796;PF01412;PF00169;PF00018;, GO:0031253;GO:0005829;GO:0043197;GO:0002102;GO:0045296;GO:0005096;GO:0046872;GO:0005547;GO:0005546;GO:0001786;GO:0060271;GO:0061000;GO:1903527;GO:0071803;, C:cell projection membrane; C:cytosol; C:dendritic spine; C:podosome;, F:cadherin binding; F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:cilium assembly; P:negative regulation of dendritic spine development; P:positive regulation of membrane tubulation; P:positive regulation of podosome assembly;|Q9ULH1 B2RNV3,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1,130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein;ADP-ribosylation factor-directed GTPase-activating protein 1;Development and differentiation-enhancing factor 1;PIP2-dependent ARF1 GAP;, PF12796;PF01412;PF00169;PF00018;, GO:0031253;GO:0005829;GO:0043197;GO:0002102;GO:0045296;GO:0005096;GO:0046872;GO:0005547;GO:0005546;GO:0001786;GO:0060271;GO:0061000;GO:1903527;GO:0071803;, C:cell projection membrane; C:cytosol; C:dendritic spine; C:podosome;, F:cadherin binding; F:GTPase activator activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding;, P:cilium assembly; P:negative regulation of dendritic spine development; P:positive regulation of membrane tubulation; P:positive regulation of podosome assembly; scaffold64 indexed_genome mRNA 96132 101966 . - . ID=transcript_10932;P51843 Q96F69,Nuclear receptor subfamily 0 group B member 1,DSS-AHC critical region on the X chromosome protein 1;Nuclear receptor DAX-1;, PF00104;PF14046;, GO:0034451;GO:0000785;GO:0005737;GO:0043231;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0042788;GO:0050682;GO:0032448;GO:0019904;GO:0042803;GO:0003723;GO:0035258;GO:0003714;GO:0008134;GO:0030325;GO:0008406;GO:0021854;GO:0033327;GO:0008584;GO:0030238;GO:0043433;GO:0033144;GO:0010894;GO:0000122;GO:0045892;GO:0021983;GO:0008104;GO:0035902;GO:0060008;GO:0007283;GO:0006367;, C:centriolar satellite; C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:polysomal ribosome;, F:AF-2 domain binding; F:DNA hairpin binding; F:protein domain specific binding; F:protein homodimerization activity; F:RNA binding; F:steroid hormone receptor binding; F:transcription corepressor activity; F:transcription factor binding;, P:adrenal gland development; P:gonad development; P:hypothalamus development; P:Leydig cell differentiation; P:male gonad development; P:male sex determination; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of intracellular steroid hormone receptor signaling pathway; P:negative regulation of steroid biosynthetic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:pituitary gland development; P:protein localization; P:response to immobilization stress; P:Sertoli cell differentiation; P:spermatogenesis; P:transcription initiation from RNA polymerase II promoter; scaffold64 indexed_genome mRNA 361734 375050 . - . ID=transcript_10933;Q9HAI6,TLR adapter interacting with SLC15A4 on the lysosome {ECO:0000303|PubMed:32433612},, PF15133;, GO:0036020;GO:0005634;GO:0045087;GO:0045089;GO:0034157;GO:0034161;GO:0035751;, C:endolysosome membrane; C:nucleus;, , P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:regulation of lysosomal lumen pH; scaffold64 indexed_genome mRNA 441437 523515 . + . ID=transcript_10934;P32189 A6NJP5 B2R833 Q6IQ27 Q8IVR5 Q9UMP0 Q9UMP1,Glycerol kinase,ATP:glycerol 3-phosphotransferase;, PF02782;PF00370;, GO:0005829;GO:0070062;GO:0005741;GO:0005739;GO:0005524;GO:0004370;GO:0016773;GO:0019563;GO:0006071;GO:0046167;GO:0016310;GO:0019432;GO:0006641;, C:cytosol; C:extracellular exosome; C:mitochondrial outer membrane; C:mitochondrion;, F:ATP binding; F:glycerol kinase activity; F:phosphotransferase activity, alcohol group as acceptor;, P:glycerol catabolic process; P:glycerol metabolic process; P:glycerol-3-phosphate biosynthetic process; P:phosphorylation; P:triglyceride biosynthetic process; P:triglyceride metabolic process;|P32189 A6NJP5 B2R833 Q6IQ27 Q8IVR5 Q9UMP0 Q9UMP1,Glycerol kinase,ATP:glycerol 3-phosphotransferase;, PF02782;PF00370;, GO:0005829;GO:0070062;GO:0005741;GO:0005739;GO:0005524;GO:0004370;GO:0016773;GO:0019563;GO:0006071;GO:0046167;GO:0016310;GO:0019432;GO:0006641;, C:cytosol; C:extracellular exosome; C:mitochondrial outer membrane; C:mitochondrion;, F:ATP binding; F:glycerol kinase activity; F:phosphotransferase activity, alcohol group as acceptor;, P:glycerol catabolic process; P:glycerol metabolic process; P:glycerol-3-phosphate biosynthetic process; P:phosphorylation; P:triglyceride biosynthetic process; P:triglyceride metabolic process;|P32189 A6NJP5 B2R833 Q6IQ27 Q8IVR5 Q9UMP0 Q9UMP1,Glycerol kinase,ATP:glycerol 3-phosphotransferase;, PF02782;PF00370;, GO:0005829;GO:0070062;GO:0005741;GO:0005739;GO:0005524;GO:0004370;GO:0016773;GO:0019563;GO:0006071;GO:0046167;GO:0016310;GO:0019432;GO:0006641;, C:cytosol; C:extracellular exosome; C:mitochondrial outer membrane; C:mitochondrion;, F:ATP binding; F:glycerol kinase activity; F:phosphotransferase activity, alcohol group as acceptor;, P:glycerol catabolic process; P:glycerol metabolic process; P:glycerol-3-phosphate biosynthetic process; P:phosphorylation; P:triglyceride biosynthetic process; P:triglyceride metabolic process; scaffold64 indexed_genome mRNA 608473 668398 . - . ID=transcript_10935;Q8N5C8 A6NDD9 Q6VQR0,TGF-beta-activated kinase 1 and MAP3K7-binding protein 3,Mitogen-activated protein kinase kinase kinase 7-interacting protein 3;NF-kappa-B-activating protein 1;TAK1-binding protein 3;TGF-beta-activated kinase 1-binding protein 3;, PF02845;, GO:0005829;GO:0010008;GO:0070062;GO:0005886;GO:0046872;GO:0043130;GO:0000187;GO:0002753;GO:0038095;GO:0007249;GO:0070498;GO:0007254;GO:0002755;GO:0010507;GO:0070423;GO:0043123;GO:0051092;GO:0002223;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:plasma membrane;, F:metal ion binding; F:ubiquitin binding;, P:activation of MAPK activity; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of autophagy; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:stimulatory C-type lectin receptor signaling pathway; scaffold64 indexed_genome mRNA 966109 2252388 . - . ID=transcript_10936;Q02295 Q14169 Q14170 Q5JYU0 Q6NSJ9 Q7KZ48 Q8N754 Q9UCW3 Q9UCW4,Dystrophin,, PF00307;PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0009986;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0016010;GO:0030175;GO:0031527;GO:0045121;GO:0044306;GO:0005634;GO:0005886;GO:0045211;GO:0032991;GO:0042383;GO:0045202;GO:0016013;GO:0030018;GO:0003779;GO:0002162;GO:0017022;GO:0050998;GO:0005200;GO:0008307;GO:0017166;GO:0008270;GO:0086001;GO:0060048;GO:0034613;GO:0034622;GO:0035633;GO:0044458;GO:0046716;GO:0048747;GO:0030049;GO:0007517;GO:1902083;GO:0033137;GO:0043043;GO:0045666;GO:0010976;GO:2000651;GO:0010881;GO:0090287;GO:0002027;GO:0010880;GO:0060314;GO:0014819;GO:0014809;GO:1901385;GO:0035994;, C:cell surface; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:dystrophin-associated glycoprotein complex; C:filopodium; C:filopodium membrane; C:membrane raft; C:neuron projection terminus; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma; C:synapse; C:syntrophin complex; C:Z disc;, F:actin binding; F:dystroglycan binding; F:myosin binding; F:nitric-oxide synthase binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:vinculin binding; F:zinc ion binding;, P:cardiac muscle cell action potential; P:cardiac muscle contraction; P:cellular protein localization; P:cellular protein-containing complex assembly; P:maintenance of blood-brain barrier; P:motile cilium assembly; P:muscle cell cellular homeostasis; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of peptidyl-serine phosphorylation; P:peptide biosynthetic process; P:positive regulation of neuron differentiation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transmembrane transporter activity; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cellular response to growth factor stimulus; P:regulation of heart rate; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of skeletal muscle contraction; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of voltage-gated calcium channel activity; P:response to muscle stretch;|Q02295 Q14169 Q14170 Q5JYU0 Q6NSJ9 Q7KZ48 Q8N754 Q9UCW3 Q9UCW4,Dystrophin,, PF00307;PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0009986;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0016010;GO:0030175;GO:0031527;GO:0045121;GO:0044306;GO:0005634;GO:0005886;GO:0045211;GO:0032991;GO:0042383;GO:0045202;GO:0016013;GO:0030018;GO:0003779;GO:0002162;GO:0017022;GO:0050998;GO:0005200;GO:0008307;GO:0017166;GO:0008270;GO:0086001;GO:0060048;GO:0034613;GO:0034622;GO:0035633;GO:0044458;GO:0046716;GO:0048747;GO:0030049;GO:0007517;GO:1902083;GO:0033137;GO:0043043;GO:0045666;GO:0010976;GO:2000651;GO:0010881;GO:0090287;GO:0002027;GO:0010880;GO:0060314;GO:0014819;GO:0014809;GO:1901385;GO:0035994;, C:cell surface; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:dystrophin-associated glycoprotein complex; C:filopodium; C:filopodium membrane; C:membrane raft; C:neuron projection terminus; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma; C:synapse; C:syntrophin complex; C:Z disc;, F:actin binding; F:dystroglycan binding; F:myosin binding; F:nitric-oxide synthase binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:vinculin binding; F:zinc ion binding;, P:cardiac muscle cell action potential; P:cardiac muscle contraction; P:cellular protein localization; P:cellular protein-containing complex assembly; P:maintenance of blood-brain barrier; P:motile cilium assembly; P:muscle cell cellular homeostasis; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of peptidyl-serine phosphorylation; P:peptide biosynthetic process; P:positive regulation of neuron differentiation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transmembrane transporter activity; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cellular response to growth factor stimulus; P:regulation of heart rate; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of skeletal muscle contraction; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of voltage-gated calcium channel activity; P:response to muscle stretch;|Q02295 Q14169 Q14170 Q5JYU0 Q6NSJ9 Q7KZ48 Q8N754 Q9UCW3 Q9UCW4,Dystrophin,, PF00307;PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0009986;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0016010;GO:0030175;GO:0031527;GO:0045121;GO:0044306;GO:0005634;GO:0005886;GO:0045211;GO:0032991;GO:0042383;GO:0045202;GO:0016013;GO:0030018;GO:0003779;GO:0002162;GO:0017022;GO:0050998;GO:0005200;GO:0008307;GO:0017166;GO:0008270;GO:0086001;GO:0060048;GO:0034613;GO:0034622;GO:0035633;GO:0044458;GO:0046716;GO:0048747;GO:0030049;GO:0007517;GO:1902083;GO:0033137;GO:0043043;GO:0045666;GO:0010976;GO:2000651;GO:0010881;GO:0090287;GO:0002027;GO:0010880;GO:0060314;GO:0014819;GO:0014809;GO:1901385;GO:0035994;, C:cell surface; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:dystrophin-associated glycoprotein complex; C:filopodium; C:filopodium membrane; C:membrane raft; C:neuron projection terminus; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma; C:synapse; C:syntrophin complex; C:Z disc;, F:actin binding; F:dystroglycan binding; F:myosin binding; F:nitric-oxide synthase binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:vinculin binding; F:zinc ion binding;, P:cardiac muscle cell action potential; P:cardiac muscle contraction; P:cellular protein localization; P:cellular protein-containing complex assembly; P:maintenance of blood-brain barrier; P:motile cilium assembly; P:muscle cell cellular homeostasis; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of peptidyl-serine phosphorylation; P:peptide biosynthetic process; P:positive regulation of neuron differentiation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transmembrane transporter activity; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cellular response to growth factor stimulus; P:regulation of heart rate; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of skeletal muscle contraction; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of voltage-gated calcium channel activity; P:response to muscle stretch;|Q02295 Q14169 Q14170 Q5JYU0 Q6NSJ9 Q7KZ48 Q8N754 Q9UCW3 Q9UCW4,Dystrophin,, PF00307;PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0009986;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0016010;GO:0030175;GO:0031527;GO:0045121;GO:0044306;GO:0005634;GO:0005886;GO:0045211;GO:0032991;GO:0042383;GO:0045202;GO:0016013;GO:0030018;GO:0003779;GO:0002162;GO:0017022;GO:0050998;GO:0005200;GO:0008307;GO:0017166;GO:0008270;GO:0086001;GO:0060048;GO:0034613;GO:0034622;GO:0035633;GO:0044458;GO:0046716;GO:0048747;GO:0030049;GO:0007517;GO:1902083;GO:0033137;GO:0043043;GO:0045666;GO:0010976;GO:2000651;GO:0010881;GO:0090287;GO:0002027;GO:0010880;GO:0060314;GO:0014819;GO:0014809;GO:1901385;GO:0035994;, C:cell surface; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:dystrophin-associated glycoprotein complex; C:filopodium; C:filopodium membrane; C:membrane raft; C:neuron projection terminus; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma; C:synapse; C:syntrophin complex; C:Z disc;, F:actin binding; F:dystroglycan binding; F:myosin binding; F:nitric-oxide synthase binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:vinculin binding; F:zinc ion binding;, P:cardiac muscle cell action potential; P:cardiac muscle contraction; P:cellular protein localization; P:cellular protein-containing complex assembly; P:maintenance of blood-brain barrier; P:motile cilium assembly; P:muscle cell cellular homeostasis; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of peptidyl-serine phosphorylation; P:peptide biosynthetic process; P:positive regulation of neuron differentiation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transmembrane transporter activity; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cellular response to growth factor stimulus; P:regulation of heart rate; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of skeletal muscle contraction; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of voltage-gated calcium channel activity; P:response to muscle stretch; scaffold64 indexed_genome mRNA 2299086 2359251 . - . ID=transcript_10937;Q02295 Q14169 Q14170 Q5JYU0 Q6NSJ9 Q7KZ48 Q8N754 Q9UCW3 Q9UCW4,Dystrophin,, PF00307;PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0009986;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0016010;GO:0030175;GO:0031527;GO:0045121;GO:0044306;GO:0005634;GO:0005886;GO:0045211;GO:0032991;GO:0042383;GO:0045202;GO:0016013;GO:0030018;GO:0003779;GO:0002162;GO:0017022;GO:0050998;GO:0005200;GO:0008307;GO:0017166;GO:0008270;GO:0086001;GO:0060048;GO:0034613;GO:0034622;GO:0035633;GO:0044458;GO:0046716;GO:0048747;GO:0030049;GO:0007517;GO:1902083;GO:0033137;GO:0043043;GO:0045666;GO:0010976;GO:2000651;GO:0010881;GO:0090287;GO:0002027;GO:0010880;GO:0060314;GO:0014819;GO:0014809;GO:1901385;GO:0035994;, C:cell surface; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:dystrophin-associated glycoprotein complex; C:filopodium; C:filopodium membrane; C:membrane raft; C:neuron projection terminus; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma; C:synapse; C:syntrophin complex; C:Z disc;, F:actin binding; F:dystroglycan binding; F:myosin binding; F:nitric-oxide synthase binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:vinculin binding; F:zinc ion binding;, P:cardiac muscle cell action potential; P:cardiac muscle contraction; P:cellular protein localization; P:cellular protein-containing complex assembly; P:maintenance of blood-brain barrier; P:motile cilium assembly; P:muscle cell cellular homeostasis; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of peptidyl-serine phosphorylation; P:peptide biosynthetic process; P:positive regulation of neuron differentiation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transmembrane transporter activity; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cellular response to growth factor stimulus; P:regulation of heart rate; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of skeletal muscle contraction; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of voltage-gated calcium channel activity; P:response to muscle stretch; scaffold64 indexed_genome mRNA 2384996 2442503 . - . ID=transcript_10938;Q02295 Q14169 Q14170 Q5JYU0 Q6NSJ9 Q7KZ48 Q8N754 Q9UCW3 Q9UCW4,Dystrophin,, PF00307;PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0009986;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0016010;GO:0030175;GO:0031527;GO:0045121;GO:0044306;GO:0005634;GO:0005886;GO:0045211;GO:0032991;GO:0042383;GO:0045202;GO:0016013;GO:0030018;GO:0003779;GO:0002162;GO:0017022;GO:0050998;GO:0005200;GO:0008307;GO:0017166;GO:0008270;GO:0086001;GO:0060048;GO:0034613;GO:0034622;GO:0035633;GO:0044458;GO:0046716;GO:0048747;GO:0030049;GO:0007517;GO:1902083;GO:0033137;GO:0043043;GO:0045666;GO:0010976;GO:2000651;GO:0010881;GO:0090287;GO:0002027;GO:0010880;GO:0060314;GO:0014819;GO:0014809;GO:1901385;GO:0035994;, C:cell surface; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:dystrophin-associated glycoprotein complex; C:filopodium; C:filopodium membrane; C:membrane raft; C:neuron projection terminus; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma; C:synapse; C:syntrophin complex; C:Z disc;, F:actin binding; F:dystroglycan binding; F:myosin binding; F:nitric-oxide synthase binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:vinculin binding; F:zinc ion binding;, P:cardiac muscle cell action potential; P:cardiac muscle contraction; P:cellular protein localization; P:cellular protein-containing complex assembly; P:maintenance of blood-brain barrier; P:motile cilium assembly; P:muscle cell cellular homeostasis; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of peptidyl-serine phosphorylation; P:peptide biosynthetic process; P:positive regulation of neuron differentiation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transmembrane transporter activity; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cellular response to growth factor stimulus; P:regulation of heart rate; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of skeletal muscle contraction; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of voltage-gated calcium channel activity; P:response to muscle stretch; scaffold64 indexed_genome mRNA 2573735 3098671 . - . ID=transcript_10939;Q02295 Q14169 Q14170 Q5JYU0 Q6NSJ9 Q7KZ48 Q8N754 Q9UCW3 Q9UCW4,Dystrophin,, PF00307;PF09068;PF09069;PF00435;PF00397;PF00569;, GO:0009986;GO:0030055;GO:0043034;GO:0005856;GO:0005829;GO:0016010;GO:0030175;GO:0031527;GO:0045121;GO:0044306;GO:0005634;GO:0005886;GO:0045211;GO:0032991;GO:0042383;GO:0045202;GO:0016013;GO:0030018;GO:0003779;GO:0002162;GO:0017022;GO:0050998;GO:0005200;GO:0008307;GO:0017166;GO:0008270;GO:0086001;GO:0060048;GO:0034613;GO:0034622;GO:0035633;GO:0044458;GO:0046716;GO:0048747;GO:0030049;GO:0007517;GO:1902083;GO:0033137;GO:0043043;GO:0045666;GO:0010976;GO:2000651;GO:0010881;GO:0090287;GO:0002027;GO:0010880;GO:0060314;GO:0014819;GO:0014809;GO:1901385;GO:0035994;, C:cell surface; C:cell-substrate junction; C:costamere; C:cytoskeleton; C:cytosol; C:dystrophin-associated glycoprotein complex; C:filopodium; C:filopodium membrane; C:membrane raft; C:neuron projection terminus; C:nucleus; C:plasma membrane; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma; C:synapse; C:syntrophin complex; C:Z disc;, F:actin binding; F:dystroglycan binding; F:myosin binding; F:nitric-oxide synthase binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:vinculin binding; F:zinc ion binding;, P:cardiac muscle cell action potential; P:cardiac muscle contraction; P:cellular protein localization; P:cellular protein-containing complex assembly; P:maintenance of blood-brain barrier; P:motile cilium assembly; P:muscle cell cellular homeostasis; P:muscle fiber development; P:muscle filament sliding; P:muscle organ development; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of peptidyl-serine phosphorylation; P:peptide biosynthetic process; P:positive regulation of neuron differentiation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transmembrane transporter activity; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cellular response to growth factor stimulus; P:regulation of heart rate; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of skeletal muscle contraction; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; P:regulation of voltage-gated calcium channel activity; P:response to muscle stretch; scaffold64 indexed_genome mRNA 4424516 4453595 . - . ID=transcript_10940;Q9BQJ4 Q5JR44,Transmembrane protein 47,Brain cell membrane protein 1;Transmembrane 4 superfamily member 10;, , GO:0005912;GO:0005911;GO:0016021;GO:0005886;GO:0098609;, C:adherens junction; C:cell-cell junction; C:integral component of membrane; C:plasma membrane;, , P:cell-cell adhesion; scaffold64 indexed_genome mRNA 6093351 6142114 . + . ID=transcript_10941;Q6ZTR5 A0A140T8X2 A6PW82 B1ARL5 Q5JRM8 Q8N6X8 Q8N9S7,Cilia- and flagella-associated protein 47 {ECO:0000305} scaffold64 indexed_genome mRNA 6748446 6752577 . - . ID=transcript_10942;O14668 B2R7A3 C9JXL7 D3DWA9 Q5JT66,Transmembrane gamma-carboxyglutamic acid protein 1,Proline-rich gamma-carboxyglutamic acid protein 1;, PF00594;, GO:0005576;GO:0005887;GO:0005509;, C:extracellular region; C:integral component of plasma membrane;, F:calcium ion binding; scaffold64 indexed_genome mRNA 7119696 7120216 . - . ID=transcript_10943;Q6ZV70 A6NHE3,LanC-like protein 3,, PF05147;, GO:0005886;GO:0005975;, C:plasma membrane;, , P:carbohydrate metabolic process; scaffold64 indexed_genome mRNA 7222467 7284223 . + . ID=transcript_10944;P51811 Q4TTN6 Q8IUK6 Q9UC77,Membrane transport protein XK,Kell complex 37 kDa component;Kx antigen;XK-related protein 1;, PF09815;, GO:0016021;GO:0005886;GO:0005215;GO:0006865;GO:0007186;, C:integral component of membrane; C:plasma membrane;, F:transporter activity;, P:amino acid transport; P:G protein-coupled receptor signaling pathway; scaffold64 indexed_genome mRNA 7328907 7362271 . + . ID=transcript_10945;P04839 A8K138 Q2PP16,Cytochrome b-245 heavy chain,CGD91-phox;Cytochrome b(558) subunit beta;Heme-binding membrane glycoprotein gp91phox;NADPH oxidase 2;Neutrophil cytochrome b 91 kDa polypeptide;Superoxide-generating NADPH oxidase heavy chain subunit;gp91-1;gp91-phox;p22 phagocyte B-cytochrome;, PF08022;PF01794;PF08030;, GO:0030425;GO:0005789;GO:0005794;GO:0005887;GO:0043020;GO:0043025;GO:0005635;GO:0097038;GO:0030670;GO:0005886;GO:0005791;GO:0035579;GO:0070821;GO:0050660;GO:0020037;GO:0046872;GO:0046982;GO:0016175;GO:0005244;GO:0002479;GO:0045454;GO:0071276;GO:0071361;GO:1904845;GO:0034599;GO:0006952;GO:0022900;GO:0097411;GO:0006954;GO:0045087;GO:0043312;GO:0045766;GO:0034765;GO:0045730;GO:1904044;GO:1990776;GO:0042493;GO:0007584;GO:0042554;GO:0006801;GO:0048010;, C:dendrite; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:NADPH oxidase complex; C:neuronal cell body; C:nuclear envelope; C:perinuclear endoplasmic reticulum; C:phagocytic vesicle membrane; C:plasma membrane; C:rough endoplasmic reticulum; C:specific granule membrane; C:tertiary granule membrane;, F:flavin adenine dinucleotide binding; F:heme binding; F:metal ion binding; F:protein heterodimerization activity; F:superoxide-generating NAD(P)H oxidase activity; F:voltage-gated ion channel activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell redox homeostasis; P:cellular response to cadmium ion; P:cellular response to ethanol; P:cellular response to L-glutamine; P:cellular response to oxidative stress; P:defense response; P:electron transport chain; P:hypoxia-inducible factor-1alpha signaling pathway; P:inflammatory response; P:innate immune response; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:regulation of ion transmembrane transport; P:respiratory burst; P:response to aldosterone; P:response to angiotensin; P:response to drug; P:response to nutrient; P:superoxide anion generation; P:superoxide metabolic process; P:vascular endothelial growth factor receptor signaling pathway;|P04839 A8K138 Q2PP16,Cytochrome b-245 heavy chain,CGD91-phox;Cytochrome b(558) subunit beta;Heme-binding membrane glycoprotein gp91phox;NADPH oxidase 2;Neutrophil cytochrome b 91 kDa polypeptide;Superoxide-generating NADPH oxidase heavy chain subunit;gp91-1;gp91-phox;p22 phagocyte B-cytochrome;, PF08022;PF01794;PF08030;, GO:0030425;GO:0005789;GO:0005794;GO:0005887;GO:0043020;GO:0043025;GO:0005635;GO:0097038;GO:0030670;GO:0005886;GO:0005791;GO:0035579;GO:0070821;GO:0050660;GO:0020037;GO:0046872;GO:0046982;GO:0016175;GO:0005244;GO:0002479;GO:0045454;GO:0071276;GO:0071361;GO:1904845;GO:0034599;GO:0006952;GO:0022900;GO:0097411;GO:0006954;GO:0045087;GO:0043312;GO:0045766;GO:0034765;GO:0045730;GO:1904044;GO:1990776;GO:0042493;GO:0007584;GO:0042554;GO:0006801;GO:0048010;, C:dendrite; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:NADPH oxidase complex; C:neuronal cell body; C:nuclear envelope; C:perinuclear endoplasmic reticulum; C:phagocytic vesicle membrane; C:plasma membrane; C:rough endoplasmic reticulum; C:specific granule membrane; C:tertiary granule membrane;, F:flavin adenine dinucleotide binding; F:heme binding; F:metal ion binding; F:protein heterodimerization activity; F:superoxide-generating NAD(P)H oxidase activity; F:voltage-gated ion channel activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell redox homeostasis; P:cellular response to cadmium ion; P:cellular response to ethanol; P:cellular response to L-glutamine; P:cellular response to oxidative stress; P:defense response; P:electron transport chain; P:hypoxia-inducible factor-1alpha signaling pathway; P:inflammatory response; P:innate immune response; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:regulation of ion transmembrane transport; P:respiratory burst; P:response to aldosterone; P:response to angiotensin; P:response to drug; P:response to nutrient; P:superoxide anion generation; P:superoxide metabolic process; P:vascular endothelial growth factor receptor signaling pathway;|P04839 A8K138 Q2PP16,Cytochrome b-245 heavy chain,CGD91-phox;Cytochrome b(558) subunit beta;Heme-binding membrane glycoprotein gp91phox;NADPH oxidase 2;Neutrophil cytochrome b 91 kDa polypeptide;Superoxide-generating NADPH oxidase heavy chain subunit;gp91-1;gp91-phox;p22 phagocyte B-cytochrome;, PF08022;PF01794;PF08030;, GO:0030425;GO:0005789;GO:0005794;GO:0005887;GO:0043020;GO:0043025;GO:0005635;GO:0097038;GO:0030670;GO:0005886;GO:0005791;GO:0035579;GO:0070821;GO:0050660;GO:0020037;GO:0046872;GO:0046982;GO:0016175;GO:0005244;GO:0002479;GO:0045454;GO:0071276;GO:0071361;GO:1904845;GO:0034599;GO:0006952;GO:0022900;GO:0097411;GO:0006954;GO:0045087;GO:0043312;GO:0045766;GO:0034765;GO:0045730;GO:1904044;GO:1990776;GO:0042493;GO:0007584;GO:0042554;GO:0006801;GO:0048010;, C:dendrite; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:NADPH oxidase complex; C:neuronal cell body; C:nuclear envelope; C:perinuclear endoplasmic reticulum; C:phagocytic vesicle membrane; C:plasma membrane; C:rough endoplasmic reticulum; C:specific granule membrane; C:tertiary granule membrane;, F:flavin adenine dinucleotide binding; F:heme binding; F:metal ion binding; F:protein heterodimerization activity; F:superoxide-generating NAD(P)H oxidase activity; F:voltage-gated ion channel activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell redox homeostasis; P:cellular response to cadmium ion; P:cellular response to ethanol; P:cellular response to L-glutamine; P:cellular response to oxidative stress; P:defense response; P:electron transport chain; P:hypoxia-inducible factor-1alpha signaling pathway; P:inflammatory response; P:innate immune response; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:regulation of ion transmembrane transport; P:respiratory burst; P:response to aldosterone; P:response to angiotensin; P:response to drug; P:response to nutrient; P:superoxide anion generation; P:superoxide metabolic process; P:vascular endothelial growth factor receptor signaling pathway;|P04839 A8K138 Q2PP16,Cytochrome b-245 heavy chain,CGD91-phox;Cytochrome b(558) subunit beta;Heme-binding membrane glycoprotein gp91phox;NADPH oxidase 2;Neutrophil cytochrome b 91 kDa polypeptide;Superoxide-generating NADPH oxidase heavy chain subunit;gp91-1;gp91-phox;p22 phagocyte B-cytochrome;, PF08022;PF01794;PF08030;, GO:0030425;GO:0005789;GO:0005794;GO:0005887;GO:0043020;GO:0043025;GO:0005635;GO:0097038;GO:0030670;GO:0005886;GO:0005791;GO:0035579;GO:0070821;GO:0050660;GO:0020037;GO:0046872;GO:0046982;GO:0016175;GO:0005244;GO:0002479;GO:0045454;GO:0071276;GO:0071361;GO:1904845;GO:0034599;GO:0006952;GO:0022900;GO:0097411;GO:0006954;GO:0045087;GO:0043312;GO:0045766;GO:0034765;GO:0045730;GO:1904044;GO:1990776;GO:0042493;GO:0007584;GO:0042554;GO:0006801;GO:0048010;, C:dendrite; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:NADPH oxidase complex; C:neuronal cell body; C:nuclear envelope; C:perinuclear endoplasmic reticulum; C:phagocytic vesicle membrane; C:plasma membrane; C:rough endoplasmic reticulum; C:specific granule membrane; C:tertiary granule membrane;, F:flavin adenine dinucleotide binding; F:heme binding; F:metal ion binding; F:protein heterodimerization activity; F:superoxide-generating NAD(P)H oxidase activity; F:voltage-gated ion channel activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell redox homeostasis; P:cellular response to cadmium ion; P:cellular response to ethanol; P:cellular response to L-glutamine; P:cellular response to oxidative stress; P:defense response; P:electron transport chain; P:hypoxia-inducible factor-1alpha signaling pathway; P:inflammatory response; P:innate immune response; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:regulation of ion transmembrane transport; P:respiratory burst; P:response to aldosterone; P:response to angiotensin; P:response to drug; P:response to nutrient; P:superoxide anion generation; P:superoxide metabolic process; P:vascular endothelial growth factor receptor signaling pathway; scaffold64 indexed_genome mRNA 7399660 7410731 . - . ID=transcript_10946;P51808 Q6ICS3,Dynein light chain Tctex-type 3,Protein 91/23;T-complex-associated testis-expressed 1-like;, PF03645;, GO:0000777;GO:0005737;GO:0005868;GO:0005874;GO:0005634;GO:0042802;GO:0007049;GO:0051301;GO:0007346;, C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic dynein complex; C:microtubule; C:nucleus;, F:identical protein binding;, P:cell cycle; P:cell division; P:regulation of mitotic cell cycle; scaffold64 indexed_genome mRNA 7767051 7904441 . - . ID=transcript_10947;Q99913,Sushi repeat-containing protein SRPX,, PF13778;PF02494;PF00084;, GO:0005776;GO:0009986;GO:0062023;GO:0005783;GO:0016020;GO:0006914;GO:0007155;GO:0060244;GO:0001845;GO:2001241;GO:0034976;, C:autophagosome; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:membrane;, , P:autophagy; P:cell adhesion; P:negative regulation of cell proliferation involved in contact inhibition; P:phagolysosome assembly; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:response to endoplasmic reticulum stress; scaffold64 indexed_genome mRNA 7934585 7960599 . - . ID=transcript_10948;Q9UMR1,X-linked retinitis pigmentosa GTPase regulator,, PF00415;, GO:0005813;GO:0036064;GO:0005794;GO:0001750;GO:0036126;GO:0005085;GO:0003723;GO:0060271;GO:0006886;GO:0042073;GO:0050896;GO:0007601;, C:centrosome; C:ciliary basal body; C:Golgi apparatus; C:photoreceptor outer segment; C:sperm flagellum;, F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:cilium assembly; P:intracellular protein transport; P:intraciliary transport; P:response to stimulus; P:visual perception;|Q9UMR1,X-linked retinitis pigmentosa GTPase regulator,, PF00415;, GO:0005813;GO:0036064;GO:0005794;GO:0001750;GO:0036126;GO:0005085;GO:0003723;GO:0060271;GO:0006886;GO:0042073;GO:0050896;GO:0007601;, C:centrosome; C:ciliary basal body; C:Golgi apparatus; C:photoreceptor outer segment; C:sperm flagellum;, F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:cilium assembly; P:intracellular protein transport; P:intraciliary transport; P:response to stimulus; P:visual perception;|Q9UMR1,X-linked retinitis pigmentosa GTPase regulator,, PF00415;, GO:0005813;GO:0036064;GO:0005794;GO:0001750;GO:0036126;GO:0005085;GO:0003723;GO:0060271;GO:0006886;GO:0042073;GO:0050896;GO:0007601;, C:centrosome; C:ciliary basal body; C:Golgi apparatus; C:photoreceptor outer segment; C:sperm flagellum;, F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:cilium assembly; P:intracellular protein transport; P:intraciliary transport; P:response to stimulus; P:visual perception; scaffold64 indexed_genome mRNA 7976397 8016170 . - . ID=transcript_10949;Q9UMR1,X-linked retinitis pigmentosa GTPase regulator,, PF00415;, GO:0005813;GO:0036064;GO:0005794;GO:0001750;GO:0036126;GO:0005085;GO:0003723;GO:0060271;GO:0006886;GO:0042073;GO:0050896;GO:0007601;, C:centrosome; C:ciliary basal body; C:Golgi apparatus; C:photoreceptor outer segment; C:sperm flagellum;, F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:cilium assembly; P:intracellular protein transport; P:intraciliary transport; P:response to stimulus; P:visual perception;|Q9UMR1,X-linked retinitis pigmentosa GTPase regulator,, PF00415;, GO:0005813;GO:0036064;GO:0005794;GO:0001750;GO:0036126;GO:0005085;GO:0003723;GO:0060271;GO:0006886;GO:0042073;GO:0050896;GO:0007601;, C:centrosome; C:ciliary basal body; C:Golgi apparatus; C:photoreceptor outer segment; C:sperm flagellum;, F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:cilium assembly; P:intracellular protein transport; P:intraciliary transport; P:response to stimulus; P:visual perception; scaffold64 indexed_genome mRNA 8047677 8114900 . + . ID=transcript_10950;P00480 A8K9P2 D3DWB0 Q3KNR1 Q6B0I1 Q9NYJ5,Ornithine transcarbamylase, mitochondrial {ECO:0000305|PubMed:3895227, ECO:0000305|PubMed:6372096},Ornithine carbamoyltransferase, mitochondrial;, PF00185;PF02729;, GO:0043231;GO:0005743;GO:0005759;GO:0005739;GO:0016597;GO:0042802;GO:0004585;GO:0042301;GO:0005543;GO:0097272;GO:0055081;GO:0042450;GO:0019240;GO:0001889;GO:0007494;GO:0006593;GO:0070781;GO:0042493;GO:0032868;GO:0010043;GO:0000050;, C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:amino acid binding; F:identical protein binding; F:ornithine carbamoyltransferase activity; F:phosphate ion binding; F:phospholipid binding;, P:ammonium homeostasis; P:anion homeostasis; P:arginine biosynthetic process via ornithine; P:citrulline biosynthetic process; P:liver development; P:midgut development; P:ornithine catabolic process; P:response to biotin; P:response to drug; P:response to insulin; P:response to zinc ion; P:urea cycle; scaffold64 indexed_genome mRNA 8351836 8376355 . + . ID=transcript_10951;P41732 B2R5W7 D3DWB1 Q8WVG5 Q9UEY9,Tetraspanin-7,Cell surface glycoprotein A15;Membrane component chromosome X surface marker 1;T-cell acute lymphoblastic leukemia-associated antigen 1;Transmembrane 4 superfamily member 2;, PF00335;, GO:0005887;GO:0016032;, C:integral component of plasma membrane;, , P:viral process;|P41732 B2R5W7 D3DWB1 Q8WVG5 Q9UEY9,Tetraspanin-7,Cell surface glycoprotein A15;Membrane component chromosome X surface marker 1;T-cell acute lymphoblastic leukemia-associated antigen 1;Transmembrane 4 superfamily member 2;, PF00335;, GO:0005887;GO:0016032;, C:integral component of plasma membrane;, , P:viral process; scaffold64 indexed_genome mRNA 8474967 8477356 . + . ID=transcript_10952;Q9NPA3 D3DWB2,Mid1-interacting protein 1,Gastrulation-specific G12-like protein;Mid1-interacting G12-like protein;Protein STRAIT11499;Spot 14-related protein;, PF07084;, GO:0005829;GO:0005874;GO:0015630;GO:0005634;GO:0042802;GO:0008022;GO:0006853;GO:0006629;GO:0007026;GO:0045723;GO:0051351;GO:0051258;GO:0046890;, C:cytosol; C:microtubule; C:microtubule cytoskeleton; C:nucleus;, F:identical protein binding; F:protein C-terminus binding;, P:carnitine shuttle; P:lipid metabolic process; P:negative regulation of microtubule depolymerization; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of ligase activity; P:protein polymerization; P:regulation of lipid biosynthetic process; scaffold64 indexed_genome mRNA 9455868 9479884 . - . ID=transcript_10953;Q9H233 Q9HCJ7 Q9NXF2,BCL-6 corepressor,, PF12796;PF15808;PF16553;, GO:0140261;GO:0005654;GO:0005634;GO:0031072;GO:0042826;GO:0000977;GO:0003714;GO:0008134;GO:0000976;GO:0001835;GO:0007507;GO:0035518;GO:0030502;GO:0000415;GO:0051572;GO:0070171;GO:0000122;GO:0045892;GO:0042476;GO:0060021;GO:0065001;, C:BCOR complex; C:nucleoplasm; C:nucleus;, F:heat shock protein binding; F:histone deacetylase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:blastocyst hatching; P:heart development; P:histone H2A monoubiquitination; P:negative regulation of bone mineralization; P:negative regulation of histone H3-K36 methylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of tooth mineralization; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:odontogenesis; P:roof of mouth development; P:specification of axis polarity;|Q9H233 Q9HCJ7 Q9NXF2,BCL-6 corepressor,, PF12796;PF15808;PF16553;, GO:0140261;GO:0005654;GO:0005634;GO:0031072;GO:0042826;GO:0000977;GO:0003714;GO:0008134;GO:0000976;GO:0001835;GO:0007507;GO:0035518;GO:0030502;GO:0000415;GO:0051572;GO:0070171;GO:0000122;GO:0045892;GO:0042476;GO:0060021;GO:0065001;, C:BCOR complex; C:nucleoplasm; C:nucleus;, F:heat shock protein binding; F:histone deacetylase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:blastocyst hatching; P:heart development; P:histone H2A monoubiquitination; P:negative regulation of bone mineralization; P:negative regulation of histone H3-K36 methylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of tooth mineralization; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:odontogenesis; P:roof of mouth development; P:specification of axis polarity;|Q9H233 Q9HCJ7 Q9NXF2,BCL-6 corepressor,, PF12796;PF15808;PF16553;, GO:0140261;GO:0005654;GO:0005634;GO:0031072;GO:0042826;GO:0000977;GO:0003714;GO:0008134;GO:0000976;GO:0001835;GO:0007507;GO:0035518;GO:0030502;GO:0000415;GO:0051572;GO:0070171;GO:0000122;GO:0045892;GO:0042476;GO:0060021;GO:0065001;, C:BCOR complex; C:nucleoplasm; C:nucleus;, F:heat shock protein binding; F:histone deacetylase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:blastocyst hatching; P:heart development; P:histone H2A monoubiquitination; P:negative regulation of bone mineralization; P:negative regulation of histone H3-K36 methylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of tooth mineralization; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:odontogenesis; P:roof of mouth development; P:specification of axis polarity;|Q9H233 Q9HCJ7 Q9NXF2,BCL-6 corepressor,, PF12796;PF15808;PF16553;, GO:0140261;GO:0005654;GO:0005634;GO:0031072;GO:0042826;GO:0000977;GO:0003714;GO:0008134;GO:0000976;GO:0001835;GO:0007507;GO:0035518;GO:0030502;GO:0000415;GO:0051572;GO:0070171;GO:0000122;GO:0045892;GO:0042476;GO:0060021;GO:0065001;, C:BCOR complex; C:nucleoplasm; C:nucleus;, F:heat shock protein binding; F:histone deacetylase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:blastocyst hatching; P:heart development; P:histone H2A monoubiquitination; P:negative regulation of bone mineralization; P:negative regulation of histone H3-K36 methylation; P:negative regulation of histone H3-K4 methylation; P:negative regulation of tooth mineralization; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:odontogenesis; P:roof of mouth development; P:specification of axis polarity; scaffold64 indexed_genome mRNA 9929177 9952324 . + . ID=transcript_10954;Q9UG89,Renin receptor {ECO:0000305},ATPase H(+)-transporting lysosomal accessory protein 2;ATPase H(+)-transporting lysosomal-interacting protein 2;ER-localized type I transmembrane adapter;Embryonic liver differentiation factor 10;N14F;Renin/prorenin receptor;Vacuolar ATP synthase membrane sector-associated protein M8-9;, PF07850;, GO:0016324;GO:0000421;GO:0030424;GO:0044297;GO:0032591;GO:0005789;GO:0010008;GO:0009897;GO:0070062;GO:0101003;GO:0016021;GO:0005765;GO:0005764;GO:0005886;GO:0045211;GO:0070821;GO:0016471;GO:0038023;GO:0002003;GO:0021626;GO:0048069;GO:0060323;GO:0007042;GO:0043312;GO:0090263;GO:0032914;GO:0030177;GO:0043408;GO:0021903;, C:apical plasma membrane; C:autophagosome membrane; C:axon; C:cell body; C:dendritic spine membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane; C:postsynaptic membrane; C:tertiary granule membrane; C:vacuolar proton-transporting V-type ATPase complex;, F:signaling receptor activity;, P:angiotensin maturation; P:central nervous system maturation; P:eye pigmentation; P:head morphogenesis; P:lysosomal lumen acidification; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transforming growth factor beta1 production; P:positive regulation of Wnt signaling pathway; P:regulation of MAPK cascade; P:rostrocaudal neural tube patterning;|Q9UG89,Renin receptor {ECO:0000305},ATPase H(+)-transporting lysosomal accessory protein 2;ATPase H(+)-transporting lysosomal-interacting protein 2;ER-localized type I transmembrane adapter;Embryonic liver differentiation factor 10;N14F;Renin/prorenin receptor;Vacuolar ATP synthase membrane sector-associated protein M8-9;, PF07850;, GO:0016324;GO:0000421;GO:0030424;GO:0044297;GO:0032591;GO:0005789;GO:0010008;GO:0009897;GO:0070062;GO:0101003;GO:0016021;GO:0005765;GO:0005764;GO:0005886;GO:0045211;GO:0070821;GO:0016471;GO:0038023;GO:0002003;GO:0021626;GO:0048069;GO:0060323;GO:0007042;GO:0043312;GO:0090263;GO:0032914;GO:0030177;GO:0043408;GO:0021903;, C:apical plasma membrane; C:autophagosome membrane; C:axon; C:cell body; C:dendritic spine membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:plasma membrane; C:postsynaptic membrane; C:tertiary granule membrane; C:vacuolar proton-transporting V-type ATPase complex;, F:signaling receptor activity;, P:angiotensin maturation; P:central nervous system maturation; P:eye pigmentation; P:head morphogenesis; P:lysosomal lumen acidification; P:neutrophil degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transforming growth factor beta1 production; P:positive regulation of Wnt signaling pathway; P:regulation of MAPK cascade; P:rostrocaudal neural tube patterning; scaffold64 indexed_genome mRNA 10012896 10033916 . - . ID=transcript_10955;Q8TB03 B3KW28 D3DWB5 Q5JPF5 Q8N941,Uncharacterized protein CXorf38,, PF15112; scaffold64 indexed_genome mRNA 10035682 10101689 . - . ID=transcript_10956;O60244 Q4KMR7 Q9UNB3,Mediator of RNA polymerase II transcription subunit 14,Activator-recruited cofactor 150 kDa component;Cofactor required for Sp1 transcriptional activation subunit 2;Mediator complex subunit 14;RGR1 homolog;Thyroid hormone receptor-associated protein complex 170 kDa component;Transcriptional coactivator CRSP150;Vitamin D3 receptor-interacting protein complex 150 kDa component;, PF08638;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0003713;GO:0003712;GO:0042809;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0019827;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:stem cell population maintenance;|O60244 Q4KMR7 Q9UNB3,Mediator of RNA polymerase II transcription subunit 14,Activator-recruited cofactor 150 kDa component;Cofactor required for Sp1 transcriptional activation subunit 2;Mediator complex subunit 14;RGR1 homolog;Thyroid hormone receptor-associated protein complex 170 kDa component;Transcriptional coactivator CRSP150;Vitamin D3 receptor-interacting protein complex 150 kDa component;, PF08638;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0003713;GO:0003712;GO:0042809;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0019827;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:stem cell population maintenance;|O60244 Q4KMR7 Q9UNB3,Mediator of RNA polymerase II transcription subunit 14,Activator-recruited cofactor 150 kDa component;Cofactor required for Sp1 transcriptional activation subunit 2;Mediator complex subunit 14;RGR1 homolog;Thyroid hormone receptor-associated protein complex 170 kDa component;Transcriptional coactivator CRSP150;Vitamin D3 receptor-interacting protein complex 150 kDa component;, PF08638;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0030374;GO:0003713;GO:0003712;GO:0042809;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0019827;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus;, F:nuclear receptor coactivator activity; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:stem cell population maintenance;|Q6R2W3 Q2NKL9 Q5SRJ3 Q8TCN2 Q96MV9 Q96PW3,SCAN domain-containing protein 3,Transposon-derived Buster4 transposase-like protein;Zinc finger BED domain-containing protein 9;, PF02023;, GO:0005737;GO:0005634;GO:0003676;GO:0015074;GO:0045787;GO:0050679;, C:cytoplasm; C:nucleus;, F:nucleic acid binding;, P:DNA integration; P:positive regulation of cell cycle; P:positive regulation of epithelial cell proliferation; scaffold64 indexed_genome mRNA 10463208 10585747 . + . ID=transcript_10957;Q93008 O75550 Q8WWT3 Q8WX12,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,Deubiquitinating enzyme FAF-X;Fat facets in mammals;Fat facets protein-related, X-linked;Ubiquitin thioesterase FAF-X;Ubiquitin-specific protease 9, X chromosome;Ubiquitin-specific-processing protease FAF-X;, PF12030;PF00443;, GO:0005737;GO:0005829;GO:0030426;GO:0016020;GO:0005634;GO:0070410;GO:0004197;GO:0008234;GO:1990380;GO:0004843;GO:0101005;GO:1990000;GO:0048675;GO:0030509;GO:0007049;GO:0051301;GO:0016477;GO:0007059;GO:0007292;GO:0000122;GO:0001764;GO:1901537;GO:0016579;GO:0071947;GO:0008104;GO:0050821;GO:0016567;GO:0042752;GO:0048511;GO:0007179;, C:cytoplasm; C:cytosol; C:growth cone; C:membrane; C:nucleus;, F:co-SMAD binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:amyloid fibril formation; P:axon extension; P:BMP signaling pathway; P:cell cycle; P:cell division; P:cell migration; P:chromosome segregation; P:female gamete generation; P:negative regulation of transcription by RNA polymerase II; P:neuron migration; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein localization; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:rhythmic process; P:transforming growth factor beta receptor signaling pathway;|Q93008 O75550 Q8WWT3 Q8WX12,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,Deubiquitinating enzyme FAF-X;Fat facets in mammals;Fat facets protein-related, X-linked;Ubiquitin thioesterase FAF-X;Ubiquitin-specific protease 9, X chromosome;Ubiquitin-specific-processing protease FAF-X;, PF12030;PF00443;, GO:0005737;GO:0005829;GO:0030426;GO:0016020;GO:0005634;GO:0070410;GO:0004197;GO:0008234;GO:1990380;GO:0004843;GO:0101005;GO:1990000;GO:0048675;GO:0030509;GO:0007049;GO:0051301;GO:0016477;GO:0007059;GO:0007292;GO:0000122;GO:0001764;GO:1901537;GO:0016579;GO:0071947;GO:0008104;GO:0050821;GO:0016567;GO:0042752;GO:0048511;GO:0007179;, C:cytoplasm; C:cytosol; C:growth cone; C:membrane; C:nucleus;, F:co-SMAD binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:amyloid fibril formation; P:axon extension; P:BMP signaling pathway; P:cell cycle; P:cell division; P:cell migration; P:chromosome segregation; P:female gamete generation; P:negative regulation of transcription by RNA polymerase II; P:neuron migration; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein localization; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:rhythmic process; P:transforming growth factor beta receptor signaling pathway;|Q93008 O75550 Q8WWT3 Q8WX12,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,Deubiquitinating enzyme FAF-X;Fat facets in mammals;Fat facets protein-related, X-linked;Ubiquitin thioesterase FAF-X;Ubiquitin-specific protease 9, X chromosome;Ubiquitin-specific-processing protease FAF-X;, PF12030;PF00443;, GO:0005737;GO:0005829;GO:0030426;GO:0016020;GO:0005634;GO:0070410;GO:0004197;GO:0008234;GO:1990380;GO:0004843;GO:0101005;GO:1990000;GO:0048675;GO:0030509;GO:0007049;GO:0051301;GO:0016477;GO:0007059;GO:0007292;GO:0000122;GO:0001764;GO:1901537;GO:0016579;GO:0071947;GO:0008104;GO:0050821;GO:0016567;GO:0042752;GO:0048511;GO:0007179;, C:cytoplasm; C:cytosol; C:growth cone; C:membrane; C:nucleus;, F:co-SMAD binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:amyloid fibril formation; P:axon extension; P:BMP signaling pathway; P:cell cycle; P:cell division; P:cell migration; P:chromosome segregation; P:female gamete generation; P:negative regulation of transcription by RNA polymerase II; P:neuron migration; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein localization; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:rhythmic process; P:transforming growth factor beta receptor signaling pathway;|Q93008 O75550 Q8WWT3 Q8WX12,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,Deubiquitinating enzyme FAF-X;Fat facets in mammals;Fat facets protein-related, X-linked;Ubiquitin thioesterase FAF-X;Ubiquitin-specific protease 9, X chromosome;Ubiquitin-specific-processing protease FAF-X;, PF12030;PF00443;, GO:0005737;GO:0005829;GO:0030426;GO:0016020;GO:0005634;GO:0070410;GO:0004197;GO:0008234;GO:1990380;GO:0004843;GO:0101005;GO:1990000;GO:0048675;GO:0030509;GO:0007049;GO:0051301;GO:0016477;GO:0007059;GO:0007292;GO:0000122;GO:0001764;GO:1901537;GO:0016579;GO:0071947;GO:0008104;GO:0050821;GO:0016567;GO:0042752;GO:0048511;GO:0007179;, C:cytoplasm; C:cytosol; C:growth cone; C:membrane; C:nucleus;, F:co-SMAD binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:amyloid fibril formation; P:axon extension; P:BMP signaling pathway; P:cell cycle; P:cell division; P:cell migration; P:chromosome segregation; P:female gamete generation; P:negative regulation of transcription by RNA polymerase II; P:neuron migration; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein localization; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:rhythmic process; P:transforming growth factor beta receptor signaling pathway;|Q93008 O75550 Q8WWT3 Q8WX12,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,Deubiquitinating enzyme FAF-X;Fat facets in mammals;Fat facets protein-related, X-linked;Ubiquitin thioesterase FAF-X;Ubiquitin-specific protease 9, X chromosome;Ubiquitin-specific-processing protease FAF-X;, PF12030;PF00443;, GO:0005737;GO:0005829;GO:0030426;GO:0016020;GO:0005634;GO:0070410;GO:0004197;GO:0008234;GO:1990380;GO:0004843;GO:0101005;GO:1990000;GO:0048675;GO:0030509;GO:0007049;GO:0051301;GO:0016477;GO:0007059;GO:0007292;GO:0000122;GO:0001764;GO:1901537;GO:0016579;GO:0071947;GO:0008104;GO:0050821;GO:0016567;GO:0042752;GO:0048511;GO:0007179;, C:cytoplasm; C:cytosol; C:growth cone; C:membrane; C:nucleus;, F:co-SMAD binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:amyloid fibril formation; P:axon extension; P:BMP signaling pathway; P:cell cycle; P:cell division; P:cell migration; P:chromosome segregation; P:female gamete generation; P:negative regulation of transcription by RNA polymerase II; P:neuron migration; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein localization; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:rhythmic process; P:transforming growth factor beta receptor signaling pathway;|Q93008 O75550 Q8WWT3 Q8WX12,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,Deubiquitinating enzyme FAF-X;Fat facets in mammals;Fat facets protein-related, X-linked;Ubiquitin thioesterase FAF-X;Ubiquitin-specific protease 9, X chromosome;Ubiquitin-specific-processing protease FAF-X;, PF12030;PF00443;, GO:0005737;GO:0005829;GO:0030426;GO:0016020;GO:0005634;GO:0070410;GO:0004197;GO:0008234;GO:1990380;GO:0004843;GO:0101005;GO:1990000;GO:0048675;GO:0030509;GO:0007049;GO:0051301;GO:0016477;GO:0007059;GO:0007292;GO:0000122;GO:0001764;GO:1901537;GO:0016579;GO:0071947;GO:0008104;GO:0050821;GO:0016567;GO:0042752;GO:0048511;GO:0007179;, C:cytoplasm; C:cytosol; C:growth cone; C:membrane; C:nucleus;, F:co-SMAD binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:amyloid fibril formation; P:axon extension; P:BMP signaling pathway; P:cell cycle; P:cell division; P:cell migration; P:chromosome segregation; P:female gamete generation; P:negative regulation of transcription by RNA polymerase II; P:neuron migration; P:positive regulation of DNA demethylation; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein localization; P:protein stabilization; P:protein ubiquitination; P:regulation of circadian rhythm; P:rhythmic process; P:transforming growth factor beta receptor signaling pathway; scaffold64 indexed_genome mRNA 10684051 10699173 . + . ID=transcript_10958;O00571 A8K538 B4E3E8 O15536,ATP-dependent RNA helicase DDX3X,CAP-Rf;DEAD box protein 3, X-chromosomal;DEAD box, X isoform;Helicase-like protein 2;, PF00270;PF00271;, GO:0031252;GO:0005813;GO:0005737;GO:0010494;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0030027;GO:0072559;GO:0005654;GO:0005634;GO:0043186;GO:0005886;GO:0034774;GO:0005524;GO:0016887;GO:0045296;GO:0043273;GO:0003677;GO:0003678;GO:0008190;GO:0043015;GO:0003924;GO:0048027;GO:0003729;GO:0017111;GO:0008143;GO:0043539;GO:0043024;GO:0003723;GO:0003724;GO:0035613;GO:0033592;GO:0008134;GO:0031369;GO:0030154;GO:0071243;GO:0071470;GO:0098586;GO:0007059;GO:0008625;GO:0007276;GO:0045087;GO:0035556;GO:0097193;GO:0055088;GO:0042256;GO:0043066;GO:0030308;GO:0043154;GO:1902042;GO:2001243;GO:1901223;GO:0031333;GO:0017148;GO:0043312;GO:0043065;GO:0090263;GO:0030307;GO:0071651;GO:0043280;GO:1900087;GO:0010628;GO:0032727;GO:0032728;GO:1901224;GO:1900227;GO:1901985;GO:0031954;GO:1902523;GO:0071902;GO:0034157;GO:0034161;GO:0045944;GO:0045727;GO:0036493;GO:0045948;GO:0045070;GO:1903608;GO:0009615;GO:0010501;GO:0034063;GO:0006413;GO:0016032;GO:0016055;, C:cell leading edge; C:centrosome; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:lamellipodium; C:NLRP3 inflammasome complex; C:nucleoplasm; C:nucleus; C:P granule; C:plasma membrane; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:CTPase activity; F:DNA binding; F:DNA helicase activity; F:eukaryotic initiation factor 4E binding; F:gamma-tubulin binding; F:GTPase activity; F:mRNA 5'-UTR binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:poly(A) binding; F:protein serine/threonine kinase activator activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:RNA strand annealing activity; F:transcription factor binding; F:translation initiation factor binding;, P:cell differentiation; P:cellular response to arsenic-containing substance; P:cellular response to osmotic stress; P:cellular response to virus; P:chromosome segregation; P:extrinsic apoptotic signaling pathway via death domain receptors; P:gamete generation; P:innate immune response; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway; P:lipid homeostasis; P:mature ribosome assembly; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of protein-containing complex assembly; P:negative regulation of translation; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:positive regulation of chemokine (C-C motif) ligand 5 production; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of protein acetylation; P:positive regulation of protein autophosphorylation; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:positive regulation of translational initiation; P:positive regulation of viral genome replication; P:protein localization to cytoplasmic stress granule; P:response to virus; P:RNA secondary structure unwinding; P:stress granule assembly; P:translational initiation; P:viral process; P:Wnt signaling pathway;|O00571 A8K538 B4E3E8 O15536,ATP-dependent RNA helicase DDX3X,CAP-Rf;DEAD box protein 3, X-chromosomal;DEAD box, X isoform;Helicase-like protein 2;, PF00270;PF00271;, GO:0031252;GO:0005813;GO:0005737;GO:0010494;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0030027;GO:0072559;GO:0005654;GO:0005634;GO:0043186;GO:0005886;GO:0034774;GO:0005524;GO:0016887;GO:0045296;GO:0043273;GO:0003677;GO:0003678;GO:0008190;GO:0043015;GO:0003924;GO:0048027;GO:0003729;GO:0017111;GO:0008143;GO:0043539;GO:0043024;GO:0003723;GO:0003724;GO:0035613;GO:0033592;GO:0008134;GO:0031369;GO:0030154;GO:0071243;GO:0071470;GO:0098586;GO:0007059;GO:0008625;GO:0007276;GO:0045087;GO:0035556;GO:0097193;GO:0055088;GO:0042256;GO:0043066;GO:0030308;GO:0043154;GO:1902042;GO:2001243;GO:1901223;GO:0031333;GO:0017148;GO:0043312;GO:0043065;GO:0090263;GO:0030307;GO:0071651;GO:0043280;GO:1900087;GO:0010628;GO:0032727;GO:0032728;GO:1901224;GO:1900227;GO:1901985;GO:0031954;GO:1902523;GO:0071902;GO:0034157;GO:0034161;GO:0045944;GO:0045727;GO:0036493;GO:0045948;GO:0045070;GO:1903608;GO:0009615;GO:0010501;GO:0034063;GO:0006413;GO:0016032;GO:0016055;, C:cell leading edge; C:centrosome; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:lamellipodium; C:NLRP3 inflammasome complex; C:nucleoplasm; C:nucleus; C:P granule; C:plasma membrane; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:CTPase activity; F:DNA binding; F:DNA helicase activity; F:eukaryotic initiation factor 4E binding; F:gamma-tubulin binding; F:GTPase activity; F:mRNA 5'-UTR binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:poly(A) binding; F:protein serine/threonine kinase activator activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:RNA strand annealing activity; F:transcription factor binding; F:translation initiation factor binding;, P:cell differentiation; P:cellular response to arsenic-containing substance; P:cellular response to osmotic stress; P:cellular response to virus; P:chromosome segregation; P:extrinsic apoptotic signaling pathway via death domain receptors; P:gamete generation; P:innate immune response; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway; P:lipid homeostasis; P:mature ribosome assembly; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of protein-containing complex assembly; P:negative regulation of translation; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:positive regulation of chemokine (C-C motif) ligand 5 production; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of protein acetylation; P:positive regulation of protein autophosphorylation; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:positive regulation of translational initiation; P:positive regulation of viral genome replication; P:protein localization to cytoplasmic stress granule; P:response to virus; P:RNA secondary structure unwinding; P:stress granule assembly; P:translational initiation; P:viral process; P:Wnt signaling pathway;|O00571 A8K538 B4E3E8 O15536,ATP-dependent RNA helicase DDX3X,CAP-Rf;DEAD box protein 3, X-chromosomal;DEAD box, X isoform;Helicase-like protein 2;, PF00270;PF00271;, GO:0031252;GO:0005813;GO:0005737;GO:0010494;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0030027;GO:0072559;GO:0005654;GO:0005634;GO:0043186;GO:0005886;GO:0034774;GO:0005524;GO:0016887;GO:0045296;GO:0043273;GO:0003677;GO:0003678;GO:0008190;GO:0043015;GO:0003924;GO:0048027;GO:0003729;GO:0017111;GO:0008143;GO:0043539;GO:0043024;GO:0003723;GO:0003724;GO:0035613;GO:0033592;GO:0008134;GO:0031369;GO:0030154;GO:0071243;GO:0071470;GO:0098586;GO:0007059;GO:0008625;GO:0007276;GO:0045087;GO:0035556;GO:0097193;GO:0055088;GO:0042256;GO:0043066;GO:0030308;GO:0043154;GO:1902042;GO:2001243;GO:1901223;GO:0031333;GO:0017148;GO:0043312;GO:0043065;GO:0090263;GO:0030307;GO:0071651;GO:0043280;GO:1900087;GO:0010628;GO:0032727;GO:0032728;GO:1901224;GO:1900227;GO:1901985;GO:0031954;GO:1902523;GO:0071902;GO:0034157;GO:0034161;GO:0045944;GO:0045727;GO:0036493;GO:0045948;GO:0045070;GO:1903608;GO:0009615;GO:0010501;GO:0034063;GO:0006413;GO:0016032;GO:0016055;, C:cell leading edge; C:centrosome; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:lamellipodium; C:NLRP3 inflammasome complex; C:nucleoplasm; C:nucleus; C:P granule; C:plasma membrane; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:CTPase activity; F:DNA binding; F:DNA helicase activity; F:eukaryotic initiation factor 4E binding; F:gamma-tubulin binding; F:GTPase activity; F:mRNA 5'-UTR binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:poly(A) binding; F:protein serine/threonine kinase activator activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:RNA strand annealing activity; F:transcription factor binding; F:translation initiation factor binding;, P:cell differentiation; P:cellular response to arsenic-containing substance; P:cellular response to osmotic stress; P:cellular response to virus; P:chromosome segregation; P:extrinsic apoptotic signaling pathway via death domain receptors; P:gamete generation; P:innate immune response; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway; P:lipid homeostasis; P:mature ribosome assembly; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of protein-containing complex assembly; P:negative regulation of translation; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:positive regulation of chemokine (C-C motif) ligand 5 production; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of protein acetylation; P:positive regulation of protein autophosphorylation; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:positive regulation of translational initiation; P:positive regulation of viral genome replication; P:protein localization to cytoplasmic stress granule; P:response to virus; P:RNA secondary structure unwinding; P:stress granule assembly; P:translational initiation; P:viral process; P:Wnt signaling pathway;|O00571 A8K538 B4E3E8 O15536,ATP-dependent RNA helicase DDX3X,CAP-Rf;DEAD box protein 3, X-chromosomal;DEAD box, X isoform;Helicase-like protein 2;, PF00270;PF00271;, GO:0031252;GO:0005813;GO:0005737;GO:0010494;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0030027;GO:0072559;GO:0005654;GO:0005634;GO:0043186;GO:0005886;GO:0034774;GO:0005524;GO:0016887;GO:0045296;GO:0043273;GO:0003677;GO:0003678;GO:0008190;GO:0043015;GO:0003924;GO:0048027;GO:0003729;GO:0017111;GO:0008143;GO:0043539;GO:0043024;GO:0003723;GO:0003724;GO:0035613;GO:0033592;GO:0008134;GO:0031369;GO:0030154;GO:0071243;GO:0071470;GO:0098586;GO:0007059;GO:0008625;GO:0007276;GO:0045087;GO:0035556;GO:0097193;GO:0055088;GO:0042256;GO:0043066;GO:0030308;GO:0043154;GO:1902042;GO:2001243;GO:1901223;GO:0031333;GO:0017148;GO:0043312;GO:0043065;GO:0090263;GO:0030307;GO:0071651;GO:0043280;GO:1900087;GO:0010628;GO:0032727;GO:0032728;GO:1901224;GO:1900227;GO:1901985;GO:0031954;GO:1902523;GO:0071902;GO:0034157;GO:0034161;GO:0045944;GO:0045727;GO:0036493;GO:0045948;GO:0045070;GO:1903608;GO:0009615;GO:0010501;GO:0034063;GO:0006413;GO:0016032;GO:0016055;, C:cell leading edge; C:centrosome; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:lamellipodium; C:NLRP3 inflammasome complex; C:nucleoplasm; C:nucleus; C:P granule; C:plasma membrane; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:CTPase activity; F:DNA binding; F:DNA helicase activity; F:eukaryotic initiation factor 4E binding; F:gamma-tubulin binding; F:GTPase activity; F:mRNA 5'-UTR binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:poly(A) binding; F:protein serine/threonine kinase activator activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:RNA strand annealing activity; F:transcription factor binding; F:translation initiation factor binding;, P:cell differentiation; P:cellular response to arsenic-containing substance; P:cellular response to osmotic stress; P:cellular response to virus; P:chromosome segregation; P:extrinsic apoptotic signaling pathway via death domain receptors; P:gamete generation; P:innate immune response; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway; P:lipid homeostasis; P:mature ribosome assembly; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of protein-containing complex assembly; P:negative regulation of translation; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:positive regulation of chemokine (C-C motif) ligand 5 production; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of protein acetylation; P:positive regulation of protein autophosphorylation; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:positive regulation of translational initiation; P:positive regulation of viral genome replication; P:protein localization to cytoplasmic stress granule; P:response to virus; P:RNA secondary structure unwinding; P:stress granule assembly; P:translational initiation; P:viral process; P:Wnt signaling pathway;|O00571 A8K538 B4E3E8 O15536,ATP-dependent RNA helicase DDX3X,CAP-Rf;DEAD box protein 3, X-chromosomal;DEAD box, X isoform;Helicase-like protein 2;, PF00270;PF00271;, GO:0031252;GO:0005813;GO:0005737;GO:0010494;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0030027;GO:0072559;GO:0005654;GO:0005634;GO:0043186;GO:0005886;GO:0034774;GO:0005524;GO:0016887;GO:0045296;GO:0043273;GO:0003677;GO:0003678;GO:0008190;GO:0043015;GO:0003924;GO:0048027;GO:0003729;GO:0017111;GO:0008143;GO:0043539;GO:0043024;GO:0003723;GO:0003724;GO:0035613;GO:0033592;GO:0008134;GO:0031369;GO:0030154;GO:0071243;GO:0071470;GO:0098586;GO:0007059;GO:0008625;GO:0007276;GO:0045087;GO:0035556;GO:0097193;GO:0055088;GO:0042256;GO:0043066;GO:0030308;GO:0043154;GO:1902042;GO:2001243;GO:1901223;GO:0031333;GO:0017148;GO:0043312;GO:0043065;GO:0090263;GO:0030307;GO:0071651;GO:0043280;GO:1900087;GO:0010628;GO:0032727;GO:0032728;GO:1901224;GO:1900227;GO:1901985;GO:0031954;GO:1902523;GO:0071902;GO:0034157;GO:0034161;GO:0045944;GO:0045727;GO:0036493;GO:0045948;GO:0045070;GO:1903608;GO:0009615;GO:0010501;GO:0034063;GO:0006413;GO:0016032;GO:0016055;, C:cell leading edge; C:centrosome; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:lamellipodium; C:NLRP3 inflammasome complex; C:nucleoplasm; C:nucleus; C:P granule; C:plasma membrane; C:secretory granule lumen;, F:ATP binding; F:ATPase activity; F:cadherin binding; F:CTPase activity; F:DNA binding; F:DNA helicase activity; F:eukaryotic initiation factor 4E binding; F:gamma-tubulin binding; F:GTPase activity; F:mRNA 5'-UTR binding; F:mRNA binding; F:nucleoside-triphosphatase activity; F:poly(A) binding; F:protein serine/threonine kinase activator activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:RNA stem-loop binding; F:RNA strand annealing activity; F:transcription factor binding; F:translation initiation factor binding;, P:cell differentiation; P:cellular response to arsenic-containing substance; P:cellular response to osmotic stress; P:cellular response to virus; P:chromosome segregation; P:extrinsic apoptotic signaling pathway via death domain receptors; P:gamete generation; P:innate immune response; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway; P:lipid homeostasis; P:mature ribosome assembly; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of protein-containing complex assembly; P:negative regulation of translation; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:positive regulation of chemokine (C-C motif) ligand 5 production; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of protein acetylation; P:positive regulation of protein autophosphorylation; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of toll-like receptor 7 signaling pathway; P:positive regulation of toll-like receptor 8 signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of translation in response to endoplasmic reticulum stress; P:positive regulation of translational initiation; P:positive regulation of viral genome replication; P:protein localization to cytoplasmic stress granule; P:response to virus; P:RNA secondary structure unwinding; P:stress granule assembly; P:translational initiation; P:viral process; P:Wnt signaling pathway; scaffold65 indexed_genome mRNA 463405 468694 . + . ID=transcript_10959;Q9Y467 B2RMX6 B9EGK8 Q8N656 Q9Y4G1,Sal-like protein 2,Zinc finger protein 795;Zinc finger protein SALL2;Zinc finger protein Spalt-2;, PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0044877;GO:0000978;GO:0000977;GO:0001654;GO:0000122;GO:0021915;GO:0045944;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:eye development; P:negative regulation of transcription by RNA polymerase II; P:neural tube development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold65 indexed_genome mRNA 480627 505567 . - . ID=transcript_10960;Q86U44 O14736 Q86V05 Q9HB32,N6-adenosine-methyltransferase catalytic subunit {ECO:0000305},Methyltransferase-like protein 3 {ECO:0000305};N6-adenosine-methyltransferase 70 kDa subunit;, PF05063;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0036396;GO:0008168;GO:0016422;GO:0001734;GO:0003729;GO:0046982;GO:0008173;GO:1904047;GO:0006382;GO:0006974;GO:0034644;GO:0007623;GO:0009048;GO:0098508;GO:0021861;GO:0042063;GO:0045087;GO:0006402;GO:0061157;GO:0080009;GO:0006397;GO:0000398;GO:0045746;GO:0060339;GO:0048477;GO:1903679;GO:0045727;GO:1990744;GO:0031053;GO:1902036;GO:0051445;GO:0045580;GO:0016070;GO:0001510;GO:0007283;GO:0019827;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:methyltransferase activity; F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:mRNA (N6-adenosine)-methyltransferase activity; F:mRNA binding; F:protein heterodimerization activity; F:RNA methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:adenosine to inosine editing; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:circadian rhythm; P:dosage compensation by inactivation of X chromosome; P:endothelial to hematopoietic transition; P:forebrain radial glial cell differentiation; P:gliogenesis; P:innate immune response; P:mRNA catabolic process; P:mRNA destabilization; P:mRNA methylation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of Notch signaling pathway; P:negative regulation of type I interferon-mediated signaling pathway; P:oogenesis; P:positive regulation of cap-independent translational initiation; P:positive regulation of translation; P:primary miRNA methylation; P:primary miRNA processing; P:regulation of hematopoietic stem cell differentiation; P:regulation of meiotic cell cycle; P:regulation of T cell differentiation; P:RNA metabolic process; P:RNA methylation; P:spermatogenesis; P:stem cell population maintenance;|Q86U44 O14736 Q86V05 Q9HB32,N6-adenosine-methyltransferase catalytic subunit {ECO:0000305},Methyltransferase-like protein 3 {ECO:0000305};N6-adenosine-methyltransferase 70 kDa subunit;, PF05063;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0036396;GO:0008168;GO:0016422;GO:0001734;GO:0003729;GO:0046982;GO:0008173;GO:1904047;GO:0006382;GO:0006974;GO:0034644;GO:0007623;GO:0009048;GO:0098508;GO:0021861;GO:0042063;GO:0045087;GO:0006402;GO:0061157;GO:0080009;GO:0006397;GO:0000398;GO:0045746;GO:0060339;GO:0048477;GO:1903679;GO:0045727;GO:1990744;GO:0031053;GO:1902036;GO:0051445;GO:0045580;GO:0016070;GO:0001510;GO:0007283;GO:0019827;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:methyltransferase activity; F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:mRNA (N6-adenosine)-methyltransferase activity; F:mRNA binding; F:protein heterodimerization activity; F:RNA methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:adenosine to inosine editing; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:circadian rhythm; P:dosage compensation by inactivation of X chromosome; P:endothelial to hematopoietic transition; P:forebrain radial glial cell differentiation; P:gliogenesis; P:innate immune response; P:mRNA catabolic process; P:mRNA destabilization; P:mRNA methylation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of Notch signaling pathway; P:negative regulation of type I interferon-mediated signaling pathway; P:oogenesis; P:positive regulation of cap-independent translational initiation; P:positive regulation of translation; P:primary miRNA methylation; P:primary miRNA processing; P:regulation of hematopoietic stem cell differentiation; P:regulation of meiotic cell cycle; P:regulation of T cell differentiation; P:RNA metabolic process; P:RNA methylation; P:spermatogenesis; P:stem cell population maintenance;|Q86U44 O14736 Q86V05 Q9HB32,N6-adenosine-methyltransferase catalytic subunit {ECO:0000305},Methyltransferase-like protein 3 {ECO:0000305};N6-adenosine-methyltransferase 70 kDa subunit;, PF05063;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0036396;GO:0008168;GO:0016422;GO:0001734;GO:0003729;GO:0046982;GO:0008173;GO:1904047;GO:0006382;GO:0006974;GO:0034644;GO:0007623;GO:0009048;GO:0098508;GO:0021861;GO:0042063;GO:0045087;GO:0006402;GO:0061157;GO:0080009;GO:0006397;GO:0000398;GO:0045746;GO:0060339;GO:0048477;GO:1903679;GO:0045727;GO:1990744;GO:0031053;GO:1902036;GO:0051445;GO:0045580;GO:0016070;GO:0001510;GO:0007283;GO:0019827;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:methyltransferase activity; F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:mRNA (N6-adenosine)-methyltransferase activity; F:mRNA binding; F:protein heterodimerization activity; F:RNA methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:adenosine to inosine editing; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:circadian rhythm; P:dosage compensation by inactivation of X chromosome; P:endothelial to hematopoietic transition; P:forebrain radial glial cell differentiation; P:gliogenesis; P:innate immune response; P:mRNA catabolic process; P:mRNA destabilization; P:mRNA methylation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of Notch signaling pathway; P:negative regulation of type I interferon-mediated signaling pathway; P:oogenesis; P:positive regulation of cap-independent translational initiation; P:positive regulation of translation; P:primary miRNA methylation; P:primary miRNA processing; P:regulation of hematopoietic stem cell differentiation; P:regulation of meiotic cell cycle; P:regulation of T cell differentiation; P:RNA metabolic process; P:RNA methylation; P:spermatogenesis; P:stem cell population maintenance;|Q86U44 O14736 Q86V05 Q9HB32,N6-adenosine-methyltransferase catalytic subunit {ECO:0000305},Methyltransferase-like protein 3 {ECO:0000305};N6-adenosine-methyltransferase 70 kDa subunit;, PF05063;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0036396;GO:0008168;GO:0016422;GO:0001734;GO:0003729;GO:0046982;GO:0008173;GO:1904047;GO:0006382;GO:0006974;GO:0034644;GO:0007623;GO:0009048;GO:0098508;GO:0021861;GO:0042063;GO:0045087;GO:0006402;GO:0061157;GO:0080009;GO:0006397;GO:0000398;GO:0045746;GO:0060339;GO:0048477;GO:1903679;GO:0045727;GO:1990744;GO:0031053;GO:1902036;GO:0051445;GO:0045580;GO:0016070;GO:0001510;GO:0007283;GO:0019827;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:methyltransferase activity; F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:mRNA (N6-adenosine)-methyltransferase activity; F:mRNA binding; F:protein heterodimerization activity; F:RNA methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:adenosine to inosine editing; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:circadian rhythm; P:dosage compensation by inactivation of X chromosome; P:endothelial to hematopoietic transition; P:forebrain radial glial cell differentiation; P:gliogenesis; P:innate immune response; P:mRNA catabolic process; P:mRNA destabilization; P:mRNA methylation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of Notch signaling pathway; P:negative regulation of type I interferon-mediated signaling pathway; P:oogenesis; P:positive regulation of cap-independent translational initiation; P:positive regulation of translation; P:primary miRNA methylation; P:primary miRNA processing; P:regulation of hematopoietic stem cell differentiation; P:regulation of meiotic cell cycle; P:regulation of T cell differentiation; P:RNA metabolic process; P:RNA methylation; P:spermatogenesis; P:stem cell population maintenance;|Q86U44 O14736 Q86V05 Q9HB32,N6-adenosine-methyltransferase catalytic subunit {ECO:0000305},Methyltransferase-like protein 3 {ECO:0000305};N6-adenosine-methyltransferase 70 kDa subunit;, PF05063;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0036396;GO:0008168;GO:0016422;GO:0001734;GO:0003729;GO:0046982;GO:0008173;GO:1904047;GO:0006382;GO:0006974;GO:0034644;GO:0007623;GO:0009048;GO:0098508;GO:0021861;GO:0042063;GO:0045087;GO:0006402;GO:0061157;GO:0080009;GO:0006397;GO:0000398;GO:0045746;GO:0060339;GO:0048477;GO:1903679;GO:0045727;GO:1990744;GO:0031053;GO:1902036;GO:0051445;GO:0045580;GO:0016070;GO:0001510;GO:0007283;GO:0019827;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus; C:RNA N6-methyladenosine methyltransferase complex;, F:methyltransferase activity; F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:mRNA (N6-adenosine)-methyltransferase activity; F:mRNA binding; F:protein heterodimerization activity; F:RNA methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:adenosine to inosine editing; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:circadian rhythm; P:dosage compensation by inactivation of X chromosome; P:endothelial to hematopoietic transition; P:forebrain radial glial cell differentiation; P:gliogenesis; P:innate immune response; P:mRNA catabolic process; P:mRNA destabilization; P:mRNA methylation; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of Notch signaling pathway; P:negative regulation of type I interferon-mediated signaling pathway; P:oogenesis; P:positive regulation of cap-independent translational initiation; P:positive regulation of translation; P:primary miRNA methylation; P:primary miRNA processing; P:regulation of hematopoietic stem cell differentiation; P:regulation of meiotic cell cycle; P:regulation of T cell differentiation; P:RNA metabolic process; P:RNA methylation; P:spermatogenesis; P:stem cell population maintenance;|O94842 B4DPY8 B4DSM0 E7EV69,TOX high mobility group box family member 4,Epidermal Langerhans cell protein LCP1;, PF00505;, GO:0000785;GO:0005634;GO:0072357;GO:0031490;GO:0006357;, C:chromatin; C:nucleus; C:PTW/PP1 phosphatase complex;, F:chromatin DNA binding;, P:regulation of transcription by RNA polymerase II;|O94842 B4DPY8 B4DSM0 E7EV69,TOX high mobility group box family member 4,Epidermal Langerhans cell protein LCP1;, PF00505;, GO:0000785;GO:0005634;GO:0072357;GO:0031490;GO:0006357;, C:chromatin; C:nucleus; C:PTW/PP1 phosphatase complex;, F:chromatin DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold65 indexed_genome mRNA 505652 520184 . + . ID=transcript_10961;Q8WUD1 B2RD03 D3DS24 Q6NZ33,Ras-related protein Rab-2B,, PF00071;, GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0005886;GO:0098793;GO:0005525;GO:0003924;GO:0045921;GO:0015031;GO:0016192;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane; C:presynapse;, F:GTP binding; F:GTPase activity;, P:positive regulation of exocytosis; P:protein transport; P:vesicle-mediated transport;|Q8WUD1 B2RD03 D3DS24 Q6NZ33,Ras-related protein Rab-2B,, PF00071;, GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0005886;GO:0098793;GO:0005525;GO:0003924;GO:0045921;GO:0015031;GO:0016192;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane; C:presynapse;, F:GTP binding; F:GTPase activity;, P:positive regulation of exocytosis; P:protein transport; P:vesicle-mediated transport;|Q8WUD1 B2RD03 D3DS24 Q6NZ33,Ras-related protein Rab-2B,, PF00071;, GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0005886;GO:0098793;GO:0005525;GO:0003924;GO:0045921;GO:0015031;GO:0016192;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane; C:presynapse;, F:GTP binding; F:GTPase activity;, P:positive regulation of exocytosis; P:protein transport; P:vesicle-mediated transport;|Q8WUD1 B2RD03 D3DS24 Q6NZ33,Ras-related protein Rab-2B,, PF00071;, GO:0005789;GO:0070062;GO:0005794;GO:0000139;GO:0005886;GO:0098793;GO:0005525;GO:0003924;GO:0045921;GO:0015031;GO:0016192;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane; C:presynapse;, F:GTP binding; F:GTPase activity;, P:positive regulation of exocytosis; P:protein transport; P:vesicle-mediated transport; scaffold65 indexed_genome mRNA 541538 582869 . + . ID=transcript_10962;Q96F26,Chromodomain-helicase-DNA-binding protein 8 {ECO:0000255|HAMAP-Rule:MF_03071},ATP-dependent helicase CHD8 {ECO:0000255|HAMAP-Rule:MF_03071};Helicase with SNF2 domain 1;, PF07533;PF00385;PF00271;PF00176;, GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0070016;GO:0005524;GO:0008013;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0042393;GO:0035064;GO:0070615;GO:0002039;GO:0043044;GO:0007420;GO:0048565;GO:0001701;GO:0090090;GO:2000270;GO:0000122;GO:0045892;GO:0045944;GO:0045945;GO:0045893;GO:0060134;GO:0035176;GO:0016055;, C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:armadillo repeat domain binding; F:ATP binding; F:beta-catenin binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:histone binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:digestive tract development; P:in utero embryonic development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription, DNA-templated; P:prepulse inhibition; P:social behavior; P:Wnt signaling pathway;|Q96F26,Chromodomain-helicase-DNA-binding protein 8 {ECO:0000255|HAMAP-Rule:MF_03071},ATP-dependent helicase CHD8 {ECO:0000255|HAMAP-Rule:MF_03071};Helicase with SNF2 domain 1;, PF07533;PF00385;PF00271;PF00176;, GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0070016;GO:0005524;GO:0008013;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0042393;GO:0035064;GO:0070615;GO:0002039;GO:0043044;GO:0007420;GO:0048565;GO:0001701;GO:0090090;GO:2000270;GO:0000122;GO:0045892;GO:0045944;GO:0045945;GO:0045893;GO:0060134;GO:0035176;GO:0016055;, C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:armadillo repeat domain binding; F:ATP binding; F:beta-catenin binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:histone binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:digestive tract development; P:in utero embryonic development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription, DNA-templated; P:prepulse inhibition; P:social behavior; P:Wnt signaling pathway;|Q96F26,Chromodomain-helicase-DNA-binding protein 8 {ECO:0000255|HAMAP-Rule:MF_03071},ATP-dependent helicase CHD8 {ECO:0000255|HAMAP-Rule:MF_03071};Helicase with SNF2 domain 1;, PF07533;PF00385;PF00271;PF00176;, GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0070016;GO:0005524;GO:0008013;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0042393;GO:0035064;GO:0070615;GO:0002039;GO:0043044;GO:0007420;GO:0048565;GO:0001701;GO:0090090;GO:2000270;GO:0000122;GO:0045892;GO:0045944;GO:0045945;GO:0045893;GO:0060134;GO:0035176;GO:0016055;, C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:armadillo repeat domain binding; F:ATP binding; F:beta-catenin binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:histone binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:digestive tract development; P:in utero embryonic development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription, DNA-templated; P:prepulse inhibition; P:social behavior; P:Wnt signaling pathway;|Q96F26,Chromodomain-helicase-DNA-binding protein 8 {ECO:0000255|HAMAP-Rule:MF_03071},ATP-dependent helicase CHD8 {ECO:0000255|HAMAP-Rule:MF_03071};Helicase with SNF2 domain 1;, PF07533;PF00385;PF00271;PF00176;, GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0070016;GO:0005524;GO:0008013;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0042393;GO:0035064;GO:0070615;GO:0002039;GO:0043044;GO:0007420;GO:0048565;GO:0001701;GO:0090090;GO:2000270;GO:0000122;GO:0045892;GO:0045944;GO:0045945;GO:0045893;GO:0060134;GO:0035176;GO:0016055;, C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:armadillo repeat domain binding; F:ATP binding; F:beta-catenin binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:histone binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:digestive tract development; P:in utero embryonic development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription, DNA-templated; P:prepulse inhibition; P:social behavior; P:Wnt signaling pathway;|Q96F26,Chromodomain-helicase-DNA-binding protein 8 {ECO:0000255|HAMAP-Rule:MF_03071},ATP-dependent helicase CHD8 {ECO:0000255|HAMAP-Rule:MF_03071};Helicase with SNF2 domain 1;, PF07533;PF00385;PF00271;PF00176;, GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0070016;GO:0005524;GO:0008013;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0042393;GO:0035064;GO:0070615;GO:0002039;GO:0043044;GO:0007420;GO:0048565;GO:0001701;GO:0090090;GO:2000270;GO:0000122;GO:0045892;GO:0045944;GO:0045945;GO:0045893;GO:0060134;GO:0035176;GO:0016055;, C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:armadillo repeat domain binding; F:ATP binding; F:beta-catenin binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:histone binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:digestive tract development; P:in utero embryonic development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription, DNA-templated; P:prepulse inhibition; P:social behavior; P:Wnt signaling pathway;|Q96F26,Chromodomain-helicase-DNA-binding protein 8 {ECO:0000255|HAMAP-Rule:MF_03071},ATP-dependent helicase CHD8 {ECO:0000255|HAMAP-Rule:MF_03071};Helicase with SNF2 domain 1;, PF07533;PF00385;PF00271;PF00176;, GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0070016;GO:0005524;GO:0008013;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0042393;GO:0035064;GO:0070615;GO:0002039;GO:0043044;GO:0007420;GO:0048565;GO:0001701;GO:0090090;GO:2000270;GO:0000122;GO:0045892;GO:0045944;GO:0045945;GO:0045893;GO:0060134;GO:0035176;GO:0016055;, C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:armadillo repeat domain binding; F:ATP binding; F:beta-catenin binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:histone binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:digestive tract development; P:in utero embryonic development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription, DNA-templated; P:prepulse inhibition; P:social behavior; P:Wnt signaling pathway;|Q96F26,Chromodomain-helicase-DNA-binding protein 8 {ECO:0000255|HAMAP-Rule:MF_03071},ATP-dependent helicase CHD8 {ECO:0000255|HAMAP-Rule:MF_03071};Helicase with SNF2 domain 1;, PF07533;PF00385;PF00271;PF00176;, GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0070016;GO:0005524;GO:0008013;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0042393;GO:0035064;GO:0070615;GO:0002039;GO:0043044;GO:0007420;GO:0048565;GO:0001701;GO:0090090;GO:2000270;GO:0000122;GO:0045892;GO:0045944;GO:0045945;GO:0045893;GO:0060134;GO:0035176;GO:0016055;, C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:armadillo repeat domain binding; F:ATP binding; F:beta-catenin binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:histone binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:digestive tract development; P:in utero embryonic development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription, DNA-templated; P:prepulse inhibition; P:social behavior; P:Wnt signaling pathway;|Q96F26,Chromodomain-helicase-DNA-binding protein 8 {ECO:0000255|HAMAP-Rule:MF_03071},ATP-dependent helicase CHD8 {ECO:0000255|HAMAP-Rule:MF_03071};Helicase with SNF2 domain 1;, PF07533;PF00385;PF00271;PF00176;, GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0070016;GO:0005524;GO:0008013;GO:0003682;GO:0003677;GO:0003678;GO:0008094;GO:0042393;GO:0035064;GO:0070615;GO:0002039;GO:0043044;GO:0007420;GO:0048565;GO:0001701;GO:0090090;GO:2000270;GO:0000122;GO:0045892;GO:0045944;GO:0045945;GO:0045893;GO:0060134;GO:0035176;GO:0016055;, C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:armadillo repeat domain binding; F:ATP binding; F:beta-catenin binding; F:chromatin binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:histone binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:digestive tract development; P:in utero embryonic development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription, DNA-templated; P:prepulse inhibition; P:social behavior; P:Wnt signaling pathway; scaffold65 indexed_genome mRNA 583961 618910 . + . ID=transcript_10963;Q9Y5B9 Q6GMT8 Q6P2F1 Q6PJM1 Q9NRX0,FACT complex subunit SPT16,Chromatin-specific transcription elongation factor 140 kDa subunit;FACT 140 kDa subunit;FACTp140;Facilitates chromatin transcription complex subunit SPT16;, PF14826;PF00557;PF08512;PF08644;, GO:0035101;GO:0005654;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:0034724;GO:0006337;GO:0032786;GO:0032968;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleoplasm;, F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:DNA replication-independent nucleosome organization; P:nucleosome disassembly; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q9Y5B9 Q6GMT8 Q6P2F1 Q6PJM1 Q9NRX0,FACT complex subunit SPT16,Chromatin-specific transcription elongation factor 140 kDa subunit;FACT 140 kDa subunit;FACTp140;Facilitates chromatin transcription complex subunit SPT16;, PF14826;PF00557;PF08512;PF08644;, GO:0035101;GO:0005654;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:0034724;GO:0006337;GO:0032786;GO:0032968;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleoplasm;, F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:DNA replication-independent nucleosome organization; P:nucleosome disassembly; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q9Y5B9 Q6GMT8 Q6P2F1 Q6PJM1 Q9NRX0,FACT complex subunit SPT16,Chromatin-specific transcription elongation factor 140 kDa subunit;FACT 140 kDa subunit;FACTp140;Facilitates chromatin transcription complex subunit SPT16;, PF14826;PF00557;PF08512;PF08644;, GO:0035101;GO:0005654;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:0034724;GO:0006337;GO:0032786;GO:0032968;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleoplasm;, F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:DNA replication-independent nucleosome organization; P:nucleosome disassembly; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q9Y5B9 Q6GMT8 Q6P2F1 Q6PJM1 Q9NRX0,FACT complex subunit SPT16,Chromatin-specific transcription elongation factor 140 kDa subunit;FACT 140 kDa subunit;FACTp140;Facilitates chromatin transcription complex subunit SPT16;, PF14826;PF00557;PF08512;PF08644;, GO:0035101;GO:0005654;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:0034724;GO:0006337;GO:0032786;GO:0032968;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleoplasm;, F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:DNA replication-independent nucleosome organization; P:nucleosome disassembly; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q9Y5B9 Q6GMT8 Q6P2F1 Q6PJM1 Q9NRX0,FACT complex subunit SPT16,Chromatin-specific transcription elongation factor 140 kDa subunit;FACT 140 kDa subunit;FACTp140;Facilitates chromatin transcription complex subunit SPT16;, PF14826;PF00557;PF08512;PF08644;, GO:0035101;GO:0005654;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:0034724;GO:0006337;GO:0032786;GO:0032968;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleoplasm;, F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:DNA replication-independent nucleosome organization; P:nucleosome disassembly; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q9Y5B9 Q6GMT8 Q6P2F1 Q6PJM1 Q9NRX0,FACT complex subunit SPT16,Chromatin-specific transcription elongation factor 140 kDa subunit;FACT 140 kDa subunit;FACTp140;Facilitates chromatin transcription complex subunit SPT16;, PF14826;PF00557;PF08512;PF08644;, GO:0035101;GO:0005654;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:0034724;GO:0006337;GO:0032786;GO:0032968;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleoplasm;, F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:DNA replication-independent nucleosome organization; P:nucleosome disassembly; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process; scaffold65 indexed_genome mRNA 620281 659669 . - . ID=transcript_10964;Q96KN7 Q7Z2W6 Q8IXV5 Q96QA8 Q9HB94 Q9HB95 Q9HBK6 Q9NR40,X-linked retinitis pigmentosa GTPase regulator-interacting protein 1,, PF00168;PF11618;PF18111;, GO:0005930;GO:0035869;GO:0032391;GO:0120206;GO:0061351;GO:1905515;GO:0050896;GO:0046548;GO:0007601;, C:axoneme; C:ciliary transition zone; C:photoreceptor connecting cilium; C:photoreceptor distal connecting cilium;, , P:neural precursor cell proliferation; P:non-motile cilium assembly; P:response to stimulus; P:retinal rod cell development; P:visual perception; scaffold65 indexed_genome mRNA 693836 747147 . + . ID=transcript_10965;Q96HK7 Q96HM4 Q96IY5 Q9BTS3,Heterogeneous nuclear ribonucleoproteins C1/C2,, PF00076;, GO:0015629;GO:0071013;GO:0000785;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005654;GO:0005634;GO:0032991;GO:0005681;GO:0005697;GO:0042802;GO:0003730;GO:1990247;GO:0031492;GO:0008266;GO:0003723;GO:0070034;GO:0070935;GO:0043044;GO:0000398;GO:0032211;GO:0001649;GO:0016070;GO:0008380;, C:actin cytoskeleton; C:catalytic step 2 spliceosome; C:chromatin; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spliceosomal complex; C:telomerase holoenzyme complex;, F:identical protein binding; F:mRNA 3'-UTR binding; F:N6-methyladenosine-containing RNA binding; F:nucleosomal DNA binding; F:poly(U) RNA binding; F:RNA binding; F:telomerase RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:ATP-dependent chromatin remodeling; P:mRNA splicing, via spliceosome; P:negative regulation of telomere maintenance via telomerase; P:osteoblast differentiation; P:RNA metabolic process; P:RNA splicing;|Q96HK7 Q96HM4 Q96IY5 Q9BTS3,Heterogeneous nuclear ribonucleoproteins C1/C2,, PF00076;, GO:0015629;GO:0071013;GO:0000785;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005654;GO:0005634;GO:0032991;GO:0005681;GO:0005697;GO:0042802;GO:0003730;GO:1990247;GO:0031492;GO:0008266;GO:0003723;GO:0070034;GO:0070935;GO:0043044;GO:0000398;GO:0032211;GO:0001649;GO:0016070;GO:0008380;, C:actin cytoskeleton; C:catalytic step 2 spliceosome; C:chromatin; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spliceosomal complex; C:telomerase holoenzyme complex;, F:identical protein binding; F:mRNA 3'-UTR binding; F:N6-methyladenosine-containing RNA binding; F:nucleosomal DNA binding; F:poly(U) RNA binding; F:RNA binding; F:telomerase RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:ATP-dependent chromatin remodeling; P:mRNA splicing, via spliceosome; P:negative regulation of telomere maintenance via telomerase; P:osteoblast differentiation; P:RNA metabolic process; P:RNA splicing;|Q96HK7 Q96HM4 Q96IY5 Q9BTS3,Heterogeneous nuclear ribonucleoproteins C1/C2,, PF00076;, GO:0015629;GO:0071013;GO:0000785;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005654;GO:0005634;GO:0032991;GO:0005681;GO:0005697;GO:0042802;GO:0003730;GO:1990247;GO:0031492;GO:0008266;GO:0003723;GO:0070034;GO:0070935;GO:0043044;GO:0000398;GO:0032211;GO:0001649;GO:0016070;GO:0008380;, C:actin cytoskeleton; C:catalytic step 2 spliceosome; C:chromatin; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spliceosomal complex; C:telomerase holoenzyme complex;, F:identical protein binding; F:mRNA 3'-UTR binding; F:N6-methyladenosine-containing RNA binding; F:nucleosomal DNA binding; F:poly(U) RNA binding; F:RNA binding; F:telomerase RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:ATP-dependent chromatin remodeling; P:mRNA splicing, via spliceosome; P:negative regulation of telomere maintenance via telomerase; P:osteoblast differentiation; P:RNA metabolic process; P:RNA splicing;|Q96HK7 Q96HM4 Q96IY5 Q9BTS3,Heterogeneous nuclear ribonucleoproteins C1/C2,, PF00076;, GO:0015629;GO:0071013;GO:0000785;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005654;GO:0005634;GO:0032991;GO:0005681;GO:0005697;GO:0042802;GO:0003730;GO:1990247;GO:0031492;GO:0008266;GO:0003723;GO:0070034;GO:0070935;GO:0043044;GO:0000398;GO:0032211;GO:0001649;GO:0016070;GO:0008380;, C:actin cytoskeleton; C:catalytic step 2 spliceosome; C:chromatin; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spliceosomal complex; C:telomerase holoenzyme complex;, F:identical protein binding; F:mRNA 3'-UTR binding; F:N6-methyladenosine-containing RNA binding; F:nucleosomal DNA binding; F:poly(U) RNA binding; F:RNA binding; F:telomerase RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:ATP-dependent chromatin remodeling; P:mRNA splicing, via spliceosome; P:negative regulation of telomere maintenance via telomerase; P:osteoblast differentiation; P:RNA metabolic process; P:RNA splicing; scaffold65 indexed_genome mRNA 803204 804332 . - . ID=transcript_10966;P0C7T8,Transmembrane protein 253,, , GO:0016021;, C:integral component of membrane; scaffold65 indexed_genome mRNA 806612 835195 . - . ID=transcript_10967;Q9P2Y4 D3DS16 Q53Y57 Q8IYC1 Q9BW28,Zinc finger protein 219,, PF00096;, GO:0016021;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0004969;GO:0046872;GO:0000978;GO:0060174;GO:0000122;GO:0045892;GO:0032332;GO:0045944;GO:0001505;GO:0006355;, C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histamine receptor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:limb bud formation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of chondrocyte differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of neurotransmitter levels; P:regulation of transcription, DNA-templated;|Q8TER5 A5PL07 Q9BWP5 Q9H7L6 Q9NTF9 Q9NW24,Rho guanine nucleotide exchange factor 40,Protein SOLO;, PF00621;, GO:0005829;GO:0005886;GO:0005085;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;|Q8TER5 A5PL07 Q9BWP5 Q9H7L6 Q9NTF9 Q9NW24,Rho guanine nucleotide exchange factor 40,Protein SOLO;, PF00621;, GO:0005829;GO:0005886;GO:0005085;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;|Q8TER5 A5PL07 Q9BWP5 Q9H7L6 Q9NTF9 Q9NW24,Rho guanine nucleotide exchange factor 40,Protein SOLO;, PF00621;, GO:0005829;GO:0005886;GO:0005085;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;|Q8TER5 A5PL07 Q9BWP5 Q9H7L6 Q9NTF9 Q9NW24,Rho guanine nucleotide exchange factor 40,Protein SOLO;, PF00621;, GO:0005829;GO:0005886;GO:0005085;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;|Q8TER5 A5PL07 Q9BWP5 Q9H7L6 Q9NTF9 Q9NW24,Rho guanine nucleotide exchange factor 40,Protein SOLO;, PF00621;, GO:0005829;GO:0005886;GO:0005085;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;|Q8TER5 A5PL07 Q9BWP5 Q9H7L6 Q9NTF9 Q9NW24,Rho guanine nucleotide exchange factor 40,Protein SOLO;, PF00621;, GO:0005829;GO:0005886;GO:0005085;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;|Q8TER5 A5PL07 Q9BWP5 Q9H7L6 Q9NTF9 Q9NW24,Rho guanine nucleotide exchange factor 40,Protein SOLO;, PF00621;, GO:0005829;GO:0005886;GO:0005085;, C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; scaffold65 indexed_genome mRNA 878553 884213 . + . ID=transcript_10968;Q5GAN3,Probable inactive ribonuclease-like protein 13,, PF00074;, GO:0005576;GO:0003676;GO:0090501;, C:extracellular region;, F:nucleic acid binding;, P:RNA phosphodiester bond hydrolysis;|P59282 Q2VYF3,Tubulin polymerization-promoting protein family member 2 {ECO:0000303|PubMed:30680919},Protein p25-beta {ECO:0000303|Ref.1};TPPP/p18 {ECO:0000303|PubMed:17105200};, PF05517;, GO:0005829;GO:0036126;GO:0015631;GO:0030154;GO:0032273;GO:1901317;GO:0007283;, C:cytosol; C:sperm flagellum;, F:tubulin binding;, P:cell differentiation; P:positive regulation of protein polymerization; P:regulation of flagellated sperm motility; P:spermatogenesis;|P59282 Q2VYF3,Tubulin polymerization-promoting protein family member 2 {ECO:0000303|PubMed:30680919},Protein p25-beta {ECO:0000303|Ref.1};TPPP/p18 {ECO:0000303|PubMed:17105200};, PF05517;, GO:0005829;GO:0036126;GO:0015631;GO:0030154;GO:0032273;GO:1901317;GO:0007283;, C:cytosol; C:sperm flagellum;, F:tubulin binding;, P:cell differentiation; P:positive regulation of protein polymerization; P:regulation of flagellated sperm motility; P:spermatogenesis; scaffold65 indexed_genome mRNA 889678 895919 . + . ID=transcript_10969;Q86U08 Q86U46 Q96FD3 Q96FT0 Q96JU0 Q96PN0 Q9BQH5 Q9ULH2,Protein NDRG2,N-myc downstream-regulated gene 2 protein;Protein Syld709613;, PF03096;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0030426;GO:0005634;GO:0048471;GO:0030154;GO:0001818;GO:0070373;GO:0048662;GO:0090361;GO:0010574;GO:0007165;GO:0021762;GO:0016055;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:growth cone; C:nucleus; C:perinuclear region of cytoplasm;, , P:cell differentiation; P:negative regulation of cytokine production; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of smooth muscle cell proliferation; P:regulation of platelet-derived growth factor production; P:regulation of vascular endothelial growth factor production; P:signal transduction; P:substantia nigra development; P:Wnt signaling pathway;|Q86U08 Q86U46 Q96FD3 Q96FT0 Q96JU0 Q96PN0 Q9BQH5 Q9ULH2,Protein NDRG2,N-myc downstream-regulated gene 2 protein;Protein Syld709613;, PF03096;, GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0030426;GO:0005634;GO:0048471;GO:0030154;GO:0001818;GO:0070373;GO:0048662;GO:0090361;GO:0010574;GO:0007165;GO:0021762;GO:0016055;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:growth cone; C:nucleus; C:perinuclear region of cytoplasm;, , P:cell differentiation; P:negative regulation of cytokine production; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of smooth muscle cell proliferation; P:regulation of platelet-derived growth factor production; P:regulation of vascular endothelial growth factor production; P:signal transduction; P:substantia nigra development; P:Wnt signaling pathway; scaffold65 indexed_genome mRNA 904791 907265 . - . ID=transcript_10970;Q9NP94 B2RC76 G3V5X2 Q4QQJ1 Q4V9S4 Q96JT6 Q9UD20,Zinc transporter ZIP2,6A1;Eti-1;Solute carrier family 39 member 2;Zrt- and Irt-like protein 2;, PF02535;, GO:0036464;GO:0031410;GO:0005887;GO:0016020;GO:0005886;GO:0005385;GO:0071577;GO:0006829;, C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic vesicle; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:zinc ion transmembrane transporter activity;, P:zinc ion transmembrane transport; P:zinc ion transport; scaffold65 indexed_genome mRNA 908192 914149 . - . ID=transcript_10971;Q9H7H0 Q9BSH1 Q9BZH2 Q9BZH3,Methyltransferase-like protein 17, mitochondrial {ECO:0000305},False p73 target gene protein {ECO:0000303|Ref.1};Methyltransferase 11 domain-containing protein 1 {ECO:0000303|PubMed:24137763};Protein RSM22 homolog, mitochondrial {ECO:0000303|PubMed:11278769};, PF09243;, GO:0005759;GO:0005739;GO:0005654;GO:0008168;GO:1904047;GO:0032259;GO:0042274;GO:0006412;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:methylation; P:ribosomal small subunit biogenesis; P:translation;|Q9H7H0 Q9BSH1 Q9BZH2 Q9BZH3,Methyltransferase-like protein 17, mitochondrial {ECO:0000305},False p73 target gene protein {ECO:0000303|Ref.1};Methyltransferase 11 domain-containing protein 1 {ECO:0000303|PubMed:24137763};Protein RSM22 homolog, mitochondrial {ECO:0000303|PubMed:11278769};, PF09243;, GO:0005759;GO:0005739;GO:0005654;GO:0008168;GO:1904047;GO:0032259;GO:0042274;GO:0006412;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:methylation; P:ribosomal small subunit biogenesis; P:translation;|Q9H7H0 Q9BSH1 Q9BZH2 Q9BZH3,Methyltransferase-like protein 17, mitochondrial {ECO:0000305},False p73 target gene protein {ECO:0000303|Ref.1};Methyltransferase 11 domain-containing protein 1 {ECO:0000303|PubMed:24137763};Protein RSM22 homolog, mitochondrial {ECO:0000303|PubMed:11278769};, PF09243;, GO:0005759;GO:0005739;GO:0005654;GO:0008168;GO:1904047;GO:0032259;GO:0042274;GO:0006412;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:methyltransferase activity; F:S-adenosyl-L-methionine binding;, P:methylation; P:ribosomal small subunit biogenesis; P:translation; scaffold65 indexed_genome mRNA 983218 983733 . - . ID=transcript_10972;P07998 B2R589 D3DS06 Q16830 Q16869 Q1KHR2 Q6ICS5 Q9UCB4 Q9UCB5,Ribonuclease pancreatic,HP-RNase;RIB-1;RNase UpI-1;Ribonuclease 1;Ribonuclease A;, PF00074;, GO:0070062;GO:0016829;GO:0003676;GO:0004522;GO:0004540;GO:0090501;, C:extracellular exosome;, F:lyase activity; F:nucleic acid binding; F:ribonuclease A activity; F:ribonuclease activity;, P:RNA phosphodiester bond hydrolysis; scaffold65 indexed_genome mRNA 1014099 1015418 . + . ID=transcript_10973;P07998 B2R589 D3DS06 Q16830 Q16869 Q1KHR2 Q6ICS5 Q9UCB4 Q9UCB5,Ribonuclease pancreatic,HP-RNase;RIB-1;RNase UpI-1;Ribonuclease 1;Ribonuclease A;, PF00074;, GO:0070062;GO:0016829;GO:0003676;GO:0004522;GO:0004540;GO:0090501;, C:extracellular exosome;, F:lyase activity; F:nucleic acid binding; F:ribonuclease A activity; F:ribonuclease activity;, P:RNA phosphodiester bond hydrolysis; scaffold65 indexed_genome mRNA 1079423 1080423 . - . ID=transcript_10974;P07998 B2R589 D3DS06 Q16830 Q16869 Q1KHR2 Q6ICS5 Q9UCB4 Q9UCB5,Ribonuclease pancreatic,HP-RNase;RIB-1;RNase UpI-1;Ribonuclease 1;Ribonuclease A;, PF00074;, GO:0070062;GO:0016829;GO:0003676;GO:0004522;GO:0004540;GO:0090501;, C:extracellular exosome;, F:lyase activity; F:nucleic acid binding; F:ribonuclease A activity; F:ribonuclease activity;, P:RNA phosphodiester bond hydrolysis; scaffold65 indexed_genome mRNA 1091719 1093342 . - . ID=transcript_10975;Q93091,Ribonuclease K6,, PF00074;, GO:0031410;GO:0005576;GO:0005615;GO:0005764;GO:0004519;GO:0003676;GO:0004540;GO:0019731;GO:0061844;GO:0019730;GO:0006952;GO:0050829;GO:0050830;GO:0051607;GO:0045087;GO:0006401;GO:0090501;, C:cytoplasmic vesicle; C:extracellular region; C:extracellular space; C:lysosome;, F:endonuclease activity; F:nucleic acid binding; F:ribonuclease activity;, P:antibacterial humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:antimicrobial humoral response; P:defense response; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:defense response to virus; P:innate immune response; P:RNA catabolic process; P:RNA phosphodiester bond hydrolysis; scaffold65 indexed_genome mRNA 1123398 1152956 . - . ID=transcript_10976;P34096,Ribonuclease 4,, PF00074;, GO:0005576;GO:0005615;GO:0003676;GO:0004522;GO:0004540;GO:0006379;GO:0090501;, C:extracellular region; C:extracellular space;, F:nucleic acid binding; F:ribonuclease A activity; F:ribonuclease activity;, P:mRNA cleavage; P:RNA phosphodiester bond hydrolysis;|P03950 Q05CV1 Q53X86 Q6P5T2 Q8WXE7,Angiogenin,Ribonuclease 5;, PF00074;, GO:0015629;GO:0032311;GO:0005604;GO:0005694;GO:0031410;GO:0005576;GO:0005615;GO:0030426;GO:0043025;GO:0005730;GO:0005634;GO:0003779;GO:0005507;GO:0003677;GO:0004519;GO:0008201;GO:0042277;GO:0042803;GO:0004540;GO:0019843;GO:0005102;GO:0030041;GO:0032431;GO:0007202;GO:0032148;GO:0034332;GO:0001525;GO:0019731;GO:0019732;GO:0061844;GO:0007154;GO:0016477;GO:0050830;GO:0006651;GO:0042592;GO:0045087;GO:0048662;GO:0017148;GO:0001556;GO:0001541;GO:0001890;GO:0001938;GO:0042327;GO:0050714;GO:0009725;GO:0001666;GO:0001878;GO:0009303;, C:actin cytoskeleton; C:angiogenin-PRI complex; C:basement membrane; C:chromosome; C:cytoplasmic vesicle; C:extracellular region; C:extracellular space; C:growth cone; C:neuronal cell body; C:nucleolus; C:nucleus;, F:actin binding; F:copper ion binding; F:DNA binding; F:endonuclease activity; F:heparin binding; F:peptide binding; F:protein homodimerization activity; F:ribonuclease activity; F:rRNA binding; F:signaling receptor binding;, P:actin filament polymerization; P:activation of phospholipase A2 activity; P:activation of phospholipase C activity; P:activation of protein kinase B activity; P:adherens junction organization; P:angiogenesis; P:antibacterial humoral response; P:antifungal humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell communication; P:cell migration; P:defense response to Gram-positive bacterium; P:diacylglycerol biosynthetic process; P:homeostatic process; P:innate immune response; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of translation; P:oocyte maturation; P:ovarian follicle development; P:placenta development; P:positive regulation of endothelial cell proliferation; P:positive regulation of phosphorylation; P:positive regulation of protein secretion; P:response to hormone; P:response to hypoxia; P:response to yeast; P:rRNA transcription; scaffold65 indexed_genome mRNA 1356807 1362034 . - . ID=transcript_10977;P00491 B2R8S5 D3DS00 Q15160 Q5PZ03,Purine nucleoside phosphorylase,Inosine phosphorylase;Inosine-guanosine phosphorylase;, PF01048;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0047975;GO:0042802;GO:0001882;GO:0042301;GO:0002060;GO:0004731;GO:0046059;GO:0006955;GO:0006204;GO:0006148;GO:0043312;GO:0006738;GO:0006139;GO:0009165;GO:0046638;GO:0032743;GO:0042102;GO:0006195;GO:0006166;GO:0043101;GO:0042493;GO:0034418;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:guanosine phosphorylase activity; F:identical protein binding; F:nucleoside binding; F:phosphate ion binding; F:purine nucleobase binding; F:purine-nucleoside phosphorylase activity;, P:dAMP catabolic process; P:immune response; P:IMP catabolic process; P:inosine catabolic process; P:neutrophil degranulation; P:nicotinamide riboside catabolic process; P:nucleobase-containing compound metabolic process; P:nucleotide biosynthetic process; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of interleukin-2 production; P:positive regulation of T cell proliferation; P:purine nucleotide catabolic process; P:purine ribonucleoside salvage; P:purine-containing compound salvage; P:response to drug; P:urate biosynthetic process;|P00491 B2R8S5 D3DS00 Q15160 Q5PZ03,Purine nucleoside phosphorylase,Inosine phosphorylase;Inosine-guanosine phosphorylase;, PF01048;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0047975;GO:0042802;GO:0001882;GO:0042301;GO:0002060;GO:0004731;GO:0046059;GO:0006955;GO:0006204;GO:0006148;GO:0043312;GO:0006738;GO:0006139;GO:0009165;GO:0046638;GO:0032743;GO:0042102;GO:0006195;GO:0006166;GO:0043101;GO:0042493;GO:0034418;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen;, F:guanosine phosphorylase activity; F:identical protein binding; F:nucleoside binding; F:phosphate ion binding; F:purine nucleobase binding; F:purine-nucleoside phosphorylase activity;, P:dAMP catabolic process; P:immune response; P:IMP catabolic process; P:inosine catabolic process; P:neutrophil degranulation; P:nicotinamide riboside catabolic process; P:nucleobase-containing compound metabolic process; P:nucleotide biosynthetic process; P:positive regulation of alpha-beta T cell differentiation; P:positive regulation of interleukin-2 production; P:positive regulation of T cell proliferation; P:purine nucleotide catabolic process; P:purine ribonucleoside salvage; P:purine-containing compound salvage; P:response to drug; P:urate biosynthetic process; scaffold65 indexed_genome mRNA 1384564 1386747 . - . ID=transcript_10978;P27695 Q969L5 Q99775,DNA-(apurinic or apyrimidinic site) endonuclease,APEX nuclease;Apurinic-apyrimidinic endonuclease 1;REF-1;Redox factor-1;, PF03372;, GO:0005813;GO:0000781;GO:0005737;GO:0005783;GO:0005739;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005840;GO:0005667;GO:0008408;GO:0031490;GO:0003684;GO:0003677;GO:0003906;GO:0008311;GO:0008309;GO:0003691;GO:0004520;GO:0004519;GO:0046872;GO:0051059;GO:0016491;GO:0004528;GO:0008081;GO:0044877;GO:0003723;GO:0004523;GO:0016890;GO:0003713;GO:0003714;GO:0004844;GO:0007568;GO:0006284;GO:0006286;GO:0006287;GO:0045454;GO:0071320;GO:0070301;GO:0071375;GO:0080111;GO:0006310;GO:0006281;GO:0014912;GO:1900087;GO:0045944;GO:0042981;GO:0043488;GO:0042493;GO:0000723;GO:0097698;, C:centrosome; C:chromosome, telomeric region; C:cytoplasm; C:endoplasmic reticulum; C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:ribosome; C:transcription regulator complex;, F:3'-5' exonuclease activity; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA 3'-5' exodeoxyribonuclease activity; F:double-stranded DNA exodeoxyribonuclease activity; F:double-stranded telomeric DNA binding; F:endodeoxyribonuclease activity; F:endonuclease activity; F:metal ion binding; F:NF-kappaB binding; F:oxidoreductase activity; F:phosphodiesterase I activity; F:phosphoric diester hydrolase activity; F:protein-containing complex binding; F:RNA binding; F:RNA-DNA hybrid ribonuclease activity; F:site-specific endodeoxyribonuclease activity, specific for altered base; F:transcription coactivator activity; F:transcription corepressor activity; F:uracil DNA N-glycosylase activity;, P:aging; P:base-excision repair; P:base-excision repair, base-free sugar-phosphate removal; P:base-excision repair, gap-filling; P:cell redox homeostasis; P:cellular response to cAMP; P:cellular response to hydrogen peroxide; P:cellular response to peptide hormone stimulus; P:DNA demethylation; P:DNA recombination; P:DNA repair; P:negative regulation of smooth muscle cell migration; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of transcription by RNA polymerase II; P:regulation of apoptotic process; P:regulation of mRNA stability; P:response to drug; P:telomere maintenance; P:telomere maintenance via base-excision repair; scaffold65 indexed_genome mRNA 1387383 1394248 . + . ID=transcript_10979;Q9NPF4 Q6IAC3,Probable tRNA N6-adenosine threonylcarbamoyltransferase {ECO:0000255|HAMAP-Rule:MF_03180},N6-L-threonylcarbamoyladenine synthase;O-sialoglycoprotein endopeptidase {ECO:0000255|HAMAP-Rule:MF_03180};t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEP {ECO:0000255|HAMAP-Rule:MF_03180};tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP {ECO:0000255|HAMAP-Rule:MF_03180};, PF00814;, GO:0005737;GO:0000408;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0061711;GO:0002949;, C:cytoplasm; C:EKC/KEOPS complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:N(6)-L-threonylcarbamoyladenine synthase activity;, P:tRNA threonylcarbamoyladenosine modification;|Q9NPF4 Q6IAC3,Probable tRNA N6-adenosine threonylcarbamoyltransferase {ECO:0000255|HAMAP-Rule:MF_03180},N6-L-threonylcarbamoyladenine synthase;O-sialoglycoprotein endopeptidase {ECO:0000255|HAMAP-Rule:MF_03180};t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEP {ECO:0000255|HAMAP-Rule:MF_03180};tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP {ECO:0000255|HAMAP-Rule:MF_03180};, PF00814;, GO:0005737;GO:0000408;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0061711;GO:0002949;, C:cytoplasm; C:EKC/KEOPS complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:N(6)-L-threonylcarbamoyladenine synthase activity;, P:tRNA threonylcarbamoyladenosine modification;|P61353 P08526 Q4G0A9,60S ribosomal protein L27,Large ribosomal subunit protein eL27 {ECO:0000303|PubMed:24524803};, PF00467;PF01777;, GO:0098556;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005840;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic side of rough endoplasmic reticulum membrane; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q9NPF4 Q6IAC3,Probable tRNA N6-adenosine threonylcarbamoyltransferase {ECO:0000255|HAMAP-Rule:MF_03180},N6-L-threonylcarbamoyladenine synthase;O-sialoglycoprotein endopeptidase {ECO:0000255|HAMAP-Rule:MF_03180};t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEP {ECO:0000255|HAMAP-Rule:MF_03180};tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP {ECO:0000255|HAMAP-Rule:MF_03180};, PF00814;, GO:0005737;GO:0000408;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0061711;GO:0002949;, C:cytoplasm; C:EKC/KEOPS complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:N(6)-L-threonylcarbamoyladenine synthase activity;, P:tRNA threonylcarbamoyladenosine modification;|Q9NPF4 Q6IAC3,Probable tRNA N6-adenosine threonylcarbamoyltransferase {ECO:0000255|HAMAP-Rule:MF_03180},N6-L-threonylcarbamoyladenine synthase;O-sialoglycoprotein endopeptidase {ECO:0000255|HAMAP-Rule:MF_03180};t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEP {ECO:0000255|HAMAP-Rule:MF_03180};tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP {ECO:0000255|HAMAP-Rule:MF_03180};, PF00814;, GO:0005737;GO:0000408;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0061711;GO:0002949;, C:cytoplasm; C:EKC/KEOPS complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:N(6)-L-threonylcarbamoyladenine synthase activity;, P:tRNA threonylcarbamoyladenosine modification;|Q9NPF4 Q6IAC3,Probable tRNA N6-adenosine threonylcarbamoyltransferase {ECO:0000255|HAMAP-Rule:MF_03180},N6-L-threonylcarbamoyladenine synthase;O-sialoglycoprotein endopeptidase {ECO:0000255|HAMAP-Rule:MF_03180};t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEP {ECO:0000255|HAMAP-Rule:MF_03180};tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP {ECO:0000255|HAMAP-Rule:MF_03180};, PF00814;, GO:0005737;GO:0000408;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0061711;GO:0002949;, C:cytoplasm; C:EKC/KEOPS complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:N(6)-L-threonylcarbamoyladenine synthase activity;, P:tRNA threonylcarbamoyladenosine modification; scaffold65 indexed_genome mRNA 1402870 1415643 . + . ID=transcript_10980;A6NCF5,Kelch-like protein 33,, PF07707;PF01344;|A6NCF5,Kelch-like protein 33,, PF07707;PF01344; scaffold65 indexed_genome mRNA 1421386 1454795 . + . ID=transcript_10981;Q99973 A0AUV9,Telomerase protein component 1,Telomerase-associated protein 1;p240;p80 telomerase homolog;, PF13271;PF05729;PF05386;PF05731;PF00400;, GO:0000781;GO:0005737;GO:0016363;GO:1990904;GO:0005697;GO:0005524;GO:0019899;GO:0002039;GO:0003723;GO:0003720;GO:0070034;GO:0000722;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:ATP binding; F:enzyme binding; F:p53 binding; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:telomere maintenance via recombination;|Q99973 A0AUV9,Telomerase protein component 1,Telomerase-associated protein 1;p240;p80 telomerase homolog;, PF13271;PF05729;PF05386;PF05731;PF00400;, GO:0000781;GO:0005737;GO:0016363;GO:1990904;GO:0005697;GO:0005524;GO:0019899;GO:0002039;GO:0003723;GO:0003720;GO:0070034;GO:0000722;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:ATP binding; F:enzyme binding; F:p53 binding; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:telomere maintenance via recombination;|Q99973 A0AUV9,Telomerase protein component 1,Telomerase-associated protein 1;p240;p80 telomerase homolog;, PF13271;PF05729;PF05386;PF05731;PF00400;, GO:0000781;GO:0005737;GO:0016363;GO:1990904;GO:0005697;GO:0005524;GO:0019899;GO:0002039;GO:0003723;GO:0003720;GO:0070034;GO:0000722;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:ATP binding; F:enzyme binding; F:p53 binding; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:telomere maintenance via recombination;|Q99973 A0AUV9,Telomerase protein component 1,Telomerase-associated protein 1;p240;p80 telomerase homolog;, PF13271;PF05729;PF05386;PF05731;PF00400;, GO:0000781;GO:0005737;GO:0016363;GO:1990904;GO:0005697;GO:0005524;GO:0019899;GO:0002039;GO:0003723;GO:0003720;GO:0070034;GO:0000722;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:ATP binding; F:enzyme binding; F:p53 binding; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:telomere maintenance via recombination; scaffold65 indexed_genome mRNA 1455077 1484496 . + . ID=transcript_10982;Q99973 A0AUV9,Telomerase protein component 1,Telomerase-associated protein 1;p240;p80 telomerase homolog;, PF13271;PF05729;PF05386;PF05731;PF00400;, GO:0000781;GO:0005737;GO:0016363;GO:1990904;GO:0005697;GO:0005524;GO:0019899;GO:0002039;GO:0003723;GO:0003720;GO:0070034;GO:0000722;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:ATP binding; F:enzyme binding; F:p53 binding; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:telomere maintenance via recombination;|Q99973 A0AUV9,Telomerase protein component 1,Telomerase-associated protein 1;p240;p80 telomerase homolog;, PF13271;PF05729;PF05386;PF05731;PF00400;, GO:0000781;GO:0005737;GO:0016363;GO:1990904;GO:0005697;GO:0005524;GO:0019899;GO:0002039;GO:0003723;GO:0003720;GO:0070034;GO:0000722;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:ATP binding; F:enzyme binding; F:p53 binding; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:telomere maintenance via recombination;|Q99973 A0AUV9,Telomerase protein component 1,Telomerase-associated protein 1;p240;p80 telomerase homolog;, PF13271;PF05729;PF05386;PF05731;PF00400;, GO:0000781;GO:0005737;GO:0016363;GO:1990904;GO:0005697;GO:0005524;GO:0019899;GO:0002039;GO:0003723;GO:0003720;GO:0070034;GO:0000722;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:ATP binding; F:enzyme binding; F:p53 binding; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:telomere maintenance via recombination;|Q99973 A0AUV9,Telomerase protein component 1,Telomerase-associated protein 1;p240;p80 telomerase homolog;, PF13271;PF05729;PF05386;PF05731;PF00400;, GO:0000781;GO:0005737;GO:0016363;GO:1990904;GO:0005697;GO:0005524;GO:0019899;GO:0002039;GO:0003723;GO:0003720;GO:0070034;GO:0000722;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:ATP binding; F:enzyme binding; F:p53 binding; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:telomere maintenance via recombination;|Q99973 A0AUV9,Telomerase protein component 1,Telomerase-associated protein 1;p240;p80 telomerase homolog;, PF13271;PF05729;PF05386;PF05731;PF00400;, GO:0000781;GO:0005737;GO:0016363;GO:1990904;GO:0005697;GO:0005524;GO:0019899;GO:0002039;GO:0003723;GO:0003720;GO:0070034;GO:0000722;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:ATP binding; F:enzyme binding; F:p53 binding; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:telomere maintenance via recombination;|Q99973 A0AUV9,Telomerase protein component 1,Telomerase-associated protein 1;p240;p80 telomerase homolog;, PF13271;PF05729;PF05386;PF05731;PF00400;, GO:0000781;GO:0005737;GO:0016363;GO:1990904;GO:0005697;GO:0005524;GO:0019899;GO:0002039;GO:0003723;GO:0003720;GO:0070034;GO:0000722;, C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:ATP binding; F:enzyme binding; F:p53 binding; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:telomere maintenance via recombination;|Q9UGN5 Q8TEU4 Q9NUV2 Q9UMR4 Q9Y6C8,Poly [ADP-ribose] polymerase 2 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 2 {ECO:0000303|PubMed:30321391};DNA ADP-ribosyltransferase PARP2 {ECO:0000305};NAD(+) ADP-ribosyltransferase 2;Poly[ADP-ribose] synthase 2 {ECO:0000303|PubMed:10338144};Protein poly-ADP-ribosyltransferase PARP2 {ECO:0000305};, PF00644;PF02877;PF05406;, GO:0005730;GO:0005654;GO:0005634;GO:0090734;GO:0003682;GO:0003677;GO:0140294;GO:0003950;GO:0031491;GO:1990404;GO:0006284;GO:0030592;GO:0006281;GO:0006302;GO:0097191;GO:0016570;GO:1901215;GO:0018312;GO:0061051;GO:0006471;GO:0070213;GO:0070212;, C:nucleolus; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:chromatin binding; F:DNA binding; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:nucleosome binding; F:protein ADP-ribosylase activity;, P:base-excision repair; P:DNA ADP-ribosylation; P:DNA repair; P:double-strand break repair; P:extrinsic apoptotic signaling pathway; P:histone modification; P:negative regulation of neuron death; P:peptidyl-serine ADP-ribosylation; P:positive regulation of cell growth involved in cardiac muscle cell development; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein poly-ADP-ribosylation;|Q9UGN5 Q8TEU4 Q9NUV2 Q9UMR4 Q9Y6C8,Poly [ADP-ribose] polymerase 2 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 2 {ECO:0000303|PubMed:30321391};DNA ADP-ribosyltransferase PARP2 {ECO:0000305};NAD(+) ADP-ribosyltransferase 2;Poly[ADP-ribose] synthase 2 {ECO:0000303|PubMed:10338144};Protein poly-ADP-ribosyltransferase PARP2 {ECO:0000305};, PF00644;PF02877;PF05406;, GO:0005730;GO:0005654;GO:0005634;GO:0090734;GO:0003682;GO:0003677;GO:0140294;GO:0003950;GO:0031491;GO:1990404;GO:0006284;GO:0030592;GO:0006281;GO:0006302;GO:0097191;GO:0016570;GO:1901215;GO:0018312;GO:0061051;GO:0006471;GO:0070213;GO:0070212;, C:nucleolus; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:chromatin binding; F:DNA binding; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:nucleosome binding; F:protein ADP-ribosylase activity;, P:base-excision repair; P:DNA ADP-ribosylation; P:DNA repair; P:double-strand break repair; P:extrinsic apoptotic signaling pathway; P:histone modification; P:negative regulation of neuron death; P:peptidyl-serine ADP-ribosylation; P:positive regulation of cell growth involved in cardiac muscle cell development; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein poly-ADP-ribosylation;|Q9UGN5 Q8TEU4 Q9NUV2 Q9UMR4 Q9Y6C8,Poly [ADP-ribose] polymerase 2 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 2 {ECO:0000303|PubMed:30321391};DNA ADP-ribosyltransferase PARP2 {ECO:0000305};NAD(+) ADP-ribosyltransferase 2;Poly[ADP-ribose] synthase 2 {ECO:0000303|PubMed:10338144};Protein poly-ADP-ribosyltransferase PARP2 {ECO:0000305};, PF00644;PF02877;PF05406;, GO:0005730;GO:0005654;GO:0005634;GO:0090734;GO:0003682;GO:0003677;GO:0140294;GO:0003950;GO:0031491;GO:1990404;GO:0006284;GO:0030592;GO:0006281;GO:0006302;GO:0097191;GO:0016570;GO:1901215;GO:0018312;GO:0061051;GO:0006471;GO:0070213;GO:0070212;, C:nucleolus; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:chromatin binding; F:DNA binding; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:nucleosome binding; F:protein ADP-ribosylase activity;, P:base-excision repair; P:DNA ADP-ribosylation; P:DNA repair; P:double-strand break repair; P:extrinsic apoptotic signaling pathway; P:histone modification; P:negative regulation of neuron death; P:peptidyl-serine ADP-ribosylation; P:positive regulation of cell growth involved in cardiac muscle cell development; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein poly-ADP-ribosylation;|Q9UGN5 Q8TEU4 Q9NUV2 Q9UMR4 Q9Y6C8,Poly [ADP-ribose] polymerase 2 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 2 {ECO:0000303|PubMed:30321391};DNA ADP-ribosyltransferase PARP2 {ECO:0000305};NAD(+) ADP-ribosyltransferase 2;Poly[ADP-ribose] synthase 2 {ECO:0000303|PubMed:10338144};Protein poly-ADP-ribosyltransferase PARP2 {ECO:0000305};, PF00644;PF02877;PF05406;, GO:0005730;GO:0005654;GO:0005634;GO:0090734;GO:0003682;GO:0003677;GO:0140294;GO:0003950;GO:0031491;GO:1990404;GO:0006284;GO:0030592;GO:0006281;GO:0006302;GO:0097191;GO:0016570;GO:1901215;GO:0018312;GO:0061051;GO:0006471;GO:0070213;GO:0070212;, C:nucleolus; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:chromatin binding; F:DNA binding; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:nucleosome binding; F:protein ADP-ribosylase activity;, P:base-excision repair; P:DNA ADP-ribosylation; P:DNA repair; P:double-strand break repair; P:extrinsic apoptotic signaling pathway; P:histone modification; P:negative regulation of neuron death; P:peptidyl-serine ADP-ribosylation; P:positive regulation of cell growth involved in cardiac muscle cell development; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein poly-ADP-ribosylation; scaffold65 indexed_genome mRNA 1486452 1507628 . + . ID=transcript_10983;Q9NPC3,E3 ubiquitin-protein ligase CCNB1IP1,Cyclin-B1-interacting protein 1;Human enhancer of invasion 10;RING-type E3 ubiquitin transferase CCNB1IP1 {ECO:0000305};, PF14634;, GO:0000795;GO:0042802;GO:0046872;GO:0061630;GO:0051026;GO:0007131;, C:synaptonemal complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:chiasma assembly; P:reciprocal meiotic recombination;|Q9NPC3,E3 ubiquitin-protein ligase CCNB1IP1,Cyclin-B1-interacting protein 1;Human enhancer of invasion 10;RING-type E3 ubiquitin transferase CCNB1IP1 {ECO:0000305};, PF14634;, GO:0000795;GO:0042802;GO:0046872;GO:0061630;GO:0051026;GO:0007131;, C:synaptonemal complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:chiasma assembly; P:reciprocal meiotic recombination;|Q9NPC3,E3 ubiquitin-protein ligase CCNB1IP1,Cyclin-B1-interacting protein 1;Human enhancer of invasion 10;RING-type E3 ubiquitin transferase CCNB1IP1 {ECO:0000305};, PF14634;, GO:0000795;GO:0042802;GO:0046872;GO:0061630;GO:0051026;GO:0007131;, C:synaptonemal complex;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:chiasma assembly; P:reciprocal meiotic recombination; scaffold65 indexed_genome mRNA 1509947 1526622 . + . ID=transcript_10984;Q8N0Z6 A8MQ18 Q96HF9,Tetratricopeptide repeat protein 5,Stress-responsive activator of p300;, PF16669;, GO:0005737;GO:0005654;GO:0003682;GO:0003677;GO:0006281;GO:0045944;GO:1901796;, C:cytoplasm; C:nucleoplasm;, F:chromatin binding; F:DNA binding;, P:DNA repair; P:positive regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator;|Q8N0Z6 A8MQ18 Q96HF9,Tetratricopeptide repeat protein 5,Stress-responsive activator of p300;, PF16669;, GO:0005737;GO:0005654;GO:0003682;GO:0003677;GO:0006281;GO:0045944;GO:1901796;, C:cytoplasm; C:nucleoplasm;, F:chromatin binding; F:DNA binding;, P:DNA repair; P:positive regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator;|Q8N0Z6 A8MQ18 Q96HF9,Tetratricopeptide repeat protein 5,Stress-responsive activator of p300;, PF16669;, GO:0005737;GO:0005654;GO:0003682;GO:0003677;GO:0006281;GO:0045944;GO:1901796;, C:cytoplasm; C:nucleoplasm;, F:chromatin binding; F:DNA binding;, P:DNA repair; P:positive regulation of transcription by RNA polymerase II; P:regulation of signal transduction by p53 class mediator; scaffold65 indexed_genome mRNA 2865758 2872561 . - . ID=transcript_10985;Q643R3 A8K2K8 O43412 Q7Z4P4 Q8IUL7 Q8TB38,Lysophospholipid acyltransferase LPCAT4,1-acylglycerol-3-phosphate O-acyltransferase 7;1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoserine O-acyltransferase;1-alkenylglycerophosphoethanolamine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acyltransferase-like 3;Lysophosphatidylcholine acyltransferase 4;Lysophosphatidylethanolamine acyltransferase 2;Plasmalogen synthase;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0047166;GO:0047192;GO:0071617;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036150;GO:0006644;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:1-alkenylglycerophosphoethanolamine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:lysophospholipid acyltransferase activity;, P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process;|Q643R3 A8K2K8 O43412 Q7Z4P4 Q8IUL7 Q8TB38,Lysophospholipid acyltransferase LPCAT4,1-acylglycerol-3-phosphate O-acyltransferase 7;1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoserine O-acyltransferase;1-alkenylglycerophosphoethanolamine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acyltransferase-like 3;Lysophosphatidylcholine acyltransferase 4;Lysophosphatidylethanolamine acyltransferase 2;Plasmalogen synthase;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0047166;GO:0047192;GO:0071617;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036150;GO:0006644;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:1-alkenylglycerophosphoethanolamine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:lysophospholipid acyltransferase activity;, P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process;|Q643R3 A8K2K8 O43412 Q7Z4P4 Q8IUL7 Q8TB38,Lysophospholipid acyltransferase LPCAT4,1-acylglycerol-3-phosphate O-acyltransferase 7;1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoserine O-acyltransferase;1-alkenylglycerophosphoethanolamine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acyltransferase-like 3;Lysophosphatidylcholine acyltransferase 4;Lysophosphatidylethanolamine acyltransferase 2;Plasmalogen synthase;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0047166;GO:0047192;GO:0071617;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036150;GO:0006644;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:1-alkenylglycerophosphoethanolamine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:lysophospholipid acyltransferase activity;, P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process;|Q643R3 A8K2K8 O43412 Q7Z4P4 Q8IUL7 Q8TB38,Lysophospholipid acyltransferase LPCAT4,1-acylglycerol-3-phosphate O-acyltransferase 7;1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoserine O-acyltransferase;1-alkenylglycerophosphoethanolamine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acyltransferase-like 3;Lysophosphatidylcholine acyltransferase 4;Lysophosphatidylethanolamine acyltransferase 2;Plasmalogen synthase;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0047166;GO:0047192;GO:0071617;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036150;GO:0006644;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:1-alkenylglycerophosphoethanolamine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:lysophospholipid acyltransferase activity;, P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process;|Q643R3 A8K2K8 O43412 Q7Z4P4 Q8IUL7 Q8TB38,Lysophospholipid acyltransferase LPCAT4,1-acylglycerol-3-phosphate O-acyltransferase 7;1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoserine O-acyltransferase;1-alkenylglycerophosphoethanolamine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acyltransferase-like 3;Lysophosphatidylcholine acyltransferase 4;Lysophosphatidylethanolamine acyltransferase 2;Plasmalogen synthase;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0047166;GO:0047192;GO:0071617;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036150;GO:0006644;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:1-alkenylglycerophosphoethanolamine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:lysophospholipid acyltransferase activity;, P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process;|Q643R3 A8K2K8 O43412 Q7Z4P4 Q8IUL7 Q8TB38,Lysophospholipid acyltransferase LPCAT4,1-acylglycerol-3-phosphate O-acyltransferase 7;1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoserine O-acyltransferase;1-alkenylglycerophosphoethanolamine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acyltransferase-like 3;Lysophosphatidylcholine acyltransferase 4;Lysophosphatidylethanolamine acyltransferase 2;Plasmalogen synthase;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0047166;GO:0047192;GO:0071617;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036150;GO:0006644;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:1-alkenylglycerophosphoethanolamine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:lysophospholipid acyltransferase activity;, P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process;|Q643R3 A8K2K8 O43412 Q7Z4P4 Q8IUL7 Q8TB38,Lysophospholipid acyltransferase LPCAT4,1-acylglycerol-3-phosphate O-acyltransferase 7;1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoserine O-acyltransferase;1-alkenylglycerophosphoethanolamine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acyltransferase-like 3;Lysophosphatidylcholine acyltransferase 4;Lysophosphatidylethanolamine acyltransferase 2;Plasmalogen synthase;, PF01553;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0047166;GO:0047192;GO:0071617;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036150;GO:0006644;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:1-alkenylglycerophosphoethanolamine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:lysophospholipid acyltransferase activity;, P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process; scaffold65 indexed_genome mRNA 2885464 2886820 . + . ID=transcript_10986;Q9NPE3,H/ACA ribonucleoprotein complex subunit 3,Nucleolar protein 10;Nucleolar protein family A member 3;snoRNP protein NOP10;, PF04135;, GO:0072589;GO:0031429;GO:0090661;GO:0016604;GO:0005654;GO:0005732;GO:0005697;GO:0034513;GO:0003723;GO:0070034;GO:1904874;GO:0001522;GO:0031118;GO:0000454;GO:0031120;GO:0007004;, C:box H/ACA scaRNP complex; C:box H/ACA snoRNP complex; C:box H/ACA telomerase RNP complex; C:nuclear body; C:nucleoplasm; C:sno(s)RNA-containing ribonucleoprotein complex; C:telomerase holoenzyme complex;, F:box H/ACA snoRNA binding; F:RNA binding; F:telomerase RNA binding;, P:positive regulation of telomerase RNA localization to Cajal body; P:pseudouridine synthesis; P:rRNA pseudouridine synthesis; P:snoRNA guided rRNA pseudouridine synthesis; P:snRNA pseudouridine synthesis; P:telomere maintenance via telomerase; scaffold65 indexed_genome mRNA 2890532 2957210 . + . ID=transcript_10987;Q9UHW9 A0AV76 Q2VI00 Q7Z2E7 Q7Z4G5 Q8TDD4 Q9UFR2 Q9Y642 Q9Y665,Solute carrier family 12 member 6,Electroneutral potassium-chloride cotransporter 3;K-Cl cotransporter 3;, PF00324;PF03522;, GO:0016323;GO:0016021;GO:0005887;GO:0005886;GO:0045202;GO:0008519;GO:0015079;GO:0015379;GO:0019901;GO:0140157;GO:0001525;GO:0006884;GO:0071476;GO:0071477;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:angiogenesis; P:cell volume homeostasis; P:cellular hypotonic response; P:cellular hypotonic salinity response; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; scaffold65 indexed_genome mRNA 2957244 2981754 . + . ID=transcript_10988;Q9UHW9 A0AV76 Q2VI00 Q7Z2E7 Q7Z4G5 Q8TDD4 Q9UFR2 Q9Y642 Q9Y665,Solute carrier family 12 member 6,Electroneutral potassium-chloride cotransporter 3;K-Cl cotransporter 3;, PF00324;PF03522;, GO:0016323;GO:0016021;GO:0005887;GO:0005886;GO:0045202;GO:0008519;GO:0015079;GO:0015379;GO:0019901;GO:0140157;GO:0001525;GO:0006884;GO:0071476;GO:0071477;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:angiogenesis; P:cell volume homeostasis; P:cellular hypotonic response; P:cellular hypotonic salinity response; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|Q9UHW9 A0AV76 Q2VI00 Q7Z2E7 Q7Z4G5 Q8TDD4 Q9UFR2 Q9Y642 Q9Y665,Solute carrier family 12 member 6,Electroneutral potassium-chloride cotransporter 3;K-Cl cotransporter 3;, PF00324;PF03522;, GO:0016323;GO:0016021;GO:0005887;GO:0005886;GO:0045202;GO:0008519;GO:0015079;GO:0015379;GO:0019901;GO:0140157;GO:0001525;GO:0006884;GO:0071476;GO:0071477;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:angiogenesis; P:cell volume homeostasis; P:cellular hypotonic response; P:cellular hypotonic salinity response; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|Q9UHW9 A0AV76 Q2VI00 Q7Z2E7 Q7Z4G5 Q8TDD4 Q9UFR2 Q9Y642 Q9Y665,Solute carrier family 12 member 6,Electroneutral potassium-chloride cotransporter 3;K-Cl cotransporter 3;, PF00324;PF03522;, GO:0016323;GO:0016021;GO:0005887;GO:0005886;GO:0045202;GO:0008519;GO:0015079;GO:0015379;GO:0019901;GO:0140157;GO:0001525;GO:0006884;GO:0071476;GO:0071477;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:angiogenesis; P:cell volume homeostasis; P:cellular hypotonic response; P:cellular hypotonic salinity response; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|Q9UHW9 A0AV76 Q2VI00 Q7Z2E7 Q7Z4G5 Q8TDD4 Q9UFR2 Q9Y642 Q9Y665,Solute carrier family 12 member 6,Electroneutral potassium-chloride cotransporter 3;K-Cl cotransporter 3;, PF00324;PF03522;, GO:0016323;GO:0016021;GO:0005887;GO:0005886;GO:0045202;GO:0008519;GO:0015079;GO:0015379;GO:0019901;GO:0140157;GO:0001525;GO:0006884;GO:0071476;GO:0071477;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:angiogenesis; P:cell volume homeostasis; P:cellular hypotonic response; P:cellular hypotonic salinity response; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|Q9UHW9 A0AV76 Q2VI00 Q7Z2E7 Q7Z4G5 Q8TDD4 Q9UFR2 Q9Y642 Q9Y665,Solute carrier family 12 member 6,Electroneutral potassium-chloride cotransporter 3;K-Cl cotransporter 3;, PF00324;PF03522;, GO:0016323;GO:0016021;GO:0005887;GO:0005886;GO:0045202;GO:0008519;GO:0015079;GO:0015379;GO:0019901;GO:0140157;GO:0001525;GO:0006884;GO:0071476;GO:0071477;GO:0007268;GO:0055064;GO:1902476;GO:0006811;GO:0055075;GO:1990573;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:ammonium transmembrane transporter activity; F:potassium ion transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:ammonium import across plasma membrane; P:angiogenesis; P:cell volume homeostasis; P:cellular hypotonic response; P:cellular hypotonic salinity response; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:ion transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; scaffold65 indexed_genome mRNA 2981920 2985592 . + . ID=transcript_10989;Q5J8M3 A8K3A9 B4DJQ4 Q96KX9 Q9BUI5 Q9P0T9,ER membrane protein complex subunit 4,Cell proliferation-inducing gene 17 protein;Transmembrane protein 85;, PF06417;, GO:0072546;GO:0030176;GO:0016021;GO:0006915;GO:0045050;GO:0071816;, C:EMC complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:apoptotic process; P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q5J8M3 A8K3A9 B4DJQ4 Q96KX9 Q9BUI5 Q9P0T9,ER membrane protein complex subunit 4,Cell proliferation-inducing gene 17 protein;Transmembrane protein 85;, PF06417;, GO:0072546;GO:0030176;GO:0016021;GO:0006915;GO:0045050;GO:0071816;, C:EMC complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:apoptotic process; P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q5J8M3 A8K3A9 B4DJQ4 Q96KX9 Q9BUI5 Q9P0T9,ER membrane protein complex subunit 4,Cell proliferation-inducing gene 17 protein;Transmembrane protein 85;, PF06417;, GO:0072546;GO:0030176;GO:0016021;GO:0006915;GO:0045050;GO:0071816;, C:EMC complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:apoptotic process; P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane; scaffold65 indexed_genome mRNA 3033912 3052035 . + . ID=transcript_10990;Q9H079 A8KAF6 Q2TAC0 Q9H670,KATNB1-like protein 1,Katanin p80 subunit B-like 1 {ECO:0000303|PubMed:26929214};, PF13925;, GO:0032154;GO:0005737;GO:0030496;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0005634;GO:0008017;GO:0051495;, C:cleavage furrow; C:cytoplasm; C:midbody; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:nucleus;, F:microtubule binding;, P:positive regulation of cytoskeleton organization;|Q9H079 A8KAF6 Q2TAC0 Q9H670,KATNB1-like protein 1,Katanin p80 subunit B-like 1 {ECO:0000303|PubMed:26929214};, PF13925;, GO:0032154;GO:0005737;GO:0030496;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0005634;GO:0008017;GO:0051495;, C:cleavage furrow; C:cytoplasm; C:midbody; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:nucleus;, F:microtubule binding;, P:positive regulation of cytoskeleton organization;|Q9H079 A8KAF6 Q2TAC0 Q9H670,KATNB1-like protein 1,Katanin p80 subunit B-like 1 {ECO:0000303|PubMed:26929214};, PF13925;, GO:0032154;GO:0005737;GO:0030496;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0005634;GO:0008017;GO:0051495;, C:cleavage furrow; C:cytoplasm; C:midbody; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:nucleus;, F:microtubule binding;, P:positive regulation of cytoskeleton organization;|Q9H079 A8KAF6 Q2TAC0 Q9H670,KATNB1-like protein 1,Katanin p80 subunit B-like 1 {ECO:0000303|PubMed:26929214};, PF13925;, GO:0032154;GO:0005737;GO:0030496;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0005634;GO:0008017;GO:0051495;, C:cleavage furrow; C:cytoplasm; C:midbody; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:nucleus;, F:microtubule binding;, P:positive regulation of cytoskeleton organization;|Q9H079 A8KAF6 Q2TAC0 Q9H670,KATNB1-like protein 1,Katanin p80 subunit B-like 1 {ECO:0000303|PubMed:26929214};, PF13925;, GO:0032154;GO:0005737;GO:0030496;GO:0072686;GO:0097431;GO:0005730;GO:0005654;GO:0005634;GO:0008017;GO:0051495;, C:cleavage furrow; C:cytoplasm; C:midbody; C:mitotic spindle; C:mitotic spindle pole; C:nucleolus; C:nucleoplasm; C:nucleus;, F:microtubule binding;, P:positive regulation of cytoskeleton organization; scaffold65 indexed_genome mRNA 3084702 3101341 . + . ID=transcript_10991;Q9NPA0 B2RC00 Q96ED5,ER membrane protein complex subunit 7,, PF09430;, GO:0072546;GO:0030176;GO:0016021;GO:0030246;GO:0045050;GO:0071816;, C:EMC complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, F:carbohydrate binding;, P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane; scaffold65 indexed_genome mRNA 3114768 3115865 . + . ID=transcript_10992;P08912 Q96RG7,Muscarinic acetylcholine receptor M5,, PF00001;, GO:0030425;GO:0005887;GO:0005886;GO:0045211;GO:0045202;GO:0016907;GO:0004993;GO:0030594;GO:0004435;GO:0007197;GO:0007268;GO:0015872;GO:0007213;GO:0007186;GO:0007187;GO:0001696;GO:0060304;GO:0019226;, C:dendrite; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:G protein-coupled acetylcholine receptor activity; F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity; F:phosphatidylinositol phospholipase C activity;, P:adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway; P:chemical synaptic transmission; P:dopamine transport; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:gastric acid secretion; P:regulation of phosphatidylinositol dephosphorylation; P:transmission of nerve impulse; scaffold65 indexed_genome mRNA 3174393 3318893 . + . ID=transcript_10993;Q9NQS1,Cell death regulator Aven,, , GO:0005829;GO:0012505;GO:0016020;GO:0006915;GO:0043066;GO:0010972;, C:cytosol; C:endomembrane system; C:membrane;, , P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle;|Q9NQS1,Cell death regulator Aven,, , GO:0005829;GO:0012505;GO:0016020;GO:0006915;GO:0043066;GO:0010972;, C:cytosol; C:endomembrane system; C:membrane;, , P:apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle; scaffold65 indexed_genome mRNA 3319010 3363845 . - . ID=transcript_10994;Q15413 O15175 Q15412,Ryanodine receptor 3,Brain ryanodine receptor-calcium release channel;Brain-type ryanodine receptor;Type 3 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0016021;GO:0005886;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0070588;GO:0006816;GO:0071318;GO:0071313;GO:0071277;GO:0071286;GO:0034220;GO:0051289;GO:1903779;GO:0051209;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular response to ATP; P:cellular response to caffeine; P:cellular response to calcium ion; P:cellular response to magnesium ion; P:ion transmembrane transport; P:protein homotetramerization; P:regulation of cardiac conduction; P:release of sequestered calcium ion into cytosol;|Q15413 O15175 Q15412,Ryanodine receptor 3,Brain ryanodine receptor-calcium release channel;Brain-type ryanodine receptor;Type 3 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0016021;GO:0005886;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0070588;GO:0006816;GO:0071318;GO:0071313;GO:0071277;GO:0071286;GO:0034220;GO:0051289;GO:1903779;GO:0051209;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular response to ATP; P:cellular response to caffeine; P:cellular response to calcium ion; P:cellular response to magnesium ion; P:ion transmembrane transport; P:protein homotetramerization; P:regulation of cardiac conduction; P:release of sequestered calcium ion into cytosol;|Q15413 O15175 Q15412,Ryanodine receptor 3,Brain ryanodine receptor-calcium release channel;Brain-type ryanodine receptor;Type 3 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0016021;GO:0005886;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0070588;GO:0006816;GO:0071318;GO:0071313;GO:0071277;GO:0071286;GO:0034220;GO:0051289;GO:1903779;GO:0051209;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular response to ATP; P:cellular response to caffeine; P:cellular response to calcium ion; P:cellular response to magnesium ion; P:ion transmembrane transport; P:protein homotetramerization; P:regulation of cardiac conduction; P:release of sequestered calcium ion into cytosol; scaffold65 indexed_genome mRNA 3366959 3385963 . - . ID=transcript_10995;Q15413 O15175 Q15412,Ryanodine receptor 3,Brain ryanodine receptor-calcium release channel;Brain-type ryanodine receptor;Type 3 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0016021;GO:0005886;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0070588;GO:0006816;GO:0071318;GO:0071313;GO:0071277;GO:0071286;GO:0034220;GO:0051289;GO:1903779;GO:0051209;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular response to ATP; P:cellular response to caffeine; P:cellular response to calcium ion; P:cellular response to magnesium ion; P:ion transmembrane transport; P:protein homotetramerization; P:regulation of cardiac conduction; P:release of sequestered calcium ion into cytosol; scaffold65 indexed_genome mRNA 4310950 4462171 . + . ID=transcript_10996;Q68DA7 Q3B7I6 Q3ZAR4 Q6ZSY1,Formin-1,Limb deformity protein homolog;, PF02181;, GO:0005884;GO:0005912;GO:0005737;GO:0005789;GO:0005634;GO:0005886;GO:0003779;GO:0008017;GO:0017124;GO:0045010;GO:0035136;GO:0010467;GO:0035137;GO:0051127;GO:0051894;GO:0048705;GO:0072092;, C:actin filament; C:adherens junction; C:cytoplasm; C:endoplasmic reticulum membrane; C:nucleus; C:plasma membrane;, F:actin binding; F:microtubule binding; F:SH3 domain binding;, P:actin nucleation; P:forelimb morphogenesis; P:gene expression; P:hindlimb morphogenesis; P:positive regulation of actin nucleation; P:positive regulation of focal adhesion assembly; P:skeletal system morphogenesis; P:ureteric bud invasion; scaffold65 indexed_genome mRNA 4546970 4558612 . - . ID=transcript_10997;O60565 Q52LV3 Q8N914 Q8N936,Gremlin-1,Cell proliferation-inducing gene 2 protein;Cysteine knot superfamily 1, BMP antagonist 1;DAN domain family member 2;Down-regulated in Mos-transformed cells protein;Increased in high glucose protein 2 {ECO:0000303|PubMed:10744662};, PF03045;, GO:0009986;GO:0062023;GO:0005615;GO:0036122;GO:0005125;GO:0016015;GO:0042803;GO:0048018;GO:0030297;GO:0043184;GO:0009887;GO:0006915;GO:0002042;GO:0000902;GO:0007267;GO:0030199;GO:0048263;GO:0030326;GO:0060173;GO:0003337;GO:0043066;GO:0030514;GO:0030502;GO:1900158;GO:0046851;GO:1900155;GO:0090090;GO:0030308;GO:0032331;GO:0090027;GO:0045668;GO:0033689;GO:0090291;GO:0060394;GO:0045892;GO:0045766;GO:0090190;GO:2000727;GO:0008284;GO:0051092;GO:1901224;GO:1900086;GO:0002092;GO:2000273;GO:0051973;GO:0045944;GO:0003257;GO:0009954;GO:0010717;GO:0051893;GO:0038098;GO:0007165;GO:0060676;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular space;, F:BMP binding; F:cytokine activity; F:morphogen activity; F:protein homodimerization activity; F:receptor ligand activity; F:transmembrane receptor protein tyrosine kinase activator activity; F:vascular endothelial growth factor receptor 2 binding;, P:animal organ morphogenesis; P:apoptotic process; P:cell migration involved in sprouting angiogenesis; P:cell morphogenesis; P:cell-cell signaling; P:collagen fibril organization; P:determination of dorsal identity; P:embryonic limb morphogenesis; P:limb development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of BMP signaling pathway; P:negative regulation of bone mineralization; P:negative regulation of bone mineralization involved in bone maturation; P:negative regulation of bone remodeling; P:negative regulation of bone trabecula formation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:negative regulation of chondrocyte differentiation; P:negative regulation of monocyte chemotaxis; P:negative regulation of osteoblast differentiation; P:negative regulation of osteoblast proliferation; P:negative regulation of osteoclast proliferation; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of angiogenesis; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of peptidyl-tyrosine autophosphorylation; P:positive regulation of receptor internalization; P:positive regulation of signaling receptor activity; P:positive regulation of telomerase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:proximal/distal pattern formation; P:regulation of epithelial to mesenchymal transition; P:regulation of focal adhesion assembly; P:sequestering of BMP from receptor via BMP binding; P:signal transduction; P:ureteric bud formation; scaffold65 indexed_genome mRNA 4584581 4640659 . - . ID=transcript_10998;P05408 P01164 Q6FHD0 Q9BS38,Neuroendocrine protein 7B2,Pituitary polypeptide;Secretogranin V;Secretogranin-5;Secretory granule endocrine protein I;, PF05281;, GO:0005576;GO:0030141;GO:0004857;GO:0030234;GO:0005525;GO:0051082;GO:0006886;GO:0007218;GO:0016486;GO:0046883;, C:extracellular region; C:secretory granule;, F:enzyme inhibitor activity; F:enzyme regulator activity; F:GTP binding; F:unfolded protein binding;, P:intracellular protein transport; P:neuropeptide signaling pathway; P:peptide hormone processing; P:regulation of hormone secretion;|P05408 P01164 Q6FHD0 Q9BS38,Neuroendocrine protein 7B2,Pituitary polypeptide;Secretogranin V;Secretogranin-5;Secretory granule endocrine protein I;, PF05281;, GO:0005576;GO:0030141;GO:0004857;GO:0030234;GO:0005525;GO:0051082;GO:0006886;GO:0007218;GO:0016486;GO:0046883;, C:extracellular region; C:secretory granule;, F:enzyme inhibitor activity; F:enzyme regulator activity; F:GTP binding; F:unfolded protein binding;, P:intracellular protein transport; P:neuropeptide signaling pathway; P:peptide hormone processing; P:regulation of hormone secretion;|P05408 P01164 Q6FHD0 Q9BS38,Neuroendocrine protein 7B2,Pituitary polypeptide;Secretogranin V;Secretogranin-5;Secretory granule endocrine protein I;, PF05281;, GO:0005576;GO:0030141;GO:0004857;GO:0030234;GO:0005525;GO:0051082;GO:0006886;GO:0007218;GO:0016486;GO:0046883;, C:extracellular region; C:secretory granule;, F:enzyme inhibitor activity; F:enzyme regulator activity; F:GTP binding; F:unfolded protein binding;, P:intracellular protein transport; P:neuropeptide signaling pathway; P:peptide hormone processing; P:regulation of hormone secretion; scaffold65 indexed_genome mRNA 4643638 4644338 . + . ID=transcript_10999;Q6P4F7 B4DZN9 Q6PI96 Q9Y3S6,Rho GTPase-activating protein 11A {ECO:0000305},Rho-type GTPase-activating protein 11A {ECO:0000305};, PF00620;, GO:0005829;GO:0005634;GO:0005096;GO:0043547;GO:0051056;GO:0007165;, C:cytosol; C:nucleus;, F:GTPase activator activity;, P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold65 indexed_genome mRNA 4840872 4846903 . - . ID=transcript_11000;P68133 P02568 P99020 Q5T8M9,Actin, alpha skeletal muscle,Alpha-actin-1;, PF00022;, GO:0015629;GO:0005884;GO:0072562;GO:0044297;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0030027;GO:0030017;GO:0001725;GO:0005865;GO:0043531;GO:0005524;GO:0017022;GO:0005200;GO:0071417;GO:0090131;GO:0006936;GO:0030049;GO:0010628;GO:0009991;GO:0010226;GO:0009612;GO:0048545;GO:0043503;GO:0048741;GO:0030240;, C:actin cytoskeleton; C:actin filament; C:blood microparticle; C:cell body; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:lamellipodium; C:sarcomere; C:stress fiber; C:striated muscle thin filament;, F:ADP binding; F:ATP binding; F:myosin binding; F:structural constituent of cytoskeleton;, P:cellular response to organonitrogen compound; P:mesenchyme migration; P:muscle contraction; P:muscle filament sliding; P:positive regulation of gene expression; P:response to extracellular stimulus; P:response to lithium ion; P:response to mechanical stimulus; P:response to steroid hormone; P:skeletal muscle fiber adaptation; P:skeletal muscle fiber development; P:skeletal muscle thin filament assembly;|P62736 B2R8A4 P03996 P04108 Q6FI19,Actin, aortic smooth muscle,Alpha-actin-2;Cell growth-inhibiting gene 46 protein;, PF00022;, GO:0044297;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0030027;GO:0032991;GO:0030485;GO:0005524;GO:0019901;GO:0072144;GO:0090131;GO:0006936;GO:0010628;GO:0045893;GO:0008217;GO:0009615;GO:0014829;, C:cell body; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:lamellipodium; C:protein-containing complex; C:smooth muscle contractile fiber;, F:ATP binding; F:protein kinase binding;, P:glomerular mesangial cell development; P:mesenchyme migration; P:muscle contraction; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:regulation of blood pressure; P:response to virus; P:vascular associated smooth muscle contraction;|P68032 P04270,Actin, alpha cardiac muscle 1,Alpha-cardiac actin;, PF00022;, GO:0005884;GO:0072562;GO:0044297;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0031674;GO:0030027;GO:0016020;GO:0030017;GO:0005524;GO:0016887;GO:0017022;GO:0007015;GO:0030048;GO:0033275;GO:0031032;GO:0060048;GO:0055008;GO:0055003;GO:0060047;GO:0090131;GO:0030049;GO:0010628;GO:0042493;GO:0045471;GO:0030240;, C:actin filament; C:blood microparticle; C:cell body; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:I band; C:lamellipodium; C:membrane; C:sarcomere;, F:ATP binding; F:ATPase activity; F:myosin binding;, P:actin filament organization; P:actin filament-based movement; P:actin-myosin filament sliding; P:actomyosin structure organization; P:cardiac muscle contraction; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:heart contraction; P:mesenchyme migration; P:muscle filament sliding; P:positive regulation of gene expression; P:response to drug; P:response to ethanol; P:skeletal muscle thin filament assembly;|P68032 P04270,Actin, alpha cardiac muscle 1,Alpha-cardiac actin;, PF00022;, GO:0005884;GO:0072562;GO:0044297;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0031674;GO:0030027;GO:0016020;GO:0030017;GO:0005524;GO:0016887;GO:0017022;GO:0007015;GO:0030048;GO:0033275;GO:0031032;GO:0060048;GO:0055008;GO:0055003;GO:0060047;GO:0090131;GO:0030049;GO:0010628;GO:0042493;GO:0045471;GO:0030240;, C:actin filament; C:blood microparticle; C:cell body; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:I band; C:lamellipodium; C:membrane; C:sarcomere;, F:ATP binding; F:ATPase activity; F:myosin binding;, P:actin filament organization; P:actin filament-based movement; P:actin-myosin filament sliding; P:actomyosin structure organization; P:cardiac muscle contraction; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:heart contraction; P:mesenchyme migration; P:muscle filament sliding; P:positive regulation of gene expression; P:response to drug; P:response to ethanol; P:skeletal muscle thin filament assembly; scaffold65 indexed_genome mRNA 4908589 4990161 . - . ID=transcript_11001;O60306 A0JP17 A5YKK3 Q2YDX9 Q6IRU8 Q6PIC8,RNA helicase aquarius {ECO:0000303|PubMed:25599396},Intron-binding protein of 160 kDa {ECO:0000303|PubMed:16949364};, PF13086;PF13087;PF16399;, GO:0071013;GO:0016020;GO:0005654;GO:0005634;GO:0071007;GO:0034458;GO:0005524;GO:0003729;GO:0003723;GO:0003727;GO:0000398;GO:0006283;, C:catalytic step 2 spliceosome; C:membrane; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 2 spliceosome;, F:3'-5' RNA helicase activity; F:ATP binding; F:mRNA binding; F:RNA binding; F:single-stranded RNA binding;, P:mRNA splicing, via spliceosome; P:transcription-coupled nucleotide-excision repair; scaffold65 indexed_genome mRNA 4997508 5006670 . - . ID=transcript_11002;Q6IQ21 Q6ZMZ6 Q9NWV2,Zinc finger protein 770,, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold65 indexed_genome mRNA 5373665 5536383 . - . ID=transcript_11003;Q7L8W6 B3KWG1 Q96HJ6,Diphthine--ammonia ligase,ATP-binding domain-containing protein 4;Diphthamide synthase;Diphthamide synthetase;Protein DPH6 homolog;, PF01902;, GO:0005829;GO:0005730;GO:0005654;GO:0005524;GO:0017178;GO:0017183;, C:cytosol; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:diphthine-ammonia ligase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; scaffold65 indexed_genome mRNA 6693894 6919468 . + . ID=transcript_11004;Q9Y2V0 B2RD87,CDAN1-interacting nuclease 1 {ECO:0000312|HGNC:HGNC:26929},Protein HH114;, PF14811;, GO:0005737;GO:0005634;GO:0030218;, C:cytoplasm; C:nucleus;, , P:erythrocyte differentiation; scaffold65 indexed_genome mRNA 6989710 7207618 . - . ID=transcript_11005;Q9NRS2 Q9NRS3,Homeobox protein Meis2,Meis1-related protein 1;, PF05920;PF16493;, GO:0000785;GO:0005634;GO:0048471;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0009887;GO:0007420;GO:0009880;GO:0001654;GO:0045638;GO:0000122;GO:0031016;GO:0110024;GO:0008284;GO:0045931;GO:0045944;GO:0006357;GO:0070848;GO:0009612;GO:0008542;, C:chromatin; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:animal organ morphogenesis; P:brain development; P:embryonic pattern specification; P:eye development; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:pancreas development; P:positive regulation of cardiac muscle myoblast proliferation; P:positive regulation of cell population proliferation; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to growth factor; P:response to mechanical stimulus; P:visual learning; scaffold65 indexed_genome mRNA 8208827 8321030 . + . ID=transcript_11006;Q7Z699 B2RPJ8 Q05D53 Q8N256,Sprouty-related, EVH1 domain-containing protein 1,, PF05210;PF00568;, GO:0005901;GO:0005829;GO:0005654;GO:0005886;GO:0019902;GO:0019901;GO:0030291;GO:0005173;GO:0008543;GO:0000188;GO:0000165;GO:0016525;GO:0090051;GO:0010719;GO:0070373;GO:1902747;GO:0043409;GO:0010801;GO:0010923;GO:0006469;GO:0030512;GO:0043517;GO:0043408;GO:0090311;GO:0060979;, C:caveola; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:phosphatase binding; F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; F:stem cell factor receptor binding;, P:fibroblast growth factor receptor signaling pathway; P:inactivation of MAPK activity; P:MAPK cascade; P:negative regulation of angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of lens fiber cell differentiation; P:negative regulation of MAPK cascade; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of phosphatase activity; P:negative regulation of protein kinase activity; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of MAPK cascade; P:regulation of protein deacetylation; P:vasculogenesis involved in coronary vascular morphogenesis; scaffold65 indexed_genome mRNA 8412839 8442284 . + . ID=transcript_11007;Q52LJ0 A8MUW5 Q8N935,Protein FAM98B,, PF10239;, GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0072669;GO:0042802;GO:0008276;GO:0003723;GO:0008284;GO:0010628;GO:0006479;GO:0006388;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:tRNA-splicing ligase complex;, F:identical protein binding; F:protein methyltransferase activity; F:RNA binding;, P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:protein methylation; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold65 indexed_genome mRNA 8447924 8527454 . - . ID=transcript_11008;Q9UNN9,RAS guanyl-releasing protein 1,Calcium and DAG-regulated guanine nucleotide exchange factor II;Ras guanyl-releasing protein;, PF00130;PF13405;PF00617;PF00618;, GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0016020;GO:0005886;GO:0005509;GO:0019992;GO:0005085;GO:0042802;GO:0008289;GO:0031210;GO:0008270;GO:0090630;GO:0002250;GO:0042113;GO:0042100;GO:0030154;GO:0000165;GO:0030101;GO:0070374;GO:0032725;GO:0043547;GO:0032729;GO:0046330;GO:0043406;GO:0045954;GO:0001934;GO:0046579;GO:0032760;GO:0007265;GO:0070372;GO:0007165;GO:0042110;GO:0042098;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:diacylglycerol binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:lipid binding; F:phosphatidylcholine binding; F:zinc ion binding;, P:activation of GTPase activity; P:adaptive immune response; P:B cell activation; P:B cell proliferation; P:cell differentiation; P:MAPK cascade; P:natural killer cell activation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of GTPase activity; P:positive regulation of interferon-gamma production; P:positive regulation of JNK cascade; P:positive regulation of MAP kinase activity; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of tumor necrosis factor production; P:Ras protein signal transduction; P:regulation of ERK1 and ERK2 cascade; P:signal transduction; P:T cell activation; P:T cell proliferation;|Q9UNN9,RAS guanyl-releasing protein 1,Calcium and DAG-regulated guanine nucleotide exchange factor II;Ras guanyl-releasing protein;, PF00130;PF13405;PF00617;PF00618;, GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0016020;GO:0005886;GO:0005509;GO:0019992;GO:0005085;GO:0042802;GO:0008289;GO:0031210;GO:0008270;GO:0090630;GO:0002250;GO:0042113;GO:0042100;GO:0030154;GO:0000165;GO:0030101;GO:0070374;GO:0032725;GO:0043547;GO:0032729;GO:0046330;GO:0043406;GO:0045954;GO:0001934;GO:0046579;GO:0032760;GO:0007265;GO:0070372;GO:0007165;GO:0042110;GO:0042098;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:diacylglycerol binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:lipid binding; F:phosphatidylcholine binding; F:zinc ion binding;, P:activation of GTPase activity; P:adaptive immune response; P:B cell activation; P:B cell proliferation; P:cell differentiation; P:MAPK cascade; P:natural killer cell activation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of GTPase activity; P:positive regulation of interferon-gamma production; P:positive regulation of JNK cascade; P:positive regulation of MAP kinase activity; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of tumor necrosis factor production; P:Ras protein signal transduction; P:regulation of ERK1 and ERK2 cascade; P:signal transduction; P:T cell activation; P:T cell proliferation;|Q9UNN9,RAS guanyl-releasing protein 1,Calcium and DAG-regulated guanine nucleotide exchange factor II;Ras guanyl-releasing protein;, PF00130;PF13405;PF00617;PF00618;, GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0016020;GO:0005886;GO:0005509;GO:0019992;GO:0005085;GO:0042802;GO:0008289;GO:0031210;GO:0008270;GO:0090630;GO:0002250;GO:0042113;GO:0042100;GO:0030154;GO:0000165;GO:0030101;GO:0070374;GO:0032725;GO:0043547;GO:0032729;GO:0046330;GO:0043406;GO:0045954;GO:0001934;GO:0046579;GO:0032760;GO:0007265;GO:0070372;GO:0007165;GO:0042110;GO:0042098;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:diacylglycerol binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:lipid binding; F:phosphatidylcholine binding; F:zinc ion binding;, P:activation of GTPase activity; P:adaptive immune response; P:B cell activation; P:B cell proliferation; P:cell differentiation; P:MAPK cascade; P:natural killer cell activation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of GTPase activity; P:positive regulation of interferon-gamma production; P:positive regulation of JNK cascade; P:positive regulation of MAP kinase activity; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of tumor necrosis factor production; P:Ras protein signal transduction; P:regulation of ERK1 and ERK2 cascade; P:signal transduction; P:T cell activation; P:T cell proliferation;|Q9UNN9,RAS guanyl-releasing protein 1,Calcium and DAG-regulated guanine nucleotide exchange factor II;Ras guanyl-releasing protein;, PF00130;PF13405;PF00617;PF00618;, GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0016020;GO:0005886;GO:0005509;GO:0019992;GO:0005085;GO:0042802;GO:0008289;GO:0031210;GO:0008270;GO:0090630;GO:0002250;GO:0042113;GO:0042100;GO:0030154;GO:0000165;GO:0030101;GO:0070374;GO:0032725;GO:0043547;GO:0032729;GO:0046330;GO:0043406;GO:0045954;GO:0001934;GO:0046579;GO:0032760;GO:0007265;GO:0070372;GO:0007165;GO:0042110;GO:0042098;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:diacylglycerol binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:lipid binding; F:phosphatidylcholine binding; F:zinc ion binding;, P:activation of GTPase activity; P:adaptive immune response; P:B cell activation; P:B cell proliferation; P:cell differentiation; P:MAPK cascade; P:natural killer cell activation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of GTPase activity; P:positive regulation of interferon-gamma production; P:positive regulation of JNK cascade; P:positive regulation of MAP kinase activity; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of tumor necrosis factor production; P:Ras protein signal transduction; P:regulation of ERK1 and ERK2 cascade; P:signal transduction; P:T cell activation; P:T cell proliferation;|Q9UNN9,RAS guanyl-releasing protein 1,Calcium and DAG-regulated guanine nucleotide exchange factor II;Ras guanyl-releasing protein;, PF00130;PF13405;PF00617;PF00618;, GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0016020;GO:0005886;GO:0005509;GO:0019992;GO:0005085;GO:0042802;GO:0008289;GO:0031210;GO:0008270;GO:0090630;GO:0002250;GO:0042113;GO:0042100;GO:0030154;GO:0000165;GO:0030101;GO:0070374;GO:0032725;GO:0043547;GO:0032729;GO:0046330;GO:0043406;GO:0045954;GO:0001934;GO:0046579;GO:0032760;GO:0007265;GO:0070372;GO:0007165;GO:0042110;GO:0042098;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:diacylglycerol binding; F:guanyl-nucleotide exchange factor activity; F:identical protein binding; F:lipid binding; F:phosphatidylcholine binding; F:zinc ion binding;, P:activation of GTPase activity; P:adaptive immune response; P:B cell activation; P:B cell proliferation; P:cell differentiation; P:MAPK cascade; P:natural killer cell activation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of GTPase activity; P:positive regulation of interferon-gamma production; P:positive regulation of JNK cascade; P:positive regulation of MAP kinase activity; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of tumor necrosis factor production; P:Ras protein signal transduction; P:regulation of ERK1 and ERK2 cascade; P:signal transduction; P:T cell activation; P:T cell proliferation; scaffold65 indexed_genome mRNA 9509028 9524391 . + . ID=transcript_11009;P07996 A8K6H4 B4E3J7 B9EGH6 Q15667 Q59E99,Thrombospondin-1,Glycoprotein G {ECO:0000303|PubMed:6777381};, PF00090;PF02412;PF05735;PF00093;, GO:0009986;GO:0062023;GO:0005783;GO:0005788;GO:0009897;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031091;GO:0031093;GO:0016529;GO:0030141;GO:0005509;GO:0070052;GO:0005201;GO:0070051;GO:0017134;GO:0001968;GO:0008201;GO:0042802;GO:0005178;GO:0043236;GO:0030169;GO:0001786;GO:0043394;GO:0050431;GO:0000187;GO:0048266;GO:0007155;GO:0007050;GO:0016477;GO:0071363;GO:0034605;GO:0071356;GO:0002544;GO:0043652;GO:0030198;GO:0006955;GO:0006954;GO:0016525;GO:0002581;GO:0043066;GO:0043537;GO:1903588;GO:0090051;GO:0001953;GO:0010754;GO:0043154;GO:0002605;GO:2001027;GO:0010596;GO:0001937;GO:2001237;GO:0051918;GO:0040037;GO:0051895;GO:0032695;GO:0010748;GO:0010751;GO:0010757;GO:1903671;GO:0018149;GO:0002576;GO:0045766;GO:0030194;GO:0043536;GO:0030335;GO:0008284;GO:0050921;GO:2000353;GO:0010595;GO:1902043;GO:0010763;GO:0043032;GO:0010759;GO:0042327;GO:0051897;GO:2000379;GO:0048661;GO:0030511;GO:0032914;GO:0045727;GO:0032760;GO:0045652;GO:0051592;GO:0042493;GO:0034976;GO:0009749;GO:0001666;GO:0032026;GO:0009612;GO:0032570;GO:0033574;GO:0006986;GO:0002040;, C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule; C:platelet alpha granule lumen; C:sarcoplasmic reticulum; C:secretory granule;, F:calcium ion binding; F:collagen V binding; F:extracellular matrix structural constituent; F:fibrinogen binding; F:fibroblast growth factor binding; F:fibronectin binding; F:heparin binding; F:identical protein binding; F:integrin binding; F:laminin binding; F:low-density lipoprotein particle binding; F:phosphatidylserine binding; F:proteoglycan binding; F:transforming growth factor beta binding;, P:activation of MAPK activity; P:behavioral response to pain; P:cell adhesion; P:cell cycle arrest; P:cell migration; P:cellular response to growth factor stimulus; P:cellular response to heat; P:cellular response to tumor necrosis factor; P:chronic inflammatory response; P:engulfment of apoptotic cell; P:extracellular matrix organization; P:immune response; P:inflammatory response; P:negative regulation of angiogenesis; P:negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; P:negative regulation of apoptotic process; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell-matrix adhesion; P:negative regulation of cGMP-mediated signaling; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell antigen processing and presentation; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fibrinolysis; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of focal adhesion assembly; P:negative regulation of interleukin-12 production; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of nitric oxide mediated signal transduction; P:negative regulation of plasminogen activation; P:negative regulation of sprouting angiogenesis; P:peptide cross-linking; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of fibroblast migration; P:positive regulation of macrophage activation; P:positive regulation of macrophage chemotaxis; P:positive regulation of phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of transforming growth factor beta1 production; P:positive regulation of translation; P:positive regulation of tumor necrosis factor production; P:regulation of megakaryocyte differentiation; P:response to calcium ion; P:response to drug; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to hypoxia; P:response to magnesium ion; P:response to mechanical stimulus; P:response to progesterone; P:response to testosterone; P:response to unfolded protein; P:sprouting angiogenesis;|P07996 A8K6H4 B4E3J7 B9EGH6 Q15667 Q59E99,Thrombospondin-1,Glycoprotein G {ECO:0000303|PubMed:6777381};, PF00090;PF02412;PF05735;PF00093;, GO:0009986;GO:0062023;GO:0005783;GO:0005788;GO:0009897;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031091;GO:0031093;GO:0016529;GO:0030141;GO:0005509;GO:0070052;GO:0005201;GO:0070051;GO:0017134;GO:0001968;GO:0008201;GO:0042802;GO:0005178;GO:0043236;GO:0030169;GO:0001786;GO:0043394;GO:0050431;GO:0000187;GO:0048266;GO:0007155;GO:0007050;GO:0016477;GO:0071363;GO:0034605;GO:0071356;GO:0002544;GO:0043652;GO:0030198;GO:0006955;GO:0006954;GO:0016525;GO:0002581;GO:0043066;GO:0043537;GO:1903588;GO:0090051;GO:0001953;GO:0010754;GO:0043154;GO:0002605;GO:2001027;GO:0010596;GO:0001937;GO:2001237;GO:0051918;GO:0040037;GO:0051895;GO:0032695;GO:0010748;GO:0010751;GO:0010757;GO:1903671;GO:0018149;GO:0002576;GO:0045766;GO:0030194;GO:0043536;GO:0030335;GO:0008284;GO:0050921;GO:2000353;GO:0010595;GO:1902043;GO:0010763;GO:0043032;GO:0010759;GO:0042327;GO:0051897;GO:2000379;GO:0048661;GO:0030511;GO:0032914;GO:0045727;GO:0032760;GO:0045652;GO:0051592;GO:0042493;GO:0034976;GO:0009749;GO:0001666;GO:0032026;GO:0009612;GO:0032570;GO:0033574;GO:0006986;GO:0002040;, C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule; C:platelet alpha granule lumen; C:sarcoplasmic reticulum; C:secretory granule;, F:calcium ion binding; F:collagen V binding; F:extracellular matrix structural constituent; F:fibrinogen binding; F:fibroblast growth factor binding; F:fibronectin binding; F:heparin binding; F:identical protein binding; F:integrin binding; F:laminin binding; F:low-density lipoprotein particle binding; F:phosphatidylserine binding; F:proteoglycan binding; F:transforming growth factor beta binding;, P:activation of MAPK activity; P:behavioral response to pain; P:cell adhesion; P:cell cycle arrest; P:cell migration; P:cellular response to growth factor stimulus; P:cellular response to heat; P:cellular response to tumor necrosis factor; P:chronic inflammatory response; P:engulfment of apoptotic cell; P:extracellular matrix organization; P:immune response; P:inflammatory response; P:negative regulation of angiogenesis; P:negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; P:negative regulation of apoptotic process; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell-matrix adhesion; P:negative regulation of cGMP-mediated signaling; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell antigen processing and presentation; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fibrinolysis; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of focal adhesion assembly; P:negative regulation of interleukin-12 production; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of nitric oxide mediated signal transduction; P:negative regulation of plasminogen activation; P:negative regulation of sprouting angiogenesis; P:peptide cross-linking; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of fibroblast migration; P:positive regulation of macrophage activation; P:positive regulation of macrophage chemotaxis; P:positive regulation of phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of transforming growth factor beta1 production; P:positive regulation of translation; P:positive regulation of tumor necrosis factor production; P:regulation of megakaryocyte differentiation; P:response to calcium ion; P:response to drug; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to hypoxia; P:response to magnesium ion; P:response to mechanical stimulus; P:response to progesterone; P:response to testosterone; P:response to unfolded protein; P:sprouting angiogenesis;|P07996 A8K6H4 B4E3J7 B9EGH6 Q15667 Q59E99,Thrombospondin-1,Glycoprotein G {ECO:0000303|PubMed:6777381};, PF00090;PF02412;PF05735;PF00093;, GO:0009986;GO:0062023;GO:0005783;GO:0005788;GO:0009897;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031091;GO:0031093;GO:0016529;GO:0030141;GO:0005509;GO:0070052;GO:0005201;GO:0070051;GO:0017134;GO:0001968;GO:0008201;GO:0042802;GO:0005178;GO:0043236;GO:0030169;GO:0001786;GO:0043394;GO:0050431;GO:0000187;GO:0048266;GO:0007155;GO:0007050;GO:0016477;GO:0071363;GO:0034605;GO:0071356;GO:0002544;GO:0043652;GO:0030198;GO:0006955;GO:0006954;GO:0016525;GO:0002581;GO:0043066;GO:0043537;GO:1903588;GO:0090051;GO:0001953;GO:0010754;GO:0043154;GO:0002605;GO:2001027;GO:0010596;GO:0001937;GO:2001237;GO:0051918;GO:0040037;GO:0051895;GO:0032695;GO:0010748;GO:0010751;GO:0010757;GO:1903671;GO:0018149;GO:0002576;GO:0045766;GO:0030194;GO:0043536;GO:0030335;GO:0008284;GO:0050921;GO:2000353;GO:0010595;GO:1902043;GO:0010763;GO:0043032;GO:0010759;GO:0042327;GO:0051897;GO:2000379;GO:0048661;GO:0030511;GO:0032914;GO:0045727;GO:0032760;GO:0045652;GO:0051592;GO:0042493;GO:0034976;GO:0009749;GO:0001666;GO:0032026;GO:0009612;GO:0032570;GO:0033574;GO:0006986;GO:0002040;, C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule; C:platelet alpha granule lumen; C:sarcoplasmic reticulum; C:secretory granule;, F:calcium ion binding; F:collagen V binding; F:extracellular matrix structural constituent; F:fibrinogen binding; F:fibroblast growth factor binding; F:fibronectin binding; F:heparin binding; F:identical protein binding; F:integrin binding; F:laminin binding; F:low-density lipoprotein particle binding; F:phosphatidylserine binding; F:proteoglycan binding; F:transforming growth factor beta binding;, P:activation of MAPK activity; P:behavioral response to pain; P:cell adhesion; P:cell cycle arrest; P:cell migration; P:cellular response to growth factor stimulus; P:cellular response to heat; P:cellular response to tumor necrosis factor; P:chronic inflammatory response; P:engulfment of apoptotic cell; P:extracellular matrix organization; P:immune response; P:inflammatory response; P:negative regulation of angiogenesis; P:negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; P:negative regulation of apoptotic process; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell-matrix adhesion; P:negative regulation of cGMP-mediated signaling; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell antigen processing and presentation; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fibrinolysis; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of focal adhesion assembly; P:negative regulation of interleukin-12 production; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of nitric oxide mediated signal transduction; P:negative regulation of plasminogen activation; P:negative regulation of sprouting angiogenesis; P:peptide cross-linking; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of fibroblast migration; P:positive regulation of macrophage activation; P:positive regulation of macrophage chemotaxis; P:positive regulation of phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of transforming growth factor beta1 production; P:positive regulation of translation; P:positive regulation of tumor necrosis factor production; P:regulation of megakaryocyte differentiation; P:response to calcium ion; P:response to drug; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to hypoxia; P:response to magnesium ion; P:response to mechanical stimulus; P:response to progesterone; P:response to testosterone; P:response to unfolded protein; P:sprouting angiogenesis;|P07996 A8K6H4 B4E3J7 B9EGH6 Q15667 Q59E99,Thrombospondin-1,Glycoprotein G {ECO:0000303|PubMed:6777381};, PF00090;PF02412;PF05735;PF00093;, GO:0009986;GO:0062023;GO:0005783;GO:0005788;GO:0009897;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031091;GO:0031093;GO:0016529;GO:0030141;GO:0005509;GO:0070052;GO:0005201;GO:0070051;GO:0017134;GO:0001968;GO:0008201;GO:0042802;GO:0005178;GO:0043236;GO:0030169;GO:0001786;GO:0043394;GO:0050431;GO:0000187;GO:0048266;GO:0007155;GO:0007050;GO:0016477;GO:0071363;GO:0034605;GO:0071356;GO:0002544;GO:0043652;GO:0030198;GO:0006955;GO:0006954;GO:0016525;GO:0002581;GO:0043066;GO:0043537;GO:1903588;GO:0090051;GO:0001953;GO:0010754;GO:0043154;GO:0002605;GO:2001027;GO:0010596;GO:0001937;GO:2001237;GO:0051918;GO:0040037;GO:0051895;GO:0032695;GO:0010748;GO:0010751;GO:0010757;GO:1903671;GO:0018149;GO:0002576;GO:0045766;GO:0030194;GO:0043536;GO:0030335;GO:0008284;GO:0050921;GO:2000353;GO:0010595;GO:1902043;GO:0010763;GO:0043032;GO:0010759;GO:0042327;GO:0051897;GO:2000379;GO:0048661;GO:0030511;GO:0032914;GO:0045727;GO:0032760;GO:0045652;GO:0051592;GO:0042493;GO:0034976;GO:0009749;GO:0001666;GO:0032026;GO:0009612;GO:0032570;GO:0033574;GO:0006986;GO:0002040;, C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule; C:platelet alpha granule lumen; C:sarcoplasmic reticulum; C:secretory granule;, F:calcium ion binding; F:collagen V binding; F:extracellular matrix structural constituent; F:fibrinogen binding; F:fibroblast growth factor binding; F:fibronectin binding; F:heparin binding; F:identical protein binding; F:integrin binding; F:laminin binding; F:low-density lipoprotein particle binding; F:phosphatidylserine binding; F:proteoglycan binding; F:transforming growth factor beta binding;, P:activation of MAPK activity; P:behavioral response to pain; P:cell adhesion; P:cell cycle arrest; P:cell migration; P:cellular response to growth factor stimulus; P:cellular response to heat; P:cellular response to tumor necrosis factor; P:chronic inflammatory response; P:engulfment of apoptotic cell; P:extracellular matrix organization; P:immune response; P:inflammatory response; P:negative regulation of angiogenesis; P:negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; P:negative regulation of apoptotic process; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell-matrix adhesion; P:negative regulation of cGMP-mediated signaling; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell antigen processing and presentation; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fibrinolysis; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of focal adhesion assembly; P:negative regulation of interleukin-12 production; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of nitric oxide mediated signal transduction; P:negative regulation of plasminogen activation; P:negative regulation of sprouting angiogenesis; P:peptide cross-linking; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of fibroblast migration; P:positive regulation of macrophage activation; P:positive regulation of macrophage chemotaxis; P:positive regulation of phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of transforming growth factor beta1 production; P:positive regulation of translation; P:positive regulation of tumor necrosis factor production; P:regulation of megakaryocyte differentiation; P:response to calcium ion; P:response to drug; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to hypoxia; P:response to magnesium ion; P:response to mechanical stimulus; P:response to progesterone; P:response to testosterone; P:response to unfolded protein; P:sprouting angiogenesis;|P07996 A8K6H4 B4E3J7 B9EGH6 Q15667 Q59E99,Thrombospondin-1,Glycoprotein G {ECO:0000303|PubMed:6777381};, PF00090;PF02412;PF05735;PF00093;, GO:0009986;GO:0062023;GO:0005783;GO:0005788;GO:0009897;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031091;GO:0031093;GO:0016529;GO:0030141;GO:0005509;GO:0070052;GO:0005201;GO:0070051;GO:0017134;GO:0001968;GO:0008201;GO:0042802;GO:0005178;GO:0043236;GO:0030169;GO:0001786;GO:0043394;GO:0050431;GO:0000187;GO:0048266;GO:0007155;GO:0007050;GO:0016477;GO:0071363;GO:0034605;GO:0071356;GO:0002544;GO:0043652;GO:0030198;GO:0006955;GO:0006954;GO:0016525;GO:0002581;GO:0043066;GO:0043537;GO:1903588;GO:0090051;GO:0001953;GO:0010754;GO:0043154;GO:0002605;GO:2001027;GO:0010596;GO:0001937;GO:2001237;GO:0051918;GO:0040037;GO:0051895;GO:0032695;GO:0010748;GO:0010751;GO:0010757;GO:1903671;GO:0018149;GO:0002576;GO:0045766;GO:0030194;GO:0043536;GO:0030335;GO:0008284;GO:0050921;GO:2000353;GO:0010595;GO:1902043;GO:0010763;GO:0043032;GO:0010759;GO:0042327;GO:0051897;GO:2000379;GO:0048661;GO:0030511;GO:0032914;GO:0045727;GO:0032760;GO:0045652;GO:0051592;GO:0042493;GO:0034976;GO:0009749;GO:0001666;GO:0032026;GO:0009612;GO:0032570;GO:0033574;GO:0006986;GO:0002040;, C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule; C:platelet alpha granule lumen; C:sarcoplasmic reticulum; C:secretory granule;, F:calcium ion binding; F:collagen V binding; F:extracellular matrix structural constituent; F:fibrinogen binding; F:fibroblast growth factor binding; F:fibronectin binding; F:heparin binding; F:identical protein binding; F:integrin binding; F:laminin binding; F:low-density lipoprotein particle binding; F:phosphatidylserine binding; F:proteoglycan binding; F:transforming growth factor beta binding;, P:activation of MAPK activity; P:behavioral response to pain; P:cell adhesion; P:cell cycle arrest; P:cell migration; P:cellular response to growth factor stimulus; P:cellular response to heat; P:cellular response to tumor necrosis factor; P:chronic inflammatory response; P:engulfment of apoptotic cell; P:extracellular matrix organization; P:immune response; P:inflammatory response; P:negative regulation of angiogenesis; P:negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; P:negative regulation of apoptotic process; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell-matrix adhesion; P:negative regulation of cGMP-mediated signaling; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell antigen processing and presentation; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fibrinolysis; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of focal adhesion assembly; P:negative regulation of interleukin-12 production; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of nitric oxide mediated signal transduction; P:negative regulation of plasminogen activation; P:negative regulation of sprouting angiogenesis; P:peptide cross-linking; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of fibroblast migration; P:positive regulation of macrophage activation; P:positive regulation of macrophage chemotaxis; P:positive regulation of phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of transforming growth factor beta1 production; P:positive regulation of translation; P:positive regulation of tumor necrosis factor production; P:regulation of megakaryocyte differentiation; P:response to calcium ion; P:response to drug; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to hypoxia; P:response to magnesium ion; P:response to mechanical stimulus; P:response to progesterone; P:response to testosterone; P:response to unfolded protein; P:sprouting angiogenesis;|P07996 A8K6H4 B4E3J7 B9EGH6 Q15667 Q59E99,Thrombospondin-1,Glycoprotein G {ECO:0000303|PubMed:6777381};, PF00090;PF02412;PF05735;PF00093;, GO:0009986;GO:0062023;GO:0005783;GO:0005788;GO:0009897;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005577;GO:0031091;GO:0031093;GO:0016529;GO:0030141;GO:0005509;GO:0070052;GO:0005201;GO:0070051;GO:0017134;GO:0001968;GO:0008201;GO:0042802;GO:0005178;GO:0043236;GO:0030169;GO:0001786;GO:0043394;GO:0050431;GO:0000187;GO:0048266;GO:0007155;GO:0007050;GO:0016477;GO:0071363;GO:0034605;GO:0071356;GO:0002544;GO:0043652;GO:0030198;GO:0006955;GO:0006954;GO:0016525;GO:0002581;GO:0043066;GO:0043537;GO:1903588;GO:0090051;GO:0001953;GO:0010754;GO:0043154;GO:0002605;GO:2001027;GO:0010596;GO:0001937;GO:2001237;GO:0051918;GO:0040037;GO:0051895;GO:0032695;GO:0010748;GO:0010751;GO:0010757;GO:1903671;GO:0018149;GO:0002576;GO:0045766;GO:0030194;GO:0043536;GO:0030335;GO:0008284;GO:0050921;GO:2000353;GO:0010595;GO:1902043;GO:0010763;GO:0043032;GO:0010759;GO:0042327;GO:0051897;GO:2000379;GO:0048661;GO:0030511;GO:0032914;GO:0045727;GO:0032760;GO:0045652;GO:0051592;GO:0042493;GO:0034976;GO:0009749;GO:0001666;GO:0032026;GO:0009612;GO:0032570;GO:0033574;GO:0006986;GO:0002040;, C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:fibrinogen complex; C:platelet alpha granule; C:platelet alpha granule lumen; C:sarcoplasmic reticulum; C:secretory granule;, F:calcium ion binding; F:collagen V binding; F:extracellular matrix structural constituent; F:fibrinogen binding; F:fibroblast growth factor binding; F:fibronectin binding; F:heparin binding; F:identical protein binding; F:integrin binding; F:laminin binding; F:low-density lipoprotein particle binding; F:phosphatidylserine binding; F:proteoglycan binding; F:transforming growth factor beta binding;, P:activation of MAPK activity; P:behavioral response to pain; P:cell adhesion; P:cell cycle arrest; P:cell migration; P:cellular response to growth factor stimulus; P:cellular response to heat; P:cellular response to tumor necrosis factor; P:chronic inflammatory response; P:engulfment of apoptotic cell; P:extracellular matrix organization; P:immune response; P:inflammatory response; P:negative regulation of angiogenesis; P:negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; P:negative regulation of apoptotic process; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell-matrix adhesion; P:negative regulation of cGMP-mediated signaling; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell antigen processing and presentation; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fibrinolysis; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of focal adhesion assembly; P:negative regulation of interleukin-12 production; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of nitric oxide mediated signal transduction; P:negative regulation of plasminogen activation; P:negative regulation of sprouting angiogenesis; P:peptide cross-linking; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of endothelial cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of fibroblast migration; P:positive regulation of macrophage activation; P:positive regulation of macrophage chemotaxis; P:positive regulation of phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of transforming growth factor beta1 production; P:positive regulation of translation; P:positive regulation of tumor necrosis factor production; P:regulation of megakaryocyte differentiation; P:response to calcium ion; P:response to drug; P:response to endoplasmic reticulum stress; P:response to glucose; P:response to hypoxia; P:response to magnesium ion; P:response to mechanical stimulus; P:response to progesterone; P:response to testosterone; P:response to unfolded protein; P:sprouting angiogenesis; scaffold65 indexed_genome mRNA 9526355 9683667 . - . ID=transcript_11010;Q8NA03 Q6X2C8 Q86Y89,Fibrous sheath-interacting protein 1,, PF15554;|Q8NA03 Q6X2C8 Q86Y89,Fibrous sheath-interacting protein 1,, PF15554; scaffold65 indexed_genome mRNA 9755781 9868675 . - . ID=transcript_11011;Q14439 B4DZ23 H9NIL9 J3KNC6 Q6NXF6,G-protein coupled receptor 176,HB-954;, PF00001;, GO:0005887;GO:0005886;GO:0045202;GO:0004930;GO:0007193;GO:0007268;GO:0048512;GO:0007186;GO:0002862;, C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:G protein-coupled receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:chemical synaptic transmission; P:circadian behavior; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; scaffold65 indexed_genome mRNA 9878598 9984094 . + . ID=transcript_11012;Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|Q9P2K8 C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05},Eukaryotic translation initiation factor 2-alpha kinase 4 {ECO:0000312|HGNC:HGNC:19687};GCN2-like protein;, PF12745;PF00069;PF05773;PF13393;, GO:0005829;GO:0022626;GO:0005844;GO:0005524;GO:0004694;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000049;GO:0002250;GO:0007050;GO:0034198;GO:0070417;GO:1990253;GO:0034644;GO:0051607;GO:0000077;GO:0036492;GO:0140469;GO:0039520;GO:0007612;GO:0007616;GO:0044828;GO:0032792;GO:0045665;GO:0045947;GO:0032057;GO:1990138;GO:0002821;GO:0002230;GO:1900273;GO:0071264;GO:0046777;GO:0006468;GO:0060259;GO:0006446;GO:0010998;GO:0002286;GO:0019081;, C:cytosol; C:cytosolic ribosome; C:polysome;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tRNA binding;, P:adaptive immune response; P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to cold; P:cellular response to leucine starvation; P:cellular response to UV; P:defense response to virus; P:DNA damage checkpoint; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; P:GCN2-mediated signaling; P:induction by virus of host autophagy; P:learning; P:long-term memory; P:negative regulation by host of viral genome replication; P:negative regulation of CREB transcription factor activity; P:negative regulation of neuron differentiation; P:negative regulation of translational initiation; P:negative regulation of translational initiation in response to stress; P:neuron projection extension; P:positive regulation of adaptive immune response; P:positive regulation of defense response to virus by host; P:positive regulation of long-term synaptic potentiation; P:positive regulation of translational initiation in response to starvation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of feeding behavior; P:regulation of translational initiation; P:regulation of translational initiation by eIF2 alpha phosphorylation; P:T cell activation involved in immune response; P:viral translation;|P37108 B5BUF5 Q6B0K5 Q96Q14,Signal recognition particle 14 kDa protein,18 kDa Alu RNA-binding protein;, PF02290;, GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0005786;GO:0008312;GO:0030942;GO:0003723;GO:0006613;GO:0043312;GO:0045047;GO:0006614;, C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:RNA binding;, P:cotranslational protein targeting to membrane; P:neutrophil degranulation; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; scaffold65 indexed_genome mRNA 10027896 10048705 . - . ID=transcript_11013;Q96LC9 Q2M396 Q6NT30 Q6NT56 Q6P9F6 Q7Z7D4 Q7Z7D5 Q9H7K7,Bcl-2-modifying factor,, PF15185;, GO:0001669;GO:0005829;GO:0005741;GO:0016459;GO:0005886;GO:0043276;GO:0034644;GO:0010507;GO:0043065;GO:2001244;GO:0031334;GO:0090200;GO:0001844;, C:acrosomal vesicle; C:cytosol; C:mitochondrial outer membrane; C:myosin complex; C:plasma membrane;, , P:anoikis; P:cellular response to UV; P:negative regulation of autophagy; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; scaffold65 indexed_genome mRNA 10120818 10126903 . + . ID=transcript_11014;Q8WV50 Q96KM4,Mitotic checkpoint serine/threonine-protein kinase BUB1 beta,MAD3/BUB1-related protein kinase;Mitotic checkpoint kinase MAD3L;Protein SSK1;, PF08311;, GO:0005680;GO:0000777;GO:0000940;GO:0000778;GO:0005737;GO:0005829;GO:0000776;GO:0005815;GO:0048471;GO:0005819;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0031145;GO:0006915;GO:0051301;GO:0051754;GO:0007091;GO:0000278;GO:0007093;GO:0007094;GO:0007052;GO:0071459;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:condensed chromosome kinetochore; C:condensed chromosome outer kinetochore; C:condensed nuclear chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:spindle;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:anaphase-promoting complex-dependent catabolic process; P:apoptotic process; P:cell division; P:meiotic sister chromatid cohesion, centromeric; P:metaphase/anaphase transition of mitotic cell cycle; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to chromosome, centromeric region; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q8WV50 Q96KM4,Mitotic checkpoint serine/threonine-protein kinase BUB1 beta,MAD3/BUB1-related protein kinase;Mitotic checkpoint kinase MAD3L;Protein SSK1;, PF08311;, GO:0005680;GO:0000777;GO:0000940;GO:0000778;GO:0005737;GO:0005829;GO:0000776;GO:0005815;GO:0048471;GO:0005819;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0031145;GO:0006915;GO:0051301;GO:0051754;GO:0007091;GO:0000278;GO:0007093;GO:0007094;GO:0007052;GO:0071459;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:condensed chromosome kinetochore; C:condensed chromosome outer kinetochore; C:condensed nuclear chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:spindle;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:anaphase-promoting complex-dependent catabolic process; P:apoptotic process; P:cell division; P:meiotic sister chromatid cohesion, centromeric; P:metaphase/anaphase transition of mitotic cell cycle; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to chromosome, centromeric region; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold65 indexed_genome mRNA 10127496 10128130 . - . ID=transcript_11015;Q8WV50 Q96KM4,Mitotic checkpoint serine/threonine-protein kinase BUB1 beta,MAD3/BUB1-related protein kinase;Mitotic checkpoint kinase MAD3L;Protein SSK1;, PF08311;, GO:0005680;GO:0000777;GO:0000940;GO:0000778;GO:0005737;GO:0005829;GO:0000776;GO:0005815;GO:0048471;GO:0005819;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0031145;GO:0006915;GO:0051301;GO:0051754;GO:0007091;GO:0000278;GO:0007093;GO:0007094;GO:0007052;GO:0071459;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:condensed chromosome kinetochore; C:condensed chromosome outer kinetochore; C:condensed nuclear chromosome kinetochore; C:cytoplasm; C:cytosol; C:kinetochore; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:spindle;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:anaphase-promoting complex-dependent catabolic process; P:apoptotic process; P:cell division; P:meiotic sister chromatid cohesion, centromeric; P:metaphase/anaphase transition of mitotic cell cycle; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:protein localization to chromosome, centromeric region; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold65 indexed_genome mRNA 10157456 10183809 . + . ID=transcript_11016;Q9NQU5 A8K2G2 B3KYB0 G5E9R2,Serine/threonine-protein kinase PAK 6,PAK-5;p21-activated kinase 6;, PF00786;PF00069;, GO:0030054;GO:0005737;GO:0001650;GO:0005654;GO:0005524;GO:0045296;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0007010;GO:0007612;GO:0007626;GO:0007613;GO:0140058;GO:1990138;GO:0006355;GO:0031098;, C:cell junction; C:cytoplasm; C:fibrillar center; C:nucleoplasm;, F:ATP binding; F:cadherin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cytoskeleton organization; P:learning; P:locomotory behavior; P:memory; P:neuron projection arborization; P:neuron projection extension; P:regulation of transcription, DNA-templated; P:stress-activated protein kinase signaling cascade;|Q9NQU5 A8K2G2 B3KYB0 G5E9R2,Serine/threonine-protein kinase PAK 6,PAK-5;p21-activated kinase 6;, PF00786;PF00069;, GO:0030054;GO:0005737;GO:0001650;GO:0005654;GO:0005524;GO:0045296;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0007010;GO:0007612;GO:0007626;GO:0007613;GO:0140058;GO:1990138;GO:0006355;GO:0031098;, C:cell junction; C:cytoplasm; C:fibrillar center; C:nucleoplasm;, F:ATP binding; F:cadherin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cytoskeleton organization; P:learning; P:locomotory behavior; P:memory; P:neuron projection arborization; P:neuron projection extension; P:regulation of transcription, DNA-templated; P:stress-activated protein kinase signaling cascade; scaffold65 indexed_genome mRNA 10194065 10215558 . - . ID=transcript_11017;Q00722 A8K6J2 B9EGH5,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 {ECO:0000305},Phosphoinositide phospholipase C-beta-2;Phospholipase C-beta-2;, PF00168;PF09279;PF17787;PF00388;PF00387;PF08703;, GO:0005829;GO:0005509;GO:0004435;GO:0004629;GO:0007202;GO:0007186;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0006644;GO:0050913;GO:0007223;, C:cytosol;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:activation of phospholipase C activity; P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:phospholipid metabolic process; P:sensory perception of bitter taste; P:Wnt signaling pathway, calcium modulating pathway; scaffold65 indexed_genome mRNA 10240318 10248825 . - . ID=transcript_11018;Q6ZUT6 B9EIQ8 Q68DG9 Q6ZTM3 Q6ZU22,Coiled-coil domain-containing protein 9B {ECO:0000312|HGNC:HGNC:33488},, PF15266;, GO:0003723;, , F:RNA binding;|Q6ZUT6 B9EIQ8 Q68DG9 Q6ZTM3 Q6ZU22,Coiled-coil domain-containing protein 9B {ECO:0000312|HGNC:HGNC:33488},, PF15266;, GO:0003723;, , F:RNA binding;|Q6ZUT6 B9EIQ8 Q68DG9 Q6ZTM3 Q6ZU22,Coiled-coil domain-containing protein 9B {ECO:0000312|HGNC:HGNC:33488},, PF15266;, GO:0003723;, , F:RNA binding;|Q6ZUT6 B9EIQ8 Q68DG9 Q6ZTM3 Q6ZU22,Coiled-coil domain-containing protein 9B {ECO:0000312|HGNC:HGNC:33488},, PF15266;, GO:0003723;, , F:RNA binding;|Q6ZUT6 B9EIQ8 Q68DG9 Q6ZTM3 Q6ZU22,Coiled-coil domain-containing protein 9B {ECO:0000312|HGNC:HGNC:33488},, PF15266;, GO:0003723;, , F:RNA binding; scaffold65 indexed_genome mRNA 10271057 10281225 . + . ID=transcript_11019;A7MBM2 Q6AHW3 Q9C0C1,Protein dispatched homolog 2,, , GO:0016021;GO:0005886;GO:0007224;, C:integral component of membrane; C:plasma membrane;, , P:smoothened signaling pathway;|A7MBM2 Q6AHW3 Q9C0C1,Protein dispatched homolog 2,, , GO:0016021;GO:0005886;GO:0007224;, C:integral component of membrane; C:plasma membrane;, , P:smoothened signaling pathway;|A7MBM2 Q6AHW3 Q9C0C1,Protein dispatched homolog 2,, , GO:0016021;GO:0005886;GO:0007224;, C:integral component of membrane; C:plasma membrane;, , P:smoothened signaling pathway;|A7MBM2 Q6AHW3 Q9C0C1,Protein dispatched homolog 2,, , GO:0016021;GO:0005886;GO:0007224;, C:integral component of membrane; C:plasma membrane;, , P:smoothened signaling pathway;|A7MBM2 Q6AHW3 Q9C0C1,Protein dispatched homolog 2,, , GO:0016021;GO:0005886;GO:0007224;, C:integral component of membrane; C:plasma membrane;, , P:smoothened signaling pathway; scaffold65 indexed_genome mRNA 10291264 10300364 . + . ID=transcript_11020;P26440 B2RCV5 B3KVI7 J3KR54 Q53XZ9 Q96AF6,Isovaleryl-CoA dehydrogenase, mitochondrial {ECO:0000305},Butyryl-CoA dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005759;GO:0031966;GO:0004085;GO:0050660;GO:0042802;GO:0008470;GO:0009083;GO:0033539;GO:0006552;, C:mitochondrial matrix; C:mitochondrial membrane;, F:butyryl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:isovaleryl-CoA dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:leucine catabolic process;|P26440 B2RCV5 B3KVI7 J3KR54 Q53XZ9 Q96AF6,Isovaleryl-CoA dehydrogenase, mitochondrial {ECO:0000305},Butyryl-CoA dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005759;GO:0031966;GO:0004085;GO:0050660;GO:0042802;GO:0008470;GO:0009083;GO:0033539;GO:0006552;, C:mitochondrial matrix; C:mitochondrial membrane;, F:butyryl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:isovaleryl-CoA dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:leucine catabolic process;|P26440 B2RCV5 B3KVI7 J3KR54 Q53XZ9 Q96AF6,Isovaleryl-CoA dehydrogenase, mitochondrial {ECO:0000305},Butyryl-CoA dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005759;GO:0031966;GO:0004085;GO:0050660;GO:0042802;GO:0008470;GO:0009083;GO:0033539;GO:0006552;, C:mitochondrial matrix; C:mitochondrial membrane;, F:butyryl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:isovaleryl-CoA dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:leucine catabolic process;|P26440 B2RCV5 B3KVI7 J3KR54 Q53XZ9 Q96AF6,Isovaleryl-CoA dehydrogenase, mitochondrial {ECO:0000305},Butyryl-CoA dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005759;GO:0031966;GO:0004085;GO:0050660;GO:0042802;GO:0008470;GO:0009083;GO:0033539;GO:0006552;, C:mitochondrial matrix; C:mitochondrial membrane;, F:butyryl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:isovaleryl-CoA dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:leucine catabolic process;|P26440 B2RCV5 B3KVI7 J3KR54 Q53XZ9 Q96AF6,Isovaleryl-CoA dehydrogenase, mitochondrial {ECO:0000305},Butyryl-CoA dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005759;GO:0031966;GO:0004085;GO:0050660;GO:0042802;GO:0008470;GO:0009083;GO:0033539;GO:0006552;, C:mitochondrial matrix; C:mitochondrial membrane;, F:butyryl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:isovaleryl-CoA dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:leucine catabolic process; scaffold65 indexed_genome mRNA 10341613 10351592 . + . ID=transcript_11021;Q8TBE0 Q8NDF7 Q9Y2F4,Bromo adjacent homology domain-containing 1 protein,, PF01426;, GO:0005677;GO:0005694;GO:0005654;GO:0003682;GO:0031507;GO:0045892;, C:chromatin silencing complex; C:chromosome; C:nucleoplasm;, F:chromatin binding;, P:heterochromatin assembly; P:negative regulation of transcription, DNA-templated;|Q8TBE0 Q8NDF7 Q9Y2F4,Bromo adjacent homology domain-containing 1 protein,, PF01426;, GO:0005677;GO:0005694;GO:0005654;GO:0003682;GO:0031507;GO:0045892;, C:chromatin silencing complex; C:chromosome; C:nucleoplasm;, F:chromatin binding;, P:heterochromatin assembly; P:negative regulation of transcription, DNA-templated; scaffold65 indexed_genome mRNA 10430699 10440146 . - . ID=transcript_11022;Q9BV29 A8KAL4 Q86TC4 Q8N788 Q8NAR7,Coiled-coil domain-containing protein 32,, PF14989;|Q9BV29 A8KAL4 Q86TC4 Q8N788 Q8NAR7,Coiled-coil domain-containing protein 32,, PF14989;|Q9BV29 A8KAL4 Q86TC4 Q8N788 Q8NAR7,Coiled-coil domain-containing protein 32,, PF14989; scaffold65 indexed_genome mRNA 10444266 10449485 . + . ID=transcript_11023;Q8IZ73 B4DDD1 Q7L989 Q92939 Q96IA7 Q96N50,RNA pseudouridylate synthase domain-containing protein 2,, PF00849;, GO:0009982;GO:0003723;GO:0000455;GO:1990481;, , F:pseudouridine synthase activity; F:RNA binding;, P:enzyme-directed rRNA pseudouridine synthesis; P:mRNA pseudouridine synthesis; scaffold65 indexed_genome mRNA 10515700 10521643 . + . ID=transcript_11024;Q8NG31 Q8NHE1 Q8WXA6 Q9HCK2 Q9NR92,Kinetochore scaffold 1,ALL1-fused gene from chromosome 15q14 protein;Bub-linking kinetochore protein;Cancer susceptibility candidate gene 5 protein;Cancer/testis antigen 29;Kinetochore-null protein 1;Protein CASC5;Protein D40/AF15q14;, PF18210;PF19221;, GO:0001669;GO:0000777;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0001675;GO:0008608;GO:0051301;GO:0034080;GO:0007052;GO:0010923;GO:0034501;, C:acrosomal vesicle; C:condensed chromosome kinetochore; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:acrosome assembly; P:attachment of spindle microtubules to kinetochore; P:cell division; P:CENP-A containing nucleosome assembly; P:mitotic spindle organization; P:negative regulation of phosphatase activity; P:protein localization to kinetochore; scaffold65 indexed_genome mRNA 10553078 10554480 . + . ID=transcript_11025;Q06609 B0FXP0 B2R8T6 Q6FHX9 Q6ZNA8 Q9BV60,DNA repair protein RAD51 homolog 1 {ECO:0000305},RAD51 homolog A;, PF08423;, GO:0000785;GO:0000781;GO:0000793;GO:0000794;GO:0005737;GO:0000800;GO:0005815;GO:0005759;GO:0005739;GO:0000228;GO:0005654;GO:0005634;GO:0048471;GO:0016605;GO:0032991;GO:0035861;GO:0005524;GO:0003682;GO:0070182;GO:0008094;GO:0003690;GO:0019899;GO:0042802;GO:0008022;GO:0000150;GO:0003697;GO:0017116;GO:0072757;GO:0072719;GO:0006974;GO:0071480;GO:0072711;GO:0071479;GO:0070192;GO:0000730;GO:0006310;GO:0006281;GO:0006268;GO:0000724;GO:0036297;GO:0051321;GO:0006312;GO:1990426;GO:0070317;GO:0051106;GO:0007131;GO:0010569;GO:0001932;GO:0031297;GO:1990414;GO:0042493;GO:1904631;GO:0009636;GO:0010165;GO:0042148;GO:0000722;GO:0010833;, C:chromatin; C:chromosome, telomeric region; C:condensed chromosome; C:condensed nuclear chromosome; C:cytoplasm; C:lateral element; C:microtubule organizing center; C:mitochondrial matrix; C:mitochondrion; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:PML body; C:protein-containing complex; C:site of double-strand break;, F:ATP binding; F:chromatin binding; F:DNA polymerase binding; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:enzyme binding; F:identical protein binding; F:protein C-terminus binding; F:recombinase activity; F:single-stranded DNA binding; F:single-stranded DNA helicase activity;, P:cellular response to camptothecin; P:cellular response to cisplatin; P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular response to hydroxyurea; P:cellular response to ionizing radiation; P:chromosome organization involved in meiotic cell cycle; P:DNA recombinase assembly; P:DNA recombination; P:DNA repair; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:meiotic cell cycle; P:mitotic recombination; P:mitotic recombination-dependent replication fork processing; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA ligation; P:reciprocal meiotic recombination; P:regulation of double-strand break repair via homologous recombination; P:regulation of protein phosphorylation; P:replication fork processing; P:replication-born double-strand break repair via sister chromatid exchange; P:response to drug; P:response to glucoside; P:response to toxic substance; P:response to X-ray; P:strand invasion; P:telomere maintenance via recombination; P:telomere maintenance via telomere lengthening; scaffold65 indexed_genome mRNA 10559830 10580632 . - . ID=transcript_11026;Q96TC7 A9UMZ9 B3KRR3 Q6ZWE9 Q96H23 Q96SD6 Q9H6G1 Q9NVQ6,Regulator of microtubule dynamics protein 3,Cerebral protein 10;Protein FAM82A2;Protein FAM82C;Protein tyrosine phosphatase-interacting protein 51;TCPTP-interacting protein 51;, , GO:0016021;GO:0045171;GO:0005741;GO:0005739;GO:0097431;GO:0005634;GO:0044232;GO:0005876;GO:0008017;GO:0006915;GO:0030154;GO:0006874;, C:integral component of membrane; C:intercellular bridge; C:mitochondrial outer membrane; C:mitochondrion; C:mitotic spindle pole; C:nucleus; C:organelle membrane contact site; C:spindle microtubule;, F:microtubule binding;, P:apoptotic process; P:cell differentiation; P:cellular calcium ion homeostasis;|Q96TC7 A9UMZ9 B3KRR3 Q6ZWE9 Q96H23 Q96SD6 Q9H6G1 Q9NVQ6,Regulator of microtubule dynamics protein 3,Cerebral protein 10;Protein FAM82A2;Protein FAM82C;Protein tyrosine phosphatase-interacting protein 51;TCPTP-interacting protein 51;, , GO:0016021;GO:0045171;GO:0005741;GO:0005739;GO:0097431;GO:0005634;GO:0044232;GO:0005876;GO:0008017;GO:0006915;GO:0030154;GO:0006874;, C:integral component of membrane; C:intercellular bridge; C:mitochondrial outer membrane; C:mitochondrion; C:mitotic spindle pole; C:nucleus; C:organelle membrane contact site; C:spindle microtubule;, F:microtubule binding;, P:apoptotic process; P:cell differentiation; P:cellular calcium ion homeostasis;|Q96TC7 A9UMZ9 B3KRR3 Q6ZWE9 Q96H23 Q96SD6 Q9H6G1 Q9NVQ6,Regulator of microtubule dynamics protein 3,Cerebral protein 10;Protein FAM82A2;Protein FAM82C;Protein tyrosine phosphatase-interacting protein 51;TCPTP-interacting protein 51;, , GO:0016021;GO:0045171;GO:0005741;GO:0005739;GO:0097431;GO:0005634;GO:0044232;GO:0005876;GO:0008017;GO:0006915;GO:0030154;GO:0006874;, C:integral component of membrane; C:intercellular bridge; C:mitochondrial outer membrane; C:mitochondrion; C:mitotic spindle pole; C:nucleus; C:organelle membrane contact site; C:spindle microtubule;, F:microtubule binding;, P:apoptotic process; P:cell differentiation; P:cellular calcium ion homeostasis; scaffold65 indexed_genome mRNA 10587972 10592279 . + . ID=transcript_11027;P30047 B2R4L6 B7ZLM8 Q2M1Q2 Q99749,GTP cyclohydrolase 1 feedback regulatory protein,GTP cyclohydrolase I feedback regulatory protein;p35;, PF06399;, GO:0005737;GO:0005829;GO:0030425;GO:0042470;GO:0031965;GO:0005654;GO:0005634;GO:0032991;GO:0016597;GO:0004857;GO:0044549;GO:0030742;GO:0044877;GO:0009890;GO:0043105;GO:0042133;GO:0006809;GO:0065003;GO:0046146;, C:cytoplasm; C:cytosol; C:dendrite; C:melanosome; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:amino acid binding; F:enzyme inhibitor activity; F:GTP cyclohydrolase binding; F:GTP-dependent protein binding; F:protein-containing complex binding;, P:negative regulation of biosynthetic process; P:negative regulation of GTP cyclohydrolase I activity; P:neurotransmitter metabolic process; P:nitric oxide biosynthetic process; P:protein-containing complex assembly; P:tetrahydrobiopterin metabolic process; scaffold65 indexed_genome mRNA 10592303 10620937 . - . ID=transcript_11028;A8K5M9 A6NK01,Uncharacterized protein C15orf62, mitochondrial,, , GO:0005737;GO:0005856;GO:0005739;GO:0005886;GO:0030838;GO:0031274;GO:0008360;GO:0007266;, C:cytoplasm; C:cytoskeleton; C:mitochondrion; C:plasma membrane;, , P:positive regulation of actin filament polymerization; P:positive regulation of pseudopodium assembly; P:regulation of cell shape; P:Rho protein signal transduction;|Q9NVM6,DnaJ homolog subfamily C member 17,, PF00226;PF00076;, GO:0005737;GO:0005634;GO:0003723;GO:0000122;GO:1901998;, C:cytoplasm; C:nucleus;, F:RNA binding;, P:negative regulation of transcription by RNA polymerase II; P:toxin transport;|Q9NVM6,DnaJ homolog subfamily C member 17,, PF00226;PF00076;, GO:0005737;GO:0005634;GO:0003723;GO:0000122;GO:1901998;, C:cytoplasm; C:nucleus;, F:RNA binding;, P:negative regulation of transcription by RNA polymerase II; P:toxin transport; scaffold65 indexed_genome mRNA 10621473 10638708 . + . ID=transcript_11029;Q96K21 B3KVB2 C9JNF4 H3BUF9 Q86WC2 Q8WU96,Abscission/NoCut checkpoint regulator,MLL partner containing FYVE domain;Zinc finger FYVE domain-containing protein 19;, PF01363;, GO:0005813;GO:0032154;GO:0005737;GO:0090543;GO:0030496;GO:0046872;GO:0032266;GO:0009838;GO:0051301;GO:0044878;GO:0032466;, C:centrosome; C:cleavage furrow; C:cytoplasm; C:Flemming body; C:midbody;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:abscission; P:cell division; P:mitotic cytokinesis checkpoint; P:negative regulation of cytokinesis;|Q96K21 B3KVB2 C9JNF4 H3BUF9 Q86WC2 Q8WU96,Abscission/NoCut checkpoint regulator,MLL partner containing FYVE domain;Zinc finger FYVE domain-containing protein 19;, PF01363;, GO:0005813;GO:0032154;GO:0005737;GO:0090543;GO:0030496;GO:0046872;GO:0032266;GO:0009838;GO:0051301;GO:0044878;GO:0032466;, C:centrosome; C:cleavage furrow; C:cytoplasm; C:Flemming body; C:midbody;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:abscission; P:cell division; P:mitotic cytokinesis checkpoint; P:negative regulation of cytokinesis;|Q96K21 B3KVB2 C9JNF4 H3BUF9 Q86WC2 Q8WU96,Abscission/NoCut checkpoint regulator,MLL partner containing FYVE domain;Zinc finger FYVE domain-containing protein 19;, PF01363;, GO:0005813;GO:0032154;GO:0005737;GO:0090543;GO:0030496;GO:0046872;GO:0032266;GO:0009838;GO:0051301;GO:0044878;GO:0032466;, C:centrosome; C:cleavage furrow; C:cytoplasm; C:Flemming body; C:midbody;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:abscission; P:cell division; P:mitotic cytokinesis checkpoint; P:negative regulation of cytokinesis;|Q96K21 B3KVB2 C9JNF4 H3BUF9 Q86WC2 Q8WU96,Abscission/NoCut checkpoint regulator,MLL partner containing FYVE domain;Zinc finger FYVE domain-containing protein 19;, PF01363;, GO:0005813;GO:0032154;GO:0005737;GO:0090543;GO:0030496;GO:0046872;GO:0032266;GO:0009838;GO:0051301;GO:0044878;GO:0032466;, C:centrosome; C:cleavage furrow; C:cytoplasm; C:Flemming body; C:midbody;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:abscission; P:cell division; P:mitotic cytokinesis checkpoint; P:negative regulation of cytokinesis;|Q9NXH3 Q4V773,Protein phosphatase 1 regulatory subunit 14D,Gastrointestinal and brain-specific PP1-inhibitory protein 1;, PF05361;, GO:0005737;GO:0004865;GO:1905183;GO:1905184;GO:0042325;, C:cytoplasm;, F:protein serine/threonine phosphatase inhibitor activity;, P:negative regulation of protein serine/threonine phosphatase activity; P:positive regulation of protein serine/threonine phosphatase activity; P:regulation of phosphorylation;|Q9NXH3 Q4V773,Protein phosphatase 1 regulatory subunit 14D,Gastrointestinal and brain-specific PP1-inhibitory protein 1;, PF05361;, GO:0005737;GO:0004865;GO:1905183;GO:1905184;GO:0042325;, C:cytoplasm;, F:protein serine/threonine phosphatase inhibitor activity;, P:negative regulation of protein serine/threonine phosphatase activity; P:positive regulation of protein serine/threonine phosphatase activity; P:regulation of phosphorylation; scaffold65 indexed_genome mRNA 10651761 10663410 . + . ID=transcript_11030;O43278 Q7Z7D2,Kunitz-type protease inhibitor 1,Hepatocyte growth factor activator inhibitor type 1;, PF00014;PF00057;PF07502;, GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005886;GO:0004867;GO:0060670;GO:0071773;GO:0030198;GO:2000178;GO:0001843;GO:0060674;GO:0045687;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:plasma membrane;, F:serine-type endopeptidase inhibitor activity;, P:branching involved in labyrinthine layer morphogenesis; P:cellular response to BMP stimulus; P:extracellular matrix organization; P:negative regulation of neural precursor cell proliferation; P:neural tube closure; P:placenta blood vessel development; P:positive regulation of glial cell differentiation; scaffold65 indexed_genome mRNA 10679193 10681563 . - . ID=transcript_11031;Q96L33 Q2KHQ5 Q8TDW6,Rho-related GTP-binding protein RhoV,CDC42-like GTPase 2;GTP-binding protein-like 2;Rho GTPase-like protein ARHV;Wnt-1 responsive Cdc42 homolog 2;, PF00071;, GO:0005829;GO:0010008;GO:0005886;GO:0005525;GO:0003924;GO:0046872;GO:0032488;GO:0016477;GO:0030031;GO:0006897;GO:0051056;, C:cytosol; C:endosome membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:metal ion binding;, P:Cdc42 protein signal transduction; P:cell migration; P:cell projection assembly; P:endocytosis; P:regulation of small GTPase mediated signal transduction;|Q96L33 Q2KHQ5 Q8TDW6,Rho-related GTP-binding protein RhoV,CDC42-like GTPase 2;GTP-binding protein-like 2;Rho GTPase-like protein ARHV;Wnt-1 responsive Cdc42 homolog 2;, PF00071;, GO:0005829;GO:0010008;GO:0005886;GO:0005525;GO:0003924;GO:0046872;GO:0032488;GO:0016477;GO:0030031;GO:0006897;GO:0051056;, C:cytosol; C:endosome membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:metal ion binding;, P:Cdc42 protein signal transduction; P:cell migration; P:cell projection assembly; P:endocytosis; P:regulation of small GTPase mediated signal transduction; scaffold65 indexed_genome mRNA 10701922 10711325 . + . ID=transcript_11032;Q9P253 Q8TCG0 Q96DI3 Q9H268,Vacuolar protein sorting-associated protein 18 homolog,, PF00637;PF05131;, GO:0005884;GO:0030123;GO:0005776;GO:0030136;GO:0033263;GO:0005769;GO:0005768;GO:0098978;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0098793;GO:0003779;GO:0046872;GO:0030674;GO:0019905;GO:0061630;GO:0006914;GO:0007032;GO:0008333;GO:0006886;GO:0007040;GO:0033147;GO:0016567;GO:0035542;GO:2000300;GO:0007033;GO:0006904;GO:0046718;, C:actin filament; C:AP-3 adaptor complex; C:autophagosome; C:clathrin-coated vesicle; C:CORVET complex; C:early endosome; C:endosome; C:glutamatergic synapse; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:presynapse;, F:actin binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:syntaxin binding; F:ubiquitin protein ligase activity;, P:autophagy; P:endosome organization; P:endosome to lysosome transport; P:intracellular protein transport; P:lysosome organization; P:negative regulation of intracellular estrogen receptor signaling pathway; P:protein ubiquitination; P:regulation of SNARE complex assembly; P:regulation of synaptic vesicle exocytosis; P:vacuole organization; P:vesicle docking involved in exocytosis; P:viral entry into host cell;|Q9P253 Q8TCG0 Q96DI3 Q9H268,Vacuolar protein sorting-associated protein 18 homolog,, PF00637;PF05131;, GO:0005884;GO:0030123;GO:0005776;GO:0030136;GO:0033263;GO:0005769;GO:0005768;GO:0098978;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0098793;GO:0003779;GO:0046872;GO:0030674;GO:0019905;GO:0061630;GO:0006914;GO:0007032;GO:0008333;GO:0006886;GO:0007040;GO:0033147;GO:0016567;GO:0035542;GO:2000300;GO:0007033;GO:0006904;GO:0046718;, C:actin filament; C:AP-3 adaptor complex; C:autophagosome; C:clathrin-coated vesicle; C:CORVET complex; C:early endosome; C:endosome; C:glutamatergic synapse; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:presynapse;, F:actin binding; F:metal ion binding; F:protein-macromolecule adaptor activity; F:syntaxin binding; F:ubiquitin protein ligase activity;, P:autophagy; P:endosome organization; P:endosome to lysosome transport; P:intracellular protein transport; P:lysosome organization; P:negative regulation of intracellular estrogen receptor signaling pathway; P:protein ubiquitination; P:regulation of SNARE complex assembly; P:regulation of synaptic vesicle exocytosis; P:vacuole organization; P:vesicle docking involved in exocytosis; P:viral entry into host cell; scaffold66 indexed_genome mRNA 147172 157162 . + . ID=transcript_11033;Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation;|Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation; scaffold66 indexed_genome mRNA 157436 159379 . + . ID=transcript_11034;Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation; scaffold66 indexed_genome mRNA 163070 170109 . - . ID=transcript_11035;Q9Y2I6 A6NJN0 B3V9H6 B7Z1V8 Q5JYP0 Q8NE38 Q9NQE3,Ninein-like protein,, PF13499;, GO:0005813;GO:0005829;GO:0045171;GO:0005874;GO:0015630;GO:0005509;GO:0097711;GO:0000086;GO:0034454;GO:0010389;, C:centrosome; C:cytosol; C:intercellular bridge; C:microtubule; C:microtubule cytoskeleton;, F:calcium ion binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring at centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q9Y2I6 A6NJN0 B3V9H6 B7Z1V8 Q5JYP0 Q8NE38 Q9NQE3,Ninein-like protein,, PF13499;, GO:0005813;GO:0005829;GO:0045171;GO:0005874;GO:0015630;GO:0005509;GO:0097711;GO:0000086;GO:0034454;GO:0010389;, C:centrosome; C:cytosol; C:intercellular bridge; C:microtubule; C:microtubule cytoskeleton;, F:calcium ion binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring at centrosome; P:regulation of G2/M transition of mitotic cell cycle; scaffold66 indexed_genome mRNA 174065 184285 . - . ID=transcript_11036;Q9Y2I6 A6NJN0 B3V9H6 B7Z1V8 Q5JYP0 Q8NE38 Q9NQE3,Ninein-like protein,, PF13499;, GO:0005813;GO:0005829;GO:0045171;GO:0005874;GO:0015630;GO:0005509;GO:0097711;GO:0000086;GO:0034454;GO:0010389;, C:centrosome; C:cytosol; C:intercellular bridge; C:microtubule; C:microtubule cytoskeleton;, F:calcium ion binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring at centrosome; P:regulation of G2/M transition of mitotic cell cycle; scaffold66 indexed_genome mRNA 213196 215054 . - . ID=transcript_11037;Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation; scaffold66 indexed_genome mRNA 330320 331522 . - . ID=transcript_11038;Q9Y2I6 A6NJN0 B3V9H6 B7Z1V8 Q5JYP0 Q8NE38 Q9NQE3,Ninein-like protein,, PF13499;, GO:0005813;GO:0005829;GO:0045171;GO:0005874;GO:0015630;GO:0005509;GO:0097711;GO:0000086;GO:0034454;GO:0010389;, C:centrosome; C:cytosol; C:intercellular bridge; C:microtubule; C:microtubule cytoskeleton;, F:calcium ion binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring at centrosome; P:regulation of G2/M transition of mitotic cell cycle; scaffold66 indexed_genome mRNA 384355 389887 . - . ID=transcript_11039;Q9Y2I6 A6NJN0 B3V9H6 B7Z1V8 Q5JYP0 Q8NE38 Q9NQE3,Ninein-like protein,, PF13499;, GO:0005813;GO:0005829;GO:0045171;GO:0005874;GO:0015630;GO:0005509;GO:0097711;GO:0000086;GO:0034454;GO:0010389;, C:centrosome; C:cytosol; C:intercellular bridge; C:microtubule; C:microtubule cytoskeleton;, F:calcium ion binding;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule anchoring at centrosome; P:regulation of G2/M transition of mitotic cell cycle; scaffold66 indexed_genome mRNA 462873 464166 . - . ID=transcript_11040;Q8TBE9 B3KP12 Q5JYN8 Q8TE97 Q9Y3N0,N-acylneuraminate-9-phosphatase,Haloacid dehalogenase-like hydrolase domain-containing protein 4;Neu5Ac-9-Pase;, PF13419;, GO:0005829;GO:0050124;GO:0005975;GO:0006045;GO:0046380;, C:cytosol;, F:N-acylneuraminate-9-phosphatase activity;, P:carbohydrate metabolic process; P:N-acetylglucosamine biosynthetic process; P:N-acetylneuraminate biosynthetic process; scaffold66 indexed_genome mRNA 503158 504536 . + . ID=transcript_11041;Q9NRC9 D3DW22 Q3MIU6,Otoraplin,Fibrocyte-derived protein;Melanoma inhibitory activity-like protein;, PF07653;, GO:0005576;GO:0001502;GO:0007605;, C:extracellular region;, , P:cartilage condensation; P:sensory perception of sound; scaffold66 indexed_genome mRNA 513042 525743 . - . ID=transcript_11042;P08579 B2R7J3 D3DW21 Q9UJD4,U2 small nuclear ribonucleoprotein B'',, PF00076;, GO:0071013;GO:0036464;GO:0001650;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005685;GO:0005686;GO:0071007;GO:0071005;GO:0070990;GO:0030619;GO:0000398;, C:catalytic step 2 spliceosome; C:cytoplasmic ribonucleoprotein granule; C:fibrillar center; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U1 snRNP; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:snRNP binding; F:U1 snRNA binding;, P:mRNA splicing, via spliceosome;|P08579 B2R7J3 D3DW21 Q9UJD4,U2 small nuclear ribonucleoprotein B'',, PF00076;, GO:0071013;GO:0036464;GO:0001650;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005685;GO:0005686;GO:0071007;GO:0071005;GO:0070990;GO:0030619;GO:0000398;, C:catalytic step 2 spliceosome; C:cytoplasmic ribonucleoprotein granule; C:fibrillar center; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U1 snRNP; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:snRNP binding; F:U1 snRNA binding;, P:mRNA splicing, via spliceosome;|P08579 B2R7J3 D3DW21 Q9UJD4,U2 small nuclear ribonucleoprotein B'',, PF00076;, GO:0071013;GO:0036464;GO:0001650;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005685;GO:0005686;GO:0071007;GO:0071005;GO:0070990;GO:0030619;GO:0000398;, C:catalytic step 2 spliceosome; C:cytoplasmic ribonucleoprotein granule; C:fibrillar center; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U1 snRNP; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:snRNP binding; F:U1 snRNA binding;, P:mRNA splicing, via spliceosome;|P08579 B2R7J3 D3DW21 Q9UJD4,U2 small nuclear ribonucleoprotein B'',, PF00076;, GO:0071013;GO:0036464;GO:0001650;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005685;GO:0005686;GO:0071007;GO:0071005;GO:0070990;GO:0030619;GO:0000398;, C:catalytic step 2 spliceosome; C:cytoplasmic ribonucleoprotein granule; C:fibrillar center; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U1 snRNP; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:snRNP binding; F:U1 snRNA binding;, P:mRNA splicing, via spliceosome; scaffold66 indexed_genome mRNA 710121 1004211 . + . ID=transcript_11043;Q9BQM0 Q9BQM1 Q9BQM5 Q9H5U0 Q9HCI2 Q9NXN9,Kinesin-like protein KIF16B,Sorting nexin-23;, PF00498;PF00225;PF00787;, GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0005871;GO:0005874;GO:0005819;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0005547;GO:0043325;GO:0080025;GO:0032266;GO:0045022;GO:0007492;GO:0007173;GO:0008543;GO:0001704;GO:0006895;GO:0007018;GO:0032801;GO:0001919;, C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:kinesin complex; C:microtubule; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding;, P:early endosome to late endosome transport; P:endoderm development; P:epidermal growth factor receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway; P:formation of primary germ layer; P:Golgi to endosome transport; P:microtubule-based movement; P:receptor catabolic process; P:regulation of receptor recycling;|Q9BQM0 Q9BQM1 Q9BQM5 Q9H5U0 Q9HCI2 Q9NXN9,Kinesin-like protein KIF16B,Sorting nexin-23;, PF00498;PF00225;PF00787;, GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0005871;GO:0005874;GO:0005819;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0005547;GO:0043325;GO:0080025;GO:0032266;GO:0045022;GO:0007492;GO:0007173;GO:0008543;GO:0001704;GO:0006895;GO:0007018;GO:0032801;GO:0001919;, C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:kinesin complex; C:microtubule; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding;, P:early endosome to late endosome transport; P:endoderm development; P:epidermal growth factor receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway; P:formation of primary germ layer; P:Golgi to endosome transport; P:microtubule-based movement; P:receptor catabolic process; P:regulation of receptor recycling; scaffold66 indexed_genome mRNA 3005048 3009621 . - . ID=transcript_11044;Q9NZU0 D3DW20 Q542Z9 Q96K39 Q96K42 Q96KB1 Q9P259,Leucine-rich repeat transmembrane protein FLRT3,Fibronectin-like domain-containing leucine-rich transmembrane protein 3;, PF13855;, GO:0043679;GO:0044295;GO:0030054;GO:0005911;GO:0005829;GO:0005789;GO:0031012;GO:0005615;GO:0005925;GO:0098978;GO:0032584;GO:0005887;GO:0099055;GO:0005886;GO:0097060;GO:0045499;GO:0005104;GO:0042803;GO:0030674;GO:0007411;GO:0098742;GO:0048598;GO:0008543;GO:0060322;GO:0007507;GO:0031175;GO:1990138;GO:0051965;GO:0003345;GO:0048678;GO:0007416;GO:0099560;, C:axon terminus; C:axonal growth cone; C:cell junction; C:cell-cell junction; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular matrix; C:extracellular space; C:focal adhesion; C:glutamatergic synapse; C:growth cone membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:synaptic membrane;, F:chemorepellent activity; F:fibroblast growth factor receptor binding; F:protein homodimerization activity; F:protein-macromolecule adaptor activity;, P:axon guidance; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:embryonic morphogenesis; P:fibroblast growth factor receptor signaling pathway; P:head development; P:heart development; P:neuron projection development; P:neuron projection extension; P:positive regulation of synapse assembly; P:proepicardium cell migration involved in pericardium morphogenesis; P:response to axon injury; P:synapse assembly; P:synaptic membrane adhesion; scaffold66 indexed_genome mRNA 3299836 3349372 . - . ID=transcript_11045;A1Z1Q3 A6NFF7 B0QZ39 B3KWV0 Q0P6D5 Q495E0 Q5W199 Q6ZN71,ADP-ribose glycohydrolase MACROD2 {ECO:0000305},MACRO domain-containing protein 2 {ECO:0000303|PubMed:23474712};O-acetyl-ADP-ribose deacetylase MACROD2;[Protein ADP-ribosylaspartate] hydrolase MACROD2 {ECO:0000305};[Protein ADP-ribosylglutamate] hydrolase MACROD2 {ECO:0000305};, PF01661;, GO:0005730;GO:0005654;GO:0005634;GO:0140293;GO:0019213;GO:0016798;GO:0006974;GO:0140291;GO:0051725;GO:0042278;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ADP-ribosylglutamate hydrolase activity; F:deacetylase activity; F:hydrolase activity, acting on glycosyl bonds;, P:cellular response to DNA damage stimulus; P:peptidyl-glutamate ADP-deribosylation; P:protein de-ADP-ribosylation; P:purine nucleoside metabolic process; scaffold66 indexed_genome mRNA 3467298 3471637 . - . ID=transcript_11046;Q5TEA6 B4DXX5,Protein sel-1 homolog 2,Suppressor of lin-12-like protein 2;, PF08238;, GO:0000839;GO:0016021;GO:0016567;GO:0030433;, C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of membrane;, , P:protein ubiquitination; P:ubiquitin-dependent ERAD pathway; scaffold66 indexed_genome mRNA 3481915 3511058 . - . ID=transcript_11047;Q5TEU4 A8K166 Q6GPH3 Q9H6F4,Arginine-hydroxylase NDUFAF5, mitochondrial {ECO:0000305},NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 {ECO:0000312|HGNC:HGNC:15899};Putative methyltransferase NDUFAF5;, PF08241;, GO:0031314;GO:0005743;GO:0005739;GO:0008168;GO:0016491;GO:0032259;GO:0032981;GO:0030961;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:methyltransferase activity; F:oxidoreductase activity;, P:methylation; P:mitochondrial respiratory chain complex I assembly; P:peptidyl-arginine hydroxylation;|Q5TEU4 A8K166 Q6GPH3 Q9H6F4,Arginine-hydroxylase NDUFAF5, mitochondrial {ECO:0000305},NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 {ECO:0000312|HGNC:HGNC:15899};Putative methyltransferase NDUFAF5;, PF08241;, GO:0031314;GO:0005743;GO:0005739;GO:0008168;GO:0016491;GO:0032259;GO:0032981;GO:0030961;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:methyltransferase activity; F:oxidoreductase activity;, P:methylation; P:mitochondrial respiratory chain complex I assembly; P:peptidyl-arginine hydroxylation;|Q5TEU4 A8K166 Q6GPH3 Q9H6F4,Arginine-hydroxylase NDUFAF5, mitochondrial {ECO:0000305},NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 {ECO:0000312|HGNC:HGNC:15899};Putative methyltransferase NDUFAF5;, PF08241;, GO:0031314;GO:0005743;GO:0005739;GO:0008168;GO:0016491;GO:0032259;GO:0032981;GO:0030961;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:methyltransferase activity; F:oxidoreductase activity;, P:methylation; P:mitochondrial respiratory chain complex I assembly; P:peptidyl-arginine hydroxylation;|Q5TEU4 A8K166 Q6GPH3 Q9H6F4,Arginine-hydroxylase NDUFAF5, mitochondrial {ECO:0000305},NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 {ECO:0000312|HGNC:HGNC:15899};Putative methyltransferase NDUFAF5;, PF08241;, GO:0031314;GO:0005743;GO:0005739;GO:0008168;GO:0016491;GO:0032259;GO:0032981;GO:0030961;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:methyltransferase activity; F:oxidoreductase activity;, P:methylation; P:mitochondrial respiratory chain complex I assembly; P:peptidyl-arginine hydroxylation; scaffold66 indexed_genome mRNA 3511131 3564534 . + . ID=transcript_11048;Q9H501 Q86X92 Q9H9Q5 Q9HA35 Q9NX93 Q9P1S6,ESF1 homolog,ABT1-associated protein;, PF08159;, GO:0005615;GO:0005730;GO:0005654;GO:0003723;GO:0006364;, C:extracellular space; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:rRNA processing;|Q9H501 Q86X92 Q9H9Q5 Q9HA35 Q9NX93 Q9P1S6,ESF1 homolog,ABT1-associated protein;, PF08159;, GO:0005615;GO:0005730;GO:0005654;GO:0003723;GO:0006364;, C:extracellular space; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:rRNA processing;|Q9H501 Q86X92 Q9H9Q5 Q9HA35 Q9NX93 Q9P1S6,ESF1 homolog,ABT1-associated protein;, PF08159;, GO:0005615;GO:0005730;GO:0005654;GO:0003723;GO:0006364;, C:extracellular space; C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:rRNA processing; scaffold66 indexed_genome mRNA 3646411 3888227 . + . ID=transcript_11049;Q9H6P5 B7Z690 B7Z963 Q5TDU9 Q9BQN0 Q9NQ08 Q9NTS6 Q9NXJ2,Threonine aspartase 1,, PF01112;, GO:0005737;GO:0042802;GO:0004298;GO:0045893;GO:0051604;GO:0006508;, C:cytoplasm;, F:identical protein binding; F:threonine-type endopeptidase activity;, P:positive regulation of transcription, DNA-templated; P:protein maturation; P:proteolysis;|Q9H6P5 B7Z690 B7Z963 Q5TDU9 Q9BQN0 Q9NQ08 Q9NTS6 Q9NXJ2,Threonine aspartase 1,, PF01112;, GO:0005737;GO:0042802;GO:0004298;GO:0045893;GO:0051604;GO:0006508;, C:cytoplasm;, F:identical protein binding; F:threonine-type endopeptidase activity;, P:positive regulation of transcription, DNA-templated; P:protein maturation; P:proteolysis;|Q9H6P5 B7Z690 B7Z963 Q5TDU9 Q9BQN0 Q9NQ08 Q9NTS6 Q9NXJ2,Threonine aspartase 1,, PF01112;, GO:0005737;GO:0042802;GO:0004298;GO:0045893;GO:0051604;GO:0006508;, C:cytoplasm;, F:identical protein binding; F:threonine-type endopeptidase activity;, P:positive regulation of transcription, DNA-templated; P:protein maturation; P:proteolysis; scaffold66 indexed_genome mRNA 3971964 4061690 . - . ID=transcript_11050;B1AKI9 Q8WVH9,Isthmin-1,, PF03782;PF00090;, GO:0005576;GO:0016525;, C:extracellular region;, , P:negative regulation of angiogenesis; scaffold66 indexed_genome mRNA 4163481 4275873 . - . ID=transcript_11051;Q9NUV7 A2A2I4 B9EK64 Q05DQ8 Q5T1U4 Q9H1L1 Q9H1Z0,Serine palmitoyltransferase 3 {ECO:0000305},Long chain base biosynthesis protein 2b;Long chain base biosynthesis protein 3;Serine-palmitoyl-CoA transferase 3;, PF00155;, GO:0005789;GO:0016021;GO:0017059;GO:0030170;GO:0004758;GO:0046513;GO:0046520;GO:0030148;GO:0046512;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:serine C-palmitoyltransferase complex;, F:pyridoxal phosphate binding; F:serine C-palmitoyltransferase activity;, P:ceramide biosynthetic process; P:sphingoid biosynthetic process; P:sphingolipid biosynthetic process; P:sphingosine biosynthetic process; scaffold66 indexed_genome mRNA 5334832 5346323 . - . ID=transcript_11052;Q9Y2F9 D3DW19 Q5JY73,BTB/POZ domain-containing protein 3,, PF07707;PF00651;PF08005;, GO:0005829;GO:0005634;GO:0042802;GO:0021987;GO:0048813;GO:0022008;, C:cytosol; C:nucleus;, F:identical protein binding;, P:cerebral cortex development; P:dendrite morphogenesis; P:neurogenesis;|Q9Y2F9 D3DW19 Q5JY73,BTB/POZ domain-containing protein 3,, PF07707;PF00651;PF08005;, GO:0005829;GO:0005634;GO:0042802;GO:0021987;GO:0048813;GO:0022008;, C:cytosol; C:nucleus;, F:identical protein binding;, P:cerebral cortex development; P:dendrite morphogenesis; P:neurogenesis;|Q9Y2F9 D3DW19 Q5JY73,BTB/POZ domain-containing protein 3,, PF07707;PF00651;PF08005;, GO:0005829;GO:0005634;GO:0042802;GO:0021987;GO:0048813;GO:0022008;, C:cytosol; C:nucleus;, F:identical protein binding;, P:cerebral cortex development; P:dendrite morphogenesis; P:neurogenesis;|Q9Y2F9 D3DW19 Q5JY73,BTB/POZ domain-containing protein 3,, PF07707;PF00651;PF08005;, GO:0005829;GO:0005634;GO:0042802;GO:0021987;GO:0048813;GO:0022008;, C:cytosol; C:nucleus;, F:identical protein binding;, P:cerebral cortex development; P:dendrite morphogenesis; P:neurogenesis; scaffold66 indexed_genome mRNA 6745752 6762374 . + . ID=transcript_11053;P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity;|P78504 A0AV43 B4DYR1 E9PCF9 O14902 O15122 Q15816,Protein jagged-1,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0005576;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0005543;GO:0005198;GO:0001525;GO:0035909;GO:0003180;GO:0001974;GO:0061309;GO:0003215;GO:0060411;GO:0001709;GO:0061073;GO:0072017;GO:0061444;GO:0045446;GO:0072015;GO:0030097;GO:0042491;GO:0030216;GO:0072070;GO:0002011;GO:0045445;GO:0030336;GO:0022408;GO:0001953;GO:0045602;GO:0045599;GO:0045665;GO:2000737;GO:0072006;GO:0007399;GO:0097150;GO:0061314;GO:0007219;GO:0062043;GO:0045639;GO:0045747;GO:0045669;GO:0045944;GO:0061156;GO:0003184;GO:0042127;GO:0032495;GO:0002456;, C:adherens junction; C:apical plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding; F:phospholipid binding; F:structural molecule activity;, P:angiogenesis; P:aorta morphogenesis; P:aortic valve morphogenesis; P:blood vessel remodeling; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cardiac right ventricle morphogenesis; P:cardiac septum morphogenesis; P:cell fate determination; P:ciliary body morphogenesis; P:distal tubule development; P:endocardial cushion cell development; P:endothelial cell differentiation; P:glomerular visceral epithelial cell development; P:hemopoiesis; P:inner ear auditory receptor cell differentiation; P:keratinocyte differentiation; P:loop of Henle development; P:morphogenesis of an epithelial sheet; P:myoblast differentiation; P:negative regulation of cell migration; P:negative regulation of cell-cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of endothelial cell differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of stem cell differentiation; P:nephron development; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of myeloid cell differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:regulation of cell population proliferation; P:response to muramyl dipeptide; P:T cell mediated immunity; scaffold66 indexed_genome mRNA 6774507 6974954 . - . ID=transcript_11054;Q5VYV7 Q05CG2 Q05CT9,Protein SLX4IP,SLX4-interacting protein;, PF15744;|Q5VYV7 Q05CG2 Q05CT9,Protein SLX4IP,SLX4-interacting protein;, PF15744;|Q5VYV7 Q05CG2 Q05CT9,Protein SLX4IP,SLX4-interacting protein;, PF15744; scaffold66 indexed_genome mRNA 6985794 7003079 . - . ID=transcript_11055;Q9NPJ1 A8K7B0 D3DW18,McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin,Bardet-Biedl syndrome 6 protein;, PF00118;, GO:0005813;GO:0005737;GO:0005829;GO:1902636;GO:0031514;GO:0005634;GO:0005524;GO:0016887;GO:0001103;GO:0051082;GO:0014824;GO:0048854;GO:0051216;GO:0021987;GO:0051131;GO:0060271;GO:0060027;GO:0050910;GO:0007368;GO:0032502;GO:0060324;GO:0045444;GO:0008406;GO:0007507;GO:0001947;GO:0021766;GO:0046907;GO:0032402;GO:0030837;GO:0038108;GO:0045776;GO:0010629;GO:0034260;GO:1905515;GO:0045494;GO:0051877;GO:0040018;GO:0006457;GO:0060296;GO:0051492;GO:0007608;GO:0035176;GO:0007286;GO:0021756;GO:0042311;GO:0007601;, C:centrosome; C:cytoplasm; C:cytosol; C:kinociliary basal body; C:motile cilium; C:nucleus;, F:ATP binding; F:ATPase activity; F:RNA polymerase II repressing transcription factor binding; F:unfolded protein binding;, P:artery smooth muscle contraction; P:brain morphogenesis; P:cartilage development; P:cerebral cortex development; P:chaperone-mediated protein complex assembly; P:cilium assembly; P:convergent extension involved in gastrulation; P:detection of mechanical stimulus involved in sensory perception of sound; P:determination of left/right symmetry; P:developmental process; P:face development; P:fat cell differentiation; P:gonad development; P:heart development; P:heart looping; P:hippocampus development; P:intracellular transport; P:melanosome transport; P:negative regulation of actin filament polymerization; P:negative regulation of appetite by leptin-mediated signaling pathway; P:negative regulation of blood pressure; P:negative regulation of gene expression; P:negative regulation of GTPase activity; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:pigment granule aggregation in cell center; P:positive regulation of multicellular organism growth; P:protein folding; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of stress fiber assembly; P:sensory perception of smell; P:social behavior; P:spermatid development; P:striatum development; P:vasodilation; P:visual perception;|Q9NPJ1 A8K7B0 D3DW18,McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin,Bardet-Biedl syndrome 6 protein;, PF00118;, GO:0005813;GO:0005737;GO:0005829;GO:1902636;GO:0031514;GO:0005634;GO:0005524;GO:0016887;GO:0001103;GO:0051082;GO:0014824;GO:0048854;GO:0051216;GO:0021987;GO:0051131;GO:0060271;GO:0060027;GO:0050910;GO:0007368;GO:0032502;GO:0060324;GO:0045444;GO:0008406;GO:0007507;GO:0001947;GO:0021766;GO:0046907;GO:0032402;GO:0030837;GO:0038108;GO:0045776;GO:0010629;GO:0034260;GO:1905515;GO:0045494;GO:0051877;GO:0040018;GO:0006457;GO:0060296;GO:0051492;GO:0007608;GO:0035176;GO:0007286;GO:0021756;GO:0042311;GO:0007601;, C:centrosome; C:cytoplasm; C:cytosol; C:kinociliary basal body; C:motile cilium; C:nucleus;, F:ATP binding; F:ATPase activity; F:RNA polymerase II repressing transcription factor binding; F:unfolded protein binding;, P:artery smooth muscle contraction; P:brain morphogenesis; P:cartilage development; P:cerebral cortex development; P:chaperone-mediated protein complex assembly; P:cilium assembly; P:convergent extension involved in gastrulation; P:detection of mechanical stimulus involved in sensory perception of sound; P:determination of left/right symmetry; P:developmental process; P:face development; P:fat cell differentiation; P:gonad development; P:heart development; P:heart looping; P:hippocampus development; P:intracellular transport; P:melanosome transport; P:negative regulation of actin filament polymerization; P:negative regulation of appetite by leptin-mediated signaling pathway; P:negative regulation of blood pressure; P:negative regulation of gene expression; P:negative regulation of GTPase activity; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:pigment granule aggregation in cell center; P:positive regulation of multicellular organism growth; P:protein folding; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of stress fiber assembly; P:sensory perception of smell; P:social behavior; P:spermatid development; P:striatum development; P:vasodilation; P:visual perception;|Q9NPJ1 A8K7B0 D3DW18,McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin,Bardet-Biedl syndrome 6 protein;, PF00118;, GO:0005813;GO:0005737;GO:0005829;GO:1902636;GO:0031514;GO:0005634;GO:0005524;GO:0016887;GO:0001103;GO:0051082;GO:0014824;GO:0048854;GO:0051216;GO:0021987;GO:0051131;GO:0060271;GO:0060027;GO:0050910;GO:0007368;GO:0032502;GO:0060324;GO:0045444;GO:0008406;GO:0007507;GO:0001947;GO:0021766;GO:0046907;GO:0032402;GO:0030837;GO:0038108;GO:0045776;GO:0010629;GO:0034260;GO:1905515;GO:0045494;GO:0051877;GO:0040018;GO:0006457;GO:0060296;GO:0051492;GO:0007608;GO:0035176;GO:0007286;GO:0021756;GO:0042311;GO:0007601;, C:centrosome; C:cytoplasm; C:cytosol; C:kinociliary basal body; C:motile cilium; C:nucleus;, F:ATP binding; F:ATPase activity; F:RNA polymerase II repressing transcription factor binding; F:unfolded protein binding;, P:artery smooth muscle contraction; P:brain morphogenesis; P:cartilage development; P:cerebral cortex development; P:chaperone-mediated protein complex assembly; P:cilium assembly; P:convergent extension involved in gastrulation; P:detection of mechanical stimulus involved in sensory perception of sound; P:determination of left/right symmetry; P:developmental process; P:face development; P:fat cell differentiation; P:gonad development; P:heart development; P:heart looping; P:hippocampus development; P:intracellular transport; P:melanosome transport; P:negative regulation of actin filament polymerization; P:negative regulation of appetite by leptin-mediated signaling pathway; P:negative regulation of blood pressure; P:negative regulation of gene expression; P:negative regulation of GTPase activity; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:pigment granule aggregation in cell center; P:positive regulation of multicellular organism growth; P:protein folding; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of stress fiber assembly; P:sensory perception of smell; P:social behavior; P:spermatid development; P:striatum development; P:vasodilation; P:visual perception;|Q9NPJ1 A8K7B0 D3DW18,McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin,Bardet-Biedl syndrome 6 protein;, PF00118;, GO:0005813;GO:0005737;GO:0005829;GO:1902636;GO:0031514;GO:0005634;GO:0005524;GO:0016887;GO:0001103;GO:0051082;GO:0014824;GO:0048854;GO:0051216;GO:0021987;GO:0051131;GO:0060271;GO:0060027;GO:0050910;GO:0007368;GO:0032502;GO:0060324;GO:0045444;GO:0008406;GO:0007507;GO:0001947;GO:0021766;GO:0046907;GO:0032402;GO:0030837;GO:0038108;GO:0045776;GO:0010629;GO:0034260;GO:1905515;GO:0045494;GO:0051877;GO:0040018;GO:0006457;GO:0060296;GO:0051492;GO:0007608;GO:0035176;GO:0007286;GO:0021756;GO:0042311;GO:0007601;, C:centrosome; C:cytoplasm; C:cytosol; C:kinociliary basal body; C:motile cilium; C:nucleus;, F:ATP binding; F:ATPase activity; F:RNA polymerase II repressing transcription factor binding; F:unfolded protein binding;, P:artery smooth muscle contraction; P:brain morphogenesis; P:cartilage development; P:cerebral cortex development; P:chaperone-mediated protein complex assembly; P:cilium assembly; P:convergent extension involved in gastrulation; P:detection of mechanical stimulus involved in sensory perception of sound; P:determination of left/right symmetry; P:developmental process; P:face development; P:fat cell differentiation; P:gonad development; P:heart development; P:heart looping; P:hippocampus development; P:intracellular transport; P:melanosome transport; P:negative regulation of actin filament polymerization; P:negative regulation of appetite by leptin-mediated signaling pathway; P:negative regulation of blood pressure; P:negative regulation of gene expression; P:negative regulation of GTPase activity; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:pigment granule aggregation in cell center; P:positive regulation of multicellular organism growth; P:protein folding; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of stress fiber assembly; P:sensory perception of smell; P:social behavior; P:spermatid development; P:striatum development; P:vasodilation; P:visual perception; scaffold66 indexed_genome mRNA 7109882 7180959 . - . ID=transcript_11056;Q5U0B5 Q8IXK3 Q96FM2 Q9BR45,Synaptosomal-associated protein 25,Super protein;Synaptosomal-associated 25 kDa protein;, PF00835;, GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0098978;GO:0030426;GO:0016020;GO:0043005;GO:0048471;GO:0001917;GO:0005886;GO:0098794;GO:0042734;GO:0031201;GO:0036477;GO:0035579;GO:0008021;GO:0070032;GO:0070821;GO:0005802;GO:0048306;GO:0005484;GO:0019905;GO:0017075;GO:0005249;GO:0008306;GO:0007268;GO:0098967;GO:0006887;GO:0007626;GO:0060291;GO:0099590;GO:0007269;GO:0006836;GO:0001504;GO:0043312;GO:0050796;GO:0010975;GO:0016081;GO:0016079;GO:0031629;GO:0016082;GO:0006906;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuron projection; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:plasma membrane; C:postsynapse; C:presynaptic membrane; C:SNARE complex; C:somatodendritic compartment; C:specific granule membrane; C:synaptic vesicle; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex; C:tertiary granule membrane; C:trans-Golgi network;, F:calcium-dependent protein binding; F:SNAP receptor activity; F:syntaxin binding; F:syntaxin-1 binding; F:voltage-gated potassium channel activity;, P:associative learning; P:chemical synaptic transmission; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:locomotory behavior; P:long-term synaptic potentiation; P:neurotransmitter receptor internalization; P:neurotransmitter secretion; P:neurotransmitter transport; P:neurotransmitter uptake; P:neutrophil degranulation; P:regulation of insulin secretion; P:regulation of neuron projection development; P:synaptic vesicle docking; P:synaptic vesicle exocytosis; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle priming; P:vesicle fusion;|Q5U0B5 Q8IXK3 Q96FM2 Q9BR45,Synaptosomal-associated protein 25,Super protein;Synaptosomal-associated 25 kDa protein;, PF00835;, GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0098978;GO:0030426;GO:0016020;GO:0043005;GO:0048471;GO:0001917;GO:0005886;GO:0098794;GO:0042734;GO:0031201;GO:0036477;GO:0035579;GO:0008021;GO:0070032;GO:0070821;GO:0005802;GO:0048306;GO:0005484;GO:0019905;GO:0017075;GO:0005249;GO:0008306;GO:0007268;GO:0098967;GO:0006887;GO:0007626;GO:0060291;GO:0099590;GO:0007269;GO:0006836;GO:0001504;GO:0043312;GO:0050796;GO:0010975;GO:0016081;GO:0016079;GO:0031629;GO:0016082;GO:0006906;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuron projection; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:plasma membrane; C:postsynapse; C:presynaptic membrane; C:SNARE complex; C:somatodendritic compartment; C:specific granule membrane; C:synaptic vesicle; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex; C:tertiary granule membrane; C:trans-Golgi network;, F:calcium-dependent protein binding; F:SNAP receptor activity; F:syntaxin binding; F:syntaxin-1 binding; F:voltage-gated potassium channel activity;, P:associative learning; P:chemical synaptic transmission; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:locomotory behavior; P:long-term synaptic potentiation; P:neurotransmitter receptor internalization; P:neurotransmitter secretion; P:neurotransmitter transport; P:neurotransmitter uptake; P:neutrophil degranulation; P:regulation of insulin secretion; P:regulation of neuron projection development; P:synaptic vesicle docking; P:synaptic vesicle exocytosis; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle priming; P:vesicle fusion;|Q5U0B5 Q8IXK3 Q96FM2 Q9BR45,Synaptosomal-associated protein 25,Super protein;Synaptosomal-associated 25 kDa protein;, PF00835;, GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0098978;GO:0030426;GO:0016020;GO:0043005;GO:0048471;GO:0001917;GO:0005886;GO:0098794;GO:0042734;GO:0031201;GO:0036477;GO:0035579;GO:0008021;GO:0070032;GO:0070821;GO:0005802;GO:0048306;GO:0005484;GO:0019905;GO:0017075;GO:0005249;GO:0008306;GO:0007268;GO:0098967;GO:0006887;GO:0007626;GO:0060291;GO:0099590;GO:0007269;GO:0006836;GO:0001504;GO:0043312;GO:0050796;GO:0010975;GO:0016081;GO:0016079;GO:0031629;GO:0016082;GO:0006906;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuron projection; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:plasma membrane; C:postsynapse; C:presynaptic membrane; C:SNARE complex; C:somatodendritic compartment; C:specific granule membrane; C:synaptic vesicle; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex; C:tertiary granule membrane; C:trans-Golgi network;, F:calcium-dependent protein binding; F:SNAP receptor activity; F:syntaxin binding; F:syntaxin-1 binding; F:voltage-gated potassium channel activity;, P:associative learning; P:chemical synaptic transmission; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:locomotory behavior; P:long-term synaptic potentiation; P:neurotransmitter receptor internalization; P:neurotransmitter secretion; P:neurotransmitter transport; P:neurotransmitter uptake; P:neutrophil degranulation; P:regulation of insulin secretion; P:regulation of neuron projection development; P:synaptic vesicle docking; P:synaptic vesicle exocytosis; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle priming; P:vesicle fusion;|Q5U0B5 Q8IXK3 Q96FM2 Q9BR45,Synaptosomal-associated protein 25,Super protein;Synaptosomal-associated 25 kDa protein;, PF00835;, GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0098978;GO:0030426;GO:0016020;GO:0043005;GO:0048471;GO:0001917;GO:0005886;GO:0098794;GO:0042734;GO:0031201;GO:0036477;GO:0035579;GO:0008021;GO:0070032;GO:0070821;GO:0005802;GO:0048306;GO:0005484;GO:0019905;GO:0017075;GO:0005249;GO:0008306;GO:0007268;GO:0098967;GO:0006887;GO:0007626;GO:0060291;GO:0099590;GO:0007269;GO:0006836;GO:0001504;GO:0043312;GO:0050796;GO:0010975;GO:0016081;GO:0016079;GO:0031629;GO:0016082;GO:0006906;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuron projection; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:plasma membrane; C:postsynapse; C:presynaptic membrane; C:SNARE complex; C:somatodendritic compartment; C:specific granule membrane; C:synaptic vesicle; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex; C:tertiary granule membrane; C:trans-Golgi network;, F:calcium-dependent protein binding; F:SNAP receptor activity; F:syntaxin binding; F:syntaxin-1 binding; F:voltage-gated potassium channel activity;, P:associative learning; P:chemical synaptic transmission; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:locomotory behavior; P:long-term synaptic potentiation; P:neurotransmitter receptor internalization; P:neurotransmitter secretion; P:neurotransmitter transport; P:neurotransmitter uptake; P:neutrophil degranulation; P:regulation of insulin secretion; P:regulation of neuron projection development; P:synaptic vesicle docking; P:synaptic vesicle exocytosis; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle priming; P:vesicle fusion;|Q5U0B5 Q8IXK3 Q96FM2 Q9BR45,Synaptosomal-associated protein 25,Super protein;Synaptosomal-associated 25 kDa protein;, PF00835;, GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0098978;GO:0030426;GO:0016020;GO:0043005;GO:0048471;GO:0001917;GO:0005886;GO:0098794;GO:0042734;GO:0031201;GO:0036477;GO:0035579;GO:0008021;GO:0070032;GO:0070821;GO:0005802;GO:0048306;GO:0005484;GO:0019905;GO:0017075;GO:0005249;GO:0008306;GO:0007268;GO:0098967;GO:0006887;GO:0007626;GO:0060291;GO:0099590;GO:0007269;GO:0006836;GO:0001504;GO:0043312;GO:0050796;GO:0010975;GO:0016081;GO:0016079;GO:0031629;GO:0016082;GO:0006906;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:growth cone; C:membrane; C:neuron projection; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:plasma membrane; C:postsynapse; C:presynaptic membrane; C:SNARE complex; C:somatodendritic compartment; C:specific granule membrane; C:synaptic vesicle; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex; C:tertiary granule membrane; C:trans-Golgi network;, F:calcium-dependent protein binding; F:SNAP receptor activity; F:syntaxin binding; F:syntaxin-1 binding; F:voltage-gated potassium channel activity;, P:associative learning; P:chemical synaptic transmission; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:locomotory behavior; P:long-term synaptic potentiation; P:neurotransmitter receptor internalization; P:neurotransmitter secretion; P:neurotransmitter transport; P:neurotransmitter uptake; P:neutrophil degranulation; P:regulation of insulin secretion; P:regulation of neuron projection development; P:synaptic vesicle docking; P:synaptic vesicle exocytosis; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle priming; P:vesicle fusion; scaffold66 indexed_genome mRNA 7956826 8068487 . + . ID=transcript_11057;Q9P286 A8K5T6 D3DW14 Q5W115 Q8TB93 Q9BX09 Q9ULF6,Serine/threonine-protein kinase PAK 5 {ECO:0000305},p21-activated kinase 5;p21-activated kinase 7;, PF00786;PF00069;, GO:0005737;GO:0005739;GO:0005654;GO:0045202;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0016477;GO:0008283;GO:0007010;GO:0007612;GO:0007626;GO:0007613;GO:2001237;GO:0001558;GO:0007165;GO:0031098;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:synapse;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cell migration; P:cell population proliferation; P:cytoskeleton organization; P:learning; P:locomotory behavior; P:memory; P:negative regulation of extrinsic apoptotic signaling pathway; P:regulation of cell growth; P:signal transduction; P:stress-activated protein kinase signaling cascade;|Q9P286 A8K5T6 D3DW14 Q5W115 Q8TB93 Q9BX09 Q9ULF6,Serine/threonine-protein kinase PAK 5 {ECO:0000305},p21-activated kinase 5;p21-activated kinase 7;, PF00786;PF00069;, GO:0005737;GO:0005739;GO:0005654;GO:0045202;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0016477;GO:0008283;GO:0007010;GO:0007612;GO:0007626;GO:0007613;GO:2001237;GO:0001558;GO:0007165;GO:0031098;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:synapse;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cell migration; P:cell population proliferation; P:cytoskeleton organization; P:learning; P:locomotory behavior; P:memory; P:negative regulation of extrinsic apoptotic signaling pathway; P:regulation of cell growth; P:signal transduction; P:stress-activated protein kinase signaling cascade;|Q9P286 A8K5T6 D3DW14 Q5W115 Q8TB93 Q9BX09 Q9ULF6,Serine/threonine-protein kinase PAK 5 {ECO:0000305},p21-activated kinase 5;p21-activated kinase 7;, PF00786;PF00069;, GO:0005737;GO:0005739;GO:0005654;GO:0045202;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0016477;GO:0008283;GO:0007010;GO:0007612;GO:0007626;GO:0007613;GO:2001237;GO:0001558;GO:0007165;GO:0031098;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:synapse;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cell migration; P:cell population proliferation; P:cytoskeleton organization; P:learning; P:locomotory behavior; P:memory; P:negative regulation of extrinsic apoptotic signaling pathway; P:regulation of cell growth; P:signal transduction; P:stress-activated protein kinase signaling cascade;|Q9P286 A8K5T6 D3DW14 Q5W115 Q8TB93 Q9BX09 Q9ULF6,Serine/threonine-protein kinase PAK 5 {ECO:0000305},p21-activated kinase 5;p21-activated kinase 7;, PF00786;PF00069;, GO:0005737;GO:0005739;GO:0005654;GO:0045202;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0016477;GO:0008283;GO:0007010;GO:0007612;GO:0007626;GO:0007613;GO:2001237;GO:0001558;GO:0007165;GO:0031098;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:synapse;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cell migration; P:cell population proliferation; P:cytoskeleton organization; P:learning; P:locomotory behavior; P:memory; P:negative regulation of extrinsic apoptotic signaling pathway; P:regulation of cell growth; P:signal transduction; P:stress-activated protein kinase signaling cascade;|Q9P286 A8K5T6 D3DW14 Q5W115 Q8TB93 Q9BX09 Q9ULF6,Serine/threonine-protein kinase PAK 5 {ECO:0000305},p21-activated kinase 5;p21-activated kinase 7;, PF00786;PF00069;, GO:0005737;GO:0005739;GO:0005654;GO:0045202;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0016477;GO:0008283;GO:0007010;GO:0007612;GO:0007626;GO:0007613;GO:2001237;GO:0001558;GO:0007165;GO:0031098;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:synapse;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cell migration; P:cell population proliferation; P:cytoskeleton organization; P:learning; P:locomotory behavior; P:memory; P:negative regulation of extrinsic apoptotic signaling pathway; P:regulation of cell growth; P:signal transduction; P:stress-activated protein kinase signaling cascade;|Q9P286 A8K5T6 D3DW14 Q5W115 Q8TB93 Q9BX09 Q9ULF6,Serine/threonine-protein kinase PAK 5 {ECO:0000305},p21-activated kinase 5;p21-activated kinase 7;, PF00786;PF00069;, GO:0005737;GO:0005739;GO:0005654;GO:0045202;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0016477;GO:0008283;GO:0007010;GO:0007612;GO:0007626;GO:0007613;GO:2001237;GO:0001558;GO:0007165;GO:0031098;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:synapse;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cell migration; P:cell population proliferation; P:cytoskeleton organization; P:learning; P:locomotory behavior; P:memory; P:negative regulation of extrinsic apoptotic signaling pathway; P:regulation of cell growth; P:signal transduction; P:stress-activated protein kinase signaling cascade;|Q9P286 A8K5T6 D3DW14 Q5W115 Q8TB93 Q9BX09 Q9ULF6,Serine/threonine-protein kinase PAK 5 {ECO:0000305},p21-activated kinase 5;p21-activated kinase 7;, PF00786;PF00069;, GO:0005737;GO:0005739;GO:0005654;GO:0045202;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0016477;GO:0008283;GO:0007010;GO:0007612;GO:0007626;GO:0007613;GO:2001237;GO:0001558;GO:0007165;GO:0031098;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:synapse;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cell migration; P:cell population proliferation; P:cytoskeleton organization; P:learning; P:locomotory behavior; P:memory; P:negative regulation of extrinsic apoptotic signaling pathway; P:regulation of cell growth; P:signal transduction; P:stress-activated protein kinase signaling cascade; scaffold66 indexed_genome mRNA 8075226 8090027 . - . ID=transcript_11058;Q9UJQ1 B4DHZ7 B7Z9Z9,Lysosome-associated membrane glycoprotein 5,Brain and dendritic cell-associated LAMP;Brain-associated LAMP-like protein;Lysosome-associated membrane protein 5;, PF01299;, GO:0030659;GO:0032590;GO:0031901;GO:0033116;GO:0010008;GO:0032584;GO:0016021;GO:0031902;GO:0005765;GO:0005886;GO:0055038;GO:0030672;GO:0072594;, C:cytoplasmic vesicle membrane; C:dendrite membrane; C:early endosome membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:endosome membrane; C:growth cone membrane; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:plasma membrane; C:recycling endosome membrane; C:synaptic vesicle membrane;, , P:establishment of protein localization to organelle; scaffold66 indexed_genome mRNA 8122520 8397383 . - . ID=transcript_11059;Q9BQW5 Q9BQW6 Q9BQW8 Q9UJQ2,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 {ECO:0000305},Phosphoinositide phospholipase C-beta-4;Phospholipase C-beta-4;, PF00168;PF06631;PF09279;PF17787;PF00388;PF00387;, GO:0005829;GO:0030425;GO:0098978;GO:0005634;GO:0098688;GO:0014069;GO:0005790;GO:0005509;GO:0004435;GO:0004629;GO:0007186;GO:0043647;GO:0016042;GO:0050804;GO:0048015;, C:cytosol; C:dendrite; C:glutamatergic synapse; C:nucleus; C:parallel fiber to Purkinje cell synapse; C:postsynaptic density; C:smooth endoplasmic reticulum;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:modulation of chemical synaptic transmission; P:phosphatidylinositol-mediated signaling;|Q9BQW5 Q9BQW6 Q9BQW8 Q9UJQ2,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 {ECO:0000305},Phosphoinositide phospholipase C-beta-4;Phospholipase C-beta-4;, PF00168;PF06631;PF09279;PF17787;PF00388;PF00387;, GO:0005829;GO:0030425;GO:0098978;GO:0005634;GO:0098688;GO:0014069;GO:0005790;GO:0005509;GO:0004435;GO:0004629;GO:0007186;GO:0043647;GO:0016042;GO:0050804;GO:0048015;, C:cytosol; C:dendrite; C:glutamatergic synapse; C:nucleus; C:parallel fiber to Purkinje cell synapse; C:postsynaptic density; C:smooth endoplasmic reticulum;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:modulation of chemical synaptic transmission; P:phosphatidylinositol-mediated signaling;|Q9BQW5 Q9BQW6 Q9BQW8 Q9UJQ2,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 {ECO:0000305},Phosphoinositide phospholipase C-beta-4;Phospholipase C-beta-4;, PF00168;PF06631;PF09279;PF17787;PF00388;PF00387;, GO:0005829;GO:0030425;GO:0098978;GO:0005634;GO:0098688;GO:0014069;GO:0005790;GO:0005509;GO:0004435;GO:0004629;GO:0007186;GO:0043647;GO:0016042;GO:0050804;GO:0048015;, C:cytosol; C:dendrite; C:glutamatergic synapse; C:nucleus; C:parallel fiber to Purkinje cell synapse; C:postsynaptic density; C:smooth endoplasmic reticulum;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:modulation of chemical synaptic transmission; P:phosphatidylinositol-mediated signaling;|Q9BQW5 Q9BQW6 Q9BQW8 Q9UJQ2,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 {ECO:0000305},Phosphoinositide phospholipase C-beta-4;Phospholipase C-beta-4;, PF00168;PF06631;PF09279;PF17787;PF00388;PF00387;, GO:0005829;GO:0030425;GO:0098978;GO:0005634;GO:0098688;GO:0014069;GO:0005790;GO:0005509;GO:0004435;GO:0004629;GO:0007186;GO:0043647;GO:0016042;GO:0050804;GO:0048015;, C:cytosol; C:dendrite; C:glutamatergic synapse; C:nucleus; C:parallel fiber to Purkinje cell synapse; C:postsynaptic density; C:smooth endoplasmic reticulum;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:modulation of chemical synaptic transmission; P:phosphatidylinositol-mediated signaling;|Q9BQW5 Q9BQW6 Q9BQW8 Q9UJQ2,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 {ECO:0000305},Phosphoinositide phospholipase C-beta-4;Phospholipase C-beta-4;, PF00168;PF06631;PF09279;PF17787;PF00388;PF00387;, GO:0005829;GO:0030425;GO:0098978;GO:0005634;GO:0098688;GO:0014069;GO:0005790;GO:0005509;GO:0004435;GO:0004629;GO:0007186;GO:0043647;GO:0016042;GO:0050804;GO:0048015;, C:cytosol; C:dendrite; C:glutamatergic synapse; C:nucleus; C:parallel fiber to Purkinje cell synapse; C:postsynaptic density; C:smooth endoplasmic reticulum;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:modulation of chemical synaptic transmission; P:phosphatidylinositol-mediated signaling;|Q9BQW5 Q9BQW6 Q9BQW8 Q9UJQ2,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 {ECO:0000305},Phosphoinositide phospholipase C-beta-4;Phospholipase C-beta-4;, PF00168;PF06631;PF09279;PF17787;PF00388;PF00387;, GO:0005829;GO:0030425;GO:0098978;GO:0005634;GO:0098688;GO:0014069;GO:0005790;GO:0005509;GO:0004435;GO:0004629;GO:0007186;GO:0043647;GO:0016042;GO:0050804;GO:0048015;, C:cytosol; C:dendrite; C:glutamatergic synapse; C:nucleus; C:parallel fiber to Purkinje cell synapse; C:postsynaptic density; C:smooth endoplasmic reticulum;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:modulation of chemical synaptic transmission; P:phosphatidylinositol-mediated signaling;|Q9BQW5 Q9BQW6 Q9BQW8 Q9UJQ2,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 {ECO:0000305},Phosphoinositide phospholipase C-beta-4;Phospholipase C-beta-4;, PF00168;PF06631;PF09279;PF17787;PF00388;PF00387;, GO:0005829;GO:0030425;GO:0098978;GO:0005634;GO:0098688;GO:0014069;GO:0005790;GO:0005509;GO:0004435;GO:0004629;GO:0007186;GO:0043647;GO:0016042;GO:0050804;GO:0048015;, C:cytosol; C:dendrite; C:glutamatergic synapse; C:nucleus; C:parallel fiber to Purkinje cell synapse; C:postsynaptic density; C:smooth endoplasmic reticulum;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:modulation of chemical synaptic transmission; P:phosphatidylinositol-mediated signaling;|Q9BQW5 Q9BQW6 Q9BQW8 Q9UJQ2,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 {ECO:0000305},Phosphoinositide phospholipase C-beta-4;Phospholipase C-beta-4;, PF00168;PF06631;PF09279;PF17787;PF00388;PF00387;, GO:0005829;GO:0030425;GO:0098978;GO:0005634;GO:0098688;GO:0014069;GO:0005790;GO:0005509;GO:0004435;GO:0004629;GO:0007186;GO:0043647;GO:0016042;GO:0050804;GO:0048015;, C:cytosol; C:dendrite; C:glutamatergic synapse; C:nucleus; C:parallel fiber to Purkinje cell synapse; C:postsynaptic density; C:smooth endoplasmic reticulum;, F:calcium ion binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:modulation of chemical synaptic transmission; P:phosphatidylinositol-mediated signaling; scaffold66 indexed_genome mRNA 8797498 9056114 . - . ID=transcript_11060;Q9H4H2 Q9H8H5 Q9NQ65 Q9NQH9 Q9NTH4 Q9UJP6 Q9UM26,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 {ECO:0000305},PLC-154;Phosphoinositide phospholipase C-beta-1;Phospholipase C-I;Phospholipase C-beta-1;, PF06631;PF09279;PF17787;PF00388;PF00387;PF08703;, GO:0000785;GO:0005737;GO:0005829;GO:0070062;GO:0098982;GO:0098978;GO:0031965;GO:0016607;GO:0005634;GO:0098794;GO:0032991;GO:0005509;GO:0005516;GO:0019899;GO:0005096;GO:0042802;GO:0005521;GO:0004435;GO:0005546;GO:0060466;GO:0021987;GO:0045444;GO:0007213;GO:0007186;GO:0000086;GO:0007215;GO:0043647;GO:0048009;GO:0070498;GO:0035722;GO:0035723;GO:0016042;GO:0007613;GO:2000438;GO:0045892;GO:0046488;GO:0048015;GO:2000344;GO:2000560;GO:0048639;GO:0040019;GO:1900087;GO:0032735;GO:0046330;GO:0045663;GO:0045893;GO:0099170;GO:1903140;GO:0080154;GO:0008277;GO:0099178;GO:0007165;GO:0007223;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:nuclear membrane; C:nuclear speck; C:nucleus; C:postsynapse; C:protein-containing complex;, F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:GTPase activator activity; F:identical protein binding; F:lamin binding; F:phosphatidylinositol phospholipase C activity; F:phosphatidylinositol-4,5-bisphosphate binding;, P:activation of meiosis involved in egg activation; P:cerebral cortex development; P:fat cell differentiation; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:glutamate receptor signaling pathway; P:inositol phosphate metabolic process; P:insulin-like growth factor receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-15-mediated signaling pathway; P:lipid catabolic process; P:memory; P:negative regulation of monocyte extravasation; P:negative regulation of transcription, DNA-templated; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:positive regulation of acrosome reaction; P:positive regulation of CD24 production; P:positive regulation of developmental growth; P:positive regulation of embryonic development; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of interleukin-12 production; P:positive regulation of JNK cascade; P:positive regulation of myoblast differentiation; P:positive regulation of transcription, DNA-templated; P:postsynaptic modulation of chemical synaptic transmission; P:regulation of establishment of endothelial barrier; P:regulation of fertilization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of retrograde trans-synaptic signaling by endocanabinoid; P:signal transduction; P:Wnt signaling pathway, calcium modulating pathway; scaffold66 indexed_genome mRNA 9836370 9836899 . - . ID=transcript_11061;Q9H1E5 Q8N4P7 Q8NCC1 Q9UJA1 Q9ULQ8,Thioredoxin-related transmembrane protein 4,Thioredoxin domain-containing protein 13;, PF00085;, GO:0016021;GO:0005637;, C:integral component of membrane; C:nuclear inner membrane; scaffold66 indexed_genome mRNA 9860287 9869001 . + . ID=transcript_11062;Q9H1E5 Q8N4P7 Q8NCC1 Q9UJA1 Q9ULQ8,Thioredoxin-related transmembrane protein 4,Thioredoxin domain-containing protein 13;, PF00085;, GO:0016021;GO:0005637;, C:integral component of membrane; C:nuclear inner membrane; scaffold67 indexed_genome mRNA 224383 230665 . + . ID=transcript_11063;Q9NTU7 A8K0S5,Cerebellin-4,Cerebellin-like glycoprotein 1;, PF00386;, GO:0062023;GO:0005576;GO:0005615;GO:0098982;GO:1904862;GO:0009306;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:GABA-ergic synapse;, , P:inhibitory synapse assembly; P:protein secretion; scaffold67 indexed_genome mRNA 1373947 1519975 . - . ID=transcript_11064;Q9P104 Q5T7Y0 Q5TE53 Q8TEW7 Q96H13 Q9BZ24 Q9NQF4 Q9Y411,Docking protein 5,Downstream of tyrosine kinase 5;Insulin receptor substrate 6;, PF02174;, GO:0005829;GO:0007411;GO:0043410;GO:0051386;GO:0007169;, C:cytosol;, , P:axon guidance; P:positive regulation of MAPK cascade; P:regulation of neurotrophin TRK receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q9P104 Q5T7Y0 Q5TE53 Q8TEW7 Q96H13 Q9BZ24 Q9NQF4 Q9Y411,Docking protein 5,Downstream of tyrosine kinase 5;Insulin receptor substrate 6;, PF02174;, GO:0005829;GO:0007411;GO:0043410;GO:0051386;GO:0007169;, C:cytosol;, , P:axon guidance; P:positive regulation of MAPK cascade; P:regulation of neurotrophin TRK receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold67 indexed_genome mRNA 1876580 1944077 . + . ID=transcript_11065;O75363 A0AVG5 Q68CZ3,Breast carcinoma-amplified sequence 1,Amplified and overexpressed in breast cancer;Novel amplified in breast cancer 1;, , GO:0005737;GO:0070062;GO:0014069;GO:0042552;, C:cytoplasm; C:extracellular exosome; C:postsynaptic density;, , P:myelination;|O75363 A0AVG5 Q68CZ3,Breast carcinoma-amplified sequence 1,Amplified and overexpressed in breast cancer;Novel amplified in breast cancer 1;, , GO:0005737;GO:0070062;GO:0014069;GO:0042552;, C:cytoplasm; C:extracellular exosome; C:postsynaptic density;, , P:myelination;|O75363 A0AVG5 Q68CZ3,Breast carcinoma-amplified sequence 1,Amplified and overexpressed in breast cancer;Novel amplified in breast cancer 1;, , GO:0005737;GO:0070062;GO:0014069;GO:0042552;, C:cytoplasm; C:extracellular exosome; C:postsynaptic density;, , P:myelination;|O75363 A0AVG5 Q68CZ3,Breast carcinoma-amplified sequence 1,Amplified and overexpressed in breast cancer;Novel amplified in breast cancer 1;, , GO:0005737;GO:0070062;GO:0014069;GO:0042552;, C:cytoplasm; C:extracellular exosome; C:postsynaptic density;, , P:myelination;|O75363 A0AVG5 Q68CZ3,Breast carcinoma-amplified sequence 1,Amplified and overexpressed in breast cancer;Novel amplified in breast cancer 1;, , GO:0005737;GO:0070062;GO:0014069;GO:0042552;, C:cytoplasm; C:extracellular exosome; C:postsynaptic density;, , P:myelination; scaffold67 indexed_genome mRNA 2221469 2232076 . + . ID=transcript_11066;O75362 E1P5Y6 Q14DB8,Zinc finger protein 217,, PF00096;, GO:0000118;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000976;GO:0000122;GO:0045892;GO:0006355;, C:histone deacetylase complex; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|O75362 E1P5Y6 Q14DB8,Zinc finger protein 217,, PF00096;, GO:0000118;GO:0005739;GO:0016607;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000976;GO:0000122;GO:0045892;GO:0006355;, C:histone deacetylase complex; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold67 indexed_genome mRNA 2461531 2466616 . + . ID=transcript_11067;Q9NRE2 B7Z7W1 J3KNQ0 Q4VXM4 Q6N003 Q8N260,Teashirt homolog 2,Ovarian cancer-related protein 10-2;Zinc finger protein 218;, , GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0007275;GO:0006357;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; scaffold67 indexed_genome mRNA 3462004 3512819 . + . ID=transcript_11068;Q9NTS7 Q9NVH4,Zinc finger protein 64 {ECO:0000305},Zinc finger protein 338 {ECO:0000312|HGNC:HGNC:15940};, PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression;|Q9NTS7 Q9NVH4,Zinc finger protein 64 {ECO:0000305},Zinc finger protein 338 {ECO:0000312|HGNC:HGNC:15940};, PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold67 indexed_genome mRNA 3783813 3883659 . + . ID=transcript_11069;O75110 E1P5Y3 E1P5Y4 Q5TFW5 Q5TFW6 Q5TFW9 Q6ZMF3 Q9NQK6 Q9NQK7,Probable phospholipid-transporting ATPase IIA,ATPase class II type 9A;, PF16212;PF16209;, GO:0005769;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0032588;GO:0005524;GO:0140326;GO:0000287;GO:0002020;GO:0006897;GO:1903542;GO:0045332;GO:2001135;GO:1905279;GO:0006890;, C:early endosome; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:protease binding;, P:endocytosis; P:negative regulation of exosomal secretion; P:phospholipid translocation; P:regulation of endocytic recycling; P:regulation of retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O75110 E1P5Y3 E1P5Y4 Q5TFW5 Q5TFW6 Q5TFW9 Q6ZMF3 Q9NQK6 Q9NQK7,Probable phospholipid-transporting ATPase IIA,ATPase class II type 9A;, PF16212;PF16209;, GO:0005769;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0032588;GO:0005524;GO:0140326;GO:0000287;GO:0002020;GO:0006897;GO:1903542;GO:0045332;GO:2001135;GO:1905279;GO:0006890;, C:early endosome; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:protease binding;, P:endocytosis; P:negative regulation of exosomal secretion; P:phospholipid translocation; P:regulation of endocytic recycling; P:regulation of retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O75110 E1P5Y3 E1P5Y4 Q5TFW5 Q5TFW6 Q5TFW9 Q6ZMF3 Q9NQK6 Q9NQK7,Probable phospholipid-transporting ATPase IIA,ATPase class II type 9A;, PF16212;PF16209;, GO:0005769;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0032588;GO:0005524;GO:0140326;GO:0000287;GO:0002020;GO:0006897;GO:1903542;GO:0045332;GO:2001135;GO:1905279;GO:0006890;, C:early endosome; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:protease binding;, P:endocytosis; P:negative regulation of exosomal secretion; P:phospholipid translocation; P:regulation of endocytic recycling; P:regulation of retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O75110 E1P5Y3 E1P5Y4 Q5TFW5 Q5TFW6 Q5TFW9 Q6ZMF3 Q9NQK6 Q9NQK7,Probable phospholipid-transporting ATPase IIA,ATPase class II type 9A;, PF16212;PF16209;, GO:0005769;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0032588;GO:0005524;GO:0140326;GO:0000287;GO:0002020;GO:0006897;GO:1903542;GO:0045332;GO:2001135;GO:1905279;GO:0006890;, C:early endosome; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:protease binding;, P:endocytosis; P:negative regulation of exosomal secretion; P:phospholipid translocation; P:regulation of endocytic recycling; P:regulation of retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O75110 E1P5Y3 E1P5Y4 Q5TFW5 Q5TFW6 Q5TFW9 Q6ZMF3 Q9NQK6 Q9NQK7,Probable phospholipid-transporting ATPase IIA,ATPase class II type 9A;, PF16212;PF16209;, GO:0005769;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0032588;GO:0005524;GO:0140326;GO:0000287;GO:0002020;GO:0006897;GO:1903542;GO:0045332;GO:2001135;GO:1905279;GO:0006890;, C:early endosome; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:protease binding;, P:endocytosis; P:negative regulation of exosomal secretion; P:phospholipid translocation; P:regulation of endocytic recycling; P:regulation of retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O75110 E1P5Y3 E1P5Y4 Q5TFW5 Q5TFW6 Q5TFW9 Q6ZMF3 Q9NQK6 Q9NQK7,Probable phospholipid-transporting ATPase IIA,ATPase class II type 9A;, PF16212;PF16209;, GO:0005769;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0032588;GO:0005524;GO:0140326;GO:0000287;GO:0002020;GO:0006897;GO:1903542;GO:0045332;GO:2001135;GO:1905279;GO:0006890;, C:early endosome; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:protease binding;, P:endocytosis; P:negative regulation of exosomal secretion; P:phospholipid translocation; P:regulation of endocytic recycling; P:regulation of retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O75110 E1P5Y3 E1P5Y4 Q5TFW5 Q5TFW6 Q5TFW9 Q6ZMF3 Q9NQK6 Q9NQK7,Probable phospholipid-transporting ATPase IIA,ATPase class II type 9A;, PF16212;PF16209;, GO:0005769;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0032588;GO:0005524;GO:0140326;GO:0000287;GO:0002020;GO:0006897;GO:1903542;GO:0045332;GO:2001135;GO:1905279;GO:0006890;, C:early endosome; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:protease binding;, P:endocytosis; P:negative regulation of exosomal secretion; P:phospholipid translocation; P:regulation of endocytic recycling; P:regulation of retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O75110 E1P5Y3 E1P5Y4 Q5TFW5 Q5TFW6 Q5TFW9 Q6ZMF3 Q9NQK6 Q9NQK7,Probable phospholipid-transporting ATPase IIA,ATPase class II type 9A;, PF16212;PF16209;, GO:0005769;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0032588;GO:0005524;GO:0140326;GO:0000287;GO:0002020;GO:0006897;GO:1903542;GO:0045332;GO:2001135;GO:1905279;GO:0006890;, C:early endosome; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:protease binding;, P:endocytosis; P:negative regulation of exosomal secretion; P:phospholipid translocation; P:regulation of endocytic recycling; P:regulation of retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O75110 E1P5Y3 E1P5Y4 Q5TFW5 Q5TFW6 Q5TFW9 Q6ZMF3 Q9NQK6 Q9NQK7,Probable phospholipid-transporting ATPase IIA,ATPase class II type 9A;, PF16212;PF16209;, GO:0005769;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0032588;GO:0005524;GO:0140326;GO:0000287;GO:0002020;GO:0006897;GO:1903542;GO:0045332;GO:2001135;GO:1905279;GO:0006890;, C:early endosome; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:protease binding;, P:endocytosis; P:negative regulation of exosomal secretion; P:phospholipid translocation; P:regulation of endocytic recycling; P:regulation of retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O75110 E1P5Y3 E1P5Y4 Q5TFW5 Q5TFW6 Q5TFW9 Q6ZMF3 Q9NQK6 Q9NQK7,Probable phospholipid-transporting ATPase IIA,ATPase class II type 9A;, PF16212;PF16209;, GO:0005769;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0032588;GO:0005524;GO:0140326;GO:0000287;GO:0002020;GO:0006897;GO:1903542;GO:0045332;GO:2001135;GO:1905279;GO:0006890;, C:early endosome; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:protease binding;, P:endocytosis; P:negative regulation of exosomal secretion; P:phospholipid translocation; P:regulation of endocytic recycling; P:regulation of retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold67 indexed_genome mRNA 3953297 4013452 . + . ID=transcript_11070;Q9NPX6 Q9NQH3 Q9UJR2,Nuclear factor of activated T-cells, cytoplasmic 2,NFAT pre-existing subunit;T-cell transcription factor NFAT1;, PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0005667;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019902;GO:0000978;GO:1990837;GO:0008134;GO:0050853;GO:0033173;GO:0016477;GO:0006974;GO:0038095;GO:0014904;GO:1905064;GO:0030890;GO:1901741;GO:0045893;GO:0045589;GO:0006357;GO:0006355;GO:0042493;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:B cell receptor signaling pathway; P:calcineurin-NFAT signaling cascade; P:cell migration; P:cellular response to DNA damage stimulus; P:Fc-epsilon receptor signaling pathway; P:myotube cell development; P:negative regulation of vascular associated smooth muscle cell differentiation; P:positive regulation of B cell proliferation; P:positive regulation of myoblast fusion; P:positive regulation of transcription, DNA-templated; P:regulation of regulatory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to drug; scaffold67 indexed_genome mRNA 4026896 4079504 . + . ID=transcript_11071;Q9NPX6 Q9NQH3 Q9UJR2,Nuclear factor of activated T-cells, cytoplasmic 2,NFAT pre-existing subunit;T-cell transcription factor NFAT1;, PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:1990904;GO:0005667;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019902;GO:0000978;GO:1990837;GO:0008134;GO:0050853;GO:0033173;GO:0016477;GO:0006974;GO:0038095;GO:0014904;GO:1905064;GO:0030890;GO:1901741;GO:0045893;GO:0045589;GO:0006357;GO:0006355;GO:0042493;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:B cell receptor signaling pathway; P:calcineurin-NFAT signaling cascade; P:cell migration; P:cellular response to DNA damage stimulus; P:Fc-epsilon receptor signaling pathway; P:myotube cell development; P:negative regulation of vascular associated smooth muscle cell differentiation; P:positive regulation of B cell proliferation; P:positive regulation of myoblast fusion; P:positive regulation of transcription, DNA-templated; P:regulation of regulatory T cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to drug; scaffold67 indexed_genome mRNA 4434988 4437280 . - . ID=transcript_11072;O95396,Adenylyltransferase and sulfurtransferase MOCS3 {ECO:0000255|HAMAP-Rule:MF_03049},Molybdenum cofactor synthesis protein 3 {ECO:0000255|HAMAP-Rule:MF_03049};Molybdopterin synthase sulfurylase;, PF00581;PF00899;, GO:0005737;GO:0005829;GO:0005524;GO:0046872;GO:0061605;GO:0061604;GO:0016779;GO:0016783;GO:0004792;GO:0042292;GO:0006777;GO:0032324;GO:0032447;GO:0034227;GO:0002143;GO:0002098;, C:cytoplasm; C:cytosol;, F:ATP binding; F:metal ion binding; F:molybdopterin-synthase adenylyltransferase activity; F:molybdopterin-synthase sulfurtransferase activity; F:nucleotidyltransferase activity; F:sulfurtransferase activity; F:thiosulfate sulfurtransferase activity; F:URM1 activating enzyme activity;, P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process; P:protein urmylation; P:tRNA thio-modification; P:tRNA wobble position uridine thiolation; P:tRNA wobble uridine modification; scaffold67 indexed_genome mRNA 4444183 4489322 . + . ID=transcript_11073;O60762 O15157 Q6IB78 Q96HK0,Dolichol-phosphate mannosyltransferase subunit 1,Dolichol-phosphate mannose synthase subunit 1;Dolichyl-phosphate beta-D-mannosyltransferase subunit 1;Mannose-P-dolichol synthase subunit 1;, PF00535;, GO:0033185;GO:0005783;GO:0005789;GO:0016020;GO:0005634;GO:0004582;GO:0004169;GO:0019348;GO:0006506;GO:0035268;GO:0018279;GO:0035269;, C:dolichol-phosphate-mannose synthase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:nucleus;, F:dolichyl-phosphate beta-D-mannosyltransferase activity; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity;, P:dolichol metabolic process; P:GPI anchor biosynthetic process; P:protein mannosylation; P:protein N-linked glycosylation via asparagine; P:protein O-linked mannosylation;|Q9H2P0 E1P5Y2 O94881 Q5BKU2 Q9UG34,Activity-dependent neuroprotector homeobox protein,Activity-dependent neuroprotective protein;, PF00046;, GO:0000785;GO:0005634;GO:0090575;GO:0003677;GO:0000981;GO:0046872;GO:0010468;, C:chromatin; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of gene expression;|O60762 O15157 Q6IB78 Q96HK0,Dolichol-phosphate mannosyltransferase subunit 1,Dolichol-phosphate mannose synthase subunit 1;Dolichyl-phosphate beta-D-mannosyltransferase subunit 1;Mannose-P-dolichol synthase subunit 1;, PF00535;, GO:0033185;GO:0005783;GO:0005789;GO:0016020;GO:0005634;GO:0004582;GO:0004169;GO:0019348;GO:0006506;GO:0035268;GO:0018279;GO:0035269;, C:dolichol-phosphate-mannose synthase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:nucleus;, F:dolichyl-phosphate beta-D-mannosyltransferase activity; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity;, P:dolichol metabolic process; P:GPI anchor biosynthetic process; P:protein mannosylation; P:protein N-linked glycosylation via asparagine; P:protein O-linked mannosylation;|O60762 O15157 Q6IB78 Q96HK0,Dolichol-phosphate mannosyltransferase subunit 1,Dolichol-phosphate mannose synthase subunit 1;Dolichyl-phosphate beta-D-mannosyltransferase subunit 1;Mannose-P-dolichol synthase subunit 1;, PF00535;, GO:0033185;GO:0005783;GO:0005789;GO:0016020;GO:0005634;GO:0004582;GO:0004169;GO:0019348;GO:0006506;GO:0035268;GO:0018279;GO:0035269;, C:dolichol-phosphate-mannose synthase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:nucleus;, F:dolichyl-phosphate beta-D-mannosyltransferase activity; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity;, P:dolichol metabolic process; P:GPI anchor biosynthetic process; P:protein mannosylation; P:protein N-linked glycosylation via asparagine; P:protein O-linked mannosylation;|Q9H2P0 E1P5Y2 O94881 Q5BKU2 Q9UG34,Activity-dependent neuroprotector homeobox protein,Activity-dependent neuroprotective protein;, PF00046;, GO:0000785;GO:0005634;GO:0090575;GO:0003677;GO:0000981;GO:0046872;GO:0010468;, C:chromatin; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of gene expression;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9H2P0 E1P5Y2 O94881 Q5BKU2 Q9UG34,Activity-dependent neuroprotector homeobox protein,Activity-dependent neuroprotective protein;, PF00046;, GO:0000785;GO:0005634;GO:0090575;GO:0003677;GO:0000981;GO:0046872;GO:0010468;, C:chromatin; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:regulation of gene expression; scaffold67 indexed_genome mRNA 4498166 4554174 . - . ID=transcript_11074;Q9NX13 Q9Y511,Breast carcinoma-amplified sequence 4,, , GO:0031083;, C:BLOC-1 complex; scaffold67 indexed_genome mRNA 4587432 4715535 . - . ID=transcript_11075;Q9BYG5 A2A2A7 Q9Y510,Partitioning defective 6 homolog beta,, PF00564;PF00595;, GO:0016324;GO:0005923;GO:0005938;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0032991;GO:0005080;GO:0007409;GO:0070830;GO:0051301;GO:0007043;GO:0007098;GO:0007163;GO:0065003;GO:0030334;GO:0060341;, C:apical plasma membrane; C:bicellular tight junction; C:cell cortex; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:protein kinase C binding;, P:axonogenesis; P:bicellular tight junction assembly; P:cell division; P:cell-cell junction assembly; P:centrosome cycle; P:establishment or maintenance of cell polarity; P:protein-containing complex assembly; P:regulation of cell migration; P:regulation of cellular localization;|Q9BYG5 A2A2A7 Q9Y510,Partitioning defective 6 homolog beta,, PF00564;PF00595;, GO:0016324;GO:0005923;GO:0005938;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0032991;GO:0005080;GO:0007409;GO:0070830;GO:0051301;GO:0007043;GO:0007098;GO:0007163;GO:0065003;GO:0030334;GO:0060341;, C:apical plasma membrane; C:bicellular tight junction; C:cell cortex; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:protein kinase C binding;, P:axonogenesis; P:bicellular tight junction assembly; P:cell division; P:cell-cell junction assembly; P:centrosome cycle; P:establishment or maintenance of cell polarity; P:protein-containing complex assembly; P:regulation of cell migration; P:regulation of cellular localization;|Q96MK2 Q5QPB6 Q9NQQ2,RIPOR family member 3 {ECO:0000312|HGNC:HGNC:16168},, PF15903;|Q96MK2 Q5QPB6 Q9NQQ2,RIPOR family member 3 {ECO:0000312|HGNC:HGNC:16168},, PF15903;|Q96MK2 Q5QPB6 Q9NQQ2,RIPOR family member 3 {ECO:0000312|HGNC:HGNC:16168},, PF15903;|Q96MK2 Q5QPB6 Q9NQQ2,RIPOR family member 3 {ECO:0000312|HGNC:HGNC:16168},, PF15903; scaffold67 indexed_genome mRNA 4716222 4778036 . - . ID=transcript_11076;P18031 Q5TGD8 Q9BQV9 Q9NQQ4,Tyrosine-protein phosphatase non-receptor type 1,Protein-tyrosine phosphatase 1B;, PF00102;, GO:0098554;GO:0005829;GO:0005769;GO:0005783;GO:0030061;GO:0005759;GO:0032991;GO:0097443;GO:0045296;GO:0019899;GO:0046875;GO:0005158;GO:0019901;GO:0051721;GO:0004725;GO:0030971;GO:0003723;GO:0008270;GO:0031532;GO:0007257;GO:0034620;GO:0030968;GO:0060397;GO:0008286;GO:0036498;GO:1902236;GO:0070373;GO:0046627;GO:0043407;GO:1903898;GO:0009968;GO:0030948;GO:0035335;GO:1990264;GO:0035791;GO:1903896;GO:0061098;GO:2000646;GO:0006470;GO:0030100;GO:1902202;GO:0033157;GO:0009966;GO:0060338;, C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:mitochondrial crista; C:mitochondrial matrix; C:protein-containing complex; C:sorting endosome;, F:cadherin binding; F:enzyme binding; F:ephrin receptor binding; F:insulin receptor binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:RNA binding; F:zinc ion binding;, P:actin cytoskeleton reorganization; P:activation of JUN kinase activity; P:cellular response to unfolded protein; P:endoplasmic reticulum unfolded protein response; P:growth hormone receptor signaling pathway via JAK-STAT; P:insulin receptor signaling pathway; P:IRE1-mediated unfolded protein response; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of signal transduction; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of receptor catabolic process; P:protein dephosphorylation; P:regulation of endocytosis; P:regulation of hepatocyte growth factor receptor signaling pathway; P:regulation of intracellular protein transport; P:regulation of signal transduction; P:regulation of type I interferon-mediated signaling pathway;|P18031 Q5TGD8 Q9BQV9 Q9NQQ4,Tyrosine-protein phosphatase non-receptor type 1,Protein-tyrosine phosphatase 1B;, PF00102;, GO:0098554;GO:0005829;GO:0005769;GO:0005783;GO:0030061;GO:0005759;GO:0032991;GO:0097443;GO:0045296;GO:0019899;GO:0046875;GO:0005158;GO:0019901;GO:0051721;GO:0004725;GO:0030971;GO:0003723;GO:0008270;GO:0031532;GO:0007257;GO:0034620;GO:0030968;GO:0060397;GO:0008286;GO:0036498;GO:1902236;GO:0070373;GO:0046627;GO:0043407;GO:1903898;GO:0009968;GO:0030948;GO:0035335;GO:1990264;GO:0035791;GO:1903896;GO:0061098;GO:2000646;GO:0006470;GO:0030100;GO:1902202;GO:0033157;GO:0009966;GO:0060338;, C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:mitochondrial crista; C:mitochondrial matrix; C:protein-containing complex; C:sorting endosome;, F:cadherin binding; F:enzyme binding; F:ephrin receptor binding; F:insulin receptor binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:RNA binding; F:zinc ion binding;, P:actin cytoskeleton reorganization; P:activation of JUN kinase activity; P:cellular response to unfolded protein; P:endoplasmic reticulum unfolded protein response; P:growth hormone receptor signaling pathway via JAK-STAT; P:insulin receptor signaling pathway; P:IRE1-mediated unfolded protein response; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of signal transduction; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of receptor catabolic process; P:protein dephosphorylation; P:regulation of endocytosis; P:regulation of hepatocyte growth factor receptor signaling pathway; P:regulation of intracellular protein transport; P:regulation of signal transduction; P:regulation of type I interferon-mediated signaling pathway;|P18031 Q5TGD8 Q9BQV9 Q9NQQ4,Tyrosine-protein phosphatase non-receptor type 1,Protein-tyrosine phosphatase 1B;, PF00102;, GO:0098554;GO:0005829;GO:0005769;GO:0005783;GO:0030061;GO:0005759;GO:0032991;GO:0097443;GO:0045296;GO:0019899;GO:0046875;GO:0005158;GO:0019901;GO:0051721;GO:0004725;GO:0030971;GO:0003723;GO:0008270;GO:0031532;GO:0007257;GO:0034620;GO:0030968;GO:0060397;GO:0008286;GO:0036498;GO:1902236;GO:0070373;GO:0046627;GO:0043407;GO:1903898;GO:0009968;GO:0030948;GO:0035335;GO:1990264;GO:0035791;GO:1903896;GO:0061098;GO:2000646;GO:0006470;GO:0030100;GO:1902202;GO:0033157;GO:0009966;GO:0060338;, C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:mitochondrial crista; C:mitochondrial matrix; C:protein-containing complex; C:sorting endosome;, F:cadherin binding; F:enzyme binding; F:ephrin receptor binding; F:insulin receptor binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:RNA binding; F:zinc ion binding;, P:actin cytoskeleton reorganization; P:activation of JUN kinase activity; P:cellular response to unfolded protein; P:endoplasmic reticulum unfolded protein response; P:growth hormone receptor signaling pathway via JAK-STAT; P:insulin receptor signaling pathway; P:IRE1-mediated unfolded protein response; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of signal transduction; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of receptor catabolic process; P:protein dephosphorylation; P:regulation of endocytosis; P:regulation of hepatocyte growth factor receptor signaling pathway; P:regulation of intracellular protein transport; P:regulation of signal transduction; P:regulation of type I interferon-mediated signaling pathway;|P18031 Q5TGD8 Q9BQV9 Q9NQQ4,Tyrosine-protein phosphatase non-receptor type 1,Protein-tyrosine phosphatase 1B;, PF00102;, GO:0098554;GO:0005829;GO:0005769;GO:0005783;GO:0030061;GO:0005759;GO:0032991;GO:0097443;GO:0045296;GO:0019899;GO:0046875;GO:0005158;GO:0019901;GO:0051721;GO:0004725;GO:0030971;GO:0003723;GO:0008270;GO:0031532;GO:0007257;GO:0034620;GO:0030968;GO:0060397;GO:0008286;GO:0036498;GO:1902236;GO:0070373;GO:0046627;GO:0043407;GO:1903898;GO:0009968;GO:0030948;GO:0035335;GO:1990264;GO:0035791;GO:1903896;GO:0061098;GO:2000646;GO:0006470;GO:0030100;GO:1902202;GO:0033157;GO:0009966;GO:0060338;, C:cytoplasmic side of endoplasmic reticulum membrane; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:mitochondrial crista; C:mitochondrial matrix; C:protein-containing complex; C:sorting endosome;, F:cadherin binding; F:enzyme binding; F:ephrin receptor binding; F:insulin receptor binding; F:protein kinase binding; F:protein phosphatase 2A binding; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding; F:RNA binding; F:zinc ion binding;, P:actin cytoskeleton reorganization; P:activation of JUN kinase activity; P:cellular response to unfolded protein; P:endoplasmic reticulum unfolded protein response; P:growth hormone receptor signaling pathway via JAK-STAT; P:insulin receptor signaling pathway; P:IRE1-mediated unfolded protein response; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of signal transduction; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of receptor catabolic process; P:protein dephosphorylation; P:regulation of endocytosis; P:regulation of hepatocyte growth factor receptor signaling pathway; P:regulation of intracellular protein transport; P:regulation of signal transduction; P:regulation of type I interferon-mediated signaling pathway; scaffold67 indexed_genome mRNA 5173715 5179709 . - . ID=transcript_11077;O95863 B2R842 Q9P113 Q9UBP7 Q9UHH7,Zinc finger protein SNAI1,Protein snail homolog 1;, PF00096;, GO:0005737;GO:0005829;GO:0001650;GO:0043231;GO:0005654;GO:0005634;GO:0005721;GO:0003700;GO:0001227;GO:0070888;GO:0019900;GO:0046872;GO:0000978;GO:0000977;GO:1990837;GO:0003180;GO:0060536;GO:0016477;GO:0001837;GO:0003198;GO:0031069;GO:0070828;GO:0060972;GO:0001707;GO:0060806;GO:0043518;GO:1902230;GO:0000122;GO:0010957;GO:0061314;GO:0001649;GO:0030335;GO:0010718;GO:0045893;GO:2000810;GO:0006357;GO:0060021;GO:0060707;, C:cytoplasm; C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:kinase binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:aortic valve morphogenesis; P:cartilage morphogenesis; P:cell migration; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:hair follicle morphogenesis; P:heterochromatin organization; P:left/right pattern formation; P:mesoderm formation; P:negative regulation of cell differentiation involved in embryonic placenta development; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D biosynthetic process; P:Notch signaling involved in heart development; P:osteoblast differentiation; P:positive regulation of cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of transcription, DNA-templated; P:regulation of bicellular tight junction assembly; P:regulation of transcription by RNA polymerase II; P:roof of mouth development; P:trophoblast giant cell differentiation; scaffold67 indexed_genome mRNA 5206596 5220332 . - . ID=transcript_11078;Q9Y508 B2RDQ9 B4DWY5 E1P627 Q6N0B0,E3 ubiquitin-protein ligase RNF114,RING finger protein 114;RING-type E3 ubiquitin transferase RNF114 {ECO:0000305};Zinc finger protein 228;Zinc finger protein 313;, PF05605;PF13445;PF18574;, GO:0005829;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0030154;GO:0007275;GO:0000209;GO:0007283;GO:0006511;, C:cytosol; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell differentiation; P:multicellular organism development; P:protein polyubiquitination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process;|Q9Y508 B2RDQ9 B4DWY5 E1P627 Q6N0B0,E3 ubiquitin-protein ligase RNF114,RING finger protein 114;RING-type E3 ubiquitin transferase RNF114 {ECO:0000305};Zinc finger protein 228;Zinc finger protein 313;, PF05605;PF13445;PF18574;, GO:0005829;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0030154;GO:0007275;GO:0000209;GO:0007283;GO:0006511;, C:cytosol; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell differentiation; P:multicellular organism development; P:protein polyubiquitination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process;|Q9Y508 B2RDQ9 B4DWY5 E1P627 Q6N0B0,E3 ubiquitin-protein ligase RNF114,RING finger protein 114;RING-type E3 ubiquitin transferase RNF114 {ECO:0000305};Zinc finger protein 228;Zinc finger protein 313;, PF05605;PF13445;PF18574;, GO:0005829;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0030154;GO:0007275;GO:0000209;GO:0007283;GO:0006511;, C:cytosol; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell differentiation; P:multicellular organism development; P:protein polyubiquitination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process;|P27635 A3KQT0 D3DWW6 Q16470 Q2HXT7 Q53FH7 Q6FGN8 Q8TDA5,60S ribosomal protein L10 {ECO:0000305},Laminin receptor homolog;Large ribosomal subunit protein uL16 {ECO:0000303|PubMed:24524803};Protein QM;Ribosomal protein L10 {ECO:0000312|HGNC:HGNC:10298};Tumor suppressor QM;, PF00252;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0005634;GO:0032991;GO:0003723;GO:0003735;GO:0045182;GO:1990403;GO:0043066;GO:0000122;GO:0000184;GO:0006417;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane; C:nucleus; C:protein-containing complex;, F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:embryonic brain development; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q9Y508 B2RDQ9 B4DWY5 E1P627 Q6N0B0,E3 ubiquitin-protein ligase RNF114,RING finger protein 114;RING-type E3 ubiquitin transferase RNF114 {ECO:0000305};Zinc finger protein 228;Zinc finger protein 313;, PF05605;PF13445;PF18574;, GO:0005829;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0030154;GO:0007275;GO:0000209;GO:0007283;GO:0006511;, C:cytosol; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell differentiation; P:multicellular organism development; P:protein polyubiquitination; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process; scaffold67 indexed_genome mRNA 5234176 5241164 . + . ID=transcript_11079;Q9UM82 E1P626 O94857,Spermatogenesis-associated protein 2 {ECO:0000303|PubMed:27307491, ECO:0000303|PubMed:27458237},, , GO:0005737;GO:0001650;GO:0005654;GO:0044877;GO:0030159;GO:1990381;GO:0070266;GO:0070536;GO:1990108;GO:0050727;GO:0060544;GO:0010803;GO:0072520;GO:0007283;, C:cytoplasm; C:fibrillar center; C:nucleoplasm;, F:protein-containing complex binding; F:signaling receptor complex adaptor activity; F:ubiquitin-specific protease binding;, P:necroptotic process; P:protein K63-linked deubiquitination; P:protein linear deubiquitination; P:regulation of inflammatory response; P:regulation of necroptotic process; P:regulation of tumor necrosis factor-mediated signaling pathway; P:seminiferous tubule development; P:spermatogenesis; scaffold67 indexed_genome mRNA 5249286 5322930 . + . ID=transcript_11080;Q9Y2E8 B4DTQ8 Q2M1U9 Q68CZ8 Q9BX15 Q9Y507,Sodium/hydrogen exchanger 8,Na(+)/H(+) exchanger 8;Solute carrier family 9 member 8;, PF00999;, GO:0005794;GO:0000139;GO:0016021;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH;|Q9Y2E8 B4DTQ8 Q2M1U9 Q68CZ8 Q9BX15 Q9Y507,Sodium/hydrogen exchanger 8,Na(+)/H(+) exchanger 8;Solute carrier family 9 member 8;, PF00999;, GO:0005794;GO:0000139;GO:0016021;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH;|Q9Y2E8 B4DTQ8 Q2M1U9 Q68CZ8 Q9BX15 Q9Y507,Sodium/hydrogen exchanger 8,Na(+)/H(+) exchanger 8;Solute carrier family 9 member 8;, PF00999;, GO:0005794;GO:0000139;GO:0016021;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH;|Q9Y2E8 B4DTQ8 Q2M1U9 Q68CZ8 Q9BX15 Q9Y507,Sodium/hydrogen exchanger 8,Na(+)/H(+) exchanger 8;Solute carrier family 9 member 8;, PF00999;, GO:0005794;GO:0000139;GO:0016021;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH;|Q9Y2E8 B4DTQ8 Q2M1U9 Q68CZ8 Q9BX15 Q9Y507,Sodium/hydrogen exchanger 8,Na(+)/H(+) exchanger 8;Solute carrier family 9 member 8;, PF00999;, GO:0005794;GO:0000139;GO:0016021;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH;|Q9Y2E8 B4DTQ8 Q2M1U9 Q68CZ8 Q9BX15 Q9Y507,Sodium/hydrogen exchanger 8,Na(+)/H(+) exchanger 8;Solute carrier family 9 member 8;, PF00999;, GO:0005794;GO:0000139;GO:0016021;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH;|Q9Y2E8 B4DTQ8 Q2M1U9 Q68CZ8 Q9BX15 Q9Y507,Sodium/hydrogen exchanger 8,Na(+)/H(+) exchanger 8;Solute carrier family 9 member 8;, PF00999;, GO:0005794;GO:0000139;GO:0016021;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH;|Q9Y2E8 B4DTQ8 Q2M1U9 Q68CZ8 Q9BX15 Q9Y507,Sodium/hydrogen exchanger 8,Na(+)/H(+) exchanger 8;Solute carrier family 9 member 8;, PF00999;, GO:0005794;GO:0000139;GO:0016021;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:0051453;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of intracellular pH; scaffold67 indexed_genome mRNA 5468709 5476518 . + . ID=transcript_11081;O43286 E1P625 Q2M394 Q9UJQ8 U6C5D7,Beta-1,4-galactosyltransferase 5,Beta-1,4-GalT II {ECO:0000303|PubMed:9435216};Glucosylceramide beta-1,4-galactosyltransferase;Lactosylceramide synthase {ECO:0000303|PubMed:24498430};UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5;, PF02709;PF13733;, GO:0032580;GO:0000139;GO:0016021;GO:0008378;GO:0046872;GO:0003945;GO:0008489;GO:0022010;GO:0021955;GO:0010706;GO:0018146;GO:0042551;GO:0016266;GO:0030311;GO:0040019;GO:0006486;GO:0031647;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:galactosyltransferase activity; F:metal ion binding; F:N-acetyllactosamine synthase activity; F:UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity;, P:central nervous system myelination; P:central nervous system neuron axonogenesis; P:ganglioside biosynthetic process via lactosylceramide; P:keratan sulfate biosynthetic process; P:neuron maturation; P:O-glycan processing; P:poly-N-acetyllactosamine biosynthetic process; P:positive regulation of embryonic development; P:protein glycosylation; P:regulation of protein stability;|O43286 E1P625 Q2M394 Q9UJQ8 U6C5D7,Beta-1,4-galactosyltransferase 5,Beta-1,4-GalT II {ECO:0000303|PubMed:9435216};Glucosylceramide beta-1,4-galactosyltransferase;Lactosylceramide synthase {ECO:0000303|PubMed:24498430};UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5;, PF02709;PF13733;, GO:0032580;GO:0000139;GO:0016021;GO:0008378;GO:0046872;GO:0003945;GO:0008489;GO:0022010;GO:0021955;GO:0010706;GO:0018146;GO:0042551;GO:0016266;GO:0030311;GO:0040019;GO:0006486;GO:0031647;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:galactosyltransferase activity; F:metal ion binding; F:N-acetyllactosamine synthase activity; F:UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity;, P:central nervous system myelination; P:central nervous system neuron axonogenesis; P:ganglioside biosynthetic process via lactosylceramide; P:keratan sulfate biosynthetic process; P:neuron maturation; P:O-glycan processing; P:poly-N-acetyllactosamine biosynthetic process; P:positive regulation of embryonic development; P:protein glycosylation; P:regulation of protein stability; scaffold67 indexed_genome mRNA 5549348 5583087 . + . ID=transcript_11082;Q16647 Q3MII8 Q9HAX2 Q9HAX3 Q9HAX4,Prostacyclin synthase,Hydroperoxy icosatetraenoate dehydratase {ECO:0000305};Prostaglandin I2 synthase;, PF00067;, GO:0005901;GO:0005783;GO:0005789;GO:0005615;GO:0016021;GO:0005634;GO:0020037;GO:0106256;GO:0005506;GO:0004497;GO:0016705;GO:0008116;GO:0097190;GO:0071456;GO:0071347;GO:0071354;GO:0019371;GO:0006690;GO:0034356;GO:0050728;GO:0032088;GO:0045019;GO:0045766;GO:1900119;GO:0035360;GO:0001516;, C:caveola; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:integral component of membrane; C:nucleus;, F:heme binding; F:hydroperoxy icosatetraenoate dehydratase activity; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:prostaglandin-I synthase activity;, P:apoptotic signaling pathway; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cyclooxygenase pathway; P:icosanoid metabolic process; P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of inflammatory response; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of angiogenesis; P:positive regulation of execution phase of apoptosis; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; P:prostaglandin biosynthetic process; scaffold67 indexed_genome mRNA 5708468 5710011 . + . ID=transcript_11083;Q14721 Q14193,Potassium voltage-gated channel subfamily B member 1 {ECO:0000312|HGNC:HGNC:6231},Delayed rectifier potassium channel 1 {ECO:0000303|PubMed:8081723};Voltage-gated potassium channel subunit Kv2.1 {ECO:0000303|PubMed:8081723};, PF02214;PF00520;PF03521;, GO:0030424;GO:0030425;GO:0032590;GO:0016021;GO:0016328;GO:0032809;GO:0043204;GO:0005886;GO:0045211;GO:0042383;GO:0008076;GO:0005251;GO:0044325;GO:0046982;GO:0005249;GO:0001508;GO:0071333;GO:0031669;GO:0042593;GO:0007215;GO:0046676;GO:0045956;GO:0033605;GO:1900454;GO:0010701;GO:0090314;GO:0071805;GO:0051260;GO:0072659;GO:0098900;GO:0050796;GO:0034765;GO:2000671;GO:0006904;, C:axon; C:dendrite; C:dendrite membrane; C:integral component of membrane; C:lateral plasma membrane; C:neuronal cell body membrane; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:ion channel binding; F:protein heterodimerization activity; F:voltage-gated potassium channel activity;, P:action potential; P:cellular response to glucose stimulus; P:cellular response to nutrient levels; P:glucose homeostasis; P:glutamate receptor signaling pathway; P:negative regulation of insulin secretion; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of catecholamine secretion; P:positive regulation of long-term synaptic depression; P:positive regulation of norepinephrine secretion; P:positive regulation of protein targeting to membrane; P:potassium ion transmembrane transport; P:protein homooligomerization; P:protein localization to plasma membrane; P:regulation of action potential; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:regulation of motor neuron apoptotic process; P:vesicle docking involved in exocytosis;|Q14721 Q14193,Potassium voltage-gated channel subfamily B member 1 {ECO:0000312|HGNC:HGNC:6231},Delayed rectifier potassium channel 1 {ECO:0000303|PubMed:8081723};Voltage-gated potassium channel subunit Kv2.1 {ECO:0000303|PubMed:8081723};, PF02214;PF00520;PF03521;, GO:0030424;GO:0030425;GO:0032590;GO:0016021;GO:0016328;GO:0032809;GO:0043204;GO:0005886;GO:0045211;GO:0042383;GO:0008076;GO:0005251;GO:0044325;GO:0046982;GO:0005249;GO:0001508;GO:0071333;GO:0031669;GO:0042593;GO:0007215;GO:0046676;GO:0045956;GO:0033605;GO:1900454;GO:0010701;GO:0090314;GO:0071805;GO:0051260;GO:0072659;GO:0098900;GO:0050796;GO:0034765;GO:2000671;GO:0006904;, C:axon; C:dendrite; C:dendrite membrane; C:integral component of membrane; C:lateral plasma membrane; C:neuronal cell body membrane; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:ion channel binding; F:protein heterodimerization activity; F:voltage-gated potassium channel activity;, P:action potential; P:cellular response to glucose stimulus; P:cellular response to nutrient levels; P:glucose homeostasis; P:glutamate receptor signaling pathway; P:negative regulation of insulin secretion; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of catecholamine secretion; P:positive regulation of long-term synaptic depression; P:positive regulation of norepinephrine secretion; P:positive regulation of protein targeting to membrane; P:potassium ion transmembrane transport; P:protein homooligomerization; P:protein localization to plasma membrane; P:regulation of action potential; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:regulation of motor neuron apoptotic process; P:vesicle docking involved in exocytosis; scaffold67 indexed_genome mRNA 5749556 5750298 . + . ID=transcript_11084;Q8IVN8 A8KAA5 Q96J64,Somatomedin-B and thrombospondin type-1 domain-containing protein,RPE-spondin;, PF19028;, GO:0062023;GO:0005576;, C:collagen-containing extracellular matrix; C:extracellular region; scaffold67 indexed_genome mRNA 5799445 5826178 . + . ID=transcript_11085;Q9P2E3 Q9BQM7 Q9BQM8 Q9H8C1 Q9H9S2 Q9NUM1 Q9NWW1,NFX1-type zinc finger-containing protein 1,, PF13086;PF13087;, GO:0031380;GO:0004386;GO:0003723;GO:0008270;GO:0031048;, C:nuclear RNA-directed RNA polymerase complex;, F:helicase activity; F:RNA binding; F:zinc ion binding;, P:heterochromatin assembly by small RNA;|Q9P2E3 Q9BQM7 Q9BQM8 Q9H8C1 Q9H9S2 Q9NUM1 Q9NWW1,NFX1-type zinc finger-containing protein 1,, PF13086;PF13087;, GO:0031380;GO:0004386;GO:0003723;GO:0008270;GO:0031048;, C:nuclear RNA-directed RNA polymerase complex;, F:helicase activity; F:RNA binding; F:zinc ion binding;, P:heterochromatin assembly by small RNA;|Q9P2E3 Q9BQM7 Q9BQM8 Q9H8C1 Q9H9S2 Q9NUM1 Q9NWW1,NFX1-type zinc finger-containing protein 1,, PF13086;PF13087;, GO:0031380;GO:0004386;GO:0003723;GO:0008270;GO:0031048;, C:nuclear RNA-directed RNA polymerase complex;, F:helicase activity; F:RNA binding; F:zinc ion binding;, P:heterochromatin assembly by small RNA;|Q9P2E3 Q9BQM7 Q9BQM8 Q9H8C1 Q9H9S2 Q9NUM1 Q9NWW1,NFX1-type zinc finger-containing protein 1,, PF13086;PF13087;, GO:0031380;GO:0004386;GO:0003723;GO:0008270;GO:0031048;, C:nuclear RNA-directed RNA polymerase complex;, F:helicase activity; F:RNA binding; F:zinc ion binding;, P:heterochromatin assembly by small RNA; scaffold67 indexed_genome mRNA 5827611 5844537 . - . ID=transcript_11086;Q9BXF0 Q9H990 Q9NWU3 Q9P0C2 Q9UGD6,Probable ATP-dependent RNA helicase DDX27,DEAD box protein 27;, PF00270;PF00271;, GO:0005694;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0006364;, C:chromosome; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:rRNA processing;|Q9BXF0 Q9H990 Q9NWU3 Q9P0C2 Q9UGD6,Probable ATP-dependent RNA helicase DDX27,DEAD box protein 27;, PF00270;PF00271;, GO:0005694;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0006364;, C:chromosome; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:rRNA processing;|Q9BXF0 Q9H990 Q9NWU3 Q9P0C2 Q9UGD6,Probable ATP-dependent RNA helicase DDX27,DEAD box protein 27;, PF00270;PF00271;, GO:0005694;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0006364;, C:chromosome; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:rRNA processing;|Q9BXF0 Q9H990 Q9NWU3 Q9P0C2 Q9UGD6,Probable ATP-dependent RNA helicase DDX27,DEAD box protein 27;, PF00270;PF00271;, GO:0005694;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0006364;, C:chromosome; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:rRNA processing;|Q9BXF0 Q9H990 Q9NWU3 Q9P0C2 Q9UGD6,Probable ATP-dependent RNA helicase DDX27,DEAD box protein 27;, PF00270;PF00271;, GO:0005694;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0006364;, C:chromosome; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:rRNA processing;|Q9BXF0 Q9H990 Q9NWU3 Q9P0C2 Q9UGD6,Probable ATP-dependent RNA helicase DDX27,DEAD box protein 27;, PF00270;PF00271;, GO:0005694;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0006364;, C:chromosome; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:rRNA processing;|Q9BXF0 Q9H990 Q9NWU3 Q9P0C2 Q9UGD6,Probable ATP-dependent RNA helicase DDX27,DEAD box protein 27;, PF00270;PF00271;, GO:0005694;GO:0005730;GO:0005524;GO:0003723;GO:0003724;GO:0006364;, C:chromosome; C:nucleolus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:rRNA processing; scaffold67 indexed_genome mRNA 5882393 5928068 . + . ID=transcript_11087;O95793 A8K9Z4 E1P5Y1 E1P608 Q5JW29 Q6GTM4 Q9H5B4 Q9H5B5 Q9Y3Q2,Double-stranded RNA-binding protein Staufen homolog 1,, PF00035;PF16482;, GO:0044297;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0030425;GO:0005783;GO:0070062;GO:0098978;GO:0016020;GO:0005875;GO:0043025;GO:0005886;GO:0005791;GO:0003725;GO:0008157;GO:0003723;GO:0034599;GO:0099010;GO:0046726;GO:1900273;GO:0045070;GO:0016032;, C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:microtubule associated complex; C:neuronal cell body; C:plasma membrane; C:rough endoplasmic reticulum;, F:double-stranded RNA binding; F:protein phosphatase 1 binding; F:RNA binding;, P:cellular response to oxidative stress; P:modification of postsynaptic structure; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of long-term synaptic potentiation; P:positive regulation of viral genome replication; P:viral process;|O95793 A8K9Z4 E1P5Y1 E1P608 Q5JW29 Q6GTM4 Q9H5B4 Q9H5B5 Q9Y3Q2,Double-stranded RNA-binding protein Staufen homolog 1,, PF00035;PF16482;, GO:0044297;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0030425;GO:0005783;GO:0070062;GO:0098978;GO:0016020;GO:0005875;GO:0043025;GO:0005886;GO:0005791;GO:0003725;GO:0008157;GO:0003723;GO:0034599;GO:0099010;GO:0046726;GO:1900273;GO:0045070;GO:0016032;, C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:microtubule associated complex; C:neuronal cell body; C:plasma membrane; C:rough endoplasmic reticulum;, F:double-stranded RNA binding; F:protein phosphatase 1 binding; F:RNA binding;, P:cellular response to oxidative stress; P:modification of postsynaptic structure; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of long-term synaptic potentiation; P:positive regulation of viral genome replication; P:viral process;|Q6AHY7 Q96HM0 Q96HM1 Q9NVI5 Q9UGG6,Double-stranded RNA-binding protein Staufen homolog 2,, PF00035;PF16482;, GO:0005783;GO:0016020;GO:0005874;GO:0005730;GO:0003725;GO:0003723;, C:endoplasmic reticulum; C:membrane; C:microtubule; C:nucleolus;, F:double-stranded RNA binding; F:RNA binding;|O95793 A8K9Z4 E1P5Y1 E1P608 Q5JW29 Q6GTM4 Q9H5B4 Q9H5B5 Q9Y3Q2,Double-stranded RNA-binding protein Staufen homolog 1,, PF00035;PF16482;, GO:0044297;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0030425;GO:0005783;GO:0070062;GO:0098978;GO:0016020;GO:0005875;GO:0043025;GO:0005886;GO:0005791;GO:0003725;GO:0008157;GO:0003723;GO:0034599;GO:0099010;GO:0046726;GO:1900273;GO:0045070;GO:0016032;, C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:microtubule associated complex; C:neuronal cell body; C:plasma membrane; C:rough endoplasmic reticulum;, F:double-stranded RNA binding; F:protein phosphatase 1 binding; F:RNA binding;, P:cellular response to oxidative stress; P:modification of postsynaptic structure; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of long-term synaptic potentiation; P:positive regulation of viral genome replication; P:viral process;|O95793 A8K9Z4 E1P5Y1 E1P608 Q5JW29 Q6GTM4 Q9H5B4 Q9H5B5 Q9Y3Q2,Double-stranded RNA-binding protein Staufen homolog 1,, PF00035;PF16482;, GO:0044297;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0030425;GO:0005783;GO:0070062;GO:0098978;GO:0016020;GO:0005875;GO:0043025;GO:0005886;GO:0005791;GO:0003725;GO:0008157;GO:0003723;GO:0034599;GO:0099010;GO:0046726;GO:1900273;GO:0045070;GO:0016032;, C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:microtubule associated complex; C:neuronal cell body; C:plasma membrane; C:rough endoplasmic reticulum;, F:double-stranded RNA binding; F:protein phosphatase 1 binding; F:RNA binding;, P:cellular response to oxidative stress; P:modification of postsynaptic structure; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of long-term synaptic potentiation; P:positive regulation of viral genome replication; P:viral process;|O95793 A8K9Z4 E1P5Y1 E1P608 Q5JW29 Q6GTM4 Q9H5B4 Q9H5B5 Q9Y3Q2,Double-stranded RNA-binding protein Staufen homolog 1,, PF00035;PF16482;, GO:0044297;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0030425;GO:0005783;GO:0070062;GO:0098978;GO:0016020;GO:0005875;GO:0043025;GO:0005886;GO:0005791;GO:0003725;GO:0008157;GO:0003723;GO:0034599;GO:0099010;GO:0046726;GO:1900273;GO:0045070;GO:0016032;, C:cell body; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:microtubule associated complex; C:neuronal cell body; C:plasma membrane; C:rough endoplasmic reticulum;, F:double-stranded RNA binding; F:protein phosphatase 1 binding; F:RNA binding;, P:cellular response to oxidative stress; P:modification of postsynaptic structure; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of long-term synaptic potentiation; P:positive regulation of viral genome replication; P:viral process; scaffold67 indexed_genome mRNA 5932161 5956874 . - . ID=transcript_11088;Q9UP98 Q9UP99 Q9UPA0,Exportin-2,Cellular apoptosis susceptibility protein {ECO:0000303|PubMed:7479798};Chromosome segregation 1-like protein;Importin-alpha re-exporter;, PF03378;PF08506;PF03810;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005635;GO:0005654;GO:0005634;GO:0005049;GO:0031267;GO:0006611;GO:0006606;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; P:protein import into nucleus;|Q9UP98 Q9UP99 Q9UPA0,Exportin-2,Cellular apoptosis susceptibility protein {ECO:0000303|PubMed:7479798};Chromosome segregation 1-like protein;Importin-alpha re-exporter;, PF03378;PF08506;PF03810;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005635;GO:0005654;GO:0005634;GO:0005049;GO:0031267;GO:0006611;GO:0006606;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; P:protein import into nucleus;|Q9UP98 Q9UP99 Q9UPA0,Exportin-2,Cellular apoptosis susceptibility protein {ECO:0000303|PubMed:7479798};Chromosome segregation 1-like protein;Importin-alpha re-exporter;, PF03378;PF08506;PF03810;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005635;GO:0005654;GO:0005634;GO:0005049;GO:0031267;GO:0006611;GO:0006606;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; P:protein import into nucleus;|Q9UP98 Q9UP99 Q9UPA0,Exportin-2,Cellular apoptosis susceptibility protein {ECO:0000303|PubMed:7479798};Chromosome segregation 1-like protein;Importin-alpha re-exporter;, PF03378;PF08506;PF03810;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005635;GO:0005654;GO:0005634;GO:0005049;GO:0031267;GO:0006611;GO:0006606;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; P:protein import into nucleus;|Q9UP98 Q9UP99 Q9UPA0,Exportin-2,Cellular apoptosis susceptibility protein {ECO:0000303|PubMed:7479798};Chromosome segregation 1-like protein;Importin-alpha re-exporter;, PF03378;PF08506;PF03810;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005635;GO:0005654;GO:0005634;GO:0005049;GO:0031267;GO:0006611;GO:0006606;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; P:protein import into nucleus;|Q9UP98 Q9UP99 Q9UPA0,Exportin-2,Cellular apoptosis susceptibility protein {ECO:0000303|PubMed:7479798};Chromosome segregation 1-like protein;Importin-alpha re-exporter;, PF03378;PF08506;PF03810;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005635;GO:0005654;GO:0005634;GO:0005049;GO:0031267;GO:0006611;GO:0006606;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; P:protein import into nucleus; scaffold67 indexed_genome mRNA 5995412 5995982 . - . ID=transcript_11089;Q9Y6D5 Q5TFT9 Q9NTS1,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ADP-ribosylation factor guanine nucleotide-exchange factor 2;, PF16213;PF09324;PF01369;PF12783;, GO:0032279;GO:0005879;GO:0031410;GO:0005829;GO:0043197;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005815;GO:0048471;GO:0055037;GO:0032280;GO:0005802;GO:0050811;GO:0005085;GO:0017022;GO:0034237;GO:0010256;GO:0007032;GO:0006887;GO:0006893;GO:0035556;GO:0032760;GO:0015031;GO:0001881;GO:0032012;, C:asymmetric synapse; C:axonemal microtubule; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:recycling endosome; C:symmetric synapse; C:trans-Golgi network;, F:GABA receptor binding; F:guanyl-nucleotide exchange factor activity; F:myosin binding; F:protein kinase A regulatory subunit binding;, P:endomembrane system organization; P:endosome organization; P:exocytosis; P:Golgi to plasma membrane transport; P:intracellular signal transduction; P:positive regulation of tumor necrosis factor production; P:protein transport; P:receptor recycling; P:regulation of ARF protein signal transduction; scaffold67 indexed_genome mRNA 6002464 6073101 . - . ID=transcript_11090;Q9Y6D5 Q5TFT9 Q9NTS1,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ADP-ribosylation factor guanine nucleotide-exchange factor 2;, PF16213;PF09324;PF01369;PF12783;, GO:0032279;GO:0005879;GO:0031410;GO:0005829;GO:0043197;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005815;GO:0048471;GO:0055037;GO:0032280;GO:0005802;GO:0050811;GO:0005085;GO:0017022;GO:0034237;GO:0010256;GO:0007032;GO:0006887;GO:0006893;GO:0035556;GO:0032760;GO:0015031;GO:0001881;GO:0032012;, C:asymmetric synapse; C:axonemal microtubule; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:recycling endosome; C:symmetric synapse; C:trans-Golgi network;, F:GABA receptor binding; F:guanyl-nucleotide exchange factor activity; F:myosin binding; F:protein kinase A regulatory subunit binding;, P:endomembrane system organization; P:endosome organization; P:exocytosis; P:Golgi to plasma membrane transport; P:intracellular signal transduction; P:positive regulation of tumor necrosis factor production; P:protein transport; P:receptor recycling; P:regulation of ARF protein signal transduction;|Q9Y6D5 Q5TFT9 Q9NTS1,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ADP-ribosylation factor guanine nucleotide-exchange factor 2;, PF16213;PF09324;PF01369;PF12783;, GO:0032279;GO:0005879;GO:0031410;GO:0005829;GO:0043197;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005815;GO:0048471;GO:0055037;GO:0032280;GO:0005802;GO:0050811;GO:0005085;GO:0017022;GO:0034237;GO:0010256;GO:0007032;GO:0006887;GO:0006893;GO:0035556;GO:0032760;GO:0015031;GO:0001881;GO:0032012;, C:asymmetric synapse; C:axonemal microtubule; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:recycling endosome; C:symmetric synapse; C:trans-Golgi network;, F:GABA receptor binding; F:guanyl-nucleotide exchange factor activity; F:myosin binding; F:protein kinase A regulatory subunit binding;, P:endomembrane system organization; P:endosome organization; P:exocytosis; P:Golgi to plasma membrane transport; P:intracellular signal transduction; P:positive regulation of tumor necrosis factor production; P:protein transport; P:receptor recycling; P:regulation of ARF protein signal transduction;|Q9Y6D5 Q5TFT9 Q9NTS1,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ADP-ribosylation factor guanine nucleotide-exchange factor 2;, PF16213;PF09324;PF01369;PF12783;, GO:0032279;GO:0005879;GO:0031410;GO:0005829;GO:0043197;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005815;GO:0048471;GO:0055037;GO:0032280;GO:0005802;GO:0050811;GO:0005085;GO:0017022;GO:0034237;GO:0010256;GO:0007032;GO:0006887;GO:0006893;GO:0035556;GO:0032760;GO:0015031;GO:0001881;GO:0032012;, C:asymmetric synapse; C:axonemal microtubule; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:recycling endosome; C:symmetric synapse; C:trans-Golgi network;, F:GABA receptor binding; F:guanyl-nucleotide exchange factor activity; F:myosin binding; F:protein kinase A regulatory subunit binding;, P:endomembrane system organization; P:endosome organization; P:exocytosis; P:Golgi to plasma membrane transport; P:intracellular signal transduction; P:positive regulation of tumor necrosis factor production; P:protein transport; P:receptor recycling; P:regulation of ARF protein signal transduction; scaffold67 indexed_genome mRNA 6149526 6329412 . + . ID=transcript_11091;Q9P2D2 Q9UGQ4,Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein,, PF00610;PF00621;, GO:0005829;GO:0043198;GO:0030426;GO:0048471;GO:0005886;GO:0019899;GO:0005096;GO:0005085;GO:0005543;GO:0030041;GO:0007186;GO:0035556;GO:0042119;GO:0030593;GO:0043065;GO:0030335;GO:1900026;GO:0030833;GO:0050773;GO:0051056;GO:0006801;GO:0030217;, C:cytosol; C:dendritic shaft; C:growth cone; C:perinuclear region of cytoplasm; C:plasma membrane;, F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:actin filament polymerization; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:neutrophil activation; P:neutrophil chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of actin filament polymerization; P:regulation of dendrite development; P:regulation of small GTPase mediated signal transduction; P:superoxide metabolic process; P:T cell differentiation;|Q9P2D2 Q9UGQ4,Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein,, PF00610;PF00621;, GO:0005829;GO:0043198;GO:0030426;GO:0048471;GO:0005886;GO:0019899;GO:0005096;GO:0005085;GO:0005543;GO:0030041;GO:0007186;GO:0035556;GO:0042119;GO:0030593;GO:0043065;GO:0030335;GO:1900026;GO:0030833;GO:0050773;GO:0051056;GO:0006801;GO:0030217;, C:cytosol; C:dendritic shaft; C:growth cone; C:perinuclear region of cytoplasm; C:plasma membrane;, F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:actin filament polymerization; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:neutrophil activation; P:neutrophil chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of actin filament polymerization; P:regulation of dendrite development; P:regulation of small GTPase mediated signal transduction; P:superoxide metabolic process; P:T cell differentiation;|Q9P2D2 Q9UGQ4,Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein,, PF00610;PF00621;, GO:0005829;GO:0043198;GO:0030426;GO:0048471;GO:0005886;GO:0019899;GO:0005096;GO:0005085;GO:0005543;GO:0030041;GO:0007186;GO:0035556;GO:0042119;GO:0030593;GO:0043065;GO:0030335;GO:1900026;GO:0030833;GO:0050773;GO:0051056;GO:0006801;GO:0030217;, C:cytosol; C:dendritic shaft; C:growth cone; C:perinuclear region of cytoplasm; C:plasma membrane;, F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:phospholipid binding;, P:actin filament polymerization; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:neutrophil activation; P:neutrophil chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of actin filament polymerization; P:regulation of dendrite development; P:regulation of small GTPase mediated signal transduction; P:superoxide metabolic process; P:T cell differentiation; scaffold67 indexed_genome mRNA 6946085 6986909 . + . ID=transcript_11092;Q8IWU5 E1P5U6 Q5JYE1 Q6UX86 Q96SG2 Q9H1H0 Q9UJR3 Q9ULH3,Extracellular sulfatase Sulf-2,, PF12548;PF00884;, GO:0009986;GO:0005783;GO:0005615;GO:0005795;GO:0005886;GO:0004065;GO:0005509;GO:0005539;GO:0008449;GO:0060348;GO:0051216;GO:0002063;GO:0048706;GO:0014846;GO:0035860;GO:0032836;GO:0003094;GO:0030201;GO:0060384;GO:0001822;GO:0097421;GO:0040037;GO:0090263;GO:0010575;GO:0030177;GO:2000345;GO:0009611;, C:cell surface; C:endoplasmic reticulum; C:extracellular space; C:Golgi stack; C:plasma membrane;, F:arylsulfatase activity; F:calcium ion binding; F:glycosaminoglycan binding; F:N-acetylglucosamine-6-sulfatase activity;, P:bone development; P:cartilage development; P:chondrocyte development; P:embryonic skeletal system development; P:esophagus smooth muscle contraction; P:glial cell-derived neurotrophic factor receptor signaling pathway; P:glomerular basement membrane development; P:glomerular filtration; P:heparan sulfate proteoglycan metabolic process; P:innervation; P:kidney development; P:liver regeneration; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of Wnt signaling pathway; P:regulation of hepatocyte proliferation; P:response to wounding;|Q8IWU5 E1P5U6 Q5JYE1 Q6UX86 Q96SG2 Q9H1H0 Q9UJR3 Q9ULH3,Extracellular sulfatase Sulf-2,, PF12548;PF00884;, GO:0009986;GO:0005783;GO:0005615;GO:0005795;GO:0005886;GO:0004065;GO:0005509;GO:0005539;GO:0008449;GO:0060348;GO:0051216;GO:0002063;GO:0048706;GO:0014846;GO:0035860;GO:0032836;GO:0003094;GO:0030201;GO:0060384;GO:0001822;GO:0097421;GO:0040037;GO:0090263;GO:0010575;GO:0030177;GO:2000345;GO:0009611;, C:cell surface; C:endoplasmic reticulum; C:extracellular space; C:Golgi stack; C:plasma membrane;, F:arylsulfatase activity; F:calcium ion binding; F:glycosaminoglycan binding; F:N-acetylglucosamine-6-sulfatase activity;, P:bone development; P:cartilage development; P:chondrocyte development; P:embryonic skeletal system development; P:esophagus smooth muscle contraction; P:glial cell-derived neurotrophic factor receptor signaling pathway; P:glomerular basement membrane development; P:glomerular filtration; P:heparan sulfate proteoglycan metabolic process; P:innervation; P:kidney development; P:liver regeneration; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of Wnt signaling pathway; P:regulation of hepatocyte proliferation; P:response to wounding; scaffold67 indexed_genome mRNA 6990639 7018712 . - . ID=transcript_11093;Q9Y6Q9 A4LAZ5 Q0VF45 Q5JYD9 Q5JYE0 Q9BR49 Q9UPC9 Q9UPG4 Q9UPG7,Nuclear receptor coactivator 3,ACTR;Amplified in breast cancer 1 protein;CBP-interacting protein;Class E basic helix-loop-helix protein 42;Receptor-associated coactivator 3;Steroid receptor coactivator protein 3;Thyroid hormone receptor activator molecule 1;, PF07469;PF16279;PF08815;PF00989;PF08832;, GO:0000785;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0097718;GO:0004402;GO:0035257;GO:0016922;GO:0030374;GO:0046983;GO:0047485;GO:0000993;GO:0046966;GO:0003713;GO:0043697;GO:0071392;GO:0032870;GO:0045618;GO:1902459;GO:0045944;GO:0035624;GO:2000035;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:disordered domain specific binding; F:histone acetyltransferase activity; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein dimerization activity; F:protein N-terminus binding; F:RNA polymerase II complex binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:cell dedifferentiation; P:cellular response to estradiol stimulus; P:cellular response to hormone stimulus; P:positive regulation of keratinocyte differentiation; P:positive regulation of stem cell population maintenance; P:positive regulation of transcription by RNA polymerase II; P:receptor transactivation; P:regulation of stem cell division;|Q9Y6Q9 A4LAZ5 Q0VF45 Q5JYD9 Q5JYE0 Q9BR49 Q9UPC9 Q9UPG4 Q9UPG7,Nuclear receptor coactivator 3,ACTR;Amplified in breast cancer 1 protein;CBP-interacting protein;Class E basic helix-loop-helix protein 42;Receptor-associated coactivator 3;Steroid receptor coactivator protein 3;Thyroid hormone receptor activator molecule 1;, PF07469;PF16279;PF08815;PF00989;PF08832;, GO:0000785;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0097718;GO:0004402;GO:0035257;GO:0016922;GO:0030374;GO:0046983;GO:0047485;GO:0000993;GO:0046966;GO:0003713;GO:0043697;GO:0071392;GO:0032870;GO:0045618;GO:1902459;GO:0045944;GO:0035624;GO:2000035;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:disordered domain specific binding; F:histone acetyltransferase activity; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein dimerization activity; F:protein N-terminus binding; F:RNA polymerase II complex binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:cell dedifferentiation; P:cellular response to estradiol stimulus; P:cellular response to hormone stimulus; P:positive regulation of keratinocyte differentiation; P:positive regulation of stem cell population maintenance; P:positive regulation of transcription by RNA polymerase II; P:receptor transactivation; P:regulation of stem cell division;|Q9Y6Q9 A4LAZ5 Q0VF45 Q5JYD9 Q5JYE0 Q9BR49 Q9UPC9 Q9UPG4 Q9UPG7,Nuclear receptor coactivator 3,ACTR;Amplified in breast cancer 1 protein;CBP-interacting protein;Class E basic helix-loop-helix protein 42;Receptor-associated coactivator 3;Steroid receptor coactivator protein 3;Thyroid hormone receptor activator molecule 1;, PF07469;PF16279;PF08815;PF00989;PF08832;, GO:0000785;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0097718;GO:0004402;GO:0035257;GO:0016922;GO:0030374;GO:0046983;GO:0047485;GO:0000993;GO:0046966;GO:0003713;GO:0043697;GO:0071392;GO:0032870;GO:0045618;GO:1902459;GO:0045944;GO:0035624;GO:2000035;, C:chromatin; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:disordered domain specific binding; F:histone acetyltransferase activity; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:protein dimerization activity; F:protein N-terminus binding; F:RNA polymerase II complex binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:cell dedifferentiation; P:cellular response to estradiol stimulus; P:cellular response to hormone stimulus; P:positive regulation of keratinocyte differentiation; P:positive regulation of stem cell population maintenance; P:positive regulation of transcription by RNA polymerase II; P:receptor transactivation; P:regulation of stem cell division; scaffold67 indexed_genome mRNA 7287206 7313845 . + . ID=transcript_11094;Q9H1F3 Q9H1F4 Q9H1F5 Q9H1L8 Q9H1L9 Q9H2G5 Q9NYN3 Q9UIX6,Protein kinase C-binding protein 1,Cutaneous T-cell lymphoma-associated antigen se14-3;Rack7;Zinc finger MYND domain-containing protein 8;, PF00439;PF12064;PF00855;, GO:0005737;GO:0043198;GO:0043197;GO:0005794;GO:0005654;GO:0005634;GO:0070577;GO:0035064;GO:0019904;GO:0047485;GO:0070491;GO:0003714;GO:0008270;GO:0098815;GO:0030336;GO:0060999;GO:1902952;GO:0051491;GO:1902897;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:methylated histone binding; F:protein domain specific binding; F:protein N-terminus binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:zinc ion binding;, P:modulation of excitatory postsynaptic potential; P:negative regulation of cell migration; P:positive regulation of dendritic spine development; P:positive regulation of dendritic spine maintenance; P:positive regulation of filopodium assembly; P:regulation of postsynaptic density protein 95 clustering; scaffold67 indexed_genome mRNA 7326047 7363938 . + . ID=transcript_11095;Q9H1F3 Q9H1F4 Q9H1F5 Q9H1L8 Q9H1L9 Q9H2G5 Q9NYN3 Q9UIX6,Protein kinase C-binding protein 1,Cutaneous T-cell lymphoma-associated antigen se14-3;Rack7;Zinc finger MYND domain-containing protein 8;, PF00439;PF12064;PF00855;, GO:0005737;GO:0043198;GO:0043197;GO:0005794;GO:0005654;GO:0005634;GO:0070577;GO:0035064;GO:0019904;GO:0047485;GO:0070491;GO:0003714;GO:0008270;GO:0098815;GO:0030336;GO:0060999;GO:1902952;GO:0051491;GO:1902897;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:methylated histone binding; F:protein domain specific binding; F:protein N-terminus binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:zinc ion binding;, P:modulation of excitatory postsynaptic potential; P:negative regulation of cell migration; P:positive regulation of dendritic spine development; P:positive regulation of dendritic spine maintenance; P:positive regulation of filopodium assembly; P:regulation of postsynaptic density protein 95 clustering;|Q9H1F3 Q9H1F4 Q9H1F5 Q9H1L8 Q9H1L9 Q9H2G5 Q9NYN3 Q9UIX6,Protein kinase C-binding protein 1,Cutaneous T-cell lymphoma-associated antigen se14-3;Rack7;Zinc finger MYND domain-containing protein 8;, PF00439;PF12064;PF00855;, GO:0005737;GO:0043198;GO:0043197;GO:0005794;GO:0005654;GO:0005634;GO:0070577;GO:0035064;GO:0019904;GO:0047485;GO:0070491;GO:0003714;GO:0008270;GO:0098815;GO:0030336;GO:0060999;GO:1902952;GO:0051491;GO:1902897;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:methylated histone binding; F:protein domain specific binding; F:protein N-terminus binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:zinc ion binding;, P:modulation of excitatory postsynaptic potential; P:negative regulation of cell migration; P:positive regulation of dendritic spine development; P:positive regulation of dendritic spine maintenance; P:positive regulation of filopodium assembly; P:regulation of postsynaptic density protein 95 clustering;|Q9H1F3 Q9H1F4 Q9H1F5 Q9H1L8 Q9H1L9 Q9H2G5 Q9NYN3 Q9UIX6,Protein kinase C-binding protein 1,Cutaneous T-cell lymphoma-associated antigen se14-3;Rack7;Zinc finger MYND domain-containing protein 8;, PF00439;PF12064;PF00855;, GO:0005737;GO:0043198;GO:0043197;GO:0005794;GO:0005654;GO:0005634;GO:0070577;GO:0035064;GO:0019904;GO:0047485;GO:0070491;GO:0003714;GO:0008270;GO:0098815;GO:0030336;GO:0060999;GO:1902952;GO:0051491;GO:1902897;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:methylated histone binding; F:protein domain specific binding; F:protein N-terminus binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:zinc ion binding;, P:modulation of excitatory postsynaptic potential; P:negative regulation of cell migration; P:positive regulation of dendritic spine development; P:positive regulation of dendritic spine maintenance; P:positive regulation of filopodium assembly; P:regulation of postsynaptic density protein 95 clustering;|Q9H1F3 Q9H1F4 Q9H1F5 Q9H1L8 Q9H1L9 Q9H2G5 Q9NYN3 Q9UIX6,Protein kinase C-binding protein 1,Cutaneous T-cell lymphoma-associated antigen se14-3;Rack7;Zinc finger MYND domain-containing protein 8;, PF00439;PF12064;PF00855;, GO:0005737;GO:0043198;GO:0043197;GO:0005794;GO:0005654;GO:0005634;GO:0070577;GO:0035064;GO:0019904;GO:0047485;GO:0070491;GO:0003714;GO:0008270;GO:0098815;GO:0030336;GO:0060999;GO:1902952;GO:0051491;GO:1902897;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:methylated histone binding; F:protein domain specific binding; F:protein N-terminus binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:zinc ion binding;, P:modulation of excitatory postsynaptic potential; P:negative regulation of cell migration; P:positive regulation of dendritic spine development; P:positive regulation of dendritic spine maintenance; P:positive regulation of filopodium assembly; P:regulation of postsynaptic density protein 95 clustering;|Q9H1F3 Q9H1F4 Q9H1F5 Q9H1L8 Q9H1L9 Q9H2G5 Q9NYN3 Q9UIX6,Protein kinase C-binding protein 1,Cutaneous T-cell lymphoma-associated antigen se14-3;Rack7;Zinc finger MYND domain-containing protein 8;, PF00439;PF12064;PF00855;, GO:0005737;GO:0043198;GO:0043197;GO:0005794;GO:0005654;GO:0005634;GO:0070577;GO:0035064;GO:0019904;GO:0047485;GO:0070491;GO:0003714;GO:0008270;GO:0098815;GO:0030336;GO:0060999;GO:1902952;GO:0051491;GO:1902897;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:methylated histone binding; F:protein domain specific binding; F:protein N-terminus binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:zinc ion binding;, P:modulation of excitatory postsynaptic potential; P:negative regulation of cell migration; P:positive regulation of dendritic spine development; P:positive regulation of dendritic spine maintenance; P:positive regulation of filopodium assembly; P:regulation of postsynaptic density protein 95 clustering;|Q9H1F3 Q9H1F4 Q9H1F5 Q9H1L8 Q9H1L9 Q9H2G5 Q9NYN3 Q9UIX6,Protein kinase C-binding protein 1,Cutaneous T-cell lymphoma-associated antigen se14-3;Rack7;Zinc finger MYND domain-containing protein 8;, PF00439;PF12064;PF00855;, GO:0005737;GO:0043198;GO:0043197;GO:0005794;GO:0005654;GO:0005634;GO:0070577;GO:0035064;GO:0019904;GO:0047485;GO:0070491;GO:0003714;GO:0008270;GO:0098815;GO:0030336;GO:0060999;GO:1902952;GO:0051491;GO:1902897;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:methylated histone binding; F:protein domain specific binding; F:protein N-terminus binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:zinc ion binding;, P:modulation of excitatory postsynaptic potential; P:negative regulation of cell migration; P:positive regulation of dendritic spine development; P:positive regulation of dendritic spine maintenance; P:positive regulation of filopodium assembly; P:regulation of postsynaptic density protein 95 clustering;|Q9H1F3 Q9H1F4 Q9H1F5 Q9H1L8 Q9H1L9 Q9H2G5 Q9NYN3 Q9UIX6,Protein kinase C-binding protein 1,Cutaneous T-cell lymphoma-associated antigen se14-3;Rack7;Zinc finger MYND domain-containing protein 8;, PF00439;PF12064;PF00855;, GO:0005737;GO:0043198;GO:0043197;GO:0005794;GO:0005654;GO:0005634;GO:0070577;GO:0035064;GO:0019904;GO:0047485;GO:0070491;GO:0003714;GO:0008270;GO:0098815;GO:0030336;GO:0060999;GO:1902952;GO:0051491;GO:1902897;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:methylated histone binding; F:protein domain specific binding; F:protein N-terminus binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:zinc ion binding;, P:modulation of excitatory postsynaptic potential; P:negative regulation of cell migration; P:positive regulation of dendritic spine development; P:positive regulation of dendritic spine maintenance; P:positive regulation of filopodium assembly; P:regulation of postsynaptic density protein 95 clustering;|Q9H1F3 Q9H1F4 Q9H1F5 Q9H1L8 Q9H1L9 Q9H2G5 Q9NYN3 Q9UIX6,Protein kinase C-binding protein 1,Cutaneous T-cell lymphoma-associated antigen se14-3;Rack7;Zinc finger MYND domain-containing protein 8;, PF00439;PF12064;PF00855;, GO:0005737;GO:0043198;GO:0043197;GO:0005794;GO:0005654;GO:0005634;GO:0070577;GO:0035064;GO:0019904;GO:0047485;GO:0070491;GO:0003714;GO:0008270;GO:0098815;GO:0030336;GO:0060999;GO:1902952;GO:0051491;GO:1902897;, C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:lysine-acetylated histone binding; F:methylated histone binding; F:protein domain specific binding; F:protein N-terminus binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:zinc ion binding;, P:modulation of excitatory postsynaptic potential; P:negative regulation of cell migration; P:positive regulation of dendritic spine development; P:positive regulation of dendritic spine maintenance; P:positive regulation of filopodium assembly; P:regulation of postsynaptic density protein 95 clustering; scaffold67 indexed_genome mRNA 7377133 7629532 . - . ID=transcript_11096;Q9H4S9 Q9NPZ4 Q9UIX7,Eyes absent homolog 2,, , GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000287;GO:0004725;GO:0008134;GO:0048856;GO:0030154;GO:0006281;GO:0097192;GO:0016576;GO:0007501;GO:0097345;GO:2001240;GO:0045739;GO:0014706;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:magnesium ion binding; F:protein tyrosine phosphatase activity; F:transcription factor binding;, P:anatomical structure development; P:cell differentiation; P:DNA repair; P:extrinsic apoptotic signaling pathway in absence of ligand; P:histone dephosphorylation; P:mesodermal cell fate specification; P:mitochondrial outer membrane permeabilization; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:striated muscle tissue development;|Q9H4S9 Q9NPZ4 Q9UIX7,Eyes absent homolog 2,, , GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000287;GO:0004725;GO:0008134;GO:0048856;GO:0030154;GO:0006281;GO:0097192;GO:0016576;GO:0007501;GO:0097345;GO:2001240;GO:0045739;GO:0014706;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:magnesium ion binding; F:protein tyrosine phosphatase activity; F:transcription factor binding;, P:anatomical structure development; P:cell differentiation; P:DNA repair; P:extrinsic apoptotic signaling pathway in absence of ligand; P:histone dephosphorylation; P:mesodermal cell fate specification; P:mitochondrial outer membrane permeabilization; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:striated muscle tissue development;|Q9H4S9 Q9NPZ4 Q9UIX7,Eyes absent homolog 2,, , GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000287;GO:0004725;GO:0008134;GO:0048856;GO:0030154;GO:0006281;GO:0097192;GO:0016576;GO:0007501;GO:0097345;GO:2001240;GO:0045739;GO:0014706;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:magnesium ion binding; F:protein tyrosine phosphatase activity; F:transcription factor binding;, P:anatomical structure development; P:cell differentiation; P:DNA repair; P:extrinsic apoptotic signaling pathway in absence of ligand; P:histone dephosphorylation; P:mesodermal cell fate specification; P:mitochondrial outer membrane permeabilization; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:positive regulation of DNA repair; P:striated muscle tissue development; scaffold67 indexed_genome mRNA 7743995 7758470 . - . ID=transcript_11097;O95528 A8K4J6 Q3MIX5 Q9H4I6,Solute carrier family 2, facilitated glucose transporter member 10 {ECO:0000305},Glucose transporter type 10 {ECO:0000303|PubMed:11247674};, PF00083;, GO:0012505;GO:0016021;GO:0048471;GO:0005886;GO:0005351;GO:0055056;GO:0033300;GO:0060840;GO:0045454;GO:0070837;GO:0072498;GO:0015757;GO:0098708;GO:1904659;GO:0008645;GO:0032683;GO:0010629;GO:2001045;GO:1902729;GO:0060392;GO:0030512;GO:0010628;GO:1902730;GO:0030511;GO:1903053;GO:0043588;GO:0150104;, C:endomembrane system; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:carbohydrate:proton symporter activity; F:D-glucose transmembrane transporter activity; F:dehydroascorbic acid transmembrane transporter activity;, P:artery development; P:cell redox homeostasis; P:dehydroascorbic acid transport; P:embryonic skeletal joint development; P:galactose transmembrane transport; P:glucose import across plasma membrane; P:glucose transmembrane transport; P:hexose transmembrane transport; P:negative regulation of connective tissue growth factor production; P:negative regulation of gene expression; P:negative regulation of integrin-mediated signaling pathway; P:negative regulation of proteoglycan biosynthetic process; P:negative regulation of SMAD protein signal transduction; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of proteoglycan biosynthetic process; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of extracellular matrix organization; P:skin development; P:transport across blood-brain barrier; scaffold67 indexed_genome mRNA 7762373 7777039 . + . ID=transcript_11098;Q96S44 B3KU44 Q3T977 Q5JZ01 Q6NZ60 Q96FM7 Q9NQE6,EKC/KEOPS complex subunit TP53RK {ECO:0000305},Atypical serine/threonine protein kinase TP53RK;Nori-2;TP53-regulating kinase;p53-related protein kinase {ECO:0000303|PubMed:11546806};, , GO:0005737;GO:0000408;GO:0005654;GO:0005634;GO:0005524;GO:0016787;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0006468;GO:1901796;GO:0008033;GO:0070525;, C:cytoplasm; C:EKC/KEOPS complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:hydrolase activity; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:tRNA processing; P:tRNA threonylcarbamoyladenosine metabolic process; scaffold67 indexed_genome mRNA 7791224 7849623 . + . ID=transcript_11099;Q8N8K4 Q96MM5 Q9BR25 Q9H1G1 Q9H3W4 Q9NQN5 Q9NS04,Solute carrier family 13 member 3,Na(+)/dicarboxylate cotransporter 3;Sodium-dependent high-affinity dicarboxylate transporter 2;, PF00939;, GO:0016323;GO:0070062;GO:0016021;GO:0005886;GO:0015139;GO:0015137;GO:0005310;GO:0034634;GO:0015362;GO:0017153;GO:0015141;GO:0098656;GO:0015746;GO:0006835;GO:0034775;GO:0071422;GO:0150104;, C:basolateral plasma membrane; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:alpha-ketoglutarate transmembrane transporter activity; F:citrate transmembrane transporter activity; F:dicarboxylic acid transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:high-affinity sodium:dicarboxylate symporter activity; F:sodium:dicarboxylate symporter activity; F:succinate transmembrane transporter activity;, P:anion transmembrane transport; P:citrate transport; P:dicarboxylic acid transport; P:glutathione transmembrane transport; P:succinate transmembrane transport; P:transport across blood-brain barrier; scaffold67 indexed_genome mRNA 7862108 7865755 . - . ID=transcript_11100;Q8N8K4 Q96MM5 Q9BR25 Q9H1G1 Q9H3W4 Q9NQN5 Q9NS04,Solute carrier family 13 member 3,Na(+)/dicarboxylate cotransporter 3;Sodium-dependent high-affinity dicarboxylate transporter 2;, PF00939;, GO:0016323;GO:0070062;GO:0016021;GO:0005886;GO:0015139;GO:0015137;GO:0005310;GO:0034634;GO:0015362;GO:0017153;GO:0015141;GO:0098656;GO:0015746;GO:0006835;GO:0034775;GO:0071422;GO:0150104;, C:basolateral plasma membrane; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:alpha-ketoglutarate transmembrane transporter activity; F:citrate transmembrane transporter activity; F:dicarboxylic acid transmembrane transporter activity; F:glutathione transmembrane transporter activity; F:high-affinity sodium:dicarboxylate symporter activity; F:sodium:dicarboxylate symporter activity; F:succinate transmembrane transporter activity;, P:anion transmembrane transport; P:citrate transport; P:dicarboxylic acid transport; P:glutathione transmembrane transport; P:succinate transmembrane transport; P:transport across blood-brain barrier; scaffold67 indexed_genome mRNA 7871810 7875105 . + . ID=transcript_11101;Q9BR26,Osteoclast stimulatory transmembrane protein,, PF07782;, GO:0016021;GO:0071391;GO:0071356;GO:0072674;GO:0034241;GO:0045672;GO:0090290;, C:integral component of membrane;, , P:cellular response to estrogen stimulus; P:cellular response to tumor necrosis factor; P:multinuclear osteoclast differentiation; P:positive regulation of macrophage fusion; P:positive regulation of osteoclast differentiation; P:positive regulation of osteoclast proliferation; scaffold67 indexed_genome mRNA 7875668 7878507 . + . ID=transcript_11102;Q9BR26,Osteoclast stimulatory transmembrane protein,, PF07782;, GO:0016021;GO:0071391;GO:0071356;GO:0072674;GO:0034241;GO:0045672;GO:0090290;, C:integral component of membrane;, , P:cellular response to estrogen stimulus; P:cellular response to tumor necrosis factor; P:multinuclear osteoclast differentiation; P:positive regulation of macrophage fusion; P:positive regulation of osteoclast differentiation; P:positive regulation of osteoclast proliferation; scaffold67 indexed_genome mRNA 7896509 7938534 . + . ID=transcript_11103;Q9NYW8 A6NDF2 A8KAK4 B2RN44 B9EGS1 F8W6M7,RB-associated KRAB zinc finger protein,RB-associated KRAB repressor;Zinc finger protein 769;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0045892;GO:0006357;GO:0006355;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|A6NDX5 Q6KAL7,Putative zinc finger protein 840,Zinc finger protein 840 pseudogene;, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold67 indexed_genome mRNA 7941460 7941966 . + . ID=transcript_11104;Q86W11 B4E0N0 Q6ZNB3 Q96PN3,Zinc finger and SCAN domain-containing protein 30,ZNF-WYM;Zinc finger protein 397 opposite strand;Zinc finger protein 397OS;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold67 indexed_genome mRNA 7997659 8024273 . + . ID=transcript_11105;Q9HAH0 Q9NQQ6,Engulfment and cell motility protein 2,Protein ced-12 homolog A;, PF11841;PF04727;PF16457;, GO:0005829;GO:0016020;GO:0030971;GO:0017124;GO:0007015;GO:0006915;GO:0060326;GO:0048870;GO:0098609;GO:0038096;GO:0048010;, C:cytosol; C:membrane;, F:receptor tyrosine kinase binding; F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell chemotaxis; P:cell motility; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:vascular endothelial growth factor receptor signaling pathway;|Q9HAH0 Q9NQQ6,Engulfment and cell motility protein 2,Protein ced-12 homolog A;, PF11841;PF04727;PF16457;, GO:0005829;GO:0016020;GO:0030971;GO:0017124;GO:0007015;GO:0006915;GO:0060326;GO:0048870;GO:0098609;GO:0038096;GO:0048010;, C:cytosol; C:membrane;, F:receptor tyrosine kinase binding; F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell chemotaxis; P:cell motility; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:vascular endothelial growth factor receptor signaling pathway;|Q9HAH0 Q9NQQ6,Engulfment and cell motility protein 2,Protein ced-12 homolog A;, PF11841;PF04727;PF16457;, GO:0005829;GO:0016020;GO:0030971;GO:0017124;GO:0007015;GO:0006915;GO:0060326;GO:0048870;GO:0098609;GO:0038096;GO:0048010;, C:cytosol; C:membrane;, F:receptor tyrosine kinase binding; F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell chemotaxis; P:cell motility; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:vascular endothelial growth factor receptor signaling pathway;|Q9HAH0 Q9NQQ6,Engulfment and cell motility protein 2,Protein ced-12 homolog A;, PF11841;PF04727;PF16457;, GO:0005829;GO:0016020;GO:0030971;GO:0017124;GO:0007015;GO:0006915;GO:0060326;GO:0048870;GO:0098609;GO:0038096;GO:0048010;, C:cytosol; C:membrane;, F:receptor tyrosine kinase binding; F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell chemotaxis; P:cell motility; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:vascular endothelial growth factor receptor signaling pathway;|Q9HAH0 Q9NQQ6,Engulfment and cell motility protein 2,Protein ced-12 homolog A;, PF11841;PF04727;PF16457;, GO:0005829;GO:0016020;GO:0030971;GO:0017124;GO:0007015;GO:0006915;GO:0060326;GO:0048870;GO:0098609;GO:0038096;GO:0048010;, C:cytosol; C:membrane;, F:receptor tyrosine kinase binding; F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell chemotaxis; P:cell motility; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:vascular endothelial growth factor receptor signaling pathway;|Q9HAH0 Q9NQQ6,Engulfment and cell motility protein 2,Protein ced-12 homolog A;, PF11841;PF04727;PF16457;, GO:0005829;GO:0016020;GO:0030971;GO:0017124;GO:0007015;GO:0006915;GO:0060326;GO:0048870;GO:0098609;GO:0038096;GO:0048010;, C:cytosol; C:membrane;, F:receptor tyrosine kinase binding; F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell chemotaxis; P:cell motility; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:vascular endothelial growth factor receptor signaling pathway;|Q9HAH0 Q9NQQ6,Engulfment and cell motility protein 2,Protein ced-12 homolog A;, PF11841;PF04727;PF16457;, GO:0005829;GO:0016020;GO:0030971;GO:0017124;GO:0007015;GO:0006915;GO:0060326;GO:0048870;GO:0098609;GO:0038096;GO:0048010;, C:cytosol; C:membrane;, F:receptor tyrosine kinase binding; F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell chemotaxis; P:cell motility; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:vascular endothelial growth factor receptor signaling pathway;|Q9HAH0 Q9NQQ6,Engulfment and cell motility protein 2,Protein ced-12 homolog A;, PF11841;PF04727;PF16457;, GO:0005829;GO:0016020;GO:0030971;GO:0017124;GO:0007015;GO:0006915;GO:0060326;GO:0048870;GO:0098609;GO:0038096;GO:0048010;, C:cytosol; C:membrane;, F:receptor tyrosine kinase binding; F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell chemotaxis; P:cell motility; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:vascular endothelial growth factor receptor signaling pathway;|Q9HAH0 Q9NQQ6,Engulfment and cell motility protein 2,Protein ced-12 homolog A;, PF11841;PF04727;PF16457;, GO:0005829;GO:0016020;GO:0030971;GO:0017124;GO:0007015;GO:0006915;GO:0060326;GO:0048870;GO:0098609;GO:0038096;GO:0048010;, C:cytosol; C:membrane;, F:receptor tyrosine kinase binding; F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell chemotaxis; P:cell motility; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:vascular endothelial growth factor receptor signaling pathway;|Q9HAH0 Q9NQQ6,Engulfment and cell motility protein 2,Protein ced-12 homolog A;, PF11841;PF04727;PF16457;, GO:0005829;GO:0016020;GO:0030971;GO:0017124;GO:0007015;GO:0006915;GO:0060326;GO:0048870;GO:0098609;GO:0038096;GO:0048010;, C:cytosol; C:membrane;, F:receptor tyrosine kinase binding; F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:cell chemotaxis; P:cell motility; P:cell-cell adhesion; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:vascular endothelial growth factor receptor signaling pathway; scaffold67 indexed_genome mRNA 8032564 8041024 . + . ID=transcript_11106;Q9NQQ7 B7Z6V6 E1P5T0 Q53GK3 Q5JW05 Q96CJ8 Q9Y304,Solute carrier family 35 member C2,Ovarian cancer-overexpressed gene 1 protein;, PF03151;, GO:0005801;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0005654;GO:0015297;GO:0010629;GO:0045747;GO:0036066;GO:0015786;, C:cis-Golgi network; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm;, F:antiporter activity;, P:negative regulation of gene expression; P:positive regulation of Notch signaling pathway; P:protein O-linked fucosylation; P:UDP-glucose transmembrane transport;|Q9NQQ7 B7Z6V6 E1P5T0 Q53GK3 Q5JW05 Q96CJ8 Q9Y304,Solute carrier family 35 member C2,Ovarian cancer-overexpressed gene 1 protein;, PF03151;, GO:0005801;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0005654;GO:0015297;GO:0010629;GO:0045747;GO:0036066;GO:0015786;, C:cis-Golgi network; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm;, F:antiporter activity;, P:negative regulation of gene expression; P:positive regulation of Notch signaling pathway; P:protein O-linked fucosylation; P:UDP-glucose transmembrane transport;|Q9NQQ7 B7Z6V6 E1P5T0 Q53GK3 Q5JW05 Q96CJ8 Q9Y304,Solute carrier family 35 member C2,Ovarian cancer-overexpressed gene 1 protein;, PF03151;, GO:0005801;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0005654;GO:0015297;GO:0010629;GO:0045747;GO:0036066;GO:0015786;, C:cis-Golgi network; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm;, F:antiporter activity;, P:negative regulation of gene expression; P:positive regulation of Notch signaling pathway; P:protein O-linked fucosylation; P:UDP-glucose transmembrane transport;|Q9NQQ7 B7Z6V6 E1P5T0 Q53GK3 Q5JW05 Q96CJ8 Q9Y304,Solute carrier family 35 member C2,Ovarian cancer-overexpressed gene 1 protein;, PF03151;, GO:0005801;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0005654;GO:0015297;GO:0010629;GO:0045747;GO:0036066;GO:0015786;, C:cis-Golgi network; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm;, F:antiporter activity;, P:negative regulation of gene expression; P:positive regulation of Notch signaling pathway; P:protein O-linked fucosylation; P:UDP-glucose transmembrane transport; scaffold67 indexed_genome mRNA 8265859 8276486 . + . ID=transcript_11107;P25942 E1P5S9 Q53GN5 Q5JY15 Q5U007 Q7M4Q8 Q86YK5 Q9BYU0,Tumor necrosis factor receptor superfamily member 5,B-cell surface antigen CD40;Bp50;CD40L receptor;CDw40;, PF00020;, GO:0035631;GO:0009986;GO:0005737;GO:0009897;GO:0070062;GO:0005887;GO:0043231;GO:0043025;GO:0005886;GO:0043196;GO:0003823;GO:0019899;GO:0019904;GO:0038023;GO:0031625;GO:0042113;GO:0042100;GO:0023035;GO:0006874;GO:0036018;GO:0071347;GO:0071222;GO:0071260;GO:0071356;GO:0042832;GO:0051607;GO:0002768;GO:0006954;GO:0030168;GO:0045766;GO:0030890;GO:0043536;GO:2000353;GO:0043547;GO:0043123;GO:0032735;GO:0048304;GO:0043406;GO:0051092;GO:0090037;GO:0001934;GO:0045944;GO:0042531;GO:0043491;GO:0065003;GO:0050776;GO:0033590;GO:0034341;GO:1901652;GO:0035666;GO:0033209;, C:CD40 receptor complex; C:cell surface; C:cytoplasm; C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:plasma membrane; C:varicosity;, F:antigen binding; F:enzyme binding; F:protein domain specific binding; F:signaling receptor activity; F:ubiquitin protein ligase binding;, P:B cell activation; P:B cell proliferation; P:CD40 signaling pathway; P:cellular calcium ion homeostasis; P:cellular response to erythropoietin; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to tumor necrosis factor; P:defense response to protozoan; P:defense response to virus; P:immune response-regulating cell surface receptor signaling pathway; P:inflammatory response; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of B cell proliferation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of GTPase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of MAP kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase C signaling; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein kinase B signaling; P:protein-containing complex assembly; P:regulation of immune response; P:response to cobalamin; P:response to interferon-gamma; P:response to peptide; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|P25942 E1P5S9 Q53GN5 Q5JY15 Q5U007 Q7M4Q8 Q86YK5 Q9BYU0,Tumor necrosis factor receptor superfamily member 5,B-cell surface antigen CD40;Bp50;CD40L receptor;CDw40;, PF00020;, GO:0035631;GO:0009986;GO:0005737;GO:0009897;GO:0070062;GO:0005887;GO:0043231;GO:0043025;GO:0005886;GO:0043196;GO:0003823;GO:0019899;GO:0019904;GO:0038023;GO:0031625;GO:0042113;GO:0042100;GO:0023035;GO:0006874;GO:0036018;GO:0071347;GO:0071222;GO:0071260;GO:0071356;GO:0042832;GO:0051607;GO:0002768;GO:0006954;GO:0030168;GO:0045766;GO:0030890;GO:0043536;GO:2000353;GO:0043547;GO:0043123;GO:0032735;GO:0048304;GO:0043406;GO:0051092;GO:0090037;GO:0001934;GO:0045944;GO:0042531;GO:0043491;GO:0065003;GO:0050776;GO:0033590;GO:0034341;GO:1901652;GO:0035666;GO:0033209;, C:CD40 receptor complex; C:cell surface; C:cytoplasm; C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:plasma membrane; C:varicosity;, F:antigen binding; F:enzyme binding; F:protein domain specific binding; F:signaling receptor activity; F:ubiquitin protein ligase binding;, P:B cell activation; P:B cell proliferation; P:CD40 signaling pathway; P:cellular calcium ion homeostasis; P:cellular response to erythropoietin; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to tumor necrosis factor; P:defense response to protozoan; P:defense response to virus; P:immune response-regulating cell surface receptor signaling pathway; P:inflammatory response; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of B cell proliferation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of GTPase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of MAP kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase C signaling; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein kinase B signaling; P:protein-containing complex assembly; P:regulation of immune response; P:response to cobalamin; P:response to interferon-gamma; P:response to peptide; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway;|P25942 E1P5S9 Q53GN5 Q5JY15 Q5U007 Q7M4Q8 Q86YK5 Q9BYU0,Tumor necrosis factor receptor superfamily member 5,B-cell surface antigen CD40;Bp50;CD40L receptor;CDw40;, PF00020;, GO:0035631;GO:0009986;GO:0005737;GO:0009897;GO:0070062;GO:0005887;GO:0043231;GO:0043025;GO:0005886;GO:0043196;GO:0003823;GO:0019899;GO:0019904;GO:0038023;GO:0031625;GO:0042113;GO:0042100;GO:0023035;GO:0006874;GO:0036018;GO:0071347;GO:0071222;GO:0071260;GO:0071356;GO:0042832;GO:0051607;GO:0002768;GO:0006954;GO:0030168;GO:0045766;GO:0030890;GO:0043536;GO:2000353;GO:0043547;GO:0043123;GO:0032735;GO:0048304;GO:0043406;GO:0051092;GO:0090037;GO:0001934;GO:0045944;GO:0042531;GO:0043491;GO:0065003;GO:0050776;GO:0033590;GO:0034341;GO:1901652;GO:0035666;GO:0033209;, C:CD40 receptor complex; C:cell surface; C:cytoplasm; C:external side of plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:plasma membrane; C:varicosity;, F:antigen binding; F:enzyme binding; F:protein domain specific binding; F:signaling receptor activity; F:ubiquitin protein ligase binding;, P:B cell activation; P:B cell proliferation; P:CD40 signaling pathway; P:cellular calcium ion homeostasis; P:cellular response to erythropoietin; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to mechanical stimulus; P:cellular response to tumor necrosis factor; P:defense response to protozoan; P:defense response to virus; P:immune response-regulating cell surface receptor signaling pathway; P:inflammatory response; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of B cell proliferation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of GTPase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of MAP kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase C signaling; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein kinase B signaling; P:protein-containing complex assembly; P:regulation of immune response; P:response to cobalamin; P:response to interferon-gamma; P:response to peptide; P:TRIF-dependent toll-like receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; scaffold67 indexed_genome mRNA 8309078 8326955 . + . ID=transcript_11108;Q9HCD5 B2RTV9 E1P5R0 Q6HA99 Q9H1F2 Q9H2T2 Q9H4Y9,Nuclear receptor coactivator 5,Coactivator independent of AF-2;, , GO:0015629;GO:0005615;GO:0005654;GO:0003682;GO:0003723;GO:0003714;GO:0042593;GO:0046627;GO:0000122;, C:actin cytoskeleton; C:extracellular space; C:nucleoplasm;, F:chromatin binding; F:RNA binding; F:transcription corepressor activity;, P:glucose homeostasis; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II;|Q9HCD5 B2RTV9 E1P5R0 Q6HA99 Q9H1F2 Q9H2T2 Q9H4Y9,Nuclear receptor coactivator 5,Coactivator independent of AF-2;, , GO:0015629;GO:0005615;GO:0005654;GO:0003682;GO:0003723;GO:0003714;GO:0042593;GO:0046627;GO:0000122;, C:actin cytoskeleton; C:extracellular space; C:nucleoplasm;, F:chromatin binding; F:RNA binding; F:transcription corepressor activity;, P:glucose homeostasis; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II;|Q9HCD5 B2RTV9 E1P5R0 Q6HA99 Q9H1F2 Q9H2T2 Q9H4Y9,Nuclear receptor coactivator 5,Coactivator independent of AF-2;, , GO:0015629;GO:0005615;GO:0005654;GO:0003682;GO:0003723;GO:0003714;GO:0042593;GO:0046627;GO:0000122;, C:actin cytoskeleton; C:extracellular space; C:nucleoplasm;, F:chromatin binding; F:RNA binding; F:transcription corepressor activity;, P:glucose homeostasis; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; scaffold67 indexed_genome mRNA 8327735 8357218 . - . ID=transcript_11109;Q9H2X9 A2RTX2 Q5VZ41 Q9H4Z0 Q9ULP4,Solute carrier family 12 member 5,Electroneutral potassium-chloride cotransporter 2;K-Cl cotransporter 2;Neuronal K-Cl cotransporter;, PF00324;PF03522;, GO:0071944;GO:0016021;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0015108;GO:0015379;GO:0019901;GO:0006884;GO:0030644;GO:0006873;GO:0007268;GO:0055064;GO:1902476;GO:0060996;GO:0006971;GO:0006811;GO:0007612;GO:0035264;GO:0055075;GO:1990573;GO:0042493;GO:0040040;, C:cell periphery; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse;, F:chloride transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular ion homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:dendritic spine development; P:hypotonic response; P:ion transport; P:learning; P:multicellular organism growth; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:response to drug; P:thermosensory behavior;|Q9H2X9 A2RTX2 Q5VZ41 Q9H4Z0 Q9ULP4,Solute carrier family 12 member 5,Electroneutral potassium-chloride cotransporter 2;K-Cl cotransporter 2;Neuronal K-Cl cotransporter;, PF00324;PF03522;, GO:0071944;GO:0016021;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0015108;GO:0015379;GO:0019901;GO:0006884;GO:0030644;GO:0006873;GO:0007268;GO:0055064;GO:1902476;GO:0060996;GO:0006971;GO:0006811;GO:0007612;GO:0035264;GO:0055075;GO:1990573;GO:0042493;GO:0040040;, C:cell periphery; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse;, F:chloride transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular ion homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:dendritic spine development; P:hypotonic response; P:ion transport; P:learning; P:multicellular organism growth; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:response to drug; P:thermosensory behavior;|Q9H2X9 A2RTX2 Q5VZ41 Q9H4Z0 Q9ULP4,Solute carrier family 12 member 5,Electroneutral potassium-chloride cotransporter 2;K-Cl cotransporter 2;Neuronal K-Cl cotransporter;, PF00324;PF03522;, GO:0071944;GO:0016021;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0015108;GO:0015379;GO:0019901;GO:0006884;GO:0030644;GO:0006873;GO:0007268;GO:0055064;GO:1902476;GO:0060996;GO:0006971;GO:0006811;GO:0007612;GO:0035264;GO:0055075;GO:1990573;GO:0042493;GO:0040040;, C:cell periphery; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse;, F:chloride transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular ion homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:dendritic spine development; P:hypotonic response; P:ion transport; P:learning; P:multicellular organism growth; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:response to drug; P:thermosensory behavior;|Q9H2X9 A2RTX2 Q5VZ41 Q9H4Z0 Q9ULP4,Solute carrier family 12 member 5,Electroneutral potassium-chloride cotransporter 2;K-Cl cotransporter 2;Neuronal K-Cl cotransporter;, PF00324;PF03522;, GO:0071944;GO:0016021;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0015108;GO:0015379;GO:0019901;GO:0006884;GO:0030644;GO:0006873;GO:0007268;GO:0055064;GO:1902476;GO:0060996;GO:0006971;GO:0006811;GO:0007612;GO:0035264;GO:0055075;GO:1990573;GO:0042493;GO:0040040;, C:cell periphery; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse;, F:chloride transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular ion homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:dendritic spine development; P:hypotonic response; P:ion transport; P:learning; P:multicellular organism growth; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:response to drug; P:thermosensory behavior;|Q9H2X9 A2RTX2 Q5VZ41 Q9H4Z0 Q9ULP4,Solute carrier family 12 member 5,Electroneutral potassium-chloride cotransporter 2;K-Cl cotransporter 2;Neuronal K-Cl cotransporter;, PF00324;PF03522;, GO:0071944;GO:0016021;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0015108;GO:0015379;GO:0019901;GO:0006884;GO:0030644;GO:0006873;GO:0007268;GO:0055064;GO:1902476;GO:0060996;GO:0006971;GO:0006811;GO:0007612;GO:0035264;GO:0055075;GO:1990573;GO:0042493;GO:0040040;, C:cell periphery; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse;, F:chloride transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular ion homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:dendritic spine development; P:hypotonic response; P:ion transport; P:learning; P:multicellular organism growth; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:response to drug; P:thermosensory behavior;|Q9H2X9 A2RTX2 Q5VZ41 Q9H4Z0 Q9ULP4,Solute carrier family 12 member 5,Electroneutral potassium-chloride cotransporter 2;K-Cl cotransporter 2;Neuronal K-Cl cotransporter;, PF00324;PF03522;, GO:0071944;GO:0016021;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0015108;GO:0015379;GO:0019901;GO:0006884;GO:0030644;GO:0006873;GO:0007268;GO:0055064;GO:1902476;GO:0060996;GO:0006971;GO:0006811;GO:0007612;GO:0035264;GO:0055075;GO:1990573;GO:0042493;GO:0040040;, C:cell periphery; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse;, F:chloride transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular ion homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:dendritic spine development; P:hypotonic response; P:ion transport; P:learning; P:multicellular organism growth; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:response to drug; P:thermosensory behavior;|Q9H2X9 A2RTX2 Q5VZ41 Q9H4Z0 Q9ULP4,Solute carrier family 12 member 5,Electroneutral potassium-chloride cotransporter 2;K-Cl cotransporter 2;Neuronal K-Cl cotransporter;, PF00324;PF03522;, GO:0071944;GO:0016021;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0015108;GO:0015379;GO:0019901;GO:0006884;GO:0030644;GO:0006873;GO:0007268;GO:0055064;GO:1902476;GO:0060996;GO:0006971;GO:0006811;GO:0007612;GO:0035264;GO:0055075;GO:1990573;GO:0042493;GO:0040040;, C:cell periphery; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse;, F:chloride transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular ion homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:dendritic spine development; P:hypotonic response; P:ion transport; P:learning; P:multicellular organism growth; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:response to drug; P:thermosensory behavior;|Q9H2X9 A2RTX2 Q5VZ41 Q9H4Z0 Q9ULP4,Solute carrier family 12 member 5,Electroneutral potassium-chloride cotransporter 2;K-Cl cotransporter 2;Neuronal K-Cl cotransporter;, PF00324;PF03522;, GO:0071944;GO:0016021;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0015108;GO:0015379;GO:0019901;GO:0006884;GO:0030644;GO:0006873;GO:0007268;GO:0055064;GO:1902476;GO:0060996;GO:0006971;GO:0006811;GO:0007612;GO:0035264;GO:0055075;GO:1990573;GO:0042493;GO:0040040;, C:cell periphery; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse;, F:chloride transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular ion homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:dendritic spine development; P:hypotonic response; P:ion transport; P:learning; P:multicellular organism growth; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:response to drug; P:thermosensory behavior;|Q9H2X9 A2RTX2 Q5VZ41 Q9H4Z0 Q9ULP4,Solute carrier family 12 member 5,Electroneutral potassium-chloride cotransporter 2;K-Cl cotransporter 2;Neuronal K-Cl cotransporter;, PF00324;PF03522;, GO:0071944;GO:0016021;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0015108;GO:0015379;GO:0019901;GO:0006884;GO:0030644;GO:0006873;GO:0007268;GO:0055064;GO:1902476;GO:0060996;GO:0006971;GO:0006811;GO:0007612;GO:0035264;GO:0055075;GO:1990573;GO:0042493;GO:0040040;, C:cell periphery; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse;, F:chloride transmembrane transporter activity; F:potassium:chloride symporter activity; F:protein kinase binding;, P:cell volume homeostasis; P:cellular chloride ion homeostasis; P:cellular ion homeostasis; P:chemical synaptic transmission; P:chloride ion homeostasis; P:chloride transmembrane transport; P:dendritic spine development; P:hypotonic response; P:ion transport; P:learning; P:multicellular organism growth; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:response to drug; P:thermosensory behavior; scaffold67 indexed_genome mRNA 8369602 8371825 . - . ID=transcript_11110;P14780 B2R7V9 Q3LR70 Q8N725 Q9H4Z1 Q9UCJ9 Q9UCL1 Q9UDK2,Matrix metalloproteinase-9,92 kDa gelatinase;92 kDa type IV collagenase {ECO:0000303|PubMed:2551898};Gelatinase B;, PF00040;PF00045;PF00413;PF01471;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:1904724;GO:0005518;GO:0004175;GO:0042802;GO:0004222;GO:0008237;GO:0008233;GO:0004252;GO:0008270;GO:0071276;GO:0034614;GO:0071492;GO:0030574;GO:0019221;GO:0007566;GO:0035987;GO:0048013;GO:0022617;GO:0030198;GO:0050900;GO:0030225;GO:0043066;GO:2001258;GO:2001268;GO:2000697;GO:2001243;GO:0043312;GO:0001503;GO:0043065;GO:0030335;GO:0043388;GO:0045742;GO:0051549;GO:0001934;GO:1900122;GO:0090200;GO:1904707;GO:0006508;GO:0150077;GO:1904645;GO:0001501;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:tertiary granule lumen;, F:collagen binding; F:endopeptidase activity; F:identical protein binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:peptidase activity; F:serine-type endopeptidase activity; F:zinc ion binding;, P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:cellular response to UV-A; P:collagen catabolic process; P:cytokine-mediated signaling pathway; P:embryo implantation; P:endodermal cell differentiation; P:ephrin receptor signaling pathway; P:extracellular matrix disassembly; P:extracellular matrix organization; P:leukocyte migration; P:macrophage differentiation; P:negative regulation of apoptotic process; P:negative regulation of cation channel activity; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of epithelial cell differentiation involved in kidney development; P:negative regulation of intrinsic apoptotic signaling pathway; P:neutrophil degranulation; P:ossification; P:positive regulation of apoptotic process; P:positive regulation of cell migration; P:positive regulation of DNA binding; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of keratinocyte migration; P:positive regulation of protein phosphorylation; P:positive regulation of receptor binding; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of vascular associated smooth muscle cell proliferation; P:proteolysis; P:regulation of neuroinflammatory response; P:response to amyloid-beta; P:skeletal system development; scaffold67 indexed_genome mRNA 8405375 8425169 . + . ID=transcript_11111;Q9H4Z2 B4DLG7 Q548D0 Q9H684,Zinc finger protein 335,NRC-interacting factor 1;, , GO:0035097;GO:0005654;GO:0005634;GO:0046872;GO:0000978;GO:0000976;GO:0007420;GO:0048854;GO:0021895;GO:0080182;GO:0001701;GO:0048812;GO:0050671;GO:0002052;GO:0050769;GO:0045944;GO:0010468;GO:0040029;GO:0051569;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:brain morphogenesis; P:cerebral cortex neuron differentiation; P:histone H3-K4 trimethylation; P:in utero embryonic development; P:neuron projection morphogenesis; P:positive regulation of lymphocyte proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neurogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of gene expression, epigenetic; P:regulation of histone H3-K4 methylation;|Q9H4Z2 B4DLG7 Q548D0 Q9H684,Zinc finger protein 335,NRC-interacting factor 1;, , GO:0035097;GO:0005654;GO:0005634;GO:0046872;GO:0000978;GO:0000976;GO:0007420;GO:0048854;GO:0021895;GO:0080182;GO:0001701;GO:0048812;GO:0050671;GO:0002052;GO:0050769;GO:0045944;GO:0010468;GO:0040029;GO:0051569;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:brain morphogenesis; P:cerebral cortex neuron differentiation; P:histone H3-K4 trimethylation; P:in utero embryonic development; P:neuron projection morphogenesis; P:positive regulation of lymphocyte proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neurogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of gene expression, epigenetic; P:regulation of histone H3-K4 methylation;|Q9H4Z2 B4DLG7 Q548D0 Q9H684,Zinc finger protein 335,NRC-interacting factor 1;, , GO:0035097;GO:0005654;GO:0005634;GO:0046872;GO:0000978;GO:0000976;GO:0007420;GO:0048854;GO:0021895;GO:0080182;GO:0001701;GO:0048812;GO:0050671;GO:0002052;GO:0050769;GO:0045944;GO:0010468;GO:0040029;GO:0051569;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:brain morphogenesis; P:cerebral cortex neuron differentiation; P:histone H3-K4 trimethylation; P:in utero embryonic development; P:neuron projection morphogenesis; P:positive regulation of lymphocyte proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neurogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of gene expression, epigenetic; P:regulation of histone H3-K4 methylation;|Q9H4Z2 B4DLG7 Q548D0 Q9H684,Zinc finger protein 335,NRC-interacting factor 1;, , GO:0035097;GO:0005654;GO:0005634;GO:0046872;GO:0000978;GO:0000976;GO:0007420;GO:0048854;GO:0021895;GO:0080182;GO:0001701;GO:0048812;GO:0050671;GO:0002052;GO:0050769;GO:0045944;GO:0010468;GO:0040029;GO:0051569;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:brain morphogenesis; P:cerebral cortex neuron differentiation; P:histone H3-K4 trimethylation; P:in utero embryonic development; P:neuron projection morphogenesis; P:positive regulation of lymphocyte proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neurogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of gene expression, epigenetic; P:regulation of histone H3-K4 methylation;|Q9H4Z2 B4DLG7 Q548D0 Q9H684,Zinc finger protein 335,NRC-interacting factor 1;, , GO:0035097;GO:0005654;GO:0005634;GO:0046872;GO:0000978;GO:0000976;GO:0007420;GO:0048854;GO:0021895;GO:0080182;GO:0001701;GO:0048812;GO:0050671;GO:0002052;GO:0050769;GO:0045944;GO:0010468;GO:0040029;GO:0051569;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:brain morphogenesis; P:cerebral cortex neuron differentiation; P:histone H3-K4 trimethylation; P:in utero embryonic development; P:neuron projection morphogenesis; P:positive regulation of lymphocyte proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neurogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of gene expression, epigenetic; P:regulation of histone H3-K4 methylation;|Q9H4Z2 B4DLG7 Q548D0 Q9H684,Zinc finger protein 335,NRC-interacting factor 1;, , GO:0035097;GO:0005654;GO:0005634;GO:0046872;GO:0000978;GO:0000976;GO:0007420;GO:0048854;GO:0021895;GO:0080182;GO:0001701;GO:0048812;GO:0050671;GO:0002052;GO:0050769;GO:0045944;GO:0010468;GO:0040029;GO:0051569;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:brain morphogenesis; P:cerebral cortex neuron differentiation; P:histone H3-K4 trimethylation; P:in utero embryonic development; P:neuron projection morphogenesis; P:positive regulation of lymphocyte proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neurogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of gene expression, epigenetic; P:regulation of histone H3-K4 methylation;|Q9H4Z2 B4DLG7 Q548D0 Q9H684,Zinc finger protein 335,NRC-interacting factor 1;, , GO:0035097;GO:0005654;GO:0005634;GO:0046872;GO:0000978;GO:0000976;GO:0007420;GO:0048854;GO:0021895;GO:0080182;GO:0001701;GO:0048812;GO:0050671;GO:0002052;GO:0050769;GO:0045944;GO:0010468;GO:0040029;GO:0051569;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:brain morphogenesis; P:cerebral cortex neuron differentiation; P:histone H3-K4 trimethylation; P:in utero embryonic development; P:neuron projection morphogenesis; P:positive regulation of lymphocyte proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neurogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of gene expression, epigenetic; P:regulation of histone H3-K4 methylation;|Q9H4Z2 B4DLG7 Q548D0 Q9H684,Zinc finger protein 335,NRC-interacting factor 1;, , GO:0035097;GO:0005654;GO:0005634;GO:0046872;GO:0000978;GO:0000976;GO:0007420;GO:0048854;GO:0021895;GO:0080182;GO:0001701;GO:0048812;GO:0050671;GO:0002052;GO:0050769;GO:0045944;GO:0010468;GO:0040029;GO:0051569;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:brain morphogenesis; P:cerebral cortex neuron differentiation; P:histone H3-K4 trimethylation; P:in utero embryonic development; P:neuron projection morphogenesis; P:positive regulation of lymphocyte proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neurogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of gene expression, epigenetic; P:regulation of histone H3-K4 methylation;|Q9H4Z2 B4DLG7 Q548D0 Q9H684,Zinc finger protein 335,NRC-interacting factor 1;, , GO:0035097;GO:0005654;GO:0005634;GO:0046872;GO:0000978;GO:0000976;GO:0007420;GO:0048854;GO:0021895;GO:0080182;GO:0001701;GO:0048812;GO:0050671;GO:0002052;GO:0050769;GO:0045944;GO:0010468;GO:0040029;GO:0051569;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:brain development; P:brain morphogenesis; P:cerebral cortex neuron differentiation; P:histone H3-K4 trimethylation; P:in utero embryonic development; P:neuron projection morphogenesis; P:positive regulation of lymphocyte proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neurogenesis; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of gene expression, epigenetic; P:regulation of histone H3-K4 methylation; scaffold67 indexed_genome mRNA 8425195 8426872 . - . ID=transcript_11112;Q9H4Z3 E1P5P1 Q54AB9 Q9NT85,mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase,Cap-specific adenosine methyltransferase {ECO:0000303|PubMed:30467178};Phosphorylated CTD-interacting factor 1 {ECO:0000303|PubMed:12565871};Protein phosphatase 1 regulatory subunit 121;, PF12237;PF00397;, GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0016422;GO:0099122;GO:1990269;GO:1904047;GO:0080009;GO:0010923;GO:0017148;GO:0045727;, C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:S-adenosyl-L-methionine binding;, P:mRNA methylation; P:negative regulation of phosphatase activity; P:negative regulation of translation; P:positive regulation of translation;|Q9H4Z3 E1P5P1 Q54AB9 Q9NT85,mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase,Cap-specific adenosine methyltransferase {ECO:0000303|PubMed:30467178};Phosphorylated CTD-interacting factor 1 {ECO:0000303|PubMed:12565871};Protein phosphatase 1 regulatory subunit 121;, PF12237;PF00397;, GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0016422;GO:0099122;GO:1990269;GO:1904047;GO:0080009;GO:0010923;GO:0017148;GO:0045727;, C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:S-adenosyl-L-methionine binding;, P:mRNA methylation; P:negative regulation of phosphatase activity; P:negative regulation of translation; P:positive regulation of translation; scaffold67 indexed_genome mRNA 8427201 8434398 . - . ID=transcript_11113;Q9H4Z3 E1P5P1 Q54AB9 Q9NT85,mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase,Cap-specific adenosine methyltransferase {ECO:0000303|PubMed:30467178};Phosphorylated CTD-interacting factor 1 {ECO:0000303|PubMed:12565871};Protein phosphatase 1 regulatory subunit 121;, PF12237;PF00397;, GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0016422;GO:0099122;GO:1990269;GO:1904047;GO:0080009;GO:0010923;GO:0017148;GO:0045727;, C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:S-adenosyl-L-methionine binding;, P:mRNA methylation; P:negative regulation of phosphatase activity; P:negative regulation of translation; P:positive regulation of translation;|Q9H4Z3 E1P5P1 Q54AB9 Q9NT85,mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase,Cap-specific adenosine methyltransferase {ECO:0000303|PubMed:30467178};Phosphorylated CTD-interacting factor 1 {ECO:0000303|PubMed:12565871};Protein phosphatase 1 regulatory subunit 121;, PF12237;PF00397;, GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0016422;GO:0099122;GO:1990269;GO:1904047;GO:0080009;GO:0010923;GO:0017148;GO:0045727;, C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:S-adenosyl-L-methionine binding;, P:mRNA methylation; P:negative regulation of phosphatase activity; P:negative regulation of translation; P:positive regulation of translation;|Q9H4Z3 E1P5P1 Q54AB9 Q9NT85,mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase,Cap-specific adenosine methyltransferase {ECO:0000303|PubMed:30467178};Phosphorylated CTD-interacting factor 1 {ECO:0000303|PubMed:12565871};Protein phosphatase 1 regulatory subunit 121;, PF12237;PF00397;, GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0016422;GO:0099122;GO:1990269;GO:1904047;GO:0080009;GO:0010923;GO:0017148;GO:0045727;, C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:S-adenosyl-L-methionine binding;, P:mRNA methylation; P:negative regulation of phosphatase activity; P:negative regulation of translation; P:positive regulation of translation;|Q9H4Z3 E1P5P1 Q54AB9 Q9NT85,mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase,Cap-specific adenosine methyltransferase {ECO:0000303|PubMed:30467178};Phosphorylated CTD-interacting factor 1 {ECO:0000303|PubMed:12565871};Protein phosphatase 1 regulatory subunit 121;, PF12237;PF00397;, GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0016422;GO:0099122;GO:1990269;GO:1904047;GO:0080009;GO:0010923;GO:0017148;GO:0045727;, C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:S-adenosyl-L-methionine binding;, P:mRNA methylation; P:negative regulation of phosphatase activity; P:negative regulation of translation; P:positive regulation of translation;|Q9H4Z3 E1P5P1 Q54AB9 Q9NT85,mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase,Cap-specific adenosine methyltransferase {ECO:0000303|PubMed:30467178};Phosphorylated CTD-interacting factor 1 {ECO:0000303|PubMed:12565871};Protein phosphatase 1 regulatory subunit 121;, PF12237;PF00397;, GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0016422;GO:0099122;GO:1990269;GO:1904047;GO:0080009;GO:0010923;GO:0017148;GO:0045727;, C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II C-terminal domain phosphoserine binding; F:S-adenosyl-L-methionine binding;, P:mRNA methylation; P:negative regulation of phosphatase activity; P:negative regulation of translation; P:positive regulation of translation; scaffold67 indexed_genome mRNA 8457434 8474526 . + . ID=transcript_11114;P55058 A8K006 B4DDD5 B4DRB4 E1P5N8 E7EV16 Q8WTT1 Q9BR07 Q9BSH8,Phospholipid transfer protein,Lipid transfer protein II;, PF01273;PF02886;, GO:0005576;GO:0005615;GO:0034364;GO:0005634;GO:0097001;GO:0120017;GO:0140340;GO:0120020;GO:0140337;GO:0019992;GO:0008035;GO:0030169;GO:0070300;GO:1990050;GO:0031210;GO:0120019;GO:0008525;GO:0008429;GO:1904121;GO:1901611;GO:0140339;GO:0008526;GO:0120014;GO:0140338;GO:0034189;GO:0035627;GO:0030317;GO:0046836;GO:0034375;GO:0030522;GO:0006629;GO:0006869;GO:0015914;GO:0010875;GO:0010189;, C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:nucleus;, F:ceramide binding; F:ceramide transfer activity; F:cerebroside transfer activity; F:cholesterol transfer activity; F:diacylglyceride transfer activity; F:diacylglycerol binding; F:high-density lipoprotein particle binding; F:low-density lipoprotein particle binding; F:phosphatidic acid binding; F:phosphatidic acid transfer activity; F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylethanolamine binding; F:phosphatidylethanolamine transfer activity; F:phosphatidylglycerol binding; F:phosphatidylglycerol transfer activity; F:phosphatidylinositol transfer activity; F:phospholipid transfer activity; F:sphingomyelin transfer activity; F:very-low-density lipoprotein particle binding;, P:ceramide transport; P:flagellated sperm motility; P:glycolipid transport; P:high-density lipoprotein particle remodeling; P:intracellular receptor signaling pathway; P:lipid metabolic process; P:lipid transport; P:phospholipid transport; P:positive regulation of cholesterol efflux; P:vitamin E biosynthetic process;|P55058 A8K006 B4DDD5 B4DRB4 E1P5N8 E7EV16 Q8WTT1 Q9BR07 Q9BSH8,Phospholipid transfer protein,Lipid transfer protein II;, PF01273;PF02886;, GO:0005576;GO:0005615;GO:0034364;GO:0005634;GO:0097001;GO:0120017;GO:0140340;GO:0120020;GO:0140337;GO:0019992;GO:0008035;GO:0030169;GO:0070300;GO:1990050;GO:0031210;GO:0120019;GO:0008525;GO:0008429;GO:1904121;GO:1901611;GO:0140339;GO:0008526;GO:0120014;GO:0140338;GO:0034189;GO:0035627;GO:0030317;GO:0046836;GO:0034375;GO:0030522;GO:0006629;GO:0006869;GO:0015914;GO:0010875;GO:0010189;, C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:nucleus;, F:ceramide binding; F:ceramide transfer activity; F:cerebroside transfer activity; F:cholesterol transfer activity; F:diacylglyceride transfer activity; F:diacylglycerol binding; F:high-density lipoprotein particle binding; F:low-density lipoprotein particle binding; F:phosphatidic acid binding; F:phosphatidic acid transfer activity; F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylethanolamine binding; F:phosphatidylethanolamine transfer activity; F:phosphatidylglycerol binding; F:phosphatidylglycerol transfer activity; F:phosphatidylinositol transfer activity; F:phospholipid transfer activity; F:sphingomyelin transfer activity; F:very-low-density lipoprotein particle binding;, P:ceramide transport; P:flagellated sperm motility; P:glycolipid transport; P:high-density lipoprotein particle remodeling; P:intracellular receptor signaling pathway; P:lipid metabolic process; P:lipid transport; P:phospholipid transport; P:positive regulation of cholesterol efflux; P:vitamin E biosynthetic process;|P55058 A8K006 B4DDD5 B4DRB4 E1P5N8 E7EV16 Q8WTT1 Q9BR07 Q9BSH8,Phospholipid transfer protein,Lipid transfer protein II;, PF01273;PF02886;, GO:0005576;GO:0005615;GO:0034364;GO:0005634;GO:0097001;GO:0120017;GO:0140340;GO:0120020;GO:0140337;GO:0019992;GO:0008035;GO:0030169;GO:0070300;GO:1990050;GO:0031210;GO:0120019;GO:0008525;GO:0008429;GO:1904121;GO:1901611;GO:0140339;GO:0008526;GO:0120014;GO:0140338;GO:0034189;GO:0035627;GO:0030317;GO:0046836;GO:0034375;GO:0030522;GO:0006629;GO:0006869;GO:0015914;GO:0010875;GO:0010189;, C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:nucleus;, F:ceramide binding; F:ceramide transfer activity; F:cerebroside transfer activity; F:cholesterol transfer activity; F:diacylglyceride transfer activity; F:diacylglycerol binding; F:high-density lipoprotein particle binding; F:low-density lipoprotein particle binding; F:phosphatidic acid binding; F:phosphatidic acid transfer activity; F:phosphatidylcholine binding; F:phosphatidylcholine transfer activity; F:phosphatidylcholine transporter activity; F:phosphatidylethanolamine binding; F:phosphatidylethanolamine transfer activity; F:phosphatidylglycerol binding; F:phosphatidylglycerol transfer activity; F:phosphatidylinositol transfer activity; F:phospholipid transfer activity; F:sphingomyelin transfer activity; F:very-low-density lipoprotein particle binding;, P:ceramide transport; P:flagellated sperm motility; P:glycolipid transport; P:high-density lipoprotein particle remodeling; P:intracellular receptor signaling pathway; P:lipid metabolic process; P:lipid transport; P:phospholipid transport; P:positive regulation of cholesterol efflux; P:vitamin E biosynthetic process;|P10619 B2R798 Q561W6 Q5JZH1 Q96KJ2 Q9BR08 Q9BW68,Lysosomal protective protein,Carboxypeptidase C;Carboxypeptidase L;Cathepsin A;Protective protein cathepsin A;Protective protein for beta-galactosidase;, PF00450;, GO:0035578;GO:0005783;GO:0070062;GO:0005576;GO:0043231;GO:0043202;GO:0005764;GO:0016020;GO:0004180;GO:0008047;GO:0004185;GO:0006687;GO:0006886;GO:1904715;GO:0043312;GO:0006508;GO:1904714;GO:0031647;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:membrane;, F:carboxypeptidase activity; F:enzyme activator activity; F:serine-type carboxypeptidase activity;, P:glycosphingolipid metabolic process; P:intracellular protein transport; P:negative regulation of chaperone-mediated autophagy; P:neutrophil degranulation; P:proteolysis; P:regulation of chaperone-mediated autophagy; P:regulation of protein stability;|P10619 B2R798 Q561W6 Q5JZH1 Q96KJ2 Q9BR08 Q9BW68,Lysosomal protective protein,Carboxypeptidase C;Carboxypeptidase L;Cathepsin A;Protective protein cathepsin A;Protective protein for beta-galactosidase;, PF00450;, GO:0035578;GO:0005783;GO:0070062;GO:0005576;GO:0043231;GO:0043202;GO:0005764;GO:0016020;GO:0004180;GO:0008047;GO:0004185;GO:0006687;GO:0006886;GO:1904715;GO:0043312;GO:0006508;GO:1904714;GO:0031647;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:membrane;, F:carboxypeptidase activity; F:enzyme activator activity; F:serine-type carboxypeptidase activity;, P:glycosphingolipid metabolic process; P:intracellular protein transport; P:negative regulation of chaperone-mediated autophagy; P:neutrophil degranulation; P:proteolysis; P:regulation of chaperone-mediated autophagy; P:regulation of protein stability;|P10619 B2R798 Q561W6 Q5JZH1 Q96KJ2 Q9BR08 Q9BW68,Lysosomal protective protein,Carboxypeptidase C;Carboxypeptidase L;Cathepsin A;Protective protein cathepsin A;Protective protein for beta-galactosidase;, PF00450;, GO:0035578;GO:0005783;GO:0070062;GO:0005576;GO:0043231;GO:0043202;GO:0005764;GO:0016020;GO:0004180;GO:0008047;GO:0004185;GO:0006687;GO:0006886;GO:1904715;GO:0043312;GO:0006508;GO:1904714;GO:0031647;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:membrane;, F:carboxypeptidase activity; F:enzyme activator activity; F:serine-type carboxypeptidase activity;, P:glycosphingolipid metabolic process; P:intracellular protein transport; P:negative regulation of chaperone-mediated autophagy; P:neutrophil degranulation; P:proteolysis; P:regulation of chaperone-mediated autophagy; P:regulation of protein stability;|P10619 B2R798 Q561W6 Q5JZH1 Q96KJ2 Q9BR08 Q9BW68,Lysosomal protective protein,Carboxypeptidase C;Carboxypeptidase L;Cathepsin A;Protective protein cathepsin A;Protective protein for beta-galactosidase;, PF00450;, GO:0035578;GO:0005783;GO:0070062;GO:0005576;GO:0043231;GO:0043202;GO:0005764;GO:0016020;GO:0004180;GO:0008047;GO:0004185;GO:0006687;GO:0006886;GO:1904715;GO:0043312;GO:0006508;GO:1904714;GO:0031647;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:membrane;, F:carboxypeptidase activity; F:enzyme activator activity; F:serine-type carboxypeptidase activity;, P:glycosphingolipid metabolic process; P:intracellular protein transport; P:negative regulation of chaperone-mediated autophagy; P:neutrophil degranulation; P:proteolysis; P:regulation of chaperone-mediated autophagy; P:regulation of protein stability;|P10619 B2R798 Q561W6 Q5JZH1 Q96KJ2 Q9BR08 Q9BW68,Lysosomal protective protein,Carboxypeptidase C;Carboxypeptidase L;Cathepsin A;Protective protein cathepsin A;Protective protein for beta-galactosidase;, PF00450;, GO:0035578;GO:0005783;GO:0070062;GO:0005576;GO:0043231;GO:0043202;GO:0005764;GO:0016020;GO:0004180;GO:0008047;GO:0004185;GO:0006687;GO:0006886;GO:1904715;GO:0043312;GO:0006508;GO:1904714;GO:0031647;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:membrane;, F:carboxypeptidase activity; F:enzyme activator activity; F:serine-type carboxypeptidase activity;, P:glycosphingolipid metabolic process; P:intracellular protein transport; P:negative regulation of chaperone-mediated autophagy; P:neutrophil degranulation; P:proteolysis; P:regulation of chaperone-mediated autophagy; P:regulation of protein stability; scaffold67 indexed_genome mRNA 8474665 8483065 . + . ID=transcript_11115;Q9BR09 Q3KR34,Neuralized-like protein 2,, PF07177;PF07525;, GO:0005829;GO:0061630;GO:0035556;GO:0043687;, C:cytosol;, F:ubiquitin protein ligase activity;, P:intracellular signal transduction; P:post-translational protein modification;|Q9BR10,Spermatogenesis-associated protein 25,Testis-specific gene 23 protein;, PF15218;, GO:0016021;GO:0030154;GO:0007283;, C:integral component of membrane;, , P:cell differentiation; P:spermatogenesis;|Q9BR11 Q5JZH2 Q9BR12 Q9BV30,Zinc finger SWIM domain-containing protein 1,, PF04434;, GO:0005634;GO:0008270;, C:nucleus;, F:zinc ion binding; scaffold67 indexed_genome mRNA 8483976 8485549 . - . ID=transcript_11116;Q96MP5 Q9BR13,Zinc finger SWIM domain-containing protein 3,, PF04434;, GO:0008270;, , F:zinc ion binding; scaffold67 indexed_genome mRNA 8485742 8499327 . - . ID=transcript_11117;Q96MP5 Q9BR13,Zinc finger SWIM domain-containing protein 3,, PF04434;, GO:0008270;, , F:zinc ion binding; scaffold67 indexed_genome mRNA 8499523 8519891 . - . ID=transcript_11118;Q969T3 Q5JZH5 Q5JZH6 Q5JZH7 Q8WUR6 Q9BR16,Sorting nexin-21,Sorting nexin L;, PF00787;, GO:0030659;GO:0031901;GO:0032266;GO:0005546;GO:0015031;, C:cytoplasmic vesicle membrane; C:early endosome membrane;, F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:protein transport;|Q969T3 Q5JZH5 Q5JZH6 Q5JZH7 Q8WUR6 Q9BR16,Sorting nexin-21,Sorting nexin L;, PF00787;, GO:0030659;GO:0031901;GO:0032266;GO:0005546;GO:0015031;, C:cytoplasmic vesicle membrane; C:early endosome membrane;, F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:protein transport;|Q969T3 Q5JZH5 Q5JZH6 Q5JZH7 Q8WUR6 Q9BR16,Sorting nexin-21,Sorting nexin L;, PF00787;, GO:0030659;GO:0031901;GO:0032266;GO:0005546;GO:0015031;, C:cytoplasmic vesicle membrane; C:early endosome membrane;, F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:protein transport; scaffold67 indexed_genome mRNA 8539790 8543191 . - . ID=transcript_11119;O00762 A6NP33 E1P5N7 G3XAB7,Ubiquitin-conjugating enzyme E2 C,(E3-independent) E2 ubiquitin-conjugating enzyme C;E2 ubiquitin-conjugating enzyme C;UbcH10;Ubiquitin carrier protein C;Ubiquitin-protein ligase C;, PF00179;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0000151;GO:0005524;GO:0061631;GO:0044389;GO:0004842;GO:0031145;GO:0051301;GO:0010458;GO:0010994;GO:0031536;GO:1904668;GO:0070979;GO:0070936;GO:0000209;GO:0016567;GO:0007096;GO:1901990;GO:0030071;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-like protein ligase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:exit from mitosis; P:free ubiquitin chain polymerization; P:positive regulation of exit from mitosis; P:positive regulation of ubiquitin protein ligase activity; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:regulation of mitotic metaphase/anaphase transition; P:ubiquitin-dependent protein catabolic process; scaffold67 indexed_genome mRNA 8544248 8552882 . - . ID=transcript_11120;Q9H147 B2RA18 Q96DE3 Q9BQP2 Q9H148,Deoxynucleotidyltransferase terminal-interacting protein 1,Terminal deoxynucleotidyltransferase-interacting factor 1;, PF18192;, GO:0005694;GO:0000118;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0031491;GO:0042803;, C:chromosome; C:histone deacetylase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:nucleosome binding; F:protein homodimerization activity;|Q9H147 B2RA18 Q96DE3 Q9BQP2 Q9H148,Deoxynucleotidyltransferase terminal-interacting protein 1,Terminal deoxynucleotidyltransferase-interacting factor 1;, PF18192;, GO:0005694;GO:0000118;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0031491;GO:0042803;, C:chromosome; C:histone deacetylase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:nucleosome binding; F:protein homodimerization activity; scaffold67 indexed_genome mRNA 8553901 8558534 . - . ID=transcript_11121;Q9H147 B2RA18 Q96DE3 Q9BQP2 Q9H148,Deoxynucleotidyltransferase terminal-interacting protein 1,Terminal deoxynucleotidyltransferase-interacting factor 1;, PF18192;, GO:0005694;GO:0000118;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0031491;GO:0042803;, C:chromosome; C:histone deacetylase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:nucleosome binding; F:protein homodimerization activity; scaffold67 indexed_genome mRNA 8565531 8575630 . + . ID=transcript_11122;Q8IUB2 A6PVF2 Q0P6A5 Q3T1C5 Q8TC52 Q9BQP3 Q9BQP4,WAP four-disulfide core domain protein 3,Putative protease inhibitor WAP14;, PF00095;, GO:0005615;GO:0004867;GO:0019731;GO:0045087;, C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:antibacterial humoral response; P:innate immune response; scaffold67 indexed_genome mRNA 8761907 8768425 . - . ID=transcript_11123;Q96KJ1,WAP four-disulfide core domain protein 2,Epididymal secretory protein E4;Major epididymis-specific protein E4;Putative protease inhibitor WAP5;, PF00095;, GO:0070062;GO:0005615;GO:0019828;GO:0004869;GO:0004866;GO:0004867;GO:0019731;GO:0045087;GO:0006508;GO:0007283;, C:extracellular exosome; C:extracellular space;, F:aspartic-type endopeptidase inhibitor activity; F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:antibacterial humoral response; P:innate immune response; P:proteolysis; P:spermatogenesis;|Q96KJ1,WAP four-disulfide core domain protein 2,Epididymal secretory protein E4;Major epididymis-specific protein E4;Putative protease inhibitor WAP5;, PF00095;, GO:0070062;GO:0005615;GO:0019828;GO:0004869;GO:0004866;GO:0004867;GO:0019731;GO:0045087;GO:0006508;GO:0007283;, C:extracellular exosome; C:extracellular space;, F:aspartic-type endopeptidase inhibitor activity; F:cysteine-type endopeptidase inhibitor activity; F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:antibacterial humoral response; P:innate immune response; P:proteolysis; P:spermatogenesis; scaffold67 indexed_genome mRNA 8785208 8795178 . - . ID=transcript_11124;P02760 P00977 P02759 P78491 Q2TU33 Q5TBD7 Q9UC58 Q9UDI8,Protein AMBP,, PF00014;PF00061;, GO:0072562;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0005886;GO:0019855;GO:0046904;GO:0020037;GO:0019862;GO:0042803;GO:0004867;GO:0007155;GO:0007565;GO:0042167;GO:0050777;GO:0046329;GO:0030163;GO:0018298;GO:0006898;GO:0016032;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:calcium channel inhibitor activity; F:calcium oxalate binding; F:heme binding; F:IgA binding; F:protein homodimerization activity; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:female pregnancy; P:heme catabolic process; P:negative regulation of immune response; P:negative regulation of JNK cascade; P:protein catabolic process; P:protein-chromophore linkage; P:receptor-mediated endocytosis; P:viral process; scaffold67 indexed_genome mRNA 8831034 8835917 . - . ID=transcript_11125;O43291 A8K667 B4DLU1 O00271 O14895 Q5TZQ3 Q969E0,Kunitz-type protease inhibitor 2,Hepatocyte growth factor activator inhibitor type 2;Placental bikunin;, PF00014;, GO:0005737;GO:0005576;GO:0016021;GO:0005886;GO:0004866;GO:0004867;GO:0071711;GO:0071773;GO:0060672;GO:0007163;GO:2000146;GO:0022408;GO:2000178;GO:0001843;, C:cytoplasm; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:basement membrane organization; P:cellular response to BMP stimulus; P:epithelial cell morphogenesis involved in placental branching; P:establishment or maintenance of cell polarity; P:negative regulation of cell motility; P:negative regulation of cell-cell adhesion; P:negative regulation of neural precursor cell proliferation; P:neural tube closure; scaffold67 indexed_genome mRNA 8860705 8866824 . + . ID=transcript_11126;Q06481 B3KXX9 H7BXI4 Q13861 Q14594 Q14662 Q71U10 Q7M4L3 Q9BT36,Amyloid-like protein 2,APPH;Amyloid protein homolog;CDEI box-binding protein;, PF10515;PF12924;PF12925;PF02177;PF00014;, GO:0005788;GO:0070062;GO:0016021;GO:0016020;GO:0005634;GO:0005886;GO:0031092;GO:0003677;GO:0008201;GO:0042802;GO:0004867;GO:0046914;GO:0044267;GO:0007186;GO:0002576;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:integral component of membrane; C:membrane; C:nucleus; C:plasma membrane; C:platelet alpha granule membrane;, F:DNA binding; F:heparin binding; F:identical protein binding; F:serine-type endopeptidase inhibitor activity; F:transition metal ion binding;, P:cellular protein metabolic process; P:G protein-coupled receptor signaling pathway; P:platelet degranulation; P:post-translational protein modification; scaffold67 indexed_genome mRNA 9292895 9380544 . - . ID=transcript_11127;Q9NZ31,Dysbindin domain-containing protein 2,Casein kinase-1 binding protein;HSMNP1;, PF04440;, GO:0005737;GO:0006469;, C:cytoplasm;, , P:negative regulation of protein kinase activity;|Q9BQY8 Q9UJG6 Q9Y2Z5,GPI transamidase component PIG-T,Phosphatidylinositol-glycan biosynthesis class T protein;, PF04113;, GO:0005789;GO:0042765;GO:0030176;GO:0016020;GO:0016255;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:integral component of endoplasmic reticulum membrane; C:membrane;, , P:attachment of GPI anchor to protein;|Q9BQY8 Q9UJG6 Q9Y2Z5,GPI transamidase component PIG-T,Phosphatidylinositol-glycan biosynthesis class T protein;, PF04113;, GO:0005789;GO:0042765;GO:0030176;GO:0016020;GO:0016255;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:integral component of endoplasmic reticulum membrane; C:membrane;, , P:attachment of GPI anchor to protein;|Q9BQY8 Q9UJG6 Q9Y2Z5,GPI transamidase component PIG-T,Phosphatidylinositol-glycan biosynthesis class T protein;, PF04113;, GO:0005789;GO:0042765;GO:0030176;GO:0016020;GO:0016255;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:integral component of endoplasmic reticulum membrane; C:membrane;, , P:attachment of GPI anchor to protein;|Q9NZ31,Dysbindin domain-containing protein 2,Casein kinase-1 binding protein;HSMNP1;, PF04440;, GO:0005737;GO:0006469;, C:cytoplasm;, , P:negative regulation of protein kinase activity; scaffold67 indexed_genome mRNA 9402806 9411536 . - . ID=transcript_11128;Q8N2H4 C9JFB3 E1P620 Q5QPU7 Q96SD8 Q9BQZ2 Q9BQZ4 Q9H1F7,Protein SYS1 homolog,, PF09801;, GO:0005829;GO:0030173;GO:0005802;GO:0032588;GO:0006895;GO:0043001;GO:0034067;, C:cytosol; C:integral component of Golgi membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, , P:Golgi to endosome transport; P:Golgi to plasma membrane protein transport; P:protein localization to Golgi apparatus; scaffold67 indexed_genome mRNA 9440458 9448264 . + . ID=transcript_11129;P31431 O00773 Q16833 Q53FN9 Q6FGN3,Syndecan-4,Amphiglycan;Ryudocan core protein;, PF01034;, GO:0009986;GO:0043034;GO:0070062;GO:0005925;GO:0005796;GO:0005887;GO:0043202;GO:0045121;GO:0005886;GO:0001968;GO:0042802;GO:0005080;GO:0070053;GO:0016477;GO:0006024;GO:0006027;GO:0060122;GO:0050900;GO:0042130;GO:0001843;GO:1903543;GO:1903553;GO:0051894;GO:0045860;GO:0051496;GO:0010762;GO:0001523;GO:0001657;GO:0042060;, C:cell surface; C:costamere; C:extracellular exosome; C:focal adhesion; C:Golgi lumen; C:integral component of plasma membrane; C:lysosomal lumen; C:membrane raft; C:plasma membrane;, F:fibronectin binding; F:identical protein binding; F:protein kinase C binding; F:thrombospondin receptor activity;, P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inner ear receptor cell stereocilium organization; P:leukocyte migration; P:negative regulation of T cell proliferation; P:neural tube closure; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:positive regulation of focal adhesion assembly; P:positive regulation of protein kinase activity; P:positive regulation of stress fiber assembly; P:regulation of fibroblast migration; P:retinoid metabolic process; P:ureteric bud development; P:wound healing;|P31431 O00773 Q16833 Q53FN9 Q6FGN3,Syndecan-4,Amphiglycan;Ryudocan core protein;, PF01034;, GO:0009986;GO:0043034;GO:0070062;GO:0005925;GO:0005796;GO:0005887;GO:0043202;GO:0045121;GO:0005886;GO:0001968;GO:0042802;GO:0005080;GO:0070053;GO:0016477;GO:0006024;GO:0006027;GO:0060122;GO:0050900;GO:0042130;GO:0001843;GO:1903543;GO:1903553;GO:0051894;GO:0045860;GO:0051496;GO:0010762;GO:0001523;GO:0001657;GO:0042060;, C:cell surface; C:costamere; C:extracellular exosome; C:focal adhesion; C:Golgi lumen; C:integral component of plasma membrane; C:lysosomal lumen; C:membrane raft; C:plasma membrane;, F:fibronectin binding; F:identical protein binding; F:protein kinase C binding; F:thrombospondin receptor activity;, P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inner ear receptor cell stereocilium organization; P:leukocyte migration; P:negative regulation of T cell proliferation; P:neural tube closure; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:positive regulation of focal adhesion assembly; P:positive regulation of protein kinase activity; P:positive regulation of stress fiber assembly; P:regulation of fibroblast migration; P:retinoid metabolic process; P:ureteric bud development; P:wound healing;|P31431 O00773 Q16833 Q53FN9 Q6FGN3,Syndecan-4,Amphiglycan;Ryudocan core protein;, PF01034;, GO:0009986;GO:0043034;GO:0070062;GO:0005925;GO:0005796;GO:0005887;GO:0043202;GO:0045121;GO:0005886;GO:0001968;GO:0042802;GO:0005080;GO:0070053;GO:0016477;GO:0006024;GO:0006027;GO:0060122;GO:0050900;GO:0042130;GO:0001843;GO:1903543;GO:1903553;GO:0051894;GO:0045860;GO:0051496;GO:0010762;GO:0001523;GO:0001657;GO:0042060;, C:cell surface; C:costamere; C:extracellular exosome; C:focal adhesion; C:Golgi lumen; C:integral component of plasma membrane; C:lysosomal lumen; C:membrane raft; C:plasma membrane;, F:fibronectin binding; F:identical protein binding; F:protein kinase C binding; F:thrombospondin receptor activity;, P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inner ear receptor cell stereocilium organization; P:leukocyte migration; P:negative regulation of T cell proliferation; P:neural tube closure; P:positive regulation of exosomal secretion; P:positive regulation of extracellular exosome assembly; P:positive regulation of focal adhesion assembly; P:positive regulation of protein kinase activity; P:positive regulation of stress fiber assembly; P:regulation of fibroblast migration; P:retinoid metabolic process; P:ureteric bud development; P:wound healing; scaffold67 indexed_genome mRNA 9473317 9473953 . - . ID=transcript_11130;Q9H1F9,Matrilin-4,, PF12662;PF10393;PF00092;, GO:0062023;GO:0005576;GO:0005509;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular region;, F:calcium ion binding;, P:extracellular matrix organization; scaffold67 indexed_genome mRNA 9475091 9484583 . + . ID=transcript_11131;Q9H1F9,Matrilin-4,, PF12662;PF10393;PF00092;, GO:0062023;GO:0005576;GO:0005509;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular region;, F:calcium ion binding;, P:extracellular matrix organization; scaffold67 indexed_genome mRNA 9548911 9550405 . - . ID=transcript_11132;Q8WWY7 Q5H980 Q9BR31,WAP four-disulfide core domain protein 12,Putative protease inhibitor WAP12;Whey acidic protein 2;, PF00095;, GO:0005615;GO:0004867;GO:0019731;GO:0042742;GO:0045087;, C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:antibacterial humoral response; P:defense response to bacterium; P:innate immune response; scaffold68 indexed_genome mRNA 8309 76346 . + . ID=transcript_11133;Q7Z2Z2 A6NKY5 B7Z6I0 Q9H8Z6,Elongation factor-like GTPase 1,Elongation factor Tu GTP-binding domain-containing protein 1;Elongation factor-like 1;Protein FAM42A;, PF00679;PF14492;PF00009;, GO:1990904;GO:0005525;GO:0003924;GO:0043022;GO:0003746;GO:0046039;GO:0042256;, C:ribonucleoprotein complex;, F:GTP binding; F:GTPase activity; F:ribosome binding; F:translation elongation factor activity;, P:GTP metabolic process; P:mature ribosome assembly; scaffold68 indexed_genome mRNA 77104 78590 . + . ID=transcript_11134;Q96RG1 Q9UMY9 Q9UN34,MAP/microtubule affinity-regulating kinase 3,C-TAK1;Cdc25C-associated protein kinase 1;ELKL motif kinase 2;Protein kinase STK10;Ser/Thr protein kinase PAR-1;Serine/threonine-protein kinase p78;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0035556;GO:0000165;GO:0000226;GO:0035331;GO:0036289;GO:0018105;GO:0032092;GO:0006468;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:intracellular signal transduction; P:MAPK cascade; P:microtubule cytoskeleton organization; P:negative regulation of hippo signaling; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:protein phosphorylation; scaffold68 indexed_genome mRNA 130711 134121 . - . ID=transcript_11135;Q96RG1 Q9UMY9 Q9UN34,MAP/microtubule affinity-regulating kinase 3,C-TAK1;Cdc25C-associated protein kinase 1;ELKL motif kinase 2;Protein kinase STK10;Ser/Thr protein kinase PAR-1;Serine/threonine-protein kinase p78;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0035556;GO:0000165;GO:0000226;GO:0035331;GO:0036289;GO:0018105;GO:0032092;GO:0006468;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:intracellular signal transduction; P:MAPK cascade; P:microtubule cytoskeleton organization; P:negative regulation of hippo signaling; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:protein phosphorylation; scaffold68 indexed_genome mRNA 154991 354623 . - . ID=transcript_11136;Q9NZ56 B0QZA7 B4DP05 Q59GF6 Q5VU37 Q9NZ55,Formin-2,, PF02181;, GO:0005938;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005783;GO:0005789;GO:0005730;GO:0005634;GO:0048471;GO:0005886;GO:0003779;GO:0006974;GO:0071456;GO:0051295;GO:0070649;GO:0051758;GO:0035556;GO:0046907;GO:0007275;GO:0043066;GO:0042177;GO:0048477;GO:0040038;GO:2000781;GO:0015031;GO:0016192;, C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin binding;, P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:homologous chromosome movement towards spindle pole in meiosis I anaphase; P:intracellular signal transduction; P:intracellular transport; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of protein catabolic process; P:oogenesis; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:protein transport; P:vesicle-mediated transport; scaffold68 indexed_genome mRNA 355009 515474 . - . ID=transcript_11137;Q9NZ56 B0QZA7 B4DP05 Q59GF6 Q5VU37 Q9NZ55,Formin-2,, PF02181;, GO:0005938;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005783;GO:0005789;GO:0005730;GO:0005634;GO:0048471;GO:0005886;GO:0003779;GO:0006974;GO:0071456;GO:0051295;GO:0070649;GO:0051758;GO:0035556;GO:0046907;GO:0007275;GO:0043066;GO:0042177;GO:0048477;GO:0040038;GO:2000781;GO:0015031;GO:0016192;, C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nucleolus; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:actin binding;, P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:establishment of meiotic spindle localization; P:formin-nucleated actin cable assembly; P:homologous chromosome movement towards spindle pole in meiosis I anaphase; P:intracellular signal transduction; P:intracellular transport; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of protein catabolic process; P:oogenesis; P:polar body extrusion after meiotic divisions; P:positive regulation of double-strand break repair; P:protein transport; P:vesicle-mediated transport; scaffold68 indexed_genome mRNA 737619 773344 . - . ID=transcript_11138;Q9H425 A8K8R8 B3KTW1 G5EA08,Uncharacterized protein C1orf198,, PF15797;, GO:0005829;, C:cytosol; scaffold68 indexed_genome mRNA 813844 899742 . - . ID=transcript_11139;Q8NBP0 B1AQI1 B1AQI2 Q8IVP8 Q8NBI0 Q8ND20,Tetratricopeptide repeat protein 13,, PF00515;PF13181;|Q8NBP0 B1AQI1 B1AQI2 Q8IVP8 Q8NBI0 Q8ND20,Tetratricopeptide repeat protein 13,, PF00515;PF13181;|Q8NBP0 B1AQI1 B1AQI2 Q8IVP8 Q8NBI0 Q8ND20,Tetratricopeptide repeat protein 13,, PF00515;PF13181;|Q8NBP0 B1AQI1 B1AQI2 Q8IVP8 Q8NBI0 Q8ND20,Tetratricopeptide repeat protein 13,, PF00515;PF13181;|Q8NBP0 B1AQI1 B1AQI2 Q8IVP8 Q8NBI0 Q8ND20,Tetratricopeptide repeat protein 13,, PF00515;PF13181;|Q8NBP0 B1AQI1 B1AQI2 Q8IVP8 Q8NBI0 Q8ND20,Tetratricopeptide repeat protein 13,, PF00515;PF13181;|Q8NBP0 B1AQI1 B1AQI2 Q8IVP8 Q8NBI0 Q8ND20,Tetratricopeptide repeat protein 13,, PF00515;PF13181;|Q8NBP0 B1AQI1 B1AQI2 Q8IVP8 Q8NBI0 Q8ND20,Tetratricopeptide repeat protein 13,, PF00515;PF13181;|Q8NBP0 B1AQI1 B1AQI2 Q8IVP8 Q8NBI0 Q8ND20,Tetratricopeptide repeat protein 13,, PF00515;PF13181; scaffold68 indexed_genome mRNA 899907 920367 . + . ID=transcript_11140;Q9UFF5,Protein ARV1,, PF04161;, GO:0032541;GO:0005789;GO:0005794;GO:0016021;GO:0006695;GO:0032366;GO:0090181;GO:0032383;GO:0097036;GO:0006665;GO:0016125;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:cholesterol biosynthetic process; P:intracellular sterol transport; P:regulation of cholesterol metabolic process; P:regulation of intracellular cholesterol transport; P:regulation of plasma membrane sterol distribution; P:sphingolipid metabolic process; P:sterol metabolic process;|Q9UFF5,Protein ARV1,, PF04161;, GO:0032541;GO:0005789;GO:0005794;GO:0016021;GO:0006695;GO:0032366;GO:0090181;GO:0032383;GO:0097036;GO:0006665;GO:0016125;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:cholesterol biosynthetic process; P:intracellular sterol transport; P:regulation of cholesterol metabolic process; P:regulation of intracellular cholesterol transport; P:regulation of plasma membrane sterol distribution; P:sphingolipid metabolic process; P:sterol metabolic process;|Q9UFF5,Protein ARV1,, PF04161;, GO:0032541;GO:0005789;GO:0005794;GO:0016021;GO:0006695;GO:0032366;GO:0090181;GO:0032383;GO:0097036;GO:0006665;GO:0016125;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:cholesterol biosynthetic process; P:intracellular sterol transport; P:regulation of cholesterol metabolic process; P:regulation of intracellular cholesterol transport; P:regulation of plasma membrane sterol distribution; P:sphingolipid metabolic process; P:sterol metabolic process; scaffold68 indexed_genome mRNA 1127526 1141007 . + . ID=transcript_11141;Q6ZTA4 Q5TER7 Q5TER8 Q7Z4K7,Tripartite motif-containing protein 67,TRIM9-like protein;, PF00041;PF00622;PF00643;PF00097;, GO:0005737;GO:0005856;GO:0008270;GO:0046580;GO:0010976;GO:2000060;GO:1903827;, C:cytoplasm; C:cytoskeleton;, F:zinc ion binding;, P:negative regulation of Ras protein signal transduction; P:positive regulation of neuron projection development; P:positive regulation of ubiquitin-dependent protein catabolic process; P:regulation of cellular protein localization; scaffold68 indexed_genome mRNA 1141861 1142735 . - . ID=transcript_11142;Q6ZTA4 Q5TER7 Q5TER8 Q7Z4K7,Tripartite motif-containing protein 67,TRIM9-like protein;, PF00041;PF00622;PF00643;PF00097;, GO:0005737;GO:0005856;GO:0008270;GO:0046580;GO:0010976;GO:2000060;GO:1903827;, C:cytoplasm; C:cytoskeleton;, F:zinc ion binding;, P:negative regulation of Ras protein signal transduction; P:positive regulation of neuron projection development; P:positive regulation of ubiquitin-dependent protein catabolic process; P:regulation of cellular protein localization; scaffold68 indexed_genome mRNA 1150917 1219993 . + . ID=transcript_11143;O15228 B4DNM9 Q5TBH7 Q9BWC2,Dihydroxyacetone phosphate acyltransferase {ECO:0000305},Acyl-CoA:dihydroxyacetonephosphateacyltransferase;Glycerone-phosphate O-acyltransferase;, PF01553;, GO:0005829;GO:0016020;GO:0031966;GO:0005782;GO:0005778;GO:0005777;GO:0016287;GO:0021587;GO:0008611;GO:0006631;GO:0061024;GO:0030913;GO:0006654;GO:0008654;GO:0008104;GO:0042493;GO:0070542;GO:0007584;GO:0042594;GO:0007416;, C:cytosol; C:membrane; C:mitochondrial membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:glycerone-phosphate O-acyltransferase activity;, P:cerebellum morphogenesis; P:ether lipid biosynthetic process; P:fatty acid metabolic process; P:membrane organization; P:paranodal junction assembly; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; P:protein localization; P:response to drug; P:response to fatty acid; P:response to nutrient; P:response to starvation; P:synapse assembly;|Q8NDD1 Q5TBI0 Q5TBI1 Q6P6B4 Q7Z6H5 Q8N432 Q96NM6,Uncharacterized protein C1orf131,, PF15375;, GO:0005694;GO:0003723;, C:chromosome;, F:RNA binding;|Q8NDD1 Q5TBI0 Q5TBI1 Q6P6B4 Q7Z6H5 Q8N432 Q96NM6,Uncharacterized protein C1orf131,, PF15375;, GO:0005694;GO:0003723;, C:chromosome;, F:RNA binding;|Q8NDD1 Q5TBI0 Q5TBI1 Q6P6B4 Q7Z6H5 Q8N432 Q96NM6,Uncharacterized protein C1orf131,, PF15375;, GO:0005694;GO:0003723;, C:chromosome;, F:RNA binding;|O15228 B4DNM9 Q5TBH7 Q9BWC2,Dihydroxyacetone phosphate acyltransferase {ECO:0000305},Acyl-CoA:dihydroxyacetonephosphateacyltransferase;Glycerone-phosphate O-acyltransferase;, PF01553;, GO:0005829;GO:0016020;GO:0031966;GO:0005782;GO:0005778;GO:0005777;GO:0016287;GO:0021587;GO:0008611;GO:0006631;GO:0061024;GO:0030913;GO:0006654;GO:0008654;GO:0008104;GO:0042493;GO:0070542;GO:0007584;GO:0042594;GO:0007416;, C:cytosol; C:membrane; C:mitochondrial membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:glycerone-phosphate O-acyltransferase activity;, P:cerebellum morphogenesis; P:ether lipid biosynthetic process; P:fatty acid metabolic process; P:membrane organization; P:paranodal junction assembly; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; P:protein localization; P:response to drug; P:response to fatty acid; P:response to nutrient; P:response to starvation; P:synapse assembly;|O15228 B4DNM9 Q5TBH7 Q9BWC2,Dihydroxyacetone phosphate acyltransferase {ECO:0000305},Acyl-CoA:dihydroxyacetonephosphateacyltransferase;Glycerone-phosphate O-acyltransferase;, PF01553;, GO:0005829;GO:0016020;GO:0031966;GO:0005782;GO:0005778;GO:0005777;GO:0016287;GO:0021587;GO:0008611;GO:0006631;GO:0061024;GO:0030913;GO:0006654;GO:0008654;GO:0008104;GO:0042493;GO:0070542;GO:0007584;GO:0042594;GO:0007416;, C:cytosol; C:membrane; C:mitochondrial membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:glycerone-phosphate O-acyltransferase activity;, P:cerebellum morphogenesis; P:ether lipid biosynthetic process; P:fatty acid metabolic process; P:membrane organization; P:paranodal junction assembly; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; P:protein localization; P:response to drug; P:response to fatty acid; P:response to nutrient; P:response to starvation; P:synapse assembly;|O15228 B4DNM9 Q5TBH7 Q9BWC2,Dihydroxyacetone phosphate acyltransferase {ECO:0000305},Acyl-CoA:dihydroxyacetonephosphateacyltransferase;Glycerone-phosphate O-acyltransferase;, PF01553;, GO:0005829;GO:0016020;GO:0031966;GO:0005782;GO:0005778;GO:0005777;GO:0016287;GO:0021587;GO:0008611;GO:0006631;GO:0061024;GO:0030913;GO:0006654;GO:0008654;GO:0008104;GO:0042493;GO:0070542;GO:0007584;GO:0042594;GO:0007416;, C:cytosol; C:membrane; C:mitochondrial membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:glycerone-phosphate O-acyltransferase activity;, P:cerebellum morphogenesis; P:ether lipid biosynthetic process; P:fatty acid metabolic process; P:membrane organization; P:paranodal junction assembly; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; P:protein localization; P:response to drug; P:response to fatty acid; P:response to nutrient; P:response to starvation; P:synapse assembly;|O15228 B4DNM9 Q5TBH7 Q9BWC2,Dihydroxyacetone phosphate acyltransferase {ECO:0000305},Acyl-CoA:dihydroxyacetonephosphateacyltransferase;Glycerone-phosphate O-acyltransferase;, PF01553;, GO:0005829;GO:0016020;GO:0031966;GO:0005782;GO:0005778;GO:0005777;GO:0016287;GO:0021587;GO:0008611;GO:0006631;GO:0061024;GO:0030913;GO:0006654;GO:0008654;GO:0008104;GO:0042493;GO:0070542;GO:0007584;GO:0042594;GO:0007416;, C:cytosol; C:membrane; C:mitochondrial membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:glycerone-phosphate O-acyltransferase activity;, P:cerebellum morphogenesis; P:ether lipid biosynthetic process; P:fatty acid metabolic process; P:membrane organization; P:paranodal junction assembly; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; P:protein localization; P:response to drug; P:response to fatty acid; P:response to nutrient; P:response to starvation; P:synapse assembly;|O15228 B4DNM9 Q5TBH7 Q9BWC2,Dihydroxyacetone phosphate acyltransferase {ECO:0000305},Acyl-CoA:dihydroxyacetonephosphateacyltransferase;Glycerone-phosphate O-acyltransferase;, PF01553;, GO:0005829;GO:0016020;GO:0031966;GO:0005782;GO:0005778;GO:0005777;GO:0016287;GO:0021587;GO:0008611;GO:0006631;GO:0061024;GO:0030913;GO:0006654;GO:0008654;GO:0008104;GO:0042493;GO:0070542;GO:0007584;GO:0042594;GO:0007416;, C:cytosol; C:membrane; C:mitochondrial membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:glycerone-phosphate O-acyltransferase activity;, P:cerebellum morphogenesis; P:ether lipid biosynthetic process; P:fatty acid metabolic process; P:membrane organization; P:paranodal junction assembly; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; P:protein localization; P:response to drug; P:response to fatty acid; P:response to nutrient; P:response to starvation; P:synapse assembly;|O15228 B4DNM9 Q5TBH7 Q9BWC2,Dihydroxyacetone phosphate acyltransferase {ECO:0000305},Acyl-CoA:dihydroxyacetonephosphateacyltransferase;Glycerone-phosphate O-acyltransferase;, PF01553;, GO:0005829;GO:0016020;GO:0031966;GO:0005782;GO:0005778;GO:0005777;GO:0016287;GO:0021587;GO:0008611;GO:0006631;GO:0061024;GO:0030913;GO:0006654;GO:0008654;GO:0008104;GO:0042493;GO:0070542;GO:0007584;GO:0042594;GO:0007416;, C:cytosol; C:membrane; C:mitochondrial membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:glycerone-phosphate O-acyltransferase activity;, P:cerebellum morphogenesis; P:ether lipid biosynthetic process; P:fatty acid metabolic process; P:membrane organization; P:paranodal junction assembly; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; P:protein localization; P:response to drug; P:response to fatty acid; P:response to nutrient; P:response to starvation; P:synapse assembly; scaffold68 indexed_genome mRNA 1234905 1253022 . + . ID=transcript_11144;Q8IYI6 B3KU33 Q5TE82,Exocyst complex component 8,Exocyst complex 84 kDa subunit;, PF16528;, GO:0031252;GO:0005829;GO:0000145;GO:0030426;GO:0005770;GO:0016020;GO:0048471;GO:0005886;GO:0035091;GO:0031267;GO:0034613;GO:0060271;GO:0007032;GO:0006887;GO:0022617;GO:0006893;GO:0008104;GO:0015031;GO:0016241;, C:cell leading edge; C:cytosol; C:exocyst; C:growth cone; C:late endosome; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:phosphatidylinositol binding; F:small GTPase binding;, P:cellular protein localization; P:cilium assembly; P:endosome organization; P:exocytosis; P:extracellular matrix disassembly; P:Golgi to plasma membrane transport; P:protein localization; P:protein transport; P:regulation of macroautophagy;|Q9H040 B1AKT0 B5MEF7 Q5TE78 Q6UWW6 Q96BC5 Q96KA0,DNA-dependent metalloprotease SPRTN {ECO:0000305},DNA damage protein targeting VCP {ECO:0000303|PubMed:23042607};Protein with SprT-like domain at the N terminus {ECO:0000303|PubMed:22894931};, PF10263;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0070530;GO:0046872;GO:0004222;GO:0031593;GO:0003697;GO:0043130;GO:0006974;GO:0070987;GO:0031398;GO:0016540;GO:0106300;GO:0006508;GO:0009411;GO:0019985;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:metalloendopeptidase activity; F:polyubiquitin modification-dependent protein binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to DNA damage stimulus; P:error-free translesion synthesis; P:positive regulation of protein ubiquitination; P:protein autoprocessing; P:protein-DNA covalent cross-linking repair; P:proteolysis; P:response to UV; P:translesion synthesis;|Q9H040 B1AKT0 B5MEF7 Q5TE78 Q6UWW6 Q96BC5 Q96KA0,DNA-dependent metalloprotease SPRTN {ECO:0000305},DNA damage protein targeting VCP {ECO:0000303|PubMed:23042607};Protein with SprT-like domain at the N terminus {ECO:0000303|PubMed:22894931};, PF10263;, GO:0000785;GO:0016607;GO:0005654;GO:0005634;GO:0003690;GO:0070530;GO:0046872;GO:0004222;GO:0031593;GO:0003697;GO:0043130;GO:0006974;GO:0070987;GO:0031398;GO:0016540;GO:0106300;GO:0006508;GO:0009411;GO:0019985;, C:chromatin; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:metalloendopeptidase activity; F:polyubiquitin modification-dependent protein binding; F:single-stranded DNA binding; F:ubiquitin binding;, P:cellular response to DNA damage stimulus; P:error-free translesion synthesis; P:positive regulation of protein ubiquitination; P:protein autoprocessing; P:protein-DNA covalent cross-linking repair; P:proteolysis; P:response to UV; P:translesion synthesis; scaffold68 indexed_genome mRNA 1255658 1272695 . - . ID=transcript_11145;Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0,Egl nine homolog 1,Hypoxia-inducible factor prolyl hydroxylase 2;Prolyl hydroxylase domain-containing protein 2;SM-20;, PF13640;PF01753;, GO:0005737;GO:0005829;GO:0005634;GO:0016706;GO:0019899;GO:0008198;GO:0031418;GO:0031545;GO:0031543;GO:0071456;GO:0051344;GO:0043433;GO:0032364;GO:0018401;GO:0045765;GO:0061418;GO:0001666;GO:0071731;, C:cytoplasm; C:cytosol; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:enzyme binding; F:ferrous iron binding; F:L-ascorbic acid binding; F:peptidyl-proline 4-dioxygenase activity; F:peptidyl-proline dioxygenase activity;, P:cellular response to hypoxia; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:negative regulation of DNA-binding transcription factor activity; P:oxygen homeostasis; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:regulation of angiogenesis; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to hypoxia; P:response to nitric oxide; scaffold68 indexed_genome mRNA 1448987 1483971 . + . ID=transcript_11146;Q99598 B1APC6,Translin-associated protein X,Translin-associated factor X;, PF01997;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0048471;GO:0003677;GO:0004521;GO:0046872;GO:0003723;GO:0043565;GO:0030154;GO:0007275;GO:0030422;GO:0007283;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:endoribonuclease activity; F:metal ion binding; F:RNA binding; F:sequence-specific DNA binding;, P:cell differentiation; P:multicellular organism development; P:production of siRNA involved in RNA interference; P:spermatogenesis;|Q99598 B1APC6,Translin-associated protein X,Translin-associated factor X;, PF01997;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0048471;GO:0003677;GO:0004521;GO:0046872;GO:0003723;GO:0043565;GO:0030154;GO:0007275;GO:0030422;GO:0007283;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:endoribonuclease activity; F:metal ion binding; F:RNA binding; F:sequence-specific DNA binding;, P:cell differentiation; P:multicellular organism development; P:production of siRNA involved in RNA interference; P:spermatogenesis; scaffold68 indexed_genome mRNA 1625564 1950323 . + . ID=transcript_11147;C9J6D0 O75045 Q5VT44 Q5VT45 Q8IXJ0 Q8IXJ1 Q9BX19 Q9NRI3 Q9NRI4,Disrupted in schizophrenia 1 protein,, , GO:0044297;GO:0090724;GO:0005813;GO:0036064;GO:0097546;GO:0005829;GO:0030286;GO:0005783;GO:0045111;GO:0005871;GO:0005874;GO:0005739;GO:0005634;GO:0048471;GO:0014069;GO:0008021;GO:0019894;GO:0060090;GO:0044877;GO:0060070;GO:0021846;GO:0060271;GO:0000226;GO:0051560;GO:0032091;GO:0001764;GO:1905515;GO:0045773;GO:0001954;GO:0002052;GO:0010976;GO:2000060;GO:0030177;GO:0071539;GO:0021852;GO:0060998;GO:0010975;GO:0090128;GO:0051966;GO:0051602;GO:0031929;, C:cell body; C:central region of growth cone; C:centrosome; C:ciliary basal body; C:ciliary base; C:cytosol; C:dynein complex; C:endoplasmic reticulum; C:intermediate filament cytoskeleton; C:kinesin complex; C:microtubule; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:synaptic vesicle;, F:kinesin binding; F:molecular adaptor activity; F:protein-containing complex binding;, P:canonical Wnt signaling pathway; P:cell proliferation in forebrain; P:cilium assembly; P:microtubule cytoskeleton organization; P:mitochondrial calcium ion homeostasis; P:negative regulation of protein binding; P:neuron migration; P:non-motile cilium assembly; P:positive regulation of axon extension; P:positive regulation of cell-matrix adhesion; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron projection development; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of Wnt signaling pathway; P:protein localization to centrosome; P:pyramidal neuron migration; P:regulation of dendritic spine development; P:regulation of neuron projection development; P:regulation of synapse maturation; P:regulation of synaptic transmission, glutamatergic; P:response to electrical stimulus; P:TOR signaling; scaffold68 indexed_genome mRNA 2263971 2378188 . - . ID=transcript_11148;Q9P2F8 Q2TV88 Q5VXR7 Q5VXR8 Q641Q4 Q8NA38 Q96DZ3 Q9H9F6,Signal-induced proliferation-associated 1-like protein 2,, PF00595;PF02145;PF11881;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9P2F8 Q2TV88 Q5VXR7 Q5VXR8 Q641Q4 Q8NA38 Q96DZ3 Q9H9F6,Signal-induced proliferation-associated 1-like protein 2,, PF00595;PF02145;PF11881;, GO:0005737;GO:0005096;GO:0090630;GO:0051056;, C:cytoplasm;, F:GTPase activator activity;, P:activation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold68 indexed_genome mRNA 2700004 2703817 . + . ID=transcript_11149;Q9P2G4 A8K2F1 Q32MI1 Q58EZ9 Q5VV83,Microtubule-associated protein 10,Microtubule regulator of 120 KDa;, PF14925;, GO:0005813;GO:0005881;GO:0030496;GO:1990023;GO:0097431;GO:0008017;GO:0051301;GO:0031122;GO:0051256;GO:0032467;GO:0032886;, C:centrosome; C:cytoplasmic microtubule; C:midbody; C:mitotic spindle midzone; C:mitotic spindle pole;, F:microtubule binding;, P:cell division; P:cytoplasmic microtubule organization; P:mitotic spindle midzone assembly; P:positive regulation of cytokinesis; P:regulation of microtubule-based process; scaffold68 indexed_genome mRNA 2890838 3162178 . - . ID=transcript_11150;A6NKB5 O43162 Q5T9Z8 Q5TDF1 Q8TEP4 Q96HP9 Q9HAL8,Pecanex-like protein 2,Pecanex homolog protein 2 {ECO:0000312|HGNC:HGNC:8736};, PF05041;, GO:0016021;, C:integral component of membrane;|A6NKB5 O43162 Q5T9Z8 Q5TDF1 Q8TEP4 Q96HP9 Q9HAL8,Pecanex-like protein 2,Pecanex homolog protein 2 {ECO:0000312|HGNC:HGNC:8736};, PF05041;, GO:0016021;, C:integral component of membrane; scaffold68 indexed_genome mRNA 3226330 3258347 . + . ID=transcript_11151;Q5TCX8 A0A1W2PKR9 B2RN34 Q5TCX7 Q5TCX9 Q8WWN1 Q8WWN2 Q96JM1 X6R610,Mitogen-activated protein kinase kinase kinase 21,Mitogen-activated protein kinase kinase kinase MLK4;Mixed lineage kinase 4;, PF07714;PF14604;, GO:0005737;GO:0005524;GO:0004709;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0007257;GO:0046777;GO:0006468;GO:0007165;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:signal transduction; scaffold68 indexed_genome mRNA 3259076 3268253 . + . ID=transcript_11152;Q5TCX8 A0A1W2PKR9 B2RN34 Q5TCX7 Q5TCX9 Q8WWN1 Q8WWN2 Q96JM1 X6R610,Mitogen-activated protein kinase kinase kinase 21,Mitogen-activated protein kinase kinase kinase MLK4;Mixed lineage kinase 4;, PF07714;PF14604;, GO:0005737;GO:0005524;GO:0004709;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0007257;GO:0046777;GO:0006468;GO:0007165;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:signal transduction;|Q5TCX8 A0A1W2PKR9 B2RN34 Q5TCX7 Q5TCX9 Q8WWN1 Q8WWN2 Q96JM1 X6R610,Mitogen-activated protein kinase kinase kinase 21,Mitogen-activated protein kinase kinase kinase MLK4;Mixed lineage kinase 4;, PF07714;PF14604;, GO:0005737;GO:0005524;GO:0004709;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0007257;GO:0046777;GO:0006468;GO:0007165;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:signal transduction;|Q5TCX8 A0A1W2PKR9 B2RN34 Q5TCX7 Q5TCX9 Q8WWN1 Q8WWN2 Q96JM1 X6R610,Mitogen-activated protein kinase kinase kinase 21,Mitogen-activated protein kinase kinase kinase MLK4;Mixed lineage kinase 4;, PF07714;PF14604;, GO:0005737;GO:0005524;GO:0004709;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0007257;GO:0046777;GO:0006468;GO:0007165;, C:cytoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:signal transduction; scaffold68 indexed_genome mRNA 3485287 3491707 . + . ID=transcript_11153;O00180 Q13307 Q5T5E8,Potassium channel subfamily K member 1,Inward rectifying potassium channel protein TWIK-1 {ECO:0000303|PubMed:8605869};Potassium channel K2P1 {ECO:0000303|PubMed:15820677};Potassium channel KCNO1;, PF07885;, GO:0016324;GO:0031526;GO:0030425;GO:0016021;GO:0005887;GO:0043231;GO:1902937;GO:0043204;GO:0005886;GO:0034705;GO:0055037;GO:0097060;GO:0008076;GO:0042802;GO:0005242;GO:0005267;GO:0022841;GO:0005272;GO:0061337;GO:0071805;GO:0006813;GO:0060075;GO:0035094;GO:0035725;GO:0030322;, C:apical plasma membrane; C:brush border membrane; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:inward rectifier potassium channel complex; C:perikaryon; C:plasma membrane; C:potassium channel complex; C:recycling endosome; C:synaptic membrane; C:voltage-gated potassium channel complex;, F:identical protein binding; F:inward rectifier potassium channel activity; F:potassium channel activity; F:potassium ion leak channel activity; F:sodium channel activity;, P:cardiac conduction; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of resting membrane potential; P:response to nicotine; P:sodium ion transmembrane transport; P:stabilization of membrane potential; scaffold68 indexed_genome mRNA 3951449 4084933 . + . ID=transcript_11154;Q8IY50 Q5TDD6 Q8N9C9,Putative thiamine transporter SLC35F3 {ECO:0000305},Solute carrier family 35 member F3;, PF00892;, GO:0016021;GO:0015888;, C:integral component of membrane;, , P:thiamine transport; scaffold68 indexed_genome mRNA 4113926 4122636 . + . ID=transcript_11155;Q5JTJ3 Q5JTJ2 Q5JTJ4 Q8TA88,Cytochrome c oxidase assembly factor 6 homolog,, PF02297;, GO:0005758;GO:0005739;GO:0005654;GO:0005886;GO:0045277;GO:0005507;GO:0003723;GO:0042774;GO:0008535;, C:mitochondrial intermembrane space; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:respiratory chain complex IV;, F:copper ion binding; F:RNA binding;, P:plasma membrane ATP synthesis coupled electron transport; P:respiratory chain complex IV assembly; scaffold68 indexed_genome mRNA 4136842 4137506 . - . ID=transcript_11156;Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation; scaffold68 indexed_genome mRNA 4139172 4141054 . - . ID=transcript_11157;Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation; scaffold68 indexed_genome mRNA 4141530 4192011 . - . ID=transcript_11158;Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation;|Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation;|Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation;|Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation;|Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation;|Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated;|Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation;|Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation; scaffold68 indexed_genome mRNA 4768051 4782717 . - . ID=transcript_11159;Q15388 A8K195 Q498B3 Q6IBT4,Mitochondrial import receptor subunit TOM20 homolog,Mitochondrial 20 kDa outer membrane protein;Outer mitochondrial membrane receptor Tom20;, PF02064;, GO:0031307;GO:0044233;GO:0005741;GO:0005742;GO:0005739;GO:0030943;GO:0015450;GO:0051082;GO:0016236;GO:0016579;GO:0030150;GO:0006626;GO:1905242;GO:0014850;GO:0016031;, C:integral component of mitochondrial outer membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:mitochondrion targeting sequence binding; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; F:unfolded protein binding;, P:macroautophagy; P:protein deubiquitination; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:response to 3,3',5-triiodo-L-thyronine; P:response to muscle activity; P:tRNA import into mitochondrion;|Q15388 A8K195 Q498B3 Q6IBT4,Mitochondrial import receptor subunit TOM20 homolog,Mitochondrial 20 kDa outer membrane protein;Outer mitochondrial membrane receptor Tom20;, PF02064;, GO:0031307;GO:0044233;GO:0005741;GO:0005742;GO:0005739;GO:0030943;GO:0015450;GO:0051082;GO:0016236;GO:0016579;GO:0030150;GO:0006626;GO:1905242;GO:0014850;GO:0016031;, C:integral component of mitochondrial outer membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:mitochondrion targeting sequence binding; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; F:unfolded protein binding;, P:macroautophagy; P:protein deubiquitination; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:response to 3,3',5-triiodo-L-thyronine; P:response to muscle activity; P:tRNA import into mitochondrion;|Q15388 A8K195 Q498B3 Q6IBT4,Mitochondrial import receptor subunit TOM20 homolog,Mitochondrial 20 kDa outer membrane protein;Outer mitochondrial membrane receptor Tom20;, PF02064;, GO:0031307;GO:0044233;GO:0005741;GO:0005742;GO:0005739;GO:0030943;GO:0015450;GO:0051082;GO:0016236;GO:0016579;GO:0030150;GO:0006626;GO:1905242;GO:0014850;GO:0016031;, C:integral component of mitochondrial outer membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:mitochondrion targeting sequence binding; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; F:unfolded protein binding;, P:macroautophagy; P:protein deubiquitination; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:response to 3,3',5-triiodo-L-thyronine; P:response to muscle activity; P:tRNA import into mitochondrion;|Q15388 A8K195 Q498B3 Q6IBT4,Mitochondrial import receptor subunit TOM20 homolog,Mitochondrial 20 kDa outer membrane protein;Outer mitochondrial membrane receptor Tom20;, PF02064;, GO:0031307;GO:0044233;GO:0005741;GO:0005742;GO:0005739;GO:0030943;GO:0015450;GO:0051082;GO:0016236;GO:0016579;GO:0030150;GO:0006626;GO:1905242;GO:0014850;GO:0016031;, C:integral component of mitochondrial outer membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:mitochondrion targeting sequence binding; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; F:unfolded protein binding;, P:macroautophagy; P:protein deubiquitination; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; P:response to 3,3',5-triiodo-L-thyronine; P:response to muscle activity; P:tRNA import into mitochondrion; scaffold68 indexed_genome mRNA 4787767 4806369 . - . ID=transcript_11160;P42696 A8K8J7 Q8N2Z8 Q9H5A1,RNA-binding protein 34,RNA-binding motif protein 34;, PF00076;, GO:0005694;GO:0005730;GO:0005654;GO:0003723;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:RNA binding;|P42696 A8K8J7 Q8N2Z8 Q9H5A1,RNA-binding protein 34,RNA-binding motif protein 34;, PF00076;, GO:0005694;GO:0005730;GO:0005654;GO:0003723;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:RNA binding;|P42696 A8K8J7 Q8N2Z8 Q9H5A1,RNA-binding protein 34,RNA-binding motif protein 34;, PF00076;, GO:0005694;GO:0005730;GO:0005654;GO:0003723;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:RNA binding; scaffold68 indexed_genome mRNA 4810492 4950202 . - . ID=transcript_11161;Q9Y6E1,AT-rich interactive domain-containing protein 4B,180 kDa Sin3-associated polypeptide;Breast cancer-associated antigen BRCAA1;Histone deacetylase complex subunit SAP180;Retinoblastoma-binding protein 1-like 1;, PF01388;PF08169;PF11717;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000976;GO:0006325;GO:0006357;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II;|Q9Y6E1,AT-rich interactive domain-containing protein 4B,180 kDa Sin3-associated polypeptide;Breast cancer-associated antigen BRCAA1;Histone deacetylase complex subunit SAP180;Retinoblastoma-binding protein 1-like 1;, PF01388;PF08169;PF11717;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000976;GO:0006325;GO:0006357;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II;|Q9Y6E1,AT-rich interactive domain-containing protein 4B,180 kDa Sin3-associated polypeptide;Breast cancer-associated antigen BRCAA1;Histone deacetylase complex subunit SAP180;Retinoblastoma-binding protein 1-like 1;, PF01388;PF08169;PF11717;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000976;GO:0006325;GO:0006357;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II;|Q9Y6E1,AT-rich interactive domain-containing protein 4B,180 kDa Sin3-associated polypeptide;Breast cancer-associated antigen BRCAA1;Histone deacetylase complex subunit SAP180;Retinoblastoma-binding protein 1-like 1;, PF01388;PF08169;PF11717;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000976;GO:0006325;GO:0006357;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II;|Q9Y6E1,AT-rich interactive domain-containing protein 4B,180 kDa Sin3-associated polypeptide;Breast cancer-associated antigen BRCAA1;Histone deacetylase complex subunit SAP180;Retinoblastoma-binding protein 1-like 1;, PF01388;PF08169;PF11717;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000976;GO:0006325;GO:0006357;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II;|Q9Y6E1,AT-rich interactive domain-containing protein 4B,180 kDa Sin3-associated polypeptide;Breast cancer-associated antigen BRCAA1;Histone deacetylase complex subunit SAP180;Retinoblastoma-binding protein 1-like 1;, PF01388;PF08169;PF11717;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000976;GO:0006325;GO:0006357;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II;|Q9Y6E1,AT-rich interactive domain-containing protein 4B,180 kDa Sin3-associated polypeptide;Breast cancer-associated antigen BRCAA1;Histone deacetylase complex subunit SAP180;Retinoblastoma-binding protein 1-like 1;, PF01388;PF08169;PF11717;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0000976;GO:0006325;GO:0006357;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II; scaffold68 indexed_genome mRNA 4952789 4966171 . + . ID=transcript_11162;O95749 A8MVQ8 Q5T2C8 Q6NW19,Geranylgeranyl pyrophosphate synthase,(2E,6E)-farnesyl diphosphate synthase;Dimethylallyltranstransferase;Farnesyl diphosphate synthase;Farnesyltranstransferase;Geranylgeranyl diphosphate synthase;Geranyltranstransferase;, PF00348;, GO:0005829;GO:0004161;GO:0004311;GO:0004337;GO:0042802;GO:0046872;GO:0004659;GO:0006695;GO:0045337;GO:0033384;GO:0033386;GO:0008299;GO:0006720;GO:0019216;, C:cytosol;, F:dimethylallyltranstransferase activity; F:farnesyltranstransferase activity; F:geranyltranstransferase activity; F:identical protein binding; F:metal ion binding; F:prenyltransferase activity;, P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process; P:geranyl diphosphate biosynthetic process; P:geranylgeranyl diphosphate biosynthetic process; P:isoprenoid biosynthetic process; P:isoprenoid metabolic process; P:regulation of lipid metabolic process;|P62253 B2R7P2 D3DTK0 Q99462,Ubiquitin-conjugating enzyme E2 G1,E2 ubiquitin-conjugating enzyme G1;E217K;UBC7;Ubiquitin carrier protein G1;Ubiquitin-protein ligase G1;, PF00179;, GO:0005829;GO:0070062;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0044257;GO:0043161;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|O95749 A8MVQ8 Q5T2C8 Q6NW19,Geranylgeranyl pyrophosphate synthase,(2E,6E)-farnesyl diphosphate synthase;Dimethylallyltranstransferase;Farnesyl diphosphate synthase;Farnesyltranstransferase;Geranylgeranyl diphosphate synthase;Geranyltranstransferase;, PF00348;, GO:0005829;GO:0004161;GO:0004311;GO:0004337;GO:0042802;GO:0046872;GO:0004659;GO:0006695;GO:0045337;GO:0033384;GO:0033386;GO:0008299;GO:0006720;GO:0019216;, C:cytosol;, F:dimethylallyltranstransferase activity; F:farnesyltranstransferase activity; F:geranyltranstransferase activity; F:identical protein binding; F:metal ion binding; F:prenyltransferase activity;, P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process; P:geranyl diphosphate biosynthetic process; P:geranylgeranyl diphosphate biosynthetic process; P:isoprenoid biosynthetic process; P:isoprenoid metabolic process; P:regulation of lipid metabolic process;|O95749 A8MVQ8 Q5T2C8 Q6NW19,Geranylgeranyl pyrophosphate synthase,(2E,6E)-farnesyl diphosphate synthase;Dimethylallyltranstransferase;Farnesyl diphosphate synthase;Farnesyltranstransferase;Geranylgeranyl diphosphate synthase;Geranyltranstransferase;, PF00348;, GO:0005829;GO:0004161;GO:0004311;GO:0004337;GO:0042802;GO:0046872;GO:0004659;GO:0006695;GO:0045337;GO:0033384;GO:0033386;GO:0008299;GO:0006720;GO:0019216;, C:cytosol;, F:dimethylallyltranstransferase activity; F:farnesyltranstransferase activity; F:geranyltranstransferase activity; F:identical protein binding; F:metal ion binding; F:prenyltransferase activity;, P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process; P:geranyl diphosphate biosynthetic process; P:geranylgeranyl diphosphate biosynthetic process; P:isoprenoid biosynthetic process; P:isoprenoid metabolic process; P:regulation of lipid metabolic process; scaffold68 indexed_genome mRNA 5004837 5071198 . + . ID=transcript_11163;Q15813 A8K8C2 B7Z3P1,Tubulin-specific chaperone E,Tubulin-folding cofactor E;, PF01302;PF14560;, GO:0005737;GO:0005874;GO:0043014;GO:0051087;GO:0000226;GO:0007052;GO:0007023;GO:0006457;GO:0007021;, C:cytoplasm; C:microtubule;, F:alpha-tubulin binding; F:chaperone binding;, P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q15813 A8K8C2 B7Z3P1,Tubulin-specific chaperone E,Tubulin-folding cofactor E;, PF01302;PF14560;, GO:0005737;GO:0005874;GO:0043014;GO:0051087;GO:0000226;GO:0007052;GO:0007023;GO:0006457;GO:0007021;, C:cytoplasm; C:microtubule;, F:alpha-tubulin binding; F:chaperone binding;, P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q15813 A8K8C2 B7Z3P1,Tubulin-specific chaperone E,Tubulin-folding cofactor E;, PF01302;PF14560;, GO:0005737;GO:0005874;GO:0043014;GO:0051087;GO:0000226;GO:0007052;GO:0007023;GO:0006457;GO:0007021;, C:cytoplasm; C:microtubule;, F:alpha-tubulin binding; F:chaperone binding;, P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q15813 A8K8C2 B7Z3P1,Tubulin-specific chaperone E,Tubulin-folding cofactor E;, PF01302;PF14560;, GO:0005737;GO:0005874;GO:0043014;GO:0051087;GO:0000226;GO:0007052;GO:0007023;GO:0006457;GO:0007021;, C:cytoplasm; C:microtubule;, F:alpha-tubulin binding; F:chaperone binding;, P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q15813 A8K8C2 B7Z3P1,Tubulin-specific chaperone E,Tubulin-folding cofactor E;, PF01302;PF14560;, GO:0005737;GO:0005874;GO:0043014;GO:0051087;GO:0000226;GO:0007052;GO:0007023;GO:0006457;GO:0007021;, C:cytoplasm; C:microtubule;, F:alpha-tubulin binding; F:chaperone binding;, P:microtubule cytoskeleton organization; P:mitotic spindle organization; P:post-chaperonin tubulin folding pathway; P:protein folding; P:tubulin complex assembly;|Q8NCR0 Q59GR3 Q5TCI3 Q96AL7,UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2,Beta-1,3-N-acetylgalactosaminyltransferase II;, PF01762;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0008376;GO:0006486;GO:0006493;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity;, P:protein glycosylation; P:protein O-linked glycosylation;|Q8NCR0 Q59GR3 Q5TCI3 Q96AL7,UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2,Beta-1,3-N-acetylgalactosaminyltransferase II;, PF01762;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0008376;GO:0006486;GO:0006493;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity;, P:protein glycosylation; P:protein O-linked glycosylation;|Q8NCR0 Q59GR3 Q5TCI3 Q96AL7,UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2,Beta-1,3-N-acetylgalactosaminyltransferase II;, PF01762;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0008376;GO:0006486;GO:0006493;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity;, P:protein glycosylation; P:protein O-linked glycosylation;|Q8NCR0 Q59GR3 Q5TCI3 Q96AL7,UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2,Beta-1,3-N-acetylgalactosaminyltransferase II;, PF01762;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0008376;GO:0006486;GO:0006493;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity;, P:protein glycosylation; P:protein O-linked glycosylation; scaffold68 indexed_genome mRNA 5071218 5128673 . - . ID=transcript_11164;Q8NCR0 Q59GR3 Q5TCI3 Q96AL7,UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2,Beta-1,3-N-acetylgalactosaminyltransferase II;, PF01762;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0008376;GO:0006486;GO:0006493;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity;, P:protein glycosylation; P:protein O-linked glycosylation;|Q8NCR0 Q59GR3 Q5TCI3 Q96AL7,UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2,Beta-1,3-N-acetylgalactosaminyltransferase II;, PF01762;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0008376;GO:0006486;GO:0006493;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity;, P:protein glycosylation; P:protein O-linked glycosylation;|Q8NCR0 Q59GR3 Q5TCI3 Q96AL7,UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2,Beta-1,3-N-acetylgalactosaminyltransferase II;, PF01762;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0008376;GO:0006486;GO:0006493;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity;, P:protein glycosylation; P:protein O-linked glycosylation; scaffold68 indexed_genome mRNA 5170263 5237010 . - . ID=transcript_11165;P50150,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4,, PF00631;, GO:0070062;GO:0031680;GO:0005834;GO:0005886;GO:0031681;GO:0007186;GO:0030308;GO:0008277;, C:extracellular exosome; C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:plasma membrane;, F:G-protein beta-subunit binding;, P:G protein-coupled receptor signaling pathway; P:negative regulation of cell growth; P:regulation of G protein-coupled receptor signaling pathway; scaffold68 indexed_genome mRNA 5254164 5381909 . + . ID=transcript_11166;Q99698 O43274 Q5T2U9 Q96TD7 Q96TD8 Q99709 Q9H133,Lysosomal-trafficking regulator,Beige homolog;, PF02138;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0015630;GO:0019901;GO:0042742;GO:0042832;GO:0051607;GO:0032510;GO:0030595;GO:0007040;GO:0033364;GO:0032438;GO:0042267;GO:0006909;GO:0043473;GO:0008104;GO:0015031;, C:cytosol; C:membrane; C:microtubule cytoskeleton;, F:protein kinase binding;, P:defense response to bacterium; P:defense response to protozoan; P:defense response to virus; P:endosome to lysosome transport via multivesicular body sorting pathway; P:leukocyte chemotaxis; P:lysosome organization; P:mast cell secretory granule organization; P:melanosome organization; P:natural killer cell mediated cytotoxicity; P:phagocytosis; P:pigmentation; P:protein localization; P:protein transport;|Q99698 O43274 Q5T2U9 Q96TD7 Q96TD8 Q99709 Q9H133,Lysosomal-trafficking regulator,Beige homolog;, PF02138;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0015630;GO:0019901;GO:0042742;GO:0042832;GO:0051607;GO:0032510;GO:0030595;GO:0007040;GO:0033364;GO:0032438;GO:0042267;GO:0006909;GO:0043473;GO:0008104;GO:0015031;, C:cytosol; C:membrane; C:microtubule cytoskeleton;, F:protein kinase binding;, P:defense response to bacterium; P:defense response to protozoan; P:defense response to virus; P:endosome to lysosome transport via multivesicular body sorting pathway; P:leukocyte chemotaxis; P:lysosome organization; P:mast cell secretory granule organization; P:melanosome organization; P:natural killer cell mediated cytotoxicity; P:phagocytosis; P:pigmentation; P:protein localization; P:protein transport;|Q99698 O43274 Q5T2U9 Q96TD7 Q96TD8 Q99709 Q9H133,Lysosomal-trafficking regulator,Beige homolog;, PF02138;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0015630;GO:0019901;GO:0042742;GO:0042832;GO:0051607;GO:0032510;GO:0030595;GO:0007040;GO:0033364;GO:0032438;GO:0042267;GO:0006909;GO:0043473;GO:0008104;GO:0015031;, C:cytosol; C:membrane; C:microtubule cytoskeleton;, F:protein kinase binding;, P:defense response to bacterium; P:defense response to protozoan; P:defense response to virus; P:endosome to lysosome transport via multivesicular body sorting pathway; P:leukocyte chemotaxis; P:lysosome organization; P:mast cell secretory granule organization; P:melanosome organization; P:natural killer cell mediated cytotoxicity; P:phagocytosis; P:pigmentation; P:protein localization; P:protein transport;|Q99698 O43274 Q5T2U9 Q96TD7 Q96TD8 Q99709 Q9H133,Lysosomal-trafficking regulator,Beige homolog;, PF02138;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0015630;GO:0019901;GO:0042742;GO:0042832;GO:0051607;GO:0032510;GO:0030595;GO:0007040;GO:0033364;GO:0032438;GO:0042267;GO:0006909;GO:0043473;GO:0008104;GO:0015031;, C:cytosol; C:membrane; C:microtubule cytoskeleton;, F:protein kinase binding;, P:defense response to bacterium; P:defense response to protozoan; P:defense response to virus; P:endosome to lysosome transport via multivesicular body sorting pathway; P:leukocyte chemotaxis; P:lysosome organization; P:mast cell secretory granule organization; P:melanosome organization; P:natural killer cell mediated cytotoxicity; P:phagocytosis; P:pigmentation; P:protein localization; P:protein transport;|Q99698 O43274 Q5T2U9 Q96TD7 Q96TD8 Q99709 Q9H133,Lysosomal-trafficking regulator,Beige homolog;, PF02138;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0015630;GO:0019901;GO:0042742;GO:0042832;GO:0051607;GO:0032510;GO:0030595;GO:0007040;GO:0033364;GO:0032438;GO:0042267;GO:0006909;GO:0043473;GO:0008104;GO:0015031;, C:cytosol; C:membrane; C:microtubule cytoskeleton;, F:protein kinase binding;, P:defense response to bacterium; P:defense response to protozoan; P:defense response to virus; P:endosome to lysosome transport via multivesicular body sorting pathway; P:leukocyte chemotaxis; P:lysosome organization; P:mast cell secretory granule organization; P:melanosome organization; P:natural killer cell mediated cytotoxicity; P:phagocytosis; P:pigmentation; P:protein localization; P:protein transport;|Q99698 O43274 Q5T2U9 Q96TD7 Q96TD8 Q99709 Q9H133,Lysosomal-trafficking regulator,Beige homolog;, PF02138;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0015630;GO:0019901;GO:0042742;GO:0042832;GO:0051607;GO:0032510;GO:0030595;GO:0007040;GO:0033364;GO:0032438;GO:0042267;GO:0006909;GO:0043473;GO:0008104;GO:0015031;, C:cytosol; C:membrane; C:microtubule cytoskeleton;, F:protein kinase binding;, P:defense response to bacterium; P:defense response to protozoan; P:defense response to virus; P:endosome to lysosome transport via multivesicular body sorting pathway; P:leukocyte chemotaxis; P:lysosome organization; P:mast cell secretory granule organization; P:melanosome organization; P:natural killer cell mediated cytotoxicity; P:phagocytosis; P:pigmentation; P:protein localization; P:protein transport;|Q99698 O43274 Q5T2U9 Q96TD7 Q96TD8 Q99709 Q9H133,Lysosomal-trafficking regulator,Beige homolog;, PF02138;PF14844;PF00400;, GO:0005829;GO:0016020;GO:0015630;GO:0019901;GO:0042742;GO:0042832;GO:0051607;GO:0032510;GO:0030595;GO:0007040;GO:0033364;GO:0032438;GO:0042267;GO:0006909;GO:0043473;GO:0008104;GO:0015031;, C:cytosol; C:membrane; C:microtubule cytoskeleton;, F:protein kinase binding;, P:defense response to bacterium; P:defense response to protozoan; P:defense response to virus; P:endosome to lysosome transport via multivesicular body sorting pathway; P:leukocyte chemotaxis; P:lysosome organization; P:mast cell secretory granule organization; P:melanosome organization; P:natural killer cell mediated cytotoxicity; P:phagocytosis; P:pigmentation; P:protein localization; P:protein transport; scaffold68 indexed_genome mRNA 5553493 5649895 . - . ID=transcript_11167;P14543 Q14942 Q59FL2 Q5TAF2 Q5TAF3 Q86XD7,Nidogen-1,Entactin;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0043236;GO:0043237;GO:0043394;GO:0071711;GO:0007160;GO:0030198;GO:0032836;GO:0010811;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent; F:laminin binding; F:laminin-1 binding; F:proteoglycan binding;, P:basement membrane organization; P:cell-matrix adhesion; P:extracellular matrix organization; P:glomerular basement membrane development; P:positive regulation of cell-substrate adhesion;|P14543 Q14942 Q59FL2 Q5TAF2 Q5TAF3 Q86XD7,Nidogen-1,Entactin;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0043236;GO:0043237;GO:0043394;GO:0071711;GO:0007160;GO:0030198;GO:0032836;GO:0010811;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent; F:laminin binding; F:laminin-1 binding; F:proteoglycan binding;, P:basement membrane organization; P:cell-matrix adhesion; P:extracellular matrix organization; P:glomerular basement membrane development; P:positive regulation of cell-substrate adhesion;|P14543 Q14942 Q59FL2 Q5TAF2 Q5TAF3 Q86XD7,Nidogen-1,Entactin;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0043236;GO:0043237;GO:0043394;GO:0071711;GO:0007160;GO:0030198;GO:0032836;GO:0010811;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent; F:laminin binding; F:laminin-1 binding; F:proteoglycan binding;, P:basement membrane organization; P:cell-matrix adhesion; P:extracellular matrix organization; P:glomerular basement membrane development; P:positive regulation of cell-substrate adhesion;|P14543 Q14942 Q59FL2 Q5TAF2 Q5TAF3 Q86XD7,Nidogen-1,Entactin;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0043236;GO:0043237;GO:0043394;GO:0071711;GO:0007160;GO:0030198;GO:0032836;GO:0010811;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent; F:laminin binding; F:laminin-1 binding; F:proteoglycan binding;, P:basement membrane organization; P:cell-matrix adhesion; P:extracellular matrix organization; P:glomerular basement membrane development; P:positive regulation of cell-substrate adhesion;|P14543 Q14942 Q59FL2 Q5TAF2 Q5TAF3 Q86XD7,Nidogen-1,Entactin;, PF12662;PF12947;PF07645;PF07474;PF00058;PF06119;PF00086;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005886;GO:0005509;GO:0005518;GO:0005201;GO:0043236;GO:0043237;GO:0043394;GO:0071711;GO:0007160;GO:0030198;GO:0032836;GO:0010811;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent; F:laminin binding; F:laminin-1 binding; F:proteoglycan binding;, P:basement membrane organization; P:cell-matrix adhesion; P:extracellular matrix organization; P:glomerular basement membrane development; P:positive regulation of cell-substrate adhesion; scaffold68 indexed_genome mRNA 5708237 5760534 . + . ID=transcript_11168;O60478 Q53EK7 Q5TAE6 Q6FHI3,Integral membrane protein GPR137B,Transmembrane 7 superfamily member 1 protein;, , GO:0005887;GO:0005765;GO:0016020;GO:0006914;GO:0045779;GO:0045671;GO:0150032;GO:1904263;GO:0010506;GO:0043087;GO:0043030;, C:integral component of plasma membrane; C:lysosomal membrane; C:membrane;, , P:autophagy; P:negative regulation of bone resorption; P:negative regulation of osteoclast differentiation; P:positive regulation of protein localization to lysosome; P:positive regulation of TORC1 signaling; P:regulation of autophagy; P:regulation of GTPase activity; P:regulation of macrophage activation; scaffold68 indexed_genome mRNA 5776439 5843263 . - . ID=transcript_11169;Q86YB8 B4DF57 Q5T1H4 Q8IZ11 Q9NR62,ERO1-like protein beta,Endoplasmic reticulum oxidoreductase beta {ECO:0000312|HGNC:HGNC:14355};Endoplasmic reticulum oxidoreductin-1-like protein B;Oxidoreductin-1-L-beta;, PF04137;, GO:0005783;GO:0005789;GO:0016491;GO:0016671;GO:0003756;GO:0015035;GO:0016972;GO:0051082;GO:0006457;GO:0034975;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity; F:thiol oxidase activity; F:unfolded protein binding;, P:protein folding; P:protein folding in endoplasmic reticulum;|Q86YB8 B4DF57 Q5T1H4 Q8IZ11 Q9NR62,ERO1-like protein beta,Endoplasmic reticulum oxidoreductase beta {ECO:0000312|HGNC:HGNC:14355};Endoplasmic reticulum oxidoreductin-1-like protein B;Oxidoreductin-1-L-beta;, PF04137;, GO:0005783;GO:0005789;GO:0016491;GO:0016671;GO:0003756;GO:0015035;GO:0016972;GO:0051082;GO:0006457;GO:0034975;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity; F:thiol oxidase activity; F:unfolded protein binding;, P:protein folding; P:protein folding in endoplasmic reticulum;|Q86YB8 B4DF57 Q5T1H4 Q8IZ11 Q9NR62,ERO1-like protein beta,Endoplasmic reticulum oxidoreductase beta {ECO:0000312|HGNC:HGNC:14355};Endoplasmic reticulum oxidoreductin-1-like protein B;Oxidoreductin-1-L-beta;, PF04137;, GO:0005783;GO:0005789;GO:0016491;GO:0016671;GO:0003756;GO:0015035;GO:0016972;GO:0051082;GO:0006457;GO:0034975;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide isomerase activity; F:protein disulfide oxidoreductase activity; F:thiol oxidase activity; F:unfolded protein binding;, P:protein folding; P:protein folding in endoplasmic reticulum; scaffold68 indexed_genome mRNA 5943953 6007639 . + . ID=transcript_11170;Q8WWZ3 A2VCK5 A8K7B5 B1AL54 B9ZVW5 Q5VYJ7,Ectodysplasin-A receptor-associated adapter protein,EDAR-associated death domain protein;Protein crinkled homolog;, PF00531;, GO:0005829;GO:0030154;GO:0007275;GO:1901224;GO:0033209;, C:cytosol;, , P:cell differentiation; P:multicellular organism development; P:positive regulation of NIK/NF-kappaB signaling; P:tumor necrosis factor-mediated signaling pathway; scaffold68 indexed_genome mRNA 6028767 6084625 . + . ID=transcript_11171;Q9H583 Q5T3Q8 Q6P197 Q9NW23,HEAT repeat-containing protein 1,Protein BAP28;U3 small nucleolar RNA-associated protein 10 homolog;, PF08146;PF12397;, GO:0030686;GO:0001650;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030515;GO:0000462;GO:2000234;GO:0045943;GO:0006364;, C:90S preribosome; C:fibrillar center; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding; F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q9UEZ6 Q9UP32 Q9UP33 Q9UP34,Galectin-8 {ECO:0000303|Ref.2},Po66 carbohydrate-binding protein;Prostate carcinoma tumor antigen 1 {ECO:0000303|PubMed:8692978};, PF00337;, GO:0005737;GO:0031410;GO:0005829;GO:0005615;GO:0016020;GO:0030246;GO:0005178;GO:0098586;GO:1904977;GO:0098792;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:extracellular space; C:membrane;, F:carbohydrate binding; F:integrin binding;, P:cellular response to virus; P:lymphatic endothelial cell migration; P:xenophagy;|Q9H583 Q5T3Q8 Q6P197 Q9NW23,HEAT repeat-containing protein 1,Protein BAP28;U3 small nucleolar RNA-associated protein 10 homolog;, PF08146;PF12397;, GO:0030686;GO:0001650;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030515;GO:0000462;GO:2000234;GO:0045943;GO:0006364;, C:90S preribosome; C:fibrillar center; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding; F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q9H583 Q5T3Q8 Q6P197 Q9NW23,HEAT repeat-containing protein 1,Protein BAP28;U3 small nucleolar RNA-associated protein 10 homolog;, PF08146;PF12397;, GO:0030686;GO:0001650;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030515;GO:0000462;GO:2000234;GO:0045943;GO:0006364;, C:90S preribosome; C:fibrillar center; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding; F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q9H583 Q5T3Q8 Q6P197 Q9NW23,HEAT repeat-containing protein 1,Protein BAP28;U3 small nucleolar RNA-associated protein 10 homolog;, PF08146;PF12397;, GO:0030686;GO:0001650;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030515;GO:0000462;GO:2000234;GO:0045943;GO:0006364;, C:90S preribosome; C:fibrillar center; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding; F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q9H583 Q5T3Q8 Q6P197 Q9NW23,HEAT repeat-containing protein 1,Protein BAP28;U3 small nucleolar RNA-associated protein 10 homolog;, PF08146;PF12397;, GO:0030686;GO:0001650;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030515;GO:0000462;GO:2000234;GO:0045943;GO:0006364;, C:90S preribosome; C:fibrillar center; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding; F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q9H583 Q5T3Q8 Q6P197 Q9NW23,HEAT repeat-containing protein 1,Protein BAP28;U3 small nucleolar RNA-associated protein 10 homolog;, PF08146;PF12397;, GO:0030686;GO:0001650;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030515;GO:0000462;GO:2000234;GO:0045943;GO:0006364;, C:90S preribosome; C:fibrillar center; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding; F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q9H583 Q5T3Q8 Q6P197 Q9NW23,HEAT repeat-containing protein 1,Protein BAP28;U3 small nucleolar RNA-associated protein 10 homolog;, PF08146;PF12397;, GO:0030686;GO:0001650;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030515;GO:0000462;GO:2000234;GO:0045943;GO:0006364;, C:90S preribosome; C:fibrillar center; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding; F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q9H583 Q5T3Q8 Q6P197 Q9NW23,HEAT repeat-containing protein 1,Protein BAP28;U3 small nucleolar RNA-associated protein 10 homolog;, PF08146;PF12397;, GO:0030686;GO:0001650;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030515;GO:0000462;GO:2000234;GO:0045943;GO:0006364;, C:90S preribosome; C:fibrillar center; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding; F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing; scaffold68 indexed_genome mRNA 6085641 6105810 . - . ID=transcript_11172;Q9H583 Q5T3Q8 Q6P197 Q9NW23,HEAT repeat-containing protein 1,Protein BAP28;U3 small nucleolar RNA-associated protein 10 homolog;, PF08146;PF12397;, GO:0030686;GO:0001650;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0032040;GO:0034455;GO:0003723;GO:0030515;GO:0000462;GO:2000234;GO:0045943;GO:0006364;, C:90S preribosome; C:fibrillar center; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:t-UTP complex;, F:RNA binding; F:snoRNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing; scaffold68 indexed_genome mRNA 6189364 6265190 . - . ID=transcript_11173;P35609 B1ANE4 B2RCS5 Q86TF4 Q86TI8,Alpha-actinin-2,Alpha-actinin skeletal muscle isoform 2;F-actin cross-linking protein;, PF00307;PF08726;PF00435;, GO:0005884;GO:0030864;GO:0005856;GO:0005829;GO:0043197;GO:0070062;GO:0005576;GO:0030175;GO:0005925;GO:0098978;GO:0031093;GO:0098839;GO:0099092;GO:0031143;GO:0030018;GO:0051015;GO:0005509;GO:0008092;GO:0051373;GO:0042802;GO:0005178;GO:0044325;GO:0030274;GO:0030374;GO:0005546;GO:0019904;GO:0008307;GO:0031432;GO:0070080;GO:0051695;GO:0055013;GO:0007155;GO:0048041;GO:0000165;GO:0030035;GO:0030049;GO:1901017;GO:0043267;GO:2000009;GO:0086097;GO:0002576;GO:2001259;GO:2001137;GO:1901018;GO:0043268;GO:0072659;GO:0042981;GO:0042391;GO:2000310;GO:0045214;, C:actin filament; C:cortical actin cytoskeleton; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extracellular exosome; C:extracellular region; C:filopodium; C:focal adhesion; C:glutamatergic synapse; C:platelet alpha granule lumen; C:postsynaptic density membrane; C:postsynaptic density, intracellular component; C:pseudopodium; C:Z disc;, F:actin filament binding; F:calcium ion binding; F:cytoskeletal protein binding; F:FATZ binding; F:identical protein binding; F:integrin binding; F:ion channel binding; F:LIM domain binding; F:nuclear receptor coactivator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein domain specific binding; F:structural constituent of muscle; F:titin binding; F:titin Z domain binding;, P:actin filament uncapping; P:cardiac muscle cell development; P:cell adhesion; P:focal adhesion assembly; P:MAPK cascade; P:microspike assembly; P:muscle filament sliding; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of potassium ion transport; P:negative regulation of protein localization to cell surface; P:phospholipase C-activating angiotensin-activated signaling pathway; P:platelet degranulation; P:positive regulation of cation channel activity; P:positive regulation of endocytic recycling; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to plasma membrane; P:regulation of apoptotic process; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:sarcomere organization;|P35609 B1ANE4 B2RCS5 Q86TF4 Q86TI8,Alpha-actinin-2,Alpha-actinin skeletal muscle isoform 2;F-actin cross-linking protein;, PF00307;PF08726;PF00435;, GO:0005884;GO:0030864;GO:0005856;GO:0005829;GO:0043197;GO:0070062;GO:0005576;GO:0030175;GO:0005925;GO:0098978;GO:0031093;GO:0098839;GO:0099092;GO:0031143;GO:0030018;GO:0051015;GO:0005509;GO:0008092;GO:0051373;GO:0042802;GO:0005178;GO:0044325;GO:0030274;GO:0030374;GO:0005546;GO:0019904;GO:0008307;GO:0031432;GO:0070080;GO:0051695;GO:0055013;GO:0007155;GO:0048041;GO:0000165;GO:0030035;GO:0030049;GO:1901017;GO:0043267;GO:2000009;GO:0086097;GO:0002576;GO:2001259;GO:2001137;GO:1901018;GO:0043268;GO:0072659;GO:0042981;GO:0042391;GO:2000310;GO:0045214;, C:actin filament; C:cortical actin cytoskeleton; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extracellular exosome; C:extracellular region; C:filopodium; C:focal adhesion; C:glutamatergic synapse; C:platelet alpha granule lumen; C:postsynaptic density membrane; C:postsynaptic density, intracellular component; C:pseudopodium; C:Z disc;, F:actin filament binding; F:calcium ion binding; F:cytoskeletal protein binding; F:FATZ binding; F:identical protein binding; F:integrin binding; F:ion channel binding; F:LIM domain binding; F:nuclear receptor coactivator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein domain specific binding; F:structural constituent of muscle; F:titin binding; F:titin Z domain binding;, P:actin filament uncapping; P:cardiac muscle cell development; P:cell adhesion; P:focal adhesion assembly; P:MAPK cascade; P:microspike assembly; P:muscle filament sliding; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of potassium ion transport; P:negative regulation of protein localization to cell surface; P:phospholipase C-activating angiotensin-activated signaling pathway; P:platelet degranulation; P:positive regulation of cation channel activity; P:positive regulation of endocytic recycling; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to plasma membrane; P:regulation of apoptotic process; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:sarcomere organization;|P35609 B1ANE4 B2RCS5 Q86TF4 Q86TI8,Alpha-actinin-2,Alpha-actinin skeletal muscle isoform 2;F-actin cross-linking protein;, PF00307;PF08726;PF00435;, GO:0005884;GO:0030864;GO:0005856;GO:0005829;GO:0043197;GO:0070062;GO:0005576;GO:0030175;GO:0005925;GO:0098978;GO:0031093;GO:0098839;GO:0099092;GO:0031143;GO:0030018;GO:0051015;GO:0005509;GO:0008092;GO:0051373;GO:0042802;GO:0005178;GO:0044325;GO:0030274;GO:0030374;GO:0005546;GO:0019904;GO:0008307;GO:0031432;GO:0070080;GO:0051695;GO:0055013;GO:0007155;GO:0048041;GO:0000165;GO:0030035;GO:0030049;GO:1901017;GO:0043267;GO:2000009;GO:0086097;GO:0002576;GO:2001259;GO:2001137;GO:1901018;GO:0043268;GO:0072659;GO:0042981;GO:0042391;GO:2000310;GO:0045214;, C:actin filament; C:cortical actin cytoskeleton; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extracellular exosome; C:extracellular region; C:filopodium; C:focal adhesion; C:glutamatergic synapse; C:platelet alpha granule lumen; C:postsynaptic density membrane; C:postsynaptic density, intracellular component; C:pseudopodium; C:Z disc;, F:actin filament binding; F:calcium ion binding; F:cytoskeletal protein binding; F:FATZ binding; F:identical protein binding; F:integrin binding; F:ion channel binding; F:LIM domain binding; F:nuclear receptor coactivator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein domain specific binding; F:structural constituent of muscle; F:titin binding; F:titin Z domain binding;, P:actin filament uncapping; P:cardiac muscle cell development; P:cell adhesion; P:focal adhesion assembly; P:MAPK cascade; P:microspike assembly; P:muscle filament sliding; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of potassium ion transport; P:negative regulation of protein localization to cell surface; P:phospholipase C-activating angiotensin-activated signaling pathway; P:platelet degranulation; P:positive regulation of cation channel activity; P:positive regulation of endocytic recycling; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to plasma membrane; P:regulation of apoptotic process; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:sarcomere organization;|P35609 B1ANE4 B2RCS5 Q86TF4 Q86TI8,Alpha-actinin-2,Alpha-actinin skeletal muscle isoform 2;F-actin cross-linking protein;, PF00307;PF08726;PF00435;, GO:0005884;GO:0030864;GO:0005856;GO:0005829;GO:0043197;GO:0070062;GO:0005576;GO:0030175;GO:0005925;GO:0098978;GO:0031093;GO:0098839;GO:0099092;GO:0031143;GO:0030018;GO:0051015;GO:0005509;GO:0008092;GO:0051373;GO:0042802;GO:0005178;GO:0044325;GO:0030274;GO:0030374;GO:0005546;GO:0019904;GO:0008307;GO:0031432;GO:0070080;GO:0051695;GO:0055013;GO:0007155;GO:0048041;GO:0000165;GO:0030035;GO:0030049;GO:1901017;GO:0043267;GO:2000009;GO:0086097;GO:0002576;GO:2001259;GO:2001137;GO:1901018;GO:0043268;GO:0072659;GO:0042981;GO:0042391;GO:2000310;GO:0045214;, C:actin filament; C:cortical actin cytoskeleton; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extracellular exosome; C:extracellular region; C:filopodium; C:focal adhesion; C:glutamatergic synapse; C:platelet alpha granule lumen; C:postsynaptic density membrane; C:postsynaptic density, intracellular component; C:pseudopodium; C:Z disc;, F:actin filament binding; F:calcium ion binding; F:cytoskeletal protein binding; F:FATZ binding; F:identical protein binding; F:integrin binding; F:ion channel binding; F:LIM domain binding; F:nuclear receptor coactivator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein domain specific binding; F:structural constituent of muscle; F:titin binding; F:titin Z domain binding;, P:actin filament uncapping; P:cardiac muscle cell development; P:cell adhesion; P:focal adhesion assembly; P:MAPK cascade; P:microspike assembly; P:muscle filament sliding; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of potassium ion transport; P:negative regulation of protein localization to cell surface; P:phospholipase C-activating angiotensin-activated signaling pathway; P:platelet degranulation; P:positive regulation of cation channel activity; P:positive regulation of endocytic recycling; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to plasma membrane; P:regulation of apoptotic process; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:sarcomere organization;|P35609 B1ANE4 B2RCS5 Q86TF4 Q86TI8,Alpha-actinin-2,Alpha-actinin skeletal muscle isoform 2;F-actin cross-linking protein;, PF00307;PF08726;PF00435;, GO:0005884;GO:0030864;GO:0005856;GO:0005829;GO:0043197;GO:0070062;GO:0005576;GO:0030175;GO:0005925;GO:0098978;GO:0031093;GO:0098839;GO:0099092;GO:0031143;GO:0030018;GO:0051015;GO:0005509;GO:0008092;GO:0051373;GO:0042802;GO:0005178;GO:0044325;GO:0030274;GO:0030374;GO:0005546;GO:0019904;GO:0008307;GO:0031432;GO:0070080;GO:0051695;GO:0055013;GO:0007155;GO:0048041;GO:0000165;GO:0030035;GO:0030049;GO:1901017;GO:0043267;GO:2000009;GO:0086097;GO:0002576;GO:2001259;GO:2001137;GO:1901018;GO:0043268;GO:0072659;GO:0042981;GO:0042391;GO:2000310;GO:0045214;, C:actin filament; C:cortical actin cytoskeleton; C:cytoskeleton; C:cytosol; C:dendritic spine; C:extracellular exosome; C:extracellular region; C:filopodium; C:focal adhesion; C:glutamatergic synapse; C:platelet alpha granule lumen; C:postsynaptic density membrane; C:postsynaptic density, intracellular component; C:pseudopodium; C:Z disc;, F:actin filament binding; F:calcium ion binding; F:cytoskeletal protein binding; F:FATZ binding; F:identical protein binding; F:integrin binding; F:ion channel binding; F:LIM domain binding; F:nuclear receptor coactivator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein domain specific binding; F:structural constituent of muscle; F:titin binding; F:titin Z domain binding;, P:actin filament uncapping; P:cardiac muscle cell development; P:cell adhesion; P:focal adhesion assembly; P:MAPK cascade; P:microspike assembly; P:muscle filament sliding; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of potassium ion transport; P:negative regulation of protein localization to cell surface; P:phospholipase C-activating angiotensin-activated signaling pathway; P:platelet degranulation; P:positive regulation of cation channel activity; P:positive regulation of endocytic recycling; P:positive regulation of potassium ion transmembrane transporter activity; P:positive regulation of potassium ion transport; P:protein localization to plasma membrane; P:regulation of apoptotic process; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:sarcomere organization; scaffold68 indexed_genome mRNA 6280030 6348980 . + . ID=transcript_11174;Q99707 A1L4N8 A9Z1W4 B7ZLW7 B9EGF7 Q99713 Q99723,Methionine synthase,5-methyltetrahydrofolate--homocysteine methyltransferase;Cobalamin-dependent methionine synthase;Vitamin-B12 dependent methionine synthase;, PF02310;PF02607;PF02965;PF00809;PF02574;, GO:0005829;GO:0031419;GO:0008705;GO:0008270;GO:0031103;GO:0071732;GO:0009235;GO:0009086;GO:0032259;GO:0007399;GO:0042558;GO:0048678;GO:0000096;, C:cytosol;, F:cobalamin binding; F:methionine synthase activity; F:zinc ion binding;, P:axon regeneration; P:cellular response to nitric oxide; P:cobalamin metabolic process; P:methionine biosynthetic process; P:methylation; P:nervous system development; P:pteridine-containing compound metabolic process; P:response to axon injury; P:sulfur amino acid metabolic process; scaffold68 indexed_genome mRNA 6360348 6361013 . - . ID=transcript_11175;Q99707 A1L4N8 A9Z1W4 B7ZLW7 B9EGF7 Q99713 Q99723,Methionine synthase,5-methyltetrahydrofolate--homocysteine methyltransferase;Cobalamin-dependent methionine synthase;Vitamin-B12 dependent methionine synthase;, PF02310;PF02607;PF02965;PF00809;PF02574;, GO:0005829;GO:0031419;GO:0008705;GO:0008270;GO:0031103;GO:0071732;GO:0009235;GO:0009086;GO:0032259;GO:0007399;GO:0042558;GO:0048678;GO:0000096;, C:cytosol;, F:cobalamin binding; F:methionine synthase activity; F:zinc ion binding;, P:axon regeneration; P:cellular response to nitric oxide; P:cobalamin metabolic process; P:methionine biosynthetic process; P:methylation; P:nervous system development; P:pteridine-containing compound metabolic process; P:response to axon injury; P:sulfur amino acid metabolic process; scaffold68 indexed_genome mRNA 6363638 6389645 . + . ID=transcript_11176;Q99707 A1L4N8 A9Z1W4 B7ZLW7 B9EGF7 Q99713 Q99723,Methionine synthase,5-methyltetrahydrofolate--homocysteine methyltransferase;Cobalamin-dependent methionine synthase;Vitamin-B12 dependent methionine synthase;, PF02310;PF02607;PF02965;PF00809;PF02574;, GO:0005829;GO:0031419;GO:0008705;GO:0008270;GO:0031103;GO:0071732;GO:0009235;GO:0009086;GO:0032259;GO:0007399;GO:0042558;GO:0048678;GO:0000096;, C:cytosol;, F:cobalamin binding; F:methionine synthase activity; F:zinc ion binding;, P:axon regeneration; P:cellular response to nitric oxide; P:cobalamin metabolic process; P:methionine biosynthetic process; P:methylation; P:nervous system development; P:pteridine-containing compound metabolic process; P:response to axon injury; P:sulfur amino acid metabolic process; scaffold68 indexed_genome mRNA 6389667 6402626 . + . ID=transcript_11177;Q99707 A1L4N8 A9Z1W4 B7ZLW7 B9EGF7 Q99713 Q99723,Methionine synthase,5-methyltetrahydrofolate--homocysteine methyltransferase;Cobalamin-dependent methionine synthase;Vitamin-B12 dependent methionine synthase;, PF02310;PF02607;PF02965;PF00809;PF02574;, GO:0005829;GO:0031419;GO:0008705;GO:0008270;GO:0031103;GO:0071732;GO:0009235;GO:0009086;GO:0032259;GO:0007399;GO:0042558;GO:0048678;GO:0000096;, C:cytosol;, F:cobalamin binding; F:methionine synthase activity; F:zinc ion binding;, P:axon regeneration; P:cellular response to nitric oxide; P:cobalamin metabolic process; P:methionine biosynthetic process; P:methylation; P:nervous system development; P:pteridine-containing compound metabolic process; P:response to axon injury; P:sulfur amino acid metabolic process;|P49207 Q6FG66 Q9BUZ2,60S ribosomal protein L34,Large ribosomal subunit protein eL34 {ECO:0000303|PubMed:24524803};, PF01199;, GO:0005829;GO:0022625;GO:0005783;GO:0070062;GO:0045296;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome;, F:cadherin binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold68 indexed_genome mRNA 6835326 7335083 . + . ID=transcript_11178;Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential;|Q92736 Q15411 Q546N8 Q5T3P2,Ryanodine receptor 2,Cardiac muscle ryanodine receptor;Cardiac muscle ryanodine receptor-calcium release channel;Type 2 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0030659;GO:0014701;GO:0016020;GO:0005886;GO:0032991;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0019899;GO:0042802;GO:0044325;GO:0034236;GO:0034237;GO:0043621;GO:0005219;GO:0043924;GO:0006816;GO:0060402;GO:0019722;GO:0035584;GO:0060048;GO:0003300;GO:0086064;GO:0006874;GO:0071313;GO:0071872;GO:0005513;GO:0003143;GO:0072599;GO:0034220;GO:0003220;GO:1901896;GO:0010460;GO:0051284;GO:0098735;GO:0086029;GO:0098910;GO:0098904;GO:1903779;GO:0055117;GO:0010882;GO:0010881;GO:0051480;GO:0002027;GO:0098907;GO:0098911;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0014850;GO:0035994;GO:0051775;GO:0070296;GO:0097050;GO:0086005;, C:calcium channel complex; C:cytoplasmic vesicle membrane; C:junctional sarcoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;, F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:ion channel binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein self-association; F:ryanodine-sensitive calcium-release channel activity; F:suramin binding;, P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling; P:calcium-mediated signaling using intracellular calcium source; P:cardiac muscle contraction; P:cardiac muscle hypertrophy; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular calcium ion homeostasis; P:cellular response to caffeine; P:cellular response to epinephrine stimulus; P:detection of calcium ion; P:embryonic heart tube morphogenesis; P:establishment of protein localization to endoplasmic reticulum; P:ion transmembrane transport; P:left ventricular cardiac muscle tissue morphogenesis; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of heart rate; P:positive regulation of sequestering of calcium ion; P:positive regulation of the force of heart contraction; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of AV node cell action potential; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of heart rate; P:regulation of SA node cell action potential; P:regulation of ventricular cardiac muscle cell action potential; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:response to muscle activity; P:response to muscle stretch; P:response to redox state; P:sarcoplasmic reticulum calcium ion transport; P:type B pancreatic cell apoptotic process; P:ventricular cardiac muscle cell action potential; scaffold68 indexed_genome mRNA 9402647 9451161 . + . ID=transcript_11179;Q06732 Q06731 Q32MA2 Q86XY8 Q8NDW3,Zinc finger protein 33B,Zinc finger protein 11B;Zinc finger protein KOX2;, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q06730 A8K9X9 B4E0M8 F6TH33 F8WAJ5 P17013 Q5VZ86,Zinc finger protein 33A,Zinc finger and ZAK-associated protein with KRAB domain;Zinc finger protein 11A;Zinc finger protein KOX31;, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0003700;GO:0046872;GO:0000978;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold68 indexed_genome mRNA 9460883 9499233 . + . ID=transcript_11180;P17032 B3KRQ3 D3DRZ3 Q96B88,Zinc finger protein 37A,Zinc finger protein KOX21;, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q7Z7J5 Q8WVF0,Developmental pluripotency-associated protein 2,Pluripotent embryonic stem cell-related gene 1 protein;, PF14047;PF14049;, GO:0005654;GO:0003682;, C:nucleoplasm;, F:chromatin binding; scaffold69 indexed_genome mRNA 13976 16181 . + . ID=transcript_11181;P35318 B2R793 D3DQV3 Q6FGW2,Pro-adrenomedullin,, PF00214;, GO:0005737;GO:0005576;GO:0005615;GO:0031700;GO:0005179;GO:0005102;GO:0007189;GO:1990410;GO:0007568;GO:0097647;GO:0008209;GO:0031100;GO:0019731;GO:0061844;GO:0060670;GO:0050829;GO:0050830;GO:0048589;GO:0007565;GO:0002031;GO:0007186;GO:0007507;GO:0046879;GO:0006954;GO:0008285;GO:0002862;GO:0043116;GO:0045906;GO:0001843;GO:0031102;GO:0042475;GO:0045766;GO:0043065;GO:0008284;GO:0007204;GO:0010460;GO:2000184;GO:2001214;GO:0031623;GO:0003073;GO:0002026;GO:0035809;GO:0009409;GO:0051384;GO:0001666;GO:0032868;GO:0032496;GO:0042594;GO:0009611;GO:0007165;GO:0060712;GO:0097084;GO:0001570;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:adrenomedullin receptor binding; F:hormone activity; F:signaling receptor binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adrenomedullin receptor signaling pathway; P:aging; P:amylin receptor signaling pathway; P:androgen metabolic process; P:animal organ regeneration; P:antibacterial humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:branching involved in labyrinthine layer morphogenesis; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:developmental growth; P:female pregnancy; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:heart development; P:hormone secretion; P:inflammatory response; P:negative regulation of cell population proliferation; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of vascular permeability; P:negative regulation of vasoconstriction; P:neural tube closure; P:neuron projection regeneration; P:odontogenesis of dentin-containing tooth; P:positive regulation of angiogenesis; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of heart rate; P:positive regulation of progesterone biosynthetic process; P:positive regulation of vasculogenesis; P:receptor internalization; P:regulation of systemic arterial blood pressure; P:regulation of the force of heart contraction; P:regulation of urine volume; P:response to cold; P:response to glucocorticoid; P:response to hypoxia; P:response to insulin; P:response to lipopolysaccharide; P:response to starvation; P:response to wounding; P:signal transduction; P:spongiotrophoblast layer development; P:vascular associated smooth muscle cell development; P:vasculogenesis; scaffold69 indexed_genome mRNA 174676 202562 . + . ID=transcript_11182;Q01432 A0AUX0 B7Z2S2 B7Z763 B7Z877,AMP deaminase 3,AMP deaminase isoform E;Erythrocyte AMP deaminase;, PF00962;, GO:0005829;GO:0005576;GO:1904813;GO:0034774;GO:0003876;GO:0046872;GO:0006196;GO:0046033;GO:0006188;GO:0032264;GO:0043312;GO:0043101;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen;, F:AMP deaminase activity; F:metal ion binding;, P:AMP catabolic process; P:AMP metabolic process; P:IMP biosynthetic process; P:IMP salvage; P:neutrophil degranulation; P:purine-containing compound salvage;|Q01432 A0AUX0 B7Z2S2 B7Z763 B7Z877,AMP deaminase 3,AMP deaminase isoform E;Erythrocyte AMP deaminase;, PF00962;, GO:0005829;GO:0005576;GO:1904813;GO:0034774;GO:0003876;GO:0046872;GO:0006196;GO:0046033;GO:0006188;GO:0032264;GO:0043312;GO:0043101;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen;, F:AMP deaminase activity; F:metal ion binding;, P:AMP catabolic process; P:AMP metabolic process; P:IMP biosynthetic process; P:IMP salvage; P:neutrophil degranulation; P:purine-containing compound salvage; scaffold69 indexed_genome mRNA 202566 213200 . + . ID=transcript_11183;Q01432 A0AUX0 B7Z2S2 B7Z763 B7Z877,AMP deaminase 3,AMP deaminase isoform E;Erythrocyte AMP deaminase;, PF00962;, GO:0005829;GO:0005576;GO:1904813;GO:0034774;GO:0003876;GO:0046872;GO:0006196;GO:0046033;GO:0006188;GO:0032264;GO:0043312;GO:0043101;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen;, F:AMP deaminase activity; F:metal ion binding;, P:AMP catabolic process; P:AMP metabolic process; P:IMP biosynthetic process; P:IMP salvage; P:neutrophil degranulation; P:purine-containing compound salvage; scaffold69 indexed_genome mRNA 215226 250353 . - . ID=transcript_11184;Q8WVD5 A8K149 Q9NZB4,RING finger protein 141,Zinc finger protein 230;, , GO:0016020;GO:0046872;GO:0004842;GO:0051865;GO:0006355;, C:membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein autoubiquitination; P:regulation of transcription, DNA-templated;|Q8WVD5 A8K149 Q9NZB4,RING finger protein 141,Zinc finger protein 230;, , GO:0016020;GO:0046872;GO:0004842;GO:0051865;GO:0006355;, C:membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein autoubiquitination; P:regulation of transcription, DNA-templated; scaffold69 indexed_genome mRNA 276262 290563 . + . ID=transcript_11185;Q9Y5Y7 Q8TC18 Q9UNF4,Lymphatic vessel endothelial hyaluronic acid receptor 1,Cell surface retention sequence-binding protein 1;Extracellular link domain-containing protein 1;Hyaluronic acid receptor;, PF00193;, GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005540;GO:0038023;GO:0004888;GO:0009653;GO:0007160;GO:0030214;GO:0009611;, C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:hyaluronic acid binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:anatomical structure morphogenesis; P:cell-matrix adhesion; P:hyaluronan catabolic process; P:response to wounding;|Q9Y5Y7 Q8TC18 Q9UNF4,Lymphatic vessel endothelial hyaluronic acid receptor 1,Cell surface retention sequence-binding protein 1;Extracellular link domain-containing protein 1;Hyaluronic acid receptor;, PF00193;, GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005540;GO:0038023;GO:0004888;GO:0009653;GO:0007160;GO:0030214;GO:0009611;, C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:hyaluronic acid binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:anatomical structure morphogenesis; P:cell-matrix adhesion; P:hyaluronan catabolic process; P:response to wounding;|Q9Y5Y7 Q8TC18 Q9UNF4,Lymphatic vessel endothelial hyaluronic acid receptor 1,Cell surface retention sequence-binding protein 1;Extracellular link domain-containing protein 1;Hyaluronic acid receptor;, PF00193;, GO:0070062;GO:0005887;GO:0016020;GO:0005886;GO:0005540;GO:0038023;GO:0004888;GO:0009653;GO:0007160;GO:0030214;GO:0009611;, C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:hyaluronic acid binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:anatomical structure morphogenesis; P:cell-matrix adhesion; P:hyaluronan catabolic process; P:response to wounding; scaffold69 indexed_genome mRNA 297424 416425 . - . ID=transcript_11186;Q9Y6F6 B7Z3T4 B7Z6I2 B7Z9A3 E9PQY6 F5H6A1 J3KQZ7 Q17S00 Q9UNY1,Inositol 1,4,5-triphosphate receptor associated 1 {ECO:0000305},Inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate;JAW1-related protein MRVI1;Protein MRVI1;, PF05781;, GO:0005789;GO:0016021;GO:0048471;GO:0031095;GO:0016529;GO:0019934;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:platelet dense tubular network membrane; C:sarcoplasmic reticulum;, , P:cGMP-mediated signaling;|Q9Y6F6 B7Z3T4 B7Z6I2 B7Z9A3 E9PQY6 F5H6A1 J3KQZ7 Q17S00 Q9UNY1,Inositol 1,4,5-triphosphate receptor associated 1 {ECO:0000305},Inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate;JAW1-related protein MRVI1;Protein MRVI1;, PF05781;, GO:0005789;GO:0016021;GO:0048471;GO:0031095;GO:0016529;GO:0019934;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:platelet dense tubular network membrane; C:sarcoplasmic reticulum;, , P:cGMP-mediated signaling; scaffold69 indexed_genome mRNA 465024 489929 . + . ID=transcript_11187;Q6PD62 D3DQV8 Q15015,RNA polymerase-associated protein CTR9 homolog,SH2 domain-binding protein 1;, PF13181;, GO:0016593;GO:0016607;GO:0005654;GO:0035327;GO:0000993;GO:0042169;GO:0001832;GO:0001835;GO:0071222;GO:0001711;GO:0033523;GO:0080182;GO:0010390;GO:0001826;GO:0070102;GO:1900364;GO:0045638;GO:0000122;GO:2001168;GO:0051571;GO:2001162;GO:0016567;GO:0007259;GO:2000653;GO:0051569;GO:0006355;GO:0019827;GO:0006366;GO:0006368;GO:0001829;GO:0016055;, C:Cdc73/Paf1 complex; C:nuclear speck; C:nucleoplasm; C:transcriptionally active chromatin;, F:RNA polymerase II complex binding; F:SH2 domain binding;, P:blastocyst growth; P:blastocyst hatching; P:cellular response to lipopolysaccharide; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone H3-K4 trimethylation; P:histone monoubiquitination; P:inner cell mass cell differentiation; P:interleukin-6-mediated signaling pathway; P:negative regulation of mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K79 methylation; P:protein ubiquitination; P:receptor signaling pathway via JAK-STAT; P:regulation of genetic imprinting; P:regulation of histone H3-K4 methylation; P:regulation of transcription, DNA-templated; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:trophectodermal cell differentiation; P:Wnt signaling pathway;|Q6PD62 D3DQV8 Q15015,RNA polymerase-associated protein CTR9 homolog,SH2 domain-binding protein 1;, PF13181;, GO:0016593;GO:0016607;GO:0005654;GO:0035327;GO:0000993;GO:0042169;GO:0001832;GO:0001835;GO:0071222;GO:0001711;GO:0033523;GO:0080182;GO:0010390;GO:0001826;GO:0070102;GO:1900364;GO:0045638;GO:0000122;GO:2001168;GO:0051571;GO:2001162;GO:0016567;GO:0007259;GO:2000653;GO:0051569;GO:0006355;GO:0019827;GO:0006366;GO:0006368;GO:0001829;GO:0016055;, C:Cdc73/Paf1 complex; C:nuclear speck; C:nucleoplasm; C:transcriptionally active chromatin;, F:RNA polymerase II complex binding; F:SH2 domain binding;, P:blastocyst growth; P:blastocyst hatching; P:cellular response to lipopolysaccharide; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone H3-K4 trimethylation; P:histone monoubiquitination; P:inner cell mass cell differentiation; P:interleukin-6-mediated signaling pathway; P:negative regulation of mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K79 methylation; P:protein ubiquitination; P:receptor signaling pathway via JAK-STAT; P:regulation of genetic imprinting; P:regulation of histone H3-K4 methylation; P:regulation of transcription, DNA-templated; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:trophectodermal cell differentiation; P:Wnt signaling pathway;|Q6PD62 D3DQV8 Q15015,RNA polymerase-associated protein CTR9 homolog,SH2 domain-binding protein 1;, PF13181;, GO:0016593;GO:0016607;GO:0005654;GO:0035327;GO:0000993;GO:0042169;GO:0001832;GO:0001835;GO:0071222;GO:0001711;GO:0033523;GO:0080182;GO:0010390;GO:0001826;GO:0070102;GO:1900364;GO:0045638;GO:0000122;GO:2001168;GO:0051571;GO:2001162;GO:0016567;GO:0007259;GO:2000653;GO:0051569;GO:0006355;GO:0019827;GO:0006366;GO:0006368;GO:0001829;GO:0016055;, C:Cdc73/Paf1 complex; C:nuclear speck; C:nucleoplasm; C:transcriptionally active chromatin;, F:RNA polymerase II complex binding; F:SH2 domain binding;, P:blastocyst growth; P:blastocyst hatching; P:cellular response to lipopolysaccharide; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone H3-K4 trimethylation; P:histone monoubiquitination; P:inner cell mass cell differentiation; P:interleukin-6-mediated signaling pathway; P:negative regulation of mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone H2B ubiquitination; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K79 methylation; P:protein ubiquitination; P:receptor signaling pathway via JAK-STAT; P:regulation of genetic imprinting; P:regulation of histone H3-K4 methylation; P:regulation of transcription, DNA-templated; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:trophectodermal cell differentiation; P:Wnt signaling pathway; scaffold69 indexed_genome mRNA 506237 527671 . - . ID=transcript_11188;Q8NI71 Q96C16,Eukaryotic translation initiation factor 4 gamma 2,Death-associated protein 5;p97;, PF02847;PF02854;PF02020;, GO:0005912;GO:0030424;GO:0005829;GO:0016281;GO:0016020;GO:0045296;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0007050;GO:0008219;GO:0034645;GO:0007507;GO:0010507;GO:0045773;GO:0030307;GO:0060999;GO:0045727;GO:0006446;, C:adherens junction; C:axon; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:cell cycle arrest; P:cell death; P:cellular macromolecule biosynthetic process; P:heart development; P:negative regulation of autophagy; P:positive regulation of axon extension; P:positive regulation of cell growth; P:positive regulation of dendritic spine development; P:positive regulation of translation; P:regulation of translational initiation;|Q8NI71 Q96C16,Eukaryotic translation initiation factor 4 gamma 2,Death-associated protein 5;p97;, PF02847;PF02854;PF02020;, GO:0005912;GO:0030424;GO:0005829;GO:0016281;GO:0016020;GO:0045296;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0007050;GO:0008219;GO:0034645;GO:0007507;GO:0010507;GO:0045773;GO:0030307;GO:0060999;GO:0045727;GO:0006446;, C:adherens junction; C:axon; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:cell cycle arrest; P:cell death; P:cellular macromolecule biosynthetic process; P:heart development; P:negative regulation of autophagy; P:positive regulation of axon extension; P:positive regulation of cell growth; P:positive regulation of dendritic spine development; P:positive regulation of translation; P:regulation of translational initiation;|Q8NI71 Q96C16,Eukaryotic translation initiation factor 4 gamma 2,Death-associated protein 5;p97;, PF02847;PF02854;PF02020;, GO:0005912;GO:0030424;GO:0005829;GO:0016281;GO:0016020;GO:0045296;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0007050;GO:0008219;GO:0034645;GO:0007507;GO:0010507;GO:0045773;GO:0030307;GO:0060999;GO:0045727;GO:0006446;, C:adherens junction; C:axon; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:cell cycle arrest; P:cell death; P:cellular macromolecule biosynthetic process; P:heart development; P:negative regulation of autophagy; P:positive regulation of axon extension; P:positive regulation of cell growth; P:positive regulation of dendritic spine development; P:positive regulation of translation; P:regulation of translational initiation;|Q8NI71 Q96C16,Eukaryotic translation initiation factor 4 gamma 2,Death-associated protein 5;p97;, PF02847;PF02854;PF02020;, GO:0005912;GO:0030424;GO:0005829;GO:0016281;GO:0016020;GO:0045296;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0007050;GO:0008219;GO:0034645;GO:0007507;GO:0010507;GO:0045773;GO:0030307;GO:0060999;GO:0045727;GO:0006446;, C:adherens junction; C:axon; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:cell cycle arrest; P:cell death; P:cellular macromolecule biosynthetic process; P:heart development; P:negative regulation of autophagy; P:positive regulation of axon extension; P:positive regulation of cell growth; P:positive regulation of dendritic spine development; P:positive regulation of translation; P:regulation of translational initiation;|Q8NI71 Q96C16,Eukaryotic translation initiation factor 4 gamma 2,Death-associated protein 5;p97;, PF02847;PF02854;PF02020;, GO:0005912;GO:0030424;GO:0005829;GO:0016281;GO:0016020;GO:0045296;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0007050;GO:0008219;GO:0034645;GO:0007507;GO:0010507;GO:0045773;GO:0030307;GO:0060999;GO:0045727;GO:0006446;, C:adherens junction; C:axon; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:cell cycle arrest; P:cell death; P:cellular macromolecule biosynthetic process; P:heart development; P:negative regulation of autophagy; P:positive regulation of axon extension; P:positive regulation of cell growth; P:positive regulation of dendritic spine development; P:positive regulation of translation; P:regulation of translational initiation;|Q8NI71 Q96C16,Eukaryotic translation initiation factor 4 gamma 2,Death-associated protein 5;p97;, PF02847;PF02854;PF02020;, GO:0005912;GO:0030424;GO:0005829;GO:0016281;GO:0016020;GO:0045296;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0007050;GO:0008219;GO:0034645;GO:0007507;GO:0010507;GO:0045773;GO:0030307;GO:0060999;GO:0045727;GO:0006446;, C:adherens junction; C:axon; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:cell cycle arrest; P:cell death; P:cellular macromolecule biosynthetic process; P:heart development; P:negative regulation of autophagy; P:positive regulation of axon extension; P:positive regulation of cell growth; P:positive regulation of dendritic spine development; P:positive regulation of translation; P:regulation of translational initiation;|Q8NI71 Q96C16,Eukaryotic translation initiation factor 4 gamma 2,Death-associated protein 5;p97;, PF02847;PF02854;PF02020;, GO:0005912;GO:0030424;GO:0005829;GO:0016281;GO:0016020;GO:0045296;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0007050;GO:0008219;GO:0034645;GO:0007507;GO:0010507;GO:0045773;GO:0030307;GO:0060999;GO:0045727;GO:0006446;, C:adherens junction; C:axon; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:cell cycle arrest; P:cell death; P:cellular macromolecule biosynthetic process; P:heart development; P:negative regulation of autophagy; P:positive regulation of axon extension; P:positive regulation of cell growth; P:positive regulation of dendritic spine development; P:positive regulation of translation; P:regulation of translational initiation; scaffold69 indexed_genome mRNA 922465 1264251 . - . ID=transcript_11189;Q6P9A2 O95903 Q8NDY9,Polypeptide N-acetylgalactosaminyltransferase 18,Polypeptide GalNAc transferase 18;Polypeptide GalNAc transferase-like protein 4;Polypeptide N-acetylgalactosaminyltransferase-like protein 4;Protein-UDP acetylgalactosaminyltransferase-like protein 4;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0006493;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:protein O-linked glycosylation; scaffold69 indexed_genome mRNA 1479505 1580190 . + . ID=transcript_11190;Q96K76 B3KXF5 E9PM46 Q658U0 Q86Y73 Q8TEP6 Q9BWI0 Q9NWN1,Ubiquitin carboxyl-terminal hydrolase 47,Deubiquitinating enzyme 47;Ubiquitin thioesterase 47;Ubiquitin-specific-processing protease 47;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0004197;GO:0004843;GO:0101005;GO:0071987;GO:0006284;GO:0006974;GO:0034644;GO:0035520;GO:0043066;GO:0043154;GO:0010972;GO:1902230;GO:0045892;GO:0090263;GO:0030307;GO:0016579;GO:0031647;GO:0042493;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity; F:WD40-repeat domain binding;, P:base-excision repair; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:monoubiquitinated protein deubiquitination; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription, DNA-templated; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:protein deubiquitination; P:regulation of protein stability; P:response to drug; P:ubiquitin-dependent protein catabolic process;|Q96K76 B3KXF5 E9PM46 Q658U0 Q86Y73 Q8TEP6 Q9BWI0 Q9NWN1,Ubiquitin carboxyl-terminal hydrolase 47,Deubiquitinating enzyme 47;Ubiquitin thioesterase 47;Ubiquitin-specific-processing protease 47;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0004197;GO:0004843;GO:0101005;GO:0071987;GO:0006284;GO:0006974;GO:0034644;GO:0035520;GO:0043066;GO:0043154;GO:0010972;GO:1902230;GO:0045892;GO:0090263;GO:0030307;GO:0016579;GO:0031647;GO:0042493;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity; F:WD40-repeat domain binding;, P:base-excision repair; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:monoubiquitinated protein deubiquitination; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription, DNA-templated; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:protein deubiquitination; P:regulation of protein stability; P:response to drug; P:ubiquitin-dependent protein catabolic process;|Q96K76 B3KXF5 E9PM46 Q658U0 Q86Y73 Q8TEP6 Q9BWI0 Q9NWN1,Ubiquitin carboxyl-terminal hydrolase 47,Deubiquitinating enzyme 47;Ubiquitin thioesterase 47;Ubiquitin-specific-processing protease 47;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0004197;GO:0004843;GO:0101005;GO:0071987;GO:0006284;GO:0006974;GO:0034644;GO:0035520;GO:0043066;GO:0043154;GO:0010972;GO:1902230;GO:0045892;GO:0090263;GO:0030307;GO:0016579;GO:0031647;GO:0042493;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity; F:WD40-repeat domain binding;, P:base-excision repair; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:monoubiquitinated protein deubiquitination; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription, DNA-templated; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:protein deubiquitination; P:regulation of protein stability; P:response to drug; P:ubiquitin-dependent protein catabolic process;|Q96K76 B3KXF5 E9PM46 Q658U0 Q86Y73 Q8TEP6 Q9BWI0 Q9NWN1,Ubiquitin carboxyl-terminal hydrolase 47,Deubiquitinating enzyme 47;Ubiquitin thioesterase 47;Ubiquitin-specific-processing protease 47;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0004197;GO:0004843;GO:0101005;GO:0071987;GO:0006284;GO:0006974;GO:0034644;GO:0035520;GO:0043066;GO:0043154;GO:0010972;GO:1902230;GO:0045892;GO:0090263;GO:0030307;GO:0016579;GO:0031647;GO:0042493;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity; F:WD40-repeat domain binding;, P:base-excision repair; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:monoubiquitinated protein deubiquitination; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription, DNA-templated; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:protein deubiquitination; P:regulation of protein stability; P:response to drug; P:ubiquitin-dependent protein catabolic process;|Q96K76 B3KXF5 E9PM46 Q658U0 Q86Y73 Q8TEP6 Q9BWI0 Q9NWN1,Ubiquitin carboxyl-terminal hydrolase 47,Deubiquitinating enzyme 47;Ubiquitin thioesterase 47;Ubiquitin-specific-processing protease 47;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0004197;GO:0004843;GO:0101005;GO:0071987;GO:0006284;GO:0006974;GO:0034644;GO:0035520;GO:0043066;GO:0043154;GO:0010972;GO:1902230;GO:0045892;GO:0090263;GO:0030307;GO:0016579;GO:0031647;GO:0042493;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity; F:WD40-repeat domain binding;, P:base-excision repair; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:monoubiquitinated protein deubiquitination; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription, DNA-templated; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:protein deubiquitination; P:regulation of protein stability; P:response to drug; P:ubiquitin-dependent protein catabolic process;|Q96K76 B3KXF5 E9PM46 Q658U0 Q86Y73 Q8TEP6 Q9BWI0 Q9NWN1,Ubiquitin carboxyl-terminal hydrolase 47,Deubiquitinating enzyme 47;Ubiquitin thioesterase 47;Ubiquitin-specific-processing protease 47;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0004197;GO:0004843;GO:0101005;GO:0071987;GO:0006284;GO:0006974;GO:0034644;GO:0035520;GO:0043066;GO:0043154;GO:0010972;GO:1902230;GO:0045892;GO:0090263;GO:0030307;GO:0016579;GO:0031647;GO:0042493;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity; F:WD40-repeat domain binding;, P:base-excision repair; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:monoubiquitinated protein deubiquitination; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription, DNA-templated; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:protein deubiquitination; P:regulation of protein stability; P:response to drug; P:ubiquitin-dependent protein catabolic process;|Q96K76 B3KXF5 E9PM46 Q658U0 Q86Y73 Q8TEP6 Q9BWI0 Q9NWN1,Ubiquitin carboxyl-terminal hydrolase 47,Deubiquitinating enzyme 47;Ubiquitin thioesterase 47;Ubiquitin-specific-processing protease 47;, PF00443;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0004197;GO:0004843;GO:0101005;GO:0071987;GO:0006284;GO:0006974;GO:0034644;GO:0035520;GO:0043066;GO:0043154;GO:0010972;GO:1902230;GO:0045892;GO:0090263;GO:0030307;GO:0016579;GO:0031647;GO:0042493;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity; F:WD40-repeat domain binding;, P:base-excision repair; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:monoubiquitinated protein deubiquitination; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of transcription, DNA-templated; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:protein deubiquitination; P:regulation of protein stability; P:response to drug; P:ubiquitin-dependent protein catabolic process; scaffold69 indexed_genome mRNA 1585305 1635406 . - . ID=transcript_11191;Q9UBP4 A8K1I2 D3DQW1 Q9ULB7,Dickkopf-related protein 3,, PF04706;, GO:0005615;GO:0039706;GO:0048019;GO:0030325;GO:0009653;GO:0032348;GO:1902613;GO:0090090;GO:2000065;GO:0045892;GO:0017015;GO:0016055;, C:extracellular space;, F:co-receptor binding; F:receptor antagonist activity;, P:adrenal gland development; P:anatomical structure morphogenesis; P:negative regulation of aldosterone biosynthetic process; P:negative regulation of anti-Mullerian hormone signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cortisol biosynthetic process; P:negative regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway;|Q9UBP4 A8K1I2 D3DQW1 Q9ULB7,Dickkopf-related protein 3,, PF04706;, GO:0005615;GO:0039706;GO:0048019;GO:0030325;GO:0009653;GO:0032348;GO:1902613;GO:0090090;GO:2000065;GO:0045892;GO:0017015;GO:0016055;, C:extracellular space;, F:co-receptor binding; F:receptor antagonist activity;, P:adrenal gland development; P:anatomical structure morphogenesis; P:negative regulation of aldosterone biosynthetic process; P:negative regulation of anti-Mullerian hormone signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cortisol biosynthetic process; P:negative regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway;|Q9UBP4 A8K1I2 D3DQW1 Q9ULB7,Dickkopf-related protein 3,, PF04706;, GO:0005615;GO:0039706;GO:0048019;GO:0030325;GO:0009653;GO:0032348;GO:1902613;GO:0090090;GO:2000065;GO:0045892;GO:0017015;GO:0016055;, C:extracellular space;, F:co-receptor binding; F:receptor antagonist activity;, P:adrenal gland development; P:anatomical structure morphogenesis; P:negative regulation of aldosterone biosynthetic process; P:negative regulation of anti-Mullerian hormone signaling pathway; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cortisol biosynthetic process; P:negative regulation of transcription, DNA-templated; P:regulation of transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway; scaffold69 indexed_genome mRNA 1818082 1873664 . + . ID=transcript_11192;O94851 B4DGZ0 B7Z849 D3DQW5 G3XAC8 Q5KTR3 Q5KTR4 Q7Z3A8,[F-actin]-monooxygenase MICAL2,Molecule interacting with CasL protein 2;, PF00307;PF01494;PF00412;, GO:0005634;GO:0003779;GO:0071949;GO:0046872;GO:0043914;GO:0016491;GO:0016709;GO:0030042;GO:0007010;GO:0007507;GO:0001947;GO:0010735;GO:0019417;, C:nucleus;, F:actin binding; F:FAD binding; F:metal ion binding; F:NADPH:sulfur oxidoreductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:actin filament depolymerization; P:cytoskeleton organization; P:heart development; P:heart looping; P:positive regulation of transcription via serum response element binding; P:sulfur oxidation;|O94851 B4DGZ0 B7Z849 D3DQW5 G3XAC8 Q5KTR3 Q5KTR4 Q7Z3A8,[F-actin]-monooxygenase MICAL2,Molecule interacting with CasL protein 2;, PF00307;PF01494;PF00412;, GO:0005634;GO:0003779;GO:0071949;GO:0046872;GO:0043914;GO:0016491;GO:0016709;GO:0030042;GO:0007010;GO:0007507;GO:0001947;GO:0010735;GO:0019417;, C:nucleus;, F:actin binding; F:FAD binding; F:metal ion binding; F:NADPH:sulfur oxidoreductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:actin filament depolymerization; P:cytoskeleton organization; P:heart development; P:heart looping; P:positive regulation of transcription via serum response element binding; P:sulfur oxidation;|O94851 B4DGZ0 B7Z849 D3DQW5 G3XAC8 Q5KTR3 Q5KTR4 Q7Z3A8,[F-actin]-monooxygenase MICAL2,Molecule interacting with CasL protein 2;, PF00307;PF01494;PF00412;, GO:0005634;GO:0003779;GO:0071949;GO:0046872;GO:0043914;GO:0016491;GO:0016709;GO:0030042;GO:0007010;GO:0007507;GO:0001947;GO:0010735;GO:0019417;, C:nucleus;, F:actin binding; F:FAD binding; F:metal ion binding; F:NADPH:sulfur oxidoreductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:actin filament depolymerization; P:cytoskeleton organization; P:heart development; P:heart looping; P:positive regulation of transcription via serum response element binding; P:sulfur oxidation;|O94851 B4DGZ0 B7Z849 D3DQW5 G3XAC8 Q5KTR3 Q5KTR4 Q7Z3A8,[F-actin]-monooxygenase MICAL2,Molecule interacting with CasL protein 2;, PF00307;PF01494;PF00412;, GO:0005634;GO:0003779;GO:0071949;GO:0046872;GO:0043914;GO:0016491;GO:0016709;GO:0030042;GO:0007010;GO:0007507;GO:0001947;GO:0010735;GO:0019417;, C:nucleus;, F:actin binding; F:FAD binding; F:metal ion binding; F:NADPH:sulfur oxidoreductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:actin filament depolymerization; P:cytoskeleton organization; P:heart development; P:heart looping; P:positive regulation of transcription via serum response element binding; P:sulfur oxidation; scaffold69 indexed_genome mRNA 1900670 1956745 . + . ID=transcript_11193;Q6ZW33 Q7RTP7 Q96JU6,MICAL C-terminal-like protein,ERK2-binding testicular protein 1;Ebitein-1;, PF12130;, GO:0005737;GO:0031941;GO:0005815;GO:0051019;GO:0030036;GO:0030154;GO:0007275;GO:0007283;, C:cytoplasm; C:filamentous actin; C:microtubule organizing center;, F:mitogen-activated protein kinase binding;, P:actin cytoskeleton organization; P:cell differentiation; P:multicellular organism development; P:spermatogenesis; scaffold69 indexed_genome mRNA 1972027 2144673 . + . ID=transcript_11194;Q9NVD7 Q96C85 Q9HA48,Alpha-parvin,Actopaxin;CH-ILKBP;Calponin-like integrin-linked kinase-binding protein;Matrix-remodeling-associated protein 2;, PF00307;, GO:0015629;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0004860;GO:0031532;GO:0070252;GO:0030031;GO:0060271;GO:0007163;GO:0034113;GO:0003148;GO:0050821;GO:0008360;GO:0071670;GO:0002040;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:protein kinase inhibitor activity;, P:actin cytoskeleton reorganization; P:actin-mediated cell contraction; P:cell projection assembly; P:cilium assembly; P:establishment or maintenance of cell polarity; P:heterotypic cell-cell adhesion; P:outflow tract septum morphogenesis; P:protein stabilization; P:regulation of cell shape; P:smooth muscle cell chemotaxis; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading;|Q9NVD7 Q96C85 Q9HA48,Alpha-parvin,Actopaxin;CH-ILKBP;Calponin-like integrin-linked kinase-binding protein;Matrix-remodeling-associated protein 2;, PF00307;, GO:0015629;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0004860;GO:0031532;GO:0070252;GO:0030031;GO:0060271;GO:0007163;GO:0034113;GO:0003148;GO:0050821;GO:0008360;GO:0071670;GO:0002040;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:protein kinase inhibitor activity;, P:actin cytoskeleton reorganization; P:actin-mediated cell contraction; P:cell projection assembly; P:cilium assembly; P:establishment or maintenance of cell polarity; P:heterotypic cell-cell adhesion; P:outflow tract septum morphogenesis; P:protein stabilization; P:regulation of cell shape; P:smooth muscle cell chemotaxis; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading;|Q9NVD7 Q96C85 Q9HA48,Alpha-parvin,Actopaxin;CH-ILKBP;Calponin-like integrin-linked kinase-binding protein;Matrix-remodeling-associated protein 2;, PF00307;, GO:0015629;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0004860;GO:0031532;GO:0070252;GO:0030031;GO:0060271;GO:0007163;GO:0034113;GO:0003148;GO:0050821;GO:0008360;GO:0071670;GO:0002040;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:protein kinase inhibitor activity;, P:actin cytoskeleton reorganization; P:actin-mediated cell contraction; P:cell projection assembly; P:cilium assembly; P:establishment or maintenance of cell polarity; P:heterotypic cell-cell adhesion; P:outflow tract septum morphogenesis; P:protein stabilization; P:regulation of cell shape; P:smooth muscle cell chemotaxis; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading;|Q9NVD7 Q96C85 Q9HA48,Alpha-parvin,Actopaxin;CH-ILKBP;Calponin-like integrin-linked kinase-binding protein;Matrix-remodeling-associated protein 2;, PF00307;, GO:0015629;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0004860;GO:0031532;GO:0070252;GO:0030031;GO:0060271;GO:0007163;GO:0034113;GO:0003148;GO:0050821;GO:0008360;GO:0071670;GO:0002040;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:protein kinase inhibitor activity;, P:actin cytoskeleton reorganization; P:actin-mediated cell contraction; P:cell projection assembly; P:cilium assembly; P:establishment or maintenance of cell polarity; P:heterotypic cell-cell adhesion; P:outflow tract septum morphogenesis; P:protein stabilization; P:regulation of cell shape; P:smooth muscle cell chemotaxis; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading;|Q9NVD7 Q96C85 Q9HA48,Alpha-parvin,Actopaxin;CH-ILKBP;Calponin-like integrin-linked kinase-binding protein;Matrix-remodeling-associated protein 2;, PF00307;, GO:0015629;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0005634;GO:0005886;GO:0030018;GO:0003779;GO:0045296;GO:0004860;GO:0031532;GO:0070252;GO:0030031;GO:0060271;GO:0007163;GO:0034113;GO:0003148;GO:0050821;GO:0008360;GO:0071670;GO:0002040;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:nucleus; C:plasma membrane; C:Z disc;, F:actin binding; F:cadherin binding; F:protein kinase inhibitor activity;, P:actin cytoskeleton reorganization; P:actin-mediated cell contraction; P:cell projection assembly; P:cilium assembly; P:establishment or maintenance of cell polarity; P:heterotypic cell-cell adhesion; P:outflow tract septum morphogenesis; P:protein stabilization; P:regulation of cell shape; P:smooth muscle cell chemotaxis; P:sprouting angiogenesis; P:substrate adhesion-dependent cell spreading; scaffold69 indexed_genome mRNA 2483959 2562175 . + . ID=transcript_11195;P28347 A4FUP2 E7EV65,Transcriptional enhancer factor TEF-1,NTEF-1;Protein GT-IIC;TEA domain family member 1;Transcription factor 13;, PF01285;PF17725;, GO:0000785;GO:0005654;GO:0140552;GO:0005667;GO:0000987;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0048568;GO:0035329;GO:0007399;GO:1902895;GO:0045944;GO:0045893;GO:0065003;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:TEAD-YAP complex; C:transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:embryonic organ development; P:hippo signaling; P:nervous system development; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold69 indexed_genome mRNA 2621010 2624932 . - . ID=transcript_11196;A6NK89,Ras association domain-containing protein 10,, , GO:0005829;GO:0005815;GO:0000922;GO:2000179;GO:0050769;GO:0007165;, C:cytosol; C:microtubule organizing center; C:spindle pole;, , P:positive regulation of neural precursor cell proliferation; P:positive regulation of neurogenesis; P:signal transduction; scaffold69 indexed_genome mRNA 2992990 3028717 . + . ID=transcript_11197;O00316 O00317 Q4G136 Q8IUT4 Q99631 Q99649,Aryl hydrocarbon receptor nuclear translocator-like protein 1,Basic-helix-loop-helix-PAS protein MOP3;Brain and muscle ARNT-like 1;Class E basic helix-loop-helix protein 5;Member of PAS protein 3;PAS domain-containing protein 3;bHLH-PAS protein JAP3;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0033391;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0005667;GO:0017162;GO:0003677;GO:0000981;GO:0140297;GO:0070888;GO:0051879;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0032922;GO:0007623;GO:0120163;GO:0045599;GO:2000323;GO:0032007;GO:0045892;GO:0090403;GO:0090263;GO:0042753;GO:1901985;GO:2001016;GO:0045944;GO:0045893;GO:0043161;GO:0051726;GO:2000772;GO:0042634;GO:0050796;GO:0050767;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007283;, C:aryl hydrocarbon receptor complex; C:chromatin; C:chromatoid body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body; C:transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:E-box binding; F:Hsp90 protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cold-induced thermogenesis; P:negative regulation of fat cell differentiation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of transcription, DNA-templated; P:oxidative stress-induced premature senescence; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of circadian rhythm; P:positive regulation of protein acetylation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell cycle; P:regulation of cellular senescence; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:spermatogenesis;|O00316 O00317 Q4G136 Q8IUT4 Q99631 Q99649,Aryl hydrocarbon receptor nuclear translocator-like protein 1,Basic-helix-loop-helix-PAS protein MOP3;Brain and muscle ARNT-like 1;Class E basic helix-loop-helix protein 5;Member of PAS protein 3;PAS domain-containing protein 3;bHLH-PAS protein JAP3;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0033391;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0005667;GO:0017162;GO:0003677;GO:0000981;GO:0140297;GO:0070888;GO:0051879;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0032922;GO:0007623;GO:0120163;GO:0045599;GO:2000323;GO:0032007;GO:0045892;GO:0090403;GO:0090263;GO:0042753;GO:1901985;GO:2001016;GO:0045944;GO:0045893;GO:0043161;GO:0051726;GO:2000772;GO:0042634;GO:0050796;GO:0050767;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007283;, C:aryl hydrocarbon receptor complex; C:chromatin; C:chromatoid body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body; C:transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:E-box binding; F:Hsp90 protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cold-induced thermogenesis; P:negative regulation of fat cell differentiation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of transcription, DNA-templated; P:oxidative stress-induced premature senescence; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of circadian rhythm; P:positive regulation of protein acetylation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell cycle; P:regulation of cellular senescence; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:spermatogenesis;|O00316 O00317 Q4G136 Q8IUT4 Q99631 Q99649,Aryl hydrocarbon receptor nuclear translocator-like protein 1,Basic-helix-loop-helix-PAS protein MOP3;Brain and muscle ARNT-like 1;Class E basic helix-loop-helix protein 5;Member of PAS protein 3;PAS domain-containing protein 3;bHLH-PAS protein JAP3;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0033391;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0005667;GO:0017162;GO:0003677;GO:0000981;GO:0140297;GO:0070888;GO:0051879;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0032922;GO:0007623;GO:0120163;GO:0045599;GO:2000323;GO:0032007;GO:0045892;GO:0090403;GO:0090263;GO:0042753;GO:1901985;GO:2001016;GO:0045944;GO:0045893;GO:0043161;GO:0051726;GO:2000772;GO:0042634;GO:0050796;GO:0050767;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007283;, C:aryl hydrocarbon receptor complex; C:chromatin; C:chromatoid body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body; C:transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:E-box binding; F:Hsp90 protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cold-induced thermogenesis; P:negative regulation of fat cell differentiation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of transcription, DNA-templated; P:oxidative stress-induced premature senescence; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of circadian rhythm; P:positive regulation of protein acetylation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell cycle; P:regulation of cellular senescence; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:spermatogenesis;|O00316 O00317 Q4G136 Q8IUT4 Q99631 Q99649,Aryl hydrocarbon receptor nuclear translocator-like protein 1,Basic-helix-loop-helix-PAS protein MOP3;Brain and muscle ARNT-like 1;Class E basic helix-loop-helix protein 5;Member of PAS protein 3;PAS domain-containing protein 3;bHLH-PAS protein JAP3;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0033391;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0005667;GO:0017162;GO:0003677;GO:0000981;GO:0140297;GO:0070888;GO:0051879;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0032922;GO:0007623;GO:0120163;GO:0045599;GO:2000323;GO:0032007;GO:0045892;GO:0090403;GO:0090263;GO:0042753;GO:1901985;GO:2001016;GO:0045944;GO:0045893;GO:0043161;GO:0051726;GO:2000772;GO:0042634;GO:0050796;GO:0050767;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007283;, C:aryl hydrocarbon receptor complex; C:chromatin; C:chromatoid body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body; C:transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:E-box binding; F:Hsp90 protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cold-induced thermogenesis; P:negative regulation of fat cell differentiation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of transcription, DNA-templated; P:oxidative stress-induced premature senescence; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of circadian rhythm; P:positive regulation of protein acetylation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell cycle; P:regulation of cellular senescence; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:spermatogenesis;|O00316 O00317 Q4G136 Q8IUT4 Q99631 Q99649,Aryl hydrocarbon receptor nuclear translocator-like protein 1,Basic-helix-loop-helix-PAS protein MOP3;Brain and muscle ARNT-like 1;Class E basic helix-loop-helix protein 5;Member of PAS protein 3;PAS domain-containing protein 3;bHLH-PAS protein JAP3;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0033391;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0005667;GO:0017162;GO:0003677;GO:0000981;GO:0140297;GO:0070888;GO:0051879;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0032922;GO:0007623;GO:0120163;GO:0045599;GO:2000323;GO:0032007;GO:0045892;GO:0090403;GO:0090263;GO:0042753;GO:1901985;GO:2001016;GO:0045944;GO:0045893;GO:0043161;GO:0051726;GO:2000772;GO:0042634;GO:0050796;GO:0050767;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007283;, C:aryl hydrocarbon receptor complex; C:chromatin; C:chromatoid body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body; C:transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:E-box binding; F:Hsp90 protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cold-induced thermogenesis; P:negative regulation of fat cell differentiation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of transcription, DNA-templated; P:oxidative stress-induced premature senescence; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of circadian rhythm; P:positive regulation of protein acetylation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell cycle; P:regulation of cellular senescence; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:spermatogenesis;|O00316 O00317 Q4G136 Q8IUT4 Q99631 Q99649,Aryl hydrocarbon receptor nuclear translocator-like protein 1,Basic-helix-loop-helix-PAS protein MOP3;Brain and muscle ARNT-like 1;Class E basic helix-loop-helix protein 5;Member of PAS protein 3;PAS domain-containing protein 3;bHLH-PAS protein JAP3;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0033391;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0005667;GO:0017162;GO:0003677;GO:0000981;GO:0140297;GO:0070888;GO:0051879;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0032922;GO:0007623;GO:0120163;GO:0045599;GO:2000323;GO:0032007;GO:0045892;GO:0090403;GO:0090263;GO:0042753;GO:1901985;GO:2001016;GO:0045944;GO:0045893;GO:0043161;GO:0051726;GO:2000772;GO:0042634;GO:0050796;GO:0050767;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007283;, C:aryl hydrocarbon receptor complex; C:chromatin; C:chromatoid body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body; C:transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:E-box binding; F:Hsp90 protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cold-induced thermogenesis; P:negative regulation of fat cell differentiation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of transcription, DNA-templated; P:oxidative stress-induced premature senescence; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of circadian rhythm; P:positive regulation of protein acetylation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell cycle; P:regulation of cellular senescence; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:spermatogenesis;|O00316 O00317 Q4G136 Q8IUT4 Q99631 Q99649,Aryl hydrocarbon receptor nuclear translocator-like protein 1,Basic-helix-loop-helix-PAS protein MOP3;Brain and muscle ARNT-like 1;Class E basic helix-loop-helix protein 5;Member of PAS protein 3;PAS domain-containing protein 3;bHLH-PAS protein JAP3;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0033391;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0005667;GO:0017162;GO:0003677;GO:0000981;GO:0140297;GO:0070888;GO:0051879;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0032922;GO:0007623;GO:0120163;GO:0045599;GO:2000323;GO:0032007;GO:0045892;GO:0090403;GO:0090263;GO:0042753;GO:1901985;GO:2001016;GO:0045944;GO:0045893;GO:0043161;GO:0051726;GO:2000772;GO:0042634;GO:0050796;GO:0050767;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007283;, C:aryl hydrocarbon receptor complex; C:chromatin; C:chromatoid body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body; C:transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:E-box binding; F:Hsp90 protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cold-induced thermogenesis; P:negative regulation of fat cell differentiation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of transcription, DNA-templated; P:oxidative stress-induced premature senescence; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of circadian rhythm; P:positive regulation of protein acetylation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell cycle; P:regulation of cellular senescence; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:spermatogenesis;|O00316 O00317 Q4G136 Q8IUT4 Q99631 Q99649,Aryl hydrocarbon receptor nuclear translocator-like protein 1,Basic-helix-loop-helix-PAS protein MOP3;Brain and muscle ARNT-like 1;Class E basic helix-loop-helix protein 5;Member of PAS protein 3;PAS domain-containing protein 3;bHLH-PAS protein JAP3;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0033391;GO:0043231;GO:0005654;GO:0005634;GO:0016605;GO:0005667;GO:0017162;GO:0003677;GO:0000981;GO:0140297;GO:0070888;GO:0051879;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0032922;GO:0007623;GO:0120163;GO:0045599;GO:2000323;GO:0032007;GO:0045892;GO:0090403;GO:0090263;GO:0042753;GO:1901985;GO:2001016;GO:0045944;GO:0045893;GO:0043161;GO:0051726;GO:2000772;GO:0042634;GO:0050796;GO:0050767;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007283;, C:aryl hydrocarbon receptor complex; C:chromatin; C:chromatoid body; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:PML body; C:transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:E-box binding; F:Hsp90 protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of cold-induced thermogenesis; P:negative regulation of fat cell differentiation; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of transcription, DNA-templated; P:oxidative stress-induced premature senescence; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of circadian rhythm; P:positive regulation of protein acetylation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell cycle; P:regulation of cellular senescence; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:spermatogenesis; scaffold69 indexed_genome mRNA 3028782 3100011 . - . ID=transcript_11198;Q9BSF8 B7Z228 Q86WG1,BTB/POZ domain-containing protein 10,Glucose metabolism-related protein 1 {ECO:0000303|PubMed:21267538};, PF16017;, GO:0005737;GO:0001650;GO:0005654;GO:1901215;GO:0042327;GO:0044342;, C:cytoplasm; C:fibrillar center; C:nucleoplasm;, , P:negative regulation of neuron death; P:positive regulation of phosphorylation; P:type B pancreatic cell proliferation;|Q9BSF8 B7Z228 Q86WG1,BTB/POZ domain-containing protein 10,Glucose metabolism-related protein 1 {ECO:0000303|PubMed:21267538};, PF16017;, GO:0005737;GO:0001650;GO:0005654;GO:1901215;GO:0042327;GO:0044342;, C:cytoplasm; C:fibrillar center; C:nucleoplasm;, , P:negative regulation of neuron death; P:positive regulation of phosphorylation; P:type B pancreatic cell proliferation;|Q9BSF8 B7Z228 Q86WG1,BTB/POZ domain-containing protein 10,Glucose metabolism-related protein 1 {ECO:0000303|PubMed:21267538};, PF16017;, GO:0005737;GO:0001650;GO:0005654;GO:1901215;GO:0042327;GO:0044342;, C:cytoplasm; C:fibrillar center; C:nucleoplasm;, , P:negative regulation of neuron death; P:positive regulation of phosphorylation; P:type B pancreatic cell proliferation; scaffold69 indexed_genome mRNA 3239980 3295957 . + . ID=transcript_11199;Q8WVX9 D3DQW8 Q5CZA3,Fatty acyl-CoA reductase 1 {ECO:0000305|PubMed:15220348},Male sterility domain-containing protein 2 {ECO:0000312|HGNC:HGNC:26222};, PF07993;PF03015;, GO:0005779;GO:0043231;GO:0005778;GO:0005777;GO:0102965;GO:0080019;GO:0008611;GO:0046474;GO:0035336;GO:0010025;, C:integral component of peroxisomal membrane; C:intracellular membrane-bounded organelle; C:peroxisomal membrane; C:peroxisome;, F:alcohol-forming fatty acyl-CoA reductase activity; F:fatty-acyl-CoA reductase (alcohol-forming) activity;, P:ether lipid biosynthetic process; P:glycerophospholipid biosynthetic process; P:long-chain fatty-acyl-CoA metabolic process; P:wax biosynthetic process;|Q8WVX9 D3DQW8 Q5CZA3,Fatty acyl-CoA reductase 1 {ECO:0000305|PubMed:15220348},Male sterility domain-containing protein 2 {ECO:0000312|HGNC:HGNC:26222};, PF07993;PF03015;, GO:0005779;GO:0043231;GO:0005778;GO:0005777;GO:0102965;GO:0080019;GO:0008611;GO:0046474;GO:0035336;GO:0010025;, C:integral component of peroxisomal membrane; C:intracellular membrane-bounded organelle; C:peroxisomal membrane; C:peroxisome;, F:alcohol-forming fatty acyl-CoA reductase activity; F:fatty-acyl-CoA reductase (alcohol-forming) activity;, P:ether lipid biosynthetic process; P:glycerophospholipid biosynthetic process; P:long-chain fatty-acyl-CoA metabolic process; P:wax biosynthetic process;|Q8WVX9 D3DQW8 Q5CZA3,Fatty acyl-CoA reductase 1 {ECO:0000305|PubMed:15220348},Male sterility domain-containing protein 2 {ECO:0000312|HGNC:HGNC:26222};, PF07993;PF03015;, GO:0005779;GO:0043231;GO:0005778;GO:0005777;GO:0102965;GO:0080019;GO:0008611;GO:0046474;GO:0035336;GO:0010025;, C:integral component of peroxisomal membrane; C:intracellular membrane-bounded organelle; C:peroxisomal membrane; C:peroxisome;, F:alcohol-forming fatty acyl-CoA reductase activity; F:fatty-acyl-CoA reductase (alcohol-forming) activity;, P:ether lipid biosynthetic process; P:glycerophospholipid biosynthetic process; P:long-chain fatty-acyl-CoA metabolic process; P:wax biosynthetic process; scaffold69 indexed_genome mRNA 3301862 3313935 . + . ID=transcript_11200;Q8WVX9 D3DQW8 Q5CZA3,Fatty acyl-CoA reductase 1 {ECO:0000305|PubMed:15220348},Male sterility domain-containing protein 2 {ECO:0000312|HGNC:HGNC:26222};, PF07993;PF03015;, GO:0005779;GO:0043231;GO:0005778;GO:0005777;GO:0102965;GO:0080019;GO:0008611;GO:0046474;GO:0035336;GO:0010025;, C:integral component of peroxisomal membrane; C:intracellular membrane-bounded organelle; C:peroxisomal membrane; C:peroxisome;, F:alcohol-forming fatty acyl-CoA reductase activity; F:fatty-acyl-CoA reductase (alcohol-forming) activity;, P:ether lipid biosynthetic process; P:glycerophospholipid biosynthetic process; P:long-chain fatty-acyl-CoA metabolic process; P:wax biosynthetic process; scaffold69 indexed_genome mRNA 3753559 3754155 . + . ID=transcript_11201;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold69 indexed_genome mRNA 3804676 3806607 . - . ID=transcript_11202;Q9HCB6 A8K6W5 O94862 Q8NCD7 Q8WUR5,Spondin-1,F-spondin;Vascular smooth muscle cell growth-promoting factor;, PF02014;PF06468;PF19028;PF00090;, GO:0005788;GO:0031012;GO:0005615;GO:0005201;GO:0050693;GO:0046872;GO:0007155;GO:1902430;GO:1902993;GO:0032092;GO:0010954;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular space;, F:extracellular matrix structural constituent; F:LBD domain binding; F:metal ion binding;, P:cell adhesion; P:negative regulation of amyloid-beta formation; P:positive regulation of amyloid precursor protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein processing; scaffold69 indexed_genome mRNA 3807745 3817068 . + . ID=transcript_11203;Q9HCB6 A8K6W5 O94862 Q8NCD7 Q8WUR5,Spondin-1,F-spondin;Vascular smooth muscle cell growth-promoting factor;, PF02014;PF06468;PF19028;PF00090;, GO:0005788;GO:0031012;GO:0005615;GO:0005201;GO:0050693;GO:0046872;GO:0007155;GO:1902430;GO:1902993;GO:0032092;GO:0010954;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular space;, F:extracellular matrix structural constituent; F:LBD domain binding; F:metal ion binding;, P:cell adhesion; P:negative regulation of amyloid-beta formation; P:positive regulation of amyloid precursor protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein processing;|Q9HCB6 A8K6W5 O94862 Q8NCD7 Q8WUR5,Spondin-1,F-spondin;Vascular smooth muscle cell growth-promoting factor;, PF02014;PF06468;PF19028;PF00090;, GO:0005788;GO:0031012;GO:0005615;GO:0005201;GO:0050693;GO:0046872;GO:0007155;GO:1902430;GO:1902993;GO:0032092;GO:0010954;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular space;, F:extracellular matrix structural constituent; F:LBD domain binding; F:metal ion binding;, P:cell adhesion; P:negative regulation of amyloid-beta formation; P:positive regulation of amyloid precursor protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein processing; scaffold69 indexed_genome mRNA 3830363 3912573 . - . ID=transcript_11204;P62070 B2R9Z3 B7Z5Z2 B7Z6C4 B7Z7H6 P17082,Ras-related protein R-Ras2,Ras-like protein TC21;Teratocarcinoma oncogene;, PF00071;, GO:0005783;GO:0070062;GO:0005925;GO:0000139;GO:0016020;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0001649;GO:0030335;GO:0007265;GO:1901214;, C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:membrane; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:osteoblast differentiation; P:positive regulation of cell migration; P:Ras protein signal transduction; P:regulation of neuron death;|P62070 B2R9Z3 B7Z5Z2 B7Z6C4 B7Z7H6 P17082,Ras-related protein R-Ras2,Ras-like protein TC21;Teratocarcinoma oncogene;, PF00071;, GO:0005783;GO:0070062;GO:0005925;GO:0000139;GO:0016020;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0001649;GO:0030335;GO:0007265;GO:1901214;, C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:membrane; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:osteoblast differentiation; P:positive regulation of cell migration; P:Ras protein signal transduction; P:regulation of neuron death;|P62070 B2R9Z3 B7Z5Z2 B7Z6C4 B7Z7H6 P17082,Ras-related protein R-Ras2,Ras-like protein TC21;Teratocarcinoma oncogene;, PF00071;, GO:0005783;GO:0070062;GO:0005925;GO:0000139;GO:0016020;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0001649;GO:0030335;GO:0007265;GO:1901214;, C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:Golgi membrane; C:membrane; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:osteoblast differentiation; P:positive regulation of cell migration; P:Ras protein signal transduction; P:regulation of neuron death; scaffold69 indexed_genome mRNA 4010322 4044494 . - . ID=transcript_11205;P53618 D3DQX0 Q6GTT7 Q9NTK2 Q9UNW7,Coatomer subunit beta,Beta-coat protein;, PF01602;PF07718;PF14806;, GO:0030126;GO:0005829;GO:0005789;GO:0005793;GO:0101003;GO:0005794;GO:0000139;GO:0005798;GO:0043231;GO:0016020;GO:0005886;GO:0030667;GO:0070821;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0043312;GO:0006890;GO:0016032;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:secretory granule membrane; C:tertiary granule membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:neutrophil degranulation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|P53618 D3DQX0 Q6GTT7 Q9NTK2 Q9UNW7,Coatomer subunit beta,Beta-coat protein;, PF01602;PF07718;PF14806;, GO:0030126;GO:0005829;GO:0005789;GO:0005793;GO:0101003;GO:0005794;GO:0000139;GO:0005798;GO:0043231;GO:0016020;GO:0005886;GO:0030667;GO:0070821;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0043312;GO:0006890;GO:0016032;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:secretory granule membrane; C:tertiary granule membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:neutrophil degranulation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process;|P53618 D3DQX0 Q6GTT7 Q9NTK2 Q9UNW7,Coatomer subunit beta,Beta-coat protein;, PF01602;PF07718;PF14806;, GO:0030126;GO:0005829;GO:0005789;GO:0005793;GO:0101003;GO:0005794;GO:0000139;GO:0005798;GO:0043231;GO:0016020;GO:0005886;GO:0030667;GO:0070821;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0043312;GO:0006890;GO:0016032;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:ficolin-1-rich granule membrane; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane; C:secretory granule membrane; C:tertiary granule membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:neutrophil degranulation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:viral process; scaffold69 indexed_genome mRNA 4052844 4065768 . - . ID=transcript_11206;P25786 A8K400 Q53YE8 Q9BRV9,Proteasome subunit alpha type-1,30 kDa prosomal protein;Macropain subunit C2;Multicatalytic endopeptidase complex subunit C2;Proteasome component C2;Proteasome nu chain;, PF00227;PF10584;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0005844;GO:0000502;GO:0005839;GO:0019773;GO:0004175;GO:0001530;GO:0003723;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0002862;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:polysome; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex;, F:endopeptidase activity; F:lipopolysaccharide binding; F:RNA binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of inflammatory response to antigenic stimulus; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold69 indexed_genome mRNA 4308393 4309141 . - . ID=transcript_11207;Q13370 B7ZM37 O00639 Q14408 Q6SEI4,cGMP-inhibited 3',5'-cyclic phosphodiesterase B,CGIPDE1;Cyclic GMP-inhibited phosphodiesterase B;, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0032045;GO:0016021;GO:0016020;GO:0004115;GO:0004114;GO:0004119;GO:0046872;GO:0043422;GO:0001525;GO:0032869;GO:0007186;GO:0016525;GO:0043951;GO:0007162;GO:0033629;GO:0050995;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:guanyl-nucleotide exchange factor complex; C:integral component of membrane; C:membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity; F:metal ion binding; F:protein kinase B binding;, P:angiogenesis; P:cellular response to insulin stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of angiogenesis; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cell adhesion; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of lipid catabolic process; P:signal transduction; scaffold69 indexed_genome mRNA 4315039 4346318 . - . ID=transcript_11208;Q13370 B7ZM37 O00639 Q14408 Q6SEI4,cGMP-inhibited 3',5'-cyclic phosphodiesterase B,CGIPDE1;Cyclic GMP-inhibited phosphodiesterase B;, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0032045;GO:0016021;GO:0016020;GO:0004115;GO:0004114;GO:0004119;GO:0046872;GO:0043422;GO:0001525;GO:0032869;GO:0007186;GO:0016525;GO:0043951;GO:0007162;GO:0033629;GO:0050995;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:guanyl-nucleotide exchange factor complex; C:integral component of membrane; C:membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity; F:metal ion binding; F:protein kinase B binding;, P:angiogenesis; P:cellular response to insulin stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of angiogenesis; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cell adhesion; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of lipid catabolic process; P:signal transduction;|Q13370 B7ZM37 O00639 Q14408 Q6SEI4,cGMP-inhibited 3',5'-cyclic phosphodiesterase B,CGIPDE1;Cyclic GMP-inhibited phosphodiesterase B;, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0032045;GO:0016021;GO:0016020;GO:0004115;GO:0004114;GO:0004119;GO:0046872;GO:0043422;GO:0001525;GO:0032869;GO:0007186;GO:0016525;GO:0043951;GO:0007162;GO:0033629;GO:0050995;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:guanyl-nucleotide exchange factor complex; C:integral component of membrane; C:membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity; F:metal ion binding; F:protein kinase B binding;, P:angiogenesis; P:cellular response to insulin stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of angiogenesis; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cell adhesion; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of lipid catabolic process; P:signal transduction;|Q13370 B7ZM37 O00639 Q14408 Q6SEI4,cGMP-inhibited 3',5'-cyclic phosphodiesterase B,CGIPDE1;Cyclic GMP-inhibited phosphodiesterase B;, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0032045;GO:0016021;GO:0016020;GO:0004115;GO:0004114;GO:0004119;GO:0046872;GO:0043422;GO:0001525;GO:0032869;GO:0007186;GO:0016525;GO:0043951;GO:0007162;GO:0033629;GO:0050995;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:guanyl-nucleotide exchange factor complex; C:integral component of membrane; C:membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity; F:metal ion binding; F:protein kinase B binding;, P:angiogenesis; P:cellular response to insulin stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of angiogenesis; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cell adhesion; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of lipid catabolic process; P:signal transduction;|Q13370 B7ZM37 O00639 Q14408 Q6SEI4,cGMP-inhibited 3',5'-cyclic phosphodiesterase B,CGIPDE1;Cyclic GMP-inhibited phosphodiesterase B;, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0032045;GO:0016021;GO:0016020;GO:0004115;GO:0004114;GO:0004119;GO:0046872;GO:0043422;GO:0001525;GO:0032869;GO:0007186;GO:0016525;GO:0043951;GO:0007162;GO:0033629;GO:0050995;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:guanyl-nucleotide exchange factor complex; C:integral component of membrane; C:membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity; F:metal ion binding; F:protein kinase B binding;, P:angiogenesis; P:cellular response to insulin stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of angiogenesis; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cell adhesion; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of lipid catabolic process; P:signal transduction;|Q13370 B7ZM37 O00639 Q14408 Q6SEI4,cGMP-inhibited 3',5'-cyclic phosphodiesterase B,CGIPDE1;Cyclic GMP-inhibited phosphodiesterase B;, PF00233;, GO:0005829;GO:0005783;GO:0005794;GO:0032045;GO:0016021;GO:0016020;GO:0004115;GO:0004114;GO:0004119;GO:0046872;GO:0043422;GO:0001525;GO:0032869;GO:0007186;GO:0016525;GO:0043951;GO:0007162;GO:0033629;GO:0050995;GO:0007165;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:guanyl-nucleotide exchange factor complex; C:integral component of membrane; C:membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity; F:metal ion binding; F:protein kinase B binding;, P:angiogenesis; P:cellular response to insulin stimulus; P:G protein-coupled receptor signaling pathway; P:negative regulation of angiogenesis; P:negative regulation of cAMP-mediated signaling; P:negative regulation of cell adhesion; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of lipid catabolic process; P:signal transduction; scaffold69 indexed_genome mRNA 4362100 4368289 . - . ID=transcript_11209;Q6VVX0 Q2M3H3 Q5RT65,Vitamin D 25-hydroxylase {ECO:0000303|PubMed:12867411},Cytochrome P450 2R1;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:1902271;GO:0020037;GO:0005506;GO:0016712;GO:0042803;GO:0008395;GO:0030343;GO:0036378;GO:0042738;GO:0006082;GO:0010164;GO:0010212;GO:0042359;GO:0006766;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:D3 vitamins binding; F:heme binding; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:protein homodimerization activity; F:steroid hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:calcitriol biosynthetic process from calciol; P:exogenous drug catabolic process; P:organic acid metabolic process; P:response to cesium ion; P:response to ionizing radiation; P:vitamin D metabolic process; P:vitamin metabolic process; P:xenobiotic metabolic process;|Q6VVX0 Q2M3H3 Q5RT65,Vitamin D 25-hydroxylase {ECO:0000303|PubMed:12867411},Cytochrome P450 2R1;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:1902271;GO:0020037;GO:0005506;GO:0016712;GO:0042803;GO:0008395;GO:0030343;GO:0036378;GO:0042738;GO:0006082;GO:0010164;GO:0010212;GO:0042359;GO:0006766;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:D3 vitamins binding; F:heme binding; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:protein homodimerization activity; F:steroid hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:calcitriol biosynthetic process from calciol; P:exogenous drug catabolic process; P:organic acid metabolic process; P:response to cesium ion; P:response to ionizing radiation; P:vitamin D metabolic process; P:vitamin metabolic process; P:xenobiotic metabolic process; scaffold69 indexed_genome mRNA 5649118 5731214 . - . ID=transcript_11210;P35712 Q86VX7 Q9BXQ3 Q9BXQ4 Q9BXQ5 Q9H0I8,Transcription factor SOX-6 {ECO:0000305},, PF00505;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001217;GO:0000978;GO:0000976;GO:0048708;GO:0001502;GO:0051216;GO:0045165;GO:0071560;GO:0007417;GO:0002062;GO:0007517;GO:2000726;GO:0061036;GO:0032332;GO:2000741;GO:0006357;GO:0006355;GO:0021529;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:astrocyte differentiation; P:cartilage condensation; P:cartilage development; P:cell fate commitment; P:cellular response to transforming growth factor beta stimulus; P:central nervous system development; P:chondrocyte differentiation; P:muscle organ development; P:negative regulation of cardiac muscle cell differentiation; P:positive regulation of cartilage development; P:positive regulation of chondrocyte differentiation; P:positive regulation of mesenchymal stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spinal cord oligodendrocyte cell differentiation; scaffold69 indexed_genome mRNA 5731302 5925026 . - . ID=transcript_11211;P35712 Q86VX7 Q9BXQ3 Q9BXQ4 Q9BXQ5 Q9H0I8,Transcription factor SOX-6 {ECO:0000305},, PF00505;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001217;GO:0000978;GO:0000976;GO:0048708;GO:0001502;GO:0051216;GO:0045165;GO:0071560;GO:0007417;GO:0002062;GO:0007517;GO:2000726;GO:0061036;GO:0032332;GO:2000741;GO:0006357;GO:0006355;GO:0021529;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:astrocyte differentiation; P:cartilage condensation; P:cartilage development; P:cell fate commitment; P:cellular response to transforming growth factor beta stimulus; P:central nervous system development; P:chondrocyte differentiation; P:muscle organ development; P:negative regulation of cardiac muscle cell differentiation; P:positive regulation of cartilage development; P:positive regulation of chondrocyte differentiation; P:positive regulation of mesenchymal stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spinal cord oligodendrocyte cell differentiation; scaffold69 indexed_genome mRNA 6412788 6439335 . + . ID=transcript_11212;O00193 B2RD28,Small acidic protein,, PF15477;|O00193 B2RD28,Small acidic protein,, PF15477; scaffold69 indexed_genome mRNA 6446220 6484646 . - . ID=transcript_11213;Q6IQ23 B4DK33 B4DWC3 Q86VZ7,Pleckstrin homology domain-containing family A member 7,, PF00169;, GO:0030054;GO:0005813;GO:0005829;GO:0070062;GO:0005654;GO:0046930;GO:0005915;GO:0070097;GO:0044331;GO:0090136;GO:0046931;GO:0045218;, C:cell junction; C:centrosome; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:pore complex; C:zonula adherens;, F:delta-catenin binding;, P:cell-cell adhesion mediated by cadherin; P:epithelial cell-cell adhesion; P:pore complex assembly; P:zonula adherens maintenance;|Q6IQ23 B4DK33 B4DWC3 Q86VZ7,Pleckstrin homology domain-containing family A member 7,, PF00169;, GO:0030054;GO:0005813;GO:0005829;GO:0070062;GO:0005654;GO:0046930;GO:0005915;GO:0070097;GO:0044331;GO:0090136;GO:0046931;GO:0045218;, C:cell junction; C:centrosome; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:pore complex; C:zonula adherens;, F:delta-catenin binding;, P:cell-cell adhesion mediated by cadherin; P:epithelial cell-cell adhesion; P:pore complex assembly; P:zonula adherens maintenance; scaffold69 indexed_genome mRNA 6484649 6519598 . - . ID=transcript_11214;Q6IQ23 B4DK33 B4DWC3 Q86VZ7,Pleckstrin homology domain-containing family A member 7,, PF00169;, GO:0030054;GO:0005813;GO:0005829;GO:0070062;GO:0005654;GO:0046930;GO:0005915;GO:0070097;GO:0044331;GO:0090136;GO:0046931;GO:0045218;, C:cell junction; C:centrosome; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:pore complex; C:zonula adherens;, F:delta-catenin binding;, P:cell-cell adhesion mediated by cadherin; P:epithelial cell-cell adhesion; P:pore complex assembly; P:zonula adherens maintenance;|Q6IQ23 B4DK33 B4DWC3 Q86VZ7,Pleckstrin homology domain-containing family A member 7,, PF00169;, GO:0030054;GO:0005813;GO:0005829;GO:0070062;GO:0005654;GO:0046930;GO:0005915;GO:0070097;GO:0044331;GO:0090136;GO:0046931;GO:0045218;, C:cell junction; C:centrosome; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:pore complex; C:zonula adherens;, F:delta-catenin binding;, P:cell-cell adhesion mediated by cadherin; P:epithelial cell-cell adhesion; P:pore complex assembly; P:zonula adherens maintenance; scaffold69 indexed_genome mRNA 6711914 6722210 . - . ID=transcript_11215;O00443 B0LPH2 B4E2G4 Q14CQ9,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha,Phosphoinositide 3-kinase-C2-alpha;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0030136;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0005802;GO:0031982;GO:0016303;GO:0035005;GO:0005524;GO:0030276;GO:0035004;GO:0035091;GO:0052742;GO:0052812;GO:0046934;GO:0016477;GO:0048268;GO:0006897;GO:0007173;GO:0006887;GO:0008286;GO:0061024;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0048008;GO:0010508;GO:0090050;GO:0014829;, C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane; C:trans-Golgi network; C:vesicle;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:clathrin binding; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:cell migration; P:clathrin coat assembly; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:exocytosis; P:insulin receptor signaling pathway; P:membrane organization; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:vascular associated smooth muscle contraction;|O00443 B0LPH2 B4E2G4 Q14CQ9,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha,Phosphoinositide 3-kinase-C2-alpha;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0030136;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0005802;GO:0031982;GO:0016303;GO:0035005;GO:0005524;GO:0030276;GO:0035004;GO:0035091;GO:0052742;GO:0052812;GO:0046934;GO:0016477;GO:0048268;GO:0006897;GO:0007173;GO:0006887;GO:0008286;GO:0061024;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0048008;GO:0010508;GO:0090050;GO:0014829;, C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane; C:trans-Golgi network; C:vesicle;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:clathrin binding; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:cell migration; P:clathrin coat assembly; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:exocytosis; P:insulin receptor signaling pathway; P:membrane organization; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:vascular associated smooth muscle contraction;|O00443 B0LPH2 B4E2G4 Q14CQ9,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha,Phosphoinositide 3-kinase-C2-alpha;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0030136;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0005802;GO:0031982;GO:0016303;GO:0035005;GO:0005524;GO:0030276;GO:0035004;GO:0035091;GO:0052742;GO:0052812;GO:0046934;GO:0016477;GO:0048268;GO:0006897;GO:0007173;GO:0006887;GO:0008286;GO:0061024;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0048008;GO:0010508;GO:0090050;GO:0014829;, C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane; C:trans-Golgi network; C:vesicle;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:clathrin binding; F:phosphatidylinositol 3-kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity; F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity;, P:cell migration; P:clathrin coat assembly; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:exocytosis; P:insulin receptor signaling pathway; P:membrane organization; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of autophagy; P:positive regulation of cell migration involved in sprouting angiogenesis; P:vascular associated smooth muscle contraction; scaffold69 indexed_genome mRNA 6995832 7003382 . - . ID=transcript_11216;Q09428 A6NMX8 E3UYX6 O75948 Q16583,ATP-binding cassette sub-family C member 8,Sulfonylurea receptor 1;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0008281;GO:0098662;GO:0071805;GO:0006813;GO:0050796;GO:0055085;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:sulfonylurea receptor activity;, P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of insulin secretion; P:transmembrane transport;|Q09428 A6NMX8 E3UYX6 O75948 Q16583,ATP-binding cassette sub-family C member 8,Sulfonylurea receptor 1;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0008281;GO:0098662;GO:0071805;GO:0006813;GO:0050796;GO:0055085;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:sulfonylurea receptor activity;, P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of insulin secretion; P:transmembrane transport;|Q09428 A6NMX8 E3UYX6 O75948 Q16583,ATP-binding cassette sub-family C member 8,Sulfonylurea receptor 1;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0008281;GO:0098662;GO:0071805;GO:0006813;GO:0050796;GO:0055085;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:sulfonylurea receptor activity;, P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of insulin secretion; P:transmembrane transport; scaffold69 indexed_genome mRNA 7006209 7074201 . + . ID=transcript_11217;Q09428 A6NMX8 E3UYX6 O75948 Q16583,ATP-binding cassette sub-family C member 8,Sulfonylurea receptor 1;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0008281;GO:0098662;GO:0071805;GO:0006813;GO:0050796;GO:0055085;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:sulfonylurea receptor activity;, P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of insulin secretion; P:transmembrane transport;|Q09428 A6NMX8 E3UYX6 O75948 Q16583,ATP-binding cassette sub-family C member 8,Sulfonylurea receptor 1;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0008281;GO:0098662;GO:0071805;GO:0006813;GO:0050796;GO:0055085;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:sulfonylurea receptor activity;, P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of insulin secretion; P:transmembrane transport;|Q09428 A6NMX8 E3UYX6 O75948 Q16583,ATP-binding cassette sub-family C member 8,Sulfonylurea receptor 1;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0008281;GO:0098662;GO:0071805;GO:0006813;GO:0050796;GO:0055085;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:sulfonylurea receptor activity;, P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of insulin secretion; P:transmembrane transport;|Q09428 A6NMX8 E3UYX6 O75948 Q16583,ATP-binding cassette sub-family C member 8,Sulfonylurea receptor 1;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0008281;GO:0098662;GO:0071805;GO:0006813;GO:0050796;GO:0055085;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:sulfonylurea receptor activity;, P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of insulin secretion; P:transmembrane transport;|Q09428 A6NMX8 E3UYX6 O75948 Q16583,ATP-binding cassette sub-family C member 8,Sulfonylurea receptor 1;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0008281;GO:0098662;GO:0071805;GO:0006813;GO:0050796;GO:0055085;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:sulfonylurea receptor activity;, P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of insulin secretion; P:transmembrane transport;|Q09428 A6NMX8 E3UYX6 O75948 Q16583,ATP-binding cassette sub-family C member 8,Sulfonylurea receptor 1;, PF00664;PF00005;, GO:0008282;GO:0016020;GO:0005886;GO:0031004;GO:0005524;GO:0016887;GO:0019829;GO:0042626;GO:0044325;GO:0005267;GO:0008281;GO:0098662;GO:0071805;GO:0006813;GO:0050796;GO:0055085;, C:inward rectifying potassium channel; C:membrane; C:plasma membrane; C:potassium ion-transporting ATPase complex;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; F:ion channel binding; F:potassium channel activity; F:sulfonylurea receptor activity;, P:inorganic cation transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of insulin secretion; P:transmembrane transport; scaffold69 indexed_genome mRNA 7094379 7142494 . - . ID=transcript_11218;Q9Y6N9 A8K423 Q7RTU8 Q96B29 Q9UM04 Q9UM17 Q9UPC3,Harmonin,Antigen NY-CO-38/NY-CO-37;Autoimmune enteropathy-related antigen AIE-75;Protein PDZ-73;Renal carcinoma antigen NY-REN-3;Usher syndrome type-1C protein;, PF00595;, GO:0045177;GO:0005903;GO:0005737;GO:0005856;GO:0005829;GO:0005902;GO:0001917;GO:0001750;GO:0005886;GO:0002142;GO:0032420;GO:0032426;GO:0045202;GO:0051015;GO:0030507;GO:0051017;GO:1904970;GO:0034622;GO:0050957;GO:0000086;GO:0042491;GO:0042472;GO:0060122;GO:0030046;GO:0045494;GO:1904106;GO:0032532;GO:0046549;GO:0050953;GO:0007605;, C:apical part of cell; C:brush border; C:cytoplasm; C:cytoskeleton; C:cytosol; C:microvillus; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:synapse;, F:actin filament binding; F:spectrin binding;, P:actin filament bundle assembly; P:brush border assembly; P:cellular protein-containing complex assembly; P:equilibrioception; P:G2/M transition of mitotic cell cycle; P:inner ear auditory receptor cell differentiation; P:inner ear morphogenesis; P:inner ear receptor cell stereocilium organization; P:parallel actin filament bundle assembly; P:photoreceptor cell maintenance; P:protein localization to microvillus; P:regulation of microvillus length; P:retinal cone cell development; P:sensory perception of light stimulus; P:sensory perception of sound;|Q9Y6N9 A8K423 Q7RTU8 Q96B29 Q9UM04 Q9UM17 Q9UPC3,Harmonin,Antigen NY-CO-38/NY-CO-37;Autoimmune enteropathy-related antigen AIE-75;Protein PDZ-73;Renal carcinoma antigen NY-REN-3;Usher syndrome type-1C protein;, PF00595;, GO:0045177;GO:0005903;GO:0005737;GO:0005856;GO:0005829;GO:0005902;GO:0001917;GO:0001750;GO:0005886;GO:0002142;GO:0032420;GO:0032426;GO:0045202;GO:0051015;GO:0030507;GO:0051017;GO:1904970;GO:0034622;GO:0050957;GO:0000086;GO:0042491;GO:0042472;GO:0060122;GO:0030046;GO:0045494;GO:1904106;GO:0032532;GO:0046549;GO:0050953;GO:0007605;, C:apical part of cell; C:brush border; C:cytoplasm; C:cytoskeleton; C:cytosol; C:microvillus; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:synapse;, F:actin filament binding; F:spectrin binding;, P:actin filament bundle assembly; P:brush border assembly; P:cellular protein-containing complex assembly; P:equilibrioception; P:G2/M transition of mitotic cell cycle; P:inner ear auditory receptor cell differentiation; P:inner ear morphogenesis; P:inner ear receptor cell stereocilium organization; P:parallel actin filament bundle assembly; P:photoreceptor cell maintenance; P:protein localization to microvillus; P:regulation of microvillus length; P:retinal cone cell development; P:sensory perception of light stimulus; P:sensory perception of sound;|Q9Y6N9 A8K423 Q7RTU8 Q96B29 Q9UM04 Q9UM17 Q9UPC3,Harmonin,Antigen NY-CO-38/NY-CO-37;Autoimmune enteropathy-related antigen AIE-75;Protein PDZ-73;Renal carcinoma antigen NY-REN-3;Usher syndrome type-1C protein;, PF00595;, GO:0045177;GO:0005903;GO:0005737;GO:0005856;GO:0005829;GO:0005902;GO:0001917;GO:0001750;GO:0005886;GO:0002142;GO:0032420;GO:0032426;GO:0045202;GO:0051015;GO:0030507;GO:0051017;GO:1904970;GO:0034622;GO:0050957;GO:0000086;GO:0042491;GO:0042472;GO:0060122;GO:0030046;GO:0045494;GO:1904106;GO:0032532;GO:0046549;GO:0050953;GO:0007605;, C:apical part of cell; C:brush border; C:cytoplasm; C:cytoskeleton; C:cytosol; C:microvillus; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:synapse;, F:actin filament binding; F:spectrin binding;, P:actin filament bundle assembly; P:brush border assembly; P:cellular protein-containing complex assembly; P:equilibrioception; P:G2/M transition of mitotic cell cycle; P:inner ear auditory receptor cell differentiation; P:inner ear morphogenesis; P:inner ear receptor cell stereocilium organization; P:parallel actin filament bundle assembly; P:photoreceptor cell maintenance; P:protein localization to microvillus; P:regulation of microvillus length; P:retinal cone cell development; P:sensory perception of light stimulus; P:sensory perception of sound;|Q9Y6N9 A8K423 Q7RTU8 Q96B29 Q9UM04 Q9UM17 Q9UPC3,Harmonin,Antigen NY-CO-38/NY-CO-37;Autoimmune enteropathy-related antigen AIE-75;Protein PDZ-73;Renal carcinoma antigen NY-REN-3;Usher syndrome type-1C protein;, PF00595;, GO:0045177;GO:0005903;GO:0005737;GO:0005856;GO:0005829;GO:0005902;GO:0001917;GO:0001750;GO:0005886;GO:0002142;GO:0032420;GO:0032426;GO:0045202;GO:0051015;GO:0030507;GO:0051017;GO:1904970;GO:0034622;GO:0050957;GO:0000086;GO:0042491;GO:0042472;GO:0060122;GO:0030046;GO:0045494;GO:1904106;GO:0032532;GO:0046549;GO:0050953;GO:0007605;, C:apical part of cell; C:brush border; C:cytoplasm; C:cytoskeleton; C:cytosol; C:microvillus; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:synapse;, F:actin filament binding; F:spectrin binding;, P:actin filament bundle assembly; P:brush border assembly; P:cellular protein-containing complex assembly; P:equilibrioception; P:G2/M transition of mitotic cell cycle; P:inner ear auditory receptor cell differentiation; P:inner ear morphogenesis; P:inner ear receptor cell stereocilium organization; P:parallel actin filament bundle assembly; P:photoreceptor cell maintenance; P:protein localization to microvillus; P:regulation of microvillus length; P:retinal cone cell development; P:sensory perception of light stimulus; P:sensory perception of sound;|Q9Y6N9 A8K423 Q7RTU8 Q96B29 Q9UM04 Q9UM17 Q9UPC3,Harmonin,Antigen NY-CO-38/NY-CO-37;Autoimmune enteropathy-related antigen AIE-75;Protein PDZ-73;Renal carcinoma antigen NY-REN-3;Usher syndrome type-1C protein;, PF00595;, GO:0045177;GO:0005903;GO:0005737;GO:0005856;GO:0005829;GO:0005902;GO:0001917;GO:0001750;GO:0005886;GO:0002142;GO:0032420;GO:0032426;GO:0045202;GO:0051015;GO:0030507;GO:0051017;GO:1904970;GO:0034622;GO:0050957;GO:0000086;GO:0042491;GO:0042472;GO:0060122;GO:0030046;GO:0045494;GO:1904106;GO:0032532;GO:0046549;GO:0050953;GO:0007605;, C:apical part of cell; C:brush border; C:cytoplasm; C:cytoskeleton; C:cytosol; C:microvillus; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:synapse;, F:actin filament binding; F:spectrin binding;, P:actin filament bundle assembly; P:brush border assembly; P:cellular protein-containing complex assembly; P:equilibrioception; P:G2/M transition of mitotic cell cycle; P:inner ear auditory receptor cell differentiation; P:inner ear morphogenesis; P:inner ear receptor cell stereocilium organization; P:parallel actin filament bundle assembly; P:photoreceptor cell maintenance; P:protein localization to microvillus; P:regulation of microvillus length; P:retinal cone cell development; P:sensory perception of light stimulus; P:sensory perception of sound;|Q9Y6N9 A8K423 Q7RTU8 Q96B29 Q9UM04 Q9UM17 Q9UPC3,Harmonin,Antigen NY-CO-38/NY-CO-37;Autoimmune enteropathy-related antigen AIE-75;Protein PDZ-73;Renal carcinoma antigen NY-REN-3;Usher syndrome type-1C protein;, PF00595;, GO:0045177;GO:0005903;GO:0005737;GO:0005856;GO:0005829;GO:0005902;GO:0001917;GO:0001750;GO:0005886;GO:0002142;GO:0032420;GO:0032426;GO:0045202;GO:0051015;GO:0030507;GO:0051017;GO:1904970;GO:0034622;GO:0050957;GO:0000086;GO:0042491;GO:0042472;GO:0060122;GO:0030046;GO:0045494;GO:1904106;GO:0032532;GO:0046549;GO:0050953;GO:0007605;, C:apical part of cell; C:brush border; C:cytoplasm; C:cytoskeleton; C:cytosol; C:microvillus; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:stereocilia ankle link complex; C:stereocilium; C:stereocilium tip; C:synapse;, F:actin filament binding; F:spectrin binding;, P:actin filament bundle assembly; P:brush border assembly; P:cellular protein-containing complex assembly; P:equilibrioception; P:G2/M transition of mitotic cell cycle; P:inner ear auditory receptor cell differentiation; P:inner ear morphogenesis; P:inner ear receptor cell stereocilium organization; P:parallel actin filament bundle assembly; P:photoreceptor cell maintenance; P:protein localization to microvillus; P:regulation of microvillus length; P:retinal cone cell development; P:sensory perception of light stimulus; P:sensory perception of sound; scaffold69 indexed_genome mRNA 7202062 7202872 . + . ID=transcript_11219;Q6ZRI0 A8MTX6 A8MUJ0 B7WPC4,Otogelin,, PF05270;PF08742;PF01826;PF00094;, GO:0016324;GO:0005829;GO:0031012;GO:0005615;GO:0046556;GO:0005198;GO:0008344;GO:0046373;GO:0007605;, C:apical plasma membrane; C:cytosol; C:extracellular matrix; C:extracellular space;, F:alpha-L-arabinofuranosidase activity; F:structural molecule activity;, P:adult locomotory behavior; P:L-arabinose metabolic process; P:sensory perception of sound; scaffold69 indexed_genome mRNA 7203672 7206885 . + . ID=transcript_11220;Q6ZRI0 A8MTX6 A8MUJ0 B7WPC4,Otogelin,, PF05270;PF08742;PF01826;PF00094;, GO:0016324;GO:0005829;GO:0031012;GO:0005615;GO:0046556;GO:0005198;GO:0008344;GO:0046373;GO:0007605;, C:apical plasma membrane; C:cytosol; C:extracellular matrix; C:extracellular space;, F:alpha-L-arabinofuranosidase activity; F:structural molecule activity;, P:adult locomotory behavior; P:L-arabinose metabolic process; P:sensory perception of sound; scaffold69 indexed_genome mRNA 7296219 7297627 . + . ID=transcript_11221;P15172 O75321,Myoblast determination protein 1,Class C basic helix-loop-helix protein 1;Myogenic factor 3;, PF01586;PF00010;PF12232;, GO:0000785;GO:0000791;GO:0030016;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0031490;GO:0001228;GO:0000981;GO:0070888;GO:0035257;GO:1990841;GO:0042803;GO:0001102;GO:0000978;GO:0000977;GO:1990837;GO:0031625;GO:0071392;GO:0071385;GO:0071453;GO:0009267;GO:0071356;GO:0043966;GO:0043967;GO:0042693;GO:0007517;GO:0007518;GO:0007520;GO:0014904;GO:0014908;GO:0035562;GO:2000818;GO:0051099;GO:0051149;GO:0045663;GO:1901741;GO:0048743;GO:0043415;GO:1905382;GO:0045944;GO:0006468;GO:0000381;GO:0043484;GO:0006357;GO:0035914;GO:0043503;GO:0048741;GO:0007519;, C:chromatin; C:euchromatin; C:myofibril; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:chromatin DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:nuclear hormone receptor binding; F:promoter-specific chromatin binding; F:protein homodimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:ubiquitin protein ligase binding;, P:cellular response to estradiol stimulus; P:cellular response to glucocorticoid stimulus; P:cellular response to oxygen levels; P:cellular response to starvation; P:cellular response to tumor necrosis factor; P:histone H3 acetylation; P:histone H4 acetylation; P:muscle cell fate commitment; P:muscle organ development; P:myoblast fate determination; P:myoblast fusion; P:myotube cell development; P:myotube differentiation involved in skeletal muscle regeneration; P:negative regulation of chromatin binding; P:negative regulation of myoblast proliferation; P:positive regulation of binding; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of myoblast fusion; P:positive regulation of skeletal muscle fiber development; P:positive regulation of skeletal muscle tissue regeneration; P:positive regulation of snRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; P:skeletal muscle fiber adaptation; P:skeletal muscle fiber development; P:skeletal muscle tissue development; scaffold69 indexed_genome mRNA 7317662 7352921 . + . ID=transcript_11222;P48547 K4DI87,Potassium voltage-gated channel subfamily C member 1,NGK2;Voltage-gated potassium channel subunit Kv3.1;Voltage-gated potassium channel subunit Kv4;, PF02214;PF00520;, GO:0030424;GO:0032590;GO:0016021;GO:0032809;GO:0005886;GO:0042734;GO:0008076;GO:0005251;GO:0005249;GO:0071805;GO:0006813;GO:0051260;GO:0051262;GO:0034765;, C:axon; C:dendrite membrane; C:integral component of membrane; C:neuronal cell body membrane; C:plasma membrane; C:presynaptic membrane; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:protein tetramerization; P:regulation of ion transmembrane transport; scaffold69 indexed_genome mRNA 7352931 7361344 . + . ID=transcript_11223;Q14003,Potassium voltage-gated channel subfamily C member 3,KSHIIID;Voltage-gated potassium channel subunit Kv3.3;, PF02214;PF00520;PF11404;, GO:0030424;GO:0005938;GO:0005856;GO:0032590;GO:0032591;GO:0016021;GO:0032809;GO:0043204;GO:0005886;GO:0045211;GO:0042734;GO:0008076;GO:0005251;GO:0005249;GO:0071805;GO:0051260;GO:0051262;GO:0034765;, C:axon; C:cell cortex; C:cytoskeleton; C:dendrite membrane; C:dendritic spine membrane; C:integral component of membrane; C:neuronal cell body membrane; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:protein homooligomerization; P:protein tetramerization; P:regulation of ion transmembrane transport; scaffold69 indexed_genome mRNA 7367299 7597635 . - . ID=transcript_11224;Q9UGK8 Q9UGK9,Secretion-regulating guanine nucleotide exchange factor,Deafness locus-associated putative guanine nucleotide exchange factor;Guanine nucleotide exchange factor-related protein;, PF00415;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005085;GO:0050709;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:guanyl-nucleotide exchange factor activity;, P:negative regulation of protein secretion; P:signal transduction; scaffold69 indexed_genome mRNA 7646196 7671423 . - . ID=transcript_11225;Q96ER3 A6NH05,Protein SAAL1,Synoviocyte proliferation-associated in collagen-induced arthritis protein 1 {ECO:0000303|PubMed:22127701};, , GO:0005654;GO:0005634;GO:1901647;, C:nucleoplasm; C:nucleus;, , P:positive regulation of synoviocyte proliferation;|Q96ER3 A6NH05,Protein SAAL1,Synoviocyte proliferation-associated in collagen-induced arthritis protein 1 {ECO:0000303|PubMed:22127701};, , GO:0005654;GO:0005634;GO:1901647;, C:nucleoplasm; C:nucleus;, , P:positive regulation of synoviocyte proliferation; scaffold69 indexed_genome mRNA 7752703 7758988 . + . ID=transcript_11226;O95125 B0LPH9 Q4JG21 Q9H1B9 Q9NSM4,Zinc finger protein 202,Zinc finger protein with KRAB and SCAN domains 10;, PF01352;PF02023;PF00096;, GO:0005694;GO:0016604;GO:0005730;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0006629;GO:0000122;GO:0006357;, C:chromosome; C:nuclear body; C:nucleolus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:lipid metabolic process; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold69 indexed_genome mRNA 7819555 7836085 . + . ID=transcript_11227;Q9NY72 A5H1I5 Q17RL3 Q9ULR2,Sodium channel subunit beta-3,, PF07686;, GO:0016021;GO:0005886;GO:0001518;GO:0030018;GO:0044325;GO:0019871;GO:0017080;GO:0005244;GO:0086006;GO:0086014;GO:0086002;GO:0060048;GO:0051899;GO:0086010;GO:0086012;GO:0007399;GO:0010460;GO:0010765;GO:0072659;GO:0060371;GO:0086091;GO:2000649;GO:0060373;GO:0086015;GO:0019233;GO:0035725;GO:0006814;GO:0086005;, C:integral component of membrane; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:ion channel binding; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential;, P:atrial cardiac muscle cell action potential; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:membrane depolarization; P:membrane depolarization during action potential; P:membrane depolarization during cardiac muscle cell action potential; P:nervous system development; P:positive regulation of heart rate; P:positive regulation of sodium ion transport; P:protein localization to plasma membrane; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:SA node cell action potential; P:sensory perception of pain; P:sodium ion transmembrane transport; P:sodium ion transport; P:ventricular cardiac muscle cell action potential;|Q9NY72 A5H1I5 Q17RL3 Q9ULR2,Sodium channel subunit beta-3,, PF07686;, GO:0016021;GO:0005886;GO:0001518;GO:0030018;GO:0044325;GO:0019871;GO:0017080;GO:0005244;GO:0086006;GO:0086014;GO:0086002;GO:0060048;GO:0051899;GO:0086010;GO:0086012;GO:0007399;GO:0010460;GO:0010765;GO:0072659;GO:0060371;GO:0086091;GO:2000649;GO:0060373;GO:0086015;GO:0019233;GO:0035725;GO:0006814;GO:0086005;, C:integral component of membrane; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:ion channel binding; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential;, P:atrial cardiac muscle cell action potential; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:membrane depolarization; P:membrane depolarization during action potential; P:membrane depolarization during cardiac muscle cell action potential; P:nervous system development; P:positive regulation of heart rate; P:positive regulation of sodium ion transport; P:protein localization to plasma membrane; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:SA node cell action potential; P:sensory perception of pain; P:sodium ion transmembrane transport; P:sodium ion transport; P:ventricular cardiac muscle cell action potential;|Q9NY72 A5H1I5 Q17RL3 Q9ULR2,Sodium channel subunit beta-3,, PF07686;, GO:0016021;GO:0005886;GO:0001518;GO:0030018;GO:0044325;GO:0019871;GO:0017080;GO:0005244;GO:0086006;GO:0086014;GO:0086002;GO:0060048;GO:0051899;GO:0086010;GO:0086012;GO:0007399;GO:0010460;GO:0010765;GO:0072659;GO:0060371;GO:0086091;GO:2000649;GO:0060373;GO:0086015;GO:0019233;GO:0035725;GO:0006814;GO:0086005;, C:integral component of membrane; C:plasma membrane; C:voltage-gated sodium channel complex; C:Z disc;, F:ion channel binding; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential;, P:atrial cardiac muscle cell action potential; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:membrane depolarization; P:membrane depolarization during action potential; P:membrane depolarization during cardiac muscle cell action potential; P:nervous system development; P:positive regulation of heart rate; P:positive regulation of sodium ion transport; P:protein localization to plasma membrane; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:SA node cell action potential; P:sensory perception of pain; P:sodium ion transmembrane transport; P:sodium ion transport; P:ventricular cardiac muscle cell action potential; scaffold69 indexed_genome mRNA 7837525 7842810 . - . ID=transcript_11228;Q3KR37 B3KXJ5 E7EPH8 Q6UW85 Q9ULL9,Protein Aster-B {ECO:0000250|UniProtKB:Q80TI0},GRAM domain-containing protein 1B;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0016020;GO:0005886;GO:0015485;GO:0120020;GO:0070300;GO:0001786;GO:0071397;GO:0042632;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidic acid binding; F:phosphatidylserine binding;, P:cellular response to cholesterol; P:cholesterol homeostasis; scaffold69 indexed_genome mRNA 7851972 7938382 . + . ID=transcript_11229;Q3KR37 B3KXJ5 E7EPH8 Q6UW85 Q9ULL9,Protein Aster-B {ECO:0000250|UniProtKB:Q80TI0},GRAM domain-containing protein 1B;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0016020;GO:0005886;GO:0015485;GO:0120020;GO:0070300;GO:0001786;GO:0071397;GO:0042632;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidic acid binding; F:phosphatidylserine binding;, P:cellular response to cholesterol; P:cholesterol homeostasis;|Q3KR37 B3KXJ5 E7EPH8 Q6UW85 Q9ULL9,Protein Aster-B {ECO:0000250|UniProtKB:Q80TI0},GRAM domain-containing protein 1B;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0016020;GO:0005886;GO:0015485;GO:0120020;GO:0070300;GO:0001786;GO:0071397;GO:0042632;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidic acid binding; F:phosphatidylserine binding;, P:cellular response to cholesterol; P:cholesterol homeostasis;|Q3KR37 B3KXJ5 E7EPH8 Q6UW85 Q9ULL9,Protein Aster-B {ECO:0000250|UniProtKB:Q80TI0},GRAM domain-containing protein 1B;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0016020;GO:0005886;GO:0015485;GO:0120020;GO:0070300;GO:0001786;GO:0071397;GO:0042632;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidic acid binding; F:phosphatidylserine binding;, P:cellular response to cholesterol; P:cholesterol homeostasis;|Q3KR37 B3KXJ5 E7EPH8 Q6UW85 Q9ULL9,Protein Aster-B {ECO:0000250|UniProtKB:Q80TI0},GRAM domain-containing protein 1B;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0016020;GO:0005886;GO:0015485;GO:0120020;GO:0070300;GO:0001786;GO:0071397;GO:0042632;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidic acid binding; F:phosphatidylserine binding;, P:cellular response to cholesterol; P:cholesterol homeostasis;|Q3KR37 B3KXJ5 E7EPH8 Q6UW85 Q9ULL9,Protein Aster-B {ECO:0000250|UniProtKB:Q80TI0},GRAM domain-containing protein 1B;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0016020;GO:0005886;GO:0015485;GO:0120020;GO:0070300;GO:0001786;GO:0071397;GO:0042632;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidic acid binding; F:phosphatidylserine binding;, P:cellular response to cholesterol; P:cholesterol homeostasis;|Q3KR37 B3KXJ5 E7EPH8 Q6UW85 Q9ULL9,Protein Aster-B {ECO:0000250|UniProtKB:Q80TI0},GRAM domain-containing protein 1B;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0016020;GO:0005886;GO:0015485;GO:0120020;GO:0070300;GO:0001786;GO:0071397;GO:0042632;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidic acid binding; F:phosphatidylserine binding;, P:cellular response to cholesterol; P:cholesterol homeostasis;|Q3KR37 B3KXJ5 E7EPH8 Q6UW85 Q9ULL9,Protein Aster-B {ECO:0000250|UniProtKB:Q80TI0},GRAM domain-containing protein 1B;, PF02893;PF16016;, GO:0005789;GO:0140268;GO:0016021;GO:0016020;GO:0005886;GO:0015485;GO:0120020;GO:0070300;GO:0001786;GO:0071397;GO:0042632;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidic acid binding; F:phosphatidylserine binding;, P:cellular response to cholesterol; P:cholesterol homeostasis; scaffold69 indexed_genome mRNA 8348344 8357929 . + . ID=transcript_11230;Q9H6B4,CXADR-like membrane protein,Adipocyte adhesion molecule;Coxsackie- and adenovirus receptor-like membrane protein;, PF13895;PF07686;, GO:0005923;GO:0009986;GO:0005881;GO:0016021;GO:0005886;GO:0048565;, C:bicellular tight junction; C:cell surface; C:cytoplasmic microtubule; C:integral component of membrane; C:plasma membrane;, , P:digestive tract development; scaffold69 indexed_genome mRNA 8358526 8363365 . + . ID=transcript_11231;P11142 Q9H3R6,Heat shock cognate 71 kDa protein {ECO:0000305},Heat shock 70 kDa protein 8;Lipopolysaccharide-associated protein 1;, PF00012;, GO:0005776;GO:0072562;GO:0101031;GO:0061202;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005925;GO:0098978;GO:0098690;GO:0005770;GO:0098575;GO:0043202;GO:0005765;GO:0005764;GO:0042470;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0098684;GO:0005886;GO:0099524;GO:0099634;GO:0099523;GO:0000974;GO:1990904;GO:0034774;GO:0005681;GO:0043195;GO:0005524;GO:0016887;GO:0055131;GO:0045296;GO:0051087;GO:1990833;GO:0019899;GO:0001664;GO:0031072;GO:0023026;GO:0051787;GO:0001786;GO:0044183;GO:0030674;GO:0003723;GO:0031625;GO:0051082;GO:0046034;GO:0009267;GO:0034620;GO:0051085;GO:0061684;GO:1904764;GO:0061741;GO:0019221;GO:0061738;GO:0061024;GO:0000398;GO:1902904;GO:0045892;GO:0007269;GO:0043312;GO:0044829;GO:0048026;GO:0006892;GO:0006457;GO:0042026;GO:0061740;GO:0051726;GO:1900034;GO:0043488;GO:0099175;GO:0061635;GO:1904589;GO:0031647;GO:0043254;GO:0006986;GO:1990832;GO:0016192;GO:0016032;, C:autophagosome; C:blood microparticle; C:chaperone complex; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:focal adhesion; C:glutamatergic synapse; C:glycinergic synapse; C:late endosome; C:lumenal side of lysosomal membrane; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor ribbon synapse; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic specialization membrane; C:presynaptic cytosol; C:Prp19 complex; C:ribonucleoprotein complex; C:secretory granule lumen; C:spliceosomal complex; C:terminal bouton;, F:ATP binding; F:ATPase activity; F:C3HC4-type RING finger domain binding; F:cadherin binding; F:chaperone binding; F:clathrin-uncoating ATPase activity; F:enzyme binding; F:G protein-coupled receptor binding; F:heat shock protein binding; F:MHC class II protein complex binding; F:misfolded protein binding; F:phosphatidylserine binding; F:protein folding chaperone; F:protein-macromolecule adaptor activity; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding;, P:ATP metabolic process; P:cellular response to starvation; P:cellular response to unfolded protein; P:chaperone cofactor-dependent protein refolding; P:chaperone-mediated autophagy; P:chaperone-mediated autophagy translocation complex disassembly; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; P:cytokine-mediated signaling pathway; P:late endosomal microautophagy; P:membrane organization; P:mRNA splicing, via spliceosome; P:negative regulation of supramolecular fiber organization; P:negative regulation of transcription, DNA-templated; P:neurotransmitter secretion; P:neutrophil degranulation; P:positive regulation by host of viral genome replication; P:positive regulation of mRNA splicing, via spliceosome; P:post-Golgi vesicle-mediated transport; P:protein folding; P:protein refolding; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of mRNA stability; P:regulation of postsynapse organization; P:regulation of protein complex stability; P:regulation of protein import; P:regulation of protein stability; P:regulation of protein-containing complex assembly; P:response to unfolded protein; P:slow axonal transport; P:vesicle-mediated transport; P:viral process; scaffold69 indexed_genome mRNA 8455941 8473523 . - . ID=transcript_11232;Q6NUN7 A8K6G0 Q96GB5 Q9H5D6,Jhy protein homolog,, PF15261;, GO:0005576;GO:0035082;GO:0007420;GO:0030154;GO:0090660;GO:0044458;GO:0090175;, C:extracellular region;, , P:axoneme assembly; P:brain development; P:cell differentiation; P:cerebrospinal fluid circulation; P:motile cilium assembly; P:regulation of establishment of planar polarity; scaffold69 indexed_genome mRNA 8542623 8553453 . - . ID=transcript_11233;O95727 Q59EI1 Q6IRX2,Cytotoxic and regulatory T-cell molecule,Class-I MHC-restricted T-cell-associated molecule;, PF08205;PF07686;, GO:0001772;GO:0016021;GO:0005886;GO:0042802;GO:0005102;GO:0002250;GO:0008037;GO:0051606;GO:0002355;GO:0001768;GO:0007157;GO:0097021;GO:0046007;GO:0001819;GO:0032729;GO:0045954;GO:0002860;GO:2001185;GO:0050776;GO:0050863;GO:0045580;, C:immunological synapse; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:signaling receptor binding;, P:adaptive immune response; P:cell recognition; P:detection of stimulus; P:detection of tumor cell; P:establishment of T cell polarity; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:lymphocyte migration into lymphoid organs; P:negative regulation of activated T cell proliferation; P:positive regulation of cytokine production; P:positive regulation of interferon-gamma production; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:regulation of CD8-positive, alpha-beta T cell activation; P:regulation of immune response; P:regulation of T cell activation; P:regulation of T cell differentiation;|O95727 Q59EI1 Q6IRX2,Cytotoxic and regulatory T-cell molecule,Class-I MHC-restricted T-cell-associated molecule;, PF08205;PF07686;, GO:0001772;GO:0016021;GO:0005886;GO:0042802;GO:0005102;GO:0002250;GO:0008037;GO:0051606;GO:0002355;GO:0001768;GO:0007157;GO:0097021;GO:0046007;GO:0001819;GO:0032729;GO:0045954;GO:0002860;GO:2001185;GO:0050776;GO:0050863;GO:0045580;, C:immunological synapse; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:signaling receptor binding;, P:adaptive immune response; P:cell recognition; P:detection of stimulus; P:detection of tumor cell; P:establishment of T cell polarity; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:lymphocyte migration into lymphoid organs; P:negative regulation of activated T cell proliferation; P:positive regulation of cytokine production; P:positive regulation of interferon-gamma production; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:regulation of CD8-positive, alpha-beta T cell activation; P:regulation of immune response; P:regulation of T cell activation; P:regulation of T cell differentiation; scaffold69 indexed_genome mRNA 8584506 8742510 . - . ID=transcript_11234;Q8TF42 Q53GT5 Q53GT8 Q8NBV7 Q96IG9 Q96NZ2,Ubiquitin-associated and SH3 domain-containing protein B,Cbl-interacting protein p70;Suppressor of T-cell receptor signaling 1;T-cell ubiquitin ligand 2;Tyrosine-protein phosphatase STS1/TULA2;, PF00300;PF14604;PF00627;, GO:0005737;GO:0005634;GO:0042802;GO:0051219;GO:0004725;GO:0031625;GO:0038063;GO:0045779;GO:0045671;GO:0090331;GO:0006469;GO:0009968;GO:0035335;GO:0070527;GO:0045670;GO:0043393;GO:0051279;, C:cytoplasm; C:nucleus;, F:identical protein binding; F:phosphoprotein binding; F:protein tyrosine phosphatase activity; F:ubiquitin protein ligase binding;, P:collagen-activated tyrosine kinase receptor signaling pathway; P:negative regulation of bone resorption; P:negative regulation of osteoclast differentiation; P:negative regulation of platelet aggregation; P:negative regulation of protein kinase activity; P:negative regulation of signal transduction; P:peptidyl-tyrosine dephosphorylation; P:platelet aggregation; P:regulation of osteoclast differentiation; P:regulation of protein binding; P:regulation of release of sequestered calcium ion into cytosol;|Q8TF42 Q53GT5 Q53GT8 Q8NBV7 Q96IG9 Q96NZ2,Ubiquitin-associated and SH3 domain-containing protein B,Cbl-interacting protein p70;Suppressor of T-cell receptor signaling 1;T-cell ubiquitin ligand 2;Tyrosine-protein phosphatase STS1/TULA2;, PF00300;PF14604;PF00627;, GO:0005737;GO:0005634;GO:0042802;GO:0051219;GO:0004725;GO:0031625;GO:0038063;GO:0045779;GO:0045671;GO:0090331;GO:0006469;GO:0009968;GO:0035335;GO:0070527;GO:0045670;GO:0043393;GO:0051279;, C:cytoplasm; C:nucleus;, F:identical protein binding; F:phosphoprotein binding; F:protein tyrosine phosphatase activity; F:ubiquitin protein ligase binding;, P:collagen-activated tyrosine kinase receptor signaling pathway; P:negative regulation of bone resorption; P:negative regulation of osteoclast differentiation; P:negative regulation of platelet aggregation; P:negative regulation of protein kinase activity; P:negative regulation of signal transduction; P:peptidyl-tyrosine dephosphorylation; P:platelet aggregation; P:regulation of osteoclast differentiation; P:regulation of protein binding; P:regulation of release of sequestered calcium ion into cytosol; scaffold70 indexed_genome mRNA 744279 744870 . - . ID=transcript_11235;Q9BZ76 B1AMA0 Q9C0E9,Contactin-associated protein-like 3,Cell recognition molecule Caspr3;, PF00754;PF02210;, GO:0005576;GO:0016021;GO:0005886;GO:0007155;GO:0008037;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, , P:cell adhesion; P:cell recognition; scaffold70 indexed_genome mRNA 786322 908344 . - . ID=transcript_11236;Q9BZ76 B1AMA0 Q9C0E9,Contactin-associated protein-like 3,Cell recognition molecule Caspr3;, PF00754;PF02210;, GO:0005576;GO:0016021;GO:0005886;GO:0007155;GO:0008037;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, , P:cell adhesion; P:cell recognition; scaffold70 indexed_genome mRNA 1300487 1342130 . + . ID=transcript_11237;Q9NXF1 B4DYV2 Q5T722 Q5T723 Q8NCN8 Q8TDY0,Testis-expressed protein 10,, PF12333;, GO:0005739;GO:0071339;GO:0005730;GO:0005654;GO:0097344;GO:0006364;, C:mitochondrion; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:rRNA processing;|Q6R2W3 Q2NKL9 Q5SRJ3 Q8TCN2 Q96MV9 Q96PW3,SCAN domain-containing protein 3,Transposon-derived Buster4 transposase-like protein;Zinc finger BED domain-containing protein 9;, PF02023;, GO:0005737;GO:0005634;GO:0003676;GO:0015074;GO:0045787;GO:0050679;, C:cytoplasm; C:nucleus;, F:nucleic acid binding;, P:DNA integration; P:positive regulation of cell cycle; P:positive regulation of epithelial cell proliferation;|Q9NXF1 B4DYV2 Q5T722 Q5T723 Q8NCN8 Q8TDY0,Testis-expressed protein 10,, PF12333;, GO:0005739;GO:0071339;GO:0005730;GO:0005654;GO:0097344;GO:0006364;, C:mitochondrion; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:rRNA processing;|Q9NXF1 B4DYV2 Q5T722 Q5T723 Q8NCN8 Q8TDY0,Testis-expressed protein 10,, PF12333;, GO:0005739;GO:0071339;GO:0005730;GO:0005654;GO:0097344;GO:0006364;, C:mitochondrion; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:rRNA processing;|Q9NXF1 B4DYV2 Q5T722 Q5T723 Q8NCN8 Q8TDY0,Testis-expressed protein 10,, PF12333;, GO:0005739;GO:0071339;GO:0005730;GO:0005654;GO:0097344;GO:0006364;, C:mitochondrion; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:rRNA processing;|Q9NXF1 B4DYV2 Q5T722 Q5T723 Q8NCN8 Q8TDY0,Testis-expressed protein 10,, PF12333;, GO:0005739;GO:0071339;GO:0005730;GO:0005654;GO:0097344;GO:0006364;, C:mitochondrion; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:rRNA processing;|Q9NXF1 B4DYV2 Q5T722 Q5T723 Q8NCN8 Q8TDY0,Testis-expressed protein 10,, PF12333;, GO:0005739;GO:0071339;GO:0005730;GO:0005654;GO:0097344;GO:0006364;, C:mitochondrion; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:rRNA processing;|Q9NXF1 B4DYV2 Q5T722 Q5T723 Q8NCN8 Q8TDY0,Testis-expressed protein 10,, PF12333;, GO:0005739;GO:0071339;GO:0005730;GO:0005654;GO:0097344;GO:0006364;, C:mitochondrion; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:rRNA processing;|Q9NXF1 B4DYV2 Q5T722 Q5T723 Q8NCN8 Q8TDY0,Testis-expressed protein 10,, PF12333;, GO:0005739;GO:0071339;GO:0005730;GO:0005654;GO:0097344;GO:0006364;, C:mitochondrion; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:rRNA processing;|Q9NXF1 B4DYV2 Q5T722 Q5T723 Q8NCN8 Q8TDY0,Testis-expressed protein 10,, PF12333;, GO:0005739;GO:0071339;GO:0005730;GO:0005654;GO:0097344;GO:0006364;, C:mitochondrion; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:rRNA processing;|Q9NXF1 B4DYV2 Q5T722 Q5T723 Q8NCN8 Q8TDY0,Testis-expressed protein 10,, PF12333;, GO:0005739;GO:0071339;GO:0005730;GO:0005654;GO:0097344;GO:0006364;, C:mitochondrion; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:Rix1 complex;, , P:rRNA processing; scaffold70 indexed_genome mRNA 1342132 1409605 . - . ID=transcript_11238;Q9Y283 A2A2Y2 Q2NKL0 Q5W0T6 Q8IVX8 Q9BRB9 Q9Y488 Q9Y498,Inversin,Inversion of embryo turning homolog;Nephrocystin-2;, PF00023;PF12796;PF00612;, GO:0005929;GO:0005737;GO:0016020;GO:0005874;GO:0005634;GO:0005819;GO:0005516;GO:0007275;GO:0090090;GO:0016055;, C:cilium; C:cytoplasm; C:membrane; C:microtubule; C:nucleus; C:spindle;, F:calmodulin binding;, P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q9Y283 A2A2Y2 Q2NKL0 Q5W0T6 Q8IVX8 Q9BRB9 Q9Y488 Q9Y498,Inversin,Inversion of embryo turning homolog;Nephrocystin-2;, PF00023;PF12796;PF00612;, GO:0005929;GO:0005737;GO:0016020;GO:0005874;GO:0005634;GO:0005819;GO:0005516;GO:0007275;GO:0090090;GO:0016055;, C:cilium; C:cytoplasm; C:membrane; C:microtubule; C:nucleus; C:spindle;, F:calmodulin binding;, P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q9Y283 A2A2Y2 Q2NKL0 Q5W0T6 Q8IVX8 Q9BRB9 Q9Y488 Q9Y498,Inversin,Inversion of embryo turning homolog;Nephrocystin-2;, PF00023;PF12796;PF00612;, GO:0005929;GO:0005737;GO:0016020;GO:0005874;GO:0005634;GO:0005819;GO:0005516;GO:0007275;GO:0090090;GO:0016055;, C:cilium; C:cytoplasm; C:membrane; C:microtubule; C:nucleus; C:spindle;, F:calmodulin binding;, P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q9Y283 A2A2Y2 Q2NKL0 Q5W0T6 Q8IVX8 Q9BRB9 Q9Y488 Q9Y498,Inversin,Inversion of embryo turning homolog;Nephrocystin-2;, PF00023;PF12796;PF00612;, GO:0005929;GO:0005737;GO:0016020;GO:0005874;GO:0005634;GO:0005819;GO:0005516;GO:0007275;GO:0090090;GO:0016055;, C:cilium; C:cytoplasm; C:membrane; C:microtubule; C:nucleus; C:spindle;, F:calmodulin binding;, P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold70 indexed_genome mRNA 1446349 1452779 . - . ID=transcript_11239;Q9Y283 A2A2Y2 Q2NKL0 Q5W0T6 Q8IVX8 Q9BRB9 Q9Y488 Q9Y498,Inversin,Inversion of embryo turning homolog;Nephrocystin-2;, PF00023;PF12796;PF00612;, GO:0005929;GO:0005737;GO:0016020;GO:0005874;GO:0005634;GO:0005819;GO:0005516;GO:0007275;GO:0090090;GO:0016055;, C:cilium; C:cytoplasm; C:membrane; C:microtubule; C:nucleus; C:spindle;, F:calmodulin binding;, P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold70 indexed_genome mRNA 1478461 1566026 . + . ID=transcript_11240;Q9BS26 O60319 Q4VXC1 Q5VWZ7 Q6UW14 Q8WX67,Endoplasmic reticulum resident protein 44,Thioredoxin domain-containing protein 4;, PF00085;, GO:0009986;GO:0005788;GO:0005789;GO:0005793;GO:0070062;GO:0005576;GO:0035580;GO:0003756;GO:0045454;GO:0009100;GO:0043312;GO:0006457;GO:0034976;GO:0006986;, C:cell surface; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular region; C:specific granule lumen;, F:protein disulfide isomerase activity;, P:cell redox homeostasis; P:glycoprotein metabolic process; P:neutrophil degranulation; P:protein folding; P:response to endoplasmic reticulum stress; P:response to unfolded protein;|Q9BS26 O60319 Q4VXC1 Q5VWZ7 Q6UW14 Q8WX67,Endoplasmic reticulum resident protein 44,Thioredoxin domain-containing protein 4;, PF00085;, GO:0009986;GO:0005788;GO:0005789;GO:0005793;GO:0070062;GO:0005576;GO:0035580;GO:0003756;GO:0045454;GO:0009100;GO:0043312;GO:0006457;GO:0034976;GO:0006986;, C:cell surface; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular region; C:specific granule lumen;, F:protein disulfide isomerase activity;, P:cell redox homeostasis; P:glycoprotein metabolic process; P:neutrophil degranulation; P:protein folding; P:response to endoplasmic reticulum stress; P:response to unfolded protein;|Q9BS26 O60319 Q4VXC1 Q5VWZ7 Q6UW14 Q8WX67,Endoplasmic reticulum resident protein 44,Thioredoxin domain-containing protein 4;, PF00085;, GO:0009986;GO:0005788;GO:0005789;GO:0005793;GO:0070062;GO:0005576;GO:0035580;GO:0003756;GO:0045454;GO:0009100;GO:0043312;GO:0006457;GO:0034976;GO:0006986;, C:cell surface; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular region; C:specific granule lumen;, F:protein disulfide isomerase activity;, P:cell redox homeostasis; P:glycoprotein metabolic process; P:neutrophil degranulation; P:protein folding; P:response to endoplasmic reticulum stress; P:response to unfolded protein; scaffold70 indexed_genome mRNA 1577499 1578110 . + . ID=transcript_11241;P56962 Q4VXC2,Syntaxin-17 {ECO:0000303|PubMed:21545355},, , GO:0005776;GO:0000421;GO:0030134;GO:0005829;GO:0012505;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0016021;GO:0044233;GO:0005739;GO:0005886;GO:0030868;GO:0031201;GO:0019901;GO:0019903;GO:0005484;GO:0000149;GO:0097352;GO:0016240;GO:0006888;GO:0097111;GO:0006887;GO:0007030;GO:0006886;GO:0034497;GO:0048278;GO:0006906;, C:autophagosome; C:autophagosome membrane; C:COPII-coated ER to Golgi transport vesicle; C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:SNARE complex;, F:protein kinase binding; F:protein phosphatase binding; F:SNAP receptor activity; F:SNARE binding;, P:autophagosome maturation; P:autophagosome membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:exocytosis; P:Golgi organization; P:intracellular protein transport; P:protein localization to phagophore assembly site; P:vesicle docking; P:vesicle fusion; scaffold70 indexed_genome mRNA 1585196 1638001 . + . ID=transcript_11242;P56962 Q4VXC2,Syntaxin-17 {ECO:0000303|PubMed:21545355},, , GO:0005776;GO:0000421;GO:0030134;GO:0005829;GO:0012505;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0016021;GO:0044233;GO:0005739;GO:0005886;GO:0030868;GO:0031201;GO:0019901;GO:0019903;GO:0005484;GO:0000149;GO:0097352;GO:0016240;GO:0006888;GO:0097111;GO:0006887;GO:0007030;GO:0006886;GO:0034497;GO:0048278;GO:0006906;, C:autophagosome; C:autophagosome membrane; C:COPII-coated ER to Golgi transport vesicle; C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:SNARE complex;, F:protein kinase binding; F:protein phosphatase binding; F:SNAP receptor activity; F:SNARE binding;, P:autophagosome maturation; P:autophagosome membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:exocytosis; P:Golgi organization; P:intracellular protein transport; P:protein localization to phagophore assembly site; P:vesicle docking; P:vesicle fusion;|P56962 Q4VXC2,Syntaxin-17 {ECO:0000303|PubMed:21545355},, , GO:0005776;GO:0000421;GO:0030134;GO:0005829;GO:0012505;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0016021;GO:0044233;GO:0005739;GO:0005886;GO:0030868;GO:0031201;GO:0019901;GO:0019903;GO:0005484;GO:0000149;GO:0097352;GO:0016240;GO:0006888;GO:0097111;GO:0006887;GO:0007030;GO:0006886;GO:0034497;GO:0048278;GO:0006906;, C:autophagosome; C:autophagosome membrane; C:COPII-coated ER to Golgi transport vesicle; C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:SNARE complex;, F:protein kinase binding; F:protein phosphatase binding; F:SNAP receptor activity; F:SNARE binding;, P:autophagosome maturation; P:autophagosome membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:exocytosis; P:Golgi organization; P:intracellular protein transport; P:protein localization to phagophore assembly site; P:vesicle docking; P:vesicle fusion;|P56962 Q4VXC2,Syntaxin-17 {ECO:0000303|PubMed:21545355},, , GO:0005776;GO:0000421;GO:0030134;GO:0005829;GO:0012505;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0016021;GO:0044233;GO:0005739;GO:0005886;GO:0030868;GO:0031201;GO:0019901;GO:0019903;GO:0005484;GO:0000149;GO:0097352;GO:0016240;GO:0006888;GO:0097111;GO:0006887;GO:0007030;GO:0006886;GO:0034497;GO:0048278;GO:0006906;, C:autophagosome; C:autophagosome membrane; C:COPII-coated ER to Golgi transport vesicle; C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:integral component of membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:SNARE complex;, F:protein kinase binding; F:protein phosphatase binding; F:SNAP receptor activity; F:SNARE binding;, P:autophagosome maturation; P:autophagosome membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum-Golgi intermediate compartment organization; P:exocytosis; P:Golgi organization; P:intracellular protein transport; P:protein localization to phagophore assembly site; P:vesicle docking; P:vesicle fusion; scaffold70 indexed_genome mRNA 2315092 2323919 . - . ID=transcript_11243;P60468 P38390 P38391 Q6IBC1,Protein transport protein Sec61 subunit beta,, PF03911;, GO:0005829;GO:0005783;GO:0005789;GO:0044322;GO:0031205;GO:0016021;GO:0016020;GO:0005784;GO:0048408;GO:0003723;GO:0031204;GO:0045048;GO:0030970;GO:0006616;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum Sec complex; C:integral component of membrane; C:membrane; C:Sec61 translocon complex;, F:epidermal growth factor binding; F:RNA binding;, P:posttranslational protein targeting to membrane, translocation; P:protein insertion into ER membrane; P:retrograde protein transport, ER to cytosol; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:ubiquitin-dependent ERAD pathway;|P60468 P38390 P38391 Q6IBC1,Protein transport protein Sec61 subunit beta,, PF03911;, GO:0005829;GO:0005783;GO:0005789;GO:0044322;GO:0031205;GO:0016021;GO:0016020;GO:0005784;GO:0048408;GO:0003723;GO:0031204;GO:0045048;GO:0030970;GO:0006616;GO:0030433;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum Sec complex; C:integral component of membrane; C:membrane; C:Sec61 translocon complex;, F:epidermal growth factor binding; F:RNA binding;, P:posttranslational protein targeting to membrane, translocation; P:protein insertion into ER membrane; P:retrograde protein transport, ER to cytosol; P:SRP-dependent cotranslational protein targeting to membrane, translocation; P:ubiquitin-dependent ERAD pathway; scaffold70 indexed_genome mRNA 2324127 2330651 . + . ID=transcript_11244;Q9H553 A2A2Y0 Q8NBX2 Q8NC39,Alpha-1,3/1,6-mannosyltransferase ALG2,Asparagine-linked glycosylation protein 2 homolog;GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase;GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase;GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase;, PF13439;PF00534;, GO:0015629;GO:0005737;GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005634;GO:0048471;GO:0000033;GO:0048306;GO:0004378;GO:0102704;GO:0046982;GO:0047485;GO:0006488;GO:0006490;GO:0033577;GO:0051592;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:alpha-1,3-mannosyltransferase activity; F:calcium-dependent protein binding; F:GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity; F:GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity; F:protein heterodimerization activity; F:protein N-terminus binding;, P:dolichol-linked oligosaccharide biosynthetic process; P:oligosaccharide-lipid intermediate biosynthetic process; P:protein glycosylation in endoplasmic reticulum; P:response to calcium ion; scaffold70 indexed_genome mRNA 2401888 2437662 . - . ID=transcript_11245;P36897 Q6IR47 Q706C0 Q706C1,TGF-beta receptor type-1,Activin A receptor type II-like protein kinase of 53kD;Activin receptor-like kinase 5;Serine/threonine-protein kinase receptor R4;TGF-beta type I receptor;Transforming growth factor-beta receptor type I;, PF01064;PF00069;PF08515;, GO:0048179;GO:0005923;GO:0009986;GO:0005768;GO:0016020;GO:0045121;GO:0005634;GO:0005886;GO:0043235;GO:0048185;GO:0016361;GO:0005524;GO:0070411;GO:0046872;GO:0004672;GO:0004674;GO:0046332;GO:0050431;GO:0005025;GO:0005024;GO:0005114;GO:0000186;GO:0032924;GO:0060978;GO:0009952;GO:0006915;GO:0048844;GO:0001824;GO:0060317;GO:0007050;GO:0048870;GO:0071363;GO:0071560;GO:0030199;GO:0060982;GO:0048701;GO:0042118;GO:0043542;GO:1905223;GO:0001837;GO:0043062;GO:0008354;GO:0007507;GO:0001701;GO:0035556;GO:0001822;GO:0002088;GO:0008584;GO:0048762;GO:0032331;GO:0001937;GO:2001237;GO:0030512;GO:0007399;GO:0048663;GO:0060017;GO:0060389;GO:0018105;GO:0018107;GO:0060037;GO:2001235;GO:0030307;GO:0030335;GO:0008284;GO:0051272;GO:0001938;GO:0010718;GO:1905007;GO:0051491;GO:0010628;GO:0010862;GO:0051897;GO:0060391;GO:0051496;GO:1905075;GO:0045893;GO:0009791;GO:0016579;GO:0006468;GO:0060043;GO:0010717;GO:0010468;GO:0043393;GO:0031396;GO:0006355;GO:0070723;GO:0060021;GO:0007165;GO:0001501;GO:0048705;GO:0048538;GO:0007179;GO:0003223;GO:0060412;GO:0003222;GO:0042060;, C:activin receptor complex; C:bicellular tight junction; C:cell surface; C:endosome; C:membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:receptor complex;, F:activin binding; F:activin receptor activity, type I; F:ATP binding; F:I-SMAD binding; F:metal ion binding; F:protein kinase activity; F:protein serine/threonine kinase activity; F:SMAD binding; F:transforming growth factor beta binding; F:transforming growth factor beta receptor activity, type I; F:transforming growth factor beta-activated receptor activity; F:type II transforming growth factor beta receptor binding;, P:activation of MAPKK activity; P:activin receptor signaling pathway; P:angiogenesis involved in coronary vascular morphogenesis; P:anterior/posterior pattern specification; P:apoptotic process; P:artery morphogenesis; P:blastocyst development; P:cardiac epithelial to mesenchymal transition; P:cell cycle arrest; P:cell motility; P:cellular response to growth factor stimulus; P:cellular response to transforming growth factor beta stimulus; P:collagen fibril organization; P:coronary artery morphogenesis; P:embryonic cranial skeleton morphogenesis; P:endothelial cell activation; P:endothelial cell migration; P:epicardium morphogenesis; P:epithelial to mesenchymal transition; P:extracellular structure organization; P:germ cell migration; P:heart development; P:in utero embryonic development; P:intracellular signal transduction; P:kidney development; P:lens development in camera-type eye; P:male gonad development; P:mesenchymal cell differentiation; P:negative regulation of chondrocyte differentiation; P:negative regulation of endothelial cell proliferation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:nervous system development; P:neuron fate commitment; P:parathyroid gland development; P:pathway-restricted SMAD protein phosphorylation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:pharyngeal system development; P:positive regulation of apoptotic signaling pathway; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of endothelial cell proliferation; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of filopodium assembly; P:positive regulation of gene expression; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of SMAD protein signal transduction; P:positive regulation of stress fiber assembly; P:positive regulation of tight junction disassembly; P:positive regulation of transcription, DNA-templated; P:post-embryonic development; P:protein deubiquitination; P:protein phosphorylation; P:regulation of cardiac muscle cell proliferation; P:regulation of epithelial to mesenchymal transition; P:regulation of gene expression; P:regulation of protein binding; P:regulation of protein ubiquitination; P:regulation of transcription, DNA-templated; P:response to cholesterol; P:roof of mouth development; P:signal transduction; P:skeletal system development; P:skeletal system morphogenesis; P:thymus development; P:transforming growth factor beta receptor signaling pathway; P:ventricular compact myocardium morphogenesis; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis; P:wound healing; scaffold70 indexed_genome mRNA 2507753 2607859 . - . ID=transcript_11246;P39059 Q5T6J4 Q9UDC5 Q9Y4W4,Collagen alpha-1(XV) chain,, PF01391;PF06482;, GO:0005582;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0016021;GO:0005201;GO:0030020;GO:0001525;GO:0007155;GO:0030574;GO:0030199;GO:0001886;GO:0030198;GO:0007165;, C:collagen type XV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:integral component of membrane;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:angiogenesis; P:cell adhesion; P:collagen catabolic process; P:collagen fibril organization; P:endothelial cell morphogenesis; P:extracellular matrix organization; P:signal transduction;|P39059 Q5T6J4 Q9UDC5 Q9Y4W4,Collagen alpha-1(XV) chain,, PF01391;PF06482;, GO:0005582;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0016021;GO:0005201;GO:0030020;GO:0001525;GO:0007155;GO:0030574;GO:0030199;GO:0001886;GO:0030198;GO:0007165;, C:collagen type XV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:integral component of membrane;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:angiogenesis; P:cell adhesion; P:collagen catabolic process; P:collagen fibril organization; P:endothelial cell morphogenesis; P:extracellular matrix organization; P:signal transduction;|P39059 Q5T6J4 Q9UDC5 Q9Y4W4,Collagen alpha-1(XV) chain,, PF01391;PF06482;, GO:0005582;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0016021;GO:0005201;GO:0030020;GO:0001525;GO:0007155;GO:0030574;GO:0030199;GO:0001886;GO:0030198;GO:0007165;, C:collagen type XV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:integral component of membrane;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:angiogenesis; P:cell adhesion; P:collagen catabolic process; P:collagen fibril organization; P:endothelial cell morphogenesis; P:extracellular matrix organization; P:signal transduction; scaffold70 indexed_genome mRNA 2685901 2738868 . - . ID=transcript_11247;Q8IXK2 Q5TCF7 Q8NG54 Q96CT9 Q9H771,Polypeptide N-acetylgalactosaminyltransferase 12,Polypeptide GalNAc transferase 12;Protein-UDP acetylgalactosaminyltransferase 12;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing;|Q8IXK2 Q5TCF7 Q8NG54 Q96CT9 Q9H771,Polypeptide N-acetylgalactosaminyltransferase 12,Polypeptide GalNAc transferase 12;Protein-UDP acetylgalactosaminyltransferase 12;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing;|Q8IXK2 Q5TCF7 Q8NG54 Q96CT9 Q9H771,Polypeptide N-acetylgalactosaminyltransferase 12,Polypeptide GalNAc transferase 12;Protein-UDP acetylgalactosaminyltransferase 12;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing;|Q8IXK2 Q5TCF7 Q8NG54 Q96CT9 Q9H771,Polypeptide N-acetylgalactosaminyltransferase 12,Polypeptide GalNAc transferase 12;Protein-UDP acetylgalactosaminyltransferase 12;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0004653;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; scaffold70 indexed_genome mRNA 2760457 2794590 . + . ID=transcript_11248;Q96D62,Ankyrin repeat and SAM domain-containing protein 6,Ankyrin repeat domain-containing protein 14;SamCystin;Sterile alpha motif domain-containing protein 6;, PF12796;PF00536;, GO:0097543;GO:0005737;GO:0007368;GO:0007507;GO:0001701;GO:0001822;, C:ciliary inversin compartment; C:cytoplasm;, , P:determination of left/right symmetry; P:heart development; P:in utero embryonic development; P:kidney development;|Q96D62,Ankyrin repeat and SAM domain-containing protein 6,Ankyrin repeat domain-containing protein 14;SamCystin;Sterile alpha motif domain-containing protein 6;, PF12796;PF00536;, GO:0097543;GO:0005737;GO:0007368;GO:0007507;GO:0001701;GO:0001822;, C:ciliary inversin compartment; C:cytoplasm;, , P:determination of left/right symmetry; P:heart development; P:in utero embryonic development; P:kidney development; scaffold70 indexed_genome mRNA 3043876 3186624 . + . ID=transcript_11249;O75899 O75974 O75975 Q5VXZ2 Q8WX04 Q9P1R2 Q9UNR1 Q9UNS9,Gamma-aminobutyric acid type B receptor subunit 2,G-protein coupled receptor 51;HG20;, PF00003;PF01094;PF18455;, GO:0005737;GO:0038039;GO:1902710;GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0004965;GO:0046982;GO:0004888;GO:0007268;GO:0007186;GO:0007214;GO:0007194;GO:0150099;GO:1901381;, C:cytoplasm; C:G protein-coupled receptor heterodimeric complex; C:GABA receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane;, F:G protein-coupled GABA receptor activity; F:protein heterodimerization activity; F:transmembrane signaling receptor activity;, P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:negative regulation of adenylate cyclase activity; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|O75899 O75974 O75975 Q5VXZ2 Q8WX04 Q9P1R2 Q9UNR1 Q9UNS9,Gamma-aminobutyric acid type B receptor subunit 2,G-protein coupled receptor 51;HG20;, PF00003;PF01094;PF18455;, GO:0005737;GO:0038039;GO:1902710;GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0004965;GO:0046982;GO:0004888;GO:0007268;GO:0007186;GO:0007214;GO:0007194;GO:0150099;GO:1901381;, C:cytoplasm; C:G protein-coupled receptor heterodimeric complex; C:GABA receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane;, F:G protein-coupled GABA receptor activity; F:protein heterodimerization activity; F:transmembrane signaling receptor activity;, P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:negative regulation of adenylate cyclase activity; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport;|O75899 O75974 O75975 Q5VXZ2 Q8WX04 Q9P1R2 Q9UNR1 Q9UNS9,Gamma-aminobutyric acid type B receptor subunit 2,G-protein coupled receptor 51;HG20;, PF00003;PF01094;PF18455;, GO:0005737;GO:0038039;GO:1902710;GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0004965;GO:0046982;GO:0004888;GO:0007268;GO:0007186;GO:0007214;GO:0007194;GO:0150099;GO:1901381;, C:cytoplasm; C:G protein-coupled receptor heterodimeric complex; C:GABA receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane;, F:G protein-coupled GABA receptor activity; F:protein heterodimerization activity; F:transmembrane signaling receptor activity;, P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:gamma-aminobutyric acid signaling pathway; P:negative regulation of adenylate cyclase activity; P:neuron-glial cell signaling; P:positive regulation of potassium ion transmembrane transport; scaffold70 indexed_genome mRNA 3210582 3256342 . + . ID=transcript_11250;Q9H6A2 Q9NSH4,TBC1 domain family member 2A,Armus;Prostate antigen recognized and identified by SEREX 1;, PF00169;PF00566;, GO:0030054;GO:0031410;GO:0005829;GO:0005654;GO:0005886;GO:0045296;GO:0005096;GO:0090630;GO:0006886;GO:0043547;, C:cell junction; C:cytoplasmic vesicle; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:cadherin binding; F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:positive regulation of GTPase activity;|Q9H6A2 Q9NSH4,TBC1 domain family member 2A,Armus;Prostate antigen recognized and identified by SEREX 1;, PF00169;PF00566;, GO:0030054;GO:0031410;GO:0005829;GO:0005654;GO:0005886;GO:0045296;GO:0005096;GO:0090630;GO:0006886;GO:0043547;, C:cell junction; C:cytoplasmic vesicle; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:cadherin binding; F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:positive regulation of GTPase activity; scaffold70 indexed_genome mRNA 3301057 3321685 . + . ID=transcript_11251;Q92828 Q5TBR5 Q92829 Q9BWS5,Coronin-2A,IR10;WD repeat-containing protein 2;, PF08953;PF00400;, GO:0017053;GO:0051015;GO:0035556;, C:transcription repressor complex;, F:actin filament binding;, P:intracellular signal transduction;|Q92828 Q5TBR5 Q92829 Q9BWS5,Coronin-2A,IR10;WD repeat-containing protein 2;, PF08953;PF00400;, GO:0017053;GO:0051015;GO:0035556;, C:transcription repressor complex;, F:actin filament binding;, P:intracellular signal transduction;|Q92828 Q5TBR5 Q92829 Q9BWS5,Coronin-2A,IR10;WD repeat-containing protein 2;, PF08953;PF00400;, GO:0017053;GO:0051015;GO:0035556;, C:transcription repressor complex;, F:actin filament binding;, P:intracellular signal transduction;|Q92828 Q5TBR5 Q92829 Q9BWS5,Coronin-2A,IR10;WD repeat-containing protein 2;, PF08953;PF00400;, GO:0017053;GO:0051015;GO:0035556;, C:transcription repressor complex;, F:actin filament binding;, P:intracellular signal transduction; scaffold70 indexed_genome mRNA 3322751 3325605 . + . ID=transcript_11252;Q92828 Q5TBR5 Q92829 Q9BWS5,Coronin-2A,IR10;WD repeat-containing protein 2;, PF08953;PF00400;, GO:0017053;GO:0051015;GO:0035556;, C:transcription repressor complex;, F:actin filament binding;, P:intracellular signal transduction; scaffold70 indexed_genome mRNA 3332669 3356218 . + . ID=transcript_11253;Q14142 A8K9W0 E7EQC4 F8W956 Q548W9 Q5TBQ8 Q6ZWL7 Q9BRD8 Q9C020,Tripartite motif-containing protein 14,, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005741;GO:0005654;GO:0045335;GO:0042803;GO:0019901;GO:0003713;GO:0061630;GO:0008270;GO:0045087;GO:0032897;GO:0010508;GO:0051091;GO:0043123;GO:0051092;GO:0000209;GO:0016567;GO:0010468;GO:0032880;GO:0046596;, C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:nucleoplasm; C:phagocytic vesicle;, F:protein homodimerization activity; F:protein kinase binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:negative regulation of viral transcription; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of gene expression; P:regulation of protein localization; P:regulation of viral entry into host cell; scaffold70 indexed_genome mRNA 3357539 3359998 . + . ID=transcript_11254;Q9NR45 B2RE98 Q8WUV9 Q9BWS6 Q9NVD4,Sialic acid synthase,N-acetylneuraminate synthase;N-acetylneuraminate-9-phosphate synthase;N-acetylneuraminic acid phosphate synthase;N-acetylneuraminic acid synthase;, PF03102;, GO:0005737;GO:0005829;GO:0070062;GO:0050462;GO:0008781;GO:0047444;GO:0016051;GO:0006055;GO:0070085;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:N-acetylneuraminate synthase activity; F:N-acylneuraminate cytidylyltransferase activity; F:N-acylneuraminate-9-phosphate synthase activity;, P:carbohydrate biosynthetic process; P:CMP-N-acetylneuraminate biosynthetic process; P:glycosylation; scaffold70 indexed_genome mRNA 3360004 3375233 . - . ID=transcript_11255;Q9NR45 B2RE98 Q8WUV9 Q9BWS6 Q9NVD4,Sialic acid synthase,N-acetylneuraminate synthase;N-acetylneuraminate-9-phosphate synthase;N-acetylneuraminic acid phosphate synthase;N-acetylneuraminic acid synthase;, PF03102;, GO:0005737;GO:0005829;GO:0070062;GO:0050462;GO:0008781;GO:0047444;GO:0016051;GO:0006055;GO:0070085;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:N-acetylneuraminate synthase activity; F:N-acylneuraminate cytidylyltransferase activity; F:N-acylneuraminate-9-phosphate synthase activity;, P:carbohydrate biosynthetic process; P:CMP-N-acetylneuraminate biosynthetic process; P:glycosylation;|Q9NR45 B2RE98 Q8WUV9 Q9BWS6 Q9NVD4,Sialic acid synthase,N-acetylneuraminate synthase;N-acetylneuraminate-9-phosphate synthase;N-acetylneuraminic acid phosphate synthase;N-acetylneuraminic acid synthase;, PF03102;, GO:0005737;GO:0005829;GO:0070062;GO:0050462;GO:0008781;GO:0047444;GO:0016051;GO:0006055;GO:0070085;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:N-acetylneuraminate synthase activity; F:N-acylneuraminate cytidylyltransferase activity; F:N-acylneuraminate-9-phosphate synthase activity;, P:carbohydrate biosynthetic process; P:CMP-N-acetylneuraminate biosynthetic process; P:glycosylation;|Q9NR45 B2RE98 Q8WUV9 Q9BWS6 Q9NVD4,Sialic acid synthase,N-acetylneuraminate synthase;N-acetylneuraminate-9-phosphate synthase;N-acetylneuraminic acid phosphate synthase;N-acetylneuraminic acid synthase;, PF03102;, GO:0005737;GO:0005829;GO:0070062;GO:0050462;GO:0008781;GO:0047444;GO:0016051;GO:0006055;GO:0070085;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:N-acetylneuraminate synthase activity; F:N-acylneuraminate cytidylyltransferase activity; F:N-acylneuraminate-9-phosphate synthase activity;, P:carbohydrate biosynthetic process; P:CMP-N-acetylneuraminate biosynthetic process; P:glycosylation;|Q9NR45 B2RE98 Q8WUV9 Q9BWS6 Q9NVD4,Sialic acid synthase,N-acetylneuraminate synthase;N-acetylneuraminate-9-phosphate synthase;N-acetylneuraminic acid phosphate synthase;N-acetylneuraminic acid synthase;, PF03102;, GO:0005737;GO:0005829;GO:0070062;GO:0050462;GO:0008781;GO:0047444;GO:0016051;GO:0006055;GO:0070085;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:N-acetylneuraminate synthase activity; F:N-acylneuraminate cytidylyltransferase activity; F:N-acylneuraminate-9-phosphate synthase activity;, P:carbohydrate biosynthetic process; P:CMP-N-acetylneuraminate biosynthetic process; P:glycosylation; scaffold70 indexed_genome mRNA 3401520 3402317 . - . ID=transcript_11256;Q92688 B2R9C7 O00655 P78458 P78459,Acidic leucine-rich nuclear phosphoprotein 32 family member B {ECO:0000303|PubMed:33045004},Acidic protein rich in leucines;Putative HLA-DR-associated protein I-2;Silver-stainable protein SSP29;, , GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0042393;GO:0070063;GO:0006919;GO:0048839;GO:0045596;GO:0006334;GO:0046827;GO:0042981;GO:0060021;GO:0001944;GO:0021591;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:histone binding; F:RNA polymerase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:inner ear development; P:negative regulation of cell differentiation; P:nucleosome assembly; P:positive regulation of protein export from nucleus; P:regulation of apoptotic process; P:roof of mouth development; P:vasculature development; P:ventricular system development; scaffold70 indexed_genome mRNA 3459424 3460403 . + . ID=transcript_11257;Q9BXL5 Q6XAR3 Q86XY5 Q9NPC0,Hemogen,Erythroid differentiation-associated gene protein;Hemopoietic gene protein;Negative differentiation regulator protein;, , GO:0005654;GO:0030154;GO:0007275;GO:0045667;, C:nucleoplasm;, , P:cell differentiation; P:multicellular organism development; P:regulation of osteoblast differentiation; scaffold70 indexed_genome mRNA 3464937 3465542 . + . ID=transcript_11258;Q9BXL5 Q6XAR3 Q86XY5 Q9NPC0,Hemogen,Erythroid differentiation-associated gene protein;Hemopoietic gene protein;Negative differentiation regulator protein;, , GO:0005654;GO:0030154;GO:0007275;GO:0045667;, C:nucleoplasm;, , P:cell differentiation; P:multicellular organism development; P:regulation of osteoblast differentiation; scaffold70 indexed_genome mRNA 3471031 3481530 . - . ID=transcript_11259;Q9BU70 Q5T113 Q86SK0 Q9NXJ7 Q9P0Q7,tRNA (adenine(37)-N6)-methyltransferase {ECO:0000305},tRNA methyltransferase O {ECO:0000303|PubMed:25063302, ECO:0000312|HGNC:HGNC:30967};, PF01980;, GO:0016430;GO:0030488;, , F:tRNA (adenine-N6-)-methyltransferase activity;, P:tRNA methylation; scaffold70 indexed_genome mRNA 3664253 3665006 . - . ID=transcript_11260;P23025 Q5T1U9 Q6LCW7 Q6LD02,DNA repair protein complementing XP-A cells,Xeroderma pigmentosum group A-complementing protein;, PF05181;PF01286;, GO:0005737;GO:0045171;GO:0005654;GO:0000110;GO:0005634;GO:0003684;GO:0046872;GO:0019904;GO:0042803;GO:1990837;GO:0006284;GO:0006281;GO:0070911;GO:1901255;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034504;GO:0010996;GO:0006283;GO:0009650;GO:0070914;, C:cytoplasm; C:intercellular bridge; C:nucleoplasm; C:nucleotide-excision repair factor 1 complex; C:nucleus;, F:damaged DNA binding; F:metal ion binding; F:protein domain specific binding; F:protein homodimerization activity; F:sequence-specific double-stranded DNA binding;, P:base-excision repair; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair involved in interstrand cross-link repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to nucleus; P:response to auditory stimulus; P:transcription-coupled nucleotide-excision repair; P:UV protection; P:UV-damage excision repair; scaffold70 indexed_genome mRNA 3666171 3716068 . + . ID=transcript_11261;P23025 Q5T1U9 Q6LCW7 Q6LD02,DNA repair protein complementing XP-A cells,Xeroderma pigmentosum group A-complementing protein;, PF05181;PF01286;, GO:0005737;GO:0045171;GO:0005654;GO:0000110;GO:0005634;GO:0003684;GO:0046872;GO:0019904;GO:0042803;GO:1990837;GO:0006284;GO:0006281;GO:0070911;GO:1901255;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034504;GO:0010996;GO:0006283;GO:0009650;GO:0070914;, C:cytoplasm; C:intercellular bridge; C:nucleoplasm; C:nucleotide-excision repair factor 1 complex; C:nucleus;, F:damaged DNA binding; F:metal ion binding; F:protein domain specific binding; F:protein homodimerization activity; F:sequence-specific double-stranded DNA binding;, P:base-excision repair; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair involved in interstrand cross-link repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to nucleus; P:response to auditory stimulus; P:transcription-coupled nucleotide-excision repair; P:UV protection; P:UV-damage excision repair;|P23025 Q5T1U9 Q6LCW7 Q6LD02,DNA repair protein complementing XP-A cells,Xeroderma pigmentosum group A-complementing protein;, PF05181;PF01286;, GO:0005737;GO:0045171;GO:0005654;GO:0000110;GO:0005634;GO:0003684;GO:0046872;GO:0019904;GO:0042803;GO:1990837;GO:0006284;GO:0006281;GO:0070911;GO:1901255;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0034504;GO:0010996;GO:0006283;GO:0009650;GO:0070914;, C:cytoplasm; C:intercellular bridge; C:nucleoplasm; C:nucleotide-excision repair factor 1 complex; C:nucleus;, F:damaged DNA binding; F:metal ion binding; F:protein domain specific binding; F:protein homodimerization activity; F:sequence-specific double-stranded DNA binding;, P:base-excision repair; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair involved in interstrand cross-link repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:protein localization to nucleus; P:response to auditory stimulus; P:transcription-coupled nucleotide-excision repair; P:UV protection; P:UV-damage excision repair;|Q09161 B2R718 Q59G76 Q5T1V0 Q5T7X2,Nuclear cap-binding protein subunit 1,80 kDa nuclear cap-binding protein;, PF02854;PF09088;PF09090;, GO:0005829;GO:0005739;GO:0005845;GO:0005846;GO:0005654;GO:0005634;GO:1990904;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0006370;GO:0008543;GO:0031047;GO:0008334;GO:0031124;GO:0045292;GO:0006406;GO:0000398;GO:0051168;GO:0000184;GO:0030307;GO:0031442;GO:0048026;GO:1905216;GO:0098789;GO:0050684;GO:0006446;GO:0006401;GO:0006405;GO:0016070;GO:0008380;GO:0042795;GO:0000245;GO:0006369;GO:0006366;GO:0006368;, C:cytosol; C:mitochondrion; C:mRNA cap binding complex; C:nuclear cap binding complex; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:gene silencing by RNA; P:histone mRNA metabolic process; P:mRNA 3'-end processing; P:mRNA cis splicing, via spliceosome; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear export; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell growth; P:positive regulation of mRNA 3'-end processing; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of RNA binding; P:pre-mRNA cleavage required for polyadenylation; P:regulation of mRNA processing; P:regulation of translational initiation; P:RNA catabolic process; P:RNA export from nucleus; P:RNA metabolic process; P:RNA splicing; P:snRNA transcription by RNA polymerase II; P:spliceosomal complex assembly; P:termination of RNA polymerase II transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q09161 B2R718 Q59G76 Q5T1V0 Q5T7X2,Nuclear cap-binding protein subunit 1,80 kDa nuclear cap-binding protein;, PF02854;PF09088;PF09090;, GO:0005829;GO:0005739;GO:0005845;GO:0005846;GO:0005654;GO:0005634;GO:1990904;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0006370;GO:0008543;GO:0031047;GO:0008334;GO:0031124;GO:0045292;GO:0006406;GO:0000398;GO:0051168;GO:0000184;GO:0030307;GO:0031442;GO:0048026;GO:1905216;GO:0098789;GO:0050684;GO:0006446;GO:0006401;GO:0006405;GO:0016070;GO:0008380;GO:0042795;GO:0000245;GO:0006369;GO:0006366;GO:0006368;, C:cytosol; C:mitochondrion; C:mRNA cap binding complex; C:nuclear cap binding complex; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:gene silencing by RNA; P:histone mRNA metabolic process; P:mRNA 3'-end processing; P:mRNA cis splicing, via spliceosome; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear export; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell growth; P:positive regulation of mRNA 3'-end processing; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of RNA binding; P:pre-mRNA cleavage required for polyadenylation; P:regulation of mRNA processing; P:regulation of translational initiation; P:RNA catabolic process; P:RNA export from nucleus; P:RNA metabolic process; P:RNA splicing; P:snRNA transcription by RNA polymerase II; P:spliceosomal complex assembly; P:termination of RNA polymerase II transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q09161 B2R718 Q59G76 Q5T1V0 Q5T7X2,Nuclear cap-binding protein subunit 1,80 kDa nuclear cap-binding protein;, PF02854;PF09088;PF09090;, GO:0005829;GO:0005739;GO:0005845;GO:0005846;GO:0005654;GO:0005634;GO:1990904;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0006370;GO:0008543;GO:0031047;GO:0008334;GO:0031124;GO:0045292;GO:0006406;GO:0000398;GO:0051168;GO:0000184;GO:0030307;GO:0031442;GO:0048026;GO:1905216;GO:0098789;GO:0050684;GO:0006446;GO:0006401;GO:0006405;GO:0016070;GO:0008380;GO:0042795;GO:0000245;GO:0006369;GO:0006366;GO:0006368;, C:cytosol; C:mitochondrion; C:mRNA cap binding complex; C:nuclear cap binding complex; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:gene silencing by RNA; P:histone mRNA metabolic process; P:mRNA 3'-end processing; P:mRNA cis splicing, via spliceosome; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear export; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell growth; P:positive regulation of mRNA 3'-end processing; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of RNA binding; P:pre-mRNA cleavage required for polyadenylation; P:regulation of mRNA processing; P:regulation of translational initiation; P:RNA catabolic process; P:RNA export from nucleus; P:RNA metabolic process; P:RNA splicing; P:snRNA transcription by RNA polymerase II; P:spliceosomal complex assembly; P:termination of RNA polymerase II transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q09161 B2R718 Q59G76 Q5T1V0 Q5T7X2,Nuclear cap-binding protein subunit 1,80 kDa nuclear cap-binding protein;, PF02854;PF09088;PF09090;, GO:0005829;GO:0005739;GO:0005845;GO:0005846;GO:0005654;GO:0005634;GO:1990904;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0006370;GO:0008543;GO:0031047;GO:0008334;GO:0031124;GO:0045292;GO:0006406;GO:0000398;GO:0051168;GO:0000184;GO:0030307;GO:0031442;GO:0048026;GO:1905216;GO:0098789;GO:0050684;GO:0006446;GO:0006401;GO:0006405;GO:0016070;GO:0008380;GO:0042795;GO:0000245;GO:0006369;GO:0006366;GO:0006368;, C:cytosol; C:mitochondrion; C:mRNA cap binding complex; C:nuclear cap binding complex; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:gene silencing by RNA; P:histone mRNA metabolic process; P:mRNA 3'-end processing; P:mRNA cis splicing, via spliceosome; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear export; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell growth; P:positive regulation of mRNA 3'-end processing; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of RNA binding; P:pre-mRNA cleavage required for polyadenylation; P:regulation of mRNA processing; P:regulation of translational initiation; P:RNA catabolic process; P:RNA export from nucleus; P:RNA metabolic process; P:RNA splicing; P:snRNA transcription by RNA polymerase II; P:spliceosomal complex assembly; P:termination of RNA polymerase II transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold70 indexed_genome mRNA 3742580 3834092 . - . ID=transcript_11262;Q9Y2M3,Tudor domain-containing protein 7,PCTAIRE2-binding protein;Tudor repeat associator with PCTAIRE-2;, PF12872;PF00567;, GO:0033391;GO:0005737;GO:0005759;GO:0035770;GO:0003729;GO:0047485;GO:0070306;GO:0002089;GO:0010608;GO:0007283;, C:chromatoid body; C:cytoplasm; C:mitochondrial matrix; C:ribonucleoprotein granule;, F:mRNA binding; F:protein N-terminus binding;, P:lens fiber cell differentiation; P:lens morphogenesis in camera-type eye; P:posttranscriptional regulation of gene expression; P:spermatogenesis; scaffold70 indexed_genome mRNA 3858611 3862866 . - . ID=transcript_11263;Q9P1Z9 Q2KHR6 Q5VV25 Q68DP5 Q69YV9 Q6AHY0,Coiled-coil domain-containing protein 180,, PF14643;PF14644;, GO:0070062;, C:extracellular exosome; scaffold70 indexed_genome mRNA 3865418 3888319 . - . ID=transcript_11264;Q9P1Z9 Q2KHR6 Q5VV25 Q68DP5 Q69YV9 Q6AHY0,Coiled-coil domain-containing protein 180,, PF14643;PF14644;, GO:0070062;, C:extracellular exosome; scaffold70 indexed_genome mRNA 3940486 3942523 . - . ID=transcript_11265;Q7L9G1 Q7Z3U9 Q8TB21 Q9BX78 Q9H9U8,Receptor for retinol uptake STRA6,Retinol-binding protein receptor STRA6 {ECO:0000303|PubMed:17503335, ECO:0000303|PubMed:22665496};Stimulated by retinoic acid gene 6 protein homolog;, , GO:0005887;GO:0005886;GO:0032991;GO:0016918;GO:0019841;GO:0034632;GO:0038023;GO:0030325;GO:0061143;GO:0048844;GO:0001568;GO:0043010;GO:0050890;GO:0048589;GO:0060539;GO:0048546;GO:0097070;GO:0043583;GO:0060900;GO:0048566;GO:0061029;GO:0060325;GO:0007631;GO:0030540;GO:0060322;GO:0060323;GO:0007507;GO:0001822;GO:0007612;GO:0048286;GO:0030324;GO:0060426;GO:0050905;GO:0043585;GO:0061205;GO:0048520;GO:0061156;GO:0003184;GO:0001523;GO:0034633;GO:0048745;GO:0061038;GO:0003281;GO:0071939;GO:0042297;, C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex;, F:retinal binding; F:retinol binding; F:retinol transmembrane transporter activity; F:signaling receptor activity;, P:adrenal gland development; P:alveolar primary septum development; P:artery morphogenesis; P:blood vessel development; P:camera-type eye development; P:cognition; P:developmental growth; P:diaphragm development; P:digestive tract morphogenesis; P:ductus arteriosus closure; P:ear development; P:embryonic camera-type eye formation; P:embryonic digestive tract development; P:eyelid development in camera-type eye; P:face morphogenesis; P:feeding behavior; P:female genitalia development; P:head development; P:head morphogenesis; P:heart development; P:kidney development; P:learning; P:lung alveolus development; P:lung development; P:lung vasculature development; P:neuromuscular process; P:nose morphogenesis; P:paramesonephric duct development; P:positive regulation of behavior; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:retinoid metabolic process; P:retinol transport; P:smooth muscle tissue development; P:uterus morphogenesis; P:ventricular septum development; P:vitamin A import; P:vocal learning; scaffold70 indexed_genome mRNA 4007702 4011600 . + . ID=transcript_11266;Q8WX77,Insulin-like growth factor-binding protein-like 1,IGFBP-related protein 10;Insulin-like growth factor-binding-related protein 4;, PF07679;PF00219;PF07648;, GO:0005615;GO:0005520;GO:0071228;GO:0001558;GO:0009966;, C:extracellular space;, F:insulin-like growth factor binding;, P:cellular response to tumor cell; P:regulation of cell growth; P:regulation of signal transduction; scaffold70 indexed_genome mRNA 4205203 5920967 . - . ID=transcript_11267;H0YFA7 Q0VA94,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,UDP-GlcNAc-2-epimerase/ManAc kinase;, PF02350;PF00480;, GO:0005737;GO:0005829;GO:0005524;GO:0004553;GO:0046872;GO:0009384;GO:0008761;GO:0007155;GO:0006045;GO:0006054;GO:0006047;, C:cytoplasm; C:cytosol;, F:ATP binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:metal ion binding; F:N-acylmannosamine kinase activity; F:UDP-N-acetylglucosamine 2-epimerase activity;, P:cell adhesion; P:N-acetylglucosamine biosynthetic process; P:N-acetylneuraminate metabolic process; P:UDP-N-acetylglucosamine metabolic process;|Q9H1U9,Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 {ECO:0000305},Mitochondrial NAD(+) transporter SLC25A51 {ECO:0000305};Mitochondrial carrier triple repeat protein 1 {ECO:0000305};Solute carrier family 25 member 51 {ECO:0000303|PubMed:32906142};, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0051724;GO:1990549;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:NAD transmembrane transporter activity;, P:mitochondrial NAD transmembrane transport;|Q5QP82 A4VCJ5 Q32NE2 Q8N2Q5 Q96ET5 Q9BTQ5 Q9H5P6,DDB1- and CUL4-associated factor 10,WD repeat-containing protein 32;, PF00400;, GO:0080008;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q5QP82 A4VCJ5 Q32NE2 Q8N2Q5 Q96ET5 Q9BTQ5 Q9H5P6,DDB1- and CUL4-associated factor 10,WD repeat-containing protein 32;, PF00400;, GO:0080008;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q5QP82 A4VCJ5 Q32NE2 Q8N2Q5 Q96ET5 Q9BTQ5 Q9H5P6,DDB1- and CUL4-associated factor 10,WD repeat-containing protein 32;, PF00400;, GO:0080008;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q9NQT5 A8K0K6 Q5QP85 Q9Y3A8,Exosome complex component RRP40,Exosome component 3;Ribosomal RNA-processing protein 40;p10;, PF15985;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0035327;GO:0000175;GO:0003723;GO:0071034;GO:0045006;GO:0043928;GO:0000467;GO:0045190;GO:0071035;GO:0071038;GO:0071049;GO:0034427;GO:0071051;GO:0045830;GO:0043488;GO:0006364;GO:0034475;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:3'-5'-exoribonuclease activity; F:RNA binding;, P:CUT catabolic process; P:DNA deamination; P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:isotype switching; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyadenylation-dependent snoRNA 3'-end processing; P:positive regulation of isotype switching; P:regulation of mRNA stability; P:rRNA processing; P:U4 snRNA 3'-end processing;|Q9NQT5 A8K0K6 Q5QP85 Q9Y3A8,Exosome complex component RRP40,Exosome component 3;Ribosomal RNA-processing protein 40;p10;, PF15985;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0035327;GO:0000175;GO:0003723;GO:0071034;GO:0045006;GO:0043928;GO:0000467;GO:0045190;GO:0071035;GO:0071038;GO:0071049;GO:0034427;GO:0071051;GO:0045830;GO:0043488;GO:0006364;GO:0034475;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus; C:transcriptionally active chromatin;, F:3'-5'-exoribonuclease activity; F:RNA binding;, P:CUT catabolic process; P:DNA deamination; P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:isotype switching; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyadenylation-dependent snoRNA 3'-end processing; P:positive regulation of isotype switching; P:regulation of mRNA stability; P:rRNA processing; P:U4 snRNA 3'-end processing;|Q6PF06 B7Z216 B7Z3D3 Q05DJ4 Q5QP83 Q8NAG2 Q96N36,tRNA methyltransferase 10 homolog B,RNA (guanine-9-)-methyltransferase domain-containing protein 3;tRNA (guanine(9)-N(1))-methyltransferase TRMT10B;, PF01746;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0052905;GO:0009019;GO:0000049;GO:0090646;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:tRNA (guanine(9)-N(1))-methyltransferase activity; F:tRNA (guanine-N1-)-methyltransferase activity; F:tRNA binding;, P:mitochondrial tRNA processing;|Q6PF06 B7Z216 B7Z3D3 Q05DJ4 Q5QP83 Q8NAG2 Q96N36,tRNA methyltransferase 10 homolog B,RNA (guanine-9-)-methyltransferase domain-containing protein 3;tRNA (guanine(9)-N(1))-methyltransferase TRMT10B;, PF01746;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0052905;GO:0009019;GO:0000049;GO:0090646;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:tRNA (guanine(9)-N(1))-methyltransferase activity; F:tRNA (guanine-N1-)-methyltransferase activity; F:tRNA binding;, P:mitochondrial tRNA processing;|Q5SYB0 B4DZC8 B7Z807 D3DRQ3 Q14C73 Q5HY96 Q9Y2H3,FERM and PDZ domain-containing protein 1,FERM domain-containing protein 2;, PF00373;PF00595;, GO:0005856;GO:0005829;GO:0005886;GO:0032991;GO:0090150;GO:0008277;, C:cytoskeleton; C:cytosol; C:plasma membrane; C:protein-containing complex;, , P:establishment of protein localization to membrane; P:regulation of G protein-coupled receptor signaling pathway;|Q5SYB0 B4DZC8 B7Z807 D3DRQ3 Q14C73 Q5HY96 Q9Y2H3,FERM and PDZ domain-containing protein 1,FERM domain-containing protein 2;, PF00373;PF00595;, GO:0005856;GO:0005829;GO:0005886;GO:0032991;GO:0090150;GO:0008277;, C:cytoskeleton; C:cytosol; C:plasma membrane; C:protein-containing complex;, , P:establishment of protein localization to membrane; P:regulation of G protein-coupled receptor signaling pathway;|Q5SYB0 B4DZC8 B7Z807 D3DRQ3 Q14C73 Q5HY96 Q9Y2H3,FERM and PDZ domain-containing protein 1,FERM domain-containing protein 2;, PF00373;PF00595;, GO:0005856;GO:0005829;GO:0005886;GO:0032991;GO:0090150;GO:0008277;, C:cytoskeleton; C:cytosol; C:plasma membrane; C:protein-containing complex;, , P:establishment of protein localization to membrane; P:regulation of G protein-coupled receptor signaling pathway;|Q8N4H5 B2DG07 F6S928 Q5JRT7,Mitochondrial import receptor subunit TOM5 homolog,, PF10642;, GO:0016021;GO:0005741;GO:0005742;GO:0005739;GO:0016236;GO:0006626;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, , P:macroautophagy; P:protein targeting to mitochondrion;|Q9UK96 Q08AL3 Q08AL4 Q5JRT8 Q9UKC3,F-box only protein 10,, PF13229;PF12937;PF05048;, GO:0005737;GO:0005829;GO:0000151;GO:0004842;GO:0006915;GO:0043687;GO:0000209;GO:0016567;GO:0042981;GO:0006511;, C:cytoplasm; C:cytosol; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:apoptotic process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of apoptotic process; P:ubiquitin-dependent protein catabolic process;|Q9UK96 Q08AL3 Q08AL4 Q5JRT8 Q9UKC3,F-box only protein 10,, PF13229;PF12937;PF05048;, GO:0005737;GO:0005829;GO:0000151;GO:0004842;GO:0006915;GO:0043687;GO:0000209;GO:0016567;GO:0042981;GO:0006511;, C:cytoplasm; C:cytosol; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:apoptotic process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of apoptotic process; P:ubiquitin-dependent protein catabolic process;|Q9UK96 Q08AL3 Q08AL4 Q5JRT8 Q9UKC3,F-box only protein 10,, PF13229;PF12937;PF05048;, GO:0005737;GO:0005829;GO:0000151;GO:0004842;GO:0006915;GO:0043687;GO:0000209;GO:0016567;GO:0042981;GO:0006511;, C:cytoplasm; C:cytosol; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:apoptotic process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of apoptotic process; P:ubiquitin-dependent protein catabolic process;|Q9UK96 Q08AL3 Q08AL4 Q5JRT8 Q9UKC3,F-box only protein 10,, PF13229;PF12937;PF05048;, GO:0005737;GO:0005829;GO:0000151;GO:0004842;GO:0006915;GO:0043687;GO:0000209;GO:0016567;GO:0042981;GO:0006511;, C:cytoplasm; C:cytosol; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:apoptotic process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of apoptotic process; P:ubiquitin-dependent protein catabolic process;|Q9UK96 Q08AL3 Q08AL4 Q5JRT8 Q9UKC3,F-box only protein 10,, PF13229;PF12937;PF05048;, GO:0005737;GO:0005829;GO:0000151;GO:0004842;GO:0006915;GO:0043687;GO:0000209;GO:0016567;GO:0042981;GO:0006511;, C:cytoplasm; C:cytosol; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:apoptotic process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of apoptotic process; P:ubiquitin-dependent protein catabolic process;|Q9GZS1 Q5VZT3 Q8NBA9 Q96L20,DNA-directed RNA polymerase I subunit RPA49,DNA-directed RNA polymerase I subunit E;RNA polymerase I-associated factor 1;RNA polymerase I-associated factor 53 {ECO:0000303|PubMed:24207024};, PF06870;, GO:0001650;GO:0005730;GO:0005654;GO:0005736;GO:0003677;GO:0003899;GO:0001179;GO:0042790;GO:0045815;GO:0001188;GO:0006363;GO:0006362;GO:0006361;, C:fibrillar center; C:nucleolus; C:nucleoplasm; C:RNA polymerase I complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:RNA polymerase I general transcription initiation factor binding;, P:nucleolar large rRNA transcription by RNA polymerase I; P:positive regulation of gene expression, epigenetic; P:RNA polymerase I preinitiation complex assembly; P:termination of RNA polymerase I transcription; P:transcription elongation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase I promoter;|Q9GZS1 Q5VZT3 Q8NBA9 Q96L20,DNA-directed RNA polymerase I subunit RPA49,DNA-directed RNA polymerase I subunit E;RNA polymerase I-associated factor 1;RNA polymerase I-associated factor 53 {ECO:0000303|PubMed:24207024};, PF06870;, GO:0001650;GO:0005730;GO:0005654;GO:0005736;GO:0003677;GO:0003899;GO:0001179;GO:0042790;GO:0045815;GO:0001188;GO:0006363;GO:0006362;GO:0006361;, C:fibrillar center; C:nucleolus; C:nucleoplasm; C:RNA polymerase I complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:RNA polymerase I general transcription initiation factor binding;, P:nucleolar large rRNA transcription by RNA polymerase I; P:positive regulation of gene expression, epigenetic; P:RNA polymerase I preinitiation complex assembly; P:termination of RNA polymerase I transcription; P:transcription elongation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase I promoter;|Q9GZS1 Q5VZT3 Q8NBA9 Q96L20,DNA-directed RNA polymerase I subunit RPA49,DNA-directed RNA polymerase I subunit E;RNA polymerase I-associated factor 1;RNA polymerase I-associated factor 53 {ECO:0000303|PubMed:24207024};, PF06870;, GO:0001650;GO:0005730;GO:0005654;GO:0005736;GO:0003677;GO:0003899;GO:0001179;GO:0042790;GO:0045815;GO:0001188;GO:0006363;GO:0006362;GO:0006361;, C:fibrillar center; C:nucleolus; C:nucleoplasm; C:RNA polymerase I complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:RNA polymerase I general transcription initiation factor binding;, P:nucleolar large rRNA transcription by RNA polymerase I; P:positive regulation of gene expression, epigenetic; P:RNA polymerase I preinitiation complex assembly; P:termination of RNA polymerase I transcription; P:transcription elongation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase I promoter;|Q9GZS1 Q5VZT3 Q8NBA9 Q96L20,DNA-directed RNA polymerase I subunit RPA49,DNA-directed RNA polymerase I subunit E;RNA polymerase I-associated factor 1;RNA polymerase I-associated factor 53 {ECO:0000303|PubMed:24207024};, PF06870;, GO:0001650;GO:0005730;GO:0005654;GO:0005736;GO:0003677;GO:0003899;GO:0001179;GO:0042790;GO:0045815;GO:0001188;GO:0006363;GO:0006362;GO:0006361;, C:fibrillar center; C:nucleolus; C:nucleoplasm; C:RNA polymerase I complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:RNA polymerase I general transcription initiation factor binding;, P:nucleolar large rRNA transcription by RNA polymerase I; P:positive regulation of gene expression, epigenetic; P:RNA polymerase I preinitiation complex assembly; P:termination of RNA polymerase I transcription; P:transcription elongation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase I promoter;|O15062,Zinc finger and BTB domain-containing protein 5,, PF00651;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:0000122;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9UBQ7 Q5T945 Q9H3E9 Q9H636 Q9UKX1,Glyoxylate reductase/hydroxypyruvate reductase,, PF00389;PF02826;, GO:1902494;GO:0005737;GO:0005829;GO:0070062;GO:0005782;GO:0008465;GO:0030267;GO:0016618;GO:0051287;GO:0070402;GO:0042803;GO:0019752;GO:0007588;GO:0046487;, C:catalytic complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal matrix;, F:glycerate dehydrogenase activity; F:glyoxylate reductase (NADP+) activity; F:hydroxypyruvate reductase activity; F:NAD binding; F:NADPH binding; F:protein homodimerization activity;, P:carboxylic acid metabolic process; P:excretion; P:glyoxylate metabolic process;|Q9UBQ7 Q5T945 Q9H3E9 Q9H636 Q9UKX1,Glyoxylate reductase/hydroxypyruvate reductase,, PF00389;PF02826;, GO:1902494;GO:0005737;GO:0005829;GO:0070062;GO:0005782;GO:0008465;GO:0030267;GO:0016618;GO:0051287;GO:0070402;GO:0042803;GO:0019752;GO:0007588;GO:0046487;, C:catalytic complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal matrix;, F:glycerate dehydrogenase activity; F:glyoxylate reductase (NADP+) activity; F:hydroxypyruvate reductase activity; F:NAD binding; F:NADPH binding; F:protein homodimerization activity;, P:carboxylic acid metabolic process; P:excretion; P:glyoxylate metabolic process;|Q9H648 Q9P0F0,Zinc finger CCHC domain-containing protein 7,TRAMP-like complex RNA-binding factor ZCCHC7;, PF00098;, GO:0005829;GO:0005730;GO:0003723;GO:0008270;, C:cytosol; C:nucleolus;, F:RNA binding; F:zinc ion binding;|Q9H648 Q9P0F0,Zinc finger CCHC domain-containing protein 7,TRAMP-like complex RNA-binding factor ZCCHC7;, PF00098;, GO:0005829;GO:0005730;GO:0003723;GO:0008270;, C:cytosol; C:nucleolus;, F:RNA binding; F:zinc ion binding;|Q9H648 Q9P0F0,Zinc finger CCHC domain-containing protein 7,TRAMP-like complex RNA-binding factor ZCCHC7;, PF00098;, GO:0005829;GO:0005730;GO:0003723;GO:0008270;, C:cytosol; C:nucleolus;, F:RNA binding; F:zinc ion binding;|B7Z7Q1 D3DRP8 F5H0Y0 F5H2R4 F5H689 Q7L3C3,Maternal embryonic leucine zipper kinase,Protein kinase Eg3;Protein kinase PK38;Tyrosine-protein kinase MELK;, PF02149;PF00069;, GO:0005938;GO:0005737;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0005509;GO:0008289;GO:0004715;GO:0106310;GO:0004674;GO:0106311;GO:0004714;GO:0006915;GO:0008283;GO:0000086;GO:0030097;GO:0035556;GO:0008631;GO:0061351;GO:0043065;GO:0046777;GO:0006468;, C:cell cortex; C:cytoplasm; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:lipid binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:apoptotic process; P:cell population proliferation; P:G2/M transition of mitotic cell cycle; P:hemopoiesis; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:neural precursor cell proliferation; P:positive regulation of apoptotic process; P:protein autophosphorylation; P:protein phosphorylation;|B7Z7Q1 D3DRP8 F5H0Y0 F5H2R4 F5H689 Q7L3C3,Maternal embryonic leucine zipper kinase,Protein kinase Eg3;Protein kinase PK38;Tyrosine-protein kinase MELK;, PF02149;PF00069;, GO:0005938;GO:0005737;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0005509;GO:0008289;GO:0004715;GO:0106310;GO:0004674;GO:0106311;GO:0004714;GO:0006915;GO:0008283;GO:0000086;GO:0030097;GO:0035556;GO:0008631;GO:0061351;GO:0043065;GO:0046777;GO:0006468;, C:cell cortex; C:cytoplasm; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:lipid binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:apoptotic process; P:cell population proliferation; P:G2/M transition of mitotic cell cycle; P:hemopoiesis; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:neural precursor cell proliferation; P:positive regulation of apoptotic process; P:protein autophosphorylation; P:protein phosphorylation;|B7Z7Q1 D3DRP8 F5H0Y0 F5H2R4 F5H689 Q7L3C3,Maternal embryonic leucine zipper kinase,Protein kinase Eg3;Protein kinase PK38;Tyrosine-protein kinase MELK;, PF02149;PF00069;, GO:0005938;GO:0005737;GO:0016020;GO:0005634;GO:0005886;GO:0005524;GO:0005509;GO:0008289;GO:0004715;GO:0106310;GO:0004674;GO:0106311;GO:0004714;GO:0006915;GO:0008283;GO:0000086;GO:0030097;GO:0035556;GO:0008631;GO:0061351;GO:0043065;GO:0046777;GO:0006468;, C:cell cortex; C:cytoplasm; C:membrane; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:lipid binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:apoptotic process; P:cell population proliferation; P:G2/M transition of mitotic cell cycle; P:hemopoiesis; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:neural precursor cell proliferation; P:positive regulation of apoptotic process; P:protein autophosphorylation; P:protein phosphorylation;|Q9H0F5 A6PVP9 B1AM81 B1AM82 B3KSG4 E7EVL3 Q7LB33 Q8N0Y0 Q9H748,E3 ubiquitin-protein ligase RNF38,RING finger protein 38;RING-type E3 ubiquitin transferase RNF38 {ECO:0000305};, PF13639;, GO:0005654;GO:0005634;GO:0036126;GO:0046872;GO:0061630;GO:0008584;GO:0016567;, C:nucleoplasm; C:nucleus; C:sperm flagellum;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:male gonad development; P:protein ubiquitination;|Q9H0F5 A6PVP9 B1AM81 B1AM82 B3KSG4 E7EVL3 Q7LB33 Q8N0Y0 Q9H748,E3 ubiquitin-protein ligase RNF38,RING finger protein 38;RING-type E3 ubiquitin transferase RNF38 {ECO:0000305};, PF13639;, GO:0005654;GO:0005634;GO:0036126;GO:0046872;GO:0061630;GO:0008584;GO:0016567;, C:nucleoplasm; C:nucleus; C:sperm flagellum;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:male gonad development; P:protein ubiquitination;|Q9H0F5 A6PVP9 B1AM81 B1AM82 B3KSG4 E7EVL3 Q7LB33 Q8N0Y0 Q9H748,E3 ubiquitin-protein ligase RNF38,RING finger protein 38;RING-type E3 ubiquitin transferase RNF38 {ECO:0000305};, PF13639;, GO:0005654;GO:0005634;GO:0036126;GO:0046872;GO:0061630;GO:0008584;GO:0016567;, C:nucleoplasm; C:nucleus; C:sperm flagellum;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:male gonad development; P:protein ubiquitination;|Q9H0F5 A6PVP9 B1AM81 B1AM82 B3KSG4 E7EVL3 Q7LB33 Q8N0Y0 Q9H748,E3 ubiquitin-protein ligase RNF38,RING finger protein 38;RING-type E3 ubiquitin transferase RNF38 {ECO:0000305};, PF13639;, GO:0005654;GO:0005634;GO:0036126;GO:0046872;GO:0061630;GO:0008584;GO:0016567;, C:nucleoplasm; C:nucleus; C:sperm flagellum;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:male gonad development; P:protein ubiquitination;|H0YFA7 Q0VA94,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,UDP-GlcNAc-2-epimerase/ManAc kinase;, PF02350;PF00480;, GO:0005737;GO:0005829;GO:0005524;GO:0004553;GO:0046872;GO:0009384;GO:0008761;GO:0007155;GO:0006045;GO:0006054;GO:0006047;, C:cytoplasm; C:cytosol;, F:ATP binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:metal ion binding; F:N-acylmannosamine kinase activity; F:UDP-N-acetylglucosamine 2-epimerase activity;, P:cell adhesion; P:N-acetylglucosamine biosynthetic process; P:N-acetylneuraminate metabolic process; P:UDP-N-acetylglucosamine metabolic process;|H0YFA7 Q0VA94,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,UDP-GlcNAc-2-epimerase/ManAc kinase;, PF02350;PF00480;, GO:0005737;GO:0005829;GO:0005524;GO:0004553;GO:0046872;GO:0009384;GO:0008761;GO:0007155;GO:0006045;GO:0006054;GO:0006047;, C:cytoplasm; C:cytosol;, F:ATP binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:metal ion binding; F:N-acylmannosamine kinase activity; F:UDP-N-acetylglucosamine 2-epimerase activity;, P:cell adhesion; P:N-acetylglucosamine biosynthetic process; P:N-acetylneuraminate metabolic process; P:UDP-N-acetylglucosamine metabolic process;|H0YFA7 Q0VA94,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,UDP-GlcNAc-2-epimerase/ManAc kinase;, PF02350;PF00480;, GO:0005737;GO:0005829;GO:0005524;GO:0004553;GO:0046872;GO:0009384;GO:0008761;GO:0007155;GO:0006045;GO:0006054;GO:0006047;, C:cytoplasm; C:cytosol;, F:ATP binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:metal ion binding; F:N-acylmannosamine kinase activity; F:UDP-N-acetylglucosamine 2-epimerase activity;, P:cell adhesion; P:N-acetylglucosamine biosynthetic process; P:N-acetylneuraminate metabolic process; P:UDP-N-acetylglucosamine metabolic process;|H0YFA7 Q0VA94,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,UDP-GlcNAc-2-epimerase/ManAc kinase;, PF02350;PF00480;, GO:0005737;GO:0005829;GO:0005524;GO:0004553;GO:0046872;GO:0009384;GO:0008761;GO:0007155;GO:0006045;GO:0006054;GO:0006047;, C:cytoplasm; C:cytosol;, F:ATP binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:metal ion binding; F:N-acylmannosamine kinase activity; F:UDP-N-acetylglucosamine 2-epimerase activity;, P:cell adhesion; P:N-acetylglucosamine biosynthetic process; P:N-acetylneuraminate metabolic process; P:UDP-N-acetylglucosamine metabolic process; scaffold70 indexed_genome mRNA 5921560 5923270 . + . ID=transcript_11268;H0YFA7 Q0VA94,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,UDP-GlcNAc-2-epimerase/ManAc kinase;, PF02350;PF00480;, GO:0005737;GO:0005829;GO:0005524;GO:0004553;GO:0046872;GO:0009384;GO:0008761;GO:0007155;GO:0006045;GO:0006054;GO:0006047;, C:cytoplasm; C:cytosol;, F:ATP binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:metal ion binding; F:N-acylmannosamine kinase activity; F:UDP-N-acetylglucosamine 2-epimerase activity;, P:cell adhesion; P:N-acetylglucosamine biosynthetic process; P:N-acetylneuraminate metabolic process; P:UDP-N-acetylglucosamine metabolic process; scaffold70 indexed_genome mRNA 5925790 5927958 . - . ID=transcript_11269;H0YFA7 Q0VA94,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,UDP-GlcNAc-2-epimerase/ManAc kinase;, PF02350;PF00480;, GO:0005737;GO:0005829;GO:0005524;GO:0004553;GO:0046872;GO:0009384;GO:0008761;GO:0007155;GO:0006045;GO:0006054;GO:0006047;, C:cytoplasm; C:cytosol;, F:ATP binding; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:metal ion binding; F:N-acylmannosamine kinase activity; F:UDP-N-acetylglucosamine 2-epimerase activity;, P:cell adhesion; P:N-acetylglucosamine biosynthetic process; P:N-acetylneuraminate metabolic process; P:UDP-N-acetylglucosamine metabolic process; scaffold70 indexed_genome mRNA 5931917 5949451 . - . ID=transcript_11270;P09496 A8K4W3 B4DIN1 F5H6N3 Q2XPN5 Q53XZ1,Clathrin light chain A,, PF01086;, GO:0030118;GO:0030132;GO:0030130;GO:0071439;GO:0030125;GO:0045334;GO:0031410;GO:0005829;GO:0036020;GO:0016020;GO:0005886;GO:0099631;GO:0098835;GO:0005819;GO:0030672;GO:0032588;GO:0032050;GO:0051020;GO:0042277;GO:0044877;GO:0005198;GO:0019886;GO:0007049;GO:0051301;GO:0048268;GO:0072583;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0006892;, C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin complex; C:clathrin vesicle coat; C:clathrin-coated endocytic vesicle; C:cytoplasmic vesicle; C:cytosol; C:endolysosome membrane; C:membrane; C:plasma membrane; C:postsynaptic endocytic zone cytoplasmic component; C:presynaptic endocytic zone membrane; C:spindle; C:synaptic vesicle membrane; C:trans-Golgi network membrane;, F:clathrin heavy chain binding; F:GTPase binding; F:peptide binding; F:protein-containing complex binding; F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell cycle; P:cell division; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:post-Golgi vesicle-mediated transport;|P09496 A8K4W3 B4DIN1 F5H6N3 Q2XPN5 Q53XZ1,Clathrin light chain A,, PF01086;, GO:0030118;GO:0030132;GO:0030130;GO:0071439;GO:0030125;GO:0045334;GO:0031410;GO:0005829;GO:0036020;GO:0016020;GO:0005886;GO:0099631;GO:0098835;GO:0005819;GO:0030672;GO:0032588;GO:0032050;GO:0051020;GO:0042277;GO:0044877;GO:0005198;GO:0019886;GO:0007049;GO:0051301;GO:0048268;GO:0072583;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0006892;, C:clathrin coat; C:clathrin coat of coated pit; C:clathrin coat of trans-Golgi network vesicle; C:clathrin complex; C:clathrin vesicle coat; C:clathrin-coated endocytic vesicle; C:cytoplasmic vesicle; C:cytosol; C:endolysosome membrane; C:membrane; C:plasma membrane; C:postsynaptic endocytic zone cytoplasmic component; C:presynaptic endocytic zone membrane; C:spindle; C:synaptic vesicle membrane; C:trans-Golgi network membrane;, F:clathrin heavy chain binding; F:GTPase binding; F:peptide binding; F:protein-containing complex binding; F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell cycle; P:cell division; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:post-Golgi vesicle-mediated transport; scaffold70 indexed_genome mRNA 5975311 5995152 . - . ID=transcript_11271;Q9H4G4 Q5VZR1 Q8N2S6 Q8WWC9 Q8WX36,Golgi-associated plant pathogenesis-related protein 1,Glioma pathogenesis-related protein 2;, PF00188;, GO:0070062;GO:0005615;GO:0000139;GO:0042803;GO:0010634;GO:0010718;GO:0070374;, C:extracellular exosome; C:extracellular space; C:Golgi membrane;, F:protein homodimerization activity;, P:positive regulation of epithelial cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade;|Q9H4G4 Q5VZR1 Q8N2S6 Q8WWC9 Q8WX36,Golgi-associated plant pathogenesis-related protein 1,Glioma pathogenesis-related protein 2;, PF00188;, GO:0070062;GO:0005615;GO:0000139;GO:0042803;GO:0010634;GO:0010718;GO:0070374;, C:extracellular exosome; C:extracellular space; C:Golgi membrane;, F:protein homodimerization activity;, P:positive regulation of epithelial cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade;|Q9H4G4 Q5VZR1 Q8N2S6 Q8WWC9 Q8WX36,Golgi-associated plant pathogenesis-related protein 1,Glioma pathogenesis-related protein 2;, PF00188;, GO:0070062;GO:0005615;GO:0000139;GO:0042803;GO:0010634;GO:0010718;GO:0070374;, C:extracellular exosome; C:extracellular space; C:Golgi membrane;, F:protein homodimerization activity;, P:positive regulation of epithelial cell migration; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; scaffold70 indexed_genome mRNA 6006951 6085197 . + . ID=transcript_11272;O95980 B2RNS1 Q5W0K6 Q8WX37,Reversion-inducing cysteine-rich protein with Kazal motifs {ECO:0000303|PubMed:9789069},Suppressor of tumorigenicity 15 protein {ECO:0000312|EMBL:BAA34060.1};, PF07648;, GO:0031225;GO:0005576;GO:0016020;GO:0005886;GO:1990909;GO:1904928;GO:0004866;GO:0008191;GO:0004867;GO:0017147;GO:0001955;GO:0007566;GO:0035115;GO:0030198;GO:0030336;GO:1904684;GO:0090263;GO:0045765;GO:0090210;GO:0002040;, C:anchored component of membrane; C:extracellular region; C:membrane; C:plasma membrane; C:Wnt signalosome;, F:coreceptor activity involved in canonical Wnt signaling pathway; F:endopeptidase inhibitor activity; F:metalloendopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity; F:Wnt-protein binding;, P:blood vessel maturation; P:embryo implantation; P:embryonic forelimb morphogenesis; P:extracellular matrix organization; P:negative regulation of cell migration; P:negative regulation of metalloendopeptidase activity; P:positive regulation of canonical Wnt signaling pathway; P:regulation of angiogenesis; P:regulation of establishment of blood-brain barrier; P:sprouting angiogenesis;|O95980 B2RNS1 Q5W0K6 Q8WX37,Reversion-inducing cysteine-rich protein with Kazal motifs {ECO:0000303|PubMed:9789069},Suppressor of tumorigenicity 15 protein {ECO:0000312|EMBL:BAA34060.1};, PF07648;, GO:0031225;GO:0005576;GO:0016020;GO:0005886;GO:1990909;GO:1904928;GO:0004866;GO:0008191;GO:0004867;GO:0017147;GO:0001955;GO:0007566;GO:0035115;GO:0030198;GO:0030336;GO:1904684;GO:0090263;GO:0045765;GO:0090210;GO:0002040;, C:anchored component of membrane; C:extracellular region; C:membrane; C:plasma membrane; C:Wnt signalosome;, F:coreceptor activity involved in canonical Wnt signaling pathway; F:endopeptidase inhibitor activity; F:metalloendopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity; F:Wnt-protein binding;, P:blood vessel maturation; P:embryo implantation; P:embryonic forelimb morphogenesis; P:extracellular matrix organization; P:negative regulation of cell migration; P:negative regulation of metalloendopeptidase activity; P:positive regulation of canonical Wnt signaling pathway; P:regulation of angiogenesis; P:regulation of establishment of blood-brain barrier; P:sprouting angiogenesis;|O95980 B2RNS1 Q5W0K6 Q8WX37,Reversion-inducing cysteine-rich protein with Kazal motifs {ECO:0000303|PubMed:9789069},Suppressor of tumorigenicity 15 protein {ECO:0000312|EMBL:BAA34060.1};, PF07648;, GO:0031225;GO:0005576;GO:0016020;GO:0005886;GO:1990909;GO:1904928;GO:0004866;GO:0008191;GO:0004867;GO:0017147;GO:0001955;GO:0007566;GO:0035115;GO:0030198;GO:0030336;GO:1904684;GO:0090263;GO:0045765;GO:0090210;GO:0002040;, C:anchored component of membrane; C:extracellular region; C:membrane; C:plasma membrane; C:Wnt signalosome;, F:coreceptor activity involved in canonical Wnt signaling pathway; F:endopeptidase inhibitor activity; F:metalloendopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity; F:Wnt-protein binding;, P:blood vessel maturation; P:embryo implantation; P:embryonic forelimb morphogenesis; P:extracellular matrix organization; P:negative regulation of cell migration; P:negative regulation of metalloendopeptidase activity; P:positive regulation of canonical Wnt signaling pathway; P:regulation of angiogenesis; P:regulation of establishment of blood-brain barrier; P:sprouting angiogenesis; scaffold70 indexed_genome mRNA 6178711 6180731 . - . ID=transcript_11273;A0A1B0GVQ0,Small regulatory polypeptide of amino acid response {ECO:0000303|PubMed:28024296},, , GO:1905103;GO:0031902;GO:0071230;GO:1904262;GO:0043416;, C:integral component of lysosomal membrane; C:late endosome membrane;, , P:cellular response to amino acid stimulus; P:negative regulation of TORC1 signaling; P:regulation of skeletal muscle tissue regeneration; scaffold70 indexed_genome mRNA 6222225 6246767 . + . ID=transcript_11274;A6NDV4 B3KQF3 O75539 Q49AB1 Q4KMX5 Q5TCW5 Q9HBY2 Q9P0U7,Transmembrane protein 8B,Nasopharyngeal carcinoma-associated gene 6 protein;Protein NAG-5;Protein NGX6;, PF12036;, GO:0009986;GO:0005783;GO:0016021;GO:0005739;GO:0005634;GO:0005886;GO:0007160;GO:0040008;GO:0007346;, C:cell surface; C:endoplasmic reticulum; C:integral component of membrane; C:mitochondrion; C:nucleus; C:plasma membrane;, , P:cell-matrix adhesion; P:regulation of growth; P:regulation of mitotic cell cycle;|A6NDV4 B3KQF3 O75539 Q49AB1 Q4KMX5 Q5TCW5 Q9HBY2 Q9P0U7,Transmembrane protein 8B,Nasopharyngeal carcinoma-associated gene 6 protein;Protein NAG-5;Protein NGX6;, PF12036;, GO:0009986;GO:0005783;GO:0016021;GO:0005739;GO:0005634;GO:0005886;GO:0007160;GO:0040008;GO:0007346;, C:cell surface; C:endoplasmic reticulum; C:integral component of membrane; C:mitochondrion; C:nucleus; C:plasma membrane;, , P:cell-matrix adhesion; P:regulation of growth; P:regulation of mitotic cell cycle;|A6NDV4 B3KQF3 O75539 Q49AB1 Q4KMX5 Q5TCW5 Q9HBY2 Q9P0U7,Transmembrane protein 8B,Nasopharyngeal carcinoma-associated gene 6 protein;Protein NAG-5;Protein NGX6;, PF12036;, GO:0009986;GO:0005783;GO:0016021;GO:0005739;GO:0005634;GO:0005886;GO:0007160;GO:0040008;GO:0007346;, C:cell surface; C:endoplasmic reticulum; C:integral component of membrane; C:mitochondrion; C:nucleus; C:plasma membrane;, , P:cell-matrix adhesion; P:regulation of growth; P:regulation of mitotic cell cycle; scaffold70 indexed_genome mRNA 6246877 6254342 . + . ID=transcript_11275;A6H8Z2 Q5TCW2,Protein FAM221B,, PF14753;|A6H8Z2 Q5TCW2,Protein FAM221B,, PF14753;|A6H8Z2 Q5TCW2,Protein FAM221B,, PF14753; scaffold70 indexed_genome mRNA 6257536 6260454 . + . ID=transcript_11276;Q9BX68 Q5TCW3,Histidine triad nucleotide-binding protein 2, mitochondrial {ECO:0000305},HINT-3 {ECO:0000303|Ref.4};HIT-17kDa {ECO:0000303|Ref.1};PKCI-1-related HIT protein {ECO:0000303|Ref.2};, PF01230;, GO:0005737;GO:0005739;GO:0016787;GO:0000166;GO:0006915;GO:0016042;GO:2000757;GO:0006694;, C:cytoplasm; C:mitochondrion;, F:hydrolase activity; F:nucleotide binding;, P:apoptotic process; P:lipid catabolic process; P:negative regulation of peptidyl-lysine acetylation; P:steroid biosynthetic process; scaffold70 indexed_genome mRNA 6260555 6275342 . - . ID=transcript_11277;Q9UQ50,Atrial natriuretic peptide receptor 2,Atrial natriuretic peptide receptor type B;Guanylate cyclase B;, PF01094;PF00211;PF07714;, GO:0005887;GO:0005886;GO:0005524;GO:0005525;GO:0004383;GO:0042562;GO:0042802;GO:0016941;GO:0017046;GO:0001653;GO:0004672;GO:0060348;GO:0097011;GO:0006182;GO:0019934;GO:0051447;GO:1900194;GO:0001503;GO:0010753;GO:0007168;GO:0008217;GO:1903779;GO:0022414;GO:0007165;, C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:guanylate cyclase activity; F:hormone binding; F:identical protein binding; F:natriuretic peptide receptor activity; F:peptide hormone binding; F:peptide receptor activity; F:protein kinase activity;, P:bone development; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:negative regulation of meiotic cell cycle; P:negative regulation of oocyte maturation; P:ossification; P:positive regulation of cGMP-mediated signaling; P:receptor guanylyl cyclase signaling pathway; P:regulation of blood pressure; P:regulation of cardiac conduction; P:reproductive process; P:signal transduction;|Q9UQ50,Atrial natriuretic peptide receptor 2,Atrial natriuretic peptide receptor type B;Guanylate cyclase B;, PF01094;PF00211;PF07714;, GO:0005887;GO:0005886;GO:0005524;GO:0005525;GO:0004383;GO:0042562;GO:0042802;GO:0016941;GO:0017046;GO:0001653;GO:0004672;GO:0060348;GO:0097011;GO:0006182;GO:0019934;GO:0051447;GO:1900194;GO:0001503;GO:0010753;GO:0007168;GO:0008217;GO:1903779;GO:0022414;GO:0007165;, C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:guanylate cyclase activity; F:hormone binding; F:identical protein binding; F:natriuretic peptide receptor activity; F:peptide hormone binding; F:peptide receptor activity; F:protein kinase activity;, P:bone development; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:negative regulation of meiotic cell cycle; P:negative regulation of oocyte maturation; P:ossification; P:positive regulation of cGMP-mediated signaling; P:receptor guanylyl cyclase signaling pathway; P:regulation of blood pressure; P:regulation of cardiac conduction; P:reproductive process; P:signal transduction;|Q9UQ50,Atrial natriuretic peptide receptor 2,Atrial natriuretic peptide receptor type B;Guanylate cyclase B;, PF01094;PF00211;PF07714;, GO:0005887;GO:0005886;GO:0005524;GO:0005525;GO:0004383;GO:0042562;GO:0042802;GO:0016941;GO:0017046;GO:0001653;GO:0004672;GO:0060348;GO:0097011;GO:0006182;GO:0019934;GO:0051447;GO:1900194;GO:0001503;GO:0010753;GO:0007168;GO:0008217;GO:1903779;GO:0022414;GO:0007165;, C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:guanylate cyclase activity; F:hormone binding; F:identical protein binding; F:natriuretic peptide receptor activity; F:peptide hormone binding; F:peptide receptor activity; F:protein kinase activity;, P:bone development; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:negative regulation of meiotic cell cycle; P:negative regulation of oocyte maturation; P:ossification; P:positive regulation of cGMP-mediated signaling; P:receptor guanylyl cyclase signaling pathway; P:regulation of blood pressure; P:regulation of cardiac conduction; P:reproductive process; P:signal transduction; scaffold70 indexed_genome mRNA 6277552 6281361 . + . ID=transcript_11278;Q9UQ50,Atrial natriuretic peptide receptor 2,Atrial natriuretic peptide receptor type B;Guanylate cyclase B;, PF01094;PF00211;PF07714;, GO:0005887;GO:0005886;GO:0005524;GO:0005525;GO:0004383;GO:0042562;GO:0042802;GO:0016941;GO:0017046;GO:0001653;GO:0004672;GO:0060348;GO:0097011;GO:0006182;GO:0019934;GO:0051447;GO:1900194;GO:0001503;GO:0010753;GO:0007168;GO:0008217;GO:1903779;GO:0022414;GO:0007165;, C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:GTP binding; F:guanylate cyclase activity; F:hormone binding; F:identical protein binding; F:natriuretic peptide receptor activity; F:peptide hormone binding; F:peptide receptor activity; F:protein kinase activity;, P:bone development; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cGMP biosynthetic process; P:cGMP-mediated signaling; P:negative regulation of meiotic cell cycle; P:negative regulation of oocyte maturation; P:ossification; P:positive regulation of cGMP-mediated signaling; P:receptor guanylyl cyclase signaling pathway; P:regulation of blood pressure; P:regulation of cardiac conduction; P:reproductive process; P:signal transduction; scaffold70 indexed_genome mRNA 6311929 6332070 . - . ID=transcript_11279;Q92546 Q5TCV5,RAB6A-GEF complex partner protein 2 {ECO:0000305},Retrograde Golgi transport protein RGP1 homolog {ECO:0000250|UniProtKB:P16664};, PF08737;, GO:0005829;GO:0000139;GO:0016020;GO:0005886;GO:0032991;GO:0034066;GO:0032588;GO:0005085;GO:0031267;GO:1903363;GO:0043547;GO:0042147;, C:cytosol; C:Golgi membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:RIC1-RGP1 guanyl-nucleotide exchange factor complex; C:trans-Golgi network membrane;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:negative regulation of cellular protein catabolic process; P:positive regulation of GTPase activity; P:retrograde transport, endosome to Golgi;|Q92546 Q5TCV5,RAB6A-GEF complex partner protein 2 {ECO:0000305},Retrograde Golgi transport protein RGP1 homolog {ECO:0000250|UniProtKB:P16664};, PF08737;, GO:0005829;GO:0000139;GO:0016020;GO:0005886;GO:0032991;GO:0034066;GO:0032588;GO:0005085;GO:0031267;GO:1903363;GO:0043547;GO:0042147;, C:cytosol; C:Golgi membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:RIC1-RGP1 guanyl-nucleotide exchange factor complex; C:trans-Golgi network membrane;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:negative regulation of cellular protein catabolic process; P:positive regulation of GTPase activity; P:retrograde transport, endosome to Golgi;|Q9HCG7 D3DRP2 Q5TCV6 Q96A51 Q96LY1 Q96SJ2 Q9H2L8,Non-lysosomal glucosylceramidase {ECO:0000305},Beta-glucocerebrosidase 2;Bile acid beta-glucosidase GBA2 {ECO:0000303|PubMed:9111029};Bile acid glucosyl transferase GBA2 {ECO:0000305|PubMed:9111029};Cholesterol glucosyltransferase GBA2 {ECO:0000250|UniProtKB:Q69ZF3};Cholesteryl-beta-glucosidase GBA2 {ECO:0000250|UniProtKB:Q69ZF3};Glucosylceramidase 2;, PF04685;PF12215;, GO:0005829;GO:0042406;GO:0090498;GO:0019898;GO:0016021;GO:0005886;GO:0005790;GO:0008422;GO:0004348;GO:0046527;GO:0050295;GO:0008206;GO:0005975;GO:0007417;GO:0021954;GO:0008203;GO:0006680;GO:0016139;GO:0006687;GO:0030259;GO:0030833;GO:0097035;GO:0031113;, C:cytosol; C:extrinsic component of endoplasmic reticulum membrane; C:extrinsic component of Golgi membrane; C:extrinsic component of membrane; C:integral component of membrane; C:plasma membrane; C:smooth endoplasmic reticulum;, F:beta-glucosidase activity; F:glucosylceramidase activity; F:glucosyltransferase activity; F:steryl-beta-glucosidase activity;, P:bile acid metabolic process; P:carbohydrate metabolic process; P:central nervous system development; P:central nervous system neuron development; P:cholesterol metabolic process; P:glucosylceramide catabolic process; P:glycoside catabolic process; P:glycosphingolipid metabolic process; P:lipid glycosylation; P:regulation of actin filament polymerization; P:regulation of membrane lipid distribution; P:regulation of microtubule polymerization;|Q9HCG7 D3DRP2 Q5TCV6 Q96A51 Q96LY1 Q96SJ2 Q9H2L8,Non-lysosomal glucosylceramidase {ECO:0000305},Beta-glucocerebrosidase 2;Bile acid beta-glucosidase GBA2 {ECO:0000303|PubMed:9111029};Bile acid glucosyl transferase GBA2 {ECO:0000305|PubMed:9111029};Cholesterol glucosyltransferase GBA2 {ECO:0000250|UniProtKB:Q69ZF3};Cholesteryl-beta-glucosidase GBA2 {ECO:0000250|UniProtKB:Q69ZF3};Glucosylceramidase 2;, PF04685;PF12215;, GO:0005829;GO:0042406;GO:0090498;GO:0019898;GO:0016021;GO:0005886;GO:0005790;GO:0008422;GO:0004348;GO:0046527;GO:0050295;GO:0008206;GO:0005975;GO:0007417;GO:0021954;GO:0008203;GO:0006680;GO:0016139;GO:0006687;GO:0030259;GO:0030833;GO:0097035;GO:0031113;, C:cytosol; C:extrinsic component of endoplasmic reticulum membrane; C:extrinsic component of Golgi membrane; C:extrinsic component of membrane; C:integral component of membrane; C:plasma membrane; C:smooth endoplasmic reticulum;, F:beta-glucosidase activity; F:glucosylceramidase activity; F:glucosyltransferase activity; F:steryl-beta-glucosidase activity;, P:bile acid metabolic process; P:carbohydrate metabolic process; P:central nervous system development; P:central nervous system neuron development; P:cholesterol metabolic process; P:glucosylceramide catabolic process; P:glycoside catabolic process; P:glycosphingolipid metabolic process; P:lipid glycosylation; P:regulation of actin filament polymerization; P:regulation of membrane lipid distribution; P:regulation of microtubule polymerization;|Q9HCG7 D3DRP2 Q5TCV6 Q96A51 Q96LY1 Q96SJ2 Q9H2L8,Non-lysosomal glucosylceramidase {ECO:0000305},Beta-glucocerebrosidase 2;Bile acid beta-glucosidase GBA2 {ECO:0000303|PubMed:9111029};Bile acid glucosyl transferase GBA2 {ECO:0000305|PubMed:9111029};Cholesterol glucosyltransferase GBA2 {ECO:0000250|UniProtKB:Q69ZF3};Cholesteryl-beta-glucosidase GBA2 {ECO:0000250|UniProtKB:Q69ZF3};Glucosylceramidase 2;, PF04685;PF12215;, GO:0005829;GO:0042406;GO:0090498;GO:0019898;GO:0016021;GO:0005886;GO:0005790;GO:0008422;GO:0004348;GO:0046527;GO:0050295;GO:0008206;GO:0005975;GO:0007417;GO:0021954;GO:0008203;GO:0006680;GO:0016139;GO:0006687;GO:0030259;GO:0030833;GO:0097035;GO:0031113;, C:cytosol; C:extrinsic component of endoplasmic reticulum membrane; C:extrinsic component of Golgi membrane; C:extrinsic component of membrane; C:integral component of membrane; C:plasma membrane; C:smooth endoplasmic reticulum;, F:beta-glucosidase activity; F:glucosylceramidase activity; F:glucosyltransferase activity; F:steryl-beta-glucosidase activity;, P:bile acid metabolic process; P:carbohydrate metabolic process; P:central nervous system development; P:central nervous system neuron development; P:cholesterol metabolic process; P:glucosylceramide catabolic process; P:glycoside catabolic process; P:glycosphingolipid metabolic process; P:lipid glycosylation; P:regulation of actin filament polymerization; P:regulation of membrane lipid distribution; P:regulation of microtubule polymerization;|O43889 D0PTW6 O14671 O14919 Q5TCV1 Q96GK8 Q9H2W3 Q9UE77,Cyclic AMP-responsive element-binding protein 3,Leucine zipper protein;Luman;Transcription factor LZIP-alpha;, PF00170;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0030176;GO:0016021;GO:0016020;GO:0043025;GO:0016604;GO:0005654;GO:0005634;GO:0035497;GO:0008140;GO:0031726;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046983;GO:0042803;GO:0000978;GO:0000977;GO:1990837;GO:0006935;GO:0042994;GO:0030968;GO:0019043;GO:0050930;GO:0045786;GO:1902236;GO:0051928;GO:0030335;GO:0090045;GO:0002230;GO:0090026;GO:0045944;GO:0006990;GO:0045893;GO:0042981;GO:0001558;GO:0042127;GO:0006357;GO:0019046;GO:0034976;GO:0006351;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:neuronal cell body; C:nuclear body; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:cAMP response element binding protein binding; F:CCR1 chemokine receptor binding; F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:chemotaxis; P:cytoplasmic sequestering of transcription factor; P:endoplasmic reticulum unfolded protein response; P:establishment of viral latency; P:induction of positive chemotaxis; P:negative regulation of cell cycle; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of calcium ion transport; P:positive regulation of cell migration; P:positive regulation of deacetylase activity; P:positive regulation of defense response to virus by host; P:positive regulation of monocyte chemotaxis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription, DNA-templated; P:regulation of apoptotic process; P:regulation of cell growth; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:release from viral latency; P:response to endoplasmic reticulum stress; P:transcription, DNA-templated; P:viral process; scaffold70 indexed_genome mRNA 6332088 6350406 . + . ID=transcript_11280;Q9Y490 A6NMY0 Q86YD0 Q9NZQ2 Q9UHH8 Q9UPX3,Talin-1,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0005912;GO:0009986;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0001726;GO:0032587;GO:0051015;GO:0045296;GO:0005178;GO:0030274;GO:0035091;GO:0001786;GO:0005200;GO:0017166;GO:0098609;GO:0007043;GO:0007044;GO:0030866;GO:0033622;GO:0007229;GO:0036498;GO:0006936;GO:0070527;GO:0002576;GO:0016032;, C:adherens junction; C:cell surface; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:actin filament binding; F:cadherin binding; F:integrin binding; F:LIM domain binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:structural constituent of cytoskeleton; F:vinculin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-substrate junction assembly; P:cortical actin cytoskeleton organization; P:integrin activation; P:integrin-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:muscle contraction; P:platelet aggregation; P:platelet degranulation; P:viral process;|Q9Y490 A6NMY0 Q86YD0 Q9NZQ2 Q9UHH8 Q9UPX3,Talin-1,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0005912;GO:0009986;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0001726;GO:0032587;GO:0051015;GO:0045296;GO:0005178;GO:0030274;GO:0035091;GO:0001786;GO:0005200;GO:0017166;GO:0098609;GO:0007043;GO:0007044;GO:0030866;GO:0033622;GO:0007229;GO:0036498;GO:0006936;GO:0070527;GO:0002576;GO:0016032;, C:adherens junction; C:cell surface; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:actin filament binding; F:cadherin binding; F:integrin binding; F:LIM domain binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:structural constituent of cytoskeleton; F:vinculin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-substrate junction assembly; P:cortical actin cytoskeleton organization; P:integrin activation; P:integrin-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:muscle contraction; P:platelet aggregation; P:platelet degranulation; P:viral process;|Q9Y490 A6NMY0 Q86YD0 Q9NZQ2 Q9UHH8 Q9UPX3,Talin-1,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0005912;GO:0009986;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0001726;GO:0032587;GO:0051015;GO:0045296;GO:0005178;GO:0030274;GO:0035091;GO:0001786;GO:0005200;GO:0017166;GO:0098609;GO:0007043;GO:0007044;GO:0030866;GO:0033622;GO:0007229;GO:0036498;GO:0006936;GO:0070527;GO:0002576;GO:0016032;, C:adherens junction; C:cell surface; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:actin filament binding; F:cadherin binding; F:integrin binding; F:LIM domain binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:structural constituent of cytoskeleton; F:vinculin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-substrate junction assembly; P:cortical actin cytoskeleton organization; P:integrin activation; P:integrin-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:muscle contraction; P:platelet aggregation; P:platelet degranulation; P:viral process;|Q9Y490 A6NMY0 Q86YD0 Q9NZQ2 Q9UHH8 Q9UPX3,Talin-1,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0005912;GO:0009986;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0001726;GO:0032587;GO:0051015;GO:0045296;GO:0005178;GO:0030274;GO:0035091;GO:0001786;GO:0005200;GO:0017166;GO:0098609;GO:0007043;GO:0007044;GO:0030866;GO:0033622;GO:0007229;GO:0036498;GO:0006936;GO:0070527;GO:0002576;GO:0016032;, C:adherens junction; C:cell surface; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:actin filament binding; F:cadherin binding; F:integrin binding; F:LIM domain binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:structural constituent of cytoskeleton; F:vinculin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-substrate junction assembly; P:cortical actin cytoskeleton organization; P:integrin activation; P:integrin-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:muscle contraction; P:platelet aggregation; P:platelet degranulation; P:viral process; scaffold70 indexed_genome mRNA 6362038 6362936 . - . ID=transcript_11281;Q15569 Q8IXZ8,Dual specificity testis-specific protein kinase 1,Testicular protein kinase 1;, PF07714;, GO:0005813;GO:0005737;GO:0031410;GO:0005829;GO:0030027;GO:0005634;GO:0048471;GO:0005524;GO:0046872;GO:0008022;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0030036;GO:0051650;GO:0090521;GO:1902018;GO:0042326;GO:0031953;GO:0071901;GO:1900182;GO:0001934;GO:0051496;GO:1900026;GO:0032956;GO:0032880;GO:0007283;, C:centrosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lamellipodium; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:metal ion binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton organization; P:establishment of vesicle localization; P:glomerular visceral epithelial cell migration; P:negative regulation of cilium assembly; P:negative regulation of phosphorylation; P:negative regulation of protein autophosphorylation; P:negative regulation of protein serine/threonine kinase activity; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of actin cytoskeleton organization; P:regulation of protein localization; P:spermatogenesis; scaffold70 indexed_genome mRNA 6367280 6389911 . + . ID=transcript_11282;A8MTA8 A1L3B2 B7ZBJ0,Protein FAM166B,, PF10629;|A8MTA8 A1L3B2 B7ZBJ0,Protein FAM166B,, PF10629;|Q8N2Y8 A2RU62 A7E2A9 O15080 Q5W134 Q641Q6 Q6P1W7,Iporin,Interacting protein of Rab1;RUN and SH3 domain-containing protein 2;, PF02759;PF07653;, GO:0031410;GO:0005829;GO:0070062;GO:0031267;, C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome;, F:small GTPase binding;|Q8N2Y8 A2RU62 A7E2A9 O15080 Q5W134 Q641Q6 Q6P1W7,Iporin,Interacting protein of Rab1;RUN and SH3 domain-containing protein 2;, PF02759;PF07653;, GO:0031410;GO:0005829;GO:0070062;GO:0031267;, C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome;, F:small GTPase binding;|Q8N2Y8 A2RU62 A7E2A9 O15080 Q5W134 Q641Q6 Q6P1W7,Iporin,Interacting protein of Rab1;RUN and SH3 domain-containing protein 2;, PF02759;PF07653;, GO:0031410;GO:0005829;GO:0070062;GO:0031267;, C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome;, F:small GTPase binding;|Q8N2Y8 A2RU62 A7E2A9 O15080 Q5W134 Q641Q6 Q6P1W7,Iporin,Interacting protein of Rab1;RUN and SH3 domain-containing protein 2;, PF02759;PF07653;, GO:0031410;GO:0005829;GO:0070062;GO:0031267;, C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome;, F:small GTPase binding;|Q8N2Y8 A2RU62 A7E2A9 O15080 Q5W134 Q641Q6 Q6P1W7,Iporin,Interacting protein of Rab1;RUN and SH3 domain-containing protein 2;, PF02759;PF07653;, GO:0031410;GO:0005829;GO:0070062;GO:0031267;, C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome;, F:small GTPase binding; scaffold70 indexed_genome mRNA 6557715 6756765 . - . ID=transcript_11283;O14795 Q2NKJ5 Q5VYM8,Protein unc-13 homolog B {ECO:0000305},Munc13-2;, PF00130;PF00168;PF06292;PF10540;, GO:0005829;GO:0005794;GO:0016020;GO:0031594;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0030742;GO:0005543;GO:0031267;GO:0017075;GO:0060478;GO:0071333;GO:0007268;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0006836;GO:0043065;GO:0097151;GO:0050714;GO:0010808;GO:0099525;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:cytosol; C:Golgi apparatus; C:membrane; C:neuromuscular junction; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:phospholipid binding; F:small GTPase binding; F:syntaxin-1 binding;, P:acrosomal vesicle exocytosis; P:cellular response to glucose stimulus; P:chemical synaptic transmission; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter transport; P:positive regulation of apoptotic process; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of protein secretion; P:positive regulation of synaptic vesicle priming; P:presynaptic dense core vesicle exocytosis; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|O14795 Q2NKJ5 Q5VYM8,Protein unc-13 homolog B {ECO:0000305},Munc13-2;, PF00130;PF00168;PF06292;PF10540;, GO:0005829;GO:0005794;GO:0016020;GO:0031594;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0030742;GO:0005543;GO:0031267;GO:0017075;GO:0060478;GO:0071333;GO:0007268;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0006836;GO:0043065;GO:0097151;GO:0050714;GO:0010808;GO:0099525;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:cytosol; C:Golgi apparatus; C:membrane; C:neuromuscular junction; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:phospholipid binding; F:small GTPase binding; F:syntaxin-1 binding;, P:acrosomal vesicle exocytosis; P:cellular response to glucose stimulus; P:chemical synaptic transmission; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter transport; P:positive regulation of apoptotic process; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of protein secretion; P:positive regulation of synaptic vesicle priming; P:presynaptic dense core vesicle exocytosis; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|O14795 Q2NKJ5 Q5VYM8,Protein unc-13 homolog B {ECO:0000305},Munc13-2;, PF00130;PF00168;PF06292;PF10540;, GO:0005829;GO:0005794;GO:0016020;GO:0031594;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0030742;GO:0005543;GO:0031267;GO:0017075;GO:0060478;GO:0071333;GO:0007268;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0006836;GO:0043065;GO:0097151;GO:0050714;GO:0010808;GO:0099525;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:cytosol; C:Golgi apparatus; C:membrane; C:neuromuscular junction; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:phospholipid binding; F:small GTPase binding; F:syntaxin-1 binding;, P:acrosomal vesicle exocytosis; P:cellular response to glucose stimulus; P:chemical synaptic transmission; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter transport; P:positive regulation of apoptotic process; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of protein secretion; P:positive regulation of synaptic vesicle priming; P:presynaptic dense core vesicle exocytosis; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|O14795 Q2NKJ5 Q5VYM8,Protein unc-13 homolog B {ECO:0000305},Munc13-2;, PF00130;PF00168;PF06292;PF10540;, GO:0005829;GO:0005794;GO:0016020;GO:0031594;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0030742;GO:0005543;GO:0031267;GO:0017075;GO:0060478;GO:0071333;GO:0007268;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0006836;GO:0043065;GO:0097151;GO:0050714;GO:0010808;GO:0099525;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:cytosol; C:Golgi apparatus; C:membrane; C:neuromuscular junction; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:phospholipid binding; F:small GTPase binding; F:syntaxin-1 binding;, P:acrosomal vesicle exocytosis; P:cellular response to glucose stimulus; P:chemical synaptic transmission; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter transport; P:positive regulation of apoptotic process; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of protein secretion; P:positive regulation of synaptic vesicle priming; P:presynaptic dense core vesicle exocytosis; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|O14795 Q2NKJ5 Q5VYM8,Protein unc-13 homolog B {ECO:0000305},Munc13-2;, PF00130;PF00168;PF06292;PF10540;, GO:0005829;GO:0005794;GO:0016020;GO:0031594;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0030742;GO:0005543;GO:0031267;GO:0017075;GO:0060478;GO:0071333;GO:0007268;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0006836;GO:0043065;GO:0097151;GO:0050714;GO:0010808;GO:0099525;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:cytosol; C:Golgi apparatus; C:membrane; C:neuromuscular junction; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:phospholipid binding; F:small GTPase binding; F:syntaxin-1 binding;, P:acrosomal vesicle exocytosis; P:cellular response to glucose stimulus; P:chemical synaptic transmission; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter transport; P:positive regulation of apoptotic process; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of protein secretion; P:positive regulation of synaptic vesicle priming; P:presynaptic dense core vesicle exocytosis; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|O14795 Q2NKJ5 Q5VYM8,Protein unc-13 homolog B {ECO:0000305},Munc13-2;, PF00130;PF00168;PF06292;PF10540;, GO:0005829;GO:0005794;GO:0016020;GO:0031594;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0030742;GO:0005543;GO:0031267;GO:0017075;GO:0060478;GO:0071333;GO:0007268;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0006836;GO:0043065;GO:0097151;GO:0050714;GO:0010808;GO:0099525;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:cytosol; C:Golgi apparatus; C:membrane; C:neuromuscular junction; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:phospholipid binding; F:small GTPase binding; F:syntaxin-1 binding;, P:acrosomal vesicle exocytosis; P:cellular response to glucose stimulus; P:chemical synaptic transmission; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter transport; P:positive regulation of apoptotic process; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of protein secretion; P:positive regulation of synaptic vesicle priming; P:presynaptic dense core vesicle exocytosis; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|O14795 Q2NKJ5 Q5VYM8,Protein unc-13 homolog B {ECO:0000305},Munc13-2;, PF00130;PF00168;PF06292;PF10540;, GO:0005829;GO:0005794;GO:0016020;GO:0031594;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0030742;GO:0005543;GO:0031267;GO:0017075;GO:0060478;GO:0071333;GO:0007268;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0006836;GO:0043065;GO:0097151;GO:0050714;GO:0010808;GO:0099525;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:cytosol; C:Golgi apparatus; C:membrane; C:neuromuscular junction; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:phospholipid binding; F:small GTPase binding; F:syntaxin-1 binding;, P:acrosomal vesicle exocytosis; P:cellular response to glucose stimulus; P:chemical synaptic transmission; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter transport; P:positive regulation of apoptotic process; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of protein secretion; P:positive regulation of synaptic vesicle priming; P:presynaptic dense core vesicle exocytosis; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming; scaffold70 indexed_genome mRNA 6778516 6782054 . + . ID=transcript_11284;Q9UJZ1 B4E1K7 D3DRN3 O60376 Q53G29 Q96FY2 Q9P042,Stomatin-like protein 2, mitochondrial,EPB72-like protein 2;Paraprotein target 7;, PF01145;PF16200;, GO:0005856;GO:0019897;GO:0045121;GO:0005743;GO:0005758;GO:1901612;GO:0051020;GO:0005102;GO:0035710;GO:0006874;GO:0010876;GO:0042776;GO:0006851;GO:0034982;GO:0007005;GO:1900210;GO:0032743;GO:0090297;GO:0010918;GO:0051259;GO:1990046;GO:0050852;, C:cytoskeleton; C:extrinsic component of plasma membrane; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrial intermembrane space;, F:cardiolipin binding; F:GTPase binding; F:signaling receptor binding;, P:CD4-positive, alpha-beta T cell activation; P:cellular calcium ion homeostasis; P:lipid localization; P:mitochondrial ATP synthesis coupled proton transport; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial protein processing; P:mitochondrion organization; P:positive regulation of cardiolipin metabolic process; P:positive regulation of interleukin-2 production; P:positive regulation of mitochondrial DNA replication; P:positive regulation of mitochondrial membrane potential; P:protein complex oligomerization; P:stress-induced mitochondrial fusion; P:T cell receptor signaling pathway;|Q9UJZ1 B4E1K7 D3DRN3 O60376 Q53G29 Q96FY2 Q9P042,Stomatin-like protein 2, mitochondrial,EPB72-like protein 2;Paraprotein target 7;, PF01145;PF16200;, GO:0005856;GO:0019897;GO:0045121;GO:0005743;GO:0005758;GO:1901612;GO:0051020;GO:0005102;GO:0035710;GO:0006874;GO:0010876;GO:0042776;GO:0006851;GO:0034982;GO:0007005;GO:1900210;GO:0032743;GO:0090297;GO:0010918;GO:0051259;GO:1990046;GO:0050852;, C:cytoskeleton; C:extrinsic component of plasma membrane; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrial intermembrane space;, F:cardiolipin binding; F:GTPase binding; F:signaling receptor binding;, P:CD4-positive, alpha-beta T cell activation; P:cellular calcium ion homeostasis; P:lipid localization; P:mitochondrial ATP synthesis coupled proton transport; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial protein processing; P:mitochondrion organization; P:positive regulation of cardiolipin metabolic process; P:positive regulation of interleukin-2 production; P:positive regulation of mitochondrial DNA replication; P:positive regulation of mitochondrial membrane potential; P:protein complex oligomerization; P:stress-induced mitochondrial fusion; P:T cell receptor signaling pathway;|Q9UJZ1 B4E1K7 D3DRN3 O60376 Q53G29 Q96FY2 Q9P042,Stomatin-like protein 2, mitochondrial,EPB72-like protein 2;Paraprotein target 7;, PF01145;PF16200;, GO:0005856;GO:0019897;GO:0045121;GO:0005743;GO:0005758;GO:1901612;GO:0051020;GO:0005102;GO:0035710;GO:0006874;GO:0010876;GO:0042776;GO:0006851;GO:0034982;GO:0007005;GO:1900210;GO:0032743;GO:0090297;GO:0010918;GO:0051259;GO:1990046;GO:0050852;, C:cytoskeleton; C:extrinsic component of plasma membrane; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrial intermembrane space;, F:cardiolipin binding; F:GTPase binding; F:signaling receptor binding;, P:CD4-positive, alpha-beta T cell activation; P:cellular calcium ion homeostasis; P:lipid localization; P:mitochondrial ATP synthesis coupled proton transport; P:mitochondrial calcium ion transmembrane transport; P:mitochondrial protein processing; P:mitochondrion organization; P:positive regulation of cardiolipin metabolic process; P:positive regulation of interleukin-2 production; P:positive regulation of mitochondrial DNA replication; P:positive regulation of mitochondrial membrane potential; P:protein complex oligomerization; P:stress-induced mitochondrial fusion; P:T cell receptor signaling pathway; scaffold70 indexed_genome mRNA 6786192 6798442 . + . ID=transcript_11285;Q8TEQ8 B1AML3 Q6P154 Q6UX80 Q8TDS8 Q96CS9 Q9BVN9 Q9Y4B0,GPI ethanolamine phosphate transferase 3,Phosphatidylinositol-glycan biosynthesis class O protein;, PF01663;, GO:0005789;GO:0016021;GO:0016020;GO:0051377;GO:0006506;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process;|O15287,Fanconi anemia group G protein,DNA repair protein XRCC9;, , GO:0005829;GO:0043240;GO:0005739;GO:0005730;GO:0005654;GO:0005886;GO:0003684;GO:0006974;GO:0006281;GO:0036297;GO:0007005;GO:0001541;GO:0009314;GO:0007286;, C:cytosol; C:Fanconi anaemia nuclear complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:damaged DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:interstrand cross-link repair; P:mitochondrion organization; P:ovarian follicle development; P:response to radiation; P:spermatid development;|O15287,Fanconi anemia group G protein,DNA repair protein XRCC9;, , GO:0005829;GO:0043240;GO:0005739;GO:0005730;GO:0005654;GO:0005886;GO:0003684;GO:0006974;GO:0006281;GO:0036297;GO:0007005;GO:0001541;GO:0009314;GO:0007286;, C:cytosol; C:Fanconi anaemia nuclear complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:damaged DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:interstrand cross-link repair; P:mitochondrion organization; P:ovarian follicle development; P:response to radiation; P:spermatid development;|O15287,Fanconi anemia group G protein,DNA repair protein XRCC9;, , GO:0005829;GO:0043240;GO:0005739;GO:0005730;GO:0005654;GO:0005886;GO:0003684;GO:0006974;GO:0006281;GO:0036297;GO:0007005;GO:0001541;GO:0009314;GO:0007286;, C:cytosol; C:Fanconi anaemia nuclear complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:damaged DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:interstrand cross-link repair; P:mitochondrion organization; P:ovarian follicle development; P:response to radiation; P:spermatid development;|O15287,Fanconi anemia group G protein,DNA repair protein XRCC9;, , GO:0005829;GO:0043240;GO:0005739;GO:0005730;GO:0005654;GO:0005886;GO:0003684;GO:0006974;GO:0006281;GO:0036297;GO:0007005;GO:0001541;GO:0009314;GO:0007286;, C:cytosol; C:Fanconi anaemia nuclear complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:damaged DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:interstrand cross-link repair; P:mitochondrion organization; P:ovarian follicle development; P:response to radiation; P:spermatid development; scaffold70 indexed_genome mRNA 6798576 6801298 . + . ID=transcript_11286;O15287,Fanconi anemia group G protein,DNA repair protein XRCC9;, , GO:0005829;GO:0043240;GO:0005739;GO:0005730;GO:0005654;GO:0005886;GO:0003684;GO:0006974;GO:0006281;GO:0036297;GO:0007005;GO:0001541;GO:0009314;GO:0007286;, C:cytosol; C:Fanconi anaemia nuclear complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:damaged DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:interstrand cross-link repair; P:mitochondrion organization; P:ovarian follicle development; P:response to radiation; P:spermatid development;|O15287,Fanconi anemia group G protein,DNA repair protein XRCC9;, , GO:0005829;GO:0043240;GO:0005739;GO:0005730;GO:0005654;GO:0005886;GO:0003684;GO:0006974;GO:0006281;GO:0036297;GO:0007005;GO:0001541;GO:0009314;GO:0007286;, C:cytosol; C:Fanconi anaemia nuclear complex; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:damaged DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:interstrand cross-link repair; P:mitochondrion organization; P:ovarian follicle development; P:response to radiation; P:spermatid development; scaffold70 indexed_genome mRNA 6802697 6819983 . + . ID=transcript_11287;P55072 B2R5T8 Q0V924 Q2TAI5 Q969G7 Q9UCD5,Transitional endoplasmic reticulum ATPase,15S Mg(2+)-ATPase p97 subunit;Valosin-containing protein;, PF00004;PF17862;PF02933;PF02359;PF09336;, GO:1904949;GO:0035578;GO:0005737;GO:0010494;GO:0005829;GO:0036513;GO:0005783;GO:0005789;GO:0070062;GO:0005576;GO:1904813;GO:0098978;GO:0043231;GO:0005811;GO:0005654;GO:0005634;GO:0048471;GO:0000502;GO:0032991;GO:0034774;GO:0035861;GO:0034098;GO:1990730;GO:0043531;GO:0005524;GO:0016887;GO:1904288;GO:0035800;GO:0042802;GO:0036435;GO:0008289;GO:0042288;GO:0031593;GO:0019904;GO:0019903;GO:0003723;GO:0031625;GO:0044389;GO:1990381;GO:0006919;GO:0070842;GO:0046034;GO:0097352;GO:0006914;GO:1903843;GO:0006974;GO:0034605;GO:0006281;GO:0006302;GO:0061857;GO:0006888;GO:0030968;GO:0032510;GO:0071712;GO:0036503;GO:0070987;GO:0045184;GO:0072389;GO:0036297;GO:0016236;GO:0051228;GO:0006734;GO:0045879;GO:0043312;GO:2001171;GO:0090263;GO:1903007;GO:0010918;GO:1903862;GO:0032436;GO:0045732;GO:1903006;GO:0031334;GO:0010498;GO:0043161;GO:0016579;GO:0006457;GO:0016567;GO:0106300;GO:1903715;GO:0042981;GO:1905634;GO:0050807;GO:0030970;GO:0035617;GO:0019985;GO:0055085;GO:0030433;GO:0019079;, C:ATPase complex; C:azurophil granule lumen; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:lipid droplet; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:proteasome complex; C:protein-containing complex; C:secretory granule lumen; C:site of double-strand break; C:VCP-NPL4-UFD1 AAA ATPase complex; C:VCP-NSFL1C complex;, F:ADP binding; F:ATP binding; F:ATPase activity; F:BAT3 complex binding; F:deubiquitinase activator activity; F:identical protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:lipid binding; F:MHC class I protein binding; F:polyubiquitin modification-dependent protein binding; F:protein domain specific binding; F:protein phosphatase binding; F:RNA binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding; F:ubiquitin-specific protease binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:aggresome assembly; P:ATP metabolic process; P:autophagosome maturation; P:autophagy; P:cellular response to arsenite ion; P:cellular response to DNA damage stimulus; P:cellular response to heat; P:DNA repair; P:double-strand break repair; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum unfolded protein response; P:endosome to lysosome transport via multivesicular body sorting pathway; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:error-free translesion synthesis; P:establishment of protein localization; P:flavin adenine dinucleotide catabolic process; P:interstrand cross-link repair; P:macroautophagy; P:mitotic spindle disassembly; P:NADH metabolic process; P:negative regulation of smoothened signaling pathway; P:neutrophil degranulation; P:positive regulation of ATP biosynthetic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Lys63-specific deubiquitinase activity; P:positive regulation of mitochondrial membrane potential; P:positive regulation of oxidative phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein K63-linked deubiquitination; P:positive regulation of protein-containing complex assembly; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein folding; P:protein ubiquitination; P:protein-DNA covalent cross-linking repair; P:regulation of aerobic respiration; P:regulation of apoptotic process; P:regulation of protein localization to chromatin; P:regulation of synapse organization; P:retrograde protein transport, ER to cytosol; P:stress granule disassembly; P:translesion synthesis; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:viral genome replication;|P55072 B2R5T8 Q0V924 Q2TAI5 Q969G7 Q9UCD5,Transitional endoplasmic reticulum ATPase,15S Mg(2+)-ATPase p97 subunit;Valosin-containing protein;, PF00004;PF17862;PF02933;PF02359;PF09336;, GO:1904949;GO:0035578;GO:0005737;GO:0010494;GO:0005829;GO:0036513;GO:0005783;GO:0005789;GO:0070062;GO:0005576;GO:1904813;GO:0098978;GO:0043231;GO:0005811;GO:0005654;GO:0005634;GO:0048471;GO:0000502;GO:0032991;GO:0034774;GO:0035861;GO:0034098;GO:1990730;GO:0043531;GO:0005524;GO:0016887;GO:1904288;GO:0035800;GO:0042802;GO:0036435;GO:0008289;GO:0042288;GO:0031593;GO:0019904;GO:0019903;GO:0003723;GO:0031625;GO:0044389;GO:1990381;GO:0006919;GO:0070842;GO:0046034;GO:0097352;GO:0006914;GO:1903843;GO:0006974;GO:0034605;GO:0006281;GO:0006302;GO:0061857;GO:0006888;GO:0030968;GO:0032510;GO:0071712;GO:0036503;GO:0070987;GO:0045184;GO:0072389;GO:0036297;GO:0016236;GO:0051228;GO:0006734;GO:0045879;GO:0043312;GO:2001171;GO:0090263;GO:1903007;GO:0010918;GO:1903862;GO:0032436;GO:0045732;GO:1903006;GO:0031334;GO:0010498;GO:0043161;GO:0016579;GO:0006457;GO:0016567;GO:0106300;GO:1903715;GO:0042981;GO:1905634;GO:0050807;GO:0030970;GO:0035617;GO:0019985;GO:0055085;GO:0030433;GO:0019079;, C:ATPase complex; C:azurophil granule lumen; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:lipid droplet; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:proteasome complex; C:protein-containing complex; C:secretory granule lumen; C:site of double-strand break; C:VCP-NPL4-UFD1 AAA ATPase complex; C:VCP-NSFL1C complex;, F:ADP binding; F:ATP binding; F:ATPase activity; F:BAT3 complex binding; F:deubiquitinase activator activity; F:identical protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:lipid binding; F:MHC class I protein binding; F:polyubiquitin modification-dependent protein binding; F:protein domain specific binding; F:protein phosphatase binding; F:RNA binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding; F:ubiquitin-specific protease binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:aggresome assembly; P:ATP metabolic process; P:autophagosome maturation; P:autophagy; P:cellular response to arsenite ion; P:cellular response to DNA damage stimulus; P:cellular response to heat; P:DNA repair; P:double-strand break repair; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum unfolded protein response; P:endosome to lysosome transport via multivesicular body sorting pathway; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:error-free translesion synthesis; P:establishment of protein localization; P:flavin adenine dinucleotide catabolic process; P:interstrand cross-link repair; P:macroautophagy; P:mitotic spindle disassembly; P:NADH metabolic process; P:negative regulation of smoothened signaling pathway; P:neutrophil degranulation; P:positive regulation of ATP biosynthetic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Lys63-specific deubiquitinase activity; P:positive regulation of mitochondrial membrane potential; P:positive regulation of oxidative phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein K63-linked deubiquitination; P:positive regulation of protein-containing complex assembly; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein folding; P:protein ubiquitination; P:protein-DNA covalent cross-linking repair; P:regulation of aerobic respiration; P:regulation of apoptotic process; P:regulation of protein localization to chromatin; P:regulation of synapse organization; P:retrograde protein transport, ER to cytosol; P:stress granule disassembly; P:translesion synthesis; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:viral genome replication;|P55072 B2R5T8 Q0V924 Q2TAI5 Q969G7 Q9UCD5,Transitional endoplasmic reticulum ATPase,15S Mg(2+)-ATPase p97 subunit;Valosin-containing protein;, PF00004;PF17862;PF02933;PF02359;PF09336;, GO:1904949;GO:0035578;GO:0005737;GO:0010494;GO:0005829;GO:0036513;GO:0005783;GO:0005789;GO:0070062;GO:0005576;GO:1904813;GO:0098978;GO:0043231;GO:0005811;GO:0005654;GO:0005634;GO:0048471;GO:0000502;GO:0032991;GO:0034774;GO:0035861;GO:0034098;GO:1990730;GO:0043531;GO:0005524;GO:0016887;GO:1904288;GO:0035800;GO:0042802;GO:0036435;GO:0008289;GO:0042288;GO:0031593;GO:0019904;GO:0019903;GO:0003723;GO:0031625;GO:0044389;GO:1990381;GO:0006919;GO:0070842;GO:0046034;GO:0097352;GO:0006914;GO:1903843;GO:0006974;GO:0034605;GO:0006281;GO:0006302;GO:0061857;GO:0006888;GO:0030968;GO:0032510;GO:0071712;GO:0036503;GO:0070987;GO:0045184;GO:0072389;GO:0036297;GO:0016236;GO:0051228;GO:0006734;GO:0045879;GO:0043312;GO:2001171;GO:0090263;GO:1903007;GO:0010918;GO:1903862;GO:0032436;GO:0045732;GO:1903006;GO:0031334;GO:0010498;GO:0043161;GO:0016579;GO:0006457;GO:0016567;GO:0106300;GO:1903715;GO:0042981;GO:1905634;GO:0050807;GO:0030970;GO:0035617;GO:0019985;GO:0055085;GO:0030433;GO:0019079;, C:ATPase complex; C:azurophil granule lumen; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:lipid droplet; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:proteasome complex; C:protein-containing complex; C:secretory granule lumen; C:site of double-strand break; C:VCP-NPL4-UFD1 AAA ATPase complex; C:VCP-NSFL1C complex;, F:ADP binding; F:ATP binding; F:ATPase activity; F:BAT3 complex binding; F:deubiquitinase activator activity; F:identical protein binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:lipid binding; F:MHC class I protein binding; F:polyubiquitin modification-dependent protein binding; F:protein domain specific binding; F:protein phosphatase binding; F:RNA binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding; F:ubiquitin-specific protease binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:aggresome assembly; P:ATP metabolic process; P:autophagosome maturation; P:autophagy; P:cellular response to arsenite ion; P:cellular response to DNA damage stimulus; P:cellular response to heat; P:DNA repair; P:double-strand break repair; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum unfolded protein response; P:endosome to lysosome transport via multivesicular body sorting pathway; P:ER-associated misfolded protein catabolic process; P:ERAD pathway; P:error-free translesion synthesis; P:establishment of protein localization; P:flavin adenine dinucleotide catabolic process; P:interstrand cross-link repair; P:macroautophagy; P:mitotic spindle disassembly; P:NADH metabolic process; P:negative regulation of smoothened signaling pathway; P:neutrophil degranulation; P:positive regulation of ATP biosynthetic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Lys63-specific deubiquitinase activity; P:positive regulation of mitochondrial membrane potential; P:positive regulation of oxidative phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein K63-linked deubiquitination; P:positive regulation of protein-containing complex assembly; P:proteasomal protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein folding; P:protein ubiquitination; P:protein-DNA covalent cross-linking repair; P:regulation of aerobic respiration; P:regulation of apoptotic process; P:regulation of protein localization to chromatin; P:regulation of synapse organization; P:retrograde protein transport, ER to cytosol; P:stress granule disassembly; P:translesion synthesis; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:viral genome replication; scaffold70 indexed_genome mRNA 6857227 6861195 . - . ID=transcript_11288;O75953 B3KN14 B4DSA6 J3KQM9 J3KR08 Q5T656 Q8TDR7 Q96EM4,DnaJ homolog subfamily B member 5,Heat shock protein Hsp40-2;Heat shock protein Hsp40-3;Heat shock protein cognate 40;, PF00226;PF01556;, GO:0005829;GO:0051087;GO:0051082;GO:0051085;GO:0006986;, C:cytosol;, F:chaperone binding; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:response to unfolded protein; scaffold70 indexed_genome mRNA 6861553 6864489 . - . ID=transcript_11289;O75953 B3KN14 B4DSA6 J3KQM9 J3KR08 Q5T656 Q8TDR7 Q96EM4,DnaJ homolog subfamily B member 5,Heat shock protein Hsp40-2;Heat shock protein Hsp40-3;Heat shock protein cognate 40;, PF00226;PF01556;, GO:0005829;GO:0051087;GO:0051082;GO:0051085;GO:0006986;, C:cytosol;, F:chaperone binding; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:response to unfolded protein; scaffold70 indexed_genome mRNA 6872941 6878473 . - . ID=transcript_11290;Q9UPV7 B7Z253 Q58FE9 Q5T662,PHD finger protein 24 {ECO:0000312|HGNC:HGNC:29180},, PF16744;, GO:0046872;GO:0050966;GO:0007214;GO:0008277;GO:0032228;, , F:metal ion binding;, P:detection of mechanical stimulus involved in sensory perception of pain; P:gamma-aminobutyric acid signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, GABAergic; scaffold70 indexed_genome mRNA 6878877 6896496 . - . ID=transcript_11291;Q9UPV7 B7Z253 Q58FE9 Q5T662,PHD finger protein 24 {ECO:0000312|HGNC:HGNC:29180},, PF16744;, GO:0046872;GO:0050966;GO:0007214;GO:0008277;GO:0032228;, , F:metal ion binding;, P:detection of mechanical stimulus involved in sensory perception of pain; P:gamma-aminobutyric acid signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, GABAergic;|Q9UPV7 B7Z253 Q58FE9 Q5T662,PHD finger protein 24 {ECO:0000312|HGNC:HGNC:29180},, PF16744;, GO:0046872;GO:0050966;GO:0007214;GO:0008277;GO:0032228;, , F:metal ion binding;, P:detection of mechanical stimulus involved in sensory perception of pain; P:gamma-aminobutyric acid signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, GABAergic;|Q9UPV7 B7Z253 Q58FE9 Q5T662,PHD finger protein 24 {ECO:0000312|HGNC:HGNC:29180},, PF16744;, GO:0046872;GO:0050966;GO:0007214;GO:0008277;GO:0032228;, , F:metal ion binding;, P:detection of mechanical stimulus involved in sensory perception of pain; P:gamma-aminobutyric acid signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, GABAergic;|Q9UPV7 B7Z253 Q58FE9 Q5T662,PHD finger protein 24 {ECO:0000312|HGNC:HGNC:29180},, PF16744;, GO:0046872;GO:0050966;GO:0007214;GO:0008277;GO:0032228;, , F:metal ion binding;, P:detection of mechanical stimulus involved in sensory perception of pain; P:gamma-aminobutyric acid signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of synaptic transmission, GABAergic; scaffold70 indexed_genome mRNA 6896951 7398204 . + . ID=transcript_11292;A6NFA0,Protein FAM205C {ECO:0000305},FAM205C pseudogene {ECO:0000312|HGNC:HGNC:42673};, PF15371;, GO:0016021;, C:integral component of membrane; scaffold70 indexed_genome mRNA 8412919 8448334 . + . ID=transcript_11293;Q04724 A8K495 Q5T3G4 Q969V9,Transducin-like enhancer protein 1,E(Sp1) homolog;Enhancer of split groucho-like protein 1;, PF03920;PF00400;, GO:1990907;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0042802;GO:0070491;GO:0003714;GO:0008134;GO:0009887;GO:1904837;GO:0007275;GO:2000811;GO:0090090;GO:0043124;GO:0045892;GO:0030178;GO:0010628;GO:0007165;GO:0016055;, C:beta-catenin-TCF complex; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:multicellular organism development; P:negative regulation of anoikis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:positive regulation of gene expression; P:signal transduction; P:Wnt signaling pathway;|Q04724 A8K495 Q5T3G4 Q969V9,Transducin-like enhancer protein 1,E(Sp1) homolog;Enhancer of split groucho-like protein 1;, PF03920;PF00400;, GO:1990907;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0042802;GO:0070491;GO:0003714;GO:0008134;GO:0009887;GO:1904837;GO:0007275;GO:2000811;GO:0090090;GO:0043124;GO:0045892;GO:0030178;GO:0010628;GO:0007165;GO:0016055;, C:beta-catenin-TCF complex; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:multicellular organism development; P:negative regulation of anoikis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:positive regulation of gene expression; P:signal transduction; P:Wnt signaling pathway;|Q04724 A8K495 Q5T3G4 Q969V9,Transducin-like enhancer protein 1,E(Sp1) homolog;Enhancer of split groucho-like protein 1;, PF03920;PF00400;, GO:1990907;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0042802;GO:0070491;GO:0003714;GO:0008134;GO:0009887;GO:1904837;GO:0007275;GO:2000811;GO:0090090;GO:0043124;GO:0045892;GO:0030178;GO:0010628;GO:0007165;GO:0016055;, C:beta-catenin-TCF complex; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:multicellular organism development; P:negative regulation of anoikis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:positive regulation of gene expression; P:signal transduction; P:Wnt signaling pathway; scaffold70 indexed_genome mRNA 8448350 8457277 . + . ID=transcript_11294;Q04724 A8K495 Q5T3G4 Q969V9,Transducin-like enhancer protein 1,E(Sp1) homolog;Enhancer of split groucho-like protein 1;, PF03920;PF00400;, GO:1990907;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0042802;GO:0070491;GO:0003714;GO:0008134;GO:0009887;GO:1904837;GO:0007275;GO:2000811;GO:0090090;GO:0043124;GO:0045892;GO:0030178;GO:0010628;GO:0007165;GO:0016055;, C:beta-catenin-TCF complex; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:repressing transcription factor binding; F:transcription corepressor activity; F:transcription factor binding;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:multicellular organism development; P:negative regulation of anoikis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:positive regulation of gene expression; P:signal transduction; P:Wnt signaling pathway;|Q9ULF9,Transducin-like enhancer protein 4,Grg-4;Groucho-related protein 4;, PF03920;PF00400;, GO:1990907;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:1904837;GO:0090090;GO:0016055;, C:beta-catenin-TCF complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold71 indexed_genome mRNA 7028 15542 . - . ID=transcript_11295;B8ZZ34 A0A087WXQ4,Protein shisa-8 {ECO:0000305},Shisa family member 8 {ECO:0000305};, PF13908;, GO:0032281;GO:0032591;GO:0014069;GO:0045211;GO:2000311;GO:0048172;, C:AMPA glutamate receptor complex; C:dendritic spine membrane; C:postsynaptic density; C:postsynaptic membrane;, , P:regulation of AMPA receptor activity; P:regulation of short-term neuronal synaptic plasticity;|B8ZZ34 A0A087WXQ4,Protein shisa-8 {ECO:0000305},Shisa family member 8 {ECO:0000305};, PF13908;, GO:0032281;GO:0032591;GO:0014069;GO:0045211;GO:2000311;GO:0048172;, C:AMPA glutamate receptor complex; C:dendritic spine membrane; C:postsynaptic density; C:postsynaptic membrane;, , P:regulation of AMPA receptor activity; P:regulation of short-term neuronal synaptic plasticity; scaffold71 indexed_genome mRNA 18271 50606 . + . ID=transcript_11296;Q12772 Q05BD5 Q6GTH7 Q86V36 Q9UH04,Sterol regulatory element-binding protein 2 {ECO:0000303|PubMed:15461802},Class D basic helix-loop-helix protein 2;Sterol regulatory element-binding transcription factor 2 {ECO:0000303|PubMed:15461802};, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0012507;GO:0000139;GO:0043231;GO:0005654;GO:0005634;GO:0032937;GO:0000981;GO:0001227;GO:0070888;GO:0008022;GO:0046983;GO:0000978;GO:1990837;GO:0071499;GO:0071404;GO:0009267;GO:0042632;GO:0008203;GO:0006629;GO:0090370;GO:0000122;GO:0007399;GO:0045542;GO:0010886;GO:1902895;GO:1903955;GO:0045944;GO:1903146;GO:0045540;GO:0019216;GO:0008593;GO:0006357;GO:0032933;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:SREBP-SCAP-Insig complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein C-terminus binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to laminar fluid shear stress; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to starvation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:lipid metabolic process; P:negative regulation of cholesterol efflux; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol storage; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:regulation of autophagy of mitochondrion; P:regulation of cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of Notch signaling pathway; P:regulation of transcription by RNA polymerase II; P:SREBP signaling pathway;|Q12772 Q05BD5 Q6GTH7 Q86V36 Q9UH04,Sterol regulatory element-binding protein 2 {ECO:0000303|PubMed:15461802},Class D basic helix-loop-helix protein 2;Sterol regulatory element-binding transcription factor 2 {ECO:0000303|PubMed:15461802};, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0012507;GO:0000139;GO:0043231;GO:0005654;GO:0005634;GO:0032937;GO:0000981;GO:0001227;GO:0070888;GO:0008022;GO:0046983;GO:0000978;GO:1990837;GO:0071499;GO:0071404;GO:0009267;GO:0042632;GO:0008203;GO:0006629;GO:0090370;GO:0000122;GO:0007399;GO:0045542;GO:0010886;GO:1902895;GO:1903955;GO:0045944;GO:1903146;GO:0045540;GO:0019216;GO:0008593;GO:0006357;GO:0032933;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:SREBP-SCAP-Insig complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein C-terminus binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to laminar fluid shear stress; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to starvation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:lipid metabolic process; P:negative regulation of cholesterol efflux; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol storage; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:regulation of autophagy of mitochondrion; P:regulation of cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of Notch signaling pathway; P:regulation of transcription by RNA polymerase II; P:SREBP signaling pathway;|Q12772 Q05BD5 Q6GTH7 Q86V36 Q9UH04,Sterol regulatory element-binding protein 2 {ECO:0000303|PubMed:15461802},Class D basic helix-loop-helix protein 2;Sterol regulatory element-binding transcription factor 2 {ECO:0000303|PubMed:15461802};, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0012507;GO:0000139;GO:0043231;GO:0005654;GO:0005634;GO:0032937;GO:0000981;GO:0001227;GO:0070888;GO:0008022;GO:0046983;GO:0000978;GO:1990837;GO:0071499;GO:0071404;GO:0009267;GO:0042632;GO:0008203;GO:0006629;GO:0090370;GO:0000122;GO:0007399;GO:0045542;GO:0010886;GO:1902895;GO:1903955;GO:0045944;GO:1903146;GO:0045540;GO:0019216;GO:0008593;GO:0006357;GO:0032933;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:SREBP-SCAP-Insig complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein C-terminus binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to laminar fluid shear stress; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to starvation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:lipid metabolic process; P:negative regulation of cholesterol efflux; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol storage; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:regulation of autophagy of mitochondrion; P:regulation of cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of Notch signaling pathway; P:regulation of transcription by RNA polymerase II; P:SREBP signaling pathway;|Q12772 Q05BD5 Q6GTH7 Q86V36 Q9UH04,Sterol regulatory element-binding protein 2 {ECO:0000303|PubMed:15461802},Class D basic helix-loop-helix protein 2;Sterol regulatory element-binding transcription factor 2 {ECO:0000303|PubMed:15461802};, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0012507;GO:0000139;GO:0043231;GO:0005654;GO:0005634;GO:0032937;GO:0000981;GO:0001227;GO:0070888;GO:0008022;GO:0046983;GO:0000978;GO:1990837;GO:0071499;GO:0071404;GO:0009267;GO:0042632;GO:0008203;GO:0006629;GO:0090370;GO:0000122;GO:0007399;GO:0045542;GO:0010886;GO:1902895;GO:1903955;GO:0045944;GO:1903146;GO:0045540;GO:0019216;GO:0008593;GO:0006357;GO:0032933;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:SREBP-SCAP-Insig complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein C-terminus binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to laminar fluid shear stress; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to starvation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:lipid metabolic process; P:negative regulation of cholesterol efflux; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol storage; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:regulation of autophagy of mitochondrion; P:regulation of cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of Notch signaling pathway; P:regulation of transcription by RNA polymerase II; P:SREBP signaling pathway;|Q12772 Q05BD5 Q6GTH7 Q86V36 Q9UH04,Sterol regulatory element-binding protein 2 {ECO:0000303|PubMed:15461802},Class D basic helix-loop-helix protein 2;Sterol regulatory element-binding transcription factor 2 {ECO:0000303|PubMed:15461802};, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0012507;GO:0000139;GO:0043231;GO:0005654;GO:0005634;GO:0032937;GO:0000981;GO:0001227;GO:0070888;GO:0008022;GO:0046983;GO:0000978;GO:1990837;GO:0071499;GO:0071404;GO:0009267;GO:0042632;GO:0008203;GO:0006629;GO:0090370;GO:0000122;GO:0007399;GO:0045542;GO:0010886;GO:1902895;GO:1903955;GO:0045944;GO:1903146;GO:0045540;GO:0019216;GO:0008593;GO:0006357;GO:0032933;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:SREBP-SCAP-Insig complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein C-terminus binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to laminar fluid shear stress; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to starvation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:lipid metabolic process; P:negative regulation of cholesterol efflux; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol storage; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:regulation of autophagy of mitochondrion; P:regulation of cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of Notch signaling pathway; P:regulation of transcription by RNA polymerase II; P:SREBP signaling pathway;|Q12772 Q05BD5 Q6GTH7 Q86V36 Q9UH04,Sterol regulatory element-binding protein 2 {ECO:0000303|PubMed:15461802},Class D basic helix-loop-helix protein 2;Sterol regulatory element-binding transcription factor 2 {ECO:0000303|PubMed:15461802};, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0012507;GO:0000139;GO:0043231;GO:0005654;GO:0005634;GO:0032937;GO:0000981;GO:0001227;GO:0070888;GO:0008022;GO:0046983;GO:0000978;GO:1990837;GO:0071499;GO:0071404;GO:0009267;GO:0042632;GO:0008203;GO:0006629;GO:0090370;GO:0000122;GO:0007399;GO:0045542;GO:0010886;GO:1902895;GO:1903955;GO:0045944;GO:1903146;GO:0045540;GO:0019216;GO:0008593;GO:0006357;GO:0032933;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:SREBP-SCAP-Insig complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein C-terminus binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to laminar fluid shear stress; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to starvation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:lipid metabolic process; P:negative regulation of cholesterol efflux; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol storage; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:regulation of autophagy of mitochondrion; P:regulation of cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of Notch signaling pathway; P:regulation of transcription by RNA polymerase II; P:SREBP signaling pathway;|Q12772 Q05BD5 Q6GTH7 Q86V36 Q9UH04,Sterol regulatory element-binding protein 2 {ECO:0000303|PubMed:15461802},Class D basic helix-loop-helix protein 2;Sterol regulatory element-binding transcription factor 2 {ECO:0000303|PubMed:15461802};, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0012507;GO:0000139;GO:0043231;GO:0005654;GO:0005634;GO:0032937;GO:0000981;GO:0001227;GO:0070888;GO:0008022;GO:0046983;GO:0000978;GO:1990837;GO:0071499;GO:0071404;GO:0009267;GO:0042632;GO:0008203;GO:0006629;GO:0090370;GO:0000122;GO:0007399;GO:0045542;GO:0010886;GO:1902895;GO:1903955;GO:0045944;GO:1903146;GO:0045540;GO:0019216;GO:0008593;GO:0006357;GO:0032933;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:SREBP-SCAP-Insig complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein C-terminus binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to laminar fluid shear stress; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to starvation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:lipid metabolic process; P:negative regulation of cholesterol efflux; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol storage; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:regulation of autophagy of mitochondrion; P:regulation of cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of Notch signaling pathway; P:regulation of transcription by RNA polymerase II; P:SREBP signaling pathway;|Q12772 Q05BD5 Q6GTH7 Q86V36 Q9UH04,Sterol regulatory element-binding protein 2 {ECO:0000303|PubMed:15461802},Class D basic helix-loop-helix protein 2;Sterol regulatory element-binding transcription factor 2 {ECO:0000303|PubMed:15461802};, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0012507;GO:0000139;GO:0043231;GO:0005654;GO:0005634;GO:0032937;GO:0000981;GO:0001227;GO:0070888;GO:0008022;GO:0046983;GO:0000978;GO:1990837;GO:0071499;GO:0071404;GO:0009267;GO:0042632;GO:0008203;GO:0006629;GO:0090370;GO:0000122;GO:0007399;GO:0045542;GO:0010886;GO:1902895;GO:1903955;GO:0045944;GO:1903146;GO:0045540;GO:0019216;GO:0008593;GO:0006357;GO:0032933;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:SREBP-SCAP-Insig complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:protein C-terminus binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to laminar fluid shear stress; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to starvation; P:cholesterol homeostasis; P:cholesterol metabolic process; P:lipid metabolic process; P:negative regulation of cholesterol efflux; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol storage; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of transcription by RNA polymerase II; P:regulation of autophagy of mitochondrion; P:regulation of cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:regulation of Notch signaling pathway; P:regulation of transcription by RNA polymerase II; P:SREBP signaling pathway; scaffold71 indexed_genome mRNA 165321 169551 . + . ID=transcript_11297;P55769,NHP2-like protein 1,High mobility group-like nuclear protein 2 homolog 1;OTK27;SNU13 homolog;U4/U6.U5 small nuclear ribonucleoprotein SNU13 {ECO:0000312|HGNC:HGNC:7819};U4/U6.U5 tri-snRNP 15.5 kDa protein;, PF01248;, GO:0031428;GO:0001651;GO:0005730;GO:0005654;GO:0005634;GO:0071011;GO:0032991;GO:0032040;GO:0071005;GO:0046540;GO:0005690;GO:0051117;GO:0034512;GO:0003723;GO:0034511;GO:0030621;GO:0030622;GO:0000470;GO:0030490;GO:0000398;GO:0006364;, C:box C/D RNP complex; C:dense fibrillar component; C:nucleolus; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:protein-containing complex; C:small-subunit processome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U4atac snRNP;, F:ATPase binding; F:box C/D RNA binding; F:RNA binding; F:U3 snoRNA binding; F:U4 snRNA binding; F:U4atac snRNA binding;, P:maturation of LSU-rRNA; P:maturation of SSU-rRNA; P:mRNA splicing, via spliceosome; P:rRNA processing;|P55769,NHP2-like protein 1,High mobility group-like nuclear protein 2 homolog 1;OTK27;SNU13 homolog;U4/U6.U5 small nuclear ribonucleoprotein SNU13 {ECO:0000312|HGNC:HGNC:7819};U4/U6.U5 tri-snRNP 15.5 kDa protein;, PF01248;, GO:0031428;GO:0001651;GO:0005730;GO:0005654;GO:0005634;GO:0071011;GO:0032991;GO:0032040;GO:0071005;GO:0046540;GO:0005690;GO:0051117;GO:0034512;GO:0003723;GO:0034511;GO:0030621;GO:0030622;GO:0000470;GO:0030490;GO:0000398;GO:0006364;, C:box C/D RNP complex; C:dense fibrillar component; C:nucleolus; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:protein-containing complex; C:small-subunit processome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U4atac snRNP;, F:ATPase binding; F:box C/D RNA binding; F:RNA binding; F:U3 snoRNA binding; F:U4 snRNA binding; F:U4atac snRNA binding;, P:maturation of LSU-rRNA; P:maturation of SSU-rRNA; P:mRNA splicing, via spliceosome; P:rRNA processing; scaffold71 indexed_genome mRNA 173015 194887 . - . ID=transcript_11298;P12956 B1AHC8 Q6FG89 Q9UCQ2 Q9UCQ3,X-ray repair cross-complementing protein 6,5'-deoxyribose-5-phosphate lyase Ku70;70 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 1;ATP-dependent DNA helicase II 70 kDa subunit;CTC box-binding factor 75 kDa subunit;DNA repair protein XRCC6;Lupus Ku autoantigen protein p70;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 6;, PF02735;PF03730;PF03731;PF02037;, GO:0000781;GO:0005829;GO:0005576;GO:1904813;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0034774;GO:0005667;GO:0051575;GO:0005524;GO:0030332;GO:0003684;GO:0003677;GO:0003678;GO:0008094;GO:0003690;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0002218;GO:0007420;GO:0071475;GO:0071480;GO:0071481;GO:0006266;GO:0006310;GO:0097680;GO:0006303;GO:0075713;GO:0045087;GO:0045892;GO:0043312;GO:0045621;GO:0045860;GO:0045944;GO:0045893;GO:0032481;GO:0048660;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:secretory granule lumen; C:transcription regulator complex;, F:5'-deoxyribose-5-phosphate lyase activity; F:ATP binding; F:cyclin binding; F:damaged DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:brain development; P:cellular hyperosmotic salinity response; P:cellular response to gamma radiation; P:cellular response to X-ray; P:DNA ligation; P:DNA recombination; P:double-strand break repair via classical nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:innate immune response; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of lymphocyte differentiation; P:positive regulation of protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of smooth muscle cell proliferation; P:telomere maintenance;|P12956 B1AHC8 Q6FG89 Q9UCQ2 Q9UCQ3,X-ray repair cross-complementing protein 6,5'-deoxyribose-5-phosphate lyase Ku70;70 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 1;ATP-dependent DNA helicase II 70 kDa subunit;CTC box-binding factor 75 kDa subunit;DNA repair protein XRCC6;Lupus Ku autoantigen protein p70;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 6;, PF02735;PF03730;PF03731;PF02037;, GO:0000781;GO:0005829;GO:0005576;GO:1904813;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0034774;GO:0005667;GO:0051575;GO:0005524;GO:0030332;GO:0003684;GO:0003677;GO:0003678;GO:0008094;GO:0003690;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0002218;GO:0007420;GO:0071475;GO:0071480;GO:0071481;GO:0006266;GO:0006310;GO:0097680;GO:0006303;GO:0075713;GO:0045087;GO:0045892;GO:0043312;GO:0045621;GO:0045860;GO:0045944;GO:0045893;GO:0032481;GO:0048660;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:secretory granule lumen; C:transcription regulator complex;, F:5'-deoxyribose-5-phosphate lyase activity; F:ATP binding; F:cyclin binding; F:damaged DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:brain development; P:cellular hyperosmotic salinity response; P:cellular response to gamma radiation; P:cellular response to X-ray; P:DNA ligation; P:DNA recombination; P:double-strand break repair via classical nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:innate immune response; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of lymphocyte differentiation; P:positive regulation of protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of smooth muscle cell proliferation; P:telomere maintenance;|P12956 B1AHC8 Q6FG89 Q9UCQ2 Q9UCQ3,X-ray repair cross-complementing protein 6,5'-deoxyribose-5-phosphate lyase Ku70;70 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 1;ATP-dependent DNA helicase II 70 kDa subunit;CTC box-binding factor 75 kDa subunit;DNA repair protein XRCC6;Lupus Ku autoantigen protein p70;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 6;, PF02735;PF03730;PF03731;PF02037;, GO:0000781;GO:0005829;GO:0005576;GO:1904813;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0034774;GO:0005667;GO:0051575;GO:0005524;GO:0030332;GO:0003684;GO:0003677;GO:0003678;GO:0008094;GO:0003690;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0002218;GO:0007420;GO:0071475;GO:0071480;GO:0071481;GO:0006266;GO:0006310;GO:0097680;GO:0006303;GO:0075713;GO:0045087;GO:0045892;GO:0043312;GO:0045621;GO:0045860;GO:0045944;GO:0045893;GO:0032481;GO:0048660;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:secretory granule lumen; C:transcription regulator complex;, F:5'-deoxyribose-5-phosphate lyase activity; F:ATP binding; F:cyclin binding; F:damaged DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:brain development; P:cellular hyperosmotic salinity response; P:cellular response to gamma radiation; P:cellular response to X-ray; P:DNA ligation; P:DNA recombination; P:double-strand break repair via classical nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:innate immune response; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of lymphocyte differentiation; P:positive regulation of protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of smooth muscle cell proliferation; P:telomere maintenance;|P12956 B1AHC8 Q6FG89 Q9UCQ2 Q9UCQ3,X-ray repair cross-complementing protein 6,5'-deoxyribose-5-phosphate lyase Ku70;70 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 1;ATP-dependent DNA helicase II 70 kDa subunit;CTC box-binding factor 75 kDa subunit;DNA repair protein XRCC6;Lupus Ku autoantigen protein p70;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 6;, PF02735;PF03730;PF03731;PF02037;, GO:0000781;GO:0005829;GO:0005576;GO:1904813;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0034774;GO:0005667;GO:0051575;GO:0005524;GO:0030332;GO:0003684;GO:0003677;GO:0003678;GO:0008094;GO:0003690;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0002218;GO:0007420;GO:0071475;GO:0071480;GO:0071481;GO:0006266;GO:0006310;GO:0097680;GO:0006303;GO:0075713;GO:0045087;GO:0045892;GO:0043312;GO:0045621;GO:0045860;GO:0045944;GO:0045893;GO:0032481;GO:0048660;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:secretory granule lumen; C:transcription regulator complex;, F:5'-deoxyribose-5-phosphate lyase activity; F:ATP binding; F:cyclin binding; F:damaged DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:brain development; P:cellular hyperosmotic salinity response; P:cellular response to gamma radiation; P:cellular response to X-ray; P:DNA ligation; P:DNA recombination; P:double-strand break repair via classical nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:innate immune response; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of lymphocyte differentiation; P:positive regulation of protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of smooth muscle cell proliferation; P:telomere maintenance;|P12956 B1AHC8 Q6FG89 Q9UCQ2 Q9UCQ3,X-ray repair cross-complementing protein 6,5'-deoxyribose-5-phosphate lyase Ku70;70 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 1;ATP-dependent DNA helicase II 70 kDa subunit;CTC box-binding factor 75 kDa subunit;DNA repair protein XRCC6;Lupus Ku autoantigen protein p70;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 6;, PF02735;PF03730;PF03731;PF02037;, GO:0000781;GO:0005829;GO:0005576;GO:1904813;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0034774;GO:0005667;GO:0051575;GO:0005524;GO:0030332;GO:0003684;GO:0003677;GO:0003678;GO:0008094;GO:0003690;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0002218;GO:0007420;GO:0071475;GO:0071480;GO:0071481;GO:0006266;GO:0006310;GO:0097680;GO:0006303;GO:0075713;GO:0045087;GO:0045892;GO:0043312;GO:0045621;GO:0045860;GO:0045944;GO:0045893;GO:0032481;GO:0048660;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:secretory granule lumen; C:transcription regulator complex;, F:5'-deoxyribose-5-phosphate lyase activity; F:ATP binding; F:cyclin binding; F:damaged DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:brain development; P:cellular hyperosmotic salinity response; P:cellular response to gamma radiation; P:cellular response to X-ray; P:DNA ligation; P:DNA recombination; P:double-strand break repair via classical nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:innate immune response; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of lymphocyte differentiation; P:positive regulation of protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of smooth muscle cell proliferation; P:telomere maintenance;|P12956 B1AHC8 Q6FG89 Q9UCQ2 Q9UCQ3,X-ray repair cross-complementing protein 6,5'-deoxyribose-5-phosphate lyase Ku70;70 kDa subunit of Ku antigen;ATP-dependent DNA helicase 2 subunit 1;ATP-dependent DNA helicase II 70 kDa subunit;CTC box-binding factor 75 kDa subunit;DNA repair protein XRCC6;Lupus Ku autoantigen protein p70;Thyroid-lupus autoantigen;X-ray repair complementing defective repair in Chinese hamster cells 6;, PF02735;PF03730;PF03731;PF02037;, GO:0000781;GO:0005829;GO:0005576;GO:1904813;GO:0043564;GO:0016020;GO:0070419;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0034774;GO:0005667;GO:0051575;GO:0005524;GO:0030332;GO:0003684;GO:0003677;GO:0003678;GO:0008094;GO:0003690;GO:0008022;GO:0044877;GO:0003723;GO:0042162;GO:0000976;GO:0002218;GO:0007420;GO:0071475;GO:0071480;GO:0071481;GO:0006266;GO:0006310;GO:0097680;GO:0006303;GO:0075713;GO:0045087;GO:0045892;GO:0043312;GO:0045621;GO:0045860;GO:0045944;GO:0045893;GO:0032481;GO:0048660;GO:0000723;, C:chromosome, telomeric region; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:Ku70:Ku80 complex; C:membrane; C:nonhomologous end joining complex; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:secretory granule lumen; C:transcription regulator complex;, F:5'-deoxyribose-5-phosphate lyase activity; F:ATP binding; F:cyclin binding; F:damaged DNA binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:protein C-terminus binding; F:protein-containing complex binding; F:RNA binding; F:telomeric DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:brain development; P:cellular hyperosmotic salinity response; P:cellular response to gamma radiation; P:cellular response to X-ray; P:DNA ligation; P:DNA recombination; P:double-strand break repair via classical nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:establishment of integrated proviral latency; P:innate immune response; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of lymphocyte differentiation; P:positive regulation of protein kinase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:regulation of smooth muscle cell proliferation; P:telomere maintenance; scaffold71 indexed_genome mRNA 195306 217503 . + . ID=transcript_11299;Q6ICB0,Desumoylating isopeptidase 1 {ECO:0000250|UniProtKB:Q9CQT7},PPPDE peptidase domain-containing protein 2 {ECO:0000305};Polyubiquitinated substrate transporter {ECO:0000303|PubMed:29666234};, PF05903;, GO:0005829;GO:0005634;GO:0032991;GO:0042802;GO:0061676;GO:0070140;GO:0016926;GO:0006611;GO:0070646;GO:0032434;, C:cytosol; C:nucleus; C:protein-containing complex;, F:identical protein binding; F:importin-alpha family protein binding; F:SUMO-specific isopeptidase activity;, P:protein desumoylation; P:protein export from nucleus; P:protein modification by small protein removal; P:regulation of proteasomal ubiquitin-dependent protein catabolic process;|Q6ICB0,Desumoylating isopeptidase 1 {ECO:0000250|UniProtKB:Q9CQT7},PPPDE peptidase domain-containing protein 2 {ECO:0000305};Polyubiquitinated substrate transporter {ECO:0000303|PubMed:29666234};, PF05903;, GO:0005829;GO:0005634;GO:0032991;GO:0042802;GO:0061676;GO:0070140;GO:0016926;GO:0006611;GO:0070646;GO:0032434;, C:cytosol; C:nucleus; C:protein-containing complex;, F:identical protein binding; F:importin-alpha family protein binding; F:SUMO-specific isopeptidase activity;, P:protein desumoylation; P:protein export from nucleus; P:protein modification by small protein removal; P:regulation of proteasomal ubiquitin-dependent protein catabolic process;|Q6ICB0,Desumoylating isopeptidase 1 {ECO:0000250|UniProtKB:Q9CQT7},PPPDE peptidase domain-containing protein 2 {ECO:0000305};Polyubiquitinated substrate transporter {ECO:0000303|PubMed:29666234};, PF05903;, GO:0005829;GO:0005634;GO:0032991;GO:0042802;GO:0061676;GO:0070140;GO:0016926;GO:0006611;GO:0070646;GO:0032434;, C:cytosol; C:nucleus; C:protein-containing complex;, F:identical protein binding; F:importin-alpha family protein binding; F:SUMO-specific isopeptidase activity;, P:protein desumoylation; P:protein export from nucleus; P:protein modification by small protein removal; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; scaffold71 indexed_genome mRNA 230240 255281 . + . ID=transcript_11300;Q92871 A8K003 Q92586,Phosphomannomutase 1 {ECO:0000303|PubMed:9070917},PMMH-22;, PF03332;, GO:0005829;GO:0043025;GO:0046872;GO:0004615;GO:1990830;GO:0009298;GO:0006013;GO:0006487;, C:cytosol; C:neuronal cell body;, F:metal ion binding; F:phosphomannomutase activity;, P:cellular response to leukemia inhibitory factor; P:GDP-mannose biosynthetic process; P:mannose metabolic process; P:protein N-linked glycosylation;|Q92871 A8K003 Q92586,Phosphomannomutase 1 {ECO:0000303|PubMed:9070917},PMMH-22;, PF03332;, GO:0005829;GO:0043025;GO:0046872;GO:0004615;GO:1990830;GO:0009298;GO:0006013;GO:0006487;, C:cytosol; C:neuronal cell body;, F:metal ion binding; F:phosphomannomutase activity;, P:cellular response to leukemia inhibitory factor; P:GDP-mannose biosynthetic process; P:mannose metabolic process; P:protein N-linked glycosylation;|Q92871 A8K003 Q92586,Phosphomannomutase 1 {ECO:0000303|PubMed:9070917},PMMH-22;, PF03332;, GO:0005829;GO:0043025;GO:0046872;GO:0004615;GO:1990830;GO:0009298;GO:0006013;GO:0006487;, C:cytosol; C:neuronal cell body;, F:metal ion binding; F:phosphomannomutase activity;, P:cellular response to leukemia inhibitory factor; P:GDP-mannose biosynthetic process; P:mannose metabolic process; P:protein N-linked glycosylation;|Q9Y534 Q8ND37,Cold shock domain-containing protein C2,RNA-binding protein PIPPin;, PF00313;, GO:0005737;GO:0005634;GO:0003730;GO:0003723;GO:0008134;GO:0006397;GO:0043488;, C:cytoplasm; C:nucleus;, F:mRNA 3'-UTR binding; F:RNA binding; F:transcription factor binding;, P:mRNA processing; P:regulation of mRNA stability; scaffold71 indexed_genome mRNA 266421 274637 . + . ID=transcript_11301;Q9Y535 B0QYH9 Q5M7Y8 Q96AE3 Q9BY95,DNA-directed RNA polymerase III subunit RPC8,DNA-directed RNA polymerase III subunit H;RNA polymerase III subunit 22.9 kDa subunit;, PF08292;PF03876;, GO:0005813;GO:0005829;GO:0043231;GO:0005654;GO:0005666;GO:0003677;GO:0003899;GO:0051607;GO:0045087;GO:0006139;GO:0032481;GO:0006383;GO:0006384;, C:centrosome; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:nucleobase-containing compound metabolic process; P:positive regulation of type I interferon production; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter;|Q9Y535 B0QYH9 Q5M7Y8 Q96AE3 Q9BY95,DNA-directed RNA polymerase III subunit RPC8,DNA-directed RNA polymerase III subunit H;RNA polymerase III subunit 22.9 kDa subunit;, PF08292;PF03876;, GO:0005813;GO:0005829;GO:0043231;GO:0005654;GO:0005666;GO:0003677;GO:0003899;GO:0051607;GO:0045087;GO:0006139;GO:0032481;GO:0006383;GO:0006384;, C:centrosome; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:nucleobase-containing compound metabolic process; P:positive regulation of type I interferon production; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter;|Q9Y535 B0QYH9 Q5M7Y8 Q96AE3 Q9BY95,DNA-directed RNA polymerase III subunit RPC8,DNA-directed RNA polymerase III subunit H;RNA polymerase III subunit 22.9 kDa subunit;, PF08292;PF03876;, GO:0005813;GO:0005829;GO:0043231;GO:0005654;GO:0005666;GO:0003677;GO:0003899;GO:0051607;GO:0045087;GO:0006139;GO:0032481;GO:0006383;GO:0006384;, C:centrosome; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:nucleobase-containing compound metabolic process; P:positive regulation of type I interferon production; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter;|Q9Y535 B0QYH9 Q5M7Y8 Q96AE3 Q9BY95,DNA-directed RNA polymerase III subunit RPC8,DNA-directed RNA polymerase III subunit H;RNA polymerase III subunit 22.9 kDa subunit;, PF08292;PF03876;, GO:0005813;GO:0005829;GO:0043231;GO:0005654;GO:0005666;GO:0003677;GO:0003899;GO:0051607;GO:0045087;GO:0006139;GO:0032481;GO:0006383;GO:0006384;, C:centrosome; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:nucleobase-containing compound metabolic process; P:positive regulation of type I interferon production; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; scaffold71 indexed_genome mRNA 275662 326319 . - . ID=transcript_11302;Q9Y535 B0QYH9 Q5M7Y8 Q96AE3 Q9BY95,DNA-directed RNA polymerase III subunit RPC8,DNA-directed RNA polymerase III subunit H;RNA polymerase III subunit 22.9 kDa subunit;, PF08292;PF03876;, GO:0005813;GO:0005829;GO:0043231;GO:0005654;GO:0005666;GO:0003677;GO:0003899;GO:0051607;GO:0045087;GO:0006139;GO:0032481;GO:0006383;GO:0006384;, C:centrosome; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:defense response to virus; P:innate immune response; P:nucleobase-containing compound metabolic process; P:positive regulation of type I interferon production; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter;|Q99798 O75809 Q5JZ41 Q6FHX0 Q8TAQ6,Aconitate hydratase, mitochondrial,Citrate hydro-lyase;, PF00330;PF00694;, GO:0005829;GO:0005759;GO:0005739;GO:0051539;GO:0003994;GO:0047780;GO:0005506;GO:0006101;GO:0006091;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron ion binding;, P:citrate metabolic process; P:generation of precursor metabolites and energy; P:tricarboxylic acid cycle;|Q99798 O75809 Q5JZ41 Q6FHX0 Q8TAQ6,Aconitate hydratase, mitochondrial,Citrate hydro-lyase;, PF00330;PF00694;, GO:0005829;GO:0005759;GO:0005739;GO:0051539;GO:0003994;GO:0047780;GO:0005506;GO:0006101;GO:0006091;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron ion binding;, P:citrate metabolic process; P:generation of precursor metabolites and energy; P:tricarboxylic acid cycle;|Q99798 O75809 Q5JZ41 Q6FHX0 Q8TAQ6,Aconitate hydratase, mitochondrial,Citrate hydro-lyase;, PF00330;PF00694;, GO:0005829;GO:0005759;GO:0005739;GO:0051539;GO:0003994;GO:0047780;GO:0005506;GO:0006101;GO:0006091;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron ion binding;, P:citrate metabolic process; P:generation of precursor metabolites and energy; P:tricarboxylic acid cycle;|Q99798 O75809 Q5JZ41 Q6FHX0 Q8TAQ6,Aconitate hydratase, mitochondrial,Citrate hydro-lyase;, PF00330;PF00694;, GO:0005829;GO:0005759;GO:0005739;GO:0051539;GO:0003994;GO:0047780;GO:0005506;GO:0006101;GO:0006091;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron ion binding;, P:citrate metabolic process; P:generation of precursor metabolites and energy; P:tricarboxylic acid cycle;|Q99798 O75809 Q5JZ41 Q6FHX0 Q8TAQ6,Aconitate hydratase, mitochondrial,Citrate hydro-lyase;, PF00330;PF00694;, GO:0005829;GO:0005759;GO:0005739;GO:0051539;GO:0003994;GO:0047780;GO:0005506;GO:0006101;GO:0006091;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron ion binding;, P:citrate metabolic process; P:generation of precursor metabolites and energy; P:tricarboxylic acid cycle;|Q99798 O75809 Q5JZ41 Q6FHX0 Q8TAQ6,Aconitate hydratase, mitochondrial,Citrate hydro-lyase;, PF00330;PF00694;, GO:0005829;GO:0005759;GO:0005739;GO:0051539;GO:0003994;GO:0047780;GO:0005506;GO:0006101;GO:0006091;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron ion binding;, P:citrate metabolic process; P:generation of precursor metabolites and energy; P:tricarboxylic acid cycle;|Q99798 O75809 Q5JZ41 Q6FHX0 Q8TAQ6,Aconitate hydratase, mitochondrial,Citrate hydro-lyase;, PF00330;PF00694;, GO:0005829;GO:0005759;GO:0005739;GO:0051539;GO:0003994;GO:0047780;GO:0005506;GO:0006101;GO:0006091;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron ion binding;, P:citrate metabolic process; P:generation of precursor metabolites and energy; P:tricarboxylic acid cycle;|Q99798 O75809 Q5JZ41 Q6FHX0 Q8TAQ6,Aconitate hydratase, mitochondrial,Citrate hydro-lyase;, PF00330;PF00694;, GO:0005829;GO:0005759;GO:0005739;GO:0051539;GO:0003994;GO:0047780;GO:0005506;GO:0006101;GO:0006091;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron ion binding;, P:citrate metabolic process; P:generation of precursor metabolites and energy; P:tricarboxylic acid cycle;|Q99798 O75809 Q5JZ41 Q6FHX0 Q8TAQ6,Aconitate hydratase, mitochondrial,Citrate hydro-lyase;, PF00330;PF00694;, GO:0005829;GO:0005759;GO:0005739;GO:0051539;GO:0003994;GO:0047780;GO:0005506;GO:0006101;GO:0006091;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:citrate dehydratase activity; F:iron ion binding;, P:citrate metabolic process; P:generation of precursor metabolites and energy; P:tricarboxylic acid cycle; scaffold71 indexed_genome mRNA 326636 341515 . + . ID=transcript_11303;Q7RTV0 Q9UH06,PHD finger-like domain-containing protein 5A,Splicing factor 3B-associated 14 kDa protein;, PF03660;, GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0005689;GO:0005686;GO:0071005;GO:0003677;GO:0003723;GO:0008270;GO:0000398;GO:0045893;GO:0048863;, C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:DNA binding; F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:positive regulation of transcription, DNA-templated; P:stem cell differentiation;|Q7RTV0 Q9UH06,PHD finger-like domain-containing protein 5A,Splicing factor 3B-associated 14 kDa protein;, PF03660;, GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0005689;GO:0005686;GO:0071005;GO:0003677;GO:0003723;GO:0008270;GO:0000398;GO:0045893;GO:0048863;, C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:DNA binding; F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:positive regulation of transcription, DNA-templated; P:stem cell differentiation;|Q7RTV0 Q9UH06,PHD finger-like domain-containing protein 5A,Splicing factor 3B-associated 14 kDa protein;, PF03660;, GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0005689;GO:0005686;GO:0071005;GO:0003677;GO:0003723;GO:0008270;GO:0000398;GO:0045893;GO:0048863;, C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:DNA binding; F:RNA binding; F:zinc ion binding;, P:mRNA splicing, via spliceosome; P:positive regulation of transcription, DNA-templated; P:stem cell differentiation; scaffold71 indexed_genome mRNA 349423 353322 . + . ID=transcript_11304;Q14106 Q6FHR7 Q6PIT9 Q9BY97 Q9UBI0,Protein Tob2,Protein Tob4;Transducer of erbB-2 2;, PF07742;PF07145;, GO:0005737;GO:0005829;GO:0005634;GO:0003714;GO:0042809;GO:0007292;GO:0008285;GO:0045671;GO:0045778;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleus;, F:transcription corepressor activity; F:vitamin D receptor binding;, P:female gamete generation; P:negative regulation of cell population proliferation; P:negative regulation of osteoclast differentiation; P:positive regulation of ossification; P:regulation of gene expression; scaffold71 indexed_genome mRNA 372277 385194 . - . ID=transcript_11305;Q10587 B0QYS8 B2RC22 Q15729 Q7Z3J7 Q8IU94 Q96TG4,Thyrotroph embryonic factor,, PF07716;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0045944;GO:0006357;GO:0048511;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:rhythmic process;|Q10587 B0QYS8 B2RC22 Q15729 Q7Z3J7 Q8IU94 Q96TG4,Thyrotroph embryonic factor,, PF07716;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0045944;GO:0006357;GO:0048511;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:rhythmic process; scaffold71 indexed_genome mRNA 399709 425477 . - . ID=transcript_11306;Q9UK03 Q9UPW9,Zinc finger CCCH domain-containing protein 7B,Rotavirus 'X'-associated non-structural protein;, PF13181;PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;GO:0016032;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:viral process;|Q9UK03 Q9UPW9,Zinc finger CCCH domain-containing protein 7B,Rotavirus 'X'-associated non-structural protein;, PF13181;PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;GO:0016032;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:viral process;|Q9UK03 Q9UPW9,Zinc finger CCCH domain-containing protein 7B,Rotavirus 'X'-associated non-structural protein;, PF13181;PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;GO:0016032;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:viral process;|Q9UK03 Q9UPW9,Zinc finger CCCH domain-containing protein 7B,Rotavirus 'X'-associated non-structural protein;, PF13181;PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;GO:0016032;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:viral process;|Q9UK03 Q9UPW9,Zinc finger CCCH domain-containing protein 7B,Rotavirus 'X'-associated non-structural protein;, PF13181;PF00642;, GO:0005634;GO:0046872;GO:0035198;GO:0003723;GO:0010608;GO:0035196;GO:0016032;, C:nucleus;, F:metal ion binding; F:miRNA binding; F:RNA binding;, P:posttranscriptional regulation of gene expression; P:production of miRNAs involved in gene silencing by miRNA; P:viral process; scaffold71 indexed_genome mRNA 472334 493217 . + . ID=transcript_11307;P46060 Q96JJ2,Ran GTPase-activating protein 1,, PF13516;PF07834;, GO:0016235;GO:1904115;GO:0000777;GO:0005737;GO:1990723;GO:0005829;GO:0030425;GO:0043231;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005654;GO:0048471;GO:0045296;GO:0005096;GO:0003723;GO:0031267;GO:0031625;GO:0090630;GO:1904117;GO:0007084;GO:0007052;GO:0046826;GO:0016925;GO:0048678;GO:0007165;, C:aggresome; C:axon cytoplasm; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:RNA binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:cellular response to vasopressin; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:negative regulation of protein export from nucleus; P:protein sumoylation; P:response to axon injury; P:signal transduction;|P46060 Q96JJ2,Ran GTPase-activating protein 1,, PF13516;PF07834;, GO:0016235;GO:1904115;GO:0000777;GO:0005737;GO:1990723;GO:0005829;GO:0030425;GO:0043231;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005654;GO:0048471;GO:0045296;GO:0005096;GO:0003723;GO:0031267;GO:0031625;GO:0090630;GO:1904117;GO:0007084;GO:0007052;GO:0046826;GO:0016925;GO:0048678;GO:0007165;, C:aggresome; C:axon cytoplasm; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:RNA binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:cellular response to vasopressin; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:negative regulation of protein export from nucleus; P:protein sumoylation; P:response to axon injury; P:signal transduction; scaffold71 indexed_genome mRNA 493240 500369 . + . ID=transcript_11308;P46060 Q96JJ2,Ran GTPase-activating protein 1,, PF13516;PF07834;, GO:0016235;GO:1904115;GO:0000777;GO:0005737;GO:1990723;GO:0005829;GO:0030425;GO:0043231;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005654;GO:0048471;GO:0045296;GO:0005096;GO:0003723;GO:0031267;GO:0031625;GO:0090630;GO:1904117;GO:0007084;GO:0007052;GO:0046826;GO:0016925;GO:0048678;GO:0007165;, C:aggresome; C:axon cytoplasm; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:RNA binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:cellular response to vasopressin; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:negative regulation of protein export from nucleus; P:protein sumoylation; P:response to axon injury; P:signal transduction;|P46060 Q96JJ2,Ran GTPase-activating protein 1,, PF13516;PF07834;, GO:0016235;GO:1904115;GO:0000777;GO:0005737;GO:1990723;GO:0005829;GO:0030425;GO:0043231;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005654;GO:0048471;GO:0045296;GO:0005096;GO:0003723;GO:0031267;GO:0031625;GO:0090630;GO:1904117;GO:0007084;GO:0007052;GO:0046826;GO:0016925;GO:0048678;GO:0007165;, C:aggresome; C:axon cytoplasm; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:RNA binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:cellular response to vasopressin; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:negative regulation of protein export from nucleus; P:protein sumoylation; P:response to axon injury; P:signal transduction;|P46060 Q96JJ2,Ran GTPase-activating protein 1,, PF13516;PF07834;, GO:0016235;GO:1904115;GO:0000777;GO:0005737;GO:1990723;GO:0005829;GO:0030425;GO:0043231;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005654;GO:0048471;GO:0045296;GO:0005096;GO:0003723;GO:0031267;GO:0031625;GO:0090630;GO:1904117;GO:0007084;GO:0007052;GO:0046826;GO:0016925;GO:0048678;GO:0007165;, C:aggresome; C:axon cytoplasm; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:RNA binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:cellular response to vasopressin; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:negative regulation of protein export from nucleus; P:protein sumoylation; P:response to axon injury; P:signal transduction;|P46060 Q96JJ2,Ran GTPase-activating protein 1,, PF13516;PF07834;, GO:0016235;GO:1904115;GO:0000777;GO:0005737;GO:1990723;GO:0005829;GO:0030425;GO:0043231;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005654;GO:0048471;GO:0045296;GO:0005096;GO:0003723;GO:0031267;GO:0031625;GO:0090630;GO:1904117;GO:0007084;GO:0007052;GO:0046826;GO:0016925;GO:0048678;GO:0007165;, C:aggresome; C:axon cytoplasm; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:RNA binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:cellular response to vasopressin; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:negative regulation of protein export from nucleus; P:protein sumoylation; P:response to axon injury; P:signal transduction;|P46060 Q96JJ2,Ran GTPase-activating protein 1,, PF13516;PF07834;, GO:0016235;GO:1904115;GO:0000777;GO:0005737;GO:1990723;GO:0005829;GO:0030425;GO:0043231;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005654;GO:0048471;GO:0045296;GO:0005096;GO:0003723;GO:0031267;GO:0031625;GO:0090630;GO:1904117;GO:0007084;GO:0007052;GO:0046826;GO:0016925;GO:0048678;GO:0007165;, C:aggresome; C:axon cytoplasm; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:RNA binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:cellular response to vasopressin; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:negative regulation of protein export from nucleus; P:protein sumoylation; P:response to axon injury; P:signal transduction;|P46060 Q96JJ2,Ran GTPase-activating protein 1,, PF13516;PF07834;, GO:0016235;GO:1904115;GO:0000777;GO:0005737;GO:1990723;GO:0005829;GO:0030425;GO:0043231;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005654;GO:0048471;GO:0045296;GO:0005096;GO:0003723;GO:0031267;GO:0031625;GO:0090630;GO:1904117;GO:0007084;GO:0007052;GO:0046826;GO:0016925;GO:0048678;GO:0007165;, C:aggresome; C:axon cytoplasm; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:RNA binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:cellular response to vasopressin; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:negative regulation of protein export from nucleus; P:protein sumoylation; P:response to axon injury; P:signal transduction;|P46060 Q96JJ2,Ran GTPase-activating protein 1,, PF13516;PF07834;, GO:0016235;GO:1904115;GO:0000777;GO:0005737;GO:1990723;GO:0005829;GO:0030425;GO:0043231;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044614;GO:0005654;GO:0048471;GO:0045296;GO:0005096;GO:0003723;GO:0031267;GO:0031625;GO:0090630;GO:1904117;GO:0007084;GO:0007052;GO:0046826;GO:0016925;GO:0048678;GO:0007165;, C:aggresome; C:axon cytoplasm; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoplasmic periphery of the nuclear pore complex; C:cytosol; C:dendrite; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore cytoplasmic filaments; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cadherin binding; F:GTPase activator activity; F:RNA binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:activation of GTPase activity; P:cellular response to vasopressin; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:negative regulation of protein export from nucleus; P:protein sumoylation; P:response to axon injury; P:signal transduction; scaffold71 indexed_genome mRNA 503923 531266 . + . ID=transcript_11309;Q6NUI6 Q05CY2 Q4G0S0 Q5JY13 Q86XY1 Q96E60,Chondroadherin-like protein,, PF13855;, GO:0062023;GO:0031012;GO:0005615;GO:0005518;GO:0098633;GO:0030021;GO:0032331;GO:1904027;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:collagen binding; F:collagen fibril binding; F:extracellular matrix structural constituent conferring compression resistance;, P:negative regulation of chondrocyte differentiation; P:negative regulation of collagen fibril organization;|Q6NUI6 Q05CY2 Q4G0S0 Q5JY13 Q86XY1 Q96E60,Chondroadherin-like protein,, PF13855;, GO:0062023;GO:0031012;GO:0005615;GO:0005518;GO:0098633;GO:0030021;GO:0032331;GO:1904027;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:collagen binding; F:collagen fibril binding; F:extracellular matrix structural constituent conferring compression resistance;, P:negative regulation of chondrocyte differentiation; P:negative regulation of collagen fibril organization;|Q6NUI6 Q05CY2 Q4G0S0 Q5JY13 Q86XY1 Q96E60,Chondroadherin-like protein,, PF13855;, GO:0062023;GO:0031012;GO:0005615;GO:0005518;GO:0098633;GO:0030021;GO:0032331;GO:1904027;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:collagen binding; F:collagen fibril binding; F:extracellular matrix structural constituent conferring compression resistance;, P:negative regulation of chondrocyte differentiation; P:negative regulation of collagen fibril organization;|Q6NUI6 Q05CY2 Q4G0S0 Q5JY13 Q86XY1 Q96E60,Chondroadherin-like protein,, PF13855;, GO:0062023;GO:0031012;GO:0005615;GO:0005518;GO:0098633;GO:0030021;GO:0032331;GO:1904027;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:collagen binding; F:collagen fibril binding; F:extracellular matrix structural constituent conferring compression resistance;, P:negative regulation of chondrocyte differentiation; P:negative regulation of collagen fibril organization;|Q969R5 Q8TEN1 Q96SC4 Q9BQI2 Q9UGS4,Lethal(3)malignant brain tumor-like protein 2,, PF02820;, GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0035064;GO:0008270;GO:0006325;GO:0070317;GO:0045892;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:methylated histone binding; F:zinc ion binding;, P:chromatin organization; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated;|Q969R5 Q8TEN1 Q96SC4 Q9BQI2 Q9UGS4,Lethal(3)malignant brain tumor-like protein 2,, PF02820;, GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0035064;GO:0008270;GO:0006325;GO:0070317;GO:0045892;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:methylated histone binding; F:zinc ion binding;, P:chromatin organization; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated;|Q969R5 Q8TEN1 Q96SC4 Q9BQI2 Q9UGS4,Lethal(3)malignant brain tumor-like protein 2,, PF02820;, GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0035064;GO:0008270;GO:0006325;GO:0070317;GO:0045892;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:methylated histone binding; F:zinc ion binding;, P:chromatin organization; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated;|Q969R5 Q8TEN1 Q96SC4 Q9BQI2 Q9UGS4,Lethal(3)malignant brain tumor-like protein 2,, PF02820;, GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0035064;GO:0008270;GO:0006325;GO:0070317;GO:0045892;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:methylated histone binding; F:zinc ion binding;, P:chromatin organization; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated; scaffold71 indexed_genome mRNA 559397 624810 . - . ID=transcript_11310;Q09472 B1AKC2,Histone acetyltransferase p300,E1A-associated protein p300;Histone butyryltransferase p300;Histone crotonyltransferase p300;Protein 2-hydroxyisobutyryltransferase p300;Protein lactyltransferas p300;Protein propionyltransferase p300;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0005694;GO:0005829;GO:0000123;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0016407;GO:0033613;GO:0050681;GO:0008013;GO:0003682;GO:0031490;GO:0003684;GO:0003677;GO:0010484;GO:0010485;GO:0004402;GO:0140069;GO:0140068;GO:0004468;GO:0051059;GO:0035257;GO:0002039;GO:0106226;GO:0140065;GO:0097157;GO:0008022;GO:0061920;GO:0001102;GO:0001085;GO:0097677;GO:0048156;GO:0003713;GO:0008134;GO:0016746;GO:0008270;GO:0009887;GO:0006915;GO:0030183;GO:0002209;GO:1904837;GO:0034644;GO:0007623;GO:0006977;GO:0060325;GO:0045444;GO:0030851;GO:0007507;GO:0016573;GO:0043969;GO:0043967;GO:0018393;GO:0006475;GO:0030522;GO:0042771;GO:0007611;GO:0030324;GO:0010742;GO:0035855;GO:0035264;GO:0018076;GO:0045721;GO:0031333;GO:0000122;GO:0007399;GO:0007219;GO:0018394;GO:0140067;GO:0140066;GO:0061921;GO:0030220;GO:0043923;GO:0051091;GO:0045815;GO:0010976;GO:0051092;GO:1901224;GO:0045747;GO:0032092;GO:1905636;GO:0045944;GO:0006990;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0016579;GO:0050821;GO:0060765;GO:0010506;GO:0051726;GO:1900034;GO:0006110;GO:0045652;GO:0010821;GO:1901796;GO:0061418;GO:0006355;GO:0090043;GO:0043627;GO:0001666;GO:0007519;GO:0001756;GO:0002223;GO:0036268;GO:0001966;GO:0006283;GO:0016032;, C:chromosome; C:cytosol; C:histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:acetyltransferase activity; F:activating transcription factor binding; F:androgen receptor binding; F:beta-catenin binding; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone butyryltransferase activity; F:histone crotonyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:NF-kappaB binding; F:nuclear hormone receptor binding; F:p53 binding; F:peptide 2-hydroxyisobutyryltransferase activity; F:peptide butyryltransferase activity; F:pre-mRNA intronic binding; F:protein C-terminus binding; F:protein propionyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:STAT family protein binding; F:tau protein binding; F:transcription coactivator activity; F:transcription factor binding; F:transferase activity, transferring acyl groups; F:zinc ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:B cell differentiation; P:behavioral defense response; P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:circadian rhythm; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:face morphogenesis; P:fat cell differentiation; P:granulocyte differentiation; P:heart development; P:histone acetylation; P:histone H2B acetylation; P:histone H4 acetylation; P:internal peptidyl-lysine acetylation; P:internal protein amino acid acetylation; P:intracellular receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:learning or memory; P:lung development; P:macrophage derived foam cell differentiation; P:megakaryocyte development; P:multicellular organism growth; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of gluconeogenesis; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:peptidyl-lysine butyrylation; P:peptidyl-lysine crotonylation; P:peptidyl-lysine propionylation; P:platelet formation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression, epigenetic; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein deubiquitination; P:protein stabilization; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:regulation of tubulin deacetylation; P:response to estrogen; P:response to hypoxia; P:skeletal muscle tissue development; P:somitogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:swimming; P:thigmotaxis; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q09472 B1AKC2,Histone acetyltransferase p300,E1A-associated protein p300;Histone butyryltransferase p300;Histone crotonyltransferase p300;Protein 2-hydroxyisobutyryltransferase p300;Protein lactyltransferas p300;Protein propionyltransferase p300;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0005694;GO:0005829;GO:0000123;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0016407;GO:0033613;GO:0050681;GO:0008013;GO:0003682;GO:0031490;GO:0003684;GO:0003677;GO:0010484;GO:0010485;GO:0004402;GO:0140069;GO:0140068;GO:0004468;GO:0051059;GO:0035257;GO:0002039;GO:0106226;GO:0140065;GO:0097157;GO:0008022;GO:0061920;GO:0001102;GO:0001085;GO:0097677;GO:0048156;GO:0003713;GO:0008134;GO:0016746;GO:0008270;GO:0009887;GO:0006915;GO:0030183;GO:0002209;GO:1904837;GO:0034644;GO:0007623;GO:0006977;GO:0060325;GO:0045444;GO:0030851;GO:0007507;GO:0016573;GO:0043969;GO:0043967;GO:0018393;GO:0006475;GO:0030522;GO:0042771;GO:0007611;GO:0030324;GO:0010742;GO:0035855;GO:0035264;GO:0018076;GO:0045721;GO:0031333;GO:0000122;GO:0007399;GO:0007219;GO:0018394;GO:0140067;GO:0140066;GO:0061921;GO:0030220;GO:0043923;GO:0051091;GO:0045815;GO:0010976;GO:0051092;GO:1901224;GO:0045747;GO:0032092;GO:1905636;GO:0045944;GO:0006990;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0016579;GO:0050821;GO:0060765;GO:0010506;GO:0051726;GO:1900034;GO:0006110;GO:0045652;GO:0010821;GO:1901796;GO:0061418;GO:0006355;GO:0090043;GO:0043627;GO:0001666;GO:0007519;GO:0001756;GO:0002223;GO:0036268;GO:0001966;GO:0006283;GO:0016032;, C:chromosome; C:cytosol; C:histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:acetyltransferase activity; F:activating transcription factor binding; F:androgen receptor binding; F:beta-catenin binding; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone butyryltransferase activity; F:histone crotonyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:NF-kappaB binding; F:nuclear hormone receptor binding; F:p53 binding; F:peptide 2-hydroxyisobutyryltransferase activity; F:peptide butyryltransferase activity; F:pre-mRNA intronic binding; F:protein C-terminus binding; F:protein propionyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:STAT family protein binding; F:tau protein binding; F:transcription coactivator activity; F:transcription factor binding; F:transferase activity, transferring acyl groups; F:zinc ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:B cell differentiation; P:behavioral defense response; P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:circadian rhythm; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:face morphogenesis; P:fat cell differentiation; P:granulocyte differentiation; P:heart development; P:histone acetylation; P:histone H2B acetylation; P:histone H4 acetylation; P:internal peptidyl-lysine acetylation; P:internal protein amino acid acetylation; P:intracellular receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:learning or memory; P:lung development; P:macrophage derived foam cell differentiation; P:megakaryocyte development; P:multicellular organism growth; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of gluconeogenesis; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:peptidyl-lysine butyrylation; P:peptidyl-lysine crotonylation; P:peptidyl-lysine propionylation; P:platelet formation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression, epigenetic; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein deubiquitination; P:protein stabilization; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:regulation of tubulin deacetylation; P:response to estrogen; P:response to hypoxia; P:skeletal muscle tissue development; P:somitogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:swimming; P:thigmotaxis; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q09472 B1AKC2,Histone acetyltransferase p300,E1A-associated protein p300;Histone butyryltransferase p300;Histone crotonyltransferase p300;Protein 2-hydroxyisobutyryltransferase p300;Protein lactyltransferas p300;Protein propionyltransferase p300;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0005694;GO:0005829;GO:0000123;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0016407;GO:0033613;GO:0050681;GO:0008013;GO:0003682;GO:0031490;GO:0003684;GO:0003677;GO:0010484;GO:0010485;GO:0004402;GO:0140069;GO:0140068;GO:0004468;GO:0051059;GO:0035257;GO:0002039;GO:0106226;GO:0140065;GO:0097157;GO:0008022;GO:0061920;GO:0001102;GO:0001085;GO:0097677;GO:0048156;GO:0003713;GO:0008134;GO:0016746;GO:0008270;GO:0009887;GO:0006915;GO:0030183;GO:0002209;GO:1904837;GO:0034644;GO:0007623;GO:0006977;GO:0060325;GO:0045444;GO:0030851;GO:0007507;GO:0016573;GO:0043969;GO:0043967;GO:0018393;GO:0006475;GO:0030522;GO:0042771;GO:0007611;GO:0030324;GO:0010742;GO:0035855;GO:0035264;GO:0018076;GO:0045721;GO:0031333;GO:0000122;GO:0007399;GO:0007219;GO:0018394;GO:0140067;GO:0140066;GO:0061921;GO:0030220;GO:0043923;GO:0051091;GO:0045815;GO:0010976;GO:0051092;GO:1901224;GO:0045747;GO:0032092;GO:1905636;GO:0045944;GO:0006990;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0016579;GO:0050821;GO:0060765;GO:0010506;GO:0051726;GO:1900034;GO:0006110;GO:0045652;GO:0010821;GO:1901796;GO:0061418;GO:0006355;GO:0090043;GO:0043627;GO:0001666;GO:0007519;GO:0001756;GO:0002223;GO:0036268;GO:0001966;GO:0006283;GO:0016032;, C:chromosome; C:cytosol; C:histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:acetyltransferase activity; F:activating transcription factor binding; F:androgen receptor binding; F:beta-catenin binding; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone butyryltransferase activity; F:histone crotonyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:NF-kappaB binding; F:nuclear hormone receptor binding; F:p53 binding; F:peptide 2-hydroxyisobutyryltransferase activity; F:peptide butyryltransferase activity; F:pre-mRNA intronic binding; F:protein C-terminus binding; F:protein propionyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:STAT family protein binding; F:tau protein binding; F:transcription coactivator activity; F:transcription factor binding; F:transferase activity, transferring acyl groups; F:zinc ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:B cell differentiation; P:behavioral defense response; P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:circadian rhythm; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:face morphogenesis; P:fat cell differentiation; P:granulocyte differentiation; P:heart development; P:histone acetylation; P:histone H2B acetylation; P:histone H4 acetylation; P:internal peptidyl-lysine acetylation; P:internal protein amino acid acetylation; P:intracellular receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:learning or memory; P:lung development; P:macrophage derived foam cell differentiation; P:megakaryocyte development; P:multicellular organism growth; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of gluconeogenesis; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:peptidyl-lysine butyrylation; P:peptidyl-lysine crotonylation; P:peptidyl-lysine propionylation; P:platelet formation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression, epigenetic; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein deubiquitination; P:protein stabilization; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:regulation of tubulin deacetylation; P:response to estrogen; P:response to hypoxia; P:skeletal muscle tissue development; P:somitogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:swimming; P:thigmotaxis; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q09472 B1AKC2,Histone acetyltransferase p300,E1A-associated protein p300;Histone butyryltransferase p300;Histone crotonyltransferase p300;Protein 2-hydroxyisobutyryltransferase p300;Protein lactyltransferas p300;Protein propionyltransferase p300;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0005694;GO:0005829;GO:0000123;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0016407;GO:0033613;GO:0050681;GO:0008013;GO:0003682;GO:0031490;GO:0003684;GO:0003677;GO:0010484;GO:0010485;GO:0004402;GO:0140069;GO:0140068;GO:0004468;GO:0051059;GO:0035257;GO:0002039;GO:0106226;GO:0140065;GO:0097157;GO:0008022;GO:0061920;GO:0001102;GO:0001085;GO:0097677;GO:0048156;GO:0003713;GO:0008134;GO:0016746;GO:0008270;GO:0009887;GO:0006915;GO:0030183;GO:0002209;GO:1904837;GO:0034644;GO:0007623;GO:0006977;GO:0060325;GO:0045444;GO:0030851;GO:0007507;GO:0016573;GO:0043969;GO:0043967;GO:0018393;GO:0006475;GO:0030522;GO:0042771;GO:0007611;GO:0030324;GO:0010742;GO:0035855;GO:0035264;GO:0018076;GO:0045721;GO:0031333;GO:0000122;GO:0007399;GO:0007219;GO:0018394;GO:0140067;GO:0140066;GO:0061921;GO:0030220;GO:0043923;GO:0051091;GO:0045815;GO:0010976;GO:0051092;GO:1901224;GO:0045747;GO:0032092;GO:1905636;GO:0045944;GO:0006990;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0016579;GO:0050821;GO:0060765;GO:0010506;GO:0051726;GO:1900034;GO:0006110;GO:0045652;GO:0010821;GO:1901796;GO:0061418;GO:0006355;GO:0090043;GO:0043627;GO:0001666;GO:0007519;GO:0001756;GO:0002223;GO:0036268;GO:0001966;GO:0006283;GO:0016032;, C:chromosome; C:cytosol; C:histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:acetyltransferase activity; F:activating transcription factor binding; F:androgen receptor binding; F:beta-catenin binding; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone butyryltransferase activity; F:histone crotonyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:NF-kappaB binding; F:nuclear hormone receptor binding; F:p53 binding; F:peptide 2-hydroxyisobutyryltransferase activity; F:peptide butyryltransferase activity; F:pre-mRNA intronic binding; F:protein C-terminus binding; F:protein propionyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:STAT family protein binding; F:tau protein binding; F:transcription coactivator activity; F:transcription factor binding; F:transferase activity, transferring acyl groups; F:zinc ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:B cell differentiation; P:behavioral defense response; P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:circadian rhythm; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:face morphogenesis; P:fat cell differentiation; P:granulocyte differentiation; P:heart development; P:histone acetylation; P:histone H2B acetylation; P:histone H4 acetylation; P:internal peptidyl-lysine acetylation; P:internal protein amino acid acetylation; P:intracellular receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:learning or memory; P:lung development; P:macrophage derived foam cell differentiation; P:megakaryocyte development; P:multicellular organism growth; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of gluconeogenesis; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:peptidyl-lysine butyrylation; P:peptidyl-lysine crotonylation; P:peptidyl-lysine propionylation; P:platelet formation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression, epigenetic; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein deubiquitination; P:protein stabilization; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:regulation of tubulin deacetylation; P:response to estrogen; P:response to hypoxia; P:skeletal muscle tissue development; P:somitogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:swimming; P:thigmotaxis; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q09472 B1AKC2,Histone acetyltransferase p300,E1A-associated protein p300;Histone butyryltransferase p300;Histone crotonyltransferase p300;Protein 2-hydroxyisobutyryltransferase p300;Protein lactyltransferas p300;Protein propionyltransferase p300;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0005694;GO:0005829;GO:0000123;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0016407;GO:0033613;GO:0050681;GO:0008013;GO:0003682;GO:0031490;GO:0003684;GO:0003677;GO:0010484;GO:0010485;GO:0004402;GO:0140069;GO:0140068;GO:0004468;GO:0051059;GO:0035257;GO:0002039;GO:0106226;GO:0140065;GO:0097157;GO:0008022;GO:0061920;GO:0001102;GO:0001085;GO:0097677;GO:0048156;GO:0003713;GO:0008134;GO:0016746;GO:0008270;GO:0009887;GO:0006915;GO:0030183;GO:0002209;GO:1904837;GO:0034644;GO:0007623;GO:0006977;GO:0060325;GO:0045444;GO:0030851;GO:0007507;GO:0016573;GO:0043969;GO:0043967;GO:0018393;GO:0006475;GO:0030522;GO:0042771;GO:0007611;GO:0030324;GO:0010742;GO:0035855;GO:0035264;GO:0018076;GO:0045721;GO:0031333;GO:0000122;GO:0007399;GO:0007219;GO:0018394;GO:0140067;GO:0140066;GO:0061921;GO:0030220;GO:0043923;GO:0051091;GO:0045815;GO:0010976;GO:0051092;GO:1901224;GO:0045747;GO:0032092;GO:1905636;GO:0045944;GO:0006990;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0016579;GO:0050821;GO:0060765;GO:0010506;GO:0051726;GO:1900034;GO:0006110;GO:0045652;GO:0010821;GO:1901796;GO:0061418;GO:0006355;GO:0090043;GO:0043627;GO:0001666;GO:0007519;GO:0001756;GO:0002223;GO:0036268;GO:0001966;GO:0006283;GO:0016032;, C:chromosome; C:cytosol; C:histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:acetyltransferase activity; F:activating transcription factor binding; F:androgen receptor binding; F:beta-catenin binding; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone butyryltransferase activity; F:histone crotonyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:NF-kappaB binding; F:nuclear hormone receptor binding; F:p53 binding; F:peptide 2-hydroxyisobutyryltransferase activity; F:peptide butyryltransferase activity; F:pre-mRNA intronic binding; F:protein C-terminus binding; F:protein propionyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:STAT family protein binding; F:tau protein binding; F:transcription coactivator activity; F:transcription factor binding; F:transferase activity, transferring acyl groups; F:zinc ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:B cell differentiation; P:behavioral defense response; P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:circadian rhythm; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:face morphogenesis; P:fat cell differentiation; P:granulocyte differentiation; P:heart development; P:histone acetylation; P:histone H2B acetylation; P:histone H4 acetylation; P:internal peptidyl-lysine acetylation; P:internal protein amino acid acetylation; P:intracellular receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:learning or memory; P:lung development; P:macrophage derived foam cell differentiation; P:megakaryocyte development; P:multicellular organism growth; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of gluconeogenesis; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:peptidyl-lysine butyrylation; P:peptidyl-lysine crotonylation; P:peptidyl-lysine propionylation; P:platelet formation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression, epigenetic; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein deubiquitination; P:protein stabilization; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:regulation of tubulin deacetylation; P:response to estrogen; P:response to hypoxia; P:skeletal muscle tissue development; P:somitogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:swimming; P:thigmotaxis; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q09472 B1AKC2,Histone acetyltransferase p300,E1A-associated protein p300;Histone butyryltransferase p300;Histone crotonyltransferase p300;Protein 2-hydroxyisobutyryltransferase p300;Protein lactyltransferas p300;Protein propionyltransferase p300;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0005694;GO:0005829;GO:0000123;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0016407;GO:0033613;GO:0050681;GO:0008013;GO:0003682;GO:0031490;GO:0003684;GO:0003677;GO:0010484;GO:0010485;GO:0004402;GO:0140069;GO:0140068;GO:0004468;GO:0051059;GO:0035257;GO:0002039;GO:0106226;GO:0140065;GO:0097157;GO:0008022;GO:0061920;GO:0001102;GO:0001085;GO:0097677;GO:0048156;GO:0003713;GO:0008134;GO:0016746;GO:0008270;GO:0009887;GO:0006915;GO:0030183;GO:0002209;GO:1904837;GO:0034644;GO:0007623;GO:0006977;GO:0060325;GO:0045444;GO:0030851;GO:0007507;GO:0016573;GO:0043969;GO:0043967;GO:0018393;GO:0006475;GO:0030522;GO:0042771;GO:0007611;GO:0030324;GO:0010742;GO:0035855;GO:0035264;GO:0018076;GO:0045721;GO:0031333;GO:0000122;GO:0007399;GO:0007219;GO:0018394;GO:0140067;GO:0140066;GO:0061921;GO:0030220;GO:0043923;GO:0051091;GO:0045815;GO:0010976;GO:0051092;GO:1901224;GO:0045747;GO:0032092;GO:1905636;GO:0045944;GO:0006990;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0016579;GO:0050821;GO:0060765;GO:0010506;GO:0051726;GO:1900034;GO:0006110;GO:0045652;GO:0010821;GO:1901796;GO:0061418;GO:0006355;GO:0090043;GO:0043627;GO:0001666;GO:0007519;GO:0001756;GO:0002223;GO:0036268;GO:0001966;GO:0006283;GO:0016032;, C:chromosome; C:cytosol; C:histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:acetyltransferase activity; F:activating transcription factor binding; F:androgen receptor binding; F:beta-catenin binding; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone butyryltransferase activity; F:histone crotonyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:NF-kappaB binding; F:nuclear hormone receptor binding; F:p53 binding; F:peptide 2-hydroxyisobutyryltransferase activity; F:peptide butyryltransferase activity; F:pre-mRNA intronic binding; F:protein C-terminus binding; F:protein propionyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:STAT family protein binding; F:tau protein binding; F:transcription coactivator activity; F:transcription factor binding; F:transferase activity, transferring acyl groups; F:zinc ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:B cell differentiation; P:behavioral defense response; P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:circadian rhythm; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:face morphogenesis; P:fat cell differentiation; P:granulocyte differentiation; P:heart development; P:histone acetylation; P:histone H2B acetylation; P:histone H4 acetylation; P:internal peptidyl-lysine acetylation; P:internal protein amino acid acetylation; P:intracellular receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:learning or memory; P:lung development; P:macrophage derived foam cell differentiation; P:megakaryocyte development; P:multicellular organism growth; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of gluconeogenesis; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:peptidyl-lysine butyrylation; P:peptidyl-lysine crotonylation; P:peptidyl-lysine propionylation; P:platelet formation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression, epigenetic; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein deubiquitination; P:protein stabilization; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:regulation of tubulin deacetylation; P:response to estrogen; P:response to hypoxia; P:skeletal muscle tissue development; P:somitogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:swimming; P:thigmotaxis; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q09472 B1AKC2,Histone acetyltransferase p300,E1A-associated protein p300;Histone butyryltransferase p300;Histone crotonyltransferase p300;Protein 2-hydroxyisobutyryltransferase p300;Protein lactyltransferas p300;Protein propionyltransferase p300;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0005694;GO:0005829;GO:0000123;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0016407;GO:0033613;GO:0050681;GO:0008013;GO:0003682;GO:0031490;GO:0003684;GO:0003677;GO:0010484;GO:0010485;GO:0004402;GO:0140069;GO:0140068;GO:0004468;GO:0051059;GO:0035257;GO:0002039;GO:0106226;GO:0140065;GO:0097157;GO:0008022;GO:0061920;GO:0001102;GO:0001085;GO:0097677;GO:0048156;GO:0003713;GO:0008134;GO:0016746;GO:0008270;GO:0009887;GO:0006915;GO:0030183;GO:0002209;GO:1904837;GO:0034644;GO:0007623;GO:0006977;GO:0060325;GO:0045444;GO:0030851;GO:0007507;GO:0016573;GO:0043969;GO:0043967;GO:0018393;GO:0006475;GO:0030522;GO:0042771;GO:0007611;GO:0030324;GO:0010742;GO:0035855;GO:0035264;GO:0018076;GO:0045721;GO:0031333;GO:0000122;GO:0007399;GO:0007219;GO:0018394;GO:0140067;GO:0140066;GO:0061921;GO:0030220;GO:0043923;GO:0051091;GO:0045815;GO:0010976;GO:0051092;GO:1901224;GO:0045747;GO:0032092;GO:1905636;GO:0045944;GO:0006990;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0016579;GO:0050821;GO:0060765;GO:0010506;GO:0051726;GO:1900034;GO:0006110;GO:0045652;GO:0010821;GO:1901796;GO:0061418;GO:0006355;GO:0090043;GO:0043627;GO:0001666;GO:0007519;GO:0001756;GO:0002223;GO:0036268;GO:0001966;GO:0006283;GO:0016032;, C:chromosome; C:cytosol; C:histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:acetyltransferase activity; F:activating transcription factor binding; F:androgen receptor binding; F:beta-catenin binding; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone butyryltransferase activity; F:histone crotonyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:NF-kappaB binding; F:nuclear hormone receptor binding; F:p53 binding; F:peptide 2-hydroxyisobutyryltransferase activity; F:peptide butyryltransferase activity; F:pre-mRNA intronic binding; F:protein C-terminus binding; F:protein propionyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:STAT family protein binding; F:tau protein binding; F:transcription coactivator activity; F:transcription factor binding; F:transferase activity, transferring acyl groups; F:zinc ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:B cell differentiation; P:behavioral defense response; P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:circadian rhythm; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:face morphogenesis; P:fat cell differentiation; P:granulocyte differentiation; P:heart development; P:histone acetylation; P:histone H2B acetylation; P:histone H4 acetylation; P:internal peptidyl-lysine acetylation; P:internal protein amino acid acetylation; P:intracellular receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:learning or memory; P:lung development; P:macrophage derived foam cell differentiation; P:megakaryocyte development; P:multicellular organism growth; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of gluconeogenesis; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:peptidyl-lysine butyrylation; P:peptidyl-lysine crotonylation; P:peptidyl-lysine propionylation; P:platelet formation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression, epigenetic; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein deubiquitination; P:protein stabilization; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:regulation of tubulin deacetylation; P:response to estrogen; P:response to hypoxia; P:skeletal muscle tissue development; P:somitogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:swimming; P:thigmotaxis; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q09472 B1AKC2,Histone acetyltransferase p300,E1A-associated protein p300;Histone butyryltransferase p300;Histone crotonyltransferase p300;Protein 2-hydroxyisobutyryltransferase p300;Protein lactyltransferas p300;Protein propionyltransferase p300;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0005694;GO:0005829;GO:0000123;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0016407;GO:0033613;GO:0050681;GO:0008013;GO:0003682;GO:0031490;GO:0003684;GO:0003677;GO:0010484;GO:0010485;GO:0004402;GO:0140069;GO:0140068;GO:0004468;GO:0051059;GO:0035257;GO:0002039;GO:0106226;GO:0140065;GO:0097157;GO:0008022;GO:0061920;GO:0001102;GO:0001085;GO:0097677;GO:0048156;GO:0003713;GO:0008134;GO:0016746;GO:0008270;GO:0009887;GO:0006915;GO:0030183;GO:0002209;GO:1904837;GO:0034644;GO:0007623;GO:0006977;GO:0060325;GO:0045444;GO:0030851;GO:0007507;GO:0016573;GO:0043969;GO:0043967;GO:0018393;GO:0006475;GO:0030522;GO:0042771;GO:0007611;GO:0030324;GO:0010742;GO:0035855;GO:0035264;GO:0018076;GO:0045721;GO:0031333;GO:0000122;GO:0007399;GO:0007219;GO:0018394;GO:0140067;GO:0140066;GO:0061921;GO:0030220;GO:0043923;GO:0051091;GO:0045815;GO:0010976;GO:0051092;GO:1901224;GO:0045747;GO:0032092;GO:1905636;GO:0045944;GO:0006990;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0016579;GO:0050821;GO:0060765;GO:0010506;GO:0051726;GO:1900034;GO:0006110;GO:0045652;GO:0010821;GO:1901796;GO:0061418;GO:0006355;GO:0090043;GO:0043627;GO:0001666;GO:0007519;GO:0001756;GO:0002223;GO:0036268;GO:0001966;GO:0006283;GO:0016032;, C:chromosome; C:cytosol; C:histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:acetyltransferase activity; F:activating transcription factor binding; F:androgen receptor binding; F:beta-catenin binding; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone butyryltransferase activity; F:histone crotonyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:NF-kappaB binding; F:nuclear hormone receptor binding; F:p53 binding; F:peptide 2-hydroxyisobutyryltransferase activity; F:peptide butyryltransferase activity; F:pre-mRNA intronic binding; F:protein C-terminus binding; F:protein propionyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:STAT family protein binding; F:tau protein binding; F:transcription coactivator activity; F:transcription factor binding; F:transferase activity, transferring acyl groups; F:zinc ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:B cell differentiation; P:behavioral defense response; P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:circadian rhythm; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:face morphogenesis; P:fat cell differentiation; P:granulocyte differentiation; P:heart development; P:histone acetylation; P:histone H2B acetylation; P:histone H4 acetylation; P:internal peptidyl-lysine acetylation; P:internal protein amino acid acetylation; P:intracellular receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:learning or memory; P:lung development; P:macrophage derived foam cell differentiation; P:megakaryocyte development; P:multicellular organism growth; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of gluconeogenesis; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:peptidyl-lysine butyrylation; P:peptidyl-lysine crotonylation; P:peptidyl-lysine propionylation; P:platelet formation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression, epigenetic; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein deubiquitination; P:protein stabilization; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:regulation of tubulin deacetylation; P:response to estrogen; P:response to hypoxia; P:skeletal muscle tissue development; P:somitogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:swimming; P:thigmotaxis; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q09472 B1AKC2,Histone acetyltransferase p300,E1A-associated protein p300;Histone butyryltransferase p300;Histone crotonyltransferase p300;Protein 2-hydroxyisobutyryltransferase p300;Protein lactyltransferas p300;Protein propionyltransferase p300;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0005694;GO:0005829;GO:0000123;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0016407;GO:0033613;GO:0050681;GO:0008013;GO:0003682;GO:0031490;GO:0003684;GO:0003677;GO:0010484;GO:0010485;GO:0004402;GO:0140069;GO:0140068;GO:0004468;GO:0051059;GO:0035257;GO:0002039;GO:0106226;GO:0140065;GO:0097157;GO:0008022;GO:0061920;GO:0001102;GO:0001085;GO:0097677;GO:0048156;GO:0003713;GO:0008134;GO:0016746;GO:0008270;GO:0009887;GO:0006915;GO:0030183;GO:0002209;GO:1904837;GO:0034644;GO:0007623;GO:0006977;GO:0060325;GO:0045444;GO:0030851;GO:0007507;GO:0016573;GO:0043969;GO:0043967;GO:0018393;GO:0006475;GO:0030522;GO:0042771;GO:0007611;GO:0030324;GO:0010742;GO:0035855;GO:0035264;GO:0018076;GO:0045721;GO:0031333;GO:0000122;GO:0007399;GO:0007219;GO:0018394;GO:0140067;GO:0140066;GO:0061921;GO:0030220;GO:0043923;GO:0051091;GO:0045815;GO:0010976;GO:0051092;GO:1901224;GO:0045747;GO:0032092;GO:1905636;GO:0045944;GO:0006990;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0016579;GO:0050821;GO:0060765;GO:0010506;GO:0051726;GO:1900034;GO:0006110;GO:0045652;GO:0010821;GO:1901796;GO:0061418;GO:0006355;GO:0090043;GO:0043627;GO:0001666;GO:0007519;GO:0001756;GO:0002223;GO:0036268;GO:0001966;GO:0006283;GO:0016032;, C:chromosome; C:cytosol; C:histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:acetyltransferase activity; F:activating transcription factor binding; F:androgen receptor binding; F:beta-catenin binding; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone butyryltransferase activity; F:histone crotonyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:NF-kappaB binding; F:nuclear hormone receptor binding; F:p53 binding; F:peptide 2-hydroxyisobutyryltransferase activity; F:peptide butyryltransferase activity; F:pre-mRNA intronic binding; F:protein C-terminus binding; F:protein propionyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:STAT family protein binding; F:tau protein binding; F:transcription coactivator activity; F:transcription factor binding; F:transferase activity, transferring acyl groups; F:zinc ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:B cell differentiation; P:behavioral defense response; P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:circadian rhythm; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:face morphogenesis; P:fat cell differentiation; P:granulocyte differentiation; P:heart development; P:histone acetylation; P:histone H2B acetylation; P:histone H4 acetylation; P:internal peptidyl-lysine acetylation; P:internal protein amino acid acetylation; P:intracellular receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:learning or memory; P:lung development; P:macrophage derived foam cell differentiation; P:megakaryocyte development; P:multicellular organism growth; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of gluconeogenesis; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:peptidyl-lysine butyrylation; P:peptidyl-lysine crotonylation; P:peptidyl-lysine propionylation; P:platelet formation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression, epigenetic; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein deubiquitination; P:protein stabilization; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:regulation of tubulin deacetylation; P:response to estrogen; P:response to hypoxia; P:skeletal muscle tissue development; P:somitogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:swimming; P:thigmotaxis; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q09472 B1AKC2,Histone acetyltransferase p300,E1A-associated protein p300;Histone butyryltransferase p300;Histone crotonyltransferase p300;Protein 2-hydroxyisobutyryltransferase p300;Protein lactyltransferas p300;Protein propionyltransferase p300;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0005694;GO:0005829;GO:0000123;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0016407;GO:0033613;GO:0050681;GO:0008013;GO:0003682;GO:0031490;GO:0003684;GO:0003677;GO:0010484;GO:0010485;GO:0004402;GO:0140069;GO:0140068;GO:0004468;GO:0051059;GO:0035257;GO:0002039;GO:0106226;GO:0140065;GO:0097157;GO:0008022;GO:0061920;GO:0001102;GO:0001085;GO:0097677;GO:0048156;GO:0003713;GO:0008134;GO:0016746;GO:0008270;GO:0009887;GO:0006915;GO:0030183;GO:0002209;GO:1904837;GO:0034644;GO:0007623;GO:0006977;GO:0060325;GO:0045444;GO:0030851;GO:0007507;GO:0016573;GO:0043969;GO:0043967;GO:0018393;GO:0006475;GO:0030522;GO:0042771;GO:0007611;GO:0030324;GO:0010742;GO:0035855;GO:0035264;GO:0018076;GO:0045721;GO:0031333;GO:0000122;GO:0007399;GO:0007219;GO:0018394;GO:0140067;GO:0140066;GO:0061921;GO:0030220;GO:0043923;GO:0051091;GO:0045815;GO:0010976;GO:0051092;GO:1901224;GO:0045747;GO:0032092;GO:1905636;GO:0045944;GO:0006990;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0016579;GO:0050821;GO:0060765;GO:0010506;GO:0051726;GO:1900034;GO:0006110;GO:0045652;GO:0010821;GO:1901796;GO:0061418;GO:0006355;GO:0090043;GO:0043627;GO:0001666;GO:0007519;GO:0001756;GO:0002223;GO:0036268;GO:0001966;GO:0006283;GO:0016032;, C:chromosome; C:cytosol; C:histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:acetyltransferase activity; F:activating transcription factor binding; F:androgen receptor binding; F:beta-catenin binding; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:DNA binding; F:H3 histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone butyryltransferase activity; F:histone crotonyltransferase activity; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:NF-kappaB binding; F:nuclear hormone receptor binding; F:p53 binding; F:peptide 2-hydroxyisobutyryltransferase activity; F:peptide butyryltransferase activity; F:pre-mRNA intronic binding; F:protein C-terminus binding; F:protein propionyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:STAT family protein binding; F:tau protein binding; F:transcription coactivator activity; F:transcription factor binding; F:transferase activity, transferring acyl groups; F:zinc ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:B cell differentiation; P:behavioral defense response; P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:circadian rhythm; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:face morphogenesis; P:fat cell differentiation; P:granulocyte differentiation; P:heart development; P:histone acetylation; P:histone H2B acetylation; P:histone H4 acetylation; P:internal peptidyl-lysine acetylation; P:internal protein amino acid acetylation; P:intracellular receptor signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:learning or memory; P:lung development; P:macrophage derived foam cell differentiation; P:megakaryocyte development; P:multicellular organism growth; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of gluconeogenesis; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:peptidyl-lysine butyrylation; P:peptidyl-lysine crotonylation; P:peptidyl-lysine propionylation; P:platelet formation; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression, epigenetic; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of Notch signaling pathway; P:positive regulation of protein binding; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein deubiquitination; P:protein stabilization; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of mitochondrion organization; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:regulation of tubulin deacetylation; P:response to estrogen; P:response to hypoxia; P:skeletal muscle tissue development; P:somitogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:swimming; P:thigmotaxis; P:transcription-coupled nucleotide-excision repair; P:viral process; scaffold71 indexed_genome mRNA 736304 740980 . - . ID=transcript_11311;P62877 B2RDY1 Q8N6Z8 Q9D1S2 Q9WUK9 Q9Y254,E3 ubiquitin-protein ligase RBX1,E3 ubiquitin-protein transferase RBX1 {ECO:0000305};Protein ZYP;RING finger protein 75;RING-box protein 1;Regulator of cullins 1;, PF12678;, GO:0031462;GO:0031463;GO:0031464;GO:0031465;GO:0031466;GO:0031467;GO:0031461;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0030891;GO:0097602;GO:0061663;GO:0044877;GO:0008134;GO:0061630;GO:0031625;GO:0034450;GO:0008270;GO:0042769;GO:0070911;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0032436;GO:1902499;GO:0043687;GO:0043161;GO:0070936;GO:0006513;GO:0045116;GO:0000209;GO:0016567;GO:0061418;GO:0010265;GO:0031146;GO:0006283;GO:0006511;GO:0016032;GO:0016055;, C:Cul2-RING ubiquitin ligase complex; C:Cul3-RING ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:Cul5-RING ubiquitin ligase complex; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex; C:VCB complex;, F:cullin family protein binding; F:NEDD8 ligase activity; F:protein-containing complex binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:DNA damage response, detection of DNA damage; P:global genome nucleotide-excision repair; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein autoubiquitination; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein neddylation; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process; P:Wnt signaling pathway; scaffold71 indexed_genome mRNA 740981 744053 . + . ID=transcript_11312;P62877 B2RDY1 Q8N6Z8 Q9D1S2 Q9WUK9 Q9Y254,E3 ubiquitin-protein ligase RBX1,E3 ubiquitin-protein transferase RBX1 {ECO:0000305};Protein ZYP;RING finger protein 75;RING-box protein 1;Regulator of cullins 1;, PF12678;, GO:0031462;GO:0031463;GO:0031464;GO:0031465;GO:0031466;GO:0031467;GO:0031461;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0030891;GO:0097602;GO:0061663;GO:0044877;GO:0008134;GO:0061630;GO:0031625;GO:0034450;GO:0008270;GO:0042769;GO:0070911;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0032436;GO:1902499;GO:0043687;GO:0043161;GO:0070936;GO:0006513;GO:0045116;GO:0000209;GO:0016567;GO:0061418;GO:0010265;GO:0031146;GO:0006283;GO:0006511;GO:0016032;GO:0016055;, C:Cul2-RING ubiquitin ligase complex; C:Cul3-RING ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:Cul5-RING ubiquitin ligase complex; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex; C:VCB complex;, F:cullin family protein binding; F:NEDD8 ligase activity; F:protein-containing complex binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:DNA damage response, detection of DNA damage; P:global genome nucleotide-excision repair; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein autoubiquitination; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein neddylation; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process; P:Wnt signaling pathway; scaffold71 indexed_genome mRNA 744584 747119 . + . ID=transcript_11313;P62877 B2RDY1 Q8N6Z8 Q9D1S2 Q9WUK9 Q9Y254,E3 ubiquitin-protein ligase RBX1,E3 ubiquitin-protein transferase RBX1 {ECO:0000305};Protein ZYP;RING finger protein 75;RING-box protein 1;Regulator of cullins 1;, PF12678;, GO:0031462;GO:0031463;GO:0031464;GO:0031465;GO:0031466;GO:0031467;GO:0031461;GO:0005829;GO:0005654;GO:0005634;GO:0019005;GO:0030891;GO:0097602;GO:0061663;GO:0044877;GO:0008134;GO:0061630;GO:0031625;GO:0034450;GO:0008270;GO:0042769;GO:0070911;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0032436;GO:1902499;GO:0043687;GO:0043161;GO:0070936;GO:0006513;GO:0045116;GO:0000209;GO:0016567;GO:0061418;GO:0010265;GO:0031146;GO:0006283;GO:0006511;GO:0016032;GO:0016055;, C:Cul2-RING ubiquitin ligase complex; C:Cul3-RING ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:Cul5-RING ubiquitin ligase complex; C:Cul7-RING ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex; C:VCB complex;, F:cullin family protein binding; F:NEDD8 ligase activity; F:protein-containing complex binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-ubiquitin ligase activity; F:zinc ion binding;, P:DNA damage response, detection of DNA damage; P:global genome nucleotide-excision repair; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein autoubiquitination; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein neddylation; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF complex assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:ubiquitin-dependent protein catabolic process; P:viral process; P:Wnt signaling pathway; scaffold71 indexed_genome mRNA 758637 760709 . + . ID=transcript_11314;Q9NQH7 B2R9G1 B7Z790 B7Z7B2 Q6I9V9 Q8NDA6 Q9BV27 Q9BVH0,Xaa-Pro aminopeptidase 3 {ECO:0000312|HGNC:HGNC:28052},Aminopeptidase P3;, PF05195;PF00557;, GO:0005737;GO:0005829;GO:0005739;GO:0004177;GO:0030145;GO:0070006;GO:0008233;GO:0042803;GO:0003094;GO:0016485;GO:0006508;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:aminopeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:peptidase activity; F:protein homodimerization activity;, P:glomerular filtration; P:protein processing; P:proteolysis; scaffold71 indexed_genome mRNA 761899 799913 . - . ID=transcript_11315;Q9NQH7 B2R9G1 B7Z790 B7Z7B2 Q6I9V9 Q8NDA6 Q9BV27 Q9BVH0,Xaa-Pro aminopeptidase 3 {ECO:0000312|HGNC:HGNC:28052},Aminopeptidase P3;, PF05195;PF00557;, GO:0005737;GO:0005829;GO:0005739;GO:0004177;GO:0030145;GO:0070006;GO:0008233;GO:0042803;GO:0003094;GO:0016485;GO:0006508;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:aminopeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:peptidase activity; F:protein homodimerization activity;, P:glomerular filtration; P:protein processing; P:proteolysis;|Q9NQH7 B2R9G1 B7Z790 B7Z7B2 Q6I9V9 Q8NDA6 Q9BV27 Q9BVH0,Xaa-Pro aminopeptidase 3 {ECO:0000312|HGNC:HGNC:28052},Aminopeptidase P3;, PF05195;PF00557;, GO:0005737;GO:0005829;GO:0005739;GO:0004177;GO:0030145;GO:0070006;GO:0008233;GO:0042803;GO:0003094;GO:0016485;GO:0006508;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:aminopeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:peptidase activity; F:protein homodimerization activity;, P:glomerular filtration; P:protein processing; P:proteolysis;|Q9NQH7 B2R9G1 B7Z790 B7Z7B2 Q6I9V9 Q8NDA6 Q9BV27 Q9BVH0,Xaa-Pro aminopeptidase 3 {ECO:0000312|HGNC:HGNC:28052},Aminopeptidase P3;, PF05195;PF00557;, GO:0005737;GO:0005829;GO:0005739;GO:0004177;GO:0030145;GO:0070006;GO:0008233;GO:0042803;GO:0003094;GO:0016485;GO:0006508;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:aminopeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:peptidase activity; F:protein homodimerization activity;, P:glomerular filtration; P:protein processing; P:proteolysis;|Q9NQH7 B2R9G1 B7Z790 B7Z7B2 Q6I9V9 Q8NDA6 Q9BV27 Q9BVH0,Xaa-Pro aminopeptidase 3 {ECO:0000312|HGNC:HGNC:28052},Aminopeptidase P3;, PF05195;PF00557;, GO:0005737;GO:0005829;GO:0005739;GO:0004177;GO:0030145;GO:0070006;GO:0008233;GO:0042803;GO:0003094;GO:0016485;GO:0006508;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:aminopeptidase activity; F:manganese ion binding; F:metalloaminopeptidase activity; F:peptidase activity; F:protein homodimerization activity;, P:glomerular filtration; P:protein processing; P:proteolysis; scaffold71 indexed_genome mRNA 800117 825692 . + . ID=transcript_11316;P50502 O14999 Q2TU77,Hsc70-interacting protein,Aging-associated protein 2;Progesterone receptor-associated p48 protein;Protein FAM10A1;Putative tumor suppressor ST13;Renal carcinoma antigen NY-REN-33;Suppression of tumorigenicity 13 protein;, PF18253;PF17830;, GO:0005737;GO:0005829;GO:0070062;GO:0032991;GO:0051087;GO:0032564;GO:0031072;GO:0030544;GO:0042802;GO:0046983;GO:0019904;GO:0044877;GO:0030674;GO:0051082;GO:0051085;GO:0061084;GO:0006457;GO:0065003;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:protein-containing complex;, F:chaperone binding; F:dATP binding; F:heat shock protein binding; F:Hsp70 protein binding; F:identical protein binding; F:protein dimerization activity; F:protein domain specific binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:negative regulation of protein refolding; P:protein folding; P:protein-containing complex assembly; P:response to bacterium;|P50502 O14999 Q2TU77,Hsc70-interacting protein,Aging-associated protein 2;Progesterone receptor-associated p48 protein;Protein FAM10A1;Putative tumor suppressor ST13;Renal carcinoma antigen NY-REN-33;Suppression of tumorigenicity 13 protein;, PF18253;PF17830;, GO:0005737;GO:0005829;GO:0070062;GO:0032991;GO:0051087;GO:0032564;GO:0031072;GO:0030544;GO:0042802;GO:0046983;GO:0019904;GO:0044877;GO:0030674;GO:0051082;GO:0051085;GO:0061084;GO:0006457;GO:0065003;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:protein-containing complex;, F:chaperone binding; F:dATP binding; F:heat shock protein binding; F:Hsp70 protein binding; F:identical protein binding; F:protein dimerization activity; F:protein domain specific binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:negative regulation of protein refolding; P:protein folding; P:protein-containing complex assembly; P:response to bacterium;|P50502 O14999 Q2TU77,Hsc70-interacting protein,Aging-associated protein 2;Progesterone receptor-associated p48 protein;Protein FAM10A1;Putative tumor suppressor ST13;Renal carcinoma antigen NY-REN-33;Suppression of tumorigenicity 13 protein;, PF18253;PF17830;, GO:0005737;GO:0005829;GO:0070062;GO:0032991;GO:0051087;GO:0032564;GO:0031072;GO:0030544;GO:0042802;GO:0046983;GO:0019904;GO:0044877;GO:0030674;GO:0051082;GO:0051085;GO:0061084;GO:0006457;GO:0065003;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:protein-containing complex;, F:chaperone binding; F:dATP binding; F:heat shock protein binding; F:Hsp70 protein binding; F:identical protein binding; F:protein dimerization activity; F:protein domain specific binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:negative regulation of protein refolding; P:protein folding; P:protein-containing complex assembly; P:response to bacterium;|Q8IZP2,Putative protein FAM10A4,Suppression of tumorigenicity 13 pseudogene 4;, PF18253;PF13181;, GO:0005737;GO:0070062;GO:0031072;GO:0046983;GO:0051085;GO:0065003;, C:cytoplasm; C:extracellular exosome;, F:heat shock protein binding; F:protein dimerization activity;, P:chaperone cofactor-dependent protein refolding; P:protein-containing complex assembly;|P50502 O14999 Q2TU77,Hsc70-interacting protein,Aging-associated protein 2;Progesterone receptor-associated p48 protein;Protein FAM10A1;Putative tumor suppressor ST13;Renal carcinoma antigen NY-REN-33;Suppression of tumorigenicity 13 protein;, PF18253;PF17830;, GO:0005737;GO:0005829;GO:0070062;GO:0032991;GO:0051087;GO:0032564;GO:0031072;GO:0030544;GO:0042802;GO:0046983;GO:0019904;GO:0044877;GO:0030674;GO:0051082;GO:0051085;GO:0061084;GO:0006457;GO:0065003;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:protein-containing complex;, F:chaperone binding; F:dATP binding; F:heat shock protein binding; F:Hsp70 protein binding; F:identical protein binding; F:protein dimerization activity; F:protein domain specific binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:negative regulation of protein refolding; P:protein folding; P:protein-containing complex assembly; P:response to bacterium;|P50502 O14999 Q2TU77,Hsc70-interacting protein,Aging-associated protein 2;Progesterone receptor-associated p48 protein;Protein FAM10A1;Putative tumor suppressor ST13;Renal carcinoma antigen NY-REN-33;Suppression of tumorigenicity 13 protein;, PF18253;PF17830;, GO:0005737;GO:0005829;GO:0070062;GO:0032991;GO:0051087;GO:0032564;GO:0031072;GO:0030544;GO:0042802;GO:0046983;GO:0019904;GO:0044877;GO:0030674;GO:0051082;GO:0051085;GO:0061084;GO:0006457;GO:0065003;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:protein-containing complex;, F:chaperone binding; F:dATP binding; F:heat shock protein binding; F:Hsp70 protein binding; F:identical protein binding; F:protein dimerization activity; F:protein domain specific binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:negative regulation of protein refolding; P:protein folding; P:protein-containing complex assembly; P:response to bacterium;|P0C7T5,Ataxin-1-like,Brother of ataxin-1;, PF08517;, GO:0030425;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0048856;GO:0007420;GO:0030198;GO:0007612;GO:0048286;GO:0007613;GO:0000122;GO:1902035;GO:0006355;GO:0035176;, C:dendrite; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding;, P:anatomical structure development; P:brain development; P:extracellular matrix organization; P:learning; P:lung alveolus development; P:memory; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hematopoietic stem cell proliferation; P:regulation of transcription, DNA-templated; P:social behavior;|Q8IZP2,Putative protein FAM10A4,Suppression of tumorigenicity 13 pseudogene 4;, PF18253;PF13181;, GO:0005737;GO:0070062;GO:0031072;GO:0046983;GO:0051085;GO:0065003;, C:cytoplasm; C:extracellular exosome;, F:heat shock protein binding; F:protein dimerization activity;, P:chaperone cofactor-dependent protein refolding; P:protein-containing complex assembly;|P50502 O14999 Q2TU77,Hsc70-interacting protein,Aging-associated protein 2;Progesterone receptor-associated p48 protein;Protein FAM10A1;Putative tumor suppressor ST13;Renal carcinoma antigen NY-REN-33;Suppression of tumorigenicity 13 protein;, PF18253;PF17830;, GO:0005737;GO:0005829;GO:0070062;GO:0032991;GO:0051087;GO:0032564;GO:0031072;GO:0030544;GO:0042802;GO:0046983;GO:0019904;GO:0044877;GO:0030674;GO:0051082;GO:0051085;GO:0061084;GO:0006457;GO:0065003;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:protein-containing complex;, F:chaperone binding; F:dATP binding; F:heat shock protein binding; F:Hsp70 protein binding; F:identical protein binding; F:protein dimerization activity; F:protein domain specific binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:negative regulation of protein refolding; P:protein folding; P:protein-containing complex assembly; P:response to bacterium;|P50502 O14999 Q2TU77,Hsc70-interacting protein,Aging-associated protein 2;Progesterone receptor-associated p48 protein;Protein FAM10A1;Putative tumor suppressor ST13;Renal carcinoma antigen NY-REN-33;Suppression of tumorigenicity 13 protein;, PF18253;PF17830;, GO:0005737;GO:0005829;GO:0070062;GO:0032991;GO:0051087;GO:0032564;GO:0031072;GO:0030544;GO:0042802;GO:0046983;GO:0019904;GO:0044877;GO:0030674;GO:0051082;GO:0051085;GO:0061084;GO:0006457;GO:0065003;GO:0009617;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:protein-containing complex;, F:chaperone binding; F:dATP binding; F:heat shock protein binding; F:Hsp70 protein binding; F:identical protein binding; F:protein dimerization activity; F:protein domain specific binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:negative regulation of protein refolding; P:protein folding; P:protein-containing complex assembly; P:response to bacterium; scaffold71 indexed_genome mRNA 832622 872149 . + . ID=transcript_11317;O43808 A8KA59 Q5TFL0 Q9UGW8 Q9UGY7,Peroxisomal membrane protein PMP34,34 kDa peroxisomal membrane protein;Solute carrier family 25 member 17;, PF00153;, GO:0005829;GO:0005779;GO:0016020;GO:0005778;GO:0005777;GO:0015217;GO:0080122;GO:0005347;GO:0051087;GO:0015228;GO:0015230;GO:0044610;GO:0051724;GO:0015867;GO:0001561;GO:0006635;GO:0015908;GO:0045046;, C:cytosol; C:integral component of peroxisomal membrane; C:membrane; C:peroxisomal membrane; C:peroxisome;, F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:chaperone binding; F:coenzyme A transmembrane transporter activity; F:FAD transmembrane transporter activity; F:FMN transmembrane transporter activity; F:NAD transmembrane transporter activity;, P:ATP transport; P:fatty acid alpha-oxidation; P:fatty acid beta-oxidation; P:fatty acid transport; P:protein import into peroxisome membrane;|O43808 A8KA59 Q5TFL0 Q9UGW8 Q9UGY7,Peroxisomal membrane protein PMP34,34 kDa peroxisomal membrane protein;Solute carrier family 25 member 17;, PF00153;, GO:0005829;GO:0005779;GO:0016020;GO:0005778;GO:0005777;GO:0015217;GO:0080122;GO:0005347;GO:0051087;GO:0015228;GO:0015230;GO:0044610;GO:0051724;GO:0015867;GO:0001561;GO:0006635;GO:0015908;GO:0045046;, C:cytosol; C:integral component of peroxisomal membrane; C:membrane; C:peroxisomal membrane; C:peroxisome;, F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:chaperone binding; F:coenzyme A transmembrane transporter activity; F:FAD transmembrane transporter activity; F:FMN transmembrane transporter activity; F:NAD transmembrane transporter activity;, P:ATP transport; P:fatty acid alpha-oxidation; P:fatty acid beta-oxidation; P:fatty acid transport; P:protein import into peroxisome membrane; scaffold71 indexed_genome mRNA 971665 1161979 . + . ID=transcript_11318;Q969V6 Q8TCL1 Q96SC5 Q96SC6 Q9P2B0,Myocardin-related transcription factor A {ECO:0000305},MKL/myocardin-like protein 1 {ECO:0000303|PubMed:11431691};Megakaryoblastic leukemia 1 protein {ECO:0000303|PubMed:11431691};Megakaryocytic acute leukemia protein {ECO:0000250|UniProtKB:Q8K4J6};, PF02755;PF02037;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003779;GO:0003785;GO:0043522;GO:0003713;GO:0030036;GO:0045944;GO:0010735;GO:0051145;GO:0044319;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:actin binding; F:actin monomer binding; F:leucine zipper domain binding; F:transcription coactivator activity;, P:actin cytoskeleton organization; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription via serum response element binding; P:smooth muscle cell differentiation; P:wound healing, spreading of cells;|Q969V6 Q8TCL1 Q96SC5 Q96SC6 Q9P2B0,Myocardin-related transcription factor A {ECO:0000305},MKL/myocardin-like protein 1 {ECO:0000303|PubMed:11431691};Megakaryoblastic leukemia 1 protein {ECO:0000303|PubMed:11431691};Megakaryocytic acute leukemia protein {ECO:0000250|UniProtKB:Q8K4J6};, PF02755;PF02037;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003779;GO:0003785;GO:0043522;GO:0003713;GO:0030036;GO:0045944;GO:0010735;GO:0051145;GO:0044319;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:actin binding; F:actin monomer binding; F:leucine zipper domain binding; F:transcription coactivator activity;, P:actin cytoskeleton organization; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription via serum response element binding; P:smooth muscle cell differentiation; P:wound healing, spreading of cells; scaffold71 indexed_genome mRNA 1178341 1179183 . - . ID=transcript_11319;Q96HU1 B0QY79 Q7Z709 Q9NT69,Small G protein signaling modulator 3,Merlin-associated protein;RUN and TBC1 domain-containing protein 3;Rab-GTPase-activating protein-like protein;, PF00566;PF02759;PF00018;, GO:0005829;GO:0005921;GO:0005096;GO:0031267;GO:0090630;GO:0007050;GO:0006886;GO:0048227;GO:0043547;GO:0045732;GO:0032486;GO:0032483;, C:cytosol; C:gap junction;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:cell cycle arrest; P:intracellular protein transport; P:plasma membrane to endosome transport; P:positive regulation of GTPase activity; P:positive regulation of protein catabolic process; P:Rap protein signal transduction; P:regulation of Rab protein signal transduction; scaffold71 indexed_genome mRNA 1179517 1180018 . - . ID=transcript_11320;Q96HU1 B0QY79 Q7Z709 Q9NT69,Small G protein signaling modulator 3,Merlin-associated protein;RUN and TBC1 domain-containing protein 3;Rab-GTPase-activating protein-like protein;, PF00566;PF02759;PF00018;, GO:0005829;GO:0005921;GO:0005096;GO:0031267;GO:0090630;GO:0007050;GO:0006886;GO:0048227;GO:0043547;GO:0045732;GO:0032486;GO:0032483;, C:cytosol; C:gap junction;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:cell cycle arrest; P:intracellular protein transport; P:plasma membrane to endosome transport; P:positive regulation of GTPase activity; P:positive regulation of protein catabolic process; P:Rap protein signal transduction; P:regulation of Rab protein signal transduction; scaffold71 indexed_genome mRNA 1181177 1209657 . - . ID=transcript_11321;Q96HU1 B0QY79 Q7Z709 Q9NT69,Small G protein signaling modulator 3,Merlin-associated protein;RUN and TBC1 domain-containing protein 3;Rab-GTPase-activating protein-like protein;, PF00566;PF02759;PF00018;, GO:0005829;GO:0005921;GO:0005096;GO:0031267;GO:0090630;GO:0007050;GO:0006886;GO:0048227;GO:0043547;GO:0045732;GO:0032486;GO:0032483;, C:cytosol; C:gap junction;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:cell cycle arrest; P:intracellular protein transport; P:plasma membrane to endosome transport; P:positive regulation of GTPase activity; P:positive regulation of protein catabolic process; P:Rap protein signal transduction; P:regulation of Rab protein signal transduction;|Q96HU1 B0QY79 Q7Z709 Q9NT69,Small G protein signaling modulator 3,Merlin-associated protein;RUN and TBC1 domain-containing protein 3;Rab-GTPase-activating protein-like protein;, PF00566;PF02759;PF00018;, GO:0005829;GO:0005921;GO:0005096;GO:0031267;GO:0090630;GO:0007050;GO:0006886;GO:0048227;GO:0043547;GO:0045732;GO:0032486;GO:0032483;, C:cytosol; C:gap junction;, F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:cell cycle arrest; P:intracellular protein transport; P:plasma membrane to endosome transport; P:positive regulation of GTPase activity; P:positive regulation of protein catabolic process; P:Rap protein signal transduction; P:regulation of Rab protein signal transduction; scaffold71 indexed_genome mRNA 1215457 1232625 . - . ID=transcript_11322;P30566 B0QY76 O75495 Q5TI34,Adenylosuccinate lyase {ECO:0000303|PubMed:8404037},Adenylosuccinase {ECO:0000303|PubMed:9266401};, PF10397;PF00206;, GO:0005829;GO:0032991;GO:0070626;GO:0042802;GO:0004018;GO:0044208;GO:0006189;GO:0006167;GO:0006164;GO:0009168;, C:cytosol; C:protein-containing complex;, F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity; F:identical protein binding; F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity;, P:'de novo' AMP biosynthetic process; P:'de novo' IMP biosynthetic process; P:AMP biosynthetic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process;|P30566 B0QY76 O75495 Q5TI34,Adenylosuccinate lyase {ECO:0000303|PubMed:8404037},Adenylosuccinase {ECO:0000303|PubMed:9266401};, PF10397;PF00206;, GO:0005829;GO:0032991;GO:0070626;GO:0042802;GO:0004018;GO:0044208;GO:0006189;GO:0006167;GO:0006164;GO:0009168;, C:cytosol; C:protein-containing complex;, F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity; F:identical protein binding; F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity;, P:'de novo' AMP biosynthetic process; P:'de novo' IMP biosynthetic process; P:AMP biosynthetic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process;|P30566 B0QY76 O75495 Q5TI34,Adenylosuccinate lyase {ECO:0000303|PubMed:8404037},Adenylosuccinase {ECO:0000303|PubMed:9266401};, PF10397;PF00206;, GO:0005829;GO:0032991;GO:0070626;GO:0042802;GO:0004018;GO:0044208;GO:0006189;GO:0006167;GO:0006164;GO:0009168;, C:cytosol; C:protein-containing complex;, F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity; F:identical protein binding; F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity;, P:'de novo' AMP biosynthetic process; P:'de novo' IMP biosynthetic process; P:AMP biosynthetic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process;|P30566 B0QY76 O75495 Q5TI34,Adenylosuccinate lyase {ECO:0000303|PubMed:8404037},Adenylosuccinase {ECO:0000303|PubMed:9266401};, PF10397;PF00206;, GO:0005829;GO:0032991;GO:0070626;GO:0042802;GO:0004018;GO:0044208;GO:0006189;GO:0006167;GO:0006164;GO:0009168;, C:cytosol; C:protein-containing complex;, F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity; F:identical protein binding; F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity;, P:'de novo' AMP biosynthetic process; P:'de novo' IMP biosynthetic process; P:AMP biosynthetic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; scaffold71 indexed_genome mRNA 1250894 1315336 . - . ID=transcript_11323;Q9UPQ9 B0QY73 B0QY78 B4DGC0 Q5TH52 Q8TBX2,Trinucleotide repeat-containing gene 6B protein,, PF10427;PF16608;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0031047;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1905618;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:gene silencing by RNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9UPQ9 B0QY73 B0QY78 B4DGC0 Q5TH52 Q8TBX2,Trinucleotide repeat-containing gene 6B protein,, PF10427;PF16608;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0031047;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1905618;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:gene silencing by RNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9UPQ9 B0QY73 B0QY78 B4DGC0 Q5TH52 Q8TBX2,Trinucleotide repeat-containing gene 6B protein,, PF10427;PF16608;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0031047;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1905618;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:gene silencing by RNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9UPQ9 B0QY73 B0QY78 B4DGC0 Q5TH52 Q8TBX2,Trinucleotide repeat-containing gene 6B protein,, PF10427;PF16608;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0031047;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1905618;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:gene silencing by RNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of miRNA mediated inhibition of translation; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway; scaffold71 indexed_genome mRNA 1562533 1628561 . - . ID=transcript_11324;O75791 B7Z8I3 O43726 Q9NRB7,GRB2-related adapter protein 2,Adapter protein GRID;GRB-2-like protein;GRBLG;GRBX;Grf40 adapter protein;Growth factor receptor-binding protein;Hematopoietic cell-associated adapter protein GrpL;P38;Protein GADS;SH3-SH2-SH3 adapter Mona;, PF00017;PF00018;, GO:0005737;GO:0005829;GO:0005768;GO:0005654;GO:0005634;GO:0005886;GO:0007267;GO:0019221;GO:0038095;GO:0007265;GO:0031295;GO:0050852;, C:cytoplasm; C:cytosol; C:endosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, , P:cell-cell signaling; P:cytokine-mediated signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Ras protein signal transduction; P:T cell costimulation; P:T cell receptor signaling pathway; scaffold71 indexed_genome mRNA 1781123 1865564 . - . ID=transcript_11325;Q9UH15 Q9UH30 Q9ULU9 Q9UNE6,Voltage-dependent T-type calcium channel subunit alpha-1I,Voltage-gated calcium channel subunit alpha Cav3.3;, PF00520;, GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0005245;GO:0005248;GO:0070509;GO:0030317;GO:0086010;GO:0019228;GO:0045956;GO:0034765;GO:0007165;GO:0030431;, C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:calcium ion import; P:flagellated sperm motility; P:membrane depolarization during action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of ion transmembrane transport; P:signal transduction; P:sleep;|Q9UH15 Q9UH30 Q9ULU9 Q9UNE6,Voltage-dependent T-type calcium channel subunit alpha-1I,Voltage-gated calcium channel subunit alpha Cav3.3;, PF00520;, GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0005245;GO:0005248;GO:0070509;GO:0030317;GO:0086010;GO:0019228;GO:0045956;GO:0034765;GO:0007165;GO:0030431;, C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:calcium ion import; P:flagellated sperm motility; P:membrane depolarization during action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of ion transmembrane transport; P:signal transduction; P:sleep;|Q9UH15 Q9UH30 Q9ULU9 Q9UNE6,Voltage-dependent T-type calcium channel subunit alpha-1I,Voltage-gated calcium channel subunit alpha Cav3.3;, PF00520;, GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0005245;GO:0005248;GO:0070509;GO:0030317;GO:0086010;GO:0019228;GO:0045956;GO:0034765;GO:0007165;GO:0030431;, C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:calcium ion import; P:flagellated sperm motility; P:membrane depolarization during action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of ion transmembrane transport; P:signal transduction; P:sleep;|Q9UH15 Q9UH30 Q9ULU9 Q9UNE6,Voltage-dependent T-type calcium channel subunit alpha-1I,Voltage-gated calcium channel subunit alpha Cav3.3;, PF00520;, GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0005245;GO:0005248;GO:0070509;GO:0030317;GO:0086010;GO:0019228;GO:0045956;GO:0034765;GO:0007165;GO:0030431;, C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:calcium ion import; P:flagellated sperm motility; P:membrane depolarization during action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of ion transmembrane transport; P:signal transduction; P:sleep;|Q9UH15 Q9UH30 Q9ULU9 Q9UNE6,Voltage-dependent T-type calcium channel subunit alpha-1I,Voltage-gated calcium channel subunit alpha Cav3.3;, PF00520;, GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0005245;GO:0005248;GO:0070509;GO:0030317;GO:0086010;GO:0019228;GO:0045956;GO:0034765;GO:0007165;GO:0030431;, C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:calcium ion import; P:flagellated sperm motility; P:membrane depolarization during action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of ion transmembrane transport; P:signal transduction; P:sleep;|Q9UH15 Q9UH30 Q9ULU9 Q9UNE6,Voltage-dependent T-type calcium channel subunit alpha-1I,Voltage-gated calcium channel subunit alpha Cav3.3;, PF00520;, GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0005245;GO:0005248;GO:0070509;GO:0030317;GO:0086010;GO:0019228;GO:0045956;GO:0034765;GO:0007165;GO:0030431;, C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:calcium ion import; P:flagellated sperm motility; P:membrane depolarization during action potential; P:neuronal action potential; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of ion transmembrane transport; P:signal transduction; P:sleep; scaffold71 indexed_genome mRNA 1925065 1928997 . + . ID=transcript_11326;Q86WX3 B0QY96 Q5JZA1,Active regulator of SIRT1,40S ribosomal protein S19-binding protein 1;, PF15684;, GO:0005829;GO:0005730;GO:0005654;GO:0019899;GO:0003723;, C:cytosol; C:nucleolus; C:nucleoplasm;, F:enzyme binding; F:RNA binding;|Q86WX3 B0QY96 Q5JZA1,Active regulator of SIRT1,40S ribosomal protein S19-binding protein 1;, PF15684;, GO:0005829;GO:0005730;GO:0005654;GO:0019899;GO:0003723;, C:cytosol; C:nucleolus; C:nucleoplasm;, F:enzyme binding; F:RNA binding;|Q86WX3 B0QY96 Q5JZA1,Active regulator of SIRT1,40S ribosomal protein S19-binding protein 1;, PF15684;, GO:0005829;GO:0005730;GO:0005654;GO:0019899;GO:0003723;, C:cytosol; C:nucleolus; C:nucleoplasm;, F:enzyme binding; F:RNA binding; scaffold71 indexed_genome mRNA 1938325 1951496 . - . ID=transcript_11327;Q9NQG6 Q7L890 Q9BUI3,Mitochondrial dynamics protein MID51,Mitochondrial dynamics protein of 51 kDa;Mitochondrial elongation factor 1;Smith-Magenis syndrome chromosomal region candidate gene 7 protein-like;, PF03281;, GO:0016021;GO:0005741;GO:0005739;GO:0043531;GO:0019003;GO:0042802;GO:0000266;GO:0090141;GO:0090314;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:ADP binding; F:GDP binding; F:identical protein binding;, P:mitochondrial fission; P:positive regulation of mitochondrial fission; P:positive regulation of protein targeting to membrane; scaffold71 indexed_genome mRNA 1966594 1971378 . + . ID=transcript_11328;Q09327 A6NGD0 Q14CK5 Q6IC49 Q9UH32,Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase {ECO:0000305},N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III;, PF04724;, GO:0000139;GO:0016021;GO:0003830;GO:0016757;GO:0050435;GO:0034599;GO:0050890;GO:0006044;GO:1905166;GO:1902966;GO:0008104;GO:0006487;GO:0030334;, C:Golgi membrane; C:integral component of membrane;, F:beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; F:transferase activity, transferring glycosyl groups;, P:amyloid-beta metabolic process; P:cellular response to oxidative stress; P:cognition; P:N-acetylglucosamine metabolic process; P:negative regulation of lysosomal protein catabolic process; P:positive regulation of protein localization to early endosome; P:protein localization; P:protein N-linked glycosylation; P:regulation of cell migration; scaffold71 indexed_genome mRNA 2017298 2030700 . - . ID=transcript_11329;Q15750 Q2PP09 Q8IZW2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1,Mitogen-activated protein kinase kinase kinase 7-interacting protein 1;TGF-beta-activated kinase 1-binding protein 1;, PF00481;, GO:0005829;GO:0010008;GO:0016607;GO:0005634;GO:0032991;GO:0008047;GO:0019209;GO:0048273;GO:0016791;GO:0044877;GO:0000187;GO:0000185;GO:0035904;GO:0003279;GO:0060976;GO:0002753;GO:0038095;GO:0003007;GO:0007249;GO:0001701;GO:0070498;GO:0007254;GO:0030324;GO:0002755;GO:0070423;GO:0051092;GO:0006470;GO:0016579;GO:0002223;GO:0007179;, C:cytosol; C:endosome membrane; C:nuclear speck; C:nucleus; C:protein-containing complex;, F:enzyme activator activity; F:kinase activator activity; F:mitogen-activated protein kinase p38 binding; F:phosphatase activity; F:protein-containing complex binding;, P:activation of MAPK activity; P:activation of MAPKKK activity; P:aorta development; P:cardiac septum development; P:coronary vasculature development; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:heart morphogenesis; P:I-kappaB kinase/NF-kappaB signaling; P:in utero embryonic development; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:lung development; P:MyD88-dependent toll-like receptor signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:protein dephosphorylation; P:protein deubiquitination; P:stimulatory C-type lectin receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway;|Q15750 Q2PP09 Q8IZW2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1,Mitogen-activated protein kinase kinase kinase 7-interacting protein 1;TGF-beta-activated kinase 1-binding protein 1;, PF00481;, GO:0005829;GO:0010008;GO:0016607;GO:0005634;GO:0032991;GO:0008047;GO:0019209;GO:0048273;GO:0016791;GO:0044877;GO:0000187;GO:0000185;GO:0035904;GO:0003279;GO:0060976;GO:0002753;GO:0038095;GO:0003007;GO:0007249;GO:0001701;GO:0070498;GO:0007254;GO:0030324;GO:0002755;GO:0070423;GO:0051092;GO:0006470;GO:0016579;GO:0002223;GO:0007179;, C:cytosol; C:endosome membrane; C:nuclear speck; C:nucleus; C:protein-containing complex;, F:enzyme activator activity; F:kinase activator activity; F:mitogen-activated protein kinase p38 binding; F:phosphatase activity; F:protein-containing complex binding;, P:activation of MAPK activity; P:activation of MAPKKK activity; P:aorta development; P:cardiac septum development; P:coronary vasculature development; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:heart morphogenesis; P:I-kappaB kinase/NF-kappaB signaling; P:in utero embryonic development; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:lung development; P:MyD88-dependent toll-like receptor signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:protein dephosphorylation; P:protein deubiquitination; P:stimulatory C-type lectin receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway;|Q15750 Q2PP09 Q8IZW2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1,Mitogen-activated protein kinase kinase kinase 7-interacting protein 1;TGF-beta-activated kinase 1-binding protein 1;, PF00481;, GO:0005829;GO:0010008;GO:0016607;GO:0005634;GO:0032991;GO:0008047;GO:0019209;GO:0048273;GO:0016791;GO:0044877;GO:0000187;GO:0000185;GO:0035904;GO:0003279;GO:0060976;GO:0002753;GO:0038095;GO:0003007;GO:0007249;GO:0001701;GO:0070498;GO:0007254;GO:0030324;GO:0002755;GO:0070423;GO:0051092;GO:0006470;GO:0016579;GO:0002223;GO:0007179;, C:cytosol; C:endosome membrane; C:nuclear speck; C:nucleus; C:protein-containing complex;, F:enzyme activator activity; F:kinase activator activity; F:mitogen-activated protein kinase p38 binding; F:phosphatase activity; F:protein-containing complex binding;, P:activation of MAPK activity; P:activation of MAPKKK activity; P:aorta development; P:cardiac septum development; P:coronary vasculature development; P:cytoplasmic pattern recognition receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:heart morphogenesis; P:I-kappaB kinase/NF-kappaB signaling; P:in utero embryonic development; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:lung development; P:MyD88-dependent toll-like receptor signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:protein dephosphorylation; P:protein deubiquitination; P:stimulatory C-type lectin receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway; scaffold71 indexed_genome mRNA 2063243 2096407 . + . ID=transcript_11330;O43759 A6NP69 A8K0E2 O43757 O43758 Q53Y02 Q96J56 Q9UGZ4,Synaptogyrin-1 {ECO:0000305},, PF01284;, GO:0035577;GO:0016021;GO:0030285;GO:0042470;GO:0031594;GO:0005886;GO:0030672;GO:1990830;GO:0043312;GO:0006605;GO:0045055;GO:0048169;GO:0048172;GO:0048499;, C:azurophil granule membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:melanosome; C:neuromuscular junction; C:plasma membrane; C:synaptic vesicle membrane;, , P:cellular response to leukemia inhibitory factor; P:neutrophil degranulation; P:protein targeting; P:regulated exocytosis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of short-term neuronal synaptic plasticity; P:synaptic vesicle membrane organization;|O43759 A6NP69 A8K0E2 O43757 O43758 Q53Y02 Q96J56 Q9UGZ4,Synaptogyrin-1 {ECO:0000305},, PF01284;, GO:0035577;GO:0016021;GO:0030285;GO:0042470;GO:0031594;GO:0005886;GO:0030672;GO:1990830;GO:0043312;GO:0006605;GO:0045055;GO:0048169;GO:0048172;GO:0048499;, C:azurophil granule membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:melanosome; C:neuromuscular junction; C:plasma membrane; C:synaptic vesicle membrane;, , P:cellular response to leukemia inhibitory factor; P:neutrophil degranulation; P:protein targeting; P:regulated exocytosis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of short-term neuronal synaptic plasticity; P:synaptic vesicle membrane organization;|O43759 A6NP69 A8K0E2 O43757 O43758 Q53Y02 Q96J56 Q9UGZ4,Synaptogyrin-1 {ECO:0000305},, PF01284;, GO:0035577;GO:0016021;GO:0030285;GO:0042470;GO:0031594;GO:0005886;GO:0030672;GO:1990830;GO:0043312;GO:0006605;GO:0045055;GO:0048169;GO:0048172;GO:0048499;, C:azurophil granule membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:melanosome; C:neuromuscular junction; C:plasma membrane; C:synaptic vesicle membrane;, , P:cellular response to leukemia inhibitory factor; P:neutrophil degranulation; P:protein targeting; P:regulated exocytosis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of short-term neuronal synaptic plasticity; P:synaptic vesicle membrane organization; scaffold71 indexed_genome mRNA 2126071 2128632 . + . ID=transcript_11331;P39023 B2RDV9 Q15548 Q5I0G0,60S ribosomal protein L3,HIV-1 TAR RNA-binding protein B;Large ribosomal subunit protein uL3 {ECO:0000303|PubMed:24524803};, PF00297;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0005730;GO:0005634;GO:0032991;GO:0045202;GO:0008097;GO:0003723;GO:0003735;GO:0071353;GO:0000184;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:nucleolus; C:nucleus; C:protein-containing complex; C:synapse;, F:5S rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cellular response to interleukin-4; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P39023 B2RDV9 Q15548 Q5I0G0,60S ribosomal protein L3,HIV-1 TAR RNA-binding protein B;Large ribosomal subunit protein uL3 {ECO:0000303|PubMed:24524803};, PF00297;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0005730;GO:0005634;GO:0032991;GO:0045202;GO:0008097;GO:0003723;GO:0003735;GO:0071353;GO:0000184;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:nucleolus; C:nucleus; C:protein-containing complex; C:synapse;, F:5S rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cellular response to interleukin-4; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold71 indexed_genome mRNA 2197072 2208788 . + . ID=transcript_11332;P01127 G3XAG8 P78431 Q15354 Q6FHE7 Q9UF23,Platelet-derived growth factor subunit B,PDGF-2;Platelet-derived growth factor B chain;Platelet-derived growth factor beta polypeptide;Proto-oncogene c-Sis;, PF00341;PF04692;, GO:0016323;GO:0009986;GO:0062023;GO:0005737;GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0000139;GO:0031093;GO:0042056;GO:0005518;GO:0008083;GO:0070851;GO:0042802;GO:0048407;GO:0005161;GO:0046982;GO:0042803;GO:0016176;GO:0032147;GO:0032148;GO:0060326;GO:0071363;GO:0071506;GO:0001892;GO:0030198;GO:0007507;GO:0035655;GO:0000165;GO:0072255;GO:0002548;GO:0010629;GO:0010512;GO:0010544;GO:1902894;GO:0032091;GO:0045892;GO:1905064;GO:0038001;GO:0018105;GO:0018108;GO:0002576;GO:0048008;GO:0043536;GO:0090280;GO:0051781;GO:0030335;GO:0008284;GO:0010811;GO:0050921;GO:0045737;GO:2000573;GO:0001938;GO:0070374;GO:0048146;GO:0010628;GO:0003104;GO:0072126;GO:1900127;GO:0043406;GO:0043410;GO:2000591;GO:0035793;GO:0045840;GO:0050731;GO:0043552;GO:0014068;GO:1902895;GO:0031954;GO:0051897;GO:0061098;GO:2000379;GO:0014911;GO:0048661;GO:0045893;GO:1905176;GO:1904754;GO:1904707;GO:0070528;GO:0006468;GO:0072593;GO:0009611;, C:basolateral plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen; C:Golgi membrane; C:platelet alpha granule lumen;, F:chemoattractant activity; F:collagen binding; F:growth factor activity; F:growth factor receptor binding; F:identical protein binding; F:platelet-derived growth factor binding; F:platelet-derived growth factor receptor binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:superoxide-generating NADPH oxidase activator activity;, P:activation of protein kinase activity; P:activation of protein kinase B activity; P:cell chemotaxis; P:cellular response to growth factor stimulus; P:cellular response to mycophenolic acid; P:embryonic placenta development; P:extracellular matrix organization; P:heart development; P:interleukin-18-mediated signaling pathway; P:MAPK cascade; P:metanephric glomerular mesangial cell development; P:monocyte chemotaxis; P:negative regulation of gene expression; P:negative regulation of phosphatidylinositol biosynthetic process; P:negative regulation of platelet activation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein binding; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular associated smooth muscle cell differentiation; P:paracrine signaling; P:peptidyl-serine phosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet degranulation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of calcium ion import; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-substrate adhesion; P:positive regulation of chemotaxis; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of DNA biosynthetic process; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of glomerular filtration; P:positive regulation of glomerular mesangial cell proliferation; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of metanephric mesenchymal cell migration; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of mitotic nuclear division; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular associated smooth muscle cell dedifferentiation; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:protein kinase C signaling; P:protein phosphorylation; P:reactive oxygen species metabolic process; P:response to wounding; scaffold71 indexed_genome mRNA 2264816 2279422 . + . ID=transcript_11333;O95931 Q86T17,Chromobox protein homolog 7,, PF17218;PF00385;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0006325;GO:0000122;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, , P:chromatin organization; P:negative regulation of transcription by RNA polymerase II;|O95931 Q86T17,Chromobox protein homolog 7,, PF17218;PF00385;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0006325;GO:0000122;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, , P:chromatin organization; P:negative regulation of transcription by RNA polymerase II; scaffold71 indexed_genome mRNA 2279456 2280806 . - . ID=transcript_11334;O95931 Q86T17,Chromobox protein homolog 7,, PF17218;PF00385;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0006325;GO:0000122;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, , P:chromatin organization; P:negative regulation of transcription by RNA polymerase II; scaffold71 indexed_genome mRNA 2280867 2284778 . - . ID=transcript_11335;O95931 Q86T17,Chromobox protein homolog 7,, PF17218;PF00385;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0006325;GO:0000122;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, , P:chromatin organization; P:negative regulation of transcription by RNA polymerase II; scaffold71 indexed_genome mRNA 2302644 2312285 . - . ID=transcript_11336;Q6NTF7 B0QYP0 B0QYP1 B7TQM5 E9PF38 M4W6S4 Q5JYL9 Q6IC87,DNA dC->dU-editing enzyme APOBEC-3H,APOBEC-related protein 10;Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3H;, PF18771;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000932;GO:0004126;GO:0047844;GO:0003723;GO:0008270;GO:0016554;GO:0051607;GO:0070383;GO:0080111;GO:0045087;GO:0045869;GO:0010529;GO:0048525;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:P-body;, F:cytidine deaminase activity; F:deoxycytidine deaminase activity; F:RNA binding; F:zinc ion binding;, P:cytidine to uridine editing; P:defense response to virus; P:DNA cytosine deamination; P:DNA demethylation; P:innate immune response; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of transposition; P:negative regulation of viral process; scaffold71 indexed_genome mRNA 2312455 2318046 . - . ID=transcript_11337;Q9NRW3 B2R884 Q5JZ92 Q7Z2N7 Q96F12,DNA dC->dU-editing enzyme APOBEC-3C,APOBEC1-like;Phorbolin I;, , GO:0005737;GO:0005634;GO:0000932;GO:0004126;GO:0047844;GO:0003723;GO:0008270;GO:0009972;GO:0016554;GO:0051607;GO:0070383;GO:0080111;GO:0045087;GO:0045869;GO:0010529;GO:0045071;GO:0016032;, C:cytoplasm; C:nucleus; C:P-body;, F:cytidine deaminase activity; F:deoxycytidine deaminase activity; F:RNA binding; F:zinc ion binding;, P:cytidine deamination; P:cytidine to uridine editing; P:defense response to virus; P:DNA cytosine deamination; P:DNA demethylation; P:innate immune response; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of transposition; P:negative regulation of viral genome replication; P:viral process; scaffold71 indexed_genome mRNA 2410332 2416707 . + . ID=transcript_11338;O95503 A8KAH0 Q96EM5,Chromobox protein homolog 6,, PF17218;PF00385;, GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0003727;GO:0006325;GO:0000122;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex;, F:single-stranded RNA binding;, P:chromatin organization; P:negative regulation of transcription by RNA polymerase II;|O95503 A8KAH0 Q96EM5,Chromobox protein homolog 6,, PF17218;PF00385;, GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0003727;GO:0006325;GO:0000122;, C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex;, F:single-stranded RNA binding;, P:chromatin organization; P:negative regulation of transcription by RNA polymerase II; scaffold71 indexed_genome mRNA 2451274 2460089 . - . ID=transcript_11339;O95502,Neuronal pentraxin receptor,, PF00354;, GO:0098978;GO:0016021;GO:0046872;GO:0098962;, C:glutamatergic synapse; C:integral component of membrane;, F:metal ion binding;, P:regulation of postsynaptic neurotransmitter receptor activity; scaffold71 indexed_genome mRNA 2476743 2480481 . + . ID=transcript_11340;O96015 Q6FGB2 Q6FGD0,Dynein light chain 4, axonemal,, PF01221;, GO:0005929;GO:0005737;GO:0030286;GO:0005874;GO:0005886;GO:0045505;GO:0051959;GO:0042802;GO:0007018;GO:2000582;, C:cilium; C:cytoplasm; C:dynein complex; C:microtubule; C:plasma membrane;, F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:identical protein binding;, P:microtubule-based movement; P:positive regulation of ATP-dependent microtubule motor activity, plus-end-directed; scaffold71 indexed_genome mRNA 2513927 2525339 . + . ID=transcript_11341;Q9UH99 B0QY62 O75156 Q2NKN8 Q2T9F7 Q504T5 Q6B4H1 Q7Z3E3,SUN domain-containing protein 2,Protein unc-84 homolog B;Rab5-interacting protein;Sad1/unc-84 protein-like 2;, PF18580;PF07738;, GO:0000781;GO:0000794;GO:0010008;GO:0005639;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0042802;GO:0005521;GO:0008017;GO:0043495;GO:0051642;GO:0051321;GO:0007052;GO:0006998;GO:0090292;GO:0007097;GO:0031022;GO:0021817;GO:0030335;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:endosome membrane; C:integral component of nuclear inner membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:identical protein binding; F:lamin binding; F:microtubule binding; F:protein-membrane adaptor activity;, P:centrosome localization; P:meiotic cell cycle; P:mitotic spindle organization; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration;|Q9UH99 B0QY62 O75156 Q2NKN8 Q2T9F7 Q504T5 Q6B4H1 Q7Z3E3,SUN domain-containing protein 2,Protein unc-84 homolog B;Rab5-interacting protein;Sad1/unc-84 protein-like 2;, PF18580;PF07738;, GO:0000781;GO:0000794;GO:0010008;GO:0005639;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0042802;GO:0005521;GO:0008017;GO:0043495;GO:0051642;GO:0051321;GO:0007052;GO:0006998;GO:0090292;GO:0007097;GO:0031022;GO:0021817;GO:0030335;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:endosome membrane; C:integral component of nuclear inner membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:identical protein binding; F:lamin binding; F:microtubule binding; F:protein-membrane adaptor activity;, P:centrosome localization; P:meiotic cell cycle; P:mitotic spindle organization; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration;|Q9UH99 B0QY62 O75156 Q2NKN8 Q2T9F7 Q504T5 Q6B4H1 Q7Z3E3,SUN domain-containing protein 2,Protein unc-84 homolog B;Rab5-interacting protein;Sad1/unc-84 protein-like 2;, PF18580;PF07738;, GO:0000781;GO:0000794;GO:0010008;GO:0005639;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0042802;GO:0005521;GO:0008017;GO:0043495;GO:0051642;GO:0051321;GO:0007052;GO:0006998;GO:0090292;GO:0007097;GO:0031022;GO:0021817;GO:0030335;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:endosome membrane; C:integral component of nuclear inner membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:identical protein binding; F:lamin binding; F:microtubule binding; F:protein-membrane adaptor activity;, P:centrosome localization; P:meiotic cell cycle; P:mitotic spindle organization; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration;|Q9UH99 B0QY62 O75156 Q2NKN8 Q2T9F7 Q504T5 Q6B4H1 Q7Z3E3,SUN domain-containing protein 2,Protein unc-84 homolog B;Rab5-interacting protein;Sad1/unc-84 protein-like 2;, PF18580;PF07738;, GO:0000781;GO:0000794;GO:0010008;GO:0005639;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0042802;GO:0005521;GO:0008017;GO:0043495;GO:0051642;GO:0051321;GO:0007052;GO:0006998;GO:0090292;GO:0007097;GO:0031022;GO:0021817;GO:0030335;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:endosome membrane; C:integral component of nuclear inner membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:identical protein binding; F:lamin binding; F:microtubule binding; F:protein-membrane adaptor activity;, P:centrosome localization; P:meiotic cell cycle; P:mitotic spindle organization; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration;|Q9UH99 B0QY62 O75156 Q2NKN8 Q2T9F7 Q504T5 Q6B4H1 Q7Z3E3,SUN domain-containing protein 2,Protein unc-84 homolog B;Rab5-interacting protein;Sad1/unc-84 protein-like 2;, PF18580;PF07738;, GO:0000781;GO:0000794;GO:0010008;GO:0005639;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0042802;GO:0005521;GO:0008017;GO:0043495;GO:0051642;GO:0051321;GO:0007052;GO:0006998;GO:0090292;GO:0007097;GO:0031022;GO:0021817;GO:0030335;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:endosome membrane; C:integral component of nuclear inner membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:identical protein binding; F:lamin binding; F:microtubule binding; F:protein-membrane adaptor activity;, P:centrosome localization; P:meiotic cell cycle; P:mitotic spindle organization; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration;|Q9UH99 B0QY62 O75156 Q2NKN8 Q2T9F7 Q504T5 Q6B4H1 Q7Z3E3,SUN domain-containing protein 2,Protein unc-84 homolog B;Rab5-interacting protein;Sad1/unc-84 protein-like 2;, PF18580;PF07738;, GO:0000781;GO:0000794;GO:0010008;GO:0005639;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0042802;GO:0005521;GO:0008017;GO:0043495;GO:0051642;GO:0051321;GO:0007052;GO:0006998;GO:0090292;GO:0007097;GO:0031022;GO:0021817;GO:0030335;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:endosome membrane; C:integral component of nuclear inner membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:identical protein binding; F:lamin binding; F:microtubule binding; F:protein-membrane adaptor activity;, P:centrosome localization; P:meiotic cell cycle; P:mitotic spindle organization; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration;|Q9UH99 B0QY62 O75156 Q2NKN8 Q2T9F7 Q504T5 Q6B4H1 Q7Z3E3,SUN domain-containing protein 2,Protein unc-84 homolog B;Rab5-interacting protein;Sad1/unc-84 protein-like 2;, PF18580;PF07738;, GO:0000781;GO:0000794;GO:0010008;GO:0005639;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0042802;GO:0005521;GO:0008017;GO:0043495;GO:0051642;GO:0051321;GO:0007052;GO:0006998;GO:0090292;GO:0007097;GO:0031022;GO:0021817;GO:0030335;, C:chromosome, telomeric region; C:condensed nuclear chromosome; C:endosome membrane; C:integral component of nuclear inner membrane; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:identical protein binding; F:lamin binding; F:microtubule binding; F:protein-membrane adaptor activity;, P:centrosome localization; P:meiotic cell cycle; P:mitotic spindle organization; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:nuclear migration; P:nuclear migration along microfilament; P:nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration; P:positive regulation of cell migration; scaffold71 indexed_genome mRNA 2527577 2549567 . - . ID=transcript_11342;O00178 Q6IC67,GTP-binding protein 1,, PF00009;, GO:0000177;GO:0005829;GO:0016020;GO:0005525;GO:0003924;GO:0003723;GO:0003746;GO:0046039;GO:0006955;GO:0061014;GO:0007165;GO:0006414;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:membrane;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation elongation factor activity;, P:GTP metabolic process; P:immune response; P:positive regulation of mRNA catabolic process; P:signal transduction; P:translational elongation;|O00178 Q6IC67,GTP-binding protein 1,, PF00009;, GO:0000177;GO:0005829;GO:0016020;GO:0005525;GO:0003924;GO:0003723;GO:0003746;GO:0046039;GO:0006955;GO:0061014;GO:0007165;GO:0006414;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:membrane;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation elongation factor activity;, P:GTP metabolic process; P:immune response; P:positive regulation of mRNA catabolic process; P:signal transduction; P:translational elongation; scaffold71 indexed_genome mRNA 2565731 2570227 . - . ID=transcript_11343;Q9NS69,Mitochondrial import receptor subunit TOM22 homolog,1C9-2;Translocase of outer membrane 22 kDa subunit homolog;, PF04281;, GO:0016021;GO:0016020;GO:0005741;GO:0005742;GO:0005739;GO:0008320;GO:0016236;GO:0043065;GO:0045040;GO:0006626;, C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:protein transmembrane transporter activity;, P:macroautophagy; P:positive regulation of apoptotic process; P:protein insertion into mitochondrial outer membrane; P:protein targeting to mitochondrion;|Q9NS69,Mitochondrial import receptor subunit TOM22 homolog,1C9-2;Translocase of outer membrane 22 kDa subunit homolog;, PF04281;, GO:0016021;GO:0016020;GO:0005741;GO:0005742;GO:0005739;GO:0008320;GO:0016236;GO:0043065;GO:0045040;GO:0006626;, C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion;, F:protein transmembrane transporter activity;, P:macroautophagy; P:positive regulation of apoptotic process; P:protein insertion into mitochondrial outer membrane; P:protein targeting to mitochondrion; scaffold71 indexed_genome mRNA 2575030 2575534 . - . ID=transcript_11344;Q9Y3M2 B2R4S2 Q66GT6 Q9UIK9,Protein chibby homolog 1,ARPP-binding protein;Cytosolic leucine-rich protein;PIGEA-14;PKD2 interactor, Golgi and endoplasmic reticulum-associated 1;, PF14645;, GO:0042995;GO:0005814;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005802;GO:0008013;GO:0042802;GO:0042803;GO:0055007;GO:0030030;GO:0045444;GO:0045892;GO:0030178;GO:0051289;GO:0008104;, C:cell projection; C:centriole; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:trans-Golgi network;, F:beta-catenin binding; F:identical protein binding; F:protein homodimerization activity;, P:cardiac muscle cell differentiation; P:cell projection organization; P:fat cell differentiation; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:protein homotetramerization; P:protein localization; scaffold71 indexed_genome mRNA 2649399 2669377 . + . ID=transcript_11345;Q14565 A8K9A2 B4DMW6 Q08AI1 Q99498 Q9UH11,Meiotic recombination protein DMC1/LIM15 homolog,, PF08423;, GO:0005694;GO:0000781;GO:0000794;GO:0005634;GO:0005524;GO:0003677;GO:0008094;GO:0003690;GO:0042802;GO:0000150;GO:0003697;GO:0070192;GO:0000730;GO:0007292;GO:0007129;GO:0007141;GO:0051321;GO:0006312;GO:0001556;GO:0001541;GO:0007131;GO:0007286;GO:0007283;GO:0042148;, C:chromosome; C:chromosome, telomeric region; C:condensed nuclear chromosome; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:identical protein binding; F:recombinase activity; F:single-stranded DNA binding;, P:chromosome organization involved in meiotic cell cycle; P:DNA recombinase assembly; P:female gamete generation; P:homologous chromosome pairing at meiosis; P:male meiosis I; P:meiotic cell cycle; P:mitotic recombination; P:oocyte maturation; P:ovarian follicle development; P:reciprocal meiotic recombination; P:spermatid development; P:spermatogenesis; P:strand invasion; scaffold71 indexed_genome mRNA 2676344 2677097 . - . ID=transcript_11346;Q14565 A8K9A2 B4DMW6 Q08AI1 Q99498 Q9UH11,Meiotic recombination protein DMC1/LIM15 homolog,, PF08423;, GO:0005694;GO:0000781;GO:0000794;GO:0005634;GO:0005524;GO:0003677;GO:0008094;GO:0003690;GO:0042802;GO:0000150;GO:0003697;GO:0070192;GO:0000730;GO:0007292;GO:0007129;GO:0007141;GO:0051321;GO:0006312;GO:0001556;GO:0001541;GO:0007131;GO:0007286;GO:0007283;GO:0042148;, C:chromosome; C:chromosome, telomeric region; C:condensed nuclear chromosome; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:double-stranded DNA binding; F:identical protein binding; F:recombinase activity; F:single-stranded DNA binding;, P:chromosome organization involved in meiotic cell cycle; P:DNA recombinase assembly; P:female gamete generation; P:homologous chromosome pairing at meiosis; P:male meiosis I; P:meiotic cell cycle; P:mitotic recombination; P:oocyte maturation; P:ovarian follicle development; P:reciprocal meiotic recombination; P:spermatid development; P:spermatogenesis; P:strand invasion; scaffold71 indexed_genome mRNA 2701775 2722703 . + . ID=transcript_11347;Q92841 B1AHM0 H3BLZ8 Q69YT1 Q6ICD6,Probable ATP-dependent RNA helicase DDX17,DEAD box protein 17;DEAD box protein p72;DEAD box protein p82 {ECO:0000303|PubMed:19995069};RNA-dependent helicase p72;, PF00270;PF00271;, GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003723;GO:0003724;GO:0008186;GO:0003713;GO:0000380;GO:0030521;GO:0051607;GO:0001837;GO:0031047;GO:0030520;GO:0010586;GO:0045445;GO:0045944;GO:0000381;GO:2001014;GO:0006357;GO:0006396;GO:0006364;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:RNA-dependent ATPase activity; F:transcription coactivator activity;, P:alternative mRNA splicing, via spliceosome; P:androgen receptor signaling pathway; P:defense response to virus; P:epithelial to mesenchymal transition; P:gene silencing by RNA; P:intracellular estrogen receptor signaling pathway; P:miRNA metabolic process; P:myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:RNA processing; P:rRNA processing;|Q92841 B1AHM0 H3BLZ8 Q69YT1 Q6ICD6,Probable ATP-dependent RNA helicase DDX17,DEAD box protein 17;DEAD box protein p72;DEAD box protein p82 {ECO:0000303|PubMed:19995069};RNA-dependent helicase p72;, PF00270;PF00271;, GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003723;GO:0003724;GO:0008186;GO:0003713;GO:0000380;GO:0030521;GO:0051607;GO:0001837;GO:0031047;GO:0030520;GO:0010586;GO:0045445;GO:0045944;GO:0000381;GO:2001014;GO:0006357;GO:0006396;GO:0006364;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:RNA-dependent ATPase activity; F:transcription coactivator activity;, P:alternative mRNA splicing, via spliceosome; P:androgen receptor signaling pathway; P:defense response to virus; P:epithelial to mesenchymal transition; P:gene silencing by RNA; P:intracellular estrogen receptor signaling pathway; P:miRNA metabolic process; P:myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:RNA processing; P:rRNA processing;|Q92841 B1AHM0 H3BLZ8 Q69YT1 Q6ICD6,Probable ATP-dependent RNA helicase DDX17,DEAD box protein 17;DEAD box protein p72;DEAD box protein p82 {ECO:0000303|PubMed:19995069};RNA-dependent helicase p72;, PF00270;PF00271;, GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003723;GO:0003724;GO:0008186;GO:0003713;GO:0000380;GO:0030521;GO:0051607;GO:0001837;GO:0031047;GO:0030520;GO:0010586;GO:0045445;GO:0045944;GO:0000381;GO:2001014;GO:0006357;GO:0006396;GO:0006364;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:RNA-dependent ATPase activity; F:transcription coactivator activity;, P:alternative mRNA splicing, via spliceosome; P:androgen receptor signaling pathway; P:defense response to virus; P:epithelial to mesenchymal transition; P:gene silencing by RNA; P:intracellular estrogen receptor signaling pathway; P:miRNA metabolic process; P:myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:RNA processing; P:rRNA processing;|Q92841 B1AHM0 H3BLZ8 Q69YT1 Q6ICD6,Probable ATP-dependent RNA helicase DDX17,DEAD box protein 17;DEAD box protein p72;DEAD box protein p82 {ECO:0000303|PubMed:19995069};RNA-dependent helicase p72;, PF00270;PF00271;, GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003723;GO:0003724;GO:0008186;GO:0003713;GO:0000380;GO:0030521;GO:0051607;GO:0001837;GO:0031047;GO:0030520;GO:0010586;GO:0045445;GO:0045944;GO:0000381;GO:2001014;GO:0006357;GO:0006396;GO:0006364;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:RNA-dependent ATPase activity; F:transcription coactivator activity;, P:alternative mRNA splicing, via spliceosome; P:androgen receptor signaling pathway; P:defense response to virus; P:epithelial to mesenchymal transition; P:gene silencing by RNA; P:intracellular estrogen receptor signaling pathway; P:miRNA metabolic process; P:myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:RNA processing; P:rRNA processing;|Q92841 B1AHM0 H3BLZ8 Q69YT1 Q6ICD6,Probable ATP-dependent RNA helicase DDX17,DEAD box protein 17;DEAD box protein p72;DEAD box protein p82 {ECO:0000303|PubMed:19995069};RNA-dependent helicase p72;, PF00270;PF00271;, GO:0005737;GO:0005829;GO:0016020;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005524;GO:0003723;GO:0003724;GO:0008186;GO:0003713;GO:0000380;GO:0030521;GO:0051607;GO:0001837;GO:0031047;GO:0030520;GO:0010586;GO:0045445;GO:0045944;GO:0000381;GO:2001014;GO:0006357;GO:0006396;GO:0006364;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:ATP binding; F:RNA binding; F:RNA helicase activity; F:RNA-dependent ATPase activity; F:transcription coactivator activity;, P:alternative mRNA splicing, via spliceosome; P:androgen receptor signaling pathway; P:defense response to virus; P:epithelial to mesenchymal transition; P:gene silencing by RNA; P:intracellular estrogen receptor signaling pathway; P:miRNA metabolic process; P:myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of skeletal muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:RNA processing; P:rRNA processing;|O43731 A8K7T7 B8ZZ26 O95557 Q4V750 Q4V767 Q53FP4 Q53GK1,ER lumen protein-retaining receptor 3,KDEL endoplasmic reticulum protein retention receptor 3;, PF00810;, GO:0005801;GO:0030663;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0030133;GO:0046923;GO:0005046;GO:0006888;GO:0036498;GO:0006621;GO:0015031;GO:0006890;, C:cis-Golgi network; C:COPI-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:ER retention sequence binding; F:KDEL sequence binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein retention in ER lumen; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O43731 A8K7T7 B8ZZ26 O95557 Q4V750 Q4V767 Q53FP4 Q53GK1,ER lumen protein-retaining receptor 3,KDEL endoplasmic reticulum protein retention receptor 3;, PF00810;, GO:0005801;GO:0030663;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0030133;GO:0046923;GO:0005046;GO:0006888;GO:0036498;GO:0006621;GO:0015031;GO:0006890;, C:cis-Golgi network; C:COPI-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:ER retention sequence binding; F:KDEL sequence binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein retention in ER lumen; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold71 indexed_genome mRNA 2727934 2728522 . - . ID=transcript_11348;O43731 A8K7T7 B8ZZ26 O95557 Q4V750 Q4V767 Q53FP4 Q53GK1,ER lumen protein-retaining receptor 3,KDEL endoplasmic reticulum protein retention receptor 3;, PF00810;, GO:0005801;GO:0030663;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0030133;GO:0046923;GO:0005046;GO:0006888;GO:0036498;GO:0006621;GO:0015031;GO:0006890;, C:cis-Golgi network; C:COPI-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:ER retention sequence binding; F:KDEL sequence binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein retention in ER lumen; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold71 indexed_genome mRNA 2770489 2772572 . - . ID=transcript_11349;P48050 Q14D44,Inward rectifier potassium channel 4,HIRK2;HRK1;Hippocampal inward rectifier;Inward rectifier K(+) channel Kir2.3;Potassium channel, inwardly rectifying subfamily J member 4;, PF01007;PF17655;, GO:0016323;GO:0030659;GO:0005886;GO:0045211;GO:0008076;GO:0005242;GO:0030165;GO:0061337;GO:1901381;GO:1990573;GO:0071805;GO:0006813;GO:0034765;, C:basolateral plasma membrane; C:cytoplasmic vesicle membrane; C:plasma membrane; C:postsynaptic membrane; C:voltage-gated potassium channel complex;, F:inward rectifier potassium channel activity; F:PDZ domain binding;, P:cardiac conduction; P:positive regulation of potassium ion transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; scaffold71 indexed_genome mRNA 2818169 2842909 . + . ID=transcript_11350;P49674,Casein kinase I isoform epsilon,, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0060070;GO:0097711;GO:0032922;GO:0006281;GO:0006897;GO:0000086;GO:0032091;GO:0018105;GO:0090263;GO:2000052;GO:0032436;GO:1905426;GO:0006468;GO:1903827;GO:0042752;GO:0010389;GO:0007165;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:canonical Wnt signaling pathway; P:ciliary basal body-plasma membrane docking; P:circadian regulation of gene expression; P:DNA repair; P:endocytosis; P:G2/M transition of mitotic cell cycle; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation; P:protein phosphorylation; P:regulation of cellular protein localization; P:regulation of circadian rhythm; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction; P:Wnt signaling pathway;|P49674,Casein kinase I isoform epsilon,, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0060070;GO:0097711;GO:0032922;GO:0006281;GO:0006897;GO:0000086;GO:0032091;GO:0018105;GO:0090263;GO:2000052;GO:0032436;GO:1905426;GO:0006468;GO:1903827;GO:0042752;GO:0010389;GO:0007165;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:canonical Wnt signaling pathway; P:ciliary basal body-plasma membrane docking; P:circadian regulation of gene expression; P:DNA repair; P:endocytosis; P:G2/M transition of mitotic cell cycle; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation; P:protein phosphorylation; P:regulation of cellular protein localization; P:regulation of circadian rhythm; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction; P:Wnt signaling pathway;|P49674,Casein kinase I isoform epsilon,, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0060070;GO:0097711;GO:0032922;GO:0006281;GO:0006897;GO:0000086;GO:0032091;GO:0018105;GO:0090263;GO:2000052;GO:0032436;GO:1905426;GO:0006468;GO:1903827;GO:0042752;GO:0010389;GO:0007165;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:canonical Wnt signaling pathway; P:ciliary basal body-plasma membrane docking; P:circadian regulation of gene expression; P:DNA repair; P:endocytosis; P:G2/M transition of mitotic cell cycle; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation; P:protein phosphorylation; P:regulation of cellular protein localization; P:regulation of circadian rhythm; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction; P:Wnt signaling pathway;|P49674,Casein kinase I isoform epsilon,, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0060070;GO:0097711;GO:0032922;GO:0006281;GO:0006897;GO:0000086;GO:0032091;GO:0018105;GO:0090263;GO:2000052;GO:0032436;GO:1905426;GO:0006468;GO:1903827;GO:0042752;GO:0010389;GO:0007165;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:canonical Wnt signaling pathway; P:ciliary basal body-plasma membrane docking; P:circadian regulation of gene expression; P:DNA repair; P:endocytosis; P:G2/M transition of mitotic cell cycle; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation; P:protein phosphorylation; P:regulation of cellular protein localization; P:regulation of circadian rhythm; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction; P:Wnt signaling pathway;|P49674,Casein kinase I isoform epsilon,, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0060070;GO:0097711;GO:0032922;GO:0006281;GO:0006897;GO:0000086;GO:0032091;GO:0018105;GO:0090263;GO:2000052;GO:0032436;GO:1905426;GO:0006468;GO:1903827;GO:0042752;GO:0010389;GO:0007165;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding;, P:canonical Wnt signaling pathway; P:ciliary basal body-plasma membrane docking; P:circadian regulation of gene expression; P:DNA repair; P:endocytosis; P:G2/M transition of mitotic cell cycle; P:negative regulation of protein binding; P:peptidyl-serine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of non-canonical Wnt signaling pathway; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation; P:protein phosphorylation; P:regulation of cellular protein localization; P:regulation of circadian rhythm; P:regulation of G2/M transition of mitotic cell cycle; P:signal transduction; P:Wnt signaling pathway; scaffold71 indexed_genome mRNA 2880908 2888261 . - . ID=transcript_11351;Q9ULX9 B4DV49 Q9Y525,Transcription factor MafF,U-Maf;V-maf musculoaponeurotic fibrosarcoma oncogene homolog F;, PF03131;, GO:0000785;GO:0005739;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0007596;GO:0001701;GO:0007567;GO:0045944;GO:0045604;GO:0006357;GO:0035914;, C:chromatin; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:blood coagulation; P:in utero embryonic development; P:parturition; P:positive regulation of transcription by RNA polymerase II; P:regulation of epidermal cell differentiation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation;|Q9ULX9 B4DV49 Q9Y525,Transcription factor MafF,U-Maf;V-maf musculoaponeurotic fibrosarcoma oncogene homolog F;, PF03131;, GO:0000785;GO:0005739;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0007596;GO:0001701;GO:0007567;GO:0045944;GO:0045604;GO:0006357;GO:0035914;, C:chromatin; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:blood coagulation; P:in utero embryonic development; P:parturition; P:positive regulation of transcription by RNA polymerase II; P:regulation of epidermal cell differentiation; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; scaffold71 indexed_genome mRNA 2913891 2959502 . + . ID=transcript_11352;O60733 A8K597 B0QYE8 O75645 Q8N452 Q9UG29 Q9UIT0 Q9Y671,85/88 kDa calcium-independent phospholipase A2,2-lysophosphatidylcholine acylhydrolase;Group VI phospholipase A2;Intracellular membrane-associated calcium-independent phospholipase A2 beta;Palmitoyl-CoA hydrolase;Patatin-like phospholipase domain-containing protein 9;, PF12796;PF01734;, GO:0034451;GO:0005829;GO:0005615;GO:0016021;GO:0005739;GO:0005886;GO:0031143;GO:0003847;GO:0047499;GO:0005516;GO:0042802;GO:0004622;GO:0102991;GO:0016290;GO:0102545;GO:0004623;GO:0102567;GO:0102568;GO:0019731;GO:0035965;GO:0032049;GO:0006935;GO:0038096;GO:0046473;GO:0036151;GO:0034638;GO:0036152;GO:0046338;GO:0046469;GO:0035774;, C:centriolar satellite; C:cytosol; C:extracellular space; C:integral component of membrane; C:mitochondrion; C:plasma membrane; C:pseudopodium;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:calcium-independent phospholipase A2 activity; F:calmodulin binding; F:identical protein binding; F:lysophospholipase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:phosphatidyl phospholipase B activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:antibacterial humoral response; P:cardiolipin acyl-chain remodeling; P:cardiolipin biosynthetic process; P:chemotaxis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:phosphatidic acid metabolic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylethanolamine catabolic process; P:platelet activating factor metabolic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O60733 A8K597 B0QYE8 O75645 Q8N452 Q9UG29 Q9UIT0 Q9Y671,85/88 kDa calcium-independent phospholipase A2,2-lysophosphatidylcholine acylhydrolase;Group VI phospholipase A2;Intracellular membrane-associated calcium-independent phospholipase A2 beta;Palmitoyl-CoA hydrolase;Patatin-like phospholipase domain-containing protein 9;, PF12796;PF01734;, GO:0034451;GO:0005829;GO:0005615;GO:0016021;GO:0005739;GO:0005886;GO:0031143;GO:0003847;GO:0047499;GO:0005516;GO:0042802;GO:0004622;GO:0102991;GO:0016290;GO:0102545;GO:0004623;GO:0102567;GO:0102568;GO:0019731;GO:0035965;GO:0032049;GO:0006935;GO:0038096;GO:0046473;GO:0036151;GO:0034638;GO:0036152;GO:0046338;GO:0046469;GO:0035774;, C:centriolar satellite; C:cytosol; C:extracellular space; C:integral component of membrane; C:mitochondrion; C:plasma membrane; C:pseudopodium;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:calcium-independent phospholipase A2 activity; F:calmodulin binding; F:identical protein binding; F:lysophospholipase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:phosphatidyl phospholipase B activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:antibacterial humoral response; P:cardiolipin acyl-chain remodeling; P:cardiolipin biosynthetic process; P:chemotaxis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:phosphatidic acid metabolic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylethanolamine catabolic process; P:platelet activating factor metabolic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O60733 A8K597 B0QYE8 O75645 Q8N452 Q9UG29 Q9UIT0 Q9Y671,85/88 kDa calcium-independent phospholipase A2,2-lysophosphatidylcholine acylhydrolase;Group VI phospholipase A2;Intracellular membrane-associated calcium-independent phospholipase A2 beta;Palmitoyl-CoA hydrolase;Patatin-like phospholipase domain-containing protein 9;, PF12796;PF01734;, GO:0034451;GO:0005829;GO:0005615;GO:0016021;GO:0005739;GO:0005886;GO:0031143;GO:0003847;GO:0047499;GO:0005516;GO:0042802;GO:0004622;GO:0102991;GO:0016290;GO:0102545;GO:0004623;GO:0102567;GO:0102568;GO:0019731;GO:0035965;GO:0032049;GO:0006935;GO:0038096;GO:0046473;GO:0036151;GO:0034638;GO:0036152;GO:0046338;GO:0046469;GO:0035774;, C:centriolar satellite; C:cytosol; C:extracellular space; C:integral component of membrane; C:mitochondrion; C:plasma membrane; C:pseudopodium;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:calcium-independent phospholipase A2 activity; F:calmodulin binding; F:identical protein binding; F:lysophospholipase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:phosphatidyl phospholipase B activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:antibacterial humoral response; P:cardiolipin acyl-chain remodeling; P:cardiolipin biosynthetic process; P:chemotaxis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:phosphatidic acid metabolic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylethanolamine catabolic process; P:platelet activating factor metabolic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O60733 A8K597 B0QYE8 O75645 Q8N452 Q9UG29 Q9UIT0 Q9Y671,85/88 kDa calcium-independent phospholipase A2,2-lysophosphatidylcholine acylhydrolase;Group VI phospholipase A2;Intracellular membrane-associated calcium-independent phospholipase A2 beta;Palmitoyl-CoA hydrolase;Patatin-like phospholipase domain-containing protein 9;, PF12796;PF01734;, GO:0034451;GO:0005829;GO:0005615;GO:0016021;GO:0005739;GO:0005886;GO:0031143;GO:0003847;GO:0047499;GO:0005516;GO:0042802;GO:0004622;GO:0102991;GO:0016290;GO:0102545;GO:0004623;GO:0102567;GO:0102568;GO:0019731;GO:0035965;GO:0032049;GO:0006935;GO:0038096;GO:0046473;GO:0036151;GO:0034638;GO:0036152;GO:0046338;GO:0046469;GO:0035774;, C:centriolar satellite; C:cytosol; C:extracellular space; C:integral component of membrane; C:mitochondrion; C:plasma membrane; C:pseudopodium;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:calcium-independent phospholipase A2 activity; F:calmodulin binding; F:identical protein binding; F:lysophospholipase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:phosphatidyl phospholipase B activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:antibacterial humoral response; P:cardiolipin acyl-chain remodeling; P:cardiolipin biosynthetic process; P:chemotaxis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:phosphatidic acid metabolic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylethanolamine catabolic process; P:platelet activating factor metabolic process; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; scaffold71 indexed_genome mRNA 2988304 2992683 . + . ID=transcript_11353;Q6UXY1 B0QYE2 Q96BG7,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2,Planar intestinal- and kidney-specific BAR domain protein;, PF08397;PF14604;, GO:0044291;GO:0071439;GO:0030659;GO:0005829;GO:0005654;GO:0005886;GO:0012506;GO:0005543;GO:0051764;GO:0051017;GO:0061024;GO:0007009;GO:2000251;GO:0030838;, C:cell-cell contact zone; C:clathrin complex; C:cytoplasmic vesicle membrane; C:cytosol; C:nucleoplasm; C:plasma membrane; C:vesicle membrane;, F:phospholipid binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:membrane organization; P:plasma membrane organization; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; scaffold71 indexed_genome mRNA 3005080 3022124 . - . ID=transcript_11354;Q9NRD5 B3KS52 O95906,PRKCA-binding protein,Protein interacting with C kinase 1;Protein kinase C-alpha-binding protein;, PF06456;PF00595;, GO:0005737;GO:0005856;GO:0005829;GO:0030666;GO:0005794;GO:0043005;GO:0048471;GO:0005886;GO:0014069;GO:0098842;GO:0042734;GO:0045202;GO:0008021;GO:0032588;GO:0051015;GO:0071933;GO:0019899;GO:0001664;GO:0042802;GO:0140090;GO:0046872;GO:0005543;GO:0008022;GO:0019904;GO:0005080;GO:0005102;GO:0036294;GO:0042149;GO:0097062;GO:0097061;GO:0043045;GO:0043046;GO:0021782;GO:0006886;GO:0060292;GO:0015844;GO:0034316;GO:0045161;GO:0002092;GO:0007205;GO:0006468;GO:0043113;GO:0034315;GO:0050796;GO:0006890;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endocytic vesicle membrane; C:Golgi apparatus; C:neuron projection; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic early endosome; C:presynaptic membrane; C:synapse; C:synaptic vesicle; C:trans-Golgi network membrane;, F:actin filament binding; F:Arp2/3 complex binding; F:enzyme binding; F:G protein-coupled receptor binding; F:identical protein binding; F:membrane curvature sensor activity; F:metal ion binding; F:phospholipid binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase C binding; F:signaling receptor binding;, P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:dendritic spine maintenance; P:dendritic spine organization; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:glial cell development; P:intracellular protein transport; P:long-term synaptic depression; P:monoamine transport; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:neuronal ion channel clustering; P:positive regulation of receptor internalization; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein phosphorylation; P:receptor clustering; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of insulin secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NRD5 B3KS52 O95906,PRKCA-binding protein,Protein interacting with C kinase 1;Protein kinase C-alpha-binding protein;, PF06456;PF00595;, GO:0005737;GO:0005856;GO:0005829;GO:0030666;GO:0005794;GO:0043005;GO:0048471;GO:0005886;GO:0014069;GO:0098842;GO:0042734;GO:0045202;GO:0008021;GO:0032588;GO:0051015;GO:0071933;GO:0019899;GO:0001664;GO:0042802;GO:0140090;GO:0046872;GO:0005543;GO:0008022;GO:0019904;GO:0005080;GO:0005102;GO:0036294;GO:0042149;GO:0097062;GO:0097061;GO:0043045;GO:0043046;GO:0021782;GO:0006886;GO:0060292;GO:0015844;GO:0034316;GO:0045161;GO:0002092;GO:0007205;GO:0006468;GO:0043113;GO:0034315;GO:0050796;GO:0006890;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endocytic vesicle membrane; C:Golgi apparatus; C:neuron projection; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic early endosome; C:presynaptic membrane; C:synapse; C:synaptic vesicle; C:trans-Golgi network membrane;, F:actin filament binding; F:Arp2/3 complex binding; F:enzyme binding; F:G protein-coupled receptor binding; F:identical protein binding; F:membrane curvature sensor activity; F:metal ion binding; F:phospholipid binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase C binding; F:signaling receptor binding;, P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:dendritic spine maintenance; P:dendritic spine organization; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:glial cell development; P:intracellular protein transport; P:long-term synaptic depression; P:monoamine transport; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:neuronal ion channel clustering; P:positive regulation of receptor internalization; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein phosphorylation; P:receptor clustering; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of insulin secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NRD5 B3KS52 O95906,PRKCA-binding protein,Protein interacting with C kinase 1;Protein kinase C-alpha-binding protein;, PF06456;PF00595;, GO:0005737;GO:0005856;GO:0005829;GO:0030666;GO:0005794;GO:0043005;GO:0048471;GO:0005886;GO:0014069;GO:0098842;GO:0042734;GO:0045202;GO:0008021;GO:0032588;GO:0051015;GO:0071933;GO:0019899;GO:0001664;GO:0042802;GO:0140090;GO:0046872;GO:0005543;GO:0008022;GO:0019904;GO:0005080;GO:0005102;GO:0036294;GO:0042149;GO:0097062;GO:0097061;GO:0043045;GO:0043046;GO:0021782;GO:0006886;GO:0060292;GO:0015844;GO:0034316;GO:0045161;GO:0002092;GO:0007205;GO:0006468;GO:0043113;GO:0034315;GO:0050796;GO:0006890;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endocytic vesicle membrane; C:Golgi apparatus; C:neuron projection; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic early endosome; C:presynaptic membrane; C:synapse; C:synaptic vesicle; C:trans-Golgi network membrane;, F:actin filament binding; F:Arp2/3 complex binding; F:enzyme binding; F:G protein-coupled receptor binding; F:identical protein binding; F:membrane curvature sensor activity; F:metal ion binding; F:phospholipid binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase C binding; F:signaling receptor binding;, P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:dendritic spine maintenance; P:dendritic spine organization; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:glial cell development; P:intracellular protein transport; P:long-term synaptic depression; P:monoamine transport; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:neuronal ion channel clustering; P:positive regulation of receptor internalization; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein phosphorylation; P:receptor clustering; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of insulin secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NRD5 B3KS52 O95906,PRKCA-binding protein,Protein interacting with C kinase 1;Protein kinase C-alpha-binding protein;, PF06456;PF00595;, GO:0005737;GO:0005856;GO:0005829;GO:0030666;GO:0005794;GO:0043005;GO:0048471;GO:0005886;GO:0014069;GO:0098842;GO:0042734;GO:0045202;GO:0008021;GO:0032588;GO:0051015;GO:0071933;GO:0019899;GO:0001664;GO:0042802;GO:0140090;GO:0046872;GO:0005543;GO:0008022;GO:0019904;GO:0005080;GO:0005102;GO:0036294;GO:0042149;GO:0097062;GO:0097061;GO:0043045;GO:0043046;GO:0021782;GO:0006886;GO:0060292;GO:0015844;GO:0034316;GO:0045161;GO:0002092;GO:0007205;GO:0006468;GO:0043113;GO:0034315;GO:0050796;GO:0006890;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endocytic vesicle membrane; C:Golgi apparatus; C:neuron projection; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic early endosome; C:presynaptic membrane; C:synapse; C:synaptic vesicle; C:trans-Golgi network membrane;, F:actin filament binding; F:Arp2/3 complex binding; F:enzyme binding; F:G protein-coupled receptor binding; F:identical protein binding; F:membrane curvature sensor activity; F:metal ion binding; F:phospholipid binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase C binding; F:signaling receptor binding;, P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:dendritic spine maintenance; P:dendritic spine organization; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:glial cell development; P:intracellular protein transport; P:long-term synaptic depression; P:monoamine transport; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:neuronal ion channel clustering; P:positive regulation of receptor internalization; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein phosphorylation; P:receptor clustering; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of insulin secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NRD5 B3KS52 O95906,PRKCA-binding protein,Protein interacting with C kinase 1;Protein kinase C-alpha-binding protein;, PF06456;PF00595;, GO:0005737;GO:0005856;GO:0005829;GO:0030666;GO:0005794;GO:0043005;GO:0048471;GO:0005886;GO:0014069;GO:0098842;GO:0042734;GO:0045202;GO:0008021;GO:0032588;GO:0051015;GO:0071933;GO:0019899;GO:0001664;GO:0042802;GO:0140090;GO:0046872;GO:0005543;GO:0008022;GO:0019904;GO:0005080;GO:0005102;GO:0036294;GO:0042149;GO:0097062;GO:0097061;GO:0043045;GO:0043046;GO:0021782;GO:0006886;GO:0060292;GO:0015844;GO:0034316;GO:0045161;GO:0002092;GO:0007205;GO:0006468;GO:0043113;GO:0034315;GO:0050796;GO:0006890;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endocytic vesicle membrane; C:Golgi apparatus; C:neuron projection; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic early endosome; C:presynaptic membrane; C:synapse; C:synaptic vesicle; C:trans-Golgi network membrane;, F:actin filament binding; F:Arp2/3 complex binding; F:enzyme binding; F:G protein-coupled receptor binding; F:identical protein binding; F:membrane curvature sensor activity; F:metal ion binding; F:phospholipid binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase C binding; F:signaling receptor binding;, P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:dendritic spine maintenance; P:dendritic spine organization; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:glial cell development; P:intracellular protein transport; P:long-term synaptic depression; P:monoamine transport; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:neuronal ion channel clustering; P:positive regulation of receptor internalization; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein phosphorylation; P:receptor clustering; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of insulin secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NRD5 B3KS52 O95906,PRKCA-binding protein,Protein interacting with C kinase 1;Protein kinase C-alpha-binding protein;, PF06456;PF00595;, GO:0005737;GO:0005856;GO:0005829;GO:0030666;GO:0005794;GO:0043005;GO:0048471;GO:0005886;GO:0014069;GO:0098842;GO:0042734;GO:0045202;GO:0008021;GO:0032588;GO:0051015;GO:0071933;GO:0019899;GO:0001664;GO:0042802;GO:0140090;GO:0046872;GO:0005543;GO:0008022;GO:0019904;GO:0005080;GO:0005102;GO:0036294;GO:0042149;GO:0097062;GO:0097061;GO:0043045;GO:0043046;GO:0021782;GO:0006886;GO:0060292;GO:0015844;GO:0034316;GO:0045161;GO:0002092;GO:0007205;GO:0006468;GO:0043113;GO:0034315;GO:0050796;GO:0006890;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endocytic vesicle membrane; C:Golgi apparatus; C:neuron projection; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic early endosome; C:presynaptic membrane; C:synapse; C:synaptic vesicle; C:trans-Golgi network membrane;, F:actin filament binding; F:Arp2/3 complex binding; F:enzyme binding; F:G protein-coupled receptor binding; F:identical protein binding; F:membrane curvature sensor activity; F:metal ion binding; F:phospholipid binding; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase C binding; F:signaling receptor binding;, P:cellular response to decreased oxygen levels; P:cellular response to glucose starvation; P:dendritic spine maintenance; P:dendritic spine organization; P:DNA methylation involved in embryo development; P:DNA methylation involved in gamete generation; P:glial cell development; P:intracellular protein transport; P:long-term synaptic depression; P:monoamine transport; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:neuronal ion channel clustering; P:positive regulation of receptor internalization; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein phosphorylation; P:receptor clustering; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of insulin secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold71 indexed_genome mRNA 3100697 3109168 . - . ID=transcript_11355;P61218 P41584 Q6IAY3,DNA-directed RNA polymerases I, II, and III subunit RPABC2,DNA-directed RNA polymerase II subunit F;DNA-directed RNA polymerases I, II, and III 14.4 kDa polypeptide;RPABC14.4;RPB6 homolog;RPC15;, PF01192;, GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0005736;GO:0005665;GO:0005666;GO:0003677;GO:0003899;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|P61218 P41584 Q6IAY3,DNA-directed RNA polymerases I, II, and III subunit RPABC2,DNA-directed RNA polymerase II subunit F;DNA-directed RNA polymerases I, II, and III 14.4 kDa polypeptide;RPABC14.4;RPB6 homolog;RPC15;, PF01192;, GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0005736;GO:0005665;GO:0005666;GO:0003677;GO:0003899;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|P61218 P41584 Q6IAY3,DNA-directed RNA polymerases I, II, and III subunit RPABC2,DNA-directed RNA polymerase II subunit F;DNA-directed RNA polymerases I, II, and III 14.4 kDa polypeptide;RPABC14.4;RPB6 homolog;RPC15;, PF01192;, GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0005736;GO:0005665;GO:0005666;GO:0003677;GO:0003899;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; scaffold71 indexed_genome mRNA 3109210 3121463 . - . ID=transcript_11356;Q9BZE7 Q5JYU9 Q96M68,UPF0193 protein EVG1,, PF05250; scaffold71 indexed_genome mRNA 3123576 3124203 . + . ID=transcript_11357;Q8N3F8 Q5TI16 Q7RTP5 Q8N3N8 Q9BVL9 Q9BY92 Q9UH43 Q9UH44 Q9UH45,MICAL-like protein 1,Molecule interacting with Rab13;, PF00307;PF12130;PF00412;, GO:0019898;GO:0005770;GO:0031902;GO:0055038;GO:0045296;GO:0042802;GO:0046872;GO:0070300;GO:0031267;GO:0006897;GO:0031175;GO:0097320;GO:0036010;GO:0006612;GO:0006898;GO:1990126;GO:0032458;, C:extrinsic component of membrane; C:late endosome; C:late endosome membrane; C:recycling endosome membrane;, F:cadherin binding; F:identical protein binding; F:metal ion binding; F:phosphatidic acid binding; F:small GTPase binding;, P:endocytosis; P:neuron projection development; P:plasma membrane tubulation; P:protein localization to endosome; P:protein targeting to membrane; P:receptor-mediated endocytosis; P:retrograde transport, endosome to plasma membrane; P:slow endocytic recycling; scaffold71 indexed_genome mRNA 3169242 3189228 . - . ID=transcript_11358;Q9Y262 B2RDG6 B4DYB2 G8JLH4 Q53HQ1 Q53HT4 Q5QTR1 Q5TI15 Q6ICD2,Eukaryotic translation initiation factor 3 subunit L {ECO:0000255|HAMAP-Rule:MF_03011},Eukaryotic translation initiation factor 3 subunit 6-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};Eukaryotic translation initiation factor 3 subunit E-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};, PF10255;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0003723;GO:0003743;GO:0001732;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane;, F:RNA binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:translational initiation; P:viral translational termination-reinitiation;|Q9Y262 B2RDG6 B4DYB2 G8JLH4 Q53HQ1 Q53HT4 Q5QTR1 Q5TI15 Q6ICD2,Eukaryotic translation initiation factor 3 subunit L {ECO:0000255|HAMAP-Rule:MF_03011},Eukaryotic translation initiation factor 3 subunit 6-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};Eukaryotic translation initiation factor 3 subunit E-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};, PF10255;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0003723;GO:0003743;GO:0001732;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane;, F:RNA binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:translational initiation; P:viral translational termination-reinitiation;|Q9Y262 B2RDG6 B4DYB2 G8JLH4 Q53HQ1 Q53HT4 Q5QTR1 Q5TI15 Q6ICD2,Eukaryotic translation initiation factor 3 subunit L {ECO:0000255|HAMAP-Rule:MF_03011},Eukaryotic translation initiation factor 3 subunit 6-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};Eukaryotic translation initiation factor 3 subunit E-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};, PF10255;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0003723;GO:0003743;GO:0001732;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane;, F:RNA binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:translational initiation; P:viral translational termination-reinitiation;|Q9Y262 B2RDG6 B4DYB2 G8JLH4 Q53HQ1 Q53HT4 Q5QTR1 Q5TI15 Q6ICD2,Eukaryotic translation initiation factor 3 subunit L {ECO:0000255|HAMAP-Rule:MF_03011},Eukaryotic translation initiation factor 3 subunit 6-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};Eukaryotic translation initiation factor 3 subunit E-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};, PF10255;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0003723;GO:0003743;GO:0001732;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane;, F:RNA binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:translational initiation; P:viral translational termination-reinitiation;|Q9Y262 B2RDG6 B4DYB2 G8JLH4 Q53HQ1 Q53HT4 Q5QTR1 Q5TI15 Q6ICD2,Eukaryotic translation initiation factor 3 subunit L {ECO:0000255|HAMAP-Rule:MF_03011},Eukaryotic translation initiation factor 3 subunit 6-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};Eukaryotic translation initiation factor 3 subunit E-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};, PF10255;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0003723;GO:0003743;GO:0001732;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane;, F:RNA binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:translational initiation; P:viral translational termination-reinitiation;|Q9Y262 B2RDG6 B4DYB2 G8JLH4 Q53HQ1 Q53HT4 Q5QTR1 Q5TI15 Q6ICD2,Eukaryotic translation initiation factor 3 subunit L {ECO:0000255|HAMAP-Rule:MF_03011},Eukaryotic translation initiation factor 3 subunit 6-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};Eukaryotic translation initiation factor 3 subunit E-interacting protein {ECO:0000255|HAMAP-Rule:MF_03011};, PF10255;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0003723;GO:0003743;GO:0001732;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane;, F:RNA binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:translational initiation; P:viral translational termination-reinitiation; scaffold71 indexed_genome mRNA 3196078 3205970 . + . ID=transcript_11359;Q6NXT1 Q6ZSB1 Q9UGV1,Ankyrin repeat domain-containing protein 54,Lyn-interacting ankyrin repeat protein;, , GO:0005737;GO:0030496;GO:0005634;GO:0019887;GO:0044877;GO:0006913;GO:0045648;GO:1902531;GO:0045859;, C:cytoplasm; C:midbody; C:nucleus;, F:protein kinase regulator activity; F:protein-containing complex binding;, P:nucleocytoplasmic transport; P:positive regulation of erythrocyte differentiation; P:regulation of intracellular signal transduction; P:regulation of protein kinase activity;|Q6NXT1 Q6ZSB1 Q9UGV1,Ankyrin repeat domain-containing protein 54,Lyn-interacting ankyrin repeat protein;, , GO:0005737;GO:0030496;GO:0005634;GO:0019887;GO:0044877;GO:0006913;GO:0045648;GO:1902531;GO:0045859;, C:cytoplasm; C:midbody; C:nucleus;, F:protein kinase regulator activity; F:protein-containing complex binding;, P:nucleocytoplasmic transport; P:positive regulation of erythrocyte differentiation; P:regulation of intracellular signal transduction; P:regulation of protein kinase activity; scaffold71 indexed_genome mRNA 3215970 3216951 . - . ID=transcript_11360;O60755 Q53YJ4,Galanin receptor type 3,, PF00001;, GO:0005929;GO:0016021;GO:0005887;GO:0097730;GO:0005886;GO:0045202;GO:0008528;GO:0004966;GO:0017046;GO:0007188;GO:0007268;GO:0007631;GO:0007186;GO:0007187;GO:0090663;GO:0007611;GO:0007194;GO:0007218;GO:0045944;, C:cilium; C:integral component of membrane; C:integral component of plasma membrane; C:non-motile cilium; C:plasma membrane; C:synapse;, F:G protein-coupled peptide receptor activity; F:galanin receptor activity; F:peptide hormone binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:chemical synaptic transmission; P:feeding behavior; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:galanin-activated signaling pathway; P:learning or memory; P:negative regulation of adenylate cyclase activity; P:neuropeptide signaling pathway; P:positive regulation of transcription by RNA polymerase II; scaffold71 indexed_genome mRNA 3220331 3227397 . - . ID=transcript_11361;O75600 E2QC23 Q6ZWF1 Q96CA9,2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial,Aminoacetone synthase;Glycine acetyltransferase;, PF00155;, GO:0005743;GO:0005739;GO:0016607;GO:0005654;GO:0008890;GO:0030170;GO:0009058;GO:0006520;GO:0019518;, C:mitochondrial inner membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm;, F:glycine C-acetyltransferase activity; F:pyridoxal phosphate binding;, P:biosynthetic process; P:cellular amino acid metabolic process; P:L-threonine catabolic process to glycine;|O75600 E2QC23 Q6ZWF1 Q96CA9,2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial,Aminoacetone synthase;Glycine acetyltransferase;, PF00155;, GO:0005743;GO:0005739;GO:0016607;GO:0005654;GO:0008890;GO:0030170;GO:0009058;GO:0006520;GO:0019518;, C:mitochondrial inner membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm;, F:glycine C-acetyltransferase activity; F:pyridoxal phosphate binding;, P:biosynthetic process; P:cellular amino acid metabolic process; P:L-threonine catabolic process to glycine;|O75600 E2QC23 Q6ZWF1 Q96CA9,2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial,Aminoacetone synthase;Glycine acetyltransferase;, PF00155;, GO:0005743;GO:0005739;GO:0016607;GO:0005654;GO:0008890;GO:0030170;GO:0009058;GO:0006520;GO:0019518;, C:mitochondrial inner membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm;, F:glycine C-acetyltransferase activity; F:pyridoxal phosphate binding;, P:biosynthetic process; P:cellular amino acid metabolic process; P:L-threonine catabolic process to glycine; scaffold71 indexed_genome mRNA 3227879 3230315 . + . ID=transcript_11362;P07305 B2R6I0 B4DRD6 Q6FG88 Q8N6R3,Histone H1.0,Histone H1';Histone H1(0);, PF00538;, GO:0015629;GO:0000785;GO:0000791;GO:0005794;GO:0016604;GO:0005654;GO:0000786;GO:0005634;GO:0017053;GO:0031490;GO:0003690;GO:0003680;GO:0031492;GO:0003723;GO:0006309;GO:0006342;GO:0030261;GO:0031936;GO:0045910;GO:0000122;GO:0006334;GO:0016584;GO:2000679;, C:actin cytoskeleton; C:chromatin; C:euchromatin; C:Golgi apparatus; C:nuclear body; C:nucleoplasm; C:nucleosome; C:nucleus; C:transcription repressor complex;, F:chromatin DNA binding; F:double-stranded DNA binding; F:minor groove of adenine-thymine-rich DNA binding; F:nucleosomal DNA binding; F:RNA binding;, P:apoptotic DNA fragmentation; P:chromatin silencing; P:chromosome condensation; P:negative regulation of chromatin silencing; P:negative regulation of DNA recombination; P:negative regulation of transcription by RNA polymerase II; P:nucleosome assembly; P:nucleosome positioning; P:positive regulation of transcription regulatory region DNA binding; scaffold71 indexed_genome mRNA 3255771 3285350 . + . ID=transcript_11363;Q5R3M6 Q96DW1 Q9BT77 Q9BTL7 Q9BY98 Q9Y3L4,TRIO and F-actin-binding protein,Protein Tara;Trio-associated repeat on actin;, PF00169;, GO:0015629;GO:0005737;GO:0005925;GO:0005815;GO:0030496;GO:0005634;GO:0120044;GO:0051015;GO:0045159;GO:0031267;GO:0031625;GO:0007015;GO:0030047;GO:0060088;GO:0051016;GO:0007049;GO:0051301;GO:1900026;GO:0007605;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:microtubule organizing center; C:midbody; C:nucleus; C:stereocilium base;, F:actin filament binding; F:myosin II binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:actin filament organization; P:actin modification; P:auditory receptor cell stereocilium organization; P:barbed-end actin filament capping; P:cell cycle; P:cell division; P:positive regulation of substrate adhesion-dependent cell spreading; P:sensory perception of sound;|Q5R3M6 Q96DW1 Q9BT77 Q9BTL7 Q9BY98 Q9Y3L4,TRIO and F-actin-binding protein,Protein Tara;Trio-associated repeat on actin;, PF00169;, GO:0015629;GO:0005737;GO:0005925;GO:0005815;GO:0030496;GO:0005634;GO:0120044;GO:0051015;GO:0045159;GO:0031267;GO:0031625;GO:0007015;GO:0030047;GO:0060088;GO:0051016;GO:0007049;GO:0051301;GO:1900026;GO:0007605;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:microtubule organizing center; C:midbody; C:nucleus; C:stereocilium base;, F:actin filament binding; F:myosin II binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:actin filament organization; P:actin modification; P:auditory receptor cell stereocilium organization; P:barbed-end actin filament capping; P:cell cycle; P:cell division; P:positive regulation of substrate adhesion-dependent cell spreading; P:sensory perception of sound;|Q5R3M6 Q96DW1 Q9BT77 Q9BTL7 Q9BY98 Q9Y3L4,TRIO and F-actin-binding protein,Protein Tara;Trio-associated repeat on actin;, PF00169;, GO:0015629;GO:0005737;GO:0005925;GO:0005815;GO:0030496;GO:0005634;GO:0120044;GO:0051015;GO:0045159;GO:0031267;GO:0031625;GO:0007015;GO:0030047;GO:0060088;GO:0051016;GO:0007049;GO:0051301;GO:1900026;GO:0007605;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:microtubule organizing center; C:midbody; C:nucleus; C:stereocilium base;, F:actin filament binding; F:myosin II binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:actin filament organization; P:actin modification; P:auditory receptor cell stereocilium organization; P:barbed-end actin filament capping; P:cell cycle; P:cell division; P:positive regulation of substrate adhesion-dependent cell spreading; P:sensory perception of sound;|Q5R3M6 Q96DW1 Q9BT77 Q9BTL7 Q9BY98 Q9Y3L4,TRIO and F-actin-binding protein,Protein Tara;Trio-associated repeat on actin;, PF00169;, GO:0015629;GO:0005737;GO:0005925;GO:0005815;GO:0030496;GO:0005634;GO:0120044;GO:0051015;GO:0045159;GO:0031267;GO:0031625;GO:0007015;GO:0030047;GO:0060088;GO:0051016;GO:0007049;GO:0051301;GO:1900026;GO:0007605;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:microtubule organizing center; C:midbody; C:nucleus; C:stereocilium base;, F:actin filament binding; F:myosin II binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:actin filament organization; P:actin modification; P:auditory receptor cell stereocilium organization; P:barbed-end actin filament capping; P:cell cycle; P:cell division; P:positive regulation of substrate adhesion-dependent cell spreading; P:sensory perception of sound;|Q5R3M6 Q96DW1 Q9BT77 Q9BTL7 Q9BY98 Q9Y3L4,TRIO and F-actin-binding protein,Protein Tara;Trio-associated repeat on actin;, PF00169;, GO:0015629;GO:0005737;GO:0005925;GO:0005815;GO:0030496;GO:0005634;GO:0120044;GO:0051015;GO:0045159;GO:0031267;GO:0031625;GO:0007015;GO:0030047;GO:0060088;GO:0051016;GO:0007049;GO:0051301;GO:1900026;GO:0007605;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion; C:microtubule organizing center; C:midbody; C:nucleus; C:stereocilium base;, F:actin filament binding; F:myosin II binding; F:small GTPase binding; F:ubiquitin protein ligase binding;, P:actin filament organization; P:actin modification; P:auditory receptor cell stereocilium organization; P:barbed-end actin filament capping; P:cell cycle; P:cell division; P:positive regulation of substrate adhesion-dependent cell spreading; P:sensory perception of sound; scaffold71 indexed_genome mRNA 3323048 3327138 . - . ID=transcript_11364;Q9UGY1,Nucleolar protein 12,, PF09805;, GO:0005730;GO:0042802;GO:0003723;GO:0019843;, C:nucleolus;, F:identical protein binding; F:RNA binding; F:rRNA binding; scaffold71 indexed_genome mRNA 3331310 3335540 . - . ID=transcript_11365;P09382 B2R5E8 Q9UDK5,Galectin-1,14 kDa laminin-binding protein;14 kDa lectin;Beta-galactoside-binding lectin L-14-I;Galaptin;HBL;HPL;Lactose-binding lectin 1;Lectin galactoside-binding soluble 1;Putative MAPK-activating protein PM12;S-Lac lectin 1;, PF00337;, GO:0009986;GO:0062023;GO:0005737;GO:0005829;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0030246;GO:0042802;GO:0030395;GO:0043236;GO:0003723;GO:0006915;GO:0044267;GO:0071333;GO:0071407;GO:0045445;GO:0010812;GO:0010977;GO:0002317;GO:0034120;GO:0043123;GO:0046598;GO:0043687;GO:0042981;GO:0048678;GO:0042493;GO:0035900;GO:0031295;, C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus;, F:carbohydrate binding; F:identical protein binding; F:lactose binding; F:laminin binding; F:RNA binding;, P:apoptotic process; P:cellular protein metabolic process; P:cellular response to glucose stimulus; P:cellular response to organic cyclic compound; P:myoblast differentiation; P:negative regulation of cell-substrate adhesion; P:negative regulation of neuron projection development; P:plasma cell differentiation; P:positive regulation of erythrocyte aggregation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of viral entry into host cell; P:post-translational protein modification; P:regulation of apoptotic process; P:response to axon injury; P:response to drug; P:response to isolation stress; P:T cell costimulation;|P09382 B2R5E8 Q9UDK5,Galectin-1,14 kDa laminin-binding protein;14 kDa lectin;Beta-galactoside-binding lectin L-14-I;Galaptin;HBL;HPL;Lactose-binding lectin 1;Lectin galactoside-binding soluble 1;Putative MAPK-activating protein PM12;S-Lac lectin 1;, PF00337;, GO:0009986;GO:0062023;GO:0005737;GO:0005829;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0030246;GO:0042802;GO:0030395;GO:0043236;GO:0003723;GO:0006915;GO:0044267;GO:0071333;GO:0071407;GO:0045445;GO:0010812;GO:0010977;GO:0002317;GO:0034120;GO:0043123;GO:0046598;GO:0043687;GO:0042981;GO:0048678;GO:0042493;GO:0035900;GO:0031295;, C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus;, F:carbohydrate binding; F:identical protein binding; F:lactose binding; F:laminin binding; F:RNA binding;, P:apoptotic process; P:cellular protein metabolic process; P:cellular response to glucose stimulus; P:cellular response to organic cyclic compound; P:myoblast differentiation; P:negative regulation of cell-substrate adhesion; P:negative regulation of neuron projection development; P:plasma cell differentiation; P:positive regulation of erythrocyte aggregation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of viral entry into host cell; P:post-translational protein modification; P:regulation of apoptotic process; P:response to axon injury; P:response to drug; P:response to isolation stress; P:T cell costimulation; scaffold71 indexed_genome mRNA 3343246 3345319 . - . ID=transcript_11366;Q96GD0 Q9UGY2,Pyridoxal phosphate phosphatase,Chronophin;, PF13344;, GO:0005911;GO:0005737;GO:0005856;GO:0005829;GO:0031258;GO:0032587;GO:0036425;GO:0043136;GO:0031072;GO:0036424;GO:0000287;GO:0016791;GO:0004721;GO:0042803;GO:0033883;GO:0031247;GO:0071318;GO:0016311;GO:0006114;GO:0006650;GO:0030836;GO:0006470;GO:0032361;GO:0032465;GO:0007088;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:lamellipodium membrane; C:ruffle membrane;, F:D-phosphoserine phosphatase activity; F:glycerol-3-phosphatase activity; F:heat shock protein binding; F:L-phosphoserine phosphatase activity; F:magnesium ion binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein homodimerization activity; F:pyridoxal phosphatase activity;, P:actin rod assembly; P:cellular response to ATP; P:dephosphorylation; P:glycerol biosynthetic process; P:glycerophospholipid metabolic process; P:positive regulation of actin filament depolymerization; P:protein dephosphorylation; P:pyridoxal phosphate catabolic process; P:regulation of cytokinesis; P:regulation of mitotic nuclear division; scaffold71 indexed_genome mRNA 3359700 3372044 . - . ID=transcript_11367;Q9Y3L3 Q5R3N0 Q6IBZ2 Q6ZVL9 Q96HQ5 Q9NSQ9,SH3 domain-binding protein 1 {ECO:0000312|HGNC:HGNC:10824},, PF03114;PF00620;, GO:0005912;GO:0005923;GO:0031252;GO:0005829;GO:0030027;GO:0005634;GO:0001891;GO:0005096;GO:0030215;GO:0017124;GO:0007015;GO:0034329;GO:0016477;GO:0045198;GO:0046847;GO:0051058;GO:0006911;GO:0043547;GO:0032956;GO:0030834;GO:0043535;GO:0035020;GO:0097178;GO:0071526;, C:adherens junction; C:bicellular tight junction; C:cell leading edge; C:cytosol; C:lamellipodium; C:nucleus; C:phagocytic cup;, F:GTPase activator activity; F:semaphorin receptor binding; F:SH3 domain binding;, P:actin filament organization; P:cell junction assembly; P:cell migration; P:establishment of epithelial cell apical/basal polarity; P:filopodium assembly; P:negative regulation of small GTPase mediated signal transduction; P:phagocytosis, engulfment; P:positive regulation of GTPase activity; P:regulation of actin cytoskeleton organization; P:regulation of actin filament depolymerization; P:regulation of blood vessel endothelial cell migration; P:regulation of Rac protein signal transduction; P:ruffle assembly; P:semaphorin-plexin signaling pathway;|Q9Y3L3 Q5R3N0 Q6IBZ2 Q6ZVL9 Q96HQ5 Q9NSQ9,SH3 domain-binding protein 1 {ECO:0000312|HGNC:HGNC:10824},, PF03114;PF00620;, GO:0005912;GO:0005923;GO:0031252;GO:0005829;GO:0030027;GO:0005634;GO:0001891;GO:0005096;GO:0030215;GO:0017124;GO:0007015;GO:0034329;GO:0016477;GO:0045198;GO:0046847;GO:0051058;GO:0006911;GO:0043547;GO:0032956;GO:0030834;GO:0043535;GO:0035020;GO:0097178;GO:0071526;, C:adherens junction; C:bicellular tight junction; C:cell leading edge; C:cytosol; C:lamellipodium; C:nucleus; C:phagocytic cup;, F:GTPase activator activity; F:semaphorin receptor binding; F:SH3 domain binding;, P:actin filament organization; P:cell junction assembly; P:cell migration; P:establishment of epithelial cell apical/basal polarity; P:filopodium assembly; P:negative regulation of small GTPase mediated signal transduction; P:phagocytosis, engulfment; P:positive regulation of GTPase activity; P:regulation of actin cytoskeleton organization; P:regulation of actin filament depolymerization; P:regulation of blood vessel endothelial cell migration; P:regulation of Rac protein signal transduction; P:ruffle assembly; P:semaphorin-plexin signaling pathway; scaffold71 indexed_genome mRNA 3377715 3397262 . - . ID=transcript_11368;Q9UG00 Q9UGW0 Q9UGW1,ADP-ribosylation factor-binding protein GGA1,Gamma-adaptin-related protein 1;Golgi-localized, gamma ear-containing, ARF-binding protein 1;, PF02883;PF03127;PF18308;PF00790;, GO:0005829;GO:0005769;GO:0031901;GO:0010008;GO:0005794;GO:0043231;GO:0016020;GO:0005654;GO:0032991;GO:0031267;GO:1990000;GO:0043001;GO:0006886;GO:0045732;GO:0008104;GO:0034394;GO:1903441;GO:0042147;GO:1901998;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:protein-containing complex;, F:small GTPase binding;, P:amyloid fibril formation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:positive regulation of protein catabolic process; P:protein localization; P:protein localization to cell surface; P:protein localization to ciliary membrane; P:retrograde transport, endosome to Golgi; P:toxin transport;|Q9UG00 Q9UGW0 Q9UGW1,ADP-ribosylation factor-binding protein GGA1,Gamma-adaptin-related protein 1;Golgi-localized, gamma ear-containing, ARF-binding protein 1;, PF02883;PF03127;PF18308;PF00790;, GO:0005829;GO:0005769;GO:0031901;GO:0010008;GO:0005794;GO:0043231;GO:0016020;GO:0005654;GO:0032991;GO:0031267;GO:1990000;GO:0043001;GO:0006886;GO:0045732;GO:0008104;GO:0034394;GO:1903441;GO:0042147;GO:1901998;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:protein-containing complex;, F:small GTPase binding;, P:amyloid fibril formation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:positive regulation of protein catabolic process; P:protein localization; P:protein localization to cell surface; P:protein localization to ciliary membrane; P:retrograde transport, endosome to Golgi; P:toxin transport; scaffold71 indexed_genome mRNA 3413300 6106934 . + . ID=transcript_11369;P43351 Q13205 Q9Y5T7 Q9Y5T8 Q9Y5T9,DNA repair protein RAD52 homolog,, PF04098;, GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0003677;GO:0042802;GO:0003697;GO:0006974;GO:0034599;GO:0010792;GO:0000730;GO:0006310;GO:0006302;GO:0000724;GO:0045002;GO:0006312;GO:2000819;, C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex;, F:DNA binding; F:identical protein binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:cellular response to oxidative stress; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA recombinase assembly; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via single-strand annealing; P:mitotic recombination; P:regulation of nucleotide-excision repair;|P05162 Q6FGY4,Galectin-2,Beta-galactoside-binding lectin L-14-II;HL14;Lactose-binding lectin 2;S-Lac lectin 2;, PF00337;, GO:0005737;GO:0030246;GO:0016936;, C:cytoplasm;, F:carbohydrate binding; F:galactoside binding;|Q00587 A8K825 Q96GN1,Cdc42 effector protein 1,Binder of Rho GTPases 5;Serum protein MSE55;, PF14957;PF00786;, GO:0005912;GO:0005737;GO:0005856;GO:0012505;GO:0005925;GO:0005886;GO:0098641;GO:0030838;GO:0031274;GO:0008360;GO:0007266;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:endomembrane system; C:focal adhesion; C:plasma membrane;, F:cadherin binding involved in cell-cell adhesion;, P:positive regulation of actin filament polymerization; P:positive regulation of pseudopodium assembly; P:regulation of cell shape; P:Rho protein signal transduction;|Q9NY65 B2RCX2 B3KPW9 B4DWG3 Q2M3N4,Tubulin alpha-8 chain,Alpha-tubulin 8;Tubulin alpha chain-like 2;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0015630;GO:0005525;GO:0003924;GO:0005200;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q9NY65 B2RCX2 B3KPW9 B4DWG3 Q2M3N4,Tubulin alpha-8 chain,Alpha-tubulin 8;Tubulin alpha chain-like 2;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0015630;GO:0005525;GO:0003924;GO:0005200;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q9NY65 B2RCX2 B3KPW9 B4DWG3 Q2M3N4,Tubulin alpha-8 chain,Alpha-tubulin 8;Tubulin alpha chain-like 2;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0015630;GO:0005525;GO:0003924;GO:0005200;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q9H853,Putative tubulin-like protein alpha-4B,Alpha-tubulin 4B;, PF00091;, GO:0005737;GO:0005874;GO:0005525;GO:0003924;GO:0005200;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q9NY65 B2RCX2 B3KPW9 B4DWG3 Q2M3N4,Tubulin alpha-8 chain,Alpha-tubulin 8;Tubulin alpha chain-like 2;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0015630;GO:0005525;GO:0003924;GO:0005200;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:microtubule cytoskeleton organization; P:mitotic cell cycle;|Q7Z412 F6UBB5 Q7Z413 Q7Z414 Q7Z415 Q7Z416 Q96B12 Q9NWQ0 Q9NXU0,Peroxisome assembly protein 26,Peroxin-26;, PF07163;, GO:0005829;GO:0005779;GO:0005778;GO:0005777;GO:0051117;GO:0008022;GO:0044877;GO:0016558;GO:0045046;GO:0008104;, C:cytosol; C:integral component of peroxisomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATPase binding; F:protein C-terminus binding; F:protein-containing complex binding;, P:protein import into peroxisome matrix; P:protein import into peroxisome membrane; P:protein localization;|Q7Z412 F6UBB5 Q7Z413 Q7Z414 Q7Z415 Q7Z416 Q96B12 Q9NWQ0 Q9NXU0,Peroxisome assembly protein 26,Peroxin-26;, PF07163;, GO:0005829;GO:0005779;GO:0005778;GO:0005777;GO:0051117;GO:0008022;GO:0044877;GO:0016558;GO:0045046;GO:0008104;, C:cytosol; C:integral component of peroxisomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATPase binding; F:protein C-terminus binding; F:protein-containing complex binding;, P:protein import into peroxisome matrix; P:protein import into peroxisome membrane; P:protein localization;|Q7Z412 F6UBB5 Q7Z413 Q7Z414 Q7Z415 Q7Z416 Q96B12 Q9NWQ0 Q9NXU0,Peroxisome assembly protein 26,Peroxin-26;, PF07163;, GO:0005829;GO:0005779;GO:0005778;GO:0005777;GO:0051117;GO:0008022;GO:0044877;GO:0016558;GO:0045046;GO:0008104;, C:cytosol; C:integral component of peroxisomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATPase binding; F:protein C-terminus binding; F:protein-containing complex binding;, P:protein import into peroxisome matrix; P:protein import into peroxisome membrane; P:protein localization;|Q7RTP6 B2RXJ5 E9PEF0 O94909 Q5U4P4 Q6ICK4 Q96DF2 Q9P2I3,[F-actin]-monooxygenase MICAL3,Molecule interacting with CasL protein 3;, PF00307;PF12130;PF01494;PF00412;, GO:0005938;GO:0042995;GO:0005829;GO:0090543;GO:0045171;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0003779;GO:0071949;GO:0046872;GO:0016709;GO:0031267;GO:0030042;GO:0007049;GO:0051301;GO:0007010;GO:0006887;, C:cell cortex; C:cell projection; C:cytosol; C:Flemming body; C:intercellular bridge; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle;, F:actin binding; F:FAD binding; F:metal ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:small GTPase binding;, P:actin filament depolymerization; P:cell cycle; P:cell division; P:cytoskeleton organization; P:exocytosis;|Q7RTP6 B2RXJ5 E9PEF0 O94909 Q5U4P4 Q6ICK4 Q96DF2 Q9P2I3,[F-actin]-monooxygenase MICAL3,Molecule interacting with CasL protein 3;, PF00307;PF12130;PF01494;PF00412;, GO:0005938;GO:0042995;GO:0005829;GO:0090543;GO:0045171;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0003779;GO:0071949;GO:0046872;GO:0016709;GO:0031267;GO:0030042;GO:0007049;GO:0051301;GO:0007010;GO:0006887;, C:cell cortex; C:cell projection; C:cytosol; C:Flemming body; C:intercellular bridge; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle;, F:actin binding; F:FAD binding; F:metal ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:small GTPase binding;, P:actin filament depolymerization; P:cell cycle; P:cell division; P:cytoskeleton organization; P:exocytosis;|Q7RTP6 B2RXJ5 E9PEF0 O94909 Q5U4P4 Q6ICK4 Q96DF2 Q9P2I3,[F-actin]-monooxygenase MICAL3,Molecule interacting with CasL protein 3;, PF00307;PF12130;PF01494;PF00412;, GO:0005938;GO:0042995;GO:0005829;GO:0090543;GO:0045171;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0003779;GO:0071949;GO:0046872;GO:0016709;GO:0031267;GO:0030042;GO:0007049;GO:0051301;GO:0007010;GO:0006887;, C:cell cortex; C:cell projection; C:cytosol; C:Flemming body; C:intercellular bridge; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle;, F:actin binding; F:FAD binding; F:metal ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:small GTPase binding;, P:actin filament depolymerization; P:cell cycle; P:cell division; P:cytoskeleton organization; P:exocytosis;|Q7RTP6 B2RXJ5 E9PEF0 O94909 Q5U4P4 Q6ICK4 Q96DF2 Q9P2I3,[F-actin]-monooxygenase MICAL3,Molecule interacting with CasL protein 3;, PF00307;PF12130;PF01494;PF00412;, GO:0005938;GO:0042995;GO:0005829;GO:0090543;GO:0045171;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0003779;GO:0071949;GO:0046872;GO:0016709;GO:0031267;GO:0030042;GO:0007049;GO:0051301;GO:0007010;GO:0006887;, C:cell cortex; C:cell projection; C:cytosol; C:Flemming body; C:intercellular bridge; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle;, F:actin binding; F:FAD binding; F:metal ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:small GTPase binding;, P:actin filament depolymerization; P:cell cycle; P:cell division; P:cytoskeleton organization; P:exocytosis;|Q7RTP6 B2RXJ5 E9PEF0 O94909 Q5U4P4 Q6ICK4 Q96DF2 Q9P2I3,[F-actin]-monooxygenase MICAL3,Molecule interacting with CasL protein 3;, PF00307;PF12130;PF01494;PF00412;, GO:0005938;GO:0042995;GO:0005829;GO:0090543;GO:0045171;GO:0005654;GO:0005634;GO:0005886;GO:0005819;GO:0003779;GO:0071949;GO:0046872;GO:0016709;GO:0031267;GO:0030042;GO:0007049;GO:0051301;GO:0007010;GO:0006887;, C:cell cortex; C:cell projection; C:cytosol; C:Flemming body; C:intercellular bridge; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle;, F:actin binding; F:FAD binding; F:metal ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:small GTPase binding;, P:actin filament depolymerization; P:cell cycle; P:cell division; P:cytoskeleton organization; P:exocytosis;|P55957 Q549M7 Q71T04 Q7Z4M9 Q8IY86,BH3-interacting domain death agonist,p22 BID;, PF06393;, GO:0005829;GO:0032592;GO:0016020;GO:0005741;GO:0005739;GO:0005123;GO:0031625;GO:0006919;GO:0008637;GO:0090150;GO:0008625;GO:0097284;GO:0042775;GO:0097345;GO:0043066;GO:1902230;GO:0051402;GO:0043065;GO:2001238;GO:2000271;GO:2001244;GO:0010918;GO:1901030;GO:1900740;GO:0031334;GO:0090200;GO:0006626;GO:0065003;GO:0042981;GO:0042127;GO:2000045;GO:0001836;GO:0042770;, C:cytosol; C:integral component of mitochondrial membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:death receptor binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic mitochondrial changes; P:establishment of protein localization to membrane; P:extrinsic apoptotic signaling pathway via death domain receptors; P:hepatocyte apoptotic process; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial outer membrane permeabilization; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:neuron apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of fibroblast apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial membrane potential; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:protein targeting to mitochondrion; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of G1/S transition of mitotic cell cycle; P:release of cytochrome c from mitochondria; P:signal transduction in response to DNA damage;|P55957 Q549M7 Q71T04 Q7Z4M9 Q8IY86,BH3-interacting domain death agonist,p22 BID;, PF06393;, GO:0005829;GO:0032592;GO:0016020;GO:0005741;GO:0005739;GO:0005123;GO:0031625;GO:0006919;GO:0008637;GO:0090150;GO:0008625;GO:0097284;GO:0042775;GO:0097345;GO:0043066;GO:1902230;GO:0051402;GO:0043065;GO:2001238;GO:2000271;GO:2001244;GO:0010918;GO:1901030;GO:1900740;GO:0031334;GO:0090200;GO:0006626;GO:0065003;GO:0042981;GO:0042127;GO:2000045;GO:0001836;GO:0042770;, C:cytosol; C:integral component of mitochondrial membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:death receptor binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic mitochondrial changes; P:establishment of protein localization to membrane; P:extrinsic apoptotic signaling pathway via death domain receptors; P:hepatocyte apoptotic process; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial outer membrane permeabilization; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:neuron apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of fibroblast apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial membrane potential; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:protein targeting to mitochondrion; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of G1/S transition of mitotic cell cycle; P:release of cytochrome c from mitochondria; P:signal transduction in response to DNA damage;|P55957 Q549M7 Q71T04 Q7Z4M9 Q8IY86,BH3-interacting domain death agonist,p22 BID;, PF06393;, GO:0005829;GO:0032592;GO:0016020;GO:0005741;GO:0005739;GO:0005123;GO:0031625;GO:0006919;GO:0008637;GO:0090150;GO:0008625;GO:0097284;GO:0042775;GO:0097345;GO:0043066;GO:1902230;GO:0051402;GO:0043065;GO:2001238;GO:2000271;GO:2001244;GO:0010918;GO:1901030;GO:1900740;GO:0031334;GO:0090200;GO:0006626;GO:0065003;GO:0042981;GO:0042127;GO:2000045;GO:0001836;GO:0042770;, C:cytosol; C:integral component of mitochondrial membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:death receptor binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic mitochondrial changes; P:establishment of protein localization to membrane; P:extrinsic apoptotic signaling pathway via death domain receptors; P:hepatocyte apoptotic process; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial outer membrane permeabilization; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:neuron apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of fibroblast apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial membrane potential; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:protein targeting to mitochondrion; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of G1/S transition of mitotic cell cycle; P:release of cytochrome c from mitochondria; P:signal transduction in response to DNA damage;|P55957 Q549M7 Q71T04 Q7Z4M9 Q8IY86,BH3-interacting domain death agonist,p22 BID;, PF06393;, GO:0005829;GO:0032592;GO:0016020;GO:0005741;GO:0005739;GO:0005123;GO:0031625;GO:0006919;GO:0008637;GO:0090150;GO:0008625;GO:0097284;GO:0042775;GO:0097345;GO:0043066;GO:1902230;GO:0051402;GO:0043065;GO:2001238;GO:2000271;GO:2001244;GO:0010918;GO:1901030;GO:1900740;GO:0031334;GO:0090200;GO:0006626;GO:0065003;GO:0042981;GO:0042127;GO:2000045;GO:0001836;GO:0042770;, C:cytosol; C:integral component of mitochondrial membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:death receptor binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic mitochondrial changes; P:establishment of protein localization to membrane; P:extrinsic apoptotic signaling pathway via death domain receptors; P:hepatocyte apoptotic process; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial outer membrane permeabilization; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:neuron apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of fibroblast apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial membrane potential; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:protein targeting to mitochondrion; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cell population proliferation; P:regulation of G1/S transition of mitotic cell cycle; P:release of cytochrome c from mitochondria; P:signal transduction in response to DNA damage;|Q9BXK5 B3KPE7 Q96B37 Q96IB7 Q9BY01 Q9HC05 Q9UFE0 Q9UKN3,Bcl-2-like protein 13,Bcl-rambo;Protein Mil1;, PF00452;, GO:0016021;GO:0031966;GO:0005739;GO:0005634;GO:0008656;GO:0006919;GO:0006915;GO:0042981;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:cysteine-type endopeptidase activator activity involved in apoptotic process;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:regulation of apoptotic process;|Q9BXK5 B3KPE7 Q96B37 Q96IB7 Q9BY01 Q9HC05 Q9UFE0 Q9UKN3,Bcl-2-like protein 13,Bcl-rambo;Protein Mil1;, PF00452;, GO:0016021;GO:0031966;GO:0005739;GO:0005634;GO:0008656;GO:0006919;GO:0006915;GO:0042981;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:cysteine-type endopeptidase activator activity involved in apoptotic process;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:regulation of apoptotic process;|Q9BXK5 B3KPE7 Q96B37 Q96IB7 Q9BY01 Q9HC05 Q9UFE0 Q9UKN3,Bcl-2-like protein 13,Bcl-rambo;Protein Mil1;, PF00452;, GO:0016021;GO:0031966;GO:0005739;GO:0005634;GO:0008656;GO:0006919;GO:0006915;GO:0042981;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:cysteine-type endopeptidase activator activity involved in apoptotic process;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:regulation of apoptotic process;|Q96A05,V-type proton ATPase subunit E 2,Vacuolar proton pump subunit E 2;, PF01991;, GO:0001669;GO:0005829;GO:0033178;GO:0008553;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:0016241;GO:0033572;, C:acrosomal vesicle; C:cytosol; C:proton-transporting two-sector ATPase complex, catalytic domain;, F:proton-exporting ATPase activity, phosphorylative mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:regulation of macroautophagy; P:transferrin transport;|P36543 A8MUE4 A8MUN4,V-type proton ATPase subunit E 1,V-ATPase 31 kDa subunit;Vacuolar proton pump subunit E 1;, PF01991;, GO:0016324;GO:0005829;GO:0005768;GO:0070062;GO:0005765;GO:0005902;GO:0016469;GO:0033178;GO:0051117;GO:0016787;GO:0008553;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endosome; C:extracellular exosome; C:lysosomal membrane; C:microvillus; C:proton-transporting two-sector ATPase complex; C:proton-transporting two-sector ATPase complex, catalytic domain;, F:ATPase binding; F:hydrolase activity; F:proton-exporting ATPase activity, phosphorylative mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P36543 A8MUE4 A8MUN4,V-type proton ATPase subunit E 1,V-ATPase 31 kDa subunit;Vacuolar proton pump subunit E 1;, PF01991;, GO:0016324;GO:0005829;GO:0005768;GO:0070062;GO:0005765;GO:0005902;GO:0016469;GO:0033178;GO:0051117;GO:0016787;GO:0008553;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endosome; C:extracellular exosome; C:lysosomal membrane; C:microvillus; C:proton-transporting two-sector ATPase complex; C:proton-transporting two-sector ATPase complex, catalytic domain;, F:ATPase binding; F:hydrolase activity; F:proton-exporting ATPase activity, phosphorylative mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P36543 A8MUE4 A8MUN4,V-type proton ATPase subunit E 1,V-ATPase 31 kDa subunit;Vacuolar proton pump subunit E 1;, PF01991;, GO:0016324;GO:0005829;GO:0005768;GO:0070062;GO:0005765;GO:0005902;GO:0016469;GO:0033178;GO:0051117;GO:0016787;GO:0008553;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endosome; C:extracellular exosome; C:lysosomal membrane; C:microvillus; C:proton-transporting two-sector ATPase complex; C:proton-transporting two-sector ATPase complex, catalytic domain;, F:ATPase binding; F:hydrolase activity; F:proton-exporting ATPase activity, phosphorylative mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P36543 A8MUE4 A8MUN4,V-type proton ATPase subunit E 1,V-ATPase 31 kDa subunit;Vacuolar proton pump subunit E 1;, PF01991;, GO:0016324;GO:0005829;GO:0005768;GO:0070062;GO:0005765;GO:0005902;GO:0016469;GO:0033178;GO:0051117;GO:0016787;GO:0008553;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endosome; C:extracellular exosome; C:lysosomal membrane; C:microvillus; C:proton-transporting two-sector ATPase complex; C:proton-transporting two-sector ATPase complex, catalytic domain;, F:ATPase binding; F:hydrolase activity; F:proton-exporting ATPase activity, phosphorylative mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|Q9H1K4,Mitochondrial glutamate carrier 2,Glutamate/H(+) symporter 2;Solute carrier family 25 member 18;, PF00153;, GO:0016021;GO:0005743;GO:0015183;GO:0005313;GO:0015293;GO:0022857;GO:0015810;GO:0006811;GO:0015813;GO:0043490;, C:integral component of membrane; C:mitochondrial inner membrane;, F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:symporter activity; F:transmembrane transporter activity;, P:aspartate transmembrane transport; P:ion transport; P:L-glutamate transmembrane transport; P:malate-aspartate shuttle;|Q9BXF3 A8MS90 A8MX16 Q658Z4 Q96P58 Q9C0C3,Cat eye syndrome critical region protein 2,, PF00439;, GO:0090537;GO:0000791;GO:0005634;GO:0006309;GO:0043044;GO:0090102;GO:0007010;GO:0061640;GO:0097194;GO:0060122;GO:0001842;GO:0001843;GO:0007338;GO:0016192;, C:CERF complex; C:euchromatin; C:nucleus;, , P:apoptotic DNA fragmentation; P:ATP-dependent chromatin remodeling; P:cochlea development; P:cytoskeleton organization; P:cytoskeleton-dependent cytokinesis; P:execution phase of apoptosis; P:inner ear receptor cell stereocilium organization; P:neural fold formation; P:neural tube closure; P:single fertilization; P:vesicle-mediated transport;|Q9BXF3 A8MS90 A8MX16 Q658Z4 Q96P58 Q9C0C3,Cat eye syndrome critical region protein 2,, PF00439;, GO:0090537;GO:0000791;GO:0005634;GO:0006309;GO:0043044;GO:0090102;GO:0007010;GO:0061640;GO:0097194;GO:0060122;GO:0001842;GO:0001843;GO:0007338;GO:0016192;, C:CERF complex; C:euchromatin; C:nucleus;, , P:apoptotic DNA fragmentation; P:ATP-dependent chromatin remodeling; P:cochlea development; P:cytoskeleton organization; P:cytoskeleton-dependent cytokinesis; P:execution phase of apoptosis; P:inner ear receptor cell stereocilium organization; P:neural fold formation; P:neural tube closure; P:single fertilization; P:vesicle-mediated transport;|Q9BXF3 A8MS90 A8MX16 Q658Z4 Q96P58 Q9C0C3,Cat eye syndrome critical region protein 2,, PF00439;, GO:0090537;GO:0000791;GO:0005634;GO:0006309;GO:0043044;GO:0090102;GO:0007010;GO:0061640;GO:0097194;GO:0060122;GO:0001842;GO:0001843;GO:0007338;GO:0016192;, C:CERF complex; C:euchromatin; C:nucleus;, , P:apoptotic DNA fragmentation; P:ATP-dependent chromatin remodeling; P:cochlea development; P:cytoskeleton organization; P:cytoskeleton-dependent cytokinesis; P:execution phase of apoptosis; P:inner ear receptor cell stereocilium organization; P:neural fold formation; P:neural tube closure; P:single fertilization; P:vesicle-mediated transport;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9BXF3 A8MS90 A8MX16 Q658Z4 Q96P58 Q9C0C3,Cat eye syndrome critical region protein 2,, PF00439;, GO:0090537;GO:0000791;GO:0005634;GO:0006309;GO:0043044;GO:0090102;GO:0007010;GO:0061640;GO:0097194;GO:0060122;GO:0001842;GO:0001843;GO:0007338;GO:0016192;, C:CERF complex; C:euchromatin; C:nucleus;, , P:apoptotic DNA fragmentation; P:ATP-dependent chromatin remodeling; P:cochlea development; P:cytoskeleton organization; P:cytoskeleton-dependent cytokinesis; P:execution phase of apoptosis; P:inner ear receptor cell stereocilium organization; P:neural fold formation; P:neural tube closure; P:single fertilization; P:vesicle-mediated transport;|Q9BXF3 A8MS90 A8MX16 Q658Z4 Q96P58 Q9C0C3,Cat eye syndrome critical region protein 2,, PF00439;, GO:0090537;GO:0000791;GO:0005634;GO:0006309;GO:0043044;GO:0090102;GO:0007010;GO:0061640;GO:0097194;GO:0060122;GO:0001842;GO:0001843;GO:0007338;GO:0016192;, C:CERF complex; C:euchromatin; C:nucleus;, , P:apoptotic DNA fragmentation; P:ATP-dependent chromatin remodeling; P:cochlea development; P:cytoskeleton organization; P:cytoskeleton-dependent cytokinesis; P:execution phase of apoptosis; P:inner ear receptor cell stereocilium organization; P:neural fold formation; P:neural tube closure; P:single fertilization; P:vesicle-mediated transport;|Q9BXF3 A8MS90 A8MX16 Q658Z4 Q96P58 Q9C0C3,Cat eye syndrome critical region protein 2,, PF00439;, GO:0090537;GO:0000791;GO:0005634;GO:0006309;GO:0043044;GO:0090102;GO:0007010;GO:0061640;GO:0097194;GO:0060122;GO:0001842;GO:0001843;GO:0007338;GO:0016192;, C:CERF complex; C:euchromatin; C:nucleus;, , P:apoptotic DNA fragmentation; P:ATP-dependent chromatin remodeling; P:cochlea development; P:cytoskeleton organization; P:cytoskeleton-dependent cytokinesis; P:execution phase of apoptosis; P:inner ear receptor cell stereocilium organization; P:neural fold formation; P:neural tube closure; P:single fertilization; P:vesicle-mediated transport;|Q9BXF3 A8MS90 A8MX16 Q658Z4 Q96P58 Q9C0C3,Cat eye syndrome critical region protein 2,, PF00439;, GO:0090537;GO:0000791;GO:0005634;GO:0006309;GO:0043044;GO:0090102;GO:0007010;GO:0061640;GO:0097194;GO:0060122;GO:0001842;GO:0001843;GO:0007338;GO:0016192;, C:CERF complex; C:euchromatin; C:nucleus;, , P:apoptotic DNA fragmentation; P:ATP-dependent chromatin remodeling; P:cochlea development; P:cytoskeleton organization; P:cytoskeleton-dependent cytokinesis; P:execution phase of apoptosis; P:inner ear receptor cell stereocilium organization; P:neural fold formation; P:neural tube closure; P:single fertilization; P:vesicle-mediated transport;|Q9NZK5 A8K9H4 Q6ICF1 Q86UB6 Q8NCJ2 Q96K41,Adenosine deaminase 2 {ECO:0000312|HGNC:HGNC:1839},Cat eye syndrome critical region protein 1;, PF00962;PF08451;, GO:0035578;GO:0005576;GO:0005615;GO:0004000;GO:0031685;GO:0008083;GO:0008201;GO:0042803;GO:0043394;GO:0008270;GO:0006154;GO:0044267;GO:0046103;GO:0007275;GO:0043312;, C:azurophil granule lumen; C:extracellular region; C:extracellular space;, F:adenosine deaminase activity; F:adenosine receptor binding; F:growth factor activity; F:heparin binding; F:protein homodimerization activity; F:proteoglycan binding; F:zinc ion binding;, P:adenosine catabolic process; P:cellular protein metabolic process; P:inosine biosynthetic process; P:multicellular organism development; P:neutrophil degranulation;|Q9BXW7 B2RCK5 Q9BXW8 Q9NWA8 Q9NX41,Haloacid dehalogenase-like hydrolase domain-containing 5 {ECO:0000312|HGNC:HGNC:1843},Cat eye syndrome critical region protein 5 {ECO:0000305};, PF13344;, GO:0005739;GO:0046474;, C:mitochondrion;, , P:glycerophospholipid biosynthetic process;|Q9BXW7 B2RCK5 Q9BXW8 Q9NWA8 Q9NX41,Haloacid dehalogenase-like hydrolase domain-containing 5 {ECO:0000312|HGNC:HGNC:1843},Cat eye syndrome critical region protein 5 {ECO:0000305};, PF13344;, GO:0005739;GO:0046474;, C:mitochondrion;, , P:glycerophospholipid biosynthetic process;|Q96F46 O43844 Q20WK1,Interleukin-17 receptor A,CDw217;, PF16556;PF08357;, GO:0005576;GO:0005887;GO:0005886;GO:0030368;GO:0002250;GO:0007166;GO:0072537;GO:0006954;GO:0045087;GO:0097400;GO:2000340;GO:0032747;GO:0032755;, C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:interleukin-17 receptor activity;, P:adaptive immune response; P:cell surface receptor signaling pathway; P:fibroblast activation; P:inflammatory response; P:innate immune response; P:interleukin-17-mediated signaling pathway; P:positive regulation of chemokine (C-X-C motif) ligand 1 production; P:positive regulation of interleukin-23 production; P:positive regulation of interleukin-6 production;|Q96F46 O43844 Q20WK1,Interleukin-17 receptor A,CDw217;, PF16556;PF08357;, GO:0005576;GO:0005887;GO:0005886;GO:0030368;GO:0002250;GO:0007166;GO:0072537;GO:0006954;GO:0045087;GO:0097400;GO:2000340;GO:0032747;GO:0032755;, C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:interleukin-17 receptor activity;, P:adaptive immune response; P:cell surface receptor signaling pathway; P:fibroblast activation; P:inflammatory response; P:innate immune response; P:interleukin-17-mediated signaling pathway; P:positive regulation of chemokine (C-X-C motif) ligand 1 production; P:positive regulation of interleukin-23 production; P:positive regulation of interleukin-6 production;|Q99025 Q99241 Q99875,Voltage-dependent L-type calcium channel subunit alpha-1C,Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;Voltage-gated calcium channel subunit alpha Cav1.2;, PF08763;PF16885;PF16905;PF00520;, GO:0005737;GO:0030425;GO:0016021;GO:0005887;GO:1990454;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0005891;GO:0030018;GO:0051393;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0086056;GO:0086007;GO:0070509;GO:0070588;GO:0061577;GO:0006816;GO:0060402;GO:0035585;GO:0043010;GO:0061337;GO:0086002;GO:0086064;GO:0035115;GO:0007507;GO:0002520;GO:0098912;GO:0086045;GO:0086012;GO:0045762;GO:0007204;GO:0010881;GO:0086091;GO:0050796;GO:0098911;GO:0016032;, C:cytoplasm; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling using extracellular calcium source; P:camera-type eye development; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:embryonic forelimb morphogenesis; P:heart development; P:immune system development; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of ventricular cardiac muscle cell action potential; P:viral process;|Q99025 Q99241 Q99875,Voltage-dependent L-type calcium channel subunit alpha-1C,Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;Voltage-gated calcium channel subunit alpha Cav1.2;, PF08763;PF16885;PF16905;PF00520;, GO:0005737;GO:0030425;GO:0016021;GO:0005887;GO:1990454;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0005891;GO:0030018;GO:0051393;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0086056;GO:0086007;GO:0070509;GO:0070588;GO:0061577;GO:0006816;GO:0060402;GO:0035585;GO:0043010;GO:0061337;GO:0086002;GO:0086064;GO:0035115;GO:0007507;GO:0002520;GO:0098912;GO:0086045;GO:0086012;GO:0045762;GO:0007204;GO:0010881;GO:0086091;GO:0050796;GO:0098911;GO:0016032;, C:cytoplasm; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling using extracellular calcium source; P:camera-type eye development; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:embryonic forelimb morphogenesis; P:heart development; P:immune system development; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of ventricular cardiac muscle cell action potential; P:viral process;|Q99025 Q99241 Q99875,Voltage-dependent L-type calcium channel subunit alpha-1C,Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;Voltage-gated calcium channel subunit alpha Cav1.2;, PF08763;PF16885;PF16905;PF00520;, GO:0005737;GO:0030425;GO:0016021;GO:0005887;GO:1990454;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0005891;GO:0030018;GO:0051393;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0086056;GO:0086007;GO:0070509;GO:0070588;GO:0061577;GO:0006816;GO:0060402;GO:0035585;GO:0043010;GO:0061337;GO:0086002;GO:0086064;GO:0035115;GO:0007507;GO:0002520;GO:0098912;GO:0086045;GO:0086012;GO:0045762;GO:0007204;GO:0010881;GO:0086091;GO:0050796;GO:0098911;GO:0016032;, C:cytoplasm; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling using extracellular calcium source; P:camera-type eye development; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:embryonic forelimb morphogenesis; P:heart development; P:immune system development; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of ventricular cardiac muscle cell action potential; P:viral process;|Q99025 Q99241 Q99875,Voltage-dependent L-type calcium channel subunit alpha-1C,Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;Voltage-gated calcium channel subunit alpha Cav1.2;, PF08763;PF16885;PF16905;PF00520;, GO:0005737;GO:0030425;GO:0016021;GO:0005887;GO:1990454;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0005891;GO:0030018;GO:0051393;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0086056;GO:0086007;GO:0070509;GO:0070588;GO:0061577;GO:0006816;GO:0060402;GO:0035585;GO:0043010;GO:0061337;GO:0086002;GO:0086064;GO:0035115;GO:0007507;GO:0002520;GO:0098912;GO:0086045;GO:0086012;GO:0045762;GO:0007204;GO:0010881;GO:0086091;GO:0050796;GO:0098911;GO:0016032;, C:cytoplasm; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling using extracellular calcium source; P:camera-type eye development; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:embryonic forelimb morphogenesis; P:heart development; P:immune system development; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of ventricular cardiac muscle cell action potential; P:viral process;|Q99025 Q99241 Q99875,Voltage-dependent L-type calcium channel subunit alpha-1C,Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;Voltage-gated calcium channel subunit alpha Cav1.2;, PF08763;PF16885;PF16905;PF00520;, GO:0005737;GO:0030425;GO:0016021;GO:0005887;GO:1990454;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0005891;GO:0030018;GO:0051393;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0086056;GO:0086007;GO:0070509;GO:0070588;GO:0061577;GO:0006816;GO:0060402;GO:0035585;GO:0043010;GO:0061337;GO:0086002;GO:0086064;GO:0035115;GO:0007507;GO:0002520;GO:0098912;GO:0086045;GO:0086012;GO:0045762;GO:0007204;GO:0010881;GO:0086091;GO:0050796;GO:0098911;GO:0016032;, C:cytoplasm; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling using extracellular calcium source; P:camera-type eye development; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:embryonic forelimb morphogenesis; P:heart development; P:immune system development; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of ventricular cardiac muscle cell action potential; P:viral process;|Q99025 Q99241 Q99875,Voltage-dependent L-type calcium channel subunit alpha-1C,Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;Voltage-gated calcium channel subunit alpha Cav1.2;, PF08763;PF16885;PF16905;PF00520;, GO:0005737;GO:0030425;GO:0016021;GO:0005887;GO:1990454;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0005891;GO:0030018;GO:0051393;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0086056;GO:0086007;GO:0070509;GO:0070588;GO:0061577;GO:0006816;GO:0060402;GO:0035585;GO:0043010;GO:0061337;GO:0086002;GO:0086064;GO:0035115;GO:0007507;GO:0002520;GO:0098912;GO:0086045;GO:0086012;GO:0045762;GO:0007204;GO:0010881;GO:0086091;GO:0050796;GO:0098911;GO:0016032;, C:cytoplasm; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling using extracellular calcium source; P:camera-type eye development; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:embryonic forelimb morphogenesis; P:heart development; P:immune system development; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of ventricular cardiac muscle cell action potential; P:viral process;|Q99025 Q99241 Q99875,Voltage-dependent L-type calcium channel subunit alpha-1C,Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;Voltage-gated calcium channel subunit alpha Cav1.2;, PF08763;PF16885;PF16905;PF00520;, GO:0005737;GO:0030425;GO:0016021;GO:0005887;GO:1990454;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0005891;GO:0030018;GO:0051393;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0086056;GO:0086007;GO:0070509;GO:0070588;GO:0061577;GO:0006816;GO:0060402;GO:0035585;GO:0043010;GO:0061337;GO:0086002;GO:0086064;GO:0035115;GO:0007507;GO:0002520;GO:0098912;GO:0086045;GO:0086012;GO:0045762;GO:0007204;GO:0010881;GO:0086091;GO:0050796;GO:0098911;GO:0016032;, C:cytoplasm; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling using extracellular calcium source; P:camera-type eye development; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:embryonic forelimb morphogenesis; P:heart development; P:immune system development; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of ventricular cardiac muscle cell action potential; P:viral process;|Q99025 Q99241 Q99875,Voltage-dependent L-type calcium channel subunit alpha-1C,Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;Voltage-gated calcium channel subunit alpha Cav1.2;, PF08763;PF16885;PF16905;PF00520;, GO:0005737;GO:0030425;GO:0016021;GO:0005887;GO:1990454;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0005891;GO:0030018;GO:0051393;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0086056;GO:0086007;GO:0070509;GO:0070588;GO:0061577;GO:0006816;GO:0060402;GO:0035585;GO:0043010;GO:0061337;GO:0086002;GO:0086064;GO:0035115;GO:0007507;GO:0002520;GO:0098912;GO:0086045;GO:0086012;GO:0045762;GO:0007204;GO:0010881;GO:0086091;GO:0050796;GO:0098911;GO:0016032;, C:cytoplasm; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling using extracellular calcium source; P:camera-type eye development; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:embryonic forelimb morphogenesis; P:heart development; P:immune system development; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of ventricular cardiac muscle cell action potential; P:viral process;|Q01668 B0FYA3 Q13916 Q13931 Q71UT1 Q9UDC3,Voltage-dependent L-type calcium channel subunit alpha-1D,Calcium channel, L type, alpha-1 polypeptide, isoform 2;Voltage-gated calcium channel subunit alpha Cav1.3;, PF08763;PF16885;PF16905;PF00520;, GO:1990454;GO:0005886;GO:0005891;GO:0030018;GO:0051393;GO:0030506;GO:0005262;GO:0046872;GO:0005245;GO:0086007;GO:0086059;GO:0007188;GO:0070509;GO:0070588;GO:0006816;GO:0086002;GO:0086012;GO:0086046;GO:0045762;GO:0051928;GO:0060372;GO:0086091;GO:0050796;GO:1901379;GO:1901016;GO:0007605;, C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:ankyrin binding; F:calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; F:voltage-gated calcium channel activity involved SA node cell action potential;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cardiac muscle cell action potential involved in contraction; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during SA node cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion transport; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of potassium ion transmembrane transport; P:regulation of potassium ion transmembrane transporter activity; P:sensory perception of sound;|Q99025 Q99241 Q99875,Voltage-dependent L-type calcium channel subunit alpha-1C,Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;Voltage-gated calcium channel subunit alpha Cav1.2;, PF08763;PF16885;PF16905;PF00520;, GO:0005737;GO:0030425;GO:0016021;GO:0005887;GO:1990454;GO:0043204;GO:0005886;GO:0014069;GO:0098839;GO:0005891;GO:0030018;GO:0051393;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0086056;GO:0086007;GO:0070509;GO:0070588;GO:0061577;GO:0006816;GO:0060402;GO:0035585;GO:0043010;GO:0061337;GO:0086002;GO:0086064;GO:0035115;GO:0007507;GO:0002520;GO:0098912;GO:0086045;GO:0086012;GO:0045762;GO:0007204;GO:0010881;GO:0086091;GO:0050796;GO:0098911;GO:0016032;, C:cytoplasm; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:voltage-gated calcium channel complex; C:Z disc;, F:alpha-actinin binding; F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in AV node cell action potential; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transmembrane transport via high voltage-gated calcium channel; P:calcium ion transport; P:calcium ion transport into cytosol; P:calcium-mediated signaling using extracellular calcium source; P:camera-type eye development; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:embryonic forelimb morphogenesis; P:heart development; P:immune system development; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of adenylate cyclase activity; P:positive regulation of cytosolic calcium ion concentration; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of ventricular cardiac muscle cell action potential; P:viral process;|Q8IZD4 B4DRD1 Q86XH9 Q96BP8 Q96MZ8,mRNA-decapping enzyme 1B,, PF06058;PF16741;, GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0000932;GO:0008047;GO:0030234;GO:0016787;GO:0003729;GO:0000290;GO:0031087;GO:0043928;GO:0000184;GO:0043085;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:P-body;, F:enzyme activator activity; F:enzyme regulator activity; F:hydrolase activity; F:mRNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of catalytic activity;|Q8IZD4 B4DRD1 Q86XH9 Q96BP8 Q96MZ8,mRNA-decapping enzyme 1B,, PF06058;PF16741;, GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0000932;GO:0008047;GO:0030234;GO:0016787;GO:0003729;GO:0000290;GO:0031087;GO:0043928;GO:0000184;GO:0043085;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:P-body;, F:enzyme activator activity; F:enzyme regulator activity; F:hydrolase activity; F:mRNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of catalytic activity;|Q8IZD4 B4DRD1 Q86XH9 Q96BP8 Q96MZ8,mRNA-decapping enzyme 1B,, PF06058;PF16741;, GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0000932;GO:0008047;GO:0030234;GO:0016787;GO:0003729;GO:0000290;GO:0031087;GO:0043928;GO:0000184;GO:0043085;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:P-body;, F:enzyme activator activity; F:enzyme regulator activity; F:hydrolase activity; F:mRNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of catalytic activity;|Q8IZD4 B4DRD1 Q86XH9 Q96BP8 Q96MZ8,mRNA-decapping enzyme 1B,, PF06058;PF16741;, GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0000932;GO:0008047;GO:0030234;GO:0016787;GO:0003729;GO:0000290;GO:0031087;GO:0043928;GO:0000184;GO:0043085;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:P-body;, F:enzyme activator activity; F:enzyme regulator activity; F:hydrolase activity; F:mRNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of catalytic activity;|Q8IZD4 B4DRD1 Q86XH9 Q96BP8 Q96MZ8,mRNA-decapping enzyme 1B,, PF06058;PF16741;, GO:0005829;GO:0043231;GO:0016020;GO:0005634;GO:0000932;GO:0008047;GO:0030234;GO:0016787;GO:0003729;GO:0000290;GO:0031087;GO:0043928;GO:0000184;GO:0043085;, C:cytosol; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:P-body;, F:enzyme activator activity; F:enzyme regulator activity; F:hydrolase activity; F:mRNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of catalytic activity;|Q86V24 Q53YY5 Q9H737,Adiponectin receptor protein 2 {ECO:0000303|PubMed:25969726},Progestin and adipoQ receptor family member 2 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member II;, PF03006;, GO:0016021;GO:0031226;GO:0005886;GO:0097003;GO:0055100;GO:0046872;GO:0038023;GO:0033211;GO:0071398;GO:0019395;GO:0007565;GO:0042593;GO:0007507;GO:0009755;GO:0030308;GO:0010629;GO:0061871;GO:0120162;GO:0046326;GO:0001934;GO:0042304;GO:0014075;GO:0042493;GO:0045471;GO:0009750;GO:0032496;GO:0007584;GO:0061042;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:adipokinetic hormone receptor activity; F:adiponectin binding; F:metal ion binding; F:signaling receptor activity;, P:adiponectin-activated signaling pathway; P:cellular response to fatty acid; P:fatty acid oxidation; P:female pregnancy; P:glucose homeostasis; P:heart development; P:hormone-mediated signaling pathway; P:negative regulation of cell growth; P:negative regulation of gene expression; P:negative regulation of hepatic stellate cell migration; P:positive regulation of cold-induced thermogenesis; P:positive regulation of glucose import; P:positive regulation of protein phosphorylation; P:regulation of fatty acid biosynthetic process; P:response to amine; P:response to drug; P:response to ethanol; P:response to fructose; P:response to lipopolysaccharide; P:response to nutrient; P:vascular wound healing;|Q86V24 Q53YY5 Q9H737,Adiponectin receptor protein 2 {ECO:0000303|PubMed:25969726},Progestin and adipoQ receptor family member 2 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member II;, PF03006;, GO:0016021;GO:0031226;GO:0005886;GO:0097003;GO:0055100;GO:0046872;GO:0038023;GO:0033211;GO:0071398;GO:0019395;GO:0007565;GO:0042593;GO:0007507;GO:0009755;GO:0030308;GO:0010629;GO:0061871;GO:0120162;GO:0046326;GO:0001934;GO:0042304;GO:0014075;GO:0042493;GO:0045471;GO:0009750;GO:0032496;GO:0007584;GO:0061042;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:adipokinetic hormone receptor activity; F:adiponectin binding; F:metal ion binding; F:signaling receptor activity;, P:adiponectin-activated signaling pathway; P:cellular response to fatty acid; P:fatty acid oxidation; P:female pregnancy; P:glucose homeostasis; P:heart development; P:hormone-mediated signaling pathway; P:negative regulation of cell growth; P:negative regulation of gene expression; P:negative regulation of hepatic stellate cell migration; P:positive regulation of cold-induced thermogenesis; P:positive regulation of glucose import; P:positive regulation of protein phosphorylation; P:regulation of fatty acid biosynthetic process; P:response to amine; P:response to drug; P:response to ethanol; P:response to fructose; P:response to lipopolysaccharide; P:response to nutrient; P:vascular wound healing;|Q8NAS1 Q9NXN5 Q9UIK7 Q9UPS1,ELKS/Rab6-interacting/CAST family member 1,Rab6-interacting protein 2;, PF10174;PF09457;, GO:0005813;GO:0036064;GO:0005737;GO:0000139;GO:0008385;GO:0042734;GO:0045202;GO:0045296;GO:0043522;GO:0030165;GO:0031267;GO:0007252;GO:0007275;GO:0043066;GO:0051092;GO:0015031;GO:0006355;GO:0042147;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:Golgi membrane; C:IkappaB kinase complex; C:presynaptic membrane; C:synapse;, F:cadherin binding; F:leucine zipper domain binding; F:PDZ domain binding; F:small GTPase binding;, P:I-kappaB phosphorylation; P:multicellular organism development; P:negative regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:protein transport; P:regulation of transcription, DNA-templated; P:retrograde transport, endosome to Golgi;|Q8NAS1 Q9NXN5 Q9UIK7 Q9UPS1,ELKS/Rab6-interacting/CAST family member 1,Rab6-interacting protein 2;, PF10174;PF09457;, GO:0005813;GO:0036064;GO:0005737;GO:0000139;GO:0008385;GO:0042734;GO:0045202;GO:0045296;GO:0043522;GO:0030165;GO:0031267;GO:0007252;GO:0007275;GO:0043066;GO:0051092;GO:0015031;GO:0006355;GO:0042147;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:Golgi membrane; C:IkappaB kinase complex; C:presynaptic membrane; C:synapse;, F:cadherin binding; F:leucine zipper domain binding; F:PDZ domain binding; F:small GTPase binding;, P:I-kappaB phosphorylation; P:multicellular organism development; P:negative regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:protein transport; P:regulation of transcription, DNA-templated; P:retrograde transport, endosome to Golgi;|P43351 Q13205 Q9Y5T7 Q9Y5T8 Q9Y5T9,DNA repair protein RAD52 homolog,, PF04098;, GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0003677;GO:0042802;GO:0003697;GO:0006974;GO:0034599;GO:0010792;GO:0000730;GO:0006310;GO:0006302;GO:0000724;GO:0045002;GO:0006312;GO:2000819;, C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex;, F:DNA binding; F:identical protein binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:cellular response to oxidative stress; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA recombinase assembly; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via single-strand annealing; P:mitotic recombination; P:regulation of nucleotide-excision repair;|P43351 Q13205 Q9Y5T7 Q9Y5T8 Q9Y5T9,DNA repair protein RAD52 homolog,, PF04098;, GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0003677;GO:0042802;GO:0003697;GO:0006974;GO:0034599;GO:0010792;GO:0000730;GO:0006310;GO:0006302;GO:0000724;GO:0045002;GO:0006312;GO:2000819;, C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex;, F:DNA binding; F:identical protein binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:cellular response to oxidative stress; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA recombinase assembly; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via single-strand annealing; P:mitotic recombination; P:regulation of nucleotide-excision repair;|P43351 Q13205 Q9Y5T7 Q9Y5T8 Q9Y5T9,DNA repair protein RAD52 homolog,, PF04098;, GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0003677;GO:0042802;GO:0003697;GO:0006974;GO:0034599;GO:0010792;GO:0000730;GO:0006310;GO:0006302;GO:0000724;GO:0045002;GO:0006312;GO:2000819;, C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex;, F:DNA binding; F:identical protein binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:cellular response to oxidative stress; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA recombinase assembly; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via single-strand annealing; P:mitotic recombination; P:regulation of nucleotide-excision repair;|P43351 Q13205 Q9Y5T7 Q9Y5T8 Q9Y5T9,DNA repair protein RAD52 homolog,, PF04098;, GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0003677;GO:0042802;GO:0003697;GO:0006974;GO:0034599;GO:0010792;GO:0000730;GO:0006310;GO:0006302;GO:0000724;GO:0045002;GO:0006312;GO:2000819;, C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex;, F:DNA binding; F:identical protein binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:cellular response to oxidative stress; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA recombinase assembly; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via single-strand annealing; P:mitotic recombination; P:regulation of nucleotide-excision repair;|P43351 Q13205 Q9Y5T7 Q9Y5T8 Q9Y5T9,DNA repair protein RAD52 homolog,, PF04098;, GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0003677;GO:0042802;GO:0003697;GO:0006974;GO:0034599;GO:0010792;GO:0000730;GO:0006310;GO:0006302;GO:0000724;GO:0045002;GO:0006312;GO:2000819;, C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex;, F:DNA binding; F:identical protein binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:cellular response to oxidative stress; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA recombinase assembly; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via single-strand annealing; P:mitotic recombination; P:regulation of nucleotide-excision repair;|P43351 Q13205 Q9Y5T7 Q9Y5T8 Q9Y5T9,DNA repair protein RAD52 homolog,, PF04098;, GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0003677;GO:0042802;GO:0003697;GO:0006974;GO:0034599;GO:0010792;GO:0000730;GO:0006310;GO:0006302;GO:0000724;GO:0045002;GO:0006312;GO:2000819;, C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex;, F:DNA binding; F:identical protein binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:cellular response to oxidative stress; P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA recombinase assembly; P:DNA recombination; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via single-strand annealing; P:mitotic recombination; P:regulation of nucleotide-excision repair;|Q6IFS5 Q86WL5 Q8N673 Q96CZ6 Q9P1S9,Serine/threonine-protein kinase WNK1 {ECO:0000305},Erythrocyte 65 kDa protein;Kinase deficient protein;Protein kinase lysine-deficient 1 {ECO:0000312|HGNC:HGNC:14540};Protein kinase with no lysine 1 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0019869;GO:0019902;GO:0019870;GO:0030295;GO:0004672;GO:0019901;GO:0004860;GO:0106310;GO:0004674;GO:0106311;GO:1990869;GO:0038116;GO:0035556;GO:0050801;GO:0006811;GO:0097022;GO:0033633;GO:0034260;GO:0034115;GO:1903038;GO:0010923;GO:0010766;GO:0048666;GO:0018105;GO:0018107;GO:0090263;GO:1903288;GO:2000651;GO:0010820;GO:0006468;GO:1904062;GO:0050794;GO:0002028;GO:0007165;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:phosphatase binding; F:potassium channel inhibitor activity; F:protein kinase activator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:intracellular signal transduction; P:ion homeostasis; P:ion transport; P:lymphocyte migration into lymph node; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of GTPase activity; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of phosphatase activity; P:negative regulation of sodium ion transport; P:neuron development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of T cell chemotaxis; P:protein phosphorylation; P:regulation of cation transmembrane transport; P:regulation of cellular process; P:regulation of sodium ion transport; P:signal transduction; P:T cell receptor signaling pathway;|Q6IFS5 Q86WL5 Q8N673 Q96CZ6 Q9P1S9,Serine/threonine-protein kinase WNK1 {ECO:0000305},Erythrocyte 65 kDa protein;Kinase deficient protein;Protein kinase lysine-deficient 1 {ECO:0000312|HGNC:HGNC:14540};Protein kinase with no lysine 1 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0019869;GO:0019902;GO:0019870;GO:0030295;GO:0004672;GO:0019901;GO:0004860;GO:0106310;GO:0004674;GO:0106311;GO:1990869;GO:0038116;GO:0035556;GO:0050801;GO:0006811;GO:0097022;GO:0033633;GO:0034260;GO:0034115;GO:1903038;GO:0010923;GO:0010766;GO:0048666;GO:0018105;GO:0018107;GO:0090263;GO:1903288;GO:2000651;GO:0010820;GO:0006468;GO:1904062;GO:0050794;GO:0002028;GO:0007165;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:phosphatase binding; F:potassium channel inhibitor activity; F:protein kinase activator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:intracellular signal transduction; P:ion homeostasis; P:ion transport; P:lymphocyte migration into lymph node; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of GTPase activity; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of phosphatase activity; P:negative regulation of sodium ion transport; P:neuron development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of T cell chemotaxis; P:protein phosphorylation; P:regulation of cation transmembrane transport; P:regulation of cellular process; P:regulation of sodium ion transport; P:signal transduction; P:T cell receptor signaling pathway;|Q6IFS5 Q86WL5 Q8N673 Q96CZ6 Q9P1S9,Serine/threonine-protein kinase WNK1 {ECO:0000305},Erythrocyte 65 kDa protein;Kinase deficient protein;Protein kinase lysine-deficient 1 {ECO:0000312|HGNC:HGNC:14540};Protein kinase with no lysine 1 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0019869;GO:0019902;GO:0019870;GO:0030295;GO:0004672;GO:0019901;GO:0004860;GO:0106310;GO:0004674;GO:0106311;GO:1990869;GO:0038116;GO:0035556;GO:0050801;GO:0006811;GO:0097022;GO:0033633;GO:0034260;GO:0034115;GO:1903038;GO:0010923;GO:0010766;GO:0048666;GO:0018105;GO:0018107;GO:0090263;GO:1903288;GO:2000651;GO:0010820;GO:0006468;GO:1904062;GO:0050794;GO:0002028;GO:0007165;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:phosphatase binding; F:potassium channel inhibitor activity; F:protein kinase activator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:intracellular signal transduction; P:ion homeostasis; P:ion transport; P:lymphocyte migration into lymph node; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of GTPase activity; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of phosphatase activity; P:negative regulation of sodium ion transport; P:neuron development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of T cell chemotaxis; P:protein phosphorylation; P:regulation of cation transmembrane transport; P:regulation of cellular process; P:regulation of sodium ion transport; P:signal transduction; P:T cell receptor signaling pathway;|Q6IFS5 Q86WL5 Q8N673 Q96CZ6 Q9P1S9,Serine/threonine-protein kinase WNK1 {ECO:0000305},Erythrocyte 65 kDa protein;Kinase deficient protein;Protein kinase lysine-deficient 1 {ECO:0000312|HGNC:HGNC:14540};Protein kinase with no lysine 1 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0019869;GO:0019902;GO:0019870;GO:0030295;GO:0004672;GO:0019901;GO:0004860;GO:0106310;GO:0004674;GO:0106311;GO:1990869;GO:0038116;GO:0035556;GO:0050801;GO:0006811;GO:0097022;GO:0033633;GO:0034260;GO:0034115;GO:1903038;GO:0010923;GO:0010766;GO:0048666;GO:0018105;GO:0018107;GO:0090263;GO:1903288;GO:2000651;GO:0010820;GO:0006468;GO:1904062;GO:0050794;GO:0002028;GO:0007165;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:phosphatase binding; F:potassium channel inhibitor activity; F:protein kinase activator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:intracellular signal transduction; P:ion homeostasis; P:ion transport; P:lymphocyte migration into lymph node; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of GTPase activity; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of phosphatase activity; P:negative regulation of sodium ion transport; P:neuron development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of T cell chemotaxis; P:protein phosphorylation; P:regulation of cation transmembrane transport; P:regulation of cellular process; P:regulation of sodium ion transport; P:signal transduction; P:T cell receptor signaling pathway;|Q6IFS5 Q86WL5 Q8N673 Q96CZ6 Q9P1S9,Serine/threonine-protein kinase WNK1 {ECO:0000305},Erythrocyte 65 kDa protein;Kinase deficient protein;Protein kinase lysine-deficient 1 {ECO:0000312|HGNC:HGNC:14540};Protein kinase with no lysine 1 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0019869;GO:0019902;GO:0019870;GO:0030295;GO:0004672;GO:0019901;GO:0004860;GO:0106310;GO:0004674;GO:0106311;GO:1990869;GO:0038116;GO:0035556;GO:0050801;GO:0006811;GO:0097022;GO:0033633;GO:0034260;GO:0034115;GO:1903038;GO:0010923;GO:0010766;GO:0048666;GO:0018105;GO:0018107;GO:0090263;GO:1903288;GO:2000651;GO:0010820;GO:0006468;GO:1904062;GO:0050794;GO:0002028;GO:0007165;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:phosphatase binding; F:potassium channel inhibitor activity; F:protein kinase activator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:intracellular signal transduction; P:ion homeostasis; P:ion transport; P:lymphocyte migration into lymph node; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of GTPase activity; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of phosphatase activity; P:negative regulation of sodium ion transport; P:neuron development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of T cell chemotaxis; P:protein phosphorylation; P:regulation of cation transmembrane transport; P:regulation of cellular process; P:regulation of sodium ion transport; P:signal transduction; P:T cell receptor signaling pathway;|Q6IFS5 Q86WL5 Q8N673 Q96CZ6 Q9P1S9,Serine/threonine-protein kinase WNK1 {ECO:0000305},Erythrocyte 65 kDa protein;Kinase deficient protein;Protein kinase lysine-deficient 1 {ECO:0000312|HGNC:HGNC:14540};Protein kinase with no lysine 1 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0019869;GO:0019902;GO:0019870;GO:0030295;GO:0004672;GO:0019901;GO:0004860;GO:0106310;GO:0004674;GO:0106311;GO:1990869;GO:0038116;GO:0035556;GO:0050801;GO:0006811;GO:0097022;GO:0033633;GO:0034260;GO:0034115;GO:1903038;GO:0010923;GO:0010766;GO:0048666;GO:0018105;GO:0018107;GO:0090263;GO:1903288;GO:2000651;GO:0010820;GO:0006468;GO:1904062;GO:0050794;GO:0002028;GO:0007165;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:phosphatase binding; F:potassium channel inhibitor activity; F:protein kinase activator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:intracellular signal transduction; P:ion homeostasis; P:ion transport; P:lymphocyte migration into lymph node; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of GTPase activity; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of phosphatase activity; P:negative regulation of sodium ion transport; P:neuron development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of T cell chemotaxis; P:protein phosphorylation; P:regulation of cation transmembrane transport; P:regulation of cellular process; P:regulation of sodium ion transport; P:signal transduction; P:T cell receptor signaling pathway;|Q6IFS5 Q86WL5 Q8N673 Q96CZ6 Q9P1S9,Serine/threonine-protein kinase WNK1 {ECO:0000305},Erythrocyte 65 kDa protein;Kinase deficient protein;Protein kinase lysine-deficient 1 {ECO:0000312|HGNC:HGNC:14540};Protein kinase with no lysine 1 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0019869;GO:0019902;GO:0019870;GO:0030295;GO:0004672;GO:0019901;GO:0004860;GO:0106310;GO:0004674;GO:0106311;GO:1990869;GO:0038116;GO:0035556;GO:0050801;GO:0006811;GO:0097022;GO:0033633;GO:0034260;GO:0034115;GO:1903038;GO:0010923;GO:0010766;GO:0048666;GO:0018105;GO:0018107;GO:0090263;GO:1903288;GO:2000651;GO:0010820;GO:0006468;GO:1904062;GO:0050794;GO:0002028;GO:0007165;GO:0050852;, C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:chloride channel inhibitor activity; F:phosphatase binding; F:potassium channel inhibitor activity; F:protein kinase activator activity; F:protein kinase activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular response to chemokine; P:chemokine (C-C motif) ligand 21 signaling pathway; P:intracellular signal transduction; P:ion homeostasis; P:ion transport; P:lymphocyte migration into lymph node; P:negative regulation of cell-cell adhesion mediated by integrin; P:negative regulation of GTPase activity; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of phosphatase activity; P:negative regulation of sodium ion transport; P:neuron development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of T cell chemotaxis; P:protein phosphorylation; P:regulation of cation transmembrane transport; P:regulation of cellular process; P:regulation of sodium ion transport; P:signal transduction; P:T cell receptor signaling pathway;|Q9NZG7,Ninjurin-2,Nerve injury-induced protein 2;, PF04923;, GO:0005887;GO:0007155;GO:0007399;GO:0007158;GO:0042246;, C:integral component of plasma membrane;, , P:cell adhesion; P:nervous system development; P:neuron cell-cell adhesion; P:tissue regeneration;|Q6L9W6 Q6ZNC1 Q8N7T6,Beta-1,4-N-acetylgalactosaminyltransferase 3,Beta-1,4-N-acetylgalactosaminyltransferase III;N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2;, PF05679;PF07691;, GO:0005794;GO:0032580;GO:0016021;GO:0043231;GO:0008376;GO:0033842;, C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:acetylgalactosaminyltransferase activity; F:N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity;|Q9BR77 B4DDE8,Coiled-coil domain-containing protein 77,, , GO:0005813;GO:0016020;, C:centrosome; C:membrane;|Q9BR77 B4DDE8,Coiled-coil domain-containing protein 77,, , GO:0005813;GO:0016020;, C:centrosome; C:membrane;|P29375 A8MV76 Q4LE72 Q86XZ1,Lysine-specific demethylase 5A,Histone demethylase JARID1A;Jumonji/ARID domain-containing protein 1A;Retinoblastoma-binding protein 2;[histone H3]-trimethyl-L-lysine(4) demethylase 5A {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0035097;GO:0005730;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0042393;GO:0032452;GO:0034648;GO:0034647;GO:0035064;GO:0003713;GO:0000976;GO:0008270;GO:0006338;GO:0032922;GO:0034720;GO:0008584;GO:1901726;GO:0045893;GO:0051090;GO:0007283;, C:histone methyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:methylated histone binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:chromatin remodeling; P:circadian regulation of gene expression; P:histone H3-K4 demethylation; P:male gonad development; P:negative regulation of histone deacetylase activity; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-binding transcription factor activity; P:spermatogenesis;|P29375 A8MV76 Q4LE72 Q86XZ1,Lysine-specific demethylase 5A,Histone demethylase JARID1A;Jumonji/ARID domain-containing protein 1A;Retinoblastoma-binding protein 2;[histone H3]-trimethyl-L-lysine(4) demethylase 5A {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0035097;GO:0005730;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0042393;GO:0032452;GO:0034648;GO:0034647;GO:0035064;GO:0003713;GO:0000976;GO:0008270;GO:0006338;GO:0032922;GO:0034720;GO:0008584;GO:1901726;GO:0045893;GO:0051090;GO:0007283;, C:histone methyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:methylated histone binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:chromatin remodeling; P:circadian regulation of gene expression; P:histone H3-K4 demethylation; P:male gonad development; P:negative regulation of histone deacetylase activity; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-binding transcription factor activity; P:spermatogenesis;|P29375 A8MV76 Q4LE72 Q86XZ1,Lysine-specific demethylase 5A,Histone demethylase JARID1A;Jumonji/ARID domain-containing protein 1A;Retinoblastoma-binding protein 2;[histone H3]-trimethyl-L-lysine(4) demethylase 5A {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0035097;GO:0005730;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0042393;GO:0032452;GO:0034648;GO:0034647;GO:0035064;GO:0003713;GO:0000976;GO:0008270;GO:0006338;GO:0032922;GO:0034720;GO:0008584;GO:1901726;GO:0045893;GO:0051090;GO:0007283;, C:histone methyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:methylated histone binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:chromatin remodeling; P:circadian regulation of gene expression; P:histone H3-K4 demethylation; P:male gonad development; P:negative regulation of histone deacetylase activity; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-binding transcription factor activity; P:spermatogenesis;|P29375 A8MV76 Q4LE72 Q86XZ1,Lysine-specific demethylase 5A,Histone demethylase JARID1A;Jumonji/ARID domain-containing protein 1A;Retinoblastoma-binding protein 2;[histone H3]-trimethyl-L-lysine(4) demethylase 5A {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0035097;GO:0005730;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0042393;GO:0032452;GO:0034648;GO:0034647;GO:0035064;GO:0003713;GO:0000976;GO:0008270;GO:0006338;GO:0032922;GO:0034720;GO:0008584;GO:1901726;GO:0045893;GO:0051090;GO:0007283;, C:histone methyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:methylated histone binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:chromatin remodeling; P:circadian regulation of gene expression; P:histone H3-K4 demethylation; P:male gonad development; P:negative regulation of histone deacetylase activity; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-binding transcription factor activity; P:spermatogenesis;|P29375 A8MV76 Q4LE72 Q86XZ1,Lysine-specific demethylase 5A,Histone demethylase JARID1A;Jumonji/ARID domain-containing protein 1A;Retinoblastoma-binding protein 2;[histone H3]-trimethyl-L-lysine(4) demethylase 5A {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0035097;GO:0005730;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0042393;GO:0032452;GO:0034648;GO:0034647;GO:0035064;GO:0003713;GO:0000976;GO:0008270;GO:0006338;GO:0032922;GO:0034720;GO:0008584;GO:1901726;GO:0045893;GO:0051090;GO:0007283;, C:histone methyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:methylated histone binding; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:chromatin remodeling; P:circadian regulation of gene expression; P:histone H3-K4 demethylation; P:male gonad development; P:negative regulation of histone deacetylase activity; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-binding transcription factor activity; P:spermatogenesis;|Q9NSD5 B4DJL1 Q8TCC2 Q8WW56,Sodium- and chloride-dependent GABA transporter 2,Solute carrier family 6 member 13;, PF00209;, GO:0016323;GO:0070062;GO:0005887;GO:0043005;GO:0005886;GO:0015171;GO:0005308;GO:0015185;GO:0005332;GO:0008028;GO:0005368;GO:0089718;GO:0015881;GO:0051939;GO:0051936;GO:0015718;GO:0071705;GO:0010940;GO:0035725;GO:0015734;GO:0150104;, C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:creatine transmembrane transporter activity; F:gamma-aminobutyric acid transmembrane transporter activity; F:gamma-aminobutyric acid:sodium symporter activity; F:monocarboxylic acid transmembrane transporter activity; F:taurine transmembrane transporter activity;, P:amino acid import across plasma membrane; P:creatine transmembrane transport; P:gamma-aminobutyric acid import; P:gamma-aminobutyric acid reuptake; P:monocarboxylic acid transport; P:nitrogen compound transport; P:positive regulation of necrotic cell death; P:sodium ion transmembrane transport; P:taurine transport; P:transport across blood-brain barrier;|Q9NSD5 B4DJL1 Q8TCC2 Q8WW56,Sodium- and chloride-dependent GABA transporter 2,Solute carrier family 6 member 13;, PF00209;, GO:0016323;GO:0070062;GO:0005887;GO:0043005;GO:0005886;GO:0015171;GO:0005308;GO:0015185;GO:0005332;GO:0008028;GO:0005368;GO:0089718;GO:0015881;GO:0051939;GO:0051936;GO:0015718;GO:0071705;GO:0010940;GO:0035725;GO:0015734;GO:0150104;, C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:creatine transmembrane transporter activity; F:gamma-aminobutyric acid transmembrane transporter activity; F:gamma-aminobutyric acid:sodium symporter activity; F:monocarboxylic acid transmembrane transporter activity; F:taurine transmembrane transporter activity;, P:amino acid import across plasma membrane; P:creatine transmembrane transport; P:gamma-aminobutyric acid import; P:gamma-aminobutyric acid reuptake; P:monocarboxylic acid transport; P:nitrogen compound transport; P:positive regulation of necrotic cell death; P:sodium ion transmembrane transport; P:taurine transport; P:transport across blood-brain barrier;|Q9NSD5 B4DJL1 Q8TCC2 Q8WW56,Sodium- and chloride-dependent GABA transporter 2,Solute carrier family 6 member 13;, PF00209;, GO:0016323;GO:0070062;GO:0005887;GO:0043005;GO:0005886;GO:0015171;GO:0005308;GO:0015185;GO:0005332;GO:0008028;GO:0005368;GO:0089718;GO:0015881;GO:0051939;GO:0051936;GO:0015718;GO:0071705;GO:0010940;GO:0035725;GO:0015734;GO:0150104;, C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:creatine transmembrane transporter activity; F:gamma-aminobutyric acid transmembrane transporter activity; F:gamma-aminobutyric acid:sodium symporter activity; F:monocarboxylic acid transmembrane transporter activity; F:taurine transmembrane transporter activity;, P:amino acid import across plasma membrane; P:creatine transmembrane transport; P:gamma-aminobutyric acid import; P:gamma-aminobutyric acid reuptake; P:monocarboxylic acid transport; P:nitrogen compound transport; P:positive regulation of necrotic cell death; P:sodium ion transmembrane transport; P:taurine transport; P:transport across blood-brain barrier;|Q9NSD5 B4DJL1 Q8TCC2 Q8WW56,Sodium- and chloride-dependent GABA transporter 2,Solute carrier family 6 member 13;, PF00209;, GO:0016323;GO:0070062;GO:0005887;GO:0043005;GO:0005886;GO:0015171;GO:0005308;GO:0015185;GO:0005332;GO:0008028;GO:0005368;GO:0089718;GO:0015881;GO:0051939;GO:0051936;GO:0015718;GO:0071705;GO:0010940;GO:0035725;GO:0015734;GO:0150104;, C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:creatine transmembrane transporter activity; F:gamma-aminobutyric acid transmembrane transporter activity; F:gamma-aminobutyric acid:sodium symporter activity; F:monocarboxylic acid transmembrane transporter activity; F:taurine transmembrane transporter activity;, P:amino acid import across plasma membrane; P:creatine transmembrane transport; P:gamma-aminobutyric acid import; P:gamma-aminobutyric acid reuptake; P:monocarboxylic acid transport; P:nitrogen compound transport; P:positive regulation of necrotic cell death; P:sodium ion transmembrane transport; P:taurine transport; P:transport across blood-brain barrier;|P48065 A0AV52 B2R992 D3DUN8,Sodium- and chloride-dependent betaine transporter,BGT-1;Na(+)/Cl(-) betaine/GABA transporter;Solute carrier family 6 member 12;, PF00209;, GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0005332;GO:0008028;GO:0006865;GO:0051936;GO:0015718;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:gamma-aminobutyric acid:sodium symporter activity; F:monocarboxylic acid transmembrane transporter activity;, P:amino acid transport; P:gamma-aminobutyric acid reuptake; P:monocarboxylic acid transport; P:sodium ion transmembrane transport;|P48065 A0AV52 B2R992 D3DUN8,Sodium- and chloride-dependent betaine transporter,BGT-1;Na(+)/Cl(-) betaine/GABA transporter;Solute carrier family 6 member 12;, PF00209;, GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0005332;GO:0008028;GO:0006865;GO:0051936;GO:0015718;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:gamma-aminobutyric acid:sodium symporter activity; F:monocarboxylic acid transmembrane transporter activity;, P:amino acid transport; P:gamma-aminobutyric acid reuptake; P:monocarboxylic acid transport; P:sodium ion transmembrane transport;|P48065 A0AV52 B2R992 D3DUN8,Sodium- and chloride-dependent betaine transporter,BGT-1;Na(+)/Cl(-) betaine/GABA transporter;Solute carrier family 6 member 12;, PF00209;, GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0005332;GO:0008028;GO:0006865;GO:0051936;GO:0015718;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:gamma-aminobutyric acid:sodium symporter activity; F:monocarboxylic acid transmembrane transporter activity;, P:amino acid transport; P:gamma-aminobutyric acid reuptake; P:monocarboxylic acid transport; P:sodium ion transmembrane transport;|Q9UPP2 A6NIF2 A6NKV9 Q8TB43,IQ motif and SEC7 domain-containing protein 3,, PF16453;PF01369;, GO:0005829;GO:0005654;GO:0014069;GO:0005085;GO:0030036;GO:0032012;, C:cytosol; C:nucleoplasm; C:postsynaptic density;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:regulation of ARF protein signal transduction;|Q9UPP2 A6NIF2 A6NKV9 Q8TB43,IQ motif and SEC7 domain-containing protein 3,, PF16453;PF01369;, GO:0005829;GO:0005654;GO:0014069;GO:0005085;GO:0030036;GO:0032012;, C:cytosol; C:nucleoplasm; C:postsynaptic density;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:regulation of ARF protein signal transduction;|Q9UPP2 A6NIF2 A6NKV9 Q8TB43,IQ motif and SEC7 domain-containing protein 3,, PF16453;PF01369;, GO:0005829;GO:0005654;GO:0014069;GO:0005085;GO:0030036;GO:0032012;, C:cytosol; C:nucleoplasm; C:postsynaptic density;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:regulation of ARF protein signal transduction;|Q9UPP2 A6NIF2 A6NKV9 Q8TB43,IQ motif and SEC7 domain-containing protein 3,, PF16453;PF01369;, GO:0005829;GO:0005654;GO:0014069;GO:0005085;GO:0030036;GO:0032012;, C:cytosol; C:nucleoplasm; C:postsynaptic density;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:regulation of ARF protein signal transduction;|Q9UPP2 A6NIF2 A6NKV9 Q8TB43,IQ motif and SEC7 domain-containing protein 3,, PF16453;PF01369;, GO:0005829;GO:0005654;GO:0014069;GO:0005085;GO:0030036;GO:0032012;, C:cytosol; C:nucleoplasm; C:postsynaptic density;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:regulation of ARF protein signal transduction;|Q9UPP2 A6NIF2 A6NKV9 Q8TB43,IQ motif and SEC7 domain-containing protein 3,, PF16453;PF01369;, GO:0005829;GO:0005654;GO:0014069;GO:0005085;GO:0030036;GO:0032012;, C:cytosol; C:nucleoplasm; C:postsynaptic density;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:regulation of ARF protein signal transduction;|Q9NQA3 A6NGF1 Q8N305,WAS protein family homolog 6,Protein FAM39A;, PF11945;, GO:0005829;GO:0005769;GO:0031901;GO:0055037;GO:0055038;GO:0071203;GO:0003779;GO:0043014;GO:0034314;GO:0016197;GO:0042147;, C:cytosol; C:early endosome; C:early endosome membrane; C:recycling endosome; C:recycling endosome membrane; C:WASH complex;, F:actin binding; F:alpha-tubulin binding;, P:Arp2/3 complex-mediated actin nucleation; P:endosomal transport; P:retrograde transport, endosome to Golgi;|Q6VEQ5,WAS protein family homolog 2,CXYorf1-like protein on chromosome 2;Protein FAM39B;, PF11945;, GO:0005776;GO:0005814;GO:0005829;GO:0005769;GO:0031901;GO:0005770;GO:0055037;GO:0055038;GO:0071203;GO:0003779;GO:0043014;GO:0034314;GO:0016197;GO:0015031;GO:0042147;, C:autophagosome; C:centriole; C:cytosol; C:early endosome; C:early endosome membrane; C:late endosome; C:recycling endosome; C:recycling endosome membrane; C:WASH complex;, F:actin binding; F:alpha-tubulin binding;, P:Arp2/3 complex-mediated actin nucleation; P:endosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|C4AMC7,Putative WAS protein family homolog 3,Protein FAM39DP;, PF11945;, GO:0005776;GO:0005814;GO:0005829;GO:0005769;GO:0031901;GO:0030175;GO:0030027;GO:0055037;GO:0055038;GO:0071203;GO:0003779;GO:0043014;GO:0034314;GO:0045022;GO:0016197;GO:0007032;GO:0006622;GO:0042147;, C:autophagosome; C:centriole; C:cytosol; C:early endosome; C:early endosome membrane; C:filopodium; C:lamellipodium; C:recycling endosome; C:recycling endosome membrane; C:WASH complex;, F:actin binding; F:alpha-tubulin binding;, P:Arp2/3 complex-mediated actin nucleation; P:early endosome to late endosome transport; P:endosomal transport; P:endosome organization; P:protein targeting to lysosome; P:retrograde transport, endosome to Golgi;|A8MPP1,Putative ATP-dependent RNA helicase DDX11-like protein 8,DEAD/H box protein 11-like 8;, PF06733;PF13307;, GO:0005730;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0003723;GO:0003724;GO:0032508;GO:0034085;GO:0006139;, C:nucleolus; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:RNA binding; F:RNA helicase activity;, P:DNA duplex unwinding; P:establishment of sister chromatid cohesion; P:nucleobase-containing compound metabolic process;|Q92771,Putative ATP-dependent RNA helicase DDX12,CHL1-related protein 2;DEAD/H box protein 12;, PF06733;PF13307;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0003723;GO:0003724;GO:0032508;GO:0034085;GO:0006139;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:RNA binding; F:RNA helicase activity;, P:DNA duplex unwinding; P:establishment of sister chromatid cohesion; P:nucleobase-containing compound metabolic process;|Q92771,Putative ATP-dependent RNA helicase DDX12,CHL1-related protein 2;DEAD/H box protein 12;, PF06733;PF13307;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0003723;GO:0003724;GO:0032508;GO:0034085;GO:0006139;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:RNA binding; F:RNA helicase activity;, P:DNA duplex unwinding; P:establishment of sister chromatid cohesion; P:nucleobase-containing compound metabolic process;|Q92771,Putative ATP-dependent RNA helicase DDX12,CHL1-related protein 2;DEAD/H box protein 12;, PF06733;PF13307;, GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0003723;GO:0003724;GO:0032508;GO:0034085;GO:0006139;, C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:RNA binding; F:RNA helicase activity;, P:DNA duplex unwinding; P:establishment of sister chromatid cohesion; P:nucleobase-containing compound metabolic process;|A8MPP1,Putative ATP-dependent RNA helicase DDX11-like protein 8,DEAD/H box protein 11-like 8;, PF06733;PF13307;, GO:0005730;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0003723;GO:0003724;GO:0032508;GO:0034085;GO:0006139;, C:nucleolus; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:RNA binding; F:RNA helicase activity;, P:DNA duplex unwinding; P:establishment of sister chromatid cohesion; P:nucleobase-containing compound metabolic process;|A8MPP1,Putative ATP-dependent RNA helicase DDX11-like protein 8,DEAD/H box protein 11-like 8;, PF06733;PF13307;, GO:0005730;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0003723;GO:0003724;GO:0032508;GO:0034085;GO:0006139;, C:nucleolus; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:RNA binding; F:RNA helicase activity;, P:DNA duplex unwinding; P:establishment of sister chromatid cohesion; P:nucleobase-containing compound metabolic process;|A8MPP1,Putative ATP-dependent RNA helicase DDX11-like protein 8,DEAD/H box protein 11-like 8;, PF06733;PF13307;, GO:0005730;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0003723;GO:0003724;GO:0032508;GO:0034085;GO:0006139;, C:nucleolus; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:RNA binding; F:RNA helicase activity;, P:DNA duplex unwinding; P:establishment of sister chromatid cohesion; P:nucleobase-containing compound metabolic process;|A8MPP1,Putative ATP-dependent RNA helicase DDX11-like protein 8,DEAD/H box protein 11-like 8;, PF06733;PF13307;, GO:0005730;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0003723;GO:0003724;GO:0032508;GO:0034085;GO:0006139;, C:nucleolus; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:RNA binding; F:RNA helicase activity;, P:DNA duplex unwinding; P:establishment of sister chromatid cohesion; P:nucleobase-containing compound metabolic process;|Q02790 D3DUQ1 Q9UCP1 Q9UCV7,Peptidyl-prolyl cis-trans isomerase FKBP4,51 kDa FK506-binding protein;52 kDa FK506-binding protein;59 kDa immunophilin;FK506-binding protein 4;FKBP59;HSP-binding immunophilin;Immunophilin FKBP52;Rotamase;, PF00254;PF00515;PF07719;, GO:0044295;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005739;GO:0043025;GO:0005654;GO:0048471;GO:0032991;GO:0032767;GO:0005528;GO:0031072;GO:0003755;GO:0030674;GO:0003723;GO:0048156;GO:0061077;GO:0006825;GO:0031115;GO:0031111;GO:0010977;GO:0006457;GO:0000413;GO:1900034;, C:axonal growth cone; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:copper-dependent protein binding; F:FK506 binding; F:heat shock protein binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein-macromolecule adaptor activity; F:RNA binding; F:tau protein binding;, P:chaperone-mediated protein folding; P:copper ion transport; P:negative regulation of microtubule polymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of neuron projection development; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of cellular response to heat;|O75386 B3KNB7 B7Z6A2 D3DUQ4 F8WBZ9 Q8N5B0,Tubby-related protein 3 {ECO:0000305},Tubby-like protein 3;, PF01167;PF16322;, GO:0097731;GO:0005930;GO:0097546;GO:0005929;GO:0005576;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0019899;GO:0001664;GO:0120160;GO:0035091;GO:0005546;GO:0044877;GO:0009952;GO:0060348;GO:0007420;GO:0060434;GO:0021953;GO:0031076;GO:0042733;GO:0048702;GO:0007186;GO:0061548;GO:0045879;GO:1901621;GO:0021914;GO:0001843;GO:0061512;GO:0008277;GO:0006355;GO:0060831;, C:9+0 non-motile cilium; C:axoneme; C:ciliary base; C:cilium; C:extracellular region; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:enzyme binding; F:G protein-coupled receptor binding; F:intraciliary transport particle A binding; F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-containing complex binding;, P:anterior/posterior pattern specification; P:bone development; P:brain development; P:bronchus morphogenesis; P:central nervous system neuron differentiation; P:embryonic camera-type eye development; P:embryonic digit morphogenesis; P:embryonic neurocranium morphogenesis; P:G protein-coupled receptor signaling pathway; P:ganglion development; P:negative regulation of smoothened signaling pathway; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning; P:neural tube closure; P:protein localization to cilium; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of transcription, DNA-templated; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning;|O75386 B3KNB7 B7Z6A2 D3DUQ4 F8WBZ9 Q8N5B0,Tubby-related protein 3 {ECO:0000305},Tubby-like protein 3;, PF01167;PF16322;, GO:0097731;GO:0005930;GO:0097546;GO:0005929;GO:0005576;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0019899;GO:0001664;GO:0120160;GO:0035091;GO:0005546;GO:0044877;GO:0009952;GO:0060348;GO:0007420;GO:0060434;GO:0021953;GO:0031076;GO:0042733;GO:0048702;GO:0007186;GO:0061548;GO:0045879;GO:1901621;GO:0021914;GO:0001843;GO:0061512;GO:0008277;GO:0006355;GO:0060831;, C:9+0 non-motile cilium; C:axoneme; C:ciliary base; C:cilium; C:extracellular region; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:enzyme binding; F:G protein-coupled receptor binding; F:intraciliary transport particle A binding; F:phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-containing complex binding;, P:anterior/posterior pattern specification; P:bone development; P:brain development; P:bronchus morphogenesis; P:central nervous system neuron differentiation; P:embryonic camera-type eye development; P:embryonic digit morphogenesis; P:embryonic neurocranium morphogenesis; P:G protein-coupled receptor signaling pathway; P:ganglion development; P:negative regulation of smoothened signaling pathway; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning; P:neural tube closure; P:protein localization to cilium; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of transcription, DNA-templated; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; scaffold71 indexed_genome mRNA 6322729 6328552 . + . ID=transcript_11370;O75954 D3DUQ7 Q53FV2 Q6FGJ8,Tetraspanin-9,Tetraspan NET-5;, PF00335;, GO:0005925;GO:0005887;GO:0005886;GO:0097197;, C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:tetraspanin-enriched microdomain;|O75954 D3DUQ7 Q53FV2 Q6FGJ8,Tetraspanin-9,Tetraspan NET-5;, PF00335;, GO:0005925;GO:0005887;GO:0005886;GO:0097197;, C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:tetraspanin-enriched microdomain; scaffold71 indexed_genome mRNA 6334456 6369952 . - . ID=transcript_11371;A1L157 A1L158 B2RUX6,Tetraspanin-11,, PF00335;, GO:0005887;GO:0016477;, C:integral component of plasma membrane;, , P:cell migration; scaffold71 indexed_genome mRNA 6493943 6573275 . + . ID=transcript_11372;Q9NR22 B2RDP0 Q8TBJ8,Protein arginine N-methyltransferase 8 {ECO:0000305},Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 4;, , GO:0098753;GO:0005886;GO:0019899;GO:0008469;GO:0042802;GO:0042803;GO:0035242;GO:0035241;GO:1904047;GO:0008757;GO:0016571;GO:0018216;GO:0019919;GO:0051260;GO:0006479;GO:0043393;, C:anchored component of the cytoplasmic side of the plasma membrane; C:plasma membrane;, F:enzyme binding; F:histone-arginine N-methyltransferase activity; F:identical protein binding; F:protein homodimerization activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:S-adenosyl-L-methionine binding; F:S-adenosylmethionine-dependent methyltransferase activity;, P:histone methylation; P:peptidyl-arginine methylation; P:peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; P:protein homooligomerization; P:protein methylation; P:regulation of protein binding; scaffold71 indexed_genome mRNA 6593541 6623972 . - . ID=transcript_11373;Q9BSW2 B4E1X0 B9EK63,EF-hand calcium-binding domain-containing protein 4B,Calcium release-activated calcium channel regulator 2A;Calcium release-activated channel regulator 2A;Ras-related protein Rab-46 {ECO:0000303|PubMed:31092558};, PF13499;, GO:0005737;GO:0005856;GO:0005576;GO:0000139;GO:0001772;GO:0016020;GO:0005815;GO:0005886;GO:0035580;GO:0032588;GO:0031982;GO:0033093;GO:0005509;GO:0005525;GO:0003924;GO:0032237;GO:0002250;GO:0016197;GO:0043312;GO:0051928;GO:0046330;GO:0034776;GO:0002115;GO:0045063;, C:cytoplasm; C:cytoskeleton; C:extracellular region; C:Golgi membrane; C:immunological synapse; C:membrane; C:microtubule organizing center; C:plasma membrane; C:specific granule lumen; C:trans-Golgi network membrane; C:vesicle; C:Weibel-Palade body;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:activation of store-operated calcium channel activity; P:adaptive immune response; P:endosomal transport; P:neutrophil degranulation; P:positive regulation of calcium ion transport; P:positive regulation of JNK cascade; P:response to histamine; P:store-operated calcium entry; P:T-helper 1 cell differentiation; scaffold71 indexed_genome mRNA 6633045 6710925 . - . ID=transcript_11374;Q9BSW2 B4E1X0 B9EK63,EF-hand calcium-binding domain-containing protein 4B,Calcium release-activated calcium channel regulator 2A;Calcium release-activated channel regulator 2A;Ras-related protein Rab-46 {ECO:0000303|PubMed:31092558};, PF13499;, GO:0005737;GO:0005856;GO:0005576;GO:0000139;GO:0001772;GO:0016020;GO:0005815;GO:0005886;GO:0035580;GO:0032588;GO:0031982;GO:0033093;GO:0005509;GO:0005525;GO:0003924;GO:0032237;GO:0002250;GO:0016197;GO:0043312;GO:0051928;GO:0046330;GO:0034776;GO:0002115;GO:0045063;, C:cytoplasm; C:cytoskeleton; C:extracellular region; C:Golgi membrane; C:immunological synapse; C:membrane; C:microtubule organizing center; C:plasma membrane; C:specific granule lumen; C:trans-Golgi network membrane; C:vesicle; C:Weibel-Palade body;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:activation of store-operated calcium channel activity; P:adaptive immune response; P:endosomal transport; P:neutrophil degranulation; P:positive regulation of calcium ion transport; P:positive regulation of JNK cascade; P:response to histamine; P:store-operated calcium entry; P:T-helper 1 cell differentiation; scaffold71 indexed_genome mRNA 6745185 6747094 . + . ID=transcript_11375;Q9NR21 B4DRQ0 F8WBZ7 Q68DS1 Q8N5Y9,Protein mono-ADP-ribosyltransferase PARP11 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 11 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 11 {ECO:0000303|PubMed:20106667};, PF00644;PF02825;, GO:0005829;GO:0016604;GO:0005635;GO:0005643;GO:0005654;GO:0003950;GO:1990404;GO:0030154;GO:0051028;GO:0006998;GO:0070213;GO:0140289;GO:0015031;GO:0007283;, C:cytosol; C:nuclear body; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell differentiation; P:mRNA transport; P:nuclear envelope organization; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein transport; P:spermatogenesis; scaffold71 indexed_genome mRNA 6747678 6761980 . - . ID=transcript_11376;Q9NR21 B4DRQ0 F8WBZ7 Q68DS1 Q8N5Y9,Protein mono-ADP-ribosyltransferase PARP11 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 11 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 11 {ECO:0000303|PubMed:20106667};, PF00644;PF02825;, GO:0005829;GO:0016604;GO:0005635;GO:0005643;GO:0005654;GO:0003950;GO:1990404;GO:0030154;GO:0051028;GO:0006998;GO:0070213;GO:0140289;GO:0015031;GO:0007283;, C:cytosol; C:nuclear body; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell differentiation; P:mRNA transport; P:nuclear envelope organization; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein transport; P:spermatogenesis;|Q9NR21 B4DRQ0 F8WBZ7 Q68DS1 Q8N5Y9,Protein mono-ADP-ribosyltransferase PARP11 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 11 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 11 {ECO:0000303|PubMed:20106667};, PF00644;PF02825;, GO:0005829;GO:0016604;GO:0005635;GO:0005643;GO:0005654;GO:0003950;GO:1990404;GO:0030154;GO:0051028;GO:0006998;GO:0070213;GO:0140289;GO:0015031;GO:0007283;, C:cytosol; C:nuclear body; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell differentiation; P:mRNA transport; P:nuclear envelope organization; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein transport; P:spermatogenesis;|Q9NR21 B4DRQ0 F8WBZ7 Q68DS1 Q8N5Y9,Protein mono-ADP-ribosyltransferase PARP11 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 11 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 11 {ECO:0000303|PubMed:20106667};, PF00644;PF02825;, GO:0005829;GO:0016604;GO:0005635;GO:0005643;GO:0005654;GO:0003950;GO:1990404;GO:0030154;GO:0051028;GO:0006998;GO:0070213;GO:0140289;GO:0015031;GO:0007283;, C:cytosol; C:nuclear body; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell differentiation; P:mRNA transport; P:nuclear envelope organization; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein transport; P:spermatogenesis;|Q9NR21 B4DRQ0 F8WBZ7 Q68DS1 Q8N5Y9,Protein mono-ADP-ribosyltransferase PARP11 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 11 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 11 {ECO:0000303|PubMed:20106667};, PF00644;PF02825;, GO:0005829;GO:0016604;GO:0005635;GO:0005643;GO:0005654;GO:0003950;GO:1990404;GO:0030154;GO:0051028;GO:0006998;GO:0070213;GO:0140289;GO:0015031;GO:0007283;, C:cytosol; C:nuclear body; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell differentiation; P:mRNA transport; P:nuclear envelope organization; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein transport; P:spermatogenesis;|Q9NR21 B4DRQ0 F8WBZ7 Q68DS1 Q8N5Y9,Protein mono-ADP-ribosyltransferase PARP11 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 11 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 11 {ECO:0000303|PubMed:20106667};, PF00644;PF02825;, GO:0005829;GO:0016604;GO:0005635;GO:0005643;GO:0005654;GO:0003950;GO:1990404;GO:0030154;GO:0051028;GO:0006998;GO:0070213;GO:0140289;GO:0015031;GO:0007283;, C:cytosol; C:nuclear body; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell differentiation; P:mRNA transport; P:nuclear envelope organization; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein transport; P:spermatogenesis;|Q9NR21 B4DRQ0 F8WBZ7 Q68DS1 Q8N5Y9,Protein mono-ADP-ribosyltransferase PARP11 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 11 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 11 {ECO:0000303|PubMed:20106667};, PF00644;PF02825;, GO:0005829;GO:0016604;GO:0005635;GO:0005643;GO:0005654;GO:0003950;GO:1990404;GO:0030154;GO:0051028;GO:0006998;GO:0070213;GO:0140289;GO:0015031;GO:0007283;, C:cytosol; C:nuclear body; C:nuclear envelope; C:nuclear pore; C:nucleoplasm;, F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;, P:cell differentiation; P:mRNA transport; P:nuclear envelope organization; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein transport; P:spermatogenesis; scaffold71 indexed_genome mRNA 6967993 6969841 . + . ID=transcript_11377;P14927 E5RJU0 Q6FGD1,Cytochrome b-c1 complex subunit 7,Complex III subunit 7;Complex III subunit VII;QP-C;Ubiquinol-cytochrome c reductase complex 14 kDa protein;, PF02271;, GO:0005743;GO:0005746;GO:0005750;GO:0009060;GO:0006122;GO:0006119;, C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex III;, , P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; scaffold71 indexed_genome mRNA 7099766 7123636 . + . ID=transcript_11378;P30279 A8K531 Q13955 Q5U035,G1/S-specific cyclin-D2,, PF02984;PF00134;, GO:0000785;GO:0000307;GO:0005737;GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0044772;GO:0043066;GO:0008284;GO:0045737;GO:1900087;GO:0001934;GO:0000079;, C:chromatin; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:mitotic cell cycle phase transition; P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein phosphorylation; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|P30279 A8K531 Q13955 Q5U035,G1/S-specific cyclin-D2,, PF02984;PF00134;, GO:0000785;GO:0000307;GO:0005737;GO:0005829;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0044772;GO:0043066;GO:0008284;GO:0045737;GO:1900087;GO:0001934;GO:0000079;, C:chromatin; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:mitotic cell cycle phase transition; P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein phosphorylation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold71 indexed_genome mRNA 7144462 7154052 . + . ID=transcript_11379;Q9NQ88 B2R840,Fructose-2,6-bisphosphatase TIGAR {ECO:0000305},TP53-induced glycolysis and apoptosis regulator {ECO:0000303|PubMed:16839880};TP53-induced glycolysis regulatory phosphatase {ECO:0000312|HGNC:HGNC:1185};, PF00300;, GO:0005737;GO:0005829;GO:0005741;GO:0005634;GO:0004083;GO:0004331;GO:0006915;GO:0006914;GO:0071279;GO:0006974;GO:0071456;GO:0030388;GO:0006003;GO:0060576;GO:1904024;GO:0045820;GO:1901525;GO:1901215;GO:0043069;GO:2000378;GO:0010666;GO:0045739;GO:1903301;GO:0043456;GO:1902153;GO:0010332;GO:0002931;GO:0009410;, C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:nucleus;, F:bisphosphoglycerate 2-phosphatase activity; F:fructose-2,6-bisphosphate 2-phosphatase activity;, P:apoptotic process; P:autophagy; P:cellular response to cobalt ion; P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:fructose 1,6-bisphosphate metabolic process; P:fructose 2,6-bisphosphate metabolic process; P:intestinal epithelial cell development; P:negative regulation of glucose catabolic process to lactate via pyruvate; P:negative regulation of glycolytic process; P:negative regulation of mitophagy; P:negative regulation of neuron death; P:negative regulation of programmed cell death; P:negative regulation of reactive oxygen species metabolic process; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of DNA repair; P:positive regulation of hexokinase activity; P:regulation of pentose-phosphate shunt; P:regulation of response to DNA damage checkpoint signaling; P:response to gamma radiation; P:response to ischemia; P:response to xenobiotic stimulus;|Q9NQ88 B2R840,Fructose-2,6-bisphosphatase TIGAR {ECO:0000305},TP53-induced glycolysis and apoptosis regulator {ECO:0000303|PubMed:16839880};TP53-induced glycolysis regulatory phosphatase {ECO:0000312|HGNC:HGNC:1185};, PF00300;, GO:0005737;GO:0005829;GO:0005741;GO:0005634;GO:0004083;GO:0004331;GO:0006915;GO:0006914;GO:0071279;GO:0006974;GO:0071456;GO:0030388;GO:0006003;GO:0060576;GO:1904024;GO:0045820;GO:1901525;GO:1901215;GO:0043069;GO:2000378;GO:0010666;GO:0045739;GO:1903301;GO:0043456;GO:1902153;GO:0010332;GO:0002931;GO:0009410;, C:cytoplasm; C:cytosol; C:mitochondrial outer membrane; C:nucleus;, F:bisphosphoglycerate 2-phosphatase activity; F:fructose-2,6-bisphosphate 2-phosphatase activity;, P:apoptotic process; P:autophagy; P:cellular response to cobalt ion; P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:fructose 1,6-bisphosphate metabolic process; P:fructose 2,6-bisphosphate metabolic process; P:intestinal epithelial cell development; P:negative regulation of glucose catabolic process to lactate via pyruvate; P:negative regulation of glycolytic process; P:negative regulation of mitophagy; P:negative regulation of neuron death; P:negative regulation of programmed cell death; P:negative regulation of reactive oxygen species metabolic process; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of DNA repair; P:positive regulation of hexokinase activity; P:regulation of pentose-phosphate shunt; P:regulation of response to DNA damage checkpoint signaling; P:response to gamma radiation; P:response to ischemia; P:response to xenobiotic stimulus; scaffold71 indexed_genome mRNA 7161058 7163294 . + . ID=transcript_11380;Q9GZV9 Q4V758,Fibroblast growth factor 23,Phosphatonin;Tumor-derived hypophosphatemia-inducing factor;, PF00167;, GO:0005737;GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0005104;GO:0008083;GO:0005105;GO:0009887;GO:0030154;GO:0030643;GO:0044267;GO:0071354;GO:0044320;GO:0071374;GO:0071305;GO:0008543;GO:0000165;GO:0030502;GO:0046888;GO:0045668;GO:0055062;GO:0006796;GO:0008284;GO:0070374;GO:0010628;GO:0090080;GO:0051897;GO:0001934;GO:0045893;GO:0010980;GO:0043687;GO:0030334;GO:0010966;GO:0032026;GO:1904383;GO:0042369;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen;, F:fibroblast growth factor receptor binding; F:growth factor activity; F:type 1 fibroblast growth factor receptor binding;, P:animal organ morphogenesis; P:cell differentiation; P:cellular phosphate ion homeostasis; P:cellular protein metabolic process; P:cellular response to interleukin-6; P:cellular response to leptin stimulus; P:cellular response to parathyroid hormone stimulus; P:cellular response to vitamin D; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:negative regulation of bone mineralization; P:negative regulation of hormone secretion; P:negative regulation of osteoblast differentiation; P:phosphate ion homeostasis; P:phosphate-containing compound metabolic process; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:positive regulation of vitamin D 24-hydroxylase activity; P:post-translational protein modification; P:regulation of cell migration; P:regulation of phosphate transport; P:response to magnesium ion; P:response to sodium phosphate; P:vitamin D catabolic process;|Q9GZV9 Q4V758,Fibroblast growth factor 23,Phosphatonin;Tumor-derived hypophosphatemia-inducing factor;, PF00167;, GO:0005737;GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0005104;GO:0008083;GO:0005105;GO:0009887;GO:0030154;GO:0030643;GO:0044267;GO:0071354;GO:0044320;GO:0071374;GO:0071305;GO:0008543;GO:0000165;GO:0030502;GO:0046888;GO:0045668;GO:0055062;GO:0006796;GO:0008284;GO:0070374;GO:0010628;GO:0090080;GO:0051897;GO:0001934;GO:0045893;GO:0010980;GO:0043687;GO:0030334;GO:0010966;GO:0032026;GO:1904383;GO:0042369;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen;, F:fibroblast growth factor receptor binding; F:growth factor activity; F:type 1 fibroblast growth factor receptor binding;, P:animal organ morphogenesis; P:cell differentiation; P:cellular phosphate ion homeostasis; P:cellular protein metabolic process; P:cellular response to interleukin-6; P:cellular response to leptin stimulus; P:cellular response to parathyroid hormone stimulus; P:cellular response to vitamin D; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:negative regulation of bone mineralization; P:negative regulation of hormone secretion; P:negative regulation of osteoblast differentiation; P:phosphate ion homeostasis; P:phosphate-containing compound metabolic process; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:positive regulation of vitamin D 24-hydroxylase activity; P:post-translational protein modification; P:regulation of cell migration; P:regulation of phosphate transport; P:response to magnesium ion; P:response to sodium phosphate; P:vitamin D catabolic process; scaffold71 indexed_genome mRNA 7248777 7281431 . - . ID=transcript_11381;Q9NQ89 D3DUQ8 Q6MZH5,Protein C12orf4,, PF10154;, GO:0005737;GO:0043304;, C:cytoplasm;, , P:regulation of mast cell degranulation;|Q9NQ89 D3DUQ8 Q6MZH5,Protein C12orf4,, PF10154;, GO:0005737;GO:0043304;, C:cytoplasm;, , P:regulation of mast cell degranulation;|Q9NQ89 D3DUQ8 Q6MZH5,Protein C12orf4,, PF10154;, GO:0005737;GO:0043304;, C:cytoplasm;, , P:regulation of mast cell degranulation;|Q9NQ89 D3DUQ8 Q6MZH5,Protein C12orf4,, PF10154;, GO:0005737;GO:0043304;, C:cytoplasm;, , P:regulation of mast cell degranulation;|Q9NQ89 D3DUQ8 Q6MZH5,Protein C12orf4,, PF10154;, GO:0005737;GO:0043304;, C:cytoplasm;, , P:regulation of mast cell degranulation; scaffold71 indexed_genome mRNA 7301385 7302705 . - . ID=transcript_11382;Q96B01 A8K7D3 O43403 Q7Z779,RAD51-associated protein 1 {ECO:0000305},RAD51-interacting protein {ECO:0000303|PubMed:9396801};, PF15696;, GO:0000785;GO:0005694;GO:0000781;GO:0005654;GO:0005634;GO:0032991;GO:0062037;GO:0003677;GO:0000217;GO:0003690;GO:0003723;GO:0003697;GO:0006974;GO:0071479;GO:0006281;GO:0000724;GO:0036297;GO:0051321;GO:1905168;GO:0010845;GO:0010569;, C:chromatin; C:chromosome; C:chromosome, telomeric region; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:D-loop DNA binding; F:DNA binding; F:DNA secondary structure binding; F:double-stranded DNA binding; F:RNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:meiotic cell cycle; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of reciprocal meiotic recombination; P:regulation of double-strand break repair via homologous recombination; scaffold71 indexed_genome mRNA 7353248 7361119 . + . ID=transcript_11383;O75969 O75945 Q86X01 Q9UM61,A-kinase anchor protein 3,A-kinase anchor protein 110 kDa;Cancer/testis antigen 82;Fibrous sheath protein of 95 kDa;Fibrousheathin I;Fibrousheathin-1;Protein kinase A-anchoring protein 3;Sperm oocyte-binding protein;, PF05716;PF10522;, GO:0001669;GO:0005737;GO:0005634;GO:0035686;GO:0097225;GO:0097228;GO:0051018;GO:0007340;GO:0001835;GO:0008104;GO:0007338;GO:0007178;, C:acrosomal vesicle; C:cytoplasm; C:nucleus; C:sperm fibrous sheath; C:sperm midpiece; C:sperm principal piece;, F:protein kinase A binding;, P:acrosome reaction; P:blastocyst hatching; P:protein localization; P:single fertilization; P:transmembrane receptor protein serine/threonine kinase signaling pathway;|O75969 O75945 Q86X01 Q9UM61,A-kinase anchor protein 3,A-kinase anchor protein 110 kDa;Cancer/testis antigen 82;Fibrous sheath protein of 95 kDa;Fibrousheathin I;Fibrousheathin-1;Protein kinase A-anchoring protein 3;Sperm oocyte-binding protein;, PF05716;PF10522;, GO:0001669;GO:0005737;GO:0005634;GO:0035686;GO:0097225;GO:0097228;GO:0051018;GO:0007340;GO:0001835;GO:0008104;GO:0007338;GO:0007178;, C:acrosomal vesicle; C:cytoplasm; C:nucleus; C:sperm fibrous sheath; C:sperm midpiece; C:sperm principal piece;, F:protein kinase A binding;, P:acrosome reaction; P:blastocyst hatching; P:protein localization; P:single fertilization; P:transmembrane receptor protein serine/threonine kinase signaling pathway; scaffold71 indexed_genome mRNA 7361213 7361954 . + . ID=transcript_11384;O75969 O75945 Q86X01 Q9UM61,A-kinase anchor protein 3,A-kinase anchor protein 110 kDa;Cancer/testis antigen 82;Fibrous sheath protein of 95 kDa;Fibrousheathin I;Fibrousheathin-1;Protein kinase A-anchoring protein 3;Sperm oocyte-binding protein;, PF05716;PF10522;, GO:0001669;GO:0005737;GO:0005634;GO:0035686;GO:0097225;GO:0097228;GO:0051018;GO:0007340;GO:0001835;GO:0008104;GO:0007338;GO:0007178;, C:acrosomal vesicle; C:cytoplasm; C:nucleus; C:sperm fibrous sheath; C:sperm midpiece; C:sperm principal piece;, F:protein kinase A binding;, P:acrosome reaction; P:blastocyst hatching; P:protein localization; P:single fertilization; P:transmembrane receptor protein serine/threonine kinase signaling pathway; scaffold71 indexed_genome mRNA 7362623 7377161 . - . ID=transcript_11385;O75969 O75945 Q86X01 Q9UM61,A-kinase anchor protein 3,A-kinase anchor protein 110 kDa;Cancer/testis antigen 82;Fibrous sheath protein of 95 kDa;Fibrousheathin I;Fibrousheathin-1;Protein kinase A-anchoring protein 3;Sperm oocyte-binding protein;, PF05716;PF10522;, GO:0001669;GO:0005737;GO:0005634;GO:0035686;GO:0097225;GO:0097228;GO:0051018;GO:0007340;GO:0001835;GO:0008104;GO:0007338;GO:0007178;, C:acrosomal vesicle; C:cytoplasm; C:nucleus; C:sperm fibrous sheath; C:sperm midpiece; C:sperm principal piece;, F:protein kinase A binding;, P:acrosome reaction; P:blastocyst hatching; P:protein localization; P:single fertilization; P:transmembrane receptor protein serine/threonine kinase signaling pathway; scaffold71 indexed_genome mRNA 7377538 7398114 . + . ID=transcript_11386;Q16795 Q14076 Q2NKX0,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial,Complex I-39kD;NADH-ubiquinone oxidoreductase 39 kDa subunit;, PF01370;, GO:0005759;GO:0031966;GO:0005747;GO:0005739;GO:0005654;GO:0005634;GO:0008137;GO:0003954;GO:0044877;GO:0007623;GO:0006120;GO:0032981;GO:0009749;GO:0006814;GO:1901006;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity; F:protein-containing complex binding;, P:circadian rhythm; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to glucose; P:sodium ion transport; P:ubiquinone-6 biosynthetic process;|Q16795 Q14076 Q2NKX0,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial,Complex I-39kD;NADH-ubiquinone oxidoreductase 39 kDa subunit;, PF01370;, GO:0005759;GO:0031966;GO:0005747;GO:0005739;GO:0005654;GO:0005634;GO:0008137;GO:0003954;GO:0044877;GO:0007623;GO:0006120;GO:0032981;GO:0009749;GO:0006814;GO:1901006;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity; F:protein-containing complex binding;, P:circadian rhythm; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to glucose; P:sodium ion transport; P:ubiquinone-6 biosynthetic process;|Q16795 Q14076 Q2NKX0,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial,Complex I-39kD;NADH-ubiquinone oxidoreductase 39 kDa subunit;, PF01370;, GO:0005759;GO:0031966;GO:0005747;GO:0005739;GO:0005654;GO:0005634;GO:0008137;GO:0003954;GO:0044877;GO:0007623;GO:0006120;GO:0032981;GO:0009749;GO:0006814;GO:1901006;, C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity; F:protein-containing complex binding;, P:circadian rhythm; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to glucose; P:sodium ion transport; P:ubiquinone-6 biosynthetic process; scaffold71 indexed_genome mRNA 7494617 7497869 . - . ID=transcript_11387;P17658,Potassium voltage-gated channel subfamily A member 6,Voltage-gated potassium channel HBK2 {ECO:0000303|PubMed:2347305};Voltage-gated potassium channel subunit Kv1.6;, PF02214;PF00520;, GO:0043679;GO:0016021;GO:0005887;GO:0005886;GO:0034705;GO:0008076;GO:0005251;GO:0005249;GO:0071805;GO:0006813;GO:0051260;GO:0034765;, C:axon terminus; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:potassium channel complex; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:regulation of ion transmembrane transport; scaffold71 indexed_genome mRNA 7587228 7591042 . + . ID=transcript_11388;Q09470 A6NM83 Q3MIQ9,Potassium voltage-gated channel subfamily A member 1,Voltage-gated K(+) channel HuKI {ECO:0000303|PubMed:19912772};Voltage-gated potassium channel HBK1 {ECO:0000303|PubMed:2128063};Voltage-gated potassium channel subunit Kv1.1;, PF02214;PF00520;, GO:0016324;GO:0043679;GO:0044305;GO:0030054;GO:0009986;GO:0031410;GO:0005829;GO:0030425;GO:0005783;GO:0098978;GO:0016021;GO:0005887;GO:0099055;GO:0099056;GO:0044224;GO:0043025;GO:0033270;GO:0043204;GO:0005886;GO:0042734;GO:0045202;GO:0008076;GO:0005251;GO:0097718;GO:0005267;GO:0015079;GO:1905030;GO:0099508;GO:0005249;GO:0010644;GO:0034613;GO:0071286;GO:0007268;GO:0050966;GO:0050976;GO:0021766;GO:0010960;GO:0007405;GO:0050905;GO:0019228;GO:0023041;GO:1903818;GO:0071805;GO:0006813;GO:0051260;GO:0042391;GO:0006937;GO:0001964;, C:apical plasma membrane; C:axon terminus; C:calyx of Held; C:cell junction; C:cell surface; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:juxtaparanode region of axon; C:neuronal cell body; C:paranode region of axon; C:perikaryon; C:plasma membrane; C:presynaptic membrane; C:synapse; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:disordered domain specific binding; F:potassium channel activity; F:potassium ion transmembrane transporter activity; F:voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:voltage-gated ion channel activity involved in regulation of presynaptic membrane potential; F:voltage-gated potassium channel activity;, P:cell communication by electrical coupling; P:cellular protein localization; P:cellular response to magnesium ion; P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception of pain; P:detection of mechanical stimulus involved in sensory perception of touch; P:hippocampus development; P:magnesium ion homeostasis; P:neuroblast proliferation; P:neuromuscular process; P:neuronal action potential; P:neuronal signal transduction; P:positive regulation of voltage-gated potassium channel activity; P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:regulation of membrane potential; P:regulation of muscle contraction; P:startle response;|Q09470 A6NM83 Q3MIQ9,Potassium voltage-gated channel subfamily A member 1,Voltage-gated K(+) channel HuKI {ECO:0000303|PubMed:19912772};Voltage-gated potassium channel HBK1 {ECO:0000303|PubMed:2128063};Voltage-gated potassium channel subunit Kv1.1;, PF02214;PF00520;, GO:0016324;GO:0043679;GO:0044305;GO:0030054;GO:0009986;GO:0031410;GO:0005829;GO:0030425;GO:0005783;GO:0098978;GO:0016021;GO:0005887;GO:0099055;GO:0099056;GO:0044224;GO:0043025;GO:0033270;GO:0043204;GO:0005886;GO:0042734;GO:0045202;GO:0008076;GO:0005251;GO:0097718;GO:0005267;GO:0015079;GO:1905030;GO:0099508;GO:0005249;GO:0010644;GO:0034613;GO:0071286;GO:0007268;GO:0050966;GO:0050976;GO:0021766;GO:0010960;GO:0007405;GO:0050905;GO:0019228;GO:0023041;GO:1903818;GO:0071805;GO:0006813;GO:0051260;GO:0042391;GO:0006937;GO:0001964;, C:apical plasma membrane; C:axon terminus; C:calyx of Held; C:cell junction; C:cell surface; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:juxtaparanode region of axon; C:neuronal cell body; C:paranode region of axon; C:perikaryon; C:plasma membrane; C:presynaptic membrane; C:synapse; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:disordered domain specific binding; F:potassium channel activity; F:potassium ion transmembrane transporter activity; F:voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:voltage-gated ion channel activity involved in regulation of presynaptic membrane potential; F:voltage-gated potassium channel activity;, P:cell communication by electrical coupling; P:cellular protein localization; P:cellular response to magnesium ion; P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception of pain; P:detection of mechanical stimulus involved in sensory perception of touch; P:hippocampus development; P:magnesium ion homeostasis; P:neuroblast proliferation; P:neuromuscular process; P:neuronal action potential; P:neuronal signal transduction; P:positive regulation of voltage-gated potassium channel activity; P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:regulation of membrane potential; P:regulation of muscle contraction; P:startle response; scaffold71 indexed_genome mRNA 7597742 7598290 . + . ID=transcript_11389;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold71 indexed_genome mRNA 7681787 7687645 . + . ID=transcript_11390;Q9BW60 B4DP24 Q53HT2 Q5JUY3 Q8WXU3 Q9NVD9 Q9Y396,Elongation of very long chain fatty acids protein 1 {ECO:0000255|HAMAP-Rule:MF_03201, ECO:0000305},3-keto acyl-CoA synthase ELOVL1 {ECO:0000255|HAMAP-Rule:MF_03201};ELOVL fatty acid elongase 1 {ECO:0000255|HAMAP-Rule:MF_03201};Very long chain 3-ketoacyl-CoA synthase 1 {ECO:0000255|HAMAP-Rule:MF_03201};Very long chain 3-oxoacyl-CoA synthase 1 {ECO:0000255|HAMAP-Rule:MF_03201};, PF01151;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0036109;GO:0046513;GO:0061436;GO:0034625;GO:0034626;GO:0019367;GO:0043651;GO:0035338;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:alpha-linolenic acid metabolic process; P:ceramide biosynthetic process; P:establishment of skin barrier; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:linoleic acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9GZR5 B2R6B5 Q5TCS2 Q86YJ1 Q9H139,Elongation of very long chain fatty acids protein 4 {ECO:0000255|HAMAP-Rule:MF_03204, ECO:0000305},3-keto acyl-CoA synthase ELOVL4 {ECO:0000255|HAMAP-Rule:MF_03204};ELOVL fatty acid elongase 4 {ECO:0000255|HAMAP-Rule:MF_03204};Very long chain 3-ketoacyl-CoA synthase 4 {ECO:0000255|HAMAP-Rule:MF_03204};Very long chain 3-oxoacyl-CoA synthase 4 {ECO:0000255|HAMAP-Rule:MF_03204};, PF01151;, GO:0005783;GO:0030176;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0008020;GO:0102756;GO:0006633;GO:0034625;GO:0034626;GO:0019367;GO:0035338;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:G protein-coupled photoreceptor activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:fatty acid biosynthetic process; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold71 indexed_genome mRNA 7707806 7710735 . + . ID=transcript_11391;P22460 Q4KKT8 Q4VAJ1 Q4VAJ2 Q9UDA4,Potassium voltage-gated channel subfamily A member 5,HPCN1;Voltage-gated potassium channel HK2;Voltage-gated potassium channel subunit Kv1.5;, PF02214;PF00520;, GO:0009986;GO:0005783;GO:0005794;GO:0016021;GO:0005887;GO:0014704;GO:0046691;GO:0045121;GO:0048471;GO:0005886;GO:0034705;GO:0008076;GO:0030018;GO:0051393;GO:0005251;GO:0015271;GO:0019901;GO:0097110;GO:0005102;GO:0005249;GO:0086089;GO:0086087;GO:0086090;GO:0086014;GO:0060081;GO:0098914;GO:0086050;GO:0086052;GO:0051481;GO:0007219;GO:1900087;GO:2000288;GO:0097623;GO:0055075;GO:0071805;GO:0006813;GO:0051260;GO:0060372;GO:0086091;GO:0050796;GO:0042391;GO:0043266;GO:0019229;GO:0042542;GO:0055093;GO:0001666;GO:0009612;GO:0010033;, C:cell surface; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intercalated disc; C:intracellular canaliculus; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:potassium channel complex; C:voltage-gated potassium channel complex; C:Z disc;, F:alpha-actinin binding; F:delayed rectifier potassium channel activity; F:outward rectifier potassium channel activity; F:protein kinase binding; F:scaffold protein binding; F:signaling receptor binding; F:voltage-gated potassium channel activity; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; F:voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization; F:voltage-gated potassium channel activity involved in SA node cell action potential repolarization;, P:atrial cardiac muscle cell action potential; P:membrane hyperpolarization; P:membrane repolarization during atrial cardiac muscle cell action potential; P:membrane repolarization during bundle of His cell action potential; P:membrane repolarization during SA node cell action potential; P:negative regulation of cytosolic calcium ion concentration; P:Notch signaling pathway; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of myoblast proliferation; P:potassium ion export across plasma membrane; P:potassium ion homeostasis; P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of heart rate by cardiac conduction; P:regulation of insulin secretion; P:regulation of membrane potential; P:regulation of potassium ion transport; P:regulation of vasoconstriction; P:response to hydrogen peroxide; P:response to hyperoxia; P:response to hypoxia; P:response to mechanical stimulus; P:response to organic substance; scaffold71 indexed_genome mRNA 8078905 8080083 . - . ID=transcript_11392;P20783 B7Z1T5 Q6FH50,Neurotrophin-3,HDNF;Nerve growth factor 2;Neurotrophic factor;, PF00243;, GO:0030424;GO:0030425;GO:0005576;GO:0005615;GO:0008021;GO:0042056;GO:0008083;GO:0005163;GO:0005102;GO:0090630;GO:0000187;GO:0032148;GO:0007267;GO:0050930;GO:0007613;GO:0050804;GO:0043524;GO:0050732;GO:0021675;GO:0038180;GO:0007399;GO:0048812;GO:0007422;GO:2000251;GO:0030335;GO:0008284;GO:0051388;GO:0033138;GO:0050731;GO:0014068;GO:0010863;GO:0002092;GO:0042981;GO:0045664;GO:0007165;GO:0007169;, C:axon; C:dendrite; C:extracellular region; C:extracellular space; C:synaptic vesicle;, F:chemoattractant activity; F:growth factor activity; F:nerve growth factor receptor binding; F:signaling receptor binding;, P:activation of GTPase activity; P:activation of MAPK activity; P:activation of protein kinase B activity; P:cell-cell signaling; P:induction of positive chemotaxis; P:memory; P:modulation of chemical synaptic transmission; P:negative regulation of neuron apoptotic process; P:negative regulation of peptidyl-tyrosine phosphorylation; P:nerve development; P:nerve growth factor signaling pathway; P:nervous system development; P:neuron projection morphogenesis; P:peripheral nervous system development; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of receptor internalization; P:regulation of apoptotic process; P:regulation of neuron differentiation; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold71 indexed_genome mRNA 8130408 8368150 . - . ID=transcript_11393;Q9NQ90 C4N787 Q9H847,Anoctamin-2,Transmembrane protein 16B;, PF16178;PF04547;, GO:0034707;GO:0005654;GO:0005886;GO:0005254;GO:0005229;GO:0046983;GO:1902476;GO:0034220;GO:0055085;, C:chloride channel complex; C:nucleoplasm; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:protein dimerization activity;, P:chloride transmembrane transport; P:ion transmembrane transport; P:transmembrane transport; scaffold71 indexed_genome mRNA 8448929 8454734 . - . ID=transcript_11394;Q9NQ90 C4N787 Q9H847,Anoctamin-2,Transmembrane protein 16B;, PF16178;PF04547;, GO:0034707;GO:0005654;GO:0005886;GO:0005254;GO:0005229;GO:0046983;GO:1902476;GO:0034220;GO:0055085;, C:chloride channel complex; C:nucleoplasm; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:protein dimerization activity;, P:chloride transmembrane transport; P:ion transmembrane transport; P:transmembrane transport; scaffold71 indexed_genome mRNA 8464025 8592687 . - . ID=transcript_11395;P04275 Q8TCE8 Q99806,von Willebrand factor,, PF08742;PF01826;PF00092;PF16164;PF00093;PF00094;, GO:0062023;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031091;GO:0031093;GO:0033093;GO:0051087;GO:0005518;GO:0042802;GO:0019865;GO:0005178;GO:0002020;GO:0047485;GO:0007596;GO:0007597;GO:0007155;GO:0031589;GO:0030198;GO:0007599;GO:0030168;GO:0002576;GO:0009611;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet alpha granule; C:platelet alpha granule lumen; C:Weibel-Palade body;, F:chaperone binding; F:collagen binding; F:identical protein binding; F:immunoglobulin binding; F:integrin binding; F:protease binding; F:protein N-terminus binding;, P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell adhesion; P:cell-substrate adhesion; P:extracellular matrix organization; P:hemostasis; P:platelet activation; P:platelet degranulation; P:response to wounding;|P04275 Q8TCE8 Q99806,von Willebrand factor,, PF08742;PF01826;PF00092;PF16164;PF00093;PF00094;, GO:0062023;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031091;GO:0031093;GO:0033093;GO:0051087;GO:0005518;GO:0042802;GO:0019865;GO:0005178;GO:0002020;GO:0047485;GO:0007596;GO:0007597;GO:0007155;GO:0031589;GO:0030198;GO:0007599;GO:0030168;GO:0002576;GO:0009611;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet alpha granule; C:platelet alpha granule lumen; C:Weibel-Palade body;, F:chaperone binding; F:collagen binding; F:identical protein binding; F:immunoglobulin binding; F:integrin binding; F:protease binding; F:protein N-terminus binding;, P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell adhesion; P:cell-substrate adhesion; P:extracellular matrix organization; P:hemostasis; P:platelet activation; P:platelet degranulation; P:response to wounding;|P04275 Q8TCE8 Q99806,von Willebrand factor,, PF08742;PF01826;PF00092;PF16164;PF00093;PF00094;, GO:0062023;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031091;GO:0031093;GO:0033093;GO:0051087;GO:0005518;GO:0042802;GO:0019865;GO:0005178;GO:0002020;GO:0047485;GO:0007596;GO:0007597;GO:0007155;GO:0031589;GO:0030198;GO:0007599;GO:0030168;GO:0002576;GO:0009611;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet alpha granule; C:platelet alpha granule lumen; C:Weibel-Palade body;, F:chaperone binding; F:collagen binding; F:identical protein binding; F:immunoglobulin binding; F:integrin binding; F:protease binding; F:protein N-terminus binding;, P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell adhesion; P:cell-substrate adhesion; P:extracellular matrix organization; P:hemostasis; P:platelet activation; P:platelet degranulation; P:response to wounding;|P04275 Q8TCE8 Q99806,von Willebrand factor,, PF08742;PF01826;PF00092;PF16164;PF00093;PF00094;, GO:0062023;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031091;GO:0031093;GO:0033093;GO:0051087;GO:0005518;GO:0042802;GO:0019865;GO:0005178;GO:0002020;GO:0047485;GO:0007596;GO:0007597;GO:0007155;GO:0031589;GO:0030198;GO:0007599;GO:0030168;GO:0002576;GO:0009611;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet alpha granule; C:platelet alpha granule lumen; C:Weibel-Palade body;, F:chaperone binding; F:collagen binding; F:identical protein binding; F:immunoglobulin binding; F:integrin binding; F:protease binding; F:protein N-terminus binding;, P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell adhesion; P:cell-substrate adhesion; P:extracellular matrix organization; P:hemostasis; P:platelet activation; P:platelet degranulation; P:response to wounding;|P04275 Q8TCE8 Q99806,von Willebrand factor,, PF08742;PF01826;PF00092;PF16164;PF00093;PF00094;, GO:0062023;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031091;GO:0031093;GO:0033093;GO:0051087;GO:0005518;GO:0042802;GO:0019865;GO:0005178;GO:0002020;GO:0047485;GO:0007596;GO:0007597;GO:0007155;GO:0031589;GO:0030198;GO:0007599;GO:0030168;GO:0002576;GO:0009611;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet alpha granule; C:platelet alpha granule lumen; C:Weibel-Palade body;, F:chaperone binding; F:collagen binding; F:identical protein binding; F:immunoglobulin binding; F:integrin binding; F:protease binding; F:protein N-terminus binding;, P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell adhesion; P:cell-substrate adhesion; P:extracellular matrix organization; P:hemostasis; P:platelet activation; P:platelet degranulation; P:response to wounding; scaffold71 indexed_genome mRNA 8676521 8686111 . + . ID=transcript_11396;P21926 D3DUQ9 Q5J7W6 Q96ES4,CD9 antigen {ECO:0000303|PubMed:1840589},5H9 antigen;Cell growth-inhibiting gene 2 protein {ECO:0000303|Ref.6};Leukocyte antigen MIC3;Motility-related protein {ECO:0000303|PubMed:8478605};Tetraspanin-29;p24 {ECO:0000303|PubMed:2037603};, PF00335;, GO:0030669;GO:0030666;GO:0070062;GO:0005615;GO:1903561;GO:0005925;GO:0005887;GO:0016020;GO:0005886;GO:0031092;GO:0032991;GO:0005178;GO:0007155;GO:0071404;GO:0007342;GO:0008347;GO:0014905;GO:0051271;GO:0090331;GO:0030913;GO:0030168;GO:0002576;GO:0031623;GO:0035036;, C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:extracellular exosome; C:extracellular space; C:extracellular vesicle; C:focal adhesion; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:platelet alpha granule membrane; C:protein-containing complex;, F:integrin binding;, P:cell adhesion; P:cellular response to low-density lipoprotein particle stimulus; P:fusion of sperm to egg plasma membrane involved in single fertilization; P:glial cell migration; P:myoblast fusion involved in skeletal muscle regeneration; P:negative regulation of cellular component movement; P:negative regulation of platelet aggregation; P:paranodal junction assembly; P:platelet activation; P:platelet degranulation; P:receptor internalization; P:sperm-egg recognition; scaffold71 indexed_genome mRNA 8755935 8780678 . + . ID=transcript_11397;Q3KR16 Q3SWR1 Q8N1P1 Q8WYY1 Q9H8F4 Q9NVK9,Pleckstrin homology domain-containing family G member 6,Myosin-interacting guanine nucleotide exchange factor;, PF00621;, GO:0030054;GO:0005813;GO:0032154;GO:0005737;GO:0005902;GO:0000922;GO:0005096;GO:0005085;, C:cell junction; C:centrosome; C:cleavage furrow; C:cytoplasm; C:microvillus; C:spindle pole;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;|P19438 A8K4X3 B2RDE4 B3KPQ1 B4DQB7 B4E309 B5M0B5 D3DUR1 Q9UCA4,Tumor necrosis factor receptor superfamily member 1A,Tumor necrosis factor receptor 1;Tumor necrosis factor receptor type I;p55;p60;, PF00531;PF00020;, GO:0009986;GO:0005576;GO:0005615;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005739;GO:0005886;GO:0043235;GO:0002947;GO:0042802;GO:0043120;GO:0005031;GO:0003176;GO:0071260;GO:0019221;GO:0071550;GO:0042742;GO:0008625;GO:0007249;GO:0006954;GO:0008630;GO:0010614;GO:0003332;GO:0050728;GO:1902339;GO:2000304;GO:0043123;GO:0050729;GO:0045944;GO:0042531;GO:0006693;GO:0072659;GO:0003177;GO:1903140;GO:0010803;GO:0033209;GO:0016032;, C:cell surface; C:extracellular region; C:extracellular space; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:receptor complex; C:tumor necrosis factor receptor superfamily complex;, F:identical protein binding; F:tumor necrosis factor binding; F:tumor necrosis factor-activated receptor activity;, P:aortic valve development; P:cellular response to mechanical stimulus; P:cytokine-mediated signaling pathway; P:death-inducing signaling complex assembly; P:defense response to bacterium; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of extracellular matrix constituent secretion; P:negative regulation of inflammatory response; P:positive regulation of apoptotic process involved in morphogenesis; P:positive regulation of ceramide biosynthetic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:prostaglandin metabolic process; P:protein localization to plasma membrane; P:pulmonary valve development; P:regulation of establishment of endothelial barrier; P:regulation of tumor necrosis factor-mediated signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|P19438 A8K4X3 B2RDE4 B3KPQ1 B4DQB7 B4E309 B5M0B5 D3DUR1 Q9UCA4,Tumor necrosis factor receptor superfamily member 1A,Tumor necrosis factor receptor 1;Tumor necrosis factor receptor type I;p55;p60;, PF00531;PF00020;, GO:0009986;GO:0005576;GO:0005615;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005739;GO:0005886;GO:0043235;GO:0002947;GO:0042802;GO:0043120;GO:0005031;GO:0003176;GO:0071260;GO:0019221;GO:0071550;GO:0042742;GO:0008625;GO:0007249;GO:0006954;GO:0008630;GO:0010614;GO:0003332;GO:0050728;GO:1902339;GO:2000304;GO:0043123;GO:0050729;GO:0045944;GO:0042531;GO:0006693;GO:0072659;GO:0003177;GO:1903140;GO:0010803;GO:0033209;GO:0016032;, C:cell surface; C:extracellular region; C:extracellular space; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:receptor complex; C:tumor necrosis factor receptor superfamily complex;, F:identical protein binding; F:tumor necrosis factor binding; F:tumor necrosis factor-activated receptor activity;, P:aortic valve development; P:cellular response to mechanical stimulus; P:cytokine-mediated signaling pathway; P:death-inducing signaling complex assembly; P:defense response to bacterium; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of extracellular matrix constituent secretion; P:negative regulation of inflammatory response; P:positive regulation of apoptotic process involved in morphogenesis; P:positive regulation of ceramide biosynthetic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:prostaglandin metabolic process; P:protein localization to plasma membrane; P:pulmonary valve development; P:regulation of establishment of endothelial barrier; P:regulation of tumor necrosis factor-mediated signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|P19438 A8K4X3 B2RDE4 B3KPQ1 B4DQB7 B4E309 B5M0B5 D3DUR1 Q9UCA4,Tumor necrosis factor receptor superfamily member 1A,Tumor necrosis factor receptor 1;Tumor necrosis factor receptor type I;p55;p60;, PF00531;PF00020;, GO:0009986;GO:0005576;GO:0005615;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0005739;GO:0005886;GO:0043235;GO:0002947;GO:0042802;GO:0043120;GO:0005031;GO:0003176;GO:0071260;GO:0019221;GO:0071550;GO:0042742;GO:0008625;GO:0007249;GO:0006954;GO:0008630;GO:0010614;GO:0003332;GO:0050728;GO:1902339;GO:2000304;GO:0043123;GO:0050729;GO:0045944;GO:0042531;GO:0006693;GO:0072659;GO:0003177;GO:1903140;GO:0010803;GO:0033209;GO:0016032;, C:cell surface; C:extracellular region; C:extracellular space; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:mitochondrion; C:plasma membrane; C:receptor complex; C:tumor necrosis factor receptor superfamily complex;, F:identical protein binding; F:tumor necrosis factor binding; F:tumor necrosis factor-activated receptor activity;, P:aortic valve development; P:cellular response to mechanical stimulus; P:cytokine-mediated signaling pathway; P:death-inducing signaling complex assembly; P:defense response to bacterium; P:extrinsic apoptotic signaling pathway via death domain receptors; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of extracellular matrix constituent secretion; P:negative regulation of inflammatory response; P:positive regulation of apoptotic process involved in morphogenesis; P:positive regulation of ceramide biosynthetic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of inflammatory response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tyrosine phosphorylation of STAT protein; P:prostaglandin metabolic process; P:protein localization to plasma membrane; P:pulmonary valve development; P:regulation of establishment of endothelial barrier; P:regulation of tumor necrosis factor-mediated signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:viral process; scaffold71 indexed_genome mRNA 8784931 8809880 . - . ID=transcript_11398;P37088 A5X2U9 B4E2Q5 C5HTZ0 O43271 Q6GSQ6 Q9UM64,Amiloride-sensitive sodium channel subunit alpha,Alpha-NaCH;Epithelial Na(+) channel subunit alpha;Nonvoltage-gated sodium channel 1 subunit alpha;SCNEA;, PF00858;, GO:0001669;GO:0016324;GO:0060170;GO:0005737;GO:0070062;GO:0005887;GO:0031514;GO:0005886;GO:0034706;GO:0097228;GO:0015280;GO:0050699;GO:0034220;GO:0050891;GO:0050896;GO:0050909;GO:0055078;GO:0035725;, C:acrosomal vesicle; C:apical plasma membrane; C:ciliary membrane; C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:motile cilium; C:plasma membrane; C:sodium channel complex; C:sperm principal piece;, F:ligand-gated sodium channel activity; F:WW domain binding;, P:ion transmembrane transport; P:multicellular organismal water homeostasis; P:response to stimulus; P:sensory perception of taste; P:sodium ion homeostasis; P:sodium ion transmembrane transport;|P37088 A5X2U9 B4E2Q5 C5HTZ0 O43271 Q6GSQ6 Q9UM64,Amiloride-sensitive sodium channel subunit alpha,Alpha-NaCH;Epithelial Na(+) channel subunit alpha;Nonvoltage-gated sodium channel 1 subunit alpha;SCNEA;, PF00858;, GO:0001669;GO:0016324;GO:0060170;GO:0005737;GO:0070062;GO:0005887;GO:0031514;GO:0005886;GO:0034706;GO:0097228;GO:0015280;GO:0050699;GO:0034220;GO:0050891;GO:0050896;GO:0050909;GO:0055078;GO:0035725;, C:acrosomal vesicle; C:apical plasma membrane; C:ciliary membrane; C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:motile cilium; C:plasma membrane; C:sodium channel complex; C:sperm principal piece;, F:ligand-gated sodium channel activity; F:WW domain binding;, P:ion transmembrane transport; P:multicellular organismal water homeostasis; P:response to stimulus; P:sensory perception of taste; P:sodium ion homeostasis; P:sodium ion transmembrane transport;|P37088 A5X2U9 B4E2Q5 C5HTZ0 O43271 Q6GSQ6 Q9UM64,Amiloride-sensitive sodium channel subunit alpha,Alpha-NaCH;Epithelial Na(+) channel subunit alpha;Nonvoltage-gated sodium channel 1 subunit alpha;SCNEA;, PF00858;, GO:0001669;GO:0016324;GO:0060170;GO:0005737;GO:0070062;GO:0005887;GO:0031514;GO:0005886;GO:0034706;GO:0097228;GO:0015280;GO:0050699;GO:0034220;GO:0050891;GO:0050896;GO:0050909;GO:0055078;GO:0035725;, C:acrosomal vesicle; C:apical plasma membrane; C:ciliary membrane; C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:motile cilium; C:plasma membrane; C:sodium channel complex; C:sperm principal piece;, F:ligand-gated sodium channel activity; F:WW domain binding;, P:ion transmembrane transport; P:multicellular organismal water homeostasis; P:response to stimulus; P:sensory perception of taste; P:sodium ion homeostasis; P:sodium ion transmembrane transport;|P37088 A5X2U9 B4E2Q5 C5HTZ0 O43271 Q6GSQ6 Q9UM64,Amiloride-sensitive sodium channel subunit alpha,Alpha-NaCH;Epithelial Na(+) channel subunit alpha;Nonvoltage-gated sodium channel 1 subunit alpha;SCNEA;, PF00858;, GO:0001669;GO:0016324;GO:0060170;GO:0005737;GO:0070062;GO:0005887;GO:0031514;GO:0005886;GO:0034706;GO:0097228;GO:0015280;GO:0050699;GO:0034220;GO:0050891;GO:0050896;GO:0050909;GO:0055078;GO:0035725;, C:acrosomal vesicle; C:apical plasma membrane; C:ciliary membrane; C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:motile cilium; C:plasma membrane; C:sodium channel complex; C:sperm principal piece;, F:ligand-gated sodium channel activity; F:WW domain binding;, P:ion transmembrane transport; P:multicellular organismal water homeostasis; P:response to stimulus; P:sensory perception of taste; P:sodium ion homeostasis; P:sodium ion transmembrane transport; scaffold71 indexed_genome mRNA 8810789 8827175 . + . ID=transcript_11399;P36941 B7Z1D2 D3DUR2 F5GXE7,Tumor necrosis factor receptor superfamily member 3,Lymphotoxin-beta receptor;Tumor necrosis factor C receptor;Tumor necrosis factor receptor 2-related protein;Tumor necrosis factor receptor type III;, PF00020;, GO:0005794;GO:0016021;GO:0005886;GO:0042802;GO:0031625;GO:0006915;GO:0071260;GO:0006955;GO:0043011;GO:2001238;GO:0043123;GO:0046330;GO:0007165;GO:0033209;GO:0016032;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cellular response to mechanical stimulus; P:immune response; P:myeloid dendritic cell differentiation; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of JNK cascade; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|P36941 B7Z1D2 D3DUR2 F5GXE7,Tumor necrosis factor receptor superfamily member 3,Lymphotoxin-beta receptor;Tumor necrosis factor C receptor;Tumor necrosis factor receptor 2-related protein;Tumor necrosis factor receptor type III;, PF00020;, GO:0005794;GO:0016021;GO:0005886;GO:0042802;GO:0031625;GO:0006915;GO:0071260;GO:0006955;GO:0043011;GO:2001238;GO:0043123;GO:0046330;GO:0007165;GO:0033209;GO:0016032;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cellular response to mechanical stimulus; P:immune response; P:myeloid dendritic cell differentiation; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of JNK cascade; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|P36941 B7Z1D2 D3DUR2 F5GXE7,Tumor necrosis factor receptor superfamily member 3,Lymphotoxin-beta receptor;Tumor necrosis factor C receptor;Tumor necrosis factor receptor 2-related protein;Tumor necrosis factor receptor type III;, PF00020;, GO:0005794;GO:0016021;GO:0005886;GO:0042802;GO:0031625;GO:0006915;GO:0071260;GO:0006955;GO:0043011;GO:2001238;GO:0043123;GO:0046330;GO:0007165;GO:0033209;GO:0016032;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cellular response to mechanical stimulus; P:immune response; P:myeloid dendritic cell differentiation; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of JNK cascade; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|P36941 B7Z1D2 D3DUR2 F5GXE7,Tumor necrosis factor receptor superfamily member 3,Lymphotoxin-beta receptor;Tumor necrosis factor C receptor;Tumor necrosis factor receptor 2-related protein;Tumor necrosis factor receptor type III;, PF00020;, GO:0005794;GO:0016021;GO:0005886;GO:0042802;GO:0031625;GO:0006915;GO:0071260;GO:0006955;GO:0043011;GO:2001238;GO:0043123;GO:0046330;GO:0007165;GO:0033209;GO:0016032;, C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cellular response to mechanical stimulus; P:immune response; P:myeloid dendritic cell differentiation; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of JNK cascade; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; P:viral process; scaffold71 indexed_genome mRNA 8862773 8870021 . + . ID=transcript_11400;P26842 B2RDZ0,CD27 antigen,CD27L receptor;T-cell activation antigen CD27;T14;Tumor necrosis factor receptor superfamily member 7;, PF00020;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043027;GO:0004888;GO:0007166;GO:0097191;GO:0016064;GO:0043066;GO:0070233;GO:0045579;GO:0046330;GO:1901224;GO:0045582;GO:0045471;GO:0033209;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:extrinsic apoptotic signaling pathway; P:immunoglobulin mediated immune response; P:negative regulation of apoptotic process; P:negative regulation of T cell apoptotic process; P:positive regulation of B cell differentiation; P:positive regulation of JNK cascade; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of T cell differentiation; P:response to ethanol; P:tumor necrosis factor-mediated signaling pathway; scaffold71 indexed_genome mRNA 8870322 8885981 . + . ID=transcript_11401;Q9BX59 Q9NWB8,Tapasin-related protein,TAP-binding protein-like;TAP-binding protein-related protein;Tapasin-like;, PF07654;PF07686;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005886;GO:0023024;GO:0002590;GO:0002502;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:MHC class I protein complex binding;, P:negative regulation of antigen processing and presentation of peptide antigen via MHC class I; P:peptide antigen assembly with MHC class I protein complex;|Q9BX59 Q9NWB8,Tapasin-related protein,TAP-binding protein-like;TAP-binding protein-related protein;Tapasin-like;, PF07654;PF07686;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005886;GO:0023024;GO:0002590;GO:0002502;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:MHC class I protein complex binding;, P:negative regulation of antigen processing and presentation of peptide antigen via MHC class I; P:peptide antigen assembly with MHC class I protein complex;|P23763 A8MVP3 D3DUR3 O75468 Q15857 Q6FG94 Q8IVC9,Vesicle-associated membrane protein 1,Synaptobrevin-1;, PF00957;, GO:0005829;GO:0005887;GO:0030285;GO:0005741;GO:0043005;GO:0005886;GO:0031201;GO:0035579;GO:0030672;GO:0070821;GO:0005484;GO:0019905;GO:0035493;GO:0006906;, C:cytosol; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:mitochondrial outer membrane; C:neuron projection; C:plasma membrane; C:SNARE complex; C:specific granule membrane; C:synaptic vesicle membrane; C:tertiary granule membrane;, F:SNAP receptor activity; F:syntaxin binding;, P:SNARE complex assembly; P:vesicle fusion; scaffold71 indexed_genome mRNA 8897048 8898365 . + . ID=transcript_11402;Q4U2R6 Q96Q57 Q9BQ36 Q9P0N7,39S ribosomal protein L51, mitochondrial,Mitochondrial large ribosomal subunit protein mL51 {ECO:0000303|PubMed:25278503};bMRP-64;, PF10244;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q4U2R6 Q96Q57 Q9BQ36 Q9P0N7,39S ribosomal protein L51, mitochondrial,Mitochondrial large ribosomal subunit protein mL51 {ECO:0000303|PubMed:25278503};bMRP-64;, PF10244;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold71 indexed_genome mRNA 8898546 8900229 . + . ID=transcript_11403;Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation; scaffold71 indexed_genome mRNA 8906962 8924124 . + . ID=transcript_11404;Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|Q15021 D3DUR4 Q8N6U3,Condensin complex subunit 1,Chromosome condensation-related SMC-associated protein 1;Chromosome-associated protein D2;Non-SMC condensin I complex subunit D2;XCAP-D2 homolog;, PF12717;PF12922;, GO:0000793;GO:0000779;GO:0000796;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome; C:condensed chromosome, centromeric region; C:condensin complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation; scaffold71 indexed_genome mRNA 8926534 8928916 . + . ID=transcript_11405;P04406 E7EUT4 P00354 Q53X65,Glyceraldehyde-3-phosphate dehydrogenase,Peptidyl-cysteine S-nitrosylase GAPDH;, PF02800;PF00044;, GO:0005737;GO:0005829;GO:0070062;GO:0097452;GO:0043231;GO:0005811;GO:0016020;GO:0015630;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:1990904;GO:0031982;GO:0019828;GO:0097718;GO:0004365;GO:0042802;GO:0008017;GO:0051287;GO:0050661;GO:0035605;GO:0061844;GO:0061621;GO:0071346;GO:0050832;GO:0006094;GO:0006096;GO:0051873;GO:0031640;GO:0000226;GO:0010951;GO:0017148;GO:0051402;GO:0035606;GO:0001819;GO:0050821;GO:0016241;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:GAIT complex; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:microtubule cytoskeleton; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ribonucleoprotein complex; C:vesicle;, F:aspartic-type endopeptidase inhibitor activity; F:disordered domain specific binding; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; F:identical protein binding; F:microtubule binding; F:NAD binding; F:NADP binding; F:peptidyl-cysteine S-nitrosylase activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:canonical glycolysis; P:cellular response to interferon-gamma; P:defense response to fungus; P:gluconeogenesis; P:glycolytic process; P:killing by host of symbiont cells; P:killing of cells of other organism; P:microtubule cytoskeleton organization; P:negative regulation of endopeptidase activity; P:negative regulation of translation; P:neuron apoptotic process; P:peptidyl-cysteine S-trans-nitrosylation; P:positive regulation of cytokine production; P:protein stabilization; P:regulation of macroautophagy; scaffold71 indexed_genome mRNA 8928921 8930620 . + . ID=transcript_11406;P04406 E7EUT4 P00354 Q53X65,Glyceraldehyde-3-phosphate dehydrogenase,Peptidyl-cysteine S-nitrosylase GAPDH;, PF02800;PF00044;, GO:0005737;GO:0005829;GO:0070062;GO:0097452;GO:0043231;GO:0005811;GO:0016020;GO:0015630;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:1990904;GO:0031982;GO:0019828;GO:0097718;GO:0004365;GO:0042802;GO:0008017;GO:0051287;GO:0050661;GO:0035605;GO:0061844;GO:0061621;GO:0071346;GO:0050832;GO:0006094;GO:0006096;GO:0051873;GO:0031640;GO:0000226;GO:0010951;GO:0017148;GO:0051402;GO:0035606;GO:0001819;GO:0050821;GO:0016241;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:GAIT complex; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:microtubule cytoskeleton; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ribonucleoprotein complex; C:vesicle;, F:aspartic-type endopeptidase inhibitor activity; F:disordered domain specific binding; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; F:identical protein binding; F:microtubule binding; F:NAD binding; F:NADP binding; F:peptidyl-cysteine S-nitrosylase activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:canonical glycolysis; P:cellular response to interferon-gamma; P:defense response to fungus; P:gluconeogenesis; P:glycolytic process; P:killing by host of symbiont cells; P:killing of cells of other organism; P:microtubule cytoskeleton organization; P:negative regulation of endopeptidase activity; P:negative regulation of translation; P:neuron apoptotic process; P:peptidyl-cysteine S-trans-nitrosylation; P:positive regulation of cytokine production; P:protein stabilization; P:regulation of macroautophagy;|P04406 E7EUT4 P00354 Q53X65,Glyceraldehyde-3-phosphate dehydrogenase,Peptidyl-cysteine S-nitrosylase GAPDH;, PF02800;PF00044;, GO:0005737;GO:0005829;GO:0070062;GO:0097452;GO:0043231;GO:0005811;GO:0016020;GO:0015630;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:1990904;GO:0031982;GO:0019828;GO:0097718;GO:0004365;GO:0042802;GO:0008017;GO:0051287;GO:0050661;GO:0035605;GO:0061844;GO:0061621;GO:0071346;GO:0050832;GO:0006094;GO:0006096;GO:0051873;GO:0031640;GO:0000226;GO:0010951;GO:0017148;GO:0051402;GO:0035606;GO:0001819;GO:0050821;GO:0016241;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:GAIT complex; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:microtubule cytoskeleton; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ribonucleoprotein complex; C:vesicle;, F:aspartic-type endopeptidase inhibitor activity; F:disordered domain specific binding; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; F:identical protein binding; F:microtubule binding; F:NAD binding; F:NADP binding; F:peptidyl-cysteine S-nitrosylase activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:canonical glycolysis; P:cellular response to interferon-gamma; P:defense response to fungus; P:gluconeogenesis; P:glycolytic process; P:killing by host of symbiont cells; P:killing of cells of other organism; P:microtubule cytoskeleton organization; P:negative regulation of endopeptidase activity; P:negative regulation of translation; P:neuron apoptotic process; P:peptidyl-cysteine S-trans-nitrosylation; P:positive regulation of cytokine production; P:protein stabilization; P:regulation of macroautophagy;|P04406 E7EUT4 P00354 Q53X65,Glyceraldehyde-3-phosphate dehydrogenase,Peptidyl-cysteine S-nitrosylase GAPDH;, PF02800;PF00044;, GO:0005737;GO:0005829;GO:0070062;GO:0097452;GO:0043231;GO:0005811;GO:0016020;GO:0015630;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:1990904;GO:0031982;GO:0019828;GO:0097718;GO:0004365;GO:0042802;GO:0008017;GO:0051287;GO:0050661;GO:0035605;GO:0061844;GO:0061621;GO:0071346;GO:0050832;GO:0006094;GO:0006096;GO:0051873;GO:0031640;GO:0000226;GO:0010951;GO:0017148;GO:0051402;GO:0035606;GO:0001819;GO:0050821;GO:0016241;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:GAIT complex; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:microtubule cytoskeleton; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ribonucleoprotein complex; C:vesicle;, F:aspartic-type endopeptidase inhibitor activity; F:disordered domain specific binding; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; F:identical protein binding; F:microtubule binding; F:NAD binding; F:NADP binding; F:peptidyl-cysteine S-nitrosylase activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:canonical glycolysis; P:cellular response to interferon-gamma; P:defense response to fungus; P:gluconeogenesis; P:glycolytic process; P:killing by host of symbiont cells; P:killing of cells of other organism; P:microtubule cytoskeleton organization; P:negative regulation of endopeptidase activity; P:negative regulation of translation; P:neuron apoptotic process; P:peptidyl-cysteine S-trans-nitrosylation; P:positive regulation of cytokine production; P:protein stabilization; P:regulation of macroautophagy; scaffold72 indexed_genome mRNA 236109 270327 . + . ID=transcript_11407;Q5VZM2 A8K042 Q15348 Q8N3T0,Ras-related GTP-binding protein B {ECO:0000305},, PF04670;, GO:0005737;GO:0005829;GO:0034448;GO:1990131;GO:0005765;GO:0005764;GO:0005634;GO:0005525;GO:0003924;GO:0051020;GO:0032561;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:1990253;GO:0009267;GO:0032008;GO:1904263;GO:0010506;GO:0016241;GO:0032006;, C:cytoplasm; C:cytosol; C:EGO complex; C:Gtr1-Gtr2 GTPase complex; C:lysosomal membrane; C:lysosome; C:nucleus;, F:GTP binding; F:GTPase activity; F:GTPase binding; F:guanyl ribonucleotide binding;, P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to leucine starvation; P:cellular response to starvation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:regulation of autophagy; P:regulation of macroautophagy; P:regulation of TOR signaling;|Q5VZM2 A8K042 Q15348 Q8N3T0,Ras-related GTP-binding protein B {ECO:0000305},, PF04670;, GO:0005737;GO:0005829;GO:0034448;GO:1990131;GO:0005765;GO:0005764;GO:0005634;GO:0005525;GO:0003924;GO:0051020;GO:0032561;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:1990253;GO:0009267;GO:0032008;GO:1904263;GO:0010506;GO:0016241;GO:0032006;, C:cytoplasm; C:cytosol; C:EGO complex; C:Gtr1-Gtr2 GTPase complex; C:lysosomal membrane; C:lysosome; C:nucleus;, F:GTP binding; F:GTPase activity; F:GTPase binding; F:guanyl ribonucleotide binding;, P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to leucine starvation; P:cellular response to starvation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:regulation of autophagy; P:regulation of macroautophagy; P:regulation of TOR signaling;|Q7L523 B2R7L1 O00290 Q15347,Ras-related GTP-binding protein A {ECO:0000305},Adenovirus E3 14.7 kDa-interacting protein 1 {ECO:0000303|PubMed:8995684};FIP-1 {ECO:0000303|PubMed:8995684};, PF04670;, GO:0005737;GO:0005829;GO:0034448;GO:1990131;GO:0005765;GO:0005764;GO:0005634;GO:0005525;GO:0003924;GO:0051219;GO:0046982;GO:0042803;GO:0031625;GO:0006915;GO:0007050;GO:0008219;GO:0034613;GO:0034198;GO:0071230;GO:0009267;GO:0019048;GO:0010507;GO:0032008;GO:1904263;GO:0016567;GO:0010506;GO:0016241;, C:cytoplasm; C:cytosol; C:EGO complex; C:Gtr1-Gtr2 GTPase complex; C:lysosomal membrane; C:lysosome; C:nucleus;, F:GTP binding; F:GTPase activity; F:phosphoprotein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell cycle arrest; P:cell death; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to starvation; P:modulation by virus of host process; P:negative regulation of autophagy; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:protein ubiquitination; P:regulation of autophagy; P:regulation of macroautophagy;|Q5VZM2 A8K042 Q15348 Q8N3T0,Ras-related GTP-binding protein B {ECO:0000305},, PF04670;, GO:0005737;GO:0005829;GO:0034448;GO:1990131;GO:0005765;GO:0005764;GO:0005634;GO:0005525;GO:0003924;GO:0051020;GO:0032561;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:1990253;GO:0009267;GO:0032008;GO:1904263;GO:0010506;GO:0016241;GO:0032006;, C:cytoplasm; C:cytosol; C:EGO complex; C:Gtr1-Gtr2 GTPase complex; C:lysosomal membrane; C:lysosome; C:nucleus;, F:GTP binding; F:GTPase activity; F:GTPase binding; F:guanyl ribonucleotide binding;, P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to leucine starvation; P:cellular response to starvation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:regulation of autophagy; P:regulation of macroautophagy; P:regulation of TOR signaling;|Q5VZM2 A8K042 Q15348 Q8N3T0,Ras-related GTP-binding protein B {ECO:0000305},, PF04670;, GO:0005737;GO:0005829;GO:0034448;GO:1990131;GO:0005765;GO:0005764;GO:0005634;GO:0005525;GO:0003924;GO:0051020;GO:0032561;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:1990253;GO:0009267;GO:0032008;GO:1904263;GO:0010506;GO:0016241;GO:0032006;, C:cytoplasm; C:cytosol; C:EGO complex; C:Gtr1-Gtr2 GTPase complex; C:lysosomal membrane; C:lysosome; C:nucleus;, F:GTP binding; F:GTPase activity; F:GTPase binding; F:guanyl ribonucleotide binding;, P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to leucine starvation; P:cellular response to starvation; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:regulation of autophagy; P:regulation of macroautophagy; P:regulation of TOR signaling;|Q7L523 B2R7L1 O00290 Q15347,Ras-related GTP-binding protein A {ECO:0000305},Adenovirus E3 14.7 kDa-interacting protein 1 {ECO:0000303|PubMed:8995684};FIP-1 {ECO:0000303|PubMed:8995684};, PF04670;, GO:0005737;GO:0005829;GO:0034448;GO:1990131;GO:0005765;GO:0005764;GO:0005634;GO:0005525;GO:0003924;GO:0051219;GO:0046982;GO:0042803;GO:0031625;GO:0006915;GO:0007050;GO:0008219;GO:0034613;GO:0034198;GO:0071230;GO:0009267;GO:0019048;GO:0010507;GO:0032008;GO:1904263;GO:0016567;GO:0010506;GO:0016241;, C:cytoplasm; C:cytosol; C:EGO complex; C:Gtr1-Gtr2 GTPase complex; C:lysosomal membrane; C:lysosome; C:nucleus;, F:GTP binding; F:GTPase activity; F:phosphoprotein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell cycle arrest; P:cell death; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to starvation; P:modulation by virus of host process; P:negative regulation of autophagy; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:protein ubiquitination; P:regulation of autophagy; P:regulation of macroautophagy; scaffold72 indexed_genome mRNA 294770 523245 . + . ID=transcript_11408;Q6MZJ7 Q9UGC4,Krueppel-like factor 8,Basic krueppel-like factor 3;Zinc finger protein 741;, PF00096;, GO:0016235;GO:0000785;GO:0005829;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000122;GO:0006357;, C:aggresome; C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold72 indexed_genome mRNA 523251 526334 . + . ID=transcript_11409;Q6MZJ7 Q9UGC4,Krueppel-like factor 8,Basic krueppel-like factor 3;Zinc finger protein 741;, PF00096;, GO:0016235;GO:0000785;GO:0005829;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000122;GO:0006357;, C:aggresome; C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold72 indexed_genome mRNA 653186 656517 . + . ID=transcript_11410;Q9UHD9 O94798 Q5D027 Q9H3W6 Q9HAZ4,Ubiquilin-2,Chap1;DSK2 homolog;Protein linking IAP with cytoskeleton 2;Ubiquitin-like product Chap1/Dsk2;, PF00627;PF00240;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0042802;GO:0031593;GO:0000045;GO:1900186;GO:1904021;GO:1903071;GO:2000785;GO:0016241;GO:0030433;GO:0006511;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:identical protein binding; F:polyubiquitin modification-dependent protein binding;, P:autophagosome assembly; P:negative regulation of clathrin-dependent endocytosis; P:negative regulation of G protein-coupled receptor internalization; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:regulation of autophagosome assembly; P:regulation of macroautophagy; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold72 indexed_genome mRNA 752725 844605 . + . ID=transcript_11411;A0A0U1RRE5,Negative regulator of P-body association {ECO:0000312|HGNC:HGNC:50713},P-body dissociating protein {ECO:0000303|PubMed:27918561};Protein NoBody {ECO:0000303|PubMed:27918561};, , GO:0000932;GO:0006397;GO:0010607;GO:0000956;, C:P-body;, , P:mRNA processing; P:negative regulation of cytoplasmic mRNA processing body assembly; P:nuclear-transcribed mRNA catabolic process; scaffold72 indexed_genome mRNA 874895 876060 . - . ID=transcript_11412;P51668 A6NLF6 A8K786,Ubiquitin-conjugating enzyme E2 D1,(E3-independent) E2 ubiquitin-conjugating enzyme D1;E2 ubiquitin-conjugating enzyme D1;Stimulator of Fe transport;UBC4/5 homolog;UbcH5;Ubiquitin carrier protein D1;Ubiquitin-conjugating enzyme E2(17)KB 1;Ubiquitin-conjugating enzyme E2-17 kDa 1;Ubiquitin-protein ligase D1;, PF00179;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0000151;GO:0005524;GO:0061631;GO:0061630;GO:0031625;GO:0004842;GO:0031145;GO:0002756;GO:0030514;GO:0000122;GO:1902916;GO:0031398;GO:0016579;GO:0070936;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:1901990;GO:0035666;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein polyubiquitination; P:positive regulation of protein ubiquitination; P:protein deubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:TRIF-dependent toll-like receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold72 indexed_genome mRNA 969641 972423 . - . ID=transcript_11413;Q9BPZ2 Q7Z2M0,Spindlin-2B,Spindlin-like protein 2B;, PF02513;, GO:0005829;GO:0005654;GO:0035064;GO:0006915;GO:0007049;GO:0007276;GO:0051726;GO:0006355;, C:cytosol; C:nucleoplasm;, F:methylated histone binding;, P:apoptotic process; P:cell cycle; P:gamete generation; P:regulation of cell cycle; P:regulation of transcription, DNA-templated; scaffold72 indexed_genome mRNA 1376682 1481253 . - . ID=transcript_11414;Q9BQS7 B1AJX8 D3DVT7 E9PHN8 O75180 Q6UW45 Q9C058,Hephaestin,, PF07731;PF07732;, GO:0016323;GO:0016021;GO:0048471;GO:0005886;GO:0005507;GO:0008198;GO:0004322;GO:0016491;GO:0006879;GO:0006825;GO:0055072;GO:0006826;, C:basolateral plasma membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:copper ion binding; F:ferrous iron binding; F:ferroxidase activity; F:oxidoreductase activity;, P:cellular iron ion homeostasis; P:copper ion transport; P:iron ion homeostasis; P:iron ion transport;|Q9BQS7 B1AJX8 D3DVT7 E9PHN8 O75180 Q6UW45 Q9C058,Hephaestin,, PF07731;PF07732;, GO:0016323;GO:0016021;GO:0048471;GO:0005886;GO:0005507;GO:0008198;GO:0004322;GO:0016491;GO:0006879;GO:0006825;GO:0055072;GO:0006826;, C:basolateral plasma membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:copper ion binding; F:ferrous iron binding; F:ferroxidase activity; F:oxidoreductase activity;, P:cellular iron ion homeostasis; P:copper ion transport; P:iron ion homeostasis; P:iron ion transport; scaffold72 indexed_genome mRNA 1484065 1495350 . - . ID=transcript_11415;Q9BQS7 B1AJX8 D3DVT7 E9PHN8 O75180 Q6UW45 Q9C058,Hephaestin,, PF07731;PF07732;, GO:0016323;GO:0016021;GO:0048471;GO:0005886;GO:0005507;GO:0008198;GO:0004322;GO:0016491;GO:0006879;GO:0006825;GO:0055072;GO:0006826;, C:basolateral plasma membrane; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:copper ion binding; F:ferrous iron binding; F:ferroxidase activity; F:oxidoreductase activity;, P:cellular iron ion homeostasis; P:copper ion transport; P:iron ion homeostasis; P:iron ion transport; scaffold72 indexed_genome mRNA 1607832 1614823 . + . ID=transcript_11416;Q9Y279 Q6UXI4,V-set and immunoglobulin domain-containing protein 4,Protein Z39Ig;, PF07686;, GO:0016021;GO:0032991;GO:0001851;GO:0006957;GO:0045957;GO:0032703;GO:0043031;GO:0042130;, C:integral component of membrane; C:protein-containing complex;, F:complement component C3b binding;, P:complement activation, alternative pathway; P:negative regulation of complement activation, alternative pathway; P:negative regulation of interleukin-2 production; P:negative regulation of macrophage activation; P:negative regulation of T cell proliferation; scaffold72 indexed_genome mRNA 1800875 1872502 . - . ID=transcript_11417;P26038,Moesin {ECO:0000303|PubMed:1924289},Membrane-organizing extension spike protein;, PF00769;PF09380;PF00373;PF09379;, GO:0045177;GO:0016324;GO:0016323;GO:0072562;GO:0071944;GO:0009986;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0005902;GO:0031528;GO:0005634;GO:0048471;GO:0005886;GO:0031143;GO:0001931;GO:0031982;GO:0003779;GO:0050839;GO:0003725;GO:0019899;GO:0019901;GO:0005102;GO:0005200;GO:0071394;GO:0061028;GO:0045198;GO:0022612;GO:0001771;GO:0035722;GO:0007159;GO:0050900;GO:0022614;GO:1903364;GO:2000643;GO:0010628;GO:0071803;GO:1902966;GO:0008360;GO:0008361;GO:2000401;GO:1902115;GO:0070489;GO:0072678;GO:0042098;GO:0016032;, C:apical part of cell; C:apical plasma membrane; C:basolateral plasma membrane; C:blood microparticle; C:cell periphery; C:cell surface; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:microvillus; C:microvillus membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:pseudopodium; C:uropod; C:vesicle;, F:actin binding; F:cell adhesion molecule binding; F:double-stranded RNA binding; F:enzyme binding; F:protein kinase binding; F:signaling receptor binding; F:structural constituent of cytoskeleton;, P:cellular response to testosterone stimulus; P:establishment of endothelial barrier; P:establishment of epithelial cell apical/basal polarity; P:gland morphogenesis; P:immunological synapse formation; P:interleukin-12-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:membrane to membrane docking; P:positive regulation of cellular protein catabolic process; P:positive regulation of early endosome to late endosome transport; P:positive regulation of gene expression; P:positive regulation of podosome assembly; P:positive regulation of protein localization to early endosome; P:regulation of cell shape; P:regulation of cell size; P:regulation of lymphocyte migration; P:regulation of organelle assembly; P:T cell aggregation; P:T cell migration; P:T cell proliferation; P:viral process;|P26038,Moesin {ECO:0000303|PubMed:1924289},Membrane-organizing extension spike protein;, PF00769;PF09380;PF00373;PF09379;, GO:0045177;GO:0016324;GO:0016323;GO:0072562;GO:0071944;GO:0009986;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005615;GO:0030175;GO:0005925;GO:0005902;GO:0031528;GO:0005634;GO:0048471;GO:0005886;GO:0031143;GO:0001931;GO:0031982;GO:0003779;GO:0050839;GO:0003725;GO:0019899;GO:0019901;GO:0005102;GO:0005200;GO:0071394;GO:0061028;GO:0045198;GO:0022612;GO:0001771;GO:0035722;GO:0007159;GO:0050900;GO:0022614;GO:1903364;GO:2000643;GO:0010628;GO:0071803;GO:1902966;GO:0008360;GO:0008361;GO:2000401;GO:1902115;GO:0070489;GO:0072678;GO:0042098;GO:0016032;, C:apical part of cell; C:apical plasma membrane; C:basolateral plasma membrane; C:blood microparticle; C:cell periphery; C:cell surface; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular space; C:filopodium; C:focal adhesion; C:microvillus; C:microvillus membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:pseudopodium; C:uropod; C:vesicle;, F:actin binding; F:cell adhesion molecule binding; F:double-stranded RNA binding; F:enzyme binding; F:protein kinase binding; F:signaling receptor binding; F:structural constituent of cytoskeleton;, P:cellular response to testosterone stimulus; P:establishment of endothelial barrier; P:establishment of epithelial cell apical/basal polarity; P:gland morphogenesis; P:immunological synapse formation; P:interleukin-12-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:membrane to membrane docking; P:positive regulation of cellular protein catabolic process; P:positive regulation of early endosome to late endosome transport; P:positive regulation of gene expression; P:positive regulation of podosome assembly; P:positive regulation of protein localization to early endosome; P:regulation of cell shape; P:regulation of cell size; P:regulation of lymphocyte migration; P:regulation of organelle assembly; P:T cell aggregation; P:T cell migration; P:T cell proliferation; P:viral process; scaffold72 indexed_genome mRNA 2069305 2080729 . - . ID=transcript_11418;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold72 indexed_genome mRNA 2080929 2086261 . + . ID=transcript_11419;Q9Y4W2 A9X410 Q5JXQ0 Q8TEN5 Q9H9V5,Ribosomal biogenesis protein LAS1L,Protein LAS1 homolog;, PF04031;, GO:0090730;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0030687;GO:0004519;GO:0003723;GO:0000460;GO:0000470;GO:0006364;, C:Las1 complex; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:endonuclease activity; F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing;|Q9Y4W2 A9X410 Q5JXQ0 Q8TEN5 Q9H9V5,Ribosomal biogenesis protein LAS1L,Protein LAS1 homolog;, PF04031;, GO:0090730;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0030687;GO:0004519;GO:0003723;GO:0000460;GO:0000470;GO:0006364;, C:Las1 complex; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:endonuclease activity; F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing;|Q9Y4W2 A9X410 Q5JXQ0 Q8TEN5 Q9H9V5,Ribosomal biogenesis protein LAS1L,Protein LAS1 homolog;, PF04031;, GO:0090730;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0030687;GO:0004519;GO:0003723;GO:0000460;GO:0000470;GO:0006364;, C:Las1 complex; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:endonuclease activity; F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing;|Q9Y4W2 A9X410 Q5JXQ0 Q8TEN5 Q9H9V5,Ribosomal biogenesis protein LAS1L,Protein LAS1 homolog;, PF04031;, GO:0090730;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0030687;GO:0004519;GO:0003723;GO:0000460;GO:0000470;GO:0006364;, C:Las1 complex; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:endonuclease activity; F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing; scaffold72 indexed_genome mRNA 2086293 2100612 . - . ID=transcript_11420;Q9Y4W2 A9X410 Q5JXQ0 Q8TEN5 Q9H9V5,Ribosomal biogenesis protein LAS1L,Protein LAS1 homolog;, PF04031;, GO:0090730;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0030687;GO:0004519;GO:0003723;GO:0000460;GO:0000470;GO:0006364;, C:Las1 complex; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:endonuclease activity; F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing;|Q9Y4W2 A9X410 Q5JXQ0 Q8TEN5 Q9H9V5,Ribosomal biogenesis protein LAS1L,Protein LAS1 homolog;, PF04031;, GO:0090730;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0030687;GO:0004519;GO:0003723;GO:0000460;GO:0000470;GO:0006364;, C:Las1 complex; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:endonuclease activity; F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing;|Q9Y4W2 A9X410 Q5JXQ0 Q8TEN5 Q9H9V5,Ribosomal biogenesis protein LAS1L,Protein LAS1 homolog;, PF04031;, GO:0090730;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0030687;GO:0004519;GO:0003723;GO:0000460;GO:0000470;GO:0006364;, C:Las1 complex; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:endonuclease activity; F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing;|Q9Y4W2 A9X410 Q5JXQ0 Q8TEN5 Q9H9V5,Ribosomal biogenesis protein LAS1L,Protein LAS1 homolog;, PF04031;, GO:0090730;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0030687;GO:0004519;GO:0003723;GO:0000460;GO:0000470;GO:0006364;, C:Las1 complex; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:preribosome, large subunit precursor;, F:endonuclease activity; F:RNA binding;, P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:rRNA processing; scaffold72 indexed_genome mRNA 2108500 2112370 . - . ID=transcript_11421;Q5HYM0 B2RTQ3 E9PAJ6 Q5H9C0,Probable ribonuclease ZC3H12B,MCP-induced protein 2;Zinc finger CCCH domain-containing protein 12B;, PF18561;PF11977;PF18039;, GO:0036464;GO:0005634;GO:0004521;GO:0046872;GO:0003729;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:nucleus;, F:endoribonuclease activity; F:metal ion binding; F:mRNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold72 indexed_genome mRNA 2112407 2164120 . - . ID=transcript_11422;Q5HYM0 B2RTQ3 E9PAJ6 Q5H9C0,Probable ribonuclease ZC3H12B,MCP-induced protein 2;Zinc finger CCCH domain-containing protein 12B;, PF18561;PF11977;PF18039;, GO:0036464;GO:0005634;GO:0004521;GO:0046872;GO:0003729;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:nucleus;, F:endoribonuclease activity; F:metal ion binding; F:mRNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic;|Q5HYM0 B2RTQ3 E9PAJ6 Q5H9C0,Probable ribonuclease ZC3H12B,MCP-induced protein 2;Zinc finger CCCH domain-containing protein 12B;, PF18561;PF11977;PF18039;, GO:0036464;GO:0005634;GO:0004521;GO:0046872;GO:0003729;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:nucleus;, F:endoribonuclease activity; F:metal ion binding; F:mRNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic;|Q5HYM0 B2RTQ3 E9PAJ6 Q5H9C0,Probable ribonuclease ZC3H12B,MCP-induced protein 2;Zinc finger CCCH domain-containing protein 12B;, PF18561;PF11977;PF18039;, GO:0036464;GO:0005634;GO:0004521;GO:0046872;GO:0003729;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:nucleus;, F:endoribonuclease activity; F:metal ion binding; F:mRNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic;|P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold72 indexed_genome mRNA 2858187 2881989 . + . ID=transcript_11423;Q9H9H7 Q9ULQ4,Zinc finger C4H2 domain-containing protein,Hepatocellular carcinoma-associated antigen 127;, PF10146;, GO:0005737;GO:0005634;GO:0045211;GO:0032991;GO:0046872;GO:0007399;GO:0007528;GO:0045666;GO:0021522;, C:cytoplasm; C:nucleus; C:postsynaptic membrane; C:protein-containing complex;, F:metal ion binding;, P:nervous system development; P:neuromuscular junction development; P:positive regulation of neuron differentiation; P:spinal cord motor neuron differentiation;|Q9H9H7 Q9ULQ4,Zinc finger C4H2 domain-containing protein,Hepatocellular carcinoma-associated antigen 127;, PF10146;, GO:0005737;GO:0005634;GO:0045211;GO:0032991;GO:0046872;GO:0007399;GO:0007528;GO:0045666;GO:0021522;, C:cytoplasm; C:nucleus; C:postsynaptic membrane; C:protein-containing complex;, F:metal ion binding;, P:nervous system development; P:neuromuscular junction development; P:positive regulation of neuron differentiation; P:spinal cord motor neuron differentiation; scaffold72 indexed_genome mRNA 2995861 3049169 . + . ID=transcript_11424;Q96EF0 Q5JT99 Q9NXP6,Myotubularin-related protein 8,Phosphatidylinositol-3,5-bisphosphate 3-phosphatase {ECO:0000305};Phosphatidylinositol-3-phosphate phosphatase {ECO:0000305};, PF06602;, GO:0005737;GO:0005829;GO:0005635;GO:0032991;GO:0052629;GO:0106018;GO:0004438;GO:0004725;GO:0010507;GO:0006661;GO:0046856;GO:0016241;, C:cytoplasm; C:cytosol; C:nuclear envelope; C:protein-containing complex;, F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,5-bisphosphate phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;, P:negative regulation of autophagy; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:regulation of macroautophagy; scaffold72 indexed_genome mRNA 3174860 3181886 . + . ID=transcript_11425;Q8WXK4 J3KP57 Q2M3D5 Q52LK4 Q6ISF9 Q8N8F5,Ankyrin repeat and SOCS box protein 12,, PF00023;PF12796;PF07525;, GO:0005829;GO:0000151;GO:0043687;GO:0016567;, C:cytosol; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein ubiquitination;|Q8WXK4 J3KP57 Q2M3D5 Q52LK4 Q6ISF9 Q8N8F5,Ankyrin repeat and SOCS box protein 12,, PF00023;PF12796;PF07525;, GO:0005829;GO:0000151;GO:0043687;GO:0016567;, C:cytosol; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein ubiquitination; scaffold72 indexed_genome mRNA 3201864 3223459 . + . ID=transcript_11426;Q5JTC6 A2IB86 Q8N885,APC membrane recruitment protein 1,Protein FAM123B;Wilms tumor gene on the X chromosome protein;, PF09422;, GO:0005829;GO:0043231;GO:0016604;GO:0005886;GO:0008013;GO:1904713;GO:0005546;GO:0060612;GO:1904885;GO:1904886;GO:0060348;GO:0072161;GO:0090090;GO:0090263;GO:1903364;GO:0031398;GO:0060828;GO:0016055;, C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear body; C:plasma membrane;, F:beta-catenin binding; F:beta-catenin destruction complex binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:adipose tissue development; P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:bone development; P:mesenchymal cell differentiation involved in kidney development; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cellular protein catabolic process; P:positive regulation of protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold72 indexed_genome mRNA 3223501 3224193 . - . ID=transcript_11427;Q5JTC6 A2IB86 Q8N885,APC membrane recruitment protein 1,Protein FAM123B;Wilms tumor gene on the X chromosome protein;, PF09422;, GO:0005829;GO:0043231;GO:0016604;GO:0005886;GO:0008013;GO:1904713;GO:0005546;GO:0060612;GO:1904885;GO:1904886;GO:0060348;GO:0072161;GO:0090090;GO:0090263;GO:1903364;GO:0031398;GO:0060828;GO:0016055;, C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear body; C:plasma membrane;, F:beta-catenin binding; F:beta-catenin destruction complex binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:adipose tissue development; P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:bone development; P:mesenchymal cell differentiation involved in kidney development; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cellular protein catabolic process; P:positive regulation of protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold72 indexed_genome mRNA 3224231 3226160 . + . ID=transcript_11428;Q5JTC6 A2IB86 Q8N885,APC membrane recruitment protein 1,Protein FAM123B;Wilms tumor gene on the X chromosome protein;, PF09422;, GO:0005829;GO:0043231;GO:0016604;GO:0005886;GO:0008013;GO:1904713;GO:0005546;GO:0060612;GO:1904885;GO:1904886;GO:0060348;GO:0072161;GO:0090090;GO:0090263;GO:1903364;GO:0031398;GO:0060828;GO:0016055;, C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear body; C:plasma membrane;, F:beta-catenin binding; F:beta-catenin destruction complex binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:adipose tissue development; P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:bone development; P:mesenchymal cell differentiation involved in kidney development; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cellular protein catabolic process; P:positive regulation of protein ubiquitination; P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold72 indexed_genome mRNA 3508832 3701995 . + . ID=transcript_11429;Q6ZML1 Q8N873 Q8TEK6,Spermatogenesis-associated protein 13,APC-stimulated guanine nucleotide exchange factor 2;, PF00169;PF00621;PF00018;, GO:0005737;GO:0005829;GO:0030175;GO:0030027;GO:0005654;GO:0032587;GO:0005085;GO:0042802;GO:0016477;GO:0046847;GO:0030032;GO:0030334;, C:cytoplasm; C:cytosol; C:filopodium; C:lamellipodium; C:nucleoplasm; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:cell migration; P:filopodium assembly; P:lamellipodium assembly; P:regulation of cell migration;|O43307 A8K1S8 B4DHC7 F8W7P8 Q5JSL6,Rho guanine nucleotide exchange factor 9,Collybistin;PEM-2 homolog;Rac/Cdc42 guanine nucleotide exchange factor 9;, PF00169;PF00621;PF00018;, GO:0005829;GO:0014069;GO:0005085;GO:0007186;GO:0043065;GO:0051056;, C:cytosol; C:postsynaptic density;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|O43307 A8K1S8 B4DHC7 F8W7P8 Q5JSL6,Rho guanine nucleotide exchange factor 9,Collybistin;PEM-2 homolog;Rac/Cdc42 guanine nucleotide exchange factor 9;, PF00169;PF00621;PF00018;, GO:0005829;GO:0014069;GO:0005085;GO:0007186;GO:0043065;GO:0051056;, C:cytosol; C:postsynaptic density;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; scaffold72 indexed_genome mRNA 3802480 3876635 . + . ID=transcript_11430;O43307 A8K1S8 B4DHC7 F8W7P8 Q5JSL6,Rho guanine nucleotide exchange factor 9,Collybistin;PEM-2 homolog;Rac/Cdc42 guanine nucleotide exchange factor 9;, PF00169;PF00621;PF00018;, GO:0005829;GO:0014069;GO:0005085;GO:0007186;GO:0043065;GO:0051056;, C:cytosol; C:postsynaptic density;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; scaffold72 indexed_genome mRNA 3998588 3999381 . + . ID=transcript_11431;P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold72 indexed_genome mRNA 4245774 4251797 . - . ID=transcript_11432;P98169 A8K151 Q9UBB3,Zinc finger X-linked protein ZXDB,, PF00096;, GO:0005634;GO:0046872;GO:0003712;GO:0006357;, C:nucleus;, F:metal ion binding; F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II; scaffold72 indexed_genome mRNA 4562056 4595593 . - . ID=transcript_11433;Q2M3X9 B4DHE2 E9PHQ4,Zinc finger protein 674,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold72 indexed_genome mRNA 5628975 5671083 . + . ID=transcript_11434;Q9H7Y0 A8MUU5 B2RPN7 Q6UWJ5,Divergent protein kinase domain 2B {ECO:0000305},Deleted in autism-related protein 1 {ECO:0000303|PubMed:21264219};, PF12260;, GO:0005576;, C:extracellular region;|Q9H7Y0 A8MUU5 B2RPN7 Q6UWJ5,Divergent protein kinase domain 2B {ECO:0000305},Deleted in autism-related protein 1 {ECO:0000303|PubMed:21264219};, PF12260;, GO:0005576;, C:extracellular region; scaffold72 indexed_genome mRNA 5704920 5716033 . + . ID=transcript_11435;O15550 Q52LL9 Q5JVQ7,Lysine-specific demethylase 6A,Histone demethylase UTX;Ubiquitously-transcribed TPR protein on the X chromosome;Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein;[histone H3]-trimethyl-L-lysine(27) demethylase 6A {ECO:0000305};, PF02373;PF13181;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0031490;GO:0051213;GO:0071558;GO:0046872;GO:0000978;GO:0006338;GO:0007507;GO:0071557;GO:0051568;GO:0010468;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K27 specific); F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin remodeling; P:heart development; P:histone H3-K27 demethylation; P:histone H3-K4 methylation; P:regulation of gene expression;|O15550 Q52LL9 Q5JVQ7,Lysine-specific demethylase 6A,Histone demethylase UTX;Ubiquitously-transcribed TPR protein on the X chromosome;Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein;[histone H3]-trimethyl-L-lysine(27) demethylase 6A {ECO:0000305};, PF02373;PF13181;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0031490;GO:0051213;GO:0071558;GO:0046872;GO:0000978;GO:0006338;GO:0007507;GO:0071557;GO:0051568;GO:0010468;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K27 specific); F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin remodeling; P:heart development; P:histone H3-K27 demethylation; P:histone H3-K4 methylation; P:regulation of gene expression; scaffold72 indexed_genome mRNA 5722362 5742087 . - . ID=transcript_11436;O15550 Q52LL9 Q5JVQ7,Lysine-specific demethylase 6A,Histone demethylase UTX;Ubiquitously-transcribed TPR protein on the X chromosome;Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein;[histone H3]-trimethyl-L-lysine(27) demethylase 6A {ECO:0000305};, PF02373;PF13181;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0031490;GO:0051213;GO:0071558;GO:0046872;GO:0000978;GO:0006338;GO:0007507;GO:0071557;GO:0051568;GO:0010468;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K27 specific); F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin remodeling; P:heart development; P:histone H3-K27 demethylation; P:histone H3-K4 methylation; P:regulation of gene expression;|O14607 A8K9Z3 E1U199 E1U1A0 F5H4V7 F8W8R7 O14608,Histone demethylase UTY,Ubiquitously-transcribed TPR protein on the Y chromosome;Ubiquitously-transcribed Y chromosome tetratricopeptide repeat protein;[histone H3]-trimethyl-L-lysine(27) demethylase UTY {ECO:0000305};, PF02373;PF13181;, GO:0044666;GO:0005654;GO:0031490;GO:0051213;GO:0071558;GO:0046872;GO:0000978;GO:0007507;GO:0071557;GO:0010468;, C:MLL3/4 complex; C:nucleoplasm;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K27 specific); F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:heart development; P:histone H3-K27 demethylation; P:regulation of gene expression; scaffold72 indexed_genome mRNA 5753380 5881731 . - . ID=transcript_11437;O15550 Q52LL9 Q5JVQ7,Lysine-specific demethylase 6A,Histone demethylase UTX;Ubiquitously-transcribed TPR protein on the X chromosome;Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein;[histone H3]-trimethyl-L-lysine(27) demethylase 6A {ECO:0000305};, PF02373;PF13181;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0031490;GO:0051213;GO:0071558;GO:0046872;GO:0000978;GO:0006338;GO:0007507;GO:0071557;GO:0051568;GO:0010468;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K27 specific); F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin remodeling; P:heart development; P:histone H3-K27 demethylation; P:histone H3-K4 methylation; P:regulation of gene expression;|O15550 Q52LL9 Q5JVQ7,Lysine-specific demethylase 6A,Histone demethylase UTX;Ubiquitously-transcribed TPR protein on the X chromosome;Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein;[histone H3]-trimethyl-L-lysine(27) demethylase 6A {ECO:0000305};, PF02373;PF13181;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0031490;GO:0051213;GO:0071558;GO:0046872;GO:0000978;GO:0006338;GO:0007507;GO:0071557;GO:0051568;GO:0010468;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K27 specific); F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin remodeling; P:heart development; P:histone H3-K27 demethylation; P:histone H3-K4 methylation; P:regulation of gene expression;|O15550 Q52LL9 Q5JVQ7,Lysine-specific demethylase 6A,Histone demethylase UTX;Ubiquitously-transcribed TPR protein on the X chromosome;Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein;[histone H3]-trimethyl-L-lysine(27) demethylase 6A {ECO:0000305};, PF02373;PF13181;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0031490;GO:0051213;GO:0071558;GO:0046872;GO:0000978;GO:0006338;GO:0007507;GO:0071557;GO:0051568;GO:0010468;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K27 specific); F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin remodeling; P:heart development; P:histone H3-K27 demethylation; P:histone H3-K4 methylation; P:regulation of gene expression;|O15550 Q52LL9 Q5JVQ7,Lysine-specific demethylase 6A,Histone demethylase UTX;Ubiquitously-transcribed TPR protein on the X chromosome;Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein;[histone H3]-trimethyl-L-lysine(27) demethylase 6A {ECO:0000305};, PF02373;PF13181;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0031490;GO:0051213;GO:0071558;GO:0046872;GO:0000978;GO:0006338;GO:0007507;GO:0071557;GO:0051568;GO:0010468;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K27 specific); F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:chromatin remodeling; P:heart development; P:histone H3-K27 demethylation; P:histone H3-K4 methylation; P:regulation of gene expression; scaffold72 indexed_genome mRNA 6128031 6140340 . + . ID=transcript_11438;Q8IVP5,FUN14 domain-containing protein 1,, PF04930;, GO:0031307;GO:0005741;GO:0000422;GO:0016236;GO:0001666;GO:0010243;, C:integral component of mitochondrial outer membrane; C:mitochondrial outer membrane;, , P:autophagy of mitochondrion; P:macroautophagy; P:response to hypoxia; P:response to organonitrogen compound;|Q8IVP5,FUN14 domain-containing protein 1,, PF04930;, GO:0031307;GO:0005741;GO:0000422;GO:0016236;GO:0001666;GO:0010243;, C:integral component of mitochondrial outer membrane; C:mitochondrial outer membrane;, , P:autophagy of mitochondrion; P:macroautophagy; P:response to hypoxia; P:response to organonitrogen compound; scaffold72 indexed_genome mRNA 6386746 6510408 . + . ID=transcript_11439;Q5JST6 Q5JST8 Q68DK4 Q8NEI0 Q9H653,EF-hand domain-containing family member C2,, PF06565;, GO:0005930;GO:0036064;GO:0072686;GO:0043014;GO:0005509;GO:1990830;GO:0060285;GO:0000281;GO:0007052;GO:0010975;, C:axoneme; C:ciliary basal body; C:mitotic spindle;, F:alpha-tubulin binding; F:calcium ion binding;, P:cellular response to leukemia inhibitory factor; P:cilium-dependent cell motility; P:mitotic cytokinesis; P:mitotic spindle organization; P:regulation of neuron projection development; scaffold72 indexed_genome mRNA 6694061 6719970 . + . ID=transcript_11440;Q00604 B2R8K6 Q5JYH5,Norrin,Norrie disease protein;X-linked exudative vitreoretinopathy 2 protein;, PF00007;, GO:0009986;GO:0062023;GO:0031012;GO:0005615;GO:0005125;GO:0005109;GO:0042803;GO:0035426;GO:0007399;GO:0110135;GO:0001890;GO:0051091;GO:0045893;GO:0061299;GO:0007033;GO:0007601;GO:0016055;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:cytokine activity; F:frizzled binding; F:protein homodimerization activity;, P:extracellular matrix-cell signaling; P:nervous system development; P:Norrin signaling pathway; P:placenta development; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription, DNA-templated; P:retina vasculature morphogenesis in camera-type eye; P:vacuole organization; P:visual perception; P:Wnt signaling pathway; scaffold72 indexed_genome mRNA 6806218 6918578 . + . ID=transcript_11441;P27338 B2R6R3 B7Z5H3 D3DWC3 Q7Z6S2,Amine oxidase [flavin-containing] B,Monoamine oxidase type B;, PF01593;, GO:0016021;GO:0005740;GO:0005741;GO:0005739;GO:0009055;GO:0050660;GO:0042802;GO:0097621;GO:0008131;GO:0042420;GO:0050665;GO:0014063;GO:0042135;GO:0045964;GO:0010044;GO:0051412;GO:0042493;GO:0045471;GO:0032496;GO:0010269;GO:0009636;GO:0021762;GO:0006805;, C:integral component of membrane; C:mitochondrial envelope; C:mitochondrial outer membrane; C:mitochondrion;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:monoamine oxidase activity; F:primary amine oxidase activity;, P:dopamine catabolic process; P:hydrogen peroxide biosynthetic process; P:negative regulation of serotonin secretion; P:neurotransmitter catabolic process; P:positive regulation of dopamine metabolic process; P:response to aluminum ion; P:response to corticosterone; P:response to drug; P:response to ethanol; P:response to lipopolysaccharide; P:response to selenium ion; P:response to toxic substance; P:substantia nigra development; P:xenobiotic metabolic process;|P27338 B2R6R3 B7Z5H3 D3DWC3 Q7Z6S2,Amine oxidase [flavin-containing] B,Monoamine oxidase type B;, PF01593;, GO:0016021;GO:0005740;GO:0005741;GO:0005739;GO:0009055;GO:0050660;GO:0042802;GO:0097621;GO:0008131;GO:0042420;GO:0050665;GO:0014063;GO:0042135;GO:0045964;GO:0010044;GO:0051412;GO:0042493;GO:0045471;GO:0032496;GO:0010269;GO:0009636;GO:0021762;GO:0006805;, C:integral component of membrane; C:mitochondrial envelope; C:mitochondrial outer membrane; C:mitochondrion;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:monoamine oxidase activity; F:primary amine oxidase activity;, P:dopamine catabolic process; P:hydrogen peroxide biosynthetic process; P:negative regulation of serotonin secretion; P:neurotransmitter catabolic process; P:positive regulation of dopamine metabolic process; P:response to aluminum ion; P:response to corticosterone; P:response to drug; P:response to ethanol; P:response to lipopolysaccharide; P:response to selenium ion; P:response to toxic substance; P:substantia nigra development; P:xenobiotic metabolic process;|P21397 B4DF46 Q16426,Amine oxidase [flavin-containing] A,Monoamine oxidase type A;, PF01593;, GO:0005829;GO:0016021;GO:0005741;GO:0005739;GO:0097621;GO:0008131;GO:0006576;GO:0019221;GO:0042420;GO:0042135;GO:0042133;GO:0009967;GO:0006805;, C:cytosol; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:monoamine oxidase activity; F:primary amine oxidase activity;, P:cellular biogenic amine metabolic process; P:cytokine-mediated signaling pathway; P:dopamine catabolic process; P:neurotransmitter catabolic process; P:neurotransmitter metabolic process; P:positive regulation of signal transduction; P:xenobiotic metabolic process;|P27338 B2R6R3 B7Z5H3 D3DWC3 Q7Z6S2,Amine oxidase [flavin-containing] B,Monoamine oxidase type B;, PF01593;, GO:0016021;GO:0005740;GO:0005741;GO:0005739;GO:0009055;GO:0050660;GO:0042802;GO:0097621;GO:0008131;GO:0042420;GO:0050665;GO:0014063;GO:0042135;GO:0045964;GO:0010044;GO:0051412;GO:0042493;GO:0045471;GO:0032496;GO:0010269;GO:0009636;GO:0021762;GO:0006805;, C:integral component of membrane; C:mitochondrial envelope; C:mitochondrial outer membrane; C:mitochondrion;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:monoamine oxidase activity; F:primary amine oxidase activity;, P:dopamine catabolic process; P:hydrogen peroxide biosynthetic process; P:negative regulation of serotonin secretion; P:neurotransmitter catabolic process; P:positive regulation of dopamine metabolic process; P:response to aluminum ion; P:response to corticosterone; P:response to drug; P:response to ethanol; P:response to lipopolysaccharide; P:response to selenium ion; P:response to toxic substance; P:substantia nigra development; P:xenobiotic metabolic process; scaffold72 indexed_genome mRNA 6936488 7012910 . - . ID=transcript_11442;P21397 B4DF46 Q16426,Amine oxidase [flavin-containing] A,Monoamine oxidase type A;, PF01593;, GO:0005829;GO:0016021;GO:0005741;GO:0005739;GO:0097621;GO:0008131;GO:0006576;GO:0019221;GO:0042420;GO:0042135;GO:0042133;GO:0009967;GO:0006805;, C:cytosol; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:monoamine oxidase activity; F:primary amine oxidase activity;, P:cellular biogenic amine metabolic process; P:cytokine-mediated signaling pathway; P:dopamine catabolic process; P:neurotransmitter catabolic process; P:neurotransmitter metabolic process; P:positive regulation of signal transduction; P:xenobiotic metabolic process; scaffold72 indexed_genome mRNA 8638408 8638948 . + . ID=transcript_11443;Q96P67 Q5VT13,Probable G-protein coupled receptor 82,, PF00001;, GO:0016021;GO:0005886;GO:0004930;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity; scaffold72 indexed_genome mRNA 8659815 8663915 . - . ID=transcript_11444;Q9UPC5 O95853,Probable G-protein coupled receptor 34,, PF00001;, GO:0005887;GO:0045028;GO:0004930;GO:0007186;, C:integral component of plasma membrane;, F:G protein-coupled purinergic nucleotide receptor activity; F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; scaffold72 indexed_genome mRNA 8779807 8815889 . + . ID=transcript_11445;Q5VT19 Q66T42 Q9BYH6 Q9NYB2 Q9NYB3,Peripheral plasma membrane protein CASK,Calcium/calmodulin-dependent serine protein kinase;Protein lin-2 homolog;, PF00625;PF02828;PF00595;PF00069;PF00018;, GO:0015629;GO:0005604;GO:0005911;GO:0060170;GO:0005737;GO:0005829;GO:0005925;GO:0005652;GO:0016363;GO:0005730;GO:0005886;GO:0042734;GO:0005524;GO:0005516;GO:0004385;GO:0106310;GO:0004674;GO:0106311;GO:0007155;GO:0001953;GO:0090288;GO:0010839;GO:0061045;GO:0006836;, C:actin cytoskeleton; C:basement membrane; C:cell-cell junction; C:ciliary membrane; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear lamina; C:nuclear matrix; C:nucleolus; C:plasma membrane; C:presynaptic membrane;, F:ATP binding; F:calmodulin binding; F:guanylate kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular response to growth factor stimulus; P:negative regulation of keratinocyte proliferation; P:negative regulation of wound healing; P:neurotransmitter transport;|Q5VT19 Q66T42 Q9BYH6 Q9NYB2 Q9NYB3,Peripheral plasma membrane protein CASK,Calcium/calmodulin-dependent serine protein kinase;Protein lin-2 homolog;, PF00625;PF02828;PF00595;PF00069;PF00018;, GO:0015629;GO:0005604;GO:0005911;GO:0060170;GO:0005737;GO:0005829;GO:0005925;GO:0005652;GO:0016363;GO:0005730;GO:0005886;GO:0042734;GO:0005524;GO:0005516;GO:0004385;GO:0106310;GO:0004674;GO:0106311;GO:0007155;GO:0001953;GO:0090288;GO:0010839;GO:0061045;GO:0006836;, C:actin cytoskeleton; C:basement membrane; C:cell-cell junction; C:ciliary membrane; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear lamina; C:nuclear matrix; C:nucleolus; C:plasma membrane; C:presynaptic membrane;, F:ATP binding; F:calmodulin binding; F:guanylate kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular response to growth factor stimulus; P:negative regulation of keratinocyte proliferation; P:negative regulation of wound healing; P:neurotransmitter transport;|Q5VT19 Q66T42 Q9BYH6 Q9NYB2 Q9NYB3,Peripheral plasma membrane protein CASK,Calcium/calmodulin-dependent serine protein kinase;Protein lin-2 homolog;, PF00625;PF02828;PF00595;PF00069;PF00018;, GO:0015629;GO:0005604;GO:0005911;GO:0060170;GO:0005737;GO:0005829;GO:0005925;GO:0005652;GO:0016363;GO:0005730;GO:0005886;GO:0042734;GO:0005524;GO:0005516;GO:0004385;GO:0106310;GO:0004674;GO:0106311;GO:0007155;GO:0001953;GO:0090288;GO:0010839;GO:0061045;GO:0006836;, C:actin cytoskeleton; C:basement membrane; C:cell-cell junction; C:ciliary membrane; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear lamina; C:nuclear matrix; C:nucleolus; C:plasma membrane; C:presynaptic membrane;, F:ATP binding; F:calmodulin binding; F:guanylate kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of cellular response to growth factor stimulus; P:negative regulation of keratinocyte proliferation; P:negative regulation of wound healing; P:neurotransmitter transport; scaffold73 indexed_genome mRNA 11334 26201 . - . ID=transcript_11446;Q99624 B2R8Q0 Q6IB34,Sodium-coupled neutral amino acid transporter 3,N-system amino acid transporter 1;Na(+)-coupled neutral amino acid transporter 3;Solute carrier family 38 member 3;System N amino acid transporter 1;, PF01490;, GO:0016324;GO:0016323;GO:0005887;GO:0005886;GO:0015171;GO:0015297;GO:0015180;GO:0015182;GO:0015186;GO:0005290;GO:0015293;GO:0003333;GO:0006865;GO:0006867;GO:0007420;GO:0051365;GO:0007565;GO:0006868;GO:0015817;GO:0015808;GO:2000487;GO:0061402;GO:0006814;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:antiporter activity; F:L-alanine transmembrane transporter activity; F:L-asparagine transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:symporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:asparagine transport; P:brain development; P:cellular response to potassium ion starvation; P:female pregnancy; P:glutamine transport; P:histidine transport; P:L-alanine transport; P:positive regulation of glutamine transport; P:positive regulation of transcription from RNA polymerase II promoter in response to acidic pH; P:sodium ion transport; P:transport across blood-brain barrier;|Q99624 B2R8Q0 Q6IB34,Sodium-coupled neutral amino acid transporter 3,N-system amino acid transporter 1;Na(+)-coupled neutral amino acid transporter 3;Solute carrier family 38 member 3;System N amino acid transporter 1;, PF01490;, GO:0016324;GO:0016323;GO:0005887;GO:0005886;GO:0015171;GO:0015297;GO:0015180;GO:0015182;GO:0015186;GO:0005290;GO:0015293;GO:0003333;GO:0006865;GO:0006867;GO:0007420;GO:0051365;GO:0007565;GO:0006868;GO:0015817;GO:0015808;GO:2000487;GO:0061402;GO:0006814;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:antiporter activity; F:L-alanine transmembrane transporter activity; F:L-asparagine transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:symporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:asparagine transport; P:brain development; P:cellular response to potassium ion starvation; P:female pregnancy; P:glutamine transport; P:histidine transport; P:L-alanine transport; P:positive regulation of glutamine transport; P:positive regulation of transcription from RNA polymerase II promoter in response to acidic pH; P:sodium ion transport; P:transport across blood-brain barrier;|Q99624 B2R8Q0 Q6IB34,Sodium-coupled neutral amino acid transporter 3,N-system amino acid transporter 1;Na(+)-coupled neutral amino acid transporter 3;Solute carrier family 38 member 3;System N amino acid transporter 1;, PF01490;, GO:0016324;GO:0016323;GO:0005887;GO:0005886;GO:0015171;GO:0015297;GO:0015180;GO:0015182;GO:0015186;GO:0005290;GO:0015293;GO:0003333;GO:0006865;GO:0006867;GO:0007420;GO:0051365;GO:0007565;GO:0006868;GO:0015817;GO:0015808;GO:2000487;GO:0061402;GO:0006814;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:antiporter activity; F:L-alanine transmembrane transporter activity; F:L-asparagine transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-histidine transmembrane transporter activity; F:symporter activity;, P:amino acid transmembrane transport; P:amino acid transport; P:asparagine transport; P:brain development; P:cellular response to potassium ion starvation; P:female pregnancy; P:glutamine transport; P:histidine transport; P:L-alanine transport; P:positive regulation of glutamine transport; P:positive regulation of transcription from RNA polymerase II promoter in response to acidic pH; P:sodium ion transport; P:transport across blood-brain barrier; scaffold73 indexed_genome mRNA 33606 37309 . + . ID=transcript_11447;P11488 Q4VBN2,Guanine nucleotide-binding protein G(t) subunit alpha-1,Transducin alpha-1 chain;, PF00503;, GO:0016324;GO:0005829;GO:0005834;GO:0016020;GO:0043025;GO:0032391;GO:0097381;GO:0001917;GO:0001750;GO:0042622;GO:0005886;GO:0000035;GO:0001664;GO:0031683;GO:0019003;GO:0005525;GO:0003924;GO:0046872;GO:0019901;GO:0007193;GO:0007188;GO:0008283;GO:0071257;GO:0001580;GO:0050908;GO:0042462;GO:0001973;GO:0051344;GO:0007603;GO:0051343;GO:0006457;GO:0022400;GO:0009642;GO:0009416;GO:0060041;GO:0016056;GO:0050917;GO:0007165;GO:0007601;, C:apical plasma membrane; C:cytosol; C:heterotrimeric G-protein complex; C:membrane; C:neuronal cell body; C:photoreceptor connecting cilium; C:photoreceptor disc membrane; C:photoreceptor inner segment; C:photoreceptor outer segment; C:photoreceptor outer segment membrane; C:plasma membrane;, F:acyl binding; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:metal ion binding; F:protein kinase binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell population proliferation; P:cellular response to electrical stimulus; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:detection of light stimulus involved in visual perception; P:eye photoreceptor cell development; P:G protein-coupled adenosine receptor signaling pathway; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:phototransduction, visible light; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:protein folding; P:regulation of rhodopsin mediated signaling pathway; P:response to light intensity; P:response to light stimulus; P:retina development in camera-type eye; P:rhodopsin mediated signaling pathway; P:sensory perception of umami taste; P:signal transduction; P:visual perception; scaffold73 indexed_genome mRNA 41263 50952 . - . ID=transcript_11448;Q13275 C9JQ85 Q13274 Q13372 Q15704 Q6GTR4,Semaphorin-3F,Sema III/F;Semaphorin IV;, PF01403;, GO:0005615;GO:0098978;GO:0005887;GO:0045499;GO:0030215;GO:0048846;GO:0007411;GO:0021785;GO:0021612;GO:0050919;GO:0048843;GO:0021675;GO:0001755;GO:1901166;GO:0030335;GO:0099175;GO:0071526;GO:1902287;GO:1902285;GO:0061549;GO:0097490;GO:0097491;GO:0021637;GO:0036486;, C:extracellular space; C:glutamatergic synapse; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon extension involved in axon guidance; P:axon guidance; P:branchiomotor neuron axon guidance; P:facial nerve structural organization; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:nerve development; P:neural crest cell migration; P:neural crest cell migration involved in autonomic nervous system development; P:positive regulation of cell migration; P:regulation of postsynapse organization; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; P:sympathetic ganglion development; P:sympathetic neuron projection extension; P:sympathetic neuron projection guidance; P:trigeminal nerve structural organization; P:ventral trunk neural crest cell migration;|Q13275 C9JQ85 Q13274 Q13372 Q15704 Q6GTR4,Semaphorin-3F,Sema III/F;Semaphorin IV;, PF01403;, GO:0005615;GO:0098978;GO:0005887;GO:0045499;GO:0030215;GO:0048846;GO:0007411;GO:0021785;GO:0021612;GO:0050919;GO:0048843;GO:0021675;GO:0001755;GO:1901166;GO:0030335;GO:0099175;GO:0071526;GO:1902287;GO:1902285;GO:0061549;GO:0097490;GO:0097491;GO:0021637;GO:0036486;, C:extracellular space; C:glutamatergic synapse; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon extension involved in axon guidance; P:axon guidance; P:branchiomotor neuron axon guidance; P:facial nerve structural organization; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:nerve development; P:neural crest cell migration; P:neural crest cell migration involved in autonomic nervous system development; P:positive regulation of cell migration; P:regulation of postsynapse organization; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; P:sympathetic ganglion development; P:sympathetic neuron projection extension; P:sympathetic neuron projection guidance; P:trigeminal nerve structural organization; P:ventral trunk neural crest cell migration;|Q13275 C9JQ85 Q13274 Q13372 Q15704 Q6GTR4,Semaphorin-3F,Sema III/F;Semaphorin IV;, PF01403;, GO:0005615;GO:0098978;GO:0005887;GO:0045499;GO:0030215;GO:0048846;GO:0007411;GO:0021785;GO:0021612;GO:0050919;GO:0048843;GO:0021675;GO:0001755;GO:1901166;GO:0030335;GO:0099175;GO:0071526;GO:1902287;GO:1902285;GO:0061549;GO:0097490;GO:0097491;GO:0021637;GO:0036486;, C:extracellular space; C:glutamatergic synapse; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon extension involved in axon guidance; P:axon guidance; P:branchiomotor neuron axon guidance; P:facial nerve structural organization; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:nerve development; P:neural crest cell migration; P:neural crest cell migration involved in autonomic nervous system development; P:positive regulation of cell migration; P:regulation of postsynapse organization; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; P:sympathetic ganglion development; P:sympathetic neuron projection extension; P:sympathetic neuron projection guidance; P:trigeminal nerve structural organization; P:ventral trunk neural crest cell migration;|Q13275 C9JQ85 Q13274 Q13372 Q15704 Q6GTR4,Semaphorin-3F,Sema III/F;Semaphorin IV;, PF01403;, GO:0005615;GO:0098978;GO:0005887;GO:0045499;GO:0030215;GO:0048846;GO:0007411;GO:0021785;GO:0021612;GO:0050919;GO:0048843;GO:0021675;GO:0001755;GO:1901166;GO:0030335;GO:0099175;GO:0071526;GO:1902287;GO:1902285;GO:0061549;GO:0097490;GO:0097491;GO:0021637;GO:0036486;, C:extracellular space; C:glutamatergic synapse; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon extension involved in axon guidance; P:axon guidance; P:branchiomotor neuron axon guidance; P:facial nerve structural organization; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:nerve development; P:neural crest cell migration; P:neural crest cell migration involved in autonomic nervous system development; P:positive regulation of cell migration; P:regulation of postsynapse organization; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; P:sympathetic ganglion development; P:sympathetic neuron projection extension; P:sympathetic neuron projection guidance; P:trigeminal nerve structural organization; P:ventral trunk neural crest cell migration; scaffold73 indexed_genome mRNA 105936 128733 . - . ID=transcript_11449;Q9UL24,RNA-binding protein 5,Protein G15;Putative tumor suppressor LUCA15;RNA-binding motif protein 5;Renal carcinoma antigen NY-REN-9;, PF01585;PF17780;PF00076;PF00641;, GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0046872;GO:0003729;GO:0003723;GO:0006915;GO:0000398;GO:0008285;GO:0043065;GO:0000381;GO:0006396;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA processing; P:spliceosomal complex assembly;|Q9UL24,RNA-binding protein 5,Protein G15;Putative tumor suppressor LUCA15;RNA-binding motif protein 5;Renal carcinoma antigen NY-REN-9;, PF01585;PF17780;PF00076;PF00641;, GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0046872;GO:0003729;GO:0003723;GO:0006915;GO:0000398;GO:0008285;GO:0043065;GO:0000381;GO:0006396;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA processing; P:spliceosomal complex assembly;|Q9UL24,RNA-binding protein 5,Protein G15;Putative tumor suppressor LUCA15;RNA-binding motif protein 5;Renal carcinoma antigen NY-REN-9;, PF01585;PF17780;PF00076;PF00641;, GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0046872;GO:0003729;GO:0003723;GO:0006915;GO:0000398;GO:0008285;GO:0043065;GO:0000381;GO:0006396;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA processing; P:spliceosomal complex assembly;|Q9UL24,RNA-binding protein 5,Protein G15;Putative tumor suppressor LUCA15;RNA-binding motif protein 5;Renal carcinoma antigen NY-REN-9;, PF01585;PF17780;PF00076;PF00641;, GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0046872;GO:0003729;GO:0003723;GO:0006915;GO:0000398;GO:0008285;GO:0043065;GO:0000381;GO:0006396;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA processing; P:spliceosomal complex assembly;|Q9UL24,RNA-binding protein 5,Protein G15;Putative tumor suppressor LUCA15;RNA-binding motif protein 5;Renal carcinoma antigen NY-REN-9;, PF01585;PF17780;PF00076;PF00641;, GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0046872;GO:0003729;GO:0003723;GO:0006915;GO:0000398;GO:0008285;GO:0043065;GO:0000381;GO:0006396;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA processing; P:spliceosomal complex assembly;|Q9UL24,RNA-binding protein 5,Protein G15;Putative tumor suppressor LUCA15;RNA-binding motif protein 5;Renal carcinoma antigen NY-REN-9;, PF01585;PF17780;PF00076;PF00641;, GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0046872;GO:0003729;GO:0003723;GO:0006915;GO:0000398;GO:0008285;GO:0043065;GO:0000381;GO:0006396;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA processing; P:spliceosomal complex assembly;|Q9UL24,RNA-binding protein 5,Protein G15;Putative tumor suppressor LUCA15;RNA-binding motif protein 5;Renal carcinoma antigen NY-REN-9;, PF01585;PF17780;PF00076;PF00641;, GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0046872;GO:0003729;GO:0003723;GO:0006915;GO:0000398;GO:0008285;GO:0043065;GO:0000381;GO:0006396;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA processing; P:spliceosomal complex assembly;|Q9UL24,RNA-binding protein 5,Protein G15;Putative tumor suppressor LUCA15;RNA-binding motif protein 5;Renal carcinoma antigen NY-REN-9;, PF01585;PF17780;PF00076;PF00641;, GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0046872;GO:0003729;GO:0003723;GO:0006915;GO:0000398;GO:0008285;GO:0043065;GO:0000381;GO:0006396;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA processing; P:spliceosomal complex assembly;|Q9UL24,RNA-binding protein 5,Protein G15;Putative tumor suppressor LUCA15;RNA-binding motif protein 5;Renal carcinoma antigen NY-REN-9;, PF01585;PF17780;PF00076;PF00641;, GO:0005654;GO:0005634;GO:0005681;GO:0003677;GO:0046872;GO:0003729;GO:0003723;GO:0006915;GO:0000398;GO:0008285;GO:0043065;GO:0000381;GO:0006396;GO:0000245;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:DNA binding; F:metal ion binding; F:mRNA binding; F:RNA binding;, P:apoptotic process; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA processing; P:spliceosomal complex assembly; scaffold73 indexed_genome mRNA 134063 144407 . - . ID=transcript_11450;P78332 B4E0G6 O60549 O75524 Q86SS3,RNA-binding protein 6,Lung cancer antigen NY-LU-12;Protein G16;RNA-binding motif protein 6;RNA-binding protein DEF-3;, PF01585;PF17780;, GO:0005634;GO:0003677;GO:0003723;GO:0000398;GO:0006396;, C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing;|P78332 B4E0G6 O60549 O75524 Q86SS3,RNA-binding protein 6,Lung cancer antigen NY-LU-12;Protein G16;RNA-binding motif protein 6;RNA-binding protein DEF-3;, PF01585;PF17780;, GO:0005634;GO:0003677;GO:0003723;GO:0000398;GO:0006396;, C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing;|P78332 B4E0G6 O60549 O75524 Q86SS3,RNA-binding protein 6,Lung cancer antigen NY-LU-12;Protein G16;RNA-binding motif protein 6;RNA-binding protein DEF-3;, PF01585;PF17780;, GO:0005634;GO:0003677;GO:0003723;GO:0000398;GO:0006396;, C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing;|P78332 B4E0G6 O60549 O75524 Q86SS3,RNA-binding protein 6,Lung cancer antigen NY-LU-12;Protein G16;RNA-binding motif protein 6;RNA-binding protein DEF-3;, PF01585;PF17780;, GO:0005634;GO:0003677;GO:0003723;GO:0000398;GO:0006396;, C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing;|P78332 B4E0G6 O60549 O75524 Q86SS3,RNA-binding protein 6,Lung cancer antigen NY-LU-12;Protein G16;RNA-binding motif protein 6;RNA-binding protein DEF-3;, PF01585;PF17780;, GO:0005634;GO:0003677;GO:0003723;GO:0000398;GO:0006396;, C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing;|P78332 B4E0G6 O60549 O75524 Q86SS3,RNA-binding protein 6,Lung cancer antigen NY-LU-12;Protein G16;RNA-binding motif protein 6;RNA-binding protein DEF-3;, PF01585;PF17780;, GO:0005634;GO:0003677;GO:0003723;GO:0000398;GO:0006396;, C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing;|P78332 B4E0G6 O60549 O75524 Q86SS3,RNA-binding protein 6,Lung cancer antigen NY-LU-12;Protein G16;RNA-binding motif protein 6;RNA-binding protein DEF-3;, PF01585;PF17780;, GO:0005634;GO:0003677;GO:0003723;GO:0000398;GO:0006396;, C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing;|P78332 B4E0G6 O60549 O75524 Q86SS3,RNA-binding protein 6,Lung cancer antigen NY-LU-12;Protein G16;RNA-binding motif protein 6;RNA-binding protein DEF-3;, PF01585;PF17780;, GO:0005634;GO:0003677;GO:0003723;GO:0000398;GO:0006396;, C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing; scaffold73 indexed_genome mRNA 146270 218178 . - . ID=transcript_11451;P78332 B4E0G6 O60549 O75524 Q86SS3,RNA-binding protein 6,Lung cancer antigen NY-LU-12;Protein G16;RNA-binding motif protein 6;RNA-binding protein DEF-3;, PF01585;PF17780;, GO:0005634;GO:0003677;GO:0003723;GO:0000398;GO:0006396;, C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing;|P78332 B4E0G6 O60549 O75524 Q86SS3,RNA-binding protein 6,Lung cancer antigen NY-LU-12;Protein G16;RNA-binding motif protein 6;RNA-binding protein DEF-3;, PF01585;PF17780;, GO:0005634;GO:0003677;GO:0003723;GO:0000398;GO:0006396;, C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA processing; scaffold73 indexed_genome mRNA 222032 233752 . + . ID=transcript_11452;Q86VX9 B2RDQ1 G5E9N1 Q8NAV7 Q9BRF3 X6R3V9,Vacuolar fusion protein MON1 homolog A,, PF19036;PF19037;PF19038;, GO:0005829;GO:0035658;GO:0005085;GO:0009306;GO:0006623;GO:0016192;, C:cytosol; C:Mon1-Ccz1 complex;, F:guanyl-nucleotide exchange factor activity;, P:protein secretion; P:protein targeting to vacuole; P:vesicle-mediated transport; scaffold73 indexed_genome mRNA 237695 238922 . - . ID=transcript_11453;Q04912 A0A087WZG2 B5A944 B5A945 B5A946 B5A947,Macrophage-stimulating protein receptor,CDw136;Protein-tyrosine kinase 8;p185-Ron;, PF07714;PF01403;PF01833;, GO:0009925;GO:0009986;GO:0005887;GO:0005886;GO:0043235;GO:0001725;GO:0005773;GO:0005524;GO:0019899;GO:0005011;GO:0004714;GO:0016477;GO:0006952;GO:0048012;GO:0045087;GO:0007275;GO:0007399;GO:0006909;GO:0008284;GO:0033674;GO:0043406;GO:0051897;GO:0009615;GO:0007165;GO:0007338;GO:0007169;, C:basal plasma membrane; C:cell surface; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:stress fiber; C:vacuole;, F:ATP binding; F:enzyme binding; F:macrophage colony-stimulating factor receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:defense response; P:hepatocyte growth factor receptor signaling pathway; P:innate immune response; P:multicellular organism development; P:nervous system development; P:phagocytosis; P:positive regulation of cell population proliferation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein kinase B signaling; P:response to virus; P:signal transduction; P:single fertilization; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold73 indexed_genome mRNA 239079 250762 . + . ID=transcript_11454;Q04912 A0A087WZG2 B5A944 B5A945 B5A946 B5A947,Macrophage-stimulating protein receptor,CDw136;Protein-tyrosine kinase 8;p185-Ron;, PF07714;PF01403;PF01833;, GO:0009925;GO:0009986;GO:0005887;GO:0005886;GO:0043235;GO:0001725;GO:0005773;GO:0005524;GO:0019899;GO:0005011;GO:0004714;GO:0016477;GO:0006952;GO:0048012;GO:0045087;GO:0007275;GO:0007399;GO:0006909;GO:0008284;GO:0033674;GO:0043406;GO:0051897;GO:0009615;GO:0007165;GO:0007338;GO:0007169;, C:basal plasma membrane; C:cell surface; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:stress fiber; C:vacuole;, F:ATP binding; F:enzyme binding; F:macrophage colony-stimulating factor receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:defense response; P:hepatocyte growth factor receptor signaling pathway; P:innate immune response; P:multicellular organism development; P:nervous system development; P:phagocytosis; P:positive regulation of cell population proliferation; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of protein kinase B signaling; P:response to virus; P:signal transduction; P:single fertilization; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold73 indexed_genome mRNA 273847 275006 . + . ID=transcript_11455;Q8NCB2 A6NFD4 Q6FIB8 Q8NBS8 Q8NC85 Q8NDU4 Q8WTT8 Q9BQC9 Q9H0Q5,CaM kinase-like vesicle-associated protein,, PF00069;, GO:0030659;GO:0098978;GO:0005886;GO:0005524;GO:0005516;GO:0004683;GO:0018105;GO:0099159;, C:cytoplasmic vesicle membrane; C:glutamatergic synapse; C:plasma membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity;, P:peptidyl-serine phosphorylation; P:regulation of modification of postsynaptic structure; scaffold73 indexed_genome mRNA 275121 276475 . + . ID=transcript_11456;Q8NCB2 A6NFD4 Q6FIB8 Q8NBS8 Q8NC85 Q8NDU4 Q8WTT8 Q9BQC9 Q9H0Q5,CaM kinase-like vesicle-associated protein,, PF00069;, GO:0030659;GO:0098978;GO:0005886;GO:0005524;GO:0005516;GO:0004683;GO:0018105;GO:0099159;, C:cytoplasmic vesicle membrane; C:glutamatergic synapse; C:plasma membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity;, P:peptidyl-serine phosphorylation; P:regulation of modification of postsynaptic structure; scaffold73 indexed_genome mRNA 279720 294494 . + . ID=transcript_11457;Q9BWF2 B5BU84 B5BUL3 O00467,E3 ubiquitin-protein ligase TRAIP {ECO:0000305},RING finger protein 206 {ECO:0000303|PubMed:26781088};TRAF-interacting protein {ECO:0000303|PubMed:26595769, ECO:0000303|PubMed:9104814};, PF13639;, GO:0005730;GO:0005654;GO:0048471;GO:0090734;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0006915;GO:0006974;GO:0032688;GO:0032088;GO:0010804;GO:0016567;GO:0106300;GO:0031297;GO:0007165;, C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:site of DNA damage;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:negative regulation of interferon-beta production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:protein ubiquitination; P:protein-DNA covalent cross-linking repair; P:replication fork processing; P:signal transduction; scaffold73 indexed_genome mRNA 294728 296041 . + . ID=transcript_11458;Q9BWF2 B5BU84 B5BUL3 O00467,E3 ubiquitin-protein ligase TRAIP {ECO:0000305},RING finger protein 206 {ECO:0000303|PubMed:26781088};TRAF-interacting protein {ECO:0000303|PubMed:26595769, ECO:0000303|PubMed:9104814};, PF13639;, GO:0005730;GO:0005654;GO:0048471;GO:0090734;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0006915;GO:0006974;GO:0032688;GO:0032088;GO:0010804;GO:0016567;GO:0106300;GO:0031297;GO:0007165;, C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:site of DNA damage;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:negative regulation of interferon-beta production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:protein ubiquitination; P:protein-DNA covalent cross-linking repair; P:replication fork processing; P:signal transduction; scaffold73 indexed_genome mRNA 299979 309080 . + . ID=transcript_11459;P41226 Q9BRB2,Ubiquitin-like modifier-activating enzyme 7,D8;Ubiquitin-activating enzyme E1 homolog;, PF16191;PF16190;PF09358;PF00899;PF10585;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0019782;GO:0004842;GO:0006464;GO:0006974;GO:0032020;GO:0019941;GO:0032480;GO:0032446;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ISG15 activating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:ISG15-protein conjugation; P:modification-dependent protein catabolic process; P:negative regulation of type I interferon production; P:protein modification by small protein conjugation;|P41226 Q9BRB2,Ubiquitin-like modifier-activating enzyme 7,D8;Ubiquitin-activating enzyme E1 homolog;, PF16191;PF16190;PF09358;PF00899;PF10585;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0019782;GO:0004842;GO:0006464;GO:0006974;GO:0032020;GO:0019941;GO:0032480;GO:0032446;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ISG15 activating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:ISG15-protein conjugation; P:modification-dependent protein catabolic process; P:negative regulation of type I interferon production; P:protein modification by small protein conjugation;|P41226 Q9BRB2,Ubiquitin-like modifier-activating enzyme 7,D8;Ubiquitin-activating enzyme E1 homolog;, PF16191;PF16190;PF09358;PF00899;PF10585;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0019782;GO:0004842;GO:0006464;GO:0006974;GO:0032020;GO:0019941;GO:0032480;GO:0032446;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ISG15 activating enzyme activity; F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:ISG15-protein conjugation; P:modification-dependent protein catabolic process; P:negative regulation of type I interferon production; P:protein modification by small protein conjugation; scaffold73 indexed_genome mRNA 309182 310423 . - . ID=transcript_11460;Q96EL1,PAK4-inhibitor INKA1 {ECO:0000305},Induced in neural crest by AP2-alpha protein homolog {ECO:0000303|PubMed:17314132};Inka box actin regulator 1 {ECO:0000312|HGNC:HGNC:32480};, PF15342;, GO:0005737;GO:0005634;GO:0019901;GO:0030291;, C:cytoplasm; C:nucleus;, F:protein kinase binding; F:protein serine/threonine kinase inhibitor activity; scaffold73 indexed_genome mRNA 313289 320626 . - . ID=transcript_11461;A6H8M9 Q6UXT0,Cadherin-related family member 4,Cadherin-like protein 29;, PF00028;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|A6H8M9 Q6UXT0,Cadherin-related family member 4,Cadherin-like protein 29;, PF00028;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|A6H8M9 Q6UXT0,Cadherin-related family member 4,Cadherin-like protein 29;, PF00028;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold73 indexed_genome mRNA 332766 360934 . + . ID=transcript_11462;Q92551 A8K157 A8MUX4 Q7L3I7 Q96E38,Inositol hexakisphosphate kinase 1,Inositol hexaphosphate kinase 1;, PF03770;, GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0016301;GO:0032958;GO:0043647;GO:0120163;GO:0046854;, C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity; F:kinase activity;, P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:negative regulation of cold-induced thermogenesis; P:phosphatidylinositol phosphorylation;|Q13155 F8W950 Q75MR1 Q96CZ5 Q9P1L2,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2,Multisynthase complex auxiliary component p38;Protein JTV-1;, PF16780;PF00043;PF18569;, GO:0017101;GO:0005829;GO:0016020;GO:0005634;GO:0060090;GO:0006915;GO:0008285;GO:1903632;GO:1901216;GO:0031398;GO:0065003;GO:0006418;GO:0060510;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytosol; C:membrane; C:nucleus;, F:molecular adaptor activity;, P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of aminoacyl-tRNA ligase activity; P:positive regulation of neuron death; P:positive regulation of protein ubiquitination; P:protein-containing complex assembly; P:tRNA aminoacylation for protein translation; P:type II pneumocyte differentiation;|Q92551 A8K157 A8MUX4 Q7L3I7 Q96E38,Inositol hexakisphosphate kinase 1,Inositol hexaphosphate kinase 1;, PF03770;, GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0052723;GO:0052724;GO:0000832;GO:0000828;GO:0000827;GO:0016301;GO:0032958;GO:0043647;GO:0120163;GO:0046854;, C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:inositol hexakisphosphate 1-kinase activity; F:inositol hexakisphosphate 3-kinase activity; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity; F:kinase activity;, P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:negative regulation of cold-induced thermogenesis; P:phosphatidylinositol phosphorylation; scaffold73 indexed_genome mRNA 361274 408447 . + . ID=transcript_11463;Q9Y5P6 A8K6N5 Q9H7U3,Mannose-1-phosphate guanyltransferase beta,GDP-mannose pyrophosphorylase B;GTP-mannose-1-phosphate guanylyltransferase beta;, PF00132;PF00483;, GO:0005737;GO:0005525;GO:0004475;GO:0009298;, C:cytoplasm;, F:GTP binding; F:mannose-1-phosphate guanylyltransferase activity;, P:GDP-mannose biosynthetic process;|Q9H9T2,E3 ubiquitin-protein ligase RNF123,Kip1 ubiquitination-promoting complex protein 1;RING finger protein 123;RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};, PF00622;, GO:0005737;GO:0005829;GO:0031965;GO:0046872;GO:0004842;GO:0016579;GO:0051603;, C:cytoplasm; C:cytosol; C:nuclear membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein deubiquitination; P:proteolysis involved in cellular protein catabolic process;|Q9H9T2,E3 ubiquitin-protein ligase RNF123,Kip1 ubiquitination-promoting complex protein 1;RING finger protein 123;RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};, PF00622;, GO:0005737;GO:0005829;GO:0031965;GO:0046872;GO:0004842;GO:0016579;GO:0051603;, C:cytoplasm; C:cytosol; C:nuclear membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein deubiquitination; P:proteolysis involved in cellular protein catabolic process;|Q86WK7 Q494V6 Q96JH6,Amphoterin-induced protein 3,AMIGO-3;Alivin-3;, PF13855;, GO:0016021;GO:0007420;GO:0007157;GO:0051965;, C:integral component of membrane;, , P:brain development; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse assembly;|Q9H9T2,E3 ubiquitin-protein ligase RNF123,Kip1 ubiquitination-promoting complex protein 1;RING finger protein 123;RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};, PF00622;, GO:0005737;GO:0005829;GO:0031965;GO:0046872;GO:0004842;GO:0016579;GO:0051603;, C:cytoplasm; C:cytosol; C:nuclear membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein deubiquitination; P:proteolysis involved in cellular protein catabolic process;|Q9H9T2,E3 ubiquitin-protein ligase RNF123,Kip1 ubiquitination-promoting complex protein 1;RING finger protein 123;RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};, PF00622;, GO:0005737;GO:0005829;GO:0031965;GO:0046872;GO:0004842;GO:0016579;GO:0051603;, C:cytoplasm; C:cytosol; C:nuclear membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein deubiquitination; P:proteolysis involved in cellular protein catabolic process;|Q9H9T2,E3 ubiquitin-protein ligase RNF123,Kip1 ubiquitination-promoting complex protein 1;RING finger protein 123;RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};, PF00622;, GO:0005737;GO:0005829;GO:0031965;GO:0046872;GO:0004842;GO:0016579;GO:0051603;, C:cytoplasm; C:cytosol; C:nuclear membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein deubiquitination; P:proteolysis involved in cellular protein catabolic process;|Q9H9T2,E3 ubiquitin-protein ligase RNF123,Kip1 ubiquitination-promoting complex protein 1;RING finger protein 123;RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};, PF00622;, GO:0005737;GO:0005829;GO:0031965;GO:0046872;GO:0004842;GO:0016579;GO:0051603;, C:cytoplasm; C:cytosol; C:nuclear membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein deubiquitination; P:proteolysis involved in cellular protein catabolic process;|Q9H9T2,E3 ubiquitin-protein ligase RNF123,Kip1 ubiquitination-promoting complex protein 1;RING finger protein 123;RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};, PF00622;, GO:0005737;GO:0005829;GO:0031965;GO:0046872;GO:0004842;GO:0016579;GO:0051603;, C:cytoplasm; C:cytosol; C:nuclear membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein deubiquitination; P:proteolysis involved in cellular protein catabolic process;|Q9H9T2,E3 ubiquitin-protein ligase RNF123,Kip1 ubiquitination-promoting complex protein 1;RING finger protein 123;RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};, PF00622;, GO:0005737;GO:0005829;GO:0031965;GO:0046872;GO:0004842;GO:0016579;GO:0051603;, C:cytoplasm; C:cytosol; C:nuclear membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein deubiquitination; P:proteolysis involved in cellular protein catabolic process;|Q9H9T2,E3 ubiquitin-protein ligase RNF123,Kip1 ubiquitination-promoting complex protein 1;RING finger protein 123;RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};, PF00622;, GO:0005737;GO:0005829;GO:0031965;GO:0046872;GO:0004842;GO:0016579;GO:0051603;, C:cytoplasm; C:cytosol; C:nuclear membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein deubiquitination; P:proteolysis involved in cellular protein catabolic process;|P26927 A6NLA3 A8MSX3 Q13350 Q14870 Q6GTN4,Hepatocyte growth factor-like protein,Macrophage stimulatory protein;Macrophage-stimulating protein;, PF00051;PF00024;PF00089;, GO:0062023;GO:0005576;GO:0005615;GO:0030971;GO:0004252;GO:0048012;GO:0035978;GO:0045721;GO:0033601;GO:2000479;GO:0010758;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:receptor tyrosine kinase binding; F:serine-type endopeptidase activity;, P:hepatocyte growth factor receptor signaling pathway; P:histone H2A-S139 phosphorylation; P:negative regulation of gluconeogenesis; P:positive regulation of mammary gland epithelial cell proliferation; P:regulation of cAMP-dependent protein kinase activity; P:regulation of macrophage chemotaxis;|Q9H9T2,E3 ubiquitin-protein ligase RNF123,Kip1 ubiquitination-promoting complex protein 1;RING finger protein 123;RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};, PF00622;, GO:0005737;GO:0005829;GO:0031965;GO:0046872;GO:0004842;GO:0016579;GO:0051603;, C:cytoplasm; C:cytosol; C:nuclear membrane;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:protein deubiquitination; P:proteolysis involved in cellular protein catabolic process;|P26927 A6NLA3 A8MSX3 Q13350 Q14870 Q6GTN4,Hepatocyte growth factor-like protein,Macrophage stimulatory protein;Macrophage-stimulating protein;, PF00051;PF00024;PF00089;, GO:0062023;GO:0005576;GO:0005615;GO:0030971;GO:0004252;GO:0048012;GO:0035978;GO:0045721;GO:0033601;GO:2000479;GO:0010758;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:receptor tyrosine kinase binding; F:serine-type endopeptidase activity;, P:hepatocyte growth factor receptor signaling pathway; P:histone H2A-S139 phosphorylation; P:negative regulation of gluconeogenesis; P:positive regulation of mammary gland epithelial cell proliferation; P:regulation of cAMP-dependent protein kinase activity; P:regulation of macrophage chemotaxis;|P26927 A6NLA3 A8MSX3 Q13350 Q14870 Q6GTN4,Hepatocyte growth factor-like protein,Macrophage stimulatory protein;Macrophage-stimulating protein;, PF00051;PF00024;PF00089;, GO:0062023;GO:0005576;GO:0005615;GO:0030971;GO:0004252;GO:0048012;GO:0035978;GO:0045721;GO:0033601;GO:2000479;GO:0010758;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:receptor tyrosine kinase binding; F:serine-type endopeptidase activity;, P:hepatocyte growth factor receptor signaling pathway; P:histone H2A-S139 phosphorylation; P:negative regulation of gluconeogenesis; P:positive regulation of mammary gland epithelial cell proliferation; P:regulation of cAMP-dependent protein kinase activity; P:regulation of macrophage chemotaxis;|P26927 A6NLA3 A8MSX3 Q13350 Q14870 Q6GTN4,Hepatocyte growth factor-like protein,Macrophage stimulatory protein;Macrophage-stimulating protein;, PF00051;PF00024;PF00089;, GO:0062023;GO:0005576;GO:0005615;GO:0030971;GO:0004252;GO:0048012;GO:0035978;GO:0045721;GO:0033601;GO:2000479;GO:0010758;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:receptor tyrosine kinase binding; F:serine-type endopeptidase activity;, P:hepatocyte growth factor receptor signaling pathway; P:histone H2A-S139 phosphorylation; P:negative regulation of gluconeogenesis; P:positive regulation of mammary gland epithelial cell proliferation; P:regulation of cAMP-dependent protein kinase activity; P:regulation of macrophage chemotaxis;|P13798 Q9BQ33 Q9P0Y2,Acylamino-acid-releasing enzyme,Acyl-peptide hydrolase;Acylaminoacyl-peptidase;Oxidized protein hydrolase;, PF00326;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0031965;GO:0042802;GO:0008242;GO:0003723;GO:0004252;GO:0050435;GO:0043312;GO:0006508;GO:0006415;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nuclear membrane;, F:identical protein binding; F:omega peptidase activity; F:RNA binding; F:serine-type endopeptidase activity;, P:amyloid-beta metabolic process; P:neutrophil degranulation; P:proteolysis; P:translational termination;|P13798 Q9BQ33 Q9P0Y2,Acylamino-acid-releasing enzyme,Acyl-peptide hydrolase;Acylaminoacyl-peptidase;Oxidized protein hydrolase;, PF00326;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0031965;GO:0042802;GO:0008242;GO:0003723;GO:0004252;GO:0050435;GO:0043312;GO:0006508;GO:0006415;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nuclear membrane;, F:identical protein binding; F:omega peptidase activity; F:RNA binding; F:serine-type endopeptidase activity;, P:amyloid-beta metabolic process; P:neutrophil degranulation; P:proteolysis; P:translational termination;|P13798 Q9BQ33 Q9P0Y2,Acylamino-acid-releasing enzyme,Acyl-peptide hydrolase;Acylaminoacyl-peptidase;Oxidized protein hydrolase;, PF00326;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0031965;GO:0042802;GO:0008242;GO:0003723;GO:0004252;GO:0050435;GO:0043312;GO:0006508;GO:0006415;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nuclear membrane;, F:identical protein binding; F:omega peptidase activity; F:RNA binding; F:serine-type endopeptidase activity;, P:amyloid-beta metabolic process; P:neutrophil degranulation; P:proteolysis; P:translational termination;|P13798 Q9BQ33 Q9P0Y2,Acylamino-acid-releasing enzyme,Acyl-peptide hydrolase;Acylaminoacyl-peptidase;Oxidized protein hydrolase;, PF00326;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0031965;GO:0042802;GO:0008242;GO:0003723;GO:0004252;GO:0050435;GO:0043312;GO:0006508;GO:0006415;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nuclear membrane;, F:identical protein binding; F:omega peptidase activity; F:RNA binding; F:serine-type endopeptidase activity;, P:amyloid-beta metabolic process; P:neutrophil degranulation; P:proteolysis; P:translational termination; scaffold73 indexed_genome mRNA 417738 428233 . - . ID=transcript_11464;Q9UPA5 O43161 Q7LGH3,Protein bassoon {ECO:0000305},Zinc finger protein 231;, PF05715;, GO:0030424;GO:0009986;GO:0048788;GO:0030425;GO:0060076;GO:0098982;GO:0098978;GO:0044306;GO:0005634;GO:0014069;GO:0048786;GO:0098685;GO:0008021;GO:0030672;GO:0046872;GO:0098882;GO:0007268;GO:0099526;GO:1904071;GO:0035418;GO:0098693;, C:axon; C:cell surface; C:cytoskeleton of presynaptic active zone; C:dendrite; C:excitatory synapse; C:GABA-ergic synapse; C:glutamatergic synapse; C:neuron projection terminus; C:nucleus; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:metal ion binding; F:structural constituent of presynaptic active zone;, P:chemical synaptic transmission; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of synaptic vesicle cycle;|Q9UPA5 O43161 Q7LGH3,Protein bassoon {ECO:0000305},Zinc finger protein 231;, PF05715;, GO:0030424;GO:0009986;GO:0048788;GO:0030425;GO:0060076;GO:0098982;GO:0098978;GO:0044306;GO:0005634;GO:0014069;GO:0048786;GO:0098685;GO:0008021;GO:0030672;GO:0046872;GO:0098882;GO:0007268;GO:0099526;GO:1904071;GO:0035418;GO:0098693;, C:axon; C:cell surface; C:cytoskeleton of presynaptic active zone; C:dendrite; C:excitatory synapse; C:GABA-ergic synapse; C:glutamatergic synapse; C:neuron projection terminus; C:nucleus; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:metal ion binding; F:structural constituent of presynaptic active zone;, P:chemical synaptic transmission; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of synaptic vesicle cycle; scaffold73 indexed_genome mRNA 428267 489055 . + . ID=transcript_11465;Q9UPA5 O43161 Q7LGH3,Protein bassoon {ECO:0000305},Zinc finger protein 231;, PF05715;, GO:0030424;GO:0009986;GO:0048788;GO:0030425;GO:0060076;GO:0098982;GO:0098978;GO:0044306;GO:0005634;GO:0014069;GO:0048786;GO:0098685;GO:0008021;GO:0030672;GO:0046872;GO:0098882;GO:0007268;GO:0099526;GO:1904071;GO:0035418;GO:0098693;, C:axon; C:cell surface; C:cytoskeleton of presynaptic active zone; C:dendrite; C:excitatory synapse; C:GABA-ergic synapse; C:glutamatergic synapse; C:neuron projection terminus; C:nucleus; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:metal ion binding; F:structural constituent of presynaptic active zone;, P:chemical synaptic transmission; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of synaptic vesicle cycle;|Q9UPA5 O43161 Q7LGH3,Protein bassoon {ECO:0000305},Zinc finger protein 231;, PF05715;, GO:0030424;GO:0009986;GO:0048788;GO:0030425;GO:0060076;GO:0098982;GO:0098978;GO:0044306;GO:0005634;GO:0014069;GO:0048786;GO:0098685;GO:0008021;GO:0030672;GO:0046872;GO:0098882;GO:0007268;GO:0099526;GO:1904071;GO:0035418;GO:0098693;, C:axon; C:cell surface; C:cytoskeleton of presynaptic active zone; C:dendrite; C:excitatory synapse; C:GABA-ergic synapse; C:glutamatergic synapse; C:neuron projection terminus; C:nucleus; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:metal ion binding; F:structural constituent of presynaptic active zone;, P:chemical synaptic transmission; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of synaptic vesicle cycle; scaffold73 indexed_genome mRNA 501532 512046 . - . ID=transcript_11466;Q14118 A8K6M7 Q969J9,Dystroglycan,Dystrophin-associated glycoprotein 1;, PF18424;PF05454;, GO:0005912;GO:0009925;GO:0005604;GO:0062023;GO:0070938;GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0016011;GO:0016010;GO:0005788;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0030175;GO:0005925;GO:0098982;GO:0098978;GO:0005796;GO:0016021;GO:0043231;GO:0030027;GO:0033268;GO:0034399;GO:0005654;GO:0005886;GO:0044853;GO:0099524;GO:0045211;GO:0042383;GO:0003779;GO:0051393;GO:0005509;GO:0002162;GO:0043236;GO:0043237;GO:0042169;GO:0008307;GO:0015631;GO:0017166;GO:0001618;GO:0007568;GO:0060055;GO:0007411;GO:0031103;GO:0071711;GO:0060445;GO:0016340;GO:0071397;GO:0071260;GO:0071679;GO:0060441;GO:0030198;GO:0006509;GO:0034453;GO:0019048;GO:0002011;GO:0002009;GO:0016203;GO:0022011;GO:0030336;GO:0043409;GO:0051898;GO:0021675;GO:0021682;GO:1904261;GO:0001954;GO:0031643;GO:0048714;GO:0045860;GO:0016476;GO:0010717;GO:0010470;GO:0098696;GO:0050807;GO:0014894;GO:0043434;GO:0098942;GO:0043403;, C:adherens junction; C:basal plasma membrane; C:basement membrane; C:collagen-containing extracellular matrix; C:contractile ring; C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dystroglycan complex; C:dystrophin-associated glycoprotein complex; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:filopodium; C:focal adhesion; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi lumen; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lamellipodium; C:node of Ranvier; C:nuclear periphery; C:nucleoplasm; C:plasma membrane; C:plasma membrane raft; C:postsynaptic cytosol; C:postsynaptic membrane; C:sarcolemma;, F:actin binding; F:alpha-actinin binding; F:calcium ion binding; F:dystroglycan binding; F:laminin binding; F:laminin-1 binding; F:SH2 domain binding; F:structural constituent of muscle; F:tubulin binding; F:vinculin binding; F:virus receptor activity;, P:aging; P:angiogenesis involved in wound healing; P:axon guidance; P:axon regeneration; P:basement membrane organization; P:branching involved in salivary gland morphogenesis; P:calcium-dependent cell-matrix adhesion; P:cellular response to cholesterol; P:cellular response to mechanical stimulus; P:commissural neuron axon guidance; P:epithelial tube branching involved in lung morphogenesis; P:extracellular matrix organization; P:membrane protein ectodomain proteolysis; P:microtubule anchoring; P:modulation by virus of host process; P:morphogenesis of an epithelial sheet; P:morphogenesis of an epithelium; P:muscle attachment; P:myelination in peripheral nervous system; P:negative regulation of cell migration; P:negative regulation of MAPK cascade; P:negative regulation of protein kinase B signaling; P:nerve development; P:nerve maturation; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of cell-matrix adhesion; P:positive regulation of myelination; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of protein kinase activity; P:regulation of embryonic cell shape; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:regulation of synapse organization; P:response to denervation involved in regulation of muscle adaptation; P:response to peptide hormone; P:retrograde trans-synaptic signaling by trans-synaptic protein complex; P:skeletal muscle tissue regeneration;|Q14118 A8K6M7 Q969J9,Dystroglycan,Dystrophin-associated glycoprotein 1;, PF18424;PF05454;, GO:0005912;GO:0009925;GO:0005604;GO:0062023;GO:0070938;GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0016011;GO:0016010;GO:0005788;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0030175;GO:0005925;GO:0098982;GO:0098978;GO:0005796;GO:0016021;GO:0043231;GO:0030027;GO:0033268;GO:0034399;GO:0005654;GO:0005886;GO:0044853;GO:0099524;GO:0045211;GO:0042383;GO:0003779;GO:0051393;GO:0005509;GO:0002162;GO:0043236;GO:0043237;GO:0042169;GO:0008307;GO:0015631;GO:0017166;GO:0001618;GO:0007568;GO:0060055;GO:0007411;GO:0031103;GO:0071711;GO:0060445;GO:0016340;GO:0071397;GO:0071260;GO:0071679;GO:0060441;GO:0030198;GO:0006509;GO:0034453;GO:0019048;GO:0002011;GO:0002009;GO:0016203;GO:0022011;GO:0030336;GO:0043409;GO:0051898;GO:0021675;GO:0021682;GO:1904261;GO:0001954;GO:0031643;GO:0048714;GO:0045860;GO:0016476;GO:0010717;GO:0010470;GO:0098696;GO:0050807;GO:0014894;GO:0043434;GO:0098942;GO:0043403;, C:adherens junction; C:basal plasma membrane; C:basement membrane; C:collagen-containing extracellular matrix; C:contractile ring; C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dystroglycan complex; C:dystrophin-associated glycoprotein complex; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:filopodium; C:focal adhesion; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi lumen; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lamellipodium; C:node of Ranvier; C:nuclear periphery; C:nucleoplasm; C:plasma membrane; C:plasma membrane raft; C:postsynaptic cytosol; C:postsynaptic membrane; C:sarcolemma;, F:actin binding; F:alpha-actinin binding; F:calcium ion binding; F:dystroglycan binding; F:laminin binding; F:laminin-1 binding; F:SH2 domain binding; F:structural constituent of muscle; F:tubulin binding; F:vinculin binding; F:virus receptor activity;, P:aging; P:angiogenesis involved in wound healing; P:axon guidance; P:axon regeneration; P:basement membrane organization; P:branching involved in salivary gland morphogenesis; P:calcium-dependent cell-matrix adhesion; P:cellular response to cholesterol; P:cellular response to mechanical stimulus; P:commissural neuron axon guidance; P:epithelial tube branching involved in lung morphogenesis; P:extracellular matrix organization; P:membrane protein ectodomain proteolysis; P:microtubule anchoring; P:modulation by virus of host process; P:morphogenesis of an epithelial sheet; P:morphogenesis of an epithelium; P:muscle attachment; P:myelination in peripheral nervous system; P:negative regulation of cell migration; P:negative regulation of MAPK cascade; P:negative regulation of protein kinase B signaling; P:nerve development; P:nerve maturation; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of cell-matrix adhesion; P:positive regulation of myelination; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of protein kinase activity; P:regulation of embryonic cell shape; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:regulation of synapse organization; P:response to denervation involved in regulation of muscle adaptation; P:response to peptide hormone; P:retrograde trans-synaptic signaling by trans-synaptic protein complex; P:skeletal muscle tissue regeneration; scaffold73 indexed_genome mRNA 517343 518610 . + . ID=transcript_11467;Q14118 A8K6M7 Q969J9,Dystroglycan,Dystrophin-associated glycoprotein 1;, PF18424;PF05454;, GO:0005912;GO:0009925;GO:0005604;GO:0062023;GO:0070938;GO:0043034;GO:0005737;GO:0005856;GO:0005829;GO:0016011;GO:0016010;GO:0005788;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0030175;GO:0005925;GO:0098982;GO:0098978;GO:0005796;GO:0016021;GO:0043231;GO:0030027;GO:0033268;GO:0034399;GO:0005654;GO:0005886;GO:0044853;GO:0099524;GO:0045211;GO:0042383;GO:0003779;GO:0051393;GO:0005509;GO:0002162;GO:0043236;GO:0043237;GO:0042169;GO:0008307;GO:0015631;GO:0017166;GO:0001618;GO:0007568;GO:0060055;GO:0007411;GO:0031103;GO:0071711;GO:0060445;GO:0016340;GO:0071397;GO:0071260;GO:0071679;GO:0060441;GO:0030198;GO:0006509;GO:0034453;GO:0019048;GO:0002011;GO:0002009;GO:0016203;GO:0022011;GO:0030336;GO:0043409;GO:0051898;GO:0021675;GO:0021682;GO:1904261;GO:0001954;GO:0031643;GO:0048714;GO:0045860;GO:0016476;GO:0010717;GO:0010470;GO:0098696;GO:0050807;GO:0014894;GO:0043434;GO:0098942;GO:0043403;, C:adherens junction; C:basal plasma membrane; C:basement membrane; C:collagen-containing extracellular matrix; C:contractile ring; C:costamere; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dystroglycan complex; C:dystrophin-associated glycoprotein complex; C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:filopodium; C:focal adhesion; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi lumen; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lamellipodium; C:node of Ranvier; C:nuclear periphery; C:nucleoplasm; C:plasma membrane; C:plasma membrane raft; C:postsynaptic cytosol; C:postsynaptic membrane; C:sarcolemma;, F:actin binding; F:alpha-actinin binding; F:calcium ion binding; F:dystroglycan binding; F:laminin binding; F:laminin-1 binding; F:SH2 domain binding; F:structural constituent of muscle; F:tubulin binding; F:vinculin binding; F:virus receptor activity;, P:aging; P:angiogenesis involved in wound healing; P:axon guidance; P:axon regeneration; P:basement membrane organization; P:branching involved in salivary gland morphogenesis; P:calcium-dependent cell-matrix adhesion; P:cellular response to cholesterol; P:cellular response to mechanical stimulus; P:commissural neuron axon guidance; P:epithelial tube branching involved in lung morphogenesis; P:extracellular matrix organization; P:membrane protein ectodomain proteolysis; P:microtubule anchoring; P:modulation by virus of host process; P:morphogenesis of an epithelial sheet; P:morphogenesis of an epithelium; P:muscle attachment; P:myelination in peripheral nervous system; P:negative regulation of cell migration; P:negative regulation of MAPK cascade; P:negative regulation of protein kinase B signaling; P:nerve development; P:nerve maturation; P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis; P:positive regulation of cell-matrix adhesion; P:positive regulation of myelination; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of protein kinase activity; P:regulation of embryonic cell shape; P:regulation of epithelial to mesenchymal transition; P:regulation of gastrulation; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:regulation of synapse organization; P:response to denervation involved in regulation of muscle adaptation; P:response to peptide hormone; P:retrograde trans-synaptic signaling by trans-synaptic protein complex; P:skeletal muscle tissue regeneration; scaffold73 indexed_genome mRNA 577154 586236 . + . ID=transcript_11468;Q9BSH3 Q8IZQ2,Nicolin-1,NPCEDRG;Tubulin polyglutamylase complex subunit 5;, , GO:0005874;GO:0005654;, C:microtubule; C:nucleoplasm;|Q9BSH3 Q8IZQ2,Nicolin-1,NPCEDRG;Tubulin polyglutamylase complex subunit 5;, , GO:0005874;GO:0005654;, C:microtubule; C:nucleoplasm;|P48728 A8K3I5 B4DE61 B4DJQ0 E9PBG1 Q96IG6,Aminomethyltransferase, mitochondrial {ECO:0000305},Glycine cleavage system T protein {ECO:0000303|PubMed:7916605};, PF01571;PF08669;, GO:0005759;GO:0005739;GO:0005654;GO:0004047;GO:0008483;GO:0006546;GO:0019464;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:aminomethyltransferase activity; F:transaminase activity;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system;|P48728 A8K3I5 B4DE61 B4DJQ0 E9PBG1 Q96IG6,Aminomethyltransferase, mitochondrial {ECO:0000305},Glycine cleavage system T protein {ECO:0000303|PubMed:7916605};, PF01571;PF08669;, GO:0005759;GO:0005739;GO:0005654;GO:0004047;GO:0008483;GO:0006546;GO:0019464;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:aminomethyltransferase activity; F:transaminase activity;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; scaffold73 indexed_genome mRNA 587651 637119 . + . ID=transcript_11469;P61586 P06749 Q53HM4 Q5U024 Q9UDJ0 Q9UEJ4,Transforming protein RhoA {ECO:0000305},Rho cDNA clone 12;, PF00071;, GO:0043296;GO:0005938;GO:0030054;GO:0071944;GO:0042995;GO:0032154;GO:0031410;GO:0005856;GO:0005829;GO:0043197;GO:0005789;GO:0005768;GO:0070062;GO:0031234;GO:0101003;GO:0005925;GO:0098978;GO:0043231;GO:0030027;GO:0030496;GO:0005886;GO:0098794;GO:0030667;GO:0031982;GO:0005525;GO:0003924;GO:0017022;GO:0019901;GO:0030036;GO:0031532;GO:0007015;GO:0043297;GO:0038027;GO:0034329;GO:0016477;GO:1990869;GO:0071345;GO:0071222;GO:0036089;GO:0030865;GO:0031122;GO:0043542;GO:0097498;GO:0048013;GO:0045198;GO:0007163;GO:0007186;GO:1903673;GO:0090307;GO:0050919;GO:0050771;GO:0090051;GO:0045792;GO:0010812;GO:0043312;GO:0043931;GO:0048015;GO:0050772;GO:0032467;GO:0043123;GO:1904996;GO:0060193;GO:0045666;GO:1901224;GO:0071902;GO:0051496;GO:2000406;GO:0016579;GO:0032956;GO:0030334;GO:2000145;GO:0008360;GO:0051893;GO:1905274;GO:0033688;GO:0051056;GO:0007266;GO:0035385;GO:1902766;GO:0043149;GO:0021762;GO:0034446;GO:0061383;GO:0007179;GO:0048010;GO:0016032;GO:0060071;GO:0044319;, C:apical junction complex; C:cell cortex; C:cell junction; C:cell periphery; C:cell projection; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:ficolin-1-rich granule membrane; C:focal adhesion; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:lamellipodium; C:midbody; C:plasma membrane; C:postsynapse; C:secretory granule membrane; C:vesicle;, F:GTP binding; F:GTPase activity; F:myosin binding; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:actin filament organization; P:apical junction assembly; P:apolipoprotein A-I-mediated signaling pathway; P:cell junction assembly; P:cell migration; P:cellular response to chemokine; P:cellular response to cytokine stimulus; P:cellular response to lipopolysaccharide; P:cleavage furrow formation; P:cortical cytoskeleton organization; P:cytoplasmic microtubule organization; P:endothelial cell migration; P:endothelial tube lumen extension; P:ephrin receptor signaling pathway; P:establishment of epithelial cell apical/basal polarity; P:establishment or maintenance of cell polarity; P:G protein-coupled receptor signaling pathway; P:mitotic cleavage furrow formation; P:mitotic spindle assembly; P:negative chemotaxis; P:negative regulation of axonogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell size; P:negative regulation of cell-substrate adhesion; P:neutrophil degranulation; P:ossification involved in bone maturation; P:phosphatidylinositol-mediated signaling; P:positive regulation of axonogenesis; P:positive regulation of cytokinesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of lipase activity; P:positive regulation of neuron differentiation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of stress fiber assembly; P:positive regulation of T cell migration; P:protein deubiquitination; P:regulation of actin cytoskeleton organization; P:regulation of cell migration; P:regulation of cell motility; P:regulation of cell shape; P:regulation of focal adhesion assembly; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of osteoblast proliferation; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway; P:skeletal muscle satellite cell migration; P:stress fiber assembly; P:substantia nigra development; P:substrate adhesion-dependent cell spreading; P:trabecula morphogenesis; P:transforming growth factor beta receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing, spreading of cells;|P57738 B2R4I4 Q6I9U4 Q9BSB0,T-cell leukemia translocation-altered gene protein,T-cell leukemia translocation-associated gene protein;, PF15128;, GO:0016021;GO:0045671;GO:0072675;, C:integral component of membrane;, , P:negative regulation of osteoclast differentiation; P:osteoclast fusion;|P61586 P06749 Q53HM4 Q5U024 Q9UDJ0 Q9UEJ4,Transforming protein RhoA {ECO:0000305},Rho cDNA clone 12;, PF00071;, GO:0043296;GO:0005938;GO:0030054;GO:0071944;GO:0042995;GO:0032154;GO:0031410;GO:0005856;GO:0005829;GO:0043197;GO:0005789;GO:0005768;GO:0070062;GO:0031234;GO:0101003;GO:0005925;GO:0098978;GO:0043231;GO:0030027;GO:0030496;GO:0005886;GO:0098794;GO:0030667;GO:0031982;GO:0005525;GO:0003924;GO:0017022;GO:0019901;GO:0030036;GO:0031532;GO:0007015;GO:0043297;GO:0038027;GO:0034329;GO:0016477;GO:1990869;GO:0071345;GO:0071222;GO:0036089;GO:0030865;GO:0031122;GO:0043542;GO:0097498;GO:0048013;GO:0045198;GO:0007163;GO:0007186;GO:1903673;GO:0090307;GO:0050919;GO:0050771;GO:0090051;GO:0045792;GO:0010812;GO:0043312;GO:0043931;GO:0048015;GO:0050772;GO:0032467;GO:0043123;GO:1904996;GO:0060193;GO:0045666;GO:1901224;GO:0071902;GO:0051496;GO:2000406;GO:0016579;GO:0032956;GO:0030334;GO:2000145;GO:0008360;GO:0051893;GO:1905274;GO:0033688;GO:0051056;GO:0007266;GO:0035385;GO:1902766;GO:0043149;GO:0021762;GO:0034446;GO:0061383;GO:0007179;GO:0048010;GO:0016032;GO:0060071;GO:0044319;, C:apical junction complex; C:cell cortex; C:cell junction; C:cell periphery; C:cell projection; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:ficolin-1-rich granule membrane; C:focal adhesion; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:lamellipodium; C:midbody; C:plasma membrane; C:postsynapse; C:secretory granule membrane; C:vesicle;, F:GTP binding; F:GTPase activity; F:myosin binding; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:actin filament organization; P:apical junction assembly; P:apolipoprotein A-I-mediated signaling pathway; P:cell junction assembly; P:cell migration; P:cellular response to chemokine; P:cellular response to cytokine stimulus; P:cellular response to lipopolysaccharide; P:cleavage furrow formation; P:cortical cytoskeleton organization; P:cytoplasmic microtubule organization; P:endothelial cell migration; P:endothelial tube lumen extension; P:ephrin receptor signaling pathway; P:establishment of epithelial cell apical/basal polarity; P:establishment or maintenance of cell polarity; P:G protein-coupled receptor signaling pathway; P:mitotic cleavage furrow formation; P:mitotic spindle assembly; P:negative chemotaxis; P:negative regulation of axonogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell size; P:negative regulation of cell-substrate adhesion; P:neutrophil degranulation; P:ossification involved in bone maturation; P:phosphatidylinositol-mediated signaling; P:positive regulation of axonogenesis; P:positive regulation of cytokinesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of lipase activity; P:positive regulation of neuron differentiation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of stress fiber assembly; P:positive regulation of T cell migration; P:protein deubiquitination; P:regulation of actin cytoskeleton organization; P:regulation of cell migration; P:regulation of cell motility; P:regulation of cell shape; P:regulation of focal adhesion assembly; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of osteoblast proliferation; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway; P:skeletal muscle satellite cell migration; P:stress fiber assembly; P:substantia nigra development; P:substrate adhesion-dependent cell spreading; P:trabecula morphogenesis; P:transforming growth factor beta receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing, spreading of cells;|P61586 P06749 Q53HM4 Q5U024 Q9UDJ0 Q9UEJ4,Transforming protein RhoA {ECO:0000305},Rho cDNA clone 12;, PF00071;, GO:0043296;GO:0005938;GO:0030054;GO:0071944;GO:0042995;GO:0032154;GO:0031410;GO:0005856;GO:0005829;GO:0043197;GO:0005789;GO:0005768;GO:0070062;GO:0031234;GO:0101003;GO:0005925;GO:0098978;GO:0043231;GO:0030027;GO:0030496;GO:0005886;GO:0098794;GO:0030667;GO:0031982;GO:0005525;GO:0003924;GO:0017022;GO:0019901;GO:0030036;GO:0031532;GO:0007015;GO:0043297;GO:0038027;GO:0034329;GO:0016477;GO:1990869;GO:0071345;GO:0071222;GO:0036089;GO:0030865;GO:0031122;GO:0043542;GO:0097498;GO:0048013;GO:0045198;GO:0007163;GO:0007186;GO:1903673;GO:0090307;GO:0050919;GO:0050771;GO:0090051;GO:0045792;GO:0010812;GO:0043312;GO:0043931;GO:0048015;GO:0050772;GO:0032467;GO:0043123;GO:1904996;GO:0060193;GO:0045666;GO:1901224;GO:0071902;GO:0051496;GO:2000406;GO:0016579;GO:0032956;GO:0030334;GO:2000145;GO:0008360;GO:0051893;GO:1905274;GO:0033688;GO:0051056;GO:0007266;GO:0035385;GO:1902766;GO:0043149;GO:0021762;GO:0034446;GO:0061383;GO:0007179;GO:0048010;GO:0016032;GO:0060071;GO:0044319;, C:apical junction complex; C:cell cortex; C:cell junction; C:cell periphery; C:cell projection; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:endosome; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:ficolin-1-rich granule membrane; C:focal adhesion; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:lamellipodium; C:midbody; C:plasma membrane; C:postsynapse; C:secretory granule membrane; C:vesicle;, F:GTP binding; F:GTPase activity; F:myosin binding; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin cytoskeleton reorganization; P:actin filament organization; P:apical junction assembly; P:apolipoprotein A-I-mediated signaling pathway; P:cell junction assembly; P:cell migration; P:cellular response to chemokine; P:cellular response to cytokine stimulus; P:cellular response to lipopolysaccharide; P:cleavage furrow formation; P:cortical cytoskeleton organization; P:cytoplasmic microtubule organization; P:endothelial cell migration; P:endothelial tube lumen extension; P:ephrin receptor signaling pathway; P:establishment of epithelial cell apical/basal polarity; P:establishment or maintenance of cell polarity; P:G protein-coupled receptor signaling pathway; P:mitotic cleavage furrow formation; P:mitotic spindle assembly; P:negative chemotaxis; P:negative regulation of axonogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell size; P:negative regulation of cell-substrate adhesion; P:neutrophil degranulation; P:ossification involved in bone maturation; P:phosphatidylinositol-mediated signaling; P:positive regulation of axonogenesis; P:positive regulation of cytokinesis; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of lipase activity; P:positive regulation of neuron differentiation; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of stress fiber assembly; P:positive regulation of T cell migration; P:protein deubiquitination; P:regulation of actin cytoskeleton organization; P:regulation of cell migration; P:regulation of cell motility; P:regulation of cell shape; P:regulation of focal adhesion assembly; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of osteoblast proliferation; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway; P:skeletal muscle satellite cell migration; P:stress fiber assembly; P:substantia nigra development; P:substrate adhesion-dependent cell spreading; P:trabecula morphogenesis; P:transforming growth factor beta receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing, spreading of cells; scaffold73 indexed_genome mRNA 637744 639337 . + . ID=transcript_11470;P07203 E9PAS1 Q7Z5H1 Q9BW12,Glutathione peroxidase 1 {ECO:0000305},Cellular glutathione peroxidase;, PF00255;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0004602;GO:0004601;GO:0047066;GO:0017124;GO:0060055;GO:0019369;GO:0051702;GO:0043534;GO:0045454;GO:0034599;GO:0001885;GO:0045444;GO:0006749;GO:0060047;GO:0042744;GO:0019372;GO:0051450;GO:0043154;GO:1902042;GO:0002862;GO:1902176;GO:0090201;GO:0051897;GO:1902905;GO:0018158;GO:0006195;GO:0040029;GO:0033599;GO:0061136;GO:0010332;GO:0042542;GO:0033194;GO:0010269;GO:0009609;GO:0009410;GO:0007605;GO:0048741;GO:0043403;GO:0001659;GO:0006641;GO:0009650;GO:0042311;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:glutathione peroxidase activity; F:peroxidase activity; F:phospholipid-hydroperoxide glutathione peroxidase activity; F:SH3 domain binding;, P:angiogenesis involved in wound healing; P:arachidonic acid metabolic process; P:biological process involved in interaction with symbiont; P:blood vessel endothelial cell migration; P:cell redox homeostasis; P:cellular response to oxidative stress; P:endothelial cell development; P:fat cell differentiation; P:glutathione metabolic process; P:heart contraction; P:hydrogen peroxide catabolic process; P:lipoxygenase pathway; P:myoblast proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of release of cytochrome c from mitochondria; P:positive regulation of protein kinase B signaling; P:positive regulation of supramolecular fiber organization; P:protein oxidation; P:purine nucleotide catabolic process; P:regulation of gene expression, epigenetic; P:regulation of mammary gland epithelial cell proliferation; P:regulation of proteasomal protein catabolic process; P:response to gamma radiation; P:response to hydrogen peroxide; P:response to hydroperoxide; P:response to selenium ion; P:response to symbiotic bacterium; P:response to xenobiotic stimulus; P:sensory perception of sound; P:skeletal muscle fiber development; P:skeletal muscle tissue regeneration; P:temperature homeostasis; P:triglyceride metabolic process; P:UV protection; P:vasodilation; scaffold73 indexed_genome mRNA 648880 694313 . + . ID=transcript_11471;Q13107 A8K6Y0 C9IY91 O43452 O43453 Q08AK8,Ubiquitin carboxyl-terminal hydrolase 4,Deubiquitinating enzyme 4;Ubiquitin thioesterase 4;Ubiquitin-specific-processing protease 4;Ubiquitous nuclear protein homolog;, PF06337;PF14836;PF00443;, GO:0005737;GO:0005829;GO:0005764;GO:0005634;GO:0005886;GO:0031685;GO:0008234;GO:0042802;GO:0046872;GO:0004843;GO:0031397;GO:0016579;GO:0034394;GO:0031647;GO:0000244;GO:0006511;, C:cytoplasm; C:cytosol; C:lysosome; C:nucleus; C:plasma membrane;, F:adenosine receptor binding; F:cysteine-type peptidase activity; F:identical protein binding; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity;, P:negative regulation of protein ubiquitination; P:protein deubiquitination; P:protein localization to cell surface; P:regulation of protein stability; P:spliceosomal tri-snRNP complex assembly; P:ubiquitin-dependent protein catabolic process;|Q13107 A8K6Y0 C9IY91 O43452 O43453 Q08AK8,Ubiquitin carboxyl-terminal hydrolase 4,Deubiquitinating enzyme 4;Ubiquitin thioesterase 4;Ubiquitin-specific-processing protease 4;Ubiquitous nuclear protein homolog;, PF06337;PF14836;PF00443;, GO:0005737;GO:0005829;GO:0005764;GO:0005634;GO:0005886;GO:0031685;GO:0008234;GO:0042802;GO:0046872;GO:0004843;GO:0031397;GO:0016579;GO:0034394;GO:0031647;GO:0000244;GO:0006511;, C:cytoplasm; C:cytosol; C:lysosome; C:nucleus; C:plasma membrane;, F:adenosine receptor binding; F:cysteine-type peptidase activity; F:identical protein binding; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity;, P:negative regulation of protein ubiquitination; P:protein deubiquitination; P:protein localization to cell surface; P:regulation of protein stability; P:spliceosomal tri-snRNP complex assembly; P:ubiquitin-dependent protein catabolic process;|Q6ZUJ4 Q6P7E9 Q7Z3X6,Uncharacterized protein C3orf62,, PF15830; scaffold73 indexed_genome mRNA 702586 703345 . - . ID=transcript_11472;Q8IYA8 C9JJL0 Q05DG9 Q96LP7,Interactor of HORMAD1 protein 1 {ECO:0000303|PubMed:27723721},Cancer/testis antigen 74;Coiled-coil domain-containing protein 36 {ECO:0000312|HGNC:HGNC:27945};, PF15771;, GO:0000794;GO:0006310;GO:0007129;GO:0042138;GO:0048477;GO:0060629;GO:0007283;, C:condensed nuclear chromosome;, , P:DNA recombination; P:homologous chromosome pairing at meiosis; P:meiotic DNA double-strand break formation; P:oogenesis; P:regulation of homologous chromosome segregation; P:spermatogenesis; scaffold73 indexed_genome mRNA 704641 705387 . + . ID=transcript_11473;P02792 B2R4B9 Q6IBT7 Q7Z2W1 Q86WI9 Q8WU07 Q96AU9 Q96CU0 Q9BTZ8,Ferritin light chain,, PF00210;, GO:0044754;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0008043;GO:0016020;GO:0008199;GO:0008198;GO:0042802;GO:0005506;GO:0006879;GO:0006880;GO:0055072;GO:0006826;GO:0043312;GO:0006892;, C:autolysosome; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular ferritin complex; C:membrane;, F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:iron ion binding;, P:cellular iron ion homeostasis; P:intracellular sequestering of iron ion; P:iron ion homeostasis; P:iron ion transport; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; scaffold73 indexed_genome mRNA 707938 709774 . + . ID=transcript_11474;Q8IYA8 C9JJL0 Q05DG9 Q96LP7,Interactor of HORMAD1 protein 1 {ECO:0000303|PubMed:27723721},Cancer/testis antigen 74;Coiled-coil domain-containing protein 36 {ECO:0000312|HGNC:HGNC:27945};, PF15771;, GO:0000794;GO:0006310;GO:0007129;GO:0042138;GO:0048477;GO:0060629;GO:0007283;, C:condensed nuclear chromosome;, , P:DNA recombination; P:homologous chromosome pairing at meiosis; P:meiotic DNA double-strand break formation; P:oogenesis; P:regulation of homologous chromosome segregation; P:spermatogenesis; scaffold73 indexed_genome mRNA 717382 717982 . - . ID=transcript_11475;Q8IYA8 C9JJL0 Q05DG9 Q96LP7,Interactor of HORMAD1 protein 1 {ECO:0000303|PubMed:27723721},Cancer/testis antigen 74;Coiled-coil domain-containing protein 36 {ECO:0000312|HGNC:HGNC:27945};, PF15771;, GO:0000794;GO:0006310;GO:0007129;GO:0042138;GO:0048477;GO:0060629;GO:0007283;, C:condensed nuclear chromosome;, , P:DNA recombination; P:homologous chromosome pairing at meiosis; P:meiotic DNA double-strand break formation; P:oogenesis; P:regulation of homologous chromosome segregation; P:spermatogenesis; scaffold73 indexed_genome mRNA 719134 719768 . + . ID=transcript_11476;Q8IYA8 C9JJL0 Q05DG9 Q96LP7,Interactor of HORMAD1 protein 1 {ECO:0000303|PubMed:27723721},Cancer/testis antigen 74;Coiled-coil domain-containing protein 36 {ECO:0000312|HGNC:HGNC:27945};, PF15771;, GO:0000794;GO:0006310;GO:0007129;GO:0042138;GO:0048477;GO:0060629;GO:0007283;, C:condensed nuclear chromosome;, , P:DNA recombination; P:homologous chromosome pairing at meiosis; P:meiotic DNA double-strand break formation; P:oogenesis; P:regulation of homologous chromosome segregation; P:spermatogenesis; scaffold73 indexed_genome mRNA 729213 731647 . - . ID=transcript_11477;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold73 indexed_genome mRNA 740032 745020 . - . ID=transcript_11478;Q8IXV7,Kelch domain-containing protein 8B {ECO:0000303|PubMed:19706467},, PF01344;, GO:0110070;GO:0005737;GO:0005829;GO:0045171;GO:0030496;GO:1902410;GO:0140014;GO:0098813;, C:cellularization cleavage furrow; C:cytoplasm; C:cytosol; C:intercellular bridge; C:midbody;, , P:mitotic cytokinetic process; P:mitotic nuclear division; P:nuclear chromosome segregation;|Q8IXV7,Kelch domain-containing protein 8B {ECO:0000303|PubMed:19706467},, PF01344;, GO:0110070;GO:0005737;GO:0005829;GO:0045171;GO:0030496;GO:1902410;GO:0140014;GO:0098813;, C:cellularization cleavage furrow; C:cytoplasm; C:cytosol; C:intercellular bridge; C:midbody;, , P:mitotic cytokinetic process; P:mitotic nuclear division; P:nuclear chromosome segregation;|Q8IXV7,Kelch domain-containing protein 8B {ECO:0000303|PubMed:19706467},, PF01344;, GO:0110070;GO:0005737;GO:0005829;GO:0045171;GO:0030496;GO:1902410;GO:0140014;GO:0098813;, C:cellularization cleavage furrow; C:cytoplasm; C:cytosol; C:intercellular bridge; C:midbody;, , P:mitotic cytokinetic process; P:mitotic nuclear division; P:nuclear chromosome segregation; scaffold73 indexed_genome mRNA 750247 752092 . - . ID=transcript_11479;Q8IV32 Q6IPE2 Q9H8H4 Q9H9F1,Coiled-coil domain-containing protein 71,, PF15374; scaffold73 indexed_genome mRNA 753094 765182 . + . ID=transcript_11480;P07942 Q14D91,Laminin subunit beta-1,Laminin B1 chain;Laminin-1 subunit beta;Laminin-10 subunit beta;Laminin-12 subunit beta;Laminin-2 subunit beta;Laminin-6 subunit beta;Laminin-8 subunit beta;, PF00053;PF00055;, GO:0005604;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0043256;GO:0005606;GO:0043259;GO:0005607;GO:0043257;GO:0048471;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0070831;GO:0007155;GO:0016477;GO:0044267;GO:0035987;GO:0030198;GO:0031175;GO:0021812;GO:0042476;GO:0030335;GO:0050679;GO:0043687;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin complex; C:laminin-1 complex; C:laminin-10 complex; C:laminin-2 complex; C:laminin-8 complex; C:perinuclear region of cytoplasm;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:basement membrane assembly; P:cell adhesion; P:cell migration; P:cellular protein metabolic process; P:endodermal cell differentiation; P:extracellular matrix organization; P:neuron projection development; P:neuronal-glial interaction involved in cerebral cortex radial glia guided migration; P:odontogenesis; P:positive regulation of cell migration; P:positive regulation of epithelial cell proliferation; P:post-translational protein modification; P:substrate adhesion-dependent cell spreading; P:tissue development;|P07942 Q14D91,Laminin subunit beta-1,Laminin B1 chain;Laminin-1 subunit beta;Laminin-10 subunit beta;Laminin-12 subunit beta;Laminin-2 subunit beta;Laminin-6 subunit beta;Laminin-8 subunit beta;, PF00053;PF00055;, GO:0005604;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0043256;GO:0005606;GO:0043259;GO:0005607;GO:0043257;GO:0048471;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0070831;GO:0007155;GO:0016477;GO:0044267;GO:0035987;GO:0030198;GO:0031175;GO:0021812;GO:0042476;GO:0030335;GO:0050679;GO:0043687;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin complex; C:laminin-1 complex; C:laminin-10 complex; C:laminin-2 complex; C:laminin-8 complex; C:perinuclear region of cytoplasm;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:basement membrane assembly; P:cell adhesion; P:cell migration; P:cellular protein metabolic process; P:endodermal cell differentiation; P:extracellular matrix organization; P:neuron projection development; P:neuronal-glial interaction involved in cerebral cortex radial glia guided migration; P:odontogenesis; P:positive regulation of cell migration; P:positive regulation of epithelial cell proliferation; P:post-translational protein modification; P:substrate adhesion-dependent cell spreading; P:tissue development;|P07942 Q14D91,Laminin subunit beta-1,Laminin B1 chain;Laminin-1 subunit beta;Laminin-10 subunit beta;Laminin-12 subunit beta;Laminin-2 subunit beta;Laminin-6 subunit beta;Laminin-8 subunit beta;, PF00053;PF00055;, GO:0005604;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0043256;GO:0005606;GO:0043259;GO:0005607;GO:0043257;GO:0048471;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0070831;GO:0007155;GO:0016477;GO:0044267;GO:0035987;GO:0030198;GO:0031175;GO:0021812;GO:0042476;GO:0030335;GO:0050679;GO:0043687;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin complex; C:laminin-1 complex; C:laminin-10 complex; C:laminin-2 complex; C:laminin-8 complex; C:perinuclear region of cytoplasm;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:basement membrane assembly; P:cell adhesion; P:cell migration; P:cellular protein metabolic process; P:endodermal cell differentiation; P:extracellular matrix organization; P:neuron projection development; P:neuronal-glial interaction involved in cerebral cortex radial glia guided migration; P:odontogenesis; P:positive regulation of cell migration; P:positive regulation of epithelial cell proliferation; P:post-translational protein modification; P:substrate adhesion-dependent cell spreading; P:tissue development; scaffold73 indexed_genome mRNA 768785 780916 . + . ID=transcript_11481;P55268 Q16321,Laminin subunit beta-2,Laminin B1s chain;Laminin-11 subunit beta;Laminin-14 subunit beta;Laminin-15 subunit beta;Laminin-3 subunit beta;Laminin-4 subunit beta;Laminin-7 subunit beta;Laminin-9 subunit beta;S-laminin subunit beta;, PF00053;PF00055;, GO:0005604;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0043256;GO:0043260;GO:0005608;GO:0031594;GO:0043083;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0014002;GO:0048677;GO:0007411;GO:0070831;GO:0016477;GO:0044267;GO:0030198;GO:0072274;GO:0072249;GO:0007528;GO:0043687;GO:0060041;GO:0014044;GO:0034446;GO:0009888;GO:0007601;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:laminin complex; C:laminin-11 complex; C:laminin-3 complex; C:neuromuscular junction; C:synaptic cleft;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:astrocyte development; P:axon extension involved in regeneration; P:axon guidance; P:basement membrane assembly; P:cell migration; P:cellular protein metabolic process; P:extracellular matrix organization; P:metanephric glomerular basement membrane development; P:metanephric glomerular visceral epithelial cell development; P:neuromuscular junction development; P:post-translational protein modification; P:retina development in camera-type eye; P:Schwann cell development; P:substrate adhesion-dependent cell spreading; P:tissue development; P:visual perception;|P55268 Q16321,Laminin subunit beta-2,Laminin B1s chain;Laminin-11 subunit beta;Laminin-14 subunit beta;Laminin-15 subunit beta;Laminin-3 subunit beta;Laminin-4 subunit beta;Laminin-7 subunit beta;Laminin-9 subunit beta;S-laminin subunit beta;, PF00053;PF00055;, GO:0005604;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0043256;GO:0043260;GO:0005608;GO:0031594;GO:0043083;GO:0005201;GO:0005178;GO:0005198;GO:0009887;GO:0014002;GO:0048677;GO:0007411;GO:0070831;GO:0016477;GO:0044267;GO:0030198;GO:0072274;GO:0072249;GO:0007528;GO:0043687;GO:0060041;GO:0014044;GO:0034446;GO:0009888;GO:0007601;, C:basement membrane; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:laminin complex; C:laminin-11 complex; C:laminin-3 complex; C:neuromuscular junction; C:synaptic cleft;, F:extracellular matrix structural constituent; F:integrin binding; F:structural molecule activity;, P:animal organ morphogenesis; P:astrocyte development; P:axon extension involved in regeneration; P:axon guidance; P:basement membrane assembly; P:cell migration; P:cellular protein metabolic process; P:extracellular matrix organization; P:metanephric glomerular basement membrane development; P:metanephric glomerular visceral epithelial cell development; P:neuromuscular junction development; P:post-translational protein modification; P:retina development in camera-type eye; P:Schwann cell development; P:substrate adhesion-dependent cell spreading; P:tissue development; P:visual perception; scaffold73 indexed_genome mRNA 786743 797341 . + . ID=transcript_11482;Q641Q9 Q6NZY8 Q86XV9,Ubiquitin carboxyl-terminal hydrolase 19,Deubiquitinating enzyme 19;Ubiquitin thioesterase 19;Ubiquitin-specific-processing protease 19;Zinc finger MYND domain-containing protein 9;, PF04969;PF00443;PF01753;, GO:0005829;GO:0005789;GO:0016021;GO:0008234;GO:0051879;GO:1990380;GO:0046872;GO:0004843;GO:0031625;GO:1901799;GO:0048642;GO:0090068;GO:0016579;GO:0050821;GO:1900037;GO:1904292;GO:0031647;GO:0034976;GO:0030433;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cysteine-type peptidase activity; F:Hsp90 protein binding; F:Lys48-specific deubiquitinase activity; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin protein ligase binding;, P:negative regulation of proteasomal protein catabolic process; P:negative regulation of skeletal muscle tissue development; P:positive regulation of cell cycle process; P:protein deubiquitination; P:protein stabilization; P:regulation of cellular response to hypoxia; P:regulation of ERAD pathway; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent ERAD pathway;|Q641Q9 Q6NZY8 Q86XV9,Ubiquitin carboxyl-terminal hydrolase 19,Deubiquitinating enzyme 19;Ubiquitin thioesterase 19;Ubiquitin-specific-processing protease 19;Zinc finger MYND domain-containing protein 9;, PF04969;PF00443;PF01753;, GO:0005829;GO:0005789;GO:0016021;GO:0008234;GO:0051879;GO:1990380;GO:0046872;GO:0004843;GO:0031625;GO:1901799;GO:0048642;GO:0090068;GO:0016579;GO:0050821;GO:1900037;GO:1904292;GO:0031647;GO:0034976;GO:0030433;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cysteine-type peptidase activity; F:Hsp90 protein binding; F:Lys48-specific deubiquitinase activity; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin protein ligase binding;, P:negative regulation of proteasomal protein catabolic process; P:negative regulation of skeletal muscle tissue development; P:positive regulation of cell cycle process; P:protein deubiquitination; P:protein stabilization; P:regulation of cellular response to hypoxia; P:regulation of ERAD pathway; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent ERAD pathway; scaffold73 indexed_genome mRNA 799926 807065 . + . ID=transcript_11483;P47897 B4DWJ2,Glutamine--tRNA ligase,Glutaminyl-tRNA synthetase;, PF00749;PF03950;PF04558;PF04557;, GO:0017101;GO:0005737;GO:0005829;GO:0005759;GO:0032991;GO:0005524;GO:0004819;GO:0019901;GO:0004860;GO:0007420;GO:0006425;GO:2001234;GO:0006469;GO:0032873;GO:0045892;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:protein-containing complex;, F:ATP binding; F:glutamine-tRNA ligase activity; F:protein kinase binding; F:protein kinase inhibitor activity;, P:brain development; P:glutaminyl-tRNA aminoacylation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of protein kinase activity; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription, DNA-templated; P:tRNA aminoacylation for protein translation;|P47897 B4DWJ2,Glutamine--tRNA ligase,Glutaminyl-tRNA synthetase;, PF00749;PF03950;PF04558;PF04557;, GO:0017101;GO:0005737;GO:0005829;GO:0005759;GO:0032991;GO:0005524;GO:0004819;GO:0019901;GO:0004860;GO:0007420;GO:0006425;GO:2001234;GO:0006469;GO:0032873;GO:0045892;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:protein-containing complex;, F:ATP binding; F:glutamine-tRNA ligase activity; F:protein kinase binding; F:protein kinase inhibitor activity;, P:brain development; P:glutaminyl-tRNA aminoacylation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of protein kinase activity; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription, DNA-templated; P:tRNA aminoacylation for protein translation;|P47897 B4DWJ2,Glutamine--tRNA ligase,Glutaminyl-tRNA synthetase;, PF00749;PF03950;PF04558;PF04557;, GO:0017101;GO:0005737;GO:0005829;GO:0005759;GO:0032991;GO:0005524;GO:0004819;GO:0019901;GO:0004860;GO:0007420;GO:0006425;GO:2001234;GO:0006469;GO:0032873;GO:0045892;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:protein-containing complex;, F:ATP binding; F:glutamine-tRNA ligase activity; F:protein kinase binding; F:protein kinase inhibitor activity;, P:brain development; P:glutaminyl-tRNA aminoacylation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of protein kinase activity; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription, DNA-templated; P:tRNA aminoacylation for protein translation; scaffold73 indexed_genome mRNA 813681 860477 . + . ID=transcript_11484;Q2TAL8 Q4G0F7 Q7L621 Q8TEA5,Glutamine-rich protein 1,, PF12012;, GO:0005654;, C:nucleoplasm;|Q2TAL8 Q4G0F7 Q7L621 Q8TEA5,Glutamine-rich protein 1,, PF12012;, GO:0005654;, C:nucleoplasm;|Q2TAL8 Q4G0F7 Q7L621 Q8TEA5,Glutamine-rich protein 1,, PF12012;, GO:0005654;, C:nucleoplasm;|Q2TAL8 Q4G0F7 Q7L621 Q8TEA5,Glutamine-rich protein 1,, PF12012;, GO:0005654;, C:nucleoplasm;|P12268 Q6LEF3,Inosine-5'-monophosphate dehydrogenase 2 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-II;, PF00571;PF00478;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005634;GO:0005778;GO:0034774;GO:0003677;GO:0003938;GO:0046872;GO:0000166;GO:0003723;GO:0007623;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleus; C:peroxisomal membrane; C:secretory granule lumen;, F:DNA binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleotide binding; F:RNA binding;, P:circadian rhythm; P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process;|P12268 Q6LEF3,Inosine-5'-monophosphate dehydrogenase 2 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-II;, PF00571;PF00478;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005634;GO:0005778;GO:0034774;GO:0003677;GO:0003938;GO:0046872;GO:0000166;GO:0003723;GO:0007623;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleus; C:peroxisomal membrane; C:secretory granule lumen;, F:DNA binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleotide binding; F:RNA binding;, P:circadian rhythm; P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process;|P12268 Q6LEF3,Inosine-5'-monophosphate dehydrogenase 2 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-II;, PF00571;PF00478;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005634;GO:0005778;GO:0034774;GO:0003677;GO:0003938;GO:0046872;GO:0000166;GO:0003723;GO:0007623;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleus; C:peroxisomal membrane; C:secretory granule lumen;, F:DNA binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleotide binding; F:RNA binding;, P:circadian rhythm; P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process;|P12268 Q6LEF3,Inosine-5'-monophosphate dehydrogenase 2 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-II;, PF00571;PF00478;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005634;GO:0005778;GO:0034774;GO:0003677;GO:0003938;GO:0046872;GO:0000166;GO:0003723;GO:0007623;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleus; C:peroxisomal membrane; C:secretory granule lumen;, F:DNA binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleotide binding; F:RNA binding;, P:circadian rhythm; P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process;|P12268 Q6LEF3,Inosine-5'-monophosphate dehydrogenase 2 {ECO:0000255|HAMAP-Rule:MF_03156},IMPDH-II;, PF00571;PF00478;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005634;GO:0005778;GO:0034774;GO:0003677;GO:0003938;GO:0046872;GO:0000166;GO:0003723;GO:0007623;GO:0006177;GO:0006183;GO:0043312;GO:0009168;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleus; C:peroxisomal membrane; C:secretory granule lumen;, F:DNA binding; F:IMP dehydrogenase activity; F:metal ion binding; F:nucleotide binding; F:RNA binding;, P:circadian rhythm; P:GMP biosynthetic process; P:GTP biosynthetic process; P:neutrophil degranulation; P:purine ribonucleoside monophosphate biosynthetic process; scaffold73 indexed_genome mRNA 860845 862938 . - . ID=transcript_11485;Q9BU61,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3,, PF04430;, GO:0005743;GO:0005634;GO:0032981;, C:mitochondrial inner membrane; C:nucleus;, , P:mitochondrial respiratory chain complex I assembly;|Q9BU61,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3,, PF04430;, GO:0005743;GO:0005634;GO:0032981;, C:mitochondrial inner membrane; C:nucleus;, , P:mitochondrial respiratory chain complex I assembly; scaffold73 indexed_genome mRNA 865435 891543 . + . ID=transcript_11486;Q5D0E6 Q7Z5S7 Q86WY1 Q8N105 Q8NA89 Q9NVU8,DALR anticodon-binding domain-containing protein 3,, PF05746;, GO:0004814;GO:0005524;GO:0000049;GO:0006420;GO:0106217;, , F:arginine-tRNA ligase activity; F:ATP binding; F:tRNA binding;, P:arginyl-tRNA aminoacylation; P:tRNA C3-cytosine methylation;|Q9NNW5 B4DHK2 Q3MIT1 Q9UF63,WD repeat-containing protein 6,, PF00400;, GO:0005737;GO:0005829;GO:0005886;GO:0003723;GO:0007050;GO:0010507;GO:0008285;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:RNA binding;, P:cell cycle arrest; P:negative regulation of autophagy; P:negative regulation of cell population proliferation;|Q9NNW5 B4DHK2 Q3MIT1 Q9UF63,WD repeat-containing protein 6,, PF00400;, GO:0005737;GO:0005829;GO:0005886;GO:0003723;GO:0007050;GO:0010507;GO:0008285;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:RNA binding;, P:cell cycle arrest; P:negative regulation of autophagy; P:negative regulation of cell population proliferation;|Q9NNW5 B4DHK2 Q3MIT1 Q9UF63,WD repeat-containing protein 6,, PF00400;, GO:0005737;GO:0005829;GO:0005886;GO:0003723;GO:0007050;GO:0010507;GO:0008285;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:RNA binding;, P:cell cycle arrest; P:negative regulation of autophagy; P:negative regulation of cell population proliferation;|Q9NXG6 Q6PAG6 Q8TCJ9 Q8WV55 Q96F22 Q9BW77,Transmembrane prolyl 4-hydroxylase,Hypoxia-inducible factor prolyl hydroxylase 4;, PF13640;PF13499;, GO:0005783;GO:0005789;GO:0016021;GO:0016706;GO:0005509;GO:0005506;GO:0031418;GO:0018401;GO:0045646;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:2-oxoglutarate-dependent dioxygenase activity; F:calcium ion binding; F:iron ion binding; F:L-ascorbic acid binding;, P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:regulation of erythrocyte differentiation;|Q9NXG6 Q6PAG6 Q8TCJ9 Q8WV55 Q96F22 Q9BW77,Transmembrane prolyl 4-hydroxylase,Hypoxia-inducible factor prolyl hydroxylase 4;, PF13640;PF13499;, GO:0005783;GO:0005789;GO:0016021;GO:0016706;GO:0005509;GO:0005506;GO:0031418;GO:0018401;GO:0045646;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:2-oxoglutarate-dependent dioxygenase activity; F:calcium ion binding; F:iron ion binding; F:L-ascorbic acid binding;, P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:regulation of erythrocyte differentiation;|Q9NXG6 Q6PAG6 Q8TCJ9 Q8WV55 Q96F22 Q9BW77,Transmembrane prolyl 4-hydroxylase,Hypoxia-inducible factor prolyl hydroxylase 4;, PF13640;PF13499;, GO:0005783;GO:0005789;GO:0016021;GO:0016706;GO:0005509;GO:0005506;GO:0031418;GO:0018401;GO:0045646;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:2-oxoglutarate-dependent dioxygenase activity; F:calcium ion binding; F:iron ion binding; F:L-ascorbic acid binding;, P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:regulation of erythrocyte differentiation;|Q5T4F7 O14780 Q86TH7,Secreted frizzled-related protein 5,Frizzled-related protein 1b;Secreted apoptosis-related protein 3;, PF01392;PF01759;, GO:0005615;GO:0017147;GO:0009653;GO:0006915;GO:0060070;GO:0030154;GO:0007163;GO:0007275;GO:0090090;GO:0008285;GO:0043433;GO:0051898;GO:0030178;GO:2000057;GO:0030510;GO:0007165;GO:0007601;, C:extracellular space;, F:Wnt-protein binding;, P:anatomical structure morphogenesis; P:apoptotic process; P:canonical Wnt signaling pathway; P:cell differentiation; P:establishment or maintenance of cell polarity; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of protein kinase B signaling; P:negative regulation of Wnt signaling pathway; P:negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis; P:regulation of BMP signaling pathway; P:signal transduction; P:visual perception;|Q9NXG6 Q6PAG6 Q8TCJ9 Q8WV55 Q96F22 Q9BW77,Transmembrane prolyl 4-hydroxylase,Hypoxia-inducible factor prolyl hydroxylase 4;, PF13640;PF13499;, GO:0005783;GO:0005789;GO:0016021;GO:0016706;GO:0005509;GO:0005506;GO:0031418;GO:0018401;GO:0045646;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:2-oxoglutarate-dependent dioxygenase activity; F:calcium ion binding; F:iron ion binding; F:L-ascorbic acid binding;, P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:regulation of erythrocyte differentiation; scaffold73 indexed_genome mRNA 891615 902823 . - . ID=transcript_11487;O95376 Q9HBZ6 Q9UEM9,E3 ubiquitin-protein ligase ARIH2,RING-type E3 ubiquitin transferase ARIH2 {ECO:0000305};Triad1 protein {ECO:0000303|PubMed:10422847};, PF01485;, GO:0005737;GO:0005654;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0004842;GO:0008270;GO:0048588;GO:0071425;GO:0007275;GO:0032436;GO:1903955;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:developmental cell growth; P:hematopoietic stem cell proliferation; P:multicellular organism development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|O95376 Q9HBZ6 Q9UEM9,E3 ubiquitin-protein ligase ARIH2,RING-type E3 ubiquitin transferase ARIH2 {ECO:0000305};Triad1 protein {ECO:0000303|PubMed:10422847};, PF01485;, GO:0005737;GO:0005654;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0004842;GO:0008270;GO:0048588;GO:0071425;GO:0007275;GO:0032436;GO:1903955;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:developmental cell growth; P:hematopoietic stem cell proliferation; P:multicellular organism development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|O95376 Q9HBZ6 Q9UEM9,E3 ubiquitin-protein ligase ARIH2,RING-type E3 ubiquitin transferase ARIH2 {ECO:0000305};Triad1 protein {ECO:0000303|PubMed:10422847};, PF01485;, GO:0005737;GO:0005654;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0004842;GO:0008270;GO:0048588;GO:0071425;GO:0007275;GO:0032436;GO:1903955;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:developmental cell growth; P:hematopoietic stem cell proliferation; P:multicellular organism development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|O95376 Q9HBZ6 Q9UEM9,E3 ubiquitin-protein ligase ARIH2,RING-type E3 ubiquitin transferase ARIH2 {ECO:0000305};Triad1 protein {ECO:0000303|PubMed:10422847};, PF01485;, GO:0005737;GO:0005654;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0004842;GO:0008270;GO:0048588;GO:0071425;GO:0007275;GO:0032436;GO:1903955;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:developmental cell growth; P:hematopoietic stem cell proliferation; P:multicellular organism development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold73 indexed_genome mRNA 903020 903854 . + . ID=transcript_11488;O95376 Q9HBZ6 Q9UEM9,E3 ubiquitin-protein ligase ARIH2,RING-type E3 ubiquitin transferase ARIH2 {ECO:0000305};Triad1 protein {ECO:0000303|PubMed:10422847};, PF01485;, GO:0005737;GO:0005654;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0004842;GO:0008270;GO:0048588;GO:0071425;GO:0007275;GO:0032436;GO:1903955;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:developmental cell growth; P:hematopoietic stem cell proliferation; P:multicellular organism development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold73 indexed_genome mRNA 904573 913513 . - . ID=transcript_11489;O95376 Q9HBZ6 Q9UEM9,E3 ubiquitin-protein ligase ARIH2,RING-type E3 ubiquitin transferase ARIH2 {ECO:0000305};Triad1 protein {ECO:0000303|PubMed:10422847};, PF01485;, GO:0005737;GO:0005654;GO:0005634;GO:0000151;GO:0031624;GO:0061630;GO:0004842;GO:0008270;GO:0048588;GO:0071425;GO:0007275;GO:0032436;GO:1903955;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:developmental cell growth; P:hematopoietic stem cell proliferation; P:multicellular organism development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold73 indexed_genome mRNA 929260 930275 . - . ID=transcript_11490;Q8N7S6,Uncharacterized protein ARIH2OS,Ariadne-2 homolog opposite strand protein;, , GO:0016021;, C:integral component of membrane; scaffold73 indexed_genome mRNA 942813 978544 . + . ID=transcript_11491;O43772 B2R7F4 Q9UIQ2,Mitochondrial carnitine/acylcarnitine carrier protein {ECO:0000305},Carnitine/acylcarnitine translocase;Solute carrier family 25 member 20;, PF00153;, GO:0005829;GO:0016021;GO:0005743;GO:0005739;GO:0015227;GO:0006853;GO:1902603;GO:0001701;, C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:acyl carnitine transmembrane transporter activity;, P:carnitine shuttle; P:carnitine transmembrane transport; P:in utero embryonic development;|O43772 B2R7F4 Q9UIQ2,Mitochondrial carnitine/acylcarnitine carrier protein {ECO:0000305},Carnitine/acylcarnitine translocase;Solute carrier family 25 member 20;, PF00153;, GO:0005829;GO:0016021;GO:0005743;GO:0005739;GO:0015227;GO:0006853;GO:1902603;GO:0001701;, C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:acyl carnitine transmembrane transporter activity;, P:carnitine shuttle; P:carnitine transmembrane transport; P:in utero embryonic development;|O43772 B2R7F4 Q9UIQ2,Mitochondrial carnitine/acylcarnitine carrier protein {ECO:0000305},Carnitine/acylcarnitine translocase;Solute carrier family 25 member 20;, PF00153;, GO:0005829;GO:0016021;GO:0005743;GO:0005739;GO:0015227;GO:0006853;GO:1902603;GO:0001701;, C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:acyl carnitine transmembrane transporter activity;, P:carnitine shuttle; P:carnitine transmembrane transport; P:in utero embryonic development; scaffold73 indexed_genome mRNA 1051141 1074203 . + . ID=transcript_11492;Q9UFU6,Inositol hexakisphosphate kinase 2,P(i)-uptake stimulator;, PF03770;, GO:0030054;GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0097243;GO:0000832;GO:0000828;GO:0016301;GO:1905396;GO:0032958;GO:0043647;GO:0030308;GO:0006817;GO:0046854;GO:0043065;GO:0060337;, C:cell junction; C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:flavonoid binding; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:kinase activity;, P:cellular response to flavonoid; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:negative regulation of cell growth; P:phosphate ion transport; P:phosphatidylinositol phosphorylation; P:positive regulation of apoptotic process; P:type I interferon signaling pathway;|Q9UFU6,Inositol hexakisphosphate kinase 2,P(i)-uptake stimulator;, PF03770;, GO:0030054;GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0097243;GO:0000832;GO:0000828;GO:0016301;GO:1905396;GO:0032958;GO:0043647;GO:0030308;GO:0006817;GO:0046854;GO:0043065;GO:0060337;, C:cell junction; C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:flavonoid binding; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:kinase activity;, P:cellular response to flavonoid; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:negative regulation of cell growth; P:phosphate ion transport; P:phosphatidylinositol phosphorylation; P:positive regulation of apoptotic process; P:type I interferon signaling pathway;|Q9UFU6,Inositol hexakisphosphate kinase 2,P(i)-uptake stimulator;, PF03770;, GO:0030054;GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0005524;GO:0097243;GO:0000832;GO:0000828;GO:0016301;GO:1905396;GO:0032958;GO:0043647;GO:0030308;GO:0006817;GO:0046854;GO:0043065;GO:0060337;, C:cell junction; C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:ATP binding; F:flavonoid binding; F:inositol hexakisphosphate 5-kinase activity; F:inositol hexakisphosphate kinase activity; F:kinase activity;, P:cellular response to flavonoid; P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:negative regulation of cell growth; P:phosphate ion transport; P:phosphatidylinositol phosphorylation; P:positive regulation of apoptotic process; P:type I interferon signaling pathway; scaffold73 indexed_genome mRNA 1087979 1089014 . + . ID=transcript_11493;Q9NZQ3 B4DFL5 Q6GU34 Q6SPF3 Q8TC10 Q9UGM8,NCK-interacting protein with SH3 domain,54 kDa VacA-interacting protein;54 kDa vimentin-interacting protein;90 kDa SH3 protein interacting with Nck;AF3p21;Dia-interacting protein 1;Diaphanous protein-interacting protein;SH3 adapter protein SPIN90;WASP-interacting SH3-domain protein;Wiskott-Aldrich syndrome protein-interacting protein;, PF09431;PF00018;, GO:0005829;GO:0005882;GO:0005634;GO:0008092;GO:0017124;GO:0007010;GO:0038096;GO:0010976;, C:cytosol; C:intermediate filament; C:nucleus;, F:cytoskeletal protein binding; F:SH3 domain binding;, P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of neuron projection development; scaffold73 indexed_genome mRNA 1091720 1093709 . + . ID=transcript_11494;Q9NZQ3 B4DFL5 Q6GU34 Q6SPF3 Q8TC10 Q9UGM8,NCK-interacting protein with SH3 domain,54 kDa VacA-interacting protein;54 kDa vimentin-interacting protein;90 kDa SH3 protein interacting with Nck;AF3p21;Dia-interacting protein 1;Diaphanous protein-interacting protein;SH3 adapter protein SPIN90;WASP-interacting SH3-domain protein;Wiskott-Aldrich syndrome protein-interacting protein;, PF09431;PF00018;, GO:0005829;GO:0005882;GO:0005634;GO:0008092;GO:0017124;GO:0007010;GO:0038096;GO:0010976;, C:cytosol; C:intermediate filament; C:nucleus;, F:cytoskeletal protein binding; F:SH3 domain binding;, P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of neuron projection development;|Q9NZQ3 B4DFL5 Q6GU34 Q6SPF3 Q8TC10 Q9UGM8,NCK-interacting protein with SH3 domain,54 kDa VacA-interacting protein;54 kDa vimentin-interacting protein;90 kDa SH3 protein interacting with Nck;AF3p21;Dia-interacting protein 1;Diaphanous protein-interacting protein;SH3 adapter protein SPIN90;WASP-interacting SH3-domain protein;Wiskott-Aldrich syndrome protein-interacting protein;, PF09431;PF00018;, GO:0005829;GO:0005882;GO:0005634;GO:0008092;GO:0017124;GO:0007010;GO:0038096;GO:0010976;, C:cytosol; C:intermediate filament; C:nucleus;, F:cytoskeletal protein binding; F:SH3 domain binding;, P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of neuron projection development; scaffold73 indexed_genome mRNA 1100500 1127986 . + . ID=transcript_11495;Q9NYQ7 O75092,Cadherin EGF LAG seven-pass G-type receptor 3,Cadherin family member 11;Epidermal growth factor-like protein 1;Flamingo homolog 1;Multiple epidermal growth factor-like domains protein 2;, PF00002;PF00028;PF00008;PF16489;PF00053;PF02210;, GO:0016021;GO:0005886;GO:0005509;GO:0004930;GO:0098609;GO:0007186;GO:0007156;GO:0007275;GO:0060071;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; P:Wnt signaling pathway, planar cell polarity pathway;|Q9NYQ7 O75092,Cadherin EGF LAG seven-pass G-type receptor 3,Cadherin family member 11;Epidermal growth factor-like protein 1;Flamingo homolog 1;Multiple epidermal growth factor-like domains protein 2;, PF00002;PF00028;PF00008;PF16489;PF00053;PF02210;, GO:0016021;GO:0005886;GO:0005509;GO:0004930;GO:0098609;GO:0007186;GO:0007156;GO:0007275;GO:0060071;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; P:Wnt signaling pathway, planar cell polarity pathway;|Q9NYQ7 O75092,Cadherin EGF LAG seven-pass G-type receptor 3,Cadherin family member 11;Epidermal growth factor-like protein 1;Flamingo homolog 1;Multiple epidermal growth factor-like domains protein 2;, PF00002;PF00028;PF00008;PF16489;PF00053;PF02210;, GO:0016021;GO:0005886;GO:0005509;GO:0004930;GO:0098609;GO:0007186;GO:0007156;GO:0007275;GO:0060071;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; P:Wnt signaling pathway, planar cell polarity pathway;|Q9NYQ7 O75092,Cadherin EGF LAG seven-pass G-type receptor 3,Cadherin family member 11;Epidermal growth factor-like protein 1;Flamingo homolog 1;Multiple epidermal growth factor-like domains protein 2;, PF00002;PF00028;PF00008;PF16489;PF00053;PF02210;, GO:0016021;GO:0005886;GO:0005509;GO:0004930;GO:0098609;GO:0007186;GO:0007156;GO:0007275;GO:0060071;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; P:Wnt signaling pathway, planar cell polarity pathway; scaffold73 indexed_genome mRNA 1128694 1140598 . + . ID=transcript_11496;Q9BXS9 B4DMZ1 Q548A7 Q96Q90 Q9NQU1,Solute carrier family 26 member 6,Anion exchange transporter;Pendrin-like protein 1;, PF01740;PF00916;, GO:0016324;GO:0016323;GO:0031526;GO:0034707;GO:0030659;GO:0005783;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0097225;GO:0031982;GO:0012506;GO:0015301;GO:0015106;GO:0005254;GO:0015108;GO:0015562;GO:0015660;GO:0015499;GO:0042802;GO:0019531;GO:0030165;GO:0008271;GO:0015116;GO:0038166;GO:0015701;GO:0071320;GO:0071332;GO:0071346;GO:0006821;GO:0042045;GO:0015724;GO:0050892;GO:0051454;GO:0006811;GO:0015797;GO:0019532;GO:0046724;GO:2001150;GO:0070528;GO:0051453;GO:0048240;GO:0008272;GO:0030321;GO:0070633;, C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:chloride channel complex; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:sperm midpiece; C:vesicle; C:vesicle membrane;, F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:chloride channel activity; F:chloride transmembrane transporter activity; F:efflux transmembrane transporter activity; F:formate efflux transmembrane transporter activity; F:formate transmembrane transporter activity; F:identical protein binding; F:oxalate transmembrane transporter activity; F:PDZ domain binding; F:secondary active sulfate transmembrane transporter activity; F:sulfate transmembrane transporter activity;, P:angiotensin-activated signaling pathway; P:bicarbonate transport; P:cellular response to cAMP; P:cellular response to fructose stimulus; P:cellular response to interferon-gamma; P:chloride transport; P:epithelial fluid transport; P:formate transport; P:intestinal absorption; P:intracellular pH elevation; P:ion transport; P:mannitol transport; P:oxalate transport; P:oxalic acid secretion; P:positive regulation of dipeptide transmembrane transport; P:protein kinase C signaling; P:regulation of intracellular pH; P:sperm capacitation; P:sulfate transport; P:transepithelial chloride transport; P:transepithelial transport; scaffold73 indexed_genome mRNA 1142006 1142515 . - . ID=transcript_11497;A2RUT3,Transmembrane protein 89,, PF15098;, GO:0016021;GO:0005634;, C:integral component of membrane; C:nucleus; scaffold73 indexed_genome mRNA 1150453 1159447 . + . ID=transcript_11498;P31930 B2R7R8 Q96DD2,Cytochrome b-c1 complex subunit 1, mitochondrial,Complex III subunit 1;Core protein I;Ubiquinol-cytochrome-c reductase complex core protein 1;, PF00675;PF05193;, GO:0005743;GO:0005746;GO:0005750;GO:0005739;GO:0046872;GO:0044877;GO:0008121;GO:0031625;GO:0009060;GO:0006122;GO:0006119;GO:0014823;GO:0043279;, C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:metal ion binding; F:protein-containing complex binding; F:ubiquinol-cytochrome-c reductase activity; F:ubiquitin protein ligase binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:response to activity; P:response to alkaloid;|P31930 B2R7R8 Q96DD2,Cytochrome b-c1 complex subunit 1, mitochondrial,Complex III subunit 1;Core protein I;Ubiquinol-cytochrome-c reductase complex core protein 1;, PF00675;PF05193;, GO:0005743;GO:0005746;GO:0005750;GO:0005739;GO:0046872;GO:0044877;GO:0008121;GO:0031625;GO:0009060;GO:0006122;GO:0006119;GO:0014823;GO:0043279;, C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:metal ion binding; F:protein-containing complex binding; F:ubiquinol-cytochrome-c reductase activity; F:ubiquitin protein ligase binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:response to activity; P:response to alkaloid;|P31930 B2R7R8 Q96DD2,Cytochrome b-c1 complex subunit 1, mitochondrial,Complex III subunit 1;Core protein I;Ubiquinol-cytochrome-c reductase complex core protein 1;, PF00675;PF05193;, GO:0005743;GO:0005746;GO:0005750;GO:0005739;GO:0046872;GO:0044877;GO:0008121;GO:0031625;GO:0009060;GO:0006122;GO:0006119;GO:0014823;GO:0043279;, C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:metal ion binding; F:protein-containing complex binding; F:ubiquinol-cytochrome-c reductase activity; F:ubiquitin protein ligase binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:response to activity; P:response to alkaloid;|P31930 B2R7R8 Q96DD2,Cytochrome b-c1 complex subunit 1, mitochondrial,Complex III subunit 1;Core protein I;Ubiquinol-cytochrome-c reductase complex core protein 1;, PF00675;PF05193;, GO:0005743;GO:0005746;GO:0005750;GO:0005739;GO:0046872;GO:0044877;GO:0008121;GO:0031625;GO:0009060;GO:0006122;GO:0006119;GO:0014823;GO:0043279;, C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:metal ion binding; F:protein-containing complex binding; F:ubiquinol-cytochrome-c reductase activity; F:ubiquitin protein ligase binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:response to activity; P:response to alkaloid;|P31930 B2R7R8 Q96DD2,Cytochrome b-c1 complex subunit 1, mitochondrial,Complex III subunit 1;Core protein I;Ubiquinol-cytochrome-c reductase complex core protein 1;, PF00675;PF05193;, GO:0005743;GO:0005746;GO:0005750;GO:0005739;GO:0046872;GO:0044877;GO:0008121;GO:0031625;GO:0009060;GO:0006122;GO:0006119;GO:0014823;GO:0043279;, C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:metal ion binding; F:protein-containing complex binding; F:ubiquinol-cytochrome-c reductase activity; F:ubiquitin protein ligase binding;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; P:response to activity; P:response to alkaloid; scaffold73 indexed_genome mRNA 1162813 1193147 . + . ID=transcript_11499;Q02388 Q14054 Q16507,Collagen alpha-1(VII) chain,Long-chain collagen;, PF01391;PF00041;PF00014;PF00092;, GO:0005604;GO:0005590;GO:0062023;GO:0030134;GO:0005788;GO:0033116;GO:0005576;GO:0005615;GO:0030020;GO:0004867;GO:0007155;GO:0030199;GO:0048208;GO:0035987;GO:0006888;GO:0008544;GO:0030198;, C:basement membrane; C:collagen type VII trimer; C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent conferring tensile strength; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:collagen fibril organization; P:COPII vesicle coating; P:endodermal cell differentiation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:epidermis development; P:extracellular matrix organization; scaffold73 indexed_genome mRNA 1193506 1194192 . + . ID=transcript_11500;Q96RP3 Q9BUG0,Urocortin-2,Stresscopin-related peptide;Urocortin II;Urocortin-related peptide;, PF00473;, GO:0005576;GO:0005615;GO:0051431;GO:0051429;GO:0005179;GO:0042562;GO:0007189;GO:0031669;GO:0007586;GO:0009755;, C:extracellular region; C:extracellular space;, F:corticotropin-releasing hormone receptor 2 binding; F:corticotropin-releasing hormone receptor binding; F:hormone activity; F:hormone binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to nutrient levels; P:digestion; P:hormone-mediated signaling pathway; scaffold73 indexed_genome mRNA 1211394 1232660 . + . ID=transcript_11501;Q16877 Q5S3G5 Q5XLC2 Q64EX5,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4,6PF-2-K/Fru-2,6-P2ase testis-type isozyme;, PF01591;PF00300;, GO:0005829;GO:0003873;GO:0005524;GO:0004331;GO:0006003;GO:0006000;GO:0045821;, C:cytosol;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:positive regulation of glycolytic process; scaffold73 indexed_genome mRNA 1233607 1236089 . + . ID=transcript_11502;Q16877 Q5S3G5 Q5XLC2 Q64EX5,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4,6PF-2-K/Fru-2,6-P2ase testis-type isozyme;, PF01591;PF00300;, GO:0005829;GO:0003873;GO:0005524;GO:0004331;GO:0006003;GO:0006000;GO:0045821;, C:cytosol;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity;, P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:positive regulation of glycolytic process; scaffold73 indexed_genome mRNA 1243916 1268606 . + . ID=transcript_11503;Q8N114 B3KW99 F8W9N8 Q69YY9 Q7Z433 Q8NHL9 Q96MW8 Q9BV58,Protein shisa-5,Putative NF-kappa-B-activating protein 120;Scotin;, PF13908;, GO:0005783;GO:0005788;GO:0005789;GO:0016021;GO:0031965;GO:0050699;GO:0044267;GO:0042771;GO:0043123;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane;, F:WW domain binding;, P:cellular protein metabolic process; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:post-translational protein modification; scaffold73 indexed_genome mRNA 1268855 1270342 . - . ID=transcript_11504;Q9NSU2 B2RCN9 Q8TEU2 Q9BPW1 Q9Y4X2,Three-prime repair exonuclease 1 {ECO:0000305},3'-5' exonuclease TREX1 {ECO:0000303|PubMed:10391904};Deoxyribonuclease III {ECO:0000303|PubMed:10393201};, , GO:0005737;GO:0005829;GO:0005789;GO:0005635;GO:0043596;GO:0008250;GO:0032993;GO:0008408;GO:0008296;GO:0032558;GO:0008301;GO:0003690;GO:0008853;GO:0000287;GO:0046872;GO:0032405;GO:0032407;GO:0042803;GO:0003697;GO:0050699;GO:0002253;GO:0043277;GO:0003228;GO:0001568;GO:0035781;GO:0071480;GO:0072711;GO:0035458;GO:0034614;GO:0051607;GO:0072421;GO:0072394;GO:0008340;GO:0000738;GO:0032508;GO:0006259;GO:0006304;GO:0006310;GO:0006281;GO:0006260;GO:1904161;GO:0045184;GO:0006091;GO:0003007;GO:0003015;GO:0097281;GO:0002383;GO:0002437;GO:0001822;GO:0002320;GO:0002281;GO:0006298;GO:0060339;GO:0050821;GO:0050790;GO:0043457;GO:0019217;GO:0006110;GO:0002637;GO:0050727;GO:0046890;GO:1905671;GO:0061635;GO:0050863;GO:0032680;GO:0032479;GO:0072422;GO:0002457;GO:0032197;GO:0060337;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:nuclear envelope; C:nuclear replication fork; C:oligosaccharyltransferase complex; C:protein-DNA complex;, F:3'-5' exonuclease activity; F:3'-5'-exodeoxyribonuclease activity; F:adenyl deoxyribonucleotide binding; F:DNA binding, bending; F:double-stranded DNA binding; F:exodeoxyribonuclease III activity; F:magnesium ion binding; F:metal ion binding; F:MutLalpha complex binding; F:MutSalpha complex binding; F:protein homodimerization activity; F:single-stranded DNA binding; F:WW domain binding;, P:activation of immune response; P:apoptotic cell clearance; P:atrial cardiac muscle tissue development; P:blood vessel development; P:CD86 biosynthetic process; P:cellular response to gamma radiation; P:cellular response to hydroxyurea; P:cellular response to interferon-beta; P:cellular response to reactive oxygen species; P:defense response to virus; P:detection of DNA damage stimulus involved in DNA damage checkpoint; P:detection of stimulus involved in cell cycle checkpoint; P:determination of adult lifespan; P:DNA catabolic process, exonucleolytic; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA modification; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA synthesis involved in UV-damage excision repair; P:establishment of protein localization; P:generation of precursor metabolites and energy; P:heart morphogenesis; P:heart process; P:immune complex formation; P:immune response in brain or nervous system; P:inflammatory response to antigenic stimulus; P:kidney development; P:lymphoid progenitor cell differentiation; P:macrophage activation involved in immune response; P:mismatch repair; P:negative regulation of type I interferon-mediated signaling pathway; P:protein stabilization; P:regulation of catalytic activity; P:regulation of cellular respiration; P:regulation of fatty acid metabolic process; P:regulation of glycolytic process; P:regulation of immunoglobulin production; P:regulation of inflammatory response; P:regulation of lipid biosynthetic process; P:regulation of lysosome organization; P:regulation of protein complex stability; P:regulation of T cell activation; P:regulation of tumor necrosis factor production; P:regulation of type I interferon production; P:signal transduction involved in DNA damage checkpoint; P:T cell antigen processing and presentation; P:transposition, RNA-mediated; P:type I interferon signaling pathway; scaffold73 indexed_genome mRNA 1270798 1288930 . - . ID=transcript_11505;Q96CL3 Q9HA30,ATR-interacting protein,ATM and Rad3-related-interacting protein;, , GO:0005654;GO:0070530;GO:0000077;GO:0006281;GO:0006260;GO:0036297;GO:1901796;, C:nucleoplasm;, F:K63-linked polyubiquitin modification-dependent protein binding;, P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:interstrand cross-link repair; P:regulation of signal transduction by p53 class mediator;|Q96CL3 Q9HA30,ATR-interacting protein,ATM and Rad3-related-interacting protein;, , GO:0005654;GO:0070530;GO:0000077;GO:0006281;GO:0006260;GO:0036297;GO:1901796;, C:nucleoplasm;, F:K63-linked polyubiquitin modification-dependent protein binding;, P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:interstrand cross-link repair; P:regulation of signal transduction by p53 class mediator;|Q96CL3 Q9HA30,ATR-interacting protein,ATM and Rad3-related-interacting protein;, , GO:0005654;GO:0070530;GO:0000077;GO:0006281;GO:0006260;GO:0036297;GO:1901796;, C:nucleoplasm;, F:K63-linked polyubiquitin modification-dependent protein binding;, P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:interstrand cross-link repair; P:regulation of signal transduction by p53 class mediator;|Q96CL3 Q9HA30,ATR-interacting protein,ATM and Rad3-related-interacting protein;, , GO:0005654;GO:0070530;GO:0000077;GO:0006281;GO:0006260;GO:0036297;GO:1901796;, C:nucleoplasm;, F:K63-linked polyubiquitin modification-dependent protein binding;, P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:interstrand cross-link repair; P:regulation of signal transduction by p53 class mediator; scaffold73 indexed_genome mRNA 1299532 1302996 . + . ID=transcript_11506;Q96ER9 Q9HA01,Mitochondrial potassium channel {ECO:0000303|PubMed:31435016},Coiled-coil domain-containing protein 51 {ECO:0000305};, , GO:0031305;GO:0062157;GO:0062156;GO:0071805;, C:integral component of mitochondrial inner membrane; C:mitochondrial ATP-gated potassium channel complex;, F:mitochondrial ATP-gated potassium channel activity;, P:potassium ion transmembrane transport;|Q96ER9 Q9HA01,Mitochondrial potassium channel {ECO:0000303|PubMed:31435016},Coiled-coil domain-containing protein 51 {ECO:0000305};, , GO:0031305;GO:0062157;GO:0062156;GO:0071805;, C:integral component of mitochondrial inner membrane; C:mitochondrial ATP-gated potassium channel complex;, F:mitochondrial ATP-gated potassium channel activity;, P:potassium ion transmembrane transport; scaffold73 indexed_genome mRNA 1304878 1344292 . + . ID=transcript_11507;O43157 A6H8Y2 Q6NY20 Q9UIV7 Q9UJ92 Q9UJ93,Plexin-B1,Semaphorin receptor SEP;, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005576;GO:0005887;GO:0005886;GO:0002116;GO:0032794;GO:0017154;GO:0030215;GO:0038023;GO:0004888;GO:0016477;GO:0007186;GO:1904862;GO:0035556;GO:0007162;GO:0033689;GO:0048812;GO:0043931;GO:0050772;GO:0043547;GO:0014068;GO:0030334;GO:0008360;GO:0051493;GO:0043087;GO:0071526;GO:1902287;GO:1900220;GO:0007165;, C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:GTPase activating protein binding; F:semaphorin receptor activity; F:semaphorin receptor binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:cell migration; P:G protein-coupled receptor signaling pathway; P:inhibitory synapse assembly; P:intracellular signal transduction; P:negative regulation of cell adhesion; P:negative regulation of osteoblast proliferation; P:neuron projection morphogenesis; P:ossification involved in bone maturation; P:positive regulation of axonogenesis; P:positive regulation of GTPase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:regulation of cell migration; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis; P:signal transduction;|O43157 A6H8Y2 Q6NY20 Q9UIV7 Q9UJ92 Q9UJ93,Plexin-B1,Semaphorin receptor SEP;, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005576;GO:0005887;GO:0005886;GO:0002116;GO:0032794;GO:0017154;GO:0030215;GO:0038023;GO:0004888;GO:0016477;GO:0007186;GO:1904862;GO:0035556;GO:0007162;GO:0033689;GO:0048812;GO:0043931;GO:0050772;GO:0043547;GO:0014068;GO:0030334;GO:0008360;GO:0051493;GO:0043087;GO:0071526;GO:1902287;GO:1900220;GO:0007165;, C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:GTPase activating protein binding; F:semaphorin receptor activity; F:semaphorin receptor binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:cell migration; P:G protein-coupled receptor signaling pathway; P:inhibitory synapse assembly; P:intracellular signal transduction; P:negative regulation of cell adhesion; P:negative regulation of osteoblast proliferation; P:neuron projection morphogenesis; P:ossification involved in bone maturation; P:positive regulation of axonogenesis; P:positive regulation of GTPase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:regulation of cell migration; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis; P:signal transduction;|O43157 A6H8Y2 Q6NY20 Q9UIV7 Q9UJ92 Q9UJ93,Plexin-B1,Semaphorin receptor SEP;, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005576;GO:0005887;GO:0005886;GO:0002116;GO:0032794;GO:0017154;GO:0030215;GO:0038023;GO:0004888;GO:0016477;GO:0007186;GO:1904862;GO:0035556;GO:0007162;GO:0033689;GO:0048812;GO:0043931;GO:0050772;GO:0043547;GO:0014068;GO:0030334;GO:0008360;GO:0051493;GO:0043087;GO:0071526;GO:1902287;GO:1900220;GO:0007165;, C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:GTPase activating protein binding; F:semaphorin receptor activity; F:semaphorin receptor binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:cell migration; P:G protein-coupled receptor signaling pathway; P:inhibitory synapse assembly; P:intracellular signal transduction; P:negative regulation of cell adhesion; P:negative regulation of osteoblast proliferation; P:neuron projection morphogenesis; P:ossification involved in bone maturation; P:positive regulation of axonogenesis; P:positive regulation of GTPase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:regulation of cell migration; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis; P:signal transduction;|O43157 A6H8Y2 Q6NY20 Q9UIV7 Q9UJ92 Q9UJ93,Plexin-B1,Semaphorin receptor SEP;, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005576;GO:0005887;GO:0005886;GO:0002116;GO:0032794;GO:0017154;GO:0030215;GO:0038023;GO:0004888;GO:0016477;GO:0007186;GO:1904862;GO:0035556;GO:0007162;GO:0033689;GO:0048812;GO:0043931;GO:0050772;GO:0043547;GO:0014068;GO:0030334;GO:0008360;GO:0051493;GO:0043087;GO:0071526;GO:1902287;GO:1900220;GO:0007165;, C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:GTPase activating protein binding; F:semaphorin receptor activity; F:semaphorin receptor binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:cell migration; P:G protein-coupled receptor signaling pathway; P:inhibitory synapse assembly; P:intracellular signal transduction; P:negative regulation of cell adhesion; P:negative regulation of osteoblast proliferation; P:neuron projection morphogenesis; P:ossification involved in bone maturation; P:positive regulation of axonogenesis; P:positive regulation of GTPase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:regulation of cell migration; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis; P:signal transduction;|O43157 A6H8Y2 Q6NY20 Q9UIV7 Q9UJ92 Q9UJ93,Plexin-B1,Semaphorin receptor SEP;, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005576;GO:0005887;GO:0005886;GO:0002116;GO:0032794;GO:0017154;GO:0030215;GO:0038023;GO:0004888;GO:0016477;GO:0007186;GO:1904862;GO:0035556;GO:0007162;GO:0033689;GO:0048812;GO:0043931;GO:0050772;GO:0043547;GO:0014068;GO:0030334;GO:0008360;GO:0051493;GO:0043087;GO:0071526;GO:1902287;GO:1900220;GO:0007165;, C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:GTPase activating protein binding; F:semaphorin receptor activity; F:semaphorin receptor binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:cell migration; P:G protein-coupled receptor signaling pathway; P:inhibitory synapse assembly; P:intracellular signal transduction; P:negative regulation of cell adhesion; P:negative regulation of osteoblast proliferation; P:neuron projection morphogenesis; P:ossification involved in bone maturation; P:positive regulation of axonogenesis; P:positive regulation of GTPase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:regulation of cell migration; P:regulation of cell shape; P:regulation of cytoskeleton organization; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis; P:signal transduction; scaffold73 indexed_genome mRNA 1440655 1441661 . - . ID=transcript_11508;Q5JXV8 Q9BUV2 Q9H443,Zinc finger protein 133,Zinc finger protein 150;, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold73 indexed_genome mRNA 1595045 1618098 . + . ID=transcript_11509;P30304 Q8IZH5 Q96IL3 Q9H2F2,M-phase inducer phosphatase 1,Dual specificity phosphatase Cdc25A;, PF06617;PF00581;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0051087;GO:0019901;GO:0004725;GO:0051301;GO:0008283;GO:0034644;GO:0000082;GO:0000086;GO:0010971;GO:0110032;GO:0016579;GO:0051726;GO:0000079;GO:0009314;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chaperone binding; F:protein kinase binding; F:protein tyrosine phosphatase activity;, P:cell division; P:cell population proliferation; P:cellular response to UV; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of G2/MI transition of meiotic cell cycle; P:protein deubiquitination; P:regulation of cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:response to radiation; scaffold73 indexed_genome mRNA 1624653 1625558 . + . ID=transcript_11510;P84103 B4E241 O08831 P23152 Q5R3K0,Serine/arginine-rich splicing factor 3,Pre-mRNA-splicing factor SRP20;Splicing factor, arginine/serine-rich 3;, PF00076;, GO:0005737;GO:0016607;GO:0005654;GO:0043274;GO:0003723;GO:1990825;GO:1990830;GO:0031124;GO:0006406;GO:0000398;GO:0048024;GO:0006405;, C:cytoplasm; C:nuclear speck; C:nucleoplasm;, F:phospholipase binding; F:RNA binding; F:sequence-specific mRNA binding;, P:cellular response to leukemia inhibitory factor; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:RNA export from nucleus; scaffold73 indexed_genome mRNA 1732982 1738469 . + . ID=transcript_11511;P27816 Q13082 Q59FT2 Q68D74 Q6ZUW9 Q86V26 Q96A76 Q96NS9,Microtubule-associated protein 4,, PF00418;, GO:0030424;GO:0005930;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0072686;GO:0043005;GO:0005886;GO:0008017;GO:0003723;GO:0005198;GO:0051301;GO:0051294;GO:0000226;GO:0051012;GO:0007052;GO:1902856;GO:0031175;, C:axon; C:axoneme; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:mitotic spindle; C:neuron projection; C:plasma membrane;, F:microtubule binding; F:RNA binding; F:structural molecule activity;, P:cell division; P:establishment of spindle orientation; P:microtubule cytoskeleton organization; P:microtubule sliding; P:mitotic spindle organization; P:negative regulation of non-motile cilium assembly; P:neuron projection development; scaffold73 indexed_genome mRNA 1762178 1808256 . + . ID=transcript_11512;P27816 Q13082 Q59FT2 Q68D74 Q6ZUW9 Q86V26 Q96A76 Q96NS9,Microtubule-associated protein 4,, PF00418;, GO:0030424;GO:0005930;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0072686;GO:0043005;GO:0005886;GO:0008017;GO:0003723;GO:0005198;GO:0051301;GO:0051294;GO:0000226;GO:0051012;GO:0007052;GO:1902856;GO:0031175;, C:axon; C:axoneme; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:mitotic spindle; C:neuron projection; C:plasma membrane;, F:microtubule binding; F:RNA binding; F:structural molecule activity;, P:cell division; P:establishment of spindle orientation; P:microtubule cytoskeleton organization; P:microtubule sliding; P:mitotic spindle organization; P:negative regulation of non-motile cilium assembly; P:neuron projection development;|P27816 Q13082 Q59FT2 Q68D74 Q6ZUW9 Q86V26 Q96A76 Q96NS9,Microtubule-associated protein 4,, PF00418;, GO:0030424;GO:0005930;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0072686;GO:0043005;GO:0005886;GO:0008017;GO:0003723;GO:0005198;GO:0051301;GO:0051294;GO:0000226;GO:0051012;GO:0007052;GO:1902856;GO:0031175;, C:axon; C:axoneme; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:mitotic spindle; C:neuron projection; C:plasma membrane;, F:microtubule binding; F:RNA binding; F:structural molecule activity;, P:cell division; P:establishment of spindle orientation; P:microtubule cytoskeleton organization; P:microtubule sliding; P:mitotic spindle organization; P:negative regulation of non-motile cilium assembly; P:neuron projection development;|P27816 Q13082 Q59FT2 Q68D74 Q6ZUW9 Q86V26 Q96A76 Q96NS9,Microtubule-associated protein 4,, PF00418;, GO:0030424;GO:0005930;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0072686;GO:0043005;GO:0005886;GO:0008017;GO:0003723;GO:0005198;GO:0051301;GO:0051294;GO:0000226;GO:0051012;GO:0007052;GO:1902856;GO:0031175;, C:axon; C:axoneme; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:mitotic spindle; C:neuron projection; C:plasma membrane;, F:microtubule binding; F:RNA binding; F:structural molecule activity;, P:cell division; P:establishment of spindle orientation; P:microtubule cytoskeleton organization; P:microtubule sliding; P:mitotic spindle organization; P:negative regulation of non-motile cilium assembly; P:neuron projection development;|P27816 Q13082 Q59FT2 Q68D74 Q6ZUW9 Q86V26 Q96A76 Q96NS9,Microtubule-associated protein 4,, PF00418;, GO:0030424;GO:0005930;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0072686;GO:0043005;GO:0005886;GO:0008017;GO:0003723;GO:0005198;GO:0051301;GO:0051294;GO:0000226;GO:0051012;GO:0007052;GO:1902856;GO:0031175;, C:axon; C:axoneme; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:mitotic spindle; C:neuron projection; C:plasma membrane;, F:microtubule binding; F:RNA binding; F:structural molecule activity;, P:cell division; P:establishment of spindle orientation; P:microtubule cytoskeleton organization; P:microtubule sliding; P:mitotic spindle organization; P:negative regulation of non-motile cilium assembly; P:neuron projection development;|P27816 Q13082 Q59FT2 Q68D74 Q6ZUW9 Q86V26 Q96A76 Q96NS9,Microtubule-associated protein 4,, PF00418;, GO:0030424;GO:0005930;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0072686;GO:0043005;GO:0005886;GO:0008017;GO:0003723;GO:0005198;GO:0051301;GO:0051294;GO:0000226;GO:0051012;GO:0007052;GO:1902856;GO:0031175;, C:axon; C:axoneme; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:mitotic spindle; C:neuron projection; C:plasma membrane;, F:microtubule binding; F:RNA binding; F:structural molecule activity;, P:cell division; P:establishment of spindle orientation; P:microtubule cytoskeleton organization; P:microtubule sliding; P:mitotic spindle organization; P:negative regulation of non-motile cilium assembly; P:neuron projection development;|P27816 Q13082 Q59FT2 Q68D74 Q6ZUW9 Q86V26 Q96A76 Q96NS9,Microtubule-associated protein 4,, PF00418;, GO:0030424;GO:0005930;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0072686;GO:0043005;GO:0005886;GO:0008017;GO:0003723;GO:0005198;GO:0051301;GO:0051294;GO:0000226;GO:0051012;GO:0007052;GO:1902856;GO:0031175;, C:axon; C:axoneme; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:mitotic spindle; C:neuron projection; C:plasma membrane;, F:microtubule binding; F:RNA binding; F:structural molecule activity;, P:cell division; P:establishment of spindle orientation; P:microtubule cytoskeleton organization; P:microtubule sliding; P:mitotic spindle organization; P:negative regulation of non-motile cilium assembly; P:neuron projection development;|P27816 Q13082 Q59FT2 Q68D74 Q6ZUW9 Q86V26 Q96A76 Q96NS9,Microtubule-associated protein 4,, PF00418;, GO:0030424;GO:0005930;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0072686;GO:0043005;GO:0005886;GO:0008017;GO:0003723;GO:0005198;GO:0051301;GO:0051294;GO:0000226;GO:0051012;GO:0007052;GO:1902856;GO:0031175;, C:axon; C:axoneme; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:mitotic spindle; C:neuron projection; C:plasma membrane;, F:microtubule binding; F:RNA binding; F:structural molecule activity;, P:cell division; P:establishment of spindle orientation; P:microtubule cytoskeleton organization; P:microtubule sliding; P:mitotic spindle organization; P:negative regulation of non-motile cilium assembly; P:neuron projection development; scaffold73 indexed_genome mRNA 1808751 1811876 . - . ID=transcript_11513;P27816 Q13082 Q59FT2 Q68D74 Q6ZUW9 Q86V26 Q96A76 Q96NS9,Microtubule-associated protein 4,, PF00418;, GO:0030424;GO:0005930;GO:0005829;GO:0005874;GO:0005875;GO:0015630;GO:0072686;GO:0043005;GO:0005886;GO:0008017;GO:0003723;GO:0005198;GO:0051301;GO:0051294;GO:0000226;GO:0051012;GO:0007052;GO:1902856;GO:0031175;, C:axon; C:axoneme; C:cytosol; C:microtubule; C:microtubule associated complex; C:microtubule cytoskeleton; C:mitotic spindle; C:neuron projection; C:plasma membrane;, F:microtubule binding; F:RNA binding; F:structural molecule activity;, P:cell division; P:establishment of spindle orientation; P:microtubule cytoskeleton organization; P:microtubule sliding; P:mitotic spindle organization; P:negative regulation of non-motile cilium assembly; P:neuron projection development; scaffold73 indexed_genome mRNA 1812064 1820836 . - . ID=transcript_11514;Q7L2E3 A8K5F1 O94965 Q7Z753 Q96CH4 Q9NUQ0,ATP-dependent RNA helicase DHX30 {ECO:0000305},DEAH box protein 30;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0005829;GO:0042645;GO:0005739;GO:0035770;GO:0005524;GO:0003682;GO:0003725;GO:0003723;GO:0003724;GO:0007417;GO:1902775;, C:cytoplasm; C:cytosol; C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:ATP binding; F:chromatin binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:central nervous system development; P:mitochondrial large ribosomal subunit assembly;|Q7L2E3 A8K5F1 O94965 Q7Z753 Q96CH4 Q9NUQ0,ATP-dependent RNA helicase DHX30 {ECO:0000305},DEAH box protein 30;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0005829;GO:0042645;GO:0005739;GO:0035770;GO:0005524;GO:0003682;GO:0003725;GO:0003723;GO:0003724;GO:0007417;GO:1902775;, C:cytoplasm; C:cytosol; C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:ATP binding; F:chromatin binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:central nervous system development; P:mitochondrial large ribosomal subunit assembly;|Q7L2E3 A8K5F1 O94965 Q7Z753 Q96CH4 Q9NUQ0,ATP-dependent RNA helicase DHX30 {ECO:0000305},DEAH box protein 30;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0005829;GO:0042645;GO:0005739;GO:0035770;GO:0005524;GO:0003682;GO:0003725;GO:0003723;GO:0003724;GO:0007417;GO:1902775;, C:cytoplasm; C:cytosol; C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:ATP binding; F:chromatin binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:central nervous system development; P:mitochondrial large ribosomal subunit assembly;|Q7L2E3 A8K5F1 O94965 Q7Z753 Q96CH4 Q9NUQ0,ATP-dependent RNA helicase DHX30 {ECO:0000305},DEAH box protein 30;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0005829;GO:0042645;GO:0005739;GO:0035770;GO:0005524;GO:0003682;GO:0003725;GO:0003723;GO:0003724;GO:0007417;GO:1902775;, C:cytoplasm; C:cytosol; C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:ATP binding; F:chromatin binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:central nervous system development; P:mitochondrial large ribosomal subunit assembly; scaffold73 indexed_genome mRNA 1823294 1840451 . + . ID=transcript_11515;Q7L2E3 A8K5F1 O94965 Q7Z753 Q96CH4 Q9NUQ0,ATP-dependent RNA helicase DHX30 {ECO:0000305},DEAH box protein 30;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0005829;GO:0042645;GO:0005739;GO:0035770;GO:0005524;GO:0003682;GO:0003725;GO:0003723;GO:0003724;GO:0007417;GO:1902775;, C:cytoplasm; C:cytosol; C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:ATP binding; F:chromatin binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:central nervous system development; P:mitochondrial large ribosomal subunit assembly;|Q7L2E3 A8K5F1 O94965 Q7Z753 Q96CH4 Q9NUQ0,ATP-dependent RNA helicase DHX30 {ECO:0000305},DEAH box protein 30;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0005829;GO:0042645;GO:0005739;GO:0035770;GO:0005524;GO:0003682;GO:0003725;GO:0003723;GO:0003724;GO:0007417;GO:1902775;, C:cytoplasm; C:cytosol; C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:ATP binding; F:chromatin binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:central nervous system development; P:mitochondrial large ribosomal subunit assembly;|Q7L2E3 A8K5F1 O94965 Q7Z753 Q96CH4 Q9NUQ0,ATP-dependent RNA helicase DHX30 {ECO:0000305},DEAH box protein 30;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0005829;GO:0042645;GO:0005739;GO:0035770;GO:0005524;GO:0003682;GO:0003725;GO:0003723;GO:0003724;GO:0007417;GO:1902775;, C:cytoplasm; C:cytosol; C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:ATP binding; F:chromatin binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:central nervous system development; P:mitochondrial large ribosomal subunit assembly;|Q7L2E3 A8K5F1 O94965 Q7Z753 Q96CH4 Q9NUQ0,ATP-dependent RNA helicase DHX30 {ECO:0000305},DEAH box protein 30;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0005829;GO:0042645;GO:0005739;GO:0035770;GO:0005524;GO:0003682;GO:0003725;GO:0003723;GO:0003724;GO:0007417;GO:1902775;, C:cytoplasm; C:cytosol; C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:ATP binding; F:chromatin binding; F:double-stranded RNA binding; F:RNA binding; F:RNA helicase activity;, P:central nervous system development; P:mitochondrial large ribosomal subunit assembly; scaffold73 indexed_genome mRNA 1889083 2003942 . + . ID=transcript_11516;Q92922 Q17RS0 Q6P172 Q8IWH2,SWI/SNF complex subunit SMARCC1 {ECO:0000305},BRG1-associated factor 155;SWI/SNF complex 155 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0005737;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0001741;GO:0003682;GO:0042393;GO:0047485;GO:0003713;GO:0009887;GO:0043044;GO:0006338;GO:0008286;GO:0032435;GO:0007399;GO:0006337;GO:0045944;GO:0045893;GO:0030850;GO:0006357;, C:chromatin; C:cytoplasm; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex; C:XY body;, F:chromatin binding; F:histone binding; F:protein N-terminus binding; F:transcription coactivator activity;, P:animal organ morphogenesis; P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:insulin receptor signaling pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:regulation of transcription by RNA polymerase II;|Q92922 Q17RS0 Q6P172 Q8IWH2,SWI/SNF complex subunit SMARCC1 {ECO:0000305},BRG1-associated factor 155;SWI/SNF complex 155 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0005737;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0001741;GO:0003682;GO:0042393;GO:0047485;GO:0003713;GO:0009887;GO:0043044;GO:0006338;GO:0008286;GO:0032435;GO:0007399;GO:0006337;GO:0045944;GO:0045893;GO:0030850;GO:0006357;, C:chromatin; C:cytoplasm; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex; C:XY body;, F:chromatin binding; F:histone binding; F:protein N-terminus binding; F:transcription coactivator activity;, P:animal organ morphogenesis; P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:insulin receptor signaling pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:regulation of transcription by RNA polymerase II; scaffold73 indexed_genome mRNA 2016480 2028503 . + . ID=transcript_11517;O95196 Q71M39 Q71M40,Chondroitin sulfate proteoglycan 5,Acidic leucine-rich EGF-like domain-containing brain protein;Neuroglycan C;, PF06566;PF06567;, GO:0009986;GO:0005789;GO:0005576;GO:0098982;GO:0098978;GO:0005794;GO:0005796;GO:0000139;GO:0030660;GO:0016021;GO:0005887;GO:0099055;GO:0043202;GO:0016020;GO:0045202;GO:0008083;GO:0048858;GO:0030206;GO:0030207;GO:0007010;GO:0030208;GO:0106091;GO:0046907;GO:0007399;GO:1900026;GO:0040008;GO:2000300;GO:0099550;, C:cell surface; C:endoplasmic reticulum membrane; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi lumen; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:lysosomal lumen; C:membrane; C:synapse;, F:growth factor activity;, P:cell projection morphogenesis; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:cytoskeleton organization; P:dermatan sulfate biosynthetic process; P:glial cell projection elongation; P:intracellular transport; P:nervous system development; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of growth; P:regulation of synaptic vesicle exocytosis; P:trans-synaptic signaling, modulating synaptic transmission;|O95196 Q71M39 Q71M40,Chondroitin sulfate proteoglycan 5,Acidic leucine-rich EGF-like domain-containing brain protein;Neuroglycan C;, PF06566;PF06567;, GO:0009986;GO:0005789;GO:0005576;GO:0098982;GO:0098978;GO:0005794;GO:0005796;GO:0000139;GO:0030660;GO:0016021;GO:0005887;GO:0099055;GO:0043202;GO:0016020;GO:0045202;GO:0008083;GO:0048858;GO:0030206;GO:0030207;GO:0007010;GO:0030208;GO:0106091;GO:0046907;GO:0007399;GO:1900026;GO:0040008;GO:2000300;GO:0099550;, C:cell surface; C:endoplasmic reticulum membrane; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi lumen; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:lysosomal lumen; C:membrane; C:synapse;, F:growth factor activity;, P:cell projection morphogenesis; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:cytoskeleton organization; P:dermatan sulfate biosynthetic process; P:glial cell projection elongation; P:intracellular transport; P:nervous system development; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of growth; P:regulation of synaptic vesicle exocytosis; P:trans-synaptic signaling, modulating synaptic transmission;|O95196 Q71M39 Q71M40,Chondroitin sulfate proteoglycan 5,Acidic leucine-rich EGF-like domain-containing brain protein;Neuroglycan C;, PF06566;PF06567;, GO:0009986;GO:0005789;GO:0005576;GO:0098982;GO:0098978;GO:0005794;GO:0005796;GO:0000139;GO:0030660;GO:0016021;GO:0005887;GO:0099055;GO:0043202;GO:0016020;GO:0045202;GO:0008083;GO:0048858;GO:0030206;GO:0030207;GO:0007010;GO:0030208;GO:0106091;GO:0046907;GO:0007399;GO:1900026;GO:0040008;GO:2000300;GO:0099550;, C:cell surface; C:endoplasmic reticulum membrane; C:extracellular region; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi lumen; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:lysosomal lumen; C:membrane; C:synapse;, F:growth factor activity;, P:cell projection morphogenesis; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:cytoskeleton organization; P:dermatan sulfate biosynthetic process; P:glial cell projection elongation; P:intracellular transport; P:nervous system development; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of growth; P:regulation of synaptic vesicle exocytosis; P:trans-synaptic signaling, modulating synaptic transmission; scaffold73 indexed_genome mRNA 2058326 2069197 . + . ID=transcript_11518;Q0PNE2 Q9BW57 Q9NXJ3,Elongator complex protein 6 {ECO:0000303|PubMed:22854966},Angiotonin-transactivated protein 1;Protein TMEM103;, PF09807;, GO:0005829;GO:0033588;GO:0005634;GO:0030335;GO:0002098;, C:cytosol; C:elongator holoenzyme complex; C:nucleus;, , P:positive regulation of cell migration; P:tRNA wobble uridine modification;|Q0PNE2 Q9BW57 Q9NXJ3,Elongator complex protein 6 {ECO:0000303|PubMed:22854966},Angiotonin-transactivated protein 1;Protein TMEM103;, PF09807;, GO:0005829;GO:0033588;GO:0005634;GO:0030335;GO:0002098;, C:cytosol; C:elongator holoenzyme complex; C:nucleus;, , P:positive regulation of cell migration; P:tRNA wobble uridine modification;|Q0PNE2 Q9BW57 Q9NXJ3,Elongator complex protein 6 {ECO:0000303|PubMed:22854966},Angiotonin-transactivated protein 1;Protein TMEM103;, PF09807;, GO:0005829;GO:0033588;GO:0005634;GO:0030335;GO:0002098;, C:cytosol; C:elongator holoenzyme complex; C:nucleus;, , P:positive regulation of cell migration; P:tRNA wobble uridine modification; scaffold73 indexed_genome mRNA 2172651 2199907 . + . ID=transcript_11519;Q12770 Q8N2E0 Q8WUA1,Sterol regulatory element-binding protein cleavage-activating protein {ECO:0000303|PubMed:10570913},, PF12349;PF00400;, GO:0005783;GO:0005789;GO:0012507;GO:0005794;GO:0000139;GO:0016021;GO:0032991;GO:0044877;GO:0032934;GO:0051082;GO:0007568;GO:0044255;GO:0008203;GO:0090110;GO:0006955;GO:0045541;GO:0045542;GO:0042304;GO:0001666;GO:0032868;GO:0032933;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:protein-containing complex;, F:protein-containing complex binding; F:sterol binding; F:unfolded protein binding;, P:aging; P:cellular lipid metabolic process; P:cholesterol metabolic process; P:COPII-coated vesicle cargo loading; P:immune response; P:negative regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol biosynthetic process; P:regulation of fatty acid biosynthetic process; P:response to hypoxia; P:response to insulin; P:SREBP signaling pathway;|Q12770 Q8N2E0 Q8WUA1,Sterol regulatory element-binding protein cleavage-activating protein {ECO:0000303|PubMed:10570913},, PF12349;PF00400;, GO:0005783;GO:0005789;GO:0012507;GO:0005794;GO:0000139;GO:0016021;GO:0032991;GO:0044877;GO:0032934;GO:0051082;GO:0007568;GO:0044255;GO:0008203;GO:0090110;GO:0006955;GO:0045541;GO:0045542;GO:0042304;GO:0001666;GO:0032868;GO:0032933;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:protein-containing complex;, F:protein-containing complex binding; F:sterol binding; F:unfolded protein binding;, P:aging; P:cellular lipid metabolic process; P:cholesterol metabolic process; P:COPII-coated vesicle cargo loading; P:immune response; P:negative regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol biosynthetic process; P:regulation of fatty acid biosynthetic process; P:response to hypoxia; P:response to insulin; P:SREBP signaling pathway;|Q12770 Q8N2E0 Q8WUA1,Sterol regulatory element-binding protein cleavage-activating protein {ECO:0000303|PubMed:10570913},, PF12349;PF00400;, GO:0005783;GO:0005789;GO:0012507;GO:0005794;GO:0000139;GO:0016021;GO:0032991;GO:0044877;GO:0032934;GO:0051082;GO:0007568;GO:0044255;GO:0008203;GO:0090110;GO:0006955;GO:0045541;GO:0045542;GO:0042304;GO:0001666;GO:0032868;GO:0032933;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:protein-containing complex;, F:protein-containing complex binding; F:sterol binding; F:unfolded protein binding;, P:aging; P:cellular lipid metabolic process; P:cholesterol metabolic process; P:COPII-coated vesicle cargo loading; P:immune response; P:negative regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol biosynthetic process; P:regulation of fatty acid biosynthetic process; P:response to hypoxia; P:response to insulin; P:SREBP signaling pathway;|Q12770 Q8N2E0 Q8WUA1,Sterol regulatory element-binding protein cleavage-activating protein {ECO:0000303|PubMed:10570913},, PF12349;PF00400;, GO:0005783;GO:0005789;GO:0012507;GO:0005794;GO:0000139;GO:0016021;GO:0032991;GO:0044877;GO:0032934;GO:0051082;GO:0007568;GO:0044255;GO:0008203;GO:0090110;GO:0006955;GO:0045541;GO:0045542;GO:0042304;GO:0001666;GO:0032868;GO:0032933;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:protein-containing complex;, F:protein-containing complex binding; F:sterol binding; F:unfolded protein binding;, P:aging; P:cellular lipid metabolic process; P:cholesterol metabolic process; P:COPII-coated vesicle cargo loading; P:immune response; P:negative regulation of cholesterol biosynthetic process; P:positive regulation of cholesterol biosynthetic process; P:regulation of fatty acid biosynthetic process; P:response to hypoxia; P:response to insulin; P:SREBP signaling pathway;|Q9H3S7 A8K0D7 Q7KZF8 Q8N6Z5 Q9BSR5 Q9P257 Q9UG03 Q9UMZ4,Tyrosine-protein phosphatase non-receptor type 23,His domain-containing protein tyrosine phosphatase;Protein tyrosine phosphatase TD14;, PF13949;PF03097;PF00102;, GO:0036064;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0019901;GO:0004725;GO:0071345;GO:0060271;GO:0045022;GO:0032456;GO:0010633;GO:1903393;GO:2000643;GO:1903387;GO:0061357;GO:0015031;GO:0043162;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:protein kinase binding; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:cilium assembly; P:early endosome to late endosome transport; P:endocytic recycling; P:negative regulation of epithelial cell migration; P:positive regulation of adherens junction organization; P:positive regulation of early endosome to late endosome transport; P:positive regulation of homophilic cell adhesion; P:positive regulation of Wnt protein secretion; P:protein transport; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9H3S7 A8K0D7 Q7KZF8 Q8N6Z5 Q9BSR5 Q9P257 Q9UG03 Q9UMZ4,Tyrosine-protein phosphatase non-receptor type 23,His domain-containing protein tyrosine phosphatase;Protein tyrosine phosphatase TD14;, PF13949;PF03097;PF00102;, GO:0036064;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0019901;GO:0004725;GO:0071345;GO:0060271;GO:0045022;GO:0032456;GO:0010633;GO:1903393;GO:2000643;GO:1903387;GO:0061357;GO:0015031;GO:0043162;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:protein kinase binding; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:cilium assembly; P:early endosome to late endosome transport; P:endocytic recycling; P:negative regulation of epithelial cell migration; P:positive regulation of adherens junction organization; P:positive regulation of early endosome to late endosome transport; P:positive regulation of homophilic cell adhesion; P:positive regulation of Wnt protein secretion; P:protein transport; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9H3S7 A8K0D7 Q7KZF8 Q8N6Z5 Q9BSR5 Q9P257 Q9UG03 Q9UMZ4,Tyrosine-protein phosphatase non-receptor type 23,His domain-containing protein tyrosine phosphatase;Protein tyrosine phosphatase TD14;, PF13949;PF03097;PF00102;, GO:0036064;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0019901;GO:0004725;GO:0071345;GO:0060271;GO:0045022;GO:0032456;GO:0010633;GO:1903393;GO:2000643;GO:1903387;GO:0061357;GO:0015031;GO:0043162;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:protein kinase binding; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:cilium assembly; P:early endosome to late endosome transport; P:endocytic recycling; P:negative regulation of epithelial cell migration; P:positive regulation of adherens junction organization; P:positive regulation of early endosome to late endosome transport; P:positive regulation of homophilic cell adhesion; P:positive regulation of Wnt protein secretion; P:protein transport; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9H3S7 A8K0D7 Q7KZF8 Q8N6Z5 Q9BSR5 Q9P257 Q9UG03 Q9UMZ4,Tyrosine-protein phosphatase non-receptor type 23,His domain-containing protein tyrosine phosphatase;Protein tyrosine phosphatase TD14;, PF13949;PF03097;PF00102;, GO:0036064;GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0019901;GO:0004725;GO:0071345;GO:0060271;GO:0045022;GO:0032456;GO:0010633;GO:1903393;GO:2000643;GO:1903387;GO:0061357;GO:0015031;GO:0043162;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:protein kinase binding; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:cilium assembly; P:early endosome to late endosome transport; P:endocytic recycling; P:negative regulation of epithelial cell migration; P:positive regulation of adherens junction organization; P:positive regulation of early endosome to late endosome transport; P:positive regulation of homophilic cell adhesion; P:positive regulation of Wnt protein secretion; P:protein transport; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold73 indexed_genome mRNA 2237085 2246084 . - . ID=transcript_11520;O94889 A8K612 Q7Z3E8 Q8N125,Kelch-like protein 18,, PF07707;PF00651;PF01344;, GO:0007049;GO:0051301;GO:1901992;GO:0016567;, , , P:cell cycle; P:cell division; P:positive regulation of mitotic cell cycle phase transition; P:protein ubiquitination;|O94889 A8K612 Q7Z3E8 Q8N125,Kelch-like protein 18,, PF07707;PF00651;PF01344;, GO:0007049;GO:0051301;GO:1901992;GO:0016567;, , , P:cell cycle; P:cell division; P:positive regulation of mitotic cell cycle phase transition; P:protein ubiquitination; scaffold73 indexed_genome mRNA 2247935 2254114 . + . ID=transcript_11521;O94889 A8K612 Q7Z3E8 Q8N125,Kelch-like protein 18,, PF07707;PF00651;PF01344;, GO:0007049;GO:0051301;GO:1901992;GO:0016567;, , , P:cell cycle; P:cell division; P:positive regulation of mitotic cell cycle phase transition; P:protein ubiquitination;|O94889 A8K612 Q7Z3E8 Q8N125,Kelch-like protein 18,, PF07707;PF00651;PF01344;, GO:0007049;GO:0051301;GO:1901992;GO:0016567;, , , P:cell cycle; P:cell division; P:positive regulation of mitotic cell cycle phase transition; P:protein ubiquitination; scaffold73 indexed_genome mRNA 2254115 2282131 . - . ID=transcript_11522;O94889 A8K612 Q7Z3E8 Q8N125,Kelch-like protein 18,, PF07707;PF00651;PF01344;, GO:0007049;GO:0051301;GO:1901992;GO:0016567;, , , P:cell cycle; P:cell division; P:positive regulation of mitotic cell cycle phase transition; P:protein ubiquitination; scaffold73 indexed_genome mRNA 2297512 2311153 . - . ID=transcript_11523;Q9HAQ2 Q86Z28 Q9H8A4,Kinesin-like protein KIF9,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0002102;GO:0031982;GO:0005524;GO:1990939;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0022617;GO:0007018;GO:1903008;GO:0071801;, C:cytoplasm; C:kinesin complex; C:microtubule; C:podosome; C:vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:extracellular matrix disassembly; P:microtubule-based movement; P:organelle disassembly; P:regulation of podosome assembly; scaffold73 indexed_genome mRNA 2314773 2316089 . + . ID=transcript_11524;Q9HAQ2 Q86Z28 Q9H8A4,Kinesin-like protein KIF9,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0002102;GO:0031982;GO:0005524;GO:1990939;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0022617;GO:0007018;GO:1903008;GO:0071801;, C:cytoplasm; C:kinesin complex; C:microtubule; C:podosome; C:vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:extracellular matrix disassembly; P:microtubule-based movement; P:organelle disassembly; P:regulation of podosome assembly; scaffold73 indexed_genome mRNA 2317931 2325673 . + . ID=transcript_11525;Q9HAQ2 Q86Z28 Q9H8A4,Kinesin-like protein KIF9,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0002102;GO:0031982;GO:0005524;GO:1990939;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0022617;GO:0007018;GO:1903008;GO:0071801;, C:cytoplasm; C:kinesin complex; C:microtubule; C:podosome; C:vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:extracellular matrix disassembly; P:microtubule-based movement; P:organelle disassembly; P:regulation of podosome assembly; scaffold73 indexed_genome mRNA 2371055 2427877 . + . ID=transcript_11526;Q6ZS25 Q8N3R0 Q8TCN0 Q9C0D1 Q9H696 Q9NZW9,Histone-lysine N-methyltransferase SETD2 {ECO:0000305},HIF-1;Huntingtin yeast partner B {ECO:0000303|PubMed:16118227};Huntingtin-interacting protein 1;Huntingtin-interacting protein B {ECO:0000303|PubMed:16118227};Lysine N-methyltransferase 3A {ECO:0000303|PubMed:19332550};Protein-lysine N-methyltransferase SETD2 {ECO:0000305};SET domain-containing protein 2 {ECO:0000303|PubMed:19332550};p231HBP {ECO:0000303|PubMed:11461154};, PF17907;PF00856;PF08236;PF00397;, GO:0005694;GO:0005654;GO:0005634;GO:0043014;GO:0046975;GO:0018024;GO:0046872;GO:0016279;GO:0001525;GO:0035441;GO:0060977;GO:0051607;GO:0048701;GO:0060669;GO:0035987;GO:0030900;GO:0097676;GO:0097198;GO:0048332;GO:1902850;GO:0006298;GO:0001763;GO:0001843;GO:0034728;GO:0018026;GO:0018023;GO:0060039;GO:0032727;GO:0032465;GO:0010569;GO:0010793;GO:1905634;GO:0006355;GO:0034340;GO:0048864;GO:0048863;GO:0006368;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:alpha-tubulin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:protein-lysine N-methyltransferase activity;, P:angiogenesis; P:cell migration involved in vasculogenesis; P:coronary vasculature morphogenesis; P:defense response to virus; P:embryonic cranial skeleton morphogenesis; P:embryonic placenta morphogenesis; P:endodermal cell differentiation; P:forebrain development; P:histone H3-K36 dimethylation; P:histone H3-K36 trimethylation; P:mesoderm morphogenesis; P:microtubule cytoskeleton organization involved in mitosis; P:mismatch repair; P:morphogenesis of a branching structure; P:neural tube closure; P:nucleosome organization; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:pericardium development; P:positive regulation of interferon-alpha production; P:regulation of cytokinesis; P:regulation of double-strand break repair via homologous recombination; P:regulation of mRNA export from nucleus; P:regulation of protein localization to chromatin; P:regulation of transcription, DNA-templated; P:response to type I interferon; P:stem cell development; P:stem cell differentiation; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q6ZS25 Q8N3R0 Q8TCN0 Q9C0D1 Q9H696 Q9NZW9,Histone-lysine N-methyltransferase SETD2 {ECO:0000305},HIF-1;Huntingtin yeast partner B {ECO:0000303|PubMed:16118227};Huntingtin-interacting protein 1;Huntingtin-interacting protein B {ECO:0000303|PubMed:16118227};Lysine N-methyltransferase 3A {ECO:0000303|PubMed:19332550};Protein-lysine N-methyltransferase SETD2 {ECO:0000305};SET domain-containing protein 2 {ECO:0000303|PubMed:19332550};p231HBP {ECO:0000303|PubMed:11461154};, PF17907;PF00856;PF08236;PF00397;, GO:0005694;GO:0005654;GO:0005634;GO:0043014;GO:0046975;GO:0018024;GO:0046872;GO:0016279;GO:0001525;GO:0035441;GO:0060977;GO:0051607;GO:0048701;GO:0060669;GO:0035987;GO:0030900;GO:0097676;GO:0097198;GO:0048332;GO:1902850;GO:0006298;GO:0001763;GO:0001843;GO:0034728;GO:0018026;GO:0018023;GO:0060039;GO:0032727;GO:0032465;GO:0010569;GO:0010793;GO:1905634;GO:0006355;GO:0034340;GO:0048864;GO:0048863;GO:0006368;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:alpha-tubulin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:protein-lysine N-methyltransferase activity;, P:angiogenesis; P:cell migration involved in vasculogenesis; P:coronary vasculature morphogenesis; P:defense response to virus; P:embryonic cranial skeleton morphogenesis; P:embryonic placenta morphogenesis; P:endodermal cell differentiation; P:forebrain development; P:histone H3-K36 dimethylation; P:histone H3-K36 trimethylation; P:mesoderm morphogenesis; P:microtubule cytoskeleton organization involved in mitosis; P:mismatch repair; P:morphogenesis of a branching structure; P:neural tube closure; P:nucleosome organization; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:pericardium development; P:positive regulation of interferon-alpha production; P:regulation of cytokinesis; P:regulation of double-strand break repair via homologous recombination; P:regulation of mRNA export from nucleus; P:regulation of protein localization to chromatin; P:regulation of transcription, DNA-templated; P:response to type I interferon; P:stem cell development; P:stem cell differentiation; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q6ZS25 Q8N3R0 Q8TCN0 Q9C0D1 Q9H696 Q9NZW9,Histone-lysine N-methyltransferase SETD2 {ECO:0000305},HIF-1;Huntingtin yeast partner B {ECO:0000303|PubMed:16118227};Huntingtin-interacting protein 1;Huntingtin-interacting protein B {ECO:0000303|PubMed:16118227};Lysine N-methyltransferase 3A {ECO:0000303|PubMed:19332550};Protein-lysine N-methyltransferase SETD2 {ECO:0000305};SET domain-containing protein 2 {ECO:0000303|PubMed:19332550};p231HBP {ECO:0000303|PubMed:11461154};, PF17907;PF00856;PF08236;PF00397;, GO:0005694;GO:0005654;GO:0005634;GO:0043014;GO:0046975;GO:0018024;GO:0046872;GO:0016279;GO:0001525;GO:0035441;GO:0060977;GO:0051607;GO:0048701;GO:0060669;GO:0035987;GO:0030900;GO:0097676;GO:0097198;GO:0048332;GO:1902850;GO:0006298;GO:0001763;GO:0001843;GO:0034728;GO:0018026;GO:0018023;GO:0060039;GO:0032727;GO:0032465;GO:0010569;GO:0010793;GO:1905634;GO:0006355;GO:0034340;GO:0048864;GO:0048863;GO:0006368;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:alpha-tubulin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:protein-lysine N-methyltransferase activity;, P:angiogenesis; P:cell migration involved in vasculogenesis; P:coronary vasculature morphogenesis; P:defense response to virus; P:embryonic cranial skeleton morphogenesis; P:embryonic placenta morphogenesis; P:endodermal cell differentiation; P:forebrain development; P:histone H3-K36 dimethylation; P:histone H3-K36 trimethylation; P:mesoderm morphogenesis; P:microtubule cytoskeleton organization involved in mitosis; P:mismatch repair; P:morphogenesis of a branching structure; P:neural tube closure; P:nucleosome organization; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:pericardium development; P:positive regulation of interferon-alpha production; P:regulation of cytokinesis; P:regulation of double-strand break repair via homologous recombination; P:regulation of mRNA export from nucleus; P:regulation of protein localization to chromatin; P:regulation of transcription, DNA-templated; P:response to type I interferon; P:stem cell development; P:stem cell differentiation; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q6ZS25 Q8N3R0 Q8TCN0 Q9C0D1 Q9H696 Q9NZW9,Histone-lysine N-methyltransferase SETD2 {ECO:0000305},HIF-1;Huntingtin yeast partner B {ECO:0000303|PubMed:16118227};Huntingtin-interacting protein 1;Huntingtin-interacting protein B {ECO:0000303|PubMed:16118227};Lysine N-methyltransferase 3A {ECO:0000303|PubMed:19332550};Protein-lysine N-methyltransferase SETD2 {ECO:0000305};SET domain-containing protein 2 {ECO:0000303|PubMed:19332550};p231HBP {ECO:0000303|PubMed:11461154};, PF17907;PF00856;PF08236;PF00397;, GO:0005694;GO:0005654;GO:0005634;GO:0043014;GO:0046975;GO:0018024;GO:0046872;GO:0016279;GO:0001525;GO:0035441;GO:0060977;GO:0051607;GO:0048701;GO:0060669;GO:0035987;GO:0030900;GO:0097676;GO:0097198;GO:0048332;GO:1902850;GO:0006298;GO:0001763;GO:0001843;GO:0034728;GO:0018026;GO:0018023;GO:0060039;GO:0032727;GO:0032465;GO:0010569;GO:0010793;GO:1905634;GO:0006355;GO:0034340;GO:0048864;GO:0048863;GO:0006368;GO:0016032;, C:chromosome; C:nucleoplasm; C:nucleus;, F:alpha-tubulin binding; F:histone methyltransferase activity (H3-K36 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:protein-lysine N-methyltransferase activity;, P:angiogenesis; P:cell migration involved in vasculogenesis; P:coronary vasculature morphogenesis; P:defense response to virus; P:embryonic cranial skeleton morphogenesis; P:embryonic placenta morphogenesis; P:endodermal cell differentiation; P:forebrain development; P:histone H3-K36 dimethylation; P:histone H3-K36 trimethylation; P:mesoderm morphogenesis; P:microtubule cytoskeleton organization involved in mitosis; P:mismatch repair; P:morphogenesis of a branching structure; P:neural tube closure; P:nucleosome organization; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:pericardium development; P:positive regulation of interferon-alpha production; P:regulation of cytokinesis; P:regulation of double-strand break repair via homologous recombination; P:regulation of mRNA export from nucleus; P:regulation of protein localization to chromatin; P:regulation of transcription, DNA-templated; P:response to type I interferon; P:stem cell development; P:stem cell differentiation; P:transcription elongation from RNA polymerase II promoter; P:viral process; scaffold73 indexed_genome mRNA 2429822 2441763 . - . ID=transcript_11527;Q6ZNJ1 O60288 Q6P994 Q6UX91 Q8NAC9,Neurobeachin-like protein 2,, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0005783;GO:0101003;GO:0016020;GO:0005886;GO:0070821;GO:0019901;GO:0043312;GO:0030220;GO:0008104;, C:cytosol; C:endoplasmic reticulum; C:ficolin-1-rich granule membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:protein kinase binding;, P:neutrophil degranulation; P:platelet formation; P:protein localization;|Q6ZNJ1 O60288 Q6P994 Q6UX91 Q8NAC9,Neurobeachin-like protein 2,, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0005783;GO:0101003;GO:0016020;GO:0005886;GO:0070821;GO:0019901;GO:0043312;GO:0030220;GO:0008104;, C:cytosol; C:endoplasmic reticulum; C:ficolin-1-rich granule membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:protein kinase binding;, P:neutrophil degranulation; P:platelet formation; P:protein localization;|Q6ZNJ1 O60288 Q6P994 Q6UX91 Q8NAC9,Neurobeachin-like protein 2,, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0005783;GO:0101003;GO:0016020;GO:0005886;GO:0070821;GO:0019901;GO:0043312;GO:0030220;GO:0008104;, C:cytosol; C:endoplasmic reticulum; C:ficolin-1-rich granule membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:protein kinase binding;, P:neutrophil degranulation; P:platelet formation; P:protein localization; scaffold73 indexed_genome mRNA 2442046 2454211 . - . ID=transcript_11528;Q6ZNJ1 O60288 Q6P994 Q6UX91 Q8NAC9,Neurobeachin-like protein 2,, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0005783;GO:0101003;GO:0016020;GO:0005886;GO:0070821;GO:0019901;GO:0043312;GO:0030220;GO:0008104;, C:cytosol; C:endoplasmic reticulum; C:ficolin-1-rich granule membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:protein kinase binding;, P:neutrophil degranulation; P:platelet formation; P:protein localization;|Q6ZNJ1 O60288 Q6P994 Q6UX91 Q8NAC9,Neurobeachin-like protein 2,, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0005783;GO:0101003;GO:0016020;GO:0005886;GO:0070821;GO:0019901;GO:0043312;GO:0030220;GO:0008104;, C:cytosol; C:endoplasmic reticulum; C:ficolin-1-rich granule membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:protein kinase binding;, P:neutrophil degranulation; P:platelet formation; P:protein localization;|Q6ZNJ1 O60288 Q6P994 Q6UX91 Q8NAC9,Neurobeachin-like protein 2,, PF02138;PF15787;PF14844;PF00400;, GO:0005829;GO:0005783;GO:0101003;GO:0016020;GO:0005886;GO:0070821;GO:0019901;GO:0043312;GO:0030220;GO:0008104;, C:cytosol; C:endoplasmic reticulum; C:ficolin-1-rich granule membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:protein kinase binding;, P:neutrophil degranulation; P:platelet formation; P:protein localization; scaffold73 indexed_genome mRNA 2475663 2515096 . + . ID=transcript_11529;Q8WUD4 Q8N8I4,Coiled-coil domain-containing protein 12,, PF08315;, GO:0071014;GO:0005684;, C:post-mRNA release spliceosomal complex; C:U2-type spliceosomal complex;|Q8WUD4 Q8N8I4,Coiled-coil domain-containing protein 12,, PF08315;, GO:0071014;GO:0005684;, C:post-mRNA release spliceosomal complex; C:U2-type spliceosomal complex;|Q8WUD4 Q8N8I4,Coiled-coil domain-containing protein 12,, PF08315;, GO:0071014;GO:0005684;, C:post-mRNA release spliceosomal complex; C:U2-type spliceosomal complex; scaffold73 indexed_genome mRNA 2526063 2551051 . - . ID=transcript_11530;Q03431 Q2M1U3,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH/PTHrP type I receptor;Parathyroid hormone 1 receptor;, PF00002;PF02793;, GO:0016324;GO:0016323;GO:0031526;GO:0005737;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0008528;GO:0004991;GO:0017046;GO:0042803;GO:0043621;GO:0007189;GO:0007188;GO:0007568;GO:0030282;GO:0045453;GO:0048469;GO:0007166;GO:0006874;GO:0002062;GO:0007186;GO:0007187;GO:0001701;GO:0008285;GO:0002862;GO:0002076;GO:0007200;GO:0008284;GO:0007204;GO:0060732;GO:0001501;, C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:cytoplasm; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:G protein-coupled peptide receptor activity; F:parathyroid hormone receptor activity; F:peptide hormone binding; F:protein homodimerization activity; F:protein self-association;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:bone mineralization; P:bone resorption; P:cell maturation; P:cell surface receptor signaling pathway; P:cellular calcium ion homeostasis; P:chondrocyte differentiation; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:in utero embryonic development; P:negative regulation of cell population proliferation; P:negative regulation of inflammatory response to antigenic stimulus; P:osteoblast development; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of inositol phosphate biosynthetic process; P:skeletal system development;|Q03431 Q2M1U3,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH/PTHrP type I receptor;Parathyroid hormone 1 receptor;, PF00002;PF02793;, GO:0016324;GO:0016323;GO:0031526;GO:0005737;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0008528;GO:0004991;GO:0017046;GO:0042803;GO:0043621;GO:0007189;GO:0007188;GO:0007568;GO:0030282;GO:0045453;GO:0048469;GO:0007166;GO:0006874;GO:0002062;GO:0007186;GO:0007187;GO:0001701;GO:0008285;GO:0002862;GO:0002076;GO:0007200;GO:0008284;GO:0007204;GO:0060732;GO:0001501;, C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:cytoplasm; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:G protein-coupled peptide receptor activity; F:parathyroid hormone receptor activity; F:peptide hormone binding; F:protein homodimerization activity; F:protein self-association;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:bone mineralization; P:bone resorption; P:cell maturation; P:cell surface receptor signaling pathway; P:cellular calcium ion homeostasis; P:chondrocyte differentiation; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:in utero embryonic development; P:negative regulation of cell population proliferation; P:negative regulation of inflammatory response to antigenic stimulus; P:osteoblast development; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of inositol phosphate biosynthetic process; P:skeletal system development;|Q03431 Q2M1U3,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH/PTHrP type I receptor;Parathyroid hormone 1 receptor;, PF00002;PF02793;, GO:0016324;GO:0016323;GO:0031526;GO:0005737;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0008528;GO:0004991;GO:0017046;GO:0042803;GO:0043621;GO:0007189;GO:0007188;GO:0007568;GO:0030282;GO:0045453;GO:0048469;GO:0007166;GO:0006874;GO:0002062;GO:0007186;GO:0007187;GO:0001701;GO:0008285;GO:0002862;GO:0002076;GO:0007200;GO:0008284;GO:0007204;GO:0060732;GO:0001501;, C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:cytoplasm; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:G protein-coupled peptide receptor activity; F:parathyroid hormone receptor activity; F:peptide hormone binding; F:protein homodimerization activity; F:protein self-association;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:bone mineralization; P:bone resorption; P:cell maturation; P:cell surface receptor signaling pathway; P:cellular calcium ion homeostasis; P:chondrocyte differentiation; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:in utero embryonic development; P:negative regulation of cell population proliferation; P:negative regulation of inflammatory response to antigenic stimulus; P:osteoblast development; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of inositol phosphate biosynthetic process; P:skeletal system development;|Q03431 Q2M1U3,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH/PTHrP type I receptor;Parathyroid hormone 1 receptor;, PF00002;PF02793;, GO:0016324;GO:0016323;GO:0031526;GO:0005737;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0008528;GO:0004991;GO:0017046;GO:0042803;GO:0043621;GO:0007189;GO:0007188;GO:0007568;GO:0030282;GO:0045453;GO:0048469;GO:0007166;GO:0006874;GO:0002062;GO:0007186;GO:0007187;GO:0001701;GO:0008285;GO:0002862;GO:0002076;GO:0007200;GO:0008284;GO:0007204;GO:0060732;GO:0001501;, C:apical plasma membrane; C:basolateral plasma membrane; C:brush border membrane; C:cytoplasm; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex;, F:G protein-coupled peptide receptor activity; F:parathyroid hormone receptor activity; F:peptide hormone binding; F:protein homodimerization activity; F:protein self-association;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:bone mineralization; P:bone resorption; P:cell maturation; P:cell surface receptor signaling pathway; P:cellular calcium ion homeostasis; P:chondrocyte differentiation; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:in utero embryonic development; P:negative regulation of cell population proliferation; P:negative regulation of inflammatory response to antigenic stimulus; P:osteoblast development; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of inositol phosphate biosynthetic process; P:skeletal system development; scaffold73 indexed_genome mRNA 2574259 2579709 . + . ID=transcript_11531;P08590 B2R534 Q9NRS8,Myosin light chain 3 {ECO:0000305},Cardiac myosin light chain 1 {ECO:0000303|Ref.5};Myosin light chain 1, slow-twitch muscle B/ventricular isoform {ECO:0000305};Ventricular myosin alkali light chain {ECO:0000303|PubMed:3417683};Ventricular myosin light chain 1 {ECO:0000303|PubMed:3357795};Ventricular/slow twitch myosin alkali light chain {ECO:0000303|PubMed:2789520};, , GO:0031672;GO:0005829;GO:0031674;GO:0005859;GO:0030017;GO:0003785;GO:0005509;GO:0003774;GO:0032038;GO:0008307;GO:0060048;GO:0030049;GO:0032781;GO:0006942;GO:0002026;GO:0007519;GO:0055010;, C:A band; C:cytosol; C:I band; C:muscle myosin complex; C:sarcomere;, F:actin monomer binding; F:calcium ion binding; F:motor activity; F:myosin II heavy chain binding; F:structural constituent of muscle;, P:cardiac muscle contraction; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of striated muscle contraction; P:regulation of the force of heart contraction; P:skeletal muscle tissue development; P:ventricular cardiac muscle tissue morphogenesis;|P08590 B2R534 Q9NRS8,Myosin light chain 3 {ECO:0000305},Cardiac myosin light chain 1 {ECO:0000303|Ref.5};Myosin light chain 1, slow-twitch muscle B/ventricular isoform {ECO:0000305};Ventricular myosin alkali light chain {ECO:0000303|PubMed:3417683};Ventricular myosin light chain 1 {ECO:0000303|PubMed:3357795};Ventricular/slow twitch myosin alkali light chain {ECO:0000303|PubMed:2789520};, , GO:0031672;GO:0005829;GO:0031674;GO:0005859;GO:0030017;GO:0003785;GO:0005509;GO:0003774;GO:0032038;GO:0008307;GO:0060048;GO:0030049;GO:0032781;GO:0006942;GO:0002026;GO:0007519;GO:0055010;, C:A band; C:cytosol; C:I band; C:muscle myosin complex; C:sarcomere;, F:actin monomer binding; F:calcium ion binding; F:motor activity; F:myosin II heavy chain binding; F:structural constituent of muscle;, P:cardiac muscle contraction; P:muscle filament sliding; P:positive regulation of ATPase activity; P:regulation of striated muscle contraction; P:regulation of the force of heart contraction; P:skeletal muscle tissue development; P:ventricular cardiac muscle tissue morphogenesis; scaffold73 indexed_genome mRNA 2629804 2631935 . + . ID=transcript_11532;Q7Z5A4,Putative serine protease 42 {ECO:0000305},Serine protease 42, pseudogene {ECO:0000312|HGNC:HGNC:30716};Testis serine protease 2;, PF00089;, GO:0031225;GO:0005737;GO:0005615;GO:0005886;GO:0004252;GO:0030154;GO:0006508;GO:0007283;, C:anchored component of membrane; C:cytoplasm; C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase activity;, P:cell differentiation; P:proteolysis; P:spermatogenesis; scaffold73 indexed_genome mRNA 2650994 2652642 . + . ID=transcript_11533;Q7RTY3 A3KN77,Putative serine protease 45 {ECO:0000305},Serine protease 45, pseudogene {ECO:0000305};Testis serine protease 5;, PF00089;, GO:0005615;GO:0004252;GO:0006508;, C:extracellular space;, F:serine-type endopeptidase activity;, P:proteolysis; scaffold73 indexed_genome mRNA 2728941 2751355 . + . ID=transcript_11534;Q60I27 Q32MA1 Q6AI56 Q6ZNC5 Q6ZNC7 Q6ZTL4 Q86YD2 Q8N9U1 Q8NAL7,ALS2 C-terminal-like protein,, PF02493;PF02204;, GO:0005829;GO:0005096;GO:0042802;GO:0007032;, C:cytosol;, F:GTPase activator activity; F:identical protein binding;, P:endosome organization;|Q60I27 Q32MA1 Q6AI56 Q6ZNC5 Q6ZNC7 Q6ZTL4 Q86YD2 Q8N9U1 Q8NAL7,ALS2 C-terminal-like protein,, PF02493;PF02204;, GO:0005829;GO:0005096;GO:0042802;GO:0007032;, C:cytosol;, F:GTPase activator activity; F:identical protein binding;, P:endosome organization;|Q60I27 Q32MA1 Q6AI56 Q6ZNC5 Q6ZNC7 Q6ZTL4 Q86YD2 Q8N9U1 Q8NAL7,ALS2 C-terminal-like protein,, PF02493;PF02204;, GO:0005829;GO:0005096;GO:0042802;GO:0007032;, C:cytosol;, F:GTPase activator activity; F:identical protein binding;, P:endosome organization;|Q60I27 Q32MA1 Q6AI56 Q6ZNC5 Q6ZNC7 Q6ZTL4 Q86YD2 Q8N9U1 Q8NAL7,ALS2 C-terminal-like protein,, PF02493;PF02204;, GO:0005829;GO:0005096;GO:0042802;GO:0007032;, C:cytosol;, F:GTPase activator activity; F:identical protein binding;, P:endosome organization; scaffold73 indexed_genome mRNA 2768658 2780185 . + . ID=transcript_11535;A0A1B0GVK7 Q6ZNS2,Protein FAM240A {ECO:0000305}|A0A1B0GVK7 Q6ZNS2,Protein FAM240A {ECO:0000305} scaffold73 indexed_genome mRNA 2812804 2850003 . + . ID=transcript_11536;Q9BYS8 B2RDQ7 Q96LT5,Leucine-rich repeat-containing protein 2,, PF13855;, GO:0005737;GO:0043231;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle;, F:protein serine/threonine phosphatase activity;, P:signal transduction;|Q9BYS8 B2RDQ7 Q96LT5,Leucine-rich repeat-containing protein 2,, PF13855;, GO:0005737;GO:0043231;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle;, F:protein serine/threonine phosphatase activity;, P:signal transduction;|Q9BYS8 B2RDQ7 Q96LT5,Leucine-rich repeat-containing protein 2,, PF13855;, GO:0005737;GO:0043231;GO:0004722;GO:0007165;, C:cytoplasm; C:intracellular membrane-bounded organelle;, F:protein serine/threonine phosphatase activity;, P:signal transduction; scaffold73 indexed_genome mRNA 2854463 2857156 . - . ID=transcript_11537;Q9BQQ7 A2RRP6,Receptor-transporting protein 3,3CxxC-type zinc finger protein 3;Transmembrane protein 7;, PF13695;, GO:0005737;GO:0016021;GO:0031849;GO:0001580;GO:0051205;GO:0006612;, C:cytoplasm; C:integral component of membrane;, F:olfactory receptor binding;, P:detection of chemical stimulus involved in sensory perception of bitter taste; P:protein insertion into membrane; P:protein targeting to membrane; scaffold73 indexed_genome mRNA 2883944 2906530 . + . ID=transcript_11538;Q16789 Q5DSM0 Q8IU92 Q8IZH6 Q8TCD2 Q96KZ4 Q96KZ5 Q9H1Z3 Q9UCY5,Lactotransferrin,Growth-inhibiting protein 12;Talalactoferrin;, PF00405;, GO:0009986;GO:0005737;GO:0005769;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0097013;GO:0005886;GO:0032991;GO:0055037;GO:0030141;GO:0042581;GO:0035580;GO:1904724;GO:0004869;GO:0003677;GO:0008201;GO:0005506;GO:0001530;GO:0043539;GO:0004252;GO:1990000;GO:0019731;GO:0019732;GO:0061844;GO:0019730;GO:0060349;GO:0050829;GO:0050830;GO:0006959;GO:0045087;GO:0002227;GO:0006826;GO:0031640;GO:0051673;GO:0044793;GO:0043066;GO:0032780;GO:2000117;GO:0031665;GO:0045837;GO:2001205;GO:1900229;GO:2000308;GO:0045071;GO:0048525;GO:0043312;GO:0001503;GO:1900159;GO:1902732;GO:0043123;GO:0051092;GO:0045669;GO:0033690;GO:0071902;GO:0034145;GO:0001817;GO:0032680;GO:0001895;GO:0033214;, C:cell surface; C:cytoplasm; C:early endosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:phagocytic vesicle lumen; C:plasma membrane; C:protein-containing complex; C:recycling endosome; C:secretory granule; C:specific granule; C:specific granule lumen; C:tertiary granule lumen;, F:cysteine-type endopeptidase inhibitor activity; F:DNA binding; F:heparin binding; F:iron ion binding; F:lipopolysaccharide binding; F:protein serine/threonine kinase activator activity; F:serine-type endopeptidase activity;, P:amyloid fibril formation; P:antibacterial humoral response; P:antifungal humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:antimicrobial humoral response; P:bone morphogenesis; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:humoral immune response; P:innate immune response; P:innate immune response in mucosa; P:iron ion transport; P:killing of cells of other organism; P:membrane disruption in other organism; P:negative regulation by host of viral process; P:negative regulation of apoptotic process; P:negative regulation of ATPase activity; P:negative regulation of cysteine-type endopeptidase activity; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of membrane potential; P:negative regulation of osteoclast development; P:negative regulation of single-species biofilm formation in or on host organism; P:negative regulation of tumor necrosis factor (ligand) superfamily member 11 production; P:negative regulation of viral genome replication; P:negative regulation of viral process; P:neutrophil degranulation; P:ossification; P:positive regulation of bone mineralization involved in bone maturation; P:positive regulation of chondrocyte proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of toll-like receptor 4 signaling pathway; P:regulation of cytokine production; P:regulation of tumor necrosis factor production; P:retina homeostasis; P:siderophore-dependent iron import into cell; scaffold73 indexed_genome mRNA 2917629 2919555 . - . ID=transcript_11539;O00421 B4DKQ8 O75307 Q4VBB0 Q6IPX0 Q7KYQ9 Q96KP5 Q9UPG0,C-C chemokine receptor-like 2,Chemokine receptor CCR11;Chemokine receptor X;Putative MCP-1 chemokine receptor;, PF00001;, GO:0005737;GO:0009897;GO:0005887;GO:0005886;GO:0019957;GO:0016493;GO:0048020;GO:0004950;GO:0042379;GO:0019722;GO:0060326;GO:0006935;GO:0007186;GO:0006955;GO:0006954;GO:0007204;, C:cytoplasm; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:CCR chemokine receptor binding; F:chemokine receptor activity; F:chemokine receptor binding;, P:calcium-mediated signaling; P:cell chemotaxis; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:positive regulation of cytosolic calcium ion concentration; scaffold73 indexed_genome mRNA 2939188 2944000 . - . ID=transcript_11540;Q9UPA4,C-C chemokine receptor type 5,CHEMR13;HIV-1 fusion coreceptor;, PF00001;, GO:0009986;GO:0005737;GO:0005768;GO:0009897;GO:0005887;GO:0005886;GO:0003779;GO:0019957;GO:0016493;GO:0071791;GO:0004950;GO:0015026;GO:0042802;GO:0004435;GO:0001618;GO:0006816;GO:0019722;GO:0060326;GO:0007166;GO:0007267;GO:0006968;GO:0071222;GO:0006935;GO:0019221;GO:0002407;GO:0044409;GO:0019064;GO:0007186;GO:0006955;GO:0006954;GO:0000165;GO:0007204;GO:0014808;GO:0070723;GO:0023052;, C:cell surface; C:cytoplasm; C:endosome; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:actin binding; F:C-C chemokine binding; F:C-C chemokine receptor activity; F:chemokine (C-C motif) ligand 5 binding; F:chemokine receptor activity; F:coreceptor activity; F:identical protein binding; F:phosphatidylinositol phospholipase C activity; F:virus receptor activity;, P:calcium ion transport; P:calcium-mediated signaling; P:cell chemotaxis; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cellular defense response; P:cellular response to lipopolysaccharide; P:chemotaxis; P:cytokine-mediated signaling pathway; P:dendritic cell chemotaxis; P:entry into host; P:fusion of virus membrane with host plasma membrane; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:MAPK cascade; P:positive regulation of cytosolic calcium ion concentration; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to cholesterol; P:signaling; scaffold73 indexed_genome mRNA 2953650 2955400 . - . ID=transcript_11541;Q9UPA4,C-C chemokine receptor type 5,CHEMR13;HIV-1 fusion coreceptor;, PF00001;, GO:0009986;GO:0005737;GO:0005768;GO:0009897;GO:0005887;GO:0005886;GO:0003779;GO:0019957;GO:0016493;GO:0071791;GO:0004950;GO:0015026;GO:0042802;GO:0004435;GO:0001618;GO:0006816;GO:0019722;GO:0060326;GO:0007166;GO:0007267;GO:0006968;GO:0071222;GO:0006935;GO:0019221;GO:0002407;GO:0044409;GO:0019064;GO:0007186;GO:0006955;GO:0006954;GO:0000165;GO:0007204;GO:0014808;GO:0070723;GO:0023052;, C:cell surface; C:cytoplasm; C:endosome; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:actin binding; F:C-C chemokine binding; F:C-C chemokine receptor activity; F:chemokine (C-C motif) ligand 5 binding; F:chemokine receptor activity; F:coreceptor activity; F:identical protein binding; F:phosphatidylinositol phospholipase C activity; F:virus receptor activity;, P:calcium ion transport; P:calcium-mediated signaling; P:cell chemotaxis; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cellular defense response; P:cellular response to lipopolysaccharide; P:chemotaxis; P:cytokine-mediated signaling pathway; P:dendritic cell chemotaxis; P:entry into host; P:fusion of virus membrane with host plasma membrane; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:MAPK cascade; P:positive regulation of cytosolic calcium ion concentration; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to cholesterol; P:signaling; scaffold73 indexed_genome mRNA 2955927 2960490 . - . ID=transcript_11542;P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2,C-C chemokine receptor type 2,Monocyte chemoattractant protein 1 receptor;, PF00001;, GO:0005737;GO:0005829;GO:0030425;GO:0009897;GO:0016021;GO:0005887;GO:0043025;GO:0043204;GO:0048471;GO:0005886;GO:0019957;GO:0016493;GO:0031727;GO:0004950;GO:0042802;GO:0001974;GO:0019722;GO:0060326;GO:0006874;GO:0006968;GO:0019725;GO:0070098;GO:0006935;GO:0019221;GO:0002407;GO:0007186;GO:0006955;GO:0006954;GO:0090594;GO:1905517;GO:0035696;GO:0007194;GO:0016525;GO:0043310;GO:0002829;GO:0046641;GO:2000464;GO:2000451;GO:0120162;GO:0007204;GO:2000473;GO:0090265;GO:0050729;GO:0032729;GO:0032743;GO:0090026;GO:2000439;GO:1904783;GO:0051968;GO:0050870;GO:0010820;GO:0002827;GO:2000412;GO:0032760;GO:0007259;GO:0050727;GO:0002724;GO:0045580;GO:0010574;GO:0009611;GO:0019233;GO:0035705;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:external side of plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:neuronal cell body; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:CCR2 chemokine receptor binding; F:chemokine receptor activity; F:identical protein binding;, P:blood vessel remodeling; P:calcium-mediated signaling; P:cell chemotaxis; P:cellular calcium ion homeostasis; P:cellular defense response; P:cellular homeostasis; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:dendritic cell chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:inflammatory response to wounding; P:macrophage migration; P:monocyte extravasation; P:negative regulation of adenylate cyclase activity; P:negative regulation of angiogenesis; P:negative regulation of eosinophil degranulation; P:negative regulation of type 2 immune response; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of astrocyte chemotaxis; P:positive regulation of CD8-positive, alpha-beta T cell extravasation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of hematopoietic stem cell migration; P:positive regulation of immune complex clearance by monocytes and macrophages; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of monocyte chemotaxis; P:positive regulation of monocyte extravasation; P:positive regulation of NMDA glutamate receptor activity; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of T cell activation; P:positive regulation of T cell chemotaxis; P:positive regulation of T-helper 1 type immune response; P:positive regulation of thymocyte migration; P:positive regulation of tumor necrosis factor production; P:receptor signaling pathway via JAK-STAT; P:regulation of inflammatory response; P:regulation of T cell cytokine production; P:regulation of T cell differentiation; P:regulation of vascular endothelial growth factor production; P:response to wounding; P:sensory perception of pain; P:T-helper 17 cell chemotaxis; P:viral process; scaffold73 indexed_genome mRNA 3038349 3052555 . - . ID=transcript_11543;P51677 B3KVQ1 F5GWL6 Q15748 Q2YDB9 Q86WD2 Q8TDP6 Q9ULY8,C-C chemokine receptor type 3,Eosinophil eotaxin receptor;, PF00001;, GO:0005737;GO:0009897;GO:0005887;GO:0005886;GO:0019957;GO:0016493;GO:0004950;GO:0007188;GO:0019722;GO:0007155;GO:0060326;GO:0006968;GO:0006935;GO:0007186;GO:0006955;GO:0006954;GO:0045766;GO:0007204;GO:0001938;GO:0016032;, C:cytoplasm; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:chemokine receptor activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling; P:cell adhesion; P:cell chemotaxis; P:cellular defense response; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:positive regulation of angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell proliferation; P:viral process; scaffold73 indexed_genome mRNA 3130214 3136202 . + . ID=transcript_11544;P32246 Q86VA9,C-C chemokine receptor type 1,HM145;LD78 receptor;Macrophage inflammatory protein 1-alpha receptor;RANTES-R;, PF00001;, GO:0005737;GO:0009897;GO:0005887;GO:0005886;GO:0019957;GO:0016493;GO:0071791;GO:0035717;GO:0004950;GO:0004435;GO:0006816;GO:0019722;GO:0007155;GO:0060326;GO:0007166;GO:0007267;GO:0006874;GO:0070098;GO:0006935;GO:0019221;GO:0002407;GO:0006887;GO:0007186;GO:0007187;GO:0006955;GO:0006954;GO:0030502;GO:0010629;GO:0051928;GO:0030335;GO:0007204;GO:0070374;GO:0090026;GO:0045672;GO:0009611;, C:cytoplasm; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:chemokine (C-C motif) ligand 5 binding; F:chemokine (C-C motif) ligand 7 binding; F:chemokine receptor activity; F:phosphatidylinositol phospholipase C activity;, P:calcium ion transport; P:calcium-mediated signaling; P:cell adhesion; P:cell chemotaxis; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cellular calcium ion homeostasis; P:chemokine-mediated signaling pathway; P:chemotaxis; P:cytokine-mediated signaling pathway; P:dendritic cell chemotaxis; P:exocytosis; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:immune response; P:inflammatory response; P:negative regulation of bone mineralization; P:negative regulation of gene expression; P:positive regulation of calcium ion transport; P:positive regulation of cell migration; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of monocyte chemotaxis; P:positive regulation of osteoclast differentiation; P:response to wounding; scaffold73 indexed_genome mRNA 3235237 3303457 . + . ID=transcript_11545;Q9BQS8 B7ZKT7 Q3MJE6 Q86T41 Q86TB1 Q8TEF9 Q96IV5 Q9H8P9,FYVE and coiled-coil domain-containing protein 1,Zinc finger FYVE domain-containing protein 7;, PF01363;PF02759;, GO:0005776;GO:0005794;GO:0043231;GO:0005770;GO:0005764;GO:0016020;GO:0046872;GO:0072383;GO:1901098;, C:autophagosome; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:membrane;, F:metal ion binding;, P:plus-end-directed vesicle transport along microtubule; P:positive regulation of autophagosome maturation;|O00574 O00575 Q9HCA5,C-X-C chemokine receptor type 6,CDw186;G-protein coupled receptor STRL33;G-protein coupled receptor bonzo;, PF00001;, GO:0009897;GO:0005887;GO:0005886;GO:0019957;GO:0016493;GO:0016494;GO:0015026;GO:0004930;GO:0019722;GO:0060326;GO:0007186;GO:0006955;GO:0006954;GO:0007204;GO:0019079;, C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:C-X-C chemokine receptor activity; F:coreceptor activity; F:G protein-coupled receptor activity;, P:calcium-mediated signaling; P:cell chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:positive regulation of cytosolic calcium ion concentration; P:viral genome replication; scaffold73 indexed_genome mRNA 3368033 3384887 . + . ID=transcript_11546;Q9NQ48 B3KSI9 B4E0K7 Q8TC61 Q9NQ56,Leucine zipper transcription factor-like protein 1,, PF15294;, GO:0005737;GO:0005829;GO:0042802;GO:0044877;GO:0060271;GO:1903568;GO:1903565;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:protein-containing complex binding;, P:cilium assembly; P:negative regulation of protein localization to ciliary membrane; P:negative regulation of protein localization to cilium;|Q9NQ48 B3KSI9 B4E0K7 Q8TC61 Q9NQ56,Leucine zipper transcription factor-like protein 1,, PF15294;, GO:0005737;GO:0005829;GO:0042802;GO:0044877;GO:0060271;GO:1903568;GO:1903565;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:protein-containing complex binding;, P:cilium assembly; P:negative regulation of protein localization to ciliary membrane; P:negative regulation of protein localization to cilium; scaffold73 indexed_genome mRNA 3408293 3455408 . + . ID=transcript_11547;Q9NP91 A1A4F2 O75590 Q8TF10 Q9NPQ2 Q9NQ77,Sodium- and chloride-dependent transporter XTRP3,Sodium/imino-acid transporter 1;Solute carrier family 6 member 20;Transporter rB21A homolog;, PF00209;, GO:0016324;GO:0005887;GO:0005886;GO:0015171;GO:0015199;GO:0015188;GO:0015193;GO:0015175;GO:0005298;GO:0089718;GO:0006865;GO:0015838;GO:0015816;GO:1903806;GO:1904271;GO:1905647;GO:0015824;GO:0035725;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:amino-acid betaine transmembrane transporter activity; F:L-isoleucine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:proline:sodium symporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:amino-acid betaine transport; P:glycine transport; P:L-isoleucine import across plasma membrane; P:L-proline import across plasma membrane; P:proline import across plasma membrane; P:proline transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier;|Q9NP91 A1A4F2 O75590 Q8TF10 Q9NPQ2 Q9NQ77,Sodium- and chloride-dependent transporter XTRP3,Sodium/imino-acid transporter 1;Solute carrier family 6 member 20;Transporter rB21A homolog;, PF00209;, GO:0016324;GO:0005887;GO:0005886;GO:0015171;GO:0015199;GO:0015188;GO:0015193;GO:0015175;GO:0005298;GO:0089718;GO:0006865;GO:0015838;GO:0015816;GO:1903806;GO:1904271;GO:1905647;GO:0015824;GO:0035725;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:amino-acid betaine transmembrane transporter activity; F:L-isoleucine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:proline:sodium symporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:amino-acid betaine transport; P:glycine transport; P:L-isoleucine import across plasma membrane; P:L-proline import across plasma membrane; P:proline import across plasma membrane; P:proline transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier;|Q9NP91 A1A4F2 O75590 Q8TF10 Q9NPQ2 Q9NQ77,Sodium- and chloride-dependent transporter XTRP3,Sodium/imino-acid transporter 1;Solute carrier family 6 member 20;Transporter rB21A homolog;, PF00209;, GO:0016324;GO:0005887;GO:0005886;GO:0015171;GO:0015199;GO:0015188;GO:0015193;GO:0015175;GO:0005298;GO:0089718;GO:0006865;GO:0015838;GO:0015816;GO:1903806;GO:1904271;GO:1905647;GO:0015824;GO:0035725;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:amino-acid betaine transmembrane transporter activity; F:L-isoleucine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:proline:sodium symporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:amino-acid betaine transport; P:glycine transport; P:L-isoleucine import across plasma membrane; P:L-proline import across plasma membrane; P:proline import across plasma membrane; P:proline transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier;|Q9NP91 A1A4F2 O75590 Q8TF10 Q9NPQ2 Q9NQ77,Sodium- and chloride-dependent transporter XTRP3,Sodium/imino-acid transporter 1;Solute carrier family 6 member 20;Transporter rB21A homolog;, PF00209;, GO:0016324;GO:0005887;GO:0005886;GO:0015171;GO:0015199;GO:0015188;GO:0015193;GO:0015175;GO:0005298;GO:0089718;GO:0006865;GO:0015838;GO:0015816;GO:1903806;GO:1904271;GO:1905647;GO:0015824;GO:0035725;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:amino-acid betaine transmembrane transporter activity; F:L-isoleucine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:proline:sodium symporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:amino-acid betaine transport; P:glycine transport; P:L-isoleucine import across plasma membrane; P:L-proline import across plasma membrane; P:proline import across plasma membrane; P:proline transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier;|Q9NP91 A1A4F2 O75590 Q8TF10 Q9NPQ2 Q9NQ77,Sodium- and chloride-dependent transporter XTRP3,Sodium/imino-acid transporter 1;Solute carrier family 6 member 20;Transporter rB21A homolog;, PF00209;, GO:0016324;GO:0005887;GO:0005886;GO:0015171;GO:0015199;GO:0015188;GO:0015193;GO:0015175;GO:0005298;GO:0089718;GO:0006865;GO:0015838;GO:0015816;GO:1903806;GO:1904271;GO:1905647;GO:0015824;GO:0035725;GO:0150104;, C:apical plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:amino-acid betaine transmembrane transporter activity; F:L-isoleucine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:proline:sodium symporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:amino-acid betaine transport; P:glycine transport; P:L-isoleucine import across plasma membrane; P:L-proline import across plasma membrane; P:proline import across plasma membrane; P:proline transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier; scaffold73 indexed_genome mRNA 3462558 3525428 . - . ID=transcript_11548;Q9NTJ5 A8K527 B4DK71 O94935 Q7LA14 Q7LA22 Q96AX7 Q9NQ46 Q9NQ57,Phosphatidylinositol-3-phosphatase SAC1,Phosphatidylinositol-4-phosphate phosphatase {ECO:0000303|PubMed:24209621, ECO:0000303|PubMed:30659099};Suppressor of actin mutations 1-like protein;, PF02383;, GO:0005783;GO:0005789;GO:0140268;GO:0005794;GO:0000139;GO:0016021;GO:0016791;GO:0004438;GO:0043812;GO:0006661;GO:0046856;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q9NTJ5 A8K527 B4DK71 O94935 Q7LA14 Q7LA22 Q96AX7 Q9NQ46 Q9NQ57,Phosphatidylinositol-3-phosphatase SAC1,Phosphatidylinositol-4-phosphate phosphatase {ECO:0000303|PubMed:24209621, ECO:0000303|PubMed:30659099};Suppressor of actin mutations 1-like protein;, PF02383;, GO:0005783;GO:0005789;GO:0140268;GO:0005794;GO:0000139;GO:0016021;GO:0016791;GO:0004438;GO:0043812;GO:0006661;GO:0046856;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q9NTJ5 A8K527 B4DK71 O94935 Q7LA14 Q7LA22 Q96AX7 Q9NQ46 Q9NQ57,Phosphatidylinositol-3-phosphatase SAC1,Phosphatidylinositol-4-phosphate phosphatase {ECO:0000303|PubMed:24209621, ECO:0000303|PubMed:30659099};Suppressor of actin mutations 1-like protein;, PF02383;, GO:0005783;GO:0005789;GO:0140268;GO:0005794;GO:0000139;GO:0016021;GO:0016791;GO:0004438;GO:0043812;GO:0006661;GO:0046856;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q9NTJ5 A8K527 B4DK71 O94935 Q7LA14 Q7LA22 Q96AX7 Q9NQ46 Q9NQ57,Phosphatidylinositol-3-phosphatase SAC1,Phosphatidylinositol-4-phosphate phosphatase {ECO:0000303|PubMed:24209621, ECO:0000303|PubMed:30659099};Suppressor of actin mutations 1-like protein;, PF02383;, GO:0005783;GO:0005789;GO:0140268;GO:0005794;GO:0000139;GO:0016021;GO:0016791;GO:0004438;GO:0043812;GO:0006661;GO:0046856;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q9NTJ5 A8K527 B4DK71 O94935 Q7LA14 Q7LA22 Q96AX7 Q9NQ46 Q9NQ57,Phosphatidylinositol-3-phosphatase SAC1,Phosphatidylinositol-4-phosphate phosphatase {ECO:0000303|PubMed:24209621, ECO:0000303|PubMed:30659099};Suppressor of actin mutations 1-like protein;, PF02383;, GO:0005783;GO:0005789;GO:0140268;GO:0005794;GO:0000139;GO:0016021;GO:0016791;GO:0004438;GO:0043812;GO:0006661;GO:0046856;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; scaffold73 indexed_genome mRNA 3529055 3604986 . - . ID=transcript_11549;Q9UGP4 Q17RQ1 Q9BQQ9 Q9NQ47,LIM domain-containing protein 1,, PF00412;, GO:0005912;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0016442;GO:0005667;GO:0046872;GO:0003714;GO:0016477;GO:0007010;GO:0035195;GO:0090090;GO:0035331;GO:0045668;GO:0045892;GO:0002076;GO:0033962;GO:0016310;GO:2000637;GO:0008360;GO:0061418;GO:0006355;GO:0001666;, C:adherens junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane; C:RISC complex; C:transcription regulator complex;, F:metal ion binding; F:transcription corepressor activity;, P:cell migration; P:cytoskeleton organization; P:gene silencing by miRNA; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of hippo signaling; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription, DNA-templated; P:osteoblast development; P:P-body assembly; P:phosphorylation; P:positive regulation of gene silencing by miRNA; P:regulation of cell shape; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia;|Q9UGP4 Q17RQ1 Q9BQQ9 Q9NQ47,LIM domain-containing protein 1,, PF00412;, GO:0005912;GO:0005737;GO:0005829;GO:0005925;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0016442;GO:0005667;GO:0046872;GO:0003714;GO:0016477;GO:0007010;GO:0035195;GO:0090090;GO:0035331;GO:0045668;GO:0045892;GO:0002076;GO:0033962;GO:0016310;GO:2000637;GO:0008360;GO:0061418;GO:0006355;GO:0001666;, C:adherens junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane; C:RISC complex; C:transcription regulator complex;, F:metal ion binding; F:transcription corepressor activity;, P:cell migration; P:cytoskeleton organization; P:gene silencing by miRNA; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of hippo signaling; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription, DNA-templated; P:osteoblast development; P:P-body assembly; P:phosphorylation; P:positive regulation of gene silencing by miRNA; P:regulation of cell shape; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia; scaffold73 indexed_genome mRNA 3640626 3777367 . - . ID=transcript_11550;Q15031,Probable leucine--tRNA ligase, mitochondrial,Leucyl-tRNA synthetase;, PF08264;PF00133;, GO:0005759;GO:0005739;GO:0002161;GO:0005524;GO:0004823;GO:0006429;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:leucine-tRNA ligase activity;, P:leucyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation;|Q15031,Probable leucine--tRNA ligase, mitochondrial,Leucyl-tRNA synthetase;, PF08264;PF00133;, GO:0005759;GO:0005739;GO:0002161;GO:0005524;GO:0004823;GO:0006429;GO:0032543;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:leucine-tRNA ligase activity;, P:leucyl-tRNA aminoacylation; P:mitochondrial translation; P:tRNA aminoacylation for protein translation; scaffold73 indexed_genome mRNA 4058319 4064673 . - . ID=transcript_11551;P05452 Q6FGX6,Tetranectin,C-type lectin domain family 3 member B;Plasminogen kringle 4-binding protein;, PF00059;, GO:0062023;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0001652;GO:0031089;GO:0005509;GO:0030246;GO:0008201;GO:0036143;GO:0030282;GO:0071310;GO:0071560;GO:0001503;GO:0002576;GO:0010756;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space; C:granular component; C:platelet dense granule lumen;, F:calcium ion binding; F:carbohydrate binding; F:heparin binding; F:kringle domain binding;, P:bone mineralization; P:cellular response to organic substance; P:cellular response to transforming growth factor beta stimulus; P:ossification; P:platelet degranulation; P:positive regulation of plasminogen activation; scaffold73 indexed_genome mRNA 4075175 4087725 . + . ID=transcript_11552;Q15024 Q96E72,Exosome complex component RRP42,Exosome component 7;Ribosomal RNA-processing protein 42;p8;, PF01138;PF03725;, GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0000175;GO:0003723;GO:0043928;GO:0000467;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0034427;GO:0043488;GO:0006401;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:regulation of mRNA stability; P:RNA catabolic process; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q15024 Q96E72,Exosome complex component RRP42,Exosome component 7;Ribosomal RNA-processing protein 42;p8;, PF01138;PF03725;, GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0000175;GO:0003723;GO:0043928;GO:0000467;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0034427;GO:0043488;GO:0006401;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:regulation of mRNA stability; P:RNA catabolic process; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q15024 Q96E72,Exosome complex component RRP42,Exosome component 7;Ribosomal RNA-processing protein 42;p8;, PF01138;PF03725;, GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0000175;GO:0003723;GO:0043928;GO:0000467;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0034427;GO:0043488;GO:0006401;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:regulation of mRNA stability; P:RNA catabolic process; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing;|Q15024 Q96E72,Exosome complex component RRP42,Exosome component 7;Ribosomal RNA-processing protein 42;p8;, PF01138;PF03725;, GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0000175;GO:0003723;GO:0043928;GO:0000467;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0034427;GO:0043488;GO:0006401;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:regulation of mRNA stability; P:RNA catabolic process; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing; scaffold73 indexed_genome mRNA 4090737 4101457 . - . ID=transcript_11553;Q15024 Q96E72,Exosome complex component RRP42,Exosome component 7;Ribosomal RNA-processing protein 42;p8;, PF01138;PF03725;, GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0000175;GO:0003723;GO:0043928;GO:0000467;GO:0071028;GO:0071042;GO:0071035;GO:0071038;GO:0034427;GO:0043488;GO:0006401;GO:0016075;GO:0006364;GO:0034473;GO:0034475;GO:0034476;, C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:RNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear mRNA surveillance; P:nuclear polyadenylation-dependent mRNA catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:regulation of mRNA stability; P:RNA catabolic process; P:rRNA catabolic process; P:rRNA processing; P:U1 snRNA 3'-end processing; P:U4 snRNA 3'-end processing; P:U5 snRNA 3'-end processing; scaffold73 indexed_genome mRNA 4142874 4149092 . + . ID=transcript_11554;Q9NYG2 Q53A17 Q96BL0,Palmitoyltransferase ZDHHC3 {ECO:0000305},Acyltransferase ZDHHC3 {ECO:0000250|UniProtKB:Q8R173};Protein DHHC1 {ECO:0000312|EMBL:AAF63570.1};Zinc finger DHHC domain-containing protein 3 {ECO:0000312|HGNC:HGNC:18470};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0016409;GO:0042803;GO:0019705;GO:0019706;GO:0140439;GO:0044873;GO:0018230;GO:1902685;GO:0032230;GO:1903546;GO:0072659;GO:0018345;GO:0006612;GO:0008277;GO:0036462;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:palmitoyltransferase activity; F:protein homodimerization activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity;, P:lipoprotein localization to membrane; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of receptor localization to synapse; P:positive regulation of synaptic transmission, GABAergic; P:protein localization to photoreceptor outer segment; P:protein localization to plasma membrane; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of G protein-coupled receptor signaling pathway; P:TRAIL-activated apoptotic signaling pathway; scaffold73 indexed_genome mRNA 4149928 4150513 . + . ID=transcript_11555;Q9NYG2 Q53A17 Q96BL0,Palmitoyltransferase ZDHHC3 {ECO:0000305},Acyltransferase ZDHHC3 {ECO:0000250|UniProtKB:Q8R173};Protein DHHC1 {ECO:0000312|EMBL:AAF63570.1};Zinc finger DHHC domain-containing protein 3 {ECO:0000312|HGNC:HGNC:18470};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0016409;GO:0042803;GO:0019705;GO:0019706;GO:0140439;GO:0044873;GO:0018230;GO:1902685;GO:0032230;GO:1903546;GO:0072659;GO:0018345;GO:0006612;GO:0008277;GO:0036462;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:palmitoyltransferase activity; F:protein homodimerization activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity;, P:lipoprotein localization to membrane; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of receptor localization to synapse; P:positive regulation of synaptic transmission, GABAergic; P:protein localization to photoreceptor outer segment; P:protein localization to plasma membrane; P:protein palmitoylation; P:protein targeting to membrane; P:regulation of G protein-coupled receptor signaling pathway; P:TRAIL-activated apoptotic signaling pathway; scaffold73 indexed_genome mRNA 4171608 4179207 . + . ID=transcript_11556;Q69YG0 Q8WUQ6,Transmembrane protein 42,, , GO:0016021;, C:integral component of membrane; scaffold73 indexed_genome mRNA 4238868 4243693 . + . ID=transcript_11557;P55735 A8MV37 B4DXJ1 Q5BJF0 Q9BRM6 Q9BUG7,Protein SEC13 homolog {ECO:0000305},GATOR complex protein SEC13 {ECO:0000305};SEC13-like protein 1;SEC13-related protein;, PF00400;, GO:0030127;GO:0005829;GO:0005789;GO:0012507;GO:0070062;GO:0061700;GO:0043657;GO:0043231;GO:0005765;GO:0005635;GO:0031080;GO:0005654;GO:0042802;GO:0005198;GO:0019886;GO:0002474;GO:0034198;GO:0048208;GO:0090114;GO:0090110;GO:0006886;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0032008;GO:1904263;GO:0032527;GO:0006606;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:GATOR2 complex; C:host cell; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nuclear envelope; C:nuclear pore outer ring; C:nucleoplasm;, F:identical protein binding; F:structural molecule activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:cellular response to amino acid starvation; P:COPII vesicle coating; P:COPII-coated vesicle budding; P:COPII-coated vesicle cargo loading; P:intracellular protein transport; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:positive regulation of TOR signaling; P:positive regulation of TORC1 signaling; P:protein exit from endoplasmic reticulum; P:protein import into nucleus; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold73 indexed_genome mRNA 4287407 4439438 . - . ID=transcript_11558;Q01814 O00766 Q12994 Q16818,Plasma membrane calcium-transporting ATPase 2,Plasma membrane calcium ATPase isoform 2;Plasma membrane calcium pump isoform 2;, PF12424;PF00689;PF00690;, GO:0005737;GO:0070062;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098839;GO:0098793;GO:0005524;GO:0019829;GO:0005509;GO:0005388;GO:1905059;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0008022;GO:0006816;GO:0006874;GO:0034220;GO:0030182;GO:1903779;GO:0051480;GO:0007605;, C:cytoplasm; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding; F:protein C-terminus binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:neuron differentiation; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:sensory perception of sound;|Q01814 O00766 Q12994 Q16818,Plasma membrane calcium-transporting ATPase 2,Plasma membrane calcium ATPase isoform 2;Plasma membrane calcium pump isoform 2;, PF12424;PF00689;PF00690;, GO:0005737;GO:0070062;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098839;GO:0098793;GO:0005524;GO:0019829;GO:0005509;GO:0005388;GO:1905059;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0008022;GO:0006816;GO:0006874;GO:0034220;GO:0030182;GO:1903779;GO:0051480;GO:0007605;, C:cytoplasm; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding; F:protein C-terminus binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:neuron differentiation; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:sensory perception of sound;|Q01814 O00766 Q12994 Q16818,Plasma membrane calcium-transporting ATPase 2,Plasma membrane calcium ATPase isoform 2;Plasma membrane calcium pump isoform 2;, PF12424;PF00689;PF00690;, GO:0005737;GO:0070062;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098839;GO:0098793;GO:0005524;GO:0019829;GO:0005509;GO:0005388;GO:1905059;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0008022;GO:0006816;GO:0006874;GO:0034220;GO:0030182;GO:1903779;GO:0051480;GO:0007605;, C:cytoplasm; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding; F:protein C-terminus binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:neuron differentiation; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:sensory perception of sound;|Q01814 O00766 Q12994 Q16818,Plasma membrane calcium-transporting ATPase 2,Plasma membrane calcium ATPase isoform 2;Plasma membrane calcium pump isoform 2;, PF12424;PF00689;PF00690;, GO:0005737;GO:0070062;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098839;GO:0098793;GO:0005524;GO:0019829;GO:0005509;GO:0005388;GO:1905059;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0008022;GO:0006816;GO:0006874;GO:0034220;GO:0030182;GO:1903779;GO:0051480;GO:0007605;, C:cytoplasm; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding; F:protein C-terminus binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:neuron differentiation; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:sensory perception of sound;|Q01814 O00766 Q12994 Q16818,Plasma membrane calcium-transporting ATPase 2,Plasma membrane calcium ATPase isoform 2;Plasma membrane calcium pump isoform 2;, PF12424;PF00689;PF00690;, GO:0005737;GO:0070062;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098839;GO:0098793;GO:0005524;GO:0019829;GO:0005509;GO:0005388;GO:1905059;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0008022;GO:0006816;GO:0006874;GO:0034220;GO:0030182;GO:1903779;GO:0051480;GO:0007605;, C:cytoplasm; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding; F:protein C-terminus binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:neuron differentiation; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:sensory perception of sound;|Q01814 O00766 Q12994 Q16818,Plasma membrane calcium-transporting ATPase 2,Plasma membrane calcium ATPase isoform 2;Plasma membrane calcium pump isoform 2;, PF12424;PF00689;PF00690;, GO:0005737;GO:0070062;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098839;GO:0098793;GO:0005524;GO:0019829;GO:0005509;GO:0005388;GO:1905059;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0008022;GO:0006816;GO:0006874;GO:0034220;GO:0030182;GO:1903779;GO:0051480;GO:0007605;, C:cytoplasm; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding; F:protein C-terminus binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:neuron differentiation; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:sensory perception of sound;|Q01814 O00766 Q12994 Q16818,Plasma membrane calcium-transporting ATPase 2,Plasma membrane calcium ATPase isoform 2;Plasma membrane calcium pump isoform 2;, PF12424;PF00689;PF00690;, GO:0005737;GO:0070062;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098839;GO:0098793;GO:0005524;GO:0019829;GO:0005509;GO:0005388;GO:1905059;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:0008022;GO:0006816;GO:0006874;GO:0034220;GO:0030182;GO:1903779;GO:0051480;GO:0007605;, C:cytoplasm; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:postsynaptic density membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding; F:protein C-terminus binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:neuron differentiation; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:sensory perception of sound; scaffold73 indexed_genome mRNA 4763142 4889149 . + . ID=transcript_11559;P48066 B2R6U6 Q8IYC9,Sodium- and chloride-dependent GABA transporter 3,Solute carrier family 6 member 11;, PF00209;, GO:0005737;GO:0098982;GO:0016021;GO:0005887;GO:0099055;GO:0099056;GO:0043005;GO:0005886;GO:0005332;GO:0008028;GO:0042165;GO:0007420;GO:0051936;GO:0015718;GO:0042493;GO:0035725;, C:cytoplasm; C:GABA-ergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:neuron projection; C:plasma membrane;, F:gamma-aminobutyric acid:sodium symporter activity; F:monocarboxylic acid transmembrane transporter activity; F:neurotransmitter binding;, P:brain development; P:gamma-aminobutyric acid reuptake; P:monocarboxylic acid transport; P:response to drug; P:sodium ion transmembrane transport;|P48066 B2R6U6 Q8IYC9,Sodium- and chloride-dependent GABA transporter 3,Solute carrier family 6 member 11;, PF00209;, GO:0005737;GO:0098982;GO:0016021;GO:0005887;GO:0099055;GO:0099056;GO:0043005;GO:0005886;GO:0005332;GO:0008028;GO:0042165;GO:0007420;GO:0051936;GO:0015718;GO:0042493;GO:0035725;, C:cytoplasm; C:GABA-ergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:neuron projection; C:plasma membrane;, F:gamma-aminobutyric acid:sodium symporter activity; F:monocarboxylic acid transmembrane transporter activity; F:neurotransmitter binding;, P:brain development; P:gamma-aminobutyric acid reuptake; P:monocarboxylic acid transport; P:response to drug; P:sodium ion transmembrane transport; scaffold73 indexed_genome mRNA 4967681 4986204 . + . ID=transcript_11560;P30531 Q8N4K8,Sodium- and chloride-dependent GABA transporter 1,Solute carrier family 6 member 1;, PF00209;, GO:0030424;GO:0009986;GO:0016021;GO:0005887;GO:0016020;GO:0043005;GO:0043025;GO:0005886;GO:0098793;GO:0015185;GO:0005332;GO:0046872;GO:0015378;GO:0008306;GO:0007268;GO:1902476;GO:0051939;GO:0051936;GO:0098658;GO:0007613;GO:0010035;GO:0098719;GO:0035725;GO:0050808;GO:0150104;, C:axon; C:cell surface; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:presynapse;, F:gamma-aminobutyric acid transmembrane transporter activity; F:gamma-aminobutyric acid:sodium symporter activity; F:metal ion binding; F:sodium:chloride symporter activity;, P:associative learning; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid import; P:gamma-aminobutyric acid reuptake; P:inorganic anion import across plasma membrane; P:memory; P:response to inorganic substance; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport; P:synapse organization; P:transport across blood-brain barrier;|P30531 Q8N4K8,Sodium- and chloride-dependent GABA transporter 1,Solute carrier family 6 member 1;, PF00209;, GO:0030424;GO:0009986;GO:0016021;GO:0005887;GO:0016020;GO:0043005;GO:0043025;GO:0005886;GO:0098793;GO:0015185;GO:0005332;GO:0046872;GO:0015378;GO:0008306;GO:0007268;GO:1902476;GO:0051939;GO:0051936;GO:0098658;GO:0007613;GO:0010035;GO:0098719;GO:0035725;GO:0050808;GO:0150104;, C:axon; C:cell surface; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:presynapse;, F:gamma-aminobutyric acid transmembrane transporter activity; F:gamma-aminobutyric acid:sodium symporter activity; F:metal ion binding; F:sodium:chloride symporter activity;, P:associative learning; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid import; P:gamma-aminobutyric acid reuptake; P:inorganic anion import across plasma membrane; P:memory; P:response to inorganic substance; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport; P:synapse organization; P:transport across blood-brain barrier; scaffold73 indexed_genome mRNA 5171362 5173922 . + . ID=transcript_11561;P35367 A8K047 Q6P9E5,Histamine H1 receptor,, PF00001;, GO:0005829;GO:0030425;GO:0005887;GO:0005886;GO:0045202;GO:0004930;GO:0004993;GO:0004969;GO:0030594;GO:0071420;GO:0007268;GO:0048245;GO:0007186;GO:0007187;GO:0006954;GO:0048016;GO:0007613;GO:0007200;GO:0032962;GO:0045907;GO:0048167;GO:0043114;GO:0008542;, C:cytosol; C:dendrite; C:integral component of plasma membrane; C:plasma membrane; C:synapse;, F:G protein-coupled receptor activity; F:G protein-coupled serotonin receptor activity; F:histamine receptor activity; F:neurotransmitter receptor activity;, P:cellular response to histamine; P:chemical synaptic transmission; P:eosinophil chemotaxis; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:inflammatory response; P:inositol phosphate-mediated signaling; P:memory; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of inositol trisphosphate biosynthetic process; P:positive regulation of vasoconstriction; P:regulation of synaptic plasticity; P:regulation of vascular permeability; P:visual learning; scaffold73 indexed_genome mRNA 5205813 5448179 . + . ID=transcript_11562;O95352 B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4,Ubiquitin-like modifier-activating enzyme ATG7,ATG12-activating enzyme E1 ATG7;Autophagy-related protein 7;Ubiquitin-activating enzyme E1-like protein;, PF16420;PF00899;, GO:0030424;GO:0005930;GO:0005737;GO:0005829;GO:0005576;GO:1904813;GO:0000407;GO:0034774;GO:0019778;GO:0019779;GO:0042803;GO:0008134;GO:0007568;GO:0000045;GO:0006914;GO:0000422;GO:0006501;GO:0071455;GO:0071315;GO:0006995;GO:0009267;GO:0061684;GO:0051607;GO:0044805;GO:0016236;GO:0090298;GO:1903204;GO:0043312;GO:0034727;GO:0075044;GO:0043065;GO:0010508;GO:0045732;GO:0031401;GO:0006497;GO:0032446;GO:0015031;GO:0042752;GO:1902617;GO:0009749;GO:0048511;GO:0039521;, C:axon; C:axoneme; C:cytoplasm; C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:phagophore assembly site; C:secretory granule lumen;, F:Atg12 activating enzyme activity; F:Atg8 activating enzyme activity; F:protein homodimerization activity; F:transcription factor binding;, P:aging; P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:C-terminal protein lipidation; P:cellular response to hyperoxia; P:cellular response to morphine; P:cellular response to nitrogen starvation; P:cellular response to starvation; P:chaperone-mediated autophagy; P:defense response to virus; P:late nucleophagy; P:macroautophagy; P:negative regulation of mitochondrial DNA replication; P:negative regulation of oxidative stress-induced neuron death; P:neutrophil degranulation; P:piecemeal microautophagy of the nucleus; P:positive regulation by symbiont of host autophagy; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of protein catabolic process; P:positive regulation of protein modification process; P:protein lipidation; P:protein modification by small protein conjugation; P:protein transport; P:regulation of circadian rhythm; P:response to fluoride; P:response to glucose; P:rhythmic process; P:suppression by virus of host autophagy; scaffold73 indexed_genome mRNA 5449900 5601903 . - . ID=transcript_11563;Q14135 B4DTS7 J3KN68 Q7L5V0 Q9BQ78,Transcription cofactor vestigial-like protein 4,, PF15245;, GO:0005634;GO:0001223;GO:0060044;GO:0030308;GO:0035331;GO:0045892;GO:0030178;GO:1903364;, C:nucleus;, F:transcription coactivator binding;, P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell growth; P:negative regulation of hippo signaling; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:positive regulation of cellular protein catabolic process;|Q14135 B4DTS7 J3KN68 Q7L5V0 Q9BQ78,Transcription cofactor vestigial-like protein 4,, PF15245;, GO:0005634;GO:0001223;GO:0060044;GO:0030308;GO:0035331;GO:0045892;GO:0030178;GO:1903364;, C:nucleus;, F:transcription coactivator binding;, P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell growth; P:negative regulation of hippo signaling; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:positive regulation of cellular protein catabolic process;|Q14135 B4DTS7 J3KN68 Q7L5V0 Q9BQ78,Transcription cofactor vestigial-like protein 4,, PF15245;, GO:0005634;GO:0001223;GO:0060044;GO:0030308;GO:0035331;GO:0045892;GO:0030178;GO:1903364;, C:nucleus;, F:transcription coactivator binding;, P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell growth; P:negative regulation of hippo signaling; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:positive regulation of cellular protein catabolic process; scaffold73 indexed_genome mRNA 5663393 5668501 . + . ID=transcript_11564;Q96BW9 B4DIY7 C9J2U4,Phosphatidate cytidylyltransferase, mitochondrial,CDP-diacylglycerol synthase;Mitochondrial translocator assembly and maintenance protein 41 homolog;, PF09139;, GO:0019898;GO:0031314;GO:0005743;GO:0004605;GO:0032049;GO:0016024;, C:extrinsic component of membrane; C:extrinsic component of mitochondrial inner membrane; C:mitochondrial inner membrane;, F:phosphatidate cytidylyltransferase activity;, P:cardiolipin biosynthetic process; P:CDP-diacylglycerol biosynthetic process; scaffold73 indexed_genome mRNA 5678541 5679132 . + . ID=transcript_11565;Q96BW9 B4DIY7 C9J2U4,Phosphatidate cytidylyltransferase, mitochondrial,CDP-diacylglycerol synthase;Mitochondrial translocator assembly and maintenance protein 41 homolog;, PF09139;, GO:0019898;GO:0031314;GO:0005743;GO:0004605;GO:0032049;GO:0016024;, C:extrinsic component of membrane; C:extrinsic component of mitochondrial inner membrane; C:mitochondrial inner membrane;, F:phosphatidate cytidylyltransferase activity;, P:cardiolipin biosynthetic process; P:CDP-diacylglycerol biosynthetic process; scaffold73 indexed_genome mRNA 5739027 5741752 . - . ID=transcript_11566;P20396 B2R8R1 Q2TB83,Pro-thyrotropin-releasing hormone,Prothyroliberin;, PF05438;, GO:0005576;GO:0005634;GO:0005886;GO:0030141;GO:0008437;GO:0007267;GO:0042755;GO:0007186;GO:0001692;GO:0009755;GO:2000252;GO:0014050;GO:0014054;GO:0032024;GO:0009409;GO:0051412;GO:0045471;GO:0009749;GO:0001666;GO:0007165;, C:extracellular region; C:nucleus; C:plasma membrane; C:secretory granule;, F:thyrotropin-releasing hormone activity;, P:cell-cell signaling; P:eating behavior; P:G protein-coupled receptor signaling pathway; P:histamine metabolic process; P:hormone-mediated signaling pathway; P:negative regulation of feeding behavior; P:negative regulation of glutamate secretion; P:positive regulation of gamma-aminobutyric acid secretion; P:positive regulation of insulin secretion; P:response to cold; P:response to corticosterone; P:response to ethanol; P:response to glucose; P:response to hypoxia; P:signal transduction; scaffold73 indexed_genome mRNA 5796571 5946368 . + . ID=transcript_11567;O94876 A8K5Y3 B4DE04 Q68E06 Q8IXM8,Transmembrane and coiled-coil domains protein 1 {ECO:0000303|PubMed:24454821},, PF10267;, GO:0005829;GO:0012505;GO:0005789;GO:0140284;GO:0016021;GO:0005791;GO:0042802;GO:0007029;GO:0016197;GO:0140285;GO:0097750;GO:0090148;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of membrane; C:rough endoplasmic reticulum;, F:identical protein binding;, P:endoplasmic reticulum organization; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:membrane fission;|O94876 A8K5Y3 B4DE04 Q68E06 Q8IXM8,Transmembrane and coiled-coil domains protein 1 {ECO:0000303|PubMed:24454821},, PF10267;, GO:0005829;GO:0012505;GO:0005789;GO:0140284;GO:0016021;GO:0005791;GO:0042802;GO:0007029;GO:0016197;GO:0140285;GO:0097750;GO:0090148;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of membrane; C:rough endoplasmic reticulum;, F:identical protein binding;, P:endoplasmic reticulum organization; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:membrane fission;|O94876 A8K5Y3 B4DE04 Q68E06 Q8IXM8,Transmembrane and coiled-coil domains protein 1 {ECO:0000303|PubMed:24454821},, PF10267;, GO:0005829;GO:0012505;GO:0005789;GO:0140284;GO:0016021;GO:0005791;GO:0042802;GO:0007029;GO:0016197;GO:0140285;GO:0097750;GO:0090148;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of membrane; C:rough endoplasmic reticulum;, F:identical protein binding;, P:endoplasmic reticulum organization; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:membrane fission;|O94876 A8K5Y3 B4DE04 Q68E06 Q8IXM8,Transmembrane and coiled-coil domains protein 1 {ECO:0000303|PubMed:24454821},, PF10267;, GO:0005829;GO:0012505;GO:0005789;GO:0140284;GO:0016021;GO:0005791;GO:0042802;GO:0007029;GO:0016197;GO:0140285;GO:0097750;GO:0090148;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of membrane; C:rough endoplasmic reticulum;, F:identical protein binding;, P:endoplasmic reticulum organization; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:membrane fission;|O94876 A8K5Y3 B4DE04 Q68E06 Q8IXM8,Transmembrane and coiled-coil domains protein 1 {ECO:0000303|PubMed:24454821},, PF10267;, GO:0005829;GO:0012505;GO:0005789;GO:0140284;GO:0016021;GO:0005791;GO:0042802;GO:0007029;GO:0016197;GO:0140285;GO:0097750;GO:0090148;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of membrane; C:rough endoplasmic reticulum;, F:identical protein binding;, P:endoplasmic reticulum organization; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:membrane fission;|O94876 A8K5Y3 B4DE04 Q68E06 Q8IXM8,Transmembrane and coiled-coil domains protein 1 {ECO:0000303|PubMed:24454821},, PF10267;, GO:0005829;GO:0012505;GO:0005789;GO:0140284;GO:0016021;GO:0005791;GO:0042802;GO:0007029;GO:0016197;GO:0140285;GO:0097750;GO:0090148;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of membrane; C:rough endoplasmic reticulum;, F:identical protein binding;, P:endoplasmic reticulum organization; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:membrane fission;|O94876 A8K5Y3 B4DE04 Q68E06 Q8IXM8,Transmembrane and coiled-coil domains protein 1 {ECO:0000303|PubMed:24454821},, PF10267;, GO:0005829;GO:0012505;GO:0005789;GO:0140284;GO:0016021;GO:0005791;GO:0042802;GO:0007029;GO:0016197;GO:0140285;GO:0097750;GO:0090148;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of membrane; C:rough endoplasmic reticulum;, F:identical protein binding;, P:endoplasmic reticulum organization; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:membrane fission; scaffold73 indexed_genome mRNA 6019219 6020254 . + . ID=transcript_11568;Q9Y4D7 A7E2C6 C9JPZ6 Q6PJS9 Q8IZJ2 Q9BTQ2,Plexin-D1,, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0005887;GO:0030027;GO:0031258;GO:0005886;GO:0002116;GO:0019904;GO:0017154;GO:0001525;GO:0035904;GO:0001569;GO:0003279;GO:0060976;GO:0060666;GO:0043542;GO:0001822;GO:0007162;GO:0003151;GO:0050772;GO:0032092;GO:0007221;GO:0045765;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0007416;, C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:plasma membrane; C:semaphorin receptor complex;, F:protein domain specific binding; F:semaphorin receptor activity;, P:angiogenesis; P:aorta development; P:branching involved in blood vessel morphogenesis; P:cardiac septum development; P:coronary vasculature development; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:endothelial cell migration; P:kidney development; P:negative regulation of cell adhesion; P:outflow tract morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of protein binding; P:positive regulation of transcription of Notch receptor target; P:regulation of angiogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:synapse assembly; scaffold73 indexed_genome mRNA 6020688 6021539 . - . ID=transcript_11569;Q9Y4D7 A7E2C6 C9JPZ6 Q6PJS9 Q8IZJ2 Q9BTQ2,Plexin-D1,, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0005887;GO:0030027;GO:0031258;GO:0005886;GO:0002116;GO:0019904;GO:0017154;GO:0001525;GO:0035904;GO:0001569;GO:0003279;GO:0060976;GO:0060666;GO:0043542;GO:0001822;GO:0007162;GO:0003151;GO:0050772;GO:0032092;GO:0007221;GO:0045765;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0007416;, C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:plasma membrane; C:semaphorin receptor complex;, F:protein domain specific binding; F:semaphorin receptor activity;, P:angiogenesis; P:aorta development; P:branching involved in blood vessel morphogenesis; P:cardiac septum development; P:coronary vasculature development; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:endothelial cell migration; P:kidney development; P:negative regulation of cell adhesion; P:outflow tract morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of protein binding; P:positive regulation of transcription of Notch receptor target; P:regulation of angiogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:synapse assembly; scaffold73 indexed_genome mRNA 6021683 6034439 . + . ID=transcript_11570;Q9Y4D7 A7E2C6 C9JPZ6 Q6PJS9 Q8IZJ2 Q9BTQ2,Plexin-D1,, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0005887;GO:0030027;GO:0031258;GO:0005886;GO:0002116;GO:0019904;GO:0017154;GO:0001525;GO:0035904;GO:0001569;GO:0003279;GO:0060976;GO:0060666;GO:0043542;GO:0001822;GO:0007162;GO:0003151;GO:0050772;GO:0032092;GO:0007221;GO:0045765;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0007416;, C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:plasma membrane; C:semaphorin receptor complex;, F:protein domain specific binding; F:semaphorin receptor activity;, P:angiogenesis; P:aorta development; P:branching involved in blood vessel morphogenesis; P:cardiac septum development; P:coronary vasculature development; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:endothelial cell migration; P:kidney development; P:negative regulation of cell adhesion; P:outflow tract morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of protein binding; P:positive regulation of transcription of Notch receptor target; P:regulation of angiogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:synapse assembly;|Q9Y4D7 A7E2C6 C9JPZ6 Q6PJS9 Q8IZJ2 Q9BTQ2,Plexin-D1,, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0005887;GO:0030027;GO:0031258;GO:0005886;GO:0002116;GO:0019904;GO:0017154;GO:0001525;GO:0035904;GO:0001569;GO:0003279;GO:0060976;GO:0060666;GO:0043542;GO:0001822;GO:0007162;GO:0003151;GO:0050772;GO:0032092;GO:0007221;GO:0045765;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0007416;, C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:plasma membrane; C:semaphorin receptor complex;, F:protein domain specific binding; F:semaphorin receptor activity;, P:angiogenesis; P:aorta development; P:branching involved in blood vessel morphogenesis; P:cardiac septum development; P:coronary vasculature development; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:endothelial cell migration; P:kidney development; P:negative regulation of cell adhesion; P:outflow tract morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of protein binding; P:positive regulation of transcription of Notch receptor target; P:regulation of angiogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:synapse assembly;|Q9Y4D7 A7E2C6 C9JPZ6 Q6PJS9 Q8IZJ2 Q9BTQ2,Plexin-D1,, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0005887;GO:0030027;GO:0031258;GO:0005886;GO:0002116;GO:0019904;GO:0017154;GO:0001525;GO:0035904;GO:0001569;GO:0003279;GO:0060976;GO:0060666;GO:0043542;GO:0001822;GO:0007162;GO:0003151;GO:0050772;GO:0032092;GO:0007221;GO:0045765;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0007416;, C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:plasma membrane; C:semaphorin receptor complex;, F:protein domain specific binding; F:semaphorin receptor activity;, P:angiogenesis; P:aorta development; P:branching involved in blood vessel morphogenesis; P:cardiac septum development; P:coronary vasculature development; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:endothelial cell migration; P:kidney development; P:negative regulation of cell adhesion; P:outflow tract morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of protein binding; P:positive regulation of transcription of Notch receptor target; P:regulation of angiogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:synapse assembly;|Q9Y4D7 A7E2C6 C9JPZ6 Q6PJS9 Q8IZJ2 Q9BTQ2,Plexin-D1,, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0005887;GO:0030027;GO:0031258;GO:0005886;GO:0002116;GO:0019904;GO:0017154;GO:0001525;GO:0035904;GO:0001569;GO:0003279;GO:0060976;GO:0060666;GO:0043542;GO:0001822;GO:0007162;GO:0003151;GO:0050772;GO:0032092;GO:0007221;GO:0045765;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0007416;, C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:plasma membrane; C:semaphorin receptor complex;, F:protein domain specific binding; F:semaphorin receptor activity;, P:angiogenesis; P:aorta development; P:branching involved in blood vessel morphogenesis; P:cardiac septum development; P:coronary vasculature development; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:endothelial cell migration; P:kidney development; P:negative regulation of cell adhesion; P:outflow tract morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of protein binding; P:positive regulation of transcription of Notch receptor target; P:regulation of angiogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:synapse assembly;|Q9Y4D7 A7E2C6 C9JPZ6 Q6PJS9 Q8IZJ2 Q9BTQ2,Plexin-D1,, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0005887;GO:0030027;GO:0031258;GO:0005886;GO:0002116;GO:0019904;GO:0017154;GO:0001525;GO:0035904;GO:0001569;GO:0003279;GO:0060976;GO:0060666;GO:0043542;GO:0001822;GO:0007162;GO:0003151;GO:0050772;GO:0032092;GO:0007221;GO:0045765;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0007416;, C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:plasma membrane; C:semaphorin receptor complex;, F:protein domain specific binding; F:semaphorin receptor activity;, P:angiogenesis; P:aorta development; P:branching involved in blood vessel morphogenesis; P:cardiac septum development; P:coronary vasculature development; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:endothelial cell migration; P:kidney development; P:negative regulation of cell adhesion; P:outflow tract morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of protein binding; P:positive regulation of transcription of Notch receptor target; P:regulation of angiogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:synapse assembly;|Q9Y4D7 A7E2C6 C9JPZ6 Q6PJS9 Q8IZJ2 Q9BTQ2,Plexin-D1,, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0005887;GO:0030027;GO:0031258;GO:0005886;GO:0002116;GO:0019904;GO:0017154;GO:0001525;GO:0035904;GO:0001569;GO:0003279;GO:0060976;GO:0060666;GO:0043542;GO:0001822;GO:0007162;GO:0003151;GO:0050772;GO:0032092;GO:0007221;GO:0045765;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0007416;, C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:plasma membrane; C:semaphorin receptor complex;, F:protein domain specific binding; F:semaphorin receptor activity;, P:angiogenesis; P:aorta development; P:branching involved in blood vessel morphogenesis; P:cardiac septum development; P:coronary vasculature development; P:dichotomous subdivision of terminal units involved in salivary gland branching; P:endothelial cell migration; P:kidney development; P:negative regulation of cell adhesion; P:outflow tract morphogenesis; P:positive regulation of axonogenesis; P:positive regulation of protein binding; P:positive regulation of transcription of Notch receptor target; P:regulation of angiogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:synapse assembly; scaffold73 indexed_genome mRNA 6038441 6067097 . - . ID=transcript_11571;Q8IZA3 Q86WT7,Histone H1.8 {ECO:0000305},Histone H1oo;Oocyte-specific histone H1;Oocyte-specific linker histone H1;, PF00538;, GO:0005737;GO:0070062;GO:0000786;GO:0005634;GO:0003690;GO:0031492;GO:0030261;GO:0051321;GO:0031936;GO:0045910;GO:2000737;GO:0006334;GO:0016584;GO:0044030;, C:cytoplasm; C:extracellular exosome; C:nucleosome; C:nucleus;, F:double-stranded DNA binding; F:nucleosomal DNA binding;, P:chromosome condensation; P:meiotic cell cycle; P:negative regulation of chromatin silencing; P:negative regulation of DNA recombination; P:negative regulation of stem cell differentiation; P:nucleosome assembly; P:nucleosome positioning; P:regulation of DNA methylation; scaffold73 indexed_genome mRNA 6086559 6148941 . - . ID=transcript_11572;Q53G36 Q8TC06 Q9BTB9 Q9BTY4 Q9HAT9 Q9HBG5 Q9NV68 Q9UF80,Intraflagellar transport protein 122 homolog {ECO:0000305},WD repeat-containing protein 10;WD repeat-containing protein 140;, PF00400;, GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0030991;GO:0016020;GO:0097730;GO:0032391;GO:0048593;GO:0060271;GO:0010172;GO:0035050;GO:0035721;GO:0042073;GO:0035735;GO:0060173;GO:0045879;GO:0001843;GO:1905515;GO:0061512;, C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle A; C:membrane; C:non-motile cilium; C:photoreceptor connecting cilium;, , P:camera-type eye morphogenesis; P:cilium assembly; P:embryonic body morphogenesis; P:embryonic heart tube development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:limb development; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:protein localization to cilium;|Q53G36 Q8TC06 Q9BTB9 Q9BTY4 Q9HAT9 Q9HBG5 Q9NV68 Q9UF80,Intraflagellar transport protein 122 homolog {ECO:0000305},WD repeat-containing protein 10;WD repeat-containing protein 140;, PF00400;, GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0030991;GO:0016020;GO:0097730;GO:0032391;GO:0048593;GO:0060271;GO:0010172;GO:0035050;GO:0035721;GO:0042073;GO:0035735;GO:0060173;GO:0045879;GO:0001843;GO:1905515;GO:0061512;, C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle A; C:membrane; C:non-motile cilium; C:photoreceptor connecting cilium;, , P:camera-type eye morphogenesis; P:cilium assembly; P:embryonic body morphogenesis; P:embryonic heart tube development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:limb development; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:protein localization to cilium;|Q53G36 Q8TC06 Q9BTB9 Q9BTY4 Q9HAT9 Q9HBG5 Q9NV68 Q9UF80,Intraflagellar transport protein 122 homolog {ECO:0000305},WD repeat-containing protein 10;WD repeat-containing protein 140;, PF00400;, GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0030991;GO:0016020;GO:0097730;GO:0032391;GO:0048593;GO:0060271;GO:0010172;GO:0035050;GO:0035721;GO:0042073;GO:0035735;GO:0060173;GO:0045879;GO:0001843;GO:1905515;GO:0061512;, C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle A; C:membrane; C:non-motile cilium; C:photoreceptor connecting cilium;, , P:camera-type eye morphogenesis; P:cilium assembly; P:embryonic body morphogenesis; P:embryonic heart tube development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:limb development; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:protein localization to cilium;|Q53G36 Q8TC06 Q9BTB9 Q9BTY4 Q9HAT9 Q9HBG5 Q9NV68 Q9UF80,Intraflagellar transport protein 122 homolog {ECO:0000305},WD repeat-containing protein 10;WD repeat-containing protein 140;, PF00400;, GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0030991;GO:0016020;GO:0097730;GO:0032391;GO:0048593;GO:0060271;GO:0010172;GO:0035050;GO:0035721;GO:0042073;GO:0035735;GO:0060173;GO:0045879;GO:0001843;GO:1905515;GO:0061512;, C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle A; C:membrane; C:non-motile cilium; C:photoreceptor connecting cilium;, , P:camera-type eye morphogenesis; P:cilium assembly; P:embryonic body morphogenesis; P:embryonic heart tube development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:limb development; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:protein localization to cilium;|Q53G36 Q8TC06 Q9BTB9 Q9BTY4 Q9HAT9 Q9HBG5 Q9NV68 Q9UF80,Intraflagellar transport protein 122 homolog {ECO:0000305},WD repeat-containing protein 10;WD repeat-containing protein 140;, PF00400;, GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0030991;GO:0016020;GO:0097730;GO:0032391;GO:0048593;GO:0060271;GO:0010172;GO:0035050;GO:0035721;GO:0042073;GO:0035735;GO:0060173;GO:0045879;GO:0001843;GO:1905515;GO:0061512;, C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle A; C:membrane; C:non-motile cilium; C:photoreceptor connecting cilium;, , P:camera-type eye morphogenesis; P:cilium assembly; P:embryonic body morphogenesis; P:embryonic heart tube development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:limb development; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:protein localization to cilium;|Q53G36 Q8TC06 Q9BTB9 Q9BTY4 Q9HAT9 Q9HBG5 Q9NV68 Q9UF80,Intraflagellar transport protein 122 homolog {ECO:0000305},WD repeat-containing protein 10;WD repeat-containing protein 140;, PF00400;, GO:0036064;GO:0097542;GO:0005929;GO:0005737;GO:0030991;GO:0016020;GO:0097730;GO:0032391;GO:0048593;GO:0060271;GO:0010172;GO:0035050;GO:0035721;GO:0042073;GO:0035735;GO:0060173;GO:0045879;GO:0001843;GO:1905515;GO:0061512;, C:ciliary basal body; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle A; C:membrane; C:non-motile cilium; C:photoreceptor connecting cilium;, , P:camera-type eye morphogenesis; P:cilium assembly; P:embryonic body morphogenesis; P:embryonic heart tube development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:limb development; P:negative regulation of smoothened signaling pathway; P:neural tube closure; P:non-motile cilium assembly; P:protein localization to cilium; scaffold73 indexed_genome mRNA 6152169 6161401 . + . ID=transcript_11573;O95243 B4DZN2 D3DNC3 D3DNC4 E9PEE4 Q2MD36 Q7Z4T3 Q96F09,Methyl-CpG-binding domain protein 4,Methyl-CpG-binding endonuclease 1;Methyl-CpG-binding protein MBD4;Mismatch-specific DNA N-glycosylase;, PF01429;, GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0004520;GO:0008263;GO:0003696;GO:0006287;GO:0045008;GO:0006281;GO:0032355;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:endodeoxyribonuclease activity; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; F:satellite DNA binding;, P:base-excision repair, gap-filling; P:depyrimidination; P:DNA repair; P:response to estradiol;|O95243 B4DZN2 D3DNC3 D3DNC4 E9PEE4 Q2MD36 Q7Z4T3 Q96F09,Methyl-CpG-binding domain protein 4,Methyl-CpG-binding endonuclease 1;Methyl-CpG-binding protein MBD4;Mismatch-specific DNA N-glycosylase;, PF01429;, GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0004520;GO:0008263;GO:0003696;GO:0006287;GO:0045008;GO:0006281;GO:0032355;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:endodeoxyribonuclease activity; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; F:satellite DNA binding;, P:base-excision repair, gap-filling; P:depyrimidination; P:DNA repair; P:response to estradiol;|O95243 B4DZN2 D3DNC3 D3DNC4 E9PEE4 Q2MD36 Q7Z4T3 Q96F09,Methyl-CpG-binding domain protein 4,Methyl-CpG-binding endonuclease 1;Methyl-CpG-binding protein MBD4;Mismatch-specific DNA N-glycosylase;, PF01429;, GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0004520;GO:0008263;GO:0003696;GO:0006287;GO:0045008;GO:0006281;GO:0032355;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:endodeoxyribonuclease activity; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; F:satellite DNA binding;, P:base-excision repair, gap-filling; P:depyrimidination; P:DNA repair; P:response to estradiol;|O95243 B4DZN2 D3DNC3 D3DNC4 E9PEE4 Q2MD36 Q7Z4T3 Q96F09,Methyl-CpG-binding domain protein 4,Methyl-CpG-binding endonuclease 1;Methyl-CpG-binding protein MBD4;Mismatch-specific DNA N-glycosylase;, PF01429;, GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0004520;GO:0008263;GO:0003696;GO:0006287;GO:0045008;GO:0006281;GO:0032355;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:endodeoxyribonuclease activity; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; F:satellite DNA binding;, P:base-excision repair, gap-filling; P:depyrimidination; P:DNA repair; P:response to estradiol;|O95243 B4DZN2 D3DNC3 D3DNC4 E9PEE4 Q2MD36 Q7Z4T3 Q96F09,Methyl-CpG-binding domain protein 4,Methyl-CpG-binding endonuclease 1;Methyl-CpG-binding protein MBD4;Mismatch-specific DNA N-glycosylase;, PF01429;, GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0004520;GO:0008263;GO:0003696;GO:0006287;GO:0045008;GO:0006281;GO:0032355;, C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:endodeoxyribonuclease activity; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; F:satellite DNA binding;, P:base-excision repair, gap-filling; P:depyrimidination; P:DNA repair; P:response to estradiol; scaffold73 indexed_genome mRNA 6182380 6184205 . + . ID=transcript_11574;Q6NXP0 Q69YX4,EF-hand calcium-binding domain-containing protein 12,, , GO:0005509;, , F:calcium ion binding; scaffold73 indexed_genome mRNA 6187198 6189492 . - . ID=transcript_11575;P62910 B2R4Q3 P02433,60S ribosomal protein L32,Large ribosomal subunit protein eL32 {ECO:0000303|PubMed:24524803};, PF01655;, GO:0005829;GO:0022625;GO:0016020;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:membrane; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold73 indexed_genome mRNA 6190922 6193821 . - . ID=transcript_11576;O75155 B9EGM9 E9KL24,Cullin-associated NEDD8-dissociated protein 2,Cullin-associated and neddylation-dissociated protein 2;Epididymis tissue protein Li 169;TBP-interacting protein of 120 kDa B;p120 CAND2;, PF08623;, GO:0005829;GO:0005634;GO:0017025;GO:0045893;GO:0016567;GO:0010265;, C:cytosol; C:nucleus;, F:TBP-class protein binding;, P:positive regulation of transcription, DNA-templated; P:protein ubiquitination; P:SCF complex assembly; scaffold73 indexed_genome mRNA 6195104 6201489 . - . ID=transcript_11577;O75155 B9EGM9 E9KL24,Cullin-associated NEDD8-dissociated protein 2,Cullin-associated and neddylation-dissociated protein 2;Epididymis tissue protein Li 169;TBP-interacting protein of 120 kDa B;p120 CAND2;, PF08623;, GO:0005829;GO:0005634;GO:0017025;GO:0045893;GO:0016567;GO:0010265;, C:cytosol; C:nucleus;, F:TBP-class protein binding;, P:positive regulation of transcription, DNA-templated; P:protein ubiquitination; P:SCF complex assembly; scaffold73 indexed_genome mRNA 6231761 6266925 . + . ID=transcript_11578;Q8WWA1 C9JID5 Q8NAL4 Q9NUZ4,Transmembrane protein 40,, PF15817;, GO:0016021;, C:integral component of membrane; scaffold73 indexed_genome mRNA 6312206 6375620 . + . ID=transcript_11579;P04049 B0LPH8 B2R5N3 Q15278 Q9UC20,RAF proto-oncogene serine/threonine-protein kinase,Proto-oncogene c-RAF;Raf-1;, PF00130;PF07714;PF02196;, GO:0005737;GO:0005829;GO:0005794;GO:0005741;GO:0005739;GO:0016607;GO:0005886;GO:0031143;GO:0010856;GO:0008179;GO:0005524;GO:0019899;GO:0042802;GO:0004709;GO:0046872;GO:0031434;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007190;GO:0000186;GO:0002250;GO:0006915;GO:0030154;GO:0071550;GO:0060324;GO:0007507;GO:0035773;GO:0045104;GO:0034220;GO:0000165;GO:0043066;GO:0008285;GO:0043154;GO:1902042;GO:0031333;GO:0048011;GO:0030168;GO:0033138;GO:0045944;GO:0006468;GO:0042981;GO:0045595;GO:2000145;GO:0035023;GO:0001666;GO:0035994;GO:0007165;GO:0035019;GO:0002223;GO:0048538;GO:0030878;GO:0042060;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:plasma membrane; C:pseudopodium;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:ATP binding; F:enzyme binding; F:identical protein binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:mitogen-activated protein kinase kinase binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of adenylate cyclase activity; P:activation of MAPKK activity; P:adaptive immune response; P:apoptotic process; P:cell differentiation; P:death-inducing signaling complex assembly; P:face development; P:heart development; P:insulin secretion involved in cellular response to glucose stimulus; P:intermediate filament cytoskeleton organization; P:ion transmembrane transport; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of protein-containing complex assembly; P:neurotrophin TRK receptor signaling pathway; P:platelet activation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell motility; P:regulation of Rho protein signal transduction; P:response to hypoxia; P:response to muscle stretch; P:signal transduction; P:somatic stem cell population maintenance; P:stimulatory C-type lectin receptor signaling pathway; P:thymus development; P:thyroid gland development; P:wound healing; scaffold73 indexed_genome mRNA 6375640 6434503 . + . ID=transcript_11580;P04049 B0LPH8 B2R5N3 Q15278 Q9UC20,RAF proto-oncogene serine/threonine-protein kinase,Proto-oncogene c-RAF;Raf-1;, PF00130;PF07714;PF02196;, GO:0005737;GO:0005829;GO:0005794;GO:0005741;GO:0005739;GO:0016607;GO:0005886;GO:0031143;GO:0010856;GO:0008179;GO:0005524;GO:0019899;GO:0042802;GO:0004709;GO:0046872;GO:0031434;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007190;GO:0000186;GO:0002250;GO:0006915;GO:0030154;GO:0071550;GO:0060324;GO:0007507;GO:0035773;GO:0045104;GO:0034220;GO:0000165;GO:0043066;GO:0008285;GO:0043154;GO:1902042;GO:0031333;GO:0048011;GO:0030168;GO:0033138;GO:0045944;GO:0006468;GO:0042981;GO:0045595;GO:2000145;GO:0035023;GO:0001666;GO:0035994;GO:0007165;GO:0035019;GO:0002223;GO:0048538;GO:0030878;GO:0042060;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:plasma membrane; C:pseudopodium;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:ATP binding; F:enzyme binding; F:identical protein binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:mitogen-activated protein kinase kinase binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of adenylate cyclase activity; P:activation of MAPKK activity; P:adaptive immune response; P:apoptotic process; P:cell differentiation; P:death-inducing signaling complex assembly; P:face development; P:heart development; P:insulin secretion involved in cellular response to glucose stimulus; P:intermediate filament cytoskeleton organization; P:ion transmembrane transport; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of protein-containing complex assembly; P:neurotrophin TRK receptor signaling pathway; P:platelet activation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell motility; P:regulation of Rho protein signal transduction; P:response to hypoxia; P:response to muscle stretch; P:signal transduction; P:somatic stem cell population maintenance; P:stimulatory C-type lectin receptor signaling pathway; P:thymus development; P:thyroid gland development; P:wound healing;|P04049 B0LPH8 B2R5N3 Q15278 Q9UC20,RAF proto-oncogene serine/threonine-protein kinase,Proto-oncogene c-RAF;Raf-1;, PF00130;PF07714;PF02196;, GO:0005737;GO:0005829;GO:0005794;GO:0005741;GO:0005739;GO:0016607;GO:0005886;GO:0031143;GO:0010856;GO:0008179;GO:0005524;GO:0019899;GO:0042802;GO:0004709;GO:0046872;GO:0031434;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007190;GO:0000186;GO:0002250;GO:0006915;GO:0030154;GO:0071550;GO:0060324;GO:0007507;GO:0035773;GO:0045104;GO:0034220;GO:0000165;GO:0043066;GO:0008285;GO:0043154;GO:1902042;GO:0031333;GO:0048011;GO:0030168;GO:0033138;GO:0045944;GO:0006468;GO:0042981;GO:0045595;GO:2000145;GO:0035023;GO:0001666;GO:0035994;GO:0007165;GO:0035019;GO:0002223;GO:0048538;GO:0030878;GO:0042060;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:plasma membrane; C:pseudopodium;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:ATP binding; F:enzyme binding; F:identical protein binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:mitogen-activated protein kinase kinase binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of adenylate cyclase activity; P:activation of MAPKK activity; P:adaptive immune response; P:apoptotic process; P:cell differentiation; P:death-inducing signaling complex assembly; P:face development; P:heart development; P:insulin secretion involved in cellular response to glucose stimulus; P:intermediate filament cytoskeleton organization; P:ion transmembrane transport; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of protein-containing complex assembly; P:neurotrophin TRK receptor signaling pathway; P:platelet activation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell motility; P:regulation of Rho protein signal transduction; P:response to hypoxia; P:response to muscle stretch; P:signal transduction; P:somatic stem cell population maintenance; P:stimulatory C-type lectin receptor signaling pathway; P:thymus development; P:thyroid gland development; P:wound healing;|P04049 B0LPH8 B2R5N3 Q15278 Q9UC20,RAF proto-oncogene serine/threonine-protein kinase,Proto-oncogene c-RAF;Raf-1;, PF00130;PF07714;PF02196;, GO:0005737;GO:0005829;GO:0005794;GO:0005741;GO:0005739;GO:0016607;GO:0005886;GO:0031143;GO:0010856;GO:0008179;GO:0005524;GO:0019899;GO:0042802;GO:0004709;GO:0046872;GO:0031434;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0007190;GO:0000186;GO:0002250;GO:0006915;GO:0030154;GO:0071550;GO:0060324;GO:0007507;GO:0035773;GO:0045104;GO:0034220;GO:0000165;GO:0043066;GO:0008285;GO:0043154;GO:1902042;GO:0031333;GO:0048011;GO:0030168;GO:0033138;GO:0045944;GO:0006468;GO:0042981;GO:0045595;GO:2000145;GO:0035023;GO:0001666;GO:0035994;GO:0007165;GO:0035019;GO:0002223;GO:0048538;GO:0030878;GO:0042060;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:plasma membrane; C:pseudopodium;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:ATP binding; F:enzyme binding; F:identical protein binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:mitogen-activated protein kinase kinase binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:activation of adenylate cyclase activity; P:activation of MAPKK activity; P:adaptive immune response; P:apoptotic process; P:cell differentiation; P:death-inducing signaling complex assembly; P:face development; P:heart development; P:insulin secretion involved in cellular response to glucose stimulus; P:intermediate filament cytoskeleton organization; P:ion transmembrane transport; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of protein-containing complex assembly; P:neurotrophin TRK receptor signaling pathway; P:platelet activation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of cell differentiation; P:regulation of cell motility; P:regulation of Rho protein signal transduction; P:response to hypoxia; P:response to muscle stretch; P:signal transduction; P:somatic stem cell population maintenance; P:stimulatory C-type lectin receptor signaling pathway; P:thymus development; P:thyroid gland development; P:wound healing;|Q9H000 A6NIA2 B3KRC5 B4DPR4 Q8N391 Q96BD4 Q9BUY2 Q9NRY1,Probable E3 ubiquitin-protein ligase makorin-2,RING finger protein 62;RING-type E3 ubiquitin transferase makorin-2 {ECO:0000305};, PF00097;PF00642;PF18044;, GO:0046872;GO:0003723;GO:0061630;GO:0016567;, , F:metal ion binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein ubiquitination;|Q9H000 A6NIA2 B3KRC5 B4DPR4 Q8N391 Q96BD4 Q9BUY2 Q9NRY1,Probable E3 ubiquitin-protein ligase makorin-2,RING finger protein 62;RING-type E3 ubiquitin transferase makorin-2 {ECO:0000305};, PF00097;PF00642;PF18044;, GO:0046872;GO:0003723;GO:0061630;GO:0016567;, , F:metal ion binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein ubiquitination;|Q9H000 A6NIA2 B3KRC5 B4DPR4 Q8N391 Q96BD4 Q9BUY2 Q9NRY1,Probable E3 ubiquitin-protein ligase makorin-2,RING finger protein 62;RING-type E3 ubiquitin transferase makorin-2 {ECO:0000305};, PF00097;PF00642;PF18044;, GO:0046872;GO:0003723;GO:0061630;GO:0016567;, , F:metal ion binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein ubiquitination; scaffold73 indexed_genome mRNA 6449544 6476235 . - . ID=transcript_11581;Q8NCE0 B7Z6K1 C9IZI7 G5E9Q3 Q8WTW7 Q9BPU7,tRNA-splicing endonuclease subunit Sen2,tRNA-intron endonuclease Sen2;, PF01974;PF02778;, GO:0005813;GO:0005829;GO:0005730;GO:0005654;GO:0000214;GO:0016829;GO:0003676;GO:0000213;GO:0006397;GO:0006388;GO:0000379;, C:centrosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;, F:lyase activity; F:nucleic acid binding; F:tRNA-intron endonuclease activity;, P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage;|Q8NCE0 B7Z6K1 C9IZI7 G5E9Q3 Q8WTW7 Q9BPU7,tRNA-splicing endonuclease subunit Sen2,tRNA-intron endonuclease Sen2;, PF01974;PF02778;, GO:0005813;GO:0005829;GO:0005730;GO:0005654;GO:0000214;GO:0016829;GO:0003676;GO:0000213;GO:0006397;GO:0006388;GO:0000379;, C:centrosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;, F:lyase activity; F:nucleic acid binding; F:tRNA-intron endonuclease activity;, P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage; scaffold73 indexed_genome mRNA 6546089 6590870 . - . ID=transcript_11582;Q15180 Q15832 Q86U60 Q96J12,Peroxisome proliferator-activated receptor gamma,Nuclear receptor subfamily 1 group C member 3;, PF00104;PF12577;PF00105;, GO:0000785;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0048471;GO:0043235;GO:0090575;GO:0033613;GO:0051393;GO:0050544;GO:0003682;GO:0003677;GO:0050692;GO:0003700;GO:0000981;GO:0001227;GO:0003690;GO:0070888;GO:0019899;GO:0030331;GO:0042802;GO:0050693;GO:0004879;GO:0042277;GO:0004955;GO:0008022;GO:0019903;GO:0043621;GO:0046965;GO:0000978;GO:0001103;GO:0008134;GO:0000976;GO:0008270;GO:0006919;GO:0031100;GO:0030154;GO:0045165;GO:0048469;GO:0071455;GO:0032869;GO:0071404;GO:0071380;GO:0071300;GO:0071306;GO:0030855;GO:0006631;GO:0019395;GO:0042593;GO:0007507;GO:0009755;GO:0045087;GO:0055088;GO:0006629;GO:0042953;GO:0015909;GO:0010742;GO:0030224;GO:0002674;GO:0016525;GO:0043537;GO:0030514;GO:0030308;GO:0010887;GO:0032966;GO:0060965;GO:0050728;GO:0060336;GO:0010745;GO:0045668;GO:2000230;GO:0010891;GO:2000272;GO:0048662;GO:0051974;GO:0000122;GO:0045892;GO:1904706;GO:1905563;GO:0035357;GO:0001890;GO:0043388;GO:0051091;GO:0045600;GO:0045923;GO:0046321;GO:1905599;GO:0048714;GO:0060100;GO:1902895;GO:0045944;GO:0045893;GO:1905461;GO:0008217;GO:0060694;GO:0042752;GO:0019216;GO:0006357;GO:0031000;GO:0009409;GO:0042493;GO:0043627;GO:0035902;GO:0033993;GO:0009612;GO:1901558;GO:0007584;GO:0042594;GO:0033189;GO:0048384;GO:0048511;GO:0007165;GO:0006367;GO:0050872;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:activating transcription factor binding; F:alpha-actinin binding; F:arachidonic acid binding; F:chromatin binding; F:DNA binding; F:DNA binding domain binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:E-box binding; F:enzyme binding; F:estrogen receptor binding; F:identical protein binding; F:LBD domain binding; F:nuclear receptor activity; F:peptide binding; F:prostaglandin receptor activity; F:protein C-terminus binding; F:protein phosphatase binding; F:protein self-association; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:animal organ regeneration; P:cell differentiation; P:cell fate commitment; P:cell maturation; P:cellular response to hyperoxia; P:cellular response to insulin stimulus; P:cellular response to low-density lipoprotein particle stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to retinoic acid; P:cellular response to vitamin E; P:epithelial cell differentiation; P:fatty acid metabolic process; P:fatty acid oxidation; P:glucose homeostasis; P:heart development; P:hormone-mediated signaling pathway; P:innate immune response; P:lipid homeostasis; P:lipid metabolic process; P:lipoprotein transport; P:long-chain fatty acid transport; P:macrophage derived foam cell differentiation; P:monocyte differentiation; P:negative regulation of acute inflammatory response; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of BMP signaling pathway; P:negative regulation of cell growth; P:negative regulation of cholesterol storage; P:negative regulation of collagen biosynthetic process; P:negative regulation of gene silencing by miRNA; P:negative regulation of inflammatory response; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of osteoblast differentiation; P:negative regulation of pancreatic stellate cell proliferation; P:negative regulation of sequestering of triglyceride; P:negative regulation of signaling receptor activity; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of vascular endothelial cell proliferation; P:peroxisome proliferator activated receptor signaling pathway; P:placenta development; P:positive regulation of DNA binding; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of fat cell differentiation; P:positive regulation of fatty acid metabolic process; P:positive regulation of fatty acid oxidation; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of phagocytosis, engulfment; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular associated smooth muscle cell apoptotic process; P:regulation of blood pressure; P:regulation of cholesterol transporter activity; P:regulation of circadian rhythm; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to caffeine; P:response to cold; P:response to drug; P:response to estrogen; P:response to immobilization stress; P:response to lipid; P:response to mechanical stimulus; P:response to metformin; P:response to nutrient; P:response to starvation; P:response to vitamin A; P:retinoic acid receptor signaling pathway; P:rhythmic process; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; P:white fat cell differentiation; scaffold73 indexed_genome mRNA 6754105 6799020 . - . ID=transcript_11583;Q92777 A0A087WW96 A0A087X2E3 A8MY98,Synapsin-2,Synapsin II;, PF02078;PF02750;PF10581;, GO:0098978;GO:0005886;GO:0014069;GO:0098685;GO:0031201;GO:0045202;GO:0030672;GO:0005524;GO:0042802;GO:0017156;GO:0007268;GO:0007269;GO:0097091;, C:glutamatergic synapse; C:plasma membrane; C:postsynaptic density; C:Schaffer collateral - CA1 synapse; C:SNARE complex; C:synapse; C:synaptic vesicle membrane;, F:ATP binding; F:identical protein binding;, P:calcium-ion regulated exocytosis; P:chemical synaptic transmission; P:neurotransmitter secretion; P:synaptic vesicle clustering;|Q99727 B2R7K6,Metalloproteinase inhibitor 4,Tissue inhibitor of metalloproteinases 4;, PF00965;, GO:0031012;GO:0005615;GO:0030017;GO:0046872;GO:0008191;GO:0002020;GO:0007417;GO:0010951;GO:0051045;GO:0007219;GO:0042698;GO:0034097;GO:0042493;GO:0009725;GO:0032496;GO:0010033;GO:0043434;, C:extracellular matrix; C:extracellular space; C:sarcomere;, F:metal ion binding; F:metalloendopeptidase inhibitor activity; F:protease binding;, P:central nervous system development; P:negative regulation of endopeptidase activity; P:negative regulation of membrane protein ectodomain proteolysis; P:Notch signaling pathway; P:ovulation cycle; P:response to cytokine; P:response to drug; P:response to hormone; P:response to lipopolysaccharide; P:response to organic substance; P:response to peptide hormone;|Q99727 B2R7K6,Metalloproteinase inhibitor 4,Tissue inhibitor of metalloproteinases 4;, PF00965;, GO:0031012;GO:0005615;GO:0030017;GO:0046872;GO:0008191;GO:0002020;GO:0007417;GO:0010951;GO:0051045;GO:0007219;GO:0042698;GO:0034097;GO:0042493;GO:0009725;GO:0032496;GO:0010033;GO:0043434;, C:extracellular matrix; C:extracellular space; C:sarcomere;, F:metal ion binding; F:metalloendopeptidase inhibitor activity; F:protease binding;, P:central nervous system development; P:negative regulation of endopeptidase activity; P:negative regulation of membrane protein ectodomain proteolysis; P:Notch signaling pathway; P:ovulation cycle; P:response to cytokine; P:response to drug; P:response to hormone; P:response to lipopolysaccharide; P:response to organic substance; P:response to peptide hormone;|Q99727 B2R7K6,Metalloproteinase inhibitor 4,Tissue inhibitor of metalloproteinases 4;, PF00965;, GO:0031012;GO:0005615;GO:0030017;GO:0046872;GO:0008191;GO:0002020;GO:0007417;GO:0010951;GO:0051045;GO:0007219;GO:0042698;GO:0034097;GO:0042493;GO:0009725;GO:0032496;GO:0010033;GO:0043434;, C:extracellular matrix; C:extracellular space; C:sarcomere;, F:metal ion binding; F:metalloendopeptidase inhibitor activity; F:protease binding;, P:central nervous system development; P:negative regulation of endopeptidase activity; P:negative regulation of membrane protein ectodomain proteolysis; P:Notch signaling pathway; P:ovulation cycle; P:response to cytokine; P:response to drug; P:response to hormone; P:response to lipopolysaccharide; P:response to organic substance; P:response to peptide hormone; scaffold73 indexed_genome mRNA 6978838 7001158 . + . ID=transcript_11584;Q9H1K0 B4DWY8 C9J4P5 Q3KP30 Q59EY8 Q8NAQ1,Rabenosyn-5 {ECO:0000303|PubMed:11062261},110 kDa protein;FYVE finger-containing Rab5 effector protein rabenosyn-5;RAB effector RBSN {ECO:0000312|HGNC:HGNC:20759};Zinc finger FYVE domain-containing protein 20;, PF01363;PF11464;, GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005886;GO:0008270;GO:0007596;GO:0034498;GO:0016197;GO:0090160;GO:0015031;GO:1903358;, C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:zinc ion binding;, P:blood coagulation; P:early endosome to Golgi transport; P:endosomal transport; P:Golgi to lysosome transport; P:protein transport; P:regulation of Golgi organization;|Q9H1K0 B4DWY8 C9J4P5 Q3KP30 Q59EY8 Q8NAQ1,Rabenosyn-5 {ECO:0000303|PubMed:11062261},110 kDa protein;FYVE finger-containing Rab5 effector protein rabenosyn-5;RAB effector RBSN {ECO:0000312|HGNC:HGNC:20759};Zinc finger FYVE domain-containing protein 20;, PF01363;PF11464;, GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005886;GO:0008270;GO:0007596;GO:0034498;GO:0016197;GO:0090160;GO:0015031;GO:1903358;, C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:zinc ion binding;, P:blood coagulation; P:early endosome to Golgi transport; P:endosomal transport; P:Golgi to lysosome transport; P:protein transport; P:regulation of Golgi organization;|Q9H1K0 B4DWY8 C9J4P5 Q3KP30 Q59EY8 Q8NAQ1,Rabenosyn-5 {ECO:0000303|PubMed:11062261},110 kDa protein;FYVE finger-containing Rab5 effector protein rabenosyn-5;RAB effector RBSN {ECO:0000312|HGNC:HGNC:20759};Zinc finger FYVE domain-containing protein 20;, PF01363;PF11464;, GO:0005829;GO:0031901;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005886;GO:0008270;GO:0007596;GO:0034498;GO:0016197;GO:0090160;GO:0015031;GO:1903358;, C:cytosol; C:early endosome membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:zinc ion binding;, P:blood coagulation; P:early endosome to Golgi transport; P:endosomal transport; P:Golgi to lysosome transport; P:protein transport; P:regulation of Golgi organization; scaffold73 indexed_genome mRNA 7043739 7056116 . - . ID=transcript_11585;P82663 B4DFJ5 B4DQG6 Q9H7P5,28S ribosomal protein S25, mitochondrial,Mitochondrial small ribosomal subunit protein mS25 {ECO:0000303|PubMed:25838379};, PF05047;, GO:0005743;GO:0005739;GO:0005840;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrion; C:ribosome;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold73 indexed_genome mRNA 7061133 7074127 . - . ID=transcript_11586;P49116 A8K3H5 B6ZGT8 P55092,Nuclear receptor subfamily 2 group C member 2,Orphan nuclear receptor TAK1;Orphan nuclear receptor TR4;Testicular receptor 4;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0007399;GO:0040019;GO:0045944;GO:0006357;GO:0006355;GO:0007283;GO:0006367;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of embryonic development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription initiation from RNA polymerase II promoter;|P49116 A8K3H5 B6ZGT8 P55092,Nuclear receptor subfamily 2 group C member 2,Orphan nuclear receptor TAK1;Orphan nuclear receptor TR4;Testicular receptor 4;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0007399;GO:0040019;GO:0045944;GO:0006357;GO:0006355;GO:0007283;GO:0006367;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of embryonic development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription initiation from RNA polymerase II promoter;|P49116 A8K3H5 B6ZGT8 P55092,Nuclear receptor subfamily 2 group C member 2,Orphan nuclear receptor TAK1;Orphan nuclear receptor TR4;Testicular receptor 4;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0007399;GO:0040019;GO:0045944;GO:0006357;GO:0006355;GO:0007283;GO:0006367;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of embryonic development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription initiation from RNA polymerase II promoter;|P49116 A8K3H5 B6ZGT8 P55092,Nuclear receptor subfamily 2 group C member 2,Orphan nuclear receptor TAK1;Orphan nuclear receptor TR4;Testicular receptor 4;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0007399;GO:0040019;GO:0045944;GO:0006357;GO:0006355;GO:0007283;GO:0006367;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of embryonic development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription initiation from RNA polymerase II promoter;|P49116 A8K3H5 B6ZGT8 P55092,Nuclear receptor subfamily 2 group C member 2,Orphan nuclear receptor TAK1;Orphan nuclear receptor TR4;Testicular receptor 4;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0007399;GO:0040019;GO:0045944;GO:0006357;GO:0006355;GO:0007283;GO:0006367;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of embryonic development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription initiation from RNA polymerase II promoter; scaffold73 indexed_genome mRNA 7177621 7286828 . - . ID=transcript_11587;Q6ZNL6 B3KVQ3 Q6MZY1 Q7Z303 Q8IYP3 Q8N861 Q8N8G4,FYVE, RhoGEF and PH domain-containing protein 5,Zinc finger FYVE domain-containing protein 23;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005769;GO:0005783;GO:0005794;GO:0030027;GO:0005886;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;, C:cytoplasm; C:cytoskeleton; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity;|Q6ZNL6 B3KVQ3 Q6MZY1 Q7Z303 Q8IYP3 Q8N861 Q8N8G4,FYVE, RhoGEF and PH domain-containing protein 5,Zinc finger FYVE domain-containing protein 23;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005769;GO:0005783;GO:0005794;GO:0030027;GO:0005886;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;, C:cytoplasm; C:cytoskeleton; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity;|Q6ZNL6 B3KVQ3 Q6MZY1 Q7Z303 Q8IYP3 Q8N861 Q8N8G4,FYVE, RhoGEF and PH domain-containing protein 5,Zinc finger FYVE domain-containing protein 23;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005769;GO:0005783;GO:0005794;GO:0030027;GO:0005886;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;, C:cytoplasm; C:cytoskeleton; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity;|Q6ZNL6 B3KVQ3 Q6MZY1 Q7Z303 Q8IYP3 Q8N861 Q8N8G4,FYVE, RhoGEF and PH domain-containing protein 5,Zinc finger FYVE domain-containing protein 23;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005769;GO:0005783;GO:0005794;GO:0030027;GO:0005886;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;, C:cytoplasm; C:cytoskeleton; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity;|Q6ZNL6 B3KVQ3 Q6MZY1 Q7Z303 Q8IYP3 Q8N861 Q8N8G4,FYVE, RhoGEF and PH domain-containing protein 5,Zinc finger FYVE domain-containing protein 23;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005769;GO:0005783;GO:0005794;GO:0030027;GO:0005886;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;, C:cytoplasm; C:cytoskeleton; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity; scaffold73 indexed_genome mRNA 7286841 7300279 . - . ID=transcript_11588;Q6ZNL6 B3KVQ3 Q6MZY1 Q7Z303 Q8IYP3 Q8N861 Q8N8G4,FYVE, RhoGEF and PH domain-containing protein 5,Zinc finger FYVE domain-containing protein 23;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005769;GO:0005783;GO:0005794;GO:0030027;GO:0005886;GO:0001726;GO:0032587;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;, C:cytoplasm; C:cytoskeleton; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:lamellipodium; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity; scaffold73 indexed_genome mRNA 7392236 7413245 . - . ID=transcript_11589;Q6PII3 Q96CS5,Coiled-coil domain-containing protein 174,, PF13300;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus;|Q6PII3 Q96CS5,Coiled-coil domain-containing protein 174,, PF13300;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus;|Q6PII3 Q96CS5,Coiled-coil domain-containing protein 174,, PF13300;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus;|Q6PII3 Q96CS5,Coiled-coil domain-containing protein 174,, PF13300;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus; scaffold73 indexed_genome mRNA 7505785 7516281 . + . ID=transcript_11590;Q9C0E4 A0A087WU38 Q8TEH9 Q9H7H3,Glutamate receptor-interacting protein 2 {ECO:0000305},, PF00595;PF17820;, GO:0005829;GO:0005886;GO:0030159;GO:0098887;, C:cytosol; C:plasma membrane;, F:signaling receptor complex adaptor activity;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane; scaffold73 indexed_genome mRNA 7520724 7526385 . + . ID=transcript_11591;Q9C0E4 A0A087WU38 Q8TEH9 Q9H7H3,Glutamate receptor-interacting protein 2 {ECO:0000305},, PF00595;PF17820;, GO:0005829;GO:0005886;GO:0030159;GO:0098887;, C:cytosol; C:plasma membrane;, F:signaling receptor complex adaptor activity;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane; scaffold73 indexed_genome mRNA 7526816 7546782 . + . ID=transcript_11592;Q9C0E4 A0A087WU38 Q8TEH9 Q9H7H3,Glutamate receptor-interacting protein 2 {ECO:0000305},, PF00595;PF17820;, GO:0005829;GO:0005886;GO:0030159;GO:0098887;, C:cytosol; C:plasma membrane;, F:signaling receptor complex adaptor activity;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane;|Q9Y3R0 C9JT59 Q1RLM0,Glutamate receptor-interacting protein 1,, PF00595;PF17820;, GO:0031410;GO:0005829;GO:0030425;GO:0005789;GO:0098978;GO:0045121;GO:0043005;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0008013;GO:0035259;GO:0008022;GO:0030159;GO:0016358;GO:0035556;GO:0098887;GO:0150012;GO:0099003;, C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:membrane raft; C:neuron projection; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:beta-catenin binding; F:glucocorticoid receptor binding; F:protein C-terminus binding; F:signaling receptor complex adaptor activity;, P:dendrite development; P:intracellular signal transduction; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:positive regulation of neuron projection arborization; P:vesicle-mediated transport in synapse;|Q9C0E4 A0A087WU38 Q8TEH9 Q9H7H3,Glutamate receptor-interacting protein 2 {ECO:0000305},, PF00595;PF17820;, GO:0005829;GO:0005886;GO:0030159;GO:0098887;, C:cytosol; C:plasma membrane;, F:signaling receptor complex adaptor activity;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane;|Q9C0E4 A0A087WU38 Q8TEH9 Q9H7H3,Glutamate receptor-interacting protein 2 {ECO:0000305},, PF00595;PF17820;, GO:0005829;GO:0005886;GO:0030159;GO:0098887;, C:cytosol; C:plasma membrane;, F:signaling receptor complex adaptor activity;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane;|Q9C0E4 A0A087WU38 Q8TEH9 Q9H7H3,Glutamate receptor-interacting protein 2 {ECO:0000305},, PF00595;PF17820;, GO:0005829;GO:0005886;GO:0030159;GO:0098887;, C:cytosol; C:plasma membrane;, F:signaling receptor complex adaptor activity;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane;|Q9C0E4 A0A087WU38 Q8TEH9 Q9H7H3,Glutamate receptor-interacting protein 2 {ECO:0000305},, PF00595;PF17820;, GO:0005829;GO:0005886;GO:0030159;GO:0098887;, C:cytosol; C:plasma membrane;, F:signaling receptor complex adaptor activity;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane; scaffold73 indexed_genome mRNA 7564253 7565353 . - . ID=transcript_11593;P31641 B2RNU7 Q9BRI2 Q9BXB0,Sodium- and chloride-dependent taurine transporter,Solute carrier family 6 member 6;, PF00209;, GO:0016324;GO:0016323;GO:0030425;GO:0016021;GO:0005887;GO:0031528;GO:0043025;GO:0005886;GO:0098797;GO:0022858;GO:0015171;GO:0015185;GO:0005368;GO:0005369;GO:0032328;GO:0089718;GO:0006865;GO:0051939;GO:0098739;GO:0006836;GO:0071705;GO:0045597;GO:0010940;GO:0035725;GO:0015734;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:microvillus membrane; C:neuronal cell body; C:plasma membrane; C:plasma membrane protein complex;, F:alanine transmembrane transporter activity; F:amino acid transmembrane transporter activity; F:gamma-aminobutyric acid transmembrane transporter activity; F:taurine transmembrane transporter activity; F:taurine:sodium symporter activity;, P:alanine transport; P:amino acid import across plasma membrane; P:amino acid transport; P:gamma-aminobutyric acid import; P:import across plasma membrane; P:neurotransmitter transport; P:nitrogen compound transport; P:positive regulation of cell differentiation; P:positive regulation of necrotic cell death; P:sodium ion transmembrane transport; P:taurine transport; P:transport across blood-brain barrier; scaffold73 indexed_genome mRNA 7566415 7638280 . - . ID=transcript_11594;P31641 B2RNU7 Q9BRI2 Q9BXB0,Sodium- and chloride-dependent taurine transporter,Solute carrier family 6 member 6;, PF00209;, GO:0016324;GO:0016323;GO:0030425;GO:0016021;GO:0005887;GO:0031528;GO:0043025;GO:0005886;GO:0098797;GO:0022858;GO:0015171;GO:0015185;GO:0005368;GO:0005369;GO:0032328;GO:0089718;GO:0006865;GO:0051939;GO:0098739;GO:0006836;GO:0071705;GO:0045597;GO:0010940;GO:0035725;GO:0015734;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:microvillus membrane; C:neuronal cell body; C:plasma membrane; C:plasma membrane protein complex;, F:alanine transmembrane transporter activity; F:amino acid transmembrane transporter activity; F:gamma-aminobutyric acid transmembrane transporter activity; F:taurine transmembrane transporter activity; F:taurine:sodium symporter activity;, P:alanine transport; P:amino acid import across plasma membrane; P:amino acid transport; P:gamma-aminobutyric acid import; P:import across plasma membrane; P:neurotransmitter transport; P:nitrogen compound transport; P:positive regulation of cell differentiation; P:positive regulation of necrotic cell death; P:sodium ion transmembrane transport; P:taurine transport; P:transport across blood-brain barrier;|P31641 B2RNU7 Q9BRI2 Q9BXB0,Sodium- and chloride-dependent taurine transporter,Solute carrier family 6 member 6;, PF00209;, GO:0016324;GO:0016323;GO:0030425;GO:0016021;GO:0005887;GO:0031528;GO:0043025;GO:0005886;GO:0098797;GO:0022858;GO:0015171;GO:0015185;GO:0005368;GO:0005369;GO:0032328;GO:0089718;GO:0006865;GO:0051939;GO:0098739;GO:0006836;GO:0071705;GO:0045597;GO:0010940;GO:0035725;GO:0015734;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:microvillus membrane; C:neuronal cell body; C:plasma membrane; C:plasma membrane protein complex;, F:alanine transmembrane transporter activity; F:amino acid transmembrane transporter activity; F:gamma-aminobutyric acid transmembrane transporter activity; F:taurine transmembrane transporter activity; F:taurine:sodium symporter activity;, P:alanine transport; P:amino acid import across plasma membrane; P:amino acid transport; P:gamma-aminobutyric acid import; P:import across plasma membrane; P:neurotransmitter transport; P:nitrogen compound transport; P:positive regulation of cell differentiation; P:positive regulation of necrotic cell death; P:sodium ion transmembrane transport; P:taurine transport; P:transport across blood-brain barrier;|P31641 B2RNU7 Q9BRI2 Q9BXB0,Sodium- and chloride-dependent taurine transporter,Solute carrier family 6 member 6;, PF00209;, GO:0016324;GO:0016323;GO:0030425;GO:0016021;GO:0005887;GO:0031528;GO:0043025;GO:0005886;GO:0098797;GO:0022858;GO:0015171;GO:0015185;GO:0005368;GO:0005369;GO:0032328;GO:0089718;GO:0006865;GO:0051939;GO:0098739;GO:0006836;GO:0071705;GO:0045597;GO:0010940;GO:0035725;GO:0015734;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:microvillus membrane; C:neuronal cell body; C:plasma membrane; C:plasma membrane protein complex;, F:alanine transmembrane transporter activity; F:amino acid transmembrane transporter activity; F:gamma-aminobutyric acid transmembrane transporter activity; F:taurine transmembrane transporter activity; F:taurine:sodium symporter activity;, P:alanine transport; P:amino acid import across plasma membrane; P:amino acid transport; P:gamma-aminobutyric acid import; P:import across plasma membrane; P:neurotransmitter transport; P:nitrogen compound transport; P:positive regulation of cell differentiation; P:positive regulation of necrotic cell death; P:sodium ion transmembrane transport; P:taurine transport; P:transport across blood-brain barrier;|P31641 B2RNU7 Q9BRI2 Q9BXB0,Sodium- and chloride-dependent taurine transporter,Solute carrier family 6 member 6;, PF00209;, GO:0016324;GO:0016323;GO:0030425;GO:0016021;GO:0005887;GO:0031528;GO:0043025;GO:0005886;GO:0098797;GO:0022858;GO:0015171;GO:0015185;GO:0005368;GO:0005369;GO:0032328;GO:0089718;GO:0006865;GO:0051939;GO:0098739;GO:0006836;GO:0071705;GO:0045597;GO:0010940;GO:0035725;GO:0015734;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:microvillus membrane; C:neuronal cell body; C:plasma membrane; C:plasma membrane protein complex;, F:alanine transmembrane transporter activity; F:amino acid transmembrane transporter activity; F:gamma-aminobutyric acid transmembrane transporter activity; F:taurine transmembrane transporter activity; F:taurine:sodium symporter activity;, P:alanine transport; P:amino acid import across plasma membrane; P:amino acid transport; P:gamma-aminobutyric acid import; P:import across plasma membrane; P:neurotransmitter transport; P:nitrogen compound transport; P:positive regulation of cell differentiation; P:positive regulation of necrotic cell death; P:sodium ion transmembrane transport; P:taurine transport; P:transport across blood-brain barrier; scaffold73 indexed_genome mRNA 7817589 7824049 . - . ID=transcript_11595;P62310 Q6IAH0 Q9Y4Z1,U6 snRNA-associated Sm-like protein LSm3,, PF01423;, GO:0071013;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0000932;GO:0071011;GO:0071005;GO:0046540;GO:0005688;GO:0003723;GO:0030629;GO:0043928;GO:0006397;GO:0000398;GO:0033962;, C:catalytic step 2 spliceosome; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:P-body; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:RNA binding; F:U6 snRNA 3'-end binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA processing; P:mRNA splicing, via spliceosome; P:P-body assembly;|P62310 Q6IAH0 Q9Y4Z1,U6 snRNA-associated Sm-like protein LSm3,, PF01423;, GO:0071013;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0000932;GO:0071011;GO:0071005;GO:0046540;GO:0005688;GO:0003723;GO:0030629;GO:0043928;GO:0006397;GO:0000398;GO:0033962;, C:catalytic step 2 spliceosome; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:P-body; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:RNA binding; F:U6 snRNA 3'-end binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA processing; P:mRNA splicing, via spliceosome; P:P-body assembly; scaffold73 indexed_genome mRNA 7824067 7826073 . - . ID=transcript_11596;P62310 Q6IAH0 Q9Y4Z1,U6 snRNA-associated Sm-like protein LSm3,, PF01423;, GO:0071013;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:0000932;GO:0071011;GO:0071005;GO:0046540;GO:0005688;GO:0003723;GO:0030629;GO:0043928;GO:0006397;GO:0000398;GO:0033962;, C:catalytic step 2 spliceosome; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:P-body; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:RNA binding; F:U6 snRNA 3'-end binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA processing; P:mRNA splicing, via spliceosome; P:P-body assembly; scaffold73 indexed_genome mRNA 7831182 7840006 . + . ID=transcript_11597;Q01831 B4DIP3 E9PB96 E9PH69 Q53GT7 Q96AX0,DNA repair protein complementing XP-C cells,Xeroderma pigmentosum group C-complementing protein;p125;, PF10403;PF10404;PF10405;PF03835;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005730;GO:0005654;GO:0000109;GO:0000111;GO:0005634;GO:0005886;GO:0090734;GO:0071942;GO:0000405;GO:0003684;GO:0000404;GO:0044877;GO:0003697;GO:0003713;GO:0006281;GO:0070911;GO:0031573;GO:0006298;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0045893;GO:0000720;GO:1901990;GO:0010996;GO:0042493;GO:0010224;GO:0070914;GO:1990731;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 2 complex; C:nucleus; C:plasma membrane; C:site of DNA damage; C:XPC complex;, F:bubble DNA binding; F:damaged DNA binding; F:heteroduplex DNA loop binding; F:protein-containing complex binding; F:single-stranded DNA binding; F:transcription coactivator activity;, P:DNA repair; P:global genome nucleotide-excision repair; P:intra-S DNA damage checkpoint; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of transcription, DNA-templated; P:pyrimidine dimer repair by nucleotide-excision repair; P:regulation of mitotic cell cycle phase transition; P:response to auditory stimulus; P:response to drug; P:response to UV-B; P:UV-damage excision repair; P:UV-damage excision repair, DNA incision;|Q01831 B4DIP3 E9PB96 E9PH69 Q53GT7 Q96AX0,DNA repair protein complementing XP-C cells,Xeroderma pigmentosum group C-complementing protein;p125;, PF10403;PF10404;PF10405;PF03835;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005730;GO:0005654;GO:0000109;GO:0000111;GO:0005634;GO:0005886;GO:0090734;GO:0071942;GO:0000405;GO:0003684;GO:0000404;GO:0044877;GO:0003697;GO:0003713;GO:0006281;GO:0070911;GO:0031573;GO:0006298;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0045893;GO:0000720;GO:1901990;GO:0010996;GO:0042493;GO:0010224;GO:0070914;GO:1990731;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 2 complex; C:nucleus; C:plasma membrane; C:site of DNA damage; C:XPC complex;, F:bubble DNA binding; F:damaged DNA binding; F:heteroduplex DNA loop binding; F:protein-containing complex binding; F:single-stranded DNA binding; F:transcription coactivator activity;, P:DNA repair; P:global genome nucleotide-excision repair; P:intra-S DNA damage checkpoint; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of transcription, DNA-templated; P:pyrimidine dimer repair by nucleotide-excision repair; P:regulation of mitotic cell cycle phase transition; P:response to auditory stimulus; P:response to drug; P:response to UV-B; P:UV-damage excision repair; P:UV-damage excision repair, DNA incision; scaffold73 indexed_genome mRNA 7840039 7856978 . + . ID=transcript_11598;Q01831 B4DIP3 E9PB96 E9PH69 Q53GT7 Q96AX0,DNA repair protein complementing XP-C cells,Xeroderma pigmentosum group C-complementing protein;p125;, PF10403;PF10404;PF10405;PF03835;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005730;GO:0005654;GO:0000109;GO:0000111;GO:0005634;GO:0005886;GO:0090734;GO:0071942;GO:0000405;GO:0003684;GO:0000404;GO:0044877;GO:0003697;GO:0003713;GO:0006281;GO:0070911;GO:0031573;GO:0006298;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0045893;GO:0000720;GO:1901990;GO:0010996;GO:0042493;GO:0010224;GO:0070914;GO:1990731;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 2 complex; C:nucleus; C:plasma membrane; C:site of DNA damage; C:XPC complex;, F:bubble DNA binding; F:damaged DNA binding; F:heteroduplex DNA loop binding; F:protein-containing complex binding; F:single-stranded DNA binding; F:transcription coactivator activity;, P:DNA repair; P:global genome nucleotide-excision repair; P:intra-S DNA damage checkpoint; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of transcription, DNA-templated; P:pyrimidine dimer repair by nucleotide-excision repair; P:regulation of mitotic cell cycle phase transition; P:response to auditory stimulus; P:response to drug; P:response to UV-B; P:UV-damage excision repair; P:UV-damage excision repair, DNA incision;|Q01831 B4DIP3 E9PB96 E9PH69 Q53GT7 Q96AX0,DNA repair protein complementing XP-C cells,Xeroderma pigmentosum group C-complementing protein;p125;, PF10403;PF10404;PF10405;PF03835;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005730;GO:0005654;GO:0000109;GO:0000111;GO:0005634;GO:0005886;GO:0090734;GO:0071942;GO:0000405;GO:0003684;GO:0000404;GO:0044877;GO:0003697;GO:0003713;GO:0006281;GO:0070911;GO:0031573;GO:0006298;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0045893;GO:0000720;GO:1901990;GO:0010996;GO:0042493;GO:0010224;GO:0070914;GO:1990731;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 2 complex; C:nucleus; C:plasma membrane; C:site of DNA damage; C:XPC complex;, F:bubble DNA binding; F:damaged DNA binding; F:heteroduplex DNA loop binding; F:protein-containing complex binding; F:single-stranded DNA binding; F:transcription coactivator activity;, P:DNA repair; P:global genome nucleotide-excision repair; P:intra-S DNA damage checkpoint; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of transcription, DNA-templated; P:pyrimidine dimer repair by nucleotide-excision repair; P:regulation of mitotic cell cycle phase transition; P:response to auditory stimulus; P:response to drug; P:response to UV-B; P:UV-damage excision repair; P:UV-damage excision repair, DNA incision;|Q01831 B4DIP3 E9PB96 E9PH69 Q53GT7 Q96AX0,DNA repair protein complementing XP-C cells,Xeroderma pigmentosum group C-complementing protein;p125;, PF10403;PF10404;PF10405;PF03835;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005730;GO:0005654;GO:0000109;GO:0000111;GO:0005634;GO:0005886;GO:0090734;GO:0071942;GO:0000405;GO:0003684;GO:0000404;GO:0044877;GO:0003697;GO:0003713;GO:0006281;GO:0070911;GO:0031573;GO:0006298;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0045893;GO:0000720;GO:1901990;GO:0010996;GO:0042493;GO:0010224;GO:0070914;GO:1990731;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 2 complex; C:nucleus; C:plasma membrane; C:site of DNA damage; C:XPC complex;, F:bubble DNA binding; F:damaged DNA binding; F:heteroduplex DNA loop binding; F:protein-containing complex binding; F:single-stranded DNA binding; F:transcription coactivator activity;, P:DNA repair; P:global genome nucleotide-excision repair; P:intra-S DNA damage checkpoint; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of transcription, DNA-templated; P:pyrimidine dimer repair by nucleotide-excision repair; P:regulation of mitotic cell cycle phase transition; P:response to auditory stimulus; P:response to drug; P:response to UV-B; P:UV-damage excision repair; P:UV-damage excision repair, DNA incision;|Q01831 B4DIP3 E9PB96 E9PH69 Q53GT7 Q96AX0,DNA repair protein complementing XP-C cells,Xeroderma pigmentosum group C-complementing protein;p125;, PF10403;PF10404;PF10405;PF03835;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005730;GO:0005654;GO:0000109;GO:0000111;GO:0005634;GO:0005886;GO:0090734;GO:0071942;GO:0000405;GO:0003684;GO:0000404;GO:0044877;GO:0003697;GO:0003713;GO:0006281;GO:0070911;GO:0031573;GO:0006298;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0045893;GO:0000720;GO:1901990;GO:0010996;GO:0042493;GO:0010224;GO:0070914;GO:1990731;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 2 complex; C:nucleus; C:plasma membrane; C:site of DNA damage; C:XPC complex;, F:bubble DNA binding; F:damaged DNA binding; F:heteroduplex DNA loop binding; F:protein-containing complex binding; F:single-stranded DNA binding; F:transcription coactivator activity;, P:DNA repair; P:global genome nucleotide-excision repair; P:intra-S DNA damage checkpoint; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of transcription, DNA-templated; P:pyrimidine dimer repair by nucleotide-excision repair; P:regulation of mitotic cell cycle phase transition; P:response to auditory stimulus; P:response to drug; P:response to UV-B; P:UV-damage excision repair; P:UV-damage excision repair, DNA incision;|Q01831 B4DIP3 E9PB96 E9PH69 Q53GT7 Q96AX0,DNA repair protein complementing XP-C cells,Xeroderma pigmentosum group C-complementing protein;p125;, PF10403;PF10404;PF10405;PF03835;, GO:0005737;GO:0005829;GO:0043231;GO:0005739;GO:0005730;GO:0005654;GO:0000109;GO:0000111;GO:0005634;GO:0005886;GO:0090734;GO:0071942;GO:0000405;GO:0003684;GO:0000404;GO:0044877;GO:0003697;GO:0003713;GO:0006281;GO:0070911;GO:0031573;GO:0006298;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0045893;GO:0000720;GO:1901990;GO:0010996;GO:0042493;GO:0010224;GO:0070914;GO:1990731;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 2 complex; C:nucleus; C:plasma membrane; C:site of DNA damage; C:XPC complex;, F:bubble DNA binding; F:damaged DNA binding; F:heteroduplex DNA loop binding; F:protein-containing complex binding; F:single-stranded DNA binding; F:transcription coactivator activity;, P:DNA repair; P:global genome nucleotide-excision repair; P:intra-S DNA damage checkpoint; P:mismatch repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of transcription, DNA-templated; P:pyrimidine dimer repair by nucleotide-excision repair; P:regulation of mitotic cell cycle phase transition; P:response to auditory stimulus; P:response to drug; P:response to UV-B; P:UV-damage excision repair; P:UV-damage excision repair, DNA incision; scaffold73 indexed_genome mRNA 7856984 7873861 . - . ID=transcript_11599;Q9BTV4 Q7L4N5 Q8NC30 Q96A63 Q96F19 Q96JX0 Q9H076,Transmembrane protein 43,Protein LUMA;, PF07787;, GO:0005783;GO:0005794;GO:0005639;GO:0042802;GO:0071763;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of nuclear inner membrane;, F:identical protein binding;, P:nuclear membrane organization;|Q9BTV4 Q7L4N5 Q8NC30 Q96A63 Q96F19 Q96JX0 Q9H076,Transmembrane protein 43,Protein LUMA;, PF07787;, GO:0005783;GO:0005794;GO:0005639;GO:0042802;GO:0071763;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of nuclear inner membrane;, F:identical protein binding;, P:nuclear membrane organization;|Q9BTV4 Q7L4N5 Q8NC30 Q96A63 Q96F19 Q96JX0 Q9H076,Transmembrane protein 43,Protein LUMA;, PF07787;, GO:0005783;GO:0005794;GO:0005639;GO:0042802;GO:0071763;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of nuclear inner membrane;, F:identical protein binding;, P:nuclear membrane organization;|Q9BTV4 Q7L4N5 Q8NC30 Q96A63 Q96F19 Q96JX0 Q9H076,Transmembrane protein 43,Protein LUMA;, PF07787;, GO:0005783;GO:0005794;GO:0005639;GO:0042802;GO:0071763;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of nuclear inner membrane;, F:identical protein binding;, P:nuclear membrane organization;|Q9BTV4 Q7L4N5 Q8NC30 Q96A63 Q96F19 Q96JX0 Q9H076,Transmembrane protein 43,Protein LUMA;, PF07787;, GO:0005783;GO:0005794;GO:0005639;GO:0042802;GO:0071763;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of nuclear inner membrane;, F:identical protein binding;, P:nuclear membrane organization; scaffold73 indexed_genome mRNA 7878361 7884016 . + . ID=transcript_11600;Q8N4Q1 A8K3Z9 Q96AI2 Q96MY6,Mitochondrial intermembrane space import and assembly protein 40,Coiled-coil-helix-coiled-coil-helix domain-containing protein 4;, PF06747;, GO:0005758;GO:0005739;GO:0015035;GO:0051084;GO:0033108;GO:0018171;GO:0045041;GO:0022417;, C:mitochondrial intermembrane space; C:mitochondrion;, F:protein disulfide oxidoreductase activity;, P:'de novo' posttranslational protein folding; P:mitochondrial respiratory chain complex assembly; P:peptidyl-cysteine oxidation; P:protein import into mitochondrial intermembrane space; P:protein maturation by protein folding; scaffold73 indexed_genome mRNA 8118139 8163005 . - . ID=transcript_11601;P98095 B7Z9C5 Q8IUI0 Q8IUI1,Fibulin-2,, PF01821;PF12662;PF07645;, GO:0062023;GO:0031012;GO:0005576;GO:1903561;GO:0005509;GO:0050840;GO:0030023;GO:0005201;GO:0030198;GO:0010811;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular vesicle;, F:calcium ion binding; F:extracellular matrix binding; F:extracellular matrix constituent conferring elasticity; F:extracellular matrix structural constituent;, P:extracellular matrix organization; P:positive regulation of cell-substrate adhesion; scaffold73 indexed_genome mRNA 8210377 8220538 . - . ID=transcript_11602;Q96DB2 B4DDK1 Q9H6I7 Q9H6X3 Q9NTC9,Histone deacetylase 11,, PF00850;, GO:0000118;GO:0005634;GO:0005886;GO:0004407;GO:0032041;GO:0008134;GO:0006325;GO:0016575;GO:0014003;, C:histone deacetylase complex; C:nucleus; C:plasma membrane;, F:histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:transcription factor binding;, P:chromatin organization; P:histone deacetylation; P:oligodendrocyte development;|Q96DB2 B4DDK1 Q9H6I7 Q9H6X3 Q9NTC9,Histone deacetylase 11,, PF00850;, GO:0000118;GO:0005634;GO:0005886;GO:0004407;GO:0032041;GO:0008134;GO:0006325;GO:0016575;GO:0014003;, C:histone deacetylase complex; C:nucleus; C:plasma membrane;, F:histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:transcription factor binding;, P:chromatin organization; P:histone deacetylation; P:oligodendrocyte development;|Q96DB2 B4DDK1 Q9H6I7 Q9H6X3 Q9NTC9,Histone deacetylase 11,, PF00850;, GO:0000118;GO:0005634;GO:0005886;GO:0004407;GO:0032041;GO:0008134;GO:0006325;GO:0016575;GO:0014003;, C:histone deacetylase complex; C:nucleus; C:plasma membrane;, F:histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:transcription factor binding;, P:chromatin organization; P:histone deacetylation; P:oligodendrocyte development;|Q96DB2 B4DDK1 Q9H6I7 Q9H6X3 Q9NTC9,Histone deacetylase 11,, PF00850;, GO:0000118;GO:0005634;GO:0005886;GO:0004407;GO:0032041;GO:0008134;GO:0006325;GO:0016575;GO:0014003;, C:histone deacetylase complex; C:nucleus; C:plasma membrane;, F:histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:transcription factor binding;, P:chromatin organization; P:histone deacetylation; P:oligodendrocyte development; scaffold73 indexed_genome mRNA 8350415 8372240 . + . ID=transcript_11603;Q8TEM1 A6NN56 O94980 Q6NXG6 Q8NBJ1 Q9H6C8 Q9UFP3,Nuclear pore membrane glycoprotein 210,Nuclear envelope pore membrane protein POM 210;Nucleoporin Nup210;Pore membrane protein of 210 kDa;, PF02368;, GO:0005789;GO:0043657;GO:0016021;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0075733;GO:0006406;GO:0016925;GO:0065003;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:endoplasmic reticulum membrane; C:host cell; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, , P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:protein-containing complex assembly; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8TEM1 A6NN56 O94980 Q6NXG6 Q8NBJ1 Q9H6C8 Q9UFP3,Nuclear pore membrane glycoprotein 210,Nuclear envelope pore membrane protein POM 210;Nucleoporin Nup210;Pore membrane protein of 210 kDa;, PF02368;, GO:0005789;GO:0043657;GO:0016021;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0075733;GO:0006406;GO:0016925;GO:0065003;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:endoplasmic reticulum membrane; C:host cell; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, , P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:protein-containing complex assembly; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8TEM1 A6NN56 O94980 Q6NXG6 Q8NBJ1 Q9H6C8 Q9UFP3,Nuclear pore membrane glycoprotein 210,Nuclear envelope pore membrane protein POM 210;Nucleoporin Nup210;Pore membrane protein of 210 kDa;, PF02368;, GO:0005789;GO:0043657;GO:0016021;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0075733;GO:0006406;GO:0016925;GO:0065003;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:endoplasmic reticulum membrane; C:host cell; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, , P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:protein-containing complex assembly; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8TEM1 A6NN56 O94980 Q6NXG6 Q8NBJ1 Q9H6C8 Q9UFP3,Nuclear pore membrane glycoprotein 210,Nuclear envelope pore membrane protein POM 210;Nucleoporin Nup210;Pore membrane protein of 210 kDa;, PF02368;, GO:0005789;GO:0043657;GO:0016021;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0075733;GO:0006406;GO:0016925;GO:0065003;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:endoplasmic reticulum membrane; C:host cell; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, , P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:protein-containing complex assembly; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8TEM1 A6NN56 O94980 Q6NXG6 Q8NBJ1 Q9H6C8 Q9UFP3,Nuclear pore membrane glycoprotein 210,Nuclear envelope pore membrane protein POM 210;Nucleoporin Nup210;Pore membrane protein of 210 kDa;, PF02368;, GO:0005789;GO:0043657;GO:0016021;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0075733;GO:0006406;GO:0016925;GO:0065003;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:endoplasmic reticulum membrane; C:host cell; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, , P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:protein-containing complex assembly; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8TEM1 A6NN56 O94980 Q6NXG6 Q8NBJ1 Q9H6C8 Q9UFP3,Nuclear pore membrane glycoprotein 210,Nuclear envelope pore membrane protein POM 210;Nucleoporin Nup210;Pore membrane protein of 210 kDa;, PF02368;, GO:0005789;GO:0043657;GO:0016021;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0075733;GO:0006406;GO:0016925;GO:0065003;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:endoplasmic reticulum membrane; C:host cell; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, , P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:protein-containing complex assembly; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8TEM1 A6NN56 O94980 Q6NXG6 Q8NBJ1 Q9H6C8 Q9UFP3,Nuclear pore membrane glycoprotein 210,Nuclear envelope pore membrane protein POM 210;Nucleoporin Nup210;Pore membrane protein of 210 kDa;, PF02368;, GO:0005789;GO:0043657;GO:0016021;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0075733;GO:0006406;GO:0016925;GO:0065003;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:endoplasmic reticulum membrane; C:host cell; C:integral component of membrane; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, , P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:protein-containing complex assembly; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold74 indexed_genome mRNA 1685650 1820548 . + . ID=transcript_11604;Q8TCM1,Protein cordon-bleu,, PF09469;PF02205;, GO:0005884;GO:0030424;GO:0044295;GO:0005938;GO:0030425;GO:0044294;GO:0016020;GO:0043025;GO:0048471;GO:0005886;GO:0001726;GO:1990357;GO:0003785;GO:0051639;GO:0030041;GO:0048669;GO:0048565;GO:0000578;GO:0033504;GO:0001889;GO:0001843;GO:0030903;GO:1900006;GO:1900029;GO:0001757;, C:actin filament; C:axon; C:axonal growth cone; C:cell cortex; C:dendrite; C:dendritic growth cone; C:membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle; C:terminal web;, F:actin monomer binding;, P:actin filament network formation; P:actin filament polymerization; P:collateral sprouting in absence of injury; P:digestive tract development; P:embryonic axis specification; P:floor plate development; P:liver development; P:neural tube closure; P:notochord development; P:positive regulation of dendrite development; P:positive regulation of ruffle assembly; P:somite specification; scaffold74 indexed_genome mRNA 2279232 2320978 . + . ID=transcript_11605;Q92907 Q92948,Growth factor receptor-bound protein 10,GRB10 adapter protein;Insulin receptor-binding protein Grb-IR;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0042802;GO:0005158;GO:0007411;GO:0019221;GO:0008286;GO:0046325;GO:0045719;GO:0046627;GO:0030178;GO:0120162;GO:0042327;GO:0030949;GO:0032868;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:insulin receptor binding;, P:axon guidance; P:cytokine-mediated signaling pathway; P:insulin receptor signaling pathway; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of Wnt signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of phosphorylation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:response to insulin;|Q92907 Q92948,Growth factor receptor-bound protein 10,GRB10 adapter protein;Insulin receptor-binding protein Grb-IR;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0042802;GO:0005158;GO:0007411;GO:0019221;GO:0008286;GO:0046325;GO:0045719;GO:0046627;GO:0030178;GO:0120162;GO:0042327;GO:0030949;GO:0032868;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:insulin receptor binding;, P:axon guidance; P:cytokine-mediated signaling pathway; P:insulin receptor signaling pathway; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of Wnt signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of phosphorylation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:response to insulin;|Q92907 Q92948,Growth factor receptor-bound protein 10,GRB10 adapter protein;Insulin receptor-binding protein Grb-IR;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0042802;GO:0005158;GO:0007411;GO:0019221;GO:0008286;GO:0046325;GO:0045719;GO:0046627;GO:0030178;GO:0120162;GO:0042327;GO:0030949;GO:0032868;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:insulin receptor binding;, P:axon guidance; P:cytokine-mediated signaling pathway; P:insulin receptor signaling pathway; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of Wnt signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of phosphorylation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:response to insulin;|Q92907 Q92948,Growth factor receptor-bound protein 10,GRB10 adapter protein;Insulin receptor-binding protein Grb-IR;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0042802;GO:0005158;GO:0007411;GO:0019221;GO:0008286;GO:0046325;GO:0045719;GO:0046627;GO:0030178;GO:0120162;GO:0042327;GO:0030949;GO:0032868;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:insulin receptor binding;, P:axon guidance; P:cytokine-mediated signaling pathway; P:insulin receptor signaling pathway; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of Wnt signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of phosphorylation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:response to insulin;|Q92907 Q92948,Growth factor receptor-bound protein 10,GRB10 adapter protein;Insulin receptor-binding protein Grb-IR;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0042802;GO:0005158;GO:0007411;GO:0019221;GO:0008286;GO:0046325;GO:0045719;GO:0046627;GO:0030178;GO:0120162;GO:0042327;GO:0030949;GO:0032868;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:insulin receptor binding;, P:axon guidance; P:cytokine-mediated signaling pathway; P:insulin receptor signaling pathway; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of Wnt signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of phosphorylation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:response to insulin;|Q92907 Q92948,Growth factor receptor-bound protein 10,GRB10 adapter protein;Insulin receptor-binding protein Grb-IR;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0042802;GO:0005158;GO:0007411;GO:0019221;GO:0008286;GO:0046325;GO:0045719;GO:0046627;GO:0030178;GO:0120162;GO:0042327;GO:0030949;GO:0032868;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:insulin receptor binding;, P:axon guidance; P:cytokine-mediated signaling pathway; P:insulin receptor signaling pathway; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of Wnt signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of phosphorylation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:response to insulin;|Q92907 Q92948,Growth factor receptor-bound protein 10,GRB10 adapter protein;Insulin receptor-binding protein Grb-IR;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0042802;GO:0005158;GO:0007411;GO:0019221;GO:0008286;GO:0046325;GO:0045719;GO:0046627;GO:0030178;GO:0120162;GO:0042327;GO:0030949;GO:0032868;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:insulin receptor binding;, P:axon guidance; P:cytokine-mediated signaling pathway; P:insulin receptor signaling pathway; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of Wnt signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of phosphorylation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:response to insulin;|Q92907 Q92948,Growth factor receptor-bound protein 10,GRB10 adapter protein;Insulin receptor-binding protein Grb-IR;, PF08947;PF00169;PF00788;PF00017;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0042802;GO:0005158;GO:0007411;GO:0019221;GO:0008286;GO:0046325;GO:0045719;GO:0046627;GO:0030178;GO:0120162;GO:0042327;GO:0030949;GO:0032868;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:insulin receptor binding;, P:axon guidance; P:cytokine-mediated signaling pathway; P:insulin receptor signaling pathway; P:negative regulation of glucose import; P:negative regulation of glycogen biosynthetic process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of Wnt signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of phosphorylation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:response to insulin; scaffold74 indexed_genome mRNA 2347658 2415392 . + . ID=transcript_11606;P20711 C9IYA0 E7ER62 E7EU95 Q16723 Q5W5T9 Q75MJ6,Aromatic-L-amino-acid decarboxylase,DOPA decarboxylase;, PF00282;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0043025;GO:0008021;GO:0036467;GO:0016597;GO:0004058;GO:0016831;GO:0019899;GO:0036468;GO:0019904;GO:0030170;GO:0015842;GO:0042423;GO:0006584;GO:0006520;GO:0071312;GO:0035690;GO:0071363;GO:0007623;GO:0042416;GO:0046219;GO:0033076;GO:0010259;GO:0052314;GO:0046684;GO:0042427;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuronal cell body; C:synaptic vesicle;, F:5-hydroxy-L-tryptophan decarboxylase activity; F:amino acid binding; F:aromatic-L-amino-acid decarboxylase activity; F:carboxy-lyase activity; F:enzyme binding; F:L-dopa decarboxylase activity; F:protein domain specific binding; F:pyridoxal phosphate binding;, P:aminergic neurotransmitter loading into synaptic vesicle; P:catecholamine biosynthetic process; P:catecholamine metabolic process; P:cellular amino acid metabolic process; P:cellular response to alkaloid; P:cellular response to drug; P:cellular response to growth factor stimulus; P:circadian rhythm; P:dopamine biosynthetic process; P:indolalkylamine biosynthetic process; P:isoquinoline alkaloid metabolic process; P:multicellular organism aging; P:phytoalexin metabolic process; P:response to pyrethroid; P:serotonin biosynthetic process; scaffold74 indexed_genome mRNA 2427862 2430435 . - . ID=transcript_11607;Q6PIW4 D3DVM6 Q86V18 Q8ND59 Q9H8P1 Q9H917,Fidgetin-like protein 1,, PF00004;PF09336;, GO:0005737;GO:0070062;GO:0000228;GO:0005634;GO:0048471;GO:0005524;GO:0016887;GO:0016787;GO:0000287;GO:0008568;GO:0046034;GO:0071479;GO:0031122;GO:0007140;GO:0043066;GO:2001243;GO:0001649;GO:0033687;GO:0051726;GO:0010569;, C:cytoplasm; C:extracellular exosome; C:nuclear chromosome; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:hydrolase activity; F:magnesium ion binding; F:microtubule-severing ATPase activity;, P:ATP metabolic process; P:cellular response to ionizing radiation; P:cytoplasmic microtubule organization; P:male meiotic nuclear division; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway; P:osteoblast differentiation; P:osteoblast proliferation; P:regulation of cell cycle; P:regulation of double-strand break repair via homologous recombination; scaffold74 indexed_genome mRNA 2470738 2471376 . + . ID=transcript_11608;Q13422 A4D260 B4E0Z1 D3DVM5 O00598 Q53XL2 Q69BM4 Q8WVA3,DNA-binding protein Ikaros,Ikaros family zinc finger protein 1;Lymphoid transcription factor LyF-1;, PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0005721;GO:0032991;GO:0003677;GO:0003700;GO:0042802;GO:0046872;GO:0019904;GO:0000978;GO:0007049;GO:0006325;GO:0030218;GO:0030098;GO:0007498;GO:0045892;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:protein-containing complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:identical protein binding; F:metal ion binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle; P:chromatin organization; P:erythrocyte differentiation; P:lymphocyte differentiation; P:mesoderm development; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold74 indexed_genome mRNA 2471387 2489225 . - . ID=transcript_11609;Q13422 A4D260 B4E0Z1 D3DVM5 O00598 Q53XL2 Q69BM4 Q8WVA3,DNA-binding protein Ikaros,Ikaros family zinc finger protein 1;Lymphoid transcription factor LyF-1;, PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0005721;GO:0032991;GO:0003677;GO:0003700;GO:0042802;GO:0046872;GO:0019904;GO:0000978;GO:0007049;GO:0006325;GO:0030218;GO:0030098;GO:0007498;GO:0045892;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:protein-containing complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:identical protein binding; F:metal ion binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle; P:chromatin organization; P:erythrocyte differentiation; P:lymphocyte differentiation; P:mesoderm development; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold74 indexed_genome mRNA 2495110 2566647 . - . ID=transcript_11610;Q13422 A4D260 B4E0Z1 D3DVM5 O00598 Q53XL2 Q69BM4 Q8WVA3,DNA-binding protein Ikaros,Ikaros family zinc finger protein 1;Lymphoid transcription factor LyF-1;, PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0005721;GO:0032991;GO:0003677;GO:0003700;GO:0042802;GO:0046872;GO:0019904;GO:0000978;GO:0007049;GO:0006325;GO:0030218;GO:0030098;GO:0007498;GO:0045892;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:protein-containing complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:identical protein binding; F:metal ion binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle; P:chromatin organization; P:erythrocyte differentiation; P:lymphocyte differentiation; P:mesoderm development; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold74 indexed_genome mRNA 2770991 2879209 . + . ID=transcript_11611;Q9BS86 A4D253 C9JPU1 Q15941 Q75KX9 Q75MI3,Zona pellucida-binding protein 1,Inner acrosomal membrane IAM38 {ECO:0000250|UniProtKB:Q62522};Sp38;, PF07354;, GO:0002080;GO:0001669;GO:0005576;GO:0005634;GO:0002199;GO:0001675;GO:0007339;, C:acrosomal membrane; C:acrosomal vesicle; C:extracellular region; C:nucleus; C:zona pellucida receptor complex;, , P:acrosome assembly; P:binding of sperm to zona pellucida; scaffold74 indexed_genome mRNA 2907520 2908574 . + . ID=transcript_11612;Q2TAL6 Q6UXE2,Brorin,Brain-specific chordin-like protein;von Willebrand factor C domain-containing protein 2;, PF00093;, GO:0032281;GO:0005604;GO:0005615;GO:0005614;GO:0045202;GO:0030514;GO:0010811;GO:0045666;, C:AMPA glutamate receptor complex; C:basement membrane; C:extracellular space; C:interstitial matrix; C:synapse;, , P:negative regulation of BMP signaling pathway; P:positive regulation of cell-substrate adhesion; P:positive regulation of neuron differentiation; scaffold74 indexed_genome mRNA 4410670 4435403 . - . ID=transcript_11613;Q16831 D3DVM4 Q15362,Uridine phosphorylase 1,, PF01048;, GO:0005829;GO:0005654;GO:0047847;GO:0042802;GO:0009032;GO:0004850;GO:0042149;GO:0006248;GO:0006249;GO:0046074;GO:0046079;GO:0006139;GO:0046135;GO:0043097;GO:0046050;GO:0044206;GO:0006218;, C:cytosol; C:nucleoplasm;, F:deoxyuridine phosphorylase activity; F:identical protein binding; F:thymidine phosphorylase activity; F:uridine phosphorylase activity;, P:cellular response to glucose starvation; P:CMP catabolic process; P:dCMP catabolic process; P:dTMP catabolic process; P:dUMP catabolic process; P:nucleobase-containing compound metabolic process; P:pyrimidine nucleoside catabolic process; P:pyrimidine nucleoside salvage; P:UMP catabolic process; P:UMP salvage; P:uridine catabolic process; scaffold74 indexed_genome mRNA 4453068 4474464 . - . ID=transcript_11614;Q8NEG2 C9JBJ8,Uncharacterized protein C7orf57,, PF17662; scaffold74 indexed_genome mRNA 4535936 4619294 . + . ID=transcript_11615;P0DTF9,PTTG1IP family member 2 {ECO:0000305},, , GO:0016021;, C:integral component of membrane;|P56749 D6W5Q4 Q7LDZ0,Claudin-12,, , GO:0005923;GO:0016021;GO:0016328;GO:0005886;GO:0042802;GO:0016338;GO:0035633;, C:bicellular tight junction; C:integral component of membrane; C:lateral plasma membrane; C:plasma membrane;, F:identical protein binding;, P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:maintenance of blood-brain barrier; scaffold74 indexed_genome mRNA 4690168 5354597 . + . ID=transcript_11616;Q9H3D7 Q9UDR0,Cyclin-dependent kinase 14,Cell division protein kinase 14;Serine/threonine-protein kinase PFTAIRE-1;, PF00069;, GO:0005737;GO:0000308;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0030332;GO:0004693;GO:0106310;GO:0106311;GO:0051301;GO:0000086;GO:0006468;GO:0060828;GO:0000083;GO:0016055;, C:cytoplasm; C:cytoplasmic cyclin-dependent protein kinase holoenzyme complex; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:G2/M transition of mitotic cell cycle; P:protein phosphorylation; P:regulation of canonical Wnt signaling pathway; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:Wnt signaling pathway; scaffold74 indexed_genome mRNA 5400007 5412227 . - . ID=transcript_11617;Q9UP38 A4D1E8 O94815 Q549T8,Frizzled-1,FzE1;, PF01534;PF01392;, GO:0009986;GO:0005925;GO:0016021;GO:0005886;GO:1990909;GO:0005109;GO:0004930;GO:0030165;GO:0005102;GO:0042813;GO:0017147;GO:0035425;GO:1904886;GO:0060070;GO:0044338;GO:0044339;GO:0007267;GO:0030182;GO:0051091;GO:0010976;GO:0045893;GO:0099054;GO:0042493;GO:1904953;GO:0060071;, C:cell surface; C:focal adhesion; C:integral component of membrane; C:plasma membrane; C:Wnt signalosome;, F:frizzled binding; F:G protein-coupled receptor activity; F:PDZ domain binding; F:signaling receptor binding; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:autocrine signaling; P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation; P:canonical Wnt signaling pathway involved in osteoblast differentiation; P:cell-cell signaling; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of transcription, DNA-templated; P:presynapse assembly; P:response to drug; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:Wnt signaling pathway, planar cell polarity pathway;|Q9UP38 A4D1E8 O94815 Q549T8,Frizzled-1,FzE1;, PF01534;PF01392;, GO:0009986;GO:0005925;GO:0016021;GO:0005886;GO:1990909;GO:0005109;GO:0004930;GO:0030165;GO:0005102;GO:0042813;GO:0017147;GO:0035425;GO:1904886;GO:0060070;GO:0044338;GO:0044339;GO:0007267;GO:0030182;GO:0051091;GO:0010976;GO:0045893;GO:0099054;GO:0042493;GO:1904953;GO:0060071;, C:cell surface; C:focal adhesion; C:integral component of membrane; C:plasma membrane; C:Wnt signalosome;, F:frizzled binding; F:G protein-coupled receptor activity; F:PDZ domain binding; F:signaling receptor binding; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:autocrine signaling; P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation; P:canonical Wnt signaling pathway involved in osteoblast differentiation; P:cell-cell signaling; P:neuron differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of transcription, DNA-templated; P:presynapse assembly; P:response to drug; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; P:Wnt signaling pathway, planar cell polarity pathway; scaffold74 indexed_genome mRNA 5528175 5575727 . - . ID=transcript_11618;Q9UEU0 O43547 Q96J28,Vesicle transport through interaction with t-SNAREs homolog 1B,Vesicle transport v-SNARE protein Vti1-like 1;Vti1-rp1;, PF05008;, GO:0005829;GO:0031901;GO:0005789;GO:0012507;GO:0005576;GO:0005794;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0043025;GO:0048471;GO:0031093;GO:0055037;GO:0055038;GO:0031201;GO:0008021;GO:0031982;GO:0019869;GO:0005484;GO:0000149;GO:0006888;GO:0006896;GO:0006891;GO:0061025;GO:0002576;GO:0006623;GO:1903076;GO:0042147;GO:0006904;GO:0048280;GO:0016192;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:extracellular region; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:recycling endosome; C:recycling endosome membrane; C:SNARE complex; C:synaptic vesicle; C:vesicle;, F:chloride channel inhibitor activity; F:SNAP receptor activity; F:SNARE binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi to vacuole transport; P:intra-Golgi vesicle-mediated transport; P:membrane fusion; P:platelet degranulation; P:protein targeting to vacuole; P:regulation of protein localization to plasma membrane; P:retrograde transport, endosome to Golgi; P:vesicle docking involved in exocytosis; P:vesicle fusion with Golgi apparatus; P:vesicle-mediated transport; scaffold74 indexed_genome mRNA 5907931 5915197 . - . ID=transcript_11619;Q99551 A4D1E3 Q32NF8 Q53H51 Q9BVR7,Transcription termination factor 1, mitochondrial,Mitochondrial transcription termination factor 1;, PF02536;, GO:0005759;GO:0042645;GO:0005739;GO:0003690;GO:0003676;GO:0003723;GO:0032392;GO:0006353;GO:0007005;GO:0006355;GO:0006393;, C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion;, F:double-stranded DNA binding; F:nucleic acid binding; F:RNA binding;, P:DNA geometric change; P:DNA-templated transcription, termination; P:mitochondrion organization; P:regulation of transcription, DNA-templated; P:termination of mitochondrial transcription; scaffold74 indexed_genome mRNA 6018386 6105801 . + . ID=transcript_11620;Q9UQQ4 Q9Y6B8 Q9Y6Y2,A-kinase anchor protein 9,A-kinase anchor protein 350 kDa;A-kinase anchor protein 450 kDa;AKAP 120-like protein;Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};Protein hyperion {ECO:0000303|Ref.4};Protein kinase A-anchoring protein 9;Protein yotiao {ECO:0000303|PubMed:9482789};, PF10495;, GO:0005813;GO:0005801;GO:0005856;GO:0005829;GO:0098978;GO:0005794;GO:0005795;GO:0043231;GO:0097060;GO:0008076;GO:0003677;GO:0044325;GO:0060090;GO:0015459;GO:0034237;GO:0005102;GO:0061337;GO:0071320;GO:0007268;GO:0097711;GO:0000086;GO:0051661;GO:0007020;GO:0031116;GO:0033138;GO:1901018;GO:0098909;GO:0010389;GO:1903358;GO:0086091;GO:0060306;GO:0098962;GO:0060307;GO:0007165;, C:centrosome; C:cis-Golgi network; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi stack; C:intracellular membrane-bounded organelle; C:synaptic membrane; C:voltage-gated potassium channel complex;, F:DNA binding; F:ion channel binding; F:molecular adaptor activity; F:potassium channel regulator activity; F:protein kinase A regulatory subunit binding; F:signaling receptor binding;, P:cardiac conduction; P:cellular response to cAMP; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:maintenance of centrosome location; P:microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of potassium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of Golgi organization; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:signal transduction;|Q9UQQ4 Q9Y6B8 Q9Y6Y2,A-kinase anchor protein 9,A-kinase anchor protein 350 kDa;A-kinase anchor protein 450 kDa;AKAP 120-like protein;Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};Protein hyperion {ECO:0000303|Ref.4};Protein kinase A-anchoring protein 9;Protein yotiao {ECO:0000303|PubMed:9482789};, PF10495;, GO:0005813;GO:0005801;GO:0005856;GO:0005829;GO:0098978;GO:0005794;GO:0005795;GO:0043231;GO:0097060;GO:0008076;GO:0003677;GO:0044325;GO:0060090;GO:0015459;GO:0034237;GO:0005102;GO:0061337;GO:0071320;GO:0007268;GO:0097711;GO:0000086;GO:0051661;GO:0007020;GO:0031116;GO:0033138;GO:1901018;GO:0098909;GO:0010389;GO:1903358;GO:0086091;GO:0060306;GO:0098962;GO:0060307;GO:0007165;, C:centrosome; C:cis-Golgi network; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi stack; C:intracellular membrane-bounded organelle; C:synaptic membrane; C:voltage-gated potassium channel complex;, F:DNA binding; F:ion channel binding; F:molecular adaptor activity; F:potassium channel regulator activity; F:protein kinase A regulatory subunit binding; F:signaling receptor binding;, P:cardiac conduction; P:cellular response to cAMP; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:maintenance of centrosome location; P:microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of potassium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of Golgi organization; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:signal transduction;|Q9UQQ4 Q9Y6B8 Q9Y6Y2,A-kinase anchor protein 9,A-kinase anchor protein 350 kDa;A-kinase anchor protein 450 kDa;AKAP 120-like protein;Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};Protein hyperion {ECO:0000303|Ref.4};Protein kinase A-anchoring protein 9;Protein yotiao {ECO:0000303|PubMed:9482789};, PF10495;, GO:0005813;GO:0005801;GO:0005856;GO:0005829;GO:0098978;GO:0005794;GO:0005795;GO:0043231;GO:0097060;GO:0008076;GO:0003677;GO:0044325;GO:0060090;GO:0015459;GO:0034237;GO:0005102;GO:0061337;GO:0071320;GO:0007268;GO:0097711;GO:0000086;GO:0051661;GO:0007020;GO:0031116;GO:0033138;GO:1901018;GO:0098909;GO:0010389;GO:1903358;GO:0086091;GO:0060306;GO:0098962;GO:0060307;GO:0007165;, C:centrosome; C:cis-Golgi network; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi stack; C:intracellular membrane-bounded organelle; C:synaptic membrane; C:voltage-gated potassium channel complex;, F:DNA binding; F:ion channel binding; F:molecular adaptor activity; F:potassium channel regulator activity; F:protein kinase A regulatory subunit binding; F:signaling receptor binding;, P:cardiac conduction; P:cellular response to cAMP; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:maintenance of centrosome location; P:microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of potassium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of Golgi organization; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:signal transduction;|Q9UQQ4 Q9Y6B8 Q9Y6Y2,A-kinase anchor protein 9,A-kinase anchor protein 350 kDa;A-kinase anchor protein 450 kDa;AKAP 120-like protein;Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};Protein hyperion {ECO:0000303|Ref.4};Protein kinase A-anchoring protein 9;Protein yotiao {ECO:0000303|PubMed:9482789};, PF10495;, GO:0005813;GO:0005801;GO:0005856;GO:0005829;GO:0098978;GO:0005794;GO:0005795;GO:0043231;GO:0097060;GO:0008076;GO:0003677;GO:0044325;GO:0060090;GO:0015459;GO:0034237;GO:0005102;GO:0061337;GO:0071320;GO:0007268;GO:0097711;GO:0000086;GO:0051661;GO:0007020;GO:0031116;GO:0033138;GO:1901018;GO:0098909;GO:0010389;GO:1903358;GO:0086091;GO:0060306;GO:0098962;GO:0060307;GO:0007165;, C:centrosome; C:cis-Golgi network; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi stack; C:intracellular membrane-bounded organelle; C:synaptic membrane; C:voltage-gated potassium channel complex;, F:DNA binding; F:ion channel binding; F:molecular adaptor activity; F:potassium channel regulator activity; F:protein kinase A regulatory subunit binding; F:signaling receptor binding;, P:cardiac conduction; P:cellular response to cAMP; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:maintenance of centrosome location; P:microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of potassium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of Golgi organization; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:signal transduction;|Q9UQQ4 Q9Y6B8 Q9Y6Y2,A-kinase anchor protein 9,A-kinase anchor protein 350 kDa;A-kinase anchor protein 450 kDa;AKAP 120-like protein;Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};Protein hyperion {ECO:0000303|Ref.4};Protein kinase A-anchoring protein 9;Protein yotiao {ECO:0000303|PubMed:9482789};, PF10495;, GO:0005813;GO:0005801;GO:0005856;GO:0005829;GO:0098978;GO:0005794;GO:0005795;GO:0043231;GO:0097060;GO:0008076;GO:0003677;GO:0044325;GO:0060090;GO:0015459;GO:0034237;GO:0005102;GO:0061337;GO:0071320;GO:0007268;GO:0097711;GO:0000086;GO:0051661;GO:0007020;GO:0031116;GO:0033138;GO:1901018;GO:0098909;GO:0010389;GO:1903358;GO:0086091;GO:0060306;GO:0098962;GO:0060307;GO:0007165;, C:centrosome; C:cis-Golgi network; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi stack; C:intracellular membrane-bounded organelle; C:synaptic membrane; C:voltage-gated potassium channel complex;, F:DNA binding; F:ion channel binding; F:molecular adaptor activity; F:potassium channel regulator activity; F:protein kinase A regulatory subunit binding; F:signaling receptor binding;, P:cardiac conduction; P:cellular response to cAMP; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:maintenance of centrosome location; P:microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of potassium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of Golgi organization; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:signal transduction;|Q9UQQ4 Q9Y6B8 Q9Y6Y2,A-kinase anchor protein 9,A-kinase anchor protein 350 kDa;A-kinase anchor protein 450 kDa;AKAP 120-like protein;Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};Protein hyperion {ECO:0000303|Ref.4};Protein kinase A-anchoring protein 9;Protein yotiao {ECO:0000303|PubMed:9482789};, PF10495;, GO:0005813;GO:0005801;GO:0005856;GO:0005829;GO:0098978;GO:0005794;GO:0005795;GO:0043231;GO:0097060;GO:0008076;GO:0003677;GO:0044325;GO:0060090;GO:0015459;GO:0034237;GO:0005102;GO:0061337;GO:0071320;GO:0007268;GO:0097711;GO:0000086;GO:0051661;GO:0007020;GO:0031116;GO:0033138;GO:1901018;GO:0098909;GO:0010389;GO:1903358;GO:0086091;GO:0060306;GO:0098962;GO:0060307;GO:0007165;, C:centrosome; C:cis-Golgi network; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi stack; C:intracellular membrane-bounded organelle; C:synaptic membrane; C:voltage-gated potassium channel complex;, F:DNA binding; F:ion channel binding; F:molecular adaptor activity; F:potassium channel regulator activity; F:protein kinase A regulatory subunit binding; F:signaling receptor binding;, P:cardiac conduction; P:cellular response to cAMP; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:maintenance of centrosome location; P:microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of potassium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of Golgi organization; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:signal transduction;|Q9UQQ4 Q9Y6B8 Q9Y6Y2,A-kinase anchor protein 9,A-kinase anchor protein 350 kDa;A-kinase anchor protein 450 kDa;AKAP 120-like protein;Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};Protein hyperion {ECO:0000303|Ref.4};Protein kinase A-anchoring protein 9;Protein yotiao {ECO:0000303|PubMed:9482789};, PF10495;, GO:0005813;GO:0005801;GO:0005856;GO:0005829;GO:0098978;GO:0005794;GO:0005795;GO:0043231;GO:0097060;GO:0008076;GO:0003677;GO:0044325;GO:0060090;GO:0015459;GO:0034237;GO:0005102;GO:0061337;GO:0071320;GO:0007268;GO:0097711;GO:0000086;GO:0051661;GO:0007020;GO:0031116;GO:0033138;GO:1901018;GO:0098909;GO:0010389;GO:1903358;GO:0086091;GO:0060306;GO:0098962;GO:0060307;GO:0007165;, C:centrosome; C:cis-Golgi network; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi stack; C:intracellular membrane-bounded organelle; C:synaptic membrane; C:voltage-gated potassium channel complex;, F:DNA binding; F:ion channel binding; F:molecular adaptor activity; F:potassium channel regulator activity; F:protein kinase A regulatory subunit binding; F:signaling receptor binding;, P:cardiac conduction; P:cellular response to cAMP; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:maintenance of centrosome location; P:microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of potassium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of Golgi organization; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:signal transduction;|Q9UQQ4 Q9Y6B8 Q9Y6Y2,A-kinase anchor protein 9,A-kinase anchor protein 350 kDa;A-kinase anchor protein 450 kDa;AKAP 120-like protein;Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};Protein hyperion {ECO:0000303|Ref.4};Protein kinase A-anchoring protein 9;Protein yotiao {ECO:0000303|PubMed:9482789};, PF10495;, GO:0005813;GO:0005801;GO:0005856;GO:0005829;GO:0098978;GO:0005794;GO:0005795;GO:0043231;GO:0097060;GO:0008076;GO:0003677;GO:0044325;GO:0060090;GO:0015459;GO:0034237;GO:0005102;GO:0061337;GO:0071320;GO:0007268;GO:0097711;GO:0000086;GO:0051661;GO:0007020;GO:0031116;GO:0033138;GO:1901018;GO:0098909;GO:0010389;GO:1903358;GO:0086091;GO:0060306;GO:0098962;GO:0060307;GO:0007165;, C:centrosome; C:cis-Golgi network; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi stack; C:intracellular membrane-bounded organelle; C:synaptic membrane; C:voltage-gated potassium channel complex;, F:DNA binding; F:ion channel binding; F:molecular adaptor activity; F:potassium channel regulator activity; F:protein kinase A regulatory subunit binding; F:signaling receptor binding;, P:cardiac conduction; P:cellular response to cAMP; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:maintenance of centrosome location; P:microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of potassium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of Golgi organization; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:signal transduction;|Q9UQQ4 Q9Y6B8 Q9Y6Y2,A-kinase anchor protein 9,A-kinase anchor protein 350 kDa;A-kinase anchor protein 450 kDa;AKAP 120-like protein;Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};Protein hyperion {ECO:0000303|Ref.4};Protein kinase A-anchoring protein 9;Protein yotiao {ECO:0000303|PubMed:9482789};, PF10495;, GO:0005813;GO:0005801;GO:0005856;GO:0005829;GO:0098978;GO:0005794;GO:0005795;GO:0043231;GO:0097060;GO:0008076;GO:0003677;GO:0044325;GO:0060090;GO:0015459;GO:0034237;GO:0005102;GO:0061337;GO:0071320;GO:0007268;GO:0097711;GO:0000086;GO:0051661;GO:0007020;GO:0031116;GO:0033138;GO:1901018;GO:0098909;GO:0010389;GO:1903358;GO:0086091;GO:0060306;GO:0098962;GO:0060307;GO:0007165;, C:centrosome; C:cis-Golgi network; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi stack; C:intracellular membrane-bounded organelle; C:synaptic membrane; C:voltage-gated potassium channel complex;, F:DNA binding; F:ion channel binding; F:molecular adaptor activity; F:potassium channel regulator activity; F:protein kinase A regulatory subunit binding; F:signaling receptor binding;, P:cardiac conduction; P:cellular response to cAMP; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:maintenance of centrosome location; P:microtubule nucleation; P:positive regulation of microtubule polymerization; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of potassium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of Golgi organization; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization; P:regulation of postsynaptic neurotransmitter receptor activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:signal transduction;|Q16850 A4D1F8 B2RAI4 B4DJ55 O00770 O00772 Q16784 Q8N1A8 Q99868,Lanosterol 14-alpha demethylase,CYPLI;Cytochrome P450 51A1;Cytochrome P450-14DM;Cytochrome P450LI;Sterol 14-alpha demethylase;, PF00067;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0008398;GO:0006695;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0006694;GO:0016125;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:sterol 14-demethylase activity;, P:cholesterol biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:steroid biosynthetic process; P:sterol metabolic process;|Q16850 A4D1F8 B2RAI4 B4DJ55 O00770 O00772 Q16784 Q8N1A8 Q99868,Lanosterol 14-alpha demethylase,CYPLI;Cytochrome P450 51A1;Cytochrome P450-14DM;Cytochrome P450LI;Sterol 14-alpha demethylase;, PF00067;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0008398;GO:0006695;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0006694;GO:0016125;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:sterol 14-demethylase activity;, P:cholesterol biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:steroid biosynthetic process; P:sterol metabolic process;|Q16850 A4D1F8 B2RAI4 B4DJ55 O00770 O00772 Q16784 Q8N1A8 Q99868,Lanosterol 14-alpha demethylase,CYPLI;Cytochrome P450 51A1;Cytochrome P450-14DM;Cytochrome P450LI;Sterol 14-alpha demethylase;, PF00067;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0008398;GO:0006695;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0006694;GO:0016125;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:sterol 14-demethylase activity;, P:cholesterol biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:steroid biosynthetic process; P:sterol metabolic process;|Q16850 A4D1F8 B2RAI4 B4DJ55 O00770 O00772 Q16784 Q8N1A8 Q99868,Lanosterol 14-alpha demethylase,CYPLI;Cytochrome P450 51A1;Cytochrome P450-14DM;Cytochrome P450LI;Sterol 14-alpha demethylase;, PF00067;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0008398;GO:0006695;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0006694;GO:0016125;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:sterol 14-demethylase activity;, P:cholesterol biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:steroid biosynthetic process; P:sterol metabolic process;|Q16850 A4D1F8 B2RAI4 B4DJ55 O00770 O00772 Q16784 Q8N1A8 Q99868,Lanosterol 14-alpha demethylase,CYPLI;Cytochrome P450 51A1;Cytochrome P450-14DM;Cytochrome P450LI;Sterol 14-alpha demethylase;, PF00067;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0008398;GO:0006695;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0006694;GO:0016125;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:sterol 14-demethylase activity;, P:cholesterol biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:steroid biosynthetic process; P:sterol metabolic process; scaffold74 indexed_genome mRNA 6106646 6109601 . - . ID=transcript_11621;Q16850 A4D1F8 B2RAI4 B4DJ55 O00770 O00772 Q16784 Q8N1A8 Q99868,Lanosterol 14-alpha demethylase,CYPLI;Cytochrome P450 51A1;Cytochrome P450-14DM;Cytochrome P450LI;Sterol 14-alpha demethylase;, PF00067;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0008398;GO:0006695;GO:1900222;GO:0042177;GO:0050709;GO:0007399;GO:0019216;GO:0006694;GO:0016125;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:sterol 14-demethylase activity;, P:cholesterol biosynthetic process; P:negative regulation of amyloid-beta clearance; P:negative regulation of protein catabolic process; P:negative regulation of protein secretion; P:nervous system development; P:regulation of lipid metabolic process; P:steroid biosynthetic process; P:sterol metabolic process; scaffold74 indexed_genome mRNA 6118492 6122207 . - . ID=transcript_11622;A4D1F6 B7ZMM9 Q49AT9,Leucine-rich repeat and death domain-containing protein 1,, PF00560;PF13855;, GO:0046579;GO:0007165;, , , P:positive regulation of Ras protein signal transduction; P:signal transduction; scaffold74 indexed_genome mRNA 6157283 6197202 . - . ID=transcript_11623;O00522 A6NNU0 O43894 Q506L6 Q6U276 Q75N19 Q9H180 Q9H264 Q9HAX5,Krev interaction trapped protein 1,Cerebral cavernous malformations 1 protein;, PF00373;PF16705;, GO:0005911;GO:0005737;GO:0005856;GO:0005615;GO:0005886;GO:0030695;GO:0008017;GO:0005546;GO:0001525;GO:0045454;GO:0016525;GO:2000352;GO:0010596;GO:0001937;GO:2000114;GO:0007264;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:plasma membrane;, F:GTPase regulator activity; F:microtubule binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:angiogenesis; P:cell redox homeostasis; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:regulation of establishment of cell polarity; P:small GTPase mediated signal transduction;|O00522 A6NNU0 O43894 Q506L6 Q6U276 Q75N19 Q9H180 Q9H264 Q9HAX5,Krev interaction trapped protein 1,Cerebral cavernous malformations 1 protein;, PF00373;PF16705;, GO:0005911;GO:0005737;GO:0005856;GO:0005615;GO:0005886;GO:0030695;GO:0008017;GO:0005546;GO:0001525;GO:0045454;GO:0016525;GO:2000352;GO:0010596;GO:0001937;GO:2000114;GO:0007264;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:plasma membrane;, F:GTPase regulator activity; F:microtubule binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:angiogenesis; P:cell redox homeostasis; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:regulation of establishment of cell polarity; P:small GTPase mediated signal transduction;|O00522 A6NNU0 O43894 Q506L6 Q6U276 Q75N19 Q9H180 Q9H264 Q9HAX5,Krev interaction trapped protein 1,Cerebral cavernous malformations 1 protein;, PF00373;PF16705;, GO:0005911;GO:0005737;GO:0005856;GO:0005615;GO:0005886;GO:0030695;GO:0008017;GO:0005546;GO:0001525;GO:0045454;GO:0016525;GO:2000352;GO:0010596;GO:0001937;GO:2000114;GO:0007264;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:plasma membrane;, F:GTPase regulator activity; F:microtubule binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:angiogenesis; P:cell redox homeostasis; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:regulation of establishment of cell polarity; P:small GTPase mediated signal transduction;|O00522 A6NNU0 O43894 Q506L6 Q6U276 Q75N19 Q9H180 Q9H264 Q9HAX5,Krev interaction trapped protein 1,Cerebral cavernous malformations 1 protein;, PF00373;PF16705;, GO:0005911;GO:0005737;GO:0005856;GO:0005615;GO:0005886;GO:0030695;GO:0008017;GO:0005546;GO:0001525;GO:0045454;GO:0016525;GO:2000352;GO:0010596;GO:0001937;GO:2000114;GO:0007264;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:plasma membrane;, F:GTPase regulator activity; F:microtubule binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:angiogenesis; P:cell redox homeostasis; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:regulation of establishment of cell polarity; P:small GTPase mediated signal transduction;|O00522 A6NNU0 O43894 Q506L6 Q6U276 Q75N19 Q9H180 Q9H264 Q9HAX5,Krev interaction trapped protein 1,Cerebral cavernous malformations 1 protein;, PF00373;PF16705;, GO:0005911;GO:0005737;GO:0005856;GO:0005615;GO:0005886;GO:0030695;GO:0008017;GO:0005546;GO:0001525;GO:0045454;GO:0016525;GO:2000352;GO:0010596;GO:0001937;GO:2000114;GO:0007264;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:plasma membrane;, F:GTPase regulator activity; F:microtubule binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:angiogenesis; P:cell redox homeostasis; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:regulation of establishment of cell polarity; P:small GTPase mediated signal transduction;|O00522 A6NNU0 O43894 Q506L6 Q6U276 Q75N19 Q9H180 Q9H264 Q9HAX5,Krev interaction trapped protein 1,Cerebral cavernous malformations 1 protein;, PF00373;PF16705;, GO:0005911;GO:0005737;GO:0005856;GO:0005615;GO:0005886;GO:0030695;GO:0008017;GO:0005546;GO:0001525;GO:0045454;GO:0016525;GO:2000352;GO:0010596;GO:0001937;GO:2000114;GO:0007264;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:plasma membrane;, F:GTPase regulator activity; F:microtubule binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:angiogenesis; P:cell redox homeostasis; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:regulation of establishment of cell polarity; P:small GTPase mediated signal transduction;|O00522 A6NNU0 O43894 Q506L6 Q6U276 Q75N19 Q9H180 Q9H264 Q9HAX5,Krev interaction trapped protein 1,Cerebral cavernous malformations 1 protein;, PF00373;PF16705;, GO:0005911;GO:0005737;GO:0005856;GO:0005615;GO:0005886;GO:0030695;GO:0008017;GO:0005546;GO:0001525;GO:0045454;GO:0016525;GO:2000352;GO:0010596;GO:0001937;GO:2000114;GO:0007264;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:plasma membrane;, F:GTPase regulator activity; F:microtubule binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:angiogenesis; P:cell redox homeostasis; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:regulation of establishment of cell polarity; P:small GTPase mediated signal transduction;|O00522 A6NNU0 O43894 Q506L6 Q6U276 Q75N19 Q9H180 Q9H264 Q9HAX5,Krev interaction trapped protein 1,Cerebral cavernous malformations 1 protein;, PF00373;PF16705;, GO:0005911;GO:0005737;GO:0005856;GO:0005615;GO:0005886;GO:0030695;GO:0008017;GO:0005546;GO:0001525;GO:0045454;GO:0016525;GO:2000352;GO:0010596;GO:0001937;GO:2000114;GO:0007264;, C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular space; C:plasma membrane;, F:GTPase regulator activity; F:microtubule binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:angiogenesis; P:cell redox homeostasis; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:regulation of establishment of cell polarity; P:small GTPase mediated signal transduction; scaffold74 indexed_genome mRNA 6280264 6351685 . + . ID=transcript_11624;Q9P2G1 Q6GMS4 Q6P3S9 Q9NTD7 Q9NW49,Ankyrin repeat and IBR domain-containing protein 1,, PF00023;PF01485;, GO:0005737;GO:0000151;GO:0046872;GO:0031624;GO:0061630;GO:0032436;GO:0000209;GO:0006511;, C:cytoplasm; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9P2G1 Q6GMS4 Q6P3S9 Q9NTD7 Q9NW49,Ankyrin repeat and IBR domain-containing protein 1,, PF00023;PF01485;, GO:0005737;GO:0000151;GO:0046872;GO:0031624;GO:0061630;GO:0032436;GO:0000209;GO:0006511;, C:cytoplasm; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9P2G1 Q6GMS4 Q6P3S9 Q9NTD7 Q9NW49,Ankyrin repeat and IBR domain-containing protein 1,, PF00023;PF01485;, GO:0005737;GO:0000151;GO:0046872;GO:0031624;GO:0061630;GO:0032436;GO:0000209;GO:0006511;, C:cytoplasm; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9P2G1 Q6GMS4 Q6P3S9 Q9NTD7 Q9NW49,Ankyrin repeat and IBR domain-containing protein 1,, PF00023;PF01485;, GO:0005737;GO:0000151;GO:0046872;GO:0031624;GO:0061630;GO:0032436;GO:0000209;GO:0006511;, C:cytoplasm; C:ubiquitin ligase complex;, F:metal ion binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold74 indexed_genome mRNA 6361324 6364346 . - . ID=transcript_11625;Q7Z429 B3KXM7 O43836 Q8IVW7,Protein lifeguard 1,Glutamate [NMDA] receptor-associated protein 1;NMDA receptor glutamate-binding subunit;Putative MAPK-activating protein PM02;Transmembrane BAX inhibitor motif-containing protein 3;, PF01027;, GO:0005783;GO:0005794;GO:0016021;GO:0044325;GO:0032469;GO:1902236;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane;, F:ion channel binding;, P:endoplasmic reticulum calcium ion homeostasis; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; scaffold74 indexed_genome mRNA 6390881 6398430 . + . ID=transcript_11626;Q8WUU5 B2RE37 D6W5Q5 Q8N5Y5 Q99995 Q9H689,GATA zinc finger domain-containing protein 1,Ocular development-associated gene protein;, , GO:0005654;GO:0005634;GO:0043565;GO:0008270;GO:0006325;GO:0006338;GO:0006355;, C:nucleoplasm; C:nucleus;, F:sequence-specific DNA binding; F:zinc ion binding;, P:chromatin organization; P:chromatin remodeling; P:regulation of transcription, DNA-templated;|Q8WUU5 B2RE37 D6W5Q5 Q8N5Y5 Q99995 Q9H689,GATA zinc finger domain-containing protein 1,Ocular development-associated gene protein;, , GO:0005654;GO:0005634;GO:0043565;GO:0008270;GO:0006325;GO:0006338;GO:0006355;, C:nucleoplasm; C:nucleus;, F:sequence-specific DNA binding; F:zinc ion binding;, P:chromatin organization; P:chromatin remodeling; P:regulation of transcription, DNA-templated; scaffold74 indexed_genome mRNA 6414816 6485917 . - . ID=transcript_11627;O43933 A4D1G3 A8KA90 B4DIM7 E9PE75 Q96S71 Q96S72 Q96S73 Q99994,Peroxisome biogenesis factor 1,Peroxin-1;Peroxisome biogenesis disorder protein 1;, PF00004;PF17862;PF09262;PF09263;, GO:0005737;GO:0005829;GO:0070062;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0008022;GO:0044877;GO:0060152;GO:0007031;GO:0016558;GO:0008104;GO:0006625;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein-containing complex binding;, P:microtubule-based peroxisome localization; P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization; P:protein targeting to peroxisome;|O43933 A4D1G3 A8KA90 B4DIM7 E9PE75 Q96S71 Q96S72 Q96S73 Q99994,Peroxisome biogenesis factor 1,Peroxin-1;Peroxisome biogenesis disorder protein 1;, PF00004;PF17862;PF09262;PF09263;, GO:0005737;GO:0005829;GO:0070062;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0008022;GO:0044877;GO:0060152;GO:0007031;GO:0016558;GO:0008104;GO:0006625;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:protein C-terminus binding; F:protein-containing complex binding;, P:microtubule-based peroxisome localization; P:peroxisome organization; P:protein import into peroxisome matrix; P:protein localization; P:protein targeting to peroxisome; scaffold74 indexed_genome mRNA 6491783 6496991 . - . ID=transcript_11628;Q5RL73 B7Z2K5 B7ZL51 Q5H9T2 Q8IYW7 Q96NS0 Q9H0V7,RNA-binding protein 48,, , GO:0005654;GO:0003723;, C:nucleoplasm;, F:RNA binding;|Q5RL73 B7Z2K5 B7ZL51 Q5H9T2 Q8IYW7 Q96NS0 Q9H0V7,RNA-binding protein 48,, , GO:0005654;GO:0003723;, C:nucleoplasm;, F:RNA binding; scaffold74 indexed_genome mRNA 6517199 6547165 . - . ID=transcript_11629;Q5BKY9 B2R994 Q05D67 Q6P5S6 Q8N0W8,Protein FAM133B,, , GO:0003723;, , F:RNA binding;|Q5BKY9 B2R994 Q05D67 Q6P5S6 Q8N0W8,Protein FAM133B,, , GO:0003723;, , F:RNA binding; scaffold74 indexed_genome mRNA 6559859 6798971 . - . ID=transcript_11630;Q00534 A4D1G0,Cyclin-dependent kinase 6,Cell division protein kinase 6;Serine/threonine-protein kinase PLSTIRE;, PF00069;, GO:0005813;GO:0000307;GO:0005737;GO:0005829;GO:0016592;GO:0005654;GO:0005634;GO:0001726;GO:0005524;GO:0030332;GO:0004693;GO:0098770;GO:0106310;GO:0106311;GO:0008353;GO:0014002;GO:0007050;GO:0043697;GO:0051301;GO:0021542;GO:0000082;GO:0048699;GO:0042063;GO:0021670;GO:0045786;GO:0045596;GO:0008285;GO:2000773;GO:0050680;GO:2000134;GO:0045656;GO:0045638;GO:0045668;GO:0001954;GO:0048146;GO:0006468;GO:0051726;GO:2000145;GO:0045646;GO:0010468;GO:0009615;GO:0003323;, C:centrosome; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:mediator complex; C:nucleoplasm; C:nucleus; C:ruffle;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase activity; F:FBXO family protein binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:astrocyte development; P:cell cycle arrest; P:cell dedifferentiation; P:cell division; P:dentate gyrus development; P:G1/S transition of mitotic cell cycle; P:generation of neurons; P:gliogenesis; P:lateral ventricle development; P:negative regulation of cell cycle; P:negative regulation of cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of cellular senescence; P:negative regulation of epithelial cell proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of monocyte differentiation; P:negative regulation of myeloid cell differentiation; P:negative regulation of osteoblast differentiation; P:positive regulation of cell-matrix adhesion; P:positive regulation of fibroblast proliferation; P:protein phosphorylation; P:regulation of cell cycle; P:regulation of cell motility; P:regulation of erythrocyte differentiation; P:regulation of gene expression; P:response to virus; P:type B pancreatic cell development; scaffold74 indexed_genome mRNA 7051413 7057011 . - . ID=transcript_11631;Q5K651 A2RU68 Q5K649 Q6P080 Q75N21 Q8IVG6 Q9NXS8,Sterile alpha motif domain-containing protein 9,, PF07647;, GO:0005737;GO:0005829;GO:0043231;GO:0034058;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle;, , P:endosomal vesicle fusion;|Q5K651 A2RU68 Q5K649 Q6P080 Q75N21 Q8IVG6 Q9NXS8,Sterile alpha motif domain-containing protein 9,, PF07647;, GO:0005737;GO:0005829;GO:0043231;GO:0034058;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle;, , P:endosomal vesicle fusion; scaffold74 indexed_genome mRNA 7057313 7057903 . + . ID=transcript_11632;Q5K651 A2RU68 Q5K649 Q6P080 Q75N21 Q8IVG6 Q9NXS8,Sterile alpha motif domain-containing protein 9,, PF07647;, GO:0005737;GO:0005829;GO:0043231;GO:0034058;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle;, , P:endosomal vesicle fusion; scaffold74 indexed_genome mRNA 7058263 7066154 . - . ID=transcript_11633;Q5K651 A2RU68 Q5K649 Q6P080 Q75N21 Q8IVG6 Q9NXS8,Sterile alpha motif domain-containing protein 9,, PF07647;, GO:0005737;GO:0005829;GO:0043231;GO:0034058;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle;, , P:endosomal vesicle fusion; scaffold74 indexed_genome mRNA 7116200 7155382 . - . ID=transcript_11634;A8MVW5 B3KTT4 B4DPJ1 B9EG93 E9PDV5 Q6UXI0,HEPACAM family member 2,Mitotic kinetics regulator;, , GO:0005813;GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0030496;GO:0072686;GO:0005654;GO:0005819;GO:0051301;GO:0007098;, C:centrosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:midbody; C:mitotic spindle; C:nucleoplasm; C:spindle;, , P:cell division; P:centrosome cycle; scaffold74 indexed_genome mRNA 7172308 7283834 . + . ID=transcript_11635;Q96JG6 B3KX22 D1MQ00 F5H5U7 Q75N07 Q8WVK3 Q9H5C6,Syndetin {ECO:0000303|PubMed:25799061},Coiled-coil domain-containing protein 132 {ECO:0000305};EARP/GARPII complex subunit VPS50 {ECO:0000312|HGNC:HGNC:25956};, PF10474;PF10475;, GO:0005829;GO:1990745;GO:0070062;GO:0016020;GO:0055037;GO:0000149;GO:0032456;GO:0015031;, C:cytosol; C:EARP complex; C:extracellular exosome; C:membrane; C:recycling endosome;, F:SNARE binding;, P:endocytic recycling; P:protein transport;|Q96JG6 B3KX22 D1MQ00 F5H5U7 Q75N07 Q8WVK3 Q9H5C6,Syndetin {ECO:0000303|PubMed:25799061},Coiled-coil domain-containing protein 132 {ECO:0000305};EARP/GARPII complex subunit VPS50 {ECO:0000312|HGNC:HGNC:25956};, PF10474;PF10475;, GO:0005829;GO:1990745;GO:0070062;GO:0016020;GO:0055037;GO:0000149;GO:0032456;GO:0015031;, C:cytosol; C:EARP complex; C:extracellular exosome; C:membrane; C:recycling endosome;, F:SNARE binding;, P:endocytic recycling; P:protein transport; scaffold74 indexed_genome mRNA 7289998 7302883 . + . ID=transcript_11636;Q96JG6 B3KX22 D1MQ00 F5H5U7 Q75N07 Q8WVK3 Q9H5C6,Syndetin {ECO:0000303|PubMed:25799061},Coiled-coil domain-containing protein 132 {ECO:0000305};EARP/GARPII complex subunit VPS50 {ECO:0000312|HGNC:HGNC:25956};, PF10474;PF10475;, GO:0005829;GO:1990745;GO:0070062;GO:0016020;GO:0055037;GO:0000149;GO:0032456;GO:0015031;, C:cytosol; C:EARP complex; C:extracellular exosome; C:membrane; C:recycling endosome;, F:SNARE binding;, P:endocytic recycling; P:protein transport;|Q96JG6 B3KX22 D1MQ00 F5H5U7 Q75N07 Q8WVK3 Q9H5C6,Syndetin {ECO:0000303|PubMed:25799061},Coiled-coil domain-containing protein 132 {ECO:0000305};EARP/GARPII complex subunit VPS50 {ECO:0000312|HGNC:HGNC:25956};, PF10474;PF10475;, GO:0005829;GO:1990745;GO:0070062;GO:0016020;GO:0055037;GO:0000149;GO:0032456;GO:0015031;, C:cytosol; C:EARP complex; C:extracellular exosome; C:membrane; C:recycling endosome;, F:SNARE binding;, P:endocytic recycling; P:protein transport;|Q96JG6 B3KX22 D1MQ00 F5H5U7 Q75N07 Q8WVK3 Q9H5C6,Syndetin {ECO:0000303|PubMed:25799061},Coiled-coil domain-containing protein 132 {ECO:0000305};EARP/GARPII complex subunit VPS50 {ECO:0000312|HGNC:HGNC:25956};, PF10474;PF10475;, GO:0005829;GO:1990745;GO:0070062;GO:0016020;GO:0055037;GO:0000149;GO:0032456;GO:0015031;, C:cytosol; C:EARP complex; C:extracellular exosome; C:membrane; C:recycling endosome;, F:SNARE binding;, P:endocytic recycling; P:protein transport; scaffold74 indexed_genome mRNA 7340046 7447730 . - . ID=transcript_11637;P30988 A4D1G6 F5H605 O14585 Q13941 Q5ZGL8 Q659U6 Q6DJU8 Q6T712,Calcitonin receptor,, PF00002;PF02793;, GO:0150056;GO:0150057;GO:0150058;GO:0030424;GO:0005887;GO:0005886;GO:0097643;GO:0001540;GO:0032841;GO:0001635;GO:0004948;GO:0008528;GO:0007189;GO:0007188;GO:0097647;GO:0007166;GO:0038041;GO:0007186;GO:0002862;GO:0045762;GO:1905665;GO:0010942;GO:0007204;GO:0070374;GO:0010628;GO:0033138;GO:0010739;GO:0051897;GO:1904645;GO:0051384;, C:amylin receptor complex 1; C:amylin receptor complex 2; C:amylin receptor complex 3; C:axon; C:integral component of plasma membrane; C:plasma membrane;, F:amylin receptor activity; F:amyloid-beta binding; F:calcitonin binding; F:calcitonin gene-related peptide receptor activity; F:calcitonin receptor activity; F:G protein-coupled peptide receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:amylin receptor signaling pathway; P:cell surface receptor signaling pathway; P:cross-receptor inhibition within G protein-coupled receptor heterodimer; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion import across plasma membrane; P:positive regulation of cell death; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein kinase A signaling; P:positive regulation of protein kinase B signaling; P:response to amyloid-beta; P:response to glucocorticoid; scaffold74 indexed_genome mRNA 7730419 7735872 . - . ID=transcript_11638;P48307 Q66ME8 Q8NAK6 Q9UC86,Tissue factor pathway inhibitor 2,Placental protein 5;, PF00014;, GO:0031012;GO:0005615;GO:0005201;GO:0004867;GO:0007596;, C:extracellular matrix; C:extracellular space;, F:extracellular matrix structural constituent; F:serine-type endopeptidase inhibitor activity;, P:blood coagulation; scaffold74 indexed_genome mRNA 7768479 7773873 . + . ID=transcript_11639;P61952 P50152,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11,, PF00631;, GO:0031680;GO:0005834;GO:0005886;GO:0031681;GO:0003924;GO:0007186;GO:0007165;, C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:plasma membrane;, F:G-protein beta-subunit binding; F:GTPase activity;, P:G protein-coupled receptor signaling pathway; P:signal transduction; scaffold74 indexed_genome mRNA 7849309 7859328 . + . ID=transcript_11640;O15155 Q96EA0,BET1 homolog,Golgi vesicular membrane-trafficking protein p18;, , GO:0005789;GO:0033116;GO:0000139;GO:0000138;GO:0030173;GO:0016020;GO:0031201;GO:0030133;GO:0005484;GO:0048208;GO:0006888;GO:0015031;GO:0048280;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of Golgi membrane; C:membrane; C:SNARE complex; C:transport vesicle;, F:SNAP receptor activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:vesicle fusion with Golgi apparatus;|O15155 Q96EA0,BET1 homolog,Golgi vesicular membrane-trafficking protein p18;, , GO:0005789;GO:0033116;GO:0000139;GO:0000138;GO:0030173;GO:0016020;GO:0031201;GO:0030133;GO:0005484;GO:0048208;GO:0006888;GO:0015031;GO:0048280;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of Golgi membrane; C:membrane; C:SNARE complex; C:transport vesicle;, F:SNAP receptor activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:vesicle fusion with Golgi apparatus;|O15155 Q96EA0,BET1 homolog,Golgi vesicular membrane-trafficking protein p18;, , GO:0005789;GO:0033116;GO:0000139;GO:0000138;GO:0030173;GO:0016020;GO:0031201;GO:0030133;GO:0005484;GO:0048208;GO:0006888;GO:0015031;GO:0048280;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of Golgi membrane; C:membrane; C:SNARE complex; C:transport vesicle;, F:SNAP receptor activity;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:vesicle fusion with Golgi apparatus; scaffold75 indexed_genome mRNA 16631 31259 . + . ID=transcript_11641;Q8WTR2 B2RA79 Q547H4 Q8WYN4,Dual specificity protein phosphatase 19,Dual specificity phosphatase TS-DSP1;Low molecular weight dual specificity phosphatase 3;Protein phosphatase SKRP1;Stress-activated protein kinase pathway-regulating phosphatase 1;, , GO:0005737;GO:0008579;GO:0005078;GO:0031435;GO:0030295;GO:0004860;GO:0106306;GO:0106307;GO:0004725;GO:0046329;GO:0043508;GO:0006469;GO:0046330;GO:0043507;GO:0043410;GO:0045860;GO:0043405;, C:cytoplasm;, F:JUN kinase phosphatase activity; F:MAP-kinase scaffold activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase activator activity; F:protein kinase inhibitor activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity;, P:negative regulation of JNK cascade; P:negative regulation of JUN kinase activity; P:negative regulation of protein kinase activity; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of protein kinase activity; P:regulation of MAP kinase activity; scaffold75 indexed_genome mRNA 36567 37732 . + . ID=transcript_11642;Q8NA31 A0AUW1,Telomere repeats-binding bouquet formation protein 1 {ECO:0000250|UniProtKB:Q8C0V1},Coiled-coil domain-containing protein 79 {ECO:0000312|HGNC:HGNC:26675};, PF00249;, GO:0000781;GO:0005637;GO:0070187;GO:0007129;GO:0070197;GO:0045141;, C:chromosome, telomeric region; C:nuclear inner membrane; C:shelterin complex;, , P:homologous chromosome pairing at meiosis; P:meiotic attachment of telomere to nuclear envelope; P:meiotic telomere clustering; scaffold75 indexed_genome mRNA 48144 80097 . + . ID=transcript_11643;Q8NFH5 B4DP57 B4DYB4 Q4ZFZ9 Q53S95 Q8TDJ1,Nucleoporin NUP35 {ECO:0000312|HGNC:HGNC:29797},35 kDa nucleoporin;Mitotic phosphoprotein 44;Nuclear pore complex protein Nup53;Nucleoporin NUP53 {ECO:0000303|PubMed:15703211};, PF05172;, GO:0005829;GO:0043657;GO:0005635;GO:0005652;GO:0031965;GO:0044613;GO:0044615;GO:0005654;GO:0005886;GO:0042802;GO:0005543;GO:0003697;GO:0017056;GO:1990830;GO:0075733;GO:0007084;GO:0006406;GO:0006607;GO:0006999;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006355;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear lamina; C:nuclear membrane; C:nuclear pore central transport channel; C:nuclear pore nuclear basket; C:nucleoplasm; C:plasma membrane;, F:identical protein binding; F:phospholipid binding; F:single-stranded DNA binding; F:structural constituent of nuclear pore;, P:cellular response to leukemia inhibitory factor; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of transcription, DNA-templated; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8NFH5 B4DP57 B4DYB4 Q4ZFZ9 Q53S95 Q8TDJ1,Nucleoporin NUP35 {ECO:0000312|HGNC:HGNC:29797},35 kDa nucleoporin;Mitotic phosphoprotein 44;Nuclear pore complex protein Nup53;Nucleoporin NUP53 {ECO:0000303|PubMed:15703211};, PF05172;, GO:0005829;GO:0043657;GO:0005635;GO:0005652;GO:0031965;GO:0044613;GO:0044615;GO:0005654;GO:0005886;GO:0042802;GO:0005543;GO:0003697;GO:0017056;GO:1990830;GO:0075733;GO:0007084;GO:0006406;GO:0006607;GO:0006999;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006355;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear lamina; C:nuclear membrane; C:nuclear pore central transport channel; C:nuclear pore nuclear basket; C:nucleoplasm; C:plasma membrane;, F:identical protein binding; F:phospholipid binding; F:single-stranded DNA binding; F:structural constituent of nuclear pore;, P:cellular response to leukemia inhibitory factor; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of transcription, DNA-templated; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8NFH5 B4DP57 B4DYB4 Q4ZFZ9 Q53S95 Q8TDJ1,Nucleoporin NUP35 {ECO:0000312|HGNC:HGNC:29797},35 kDa nucleoporin;Mitotic phosphoprotein 44;Nuclear pore complex protein Nup53;Nucleoporin NUP53 {ECO:0000303|PubMed:15703211};, PF05172;, GO:0005829;GO:0043657;GO:0005635;GO:0005652;GO:0031965;GO:0044613;GO:0044615;GO:0005654;GO:0005886;GO:0042802;GO:0005543;GO:0003697;GO:0017056;GO:1990830;GO:0075733;GO:0007084;GO:0006406;GO:0006607;GO:0006999;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006355;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear envelope; C:nuclear lamina; C:nuclear membrane; C:nuclear pore central transport channel; C:nuclear pore nuclear basket; C:nucleoplasm; C:plasma membrane;, F:identical protein binding; F:phospholipid binding; F:single-stranded DNA binding; F:structural constituent of nuclear pore;, P:cellular response to leukemia inhibitory factor; P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of transcription, DNA-templated; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold75 indexed_genome mRNA 3039202 3060231 . + . ID=transcript_11644;Q8WU90 B4DMW2 D3DPG7 Q5QTQ4 Q8WZ06 Q9NUZ3 Q9NZ37 Q9P079,Zinc finger CCCH domain-containing protein 15,DRG family-regulatory protein 1;Likely ortholog of mouse immediate early response erythropoietin 4;, PF16543;PF18044;, GO:0005829;GO:0005634;GO:0045296;GO:0046872;GO:0003723;GO:0019221;GO:0002181;GO:0043547;, C:cytosol; C:nucleus;, F:cadherin binding; F:metal ion binding; F:RNA binding;, P:cytokine-mediated signaling pathway; P:cytoplasmic translation; P:positive regulation of GTPase activity;|Q8WU90 B4DMW2 D3DPG7 Q5QTQ4 Q8WZ06 Q9NUZ3 Q9NZ37 Q9P079,Zinc finger CCCH domain-containing protein 15,DRG family-regulatory protein 1;Likely ortholog of mouse immediate early response erythropoietin 4;, PF16543;PF18044;, GO:0005829;GO:0005634;GO:0045296;GO:0046872;GO:0003723;GO:0019221;GO:0002181;GO:0043547;, C:cytosol; C:nucleus;, F:cadherin binding; F:metal ion binding; F:RNA binding;, P:cytokine-mediated signaling pathway; P:cytoplasmic translation; P:positive regulation of GTPase activity;|Q8WU90 B4DMW2 D3DPG7 Q5QTQ4 Q8WZ06 Q9NUZ3 Q9NZ37 Q9P079,Zinc finger CCCH domain-containing protein 15,DRG family-regulatory protein 1;Likely ortholog of mouse immediate early response erythropoietin 4;, PF16543;PF18044;, GO:0005829;GO:0005634;GO:0045296;GO:0046872;GO:0003723;GO:0019221;GO:0002181;GO:0043547;, C:cytosol; C:nucleus;, F:cadherin binding; F:metal ion binding; F:RNA binding;, P:cytokine-mediated signaling pathway; P:cytoplasmic translation; P:positive regulation of GTPase activity; scaffold75 indexed_genome mRNA 3152179 3256528 . + . ID=transcript_11645;Q6LD15,Integrin alpha-V,Vitronectin receptor {ECO:0000312|HGNC:HGNC:6150};Vitronectin receptor subunit alpha;, PF01839;PF00357;PF08441;, GO:0035868;GO:0035867;GO:0035866;GO:0009986;GO:0005829;GO:0009897;GO:0070062;GO:0031527;GO:0005925;GO:0005887;GO:0034683;GO:0034684;GO:0034685;GO:0034686;GO:0008305;GO:0031258;GO:0016020;GO:0031528;GO:0045335;GO:0005886;GO:0032587;GO:0035579;GO:0015026;GO:0050840;GO:1990430;GO:0001968;GO:0005178;GO:0046872;GO:0001846;GO:0002020;GO:0005080;GO:0050431;GO:0001618;GO:0005245;GO:0001525;GO:0002479;GO:0038027;GO:0043277;GO:0070588;GO:0007155;GO:0033627;GO:0007160;GO:0031589;GO:0035987;GO:0085017;GO:0070371;GO:0030198;GO:0097192;GO:0034113;GO:0007229;GO:0050900;GO:0050919;GO:2000536;GO:2001237;GO:0010888;GO:0032369;GO:0050748;GO:1905598;GO:0010745;GO:0043312;GO:0045785;GO:0030335;GO:0008284;GO:0007204;GO:0033690;GO:0050764;GO:1901388;GO:0034446;GO:0071604;GO:0048010;GO:0001570;GO:0046718;, C:alphav-beta3 integrin-HMGB1 complex; C:alphav-beta3 integrin-IGF-1-IGF1R complex; C:alphav-beta3 integrin-PKCalpha complex; C:cell surface; C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of plasma membrane; C:integrin alphav-beta3 complex; C:integrin alphav-beta5 complex; C:integrin alphav-beta6 complex; C:integrin alphav-beta8 complex; C:integrin complex; C:lamellipodium membrane; C:membrane; C:microvillus membrane; C:phagocytic vesicle; C:plasma membrane; C:ruffle membrane; C:specific granule membrane;, F:coreceptor activity; F:extracellular matrix binding; F:extracellular matrix protein binding; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:opsonin binding; F:protease binding; F:protein kinase C binding; F:transforming growth factor beta binding; F:virus receptor activity; F:voltage-gated calcium channel activity;, P:angiogenesis; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apolipoprotein A-I-mediated signaling pathway; P:apoptotic cell clearance; P:calcium ion transmembrane transport; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-substrate adhesion; P:endodermal cell differentiation; P:entry into host cell by a symbiont-containing vacuole; P:ERK1 and ERK2 cascade; P:extracellular matrix organization; P:extrinsic apoptotic signaling pathway in absence of ligand; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte migration; P:negative chemotaxis; P:negative regulation of entry of bacterium into host cell; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of lipid storage; P:negative regulation of lipid transport; P:negative regulation of lipoprotein metabolic process; P:negative regulation of low-density lipoprotein receptor activity; P:negative regulation of macrophage derived foam cell differentiation; P:neutrophil degranulation; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of osteoblast proliferation; P:regulation of phagocytosis; P:regulation of transforming growth factor beta activation; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta production; P:vascular endothelial growth factor receptor signaling pathway; P:vasculogenesis; P:viral entry into host cell;|Q6LD15,Integrin alpha-V,Vitronectin receptor {ECO:0000312|HGNC:HGNC:6150};Vitronectin receptor subunit alpha;, PF01839;PF00357;PF08441;, GO:0035868;GO:0035867;GO:0035866;GO:0009986;GO:0005829;GO:0009897;GO:0070062;GO:0031527;GO:0005925;GO:0005887;GO:0034683;GO:0034684;GO:0034685;GO:0034686;GO:0008305;GO:0031258;GO:0016020;GO:0031528;GO:0045335;GO:0005886;GO:0032587;GO:0035579;GO:0015026;GO:0050840;GO:1990430;GO:0001968;GO:0005178;GO:0046872;GO:0001846;GO:0002020;GO:0005080;GO:0050431;GO:0001618;GO:0005245;GO:0001525;GO:0002479;GO:0038027;GO:0043277;GO:0070588;GO:0007155;GO:0033627;GO:0007160;GO:0031589;GO:0035987;GO:0085017;GO:0070371;GO:0030198;GO:0097192;GO:0034113;GO:0007229;GO:0050900;GO:0050919;GO:2000536;GO:2001237;GO:0010888;GO:0032369;GO:0050748;GO:1905598;GO:0010745;GO:0043312;GO:0045785;GO:0030335;GO:0008284;GO:0007204;GO:0033690;GO:0050764;GO:1901388;GO:0034446;GO:0071604;GO:0048010;GO:0001570;GO:0046718;, C:alphav-beta3 integrin-HMGB1 complex; C:alphav-beta3 integrin-IGF-1-IGF1R complex; C:alphav-beta3 integrin-PKCalpha complex; C:cell surface; C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:integral component of plasma membrane; C:integrin alphav-beta3 complex; C:integrin alphav-beta5 complex; C:integrin alphav-beta6 complex; C:integrin alphav-beta8 complex; C:integrin complex; C:lamellipodium membrane; C:membrane; C:microvillus membrane; C:phagocytic vesicle; C:plasma membrane; C:ruffle membrane; C:specific granule membrane;, F:coreceptor activity; F:extracellular matrix binding; F:extracellular matrix protein binding; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:opsonin binding; F:protease binding; F:protein kinase C binding; F:transforming growth factor beta binding; F:virus receptor activity; F:voltage-gated calcium channel activity;, P:angiogenesis; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apolipoprotein A-I-mediated signaling pathway; P:apoptotic cell clearance; P:calcium ion transmembrane transport; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-substrate adhesion; P:endodermal cell differentiation; P:entry into host cell by a symbiont-containing vacuole; P:ERK1 and ERK2 cascade; P:extracellular matrix organization; P:extrinsic apoptotic signaling pathway in absence of ligand; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte migration; P:negative chemotaxis; P:negative regulation of entry of bacterium into host cell; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of lipid storage; P:negative regulation of lipid transport; P:negative regulation of lipoprotein metabolic process; P:negative regulation of low-density lipoprotein receptor activity; P:negative regulation of macrophage derived foam cell differentiation; P:neutrophil degranulation; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of osteoblast proliferation; P:regulation of phagocytosis; P:regulation of transforming growth factor beta activation; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta production; P:vascular endothelial growth factor receptor signaling pathway; P:vasculogenesis; P:viral entry into host cell; scaffold75 indexed_genome mRNA 3312171 3338136 . + . ID=transcript_11646;Q6P995 Q53SK3 Q8N1Y4 Q8N3K1 Q8N970 Q8NB81 Q8TF55 Q8WYR8,Protein FAM171B,, PF10577;, GO:0016021;, C:integral component of membrane;|Q6P995 Q53SK3 Q8N1Y4 Q8N3K1 Q8N970 Q8NB81 Q8TF55 Q8WYR8,Protein FAM171B,, PF10577;, GO:0016021;, C:integral component of membrane;|Q6P995 Q53SK3 Q8N1Y4 Q8N3K1 Q8N970 Q8NB81 Q8TF55 Q8WYR8,Protein FAM171B,, PF10577;, GO:0016021;, C:integral component of membrane; scaffold75 indexed_genome mRNA 3848048 3899543 . - . ID=transcript_11647;Q16602 A8K6G5 A8KAD3 Q53S02 Q53TS5,Calcitonin gene-related peptide type 1 receptor,Calcitonin receptor-like receptor;, PF00002;PF02793;, GO:1903143;GO:1990406;GO:0005737;GO:0005783;GO:0005768;GO:0005887;GO:0005764;GO:0005886;GO:1990409;GO:0001605;GO:0001635;GO:0004948;GO:0008528;GO:0004930;GO:0007189;GO:0007188;GO:1990410;GO:0001525;GO:1990408;GO:0006816;GO:0007166;GO:0071329;GO:0007186;GO:0007187;GO:0007507;GO:0002862;GO:0045986;GO:0048661;GO:0015031;GO:0031623;, C:adrenomedullin receptor complex; C:CGRP receptor complex; C:cytoplasm; C:endoplasmic reticulum; C:endosome; C:integral component of plasma membrane; C:lysosome; C:plasma membrane;, F:adrenomedullin binding; F:adrenomedullin receptor activity; F:calcitonin gene-related peptide receptor activity; F:calcitonin receptor activity; F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:adrenomedullin receptor signaling pathway; P:angiogenesis; P:calcitonin gene-related peptide receptor signaling pathway; P:calcium ion transport; P:cell surface receptor signaling pathway; P:cellular response to sucrose stimulus; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:heart development; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of smooth muscle contraction; P:positive regulation of smooth muscle cell proliferation; P:protein transport; P:receptor internalization; scaffold75 indexed_genome mRNA 3995762 4039290 . - . ID=transcript_11648;P10646 O95103 Q53TS4,Tissue factor pathway inhibitor,Extrinsic pathway inhibitor;Lipoprotein-associated coagulation inhibitor;, PF00014;, GO:0031225;GO:0005901;GO:0009986;GO:0005783;GO:0005576;GO:0005615;GO:0005886;GO:0004866;GO:0004867;GO:0007596;GO:0071347;GO:0071222;GO:0071383;GO:0030195;GO:2000264;GO:0032355;, C:anchored component of membrane; C:caveola; C:cell surface; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:plasma membrane;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:blood coagulation; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to steroid hormone stimulus; P:negative regulation of blood coagulation; P:negative regulation of blood coagulation, extrinsic pathway; P:response to estradiol; scaffold75 indexed_genome mRNA 4757708 5068211 . + . ID=transcript_11649;Q9UBP9 B2RB51 B4DQ40 B8ZZ72 D3DPH1 E9PB86 Q53PC1 Q53RF3 Q9BVL3,PTB domain-containing engulfment adapter protein 1,Cell death protein 6 homolog;PTB domain adapter protein CED-6;Protein GULP;, PF00640;, GO:0005737;GO:0006915;GO:0006869;GO:0006911;, C:cytoplasm;, , P:apoptotic process; P:lipid transport; P:phagocytosis, engulfment; scaffold75 indexed_genome mRNA 5445185 5474728 . + . ID=transcript_11650;V9GZI1,Collagen alpha-1(III) chain,, PF01410;PF01391;PF00093;, GO:0005586;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0005178;GO:0046872;GO:0048407;GO:0002020;GO:0007160;GO:0021987;GO:0030199;GO:0030198;GO:0007507;GO:0007229;GO:0050777;GO:2001223;GO:0018149;GO:0030168;GO:0035025;GO:0050776;GO:0034097;GO:0009612;GO:0009314;GO:0001501;GO:0043588;GO:0097435;GO:0007179;GO:0042060;, C:collagen type III trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor binding; F:protease binding;, P:cell-matrix adhesion; P:cerebral cortex development; P:collagen fibril organization; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:negative regulation of immune response; P:negative regulation of neuron migration; P:peptide cross-linking; P:platelet activation; P:positive regulation of Rho protein signal transduction; P:regulation of immune response; P:response to cytokine; P:response to mechanical stimulus; P:response to radiation; P:skeletal system development; P:skin development; P:supramolecular fiber organization; P:transforming growth factor beta receptor signaling pathway; P:wound healing;|V9GZI1,Collagen alpha-1(III) chain,, PF01410;PF01391;PF00093;, GO:0005586;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0005178;GO:0046872;GO:0048407;GO:0002020;GO:0007160;GO:0021987;GO:0030199;GO:0030198;GO:0007507;GO:0007229;GO:0050777;GO:2001223;GO:0018149;GO:0030168;GO:0035025;GO:0050776;GO:0034097;GO:0009612;GO:0009314;GO:0001501;GO:0043588;GO:0097435;GO:0007179;GO:0042060;, C:collagen type III trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor binding; F:protease binding;, P:cell-matrix adhesion; P:cerebral cortex development; P:collagen fibril organization; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:negative regulation of immune response; P:negative regulation of neuron migration; P:peptide cross-linking; P:platelet activation; P:positive regulation of Rho protein signal transduction; P:regulation of immune response; P:response to cytokine; P:response to mechanical stimulus; P:response to radiation; P:skeletal system development; P:skin development; P:supramolecular fiber organization; P:transforming growth factor beta receptor signaling pathway; P:wound healing;|V9GZI1,Collagen alpha-1(III) chain,, PF01410;PF01391;PF00093;, GO:0005586;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0005178;GO:0046872;GO:0048407;GO:0002020;GO:0007160;GO:0021987;GO:0030199;GO:0030198;GO:0007507;GO:0007229;GO:0050777;GO:2001223;GO:0018149;GO:0030168;GO:0035025;GO:0050776;GO:0034097;GO:0009612;GO:0009314;GO:0001501;GO:0043588;GO:0097435;GO:0007179;GO:0042060;, C:collagen type III trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor binding; F:protease binding;, P:cell-matrix adhesion; P:cerebral cortex development; P:collagen fibril organization; P:extracellular matrix organization; P:heart development; P:integrin-mediated signaling pathway; P:negative regulation of immune response; P:negative regulation of neuron migration; P:peptide cross-linking; P:platelet activation; P:positive regulation of Rho protein signal transduction; P:regulation of immune response; P:response to cytokine; P:response to mechanical stimulus; P:response to radiation; P:skeletal system development; P:skin development; P:supramolecular fiber organization; P:transforming growth factor beta receptor signaling pathway; P:wound healing; scaffold75 indexed_genome mRNA 5489884 5565609 . - . ID=transcript_11651;Q96QB3,Collagen alpha-2(V) chain,, PF01410;PF01391;PF00093;, GO:0005588;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0046872;GO:0046332;GO:0071230;GO:0030199;GO:0030198;GO:0048592;GO:1903225;GO:0001503;GO:0001501;GO:0043588;, C:collagen type V trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding; F:SMAD binding;, P:cellular response to amino acid stimulus; P:collagen fibril organization; P:extracellular matrix organization; P:eye morphogenesis; P:negative regulation of endodermal cell differentiation; P:ossification; P:skeletal system development; P:skin development; scaffold75 indexed_genome mRNA 5877157 5911359 . + . ID=transcript_11652;Q8IWA0 Q96J10 Q9H8U8 Q9H9U5 Q9H9V8 Q9UIX2,WD repeat-containing protein 75,U3 small nucleolar RNA-associated protein 17 homolog;, PF00400;, GO:0005730;GO:0005654;GO:0003723;GO:2000234;GO:0045943;GO:0006364;, C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q8IWA0 Q96J10 Q9H8U8 Q9H9U5 Q9H9V8 Q9UIX2,WD repeat-containing protein 75,U3 small nucleolar RNA-associated protein 17 homolog;, PF00400;, GO:0005730;GO:0005654;GO:0003723;GO:2000234;GO:0045943;GO:0006364;, C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q8IWA0 Q96J10 Q9H8U8 Q9H9U5 Q9H9V8 Q9UIX2,WD repeat-containing protein 75,U3 small nucleolar RNA-associated protein 17 homolog;, PF00400;, GO:0005730;GO:0005654;GO:0003723;GO:2000234;GO:0045943;GO:0006364;, C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing;|Q8IWA0 Q96J10 Q9H8U8 Q9H9U5 Q9H9V8 Q9UIX2,WD repeat-containing protein 75,U3 small nucleolar RNA-associated protein 17 homolog;, PF00400;, GO:0005730;GO:0005654;GO:0003723;GO:2000234;GO:0045943;GO:0006364;, C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:positive regulation of rRNA processing; P:positive regulation of transcription by RNA polymerase I; P:rRNA processing; scaffold75 indexed_genome mRNA 5940536 5941060 . + . ID=transcript_11653;Q9Y4C1 D6W5M3 Q53S72 Q68D47 Q68UT9 Q6N050 Q8IY08,Lysine-specific demethylase 3A,JmjC domain-containing histone demethylation protein 2A;Jumonji domain-containing protein 1A;[histone H3]-dimethyl-L-lysine(9) demethylase 3A {ECO:0000305};, PF02373;, GO:0000785;GO:0005737;GO:0000118;GO:0016020;GO:0005654;GO:0005634;GO:0050681;GO:0031490;GO:0051213;GO:0032454;GO:0005506;GO:0003712;GO:0030521;GO:1990830;GO:0046293;GO:0033169;GO:0036123;GO:0009755;GO:0030522;GO:0051573;GO:0120162;GO:0045944;GO:0045893;GO:2000736;GO:2000036;GO:0006357;GO:0007290;, C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:membrane; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:iron ion binding; F:transcription coregulator activity;, P:androgen receptor signaling pathway; P:cellular response to leukemia inhibitory factor; P:formaldehyde biosynthetic process; P:histone H3-K9 demethylation; P:histone H3-K9 dimethylation; P:hormone-mediated signaling pathway; P:intracellular receptor signaling pathway; P:negative regulation of histone H3-K9 methylation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of stem cell differentiation; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:spermatid nucleus elongation; scaffold75 indexed_genome mRNA 5941074 5941816 . - . ID=transcript_11654;Q9Y4C1 D6W5M3 Q53S72 Q68D47 Q68UT9 Q6N050 Q8IY08,Lysine-specific demethylase 3A,JmjC domain-containing histone demethylation protein 2A;Jumonji domain-containing protein 1A;[histone H3]-dimethyl-L-lysine(9) demethylase 3A {ECO:0000305};, PF02373;, GO:0000785;GO:0005737;GO:0000118;GO:0016020;GO:0005654;GO:0005634;GO:0050681;GO:0031490;GO:0051213;GO:0032454;GO:0005506;GO:0003712;GO:0030521;GO:1990830;GO:0046293;GO:0033169;GO:0036123;GO:0009755;GO:0030522;GO:0051573;GO:0120162;GO:0045944;GO:0045893;GO:2000736;GO:2000036;GO:0006357;GO:0007290;, C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:membrane; C:nucleoplasm; C:nucleus;, F:androgen receptor binding; F:chromatin DNA binding; F:dioxygenase activity; F:histone demethylase activity (H3-K9 specific); F:iron ion binding; F:transcription coregulator activity;, P:androgen receptor signaling pathway; P:cellular response to leukemia inhibitory factor; P:formaldehyde biosynthetic process; P:histone H3-K9 demethylation; P:histone H3-K9 dimethylation; P:hormone-mediated signaling pathway; P:intracellular receptor signaling pathway; P:negative regulation of histone H3-K9 methylation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of stem cell differentiation; P:regulation of stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:spermatid nucleus elongation; scaffold75 indexed_genome mRNA 6038268 7175131 . - . ID=transcript_11655;Q9NP59 Q6FI62 Q7Z4F8 Q8IVB2 Q9NRL0,Solute carrier family 40 member 1,Ferroportin-1;Iron-regulated transporter 1;, PF06963;, GO:0016323;GO:0005737;GO:0005829;GO:0016021;GO:0005887;GO:0005654;GO:0005886;GO:0015093;GO:0005381;GO:0017046;GO:0006879;GO:1903988;GO:0055072;GO:0034755;GO:0060586;, C:basolateral plasma membrane; C:cytoplasm; C:cytosol; C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:ferrous iron transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:peptide hormone binding;, P:cellular iron ion homeostasis; P:iron ion export across plasma membrane; P:iron ion homeostasis; P:iron ion transmembrane transport; P:multicellular organismal iron ion homeostasis;|Q9NP59 Q6FI62 Q7Z4F8 Q8IVB2 Q9NRL0,Solute carrier family 40 member 1,Ferroportin-1;Iron-regulated transporter 1;, PF06963;, GO:0016323;GO:0005737;GO:0005829;GO:0016021;GO:0005887;GO:0005654;GO:0005886;GO:0015093;GO:0005381;GO:0017046;GO:0006879;GO:1903988;GO:0055072;GO:0034755;GO:0060586;, C:basolateral plasma membrane; C:cytoplasm; C:cytosol; C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:ferrous iron transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:peptide hormone binding;, P:cellular iron ion homeostasis; P:iron ion export across plasma membrane; P:iron ion homeostasis; P:iron ion transmembrane transport; P:multicellular organismal iron ion homeostasis;|Q9NP59 Q6FI62 Q7Z4F8 Q8IVB2 Q9NRL0,Solute carrier family 40 member 1,Ferroportin-1;Iron-regulated transporter 1;, PF06963;, GO:0016323;GO:0005737;GO:0005829;GO:0016021;GO:0005887;GO:0005654;GO:0005886;GO:0015093;GO:0005381;GO:0017046;GO:0006879;GO:1903988;GO:0055072;GO:0034755;GO:0060586;, C:basolateral plasma membrane; C:cytoplasm; C:cytosol; C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane;, F:ferrous iron transmembrane transporter activity; F:iron ion transmembrane transporter activity; F:peptide hormone binding;, P:cellular iron ion homeostasis; P:iron ion export across plasma membrane; P:iron ion homeostasis; P:iron ion transmembrane transport; P:multicellular organismal iron ion homeostasis;|Q13506 O75383 O75384 Q6GTU1 Q9UEV1,NGFI-A-binding protein 1,EGR-1-binding protein 1;Transcriptional regulatory protein p54;, PF04902;PF04904;PF04905;, GO:0005654;GO:0005634;GO:0003712;GO:0008134;GO:0001958;GO:0042552;GO:0045892;GO:0007399;GO:0045682;GO:0006355;GO:0014037;, C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription factor binding;, P:endochondral ossification; P:myelination; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:regulation of epidermis development; P:regulation of transcription, DNA-templated; P:Schwann cell differentiation;|L0R819,ASNSD1 upstream open reading frame protein {ECO:0000312|HGNC:HGNC:53619},ASNSD1 small/short open reading frame-encoded polypeptide {ECO:0000303|PubMed:23160002, ECO:0000303|PubMed:25857697};, , GO:0005737;, C:cytoplasm;|Q9NWL6 D3DPH6 Q3LIC3 Q4ZG45,Asparagine synthetase domain-containing protein 1,HCV NS3-transactivated protein 1;, PF00733;, GO:0004066;GO:0006529;GO:0006541;, , F:asparagine synthase (glutamine-hydrolyzing) activity;, P:asparagine biosynthetic process; P:glutamine metabolic process;|Q9NWL6 D3DPH6 Q3LIC3 Q4ZG45,Asparagine synthetase domain-containing protein 1,HCV NS3-transactivated protein 1;, PF00733;, GO:0004066;GO:0006529;GO:0006541;, , F:asparagine synthase (glutamine-hydrolyzing) activity;, P:asparagine biosynthetic process; P:glutamine metabolic process;|Q9NWL6 D3DPH6 Q3LIC3 Q4ZG45,Asparagine synthetase domain-containing protein 1,HCV NS3-transactivated protein 1;, PF00733;, GO:0004066;GO:0006529;GO:0006541;, , F:asparagine synthase (glutamine-hydrolyzing) activity;, P:asparagine biosynthetic process; P:glutamine metabolic process;|Q9NWL6 D3DPH6 Q3LIC3 Q4ZG45,Asparagine synthetase domain-containing protein 1,HCV NS3-transactivated protein 1;, PF00733;, GO:0004066;GO:0006529;GO:0006541;, , F:asparagine synthase (glutamine-hydrolyzing) activity;, P:asparagine biosynthetic process; P:glutamine metabolic process;|Q7Z5J8 Q3ZCS6 Q4G0M2 Q6ZU02,Ankyrin and armadillo repeat-containing protein,, PF00514;, GO:0016021;, C:integral component of membrane;|Q7Z5J8 Q3ZCS6 Q4G0M2 Q6ZU02,Ankyrin and armadillo repeat-containing protein,, PF00514;, GO:0016021;, C:integral component of membrane;|Q7Z5J8 Q3ZCS6 Q4G0M2 Q6ZU02,Ankyrin and armadillo repeat-containing protein,, PF00514;, GO:0016021;, C:integral component of membrane;|Q9H4B0 Q96EV9 Q96NH5,Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03179},N6-L-threonylcarbamoyladenine synthase {ECO:0000255|HAMAP-Rule:MF_03179};O-sialoglycoprotein endopeptidase-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03179};t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEPL1 {ECO:0000255|HAMAP-Rule:MF_03179};tRNA threonylcarbamoyladenosine biosynthesis protein OSGEPL1 {ECO:0000255|HAMAP-Rule:MF_03179};, PF00814;, GO:0000408;GO:0005739;GO:0046872;GO:0061711;GO:0002949;, C:EKC/KEOPS complex; C:mitochondrion;, F:metal ion binding; F:N(6)-L-threonylcarbamoyladenine synthase activity;, P:tRNA threonylcarbamoyladenosine modification;|Q9H4B0 Q96EV9 Q96NH5,Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03179},N6-L-threonylcarbamoyladenine synthase {ECO:0000255|HAMAP-Rule:MF_03179};O-sialoglycoprotein endopeptidase-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03179};t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEPL1 {ECO:0000255|HAMAP-Rule:MF_03179};tRNA threonylcarbamoyladenosine biosynthesis protein OSGEPL1 {ECO:0000255|HAMAP-Rule:MF_03179};, PF00814;, GO:0000408;GO:0005739;GO:0046872;GO:0061711;GO:0002949;, C:EKC/KEOPS complex; C:mitochondrion;, F:metal ion binding; F:N(6)-L-threonylcarbamoyladenine synthase activity;, P:tRNA threonylcarbamoyladenosine modification;|Q9H4B0 Q96EV9 Q96NH5,Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03179},N6-L-threonylcarbamoyladenine synthase {ECO:0000255|HAMAP-Rule:MF_03179};O-sialoglycoprotein endopeptidase-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03179};t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEPL1 {ECO:0000255|HAMAP-Rule:MF_03179};tRNA threonylcarbamoyladenosine biosynthesis protein OSGEPL1 {ECO:0000255|HAMAP-Rule:MF_03179};, PF00814;, GO:0000408;GO:0005739;GO:0046872;GO:0061711;GO:0002949;, C:EKC/KEOPS complex; C:mitochondrion;, F:metal ion binding; F:N(6)-L-threonylcarbamoyladenine synthase activity;, P:tRNA threonylcarbamoyladenosine modification;|Q9H4B0 Q96EV9 Q96NH5,Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03179},N6-L-threonylcarbamoyladenine synthase {ECO:0000255|HAMAP-Rule:MF_03179};O-sialoglycoprotein endopeptidase-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03179};t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEPL1 {ECO:0000255|HAMAP-Rule:MF_03179};tRNA threonylcarbamoyladenosine biosynthesis protein OSGEPL1 {ECO:0000255|HAMAP-Rule:MF_03179};, PF00814;, GO:0000408;GO:0005739;GO:0046872;GO:0061711;GO:0002949;, C:EKC/KEOPS complex; C:mitochondrion;, F:metal ion binding; F:N(6)-L-threonylcarbamoyladenine synthase activity;, P:tRNA threonylcarbamoyladenosine modification;|Q9P0S3 B2R8W3 D3DPH9,ORM1-like protein 1,Adoplin-1;, PF04061;, GO:0005783;GO:0005789;GO:0016021;GO:0035339;GO:0090156;GO:0006672;GO:1900060;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:SPOTS complex;, , P:cellular sphingolipid homeostasis; P:ceramide metabolic process; P:negative regulation of ceramide biosynthetic process;|Q9P0S3 B2R8W3 D3DPH9,ORM1-like protein 1,Adoplin-1;, PF04061;, GO:0005783;GO:0005789;GO:0016021;GO:0035339;GO:0090156;GO:0006672;GO:1900060;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:SPOTS complex;, , P:cellular sphingolipid homeostasis; P:ceramide metabolic process; P:negative regulation of ceramide biosynthetic process;|P54277 D3DPI1 Q4VAL4 Q5FBZ3 Q5FBZ6 Q5FBZ8,PMS1 protein homolog 1,DNA mismatch repair protein PMS1;, PF01119;PF00505;, GO:0032300;GO:0005634;GO:0005524;GO:0016887;GO:0003677;GO:0019899;GO:0030983;GO:0006298;GO:0042493;, C:mismatch repair complex; C:nucleus;, F:ATP binding; F:ATPase activity; F:DNA binding; F:enzyme binding; F:mismatched DNA binding;, P:mismatch repair; P:response to drug;|P54277 D3DPI1 Q4VAL4 Q5FBZ3 Q5FBZ6 Q5FBZ8,PMS1 protein homolog 1,DNA mismatch repair protein PMS1;, PF01119;PF00505;, GO:0032300;GO:0005634;GO:0005524;GO:0016887;GO:0003677;GO:0019899;GO:0030983;GO:0006298;GO:0042493;, C:mismatch repair complex; C:nucleus;, F:ATP binding; F:ATPase activity; F:DNA binding; F:enzyme binding; F:mismatched DNA binding;, P:mismatch repair; P:response to drug;|P54277 D3DPI1 Q4VAL4 Q5FBZ3 Q5FBZ6 Q5FBZ8,PMS1 protein homolog 1,DNA mismatch repair protein PMS1;, PF01119;PF00505;, GO:0032300;GO:0005634;GO:0005524;GO:0016887;GO:0003677;GO:0019899;GO:0030983;GO:0006298;GO:0042493;, C:mismatch repair complex; C:nucleus;, F:ATP binding; F:ATPase activity; F:DNA binding; F:enzyme binding; F:mismatched DNA binding;, P:mismatch repair; P:response to drug;|O14793 A1C2J7 A1C2K0 Q6B0H2,Growth/differentiation factor 8,Myostatin;, PF00019;PF00688;, GO:0005737;GO:0005615;GO:0005125;GO:0008083;GO:0008201;GO:0042802;GO:0042803;GO:0005102;GO:0071549;GO:0046716;GO:0007517;GO:0014839;GO:0046627;GO:0033673;GO:0014741;GO:0045662;GO:2000818;GO:0051898;GO:1902725;GO:1902723;GO:0048632;GO:0022602;GO:0010592;GO:0010759;GO:0010862;GO:0045893;GO:0051602;GO:0043627;GO:0045471;GO:0009629;GO:0009408;GO:0014850;GO:0033574;GO:0014732;GO:0060395;GO:0007179;, C:cytoplasm; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:heparin binding; F:identical protein binding; F:protein homodimerization activity; F:signaling receptor binding;, P:cellular response to dexamethasone stimulus; P:muscle cell cellular homeostasis; P:muscle organ development; P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of kinase activity; P:negative regulation of muscle hypertrophy; P:negative regulation of myoblast differentiation; P:negative regulation of myoblast proliferation; P:negative regulation of protein kinase B signaling; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:negative regulation of skeletal muscle tissue growth; P:ovulation cycle process; P:positive regulation of lamellipodium assembly; P:positive regulation of macrophage chemotaxis; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:response to electrical stimulus; P:response to estrogen; P:response to ethanol; P:response to gravity; P:response to heat; P:response to muscle activity; P:response to testosterone; P:skeletal muscle atrophy; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway;|Q9BSF0 D3DPI3 P0C876 Q53TC7,Small membrane A-kinase anchor protein,, PF15127;, GO:0005886;GO:0034237;, C:plasma membrane;, F:protein kinase A regulatory subunit binding;|Q6NVY1 D3DPI4 Q53GA8 Q53GF2 Q53RF7 Q53TC6 Q92931 Q9BS94,3-hydroxyisobutyryl-CoA hydrolase, mitochondrial,3-hydroxyisobutyryl-coenzyme A hydrolase;, PF16113;, GO:0005759;GO:0005739;GO:0003860;GO:0009083;GO:0006574;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxyisobutyryl-CoA hydrolase activity;, P:branched-chain amino acid catabolic process; P:valine catabolic process;|P49441,Inositol polyphosphate 1-phosphatase,, PF00459;, GO:0005829;GO:0004441;GO:0046872;GO:0046855;GO:0043647;GO:0006796;GO:0046854;GO:0007165;, C:cytosol;, F:inositol-1,4-bisphosphate 1-phosphatase activity; F:metal ion binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphate-containing compound metabolic process; P:phosphatidylinositol phosphorylation; P:signal transduction;|P49441,Inositol polyphosphate 1-phosphatase,, PF00459;, GO:0005829;GO:0004441;GO:0046872;GO:0046855;GO:0043647;GO:0006796;GO:0046854;GO:0007165;, C:cytosol;, F:inositol-1,4-bisphosphate 1-phosphatase activity; F:metal ion binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphate-containing compound metabolic process; P:phosphatidylinositol phosphorylation; P:signal transduction;|P49441,Inositol polyphosphate 1-phosphatase,, PF00459;, GO:0005829;GO:0004441;GO:0046872;GO:0046855;GO:0043647;GO:0006796;GO:0046854;GO:0007165;, C:cytosol;, F:inositol-1,4-bisphosphate 1-phosphatase activity; F:metal ion binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphate-containing compound metabolic process; P:phosphatidylinositol phosphorylation; P:signal transduction;|P49441,Inositol polyphosphate 1-phosphatase,, PF00459;, GO:0005829;GO:0004441;GO:0046872;GO:0046855;GO:0043647;GO:0006796;GO:0046854;GO:0007165;, C:cytosol;, F:inositol-1,4-bisphosphate 1-phosphatase activity; F:metal ion binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphate-containing compound metabolic process; P:phosphatidylinositol phosphorylation; P:signal transduction;|P49441,Inositol polyphosphate 1-phosphatase,, PF00459;, GO:0005829;GO:0004441;GO:0046872;GO:0046855;GO:0043647;GO:0006796;GO:0046854;GO:0007165;, C:cytosol;, F:inositol-1,4-bisphosphate 1-phosphatase activity; F:metal ion binding;, P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphate-containing compound metabolic process; P:phosphatidylinositol phosphorylation; P:signal transduction;|Q15651 B2RD37 Q5HYD3 Q7RTT0 Q969M5 Q9BZT7,High mobility group nucleosome-binding domain-containing protein 3,Thyroid receptor-interacting protein 7;, PF01101;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0031492;GO:0046966;GO:0006325;GO:0045944;GO:0061178;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:nucleosomal DNA binding; F:thyroid hormone receptor binding;, P:chromatin organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of insulin secretion involved in cellular response to glucose stimulus;|Q6ZSS7 D3KSZ4 Q86TH2 Q9NXM3,Major facilitator superfamily domain-containing protein 6,Macrophage MHC class I receptor 2 homolog;, PF12832;, GO:0016021;GO:0016020;GO:0005886;GO:0042590;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class I;|Q6ZSS7 D3KSZ4 Q86TH2 Q9NXM3,Major facilitator superfamily domain-containing protein 6,Macrophage MHC class I receptor 2 homolog;, PF12832;, GO:0016021;GO:0016020;GO:0005886;GO:0042590;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class I;|Q6ZSS7 D3KSZ4 Q86TH2 Q9NXM3,Major facilitator superfamily domain-containing protein 6,Macrophage MHC class I receptor 2 homolog;, PF12832;, GO:0016021;GO:0016020;GO:0005886;GO:0042590;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class I;|A6NFY4 B4DYG6,Nuclear envelope integral membrane protein 2,, PF10225;, GO:0016021;GO:0005635;GO:0005637;, C:integral component of membrane; C:nuclear envelope; C:nuclear inner membrane;|Q13506 O75383 O75384 Q6GTU1 Q9UEV1,NGFI-A-binding protein 1,EGR-1-binding protein 1;Transcriptional regulatory protein p54;, PF04902;PF04904;PF04905;, GO:0005654;GO:0005634;GO:0003712;GO:0008134;GO:0001958;GO:0042552;GO:0045892;GO:0007399;GO:0045682;GO:0006355;GO:0014037;, C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription factor binding;, P:endochondral ossification; P:myelination; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:regulation of epidermis development; P:regulation of transcription, DNA-templated; P:Schwann cell differentiation;|Q13506 O75383 O75384 Q6GTU1 Q9UEV1,NGFI-A-binding protein 1,EGR-1-binding protein 1;Transcriptional regulatory protein p54;, PF04902;PF04904;PF04905;, GO:0005654;GO:0005634;GO:0003712;GO:0008134;GO:0001958;GO:0042552;GO:0045892;GO:0007399;GO:0045682;GO:0006355;GO:0014037;, C:nucleoplasm; C:nucleus;, F:transcription coregulator activity; F:transcription factor binding;, P:endochondral ossification; P:myelination; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:regulation of epidermis development; P:regulation of transcription, DNA-templated; P:Schwann cell differentiation; scaffold75 indexed_genome mRNA 7324819 7343736 . - . ID=transcript_11656;O75515 O75516 O75517 O75518 Q659B7 Q92944 Q99688,Myc box-dependent-interacting protein 1,Amphiphysin II;Amphiphysin-like protein;Box-dependent myc-interacting protein 1;Bridging integrator 1;, PF03114;PF14604;, GO:0015629;GO:0030424;GO:0043194;GO:0005737;GO:0005829;GO:0030425;GO:0005768;GO:0031674;GO:0060987;GO:0016020;GO:0033268;GO:0005635;GO:0005634;GO:0005886;GO:0008021;GO:0030315;GO:0031982;GO:0030018;GO:0051015;GO:0019828;GO:0051087;GO:0030276;GO:0042802;GO:0005543;GO:0002020;GO:0070063;GO:0048156;GO:0007010;GO:0006897;GO:0008333;GO:0060988;GO:0061024;GO:1902430;GO:1902960;GO:1904878;GO:1901380;GO:1903946;GO:0051647;GO:0006997;GO:0030838;GO:0043065;GO:0048711;GO:0071156;GO:0030100;GO:0086091;GO:0045664;GO:0033292;GO:0016032;, C:actin cytoskeleton; C:axon; C:axon initial segment; C:cytoplasm; C:cytosol; C:dendrite; C:endosome; C:I band; C:lipid tube; C:membrane; C:node of Ranvier; C:nuclear envelope; C:nucleus; C:plasma membrane; C:synaptic vesicle; C:T-tubule; C:vesicle; C:Z disc;, F:actin filament binding; F:aspartic-type endopeptidase inhibitor activity; F:chaperone binding; F:clathrin binding; F:identical protein binding; F:phospholipid binding; F:protease binding; F:RNA polymerase binding; F:tau protein binding;, P:cytoskeleton organization; P:endocytosis; P:endosome to lysosome transport; P:lipid tube assembly; P:membrane organization; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of ventricular cardiac muscle cell action potential; P:nucleus localization; P:nucleus organization; P:positive regulation of actin filament polymerization; P:positive regulation of apoptotic process; P:positive regulation of astrocyte differentiation; P:regulation of cell cycle arrest; P:regulation of endocytosis; P:regulation of heart rate by cardiac conduction; P:regulation of neuron differentiation; P:T-tubule organization; P:viral process;|O75515 O75516 O75517 O75518 Q659B7 Q92944 Q99688,Myc box-dependent-interacting protein 1,Amphiphysin II;Amphiphysin-like protein;Box-dependent myc-interacting protein 1;Bridging integrator 1;, PF03114;PF14604;, GO:0015629;GO:0030424;GO:0043194;GO:0005737;GO:0005829;GO:0030425;GO:0005768;GO:0031674;GO:0060987;GO:0016020;GO:0033268;GO:0005635;GO:0005634;GO:0005886;GO:0008021;GO:0030315;GO:0031982;GO:0030018;GO:0051015;GO:0019828;GO:0051087;GO:0030276;GO:0042802;GO:0005543;GO:0002020;GO:0070063;GO:0048156;GO:0007010;GO:0006897;GO:0008333;GO:0060988;GO:0061024;GO:1902430;GO:1902960;GO:1904878;GO:1901380;GO:1903946;GO:0051647;GO:0006997;GO:0030838;GO:0043065;GO:0048711;GO:0071156;GO:0030100;GO:0086091;GO:0045664;GO:0033292;GO:0016032;, C:actin cytoskeleton; C:axon; C:axon initial segment; C:cytoplasm; C:cytosol; C:dendrite; C:endosome; C:I band; C:lipid tube; C:membrane; C:node of Ranvier; C:nuclear envelope; C:nucleus; C:plasma membrane; C:synaptic vesicle; C:T-tubule; C:vesicle; C:Z disc;, F:actin filament binding; F:aspartic-type endopeptidase inhibitor activity; F:chaperone binding; F:clathrin binding; F:identical protein binding; F:phospholipid binding; F:protease binding; F:RNA polymerase binding; F:tau protein binding;, P:cytoskeleton organization; P:endocytosis; P:endosome to lysosome transport; P:lipid tube assembly; P:membrane organization; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of ventricular cardiac muscle cell action potential; P:nucleus localization; P:nucleus organization; P:positive regulation of actin filament polymerization; P:positive regulation of apoptotic process; P:positive regulation of astrocyte differentiation; P:regulation of cell cycle arrest; P:regulation of endocytosis; P:regulation of heart rate by cardiac conduction; P:regulation of neuron differentiation; P:T-tubule organization; P:viral process;|O75515 O75516 O75517 O75518 Q659B7 Q92944 Q99688,Myc box-dependent-interacting protein 1,Amphiphysin II;Amphiphysin-like protein;Box-dependent myc-interacting protein 1;Bridging integrator 1;, PF03114;PF14604;, GO:0015629;GO:0030424;GO:0043194;GO:0005737;GO:0005829;GO:0030425;GO:0005768;GO:0031674;GO:0060987;GO:0016020;GO:0033268;GO:0005635;GO:0005634;GO:0005886;GO:0008021;GO:0030315;GO:0031982;GO:0030018;GO:0051015;GO:0019828;GO:0051087;GO:0030276;GO:0042802;GO:0005543;GO:0002020;GO:0070063;GO:0048156;GO:0007010;GO:0006897;GO:0008333;GO:0060988;GO:0061024;GO:1902430;GO:1902960;GO:1904878;GO:1901380;GO:1903946;GO:0051647;GO:0006997;GO:0030838;GO:0043065;GO:0048711;GO:0071156;GO:0030100;GO:0086091;GO:0045664;GO:0033292;GO:0016032;, C:actin cytoskeleton; C:axon; C:axon initial segment; C:cytoplasm; C:cytosol; C:dendrite; C:endosome; C:I band; C:lipid tube; C:membrane; C:node of Ranvier; C:nuclear envelope; C:nucleus; C:plasma membrane; C:synaptic vesicle; C:T-tubule; C:vesicle; C:Z disc;, F:actin filament binding; F:aspartic-type endopeptidase inhibitor activity; F:chaperone binding; F:clathrin binding; F:identical protein binding; F:phospholipid binding; F:protease binding; F:RNA polymerase binding; F:tau protein binding;, P:cytoskeleton organization; P:endocytosis; P:endosome to lysosome transport; P:lipid tube assembly; P:membrane organization; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of ventricular cardiac muscle cell action potential; P:nucleus localization; P:nucleus organization; P:positive regulation of actin filament polymerization; P:positive regulation of apoptotic process; P:positive regulation of astrocyte differentiation; P:regulation of cell cycle arrest; P:regulation of endocytosis; P:regulation of heart rate by cardiac conduction; P:regulation of neuron differentiation; P:T-tubule organization; P:viral process;|O75515 O75516 O75517 O75518 Q659B7 Q92944 Q99688,Myc box-dependent-interacting protein 1,Amphiphysin II;Amphiphysin-like protein;Box-dependent myc-interacting protein 1;Bridging integrator 1;, PF03114;PF14604;, GO:0015629;GO:0030424;GO:0043194;GO:0005737;GO:0005829;GO:0030425;GO:0005768;GO:0031674;GO:0060987;GO:0016020;GO:0033268;GO:0005635;GO:0005634;GO:0005886;GO:0008021;GO:0030315;GO:0031982;GO:0030018;GO:0051015;GO:0019828;GO:0051087;GO:0030276;GO:0042802;GO:0005543;GO:0002020;GO:0070063;GO:0048156;GO:0007010;GO:0006897;GO:0008333;GO:0060988;GO:0061024;GO:1902430;GO:1902960;GO:1904878;GO:1901380;GO:1903946;GO:0051647;GO:0006997;GO:0030838;GO:0043065;GO:0048711;GO:0071156;GO:0030100;GO:0086091;GO:0045664;GO:0033292;GO:0016032;, C:actin cytoskeleton; C:axon; C:axon initial segment; C:cytoplasm; C:cytosol; C:dendrite; C:endosome; C:I band; C:lipid tube; C:membrane; C:node of Ranvier; C:nuclear envelope; C:nucleus; C:plasma membrane; C:synaptic vesicle; C:T-tubule; C:vesicle; C:Z disc;, F:actin filament binding; F:aspartic-type endopeptidase inhibitor activity; F:chaperone binding; F:clathrin binding; F:identical protein binding; F:phospholipid binding; F:protease binding; F:RNA polymerase binding; F:tau protein binding;, P:cytoskeleton organization; P:endocytosis; P:endosome to lysosome transport; P:lipid tube assembly; P:membrane organization; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of ventricular cardiac muscle cell action potential; P:nucleus localization; P:nucleus organization; P:positive regulation of actin filament polymerization; P:positive regulation of apoptotic process; P:positive regulation of astrocyte differentiation; P:regulation of cell cycle arrest; P:regulation of endocytosis; P:regulation of heart rate by cardiac conduction; P:regulation of neuron differentiation; P:T-tubule organization; P:viral process;|O75515 O75516 O75517 O75518 Q659B7 Q92944 Q99688,Myc box-dependent-interacting protein 1,Amphiphysin II;Amphiphysin-like protein;Box-dependent myc-interacting protein 1;Bridging integrator 1;, PF03114;PF14604;, GO:0015629;GO:0030424;GO:0043194;GO:0005737;GO:0005829;GO:0030425;GO:0005768;GO:0031674;GO:0060987;GO:0016020;GO:0033268;GO:0005635;GO:0005634;GO:0005886;GO:0008021;GO:0030315;GO:0031982;GO:0030018;GO:0051015;GO:0019828;GO:0051087;GO:0030276;GO:0042802;GO:0005543;GO:0002020;GO:0070063;GO:0048156;GO:0007010;GO:0006897;GO:0008333;GO:0060988;GO:0061024;GO:1902430;GO:1902960;GO:1904878;GO:1901380;GO:1903946;GO:0051647;GO:0006997;GO:0030838;GO:0043065;GO:0048711;GO:0071156;GO:0030100;GO:0086091;GO:0045664;GO:0033292;GO:0016032;, C:actin cytoskeleton; C:axon; C:axon initial segment; C:cytoplasm; C:cytosol; C:dendrite; C:endosome; C:I band; C:lipid tube; C:membrane; C:node of Ranvier; C:nuclear envelope; C:nucleus; C:plasma membrane; C:synaptic vesicle; C:T-tubule; C:vesicle; C:Z disc;, F:actin filament binding; F:aspartic-type endopeptidase inhibitor activity; F:chaperone binding; F:clathrin binding; F:identical protein binding; F:phospholipid binding; F:protease binding; F:RNA polymerase binding; F:tau protein binding;, P:cytoskeleton organization; P:endocytosis; P:endosome to lysosome transport; P:lipid tube assembly; P:membrane organization; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of ventricular cardiac muscle cell action potential; P:nucleus localization; P:nucleus organization; P:positive regulation of actin filament polymerization; P:positive regulation of apoptotic process; P:positive regulation of astrocyte differentiation; P:regulation of cell cycle arrest; P:regulation of endocytosis; P:regulation of heart rate by cardiac conduction; P:regulation of neuron differentiation; P:T-tubule organization; P:viral process;|O75515 O75516 O75517 O75518 Q659B7 Q92944 Q99688,Myc box-dependent-interacting protein 1,Amphiphysin II;Amphiphysin-like protein;Box-dependent myc-interacting protein 1;Bridging integrator 1;, PF03114;PF14604;, GO:0015629;GO:0030424;GO:0043194;GO:0005737;GO:0005829;GO:0030425;GO:0005768;GO:0031674;GO:0060987;GO:0016020;GO:0033268;GO:0005635;GO:0005634;GO:0005886;GO:0008021;GO:0030315;GO:0031982;GO:0030018;GO:0051015;GO:0019828;GO:0051087;GO:0030276;GO:0042802;GO:0005543;GO:0002020;GO:0070063;GO:0048156;GO:0007010;GO:0006897;GO:0008333;GO:0060988;GO:0061024;GO:1902430;GO:1902960;GO:1904878;GO:1901380;GO:1903946;GO:0051647;GO:0006997;GO:0030838;GO:0043065;GO:0048711;GO:0071156;GO:0030100;GO:0086091;GO:0045664;GO:0033292;GO:0016032;, C:actin cytoskeleton; C:axon; C:axon initial segment; C:cytoplasm; C:cytosol; C:dendrite; C:endosome; C:I band; C:lipid tube; C:membrane; C:node of Ranvier; C:nuclear envelope; C:nucleus; C:plasma membrane; C:synaptic vesicle; C:T-tubule; C:vesicle; C:Z disc;, F:actin filament binding; F:aspartic-type endopeptidase inhibitor activity; F:chaperone binding; F:clathrin binding; F:identical protein binding; F:phospholipid binding; F:protease binding; F:RNA polymerase binding; F:tau protein binding;, P:cytoskeleton organization; P:endocytosis; P:endosome to lysosome transport; P:lipid tube assembly; P:membrane organization; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of ventricular cardiac muscle cell action potential; P:nucleus localization; P:nucleus organization; P:positive regulation of actin filament polymerization; P:positive regulation of apoptotic process; P:positive regulation of astrocyte differentiation; P:regulation of cell cycle arrest; P:regulation of endocytosis; P:regulation of heart rate by cardiac conduction; P:regulation of neuron differentiation; P:T-tubule organization; P:viral process; scaffold75 indexed_genome mRNA 7345757 7353693 . - . ID=transcript_11657;O75515 O75516 O75517 O75518 Q659B7 Q92944 Q99688,Myc box-dependent-interacting protein 1,Amphiphysin II;Amphiphysin-like protein;Box-dependent myc-interacting protein 1;Bridging integrator 1;, PF03114;PF14604;, GO:0015629;GO:0030424;GO:0043194;GO:0005737;GO:0005829;GO:0030425;GO:0005768;GO:0031674;GO:0060987;GO:0016020;GO:0033268;GO:0005635;GO:0005634;GO:0005886;GO:0008021;GO:0030315;GO:0031982;GO:0030018;GO:0051015;GO:0019828;GO:0051087;GO:0030276;GO:0042802;GO:0005543;GO:0002020;GO:0070063;GO:0048156;GO:0007010;GO:0006897;GO:0008333;GO:0060988;GO:0061024;GO:1902430;GO:1902960;GO:1904878;GO:1901380;GO:1903946;GO:0051647;GO:0006997;GO:0030838;GO:0043065;GO:0048711;GO:0071156;GO:0030100;GO:0086091;GO:0045664;GO:0033292;GO:0016032;, C:actin cytoskeleton; C:axon; C:axon initial segment; C:cytoplasm; C:cytosol; C:dendrite; C:endosome; C:I band; C:lipid tube; C:membrane; C:node of Ranvier; C:nuclear envelope; C:nucleus; C:plasma membrane; C:synaptic vesicle; C:T-tubule; C:vesicle; C:Z disc;, F:actin filament binding; F:aspartic-type endopeptidase inhibitor activity; F:chaperone binding; F:clathrin binding; F:identical protein binding; F:phospholipid binding; F:protease binding; F:RNA polymerase binding; F:tau protein binding;, P:cytoskeleton organization; P:endocytosis; P:endosome to lysosome transport; P:lipid tube assembly; P:membrane organization; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of ventricular cardiac muscle cell action potential; P:nucleus localization; P:nucleus organization; P:positive regulation of actin filament polymerization; P:positive regulation of apoptotic process; P:positive regulation of astrocyte differentiation; P:regulation of cell cycle arrest; P:regulation of endocytosis; P:regulation of heart rate by cardiac conduction; P:regulation of neuron differentiation; P:T-tubule organization; P:viral process; scaffold75 indexed_genome mRNA 7511846 7541318 . - . ID=transcript_11658;P19447 Q53QM0,General transcription and DNA repair factor IIH helicase subunit XPB,Basic transcription factor 2 89 kDa subunit;DNA excision repair protein ERCC-3;DNA repair protein complementing XP-B cells;TFIIH basal transcription factor complex 89 kDa subunit;Xeroderma pigmentosum group B-complementing protein;, PF16203;PF13625;PF04851;, GO:0005654;GO:0000112;GO:0005634;GO:0005669;GO:0000439;GO:0005675;GO:0097550;GO:0043138;GO:0005524;GO:0016887;GO:0003684;GO:0003677;GO:0008022;GO:0047485;GO:0008134;GO:0006370;GO:0006915;GO:0006281;GO:0006265;GO:0048568;GO:0070911;GO:0035315;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043065;GO:0008104;GO:1901990;GO:0006979;GO:0009411;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;GO:0016032;, C:nucleoplasm; C:nucleotide-excision repair factor 3 complex; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex; C:transcription preinitiation complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:ATPase activity; F:damaged DNA binding; F:DNA binding; F:protein C-terminus binding; F:protein N-terminus binding; F:transcription factor binding;, P:7-methylguanosine mRNA capping; P:apoptotic process; P:DNA repair; P:DNA topological change; P:embryonic organ development; P:global genome nucleotide-excision repair; P:hair cell differentiation; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of apoptotic process; P:protein localization; P:regulation of mitotic cell cycle phase transition; P:response to oxidative stress; P:response to UV; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; P:viral process;|P19447 Q53QM0,General transcription and DNA repair factor IIH helicase subunit XPB,Basic transcription factor 2 89 kDa subunit;DNA excision repair protein ERCC-3;DNA repair protein complementing XP-B cells;TFIIH basal transcription factor complex 89 kDa subunit;Xeroderma pigmentosum group B-complementing protein;, PF16203;PF13625;PF04851;, GO:0005654;GO:0000112;GO:0005634;GO:0005669;GO:0000439;GO:0005675;GO:0097550;GO:0043138;GO:0005524;GO:0016887;GO:0003684;GO:0003677;GO:0008022;GO:0047485;GO:0008134;GO:0006370;GO:0006915;GO:0006281;GO:0006265;GO:0048568;GO:0070911;GO:0035315;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043065;GO:0008104;GO:1901990;GO:0006979;GO:0009411;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;GO:0016032;, C:nucleoplasm; C:nucleotide-excision repair factor 3 complex; C:nucleus; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex; C:transcription preinitiation complex;, F:3'-5' DNA helicase activity; F:ATP binding; F:ATPase activity; F:damaged DNA binding; F:DNA binding; F:protein C-terminus binding; F:protein N-terminus binding; F:transcription factor binding;, P:7-methylguanosine mRNA capping; P:apoptotic process; P:DNA repair; P:DNA topological change; P:embryonic organ development; P:global genome nucleotide-excision repair; P:hair cell differentiation; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of apoptotic process; P:protein localization; P:regulation of mitotic cell cycle phase transition; P:response to oxidative stress; P:response to UV; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; P:viral process; scaffold75 indexed_genome mRNA 7554693 7589786 . - . ID=transcript_11659;Q9Y2U5 B9EG87 Q53QL9 Q53S75 Q59GZ6 Q8NC32 Q9NYK3,Mitogen-activated protein kinase kinase kinase 2,MAPK/ERK kinase kinase 2;, PF00564;PF00069;, GO:0005829;GO:0005654;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000187;GO:0071260;GO:0045893;GO:0006468;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:cellular response to mechanical stimulus; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation;|P68104 P04719 P04720 Q6IQ15,Elongation factor 1-alpha 1,Elongation factor Tu;Eukaryotic elongation factor 1 A-1;Leukocyte receptor cluster member 7;, PF00009;PF03144;PF03143;, GO:0030864;GO:0005737;GO:0098574;GO:0005829;GO:0005853;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0016020;GO:0005730;GO:0005634;GO:0005886;GO:0032587;GO:0034774;GO:0005516;GO:0005525;GO:0003924;GO:0019900;GO:0019901;GO:0003723;GO:0003746;GO:0000049;GO:0071364;GO:0043312;GO:1904714;GO:1900022;GO:0006412;GO:0006414;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of lysosomal membrane; C:cytosol; C:eukaryotic translation elongation factor 1 complex; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:membrane; C:nucleolus; C:nucleus; C:plasma membrane; C:ruffle membrane; C:secretory granule lumen;, F:calmodulin binding; F:GTP binding; F:GTPase activity; F:kinase binding; F:protein kinase binding; F:RNA binding; F:translation elongation factor activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:neutrophil degranulation; P:regulation of chaperone-mediated autophagy; P:regulation of D-erythro-sphingosine kinase activity; P:translation; P:translational elongation;|Q9Y2U5 B9EG87 Q53QL9 Q53S75 Q59GZ6 Q8NC32 Q9NYK3,Mitogen-activated protein kinase kinase kinase 2,MAPK/ERK kinase kinase 2;, PF00564;PF00069;, GO:0005829;GO:0005654;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000187;GO:0071260;GO:0045893;GO:0006468;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:cellular response to mechanical stimulus; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; scaffold75 indexed_genome mRNA 7702940 7710916 . - . ID=transcript_11660;P04070 B4DPQ7 Q15189 Q15190 Q16001 Q53S74 Q9UC55,Vitamin K-dependent protein C,Anticoagulant protein C;Autoprothrombin IIA;Blood coagulation factor XIV;, PF00008;PF00594;PF00089;, GO:0005783;GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0005796;GO:0005509;GO:0004252;GO:0007596;GO:0044267;GO:0006888;GO:0043066;GO:0030195;GO:0050819;GO:0050728;GO:1903142;GO:0043687;GO:0006508;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi lumen;, F:calcium ion binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:cellular protein metabolic process; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of apoptotic process; P:negative regulation of blood coagulation; P:negative regulation of coagulation; P:negative regulation of inflammatory response; P:positive regulation of establishment of endothelial barrier; P:post-translational protein modification; P:proteolysis;|P04070 B4DPQ7 Q15189 Q15190 Q16001 Q53S74 Q9UC55,Vitamin K-dependent protein C,Anticoagulant protein C;Autoprothrombin IIA;Blood coagulation factor XIV;, PF00008;PF00594;PF00089;, GO:0005783;GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0005796;GO:0005509;GO:0004252;GO:0007596;GO:0044267;GO:0006888;GO:0043066;GO:0030195;GO:0050819;GO:0050728;GO:1903142;GO:0043687;GO:0006508;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi lumen;, F:calcium ion binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:cellular protein metabolic process; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of apoptotic process; P:negative regulation of blood coagulation; P:negative regulation of coagulation; P:negative regulation of inflammatory response; P:positive regulation of establishment of endothelial barrier; P:post-translational protein modification; P:proteolysis;|P04070 B4DPQ7 Q15189 Q15190 Q16001 Q53S74 Q9UC55,Vitamin K-dependent protein C,Anticoagulant protein C;Autoprothrombin IIA;Blood coagulation factor XIV;, PF00008;PF00594;PF00089;, GO:0005783;GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0005796;GO:0005509;GO:0004252;GO:0007596;GO:0044267;GO:0006888;GO:0043066;GO:0030195;GO:0050819;GO:0050728;GO:1903142;GO:0043687;GO:0006508;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi lumen;, F:calcium ion binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:cellular protein metabolic process; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of apoptotic process; P:negative regulation of blood coagulation; P:negative regulation of coagulation; P:negative regulation of inflammatory response; P:positive regulation of establishment of endothelial barrier; P:post-translational protein modification; P:proteolysis;|P04070 B4DPQ7 Q15189 Q15190 Q16001 Q53S74 Q9UC55,Vitamin K-dependent protein C,Anticoagulant protein C;Autoprothrombin IIA;Blood coagulation factor XIV;, PF00008;PF00594;PF00089;, GO:0005783;GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0005796;GO:0005509;GO:0004252;GO:0007596;GO:0044267;GO:0006888;GO:0043066;GO:0030195;GO:0050819;GO:0050728;GO:1903142;GO:0043687;GO:0006508;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi lumen;, F:calcium ion binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:cellular protein metabolic process; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of apoptotic process; P:negative regulation of blood coagulation; P:negative regulation of coagulation; P:negative regulation of inflammatory response; P:positive regulation of establishment of endothelial barrier; P:post-translational protein modification; P:proteolysis; scaffold75 indexed_genome mRNA 7711475 7713267 . - . ID=transcript_11661;P04070 B4DPQ7 Q15189 Q15190 Q16001 Q53S74 Q9UC55,Vitamin K-dependent protein C,Anticoagulant protein C;Autoprothrombin IIA;Blood coagulation factor XIV;, PF00008;PF00594;PF00089;, GO:0005783;GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0005796;GO:0005509;GO:0004252;GO:0007596;GO:0044267;GO:0006888;GO:0043066;GO:0030195;GO:0050819;GO:0050728;GO:1903142;GO:0043687;GO:0006508;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi lumen;, F:calcium ion binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:cellular protein metabolic process; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of apoptotic process; P:negative regulation of blood coagulation; P:negative regulation of coagulation; P:negative regulation of inflammatory response; P:positive regulation of establishment of endothelial barrier; P:post-translational protein modification; P:proteolysis; scaffold75 indexed_genome mRNA 7776939 7778681 . + . ID=transcript_11662;Q96ST2 Q2TB65 Q6P157 Q8N3E8 Q96MI7 Q9NV97 Q9NWH8,Protein IWS1 homolog,IWS1-like protein;, PF08711;, GO:0005654;GO:0005634;GO:0006397;GO:0016973;GO:2001253;GO:0090239;GO:0010793;GO:0050684;GO:0008380;GO:0006366;GO:0006368;, C:nucleoplasm; C:nucleus;, , P:mRNA processing; P:poly(A)+ mRNA export from nucleus; P:regulation of histone H3-K36 trimethylation; P:regulation of histone H4 acetylation; P:regulation of mRNA export from nucleus; P:regulation of mRNA processing; P:RNA splicing; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold76 indexed_genome mRNA 8748 15075 . + . ID=transcript_11663;Q5TGY3 Q5TGY4 Q6PJK1 Q6ZUQ6 Q99769 Q9NUF5,AT-hook DNA-binding motif-containing protein 1,, PF15735;, GO:0003677;, , F:DNA binding; scaffold76 indexed_genome mRNA 58272 128894 . + . ID=transcript_11664;Q9Y6W5 B4DZN0 O60794 Q9UDY7,Wiskott-Aldrich syndrome protein family member 2,Protein WAVE-2;Verprolin homology domain-containing protein 2;, PF02205;, GO:0015629;GO:0016323;GO:0005911;GO:0005829;GO:0005769;GO:0070062;GO:0030027;GO:0032991;GO:0001726;GO:0031209;GO:0045202;GO:0003779;GO:0071933;GO:0045296;GO:0051018;GO:0034237;GO:0017124;GO:0030036;GO:0030048;GO:0007188;GO:0001667;GO:0001525;GO:0006897;GO:0038096;GO:0030032;GO:0072673;GO:0035855;GO:0051497;GO:2000601;GO:0010592;GO:0098974;GO:0016601;GO:0048010;GO:0016032;, C:actin cytoskeleton; C:basolateral plasma membrane; C:cell-cell junction; C:cytosol; C:early endosome; C:extracellular exosome; C:lamellipodium; C:protein-containing complex; C:ruffle; C:SCAR complex; C:synapse;, F:actin binding; F:Arp2/3 complex binding; F:cadherin binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding; F:SH3 domain binding;, P:actin cytoskeleton organization; P:actin filament-based movement; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:ameboidal-type cell migration; P:angiogenesis; P:endocytosis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium assembly; P:lamellipodium morphogenesis; P:megakaryocyte development; P:negative regulation of stress fiber assembly; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:postsynaptic actin cytoskeleton organization; P:Rac protein signal transduction; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|Q92558 E1P5F2 Q5SZK7,Wiskott-Aldrich syndrome protein family member 1 {ECO:0000305},Protein WAVE-1;Verprolin homology domain-containing protein 1;, PF02205;, GO:0015629;GO:0005856;GO:0032839;GO:0005925;GO:0030027;GO:0005741;GO:0098794;GO:0032991;GO:0031209;GO:0003779;GO:0071933;GO:0051018;GO:0034237;GO:0030036;GO:0030041;GO:1990416;GO:0097484;GO:0098939;GO:0072673;GO:0070584;GO:0098885;GO:2000601;GO:0051388;GO:0065003;GO:0016601;GO:0006898;, C:actin cytoskeleton; C:cytoskeleton; C:dendrite cytoplasm; C:focal adhesion; C:lamellipodium; C:mitochondrial outer membrane; C:postsynapse; C:protein-containing complex; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dendritic transport of mitochondrion; P:lamellipodium morphogenesis; P:mitochondrion morphogenesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:protein-containing complex assembly; P:Rac protein signal transduction; P:receptor-mediated endocytosis; scaffold76 indexed_genome mRNA 135884 137196 . - . ID=transcript_11665;P46089 A8K570,G-protein coupled receptor 3,ACCA orphan receptor;, PF00001;, GO:0005737;GO:0005887;GO:0005886;GO:0004930;GO:0007189;GO:0120162;GO:0040020;GO:0019222;, C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:positive regulation of cold-induced thermogenesis; P:regulation of meiotic nuclear division; P:regulation of metabolic process; scaffold76 indexed_genome mRNA 148340 152370 . + . ID=transcript_11666;Q6UWJ8 B2RPJ0 Q5JXD6,CD164 sialomucin-like 2 protein,, PF05283;, GO:0031410;GO:0016021;, C:cytoplasmic vesicle; C:integral component of membrane; scaffold76 indexed_genome mRNA 171640 188368 . + . ID=transcript_11667;O95382 A2ACE8 A2VDG4 A2VDG5 Q59HF4 Q5SSD4 Q75PK3 Q96B75,Mitogen-activated protein kinase kinase kinase 6,Apoptosis signal-regulating kinase 2;, PF19039;PF13281;PF00069;, GO:0005524;GO:0000287;GO:0004709;GO:0004672;GO:0106310;GO:0106311;GO:0007257;GO:0000186;GO:0006468;GO:0007165;, , F:ATP binding; F:magnesium ion binding; F:MAP kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPKK activity; P:protein phosphorylation; P:signal transduction;|O95382 A2ACE8 A2VDG4 A2VDG5 Q59HF4 Q5SSD4 Q75PK3 Q96B75,Mitogen-activated protein kinase kinase kinase 6,Apoptosis signal-regulating kinase 2;, PF19039;PF13281;PF00069;, GO:0005524;GO:0000287;GO:0004709;GO:0004672;GO:0106310;GO:0106311;GO:0007257;GO:0000186;GO:0006468;GO:0007165;, , F:ATP binding; F:magnesium ion binding; F:MAP kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPKK activity; P:protein phosphorylation; P:signal transduction;|O95382 A2ACE8 A2VDG4 A2VDG5 Q59HF4 Q5SSD4 Q75PK3 Q96B75,Mitogen-activated protein kinase kinase kinase 6,Apoptosis signal-regulating kinase 2;, PF19039;PF13281;PF00069;, GO:0005524;GO:0000287;GO:0004709;GO:0004672;GO:0106310;GO:0106311;GO:0007257;GO:0000186;GO:0006468;GO:0007165;, , F:ATP binding; F:magnesium ion binding; F:MAP kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPKK activity; P:protein phosphorylation; P:signal transduction;|Q8IYJ3 Q5SSC9 Q96BB6 Q96GU6 Q96S89 Q96SI0,Synaptotagmin-like protein 1,Exophilin-7;Protein JFC1;, PF00168;, GO:0070382;GO:0070062;GO:0019897;GO:0042470;GO:0031528;GO:0005886;GO:0042043;GO:0031267;GO:0006887;GO:0006886;, C:exocytic vesicle; C:extracellular exosome; C:extrinsic component of plasma membrane; C:melanosome; C:microvillus membrane; C:plasma membrane;, F:neurexin family protein binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport;|Q8IYJ3 Q5SSC9 Q96BB6 Q96GU6 Q96S89 Q96SI0,Synaptotagmin-like protein 1,Exophilin-7;Protein JFC1;, PF00168;, GO:0070382;GO:0070062;GO:0019897;GO:0042470;GO:0031528;GO:0005886;GO:0042043;GO:0031267;GO:0006887;GO:0006886;, C:exocytic vesicle; C:extracellular exosome; C:extrinsic component of plasma membrane; C:melanosome; C:microvillus membrane; C:plasma membrane;, F:neurexin family protein binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport;|Q8IYJ3 Q5SSC9 Q96BB6 Q96GU6 Q96S89 Q96SI0,Synaptotagmin-like protein 1,Exophilin-7;Protein JFC1;, PF00168;, GO:0070382;GO:0070062;GO:0019897;GO:0042470;GO:0031528;GO:0005886;GO:0042043;GO:0031267;GO:0006887;GO:0006886;, C:exocytic vesicle; C:extracellular exosome; C:extrinsic component of plasma membrane; C:melanosome; C:microvillus membrane; C:plasma membrane;, F:neurexin family protein binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport;|Q8IYJ3 Q5SSC9 Q96BB6 Q96GU6 Q96S89 Q96SI0,Synaptotagmin-like protein 1,Exophilin-7;Protein JFC1;, PF00168;, GO:0070382;GO:0070062;GO:0019897;GO:0042470;GO:0031528;GO:0005886;GO:0042043;GO:0031267;GO:0006887;GO:0006886;, C:exocytic vesicle; C:extracellular exosome; C:extrinsic component of plasma membrane; C:melanosome; C:microvillus membrane; C:plasma membrane;, F:neurexin family protein binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport;|Q8IYJ3 Q5SSC9 Q96BB6 Q96GU6 Q96S89 Q96SI0,Synaptotagmin-like protein 1,Exophilin-7;Protein JFC1;, PF00168;, GO:0070382;GO:0070062;GO:0019897;GO:0042470;GO:0031528;GO:0005886;GO:0042043;GO:0031267;GO:0006887;GO:0006886;, C:exocytic vesicle; C:extracellular exosome; C:extrinsic component of plasma membrane; C:melanosome; C:microvillus membrane; C:plasma membrane;, F:neurexin family protein binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport;|Q8IYJ3 Q5SSC9 Q96BB6 Q96GU6 Q96S89 Q96SI0,Synaptotagmin-like protein 1,Exophilin-7;Protein JFC1;, PF00168;, GO:0070382;GO:0070062;GO:0019897;GO:0042470;GO:0031528;GO:0005886;GO:0042043;GO:0031267;GO:0006887;GO:0006886;, C:exocytic vesicle; C:extracellular exosome; C:extrinsic component of plasma membrane; C:melanosome; C:microvillus membrane; C:plasma membrane;, F:neurexin family protein binding; F:small GTPase binding;, P:exocytosis; P:intracellular protein transport; scaffold76 indexed_genome mRNA 192220 203254 . + . ID=transcript_11668;Q9H0R3 D3DPL6 Q53HD8 Q5FVE9,Transmembrane protein 222,, PF05608;, GO:0016021;, C:integral component of membrane;|Q9H0R3 D3DPL6 Q53HD8 Q5FVE9,Transmembrane protein 222,, PF05608;, GO:0016021;, C:integral component of membrane;|Q9H0R3 D3DPL6 Q53HD8 Q5FVE9,Transmembrane protein 222,, PF05608;, GO:0016021;, C:integral component of membrane;|Q9H0R3 D3DPL6 Q53HD8 Q5FVE9,Transmembrane protein 222,, PF05608;, GO:0016021;, C:integral component of membrane; scaffold76 indexed_genome mRNA 215738 272491 . - . ID=transcript_11669;Q8N5D0 D3DPL5 Q5SSC5 Q9NV87 Q9UPW4,WD and tetratricopeptide repeats protein 1,, PF00400;, GO:0080008;GO:0005737;GO:0005829;GO:0005654;GO:0004857;GO:0042393;GO:0042826;GO:0055082;GO:0032869;GO:0006006;GO:0001701;GO:0035264;GO:0045717;GO:0000122;GO:0043687;GO:0016567;GO:0008361;, C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:enzyme inhibitor activity; F:histone binding; F:histone deacetylase binding;, P:cellular chemical homeostasis; P:cellular response to insulin stimulus; P:glucose metabolic process; P:in utero embryonic development; P:multicellular organism growth; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein ubiquitination; P:regulation of cell size; scaffold76 indexed_genome mRNA 335877 336874 . - . ID=transcript_11670;P19634 B1ALD6 D3DPL4 Q96EM2,Sodium/hydrogen exchanger 1,APNH;Na(+)/H(+) antiporter, amiloride-sensitive;Na(+)/H(+) exchanger 1;Solute carrier family 9 member 1;, PF00999;PF16644;, GO:0016324;GO:0016323;GO:0090533;GO:0009986;GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0014704;GO:0030027;GO:0045121;GO:0005739;GO:0005654;GO:0048471;GO:0005886;GO:0030315;GO:0048306;GO:0005516;GO:0060090;GO:0005546;GO:0015386;GO:0030346;GO:0030674;GO:0015385;GO:0086040;GO:0015299;GO:0086003;GO:0055007;GO:0016477;GO:0071468;GO:0071236;GO:0070417;GO:0071257;GO:0071872;GO:0071456;GO:0032869;GO:0071260;GO:0006883;GO:0030214;GO:0006811;GO:0030011;GO:0043066;GO:0070997;GO:0045760;GO:0043065;GO:0070886;GO:1903281;GO:0010613;GO:0030307;GO:0035794;GO:0098735;GO:0045944;GO:0071805;GO:0051259;GO:1902600;GO:0086036;GO:0010882;GO:0051893;GO:0051453;GO:0006885;GO:0051930;GO:0051492;GO:0086092;GO:0010447;GO:0035994;GO:0036376;GO:0098719;, C:apical plasma membrane; C:basolateral plasma membrane; C:cation-transporting ATPase complex; C:cell surface; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:intercalated disc; C:lamellipodium; C:membrane raft; C:mitochondrion; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:T-tubule;, F:calcium-dependent protein binding; F:calmodulin binding; F:molecular adaptor activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:potassium:proton antiporter activity; F:protein phosphatase 2B binding; F:protein-macromolecule adaptor activity; F:sodium:proton antiporter activity; F:sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential; F:solute:proton antiporter activity;, P:cardiac muscle cell contraction; P:cardiac muscle cell differentiation; P:cell migration; P:cellular response to acidic pH; P:cellular response to antibiotic; P:cellular response to cold; P:cellular response to electrical stimulus; P:cellular response to epinephrine stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:cellular sodium ion homeostasis; P:hyaluronan catabolic process; P:ion transport; P:maintenance of cell polarity; P:negative regulation of apoptotic process; P:neuron death; P:positive regulation of action potential; P:positive regulation of apoptotic process; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of calcium:sodium antiporter activity; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell growth; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of the force of heart contraction; P:positive regulation of transcription by RNA polymerase II; P:potassium ion transmembrane transport; P:protein complex oligomerization; P:proton transmembrane transport; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of focal adhesion assembly; P:regulation of intracellular pH; P:regulation of pH; P:regulation of sensory perception of pain; P:regulation of stress fiber assembly; P:regulation of the force of heart contraction by cardiac conduction; P:response to acidic pH; P:response to muscle stretch; P:sodium ion export across plasma membrane; P:sodium ion import across plasma membrane; scaffold76 indexed_genome mRNA 336909 386628 . + . ID=transcript_11671;P19634 B1ALD6 D3DPL4 Q96EM2,Sodium/hydrogen exchanger 1,APNH;Na(+)/H(+) antiporter, amiloride-sensitive;Na(+)/H(+) exchanger 1;Solute carrier family 9 member 1;, PF00999;PF16644;, GO:0016324;GO:0016323;GO:0090533;GO:0009986;GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0014704;GO:0030027;GO:0045121;GO:0005739;GO:0005654;GO:0048471;GO:0005886;GO:0030315;GO:0048306;GO:0005516;GO:0060090;GO:0005546;GO:0015386;GO:0030346;GO:0030674;GO:0015385;GO:0086040;GO:0015299;GO:0086003;GO:0055007;GO:0016477;GO:0071468;GO:0071236;GO:0070417;GO:0071257;GO:0071872;GO:0071456;GO:0032869;GO:0071260;GO:0006883;GO:0030214;GO:0006811;GO:0030011;GO:0043066;GO:0070997;GO:0045760;GO:0043065;GO:0070886;GO:1903281;GO:0010613;GO:0030307;GO:0035794;GO:0098735;GO:0045944;GO:0071805;GO:0051259;GO:1902600;GO:0086036;GO:0010882;GO:0051893;GO:0051453;GO:0006885;GO:0051930;GO:0051492;GO:0086092;GO:0010447;GO:0035994;GO:0036376;GO:0098719;, C:apical plasma membrane; C:basolateral plasma membrane; C:cation-transporting ATPase complex; C:cell surface; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:intercalated disc; C:lamellipodium; C:membrane raft; C:mitochondrion; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:T-tubule;, F:calcium-dependent protein binding; F:calmodulin binding; F:molecular adaptor activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:potassium:proton antiporter activity; F:protein phosphatase 2B binding; F:protein-macromolecule adaptor activity; F:sodium:proton antiporter activity; F:sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential; F:solute:proton antiporter activity;, P:cardiac muscle cell contraction; P:cardiac muscle cell differentiation; P:cell migration; P:cellular response to acidic pH; P:cellular response to antibiotic; P:cellular response to cold; P:cellular response to electrical stimulus; P:cellular response to epinephrine stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:cellular sodium ion homeostasis; P:hyaluronan catabolic process; P:ion transport; P:maintenance of cell polarity; P:negative regulation of apoptotic process; P:neuron death; P:positive regulation of action potential; P:positive regulation of apoptotic process; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of calcium:sodium antiporter activity; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell growth; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of the force of heart contraction; P:positive regulation of transcription by RNA polymerase II; P:potassium ion transmembrane transport; P:protein complex oligomerization; P:proton transmembrane transport; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of focal adhesion assembly; P:regulation of intracellular pH; P:regulation of pH; P:regulation of sensory perception of pain; P:regulation of stress fiber assembly; P:regulation of the force of heart contraction by cardiac conduction; P:response to acidic pH; P:response to muscle stretch; P:sodium ion export across plasma membrane; P:sodium ion import across plasma membrane;|P19634 B1ALD6 D3DPL4 Q96EM2,Sodium/hydrogen exchanger 1,APNH;Na(+)/H(+) antiporter, amiloride-sensitive;Na(+)/H(+) exchanger 1;Solute carrier family 9 member 1;, PF00999;PF16644;, GO:0016324;GO:0016323;GO:0090533;GO:0009986;GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0014704;GO:0030027;GO:0045121;GO:0005739;GO:0005654;GO:0048471;GO:0005886;GO:0030315;GO:0048306;GO:0005516;GO:0060090;GO:0005546;GO:0015386;GO:0030346;GO:0030674;GO:0015385;GO:0086040;GO:0015299;GO:0086003;GO:0055007;GO:0016477;GO:0071468;GO:0071236;GO:0070417;GO:0071257;GO:0071872;GO:0071456;GO:0032869;GO:0071260;GO:0006883;GO:0030214;GO:0006811;GO:0030011;GO:0043066;GO:0070997;GO:0045760;GO:0043065;GO:0070886;GO:1903281;GO:0010613;GO:0030307;GO:0035794;GO:0098735;GO:0045944;GO:0071805;GO:0051259;GO:1902600;GO:0086036;GO:0010882;GO:0051893;GO:0051453;GO:0006885;GO:0051930;GO:0051492;GO:0086092;GO:0010447;GO:0035994;GO:0036376;GO:0098719;, C:apical plasma membrane; C:basolateral plasma membrane; C:cation-transporting ATPase complex; C:cell surface; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:intercalated disc; C:lamellipodium; C:membrane raft; C:mitochondrion; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:T-tubule;, F:calcium-dependent protein binding; F:calmodulin binding; F:molecular adaptor activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:potassium:proton antiporter activity; F:protein phosphatase 2B binding; F:protein-macromolecule adaptor activity; F:sodium:proton antiporter activity; F:sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential; F:solute:proton antiporter activity;, P:cardiac muscle cell contraction; P:cardiac muscle cell differentiation; P:cell migration; P:cellular response to acidic pH; P:cellular response to antibiotic; P:cellular response to cold; P:cellular response to electrical stimulus; P:cellular response to epinephrine stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:cellular sodium ion homeostasis; P:hyaluronan catabolic process; P:ion transport; P:maintenance of cell polarity; P:negative regulation of apoptotic process; P:neuron death; P:positive regulation of action potential; P:positive regulation of apoptotic process; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of calcium:sodium antiporter activity; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell growth; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of the force of heart contraction; P:positive regulation of transcription by RNA polymerase II; P:potassium ion transmembrane transport; P:protein complex oligomerization; P:proton transmembrane transport; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of focal adhesion assembly; P:regulation of intracellular pH; P:regulation of pH; P:regulation of sensory perception of pain; P:regulation of stress fiber assembly; P:regulation of the force of heart contraction by cardiac conduction; P:response to acidic pH; P:response to muscle stretch; P:sodium ion export across plasma membrane; P:sodium ion import across plasma membrane;|P19634 B1ALD6 D3DPL4 Q96EM2,Sodium/hydrogen exchanger 1,APNH;Na(+)/H(+) antiporter, amiloride-sensitive;Na(+)/H(+) exchanger 1;Solute carrier family 9 member 1;, PF00999;PF16644;, GO:0016324;GO:0016323;GO:0090533;GO:0009986;GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0014704;GO:0030027;GO:0045121;GO:0005739;GO:0005654;GO:0048471;GO:0005886;GO:0030315;GO:0048306;GO:0005516;GO:0060090;GO:0005546;GO:0015386;GO:0030346;GO:0030674;GO:0015385;GO:0086040;GO:0015299;GO:0086003;GO:0055007;GO:0016477;GO:0071468;GO:0071236;GO:0070417;GO:0071257;GO:0071872;GO:0071456;GO:0032869;GO:0071260;GO:0006883;GO:0030214;GO:0006811;GO:0030011;GO:0043066;GO:0070997;GO:0045760;GO:0043065;GO:0070886;GO:1903281;GO:0010613;GO:0030307;GO:0035794;GO:0098735;GO:0045944;GO:0071805;GO:0051259;GO:1902600;GO:0086036;GO:0010882;GO:0051893;GO:0051453;GO:0006885;GO:0051930;GO:0051492;GO:0086092;GO:0010447;GO:0035994;GO:0036376;GO:0098719;, C:apical plasma membrane; C:basolateral plasma membrane; C:cation-transporting ATPase complex; C:cell surface; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:intercalated disc; C:lamellipodium; C:membrane raft; C:mitochondrion; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:T-tubule;, F:calcium-dependent protein binding; F:calmodulin binding; F:molecular adaptor activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:potassium:proton antiporter activity; F:protein phosphatase 2B binding; F:protein-macromolecule adaptor activity; F:sodium:proton antiporter activity; F:sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential; F:solute:proton antiporter activity;, P:cardiac muscle cell contraction; P:cardiac muscle cell differentiation; P:cell migration; P:cellular response to acidic pH; P:cellular response to antibiotic; P:cellular response to cold; P:cellular response to electrical stimulus; P:cellular response to epinephrine stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:cellular sodium ion homeostasis; P:hyaluronan catabolic process; P:ion transport; P:maintenance of cell polarity; P:negative regulation of apoptotic process; P:neuron death; P:positive regulation of action potential; P:positive regulation of apoptotic process; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of calcium:sodium antiporter activity; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cell growth; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of the force of heart contraction; P:positive regulation of transcription by RNA polymerase II; P:potassium ion transmembrane transport; P:protein complex oligomerization; P:proton transmembrane transport; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of focal adhesion assembly; P:regulation of intracellular pH; P:regulation of pH; P:regulation of sensory perception of pain; P:regulation of stress fiber assembly; P:regulation of the force of heart contraction by cardiac conduction; P:response to acidic pH; P:response to muscle stretch; P:sodium ion export across plasma membrane; P:sodium ion import across plasma membrane; scaffold76 indexed_genome mRNA 471360 478740 . + . ID=transcript_11672;Q96A09,Terminal nucleotidyltransferase 5B {ECO:0000305},, PF07984;, GO:1990817;GO:0048255;, , F:RNA adenylyltransferase activity;, P:mRNA stabilization; scaffold76 indexed_genome mRNA 482299 489401 . - . ID=transcript_11673;Q6NT89,TMF-regulated nuclear protein 1,, , GO:0000791;GO:0005634;GO:0003677;GO:0007049;GO:0021696;GO:0061351;GO:0051726;GO:0042127;, C:euchromatin; C:nucleus;, F:DNA binding;, P:cell cycle; P:cerebellar cortex morphogenesis; P:neural precursor cell proliferation; P:regulation of cell cycle; P:regulation of cell population proliferation; scaffold76 indexed_genome mRNA 517578 528781 . + . ID=transcript_11674;Q8NAX2 Q5QP32 Q8N0S7,Keratinocyte differentiation factor 1,, PF15551;, GO:0005938;GO:0030054;GO:0031252;GO:0005737;GO:0072686;GO:0005654;GO:0048589;GO:0061436;GO:0003334;GO:0060887;GO:0016331;GO:0010839;GO:2000647;GO:0045606;GO:0010482;, C:cell cortex; C:cell junction; C:cell leading edge; C:cytoplasm; C:mitotic spindle; C:nucleoplasm;, , P:developmental growth; P:establishment of skin barrier; P:keratinocyte development; P:limb epidermis development; P:morphogenesis of embryonic epithelium; P:negative regulation of keratinocyte proliferation; P:negative regulation of stem cell proliferation; P:positive regulation of epidermal cell differentiation; P:regulation of epidermal cell division; scaffold76 indexed_genome mRNA 532010 545935 . - . ID=transcript_11675;Q9Y266 Q5QP31 Q5QP35 Q9H0N2 Q9Y2B6,Nuclear migration protein nudC,Nuclear distribution protein C homolog;, PF04969;PF16273;PF14050;, GO:0005737;GO:0005829;GO:0005874;GO:0030496;GO:0072686;GO:0005654;GO:0005819;GO:0045296;GO:0051082;GO:0051301;GO:0007080;GO:0007052;GO:0006457;, C:cytoplasm; C:cytosol; C:microtubule; C:midbody; C:mitotic spindle; C:nucleoplasm; C:spindle;, F:cadherin binding; F:unfolded protein binding;, P:cell division; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein folding;|Q9Y266 Q5QP31 Q5QP35 Q9H0N2 Q9Y2B6,Nuclear migration protein nudC,Nuclear distribution protein C homolog;, PF04969;PF16273;PF14050;, GO:0005737;GO:0005829;GO:0005874;GO:0030496;GO:0072686;GO:0005654;GO:0005819;GO:0045296;GO:0051082;GO:0051301;GO:0007080;GO:0007052;GO:0006457;, C:cytoplasm; C:cytosol; C:microtubule; C:midbody; C:mitotic spindle; C:nucleoplasm; C:spindle;, F:cadherin binding; F:unfolded protein binding;, P:cell division; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein folding;|Q9Y266 Q5QP31 Q5QP35 Q9H0N2 Q9Y2B6,Nuclear migration protein nudC,Nuclear distribution protein C homolog;, PF04969;PF16273;PF14050;, GO:0005737;GO:0005829;GO:0005874;GO:0030496;GO:0072686;GO:0005654;GO:0005819;GO:0045296;GO:0051082;GO:0051301;GO:0007080;GO:0007052;GO:0006457;, C:cytoplasm; C:cytosol; C:microtubule; C:midbody; C:mitotic spindle; C:nucleoplasm; C:spindle;, F:cadherin binding; F:unfolded protein binding;, P:cell division; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein folding; scaffold76 indexed_genome mRNA 559503 561626 . + . ID=transcript_11676;Q15466 F1D8P5 Q5QP36,Nuclear receptor subfamily 0 group B member 2,Orphan nuclear receptor SHP;Small heterodimer partner;, PF00104;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0042975;GO:0019904;GO:0042803;GO:0044877;GO:0046965;GO:0046966;GO:0003714;GO:0008134;GO:0140416;GO:0031100;GO:0015721;GO:0008203;GO:0032922;GO:0007623;GO:0043433;GO:0010629;GO:0000122;GO:0045892;GO:0007219;GO:0010628;GO:0032024;GO:0045893;GO:0045471;GO:0009749;GO:0014070;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:peroxisome proliferator activated receptor binding; F:protein domain specific binding; F:protein homodimerization activity; F:protein-containing complex binding; F:retinoid X receptor binding; F:thyroid hormone receptor binding; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulator inhibitor activity;, P:animal organ regeneration; P:bile acid and bile salt transport; P:cholesterol metabolic process; P:circadian regulation of gene expression; P:circadian rhythm; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:positive regulation of gene expression; P:positive regulation of insulin secretion; P:positive regulation of transcription, DNA-templated; P:response to ethanol; P:response to glucose; P:response to organic cyclic compound; P:transcription initiation from RNA polymerase II promoter; scaffold76 indexed_genome mRNA 570684 587186 . + . ID=transcript_11677;Q96I76 Q5JYH2 Q8NDJ2 Q9H9Z3,G patch domain-containing protein 3,, PF01585;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003676;GO:0039536;GO:0032480;GO:0045893;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:nucleic acid binding;, P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of transcription, DNA-templated;|Q9H9Y4 Q96HG4 Q9NUE1 Q9NW30,GPN-loop GTPase 2 {ECO:0000305},ATP-binding domain 1 family member B;, PF03029;, GO:0005525;GO:0003924;, , F:GTP binding; F:GTPase activity;|Q9H9Y4 Q96HG4 Q9NUE1 Q9NW30,GPN-loop GTPase 2 {ECO:0000305},ATP-binding domain 1 family member B;, PF03029;, GO:0005525;GO:0003924;, , F:GTP binding; F:GTPase activity;|Q9H9Y4 Q96HG4 Q9NUE1 Q9NW30,GPN-loop GTPase 2 {ECO:0000305},ATP-binding domain 1 family member B;, PF03029;, GO:0005525;GO:0003924;, , F:GTP binding; F:GTPase activity; scaffold76 indexed_genome mRNA 595905 597309 . - . ID=transcript_11678;P31947 Q6FH30 Q6FH51 Q96DH0,14-3-3 protein sigma,Epithelial cell marker protein 1;Stratifin;, PF00244;, GO:0005829;GO:0070062;GO:0005615;GO:0005739;GO:0005634;GO:0045296;GO:0042802;GO:0051219;GO:0019901;GO:0008426;GO:0006977;GO:0061436;GO:0008630;GO:0031424;GO:0003334;GO:0043154;GO:0010839;GO:0006469;GO:0030307;GO:0045606;GO:0046827;GO:1900740;GO:0000079;GO:0010482;GO:0001836;GO:0007165;, C:cytosol; C:extracellular exosome; C:extracellular space; C:mitochondrion; C:nucleus;, F:cadherin binding; F:identical protein binding; F:phosphoprotein binding; F:protein kinase binding; F:protein kinase C inhibitor activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:establishment of skin barrier; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:keratinization; P:keratinocyte development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of keratinocyte proliferation; P:negative regulation of protein kinase activity; P:positive regulation of cell growth; P:positive regulation of epidermal cell differentiation; P:positive regulation of protein export from nucleus; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of epidermal cell division; P:release of cytochrome c from mitochondria; P:signal transduction; scaffold76 indexed_genome mRNA 601528 610154 . - . ID=transcript_11679;Q9NUE0 A6NHY9 B4DQ84 Q5JYH0 Q9H020,Palmitoyltransferase ZDHHC18 {ECO:0000305},DHHC domain-containing cysteine-rich protein 18 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 18 {ECO:0000312|HGNC:HGNC:20712};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016409;GO:0019706;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane;|Q9NUE0 A6NHY9 B4DQ84 Q5JYH0 Q9H020,Palmitoyltransferase ZDHHC18 {ECO:0000305},DHHC domain-containing cysteine-rich protein 18 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 18 {ECO:0000312|HGNC:HGNC:20712};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016409;GO:0019706;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane;|Q9NUE0 A6NHY9 B4DQ84 Q5JYH0 Q9H020,Palmitoyltransferase ZDHHC18 {ECO:0000305},DHHC domain-containing cysteine-rich protein 18 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 18 {ECO:0000312|HGNC:HGNC:20712};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016409;GO:0019706;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane;|Q9NUE0 A6NHY9 B4DQ84 Q5JYH0 Q9H020,Palmitoyltransferase ZDHHC18 {ECO:0000305},DHHC domain-containing cysteine-rich protein 18 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 18 {ECO:0000312|HGNC:HGNC:20712};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016409;GO:0019706;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane;|Q9NUE0 A6NHY9 B4DQ84 Q5JYH0 Q9H020,Palmitoyltransferase ZDHHC18 {ECO:0000305},DHHC domain-containing cysteine-rich protein 18 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 18 {ECO:0000312|HGNC:HGNC:20712};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016409;GO:0019706;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane;|Q9NUE0 A6NHY9 B4DQ84 Q5JYH0 Q9H020,Palmitoyltransferase ZDHHC18 {ECO:0000305},DHHC domain-containing cysteine-rich protein 18 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 18 {ECO:0000312|HGNC:HGNC:20712};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016409;GO:0019706;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane; scaffold76 indexed_genome mRNA 610322 615487 . + . ID=transcript_11680;Q9NUE0 A6NHY9 B4DQ84 Q5JYH0 Q9H020,Palmitoyltransferase ZDHHC18 {ECO:0000305},DHHC domain-containing cysteine-rich protein 18 {ECO:0000303|PubMed:16647879};Zinc finger DHHC domain-containing protein 18 {ECO:0000312|HGNC:HGNC:20712};, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016409;GO:0019706;GO:0018230;GO:0018345;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane; scaffold76 indexed_genome mRNA 651619 661398 . - . ID=transcript_11681;Q9NUD9 D3DPL2 Q5JYG7 Q5JYG8 Q5JYG9 Q9NX26,GPI mannosyltransferase 2,GPI mannosyltransferase II;Phosphatidylinositol-glycan biosynthesis class V protein;, PF04188;, GO:0005789;GO:0016021;GO:0031501;GO:0000009;GO:0004376;GO:0000030;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mannosyltransferase complex;, F:alpha-1,6-mannosyltransferase activity; F:glycolipid mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NUD9 D3DPL2 Q5JYG7 Q5JYG8 Q5JYG9 Q9NX26,GPI mannosyltransferase 2,GPI mannosyltransferase II;Phosphatidylinositol-glycan biosynthesis class V protein;, PF04188;, GO:0005789;GO:0016021;GO:0031501;GO:0000009;GO:0004376;GO:0000030;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mannosyltransferase complex;, F:alpha-1,6-mannosyltransferase activity; F:glycolipid mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9NUD9 D3DPL2 Q5JYG7 Q5JYG8 Q5JYG9 Q9NX26,GPI mannosyltransferase 2,GPI mannosyltransferase II;Phosphatidylinositol-glycan biosynthesis class V protein;, PF04188;, GO:0005789;GO:0016021;GO:0031501;GO:0000009;GO:0004376;GO:0000030;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mannosyltransferase complex;, F:alpha-1,6-mannosyltransferase activity; F:glycolipid mannosyltransferase activity; F:mannosyltransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold76 indexed_genome mRNA 667630 712773 . - . ID=transcript_11682;Q9HBJ5 Q9UPZ1,AT-rich interactive domain-containing protein 1A,B120;BRG1-associated factor 250;BRG1-associated factor 250a;Osa homolog 1;SWI-like protein;SWI/SNF complex protein p270;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;hELD;, PF01388;PF12031;, GO:0035060;GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003677;GO:0016922;GO:0003713;GO:0030521;GO:0043044;GO:0006338;GO:0048096;GO:0042921;GO:0030520;GO:0007399;GO:0006337;GO:0042766;GO:0045893;GO:0006357;, C:brahma complex; C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:DNA binding; F:nuclear receptor binding; F:transcription coactivator activity;, P:androgen receptor signaling pathway; P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:glucocorticoid receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:nervous system development; P:nucleosome disassembly; P:nucleosome mobilization; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9HBJ5 Q9UPZ1,AT-rich interactive domain-containing protein 1A,B120;BRG1-associated factor 250;BRG1-associated factor 250a;Osa homolog 1;SWI-like protein;SWI/SNF complex protein p270;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;hELD;, PF01388;PF12031;, GO:0035060;GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003677;GO:0016922;GO:0003713;GO:0030521;GO:0043044;GO:0006338;GO:0048096;GO:0042921;GO:0030520;GO:0007399;GO:0006337;GO:0042766;GO:0045893;GO:0006357;, C:brahma complex; C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:DNA binding; F:nuclear receptor binding; F:transcription coactivator activity;, P:androgen receptor signaling pathway; P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:glucocorticoid receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:nervous system development; P:nucleosome disassembly; P:nucleosome mobilization; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9HBJ5 Q9UPZ1,AT-rich interactive domain-containing protein 1A,B120;BRG1-associated factor 250;BRG1-associated factor 250a;Osa homolog 1;SWI-like protein;SWI/SNF complex protein p270;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;hELD;, PF01388;PF12031;, GO:0035060;GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003677;GO:0016922;GO:0003713;GO:0030521;GO:0043044;GO:0006338;GO:0048096;GO:0042921;GO:0030520;GO:0007399;GO:0006337;GO:0042766;GO:0045893;GO:0006357;, C:brahma complex; C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:DNA binding; F:nuclear receptor binding; F:transcription coactivator activity;, P:androgen receptor signaling pathway; P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:glucocorticoid receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:nervous system development; P:nucleosome disassembly; P:nucleosome mobilization; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9HBJ5 Q9UPZ1,AT-rich interactive domain-containing protein 1A,B120;BRG1-associated factor 250;BRG1-associated factor 250a;Osa homolog 1;SWI-like protein;SWI/SNF complex protein p270;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;hELD;, PF01388;PF12031;, GO:0035060;GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003677;GO:0016922;GO:0003713;GO:0030521;GO:0043044;GO:0006338;GO:0048096;GO:0042921;GO:0030520;GO:0007399;GO:0006337;GO:0042766;GO:0045893;GO:0006357;, C:brahma complex; C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:DNA binding; F:nuclear receptor binding; F:transcription coactivator activity;, P:androgen receptor signaling pathway; P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:glucocorticoid receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:nervous system development; P:nucleosome disassembly; P:nucleosome mobilization; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9HBJ5 Q9UPZ1,AT-rich interactive domain-containing protein 1A,B120;BRG1-associated factor 250;BRG1-associated factor 250a;Osa homolog 1;SWI-like protein;SWI/SNF complex protein p270;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;hELD;, PF01388;PF12031;, GO:0035060;GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003677;GO:0016922;GO:0003713;GO:0030521;GO:0043044;GO:0006338;GO:0048096;GO:0042921;GO:0030520;GO:0007399;GO:0006337;GO:0042766;GO:0045893;GO:0006357;, C:brahma complex; C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:DNA binding; F:nuclear receptor binding; F:transcription coactivator activity;, P:androgen receptor signaling pathway; P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:glucocorticoid receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:nervous system development; P:nucleosome disassembly; P:nucleosome mobilization; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9HBJ5 Q9UPZ1,AT-rich interactive domain-containing protein 1A,B120;BRG1-associated factor 250;BRG1-associated factor 250a;Osa homolog 1;SWI-like protein;SWI/SNF complex protein p270;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;hELD;, PF01388;PF12031;, GO:0035060;GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003677;GO:0016922;GO:0003713;GO:0030521;GO:0043044;GO:0006338;GO:0048096;GO:0042921;GO:0030520;GO:0007399;GO:0006337;GO:0042766;GO:0045893;GO:0006357;, C:brahma complex; C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:DNA binding; F:nuclear receptor binding; F:transcription coactivator activity;, P:androgen receptor signaling pathway; P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:glucocorticoid receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:nervous system development; P:nucleosome disassembly; P:nucleosome mobilization; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9HBJ5 Q9UPZ1,AT-rich interactive domain-containing protein 1A,B120;BRG1-associated factor 250;BRG1-associated factor 250a;Osa homolog 1;SWI-like protein;SWI/SNF complex protein p270;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;hELD;, PF01388;PF12031;, GO:0035060;GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003677;GO:0016922;GO:0003713;GO:0030521;GO:0043044;GO:0006338;GO:0048096;GO:0042921;GO:0030520;GO:0007399;GO:0006337;GO:0042766;GO:0045893;GO:0006357;, C:brahma complex; C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:DNA binding; F:nuclear receptor binding; F:transcription coactivator activity;, P:androgen receptor signaling pathway; P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:glucocorticoid receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:nervous system development; P:nucleosome disassembly; P:nucleosome mobilization; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9HBJ5 Q9UPZ1,AT-rich interactive domain-containing protein 1A,B120;BRG1-associated factor 250;BRG1-associated factor 250a;Osa homolog 1;SWI-like protein;SWI/SNF complex protein p270;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;hELD;, PF01388;PF12031;, GO:0035060;GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003677;GO:0016922;GO:0003713;GO:0030521;GO:0043044;GO:0006338;GO:0048096;GO:0042921;GO:0030520;GO:0007399;GO:0006337;GO:0042766;GO:0045893;GO:0006357;, C:brahma complex; C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:DNA binding; F:nuclear receptor binding; F:transcription coactivator activity;, P:androgen receptor signaling pathway; P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:chromatin-mediated maintenance of transcription; P:glucocorticoid receptor signaling pathway; P:intracellular estrogen receptor signaling pathway; P:nervous system development; P:nucleosome disassembly; P:nucleosome mobilization; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold76 indexed_genome mRNA 830821 832354 . - . ID=transcript_11683;Q96C05 Q9BQK2,Ribosomal protein S6 kinase alpha-1,90 kDa ribosomal protein S6 kinase 1;MAP kinase-activated protein kinase 1a;Ribosomal S6 kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0043027;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007049;GO:0007268;GO:0072574;GO:0035556;GO:0043066;GO:0043154;GO:0018105;GO:0045597;GO:0030307;GO:2000491;GO:0045944;GO:0045893;GO:0043620;GO:0043555;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:cell cycle; P:chemical synaptic transmission; P:hepatocyte proliferation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of cell differentiation; P:positive regulation of cell growth; P:positive regulation of hepatic stellate cell activation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-templated transcription in response to stress; P:regulation of translation in response to stress; P:signal transduction;|Q96C05 Q9BQK2,Ribosomal protein S6 kinase alpha-1,90 kDa ribosomal protein S6 kinase 1;MAP kinase-activated protein kinase 1a;Ribosomal S6 kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0043027;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007049;GO:0007268;GO:0072574;GO:0035556;GO:0043066;GO:0043154;GO:0018105;GO:0045597;GO:0030307;GO:2000491;GO:0045944;GO:0045893;GO:0043620;GO:0043555;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:cell cycle; P:chemical synaptic transmission; P:hepatocyte proliferation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of cell differentiation; P:positive regulation of cell growth; P:positive regulation of hepatic stellate cell activation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-templated transcription in response to stress; P:regulation of translation in response to stress; P:signal transduction; scaffold76 indexed_genome mRNA 834000 856652 . - . ID=transcript_11684;Q96C05 Q9BQK2,Ribosomal protein S6 kinase alpha-1,90 kDa ribosomal protein S6 kinase 1;MAP kinase-activated protein kinase 1a;Ribosomal S6 kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0043027;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007049;GO:0007268;GO:0072574;GO:0035556;GO:0043066;GO:0043154;GO:0018105;GO:0045597;GO:0030307;GO:2000491;GO:0045944;GO:0045893;GO:0043620;GO:0043555;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:cell cycle; P:chemical synaptic transmission; P:hepatocyte proliferation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of cell differentiation; P:positive regulation of cell growth; P:positive regulation of hepatic stellate cell activation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-templated transcription in response to stress; P:regulation of translation in response to stress; P:signal transduction;|Q96C05 Q9BQK2,Ribosomal protein S6 kinase alpha-1,90 kDa ribosomal protein S6 kinase 1;MAP kinase-activated protein kinase 1a;Ribosomal S6 kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0043027;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007049;GO:0007268;GO:0072574;GO:0035556;GO:0043066;GO:0043154;GO:0018105;GO:0045597;GO:0030307;GO:2000491;GO:0045944;GO:0045893;GO:0043620;GO:0043555;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:cell cycle; P:chemical synaptic transmission; P:hepatocyte proliferation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of cell differentiation; P:positive regulation of cell growth; P:positive regulation of hepatic stellate cell activation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-templated transcription in response to stress; P:regulation of translation in response to stress; P:signal transduction;|Q96C05 Q9BQK2,Ribosomal protein S6 kinase alpha-1,90 kDa ribosomal protein S6 kinase 1;MAP kinase-activated protein kinase 1a;Ribosomal S6 kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0043027;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007049;GO:0007268;GO:0072574;GO:0035556;GO:0043066;GO:0043154;GO:0018105;GO:0045597;GO:0030307;GO:2000491;GO:0045944;GO:0045893;GO:0043620;GO:0043555;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:cell cycle; P:chemical synaptic transmission; P:hepatocyte proliferation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of cell differentiation; P:positive regulation of cell growth; P:positive regulation of hepatic stellate cell activation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-templated transcription in response to stress; P:regulation of translation in response to stress; P:signal transduction;|Q96C05 Q9BQK2,Ribosomal protein S6 kinase alpha-1,90 kDa ribosomal protein S6 kinase 1;MAP kinase-activated protein kinase 1a;Ribosomal S6 kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0043027;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007049;GO:0007268;GO:0072574;GO:0035556;GO:0043066;GO:0043154;GO:0018105;GO:0045597;GO:0030307;GO:2000491;GO:0045944;GO:0045893;GO:0043620;GO:0043555;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:cell cycle; P:chemical synaptic transmission; P:hepatocyte proliferation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of cell differentiation; P:positive regulation of cell growth; P:positive regulation of hepatic stellate cell activation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-templated transcription in response to stress; P:regulation of translation in response to stress; P:signal transduction;|Q96C05 Q9BQK2,Ribosomal protein S6 kinase alpha-1,90 kDa ribosomal protein S6 kinase 1;MAP kinase-activated protein kinase 1a;Ribosomal S6 kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0043027;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007049;GO:0007268;GO:0072574;GO:0035556;GO:0043066;GO:0043154;GO:0018105;GO:0045597;GO:0030307;GO:2000491;GO:0045944;GO:0045893;GO:0043620;GO:0043555;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:cell cycle; P:chemical synaptic transmission; P:hepatocyte proliferation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of cell differentiation; P:positive regulation of cell growth; P:positive regulation of hepatic stellate cell activation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-templated transcription in response to stress; P:regulation of translation in response to stress; P:signal transduction;|Q96C05 Q9BQK2,Ribosomal protein S6 kinase alpha-1,90 kDa ribosomal protein S6 kinase 1;MAP kinase-activated protein kinase 1a;Ribosomal S6 kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0043027;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007049;GO:0007268;GO:0072574;GO:0035556;GO:0043066;GO:0043154;GO:0018105;GO:0045597;GO:0030307;GO:2000491;GO:0045944;GO:0045893;GO:0043620;GO:0043555;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:cell cycle; P:chemical synaptic transmission; P:hepatocyte proliferation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of cell differentiation; P:positive regulation of cell growth; P:positive regulation of hepatic stellate cell activation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-templated transcription in response to stress; P:regulation of translation in response to stress; P:signal transduction;|Q96C05 Q9BQK2,Ribosomal protein S6 kinase alpha-1,90 kDa ribosomal protein S6 kinase 1;MAP kinase-activated protein kinase 1a;Ribosomal S6 kinase 1;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0043027;GO:0000287;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004711;GO:0007049;GO:0007268;GO:0072574;GO:0035556;GO:0043066;GO:0043154;GO:0018105;GO:0045597;GO:0030307;GO:2000491;GO:0045944;GO:0045893;GO:0043620;GO:0043555;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:cell cycle; P:chemical synaptic transmission; P:hepatocyte proliferation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of cell differentiation; P:positive regulation of cell growth; P:positive regulation of hepatic stellate cell activation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-templated transcription in response to stress; P:regulation of translation in response to stress; P:signal transduction; scaffold76 indexed_genome mRNA 907190 910144 . + . ID=transcript_11685;Q9CWI7 Q9CZA2 Q9UDJ5 Q9UEU9,GTP-binding nuclear protein Ran,Androgen receptor-associated protein 24 {ECO:0000303|PubMed:10400640};GTPase Ran;Ras-like protein TC4 {ECO:0000303|PubMed:2108320, ECO:0000303|PubMed:8276887, ECO:0000303|PubMed:8421051};Ras-related nuclear protein;, PF00071;, GO:0005814;GO:0005737;GO:0005829;GO:0070062;GO:0043657;GO:0042470;GO:0016020;GO:0030496;GO:0005635;GO:0005643;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0055037;GO:0042565;GO:0045296;GO:0003682;GO:0019003;GO:0005525;GO:0003924;GO:0000287;GO:0046982;GO:0003723;GO:0051301;GO:0006259;GO:0046039;GO:0075733;GO:0010586;GO:0000278;GO:0007084;GO:0000070;GO:0007052;GO:0032092;GO:0042307;GO:0035281;GO:0006611;GO:0006606;GO:1902570;GO:0045540;GO:0000055;GO:0000056;GO:0000054;GO:0061015;GO:0006409;GO:0016032;, C:centriole; C:cytoplasm; C:cytosol; C:extracellular exosome; C:host cell; C:melanosome; C:membrane; C:midbody; C:nuclear envelope; C:nuclear pore; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:recycling endosome; C:RNA nuclear export complex;, F:cadherin binding; F:chromatin binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:magnesium ion binding; F:protein heterodimerization activity; F:RNA binding;, P:cell division; P:DNA metabolic process; P:GTP metabolic process; P:intracellular transport of virus; P:miRNA metabolic process; P:mitotic cell cycle; P:mitotic nuclear envelope reassembly; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:pre-miRNA export from nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein localization to nucleolus; P:regulation of cholesterol biosynthetic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:ribosomal subunit export from nucleus; P:snRNA import into nucleus; P:tRNA export from nucleus; P:viral process; scaffold76 indexed_genome mRNA 910162 915631 . - . ID=transcript_11686;Q86SG4 Q495B5 Q86SH8 Q8N8I5,Putative Dresden prostate carcinoma protein 2,High mobility group nucleosome-binding domain-containing protein 2 pseudogene 46;, , GO:0005634;GO:0003682;GO:0006325;, C:nucleus;, F:chromatin binding;, P:chromatin organization;|Q86SG4 Q495B5 Q86SH8 Q8N8I5,Putative Dresden prostate carcinoma protein 2,High mobility group nucleosome-binding domain-containing protein 2 pseudogene 46;, , GO:0005634;GO:0003682;GO:0006325;, C:nucleus;, F:chromatin binding;, P:chromatin organization; scaffold76 indexed_genome mRNA 917078 952000 . - . ID=transcript_11687;Q9BTG5 Q9BTK3 Q9H905,Dehydrodolichyl diphosphate synthase complex subunit DHDDS {ECO:0000305},Cis-isoprenyltransferase {ECO:0000303|PubMed:14652022};Cis-prenyltransferase subunit hCIT {ECO:0000303|PubMed:28842490};Epididymis tissue protein Li 189m;, PF01255;, GO:1904423;GO:0005783;GO:0005789;GO:0045547;GO:0046872;GO:0006489;GO:0016094;, C:dehydrodolichyl diphosphate synthase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:dehydrodolichyl diphosphate synthase activity; F:metal ion binding;, P:dolichyl diphosphate biosynthetic process; P:polyprenol biosynthetic process;|Q9BTG5 Q9BTK3 Q9H905,Dehydrodolichyl diphosphate synthase complex subunit DHDDS {ECO:0000305},Cis-isoprenyltransferase {ECO:0000303|PubMed:14652022};Cis-prenyltransferase subunit hCIT {ECO:0000303|PubMed:28842490};Epididymis tissue protein Li 189m;, PF01255;, GO:1904423;GO:0005783;GO:0005789;GO:0045547;GO:0046872;GO:0006489;GO:0016094;, C:dehydrodolichyl diphosphate synthase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:dehydrodolichyl diphosphate synthase activity; F:metal ion binding;, P:dolichyl diphosphate biosynthetic process; P:polyprenol biosynthetic process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9BTG5 Q9BTK3 Q9H905,Dehydrodolichyl diphosphate synthase complex subunit DHDDS {ECO:0000305},Cis-isoprenyltransferase {ECO:0000303|PubMed:14652022};Cis-prenyltransferase subunit hCIT {ECO:0000303|PubMed:28842490};Epididymis tissue protein Li 189m;, PF01255;, GO:1904423;GO:0005783;GO:0005789;GO:0045547;GO:0046872;GO:0006489;GO:0016094;, C:dehydrodolichyl diphosphate synthase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:dehydrodolichyl diphosphate synthase activity; F:metal ion binding;, P:dolichyl diphosphate biosynthetic process; P:polyprenol biosynthetic process;|Q9BTG5 Q9BTK3 Q9H905,Dehydrodolichyl diphosphate synthase complex subunit DHDDS {ECO:0000305},Cis-isoprenyltransferase {ECO:0000303|PubMed:14652022};Cis-prenyltransferase subunit hCIT {ECO:0000303|PubMed:28842490};Epididymis tissue protein Li 189m;, PF01255;, GO:1904423;GO:0005783;GO:0005789;GO:0045547;GO:0046872;GO:0006489;GO:0016094;, C:dehydrodolichyl diphosphate synthase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:dehydrodolichyl diphosphate synthase activity; F:metal ion binding;, P:dolichyl diphosphate biosynthetic process; P:polyprenol biosynthetic process;|Q9BTG5 Q9BTK3 Q9H905,Dehydrodolichyl diphosphate synthase complex subunit DHDDS {ECO:0000305},Cis-isoprenyltransferase {ECO:0000303|PubMed:14652022};Cis-prenyltransferase subunit hCIT {ECO:0000303|PubMed:28842490};Epididymis tissue protein Li 189m;, PF01255;, GO:1904423;GO:0005783;GO:0005789;GO:0045547;GO:0046872;GO:0006489;GO:0016094;, C:dehydrodolichyl diphosphate synthase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:dehydrodolichyl diphosphate synthase activity; F:metal ion binding;, P:dolichyl diphosphate biosynthetic process; P:polyprenol biosynthetic process; scaffold76 indexed_genome mRNA 1007298 1010816 . + . ID=transcript_11688;Q8IZ20 Q5T141 Q5T146 Q5T147 Q5T149 Q8NEN4,Tissue-resident T-cell transcription regulator protein ZNF683 {ECO:0000305},Homolog of Blimp-1 in T-cell {ECO:0000250|UniProtKB:I7HJS4};Zinc finger protein 683 {ECO:0000312|HGNC:HGNC:28495};, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:1990841;GO:0000978;GO:0002250;GO:1904637;GO:0045087;GO:0032689;GO:0000122;GO:0010628;GO:0033082;GO:0010468;GO:0032823;GO:0032826;GO:0051136;GO:0006357;GO:0050852;GO:0016032;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:adaptive immune response; P:cellular response to ionomycin; P:innate immune response; P:negative regulation of interferon-gamma production; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of gene expression; P:regulation of extrathymic T cell differentiation; P:regulation of gene expression; P:regulation of natural killer cell differentiation; P:regulation of natural killer cell differentiation involved in immune response; P:regulation of NK T cell differentiation; P:regulation of transcription by RNA polymerase II; P:T cell receptor signaling pathway; P:viral process; scaffold76 indexed_genome mRNA 1029353 1036308 . + . ID=transcript_11689;Q8N1P7 B2RNG3 Q5T137 Q5T150,Beta/gamma crystallin domain-containing protein 2 {ECO:0000312|HGNC:HGNC:17295},Absent in melanoma 1-like protein;, PF00030;, GO:0030246;, , F:carbohydrate binding; scaffold76 indexed_genome mRNA 1036558 1046292 . - . ID=transcript_11690;Q8N1P7 B2RNG3 Q5T137 Q5T150,Beta/gamma crystallin domain-containing protein 2 {ECO:0000312|HGNC:HGNC:17295},Absent in melanoma 1-like protein;, PF00030;, GO:0030246;, , F:carbohydrate binding; scaffold76 indexed_genome mRNA 1047632 1081335 . + . ID=transcript_11691;Q63HM6 Q71RB3 Q8IY27 Q8N1L6 Q8N9M4 Q8NA18 Q8NFE3 Q8NFE4 Q8NFE6,UBX domain-containing protein 11,Colorectal tumor-associated antigen COA-1;Socius;UBX domain-containing protein 5;, PF08059;PF00789;, GO:0005737;GO:0005856;GO:0043130;GO:0043161;, C:cytoplasm; C:cytoskeleton;, F:ubiquitin binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q63HM6 Q71RB3 Q8IY27 Q8N1L6 Q8N9M4 Q8NA18 Q8NFE3 Q8NFE4 Q8NFE6,UBX domain-containing protein 11,Colorectal tumor-associated antigen COA-1;Socius;UBX domain-containing protein 5;, PF08059;PF00789;, GO:0005737;GO:0005856;GO:0043130;GO:0043161;, C:cytoplasm; C:cytoskeleton;, F:ubiquitin binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; scaffold76 indexed_genome mRNA 1081915 1083362 . - . ID=transcript_11692;Q9H299 Q5T122,SH3 domain-binding glutamic acid-rich-like protein 3,SH3 domain-binding protein 1;, PF04908;, GO:0005737;GO:0070062;GO:0016604;GO:0015035;, C:cytoplasm; C:extracellular exosome; C:nuclear body;, F:protein disulfide oxidoreductase activity;|Q9H299 Q5T122,SH3 domain-binding glutamic acid-rich-like protein 3,SH3 domain-binding protein 1;, PF04908;, GO:0005737;GO:0070062;GO:0016604;GO:0015035;, C:cytoplasm; C:extracellular exosome; C:nuclear body;, F:protein disulfide oxidoreductase activity; scaffold76 indexed_genome mRNA 1088401 1090939 . - . ID=transcript_11693;Q6P2H3 B4DRL1 D3DPK4 F8W7K4 Q5VY68 Q5VY70 Q9H6Q1 Q9H828 Q9UF52,Centrosomal protein of 85 kDa,Coiled-coil domain-containing protein 21;, , GO:0005813;GO:0005829;GO:0005794;GO:0005730;GO:0000242;GO:0000922;GO:0007059;GO:0006469;GO:0046602;, C:centrosome; C:cytosol; C:Golgi apparatus; C:nucleolus; C:pericentriolar material; C:spindle pole;, , P:chromosome segregation; P:negative regulation of protein kinase activity; P:regulation of mitotic centrosome separation; scaffold76 indexed_genome mRNA 1094789 1095607 . + . ID=transcript_11694;Q6P2H3 B4DRL1 D3DPK4 F8W7K4 Q5VY68 Q5VY70 Q9H6Q1 Q9H828 Q9UF52,Centrosomal protein of 85 kDa,Coiled-coil domain-containing protein 21;, , GO:0005813;GO:0005829;GO:0005794;GO:0005730;GO:0000242;GO:0000922;GO:0007059;GO:0006469;GO:0046602;, C:centrosome; C:cytosol; C:Golgi apparatus; C:nucleolus; C:pericentriolar material; C:spindle pole;, , P:chromosome segregation; P:negative regulation of protein kinase activity; P:regulation of mitotic centrosome separation; scaffold76 indexed_genome mRNA 1125032 1138274 . - . ID=transcript_11695;P55259 A6NFM9 A6NJA8 Q13338 Q9UIF1,Pancreatic secretory granule membrane major glycoprotein GP2,Pancreatic zymogen granule membrane protein GP-2;ZAP75;, PF00100;, GO:0031225;GO:0016324;GO:0009986;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0005201;GO:1990266;, C:anchored component of membrane; C:apical plasma membrane; C:cell surface; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:extracellular matrix structural constituent;, P:neutrophil migration; scaffold76 indexed_genome mRNA 1159401 1171317 . - . ID=transcript_11696;Q969H4 B1AMW9 O95381,Connector enhancer of kinase suppressor of ras 1,CNK homolog protein 1;Connector enhancer of KSR-like;, PF10534;PF00169;PF00536;, GO:0005938;GO:0005911;GO:0005886;GO:0030674;GO:0007265;GO:0007266;GO:0007169;, C:cell cortex; C:cell-cell junction; C:plasma membrane;, F:protein-macromolecule adaptor activity;, P:Ras protein signal transduction; P:Rho protein signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold76 indexed_genome mRNA 1176409 1177387 . - . ID=transcript_11697;O00488 B2R4S0 Q5T2H7,Zinc finger protein 593,Zinc finger protein T86;, PF12171;, GO:0005730;GO:0005654;GO:0003677;GO:0008270;GO:1903026;GO:0045944;, C:nucleolus; C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; scaffold76 indexed_genome mRNA 1183570 1186666 . - . ID=transcript_11698;Q8TAY7 A8K3V0 Q9H7Z4,Protein FAM110D,, PF14160;PF14161; scaffold76 indexed_genome mRNA 1214473 1221778 . - . ID=transcript_11699;Q8N165 B2R777 D3DPK2 Q5T2I0 Q8NDB3,Serine/threonine-protein kinase PDIK1L,PDLIM1-interacting kinase 1-like;, PF00069;, GO:0005654;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0051321;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:meiotic cell cycle;|Q8N165 B2R777 D3DPK2 Q5T2I0 Q8NDB3,Serine/threonine-protein kinase PDIK1L,PDLIM1-interacting kinase 1-like;, PF00069;, GO:0005654;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0051321;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:meiotic cell cycle;|Q8N165 B2R777 D3DPK2 Q5T2I0 Q8NDB3,Serine/threonine-protein kinase PDIK1L,PDLIM1-interacting kinase 1-like;, PF00069;, GO:0005654;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0051321;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:meiotic cell cycle; scaffold76 indexed_genome mRNA 1275082 1289346 . + . ID=transcript_11700;Q969Q1 B4DN95 Q5T2I1 Q96BD3 Q96KD9 Q9BYV4,E3 ubiquitin-protein ligase TRIM63,Iris RING finger protein;Muscle-specific RING finger protein 1;RING finger protein 28;RING-type E3 ubiquitin transferase TRIM63 {ECO:0000305};Striated muscle RING zinc finger protein;Tripartite motif-containing protein 63;, PF00643;PF13445;, GO:0005737;GO:0031430;GO:0005874;GO:0005634;GO:0030018;GO:0031432;GO:0061630;GO:0008270;GO:0006936;GO:0010614;GO:0016567;GO:0014878;GO:0051384;GO:0070555;GO:0007165;GO:0014732;, C:cytoplasm; C:M band; C:microtubule; C:nucleus; C:Z disc;, F:titin binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:muscle contraction; P:negative regulation of cardiac muscle hypertrophy; P:protein ubiquitination; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to glucocorticoid; P:response to interleukin-1; P:signal transduction; P:skeletal muscle atrophy;|Q969Q1 B4DN95 Q5T2I1 Q96BD3 Q96KD9 Q9BYV4,E3 ubiquitin-protein ligase TRIM63,Iris RING finger protein;Muscle-specific RING finger protein 1;RING finger protein 28;RING-type E3 ubiquitin transferase TRIM63 {ECO:0000305};Striated muscle RING zinc finger protein;Tripartite motif-containing protein 63;, PF00643;PF13445;, GO:0005737;GO:0031430;GO:0005874;GO:0005634;GO:0030018;GO:0031432;GO:0061630;GO:0008270;GO:0006936;GO:0010614;GO:0016567;GO:0014878;GO:0051384;GO:0070555;GO:0007165;GO:0014732;, C:cytoplasm; C:M band; C:microtubule; C:nucleus; C:Z disc;, F:titin binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:muscle contraction; P:negative regulation of cardiac muscle hypertrophy; P:protein ubiquitination; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to glucocorticoid; P:response to interleukin-1; P:signal transduction; P:skeletal muscle atrophy;|Q969Q1 B4DN95 Q5T2I1 Q96BD3 Q96KD9 Q9BYV4,E3 ubiquitin-protein ligase TRIM63,Iris RING finger protein;Muscle-specific RING finger protein 1;RING finger protein 28;RING-type E3 ubiquitin transferase TRIM63 {ECO:0000305};Striated muscle RING zinc finger protein;Tripartite motif-containing protein 63;, PF00643;PF13445;, GO:0005737;GO:0031430;GO:0005874;GO:0005634;GO:0030018;GO:0031432;GO:0061630;GO:0008270;GO:0006936;GO:0010614;GO:0016567;GO:0014878;GO:0051384;GO:0070555;GO:0007165;GO:0014732;, C:cytoplasm; C:M band; C:microtubule; C:nucleus; C:Z disc;, F:titin binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:muscle contraction; P:negative regulation of cardiac muscle hypertrophy; P:protein ubiquitination; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to glucocorticoid; P:response to interleukin-1; P:signal transduction; P:skeletal muscle atrophy;|Q969Q1 B4DN95 Q5T2I1 Q96BD3 Q96KD9 Q9BYV4,E3 ubiquitin-protein ligase TRIM63,Iris RING finger protein;Muscle-specific RING finger protein 1;RING finger protein 28;RING-type E3 ubiquitin transferase TRIM63 {ECO:0000305};Striated muscle RING zinc finger protein;Tripartite motif-containing protein 63;, PF00643;PF13445;, GO:0005737;GO:0031430;GO:0005874;GO:0005634;GO:0030018;GO:0031432;GO:0061630;GO:0008270;GO:0006936;GO:0010614;GO:0016567;GO:0014878;GO:0051384;GO:0070555;GO:0007165;GO:0014732;, C:cytoplasm; C:M band; C:microtubule; C:nucleus; C:Z disc;, F:titin binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:muscle contraction; P:negative regulation of cardiac muscle hypertrophy; P:protein ubiquitination; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to glucocorticoid; P:response to interleukin-1; P:signal transduction; P:skeletal muscle atrophy; scaffold76 indexed_genome mRNA 1302640 1304965 . + . ID=transcript_11701;Q9BRI3 Q71RC8,Zinc transporter 2,Solute carrier family 30 member 2;, PF01545;, GO:0005737;GO:0016021;GO:0043231;GO:0005770;GO:0005765;GO:0005886;GO:0042802;GO:0005385;GO:0061090;GO:0061088;GO:0010043;GO:0071577;, C:cytoplasm; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal membrane; C:plasma membrane;, F:identical protein binding; F:zinc ion transmembrane transporter activity;, P:positive regulation of sequestering of zinc ion; P:regulation of sequestering of zinc ion; P:response to zinc ion; P:zinc ion transmembrane transport; scaffold76 indexed_genome mRNA 1307133 1323287 . - . ID=transcript_11702;Q92935 Q6GSC1,Exostosin-like 1,Exostosin-L;Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;Multiple exostosis-like protein;, PF03016;PF09258;, GO:0005789;GO:0005794;GO:0016021;GO:0008375;GO:0050508;GO:0015020;GO:0016757;GO:0036498;GO:0006486;GO:0001501;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronosyltransferase activity; F:transferase activity, transferring glycosyl groups;, P:IRE1-mediated unfolded protein response; P:protein glycosylation; P:skeletal system development; scaffold76 indexed_genome mRNA 1339650 1375976 . + . ID=transcript_11703;Q99487 D3DPK1 O15458 Q5SY02,Platelet-activating factor acetylhydrolase 2, cytoplasmic {ECO:0000303|PubMed:8955149},PAF:lysophospholipid transacetylase {ECO:0000250|UniProtKB:P83006};PAF:sphingosine transacetylase {ECO:0000250|UniProtKB:P83006};Platelet-activating factor acetyltransferase PAFAH2 {ECO:0000250|UniProtKB:P83006};Serine-dependent phospholipase A2 {ECO:0000303|PubMed:9494101};, PF03403;, GO:0005737;GO:0005789;GO:0003847;GO:0005543;GO:0047179;GO:0007596;GO:0016042;GO:0006629;GO:0043066;, C:cytoplasm; C:endoplasmic reticulum membrane;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:phospholipid binding; F:platelet-activating factor acetyltransferase activity;, P:blood coagulation; P:lipid catabolic process; P:lipid metabolic process; P:negative regulation of apoptotic process; scaffold76 indexed_genome mRNA 1426586 1431896 . + . ID=transcript_11704;P16949 A2A2D1 B2R4E7 B7Z8N4 D3DPJ5,Stathmin,Leukemia-associated phosphoprotein p18;Metablastin;Oncoprotein 18;Phosphoprotein p19;Prosolin;Protein Pr22;pp17;, PF00836;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005874;GO:0043005;GO:0015631;GO:0007409;GO:0007420;GO:0061436;GO:0048012;GO:0035556;GO:0007019;GO:0000281;GO:0007052;GO:1905098;GO:0031115;GO:0035024;GO:0051497;GO:0070495;GO:0031175;GO:0051272;GO:0031110;GO:0009615;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:microtubule; C:neuron projection;, F:tubulin binding;, P:axonogenesis; P:brain development; P:establishment of skin barrier; P:hepatocyte growth factor receptor signaling pathway; P:intracellular signal transduction; P:microtubule depolymerization; P:mitotic cytokinesis; P:mitotic spindle organization; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of microtubule polymerization; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:negative regulation of thrombin-activated receptor signaling pathway; P:neuron projection development; P:positive regulation of cellular component movement; P:regulation of microtubule polymerization or depolymerization; P:response to virus; P:signal transduction;|P16949 A2A2D1 B2R4E7 B7Z8N4 D3DPJ5,Stathmin,Leukemia-associated phosphoprotein p18;Metablastin;Oncoprotein 18;Phosphoprotein p19;Prosolin;Protein Pr22;pp17;, PF00836;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005874;GO:0043005;GO:0015631;GO:0007409;GO:0007420;GO:0061436;GO:0048012;GO:0035556;GO:0007019;GO:0000281;GO:0007052;GO:1905098;GO:0031115;GO:0035024;GO:0051497;GO:0070495;GO:0031175;GO:0051272;GO:0031110;GO:0009615;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:microtubule; C:neuron projection;, F:tubulin binding;, P:axonogenesis; P:brain development; P:establishment of skin barrier; P:hepatocyte growth factor receptor signaling pathway; P:intracellular signal transduction; P:microtubule depolymerization; P:mitotic cytokinesis; P:mitotic spindle organization; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of microtubule polymerization; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:negative regulation of thrombin-activated receptor signaling pathway; P:neuron projection development; P:positive regulation of cellular component movement; P:regulation of microtubule polymerization or depolymerization; P:response to virus; P:signal transduction;|P16949 A2A2D1 B2R4E7 B7Z8N4 D3DPJ5,Stathmin,Leukemia-associated phosphoprotein p18;Metablastin;Oncoprotein 18;Phosphoprotein p19;Prosolin;Protein Pr22;pp17;, PF00836;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005874;GO:0043005;GO:0015631;GO:0007409;GO:0007420;GO:0061436;GO:0048012;GO:0035556;GO:0007019;GO:0000281;GO:0007052;GO:1905098;GO:0031115;GO:0035024;GO:0051497;GO:0070495;GO:0031175;GO:0051272;GO:0031110;GO:0009615;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:microtubule; C:neuron projection;, F:tubulin binding;, P:axonogenesis; P:brain development; P:establishment of skin barrier; P:hepatocyte growth factor receptor signaling pathway; P:intracellular signal transduction; P:microtubule depolymerization; P:mitotic cytokinesis; P:mitotic spindle organization; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of microtubule polymerization; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:negative regulation of thrombin-activated receptor signaling pathway; P:neuron projection development; P:positive regulation of cellular component movement; P:regulation of microtubule polymerization or depolymerization; P:response to virus; P:signal transduction;|P16949 A2A2D1 B2R4E7 B7Z8N4 D3DPJ5,Stathmin,Leukemia-associated phosphoprotein p18;Metablastin;Oncoprotein 18;Phosphoprotein p19;Prosolin;Protein Pr22;pp17;, PF00836;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005874;GO:0043005;GO:0015631;GO:0007409;GO:0007420;GO:0061436;GO:0048012;GO:0035556;GO:0007019;GO:0000281;GO:0007052;GO:1905098;GO:0031115;GO:0035024;GO:0051497;GO:0070495;GO:0031175;GO:0051272;GO:0031110;GO:0009615;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:microtubule; C:neuron projection;, F:tubulin binding;, P:axonogenesis; P:brain development; P:establishment of skin barrier; P:hepatocyte growth factor receptor signaling pathway; P:intracellular signal transduction; P:microtubule depolymerization; P:mitotic cytokinesis; P:mitotic spindle organization; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of microtubule polymerization; P:negative regulation of Rho protein signal transduction; P:negative regulation of stress fiber assembly; P:negative regulation of thrombin-activated receptor signaling pathway; P:neuron projection development; P:positive regulation of cellular component movement; P:regulation of microtubule polymerization or depolymerization; P:response to virus; P:signal transduction; scaffold76 indexed_genome mRNA 1467038 1474236 . + . ID=transcript_11705;Q86WK9 A2A2D3 Q5XKF9 Q86VE4,Membrane progestin receptor alpha {ECO:0000303|PubMed:23763432},Membrane progesterone P4 receptor alpha {ECO:0000303|PubMed:23763432};Membrane progesterone receptor alpha {ECO:0000303|PubMed:23763432};Progesterone and adipoQ receptor family member 7;Progestin and adipoQ receptor family member 7 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member VII;, PF03006;, GO:0016021;GO:0005886;GO:0038023;GO:0005496;GO:0003707;GO:0007275;GO:0048477;GO:0048545;, C:integral component of membrane; C:plasma membrane;, F:signaling receptor activity; F:steroid binding; F:steroid hormone receptor activity;, P:multicellular organism development; P:oogenesis; P:response to steroid hormone; scaffold76 indexed_genome mRNA 1499353 1516865 . - . ID=transcript_11706;Q9H7T9 C9EI59 Q53F70,Aurora kinase A and ninein-interacting protein {ECO:0000303|PubMed:20596670},, PF15334;, GO:0005813;GO:0005737;GO:0005634;GO:0090734;GO:0000922;GO:0003684;GO:0000724;GO:2001033;GO:0007051;, C:centrosome; C:cytoplasm; C:nucleus; C:site of DNA damage; C:spindle pole;, F:damaged DNA binding;, P:double-strand break repair via homologous recombination; P:negative regulation of double-strand break repair via nonhomologous end joining; P:spindle organization;|Q9H019 A6NCB4 B7WNV5 D3DPJ4 Q63HP1 Q7Z2S7 Q9NUI7,Mitochondrial fission regulator 1-like,, PF05308;, GO:0005739;GO:0009060;GO:0000266;, C:mitochondrion;, , P:aerobic respiration; P:mitochondrial fission;|Q9H019 A6NCB4 B7WNV5 D3DPJ4 Q63HP1 Q7Z2S7 Q9NUI7,Mitochondrial fission regulator 1-like,, PF05308;, GO:0005739;GO:0009060;GO:0000266;, C:mitochondrion;, , P:aerobic respiration; P:mitochondrial fission; scaffold76 indexed_genome mRNA 1518761 1533170 . - . ID=transcript_11707;Q9NZV5 A6NJG8 A8MQ64 Q6PI70 Q969F6 Q9NUI6,Selenoprotein N {ECO:0000303|PubMed:27645994},, , GO:0005789;GO:0005509;GO:0016491;GO:0055074;GO:1902884;GO:0060314;GO:0048741;, C:endoplasmic reticulum membrane;, F:calcium ion binding; F:oxidoreductase activity;, P:calcium ion homeostasis; P:positive regulation of response to oxidative stress; P:regulation of ryanodine-sensitive calcium-release channel activity; P:skeletal muscle fiber development;|Q9NZV5 A6NJG8 A8MQ64 Q6PI70 Q969F6 Q9NUI6,Selenoprotein N {ECO:0000303|PubMed:27645994},, , GO:0005789;GO:0005509;GO:0016491;GO:0055074;GO:1902884;GO:0060314;GO:0048741;, C:endoplasmic reticulum membrane;, F:calcium ion binding; F:oxidoreductase activity;, P:calcium ion homeostasis; P:positive regulation of response to oxidative stress; P:regulation of ryanodine-sensitive calcium-release channel activity; P:skeletal muscle fiber development;|Q9NZV5 A6NJG8 A8MQ64 Q6PI70 Q969F6 Q9NUI6,Selenoprotein N {ECO:0000303|PubMed:27645994},, , GO:0005789;GO:0005509;GO:0016491;GO:0055074;GO:1902884;GO:0060314;GO:0048741;, C:endoplasmic reticulum membrane;, F:calcium ion binding; F:oxidoreductase activity;, P:calcium ion homeostasis; P:positive regulation of response to oxidative stress; P:regulation of ryanodine-sensitive calcium-release channel activity; P:skeletal muscle fiber development;|Q9NZV5 A6NJG8 A8MQ64 Q6PI70 Q969F6 Q9NUI6,Selenoprotein N {ECO:0000303|PubMed:27645994},, , GO:0005789;GO:0005509;GO:0016491;GO:0055074;GO:1902884;GO:0060314;GO:0048741;, C:endoplasmic reticulum membrane;, F:calcium ion binding; F:oxidoreductase activity;, P:calcium ion homeostasis; P:positive regulation of response to oxidative stress; P:regulation of ryanodine-sensitive calcium-release channel activity; P:skeletal muscle fiber development;|Q9NZV5 A6NJG8 A8MQ64 Q6PI70 Q969F6 Q9NUI6,Selenoprotein N {ECO:0000303|PubMed:27645994},, , GO:0005789;GO:0005509;GO:0016491;GO:0055074;GO:1902884;GO:0060314;GO:0048741;, C:endoplasmic reticulum membrane;, F:calcium ion binding; F:oxidoreductase activity;, P:calcium ion homeostasis; P:positive regulation of response to oxidative stress; P:regulation of ryanodine-sensitive calcium-release channel activity; P:skeletal muscle fiber development; scaffold76 indexed_genome mRNA 1553311 1556238 . - . ID=transcript_11708;Q9NR34 A6NNE2 B2RNP2 Q9Y545,Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC,HMIC;Mannosidase alpha class 1C member 1;Processing alpha-1,2-mannosidase IC;, PF01532;, GO:0005783;GO:0070062;GO:0000139;GO:0030173;GO:0005509;GO:0004571;GO:0005975;GO:1904381;GO:0006491;GO:0006487;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi membrane; C:integral component of Golgi membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:Golgi apparatus mannose trimming; P:N-glycan processing; P:protein N-linked glycosylation;|Q9NR34 A6NNE2 B2RNP2 Q9Y545,Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC,HMIC;Mannosidase alpha class 1C member 1;Processing alpha-1,2-mannosidase IC;, PF01532;, GO:0005783;GO:0070062;GO:0000139;GO:0030173;GO:0005509;GO:0004571;GO:0005975;GO:1904381;GO:0006491;GO:0006487;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi membrane; C:integral component of Golgi membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:Golgi apparatus mannose trimming; P:N-glycan processing; P:protein N-linked glycosylation; scaffold76 indexed_genome mRNA 1565015 1566599 . + . ID=transcript_11709;Q9NR34 A6NNE2 B2RNP2 Q9Y545,Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC,HMIC;Mannosidase alpha class 1C member 1;Processing alpha-1,2-mannosidase IC;, PF01532;, GO:0005783;GO:0070062;GO:0000139;GO:0030173;GO:0005509;GO:0004571;GO:0005975;GO:1904381;GO:0006491;GO:0006487;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi membrane; C:integral component of Golgi membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:Golgi apparatus mannose trimming; P:N-glycan processing; P:protein N-linked glycosylation; scaffold76 indexed_genome mRNA 1574155 1577944 . + . ID=transcript_11710;Q9NR34 A6NNE2 B2RNP2 Q9Y545,Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC,HMIC;Mannosidase alpha class 1C member 1;Processing alpha-1,2-mannosidase IC;, PF01532;, GO:0005783;GO:0070062;GO:0000139;GO:0030173;GO:0005509;GO:0004571;GO:0005975;GO:1904381;GO:0006491;GO:0006487;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi membrane; C:integral component of Golgi membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:Golgi apparatus mannose trimming; P:N-glycan processing; P:protein N-linked glycosylation; scaffold76 indexed_genome mRNA 1585927 1586509 . + . ID=transcript_11711;Q9NR34 A6NNE2 B2RNP2 Q9Y545,Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC,HMIC;Mannosidase alpha class 1C member 1;Processing alpha-1,2-mannosidase IC;, PF01532;, GO:0005783;GO:0070062;GO:0000139;GO:0030173;GO:0005509;GO:0004571;GO:0005975;GO:1904381;GO:0006491;GO:0006487;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi membrane; C:integral component of Golgi membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:Golgi apparatus mannose trimming; P:N-glycan processing; P:protein N-linked glycosylation; scaffold76 indexed_genome mRNA 1588926 1594217 . - . ID=transcript_11712;Q9NR34 A6NNE2 B2RNP2 Q9Y545,Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC,HMIC;Mannosidase alpha class 1C member 1;Processing alpha-1,2-mannosidase IC;, PF01532;, GO:0005783;GO:0070062;GO:0000139;GO:0030173;GO:0005509;GO:0004571;GO:0005975;GO:1904381;GO:0006491;GO:0006487;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi membrane; C:integral component of Golgi membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:Golgi apparatus mannose trimming; P:N-glycan processing; P:protein N-linked glycosylation; scaffold76 indexed_genome mRNA 1738451 1750840 . - . ID=transcript_11713;Q5SW96 A2BHI5 Q6TQS9 Q8N2Y0 Q9UFI9,Low density lipoprotein receptor adapter protein 1 {ECO:0000305},Autosomal recessive hypercholesterolemia protein {ECO:0000303|PubMed:11326085};, PF14719;, GO:0030424;GO:0009925;GO:0030669;GO:0009898;GO:0005829;GO:0005769;GO:0005883;GO:0005886;GO:0055037;GO:0001540;GO:0035650;GO:0035612;GO:0035615;GO:0030276;GO:0050750;GO:0005546;GO:0001784;GO:0035591;GO:0030159;GO:0042982;GO:0071345;GO:0042632;GO:0008203;GO:0030301;GO:0034383;GO:0061024;GO:0090205;GO:1905581;GO:0048260;GO:1905602;GO:1904707;GO:0031623;GO:0006898;GO:0090118;GO:0043393;GO:1903076;, C:axon; C:basal plasma membrane; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic side of plasma membrane; C:cytosol; C:early endosome; C:neurofilament; C:plasma membrane; C:recycling endosome;, F:amyloid-beta binding; F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphotyrosine residue binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity;, P:amyloid precursor protein metabolic process; P:cellular response to cytokine stimulus; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:low-density lipoprotein particle clearance; P:membrane organization; P:positive regulation of cholesterol metabolic process; P:positive regulation of low-density lipoprotein particle clearance; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of vascular associated smooth muscle cell proliferation; P:receptor internalization; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of protein binding; P:regulation of protein localization to plasma membrane;|Q5SW96 A2BHI5 Q6TQS9 Q8N2Y0 Q9UFI9,Low density lipoprotein receptor adapter protein 1 {ECO:0000305},Autosomal recessive hypercholesterolemia protein {ECO:0000303|PubMed:11326085};, PF14719;, GO:0030424;GO:0009925;GO:0030669;GO:0009898;GO:0005829;GO:0005769;GO:0005883;GO:0005886;GO:0055037;GO:0001540;GO:0035650;GO:0035612;GO:0035615;GO:0030276;GO:0050750;GO:0005546;GO:0001784;GO:0035591;GO:0030159;GO:0042982;GO:0071345;GO:0042632;GO:0008203;GO:0030301;GO:0034383;GO:0061024;GO:0090205;GO:1905581;GO:0048260;GO:1905602;GO:1904707;GO:0031623;GO:0006898;GO:0090118;GO:0043393;GO:1903076;, C:axon; C:basal plasma membrane; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic side of plasma membrane; C:cytosol; C:early endosome; C:neurofilament; C:plasma membrane; C:recycling endosome;, F:amyloid-beta binding; F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphotyrosine residue binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity;, P:amyloid precursor protein metabolic process; P:cellular response to cytokine stimulus; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:low-density lipoprotein particle clearance; P:membrane organization; P:positive regulation of cholesterol metabolic process; P:positive regulation of low-density lipoprotein particle clearance; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of vascular associated smooth muscle cell proliferation; P:receptor internalization; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of protein binding; P:regulation of protein localization to plasma membrane;|Q5SW96 A2BHI5 Q6TQS9 Q8N2Y0 Q9UFI9,Low density lipoprotein receptor adapter protein 1 {ECO:0000305},Autosomal recessive hypercholesterolemia protein {ECO:0000303|PubMed:11326085};, PF14719;, GO:0030424;GO:0009925;GO:0030669;GO:0009898;GO:0005829;GO:0005769;GO:0005883;GO:0005886;GO:0055037;GO:0001540;GO:0035650;GO:0035612;GO:0035615;GO:0030276;GO:0050750;GO:0005546;GO:0001784;GO:0035591;GO:0030159;GO:0042982;GO:0071345;GO:0042632;GO:0008203;GO:0030301;GO:0034383;GO:0061024;GO:0090205;GO:1905581;GO:0048260;GO:1905602;GO:1904707;GO:0031623;GO:0006898;GO:0090118;GO:0043393;GO:1903076;, C:axon; C:basal plasma membrane; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic side of plasma membrane; C:cytosol; C:early endosome; C:neurofilament; C:plasma membrane; C:recycling endosome;, F:amyloid-beta binding; F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphotyrosine residue binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity;, P:amyloid precursor protein metabolic process; P:cellular response to cytokine stimulus; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:low-density lipoprotein particle clearance; P:membrane organization; P:positive regulation of cholesterol metabolic process; P:positive regulation of low-density lipoprotein particle clearance; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of vascular associated smooth muscle cell proliferation; P:receptor internalization; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of protein binding; P:regulation of protein localization to plasma membrane;|Q5SW96 A2BHI5 Q6TQS9 Q8N2Y0 Q9UFI9,Low density lipoprotein receptor adapter protein 1 {ECO:0000305},Autosomal recessive hypercholesterolemia protein {ECO:0000303|PubMed:11326085};, PF14719;, GO:0030424;GO:0009925;GO:0030669;GO:0009898;GO:0005829;GO:0005769;GO:0005883;GO:0005886;GO:0055037;GO:0001540;GO:0035650;GO:0035612;GO:0035615;GO:0030276;GO:0050750;GO:0005546;GO:0001784;GO:0035591;GO:0030159;GO:0042982;GO:0071345;GO:0042632;GO:0008203;GO:0030301;GO:0034383;GO:0061024;GO:0090205;GO:1905581;GO:0048260;GO:1905602;GO:1904707;GO:0031623;GO:0006898;GO:0090118;GO:0043393;GO:1903076;, C:axon; C:basal plasma membrane; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic side of plasma membrane; C:cytosol; C:early endosome; C:neurofilament; C:plasma membrane; C:recycling endosome;, F:amyloid-beta binding; F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphotyrosine residue binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity;, P:amyloid precursor protein metabolic process; P:cellular response to cytokine stimulus; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:low-density lipoprotein particle clearance; P:membrane organization; P:positive regulation of cholesterol metabolic process; P:positive regulation of low-density lipoprotein particle clearance; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of vascular associated smooth muscle cell proliferation; P:receptor internalization; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of protein binding; P:regulation of protein localization to plasma membrane; scaffold76 indexed_genome mRNA 1750847 1752497 . + . ID=transcript_11714;Q5SW96 A2BHI5 Q6TQS9 Q8N2Y0 Q9UFI9,Low density lipoprotein receptor adapter protein 1 {ECO:0000305},Autosomal recessive hypercholesterolemia protein {ECO:0000303|PubMed:11326085};, PF14719;, GO:0030424;GO:0009925;GO:0030669;GO:0009898;GO:0005829;GO:0005769;GO:0005883;GO:0005886;GO:0055037;GO:0001540;GO:0035650;GO:0035612;GO:0035615;GO:0030276;GO:0050750;GO:0005546;GO:0001784;GO:0035591;GO:0030159;GO:0042982;GO:0071345;GO:0042632;GO:0008203;GO:0030301;GO:0034383;GO:0061024;GO:0090205;GO:1905581;GO:0048260;GO:1905602;GO:1904707;GO:0031623;GO:0006898;GO:0090118;GO:0043393;GO:1903076;, C:axon; C:basal plasma membrane; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic side of plasma membrane; C:cytosol; C:early endosome; C:neurofilament; C:plasma membrane; C:recycling endosome;, F:amyloid-beta binding; F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphotyrosine residue binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity;, P:amyloid precursor protein metabolic process; P:cellular response to cytokine stimulus; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:low-density lipoprotein particle clearance; P:membrane organization; P:positive regulation of cholesterol metabolic process; P:positive regulation of low-density lipoprotein particle clearance; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of vascular associated smooth muscle cell proliferation; P:receptor internalization; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of protein binding; P:regulation of protein localization to plasma membrane; scaffold76 indexed_genome mRNA 1752603 1755138 . - . ID=transcript_11715;Q5SW96 A2BHI5 Q6TQS9 Q8N2Y0 Q9UFI9,Low density lipoprotein receptor adapter protein 1 {ECO:0000305},Autosomal recessive hypercholesterolemia protein {ECO:0000303|PubMed:11326085};, PF14719;, GO:0030424;GO:0009925;GO:0030669;GO:0009898;GO:0005829;GO:0005769;GO:0005883;GO:0005886;GO:0055037;GO:0001540;GO:0035650;GO:0035612;GO:0035615;GO:0030276;GO:0050750;GO:0005546;GO:0001784;GO:0035591;GO:0030159;GO:0042982;GO:0071345;GO:0042632;GO:0008203;GO:0030301;GO:0034383;GO:0061024;GO:0090205;GO:1905581;GO:0048260;GO:1905602;GO:1904707;GO:0031623;GO:0006898;GO:0090118;GO:0043393;GO:1903076;, C:axon; C:basal plasma membrane; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic side of plasma membrane; C:cytosol; C:early endosome; C:neurofilament; C:plasma membrane; C:recycling endosome;, F:amyloid-beta binding; F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphotyrosine residue binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity;, P:amyloid precursor protein metabolic process; P:cellular response to cytokine stimulus; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:low-density lipoprotein particle clearance; P:membrane organization; P:positive regulation of cholesterol metabolic process; P:positive regulation of low-density lipoprotein particle clearance; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of vascular associated smooth muscle cell proliferation; P:receptor internalization; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of protein binding; P:regulation of protein localization to plasma membrane; scaffold76 indexed_genome mRNA 1760639 1761480 . - . ID=transcript_11716;Q5SW96 A2BHI5 Q6TQS9 Q8N2Y0 Q9UFI9,Low density lipoprotein receptor adapter protein 1 {ECO:0000305},Autosomal recessive hypercholesterolemia protein {ECO:0000303|PubMed:11326085};, PF14719;, GO:0030424;GO:0009925;GO:0030669;GO:0009898;GO:0005829;GO:0005769;GO:0005883;GO:0005886;GO:0055037;GO:0001540;GO:0035650;GO:0035612;GO:0035615;GO:0030276;GO:0050750;GO:0005546;GO:0001784;GO:0035591;GO:0030159;GO:0042982;GO:0071345;GO:0042632;GO:0008203;GO:0030301;GO:0034383;GO:0061024;GO:0090205;GO:1905581;GO:0048260;GO:1905602;GO:1904707;GO:0031623;GO:0006898;GO:0090118;GO:0043393;GO:1903076;, C:axon; C:basal plasma membrane; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic side of plasma membrane; C:cytosol; C:early endosome; C:neurofilament; C:plasma membrane; C:recycling endosome;, F:amyloid-beta binding; F:AP-1 adaptor complex binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:low-density lipoprotein particle receptor binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphotyrosine residue binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity;, P:amyloid precursor protein metabolic process; P:cellular response to cytokine stimulus; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:low-density lipoprotein particle clearance; P:membrane organization; P:positive regulation of cholesterol metabolic process; P:positive regulation of low-density lipoprotein particle clearance; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of vascular associated smooth muscle cell proliferation; P:receptor internalization; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of protein binding; P:regulation of protein localization to plasma membrane; scaffold76 indexed_genome mRNA 1796246 1805302 . - . ID=transcript_11717;Q8N5G2 B1AK00 Q2TLX5 Q2TLX6 Q9NVG6,Macoilin {ECO:0000303|PubMed:21589894},Macoilin-1 {ECO:0000312|HGNC:HGNC:25572};Transmembrane protein 57;, PF09726;, GO:0030424;GO:0016021;GO:0044306;GO:0031965;GO:0005634;GO:0030867;GO:0045202;GO:0051015;GO:0008017;GO:0007420;GO:0006935;GO:0023041;, C:axon; C:integral component of membrane; C:neuron projection terminus; C:nuclear membrane; C:nucleus; C:rough endoplasmic reticulum membrane; C:synapse;, F:actin filament binding; F:microtubule binding;, P:brain development; P:chemotaxis; P:neuronal signal transduction;|Q8N5G2 B1AK00 Q2TLX5 Q2TLX6 Q9NVG6,Macoilin {ECO:0000303|PubMed:21589894},Macoilin-1 {ECO:0000312|HGNC:HGNC:25572};Transmembrane protein 57;, PF09726;, GO:0030424;GO:0016021;GO:0044306;GO:0031965;GO:0005634;GO:0030867;GO:0045202;GO:0051015;GO:0008017;GO:0007420;GO:0006935;GO:0023041;, C:axon; C:integral component of membrane; C:neuron projection terminus; C:nuclear membrane; C:nucleus; C:rough endoplasmic reticulum membrane; C:synapse;, F:actin filament binding; F:microtubule binding;, P:brain development; P:chemotaxis; P:neuronal signal transduction; scaffold76 indexed_genome mRNA 1805931 1813577 . - . ID=transcript_11718;Q8N5G2 B1AK00 Q2TLX5 Q2TLX6 Q9NVG6,Macoilin {ECO:0000303|PubMed:21589894},Macoilin-1 {ECO:0000312|HGNC:HGNC:25572};Transmembrane protein 57;, PF09726;, GO:0030424;GO:0016021;GO:0044306;GO:0031965;GO:0005634;GO:0030867;GO:0045202;GO:0051015;GO:0008017;GO:0007420;GO:0006935;GO:0023041;, C:axon; C:integral component of membrane; C:neuron projection terminus; C:nuclear membrane; C:nucleus; C:rough endoplasmic reticulum membrane; C:synapse;, F:actin filament binding; F:microtubule binding;, P:brain development; P:chemotaxis; P:neuronal signal transduction;|Q8N5G2 B1AK00 Q2TLX5 Q2TLX6 Q9NVG6,Macoilin {ECO:0000303|PubMed:21589894},Macoilin-1 {ECO:0000312|HGNC:HGNC:25572};Transmembrane protein 57;, PF09726;, GO:0030424;GO:0016021;GO:0044306;GO:0031965;GO:0005634;GO:0030867;GO:0045202;GO:0051015;GO:0008017;GO:0007420;GO:0006935;GO:0023041;, C:axon; C:integral component of membrane; C:neuron projection terminus; C:nuclear membrane; C:nucleus; C:rough endoplasmic reticulum membrane; C:synapse;, F:actin filament binding; F:microtubule binding;, P:brain development; P:chemotaxis; P:neuronal signal transduction; scaffold76 indexed_genome mRNA 1916493 1942301 . - . ID=transcript_11719;O95807,Transmembrane protein 50A,Small membrane protein 1;, PF05255;, GO:0005783;GO:0097386;GO:0016021;GO:0043025;GO:0032511;, C:endoplasmic reticulum; C:glial cell projection; C:integral component of membrane; C:neuronal cell body;, , P:late endosome to vacuole transport via multivesicular body sorting pathway;|O95807,Transmembrane protein 50A,Small membrane protein 1;, PF05255;, GO:0005783;GO:0097386;GO:0016021;GO:0043025;GO:0032511;, C:endoplasmic reticulum; C:glial cell projection; C:integral component of membrane; C:neuronal cell body;, , P:late endosome to vacuole transport via multivesicular body sorting pathway;|O95807,Transmembrane protein 50A,Small membrane protein 1;, PF05255;, GO:0005783;GO:0097386;GO:0016021;GO:0043025;GO:0032511;, C:endoplasmic reticulum; C:glial cell projection; C:integral component of membrane; C:neuronal cell body;, , P:late endosome to vacuole transport via multivesicular body sorting pathway; scaffold76 indexed_genome mRNA 1965831 1968318 . + . ID=transcript_11720;Q9BUV0 A8K917 Q49AA4 Q5TH71 Q9GZP6,Arginine/serine-rich protein 1|Q9BUV0 A8K917 Q49AA4 Q5TH71 Q9GZP6,Arginine/serine-rich protein 1 scaffold76 indexed_genome mRNA 1985508 1992037 . + . ID=transcript_11721;O95926 Q5TH73,Pre-mRNA-splicing factor SYF2,CCNDBP1-interactor;p29 {ECO:0000303|PubMed:11118353};, PF08231;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071014;GO:0000974;GO:0071007;GO:0003723;GO:0048568;GO:0007369;GO:0001701;GO:0007095;GO:0000398;GO:0008284;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:embryonic organ development; P:gastrulation; P:in utero embryonic development; P:mitotic G2 DNA damage checkpoint; P:mRNA splicing, via spliceosome; P:positive regulation of cell population proliferation;|O95926 Q5TH73,Pre-mRNA-splicing factor SYF2,CCNDBP1-interactor;p29 {ECO:0000303|PubMed:11118353};, PF08231;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071014;GO:0000974;GO:0071007;GO:0003723;GO:0048568;GO:0007369;GO:0001701;GO:0007095;GO:0000398;GO:0008284;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 2 spliceosome;, F:RNA binding;, P:embryonic organ development; P:gastrulation; P:in utero embryonic development; P:mitotic G2 DNA damage checkpoint; P:mRNA splicing, via spliceosome; P:positive regulation of cell population proliferation; scaffold76 indexed_genome mRNA 2286966 2315781 . + . ID=transcript_11722;Q13761 B1AJV5 Q12969 Q13760,Runt-related transcription factor 3,Acute myeloid leukemia 2 protein;Core-binding factor subunit alpha-3;Oncogene AML-2;Polyomavirus enhancer-binding protein 2 alpha C subunit;SL3-3 enhancer factor 1 alpha C subunit;SL3/AKV core-binding factor alpha C subunit;, PF00853;PF08504;, GO:0000785;GO:0016513;GO:0005737;GO:0005829;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003700;GO:0000981;GO:0000978;GO:0000977;GO:1990837;GO:0002062;GO:0030097;GO:0043371;GO:0045786;GO:0050680;GO:0000122;GO:0030182;GO:0001503;GO:0048935;GO:0043378;GO:0045893;GO:0006468;GO:0045595;GO:0006357;GO:0006355;GO:0071559;, C:chromatin; C:core-binding factor complex; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:chondrocyte differentiation; P:hemopoiesis; P:negative regulation of CD4-positive, alpha-beta T cell differentiation; P:negative regulation of cell cycle; P:negative regulation of epithelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:ossification; P:peripheral nervous system neuron development; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to transforming growth factor beta; scaffold76 indexed_genome mRNA 2363089 2440886 . - . ID=transcript_11723;Q9Y696 Q9UFW9 Q9UQJ6,Chloride intracellular channel protein 4,Intracellular chloride ion channel protein p64H1;, , GO:0015629;GO:0045177;GO:0009986;GO:0005911;GO:0005813;GO:0034707;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0005902;GO:0030496;GO:0005739;GO:0016363;GO:0005634;GO:0048471;GO:0005886;GO:0005254;GO:0005244;GO:0001525;GO:0048754;GO:0030154;GO:0071277;GO:0006821;GO:0001886;GO:0035088;GO:0009566;GO:0030216;GO:0035264;GO:0030336;GO:0051493;GO:0034765;GO:0061299;GO:0007035;, C:actin cytoskeleton; C:apical part of cell; C:cell surface; C:cell-cell junction; C:centrosome; C:chloride channel complex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:microvillus; C:midbody; C:mitochondrion; C:nuclear matrix; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:chloride channel activity; F:voltage-gated ion channel activity;, P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:cell differentiation; P:cellular response to calcium ion; P:chloride transport; P:endothelial cell morphogenesis; P:establishment or maintenance of apical/basal cell polarity; P:fertilization; P:keratinocyte differentiation; P:multicellular organism growth; P:negative regulation of cell migration; P:regulation of cytoskeleton organization; P:regulation of ion transmembrane transport; P:retina vasculature morphogenesis in camera-type eye; P:vacuolar acidification; scaffold76 indexed_genome mRNA 2504355 2512634 . - . ID=transcript_11724;Q8IYB3 O60585 Q5VVN4,Serine/arginine repetitive matrix protein 1,SR-related nuclear matrix protein of 160 kDa;Ser/Arg-related nuclear matrix protein;, PF01480;, GO:0071013;GO:0005829;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0006405;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold76 indexed_genome mRNA 2512690 2532967 . - . ID=transcript_11725;Q8IYB3 O60585 Q5VVN4,Serine/arginine repetitive matrix protein 1,SR-related nuclear matrix protein of 160 kDa;Ser/Arg-related nuclear matrix protein;, PF01480;, GO:0071013;GO:0005829;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0006405;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q8IYB3 O60585 Q5VVN4,Serine/arginine repetitive matrix protein 1,SR-related nuclear matrix protein of 160 kDa;Ser/Arg-related nuclear matrix protein;, PF01480;, GO:0071013;GO:0005829;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0006405;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold76 indexed_genome mRNA 2566721 2569656 . - . ID=transcript_11726;Q5T1S8 A0PK04 B2RV34,Noncompact myelin-associated protein,Myelin protein of 11 kDa;, , GO:0005887;GO:0033270;GO:0043220;GO:0019911;GO:0032290;GO:0031643;, C:integral component of plasma membrane; C:paranode region of axon; C:Schmidt-Lanterman incisure;, F:structural constituent of myelin sheath;, P:peripheral nervous system myelin formation; P:positive regulation of myelination; scaffold76 indexed_genome mRNA 2629754 2659119 . - . ID=transcript_11727;G1FLF0 Q5ECL3 Q5TGC6 Q9NUC8 Q9UKA7,Calcipressin-3,Down syndrome candidate region 1-like protein 2;Myocyte-enriched calcineurin-interacting protein 3;Regulator of calcineurin 3;, PF04847;, GO:0005737;GO:0005634;GO:0008597;GO:0019902;GO:0003723;GO:0031013;GO:0009653;GO:0019722;, C:cytoplasm; C:nucleus;, F:calcium-dependent protein serine/threonine phosphatase regulator activity; F:phosphatase binding; F:RNA binding; F:troponin I binding;, P:anatomical structure morphogenesis; P:calcium-mediated signaling; scaffold76 indexed_genome mRNA 2693045 2695449 . - . ID=transcript_11728;Q6P499 A2A298 Q6MZT9 Q9BVE6,NIPA-like protein 3,, PF05653;, GO:0016021;GO:0016020;GO:0015095;GO:0015693;, C:integral component of membrane; C:membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport;|Q6P499 A2A298 Q6MZT9 Q9BVE6,NIPA-like protein 3,, PF05653;, GO:0016021;GO:0016020;GO:0015095;GO:0015693;, C:integral component of membrane; C:membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport; scaffold76 indexed_genome mRNA 2964617 2975007 . + . ID=transcript_11729;Q8IU57 Q5VTX5 Q5VTX7 Q5VTX8 Q6ZML8 Q8IV66 Q8IZI7 Q8IZI8,Interferon lambda receptor 1,Cytokine receptor class-II member 12;Cytokine receptor family 2 member 12;Interleukin-28 receptor subunit alpha;Likely interleukin or cytokine receptor 2;, PF01108;, GO:0016021;GO:0032002;GO:0005886;GO:0004896;GO:0019221;GO:0051607;GO:0002385;GO:0008285;GO:0050691;GO:0034342;, C:integral component of membrane; C:interleukin-28 receptor complex; C:plasma membrane;, F:cytokine receptor activity;, P:cytokine-mediated signaling pathway; P:defense response to virus; P:mucosal immune response; P:negative regulation of cell population proliferation; P:regulation of defense response to virus by host; P:response to type III interferon;|Q8IU57 Q5VTX5 Q5VTX7 Q5VTX8 Q6ZML8 Q8IV66 Q8IZI7 Q8IZI8,Interferon lambda receptor 1,Cytokine receptor class-II member 12;Cytokine receptor family 2 member 12;Interleukin-28 receptor subunit alpha;Likely interleukin or cytokine receptor 2;, PF01108;, GO:0016021;GO:0032002;GO:0005886;GO:0004896;GO:0019221;GO:0051607;GO:0002385;GO:0008285;GO:0050691;GO:0034342;, C:integral component of membrane; C:interleukin-28 receptor complex; C:plasma membrane;, F:cytokine receptor activity;, P:cytokine-mediated signaling pathway; P:defense response to virus; P:mucosal immune response; P:negative regulation of cell population proliferation; P:regulation of defense response to virus by host; P:response to type III interferon; scaffold76 indexed_genome mRNA 2989043 3015668 . + . ID=transcript_11730;Q8N6P7 A8K839 B2R9Y9 Q9HB22,Interleukin-22 receptor subunit alpha-1,Cytokine receptor class-II member 9;Cytokine receptor family 2 member 9;ZcytoR11;, PF01108;, GO:0016021;GO:0005886;GO:0004896;GO:0004904;GO:0042015;GO:0019221;GO:0050829;, C:integral component of membrane; C:plasma membrane;, F:cytokine receptor activity; F:interferon receptor activity; F:interleukin-20 binding;, P:cytokine-mediated signaling pathway; P:defense response to Gram-negative bacterium; scaffold76 indexed_genome mRNA 3023394 3074515 . + . ID=transcript_11731;Q96C54,Myomesin-3,Myomesin family member 3;, PF00041;PF07679;PF00047;, GO:0031430;GO:0051015;GO:0042803;GO:0006936;, C:M band;, F:actin filament binding; F:protein homodimerization activity;, P:muscle contraction;|Q96C54,Myomesin-3,Myomesin family member 3;, PF00041;PF07679;PF00047;, GO:0031430;GO:0051015;GO:0042803;GO:0006936;, C:M band;, F:actin filament binding; F:protein homodimerization activity;, P:muscle contraction; scaffold76 indexed_genome mRNA 3150783 3168545 . + . ID=transcript_11732;Q5JRI3 Q5JRI4 Q96G09 Q96P17,Serine/arginine-rich splicing factor 10,40 kDa SR-repressor protein;FUS-interacting serine-arginine-rich protein 1;Splicing factor SRp38;Splicing factor, arginine/serine-rich 13A;TLS-associated protein with Ser-Arg repeats;TLS-associated serine-arginine protein;, PF00076;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0050733;GO:0051082;GO:0016482;GO:0006376;GO:0000398;GO:0048025;GO:0048024;GO:0006355;GO:0000375;GO:0000244;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding; F:RS domain binding; F:unfolded protein binding;, P:cytosolic transport; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription, DNA-templated; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|Q5JRI3 Q5JRI4 Q96G09 Q96P17,Serine/arginine-rich splicing factor 10,40 kDa SR-repressor protein;FUS-interacting serine-arginine-rich protein 1;Splicing factor SRp38;Splicing factor, arginine/serine-rich 13A;TLS-associated protein with Ser-Arg repeats;TLS-associated serine-arginine protein;, PF00076;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0050733;GO:0051082;GO:0016482;GO:0006376;GO:0000398;GO:0048025;GO:0048024;GO:0006355;GO:0000375;GO:0000244;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding; F:RS domain binding; F:unfolded protein binding;, P:cytosolic transport; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription, DNA-templated; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|Q5JRI3 Q5JRI4 Q96G09 Q96P17,Serine/arginine-rich splicing factor 10,40 kDa SR-repressor protein;FUS-interacting serine-arginine-rich protein 1;Splicing factor SRp38;Splicing factor, arginine/serine-rich 13A;TLS-associated protein with Ser-Arg repeats;TLS-associated serine-arginine protein;, PF00076;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0050733;GO:0051082;GO:0016482;GO:0006376;GO:0000398;GO:0048025;GO:0048024;GO:0006355;GO:0000375;GO:0000244;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding; F:RS domain binding; F:unfolded protein binding;, P:cytosolic transport; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription, DNA-templated; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|Q5JRI3 Q5JRI4 Q96G09 Q96P17,Serine/arginine-rich splicing factor 10,40 kDa SR-repressor protein;FUS-interacting serine-arginine-rich protein 1;Splicing factor SRp38;Splicing factor, arginine/serine-rich 13A;TLS-associated protein with Ser-Arg repeats;TLS-associated serine-arginine protein;, PF00076;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0050733;GO:0051082;GO:0016482;GO:0006376;GO:0000398;GO:0048025;GO:0048024;GO:0006355;GO:0000375;GO:0000244;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding; F:RS domain binding; F:unfolded protein binding;, P:cytosolic transport; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:regulation of transcription, DNA-templated; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly; scaffold76 indexed_genome mRNA 3168573 3173299 . - . ID=transcript_11733;Q9NPJ4 B4DU72,Proline-rich nuclear receptor coactivator 2,, , GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0000932;GO:0031087;GO:0000184;, C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:P-body;, , P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; scaffold76 indexed_genome mRNA 3263481 3283575 . + . ID=transcript_11734;P04066 B2RBG3 Q14334 Q14335 Q3LID0 Q8NAC2,Tissue alpha-L-fucosidase {ECO:0000305},Alpha-L-fucosidase I;Alpha-L-fucoside fucohydrolase 1;, PF01120;PF16757;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0043202;GO:0005764;GO:0004560;GO:0006004;GO:0019377;GO:0006027;GO:0016139;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:lysosomal lumen; C:lysosome;, F:alpha-L-fucosidase activity;, P:fucose metabolic process; P:glycolipid catabolic process; P:glycosaminoglycan catabolic process; P:glycoside catabolic process; P:neutrophil degranulation;|P04066 B2RBG3 Q14334 Q14335 Q3LID0 Q8NAC2,Tissue alpha-L-fucosidase {ECO:0000305},Alpha-L-fucosidase I;Alpha-L-fucoside fucohydrolase 1;, PF01120;PF16757;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0043202;GO:0005764;GO:0004560;GO:0006004;GO:0019377;GO:0006027;GO:0016139;GO:0043312;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:lysosomal lumen; C:lysosome;, F:alpha-L-fucosidase activity;, P:fucose metabolic process; P:glycolipid catabolic process; P:glycosaminoglycan catabolic process; P:glycoside catabolic process; P:neutrophil degranulation; scaffold76 indexed_genome mRNA 3294845 3298161 . + . ID=transcript_11735;P35914 B4DUP4 B7UCC6 D3Y5K7 Q6IBC0 Q96FP8,Hydroxymethylglutaryl-CoA lyase, mitochondrial,3-hydroxy-3-methylglutarate-CoA lyase;, PF00682;, GO:0005829;GO:0005759;GO:0005739;GO:0005782;GO:0005777;GO:0032991;GO:0031406;GO:0000062;GO:0004419;GO:0000287;GO:0030145;GO:0046872;GO:0005198;GO:0006637;GO:0046951;GO:0006552;GO:0006629;GO:0001889;GO:0007005;GO:0008104;GO:0070542;GO:0007584;GO:0042594;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:peroxisomal matrix; C:peroxisome; C:protein-containing complex;, F:carboxylic acid binding; F:fatty-acyl-CoA binding; F:hydroxymethylglutaryl-CoA lyase activity; F:magnesium ion binding; F:manganese ion binding; F:metal ion binding; F:structural molecule activity;, P:acyl-CoA metabolic process; P:ketone body biosynthetic process; P:leucine catabolic process; P:lipid metabolic process; P:liver development; P:mitochondrion organization; P:protein localization; P:response to fatty acid; P:response to nutrient; P:response to starvation; scaffold76 indexed_genome mRNA 3298840 3311991 . + . ID=transcript_11736;P35914 B4DUP4 B7UCC6 D3Y5K7 Q6IBC0 Q96FP8,Hydroxymethylglutaryl-CoA lyase, mitochondrial,3-hydroxy-3-methylglutarate-CoA lyase;, PF00682;, GO:0005829;GO:0005759;GO:0005739;GO:0005782;GO:0005777;GO:0032991;GO:0031406;GO:0000062;GO:0004419;GO:0000287;GO:0030145;GO:0046872;GO:0005198;GO:0006637;GO:0046951;GO:0006552;GO:0006629;GO:0001889;GO:0007005;GO:0008104;GO:0070542;GO:0007584;GO:0042594;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:peroxisomal matrix; C:peroxisome; C:protein-containing complex;, F:carboxylic acid binding; F:fatty-acyl-CoA binding; F:hydroxymethylglutaryl-CoA lyase activity; F:magnesium ion binding; F:manganese ion binding; F:metal ion binding; F:structural molecule activity;, P:acyl-CoA metabolic process; P:ketone body biosynthetic process; P:leucine catabolic process; P:lipid metabolic process; P:liver development; P:mitochondrion organization; P:protein localization; P:response to fatty acid; P:response to nutrient; P:response to starvation;|P35914 B4DUP4 B7UCC6 D3Y5K7 Q6IBC0 Q96FP8,Hydroxymethylglutaryl-CoA lyase, mitochondrial,3-hydroxy-3-methylglutarate-CoA lyase;, PF00682;, GO:0005829;GO:0005759;GO:0005739;GO:0005782;GO:0005777;GO:0032991;GO:0031406;GO:0000062;GO:0004419;GO:0000287;GO:0030145;GO:0046872;GO:0005198;GO:0006637;GO:0046951;GO:0006552;GO:0006629;GO:0001889;GO:0007005;GO:0008104;GO:0070542;GO:0007584;GO:0042594;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:peroxisomal matrix; C:peroxisome; C:protein-containing complex;, F:carboxylic acid binding; F:fatty-acyl-CoA binding; F:hydroxymethylglutaryl-CoA lyase activity; F:magnesium ion binding; F:manganese ion binding; F:metal ion binding; F:structural molecule activity;, P:acyl-CoA metabolic process; P:ketone body biosynthetic process; P:leucine catabolic process; P:lipid metabolic process; P:liver development; P:mitochondrion organization; P:protein localization; P:response to fatty acid; P:response to nutrient; P:response to starvation;|P35914 B4DUP4 B7UCC6 D3Y5K7 Q6IBC0 Q96FP8,Hydroxymethylglutaryl-CoA lyase, mitochondrial,3-hydroxy-3-methylglutarate-CoA lyase;, PF00682;, GO:0005829;GO:0005759;GO:0005739;GO:0005782;GO:0005777;GO:0032991;GO:0031406;GO:0000062;GO:0004419;GO:0000287;GO:0030145;GO:0046872;GO:0005198;GO:0006637;GO:0046951;GO:0006552;GO:0006629;GO:0001889;GO:0007005;GO:0008104;GO:0070542;GO:0007584;GO:0042594;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:peroxisomal matrix; C:peroxisome; C:protein-containing complex;, F:carboxylic acid binding; F:fatty-acyl-CoA binding; F:hydroxymethylglutaryl-CoA lyase activity; F:magnesium ion binding; F:manganese ion binding; F:metal ion binding; F:structural molecule activity;, P:acyl-CoA metabolic process; P:ketone body biosynthetic process; P:leucine catabolic process; P:lipid metabolic process; P:liver development; P:mitochondrion organization; P:protein localization; P:response to fatty acid; P:response to nutrient; P:response to starvation; scaffold76 indexed_genome mRNA 3313348 3317715 . + . ID=transcript_11737;Q14376 A0A024RAH5 B3KQ39 Q38G75 Q86W41 Q9BVE3 Q9UJB4,UDP-glucose 4-epimerase {ECO:0000303|PubMed:22654673},Galactowaldenase;UDP-N-acetylgalactosamine 4-epimerase {ECO:0000303|PubMed:22654673};UDP-N-acetylglucosamine 4-epimerase {ECO:0000303|PubMed:22654673};UDP-galactose 4-epimerase {ECO:0000303|PubMed:22654673};, PF16363;, GO:0005829;GO:0042802;GO:0042803;GO:0003978;GO:0003974;GO:0019388;GO:0033499;, C:cytosol;, F:identical protein binding; F:protein homodimerization activity; F:UDP-glucose 4-epimerase activity; F:UDP-N-acetylglucosamine 4-epimerase activity;, P:galactose catabolic process; P:galactose catabolic process via UDP-galactose;|Q14376 A0A024RAH5 B3KQ39 Q38G75 Q86W41 Q9BVE3 Q9UJB4,UDP-glucose 4-epimerase {ECO:0000303|PubMed:22654673},Galactowaldenase;UDP-N-acetylgalactosamine 4-epimerase {ECO:0000303|PubMed:22654673};UDP-N-acetylglucosamine 4-epimerase {ECO:0000303|PubMed:22654673};UDP-galactose 4-epimerase {ECO:0000303|PubMed:22654673};, PF16363;, GO:0005829;GO:0042802;GO:0042803;GO:0003978;GO:0003974;GO:0019388;GO:0033499;, C:cytosol;, F:identical protein binding; F:protein homodimerization activity; F:UDP-glucose 4-epimerase activity; F:UDP-N-acetylglucosamine 4-epimerase activity;, P:galactose catabolic process; P:galactose catabolic process via UDP-galactose; scaffold76 indexed_genome mRNA 3317762 3322352 . - . ID=transcript_11738;O95372 Q7Z4Z2,Acyl-protein thioesterase 2,Lysophospholipase II;, PF02230;, GO:0005737;GO:0005829;GO:0070062;GO:0005795;GO:0045296;GO:0052689;GO:0004622;GO:0008474;GO:0046464;GO:0007411;GO:0006631;GO:1905344;GO:0002084;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi stack;, F:cadherin binding; F:carboxylic ester hydrolase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity;, P:acylglycerol catabolic process; P:axon guidance; P:fatty acid metabolic process; P:prostaglandin catabolic process; P:protein depalmitoylation;|O95372 Q7Z4Z2,Acyl-protein thioesterase 2,Lysophospholipase II;, PF02230;, GO:0005737;GO:0005829;GO:0070062;GO:0005795;GO:0045296;GO:0052689;GO:0004622;GO:0008474;GO:0046464;GO:0007411;GO:0006631;GO:1905344;GO:0002084;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi stack;, F:cadherin binding; F:carboxylic ester hydrolase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity;, P:acylglycerol catabolic process; P:axon guidance; P:fatty acid metabolic process; P:prostaglandin catabolic process; P:protein depalmitoylation;|O95372 Q7Z4Z2,Acyl-protein thioesterase 2,Lysophospholipase II;, PF02230;, GO:0005737;GO:0005829;GO:0070062;GO:0005795;GO:0045296;GO:0052689;GO:0004622;GO:0008474;GO:0046464;GO:0007411;GO:0006631;GO:1905344;GO:0002084;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi stack;, F:cadherin binding; F:carboxylic ester hydrolase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity;, P:acylglycerol catabolic process; P:axon guidance; P:fatty acid metabolic process; P:prostaglandin catabolic process; P:protein depalmitoylation;|O95372 Q7Z4Z2,Acyl-protein thioesterase 2,Lysophospholipase II;, PF02230;, GO:0005737;GO:0005829;GO:0070062;GO:0005795;GO:0045296;GO:0052689;GO:0004622;GO:0008474;GO:0046464;GO:0007411;GO:0006631;GO:1905344;GO:0002084;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi stack;, F:cadherin binding; F:carboxylic ester hydrolase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity;, P:acylglycerol catabolic process; P:axon guidance; P:fatty acid metabolic process; P:prostaglandin catabolic process; P:protein depalmitoylation;|O95372 Q7Z4Z2,Acyl-protein thioesterase 2,Lysophospholipase II;, PF02230;, GO:0005737;GO:0005829;GO:0070062;GO:0005795;GO:0045296;GO:0052689;GO:0004622;GO:0008474;GO:0046464;GO:0007411;GO:0006631;GO:1905344;GO:0002084;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi stack;, F:cadherin binding; F:carboxylic ester hydrolase activity; F:lysophospholipase activity; F:palmitoyl-(protein) hydrolase activity;, P:acylglycerol catabolic process; P:axon guidance; P:fatty acid metabolic process; P:prostaglandin catabolic process; P:protein depalmitoylation; scaffold76 indexed_genome mRNA 3323298 3331429 . - . ID=transcript_11739;Q9GZP4 B2R7J4 Q5QPN6 Q5QPN7 Q9NRI8,PITH domain-containing protein 1,, PF06201;, GO:0005737;GO:0005634;GO:0097598;GO:0061956;GO:0007341;GO:0045654;GO:0045893;GO:0061136;GO:0007286;, C:cytoplasm; C:nucleus; C:sperm cytoplasmic droplet;, , P:penetration of cumulus oophorus; P:penetration of zona pellucida; P:positive regulation of megakaryocyte differentiation; P:positive regulation of transcription, DNA-templated; P:regulation of proteasomal protein catabolic process; P:spermatid development;|Q9GZP4 B2R7J4 Q5QPN6 Q5QPN7 Q9NRI8,PITH domain-containing protein 1,, PF06201;, GO:0005737;GO:0005634;GO:0097598;GO:0061956;GO:0007341;GO:0045654;GO:0045893;GO:0061136;GO:0007286;, C:cytoplasm; C:nucleus; C:sperm cytoplasmic droplet;, , P:penetration of cumulus oophorus; P:penetration of zona pellucida; P:positive regulation of megakaryocyte differentiation; P:positive regulation of transcription, DNA-templated; P:regulation of proteasomal protein catabolic process; P:spermatid development; scaffold76 indexed_genome mRNA 3339393 3398188 . - . ID=transcript_11740;Q14241 B2R7Q8 Q8IXH1,Elongin-A,Elongin 110 kDa subunit;RNA polymerase II transcription factor SIII subunit A1;SIII p110;Transcription elongation factor B polypeptide 3;, PF06881;PF08711;, GO:0070449;GO:0005615;GO:0005654;GO:0090734;GO:0006357;GO:0006366;GO:0006368;, C:elongin complex; C:extracellular space; C:nucleoplasm; C:site of DNA damage;, , P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q14241 B2R7Q8 Q8IXH1,Elongin-A,Elongin 110 kDa subunit;RNA polymerase II transcription factor SIII subunit A1;SIII p110;Transcription elongation factor B polypeptide 3;, PF06881;PF08711;, GO:0070449;GO:0005615;GO:0005654;GO:0090734;GO:0006357;GO:0006366;GO:0006368;, C:elongin complex; C:extracellular space; C:nucleoplasm; C:site of DNA damage;, , P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q14241 B2R7Q8 Q8IXH1,Elongin-A,Elongin 110 kDa subunit;RNA polymerase II transcription factor SIII subunit A1;SIII p110;Transcription elongation factor B polypeptide 3;, PF06881;PF08711;, GO:0070449;GO:0005615;GO:0005654;GO:0090734;GO:0006357;GO:0006366;GO:0006368;, C:elongin complex; C:extracellular space; C:nucleoplasm; C:site of DNA damage;, , P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q14241 B2R7Q8 Q8IXH1,Elongin-A,Elongin 110 kDa subunit;RNA polymerase II transcription factor SIII subunit A1;SIII p110;Transcription elongation factor B polypeptide 3;, PF06881;PF08711;, GO:0070449;GO:0005615;GO:0005654;GO:0090734;GO:0006357;GO:0006366;GO:0006368;, C:elongin complex; C:extracellular space; C:nucleoplasm; C:site of DNA damage;, , P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P62913 P25121 P39026 Q8TDH2 Q9Y674,60S ribosomal protein L11,CLL-associated antigen KW-12;Large ribosomal subunit protein uL5 {ECO:0000303|PubMed:24524803};, PF00281;PF00673;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0042788;GO:0032991;GO:0008097;GO:0003723;GO:0003735;GO:1990948;GO:0031625;GO:0002181;GO:0032435;GO:2000435;GO:1904667;GO:2000059;GO:0000184;GO:0010628;GO:1902255;GO:0032092;GO:0034504;GO:0050821;GO:0006605;GO:1901796;GO:0000027;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:polysomal ribosome; C:protein-containing complex;, F:5S rRNA binding; F:RNA binding; F:structural constituent of ribosome; F:ubiquitin ligase inhibitor activity; F:ubiquitin protein ligase binding;, P:cytoplasmic translation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein neddylation; P:negative regulation of ubiquitin protein ligase activity; P:negative regulation of ubiquitin-dependent protein catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of gene expression; P:positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:positive regulation of protein binding; P:protein localization to nucleus; P:protein stabilization; P:protein targeting; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62913 P25121 P39026 Q8TDH2 Q9Y674,60S ribosomal protein L11,CLL-associated antigen KW-12;Large ribosomal subunit protein uL5 {ECO:0000303|PubMed:24524803};, PF00281;PF00673;, GO:0005737;GO:0005829;GO:0022625;GO:0070062;GO:0016020;GO:0005730;GO:0005654;GO:0042788;GO:0032991;GO:0008097;GO:0003723;GO:0003735;GO:1990948;GO:0031625;GO:0002181;GO:0032435;GO:2000435;GO:1904667;GO:2000059;GO:0000184;GO:0010628;GO:1902255;GO:0032092;GO:0034504;GO:0050821;GO:0006605;GO:1901796;GO:0000027;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleolus; C:nucleoplasm; C:polysomal ribosome; C:protein-containing complex;, F:5S rRNA binding; F:RNA binding; F:structural constituent of ribosome; F:ubiquitin ligase inhibitor activity; F:ubiquitin protein ligase binding;, P:cytoplasmic translation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein neddylation; P:negative regulation of ubiquitin protein ligase activity; P:negative regulation of ubiquitin-dependent protein catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of gene expression; P:positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:positive regulation of protein binding; P:protein localization to nucleus; P:protein stabilization; P:protein targeting; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold76 indexed_genome mRNA 3493078 3494904 . + . ID=transcript_11741;Q02535 A8K1T8 O75641,DNA-binding protein inhibitor ID-3,Class B basic helix-loop-helix protein 25;Helix-loop-helix protein HEIR-1;ID-like protein inhibitor HLH 1R21;Inhibitor of DNA binding 3;Inhibitor of differentiation 3;, PF00010;, GO:0005737;GO:0005654;GO:0005634;GO:1901707;GO:0046983;GO:0019904;GO:0008134;GO:0140416;GO:0030154;GO:0072750;GO:0007417;GO:0032922;GO:0030855;GO:0007507;GO:0001656;GO:0007275;GO:0007517;GO:0043433;GO:0045662;GO:0045668;GO:0000122;GO:0045892;GO:0030182;GO:0030903;GO:0042476;GO:0043065;GO:0010628;GO:0051726;GO:0006275;GO:0009611;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:leptomycin B binding; F:protein dimerization activity; F:protein domain specific binding; F:transcription factor binding; F:transcription regulator inhibitor activity;, P:cell differentiation; P:cellular response to leptomycin B; P:central nervous system development; P:circadian regulation of gene expression; P:epithelial cell differentiation; P:heart development; P:metanephros development; P:multicellular organism development; P:muscle organ development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of myoblast differentiation; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:notochord development; P:odontogenesis; P:positive regulation of apoptotic process; P:positive regulation of gene expression; P:regulation of cell cycle; P:regulation of DNA replication; P:response to wounding;|Q02535 A8K1T8 O75641,DNA-binding protein inhibitor ID-3,Class B basic helix-loop-helix protein 25;Helix-loop-helix protein HEIR-1;ID-like protein inhibitor HLH 1R21;Inhibitor of DNA binding 3;Inhibitor of differentiation 3;, PF00010;, GO:0005737;GO:0005654;GO:0005634;GO:1901707;GO:0046983;GO:0019904;GO:0008134;GO:0140416;GO:0030154;GO:0072750;GO:0007417;GO:0032922;GO:0030855;GO:0007507;GO:0001656;GO:0007275;GO:0007517;GO:0043433;GO:0045662;GO:0045668;GO:0000122;GO:0045892;GO:0030182;GO:0030903;GO:0042476;GO:0043065;GO:0010628;GO:0051726;GO:0006275;GO:0009611;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:leptomycin B binding; F:protein dimerization activity; F:protein domain specific binding; F:transcription factor binding; F:transcription regulator inhibitor activity;, P:cell differentiation; P:cellular response to leptomycin B; P:central nervous system development; P:circadian regulation of gene expression; P:epithelial cell differentiation; P:heart development; P:metanephros development; P:multicellular organism development; P:muscle organ development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of myoblast differentiation; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:notochord development; P:odontogenesis; P:positive regulation of apoptotic process; P:positive regulation of gene expression; P:regulation of cell cycle; P:regulation of DNA replication; P:response to wounding; scaffold76 indexed_genome mRNA 3571654 3609388 . + . ID=transcript_11742;Q8TDY4 B3KRW0 B4DHH4 Q6P9F4 Q86UY1 Q9NXK2,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3,Development and differentiation-enhancing factor-like 1;Protein up-regulated in liver cancer 1;, PF12796;PF01412;PF00169;, GO:0005829;GO:0005925;GO:0043231;GO:0005654;GO:0001726;GO:0005096;GO:0046872;GO:0016477;GO:0043547;GO:0051492;, C:cytosol; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:ruffle;, F:GTPase activator activity; F:metal ion binding;, P:cell migration; P:positive regulation of GTPase activity; P:regulation of stress fiber assembly;|Q8TDY4 B3KRW0 B4DHH4 Q6P9F4 Q86UY1 Q9NXK2,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3,Development and differentiation-enhancing factor-like 1;Protein up-regulated in liver cancer 1;, PF12796;PF01412;PF00169;, GO:0005829;GO:0005925;GO:0043231;GO:0005654;GO:0001726;GO:0005096;GO:0046872;GO:0016477;GO:0043547;GO:0051492;, C:cytosol; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:ruffle;, F:GTPase activator activity; F:metal ion binding;, P:cell migration; P:positive regulation of GTPase activity; P:regulation of stress fiber assembly; scaffold76 indexed_genome mRNA 3609678 3619387 . + . ID=transcript_11743;Q8TDY4 B3KRW0 B4DHH4 Q6P9F4 Q86UY1 Q9NXK2,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3,Development and differentiation-enhancing factor-like 1;Protein up-regulated in liver cancer 1;, PF12796;PF01412;PF00169;, GO:0005829;GO:0005925;GO:0043231;GO:0005654;GO:0001726;GO:0005096;GO:0046872;GO:0016477;GO:0043547;GO:0051492;, C:cytosol; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:ruffle;, F:GTPase activator activity; F:metal ion binding;, P:cell migration; P:positive regulation of GTPase activity; P:regulation of stress fiber assembly;|Q8TDY4 B3KRW0 B4DHH4 Q6P9F4 Q86UY1 Q9NXK2,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3,Development and differentiation-enhancing factor-like 1;Protein up-regulated in liver cancer 1;, PF12796;PF01412;PF00169;, GO:0005829;GO:0005925;GO:0043231;GO:0005654;GO:0001726;GO:0005096;GO:0046872;GO:0016477;GO:0043547;GO:0051492;, C:cytosol; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:ruffle;, F:GTPase activator activity; F:metal ion binding;, P:cell migration; P:positive regulation of GTPase activity; P:regulation of stress fiber assembly; scaffold76 indexed_genome mRNA 3623543 3671753 . + . ID=transcript_11744;O75764 A8K2K7 Q5DR83,Transcription elongation factor A protein 3,Transcription elongation factor S-II protein 3;Transcription elongation factor TFIIS.h;, PF08711;PF01096;PF07500;, GO:0005634;GO:0003677;GO:0008270;GO:0006355;GO:0006351;, C:nucleus;, F:DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated; P:transcription, DNA-templated;|O75764 A8K2K7 Q5DR83,Transcription elongation factor A protein 3,Transcription elongation factor S-II protein 3;Transcription elongation factor TFIIS.h;, PF08711;PF01096;PF07500;, GO:0005634;GO:0003677;GO:0008270;GO:0006355;GO:0006351;, C:nucleus;, F:DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold76 indexed_genome mRNA 3674952 3677974 . - . ID=transcript_11745;Q8NC38 Q2VPR7,Putative uncharacterized protein ZNF436-AS1 {ECO:0000312|HGNC:HGNC:25122},ZNF436 antisense RNA 1 {ECO:0000312|HGNC:HGNC:25122};ZNF436 antisense gene protein 1 {ECO:0000305}; scaffold76 indexed_genome mRNA 3678173 3685987 . + . ID=transcript_11746;Q9C0F3 Q658I9,Zinc finger protein 436,, PF01352;PF00096;, GO:0005829;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:cytosol; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold76 indexed_genome mRNA 3697947 3728735 . + . ID=transcript_11747;O43390 Q2L7G6 Q5TEH1 Q9BV64 S4R3J4,Heterogeneous nuclear ribonucleoprotein R,, PF18360;PF00076;, GO:0043679;GO:0071013;GO:0030425;GO:0005783;GO:0030426;GO:0005654;GO:0005634;GO:1990904;GO:0005681;GO:0003730;GO:0003729;GO:0003723;GO:0007623;GO:0061157;GO:0006397;GO:0000398;GO:0043086;GO:0016070;, C:axon terminus; C:catalytic step 2 spliceosome; C:dendrite; C:endoplasmic reticulum; C:growth cone; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal complex;, F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:circadian rhythm; P:mRNA destabilization; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of catalytic activity; P:RNA metabolic process; scaffold76 indexed_genome mRNA 3920202 4016223 . + . ID=transcript_11748;Q86V48 Q5TH93 Q8N4X3 Q8TEH1,Leucine zipper protein 1,, , GO:0070062;GO:0016020;GO:0005634;GO:0060840;GO:0021503;GO:0003281;, C:extracellular exosome; C:membrane; C:nucleus;, , P:artery development; P:neural fold bending; P:ventricular septum development;|Q86V48 Q5TH93 Q8N4X3 Q8TEH1,Leucine zipper protein 1,, , GO:0070062;GO:0016020;GO:0005634;GO:0060840;GO:0021503;GO:0003281;, C:extracellular exosome; C:membrane; C:nucleus;, , P:artery development; P:neural fold bending; P:ventricular septum development;|O60341 A8MWP9 Q5TH94 Q5TH95 Q86VT7 Q8IXK4 Q8NDP6 Q8TAZ3 Q96AW4,Lysine-specific histone demethylase 1A,BRAF35-HDAC complex protein BHC110;Flavin-containing amine oxidase domain-containing protein 2;[histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A;, PF01593;PF04433;, GO:0000785;GO:0000781;GO:1990391;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0050681;GO:0003682;GO:0032451;GO:0019899;GO:0050660;GO:0032452;GO:0034648;GO:0032453;GO:0032454;GO:0043426;GO:0030374;GO:0016491;GO:0002039;GO:1990841;GO:0001085;GO:0061752;GO:0008134;GO:0000380;GO:0007596;GO:0071320;GO:0071480;GO:0034644;GO:0021987;GO:0046098;GO:0034720;GO:0033169;GO:0030522;GO:0055001;GO:0043392;GO:0043518;GO:0043433;GO:0051572;GO:0051573;GO:1902166;GO:0032091;GO:0000122;GO:0045892;GO:0042551;GO:0045793;GO:0035563;GO:0120162;GO:0051091;GO:0033184;GO:2000179;GO:0002052;GO:0010976;GO:2000648;GO:0045944;GO:0006482;GO:0060765;GO:1903827;GO:0010569;GO:0006357;GO:0060992;, C:chromatin; C:chromosome, telomeric region; C:DNA repair complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:androgen receptor binding; F:chromatin binding; F:demethylase activity; F:enzyme binding; F:flavin adenine dinucleotide binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-K9 specific); F:MRF binding; F:nuclear receptor coactivator activity; F:oxidoreductase activity; F:p53 binding; F:promoter-specific chromatin binding; F:RNA polymerase II transcription factor binding; F:telomeric repeat-containing RNA binding; F:transcription factor binding;, P:alternative mRNA splicing, via spliceosome; P:blood coagulation; P:cellular response to cAMP; P:cellular response to gamma radiation; P:cellular response to UV; P:cerebral cortex development; P:guanine metabolic process; P:histone H3-K4 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:muscle cell development; P:negative regulation of DNA binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone H3-K9 methylation; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of protein binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron maturation; P:positive regulation of cell size; P:positive regulation of chromatin binding; P:positive regulation of cold-induced thermogenesis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of histone ubiquitination; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron projection development; P:positive regulation of stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:protein demethylation; P:regulation of androgen receptor signaling pathway; P:regulation of cellular protein localization; P:regulation of double-strand break repair via homologous recombination; P:regulation of transcription by RNA polymerase II; P:response to fungicide;|O60341 A8MWP9 Q5TH94 Q5TH95 Q86VT7 Q8IXK4 Q8NDP6 Q8TAZ3 Q96AW4,Lysine-specific histone demethylase 1A,BRAF35-HDAC complex protein BHC110;Flavin-containing amine oxidase domain-containing protein 2;[histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A;, PF01593;PF04433;, GO:0000785;GO:0000781;GO:1990391;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0050681;GO:0003682;GO:0032451;GO:0019899;GO:0050660;GO:0032452;GO:0034648;GO:0032453;GO:0032454;GO:0043426;GO:0030374;GO:0016491;GO:0002039;GO:1990841;GO:0001085;GO:0061752;GO:0008134;GO:0000380;GO:0007596;GO:0071320;GO:0071480;GO:0034644;GO:0021987;GO:0046098;GO:0034720;GO:0033169;GO:0030522;GO:0055001;GO:0043392;GO:0043518;GO:0043433;GO:0051572;GO:0051573;GO:1902166;GO:0032091;GO:0000122;GO:0045892;GO:0042551;GO:0045793;GO:0035563;GO:0120162;GO:0051091;GO:0033184;GO:2000179;GO:0002052;GO:0010976;GO:2000648;GO:0045944;GO:0006482;GO:0060765;GO:1903827;GO:0010569;GO:0006357;GO:0060992;, C:chromatin; C:chromosome, telomeric region; C:DNA repair complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:androgen receptor binding; F:chromatin binding; F:demethylase activity; F:enzyme binding; F:flavin adenine dinucleotide binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-K9 specific); F:MRF binding; F:nuclear receptor coactivator activity; F:oxidoreductase activity; F:p53 binding; F:promoter-specific chromatin binding; F:RNA polymerase II transcription factor binding; F:telomeric repeat-containing RNA binding; F:transcription factor binding;, P:alternative mRNA splicing, via spliceosome; P:blood coagulation; P:cellular response to cAMP; P:cellular response to gamma radiation; P:cellular response to UV; P:cerebral cortex development; P:guanine metabolic process; P:histone H3-K4 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:muscle cell development; P:negative regulation of DNA binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone H3-K9 methylation; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of protein binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron maturation; P:positive regulation of cell size; P:positive regulation of chromatin binding; P:positive regulation of cold-induced thermogenesis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of histone ubiquitination; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron projection development; P:positive regulation of stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:protein demethylation; P:regulation of androgen receptor signaling pathway; P:regulation of cellular protein localization; P:regulation of double-strand break repair via homologous recombination; P:regulation of transcription by RNA polymerase II; P:response to fungicide;|O60341 A8MWP9 Q5TH94 Q5TH95 Q86VT7 Q8IXK4 Q8NDP6 Q8TAZ3 Q96AW4,Lysine-specific histone demethylase 1A,BRAF35-HDAC complex protein BHC110;Flavin-containing amine oxidase domain-containing protein 2;[histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A;, PF01593;PF04433;, GO:0000785;GO:0000781;GO:1990391;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0050681;GO:0003682;GO:0032451;GO:0019899;GO:0050660;GO:0032452;GO:0034648;GO:0032453;GO:0032454;GO:0043426;GO:0030374;GO:0016491;GO:0002039;GO:1990841;GO:0001085;GO:0061752;GO:0008134;GO:0000380;GO:0007596;GO:0071320;GO:0071480;GO:0034644;GO:0021987;GO:0046098;GO:0034720;GO:0033169;GO:0030522;GO:0055001;GO:0043392;GO:0043518;GO:0043433;GO:0051572;GO:0051573;GO:1902166;GO:0032091;GO:0000122;GO:0045892;GO:0042551;GO:0045793;GO:0035563;GO:0120162;GO:0051091;GO:0033184;GO:2000179;GO:0002052;GO:0010976;GO:2000648;GO:0045944;GO:0006482;GO:0060765;GO:1903827;GO:0010569;GO:0006357;GO:0060992;, C:chromatin; C:chromosome, telomeric region; C:DNA repair complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:androgen receptor binding; F:chromatin binding; F:demethylase activity; F:enzyme binding; F:flavin adenine dinucleotide binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-K9 specific); F:MRF binding; F:nuclear receptor coactivator activity; F:oxidoreductase activity; F:p53 binding; F:promoter-specific chromatin binding; F:RNA polymerase II transcription factor binding; F:telomeric repeat-containing RNA binding; F:transcription factor binding;, P:alternative mRNA splicing, via spliceosome; P:blood coagulation; P:cellular response to cAMP; P:cellular response to gamma radiation; P:cellular response to UV; P:cerebral cortex development; P:guanine metabolic process; P:histone H3-K4 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:muscle cell development; P:negative regulation of DNA binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone H3-K9 methylation; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of protein binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron maturation; P:positive regulation of cell size; P:positive regulation of chromatin binding; P:positive regulation of cold-induced thermogenesis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of histone ubiquitination; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron projection development; P:positive regulation of stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:protein demethylation; P:regulation of androgen receptor signaling pathway; P:regulation of cellular protein localization; P:regulation of double-strand break repair via homologous recombination; P:regulation of transcription by RNA polymerase II; P:response to fungicide;|O60341 A8MWP9 Q5TH94 Q5TH95 Q86VT7 Q8IXK4 Q8NDP6 Q8TAZ3 Q96AW4,Lysine-specific histone demethylase 1A,BRAF35-HDAC complex protein BHC110;Flavin-containing amine oxidase domain-containing protein 2;[histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A;, PF01593;PF04433;, GO:0000785;GO:0000781;GO:1990391;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0050681;GO:0003682;GO:0032451;GO:0019899;GO:0050660;GO:0032452;GO:0034648;GO:0032453;GO:0032454;GO:0043426;GO:0030374;GO:0016491;GO:0002039;GO:1990841;GO:0001085;GO:0061752;GO:0008134;GO:0000380;GO:0007596;GO:0071320;GO:0071480;GO:0034644;GO:0021987;GO:0046098;GO:0034720;GO:0033169;GO:0030522;GO:0055001;GO:0043392;GO:0043518;GO:0043433;GO:0051572;GO:0051573;GO:1902166;GO:0032091;GO:0000122;GO:0045892;GO:0042551;GO:0045793;GO:0035563;GO:0120162;GO:0051091;GO:0033184;GO:2000179;GO:0002052;GO:0010976;GO:2000648;GO:0045944;GO:0006482;GO:0060765;GO:1903827;GO:0010569;GO:0006357;GO:0060992;, C:chromatin; C:chromosome, telomeric region; C:DNA repair complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:androgen receptor binding; F:chromatin binding; F:demethylase activity; F:enzyme binding; F:flavin adenine dinucleotide binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-K9 specific); F:MRF binding; F:nuclear receptor coactivator activity; F:oxidoreductase activity; F:p53 binding; F:promoter-specific chromatin binding; F:RNA polymerase II transcription factor binding; F:telomeric repeat-containing RNA binding; F:transcription factor binding;, P:alternative mRNA splicing, via spliceosome; P:blood coagulation; P:cellular response to cAMP; P:cellular response to gamma radiation; P:cellular response to UV; P:cerebral cortex development; P:guanine metabolic process; P:histone H3-K4 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:muscle cell development; P:negative regulation of DNA binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone H3-K9 methylation; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of protein binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron maturation; P:positive regulation of cell size; P:positive regulation of chromatin binding; P:positive regulation of cold-induced thermogenesis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of histone ubiquitination; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron projection development; P:positive regulation of stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:protein demethylation; P:regulation of androgen receptor signaling pathway; P:regulation of cellular protein localization; P:regulation of double-strand break repair via homologous recombination; P:regulation of transcription by RNA polymerase II; P:response to fungicide;|O60341 A8MWP9 Q5TH94 Q5TH95 Q86VT7 Q8IXK4 Q8NDP6 Q8TAZ3 Q96AW4,Lysine-specific histone demethylase 1A,BRAF35-HDAC complex protein BHC110;Flavin-containing amine oxidase domain-containing protein 2;[histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A;, PF01593;PF04433;, GO:0000785;GO:0000781;GO:1990391;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0050681;GO:0003682;GO:0032451;GO:0019899;GO:0050660;GO:0032452;GO:0034648;GO:0032453;GO:0032454;GO:0043426;GO:0030374;GO:0016491;GO:0002039;GO:1990841;GO:0001085;GO:0061752;GO:0008134;GO:0000380;GO:0007596;GO:0071320;GO:0071480;GO:0034644;GO:0021987;GO:0046098;GO:0034720;GO:0033169;GO:0030522;GO:0055001;GO:0043392;GO:0043518;GO:0043433;GO:0051572;GO:0051573;GO:1902166;GO:0032091;GO:0000122;GO:0045892;GO:0042551;GO:0045793;GO:0035563;GO:0120162;GO:0051091;GO:0033184;GO:2000179;GO:0002052;GO:0010976;GO:2000648;GO:0045944;GO:0006482;GO:0060765;GO:1903827;GO:0010569;GO:0006357;GO:0060992;, C:chromatin; C:chromosome, telomeric region; C:DNA repair complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:androgen receptor binding; F:chromatin binding; F:demethylase activity; F:enzyme binding; F:flavin adenine dinucleotide binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-K9 specific); F:MRF binding; F:nuclear receptor coactivator activity; F:oxidoreductase activity; F:p53 binding; F:promoter-specific chromatin binding; F:RNA polymerase II transcription factor binding; F:telomeric repeat-containing RNA binding; F:transcription factor binding;, P:alternative mRNA splicing, via spliceosome; P:blood coagulation; P:cellular response to cAMP; P:cellular response to gamma radiation; P:cellular response to UV; P:cerebral cortex development; P:guanine metabolic process; P:histone H3-K4 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:muscle cell development; P:negative regulation of DNA binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of histone H3-K4 methylation; P:negative regulation of histone H3-K9 methylation; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of protein binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neuron maturation; P:positive regulation of cell size; P:positive regulation of chromatin binding; P:positive regulation of cold-induced thermogenesis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of histone ubiquitination; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuroblast proliferation; P:positive regulation of neuron projection development; P:positive regulation of stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:protein demethylation; P:regulation of androgen receptor signaling pathway; P:regulation of cellular protein localization; P:regulation of double-strand break repair via homologous recombination; P:regulation of transcription by RNA polymerase II; P:response to fungicide; scaffold76 indexed_genome mRNA 4083733 4090546 . - . ID=transcript_11749;P29323 O43477 Q5T0U6 Q5T0U7 Q5T0U8,Ephrin type-B receptor 2,Developmentally-regulated Eph-related tyrosine kinase;ELK-related tyrosine kinase;EPH tyrosine kinase 3;EPH-like kinase 5;Renal carcinoma antigen NY-REN-47;Tyrosine-protein kinase TYRO5;Tyrosine-protein kinase receptor EPH-3;, PF14575;PF01404;PF07699;PF00041;PF07714;PF00536;, GO:0030424;GO:0005829;GO:0030425;GO:0005576;GO:0098978;GO:0005887;GO:0099055;GO:0099056;GO:0043005;GO:0043025;GO:0005654;GO:0005886;GO:0098794;GO:0043235;GO:0001540;GO:0005524;GO:0008046;GO:0042802;GO:0004713;GO:0044877;GO:0005102;GO:0004714;GO:0005005;GO:0001525;GO:0007411;GO:0007413;GO:0048593;GO:0021952;GO:0071679;GO:0022038;GO:0060996;GO:0060997;GO:0048013;GO:0051389;GO:0042472;GO:0007612;GO:0007611;GO:0007275;GO:0050771;GO:0070373;GO:1904782;GO:0001933;GO:0046580;GO:0007399;GO:0106028;GO:0021631;GO:0018108;GO:0016310;GO:0010628;GO:0033674;GO:0048170;GO:1900273;GO:1904783;GO:1903078;GO:0051965;GO:0031915;GO:0097104;GO:0030193;GO:0050878;GO:0048168;GO:0031290;GO:0060021;GO:0099557;GO:0007169;GO:0001655;, C:axon; C:cytosol; C:dendrite; C:extracellular region; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:postsynapse; C:receptor complex;, F:amyloid-beta binding; F:ATP binding; F:axon guidance receptor activity; F:identical protein binding; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:angiogenesis; P:axon guidance; P:axonal fasciculation; P:camera-type eye morphogenesis; P:central nervous system projection neuron axonogenesis; P:commissural neuron axon guidance; P:corpus callosum development; P:dendritic spine development; P:dendritic spine morphogenesis; P:ephrin receptor signaling pathway; P:inactivation of MAPKK activity; P:inner ear morphogenesis; P:learning; P:learning or memory; P:multicellular organism development; P:negative regulation of axonogenesis; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of NMDA glutamate receptor activity; P:negative regulation of protein phosphorylation; P:negative regulation of Ras protein signal transduction; P:nervous system development; P:neuron projection retraction; P:optic nerve morphogenesis; P:peptidyl-tyrosine phosphorylation; P:phosphorylation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of NMDA glutamate receptor activity; P:positive regulation of protein localization to plasma membrane; P:positive regulation of synapse assembly; P:positive regulation of synaptic plasticity; P:postsynaptic membrane assembly; P:regulation of blood coagulation; P:regulation of body fluid levels; P:regulation of neuronal synaptic plasticity; P:retinal ganglion cell axon guidance; P:roof of mouth development; P:trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:urogenital system development; scaffold76 indexed_genome mRNA 4348593 4355708 . + . ID=transcript_11750;P02746 Q5T959 Q96H17,Complement C1q subcomponent subunit B,, PF00386;PF01391;, GO:0072562;GO:0005581;GO:0062023;GO:0005602;GO:0005576;GO:0098794;GO:0045202;GO:0006956;GO:0006958;GO:0045087;GO:0030449;GO:0098883;, C:blood microparticle; C:collagen trimer; C:collagen-containing extracellular matrix; C:complement component C1 complex; C:extracellular region; C:postsynapse; C:synapse;, , P:complement activation; P:complement activation, classical pathway; P:innate immune response; P:regulation of complement activation; P:synapse pruning; scaffold76 indexed_genome mRNA 4359718 4367860 . - . ID=transcript_11751;P02747 Q7Z502 Q96DL2 Q96H05,Complement C1q subcomponent subunit C,, PF00386;PF01391;, GO:0072562;GO:0005581;GO:0062023;GO:0005576;GO:0005615;GO:0098794;GO:0045202;GO:0006956;GO:0006958;GO:0006955;GO:0045087;GO:0030853;GO:0045650;GO:0030449;GO:0098883;, C:blood microparticle; C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:postsynapse; C:synapse;, , P:complement activation; P:complement activation, classical pathway; P:immune response; P:innate immune response; P:negative regulation of granulocyte differentiation; P:negative regulation of macrophage differentiation; P:regulation of complement activation; P:synapse pruning; scaffold76 indexed_genome mRNA 4371525 4373703 . - . ID=transcript_11752;P02745 B2R4X2 Q5T963,Complement C1q subcomponent subunit A,, PF00386;PF01391;, GO:0005581;GO:0062023;GO:0005602;GO:0005576;GO:0098794;GO:0045202;GO:0001540;GO:0007568;GO:0048143;GO:0007267;GO:0006956;GO:0006958;GO:0150062;GO:0045087;GO:0001774;GO:0016322;GO:1901216;GO:0030449;GO:0010039;GO:0050808;GO:0098883;GO:0150064;GO:0016032;, C:collagen trimer; C:collagen-containing extracellular matrix; C:complement component C1 complex; C:extracellular region; C:postsynapse; C:synapse;, F:amyloid-beta binding;, P:aging; P:astrocyte activation; P:cell-cell signaling; P:complement activation; P:complement activation, classical pathway; P:complement-mediated synapse pruning; P:innate immune response; P:microglial cell activation; P:neuron remodeling; P:positive regulation of neuron death; P:regulation of complement activation; P:response to iron ion; P:synapse organization; P:synapse pruning; P:vertebrate eye-specific patterning; P:viral process; scaffold76 indexed_genome mRNA 4407182 4416449 . + . ID=transcript_11753;P29322 Q6IN80 Q8IUX6 Q9NUA9 Q9P269,Ephrin type-A receptor 8,EPH- and ELK-related kinase;EPH-like kinase 3;Tyrosine-protein kinase receptor EEK;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0031901;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0005004;GO:0019838;GO:0004714;GO:0005005;GO:0007411;GO:0007155;GO:0071372;GO:0048013;GO:0007275;GO:0031175;GO:0016322;GO:0033674;GO:0043410;GO:0043552;GO:0046777;GO:0030155;GO:0033628;GO:0006929;GO:0007169;, C:early endosome membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:GPI-linked ephrin receptor activity; F:growth factor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:cell adhesion; P:cellular response to follicle-stimulating hormone stimulus; P:ephrin receptor signaling pathway; P:multicellular organism development; P:neuron projection development; P:neuron remodeling; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:substrate-dependent cell migration; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P29322 Q6IN80 Q8IUX6 Q9NUA9 Q9P269,Ephrin type-A receptor 8,EPH- and ELK-related kinase;EPH-like kinase 3;Tyrosine-protein kinase receptor EEK;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0031901;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0005004;GO:0019838;GO:0004714;GO:0005005;GO:0007411;GO:0007155;GO:0071372;GO:0048013;GO:0007275;GO:0031175;GO:0016322;GO:0033674;GO:0043410;GO:0043552;GO:0046777;GO:0030155;GO:0033628;GO:0006929;GO:0007169;, C:early endosome membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:GPI-linked ephrin receptor activity; F:growth factor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:cell adhesion; P:cellular response to follicle-stimulating hormone stimulus; P:ephrin receptor signaling pathway; P:multicellular organism development; P:neuron projection development; P:neuron remodeling; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:protein autophosphorylation; P:regulation of cell adhesion; P:regulation of cell adhesion mediated by integrin; P:substrate-dependent cell migration; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold76 indexed_genome mRNA 4473958 4545925 . + . ID=transcript_11754;Q9NUA8 O75066 Q5TFU5 Q8N1R1,Zinc finger and BTB domain-containing protein 40,, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0030282;GO:0006974;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:bone mineralization; P:cellular response to DNA damage stimulus; P:regulation of transcription by RNA polymerase II;|Q9NUA8 O75066 Q5TFU5 Q8N1R1,Zinc finger and BTB domain-containing protein 40,, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0030282;GO:0006974;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:bone mineralization; P:cellular response to DNA damage stimulus; P:regulation of transcription by RNA polymerase II;|Q9NUA8 O75066 Q5TFU5 Q8N1R1,Zinc finger and BTB domain-containing protein 40,, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0030282;GO:0006974;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:bone mineralization; P:cellular response to DNA damage stimulus; P:regulation of transcription by RNA polymerase II;|Q9NUA8 O75066 Q5TFU5 Q8N1R1,Zinc finger and BTB domain-containing protein 40,, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0030282;GO:0006974;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:bone mineralization; P:cellular response to DNA damage stimulus; P:regulation of transcription by RNA polymerase II;|Q9NUA8 O75066 Q5TFU5 Q8N1R1,Zinc finger and BTB domain-containing protein 40,, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0030282;GO:0006974;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:bone mineralization; P:cellular response to DNA damage stimulus; P:regulation of transcription by RNA polymerase II;|Q9NUA8 O75066 Q5TFU5 Q8N1R1,Zinc finger and BTB domain-containing protein 40,, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0030282;GO:0006974;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:bone mineralization; P:cellular response to DNA damage stimulus; P:regulation of transcription by RNA polymerase II; scaffold76 indexed_genome mRNA 4864838 4870761 . + . ID=transcript_11755;P56705 B4DJF9 Q5TZQ0 Q96T81 Q9BXF5 Q9H1J8 Q9UJM2,Protein Wnt-4,, PF00110;, GO:0009986;GO:0005737;GO:0030666;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0005125;GO:0005109;GO:0048018;GO:0003714;GO:0030325;GO:0001658;GO:0060070;GO:0045165;GO:0009267;GO:0071560;GO:0001838;GO:0001837;GO:0008585;GO:0030237;GO:0042445;GO:0033080;GO:0001822;GO:0001889;GO:0008584;GO:0061180;GO:0060231;GO:0072162;GO:0072273;GO:0072174;GO:2000180;GO:2001234;GO:0045596;GO:0030336;GO:0040037;GO:0010629;GO:2000019;GO:0010894;GO:0061369;GO:2000225;GO:0045892;GO:0061045;GO:0030182;GO:0038030;GO:0048599;GO:0061205;GO:0032349;GO:0030501;GO:0032967;GO:2000066;GO:0061184;GO:0051894;GO:0043547;GO:0045836;GO:0045669;GO:0051496;GO:0045893;GO:0022407;GO:0072033;GO:0072034;GO:0051145;GO:0060126;GO:0060748;GO:0060129;GO:0016055;, C:cell surface; C:cytoplasm; C:endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane;, F:cytokine activity; F:frizzled binding; F:receptor ligand activity; F:transcription corepressor activity;, P:adrenal gland development; P:branching involved in ureteric bud morphogenesis; P:canonical Wnt signaling pathway; P:cell fate commitment; P:cellular response to starvation; P:cellular response to transforming growth factor beta stimulus; P:embryonic epithelial tube formation; P:epithelial to mesenchymal transition; P:female gonad development; P:female sex determination; P:hormone metabolic process; P:immature T cell proliferation in thymus; P:kidney development; P:liver development; P:male gonad development; P:mammary gland epithelium development; P:mesenchymal to epithelial transition; P:metanephric mesenchymal cell differentiation; P:metanephric nephron morphogenesis; P:metanephric tubule formation; P:negative regulation of androgen biosynthetic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell differentiation; P:negative regulation of cell migration; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of gene expression; P:negative regulation of male gonad development; P:negative regulation of steroid biosynthetic process; P:negative regulation of testicular blood vessel morphogenesis; P:negative regulation of testosterone biosynthetic process; P:negative regulation of transcription, DNA-templated; P:negative regulation of wound healing; P:neuron differentiation; P:non-canonical Wnt signaling pathway via MAPK cascade; P:oocyte development; P:paramesonephric duct development; P:positive regulation of aldosterone biosynthetic process; P:positive regulation of bone mineralization; P:positive regulation of collagen biosynthetic process; P:positive regulation of cortisol biosynthetic process; P:positive regulation of dermatome development; P:positive regulation of focal adhesion assembly; P:positive regulation of GTPase activity; P:positive regulation of meiotic nuclear division; P:positive regulation of osteoblast differentiation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription, DNA-templated; P:regulation of cell-cell adhesion; P:renal vesicle formation; P:renal vesicle induction; P:smooth muscle cell differentiation; P:somatotropin secreting cell differentiation; P:tertiary branching involved in mammary gland duct morphogenesis; P:thyroid-stimulating hormone-secreting cell differentiation; P:Wnt signaling pathway;|P56705 B4DJF9 Q5TZQ0 Q96T81 Q9BXF5 Q9H1J8 Q9UJM2,Protein Wnt-4,, PF00110;, GO:0009986;GO:0005737;GO:0030666;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0005125;GO:0005109;GO:0048018;GO:0003714;GO:0030325;GO:0001658;GO:0060070;GO:0045165;GO:0009267;GO:0071560;GO:0001838;GO:0001837;GO:0008585;GO:0030237;GO:0042445;GO:0033080;GO:0001822;GO:0001889;GO:0008584;GO:0061180;GO:0060231;GO:0072162;GO:0072273;GO:0072174;GO:2000180;GO:2001234;GO:0045596;GO:0030336;GO:0040037;GO:0010629;GO:2000019;GO:0010894;GO:0061369;GO:2000225;GO:0045892;GO:0061045;GO:0030182;GO:0038030;GO:0048599;GO:0061205;GO:0032349;GO:0030501;GO:0032967;GO:2000066;GO:0061184;GO:0051894;GO:0043547;GO:0045836;GO:0045669;GO:0051496;GO:0045893;GO:0022407;GO:0072033;GO:0072034;GO:0051145;GO:0060126;GO:0060748;GO:0060129;GO:0016055;, C:cell surface; C:cytoplasm; C:endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane;, F:cytokine activity; F:frizzled binding; F:receptor ligand activity; F:transcription corepressor activity;, P:adrenal gland development; P:branching involved in ureteric bud morphogenesis; P:canonical Wnt signaling pathway; P:cell fate commitment; P:cellular response to starvation; P:cellular response to transforming growth factor beta stimulus; P:embryonic epithelial tube formation; P:epithelial to mesenchymal transition; P:female gonad development; P:female sex determination; P:hormone metabolic process; P:immature T cell proliferation in thymus; P:kidney development; P:liver development; P:male gonad development; P:mammary gland epithelium development; P:mesenchymal to epithelial transition; P:metanephric mesenchymal cell differentiation; P:metanephric nephron morphogenesis; P:metanephric tubule formation; P:negative regulation of androgen biosynthetic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cell differentiation; P:negative regulation of cell migration; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of gene expression; P:negative regulation of male gonad development; P:negative regulation of steroid biosynthetic process; P:negative regulation of testicular blood vessel morphogenesis; P:negative regulation of testosterone biosynthetic process; P:negative regulation of transcription, DNA-templated; P:negative regulation of wound healing; P:neuron differentiation; P:non-canonical Wnt signaling pathway via MAPK cascade; P:oocyte development; P:paramesonephric duct development; P:positive regulation of aldosterone biosynthetic process; P:positive regulation of bone mineralization; P:positive regulation of collagen biosynthetic process; P:positive regulation of cortisol biosynthetic process; P:positive regulation of dermatome development; P:positive regulation of focal adhesion assembly; P:positive regulation of GTPase activity; P:positive regulation of meiotic nuclear division; P:positive regulation of osteoblast differentiation; P:positive regulation of stress fiber assembly; P:positive regulation of transcription, DNA-templated; P:regulation of cell-cell adhesion; P:renal vesicle formation; P:renal vesicle induction; P:smooth muscle cell differentiation; P:somatotropin secreting cell differentiation; P:tertiary branching involved in mammary gland duct morphogenesis; P:thyroid-stimulating hormone-secreting cell differentiation; P:Wnt signaling pathway; scaffold76 indexed_genome mRNA 4891583 4921933 . - . ID=transcript_11756;P60953 P21181 P25763 Q7L8R5 Q9UDI2,Cell division control protein 42 homolog {ECO:0000305},G25K GTP-binding protein;, PF00071;, GO:0045177;GO:0005911;GO:0005737;GO:0036464;GO:0005829;GO:0043197;GO:0005789;GO:0070062;GO:0030175;GO:0005925;GO:0000139;GO:0017119;GO:0031256;GO:0016020;GO:0005815;GO:0030496;GO:0072686;GO:0043005;GO:0043025;GO:0045335;GO:0005886;GO:0032991;GO:0098685;GO:0030141;GO:0051233;GO:0000322;GO:0034191;GO:0032427;GO:0005525;GO:0030742;GO:0003924;GO:0042802;GO:0031435;GO:0019901;GO:0031996;GO:0061630;GO:0030036;GO:0090135;GO:0007015;GO:0034332;GO:0007596;GO:0003161;GO:0032488;GO:0034329;GO:0016477;GO:0030031;GO:0034613;GO:0071346;GO:0036336;GO:0060997;GO:0006897;GO:0048013;GO:0045198;GO:0051683;GO:0007163;GO:0038096;GO:0046847;GO:0007030;GO:0060047;GO:0007229;GO:0035722;GO:0030225;GO:0099563;GO:0042059;GO:0031333;GO:0048664;GO:0038189;GO:0007097;GO:0072384;GO:0006911;GO:2000251;GO:0030307;GO:0032467;GO:0045740;GO:0060501;GO:0051491;GO:0090316;GO:0046330;GO:0010592;GO:0051149;GO:0043525;GO:0043552;GO:0048549;GO:0031274;GO:0051496;GO:1900026;GO:0051835;GO:0051988;GO:0051489;GO:0010591;GO:0007088;GO:0099159;GO:0043393;GO:0051056;GO:0051492;GO:0002040;GO:0060661;GO:0021762;GO:0031295;GO:0048010;GO:0039694;GO:0060071;, C:apical part of cell; C:cell-cell junction; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:Golgi membrane; C:Golgi transport complex; C:leading edge membrane; C:membrane; C:microtubule organizing center; C:midbody; C:mitotic spindle; C:neuron projection; C:neuronal cell body; C:phagocytic vesicle; C:plasma membrane; C:protein-containing complex; C:Schaffer collateral - CA1 synapse; C:secretory granule; C:spindle midzone; C:storage vacuole;, F:apolipoprotein A-I receptor binding; F:GBD domain binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity; F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase binding; F:thioesterase binding; F:ubiquitin protein ligase activity;, P:actin cytoskeleton organization; P:actin filament branching; P:actin filament organization; P:adherens junction organization; P:blood coagulation; P:cardiac conduction system development; P:Cdc42 protein signal transduction; P:cell junction assembly; P:cell migration; P:cell projection assembly; P:cellular protein localization; P:cellular response to interferon-gamma; P:dendritic cell migration; P:dendritic spine morphogenesis; P:endocytosis; P:ephrin receptor signaling pathway; P:establishment of epithelial cell apical/basal polarity; P:establishment of Golgi localization; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:filopodium assembly; P:Golgi organization; P:heart contraction; P:integrin-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:macrophage differentiation; P:modification of synaptic structure; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of protein-containing complex assembly; P:neuron fate determination; P:neuropilin signaling pathway; P:nuclear migration; P:organelle transport along microtubule; P:phagocytosis, engulfment; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of cell growth; P:positive regulation of cytokinesis; P:positive regulation of DNA replication; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; P:positive regulation of filopodium assembly; P:positive regulation of intracellular protein transport; P:positive regulation of JNK cascade; P:positive regulation of lamellipodium assembly; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of pinocytosis; P:positive regulation of pseudopodium assembly; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of synapse structural plasticity; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of filopodium assembly; P:regulation of lamellipodium assembly; P:regulation of mitotic nuclear division; P:regulation of modification of postsynaptic structure; P:regulation of protein binding; P:regulation of small GTPase mediated signal transduction; P:regulation of stress fiber assembly; P:sprouting angiogenesis; P:submandibular salivary gland formation; P:substantia nigra development; P:T cell costimulation; P:vascular endothelial growth factor receptor signaling pathway; P:viral RNA genome replication; P:Wnt signaling pathway, planar cell polarity pathway;|P60953 P21181 P25763 Q7L8R5 Q9UDI2,Cell division control protein 42 homolog {ECO:0000305},G25K GTP-binding protein;, PF00071;, GO:0045177;GO:0005911;GO:0005737;GO:0036464;GO:0005829;GO:0043197;GO:0005789;GO:0070062;GO:0030175;GO:0005925;GO:0000139;GO:0017119;GO:0031256;GO:0016020;GO:0005815;GO:0030496;GO:0072686;GO:0043005;GO:0043025;GO:0045335;GO:0005886;GO:0032991;GO:0098685;GO:0030141;GO:0051233;GO:0000322;GO:0034191;GO:0032427;GO:0005525;GO:0030742;GO:0003924;GO:0042802;GO:0031435;GO:0019901;GO:0031996;GO:0061630;GO:0030036;GO:0090135;GO:0007015;GO:0034332;GO:0007596;GO:0003161;GO:0032488;GO:0034329;GO:0016477;GO:0030031;GO:0034613;GO:0071346;GO:0036336;GO:0060997;GO:0006897;GO:0048013;GO:0045198;GO:0051683;GO:0007163;GO:0038096;GO:0046847;GO:0007030;GO:0060047;GO:0007229;GO:0035722;GO:0030225;GO:0099563;GO:0042059;GO:0031333;GO:0048664;GO:0038189;GO:0007097;GO:0072384;GO:0006911;GO:2000251;GO:0030307;GO:0032467;GO:0045740;GO:0060501;GO:0051491;GO:0090316;GO:0046330;GO:0010592;GO:0051149;GO:0043525;GO:0043552;GO:0048549;GO:0031274;GO:0051496;GO:1900026;GO:0051835;GO:0051988;GO:0051489;GO:0010591;GO:0007088;GO:0099159;GO:0043393;GO:0051056;GO:0051492;GO:0002040;GO:0060661;GO:0021762;GO:0031295;GO:0048010;GO:0039694;GO:0060071;, C:apical part of cell; C:cell-cell junction; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:Golgi membrane; C:Golgi transport complex; C:leading edge membrane; C:membrane; C:microtubule organizing center; C:midbody; C:mitotic spindle; C:neuron projection; C:neuronal cell body; C:phagocytic vesicle; C:plasma membrane; C:protein-containing complex; C:Schaffer collateral - CA1 synapse; C:secretory granule; C:spindle midzone; C:storage vacuole;, F:apolipoprotein A-I receptor binding; F:GBD domain binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity; F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase binding; F:thioesterase binding; F:ubiquitin protein ligase activity;, P:actin cytoskeleton organization; P:actin filament branching; P:actin filament organization; P:adherens junction organization; P:blood coagulation; P:cardiac conduction system development; P:Cdc42 protein signal transduction; P:cell junction assembly; P:cell migration; P:cell projection assembly; P:cellular protein localization; P:cellular response to interferon-gamma; P:dendritic cell migration; P:dendritic spine morphogenesis; P:endocytosis; P:ephrin receptor signaling pathway; P:establishment of epithelial cell apical/basal polarity; P:establishment of Golgi localization; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:filopodium assembly; P:Golgi organization; P:heart contraction; P:integrin-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:macrophage differentiation; P:modification of synaptic structure; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of protein-containing complex assembly; P:neuron fate determination; P:neuropilin signaling pathway; P:nuclear migration; P:organelle transport along microtubule; P:phagocytosis, engulfment; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of cell growth; P:positive regulation of cytokinesis; P:positive regulation of DNA replication; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; P:positive regulation of filopodium assembly; P:positive regulation of intracellular protein transport; P:positive regulation of JNK cascade; P:positive regulation of lamellipodium assembly; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of pinocytosis; P:positive regulation of pseudopodium assembly; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of synapse structural plasticity; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of filopodium assembly; P:regulation of lamellipodium assembly; P:regulation of mitotic nuclear division; P:regulation of modification of postsynaptic structure; P:regulation of protein binding; P:regulation of small GTPase mediated signal transduction; P:regulation of stress fiber assembly; P:sprouting angiogenesis; P:submandibular salivary gland formation; P:substantia nigra development; P:T cell costimulation; P:vascular endothelial growth factor receptor signaling pathway; P:viral RNA genome replication; P:Wnt signaling pathway, planar cell polarity pathway;|P60953 P21181 P25763 Q7L8R5 Q9UDI2,Cell division control protein 42 homolog {ECO:0000305},G25K GTP-binding protein;, PF00071;, GO:0045177;GO:0005911;GO:0005737;GO:0036464;GO:0005829;GO:0043197;GO:0005789;GO:0070062;GO:0030175;GO:0005925;GO:0000139;GO:0017119;GO:0031256;GO:0016020;GO:0005815;GO:0030496;GO:0072686;GO:0043005;GO:0043025;GO:0045335;GO:0005886;GO:0032991;GO:0098685;GO:0030141;GO:0051233;GO:0000322;GO:0034191;GO:0032427;GO:0005525;GO:0030742;GO:0003924;GO:0042802;GO:0031435;GO:0019901;GO:0031996;GO:0061630;GO:0030036;GO:0090135;GO:0007015;GO:0034332;GO:0007596;GO:0003161;GO:0032488;GO:0034329;GO:0016477;GO:0030031;GO:0034613;GO:0071346;GO:0036336;GO:0060997;GO:0006897;GO:0048013;GO:0045198;GO:0051683;GO:0007163;GO:0038096;GO:0046847;GO:0007030;GO:0060047;GO:0007229;GO:0035722;GO:0030225;GO:0099563;GO:0042059;GO:0031333;GO:0048664;GO:0038189;GO:0007097;GO:0072384;GO:0006911;GO:2000251;GO:0030307;GO:0032467;GO:0045740;GO:0060501;GO:0051491;GO:0090316;GO:0046330;GO:0010592;GO:0051149;GO:0043525;GO:0043552;GO:0048549;GO:0031274;GO:0051496;GO:1900026;GO:0051835;GO:0051988;GO:0051489;GO:0010591;GO:0007088;GO:0099159;GO:0043393;GO:0051056;GO:0051492;GO:0002040;GO:0060661;GO:0021762;GO:0031295;GO:0048010;GO:0039694;GO:0060071;, C:apical part of cell; C:cell-cell junction; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:extracellular exosome; C:filopodium; C:focal adhesion; C:Golgi membrane; C:Golgi transport complex; C:leading edge membrane; C:membrane; C:microtubule organizing center; C:midbody; C:mitotic spindle; C:neuron projection; C:neuronal cell body; C:phagocytic vesicle; C:plasma membrane; C:protein-containing complex; C:Schaffer collateral - CA1 synapse; C:secretory granule; C:spindle midzone; C:storage vacuole;, F:apolipoprotein A-I receptor binding; F:GBD domain binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity; F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase binding; F:thioesterase binding; F:ubiquitin protein ligase activity;, P:actin cytoskeleton organization; P:actin filament branching; P:actin filament organization; P:adherens junction organization; P:blood coagulation; P:cardiac conduction system development; P:Cdc42 protein signal transduction; P:cell junction assembly; P:cell migration; P:cell projection assembly; P:cellular protein localization; P:cellular response to interferon-gamma; P:dendritic cell migration; P:dendritic spine morphogenesis; P:endocytosis; P:ephrin receptor signaling pathway; P:establishment of epithelial cell apical/basal polarity; P:establishment of Golgi localization; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:filopodium assembly; P:Golgi organization; P:heart contraction; P:integrin-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:macrophage differentiation; P:modification of synaptic structure; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of protein-containing complex assembly; P:neuron fate determination; P:neuropilin signaling pathway; P:nuclear migration; P:organelle transport along microtubule; P:phagocytosis, engulfment; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of cell growth; P:positive regulation of cytokinesis; P:positive regulation of DNA replication; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; P:positive regulation of filopodium assembly; P:positive regulation of intracellular protein transport; P:positive regulation of JNK cascade; P:positive regulation of lamellipodium assembly; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of pinocytosis; P:positive regulation of pseudopodium assembly; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of synapse structural plasticity; P:regulation of attachment of spindle microtubules to kinetochore; P:regulation of filopodium assembly; P:regulation of lamellipodium assembly; P:regulation of mitotic nuclear division; P:regulation of modification of postsynaptic structure; P:regulation of protein binding; P:regulation of small GTPase mediated signal transduction; P:regulation of stress fiber assembly; P:sprouting angiogenesis; P:submandibular salivary gland formation; P:substantia nigra development; P:T cell costimulation; P:vascular endothelial growth factor receptor signaling pathway; P:viral RNA genome replication; P:Wnt signaling pathway, planar cell polarity pathway; scaffold76 indexed_genome mRNA 4953378 4956002 . - . ID=transcript_11757;P57086 Q6IAG7,SCAN domain-containing protein 1,, PF02023;, GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated; scaffold76 indexed_genome mRNA 5051131 5122493 . + . ID=transcript_11758;P98160 Q16287 Q5SZI3 Q9H3V5,Basement membrane-specific heparan sulfate proteoglycan core protein,Perlecan;, PF00008;PF07679;PF13895;PF00052;PF00053;PF00054;PF00057;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005796;GO:0043202;GO:0005886;GO:0098797;GO:0001540;GO:0005509;GO:0030021;GO:0005178;GO:0050750;GO:0008022;GO:1990000;GO:0001525;GO:0009887;GO:0007420;GO:0030154;GO:0072359;GO:0030198;GO:0006024;GO:0006027;GO:0006954;GO:0006629;GO:1905907;GO:0016525;GO:0060548;GO:0006898;GO:0001523;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:Golgi lumen; C:lysosomal lumen; C:plasma membrane; C:plasma membrane protein complex;, F:amyloid-beta binding; F:calcium ion binding; F:extracellular matrix structural constituent conferring compression resistance; F:integrin binding; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding;, P:amyloid fibril formation; P:angiogenesis; P:animal organ morphogenesis; P:brain development; P:cell differentiation; P:circulatory system development; P:extracellular matrix organization; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inflammatory response; P:lipid metabolic process; P:negative regulation of amyloid fibril formation; P:negative regulation of angiogenesis; P:negative regulation of cell death; P:receptor-mediated endocytosis; P:retinoid metabolic process; P:tissue development;|P98160 Q16287 Q5SZI3 Q9H3V5,Basement membrane-specific heparan sulfate proteoglycan core protein,Perlecan;, PF00008;PF07679;PF13895;PF00052;PF00053;PF00054;PF00057;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005796;GO:0043202;GO:0005886;GO:0098797;GO:0001540;GO:0005509;GO:0030021;GO:0005178;GO:0050750;GO:0008022;GO:1990000;GO:0001525;GO:0009887;GO:0007420;GO:0030154;GO:0072359;GO:0030198;GO:0006024;GO:0006027;GO:0006954;GO:0006629;GO:1905907;GO:0016525;GO:0060548;GO:0006898;GO:0001523;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:Golgi lumen; C:lysosomal lumen; C:plasma membrane; C:plasma membrane protein complex;, F:amyloid-beta binding; F:calcium ion binding; F:extracellular matrix structural constituent conferring compression resistance; F:integrin binding; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding;, P:amyloid fibril formation; P:angiogenesis; P:animal organ morphogenesis; P:brain development; P:cell differentiation; P:circulatory system development; P:extracellular matrix organization; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inflammatory response; P:lipid metabolic process; P:negative regulation of amyloid fibril formation; P:negative regulation of angiogenesis; P:negative regulation of cell death; P:receptor-mediated endocytosis; P:retinoid metabolic process; P:tissue development;|P98160 Q16287 Q5SZI3 Q9H3V5,Basement membrane-specific heparan sulfate proteoglycan core protein,Perlecan;, PF00008;PF07679;PF13895;PF00052;PF00053;PF00054;PF00057;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005796;GO:0043202;GO:0005886;GO:0098797;GO:0001540;GO:0005509;GO:0030021;GO:0005178;GO:0050750;GO:0008022;GO:1990000;GO:0001525;GO:0009887;GO:0007420;GO:0030154;GO:0072359;GO:0030198;GO:0006024;GO:0006027;GO:0006954;GO:0006629;GO:1905907;GO:0016525;GO:0060548;GO:0006898;GO:0001523;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:Golgi lumen; C:lysosomal lumen; C:plasma membrane; C:plasma membrane protein complex;, F:amyloid-beta binding; F:calcium ion binding; F:extracellular matrix structural constituent conferring compression resistance; F:integrin binding; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding;, P:amyloid fibril formation; P:angiogenesis; P:animal organ morphogenesis; P:brain development; P:cell differentiation; P:circulatory system development; P:extracellular matrix organization; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inflammatory response; P:lipid metabolic process; P:negative regulation of amyloid fibril formation; P:negative regulation of angiogenesis; P:negative regulation of cell death; P:receptor-mediated endocytosis; P:retinoid metabolic process; P:tissue development;|P98160 Q16287 Q5SZI3 Q9H3V5,Basement membrane-specific heparan sulfate proteoglycan core protein,Perlecan;, PF00008;PF07679;PF13895;PF00052;PF00053;PF00054;PF00057;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005796;GO:0043202;GO:0005886;GO:0098797;GO:0001540;GO:0005509;GO:0030021;GO:0005178;GO:0050750;GO:0008022;GO:1990000;GO:0001525;GO:0009887;GO:0007420;GO:0030154;GO:0072359;GO:0030198;GO:0006024;GO:0006027;GO:0006954;GO:0006629;GO:1905907;GO:0016525;GO:0060548;GO:0006898;GO:0001523;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:Golgi lumen; C:lysosomal lumen; C:plasma membrane; C:plasma membrane protein complex;, F:amyloid-beta binding; F:calcium ion binding; F:extracellular matrix structural constituent conferring compression resistance; F:integrin binding; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding;, P:amyloid fibril formation; P:angiogenesis; P:animal organ morphogenesis; P:brain development; P:cell differentiation; P:circulatory system development; P:extracellular matrix organization; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inflammatory response; P:lipid metabolic process; P:negative regulation of amyloid fibril formation; P:negative regulation of angiogenesis; P:negative regulation of cell death; P:receptor-mediated endocytosis; P:retinoid metabolic process; P:tissue development;|P98160 Q16287 Q5SZI3 Q9H3V5,Basement membrane-specific heparan sulfate proteoglycan core protein,Perlecan;, PF00008;PF07679;PF13895;PF00052;PF00053;PF00054;PF00057;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005796;GO:0043202;GO:0005886;GO:0098797;GO:0001540;GO:0005509;GO:0030021;GO:0005178;GO:0050750;GO:0008022;GO:1990000;GO:0001525;GO:0009887;GO:0007420;GO:0030154;GO:0072359;GO:0030198;GO:0006024;GO:0006027;GO:0006954;GO:0006629;GO:1905907;GO:0016525;GO:0060548;GO:0006898;GO:0001523;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:Golgi lumen; C:lysosomal lumen; C:plasma membrane; C:plasma membrane protein complex;, F:amyloid-beta binding; F:calcium ion binding; F:extracellular matrix structural constituent conferring compression resistance; F:integrin binding; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding;, P:amyloid fibril formation; P:angiogenesis; P:animal organ morphogenesis; P:brain development; P:cell differentiation; P:circulatory system development; P:extracellular matrix organization; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inflammatory response; P:lipid metabolic process; P:negative regulation of amyloid fibril formation; P:negative regulation of angiogenesis; P:negative regulation of cell death; P:receptor-mediated endocytosis; P:retinoid metabolic process; P:tissue development;|P98160 Q16287 Q5SZI3 Q9H3V5,Basement membrane-specific heparan sulfate proteoglycan core protein,Perlecan;, PF00008;PF07679;PF13895;PF00052;PF00053;PF00054;PF00057;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005796;GO:0043202;GO:0005886;GO:0098797;GO:0001540;GO:0005509;GO:0030021;GO:0005178;GO:0050750;GO:0008022;GO:1990000;GO:0001525;GO:0009887;GO:0007420;GO:0030154;GO:0072359;GO:0030198;GO:0006024;GO:0006027;GO:0006954;GO:0006629;GO:1905907;GO:0016525;GO:0060548;GO:0006898;GO:0001523;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:Golgi lumen; C:lysosomal lumen; C:plasma membrane; C:plasma membrane protein complex;, F:amyloid-beta binding; F:calcium ion binding; F:extracellular matrix structural constituent conferring compression resistance; F:integrin binding; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding;, P:amyloid fibril formation; P:angiogenesis; P:animal organ morphogenesis; P:brain development; P:cell differentiation; P:circulatory system development; P:extracellular matrix organization; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inflammatory response; P:lipid metabolic process; P:negative regulation of amyloid fibril formation; P:negative regulation of angiogenesis; P:negative regulation of cell death; P:receptor-mediated endocytosis; P:retinoid metabolic process; P:tissue development;|P98160 Q16287 Q5SZI3 Q9H3V5,Basement membrane-specific heparan sulfate proteoglycan core protein,Perlecan;, PF00008;PF07679;PF13895;PF00052;PF00053;PF00054;PF00057;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005796;GO:0043202;GO:0005886;GO:0098797;GO:0001540;GO:0005509;GO:0030021;GO:0005178;GO:0050750;GO:0008022;GO:1990000;GO:0001525;GO:0009887;GO:0007420;GO:0030154;GO:0072359;GO:0030198;GO:0006024;GO:0006027;GO:0006954;GO:0006629;GO:1905907;GO:0016525;GO:0060548;GO:0006898;GO:0001523;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:Golgi lumen; C:lysosomal lumen; C:plasma membrane; C:plasma membrane protein complex;, F:amyloid-beta binding; F:calcium ion binding; F:extracellular matrix structural constituent conferring compression resistance; F:integrin binding; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding;, P:amyloid fibril formation; P:angiogenesis; P:animal organ morphogenesis; P:brain development; P:cell differentiation; P:circulatory system development; P:extracellular matrix organization; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:inflammatory response; P:lipid metabolic process; P:negative regulation of amyloid fibril formation; P:negative regulation of angiogenesis; P:negative regulation of cell death; P:receptor-mediated endocytosis; P:retinoid metabolic process; P:tissue development;|Q9BWM5 Q9NWW8,Zinc finger protein 416,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold76 indexed_genome mRNA 5180538 5231990 . + . ID=transcript_11759;Q9H5N3 Q9H5T7 Q9NUJ6 Q9NXR0,Ubiquitin carboxyl-terminal hydrolase 48,Deubiquitinating enzyme 48;Ubiquitin thioesterase 48;Ubiquitin-specific peptidase 48;Ubiquitin-specific protease 48;Ubiquitin-specific-processing protease 48;, PF00443;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H5N3 Q9H5T7 Q9NUJ6 Q9NXR0,Ubiquitin carboxyl-terminal hydrolase 48,Deubiquitinating enzyme 48;Ubiquitin thioesterase 48;Ubiquitin-specific peptidase 48;Ubiquitin-specific protease 48;Ubiquitin-specific-processing protease 48;, PF00443;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H5N3 Q9H5T7 Q9NUJ6 Q9NXR0,Ubiquitin carboxyl-terminal hydrolase 48,Deubiquitinating enzyme 48;Ubiquitin thioesterase 48;Ubiquitin-specific peptidase 48;Ubiquitin-specific protease 48;Ubiquitin-specific-processing protease 48;, PF00443;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H5N3 Q9H5T7 Q9NUJ6 Q9NXR0,Ubiquitin carboxyl-terminal hydrolase 48,Deubiquitinating enzyme 48;Ubiquitin thioesterase 48;Ubiquitin-specific peptidase 48;Ubiquitin-specific protease 48;Ubiquitin-specific-processing protease 48;, PF00443;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H5N3 Q9H5T7 Q9NUJ6 Q9NXR0,Ubiquitin carboxyl-terminal hydrolase 48,Deubiquitinating enzyme 48;Ubiquitin thioesterase 48;Ubiquitin-specific peptidase 48;Ubiquitin-specific protease 48;Ubiquitin-specific-processing protease 48;, PF00443;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H5N3 Q9H5T7 Q9NUJ6 Q9NXR0,Ubiquitin carboxyl-terminal hydrolase 48,Deubiquitinating enzyme 48;Ubiquitin thioesterase 48;Ubiquitin-specific peptidase 48;Ubiquitin-specific protease 48;Ubiquitin-specific-processing protease 48;, PF00443;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H5N3 Q9H5T7 Q9NUJ6 Q9NXR0,Ubiquitin carboxyl-terminal hydrolase 48,Deubiquitinating enzyme 48;Ubiquitin thioesterase 48;Ubiquitin-specific peptidase 48;Ubiquitin-specific protease 48;Ubiquitin-specific-processing protease 48;, PF00443;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0006511;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold76 indexed_genome mRNA 5290221 5313968 . + . ID=transcript_11760;P47736 J3QSS6 O75062 Q5T3S9 Q5T3T4 Q7Z5S8 Q9UQ51,Rap1 GTPase-activating protein 1,, PF02188;PF02145;, GO:0005737;GO:0005829;GO:0000139;GO:0016020;GO:0005096;GO:0003924;GO:0042803;GO:0031267;GO:0090630;GO:0002250;GO:0007411;GO:1903697;GO:0043547;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi membrane; C:membrane;, F:GTPase activator activity; F:GTPase activity; F:protein homodimerization activity; F:small GTPase binding;, P:activation of GTPase activity; P:adaptive immune response; P:axon guidance; P:negative regulation of microvillus assembly; P:positive regulation of GTPase activity; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|P47736 J3QSS6 O75062 Q5T3S9 Q5T3T4 Q7Z5S8 Q9UQ51,Rap1 GTPase-activating protein 1,, PF02188;PF02145;, GO:0005737;GO:0005829;GO:0000139;GO:0016020;GO:0005096;GO:0003924;GO:0042803;GO:0031267;GO:0090630;GO:0002250;GO:0007411;GO:1903697;GO:0043547;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi membrane; C:membrane;, F:GTPase activator activity; F:GTPase activity; F:protein homodimerization activity; F:small GTPase binding;, P:activation of GTPase activity; P:adaptive immune response; P:axon guidance; P:negative regulation of microvillus assembly; P:positive regulation of GTPase activity; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|P47736 J3QSS6 O75062 Q5T3S9 Q5T3T4 Q7Z5S8 Q9UQ51,Rap1 GTPase-activating protein 1,, PF02188;PF02145;, GO:0005737;GO:0005829;GO:0000139;GO:0016020;GO:0005096;GO:0003924;GO:0042803;GO:0031267;GO:0090630;GO:0002250;GO:0007411;GO:1903697;GO:0043547;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi membrane; C:membrane;, F:GTPase activator activity; F:GTPase activity; F:protein homodimerization activity; F:small GTPase binding;, P:activation of GTPase activity; P:adaptive immune response; P:axon guidance; P:negative regulation of microvillus assembly; P:positive regulation of GTPase activity; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|P47736 J3QSS6 O75062 Q5T3S9 Q5T3T4 Q7Z5S8 Q9UQ51,Rap1 GTPase-activating protein 1,, PF02188;PF02145;, GO:0005737;GO:0005829;GO:0000139;GO:0016020;GO:0005096;GO:0003924;GO:0042803;GO:0031267;GO:0090630;GO:0002250;GO:0007411;GO:1903697;GO:0043547;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi membrane; C:membrane;, F:GTPase activator activity; F:GTPase activity; F:protein homodimerization activity; F:small GTPase binding;, P:activation of GTPase activity; P:adaptive immune response; P:axon guidance; P:negative regulation of microvillus assembly; P:positive regulation of GTPase activity; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|P47736 J3QSS6 O75062 Q5T3S9 Q5T3T4 Q7Z5S8 Q9UQ51,Rap1 GTPase-activating protein 1,, PF02188;PF02145;, GO:0005737;GO:0005829;GO:0000139;GO:0016020;GO:0005096;GO:0003924;GO:0042803;GO:0031267;GO:0090630;GO:0002250;GO:0007411;GO:1903697;GO:0043547;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi membrane; C:membrane;, F:GTPase activator activity; F:GTPase activity; F:protein homodimerization activity; F:small GTPase binding;, P:activation of GTPase activity; P:adaptive immune response; P:axon guidance; P:negative regulation of microvillus assembly; P:positive regulation of GTPase activity; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold76 indexed_genome mRNA 5328768 5392841 . - . ID=transcript_11761;Q5VTG5 Q6NZI8 Q8WU32 Q9UBK0,Alkaline phosphatase, tissue-nonspecific isozyme,Alkaline phosphatase liver/bone/kidney isozyme;, PF00245;, GO:0031225;GO:0070062;GO:0031012;GO:0065010;GO:0005576;GO:0016020;GO:0005886;GO:0004035;GO:0046872;GO:0016462;GO:0071407;GO:0071529;GO:0016311;GO:0003006;GO:0001958;GO:0001649;GO:0046677;GO:0051384;GO:0032496;GO:0033280;GO:0001501;, C:anchored component of membrane; C:extracellular exosome; C:extracellular matrix; C:extracellular membrane-bounded organelle; C:extracellular region; C:membrane; C:plasma membrane;, F:alkaline phosphatase activity; F:metal ion binding; F:pyrophosphatase activity;, P:cellular response to organic cyclic compound; P:cementum mineralization; P:dephosphorylation; P:developmental process involved in reproduction; P:endochondral ossification; P:osteoblast differentiation; P:response to antibiotic; P:response to glucocorticoid; P:response to lipopolysaccharide; P:response to vitamin D; P:skeletal system development;|Q5VTG5 Q6NZI8 Q8WU32 Q9UBK0,Alkaline phosphatase, tissue-nonspecific isozyme,Alkaline phosphatase liver/bone/kidney isozyme;, PF00245;, GO:0031225;GO:0070062;GO:0031012;GO:0065010;GO:0005576;GO:0016020;GO:0005886;GO:0004035;GO:0046872;GO:0016462;GO:0071407;GO:0071529;GO:0016311;GO:0003006;GO:0001958;GO:0001649;GO:0046677;GO:0051384;GO:0032496;GO:0033280;GO:0001501;, C:anchored component of membrane; C:extracellular exosome; C:extracellular matrix; C:extracellular membrane-bounded organelle; C:extracellular region; C:membrane; C:plasma membrane;, F:alkaline phosphatase activity; F:metal ion binding; F:pyrophosphatase activity;, P:cellular response to organic cyclic compound; P:cementum mineralization; P:dephosphorylation; P:developmental process involved in reproduction; P:endochondral ossification; P:osteoblast differentiation; P:response to antibiotic; P:response to glucocorticoid; P:response to lipopolysaccharide; P:response to vitamin D; P:skeletal system development; scaffold76 indexed_genome mRNA 5533079 5608092 . + . ID=transcript_11762;Q5THM8 Q9UJQ6 Q9UPF4 Q9UPM4 Q9Y501,Endothelin-converting enzyme 1,, PF01431;PF05649;, GO:0005769;GO:0005768;GO:0009897;GO:0070062;GO:0016021;GO:0031302;GO:0005765;GO:0016020;GO:0048471;GO:0005886;GO:0031982;GO:0033093;GO:0004175;GO:0004222;GO:0017046;GO:0042803;GO:0008270;GO:0010815;GO:0010816;GO:0043583;GO:0042733;GO:0034959;GO:0007186;GO:0007507;GO:0042447;GO:0016486;GO:0001921;GO:0016485;GO:0003100;GO:0019229;GO:0010814;, C:early endosome; C:endosome; C:external side of plasma membrane; C:extracellular exosome; C:integral component of membrane; C:intrinsic component of endosome membrane; C:lysosomal membrane; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle; C:Weibel-Palade body;, F:endopeptidase activity; F:metalloendopeptidase activity; F:peptide hormone binding; F:protein homodimerization activity; F:zinc ion binding;, P:bradykinin catabolic process; P:calcitonin catabolic process; P:ear development; P:embryonic digit morphogenesis; P:endothelin maturation; P:G protein-coupled receptor signaling pathway; P:heart development; P:hormone catabolic process; P:peptide hormone processing; P:positive regulation of receptor recycling; P:protein processing; P:regulation of systemic arterial blood pressure by endothelin; P:regulation of vasoconstriction; P:substance P catabolic process;|Q5THM8 Q9UJQ6 Q9UPF4 Q9UPM4 Q9Y501,Endothelin-converting enzyme 1,, PF01431;PF05649;, GO:0005769;GO:0005768;GO:0009897;GO:0070062;GO:0016021;GO:0031302;GO:0005765;GO:0016020;GO:0048471;GO:0005886;GO:0031982;GO:0033093;GO:0004175;GO:0004222;GO:0017046;GO:0042803;GO:0008270;GO:0010815;GO:0010816;GO:0043583;GO:0042733;GO:0034959;GO:0007186;GO:0007507;GO:0042447;GO:0016486;GO:0001921;GO:0016485;GO:0003100;GO:0019229;GO:0010814;, C:early endosome; C:endosome; C:external side of plasma membrane; C:extracellular exosome; C:integral component of membrane; C:intrinsic component of endosome membrane; C:lysosomal membrane; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle; C:Weibel-Palade body;, F:endopeptidase activity; F:metalloendopeptidase activity; F:peptide hormone binding; F:protein homodimerization activity; F:zinc ion binding;, P:bradykinin catabolic process; P:calcitonin catabolic process; P:ear development; P:embryonic digit morphogenesis; P:endothelin maturation; P:G protein-coupled receptor signaling pathway; P:heart development; P:hormone catabolic process; P:peptide hormone processing; P:positive regulation of receptor recycling; P:protein processing; P:regulation of systemic arterial blood pressure by endothelin; P:regulation of vasoconstriction; P:substance P catabolic process; scaffold76 indexed_genome mRNA 5740236 6010904 . + . ID=transcript_11763;O43432 B9EGQ7 Q15597 Q504Z1 Q5SWC3 Q8NEN1,Eukaryotic translation initiation factor 4 gamma 3,eIF-4-gamma II;, PF02847;PF02854;PF02020;, GO:0005829;GO:0016281;GO:0003729;GO:0003723;GO:0000339;GO:0008135;GO:0003743;GO:0006446;, C:cytosol; C:eukaryotic translation initiation factor 4F complex;, F:mRNA binding; F:RNA binding; F:RNA cap binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation;|O43432 B9EGQ7 Q15597 Q504Z1 Q5SWC3 Q8NEN1,Eukaryotic translation initiation factor 4 gamma 3,eIF-4-gamma II;, PF02847;PF02854;PF02020;, GO:0005829;GO:0016281;GO:0003729;GO:0003723;GO:0000339;GO:0008135;GO:0003743;GO:0006446;, C:cytosol; C:eukaryotic translation initiation factor 4F complex;, F:mRNA binding; F:RNA binding; F:RNA cap binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation;|O43432 B9EGQ7 Q15597 Q504Z1 Q5SWC3 Q8NEN1,Eukaryotic translation initiation factor 4 gamma 3,eIF-4-gamma II;, PF02847;PF02854;PF02020;, GO:0005829;GO:0016281;GO:0003729;GO:0003723;GO:0000339;GO:0008135;GO:0003743;GO:0006446;, C:cytosol; C:eukaryotic translation initiation factor 4F complex;, F:mRNA binding; F:RNA binding; F:RNA cap binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation;|O43432 B9EGQ7 Q15597 Q504Z1 Q5SWC3 Q8NEN1,Eukaryotic translation initiation factor 4 gamma 3,eIF-4-gamma II;, PF02847;PF02854;PF02020;, GO:0005829;GO:0016281;GO:0003729;GO:0003723;GO:0000339;GO:0008135;GO:0003743;GO:0006446;, C:cytosol; C:eukaryotic translation initiation factor 4F complex;, F:mRNA binding; F:RNA binding; F:RNA cap binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation;|O43432 B9EGQ7 Q15597 Q504Z1 Q5SWC3 Q8NEN1,Eukaryotic translation initiation factor 4 gamma 3,eIF-4-gamma II;, PF02847;PF02854;PF02020;, GO:0005829;GO:0016281;GO:0003729;GO:0003723;GO:0000339;GO:0008135;GO:0003743;GO:0006446;, C:cytosol; C:eukaryotic translation initiation factor 4F complex;, F:mRNA binding; F:RNA binding; F:RNA cap binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation; scaffold76 indexed_genome mRNA 6030124 6071414 . + . ID=transcript_11764;Q8NDF0 Q9UHY0,Heterochromatin protein 1-binding protein 3,Protein HP1-BP74 {ECO:0000303|PubMed:20042602};, PF00538;, GO:0005694;GO:0016607;GO:0000786;GO:0005634;GO:0003677;GO:0031491;GO:0071456;GO:0070828;GO:0006334;GO:0042127;GO:0097298;GO:0006355;, C:chromosome; C:nuclear speck; C:nucleosome; C:nucleus;, F:DNA binding; F:nucleosome binding;, P:cellular response to hypoxia; P:heterochromatin organization; P:nucleosome assembly; P:regulation of cell population proliferation; P:regulation of nucleus size; P:regulation of transcription, DNA-templated;|Q8NDF0 Q9UHY0,Heterochromatin protein 1-binding protein 3,Protein HP1-BP74 {ECO:0000303|PubMed:20042602};, PF00538;, GO:0005694;GO:0016607;GO:0000786;GO:0005634;GO:0003677;GO:0031491;GO:0071456;GO:0070828;GO:0006334;GO:0042127;GO:0097298;GO:0006355;, C:chromosome; C:nuclear speck; C:nucleosome; C:nucleus;, F:DNA binding; F:nucleosome binding;, P:cellular response to hypoxia; P:heterochromatin organization; P:nucleosome assembly; P:regulation of cell population proliferation; P:regulation of nucleus size; P:regulation of transcription, DNA-templated;|Q8NDF0 Q9UHY0,Heterochromatin protein 1-binding protein 3,Protein HP1-BP74 {ECO:0000303|PubMed:20042602};, PF00538;, GO:0005694;GO:0016607;GO:0000786;GO:0005634;GO:0003677;GO:0031491;GO:0071456;GO:0070828;GO:0006334;GO:0042127;GO:0097298;GO:0006355;, C:chromosome; C:nuclear speck; C:nucleosome; C:nucleus;, F:DNA binding; F:nucleosome binding;, P:cellular response to hypoxia; P:heterochromatin organization; P:nucleosome assembly; P:regulation of cell population proliferation; P:regulation of nucleus size; P:regulation of transcription, DNA-templated;|Q8NDF0 Q9UHY0,Heterochromatin protein 1-binding protein 3,Protein HP1-BP74 {ECO:0000303|PubMed:20042602};, PF00538;, GO:0005694;GO:0016607;GO:0000786;GO:0005634;GO:0003677;GO:0031491;GO:0071456;GO:0070828;GO:0006334;GO:0042127;GO:0097298;GO:0006355;, C:chromosome; C:nuclear speck; C:nucleosome; C:nucleus;, F:DNA binding; F:nucleosome binding;, P:cellular response to hypoxia; P:heterochromatin organization; P:nucleosome assembly; P:regulation of cell population proliferation; P:regulation of nucleus size; P:regulation of transcription, DNA-templated;|Q8NDF0 Q9UHY0,Heterochromatin protein 1-binding protein 3,Protein HP1-BP74 {ECO:0000303|PubMed:20042602};, PF00538;, GO:0005694;GO:0016607;GO:0000786;GO:0005634;GO:0003677;GO:0031491;GO:0071456;GO:0070828;GO:0006334;GO:0042127;GO:0097298;GO:0006355;, C:chromosome; C:nuclear speck; C:nucleosome; C:nucleus;, F:DNA binding; F:nucleosome binding;, P:cellular response to hypoxia; P:heterochromatin organization; P:nucleosome assembly; P:regulation of cell population proliferation; P:regulation of nucleus size; P:regulation of transcription, DNA-templated;|Q8NDF0 Q9UHY0,Heterochromatin protein 1-binding protein 3,Protein HP1-BP74 {ECO:0000303|PubMed:20042602};, PF00538;, GO:0005694;GO:0016607;GO:0000786;GO:0005634;GO:0003677;GO:0031491;GO:0071456;GO:0070828;GO:0006334;GO:0042127;GO:0097298;GO:0006355;, C:chromosome; C:nuclear speck; C:nucleosome; C:nucleus;, F:DNA binding; F:nucleosome binding;, P:cellular response to hypoxia; P:heterochromatin organization; P:nucleosome assembly; P:regulation of cell population proliferation; P:regulation of nucleus size; P:regulation of transcription, DNA-templated; scaffold76 indexed_genome mRNA 6083745 6095215 . + . ID=transcript_11765;Q6ZV89 B7Z3W3 Q5SSJ2,SH2 domain-containing protein 5 {ECO:0000312|HGNC:HGNC:28819},, , GO:0014069;, C:postsynaptic density;|Q6ZV89 B7Z3W3 Q5SSJ2,SH2 domain-containing protein 5 {ECO:0000312|HGNC:HGNC:28819},, , GO:0014069;, C:postsynaptic density;|Q6ZV89 B7Z3W3 Q5SSJ2,SH2 domain-containing protein 5 {ECO:0000312|HGNC:HGNC:28819},, , GO:0014069;, C:postsynaptic density; scaffold76 indexed_genome mRNA 6111796 6142771 . + . ID=transcript_11766;Q9P2E2 A2A3Q7 A2A3Q8 O95077 Q53YS6 Q5VWA9 Q6GSA8 Q8N411,Kinesin-like protein KIF17,KIF3-related motor protein;, PF00225;, GO:0005930;GO:0036064;GO:0005929;GO:0005829;GO:0032839;GO:0005871;GO:0005874;GO:0005815;GO:0043005;GO:1990075;GO:0032391;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0098971;GO:0030030;GO:0035735;GO:0007018;GO:0016192;, C:axoneme; C:ciliary basal body; C:cilium; C:cytosol; C:dendrite cytoplasm; C:kinesin complex; C:microtubule; C:microtubule organizing center; C:neuron projection; C:periciliary membrane compartment; C:photoreceptor connecting cilium;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:anterograde dendritic transport of neurotransmitter receptor complex; P:cell projection organization; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:vesicle-mediated transport;|Q9P2E2 A2A3Q7 A2A3Q8 O95077 Q53YS6 Q5VWA9 Q6GSA8 Q8N411,Kinesin-like protein KIF17,KIF3-related motor protein;, PF00225;, GO:0005930;GO:0036064;GO:0005929;GO:0005829;GO:0032839;GO:0005871;GO:0005874;GO:0005815;GO:0043005;GO:1990075;GO:0032391;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0098971;GO:0030030;GO:0035735;GO:0007018;GO:0016192;, C:axoneme; C:ciliary basal body; C:cilium; C:cytosol; C:dendrite cytoplasm; C:kinesin complex; C:microtubule; C:microtubule organizing center; C:neuron projection; C:periciliary membrane compartment; C:photoreceptor connecting cilium;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:anterograde dendritic transport of neurotransmitter receptor complex; P:cell projection organization; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:vesicle-mediated transport; scaffold76 indexed_genome mRNA 6145791 6163296 . + . ID=transcript_11767;P39656 B2RDQ4 B4DJE3 B4DLI2 O43244 Q5VWA5 Q8NI93 Q9BUI2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit,, PF03345;, GO:0035577;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0008250;GO:0005886;GO:0008047;GO:0043312;GO:0006486;GO:0006487;GO:0018279;GO:0031647;GO:0034097;GO:0042110;GO:0019082;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:oligosaccharyltransferase complex; C:plasma membrane;, F:enzyme activator activity;, P:neutrophil degranulation; P:protein glycosylation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:regulation of protein stability; P:response to cytokine; P:T cell activation; P:viral protein processing;|P39656 B2RDQ4 B4DJE3 B4DLI2 O43244 Q5VWA5 Q8NI93 Q9BUI2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit,, PF03345;, GO:0035577;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0008250;GO:0005886;GO:0008047;GO:0043312;GO:0006486;GO:0006487;GO:0018279;GO:0031647;GO:0034097;GO:0042110;GO:0019082;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:oligosaccharyltransferase complex; C:plasma membrane;, F:enzyme activator activity;, P:neutrophil degranulation; P:protein glycosylation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:regulation of protein stability; P:response to cytokine; P:T cell activation; P:viral protein processing;|P39656 B2RDQ4 B4DJE3 B4DLI2 O43244 Q5VWA5 Q8NI93 Q9BUI2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit,, PF03345;, GO:0035577;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0008250;GO:0005886;GO:0008047;GO:0043312;GO:0006486;GO:0006487;GO:0018279;GO:0031647;GO:0034097;GO:0042110;GO:0019082;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:oligosaccharyltransferase complex; C:plasma membrane;, F:enzyme activator activity;, P:neutrophil degranulation; P:protein glycosylation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:regulation of protein stability; P:response to cytokine; P:T cell activation; P:viral protein processing;|Q9BXM7 Q8N6T9 Q8NBU3 Q96DE4,Serine/threonine-protein kinase PINK1, mitochondrial,BRPK;PTEN-induced putative kinase protein 1;, PF00069;, GO:0097449;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005856;GO:0005829;GO:0005783;GO:0030426;GO:0031307;GO:0097413;GO:0016020;GO:0005743;GO:0005758;GO:0005741;GO:0005739;GO:0005634;GO:0048471;GO:0005524;GO:0055131;GO:0010857;GO:0016301;GO:0000287;GO:0016504;GO:0002020;GO:0004672;GO:0043422;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:1904841;GO:0031625;GO:0032148;GO:0000422;GO:1904881;GO:0071456;GO:0034599;GO:0097237;GO:0072655;GO:0035556;GO:0016236;GO:0072656;GO:0007005;GO:0099074;GO:1902902;GO:1903147;GO:0010629;GO:1903384;GO:1903298;GO:2001243;GO:1903751;GO:0046329;GO:0016242;GO:0090258;GO:0043524;GO:1903202;GO:1903204;GO:2000378;GO:0036289;GO:0018105;GO:2001171;GO:1903852;GO:0051091;GO:0033603;GO:1904544;GO:1901727;GO:0043123;GO:0016239;GO:1902958;GO:0090141;GO:0098779;GO:1904783;GO:0010952;GO:0033138;GO:0035307;GO:0051897;GO:0001934;GO:1903955;GO:0031398;GO:0090200;GO:0032226;GO:0045727;GO:0051443;GO:0006468;GO:0050821;GO:0016567;GO:0042981;GO:1903146;GO:1900407;GO:0010310;GO:0051881;GO:0010821;GO:0002082;GO:0061136;GO:1903214;GO:0031396;GO:0043254;GO:2000377;GO:1902803;GO:0022904;GO:0002931;GO:0006979;GO:0038203;GO:0006511;, C:astrocyte projection; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:growth cone; C:integral component of mitochondrial outer membrane; C:Lewy body; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:C3HC4-type RING finger domain binding; F:calcium-dependent protein kinase activity; F:kinase activity; F:magnesium ion binding; F:peptidase activator activity; F:protease binding; F:protein kinase activity; F:protein kinase B binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:TORC2 complex binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase B activity; P:autophagy of mitochondrion; P:cellular response to hydrogen sulfide; P:cellular response to hypoxia; P:cellular response to oxidative stress; P:cellular response to toxic substance; P:establishment of protein localization to mitochondrion; P:intracellular signal transduction; P:macroautophagy; P:maintenance of protein location in mitochondrion; P:mitochondrion organization; P:mitochondrion to lysosome transport; P:negative regulation of autophagosome assembly; P:negative regulation of autophagy of mitochondrion; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of JNK cascade; P:negative regulation of macroautophagy; P:negative regulation of mitochondrial fission; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of reactive oxygen species metabolic process; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of ATP biosynthetic process; P:positive regulation of cristae formation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine secretion; P:positive regulation of free ubiquitin chain polymerization; P:positive regulation of histone deacetylase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of mitochondrial fission; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of NMDA glutamate receptor activity; P:positive regulation of peptidase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of translation; P:positive regulation of ubiquitin-protein transferase activity; P:protein phosphorylation; P:protein stabilization; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of cellular response to oxidative stress; P:regulation of hydrogen peroxide metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of mitochondrion organization; P:regulation of oxidative phosphorylation; P:regulation of proteasomal protein catabolic process; P:regulation of protein targeting to mitochondrion; P:regulation of protein ubiquitination; P:regulation of protein-containing complex assembly; P:regulation of reactive oxygen species metabolic process; P:regulation of synaptic vesicle transport; P:respiratory electron transport chain; P:response to ischemia; P:response to oxidative stress; P:TORC2 signaling; P:ubiquitin-dependent protein catabolic process;|Q9BXM7 Q8N6T9 Q8NBU3 Q96DE4,Serine/threonine-protein kinase PINK1, mitochondrial,BRPK;PTEN-induced putative kinase protein 1;, PF00069;, GO:0097449;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005856;GO:0005829;GO:0005783;GO:0030426;GO:0031307;GO:0097413;GO:0016020;GO:0005743;GO:0005758;GO:0005741;GO:0005739;GO:0005634;GO:0048471;GO:0005524;GO:0055131;GO:0010857;GO:0016301;GO:0000287;GO:0016504;GO:0002020;GO:0004672;GO:0043422;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:1904841;GO:0031625;GO:0032148;GO:0000422;GO:1904881;GO:0071456;GO:0034599;GO:0097237;GO:0072655;GO:0035556;GO:0016236;GO:0072656;GO:0007005;GO:0099074;GO:1902902;GO:1903147;GO:0010629;GO:1903384;GO:1903298;GO:2001243;GO:1903751;GO:0046329;GO:0016242;GO:0090258;GO:0043524;GO:1903202;GO:1903204;GO:2000378;GO:0036289;GO:0018105;GO:2001171;GO:1903852;GO:0051091;GO:0033603;GO:1904544;GO:1901727;GO:0043123;GO:0016239;GO:1902958;GO:0090141;GO:0098779;GO:1904783;GO:0010952;GO:0033138;GO:0035307;GO:0051897;GO:0001934;GO:1903955;GO:0031398;GO:0090200;GO:0032226;GO:0045727;GO:0051443;GO:0006468;GO:0050821;GO:0016567;GO:0042981;GO:1903146;GO:1900407;GO:0010310;GO:0051881;GO:0010821;GO:0002082;GO:0061136;GO:1903214;GO:0031396;GO:0043254;GO:2000377;GO:1902803;GO:0022904;GO:0002931;GO:0006979;GO:0038203;GO:0006511;, C:astrocyte projection; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:growth cone; C:integral component of mitochondrial outer membrane; C:Lewy body; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:C3HC4-type RING finger domain binding; F:calcium-dependent protein kinase activity; F:kinase activity; F:magnesium ion binding; F:peptidase activator activity; F:protease binding; F:protein kinase activity; F:protein kinase B binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:TORC2 complex binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase B activity; P:autophagy of mitochondrion; P:cellular response to hydrogen sulfide; P:cellular response to hypoxia; P:cellular response to oxidative stress; P:cellular response to toxic substance; P:establishment of protein localization to mitochondrion; P:intracellular signal transduction; P:macroautophagy; P:maintenance of protein location in mitochondrion; P:mitochondrion organization; P:mitochondrion to lysosome transport; P:negative regulation of autophagosome assembly; P:negative regulation of autophagy of mitochondrion; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of JNK cascade; P:negative regulation of macroautophagy; P:negative regulation of mitochondrial fission; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of reactive oxygen species metabolic process; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of ATP biosynthetic process; P:positive regulation of cristae formation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine secretion; P:positive regulation of free ubiquitin chain polymerization; P:positive regulation of histone deacetylase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of mitochondrial fission; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of NMDA glutamate receptor activity; P:positive regulation of peptidase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of translation; P:positive regulation of ubiquitin-protein transferase activity; P:protein phosphorylation; P:protein stabilization; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of cellular response to oxidative stress; P:regulation of hydrogen peroxide metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of mitochondrion organization; P:regulation of oxidative phosphorylation; P:regulation of proteasomal protein catabolic process; P:regulation of protein targeting to mitochondrion; P:regulation of protein ubiquitination; P:regulation of protein-containing complex assembly; P:regulation of reactive oxygen species metabolic process; P:regulation of synaptic vesicle transport; P:respiratory electron transport chain; P:response to ischemia; P:response to oxidative stress; P:TORC2 signaling; P:ubiquitin-dependent protein catabolic process;|Q9BXM7 Q8N6T9 Q8NBU3 Q96DE4,Serine/threonine-protein kinase PINK1, mitochondrial,BRPK;PTEN-induced putative kinase protein 1;, PF00069;, GO:0097449;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005856;GO:0005829;GO:0005783;GO:0030426;GO:0031307;GO:0097413;GO:0016020;GO:0005743;GO:0005758;GO:0005741;GO:0005739;GO:0005634;GO:0048471;GO:0005524;GO:0055131;GO:0010857;GO:0016301;GO:0000287;GO:0016504;GO:0002020;GO:0004672;GO:0043422;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:1904841;GO:0031625;GO:0032148;GO:0000422;GO:1904881;GO:0071456;GO:0034599;GO:0097237;GO:0072655;GO:0035556;GO:0016236;GO:0072656;GO:0007005;GO:0099074;GO:1902902;GO:1903147;GO:0010629;GO:1903384;GO:1903298;GO:2001243;GO:1903751;GO:0046329;GO:0016242;GO:0090258;GO:0043524;GO:1903202;GO:1903204;GO:2000378;GO:0036289;GO:0018105;GO:2001171;GO:1903852;GO:0051091;GO:0033603;GO:1904544;GO:1901727;GO:0043123;GO:0016239;GO:1902958;GO:0090141;GO:0098779;GO:1904783;GO:0010952;GO:0033138;GO:0035307;GO:0051897;GO:0001934;GO:1903955;GO:0031398;GO:0090200;GO:0032226;GO:0045727;GO:0051443;GO:0006468;GO:0050821;GO:0016567;GO:0042981;GO:1903146;GO:1900407;GO:0010310;GO:0051881;GO:0010821;GO:0002082;GO:0061136;GO:1903214;GO:0031396;GO:0043254;GO:2000377;GO:1902803;GO:0022904;GO:0002931;GO:0006979;GO:0038203;GO:0006511;, C:astrocyte projection; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:growth cone; C:integral component of mitochondrial outer membrane; C:Lewy body; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:C3HC4-type RING finger domain binding; F:calcium-dependent protein kinase activity; F:kinase activity; F:magnesium ion binding; F:peptidase activator activity; F:protease binding; F:protein kinase activity; F:protein kinase B binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:TORC2 complex binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase B activity; P:autophagy of mitochondrion; P:cellular response to hydrogen sulfide; P:cellular response to hypoxia; P:cellular response to oxidative stress; P:cellular response to toxic substance; P:establishment of protein localization to mitochondrion; P:intracellular signal transduction; P:macroautophagy; P:maintenance of protein location in mitochondrion; P:mitochondrion organization; P:mitochondrion to lysosome transport; P:negative regulation of autophagosome assembly; P:negative regulation of autophagy of mitochondrion; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of JNK cascade; P:negative regulation of macroautophagy; P:negative regulation of mitochondrial fission; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of reactive oxygen species metabolic process; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of ATP biosynthetic process; P:positive regulation of cristae formation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine secretion; P:positive regulation of free ubiquitin chain polymerization; P:positive regulation of histone deacetylase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of mitochondrial fission; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of NMDA glutamate receptor activity; P:positive regulation of peptidase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of translation; P:positive regulation of ubiquitin-protein transferase activity; P:protein phosphorylation; P:protein stabilization; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of cellular response to oxidative stress; P:regulation of hydrogen peroxide metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of mitochondrion organization; P:regulation of oxidative phosphorylation; P:regulation of proteasomal protein catabolic process; P:regulation of protein targeting to mitochondrion; P:regulation of protein ubiquitination; P:regulation of protein-containing complex assembly; P:regulation of reactive oxygen species metabolic process; P:regulation of synaptic vesicle transport; P:respiratory electron transport chain; P:response to ischemia; P:response to oxidative stress; P:TORC2 signaling; P:ubiquitin-dependent protein catabolic process; scaffold76 indexed_genome mRNA 6163588 6164486 . - . ID=transcript_11768;Q9BXM7 Q8N6T9 Q8NBU3 Q96DE4,Serine/threonine-protein kinase PINK1, mitochondrial,BRPK;PTEN-induced putative kinase protein 1;, PF00069;, GO:0097449;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005856;GO:0005829;GO:0005783;GO:0030426;GO:0031307;GO:0097413;GO:0016020;GO:0005743;GO:0005758;GO:0005741;GO:0005739;GO:0005634;GO:0048471;GO:0005524;GO:0055131;GO:0010857;GO:0016301;GO:0000287;GO:0016504;GO:0002020;GO:0004672;GO:0043422;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:1904841;GO:0031625;GO:0032148;GO:0000422;GO:1904881;GO:0071456;GO:0034599;GO:0097237;GO:0072655;GO:0035556;GO:0016236;GO:0072656;GO:0007005;GO:0099074;GO:1902902;GO:1903147;GO:0010629;GO:1903384;GO:1903298;GO:2001243;GO:1903751;GO:0046329;GO:0016242;GO:0090258;GO:0043524;GO:1903202;GO:1903204;GO:2000378;GO:0036289;GO:0018105;GO:2001171;GO:1903852;GO:0051091;GO:0033603;GO:1904544;GO:1901727;GO:0043123;GO:0016239;GO:1902958;GO:0090141;GO:0098779;GO:1904783;GO:0010952;GO:0033138;GO:0035307;GO:0051897;GO:0001934;GO:1903955;GO:0031398;GO:0090200;GO:0032226;GO:0045727;GO:0051443;GO:0006468;GO:0050821;GO:0016567;GO:0042981;GO:1903146;GO:1900407;GO:0010310;GO:0051881;GO:0010821;GO:0002082;GO:0061136;GO:1903214;GO:0031396;GO:0043254;GO:2000377;GO:1902803;GO:0022904;GO:0002931;GO:0006979;GO:0038203;GO:0006511;, C:astrocyte projection; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:growth cone; C:integral component of mitochondrial outer membrane; C:Lewy body; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:C3HC4-type RING finger domain binding; F:calcium-dependent protein kinase activity; F:kinase activity; F:magnesium ion binding; F:peptidase activator activity; F:protease binding; F:protein kinase activity; F:protein kinase B binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:TORC2 complex binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase B activity; P:autophagy of mitochondrion; P:cellular response to hydrogen sulfide; P:cellular response to hypoxia; P:cellular response to oxidative stress; P:cellular response to toxic substance; P:establishment of protein localization to mitochondrion; P:intracellular signal transduction; P:macroautophagy; P:maintenance of protein location in mitochondrion; P:mitochondrion organization; P:mitochondrion to lysosome transport; P:negative regulation of autophagosome assembly; P:negative regulation of autophagy of mitochondrion; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of JNK cascade; P:negative regulation of macroautophagy; P:negative regulation of mitochondrial fission; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of reactive oxygen species metabolic process; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of ATP biosynthetic process; P:positive regulation of cristae formation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine secretion; P:positive regulation of free ubiquitin chain polymerization; P:positive regulation of histone deacetylase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of mitochondrial fission; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of NMDA glutamate receptor activity; P:positive regulation of peptidase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of translation; P:positive regulation of ubiquitin-protein transferase activity; P:protein phosphorylation; P:protein stabilization; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of cellular response to oxidative stress; P:regulation of hydrogen peroxide metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of mitochondrion organization; P:regulation of oxidative phosphorylation; P:regulation of proteasomal protein catabolic process; P:regulation of protein targeting to mitochondrion; P:regulation of protein ubiquitination; P:regulation of protein-containing complex assembly; P:regulation of reactive oxygen species metabolic process; P:regulation of synaptic vesicle transport; P:respiratory electron transport chain; P:response to ischemia; P:response to oxidative stress; P:TORC2 signaling; P:ubiquitin-dependent protein catabolic process; scaffold76 indexed_genome mRNA 6166509 6167424 . + . ID=transcript_11769;Q9BXM7 Q8N6T9 Q8NBU3 Q96DE4,Serine/threonine-protein kinase PINK1, mitochondrial,BRPK;PTEN-induced putative kinase protein 1;, PF00069;, GO:0097449;GO:0030424;GO:0044297;GO:0000785;GO:0005737;GO:0005856;GO:0005829;GO:0005783;GO:0030426;GO:0031307;GO:0097413;GO:0016020;GO:0005743;GO:0005758;GO:0005741;GO:0005739;GO:0005634;GO:0048471;GO:0005524;GO:0055131;GO:0010857;GO:0016301;GO:0000287;GO:0016504;GO:0002020;GO:0004672;GO:0043422;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:1904841;GO:0031625;GO:0032148;GO:0000422;GO:1904881;GO:0071456;GO:0034599;GO:0097237;GO:0072655;GO:0035556;GO:0016236;GO:0072656;GO:0007005;GO:0099074;GO:1902902;GO:1903147;GO:0010629;GO:1903384;GO:1903298;GO:2001243;GO:1903751;GO:0046329;GO:0016242;GO:0090258;GO:0043524;GO:1903202;GO:1903204;GO:2000378;GO:0036289;GO:0018105;GO:2001171;GO:1903852;GO:0051091;GO:0033603;GO:1904544;GO:1901727;GO:0043123;GO:0016239;GO:1902958;GO:0090141;GO:0098779;GO:1904783;GO:0010952;GO:0033138;GO:0035307;GO:0051897;GO:0001934;GO:1903955;GO:0031398;GO:0090200;GO:0032226;GO:0045727;GO:0051443;GO:0006468;GO:0050821;GO:0016567;GO:0042981;GO:1903146;GO:1900407;GO:0010310;GO:0051881;GO:0010821;GO:0002082;GO:0061136;GO:1903214;GO:0031396;GO:0043254;GO:2000377;GO:1902803;GO:0022904;GO:0002931;GO:0006979;GO:0038203;GO:0006511;, C:astrocyte projection; C:axon; C:cell body; C:chromatin; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:growth cone; C:integral component of mitochondrial outer membrane; C:Lewy body; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:C3HC4-type RING finger domain binding; F:calcium-dependent protein kinase activity; F:kinase activity; F:magnesium ion binding; F:peptidase activator activity; F:protease binding; F:protein kinase activity; F:protein kinase B binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding; F:TORC2 complex binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase B activity; P:autophagy of mitochondrion; P:cellular response to hydrogen sulfide; P:cellular response to hypoxia; P:cellular response to oxidative stress; P:cellular response to toxic substance; P:establishment of protein localization to mitochondrion; P:intracellular signal transduction; P:macroautophagy; P:maintenance of protein location in mitochondrion; P:mitochondrion organization; P:mitochondrion to lysosome transport; P:negative regulation of autophagosome assembly; P:negative regulation of autophagy of mitochondrion; P:negative regulation of gene expression; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of JNK cascade; P:negative regulation of macroautophagy; P:negative regulation of mitochondrial fission; P:negative regulation of neuron apoptotic process; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of reactive oxygen species metabolic process; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of ATP biosynthetic process; P:positive regulation of cristae formation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of dopamine secretion; P:positive regulation of free ubiquitin chain polymerization; P:positive regulation of histone deacetylase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; P:positive regulation of mitochondrial fission; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of NMDA glutamate receptor activity; P:positive regulation of peptidase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of translation; P:positive regulation of ubiquitin-protein transferase activity; P:protein phosphorylation; P:protein stabilization; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of cellular response to oxidative stress; P:regulation of hydrogen peroxide metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of mitochondrion organization; P:regulation of oxidative phosphorylation; P:regulation of proteasomal protein catabolic process; P:regulation of protein targeting to mitochondrion; P:regulation of protein ubiquitination; P:regulation of protein-containing complex assembly; P:regulation of reactive oxygen species metabolic process; P:regulation of synaptic vesicle transport; P:respiratory electron transport chain; P:response to ischemia; P:response to oxidative stress; P:TORC2 signaling; P:ubiquitin-dependent protein catabolic process; scaffold76 indexed_genome mRNA 6193456 6214317 . - . ID=transcript_11770;P32320,Cytidine deaminase,Cytidine aminohydrolase;, PF00383;, GO:0005829;GO:0005576;GO:1904813;GO:0034774;GO:1904724;GO:0004126;GO:0047844;GO:0042802;GO:0001882;GO:0042803;GO:0008270;GO:0007166;GO:0009972;GO:0019858;GO:0030308;GO:0045980;GO:0043312;GO:0043097;GO:0008655;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen; C:tertiary granule lumen;, F:cytidine deaminase activity; F:deoxycytidine deaminase activity; F:identical protein binding; F:nucleoside binding; F:protein homodimerization activity; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:cytidine deamination; P:cytosine metabolic process; P:negative regulation of cell growth; P:negative regulation of nucleotide metabolic process; P:neutrophil degranulation; P:pyrimidine nucleoside salvage; P:pyrimidine-containing compound salvage; scaffold76 indexed_genome mRNA 6291710 6299336 . + . ID=transcript_11771;Q969V5 B5M497 Q7Z431 Q9H9B5,Mitochondrial ubiquitin ligase activator of NFKB 1,E3 SUMO-protein ligase MUL1;E3 ubiquitin-protein ligase MUL1;Growth inhibition and death E3 ligase;Mitochondrial-anchored protein ligase;Protein Hades {ECO:0000303|PubMed:21597459};Putative NF-kappa-B-activating protein 266;RING finger protein 218;RING-type E3 ubiquitin transferase NFKB 1 {ECO:0000305};, PF12483;, GO:0030424;GO:0031307;GO:0016020;GO:0005739;GO:0043025;GO:0005777;GO:0042802;GO:0046872;GO:0002039;GO:0019789;GO:0061630;GO:0031625;GO:0004842;GO:0006919;GO:0007257;GO:0006915;GO:0071360;GO:0000266;GO:0051646;GO:0030308;GO:0071650;GO:0050689;GO:0045824;GO:0010637;GO:0051898;GO:0060339;GO:1904925;GO:1903861;GO:0043123;GO:0090141;GO:0033235;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:0051881;GO:1901028;GO:0010821;, C:axon; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrion; C:neuronal cell body; C:peroxisome;, F:identical protein binding; F:metal ion binding; F:p53 binding; F:SUMO transferase activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:apoptotic process; P:cellular response to exogenous dsRNA; P:mitochondrial fission; P:mitochondrion localization; P:negative regulation of cell growth; P:negative regulation of chemokine (C-C motif) ligand 5 production; P:negative regulation of defense response to virus by host; P:negative regulation of innate immune response; P:negative regulation of mitochondrial fusion; P:negative regulation of protein kinase B signaling; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization; P:positive regulation of dendrite extension; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of mitochondrial fission; P:positive regulation of protein sumoylation; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of mitochondrial membrane potential; P:regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:regulation of mitochondrion organization;|Q969V5 B5M497 Q7Z431 Q9H9B5,Mitochondrial ubiquitin ligase activator of NFKB 1,E3 SUMO-protein ligase MUL1;E3 ubiquitin-protein ligase MUL1;Growth inhibition and death E3 ligase;Mitochondrial-anchored protein ligase;Protein Hades {ECO:0000303|PubMed:21597459};Putative NF-kappa-B-activating protein 266;RING finger protein 218;RING-type E3 ubiquitin transferase NFKB 1 {ECO:0000305};, PF12483;, GO:0030424;GO:0031307;GO:0016020;GO:0005739;GO:0043025;GO:0005777;GO:0042802;GO:0046872;GO:0002039;GO:0019789;GO:0061630;GO:0031625;GO:0004842;GO:0006919;GO:0007257;GO:0006915;GO:0071360;GO:0000266;GO:0051646;GO:0030308;GO:0071650;GO:0050689;GO:0045824;GO:0010637;GO:0051898;GO:0060339;GO:1904925;GO:1903861;GO:0043123;GO:0090141;GO:0033235;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:0051881;GO:1901028;GO:0010821;, C:axon; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrion; C:neuronal cell body; C:peroxisome;, F:identical protein binding; F:metal ion binding; F:p53 binding; F:SUMO transferase activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:apoptotic process; P:cellular response to exogenous dsRNA; P:mitochondrial fission; P:mitochondrion localization; P:negative regulation of cell growth; P:negative regulation of chemokine (C-C motif) ligand 5 production; P:negative regulation of defense response to virus by host; P:negative regulation of innate immune response; P:negative regulation of mitochondrial fusion; P:negative regulation of protein kinase B signaling; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization; P:positive regulation of dendrite extension; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of mitochondrial fission; P:positive regulation of protein sumoylation; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of mitochondrial membrane potential; P:regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:regulation of mitochondrion organization;|Q969V5 B5M497 Q7Z431 Q9H9B5,Mitochondrial ubiquitin ligase activator of NFKB 1,E3 SUMO-protein ligase MUL1;E3 ubiquitin-protein ligase MUL1;Growth inhibition and death E3 ligase;Mitochondrial-anchored protein ligase;Protein Hades {ECO:0000303|PubMed:21597459};Putative NF-kappa-B-activating protein 266;RING finger protein 218;RING-type E3 ubiquitin transferase NFKB 1 {ECO:0000305};, PF12483;, GO:0030424;GO:0031307;GO:0016020;GO:0005739;GO:0043025;GO:0005777;GO:0042802;GO:0046872;GO:0002039;GO:0019789;GO:0061630;GO:0031625;GO:0004842;GO:0006919;GO:0007257;GO:0006915;GO:0071360;GO:0000266;GO:0051646;GO:0030308;GO:0071650;GO:0050689;GO:0045824;GO:0010637;GO:0051898;GO:0060339;GO:1904925;GO:1903861;GO:0043123;GO:0090141;GO:0033235;GO:0031648;GO:0000209;GO:0050821;GO:0016567;GO:0051881;GO:1901028;GO:0010821;, C:axon; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrion; C:neuronal cell body; C:peroxisome;, F:identical protein binding; F:metal ion binding; F:p53 binding; F:SUMO transferase activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of JUN kinase activity; P:apoptotic process; P:cellular response to exogenous dsRNA; P:mitochondrial fission; P:mitochondrion localization; P:negative regulation of cell growth; P:negative regulation of chemokine (C-C motif) ligand 5 production; P:negative regulation of defense response to virus by host; P:negative regulation of innate immune response; P:negative regulation of mitochondrial fusion; P:negative regulation of protein kinase B signaling; P:negative regulation of type I interferon-mediated signaling pathway; P:positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization; P:positive regulation of dendrite extension; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of mitochondrial fission; P:positive regulation of protein sumoylation; P:protein destabilization; P:protein polyubiquitination; P:protein stabilization; P:protein ubiquitination; P:regulation of mitochondrial membrane potential; P:regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:regulation of mitochondrion organization; scaffold76 indexed_genome mRNA 6316463 6316994 . + . ID=transcript_11772;Q7Z7J9,Calcium/calmodulin-dependent protein kinase II inhibitor 1,CaMKII inhibitory protein alpha;, PF15170;, GO:0030425;GO:0043025;GO:0014069;GO:0008427;GO:0019901;GO:0055074;GO:0045786;GO:0008285;GO:1904030;GO:0070373;GO:0006469;GO:0045861;GO:0010628;GO:0035774;GO:0003084;, C:dendrite; C:neuronal cell body; C:postsynaptic density;, F:calcium-dependent protein kinase inhibitor activity; F:protein kinase binding;, P:calcium ion homeostasis; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein kinase activity; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of protein kinase activity; P:negative regulation of proteolysis; P:positive regulation of gene expression; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of systemic arterial blood pressure; scaffold76 indexed_genome mRNA 6317023 6318285 . + . ID=transcript_11773;Q7Z7J9,Calcium/calmodulin-dependent protein kinase II inhibitor 1,CaMKII inhibitory protein alpha;, PF15170;, GO:0030425;GO:0043025;GO:0014069;GO:0008427;GO:0019901;GO:0055074;GO:0045786;GO:0008285;GO:1904030;GO:0070373;GO:0006469;GO:0045861;GO:0010628;GO:0035774;GO:0003084;, C:dendrite; C:neuronal cell body; C:postsynaptic density;, F:calcium-dependent protein kinase inhibitor activity; F:protein kinase binding;, P:calcium ion homeostasis; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein kinase activity; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of protein kinase activity; P:negative regulation of proteolysis; P:positive regulation of gene expression; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of systemic arterial blood pressure; scaffold76 indexed_genome mRNA 6439469 6477501 . - . ID=transcript_11774;Q5TIE3 A4IF35 A4IF36 Q3ZCM4 Q6ZUB4 Q96M71,von Willebrand factor A domain-containing protein 5B1,, PF13757;PF13768;, GO:0005576;, C:extracellular region; scaffold76 indexed_genome mRNA 6610702 6616517 . - . ID=transcript_11775;Q96LJ8 Q5R386,UBX domain-containing protein 10 {ECO:0000305},UBX domain-containing protein 3;, PF00789;, GO:0005929;GO:0060271;, C:cilium;, , P:cilium assembly; scaffold76 indexed_genome mRNA 6736308 6745192 . - . ID=transcript_11776;P39877 Q8N435,Phospholipase A2 group V,PLA2-10;Phosphatidylcholine 2-acylhydrolase 5;, PF00068;, GO:0032009;GO:0005576;GO:0005794;GO:0032010;GO:0005886;GO:0055037;GO:0005509;GO:0047498;GO:0047499;GO:0102567;GO:0102568;GO:0005543;GO:0050482;GO:0035965;GO:0006631;GO:0019370;GO:0034374;GO:0090385;GO:0006654;GO:0036151;GO:0034638;GO:0036152;GO:0036148;GO:0036149;GO:0036150;GO:0006644;GO:1905036;GO:0070374;GO:0090265;GO:0010744;GO:1903028;GO:0050766;GO:1905164;GO:0010518;, C:early phagosome; C:extracellular region; C:Golgi apparatus; C:phagolysosome; C:plasma membrane; C:recycling endosome;, F:calcium ion binding; F:calcium-dependent phospholipase A2 activity; F:calcium-independent phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:phospholipid binding;, P:arachidonic acid secretion; P:cardiolipin acyl-chain remodeling; P:fatty acid metabolic process; P:leukotriene biosynthetic process; P:low-density lipoprotein particle remodeling; P:phagosome-lysosome fusion; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid metabolic process; P:positive regulation of antifungal innate immune response; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of immune complex clearance by monocytes and macrophages; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of opsonization; P:positive regulation of phagocytosis; P:positive regulation of phagosome maturation; P:positive regulation of phospholipase activity; scaffold76 indexed_genome mRNA 6888292 6903006 . - . ID=transcript_11777;Q5T2D3 O75047,OTU domain-containing protein 3,, PF02338;, GO:0005737;GO:0005829;GO:0008234;GO:0004843;GO:0051898;GO:0016579;GO:0035871;GO:1990167;GO:0071108;GO:0044313;GO:0050821;, C:cytoplasm; C:cytosol;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:negative regulation of protein kinase B signaling; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K27-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein K6-linked deubiquitination; P:protein stabilization;|Q5T2D3 O75047,OTU domain-containing protein 3,, PF02338;, GO:0005737;GO:0005829;GO:0008234;GO:0004843;GO:0051898;GO:0016579;GO:0035871;GO:1990167;GO:0071108;GO:0044313;GO:0050821;, C:cytoplasm; C:cytosol;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:negative regulation of protein kinase B signaling; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K27-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein K6-linked deubiquitination; P:protein stabilization; scaffold76 indexed_genome mRNA 6905825 6907559 . - . ID=transcript_11778;Q5T2D3 O75047,OTU domain-containing protein 3,, PF02338;, GO:0005737;GO:0005829;GO:0008234;GO:0004843;GO:0051898;GO:0016579;GO:0035871;GO:1990167;GO:0071108;GO:0044313;GO:0050821;, C:cytoplasm; C:cytosol;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:negative regulation of protein kinase B signaling; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K27-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein K6-linked deubiquitination; P:protein stabilization; scaffold76 indexed_genome mRNA 7015832 7125042 . + . ID=transcript_11779;Q5TGY1 Q5TGY2 Q6MZN5 Q7Z6K6 Q9UQP4 Q9Y3K1,Transmembrane and coiled-coil domain-containing protein 4,, PF05277;, GO:0016021;, C:integral component of membrane;|Q5TGY1 Q5TGY2 Q6MZN5 Q7Z6K6 Q9UQP4 Q9Y3K1,Transmembrane and coiled-coil domain-containing protein 4,, PF05277;, GO:0016021;, C:integral component of membrane;|Q5TGY1 Q5TGY2 Q6MZN5 Q7Z6K6 Q9UQP4 Q9Y3K1,Transmembrane and coiled-coil domain-containing protein 4,, PF05277;, GO:0016021;, C:integral component of membrane; scaffold76 indexed_genome mRNA 7146377 7149962 . - . ID=transcript_11780;P41271 A3KFI7 Q5TGZ2 Q5U0N4 Q96L68,Neuroblastoma suppressor of tumorigenicity 1,DAN domain family member 1;Protein N03;Zinc finger protein DAN;, PF03045;, GO:0005615;GO:0036122;GO:0042802;GO:0016015;GO:0048018;GO:0009887;GO:0048263;GO:0030514;GO:0090027;GO:0007399;GO:0048812;GO:0045666;GO:0038098;GO:0035582;, C:extracellular space;, F:BMP binding; F:identical protein binding; F:morphogen activity; F:receptor ligand activity;, P:animal organ morphogenesis; P:determination of dorsal identity; P:negative regulation of BMP signaling pathway; P:negative regulation of monocyte chemotaxis; P:nervous system development; P:neuron projection morphogenesis; P:positive regulation of neuron differentiation; P:sequestering of BMP from receptor via BMP binding; P:sequestering of BMP in extracellular matrix; scaffold76 indexed_genome mRNA 7150254 7151430 . - . ID=transcript_11781;P41271 A3KFI7 Q5TGZ2 Q5U0N4 Q96L68,Neuroblastoma suppressor of tumorigenicity 1,DAN domain family member 1;Protein N03;Zinc finger protein DAN;, PF03045;, GO:0005615;GO:0036122;GO:0042802;GO:0016015;GO:0048018;GO:0009887;GO:0048263;GO:0030514;GO:0090027;GO:0007399;GO:0048812;GO:0045666;GO:0038098;GO:0035582;, C:extracellular space;, F:BMP binding; F:identical protein binding; F:morphogen activity; F:receptor ligand activity;, P:animal organ morphogenesis; P:determination of dorsal identity; P:negative regulation of BMP signaling pathway; P:negative regulation of monocyte chemotaxis; P:nervous system development; P:neuron projection morphogenesis; P:positive regulation of neuron differentiation; P:sequestering of BMP from receptor via BMP binding; P:sequestering of BMP in extracellular matrix; scaffold76 indexed_genome mRNA 7184446 7219074 . + . ID=transcript_11782;Q5TGZ0 Q96G68,MICOS complex subunit MIC10 {ECO:0000305},Mitochondrial inner membrane organizing system protein 1;, PF04418;, GO:0140275;GO:0061617;GO:0005739;GO:0001401;GO:0007007;, C:MIB complex; C:MICOS complex; C:mitochondrion; C:SAM complex;, , P:inner mitochondrial membrane organization; scaffold76 indexed_genome mRNA 7439492 7440375 . + . ID=transcript_11783;P47756 Q32Q68 Q5U0L4 Q8TB49 Q9NUC4,F-actin-capping protein subunit beta,CapZ beta;, PF01115;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0008290;GO:0030017;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0000902;GO:0007010;GO:0006888;GO:0051490;GO:0022604;GO:0010591;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:F-actin capping protein complex; C:sarcomere; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell morphogenesis; P:cytoskeleton organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of filopodium assembly; P:regulation of cell morphogenesis; P:regulation of lamellipodium assembly; scaffold76 indexed_genome mRNA 7447669 7453156 . + . ID=transcript_11784;P47756 Q32Q68 Q5U0L4 Q8TB49 Q9NUC4,F-actin-capping protein subunit beta,CapZ beta;, PF01115;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0008290;GO:0030017;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0000902;GO:0007010;GO:0006888;GO:0051490;GO:0022604;GO:0010591;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:F-actin capping protein complex; C:sarcomere; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell morphogenesis; P:cytoskeleton organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of filopodium assembly; P:regulation of cell morphogenesis; P:regulation of lamellipodium assembly;|P47756 Q32Q68 Q5U0L4 Q8TB49 Q9NUC4,F-actin-capping protein subunit beta,CapZ beta;, PF01115;, GO:0015629;GO:0005856;GO:0005829;GO:0070062;GO:0008290;GO:0030017;GO:0071203;GO:0003779;GO:0051015;GO:0045296;GO:0030036;GO:0019886;GO:0051016;GO:0007596;GO:0000902;GO:0007010;GO:0006888;GO:0051490;GO:0022604;GO:0010591;, C:actin cytoskeleton; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:F-actin capping protein complex; C:sarcomere; C:WASH complex;, F:actin binding; F:actin filament binding; F:cadherin binding;, P:actin cytoskeleton organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:barbed-end actin filament capping; P:blood coagulation; P:cell morphogenesis; P:cytoskeleton organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of filopodium assembly; P:regulation of cell morphogenesis; P:regulation of lamellipodium assembly; scaffold76 indexed_genome mRNA 7461768 7463401 . + . ID=transcript_11785;Q6ZP29 B3KWQ5 Q6ZMJ3 Q6ZP27 Q9NXC7,Lysosomal amino acid transporter 1 homolog {ECO:0000305},PQ-loop repeat-containing protein 2;Solute carrier family 66 member 1 {ECO:0000312|HGNC:HGNC:26001};, PF04193;, GO:0016021;GO:0031301;GO:0043231;GO:0005765;GO:0015181;GO:0015174;GO:0015189;GO:0080144;GO:0015809;GO:0015819;GO:0055085;, C:integral component of membrane; C:integral component of organelle membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:arginine transmembrane transporter activity; F:basic amino acid transmembrane transporter activity; F:L-lysine transmembrane transporter activity;, P:amino acid homeostasis; P:arginine transport; P:lysine transport; P:transmembrane transport; scaffold76 indexed_genome mRNA 7465188 7484359 . + . ID=transcript_11786;Q6ZP29 B3KWQ5 Q6ZMJ3 Q6ZP27 Q9NXC7,Lysosomal amino acid transporter 1 homolog {ECO:0000305},PQ-loop repeat-containing protein 2;Solute carrier family 66 member 1 {ECO:0000312|HGNC:HGNC:26001};, PF04193;, GO:0016021;GO:0031301;GO:0043231;GO:0005765;GO:0015181;GO:0015174;GO:0015189;GO:0080144;GO:0015809;GO:0015819;GO:0055085;, C:integral component of membrane; C:integral component of organelle membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:arginine transmembrane transporter activity; F:basic amino acid transmembrane transporter activity; F:L-lysine transmembrane transporter activity;, P:amino acid homeostasis; P:arginine transport; P:lysine transport; P:transmembrane transport;|Q6ZP29 B3KWQ5 Q6ZMJ3 Q6ZP27 Q9NXC7,Lysosomal amino acid transporter 1 homolog {ECO:0000305},PQ-loop repeat-containing protein 2;Solute carrier family 66 member 1 {ECO:0000312|HGNC:HGNC:26001};, PF04193;, GO:0016021;GO:0031301;GO:0043231;GO:0005765;GO:0015181;GO:0015174;GO:0015189;GO:0080144;GO:0015809;GO:0015819;GO:0055085;, C:integral component of membrane; C:integral component of organelle membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:arginine transmembrane transporter activity; F:basic amino acid transmembrane transporter activity; F:L-lysine transmembrane transporter activity;, P:amino acid homeostasis; P:arginine transport; P:lysine transport; P:transmembrane transport;|Q6ZP29 B3KWQ5 Q6ZMJ3 Q6ZP27 Q9NXC7,Lysosomal amino acid transporter 1 homolog {ECO:0000305},PQ-loop repeat-containing protein 2;Solute carrier family 66 member 1 {ECO:0000312|HGNC:HGNC:26001};, PF04193;, GO:0016021;GO:0031301;GO:0043231;GO:0005765;GO:0015181;GO:0015174;GO:0015189;GO:0080144;GO:0015809;GO:0015819;GO:0055085;, C:integral component of membrane; C:integral component of organelle membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, F:arginine transmembrane transporter activity; F:basic amino acid transmembrane transporter activity; F:L-lysine transmembrane transporter activity;, P:amino acid homeostasis; P:arginine transport; P:lysine transport; P:transmembrane transport; scaffold76 indexed_genome mRNA 7507753 7511957 . - . ID=transcript_11787;O95154 Q86SR4 Q8IVN6 Q8N5V6 Q8TAX1 Q9NUC3,Aflatoxin B1 aldehyde reductase member 3,AFB1 aldehyde reductase 2;, PF00248;, GO:0005829;GO:0070062;GO:0004033;GO:0047834;GO:0009055;GO:0042802;GO:0046223;GO:0046222;GO:0006081;, C:cytosol; C:extracellular exosome;, F:aldo-keto reductase (NADP) activity; F:D-threo-aldose 1-dehydrogenase activity; F:electron transfer activity; F:identical protein binding;, P:aflatoxin catabolic process; P:aflatoxin metabolic process; P:cellular aldehyde metabolic process; scaffold76 indexed_genome mRNA 7524803 7528444 . - . ID=transcript_11788;Q9UKD2 B3KNB3 Q5TG55 Q96SS6 Q9BPV9,mRNA turnover protein 4 homolog {ECO:0000250|UniProtKB:P33201},Ribosome assembly factor MRTO4 {ECO:0000250|UniProtKB:P33201, ECO:0000305};, PF00466;PF17777;, GO:0005737;GO:0005730;GO:0030687;GO:0003723;GO:0000956;GO:0000027;GO:0042273;GO:0006364;, C:cytoplasm; C:nucleolus; C:preribosome, large subunit precursor;, F:RNA binding;, P:nuclear-transcribed mRNA catabolic process; P:ribosomal large subunit assembly; P:ribosomal large subunit biogenesis; P:rRNA processing; scaffold76 indexed_genome mRNA 7531620 7532188 . - . ID=transcript_11789;Q8N766 A8K6F3 Q14700 Q5TG62 Q63HL0 Q63HL3 Q8NBH8,ER membrane protein complex subunit 1,, PF07774;PF13360;, GO:0072546;GO:0005789;GO:0030176;GO:0016021;GO:0032991;GO:0045050;GO:0071816;, C:EMC complex; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane; scaffold76 indexed_genome mRNA 7532428 7551778 . + . ID=transcript_11790;Q8N766 A8K6F3 Q14700 Q5TG62 Q63HL0 Q63HL3 Q8NBH8,ER membrane protein complex subunit 1,, PF07774;PF13360;, GO:0072546;GO:0005789;GO:0030176;GO:0016021;GO:0032991;GO:0045050;GO:0071816;, C:EMC complex; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q8N766 A8K6F3 Q14700 Q5TG62 Q63HL0 Q63HL3 Q8NBH8,ER membrane protein complex subunit 1,, PF07774;PF13360;, GO:0072546;GO:0005789;GO:0030176;GO:0016021;GO:0032991;GO:0045050;GO:0071816;, C:EMC complex; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q8N766 A8K6F3 Q14700 Q5TG62 Q63HL0 Q63HL3 Q8NBH8,ER membrane protein complex subunit 1,, PF07774;PF13360;, GO:0072546;GO:0005789;GO:0030176;GO:0016021;GO:0032991;GO:0045050;GO:0071816;, C:EMC complex; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q8N766 A8K6F3 Q14700 Q5TG62 Q63HL0 Q63HL3 Q8NBH8,ER membrane protein complex subunit 1,, PF07774;PF13360;, GO:0072546;GO:0005789;GO:0030176;GO:0016021;GO:0032991;GO:0045050;GO:0071816;, C:EMC complex; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q8N766 A8K6F3 Q14700 Q5TG62 Q63HL0 Q63HL3 Q8NBH8,ER membrane protein complex subunit 1,, PF07774;PF13360;, GO:0072546;GO:0005789;GO:0030176;GO:0016021;GO:0032991;GO:0045050;GO:0071816;, C:EMC complex; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q8N766 A8K6F3 Q14700 Q5TG62 Q63HL0 Q63HL3 Q8NBH8,ER membrane protein complex subunit 1,, PF07774;PF13360;, GO:0072546;GO:0005789;GO:0030176;GO:0016021;GO:0032991;GO:0045050;GO:0071816;, C:EMC complex; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q8N766 A8K6F3 Q14700 Q5TG62 Q63HL0 Q63HL3 Q8NBH8,ER membrane protein complex subunit 1,, PF07774;PF13360;, GO:0072546;GO:0005789;GO:0030176;GO:0016021;GO:0032991;GO:0045050;GO:0071816;, C:EMC complex; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:protein-containing complex;, , P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane; scaffold76 indexed_genome mRNA 7643490 7644087 . - . ID=transcript_11791;Q9P2N9 Q9UG82,E3 ubiquitin-protein ligase UBR4,600 kDa retinoblastoma protein-associated factor;N-recognin-4;RING-type E3 ubiquitin transferase UBR4;Retinoblastoma-associated factor of 600 kDa;Zinc finger UBR1-type protein 1;, PF13764;PF02207;, GO:0005813;GO:0005829;GO:0101003;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0035579;GO:0070821;GO:0005516;GO:0061630;GO:0004842;GO:0008270;GO:0043312;GO:0006511;GO:0016032;, C:centrosome; C:cytosol; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calmodulin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:neutrophil degranulation; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold76 indexed_genome mRNA 7686790 7687641 . - . ID=transcript_11792;Q9P2N9 Q9UG82,E3 ubiquitin-protein ligase UBR4,600 kDa retinoblastoma protein-associated factor;N-recognin-4;RING-type E3 ubiquitin transferase UBR4;Retinoblastoma-associated factor of 600 kDa;Zinc finger UBR1-type protein 1;, PF13764;PF02207;, GO:0005813;GO:0005829;GO:0101003;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0035579;GO:0070821;GO:0005516;GO:0061630;GO:0004842;GO:0008270;GO:0043312;GO:0006511;GO:0016032;, C:centrosome; C:cytosol; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calmodulin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:neutrophil degranulation; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold76 indexed_genome mRNA 7689738 7694809 . + . ID=transcript_11793;Q9P2N9 Q9UG82,E3 ubiquitin-protein ligase UBR4,600 kDa retinoblastoma protein-associated factor;N-recognin-4;RING-type E3 ubiquitin transferase UBR4;Retinoblastoma-associated factor of 600 kDa;Zinc finger UBR1-type protein 1;, PF13764;PF02207;, GO:0005813;GO:0005829;GO:0101003;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0035579;GO:0070821;GO:0005516;GO:0061630;GO:0004842;GO:0008270;GO:0043312;GO:0006511;GO:0016032;, C:centrosome; C:cytosol; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calmodulin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:neutrophil degranulation; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9P2N9 Q9UG82,E3 ubiquitin-protein ligase UBR4,600 kDa retinoblastoma protein-associated factor;N-recognin-4;RING-type E3 ubiquitin transferase UBR4;Retinoblastoma-associated factor of 600 kDa;Zinc finger UBR1-type protein 1;, PF13764;PF02207;, GO:0005813;GO:0005829;GO:0101003;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0035579;GO:0070821;GO:0005516;GO:0061630;GO:0004842;GO:0008270;GO:0043312;GO:0006511;GO:0016032;, C:centrosome; C:cytosol; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:calmodulin binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:neutrophil degranulation; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold77 indexed_genome mRNA 124299 136115 . + . ID=transcript_11794;Q6P656 Q8N906,Cilia- and flagella-associated protein 161 {ECO:0000312|HGNC:HGNC:26782} scaffold77 indexed_genome mRNA 170244 279816 . + . ID=transcript_11795;Q9UP18,Pro-interleukin-16,, PF00595;, GO:0005829;GO:0005576;GO:0005615;GO:0090543;GO:0005925;GO:0016607;GO:0005886;GO:0042609;GO:0005125;GO:0019221;GO:0006955;GO:0050930;GO:0030595;GO:0050729;GO:0032730;GO:0032735;GO:0032755;GO:1902565;GO:0051924;GO:0016032;, C:cytosol; C:extracellular region; C:extracellular space; C:Flemming body; C:focal adhesion; C:nuclear speck; C:plasma membrane;, F:CD4 receptor binding; F:cytokine activity;, P:cytokine-mediated signaling pathway; P:immune response; P:induction of positive chemotaxis; P:leukocyte chemotaxis; P:positive regulation of inflammatory response; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of neutrophil activation; P:regulation of calcium ion transport; P:viral process;|Q9UP18,Pro-interleukin-16,, PF00595;, GO:0005829;GO:0005576;GO:0005615;GO:0090543;GO:0005925;GO:0016607;GO:0005886;GO:0042609;GO:0005125;GO:0019221;GO:0006955;GO:0050930;GO:0030595;GO:0050729;GO:0032730;GO:0032735;GO:0032755;GO:1902565;GO:0051924;GO:0016032;, C:cytosol; C:extracellular region; C:extracellular space; C:Flemming body; C:focal adhesion; C:nuclear speck; C:plasma membrane;, F:CD4 receptor binding; F:cytokine activity;, P:cytokine-mediated signaling pathway; P:immune response; P:induction of positive chemotaxis; P:leukocyte chemotaxis; P:positive regulation of inflammatory response; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of neutrophil activation; P:regulation of calcium ion transport; P:viral process;|Q9UP18,Pro-interleukin-16,, PF00595;, GO:0005829;GO:0005576;GO:0005615;GO:0090543;GO:0005925;GO:0016607;GO:0005886;GO:0042609;GO:0005125;GO:0019221;GO:0006955;GO:0050930;GO:0030595;GO:0050729;GO:0032730;GO:0032735;GO:0032755;GO:1902565;GO:0051924;GO:0016032;, C:cytosol; C:extracellular region; C:extracellular space; C:Flemming body; C:focal adhesion; C:nuclear speck; C:plasma membrane;, F:CD4 receptor binding; F:cytokine activity;, P:cytokine-mediated signaling pathway; P:immune response; P:induction of positive chemotaxis; P:leukocyte chemotaxis; P:positive regulation of inflammatory response; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of neutrophil activation; P:regulation of calcium ion transport; P:viral process;|Q9UP18,Pro-interleukin-16,, PF00595;, GO:0005829;GO:0005576;GO:0005615;GO:0090543;GO:0005925;GO:0016607;GO:0005886;GO:0042609;GO:0005125;GO:0019221;GO:0006955;GO:0050930;GO:0030595;GO:0050729;GO:0032730;GO:0032735;GO:0032755;GO:1902565;GO:0051924;GO:0016032;, C:cytosol; C:extracellular region; C:extracellular space; C:Flemming body; C:focal adhesion; C:nuclear speck; C:plasma membrane;, F:CD4 receptor binding; F:cytokine activity;, P:cytokine-mediated signaling pathway; P:immune response; P:induction of positive chemotaxis; P:leukocyte chemotaxis; P:positive regulation of inflammatory response; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of neutrophil activation; P:regulation of calcium ion transport; P:viral process;|Q9UP18,Pro-interleukin-16,, PF00595;, GO:0005829;GO:0005576;GO:0005615;GO:0090543;GO:0005925;GO:0016607;GO:0005886;GO:0042609;GO:0005125;GO:0019221;GO:0006955;GO:0050930;GO:0030595;GO:0050729;GO:0032730;GO:0032735;GO:0032755;GO:1902565;GO:0051924;GO:0016032;, C:cytosol; C:extracellular region; C:extracellular space; C:Flemming body; C:focal adhesion; C:nuclear speck; C:plasma membrane;, F:CD4 receptor binding; F:cytokine activity;, P:cytokine-mediated signaling pathway; P:immune response; P:induction of positive chemotaxis; P:leukocyte chemotaxis; P:positive regulation of inflammatory response; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of neutrophil activation; P:regulation of calcium ion transport; P:viral process;|Q9UP18,Pro-interleukin-16,, PF00595;, GO:0005829;GO:0005576;GO:0005615;GO:0090543;GO:0005925;GO:0016607;GO:0005886;GO:0042609;GO:0005125;GO:0019221;GO:0006955;GO:0050930;GO:0030595;GO:0050729;GO:0032730;GO:0032735;GO:0032755;GO:1902565;GO:0051924;GO:0016032;, C:cytosol; C:extracellular region; C:extracellular space; C:Flemming body; C:focal adhesion; C:nuclear speck; C:plasma membrane;, F:CD4 receptor binding; F:cytokine activity;, P:cytokine-mediated signaling pathway; P:immune response; P:induction of positive chemotaxis; P:leukocyte chemotaxis; P:positive regulation of inflammatory response; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of neutrophil activation; P:regulation of calcium ion transport; P:viral process;|Q9UP18,Pro-interleukin-16,, PF00595;, GO:0005829;GO:0005576;GO:0005615;GO:0090543;GO:0005925;GO:0016607;GO:0005886;GO:0042609;GO:0005125;GO:0019221;GO:0006955;GO:0050930;GO:0030595;GO:0050729;GO:0032730;GO:0032735;GO:0032755;GO:1902565;GO:0051924;GO:0016032;, C:cytosol; C:extracellular region; C:extracellular space; C:Flemming body; C:focal adhesion; C:nuclear speck; C:plasma membrane;, F:CD4 receptor binding; F:cytokine activity;, P:cytokine-mediated signaling pathway; P:immune response; P:induction of positive chemotaxis; P:leukocyte chemotaxis; P:positive regulation of inflammatory response; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of neutrophil activation; P:regulation of calcium ion transport; P:viral process;|Q9UP18,Pro-interleukin-16,, PF00595;, GO:0005829;GO:0005576;GO:0005615;GO:0090543;GO:0005925;GO:0016607;GO:0005886;GO:0042609;GO:0005125;GO:0019221;GO:0006955;GO:0050930;GO:0030595;GO:0050729;GO:0032730;GO:0032735;GO:0032755;GO:1902565;GO:0051924;GO:0016032;, C:cytosol; C:extracellular region; C:extracellular space; C:Flemming body; C:focal adhesion; C:nuclear speck; C:plasma membrane;, F:CD4 receptor binding; F:cytokine activity;, P:cytokine-mediated signaling pathway; P:immune response; P:induction of positive chemotaxis; P:leukocyte chemotaxis; P:positive regulation of inflammatory response; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of neutrophil activation; P:regulation of calcium ion transport; P:viral process;|Q9NSY2 P59094,StAR-related lipid transfer protein 5,START domain-containing protein 5;, PF01852;, GO:0005829;GO:0032052;GO:0015485;GO:0120020;GO:0015721;GO:0070508;, C:cytosol;, F:bile acid binding; F:cholesterol binding; F:cholesterol transfer activity;, P:bile acid and bile salt transport; P:cholesterol import; scaffold77 indexed_genome mRNA 286507 291345 . - . ID=transcript_11796;Q7Z5M5 A2RTY2 B2RXJ3 Q7Z405,Transmembrane channel-like protein 3,, PF07810;, GO:0005887;GO:0008381;, C:integral component of plasma membrane;, F:mechanosensitive ion channel activity; scaffold77 indexed_genome mRNA 300033 304162 . - . ID=transcript_11797;Q7Z5M5 A2RTY2 B2RXJ3 Q7Z405,Transmembrane channel-like protein 3,, PF07810;, GO:0005887;GO:0008381;, C:integral component of plasma membrane;, F:mechanosensitive ion channel activity; scaffold77 indexed_genome mRNA 310866 316906 . - . ID=transcript_11798;Q7Z5M5 A2RTY2 B2RXJ3 Q7Z405,Transmembrane channel-like protein 3,, PF07810;, GO:0005887;GO:0008381;, C:integral component of plasma membrane;, F:mechanosensitive ion channel activity; scaffold77 indexed_genome mRNA 317746 319153 . - . ID=transcript_11799;Q7Z5M5 A2RTY2 B2RXJ3 Q7Z405,Transmembrane channel-like protein 3,, PF07810;, GO:0005887;GO:0008381;, C:integral component of plasma membrane;, F:mechanosensitive ion channel activity; scaffold77 indexed_genome mRNA 608946 630291 . - . ID=transcript_11800;Q96PE7 Q53TP1 Q8WW63,Methylmalonyl-CoA epimerase, mitochondrial {ECO:0000305},DL-methylmalonyl-CoA racemase {ECO:0000303|PubMed:11481338};, , GO:0005759;GO:0046872;GO:0004493;GO:0046491;GO:0019626;, C:mitochondrial matrix;, F:metal ion binding; F:methylmalonyl-CoA epimerase activity;, P:L-methylmalonyl-CoA metabolic process; P:short-chain fatty acid catabolic process;|O00566 A0AVJ8,U3 small nucleolar ribonucleoprotein protein MPP10,M phase phosphoprotein 10;, PF04006;, GO:0005694;GO:0034457;GO:0005730;GO:0005654;GO:0032040;GO:0005732;GO:0003723;GO:0010923;GO:0006396;GO:0008380;GO:0000375;GO:0006364;, C:chromosome; C:Mpp10 complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:RNA binding;, P:negative regulation of phosphatase activity; P:RNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:rRNA processing;|O00566 A0AVJ8,U3 small nucleolar ribonucleoprotein protein MPP10,M phase phosphoprotein 10;, PF04006;, GO:0005694;GO:0034457;GO:0005730;GO:0005654;GO:0032040;GO:0005732;GO:0003723;GO:0010923;GO:0006396;GO:0008380;GO:0000375;GO:0006364;, C:chromosome; C:Mpp10 complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:RNA binding;, P:negative regulation of phosphatase activity; P:RNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:rRNA processing;|O00566 A0AVJ8,U3 small nucleolar ribonucleoprotein protein MPP10,M phase phosphoprotein 10;, PF04006;, GO:0005694;GO:0034457;GO:0005730;GO:0005654;GO:0032040;GO:0005732;GO:0003723;GO:0010923;GO:0006396;GO:0008380;GO:0000375;GO:0006364;, C:chromosome; C:Mpp10 complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:RNA binding;, P:negative regulation of phosphatase activity; P:RNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:rRNA processing; scaffold77 indexed_genome mRNA 633897 654890 . + . ID=transcript_11801;Q9Y2M0 A8K4M2 Q86WU8,Fanconi-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156},FANCD2/FANCI-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156};Myotubularin-related protein 15;, PF08774;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0008409;GO:0017108;GO:0070336;GO:0000287;GO:0004528;GO:0140036;GO:0006281;GO:0000724;GO:0036297;GO:0006289;GO:0033683;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:5'-3' exonuclease activity; F:5'-flap endonuclease activity; F:flap-structured DNA binding; F:magnesium ion binding; F:phosphodiesterase I activity; F:ubiquitin-dependent protein binding;, P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision;|Q9Y2M0 A8K4M2 Q86WU8,Fanconi-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156},FANCD2/FANCI-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156};Myotubularin-related protein 15;, PF08774;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0008409;GO:0017108;GO:0070336;GO:0000287;GO:0004528;GO:0140036;GO:0006281;GO:0000724;GO:0036297;GO:0006289;GO:0033683;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:5'-3' exonuclease activity; F:5'-flap endonuclease activity; F:flap-structured DNA binding; F:magnesium ion binding; F:phosphodiesterase I activity; F:ubiquitin-dependent protein binding;, P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision;|Q9Y2M0 A8K4M2 Q86WU8,Fanconi-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156},FANCD2/FANCI-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156};Myotubularin-related protein 15;, PF08774;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0008409;GO:0017108;GO:0070336;GO:0000287;GO:0004528;GO:0140036;GO:0006281;GO:0000724;GO:0036297;GO:0006289;GO:0033683;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:5'-3' exonuclease activity; F:5'-flap endonuclease activity; F:flap-structured DNA binding; F:magnesium ion binding; F:phosphodiesterase I activity; F:ubiquitin-dependent protein binding;, P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision;|Q9Y2M0 A8K4M2 Q86WU8,Fanconi-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156},FANCD2/FANCI-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156};Myotubularin-related protein 15;, PF08774;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0008409;GO:0017108;GO:0070336;GO:0000287;GO:0004528;GO:0140036;GO:0006281;GO:0000724;GO:0036297;GO:0006289;GO:0033683;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:5'-3' exonuclease activity; F:5'-flap endonuclease activity; F:flap-structured DNA binding; F:magnesium ion binding; F:phosphodiesterase I activity; F:ubiquitin-dependent protein binding;, P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision;|Q9Y2M0 A8K4M2 Q86WU8,Fanconi-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156},FANCD2/FANCI-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156};Myotubularin-related protein 15;, PF08774;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0008409;GO:0017108;GO:0070336;GO:0000287;GO:0004528;GO:0140036;GO:0006281;GO:0000724;GO:0036297;GO:0006289;GO:0033683;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:5'-3' exonuclease activity; F:5'-flap endonuclease activity; F:flap-structured DNA binding; F:magnesium ion binding; F:phosphodiesterase I activity; F:ubiquitin-dependent protein binding;, P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision;|Q9Y2M0 A8K4M2 Q86WU8,Fanconi-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156},FANCD2/FANCI-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156};Myotubularin-related protein 15;, PF08774;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0008409;GO:0017108;GO:0070336;GO:0000287;GO:0004528;GO:0140036;GO:0006281;GO:0000724;GO:0036297;GO:0006289;GO:0033683;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:5'-3' exonuclease activity; F:5'-flap endonuclease activity; F:flap-structured DNA binding; F:magnesium ion binding; F:phosphodiesterase I activity; F:ubiquitin-dependent protein binding;, P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision;|Q9Y2M0 A8K4M2 Q86WU8,Fanconi-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156},FANCD2/FANCI-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156};Myotubularin-related protein 15;, PF08774;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0008409;GO:0017108;GO:0070336;GO:0000287;GO:0004528;GO:0140036;GO:0006281;GO:0000724;GO:0036297;GO:0006289;GO:0033683;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:5'-3' exonuclease activity; F:5'-flap endonuclease activity; F:flap-structured DNA binding; F:magnesium ion binding; F:phosphodiesterase I activity; F:ubiquitin-dependent protein binding;, P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; scaffold77 indexed_genome mRNA 654900 657016 . + . ID=transcript_11802;Q9Y2M0 A8K4M2 Q86WU8,Fanconi-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156},FANCD2/FANCI-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156};Myotubularin-related protein 15;, PF08774;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0008409;GO:0017108;GO:0070336;GO:0000287;GO:0004528;GO:0140036;GO:0006281;GO:0000724;GO:0036297;GO:0006289;GO:0033683;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:5'-3' exonuclease activity; F:5'-flap endonuclease activity; F:flap-structured DNA binding; F:magnesium ion binding; F:phosphodiesterase I activity; F:ubiquitin-dependent protein binding;, P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision;|Q9Y2M0 A8K4M2 Q86WU8,Fanconi-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156},FANCD2/FANCI-associated nuclease 1 {ECO:0000303|PubMed:20603015, ECO:0000303|PubMed:20603016, ECO:0000303|PubMed:20671156};Myotubularin-related protein 15;, PF08774;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0008409;GO:0017108;GO:0070336;GO:0000287;GO:0004528;GO:0140036;GO:0006281;GO:0000724;GO:0036297;GO:0006289;GO:0033683;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:5'-3' exonuclease activity; F:5'-flap endonuclease activity; F:flap-structured DNA binding; F:magnesium ion binding; F:phosphodiesterase I activity; F:ubiquitin-dependent protein binding;, P:DNA repair; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; scaffold77 indexed_genome mRNA 657520 662049 . + . ID=transcript_11803;Q9NXD2 Q6P4Q6,Myotubularin-related protein 10,Inactive phosphatidylinositol 3-phosphatase 10 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0004438;GO:0046856;, C:cytoplasm; C:cytosol;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation; scaffold77 indexed_genome mRNA 662529 663534 . + . ID=transcript_11804;Q9NXD2 Q6P4Q6,Myotubularin-related protein 10,Inactive phosphatidylinositol 3-phosphatase 10 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0004438;GO:0046856;, C:cytoplasm; C:cytosol;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation; scaffold77 indexed_genome mRNA 663726 695657 . - . ID=transcript_11805;Q9NXD2 Q6P4Q6,Myotubularin-related protein 10,Inactive phosphatidylinositol 3-phosphatase 10 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0004438;GO:0046856;, C:cytoplasm; C:cytosol;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation;|Q9NXD2 Q6P4Q6,Myotubularin-related protein 10,Inactive phosphatidylinositol 3-phosphatase 10 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0004438;GO:0046856;, C:cytoplasm; C:cytosol;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation;|Q9NXD2 Q6P4Q6,Myotubularin-related protein 10,Inactive phosphatidylinositol 3-phosphatase 10 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0004438;GO:0046856;, C:cytoplasm; C:cytosol;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation;|Q9NXD2 Q6P4Q6,Myotubularin-related protein 10,Inactive phosphatidylinositol 3-phosphatase 10 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0004438;GO:0046856;, C:cytoplasm; C:cytosol;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation;|Q9NXD2 Q6P4Q6,Myotubularin-related protein 10,Inactive phosphatidylinositol 3-phosphatase 10 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0005829;GO:0004438;GO:0046856;, C:cytoplasm; C:cytosol;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation; scaffold77 indexed_genome mRNA 714440 714971 . + . ID=transcript_11806;Q7Z4N4 Q7Z4N5,Transient receptor potential cation channel subfamily M member 1,Long transient receptor potential channel 1;Melastatin-1;, PF00520;PF18139;PF16519;, GO:0030424;GO:0005789;GO:0005887;GO:0005886;GO:0005262;GO:0005261;GO:0070588;GO:0060402;GO:0098655;GO:0071482;GO:0007216;GO:0030001;GO:0051262;GO:0007601;, C:axon; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium channel activity; F:cation channel activity;, P:calcium ion transmembrane transport; P:calcium ion transport into cytosol; P:cation transmembrane transport; P:cellular response to light stimulus; P:G protein-coupled glutamate receptor signaling pathway; P:metal ion transport; P:protein tetramerization; P:visual perception; scaffold77 indexed_genome mRNA 933063 938782 . + . ID=transcript_11807;Q9Y2Y9 Q9Y356,Krueppel-like factor 13,Basic transcription element-binding protein 3;Novel Sp1-like zinc finger transcription factor 1;RANTES factor of late activated T-lymphocytes 1;Transcription factor BTEB3;Transcription factor NSLP1;, PF00096;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0008285;GO:0045647;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of cell population proliferation; P:negative regulation of erythrocyte differentiation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold77 indexed_genome mRNA 1022398 1026965 . + . ID=transcript_11808;P15880 B2R5G0 D3DU82 Q3MIB1,40S ribosomal protein S2,40S ribosomal protein S4;Protein LLRep3;Small ribosomal subunit protein uS5 {ECO:0000303|PubMed:24524803};, PF00333;PF03719;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0045296;GO:0019899;GO:0017134;GO:0003729;GO:0003723;GO:0003735;GO:0000184;GO:0051443;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus;, F:cadherin binding; F:enzyme binding; F:fibroblast growth factor binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of ubiquitin-protein transferase activity; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P15880 B2R5G0 D3DU82 Q3MIB1,40S ribosomal protein S2,40S ribosomal protein S4;Protein LLRep3;Small ribosomal subunit protein uS5 {ECO:0000303|PubMed:24524803};, PF00333;PF03719;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0045296;GO:0019899;GO:0017134;GO:0003729;GO:0003723;GO:0003735;GO:0000184;GO:0051443;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus;, F:cadherin binding; F:enzyme binding; F:fibroblast growth factor binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of ubiquitin-protein transferase activity; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold77 indexed_genome mRNA 1108356 1112174 . + . ID=transcript_11809;P13693 B2R7E5 Q6YLS2 Q7Z4J4 Q8TBK7 Q96EE2 Q9UC70,Translationally-controlled tumor protein,Fortilin;Histamine-releasing factor;p23;, PF00838;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0005615;GO:0005771;GO:0005634;GO:0000922;GO:0005509;GO:0003723;GO:0006816;GO:0006874;GO:0043066;GO:1902230;GO:0042981;GO:0009615;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extracellular space; C:multivesicular body; C:nucleus; C:spindle pole;, F:calcium ion binding; F:RNA binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:regulation of apoptotic process; P:response to virus;|P13693 B2R7E5 Q6YLS2 Q7Z4J4 Q8TBK7 Q96EE2 Q9UC70,Translationally-controlled tumor protein,Fortilin;Histamine-releasing factor;p23;, PF00838;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0005615;GO:0005771;GO:0005634;GO:0000922;GO:0005509;GO:0003723;GO:0006816;GO:0006874;GO:0043066;GO:1902230;GO:0042981;GO:0009615;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extracellular space; C:multivesicular body; C:nucleus; C:spindle pole;, F:calcium ion binding; F:RNA binding;, P:calcium ion transport; P:cellular calcium ion homeostasis; P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:regulation of apoptotic process; P:response to virus; scaffold77 indexed_genome mRNA 1196624 1299241 . + . ID=transcript_11810;Q99767 E9PGI4 O60571 Q5XKC0,Amyloid-beta A4 precursor protein-binding family A member 2,Adapter protein X11beta;Neuron-specific X11L protein;Neuronal Munc18-1-interacting protein 2;, PF00595;PF00640;, GO:0005737;GO:0043197;GO:0005886;GO:0008021;GO:0001540;GO:0042802;GO:0007268;GO:0007399;GO:0015031;, C:cytoplasm; C:dendritic spine; C:plasma membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:identical protein binding;, P:chemical synaptic transmission; P:nervous system development; P:protein transport; scaffold77 indexed_genome mRNA 1317386 1334443 . + . ID=transcript_11811;Q99767 E9PGI4 O60571 Q5XKC0,Amyloid-beta A4 precursor protein-binding family A member 2,Adapter protein X11beta;Neuron-specific X11L protein;Neuronal Munc18-1-interacting protein 2;, PF00595;PF00640;, GO:0005737;GO:0043197;GO:0005886;GO:0008021;GO:0001540;GO:0042802;GO:0007268;GO:0007399;GO:0015031;, C:cytoplasm; C:dendritic spine; C:plasma membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:identical protein binding;, P:chemical synaptic transmission; P:nervous system development; P:protein transport;|Q99767 E9PGI4 O60571 Q5XKC0,Amyloid-beta A4 precursor protein-binding family A member 2,Adapter protein X11beta;Neuron-specific X11L protein;Neuronal Munc18-1-interacting protein 2;, PF00595;PF00640;, GO:0005737;GO:0043197;GO:0005886;GO:0008021;GO:0001540;GO:0042802;GO:0007268;GO:0007399;GO:0015031;, C:cytoplasm; C:dendritic spine; C:plasma membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:identical protein binding;, P:chemical synaptic transmission; P:nervous system development; P:protein transport;|Q99767 E9PGI4 O60571 Q5XKC0,Amyloid-beta A4 precursor protein-binding family A member 2,Adapter protein X11beta;Neuron-specific X11L protein;Neuronal Munc18-1-interacting protein 2;, PF00595;PF00640;, GO:0005737;GO:0043197;GO:0005886;GO:0008021;GO:0001540;GO:0042802;GO:0007268;GO:0007399;GO:0015031;, C:cytoplasm; C:dendritic spine; C:plasma membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:identical protein binding;, P:chemical synaptic transmission; P:nervous system development; P:protein transport;|Q99767 E9PGI4 O60571 Q5XKC0,Amyloid-beta A4 precursor protein-binding family A member 2,Adapter protein X11beta;Neuron-specific X11L protein;Neuronal Munc18-1-interacting protein 2;, PF00595;PF00640;, GO:0005737;GO:0043197;GO:0005886;GO:0008021;GO:0001540;GO:0042802;GO:0007268;GO:0007399;GO:0015031;, C:cytoplasm; C:dendritic spine; C:plasma membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:identical protein binding;, P:chemical synaptic transmission; P:nervous system development; P:protein transport;|Q99767 E9PGI4 O60571 Q5XKC0,Amyloid-beta A4 precursor protein-binding family A member 2,Adapter protein X11beta;Neuron-specific X11L protein;Neuronal Munc18-1-interacting protein 2;, PF00595;PF00640;, GO:0005737;GO:0043197;GO:0005886;GO:0008021;GO:0001540;GO:0042802;GO:0007268;GO:0007399;GO:0015031;, C:cytoplasm; C:dendritic spine; C:plasma membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:identical protein binding;, P:chemical synaptic transmission; P:nervous system development; P:protein transport;|Q99767 E9PGI4 O60571 Q5XKC0,Amyloid-beta A4 precursor protein-binding family A member 2,Adapter protein X11beta;Neuron-specific X11L protein;Neuronal Munc18-1-interacting protein 2;, PF00595;PF00640;, GO:0005737;GO:0043197;GO:0005886;GO:0008021;GO:0001540;GO:0042802;GO:0007268;GO:0007399;GO:0015031;, C:cytoplasm; C:dendritic spine; C:plasma membrane; C:synaptic vesicle;, F:amyloid-beta binding; F:identical protein binding;, P:chemical synaptic transmission; P:nervous system development; P:protein transport; scaffold77 indexed_genome mRNA 1398339 1400402 . - . ID=transcript_11812;Q96MG7 Q8IW16 Q8TEI6 Q9H214,Non-structural maintenance of chromosomes element 3 homolog,Hepatocellular carcinoma-associated protein 4;MAGE-G1 antigen;Melanoma-associated antigen G1;Necdin-like protein 2;, PF01454;, GO:0000781;GO:0005737;GO:0005654;GO:0030915;GO:0046983;GO:0072711;GO:0071478;GO:0034644;GO:0006310;GO:0006281;GO:0031398;GO:0040008;, C:chromosome, telomeric region; C:cytoplasm; C:nucleoplasm; C:Smc5-Smc6 complex;, F:protein dimerization activity;, P:cellular response to hydroxyurea; P:cellular response to radiation; P:cellular response to UV; P:DNA recombination; P:DNA repair; P:positive regulation of protein ubiquitination; P:regulation of growth; scaffold77 indexed_genome mRNA 1639206 1655881 . - . ID=transcript_11813;Q07157 B4E3K1 Q2NKP3 Q4ZGJ6,Tight junction protein ZO-1,Tight junction protein 1;Zona occludens protein 1;Zonula occludens protein 1;, PF00625;PF00595;PF07653;PF00791;, GO:0005912;GO:0043296;GO:0045177;GO:0016323;GO:0005923;GO:0030054;GO:0042995;GO:0005737;GO:0005829;GO:0005921;GO:0005886;GO:0002102;GO:0032991;GO:0070160;GO:0045296;GO:0005516;GO:0050839;GO:0031032;GO:0034334;GO:0098609;GO:0007043;GO:0045216;GO:0090557;GO:0035329;GO:0035633;GO:2000250;GO:0043066;GO:0051497;GO:1905605;GO:0030335;GO:0008284;GO:2000049;GO:1903672;GO:0071896;GO:1902396;GO:0150105;GO:2000810;GO:1901888;GO:0051493;, C:adherens junction; C:apical junction complex; C:apical part of cell; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection; C:cytoplasm; C:cytosol; C:gap junction; C:plasma membrane; C:podosome; C:protein-containing complex; C:tight junction;, F:cadherin binding; F:calmodulin binding; F:cell adhesion molecule binding;, P:actomyosin structure organization; P:adherens junction maintenance; P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:maintenance of blood-brain barrier; P:negative regulation of actin cytoskeleton reorganization; P:negative regulation of apoptotic process; P:negative regulation of stress fiber assembly; P:positive regulation of blood-brain barrier permeability; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of sprouting angiogenesis; P:protein localization to adherens junction; P:protein localization to bicellular tight junction; P:protein localization to cell-cell junction; P:regulation of bicellular tight junction assembly; P:regulation of cell junction assembly; P:regulation of cytoskeleton organization;|Q07157 B4E3K1 Q2NKP3 Q4ZGJ6,Tight junction protein ZO-1,Tight junction protein 1;Zona occludens protein 1;Zonula occludens protein 1;, PF00625;PF00595;PF07653;PF00791;, GO:0005912;GO:0043296;GO:0045177;GO:0016323;GO:0005923;GO:0030054;GO:0042995;GO:0005737;GO:0005829;GO:0005921;GO:0005886;GO:0002102;GO:0032991;GO:0070160;GO:0045296;GO:0005516;GO:0050839;GO:0031032;GO:0034334;GO:0098609;GO:0007043;GO:0045216;GO:0090557;GO:0035329;GO:0035633;GO:2000250;GO:0043066;GO:0051497;GO:1905605;GO:0030335;GO:0008284;GO:2000049;GO:1903672;GO:0071896;GO:1902396;GO:0150105;GO:2000810;GO:1901888;GO:0051493;, C:adherens junction; C:apical junction complex; C:apical part of cell; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection; C:cytoplasm; C:cytosol; C:gap junction; C:plasma membrane; C:podosome; C:protein-containing complex; C:tight junction;, F:cadherin binding; F:calmodulin binding; F:cell adhesion molecule binding;, P:actomyosin structure organization; P:adherens junction maintenance; P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:maintenance of blood-brain barrier; P:negative regulation of actin cytoskeleton reorganization; P:negative regulation of apoptotic process; P:negative regulation of stress fiber assembly; P:positive regulation of blood-brain barrier permeability; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of sprouting angiogenesis; P:protein localization to adherens junction; P:protein localization to bicellular tight junction; P:protein localization to cell-cell junction; P:regulation of bicellular tight junction assembly; P:regulation of cell junction assembly; P:regulation of cytoskeleton organization;|Q07157 B4E3K1 Q2NKP3 Q4ZGJ6,Tight junction protein ZO-1,Tight junction protein 1;Zona occludens protein 1;Zonula occludens protein 1;, PF00625;PF00595;PF07653;PF00791;, GO:0005912;GO:0043296;GO:0045177;GO:0016323;GO:0005923;GO:0030054;GO:0042995;GO:0005737;GO:0005829;GO:0005921;GO:0005886;GO:0002102;GO:0032991;GO:0070160;GO:0045296;GO:0005516;GO:0050839;GO:0031032;GO:0034334;GO:0098609;GO:0007043;GO:0045216;GO:0090557;GO:0035329;GO:0035633;GO:2000250;GO:0043066;GO:0051497;GO:1905605;GO:0030335;GO:0008284;GO:2000049;GO:1903672;GO:0071896;GO:1902396;GO:0150105;GO:2000810;GO:1901888;GO:0051493;, C:adherens junction; C:apical junction complex; C:apical part of cell; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection; C:cytoplasm; C:cytosol; C:gap junction; C:plasma membrane; C:podosome; C:protein-containing complex; C:tight junction;, F:cadherin binding; F:calmodulin binding; F:cell adhesion molecule binding;, P:actomyosin structure organization; P:adherens junction maintenance; P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:maintenance of blood-brain barrier; P:negative regulation of actin cytoskeleton reorganization; P:negative regulation of apoptotic process; P:negative regulation of stress fiber assembly; P:positive regulation of blood-brain barrier permeability; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of sprouting angiogenesis; P:protein localization to adherens junction; P:protein localization to bicellular tight junction; P:protein localization to cell-cell junction; P:regulation of bicellular tight junction assembly; P:regulation of cell junction assembly; P:regulation of cytoskeleton organization;|Q07157 B4E3K1 Q2NKP3 Q4ZGJ6,Tight junction protein ZO-1,Tight junction protein 1;Zona occludens protein 1;Zonula occludens protein 1;, PF00625;PF00595;PF07653;PF00791;, GO:0005912;GO:0043296;GO:0045177;GO:0016323;GO:0005923;GO:0030054;GO:0042995;GO:0005737;GO:0005829;GO:0005921;GO:0005886;GO:0002102;GO:0032991;GO:0070160;GO:0045296;GO:0005516;GO:0050839;GO:0031032;GO:0034334;GO:0098609;GO:0007043;GO:0045216;GO:0090557;GO:0035329;GO:0035633;GO:2000250;GO:0043066;GO:0051497;GO:1905605;GO:0030335;GO:0008284;GO:2000049;GO:1903672;GO:0071896;GO:1902396;GO:0150105;GO:2000810;GO:1901888;GO:0051493;, C:adherens junction; C:apical junction complex; C:apical part of cell; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection; C:cytoplasm; C:cytosol; C:gap junction; C:plasma membrane; C:podosome; C:protein-containing complex; C:tight junction;, F:cadherin binding; F:calmodulin binding; F:cell adhesion molecule binding;, P:actomyosin structure organization; P:adherens junction maintenance; P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:maintenance of blood-brain barrier; P:negative regulation of actin cytoskeleton reorganization; P:negative regulation of apoptotic process; P:negative regulation of stress fiber assembly; P:positive regulation of blood-brain barrier permeability; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of sprouting angiogenesis; P:protein localization to adherens junction; P:protein localization to bicellular tight junction; P:protein localization to cell-cell junction; P:regulation of bicellular tight junction assembly; P:regulation of cell junction assembly; P:regulation of cytoskeleton organization;|Q07157 B4E3K1 Q2NKP3 Q4ZGJ6,Tight junction protein ZO-1,Tight junction protein 1;Zona occludens protein 1;Zonula occludens protein 1;, PF00625;PF00595;PF07653;PF00791;, GO:0005912;GO:0043296;GO:0045177;GO:0016323;GO:0005923;GO:0030054;GO:0042995;GO:0005737;GO:0005829;GO:0005921;GO:0005886;GO:0002102;GO:0032991;GO:0070160;GO:0045296;GO:0005516;GO:0050839;GO:0031032;GO:0034334;GO:0098609;GO:0007043;GO:0045216;GO:0090557;GO:0035329;GO:0035633;GO:2000250;GO:0043066;GO:0051497;GO:1905605;GO:0030335;GO:0008284;GO:2000049;GO:1903672;GO:0071896;GO:1902396;GO:0150105;GO:2000810;GO:1901888;GO:0051493;, C:adherens junction; C:apical junction complex; C:apical part of cell; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection; C:cytoplasm; C:cytosol; C:gap junction; C:plasma membrane; C:podosome; C:protein-containing complex; C:tight junction;, F:cadherin binding; F:calmodulin binding; F:cell adhesion molecule binding;, P:actomyosin structure organization; P:adherens junction maintenance; P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:maintenance of blood-brain barrier; P:negative regulation of actin cytoskeleton reorganization; P:negative regulation of apoptotic process; P:negative regulation of stress fiber assembly; P:positive regulation of blood-brain barrier permeability; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of sprouting angiogenesis; P:protein localization to adherens junction; P:protein localization to bicellular tight junction; P:protein localization to cell-cell junction; P:regulation of bicellular tight junction assembly; P:regulation of cell junction assembly; P:regulation of cytoskeleton organization;|Q07157 B4E3K1 Q2NKP3 Q4ZGJ6,Tight junction protein ZO-1,Tight junction protein 1;Zona occludens protein 1;Zonula occludens protein 1;, PF00625;PF00595;PF07653;PF00791;, GO:0005912;GO:0043296;GO:0045177;GO:0016323;GO:0005923;GO:0030054;GO:0042995;GO:0005737;GO:0005829;GO:0005921;GO:0005886;GO:0002102;GO:0032991;GO:0070160;GO:0045296;GO:0005516;GO:0050839;GO:0031032;GO:0034334;GO:0098609;GO:0007043;GO:0045216;GO:0090557;GO:0035329;GO:0035633;GO:2000250;GO:0043066;GO:0051497;GO:1905605;GO:0030335;GO:0008284;GO:2000049;GO:1903672;GO:0071896;GO:1902396;GO:0150105;GO:2000810;GO:1901888;GO:0051493;, C:adherens junction; C:apical junction complex; C:apical part of cell; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection; C:cytoplasm; C:cytosol; C:gap junction; C:plasma membrane; C:podosome; C:protein-containing complex; C:tight junction;, F:cadherin binding; F:calmodulin binding; F:cell adhesion molecule binding;, P:actomyosin structure organization; P:adherens junction maintenance; P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:maintenance of blood-brain barrier; P:negative regulation of actin cytoskeleton reorganization; P:negative regulation of apoptotic process; P:negative regulation of stress fiber assembly; P:positive regulation of blood-brain barrier permeability; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of sprouting angiogenesis; P:protein localization to adherens junction; P:protein localization to bicellular tight junction; P:protein localization to cell-cell junction; P:regulation of bicellular tight junction assembly; P:regulation of cell junction assembly; P:regulation of cytoskeleton organization; scaffold77 indexed_genome mRNA 1657352 1759564 . - . ID=transcript_11814;Q07157 B4E3K1 Q2NKP3 Q4ZGJ6,Tight junction protein ZO-1,Tight junction protein 1;Zona occludens protein 1;Zonula occludens protein 1;, PF00625;PF00595;PF07653;PF00791;, GO:0005912;GO:0043296;GO:0045177;GO:0016323;GO:0005923;GO:0030054;GO:0042995;GO:0005737;GO:0005829;GO:0005921;GO:0005886;GO:0002102;GO:0032991;GO:0070160;GO:0045296;GO:0005516;GO:0050839;GO:0031032;GO:0034334;GO:0098609;GO:0007043;GO:0045216;GO:0090557;GO:0035329;GO:0035633;GO:2000250;GO:0043066;GO:0051497;GO:1905605;GO:0030335;GO:0008284;GO:2000049;GO:1903672;GO:0071896;GO:1902396;GO:0150105;GO:2000810;GO:1901888;GO:0051493;, C:adherens junction; C:apical junction complex; C:apical part of cell; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection; C:cytoplasm; C:cytosol; C:gap junction; C:plasma membrane; C:podosome; C:protein-containing complex; C:tight junction;, F:cadherin binding; F:calmodulin binding; F:cell adhesion molecule binding;, P:actomyosin structure organization; P:adherens junction maintenance; P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:maintenance of blood-brain barrier; P:negative regulation of actin cytoskeleton reorganization; P:negative regulation of apoptotic process; P:negative regulation of stress fiber assembly; P:positive regulation of blood-brain barrier permeability; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of sprouting angiogenesis; P:protein localization to adherens junction; P:protein localization to bicellular tight junction; P:protein localization to cell-cell junction; P:regulation of bicellular tight junction assembly; P:regulation of cell junction assembly; P:regulation of cytoskeleton organization;|Q07157 B4E3K1 Q2NKP3 Q4ZGJ6,Tight junction protein ZO-1,Tight junction protein 1;Zona occludens protein 1;Zonula occludens protein 1;, PF00625;PF00595;PF07653;PF00791;, GO:0005912;GO:0043296;GO:0045177;GO:0016323;GO:0005923;GO:0030054;GO:0042995;GO:0005737;GO:0005829;GO:0005921;GO:0005886;GO:0002102;GO:0032991;GO:0070160;GO:0045296;GO:0005516;GO:0050839;GO:0031032;GO:0034334;GO:0098609;GO:0007043;GO:0045216;GO:0090557;GO:0035329;GO:0035633;GO:2000250;GO:0043066;GO:0051497;GO:1905605;GO:0030335;GO:0008284;GO:2000049;GO:1903672;GO:0071896;GO:1902396;GO:0150105;GO:2000810;GO:1901888;GO:0051493;, C:adherens junction; C:apical junction complex; C:apical part of cell; C:basolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell projection; C:cytoplasm; C:cytosol; C:gap junction; C:plasma membrane; C:podosome; C:protein-containing complex; C:tight junction;, F:cadherin binding; F:calmodulin binding; F:cell adhesion molecule binding;, P:actomyosin structure organization; P:adherens junction maintenance; P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:hippo signaling; P:maintenance of blood-brain barrier; P:negative regulation of actin cytoskeleton reorganization; P:negative regulation of apoptotic process; P:negative regulation of stress fiber assembly; P:positive regulation of blood-brain barrier permeability; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of sprouting angiogenesis; P:protein localization to adherens junction; P:protein localization to bicellular tight junction; P:protein localization to cell-cell junction; P:regulation of bicellular tight junction assembly; P:regulation of cell junction assembly; P:regulation of cytoskeleton organization; scaffold77 indexed_genome mRNA 1992605 2035672 . + . ID=transcript_11815;A2RTX5 B2RMP7 Q6B0A1 Q6IS76 Q96LW3 Q96MP4,Threonine--tRNA ligase 2, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase protein 3;, PF03129;PF02824;PF00587;PF07973;, GO:0005737;GO:0005634;GO:0005524;GO:0004829;GO:0006435;, C:cytoplasm; C:nucleus;, F:ATP binding; F:threonine-tRNA ligase activity;, P:threonyl-tRNA aminoacylation;|A2RTX5 B2RMP7 Q6B0A1 Q6IS76 Q96LW3 Q96MP4,Threonine--tRNA ligase 2, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase protein 3;, PF03129;PF02824;PF00587;PF07973;, GO:0005737;GO:0005634;GO:0005524;GO:0004829;GO:0006435;, C:cytoplasm; C:nucleus;, F:ATP binding; F:threonine-tRNA ligase activity;, P:threonyl-tRNA aminoacylation;|A2RTX5 B2RMP7 Q6B0A1 Q6IS76 Q96LW3 Q96MP4,Threonine--tRNA ligase 2, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase protein 3;, PF03129;PF02824;PF00587;PF07973;, GO:0005737;GO:0005634;GO:0005524;GO:0004829;GO:0006435;, C:cytoplasm; C:nucleus;, F:ATP binding; F:threonine-tRNA ligase activity;, P:threonyl-tRNA aminoacylation;|A2RTX5 B2RMP7 Q6B0A1 Q6IS76 Q96LW3 Q96MP4,Threonine--tRNA ligase 2, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase protein 3;, PF03129;PF02824;PF00587;PF07973;, GO:0005737;GO:0005634;GO:0005524;GO:0004829;GO:0006435;, C:cytoplasm; C:nucleus;, F:ATP binding; F:threonine-tRNA ligase activity;, P:threonyl-tRNA aminoacylation;|A2RTX5 B2RMP7 Q6B0A1 Q6IS76 Q96LW3 Q96MP4,Threonine--tRNA ligase 2, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase protein 3;, PF03129;PF02824;PF00587;PF07973;, GO:0005737;GO:0005634;GO:0005524;GO:0004829;GO:0006435;, C:cytoplasm; C:nucleus;, F:ATP binding; F:threonine-tRNA ligase activity;, P:threonyl-tRNA aminoacylation;|A2RTX5 B2RMP7 Q6B0A1 Q6IS76 Q96LW3 Q96MP4,Threonine--tRNA ligase 2, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase protein 3;, PF03129;PF02824;PF00587;PF07973;, GO:0005737;GO:0005634;GO:0005524;GO:0004829;GO:0006435;, C:cytoplasm; C:nucleus;, F:ATP binding; F:threonine-tRNA ligase activity;, P:threonyl-tRNA aminoacylation;|A2RTX5 B2RMP7 Q6B0A1 Q6IS76 Q96LW3 Q96MP4,Threonine--tRNA ligase 2, cytoplasmic {ECO:0000305},Threonyl-tRNA synthetase;Threonyl-tRNA synthetase protein 3;, PF03129;PF02824;PF00587;PF07973;, GO:0005737;GO:0005634;GO:0005524;GO:0004829;GO:0006435;, C:cytoplasm; C:nucleus;, F:ATP binding; F:threonine-tRNA ligase activity;, P:threonyl-tRNA aminoacylation; scaffold77 indexed_genome mRNA 2042332 2054726 . + . ID=transcript_11816;Q9BRN9 B2RDK9 Q9H046 Q9H651,TM2 domain-containing protein 3,Beta-amyloid-binding protein-like protein 2;, PF05154;, GO:0044214;GO:0046331;GO:0045747;, C:spanning component of plasma membrane;, , P:lateral inhibition; P:positive regulation of Notch signaling pathway;|Q9BRN9 B2RDK9 Q9H046 Q9H651,TM2 domain-containing protein 3,Beta-amyloid-binding protein-like protein 2;, PF05154;, GO:0044214;GO:0046331;GO:0045747;, C:spanning component of plasma membrane;, , P:lateral inhibition; P:positive regulation of Notch signaling pathway; scaffold77 indexed_genome mRNA 2191520 2358022 . + . ID=transcript_11817;Q9Y4G9 Q9Y4H0 Q9Y4H1,Proprotein convertase subtilisin/kexin type 6,Paired basic amino acid cleaving enzyme 4;Subtilisin-like proprotein convertase 4;Subtilisin/kexin-like protease PACE4;, PF14843;PF01483;PF00082;PF08686;PF16470;, GO:0009986;GO:0062023;GO:0005783;GO:0005576;GO:0005615;GO:0005796;GO:0016020;GO:0005886;GO:0004175;GO:0008201;GO:0048406;GO:0004252;GO:0070268;GO:0009100;GO:0032455;GO:0032902;GO:0016486;GO:0016485;GO:0030510;GO:0051004;GO:0032940;, C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:Golgi lumen; C:membrane; C:plasma membrane;, F:endopeptidase activity; F:heparin binding; F:nerve growth factor binding; F:serine-type endopeptidase activity;, P:cornification; P:glycoprotein metabolic process; P:nerve growth factor processing; P:nerve growth factor production; P:peptide hormone processing; P:protein processing; P:regulation of BMP signaling pathway; P:regulation of lipoprotein lipase activity; P:secretion by cell; scaffold77 indexed_genome mRNA 2368098 2379689 . + . ID=transcript_11818;P09661 B2R5I6 Q8TBD2,U2 small nuclear ribonucleoprotein A',, , GO:0071013;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0030532;GO:0005681;GO:0005686;GO:0071007;GO:0071005;GO:0003723;GO:0030620;GO:0035722;GO:0000398;GO:0008380;GO:0007283;, C:catalytic step 2 spliceosome; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex; C:spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding; F:U2 snRNA binding;, P:interleukin-12-mediated signaling pathway; P:mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis;|P09661 B2R5I6 Q8TBD2,U2 small nuclear ribonucleoprotein A',, , GO:0071013;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0030532;GO:0005681;GO:0005686;GO:0071007;GO:0071005;GO:0003723;GO:0030620;GO:0035722;GO:0000398;GO:0008380;GO:0007283;, C:catalytic step 2 spliceosome; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex; C:spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding; F:U2 snRNA binding;, P:interleukin-12-mediated signaling pathway; P:mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis;|P09661 B2R5I6 Q8TBD2,U2 small nuclear ribonucleoprotein A',, , GO:0071013;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0030532;GO:0005681;GO:0005686;GO:0071007;GO:0071005;GO:0003723;GO:0030620;GO:0035722;GO:0000398;GO:0008380;GO:0007283;, C:catalytic step 2 spliceosome; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex; C:spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding; F:U2 snRNA binding;, P:interleukin-12-mediated signaling pathway; P:mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis;|P09661 B2R5I6 Q8TBD2,U2 small nuclear ribonucleoprotein A',, , GO:0071013;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0030532;GO:0005681;GO:0005686;GO:0071007;GO:0071005;GO:0003723;GO:0030620;GO:0035722;GO:0000398;GO:0008380;GO:0007283;, C:catalytic step 2 spliceosome; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex; C:spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding; F:U2 snRNA binding;, P:interleukin-12-mediated signaling pathway; P:mRNA splicing, via spliceosome; P:RNA splicing; P:spermatogenesis; scaffold77 indexed_genome mRNA 2724583 2844507 . - . ID=transcript_11819;P36544 A8K7Q4 B4DFS0 Q15826 Q8IUZ4 Q96RH2 Q99555 Q9BXH0,Neuronal acetylcholine receptor subunit alpha-7,, PF02931;PF02932;, GO:0005892;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0044853;GO:0098794;GO:0045211;GO:0045202;GO:0042166;GO:0015464;GO:0022848;GO:0001540;GO:0005262;GO:0017081;GO:0005216;GO:0030594;GO:0042803;GO:0015643;GO:0095500;GO:0000187;GO:0006816;GO:0006874;GO:0007268;GO:0050890;GO:0140059;GO:0097061;GO:0034220;GO:0006811;GO:0007611;GO:0007613;GO:0098815;GO:1902430;GO:0032720;GO:0050877;GO:1902004;GO:0045766;GO:0008284;GO:1905920;GO:0070374;GO:2000463;GO:1900273;GO:0051247;GO:0001934;GO:1905906;GO:1902991;GO:0042391;GO:1901214;GO:1905144;GO:1904645;GO:0001666;GO:0035094;GO:0050893;GO:0007614;GO:0007165;GO:0050808;GO:0007271;, C:acetylcholine-gated channel complex; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:plasma membrane raft; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:acetylcholine binding; F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:amyloid-beta binding; F:calcium channel activity; F:chloride channel regulator activity; F:ion channel activity; F:neurotransmitter receptor activity; F:protein homodimerization activity; F:toxic substance binding;, P:acetylcholine receptor signaling pathway; P:activation of MAPK activity; P:calcium ion transport; P:cellular calcium ion homeostasis; P:chemical synaptic transmission; P:cognition; P:dendrite arborization; P:dendritic spine organization; P:ion transmembrane transport; P:ion transport; P:learning or memory; P:memory; P:modulation of excitatory postsynaptic potential; P:negative regulation of amyloid-beta formation; P:negative regulation of tumor necrosis factor production; P:nervous system process; P:positive regulation of amyloid-beta formation; P:positive regulation of angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of CoA-transferase activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of long-term synaptic potentiation; P:positive regulation of protein metabolic process; P:positive regulation of protein phosphorylation; P:regulation of amyloid fibril formation; P:regulation of amyloid precursor protein catabolic process; P:regulation of membrane potential; P:regulation of neuron death; P:response to acetylcholine; P:response to amyloid-beta; P:response to hypoxia; P:response to nicotine; P:sensory processing; P:short-term memory; P:signal transduction; P:synapse organization; P:synaptic transmission, cholinergic; scaffold77 indexed_genome mRNA 3371245 3371779 . - . ID=transcript_11820;P60228 O43902 Q64058 Q64059 Q64252 Q6FG33 Q8WVK4,Eukaryotic translation initiation factor 3 subunit E {ECO:0000255|HAMAP-Rule:MF_03004},Eukaryotic translation initiation factor 3 subunit 6 {ECO:0000255|HAMAP-Rule:MF_03004};Viral integration site protein INT-6 homolog;eIF-3 p48 {ECO:0000255|HAMAP-Rule:MF_03004};, PF09440;PF01399;, GO:0005737;GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071540;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0016605;GO:0045296;GO:0047485;GO:0003723;GO:0003743;GO:0001732;GO:0045947;GO:0000184;GO:1902416;GO:0045727;GO:0006446;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:PML body;, F:cadherin binding; F:protein N-terminus binding; F:RNA binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:negative regulation of translational initiation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA binding; P:positive regulation of translation; P:regulation of translational initiation; P:translational initiation; scaffold77 indexed_genome mRNA 3471597 3516680 . + . ID=transcript_11821;Q9UKP4 Q14F51 Q6P7J9,A disintegrin and metalloproteinase with thrombospondin motifs 7,COMPase;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0005788;GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0071773;GO:0071347;GO:0071356;GO:0030198;GO:0032331;GO:0051603;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cellular response to BMP stimulus; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:extracellular matrix organization; P:negative regulation of chondrocyte differentiation; P:proteolysis involved in cellular protein catabolic process;|Q9UKP4 Q14F51 Q6P7J9,A disintegrin and metalloproteinase with thrombospondin motifs 7,COMPase;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0005788;GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0071773;GO:0071347;GO:0071356;GO:0030198;GO:0032331;GO:0051603;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cellular response to BMP stimulus; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:extracellular matrix organization; P:negative regulation of chondrocyte differentiation; P:proteolysis involved in cellular protein catabolic process;|Q9UKP4 Q14F51 Q6P7J9,A disintegrin and metalloproteinase with thrombospondin motifs 7,COMPase;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0005788;GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0071773;GO:0071347;GO:0071356;GO:0030198;GO:0032331;GO:0051603;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cellular response to BMP stimulus; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:extracellular matrix organization; P:negative regulation of chondrocyte differentiation; P:proteolysis involved in cellular protein catabolic process;|Q9UKP4 Q14F51 Q6P7J9,A disintegrin and metalloproteinase with thrombospondin motifs 7,COMPase;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0005788;GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0071773;GO:0071347;GO:0071356;GO:0030198;GO:0032331;GO:0051603;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cellular response to BMP stimulus; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:extracellular matrix organization; P:negative regulation of chondrocyte differentiation; P:proteolysis involved in cellular protein catabolic process;|Q9UKP4 Q14F51 Q6P7J9,A disintegrin and metalloproteinase with thrombospondin motifs 7,COMPase;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0005788;GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0071773;GO:0071347;GO:0071356;GO:0030198;GO:0032331;GO:0051603;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cellular response to BMP stimulus; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:extracellular matrix organization; P:negative regulation of chondrocyte differentiation; P:proteolysis involved in cellular protein catabolic process; scaffold77 indexed_genome mRNA 3516944 3527366 . + . ID=transcript_11822;Q9UKP4 Q14F51 Q6P7J9,A disintegrin and metalloproteinase with thrombospondin motifs 7,COMPase;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0005788;GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0071773;GO:0071347;GO:0071356;GO:0030198;GO:0032331;GO:0051603;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cellular response to BMP stimulus; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:extracellular matrix organization; P:negative regulation of chondrocyte differentiation; P:proteolysis involved in cellular protein catabolic process;|Q9UKP4 Q14F51 Q6P7J9,A disintegrin and metalloproteinase with thrombospondin motifs 7,COMPase;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0005788;GO:0031012;GO:0005576;GO:0046872;GO:0004222;GO:0008237;GO:0071773;GO:0071347;GO:0071356;GO:0030198;GO:0032331;GO:0051603;, C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region;, F:metal ion binding; F:metalloendopeptidase activity; F:metallopeptidase activity;, P:cellular response to BMP stimulus; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:extracellular matrix organization; P:negative regulation of chondrocyte differentiation; P:proteolysis involved in cellular protein catabolic process; scaffold77 indexed_genome mRNA 3530611 3618150 . - . ID=transcript_11823;Q9UPU7 A7MD42 Q8N1F9 Q9NXM0,TBC1 domain family member 2B,, PF00169;PF00566;, GO:0005829;GO:0005096;GO:0090630;GO:0006886;, C:cytosol;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport;|Q9UPU7 A7MD42 Q8N1F9 Q9NXM0,TBC1 domain family member 2B,, PF00169;PF00566;, GO:0005829;GO:0005096;GO:0090630;GO:0006886;, C:cytosol;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; scaffold77 indexed_genome mRNA 3696952 3714641 . + . ID=transcript_11824;P50213 D3DW83 Q9H3X0,Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial,Isocitric dehydrogenase subunit alpha;NAD(+)-specific ICDH subunit alpha;, PF00180;, GO:0005759;GO:0005739;GO:0005634;GO:0004449;GO:0000287;GO:0051287;GO:0005975;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:carbohydrate metabolic process; P:isocitrate metabolic process; P:tricarboxylic acid cycle;|P50213 D3DW83 Q9H3X0,Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial,Isocitric dehydrogenase subunit alpha;NAD(+)-specific ICDH subunit alpha;, PF00180;, GO:0005759;GO:0005739;GO:0005634;GO:0004449;GO:0000287;GO:0051287;GO:0005975;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:carbohydrate metabolic process; P:isocitrate metabolic process; P:tricarboxylic acid cycle;|P50213 D3DW83 Q9H3X0,Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial,Isocitric dehydrogenase subunit alpha;NAD(+)-specific ICDH subunit alpha;, PF00180;, GO:0005759;GO:0005739;GO:0005634;GO:0004449;GO:0000287;GO:0051287;GO:0005975;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:carbohydrate metabolic process; P:isocitrate metabolic process; P:tricarboxylic acid cycle;|P50213 D3DW83 Q9H3X0,Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial,Isocitric dehydrogenase subunit alpha;NAD(+)-specific ICDH subunit alpha;, PF00180;, GO:0005759;GO:0005739;GO:0005634;GO:0004449;GO:0000287;GO:0051287;GO:0005975;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:carbohydrate metabolic process; P:isocitrate metabolic process; P:tricarboxylic acid cycle;|P50213 D3DW83 Q9H3X0,Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial,Isocitric dehydrogenase subunit alpha;NAD(+)-specific ICDH subunit alpha;, PF00180;, GO:0005759;GO:0005739;GO:0005634;GO:0004449;GO:0000287;GO:0051287;GO:0005975;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:carbohydrate metabolic process; P:isocitrate metabolic process; P:tricarboxylic acid cycle; scaffold77 indexed_genome mRNA 3714804 3719245 . - . ID=transcript_11825;Q96GR2 B2RB61 O75126 Q76N27 Q9HC26,Long-chain-fatty-acid--CoA ligase ACSBG1 {ECO:0000305},Acyl-CoA synthetase bubblegum family member 1;Lipidosin;, PF00501;, GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005886;GO:0005524;GO:0016405;GO:0004467;GO:0031957;GO:0042759;GO:0001676;GO:0035338;GO:0042552;GO:0051384;GO:0000038;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:plasma membrane;, F:ATP binding; F:CoA-ligase activity; F:long-chain fatty acid-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:long-chain fatty acid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:myelination; P:response to glucocorticoid; P:very long-chain fatty acid metabolic process;|Q96GR2 B2RB61 O75126 Q76N27 Q9HC26,Long-chain-fatty-acid--CoA ligase ACSBG1 {ECO:0000305},Acyl-CoA synthetase bubblegum family member 1;Lipidosin;, PF00501;, GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005886;GO:0005524;GO:0016405;GO:0004467;GO:0031957;GO:0042759;GO:0001676;GO:0035338;GO:0042552;GO:0051384;GO:0000038;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:plasma membrane;, F:ATP binding; F:CoA-ligase activity; F:long-chain fatty acid-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:long-chain fatty acid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:myelination; P:response to glucocorticoid; P:very long-chain fatty acid metabolic process;|Q96GR2 B2RB61 O75126 Q76N27 Q9HC26,Long-chain-fatty-acid--CoA ligase ACSBG1 {ECO:0000305},Acyl-CoA synthetase bubblegum family member 1;Lipidosin;, PF00501;, GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005886;GO:0005524;GO:0016405;GO:0004467;GO:0031957;GO:0042759;GO:0001676;GO:0035338;GO:0042552;GO:0051384;GO:0000038;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:plasma membrane;, F:ATP binding; F:CoA-ligase activity; F:long-chain fatty acid-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:long-chain fatty acid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:myelination; P:response to glucocorticoid; P:very long-chain fatty acid metabolic process; scaffold77 indexed_genome mRNA 3719296 3743839 . - . ID=transcript_11826;Q96GR2 B2RB61 O75126 Q76N27 Q9HC26,Long-chain-fatty-acid--CoA ligase ACSBG1 {ECO:0000305},Acyl-CoA synthetase bubblegum family member 1;Lipidosin;, PF00501;, GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005886;GO:0005524;GO:0016405;GO:0004467;GO:0031957;GO:0042759;GO:0001676;GO:0035338;GO:0042552;GO:0051384;GO:0000038;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:plasma membrane;, F:ATP binding; F:CoA-ligase activity; F:long-chain fatty acid-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:long-chain fatty acid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:myelination; P:response to glucocorticoid; P:very long-chain fatty acid metabolic process;|Q96GR2 B2RB61 O75126 Q76N27 Q9HC26,Long-chain-fatty-acid--CoA ligase ACSBG1 {ECO:0000305},Acyl-CoA synthetase bubblegum family member 1;Lipidosin;, PF00501;, GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005886;GO:0005524;GO:0016405;GO:0004467;GO:0031957;GO:0042759;GO:0001676;GO:0035338;GO:0042552;GO:0051384;GO:0000038;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:plasma membrane;, F:ATP binding; F:CoA-ligase activity; F:long-chain fatty acid-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:long-chain fatty acid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:myelination; P:response to glucocorticoid; P:very long-chain fatty acid metabolic process;|Q96GR2 B2RB61 O75126 Q76N27 Q9HC26,Long-chain-fatty-acid--CoA ligase ACSBG1 {ECO:0000305},Acyl-CoA synthetase bubblegum family member 1;Lipidosin;, PF00501;, GO:0005737;GO:0031410;GO:0005829;GO:0005783;GO:0005886;GO:0005524;GO:0016405;GO:0004467;GO:0031957;GO:0042759;GO:0001676;GO:0035338;GO:0042552;GO:0051384;GO:0000038;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:plasma membrane;, F:ATP binding; F:CoA-ligase activity; F:long-chain fatty acid-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:long-chain fatty acid biosynthetic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:myelination; P:response to glucocorticoid; P:very long-chain fatty acid metabolic process; scaffold77 indexed_genome mRNA 3816979 3843788 . + . ID=transcript_11827;Q8WW22 E9PDM9 Q6AW87 Q8N5Z4 Q8N7P2,DnaJ homolog subfamily A member 4,, PF00226;PF01556;PF00684;, GO:0005829;GO:0016020;GO:0005524;GO:0051087;GO:0031072;GO:0046872;GO:0051082;GO:0010596;GO:0090084;GO:0010628;GO:0042026;GO:0009408;, C:cytosol; C:membrane;, F:ATP binding; F:chaperone binding; F:heat shock protein binding; F:metal ion binding; F:unfolded protein binding;, P:negative regulation of endothelial cell migration; P:negative regulation of inclusion body assembly; P:positive regulation of gene expression; P:protein refolding; P:response to heat;|Q8WW22 E9PDM9 Q6AW87 Q8N5Z4 Q8N7P2,DnaJ homolog subfamily A member 4,, PF00226;PF01556;PF00684;, GO:0005829;GO:0016020;GO:0005524;GO:0051087;GO:0031072;GO:0046872;GO:0051082;GO:0010596;GO:0090084;GO:0010628;GO:0042026;GO:0009408;, C:cytosol; C:membrane;, F:ATP binding; F:chaperone binding; F:heat shock protein binding; F:metal ion binding; F:unfolded protein binding;, P:negative regulation of endothelial cell migration; P:negative regulation of inclusion body assembly; P:positive regulation of gene expression; P:protein refolding; P:response to heat;|Q8WW22 E9PDM9 Q6AW87 Q8N5Z4 Q8N7P2,DnaJ homolog subfamily A member 4,, PF00226;PF01556;PF00684;, GO:0005829;GO:0016020;GO:0005524;GO:0051087;GO:0031072;GO:0046872;GO:0051082;GO:0010596;GO:0090084;GO:0010628;GO:0042026;GO:0009408;, C:cytosol; C:membrane;, F:ATP binding; F:chaperone binding; F:heat shock protein binding; F:metal ion binding; F:unfolded protein binding;, P:negative regulation of endothelial cell migration; P:negative regulation of inclusion body assembly; P:positive regulation of gene expression; P:protein refolding; P:response to heat;|Q8WW22 E9PDM9 Q6AW87 Q8N5Z4 Q8N7P2,DnaJ homolog subfamily A member 4,, PF00226;PF01556;PF00684;, GO:0005829;GO:0016020;GO:0005524;GO:0051087;GO:0031072;GO:0046872;GO:0051082;GO:0010596;GO:0090084;GO:0010628;GO:0042026;GO:0009408;, C:cytosol; C:membrane;, F:ATP binding; F:chaperone binding; F:heat shock protein binding; F:metal ion binding; F:unfolded protein binding;, P:negative regulation of endothelial cell migration; P:negative regulation of inclusion body assembly; P:positive regulation of gene expression; P:protein refolding; P:response to heat;|Q8WW22 E9PDM9 Q6AW87 Q8N5Z4 Q8N7P2,DnaJ homolog subfamily A member 4,, PF00226;PF01556;PF00684;, GO:0005829;GO:0016020;GO:0005524;GO:0051087;GO:0031072;GO:0046872;GO:0051082;GO:0010596;GO:0090084;GO:0010628;GO:0042026;GO:0009408;, C:cytosol; C:membrane;, F:ATP binding; F:chaperone binding; F:heat shock protein binding; F:metal ion binding; F:unfolded protein binding;, P:negative regulation of endothelial cell migration; P:negative regulation of inclusion body assembly; P:positive regulation of gene expression; P:protein refolding; P:response to heat;|Q8WW22 E9PDM9 Q6AW87 Q8N5Z4 Q8N7P2,DnaJ homolog subfamily A member 4,, PF00226;PF01556;PF00684;, GO:0005829;GO:0016020;GO:0005524;GO:0051087;GO:0031072;GO:0046872;GO:0051082;GO:0010596;GO:0090084;GO:0010628;GO:0042026;GO:0009408;, C:cytosol; C:membrane;, F:ATP binding; F:chaperone binding; F:heat shock protein binding; F:metal ion binding; F:unfolded protein binding;, P:negative regulation of endothelial cell migration; P:negative regulation of inclusion body assembly; P:positive regulation of gene expression; P:protein refolding; P:response to heat; scaffold77 indexed_genome mRNA 3845309 3848675 . - . ID=transcript_11828;Q9GZS3 D3DW84 Q6IA22 Q7Z4X4,WD repeat-containing protein 61,Meiotic recombination REC14 protein homolog;SKI8 homolog;, PF00400;, GO:0016593;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0080182;GO:0045638;GO:0051571;GO:2001162;GO:0016567;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:histone H3-K4 trimethylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K79 methylation; P:protein ubiquitination; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q9GZS3 D3DW84 Q6IA22 Q7Z4X4,WD repeat-containing protein 61,Meiotic recombination REC14 protein homolog;SKI8 homolog;, PF00400;, GO:0016593;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0080182;GO:0045638;GO:0051571;GO:2001162;GO:0016567;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:histone H3-K4 trimethylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K79 methylation; P:protein ubiquitination; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q9GZS3 D3DW84 Q6IA22 Q7Z4X4,WD repeat-containing protein 61,Meiotic recombination REC14 protein homolog;SKI8 homolog;, PF00400;, GO:0016593;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0080182;GO:0045638;GO:0051571;GO:2001162;GO:0016567;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:histone H3-K4 trimethylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K79 methylation; P:protein ubiquitination; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway; scaffold77 indexed_genome mRNA 3848792 3851507 . + . ID=transcript_11829;Q9GZS3 D3DW84 Q6IA22 Q7Z4X4,WD repeat-containing protein 61,Meiotic recombination REC14 protein homolog;SKI8 homolog;, PF00400;, GO:0016593;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0080182;GO:0045638;GO:0051571;GO:2001162;GO:0016567;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:histone H3-K4 trimethylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K79 methylation; P:protein ubiquitination; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway; scaffold77 indexed_genome mRNA 3852011 3858327 . + . ID=transcript_11830;Q9GZS3 D3DW84 Q6IA22 Q7Z4X4,WD repeat-containing protein 61,Meiotic recombination REC14 protein homolog;SKI8 homolog;, PF00400;, GO:0016593;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0080182;GO:0045638;GO:0051571;GO:2001162;GO:0016567;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:histone H3-K4 trimethylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K79 methylation; P:protein ubiquitination; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q9GZS3 D3DW84 Q6IA22 Q7Z4X4,WD repeat-containing protein 61,Meiotic recombination REC14 protein homolog;SKI8 homolog;, PF00400;, GO:0016593;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0055087;GO:0035327;GO:0043928;GO:0080182;GO:0045638;GO:0051571;GO:2001162;GO:0016567;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:Ski complex; C:transcriptionally active chromatin;, , P:exonucleolytic catabolism of deadenylated mRNA; P:histone H3-K4 trimethylation; P:negative regulation of myeloid cell differentiation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H3-K79 methylation; P:protein ubiquitination; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway; scaffold77 indexed_genome mRNA 3905863 3912804 . + . ID=transcript_11831;P29762 Q6IAY7 Q8WTV5,Cellular retinoic acid-binding protein 1,Cellular retinoic acid-binding protein I;, PF00061;, GO:0005829;GO:0016918;GO:0001972;GO:0005501;GO:0019841;GO:0007275;GO:0034653;GO:0007165;, C:cytosol;, F:retinal binding; F:retinoic acid binding; F:retinoid binding; F:retinol binding;, P:multicellular organism development; P:retinoic acid catabolic process; P:signal transduction; scaffold77 indexed_genome mRNA 3989825 4038368 . + . ID=transcript_11832;Q9UF17,Iron-responsive element-binding protein 2,Iron regulatory protein 2;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005739;GO:0051539;GO:0003994;GO:0030350;GO:0046872;GO:0003723;GO:0030371;GO:0006879;GO:0006101;GO:0034101;GO:0050892;GO:0055072;GO:0006826;GO:0030316;GO:0009791;GO:0006782;GO:0006099;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding; F:translation repressor activity;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:erythrocyte homeostasis; P:intestinal absorption; P:iron ion homeostasis; P:iron ion transport; P:osteoclast differentiation; P:post-embryonic development; P:protoporphyrinogen IX biosynthetic process; P:tricarboxylic acid cycle;|Q9UF17,Iron-responsive element-binding protein 2,Iron regulatory protein 2;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005739;GO:0051539;GO:0003994;GO:0030350;GO:0046872;GO:0003723;GO:0030371;GO:0006879;GO:0006101;GO:0034101;GO:0050892;GO:0055072;GO:0006826;GO:0030316;GO:0009791;GO:0006782;GO:0006099;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding; F:translation repressor activity;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:erythrocyte homeostasis; P:intestinal absorption; P:iron ion homeostasis; P:iron ion transport; P:osteoclast differentiation; P:post-embryonic development; P:protoporphyrinogen IX biosynthetic process; P:tricarboxylic acid cycle;|Q9UF17,Iron-responsive element-binding protein 2,Iron regulatory protein 2;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005739;GO:0051539;GO:0003994;GO:0030350;GO:0046872;GO:0003723;GO:0030371;GO:0006879;GO:0006101;GO:0034101;GO:0050892;GO:0055072;GO:0006826;GO:0030316;GO:0009791;GO:0006782;GO:0006099;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding; F:translation repressor activity;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:erythrocyte homeostasis; P:intestinal absorption; P:iron ion homeostasis; P:iron ion transport; P:osteoclast differentiation; P:post-embryonic development; P:protoporphyrinogen IX biosynthetic process; P:tricarboxylic acid cycle;|Q9UF17,Iron-responsive element-binding protein 2,Iron regulatory protein 2;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005739;GO:0051539;GO:0003994;GO:0030350;GO:0046872;GO:0003723;GO:0030371;GO:0006879;GO:0006101;GO:0034101;GO:0050892;GO:0055072;GO:0006826;GO:0030316;GO:0009791;GO:0006782;GO:0006099;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding; F:translation repressor activity;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:erythrocyte homeostasis; P:intestinal absorption; P:iron ion homeostasis; P:iron ion transport; P:osteoclast differentiation; P:post-embryonic development; P:protoporphyrinogen IX biosynthetic process; P:tricarboxylic acid cycle;|Q9UF17,Iron-responsive element-binding protein 2,Iron regulatory protein 2;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005739;GO:0051539;GO:0003994;GO:0030350;GO:0046872;GO:0003723;GO:0030371;GO:0006879;GO:0006101;GO:0034101;GO:0050892;GO:0055072;GO:0006826;GO:0030316;GO:0009791;GO:0006782;GO:0006099;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding; F:translation repressor activity;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:erythrocyte homeostasis; P:intestinal absorption; P:iron ion homeostasis; P:iron ion transport; P:osteoclast differentiation; P:post-embryonic development; P:protoporphyrinogen IX biosynthetic process; P:tricarboxylic acid cycle;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9UF17,Iron-responsive element-binding protein 2,Iron regulatory protein 2;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005739;GO:0051539;GO:0003994;GO:0030350;GO:0046872;GO:0003723;GO:0030371;GO:0006879;GO:0006101;GO:0034101;GO:0050892;GO:0055072;GO:0006826;GO:0030316;GO:0009791;GO:0006782;GO:0006099;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding; F:translation repressor activity;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:erythrocyte homeostasis; P:intestinal absorption; P:iron ion homeostasis; P:iron ion transport; P:osteoclast differentiation; P:post-embryonic development; P:protoporphyrinogen IX biosynthetic process; P:tricarboxylic acid cycle;|Q9UF17,Iron-responsive element-binding protein 2,Iron regulatory protein 2;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005739;GO:0051539;GO:0003994;GO:0030350;GO:0046872;GO:0003723;GO:0030371;GO:0006879;GO:0006101;GO:0034101;GO:0050892;GO:0055072;GO:0006826;GO:0030316;GO:0009791;GO:0006782;GO:0006099;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding; F:translation repressor activity;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:erythrocyte homeostasis; P:intestinal absorption; P:iron ion homeostasis; P:iron ion transport; P:osteoclast differentiation; P:post-embryonic development; P:protoporphyrinogen IX biosynthetic process; P:tricarboxylic acid cycle;|Q9UF17,Iron-responsive element-binding protein 2,Iron regulatory protein 2;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005739;GO:0051539;GO:0003994;GO:0030350;GO:0046872;GO:0003723;GO:0030371;GO:0006879;GO:0006101;GO:0034101;GO:0050892;GO:0055072;GO:0006826;GO:0030316;GO:0009791;GO:0006782;GO:0006099;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding; F:translation repressor activity;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:erythrocyte homeostasis; P:intestinal absorption; P:iron ion homeostasis; P:iron ion transport; P:osteoclast differentiation; P:post-embryonic development; P:protoporphyrinogen IX biosynthetic process; P:tricarboxylic acid cycle;|Q9UF17,Iron-responsive element-binding protein 2,Iron regulatory protein 2;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005739;GO:0051539;GO:0003994;GO:0030350;GO:0046872;GO:0003723;GO:0030371;GO:0006879;GO:0006101;GO:0034101;GO:0050892;GO:0055072;GO:0006826;GO:0030316;GO:0009791;GO:0006782;GO:0006099;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding; F:translation repressor activity;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:erythrocyte homeostasis; P:intestinal absorption; P:iron ion homeostasis; P:iron ion transport; P:osteoclast differentiation; P:post-embryonic development; P:protoporphyrinogen IX biosynthetic process; P:tricarboxylic acid cycle;|Q9UF17,Iron-responsive element-binding protein 2,Iron regulatory protein 2;, PF00330;PF00694;, GO:0005737;GO:0005829;GO:0005739;GO:0051539;GO:0003994;GO:0030350;GO:0046872;GO:0003723;GO:0030371;GO:0006879;GO:0006101;GO:0034101;GO:0050892;GO:0055072;GO:0006826;GO:0030316;GO:0009791;GO:0006782;GO:0006099;, C:cytoplasm; C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; F:iron-responsive element binding; F:metal ion binding; F:RNA binding; F:translation repressor activity;, P:cellular iron ion homeostasis; P:citrate metabolic process; P:erythrocyte homeostasis; P:intestinal absorption; P:iron ion homeostasis; P:iron ion transport; P:osteoclast differentiation; P:post-embryonic development; P:protoporphyrinogen IX biosynthetic process; P:tricarboxylic acid cycle; scaffold77 indexed_genome mRNA 4042595 4070131 . + . ID=transcript_11833;A2RU49 B7ZMA5 F8W6X5 Q6ZTN0,Hydroxylysine kinase,Aminoglycoside phosphotransferase domain-containing protein 1;, PF01636;, GO:0005759;GO:0019202;GO:0047992;GO:0006554;, C:mitochondrial matrix;, F:amino acid kinase activity; F:hydroxylysine kinase activity;, P:lysine catabolic process; scaffold77 indexed_genome mRNA 4075619 4087344 . + . ID=transcript_11834;P25789 D3DW86 Q53XP2 Q567Q5 Q8TBD1,Proteasome subunit alpha type-4,Macropain subunit C9;Multicatalytic endopeptidase complex subunit C9;Proteasome component C9;Proteasome subunit L;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0005654;GO:0005634;GO:0000932;GO:0000502;GO:0005839;GO:0019773;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P25789 D3DW86 Q53XP2 Q567Q5 Q8TBD1,Proteasome subunit alpha type-4,Macropain subunit C9;Multicatalytic endopeptidase complex subunit C9;Proteasome component C9;Proteasome subunit L;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0005654;GO:0005634;GO:0000932;GO:0000502;GO:0005839;GO:0019773;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P25789 D3DW86 Q53XP2 Q567Q5 Q8TBD1,Proteasome subunit alpha type-4,Macropain subunit C9;Multicatalytic endopeptidase complex subunit C9;Proteasome component C9;Proteasome subunit L;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0005654;GO:0005634;GO:0000932;GO:0000502;GO:0005839;GO:0019773;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:P-body; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold77 indexed_genome mRNA 4103516 4129013 . + . ID=transcript_11835;P30532 Q15824 Q99554,Neuronal acetylcholine receptor subunit alpha-5,, PF02931;PF02932;, GO:0005892;GO:0098691;GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0015464;GO:0022848;GO:0015276;GO:0030594;GO:0035095;GO:0007268;GO:0034220;GO:0050877;GO:0042391;GO:2000300;GO:0035094;GO:0007165;GO:0007271;, C:acetylcholine-gated channel complex; C:dopaminergic synapse; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity;, P:behavioral response to nicotine; P:chemical synaptic transmission; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of synaptic vesicle exocytosis; P:response to nicotine; P:signal transduction; P:synaptic transmission, cholinergic; scaffold77 indexed_genome mRNA 4319178 4321222 . + . ID=transcript_11836;Q8WVN8 B7Z3Q2 H3BRG2 Q8N4G6 Q96J08,Ubiquitin-conjugating enzyme E2 Q2,E2 ubiquitin-conjugating enzyme Q2;Ubiquitin carrier protein Q2;Ubiquitin-protein ligase Q2;, PF00179;, GO:0005829;GO:0005634;GO:0005524;GO:0061631;GO:0004842;GO:0070936;GO:0000209;GO:0016567;, C:cytosol; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; scaffold77 indexed_genome mRNA 4332420 4337298 . + . ID=transcript_11837;Q8WVN8 B7Z3Q2 H3BRG2 Q8N4G6 Q96J08,Ubiquitin-conjugating enzyme E2 Q2,E2 ubiquitin-conjugating enzyme Q2;Ubiquitin carrier protein Q2;Ubiquitin-protein ligase Q2;, PF00179;, GO:0005829;GO:0005634;GO:0005524;GO:0061631;GO:0004842;GO:0070936;GO:0000209;GO:0016567;, C:cytosol; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; scaffold77 indexed_genome mRNA 4341868 4470777 . + . ID=transcript_11838;Q8NEZ5 Q0D2P8 Q6PIL5 Q8IXW3 Q9H824 Q9UKC0,F-box only protein 22,F-box protein FBX22p44;, PF00646;PF10442;, GO:0005829;GO:0030018;GO:0004842;GO:0006464;GO:0032436;GO:0043687;GO:0000209;GO:0048742;GO:0006511;, C:cytosol; C:Z disc;, F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein polyubiquitination; P:regulation of skeletal muscle fiber development; P:ubiquitin-dependent protein catabolic process;|Q8NEZ5 Q0D2P8 Q6PIL5 Q8IXW3 Q9H824 Q9UKC0,F-box only protein 22,F-box protein FBX22p44;, PF00646;PF10442;, GO:0005829;GO:0030018;GO:0004842;GO:0006464;GO:0032436;GO:0043687;GO:0000209;GO:0048742;GO:0006511;, C:cytosol; C:Z disc;, F:ubiquitin-protein transferase activity;, P:cellular protein modification process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein polyubiquitination; P:regulation of skeletal muscle fiber development; P:ubiquitin-dependent protein catabolic process;|Q8WWG1 A6NIE8,Pro-neuregulin-4, membrane-bound isoform,, PF00008;, GO:0005576;GO:0016021;GO:0005886;GO:0008083;GO:0038128;GO:0000165;GO:0007399;GO:0051897;GO:2000145;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:growth factor activity;, P:ERBB2 signaling pathway; P:MAPK cascade; P:nervous system development; P:positive regulation of protein kinase B signaling; P:regulation of cell motility;|Q8WWG1 A6NIE8,Pro-neuregulin-4, membrane-bound isoform,, PF00008;, GO:0005576;GO:0016021;GO:0005886;GO:0008083;GO:0038128;GO:0000165;GO:0007399;GO:0051897;GO:2000145;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:growth factor activity;, P:ERBB2 signaling pathway; P:MAPK cascade; P:nervous system development; P:positive regulation of protein kinase B signaling; P:regulation of cell motility;|Q8WWG1 A6NIE8,Pro-neuregulin-4, membrane-bound isoform,, PF00008;, GO:0005576;GO:0016021;GO:0005886;GO:0008083;GO:0038128;GO:0000165;GO:0007399;GO:0051897;GO:2000145;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:growth factor activity;, P:ERBB2 signaling pathway; P:MAPK cascade; P:nervous system development; P:positive regulation of protein kinase B signaling; P:regulation of cell motility;|Q15526 Q5T8T3 Q5T8T4,Surfeit locus protein 1,, PF02104;, GO:0016021;GO:0005746;GO:0004129;GO:0009060;GO:0033617;GO:0006119;GO:0008535;, C:integral component of membrane; C:mitochondrial respirasome;, F:cytochrome-c oxidase activity;, P:aerobic respiration; P:mitochondrial cytochrome c oxidase assembly; P:oxidative phosphorylation; P:respiratory chain complex IV assembly; scaffold77 indexed_genome mRNA 4522814 4524928 . - . ID=transcript_11839;P60228 O43902 Q64058 Q64059 Q64252 Q6FG33 Q8WVK4,Eukaryotic translation initiation factor 3 subunit E {ECO:0000255|HAMAP-Rule:MF_03004},Eukaryotic translation initiation factor 3 subunit 6 {ECO:0000255|HAMAP-Rule:MF_03004};Viral integration site protein INT-6 homolog;eIF-3 p48 {ECO:0000255|HAMAP-Rule:MF_03004};, PF09440;PF01399;, GO:0005737;GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071540;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0016605;GO:0045296;GO:0047485;GO:0003723;GO:0003743;GO:0001732;GO:0045947;GO:0000184;GO:1902416;GO:0045727;GO:0006446;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3e; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:PML body;, F:cadherin binding; F:protein N-terminus binding; F:RNA binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:negative regulation of translational initiation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA binding; P:positive regulation of translation; P:regulation of translational initiation; P:translational initiation; scaffold77 indexed_genome mRNA 4568874 4569983 . - . ID=transcript_11840;Q2M3C6 Q8N993 Q96LL5,Transmembrane protein 266 {ECO:0000305},HV1-related protein 1 {ECO:0000303|PubMed:25165868};, , GO:0005829;GO:0030425;GO:0005887;GO:0043204;GO:0005886;GO:0042803;GO:0055085;, C:cytosol; C:dendrite; C:integral component of plasma membrane; C:perikaryon; C:plasma membrane;, F:protein homodimerization activity;, P:transmembrane transport; scaffold77 indexed_genome mRNA 4573004 4573942 . - . ID=transcript_11841;Q2M3C6 Q8N993 Q96LL5,Transmembrane protein 266 {ECO:0000305},HV1-related protein 1 {ECO:0000303|PubMed:25165868};, , GO:0005829;GO:0030425;GO:0005887;GO:0043204;GO:0005886;GO:0042803;GO:0055085;, C:cytosol; C:dendrite; C:integral component of plasma membrane; C:perikaryon; C:plasma membrane;, F:protein homodimerization activity;, P:transmembrane transport; scaffold77 indexed_genome mRNA 4585913 4600513 . + . ID=transcript_11842;Q2M3C6 Q8N993 Q96LL5,Transmembrane protein 266 {ECO:0000305},HV1-related protein 1 {ECO:0000303|PubMed:25165868};, , GO:0005829;GO:0030425;GO:0005887;GO:0043204;GO:0005886;GO:0042803;GO:0055085;, C:cytosol; C:dendrite; C:integral component of plasma membrane; C:perikaryon; C:plasma membrane;, F:protein homodimerization activity;, P:transmembrane transport; scaffold77 indexed_genome mRNA 4617011 4689515 . + . ID=transcript_11843;P13804 B4DT43 Q53XN3,Electron transfer flavoprotein subunit alpha, mitochondrial,, PF01012;PF00766;, GO:0005759;GO:0005739;GO:0009055;GO:0050660;GO:0016491;GO:0033539;GO:0022904;, C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:respiratory electron transport chain;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|P13804 B4DT43 Q53XN3,Electron transfer flavoprotein subunit alpha, mitochondrial,, PF01012;PF00766;, GO:0005759;GO:0005739;GO:0009055;GO:0050660;GO:0016491;GO:0033539;GO:0022904;, C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:respiratory electron transport chain;|P13804 B4DT43 Q53XN3,Electron transfer flavoprotein subunit alpha, mitochondrial,, PF01012;PF00766;, GO:0005759;GO:0005739;GO:0009055;GO:0050660;GO:0016491;GO:0033539;GO:0022904;, C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:respiratory electron transport chain;|P13804 B4DT43 Q53XN3,Electron transfer flavoprotein subunit alpha, mitochondrial,, PF01012;PF00766;, GO:0005759;GO:0005739;GO:0009055;GO:0050660;GO:0016491;GO:0033539;GO:0022904;, C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity; F:flavin adenine dinucleotide binding; F:oxidoreductase activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:respiratory electron transport chain; scaffold77 indexed_genome mRNA 4734387 5097435 . - . ID=transcript_11844;Q9BY12 F5H7X8 H3BNR7 Q3B7X7 Q96BS9 Q9H3D8 Q9NT03 Q9P274,S phase cyclin A-associated protein in the endoplasmic reticulum,Zinc finger protein 291;, PF16501;, GO:0005829;GO:0005783;GO:0016607;GO:0005654;GO:0003676;GO:0008270;, C:cytosol; C:endoplasmic reticulum; C:nuclear speck; C:nucleoplasm;, F:nucleic acid binding; F:zinc ion binding;|Q9BY12 F5H7X8 H3BNR7 Q3B7X7 Q96BS9 Q9H3D8 Q9NT03 Q9P274,S phase cyclin A-associated protein in the endoplasmic reticulum,Zinc finger protein 291;, PF16501;, GO:0005829;GO:0005783;GO:0016607;GO:0005654;GO:0003676;GO:0008270;, C:cytosol; C:endoplasmic reticulum; C:nuclear speck; C:nucleoplasm;, F:nucleic acid binding; F:zinc ion binding;|Q9BY12 F5H7X8 H3BNR7 Q3B7X7 Q96BS9 Q9H3D8 Q9NT03 Q9P274,S phase cyclin A-associated protein in the endoplasmic reticulum,Zinc finger protein 291;, PF16501;, GO:0005829;GO:0005783;GO:0016607;GO:0005654;GO:0003676;GO:0008270;, C:cytosol; C:endoplasmic reticulum; C:nuclear speck; C:nucleoplasm;, F:nucleic acid binding; F:zinc ion binding; scaffold77 indexed_genome mRNA 5173155 5196700 . + . ID=transcript_11845;Q14257 A8MTG6 F8WCY5 Q53XN8,Reticulocalbin-2,Calcium-binding protein ERC-55;E6-binding protein;, PF13202;, GO:0005783;GO:0005788;GO:0005730;GO:0005509;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:nucleolus;, F:calcium ion binding;|Q14257 A8MTG6 F8WCY5 Q53XN8,Reticulocalbin-2,Calcium-binding protein ERC-55;E6-binding protein;, PF13202;, GO:0005783;GO:0005788;GO:0005730;GO:0005509;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:nucleolus;, F:calcium ion binding;|Q14257 A8MTG6 F8WCY5 Q53XN8,Reticulocalbin-2,Calcium-binding protein ERC-55;E6-binding protein;, PF13202;, GO:0005783;GO:0005788;GO:0005730;GO:0005509;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:nucleolus;, F:calcium ion binding;|Q14257 A8MTG6 F8WCY5 Q53XN8,Reticulocalbin-2,Calcium-binding protein ERC-55;E6-binding protein;, PF13202;, GO:0005783;GO:0005788;GO:0005730;GO:0005509;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:nucleolus;, F:calcium ion binding;|Q14257 A8MTG6 F8WCY5 Q53XN8,Reticulocalbin-2,Calcium-binding protein ERC-55;E6-binding protein;, PF13202;, GO:0005783;GO:0005788;GO:0005730;GO:0005509;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:nucleolus;, F:calcium ion binding; scaffold77 indexed_genome mRNA 5242228 5281620 . + . ID=transcript_11846;O43586 B5BU74 B5BUK4 O43585 O95657,Proline-serine-threonine phosphatase-interacting protein 1,CD2-binding protein 1;H-PIP;, PF00611;PF00018;, GO:0005884;GO:0032154;GO:0005737;GO:0005856;GO:0005829;GO:0030027;GO:0016020;GO:0048471;GO:0005886;GO:0001931;GO:0051015;GO:0042802;GO:0030041;GO:0007155;GO:0006897;GO:0006954;GO:0045087;GO:0035590;GO:0007165;, C:actin filament; C:cleavage furrow; C:cytoplasm; C:cytoskeleton; C:cytosol; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:uropod;, F:actin filament binding; F:identical protein binding;, P:actin filament polymerization; P:cell adhesion; P:endocytosis; P:inflammatory response; P:innate immune response; P:purinergic nucleotide receptor signaling pathway; P:signal transduction;|O43586 B5BU74 B5BUK4 O43585 O95657,Proline-serine-threonine phosphatase-interacting protein 1,CD2-binding protein 1;H-PIP;, PF00611;PF00018;, GO:0005884;GO:0032154;GO:0005737;GO:0005856;GO:0005829;GO:0030027;GO:0016020;GO:0048471;GO:0005886;GO:0001931;GO:0051015;GO:0042802;GO:0030041;GO:0007155;GO:0006897;GO:0006954;GO:0045087;GO:0035590;GO:0007165;, C:actin filament; C:cleavage furrow; C:cytoplasm; C:cytoskeleton; C:cytosol; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:uropod;, F:actin filament binding; F:identical protein binding;, P:actin filament polymerization; P:cell adhesion; P:endocytosis; P:inflammatory response; P:innate immune response; P:purinergic nucleotide receptor signaling pathway; P:signal transduction;|O43586 B5BU74 B5BUK4 O43585 O95657,Proline-serine-threonine phosphatase-interacting protein 1,CD2-binding protein 1;H-PIP;, PF00611;PF00018;, GO:0005884;GO:0032154;GO:0005737;GO:0005856;GO:0005829;GO:0030027;GO:0016020;GO:0048471;GO:0005886;GO:0001931;GO:0051015;GO:0042802;GO:0030041;GO:0007155;GO:0006897;GO:0006954;GO:0045087;GO:0035590;GO:0007165;, C:actin filament; C:cleavage furrow; C:cytoplasm; C:cytoskeleton; C:cytosol; C:lamellipodium; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:uropod;, F:actin filament binding; F:identical protein binding;, P:actin filament polymerization; P:cell adhesion; P:endocytosis; P:inflammatory response; P:innate immune response; P:purinergic nucleotide receptor signaling pathway; P:signal transduction; scaffold77 indexed_genome mRNA 5299105 5325915 . - . ID=transcript_11847;O60637 A6NEH4 B3KQQ2 B4DP19 Q9BW22 Q9NVX9,Tetraspanin-3,Tetraspanin TM4-A;Transmembrane 4 superfamily member 8;, PF00335;, GO:0070062;GO:0005887;, C:extracellular exosome; C:integral component of plasma membrane;|O60637 A6NEH4 B3KQQ2 B4DP19 Q9BW22 Q9NVX9,Tetraspanin-3,Tetraspanin TM4-A;Transmembrane 4 superfamily member 8;, PF00335;, GO:0070062;GO:0005887;, C:extracellular exosome; C:integral component of plasma membrane; scaffold77 indexed_genome mRNA 5366676 5367291 . + . ID=transcript_11848;Q9H792 Q6ZS78 Q8NAZ4 Q8NCM3 Q8TEG7,Inactive tyrosine-protein kinase PEAK1 {ECO:0000305},Pseudopodium-enriched atypical kinase 1 {ECO:0000303|PubMed:20534451};Sugen kinase 269 {ECO:0000303|PubMed:29212708};Tyrosine-protein kinase SgK269;, PF00069;, GO:0015629;GO:0005737;GO:0005925;GO:0042802;GO:0004715;GO:0004672;GO:0016477;GO:0048041;GO:0046777;GO:0006468;GO:0051893;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:identical protein binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity;, P:cell migration; P:focal adhesion assembly; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of focal adhesion assembly; P:substrate adhesion-dependent cell spreading; scaffold77 indexed_genome mRNA 5367398 5387964 . - . ID=transcript_11849;Q9H792 Q6ZS78 Q8NAZ4 Q8NCM3 Q8TEG7,Inactive tyrosine-protein kinase PEAK1 {ECO:0000305},Pseudopodium-enriched atypical kinase 1 {ECO:0000303|PubMed:20534451};Sugen kinase 269 {ECO:0000303|PubMed:29212708};Tyrosine-protein kinase SgK269;, PF00069;, GO:0015629;GO:0005737;GO:0005925;GO:0042802;GO:0004715;GO:0004672;GO:0016477;GO:0048041;GO:0046777;GO:0006468;GO:0051893;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:identical protein binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity;, P:cell migration; P:focal adhesion assembly; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of focal adhesion assembly; P:substrate adhesion-dependent cell spreading; scaffold77 indexed_genome mRNA 5426473 5427037 . - . ID=transcript_11850;Q9H792 Q6ZS78 Q8NAZ4 Q8NCM3 Q8TEG7,Inactive tyrosine-protein kinase PEAK1 {ECO:0000305},Pseudopodium-enriched atypical kinase 1 {ECO:0000303|PubMed:20534451};Sugen kinase 269 {ECO:0000303|PubMed:29212708};Tyrosine-protein kinase SgK269;, PF00069;, GO:0015629;GO:0005737;GO:0005925;GO:0042802;GO:0004715;GO:0004672;GO:0016477;GO:0048041;GO:0046777;GO:0006468;GO:0051893;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:identical protein binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity;, P:cell migration; P:focal adhesion assembly; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of focal adhesion assembly; P:substrate adhesion-dependent cell spreading; scaffold77 indexed_genome mRNA 5427421 5429532 . - . ID=transcript_11851;Q9H792 Q6ZS78 Q8NAZ4 Q8NCM3 Q8TEG7,Inactive tyrosine-protein kinase PEAK1 {ECO:0000305},Pseudopodium-enriched atypical kinase 1 {ECO:0000303|PubMed:20534451};Sugen kinase 269 {ECO:0000303|PubMed:29212708};Tyrosine-protein kinase SgK269;, PF00069;, GO:0015629;GO:0005737;GO:0005925;GO:0042802;GO:0004715;GO:0004672;GO:0016477;GO:0048041;GO:0046777;GO:0006468;GO:0051893;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:identical protein binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity;, P:cell migration; P:focal adhesion assembly; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of focal adhesion assembly; P:substrate adhesion-dependent cell spreading;|Q9H792 Q6ZS78 Q8NAZ4 Q8NCM3 Q8TEG7,Inactive tyrosine-protein kinase PEAK1 {ECO:0000305},Pseudopodium-enriched atypical kinase 1 {ECO:0000303|PubMed:20534451};Sugen kinase 269 {ECO:0000303|PubMed:29212708};Tyrosine-protein kinase SgK269;, PF00069;, GO:0015629;GO:0005737;GO:0005925;GO:0042802;GO:0004715;GO:0004672;GO:0016477;GO:0048041;GO:0046777;GO:0006468;GO:0051893;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:identical protein binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity;, P:cell migration; P:focal adhesion assembly; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of focal adhesion assembly; P:substrate adhesion-dependent cell spreading; scaffold77 indexed_genome mRNA 5670251 5735656 . + . ID=transcript_11852;Q9NP66 A6NHY3 D3DW78 Q53G31 Q9NSF6,High mobility group protein 20A,HMG box-containing protein 20A;HMG domain-containing protein 1;HMG domain-containing protein HMGX1;, PF00505;, GO:0005634;GO:0003677;GO:0042802;GO:0006325;GO:0045665;GO:0033234;GO:0000122;GO:0010468;GO:0006355;, C:nucleus;, F:DNA binding; F:identical protein binding;, P:chromatin organization; P:negative regulation of neuron differentiation; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription, DNA-templated;|Q9NP66 A6NHY3 D3DW78 Q53G31 Q9NSF6,High mobility group protein 20A,HMG box-containing protein 20A;HMG domain-containing protein 1;HMG domain-containing protein HMGX1;, PF00505;, GO:0005634;GO:0003677;GO:0042802;GO:0006325;GO:0045665;GO:0033234;GO:0000122;GO:0010468;GO:0006355;, C:nucleus;, F:DNA binding; F:identical protein binding;, P:chromatin organization; P:negative regulation of neuron differentiation; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription, DNA-templated;|Q9NP66 A6NHY3 D3DW78 Q53G31 Q9NSF6,High mobility group protein 20A,HMG box-containing protein 20A;HMG domain-containing protein 1;HMG domain-containing protein HMGX1;, PF00505;, GO:0005634;GO:0003677;GO:0042802;GO:0006325;GO:0045665;GO:0033234;GO:0000122;GO:0010468;GO:0006355;, C:nucleus;, F:DNA binding; F:identical protein binding;, P:chromatin organization; P:negative regulation of neuron differentiation; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription, DNA-templated;|Q9NP66 A6NHY3 D3DW78 Q53G31 Q9NSF6,High mobility group protein 20A,HMG box-containing protein 20A;HMG domain-containing protein 1;HMG domain-containing protein HMGX1;, PF00505;, GO:0005634;GO:0003677;GO:0042802;GO:0006325;GO:0045665;GO:0033234;GO:0000122;GO:0010468;GO:0006355;, C:nucleus;, F:DNA binding; F:identical protein binding;, P:chromatin organization; P:negative regulation of neuron differentiation; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription, DNA-templated;|Q9NP66 A6NHY3 D3DW78 Q53G31 Q9NSF6,High mobility group protein 20A,HMG box-containing protein 20A;HMG domain-containing protein 1;HMG domain-containing protein HMGX1;, PF00505;, GO:0005634;GO:0003677;GO:0042802;GO:0006325;GO:0045665;GO:0033234;GO:0000122;GO:0010468;GO:0006355;, C:nucleus;, F:DNA binding; F:identical protein binding;, P:chromatin organization; P:negative regulation of neuron differentiation; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription, DNA-templated;|Q9NP66 A6NHY3 D3DW78 Q53G31 Q9NSF6,High mobility group protein 20A,HMG box-containing protein 20A;HMG domain-containing protein 1;HMG domain-containing protein HMGX1;, PF00505;, GO:0005634;GO:0003677;GO:0042802;GO:0006325;GO:0045665;GO:0033234;GO:0000122;GO:0010468;GO:0006355;, C:nucleus;, F:DNA binding; F:identical protein binding;, P:chromatin organization; P:negative regulation of neuron differentiation; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription, DNA-templated; scaffold77 indexed_genome mRNA 5866994 5885974 . - . ID=transcript_11853;Q96FE5 D3DW80 Q6NUK3 Q6UXM3 Q6VVG0 Q6VVG1 Q6VVG2 Q8N3K5 Q96K52,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1,Leucine-rich repeat and immunoglobulin domain-containing protein 1;Leucine-rich repeat neuronal protein 1;Leucine-rich repeat neuronal protein 6A;, PF07679;PF13306;PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0005154;GO:0050771;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:epidermal growth factor receptor binding;, P:negative regulation of axonogenesis; scaffold77 indexed_genome mRNA 6150064 6171271 . + . ID=transcript_11854;Q6UVK1 D3DW77 Q92675,Chondroitin sulfate proteoglycan 4,Chondroitin sulfate proteoglycan NG2;Melanoma chondroitin sulfate proteoglycan;Melanoma-associated chondroitin sulfate proteoglycan;, PF00054;PF02210;, GO:0016324;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005925;GO:0005796;GO:0005887;GO:0031258;GO:0043202;GO:0005654;GO:0005886;GO:0001726;GO:0015026;GO:0019901;GO:0000187;GO:0001525;GO:0008283;GO:0030206;GO:0030207;GO:0030208;GO:0008347;GO:0035556;GO:0048008;GO:0050731;GO:0097178;GO:0006929;GO:0048771;, C:apical plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:Golgi lumen; C:integral component of plasma membrane; C:lamellipodium membrane; C:lysosomal lumen; C:nucleoplasm; C:plasma membrane; C:ruffle;, F:coreceptor activity; F:protein kinase binding;, P:activation of MAPK activity; P:angiogenesis; P:cell population proliferation; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:glial cell migration; P:intracellular signal transduction; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of peptidyl-tyrosine phosphorylation; P:ruffle assembly; P:substrate-dependent cell migration; P:tissue remodeling; scaffold77 indexed_genome mRNA 6173108 6176475 . - . ID=transcript_11855;Q6UVK1 D3DW77 Q92675,Chondroitin sulfate proteoglycan 4,Chondroitin sulfate proteoglycan NG2;Melanoma chondroitin sulfate proteoglycan;Melanoma-associated chondroitin sulfate proteoglycan;, PF00054;PF02210;, GO:0016324;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005925;GO:0005796;GO:0005887;GO:0031258;GO:0043202;GO:0005654;GO:0005886;GO:0001726;GO:0015026;GO:0019901;GO:0000187;GO:0001525;GO:0008283;GO:0030206;GO:0030207;GO:0030208;GO:0008347;GO:0035556;GO:0048008;GO:0050731;GO:0097178;GO:0006929;GO:0048771;, C:apical plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:Golgi lumen; C:integral component of plasma membrane; C:lamellipodium membrane; C:lysosomal lumen; C:nucleoplasm; C:plasma membrane; C:ruffle;, F:coreceptor activity; F:protein kinase binding;, P:activation of MAPK activity; P:angiogenesis; P:cell population proliferation; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:glial cell migration; P:intracellular signal transduction; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of peptidyl-tyrosine phosphorylation; P:ruffle assembly; P:substrate-dependent cell migration; P:tissue remodeling;|Q6UVK1 D3DW77 Q92675,Chondroitin sulfate proteoglycan 4,Chondroitin sulfate proteoglycan NG2;Melanoma chondroitin sulfate proteoglycan;Melanoma-associated chondroitin sulfate proteoglycan;, PF00054;PF02210;, GO:0016324;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005925;GO:0005796;GO:0005887;GO:0031258;GO:0043202;GO:0005654;GO:0005886;GO:0001726;GO:0015026;GO:0019901;GO:0000187;GO:0001525;GO:0008283;GO:0030206;GO:0030207;GO:0030208;GO:0008347;GO:0035556;GO:0048008;GO:0050731;GO:0097178;GO:0006929;GO:0048771;, C:apical plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:Golgi lumen; C:integral component of plasma membrane; C:lamellipodium membrane; C:lysosomal lumen; C:nucleoplasm; C:plasma membrane; C:ruffle;, F:coreceptor activity; F:protein kinase binding;, P:activation of MAPK activity; P:angiogenesis; P:cell population proliferation; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:glial cell migration; P:intracellular signal transduction; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of peptidyl-tyrosine phosphorylation; P:ruffle assembly; P:substrate-dependent cell migration; P:tissue remodeling; scaffold77 indexed_genome mRNA 6178228 6185601 . + . ID=transcript_11856;Q6UVK1 D3DW77 Q92675,Chondroitin sulfate proteoglycan 4,Chondroitin sulfate proteoglycan NG2;Melanoma chondroitin sulfate proteoglycan;Melanoma-associated chondroitin sulfate proteoglycan;, PF00054;PF02210;, GO:0016324;GO:0009986;GO:0062023;GO:0070062;GO:0005576;GO:0005925;GO:0005796;GO:0005887;GO:0031258;GO:0043202;GO:0005654;GO:0005886;GO:0001726;GO:0015026;GO:0019901;GO:0000187;GO:0001525;GO:0008283;GO:0030206;GO:0030207;GO:0030208;GO:0008347;GO:0035556;GO:0048008;GO:0050731;GO:0097178;GO:0006929;GO:0048771;, C:apical plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:Golgi lumen; C:integral component of plasma membrane; C:lamellipodium membrane; C:lysosomal lumen; C:nucleoplasm; C:plasma membrane; C:ruffle;, F:coreceptor activity; F:protein kinase binding;, P:activation of MAPK activity; P:angiogenesis; P:cell population proliferation; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:glial cell migration; P:intracellular signal transduction; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of peptidyl-tyrosine phosphorylation; P:ruffle assembly; P:substrate-dependent cell migration; P:tissue remodeling; scaffold77 indexed_genome mRNA 6196513 6210616 . - . ID=transcript_11857;Q8WV41 B1NM17,Sorting nexin-33,SH3 and PX domain-containing protein 3;, PF10456;PF00787;PF14604;, GO:0031410;GO:0030659;GO:0005829;GO:0019898;GO:0016020;GO:0042802;GO:0035091;GO:0036089;GO:0006897;GO:0016197;GO:0007032;GO:0006886;GO:0044351;GO:0000281;GO:0045806;GO:2000009;GO:0097320;GO:0051044;GO:2000010;GO:0017038;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extrinsic component of membrane; C:membrane;, F:identical protein binding; F:phosphatidylinositol binding;, P:cleavage furrow formation; P:endocytosis; P:endosomal transport; P:endosome organization; P:intracellular protein transport; P:macropinocytosis; P:mitotic cytokinesis; P:negative regulation of endocytosis; P:negative regulation of protein localization to cell surface; P:plasma membrane tubulation; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein localization to cell surface; P:protein import; scaffold77 indexed_genome mRNA 6220187 6221395 . + . ID=transcript_11858;Q9NV31 B3KQ67 Q53G10,U3 small nucleolar ribonucleoprotein protein IMP3,BRMS2;, PF00163;PF01479;, GO:0034457;GO:0005730;GO:0005654;GO:0005634;GO:0030684;GO:0032040;GO:0003723;GO:0019843;GO:0030515;GO:0006364;, C:Mpp10 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome; C:small-subunit processome;, F:RNA binding; F:rRNA binding; F:snoRNA binding;, P:rRNA processing; scaffold77 indexed_genome mRNA 6235195 6255375 . + . ID=transcript_11859;O95149 A6NE34 A8K0B0 D3DW76,Snurportin-1,RNA U transporter 1;, PF11538;, GO:0005829;GO:0005643;GO:0061608;GO:0000339;GO:0051170;GO:0006606;GO:0061015;GO:0000387;, C:cytosol; C:nuclear pore;, F:nuclear import signal receptor activity; F:RNA cap binding;, P:import into nucleus; P:protein import into nucleus; P:snRNA import into nucleus; P:spliceosomal snRNP assembly;|O95149 A6NE34 A8K0B0 D3DW76,Snurportin-1,RNA U transporter 1;, PF11538;, GO:0005829;GO:0005643;GO:0061608;GO:0000339;GO:0051170;GO:0006606;GO:0061015;GO:0000387;, C:cytosol; C:nuclear pore;, F:nuclear import signal receptor activity; F:RNA cap binding;, P:import into nucleus; P:protein import into nucleus; P:snRNA import into nucleus; P:spliceosomal snRNP assembly; scaffold77 indexed_genome mRNA 6301909 6341102 . + . ID=transcript_11860;P43378 Q53XR9,Tyrosine-protein phosphatase non-receptor type 9,Protein-tyrosine phosphatase MEG2;, PF00650;PF00102;, GO:0005737;GO:0044306;GO:0005654;GO:0004726;GO:0004725;GO:0071345;GO:0010977;GO:0035335;GO:1903078;GO:0006470;, C:cytoplasm; C:neuron projection terminus; C:nucleoplasm;, F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:negative regulation of neuron projection development; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of protein localization to plasma membrane; P:protein dephosphorylation; scaffold77 indexed_genome mRNA 6370659 6433681 . + . ID=transcript_11861;Q96ST3 B2RNS5 Q8N8N4 Q8NC83 Q8WV18 Q96L98 Q9UFQ1,Paired amphipathic helix protein Sin3a,Histone deacetylase complex subunit Sin3a;Transcriptional corepressor Sin3a;, PF02671;PF08295;PF16879;, GO:0000785;GO:0000118;GO:0000776;GO:0005730;GO:0005654;GO:0005634;GO:0016580;GO:0017053;GO:0003682;GO:0003677;GO:0044877;GO:0003723;GO:0001102;GO:0001103;GO:0003713;GO:0003714;GO:0140416;GO:0002218;GO:0007568;GO:0034613;GO:1903351;GO:0071333;GO:0021895;GO:0006260;GO:0002244;GO:0016575;GO:0001701;GO:0043066;GO:0042754;GO:1901675;GO:1900181;GO:0000122;GO:2000678;GO:0045892;GO:0031937;GO:0002230;GO:0010971;GO:0045666;GO:0045944;GO:0006476;GO:0030516;GO:0010817;GO:0019216;GO:0045652;GO:0043619;GO:0051595;GO:0048511;, C:chromatin; C:histone deacetylase complex; C:kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:transcription repressor complex;, F:chromatin binding; F:DNA binding; F:protein-containing complex binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription regulator inhibitor activity;, P:activation of innate immune response; P:aging; P:cellular protein localization; P:cellular response to dopamine; P:cellular response to glucose stimulus; P:cerebral cortex neuron differentiation; P:DNA replication; P:hematopoietic progenitor cell differentiation; P:histone deacetylation; P:in utero embryonic development; P:negative regulation of apoptotic process; P:negative regulation of circadian rhythm; P:negative regulation of histone H3-K27 acetylation; P:negative regulation of protein localization to nucleus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin silencing; P:positive regulation of defense response to virus by host; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of axon extension; P:regulation of hormone levels; P:regulation of lipid metabolic process; P:regulation of megakaryocyte differentiation; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to methylglyoxal; P:rhythmic process;|Q96ST3 B2RNS5 Q8N8N4 Q8NC83 Q8WV18 Q96L98 Q9UFQ1,Paired amphipathic helix protein Sin3a,Histone deacetylase complex subunit Sin3a;Transcriptional corepressor Sin3a;, PF02671;PF08295;PF16879;, GO:0000785;GO:0000118;GO:0000776;GO:0005730;GO:0005654;GO:0005634;GO:0016580;GO:0017053;GO:0003682;GO:0003677;GO:0044877;GO:0003723;GO:0001102;GO:0001103;GO:0003713;GO:0003714;GO:0140416;GO:0002218;GO:0007568;GO:0034613;GO:1903351;GO:0071333;GO:0021895;GO:0006260;GO:0002244;GO:0016575;GO:0001701;GO:0043066;GO:0042754;GO:1901675;GO:1900181;GO:0000122;GO:2000678;GO:0045892;GO:0031937;GO:0002230;GO:0010971;GO:0045666;GO:0045944;GO:0006476;GO:0030516;GO:0010817;GO:0019216;GO:0045652;GO:0043619;GO:0051595;GO:0048511;, C:chromatin; C:histone deacetylase complex; C:kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:transcription repressor complex;, F:chromatin binding; F:DNA binding; F:protein-containing complex binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription regulator inhibitor activity;, P:activation of innate immune response; P:aging; P:cellular protein localization; P:cellular response to dopamine; P:cellular response to glucose stimulus; P:cerebral cortex neuron differentiation; P:DNA replication; P:hematopoietic progenitor cell differentiation; P:histone deacetylation; P:in utero embryonic development; P:negative regulation of apoptotic process; P:negative regulation of circadian rhythm; P:negative regulation of histone H3-K27 acetylation; P:negative regulation of protein localization to nucleus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin silencing; P:positive regulation of defense response to virus by host; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of axon extension; P:regulation of hormone levels; P:regulation of lipid metabolic process; P:regulation of megakaryocyte differentiation; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to methylglyoxal; P:rhythmic process;|Q96ST3 B2RNS5 Q8N8N4 Q8NC83 Q8WV18 Q96L98 Q9UFQ1,Paired amphipathic helix protein Sin3a,Histone deacetylase complex subunit Sin3a;Transcriptional corepressor Sin3a;, PF02671;PF08295;PF16879;, GO:0000785;GO:0000118;GO:0000776;GO:0005730;GO:0005654;GO:0005634;GO:0016580;GO:0017053;GO:0003682;GO:0003677;GO:0044877;GO:0003723;GO:0001102;GO:0001103;GO:0003713;GO:0003714;GO:0140416;GO:0002218;GO:0007568;GO:0034613;GO:1903351;GO:0071333;GO:0021895;GO:0006260;GO:0002244;GO:0016575;GO:0001701;GO:0043066;GO:0042754;GO:1901675;GO:1900181;GO:0000122;GO:2000678;GO:0045892;GO:0031937;GO:0002230;GO:0010971;GO:0045666;GO:0045944;GO:0006476;GO:0030516;GO:0010817;GO:0019216;GO:0045652;GO:0043619;GO:0051595;GO:0048511;, C:chromatin; C:histone deacetylase complex; C:kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:transcription repressor complex;, F:chromatin binding; F:DNA binding; F:protein-containing complex binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription regulator inhibitor activity;, P:activation of innate immune response; P:aging; P:cellular protein localization; P:cellular response to dopamine; P:cellular response to glucose stimulus; P:cerebral cortex neuron differentiation; P:DNA replication; P:hematopoietic progenitor cell differentiation; P:histone deacetylation; P:in utero embryonic development; P:negative regulation of apoptotic process; P:negative regulation of circadian rhythm; P:negative regulation of histone H3-K27 acetylation; P:negative regulation of protein localization to nucleus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin silencing; P:positive regulation of defense response to virus by host; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of axon extension; P:regulation of hormone levels; P:regulation of lipid metabolic process; P:regulation of megakaryocyte differentiation; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to methylglyoxal; P:rhythmic process;|Q9NTJ4 H3BMX2 H3BQY8 H3BUT6 Q13358 Q68EM8 Q9UL64,Alpha-mannosidase 2C1,Alpha mannosidase 6A8B;Alpha-D-mannoside mannohydrolase;Mannosidase alpha class 2C member 1;, PF09261;PF17677;PF07748;PF01074;, GO:0005829;GO:0005654;GO:0004559;GO:0030246;GO:0046872;GO:0006013;GO:0009313;, C:cytosol; C:nucleoplasm;, F:alpha-mannosidase activity; F:carbohydrate binding; F:metal ion binding;, P:mannose metabolic process; P:oligosaccharide catabolic process;|Q96ST3 B2RNS5 Q8N8N4 Q8NC83 Q8WV18 Q96L98 Q9UFQ1,Paired amphipathic helix protein Sin3a,Histone deacetylase complex subunit Sin3a;Transcriptional corepressor Sin3a;, PF02671;PF08295;PF16879;, GO:0000785;GO:0000118;GO:0000776;GO:0005730;GO:0005654;GO:0005634;GO:0016580;GO:0017053;GO:0003682;GO:0003677;GO:0044877;GO:0003723;GO:0001102;GO:0001103;GO:0003713;GO:0003714;GO:0140416;GO:0002218;GO:0007568;GO:0034613;GO:1903351;GO:0071333;GO:0021895;GO:0006260;GO:0002244;GO:0016575;GO:0001701;GO:0043066;GO:0042754;GO:1901675;GO:1900181;GO:0000122;GO:2000678;GO:0045892;GO:0031937;GO:0002230;GO:0010971;GO:0045666;GO:0045944;GO:0006476;GO:0030516;GO:0010817;GO:0019216;GO:0045652;GO:0043619;GO:0051595;GO:0048511;, C:chromatin; C:histone deacetylase complex; C:kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:transcription repressor complex;, F:chromatin binding; F:DNA binding; F:protein-containing complex binding; F:RNA binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription regulator inhibitor activity;, P:activation of innate immune response; P:aging; P:cellular protein localization; P:cellular response to dopamine; P:cellular response to glucose stimulus; P:cerebral cortex neuron differentiation; P:DNA replication; P:hematopoietic progenitor cell differentiation; P:histone deacetylation; P:in utero embryonic development; P:negative regulation of apoptotic process; P:negative regulation of circadian rhythm; P:negative regulation of histone H3-K27 acetylation; P:negative regulation of protein localization to nucleus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:positive regulation of chromatin silencing; P:positive regulation of defense response to virus by host; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein deacetylation; P:regulation of axon extension; P:regulation of hormone levels; P:regulation of lipid metabolic process; P:regulation of megakaryocyte differentiation; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to methylglyoxal; P:rhythmic process;|Q9NTJ4 H3BMX2 H3BQY8 H3BUT6 Q13358 Q68EM8 Q9UL64,Alpha-mannosidase 2C1,Alpha mannosidase 6A8B;Alpha-D-mannoside mannohydrolase;Mannosidase alpha class 2C member 1;, PF09261;PF17677;PF07748;PF01074;, GO:0005829;GO:0005654;GO:0004559;GO:0030246;GO:0046872;GO:0006013;GO:0009313;, C:cytosol; C:nucleoplasm;, F:alpha-mannosidase activity; F:carbohydrate binding; F:metal ion binding;, P:mannose metabolic process; P:oligosaccharide catabolic process;|Q9NTJ4 H3BMX2 H3BQY8 H3BUT6 Q13358 Q68EM8 Q9UL64,Alpha-mannosidase 2C1,Alpha mannosidase 6A8B;Alpha-D-mannoside mannohydrolase;Mannosidase alpha class 2C member 1;, PF09261;PF17677;PF07748;PF01074;, GO:0005829;GO:0005654;GO:0004559;GO:0030246;GO:0046872;GO:0006013;GO:0009313;, C:cytosol; C:nucleoplasm;, F:alpha-mannosidase activity; F:carbohydrate binding; F:metal ion binding;, P:mannose metabolic process; P:oligosaccharide catabolic process;|Q9NTJ4 H3BMX2 H3BQY8 H3BUT6 Q13358 Q68EM8 Q9UL64,Alpha-mannosidase 2C1,Alpha mannosidase 6A8B;Alpha-D-mannoside mannohydrolase;Mannosidase alpha class 2C member 1;, PF09261;PF17677;PF07748;PF01074;, GO:0005829;GO:0005654;GO:0004559;GO:0030246;GO:0046872;GO:0006013;GO:0009313;, C:cytosol; C:nucleoplasm;, F:alpha-mannosidase activity; F:carbohydrate binding; F:metal ion binding;, P:mannose metabolic process; P:oligosaccharide catabolic process; scaffold77 indexed_genome mRNA 6433749 6439271 . + . ID=transcript_11862;Q96FI4 D3DW75 Q6ZRA7 Q86XW7 Q9H6C3,Endonuclease 8-like 1,DNA glycosylase/AP lyase Neil1;DNA-(apurinic or apyrimidinic site) lyase Neil1;Endonuclease VIII-like 1;FPG1;Nei homolog 1;Nei-like protein 1;, PF01149;PF09292;, GO:0005694;GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005634;GO:0140078;GO:0003684;GO:0019104;GO:0003906;GO:0016798;GO:0008022;GO:0008270;GO:0006284;GO:0006287;GO:0045008;GO:0032074;GO:0006979;, C:chromosome; C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:nucleus;, F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA N-glycosylase activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:hydrolase activity, acting on glycosyl bonds; F:protein C-terminus binding; F:zinc ion binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:depyrimidination; P:negative regulation of nuclease activity; P:response to oxidative stress;|Q96FI4 D3DW75 Q6ZRA7 Q86XW7 Q9H6C3,Endonuclease 8-like 1,DNA glycosylase/AP lyase Neil1;DNA-(apurinic or apyrimidinic site) lyase Neil1;Endonuclease VIII-like 1;FPG1;Nei homolog 1;Nei-like protein 1;, PF01149;PF09292;, GO:0005694;GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005634;GO:0140078;GO:0003684;GO:0019104;GO:0003906;GO:0016798;GO:0008022;GO:0008270;GO:0006284;GO:0006287;GO:0045008;GO:0032074;GO:0006979;, C:chromosome; C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:nucleus;, F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA N-glycosylase activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:hydrolase activity, acting on glycosyl bonds; F:protein C-terminus binding; F:zinc ion binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:depyrimidination; P:negative regulation of nuclease activity; P:response to oxidative stress;|Q96FI4 D3DW75 Q6ZRA7 Q86XW7 Q9H6C3,Endonuclease 8-like 1,DNA glycosylase/AP lyase Neil1;DNA-(apurinic or apyrimidinic site) lyase Neil1;Endonuclease VIII-like 1;FPG1;Nei homolog 1;Nei-like protein 1;, PF01149;PF09292;, GO:0005694;GO:0005737;GO:0005829;GO:0005815;GO:0005654;GO:0005634;GO:0140078;GO:0003684;GO:0019104;GO:0003906;GO:0016798;GO:0008022;GO:0008270;GO:0006284;GO:0006287;GO:0045008;GO:0032074;GO:0006979;, C:chromosome; C:cytoplasm; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:nucleus;, F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA N-glycosylase activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:hydrolase activity, acting on glycosyl bonds; F:protein C-terminus binding; F:zinc ion binding;, P:base-excision repair; P:base-excision repair, gap-filling; P:depyrimidination; P:negative regulation of nuclease activity; P:response to oxidative stress; scaffold77 indexed_genome mRNA 6451190 6455835 . - . ID=transcript_11863;Q9H0A8 B2RBN4 H3BUL2 Q7L637 Q9NX43,COMM domain-containing protein 4,, PF07258;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;|Q9H0A8 B2RBN4 H3BUL2 Q7L637 Q9NX43,COMM domain-containing protein 4,, PF07258;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane; scaffold77 indexed_genome mRNA 6514678 6520843 . - . ID=transcript_11864;Q6ZRI6 B3KWI3 C9J888 Q71JB1 Q7L3S0 Q8N3F2 Q96FB6 Q9NTU5,Uncharacterized protein C15orf39,, PF17663;, GO:0005829;, C:cytosol; scaffold77 indexed_genome mRNA 6635561 6636787 . - . ID=transcript_11865;Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold77 indexed_genome mRNA 6648042 6656460 . - . ID=transcript_11866;Q96CD2 Q96SX0 Q9HC17,Phosphopantothenoylcysteine decarboxylase,CoaC;, PF02441;, GO:0005829;GO:0071513;GO:0010181;GO:0042802;GO:0004633;GO:0015937;, C:cytosol; C:phosphopantothenoylcysteine decarboxylase complex;, F:FMN binding; F:identical protein binding; F:phosphopantothenoylcysteine decarboxylase activity;, P:coenzyme A biosynthetic process;|Q96CD2 Q96SX0 Q9HC17,Phosphopantothenoylcysteine decarboxylase,CoaC;, PF02441;, GO:0005829;GO:0071513;GO:0010181;GO:0042802;GO:0004633;GO:0015937;, C:cytosol; C:phosphopantothenoylcysteine decarboxylase complex;, F:FMN binding; F:identical protein binding; F:phosphopantothenoylcysteine decarboxylase activity;, P:coenzyme A biosynthetic process;|Q96CD2 Q96SX0 Q9HC17,Phosphopantothenoylcysteine decarboxylase,CoaC;, PF02441;, GO:0005829;GO:0071513;GO:0010181;GO:0042802;GO:0004633;GO:0015937;, C:cytosol; C:phosphopantothenoylcysteine decarboxylase complex;, F:FMN binding; F:identical protein binding; F:phosphopantothenoylcysteine decarboxylase activity;, P:coenzyme A biosynthetic process; scaffold77 indexed_genome mRNA 6674532 6680859 . - . ID=transcript_11867;Q8TAC9 B3KPJ7 B7Z762 D3DW71 Q8N3M4,Secretory carrier-associated membrane protein 5,, PF04144;, GO:0000139;GO:0016021;GO:0005886;GO:0055038;GO:0030672;GO:0032588;GO:0044877;GO:0006887;GO:0045806;GO:0045956;GO:0001819;GO:0015031;GO:0034976;, C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:recycling endosome membrane; C:synaptic vesicle membrane; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:exocytosis; P:negative regulation of endocytosis; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of cytokine production; P:protein transport; P:response to endoplasmic reticulum stress;|Q8TAC9 B3KPJ7 B7Z762 D3DW71 Q8N3M4,Secretory carrier-associated membrane protein 5,, PF04144;, GO:0000139;GO:0016021;GO:0005886;GO:0055038;GO:0030672;GO:0032588;GO:0044877;GO:0006887;GO:0045806;GO:0045956;GO:0001819;GO:0015031;GO:0034976;, C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:recycling endosome membrane; C:synaptic vesicle membrane; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:exocytosis; P:negative regulation of endocytosis; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of cytokine production; P:protein transport; P:response to endoplasmic reticulum stress;|Q8TAC9 B3KPJ7 B7Z762 D3DW71 Q8N3M4,Secretory carrier-associated membrane protein 5,, PF04144;, GO:0000139;GO:0016021;GO:0005886;GO:0055038;GO:0030672;GO:0032588;GO:0044877;GO:0006887;GO:0045806;GO:0045956;GO:0001819;GO:0015031;GO:0034976;, C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:recycling endosome membrane; C:synaptic vesicle membrane; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:exocytosis; P:negative regulation of endocytosis; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of cytokine production; P:protein transport; P:response to endoplasmic reticulum stress; scaffold77 indexed_genome mRNA 6729373 6730423 . - . ID=transcript_11868;Q9BUL9 D3DW70 Q9NX88,Ribonuclease P protein subunit p25,, PF01918;, GO:0034451;GO:0030681;GO:0005730;GO:0005654;GO:0000172;GO:0004526;GO:0033204;GO:0003723;GO:0006364;GO:0001682;, C:centriolar satellite; C:multimeric ribonuclease P complex; C:nucleolus; C:nucleoplasm; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding; F:RNA binding;, P:rRNA processing; P:tRNA 5'-leader removal; scaffold77 indexed_genome mRNA 6741187 6751537 . + . ID=transcript_11869;P20674 P30045 Q8TB65,Cytochrome c oxidase subunit 5A, mitochondrial,Cytochrome c oxidase polypeptide Va;, PF02284;, GO:0005743;GO:0005751;GO:0004129;GO:0009055;GO:0046872;GO:0006123;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:electron transfer activity; F:metal ion binding;, P:mitochondrial electron transport, cytochrome c to oxygen;|P20674 P30045 Q8TB65,Cytochrome c oxidase subunit 5A, mitochondrial,Cytochrome c oxidase polypeptide Va;, PF02284;, GO:0005743;GO:0005751;GO:0004129;GO:0009055;GO:0046872;GO:0006123;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:electron transfer activity; F:metal ion binding;, P:mitochondrial electron transport, cytochrome c to oxygen;|P20674 P30045 Q8TB65,Cytochrome c oxidase subunit 5A, mitochondrial,Cytochrome c oxidase polypeptide Va;, PF02284;, GO:0005743;GO:0005751;GO:0004129;GO:0009055;GO:0046872;GO:0006123;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:electron transfer activity; F:metal ion binding;, P:mitochondrial electron transport, cytochrome c to oxygen;|P20674 P30045 Q8TB65,Cytochrome c oxidase subunit 5A, mitochondrial,Cytochrome c oxidase polypeptide Va;, PF02284;, GO:0005743;GO:0005751;GO:0004129;GO:0009055;GO:0046872;GO:0006123;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:electron transfer activity; F:metal ion binding;, P:mitochondrial electron transport, cytochrome c to oxygen;|P20674 P30045 Q8TB65,Cytochrome c oxidase subunit 5A, mitochondrial,Cytochrome c oxidase polypeptide Va;, PF02284;, GO:0005743;GO:0005751;GO:0004129;GO:0009055;GO:0046872;GO:0006123;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV;, F:cytochrome-c oxidase activity; F:electron transfer activity; F:metal ion binding;, P:mitochondrial electron transport, cytochrome c to oxygen; scaffold77 indexed_genome mRNA 6765580 6767058 . + . ID=transcript_11870;Q5XKK7 A8K4Q5 B4DK57 Q9NXY0,Protein FAM219B,, PF15260; scaffold77 indexed_genome mRNA 6771202 6773795 . - . ID=transcript_11871;P34949 A8K8K9 Q96AB0,Mannose-6-phosphate isomerase,Phosphohexomutase;Phosphomannose isomerase;, PF01238;, GO:0005829;GO:0070062;GO:0004476;GO:0008270;GO:0009298;GO:0061611;GO:0006486;, C:cytosol; C:extracellular exosome;, F:mannose-6-phosphate isomerase activity; F:zinc ion binding;, P:GDP-mannose biosynthetic process; P:mannose to fructose-6-phosphate metabolic process; P:protein glycosylation; scaffold77 indexed_genome mRNA 6775257 6778991 . - . ID=transcript_11872;P34949 A8K8K9 Q96AB0,Mannose-6-phosphate isomerase,Phosphohexomutase;Phosphomannose isomerase;, PF01238;, GO:0005829;GO:0070062;GO:0004476;GO:0008270;GO:0009298;GO:0061611;GO:0006486;, C:cytosol; C:extracellular exosome;, F:mannose-6-phosphate isomerase activity; F:zinc ion binding;, P:GDP-mannose biosynthetic process; P:mannose to fructose-6-phosphate metabolic process; P:protein glycosylation;|P34949 A8K8K9 Q96AB0,Mannose-6-phosphate isomerase,Phosphohexomutase;Phosphomannose isomerase;, PF01238;, GO:0005829;GO:0070062;GO:0004476;GO:0008270;GO:0009298;GO:0061611;GO:0006486;, C:cytosol; C:extracellular exosome;, F:mannose-6-phosphate isomerase activity; F:zinc ion binding;, P:GDP-mannose biosynthetic process; P:mannose to fructose-6-phosphate metabolic process; P:protein glycosylation; scaffold77 indexed_genome mRNA 6788069 6810290 . + . ID=transcript_11873;O15127 B2RDF0 Q9BQE8,Secretory carrier-associated membrane protein 2,, PF04144;, GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0055038;GO:0032588;GO:0030133;GO:0006892;GO:0015031;, C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:recycling endosome membrane; C:trans-Golgi network membrane; C:transport vesicle;, , P:post-Golgi vesicle-mediated transport; P:protein transport;|O15127 B2RDF0 Q9BQE8,Secretory carrier-associated membrane protein 2,, PF04144;, GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0055038;GO:0032588;GO:0030133;GO:0006892;GO:0015031;, C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:recycling endosome membrane; C:trans-Golgi network membrane; C:transport vesicle;, , P:post-Golgi vesicle-mediated transport; P:protein transport;|O15127 B2RDF0 Q9BQE8,Secretory carrier-associated membrane protein 2,, PF04144;, GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0055038;GO:0032588;GO:0030133;GO:0006892;GO:0015031;, C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:recycling endosome membrane; C:trans-Golgi network membrane; C:transport vesicle;, , P:post-Golgi vesicle-mediated transport; P:protein transport; scaffold77 indexed_genome mRNA 6811379 6818090 . + . ID=transcript_11874;Q6PHR2 B2RXK3 B4DFT0 B4DRQ7 D3DW68 Q9NPN5 Q9UFS4,Serine/threonine-protein kinase ULK3,Unc-51-like kinase 3;, PF04212;PF00069;, GO:0097542;GO:0005737;GO:0000407;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0090398;GO:0072537;GO:0045879;GO:0045880;GO:0046777;GO:0007224;, C:ciliary tip; C:cytoplasm; C:phagophore assembly site;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:cellular senescence; P:fibroblast activation; P:negative regulation of smoothened signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein autophosphorylation; P:smoothened signaling pathway;|Q6PHR2 B2RXK3 B4DFT0 B4DRQ7 D3DW68 Q9NPN5 Q9UFS4,Serine/threonine-protein kinase ULK3,Unc-51-like kinase 3;, PF04212;PF00069;, GO:0097542;GO:0005737;GO:0000407;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0090398;GO:0072537;GO:0045879;GO:0045880;GO:0046777;GO:0007224;, C:ciliary tip; C:cytoplasm; C:phagophore assembly site;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:cellular senescence; P:fibroblast activation; P:negative regulation of smoothened signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein autophosphorylation; P:smoothened signaling pathway;|Q6PHR2 B2RXK3 B4DFT0 B4DRQ7 D3DW68 Q9NPN5 Q9UFS4,Serine/threonine-protein kinase ULK3,Unc-51-like kinase 3;, PF04212;PF00069;, GO:0097542;GO:0005737;GO:0000407;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0090398;GO:0072537;GO:0045879;GO:0045880;GO:0046777;GO:0007224;, C:ciliary tip; C:cytoplasm; C:phagophore assembly site;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:cellular senescence; P:fibroblast activation; P:negative regulation of smoothened signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein autophosphorylation; P:smoothened signaling pathway;|Q6PHR2 B2RXK3 B4DFT0 B4DRQ7 D3DW68 Q9NPN5 Q9UFS4,Serine/threonine-protein kinase ULK3,Unc-51-like kinase 3;, PF04212;PF00069;, GO:0097542;GO:0005737;GO:0000407;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0090398;GO:0072537;GO:0045879;GO:0045880;GO:0046777;GO:0007224;, C:ciliary tip; C:cytoplasm; C:phagophore assembly site;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:cellular senescence; P:fibroblast activation; P:negative regulation of smoothened signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein autophosphorylation; P:smoothened signaling pathway;|Q6PHR2 B2RXK3 B4DFT0 B4DRQ7 D3DW68 Q9NPN5 Q9UFS4,Serine/threonine-protein kinase ULK3,Unc-51-like kinase 3;, PF04212;PF00069;, GO:0097542;GO:0005737;GO:0000407;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006914;GO:0090398;GO:0072537;GO:0045879;GO:0045880;GO:0046777;GO:0007224;, C:ciliary tip; C:cytoplasm; C:phagophore assembly site;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:autophagy; P:cellular senescence; P:fibroblast activation; P:negative regulation of smoothened signaling pathway; P:positive regulation of smoothened signaling pathway; P:protein autophosphorylation; P:smoothened signaling pathway; scaffold77 indexed_genome mRNA 6844203 6848470 . - . ID=transcript_11875;P41240 Q2M3N2 Q6FGZ6,Tyrosine-protein kinase CSK,C-Src kinase;Protein-tyrosine kinase CYL;, PF07714;PF00017;PF00018;, GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0045121;GO:0005886;GO:0005524;GO:0042802;GO:0046872;GO:0004715;GO:0070064;GO:0008022;GO:0034236;GO:0019903;GO:0004713;GO:0004714;GO:0002250;GO:0034332;GO:0007420;GO:0071375;GO:0019221;GO:0045779;GO:0008285;GO:0070373;GO:0042997;GO:0032715;GO:0033673;GO:0010989;GO:0050765;GO:0048709;GO:0043406;GO:0046777;GO:0006468;GO:0060368;GO:0031295;GO:0050852;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane raft; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase A catalytic subunit binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:adherens junction organization; P:brain development; P:cellular response to peptide hormone stimulus; P:cytokine-mediated signaling pathway; P:negative regulation of bone resorption; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of Golgi to plasma membrane protein transport; P:negative regulation of interleukin-6 production; P:negative regulation of kinase activity; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of phagocytosis; P:oligodendrocyte differentiation; P:positive regulation of MAP kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Fc receptor mediated stimulatory signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway;|P41240 Q2M3N2 Q6FGZ6,Tyrosine-protein kinase CSK,C-Src kinase;Protein-tyrosine kinase CYL;, PF07714;PF00017;PF00018;, GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0045121;GO:0005886;GO:0005524;GO:0042802;GO:0046872;GO:0004715;GO:0070064;GO:0008022;GO:0034236;GO:0019903;GO:0004713;GO:0004714;GO:0002250;GO:0034332;GO:0007420;GO:0071375;GO:0019221;GO:0045779;GO:0008285;GO:0070373;GO:0042997;GO:0032715;GO:0033673;GO:0010989;GO:0050765;GO:0048709;GO:0043406;GO:0046777;GO:0006468;GO:0060368;GO:0031295;GO:0050852;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane raft; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase A catalytic subunit binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:adherens junction organization; P:brain development; P:cellular response to peptide hormone stimulus; P:cytokine-mediated signaling pathway; P:negative regulation of bone resorption; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of Golgi to plasma membrane protein transport; P:negative regulation of interleukin-6 production; P:negative regulation of kinase activity; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of phagocytosis; P:oligodendrocyte differentiation; P:positive regulation of MAP kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Fc receptor mediated stimulatory signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway;|P41240 Q2M3N2 Q6FGZ6,Tyrosine-protein kinase CSK,C-Src kinase;Protein-tyrosine kinase CYL;, PF07714;PF00017;PF00018;, GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0045121;GO:0005886;GO:0005524;GO:0042802;GO:0046872;GO:0004715;GO:0070064;GO:0008022;GO:0034236;GO:0019903;GO:0004713;GO:0004714;GO:0002250;GO:0034332;GO:0007420;GO:0071375;GO:0019221;GO:0045779;GO:0008285;GO:0070373;GO:0042997;GO:0032715;GO:0033673;GO:0010989;GO:0050765;GO:0048709;GO:0043406;GO:0046777;GO:0006468;GO:0060368;GO:0031295;GO:0050852;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane raft; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase A catalytic subunit binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:adherens junction organization; P:brain development; P:cellular response to peptide hormone stimulus; P:cytokine-mediated signaling pathway; P:negative regulation of bone resorption; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of Golgi to plasma membrane protein transport; P:negative regulation of interleukin-6 production; P:negative regulation of kinase activity; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of phagocytosis; P:oligodendrocyte differentiation; P:positive regulation of MAP kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Fc receptor mediated stimulatory signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway;|P41240 Q2M3N2 Q6FGZ6,Tyrosine-protein kinase CSK,C-Src kinase;Protein-tyrosine kinase CYL;, PF07714;PF00017;PF00018;, GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0045121;GO:0005886;GO:0005524;GO:0042802;GO:0046872;GO:0004715;GO:0070064;GO:0008022;GO:0034236;GO:0019903;GO:0004713;GO:0004714;GO:0002250;GO:0034332;GO:0007420;GO:0071375;GO:0019221;GO:0045779;GO:0008285;GO:0070373;GO:0042997;GO:0032715;GO:0033673;GO:0010989;GO:0050765;GO:0048709;GO:0043406;GO:0046777;GO:0006468;GO:0060368;GO:0031295;GO:0050852;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane raft; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase A catalytic subunit binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:adherens junction organization; P:brain development; P:cellular response to peptide hormone stimulus; P:cytokine-mediated signaling pathway; P:negative regulation of bone resorption; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of Golgi to plasma membrane protein transport; P:negative regulation of interleukin-6 production; P:negative regulation of kinase activity; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of phagocytosis; P:oligodendrocyte differentiation; P:positive regulation of MAP kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Fc receptor mediated stimulatory signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; scaffold77 indexed_genome mRNA 6848653 6850383 . - . ID=transcript_11876;P41240 Q2M3N2 Q6FGZ6,Tyrosine-protein kinase CSK,C-Src kinase;Protein-tyrosine kinase CYL;, PF07714;PF00017;PF00018;, GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0045121;GO:0005886;GO:0005524;GO:0042802;GO:0046872;GO:0004715;GO:0070064;GO:0008022;GO:0034236;GO:0019903;GO:0004713;GO:0004714;GO:0002250;GO:0034332;GO:0007420;GO:0071375;GO:0019221;GO:0045779;GO:0008285;GO:0070373;GO:0042997;GO:0032715;GO:0033673;GO:0010989;GO:0050765;GO:0048709;GO:0043406;GO:0046777;GO:0006468;GO:0060368;GO:0031295;GO:0050852;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane raft; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase A catalytic subunit binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:adherens junction organization; P:brain development; P:cellular response to peptide hormone stimulus; P:cytokine-mediated signaling pathway; P:negative regulation of bone resorption; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of Golgi to plasma membrane protein transport; P:negative regulation of interleukin-6 production; P:negative regulation of kinase activity; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of phagocytosis; P:oligodendrocyte differentiation; P:positive regulation of MAP kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Fc receptor mediated stimulatory signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; scaffold77 indexed_genome mRNA 6895046 6902172 . - . ID=transcript_11877;P05177 Q16754 Q6NWU3 Q6NWU5 Q9BXX7 Q9UK49,Cytochrome P450 1A2 {ECO:0000303|PubMed:14725854},CYPIA2;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P(3)450;Cytochrome P450 4;Cytochrome P450-P3;Hydroperoxy icosatetraenoate dehydratase {ECO:0000305|PubMed:21068195};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0034875;GO:0032451;GO:0009055;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0106256;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0046222;GO:0009820;GO:0045333;GO:0071276;GO:0071280;GO:0008203;GO:0018894;GO:0042737;GO:0017144;GO:0019373;GO:0008210;GO:0042738;GO:0046483;GO:0050665;GO:0042759;GO:0030324;GO:0032259;GO:0032787;GO:0016098;GO:0097267;GO:0070989;GO:0006778;GO:0009791;GO:0010468;GO:0032355;GO:0035902;GO:0032496;GO:0042572;GO:0006706;GO:0009403;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:caffeine oxidase activity; F:demethylase activity; F:electron transfer activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:hydroperoxy icosatetraenoate dehydratase activity; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;, P:aflatoxin metabolic process; P:alkaloid metabolic process; P:cellular respiration; P:cellular response to cadmium ion; P:cellular response to copper ion; P:cholesterol metabolic process; P:dibenzo-p-dioxin metabolic process; P:drug catabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:hydrogen peroxide biosynthetic process; P:long-chain fatty acid biosynthetic process; P:lung development; P:methylation; P:monocarboxylic acid metabolic process; P:monoterpenoid metabolic process; P:omega-hydroxylase P450 pathway; P:oxidative demethylation; P:porphyrin-containing compound metabolic process; P:post-embryonic development; P:regulation of gene expression; P:response to estradiol; P:response to immobilization stress; P:response to lipopolysaccharide; P:retinol metabolic process; P:steroid catabolic process; P:toxin biosynthetic process; P:xenobiotic metabolic process; scaffold77 indexed_genome mRNA 6923637 6926848 . + . ID=transcript_11878;P04798 A4F3V9 A4F3W0 Q53G18,Cytochrome P450 1A1 {ECO:0000303|PubMed:11555828},Cytochrome P450 form 6;Cytochrome P450-C;Cytochrome P450-P1;Hydroperoxy icosatetraenoate dehydratase {ECO:0000305|PubMed:21068195};, PF00067;, GO:0005789;GO:0043231;GO:0005743;GO:0008391;GO:0070330;GO:0032451;GO:0019899;GO:0101020;GO:0101021;GO:0016711;GO:0020037;GO:0030544;GO:0051879;GO:0106256;GO:0005506;GO:0004497;GO:0016491;GO:0016679;GO:0019825;GO:0070576;GO:0042904;GO:0007568;GO:0009308;GO:0043010;GO:0008283;GO:0071280;GO:0071407;GO:0009804;GO:0019341;GO:0048565;GO:0006306;GO:0017144;GO:0019373;GO:0008210;GO:0009692;GO:0006631;GO:0009812;GO:0070365;GO:0050665;GO:0017143;GO:0002933;GO:0042759;GO:0060137;GO:0097267;GO:0006778;GO:1900087;GO:0019222;GO:0046677;GO:0046685;GO:0042493;GO:0032094;GO:0009635;GO:0055093;GO:0001666;GO:0035902;GO:0010041;GO:0032496;GO:0009624;GO:0009615;GO:0033189;GO:0009611;GO:0042572;GO:0006694;GO:0008202;GO:0042359;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane;, F:arachidonic acid monooxygenase activity; F:aromatase activity; F:demethylase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:flavonoid 3'-monooxygenase activity; F:heme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:hydroperoxy icosatetraenoate dehydratase activity; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on diphenols and related substances as donors; F:oxygen binding; F:vitamin D 24-hydroxylase activity;, P:9-cis-retinoic acid biosynthetic process; P:aging; P:amine metabolic process; P:camera-type eye development; P:cell population proliferation; P:cellular response to copper ion; P:cellular response to organic cyclic compound; P:coumarin metabolic process; P:dibenzo-p-dioxin catabolic process; P:digestive tract development; P:DNA methylation; P:drug metabolic process; P:epoxygenase P450 pathway; P:estrogen metabolic process; P:ethylene metabolic process; P:fatty acid metabolic process; P:flavonoid metabolic process; P:hepatocyte differentiation; P:hydrogen peroxide biosynthetic process; P:insecticide metabolic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:maternal process involved in parturition; P:omega-hydroxylase P450 pathway; P:porphyrin-containing compound metabolic process; P:positive regulation of G1/S transition of mitotic cell cycle; P:regulation of metabolic process; P:response to antibiotic; P:response to arsenic-containing substance; P:response to drug; P:response to food; P:response to herbicide; P:response to hyperoxia; P:response to hypoxia; P:response to immobilization stress; P:response to iron(III) ion; P:response to lipopolysaccharide; P:response to nematode; P:response to virus; P:response to vitamin A; P:response to wounding; P:retinol metabolic process; P:steroid biosynthetic process; P:steroid metabolic process; P:vitamin D metabolic process; scaffold77 indexed_genome mRNA 6959173 7015081 . + . ID=transcript_11879;Q96F86 B3KPH0 D3DW61 Q9H797,Enhancer of mRNA-decapping protein 3,LSM16 homolog;YjeF N-terminal domain-containing protein 2;YjeF domain-containing protein 1;, PF09532;PF12701;PF03853;, GO:0036464;GO:0005829;GO:0016020;GO:0000932;GO:0042802;GO:0003729;GO:1990174;GO:0031087;GO:0043928;GO:0033962;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:P-body;, F:identical protein binding; F:mRNA binding; F:phosphodiesterase decapping endonuclease activity;, P:deadenylation-independent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:P-body assembly; scaffold77 indexed_genome mRNA 7015197 7031257 . - . ID=transcript_11880;P49761 D3DW59 Q53Y48 Q9BRS3 Q9BUJ7,Dual specificity protein kinase CLK3,CDC-like kinase 3;, PF00069;, GO:0001669;GO:0045111;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0003723;GO:0004714;GO:0046777;GO:0006468;GO:0043484;, C:acrosomal vesicle; C:intermediate filament cytoskeleton; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing;|P49761 D3DW59 Q53Y48 Q9BRS3 Q9BUJ7,Dual specificity protein kinase CLK3,CDC-like kinase 3;, PF00069;, GO:0001669;GO:0045111;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0003723;GO:0004714;GO:0046777;GO:0006468;GO:0043484;, C:acrosomal vesicle; C:intermediate filament cytoskeleton; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing;|P49761 D3DW59 Q53Y48 Q9BRS3 Q9BUJ7,Dual specificity protein kinase CLK3,CDC-like kinase 3;, PF00069;, GO:0001669;GO:0045111;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0003723;GO:0004714;GO:0046777;GO:0006468;GO:0043484;, C:acrosomal vesicle; C:intermediate filament cytoskeleton; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing;|P49761 D3DW59 Q53Y48 Q9BRS3 Q9BUJ7,Dual specificity protein kinase CLK3,CDC-like kinase 3;, PF00069;, GO:0001669;GO:0045111;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0003723;GO:0004714;GO:0046777;GO:0006468;GO:0043484;, C:acrosomal vesicle; C:intermediate filament cytoskeleton; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing;|P49761 D3DW59 Q53Y48 Q9BRS3 Q9BUJ7,Dual specificity protein kinase CLK3,CDC-like kinase 3;, PF00069;, GO:0001669;GO:0045111;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0042802;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0003723;GO:0004714;GO:0046777;GO:0006468;GO:0043484;, C:acrosomal vesicle; C:intermediate filament cytoskeleton; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:identical protein binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transmembrane receptor protein tyrosine kinase activity;, P:protein autophosphorylation; P:protein phosphorylation; P:regulation of RNA splicing; scaffold77 indexed_genome mRNA 7051646 7098580 . - . ID=transcript_11881;Q8IVW6 O95443 Q59HC9 Q6P9C9,AT-rich interactive domain-containing protein 3B,Bright and dead ringer protein;Bright-like protein;, PF01388;, GO:0005654;GO:0005634;GO:0003677;GO:0045944;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold77 indexed_genome mRNA 7142026 7144680 . - . ID=transcript_11882;Q01105 A5A5H4 A6NGV1 B4DUE2 Q15541 Q5VXV1 Q5VXV2 Q6FHZ5,Protein SET,HLA-DR-associated protein II;Inhibitor of granzyme A-activated DNase;PHAPII;Phosphatase 2A inhibitor I2PP2A;Template-activating factor I;, PF00956;, GO:0000785;GO:0005737;GO:0005829;GO:0005783;GO:0005811;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0003682;GO:0003677;GO:0042393;GO:0004864;GO:0019888;GO:0006260;GO:0007076;GO:0035067;GO:0043524;GO:0045892;GO:0006334;GO:0006337;GO:0043488;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:lipid droplet; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity;, P:DNA replication; P:mitotic chromosome condensation; P:negative regulation of histone acetylation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:nucleosome disassembly; P:regulation of mRNA stability; P:viral process; scaffold77 indexed_genome mRNA 7152965 7155278 . - . ID=transcript_11883;Q96S82 D3DW57 Q96I03,Ubiquitin-like protein 7,Bone marrow stromal cell ubiquitin-like protein;Ubiquitin-like protein SB132;, PF00240;, GO:0005829;GO:0031593;GO:0006511;, C:cytosol;, F:polyubiquitin modification-dependent protein binding;, P:ubiquitin-dependent protein catabolic process; scaffold77 indexed_genome mRNA 7171037 7186989 . + . ID=transcript_11884;Q96S82 D3DW57 Q96I03,Ubiquitin-like protein 7,Bone marrow stromal cell ubiquitin-like protein;Ubiquitin-like protein SB132;, PF00240;, GO:0005829;GO:0031593;GO:0006511;, C:cytosol;, F:polyubiquitin modification-dependent protein binding;, P:ubiquitin-dependent protein catabolic process;|Q96S82 D3DW57 Q96I03,Ubiquitin-like protein 7,Bone marrow stromal cell ubiquitin-like protein;Ubiquitin-like protein SB132;, PF00240;, GO:0005829;GO:0031593;GO:0006511;, C:cytosol;, F:polyubiquitin modification-dependent protein binding;, P:ubiquitin-dependent protein catabolic process;|Q96S82 D3DW57 Q96I03,Ubiquitin-like protein 7,Bone marrow stromal cell ubiquitin-like protein;Ubiquitin-like protein SB132;, PF00240;, GO:0005829;GO:0031593;GO:0006511;, C:cytosol;, F:polyubiquitin modification-dependent protein binding;, P:ubiquitin-dependent protein catabolic process;|Q96S82 D3DW57 Q96I03,Ubiquitin-like protein 7,Bone marrow stromal cell ubiquitin-like protein;Ubiquitin-like protein SB132;, PF00240;, GO:0005829;GO:0031593;GO:0006511;, C:cytosol;, F:polyubiquitin modification-dependent protein binding;, P:ubiquitin-dependent protein catabolic process;|Q96S82 D3DW57 Q96I03,Ubiquitin-like protein 7,Bone marrow stromal cell ubiquitin-like protein;Ubiquitin-like protein SB132;, PF00240;, GO:0005829;GO:0031593;GO:0006511;, C:cytosol;, F:polyubiquitin modification-dependent protein binding;, P:ubiquitin-dependent protein catabolic process; scaffold77 indexed_genome mRNA 7195431 7219021 . + . ID=transcript_11885;O75326 B4DDP7 F5H1S0 Q1XE81 Q1XE82 Q1XE83 Q1XE84 Q3MIY5,Semaphorin-7A,CDw108;JMH blood group antigen;John-Milton-Hargen human blood group Ag;Semaphorin-K1;Semaphorin-L;, PF13895;PF01437;PF01403;, GO:0031225;GO:0009897;GO:0005615;GO:0005887;GO:0016020;GO:0005886;GO:0045499;GO:0005178;GO:0030215;GO:0048675;GO:0007411;GO:0006955;GO:0006954;GO:0007229;GO:0050919;GO:0048843;GO:0001755;GO:0021988;GO:0001649;GO:0045773;GO:0030335;GO:0070374;GO:0060907;GO:0001934;GO:0050727;GO:0071526;, C:anchored component of membrane; C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:chemorepellent activity; F:integrin binding; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:olfactory lobe development; P:osteoblast differentiation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of macrophage cytokine production; P:positive regulation of protein phosphorylation; P:regulation of inflammatory response; P:semaphorin-plexin signaling pathway;|O75326 B4DDP7 F5H1S0 Q1XE81 Q1XE82 Q1XE83 Q1XE84 Q3MIY5,Semaphorin-7A,CDw108;JMH blood group antigen;John-Milton-Hargen human blood group Ag;Semaphorin-K1;Semaphorin-L;, PF13895;PF01437;PF01403;, GO:0031225;GO:0009897;GO:0005615;GO:0005887;GO:0016020;GO:0005886;GO:0045499;GO:0005178;GO:0030215;GO:0048675;GO:0007411;GO:0006955;GO:0006954;GO:0007229;GO:0050919;GO:0048843;GO:0001755;GO:0021988;GO:0001649;GO:0045773;GO:0030335;GO:0070374;GO:0060907;GO:0001934;GO:0050727;GO:0071526;, C:anchored component of membrane; C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:chemorepellent activity; F:integrin binding; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:olfactory lobe development; P:osteoblast differentiation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of macrophage cytokine production; P:positive regulation of protein phosphorylation; P:regulation of inflammatory response; P:semaphorin-plexin signaling pathway;|O75326 B4DDP7 F5H1S0 Q1XE81 Q1XE82 Q1XE83 Q1XE84 Q3MIY5,Semaphorin-7A,CDw108;JMH blood group antigen;John-Milton-Hargen human blood group Ag;Semaphorin-K1;Semaphorin-L;, PF13895;PF01437;PF01403;, GO:0031225;GO:0009897;GO:0005615;GO:0005887;GO:0016020;GO:0005886;GO:0045499;GO:0005178;GO:0030215;GO:0048675;GO:0007411;GO:0006955;GO:0006954;GO:0007229;GO:0050919;GO:0048843;GO:0001755;GO:0021988;GO:0001649;GO:0045773;GO:0030335;GO:0070374;GO:0060907;GO:0001934;GO:0050727;GO:0071526;, C:anchored component of membrane; C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:chemorepellent activity; F:integrin binding; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:olfactory lobe development; P:osteoblast differentiation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of macrophage cytokine production; P:positive regulation of protein phosphorylation; P:regulation of inflammatory response; P:semaphorin-plexin signaling pathway;|O75326 B4DDP7 F5H1S0 Q1XE81 Q1XE82 Q1XE83 Q1XE84 Q3MIY5,Semaphorin-7A,CDw108;JMH blood group antigen;John-Milton-Hargen human blood group Ag;Semaphorin-K1;Semaphorin-L;, PF13895;PF01437;PF01403;, GO:0031225;GO:0009897;GO:0005615;GO:0005887;GO:0016020;GO:0005886;GO:0045499;GO:0005178;GO:0030215;GO:0048675;GO:0007411;GO:0006955;GO:0006954;GO:0007229;GO:0050919;GO:0048843;GO:0001755;GO:0021988;GO:0001649;GO:0045773;GO:0030335;GO:0070374;GO:0060907;GO:0001934;GO:0050727;GO:0071526;, C:anchored component of membrane; C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:chemorepellent activity; F:integrin binding; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:olfactory lobe development; P:osteoblast differentiation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of macrophage cytokine production; P:positive regulation of protein phosphorylation; P:regulation of inflammatory response; P:semaphorin-plexin signaling pathway;|O75326 B4DDP7 F5H1S0 Q1XE81 Q1XE82 Q1XE83 Q1XE84 Q3MIY5,Semaphorin-7A,CDw108;JMH blood group antigen;John-Milton-Hargen human blood group Ag;Semaphorin-K1;Semaphorin-L;, PF13895;PF01437;PF01403;, GO:0031225;GO:0009897;GO:0005615;GO:0005887;GO:0016020;GO:0005886;GO:0045499;GO:0005178;GO:0030215;GO:0048675;GO:0007411;GO:0006955;GO:0006954;GO:0007229;GO:0050919;GO:0048843;GO:0001755;GO:0021988;GO:0001649;GO:0045773;GO:0030335;GO:0070374;GO:0060907;GO:0001934;GO:0050727;GO:0071526;, C:anchored component of membrane; C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:chemorepellent activity; F:integrin binding; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:olfactory lobe development; P:osteoblast differentiation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of macrophage cytokine production; P:positive regulation of protein phosphorylation; P:regulation of inflammatory response; P:semaphorin-plexin signaling pathway;|O75326 B4DDP7 F5H1S0 Q1XE81 Q1XE82 Q1XE83 Q1XE84 Q3MIY5,Semaphorin-7A,CDw108;JMH blood group antigen;John-Milton-Hargen human blood group Ag;Semaphorin-K1;Semaphorin-L;, PF13895;PF01437;PF01403;, GO:0031225;GO:0009897;GO:0005615;GO:0005887;GO:0016020;GO:0005886;GO:0045499;GO:0005178;GO:0030215;GO:0048675;GO:0007411;GO:0006955;GO:0006954;GO:0007229;GO:0050919;GO:0048843;GO:0001755;GO:0021988;GO:0001649;GO:0045773;GO:0030335;GO:0070374;GO:0060907;GO:0001934;GO:0050727;GO:0071526;, C:anchored component of membrane; C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:chemorepellent activity; F:integrin binding; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:olfactory lobe development; P:osteoblast differentiation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of macrophage cytokine production; P:positive regulation of protein phosphorylation; P:regulation of inflammatory response; P:semaphorin-plexin signaling pathway;|O75326 B4DDP7 F5H1S0 Q1XE81 Q1XE82 Q1XE83 Q1XE84 Q3MIY5,Semaphorin-7A,CDw108;JMH blood group antigen;John-Milton-Hargen human blood group Ag;Semaphorin-K1;Semaphorin-L;, PF13895;PF01437;PF01403;, GO:0031225;GO:0009897;GO:0005615;GO:0005887;GO:0016020;GO:0005886;GO:0045499;GO:0005178;GO:0030215;GO:0048675;GO:0007411;GO:0006955;GO:0006954;GO:0007229;GO:0050919;GO:0048843;GO:0001755;GO:0021988;GO:0001649;GO:0045773;GO:0030335;GO:0070374;GO:0060907;GO:0001934;GO:0050727;GO:0071526;, C:anchored component of membrane; C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:chemorepellent activity; F:integrin binding; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:olfactory lobe development; P:osteoblast differentiation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of macrophage cytokine production; P:positive regulation of protein phosphorylation; P:regulation of inflammatory response; P:semaphorin-plexin signaling pathway;|O75326 B4DDP7 F5H1S0 Q1XE81 Q1XE82 Q1XE83 Q1XE84 Q3MIY5,Semaphorin-7A,CDw108;JMH blood group antigen;John-Milton-Hargen human blood group Ag;Semaphorin-K1;Semaphorin-L;, PF13895;PF01437;PF01403;, GO:0031225;GO:0009897;GO:0005615;GO:0005887;GO:0016020;GO:0005886;GO:0045499;GO:0005178;GO:0030215;GO:0048675;GO:0007411;GO:0006955;GO:0006954;GO:0007229;GO:0050919;GO:0048843;GO:0001755;GO:0021988;GO:0001649;GO:0045773;GO:0030335;GO:0070374;GO:0060907;GO:0001934;GO:0050727;GO:0071526;, C:anchored component of membrane; C:external side of plasma membrane; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:chemorepellent activity; F:integrin binding; F:semaphorin receptor binding;, P:axon extension; P:axon guidance; P:immune response; P:inflammatory response; P:integrin-mediated signaling pathway; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:olfactory lobe development; P:osteoblast differentiation; P:positive regulation of axon extension; P:positive regulation of cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of macrophage cytokine production; P:positive regulation of protein phosphorylation; P:regulation of inflammatory response; P:semaphorin-plexin signaling pathway; scaffold77 indexed_genome mRNA 7383649 7390221 . + . ID=transcript_11886;Q8N5R6 A8K3U4 A8MPQ6 A8MV61 A8MVU9 B3KQ49 Q8TAX6 Q9H5Q6,Coiled-coil domain-containing protein 33,Cancer/testis antigen 61;, PF00168;, GO:0005777;, C:peroxisome; scaffold77 indexed_genome mRNA 7462093 7477302 . + . ID=transcript_11887;Q7L9G1 Q7Z3U9 Q8TB21 Q9BX78 Q9H9U8,Receptor for retinol uptake STRA6,Retinol-binding protein receptor STRA6 {ECO:0000303|PubMed:17503335, ECO:0000303|PubMed:22665496};Stimulated by retinoic acid gene 6 protein homolog;, , GO:0005887;GO:0005886;GO:0032991;GO:0016918;GO:0019841;GO:0034632;GO:0038023;GO:0030325;GO:0061143;GO:0048844;GO:0001568;GO:0043010;GO:0050890;GO:0048589;GO:0060539;GO:0048546;GO:0097070;GO:0043583;GO:0060900;GO:0048566;GO:0061029;GO:0060325;GO:0007631;GO:0030540;GO:0060322;GO:0060323;GO:0007507;GO:0001822;GO:0007612;GO:0048286;GO:0030324;GO:0060426;GO:0050905;GO:0043585;GO:0061205;GO:0048520;GO:0061156;GO:0003184;GO:0001523;GO:0034633;GO:0048745;GO:0061038;GO:0003281;GO:0071939;GO:0042297;, C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex;, F:retinal binding; F:retinol binding; F:retinol transmembrane transporter activity; F:signaling receptor activity;, P:adrenal gland development; P:alveolar primary septum development; P:artery morphogenesis; P:blood vessel development; P:camera-type eye development; P:cognition; P:developmental growth; P:diaphragm development; P:digestive tract morphogenesis; P:ductus arteriosus closure; P:ear development; P:embryonic camera-type eye formation; P:embryonic digestive tract development; P:eyelid development in camera-type eye; P:face morphogenesis; P:feeding behavior; P:female genitalia development; P:head development; P:head morphogenesis; P:heart development; P:kidney development; P:learning; P:lung alveolus development; P:lung development; P:lung vasculature development; P:neuromuscular process; P:nose morphogenesis; P:paramesonephric duct development; P:positive regulation of behavior; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:retinoid metabolic process; P:retinol transport; P:smooth muscle tissue development; P:uterus morphogenesis; P:ventricular septum development; P:vitamin A import; P:vocal learning;|Q7L9G1 Q7Z3U9 Q8TB21 Q9BX78 Q9H9U8,Receptor for retinol uptake STRA6,Retinol-binding protein receptor STRA6 {ECO:0000303|PubMed:17503335, ECO:0000303|PubMed:22665496};Stimulated by retinoic acid gene 6 protein homolog;, , GO:0005887;GO:0005886;GO:0032991;GO:0016918;GO:0019841;GO:0034632;GO:0038023;GO:0030325;GO:0061143;GO:0048844;GO:0001568;GO:0043010;GO:0050890;GO:0048589;GO:0060539;GO:0048546;GO:0097070;GO:0043583;GO:0060900;GO:0048566;GO:0061029;GO:0060325;GO:0007631;GO:0030540;GO:0060322;GO:0060323;GO:0007507;GO:0001822;GO:0007612;GO:0048286;GO:0030324;GO:0060426;GO:0050905;GO:0043585;GO:0061205;GO:0048520;GO:0061156;GO:0003184;GO:0001523;GO:0034633;GO:0048745;GO:0061038;GO:0003281;GO:0071939;GO:0042297;, C:integral component of plasma membrane; C:plasma membrane; C:protein-containing complex;, F:retinal binding; F:retinol binding; F:retinol transmembrane transporter activity; F:signaling receptor activity;, P:adrenal gland development; P:alveolar primary septum development; P:artery morphogenesis; P:blood vessel development; P:camera-type eye development; P:cognition; P:developmental growth; P:diaphragm development; P:digestive tract morphogenesis; P:ductus arteriosus closure; P:ear development; P:embryonic camera-type eye formation; P:embryonic digestive tract development; P:eyelid development in camera-type eye; P:face morphogenesis; P:feeding behavior; P:female genitalia development; P:head development; P:head morphogenesis; P:heart development; P:kidney development; P:learning; P:lung alveolus development; P:lung development; P:lung vasculature development; P:neuromuscular process; P:nose morphogenesis; P:paramesonephric duct development; P:positive regulation of behavior; P:pulmonary artery morphogenesis; P:pulmonary valve morphogenesis; P:retinoid metabolic process; P:retinol transport; P:smooth muscle tissue development; P:uterus morphogenesis; P:ventricular septum development; P:vitamin A import; P:vocal learning; scaffold77 indexed_genome mRNA 7479290 7482419 . - . ID=transcript_11888;O14498,Immunoglobulin superfamily containing leucine-rich repeat protein,, PF07679;PF13855;, GO:0070062;GO:0005576;GO:0031093;GO:0007155;GO:0002576;, C:extracellular exosome; C:extracellular region; C:platelet alpha granule lumen;, , P:cell adhesion; P:platelet degranulation; scaffold77 indexed_genome mRNA 7519128 7527440 . - . ID=transcript_11889;Q6UXK2 A8K352 Q9P263,Immunoglobulin superfamily containing leucine-rich repeat protein 2,Leucine-rich repeat domain and immunoglobulin domain-containing axon extension protein;, PF13855;, GO:0009986;GO:0016021;GO:0005886;GO:0045773;, C:cell surface; C:integral component of membrane; C:plasma membrane;, , P:positive regulation of axon extension; scaffold77 indexed_genome mRNA 7540043 7593245 . - . ID=transcript_11890;Q9BZY3,Protein PML,Promyelocytic leukemia protein;RING finger protein 71;Tripartite motif-containing protein 19;, PF12126;PF00643;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0031901;GO:0042406;GO:0000792;GO:0016363;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0050897;GO:0003677;GO:0042802;GO:0046982;GO:0042803;GO:0046332;GO:0032183;GO:0140037;GO:0003713;GO:0031625;GO:0004842;GO:0008270;GO:0006919;GO:0006915;GO:0060444;GO:0007050;GO:0045165;GO:0071353;GO:1990830;GO:0090398;GO:0032922;GO:0007182;GO:0051607;GO:0006977;GO:0032469;GO:0043153;GO:0097191;GO:0010761;GO:0030851;GO:0045087;GO:0060333;GO:0008630;GO:0042771;GO:0070059;GO:0008631;GO:0051457;GO:0016525;GO:0030308;GO:0008285;GO:0032691;GO:0045930;GO:0051974;GO:0032211;GO:0045892;GO:0032938;GO:2000059;GO:1902187;GO:0030578;GO:0060058;GO:0002230;GO:2001238;GO:0048146;GO:0031065;GO:1904816;GO:0032206;GO:0045893;GO:0043161;GO:0006606;GO:0050821;GO:0006605;GO:0065003;GO:0010522;GO:0030155;GO:0042752;GO:2000779;GO:0001932;GO:1901796;GO:0006355;GO:0034097;GO:0010332;GO:0001666;GO:0009411;GO:0048384;GO:0007179;GO:0019058;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:early endosome membrane; C:extrinsic component of endoplasmic reticulum membrane; C:heterochromatin; C:nuclear matrix; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:cobalt ion binding; F:DNA binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:SMAD binding; F:SUMO binding; F:sumo-dependent protein binding; F:transcription coactivator activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:branching involved in mammary gland duct morphogenesis; P:cell cycle arrest; P:cell fate commitment; P:cellular response to interleukin-4; P:cellular response to leukemia inhibitory factor; P:cellular senescence; P:circadian regulation of gene expression; P:common-partner SMAD protein phosphorylation; P:defense response to virus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:endoplasmic reticulum calcium ion homeostasis; P:entrainment of circadian clock by photoperiod; P:extrinsic apoptotic signaling pathway; P:fibroblast migration; P:granulocyte differentiation; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:maintenance of protein location in nucleus; P:negative regulation of angiogenesis; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of interleukin-1 beta production; P:negative regulation of mitotic cell cycle; P:negative regulation of telomerase activity; P:negative regulation of telomere maintenance via telomerase; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation in response to oxidative stress; P:negative regulation of ubiquitin-dependent protein catabolic process; P:negative regulation of viral release from host cell; P:PML body organization; P:positive regulation of apoptotic process involved in mammary gland involution; P:positive regulation of defense response to virus by host; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of fibroblast proliferation; P:positive regulation of histone deacetylation; P:positive regulation of protein localization to chromosome, telomeric region; P:positive regulation of telomere maintenance; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein import into nucleus; P:protein stabilization; P:protein targeting; P:protein-containing complex assembly; P:regulation of calcium ion transport into cytosol; P:regulation of cell adhesion; P:regulation of circadian rhythm; P:regulation of double-strand break repair; P:regulation of protein phosphorylation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:response to cytokine; P:response to gamma radiation; P:response to hypoxia; P:response to UV; P:retinoic acid receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway; P:viral life cycle; scaffold77 indexed_genome mRNA 7595875 7604772 . + . ID=transcript_11891;Q8WYI7 Q9UMB9 Q9UMC0 Q9Y6H9,Stomatin-like protein 1,EPB72-like protein 1;Protein unc-24 homolog;Stomatin-related protein;, PF01145;PF02036;, GO:0016021;GO:0031902;GO:0045121;GO:0005886;GO:0006869;, C:integral component of membrane; C:late endosome membrane; C:membrane raft; C:plasma membrane;, , P:lipid transport;|Q8WYI7 Q9UMB9 Q9UMC0 Q9Y6H9,Stomatin-like protein 1,EPB72-like protein 1;Protein unc-24 homolog;Stomatin-related protein;, PF01145;PF02036;, GO:0016021;GO:0031902;GO:0045121;GO:0005886;GO:0006869;, C:integral component of membrane; C:late endosome membrane; C:membrane raft; C:plasma membrane;, , P:lipid transport;|Q8WYI7 Q9UMB9 Q9UMC0 Q9Y6H9,Stomatin-like protein 1,EPB72-like protein 1;Protein unc-24 homolog;Stomatin-related protein;, PF01145;PF02036;, GO:0016021;GO:0031902;GO:0045121;GO:0005886;GO:0006869;, C:integral component of membrane; C:late endosome membrane; C:membrane raft; C:plasma membrane;, , P:lipid transport; scaffold78 indexed_genome mRNA 2123 9837 . + . ID=transcript_11892;Q969S6 Q6NW08,Transmembrane protein 203,, , GO:0005783;GO:0005789;GO:0016021;GO:0006874;GO:0007283;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:cellular calcium ion homeostasis; P:spermatogenesis;|Q9UHB4 D3YTG6 D3YTH9 Q5VSG4 Q86US9 Q96BC6,NADPH-dependent diflavin oxidoreductase 1 {ECO:0000255|HAMAP-Rule:MF_03178},NADPH-dependent FMN and FAD-containing oxidoreductase {ECO:0000255|HAMAP-Rule:MF_03178};Novel reductase 1;, PF00667;PF00258;PF00175;, GO:0005737;GO:0005829;GO:0045111;GO:0005654;GO:0048471;GO:0071949;GO:0050660;GO:0010181;GO:0070402;GO:0008753;GO:0003958;GO:0016491;GO:0016709;GO:0008219;GO:0036245;GO:0022900;GO:0016226;, C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:FAD binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADPH binding; F:NADPH dehydrogenase (quinone) activity; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:cell death; P:cellular response to menadione; P:electron transport chain; P:iron-sulfur cluster assembly;|Q9UHB4 D3YTG6 D3YTH9 Q5VSG4 Q86US9 Q96BC6,NADPH-dependent diflavin oxidoreductase 1 {ECO:0000255|HAMAP-Rule:MF_03178},NADPH-dependent FMN and FAD-containing oxidoreductase {ECO:0000255|HAMAP-Rule:MF_03178};Novel reductase 1;, PF00667;PF00258;PF00175;, GO:0005737;GO:0005829;GO:0045111;GO:0005654;GO:0048471;GO:0071949;GO:0050660;GO:0010181;GO:0070402;GO:0008753;GO:0003958;GO:0016491;GO:0016709;GO:0008219;GO:0036245;GO:0022900;GO:0016226;, C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:FAD binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADPH binding; F:NADPH dehydrogenase (quinone) activity; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:cell death; P:cellular response to menadione; P:electron transport chain; P:iron-sulfur cluster assembly;|Q9UHB4 D3YTG6 D3YTH9 Q5VSG4 Q86US9 Q96BC6,NADPH-dependent diflavin oxidoreductase 1 {ECO:0000255|HAMAP-Rule:MF_03178},NADPH-dependent FMN and FAD-containing oxidoreductase {ECO:0000255|HAMAP-Rule:MF_03178};Novel reductase 1;, PF00667;PF00258;PF00175;, GO:0005737;GO:0005829;GO:0045111;GO:0005654;GO:0048471;GO:0071949;GO:0050660;GO:0010181;GO:0070402;GO:0008753;GO:0003958;GO:0016491;GO:0016709;GO:0008219;GO:0036245;GO:0022900;GO:0016226;, C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:FAD binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:NADPH binding; F:NADPH dehydrogenase (quinone) activity; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:cell death; P:cellular response to menadione; P:electron transport chain; P:iron-sulfur cluster assembly; scaffold78 indexed_genome mRNA 16951 20867 . + . ID=transcript_11893;A8MQ03 Q86UY7,Cysteine-rich tail protein 1,, PF10631;, GO:0070062;GO:0042802;, C:extracellular exosome;, F:identical protein binding; scaffold78 indexed_genome mRNA 21319 22144 . + . ID=transcript_11894;P0DH78,RING finger protein 224,, PF13445;, GO:0046872;, , F:metal ion binding; scaffold78 indexed_genome mRNA 24915 26662 . + . ID=transcript_11895;Q8N130 A2BFA1,Sodium-dependent phosphate transport protein 2C,Na(+)-dependent phosphate cotransporter 2C;Sodium/inorganic phosphate cotransporter IIC;Sodium/phosphate cotransporter 2C;Solute carrier family 34 member 3;, PF02690;, GO:0016324;GO:0005903;GO:0031526;GO:0016021;GO:0005886;GO:0031982;GO:0005436;GO:0030643;GO:0006817;GO:0006814;GO:0044341;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:integral component of membrane; C:plasma membrane; C:vesicle;, F:sodium:phosphate symporter activity;, P:cellular phosphate ion homeostasis; P:phosphate ion transport; P:sodium ion transport; P:sodium-dependent phosphate transport; scaffold78 indexed_genome mRNA 49456 56744 . + . ID=transcript_11896;Q8WX92 A0A0X1KG71 A2BFA3 Q96EW5 Q9H9R4 Q9ULN8 Q9Y3W0,Negative elongation factor B,Cofactor of BRCA1 {ECO:0000303|PubMed:11739404};, PF06209;, GO:0005737;GO:0032021;GO:0005654;GO:0003723;GO:0008283;GO:2000737;GO:0034244;GO:0050434;GO:0048863;GO:0006366;GO:0006368;, C:cytoplasm; C:NELF complex; C:nucleoplasm;, F:RNA binding;, P:cell population proliferation; P:negative regulation of stem cell differentiation; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:stem cell differentiation; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q8WX92 A0A0X1KG71 A2BFA3 Q96EW5 Q9H9R4 Q9ULN8 Q9Y3W0,Negative elongation factor B,Cofactor of BRCA1 {ECO:0000303|PubMed:11739404};, PF06209;, GO:0005737;GO:0032021;GO:0005654;GO:0003723;GO:0008283;GO:2000737;GO:0034244;GO:0050434;GO:0048863;GO:0006366;GO:0006368;, C:cytoplasm; C:NELF complex; C:nucleoplasm;, F:RNA binding;, P:cell population proliferation; P:negative regulation of stem cell differentiation; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:stem cell differentiation; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q8WX92 A0A0X1KG71 A2BFA3 Q96EW5 Q9H9R4 Q9ULN8 Q9Y3W0,Negative elongation factor B,Cofactor of BRCA1 {ECO:0000303|PubMed:11739404};, PF06209;, GO:0005737;GO:0032021;GO:0005654;GO:0003723;GO:0008283;GO:2000737;GO:0034244;GO:0050434;GO:0048863;GO:0006366;GO:0006368;, C:cytoplasm; C:NELF complex; C:nucleoplasm;, F:RNA binding;, P:cell population proliferation; P:negative regulation of stem cell differentiation; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:stem cell differentiation; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q8WX92 A0A0X1KG71 A2BFA3 Q96EW5 Q9H9R4 Q9ULN8 Q9Y3W0,Negative elongation factor B,Cofactor of BRCA1 {ECO:0000303|PubMed:11739404};, PF06209;, GO:0005737;GO:0032021;GO:0005654;GO:0003723;GO:0008283;GO:2000737;GO:0034244;GO:0050434;GO:0048863;GO:0006366;GO:0006368;, C:cytoplasm; C:NELF complex; C:nucleoplasm;, F:RNA binding;, P:cell population proliferation; P:negative regulation of stem cell differentiation; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:stem cell differentiation; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold78 indexed_genome mRNA 119194 212664 . - . ID=transcript_11897;Q8NHD1 Q96NP1 Q9NX53,Exonuclease mut-7 homolog,Exonuclease 3'-5' domain-containing protein 3;, PF01612;PF01927;, GO:0008408;GO:0046872;GO:0003676;, , F:3'-5' exonuclease activity; F:metal ion binding; F:nucleic acid binding;|Q8NHD1 Q96NP1 Q9NX53,Exonuclease mut-7 homolog,Exonuclease 3'-5' domain-containing protein 3;, PF01612;PF01927;, GO:0008408;GO:0046872;GO:0003676;, , F:3'-5' exonuclease activity; F:metal ion binding; F:nucleic acid binding;|Q8NHD1 Q96NP1 Q9NX53,Exonuclease mut-7 homolog,Exonuclease 3'-5' domain-containing protein 3;, PF01612;PF01927;, GO:0008408;GO:0046872;GO:0003676;, , F:3'-5' exonuclease activity; F:metal ion binding; F:nucleic acid binding;|Q86UR1 O60533 Q29VU9 Q29VV0 Q2TAM1 Q8IUS3,NADPH oxidase activator 1,Antigen NY-CO-31;NCF2-like protein;P67phox-like factor;p51-nox;, PF00564;PF00018;, GO:0005829;GO:0043020;GO:0019899;GO:0042802;GO:0017124;GO:0031267;GO:0016176;GO:0031343;GO:0010310;GO:0060263;GO:0042554;GO:0006801;, C:cytosol; C:NADPH oxidase complex;, F:enzyme binding; F:identical protein binding; F:SH3 domain binding; F:small GTPase binding; F:superoxide-generating NADPH oxidase activator activity;, P:positive regulation of cell killing; P:regulation of hydrogen peroxide metabolic process; P:regulation of respiratory burst; P:superoxide anion generation; P:superoxide metabolic process;|Q86UR1 O60533 Q29VU9 Q29VV0 Q2TAM1 Q8IUS3,NADPH oxidase activator 1,Antigen NY-CO-31;NCF2-like protein;P67phox-like factor;p51-nox;, PF00564;PF00018;, GO:0005829;GO:0043020;GO:0019899;GO:0042802;GO:0017124;GO:0031267;GO:0016176;GO:0031343;GO:0010310;GO:0060263;GO:0042554;GO:0006801;, C:cytosol; C:NADPH oxidase complex;, F:enzyme binding; F:identical protein binding; F:SH3 domain binding; F:small GTPase binding; F:superoxide-generating NADPH oxidase activator activity;, P:positive regulation of cell killing; P:regulation of hydrogen peroxide metabolic process; P:regulation of respiratory burst; P:superoxide anion generation; P:superoxide metabolic process;|Q86UR1 O60533 Q29VU9 Q29VV0 Q2TAM1 Q8IUS3,NADPH oxidase activator 1,Antigen NY-CO-31;NCF2-like protein;P67phox-like factor;p51-nox;, PF00564;PF00018;, GO:0005829;GO:0043020;GO:0019899;GO:0042802;GO:0017124;GO:0031267;GO:0016176;GO:0031343;GO:0010310;GO:0060263;GO:0042554;GO:0006801;, C:cytosol; C:NADPH oxidase complex;, F:enzyme binding; F:identical protein binding; F:SH3 domain binding; F:small GTPase binding; F:superoxide-generating NADPH oxidase activator activity;, P:positive regulation of cell killing; P:regulation of hydrogen peroxide metabolic process; P:regulation of respiratory burst; P:superoxide anion generation; P:superoxide metabolic process;|Q86UR1 O60533 Q29VU9 Q29VV0 Q2TAM1 Q8IUS3,NADPH oxidase activator 1,Antigen NY-CO-31;NCF2-like protein;P67phox-like factor;p51-nox;, PF00564;PF00018;, GO:0005829;GO:0043020;GO:0019899;GO:0042802;GO:0017124;GO:0031267;GO:0016176;GO:0031343;GO:0010310;GO:0060263;GO:0042554;GO:0006801;, C:cytosol; C:NADPH oxidase complex;, F:enzyme binding; F:identical protein binding; F:SH3 domain binding; F:small GTPase binding; F:superoxide-generating NADPH oxidase activator activity;, P:positive regulation of cell killing; P:regulation of hydrogen peroxide metabolic process; P:regulation of respiratory burst; P:superoxide anion generation; P:superoxide metabolic process;|Q5MY95 A2BG17 Q6UVZ0,Ectonucleoside triphosphate diphosphohydrolase 8,, PF01150;, GO:0016021;GO:0016020;GO:0005886;GO:0102490;GO:0005524;GO:0102485;GO:0102486;GO:0102491;GO:0102488;GO:0102487;GO:0102489;GO:0004382;GO:0046872;GO:0017110;GO:0017111;GO:0045134;GO:0034656;GO:0009133;GO:0009134;GO:0009124;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:8-oxo-dGTP phosphohydrolase activity; F:ATP binding; F:dATP phosphohydrolase activity; F:dCTP phosphohydrolase activity; F:dGTP phosphohydrolase activity; F:dTTP phosphohydrolase activity; F:dUTP phosphohydrolase activity; F:GTP phosphohydrolase activity; F:guanosine-diphosphatase activity; F:metal ion binding; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate biosynthetic process; P:nucleoside diphosphate catabolic process; P:nucleoside monophosphate biosynthetic process;|Q86UR1 O60533 Q29VU9 Q29VV0 Q2TAM1 Q8IUS3,NADPH oxidase activator 1,Antigen NY-CO-31;NCF2-like protein;P67phox-like factor;p51-nox;, PF00564;PF00018;, GO:0005829;GO:0043020;GO:0019899;GO:0042802;GO:0017124;GO:0031267;GO:0016176;GO:0031343;GO:0010310;GO:0060263;GO:0042554;GO:0006801;, C:cytosol; C:NADPH oxidase complex;, F:enzyme binding; F:identical protein binding; F:SH3 domain binding; F:small GTPase binding; F:superoxide-generating NADPH oxidase activator activity;, P:positive regulation of cell killing; P:regulation of hydrogen peroxide metabolic process; P:regulation of respiratory burst; P:superoxide anion generation; P:superoxide metabolic process; scaffold78 indexed_genome mRNA 230193 268883 . - . ID=transcript_11898;Q9NPS3,NMDA receptor synaptonuclear signaling and neuronal migration factor,Nasal embryonic luteinizing hormone-releasing hormone factor;, , GO:0097440;GO:0030863;GO:0005737;GO:0030425;GO:0000791;GO:0016020;GO:0043005;GO:0005635;GO:0016363;GO:0031965;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0045202;GO:0048306;GO:0071230;GO:0071257;GO:0071371;GO:2001224;GO:0035307;GO:0048814;GO:0043523;GO:0048168;, C:apical dendrite; C:cortical cytoskeleton; C:cytoplasm; C:dendrite; C:euchromatin; C:membrane; C:neuron projection; C:nuclear envelope; C:nuclear matrix; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:synapse;, F:calcium-dependent protein binding;, P:cellular response to amino acid stimulus; P:cellular response to electrical stimulus; P:cellular response to gonadotropin stimulus; P:positive regulation of neuron migration; P:positive regulation of protein dephosphorylation; P:regulation of dendrite morphogenesis; P:regulation of neuron apoptotic process; P:regulation of neuronal synaptic plasticity;|Q9NPS3,NMDA receptor synaptonuclear signaling and neuronal migration factor,Nasal embryonic luteinizing hormone-releasing hormone factor;, , GO:0097440;GO:0030863;GO:0005737;GO:0030425;GO:0000791;GO:0016020;GO:0043005;GO:0005635;GO:0016363;GO:0031965;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0045202;GO:0048306;GO:0071230;GO:0071257;GO:0071371;GO:2001224;GO:0035307;GO:0048814;GO:0043523;GO:0048168;, C:apical dendrite; C:cortical cytoskeleton; C:cytoplasm; C:dendrite; C:euchromatin; C:membrane; C:neuron projection; C:nuclear envelope; C:nuclear matrix; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:synapse;, F:calcium-dependent protein binding;, P:cellular response to amino acid stimulus; P:cellular response to electrical stimulus; P:cellular response to gonadotropin stimulus; P:positive regulation of neuron migration; P:positive regulation of protein dephosphorylation; P:regulation of dendrite morphogenesis; P:regulation of neuron apoptotic process; P:regulation of neuronal synaptic plasticity;|Q9NPS3,NMDA receptor synaptonuclear signaling and neuronal migration factor,Nasal embryonic luteinizing hormone-releasing hormone factor;, , GO:0097440;GO:0030863;GO:0005737;GO:0030425;GO:0000791;GO:0016020;GO:0043005;GO:0005635;GO:0016363;GO:0031965;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0045202;GO:0048306;GO:0071230;GO:0071257;GO:0071371;GO:2001224;GO:0035307;GO:0048814;GO:0043523;GO:0048168;, C:apical dendrite; C:cortical cytoskeleton; C:cytoplasm; C:dendrite; C:euchromatin; C:membrane; C:neuron projection; C:nuclear envelope; C:nuclear matrix; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:synapse;, F:calcium-dependent protein binding;, P:cellular response to amino acid stimulus; P:cellular response to electrical stimulus; P:cellular response to gonadotropin stimulus; P:positive regulation of neuron migration; P:positive regulation of protein dephosphorylation; P:regulation of dendrite morphogenesis; P:regulation of neuron apoptotic process; P:regulation of neuronal synaptic plasticity;|Q9NPS3,NMDA receptor synaptonuclear signaling and neuronal migration factor,Nasal embryonic luteinizing hormone-releasing hormone factor;, , GO:0097440;GO:0030863;GO:0005737;GO:0030425;GO:0000791;GO:0016020;GO:0043005;GO:0005635;GO:0016363;GO:0031965;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0045202;GO:0048306;GO:0071230;GO:0071257;GO:0071371;GO:2001224;GO:0035307;GO:0048814;GO:0043523;GO:0048168;, C:apical dendrite; C:cortical cytoskeleton; C:cytoplasm; C:dendrite; C:euchromatin; C:membrane; C:neuron projection; C:nuclear envelope; C:nuclear matrix; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:synapse;, F:calcium-dependent protein binding;, P:cellular response to amino acid stimulus; P:cellular response to electrical stimulus; P:cellular response to gonadotropin stimulus; P:positive regulation of neuron migration; P:positive regulation of protein dephosphorylation; P:regulation of dendrite morphogenesis; P:regulation of neuron apoptotic process; P:regulation of neuronal synaptic plasticity;|Q9H7N5,Patatin-like phospholipase domain-containing protein 7,, PF00027;PF01734;, GO:0005783;GO:0005789;GO:0016021;GO:0005811;GO:0004622;GO:0102545;GO:0034638;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:phosphatidylcholine catabolic process;|Q9H7N5,Patatin-like phospholipase domain-containing protein 7,, PF00027;PF01734;, GO:0005783;GO:0005789;GO:0016021;GO:0005811;GO:0004622;GO:0102545;GO:0034638;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:phosphatidylcholine catabolic process;|Q9H7N5,Patatin-like phospholipase domain-containing protein 7,, PF00027;PF01734;, GO:0005783;GO:0005789;GO:0016021;GO:0005811;GO:0004622;GO:0102545;GO:0034638;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:phosphatidylcholine catabolic process;|Q9H7N5,Patatin-like phospholipase domain-containing protein 7,, PF00027;PF01734;, GO:0005783;GO:0005789;GO:0016021;GO:0005811;GO:0004622;GO:0102545;GO:0034638;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:phosphatidylcholine catabolic process;|Q9H7N5,Patatin-like phospholipase domain-containing protein 7,, PF00027;PF01734;, GO:0005783;GO:0005789;GO:0016021;GO:0005811;GO:0004622;GO:0102545;GO:0034638;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:phosphatidylcholine catabolic process;|Q9H7N5,Patatin-like phospholipase domain-containing protein 7,, PF00027;PF01734;, GO:0005783;GO:0005789;GO:0016021;GO:0005811;GO:0004622;GO:0102545;GO:0034638;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:phosphatidylcholine catabolic process; scaffold78 indexed_genome mRNA 268907 316320 . - . ID=transcript_11899;Q9H7N5,Patatin-like phospholipase domain-containing protein 7,, PF00027;PF01734;, GO:0005783;GO:0005789;GO:0016021;GO:0005811;GO:0004622;GO:0102545;GO:0034638;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:phosphatidylcholine catabolic process; scaffold78 indexed_genome mRNA 329037 336750 . - . ID=transcript_11900;Q9BTV6 Q96AB7,Diphthine methyltransferase,Diphthamide biosynthesis protein 7;WD repeat-containing protein 85;, PF00400;, GO:0061685;GO:0017183;, , F:diphthine methylesterase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|Q9BTV6 Q96AB7,Diphthine methyltransferase,Diphthamide biosynthesis protein 7;WD repeat-containing protein 85;, PF00400;, GO:0061685;GO:0017183;, , F:diphthine methylesterase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|Q9BTV6 Q96AB7,Diphthine methyltransferase,Diphthamide biosynthesis protein 7;WD repeat-containing protein 85;, PF00400;, GO:0061685;GO:0017183;, , F:diphthine methylesterase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; scaffold78 indexed_genome mRNA 339906 347848 . - . ID=transcript_11901;Q96E35 Q5T366,Zinc finger MYND domain-containing protein 19,Melanin-concentrating hormone receptor 1-interacting zinc finger protein;, PF13392;PF01753;, GO:0005737;GO:0005886;GO:0045202;GO:0046872;, C:cytoplasm; C:plasma membrane; C:synapse;, F:metal ion binding;|Q96E35 Q5T366,Zinc finger MYND domain-containing protein 19,Melanin-concentrating hormone receptor 1-interacting zinc finger protein;, PF13392;PF01753;, GO:0005737;GO:0005886;GO:0045202;GO:0046872;, C:cytoplasm; C:plasma membrane; C:synapse;, F:metal ion binding; scaffold78 indexed_genome mRNA 373076 380342 . - . ID=transcript_11902;Q8N5I2,Arrestin domain-containing protein 1 {ECO:0000305},Alpha-arrestin 1 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0005737;GO:0031410;GO:0070062;GO:1903561;GO:0005886;GO:1990763;GO:0042802;GO:1990756;GO:0031625;GO:0006858;GO:0140112;GO:0045746;GO:0015031;GO:0016567;GO:0006511;, C:cytoplasm; C:cytoplasmic vesicle; C:extracellular exosome; C:extracellular vesicle; C:plasma membrane;, F:arrestin family protein binding; F:identical protein binding; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding;, P:extracellular transport; P:extracellular vesicle biogenesis; P:negative regulation of Notch signaling pathway; P:protein transport; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8N5I2,Arrestin domain-containing protein 1 {ECO:0000305},Alpha-arrestin 1 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0005737;GO:0031410;GO:0070062;GO:1903561;GO:0005886;GO:1990763;GO:0042802;GO:1990756;GO:0031625;GO:0006858;GO:0140112;GO:0045746;GO:0015031;GO:0016567;GO:0006511;, C:cytoplasm; C:cytoplasmic vesicle; C:extracellular exosome; C:extracellular vesicle; C:plasma membrane;, F:arrestin family protein binding; F:identical protein binding; F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding;, P:extracellular transport; P:extracellular vesicle biogenesis; P:negative regulation of Notch signaling pathway; P:protein transport; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold78 indexed_genome mRNA 442472 484784 . + . ID=transcript_11903;Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4,Histone-lysine N-methyltransferase EHMT1,Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;, PF12796;PF05033;PF00856;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide;|Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4,Histone-lysine N-methyltransferase EHMT1,Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;, PF12796;PF05033;PF00856;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide;|Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4,Histone-lysine N-methyltransferase EHMT1,Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;, PF12796;PF05033;PF00856;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide;|Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4,Histone-lysine N-methyltransferase EHMT1,Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;, PF12796;PF05033;PF00856;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide;|Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4,Histone-lysine N-methyltransferase EHMT1,Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;, PF12796;PF05033;PF00856;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide;|Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4,Histone-lysine N-methyltransferase EHMT1,Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;, PF12796;PF05033;PF00856;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide;|Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4,Histone-lysine N-methyltransferase EHMT1,Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;, PF12796;PF05033;PF00856;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide; scaffold78 indexed_genome mRNA 484819 493491 . + . ID=transcript_11904;Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4,Histone-lysine N-methyltransferase EHMT1,Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;, PF12796;PF05033;PF00856;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide;|Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4,Histone-lysine N-methyltransferase EHMT1,Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;, PF12796;PF05033;PF00856;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide; scaffold78 indexed_genome mRNA 493530 496419 . + . ID=transcript_11905;Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4,Histone-lysine N-methyltransferase EHMT1,Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;, PF12796;PF05033;PF00856;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide; scaffold78 indexed_genome mRNA 580936 581506 . + . ID=transcript_11906;Q00975 B1AQK5,Voltage-dependent N-type calcium channel subunit alpha-1B,Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0005524;GO:0005509;GO:0008331;GO:0008022;GO:0005245;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050804;GO:0034765;GO:1904645;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:ATP binding; F:calcium ion binding; F:high voltage-gated calcium channel activity; F:protein C-terminus binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:regulation of ion transmembrane transport; P:response to amyloid-beta; scaffold78 indexed_genome mRNA 606008 695771 . + . ID=transcript_11907;Q00975 B1AQK5,Voltage-dependent N-type calcium channel subunit alpha-1B,Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0005524;GO:0005509;GO:0008331;GO:0008022;GO:0005245;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050804;GO:0034765;GO:1904645;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:ATP binding; F:calcium ion binding; F:high voltage-gated calcium channel activity; F:protein C-terminus binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q3ZCU0 Q8N9C3,Protein GVQW3 {ECO:0000305},GVQW motif-containing protein 3 {ECO:0000305};, PF17906; scaffold78 indexed_genome mRNA 706259 737797 . + . ID=transcript_11908;Q00975 B1AQK5,Voltage-dependent N-type calcium channel subunit alpha-1B,Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0005524;GO:0005509;GO:0008331;GO:0008022;GO:0005245;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050804;GO:0034765;GO:1904645;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:ATP binding; F:calcium ion binding; F:high voltage-gated calcium channel activity; F:protein C-terminus binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q00975 B1AQK5,Voltage-dependent N-type calcium channel subunit alpha-1B,Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0005524;GO:0005509;GO:0008331;GO:0008022;GO:0005245;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050804;GO:0034765;GO:1904645;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:ATP binding; F:calcium ion binding; F:high voltage-gated calcium channel activity; F:protein C-terminus binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q15878 B1AM12 B1AM13 B1AM14 Q14580 Q14581,Voltage-dependent R-type calcium channel subunit alpha-1E,Brain calcium channel II;Calcium channel, L type, alpha-1 polypeptide, isoform 6;Voltage-gated calcium channel subunit alpha Cav2.3;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0005509;GO:0005245;GO:0022843;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050796;GO:0034765;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:calcium ion binding; F:voltage-gated calcium channel activity; F:voltage-gated cation channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:regulation of insulin secretion; P:regulation of ion transmembrane transport;|Q00975 B1AQK5,Voltage-dependent N-type calcium channel subunit alpha-1B,Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0005524;GO:0005509;GO:0008331;GO:0008022;GO:0005245;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050804;GO:0034765;GO:1904645;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:ATP binding; F:calcium ion binding; F:high voltage-gated calcium channel activity; F:protein C-terminus binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q00975 B1AQK5,Voltage-dependent N-type calcium channel subunit alpha-1B,Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0005524;GO:0005509;GO:0008331;GO:0008022;GO:0005245;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050804;GO:0034765;GO:1904645;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:ATP binding; F:calcium ion binding; F:high voltage-gated calcium channel activity; F:protein C-terminus binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q00975 B1AQK5,Voltage-dependent N-type calcium channel subunit alpha-1B,Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0005524;GO:0005509;GO:0008331;GO:0008022;GO:0005245;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050804;GO:0034765;GO:1904645;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:ATP binding; F:calcium ion binding; F:high voltage-gated calcium channel activity; F:protein C-terminus binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q00975 B1AQK5,Voltage-dependent N-type calcium channel subunit alpha-1B,Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0005524;GO:0005509;GO:0008331;GO:0008022;GO:0005245;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050804;GO:0034765;GO:1904645;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:ATP binding; F:calcium ion binding; F:high voltage-gated calcium channel activity; F:protein C-terminus binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:regulation of ion transmembrane transport; P:response to amyloid-beta; scaffold78 indexed_genome mRNA 854262 880107 . + . ID=transcript_11909;P42681 Q14220,Tyrosine-protein kinase TXK,Protein-tyrosine kinase 4;Resting lymphocyte kinase;, PF07714;PF00017;PF00018;, GO:0005737;GO:0005634;GO:0005886;GO:0005524;GO:0004715;GO:0004713;GO:0004714;GO:0007202;GO:0002250;GO:0007229;GO:0038083;GO:0001819;GO:0032729;GO:0060335;GO:0045944;GO:0046777;GO:0006468;GO:0010468;GO:0010543;GO:0050852;GO:0042246;, C:cytoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of phospholipase C activity; P:adaptive immune response; P:integrin-mediated signaling pathway; P:peptidyl-tyrosine autophosphorylation; P:positive regulation of cytokine production; P:positive regulation of interferon-gamma production; P:positive regulation of interferon-gamma-mediated signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of gene expression; P:regulation of platelet activation; P:T cell receptor signaling pathway; P:tissue regeneration; scaffold78 indexed_genome mRNA 904748 929132 . - . ID=transcript_11910;Q6NVV3 B3KTB0 Q68DA9,Magnesium transporter NIPA3,NIPA-like protein 1;Non-imprinted in Prader-Willi/Angelman syndrome region protein 3;, PF05653;, GO:0016021;GO:0016020;GO:0015095;GO:0015693;, C:integral component of membrane; C:membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport; scaffold78 indexed_genome mRNA 976811 980247 . + . ID=transcript_11911;P29973 A8K7K6 J3KPZ2 Q16279 Q16485 Q4W5E3,cGMP-gated cation channel alpha-1,Cyclic nucleotide-gated cation channel 1;Cyclic nucleotide-gated channel alpha-1;Cyclic nucleotide-gated channel, photoreceptor;Rod photoreceptor cGMP-gated channel subunit alpha;, PF16526;PF00027;PF00520;, GO:0005887;GO:0042622;GO:0005886;GO:0030553;GO:0005222;GO:0005223;GO:0022400;GO:0016056;GO:0007601;, C:integral component of plasma membrane; C:photoreceptor outer segment membrane; C:plasma membrane;, F:cGMP binding; F:intracellular cAMP-activated cation channel activity; F:intracellular cGMP-activated cation channel activity;, P:regulation of rhodopsin mediated signaling pathway; P:rhodopsin mediated signaling pathway; P:visual perception; scaffold78 indexed_genome mRNA 980656 981243 . - . ID=transcript_11912;P29973 A8K7K6 J3KPZ2 Q16279 Q16485 Q4W5E3,cGMP-gated cation channel alpha-1,Cyclic nucleotide-gated cation channel 1;Cyclic nucleotide-gated channel alpha-1;Cyclic nucleotide-gated channel, photoreceptor;Rod photoreceptor cGMP-gated channel subunit alpha;, PF16526;PF00027;PF00520;, GO:0005887;GO:0042622;GO:0005886;GO:0030553;GO:0005222;GO:0005223;GO:0022400;GO:0016056;GO:0007601;, C:integral component of plasma membrane; C:photoreceptor outer segment membrane; C:plasma membrane;, F:cGMP binding; F:intracellular cAMP-activated cation channel activity; F:intracellular cGMP-activated cation channel activity;, P:regulation of rhodopsin mediated signaling pathway; P:rhodopsin mediated signaling pathway; P:visual perception; scaffold78 indexed_genome mRNA 998830 1052644 . + . ID=transcript_11913;Q6ZNB6 B1Q2K1 Q86VG1 Q8WVH1,NF-X1-type zinc finger protein NFXL1,Ovarian zinc finger protein;, PF01422;, GO:0000785;GO:0016021;GO:0016020;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0006355;, C:chromatin; C:integral component of membrane; C:membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated;|Q6ZNB6 B1Q2K1 Q86VG1 Q8WVH1,NF-X1-type zinc finger protein NFXL1,Ovarian zinc finger protein;, PF01422;, GO:0000785;GO:0016021;GO:0016020;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0006355;, C:chromatin; C:integral component of membrane; C:membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated;|Q6ZNB6 B1Q2K1 Q86VG1 Q8WVH1,NF-X1-type zinc finger protein NFXL1,Ovarian zinc finger protein;, PF01422;, GO:0000785;GO:0016021;GO:0016020;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0006355;, C:chromatin; C:integral component of membrane; C:membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated;|Q6ZNB6 B1Q2K1 Q86VG1 Q8WVH1,NF-X1-type zinc finger protein NFXL1,Ovarian zinc finger protein;, PF01422;, GO:0000785;GO:0016021;GO:0016020;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0006355;, C:chromatin; C:integral component of membrane; C:membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated;|Q6ZNB6 B1Q2K1 Q86VG1 Q8WVH1,NF-X1-type zinc finger protein NFXL1,Ovarian zinc finger protein;, PF01422;, GO:0000785;GO:0016021;GO:0016020;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0006355;, C:chromatin; C:integral component of membrane; C:membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated;|Q6ZNB6 B1Q2K1 Q86VG1 Q8WVH1,NF-X1-type zinc finger protein NFXL1,Ovarian zinc finger protein;, PF01422;, GO:0000785;GO:0016021;GO:0016020;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0006355;, C:chromatin; C:integral component of membrane; C:membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated;|Q6ZNB6 B1Q2K1 Q86VG1 Q8WVH1,NF-X1-type zinc finger protein NFXL1,Ovarian zinc finger protein;, PF01422;, GO:0000785;GO:0016021;GO:0016020;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0006355;, C:chromatin; C:integral component of membrane; C:membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated;|Q6ZNB6 B1Q2K1 Q86VG1 Q8WVH1,NF-X1-type zinc finger protein NFXL1,Ovarian zinc finger protein;, PF01422;, GO:0000785;GO:0016021;GO:0016020;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0006355;, C:chromatin; C:integral component of membrane; C:membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated;|Q6ZNB6 B1Q2K1 Q86VG1 Q8WVH1,NF-X1-type zinc finger protein NFXL1,Ovarian zinc finger protein;, PF01422;, GO:0000785;GO:0016021;GO:0016020;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0006355;, C:chromatin; C:integral component of membrane; C:membrane; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated; scaffold78 indexed_genome mRNA 1123777 1229426 . + . ID=transcript_11914;Q9Y5Q5 B0ZBE3 Q2TBD2 Q4W5E5 Q4W5G6 Q9UHY2,Atrial natriuretic peptide-converting enzyme,Corin;Heart-specific serine proteinase ATC2;Pro-ANP-converting enzyme;Transmembrane protease serine 10;, PF01392;PF00057;PF15494;PF00089;, GO:0015629;GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0016604;GO:0005886;GO:0004175;GO:0004252;GO:0007565;GO:0016486;GO:0008217;GO:1903779;GO:0035813;GO:0003050;, C:actin cytoskeleton; C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear body; C:plasma membrane;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:female pregnancy; P:peptide hormone processing; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of renal sodium excretion; P:regulation of systemic arterial blood pressure by atrial natriuretic peptide; scaffold78 indexed_genome mRNA 1245305 1277026 . + . ID=transcript_11915;Q9Y5Q5 B0ZBE3 Q2TBD2 Q4W5E5 Q4W5G6 Q9UHY2,Atrial natriuretic peptide-converting enzyme,Corin;Heart-specific serine proteinase ATC2;Pro-ANP-converting enzyme;Transmembrane protease serine 10;, PF01392;PF00057;PF15494;PF00089;, GO:0015629;GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0016604;GO:0005886;GO:0004175;GO:0004252;GO:0007565;GO:0016486;GO:0008217;GO:1903779;GO:0035813;GO:0003050;, C:actin cytoskeleton; C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear body; C:plasma membrane;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:female pregnancy; P:peptide hormone processing; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of renal sodium excretion; P:regulation of systemic arterial blood pressure by atrial natriuretic peptide; scaffold78 indexed_genome mRNA 1314758 1325167 . + . ID=transcript_11916;Q9Y5Q5 B0ZBE3 Q2TBD2 Q4W5E5 Q4W5G6 Q9UHY2,Atrial natriuretic peptide-converting enzyme,Corin;Heart-specific serine proteinase ATC2;Pro-ANP-converting enzyme;Transmembrane protease serine 10;, PF01392;PF00057;PF15494;PF00089;, GO:0015629;GO:0009986;GO:0005576;GO:0016021;GO:0005887;GO:0016604;GO:0005886;GO:0004175;GO:0004252;GO:0007565;GO:0016486;GO:0008217;GO:1903779;GO:0035813;GO:0003050;, C:actin cytoskeleton; C:cell surface; C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear body; C:plasma membrane;, F:endopeptidase activity; F:serine-type endopeptidase activity;, P:female pregnancy; P:peptide hormone processing; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of renal sodium excretion; P:regulation of systemic arterial blood pressure by atrial natriuretic peptide; scaffold78 indexed_genome mRNA 1327999 1417033 . - . ID=transcript_11917;Q9P241 A2RRC8 D6REN2 Q8NC70 Q96SR3,Phospholipid-transporting ATPase VD,ATPase class V type 10D;P4-ATPase flippase complex alpha subunit ATP10D;, PF16212;PF16209;, GO:0005783;GO:0005789;GO:0016021;GO:0005887;GO:0005654;GO:1990531;GO:0005886;GO:0005524;GO:0140326;GO:0140351;GO:0000287;GO:0006812;GO:0034220;GO:0045332;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:phospholipid-translocating ATPase complex; C:plasma membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:glycosylceramide flippase activity; F:magnesium ion binding;, P:cation transport; P:ion transmembrane transport; P:phospholipid translocation;|Q9P241 A2RRC8 D6REN2 Q8NC70 Q96SR3,Phospholipid-transporting ATPase VD,ATPase class V type 10D;P4-ATPase flippase complex alpha subunit ATP10D;, PF16212;PF16209;, GO:0005783;GO:0005789;GO:0016021;GO:0005887;GO:0005654;GO:1990531;GO:0005886;GO:0005524;GO:0140326;GO:0140351;GO:0000287;GO:0006812;GO:0034220;GO:0045332;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:phospholipid-translocating ATPase complex; C:plasma membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:glycosylceramide flippase activity; F:magnesium ion binding;, P:cation transport; P:ion transmembrane transport; P:phospholipid translocation;|Q9P241 A2RRC8 D6REN2 Q8NC70 Q96SR3,Phospholipid-transporting ATPase VD,ATPase class V type 10D;P4-ATPase flippase complex alpha subunit ATP10D;, PF16212;PF16209;, GO:0005783;GO:0005789;GO:0016021;GO:0005887;GO:0005654;GO:1990531;GO:0005886;GO:0005524;GO:0140326;GO:0140351;GO:0000287;GO:0006812;GO:0034220;GO:0045332;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:nucleoplasm; C:phospholipid-translocating ATPase complex; C:plasma membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:glycosylceramide flippase activity; F:magnesium ion binding;, P:cation transport; P:ion transmembrane transport; P:phospholipid translocation; scaffold78 indexed_genome mRNA 1481435 1495864 . + . ID=transcript_11918;Q9NX08 Q8WUR4 Q9HC15,COMM domain-containing protein 8,, PF07258;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold78 indexed_genome mRNA 1516056 1547072 . - . ID=transcript_11919;P18505 B2R6U7 D6REL3 Q16166 Q8TBK3,Gamma-aminobutyric acid receptor subunit beta-1,GABA(A) receptor subunit beta-1;, PF02931;PF02932;, GO:0034707;GO:0005737;GO:0030425;GO:1902711;GO:0098982;GO:0005887;GO:0043005;GO:0005635;GO:0005886;GO:0045211;GO:0045202;GO:0050811;GO:0004890;GO:0022851;GO:0015276;GO:0030594;GO:1904315;GO:0071420;GO:0021954;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0006811;GO:0050877;GO:0042698;GO:0042391;GO:0032570;GO:0009636;GO:0007165;, C:chloride channel complex; C:cytoplasm; C:dendrite; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:neuron projection; C:nuclear envelope; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:GABA receptor binding; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to histamine; P:central nervous system neuron development; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:ion transport; P:nervous system process; P:ovulation cycle; P:regulation of membrane potential; P:response to progesterone; P:response to toxic substance; P:signal transduction; scaffold78 indexed_genome mRNA 1631461 1926205 . - . ID=transcript_11920;P18505 B2R6U7 D6REL3 Q16166 Q8TBK3,Gamma-aminobutyric acid receptor subunit beta-1,GABA(A) receptor subunit beta-1;, PF02931;PF02932;, GO:0034707;GO:0005737;GO:0030425;GO:1902711;GO:0098982;GO:0005887;GO:0043005;GO:0005635;GO:0005886;GO:0045211;GO:0045202;GO:0050811;GO:0004890;GO:0022851;GO:0015276;GO:0030594;GO:1904315;GO:0071420;GO:0021954;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0006811;GO:0050877;GO:0042698;GO:0042391;GO:0032570;GO:0009636;GO:0007165;, C:chloride channel complex; C:cytoplasm; C:dendrite; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:neuron projection; C:nuclear envelope; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:GABA receptor binding; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to histamine; P:central nervous system neuron development; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:ion transport; P:nervous system process; P:ovulation cycle; P:regulation of membrane potential; P:response to progesterone; P:response to toxic substance; P:signal transduction;|P18505 B2R6U7 D6REL3 Q16166 Q8TBK3,Gamma-aminobutyric acid receptor subunit beta-1,GABA(A) receptor subunit beta-1;, PF02931;PF02932;, GO:0034707;GO:0005737;GO:0030425;GO:1902711;GO:0098982;GO:0005887;GO:0043005;GO:0005635;GO:0005886;GO:0045211;GO:0045202;GO:0050811;GO:0004890;GO:0022851;GO:0015276;GO:0030594;GO:1904315;GO:0071420;GO:0021954;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0006811;GO:0050877;GO:0042698;GO:0042391;GO:0032570;GO:0009636;GO:0007165;, C:chloride channel complex; C:cytoplasm; C:dendrite; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:neuron projection; C:nuclear envelope; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:GABA receptor binding; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to histamine; P:central nervous system neuron development; P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:ion transport; P:nervous system process; P:ovulation cycle; P:regulation of membrane potential; P:response to progesterone; P:response to toxic substance; P:signal transduction; scaffold78 indexed_genome mRNA 1973377 2034000 . + . ID=transcript_11921;P48169 Q8IYR7,Gamma-aminobutyric acid receptor subunit alpha-4,GABA(A) receptor subunit alpha-4;, PF02931;PF02932;, GO:0034707;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0099060;GO:0043005;GO:0005886;GO:0098794;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;|P48169 Q8IYR7,Gamma-aminobutyric acid receptor subunit alpha-4,GABA(A) receptor subunit alpha-4;, PF02931;PF02932;, GO:0034707;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0099060;GO:0043005;GO:0005886;GO:0098794;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold78 indexed_genome mRNA 2516881 2656568 . + . ID=transcript_11922;P47869 A8K0U7 B7Z1H8 Q59G14,Gamma-aminobutyric acid receptor subunit alpha-2,GABA(A) receptor subunit alpha-2;, PF02931;PF02932;, GO:0034707;GO:0032590;GO:1902711;GO:0005887;GO:0030285;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0006836;GO:0042391;GO:0001505;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:neurotransmitter transport; P:regulation of membrane potential; P:regulation of neurotransmitter levels; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold78 indexed_genome mRNA 2765009 2837693 . + . ID=transcript_11923;Q8N1C3 Q5H9T8,Gamma-aminobutyric acid receptor subunit gamma-1,GABA(A) receptor subunit gamma-1;, PF02931;PF02932;, GO:0034707;GO:0032590;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0050811;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:GABA receptor binding; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold78 indexed_genome mRNA 3903094 3911180 . + . ID=transcript_11924;Q8TDQ7 B4DJF3 Q2VYF1 Q59EA7 Q8NCZ8 Q96BJ4 Q96NC6,Glucosamine-6-phosphate isomerase 2,Glucosamine-6-phosphate deaminase 2;Glucosamine-6-phosphate isomerase SB52;, PF01182;, GO:0005737;GO:0005829;GO:0005634;GO:0004342;GO:0042802;GO:0005975;GO:0006043;GO:0006046;GO:0019262;GO:0006048;, C:cytoplasm; C:cytosol; C:nucleus;, F:glucosamine-6-phosphate deaminase activity; F:identical protein binding;, P:carbohydrate metabolic process; P:glucosamine catabolic process; P:N-acetylglucosamine catabolic process; P:N-acetylneuraminate catabolic process; P:UDP-N-acetylglucosamine biosynthetic process; scaffold78 indexed_genome mRNA 3912132 3951573 . - . ID=transcript_11925;Q8TDQ7 B4DJF3 Q2VYF1 Q59EA7 Q8NCZ8 Q96BJ4 Q96NC6,Glucosamine-6-phosphate isomerase 2,Glucosamine-6-phosphate deaminase 2;Glucosamine-6-phosphate isomerase SB52;, PF01182;, GO:0005737;GO:0005829;GO:0005634;GO:0004342;GO:0042802;GO:0005975;GO:0006043;GO:0006046;GO:0019262;GO:0006048;, C:cytoplasm; C:cytosol; C:nucleus;, F:glucosamine-6-phosphate deaminase activity; F:identical protein binding;, P:carbohydrate metabolic process; P:glucosamine catabolic process; P:N-acetylglucosamine catabolic process; P:N-acetylneuraminate catabolic process; P:UDP-N-acetylglucosamine biosynthetic process;|Q8TDQ7 B4DJF3 Q2VYF1 Q59EA7 Q8NCZ8 Q96BJ4 Q96NC6,Glucosamine-6-phosphate isomerase 2,Glucosamine-6-phosphate deaminase 2;Glucosamine-6-phosphate isomerase SB52;, PF01182;, GO:0005737;GO:0005829;GO:0005634;GO:0004342;GO:0042802;GO:0005975;GO:0006043;GO:0006046;GO:0019262;GO:0006048;, C:cytoplasm; C:cytosol; C:nucleus;, F:glucosamine-6-phosphate deaminase activity; F:identical protein binding;, P:carbohydrate metabolic process; P:glucosamine catabolic process; P:N-acetylglucosamine catabolic process; P:N-acetylneuraminate catabolic process; P:UDP-N-acetylglucosamine biosynthetic process;|Q8N442 Q5XKM8 Q9H710 Q9H8U4,Translation factor GUF1, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03137},Elongation factor 4 homolog {ECO:0000255|HAMAP-Rule:MF_03137};GTPase GUF1 {ECO:0000255|HAMAP-Rule:MF_03137};Ribosomal back-translocase {ECO:0000255|HAMAP-Rule:MF_03137};, PF00679;PF00009;PF03144;PF06421;, GO:0005743;GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0043022;GO:0045727;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ribosome binding;, P:positive regulation of translation; P:translation;|Q8N442 Q5XKM8 Q9H710 Q9H8U4,Translation factor GUF1, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03137},Elongation factor 4 homolog {ECO:0000255|HAMAP-Rule:MF_03137};GTPase GUF1 {ECO:0000255|HAMAP-Rule:MF_03137};Ribosomal back-translocase {ECO:0000255|HAMAP-Rule:MF_03137};, PF00679;PF00009;PF03144;PF06421;, GO:0005743;GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0043022;GO:0045727;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ribosome binding;, P:positive regulation of translation; P:translation;|Q8N442 Q5XKM8 Q9H710 Q9H8U4,Translation factor GUF1, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03137},Elongation factor 4 homolog {ECO:0000255|HAMAP-Rule:MF_03137};GTPase GUF1 {ECO:0000255|HAMAP-Rule:MF_03137};Ribosomal back-translocase {ECO:0000255|HAMAP-Rule:MF_03137};, PF00679;PF00009;PF03144;PF06421;, GO:0005743;GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0043022;GO:0045727;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ribosome binding;, P:positive regulation of translation; P:translation;|Q8N442 Q5XKM8 Q9H710 Q9H8U4,Translation factor GUF1, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03137},Elongation factor 4 homolog {ECO:0000255|HAMAP-Rule:MF_03137};GTPase GUF1 {ECO:0000255|HAMAP-Rule:MF_03137};Ribosomal back-translocase {ECO:0000255|HAMAP-Rule:MF_03137};, PF00679;PF00009;PF03144;PF06421;, GO:0005743;GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0043022;GO:0045727;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ribosome binding;, P:positive regulation of translation; P:translation;|Q8N442 Q5XKM8 Q9H710 Q9H8U4,Translation factor GUF1, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03137},Elongation factor 4 homolog {ECO:0000255|HAMAP-Rule:MF_03137};GTPase GUF1 {ECO:0000255|HAMAP-Rule:MF_03137};Ribosomal back-translocase {ECO:0000255|HAMAP-Rule:MF_03137};, PF00679;PF00009;PF03144;PF06421;, GO:0005743;GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0043022;GO:0045727;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ribosome binding;, P:positive regulation of translation; P:translation;|Q8N442 Q5XKM8 Q9H710 Q9H8U4,Translation factor GUF1, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03137},Elongation factor 4 homolog {ECO:0000255|HAMAP-Rule:MF_03137};GTPase GUF1 {ECO:0000255|HAMAP-Rule:MF_03137};Ribosomal back-translocase {ECO:0000255|HAMAP-Rule:MF_03137};, PF00679;PF00009;PF03144;PF06421;, GO:0005743;GO:0005759;GO:0005739;GO:0005525;GO:0003924;GO:0043022;GO:0045727;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:ribosome binding;, P:positive regulation of translation; P:translation; scaffold78 indexed_genome mRNA 3968180 3996063 . + . ID=transcript_11926;Q8N8F6 Q3SY21 Q3SY22,Protein YIPF7,Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 9;YIP1 family member 7;, PF04893;, GO:0005789;GO:0005794;GO:0016021;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;|Q8N8F6 Q3SY21 Q3SY22,Protein YIPF7,Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 9;YIP1 family member 7;, PF04893;, GO:0005789;GO:0005794;GO:0016021;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; scaffold78 indexed_genome mRNA 4115214 4115933 . - . ID=transcript_11927;Q6ZWB6 A2RU39,BTB/POZ domain-containing protein KCTD8,, PF02214;, GO:0042995;GO:0045211;GO:0042734;GO:0043235;GO:0051260;GO:0008277;, C:cell projection; C:postsynaptic membrane; C:presynaptic membrane; C:receptor complex;, , P:protein homooligomerization; P:regulation of G protein-coupled receptor signaling pathway; scaffold78 indexed_genome mRNA 5576097 5816905 . + . ID=transcript_11928;Q9Y2Q0 Q32M35 Q32M36 Q4W5J7 Q4W5P2,Phospholipid-transporting ATPase IA {ECO:0000305},ATPase class I type 8A member 1;Chromaffin granule ATPase II;P4-ATPase flippase complex alpha subunit ATP8A1;, PF16212;PF16209;, GO:0035577;GO:0042584;GO:0031410;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0031090;GO:1990531;GO:0005886;GO:0035579;GO:0005802;GO:0005524;GO:0016887;GO:0019829;GO:0140326;GO:0140327;GO:0000287;GO:0140346;GO:0022857;GO:0140331;GO:0034220;GO:0007612;GO:0006869;GO:0043312;GO:0045332;GO:0030335;GO:0061092;GO:0055085;GO:0150104;, C:azurophil granule membrane; C:chromaffin granule membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled intramembrane lipid transporter activity; F:flippase activity; F:magnesium ion binding; F:phosphatidylserine flippase activity; F:transmembrane transporter activity;, P:aminophospholipid translocation; P:ion transmembrane transport; P:learning; P:lipid transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of cell migration; P:positive regulation of phospholipid translocation; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y2Q0 Q32M35 Q32M36 Q4W5J7 Q4W5P2,Phospholipid-transporting ATPase IA {ECO:0000305},ATPase class I type 8A member 1;Chromaffin granule ATPase II;P4-ATPase flippase complex alpha subunit ATP8A1;, PF16212;PF16209;, GO:0035577;GO:0042584;GO:0031410;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0031090;GO:1990531;GO:0005886;GO:0035579;GO:0005802;GO:0005524;GO:0016887;GO:0019829;GO:0140326;GO:0140327;GO:0000287;GO:0140346;GO:0022857;GO:0140331;GO:0034220;GO:0007612;GO:0006869;GO:0043312;GO:0045332;GO:0030335;GO:0061092;GO:0055085;GO:0150104;, C:azurophil granule membrane; C:chromaffin granule membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled intramembrane lipid transporter activity; F:flippase activity; F:magnesium ion binding; F:phosphatidylserine flippase activity; F:transmembrane transporter activity;, P:aminophospholipid translocation; P:ion transmembrane transport; P:learning; P:lipid transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of cell migration; P:positive regulation of phospholipid translocation; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y2Q0 Q32M35 Q32M36 Q4W5J7 Q4W5P2,Phospholipid-transporting ATPase IA {ECO:0000305},ATPase class I type 8A member 1;Chromaffin granule ATPase II;P4-ATPase flippase complex alpha subunit ATP8A1;, PF16212;PF16209;, GO:0035577;GO:0042584;GO:0031410;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0031090;GO:1990531;GO:0005886;GO:0035579;GO:0005802;GO:0005524;GO:0016887;GO:0019829;GO:0140326;GO:0140327;GO:0000287;GO:0140346;GO:0022857;GO:0140331;GO:0034220;GO:0007612;GO:0006869;GO:0043312;GO:0045332;GO:0030335;GO:0061092;GO:0055085;GO:0150104;, C:azurophil granule membrane; C:chromaffin granule membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled intramembrane lipid transporter activity; F:flippase activity; F:magnesium ion binding; F:phosphatidylserine flippase activity; F:transmembrane transporter activity;, P:aminophospholipid translocation; P:ion transmembrane transport; P:learning; P:lipid transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of cell migration; P:positive regulation of phospholipid translocation; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y2Q0 Q32M35 Q32M36 Q4W5J7 Q4W5P2,Phospholipid-transporting ATPase IA {ECO:0000305},ATPase class I type 8A member 1;Chromaffin granule ATPase II;P4-ATPase flippase complex alpha subunit ATP8A1;, PF16212;PF16209;, GO:0035577;GO:0042584;GO:0031410;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0031090;GO:1990531;GO:0005886;GO:0035579;GO:0005802;GO:0005524;GO:0016887;GO:0019829;GO:0140326;GO:0140327;GO:0000287;GO:0140346;GO:0022857;GO:0140331;GO:0034220;GO:0007612;GO:0006869;GO:0043312;GO:0045332;GO:0030335;GO:0061092;GO:0055085;GO:0150104;, C:azurophil granule membrane; C:chromaffin granule membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled intramembrane lipid transporter activity; F:flippase activity; F:magnesium ion binding; F:phosphatidylserine flippase activity; F:transmembrane transporter activity;, P:aminophospholipid translocation; P:ion transmembrane transport; P:learning; P:lipid transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of cell migration; P:positive regulation of phospholipid translocation; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y2Q0 Q32M35 Q32M36 Q4W5J7 Q4W5P2,Phospholipid-transporting ATPase IA {ECO:0000305},ATPase class I type 8A member 1;Chromaffin granule ATPase II;P4-ATPase flippase complex alpha subunit ATP8A1;, PF16212;PF16209;, GO:0035577;GO:0042584;GO:0031410;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0031090;GO:1990531;GO:0005886;GO:0035579;GO:0005802;GO:0005524;GO:0016887;GO:0019829;GO:0140326;GO:0140327;GO:0000287;GO:0140346;GO:0022857;GO:0140331;GO:0034220;GO:0007612;GO:0006869;GO:0043312;GO:0045332;GO:0030335;GO:0061092;GO:0055085;GO:0150104;, C:azurophil granule membrane; C:chromaffin granule membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled intramembrane lipid transporter activity; F:flippase activity; F:magnesium ion binding; F:phosphatidylserine flippase activity; F:transmembrane transporter activity;, P:aminophospholipid translocation; P:ion transmembrane transport; P:learning; P:lipid transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of cell migration; P:positive regulation of phospholipid translocation; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y2Q0 Q32M35 Q32M36 Q4W5J7 Q4W5P2,Phospholipid-transporting ATPase IA {ECO:0000305},ATPase class I type 8A member 1;Chromaffin granule ATPase II;P4-ATPase flippase complex alpha subunit ATP8A1;, PF16212;PF16209;, GO:0035577;GO:0042584;GO:0031410;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0031090;GO:1990531;GO:0005886;GO:0035579;GO:0005802;GO:0005524;GO:0016887;GO:0019829;GO:0140326;GO:0140327;GO:0000287;GO:0140346;GO:0022857;GO:0140331;GO:0034220;GO:0007612;GO:0006869;GO:0043312;GO:0045332;GO:0030335;GO:0061092;GO:0055085;GO:0150104;, C:azurophil granule membrane; C:chromaffin granule membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled intramembrane lipid transporter activity; F:flippase activity; F:magnesium ion binding; F:phosphatidylserine flippase activity; F:transmembrane transporter activity;, P:aminophospholipid translocation; P:ion transmembrane transport; P:learning; P:lipid transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of cell migration; P:positive regulation of phospholipid translocation; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y2Q0 Q32M35 Q32M36 Q4W5J7 Q4W5P2,Phospholipid-transporting ATPase IA {ECO:0000305},ATPase class I type 8A member 1;Chromaffin granule ATPase II;P4-ATPase flippase complex alpha subunit ATP8A1;, PF16212;PF16209;, GO:0035577;GO:0042584;GO:0031410;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0031090;GO:1990531;GO:0005886;GO:0035579;GO:0005802;GO:0005524;GO:0016887;GO:0019829;GO:0140326;GO:0140327;GO:0000287;GO:0140346;GO:0022857;GO:0140331;GO:0034220;GO:0007612;GO:0006869;GO:0043312;GO:0045332;GO:0030335;GO:0061092;GO:0055085;GO:0150104;, C:azurophil granule membrane; C:chromaffin granule membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled intramembrane lipid transporter activity; F:flippase activity; F:magnesium ion binding; F:phosphatidylserine flippase activity; F:transmembrane transporter activity;, P:aminophospholipid translocation; P:ion transmembrane transport; P:learning; P:lipid transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of cell migration; P:positive regulation of phospholipid translocation; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y2Q0 Q32M35 Q32M36 Q4W5J7 Q4W5P2,Phospholipid-transporting ATPase IA {ECO:0000305},ATPase class I type 8A member 1;Chromaffin granule ATPase II;P4-ATPase flippase complex alpha subunit ATP8A1;, PF16212;PF16209;, GO:0035577;GO:0042584;GO:0031410;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0031090;GO:1990531;GO:0005886;GO:0035579;GO:0005802;GO:0005524;GO:0016887;GO:0019829;GO:0140326;GO:0140327;GO:0000287;GO:0140346;GO:0022857;GO:0140331;GO:0034220;GO:0007612;GO:0006869;GO:0043312;GO:0045332;GO:0030335;GO:0061092;GO:0055085;GO:0150104;, C:azurophil granule membrane; C:chromaffin granule membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled intramembrane lipid transporter activity; F:flippase activity; F:magnesium ion binding; F:phosphatidylserine flippase activity; F:transmembrane transporter activity;, P:aminophospholipid translocation; P:ion transmembrane transport; P:learning; P:lipid transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of cell migration; P:positive regulation of phospholipid translocation; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y2Q0 Q32M35 Q32M36 Q4W5J7 Q4W5P2,Phospholipid-transporting ATPase IA {ECO:0000305},ATPase class I type 8A member 1;Chromaffin granule ATPase II;P4-ATPase flippase complex alpha subunit ATP8A1;, PF16212;PF16209;, GO:0035577;GO:0042584;GO:0031410;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0031090;GO:1990531;GO:0005886;GO:0035579;GO:0005802;GO:0005524;GO:0016887;GO:0019829;GO:0140326;GO:0140327;GO:0000287;GO:0140346;GO:0022857;GO:0140331;GO:0034220;GO:0007612;GO:0006869;GO:0043312;GO:0045332;GO:0030335;GO:0061092;GO:0055085;GO:0150104;, C:azurophil granule membrane; C:chromaffin granule membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled intramembrane lipid transporter activity; F:flippase activity; F:magnesium ion binding; F:phosphatidylserine flippase activity; F:transmembrane transporter activity;, P:aminophospholipid translocation; P:ion transmembrane transport; P:learning; P:lipid transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of cell migration; P:positive regulation of phospholipid translocation; P:transmembrane transport; P:transport across blood-brain barrier;|Q9Y2Q0 Q32M35 Q32M36 Q4W5J7 Q4W5P2,Phospholipid-transporting ATPase IA {ECO:0000305},ATPase class I type 8A member 1;Chromaffin granule ATPase II;P4-ATPase flippase complex alpha subunit ATP8A1;, PF16212;PF16209;, GO:0035577;GO:0042584;GO:0031410;GO:0005783;GO:0070062;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0031090;GO:1990531;GO:0005886;GO:0035579;GO:0005802;GO:0005524;GO:0016887;GO:0019829;GO:0140326;GO:0140327;GO:0000287;GO:0140346;GO:0022857;GO:0140331;GO:0034220;GO:0007612;GO:0006869;GO:0043312;GO:0045332;GO:0030335;GO:0061092;GO:0055085;GO:0150104;, C:azurophil granule membrane; C:chromaffin granule membrane; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:ATPase-coupled cation transmembrane transporter activity; F:ATPase-coupled intramembrane lipid transporter activity; F:flippase activity; F:magnesium ion binding; F:phosphatidylserine flippase activity; F:transmembrane transporter activity;, P:aminophospholipid translocation; P:ion transmembrane transport; P:learning; P:lipid transport; P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of cell migration; P:positive regulation of phospholipid translocation; P:transmembrane transport; P:transport across blood-brain barrier; scaffold78 indexed_genome mRNA 6099750 6151862 . - . ID=transcript_11929;Q6PML9 Q4W5B6 Q7Z5I7 Q8TBB2 Q9Y6R2,Zinc transporter 9,Human embryonic lung protein {ECO:0000303|PubMed:10409434};Solute carrier family 30 member 9;, PF01545;, GO:0031410;GO:0005856;GO:0005783;GO:0016021;GO:0005634;GO:0008324;GO:0003682;GO:0016922;GO:0030374;GO:0006882;GO:0006289;GO:0045944;GO:0006829;, C:cytoplasmic vesicle; C:cytoskeleton; C:endoplasmic reticulum; C:integral component of membrane; C:nucleus;, F:cation transmembrane transporter activity; F:chromatin binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity;, P:cellular zinc ion homeostasis; P:nucleotide-excision repair; P:positive regulation of transcription by RNA polymerase II; P:zinc ion transport;|Q6PML9 Q4W5B6 Q7Z5I7 Q8TBB2 Q9Y6R2,Zinc transporter 9,Human embryonic lung protein {ECO:0000303|PubMed:10409434};Solute carrier family 30 member 9;, PF01545;, GO:0031410;GO:0005856;GO:0005783;GO:0016021;GO:0005634;GO:0008324;GO:0003682;GO:0016922;GO:0030374;GO:0006882;GO:0006289;GO:0045944;GO:0006829;, C:cytoplasmic vesicle; C:cytoskeleton; C:endoplasmic reticulum; C:integral component of membrane; C:nucleus;, F:cation transmembrane transporter activity; F:chromatin binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity;, P:cellular zinc ion homeostasis; P:nucleotide-excision repair; P:positive regulation of transcription by RNA polymerase II; P:zinc ion transport;|Q6PML9 Q4W5B6 Q7Z5I7 Q8TBB2 Q9Y6R2,Zinc transporter 9,Human embryonic lung protein {ECO:0000303|PubMed:10409434};Solute carrier family 30 member 9;, PF01545;, GO:0031410;GO:0005856;GO:0005783;GO:0016021;GO:0005634;GO:0008324;GO:0003682;GO:0016922;GO:0030374;GO:0006882;GO:0006289;GO:0045944;GO:0006829;, C:cytoplasmic vesicle; C:cytoskeleton; C:endoplasmic reticulum; C:integral component of membrane; C:nucleus;, F:cation transmembrane transporter activity; F:chromatin binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity;, P:cellular zinc ion homeostasis; P:nucleotide-excision repair; P:positive regulation of transcription by RNA polymerase II; P:zinc ion transport;|Q6PML9 Q4W5B6 Q7Z5I7 Q8TBB2 Q9Y6R2,Zinc transporter 9,Human embryonic lung protein {ECO:0000303|PubMed:10409434};Solute carrier family 30 member 9;, PF01545;, GO:0031410;GO:0005856;GO:0005783;GO:0016021;GO:0005634;GO:0008324;GO:0003682;GO:0016922;GO:0030374;GO:0006882;GO:0006289;GO:0045944;GO:0006829;, C:cytoplasmic vesicle; C:cytoskeleton; C:endoplasmic reticulum; C:integral component of membrane; C:nucleus;, F:cation transmembrane transporter activity; F:chromatin binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity;, P:cellular zinc ion homeostasis; P:nucleotide-excision repair; P:positive regulation of transcription by RNA polymerase II; P:zinc ion transport;|Q6PML9 Q4W5B6 Q7Z5I7 Q8TBB2 Q9Y6R2,Zinc transporter 9,Human embryonic lung protein {ECO:0000303|PubMed:10409434};Solute carrier family 30 member 9;, PF01545;, GO:0031410;GO:0005856;GO:0005783;GO:0016021;GO:0005634;GO:0008324;GO:0003682;GO:0016922;GO:0030374;GO:0006882;GO:0006289;GO:0045944;GO:0006829;, C:cytoplasmic vesicle; C:cytoskeleton; C:endoplasmic reticulum; C:integral component of membrane; C:nucleus;, F:cation transmembrane transporter activity; F:chromatin binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity;, P:cellular zinc ion homeostasis; P:nucleotide-excision repair; P:positive regulation of transcription by RNA polymerase II; P:zinc ion transport;|Q6PML9 Q4W5B6 Q7Z5I7 Q8TBB2 Q9Y6R2,Zinc transporter 9,Human embryonic lung protein {ECO:0000303|PubMed:10409434};Solute carrier family 30 member 9;, PF01545;, GO:0031410;GO:0005856;GO:0005783;GO:0016021;GO:0005634;GO:0008324;GO:0003682;GO:0016922;GO:0030374;GO:0006882;GO:0006289;GO:0045944;GO:0006829;, C:cytoplasmic vesicle; C:cytoskeleton; C:endoplasmic reticulum; C:integral component of membrane; C:nucleus;, F:cation transmembrane transporter activity; F:chromatin binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity;, P:cellular zinc ion homeostasis; P:nucleotide-excision repair; P:positive regulation of transcription by RNA polymerase II; P:zinc ion transport;|Q6PML9 Q4W5B6 Q7Z5I7 Q8TBB2 Q9Y6R2,Zinc transporter 9,Human embryonic lung protein {ECO:0000303|PubMed:10409434};Solute carrier family 30 member 9;, PF01545;, GO:0031410;GO:0005856;GO:0005783;GO:0016021;GO:0005634;GO:0008324;GO:0003682;GO:0016922;GO:0030374;GO:0006882;GO:0006289;GO:0045944;GO:0006829;, C:cytoplasmic vesicle; C:cytoskeleton; C:endoplasmic reticulum; C:integral component of membrane; C:nucleus;, F:cation transmembrane transporter activity; F:chromatin binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity;, P:cellular zinc ion homeostasis; P:nucleotide-excision repair; P:positive regulation of transcription by RNA polymerase II; P:zinc ion transport; scaffold78 indexed_genome mRNA 6196796 6210958 . - . ID=transcript_11930;P57088 B3KSS8 Q9H953,Transmembrane protein 33,Protein DB83;SHINC-3 {ECO:0000303|PubMed:26268696};, PF03661;, GO:0005783;GO:0005789;GO:0030176;GO:0042470;GO:0005635;GO:0071786;GO:0061024;GO:1903896;GO:1903899;GO:1903371;GO:0034976;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:melanosome; C:nuclear envelope;, , P:endoplasmic reticulum tubular network organization; P:membrane organization; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of PERK-mediated unfolded protein response; P:regulation of endoplasmic reticulum tubular network organization; P:response to endoplasmic reticulum stress;|P57088 B3KSS8 Q9H953,Transmembrane protein 33,Protein DB83;SHINC-3 {ECO:0000303|PubMed:26268696};, PF03661;, GO:0005783;GO:0005789;GO:0030176;GO:0042470;GO:0005635;GO:0071786;GO:0061024;GO:1903896;GO:1903899;GO:1903371;GO:0034976;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:melanosome; C:nuclear envelope;, , P:endoplasmic reticulum tubular network organization; P:membrane organization; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of PERK-mediated unfolded protein response; P:regulation of endoplasmic reticulum tubular network organization; P:response to endoplasmic reticulum stress;|P57088 B3KSS8 Q9H953,Transmembrane protein 33,Protein DB83;SHINC-3 {ECO:0000303|PubMed:26268696};, PF03661;, GO:0005783;GO:0005789;GO:0030176;GO:0042470;GO:0005635;GO:0071786;GO:0061024;GO:1903896;GO:1903899;GO:1903371;GO:0034976;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:melanosome; C:nuclear envelope;, , P:endoplasmic reticulum tubular network organization; P:membrane organization; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of PERK-mediated unfolded protein response; P:regulation of endoplasmic reticulum tubular network organization; P:response to endoplasmic reticulum stress;|P57088 B3KSS8 Q9H953,Transmembrane protein 33,Protein DB83;SHINC-3 {ECO:0000303|PubMed:26268696};, PF03661;, GO:0005783;GO:0005789;GO:0030176;GO:0042470;GO:0005635;GO:0071786;GO:0061024;GO:1903896;GO:1903899;GO:1903371;GO:0034976;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:melanosome; C:nuclear envelope;, , P:endoplasmic reticulum tubular network organization; P:membrane organization; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of PERK-mediated unfolded protein response; P:regulation of endoplasmic reticulum tubular network organization; P:response to endoplasmic reticulum stress; scaffold78 indexed_genome mRNA 6452483 6519997 . - . ID=transcript_11931;Q7Z3G5 Q8N3S9 Q8N6M2,LIM and calponin homology domains-containing protein 1 {ECO:0000305},, PF00307;PF15949;PF00412;, GO:0005737;GO:0001725;GO:0003779;GO:0046872;GO:0032034;GO:0031032;GO:0060327;GO:0030336;GO:0001934;GO:0051496;GO:0051893;, C:cytoplasm; C:stress fiber;, F:actin binding; F:metal ion binding; F:myosin II head/neck binding;, P:actomyosin structure organization; P:cytoplasmic actin-based contraction involved in cell motility; P:negative regulation of cell migration; P:positive regulation of protein phosphorylation; P:positive regulation of stress fiber assembly; P:regulation of focal adhesion assembly;|Q7Z3G5 Q8N3S9 Q8N6M2,LIM and calponin homology domains-containing protein 1 {ECO:0000305},, PF00307;PF15949;PF00412;, GO:0005737;GO:0001725;GO:0003779;GO:0046872;GO:0032034;GO:0031032;GO:0060327;GO:0030336;GO:0001934;GO:0051496;GO:0051893;, C:cytoplasm; C:stress fiber;, F:actin binding; F:metal ion binding; F:myosin II head/neck binding;, P:actomyosin structure organization; P:cytoplasmic actin-based contraction involved in cell motility; P:negative regulation of cell migration; P:positive regulation of protein phosphorylation; P:positive regulation of stress fiber assembly; P:regulation of focal adhesion assembly;|Q7Z3G5 Q8N3S9 Q8N6M2,LIM and calponin homology domains-containing protein 1 {ECO:0000305},, PF00307;PF15949;PF00412;, GO:0005737;GO:0001725;GO:0003779;GO:0046872;GO:0032034;GO:0031032;GO:0060327;GO:0030336;GO:0001934;GO:0051496;GO:0051893;, C:cytoplasm; C:stress fiber;, F:actin binding; F:metal ion binding; F:myosin II head/neck binding;, P:actomyosin structure organization; P:cytoplasmic actin-based contraction involved in cell motility; P:negative regulation of cell migration; P:positive regulation of protein phosphorylation; P:positive regulation of stress fiber assembly; P:regulation of focal adhesion assembly;|Q7Z3G5 Q8N3S9 Q8N6M2,LIM and calponin homology domains-containing protein 1 {ECO:0000305},, PF00307;PF15949;PF00412;, GO:0005737;GO:0001725;GO:0003779;GO:0046872;GO:0032034;GO:0031032;GO:0060327;GO:0030336;GO:0001934;GO:0051496;GO:0051893;, C:cytoplasm; C:stress fiber;, F:actin binding; F:metal ion binding; F:myosin II head/neck binding;, P:actomyosin structure organization; P:cytoplasmic actin-based contraction involved in cell motility; P:negative regulation of cell migration; P:positive regulation of protein phosphorylation; P:positive regulation of stress fiber assembly; P:regulation of focal adhesion assembly; scaffold78 indexed_genome mRNA 6799753 6810338 . + . ID=transcript_11932;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold78 indexed_genome mRNA 6865606 6876695 . - . ID=transcript_11933;P09936 Q4W5K6 Q71UM0,Ubiquitin carboxyl-terminal hydrolase isozyme L1,Neuron cytoplasmic protein 9.5;PGP 9.5;Ubiquitin thioesterase L1;, PF01088;, GO:0005737;GO:0005829;GO:0005789;GO:0005654;GO:0031694;GO:0004197;GO:0016874;GO:0008242;GO:0004843;GO:0043130;GO:0031625;GO:0043407;GO:0043161;GO:0016579;GO:0016241;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm;, F:alpha-2A adrenergic receptor binding; F:cysteine-type endopeptidase activity; F:ligase activity; F:omega peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:negative regulation of MAP kinase activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of macroautophagy;|P09936 Q4W5K6 Q71UM0,Ubiquitin carboxyl-terminal hydrolase isozyme L1,Neuron cytoplasmic protein 9.5;PGP 9.5;Ubiquitin thioesterase L1;, PF01088;, GO:0005737;GO:0005829;GO:0005789;GO:0005654;GO:0031694;GO:0004197;GO:0016874;GO:0008242;GO:0004843;GO:0043130;GO:0031625;GO:0043407;GO:0043161;GO:0016579;GO:0016241;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:nucleoplasm;, F:alpha-2A adrenergic receptor binding; F:cysteine-type endopeptidase activity; F:ligase activity; F:omega peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:negative regulation of MAP kinase activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of macroautophagy; scaffold78 indexed_genome mRNA 7120023 7120531 . - . ID=transcript_11934;Q92870 B4DSL4 E9PG87 Q8IUI6,Amyloid-beta A4 precursor protein-binding family B member 2,Protein Fe65-like 1;, PF00640;PF00397;, GO:0005737;GO:0030426;GO:0030027;GO:0016020;GO:0005634;GO:0045202;GO:0001540;GO:0008134;GO:0007050;GO:0035556;GO:0030308;GO:0006355;GO:0050808;, C:cytoplasm; C:growth cone; C:lamellipodium; C:membrane; C:nucleus; C:synapse;, F:amyloid-beta binding; F:transcription factor binding;, P:cell cycle arrest; P:intracellular signal transduction; P:negative regulation of cell growth; P:regulation of transcription, DNA-templated; P:synapse organization; scaffold78 indexed_genome mRNA 7213629 7214453 . + . ID=transcript_11935;Q92870 B4DSL4 E9PG87 Q8IUI6,Amyloid-beta A4 precursor protein-binding family B member 2,Protein Fe65-like 1;, PF00640;PF00397;, GO:0005737;GO:0030426;GO:0030027;GO:0016020;GO:0005634;GO:0045202;GO:0001540;GO:0008134;GO:0007050;GO:0035556;GO:0030308;GO:0006355;GO:0050808;, C:cytoplasm; C:growth cone; C:lamellipodium; C:membrane; C:nucleus; C:synapse;, F:amyloid-beta binding; F:transcription factor binding;, P:cell cycle arrest; P:intracellular signal transduction; P:negative regulation of cell growth; P:regulation of transcription, DNA-templated; P:synapse organization; scaffold78 indexed_genome mRNA 7215367 7227624 . + . ID=transcript_11936;Q92870 B4DSL4 E9PG87 Q8IUI6,Amyloid-beta A4 precursor protein-binding family B member 2,Protein Fe65-like 1;, PF00640;PF00397;, GO:0005737;GO:0030426;GO:0030027;GO:0016020;GO:0005634;GO:0045202;GO:0001540;GO:0008134;GO:0007050;GO:0035556;GO:0030308;GO:0006355;GO:0050808;, C:cytoplasm; C:growth cone; C:lamellipodium; C:membrane; C:nucleus; C:synapse;, F:amyloid-beta binding; F:transcription factor binding;, P:cell cycle arrest; P:intracellular signal transduction; P:negative regulation of cell growth; P:regulation of transcription, DNA-templated; P:synapse organization;|Q92870 B4DSL4 E9PG87 Q8IUI6,Amyloid-beta A4 precursor protein-binding family B member 2,Protein Fe65-like 1;, PF00640;PF00397;, GO:0005737;GO:0030426;GO:0030027;GO:0016020;GO:0005634;GO:0045202;GO:0001540;GO:0008134;GO:0007050;GO:0035556;GO:0030308;GO:0006355;GO:0050808;, C:cytoplasm; C:growth cone; C:lamellipodium; C:membrane; C:nucleus; C:synapse;, F:amyloid-beta binding; F:transcription factor binding;, P:cell cycle arrest; P:intracellular signal transduction; P:negative regulation of cell growth; P:regulation of transcription, DNA-templated; P:synapse organization; scaffold78 indexed_genome mRNA 7229256 7266701 . - . ID=transcript_11937;Q8NE18 C9JI19 Q8N9K8 Q9H815,Putative methyltransferase NSUN7,NOL1/NOP2/Sun domain family member 7;, PF01189;, GO:0008168;GO:0003723;GO:0032259;, , F:methyltransferase activity; F:RNA binding;, P:methylation;|Q8NE18 C9JI19 Q8N9K8 Q9H815,Putative methyltransferase NSUN7,NOL1/NOP2/Sun domain family member 7;, PF01189;, GO:0008168;GO:0003723;GO:0032259;, , F:methyltransferase activity; F:RNA binding;, P:methylation;|Q8NE18 C9JI19 Q8N9K8 Q9H815,Putative methyltransferase NSUN7,NOL1/NOP2/Sun domain family member 7;, PF01189;, GO:0008168;GO:0003723;GO:0032259;, , F:methyltransferase activity; F:RNA binding;, P:methylation; scaffold79 indexed_genome mRNA 8862 10812 . - . ID=transcript_11938;Q96IK5 Q9H826 Q9H8V7 Q9H927,Germ cell-less protein-like 1,Spermatogenesis-associated protein 29;, PF07707;PF00651;, GO:0016363;GO:0005634;GO:0042802;GO:0007281;GO:0007275;GO:0007283;, C:nuclear matrix; C:nucleus;, F:identical protein binding;, P:germ cell development; P:multicellular organism development; P:spermatogenesis; scaffold79 indexed_genome mRNA 1702566 1892178 . + . ID=transcript_11939;P10275 A0A0B4J1T2 A2RUN2 B1AKD7 C0JKD3 C0JKD4 E7EVX6 Q9UD95,Androgen receptor,Dihydrotestosterone receptor;Nuclear receptor subfamily 3 group C member 4;, PF02166;PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005497;GO:0051117;GO:0008013;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0004879;GO:0070974;GO:0000978;GO:0001091;GO:0001225;GO:0001085;GO:0005102;GO:0005496;GO:0008134;GO:0000976;GO:0008270;GO:0060520;GO:0030521;GO:0048645;GO:0007267;GO:0071391;GO:0071383;GO:0071394;GO:0060742;GO:0003382;GO:0001701;GO:0030520;GO:0030522;GO:0030518;GO:0060599;GO:0033327;GO:0048808;GO:0008584;GO:0019102;GO:0060749;GO:0060571;GO:0035264;GO:0008285;GO:0050680;GO:2001237;GO:0045720;GO:0000122;GO:0045597;GO:0008284;GO:0060769;GO:0010628;GO:0043568;GO:0045726;GO:0033148;GO:0043410;GO:0051092;GO:0042327;GO:0045944;GO:0045945;GO:0045893;GO:0060740;GO:0060736;GO:0016579;GO:0060765;GO:0048638;GO:1903076;GO:0003073;GO:0006357;GO:0072520;GO:0007165;GO:0007338;GO:0007283;GO:0060748;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:androgen binding; F:ATPase binding; F:beta-catenin binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:nuclear receptor activity; F:POU domain binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription factor binding; F:signaling receptor binding; F:steroid binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:activation of prostate induction by androgen receptor signaling pathway; P:androgen receptor signaling pathway; P:animal organ formation; P:cell-cell signaling; P:cellular response to estrogen stimulus; P:cellular response to steroid hormone stimulus; P:cellular response to testosterone stimulus; P:epithelial cell differentiation involved in prostate gland development; P:epithelial cell morphogenesis; P:in utero embryonic development; P:intracellular estrogen receptor signaling pathway; P:intracellular receptor signaling pathway; P:intracellular steroid hormone receptor signaling pathway; P:lateral sprouting involved in mammary gland duct morphogenesis; P:Leydig cell differentiation; P:male genitalia morphogenesis; P:male gonad development; P:male somatic sex determination; P:mammary gland alveolus development; P:morphogenesis of an epithelial fold; P:multicellular organism growth; P:negative regulation of cell population proliferation; P:negative regulation of epithelial cell proliferation; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of integrin biosynthetic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation involved in prostate gland development; P:positive regulation of gene expression; P:positive regulation of insulin-like growth factor receptor signaling pathway; P:positive regulation of integrin biosynthetic process; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of MAPK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription, DNA-templated; P:prostate gland epithelium morphogenesis; P:prostate gland growth; P:protein deubiquitination; P:regulation of androgen receptor signaling pathway; P:regulation of developmental growth; P:regulation of protein localization to plasma membrane; P:regulation of systemic arterial blood pressure; P:regulation of transcription by RNA polymerase II; P:seminiferous tubule development; P:signal transduction; P:single fertilization; P:spermatogenesis; P:tertiary branching involved in mammary gland duct morphogenesis; P:transcription initiation from RNA polymerase II promoter; scaffold79 indexed_genome mRNA 2374606 2402160 . - . ID=transcript_11940;O60890 B9EIP8 Q5JQ81 Q6PCC1 Q8WX47,Oligophrenin-1,, PF00169;PF00620;, GO:0015629;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0043195;GO:0003779;GO:0005096;GO:0035255;GO:0005543;GO:0030036;GO:0007411;GO:0034329;GO:0048667;GO:0021707;GO:0021895;GO:0045198;GO:0098880;GO:1901799;GO:0007399;GO:0030182;GO:0031175;GO:0030100;GO:0099149;GO:0035023;GO:0051056;GO:0051966;GO:0007165;GO:0006930;GO:0048488;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:terminal bouton;, F:actin binding; F:GTPase activator activity; F:ionotropic glutamate receptor binding; F:phospholipid binding;, P:actin cytoskeleton organization; P:axon guidance; P:cell junction assembly; P:cell morphogenesis involved in neuron differentiation; P:cerebellar granule cell differentiation; P:cerebral cortex neuron differentiation; P:establishment of epithelial cell apical/basal polarity; P:maintenance of postsynaptic specialization structure; P:negative regulation of proteasomal protein catabolic process; P:nervous system development; P:neuron differentiation; P:neuron projection development; P:regulation of endocytosis; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:regulation of synaptic transmission, glutamatergic; P:signal transduction; P:substrate-dependent cell migration, cell extension; P:synaptic vesicle endocytosis;|O60890 B9EIP8 Q5JQ81 Q6PCC1 Q8WX47,Oligophrenin-1,, PF00169;PF00620;, GO:0015629;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0043195;GO:0003779;GO:0005096;GO:0035255;GO:0005543;GO:0030036;GO:0007411;GO:0034329;GO:0048667;GO:0021707;GO:0021895;GO:0045198;GO:0098880;GO:1901799;GO:0007399;GO:0030182;GO:0031175;GO:0030100;GO:0099149;GO:0035023;GO:0051056;GO:0051966;GO:0007165;GO:0006930;GO:0048488;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:terminal bouton;, F:actin binding; F:GTPase activator activity; F:ionotropic glutamate receptor binding; F:phospholipid binding;, P:actin cytoskeleton organization; P:axon guidance; P:cell junction assembly; P:cell morphogenesis involved in neuron differentiation; P:cerebellar granule cell differentiation; P:cerebral cortex neuron differentiation; P:establishment of epithelial cell apical/basal polarity; P:maintenance of postsynaptic specialization structure; P:negative regulation of proteasomal protein catabolic process; P:nervous system development; P:neuron differentiation; P:neuron projection development; P:regulation of endocytosis; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:regulation of synaptic transmission, glutamatergic; P:signal transduction; P:substrate-dependent cell migration, cell extension; P:synaptic vesicle endocytosis; scaffold79 indexed_genome mRNA 2678995 2681297 . + . ID=transcript_11941;O60890 B9EIP8 Q5JQ81 Q6PCC1 Q8WX47,Oligophrenin-1,, PF00169;PF00620;, GO:0015629;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0043195;GO:0003779;GO:0005096;GO:0035255;GO:0005543;GO:0030036;GO:0007411;GO:0034329;GO:0048667;GO:0021707;GO:0021895;GO:0045198;GO:0098880;GO:1901799;GO:0007399;GO:0030182;GO:0031175;GO:0030100;GO:0099149;GO:0035023;GO:0051056;GO:0051966;GO:0007165;GO:0006930;GO:0048488;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:terminal bouton;, F:actin binding; F:GTPase activator activity; F:ionotropic glutamate receptor binding; F:phospholipid binding;, P:actin cytoskeleton organization; P:axon guidance; P:cell junction assembly; P:cell morphogenesis involved in neuron differentiation; P:cerebellar granule cell differentiation; P:cerebral cortex neuron differentiation; P:establishment of epithelial cell apical/basal polarity; P:maintenance of postsynaptic specialization structure; P:negative regulation of proteasomal protein catabolic process; P:nervous system development; P:neuron differentiation; P:neuron projection development; P:regulation of endocytosis; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:regulation of synaptic transmission, glutamatergic; P:signal transduction; P:substrate-dependent cell migration, cell extension; P:synaptic vesicle endocytosis; scaffold79 indexed_genome mRNA 2681963 3010983 . - . ID=transcript_11942;O60890 B9EIP8 Q5JQ81 Q6PCC1 Q8WX47,Oligophrenin-1,, PF00169;PF00620;, GO:0015629;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0043195;GO:0003779;GO:0005096;GO:0035255;GO:0005543;GO:0030036;GO:0007411;GO:0034329;GO:0048667;GO:0021707;GO:0021895;GO:0045198;GO:0098880;GO:1901799;GO:0007399;GO:0030182;GO:0031175;GO:0030100;GO:0099149;GO:0035023;GO:0051056;GO:0051966;GO:0007165;GO:0006930;GO:0048488;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:terminal bouton;, F:actin binding; F:GTPase activator activity; F:ionotropic glutamate receptor binding; F:phospholipid binding;, P:actin cytoskeleton organization; P:axon guidance; P:cell junction assembly; P:cell morphogenesis involved in neuron differentiation; P:cerebellar granule cell differentiation; P:cerebral cortex neuron differentiation; P:establishment of epithelial cell apical/basal polarity; P:maintenance of postsynaptic specialization structure; P:negative regulation of proteasomal protein catabolic process; P:nervous system development; P:neuron differentiation; P:neuron projection development; P:regulation of endocytosis; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:regulation of synaptic transmission, glutamatergic; P:signal transduction; P:substrate-dependent cell migration, cell extension; P:synaptic vesicle endocytosis;|O60890 B9EIP8 Q5JQ81 Q6PCC1 Q8WX47,Oligophrenin-1,, PF00169;PF00620;, GO:0015629;GO:0005737;GO:0005829;GO:0043197;GO:0098978;GO:0043195;GO:0003779;GO:0005096;GO:0035255;GO:0005543;GO:0030036;GO:0007411;GO:0034329;GO:0048667;GO:0021707;GO:0021895;GO:0045198;GO:0098880;GO:1901799;GO:0007399;GO:0030182;GO:0031175;GO:0030100;GO:0099149;GO:0035023;GO:0051056;GO:0051966;GO:0007165;GO:0006930;GO:0048488;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic spine; C:glutamatergic synapse; C:terminal bouton;, F:actin binding; F:GTPase activator activity; F:ionotropic glutamate receptor binding; F:phospholipid binding;, P:actin cytoskeleton organization; P:axon guidance; P:cell junction assembly; P:cell morphogenesis involved in neuron differentiation; P:cerebellar granule cell differentiation; P:cerebral cortex neuron differentiation; P:establishment of epithelial cell apical/basal polarity; P:maintenance of postsynaptic specialization structure; P:negative regulation of proteasomal protein catabolic process; P:nervous system development; P:neuron differentiation; P:neuron projection development; P:regulation of endocytosis; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:regulation of synaptic transmission, glutamatergic; P:signal transduction; P:substrate-dependent cell migration, cell extension; P:synaptic vesicle endocytosis; scaffold79 indexed_genome mRNA 3067104 3098044 . + . ID=transcript_11943;Q96EC8 B4E1U7 G5E997 Q5JP08,Protein YIPF6,YIP1 family member 6;, PF04893;, GO:0005801;GO:0030134;GO:0005783;GO:0005797;GO:0000139;GO:0000138;GO:0016021;GO:0005802;GO:0042802;GO:0060576;, C:cis-Golgi network; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:Golgi medial cisterna; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of membrane; C:trans-Golgi network;, F:identical protein binding;, P:intestinal epithelial cell development;|Q96EC8 B4E1U7 G5E997 Q5JP08,Protein YIPF6,YIP1 family member 6;, PF04893;, GO:0005801;GO:0030134;GO:0005783;GO:0005797;GO:0000139;GO:0000138;GO:0016021;GO:0005802;GO:0042802;GO:0060576;, C:cis-Golgi network; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:Golgi medial cisterna; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of membrane; C:trans-Golgi network;, F:identical protein binding;, P:intestinal epithelial cell development; scaffold79 indexed_genome mRNA 3247334 3287479 . + . ID=transcript_11944;Q92502 A8K6T2 D3DVT9 Q5JST0 Q68DG7,StAR-related lipid transfer protein 8,Deleted in liver cancer 3 protein;START domain-containing protein 8;START-GAP3;, PF00620;PF01852;, GO:0005829;GO:0005925;GO:0005096;GO:0008289;GO:0030036;GO:0035023;GO:0051056;GO:0007165;, C:cytosol; C:focal adhesion;, F:GTPase activator activity; F:lipid binding;, P:actin cytoskeleton organization; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold79 indexed_genome mRNA 3362744 3374526 . + . ID=transcript_11945;P98172 D3DVU0,Ephrin-B1,EFL-3;ELK ligand;EPH-related receptor tyrosine kinase ligand 2;, PF00812;, GO:0005737;GO:0070062;GO:0005887;GO:0045121;GO:0005634;GO:0005886;GO:0045202;GO:0046875;GO:0007411;GO:0007155;GO:0007267;GO:0009880;GO:0048013;GO:0001755;GO:0042102;GO:0031295;, C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:synapse;, F:ephrin receptor binding;, P:axon guidance; P:cell adhesion; P:cell-cell signaling; P:embryonic pattern specification; P:ephrin receptor signaling pathway; P:neural crest cell migration; P:positive regulation of T cell proliferation; P:T cell costimulation; scaffold79 indexed_genome mRNA 3706239 3710628 . - . ID=transcript_11946;Q8NG27 A2A322 Q5JUT8 Q5JUT9 Q8NG28 Q9HAC1,E3 ubiquitin-protein ligase Praja-1,RING finger protein 70;RING-type E3 ubiquitin transferase Praja-1 {ECO:0000305};, PF13639;, GO:0005737;GO:0046872;GO:0061630;GO:0030163;, C:cytoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:protein catabolic process; scaffold79 indexed_genome mRNA 4054891 4080636 . + . ID=transcript_11947;O75949 B1ALV6 B9EGK1 D3DVU1,Transmembrane protein FAM155B,Protein TED;Transmembrane protein 28;, , GO:0016021;GO:0005886;GO:0098703;, C:integral component of membrane; C:plasma membrane;, , P:calcium ion import across plasma membrane; scaffold79 indexed_genome mRNA 4202096 4558463 . + . ID=transcript_11948;Q9Y6L0 Q9Y6L1 Q9Y6L2 Q9Y6L3 Q9Y6L4,Ectodysplasin-A,Ectodermal dysplasia protein;, PF00229;, GO:0045177;GO:0005581;GO:0005856;GO:0005789;GO:0005615;GO:0016021;GO:0005887;GO:0043231;GO:0005811;GO:0016020;GO:0005886;GO:0038177;GO:0005123;GO:0048018;GO:0005102;GO:0005164;GO:0048513;GO:0030154;GO:0007160;GO:0019221;GO:0010467;GO:0060789;GO:0006955;GO:0042475;GO:0043473;GO:0090263;GO:0010628;GO:0043123;GO:0051092;GO:1901224;GO:1901222;GO:0060662;GO:0061153;GO:0033209;, C:apical part of cell; C:collagen trimer; C:cytoskeleton; C:endoplasmic reticulum membrane; C:extracellular space; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:plasma membrane;, F:death receptor agonist activity; F:death receptor binding; F:receptor ligand activity; F:signaling receptor binding; F:tumor necrosis factor receptor binding;, P:animal organ development; P:cell differentiation; P:cell-matrix adhesion; P:cytokine-mediated signaling pathway; P:gene expression; P:hair follicle placode formation; P:immune response; P:odontogenesis of dentin-containing tooth; P:pigmentation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of NIK/NF-kappaB signaling; P:salivary gland cavitation; P:trachea gland development; P:tumor necrosis factor-mediated signaling pathway;|Q9UNP3,Krueppel-like factor 4,Epithelial zinc finger protein EZF;Gut-enriched krueppel-like factor;, PF00096;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005667;GO:0008013;GO:0000987;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0035014;GO:1990841;GO:0000978;GO:0001010;GO:0001085;GO:1990837;GO:0001221;GO:0000976;GO:0008270;GO:0060070;GO:0071409;GO:0071363;GO:0070301;GO:0071499;GO:1990830;GO:1901653;GO:0071300;GO:0002357;GO:0009913;GO:0048730;GO:0045444;GO:0007500;GO:0016525;GO:0090051;GO:0008285;GO:2000342;GO:0043154;GO:0070373;GO:2000134;GO:0010629;GO:0034115;GO:0050728;GO:0032717;GO:1904998;GO:0014740;GO:0032088;GO:0014067;GO:0051898;GO:0060761;GO:0048662;GO:0000122;GO:0045892;GO:0032270;GO:1904798;GO:0010628;GO:0046985;GO:0045429;GO:1902895;GO:0051247;GO:1903672;GO:0051973;GO:0045944;GO:0045893;GO:0031077;GO:0035166;GO:0048679;GO:0120222;GO:0045595;GO:0006357;GO:0035019;GO:0019827;GO:0006351;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:transcription regulator complex;, F:beta-catenin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:phosphatidylinositol 3-kinase regulator activity; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity; F:RNA polymerase II transcription factor binding; F:sequence-specific double-stranded DNA binding; F:transcription coregulator binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:canonical Wnt signaling pathway; P:cellular response to cycloheximide; P:cellular response to growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to laminar fluid shear stress; P:cellular response to leukemia inhibitory factor; P:cellular response to peptide; P:cellular response to retinoic acid; P:defense response to tumor cell; P:epidermal cell differentiation; P:epidermis morphogenesis; P:fat cell differentiation; P:mesodermal cell fate determination; P:negative regulation of angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of chemokine (C-X-C motif) ligand 2 production; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of heterotypic cell-cell adhesion; P:negative regulation of inflammatory response; P:negative regulation of interleukin-8 production; P:negative regulation of leukocyte adhesion to arterial endothelial cell; P:negative regulation of muscle hyperplasia; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein kinase B signaling; P:negative regulation of response to cytokine stimulus; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cellular protein metabolic process; P:positive regulation of core promoter binding; P:positive regulation of gene expression; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein metabolic process; P:positive regulation of sprouting angiogenesis; P:positive regulation of telomerase activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:post-embryonic camera-type eye development; P:post-embryonic hemopoiesis; P:regulation of axon regeneration; P:regulation of blastocyst development; P:regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; P:somatic stem cell population maintenance; P:stem cell population maintenance; P:transcription, DNA-templated; scaffold79 indexed_genome mRNA 4636081 4647456 . + . ID=transcript_11949;P78318 Q8TAB2,Immunoglobulin-binding protein 1,B-cell signal transduction molecule alpha 4;CD79a-binding protein 1;Protein phosphatase 2/4/6 regulatory subunit;Renal carcinoma antigen NY-REN-16;, PF04177;, GO:0005737;GO:0005829;GO:0051721;GO:0019888;GO:0042113;GO:0043154;GO:0032873;GO:0000122;GO:0035303;GO:0060632;GO:0070555;GO:0034612;GO:0007165;, C:cytoplasm; C:cytosol;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity;, P:B cell activation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription by RNA polymerase II; P:regulation of dephosphorylation; P:regulation of microtubule-based movement; P:response to interleukin-1; P:response to tumor necrosis factor; P:signal transduction; scaffold79 indexed_genome mRNA 4671164 4673971 . - . ID=transcript_11950;P78318 Q8TAB2,Immunoglobulin-binding protein 1,B-cell signal transduction molecule alpha 4;CD79a-binding protein 1;Protein phosphatase 2/4/6 regulatory subunit;Renal carcinoma antigen NY-REN-16;, PF04177;, GO:0005737;GO:0005829;GO:0051721;GO:0019888;GO:0042113;GO:0043154;GO:0032873;GO:0000122;GO:0035303;GO:0060632;GO:0070555;GO:0034612;GO:0007165;, C:cytoplasm; C:cytosol;, F:protein phosphatase 2A binding; F:protein phosphatase regulator activity;, P:B cell activation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription by RNA polymerase II; P:regulation of dephosphorylation; P:regulation of microtubule-based movement; P:response to interleukin-1; P:response to tumor necrosis factor; P:signal transduction; scaffold79 indexed_genome mRNA 4767062 4771873 . + . ID=transcript_11951;P51582 Q4VBB7 Q4VBB8 Q502W2 Q5JT22,P2Y purinoceptor 4,P2P;Uridine nucleotide receptor;, PF00001;, GO:0016324;GO:0016323;GO:0098978;GO:0005887;GO:0099059;GO:0005886;GO:0005524;GO:0045028;GO:0045030;GO:0071318;GO:0071380;GO:0007186;GO:0007200;GO:0007204;GO:0099509;GO:2000300;GO:0030321;, C:apical plasma membrane; C:basolateral plasma membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:plasma membrane;, F:ATP binding; F:G protein-coupled purinergic nucleotide receptor activity; F:G protein-coupled UTP receptor activity;, P:cellular response to ATP; P:cellular response to prostaglandin E stimulus; P:G protein-coupled receptor signaling pathway; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:regulation of presynaptic cytosolic calcium ion concentration; P:regulation of synaptic vesicle exocytosis; P:transepithelial chloride transport; scaffold79 indexed_genome mRNA 4793894 4796456 . - . ID=transcript_11952;Q5JT25 Q17RQ0,Ras-related protein Rab-41,, PF00071;, GO:0005829;GO:0012505;GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0006891;GO:0006886;GO:0042147;GO:0006890;, C:cytosol; C:endomembrane system; C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold79 indexed_genome mRNA 4797428 4801092 . - . ID=transcript_11953;Q5EBL8 D3DVU3 Q6UWE1 Q9P0Q1,PDZ domain-containing protein 11,ATPase-interacting PDZ protein;Plasma membrane calcium ATPase-interacting single-PDZ protein;, PF00595;, GO:0005912;GO:0016323;GO:0005911;GO:0005829;GO:0005576;GO:0046930;GO:0098793;GO:0045202;GO:0008022;GO:0019730;GO:0006768;GO:0034220;GO:0045199;GO:0007269;GO:0015939;GO:0046931;GO:1903361;GO:0055085;, C:adherens junction; C:basolateral plasma membrane; C:cell-cell junction; C:cytosol; C:extracellular region; C:pore complex; C:presynapse; C:synapse;, F:protein C-terminus binding;, P:antimicrobial humoral response; P:biotin metabolic process; P:ion transmembrane transport; P:maintenance of epithelial cell apical/basal polarity; P:neurotransmitter secretion; P:pantothenate metabolic process; P:pore complex assembly; P:protein localization to basolateral plasma membrane; P:transmembrane transport; scaffold79 indexed_genome mRNA 4931847 4932413 . - . ID=transcript_11954;O95239 B2R7V5 D3DVU4 Q86TN3 Q86XX7 Q9NNY6 Q9NY24 Q9UMW3,Chromosome-associated kinesin KIF4A,Chromokinesin-A;, PF00225;, GO:1904115;GO:0005694;GO:0005737;GO:0005829;GO:0016020;GO:0030496;GO:0016363;GO:0005654;GO:0005876;GO:0005524;GO:1990939;GO:0003677;GO:0051536;GO:0046872;GO:0008017;GO:0003777;GO:0008089;GO:0019886;GO:0007018;GO:0000281;GO:0051256;GO:0007052;GO:0006996;GO:0006890;, C:axon cytoplasm; C:chromosome; C:cytoplasm; C:cytosol; C:membrane; C:midbody; C:nuclear matrix; C:nucleoplasm; C:spindle microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:DNA binding; F:iron-sulfur cluster binding; F:metal ion binding; F:microtubule binding; F:microtubule motor activity;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:mitotic cytokinesis; P:mitotic spindle midzone assembly; P:mitotic spindle organization; P:organelle organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold79 indexed_genome mRNA 4942545 4943881 . + . ID=transcript_11955;Q9HCC8 B4DRH4 B4DVC9 Q9NXJ6,Glycerophosphoinositol inositolphosphodiesterase GDPD2,Glycerophosphodiester phosphodiesterase 3;Glycerophosphodiester phosphodiesterase domain-containing protein 2;Osteoblast differentiation promoting factor;, PF03009;, GO:0005884;GO:0005737;GO:0016021;GO:0030027;GO:0005886;GO:0047394;GO:0046872;GO:0090527;GO:0006629;GO:0045669;, C:actin filament; C:cytoplasm; C:integral component of membrane; C:lamellipodium; C:plasma membrane;, F:glycerophosphoinositol inositolphosphodiesterase activity; F:metal ion binding;, P:actin filament reorganization; P:lipid metabolic process; P:positive regulation of osteoblast differentiation; scaffold79 indexed_genome mRNA 4954784 5008937 . + . ID=transcript_11956;Q92796 B4E0H1 D3DVU5 Q5JUW6 Q5JUW7 Q9ULI8,Disks large homolog 3,Neuroendocrine-DLG;Synapse-associated protein 102;XLMR;, PF00625;PF00595;PF10600;PF00018;, GO:0016323;GO:0030054;GO:0005829;GO:0005615;GO:0005886;GO:0019900;GO:0019902;GO:0098609;GO:0045197;GO:0000165;GO:0008285;GO:0010923;GO:0061098;GO:0043113;GO:0097120;GO:2000310;, C:basolateral plasma membrane; C:cell junction; C:cytosol; C:extracellular space; C:plasma membrane;, F:kinase binding; F:phosphatase binding;, P:cell-cell adhesion; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of phosphatase activity; P:positive regulation of protein tyrosine kinase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity;|Q92796 B4E0H1 D3DVU5 Q5JUW6 Q5JUW7 Q9ULI8,Disks large homolog 3,Neuroendocrine-DLG;Synapse-associated protein 102;XLMR;, PF00625;PF00595;PF10600;PF00018;, GO:0016323;GO:0030054;GO:0005829;GO:0005615;GO:0005886;GO:0019900;GO:0019902;GO:0098609;GO:0045197;GO:0000165;GO:0008285;GO:0010923;GO:0061098;GO:0043113;GO:0097120;GO:2000310;, C:basolateral plasma membrane; C:cell junction; C:cytosol; C:extracellular space; C:plasma membrane;, F:kinase binding; F:phosphatase binding;, P:cell-cell adhesion; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of phosphatase activity; P:positive regulation of protein tyrosine kinase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity;|Q92796 B4E0H1 D3DVU5 Q5JUW6 Q5JUW7 Q9ULI8,Disks large homolog 3,Neuroendocrine-DLG;Synapse-associated protein 102;XLMR;, PF00625;PF00595;PF10600;PF00018;, GO:0016323;GO:0030054;GO:0005829;GO:0005615;GO:0005886;GO:0019900;GO:0019902;GO:0098609;GO:0045197;GO:0000165;GO:0008285;GO:0010923;GO:0061098;GO:0043113;GO:0097120;GO:2000310;, C:basolateral plasma membrane; C:cell junction; C:cytosol; C:extracellular space; C:plasma membrane;, F:kinase binding; F:phosphatase binding;, P:cell-cell adhesion; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of phosphatase activity; P:positive regulation of protein tyrosine kinase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity;|Q92796 B4E0H1 D3DVU5 Q5JUW6 Q5JUW7 Q9ULI8,Disks large homolog 3,Neuroendocrine-DLG;Synapse-associated protein 102;XLMR;, PF00625;PF00595;PF10600;PF00018;, GO:0016323;GO:0030054;GO:0005829;GO:0005615;GO:0005886;GO:0019900;GO:0019902;GO:0098609;GO:0045197;GO:0000165;GO:0008285;GO:0010923;GO:0061098;GO:0043113;GO:0097120;GO:2000310;, C:basolateral plasma membrane; C:cell junction; C:cytosol; C:extracellular space; C:plasma membrane;, F:kinase binding; F:phosphatase binding;, P:cell-cell adhesion; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of phosphatase activity; P:positive regulation of protein tyrosine kinase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity;|Q92796 B4E0H1 D3DVU5 Q5JUW6 Q5JUW7 Q9ULI8,Disks large homolog 3,Neuroendocrine-DLG;Synapse-associated protein 102;XLMR;, PF00625;PF00595;PF10600;PF00018;, GO:0016323;GO:0030054;GO:0005829;GO:0005615;GO:0005886;GO:0019900;GO:0019902;GO:0098609;GO:0045197;GO:0000165;GO:0008285;GO:0010923;GO:0061098;GO:0043113;GO:0097120;GO:2000310;, C:basolateral plasma membrane; C:cell junction; C:cytosol; C:extracellular space; C:plasma membrane;, F:kinase binding; F:phosphatase binding;, P:cell-cell adhesion; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of phosphatase activity; P:positive regulation of protein tyrosine kinase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity;|Q92796 B4E0H1 D3DVU5 Q5JUW6 Q5JUW7 Q9ULI8,Disks large homolog 3,Neuroendocrine-DLG;Synapse-associated protein 102;XLMR;, PF00625;PF00595;PF10600;PF00018;, GO:0016323;GO:0030054;GO:0005829;GO:0005615;GO:0005886;GO:0019900;GO:0019902;GO:0098609;GO:0045197;GO:0000165;GO:0008285;GO:0010923;GO:0061098;GO:0043113;GO:0097120;GO:2000310;, C:basolateral plasma membrane; C:cell junction; C:cytosol; C:extracellular space; C:plasma membrane;, F:kinase binding; F:phosphatase binding;, P:cell-cell adhesion; P:establishment or maintenance of epithelial cell apical/basal polarity; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of phosphatase activity; P:positive regulation of protein tyrosine kinase activity; P:receptor clustering; P:receptor localization to synapse; P:regulation of NMDA receptor activity; scaffold79 indexed_genome mRNA 5460871 5468153 . - . ID=transcript_11957;Q9UMY4 F8W8K5 Q8WUG9,Sorting nexin-12,, PF00787;, GO:0005769;GO:0031901;GO:0030904;GO:0019899;GO:0035091;GO:0032266;GO:0032456;GO:0034499;GO:2000642;GO:0010629;GO:0042177;GO:0010955;GO:0051224;GO:0015031;GO:0030100;, C:early endosome; C:early endosome membrane; C:retromer complex;, F:enzyme binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3-phosphate binding;, P:endocytic recycling; P:late endosome to Golgi transport; P:negative regulation of early endosome to late endosome transport; P:negative regulation of gene expression; P:negative regulation of protein catabolic process; P:negative regulation of protein processing; P:negative regulation of protein transport; P:protein transport; P:regulation of endocytosis; scaffold79 indexed_genome mRNA 5491987 5497884 . + . ID=transcript_11958;P98177 B7WPJ7 O43821 Q13720 Q3KPF1 Q8TDK9,Forkhead box protein O4,Fork head domain transcription factor AFX1;, PF00250;PF16676;, GO:0000785;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0008013;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0019899;GO:0042802;GO:1990841;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0007568;GO:0007050;GO:0008286;GO:0007095;GO:0007517;GO:0016525;GO:0008285;GO:0070317;GO:0051151;GO:0071158;GO:0014911;GO:0045944;GO:0016579;GO:0006357;GO:0006355;GO:0031667;GO:1990785;GO:0048863;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:enzyme binding; F:identical protein binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:aging; P:cell cycle arrest; P:insulin receptor signaling pathway; P:mitotic G2 DNA damage checkpoint; P:muscle organ development; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of smooth muscle cell differentiation; P:positive regulation of cell cycle arrest; P:positive regulation of smooth muscle cell migration; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to nutrient levels; P:response to water-immersion restraint stress; P:stem cell differentiation; scaffold79 indexed_genome mRNA 5502052 5505712 . - . ID=transcript_11959;P31785 Q5FC12,Cytokine receptor common subunit gamma,Interleukin-2 receptor subunit gamma;gammaC;p64;, PF09240;, GO:0009986;GO:0005829;GO:0005768;GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0042010;GO:0019976;GO:0019221;GO:0006955;GO:0035723;GO:0038110;GO:0038114;GO:0035771;GO:0038111;GO:0038113;GO:0000165;GO:0050766;GO:0007165;GO:0016032;, C:cell surface; C:cytosol; C:endosome; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-15 receptor activity; F:interleukin-2 binding;, P:cytokine-mediated signaling pathway; P:immune response; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-4-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:MAPK cascade; P:positive regulation of phagocytosis; P:signal transduction; P:viral process; scaffold79 indexed_genome mRNA 5510156 5521167 . + . ID=transcript_11960;Q93074 O15410 O75557 Q9UHV6 Q9UND7,Mediator of RNA polymerase II transcription subunit 12,Activator-recruited cofactor 240 kDa component;CAG repeat protein 45;Mediator complex subunit 12;OPA-containing protein;Thyroid hormone receptor-associated protein complex 230 kDa component;Trinucleotide repeat-containing gene 11 protein;, PF09497;PF12145;PF12144;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0000151;GO:0008013;GO:0003682;GO:0030374;GO:0008022;GO:0019904;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0061630;GO:0042809;GO:0090245;GO:0060070;GO:1990403;GO:0048702;GO:0007492;GO:0007507;GO:0001843;GO:0014003;GO:0045944;GO:0060261;GO:0045893;GO:0036342;GO:0006357;GO:0060260;GO:0014044;GO:0021510;GO:0019827;GO:0060071;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:beta-catenin binding; F:chromatin binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:axis elongation involved in somitogenesis; P:canonical Wnt signaling pathway; P:embryonic brain development; P:embryonic neurocranium morphogenesis; P:endoderm development; P:heart development; P:neural tube closure; P:oligodendrocyte development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:post-anal tail morphogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:Schwann cell development; P:spinal cord development; P:stem cell population maintenance; P:Wnt signaling pathway, planar cell polarity pathway;|Q93074 O15410 O75557 Q9UHV6 Q9UND7,Mediator of RNA polymerase II transcription subunit 12,Activator-recruited cofactor 240 kDa component;CAG repeat protein 45;Mediator complex subunit 12;OPA-containing protein;Thyroid hormone receptor-associated protein complex 230 kDa component;Trinucleotide repeat-containing gene 11 protein;, PF09497;PF12145;PF12144;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0000151;GO:0008013;GO:0003682;GO:0030374;GO:0008022;GO:0019904;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0061630;GO:0042809;GO:0090245;GO:0060070;GO:1990403;GO:0048702;GO:0007492;GO:0007507;GO:0001843;GO:0014003;GO:0045944;GO:0060261;GO:0045893;GO:0036342;GO:0006357;GO:0060260;GO:0014044;GO:0021510;GO:0019827;GO:0060071;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:beta-catenin binding; F:chromatin binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:axis elongation involved in somitogenesis; P:canonical Wnt signaling pathway; P:embryonic brain development; P:embryonic neurocranium morphogenesis; P:endoderm development; P:heart development; P:neural tube closure; P:oligodendrocyte development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:post-anal tail morphogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:Schwann cell development; P:spinal cord development; P:stem cell population maintenance; P:Wnt signaling pathway, planar cell polarity pathway;|Q93074 O15410 O75557 Q9UHV6 Q9UND7,Mediator of RNA polymerase II transcription subunit 12,Activator-recruited cofactor 240 kDa component;CAG repeat protein 45;Mediator complex subunit 12;OPA-containing protein;Thyroid hormone receptor-associated protein complex 230 kDa component;Trinucleotide repeat-containing gene 11 protein;, PF09497;PF12145;PF12144;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0000151;GO:0008013;GO:0003682;GO:0030374;GO:0008022;GO:0019904;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0061630;GO:0042809;GO:0090245;GO:0060070;GO:1990403;GO:0048702;GO:0007492;GO:0007507;GO:0001843;GO:0014003;GO:0045944;GO:0060261;GO:0045893;GO:0036342;GO:0006357;GO:0060260;GO:0014044;GO:0021510;GO:0019827;GO:0060071;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:beta-catenin binding; F:chromatin binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:axis elongation involved in somitogenesis; P:canonical Wnt signaling pathway; P:embryonic brain development; P:embryonic neurocranium morphogenesis; P:endoderm development; P:heart development; P:neural tube closure; P:oligodendrocyte development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:post-anal tail morphogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:Schwann cell development; P:spinal cord development; P:stem cell population maintenance; P:Wnt signaling pathway, planar cell polarity pathway; scaffold79 indexed_genome mRNA 5521332 5532747 . - . ID=transcript_11961;Q93074 O15410 O75557 Q9UHV6 Q9UND7,Mediator of RNA polymerase II transcription subunit 12,Activator-recruited cofactor 240 kDa component;CAG repeat protein 45;Mediator complex subunit 12;OPA-containing protein;Thyroid hormone receptor-associated protein complex 230 kDa component;Trinucleotide repeat-containing gene 11 protein;, PF09497;PF12145;PF12144;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0000151;GO:0008013;GO:0003682;GO:0030374;GO:0008022;GO:0019904;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0061630;GO:0042809;GO:0090245;GO:0060070;GO:1990403;GO:0048702;GO:0007492;GO:0007507;GO:0001843;GO:0014003;GO:0045944;GO:0060261;GO:0045893;GO:0036342;GO:0006357;GO:0060260;GO:0014044;GO:0021510;GO:0019827;GO:0060071;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:beta-catenin binding; F:chromatin binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:axis elongation involved in somitogenesis; P:canonical Wnt signaling pathway; P:embryonic brain development; P:embryonic neurocranium morphogenesis; P:endoderm development; P:heart development; P:neural tube closure; P:oligodendrocyte development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:post-anal tail morphogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:Schwann cell development; P:spinal cord development; P:stem cell population maintenance; P:Wnt signaling pathway, planar cell polarity pathway;|Q93074 O15410 O75557 Q9UHV6 Q9UND7,Mediator of RNA polymerase II transcription subunit 12,Activator-recruited cofactor 240 kDa component;CAG repeat protein 45;Mediator complex subunit 12;OPA-containing protein;Thyroid hormone receptor-associated protein complex 230 kDa component;Trinucleotide repeat-containing gene 11 protein;, PF09497;PF12145;PF12144;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0000151;GO:0008013;GO:0003682;GO:0030374;GO:0008022;GO:0019904;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0061630;GO:0042809;GO:0090245;GO:0060070;GO:1990403;GO:0048702;GO:0007492;GO:0007507;GO:0001843;GO:0014003;GO:0045944;GO:0060261;GO:0045893;GO:0036342;GO:0006357;GO:0060260;GO:0014044;GO:0021510;GO:0019827;GO:0060071;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:beta-catenin binding; F:chromatin binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:axis elongation involved in somitogenesis; P:canonical Wnt signaling pathway; P:embryonic brain development; P:embryonic neurocranium morphogenesis; P:endoderm development; P:heart development; P:neural tube closure; P:oligodendrocyte development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:post-anal tail morphogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:Schwann cell development; P:spinal cord development; P:stem cell population maintenance; P:Wnt signaling pathway, planar cell polarity pathway;|Q93074 O15410 O75557 Q9UHV6 Q9UND7,Mediator of RNA polymerase II transcription subunit 12,Activator-recruited cofactor 240 kDa component;CAG repeat protein 45;Mediator complex subunit 12;OPA-containing protein;Thyroid hormone receptor-associated protein complex 230 kDa component;Trinucleotide repeat-containing gene 11 protein;, PF09497;PF12145;PF12144;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0000151;GO:0008013;GO:0003682;GO:0030374;GO:0008022;GO:0019904;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0061630;GO:0042809;GO:0090245;GO:0060070;GO:1990403;GO:0048702;GO:0007492;GO:0007507;GO:0001843;GO:0014003;GO:0045944;GO:0060261;GO:0045893;GO:0036342;GO:0006357;GO:0060260;GO:0014044;GO:0021510;GO:0019827;GO:0060071;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:beta-catenin binding; F:chromatin binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:axis elongation involved in somitogenesis; P:canonical Wnt signaling pathway; P:embryonic brain development; P:embryonic neurocranium morphogenesis; P:endoderm development; P:heart development; P:neural tube closure; P:oligodendrocyte development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:post-anal tail morphogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:Schwann cell development; P:spinal cord development; P:stem cell population maintenance; P:Wnt signaling pathway, planar cell polarity pathway;|Q93074 O15410 O75557 Q9UHV6 Q9UND7,Mediator of RNA polymerase II transcription subunit 12,Activator-recruited cofactor 240 kDa component;CAG repeat protein 45;Mediator complex subunit 12;OPA-containing protein;Thyroid hormone receptor-associated protein complex 230 kDa component;Trinucleotide repeat-containing gene 11 protein;, PF09497;PF12145;PF12144;, GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0000151;GO:0008013;GO:0003682;GO:0030374;GO:0008022;GO:0019904;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0061630;GO:0042809;GO:0090245;GO:0060070;GO:1990403;GO:0048702;GO:0007492;GO:0007507;GO:0001843;GO:0014003;GO:0045944;GO:0060261;GO:0045893;GO:0036342;GO:0006357;GO:0060260;GO:0014044;GO:0021510;GO:0019827;GO:0060071;, C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:beta-catenin binding; F:chromatin binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:ubiquitin protein ligase activity; F:vitamin D receptor binding;, P:axis elongation involved in somitogenesis; P:canonical Wnt signaling pathway; P:embryonic brain development; P:embryonic neurocranium morphogenesis; P:endoderm development; P:heart development; P:neural tube closure; P:oligodendrocyte development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:post-anal tail morphogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:Schwann cell development; P:spinal cord development; P:stem cell population maintenance; P:Wnt signaling pathway, planar cell polarity pathway; scaffold79 indexed_genome mRNA 5534424 5556513 . + . ID=transcript_11962;Q9NZ97 Q9P248,Neuroligin-3,Gliotactin homolog;, PF00135;, GO:0098985;GO:0009986;GO:0030139;GO:0060076;GO:0005887;GO:0099055;GO:0005886;GO:0098793;GO:0089717;GO:0098983;GO:0045202;GO:0050839;GO:0042043;GO:0097110;GO:0038023;GO:0030534;GO:0048675;GO:0007268;GO:0060080;GO:0007612;GO:0050804;GO:0007158;GO:2000969;GO:2000463;GO:0051965;GO:0051968;GO:0097104;GO:0099054;GO:0097105;GO:0006898;GO:0002087;GO:0060024;GO:0035176;GO:0007416;GO:0050808;GO:0048488;GO:0071625;, C:asymmetric, glutamatergic, excitatory synapse; C:cell surface; C:endocytic vesicle; C:excitatory synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:presynapse; C:spanning component of membrane; C:symmetric, GABA-ergic, inhibitory synapse; C:synapse;, F:cell adhesion molecule binding; F:neurexin family protein binding; F:scaffold protein binding; F:signaling receptor activity;, P:adult behavior; P:axon extension; P:chemical synaptic transmission; P:inhibitory postsynaptic potential; P:learning; P:modulation of chemical synaptic transmission; P:neuron cell-cell adhesion; P:positive regulation of AMPA receptor activity; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic membrane assembly; P:presynapse assembly; P:presynaptic membrane assembly; P:receptor-mediated endocytosis; P:regulation of respiratory gaseous exchange by nervous system process; P:rhythmic synaptic transmission; P:social behavior; P:synapse assembly; P:synapse organization; P:synaptic vesicle endocytosis; P:vocalization behavior;|Q9NZ97 Q9P248,Neuroligin-3,Gliotactin homolog;, PF00135;, GO:0098985;GO:0009986;GO:0030139;GO:0060076;GO:0005887;GO:0099055;GO:0005886;GO:0098793;GO:0089717;GO:0098983;GO:0045202;GO:0050839;GO:0042043;GO:0097110;GO:0038023;GO:0030534;GO:0048675;GO:0007268;GO:0060080;GO:0007612;GO:0050804;GO:0007158;GO:2000969;GO:2000463;GO:0051965;GO:0051968;GO:0097104;GO:0099054;GO:0097105;GO:0006898;GO:0002087;GO:0060024;GO:0035176;GO:0007416;GO:0050808;GO:0048488;GO:0071625;, C:asymmetric, glutamatergic, excitatory synapse; C:cell surface; C:endocytic vesicle; C:excitatory synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:presynapse; C:spanning component of membrane; C:symmetric, GABA-ergic, inhibitory synapse; C:synapse;, F:cell adhesion molecule binding; F:neurexin family protein binding; F:scaffold protein binding; F:signaling receptor activity;, P:adult behavior; P:axon extension; P:chemical synaptic transmission; P:inhibitory postsynaptic potential; P:learning; P:modulation of chemical synaptic transmission; P:neuron cell-cell adhesion; P:positive regulation of AMPA receptor activity; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic membrane assembly; P:presynapse assembly; P:presynaptic membrane assembly; P:receptor-mediated endocytosis; P:regulation of respiratory gaseous exchange by nervous system process; P:rhythmic synaptic transmission; P:social behavior; P:synapse assembly; P:synapse organization; P:synaptic vesicle endocytosis; P:vocalization behavior;|Q9NZ97 Q9P248,Neuroligin-3,Gliotactin homolog;, PF00135;, GO:0098985;GO:0009986;GO:0030139;GO:0060076;GO:0005887;GO:0099055;GO:0005886;GO:0098793;GO:0089717;GO:0098983;GO:0045202;GO:0050839;GO:0042043;GO:0097110;GO:0038023;GO:0030534;GO:0048675;GO:0007268;GO:0060080;GO:0007612;GO:0050804;GO:0007158;GO:2000969;GO:2000463;GO:0051965;GO:0051968;GO:0097104;GO:0099054;GO:0097105;GO:0006898;GO:0002087;GO:0060024;GO:0035176;GO:0007416;GO:0050808;GO:0048488;GO:0071625;, C:asymmetric, glutamatergic, excitatory synapse; C:cell surface; C:endocytic vesicle; C:excitatory synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:presynapse; C:spanning component of membrane; C:symmetric, GABA-ergic, inhibitory synapse; C:synapse;, F:cell adhesion molecule binding; F:neurexin family protein binding; F:scaffold protein binding; F:signaling receptor activity;, P:adult behavior; P:axon extension; P:chemical synaptic transmission; P:inhibitory postsynaptic potential; P:learning; P:modulation of chemical synaptic transmission; P:neuron cell-cell adhesion; P:positive regulation of AMPA receptor activity; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic membrane assembly; P:presynapse assembly; P:presynaptic membrane assembly; P:receptor-mediated endocytosis; P:regulation of respiratory gaseous exchange by nervous system process; P:rhythmic synaptic transmission; P:social behavior; P:synapse assembly; P:synapse organization; P:synaptic vesicle endocytosis; P:vocalization behavior;|Q8NFZ4 Q9P2I1,Neuroligin-2,, PF00135;, GO:0042995;GO:0009986;GO:0098691;GO:0098690;GO:0060077;GO:0005887;GO:0099055;GO:0099060;GO:0016020;GO:0005886;GO:0045211;GO:0042734;GO:0089717;GO:0098983;GO:0045202;GO:0050839;GO:0042802;GO:0042043;GO:0038023;GO:0098609;GO:0045217;GO:0007268;GO:0097116;GO:1904862;GO:0035641;GO:0050804;GO:0050885;GO:0007158;GO:2000463;GO:0097151;GO:0032024;GO:1902474;GO:0051965;GO:0032230;GO:0051968;GO:2000809;GO:0097119;GO:0097104;GO:0099054;GO:0097105;GO:0035418;GO:2000311;GO:0002087;GO:0019233;GO:0007416;GO:0050808;GO:0048488;GO:0072553;, C:cell projection; C:cell surface; C:dopaminergic synapse; C:glycinergic synapse; C:inhibitory synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of postsynaptic specialization membrane; C:membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:spanning component of membrane; C:symmetric, GABA-ergic, inhibitory synapse; C:synapse;, F:cell adhesion molecule binding; F:identical protein binding; F:neurexin family protein binding; F:signaling receptor activity;, P:cell-cell adhesion; P:cell-cell junction maintenance; P:chemical synaptic transmission; P:gephyrin clustering involved in postsynaptic density assembly; P:inhibitory synapse assembly; P:locomotory exploration behavior; P:modulation of chemical synaptic transmission; P:neuromuscular process controlling balance; P:neuron cell-cell adhesion; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of insulin secretion; P:positive regulation of protein localization to synapse; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission, GABAergic; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of synaptic vesicle clustering; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:presynapse assembly; P:presynaptic membrane assembly; P:protein localization to synapse; P:regulation of AMPA receptor activity; P:regulation of respiratory gaseous exchange by nervous system process; P:sensory perception of pain; P:synapse assembly; P:synapse organization; P:synaptic vesicle endocytosis; P:terminal button organization; scaffold79 indexed_genome mRNA 5597133 5602966 . + . ID=transcript_11963;P08034 B2R8R2 D3DVV2 Q5U0S4,Gap junction beta-1 protein,Connexin-32;GAP junction 28 kDa liver protein;, PF00029;, GO:0005922;GO:0005789;GO:0016021;GO:0005243;GO:0007267;GO:0016264;GO:0007399;, C:connexin complex; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:gap junction channel activity;, P:cell-cell signaling; P:gap junction assembly; P:nervous system development; scaffold79 indexed_genome mRNA 5614882 5629089 . - . ID=transcript_11964;Q14202 D3DVV3 O15089 Q96E26,Zinc finger MYM-type protein 3,Zinc finger protein 261;, PF12012;PF06467;, GO:0005654;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q14202 D3DVV3 O15089 Q96E26,Zinc finger MYM-type protein 3,Zinc finger protein 261;, PF12012;PF06467;, GO:0005654;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q14202 D3DVV3 O15089 Q96E26,Zinc finger MYM-type protein 3,Zinc finger protein 261;, PF12012;PF06467;, GO:0005654;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q14202 D3DVV3 O15089 Q96E26,Zinc finger MYM-type protein 3,Zinc finger protein 261;, PF12012;PF06467;, GO:0005654;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q14202 D3DVV3 O15089 Q96E26,Zinc finger MYM-type protein 3,Zinc finger protein 261;, PF12012;PF06467;, GO:0005654;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q14202 D3DVV3 O15089 Q96E26,Zinc finger MYM-type protein 3,Zinc finger protein 261;, PF12012;PF06467;, GO:0005654;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleoplasm;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis; scaffold79 indexed_genome mRNA 5643896 5661212 . + . ID=transcript_11965;Q15233 B7Z4C2 D3DVV4 F5GYZ3 O00201 P30807 Q12786 Q9BQC5,Non-POU domain-containing octamer-binding protein,54 kDa nuclear RNA- and DNA-binding protein;55 kDa nuclear protein;DNA-binding p52/p100 complex, 52 kDa subunit;NMT55;p54(nrb);, PF08075;PF00076;, GO:0001650;GO:0016020;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0042382;GO:0090575;GO:0003682;GO:0042802;GO:0003676;GO:0003723;GO:0000976;GO:0002218;GO:0007623;GO:0006310;GO:0006281;GO:0045087;GO:0006397;GO:0000398;GO:1903377;GO:0045892;GO:0042752;GO:0006355;GO:0008380;, C:fibrillar center; C:membrane; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:paraspeckles; C:RNA polymerase II transcription regulator complex;, F:chromatin binding; F:identical protein binding; F:nucleic acid binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:circadian rhythm; P:DNA recombination; P:DNA repair; P:innate immune response; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of transcription, DNA-templated; P:RNA splicing;|Q15233 B7Z4C2 D3DVV4 F5GYZ3 O00201 P30807 Q12786 Q9BQC5,Non-POU domain-containing octamer-binding protein,54 kDa nuclear RNA- and DNA-binding protein;55 kDa nuclear protein;DNA-binding p52/p100 complex, 52 kDa subunit;NMT55;p54(nrb);, PF08075;PF00076;, GO:0001650;GO:0016020;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0042382;GO:0090575;GO:0003682;GO:0042802;GO:0003676;GO:0003723;GO:0000976;GO:0002218;GO:0007623;GO:0006310;GO:0006281;GO:0045087;GO:0006397;GO:0000398;GO:1903377;GO:0045892;GO:0042752;GO:0006355;GO:0008380;, C:fibrillar center; C:membrane; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:paraspeckles; C:RNA polymerase II transcription regulator complex;, F:chromatin binding; F:identical protein binding; F:nucleic acid binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:circadian rhythm; P:DNA recombination; P:DNA repair; P:innate immune response; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:negative regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of transcription, DNA-templated; P:RNA splicing;|Q9UKP3 Q32N04 Q549J7,Integrin beta-1-binding protein 2,Melusin;, PF04968;PF04969;, GO:0030018;GO:0005509;GO:0005178;GO:0017124;GO:0008270;GO:0007517;GO:0007165;, C:Z disc;, F:calcium ion binding; F:integrin binding; F:SH3 domain binding; F:zinc ion binding;, P:muscle organ development; P:signal transduction;|Q9UKP3 Q32N04 Q549J7,Integrin beta-1-binding protein 2,Melusin;, PF04968;PF04969;, GO:0030018;GO:0005509;GO:0005178;GO:0017124;GO:0008270;GO:0007517;GO:0007165;, C:Z disc;, F:calcium ion binding; F:integrin binding; F:SH3 domain binding; F:zinc ion binding;, P:muscle organ development; P:signal transduction; scaffold79 indexed_genome mRNA 5703899 5713035 . + . ID=transcript_11966;P84095 P35238 Q8NI04,Rho-related GTP-binding protein RhoG,, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0005789;GO:0070062;GO:0005925;GO:0043231;GO:0005886;GO:0030667;GO:0005525;GO:0003924;GO:0019901;GO:0030036;GO:0007015;GO:0090630;GO:0060326;GO:0030031;GO:0030865;GO:0043652;GO:0007163;GO:0008045;GO:0043312;GO:0008284;GO:0051897;GO:1903078;GO:0045893;GO:0016601;GO:0032956;GO:0008360;GO:1902622;GO:1900027;GO:0051056;GO:0007266;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:focal adhesion; C:intracellular membrane-bounded organelle; C:plasma membrane; C:secretory granule membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:activation of GTPase activity; P:cell chemotaxis; P:cell projection assembly; P:cortical cytoskeleton organization; P:engulfment of apoptotic cell; P:establishment or maintenance of cell polarity; P:motor neuron axon guidance; P:neutrophil degranulation; P:positive regulation of cell population proliferation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of transcription, DNA-templated; P:Rac protein signal transduction; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of neutrophil migration; P:regulation of ruffle assembly; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold79 indexed_genome mRNA 5723930 5799925 . + . ID=transcript_11967;Q70Q87 Q70T00 Q70T01 Q70T02 Q70T03,Transcription initiation factor TFIID subunit 1,Cell cycle gene 1 protein;TBP-associated factor 250 kDa;Transcription initiation factor TFIID 250 kDa subunit;, PF00439;PF12157;PF09247;PF15288;, GO:0000785;GO:0071339;GO:0005654;GO:0005634;GO:0005669;GO:0005667;GO:0005524;GO:0004402;GO:0016301;GO:0070577;GO:0035257;GO:0002039;GO:0046982;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0001181;GO:0000979;GO:0016251;GO:0061629;GO:0043565;GO:0017025;GO:0008134;GO:0140416;GO:0061631;GO:0007049;GO:0071318;GO:0006974;GO:0034644;GO:0030901;GO:0043433;GO:0010629;GO:1905524;GO:1903026;GO:0000122;GO:2000059;GO:0018105;GO:0018107;GO:2000825;GO:0032436;GO:0032092;GO:0046777;GO:0006468;GO:0000209;GO:0050821;GO:1902806;GO:1901796;GO:0051123;GO:0006366;GO:0036369;GO:0006361;GO:0006367;GO:0006511;GO:0016032;, C:chromatin; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription regulator complex;, F:ATP binding; F:histone acetyltransferase activity; F:kinase activity; F:lysine-acetylated histone binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein heterodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase I general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific DNA binding; F:TBP-class protein binding; F:transcription factor binding; F:transcription regulator inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:cell cycle; P:cellular response to ATP; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:midbrain development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of protein autoubiquitination; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of androgen receptor activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:protein autophosphorylation; P:protein phosphorylation; P:protein polyubiquitination; P:protein stabilization; P:regulation of cell cycle G1/S phase transition; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:transcription by RNA polymerase II; P:transcription factor catabolic process; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q70Q87 Q70T00 Q70T01 Q70T02 Q70T03,Transcription initiation factor TFIID subunit 1,Cell cycle gene 1 protein;TBP-associated factor 250 kDa;Transcription initiation factor TFIID 250 kDa subunit;, PF00439;PF12157;PF09247;PF15288;, GO:0000785;GO:0071339;GO:0005654;GO:0005634;GO:0005669;GO:0005667;GO:0005524;GO:0004402;GO:0016301;GO:0070577;GO:0035257;GO:0002039;GO:0046982;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0001181;GO:0000979;GO:0016251;GO:0061629;GO:0043565;GO:0017025;GO:0008134;GO:0140416;GO:0061631;GO:0007049;GO:0071318;GO:0006974;GO:0034644;GO:0030901;GO:0043433;GO:0010629;GO:1905524;GO:1903026;GO:0000122;GO:2000059;GO:0018105;GO:0018107;GO:2000825;GO:0032436;GO:0032092;GO:0046777;GO:0006468;GO:0000209;GO:0050821;GO:1902806;GO:1901796;GO:0051123;GO:0006366;GO:0036369;GO:0006361;GO:0006367;GO:0006511;GO:0016032;, C:chromatin; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription regulator complex;, F:ATP binding; F:histone acetyltransferase activity; F:kinase activity; F:lysine-acetylated histone binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein heterodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase I general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific DNA binding; F:TBP-class protein binding; F:transcription factor binding; F:transcription regulator inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:cell cycle; P:cellular response to ATP; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:midbrain development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of protein autoubiquitination; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of androgen receptor activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:protein autophosphorylation; P:protein phosphorylation; P:protein polyubiquitination; P:protein stabilization; P:regulation of cell cycle G1/S phase transition; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:transcription by RNA polymerase II; P:transcription factor catabolic process; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q70Q87 Q70T00 Q70T01 Q70T02 Q70T03,Transcription initiation factor TFIID subunit 1,Cell cycle gene 1 protein;TBP-associated factor 250 kDa;Transcription initiation factor TFIID 250 kDa subunit;, PF00439;PF12157;PF09247;PF15288;, GO:0000785;GO:0071339;GO:0005654;GO:0005634;GO:0005669;GO:0005667;GO:0005524;GO:0004402;GO:0016301;GO:0070577;GO:0035257;GO:0002039;GO:0046982;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0001181;GO:0000979;GO:0016251;GO:0061629;GO:0043565;GO:0017025;GO:0008134;GO:0140416;GO:0061631;GO:0007049;GO:0071318;GO:0006974;GO:0034644;GO:0030901;GO:0043433;GO:0010629;GO:1905524;GO:1903026;GO:0000122;GO:2000059;GO:0018105;GO:0018107;GO:2000825;GO:0032436;GO:0032092;GO:0046777;GO:0006468;GO:0000209;GO:0050821;GO:1902806;GO:1901796;GO:0051123;GO:0006366;GO:0036369;GO:0006361;GO:0006367;GO:0006511;GO:0016032;, C:chromatin; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription regulator complex;, F:ATP binding; F:histone acetyltransferase activity; F:kinase activity; F:lysine-acetylated histone binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein heterodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase I general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific DNA binding; F:TBP-class protein binding; F:transcription factor binding; F:transcription regulator inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:cell cycle; P:cellular response to ATP; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:midbrain development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of protein autoubiquitination; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of androgen receptor activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:protein autophosphorylation; P:protein phosphorylation; P:protein polyubiquitination; P:protein stabilization; P:regulation of cell cycle G1/S phase transition; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:transcription by RNA polymerase II; P:transcription factor catabolic process; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q70Q87 Q70T00 Q70T01 Q70T02 Q70T03,Transcription initiation factor TFIID subunit 1,Cell cycle gene 1 protein;TBP-associated factor 250 kDa;Transcription initiation factor TFIID 250 kDa subunit;, PF00439;PF12157;PF09247;PF15288;, GO:0000785;GO:0071339;GO:0005654;GO:0005634;GO:0005669;GO:0005667;GO:0005524;GO:0004402;GO:0016301;GO:0070577;GO:0035257;GO:0002039;GO:0046982;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0001181;GO:0000979;GO:0016251;GO:0061629;GO:0043565;GO:0017025;GO:0008134;GO:0140416;GO:0061631;GO:0007049;GO:0071318;GO:0006974;GO:0034644;GO:0030901;GO:0043433;GO:0010629;GO:1905524;GO:1903026;GO:0000122;GO:2000059;GO:0018105;GO:0018107;GO:2000825;GO:0032436;GO:0032092;GO:0046777;GO:0006468;GO:0000209;GO:0050821;GO:1902806;GO:1901796;GO:0051123;GO:0006366;GO:0036369;GO:0006361;GO:0006367;GO:0006511;GO:0016032;, C:chromatin; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription regulator complex;, F:ATP binding; F:histone acetyltransferase activity; F:kinase activity; F:lysine-acetylated histone binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein heterodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase I general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific DNA binding; F:TBP-class protein binding; F:transcription factor binding; F:transcription regulator inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:cell cycle; P:cellular response to ATP; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:midbrain development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of protein autoubiquitination; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of androgen receptor activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:protein autophosphorylation; P:protein phosphorylation; P:protein polyubiquitination; P:protein stabilization; P:regulation of cell cycle G1/S phase transition; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:transcription by RNA polymerase II; P:transcription factor catabolic process; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q70Q87 Q70T00 Q70T01 Q70T02 Q70T03,Transcription initiation factor TFIID subunit 1,Cell cycle gene 1 protein;TBP-associated factor 250 kDa;Transcription initiation factor TFIID 250 kDa subunit;, PF00439;PF12157;PF09247;PF15288;, GO:0000785;GO:0071339;GO:0005654;GO:0005634;GO:0005669;GO:0005667;GO:0005524;GO:0004402;GO:0016301;GO:0070577;GO:0035257;GO:0002039;GO:0046982;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0001181;GO:0000979;GO:0016251;GO:0061629;GO:0043565;GO:0017025;GO:0008134;GO:0140416;GO:0061631;GO:0007049;GO:0071318;GO:0006974;GO:0034644;GO:0030901;GO:0043433;GO:0010629;GO:1905524;GO:1903026;GO:0000122;GO:2000059;GO:0018105;GO:0018107;GO:2000825;GO:0032436;GO:0032092;GO:0046777;GO:0006468;GO:0000209;GO:0050821;GO:1902806;GO:1901796;GO:0051123;GO:0006366;GO:0036369;GO:0006361;GO:0006367;GO:0006511;GO:0016032;, C:chromatin; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription regulator complex;, F:ATP binding; F:histone acetyltransferase activity; F:kinase activity; F:lysine-acetylated histone binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein heterodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase I general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific DNA binding; F:TBP-class protein binding; F:transcription factor binding; F:transcription regulator inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:cell cycle; P:cellular response to ATP; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:midbrain development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of protein autoubiquitination; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of androgen receptor activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:protein autophosphorylation; P:protein phosphorylation; P:protein polyubiquitination; P:protein stabilization; P:regulation of cell cycle G1/S phase transition; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:transcription by RNA polymerase II; P:transcription factor catabolic process; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q70Q87 Q70T00 Q70T01 Q70T02 Q70T03,Transcription initiation factor TFIID subunit 1,Cell cycle gene 1 protein;TBP-associated factor 250 kDa;Transcription initiation factor TFIID 250 kDa subunit;, PF00439;PF12157;PF09247;PF15288;, GO:0000785;GO:0071339;GO:0005654;GO:0005634;GO:0005669;GO:0005667;GO:0005524;GO:0004402;GO:0016301;GO:0070577;GO:0035257;GO:0002039;GO:0046982;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0001181;GO:0000979;GO:0016251;GO:0061629;GO:0043565;GO:0017025;GO:0008134;GO:0140416;GO:0061631;GO:0007049;GO:0071318;GO:0006974;GO:0034644;GO:0030901;GO:0043433;GO:0010629;GO:1905524;GO:1903026;GO:0000122;GO:2000059;GO:0018105;GO:0018107;GO:2000825;GO:0032436;GO:0032092;GO:0046777;GO:0006468;GO:0000209;GO:0050821;GO:1902806;GO:1901796;GO:0051123;GO:0006366;GO:0036369;GO:0006361;GO:0006367;GO:0006511;GO:0016032;, C:chromatin; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription regulator complex;, F:ATP binding; F:histone acetyltransferase activity; F:kinase activity; F:lysine-acetylated histone binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein heterodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase I general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific DNA binding; F:TBP-class protein binding; F:transcription factor binding; F:transcription regulator inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:cell cycle; P:cellular response to ATP; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:midbrain development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of protein autoubiquitination; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of androgen receptor activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:protein autophosphorylation; P:protein phosphorylation; P:protein polyubiquitination; P:protein stabilization; P:regulation of cell cycle G1/S phase transition; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:transcription by RNA polymerase II; P:transcription factor catabolic process; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q70Q87 Q70T00 Q70T01 Q70T02 Q70T03,Transcription initiation factor TFIID subunit 1,Cell cycle gene 1 protein;TBP-associated factor 250 kDa;Transcription initiation factor TFIID 250 kDa subunit;, PF00439;PF12157;PF09247;PF15288;, GO:0000785;GO:0071339;GO:0005654;GO:0005634;GO:0005669;GO:0005667;GO:0005524;GO:0004402;GO:0016301;GO:0070577;GO:0035257;GO:0002039;GO:0046982;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0001181;GO:0000979;GO:0016251;GO:0061629;GO:0043565;GO:0017025;GO:0008134;GO:0140416;GO:0061631;GO:0007049;GO:0071318;GO:0006974;GO:0034644;GO:0030901;GO:0043433;GO:0010629;GO:1905524;GO:1903026;GO:0000122;GO:2000059;GO:0018105;GO:0018107;GO:2000825;GO:0032436;GO:0032092;GO:0046777;GO:0006468;GO:0000209;GO:0050821;GO:1902806;GO:1901796;GO:0051123;GO:0006366;GO:0036369;GO:0006361;GO:0006367;GO:0006511;GO:0016032;, C:chromatin; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:transcription factor TFIID complex; C:transcription regulator complex;, F:ATP binding; F:histone acetyltransferase activity; F:kinase activity; F:lysine-acetylated histone binding; F:nuclear hormone receptor binding; F:p53 binding; F:protein heterodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase I general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific DNA binding; F:TBP-class protein binding; F:transcription factor binding; F:transcription regulator inhibitor activity; F:ubiquitin conjugating enzyme activity;, P:cell cycle; P:cellular response to ATP; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:midbrain development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of protein autoubiquitination; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of androgen receptor activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:protein autophosphorylation; P:protein phosphorylation; P:protein polyubiquitination; P:protein stabilization; P:regulation of cell cycle G1/S phase transition; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:transcription by RNA polymerase II; P:transcription factor catabolic process; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold79 indexed_genome mRNA 5848575 5895319 . + . ID=transcript_11968;O15294 Q7Z3K0 Q8WWM8 Q96CC1 Q9UG57,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,O-GlcNAc transferase subunit p110;O-linked N-acetylglucosamine transferase 110 kDa subunit;, PF13844;PF00515;PF13181;, GO:0042995;GO:0005829;GO:0000123;GO:0031966;GO:0005654;GO:0005634;GO:0005886;GO:0017122;GO:0032991;GO:0008375;GO:0005547;GO:0016262;GO:0097363;GO:0006915;GO:0032922;GO:0080182;GO:0043984;GO:0043981;GO:0043982;GO:0032435;GO:0031397;GO:0048015;GO:0120162;GO:0061087;GO:0045862;GO:0045944;GO:0016579;GO:0006493;GO:0016485;GO:0006111;GO:0006110;GO:0046626;GO:0060544;GO:0035020;GO:0006357;GO:0032868;GO:0007584;GO:0007165;GO:0016032;, C:cell projection; C:cytosol; C:histone acetyltransferase complex; C:mitochondrial membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein N-acetylglucosaminyltransferase complex; C:protein-containing complex;, F:acetylglucosaminyltransferase activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity;, P:apoptotic process; P:circadian regulation of gene expression; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:phosphatidylinositol-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of histone H3-K27 methylation; P:positive regulation of proteolysis; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein O-linked glycosylation; P:protein processing; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:regulation of insulin receptor signaling pathway; P:regulation of necroptotic process; P:regulation of Rac protein signal transduction; P:regulation of transcription by RNA polymerase II; P:response to insulin; P:response to nutrient; P:signal transduction; P:viral process;|O15294 Q7Z3K0 Q8WWM8 Q96CC1 Q9UG57,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,O-GlcNAc transferase subunit p110;O-linked N-acetylglucosamine transferase 110 kDa subunit;, PF13844;PF00515;PF13181;, GO:0042995;GO:0005829;GO:0000123;GO:0031966;GO:0005654;GO:0005634;GO:0005886;GO:0017122;GO:0032991;GO:0008375;GO:0005547;GO:0016262;GO:0097363;GO:0006915;GO:0032922;GO:0080182;GO:0043984;GO:0043981;GO:0043982;GO:0032435;GO:0031397;GO:0048015;GO:0120162;GO:0061087;GO:0045862;GO:0045944;GO:0016579;GO:0006493;GO:0016485;GO:0006111;GO:0006110;GO:0046626;GO:0060544;GO:0035020;GO:0006357;GO:0032868;GO:0007584;GO:0007165;GO:0016032;, C:cell projection; C:cytosol; C:histone acetyltransferase complex; C:mitochondrial membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein N-acetylglucosaminyltransferase complex; C:protein-containing complex;, F:acetylglucosaminyltransferase activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity;, P:apoptotic process; P:circadian regulation of gene expression; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:phosphatidylinositol-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of histone H3-K27 methylation; P:positive regulation of proteolysis; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein O-linked glycosylation; P:protein processing; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:regulation of insulin receptor signaling pathway; P:regulation of necroptotic process; P:regulation of Rac protein signal transduction; P:regulation of transcription by RNA polymerase II; P:response to insulin; P:response to nutrient; P:signal transduction; P:viral process;|O15294 Q7Z3K0 Q8WWM8 Q96CC1 Q9UG57,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,O-GlcNAc transferase subunit p110;O-linked N-acetylglucosamine transferase 110 kDa subunit;, PF13844;PF00515;PF13181;, GO:0042995;GO:0005829;GO:0000123;GO:0031966;GO:0005654;GO:0005634;GO:0005886;GO:0017122;GO:0032991;GO:0008375;GO:0005547;GO:0016262;GO:0097363;GO:0006915;GO:0032922;GO:0080182;GO:0043984;GO:0043981;GO:0043982;GO:0032435;GO:0031397;GO:0048015;GO:0120162;GO:0061087;GO:0045862;GO:0045944;GO:0016579;GO:0006493;GO:0016485;GO:0006111;GO:0006110;GO:0046626;GO:0060544;GO:0035020;GO:0006357;GO:0032868;GO:0007584;GO:0007165;GO:0016032;, C:cell projection; C:cytosol; C:histone acetyltransferase complex; C:mitochondrial membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein N-acetylglucosaminyltransferase complex; C:protein-containing complex;, F:acetylglucosaminyltransferase activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity;, P:apoptotic process; P:circadian regulation of gene expression; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:phosphatidylinositol-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of histone H3-K27 methylation; P:positive regulation of proteolysis; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein O-linked glycosylation; P:protein processing; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:regulation of insulin receptor signaling pathway; P:regulation of necroptotic process; P:regulation of Rac protein signal transduction; P:regulation of transcription by RNA polymerase II; P:response to insulin; P:response to nutrient; P:signal transduction; P:viral process;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|O15294 Q7Z3K0 Q8WWM8 Q96CC1 Q9UG57,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,O-GlcNAc transferase subunit p110;O-linked N-acetylglucosamine transferase 110 kDa subunit;, PF13844;PF00515;PF13181;, GO:0042995;GO:0005829;GO:0000123;GO:0031966;GO:0005654;GO:0005634;GO:0005886;GO:0017122;GO:0032991;GO:0008375;GO:0005547;GO:0016262;GO:0097363;GO:0006915;GO:0032922;GO:0080182;GO:0043984;GO:0043981;GO:0043982;GO:0032435;GO:0031397;GO:0048015;GO:0120162;GO:0061087;GO:0045862;GO:0045944;GO:0016579;GO:0006493;GO:0016485;GO:0006111;GO:0006110;GO:0046626;GO:0060544;GO:0035020;GO:0006357;GO:0032868;GO:0007584;GO:0007165;GO:0016032;, C:cell projection; C:cytosol; C:histone acetyltransferase complex; C:mitochondrial membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein N-acetylglucosaminyltransferase complex; C:protein-containing complex;, F:acetylglucosaminyltransferase activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity;, P:apoptotic process; P:circadian regulation of gene expression; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:phosphatidylinositol-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of histone H3-K27 methylation; P:positive regulation of proteolysis; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein O-linked glycosylation; P:protein processing; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:regulation of insulin receptor signaling pathway; P:regulation of necroptotic process; P:regulation of Rac protein signal transduction; P:regulation of transcription by RNA polymerase II; P:response to insulin; P:response to nutrient; P:signal transduction; P:viral process;|O15294 Q7Z3K0 Q8WWM8 Q96CC1 Q9UG57,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,O-GlcNAc transferase subunit p110;O-linked N-acetylglucosamine transferase 110 kDa subunit;, PF13844;PF00515;PF13181;, GO:0042995;GO:0005829;GO:0000123;GO:0031966;GO:0005654;GO:0005634;GO:0005886;GO:0017122;GO:0032991;GO:0008375;GO:0005547;GO:0016262;GO:0097363;GO:0006915;GO:0032922;GO:0080182;GO:0043984;GO:0043981;GO:0043982;GO:0032435;GO:0031397;GO:0048015;GO:0120162;GO:0061087;GO:0045862;GO:0045944;GO:0016579;GO:0006493;GO:0016485;GO:0006111;GO:0006110;GO:0046626;GO:0060544;GO:0035020;GO:0006357;GO:0032868;GO:0007584;GO:0007165;GO:0016032;, C:cell projection; C:cytosol; C:histone acetyltransferase complex; C:mitochondrial membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein N-acetylglucosaminyltransferase complex; C:protein-containing complex;, F:acetylglucosaminyltransferase activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity;, P:apoptotic process; P:circadian regulation of gene expression; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:phosphatidylinositol-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of histone H3-K27 methylation; P:positive regulation of proteolysis; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein O-linked glycosylation; P:protein processing; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:regulation of insulin receptor signaling pathway; P:regulation of necroptotic process; P:regulation of Rac protein signal transduction; P:regulation of transcription by RNA polymerase II; P:response to insulin; P:response to nutrient; P:signal transduction; P:viral process;|O15294 Q7Z3K0 Q8WWM8 Q96CC1 Q9UG57,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,O-GlcNAc transferase subunit p110;O-linked N-acetylglucosamine transferase 110 kDa subunit;, PF13844;PF00515;PF13181;, GO:0042995;GO:0005829;GO:0000123;GO:0031966;GO:0005654;GO:0005634;GO:0005886;GO:0017122;GO:0032991;GO:0008375;GO:0005547;GO:0016262;GO:0097363;GO:0006915;GO:0032922;GO:0080182;GO:0043984;GO:0043981;GO:0043982;GO:0032435;GO:0031397;GO:0048015;GO:0120162;GO:0061087;GO:0045862;GO:0045944;GO:0016579;GO:0006493;GO:0016485;GO:0006111;GO:0006110;GO:0046626;GO:0060544;GO:0035020;GO:0006357;GO:0032868;GO:0007584;GO:0007165;GO:0016032;, C:cell projection; C:cytosol; C:histone acetyltransferase complex; C:mitochondrial membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein N-acetylglucosaminyltransferase complex; C:protein-containing complex;, F:acetylglucosaminyltransferase activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:protein N-acetylglucosaminyltransferase activity; F:protein O-GlcNAc transferase activity;, P:apoptotic process; P:circadian regulation of gene expression; P:histone H3-K4 trimethylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein ubiquitination; P:phosphatidylinositol-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of histone H3-K27 methylation; P:positive regulation of proteolysis; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein O-linked glycosylation; P:protein processing; P:regulation of gluconeogenesis; P:regulation of glycolytic process; P:regulation of insulin receptor signaling pathway; P:regulation of necroptotic process; P:regulation of Rac protein signal transduction; P:regulation of transcription by RNA polymerase II; P:response to insulin; P:response to nutrient; P:signal transduction; P:viral process; scaffold79 indexed_genome mRNA 5912416 5924998 . + . ID=transcript_11969;Q96QF7 B9EG62,Acidic repeat-containing protein {ECO:0000303|PubMed:11714101},Germ cell nuclear antigen {ECO:0000303|PubMed:27718356};, PF10263;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus;|Q96QF7 B9EG62,Acidic repeat-containing protein {ECO:0000303|PubMed:11714101},Germ cell nuclear antigen {ECO:0000303|PubMed:27718356};, PF10263;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus;|Q96QF7 B9EG62,Acidic repeat-containing protein {ECO:0000303|PubMed:11714101},Germ cell nuclear antigen {ECO:0000303|PubMed:27718356};, PF10263;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus;|Q96QF7 B9EG62,Acidic repeat-containing protein {ECO:0000303|PubMed:11714101},Germ cell nuclear antigen {ECO:0000303|PubMed:27718356};, PF10263;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus;|Q96QF7 B9EG62,Acidic repeat-containing protein {ECO:0000303|PubMed:11714101},Germ cell nuclear antigen {ECO:0000303|PubMed:27718356};, PF10263;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus; scaffold79 indexed_genome mRNA 5927001 5928313 . - . ID=transcript_11970;P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5,C-X-C chemokine receptor type 3,CKR-L2;G protein-coupled receptor 9;Interferon-inducible protein 10 receptor;, PF00001;, GO:0005737;GO:0009897;GO:0005887;GO:0005886;GO:0019957;GO:0016493;GO:0019958;GO:0016494;GO:0019956;GO:0004950;GO:0038023;GO:0007189;GO:0001525;GO:0006915;GO:0019722;GO:0007155;GO:0060326;GO:0007166;GO:0071954;GO:0006935;GO:0007186;GO:0006955;GO:0006954;GO:0016525;GO:0001937;GO:1900118;GO:0045766;GO:0008284;GO:0050921;GO:0007204;GO:1900119;GO:0051281;GO:0045944;GO:0030155;GO:0002685;GO:0010818;, C:cytoplasm; C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:C-X-C chemokine binding; F:C-X-C chemokine receptor activity; F:chemokine binding; F:chemokine receptor activity; F:signaling receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:angiogenesis; P:apoptotic process; P:calcium-mediated signaling; P:cell adhesion; P:cell chemotaxis; P:cell surface receptor signaling pathway; P:chemokine (C-C motif) ligand 11 production; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:negative regulation of angiogenesis; P:negative regulation of endothelial cell proliferation; P:negative regulation of execution phase of apoptosis; P:positive regulation of angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of execution phase of apoptosis; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell adhesion; P:regulation of leukocyte migration; P:T cell chemotaxis; scaffold79 indexed_genome mRNA 6472782 6477264 . - . ID=transcript_11971;Q5HYW3 A7E2W7 Q8NCM4 Q9NPX1,Retrotransposon Gag-like protein 5 {ECO:0000312|HGNC:HGNC:29430},Retrotransposon gag domain-containing protein 4 {ECO:0000305};, PF16297; scaffold79 indexed_genome mRNA 6477547 6498643 . + . ID=transcript_11972;Q5HYW2 A0A0J9YY34 B2RN94,NHS-like protein 2 {ECO:0000305},, PF15273;, GO:0030154;, , , P:cell differentiation;|Q5HYW2 A0A0J9YY34 B2RN94,NHS-like protein 2 {ECO:0000305},, PF15273;, GO:0030154;, , , P:cell differentiation; scaffold79 indexed_genome mRNA 6533910 6543553 . + . ID=transcript_11973;Q9Y237 A8E0G6 B3KXM0 F5H1P5 Q0D2H3 Q3MHV0 Q52M21 Q5HYW6 Q6IRW4,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4,Parvulin-14;Parvulin-17;Peptidyl-prolyl cis-trans isomerase Pin4;Peptidyl-prolyl cis/trans isomerase EPVH;Rotamase Pin4;, , GO:0005694;GO:0005737;GO:0005759;GO:0005730;GO:0005654;GO:0005634;GO:0030684;GO:0005819;GO:0003681;GO:0003677;GO:0003690;GO:0003755;GO:0003723;GO:0006364;, C:chromosome; C:cytoplasm; C:mitochondrial matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome; C:spindle;, F:bent DNA binding; F:DNA binding; F:double-stranded DNA binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:rRNA processing;|Q9Y237 A8E0G6 B3KXM0 F5H1P5 Q0D2H3 Q3MHV0 Q52M21 Q5HYW6 Q6IRW4,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4,Parvulin-14;Parvulin-17;Peptidyl-prolyl cis-trans isomerase Pin4;Peptidyl-prolyl cis/trans isomerase EPVH;Rotamase Pin4;, , GO:0005694;GO:0005737;GO:0005759;GO:0005730;GO:0005654;GO:0005634;GO:0030684;GO:0005819;GO:0003681;GO:0003677;GO:0003690;GO:0003755;GO:0003723;GO:0006364;, C:chromosome; C:cytoplasm; C:mitochondrial matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome; C:spindle;, F:bent DNA binding; F:DNA binding; F:double-stranded DNA binding; F:peptidyl-prolyl cis-trans isomerase activity; F:RNA binding;, P:rRNA processing; scaffold79 indexed_genome mRNA 6548713 6549418 . + . ID=transcript_11974;Q2NKX8 Q8NCI1 Q96H93 Q9NXQ8,DNA excision repair protein ERCC-6-like,ATP-dependent helicase ERCC6-like;PLK1-interacting checkpoint helicase;Tumor antigen BJ-HCC-15;, PF00271;PF00176;, GO:0000777;GO:0005829;GO:0016020;GO:0005524;GO:0003677;GO:0003678;GO:0015616;GO:0070615;GO:0051301;GO:0007052;, C:condensed chromosome kinetochore; C:cytosol; C:membrane;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:nucleosome-dependent ATPase activity;, P:cell division; P:mitotic spindle organization; scaffold79 indexed_genome mRNA 6616639 6617153 . - . ID=transcript_11975;P62701 P12631 P12750 P27576 P55831 Q14727 Q6IPY4,40S ribosomal protein S4, X isoform,SCR10;Single copy abundant mRNA protein;Small ribosomal subunit protein eS4 {ECO:0000303|PubMed:24524803};, PF16121;PF00467;PF00900;PF08071;PF01479;, GO:0036464;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005844;GO:1990904;GO:0005840;GO:0015935;GO:0045202;GO:0003723;GO:0019843;GO:0003735;GO:0007275;GO:0000184;GO:0008284;GO:0045727;GO:0045471;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:polysome; C:ribonucleoprotein complex; C:ribosome; C:small ribosomal subunit; C:synapse;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:multicellular organism development; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell population proliferation; P:positive regulation of translation; P:response to ethanol; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold79 indexed_genome mRNA 6617305 6617846 . + . ID=transcript_11976;P62701 P12631 P12750 P27576 P55831 Q14727 Q6IPY4,40S ribosomal protein S4, X isoform,SCR10;Single copy abundant mRNA protein;Small ribosomal subunit protein eS4 {ECO:0000303|PubMed:24524803};, PF16121;PF00467;PF00900;PF08071;PF01479;, GO:0036464;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005844;GO:1990904;GO:0005840;GO:0015935;GO:0045202;GO:0003723;GO:0019843;GO:0003735;GO:0007275;GO:0000184;GO:0008284;GO:0045727;GO:0045471;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:polysome; C:ribonucleoprotein complex; C:ribosome; C:small ribosomal subunit; C:synapse;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:multicellular organism development; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell population proliferation; P:positive regulation of translation; P:response to ethanol; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold79 indexed_genome mRNA 6648295 6650658 . - . ID=transcript_11977;Q99966 B5BU50 B5BUI2,Cbp/p300-interacting transactivator 1,Melanocyte-specific protein 1;, PF04487;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0070410;GO:0050693;GO:0008022;GO:0042803;GO:0003713;GO:0006915;GO:0007420;GO:0001658;GO:0000578;GO:0060711;GO:0042438;GO:0030318;GO:0060231;GO:0001656;GO:0003340;GO:0043524;GO:0045668;GO:0045892;GO:0030178;GO:0006913;GO:0043473;GO:0001890;GO:0010628;GO:1902462;GO:0045944;GO:0045893;GO:0030511;GO:0042981;GO:0006357;GO:0051591;GO:0034097;GO:0043627;GO:0032868;GO:0034341;GO:0070555;GO:0071105;GO:0070669;GO:0070670;GO:0070741;GO:0071104;GO:0032496;GO:0071107;GO:0071559;GO:0060395;GO:0060712;GO:0007179;GO:0001570;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:co-SMAD binding; F:LBD domain binding; F:protein C-terminus binding; F:protein homodimerization activity; F:transcription coactivator activity;, P:apoptotic process; P:brain development; P:branching involved in ureteric bud morphogenesis; P:embryonic axis specification; P:labyrinthine layer development; P:melanin biosynthetic process; P:melanocyte differentiation; P:mesenchymal to epithelial transition; P:metanephros development; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:nucleocytoplasmic transport; P:pigmentation; P:placenta development; P:positive regulation of gene expression; P:positive regulation of mesenchymal stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of apoptotic process; P:regulation of transcription by RNA polymerase II; P:response to cAMP; P:response to cytokine; P:response to estrogen; P:response to insulin; P:response to interferon-gamma; P:response to interleukin-1; P:response to interleukin-11; P:response to interleukin-2; P:response to interleukin-4; P:response to interleukin-6; P:response to interleukin-9; P:response to lipopolysaccharide; P:response to parathyroid hormone; P:response to transforming growth factor beta; P:SMAD protein signal transduction; P:spongiotrophoblast layer development; P:transforming growth factor beta receptor signaling pathway; P:vasculogenesis;|Q99966 B5BU50 B5BUI2,Cbp/p300-interacting transactivator 1,Melanocyte-specific protein 1;, PF04487;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0070410;GO:0050693;GO:0008022;GO:0042803;GO:0003713;GO:0006915;GO:0007420;GO:0001658;GO:0000578;GO:0060711;GO:0042438;GO:0030318;GO:0060231;GO:0001656;GO:0003340;GO:0043524;GO:0045668;GO:0045892;GO:0030178;GO:0006913;GO:0043473;GO:0001890;GO:0010628;GO:1902462;GO:0045944;GO:0045893;GO:0030511;GO:0042981;GO:0006357;GO:0051591;GO:0034097;GO:0043627;GO:0032868;GO:0034341;GO:0070555;GO:0071105;GO:0070669;GO:0070670;GO:0070741;GO:0071104;GO:0032496;GO:0071107;GO:0071559;GO:0060395;GO:0060712;GO:0007179;GO:0001570;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:co-SMAD binding; F:LBD domain binding; F:protein C-terminus binding; F:protein homodimerization activity; F:transcription coactivator activity;, P:apoptotic process; P:brain development; P:branching involved in ureteric bud morphogenesis; P:embryonic axis specification; P:labyrinthine layer development; P:melanin biosynthetic process; P:melanocyte differentiation; P:mesenchymal to epithelial transition; P:metanephros development; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription, DNA-templated; P:negative regulation of Wnt signaling pathway; P:nucleocytoplasmic transport; P:pigmentation; P:placenta development; P:positive regulation of gene expression; P:positive regulation of mesenchymal stem cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:regulation of apoptotic process; P:regulation of transcription by RNA polymerase II; P:response to cAMP; P:response to cytokine; P:response to estrogen; P:response to insulin; P:response to interferon-gamma; P:response to interleukin-1; P:response to interleukin-11; P:response to interleukin-2; P:response to interleukin-4; P:response to interleukin-6; P:response to interleukin-9; P:response to lipopolysaccharide; P:response to parathyroid hormone; P:response to transforming growth factor beta; P:SMAD protein signal transduction; P:spongiotrophoblast layer development; P:transforming growth factor beta receptor signaling pathway; P:vasculogenesis; scaffold79 indexed_genome mRNA 6673591 6929705 . - . ID=transcript_11978;Q9NP76 Q9NYH4,Histone deacetylase 8,, PF00850;, GO:0005737;GO:0000118;GO:0000228;GO:0005654;GO:0005634;GO:0005886;GO:0004407;GO:0030544;GO:0051879;GO:0046872;GO:0032041;GO:0008134;GO:0006333;GO:0006325;GO:0070932;GO:0070933;GO:0031397;GO:0000122;GO:0045944;GO:0071922;GO:0031647;GO:0032204;GO:0007062;, C:cytoplasm; C:histone deacetylase complex; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:histone deacetylase activity; F:Hsp70 protein binding; F:Hsp90 protein binding; F:metal ion binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:transcription factor binding;, P:chromatin assembly or disassembly; P:chromatin organization; P:histone H3 deacetylation; P:histone H4 deacetylation; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of cohesin loading; P:regulation of protein stability; P:regulation of telomere maintenance; P:sister chromatid cohesion; scaffold79 indexed_genome mRNA 6937900 6985877 . - . ID=transcript_11979;P46020 B7ZL05 B7ZL07 Q2M3D7,Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0006091;GO:0005980;GO:0005977;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process;|P46020 B7ZL05 B7ZL07 Q2M3D7,Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0006091;GO:0005980;GO:0005977;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process;|P46020 B7ZL05 B7ZL07 Q2M3D7,Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0006091;GO:0005980;GO:0005977;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process;|P46020 B7ZL05 B7ZL07 Q2M3D7,Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0006091;GO:0005980;GO:0005977;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process; scaffold79 indexed_genome mRNA 6986588 7097222 . - . ID=transcript_11980;P46020 B7ZL05 B7ZL07 Q2M3D7,Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0006091;GO:0005980;GO:0005977;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process;|P46020 B7ZL05 B7ZL07 Q2M3D7,Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0006091;GO:0005980;GO:0005977;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process;|P46020 B7ZL05 B7ZL07 Q2M3D7,Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0006091;GO:0005980;GO:0005977;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:generation of precursor metabolites and energy; P:glycogen catabolic process; P:glycogen metabolic process; scaffold80 indexed_genome mRNA 21482 22311 . + . ID=transcript_11981;P48029 B2KY47 B4DIA3 E9PFC0 Q13032 Q66I36,Sodium- and chloride-dependent creatine transporter 1,Solute carrier family 6 member 8;, PF00209;, GO:0016021;GO:0005887;GO:0005886;GO:0005308;GO:0005309;GO:0006600;GO:0015881;GO:0006936;GO:0006836;GO:0071705;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:creatine transmembrane transporter activity; F:creatine:sodium symporter activity;, P:creatine metabolic process; P:creatine transmembrane transport; P:muscle contraction; P:neurotransmitter transport; P:nitrogen compound transport; P:sodium ion transmembrane transport; scaffold80 indexed_genome mRNA 439433 1246972 . - . ID=transcript_11982;Q9NS85 B2R7J0 B4DGL6,Carbonic anhydrase-related protein 10,Carbonic anhydrase-related protein X;Cerebral protein 15;, PF00194;, GO:0004089;GO:0016836;GO:0008270;GO:0007420;GO:0006730;, , F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:brain development; P:one-carbon metabolic process;|Q9NS85 B2R7J0 B4DGL6,Carbonic anhydrase-related protein 10,Carbonic anhydrase-related protein X;Cerebral protein 15;, PF00194;, GO:0004089;GO:0016836;GO:0008270;GO:0007420;GO:0006730;, , F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:brain development; P:one-carbon metabolic process;|B6SEH9,Endogenous retrovirus group V member 2 Env polyprotein,HERV-V_19q13.41 provirus ancestral Env polyprotein 2;, PF00429;, GO:0016021;, C:integral component of membrane; scaffold80 indexed_genome mRNA 4851159 4918698 . + . ID=transcript_11983;O75674 B7Z9E2 Q53G06 Q8N749,TOM1-like protein 1,Src-activating and signaling molecule protein;Target of Myb-like protein 1;, PF03127;PF00790;, GO:0005737;GO:0005829;GO:0005768;GO:0010008;GO:0070062;GO:0005795;GO:0005764;GO:0016020;GO:0030276;GO:0030295;GO:0019901;GO:0017124;GO:0043130;GO:0032147;GO:0006886;GO:0045839;GO:0031954;GO:0007165;GO:0043162;, C:cytoplasm; C:cytosol; C:endosome; C:endosome membrane; C:extracellular exosome; C:Golgi stack; C:lysosome; C:membrane;, F:clathrin binding; F:protein kinase activator activity; F:protein kinase binding; F:SH3 domain binding; F:ubiquitin binding;, P:activation of protein kinase activity; P:intracellular protein transport; P:negative regulation of mitotic nuclear division; P:positive regulation of protein autophosphorylation; P:signal transduction; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|O75674 B7Z9E2 Q53G06 Q8N749,TOM1-like protein 1,Src-activating and signaling molecule protein;Target of Myb-like protein 1;, PF03127;PF00790;, GO:0005737;GO:0005829;GO:0005768;GO:0010008;GO:0070062;GO:0005795;GO:0005764;GO:0016020;GO:0030276;GO:0030295;GO:0019901;GO:0017124;GO:0043130;GO:0032147;GO:0006886;GO:0045839;GO:0031954;GO:0007165;GO:0043162;, C:cytoplasm; C:cytosol; C:endosome; C:endosome membrane; C:extracellular exosome; C:Golgi stack; C:lysosome; C:membrane;, F:clathrin binding; F:protein kinase activator activity; F:protein kinase binding; F:SH3 domain binding; F:ubiquitin binding;, P:activation of protein kinase activity; P:intracellular protein transport; P:negative regulation of mitotic nuclear division; P:positive regulation of protein autophosphorylation; P:signal transduction; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9Y6N1 D3DTY5 I3L220 Q6FHB7 Q9BRX0 Q9UME8,Cytochrome c oxidase assembly protein COX11, mitochondrial,, PF04442;, GO:0031305;GO:0031304;GO:0005739;GO:0032991;GO:0005507;GO:0009055;GO:0055065;GO:0033132;, C:integral component of mitochondrial inner membrane; C:intrinsic component of mitochondrial inner membrane; C:mitochondrion; C:protein-containing complex;, F:copper ion binding; F:electron transfer activity;, P:metal ion homeostasis; P:negative regulation of glucokinase activity;|Q9Y6N1 D3DTY5 I3L220 Q6FHB7 Q9BRX0 Q9UME8,Cytochrome c oxidase assembly protein COX11, mitochondrial,, PF04442;, GO:0031305;GO:0031304;GO:0005739;GO:0032991;GO:0005507;GO:0009055;GO:0055065;GO:0033132;, C:integral component of mitochondrial inner membrane; C:intrinsic component of mitochondrial inner membrane; C:mitochondrion; C:protein-containing complex;, F:copper ion binding; F:electron transfer activity;, P:metal ion homeostasis; P:negative regulation of glucokinase activity;|Q9Y6N1 D3DTY5 I3L220 Q6FHB7 Q9BRX0 Q9UME8,Cytochrome c oxidase assembly protein COX11, mitochondrial,, PF04442;, GO:0031305;GO:0031304;GO:0005739;GO:0032991;GO:0005507;GO:0009055;GO:0055065;GO:0033132;, C:integral component of mitochondrial inner membrane; C:intrinsic component of mitochondrial inner membrane; C:mitochondrion; C:protein-containing complex;, F:copper ion binding; F:electron transfer activity;, P:metal ion homeostasis; P:negative regulation of glucokinase activity;|Q9Y6N1 D3DTY5 I3L220 Q6FHB7 Q9BRX0 Q9UME8,Cytochrome c oxidase assembly protein COX11, mitochondrial,, PF04442;, GO:0031305;GO:0031304;GO:0005739;GO:0032991;GO:0005507;GO:0009055;GO:0055065;GO:0033132;, C:integral component of mitochondrial inner membrane; C:intrinsic component of mitochondrial inner membrane; C:mitochondrion; C:protein-containing complex;, F:copper ion binding; F:electron transfer activity;, P:metal ion homeostasis; P:negative regulation of glucokinase activity; scaffold80 indexed_genome mRNA 4918752 5121992 . + . ID=transcript_11984;Q6ZWJ1 Q8IVZ5,Syntaxin-binding protein 4,Syntaxin 4-interacting protein;, PF00595;PF00397;, GO:0070062;GO:0045335;GO:0019905;GO:0006974;GO:0071346;GO:0008286;GO:1902808;GO:0010838;GO:0050821;GO:0006605;GO:0010827;GO:0061178;, C:extracellular exosome; C:phagocytic vesicle;, F:syntaxin binding;, P:cellular response to DNA damage stimulus; P:cellular response to interferon-gamma; P:insulin receptor signaling pathway; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of keratinocyte proliferation; P:protein stabilization; P:protein targeting; P:regulation of glucose transmembrane transport; P:regulation of insulin secretion involved in cellular response to glucose stimulus; scaffold80 indexed_genome mRNA 5283875 5337933 . + . ID=transcript_11985;Q16534 A8K1X8 Q6FHS9,Hepatic leukemia factor,, PF07716;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0003690;GO:0000978;GO:0043565;GO:1990837;GO:0007275;GO:0045944;GO:0006357;GO:0048511;GO:0035914;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:multicellular organism development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:rhythmic process; P:skeletal muscle cell differentiation; scaffold80 indexed_genome mRNA 5400970 5406157 . - . ID=transcript_11986;Q15546 B2R6X9 D3DTY6 Q8TAN7,Monocyte to macrophage differentiation factor {ECO:0000303|PubMed:7503749},Progestin and adipoQ receptor family member 11 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member XI;, PF03006;, GO:0005794;GO:0005887;GO:0031902;GO:0005765;GO:0016020;GO:0004672;GO:0038023;GO:0019835;GO:0045666;GO:0045860;GO:0032880;, C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:membrane;, F:protein kinase activity; F:signaling receptor activity;, P:cytolysis; P:positive regulation of neuron differentiation; P:positive regulation of protein kinase activity; P:regulation of protein localization; scaffold80 indexed_genome mRNA 5407863 5410915 . - . ID=transcript_11987;Q15546 B2R6X9 D3DTY6 Q8TAN7,Monocyte to macrophage differentiation factor {ECO:0000303|PubMed:7503749},Progestin and adipoQ receptor family member 11 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member XI;, PF03006;, GO:0005794;GO:0005887;GO:0031902;GO:0005765;GO:0016020;GO:0004672;GO:0038023;GO:0019835;GO:0045666;GO:0045860;GO:0032880;, C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:membrane;, F:protein kinase activity; F:signaling receptor activity;, P:cytolysis; P:positive regulation of neuron differentiation; P:positive regulation of protein kinase activity; P:regulation of protein localization; scaffold80 indexed_genome mRNA 5861500 5871154 . + . ID=transcript_11988;Q9UKL6 Q9BSC9 Q9UIT3 Q9UKW7,Phosphatidylcholine transfer protein,START domain-containing protein 2;StAR-related lipid transfer protein 2;, PF01852;, GO:0005829;GO:0031210;GO:0008525;GO:0006869;GO:0120163;GO:0006656;GO:0015914;, C:cytosol;, F:phosphatidylcholine binding; F:phosphatidylcholine transporter activity;, P:lipid transport; P:negative regulation of cold-induced thermogenesis; P:phosphatidylcholine biosynthetic process; P:phospholipid transport; scaffold80 indexed_genome mRNA 6528885 6529628 . - . ID=transcript_11989;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold81 indexed_genome mRNA 2604855 2625012 . + . ID=transcript_11990;Q9ULC3 B2R9I5 Q68DJ6 Q8NI06 Q9P023,Ras-related protein Rab-23,, PF00071;, GO:0005776;GO:0030054;GO:0005813;GO:0005737;GO:0005829;GO:0012505;GO:0010008;GO:0045335;GO:0030670;GO:0005886;GO:0005525;GO:0003924;GO:0000045;GO:0006968;GO:0060271;GO:0097094;GO:0046039;GO:0006886;GO:0042308;, C:autophagosome; C:cell junction; C:centrosome; C:cytoplasm; C:cytosol; C:endomembrane system; C:endosome membrane; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:autophagosome assembly; P:cellular defense response; P:cilium assembly; P:craniofacial suture morphogenesis; P:GTP metabolic process; P:intracellular protein transport; P:negative regulation of protein import into nucleus;|Q9ULC3 B2R9I5 Q68DJ6 Q8NI06 Q9P023,Ras-related protein Rab-23,, PF00071;, GO:0005776;GO:0030054;GO:0005813;GO:0005737;GO:0005829;GO:0012505;GO:0010008;GO:0045335;GO:0030670;GO:0005886;GO:0005525;GO:0003924;GO:0000045;GO:0006968;GO:0060271;GO:0097094;GO:0046039;GO:0006886;GO:0042308;, C:autophagosome; C:cell junction; C:centrosome; C:cytoplasm; C:cytosol; C:endomembrane system; C:endosome membrane; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:autophagosome assembly; P:cellular defense response; P:cilium assembly; P:craniofacial suture morphogenesis; P:GTP metabolic process; P:intracellular protein transport; P:negative regulation of protein import into nucleus; scaffold81 indexed_genome mRNA 2625020 2632937 . + . ID=transcript_11991;O95816 B4DXE2 Q08AS9 Q6FID0,BAG family molecular chaperone regulator 2,Bcl-2-associated athanogene 2;, , GO:0030424;GO:0101031;GO:0005829;GO:0030425;GO:1901588;GO:0000774;GO:0051087;GO:0031072;GO:0042802;GO:0044325;GO:0048156;GO:0031625;GO:0032091;GO:0031397;GO:1904667;GO:1901800;GO:0010954;GO:0006457;GO:0019538;GO:0050821;GO:1900034;, C:axon; C:chaperone complex; C:cytosol; C:dendrite; C:dendritic microtubule;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:tau protein binding; F:ubiquitin protein ligase binding;, P:negative regulation of protein binding; P:negative regulation of protein ubiquitination; P:negative regulation of ubiquitin protein ligase activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein processing; P:protein folding; P:protein metabolic process; P:protein stabilization; P:regulation of cellular response to heat;|O95816 B4DXE2 Q08AS9 Q6FID0,BAG family molecular chaperone regulator 2,Bcl-2-associated athanogene 2;, , GO:0030424;GO:0101031;GO:0005829;GO:0030425;GO:1901588;GO:0000774;GO:0051087;GO:0031072;GO:0042802;GO:0044325;GO:0048156;GO:0031625;GO:0032091;GO:0031397;GO:1904667;GO:1901800;GO:0010954;GO:0006457;GO:0019538;GO:0050821;GO:1900034;, C:axon; C:chaperone complex; C:cytosol; C:dendrite; C:dendritic microtubule;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:tau protein binding; F:ubiquitin protein ligase binding;, P:negative regulation of protein binding; P:negative regulation of protein ubiquitination; P:negative regulation of ubiquitin protein ligase activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein processing; P:protein folding; P:protein metabolic process; P:protein stabilization; P:regulation of cellular response to heat;|O95816 B4DXE2 Q08AS9 Q6FID0,BAG family molecular chaperone regulator 2,Bcl-2-associated athanogene 2;, , GO:0030424;GO:0101031;GO:0005829;GO:0030425;GO:1901588;GO:0000774;GO:0051087;GO:0031072;GO:0042802;GO:0044325;GO:0048156;GO:0031625;GO:0032091;GO:0031397;GO:1904667;GO:1901800;GO:0010954;GO:0006457;GO:0019538;GO:0050821;GO:1900034;, C:axon; C:chaperone complex; C:cytosol; C:dendrite; C:dendritic microtubule;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:tau protein binding; F:ubiquitin protein ligase binding;, P:negative regulation of protein binding; P:negative regulation of protein ubiquitination; P:negative regulation of ubiquitin protein ligase activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein processing; P:protein folding; P:protein metabolic process; P:protein stabilization; P:regulation of cellular response to heat;|O95816 B4DXE2 Q08AS9 Q6FID0,BAG family molecular chaperone regulator 2,Bcl-2-associated athanogene 2;, , GO:0030424;GO:0101031;GO:0005829;GO:0030425;GO:1901588;GO:0000774;GO:0051087;GO:0031072;GO:0042802;GO:0044325;GO:0048156;GO:0031625;GO:0032091;GO:0031397;GO:1904667;GO:1901800;GO:0010954;GO:0006457;GO:0019538;GO:0050821;GO:1900034;, C:axon; C:chaperone complex; C:cytosol; C:dendrite; C:dendritic microtubule;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:tau protein binding; F:ubiquitin protein ligase binding;, P:negative regulation of protein binding; P:negative regulation of protein ubiquitination; P:negative regulation of ubiquitin protein ligase activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein processing; P:protein folding; P:protein metabolic process; P:protein stabilization; P:regulation of cellular response to heat; scaffold81 indexed_genome mRNA 2638850 2707598 . - . ID=transcript_11992;Q9Y4E5 Q5VVE9 Q5VVF1 Q86YE4 Q8N380 Q8TD15 Q9C0G1 Q9NQM1,E3 SUMO-protein ligase ZNF451 {ECO:0000303|PubMed:26524494},Coactivator for steroid receptors {ECO:0000303|Ref.1};E3 SUMO-protein transferase ZNF451 {ECO:0000305};Zinc finger protein 451;, PF18479;, GO:0005634;GO:0016605;GO:0046872;GO:0061665;GO:0003714;GO:2000616;GO:0060633;GO:0030512;GO:0045944;GO:0016925;GO:0010468;, C:nucleus; C:PML body;, F:metal ion binding; F:SUMO ligase activity; F:transcription corepressor activity;, P:negative regulation of histone H3-K9 acetylation; P:negative regulation of transcription initiation from RNA polymerase II promoter; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:protein sumoylation; P:regulation of gene expression;|Q9Y4E5 Q5VVE9 Q5VVF1 Q86YE4 Q8N380 Q8TD15 Q9C0G1 Q9NQM1,E3 SUMO-protein ligase ZNF451 {ECO:0000303|PubMed:26524494},Coactivator for steroid receptors {ECO:0000303|Ref.1};E3 SUMO-protein transferase ZNF451 {ECO:0000305};Zinc finger protein 451;, PF18479;, GO:0005634;GO:0016605;GO:0046872;GO:0061665;GO:0003714;GO:2000616;GO:0060633;GO:0030512;GO:0045944;GO:0016925;GO:0010468;, C:nucleus; C:PML body;, F:metal ion binding; F:SUMO ligase activity; F:transcription corepressor activity;, P:negative regulation of histone H3-K9 acetylation; P:negative regulation of transcription initiation from RNA polymerase II promoter; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:protein sumoylation; P:regulation of gene expression; scaffold81 indexed_genome mRNA 2761832 2769447 . - . ID=transcript_11993;Q6ZTR7 A0A0D9SG36,CBY1-interacting BAR domain-containing protein 2 {ECO:0000312|HGNC:HGNC:24781},Protein FAM92B;, PF06730;, GO:0042995;GO:0005814;GO:0005737;GO:0030030;, C:cell projection; C:centriole; C:cytoplasm;, , P:cell projection organization;|Q9HCI6 A8K4M3 Q8IW25,E3 SUMO-protein ligase KIAA1586 {ECO:0000305},E3 SUMO-protein transferase KIAA1586 {ECO:0000305};, , GO:0061665;GO:0016925;, , F:SUMO ligase activity;, P:protein sumoylation; scaffold81 indexed_genome mRNA 2784249 2830490 . - . ID=transcript_11994;Q5SZJ8 Q4G0W8 Q8N662 Q96NS6,BEN domain-containing protein 6,, PF10523;, GO:0005634;GO:0003682;GO:0003714;GO:0045746;GO:0007399;GO:0045666;, C:nucleus;, F:chromatin binding; F:transcription corepressor activity;, P:negative regulation of Notch signaling pathway; P:nervous system development; P:positive regulation of neuron differentiation;|Q5SZJ8 Q4G0W8 Q8N662 Q96NS6,BEN domain-containing protein 6,, PF10523;, GO:0005634;GO:0003682;GO:0003714;GO:0045746;GO:0007399;GO:0045666;, C:nucleus;, F:chromatin binding; F:transcription corepressor activity;, P:negative regulation of Notch signaling pathway; P:nervous system development; P:positive regulation of neuron differentiation;|Q5SZJ8 Q4G0W8 Q8N662 Q96NS6,BEN domain-containing protein 6,, PF10523;, GO:0005634;GO:0003682;GO:0003714;GO:0045746;GO:0007399;GO:0045666;, C:nucleus;, F:chromatin binding; F:transcription corepressor activity;, P:negative regulation of Notch signaling pathway; P:nervous system development; P:positive regulation of neuron differentiation;|Q5SZJ8 Q4G0W8 Q8N662 Q96NS6,BEN domain-containing protein 6,, PF10523;, GO:0005634;GO:0003682;GO:0003714;GO:0045746;GO:0007399;GO:0045666;, C:nucleus;, F:chromatin binding; F:transcription corepressor activity;, P:negative regulation of Notch signaling pathway; P:nervous system development; P:positive regulation of neuron differentiation;|Q5SZJ8 Q4G0W8 Q8N662 Q96NS6,BEN domain-containing protein 6,, PF10523;, GO:0005634;GO:0003682;GO:0003714;GO:0045746;GO:0007399;GO:0045666;, C:nucleus;, F:chromatin binding; F:transcription corepressor activity;, P:negative regulation of Notch signaling pathway; P:nervous system development; P:positive regulation of neuron differentiation;|P49207 Q6FG66 Q9BUZ2,60S ribosomal protein L34,Large ribosomal subunit protein eL34 {ECO:0000303|PubMed:24524803};, PF01199;, GO:0005829;GO:0022625;GO:0005783;GO:0070062;GO:0045296;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome;, F:cadherin binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q5SZJ8 Q4G0W8 Q8N662 Q96NS6,BEN domain-containing protein 6,, PF10523;, GO:0005634;GO:0003682;GO:0003714;GO:0045746;GO:0007399;GO:0045666;, C:nucleus;, F:chromatin binding; F:transcription corepressor activity;, P:negative regulation of Notch signaling pathway; P:nervous system development; P:positive regulation of neuron differentiation; scaffold81 indexed_genome mRNA 3110736 3368849 . + . ID=transcript_11995;Q96J76 Q96QT5 Q9H555 Q9UGD7 Q9UGD8 Q9UN10,Dystonin,230 kDa bullous pemphigoid antigen;230/240 kDa bullous pemphigoid antigen;Bullous pemphigoid antigen 1;Dystonia musculorum protein;Hemidesmosomal plaque protein;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0030424;GO:1904115;GO:0009925;GO:0005604;GO:0005938;GO:0031252;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005925;GO:0031673;GO:0030056;GO:0016021;GO:0005882;GO:0045111;GO:0016020;GO:0015630;GO:0035371;GO:0005635;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0005509;GO:0005178;GO:0008017;GO:0051010;GO:0008022;GO:0042803;GO:0005198;GO:0007155;GO:0048870;GO:0030199;GO:0031122;GO:0007010;GO:0031581;GO:0007229;GO:0045104;GO:0030011;GO:0000226;GO:0009611;GO:0008090;GO:0042060;, C:actin cytoskeleton; C:axon; C:axon cytoplasm; C:basal plasma membrane; C:basement membrane; C:cell cortex; C:cell leading edge; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:focal adhesion; C:H zone; C:hemidesmosome; C:integral component of membrane; C:intermediate filament; C:intermediate filament cytoskeleton; C:membrane; C:microtubule cytoskeleton; C:microtubule plus-end; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding; F:calcium ion binding; F:integrin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein C-terminus binding; F:protein homodimerization activity; F:structural molecule activity;, P:cell adhesion; P:cell motility; P:collagen fibril organization; P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:maintenance of cell polarity; P:microtubule cytoskeleton organization; P:response to wounding; P:retrograde axonal transport; P:wound healing;|Q6S382 Q6S383,Plectin,Hemidesmosomal protein 1;Plectin-1;, PF00307;PF00681;PF03501;PF17902;PF18373;, GO:0005903;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030056;GO:0045111;GO:0016020;GO:0048471;GO:0005886;GO:0042383;GO:0016528;GO:0003779;GO:0030506;GO:0045296;GO:0003723;GO:0005200;GO:0008307;GO:0005198;GO:0030199;GO:0031581;GO:0045104;GO:0042060;, C:brush border; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:intermediate filament cytoskeleton; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:sarcoplasm;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:structural molecule activity;, P:collagen fibril organization; P:hemidesmosome assembly; P:intermediate filament cytoskeleton organization; P:wound healing;|Q96J76 Q96QT5 Q9H555 Q9UGD7 Q9UGD8 Q9UN10,Dystonin,230 kDa bullous pemphigoid antigen;230/240 kDa bullous pemphigoid antigen;Bullous pemphigoid antigen 1;Dystonia musculorum protein;Hemidesmosomal plaque protein;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0030424;GO:1904115;GO:0009925;GO:0005604;GO:0005938;GO:0031252;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005925;GO:0031673;GO:0030056;GO:0016021;GO:0005882;GO:0045111;GO:0016020;GO:0015630;GO:0035371;GO:0005635;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0005509;GO:0005178;GO:0008017;GO:0051010;GO:0008022;GO:0042803;GO:0005198;GO:0007155;GO:0048870;GO:0030199;GO:0031122;GO:0007010;GO:0031581;GO:0007229;GO:0045104;GO:0030011;GO:0000226;GO:0009611;GO:0008090;GO:0042060;, C:actin cytoskeleton; C:axon; C:axon cytoplasm; C:basal plasma membrane; C:basement membrane; C:cell cortex; C:cell leading edge; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:focal adhesion; C:H zone; C:hemidesmosome; C:integral component of membrane; C:intermediate filament; C:intermediate filament cytoskeleton; C:membrane; C:microtubule cytoskeleton; C:microtubule plus-end; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding; F:calcium ion binding; F:integrin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein C-terminus binding; F:protein homodimerization activity; F:structural molecule activity;, P:cell adhesion; P:cell motility; P:collagen fibril organization; P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:maintenance of cell polarity; P:microtubule cytoskeleton organization; P:response to wounding; P:retrograde axonal transport; P:wound healing;|Q96J76 Q96QT5 Q9H555 Q9UGD7 Q9UGD8 Q9UN10,Dystonin,230 kDa bullous pemphigoid antigen;230/240 kDa bullous pemphigoid antigen;Bullous pemphigoid antigen 1;Dystonia musculorum protein;Hemidesmosomal plaque protein;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0030424;GO:1904115;GO:0009925;GO:0005604;GO:0005938;GO:0031252;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005925;GO:0031673;GO:0030056;GO:0016021;GO:0005882;GO:0045111;GO:0016020;GO:0015630;GO:0035371;GO:0005635;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0005509;GO:0005178;GO:0008017;GO:0051010;GO:0008022;GO:0042803;GO:0005198;GO:0007155;GO:0048870;GO:0030199;GO:0031122;GO:0007010;GO:0031581;GO:0007229;GO:0045104;GO:0030011;GO:0000226;GO:0009611;GO:0008090;GO:0042060;, C:actin cytoskeleton; C:axon; C:axon cytoplasm; C:basal plasma membrane; C:basement membrane; C:cell cortex; C:cell leading edge; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:focal adhesion; C:H zone; C:hemidesmosome; C:integral component of membrane; C:intermediate filament; C:intermediate filament cytoskeleton; C:membrane; C:microtubule cytoskeleton; C:microtubule plus-end; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding; F:calcium ion binding; F:integrin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein C-terminus binding; F:protein homodimerization activity; F:structural molecule activity;, P:cell adhesion; P:cell motility; P:collagen fibril organization; P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:maintenance of cell polarity; P:microtubule cytoskeleton organization; P:response to wounding; P:retrograde axonal transport; P:wound healing;|Q96J76 Q96QT5 Q9H555 Q9UGD7 Q9UGD8 Q9UN10,Dystonin,230 kDa bullous pemphigoid antigen;230/240 kDa bullous pemphigoid antigen;Bullous pemphigoid antigen 1;Dystonia musculorum protein;Hemidesmosomal plaque protein;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0030424;GO:1904115;GO:0009925;GO:0005604;GO:0005938;GO:0031252;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005925;GO:0031673;GO:0030056;GO:0016021;GO:0005882;GO:0045111;GO:0016020;GO:0015630;GO:0035371;GO:0005635;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0005509;GO:0005178;GO:0008017;GO:0051010;GO:0008022;GO:0042803;GO:0005198;GO:0007155;GO:0048870;GO:0030199;GO:0031122;GO:0007010;GO:0031581;GO:0007229;GO:0045104;GO:0030011;GO:0000226;GO:0009611;GO:0008090;GO:0042060;, C:actin cytoskeleton; C:axon; C:axon cytoplasm; C:basal plasma membrane; C:basement membrane; C:cell cortex; C:cell leading edge; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:focal adhesion; C:H zone; C:hemidesmosome; C:integral component of membrane; C:intermediate filament; C:intermediate filament cytoskeleton; C:membrane; C:microtubule cytoskeleton; C:microtubule plus-end; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding; F:calcium ion binding; F:integrin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein C-terminus binding; F:protein homodimerization activity; F:structural molecule activity;, P:cell adhesion; P:cell motility; P:collagen fibril organization; P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:maintenance of cell polarity; P:microtubule cytoskeleton organization; P:response to wounding; P:retrograde axonal transport; P:wound healing;|Q96J76 Q96QT5 Q9H555 Q9UGD7 Q9UGD8 Q9UN10,Dystonin,230 kDa bullous pemphigoid antigen;230/240 kDa bullous pemphigoid antigen;Bullous pemphigoid antigen 1;Dystonia musculorum protein;Hemidesmosomal plaque protein;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0030424;GO:1904115;GO:0009925;GO:0005604;GO:0005938;GO:0031252;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005925;GO:0031673;GO:0030056;GO:0016021;GO:0005882;GO:0045111;GO:0016020;GO:0015630;GO:0035371;GO:0005635;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0005509;GO:0005178;GO:0008017;GO:0051010;GO:0008022;GO:0042803;GO:0005198;GO:0007155;GO:0048870;GO:0030199;GO:0031122;GO:0007010;GO:0031581;GO:0007229;GO:0045104;GO:0030011;GO:0000226;GO:0009611;GO:0008090;GO:0042060;, C:actin cytoskeleton; C:axon; C:axon cytoplasm; C:basal plasma membrane; C:basement membrane; C:cell cortex; C:cell leading edge; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:focal adhesion; C:H zone; C:hemidesmosome; C:integral component of membrane; C:intermediate filament; C:intermediate filament cytoskeleton; C:membrane; C:microtubule cytoskeleton; C:microtubule plus-end; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding; F:calcium ion binding; F:integrin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein C-terminus binding; F:protein homodimerization activity; F:structural molecule activity;, P:cell adhesion; P:cell motility; P:collagen fibril organization; P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:maintenance of cell polarity; P:microtubule cytoskeleton organization; P:response to wounding; P:retrograde axonal transport; P:wound healing;|Q96J76 Q96QT5 Q9H555 Q9UGD7 Q9UGD8 Q9UN10,Dystonin,230 kDa bullous pemphigoid antigen;230/240 kDa bullous pemphigoid antigen;Bullous pemphigoid antigen 1;Dystonia musculorum protein;Hemidesmosomal plaque protein;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0030424;GO:1904115;GO:0009925;GO:0005604;GO:0005938;GO:0031252;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005925;GO:0031673;GO:0030056;GO:0016021;GO:0005882;GO:0045111;GO:0016020;GO:0015630;GO:0035371;GO:0005635;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0005509;GO:0005178;GO:0008017;GO:0051010;GO:0008022;GO:0042803;GO:0005198;GO:0007155;GO:0048870;GO:0030199;GO:0031122;GO:0007010;GO:0031581;GO:0007229;GO:0045104;GO:0030011;GO:0000226;GO:0009611;GO:0008090;GO:0042060;, C:actin cytoskeleton; C:axon; C:axon cytoplasm; C:basal plasma membrane; C:basement membrane; C:cell cortex; C:cell leading edge; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:focal adhesion; C:H zone; C:hemidesmosome; C:integral component of membrane; C:intermediate filament; C:intermediate filament cytoskeleton; C:membrane; C:microtubule cytoskeleton; C:microtubule plus-end; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding; F:calcium ion binding; F:integrin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein C-terminus binding; F:protein homodimerization activity; F:structural molecule activity;, P:cell adhesion; P:cell motility; P:collagen fibril organization; P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:maintenance of cell polarity; P:microtubule cytoskeleton organization; P:response to wounding; P:retrograde axonal transport; P:wound healing;|Q96J76 Q96QT5 Q9H555 Q9UGD7 Q9UGD8 Q9UN10,Dystonin,230 kDa bullous pemphigoid antigen;230/240 kDa bullous pemphigoid antigen;Bullous pemphigoid antigen 1;Dystonia musculorum protein;Hemidesmosomal plaque protein;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0030424;GO:1904115;GO:0009925;GO:0005604;GO:0005938;GO:0031252;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005925;GO:0031673;GO:0030056;GO:0016021;GO:0005882;GO:0045111;GO:0016020;GO:0015630;GO:0035371;GO:0005635;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0005509;GO:0005178;GO:0008017;GO:0051010;GO:0008022;GO:0042803;GO:0005198;GO:0007155;GO:0048870;GO:0030199;GO:0031122;GO:0007010;GO:0031581;GO:0007229;GO:0045104;GO:0030011;GO:0000226;GO:0009611;GO:0008090;GO:0042060;, C:actin cytoskeleton; C:axon; C:axon cytoplasm; C:basal plasma membrane; C:basement membrane; C:cell cortex; C:cell leading edge; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:focal adhesion; C:H zone; C:hemidesmosome; C:integral component of membrane; C:intermediate filament; C:intermediate filament cytoskeleton; C:membrane; C:microtubule cytoskeleton; C:microtubule plus-end; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding; F:calcium ion binding; F:integrin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein C-terminus binding; F:protein homodimerization activity; F:structural molecule activity;, P:cell adhesion; P:cell motility; P:collagen fibril organization; P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:maintenance of cell polarity; P:microtubule cytoskeleton organization; P:response to wounding; P:retrograde axonal transport; P:wound healing;|Q96J76 Q96QT5 Q9H555 Q9UGD7 Q9UGD8 Q9UN10,Dystonin,230 kDa bullous pemphigoid antigen;230/240 kDa bullous pemphigoid antigen;Bullous pemphigoid antigen 1;Dystonia musculorum protein;Hemidesmosomal plaque protein;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0030424;GO:1904115;GO:0009925;GO:0005604;GO:0005938;GO:0031252;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005925;GO:0031673;GO:0030056;GO:0016021;GO:0005882;GO:0045111;GO:0016020;GO:0015630;GO:0035371;GO:0005635;GO:0005654;GO:0005634;GO:0030018;GO:0003779;GO:0005509;GO:0005178;GO:0008017;GO:0051010;GO:0008022;GO:0042803;GO:0005198;GO:0007155;GO:0048870;GO:0030199;GO:0031122;GO:0007010;GO:0031581;GO:0007229;GO:0045104;GO:0030011;GO:0000226;GO:0009611;GO:0008090;GO:0042060;, C:actin cytoskeleton; C:axon; C:axon cytoplasm; C:basal plasma membrane; C:basement membrane; C:cell cortex; C:cell leading edge; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:focal adhesion; C:H zone; C:hemidesmosome; C:integral component of membrane; C:intermediate filament; C:intermediate filament cytoskeleton; C:membrane; C:microtubule cytoskeleton; C:microtubule plus-end; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:Z disc;, F:actin binding; F:calcium ion binding; F:integrin binding; F:microtubule binding; F:microtubule plus-end binding; F:protein C-terminus binding; F:protein homodimerization activity; F:structural molecule activity;, P:cell adhesion; P:cell motility; P:collagen fibril organization; P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:maintenance of cell polarity; P:microtubule cytoskeleton organization; P:response to wounding; P:retrograde axonal transport; P:wound healing; scaffold81 indexed_genome mRNA 3632711 3844241 . + . ID=transcript_11996;Q96P44 A6NIX5 B2R8J9 Q49A51 Q71RF4 Q8WXV8 Q9H0V3,Collagen alpha-1(XXI) chain,, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005829;GO:0005788;GO:0005576;GO:0005615;GO:0030199;, C:collagen trimer; C:collagen-containing extracellular matrix; C:cytosol; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space;, , P:collagen fibril organization; scaffold81 indexed_genome mRNA 4037864 4174445 . + . ID=transcript_11997;P22003 B4E0Y4 Q9H547 Q9NTM5,Bone morphogenetic protein 5,, PF00019;PF00688;, GO:0005615;GO:0031982;GO:0070700;GO:0005125;GO:0008083;GO:1905069;GO:0030509;GO:0048738;GO:0060411;GO:0051216;GO:0060710;GO:0003272;GO:0061384;GO:0030902;GO:0032348;GO:0008285;GO:2000065;GO:0010719;GO:1902042;GO:0043569;GO:0071676;GO:0010894;GO:0021502;GO:0001503;GO:0003344;GO:0060037;GO:0008284;GO:1900006;GO:0050679;GO:0010862;GO:0045944;GO:0001501;GO:0060395;GO:0003323;, C:extracellular space; C:vesicle;, F:BMP receptor binding; F:cytokine activity; F:growth factor activity;, P:allantois development; P:BMP signaling pathway; P:cardiac muscle tissue development; P:cardiac septum morphogenesis; P:cartilage development; P:chorio-allantoic fusion; P:endocardial cushion formation; P:heart trabecula morphogenesis; P:hindbrain development; P:negative regulation of aldosterone biosynthetic process; P:negative regulation of cell population proliferation; P:negative regulation of cortisol biosynthetic process; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of insulin-like growth factor receptor signaling pathway; P:negative regulation of mononuclear cell migration; P:negative regulation of steroid biosynthetic process; P:neural fold elevation formation; P:ossification; P:pericardium morphogenesis; P:pharyngeal system development; P:positive regulation of cell population proliferation; P:positive regulation of dendrite development; P:positive regulation of epithelial cell proliferation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:skeletal system development; P:SMAD protein signal transduction; P:type B pancreatic cell development; scaffold81 indexed_genome mRNA 4361370 4548668 . + . ID=transcript_11998;Q8TB92 B1AQ42 B3KNV0 B7Z1S7 F8W793 Q6ZSA9,3-hydroxy-3-methylglutaryl-CoA lyase, cytoplasmic,3-hydroxy-3-methylglutaryl-CoA lyase-like protein 1;Endoplasmic reticulum 3-hydroxy-3-methylglutaryl-CoA lyase {ECO:0000303|PubMed:22847177};, PF00682;, GO:0005829;GO:0005783;GO:0005789;GO:0016020;GO:0048471;GO:0004419;GO:0046872;GO:0046951;GO:0006552;GO:0006629;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:perinuclear region of cytoplasm;, F:hydroxymethylglutaryl-CoA lyase activity; F:metal ion binding;, P:ketone body biosynthetic process; P:leucine catabolic process; P:lipid metabolic process; scaffold81 indexed_genome mRNA 4575189 4575909 . + . ID=transcript_11999;Q6UXV0 Q5VTF6,GDNF family receptor alpha-like {ECO:0000305},, PF02351;, GO:0009897;GO:0016021;GO:0043235;GO:0016167;GO:0030971;GO:0038023;GO:0000187;GO:0035860;GO:2001240;GO:0043524;GO:0007399;GO:0043410;GO:0051897;GO:0002023;GO:0031098;, C:external side of plasma membrane; C:integral component of membrane; C:receptor complex;, F:glial cell-derived neurotrophic factor receptor activity; F:receptor tyrosine kinase binding; F:signaling receptor activity;, P:activation of MAPK activity; P:glial cell-derived neurotrophic factor receptor signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of neuron apoptotic process; P:nervous system development; P:positive regulation of MAPK cascade; P:positive regulation of protein kinase B signaling; P:reduction of food intake in response to dietary excess; P:stress-activated protein kinase signaling cascade; scaffold81 indexed_genome mRNA 5689924 5840844 . - . ID=transcript_12000;Q5VWP3 B7Z2N0 D6RE05 Q96H08 Q96NF7,Muscular LMNA-interacting protein {ECO:0000312|HGNC:HGNC:21355},Cardiac Isl1-interacting protein {ECO:0000303|PubMed:26436652};Muscular-enriched A-type laminin-interacting protein;, PF15274;, GO:0005635;GO:0031981;GO:0005634;GO:0016605;GO:0042383;GO:0005521;GO:0003714;GO:0010614;GO:1903243;GO:0000122;GO:0045944;, C:nuclear envelope; C:nuclear lumen; C:nucleus; C:PML body; C:sarcolemma;, F:lamin binding; F:transcription corepressor activity;, P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II;|Q5VWP3 B7Z2N0 D6RE05 Q96H08 Q96NF7,Muscular LMNA-interacting protein {ECO:0000312|HGNC:HGNC:21355},Cardiac Isl1-interacting protein {ECO:0000303|PubMed:26436652};Muscular-enriched A-type laminin-interacting protein;, PF15274;, GO:0005635;GO:0031981;GO:0005634;GO:0016605;GO:0042383;GO:0005521;GO:0003714;GO:0010614;GO:1903243;GO:0000122;GO:0045944;, C:nuclear envelope; C:nuclear lumen; C:nucleus; C:PML body; C:sarcolemma;, F:lamin binding; F:transcription corepressor activity;, P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; scaffold81 indexed_genome mRNA 6056755 6075735 . - . ID=transcript_12001;Q9BTT6 Q5TGN3 Q9HAC0 Q9NVF1,Leucine-rich repeat-containing protein 1,LANO adapter protein;LAP and no PDZ protein;, PF13855;, GO:0005829;GO:0016020;, C:cytosol; C:membrane;|Q9BTT6 Q5TGN3 Q9HAC0 Q9NVF1,Leucine-rich repeat-containing protein 1,LANO adapter protein;LAP and no PDZ protein;, PF13855;, GO:0005829;GO:0016020;, C:cytosol; C:membrane; scaffold81 indexed_genome mRNA 6076500 6085775 . - . ID=transcript_12002;Q9BTT6 Q5TGN3 Q9HAC0 Q9NVF1,Leucine-rich repeat-containing protein 1,LANO adapter protein;LAP and no PDZ protein;, PF13855;, GO:0005829;GO:0016020;, C:cytosol; C:membrane; scaffold81 indexed_genome mRNA 6286547 6310241 . + . ID=transcript_12003;Q9H511 A6N9J2 B2RP49,Kelch-like protein 31,BTB and kelch domain-containing protein 6;Kelch repeat and BTB domain-containing protein 1;Kelch-like protein KLHL;, PF07707;PF00651;PF01344;, GO:0005737;GO:0005634;GO:0046329;GO:0001933;, C:cytoplasm; C:nucleus;, , P:negative regulation of JNK cascade; P:negative regulation of protein phosphorylation;|Q9H511 A6N9J2 B2RP49,Kelch-like protein 31,BTB and kelch domain-containing protein 6;Kelch repeat and BTB domain-containing protein 1;Kelch-like protein KLHL;, PF07707;PF00651;PF01344;, GO:0005737;GO:0005634;GO:0046329;GO:0001933;, C:cytoplasm; C:nucleus;, , P:negative regulation of JNK cascade; P:negative regulation of protein phosphorylation; scaffold81 indexed_genome mRNA 6475818 6479876 . + . ID=transcript_12004;P48506 Q14399,Glutamate--cysteine ligase catalytic subunit,GCS heavy chain;Gamma-ECS;Gamma-glutamylcysteine synthetase;, PF03074;, GO:0005829;GO:0017109;GO:0043531;GO:0005524;GO:0016595;GO:0004357;GO:0000287;GO:0097746;GO:0045454;GO:0006534;GO:0006536;GO:0006750;GO:0043066;GO:0045892;GO:0009408;GO:0009725;GO:0006979;, C:cytosol; C:glutamate-cysteine ligase complex;, F:ADP binding; F:ATP binding; F:glutamate binding; F:glutamate-cysteine ligase activity; F:magnesium ion binding;, P:blood vessel diameter maintenance; P:cell redox homeostasis; P:cysteine metabolic process; P:glutamate metabolic process; P:glutathione biosynthetic process; P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:response to heat; P:response to hormone; P:response to oxidative stress; scaffold81 indexed_genome mRNA 6481669 6488953 . + . ID=transcript_12005;P48506 Q14399,Glutamate--cysteine ligase catalytic subunit,GCS heavy chain;Gamma-ECS;Gamma-glutamylcysteine synthetase;, PF03074;, GO:0005829;GO:0017109;GO:0043531;GO:0005524;GO:0016595;GO:0004357;GO:0000287;GO:0097746;GO:0045454;GO:0006534;GO:0006536;GO:0006750;GO:0043066;GO:0045892;GO:0009408;GO:0009725;GO:0006979;, C:cytosol; C:glutamate-cysteine ligase complex;, F:ADP binding; F:ATP binding; F:glutamate binding; F:glutamate-cysteine ligase activity; F:magnesium ion binding;, P:blood vessel diameter maintenance; P:cell redox homeostasis; P:cysteine metabolic process; P:glutamate metabolic process; P:glutathione biosynthetic process; P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:response to heat; P:response to hormone; P:response to oxidative stress;|P48506 Q14399,Glutamate--cysteine ligase catalytic subunit,GCS heavy chain;Gamma-ECS;Gamma-glutamylcysteine synthetase;, PF03074;, GO:0005829;GO:0017109;GO:0043531;GO:0005524;GO:0016595;GO:0004357;GO:0000287;GO:0097746;GO:0045454;GO:0006534;GO:0006536;GO:0006750;GO:0043066;GO:0045892;GO:0009408;GO:0009725;GO:0006979;, C:cytosol; C:glutamate-cysteine ligase complex;, F:ADP binding; F:ATP binding; F:glutamate binding; F:glutamate-cysteine ligase activity; F:magnesium ion binding;, P:blood vessel diameter maintenance; P:cell redox homeostasis; P:cysteine metabolic process; P:glutamate metabolic process; P:glutathione biosynthetic process; P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:response to heat; P:response to hormone; P:response to oxidative stress; scaffold81 indexed_genome mRNA 6557066 6567258 . - . ID=transcript_12006;Q9MYH2 Q9TPA9 Q9XRY6 Q9XRY7 Q9XRZ2,HLA class II histocompatibility antigen, DQ beta 1 chain,MHC class II antigen DQB1;, PF07654;PF00969;, GO:0030669;GO:0030666;GO:0010008;GO:0012507;GO:0000139;GO:0071556;GO:0005765;GO:0016020;GO:0042613;GO:0005886;GO:0032588;GO:0030658;GO:0032395;GO:0042605;GO:0002250;GO:0019886;GO:0006959;GO:0006955;GO:0060333;GO:0050852;, C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:endosome membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:lysosomal membrane; C:membrane; C:MHC class II protein complex; C:plasma membrane; C:trans-Golgi network membrane; C:transport vesicle membrane;, F:MHC class II receptor activity; F:peptide antigen binding;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:humoral immune response; P:immune response; P:interferon-gamma-mediated signaling pathway; P:T cell receptor signaling pathway;|P05538 A6NIA5 Q29826 Q29870 Q29871 Q29872 Q29873 Q5SR06,HLA class II histocompatibility antigen, DQ beta 2 chain,HLA class II histocompatibility antigen, DX beta chain;MHC class II antigen DQB2;, PF07654;PF00969;, GO:0030669;GO:0030666;GO:0010008;GO:0012507;GO:0000139;GO:0071556;GO:0005765;GO:0042613;GO:0005886;GO:0032588;GO:0030658;GO:0032395;GO:0002250;GO:0019886;GO:0006955;GO:0060333;GO:0050852;, C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:endosome membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:lysosomal membrane; C:MHC class II protein complex; C:plasma membrane; C:trans-Golgi network membrane; C:transport vesicle membrane;, F:MHC class II receptor activity;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:immune response; P:interferon-gamma-mediated signaling pathway; P:T cell receptor signaling pathway;|P05538 A6NIA5 Q29826 Q29870 Q29871 Q29872 Q29873 Q5SR06,HLA class II histocompatibility antigen, DQ beta 2 chain,HLA class II histocompatibility antigen, DX beta chain;MHC class II antigen DQB2;, PF07654;PF00969;, GO:0030669;GO:0030666;GO:0010008;GO:0012507;GO:0000139;GO:0071556;GO:0005765;GO:0042613;GO:0005886;GO:0032588;GO:0030658;GO:0032395;GO:0002250;GO:0019886;GO:0006955;GO:0060333;GO:0050852;, C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:endosome membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:lysosomal membrane; C:MHC class II protein complex; C:plasma membrane; C:trans-Golgi network membrane; C:transport vesicle membrane;, F:MHC class II receptor activity;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:immune response; P:interferon-gamma-mediated signaling pathway; P:T cell receptor signaling pathway;|Q9MYH2 Q9TPA9 Q9XRY6 Q9XRY7 Q9XRZ2,HLA class II histocompatibility antigen, DQ beta 1 chain,MHC class II antigen DQB1;, PF07654;PF00969;, GO:0030669;GO:0030666;GO:0010008;GO:0012507;GO:0000139;GO:0071556;GO:0005765;GO:0016020;GO:0042613;GO:0005886;GO:0032588;GO:0030658;GO:0032395;GO:0042605;GO:0002250;GO:0019886;GO:0006959;GO:0006955;GO:0060333;GO:0050852;, C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle membrane; C:endosome membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:lysosomal membrane; C:membrane; C:MHC class II protein complex; C:plasma membrane; C:trans-Golgi network membrane; C:transport vesicle membrane;, F:MHC class II receptor activity; F:peptide antigen binding;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:humoral immune response; P:immune response; P:interferon-gamma-mediated signaling pathway; P:T cell receptor signaling pathway; scaffold81 indexed_genome mRNA 6574621 6583335 . - . ID=transcript_12007;P13765 B0V0Y0 Q29746 Q29825 Q6FHC2,HLA class II histocompatibility antigen, DO beta chain,MHC class II antigen DOB;, PF07654;PF00969;, GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042613;GO:0023026;GO:0032395;GO:0002250;GO:0019886;GO:0002587;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome; C:MHC class II protein complex;, F:MHC class II protein complex binding; F:MHC class II receptor activity;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:negative regulation of antigen processing and presentation of peptide antigen via MHC class II; scaffold81 indexed_genome mRNA 6595602 6603689 . - . ID=transcript_12008;Q03519 B0V2J8 O95410 Q53FI6 Q5HY71 Q96PT8 Q9UQ83,Antigen peptide transporter 2,ATP-binding cassette sub-family B member 3;Peptide supply factor 2 {ECO:0000303|PubMed:1946428};Peptide transporter PSF2;Peptide transporter TAP2;Peptide transporter involved in antigen processing 2;Really interesting new gene 11 protein;, PF00664;PF00005;, GO:0005783;GO:0005789;GO:0033116;GO:0030176;GO:0016021;GO:0016020;GO:0042824;GO:0016607;GO:0030670;GO:0042825;GO:0015433;GO:0015440;GO:0005524;GO:0016887;GO:0042626;GO:0046872;GO:0023029;GO:0042605;GO:0046978;GO:0046980;GO:0002250;GO:0019885;GO:0002489;GO:0002479;GO:0002474;GO:0046967;GO:0046968;GO:0015833;GO:0015031;GO:0055085;GO:1990668;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:MHC class I peptide loading complex; C:nuclear speck; C:phagocytic vesicle membrane; C:TAP complex;, F:ABC-type peptide antigen transporter activity; F:ABC-type peptide transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:metal ion binding; F:MHC class Ib protein binding; F:peptide antigen binding; F:TAP1 binding; F:tapasin binding;, P:adaptive immune response; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cytosol to endoplasmic reticulum transport; P:peptide antigen transport; P:peptide transport; P:protein transport; P:transmembrane transport; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane; P:viral process; scaffold81 indexed_genome mRNA 6607532 6611568 . - . ID=transcript_12009;P28062 B0UZC0 Q29824 Q5JNW6 Q5QNR8 Q96J48,Proteasome subunit beta type-8,Low molecular mass protein 7;Macropain subunit C13;Multicatalytic endopeptidase complex subunit C13;Proteasome component C13;Proteasome subunit beta-5i;Really interesting new gene 10 protein;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:1990111;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0045444;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:0052548;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060337;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:spermatoproteasome complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:fat cell differentiation; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of endopeptidase activity; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:type I interferon signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P28062 B0UZC0 Q29824 Q5JNW6 Q5QNR8 Q96J48,Proteasome subunit beta type-8,Low molecular mass protein 7;Macropain subunit C13;Multicatalytic endopeptidase complex subunit C13;Proteasome component C13;Proteasome subunit beta-5i;Really interesting new gene 10 protein;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:1990111;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0045444;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:0052548;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060337;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:spermatoproteasome complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:fat cell differentiation; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of endopeptidase activity; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:type I interferon signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P28062 B0UZC0 Q29824 Q5JNW6 Q5QNR8 Q96J48,Proteasome subunit beta type-8,Low molecular mass protein 7;Macropain subunit C13;Multicatalytic endopeptidase complex subunit C13;Proteasome component C13;Proteasome subunit beta-5i;Really interesting new gene 10 protein;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:1990111;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0045444;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:0052548;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060337;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:spermatoproteasome complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:fat cell differentiation; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of endopeptidase activity; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:type I interferon signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P28062 B0UZC0 Q29824 Q5JNW6 Q5QNR8 Q96J48,Proteasome subunit beta type-8,Low molecular mass protein 7;Macropain subunit C13;Multicatalytic endopeptidase complex subunit C13;Proteasome component C13;Proteasome subunit beta-5i;Really interesting new gene 10 protein;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:1990111;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0045444;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:0052548;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060337;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:spermatoproteasome complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:fat cell differentiation; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of endopeptidase activity; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:type I interferon signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold81 indexed_genome mRNA 6612100 6627910 . - . ID=transcript_12010;Q03518 Q16149 Q96CP4,Antigen peptide transporter 1,ATP-binding cassette sub-family B member 2;Peptide supply factor 1 {ECO:0000303|PubMed:1946428};Peptide transporter PSF1;Peptide transporter TAP1;Peptide transporter involved in antigen processing 1;Really interesting new gene 4 protein;, PF00664;PF00005;, GO:0034451;GO:0005783;GO:0005789;GO:0033116;GO:0030176;GO:0016021;GO:0016020;GO:0042824;GO:0030670;GO:0042825;GO:0015433;GO:0015440;GO:0043531;GO:0005524;GO:0016887;GO:0042626;GO:0046872;GO:0042288;GO:0023029;GO:0042605;GO:1904680;GO:0042803;GO:0046978;GO:0046979;GO:0002250;GO:0019885;GO:0002479;GO:0002474;GO:0046967;GO:0006952;GO:0015833;GO:0015031;GO:0055085;GO:1990668;GO:0016032;, C:centriolar satellite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:MHC class I peptide loading complex; C:phagocytic vesicle membrane; C:TAP complex;, F:ABC-type peptide antigen transporter activity; F:ABC-type peptide transporter activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:metal ion binding; F:MHC class I protein binding; F:MHC class Ib protein binding; F:peptide antigen binding; F:peptide transmembrane transporter activity; F:protein homodimerization activity; F:TAP1 binding; F:TAP2 binding;, P:adaptive immune response; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cytosol to endoplasmic reticulum transport; P:defense response; P:peptide transport; P:protein transport; P:transmembrane transport; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane; P:viral process;|Q03518 Q16149 Q96CP4,Antigen peptide transporter 1,ATP-binding cassette sub-family B member 2;Peptide supply factor 1 {ECO:0000303|PubMed:1946428};Peptide transporter PSF1;Peptide transporter TAP1;Peptide transporter involved in antigen processing 1;Really interesting new gene 4 protein;, PF00664;PF00005;, GO:0034451;GO:0005783;GO:0005789;GO:0033116;GO:0030176;GO:0016021;GO:0016020;GO:0042824;GO:0030670;GO:0042825;GO:0015433;GO:0015440;GO:0043531;GO:0005524;GO:0016887;GO:0042626;GO:0046872;GO:0042288;GO:0023029;GO:0042605;GO:1904680;GO:0042803;GO:0046978;GO:0046979;GO:0002250;GO:0019885;GO:0002479;GO:0002474;GO:0046967;GO:0006952;GO:0015833;GO:0015031;GO:0055085;GO:1990668;GO:0016032;, C:centriolar satellite; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:MHC class I peptide loading complex; C:phagocytic vesicle membrane; C:TAP complex;, F:ABC-type peptide antigen transporter activity; F:ABC-type peptide transporter activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:metal ion binding; F:MHC class I protein binding; F:MHC class Ib protein binding; F:peptide antigen binding; F:peptide transmembrane transporter activity; F:protein homodimerization activity; F:TAP1 binding; F:TAP2 binding;, P:adaptive immune response; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:cytosol to endoplasmic reticulum transport; P:defense response; P:peptide transport; P:protein transport; P:transmembrane transport; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane; P:viral process; scaffold81 indexed_genome mRNA 6676595 6678661 . - . ID=transcript_12011;P28068 O77936 Q13012 Q29751 Q58ZE2 Q5SNZ8 Q5STC4 Q9XRX2,HLA class II histocompatibility antigen, DM beta chain,MHC class II antigen DMB;Really interesting new gene 7 protein;, PF07654;PF00969;, GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0042613;GO:0023026;GO:0002250;GO:0019886;GO:0002399;GO:0002503;GO:2001190;GO:0042102;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:MHC class II protein complex;, F:MHC class II protein complex binding;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:MHC class II protein complex assembly; P:peptide antigen assembly with MHC class II protein complex; P:positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:positive regulation of T cell proliferation; scaffold81 indexed_genome mRNA 6692781 6693412 . - . ID=transcript_12012;P28067 Q29639 Q29640,HLA class II histocompatibility antigen, DM alpha chain,MHC class II antigen DMA;Really interesting new gene 6 protein;, PF07654;PF00993;, GO:0009986;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0016020;GO:0042613;GO:0023026;GO:0002250;GO:0019886;GO:0002503;, C:cell surface; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:MHC class II protein complex;, F:MHC class II protein complex binding;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:peptide antigen assembly with MHC class II protein complex; scaffold81 indexed_genome mRNA 6694396 6698351 . - . ID=transcript_12013;P28067 Q29639 Q29640,HLA class II histocompatibility antigen, DM alpha chain,MHC class II antigen DMA;Really interesting new gene 6 protein;, PF07654;PF00993;, GO:0009986;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0016020;GO:0042613;GO:0023026;GO:0002250;GO:0019886;GO:0002503;, C:cell surface; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:MHC class II protein complex;, F:MHC class II protein complex binding;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:peptide antigen assembly with MHC class II protein complex; scaffold81 indexed_genome mRNA 6715433 6724377 . + . ID=transcript_12014;Q658Y7 Q6P3U2 Q969U4,Bromodomain-containing protein 2,O27.1.1;Really interesting new gene 3 protein;, PF17035;PF00439;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0070577;GO:0004674;GO:0001843;GO:0006334;GO:0006468;GO:0006357;GO:0007283;GO:0016032;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:lysine-acetylated histone binding; F:protein serine/threonine kinase activity;, P:neural tube closure; P:nucleosome assembly; P:protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:viral process;|Q658Y7 Q6P3U2 Q969U4,Bromodomain-containing protein 2,O27.1.1;Really interesting new gene 3 protein;, PF17035;PF00439;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0070577;GO:0004674;GO:0001843;GO:0006334;GO:0006468;GO:0006357;GO:0007283;GO:0016032;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:lysine-acetylated histone binding; F:protein serine/threonine kinase activity;, P:neural tube closure; P:nucleosome assembly; P:protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:viral process;|Q658Y7 Q6P3U2 Q969U4,Bromodomain-containing protein 2,O27.1.1;Really interesting new gene 3 protein;, PF17035;PF00439;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0070577;GO:0004674;GO:0001843;GO:0006334;GO:0006468;GO:0006357;GO:0007283;GO:0016032;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:lysine-acetylated histone binding; F:protein serine/threonine kinase activity;, P:neural tube closure; P:nucleosome assembly; P:protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:viral process;|Q658Y7 Q6P3U2 Q969U4,Bromodomain-containing protein 2,O27.1.1;Really interesting new gene 3 protein;, PF17035;PF00439;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0070577;GO:0004674;GO:0001843;GO:0006334;GO:0006468;GO:0006357;GO:0007283;GO:0016032;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:lysine-acetylated histone binding; F:protein serine/threonine kinase activity;, P:neural tube closure; P:nucleosome assembly; P:protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:viral process;|Q658Y7 Q6P3U2 Q969U4,Bromodomain-containing protein 2,O27.1.1;Really interesting new gene 3 protein;, PF17035;PF00439;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0070577;GO:0004674;GO:0001843;GO:0006334;GO:0006468;GO:0006357;GO:0007283;GO:0016032;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:lysine-acetylated histone binding; F:protein serine/threonine kinase activity;, P:neural tube closure; P:nucleosome assembly; P:protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:viral process;|Q658Y7 Q6P3U2 Q969U4,Bromodomain-containing protein 2,O27.1.1;Really interesting new gene 3 protein;, PF17035;PF00439;, GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0003682;GO:0070577;GO:0004674;GO:0001843;GO:0006334;GO:0006468;GO:0006357;GO:0007283;GO:0016032;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:lysine-acetylated histone binding; F:protein serine/threonine kinase activity;, P:neural tube closure; P:nucleosome assembly; P:protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:viral process; scaffold81 indexed_genome mRNA 6776776 6803861 . - . ID=transcript_12015;Q7Z6C3 Q99866 Q9UIP9,Collagen alpha-2(XI) chain,, PF01410;PF01391;PF02210;, GO:0005581;GO:0005592;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0046872;GO:0030674;GO:0051216;GO:0030199;GO:0030198;GO:0060021;GO:0007605;GO:0001501;GO:0060023;, C:collagen trimer; C:collagen type XI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding; F:protein-macromolecule adaptor activity;, P:cartilage development; P:collagen fibril organization; P:extracellular matrix organization; P:roof of mouth development; P:sensory perception of sound; P:skeletal system development; P:soft palate development;|Q7Z6C3 Q99866 Q9UIP9,Collagen alpha-2(XI) chain,, PF01410;PF01391;PF02210;, GO:0005581;GO:0005592;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0046872;GO:0030674;GO:0051216;GO:0030199;GO:0030198;GO:0060021;GO:0007605;GO:0001501;GO:0060023;, C:collagen trimer; C:collagen type XI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding; F:protein-macromolecule adaptor activity;, P:cartilage development; P:collagen fibril organization; P:extracellular matrix organization; P:roof of mouth development; P:sensory perception of sound; P:skeletal system development; P:soft palate development;|Q7Z6C3 Q99866 Q9UIP9,Collagen alpha-2(XI) chain,, PF01410;PF01391;PF02210;, GO:0005581;GO:0005592;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0046872;GO:0030674;GO:0051216;GO:0030199;GO:0030198;GO:0060021;GO:0007605;GO:0001501;GO:0060023;, C:collagen trimer; C:collagen type XI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:metal ion binding; F:protein-macromolecule adaptor activity;, P:cartilage development; P:collagen fibril organization; P:extracellular matrix organization; P:roof of mouth development; P:sensory perception of sound; P:skeletal system development; P:soft palate development; scaffold81 indexed_genome mRNA 6808157 6813647 . + . ID=transcript_12016;P28702 P28703 Q59G65 Q5JP92 Q5STQ1,Retinoic acid receptor RXR-beta,Nuclear receptor subfamily 2 group B member 2;Retinoid X receptor beta;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0090575;GO:0001228;GO:0000981;GO:0004879;GO:0044323;GO:0000978;GO:0000977;GO:1990837;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0030522;GO:0045944;GO:0045893;GO:0006357;GO:0032526;GO:0048384;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:intracellular receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter;|P28702 P28703 Q59G65 Q5JP92 Q5STQ1,Retinoic acid receptor RXR-beta,Nuclear receptor subfamily 2 group B member 2;Retinoid X receptor beta;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0090575;GO:0001228;GO:0000981;GO:0004879;GO:0044323;GO:0000978;GO:0000977;GO:1990837;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0030522;GO:0045944;GO:0045893;GO:0006357;GO:0032526;GO:0048384;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:intracellular receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter;|P28702 P28703 Q59G65 Q5JP92 Q5STQ1,Retinoic acid receptor RXR-beta,Nuclear receptor subfamily 2 group B member 2;Retinoid X receptor beta;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0090575;GO:0001228;GO:0000981;GO:0004879;GO:0044323;GO:0000978;GO:0000977;GO:1990837;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0030522;GO:0045944;GO:0045893;GO:0006357;GO:0032526;GO:0048384;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:intracellular receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter;|P19793 B3KY83 Q2NL52 Q2V504,Retinoic acid receptor RXR-alpha,Nuclear receptor subfamily 2 group B member 1;Retinoid X receptor alpha;, PF00104;PF11825;PF00105;, GO:0000785;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043235;GO:0090575;GO:0050692;GO:0003700;GO:0000981;GO:0003690;GO:0019899;GO:0042802;GO:0050693;GO:0004879;GO:0016922;GO:0042277;GO:0001972;GO:0044323;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0003707;GO:0000976;GO:0042809;GO:0008270;GO:0048856;GO:0015721;GO:0030154;GO:0008203;GO:0030851;GO:0030522;GO:0019048;GO:0000122;GO:0035357;GO:0045944;GO:0045893;GO:0019216;GO:0006357;GO:0032526;GO:0048384;GO:0006367;, C:chromatin; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding domain binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:enzyme binding; F:identical protein binding; F:LBD domain binding; F:nuclear receptor activity; F:nuclear receptor binding; F:peptide binding; F:retinoic acid binding; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription regulatory region sequence-specific DNA binding; F:vitamin D receptor binding; F:zinc ion binding;, P:anatomical structure development; P:bile acid and bile salt transport; P:cell differentiation; P:cholesterol metabolic process; P:granulocyte differentiation; P:intracellular receptor signaling pathway; P:modulation by virus of host process; P:negative regulation of transcription by RNA polymerase II; P:peroxisome proliferator activated receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter;|P28702 P28703 Q59G65 Q5JP92 Q5STQ1,Retinoic acid receptor RXR-beta,Nuclear receptor subfamily 2 group B member 2;Retinoid X receptor beta;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0090575;GO:0001228;GO:0000981;GO:0004879;GO:0044323;GO:0000978;GO:0000977;GO:1990837;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0030522;GO:0045944;GO:0045893;GO:0006357;GO:0032526;GO:0048384;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:intracellular receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; scaffold81 indexed_genome mRNA 6813759 6817605 . - . ID=transcript_12017;Q92504 B0UXF6 Q5STP8 Q9UIQ0,Zinc transporter SLC39A7,Histidine-rich membrane protein Ke4;Really interesting new gene 5 protein;Solute carrier family 39 member 7;Zrt-, Irt-like protein 7;, PF02535;, GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0016020;GO:0005654;GO:0005385;GO:0006882;GO:0071577;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:nucleoplasm;, F:zinc ion transmembrane transporter activity;, P:cellular zinc ion homeostasis; P:zinc ion transmembrane transport; scaffold81 indexed_genome mRNA 6822816 6823868 . + . ID=transcript_12018;Q92506 A6NLX7 Q5STP7 Q9UIQ1,Estradiol 17-beta-dehydrogenase 8,17-beta-hydroxysteroid dehydrogenase 8 {ECO:0000303|PubMed:17978863};3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit {ECO:0000303|PubMed:25203508};3-oxoacyl-[acyl-carrier-protein] reductase;Protein Ke6;Really interesting new gene 2 protein;Short chain dehydrogenase/reductase family 30C member 1;Testosterone 17-beta-dehydrogenase 8;, , GO:0005740;GO:0005759;GO:0005886;GO:0044594;GO:0072582;GO:0003857;GO:0047025;GO:0004303;GO:0070404;GO:0016616;GO:0048038;GO:0047035;GO:0008209;GO:0006703;GO:0006633;GO:0046949;GO:0051290;, C:mitochondrial envelope; C:mitochondrial matrix; C:plasma membrane;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:3-hydroxyacyl-CoA dehydrogenase activity; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity; F:estradiol 17-beta-dehydrogenase activity; F:NADH binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:quinone binding; F:testosterone dehydrogenase (NAD+) activity;, P:androgen metabolic process; P:estrogen biosynthetic process; P:fatty acid biosynthetic process; P:fatty-acyl-CoA biosynthetic process; P:protein heterotetramerization; scaffold81 indexed_genome mRNA 6827489 6828599 . - . ID=transcript_12019;Q06587 A8JZZ0 Q5JP96 Q5SQW2 Q86V19,E3 ubiquitin-protein ligase RING1,Polycomb complex protein RING1;RING finger protein 1;RING-type E3 ubiquitin transferase RING1 {ECO:0000305};Really interesting new gene 1 protein;, PF16207;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0001739;GO:0000151;GO:0003682;GO:0046872;GO:0061630;GO:0097027;GO:0009952;GO:0048593;GO:0035518;GO:0070317;GO:0045892;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:sex chromatin; C:ubiquitin ligase complex;, F:chromatin binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activator activity;, P:anterior/posterior pattern specification; P:camera-type eye morphogenesis; P:histone H2A monoubiquitination; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated; scaffold81 indexed_genome mRNA 6828672 6829967 . + . ID=transcript_12020;Q06587 A8JZZ0 Q5JP96 Q5SQW2 Q86V19,E3 ubiquitin-protein ligase RING1,Polycomb complex protein RING1;RING finger protein 1;RING-type E3 ubiquitin transferase RING1 {ECO:0000305};Really interesting new gene 1 protein;, PF16207;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0001739;GO:0000151;GO:0003682;GO:0046872;GO:0061630;GO:0097027;GO:0009952;GO:0048593;GO:0035518;GO:0070317;GO:0045892;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:sex chromatin; C:ubiquitin ligase complex;, F:chromatin binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activator activity;, P:anterior/posterior pattern specification; P:camera-type eye morphogenesis; P:histone H2A monoubiquitination; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated; scaffold81 indexed_genome mRNA 6855661 6856167 . - . ID=transcript_12021;Q8N1B4 A2BF38 B0UZZ4 B4DNI9 Q53GR4 Q5JPA0 Q5SQW1 Q8IUN6 Q9NPT5,Vacuolar protein sorting-associated protein 52 homolog,SAC2 suppressor of actin mutations 2-like protein;, PF04129;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0019905;GO:0010668;GO:0048611;GO:0032456;GO:0006896;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, F:syntaxin binding;, P:ectodermal cell differentiation; P:embryonic ectodermal digestive tract development; P:endocytic recycling; P:Golgi to vacuole transport; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi; scaffold81 indexed_genome mRNA 6864762 6870724 . - . ID=transcript_12022;Q8N1B4 A2BF38 B0UZZ4 B4DNI9 Q53GR4 Q5JPA0 Q5SQW1 Q8IUN6 Q9NPT5,Vacuolar protein sorting-associated protein 52 homolog,SAC2 suppressor of actin mutations 2-like protein;, PF04129;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0019905;GO:0010668;GO:0048611;GO:0032456;GO:0006896;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, F:syntaxin binding;, P:ectodermal cell differentiation; P:embryonic ectodermal digestive tract development; P:endocytic recycling; P:Golgi to vacuole transport; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q8N1B4 A2BF38 B0UZZ4 B4DNI9 Q53GR4 Q5JPA0 Q5SQW1 Q8IUN6 Q9NPT5,Vacuolar protein sorting-associated protein 52 homolog,SAC2 suppressor of actin mutations 2-like protein;, PF04129;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0019905;GO:0010668;GO:0048611;GO:0032456;GO:0006896;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, F:syntaxin binding;, P:ectodermal cell differentiation; P:embryonic ectodermal digestive tract development; P:endocytic recycling; P:Golgi to vacuole transport; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q8N1B4 A2BF38 B0UZZ4 B4DNI9 Q53GR4 Q5JPA0 Q5SQW1 Q8IUN6 Q9NPT5,Vacuolar protein sorting-associated protein 52 homolog,SAC2 suppressor of actin mutations 2-like protein;, PF04129;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0019905;GO:0010668;GO:0048611;GO:0032456;GO:0006896;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, F:syntaxin binding;, P:ectodermal cell differentiation; P:embryonic ectodermal digestive tract development; P:endocytic recycling; P:Golgi to vacuole transport; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q8N1B4 A2BF38 B0UZZ4 B4DNI9 Q53GR4 Q5JPA0 Q5SQW1 Q8IUN6 Q9NPT5,Vacuolar protein sorting-associated protein 52 homolog,SAC2 suppressor of actin mutations 2-like protein;, PF04129;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0019905;GO:0010668;GO:0048611;GO:0032456;GO:0006896;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, F:syntaxin binding;, P:ectodermal cell differentiation; P:embryonic ectodermal digestive tract development; P:endocytic recycling; P:Golgi to vacuole transport; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q8N1B4 A2BF38 B0UZZ4 B4DNI9 Q53GR4 Q5JPA0 Q5SQW1 Q8IUN6 Q9NPT5,Vacuolar protein sorting-associated protein 52 homolog,SAC2 suppressor of actin mutations 2-like protein;, PF04129;, GO:0005829;GO:1990745;GO:0010008;GO:0000938;GO:0005794;GO:0016020;GO:0048471;GO:0055037;GO:0032588;GO:0019905;GO:0010668;GO:0048611;GO:0032456;GO:0006896;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:endosome membrane; C:GARP complex; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:recycling endosome; C:trans-Golgi network membrane;, F:syntaxin binding;, P:ectodermal cell differentiation; P:embryonic ectodermal digestive tract development; P:endocytic recycling; P:Golgi to vacuole transport; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi; scaffold81 indexed_genome mRNA 6871787 6875082 . + . ID=transcript_12023;P62269 P25232 Q5SUJ3 Q6IPF8,40S ribosomal protein S18,Ke-3;Small ribosomal subunit protein uS13 {ECO:0000303|PubMed:24524803};, PF00416;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0014069;GO:0005840;GO:0015935;GO:0003723;GO:0019843;GO:0003735;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:postsynaptic density; C:ribosome; C:small ribosomal subunit;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold81 indexed_genome mRNA 6876074 6876699 . - . ID=transcript_12024;O96024,Beta-1,3-galactosyltransferase 4 {ECO:0000305},Gal-T2;Ganglioside galactosyltransferase;UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase;, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0047915;GO:0008499;GO:0001574;GO:0009312;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:ganglioside galactosyltransferase activity; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity;, P:ganglioside biosynthetic process; P:oligosaccharide biosynthetic process; P:protein glycosylation; scaffold81 indexed_genome mRNA 6876702 6877619 . + . ID=transcript_12025;O96024,Beta-1,3-galactosyltransferase 4 {ECO:0000305},Gal-T2;Ganglioside galactosyltransferase;UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase;, PF01762;, GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0047915;GO:0008499;GO:0001574;GO:0009312;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:ganglioside galactosyltransferase activity; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity;, P:ganglioside biosynthetic process; P:oligosaccharide biosynthetic process; P:protein glycosylation; scaffold81 indexed_genome mRNA 6877835 6879001 . - . ID=transcript_12026;O15213 A6NDP5 Q5HYZ0 Q5STK5 Q5STR3,WD repeat-containing protein 46,WD repeat-containing protein BING4;, PF08149;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0000462;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|O15213 A6NDP5 Q5HYZ0 Q5STK5 Q5STR3,WD repeat-containing protein 46,WD repeat-containing protein BING4;, PF08149;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0000462;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing; scaffold81 indexed_genome mRNA 6879021 6880513 . - . ID=transcript_12027;O15213 A6NDP5 Q5HYZ0 Q5STK5 Q5STR3,WD repeat-containing protein 46,WD repeat-containing protein BING4;, PF08149;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0000462;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing; scaffold81 indexed_genome mRNA 6884756 6887210 . - . ID=transcript_12028;O15213 A6NDP5 Q5HYZ0 Q5STK5 Q5STR3,WD repeat-containing protein 46,WD repeat-containing protein BING4;, PF08149;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0000462;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing; scaffold81 indexed_genome mRNA 6887728 6888994 . + . ID=transcript_12029;O15212,Prefoldin subunit 6,Protein Ke2;, PF01920;, GO:0005737;GO:0016272;GO:0001540;GO:0051087;GO:0051082;GO:0051131;GO:1905907;GO:0006457;, C:cytoplasm; C:prefoldin complex;, F:amyloid-beta binding; F:chaperone binding; F:unfolded protein binding;, P:chaperone-mediated protein complex assembly; P:negative regulation of amyloid fibril formation; P:protein folding;|O15212,Prefoldin subunit 6,Protein Ke2;, PF01920;, GO:0005737;GO:0016272;GO:0001540;GO:0051087;GO:0051082;GO:0051131;GO:1905907;GO:0006457;, C:cytoplasm; C:prefoldin complex;, F:amyloid-beta binding; F:chaperone binding; F:unfolded protein binding;, P:chaperone-mediated protein complex assembly; P:negative regulation of amyloid fibril formation; P:protein folding;|O15212,Prefoldin subunit 6,Protein Ke2;, PF01920;, GO:0005737;GO:0016272;GO:0001540;GO:0051087;GO:0051082;GO:0051131;GO:1905907;GO:0006457;, C:cytoplasm; C:prefoldin complex;, F:amyloid-beta binding; F:chaperone binding; F:unfolded protein binding;, P:chaperone-mediated protein complex assembly; P:negative regulation of amyloid fibril formation; P:protein folding; scaffold81 indexed_genome mRNA 6889085 6896796 . - . ID=transcript_12030;O15211 B4DG72 Q5STK0 Q9Y3F3,Ral guanine nucleotide dissociation stimulator-like 2,RalGDS-like factor;Ras-associated protein RAB2L;, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0000165;GO:0010667;GO:0014068;GO:0007265;GO:0032485;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:negative regulation of cardiac muscle cell apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:Ras protein signal transduction; P:regulation of Ral protein signal transduction;|O15211 B4DG72 Q5STK0 Q9Y3F3,Ral guanine nucleotide dissociation stimulator-like 2,RalGDS-like factor;Ras-associated protein RAB2L;, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0000165;GO:0010667;GO:0014068;GO:0007265;GO:0032485;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:negative regulation of cardiac muscle cell apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:Ras protein signal transduction; P:regulation of Ral protein signal transduction;|O15211 B4DG72 Q5STK0 Q9Y3F3,Ral guanine nucleotide dissociation stimulator-like 2,RalGDS-like factor;Ras-associated protein RAB2L;, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0000165;GO:0010667;GO:0014068;GO:0007265;GO:0032485;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:negative regulation of cardiac muscle cell apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:Ras protein signal transduction; P:regulation of Ral protein signal transduction;|O15211 B4DG72 Q5STK0 Q9Y3F3,Ral guanine nucleotide dissociation stimulator-like 2,RalGDS-like factor;Ras-associated protein RAB2L;, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0000165;GO:0010667;GO:0014068;GO:0007265;GO:0032485;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:negative regulation of cardiac muscle cell apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:Ras protein signal transduction; P:regulation of Ral protein signal transduction;|O15211 B4DG72 Q5STK0 Q9Y3F3,Ral guanine nucleotide dissociation stimulator-like 2,RalGDS-like factor;Ras-associated protein RAB2L;, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0000165;GO:0010667;GO:0014068;GO:0007265;GO:0032485;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:negative regulation of cardiac muscle cell apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:Ras protein signal transduction; P:regulation of Ral protein signal transduction;|O15211 B4DG72 Q5STK0 Q9Y3F3,Ral guanine nucleotide dissociation stimulator-like 2,RalGDS-like factor;Ras-associated protein RAB2L;, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0000165;GO:0010667;GO:0014068;GO:0007265;GO:0032485;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:negative regulation of cardiac muscle cell apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:Ras protein signal transduction; P:regulation of Ral protein signal transduction; scaffold81 indexed_genome mRNA 6896842 6910264 . - . ID=transcript_12031;Q9UIZ6 Q9Y6K2,Tapasin {ECO:0000303|PubMed:12582157},NGS-17;TAP-associated protein;TAP-binding protein;, PF07654;, GO:0005783;GO:0005789;GO:0033116;GO:0000139;GO:0071556;GO:0016021;GO:0042824;GO:0030670;GO:0015433;GO:0042288;GO:0042605;GO:0062061;GO:0046978;GO:0046979;GO:0051082;GO:0019885;GO:0002479;GO:0002474;GO:0006955;GO:0002398;GO:0050823;GO:0065003;GO:0010468;GO:0061635;GO:0006890;GO:1990668;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of membrane; C:MHC class I peptide loading complex; C:phagocytic vesicle membrane;, F:ABC-type peptide antigen transporter activity; F:MHC class I protein binding; F:peptide antigen binding; F:TAP complex binding; F:TAP1 binding; F:TAP2 binding; F:unfolded protein binding;, P:antigen processing and presentation of endogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:immune response; P:MHC class Ib protein complex assembly; P:peptide antigen stabilization; P:protein-containing complex assembly; P:regulation of gene expression; P:regulation of protein complex stability; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane; scaffold81 indexed_genome mRNA 6910299 6913168 . + . ID=transcript_12032;O15209 B0V007 Q5HYV4 Q5STL0 Q5STR7 Q8WV82,Zinc finger and BTB domain-containing protein 22,Protein BING1;Zinc finger and BTB domain-containing protein 22A;Zinc finger protein 297;, PF00651;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0006357;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|O15209 B0V007 Q5HYV4 Q5STL0 Q5STR7 Q8WV82,Zinc finger and BTB domain-containing protein 22,Protein BING1;Zinc finger and BTB domain-containing protein 22A;Zinc finger protein 297;, PF00651;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0006357;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold81 indexed_genome mRNA 6913775 6919016 . - . ID=transcript_12033;Q9BWI3,Death domain-associated protein 6,Daxx;ETS1-associated protein 1;Fas death domain-associated protein;, PF03344;, GO:0000775;GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0016605;GO:0050681;GO:0019899;GO:0031072;GO:0042393;GO:0002039;GO:0042803;GO:0030295;GO:0019901;GO:0047485;GO:0140037;GO:0003713;GO:0003714;GO:0008134;GO:0140416;GO:0031625;GO:0007257;GO:0030521;GO:0071276;GO:0071280;GO:0072738;GO:0034605;GO:1903936;GO:0034620;GO:0006338;GO:0008625;GO:0048239;GO:0045892;GO:0006334;GO:1900051;GO:1901216;GO:0045860;GO:0001934;GO:0042981;GO:0031396;GO:1901796;GO:0006355;GO:0019058;, C:chromosome, centromeric region; C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus; C:PML body;, F:androgen receptor binding; F:enzyme binding; F:heat shock protein binding; F:histone binding; F:p53 binding; F:protein homodimerization activity; F:protein kinase activator activity; F:protein kinase binding; F:protein N-terminus binding; F:sumo-dependent protein binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulator inhibitor activity; F:ubiquitin protein ligase binding;, P:activation of JUN kinase activity; P:androgen receptor signaling pathway; P:cellular response to cadmium ion; P:cellular response to copper ion; P:cellular response to diamide; P:cellular response to heat; P:cellular response to sodium arsenite; P:cellular response to unfolded protein; P:chromatin remodeling; P:extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of DNA recombination at telomere; P:negative regulation of transcription, DNA-templated; P:nucleosome assembly; P:positive regulation of histone exchange; P:positive regulation of neuron death; P:positive regulation of protein kinase activity; P:positive regulation of protein phosphorylation; P:regulation of apoptotic process; P:regulation of protein ubiquitination; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:viral life cycle; scaffold81 indexed_genome mRNA 6987054 6998157 . + . ID=transcript_12034;Q9BW19 O60887 Q14834 Q4KMP0 Q5SU09 Q6GMS7 Q6P4A5 Q9UQP7,Kinesin-like protein KIFC1,Kinesin-like protein 2;Kinesin-related protein HSET;, PF00225;, GO:0005769;GO:0005871;GO:0016020;GO:0005874;GO:0005815;GO:0072686;GO:0005634;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0051301;GO:0007018;GO:0007080;GO:0000070;GO:0090307;GO:0007283;, C:early endosome; C:kinesin complex; C:membrane; C:microtubule; C:microtubule organizing center; C:mitotic spindle; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:cell division; P:microtubule-based movement; P:mitotic metaphase plate congression; P:mitotic sister chromatid segregation; P:mitotic spindle assembly; P:spermatogenesis; scaffold81 indexed_genome mRNA 7002248 7003364 . - . ID=transcript_12035;O43189 B1AZX2 B1AZX3 O60929 Q5SU07 Q5SU08 Q96KM7,PHD finger protein 1,Polycomb-like protein 1;, PF14061;PF00628;PF18104;, GO:0005737;GO:0005815;GO:0005654;GO:0005634;GO:0035861;GO:0003682;GO:0003677;GO:1990226;GO:0042802;GO:0046872;GO:0035064;GO:0001226;GO:0006974;GO:0006325;GO:0045814;GO:0061086;GO:0061087;GO:0006355;, C:cytoplasm; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:chromatin binding; F:DNA binding; F:histone methyltransferase binding; F:identical protein binding; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:positive regulation of histone H3-K27 methylation; P:regulation of transcription, DNA-templated; scaffold81 indexed_genome mRNA 7003693 7004530 . + . ID=transcript_12036;O43189 B1AZX2 B1AZX3 O60929 Q5SU07 Q5SU08 Q96KM7,PHD finger protein 1,Polycomb-like protein 1;, PF14061;PF00628;PF18104;, GO:0005737;GO:0005815;GO:0005654;GO:0005634;GO:0035861;GO:0003682;GO:0003677;GO:1990226;GO:0042802;GO:0046872;GO:0035064;GO:0001226;GO:0006974;GO:0006325;GO:0045814;GO:0061086;GO:0061087;GO:0006355;, C:cytoplasm; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:chromatin binding; F:DNA binding; F:histone methyltransferase binding; F:identical protein binding; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:positive regulation of histone H3-K27 methylation; P:regulation of transcription, DNA-templated; scaffold81 indexed_genome mRNA 7004991 7005976 . + . ID=transcript_12037;O43189 B1AZX2 B1AZX3 O60929 Q5SU07 Q5SU08 Q96KM7,PHD finger protein 1,Polycomb-like protein 1;, PF14061;PF00628;PF18104;, GO:0005737;GO:0005815;GO:0005654;GO:0005634;GO:0035861;GO:0003682;GO:0003677;GO:1990226;GO:0042802;GO:0046872;GO:0035064;GO:0001226;GO:0006974;GO:0006325;GO:0045814;GO:0061086;GO:0061087;GO:0006355;, C:cytoplasm; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:chromatin binding; F:DNA binding; F:histone methyltransferase binding; F:identical protein binding; F:metal ion binding; F:methylated histone binding; F:RNA polymerase II transcription corepressor binding;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K27 methylation; P:positive regulation of histone H3-K27 methylation; P:regulation of transcription, DNA-templated; scaffold81 indexed_genome mRNA 7006646 7007657 . - . ID=transcript_12038;O60888 A2AB26 A2BEL4 Q3B784 Q5JXM9 Q5SU05 Q9NYQ9,Protein CutA,Acetylcholinesterase-associated protein;Brain acetylcholinesterase putative membrane anchor;, PF03091;, GO:0070062;GO:0016020;GO:0005507;GO:0019899;GO:0008104;GO:0010038;, C:extracellular exosome; C:membrane;, F:copper ion binding; F:enzyme binding;, P:protein localization; P:response to metal ion;|O60888 A2AB26 A2BEL4 Q3B784 Q5JXM9 Q5SU05 Q9NYQ9,Protein CutA,Acetylcholinesterase-associated protein;Brain acetylcholinesterase putative membrane anchor;, PF03091;, GO:0070062;GO:0016020;GO:0005507;GO:0019899;GO:0008104;GO:0010038;, C:extracellular exosome; C:membrane;, F:copper ion binding; F:enzyme binding;, P:protein localization; P:response to metal ion; scaffold82 indexed_genome mRNA 10497 12341 . + . ID=transcript_12039;Q6PCT2 A8MT10 Q8N789 Q9NT14,F-box/LRR-repeat protein 19,F-box and leucine-rich repeat protein 19;, PF00646;PF16866;PF02008;, GO:0005829;GO:0019005;GO:0032452;GO:0003712;GO:0045322;GO:0008270;GO:0043687;GO:0043161;GO:0006482;GO:0000209;GO:0006357;, C:cytosol; C:SCF ubiquitin ligase complex;, F:histone demethylase activity; F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein demethylation; P:protein polyubiquitination; P:regulation of transcription by RNA polymerase II; scaffold82 indexed_genome mRNA 72138 87932 . + . ID=transcript_12040;Q6PCT2 A8MT10 Q8N789 Q9NT14,F-box/LRR-repeat protein 19,F-box and leucine-rich repeat protein 19;, PF00646;PF16866;PF02008;, GO:0005829;GO:0019005;GO:0032452;GO:0003712;GO:0045322;GO:0008270;GO:0043687;GO:0043161;GO:0006482;GO:0000209;GO:0006357;, C:cytosol; C:SCF ubiquitin ligase complex;, F:histone demethylase activity; F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein demethylation; P:protein polyubiquitination; P:regulation of transcription by RNA polymerase II;|Q6PCT2 A8MT10 Q8N789 Q9NT14,F-box/LRR-repeat protein 19,F-box and leucine-rich repeat protein 19;, PF00646;PF16866;PF02008;, GO:0005829;GO:0019005;GO:0032452;GO:0003712;GO:0045322;GO:0008270;GO:0043687;GO:0043161;GO:0006482;GO:0000209;GO:0006357;, C:cytosol; C:SCF ubiquitin ligase complex;, F:histone demethylase activity; F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein demethylation; P:protein polyubiquitination; P:regulation of transcription by RNA polymerase II;|Q6PCT2 A8MT10 Q8N789 Q9NT14,F-box/LRR-repeat protein 19,F-box and leucine-rich repeat protein 19;, PF00646;PF16866;PF02008;, GO:0005829;GO:0019005;GO:0032452;GO:0003712;GO:0045322;GO:0008270;GO:0043687;GO:0043161;GO:0006482;GO:0000209;GO:0006357;, C:cytosol; C:SCF ubiquitin ligase complex;, F:histone demethylase activity; F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein demethylation; P:protein polyubiquitination; P:regulation of transcription by RNA polymerase II;|Q6PCT2 A8MT10 Q8N789 Q9NT14,F-box/LRR-repeat protein 19,F-box and leucine-rich repeat protein 19;, PF00646;PF16866;PF02008;, GO:0005829;GO:0019005;GO:0032452;GO:0003712;GO:0045322;GO:0008270;GO:0043687;GO:0043161;GO:0006482;GO:0000209;GO:0006357;, C:cytosol; C:SCF ubiquitin ligase complex;, F:histone demethylase activity; F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein demethylation; P:protein polyubiquitination; P:regulation of transcription by RNA polymerase II; scaffold82 indexed_genome mRNA 89876 94558 . + . ID=transcript_12041;Q9BRQ5 Q96BI8,Protein orai-3,Transmembrane protein 142C;, PF07856;, GO:0016021;GO:0016020;GO:0005886;GO:0015279;GO:0002115;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:store-operated calcium channel activity;, P:store-operated calcium entry; scaffold82 indexed_genome mRNA 97338 104470 . + . ID=transcript_12042;O15047 A6NP62 Q6PIF3 Q8TAJ6,Histone-lysine N-methyltransferase SETD1A,Lysine N-methyltransferase 2F;SET domain-containing protein 1A;Set1/Ash2 histone methyltransferase complex subunit SET1;, PF11764;PF00076;PF00856;, GO:0000785;GO:0035097;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0042800;GO:0003723;GO:0008134;GO:0007420;GO:0044648;GO:0097692;GO:0080182;GO:1902275;GO:1902036;GO:0045652;, C:chromatin; C:histone methyltransferase complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:histone methyltransferase activity (H3-K4 specific); F:RNA binding; F:transcription factor binding;, P:brain development; P:histone H3-K4 dimethylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:regulation of chromatin organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of megakaryocyte differentiation;|O15047 A6NP62 Q6PIF3 Q8TAJ6,Histone-lysine N-methyltransferase SETD1A,Lysine N-methyltransferase 2F;SET domain-containing protein 1A;Set1/Ash2 histone methyltransferase complex subunit SET1;, PF11764;PF00076;PF00856;, GO:0000785;GO:0035097;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0042800;GO:0003723;GO:0008134;GO:0007420;GO:0044648;GO:0097692;GO:0080182;GO:1902275;GO:1902036;GO:0045652;, C:chromatin; C:histone methyltransferase complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:histone methyltransferase activity (H3-K4 specific); F:RNA binding; F:transcription factor binding;, P:brain development; P:histone H3-K4 dimethylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:regulation of chromatin organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of megakaryocyte differentiation; scaffold82 indexed_genome mRNA 104513 148829 . + . ID=transcript_12043;O15047 A6NP62 Q6PIF3 Q8TAJ6,Histone-lysine N-methyltransferase SETD1A,Lysine N-methyltransferase 2F;SET domain-containing protein 1A;Set1/Ash2 histone methyltransferase complex subunit SET1;, PF11764;PF00076;PF00856;, GO:0000785;GO:0035097;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0042800;GO:0003723;GO:0008134;GO:0007420;GO:0044648;GO:0097692;GO:0080182;GO:1902275;GO:1902036;GO:0045652;, C:chromatin; C:histone methyltransferase complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:histone methyltransferase activity (H3-K4 specific); F:RNA binding; F:transcription factor binding;, P:brain development; P:histone H3-K4 dimethylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:regulation of chromatin organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of megakaryocyte differentiation;|O15047 A6NP62 Q6PIF3 Q8TAJ6,Histone-lysine N-methyltransferase SETD1A,Lysine N-methyltransferase 2F;SET domain-containing protein 1A;Set1/Ash2 histone methyltransferase complex subunit SET1;, PF11764;PF00076;PF00856;, GO:0000785;GO:0035097;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0042800;GO:0003723;GO:0008134;GO:0007420;GO:0044648;GO:0097692;GO:0080182;GO:1902275;GO:1902036;GO:0045652;, C:chromatin; C:histone methyltransferase complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:histone methyltransferase activity (H3-K4 specific); F:RNA binding; F:transcription factor binding;, P:brain development; P:histone H3-K4 dimethylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:regulation of chromatin organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of megakaryocyte differentiation;|O15047 A6NP62 Q6PIF3 Q8TAJ6,Histone-lysine N-methyltransferase SETD1A,Lysine N-methyltransferase 2F;SET domain-containing protein 1A;Set1/Ash2 histone methyltransferase complex subunit SET1;, PF11764;PF00076;PF00856;, GO:0000785;GO:0035097;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0008013;GO:0042800;GO:0003723;GO:0008134;GO:0007420;GO:0044648;GO:0097692;GO:0080182;GO:1902275;GO:1902036;GO:0045652;, C:chromatin; C:histone methyltransferase complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:beta-catenin binding; F:histone methyltransferase activity (H3-K4 specific); F:RNA binding; F:transcription factor binding;, P:brain development; P:histone H3-K4 dimethylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:regulation of chromatin organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of megakaryocyte differentiation;|Q9H2F3 Q96M28 Q9BSN9,3 beta-hydroxysteroid dehydrogenase type 7 {ECO:0000305},3 beta-hydroxysteroid dehydrogenase type VII;3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase;Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase;, PF01073;, GO:0005789;GO:0016021;GO:0005811;GO:0003854;GO:0047016;GO:0016616;GO:0035754;GO:0006699;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; F:cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:B cell chemotaxis; P:bile acid biosynthetic process;|Q9H2F3 Q96M28 Q9BSN9,3 beta-hydroxysteroid dehydrogenase type 7 {ECO:0000305},3 beta-hydroxysteroid dehydrogenase type VII;3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase;Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase;, PF01073;, GO:0005789;GO:0016021;GO:0005811;GO:0003854;GO:0047016;GO:0016616;GO:0035754;GO:0006699;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; F:cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:B cell chemotaxis; P:bile acid biosynthetic process;|Q9H2F3 Q96M28 Q9BSN9,3 beta-hydroxysteroid dehydrogenase type 7 {ECO:0000305},3 beta-hydroxysteroid dehydrogenase type VII;3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase;Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase;, PF01073;, GO:0005789;GO:0016021;GO:0005811;GO:0003854;GO:0047016;GO:0016616;GO:0035754;GO:0006699;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; F:cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;, P:B cell chemotaxis; P:bile acid biosynthetic process;|P61266 Q15531 Q2VPS2,Syntaxin-1B,Syntaxin-1B1;Syntaxin-1B2;, PF05739;PF00804;, GO:0030424;GO:0005813;GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0016020;GO:0005815;GO:0031594;GO:0005652;GO:0005654;GO:0005634;GO:0005886;GO:0048787;GO:0031201;GO:0005819;GO:0008021;GO:0019904;GO:0019901;GO:0005102;GO:0005484;GO:0000149;GO:0048791;GO:0098967;GO:0006887;GO:0006886;GO:1905302;GO:0010977;GO:1903422;GO:2000463;GO:0001956;GO:1904050;GO:0017157;GO:0010468;GO:0060025;GO:0010807;GO:0061669;GO:0016081;GO:0031629;GO:0048278;GO:0006904;GO:0006906;, C:axon; C:centrosome; C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:membrane; C:microtubule organizing center; C:neuromuscular junction; C:nuclear lamina; C:nucleoplasm; C:nucleus; C:plasma membrane; C:presynaptic active zone membrane; C:SNARE complex; C:spindle; C:synaptic vesicle;, F:protein domain specific binding; F:protein kinase binding; F:signaling receptor binding; F:SNAP receptor activity; F:SNARE binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:intracellular protein transport; P:negative regulation of macropinocytosis; P:negative regulation of neuron projection development; P:negative regulation of synaptic vesicle recycling; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neurotransmitter secretion; P:positive regulation of spontaneous neurotransmitter secretion; P:regulation of exocytosis; P:regulation of gene expression; P:regulation of synaptic activity; P:regulation of synaptic vesicle priming; P:spontaneous neurotransmitter secretion; P:synaptic vesicle docking; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle docking involved in exocytosis; P:vesicle fusion;|P61266 Q15531 Q2VPS2,Syntaxin-1B,Syntaxin-1B1;Syntaxin-1B2;, PF05739;PF00804;, GO:0030424;GO:0005813;GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0016020;GO:0005815;GO:0031594;GO:0005652;GO:0005654;GO:0005634;GO:0005886;GO:0048787;GO:0031201;GO:0005819;GO:0008021;GO:0019904;GO:0019901;GO:0005102;GO:0005484;GO:0000149;GO:0048791;GO:0098967;GO:0006887;GO:0006886;GO:1905302;GO:0010977;GO:1903422;GO:2000463;GO:0001956;GO:1904050;GO:0017157;GO:0010468;GO:0060025;GO:0010807;GO:0061669;GO:0016081;GO:0031629;GO:0048278;GO:0006904;GO:0006906;, C:axon; C:centrosome; C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:membrane; C:microtubule organizing center; C:neuromuscular junction; C:nuclear lamina; C:nucleoplasm; C:nucleus; C:plasma membrane; C:presynaptic active zone membrane; C:SNARE complex; C:spindle; C:synaptic vesicle;, F:protein domain specific binding; F:protein kinase binding; F:signaling receptor binding; F:SNAP receptor activity; F:SNARE binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:intracellular protein transport; P:negative regulation of macropinocytosis; P:negative regulation of neuron projection development; P:negative regulation of synaptic vesicle recycling; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neurotransmitter secretion; P:positive regulation of spontaneous neurotransmitter secretion; P:regulation of exocytosis; P:regulation of gene expression; P:regulation of synaptic activity; P:regulation of synaptic vesicle priming; P:spontaneous neurotransmitter secretion; P:synaptic vesicle docking; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle docking involved in exocytosis; P:vesicle fusion;|P61266 Q15531 Q2VPS2,Syntaxin-1B,Syntaxin-1B1;Syntaxin-1B2;, PF05739;PF00804;, GO:0030424;GO:0005813;GO:0005737;GO:0005829;GO:0012505;GO:0016021;GO:0016020;GO:0005815;GO:0031594;GO:0005652;GO:0005654;GO:0005634;GO:0005886;GO:0048787;GO:0031201;GO:0005819;GO:0008021;GO:0019904;GO:0019901;GO:0005102;GO:0005484;GO:0000149;GO:0048791;GO:0098967;GO:0006887;GO:0006886;GO:1905302;GO:0010977;GO:1903422;GO:2000463;GO:0001956;GO:1904050;GO:0017157;GO:0010468;GO:0060025;GO:0010807;GO:0061669;GO:0016081;GO:0031629;GO:0048278;GO:0006904;GO:0006906;, C:axon; C:centrosome; C:cytoplasm; C:cytosol; C:endomembrane system; C:integral component of membrane; C:membrane; C:microtubule organizing center; C:neuromuscular junction; C:nuclear lamina; C:nucleoplasm; C:nucleus; C:plasma membrane; C:presynaptic active zone membrane; C:SNARE complex; C:spindle; C:synaptic vesicle;, F:protein domain specific binding; F:protein kinase binding; F:signaling receptor binding; F:SNAP receptor activity; F:SNARE binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:intracellular protein transport; P:negative regulation of macropinocytosis; P:negative regulation of neuron projection development; P:negative regulation of synaptic vesicle recycling; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neurotransmitter secretion; P:positive regulation of spontaneous neurotransmitter secretion; P:regulation of exocytosis; P:regulation of gene expression; P:regulation of synaptic activity; P:regulation of synaptic vesicle priming; P:spontaneous neurotransmitter secretion; P:synaptic vesicle docking; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle docking involved in exocytosis; P:vesicle fusion; scaffold82 indexed_genome mRNA 162366 172788 . + . ID=transcript_12044;Q12846 A8MXY0 Q15525 Q6FHE8,Syntaxin-4,Renal carcinoma antigen NY-REN-31;, PF05739;PF00804;, GO:0016323;GO:0009986;GO:0005829;GO:0043197;GO:0012505;GO:0005768;GO:0070062;GO:0005615;GO:0098978;GO:0016021;GO:0030027;GO:0043219;GO:0016020;GO:0035749;GO:0048471;GO:0030670;GO:0005886;GO:0098794;GO:0048787;GO:0031201;GO:0036477;GO:0042581;GO:0000322;GO:0045202;GO:0008021;GO:0005802;GO:0005773;GO:0005484;GO:0000149;GO:0016230;GO:0071346;GO:0034599;GO:1903575;GO:0019221;GO:0006887;GO:0006886;GO:0060291;GO:0048284;GO:0043085;GO:0045785;GO:0030335;GO:0008284;GO:0050921;GO:0043311;GO:0002639;GO:0035774;GO:2000010;GO:1903078;GO:0006892;GO:0017157;GO:1902041;GO:0035493;GO:0031629;GO:0048278;GO:0006906;GO:1990668;, C:basolateral plasma membrane; C:cell surface; C:cytosol; C:dendritic spine; C:endomembrane system; C:endosome; C:extracellular exosome; C:extracellular space; C:glutamatergic synapse; C:integral component of membrane; C:lamellipodium; C:lateral loop; C:membrane; C:myelin sheath adaxonal region; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynapse; C:presynaptic active zone membrane; C:SNARE complex; C:somatodendritic compartment; C:specific granule; C:storage vacuole; C:synapse; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:SNAP receptor activity; F:SNARE binding; F:sphingomyelin phosphodiesterase activator activity;, P:cellular response to interferon-gamma; P:cellular response to oxidative stress; P:cornified envelope assembly; P:cytokine-mediated signaling pathway; P:exocytosis; P:intracellular protein transport; P:long-term synaptic potentiation; P:organelle fusion; P:positive regulation of catalytic activity; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of eosinophil degranulation; P:positive regulation of immunoglobulin production; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to plasma membrane; P:post-Golgi vesicle-mediated transport; P:regulation of exocytosis; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:SNARE complex assembly; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle fusion; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;|Q12846 A8MXY0 Q15525 Q6FHE8,Syntaxin-4,Renal carcinoma antigen NY-REN-31;, PF05739;PF00804;, GO:0016323;GO:0009986;GO:0005829;GO:0043197;GO:0012505;GO:0005768;GO:0070062;GO:0005615;GO:0098978;GO:0016021;GO:0030027;GO:0043219;GO:0016020;GO:0035749;GO:0048471;GO:0030670;GO:0005886;GO:0098794;GO:0048787;GO:0031201;GO:0036477;GO:0042581;GO:0000322;GO:0045202;GO:0008021;GO:0005802;GO:0005773;GO:0005484;GO:0000149;GO:0016230;GO:0071346;GO:0034599;GO:1903575;GO:0019221;GO:0006887;GO:0006886;GO:0060291;GO:0048284;GO:0043085;GO:0045785;GO:0030335;GO:0008284;GO:0050921;GO:0043311;GO:0002639;GO:0035774;GO:2000010;GO:1903078;GO:0006892;GO:0017157;GO:1902041;GO:0035493;GO:0031629;GO:0048278;GO:0006906;GO:1990668;, C:basolateral plasma membrane; C:cell surface; C:cytosol; C:dendritic spine; C:endomembrane system; C:endosome; C:extracellular exosome; C:extracellular space; C:glutamatergic synapse; C:integral component of membrane; C:lamellipodium; C:lateral loop; C:membrane; C:myelin sheath adaxonal region; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynapse; C:presynaptic active zone membrane; C:SNARE complex; C:somatodendritic compartment; C:specific granule; C:storage vacuole; C:synapse; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:SNAP receptor activity; F:SNARE binding; F:sphingomyelin phosphodiesterase activator activity;, P:cellular response to interferon-gamma; P:cellular response to oxidative stress; P:cornified envelope assembly; P:cytokine-mediated signaling pathway; P:exocytosis; P:intracellular protein transport; P:long-term synaptic potentiation; P:organelle fusion; P:positive regulation of catalytic activity; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of eosinophil degranulation; P:positive regulation of immunoglobulin production; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to plasma membrane; P:post-Golgi vesicle-mediated transport; P:regulation of exocytosis; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:SNARE complex assembly; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle fusion; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;|Q12846 A8MXY0 Q15525 Q6FHE8,Syntaxin-4,Renal carcinoma antigen NY-REN-31;, PF05739;PF00804;, GO:0016323;GO:0009986;GO:0005829;GO:0043197;GO:0012505;GO:0005768;GO:0070062;GO:0005615;GO:0098978;GO:0016021;GO:0030027;GO:0043219;GO:0016020;GO:0035749;GO:0048471;GO:0030670;GO:0005886;GO:0098794;GO:0048787;GO:0031201;GO:0036477;GO:0042581;GO:0000322;GO:0045202;GO:0008021;GO:0005802;GO:0005773;GO:0005484;GO:0000149;GO:0016230;GO:0071346;GO:0034599;GO:1903575;GO:0019221;GO:0006887;GO:0006886;GO:0060291;GO:0048284;GO:0043085;GO:0045785;GO:0030335;GO:0008284;GO:0050921;GO:0043311;GO:0002639;GO:0035774;GO:2000010;GO:1903078;GO:0006892;GO:0017157;GO:1902041;GO:0035493;GO:0031629;GO:0048278;GO:0006906;GO:1990668;, C:basolateral plasma membrane; C:cell surface; C:cytosol; C:dendritic spine; C:endomembrane system; C:endosome; C:extracellular exosome; C:extracellular space; C:glutamatergic synapse; C:integral component of membrane; C:lamellipodium; C:lateral loop; C:membrane; C:myelin sheath adaxonal region; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynapse; C:presynaptic active zone membrane; C:SNARE complex; C:somatodendritic compartment; C:specific granule; C:storage vacuole; C:synapse; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:SNAP receptor activity; F:SNARE binding; F:sphingomyelin phosphodiesterase activator activity;, P:cellular response to interferon-gamma; P:cellular response to oxidative stress; P:cornified envelope assembly; P:cytokine-mediated signaling pathway; P:exocytosis; P:intracellular protein transport; P:long-term synaptic potentiation; P:organelle fusion; P:positive regulation of catalytic activity; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of eosinophil degranulation; P:positive regulation of immunoglobulin production; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to plasma membrane; P:post-Golgi vesicle-mediated transport; P:regulation of exocytosis; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:SNARE complex assembly; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle fusion; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;|Q12846 A8MXY0 Q15525 Q6FHE8,Syntaxin-4,Renal carcinoma antigen NY-REN-31;, PF05739;PF00804;, GO:0016323;GO:0009986;GO:0005829;GO:0043197;GO:0012505;GO:0005768;GO:0070062;GO:0005615;GO:0098978;GO:0016021;GO:0030027;GO:0043219;GO:0016020;GO:0035749;GO:0048471;GO:0030670;GO:0005886;GO:0098794;GO:0048787;GO:0031201;GO:0036477;GO:0042581;GO:0000322;GO:0045202;GO:0008021;GO:0005802;GO:0005773;GO:0005484;GO:0000149;GO:0016230;GO:0071346;GO:0034599;GO:1903575;GO:0019221;GO:0006887;GO:0006886;GO:0060291;GO:0048284;GO:0043085;GO:0045785;GO:0030335;GO:0008284;GO:0050921;GO:0043311;GO:0002639;GO:0035774;GO:2000010;GO:1903078;GO:0006892;GO:0017157;GO:1902041;GO:0035493;GO:0031629;GO:0048278;GO:0006906;GO:1990668;, C:basolateral plasma membrane; C:cell surface; C:cytosol; C:dendritic spine; C:endomembrane system; C:endosome; C:extracellular exosome; C:extracellular space; C:glutamatergic synapse; C:integral component of membrane; C:lamellipodium; C:lateral loop; C:membrane; C:myelin sheath adaxonal region; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynapse; C:presynaptic active zone membrane; C:SNARE complex; C:somatodendritic compartment; C:specific granule; C:storage vacuole; C:synapse; C:synaptic vesicle; C:trans-Golgi network; C:vacuole;, F:SNAP receptor activity; F:SNARE binding; F:sphingomyelin phosphodiesterase activator activity;, P:cellular response to interferon-gamma; P:cellular response to oxidative stress; P:cornified envelope assembly; P:cytokine-mediated signaling pathway; P:exocytosis; P:intracellular protein transport; P:long-term synaptic potentiation; P:organelle fusion; P:positive regulation of catalytic activity; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of eosinophil degranulation; P:positive regulation of immunoglobulin production; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to plasma membrane; P:post-Golgi vesicle-mediated transport; P:regulation of exocytosis; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:SNARE complex assembly; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle fusion; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane; scaffold82 indexed_genome mRNA 180575 181704 . - . ID=transcript_12045;Q96K58 C9JHH8 F5H7E7 Q59EV1 Q8N669 Q9H8L4,Zinc finger protein 668,, PF00096;, GO:0005634;GO:0001228;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold82 indexed_genome mRNA 181831 183803 . - . ID=transcript_12046;Q96K58 C9JHH8 F5H7E7 Q59EV1 Q8N669 Q9H8L4,Zinc finger protein 668,, PF00096;, GO:0005634;GO:0001228;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold82 indexed_genome mRNA 192549 193316 . - . ID=transcript_12047;O15015 Q8IVD8,Zinc finger protein 646 {ECO:0000305},, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold82 indexed_genome mRNA 193366 205775 . + . ID=transcript_12048;O15015 Q8IVD8,Zinc finger protein 646 {ECO:0000305},, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|O15015 Q8IVD8,Zinc finger protein 646 {ECO:0000305},, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q2L4Q9,Serine protease 53,Polyserine protease 3;, PF00089;, GO:0005576;GO:0004252;, C:extracellular region;, F:serine-type endopeptidase activity;|Q2L4Q9,Serine protease 53,Polyserine protease 3;, PF00089;, GO:0005576;GO:0004252;, C:extracellular region;, F:serine-type endopeptidase activity; scaffold82 indexed_genome mRNA 205796 208686 . - . ID=transcript_12049;Q9BQB6 A6NIQ6 B2R4Z6 Q6UX90 Q7Z2R4,Vitamin K epoxide reductase complex subunit 1,Vitamin K1 2,3-epoxide reductase subunit 1;, PF07884;, GO:0005783;GO:0005789;GO:0016021;GO:0048038;GO:0047058;GO:0047057;GO:0007596;GO:0060348;GO:0017144;GO:0017187;GO:0030193;GO:0046677;GO:0014070;GO:0010243;GO:0042373;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:quinone binding; F:vitamin-K-epoxide reductase (warfarin-insensitive) activity; F:vitamin-K-epoxide reductase (warfarin-sensitive) activity;, P:blood coagulation; P:bone development; P:drug metabolic process; P:peptidyl-glutamic acid carboxylation; P:regulation of blood coagulation; P:response to antibiotic; P:response to organic cyclic compound; P:response to organonitrogen compound; P:vitamin K metabolic process; scaffold82 indexed_genome mRNA 218767 236383 . + . ID=transcript_12050;O14874 A8MY43 Q6FGL4 Q96G95 Q96IN5,[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial,Branched-chain alpha-ketoacid dehydrogenase kinase;, PF10436;PF02518;, GO:0005947;GO:0005759;GO:0005739;GO:0047323;GO:0005524;GO:0016301;GO:0004674;GO:0004740;GO:0009083;GO:0009063;GO:0045763;GO:0016310;GO:0006468;GO:0010906;, C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrion;, F:[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity; F:ATP binding; F:kinase activity; F:protein serine/threonine kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:branched-chain amino acid catabolic process; P:cellular amino acid catabolic process; P:negative regulation of cellular amino acid metabolic process; P:phosphorylation; P:protein phosphorylation; P:regulation of glucose metabolic process;|O14874 A8MY43 Q6FGL4 Q96G95 Q96IN5,[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial,Branched-chain alpha-ketoacid dehydrogenase kinase;, PF10436;PF02518;, GO:0005947;GO:0005759;GO:0005739;GO:0047323;GO:0005524;GO:0016301;GO:0004674;GO:0004740;GO:0009083;GO:0009063;GO:0045763;GO:0016310;GO:0006468;GO:0010906;, C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrion;, F:[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity; F:ATP binding; F:kinase activity; F:protein serine/threonine kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:branched-chain amino acid catabolic process; P:cellular amino acid catabolic process; P:negative regulation of cellular amino acid metabolic process; P:phosphorylation; P:protein phosphorylation; P:regulation of glucose metabolic process;|O14874 A8MY43 Q6FGL4 Q96G95 Q96IN5,[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial,Branched-chain alpha-ketoacid dehydrogenase kinase;, PF10436;PF02518;, GO:0005947;GO:0005759;GO:0005739;GO:0047323;GO:0005524;GO:0016301;GO:0004674;GO:0004740;GO:0009083;GO:0009063;GO:0045763;GO:0016310;GO:0006468;GO:0010906;, C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrion;, F:[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity; F:ATP binding; F:kinase activity; F:protein serine/threonine kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:branched-chain amino acid catabolic process; P:cellular amino acid catabolic process; P:negative regulation of cellular amino acid metabolic process; P:phosphorylation; P:protein phosphorylation; P:regulation of glucose metabolic process;|O14874 A8MY43 Q6FGL4 Q96G95 Q96IN5,[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial,Branched-chain alpha-ketoacid dehydrogenase kinase;, PF10436;PF02518;, GO:0005947;GO:0005759;GO:0005739;GO:0047323;GO:0005524;GO:0016301;GO:0004674;GO:0004740;GO:0009083;GO:0009063;GO:0045763;GO:0016310;GO:0006468;GO:0010906;, C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrion;, F:[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity; F:ATP binding; F:kinase activity; F:protein serine/threonine kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:branched-chain amino acid catabolic process; P:cellular amino acid catabolic process; P:negative regulation of cellular amino acid metabolic process; P:phosphorylation; P:protein phosphorylation; P:regulation of glucose metabolic process;|Q9NR35,Histone acetyltransferase KAT8,Lysine acetyltransferase 8;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1;, PF01853;PF11717;PF17772;, GO:0000123;GO:0000776;GO:0071339;GO:0072487;GO:0016363;GO:0005654;GO:0005634;GO:0016407;GO:0019899;GO:0004402;GO:0046972;GO:0043995;GO:0043996;GO:0042393;GO:0046872;GO:0035064;GO:0003712;GO:0008134;GO:0016573;GO:0043984;GO:0043981;GO:0043982;GO:0030099;GO:0045892;GO:0045944;GO:0045893;GO:0010506;, C:histone acetyltransferase complex; C:kinetochore; C:MLL1 complex; C:MSL complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:acetyltransferase activity; F:enzyme binding; F:histone acetyltransferase activity; F:histone acetyltransferase activity (H4-K16 specific); F:histone acetyltransferase activity (H4-K5 specific); F:histone acetyltransferase activity (H4-K8 specific); F:histone binding; F:metal ion binding; F:methylated histone binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:myeloid cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of autophagy;|Q9NR35,Histone acetyltransferase KAT8,Lysine acetyltransferase 8;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1;, PF01853;PF11717;PF17772;, GO:0000123;GO:0000776;GO:0071339;GO:0072487;GO:0016363;GO:0005654;GO:0005634;GO:0016407;GO:0019899;GO:0004402;GO:0046972;GO:0043995;GO:0043996;GO:0042393;GO:0046872;GO:0035064;GO:0003712;GO:0008134;GO:0016573;GO:0043984;GO:0043981;GO:0043982;GO:0030099;GO:0045892;GO:0045944;GO:0045893;GO:0010506;, C:histone acetyltransferase complex; C:kinetochore; C:MLL1 complex; C:MSL complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:acetyltransferase activity; F:enzyme binding; F:histone acetyltransferase activity; F:histone acetyltransferase activity (H4-K16 specific); F:histone acetyltransferase activity (H4-K5 specific); F:histone acetyltransferase activity (H4-K8 specific); F:histone binding; F:metal ion binding; F:methylated histone binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:myeloid cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of autophagy;|Q9NR35,Histone acetyltransferase KAT8,Lysine acetyltransferase 8;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1;, PF01853;PF11717;PF17772;, GO:0000123;GO:0000776;GO:0071339;GO:0072487;GO:0016363;GO:0005654;GO:0005634;GO:0016407;GO:0019899;GO:0004402;GO:0046972;GO:0043995;GO:0043996;GO:0042393;GO:0046872;GO:0035064;GO:0003712;GO:0008134;GO:0016573;GO:0043984;GO:0043981;GO:0043982;GO:0030099;GO:0045892;GO:0045944;GO:0045893;GO:0010506;, C:histone acetyltransferase complex; C:kinetochore; C:MLL1 complex; C:MSL complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:acetyltransferase activity; F:enzyme binding; F:histone acetyltransferase activity; F:histone acetyltransferase activity (H4-K16 specific); F:histone acetyltransferase activity (H4-K5 specific); F:histone acetyltransferase activity (H4-K8 specific); F:histone binding; F:metal ion binding; F:methylated histone binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:myeloid cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of autophagy;|Q9NR35,Histone acetyltransferase KAT8,Lysine acetyltransferase 8;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1;, PF01853;PF11717;PF17772;, GO:0000123;GO:0000776;GO:0071339;GO:0072487;GO:0016363;GO:0005654;GO:0005634;GO:0016407;GO:0019899;GO:0004402;GO:0046972;GO:0043995;GO:0043996;GO:0042393;GO:0046872;GO:0035064;GO:0003712;GO:0008134;GO:0016573;GO:0043984;GO:0043981;GO:0043982;GO:0030099;GO:0045892;GO:0045944;GO:0045893;GO:0010506;, C:histone acetyltransferase complex; C:kinetochore; C:MLL1 complex; C:MSL complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:acetyltransferase activity; F:enzyme binding; F:histone acetyltransferase activity; F:histone acetyltransferase activity (H4-K16 specific); F:histone acetyltransferase activity (H4-K5 specific); F:histone acetyltransferase activity (H4-K8 specific); F:histone binding; F:metal ion binding; F:methylated histone binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:myeloid cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of autophagy;|Q9NR35,Histone acetyltransferase KAT8,Lysine acetyltransferase 8;MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1;, PF01853;PF11717;PF17772;, GO:0000123;GO:0000776;GO:0071339;GO:0072487;GO:0016363;GO:0005654;GO:0005634;GO:0016407;GO:0019899;GO:0004402;GO:0046972;GO:0043995;GO:0043996;GO:0042393;GO:0046872;GO:0035064;GO:0003712;GO:0008134;GO:0016573;GO:0043984;GO:0043981;GO:0043982;GO:0030099;GO:0045892;GO:0045944;GO:0045893;GO:0010506;, C:histone acetyltransferase complex; C:kinetochore; C:MLL1 complex; C:MSL complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:acetyltransferase activity; F:enzyme binding; F:histone acetyltransferase activity; F:histone acetyltransferase activity (H4-K16 specific); F:histone acetyltransferase activity (H4-K5 specific); F:histone acetyltransferase activity (H4-K8 specific); F:histone binding; F:metal ion binding; F:methylated histone binding; F:transcription coregulator activity; F:transcription factor binding;, P:histone acetylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:myeloid cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of autophagy; scaffold82 indexed_genome mRNA 236417 241052 . - . ID=transcript_12051;Q16651 B4DWP2 Q9UCA3,Prostasin,Channel-activating protease 1;Serine protease 8;, PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0016021;GO:0005886;GO:0004252;GO:0008236;GO:0017080;GO:0070268;GO:0010765;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:sodium channel regulator activity;, P:cornification; P:positive regulation of sodium ion transport; scaffold82 indexed_genome mRNA 245360 246832 . - . ID=transcript_12052;Q5K4E3 A8K2P5 B4DW80 B7ZMK8 E7EX56 Q8NBY4,Polyserase-2,Polyserine protease 2;Serine protease 36;, PF00089;, GO:0005737;GO:0005576;GO:0004252;, C:cytoplasm; C:extracellular region;, F:serine-type endopeptidase activity; scaffold82 indexed_genome mRNA 247198 250780 . - . ID=transcript_12053;Q5K4E3 A8K2P5 B4DW80 B7ZMK8 E7EX56 Q8NBY4,Polyserase-2,Polyserine protease 2;Serine protease 36;, PF00089;, GO:0005737;GO:0005576;GO:0004252;, C:cytoplasm; C:extracellular region;, F:serine-type endopeptidase activity; scaffold82 indexed_genome mRNA 271679 282169 . + . ID=transcript_12054;P35637 Q9H4A8,RNA-binding protein FUS,75 kDa DNA-pairing protein;Oncogene FUS;Oncogene TLS;POMp75;Translocated in liposarcoma protein;, PF00076;PF00641;, GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0042802;GO:0046872;GO:0003723;GO:0003713;GO:0003712;GO:0000398;GO:0048255;GO:1905168;GO:0051260;GO:0043484;GO:0006357;GO:0006355;GO:0008380;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:positive regulation of double-strand break repair via homologous recombination; P:protein homooligomerization; P:regulation of RNA splicing; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:RNA splicing;|P35637 Q9H4A8,RNA-binding protein FUS,75 kDa DNA-pairing protein;Oncogene FUS;Oncogene TLS;POMp75;Translocated in liposarcoma protein;, PF00076;PF00641;, GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0042802;GO:0046872;GO:0003723;GO:0003713;GO:0003712;GO:0000398;GO:0048255;GO:1905168;GO:0051260;GO:0043484;GO:0006357;GO:0006355;GO:0008380;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:identical protein binding; F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:positive regulation of double-strand break repair via homologous recombination; P:protein homooligomerization; P:regulation of RNA splicing; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:RNA splicing; scaffold82 indexed_genome mRNA 288257 290212 . + . ID=transcript_12055;Q9ULZ3 Q96D12 Q9BSZ5 Q9HBD0 Q9NXJ8,Apoptosis-associated speck-like protein containing a CARD,Caspase recruitment domain-containing protein 5;PYD and CARD domain-containing protein;Target of methylation-induced silencing 1;, PF00619;PF02758;, GO:0097169;GO:0035578;GO:0005737;GO:0005829;GO:0005783;GO:0005576;GO:0000139;GO:0008385;GO:0005739;GO:0043025;GO:0072558;GO:0072559;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0034774;GO:0070700;GO:0008656;GO:0097153;GO:0019899;GO:0042802;GO:0005138;GO:0044325;GO:0017024;GO:0002020;GO:0046983;GO:0042803;GO:0032090;GO:0005523;GO:0097202;GO:0006919;GO:0002218;GO:0006915;GO:0071347;GO:0071222;GO:0071356;GO:0050829;GO:0051607;GO:0006954;GO:0045087;GO:0072332;GO:0042771;GO:0044351;GO:0001773;GO:0002277;GO:1900016;GO:0043124;GO:0032688;GO:0032088;GO:0071901;GO:0043312;GO:0030838;GO:0042104;GO:0002821;GO:0002588;GO:0043065;GO:0032722;GO:2001056;GO:0043280;GO:0002230;GO:0051091;GO:0070374;GO:2001238;GO:0032729;GO:0032731;GO:0032733;GO:0032755;GO:0032757;GO:0046330;GO:0051092;GO:0050766;GO:0090200;GO:0050870;GO:2000406;GO:0032760;GO:0051260;GO:0035590;GO:0010506;GO:0043087;GO:0050727;GO:2001242;GO:0031647;GO:0010803;GO:0007165;GO:0033209;, C:AIM2 inflammasome complex; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular region; C:Golgi membrane; C:IkappaB kinase complex; C:mitochondrion; C:neuronal cell body; C:NLRP1 inflammasome complex; C:NLRP3 inflammasome complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:secretory granule lumen;, F:BMP receptor binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in apoptotic process; F:enzyme binding; F:identical protein binding; F:interleukin-6 receptor binding; F:ion channel binding; F:myosin I binding; F:protease binding; F:protein dimerization activity; F:protein homodimerization activity; F:Pyrin domain binding; F:tropomyosin binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of innate immune response; P:apoptotic process; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:defense response to Gram-negative bacterium; P:defense response to virus; P:inflammatory response; P:innate immune response; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:macropinocytosis; P:myeloid dendritic cell activation; P:myeloid dendritic cell activation involved in immune response; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interferon-beta production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein serine/threonine kinase activity; P:neutrophil degranulation; P:positive regulation of actin filament polymerization; P:positive regulation of activated T cell proliferation; P:positive regulation of adaptive immune response; P:positive regulation of antigen processing and presentation of peptide antigen via MHC class II; P:positive regulation of apoptotic process; P:positive regulation of chemokine production; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of defense response to virus by host; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of JNK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of phagocytosis; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of T cell activation; P:positive regulation of T cell migration; P:positive regulation of tumor necrosis factor production; P:protein homooligomerization; P:purinergic nucleotide receptor signaling pathway; P:regulation of autophagy; P:regulation of GTPase activity; P:regulation of inflammatory response; P:regulation of intrinsic apoptotic signaling pathway; P:regulation of protein stability; P:regulation of tumor necrosis factor-mediated signaling pathway; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; scaffold82 indexed_genome mRNA 299128 310075 . + . ID=transcript_12056;Q6ZMU5 Q8N4X6 Q8NBD9,Tripartite motif-containing protein 72,Mitsugumin-53;, PF13765;PF00622;PF00643;, GO:0005737;GO:0030659;GO:0042383;GO:0042802;GO:0001786;GO:0031624;GO:0061630;GO:0008270;GO:0006887;GO:0006936;GO:0007517;GO:0003012;GO:0046627;GO:0043569;GO:0010832;GO:0001778;GO:0043161;GO:0051260;GO:0016567;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:sarcolemma;, F:identical protein binding; F:phosphatidylserine binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:exocytosis; P:muscle contraction; P:muscle organ development; P:muscle system process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of insulin-like growth factor receptor signaling pathway; P:negative regulation of myotube differentiation; P:plasma membrane repair; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination;|Q6ZMU5 Q8N4X6 Q8NBD9,Tripartite motif-containing protein 72,Mitsugumin-53;, PF13765;PF00622;PF00643;, GO:0005737;GO:0030659;GO:0042383;GO:0042802;GO:0001786;GO:0031624;GO:0061630;GO:0008270;GO:0006887;GO:0006936;GO:0007517;GO:0003012;GO:0046627;GO:0043569;GO:0010832;GO:0001778;GO:0043161;GO:0051260;GO:0016567;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:sarcolemma;, F:identical protein binding; F:phosphatidylserine binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:exocytosis; P:muscle contraction; P:muscle organ development; P:muscle system process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of insulin-like growth factor receptor signaling pathway; P:negative regulation of myotube differentiation; P:plasma membrane repair; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination;|Q6ZMU5 Q8N4X6 Q8NBD9,Tripartite motif-containing protein 72,Mitsugumin-53;, PF13765;PF00622;PF00643;, GO:0005737;GO:0030659;GO:0042383;GO:0042802;GO:0001786;GO:0031624;GO:0061630;GO:0008270;GO:0006887;GO:0006936;GO:0007517;GO:0003012;GO:0046627;GO:0043569;GO:0010832;GO:0001778;GO:0043161;GO:0051260;GO:0016567;, C:cytoplasm; C:cytoplasmic vesicle membrane; C:sarcolemma;, F:identical protein binding; F:phosphatidylserine binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:exocytosis; P:muscle contraction; P:muscle organ development; P:muscle system process; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of insulin-like growth factor receptor signaling pathway; P:negative regulation of myotube differentiation; P:plasma membrane repair; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; scaffold82 indexed_genome mRNA 350124 385816 . + . ID=transcript_12057;P11215 Q4VAK0 Q4VAK1 Q4VAK2,Integrin alpha-M,CD11 antigen-like family member B;CR-3 alpha chain;Cell surface glycoprotein MAC-1 subunit alpha;Leukocyte adhesion receptor MO1;Neutrophil adherence receptor;, PF01839;PF00357;PF08441;PF00092;, GO:0009986;GO:0009897;GO:0070062;GO:0005615;GO:0034688;GO:0008305;GO:0005886;GO:0044853;GO:0035579;GO:0070821;GO:0001540;GO:0038024;GO:0001851;GO:0031072;GO:0005178;GO:0046872;GO:0097242;GO:0097190;GO:0007155;GO:1905114;GO:0098742;GO:0150062;GO:0019221;GO:0010668;GO:0030198;GO:0030900;GO:0045087;GO:0007229;GO:0050900;GO:0001774;GO:0045963;GO:0043312;GO:0006911;GO:0110090;GO:1904151;GO:1901216;GO:0043315;GO:2000363;GO:0090314;GO:0032930;GO:0006898;GO:0034142;GO:0150064;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:integrin alphaM-beta2 complex; C:integrin complex; C:plasma membrane; C:plasma membrane raft; C:specific granule membrane; C:tertiary granule membrane;, F:amyloid-beta binding; F:cargo receptor activity; F:complement component C3b binding; F:heat shock protein binding; F:integrin binding; F:metal ion binding;, P:amyloid-beta clearance; P:apoptotic signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:complement-mediated synapse pruning; P:cytokine-mediated signaling pathway; P:ectodermal cell differentiation; P:extracellular matrix organization; P:forebrain development; P:innate immune response; P:integrin-mediated signaling pathway; P:leukocyte migration; P:microglial cell activation; P:negative regulation of dopamine metabolic process; P:neutrophil degranulation; P:phagocytosis, engulfment; P:positive regulation of hippocampal neuron apoptotic process; P:positive regulation of microglial cell mediated cytotoxicity; P:positive regulation of neuron death; P:positive regulation of neutrophil degranulation; P:positive regulation of prostaglandin-E synthase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of superoxide anion generation; P:receptor-mediated endocytosis; P:toll-like receptor 4 signaling pathway; P:vertebrate eye-specific patterning;|P11215 Q4VAK0 Q4VAK1 Q4VAK2,Integrin alpha-M,CD11 antigen-like family member B;CR-3 alpha chain;Cell surface glycoprotein MAC-1 subunit alpha;Leukocyte adhesion receptor MO1;Neutrophil adherence receptor;, PF01839;PF00357;PF08441;PF00092;, GO:0009986;GO:0009897;GO:0070062;GO:0005615;GO:0034688;GO:0008305;GO:0005886;GO:0044853;GO:0035579;GO:0070821;GO:0001540;GO:0038024;GO:0001851;GO:0031072;GO:0005178;GO:0046872;GO:0097242;GO:0097190;GO:0007155;GO:1905114;GO:0098742;GO:0150062;GO:0019221;GO:0010668;GO:0030198;GO:0030900;GO:0045087;GO:0007229;GO:0050900;GO:0001774;GO:0045963;GO:0043312;GO:0006911;GO:0110090;GO:1904151;GO:1901216;GO:0043315;GO:2000363;GO:0090314;GO:0032930;GO:0006898;GO:0034142;GO:0150064;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:integrin alphaM-beta2 complex; C:integrin complex; C:plasma membrane; C:plasma membrane raft; C:specific granule membrane; C:tertiary granule membrane;, F:amyloid-beta binding; F:cargo receptor activity; F:complement component C3b binding; F:heat shock protein binding; F:integrin binding; F:metal ion binding;, P:amyloid-beta clearance; P:apoptotic signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:complement-mediated synapse pruning; P:cytokine-mediated signaling pathway; P:ectodermal cell differentiation; P:extracellular matrix organization; P:forebrain development; P:innate immune response; P:integrin-mediated signaling pathway; P:leukocyte migration; P:microglial cell activation; P:negative regulation of dopamine metabolic process; P:neutrophil degranulation; P:phagocytosis, engulfment; P:positive regulation of hippocampal neuron apoptotic process; P:positive regulation of microglial cell mediated cytotoxicity; P:positive regulation of neuron death; P:positive regulation of neutrophil degranulation; P:positive regulation of prostaglandin-E synthase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of superoxide anion generation; P:receptor-mediated endocytosis; P:toll-like receptor 4 signaling pathway; P:vertebrate eye-specific patterning;|P11215 Q4VAK0 Q4VAK1 Q4VAK2,Integrin alpha-M,CD11 antigen-like family member B;CR-3 alpha chain;Cell surface glycoprotein MAC-1 subunit alpha;Leukocyte adhesion receptor MO1;Neutrophil adherence receptor;, PF01839;PF00357;PF08441;PF00092;, GO:0009986;GO:0009897;GO:0070062;GO:0005615;GO:0034688;GO:0008305;GO:0005886;GO:0044853;GO:0035579;GO:0070821;GO:0001540;GO:0038024;GO:0001851;GO:0031072;GO:0005178;GO:0046872;GO:0097242;GO:0097190;GO:0007155;GO:1905114;GO:0098742;GO:0150062;GO:0019221;GO:0010668;GO:0030198;GO:0030900;GO:0045087;GO:0007229;GO:0050900;GO:0001774;GO:0045963;GO:0043312;GO:0006911;GO:0110090;GO:1904151;GO:1901216;GO:0043315;GO:2000363;GO:0090314;GO:0032930;GO:0006898;GO:0034142;GO:0150064;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:integrin alphaM-beta2 complex; C:integrin complex; C:plasma membrane; C:plasma membrane raft; C:specific granule membrane; C:tertiary granule membrane;, F:amyloid-beta binding; F:cargo receptor activity; F:complement component C3b binding; F:heat shock protein binding; F:integrin binding; F:metal ion binding;, P:amyloid-beta clearance; P:apoptotic signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:complement-mediated synapse pruning; P:cytokine-mediated signaling pathway; P:ectodermal cell differentiation; P:extracellular matrix organization; P:forebrain development; P:innate immune response; P:integrin-mediated signaling pathway; P:leukocyte migration; P:microglial cell activation; P:negative regulation of dopamine metabolic process; P:neutrophil degranulation; P:phagocytosis, engulfment; P:positive regulation of hippocampal neuron apoptotic process; P:positive regulation of microglial cell mediated cytotoxicity; P:positive regulation of neuron death; P:positive regulation of neutrophil degranulation; P:positive regulation of prostaglandin-E synthase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of superoxide anion generation; P:receptor-mediated endocytosis; P:toll-like receptor 4 signaling pathway; P:vertebrate eye-specific patterning;|P11215 Q4VAK0 Q4VAK1 Q4VAK2,Integrin alpha-M,CD11 antigen-like family member B;CR-3 alpha chain;Cell surface glycoprotein MAC-1 subunit alpha;Leukocyte adhesion receptor MO1;Neutrophil adherence receptor;, PF01839;PF00357;PF08441;PF00092;, GO:0009986;GO:0009897;GO:0070062;GO:0005615;GO:0034688;GO:0008305;GO:0005886;GO:0044853;GO:0035579;GO:0070821;GO:0001540;GO:0038024;GO:0001851;GO:0031072;GO:0005178;GO:0046872;GO:0097242;GO:0097190;GO:0007155;GO:1905114;GO:0098742;GO:0150062;GO:0019221;GO:0010668;GO:0030198;GO:0030900;GO:0045087;GO:0007229;GO:0050900;GO:0001774;GO:0045963;GO:0043312;GO:0006911;GO:0110090;GO:1904151;GO:1901216;GO:0043315;GO:2000363;GO:0090314;GO:0032930;GO:0006898;GO:0034142;GO:0150064;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:integrin alphaM-beta2 complex; C:integrin complex; C:plasma membrane; C:plasma membrane raft; C:specific granule membrane; C:tertiary granule membrane;, F:amyloid-beta binding; F:cargo receptor activity; F:complement component C3b binding; F:heat shock protein binding; F:integrin binding; F:metal ion binding;, P:amyloid-beta clearance; P:apoptotic signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:complement-mediated synapse pruning; P:cytokine-mediated signaling pathway; P:ectodermal cell differentiation; P:extracellular matrix organization; P:forebrain development; P:innate immune response; P:integrin-mediated signaling pathway; P:leukocyte migration; P:microglial cell activation; P:negative regulation of dopamine metabolic process; P:neutrophil degranulation; P:phagocytosis, engulfment; P:positive regulation of hippocampal neuron apoptotic process; P:positive regulation of microglial cell mediated cytotoxicity; P:positive regulation of neuron death; P:positive regulation of neutrophil degranulation; P:positive regulation of prostaglandin-E synthase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of superoxide anion generation; P:receptor-mediated endocytosis; P:toll-like receptor 4 signaling pathway; P:vertebrate eye-specific patterning; scaffold82 indexed_genome mRNA 399731 419472 . + . ID=transcript_12058;P20702 Q8IVA6,Integrin alpha-X,CD11 antigen-like family member C;Leu M5;Leukocyte adhesion glycoprotein p150,95 alpha chain;Leukocyte adhesion receptor p150,95;, PF01839;PF00357;PF08441;PF00092;, GO:0009986;GO:0101003;GO:0034689;GO:0008305;GO:0016020;GO:0005886;GO:0030667;GO:0070821;GO:0005178;GO:0046872;GO:0030971;GO:0038023;GO:0009887;GO:0007155;GO:0019221;GO:0030198;GO:0034113;GO:0007229;GO:0050900;GO:0043312;GO:0045766;GO:0030335;GO:0008284;GO:1905956;GO:0010628;GO:0031643;, C:cell surface; C:ficolin-1-rich granule membrane; C:integrin alphaX-beta2 complex; C:integrin complex; C:membrane; C:plasma membrane; C:secretory granule membrane; C:tertiary granule membrane;, F:integrin binding; F:metal ion binding; F:receptor tyrosine kinase binding; F:signaling receptor activity;, P:animal organ morphogenesis; P:cell adhesion; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte migration; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of endothelial tube morphogenesis; P:positive regulation of gene expression; P:positive regulation of myelination; scaffold82 indexed_genome mRNA 482874 486384 . + . ID=transcript_12059;Q9UEG4 Q15938,Zinc finger protein 629,Zinc finger protein 65;, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold82 indexed_genome mRNA 486634 493457 . + . ID=transcript_12060;Q96C12 Q86WM9 Q9H7P8 Q9H925,Armadillo repeat-containing protein 5 {ECO:0000305},, , GO:0005737;GO:0005829;GO:0005925;GO:0005654;, C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleoplasm; scaffold82 indexed_genome mRNA 495748 502434 . + . ID=transcript_12061;O43294 B2R8D5 Q9BPW3 Q9Y2V5,Transforming growth factor beta-1-induced transcript 1 protein,Androgen receptor coactivator 55 kDa protein;Androgen receptor-associated protein of 55 kDa;Hydrogen peroxide-inducible clone 5 protein;, PF00412;, GO:0005856;GO:0005829;GO:0005925;GO:0016363;GO:0005886;GO:0050681;GO:0070411;GO:0046872;GO:0048495;GO:0003713;GO:0003712;GO:0007155;GO:0045165;GO:0030855;GO:0016331;GO:0008285;GO:0045599;GO:0030512;GO:0010718;GO:0045893;GO:0030511;GO:0009408;GO:0030579;GO:0016055;, C:cytoskeleton; C:cytosol; C:focal adhesion; C:nuclear matrix; C:plasma membrane;, F:androgen receptor binding; F:I-SMAD binding; F:metal ion binding; F:Roundabout binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:cell adhesion; P:cell fate commitment; P:epithelial cell differentiation; P:morphogenesis of embryonic epithelium; P:negative regulation of cell population proliferation; P:negative regulation of fat cell differentiation; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:response to heat; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway; scaffold82 indexed_genome mRNA 512124 527600 . - . ID=transcript_12062;Q96GQ5 Q53GL8 Q8NAJ4 Q9BVY3 Q9H887,RUS family member 1 {ECO:0000305},, PF04884;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q96GQ5 Q53GL8 Q8NAJ4 Q9BVY3 Q9H887,RUS family member 1 {ECO:0000305},, PF04884;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q96GQ5 Q53GL8 Q8NAJ4 Q9BVY3 Q9H887,RUS family member 1 {ECO:0000305},, PF04884;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q96GQ5 Q53GL8 Q8NAJ4 Q9BVY3 Q9H887,RUS family member 1 {ECO:0000305},, PF04884;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane;|Q96GQ5 Q53GL8 Q8NAJ4 Q9BVY3 Q9H887,RUS family member 1 {ECO:0000305},, PF04884;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane; scaffold82 indexed_genome mRNA 532683 533446 . + . ID=transcript_12063;Q9NZD4 Q8TD01,Alpha-hemoglobin-stabilizing protein,Erythroid differentiation-related factor;Erythroid-associated factor;, PF09236;, GO:0005737;GO:0005833;GO:0030492;GO:0051082;GO:0030218;GO:0020027;GO:0030097;GO:0006457;GO:0050821;, C:cytoplasm; C:hemoglobin complex;, F:hemoglobin binding; F:unfolded protein binding;, P:erythrocyte differentiation; P:hemoglobin metabolic process; P:hemopoiesis; P:protein folding; P:protein stabilization; scaffold82 indexed_genome mRNA 600223 619222 . + . ID=transcript_12064;Q8N859,Zinc finger protein 713,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription, DNA-templated;|Q8N859,Zinc finger protein 713,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription, DNA-templated; scaffold82 indexed_genome mRNA 625703 630188 . + . ID=transcript_12065;Q9Y2R5 Q86X15,28S ribosomal protein S17, mitochondrial,Mitochondrial small ribosomal subunit protein uS17m {ECO:0000303|PubMed:25838379};, PF00366;, GO:0005743;GO:0005763;GO:0019843;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit;, F:rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9Y2R5 Q86X15,28S ribosomal protein S17, mitochondrial,Mitochondrial small ribosomal subunit protein uS17m {ECO:0000303|PubMed:25838379};, PF00366;, GO:0005743;GO:0005763;GO:0019843;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit;, F:rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9Y2R5 Q86X15,28S ribosomal protein S17, mitochondrial,Mitochondrial small ribosomal subunit protein uS17m {ECO:0000303|PubMed:25838379};, PF00366;, GO:0005743;GO:0005763;GO:0019843;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit;, F:rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold82 indexed_genome mRNA 644969 649444 . + . ID=transcript_12066;O75323 C9IYJ3 O43801 Q53X96,Protein NipSnap homolog 2,Glioblastoma-amplified sequence {ECO:0000303|PubMed:9615231};, PF07978;, GO:0005741;GO:0005739;GO:0007005;GO:0006119;GO:1901843;, C:mitochondrial outer membrane; C:mitochondrion;, , P:mitochondrion organization; P:oxidative phosphorylation; P:positive regulation of high voltage-gated calcium channel activity; scaffold82 indexed_genome mRNA 655424 660880 . - . ID=transcript_12067;O75323 C9IYJ3 O43801 Q53X96,Protein NipSnap homolog 2,Glioblastoma-amplified sequence {ECO:0000303|PubMed:9615231};, PF07978;, GO:0005741;GO:0005739;GO:0007005;GO:0006119;GO:1901843;, C:mitochondrial outer membrane; C:mitochondrion;, , P:mitochondrion organization; P:oxidative phosphorylation; P:positive regulation of high voltage-gated calcium channel activity; scaffold82 indexed_genome mRNA 669819 693264 . - . ID=transcript_12068;P78330 B2RCR5 Q7Z3S5,Phosphoserine phosphatase,L-3-phosphoserine phosphatase;O-phosphoserine phosphohydrolase;, , GO:0005737;GO:0005829;GO:0043005;GO:0005509;GO:0036425;GO:0042802;GO:0036424;GO:0000287;GO:0004647;GO:0042803;GO:0016311;GO:0001701;GO:0006564;GO:0006563;GO:0009612;GO:0031667;GO:0033574;, C:cytoplasm; C:cytosol; C:neuron projection;, F:calcium ion binding; F:D-phosphoserine phosphatase activity; F:identical protein binding; F:L-phosphoserine phosphatase activity; F:magnesium ion binding; F:phosphoserine phosphatase activity; F:protein homodimerization activity;, P:dephosphorylation; P:in utero embryonic development; P:L-serine biosynthetic process; P:L-serine metabolic process; P:response to mechanical stimulus; P:response to nutrient levels; P:response to testosterone; scaffold82 indexed_genome mRNA 705300 715619 . + . ID=transcript_12069;P40227 A6NCD2 Q3KP28 Q75LP4 Q96S46,T-complex protein 1 subunit zeta,Acute morphine dependence-related protein 2;CCT-zeta-1;HTR3;Tcp20 {ECO:0000303|PubMed:8034610};, PF00118;, GO:0005832;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0071987;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;, C:chaperonin-containing T-complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding; F:WD40-repeat domain binding;, P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization;|P40227 A6NCD2 Q3KP28 Q75LP4 Q96S46,T-complex protein 1 subunit zeta,Acute morphine dependence-related protein 2;CCT-zeta-1;HTR3;Tcp20 {ECO:0000303|PubMed:8034610};, PF00118;, GO:0005832;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0071987;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;, C:chaperonin-containing T-complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding; F:WD40-repeat domain binding;, P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization;|P40227 A6NCD2 Q3KP28 Q75LP4 Q96S46,T-complex protein 1 subunit zeta,Acute morphine dependence-related protein 2;CCT-zeta-1;HTR3;Tcp20 {ECO:0000303|PubMed:8034610};, PF00118;, GO:0005832;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0071987;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;, C:chaperonin-containing T-complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding; F:WD40-repeat domain binding;, P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization;|P40227 A6NCD2 Q3KP28 Q75LP4 Q96S46,T-complex protein 1 subunit zeta,Acute morphine dependence-related protein 2;CCT-zeta-1;HTR3;Tcp20 {ECO:0000303|PubMed:8034610};, PF00118;, GO:0005832;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0071987;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;, C:chaperonin-containing T-complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding; F:WD40-repeat domain binding;, P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization;|P40227 A6NCD2 Q3KP28 Q75LP4 Q96S46,T-complex protein 1 subunit zeta,Acute morphine dependence-related protein 2;CCT-zeta-1;HTR3;Tcp20 {ECO:0000303|PubMed:8034610};, PF00118;, GO:0005832;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0071987;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;, C:chaperonin-containing T-complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding; F:WD40-repeat domain binding;, P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization;|P40227 A6NCD2 Q3KP28 Q75LP4 Q96S46,T-complex protein 1 subunit zeta,Acute morphine dependence-related protein 2;CCT-zeta-1;HTR3;Tcp20 {ECO:0000303|PubMed:8034610};, PF00118;, GO:0005832;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005524;GO:0016887;GO:0044183;GO:0003723;GO:0051082;GO:0071987;GO:1904851;GO:1904871;GO:1904874;GO:0032212;GO:0006457;GO:0050821;, C:chaperonin-containing T-complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule;, F:ATP binding; F:ATPase activity; F:protein folding chaperone; F:RNA binding; F:unfolded protein binding; F:WD40-repeat domain binding;, P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:protein folding; P:protein stabilization; scaffold82 indexed_genome mRNA 716206 736221 . - . ID=transcript_12070;Q8NBJ7 B4DU41 B4DWQ0 Q14DW5 Q53ZE3 Q96BH2 Q9BRN3 Q9BWI1 Q9Y405,Inactive C-alpha-formylglycine-generating enzyme 2 {ECO:0000305},Paralog of formylglycine-generating enzyme {ECO:0000303|PubMed:15687489, ECO:0000303|PubMed:15708861, ECO:0000303|PubMed:18266766};Sulfatase-modifying factor 2 {ECO:0000303|PubMed:15962010};, PF03781;, GO:0005783;GO:0005788;GO:0046872;GO:0006687;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:metal ion binding;, P:glycosphingolipid metabolic process; P:post-translational protein modification;|Q8NBJ7 B4DU41 B4DWQ0 Q14DW5 Q53ZE3 Q96BH2 Q9BRN3 Q9BWI1 Q9Y405,Inactive C-alpha-formylglycine-generating enzyme 2 {ECO:0000305},Paralog of formylglycine-generating enzyme {ECO:0000303|PubMed:15687489, ECO:0000303|PubMed:15708861, ECO:0000303|PubMed:18266766};Sulfatase-modifying factor 2 {ECO:0000303|PubMed:15962010};, PF03781;, GO:0005783;GO:0005788;GO:0046872;GO:0006687;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:metal ion binding;, P:glycosphingolipid metabolic process; P:post-translational protein modification;|Q8NBJ7 B4DU41 B4DWQ0 Q14DW5 Q53ZE3 Q96BH2 Q9BRN3 Q9BWI1 Q9Y405,Inactive C-alpha-formylglycine-generating enzyme 2 {ECO:0000305},Paralog of formylglycine-generating enzyme {ECO:0000303|PubMed:15687489, ECO:0000303|PubMed:15708861, ECO:0000303|PubMed:18266766};Sulfatase-modifying factor 2 {ECO:0000303|PubMed:15962010};, PF03781;, GO:0005783;GO:0005788;GO:0046872;GO:0006687;GO:0043687;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:metal ion binding;, P:glycosphingolipid metabolic process; P:post-translational protein modification;|Q16816 B7Z1D0 F5H2S1 Q75LP5,Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform,Phosphorylase kinase subunit gamma-1;Serine/threonine-protein kinase PHKG1;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0019899;GO:0004689;GO:0106310;GO:0106311;GO:0050321;GO:0005975;GO:0005978;GO:0005980;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:enzyme binding; F:phosphorylase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:carbohydrate metabolic process; P:glycogen biosynthetic process; P:glycogen catabolic process;|Q16816 B7Z1D0 F5H2S1 Q75LP5,Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform,Phosphorylase kinase subunit gamma-1;Serine/threonine-protein kinase PHKG1;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0019899;GO:0004689;GO:0106310;GO:0106311;GO:0050321;GO:0005975;GO:0005978;GO:0005980;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:enzyme binding; F:phosphorylase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:carbohydrate metabolic process; P:glycogen biosynthetic process; P:glycogen catabolic process;|Q16816 B7Z1D0 F5H2S1 Q75LP5,Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform,Phosphorylase kinase subunit gamma-1;Serine/threonine-protein kinase PHKG1;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0019899;GO:0004689;GO:0106310;GO:0106311;GO:0050321;GO:0005975;GO:0005978;GO:0005980;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:enzyme binding; F:phosphorylase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:carbohydrate metabolic process; P:glycogen biosynthetic process; P:glycogen catabolic process;|Q16816 B7Z1D0 F5H2S1 Q75LP5,Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform,Phosphorylase kinase subunit gamma-1;Serine/threonine-protein kinase PHKG1;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0019899;GO:0004689;GO:0106310;GO:0106311;GO:0050321;GO:0005975;GO:0005978;GO:0005980;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:enzyme binding; F:phosphorylase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:carbohydrate metabolic process; P:glycogen biosynthetic process; P:glycogen catabolic process;|Q16816 B7Z1D0 F5H2S1 Q75LP5,Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform,Phosphorylase kinase subunit gamma-1;Serine/threonine-protein kinase PHKG1;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0019899;GO:0004689;GO:0106310;GO:0106311;GO:0050321;GO:0005975;GO:0005978;GO:0005980;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:enzyme binding; F:phosphorylase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:carbohydrate metabolic process; P:glycogen biosynthetic process; P:glycogen catabolic process;|Q16816 B7Z1D0 F5H2S1 Q75LP5,Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform,Phosphorylase kinase subunit gamma-1;Serine/threonine-protein kinase PHKG1;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0019899;GO:0004689;GO:0106310;GO:0106311;GO:0050321;GO:0005975;GO:0005978;GO:0005980;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:enzyme binding; F:phosphorylase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:tau-protein kinase activity;, P:carbohydrate metabolic process; P:glycogen biosynthetic process; P:glycogen catabolic process; scaffold82 indexed_genome mRNA 739968 744594 . - . ID=transcript_12071;Q9Y6H1 Q498C3 Q6NZ50,Coiled-coil-helix-coiled-coil-helix domain-containing protein 2,Aging-associated gene 10 protein;HCV NS2 trans-regulated protein;, PF06747;, GO:0005758;GO:0005739;GO:0005634;GO:0043565;GO:0008134;GO:0034599;GO:0007005;GO:1905448;GO:0045944;GO:1900037;, C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus;, F:sequence-specific DNA binding; F:transcription factor binding;, P:cellular response to oxidative stress; P:mitochondrion organization; P:positive regulation of mitochondrial ATP synthesis coupled electron transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of cellular response to hypoxia; scaffold82 indexed_genome mRNA 750281 752144 . - . ID=transcript_12072;A6NF83,Nuclear protein 2 {ECO:0000305},Nuclear transcriptional regulator 1-like protein {ECO:0000303|PubMed:25899918};Nuclear transcriptional regulator protein 2 {ECO:0000312|HGNC:HGNC:44164};, PF10195;, GO:0005634;GO:0007050;GO:0006974;GO:0009267;GO:0045786;GO:0071157;GO:0008285;GO:0000122;GO:0006357;, C:nucleus;, , P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to starvation; P:negative regulation of cell cycle; P:negative regulation of cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold82 indexed_genome mRNA 864734 874495 . - . ID=transcript_12073;Q8N0U8 B4E222 E7ETM5 Q6AHW9 Q6TEK6,Vitamin K epoxide reductase complex subunit 1-like protein 1,, PF07884;, GO:0005783;GO:0005789;GO:0016021;GO:0048038;GO:0047057;GO:0034599;GO:0017187;GO:0042373;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:quinone binding; F:vitamin-K-epoxide reductase (warfarin-sensitive) activity;, P:cellular response to oxidative stress; P:peptidyl-glutamic acid carboxylation; P:vitamin K metabolic process;|Q8N0U8 B4E222 E7ETM5 Q6AHW9 Q6TEK6,Vitamin K epoxide reductase complex subunit 1-like protein 1,, PF07884;, GO:0005783;GO:0005789;GO:0016021;GO:0048038;GO:0047057;GO:0034599;GO:0017187;GO:0042373;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:quinone binding; F:vitamin-K-epoxide reductase (warfarin-sensitive) activity;, P:cellular response to oxidative stress; P:peptidyl-glutamic acid carboxylation; P:vitamin K metabolic process;|Q8N0U8 B4E222 E7ETM5 Q6AHW9 Q6TEK6,Vitamin K epoxide reductase complex subunit 1-like protein 1,, PF07884;, GO:0005783;GO:0005789;GO:0016021;GO:0048038;GO:0047057;GO:0034599;GO:0017187;GO:0042373;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:quinone binding; F:vitamin-K-epoxide reductase (warfarin-sensitive) activity;, P:cellular response to oxidative stress; P:peptidyl-glutamic acid carboxylation; P:vitamin K metabolic process; scaffold82 indexed_genome mRNA 883291 883872 . - . ID=transcript_12074;P08236 B4E1F6 E9PCV0 Q549U0 Q96CL9,Beta-glucuronidase,Beta-G1;, PF00703;PF02836;PF02837;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0043202;GO:0016020;GO:0004566;GO:0030246;GO:0019904;GO:0005102;GO:0005975;GO:0019391;GO:0006027;GO:0030214;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:membrane;, F:beta-glucuronidase activity; F:carbohydrate binding; F:protein domain specific binding; F:signaling receptor binding;, P:carbohydrate metabolic process; P:glucuronoside catabolic process; P:glycosaminoglycan catabolic process; P:hyaluronan catabolic process; P:neutrophil degranulation; scaffold82 indexed_genome mRNA 884982 886190 . + . ID=transcript_12075;P08236 B4E1F6 E9PCV0 Q549U0 Q96CL9,Beta-glucuronidase,Beta-G1;, PF00703;PF02836;PF02837;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0043202;GO:0016020;GO:0004566;GO:0030246;GO:0019904;GO:0005102;GO:0005975;GO:0019391;GO:0006027;GO:0030214;GO:0043312;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:membrane;, F:beta-glucuronidase activity; F:carbohydrate binding; F:protein domain specific binding; F:signaling receptor binding;, P:carbohydrate metabolic process; P:glucuronoside catabolic process; P:glycosaminoglycan catabolic process; P:hyaluronan catabolic process; P:neutrophil degranulation; scaffold82 indexed_genome mRNA 901833 907563 . + . ID=transcript_12076;Q9UQF0 B2RPD4 O95244 O95245 Q8NHY7 Q9NRZ2 Q9NZG3,Syncytin-1,Endogenous retrovirus group W member 1;Env-W;Envelope polyprotein gPr73;Enverin;HERV-7q Envelope protein;HERV-W envelope protein;HERV-W_7q21.2 provirus ancestral Env polyprotein;Syncytin;, PF00429;, GO:0016021;GO:0005886;GO:0009653;GO:0007520;GO:0006949;GO:0000768;, C:integral component of membrane; C:plasma membrane;, , P:anatomical structure morphogenesis; P:myoblast fusion; P:syncytium formation; P:syncytium formation by plasma membrane fusion; scaffold82 indexed_genome mRNA 937034 947665 . - . ID=transcript_12077;P04424 E7EMI0 E9PE48 Q6LDS5 Q96HS2,Argininosuccinate lyase,Arginosuccinase;, PF14698;PF00206;, GO:0005737;GO:0005829;GO:0070062;GO:0004056;GO:0042802;GO:0042450;GO:0000050;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:argininosuccinate lyase activity; F:identical protein binding;, P:arginine biosynthetic process via ornithine; P:urea cycle;|P04424 E7EMI0 E9PE48 Q6LDS5 Q96HS2,Argininosuccinate lyase,Arginosuccinase;, PF14698;PF00206;, GO:0005737;GO:0005829;GO:0070062;GO:0004056;GO:0042802;GO:0042450;GO:0000050;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:argininosuccinate lyase activity; F:identical protein binding;, P:arginine biosynthetic process via ornithine; P:urea cycle;|P04424 E7EMI0 E9PE48 Q6LDS5 Q96HS2,Argininosuccinate lyase,Arginosuccinase;, PF14698;PF00206;, GO:0005737;GO:0005829;GO:0070062;GO:0004056;GO:0042802;GO:0042450;GO:0000050;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:argininosuccinate lyase activity; F:identical protein binding;, P:arginine biosynthetic process via ornithine; P:urea cycle;|P04424 E7EMI0 E9PE48 Q6LDS5 Q96HS2,Argininosuccinate lyase,Arginosuccinase;, PF14698;PF00206;, GO:0005737;GO:0005829;GO:0070062;GO:0004056;GO:0042802;GO:0042450;GO:0000050;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:argininosuccinate lyase activity; F:identical protein binding;, P:arginine biosynthetic process via ornithine; P:urea cycle; scaffold82 indexed_genome mRNA 961982 988841 . + . ID=transcript_12078;O75575 A8MUZ4 A8MW23 B2R4H4 B4E198 Q3KRA3 Q5HYF1 Q8IXL4,DNA-directed RNA polymerase III subunit RPC9,Calcitonin gene-related peptide-receptor component protein;, PF03874;, GO:0001669;GO:0005829;GO:0009360;GO:0005654;GO:0005886;GO:0005666;GO:0001635;GO:0003899;GO:0000166;GO:0051607;GO:0045087;GO:0007218;GO:0032481;GO:0006383;GO:0006384;, C:acrosomal vesicle; C:cytosol; C:DNA polymerase III complex; C:nucleoplasm; C:plasma membrane; C:RNA polymerase III complex;, F:calcitonin gene-related peptide receptor activity; F:DNA-directed 5'-3' RNA polymerase activity; F:nucleotide binding;, P:defense response to virus; P:innate immune response; P:neuropeptide signaling pathway; P:positive regulation of type I interferon production; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter;|O75575 A8MUZ4 A8MW23 B2R4H4 B4E198 Q3KRA3 Q5HYF1 Q8IXL4,DNA-directed RNA polymerase III subunit RPC9,Calcitonin gene-related peptide-receptor component protein;, PF03874;, GO:0001669;GO:0005829;GO:0009360;GO:0005654;GO:0005886;GO:0005666;GO:0001635;GO:0003899;GO:0000166;GO:0051607;GO:0045087;GO:0007218;GO:0032481;GO:0006383;GO:0006384;, C:acrosomal vesicle; C:cytosol; C:DNA polymerase III complex; C:nucleoplasm; C:plasma membrane; C:RNA polymerase III complex;, F:calcitonin gene-related peptide receptor activity; F:DNA-directed 5'-3' RNA polymerase activity; F:nucleotide binding;, P:defense response to virus; P:innate immune response; P:neuropeptide signaling pathway; P:positive regulation of type I interferon production; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; scaffold82 indexed_genome mRNA 1067702 1152288 . + . ID=transcript_12079;O60507 A4D2M0 Q6FGM7,Protein-tyrosine sulfotransferase 1,Tyrosylprotein sulfotransferase 1;, , GO:0005794;GO:0000139;GO:0030173;GO:0016020;GO:0042803;GO:0008476;GO:0008146;GO:0050427;GO:0006954;GO:0006478;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:membrane;, F:protein homodimerization activity; F:protein-tyrosine sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:inflammatory response; P:peptidyl-tyrosine sulfation; scaffold82 indexed_genome mRNA 1165508 1175960 . + . ID=transcript_12080;Q96MP8 A4D2M4 Q8IVR0,BTB/POZ domain-containing protein KCTD7,, PF02214;, GO:0005737;GO:0005829;GO:0005886;GO:0042802;GO:0090461;GO:0060081;GO:0032411;GO:0043687;GO:0051260;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:identical protein binding;, P:glutamate homeostasis; P:membrane hyperpolarization; P:positive regulation of transporter activity; P:post-translational protein modification; P:protein homooligomerization;|Q96MP8 A4D2M4 Q8IVR0,BTB/POZ domain-containing protein KCTD7,, PF02214;, GO:0005737;GO:0005829;GO:0005886;GO:0042802;GO:0090461;GO:0060081;GO:0032411;GO:0043687;GO:0051260;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:identical protein binding;, P:glutamate homeostasis; P:membrane hyperpolarization; P:positive regulation of transporter activity; P:post-translational protein modification; P:protein homooligomerization; scaffold82 indexed_genome mRNA 1185097 1237858 . + . ID=transcript_12081;Q9UJ41 B4DZM7 Q3HKR2 Q3HKR3 Q53FG0,Rab5 GDP/GTP exchange factor,RAP1;Rabaptin-5-associated exchange factor for Rab5;Rabex-5;, PF18151;PF02204;PF01754;, GO:0005829;GO:0005769;GO:0031901;GO:0005730;GO:0055037;GO:0003677;GO:0005085;GO:0031267;GO:0008270;GO:0006897;GO:0006612;, C:cytosol; C:early endosome; C:early endosome membrane; C:nucleolus; C:recycling endosome;, F:DNA binding; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:zinc ion binding;, P:endocytosis; P:protein targeting to membrane;|Q9UJ41 B4DZM7 Q3HKR2 Q3HKR3 Q53FG0,Rab5 GDP/GTP exchange factor,RAP1;Rabaptin-5-associated exchange factor for Rab5;Rabex-5;, PF18151;PF02204;PF01754;, GO:0005829;GO:0005769;GO:0031901;GO:0005730;GO:0055037;GO:0003677;GO:0005085;GO:0031267;GO:0008270;GO:0006897;GO:0006612;, C:cytosol; C:early endosome; C:early endosome membrane; C:nucleolus; C:recycling endosome;, F:DNA binding; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:zinc ion binding;, P:endocytosis; P:protein targeting to membrane; scaffold82 indexed_genome mRNA 1279032 1280407 . + . ID=transcript_12082;Q9NWD8 Q53H07 Q96FR2,Transmembrane protein 248,, PF14940;, GO:0016021;, C:integral component of membrane; scaffold82 indexed_genome mRNA 1281240 1310328 . + . ID=transcript_12083;Q9NWD8 Q53H07 Q96FR2,Transmembrane protein 248,, PF14940;, GO:0016021;, C:integral component of membrane;|Q9NWD8 Q53H07 Q96FR2,Transmembrane protein 248,, PF14940;, GO:0016021;, C:integral component of membrane; scaffold82 indexed_genome mRNA 1335448 1341345 . - . ID=transcript_12084;Q9Y3A5 A8K0P4 Q96FX0 Q9NV53,Ribosome maturation protein SBDS,Shwachman-Bodian-Diamond syndrome protein;, PF01172;PF09377;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000922;GO:0008017;GO:0043022;GO:0003723;GO:0019843;GO:0048539;GO:0030282;GO:0002244;GO:0001833;GO:0030595;GO:0042256;GO:0007052;GO:0006364;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle pole;, F:microtubule binding; F:ribosome binding; F:RNA binding; F:rRNA binding;, P:bone marrow development; P:bone mineralization; P:hematopoietic progenitor cell differentiation; P:inner cell mass cell proliferation; P:leukocyte chemotaxis; P:mature ribosome assembly; P:mitotic spindle organization; P:rRNA processing;|Q9Y3A5 A8K0P4 Q96FX0 Q9NV53,Ribosome maturation protein SBDS,Shwachman-Bodian-Diamond syndrome protein;, PF01172;PF09377;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000922;GO:0008017;GO:0043022;GO:0003723;GO:0019843;GO:0048539;GO:0030282;GO:0002244;GO:0001833;GO:0030595;GO:0042256;GO:0007052;GO:0006364;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle pole;, F:microtubule binding; F:ribosome binding; F:RNA binding; F:rRNA binding;, P:bone marrow development; P:bone mineralization; P:hematopoietic progenitor cell differentiation; P:inner cell mass cell proliferation; P:leukocyte chemotaxis; P:mature ribosome assembly; P:mitotic spindle organization; P:rRNA processing;|Q9Y3A5 A8K0P4 Q96FX0 Q9NV53,Ribosome maturation protein SBDS,Shwachman-Bodian-Diamond syndrome protein;, PF01172;PF09377;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000922;GO:0008017;GO:0043022;GO:0003723;GO:0019843;GO:0048539;GO:0030282;GO:0002244;GO:0001833;GO:0030595;GO:0042256;GO:0007052;GO:0006364;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle pole;, F:microtubule binding; F:ribosome binding; F:RNA binding; F:rRNA binding;, P:bone marrow development; P:bone mineralization; P:hematopoietic progenitor cell differentiation; P:inner cell mass cell proliferation; P:leukocyte chemotaxis; P:mature ribosome assembly; P:mitotic spindle organization; P:rRNA processing; scaffold82 indexed_genome mRNA 1342548 1482010 . + . ID=transcript_12085;Q9NV66 Q6PJG8 Q75MG8 Q75MN3 Q86V12 Q8IVS7 Q9H9C4,S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1,Radical S-adenosyl methionine and flavodoxin domain-containing protein 1;tRNA wybutosine-synthesizing protein 1 homolog;tRNA-yW-synthesizing protein;, PF00258;PF04055;PF08608;, GO:0051539;GO:0010181;GO:0046872;GO:0102521;GO:0031591;, , F:4 iron, 4 sulfur cluster binding; F:FMN binding; F:metal ion binding; F:tRNA-4-demethylwyosine synthase activity;, P:wybutosine biosynthetic process; scaffold82 indexed_genome mRNA 1594732 2048982 . + . ID=transcript_12086;Q9BXU9 J3KQA7,Calcium-binding protein 8,Calneuron I;Calneuron-1;, PF13499;, GO:0016021;GO:0048471;GO:0005886;GO:0032588;GO:0005509;, C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network membrane;, F:calcium ion binding; scaffold82 indexed_genome mRNA 2722694 2732479 . - . ID=transcript_12087;Q8WXX7 A4D1Y9 L7QET3 L7QF75 Q5D049 Q6PJU5 Q9Y4F2,Autism susceptibility gene 2 protein,, PF15336;, GO:0005737;GO:0005856;GO:0030426;GO:0005634;GO:0003682;GO:0031532;GO:0048675;GO:0097484;GO:0001764;GO:0051571;GO:2000620;GO:0010592;GO:0035022;GO:0045944;, C:cytoplasm; C:cytoskeleton; C:growth cone; C:nucleus;, F:chromatin binding;, P:actin cytoskeleton reorganization; P:axon extension; P:dendrite extension; P:neuron migration; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H4-K16 acetylation; P:positive regulation of lamellipodium assembly; P:positive regulation of Rac protein signal transduction; P:positive regulation of transcription by RNA polymerase II;|Q8WXX7 A4D1Y9 L7QET3 L7QF75 Q5D049 Q6PJU5 Q9Y4F2,Autism susceptibility gene 2 protein,, PF15336;, GO:0005737;GO:0005856;GO:0030426;GO:0005634;GO:0003682;GO:0031532;GO:0048675;GO:0097484;GO:0001764;GO:0051571;GO:2000620;GO:0010592;GO:0035022;GO:0045944;, C:cytoplasm; C:cytoskeleton; C:growth cone; C:nucleus;, F:chromatin binding;, P:actin cytoskeleton reorganization; P:axon extension; P:dendrite extension; P:neuron migration; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H4-K16 acetylation; P:positive regulation of lamellipodium assembly; P:positive regulation of Rac protein signal transduction; P:positive regulation of transcription by RNA polymerase II;|Q8WXX7 A4D1Y9 L7QET3 L7QF75 Q5D049 Q6PJU5 Q9Y4F2,Autism susceptibility gene 2 protein,, PF15336;, GO:0005737;GO:0005856;GO:0030426;GO:0005634;GO:0003682;GO:0031532;GO:0048675;GO:0097484;GO:0001764;GO:0051571;GO:2000620;GO:0010592;GO:0035022;GO:0045944;, C:cytoplasm; C:cytoskeleton; C:growth cone; C:nucleus;, F:chromatin binding;, P:actin cytoskeleton reorganization; P:axon extension; P:dendrite extension; P:neuron migration; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H4-K16 acetylation; P:positive regulation of lamellipodium assembly; P:positive regulation of Rac protein signal transduction; P:positive regulation of transcription by RNA polymerase II;|Q8WXX7 A4D1Y9 L7QET3 L7QF75 Q5D049 Q6PJU5 Q9Y4F2,Autism susceptibility gene 2 protein,, PF15336;, GO:0005737;GO:0005856;GO:0030426;GO:0005634;GO:0003682;GO:0031532;GO:0048675;GO:0097484;GO:0001764;GO:0051571;GO:2000620;GO:0010592;GO:0035022;GO:0045944;, C:cytoplasm; C:cytoskeleton; C:growth cone; C:nucleus;, F:chromatin binding;, P:actin cytoskeleton reorganization; P:axon extension; P:dendrite extension; P:neuron migration; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H4-K16 acetylation; P:positive regulation of lamellipodium assembly; P:positive regulation of Rac protein signal transduction; P:positive regulation of transcription by RNA polymerase II;|Q8WXX7 A4D1Y9 L7QET3 L7QF75 Q5D049 Q6PJU5 Q9Y4F2,Autism susceptibility gene 2 protein,, PF15336;, GO:0005737;GO:0005856;GO:0030426;GO:0005634;GO:0003682;GO:0031532;GO:0048675;GO:0097484;GO:0001764;GO:0051571;GO:2000620;GO:0010592;GO:0035022;GO:0045944;, C:cytoplasm; C:cytoskeleton; C:growth cone; C:nucleus;, F:chromatin binding;, P:actin cytoskeleton reorganization; P:axon extension; P:dendrite extension; P:neuron migration; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H4-K16 acetylation; P:positive regulation of lamellipodium assembly; P:positive regulation of Rac protein signal transduction; P:positive regulation of transcription by RNA polymerase II; scaffold82 indexed_genome mRNA 2735858 2743273 . - . ID=transcript_12088;Q8WXX7 A4D1Y9 L7QET3 L7QF75 Q5D049 Q6PJU5 Q9Y4F2,Autism susceptibility gene 2 protein,, PF15336;, GO:0005737;GO:0005856;GO:0030426;GO:0005634;GO:0003682;GO:0031532;GO:0048675;GO:0097484;GO:0001764;GO:0051571;GO:2000620;GO:0010592;GO:0035022;GO:0045944;, C:cytoplasm; C:cytoskeleton; C:growth cone; C:nucleus;, F:chromatin binding;, P:actin cytoskeleton reorganization; P:axon extension; P:dendrite extension; P:neuron migration; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H4-K16 acetylation; P:positive regulation of lamellipodium assembly; P:positive regulation of Rac protein signal transduction; P:positive regulation of transcription by RNA polymerase II;|Q8WXX7 A4D1Y9 L7QET3 L7QF75 Q5D049 Q6PJU5 Q9Y4F2,Autism susceptibility gene 2 protein,, PF15336;, GO:0005737;GO:0005856;GO:0030426;GO:0005634;GO:0003682;GO:0031532;GO:0048675;GO:0097484;GO:0001764;GO:0051571;GO:2000620;GO:0010592;GO:0035022;GO:0045944;, C:cytoplasm; C:cytoskeleton; C:growth cone; C:nucleus;, F:chromatin binding;, P:actin cytoskeleton reorganization; P:axon extension; P:dendrite extension; P:neuron migration; P:positive regulation of histone H3-K4 methylation; P:positive regulation of histone H4-K16 acetylation; P:positive regulation of lamellipodium assembly; P:positive regulation of Rac protein signal transduction; P:positive regulation of transcription by RNA polymerase II; scaffold82 indexed_genome mRNA 5482357 5483543 . + . ID=transcript_12089;Q59GN2,Putative 60S ribosomal protein L39-like 5,60S ribosomal protein L39 pseudogene 5;, PF00832;, GO:0022625;GO:0003735;GO:0006412;, C:cytosolic large ribosomal subunit;, F:structural constituent of ribosome;, P:translation; scaffold82 indexed_genome mRNA 5537002 5558230 . + . ID=transcript_12090;Q8NAP1 D6W5V0 Q68D93 Q6P198 Q6PII7 Q7Z720 Q86UK9,Putative protein CASTOR 3 {ECO:0000305},STAG3 opposite strand transcript protein {ECO:0000305};, PF13840;PF18700;, GO:0005829;GO:1903577;GO:1904262;GO:1902531;, C:cytosol;, , P:cellular response to L-arginine; P:negative regulation of TORC1 signaling; P:regulation of intracellular signal transduction;|A6NHX0 A6NNH0 B9EJH9,Cytosolic arginine sensor for mTORC1 subunit 2 {ECO:0000312|HGNC:HGNC:37073},Cellular arginine sensor for mTORC1 protein 2 {ECO:0000305|PubMed:26972053};GATS-like protein 2 {ECO:0000305};, PF13840;PF18700;, GO:0005829;GO:0042802;GO:0034198;GO:1903577;GO:1904262;GO:1902531;, C:cytosol;, F:identical protein binding;, P:cellular response to amino acid starvation; P:cellular response to L-arginine; P:negative regulation of TORC1 signaling; P:regulation of intracellular signal transduction;|Q8NAP1 D6W5V0 Q68D93 Q6P198 Q6PII7 Q7Z720 Q86UK9,Putative protein CASTOR 3 {ECO:0000305},STAG3 opposite strand transcript protein {ECO:0000305};, PF13840;PF18700;, GO:0005829;GO:1903577;GO:1904262;GO:1902531;, C:cytosol;, , P:cellular response to L-arginine; P:negative regulation of TORC1 signaling; P:regulation of intracellular signal transduction;|A6NHX0 A6NNH0 B9EJH9,Cytosolic arginine sensor for mTORC1 subunit 2 {ECO:0000312|HGNC:HGNC:37073},Cellular arginine sensor for mTORC1 protein 2 {ECO:0000305|PubMed:26972053};GATS-like protein 2 {ECO:0000305};, PF13840;PF18700;, GO:0005829;GO:0042802;GO:0034198;GO:1903577;GO:1904262;GO:1902531;, C:cytosol;, F:identical protein binding;, P:cellular response to amino acid starvation; P:cellular response to L-arginine; P:negative regulation of TORC1 signaling; P:regulation of intracellular signal transduction; scaffold82 indexed_genome mRNA 5558329 5582270 . + . ID=transcript_12091;Q96I51 D3DXK0 F5GX55 F5H6C7 Q548B1 Q8IW88 Q8N572 Q9H0G7,RCC1-like G exchanging factor-like protein,Williams-Beuren syndrome chromosomal region 16 protein {ECO:0000303|PubMed:28608466};, PF00415;, GO:0005743;GO:0031966;GO:0005525;GO:0005085;GO:0003723;GO:0019843;GO:1990613;GO:0070131;, C:mitochondrial inner membrane; C:mitochondrial membrane;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:RNA binding; F:rRNA binding;, P:mitochondrial membrane fusion; P:positive regulation of mitochondrial translation;|Q96I51 D3DXK0 F5GX55 F5H6C7 Q548B1 Q8IW88 Q8N572 Q9H0G7,RCC1-like G exchanging factor-like protein,Williams-Beuren syndrome chromosomal region 16 protein {ECO:0000303|PubMed:28608466};, PF00415;, GO:0005743;GO:0031966;GO:0005525;GO:0005085;GO:0003723;GO:0019843;GO:1990613;GO:0070131;, C:mitochondrial inner membrane; C:mitochondrial membrane;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:RNA binding; F:rRNA binding;, P:mitochondrial membrane fusion; P:positive regulation of mitochondrial translation;|Q96I51 D3DXK0 F5GX55 F5H6C7 Q548B1 Q8IW88 Q8N572 Q9H0G7,RCC1-like G exchanging factor-like protein,Williams-Beuren syndrome chromosomal region 16 protein {ECO:0000303|PubMed:28608466};, PF00415;, GO:0005743;GO:0031966;GO:0005525;GO:0005085;GO:0003723;GO:0019843;GO:1990613;GO:0070131;, C:mitochondrial inner membrane; C:mitochondrial membrane;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:RNA binding; F:rRNA binding;, P:mitochondrial membrane fusion; P:positive regulation of mitochondrial translation;|Q96I51 D3DXK0 F5GX55 F5H6C7 Q548B1 Q8IW88 Q8N572 Q9H0G7,RCC1-like G exchanging factor-like protein,Williams-Beuren syndrome chromosomal region 16 protein {ECO:0000303|PubMed:28608466};, PF00415;, GO:0005743;GO:0031966;GO:0005525;GO:0005085;GO:0003723;GO:0019843;GO:1990613;GO:0070131;, C:mitochondrial inner membrane; C:mitochondrial membrane;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:RNA binding; F:rRNA binding;, P:mitochondrial membrane fusion; P:positive regulation of mitochondrial translation;|Q96I51 D3DXK0 F5GX55 F5H6C7 Q548B1 Q8IW88 Q8N572 Q9H0G7,RCC1-like G exchanging factor-like protein,Williams-Beuren syndrome chromosomal region 16 protein {ECO:0000303|PubMed:28608466};, PF00415;, GO:0005743;GO:0031966;GO:0005525;GO:0005085;GO:0003723;GO:0019843;GO:1990613;GO:0070131;, C:mitochondrial inner membrane; C:mitochondrial membrane;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:RNA binding; F:rRNA binding;, P:mitochondrial membrane fusion; P:positive regulation of mitochondrial translation;|Q96I51 D3DXK0 F5GX55 F5H6C7 Q548B1 Q8IW88 Q8N572 Q9H0G7,RCC1-like G exchanging factor-like protein,Williams-Beuren syndrome chromosomal region 16 protein {ECO:0000303|PubMed:28608466};, PF00415;, GO:0005743;GO:0031966;GO:0005525;GO:0005085;GO:0003723;GO:0019843;GO:1990613;GO:0070131;, C:mitochondrial inner membrane; C:mitochondrial membrane;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:RNA binding; F:rRNA binding;, P:mitochondrial membrane fusion; P:positive regulation of mitochondrial translation;|Q96I51 D3DXK0 F5GX55 F5H6C7 Q548B1 Q8IW88 Q8N572 Q9H0G7,RCC1-like G exchanging factor-like protein,Williams-Beuren syndrome chromosomal region 16 protein {ECO:0000303|PubMed:28608466};, PF00415;, GO:0005743;GO:0031966;GO:0005525;GO:0005085;GO:0003723;GO:0019843;GO:1990613;GO:0070131;, C:mitochondrial inner membrane; C:mitochondrial membrane;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:RNA binding; F:rRNA binding;, P:mitochondrial membrane fusion; P:positive regulation of mitochondrial translation;|Q96I51 D3DXK0 F5GX55 F5H6C7 Q548B1 Q8IW88 Q8N572 Q9H0G7,RCC1-like G exchanging factor-like protein,Williams-Beuren syndrome chromosomal region 16 protein {ECO:0000303|PubMed:28608466};, PF00415;, GO:0005743;GO:0031966;GO:0005525;GO:0005085;GO:0003723;GO:0019843;GO:1990613;GO:0070131;, C:mitochondrial inner membrane; C:mitochondrial membrane;, F:GTP binding; F:guanyl-nucleotide exchange factor activity; F:RNA binding; F:rRNA binding;, P:mitochondrial membrane fusion; P:positive regulation of mitochondrial translation; scaffold82 indexed_genome mRNA 5591392 5635162 . + . ID=transcript_12092;Q86WX4 Q8ND85 Q8NDE5,General transcription factor II-I repeat domain-containing protein 2A,Transcription factor GTF2IRD2-alpha;, PF02946;, GO:0005634;GO:0003677;GO:0000981;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific;|Q6EKJ0 B2RNE9 Q69GU6 Q8N979 Q9H739,General transcription factor II-I repeat domain-containing protein 2B,Transcription factor GTF2IRD2-beta;, PF02946;PF18658;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; scaffold82 indexed_genome mRNA 5635164 5640753 . - . ID=transcript_12093;Q6EKJ0 B2RNE9 Q69GU6 Q8N979 Q9H739,General transcription factor II-I repeat domain-containing protein 2B,Transcription factor GTF2IRD2-beta;, PF02946;PF18658;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; scaffold82 indexed_genome mRNA 5646242 5661258 . - . ID=transcript_12094;A8MVU1,Putative neutrophil cytosol factor 1C,Putative SH3 and PX domain-containing protein 1C;, PF16621;PF08944;PF00787;PF00018;, GO:0005737;GO:0060090;GO:0035091;GO:0016175;GO:0016176;GO:0045730;GO:0006801;, C:cytoplasm;, F:molecular adaptor activity; F:phosphatidylinositol binding; F:superoxide-generating NAD(P)H oxidase activity; F:superoxide-generating NADPH oxidase activator activity;, P:respiratory burst; P:superoxide metabolic process;|Q9UDV9 Q9UMU2,Neutrophil cytosol factor 1,47 kDa autosomal chronic granulomatous disease protein;47 kDa neutrophil oxidase factor;NCF-47K;Neutrophil NADPH oxidase factor 1;Nox organizer 2;Nox-organizing protein 2;SH3 and PX domain-containing protein 1A;p47-phox;, PF16621;PF08944;PF00787;PF00018;, GO:0005737;GO:0005829;GO:0030425;GO:0019898;GO:0005794;GO:0016020;GO:0043020;GO:0043025;GO:0032010;GO:0005886;GO:0005791;GO:0009055;GO:0060090;GO:0035091;GO:0043325;GO:0017124;GO:0016175;GO:0016176;GO:0002479;GO:0006915;GO:0045454;GO:0006968;GO:0071276;GO:0034599;GO:0034614;GO:0045087;GO:0045741;GO:0046330;GO:1900745;GO:0014068;GO:0045893;GO:0006612;GO:0045730;GO:0042554;GO:0006801;GO:0048010;, C:cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of membrane; C:Golgi apparatus; C:membrane; C:NADPH oxidase complex; C:neuronal cell body; C:phagolysosome; C:plasma membrane; C:rough endoplasmic reticulum;, F:electron transfer activity; F:molecular adaptor activity; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:SH3 domain binding; F:superoxide-generating NAD(P)H oxidase activity; F:superoxide-generating NADPH oxidase activator activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic process; P:cell redox homeostasis; P:cellular defense response; P:cellular response to cadmium ion; P:cellular response to oxidative stress; P:cellular response to reactive oxygen species; P:innate immune response; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of transcription, DNA-templated; P:protein targeting to membrane; P:respiratory burst; P:superoxide anion generation; P:superoxide metabolic process; P:vascular endothelial growth factor receptor signaling pathway; scaffold82 indexed_genome mRNA 5669858 5731200 . - . ID=transcript_12095;Q75M88 Q86U51 Q9BSZ4,General transcription factor II-I,Bruton tyrosine kinase-associated protein 135;SRF-Phox1-interacting protein;Williams-Beuren syndrome chromosomal region 6 protein;, PF02946;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001102;GO:0016525;GO:0100026;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of angiogenesis; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter;|Q75M88 Q86U51 Q9BSZ4,General transcription factor II-I,Bruton tyrosine kinase-associated protein 135;SRF-Phox1-interacting protein;Williams-Beuren syndrome chromosomal region 6 protein;, PF02946;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001102;GO:0016525;GO:0100026;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of angiogenesis; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter;|Q75M88 Q86U51 Q9BSZ4,General transcription factor II-I,Bruton tyrosine kinase-associated protein 135;SRF-Phox1-interacting protein;Williams-Beuren syndrome chromosomal region 6 protein;, PF02946;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001102;GO:0016525;GO:0100026;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of angiogenesis; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter;|Q75M88 Q86U51 Q9BSZ4,General transcription factor II-I,Bruton tyrosine kinase-associated protein 135;SRF-Phox1-interacting protein;Williams-Beuren syndrome chromosomal region 6 protein;, PF02946;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001102;GO:0016525;GO:0100026;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of angiogenesis; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter;|Q75M88 Q86U51 Q9BSZ4,General transcription factor II-I,Bruton tyrosine kinase-associated protein 135;SRF-Phox1-interacting protein;Williams-Beuren syndrome chromosomal region 6 protein;, PF02946;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001102;GO:0016525;GO:0100026;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of angiogenesis; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter;|Q75M88 Q86U51 Q9BSZ4,General transcription factor II-I,Bruton tyrosine kinase-associated protein 135;SRF-Phox1-interacting protein;Williams-Beuren syndrome chromosomal region 6 protein;, PF02946;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001102;GO:0016525;GO:0100026;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of angiogenesis; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter;|Q75M88 Q86U51 Q9BSZ4,General transcription factor II-I,Bruton tyrosine kinase-associated protein 135;SRF-Phox1-interacting protein;Williams-Beuren syndrome chromosomal region 6 protein;, PF02946;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001102;GO:0016525;GO:0100026;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of angiogenesis; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter;|Q75M88 Q86U51 Q9BSZ4,General transcription factor II-I,Bruton tyrosine kinase-associated protein 135;SRF-Phox1-interacting protein;Williams-Beuren syndrome chromosomal region 6 protein;, PF02946;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001102;GO:0016525;GO:0100026;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of angiogenesis; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter;|Q75M88 Q86U51 Q9BSZ4,General transcription factor II-I,Bruton tyrosine kinase-associated protein 135;SRF-Phox1-interacting protein;Williams-Beuren syndrome chromosomal region 6 protein;, PF02946;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001102;GO:0016525;GO:0100026;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of angiogenesis; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter;|Q75M88 Q86U51 Q9BSZ4,General transcription factor II-I,Bruton tyrosine kinase-associated protein 135;SRF-Phox1-interacting protein;Williams-Beuren syndrome chromosomal region 6 protein;, PF02946;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001102;GO:0016525;GO:0100026;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding;, P:negative regulation of angiogenesis; P:positive regulation of DNA repair by transcription from RNA polymerase II promoter; scaffold82 indexed_genome mRNA 5807847 5879918 . - . ID=transcript_12096;Q9UHL9 O95444 Q6DSU6 Q75MX7 Q86UM3 Q8WVC4 Q9UHK8 Q9UI91,General transcription factor II-I repeat domain-containing protein 1,General transcription factor III;MusTRD1/BEN;Muscle TFII-I repeat domain-containing protein 1;Slow-muscle-fiber enhancer-binding protein;USE B1-binding protein;Williams-Beuren syndrome chromosomal region 11 protein;Williams-Beuren syndrome chromosomal region 12 protein;, PF02946;, GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0007275;GO:0000122;GO:0006355;GO:0006366;GO:0014886;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; P:transition between slow and fast fiber; scaffold82 indexed_genome mRNA 5960368 6011091 . - . ID=transcript_12097;Q9UDT6 O14527 O43611,CAP-Gly domain-containing linker protein 2,Cytoplasmic linker protein 115;Cytoplasmic linker protein 2;Williams-Beuren syndrome chromosomal region 3 protein;Williams-Beuren syndrome chromosomal region 4 protein;, PF01302;, GO:0005737;GO:0005875;GO:0035371;GO:0005634;GO:0008017;GO:0051010;GO:0031122;, C:cytoplasm; C:microtubule associated complex; C:microtubule plus-end; C:nucleus;, F:microtubule binding; F:microtubule plus-end binding;, P:cytoplasmic microtubule organization;|Q9UDT6 O14527 O43611,CAP-Gly domain-containing linker protein 2,Cytoplasmic linker protein 115;Cytoplasmic linker protein 2;Williams-Beuren syndrome chromosomal region 3 protein;Williams-Beuren syndrome chromosomal region 4 protein;, PF01302;, GO:0005737;GO:0005875;GO:0035371;GO:0005634;GO:0008017;GO:0051010;GO:0031122;, C:cytoplasm; C:microtubule associated complex; C:microtubule plus-end; C:nucleus;, F:microtubule binding; F:microtubule plus-end binding;, P:cytoplasmic microtubule organization;|Q9UDT6 O14527 O43611,CAP-Gly domain-containing linker protein 2,Cytoplasmic linker protein 115;Cytoplasmic linker protein 2;Williams-Beuren syndrome chromosomal region 3 protein;Williams-Beuren syndrome chromosomal region 4 protein;, PF01302;, GO:0005737;GO:0005875;GO:0035371;GO:0005634;GO:0008017;GO:0051010;GO:0031122;, C:cytoplasm; C:microtubule associated complex; C:microtubule plus-end; C:nucleus;, F:microtubule binding; F:microtubule plus-end binding;, P:cytoplasmic microtubule organization; scaffold82 indexed_genome mRNA 6059521 6072273 . + . ID=transcript_12098;P35250 B5BU07 D3DXG3 P32846 Q9BU93,Replication factor C subunit 2,Activator 1 40 kDa subunit;Activator 1 subunit 2;Replication factor C 40 kDa subunit;, PF00004;PF08542;, GO:0031390;GO:0005663;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003677;GO:0019899;GO:0006287;GO:0042769;GO:0032508;GO:0006281;GO:0006260;GO:0006261;GO:0070987;GO:0042276;GO:0006297;GO:0033683;GO:0006296;GO:1900264;GO:1901796;GO:0032201;GO:0006283;GO:0019985;, C:Ctf18 RFC-like complex; C:DNA replication factor C complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:DNA binding; F:enzyme binding;, P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA duplex unwinding; P:DNA repair; P:DNA replication; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of DNA-directed DNA polymerase activity; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis;|P35250 B5BU07 D3DXG3 P32846 Q9BU93,Replication factor C subunit 2,Activator 1 40 kDa subunit;Activator 1 subunit 2;Replication factor C 40 kDa subunit;, PF00004;PF08542;, GO:0031390;GO:0005663;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003677;GO:0019899;GO:0006287;GO:0042769;GO:0032508;GO:0006281;GO:0006260;GO:0006261;GO:0070987;GO:0042276;GO:0006297;GO:0033683;GO:0006296;GO:1900264;GO:1901796;GO:0032201;GO:0006283;GO:0019985;, C:Ctf18 RFC-like complex; C:DNA replication factor C complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:DNA binding; F:enzyme binding;, P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA duplex unwinding; P:DNA repair; P:DNA replication; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of DNA-directed DNA polymerase activity; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold82 indexed_genome mRNA 6076632 6089387 . - . ID=transcript_12099;Q9GZY6 A6NFK6 A8K209 A8K4F1 D3DXF9 Q9BXX8 Q9NZY9,Linker for activation of T-cells family member 2,Linker for activation of B-cells;Membrane-associated adapter molecule;Non-T-cell activation linker;Williams-Beuren syndrome chromosomal region 15 protein;Williams-Beuren syndrome chromosomal region 5 protein;, PF15703;, GO:0070062;GO:0016021;GO:0045121;GO:0005886;GO:0042169;GO:0002250;GO:0042113;GO:0050853;GO:0019722;GO:0038095;GO:0035556;GO:0043303;, C:extracellular exosome; C:integral component of membrane; C:membrane raft; C:plasma membrane;, F:SH2 domain binding;, P:adaptive immune response; P:B cell activation; P:B cell receptor signaling pathway; P:calcium-mediated signaling; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:mast cell degranulation;|Q9GZY6 A6NFK6 A8K209 A8K4F1 D3DXF9 Q9BXX8 Q9NZY9,Linker for activation of T-cells family member 2,Linker for activation of B-cells;Membrane-associated adapter molecule;Non-T-cell activation linker;Williams-Beuren syndrome chromosomal region 15 protein;Williams-Beuren syndrome chromosomal region 5 protein;, PF15703;, GO:0070062;GO:0016021;GO:0045121;GO:0005886;GO:0042169;GO:0002250;GO:0042113;GO:0050853;GO:0019722;GO:0038095;GO:0035556;GO:0043303;, C:extracellular exosome; C:integral component of membrane; C:membrane raft; C:plasma membrane;, F:SH2 domain binding;, P:adaptive immune response; P:B cell activation; P:B cell receptor signaling pathway; P:calcium-mediated signaling; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:mast cell degranulation; scaffold82 indexed_genome mRNA 6094550 6097021 . - . ID=transcript_12100;Q15056 A8K3R1 D3DXF6 D3DXF8,Eukaryotic translation initiation factor 4H,Williams-Beuren syndrome chromosomal region 1 protein;, PF00076;, GO:0005829;GO:0016281;GO:0016020;GO:0048471;GO:0045296;GO:0043024;GO:0003723;GO:0033592;GO:0034057;GO:0008135;GO:0003743;GO:0048589;GO:0097010;GO:0001731;GO:0006446;GO:0019953;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane; C:perinuclear region of cytoplasm;, F:cadherin binding; F:ribosomal small subunit binding; F:RNA binding; F:RNA strand annealing activity; F:RNA strand-exchange activity; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:developmental growth; P:eukaryotic translation initiation factor 4F complex assembly; P:formation of translation preinitiation complex; P:regulation of translational initiation; P:sexual reproduction; P:translational initiation; P:viral process; scaffold82 indexed_genome mRNA 6100003 6101696 . - . ID=transcript_12101;Q15056 A8K3R1 D3DXF6 D3DXF8,Eukaryotic translation initiation factor 4H,Williams-Beuren syndrome chromosomal region 1 protein;, PF00076;, GO:0005829;GO:0016281;GO:0016020;GO:0048471;GO:0045296;GO:0043024;GO:0003723;GO:0033592;GO:0034057;GO:0008135;GO:0003743;GO:0048589;GO:0097010;GO:0001731;GO:0006446;GO:0019953;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:membrane; C:perinuclear region of cytoplasm;, F:cadherin binding; F:ribosomal small subunit binding; F:RNA binding; F:RNA strand annealing activity; F:RNA strand-exchange activity; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:developmental growth; P:eukaryotic translation initiation factor 4F complex assembly; P:formation of translation preinitiation complex; P:regulation of translational initiation; P:sexual reproduction; P:translational initiation; P:viral process; scaffold82 indexed_genome mRNA 6144692 6150655 . - . ID=transcript_12102;P53667 B7Z6I8 D3DXF4 D3DXF5 O15283 Q15820 Q15821 Q75MU3 Q9Y5Q1,LIM domain kinase 1,, PF00412;PF00595;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0030027;GO:0043005;GO:0016607;GO:0005634;GO:0005524;GO:0031072;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0038096;GO:0051444;GO:0007399;GO:0032233;GO:0045773;GO:0051496;GO:0006468;GO:0007266;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:lamellipodium; C:neuron projection; C:nuclear speck; C:nucleus;, F:ATP binding; F:heat shock protein binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of ubiquitin-protein transferase activity; P:nervous system development; P:positive regulation of actin filament bundle assembly; P:positive regulation of axon extension; P:positive regulation of stress fiber assembly; P:protein phosphorylation; P:Rho protein signal transduction; P:signal transduction; scaffold82 indexed_genome mRNA 6151103 6167839 . - . ID=transcript_12103;P53667 B7Z6I8 D3DXF4 D3DXF5 O15283 Q15820 Q15821 Q75MU3 Q9Y5Q1,LIM domain kinase 1,, PF00412;PF00595;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0030027;GO:0043005;GO:0016607;GO:0005634;GO:0005524;GO:0031072;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0038096;GO:0051444;GO:0007399;GO:0032233;GO:0045773;GO:0051496;GO:0006468;GO:0007266;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:lamellipodium; C:neuron projection; C:nuclear speck; C:nucleus;, F:ATP binding; F:heat shock protein binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:negative regulation of ubiquitin-protein transferase activity; P:nervous system development; P:positive regulation of actin filament bundle assembly; P:positive regulation of axon extension; P:positive regulation of stress fiber assembly; P:protein phosphorylation; P:Rho protein signal transduction; P:signal transduction; scaffold82 indexed_genome mRNA 6187514 6212026 . - . ID=transcript_12104;Q6ZWJ6 Q75MU5 Q7Z316 Q7Z3F5 Q9UMF5,Elastin,Tropoelastin;, , GO:0062023;GO:0071953;GO:0031012;GO:0005576;GO:0050840;GO:0005201;GO:0009887;GO:0003180;GO:0008015;GO:0030198;GO:0003151;GO:0030833;GO:0048660;GO:0007585;GO:0007519;GO:0043149;, C:collagen-containing extracellular matrix; C:elastic fiber; C:extracellular matrix; C:extracellular region;, F:extracellular matrix binding; F:extracellular matrix structural constituent;, P:animal organ morphogenesis; P:aortic valve morphogenesis; P:blood circulation; P:extracellular matrix organization; P:outflow tract morphogenesis; P:regulation of actin filament polymerization; P:regulation of smooth muscle cell proliferation; P:respiratory gaseous exchange by respiratory system; P:skeletal muscle tissue development; P:stress fiber assembly; scaffold82 indexed_genome mRNA 6356016 6359346 . + . ID=transcript_12105;Q8N6F8,Methyltransferase-like protein 27 {ECO:0000312|HGNC:HGNC:19068},Williams-Beuren syndrome chromosomal region 27 protein {ECO:0000312|HGNC:HGNC:19068};, PF13649;, GO:0008168;, , F:methyltransferase activity;|Q8N6F8,Methyltransferase-like protein 27 {ECO:0000312|HGNC:HGNC:19068},Williams-Beuren syndrome chromosomal region 27 protein {ECO:0000312|HGNC:HGNC:19068};, PF13649;, GO:0008168;, , F:methyltransferase activity; scaffold82 indexed_genome mRNA 6360204 6361900 . + . ID=transcript_12106;O14493,Claudin-4,Clostridium perfringens enterotoxin receptor {ECO:0000303|PubMed:9334247};Williams-Beuren syndrome chromosomal region 8 protein;, PF00822;, GO:0016324;GO:0016327;GO:0009925;GO:0005923;GO:0005911;GO:0034707;GO:0005887;GO:0016328;GO:0005886;GO:0070160;GO:0005254;GO:0042802;GO:0005198;GO:0004888;GO:0070830;GO:0016338;GO:0007155;GO:0007623;GO:0061436;GO:0007565;GO:0030335;GO:1905050;GO:0090303;GO:0022604;GO:0070293;GO:0032570;, C:apical plasma membrane; C:apicolateral plasma membrane; C:basal plasma membrane; C:bicellular tight junction; C:cell-cell junction; C:chloride channel complex; C:integral component of plasma membrane; C:lateral plasma membrane; C:plasma membrane; C:tight junction;, F:chloride channel activity; F:identical protein binding; F:structural molecule activity; F:transmembrane signaling receptor activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:circadian rhythm; P:establishment of skin barrier; P:female pregnancy; P:positive regulation of cell migration; P:positive regulation of metallopeptidase activity; P:positive regulation of wound healing; P:regulation of cell morphogenesis; P:renal absorption; P:response to progesterone; scaffold82 indexed_genome mRNA 6391986 6393279 . + . ID=transcript_12107;O15551,Claudin-3,Clostridium perfringens enterotoxin receptor 2;Rat ventral prostate.1 protein homolog;, PF00822;, GO:0043296;GO:0016327;GO:0005923;GO:0005911;GO:0005737;GO:0016021;GO:0005887;GO:0016328;GO:0005886;GO:0032991;GO:0070160;GO:0042802;GO:0005198;GO:0004888;GO:0031532;GO:0070830;GO:0016338;GO:0007155;GO:0034331;GO:0003382;GO:0014045;GO:0035633;GO:0030336;GO:0008285;GO:0010629;GO:0061045;GO:1903348;GO:1901890;GO:0030335;GO:0010628;GO:1905050;GO:0001934;GO:0090303;GO:0022604;GO:0090559;GO:0150111;GO:0045471;GO:0001666;, C:apical junction complex; C:apicolateral plasma membrane; C:bicellular tight junction; C:cell-cell junction; C:cytoplasm; C:integral component of membrane; C:integral component of plasma membrane; C:lateral plasma membrane; C:plasma membrane; C:protein-containing complex; C:tight junction;, F:identical protein binding; F:structural molecule activity; F:transmembrane signaling receptor activity;, P:actin cytoskeleton reorganization; P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:cell junction maintenance; P:epithelial cell morphogenesis; P:establishment of endothelial blood-brain barrier; P:maintenance of blood-brain barrier; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of wound healing; P:positive regulation of bicellular tight junction assembly; P:positive regulation of cell junction assembly; P:positive regulation of cell migration; P:positive regulation of gene expression; P:positive regulation of metallopeptidase activity; P:positive regulation of protein phosphorylation; P:positive regulation of wound healing; P:regulation of cell morphogenesis; P:regulation of membrane permeability; P:regulation of transepithelial transport; P:response to ethanol; P:response to hypoxia; scaffold82 indexed_genome mRNA 6413508 6415979 . + . ID=transcript_12108;Q8NFV4 H7BYM8 Q6PJU0 Q8N722 Q8N723 Q8NFV2 Q8NFV3 Q9HBS8,Protein ABHD11 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 11 {ECO:0000305};Williams-Beuren syndrome chromosomal region 21 protein;, PF12697;, GO:0005739;GO:0016787;, C:mitochondrion;, F:hydrolase activity; scaffold82 indexed_genome mRNA 6448720 6460444 . - . ID=transcript_12109;O43709 A8K501 C9K060 Q96P12 Q9BQ58 Q9HBP9,Probable 18S rRNA (guanine-N(7))-methyltransferase {ECO:0000305},Bud site selection protein 23 homolog;Metastasis-related methyltransferase 1;Williams-Beuren syndrome chromosomal region 22 protein;rRNA methyltransferase and ribosome maturation factor {ECO:0000312|HGNC:HGNC:16405};, PF08241;PF12589;, GO:0005730;GO:0005654;GO:0048471;GO:0008168;GO:0046982;GO:0003723;GO:0016435;GO:0006325;GO:2000234;GO:0070476;GO:0031167;, C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:methyltransferase activity; F:protein heterodimerization activity; F:RNA binding; F:rRNA (guanine) methyltransferase activity;, P:chromatin organization; P:positive regulation of rRNA processing; P:rRNA (guanine-N7)-methylation; P:rRNA methylation;|O43709 A8K501 C9K060 Q96P12 Q9BQ58 Q9HBP9,Probable 18S rRNA (guanine-N(7))-methyltransferase {ECO:0000305},Bud site selection protein 23 homolog;Metastasis-related methyltransferase 1;Williams-Beuren syndrome chromosomal region 22 protein;rRNA methyltransferase and ribosome maturation factor {ECO:0000312|HGNC:HGNC:16405};, PF08241;PF12589;, GO:0005730;GO:0005654;GO:0048471;GO:0008168;GO:0046982;GO:0003723;GO:0016435;GO:0006325;GO:2000234;GO:0070476;GO:0031167;, C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:methyltransferase activity; F:protein heterodimerization activity; F:RNA binding; F:rRNA (guanine) methyltransferase activity;, P:chromatin organization; P:positive regulation of rRNA processing; P:rRNA (guanine-N7)-methylation; P:rRNA methylation;|O43709 A8K501 C9K060 Q96P12 Q9BQ58 Q9HBP9,Probable 18S rRNA (guanine-N(7))-methyltransferase {ECO:0000305},Bud site selection protein 23 homolog;Metastasis-related methyltransferase 1;Williams-Beuren syndrome chromosomal region 22 protein;rRNA methyltransferase and ribosome maturation factor {ECO:0000312|HGNC:HGNC:16405};, PF08241;PF12589;, GO:0005730;GO:0005654;GO:0048471;GO:0008168;GO:0046982;GO:0003723;GO:0016435;GO:0006325;GO:2000234;GO:0070476;GO:0031167;, C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:methyltransferase activity; F:protein heterodimerization activity; F:RNA binding; F:rRNA (guanine) methyltransferase activity;, P:chromatin organization; P:positive regulation of rRNA processing; P:rRNA (guanine-N7)-methylation; P:rRNA methylation;|O43709 A8K501 C9K060 Q96P12 Q9BQ58 Q9HBP9,Probable 18S rRNA (guanine-N(7))-methyltransferase {ECO:0000305},Bud site selection protein 23 homolog;Metastasis-related methyltransferase 1;Williams-Beuren syndrome chromosomal region 22 protein;rRNA methyltransferase and ribosome maturation factor {ECO:0000312|HGNC:HGNC:16405};, PF08241;PF12589;, GO:0005730;GO:0005654;GO:0048471;GO:0008168;GO:0046982;GO:0003723;GO:0016435;GO:0006325;GO:2000234;GO:0070476;GO:0031167;, C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:methyltransferase activity; F:protein heterodimerization activity; F:RNA binding; F:rRNA (guanine) methyltransferase activity;, P:chromatin organization; P:positive regulation of rRNA processing; P:rRNA (guanine-N7)-methylation; P:rRNA methylation;|O43709 A8K501 C9K060 Q96P12 Q9BQ58 Q9HBP9,Probable 18S rRNA (guanine-N(7))-methyltransferase {ECO:0000305},Bud site selection protein 23 homolog;Metastasis-related methyltransferase 1;Williams-Beuren syndrome chromosomal region 22 protein;rRNA methyltransferase and ribosome maturation factor {ECO:0000312|HGNC:HGNC:16405};, PF08241;PF12589;, GO:0005730;GO:0005654;GO:0048471;GO:0008168;GO:0046982;GO:0003723;GO:0016435;GO:0006325;GO:2000234;GO:0070476;GO:0031167;, C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:methyltransferase activity; F:protein heterodimerization activity; F:RNA binding; F:rRNA (guanine) methyltransferase activity;, P:chromatin organization; P:positive regulation of rRNA processing; P:rRNA (guanine-N7)-methylation; P:rRNA methylation;|O43709 A8K501 C9K060 Q96P12 Q9BQ58 Q9HBP9,Probable 18S rRNA (guanine-N(7))-methyltransferase {ECO:0000305},Bud site selection protein 23 homolog;Metastasis-related methyltransferase 1;Williams-Beuren syndrome chromosomal region 22 protein;rRNA methyltransferase and ribosome maturation factor {ECO:0000312|HGNC:HGNC:16405};, PF08241;PF12589;, GO:0005730;GO:0005654;GO:0048471;GO:0008168;GO:0046982;GO:0003723;GO:0016435;GO:0006325;GO:2000234;GO:0070476;GO:0031167;, C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:methyltransferase activity; F:protein heterodimerization activity; F:RNA binding; F:rRNA (guanine) methyltransferase activity;, P:chromatin organization; P:positive regulation of rRNA processing; P:rRNA (guanine-N7)-methylation; P:rRNA methylation; scaffold82 indexed_genome mRNA 6460593 6463566 . - . ID=transcript_12110;Q96LL9 Q9BSG8,DnaJ homolog subfamily C member 30, mitochondrial {ECO:0000303|PubMed:30318146},Williams-Beuren syndrome chromosomal region 18 protein {ECO:0000303|PubMed:12073013};, PF00226;, GO:0016021;GO:0005743;GO:0006754;GO:0007420;GO:1905706;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:ATP biosynthetic process; P:brain development; P:regulation of mitochondrial ATP synthesis coupled proton transport; scaffold82 indexed_genome mRNA 6502348 6517283 . + . ID=transcript_12111;Q9Y2P3,Carbohydrate-responsive element-binding protein,Class D basic helix-loop-helix protein 14;MLX interactor;MLX-interacting protein-like;WS basic-helix-loop-helix leucine zipper protein;Williams-Beuren syndrome chromosomal region 14 protein;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0035538;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0000978;GO:0008134;GO:0009653;GO:0097009;GO:0055089;GO:0042593;GO:0010255;GO:0035556;GO:0071157;GO:0090324;GO:0033137;GO:0045892;GO:0008284;GO:0045723;GO:0045821;GO:0046889;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:carbohydrate response element binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anatomical structure morphogenesis; P:energy homeostasis; P:fatty acid homeostasis; P:glucose homeostasis; P:glucose mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell cycle arrest; P:negative regulation of oxidative phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:triglyceride homeostasis;|Q9Y2P3,Carbohydrate-responsive element-binding protein,Class D basic helix-loop-helix protein 14;MLX interactor;MLX-interacting protein-like;WS basic-helix-loop-helix leucine zipper protein;Williams-Beuren syndrome chromosomal region 14 protein;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0035538;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0000978;GO:0008134;GO:0009653;GO:0097009;GO:0055089;GO:0042593;GO:0010255;GO:0035556;GO:0071157;GO:0090324;GO:0033137;GO:0045892;GO:0008284;GO:0045723;GO:0045821;GO:0046889;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:carbohydrate response element binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anatomical structure morphogenesis; P:energy homeostasis; P:fatty acid homeostasis; P:glucose homeostasis; P:glucose mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell cycle arrest; P:negative regulation of oxidative phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:triglyceride homeostasis;|Q9Y2P3,Carbohydrate-responsive element-binding protein,Class D basic helix-loop-helix protein 14;MLX interactor;MLX-interacting protein-like;WS basic-helix-loop-helix leucine zipper protein;Williams-Beuren syndrome chromosomal region 14 protein;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0035538;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0000978;GO:0008134;GO:0009653;GO:0097009;GO:0055089;GO:0042593;GO:0010255;GO:0035556;GO:0071157;GO:0090324;GO:0033137;GO:0045892;GO:0008284;GO:0045723;GO:0045821;GO:0046889;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:carbohydrate response element binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anatomical structure morphogenesis; P:energy homeostasis; P:fatty acid homeostasis; P:glucose homeostasis; P:glucose mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell cycle arrest; P:negative regulation of oxidative phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:triglyceride homeostasis;|Q9Y2P3,Carbohydrate-responsive element-binding protein,Class D basic helix-loop-helix protein 14;MLX interactor;MLX-interacting protein-like;WS basic-helix-loop-helix leucine zipper protein;Williams-Beuren syndrome chromosomal region 14 protein;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0035538;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0000978;GO:0008134;GO:0009653;GO:0097009;GO:0055089;GO:0042593;GO:0010255;GO:0035556;GO:0071157;GO:0090324;GO:0033137;GO:0045892;GO:0008284;GO:0045723;GO:0045821;GO:0046889;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:carbohydrate response element binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anatomical structure morphogenesis; P:energy homeostasis; P:fatty acid homeostasis; P:glucose homeostasis; P:glucose mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell cycle arrest; P:negative regulation of oxidative phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:triglyceride homeostasis;|Q9Y2P3,Carbohydrate-responsive element-binding protein,Class D basic helix-loop-helix protein 14;MLX interactor;MLX-interacting protein-like;WS basic-helix-loop-helix leucine zipper protein;Williams-Beuren syndrome chromosomal region 14 protein;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0035538;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0000978;GO:0008134;GO:0009653;GO:0097009;GO:0055089;GO:0042593;GO:0010255;GO:0035556;GO:0071157;GO:0090324;GO:0033137;GO:0045892;GO:0008284;GO:0045723;GO:0045821;GO:0046889;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:carbohydrate response element binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anatomical structure morphogenesis; P:energy homeostasis; P:fatty acid homeostasis; P:glucose homeostasis; P:glucose mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell cycle arrest; P:negative regulation of oxidative phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:triglyceride homeostasis;|Q9Y2P3,Carbohydrate-responsive element-binding protein,Class D basic helix-loop-helix protein 14;MLX interactor;MLX-interacting protein-like;WS basic-helix-loop-helix leucine zipper protein;Williams-Beuren syndrome chromosomal region 14 protein;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0035538;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0000978;GO:0008134;GO:0009653;GO:0097009;GO:0055089;GO:0042593;GO:0010255;GO:0035556;GO:0071157;GO:0090324;GO:0033137;GO:0045892;GO:0008284;GO:0045723;GO:0045821;GO:0046889;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:carbohydrate response element binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anatomical structure morphogenesis; P:energy homeostasis; P:fatty acid homeostasis; P:glucose homeostasis; P:glucose mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell cycle arrest; P:negative regulation of oxidative phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:triglyceride homeostasis; scaffold82 indexed_genome mRNA 6517392 6520870 . + . ID=transcript_12112;Q9Y2P3,Carbohydrate-responsive element-binding protein,Class D basic helix-loop-helix protein 14;MLX interactor;MLX-interacting protein-like;WS basic-helix-loop-helix leucine zipper protein;Williams-Beuren syndrome chromosomal region 14 protein;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0035538;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0000978;GO:0008134;GO:0009653;GO:0097009;GO:0055089;GO:0042593;GO:0010255;GO:0035556;GO:0071157;GO:0090324;GO:0033137;GO:0045892;GO:0008284;GO:0045723;GO:0045821;GO:0046889;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:carbohydrate response element binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anatomical structure morphogenesis; P:energy homeostasis; P:fatty acid homeostasis; P:glucose homeostasis; P:glucose mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell cycle arrest; P:negative regulation of oxidative phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:triglyceride homeostasis;|Q9Y2P3,Carbohydrate-responsive element-binding protein,Class D basic helix-loop-helix protein 14;MLX interactor;MLX-interacting protein-like;WS basic-helix-loop-helix leucine zipper protein;Williams-Beuren syndrome chromosomal region 14 protein;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0035538;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0000978;GO:0008134;GO:0009653;GO:0097009;GO:0055089;GO:0042593;GO:0010255;GO:0035556;GO:0071157;GO:0090324;GO:0033137;GO:0045892;GO:0008284;GO:0045723;GO:0045821;GO:0046889;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:carbohydrate response element binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anatomical structure morphogenesis; P:energy homeostasis; P:fatty acid homeostasis; P:glucose homeostasis; P:glucose mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell cycle arrest; P:negative regulation of oxidative phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:triglyceride homeostasis;|Q9Y2P3,Carbohydrate-responsive element-binding protein,Class D basic helix-loop-helix protein 14;MLX interactor;MLX-interacting protein-like;WS basic-helix-loop-helix leucine zipper protein;Williams-Beuren syndrome chromosomal region 14 protein;, PF00010;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0035538;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046982;GO:0000978;GO:0008134;GO:0009653;GO:0097009;GO:0055089;GO:0042593;GO:0010255;GO:0035556;GO:0071157;GO:0090324;GO:0033137;GO:0045892;GO:0008284;GO:0045723;GO:0045821;GO:0046889;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0070328;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:carbohydrate response element binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anatomical structure morphogenesis; P:energy homeostasis; P:fatty acid homeostasis; P:glucose homeostasis; P:glucose mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell cycle arrest; P:negative regulation of oxidative phosphorylation; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:triglyceride homeostasis; scaffold82 indexed_genome mRNA 6528065 6535650 . + . ID=transcript_12113;Q9Y4P3 Q9UQE2,Transducin beta-like protein 2,WS beta-transducin repeats protein;Williams-Beuren syndrome chromosomal region 13 protein;, PF00400;, GO:0005783;GO:0030176;GO:0051219;GO:0019901;GO:0003723;GO:0031369;GO:0042149;GO:0071456;GO:0030968;, C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane;, F:phosphoprotein binding; F:protein kinase binding; F:RNA binding; F:translation initiation factor binding;, P:cellular response to glucose starvation; P:cellular response to hypoxia; P:endoplasmic reticulum unfolded protein response; scaffold82 indexed_genome mRNA 6552375 6566123 . + . ID=transcript_12114;Q9BQE9 A8K226 C9JWD3 D3DXF0 O43769 Q13845 Q6ZW75,B-cell CLL/lymphoma 7 protein family member B,, PF04714;, GO:0003779;GO:0006915;GO:0030154;GO:0016055;, , F:actin binding;, P:apoptotic process; P:cell differentiation; P:Wnt signaling pathway;|Q9BQE9 A8K226 C9JWD3 D3DXF0 O43769 Q13845 Q6ZW75,B-cell CLL/lymphoma 7 protein family member B,, PF04714;, GO:0003779;GO:0006915;GO:0030154;GO:0016055;, , F:actin binding;, P:apoptotic process; P:cell differentiation; P:Wnt signaling pathway;|Q9BQE9 A8K226 C9JWD3 D3DXF0 O43769 Q13845 Q6ZW75,B-cell CLL/lymphoma 7 protein family member B,, PF04714;, GO:0003779;GO:0006915;GO:0030154;GO:0016055;, , F:actin binding;, P:apoptotic process; P:cell differentiation; P:Wnt signaling pathway; scaffold82 indexed_genome mRNA 6570459 6622256 . + . ID=transcript_12115;Q9UIG0 B9EGK3 D3DXE9 O95039 O95247 O95277 Q6P1K4 Q86UJ6,Tyrosine-protein kinase BAZ1B,Bromodomain adjacent to zinc finger domain protein 1B;Williams syndrome transcription factor;Williams-Beuren syndrome chromosomal region 10 protein;Williams-Beuren syndrome chromosomal region 9 protein;hWALp2;, PF00439;PF00628;PF10537;PF15612;PF15613;, GO:0000793;GO:0016604;GO:0005654;GO:0005721;GO:0005524;GO:0042393;GO:0035173;GO:0004715;GO:0004713;GO:0004714;GO:0008270;GO:0006974;GO:0006333;GO:0006338;GO:0006302;GO:0016572;GO:0045815;GO:0006357;, C:condensed chromosome; C:nuclear body; C:nucleoplasm; C:pericentric heterochromatin;, F:ATP binding; F:histone binding; F:histone kinase activity; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:chromatin assembly or disassembly; P:chromatin remodeling; P:double-strand break repair; P:histone phosphorylation; P:positive regulation of gene expression, epigenetic; P:regulation of transcription by RNA polymerase II;|Q9UIG0 B9EGK3 D3DXE9 O95039 O95247 O95277 Q6P1K4 Q86UJ6,Tyrosine-protein kinase BAZ1B,Bromodomain adjacent to zinc finger domain protein 1B;Williams syndrome transcription factor;Williams-Beuren syndrome chromosomal region 10 protein;Williams-Beuren syndrome chromosomal region 9 protein;hWALp2;, PF00439;PF00628;PF10537;PF15612;PF15613;, GO:0000793;GO:0016604;GO:0005654;GO:0005721;GO:0005524;GO:0042393;GO:0035173;GO:0004715;GO:0004713;GO:0004714;GO:0008270;GO:0006974;GO:0006333;GO:0006338;GO:0006302;GO:0016572;GO:0045815;GO:0006357;, C:condensed chromosome; C:nuclear body; C:nucleoplasm; C:pericentric heterochromatin;, F:ATP binding; F:histone binding; F:histone kinase activity; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:chromatin assembly or disassembly; P:chromatin remodeling; P:double-strand break repair; P:histone phosphorylation; P:positive regulation of gene expression, epigenetic; P:regulation of transcription by RNA polymerase II; scaffold82 indexed_genome mRNA 6679512 6699368 . - . ID=transcript_12116;O75344 B4DXT7 G3V0I2 Q7Z4T4 Q9UDS0,Inactive peptidyl-prolyl cis-trans isomerase FKBP6,36 kDa FK506-binding protein;FK506-binding protein 6;Immunophilin FKBP36;, PF00254;, GO:0005737;GO:0005829;GO:0000795;GO:0005528;GO:0051879;GO:0042802;GO:0030154;GO:0043046;GO:0031047;GO:0051321;GO:0034587;GO:0045070;GO:0006457;GO:0000413;GO:0007283;, C:cytoplasm; C:cytosol; C:synaptonemal complex;, F:FK506 binding; F:Hsp90 protein binding; F:identical protein binding;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:gene silencing by RNA; P:meiotic cell cycle; P:piRNA metabolic process; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:spermatogenesis; scaffold82 indexed_genome mRNA 6719894 6742819 . + . ID=transcript_12117;Q96P11 B3KX04 B4DP79 G3V0G9 Q6ZUI8 Q96HT9 Q9NW70,28S rRNA (cytosine-C(5))-methyltransferase {ECO:0000305},NOL1-related protein {ECO:0000312|HGNC:HGNC:16385};NOL1/NOP2/Sun domain family member 5 {ECO:0000303|PubMed:23913415};Williams-Beuren syndrome chromosomal region 20A protein {ECO:0000303|PubMed:12073013};, PF01189;, GO:0005730;GO:0005654;GO:0003723;GO:0009383;GO:0021987;GO:0050890;GO:0022038;GO:0014003;GO:0045727;GO:0031641;GO:0001510;GO:0070475;, C:nucleolus; C:nucleoplasm;, F:RNA binding; F:rRNA (cytosine-C5-)-methyltransferase activity;, P:cerebral cortex development; P:cognition; P:corpus callosum development; P:oligodendrocyte development; P:positive regulation of translation; P:regulation of myelination; P:RNA methylation; P:rRNA base methylation;|Q9Y4S7,Nuclear envelope pore membrane protein POM 121,Nuclear envelope pore membrane protein POM 121A;Nucleoporin Nup121;Pore membrane protein of 121 kDa;, , GO:0005789;GO:0043657;GO:0016021;GO:0005635;GO:0031965;GO:0005643;GO:0005654;GO:0008139;GO:0017056;GO:0075733;GO:0007084;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:endoplasmic reticulum membrane; C:host cell; C:integral component of membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nucleoplasm;, F:nuclear localization sequence binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|A8CG34 A0A075B7F8 A0A087WY75 O75115 Q9Y2N3 Q9Y4S7,Nuclear envelope pore membrane protein POM 121C,Nuclear pore membrane protein 121-2;Pore membrane protein of 121 kDa C;, , GO:0005789;GO:0043657;GO:0016021;GO:0005635;GO:0031965;GO:0005643;GO:0008139;GO:0017056;GO:0075733;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:endoplasmic reticulum membrane; C:host cell; C:integral component of membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, F:nuclear localization sequence binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold82 indexed_genome mRNA 6778600 6810976 . - . ID=transcript_12118;O00291 B4E3I7 E7ES17 O00328 Q2TB58 Q8TDL4 V5LU97,Huntingtin-interacting protein 1,Huntingtin-interacting protein I;, PF07651;PF16515;PF01608;, GO:0030136;GO:0030665;GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0098890;GO:0098888;GO:0098978;GO:0005794;GO:0043231;GO:0016020;GO:0005634;GO:0098794;GO:0098793;GO:0051015;GO:0035612;GO:0035615;GO:0030276;GO:0032051;GO:0005154;GO:0035254;GO:0035091;GO:0043325;GO:0080025;GO:0032266;GO:0046982;GO:0042803;GO:0005200;GO:0007015;GO:0006919;GO:0006915;GO:0097190;GO:0030154;GO:0048268;GO:0072583;GO:0061024;GO:0099637;GO:0045742;GO:2000588;GO:0051897;GO:0048260;GO:0050821;GO:0042981;GO:0030100;, C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic membrane; C:extrinsic component of presynaptic membrane; C:glutamatergic synapse; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:postsynapse; C:presynapse;, F:actin filament binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:epidermal growth factor receptor binding; F:glutamate receptor binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of cytoskeleton;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:apoptotic signaling pathway; P:cell differentiation; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane organization; P:neurotransmitter receptor transport; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:regulation of apoptotic process; P:regulation of endocytosis;|O00291 B4E3I7 E7ES17 O00328 Q2TB58 Q8TDL4 V5LU97,Huntingtin-interacting protein 1,Huntingtin-interacting protein I;, PF07651;PF16515;PF01608;, GO:0030136;GO:0030665;GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0098890;GO:0098888;GO:0098978;GO:0005794;GO:0043231;GO:0016020;GO:0005634;GO:0098794;GO:0098793;GO:0051015;GO:0035612;GO:0035615;GO:0030276;GO:0032051;GO:0005154;GO:0035254;GO:0035091;GO:0043325;GO:0080025;GO:0032266;GO:0046982;GO:0042803;GO:0005200;GO:0007015;GO:0006919;GO:0006915;GO:0097190;GO:0030154;GO:0048268;GO:0072583;GO:0061024;GO:0099637;GO:0045742;GO:2000588;GO:0051897;GO:0048260;GO:0050821;GO:0042981;GO:0030100;, C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic membrane; C:extrinsic component of presynaptic membrane; C:glutamatergic synapse; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:postsynapse; C:presynapse;, F:actin filament binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:epidermal growth factor receptor binding; F:glutamate receptor binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of cytoskeleton;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:apoptotic signaling pathway; P:cell differentiation; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane organization; P:neurotransmitter receptor transport; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:regulation of apoptotic process; P:regulation of endocytosis;|O00291 B4E3I7 E7ES17 O00328 Q2TB58 Q8TDL4 V5LU97,Huntingtin-interacting protein 1,Huntingtin-interacting protein I;, PF07651;PF16515;PF01608;, GO:0030136;GO:0030665;GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0098890;GO:0098888;GO:0098978;GO:0005794;GO:0043231;GO:0016020;GO:0005634;GO:0098794;GO:0098793;GO:0051015;GO:0035612;GO:0035615;GO:0030276;GO:0032051;GO:0005154;GO:0035254;GO:0035091;GO:0043325;GO:0080025;GO:0032266;GO:0046982;GO:0042803;GO:0005200;GO:0007015;GO:0006919;GO:0006915;GO:0097190;GO:0030154;GO:0048268;GO:0072583;GO:0061024;GO:0099637;GO:0045742;GO:2000588;GO:0051897;GO:0048260;GO:0050821;GO:0042981;GO:0030100;, C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic membrane; C:extrinsic component of presynaptic membrane; C:glutamatergic synapse; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:postsynapse; C:presynapse;, F:actin filament binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:epidermal growth factor receptor binding; F:glutamate receptor binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of cytoskeleton;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:apoptotic signaling pathway; P:cell differentiation; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane organization; P:neurotransmitter receptor transport; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:regulation of apoptotic process; P:regulation of endocytosis;|O00291 B4E3I7 E7ES17 O00328 Q2TB58 Q8TDL4 V5LU97,Huntingtin-interacting protein 1,Huntingtin-interacting protein I;, PF07651;PF16515;PF01608;, GO:0030136;GO:0030665;GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0098890;GO:0098888;GO:0098978;GO:0005794;GO:0043231;GO:0016020;GO:0005634;GO:0098794;GO:0098793;GO:0051015;GO:0035612;GO:0035615;GO:0030276;GO:0032051;GO:0005154;GO:0035254;GO:0035091;GO:0043325;GO:0080025;GO:0032266;GO:0046982;GO:0042803;GO:0005200;GO:0007015;GO:0006919;GO:0006915;GO:0097190;GO:0030154;GO:0048268;GO:0072583;GO:0061024;GO:0099637;GO:0045742;GO:2000588;GO:0051897;GO:0048260;GO:0050821;GO:0042981;GO:0030100;, C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:extrinsic component of postsynaptic membrane; C:extrinsic component of presynaptic membrane; C:glutamatergic synapse; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus; C:postsynapse; C:presynapse;, F:actin filament binding; F:AP-2 adaptor complex binding; F:clathrin adaptor activity; F:clathrin binding; F:clathrin light chain binding; F:epidermal growth factor receptor binding; F:glutamate receptor binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of cytoskeleton;, P:actin filament organization; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:apoptotic signaling pathway; P:cell differentiation; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane organization; P:neurotransmitter receptor transport; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor-mediated endocytosis; P:protein stabilization; P:regulation of apoptotic process; P:regulation of endocytosis; scaffold83 indexed_genome mRNA 202432 210468 . - . ID=transcript_12119;P13584 Q1HBI2 Q8TD85 Q8WWF2 Q8WWU9 Q8WWV0,Cytochrome P450 4B1,CYPIVB1;Cytochrome P450-HP;, PF00067;, GO:0005789;GO:0070330;GO:0020037;GO:0005506;GO:0019825;GO:0018879;GO:0006631;, C:endoplasmic reticulum membrane;, F:aromatase activity; F:heme binding; F:iron ion binding; F:oxygen binding;, P:biphenyl metabolic process; P:fatty acid metabolic process;|P13584 Q1HBI2 Q8TD85 Q8WWF2 Q8WWU9 Q8WWV0,Cytochrome P450 4B1,CYPIVB1;Cytochrome P450-HP;, PF00067;, GO:0005789;GO:0070330;GO:0020037;GO:0005506;GO:0019825;GO:0018879;GO:0006631;, C:endoplasmic reticulum membrane;, F:aromatase activity; F:heme binding; F:iron ion binding; F:oxygen binding;, P:biphenyl metabolic process; P:fatty acid metabolic process;|P13584 Q1HBI2 Q8TD85 Q8WWF2 Q8WWU9 Q8WWV0,Cytochrome P450 4B1,CYPIVB1;Cytochrome P450-HP;, PF00067;, GO:0005789;GO:0070330;GO:0020037;GO:0005506;GO:0019825;GO:0018879;GO:0006631;, C:endoplasmic reticulum membrane;, F:aromatase activity; F:heme binding; F:iron ion binding; F:oxygen binding;, P:biphenyl metabolic process; P:fatty acid metabolic process;|P13584 Q1HBI2 Q8TD85 Q8WWF2 Q8WWU9 Q8WWV0,Cytochrome P450 4B1,CYPIVB1;Cytochrome P450-HP;, PF00067;, GO:0005789;GO:0070330;GO:0020037;GO:0005506;GO:0019825;GO:0018879;GO:0006631;, C:endoplasmic reticulum membrane;, F:aromatase activity; F:heme binding; F:iron ion binding; F:oxygen binding;, P:biphenyl metabolic process; P:fatty acid metabolic process;|P13584 Q1HBI2 Q8TD85 Q8WWF2 Q8WWU9 Q8WWV0,Cytochrome P450 4B1,CYPIVB1;Cytochrome P450-HP;, PF00067;, GO:0005789;GO:0070330;GO:0020037;GO:0005506;GO:0019825;GO:0018879;GO:0006631;, C:endoplasmic reticulum membrane;, F:aromatase activity; F:heme binding; F:iron ion binding; F:oxygen binding;, P:biphenyl metabolic process; P:fatty acid metabolic process; scaffold83 indexed_genome mRNA 278759 319622 . + . ID=transcript_12120;O75071 D3DQ23 Q5SXB8,EF-hand calcium-binding domain-containing protein 14,, , GO:0005509;, , F:calcium ion binding;|O75071 D3DQ23 Q5SXB8,EF-hand calcium-binding domain-containing protein 14,, , GO:0005509;, , F:calcium ion binding;|O75071 D3DQ23 Q5SXB8,EF-hand calcium-binding domain-containing protein 14,, , GO:0005509;, , F:calcium ion binding;|O75071 D3DQ23 Q5SXB8,EF-hand calcium-binding domain-containing protein 14,, , GO:0005509;, , F:calcium ion binding; scaffold83 indexed_genome mRNA 326270 366774 . + . ID=transcript_12121;Q5TC12 B1AQW7 B7Z7D6 B7Z7I6 Q9H6E3,ATP synthase mitochondrial F1 complex assembly factor 1,ATP11 homolog;, PF06644;, GO:0005739;GO:0033615;, C:mitochondrion;, , P:mitochondrial proton-transporting ATP synthase complex assembly;|Q9UMX5 A1KYQ8 Q53FZ6 Q5TM90,Neudesin,Cell immortalization-related protein 2;Neuron-derived neurotrophic factor;Protein GIG47 {ECO:0000303|PubMed:22748190};Secreted protein of unknown function;, PF00173;, GO:0012505;GO:0005783;GO:0005615;GO:0016020;GO:0005739;GO:0008083;GO:0046872;GO:0032099;GO:1901215;GO:0043410;, C:endomembrane system; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:mitochondrion;, F:growth factor activity; F:metal ion binding;, P:negative regulation of appetite; P:negative regulation of neuron death; P:positive regulation of MAPK cascade;|Q5TC12 B1AQW7 B7Z7D6 B7Z7I6 Q9H6E3,ATP synthase mitochondrial F1 complex assembly factor 1,ATP11 homolog;, PF06644;, GO:0005739;GO:0033615;, C:mitochondrion;, , P:mitochondrial proton-transporting ATP synthase complex assembly;|Q5TC12 B1AQW7 B7Z7D6 B7Z7I6 Q9H6E3,ATP synthase mitochondrial F1 complex assembly factor 1,ATP11 homolog;, PF06644;, GO:0005739;GO:0033615;, C:mitochondrion;, , P:mitochondrial proton-transporting ATP synthase complex assembly;|Q5TC12 B1AQW7 B7Z7D6 B7Z7I6 Q9H6E3,ATP synthase mitochondrial F1 complex assembly factor 1,ATP11 homolog;, PF06644;, GO:0005739;GO:0033615;, C:mitochondrion;, , P:mitochondrial proton-transporting ATP synthase complex assembly; scaffold83 indexed_genome mRNA 369529 378546 . + . ID=transcript_12122;Q70IA8 D3DQ22 Q0VA98 Q5TC10 Q5TC11 Q8NAZ2 Q8NF28,MOB kinase activator 3C,Mob1 homolog 2C;Mps one binder kinase activator-like 2C;, PF03637;, GO:0046872;, , F:metal ion binding; scaffold83 indexed_genome mRNA 405999 426410 . + . ID=transcript_12123;Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6,MAP kinase-interacting serine/threonine-protein kinase 1,MAP kinase signal-integrating kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation; scaffold83 indexed_genome mRNA 539468 549992 . - . ID=transcript_12124;O00519 D3DQ19 Q52M86 Q5TDF8,Fatty-acid amide hydrolase 1,Anandamide amidohydrolase 1;Fatty acid ester hydrolase {ECO:0000305|PubMed:21049984};Oleamide hydrolase 1;, PF01425;, GO:0005856;GO:0005789;GO:0016021;GO:0031090;GO:0047372;GO:0004040;GO:0103073;GO:0017064;GO:0102077;GO:0019369;GO:0009062;GO:0052651;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:organelle membrane;, F:acylglycerol lipase activity; F:amidase activity; F:anandamide amidohydrolase activity; F:fatty acid amide hydrolase activity; F:oleamide hydrolase activity;, P:arachidonic acid metabolic process; P:fatty acid catabolic process; P:monoacylglycerol catabolic process; scaffold83 indexed_genome mRNA 553142 554454 . + . ID=transcript_12125;O00519 D3DQ19 Q52M86 Q5TDF8,Fatty-acid amide hydrolase 1,Anandamide amidohydrolase 1;Fatty acid ester hydrolase {ECO:0000305|PubMed:21049984};Oleamide hydrolase 1;, PF01425;, GO:0005856;GO:0005789;GO:0016021;GO:0031090;GO:0047372;GO:0004040;GO:0103073;GO:0017064;GO:0102077;GO:0019369;GO:0009062;GO:0052651;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:organelle membrane;, F:acylglycerol lipase activity; F:amidase activity; F:anandamide amidohydrolase activity; F:fatty acid amide hydrolase activity; F:oleamide hydrolase activity;, P:arachidonic acid metabolic process; P:fatty acid catabolic process; P:monoacylglycerol catabolic process; scaffold83 indexed_genome mRNA 570190 589508 . - . ID=transcript_12126;O00519 D3DQ19 Q52M86 Q5TDF8,Fatty-acid amide hydrolase 1,Anandamide amidohydrolase 1;Fatty acid ester hydrolase {ECO:0000305|PubMed:21049984};Oleamide hydrolase 1;, PF01425;, GO:0005856;GO:0005789;GO:0016021;GO:0031090;GO:0047372;GO:0004040;GO:0103073;GO:0017064;GO:0102077;GO:0019369;GO:0009062;GO:0052651;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:organelle membrane;, F:acylglycerol lipase activity; F:amidase activity; F:anandamide amidohydrolase activity; F:fatty acid amide hydrolase activity; F:oleamide hydrolase activity;, P:arachidonic acid metabolic process; P:fatty acid catabolic process; P:monoacylglycerol catabolic process;|O00519 D3DQ19 Q52M86 Q5TDF8,Fatty-acid amide hydrolase 1,Anandamide amidohydrolase 1;Fatty acid ester hydrolase {ECO:0000305|PubMed:21049984};Oleamide hydrolase 1;, PF01425;, GO:0005856;GO:0005789;GO:0016021;GO:0031090;GO:0047372;GO:0004040;GO:0103073;GO:0017064;GO:0102077;GO:0019369;GO:0009062;GO:0052651;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:organelle membrane;, F:acylglycerol lipase activity; F:amidase activity; F:anandamide amidohydrolase activity; F:fatty acid amide hydrolase activity; F:oleamide hydrolase activity;, P:arachidonic acid metabolic process; P:fatty acid catabolic process; P:monoacylglycerol catabolic process;|O00519 D3DQ19 Q52M86 Q5TDF8,Fatty-acid amide hydrolase 1,Anandamide amidohydrolase 1;Fatty acid ester hydrolase {ECO:0000305|PubMed:21049984};Oleamide hydrolase 1;, PF01425;, GO:0005856;GO:0005789;GO:0016021;GO:0031090;GO:0047372;GO:0004040;GO:0103073;GO:0017064;GO:0102077;GO:0019369;GO:0009062;GO:0052651;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:organelle membrane;, F:acylglycerol lipase activity; F:amidase activity; F:anandamide amidohydrolase activity; F:fatty acid amide hydrolase activity; F:oleamide hydrolase activity;, P:arachidonic acid metabolic process; P:fatty acid catabolic process; P:monoacylglycerol catabolic process;|O00519 D3DQ19 Q52M86 Q5TDF8,Fatty-acid amide hydrolase 1,Anandamide amidohydrolase 1;Fatty acid ester hydrolase {ECO:0000305|PubMed:21049984};Oleamide hydrolase 1;, PF01425;, GO:0005856;GO:0005789;GO:0016021;GO:0031090;GO:0047372;GO:0004040;GO:0103073;GO:0017064;GO:0102077;GO:0019369;GO:0009062;GO:0052651;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:organelle membrane;, F:acylglycerol lipase activity; F:amidase activity; F:anandamide amidohydrolase activity; F:fatty acid amide hydrolase activity; F:oleamide hydrolase activity;, P:arachidonic acid metabolic process; P:fatty acid catabolic process; P:monoacylglycerol catabolic process;|O00519 D3DQ19 Q52M86 Q5TDF8,Fatty-acid amide hydrolase 1,Anandamide amidohydrolase 1;Fatty acid ester hydrolase {ECO:0000305|PubMed:21049984};Oleamide hydrolase 1;, PF01425;, GO:0005856;GO:0005789;GO:0016021;GO:0031090;GO:0047372;GO:0004040;GO:0103073;GO:0017064;GO:0102077;GO:0019369;GO:0009062;GO:0052651;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:organelle membrane;, F:acylglycerol lipase activity; F:amidase activity; F:anandamide amidohydrolase activity; F:fatty acid amide hydrolase activity; F:oleamide hydrolase activity;, P:arachidonic acid metabolic process; P:fatty acid catabolic process; P:monoacylglycerol catabolic process;|O00519 D3DQ19 Q52M86 Q5TDF8,Fatty-acid amide hydrolase 1,Anandamide amidohydrolase 1;Fatty acid ester hydrolase {ECO:0000305|PubMed:21049984};Oleamide hydrolase 1;, PF01425;, GO:0005856;GO:0005789;GO:0016021;GO:0031090;GO:0047372;GO:0004040;GO:0103073;GO:0017064;GO:0102077;GO:0019369;GO:0009062;GO:0052651;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:organelle membrane;, F:acylglycerol lipase activity; F:amidase activity; F:anandamide amidohydrolase activity; F:fatty acid amide hydrolase activity; F:oleamide hydrolase activity;, P:arachidonic acid metabolic process; P:fatty acid catabolic process; P:monoacylglycerol catabolic process;|O00519 D3DQ19 Q52M86 Q5TDF8,Fatty-acid amide hydrolase 1,Anandamide amidohydrolase 1;Fatty acid ester hydrolase {ECO:0000305|PubMed:21049984};Oleamide hydrolase 1;, PF01425;, GO:0005856;GO:0005789;GO:0016021;GO:0031090;GO:0047372;GO:0004040;GO:0103073;GO:0017064;GO:0102077;GO:0019369;GO:0009062;GO:0052651;, C:cytoskeleton; C:endoplasmic reticulum membrane; C:integral component of membrane; C:organelle membrane;, F:acylglycerol lipase activity; F:amidase activity; F:anandamide amidohydrolase activity; F:fatty acid amide hydrolase activity; F:oleamide hydrolase activity;, P:arachidonic acid metabolic process; P:fatty acid catabolic process; P:monoacylglycerol catabolic process; scaffold83 indexed_genome mRNA 600507 603559 . + . ID=transcript_12127;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold83 indexed_genome mRNA 606677 629404 . - . ID=transcript_12128;Q96CB9 A8K6S6 B3KQ50 B4DHA4 Q5TDF7 Q96AN8 Q9HAJ8,5-methylcytosine rRNA methyltransferase NSUN4,NOL1/NOP2/Sun domain family member 4;, PF01189;, GO:0005762;GO:0005759;GO:0008168;GO:0009383;GO:0019843;GO:0001510;GO:0031167;, C:mitochondrial large ribosomal subunit; C:mitochondrial matrix;, F:methyltransferase activity; F:rRNA (cytosine-C5-)-methyltransferase activity; F:rRNA binding;, P:RNA methylation; P:rRNA methylation;|Q96CB9 A8K6S6 B3KQ50 B4DHA4 Q5TDF7 Q96AN8 Q9HAJ8,5-methylcytosine rRNA methyltransferase NSUN4,NOL1/NOP2/Sun domain family member 4;, PF01189;, GO:0005762;GO:0005759;GO:0008168;GO:0009383;GO:0019843;GO:0001510;GO:0031167;, C:mitochondrial large ribosomal subunit; C:mitochondrial matrix;, F:methyltransferase activity; F:rRNA (cytosine-C5-)-methyltransferase activity; F:rRNA binding;, P:RNA methylation; P:rRNA methylation;|Q96CB9 A8K6S6 B3KQ50 B4DHA4 Q5TDF7 Q96AN8 Q9HAJ8,5-methylcytosine rRNA methyltransferase NSUN4,NOL1/NOP2/Sun domain family member 4;, PF01189;, GO:0005762;GO:0005759;GO:0008168;GO:0009383;GO:0019843;GO:0001510;GO:0031167;, C:mitochondrial large ribosomal subunit; C:mitochondrial matrix;, F:methyltransferase activity; F:rRNA (cytosine-C5-)-methyltransferase activity; F:rRNA binding;, P:RNA methylation; P:rRNA methylation; scaffold83 indexed_genome mRNA 646974 652014 . - . ID=transcript_12129;P07919 B2R4V9 D3DQ18 Q5TDF6 Q6LDB8 Q9BQ91,Cytochrome b-c1 complex subunit 6, mitochondrial,Complex III subunit 6;Complex III subunit VIII;Cytochrome c1 non-heme 11 kDa protein;Mitochondrial hinge protein;Ubiquinol-cytochrome c reductase complex 11 kDa protein;, PF02320;, GO:0005743;GO:0005746;GO:0005750;GO:0005739;GO:0008121;GO:0009060;GO:0006122;GO:0006119;, C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:ubiquinol-cytochrome-c reductase activity;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation;|P07919 B2R4V9 D3DQ18 Q5TDF6 Q6LDB8 Q9BQ91,Cytochrome b-c1 complex subunit 6, mitochondrial,Complex III subunit 6;Complex III subunit VIII;Cytochrome c1 non-heme 11 kDa protein;Mitochondrial hinge protein;Ubiquinol-cytochrome c reductase complex 11 kDa protein;, PF02320;, GO:0005743;GO:0005746;GO:0005750;GO:0005739;GO:0008121;GO:0009060;GO:0006122;GO:0006119;, C:mitochondrial inner membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:ubiquinol-cytochrome-c reductase activity;, P:aerobic respiration; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:oxidative phosphorylation; scaffold83 indexed_genome mRNA 655704 682865 . + . ID=transcript_12130;Q15345 A8K5G8 Q3MJ96 Q5TDF5 Q71RA8 Q9BSM0,Leucine-rich repeat-containing protein 41,Protein Muf1;, , GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, , P:post-translational protein modification; P:protein ubiquitination;|Q15345 A8K5G8 Q3MJ96 Q5TDF5 Q71RA8 Q9BSM0,Leucine-rich repeat-containing protein 41,Protein Muf1;, , GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, , P:post-translational protein modification; P:protein ubiquitination;|Q15345 A8K5G8 Q3MJ96 Q5TDF5 Q71RA8 Q9BSM0,Leucine-rich repeat-containing protein 41,Protein Muf1;, , GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, , P:post-translational protein modification; P:protein ubiquitination;|Q15345 A8K5G8 Q3MJ96 Q5TDF5 Q71RA8 Q9BSM0,Leucine-rich repeat-containing protein 41,Protein Muf1;, , GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, , P:post-translational protein modification; P:protein ubiquitination;|Q15345 A8K5G8 Q3MJ96 Q5TDF5 Q71RA8 Q9BSM0,Leucine-rich repeat-containing protein 41,Protein Muf1;, , GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, , P:post-translational protein modification; P:protein ubiquitination;|Q92698 Q5TE31 Q6IUY3,DNA repair and recombination protein RAD54-like,RAD54 homolog;, PF00271;PF00176;, GO:0005654;GO:0005634;GO:0032991;GO:0036310;GO:0005524;GO:0003677;GO:0003678;GO:0015616;GO:0046872;GO:0070615;GO:0008340;GO:0006310;GO:0006281;GO:0045003;GO:0051321;GO:0007131;GO:0042493;GO:0010212;, C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:annealing helicase activity; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:determination of adult lifespan; P:DNA recombination; P:DNA repair; P:double-strand break repair via synthesis-dependent strand annealing; P:meiotic cell cycle; P:reciprocal meiotic recombination; P:response to drug; P:response to ionizing radiation;|Q15345 A8K5G8 Q3MJ96 Q5TDF5 Q71RA8 Q9BSM0,Leucine-rich repeat-containing protein 41,Protein Muf1;, , GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, , P:post-translational protein modification; P:protein ubiquitination;|Q92698 Q5TE31 Q6IUY3,DNA repair and recombination protein RAD54-like,RAD54 homolog;, PF00271;PF00176;, GO:0005654;GO:0005634;GO:0032991;GO:0036310;GO:0005524;GO:0003677;GO:0003678;GO:0015616;GO:0046872;GO:0070615;GO:0008340;GO:0006310;GO:0006281;GO:0045003;GO:0051321;GO:0007131;GO:0042493;GO:0010212;, C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:annealing helicase activity; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:determination of adult lifespan; P:DNA recombination; P:DNA repair; P:double-strand break repair via synthesis-dependent strand annealing; P:meiotic cell cycle; P:reciprocal meiotic recombination; P:response to drug; P:response to ionizing radiation; scaffold83 indexed_genome mRNA 687199 699342 . - . ID=transcript_12131;Q92698 Q5TE31 Q6IUY3,DNA repair and recombination protein RAD54-like,RAD54 homolog;, PF00271;PF00176;, GO:0005654;GO:0005634;GO:0032991;GO:0036310;GO:0005524;GO:0003677;GO:0003678;GO:0015616;GO:0046872;GO:0070615;GO:0008340;GO:0006310;GO:0006281;GO:0045003;GO:0051321;GO:0007131;GO:0042493;GO:0010212;, C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:annealing helicase activity; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:metal ion binding; F:nucleosome-dependent ATPase activity;, P:determination of adult lifespan; P:DNA recombination; P:DNA repair; P:double-strand break repair via synthesis-dependent strand annealing; P:meiotic cell cycle; P:reciprocal meiotic recombination; P:response to drug; P:response to ionizing radiation; scaffold83 indexed_genome mRNA 719954 720828 . - . ID=transcript_12132;Q9Y241 Q9UFZ2,HIG1 domain family member 1A, mitochondrial,Hypoxia-inducible gene 1 protein;RCF1 homolog A;, PF04588;, GO:0016021;GO:0005743;GO:0005739;GO:0005654;GO:0032991;GO:0070469;GO:0097250;GO:0043066;GO:0061418;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:protein-containing complex; C:respirasome;, , P:mitochondrial respirasome assembly; P:negative regulation of apoptotic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; scaffold83 indexed_genome mRNA 720838 738170 . - . ID=transcript_12133;Q96LR2,Leucine rich adaptor protein 1,Leucine repeat adapter protein 35A;, PF14854;, GO:0042641;GO:0005737;GO:0005829;GO:0043231;GO:0031032;GO:0016477;GO:0001819;GO:0043123;, C:actomyosin; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle;, , P:actomyosin structure organization; P:cell migration; P:positive regulation of cytokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold83 indexed_genome mRNA 745834 754326 . + . ID=transcript_12134;Q8WZA1 D3DQ16 Q5VST2 Q5VST3 Q9BV55 Q9H9L8 Q9NXF9 Q9NYF7,Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1,UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2;, PF03071;PF15711;, GO:0000139;GO:0030173;GO:0016021;GO:0008375;GO:0047223;GO:0030145;GO:0016266;GO:0006493;, C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity; F:manganese ion binding;, P:O-glycan processing; P:protein O-linked glycosylation;|Q8WZA1 D3DQ16 Q5VST2 Q5VST3 Q9BV55 Q9H9L8 Q9NXF9 Q9NYF7,Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1,UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2;, PF03071;PF15711;, GO:0000139;GO:0030173;GO:0016021;GO:0008375;GO:0047223;GO:0030145;GO:0016266;GO:0006493;, C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity; F:manganese ion binding;, P:O-glycan processing; P:protein O-linked glycosylation;|Q8WZA1 D3DQ16 Q5VST2 Q5VST3 Q9BV55 Q9H9L8 Q9NXF9 Q9NYF7,Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1,UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2;, PF03071;PF15711;, GO:0000139;GO:0030173;GO:0016021;GO:0008375;GO:0047223;GO:0030145;GO:0016266;GO:0006493;, C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity; F:manganese ion binding;, P:O-glycan processing; P:protein O-linked glycosylation; scaffold83 indexed_genome mRNA 756851 761602 . - . ID=transcript_12135;O60635 D3DQ14 O60745 Q5VST0,Tetraspanin-1,Tetraspan NET-1;Tetraspanin TM4-C;, PF00335;, GO:0030054;GO:0005737;GO:0070062;GO:0005887;GO:0043231;GO:0005765;GO:0016020;GO:0005654;GO:0048471;GO:0005886;GO:0031982;GO:0050821;, C:cell junction; C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, , P:protein stabilization; scaffold83 indexed_genome mRNA 816225 921733 . + . ID=transcript_12136;Q92569 B2R9C1 D3DQ12 O60482 Q5T4P1 Q5T4P2,Phosphatidylinositol 3-kinase regulatory subunit gamma,Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma;p55PIK;, PF16454;PF00017;, GO:0005829;GO:0005942;GO:0016303;GO:0046935;GO:0001784;GO:0002042;GO:0008286;GO:0006661;GO:0046854;GO:0030335;GO:0010628;GO:0001934;GO:0043491;GO:0043551;, C:cytosol; C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-3-kinase regulator activity; F:phosphotyrosine residue binding;, P:cell migration involved in sprouting angiogenesis; P:insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:positive regulation of cell migration; P:positive regulation of gene expression; P:positive regulation of protein phosphorylation; P:protein kinase B signaling; P:regulation of phosphatidylinositol 3-kinase activity;|Q92569 B2R9C1 D3DQ12 O60482 Q5T4P1 Q5T4P2,Phosphatidylinositol 3-kinase regulatory subunit gamma,Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma;p55PIK;, PF16454;PF00017;, GO:0005829;GO:0005942;GO:0016303;GO:0046935;GO:0001784;GO:0002042;GO:0008286;GO:0006661;GO:0046854;GO:0030335;GO:0010628;GO:0001934;GO:0043491;GO:0043551;, C:cytosol; C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-3-kinase regulator activity; F:phosphotyrosine residue binding;, P:cell migration involved in sprouting angiogenesis; P:insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:positive regulation of cell migration; P:positive regulation of gene expression; P:positive regulation of protein phosphorylation; P:protein kinase B signaling; P:regulation of phosphatidylinositol 3-kinase activity; scaffold83 indexed_genome mRNA 925662 1014497 . - . ID=transcript_12137;Q6P0Q8 O94899 Q5VT07 Q5VT08 Q7LGC4 Q8NDG1 Q96B94 Q9BYE8,Microtubule-associated serine/threonine-protein kinase 2,, PF08926;PF17820;PF00069;, GO:0005737;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0019902;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;GO:0006468;GO:0032655;GO:0048515;, C:cytoplasm; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of interleukin-12 production; P:spermatid differentiation;|Q6P0Q8 O94899 Q5VT07 Q5VT08 Q7LGC4 Q8NDG1 Q96B94 Q9BYE8,Microtubule-associated serine/threonine-protein kinase 2,, PF08926;PF17820;PF00069;, GO:0005737;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0019902;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;GO:0006468;GO:0032655;GO:0048515;, C:cytoplasm; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of interleukin-12 production; P:spermatid differentiation;|Q6P0Q8 O94899 Q5VT07 Q5VT08 Q7LGC4 Q8NDG1 Q96B94 Q9BYE8,Microtubule-associated serine/threonine-protein kinase 2,, PF08926;PF17820;PF00069;, GO:0005737;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0019902;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;GO:0006468;GO:0032655;GO:0048515;, C:cytoplasm; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of interleukin-12 production; P:spermatid differentiation;|Q6P0Q8 O94899 Q5VT07 Q5VT08 Q7LGC4 Q8NDG1 Q96B94 Q9BYE8,Microtubule-associated serine/threonine-protein kinase 2,, PF08926;PF17820;PF00069;, GO:0005737;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0019902;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;GO:0006468;GO:0032655;GO:0048515;, C:cytoplasm; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of interleukin-12 production; P:spermatid differentiation;|Q6P0Q8 O94899 Q5VT07 Q5VT08 Q7LGC4 Q8NDG1 Q96B94 Q9BYE8,Microtubule-associated serine/threonine-protein kinase 2,, PF08926;PF17820;PF00069;, GO:0005737;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0019902;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;GO:0006468;GO:0032655;GO:0048515;, C:cytoplasm; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of interleukin-12 production; P:spermatid differentiation;|Q6P0Q8 O94899 Q5VT07 Q5VT08 Q7LGC4 Q8NDG1 Q96B94 Q9BYE8,Microtubule-associated serine/threonine-protein kinase 2,, PF08926;PF17820;PF00069;, GO:0005737;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0019902;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;GO:0006468;GO:0032655;GO:0048515;, C:cytoplasm; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of interleukin-12 production; P:spermatid differentiation;|Q6P0Q8 O94899 Q5VT07 Q5VT08 Q7LGC4 Q8NDG1 Q96B94 Q9BYE8,Microtubule-associated serine/threonine-protein kinase 2,, PF08926;PF17820;PF00069;, GO:0005737;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0019902;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;GO:0006468;GO:0032655;GO:0048515;, C:cytoplasm; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of interleukin-12 production; P:spermatid differentiation;|O15021 A6NL49 B5ME48 E7EWQ5 J3QT34 Q05EE6 Q6ZN07 Q8N4X4 Q96LY3,Microtubule-associated serine/threonine-protein kinase 4 {ECO:0000305},, PF08926;PF17820;PF00069;, GO:0005737;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;, C:cytoplasm;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation;|Q6P0Q8 O94899 Q5VT07 Q5VT08 Q7LGC4 Q8NDG1 Q96B94 Q9BYE8,Microtubule-associated serine/threonine-protein kinase 2,, PF08926;PF17820;PF00069;, GO:0005737;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0019902;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;GO:0006468;GO:0032655;GO:0048515;, C:cytoplasm; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of interleukin-12 production; P:spermatid differentiation;|Q6P0Q8 O94899 Q5VT07 Q5VT08 Q7LGC4 Q8NDG1 Q96B94 Q9BYE8,Microtubule-associated serine/threonine-protein kinase 2,, PF08926;PF17820;PF00069;, GO:0005737;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0019902;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;GO:0006468;GO:0032655;GO:0048515;, C:cytoplasm; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:phosphatase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of interleukin-12 production; P:spermatid differentiation; scaffold83 indexed_genome mRNA 1178179 1214651 . + . ID=transcript_12138;Q9Y573 A2A6V4 D3DQ11 Q8N5C3,Actin-binding protein IPP,Intracisternal A particle-promoted polypeptide;Kelch-like protein 27;, PF07707;PF00651;PF01344;, GO:0015629;GO:0005737;GO:0003779;, C:actin cytoskeleton; C:cytoplasm;, F:actin binding; scaffold83 indexed_genome mRNA 1220743 1226138 . - . ID=transcript_12139;Q5SWH9 Q3SWW5 Q7Z2G0 Q9P0P9,Transmembrane protein 69,, PF11911;, GO:0016021;, C:integral component of membrane; scaffold83 indexed_genome mRNA 1255087 1286967 . + . ID=transcript_12140;Q9HC44 D3DQ10 Q9H751,Vasculin-like protein 1,GC-rich promoter-binding protein 1-like 1;, PF15337;, GO:0005634;GO:0003677;GO:0003723;GO:0045893;GO:0006355;GO:0006351;, C:nucleus;, F:DNA binding; F:RNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q9HC44 D3DQ10 Q9H751,Vasculin-like protein 1,GC-rich promoter-binding protein 1-like 1;, PF15337;, GO:0005634;GO:0003677;GO:0003723;GO:0045893;GO:0006355;GO:0006351;, C:nucleus;, F:DNA binding; F:RNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9HC44 D3DQ10 Q9H751,Vasculin-like protein 1,GC-rich promoter-binding protein 1-like 1;, PF15337;, GO:0005634;GO:0003677;GO:0003723;GO:0045893;GO:0006355;GO:0006351;, C:nucleus;, F:DNA binding; F:RNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold83 indexed_genome mRNA 1288595 1292878 . + . ID=transcript_12141;Q96LX7 A1A4Y7 B4DNX7 B4E1Q5 C9J8L2 Q0P683 Q5T629,Coiled-coil domain-containing protein 17|Q96LX7 A1A4Y7 B4DNX7 B4E1Q5 C9J8L2 Q0P683 Q5T629,Coiled-coil domain-containing protein 17 scaffold83 indexed_genome mRNA 1293495 1323278 . - . ID=transcript_12142;Q9BTW2,Nuclear autoantigenic sperm protein,, PF10516;PF13181;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0042393;GO:0044877;GO:0001824;GO:0034080;GO:0006260;GO:0006335;GO:0006336;GO:0000082;GO:0043486;GO:0008584;GO:0006334;GO:0015031;GO:0033574;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:histone binding; F:protein-containing complex binding;, P:blastocyst development; P:CENP-A containing nucleosome assembly; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:G1/S transition of mitotic cell cycle; P:histone exchange; P:male gonad development; P:nucleosome assembly; P:protein transport; P:response to testosterone;|Q9BTW2,Nuclear autoantigenic sperm protein,, PF10516;PF13181;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0042393;GO:0044877;GO:0001824;GO:0034080;GO:0006260;GO:0006335;GO:0006336;GO:0000082;GO:0043486;GO:0008584;GO:0006334;GO:0015031;GO:0033574;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:histone binding; F:protein-containing complex binding;, P:blastocyst development; P:CENP-A containing nucleosome assembly; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:G1/S transition of mitotic cell cycle; P:histone exchange; P:male gonad development; P:nucleosome assembly; P:protein transport; P:response to testosterone;|Q9BTW2,Nuclear autoantigenic sperm protein,, PF10516;PF13181;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0042393;GO:0044877;GO:0001824;GO:0034080;GO:0006260;GO:0006335;GO:0006336;GO:0000082;GO:0043486;GO:0008584;GO:0006334;GO:0015031;GO:0033574;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:histone binding; F:protein-containing complex binding;, P:blastocyst development; P:CENP-A containing nucleosome assembly; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:G1/S transition of mitotic cell cycle; P:histone exchange; P:male gonad development; P:nucleosome assembly; P:protein transport; P:response to testosterone; scaffold83 indexed_genome mRNA 1381042 1395324 . + . ID=transcript_12143;Q06830 B5BU26 D3DPZ8 P35703 Q2V576 Q5T154 Q5T155,Peroxiredoxin-1,Natural killer cell-enhancing factor A;Proliferation-associated gene protein;Thioredoxin peroxidase 2;Thioredoxin-dependent peroxide reductase 2;Thioredoxin-dependent peroxiredoxin 1 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0042470;GO:0005634;GO:0045296;GO:0004601;GO:0003723;GO:0008379;GO:0008283;GO:0045454;GO:0034599;GO:0042744;GO:0045321;GO:0030101;GO:0019430;GO:0001895;GO:0001501;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:melanosome; C:nucleus;, F:cadherin binding; F:peroxidase activity; F:RNA binding; F:thioredoxin peroxidase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:hydrogen peroxide catabolic process; P:leukocyte activation; P:natural killer cell activation; P:removal of superoxide radicals; P:retina homeostasis; P:skeletal system development;|Q06830 B5BU26 D3DPZ8 P35703 Q2V576 Q5T154 Q5T155,Peroxiredoxin-1,Natural killer cell-enhancing factor A;Proliferation-associated gene protein;Thioredoxin peroxidase 2;Thioredoxin-dependent peroxide reductase 2;Thioredoxin-dependent peroxiredoxin 1 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0042470;GO:0005634;GO:0045296;GO:0004601;GO:0003723;GO:0008379;GO:0008283;GO:0045454;GO:0034599;GO:0042744;GO:0045321;GO:0030101;GO:0019430;GO:0001895;GO:0001501;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:melanosome; C:nucleus;, F:cadherin binding; F:peroxidase activity; F:RNA binding; F:thioredoxin peroxidase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:hydrogen peroxide catabolic process; P:leukocyte activation; P:natural killer cell activation; P:removal of superoxide radicals; P:retina homeostasis; P:skeletal system development;|Q06830 B5BU26 D3DPZ8 P35703 Q2V576 Q5T154 Q5T155,Peroxiredoxin-1,Natural killer cell-enhancing factor A;Proliferation-associated gene protein;Thioredoxin peroxidase 2;Thioredoxin-dependent peroxide reductase 2;Thioredoxin-dependent peroxiredoxin 1 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0042470;GO:0005634;GO:0045296;GO:0004601;GO:0003723;GO:0008379;GO:0008283;GO:0045454;GO:0034599;GO:0042744;GO:0045321;GO:0030101;GO:0019430;GO:0001895;GO:0001501;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:melanosome; C:nucleus;, F:cadherin binding; F:peroxidase activity; F:RNA binding; F:thioredoxin peroxidase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:hydrogen peroxide catabolic process; P:leukocyte activation; P:natural killer cell activation; P:removal of superoxide radicals; P:retina homeostasis; P:skeletal system development;|Q06830 B5BU26 D3DPZ8 P35703 Q2V576 Q5T154 Q5T155,Peroxiredoxin-1,Natural killer cell-enhancing factor A;Proliferation-associated gene protein;Thioredoxin peroxidase 2;Thioredoxin-dependent peroxide reductase 2;Thioredoxin-dependent peroxiredoxin 1 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0042470;GO:0005634;GO:0045296;GO:0004601;GO:0003723;GO:0008379;GO:0008283;GO:0045454;GO:0034599;GO:0042744;GO:0045321;GO:0030101;GO:0019430;GO:0001895;GO:0001501;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:melanosome; C:nucleus;, F:cadherin binding; F:peroxidase activity; F:RNA binding; F:thioredoxin peroxidase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:hydrogen peroxide catabolic process; P:leukocyte activation; P:natural killer cell activation; P:removal of superoxide radicals; P:retina homeostasis; P:skeletal system development;|Q06830 B5BU26 D3DPZ8 P35703 Q2V576 Q5T154 Q5T155,Peroxiredoxin-1,Natural killer cell-enhancing factor A;Proliferation-associated gene protein;Thioredoxin peroxidase 2;Thioredoxin-dependent peroxide reductase 2;Thioredoxin-dependent peroxiredoxin 1 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0042470;GO:0005634;GO:0045296;GO:0004601;GO:0003723;GO:0008379;GO:0008283;GO:0045454;GO:0034599;GO:0042744;GO:0045321;GO:0030101;GO:0019430;GO:0001895;GO:0001501;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:melanosome; C:nucleus;, F:cadherin binding; F:peroxidase activity; F:RNA binding; F:thioredoxin peroxidase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:hydrogen peroxide catabolic process; P:leukocyte activation; P:natural killer cell activation; P:removal of superoxide radicals; P:retina homeostasis; P:skeletal system development;|Q06830 B5BU26 D3DPZ8 P35703 Q2V576 Q5T154 Q5T155,Peroxiredoxin-1,Natural killer cell-enhancing factor A;Proliferation-associated gene protein;Thioredoxin peroxidase 2;Thioredoxin-dependent peroxide reductase 2;Thioredoxin-dependent peroxiredoxin 1 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0042470;GO:0005634;GO:0045296;GO:0004601;GO:0003723;GO:0008379;GO:0008283;GO:0045454;GO:0034599;GO:0042744;GO:0045321;GO:0030101;GO:0019430;GO:0001895;GO:0001501;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:melanosome; C:nucleus;, F:cadherin binding; F:peroxidase activity; F:RNA binding; F:thioredoxin peroxidase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:hydrogen peroxide catabolic process; P:leukocyte activation; P:natural killer cell activation; P:removal of superoxide radicals; P:retina homeostasis; P:skeletal system development;|Q9Y4U1 Q5T157 Q9BRQ7,Cyanocobalamin reductase / alkylcobalamin dealkylase,Alkylcobalamin:glutathione S-alkyltransferase;CblC {ECO:0000303|PubMed:23415655, ECO:0000303|PubMed:25809485};Cyanocobalamin reductase (cyanide-eliminating);Methylmalonic aciduria and homocystinuria type C protein {ECO:0000303|PubMed:19700356};, PF16690;, GO:0005737;GO:0005829;GO:0031419;GO:0033787;GO:0032451;GO:0071949;GO:0043295;GO:0016491;GO:0042803;GO:0016740;GO:0009235;GO:0070988;GO:0006749;, C:cytoplasm; C:cytosol;, F:cobalamin binding; F:cyanocobalamin reductase (cyanide-eliminating) activity; F:demethylase activity; F:FAD binding; F:glutathione binding; F:oxidoreductase activity; F:protein homodimerization activity; F:transferase activity;, P:cobalamin metabolic process; P:demethylation; P:glutathione metabolic process; scaffold83 indexed_genome mRNA 1398621 1401917 . + . ID=transcript_12144;A0A0D9SF12,Transmembrane protein CCDC163 {ECO:0000305},Coiled-coil domain-containing protein 163 {ECO:0000305};coiled-coil domain containing 163 pseudogene {ECO:0000312|HGNC:HGNC:27003};, , GO:0016021;, C:integral component of membrane;|A0A0D9SF12,Transmembrane protein CCDC163 {ECO:0000305},Coiled-coil domain-containing protein 163 {ECO:0000305};coiled-coil domain containing 163 pseudogene {ECO:0000312|HGNC:HGNC:27003};, , GO:0016021;, C:integral component of membrane;|A0A0D9SF12,Transmembrane protein CCDC163 {ECO:0000305},Coiled-coil domain-containing protein 163 {ECO:0000305};coiled-coil domain containing 163 pseudogene {ECO:0000312|HGNC:HGNC:27003};, , GO:0016021;, C:integral component of membrane; scaffold83 indexed_genome mRNA 1405897 1540796 . + . ID=transcript_12145;Q96S53 Q5T422 Q5T423 Q8N520 Q9Y3Q6,Dual specificity testis-specific protein kinase 2,Testicular protein kinase 2;, PF07714;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0030036;GO:0048041;GO:0006468;GO:0007283;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton organization; P:focal adhesion assembly; P:protein phosphorylation; P:spermatogenesis; scaffold83 indexed_genome mRNA 1540879 1543887 . + . ID=transcript_12146;Q96S53 Q5T422 Q5T423 Q8N520 Q9Y3Q6,Dual specificity testis-specific protein kinase 2,Testicular protein kinase 2;, PF07714;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0030036;GO:0048041;GO:0006468;GO:0007283;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton organization; P:focal adhesion assembly; P:protein phosphorylation; P:spermatogenesis;|Q96S53 Q5T422 Q5T423 Q8N520 Q9Y3Q6,Dual specificity testis-specific protein kinase 2,Testicular protein kinase 2;, PF07714;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0004714;GO:0030036;GO:0048041;GO:0006468;GO:0007283;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton organization; P:focal adhesion assembly; P:protein phosphorylation; P:spermatogenesis; scaffold83 indexed_genome mRNA 1543905 1555592 . - . ID=transcript_12147;Q96GM8 B4DEM6 Q6IA35 Q8IWN5 Q9H846,Target of EGR1 protein 1,, PF04857;PF00642;, GO:0015030;GO:0005737;GO:0016604;GO:0016607;GO:0005730;GO:0005654;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0017069;GO:0090503;GO:0034472;, C:Cajal body; C:cytoplasm; C:nuclear body; C:nuclear speck; C:nucleolus; C:nucleoplasm;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding; F:snRNA binding;, P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:snRNA 3'-end processing;|Q9UIF7 D3DPZ4 Q15830 Q9UBP2 Q9UBS7 Q9UIF4 Q9UIF5 Q9UIF6,Adenine DNA glycosylase,MutY homolog;, PF00633;PF00730;PF14815;, GO:0005739;GO:0005654;GO:0005634;GO:0051539;GO:0034039;GO:0035485;GO:0046872;GO:0032407;GO:0032357;GO:0000701;GO:0006284;GO:0006287;GO:0045007;GO:0006281;GO:0006298;, C:mitochondrion; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:8-oxo-7,8-dihydroguanine DNA N-glycosylase activity; F:adenine/guanine mispair binding; F:metal ion binding; F:MutSalpha complex binding; F:oxidized purine DNA binding; F:purine-specific mismatch base pair DNA N-glycosylase activity;, P:base-excision repair; P:base-excision repair, gap-filling; P:depurination; P:DNA repair; P:mismatch repair;|Q9UIF7 D3DPZ4 Q15830 Q9UBP2 Q9UBS7 Q9UIF4 Q9UIF5 Q9UIF6,Adenine DNA glycosylase,MutY homolog;, PF00633;PF00730;PF14815;, GO:0005739;GO:0005654;GO:0005634;GO:0051539;GO:0034039;GO:0035485;GO:0046872;GO:0032407;GO:0032357;GO:0000701;GO:0006284;GO:0006287;GO:0045007;GO:0006281;GO:0006298;, C:mitochondrion; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:8-oxo-7,8-dihydroguanine DNA N-glycosylase activity; F:adenine/guanine mispair binding; F:metal ion binding; F:MutSalpha complex binding; F:oxidized purine DNA binding; F:purine-specific mismatch base pair DNA N-glycosylase activity;, P:base-excision repair; P:base-excision repair, gap-filling; P:depurination; P:DNA repair; P:mismatch repair;|Q9UIF7 D3DPZ4 Q15830 Q9UBP2 Q9UBS7 Q9UIF4 Q9UIF5 Q9UIF6,Adenine DNA glycosylase,MutY homolog;, PF00633;PF00730;PF14815;, GO:0005739;GO:0005654;GO:0005634;GO:0051539;GO:0034039;GO:0035485;GO:0046872;GO:0032407;GO:0032357;GO:0000701;GO:0006284;GO:0006287;GO:0045007;GO:0006281;GO:0006298;, C:mitochondrion; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:8-oxo-7,8-dihydroguanine DNA N-glycosylase activity; F:adenine/guanine mispair binding; F:metal ion binding; F:MutSalpha complex binding; F:oxidized purine DNA binding; F:purine-specific mismatch base pair DNA N-glycosylase activity;, P:base-excision repair; P:base-excision repair, gap-filling; P:depurination; P:DNA repair; P:mismatch repair; scaffold83 indexed_genome mRNA 1556245 1558166 . - . ID=transcript_12148;Q96IR7 B2R9B0,4-hydroxyphenylpyruvate dioxygenase-like protein,Glyoxalase domain-containing protein 1;, , GO:0003868;GO:0046872;GO:0009072;, , F:4-hydroxyphenylpyruvate dioxygenase activity; F:metal ion binding;, P:aromatic amino acid family metabolic process; scaffold83 indexed_genome mRNA 1677317 1822907 . + . ID=transcript_12149;Q9P217 Q5SXQ9,Zinc finger SWIM domain-containing protein 5,, , GO:0031462;GO:0005615;GO:0008270;GO:1902667;, C:Cul2-RING ubiquitin ligase complex; C:extracellular space;, F:zinc ion binding;, P:regulation of axon guidance; scaffold83 indexed_genome mRNA 1823314 1824095 . + . ID=transcript_12150;Q9P217 Q5SXQ9,Zinc finger SWIM domain-containing protein 5,, , GO:0031462;GO:0005615;GO:0008270;GO:1902667;, C:Cul2-RING ubiquitin ligase complex; C:extracellular space;, F:zinc ion binding;, P:regulation of axon guidance; scaffold83 indexed_genome mRNA 1824217 1853506 . + . ID=transcript_12151;Q9P217 Q5SXQ9,Zinc finger SWIM domain-containing protein 5,, , GO:0031462;GO:0005615;GO:0008270;GO:1902667;, C:Cul2-RING ubiquitin ligase complex; C:extracellular space;, F:zinc ion binding;, P:regulation of axon guidance;|Q9P217 Q5SXQ9,Zinc finger SWIM domain-containing protein 5,, , GO:0031462;GO:0005615;GO:0008270;GO:1902667;, C:Cul2-RING ubiquitin ligase complex; C:extracellular space;, F:zinc ion binding;, P:regulation of axon guidance;|Q9P217 Q5SXQ9,Zinc finger SWIM domain-containing protein 5,, , GO:0031462;GO:0005615;GO:0008270;GO:1902667;, C:Cul2-RING ubiquitin ligase complex; C:extracellular space;, F:zinc ion binding;, P:regulation of axon guidance; scaffold83 indexed_genome mRNA 1854040 1857331 . - . ID=transcript_12152;P06132 A8K762 Q16863 Q16883 Q53YB8 Q53ZP6 Q6IB28 Q9BUZ0,Uroporphyrinogen decarboxylase,, PF01208;, GO:0005829;GO:0005654;GO:0004853;GO:0006783;GO:0006782;, C:cytosol; C:nucleoplasm;, F:uroporphyrinogen decarboxylase activity;, P:heme biosynthetic process; P:protoporphyrinogen IX biosynthetic process;|P06132 A8K762 Q16863 Q16883 Q53YB8 Q53ZP6 Q6IB28 Q9BUZ0,Uroporphyrinogen decarboxylase,, PF01208;, GO:0005829;GO:0005654;GO:0004853;GO:0006783;GO:0006782;, C:cytosol; C:nucleoplasm;, F:uroporphyrinogen decarboxylase activity;, P:heme biosynthetic process; P:protoporphyrinogen IX biosynthetic process;|P06132 A8K762 Q16863 Q16883 Q53YB8 Q53ZP6 Q6IB28 Q9BUZ0,Uroporphyrinogen decarboxylase,, PF01208;, GO:0005829;GO:0005654;GO:0004853;GO:0006783;GO:0006782;, C:cytosol; C:nucleoplasm;, F:uroporphyrinogen decarboxylase activity;, P:heme biosynthetic process; P:protoporphyrinogen IX biosynthetic process;|P06132 A8K762 Q16863 Q16883 Q53YB8 Q53ZP6 Q6IB28 Q9BUZ0,Uroporphyrinogen decarboxylase,, PF01208;, GO:0005829;GO:0005654;GO:0004853;GO:0006783;GO:0006782;, C:cytosol; C:nucleoplasm;, F:uroporphyrinogen decarboxylase activity;, P:heme biosynthetic process; P:protoporphyrinogen IX biosynthetic process; scaffold83 indexed_genome mRNA 1859785 1867233 . + . ID=transcript_12153;Q5T447 B3KPV7 B3KRH4 Q5T448 Q9H783,E3 ubiquitin-protein ligase HECTD3,HECT domain-containing protein 3;HECT-type E3 ubiquitin transferase HECTD3;, PF03256;PF00632;, GO:0048471;GO:0019905;GO:0004842;GO:0043161;, C:perinuclear region of cytoplasm;, F:syntaxin binding; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q5T447 B3KPV7 B3KRH4 Q5T448 Q9H783,E3 ubiquitin-protein ligase HECTD3,HECT domain-containing protein 3;HECT-type E3 ubiquitin transferase HECTD3;, PF03256;PF00632;, GO:0048471;GO:0019905;GO:0004842;GO:0043161;, C:perinuclear region of cytoplasm;, F:syntaxin binding; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q5T447 B3KPV7 B3KRH4 Q5T448 Q9H783,E3 ubiquitin-protein ligase HECTD3,HECT domain-containing protein 3;HECT-type E3 ubiquitin transferase HECTD3;, PF03256;PF00632;, GO:0048471;GO:0019905;GO:0004842;GO:0043161;, C:perinuclear region of cytoplasm;, F:syntaxin binding; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q5T447 B3KPV7 B3KRH4 Q5T448 Q9H783,E3 ubiquitin-protein ligase HECTD3,HECT domain-containing protein 3;HECT-type E3 ubiquitin transferase HECTD3;, PF03256;PF00632;, GO:0048471;GO:0019905;GO:0004842;GO:0043161;, C:perinuclear region of cytoplasm;, F:syntaxin binding; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q5T447 B3KPV7 B3KRH4 Q5T448 Q9H783,E3 ubiquitin-protein ligase HECTD3,HECT domain-containing protein 3;HECT-type E3 ubiquitin transferase HECTD3;, PF03256;PF00632;, GO:0048471;GO:0019905;GO:0004842;GO:0043161;, C:perinuclear region of cytoplasm;, F:syntaxin binding; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q5T447 B3KPV7 B3KRH4 Q5T448 Q9H783,E3 ubiquitin-protein ligase HECTD3,HECT domain-containing protein 3;HECT-type E3 ubiquitin transferase HECTD3;, PF03256;PF00632;, GO:0048471;GO:0019905;GO:0004842;GO:0043161;, C:perinuclear region of cytoplasm;, F:syntaxin binding; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q5T447 B3KPV7 B3KRH4 Q5T448 Q9H783,E3 ubiquitin-protein ligase HECTD3,HECT domain-containing protein 3;HECT-type E3 ubiquitin transferase HECTD3;, PF03256;PF00632;, GO:0048471;GO:0019905;GO:0004842;GO:0043161;, C:perinuclear region of cytoplasm;, F:syntaxin binding; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q5T447 B3KPV7 B3KRH4 Q5T448 Q9H783,E3 ubiquitin-protein ligase HECTD3,HECT domain-containing protein 3;HECT-type E3 ubiquitin transferase HECTD3;, PF03256;PF00632;, GO:0048471;GO:0019905;GO:0004842;GO:0043161;, C:perinuclear region of cytoplasm;, F:syntaxin binding; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; scaffold83 indexed_genome mRNA 1878050 1987692 . + . ID=transcript_12154;Q9NR50 B2RBH8 D3DPZ2 Q5QP89 Q5QP90 Q8NDB5 Q8WV57 Q9H850,Translation initiation factor eIF-2B subunit gamma,eIF-2B GDP-GTP exchange factor subunit gamma;, PF12804;, GO:0005737;GO:0005829;GO:0005851;GO:0032045;GO:0005085;GO:0003743;GO:0002183;GO:0021766;GO:0014003;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex; C:guanyl-nucleotide exchange factor complex;, F:guanyl-nucleotide exchange factor activity; F:translation initiation factor activity;, P:cytoplasmic translational initiation; P:hippocampus development; P:oligodendrocyte development; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|Q9NR50 B2RBH8 D3DPZ2 Q5QP89 Q5QP90 Q8NDB5 Q8WV57 Q9H850,Translation initiation factor eIF-2B subunit gamma,eIF-2B GDP-GTP exchange factor subunit gamma;, PF12804;, GO:0005737;GO:0005829;GO:0005851;GO:0032045;GO:0005085;GO:0003743;GO:0002183;GO:0021766;GO:0014003;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex; C:guanyl-nucleotide exchange factor complex;, F:guanyl-nucleotide exchange factor activity; F:translation initiation factor activity;, P:cytoplasmic translational initiation; P:hippocampus development; P:oligodendrocyte development; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation; scaffold83 indexed_genome mRNA 1992331 2008144 . + . ID=transcript_12155;Q9Y6C5 O95341 O95856 Q53Z57 Q5QP87 Q6UX14,Protein patched homolog 2,, PF02460;PF12349;, GO:0016021;GO:0005886;GO:0097108;GO:0008158;GO:0005119;GO:0001709;GO:0009957;GO:0042633;GO:0045879;GO:0045606;GO:0001558;GO:0043588;GO:0007224;, C:integral component of membrane; C:plasma membrane;, F:hedgehog family protein binding; F:hedgehog receptor activity; F:smoothened binding;, P:cell fate determination; P:epidermal cell fate specification; P:hair cycle; P:negative regulation of smoothened signaling pathway; P:positive regulation of epidermal cell differentiation; P:regulation of cell growth; P:skin development; P:smoothened signaling pathway;|Q9Y6C5 O95341 O95856 Q53Z57 Q5QP87 Q6UX14,Protein patched homolog 2,, PF02460;PF12349;, GO:0016021;GO:0005886;GO:0097108;GO:0008158;GO:0005119;GO:0001709;GO:0009957;GO:0042633;GO:0045879;GO:0045606;GO:0001558;GO:0043588;GO:0007224;, C:integral component of membrane; C:plasma membrane;, F:hedgehog family protein binding; F:hedgehog receptor activity; F:smoothened binding;, P:cell fate determination; P:epidermal cell fate specification; P:hair cycle; P:negative regulation of smoothened signaling pathway; P:positive regulation of epidermal cell differentiation; P:regulation of cell growth; P:skin development; P:smoothened signaling pathway;|Q9Y6C5 O95341 O95856 Q53Z57 Q5QP87 Q6UX14,Protein patched homolog 2,, PF02460;PF12349;, GO:0016021;GO:0005886;GO:0097108;GO:0008158;GO:0005119;GO:0001709;GO:0009957;GO:0042633;GO:0045879;GO:0045606;GO:0001558;GO:0043588;GO:0007224;, C:integral component of membrane; C:plasma membrane;, F:hedgehog family protein binding; F:hedgehog receptor activity; F:smoothened binding;, P:cell fate determination; P:epidermal cell fate specification; P:hair cycle; P:negative regulation of smoothened signaling pathway; P:positive regulation of epidermal cell differentiation; P:regulation of cell growth; P:skin development; P:smoothened signaling pathway; scaffold83 indexed_genome mRNA 2013399 2019276 . - . ID=transcript_12156;C9JJ37 B4E384 B7ZC36 B7ZC37,BTB/POZ domain-containing protein 19,, PF07707;PF00651; scaffold83 indexed_genome mRNA 2026185 2028761 . - . ID=transcript_12157;Q9H4B4 Q15767 Q5JR99 Q96CV1,Serine/threonine-protein kinase PLK3,Cytokine-inducible serine/threonine-protein kinase;FGF-inducible kinase;Polo-like kinase 3;Proliferation-related kinase;, PF00069;PF00659;, GO:0005813;GO:0005737;GO:0030425;GO:0005795;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0000922;GO:0005524;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0006974;GO:0031122;GO:0006977;GO:0007113;GO:0000082;GO:0000086;GO:0090166;GO:0000278;GO:0007093;GO:0044819;GO:0043066;GO:0000122;GO:1904716;GO:0090316;GO:2000777;GO:0043491;GO:0006468;GO:0051302;GO:0032465;GO:1901796;GO:0006970;GO:0009314;GO:0000302;, C:centrosome; C:cytoplasm; C:dendrite; C:Golgi stack; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle pole;, F:ATP binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cytoplasmic microtubule organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:endomitotic cell cycle; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:Golgi disassembly; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic G1/S transition checkpoint; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chaperone-mediated autophagy; P:positive regulation of intracellular protein transport; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:protein kinase B signaling; P:protein phosphorylation; P:regulation of cell division; P:regulation of cytokinesis; P:regulation of signal transduction by p53 class mediator; P:response to osmotic stress; P:response to radiation; P:response to reactive oxygen species;|Q9H4B4 Q15767 Q5JR99 Q96CV1,Serine/threonine-protein kinase PLK3,Cytokine-inducible serine/threonine-protein kinase;FGF-inducible kinase;Polo-like kinase 3;Proliferation-related kinase;, PF00069;PF00659;, GO:0005813;GO:0005737;GO:0030425;GO:0005795;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0000922;GO:0005524;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0006974;GO:0031122;GO:0006977;GO:0007113;GO:0000082;GO:0000086;GO:0090166;GO:0000278;GO:0007093;GO:0044819;GO:0043066;GO:0000122;GO:1904716;GO:0090316;GO:2000777;GO:0043491;GO:0006468;GO:0051302;GO:0032465;GO:1901796;GO:0006970;GO:0009314;GO:0000302;, C:centrosome; C:cytoplasm; C:dendrite; C:Golgi stack; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle pole;, F:ATP binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cytoplasmic microtubule organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:endomitotic cell cycle; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:Golgi disassembly; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic G1/S transition checkpoint; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chaperone-mediated autophagy; P:positive regulation of intracellular protein transport; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:protein kinase B signaling; P:protein phosphorylation; P:regulation of cell division; P:regulation of cytokinesis; P:regulation of signal transduction by p53 class mediator; P:response to osmotic stress; P:response to radiation; P:response to reactive oxygen species;|Q9H4B4 Q15767 Q5JR99 Q96CV1,Serine/threonine-protein kinase PLK3,Cytokine-inducible serine/threonine-protein kinase;FGF-inducible kinase;Polo-like kinase 3;Proliferation-related kinase;, PF00069;PF00659;, GO:0005813;GO:0005737;GO:0030425;GO:0005795;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0000922;GO:0005524;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0006974;GO:0031122;GO:0006977;GO:0007113;GO:0000082;GO:0000086;GO:0090166;GO:0000278;GO:0007093;GO:0044819;GO:0043066;GO:0000122;GO:1904716;GO:0090316;GO:2000777;GO:0043491;GO:0006468;GO:0051302;GO:0032465;GO:1901796;GO:0006970;GO:0009314;GO:0000302;, C:centrosome; C:cytoplasm; C:dendrite; C:Golgi stack; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle pole;, F:ATP binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cytoplasmic microtubule organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:endomitotic cell cycle; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:Golgi disassembly; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic G1/S transition checkpoint; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chaperone-mediated autophagy; P:positive regulation of intracellular protein transport; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:protein kinase B signaling; P:protein phosphorylation; P:regulation of cell division; P:regulation of cytokinesis; P:regulation of signal transduction by p53 class mediator; P:response to osmotic stress; P:response to radiation; P:response to reactive oxygen species; scaffold83 indexed_genome mRNA 2028888 2031186 . - . ID=transcript_12158;Q9H4B4 Q15767 Q5JR99 Q96CV1,Serine/threonine-protein kinase PLK3,Cytokine-inducible serine/threonine-protein kinase;FGF-inducible kinase;Polo-like kinase 3;Proliferation-related kinase;, PF00069;PF00659;, GO:0005813;GO:0005737;GO:0030425;GO:0005795;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0000922;GO:0005524;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0006974;GO:0031122;GO:0006977;GO:0007113;GO:0000082;GO:0000086;GO:0090166;GO:0000278;GO:0007093;GO:0044819;GO:0043066;GO:0000122;GO:1904716;GO:0090316;GO:2000777;GO:0043491;GO:0006468;GO:0051302;GO:0032465;GO:1901796;GO:0006970;GO:0009314;GO:0000302;, C:centrosome; C:cytoplasm; C:dendrite; C:Golgi stack; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle pole;, F:ATP binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cytoplasmic microtubule organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:endomitotic cell cycle; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:Golgi disassembly; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic G1/S transition checkpoint; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chaperone-mediated autophagy; P:positive regulation of intracellular protein transport; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:protein kinase B signaling; P:protein phosphorylation; P:regulation of cell division; P:regulation of cytokinesis; P:regulation of signal transduction by p53 class mediator; P:response to osmotic stress; P:response to radiation; P:response to reactive oxygen species;|Q9H4B4 Q15767 Q5JR99 Q96CV1,Serine/threonine-protein kinase PLK3,Cytokine-inducible serine/threonine-protein kinase;FGF-inducible kinase;Polo-like kinase 3;Proliferation-related kinase;, PF00069;PF00659;, GO:0005813;GO:0005737;GO:0030425;GO:0005795;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0000922;GO:0005524;GO:0002039;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0006974;GO:0031122;GO:0006977;GO:0007113;GO:0000082;GO:0000086;GO:0090166;GO:0000278;GO:0007093;GO:0044819;GO:0043066;GO:0000122;GO:1904716;GO:0090316;GO:2000777;GO:0043491;GO:0006468;GO:0051302;GO:0032465;GO:1901796;GO:0006970;GO:0009314;GO:0000302;, C:centrosome; C:cytoplasm; C:dendrite; C:Golgi stack; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle pole;, F:ATP binding; F:p53 binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cytoplasmic microtubule organization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:endomitotic cell cycle; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:Golgi disassembly; P:mitotic cell cycle; P:mitotic cell cycle checkpoint; P:mitotic G1/S transition checkpoint; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of chaperone-mediated autophagy; P:positive regulation of intracellular protein transport; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:protein kinase B signaling; P:protein phosphorylation; P:regulation of cell division; P:regulation of cytokinesis; P:regulation of signal transduction by p53 class mediator; P:response to osmotic stress; P:response to radiation; P:response to reactive oxygen species; scaffold83 indexed_genome mRNA 2049404 2052253 . - . ID=transcript_12159;P62241 P09058 Q6IRL7,40S ribosomal protein S8,Small ribosomal subunit protein eS8 {ECO:0000303|PubMed:24524803};, PF01201;, GO:0005829;GO:0022627;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0003723;GO:0003735;GO:0000462;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:RNA binding; F:structural constituent of ribosome;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62241 P09058 Q6IRL7,40S ribosomal protein S8,Small ribosomal subunit protein eS8 {ECO:0000303|PubMed:24524803};, PF01201;, GO:0005829;GO:0022627;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0003723;GO:0003735;GO:0000462;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:RNA binding; F:structural constituent of ribosome;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62241 P09058 Q6IRL7,40S ribosomal protein S8,Small ribosomal subunit protein eS8 {ECO:0000303|PubMed:24524803};, PF01201;, GO:0005829;GO:0022627;GO:0005783;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0003723;GO:0003735;GO:0000462;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:endoplasmic reticulum; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:RNA binding; F:structural constituent of ribosome;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold83 indexed_genome mRNA 2065737 2067866 . - . ID=transcript_12160;Q99661 B3ITR9 Q5JR88 Q6ICU1 Q96C18 Q96HB8 Q9BWV8,Kinesin-like protein KIF2C,Kinesin-like protein 6;Mitotic centromere-associated kinesin;, PF00225;, GO:0005813;GO:0000775;GO:0000777;GO:0005829;GO:0005871;GO:0000776;GO:0016020;GO:0005874;GO:0015630;GO:0035371;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0019237;GO:0008017;GO:0003777;GO:0051010;GO:0019886;GO:0051315;GO:0051301;GO:0030951;GO:0051310;GO:0007019;GO:0007018;GO:0007080;GO:0007052;GO:0051983;GO:0006890;, C:centrosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:cytosol; C:kinesin complex; C:kinetochore; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:microtubule plus-end; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:centromeric DNA binding; F:microtubule binding; F:microtubule motor activity; F:microtubule plus-end binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:establishment or maintenance of microtubule cytoskeleton polarity; P:metaphase plate congression; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:regulation of chromosome segregation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold83 indexed_genome mRNA 2068842 2070223 . - . ID=transcript_12161;Q99661 B3ITR9 Q5JR88 Q6ICU1 Q96C18 Q96HB8 Q9BWV8,Kinesin-like protein KIF2C,Kinesin-like protein 6;Mitotic centromere-associated kinesin;, PF00225;, GO:0005813;GO:0000775;GO:0000777;GO:0005829;GO:0005871;GO:0000776;GO:0016020;GO:0005874;GO:0015630;GO:0035371;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0019237;GO:0008017;GO:0003777;GO:0051010;GO:0019886;GO:0051315;GO:0051301;GO:0030951;GO:0051310;GO:0007019;GO:0007018;GO:0007080;GO:0007052;GO:0051983;GO:0006890;, C:centrosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:cytosol; C:kinesin complex; C:kinetochore; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:microtubule plus-end; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:centromeric DNA binding; F:microtubule binding; F:microtubule motor activity; F:microtubule plus-end binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:establishment or maintenance of microtubule cytoskeleton polarity; P:metaphase plate congression; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:regulation of chromosome segregation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold83 indexed_genome mRNA 2070264 2071380 . - . ID=transcript_12162;Q99661 B3ITR9 Q5JR88 Q6ICU1 Q96C18 Q96HB8 Q9BWV8,Kinesin-like protein KIF2C,Kinesin-like protein 6;Mitotic centromere-associated kinesin;, PF00225;, GO:0005813;GO:0000775;GO:0000777;GO:0005829;GO:0005871;GO:0000776;GO:0016020;GO:0005874;GO:0015630;GO:0035371;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0019237;GO:0008017;GO:0003777;GO:0051010;GO:0019886;GO:0051315;GO:0051301;GO:0030951;GO:0051310;GO:0007019;GO:0007018;GO:0007080;GO:0007052;GO:0051983;GO:0006890;, C:centrosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:cytosol; C:kinesin complex; C:kinetochore; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:microtubule plus-end; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:centromeric DNA binding; F:microtubule binding; F:microtubule motor activity; F:microtubule plus-end binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:establishment or maintenance of microtubule cytoskeleton polarity; P:metaphase plate congression; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:regulation of chromosome segregation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold83 indexed_genome mRNA 2071447 2073625 . + . ID=transcript_12163;Q99661 B3ITR9 Q5JR88 Q6ICU1 Q96C18 Q96HB8 Q9BWV8,Kinesin-like protein KIF2C,Kinesin-like protein 6;Mitotic centromere-associated kinesin;, PF00225;, GO:0005813;GO:0000775;GO:0000777;GO:0005829;GO:0005871;GO:0000776;GO:0016020;GO:0005874;GO:0015630;GO:0035371;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0019237;GO:0008017;GO:0003777;GO:0051010;GO:0019886;GO:0051315;GO:0051301;GO:0030951;GO:0051310;GO:0007019;GO:0007018;GO:0007080;GO:0007052;GO:0051983;GO:0006890;, C:centrosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:cytosol; C:kinesin complex; C:kinetochore; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:microtubule plus-end; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:centromeric DNA binding; F:microtubule binding; F:microtubule motor activity; F:microtubule plus-end binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:establishment or maintenance of microtubule cytoskeleton polarity; P:metaphase plate congression; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:regulation of chromosome segregation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q99661 B3ITR9 Q5JR88 Q6ICU1 Q96C18 Q96HB8 Q9BWV8,Kinesin-like protein KIF2C,Kinesin-like protein 6;Mitotic centromere-associated kinesin;, PF00225;, GO:0005813;GO:0000775;GO:0000777;GO:0005829;GO:0005871;GO:0000776;GO:0016020;GO:0005874;GO:0015630;GO:0035371;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0019237;GO:0008017;GO:0003777;GO:0051010;GO:0019886;GO:0051315;GO:0051301;GO:0030951;GO:0051310;GO:0007019;GO:0007018;GO:0007080;GO:0007052;GO:0051983;GO:0006890;, C:centrosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:cytosol; C:kinesin complex; C:kinetochore; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:microtubule plus-end; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:centromeric DNA binding; F:microtubule binding; F:microtubule motor activity; F:microtubule plus-end binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:establishment or maintenance of microtubule cytoskeleton polarity; P:metaphase plate congression; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:regulation of chromosome segregation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold83 indexed_genome mRNA 2073885 2076913 . - . ID=transcript_12164;Q99661 B3ITR9 Q5JR88 Q6ICU1 Q96C18 Q96HB8 Q9BWV8,Kinesin-like protein KIF2C,Kinesin-like protein 6;Mitotic centromere-associated kinesin;, PF00225;, GO:0005813;GO:0000775;GO:0000777;GO:0005829;GO:0005871;GO:0000776;GO:0016020;GO:0005874;GO:0015630;GO:0035371;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0019237;GO:0008017;GO:0003777;GO:0051010;GO:0019886;GO:0051315;GO:0051301;GO:0030951;GO:0051310;GO:0007019;GO:0007018;GO:0007080;GO:0007052;GO:0051983;GO:0006890;, C:centrosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:cytosol; C:kinesin complex; C:kinetochore; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:microtubule plus-end; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:centromeric DNA binding; F:microtubule binding; F:microtubule motor activity; F:microtubule plus-end binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:establishment or maintenance of microtubule cytoskeleton polarity; P:metaphase plate congression; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:regulation of chromosome segregation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold83 indexed_genome mRNA 2076951 2079366 . + . ID=transcript_12165;Q99661 B3ITR9 Q5JR88 Q6ICU1 Q96C18 Q96HB8 Q9BWV8,Kinesin-like protein KIF2C,Kinesin-like protein 6;Mitotic centromere-associated kinesin;, PF00225;, GO:0005813;GO:0000775;GO:0000777;GO:0005829;GO:0005871;GO:0000776;GO:0016020;GO:0005874;GO:0015630;GO:0035371;GO:0005634;GO:0005819;GO:0005524;GO:1990939;GO:0016887;GO:0019237;GO:0008017;GO:0003777;GO:0051010;GO:0019886;GO:0051315;GO:0051301;GO:0030951;GO:0051310;GO:0007019;GO:0007018;GO:0007080;GO:0007052;GO:0051983;GO:0006890;, C:centrosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:cytosol; C:kinesin complex; C:kinetochore; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:microtubule plus-end; C:nucleus; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:centromeric DNA binding; F:microtubule binding; F:microtubule motor activity; F:microtubule plus-end binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:establishment or maintenance of microtubule cytoskeleton polarity; P:metaphase plate congression; P:microtubule depolymerization; P:microtubule-based movement; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:regulation of chromosome segregation; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold83 indexed_genome mRNA 2102525 2144112 . - . ID=transcript_12166;Q6PIY5 A1KXE5,Armadillo-like helical domain containing protein 1 {ECO:0000305},p40;, PF17741; scaffold83 indexed_genome mRNA 2179548 2182212 . - . ID=transcript_12167;Q6P2H8 B4DKG0 Q5JPH2 Q6IA07 Q9H6E2,Transmembrane protein 53,, PF05705;, GO:0016021;GO:0005634;, C:integral component of membrane; C:nucleus;|Q6P2H8 B4DKG0 Q5JPH2 Q6IA07 Q9H6E2,Transmembrane protein 53,, PF05705;, GO:0016021;GO:0005634;, C:integral component of membrane; C:nucleus; scaffold83 indexed_genome mRNA 2183641 2455506 . - . ID=transcript_12168;Q5VTB9 B3KPJ3 B4DLZ9 E9PCS1 Q4KMX2 Q9NVP6,E3 ubiquitin-protein ligase RNF220,RING finger protein 220;RING-type E3 ubiquitin transferase RNF220 {ECO:0000305};, PF15926;, GO:0005737;GO:0032991;GO:0046872;GO:0061630;GO:0004842;GO:0021904;GO:0090263;GO:0051865;GO:0016567;, C:cytoplasm; C:protein-containing complex;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:dorsal/ventral neural tube patterning; P:positive regulation of canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein ubiquitination;|Q5VTB9 B3KPJ3 B4DLZ9 E9PCS1 Q4KMX2 Q9NVP6,E3 ubiquitin-protein ligase RNF220,RING finger protein 220;RING-type E3 ubiquitin transferase RNF220 {ECO:0000305};, PF15926;, GO:0005737;GO:0032991;GO:0046872;GO:0061630;GO:0004842;GO:0021904;GO:0090263;GO:0051865;GO:0016567;, C:cytoplasm; C:protein-containing complex;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:dorsal/ventral neural tube patterning; P:positive regulation of canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein ubiquitination;|Q5VTB9 B3KPJ3 B4DLZ9 E9PCS1 Q4KMX2 Q9NVP6,E3 ubiquitin-protein ligase RNF220,RING finger protein 220;RING-type E3 ubiquitin transferase RNF220 {ECO:0000305};, PF15926;, GO:0005737;GO:0032991;GO:0046872;GO:0061630;GO:0004842;GO:0021904;GO:0090263;GO:0051865;GO:0016567;, C:cytoplasm; C:protein-containing complex;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:dorsal/ventral neural tube patterning; P:positive regulation of canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein ubiquitination;|Q5VTB9 B3KPJ3 B4DLZ9 E9PCS1 Q4KMX2 Q9NVP6,E3 ubiquitin-protein ligase RNF220,RING finger protein 220;RING-type E3 ubiquitin transferase RNF220 {ECO:0000305};, PF15926;, GO:0005737;GO:0032991;GO:0046872;GO:0061630;GO:0004842;GO:0021904;GO:0090263;GO:0051865;GO:0016567;, C:cytoplasm; C:protein-containing complex;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:dorsal/ventral neural tube patterning; P:positive regulation of canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein ubiquitination; scaffold83 indexed_genome mRNA 2506039 2635385 . + . ID=transcript_12169;O43414 B1AK98 Q5T2T7 Q5T2T9 Q5TG35 Q9BQA0 Q9UEB4,ERI1 exoribonuclease 3,Prion interactor 1;Prion protein-interacting protein;, PF00929;, GO:0000175;GO:0046872;GO:0003723;GO:0000738;GO:0000467;, , F:3'-5'-exoribonuclease activity; F:metal ion binding; F:RNA binding;, P:DNA catabolic process, exonucleolytic; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|O43414 B1AK98 Q5T2T7 Q5T2T9 Q5TG35 Q9BQA0 Q9UEB4,ERI1 exoribonuclease 3,Prion interactor 1;Prion protein-interacting protein;, PF00929;, GO:0000175;GO:0046872;GO:0003723;GO:0000738;GO:0000467;, , F:3'-5'-exoribonuclease activity; F:metal ion binding; F:RNA binding;, P:DNA catabolic process, exonucleolytic; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|O43414 B1AK98 Q5T2T7 Q5T2T9 Q5TG35 Q9BQA0 Q9UEB4,ERI1 exoribonuclease 3,Prion interactor 1;Prion protein-interacting protein;, PF00929;, GO:0000175;GO:0046872;GO:0003723;GO:0000738;GO:0000467;, , F:3'-5'-exoribonuclease activity; F:metal ion binding; F:RNA binding;, P:DNA catabolic process, exonucleolytic; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|O43414 B1AK98 Q5T2T7 Q5T2T9 Q5TG35 Q9BQA0 Q9UEB4,ERI1 exoribonuclease 3,Prion interactor 1;Prion protein-interacting protein;, PF00929;, GO:0000175;GO:0046872;GO:0003723;GO:0000738;GO:0000467;, , F:3'-5'-exoribonuclease activity; F:metal ion binding; F:RNA binding;, P:DNA catabolic process, exonucleolytic; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); scaffold83 indexed_genome mRNA 2635790 2644977 . - . ID=transcript_12170;Q9NPF5 A8K001 D3DPY8 Q0JSM4 Q5TG41 Q7Z3H7 Q9H0S8 Q9P2C2,DNA methyltransferase 1-associated protein 1,, PF05499;PF16282;, GO:0005737;GO:0005829;GO:0035267;GO:0005654;GO:0005634;GO:0005657;GO:0000812;GO:0001103;GO:0003714;GO:0006306;GO:0006281;GO:0043486;GO:0043968;GO:0043967;GO:0000122;GO:0045892;GO:0042307;GO:0040008;GO:0045471;, C:cytoplasm; C:cytosol; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:replication fork; C:Swr1 complex;, F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:DNA methylation; P:DNA repair; P:histone exchange; P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein import into nucleus; P:regulation of growth; P:response to ethanol;|Q9NPF5 A8K001 D3DPY8 Q0JSM4 Q5TG41 Q7Z3H7 Q9H0S8 Q9P2C2,DNA methyltransferase 1-associated protein 1,, PF05499;PF16282;, GO:0005737;GO:0005829;GO:0035267;GO:0005654;GO:0005634;GO:0005657;GO:0000812;GO:0001103;GO:0003714;GO:0006306;GO:0006281;GO:0043486;GO:0043968;GO:0043967;GO:0000122;GO:0045892;GO:0042307;GO:0040008;GO:0045471;, C:cytoplasm; C:cytosol; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:replication fork; C:Swr1 complex;, F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:DNA methylation; P:DNA repair; P:histone exchange; P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein import into nucleus; P:regulation of growth; P:response to ethanol;|Q9NPF5 A8K001 D3DPY8 Q0JSM4 Q5TG41 Q7Z3H7 Q9H0S8 Q9P2C2,DNA methyltransferase 1-associated protein 1,, PF05499;PF16282;, GO:0005737;GO:0005829;GO:0035267;GO:0005654;GO:0005634;GO:0005657;GO:0000812;GO:0001103;GO:0003714;GO:0006306;GO:0006281;GO:0043486;GO:0043968;GO:0043967;GO:0000122;GO:0045892;GO:0042307;GO:0040008;GO:0045471;, C:cytoplasm; C:cytosol; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:replication fork; C:Swr1 complex;, F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:DNA methylation; P:DNA repair; P:histone exchange; P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein import into nucleus; P:regulation of growth; P:response to ethanol;|Q9NPF5 A8K001 D3DPY8 Q0JSM4 Q5TG41 Q7Z3H7 Q9H0S8 Q9P2C2,DNA methyltransferase 1-associated protein 1,, PF05499;PF16282;, GO:0005737;GO:0005829;GO:0035267;GO:0005654;GO:0005634;GO:0005657;GO:0000812;GO:0001103;GO:0003714;GO:0006306;GO:0006281;GO:0043486;GO:0043968;GO:0043967;GO:0000122;GO:0045892;GO:0042307;GO:0040008;GO:0045471;, C:cytoplasm; C:cytosol; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:replication fork; C:Swr1 complex;, F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:DNA methylation; P:DNA repair; P:histone exchange; P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein import into nucleus; P:regulation of growth; P:response to ethanol;|Q9NPF5 A8K001 D3DPY8 Q0JSM4 Q5TG41 Q7Z3H7 Q9H0S8 Q9P2C2,DNA methyltransferase 1-associated protein 1,, PF05499;PF16282;, GO:0005737;GO:0005829;GO:0035267;GO:0005654;GO:0005634;GO:0005657;GO:0000812;GO:0001103;GO:0003714;GO:0006306;GO:0006281;GO:0043486;GO:0043968;GO:0043967;GO:0000122;GO:0045892;GO:0042307;GO:0040008;GO:0045471;, C:cytoplasm; C:cytosol; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:replication fork; C:Swr1 complex;, F:RNA polymerase II repressing transcription factor binding; F:transcription corepressor activity;, P:DNA methylation; P:DNA repair; P:histone exchange; P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein import into nucleus; P:regulation of growth; P:response to ethanol; scaffold83 indexed_genome mRNA 2829732 2860901 . + . ID=transcript_12171;P48067 A6NDH1 A6NII2 A6NNZ8 Q5TAB8 Q5TAB9 Q5TAC0,Sodium- and chloride-dependent glycine transporter 1,Solute carrier family 6 member 9;, PF00209;, GO:0016324;GO:0009925;GO:0016323;GO:0031045;GO:0005768;GO:0098686;GO:0005887;GO:0099055;GO:0099056;GO:0030285;GO:0016328;GO:0016020;GO:0098688;GO:0005886;GO:0014069;GO:0015187;GO:0015375;GO:1903804;GO:0015816;GO:1904782;GO:0006836;GO:0070455;GO:0046985;GO:1904440;GO:1904256;GO:0035725;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:dense core granule; C:endosome; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:lateral plasma membrane; C:membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic density;, F:glycine transmembrane transporter activity; F:glycine:sodium symporter activity;, P:glycine import across plasma membrane; P:glycine transport; P:negative regulation of NMDA glutamate receptor activity; P:neurotransmitter transport; P:positive regulation of heme biosynthetic process; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of iron ion import across plasma membrane; P:positive regulation of iron ion transmembrane transporter activity; P:sodium ion transmembrane transport; P:transport across blood-brain barrier;|P48067 A6NDH1 A6NII2 A6NNZ8 Q5TAB8 Q5TAB9 Q5TAC0,Sodium- and chloride-dependent glycine transporter 1,Solute carrier family 6 member 9;, PF00209;, GO:0016324;GO:0009925;GO:0016323;GO:0031045;GO:0005768;GO:0098686;GO:0005887;GO:0099055;GO:0099056;GO:0030285;GO:0016328;GO:0016020;GO:0098688;GO:0005886;GO:0014069;GO:0015187;GO:0015375;GO:1903804;GO:0015816;GO:1904782;GO:0006836;GO:0070455;GO:0046985;GO:1904440;GO:1904256;GO:0035725;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:dense core granule; C:endosome; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:lateral plasma membrane; C:membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic density;, F:glycine transmembrane transporter activity; F:glycine:sodium symporter activity;, P:glycine import across plasma membrane; P:glycine transport; P:negative regulation of NMDA glutamate receptor activity; P:neurotransmitter transport; P:positive regulation of heme biosynthetic process; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of iron ion import across plasma membrane; P:positive regulation of iron ion transmembrane transporter activity; P:sodium ion transmembrane transport; P:transport across blood-brain barrier;|P48067 A6NDH1 A6NII2 A6NNZ8 Q5TAB8 Q5TAB9 Q5TAC0,Sodium- and chloride-dependent glycine transporter 1,Solute carrier family 6 member 9;, PF00209;, GO:0016324;GO:0009925;GO:0016323;GO:0031045;GO:0005768;GO:0098686;GO:0005887;GO:0099055;GO:0099056;GO:0030285;GO:0016328;GO:0016020;GO:0098688;GO:0005886;GO:0014069;GO:0015187;GO:0015375;GO:1903804;GO:0015816;GO:1904782;GO:0006836;GO:0070455;GO:0046985;GO:1904440;GO:1904256;GO:0035725;GO:0150104;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:dense core granule; C:endosome; C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:lateral plasma membrane; C:membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic density;, F:glycine transmembrane transporter activity; F:glycine:sodium symporter activity;, P:glycine import across plasma membrane; P:glycine transport; P:negative regulation of NMDA glutamate receptor activity; P:neurotransmitter transport; P:positive regulation of heme biosynthetic process; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of iron ion import across plasma membrane; P:positive regulation of iron ion transmembrane transporter activity; P:sodium ion transmembrane transport; P:transport across blood-brain barrier; scaffold83 indexed_genome mRNA 2864528 2865463 . - . ID=transcript_12172;Q8N4L8 Q6RWT2,Coiled-coil domain-containing protein 24,, PF15669;, GO:0001835;, , , P:blastocyst hatching; scaffold83 indexed_genome mRNA 2865950 2874577 . + . ID=transcript_12173;Q9BUP6 Q9NSY7,Beta-1,4-galactosyltransferase 2 {ECO:0000305},Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:9405390};Lactose synthase A protein;N-acetyllactosamine synthase {ECO:0000303|PubMed:9405390};Nal synthase;UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2;, PF02709;PF13733;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0043231;GO:0005654;GO:0003831;GO:0008378;GO:0004461;GO:0046872;GO:0003945;GO:0005975;GO:0021680;GO:0018146;GO:0007626;GO:0007613;GO:0006486;GO:0008542;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; F:galactosyltransferase activity; F:lactose synthase activity; F:metal ion binding; F:N-acetyllactosamine synthase activity;, P:carbohydrate metabolic process; P:cerebellar Purkinje cell layer development; P:keratan sulfate biosynthetic process; P:locomotory behavior; P:memory; P:protein glycosylation; P:visual learning;|Q9BUP6 Q9NSY7,Beta-1,4-galactosyltransferase 2 {ECO:0000305},Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:9405390};Lactose synthase A protein;N-acetyllactosamine synthase {ECO:0000303|PubMed:9405390};Nal synthase;UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2;UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2;, PF02709;PF13733;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0043231;GO:0005654;GO:0003831;GO:0008378;GO:0004461;GO:0046872;GO:0003945;GO:0005975;GO:0021680;GO:0018146;GO:0007626;GO:0007613;GO:0006486;GO:0008542;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; F:galactosyltransferase activity; F:lactose synthase activity; F:metal ion binding; F:N-acetyllactosamine synthase activity;, P:carbohydrate metabolic process; P:cerebellar Purkinje cell layer development; P:keratan sulfate biosynthetic process; P:locomotory behavior; P:memory; P:protein glycosylation; P:visual learning; scaffold83 indexed_genome mRNA 2876760 2879889 . - . ID=transcript_12174;Q99437 D3DPY5 Q6IB32,V-type proton ATPase 21 kDa proteolipid subunit,Vacuolar proton pump 21 kDa proteolipid subunit;hATPL;, PF00137;, GO:0010008;GO:0016021;GO:0005765;GO:0030670;GO:0033179;GO:0046961;GO:0005215;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:phagocytic vesicle membrane; C:proton-transporting V-type ATPase, V0 domain;, F:proton-transporting ATPase activity, rotational mechanism; F:transporter activity;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|Q99437 D3DPY5 Q6IB32,V-type proton ATPase 21 kDa proteolipid subunit,Vacuolar proton pump 21 kDa proteolipid subunit;hATPL;, PF00137;, GO:0010008;GO:0016021;GO:0005765;GO:0030670;GO:0033179;GO:0046961;GO:0005215;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:phagocytic vesicle membrane; C:proton-transporting V-type ATPase, V0 domain;, F:proton-transporting ATPase activity, rotational mechanism; F:transporter activity;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; scaffold83 indexed_genome mRNA 2881834 2907335 . - . ID=transcript_12175;Q9BQC3 A8MVC9 B2RDE3 B4DNI8 O60623,2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 {ECO:0000305},Diphthamide biosynthesis protein 2;Diphtheria toxin resistance protein 2 {ECO:0000305};S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2 {ECO:0000305};, PF01866;, GO:0005829;GO:0090560;GO:0017183;, C:cytosol;, F:2-(3-amino-3-carboxypropyl)histidine synthase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|Q9BQC3 A8MVC9 B2RDE3 B4DNI8 O60623,2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 {ECO:0000305},Diphthamide biosynthesis protein 2;Diphtheria toxin resistance protein 2 {ECO:0000305};S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2 {ECO:0000305};, PF01866;, GO:0005829;GO:0090560;GO:0017183;, C:cytosol;, F:2-(3-amino-3-carboxypropyl)histidine synthase activity;, P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine;|O94829 D3DPY4 Q5T4X3 Q7LC04 Q96HS3 Q9H8N3 Q9UFR1,Importin-13,Karyopherin-13;Ran-binding protein 13;, PF03810;PF18773;PF18786;PF18806;PF08389;, GO:0005737;GO:0005634;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:small GTPase binding;, P:protein import into nucleus;|O94829 D3DPY4 Q5T4X3 Q7LC04 Q96HS3 Q9H8N3 Q9UFR1,Importin-13,Karyopherin-13;Ran-binding protein 13;, PF03810;PF18773;PF18786;PF18806;PF08389;, GO:0005737;GO:0005634;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:small GTPase binding;, P:protein import into nucleus;|O94829 D3DPY4 Q5T4X3 Q7LC04 Q96HS3 Q9H8N3 Q9UFR1,Importin-13,Karyopherin-13;Ran-binding protein 13;, PF03810;PF18773;PF18786;PF18806;PF08389;, GO:0005737;GO:0005634;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:small GTPase binding;, P:protein import into nucleus;|O94829 D3DPY4 Q5T4X3 Q7LC04 Q96HS3 Q9H8N3 Q9UFR1,Importin-13,Karyopherin-13;Ran-binding protein 13;, PF03810;PF18773;PF18786;PF18806;PF08389;, GO:0005737;GO:0005634;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:small GTPase binding;, P:protein import into nucleus; scaffold83 indexed_genome mRNA 2915748 2932295 . - . ID=transcript_12176;Q5T4W7 D3DPY1 D3DPY3 O95441 O96030 Q6P6A3,Artemin,Enovin;Neublastin;, PF00019;, GO:0005576;GO:0005615;GO:0030116;GO:0008083;GO:0030971;GO:0005102;GO:0007411;GO:0050930;GO:0097021;GO:0000165;GO:0007405;GO:0007422;GO:0061146;GO:0007165;, C:extracellular region; C:extracellular space;, F:glial cell-derived neurotrophic factor receptor binding; F:growth factor activity; F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:axon guidance; P:induction of positive chemotaxis; P:lymphocyte migration into lymphoid organs; P:MAPK cascade; P:neuroblast proliferation; P:peripheral nervous system development; P:Peyer's patch morphogenesis; P:signal transduction;|Q8IX58,CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase,Beta-galactoside alpha-2,3-sialyltransferase 3;Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase;N-acetyllactosaminide alpha-2,3-sialyltransferase;ST3Gal III;ST3N;Sialyltransferase 6;, PF00777;, GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0008118;GO:0008373;GO:0018146;GO:0016266;GO:0009312;GO:0006486;GO:0019082;, C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:N-acetyllactosaminide alpha-2,3-sialyltransferase activity; F:sialyltransferase activity;, P:keratan sulfate biosynthetic process; P:O-glycan processing; P:oligosaccharide biosynthetic process; P:protein glycosylation; P:viral protein processing; scaffold83 indexed_genome mRNA 2941415 3145743 . - . ID=transcript_12177;Q8IX58,CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase,Beta-galactoside alpha-2,3-sialyltransferase 3;Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase;N-acetyllactosaminide alpha-2,3-sialyltransferase;ST3Gal III;ST3N;Sialyltransferase 6;, PF00777;, GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0008118;GO:0008373;GO:0018146;GO:0016266;GO:0009312;GO:0006486;GO:0019082;, C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:N-acetyllactosaminide alpha-2,3-sialyltransferase activity; F:sialyltransferase activity;, P:keratan sulfate biosynthetic process; P:O-glycan processing; P:oligosaccharide biosynthetic process; P:protein glycosylation; P:viral protein processing; scaffold83 indexed_genome mRNA 3147351 3179357 . - . ID=transcript_12178;O75164 Q5VVB1,Lysine-specific demethylase 4A,JmjC domain-containing histone demethylation protein 3A;Jumonji domain-containing protein 2A;[histone H3]-trimethyl-L-lysine(36) demethylase 4A {ECO:0000305};[histone H3]-trimethyl-L-lysine(9) demethylase 4A {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0005829;GO:0001650;GO:0035097;GO:0005654;GO:0005634;GO:0032452;GO:0051864;GO:0032454;GO:0035064;GO:0031625;GO:0008270;GO:0006338;GO:0006302;GO:0016577;GO:0070544;GO:0033169;GO:0030522;GO:0010507;GO:0010629;GO:0045892;GO:0016032;, C:cytosol; C:fibrillar center; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:methylated histone binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:negative regulation of autophagy; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:viral process;|O75164 Q5VVB1,Lysine-specific demethylase 4A,JmjC domain-containing histone demethylation protein 3A;Jumonji domain-containing protein 2A;[histone H3]-trimethyl-L-lysine(36) demethylase 4A {ECO:0000305};[histone H3]-trimethyl-L-lysine(9) demethylase 4A {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0005829;GO:0001650;GO:0035097;GO:0005654;GO:0005634;GO:0032452;GO:0051864;GO:0032454;GO:0035064;GO:0031625;GO:0008270;GO:0006338;GO:0006302;GO:0016577;GO:0070544;GO:0033169;GO:0030522;GO:0010507;GO:0010629;GO:0045892;GO:0016032;, C:cytosol; C:fibrillar center; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:methylated histone binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:negative regulation of autophagy; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:viral process;|O75164 Q5VVB1,Lysine-specific demethylase 4A,JmjC domain-containing histone demethylation protein 3A;Jumonji domain-containing protein 2A;[histone H3]-trimethyl-L-lysine(36) demethylase 4A {ECO:0000305};[histone H3]-trimethyl-L-lysine(9) demethylase 4A {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0005829;GO:0001650;GO:0035097;GO:0005654;GO:0005634;GO:0032452;GO:0051864;GO:0032454;GO:0035064;GO:0031625;GO:0008270;GO:0006338;GO:0006302;GO:0016577;GO:0070544;GO:0033169;GO:0030522;GO:0010507;GO:0010629;GO:0045892;GO:0016032;, C:cytosol; C:fibrillar center; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:methylated histone binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:negative regulation of autophagy; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:viral process;|O75164 Q5VVB1,Lysine-specific demethylase 4A,JmjC domain-containing histone demethylation protein 3A;Jumonji domain-containing protein 2A;[histone H3]-trimethyl-L-lysine(36) demethylase 4A {ECO:0000305};[histone H3]-trimethyl-L-lysine(9) demethylase 4A {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0005829;GO:0001650;GO:0035097;GO:0005654;GO:0005634;GO:0032452;GO:0051864;GO:0032454;GO:0035064;GO:0031625;GO:0008270;GO:0006338;GO:0006302;GO:0016577;GO:0070544;GO:0033169;GO:0030522;GO:0010507;GO:0010629;GO:0045892;GO:0016032;, C:cytosol; C:fibrillar center; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:methylated histone binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:negative regulation of autophagy; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:viral process;|O75164 Q5VVB1,Lysine-specific demethylase 4A,JmjC domain-containing histone demethylation protein 3A;Jumonji domain-containing protein 2A;[histone H3]-trimethyl-L-lysine(36) demethylase 4A {ECO:0000305};[histone H3]-trimethyl-L-lysine(9) demethylase 4A {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0005829;GO:0001650;GO:0035097;GO:0005654;GO:0005634;GO:0032452;GO:0051864;GO:0032454;GO:0035064;GO:0031625;GO:0008270;GO:0006338;GO:0006302;GO:0016577;GO:0070544;GO:0033169;GO:0030522;GO:0010507;GO:0010629;GO:0045892;GO:0016032;, C:cytosol; C:fibrillar center; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:methylated histone binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:negative regulation of autophagy; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:viral process;|O75164 Q5VVB1,Lysine-specific demethylase 4A,JmjC domain-containing histone demethylation protein 3A;Jumonji domain-containing protein 2A;[histone H3]-trimethyl-L-lysine(36) demethylase 4A {ECO:0000305};[histone H3]-trimethyl-L-lysine(9) demethylase 4A {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0005829;GO:0001650;GO:0035097;GO:0005654;GO:0005634;GO:0032452;GO:0051864;GO:0032454;GO:0035064;GO:0031625;GO:0008270;GO:0006338;GO:0006302;GO:0016577;GO:0070544;GO:0033169;GO:0030522;GO:0010507;GO:0010629;GO:0045892;GO:0016032;, C:cytosol; C:fibrillar center; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:methylated histone binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:negative regulation of autophagy; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:viral process; scaffold83 indexed_genome mRNA 3179607 3184643 . - . ID=transcript_12179;O75164 Q5VVB1,Lysine-specific demethylase 4A,JmjC domain-containing histone demethylation protein 3A;Jumonji domain-containing protein 2A;[histone H3]-trimethyl-L-lysine(36) demethylase 4A {ECO:0000305};[histone H3]-trimethyl-L-lysine(9) demethylase 4A {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0005829;GO:0001650;GO:0035097;GO:0005654;GO:0005634;GO:0032452;GO:0051864;GO:0032454;GO:0035064;GO:0031625;GO:0008270;GO:0006338;GO:0006302;GO:0016577;GO:0070544;GO:0033169;GO:0030522;GO:0010507;GO:0010629;GO:0045892;GO:0016032;, C:cytosol; C:fibrillar center; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:methylated histone binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:negative regulation of autophagy; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:viral process;|O75164 Q5VVB1,Lysine-specific demethylase 4A,JmjC domain-containing histone demethylation protein 3A;Jumonji domain-containing protein 2A;[histone H3]-trimethyl-L-lysine(36) demethylase 4A {ECO:0000305};[histone H3]-trimethyl-L-lysine(9) demethylase 4A {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0005829;GO:0001650;GO:0035097;GO:0005654;GO:0005634;GO:0032452;GO:0051864;GO:0032454;GO:0035064;GO:0031625;GO:0008270;GO:0006338;GO:0006302;GO:0016577;GO:0070544;GO:0033169;GO:0030522;GO:0010507;GO:0010629;GO:0045892;GO:0016032;, C:cytosol; C:fibrillar center; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:methylated histone binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:intracellular receptor signaling pathway; P:negative regulation of autophagy; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:viral process; scaffold83 indexed_genome mRNA 3210850 3287750 . - . ID=transcript_12180;P10586 D3DPX6 D3DPX7 Q5T021 Q5T022 Q5W9G2 Q86WS0,Receptor-type tyrosine-protein phosphatase F,Leukocyte common antigen related;, PF00041;PF07679;PF00102;, GO:0070062;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0050839;GO:0035373;GO:0008201;GO:0004725;GO:0044877;GO:0005001;GO:0007155;GO:0016477;GO:1900121;GO:0031102;GO:0035335;GO:0006470;GO:0048679;GO:0099560;GO:0007185;, C:extracellular exosome; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:cell adhesion molecule binding; F:chondroitin sulfate proteoglycan binding; F:heparin binding; F:protein tyrosine phosphatase activity; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:cell adhesion; P:cell migration; P:negative regulation of receptor binding; P:neuron projection regeneration; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of axon regeneration; P:synaptic membrane adhesion; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|P10586 D3DPX6 D3DPX7 Q5T021 Q5T022 Q5W9G2 Q86WS0,Receptor-type tyrosine-protein phosphatase F,Leukocyte common antigen related;, PF00041;PF07679;PF00102;, GO:0070062;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0050839;GO:0035373;GO:0008201;GO:0004725;GO:0044877;GO:0005001;GO:0007155;GO:0016477;GO:1900121;GO:0031102;GO:0035335;GO:0006470;GO:0048679;GO:0099560;GO:0007185;, C:extracellular exosome; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:cell adhesion molecule binding; F:chondroitin sulfate proteoglycan binding; F:heparin binding; F:protein tyrosine phosphatase activity; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:cell adhesion; P:cell migration; P:negative regulation of receptor binding; P:neuron projection regeneration; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of axon regeneration; P:synaptic membrane adhesion; P:transmembrane receptor protein tyrosine phosphatase signaling pathway;|P10586 D3DPX6 D3DPX7 Q5T021 Q5T022 Q5W9G2 Q86WS0,Receptor-type tyrosine-protein phosphatase F,Leukocyte common antigen related;, PF00041;PF07679;PF00102;, GO:0070062;GO:0005887;GO:0043005;GO:0043025;GO:0005886;GO:0050839;GO:0035373;GO:0008201;GO:0004725;GO:0044877;GO:0005001;GO:0007155;GO:0016477;GO:1900121;GO:0031102;GO:0035335;GO:0006470;GO:0048679;GO:0099560;GO:0007185;, C:extracellular exosome; C:integral component of plasma membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:cell adhesion molecule binding; F:chondroitin sulfate proteoglycan binding; F:heparin binding; F:protein tyrosine phosphatase activity; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:cell adhesion; P:cell migration; P:negative regulation of receptor binding; P:neuron projection regeneration; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of axon regeneration; P:synaptic membrane adhesion; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; scaffold83 indexed_genome mRNA 3365126 3419539 . + . ID=transcript_12181;Q5T013 D3DPX4 D3DPX5 Q5Q9A2 Q7Z778 Q96S83 Q9BZR3 Q9BZR4,Putative hydroxypyruvate isomerase,Endothelial cell apoptosis protein E-CE1;, PF01261;, GO:0008903;GO:0046487;, , F:hydroxypyruvate isomerase activity;, P:glyoxylate metabolic process;|Q7Z636 Q8NAY9 Q9H5H7 Q9UFQ8,KICSTOR complex protein SZT2 {ECO:0000305},Seizure threshold 2 protein homolog {ECO:0000312|HGNC:HGNC:29040};, , GO:0140007;GO:0005765;GO:0005777;GO:0034198;GO:0042149;GO:0007417;GO:0021540;GO:1904262;GO:0043473;GO:0009791;GO:0061462;GO:1901668;, C:KICSTOR complex; C:lysosomal membrane; C:peroxisome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:central nervous system development; P:corpus callosum morphogenesis; P:negative regulation of TORC1 signaling; P:pigmentation; P:post-embryonic development; P:protein localization to lysosome; P:regulation of superoxide dismutase activity;|Q7Z636 Q8NAY9 Q9H5H7 Q9UFQ8,KICSTOR complex protein SZT2 {ECO:0000305},Seizure threshold 2 protein homolog {ECO:0000312|HGNC:HGNC:29040};, , GO:0140007;GO:0005765;GO:0005777;GO:0034198;GO:0042149;GO:0007417;GO:0021540;GO:1904262;GO:0043473;GO:0009791;GO:0061462;GO:1901668;, C:KICSTOR complex; C:lysosomal membrane; C:peroxisome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:central nervous system development; P:corpus callosum morphogenesis; P:negative regulation of TORC1 signaling; P:pigmentation; P:post-embryonic development; P:protein localization to lysosome; P:regulation of superoxide dismutase activity;|Q7Z636 Q8NAY9 Q9H5H7 Q9UFQ8,KICSTOR complex protein SZT2 {ECO:0000305},Seizure threshold 2 protein homolog {ECO:0000312|HGNC:HGNC:29040};, , GO:0140007;GO:0005765;GO:0005777;GO:0034198;GO:0042149;GO:0007417;GO:0021540;GO:1904262;GO:0043473;GO:0009791;GO:0061462;GO:1901668;, C:KICSTOR complex; C:lysosomal membrane; C:peroxisome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:central nervous system development; P:corpus callosum morphogenesis; P:negative regulation of TORC1 signaling; P:pigmentation; P:post-embryonic development; P:protein localization to lysosome; P:regulation of superoxide dismutase activity;|Q7Z636 Q8NAY9 Q9H5H7 Q9UFQ8,KICSTOR complex protein SZT2 {ECO:0000305},Seizure threshold 2 protein homolog {ECO:0000312|HGNC:HGNC:29040};, , GO:0140007;GO:0005765;GO:0005777;GO:0034198;GO:0042149;GO:0007417;GO:0021540;GO:1904262;GO:0043473;GO:0009791;GO:0061462;GO:1901668;, C:KICSTOR complex; C:lysosomal membrane; C:peroxisome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:central nervous system development; P:corpus callosum morphogenesis; P:negative regulation of TORC1 signaling; P:pigmentation; P:post-embryonic development; P:protein localization to lysosome; P:regulation of superoxide dismutase activity;|Q7Z636 Q8NAY9 Q9H5H7 Q9UFQ8,KICSTOR complex protein SZT2 {ECO:0000305},Seizure threshold 2 protein homolog {ECO:0000312|HGNC:HGNC:29040};, , GO:0140007;GO:0005765;GO:0005777;GO:0034198;GO:0042149;GO:0007417;GO:0021540;GO:1904262;GO:0043473;GO:0009791;GO:0061462;GO:1901668;, C:KICSTOR complex; C:lysosomal membrane; C:peroxisome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:central nervous system development; P:corpus callosum morphogenesis; P:negative regulation of TORC1 signaling; P:pigmentation; P:post-embryonic development; P:protein localization to lysosome; P:regulation of superoxide dismutase activity;|Q7Z636 Q8NAY9 Q9H5H7 Q9UFQ8,KICSTOR complex protein SZT2 {ECO:0000305},Seizure threshold 2 protein homolog {ECO:0000312|HGNC:HGNC:29040};, , GO:0140007;GO:0005765;GO:0005777;GO:0034198;GO:0042149;GO:0007417;GO:0021540;GO:1904262;GO:0043473;GO:0009791;GO:0061462;GO:1901668;, C:KICSTOR complex; C:lysosomal membrane; C:peroxisome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:central nervous system development; P:corpus callosum morphogenesis; P:negative regulation of TORC1 signaling; P:pigmentation; P:post-embryonic development; P:protein localization to lysosome; P:regulation of superoxide dismutase activity;|Q7Z636 Q8NAY9 Q9H5H7 Q9UFQ8,KICSTOR complex protein SZT2 {ECO:0000305},Seizure threshold 2 protein homolog {ECO:0000312|HGNC:HGNC:29040};, , GO:0140007;GO:0005765;GO:0005777;GO:0034198;GO:0042149;GO:0007417;GO:0021540;GO:1904262;GO:0043473;GO:0009791;GO:0061462;GO:1901668;, C:KICSTOR complex; C:lysosomal membrane; C:peroxisome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:central nervous system development; P:corpus callosum morphogenesis; P:negative regulation of TORC1 signaling; P:pigmentation; P:post-embryonic development; P:protein localization to lysosome; P:regulation of superoxide dismutase activity;|Q7Z636 Q8NAY9 Q9H5H7 Q9UFQ8,KICSTOR complex protein SZT2 {ECO:0000305},Seizure threshold 2 protein homolog {ECO:0000312|HGNC:HGNC:29040};, , GO:0140007;GO:0005765;GO:0005777;GO:0034198;GO:0042149;GO:0007417;GO:0021540;GO:1904262;GO:0043473;GO:0009791;GO:0061462;GO:1901668;, C:KICSTOR complex; C:lysosomal membrane; C:peroxisome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:central nervous system development; P:corpus callosum morphogenesis; P:negative regulation of TORC1 signaling; P:pigmentation; P:post-embryonic development; P:protein localization to lysosome; P:regulation of superoxide dismutase activity;|Q7Z636 Q8NAY9 Q9H5H7 Q9UFQ8,KICSTOR complex protein SZT2 {ECO:0000305},Seizure threshold 2 protein homolog {ECO:0000312|HGNC:HGNC:29040};, , GO:0140007;GO:0005765;GO:0005777;GO:0034198;GO:0042149;GO:0007417;GO:0021540;GO:1904262;GO:0043473;GO:0009791;GO:0061462;GO:1901668;, C:KICSTOR complex; C:lysosomal membrane; C:peroxisome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:central nervous system development; P:corpus callosum morphogenesis; P:negative regulation of TORC1 signaling; P:pigmentation; P:post-embryonic development; P:protein localization to lysosome; P:regulation of superoxide dismutase activity;|Q7Z636 Q8NAY9 Q9H5H7 Q9UFQ8,KICSTOR complex protein SZT2 {ECO:0000305},Seizure threshold 2 protein homolog {ECO:0000312|HGNC:HGNC:29040};, , GO:0140007;GO:0005765;GO:0005777;GO:0034198;GO:0042149;GO:0007417;GO:0021540;GO:1904262;GO:0043473;GO:0009791;GO:0061462;GO:1901668;, C:KICSTOR complex; C:lysosomal membrane; C:peroxisome;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:central nervous system development; P:corpus callosum morphogenesis; P:negative regulation of TORC1 signaling; P:pigmentation; P:post-embryonic development; P:protein localization to lysosome; P:regulation of superoxide dismutase activity; scaffold83 indexed_genome mRNA 3419615 3429968 . + . ID=transcript_12182;Q96G25 A9IZ91 A9IZ92 Q5JUY8 Q96FQ4,Mediator of RNA polymerase II transcription subunit 8,Activator-recruited cofactor 32 kDa component;Mediator complex subunit 8;, PF10232;, GO:0070847;GO:0016592;GO:0005654;GO:0000978;GO:0003712;GO:0016567;GO:0006357;GO:0060260;, C:core mediator complex; C:mediator complex; C:nucleoplasm;, F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coregulator activity;, P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|Q96G25 A9IZ91 A9IZ92 Q5JUY8 Q96FQ4,Mediator of RNA polymerase II transcription subunit 8,Activator-recruited cofactor 32 kDa component;Mediator complex subunit 8;, PF10232;, GO:0070847;GO:0016592;GO:0005654;GO:0000978;GO:0003712;GO:0016567;GO:0006357;GO:0060260;, C:core mediator complex; C:mediator complex; C:nucleoplasm;, F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coregulator activity;, P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|Q96G25 A9IZ91 A9IZ92 Q5JUY8 Q96FQ4,Mediator of RNA polymerase II transcription subunit 8,Activator-recruited cofactor 32 kDa component;Mediator complex subunit 8;, PF10232;, GO:0070847;GO:0016592;GO:0005654;GO:0000978;GO:0003712;GO:0016567;GO:0006357;GO:0060260;, C:core mediator complex; C:mediator complex; C:nucleoplasm;, F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coregulator activity;, P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; scaffold83 indexed_genome mRNA 3438530 3448937 . + . ID=transcript_12183;Q9BW60 B4DP24 Q53HT2 Q5JUY3 Q8WXU3 Q9NVD9 Q9Y396,Elongation of very long chain fatty acids protein 1 {ECO:0000255|HAMAP-Rule:MF_03201, ECO:0000305},3-keto acyl-CoA synthase ELOVL1 {ECO:0000255|HAMAP-Rule:MF_03201};ELOVL fatty acid elongase 1 {ECO:0000255|HAMAP-Rule:MF_03201};Very long chain 3-ketoacyl-CoA synthase 1 {ECO:0000255|HAMAP-Rule:MF_03201};Very long chain 3-oxoacyl-CoA synthase 1 {ECO:0000255|HAMAP-Rule:MF_03201};, PF01151;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0036109;GO:0046513;GO:0061436;GO:0034625;GO:0034626;GO:0019367;GO:0043651;GO:0035338;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:alpha-linolenic acid metabolic process; P:ceramide biosynthetic process; P:establishment of skin barrier; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:linoleic acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process;|Q9BW60 B4DP24 Q53HT2 Q5JUY3 Q8WXU3 Q9NVD9 Q9Y396,Elongation of very long chain fatty acids protein 1 {ECO:0000255|HAMAP-Rule:MF_03201, ECO:0000305},3-keto acyl-CoA synthase ELOVL1 {ECO:0000255|HAMAP-Rule:MF_03201};ELOVL fatty acid elongase 1 {ECO:0000255|HAMAP-Rule:MF_03201};Very long chain 3-ketoacyl-CoA synthase 1 {ECO:0000255|HAMAP-Rule:MF_03201};Very long chain 3-oxoacyl-CoA synthase 1 {ECO:0000255|HAMAP-Rule:MF_03201};, PF01151;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0036109;GO:0046513;GO:0061436;GO:0034625;GO:0034626;GO:0019367;GO:0043651;GO:0035338;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:alpha-linolenic acid metabolic process; P:ceramide biosynthetic process; P:establishment of skin barrier; P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:linoleic acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold83 indexed_genome mRNA 3449076 3451103 . - . ID=transcript_12184;Q12834 B2R6Z6 D3DPJ1 Q5JUY4 Q9BW56 Q9UQI9,Cell division cycle protein 20 homolog,p55CDC;, PF12894;PF00400;, GO:0005813;GO:0005829;GO:0005654;GO:0048471;GO:0032991;GO:0005819;GO:0000922;GO:0010997;GO:0019899;GO:0042826;GO:0008022;GO:1990757;GO:0031145;GO:0030154;GO:0051301;GO:0007064;GO:0090307;GO:0007094;GO:0007052;GO:0007399;GO:1905786;GO:0008284;GO:0090129;GO:0031915;GO:1904668;GO:0016579;GO:0016567;GO:0050773;GO:0007096;GO:0040020;GO:1901990;GO:0006511;, C:centrosome; C:cytosol; C:nucleoplasm; C:perinuclear region of cytoplasm; C:protein-containing complex; C:spindle; C:spindle pole;, F:anaphase-promoting complex binding; F:enzyme binding; F:histone deacetylase binding; F:protein C-terminus binding; F:ubiquitin ligase activator activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell differentiation; P:cell division; P:mitotic sister chromatid cohesion; P:mitotic spindle assembly; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:nervous system development; P:positive regulation of anaphase-promoting complex-dependent catabolic process; P:positive regulation of cell population proliferation; P:positive regulation of synapse maturation; P:positive regulation of synaptic plasticity; P:positive regulation of ubiquitin protein ligase activity; P:protein deubiquitination; P:protein ubiquitination; P:regulation of dendrite development; P:regulation of exit from mitosis; P:regulation of meiotic nuclear division; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold83 indexed_genome mRNA 3488119 3508893 . - . ID=transcript_12185;P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P35590 B5A949 B5A950,Tyrosine-protein kinase receptor Tie-1,, PF00041;PF00047;PF07714;, GO:0005887;GO:0043235;GO:0005524;GO:0004714;GO:0001525;GO:0003180;GO:0060854;GO:0001701;GO:0060836;GO:0007498;GO:0007275;GO:0016525;GO:0030336;GO:0045026;GO:0045766;GO:0033674;GO:0001936;GO:1901201;GO:0032526;GO:0007165;GO:0048771;GO:0007169;GO:0001570;, C:integral component of plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:angiogenesis; P:aortic valve morphogenesis; P:branching involved in lymph vessel morphogenesis; P:in utero embryonic development; P:lymphatic endothelial cell differentiation; P:mesoderm development; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:plasma membrane fusion; P:positive regulation of angiogenesis; P:positive regulation of kinase activity; P:regulation of endothelial cell proliferation; P:regulation of extracellular matrix assembly; P:response to retinoic acid; P:signal transduction; P:tissue remodeling; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis; scaffold83 indexed_genome mRNA 3528121 3537495 . + . ID=transcript_12186;P00492 A6NHF0 B2R8M9,Hypoxanthine-guanine phosphoribosyltransferase,, PF00156;, GO:0005737;GO:0005829;GO:0070062;GO:0052657;GO:0004422;GO:0042802;GO:0000287;GO:0000166;GO:0006168;GO:0021954;GO:0021895;GO:0048813;GO:0042417;GO:0046038;GO:0032263;GO:0007625;GO:0006178;GO:0046100;GO:0043103;GO:0046040;GO:0032264;GO:0007626;GO:0046651;GO:0045964;GO:0051289;GO:0006164;GO:0006166;GO:0043101;GO:0001975;GO:0021756;GO:0001913;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:guanine phosphoribosyltransferase activity; F:hypoxanthine phosphoribosyltransferase activity; F:identical protein binding; F:magnesium ion binding; F:nucleotide binding;, P:adenine salvage; P:central nervous system neuron development; P:cerebral cortex neuron differentiation; P:dendrite morphogenesis; P:dopamine metabolic process; P:GMP catabolic process; P:GMP salvage; P:grooming behavior; P:guanine salvage; P:hypoxanthine metabolic process; P:hypoxanthine salvage; P:IMP metabolic process; P:IMP salvage; P:locomotory behavior; P:lymphocyte proliferation; P:positive regulation of dopamine metabolic process; P:protein homotetramerization; P:purine nucleotide biosynthetic process; P:purine ribonucleoside salvage; P:purine-containing compound salvage; P:response to amphetamine; P:striatum development; P:T cell mediated cytotoxicity; scaffold83 indexed_genome mRNA 3546384 3549765 . - . ID=transcript_12187;Q96AQ2 D3DPX1,Transmembrane protein 125,, PF15109;, GO:0016021;, C:integral component of membrane; scaffold83 indexed_genome mRNA 3562046 3570431 . - . ID=transcript_12188;Q96MR6 A6NKQ3 Q17RI9 Q5TAI0,Cilia- and flagella-associated protein 57 {ECO:0000312|HGNC:HGNC:26485},WD repeat-containing protein 65 {ECO:0000312|HGNC:HGNC:26485};, PF00400; scaffold83 indexed_genome mRNA 3573935 3591643 . - . ID=transcript_12189;Q96MR6 A6NKQ3 Q17RI9 Q5TAI0,Cilia- and flagella-associated protein 57 {ECO:0000312|HGNC:HGNC:26485},WD repeat-containing protein 65 {ECO:0000312|HGNC:HGNC:26485};, PF00400; scaffold83 indexed_genome mRNA 3592478 3601828 . - . ID=transcript_12190;Q96MR6 A6NKQ3 Q17RI9 Q5TAI0,Cilia- and flagella-associated protein 57 {ECO:0000312|HGNC:HGNC:26485},WD repeat-containing protein 65 {ECO:0000312|HGNC:HGNC:26485};, PF00400; scaffold83 indexed_genome mRNA 3627197 3634168 . + . ID=transcript_12191;Q99848 Q96A66,Probable rRNA-processing protein EBP2,EBNA1-binding protein 2;Nucleolar protein p40;, PF05890;, GO:0005694;GO:0034399;GO:0005730;GO:0030687;GO:0003723;GO:0042273;GO:0006364;, C:chromosome; C:nuclear periphery; C:nucleolus; C:preribosome, large subunit precursor;, F:RNA binding;, P:ribosomal large subunit biogenesis; P:rRNA processing;|Q99848 Q96A66,Probable rRNA-processing protein EBP2,EBNA1-binding protein 2;Nucleolar protein p40;, PF05890;, GO:0005694;GO:0034399;GO:0005730;GO:0030687;GO:0003723;GO:0042273;GO:0006364;, C:chromosome; C:nuclear periphery; C:nucleolus; C:preribosome, large subunit precursor;, F:RNA binding;, P:ribosomal large subunit biogenesis; P:rRNA processing; scaffold83 indexed_genome mRNA 3639080 3647086 . - . ID=transcript_12192;Q6ZVS7 A4D1Y1 C9W8M8,Protein FAM183BP,Testis highly expressed protein 6;, PF14886;, GO:0097546;GO:0005737;GO:0005856;, C:ciliary base; C:cytoplasm; C:cytoskeleton; scaffold83 indexed_genome mRNA 4035150 4051907 . + . ID=transcript_12193;P11166 A8K9S6 B2R620 D3DPX0 O75535 Q0P512 Q147X2,Solute carrier family 2, facilitated glucose transporter member 1 {ECO:0000305},Glucose transporter type 1, erythrocyte/brain {ECO:0000303|PubMed:18245775};HepG2 glucose transporter {ECO:0000303|PubMed:2834252, ECO:0000303|PubMed:3839598};, PF00083;, GO:0016324;GO:0016323;GO:0072562;GO:0005901;GO:0030864;GO:0005829;GO:0070062;GO:0001939;GO:0000139;GO:0005887;GO:0014704;GO:0042470;GO:0016020;GO:0030496;GO:0001917;GO:0005886;GO:0098793;GO:0042383;GO:0030018;GO:0055056;GO:0033300;GO:0005355;GO:0042802;GO:0019900;GO:0005324;GO:0043621;GO:0042910;GO:0071474;GO:0042149;GO:0071260;GO:0007417;GO:0021987;GO:0007565;GO:0098708;GO:1904659;GO:0019852;GO:0005989;GO:0015911;GO:0045494;GO:0065003;GO:0010827;GO:0050796;GO:0001666;GO:0032868;GO:1904016;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:blood microparticle; C:caveola; C:cortical actin cytoskeleton; C:cytosol; C:extracellular exosome; C:female pronucleus; C:Golgi membrane; C:integral component of plasma membrane; C:intercalated disc; C:melanosome; C:membrane; C:midbody; C:photoreceptor inner segment; C:plasma membrane; C:presynapse; C:sarcolemma; C:Z disc;, F:D-glucose transmembrane transporter activity; F:dehydroascorbic acid transmembrane transporter activity; F:glucose transmembrane transporter activity; F:identical protein binding; F:kinase binding; F:long-chain fatty acid transporter activity; F:protein self-association; F:xenobiotic transmembrane transporter activity;, P:cellular hyperosmotic response; P:cellular response to glucose starvation; P:cellular response to mechanical stimulus; P:central nervous system development; P:cerebral cortex development; P:female pregnancy; P:glucose import across plasma membrane; P:glucose transmembrane transport; P:L-ascorbic acid metabolic process; P:lactose biosynthetic process; P:long-chain fatty acid import across plasma membrane; P:photoreceptor cell maintenance; P:protein-containing complex assembly; P:regulation of glucose transmembrane transport; P:regulation of insulin secretion; P:response to hypoxia; P:response to insulin; P:response to Thyroglobulin triiodothyronine; P:transport across blood-brain barrier; scaffold83 indexed_genome mRNA 4056208 4057468 . + . ID=transcript_12194;Q00994 B2RD17 D3DXA3 Q5JQT4 Q5JQT5,Protein BEX3 {ECO:0000305},Brain-expressed X-linked protein 3 {ECO:0000312|HGNC:HGNC:13388};Nerve growth factor receptor-associated protein 1;Ovarian granulosa cell 13.0 kDa protein HGR74;p75NTR-associated cell death executor;, PF04538;, GO:0005737;GO:0005829;GO:0005634;GO:0042802;GO:0046872;GO:0005163;GO:0005102;GO:0006919;GO:0006915;GO:0007275;GO:0043154;GO:0043281;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleus;, F:identical protein binding; F:metal ion binding; F:nerve growth factor receptor binding; F:signaling receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:multicellular organism development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:signal transduction; scaffold83 indexed_genome mRNA 4098291 4105639 . - . ID=transcript_12195;Q5VV52 A8MXP6 B4DJR7 O95878 Q9NWE8,Zinc finger protein 691,, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold83 indexed_genome mRNA 4138545 4139685 . + . ID=transcript_12196;Q8N300 A8K5P1 D3DPW7,Small vasohibin-binding protein {ECO:0000303|PubMed:20736312},Coiled coil domain-containing protein 23 {ECO:0000312|HGNC:HGNC:29204};, PF15674;, GO:0045177;GO:0005737;GO:0005856;GO:0005576;GO:0008017;GO:0061564;GO:0010596;GO:0031397;GO:0009306;GO:0006508;GO:1905048;, C:apical part of cell; C:cytoplasm; C:cytoskeleton; C:extracellular region;, F:microtubule binding;, P:axon development; P:negative regulation of endothelial cell migration; P:negative regulation of protein ubiquitination; P:protein secretion; P:proteolysis; P:regulation of metallopeptidase activity; scaffold83 indexed_genome mRNA 4143752 4144701 . + . ID=transcript_12197;Q8N300 A8K5P1 D3DPW7,Small vasohibin-binding protein {ECO:0000303|PubMed:20736312},Coiled coil domain-containing protein 23 {ECO:0000312|HGNC:HGNC:29204};, PF15674;, GO:0045177;GO:0005737;GO:0005856;GO:0005576;GO:0008017;GO:0061564;GO:0010596;GO:0031397;GO:0009306;GO:0006508;GO:1905048;, C:apical part of cell; C:cytoplasm; C:cytoskeleton; C:extracellular region;, F:microtubule binding;, P:axon development; P:negative regulation of endothelial cell migration; P:negative regulation of protein ubiquitination; P:protein secretion; P:proteolysis; P:regulation of metallopeptidase activity; scaffold83 indexed_genome mRNA 4166323 4171853 . - . ID=transcript_12198;Q9BV19,Uncharacterized protein C1orf50,, PF10504;, GO:0042802;, , F:identical protein binding;|Q9BV19,Uncharacterized protein C1orf50,, PF10504;, GO:0042802;, , F:identical protein binding;|Q9BV19,Uncharacterized protein C1orf50,, PF10504;, GO:0042802;, , F:identical protein binding; scaffold83 indexed_genome mRNA 4171996 4194940 . + . ID=transcript_12199;Q32P28 Q7KZR4 Q96BR8 Q96SK8 Q96SL5 Q96SN3 Q9H6K3 Q9HC86 Q9HC87,Prolyl 3-hydroxylase 1 {ECO:0000312|HGNC:HGNC:19316},Growth suppressor 1 {ECO:0000303|PubMed:10951563};Leucine- and proline-enriched proteoglycan 1 {ECO:0000250|UniProtKB:Q9R1J8};, PF13640;, GO:0005737;GO:0005783;GO:0005788;GO:0070062;GO:0016020;GO:0005634;GO:0032991;GO:0005506;GO:0031418;GO:0019797;GO:0060348;GO:0061077;GO:0030199;GO:0032963;GO:0008285;GO:1901874;GO:0010976;GO:0006457;GO:0018126;GO:0050821;GO:0050708;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:membrane; C:nucleus; C:protein-containing complex;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:bone development; P:chaperone-mediated protein folding; P:collagen fibril organization; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:negative regulation of post-translational protein modification; P:positive regulation of neuron projection development; P:protein folding; P:protein hydroxylation; P:protein stabilization; P:regulation of protein secretion;|Q32P28 Q7KZR4 Q96BR8 Q96SK8 Q96SL5 Q96SN3 Q9H6K3 Q9HC86 Q9HC87,Prolyl 3-hydroxylase 1 {ECO:0000312|HGNC:HGNC:19316},Growth suppressor 1 {ECO:0000303|PubMed:10951563};Leucine- and proline-enriched proteoglycan 1 {ECO:0000250|UniProtKB:Q9R1J8};, PF13640;, GO:0005737;GO:0005783;GO:0005788;GO:0070062;GO:0016020;GO:0005634;GO:0032991;GO:0005506;GO:0031418;GO:0019797;GO:0060348;GO:0061077;GO:0030199;GO:0032963;GO:0008285;GO:1901874;GO:0010976;GO:0006457;GO:0018126;GO:0050821;GO:0050708;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:membrane; C:nucleus; C:protein-containing complex;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:bone development; P:chaperone-mediated protein folding; P:collagen fibril organization; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:negative regulation of post-translational protein modification; P:positive regulation of neuron projection development; P:protein folding; P:protein hydroxylation; P:protein stabilization; P:regulation of protein secretion;|Q32P28 Q7KZR4 Q96BR8 Q96SK8 Q96SL5 Q96SN3 Q9H6K3 Q9HC86 Q9HC87,Prolyl 3-hydroxylase 1 {ECO:0000312|HGNC:HGNC:19316},Growth suppressor 1 {ECO:0000303|PubMed:10951563};Leucine- and proline-enriched proteoglycan 1 {ECO:0000250|UniProtKB:Q9R1J8};, PF13640;, GO:0005737;GO:0005783;GO:0005788;GO:0070062;GO:0016020;GO:0005634;GO:0032991;GO:0005506;GO:0031418;GO:0019797;GO:0060348;GO:0061077;GO:0030199;GO:0032963;GO:0008285;GO:1901874;GO:0010976;GO:0006457;GO:0018126;GO:0050821;GO:0050708;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:membrane; C:nucleus; C:protein-containing complex;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:bone development; P:chaperone-mediated protein folding; P:collagen fibril organization; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:negative regulation of post-translational protein modification; P:positive regulation of neuron projection development; P:protein folding; P:protein hydroxylation; P:protein stabilization; P:regulation of protein secretion;|Q32P28 Q7KZR4 Q96BR8 Q96SK8 Q96SL5 Q96SN3 Q9H6K3 Q9HC86 Q9HC87,Prolyl 3-hydroxylase 1 {ECO:0000312|HGNC:HGNC:19316},Growth suppressor 1 {ECO:0000303|PubMed:10951563};Leucine- and proline-enriched proteoglycan 1 {ECO:0000250|UniProtKB:Q9R1J8};, PF13640;, GO:0005737;GO:0005783;GO:0005788;GO:0070062;GO:0016020;GO:0005634;GO:0032991;GO:0005506;GO:0031418;GO:0019797;GO:0060348;GO:0061077;GO:0030199;GO:0032963;GO:0008285;GO:1901874;GO:0010976;GO:0006457;GO:0018126;GO:0050821;GO:0050708;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:membrane; C:nucleus; C:protein-containing complex;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:bone development; P:chaperone-mediated protein folding; P:collagen fibril organization; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:negative regulation of post-translational protein modification; P:positive regulation of neuron projection development; P:protein folding; P:protein hydroxylation; P:protein stabilization; P:regulation of protein secretion; scaffold83 indexed_genome mRNA 4202076 4206237 . + . ID=transcript_12200;Q8N6F1 B7Z5I2 F5H5P9 Q5QT57 Q8N8X0,Claudin-19,, PF00822;, GO:0043296;GO:0016323;GO:0005923;GO:0016021;GO:0005634;GO:0048471;GO:0005886;GO:0042802;GO:0005198;GO:0031532;GO:0070830;GO:0016338;GO:0007155;GO:0030336;GO:0008285;GO:0010629;GO:0061045;GO:0019227;GO:1901890;GO:0010628;GO:0001934;GO:0150111;GO:0050896;GO:0007601;, C:apical junction complex; C:basolateral plasma membrane; C:bicellular tight junction; C:integral component of membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding; F:structural molecule activity;, P:actin cytoskeleton reorganization; P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of wound healing; P:neuronal action potential propagation; P:positive regulation of cell junction assembly; P:positive regulation of gene expression; P:positive regulation of protein phosphorylation; P:regulation of transepithelial transport; P:response to stimulus; P:visual perception; scaffold83 indexed_genome mRNA 4221366 4222538 . - . ID=transcript_12201;P67809 P16990 P16991 Q14972 Q15325 Q5FVF0,Y-box-binding protein 1 {ECO:0000303|PubMed:10817758},CCAAT-binding transcription factor I subunit A;DNA-binding protein B {ECO:0000250|UniProtKB:P62960};Enhancer factor I subunit A {ECO:0000250|UniProtKB:P62961};Nuclease-sensitive element-binding protein 1 {ECO:0000303|PubMed:1891370};Y-box transcription factor;, PF00313;, GO:0070937;GO:0005737;GO:0010494;GO:0005829;GO:0070062;GO:0005576;GO:0071204;GO:0043231;GO:1990124;GO:0031965;GO:0005654;GO:0005634;GO:1990904;GO:0005689;GO:0062153;GO:0003677;GO:0003690;GO:0051020;GO:0035198;GO:0003676;GO:0003723;GO:1990837;GO:0070934;GO:0048598;GO:0008544;GO:1990428;GO:0000398;GO:0048255;GO:2000773;GO:0017148;GO:0007219;GO:0051781;GO:0045944;GO:1903608;GO:0010468;GO:0006355;GO:0050658;GO:0051031;, C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:histone pre-mRNA 3'end processing complex; C:intracellular membrane-bounded organelle; C:messenger ribonucleoprotein complex; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:U12-type spliceosomal complex;, F:C5-methylcytidine-containing RNA binding; F:DNA binding; F:double-stranded DNA binding; F:GTPase binding; F:miRNA binding; F:nucleic acid binding; F:RNA binding; F:sequence-specific double-stranded DNA binding;, P:CRD-mediated mRNA stabilization; P:embryonic morphogenesis; P:epidermis development; P:miRNA transport; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:negative regulation of cellular senescence; P:negative regulation of translation; P:Notch signaling pathway; P:positive regulation of cell division; P:positive regulation of transcription by RNA polymerase II; P:protein localization to cytoplasmic stress granule; P:regulation of gene expression; P:regulation of transcription, DNA-templated; P:RNA transport; P:tRNA transport; scaffold83 indexed_genome mRNA 4226424 4238158 . - . ID=transcript_12202;P67809 P16990 P16991 Q14972 Q15325 Q5FVF0,Y-box-binding protein 1 {ECO:0000303|PubMed:10817758},CCAAT-binding transcription factor I subunit A;DNA-binding protein B {ECO:0000250|UniProtKB:P62960};Enhancer factor I subunit A {ECO:0000250|UniProtKB:P62961};Nuclease-sensitive element-binding protein 1 {ECO:0000303|PubMed:1891370};Y-box transcription factor;, PF00313;, GO:0070937;GO:0005737;GO:0010494;GO:0005829;GO:0070062;GO:0005576;GO:0071204;GO:0043231;GO:1990124;GO:0031965;GO:0005654;GO:0005634;GO:1990904;GO:0005689;GO:0062153;GO:0003677;GO:0003690;GO:0051020;GO:0035198;GO:0003676;GO:0003723;GO:1990837;GO:0070934;GO:0048598;GO:0008544;GO:1990428;GO:0000398;GO:0048255;GO:2000773;GO:0017148;GO:0007219;GO:0051781;GO:0045944;GO:1903608;GO:0010468;GO:0006355;GO:0050658;GO:0051031;, C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:histone pre-mRNA 3'end processing complex; C:intracellular membrane-bounded organelle; C:messenger ribonucleoprotein complex; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:U12-type spliceosomal complex;, F:C5-methylcytidine-containing RNA binding; F:DNA binding; F:double-stranded DNA binding; F:GTPase binding; F:miRNA binding; F:nucleic acid binding; F:RNA binding; F:sequence-specific double-stranded DNA binding;, P:CRD-mediated mRNA stabilization; P:embryonic morphogenesis; P:epidermis development; P:miRNA transport; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:negative regulation of cellular senescence; P:negative regulation of translation; P:Notch signaling pathway; P:positive regulation of cell division; P:positive regulation of transcription by RNA polymerase II; P:protein localization to cytoplasmic stress granule; P:regulation of gene expression; P:regulation of transcription, DNA-templated; P:RNA transport; P:tRNA transport;|P67809 P16990 P16991 Q14972 Q15325 Q5FVF0,Y-box-binding protein 1 {ECO:0000303|PubMed:10817758},CCAAT-binding transcription factor I subunit A;DNA-binding protein B {ECO:0000250|UniProtKB:P62960};Enhancer factor I subunit A {ECO:0000250|UniProtKB:P62961};Nuclease-sensitive element-binding protein 1 {ECO:0000303|PubMed:1891370};Y-box transcription factor;, PF00313;, GO:0070937;GO:0005737;GO:0010494;GO:0005829;GO:0070062;GO:0005576;GO:0071204;GO:0043231;GO:1990124;GO:0031965;GO:0005654;GO:0005634;GO:1990904;GO:0005689;GO:0062153;GO:0003677;GO:0003690;GO:0051020;GO:0035198;GO:0003676;GO:0003723;GO:1990837;GO:0070934;GO:0048598;GO:0008544;GO:1990428;GO:0000398;GO:0048255;GO:2000773;GO:0017148;GO:0007219;GO:0051781;GO:0045944;GO:1903608;GO:0010468;GO:0006355;GO:0050658;GO:0051031;, C:CRD-mediated mRNA stability complex; C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:histone pre-mRNA 3'end processing complex; C:intracellular membrane-bounded organelle; C:messenger ribonucleoprotein complex; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:U12-type spliceosomal complex;, F:C5-methylcytidine-containing RNA binding; F:DNA binding; F:double-stranded DNA binding; F:GTPase binding; F:miRNA binding; F:nucleic acid binding; F:RNA binding; F:sequence-specific double-stranded DNA binding;, P:CRD-mediated mRNA stabilization; P:embryonic morphogenesis; P:epidermis development; P:miRNA transport; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:negative regulation of cellular senescence; P:negative regulation of translation; P:Notch signaling pathway; P:positive regulation of cell division; P:positive regulation of transcription by RNA polymerase II; P:protein localization to cytoplasmic stress granule; P:regulation of gene expression; P:regulation of transcription, DNA-templated; P:RNA transport; P:tRNA transport; scaffold83 indexed_genome mRNA 4253448 4258629 . - . ID=transcript_12203;O43447 A6NNE7,Peptidyl-prolyl cis-trans isomerase H,Rotamase H;Small nuclear ribonucleoprotein particle-specific cyclophilin H;U-snRNP-associated cyclophilin SnuCyp-20;, PF00160;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005681;GO:0071001;GO:0046540;GO:0016018;GO:0003755;GO:0043021;GO:0000398;GO:0045070;GO:0006457;GO:0000413;GO:0065003;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:spliceosomal complex; C:U4/U6 snRNP; C:U4/U6 x U5 tri-snRNP complex;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:ribonucleoprotein complex binding;, P:mRNA splicing, via spliceosome; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein-containing complex assembly; scaffold83 indexed_genome mRNA 4258778 4263915 . - . ID=transcript_12204;O43447 A6NNE7,Peptidyl-prolyl cis-trans isomerase H,Rotamase H;Small nuclear ribonucleoprotein particle-specific cyclophilin H;U-snRNP-associated cyclophilin SnuCyp-20;, PF00160;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005681;GO:0071001;GO:0046540;GO:0016018;GO:0003755;GO:0043021;GO:0000398;GO:0045070;GO:0006457;GO:0000413;GO:0065003;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:spliceosomal complex; C:U4/U6 snRNP; C:U4/U6 x U5 tri-snRNP complex;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:ribonucleoprotein complex binding;, P:mRNA splicing, via spliceosome; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein-containing complex assembly; scaffold83 indexed_genome mRNA 4265560 4266564 . - . ID=transcript_12205;O43447 A6NNE7,Peptidyl-prolyl cis-trans isomerase H,Rotamase H;Small nuclear ribonucleoprotein particle-specific cyclophilin H;U-snRNP-associated cyclophilin SnuCyp-20;, PF00160;, GO:0005737;GO:0043231;GO:0016607;GO:0005654;GO:0005681;GO:0071001;GO:0046540;GO:0016018;GO:0003755;GO:0043021;GO:0000398;GO:0045070;GO:0006457;GO:0000413;GO:0065003;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:spliceosomal complex; C:U4/U6 snRNP; C:U4/U6 x U5 tri-snRNP complex;, F:cyclosporin A binding; F:peptidyl-prolyl cis-trans isomerase activity; F:ribonucleoprotein complex binding;, P:mRNA splicing, via spliceosome; P:positive regulation of viral genome replication; P:protein folding; P:protein peptidyl-prolyl isomerization; P:protein-containing complex assembly; scaffold83 indexed_genome mRNA 4270408 4330734 . - . ID=transcript_12206;Q5VVM6 Q14F06 Q5VVM5,Coiled-coil domain-containing protein 30,Prefoldin subunit 6-like protein;, PF15742;|Q5VVM6 Q14F06 Q5VVM5,Coiled-coil domain-containing protein 30,Prefoldin subunit 6-like protein;, PF15742;|Q5VVM6 Q14F06 Q5VVM5,Coiled-coil domain-containing protein 30,Prefoldin subunit 6-like protein;, PF15742;|Q5VVM6 Q14F06 Q5VVM5,Coiled-coil domain-containing protein 30,Prefoldin subunit 6-like protein;, PF15742;|Q5VVM6 Q14F06 Q5VVM5,Coiled-coil domain-containing protein 30,Prefoldin subunit 6-like protein;, PF15742;|Q5VVM6 Q14F06 Q5VVM5,Coiled-coil domain-containing protein 30,Prefoldin subunit 6-like protein;, PF15742;|Q5VVM6 Q14F06 Q5VVM5,Coiled-coil domain-containing protein 30,Prefoldin subunit 6-like protein;, PF15742; scaffold83 indexed_genome mRNA 4396572 4400279 . - . ID=transcript_12207;Q9HAB8 Q3KQT2 Q5VVM0,Phosphopantothenate--cysteine ligase,Phosphopantothenoylcysteine synthetase;, PF04127;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0042802;GO:0004632;GO:0042803;GO:0006085;GO:0015937;GO:0003015;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:identical protein binding; F:phosphopantothenate--cysteine ligase activity; F:protein homodimerization activity;, P:acetyl-CoA biosynthetic process; P:coenzyme A biosynthetic process; P:heart process;|Q9HAB8 Q3KQT2 Q5VVM0,Phosphopantothenate--cysteine ligase,Phosphopantothenoylcysteine synthetase;, PF04127;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0042802;GO:0004632;GO:0042803;GO:0006085;GO:0015937;GO:0003015;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:identical protein binding; F:phosphopantothenate--cysteine ligase activity; F:protein homodimerization activity;, P:acetyl-CoA biosynthetic process; P:coenzyme A biosynthetic process; P:heart process;|Q9HAB8 Q3KQT2 Q5VVM0,Phosphopantothenate--cysteine ligase,Phosphopantothenoylcysteine synthetase;, PF04127;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0042802;GO:0004632;GO:0042803;GO:0006085;GO:0015937;GO:0003015;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:identical protein binding; F:phosphopantothenate--cysteine ligase activity; F:protein homodimerization activity;, P:acetyl-CoA biosynthetic process; P:coenzyme A biosynthetic process; P:heart process; scaffold83 indexed_genome mRNA 4400765 4434128 . + . ID=transcript_12208;Q9H0C1 Q5VUS6 Q8TC87 Q96M51,Zinc finger MYND domain-containing protein 12,, PF01753;, GO:0046872;, , F:metal ion binding; scaffold83 indexed_genome mRNA 4450939 4486871 . - . ID=transcript_12209;Q8IXN7 Q5VUS5,N-acetylaspartylglutamate synthase A,N-acetylaspartylglutamylglutamate synthase A;Ribosomal protein S6 modification-like protein A;, PF08443;, GO:0005737;GO:0005829;GO:0005524;GO:0016879;GO:0046872;GO:0072590;GO:0006464;GO:0009064;, C:cytoplasm; C:cytosol;, F:ATP binding; F:ligase activity, forming carbon-nitrogen bonds; F:metal ion binding; F:N-acetyl-L-aspartate-L-glutamate ligase activity;, P:cellular protein modification process; P:glutamine family amino acid metabolic process;|Q8IXN7 Q5VUS5,N-acetylaspartylglutamate synthase A,N-acetylaspartylglutamylglutamate synthase A;Ribosomal protein S6 modification-like protein A;, PF08443;, GO:0005737;GO:0005829;GO:0005524;GO:0016879;GO:0046872;GO:0072590;GO:0006464;GO:0009064;, C:cytoplasm; C:cytosol;, F:ATP binding; F:ligase activity, forming carbon-nitrogen bonds; F:metal ion binding; F:N-acetyl-L-aspartate-L-glutamate ligase activity;, P:cellular protein modification process; P:glutamine family amino acid metabolic process; scaffold83 indexed_genome mRNA 4651385 4700480 . + . ID=transcript_12210;Q9UPW0 A7MBL7 A7MD18 D3DPW2 Q9NSS7,Forkhead box protein J3,, PF00250;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0007141;GO:0045944;GO:0006357;GO:0007283;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:male meiosis I; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9UPW0 A7MBL7 A7MD18 D3DPW2 Q9NSS7,Forkhead box protein J3,, PF00250;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0007141;GO:0045944;GO:0006357;GO:0007283;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:male meiosis I; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold83 indexed_genome mRNA 4865653 4866238 . + . ID=transcript_12211;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold83 indexed_genome mRNA 5297285 5298038 . + . ID=transcript_12212;Q5T1R4 A7YY91 Q5T1R5 Q9BZS0 Q9HCL7,Transcription factor HIVEP3,Human immunodeficiency virus type I enhancer-binding protein 3;Kappa-B and V(D)J recombination signal sequences-binding protein;Kappa-binding protein 1;Zinc finger protein ZAS3;, PF00096;, GO:0005737;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0045893;GO:0006357;GO:0035914;, C:cytoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; scaffold83 indexed_genome mRNA 5299439 5300655 . + . ID=transcript_12213;Q5T1R4 A7YY91 Q5T1R5 Q9BZS0 Q9HCL7,Transcription factor HIVEP3,Human immunodeficiency virus type I enhancer-binding protein 3;Kappa-B and V(D)J recombination signal sequences-binding protein;Kappa-binding protein 1;Zinc finger protein ZAS3;, PF00096;, GO:0005737;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0045893;GO:0006357;GO:0035914;, C:cytoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation;|Q5T1R4 A7YY91 Q5T1R5 Q9BZS0 Q9HCL7,Transcription factor HIVEP3,Human immunodeficiency virus type I enhancer-binding protein 3;Kappa-B and V(D)J recombination signal sequences-binding protein;Kappa-binding protein 1;Zinc finger protein ZAS3;, PF00096;, GO:0005737;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0045893;GO:0006357;GO:0035914;, C:cytoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; scaffold83 indexed_genome mRNA 5301341 5307404 . + . ID=transcript_12214;Q5T1R4 A7YY91 Q5T1R5 Q9BZS0 Q9HCL7,Transcription factor HIVEP3,Human immunodeficiency virus type I enhancer-binding protein 3;Kappa-B and V(D)J recombination signal sequences-binding protein;Kappa-binding protein 1;Zinc finger protein ZAS3;, PF00096;, GO:0005737;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0045893;GO:0006357;GO:0035914;, C:cytoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; scaffold83 indexed_genome mRNA 5344603 5351612 . + . ID=transcript_12215;Q5T1R4 A7YY91 Q5T1R5 Q9BZS0 Q9HCL7,Transcription factor HIVEP3,Human immunodeficiency virus type I enhancer-binding protein 3;Kappa-B and V(D)J recombination signal sequences-binding protein;Kappa-binding protein 1;Zinc finger protein ZAS3;, PF00096;, GO:0005737;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0045893;GO:0006357;GO:0035914;, C:cytoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; scaffold83 indexed_genome mRNA 5351702 5352381 . + . ID=transcript_12216;Q5T1R4 A7YY91 Q5T1R5 Q9BZS0 Q9HCL7,Transcription factor HIVEP3,Human immunodeficiency virus type I enhancer-binding protein 3;Kappa-B and V(D)J recombination signal sequences-binding protein;Kappa-binding protein 1;Zinc finger protein ZAS3;, PF00096;, GO:0005737;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0045893;GO:0006357;GO:0035914;, C:cytoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; scaffold83 indexed_genome mRNA 5633315 5845421 . + . ID=transcript_12217;Q96GD3 B4DRQ8 Q5VT76 Q6IAJ4 Q8WU48 Q9UKM5 Q9UKM6,Polycomb protein SCMH1,Sex comb on midleg homolog 1;, PF02820;PF17208;PF00536;PF12140;, GO:0010369;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0009952;GO:0006338;GO:0016458;GO:0045892;GO:0007283;, C:chromocenter; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:anterior/posterior pattern specification; P:chromatin remodeling; P:gene silencing; P:negative regulation of transcription, DNA-templated; P:spermatogenesis;|Q96GD3 B4DRQ8 Q5VT76 Q6IAJ4 Q8WU48 Q9UKM5 Q9UKM6,Polycomb protein SCMH1,Sex comb on midleg homolog 1;, PF02820;PF17208;PF00536;PF12140;, GO:0010369;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0009952;GO:0006338;GO:0016458;GO:0045892;GO:0007283;, C:chromocenter; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:anterior/posterior pattern specification; P:chromatin remodeling; P:gene silencing; P:negative regulation of transcription, DNA-templated; P:spermatogenesis;|Q96GD3 B4DRQ8 Q5VT76 Q6IAJ4 Q8WU48 Q9UKM5 Q9UKM6,Polycomb protein SCMH1,Sex comb on midleg homolog 1;, PF02820;PF17208;PF00536;PF12140;, GO:0010369;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0009952;GO:0006338;GO:0016458;GO:0045892;GO:0007283;, C:chromocenter; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:anterior/posterior pattern specification; P:chromatin remodeling; P:gene silencing; P:negative regulation of transcription, DNA-templated; P:spermatogenesis;|Q96GD3 B4DRQ8 Q5VT76 Q6IAJ4 Q8WU48 Q9UKM5 Q9UKM6,Polycomb protein SCMH1,Sex comb on midleg homolog 1;, PF02820;PF17208;PF00536;PF12140;, GO:0010369;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0009952;GO:0006338;GO:0016458;GO:0045892;GO:0007283;, C:chromocenter; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:anterior/posterior pattern specification; P:chromatin remodeling; P:gene silencing; P:negative regulation of transcription, DNA-templated; P:spermatogenesis;|Q96GD3 B4DRQ8 Q5VT76 Q6IAJ4 Q8WU48 Q9UKM5 Q9UKM6,Polycomb protein SCMH1,Sex comb on midleg homolog 1;, PF02820;PF17208;PF00536;PF12140;, GO:0010369;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0009952;GO:0006338;GO:0016458;GO:0045892;GO:0007283;, C:chromocenter; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:anterior/posterior pattern specification; P:chromatin remodeling; P:gene silencing; P:negative regulation of transcription, DNA-templated; P:spermatogenesis;|Q96GD3 B4DRQ8 Q5VT76 Q6IAJ4 Q8WU48 Q9UKM5 Q9UKM6,Polycomb protein SCMH1,Sex comb on midleg homolog 1;, PF02820;PF17208;PF00536;PF12140;, GO:0010369;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0009952;GO:0006338;GO:0016458;GO:0045892;GO:0007283;, C:chromocenter; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding;, P:anterior/posterior pattern specification; P:chromatin remodeling; P:gene silencing; P:negative regulation of transcription, DNA-templated; P:spermatogenesis; scaffold83 indexed_genome mRNA 5857337 5893125 . - . ID=transcript_12218;P17812 B4DR64 D3DPW1 Q5VW67 Q96GK6,CTP synthase 1 {ECO:0000305},CTP synthetase 1;UTP--ammonia ligase 1;, PF06418;PF00117;, GO:0097268;GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0003883;GO:0042802;GO:0044210;GO:0042100;GO:0006241;GO:0006541;GO:0006139;GO:0015949;GO:0019856;GO:0042493;GO:0042098;, C:cytoophidium; C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:CTP synthase activity; F:identical protein binding;, P:'de novo' CTP biosynthetic process; P:B cell proliferation; P:CTP biosynthetic process; P:glutamine metabolic process; P:nucleobase-containing compound metabolic process; P:nucleobase-containing small molecule interconversion; P:pyrimidine nucleobase biosynthetic process; P:response to drug; P:T cell proliferation;|P17812 B4DR64 D3DPW1 Q5VW67 Q96GK6,CTP synthase 1 {ECO:0000305},CTP synthetase 1;UTP--ammonia ligase 1;, PF06418;PF00117;, GO:0097268;GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0003883;GO:0042802;GO:0044210;GO:0042100;GO:0006241;GO:0006541;GO:0006139;GO:0015949;GO:0019856;GO:0042493;GO:0042098;, C:cytoophidium; C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:CTP synthase activity; F:identical protein binding;, P:'de novo' CTP biosynthetic process; P:B cell proliferation; P:CTP biosynthetic process; P:glutamine metabolic process; P:nucleobase-containing compound metabolic process; P:nucleobase-containing small molecule interconversion; P:pyrimidine nucleobase biosynthetic process; P:response to drug; P:T cell proliferation;|P17812 B4DR64 D3DPW1 Q5VW67 Q96GK6,CTP synthase 1 {ECO:0000305},CTP synthetase 1;UTP--ammonia ligase 1;, PF06418;PF00117;, GO:0097268;GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0003883;GO:0042802;GO:0044210;GO:0042100;GO:0006241;GO:0006541;GO:0006139;GO:0015949;GO:0019856;GO:0042493;GO:0042098;, C:cytoophidium; C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:CTP synthase activity; F:identical protein binding;, P:'de novo' CTP biosynthetic process; P:B cell proliferation; P:CTP biosynthetic process; P:glutamine metabolic process; P:nucleobase-containing compound metabolic process; P:nucleobase-containing small molecule interconversion; P:pyrimidine nucleobase biosynthetic process; P:response to drug; P:T cell proliferation;|P17812 B4DR64 D3DPW1 Q5VW67 Q96GK6,CTP synthase 1 {ECO:0000305},CTP synthetase 1;UTP--ammonia ligase 1;, PF06418;PF00117;, GO:0097268;GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0003883;GO:0042802;GO:0044210;GO:0042100;GO:0006241;GO:0006541;GO:0006139;GO:0015949;GO:0019856;GO:0042493;GO:0042098;, C:cytoophidium; C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:CTP synthase activity; F:identical protein binding;, P:'de novo' CTP biosynthetic process; P:B cell proliferation; P:CTP biosynthetic process; P:glutamine metabolic process; P:nucleobase-containing compound metabolic process; P:nucleobase-containing small molecule interconversion; P:pyrimidine nucleobase biosynthetic process; P:response to drug; P:T cell proliferation;|P17812 B4DR64 D3DPW1 Q5VW67 Q96GK6,CTP synthase 1 {ECO:0000305},CTP synthetase 1;UTP--ammonia ligase 1;, PF06418;PF00117;, GO:0097268;GO:0005737;GO:0005829;GO:0016020;GO:0005524;GO:0003883;GO:0042802;GO:0044210;GO:0042100;GO:0006241;GO:0006541;GO:0006139;GO:0015949;GO:0019856;GO:0042493;GO:0042098;, C:cytoophidium; C:cytoplasm; C:cytosol; C:membrane;, F:ATP binding; F:CTP synthase activity; F:identical protein binding;, P:'de novo' CTP biosynthetic process; P:B cell proliferation; P:CTP biosynthetic process; P:glutamine metabolic process; P:nucleobase-containing compound metabolic process; P:nucleobase-containing small molecule interconversion; P:pyrimidine nucleobase biosynthetic process; P:response to drug; P:T cell proliferation; scaffold83 indexed_genome mRNA 6026524 6089401 . - . ID=transcript_12219;P56696 O96025,Potassium voltage-gated channel subfamily KQT member 4,KQT-like 4;Potassium channel subunit alpha KvLQT4;Voltage-gated potassium channel subunit Kv7.4;, PF00520;PF03520;, GO:0009925;GO:0016021;GO:0005886;GO:0008076;GO:0005516;GO:0005251;GO:0005267;GO:0005249;GO:0042472;GO:0071805;GO:0006813;GO:0034765;GO:0007605;, C:basal plasma membrane; C:integral component of membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calmodulin binding; F:delayed rectifier potassium channel activity; F:potassium channel activity; F:voltage-gated potassium channel activity;, P:inner ear morphogenesis; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:sensory perception of sound;|P56696 O96025,Potassium voltage-gated channel subfamily KQT member 4,KQT-like 4;Potassium channel subunit alpha KvLQT4;Voltage-gated potassium channel subunit Kv7.4;, PF00520;PF03520;, GO:0009925;GO:0016021;GO:0005886;GO:0008076;GO:0005516;GO:0005251;GO:0005267;GO:0005249;GO:0042472;GO:0071805;GO:0006813;GO:0034765;GO:0007605;, C:basal plasma membrane; C:integral component of membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calmodulin binding; F:delayed rectifier potassium channel activity; F:potassium channel activity; F:voltage-gated potassium channel activity;, P:inner ear morphogenesis; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:sensory perception of sound;|P56696 O96025,Potassium voltage-gated channel subfamily KQT member 4,KQT-like 4;Potassium channel subunit alpha KvLQT4;Voltage-gated potassium channel subunit Kv7.4;, PF00520;PF03520;, GO:0009925;GO:0016021;GO:0005886;GO:0008076;GO:0005516;GO:0005251;GO:0005267;GO:0005249;GO:0042472;GO:0071805;GO:0006813;GO:0034765;GO:0007605;, C:basal plasma membrane; C:integral component of membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calmodulin binding; F:delayed rectifier potassium channel activity; F:potassium channel activity; F:voltage-gated potassium channel activity;, P:inner ear morphogenesis; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:sensory perception of sound; scaffold83 indexed_genome mRNA 6098843 6146639 . - . ID=transcript_12220;Q5TZR6 Q92869 Q9HBX1 Q9NXB5 Q9UM67 Q9UML0 Q9UMT7,Nuclear transcription factor Y subunit gamma,CAAT box DNA-binding protein subunit C;Nuclear transcription factor Y subunit C;Transactivator HSM-1/2;, PF00125;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0000978;GO:0008134;GO:0006457;GO:0019216;GO:0006357;GO:0006355;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:protein folding; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q5TZR6 Q92869 Q9HBX1 Q9NXB5 Q9UM67 Q9UML0 Q9UMT7,Nuclear transcription factor Y subunit gamma,CAAT box DNA-binding protein subunit C;Nuclear transcription factor Y subunit C;Transactivator HSM-1/2;, PF00125;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0000978;GO:0008134;GO:0006457;GO:0019216;GO:0006357;GO:0006355;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:protein folding; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q5TZR6 Q92869 Q9HBX1 Q9NXB5 Q9UM67 Q9UML0 Q9UMT7,Nuclear transcription factor Y subunit gamma,CAAT box DNA-binding protein subunit C;Nuclear transcription factor Y subunit C;Transactivator HSM-1/2;, PF00125;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0000978;GO:0008134;GO:0006457;GO:0019216;GO:0006357;GO:0006355;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:protein folding; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q5TZR6 Q92869 Q9HBX1 Q9NXB5 Q9UM67 Q9UML0 Q9UMT7,Nuclear transcription factor Y subunit gamma,CAAT box DNA-binding protein subunit C;Nuclear transcription factor Y subunit C;Transactivator HSM-1/2;, PF00125;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0000978;GO:0008134;GO:0006457;GO:0019216;GO:0006357;GO:0006355;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:protein folding; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q5TZR6 Q92869 Q9HBX1 Q9NXB5 Q9UM67 Q9UML0 Q9UMT7,Nuclear transcription factor Y subunit gamma,CAAT box DNA-binding protein subunit C;Nuclear transcription factor Y subunit C;Transactivator HSM-1/2;, PF00125;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0000978;GO:0008134;GO:0006457;GO:0019216;GO:0006357;GO:0006355;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:protein folding; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold83 indexed_genome mRNA 6184188 6208217 . + . ID=transcript_12221;Q9UJD0 D3DPV8 Q92511 X5D7U7,Regulating synaptic membrane exocytosis protein 3,RIM3 gamma;Rab-3-interacting molecule 3;, PF00168;, GO:0048788;GO:0048786;GO:0042734;GO:0044325;GO:0031267;GO:0048791;GO:0017156;GO:0050806;GO:0042391;GO:0048167;GO:2000300;, C:cytoskeleton of presynaptic active zone; C:presynaptic active zone; C:presynaptic membrane;, F:ion channel binding; F:small GTPase binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:positive regulation of synaptic transmission; P:regulation of membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; scaffold83 indexed_genome mRNA 6208281 6222772 . + . ID=transcript_12222;Q9UJD0 D3DPV8 Q92511 X5D7U7,Regulating synaptic membrane exocytosis protein 3,RIM3 gamma;Rab-3-interacting molecule 3;, PF00168;, GO:0048788;GO:0048786;GO:0042734;GO:0044325;GO:0031267;GO:0048791;GO:0017156;GO:0050806;GO:0042391;GO:0048167;GO:2000300;, C:cytoskeleton of presynaptic active zone; C:presynaptic active zone; C:presynaptic membrane;, F:ion channel binding; F:small GTPase binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:positive regulation of synaptic transmission; P:regulation of membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis;|Q9UJD0 D3DPV8 Q92511 X5D7U7,Regulating synaptic membrane exocytosis protein 3,RIM3 gamma;Rab-3-interacting molecule 3;, PF00168;, GO:0048788;GO:0048786;GO:0042734;GO:0044325;GO:0031267;GO:0048791;GO:0017156;GO:0050806;GO:0042391;GO:0048167;GO:2000300;, C:cytoskeleton of presynaptic active zone; C:presynaptic active zone; C:presynaptic membrane;, F:ion channel binding; F:small GTPase binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:positive regulation of synaptic transmission; P:regulation of membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis;|Q9UJD0 D3DPV8 Q92511 X5D7U7,Regulating synaptic membrane exocytosis protein 3,RIM3 gamma;Rab-3-interacting molecule 3;, PF00168;, GO:0048788;GO:0048786;GO:0042734;GO:0044325;GO:0031267;GO:0048791;GO:0017156;GO:0050806;GO:0042391;GO:0048167;GO:2000300;, C:cytoskeleton of presynaptic active zone; C:presynaptic active zone; C:presynaptic membrane;, F:ion channel binding; F:small GTPase binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:positive regulation of synaptic transmission; P:regulation of membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; scaffold83 indexed_genome mRNA 6244785 6245293 . - . ID=transcript_12223;P13984 A6NNS5 Q5W0H3,General transcription factor IIF subunit 2,ATP-dependent helicase GTF2F2;General transcription factor IIF 30 kDa subunit;Transcription initiation factor IIF subunit beta;Transcription initiation factor RAP30;, PF02270;PF17683;, GO:0015630;GO:0005654;GO:0005634;GO:0005674;GO:0097550;GO:0005524;GO:0003677;GO:0003678;GO:0016251;GO:0006370;GO:0008543;GO:0000398;GO:0050434;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;, C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:transcription factor TFIIF complex; C:transcription preinitiation complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:RNA polymerase II general transcription initiation factor activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:positive regulation of viral transcription; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; scaffold83 indexed_genome mRNA 6259626 6261576 . - . ID=transcript_12224;Q5T5D7 Q2NKY4,Zinc finger protein 684,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:1990837;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold83 indexed_genome mRNA 6265904 6292867 . + . ID=transcript_12225;Q5T5D7 Q2NKY4,Zinc finger protein 684,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:1990837;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q5T5D7 Q2NKY4,Zinc finger protein 684,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:1990837;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9H790 D3DPV4 Q5SWM7 Q5SWM8 Q5SWM9 Q5SWN0 Q5SWN1 Q8WTW9,Exonuclease V,Defects in morphology protein 1 homolog;, PF09810;, GO:0005829;GO:0005654;GO:0005634;GO:0051539;GO:0003677;GO:0046872;GO:0008310;GO:0045145;GO:0036297;, C:cytosol; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:metal ion binding; F:single-stranded DNA 3'-5' exodeoxyribonuclease activity; F:single-stranded DNA 5'-3' exodeoxyribonuclease activity;, P:interstrand cross-link repair;|Q9H790 D3DPV4 Q5SWM7 Q5SWM8 Q5SWM9 Q5SWN0 Q5SWN1 Q8WTW9,Exonuclease V,Defects in morphology protein 1 homolog;, PF09810;, GO:0005829;GO:0005654;GO:0005634;GO:0051539;GO:0003677;GO:0046872;GO:0008310;GO:0045145;GO:0036297;, C:cytosol; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:DNA binding; F:metal ion binding; F:single-stranded DNA 3'-5' exodeoxyribonuclease activity; F:single-stranded DNA 5'-3' exodeoxyribonuclease activity;, P:interstrand cross-link repair; scaffold83 indexed_genome mRNA 6317792 6319178 . - . ID=transcript_12226;P09669 B2R4D7,Cytochrome c oxidase subunit 6C,Cytochrome c oxidase polypeptide VIc;, PF02937;, GO:0016021;GO:0005743;GO:0005739;GO:0004129;GO:0006091;GO:0006123;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen; scaffold83 indexed_genome mRNA 6321415 6323706 . - . ID=transcript_12227;Q49AA0 Q5SWM5 Q6ZWK8,Zinc finger protein 69 homolog {ECO:0000250|UniProtKB:A2A761},Zinc finger protein 642;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0006629;GO:0000122;GO:0019216;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:lipid metabolic process; P:negative regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; scaffold83 indexed_genome mRNA 6356770 6407176 . - . ID=transcript_12228;Q8WU79 B2R7T1 B7Z5B5 B7Z8V2 D3DPV2 Q5QPL2 Q96C93 Q9NST2 Q9UJL8,Stromal membrane-associated protein 2,Stromal membrane-associated protein 1-like;, PF01412;, GO:0005737;GO:0005096;GO:0046872;, C:cytoplasm;, F:GTPase activator activity; F:metal ion binding;|Q8WU79 B2R7T1 B7Z5B5 B7Z8V2 D3DPV2 Q5QPL2 Q96C93 Q9NST2 Q9UJL8,Stromal membrane-associated protein 2,Stromal membrane-associated protein 1-like;, PF01412;, GO:0005737;GO:0005096;GO:0046872;, C:cytoplasm;, F:GTPase activator activity; F:metal ion binding;|Q8WU79 B2R7T1 B7Z5B5 B7Z8V2 D3DPV2 Q5QPL2 Q96C93 Q9NST2 Q9UJL8,Stromal membrane-associated protein 2,Stromal membrane-associated protein 1-like;, PF01412;, GO:0005737;GO:0005096;GO:0046872;, C:cytoplasm;, F:GTPase activator activity; F:metal ion binding;|Q8WU79 B2R7T1 B7Z5B5 B7Z8V2 D3DPV2 Q5QPL2 Q96C93 Q9NST2 Q9UJL8,Stromal membrane-associated protein 2,Stromal membrane-associated protein 1-like;, PF01412;, GO:0005737;GO:0005096;GO:0046872;, C:cytoplasm;, F:GTPase activator activity; F:metal ion binding; scaffold83 indexed_genome mRNA 6444071 6458080 . + . ID=transcript_12229;Q14055 B2RMP9,Collagen alpha-2(IX) chain {ECO:0000305},, PF01391;, GO:0005594;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0030199;GO:0030198;GO:0001501;, C:collagen type IX trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:collagen fibril organization; P:extracellular matrix organization; P:skeletal system development; scaffold83 indexed_genome mRNA 6464946 6512830 . - . ID=transcript_12230;O75844 B3KQI7 D3DPU7 Q8NDZ8 Q9UBQ2,CAAX prenyl protease 1 homolog,Farnesylated proteins-converting enzyme 1;Prenyl protein-specific endoprotease 1;Zinc metalloproteinase Ste24 homolog;, PF01435;PF16491;, GO:0070062;GO:0030176;GO:0016020;GO:0005637;GO:0032991;GO:0003690;GO:0046872;GO:0004222;GO:0008235;GO:0007628;GO:0030282;GO:0071586;GO:1990036;GO:0061762;GO:0061337;GO:0048739;GO:0003231;GO:0044255;GO:0071480;GO:0008340;GO:0006281;GO:0003417;GO:0001942;GO:0003007;GO:1990164;GO:0043979;GO:0044029;GO:0006925;GO:0060993;GO:0001889;GO:0043007;GO:0035264;GO:1903799;GO:0050905;GO:0006998;GO:0030327;GO:0006508;GO:0010506;GO:0030500;GO:0008360;GO:2000772;GO:0050688;GO:0043516;GO:0048145;GO:0010906;GO:2000618;GO:0032350;GO:0019216;GO:1903463;GO:0040014;GO:1903025;GO:0070302;GO:2000730;GO:0032006;GO:0060307;GO:0072423;GO:0048538;GO:0003229;, C:extracellular exosome; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear inner membrane; C:protein-containing complex;, F:double-stranded DNA binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloexopeptidase activity;, P:adult walking behavior; P:bone mineralization; P:CAAX-box protein processing; P:calcium ion import into sarcoplasmic reticulum; P:CAMKK-AMPK signaling cascade; P:cardiac conduction; P:cardiac muscle fiber development; P:cardiac ventricle development; P:cellular lipid metabolic process; P:cellular response to gamma radiation; P:determination of adult lifespan; P:DNA repair; P:growth plate cartilage development; P:hair follicle development; P:heart morphogenesis; P:histone H2A phosphorylation; P:histone H2B-K5 acetylation; P:hypomethylation of CpG island; P:inflammatory cell apoptotic process; P:kidney morphogenesis; P:liver development; P:maintenance of rDNA; P:multicellular organism growth; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:neuromuscular process; P:nuclear envelope organization; P:prenylated protein catabolic process; P:proteolysis; P:regulation of autophagy; P:regulation of bone mineralization; P:regulation of cell shape; P:regulation of cellular senescence; P:regulation of defense response to virus; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of fibroblast proliferation; P:regulation of glucose metabolic process; P:regulation of histone H4-K16 acetylation; P:regulation of hormone metabolic process; P:regulation of lipid metabolic process; P:regulation of mitotic cell cycle DNA replication; P:regulation of multicellular organism growth; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of stress-activated protein kinase signaling cascade; P:regulation of termination of RNA polymerase I transcription; P:regulation of TOR signaling; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:response to DNA damage checkpoint signaling; P:thymus development; P:ventricular cardiac muscle tissue development;|O75844 B3KQI7 D3DPU7 Q8NDZ8 Q9UBQ2,CAAX prenyl protease 1 homolog,Farnesylated proteins-converting enzyme 1;Prenyl protein-specific endoprotease 1;Zinc metalloproteinase Ste24 homolog;, PF01435;PF16491;, GO:0070062;GO:0030176;GO:0016020;GO:0005637;GO:0032991;GO:0003690;GO:0046872;GO:0004222;GO:0008235;GO:0007628;GO:0030282;GO:0071586;GO:1990036;GO:0061762;GO:0061337;GO:0048739;GO:0003231;GO:0044255;GO:0071480;GO:0008340;GO:0006281;GO:0003417;GO:0001942;GO:0003007;GO:1990164;GO:0043979;GO:0044029;GO:0006925;GO:0060993;GO:0001889;GO:0043007;GO:0035264;GO:1903799;GO:0050905;GO:0006998;GO:0030327;GO:0006508;GO:0010506;GO:0030500;GO:0008360;GO:2000772;GO:0050688;GO:0043516;GO:0048145;GO:0010906;GO:2000618;GO:0032350;GO:0019216;GO:1903463;GO:0040014;GO:1903025;GO:0070302;GO:2000730;GO:0032006;GO:0060307;GO:0072423;GO:0048538;GO:0003229;, C:extracellular exosome; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear inner membrane; C:protein-containing complex;, F:double-stranded DNA binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloexopeptidase activity;, P:adult walking behavior; P:bone mineralization; P:CAAX-box protein processing; P:calcium ion import into sarcoplasmic reticulum; P:CAMKK-AMPK signaling cascade; P:cardiac conduction; P:cardiac muscle fiber development; P:cardiac ventricle development; P:cellular lipid metabolic process; P:cellular response to gamma radiation; P:determination of adult lifespan; P:DNA repair; P:growth plate cartilage development; P:hair follicle development; P:heart morphogenesis; P:histone H2A phosphorylation; P:histone H2B-K5 acetylation; P:hypomethylation of CpG island; P:inflammatory cell apoptotic process; P:kidney morphogenesis; P:liver development; P:maintenance of rDNA; P:multicellular organism growth; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:neuromuscular process; P:nuclear envelope organization; P:prenylated protein catabolic process; P:proteolysis; P:regulation of autophagy; P:regulation of bone mineralization; P:regulation of cell shape; P:regulation of cellular senescence; P:regulation of defense response to virus; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of fibroblast proliferation; P:regulation of glucose metabolic process; P:regulation of histone H4-K16 acetylation; P:regulation of hormone metabolic process; P:regulation of lipid metabolic process; P:regulation of mitotic cell cycle DNA replication; P:regulation of multicellular organism growth; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of stress-activated protein kinase signaling cascade; P:regulation of termination of RNA polymerase I transcription; P:regulation of TOR signaling; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:response to DNA damage checkpoint signaling; P:thymus development; P:ventricular cardiac muscle tissue development;|O75844 B3KQI7 D3DPU7 Q8NDZ8 Q9UBQ2,CAAX prenyl protease 1 homolog,Farnesylated proteins-converting enzyme 1;Prenyl protein-specific endoprotease 1;Zinc metalloproteinase Ste24 homolog;, PF01435;PF16491;, GO:0070062;GO:0030176;GO:0016020;GO:0005637;GO:0032991;GO:0003690;GO:0046872;GO:0004222;GO:0008235;GO:0007628;GO:0030282;GO:0071586;GO:1990036;GO:0061762;GO:0061337;GO:0048739;GO:0003231;GO:0044255;GO:0071480;GO:0008340;GO:0006281;GO:0003417;GO:0001942;GO:0003007;GO:1990164;GO:0043979;GO:0044029;GO:0006925;GO:0060993;GO:0001889;GO:0043007;GO:0035264;GO:1903799;GO:0050905;GO:0006998;GO:0030327;GO:0006508;GO:0010506;GO:0030500;GO:0008360;GO:2000772;GO:0050688;GO:0043516;GO:0048145;GO:0010906;GO:2000618;GO:0032350;GO:0019216;GO:1903463;GO:0040014;GO:1903025;GO:0070302;GO:2000730;GO:0032006;GO:0060307;GO:0072423;GO:0048538;GO:0003229;, C:extracellular exosome; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear inner membrane; C:protein-containing complex;, F:double-stranded DNA binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloexopeptidase activity;, P:adult walking behavior; P:bone mineralization; P:CAAX-box protein processing; P:calcium ion import into sarcoplasmic reticulum; P:CAMKK-AMPK signaling cascade; P:cardiac conduction; P:cardiac muscle fiber development; P:cardiac ventricle development; P:cellular lipid metabolic process; P:cellular response to gamma radiation; P:determination of adult lifespan; P:DNA repair; P:growth plate cartilage development; P:hair follicle development; P:heart morphogenesis; P:histone H2A phosphorylation; P:histone H2B-K5 acetylation; P:hypomethylation of CpG island; P:inflammatory cell apoptotic process; P:kidney morphogenesis; P:liver development; P:maintenance of rDNA; P:multicellular organism growth; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:neuromuscular process; P:nuclear envelope organization; P:prenylated protein catabolic process; P:proteolysis; P:regulation of autophagy; P:regulation of bone mineralization; P:regulation of cell shape; P:regulation of cellular senescence; P:regulation of defense response to virus; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of fibroblast proliferation; P:regulation of glucose metabolic process; P:regulation of histone H4-K16 acetylation; P:regulation of hormone metabolic process; P:regulation of lipid metabolic process; P:regulation of mitotic cell cycle DNA replication; P:regulation of multicellular organism growth; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of stress-activated protein kinase signaling cascade; P:regulation of termination of RNA polymerase I transcription; P:regulation of TOR signaling; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:response to DNA damage checkpoint signaling; P:thymus development; P:ventricular cardiac muscle tissue development;|O75844 B3KQI7 D3DPU7 Q8NDZ8 Q9UBQ2,CAAX prenyl protease 1 homolog,Farnesylated proteins-converting enzyme 1;Prenyl protein-specific endoprotease 1;Zinc metalloproteinase Ste24 homolog;, PF01435;PF16491;, GO:0070062;GO:0030176;GO:0016020;GO:0005637;GO:0032991;GO:0003690;GO:0046872;GO:0004222;GO:0008235;GO:0007628;GO:0030282;GO:0071586;GO:1990036;GO:0061762;GO:0061337;GO:0048739;GO:0003231;GO:0044255;GO:0071480;GO:0008340;GO:0006281;GO:0003417;GO:0001942;GO:0003007;GO:1990164;GO:0043979;GO:0044029;GO:0006925;GO:0060993;GO:0001889;GO:0043007;GO:0035264;GO:1903799;GO:0050905;GO:0006998;GO:0030327;GO:0006508;GO:0010506;GO:0030500;GO:0008360;GO:2000772;GO:0050688;GO:0043516;GO:0048145;GO:0010906;GO:2000618;GO:0032350;GO:0019216;GO:1903463;GO:0040014;GO:1903025;GO:0070302;GO:2000730;GO:0032006;GO:0060307;GO:0072423;GO:0048538;GO:0003229;, C:extracellular exosome; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear inner membrane; C:protein-containing complex;, F:double-stranded DNA binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloexopeptidase activity;, P:adult walking behavior; P:bone mineralization; P:CAAX-box protein processing; P:calcium ion import into sarcoplasmic reticulum; P:CAMKK-AMPK signaling cascade; P:cardiac conduction; P:cardiac muscle fiber development; P:cardiac ventricle development; P:cellular lipid metabolic process; P:cellular response to gamma radiation; P:determination of adult lifespan; P:DNA repair; P:growth plate cartilage development; P:hair follicle development; P:heart morphogenesis; P:histone H2A phosphorylation; P:histone H2B-K5 acetylation; P:hypomethylation of CpG island; P:inflammatory cell apoptotic process; P:kidney morphogenesis; P:liver development; P:maintenance of rDNA; P:multicellular organism growth; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:neuromuscular process; P:nuclear envelope organization; P:prenylated protein catabolic process; P:proteolysis; P:regulation of autophagy; P:regulation of bone mineralization; P:regulation of cell shape; P:regulation of cellular senescence; P:regulation of defense response to virus; P:regulation of DNA damage response, signal transduction by p53 class mediator; P:regulation of fibroblast proliferation; P:regulation of glucose metabolic process; P:regulation of histone H4-K16 acetylation; P:regulation of hormone metabolic process; P:regulation of lipid metabolic process; P:regulation of mitotic cell cycle DNA replication; P:regulation of multicellular organism growth; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of stress-activated protein kinase signaling cascade; P:regulation of termination of RNA polymerase I transcription; P:regulation of TOR signaling; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:response to DNA damage checkpoint signaling; P:thymus development; P:ventricular cardiac muscle tissue development; scaffold83 indexed_genome mRNA 6529062 6529745 . + . ID=transcript_12231;Q7Z6W1,Transmembrane and coiled-coil domain-containing protein 2,, PF15844;, GO:0016021;GO:0005634;, C:integral component of membrane; C:nucleus; scaffold83 indexed_genome mRNA 6531220 6531803 . - . ID=transcript_12232;Q7Z6W1,Transmembrane and coiled-coil domain-containing protein 2,, PF15844;, GO:0016021;GO:0005634;, C:integral component of membrane; C:nucleus; scaffold83 indexed_genome mRNA 6538983 6620386 . - . ID=transcript_12233;Q13129 Q14CQ1 Q9NU60,Zinc finger protein Rlf,Rearranged L-myc fusion gene protein;Zn-15-related protein;, PF00096;, GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0046872;GO:0097692;GO:0045944;GO:0045893;GO:0044030;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA methylation; P:regulation of transcription by RNA polymerase II;|Q13129 Q14CQ1 Q9NU60,Zinc finger protein Rlf,Rearranged L-myc fusion gene protein;Zn-15-related protein;, PF00096;, GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0046872;GO:0097692;GO:0045944;GO:0045893;GO:0044030;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA methylation; P:regulation of transcription by RNA polymerase II; scaffold83 indexed_genome mRNA 6668503 6684729 . + . ID=transcript_12234;P50897 B4DY24 Q6FGQ4,Palmitoyl-protein thioesterase 1,Palmitoyl-protein hydrolase 1;, , GO:0030424;GO:0005829;GO:0070062;GO:0005576;GO:0005794;GO:0043231;GO:0043202;GO:0005764;GO:0016020;GO:0045121;GO:0005634;GO:0008021;GO:0035727;GO:0008474;GO:0016290;GO:0120146;GO:0016790;GO:0007420;GO:0046949;GO:0016042;GO:0007042;GO:0031579;GO:0043066;GO:0030308;GO:0043524;GO:0007399;GO:0048666;GO:0006907;GO:0048549;GO:0048260;GO:0030163;GO:0002084;GO:0015031;GO:0006898;GO:0050803;GO:0050896;GO:0030149;GO:0007601;, C:axon; C:cytosol; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:membrane; C:membrane raft; C:nucleus; C:synaptic vesicle;, F:lysophosphatidic acid binding; F:palmitoyl-(protein) hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:sulfatide binding; F:thiolester hydrolase activity;, P:brain development; P:fatty-acyl-CoA biosynthetic process; P:lipid catabolic process; P:lysosomal lumen acidification; P:membrane raft organization; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of neuron apoptotic process; P:nervous system development; P:neuron development; P:pinocytosis; P:positive regulation of pinocytosis; P:positive regulation of receptor-mediated endocytosis; P:protein catabolic process; P:protein depalmitoylation; P:protein transport; P:receptor-mediated endocytosis; P:regulation of synapse structure or activity; P:response to stimulus; P:sphingolipid catabolic process; P:visual perception;|P50897 B4DY24 Q6FGQ4,Palmitoyl-protein thioesterase 1,Palmitoyl-protein hydrolase 1;, , GO:0030424;GO:0005829;GO:0070062;GO:0005576;GO:0005794;GO:0043231;GO:0043202;GO:0005764;GO:0016020;GO:0045121;GO:0005634;GO:0008021;GO:0035727;GO:0008474;GO:0016290;GO:0120146;GO:0016790;GO:0007420;GO:0046949;GO:0016042;GO:0007042;GO:0031579;GO:0043066;GO:0030308;GO:0043524;GO:0007399;GO:0048666;GO:0006907;GO:0048549;GO:0048260;GO:0030163;GO:0002084;GO:0015031;GO:0006898;GO:0050803;GO:0050896;GO:0030149;GO:0007601;, C:axon; C:cytosol; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:membrane; C:membrane raft; C:nucleus; C:synaptic vesicle;, F:lysophosphatidic acid binding; F:palmitoyl-(protein) hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:sulfatide binding; F:thiolester hydrolase activity;, P:brain development; P:fatty-acyl-CoA biosynthetic process; P:lipid catabolic process; P:lysosomal lumen acidification; P:membrane raft organization; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of neuron apoptotic process; P:nervous system development; P:neuron development; P:pinocytosis; P:positive regulation of pinocytosis; P:positive regulation of receptor-mediated endocytosis; P:protein catabolic process; P:protein depalmitoylation; P:protein transport; P:receptor-mediated endocytosis; P:regulation of synapse structure or activity; P:response to stimulus; P:sphingolipid catabolic process; P:visual perception;|P50897 B4DY24 Q6FGQ4,Palmitoyl-protein thioesterase 1,Palmitoyl-protein hydrolase 1;, , GO:0030424;GO:0005829;GO:0070062;GO:0005576;GO:0005794;GO:0043231;GO:0043202;GO:0005764;GO:0016020;GO:0045121;GO:0005634;GO:0008021;GO:0035727;GO:0008474;GO:0016290;GO:0120146;GO:0016790;GO:0007420;GO:0046949;GO:0016042;GO:0007042;GO:0031579;GO:0043066;GO:0030308;GO:0043524;GO:0007399;GO:0048666;GO:0006907;GO:0048549;GO:0048260;GO:0030163;GO:0002084;GO:0015031;GO:0006898;GO:0050803;GO:0050896;GO:0030149;GO:0007601;, C:axon; C:cytosol; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:membrane; C:membrane raft; C:nucleus; C:synaptic vesicle;, F:lysophosphatidic acid binding; F:palmitoyl-(protein) hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:sulfatide binding; F:thiolester hydrolase activity;, P:brain development; P:fatty-acyl-CoA biosynthetic process; P:lipid catabolic process; P:lysosomal lumen acidification; P:membrane raft organization; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of neuron apoptotic process; P:nervous system development; P:neuron development; P:pinocytosis; P:positive regulation of pinocytosis; P:positive regulation of receptor-mediated endocytosis; P:protein catabolic process; P:protein depalmitoylation; P:protein transport; P:receptor-mediated endocytosis; P:regulation of synapse structure or activity; P:response to stimulus; P:sphingolipid catabolic process; P:visual perception; scaffold83 indexed_genome mRNA 6684762 6712886 . - . ID=transcript_12235;Q01518 Q53HR7 Q5T0S1 Q5T0S2 Q6I9U6,Adenylyl cyclase-associated protein 1,, PF08603;PF01213;, GO:0035578;GO:0030864;GO:0005737;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0003779;GO:0008179;GO:0030036;GO:0007190;GO:0001667;GO:0019933;GO:0000902;GO:0007163;GO:0043312;GO:0006898;GO:0045761;GO:0007165;, C:azurophil granule lumen; C:cortical actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane;, F:actin binding; F:adenylate cyclase binding;, P:actin cytoskeleton organization; P:activation of adenylate cyclase activity; P:ameboidal-type cell migration; P:cAMP-mediated signaling; P:cell morphogenesis; P:establishment or maintenance of cell polarity; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of adenylate cyclase activity; P:signal transduction;|Q01518 Q53HR7 Q5T0S1 Q5T0S2 Q6I9U6,Adenylyl cyclase-associated protein 1,, PF08603;PF01213;, GO:0035578;GO:0030864;GO:0005737;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0003779;GO:0008179;GO:0030036;GO:0007190;GO:0001667;GO:0019933;GO:0000902;GO:0007163;GO:0043312;GO:0006898;GO:0045761;GO:0007165;, C:azurophil granule lumen; C:cortical actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane;, F:actin binding; F:adenylate cyclase binding;, P:actin cytoskeleton organization; P:activation of adenylate cyclase activity; P:ameboidal-type cell migration; P:cAMP-mediated signaling; P:cell morphogenesis; P:establishment or maintenance of cell polarity; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of adenylate cyclase activity; P:signal transduction;|Q01518 Q53HR7 Q5T0S1 Q5T0S2 Q6I9U6,Adenylyl cyclase-associated protein 1,, PF08603;PF01213;, GO:0035578;GO:0030864;GO:0005737;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0003779;GO:0008179;GO:0030036;GO:0007190;GO:0001667;GO:0019933;GO:0000902;GO:0007163;GO:0043312;GO:0006898;GO:0045761;GO:0007165;, C:azurophil granule lumen; C:cortical actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane;, F:actin binding; F:adenylate cyclase binding;, P:actin cytoskeleton organization; P:activation of adenylate cyclase activity; P:ameboidal-type cell migration; P:cAMP-mediated signaling; P:cell morphogenesis; P:establishment or maintenance of cell polarity; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of adenylate cyclase activity; P:signal transduction;|Q01518 Q53HR7 Q5T0S1 Q5T0S2 Q6I9U6,Adenylyl cyclase-associated protein 1,, PF08603;PF01213;, GO:0035578;GO:0030864;GO:0005737;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0003779;GO:0008179;GO:0030036;GO:0007190;GO:0001667;GO:0019933;GO:0000902;GO:0007163;GO:0043312;GO:0006898;GO:0045761;GO:0007165;, C:azurophil granule lumen; C:cortical actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane;, F:actin binding; F:adenylate cyclase binding;, P:actin cytoskeleton organization; P:activation of adenylate cyclase activity; P:ameboidal-type cell migration; P:cAMP-mediated signaling; P:cell morphogenesis; P:establishment or maintenance of cell polarity; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of adenylate cyclase activity; P:signal transduction;|Q01518 Q53HR7 Q5T0S1 Q5T0S2 Q6I9U6,Adenylyl cyclase-associated protein 1,, PF08603;PF01213;, GO:0035578;GO:0030864;GO:0005737;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0003779;GO:0008179;GO:0030036;GO:0007190;GO:0001667;GO:0019933;GO:0000902;GO:0007163;GO:0043312;GO:0006898;GO:0045761;GO:0007165;, C:azurophil granule lumen; C:cortical actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane;, F:actin binding; F:adenylate cyclase binding;, P:actin cytoskeleton organization; P:activation of adenylate cyclase activity; P:ameboidal-type cell migration; P:cAMP-mediated signaling; P:cell morphogenesis; P:establishment or maintenance of cell polarity; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of adenylate cyclase activity; P:signal transduction; scaffold83 indexed_genome mRNA 6765353 6778070 . - . ID=transcript_12236;Q8NA29 A8K675 Q6UWU5 Q96F59 Q9BRC8,Sodium-dependent lysophosphatidylcholine symporter 1 {ECO:0000305},Major facilitator superfamily domain-containing protein 2A;, , GO:0005789;GO:0016021;GO:0005887;GO:0005886;GO:0015245;GO:0005324;GO:0140348;GO:0051978;GO:1901480;GO:0015293;GO:0007420;GO:0008643;GO:0009267;GO:0050890;GO:0097009;GO:0060856;GO:0015908;GO:0021766;GO:1990379;GO:0015909;GO:0140329;GO:0051977;GO:0035633;GO:0061744;GO:0031999;GO:0071702;GO:0006656;GO:0008594;GO:0035845;GO:0030307;GO:0010867;GO:0050773;GO:0040014;GO:0150011;GO:0150172;GO:0150175;GO:0150178;GO:0060042;GO:0003406;GO:0045056;GO:0150104;GO:0034379;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:fatty acid transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:lysophosphatidylcholine flippase activity; F:lysophospholipid:sodium symporter activity; F:oleate transmembrane transporter activity; F:symporter activity;, P:brain development; P:carbohydrate transport; P:cellular response to starvation; P:cognition; P:energy homeostasis; P:establishment of blood-brain barrier; P:fatty acid transport; P:hippocampus development; P:lipid transport across blood-brain barrier; P:long-chain fatty acid transport; P:lysophospholipid translocation; P:lysophospholipid transport; P:maintenance of blood-brain barrier; P:motor behavior; P:negative regulation of fatty acid beta-oxidation; P:organic substance transport; P:phosphatidylcholine biosynthetic process; P:photoreceptor cell morphogenesis; P:photoreceptor cell outer segment organization; P:positive regulation of cell growth; P:positive regulation of triglyceride biosynthetic process; P:regulation of dendrite development; P:regulation of multicellular organism growth; P:regulation of neuron projection arborization; P:regulation of phosphatidylcholine metabolic process; P:regulation of phosphatidylethanolamine metabolic process; P:regulation of phosphatidylserine metabolic process; P:retina morphogenesis in camera-type eye; P:retinal pigment epithelium development; P:transcytosis; P:transport across blood-brain barrier; P:very-low-density lipoprotein particle assembly; scaffold83 indexed_genome mRNA 6821201 6827498 . + . ID=transcript_12237;P12524 A2A2C9 B4DJH2 Q14897 Q5QPL0 Q5QPL1 Q9NUE9,Protein L-Myc,Class E basic helix-loop-helix protein 38;Protein L-Myc-1;V-myc myelocytomatosis viral oncogene homolog;, PF00010;PF01056;, GO:0000785;GO:0005694;GO:0005654;GO:0003677;GO:0000981;GO:0046983;GO:0000978;GO:0045607;GO:0006357;, C:chromatin; C:chromosome; C:nucleoplasm;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of inner ear auditory receptor cell differentiation; P:regulation of transcription by RNA polymerase II;|P12524 A2A2C9 B4DJH2 Q14897 Q5QPL0 Q5QPL1 Q9NUE9,Protein L-Myc,Class E basic helix-loop-helix protein 38;Protein L-Myc-1;V-myc myelocytomatosis viral oncogene homolog;, PF00010;PF01056;, GO:0000785;GO:0005694;GO:0005654;GO:0003677;GO:0000981;GO:0046983;GO:0000978;GO:0045607;GO:0006357;, C:chromatin; C:chromosome; C:nucleoplasm;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of inner ear auditory receptor cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold83 indexed_genome mRNA 6839604 6879896 . + . ID=transcript_12238;Q9H3H1 A1A4X7 Q3T7B5 Q5QPK5 Q5QPK6 Q6IAC9 Q96FJ3 Q96L45 Q9NXT7,tRNA dimethylallyltransferase,Isopentenyl-diphosphate:tRNA isopentenyltransferase;hGRO1;tRNA isopentenyltransferase 1;, PF12171;, GO:0005759;GO:0005739;GO:0005524;GO:0003676;GO:0052381;GO:0008270;GO:0070900;GO:0006400;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:nucleic acid binding; F:tRNA dimethylallyltransferase activity; F:zinc ion binding;, P:mitochondrial tRNA modification; P:tRNA modification;|Q9H3H1 A1A4X7 Q3T7B5 Q5QPK5 Q5QPK6 Q6IAC9 Q96FJ3 Q96L45 Q9NXT7,tRNA dimethylallyltransferase,Isopentenyl-diphosphate:tRNA isopentenyltransferase;hGRO1;tRNA isopentenyltransferase 1;, PF12171;, GO:0005759;GO:0005739;GO:0005524;GO:0003676;GO:0052381;GO:0008270;GO:0070900;GO:0006400;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:nucleic acid binding; F:tRNA dimethylallyltransferase activity; F:zinc ion binding;, P:mitochondrial tRNA modification; P:tRNA modification;|Q9H3H1 A1A4X7 Q3T7B5 Q5QPK5 Q5QPK6 Q6IAC9 Q96FJ3 Q96L45 Q9NXT7,tRNA dimethylallyltransferase,Isopentenyl-diphosphate:tRNA isopentenyltransferase;hGRO1;tRNA isopentenyltransferase 1;, PF12171;, GO:0005759;GO:0005739;GO:0005524;GO:0003676;GO:0052381;GO:0008270;GO:0070900;GO:0006400;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:nucleic acid binding; F:tRNA dimethylallyltransferase activity; F:zinc ion binding;, P:mitochondrial tRNA modification; P:tRNA modification;|Q9H3H1 A1A4X7 Q3T7B5 Q5QPK5 Q5QPK6 Q6IAC9 Q96FJ3 Q96L45 Q9NXT7,tRNA dimethylallyltransferase,Isopentenyl-diphosphate:tRNA isopentenyltransferase;hGRO1;tRNA isopentenyltransferase 1;, PF12171;, GO:0005759;GO:0005739;GO:0005524;GO:0003676;GO:0052381;GO:0008270;GO:0070900;GO:0006400;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:nucleic acid binding; F:tRNA dimethylallyltransferase activity; F:zinc ion binding;, P:mitochondrial tRNA modification; P:tRNA modification;|Q9H3H1 A1A4X7 Q3T7B5 Q5QPK5 Q5QPK6 Q6IAC9 Q96FJ3 Q96L45 Q9NXT7,tRNA dimethylallyltransferase,Isopentenyl-diphosphate:tRNA isopentenyltransferase;hGRO1;tRNA isopentenyltransferase 1;, PF12171;, GO:0005759;GO:0005739;GO:0005524;GO:0003676;GO:0052381;GO:0008270;GO:0070900;GO:0006400;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:nucleic acid binding; F:tRNA dimethylallyltransferase activity; F:zinc ion binding;, P:mitochondrial tRNA modification; P:tRNA modification;|Q9H3H1 A1A4X7 Q3T7B5 Q5QPK5 Q5QPK6 Q6IAC9 Q96FJ3 Q96L45 Q9NXT7,tRNA dimethylallyltransferase,Isopentenyl-diphosphate:tRNA isopentenyltransferase;hGRO1;tRNA isopentenyltransferase 1;, PF12171;, GO:0005759;GO:0005739;GO:0005524;GO:0003676;GO:0052381;GO:0008270;GO:0070900;GO:0006400;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:nucleic acid binding; F:tRNA dimethylallyltransferase activity; F:zinc ion binding;, P:mitochondrial tRNA modification; P:tRNA modification;|Q9H3H1 A1A4X7 Q3T7B5 Q5QPK5 Q5QPK6 Q6IAC9 Q96FJ3 Q96L45 Q9NXT7,tRNA dimethylallyltransferase,Isopentenyl-diphosphate:tRNA isopentenyltransferase;hGRO1;tRNA isopentenyltransferase 1;, PF12171;, GO:0005759;GO:0005739;GO:0005524;GO:0003676;GO:0052381;GO:0008270;GO:0070900;GO:0006400;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:nucleic acid binding; F:tRNA dimethylallyltransferase activity; F:zinc ion binding;, P:mitochondrial tRNA modification; P:tRNA modification; scaffold84 indexed_genome mRNA 6021 24582 . - . ID=transcript_12239;Q7Z2Z2 A6NKY5 B7Z6I0 Q9H8Z6,Elongation factor-like GTPase 1,Elongation factor Tu GTP-binding domain-containing protein 1;Elongation factor-like 1;Protein FAM42A;, PF00679;PF14492;PF00009;, GO:1990904;GO:0005525;GO:0003924;GO:0043022;GO:0003746;GO:0046039;GO:0042256;, C:ribonucleoprotein complex;, F:GTP binding; F:GTPase activity; F:ribosome binding; F:translation elongation factor activity;, P:GTP metabolic process; P:mature ribosome assembly;|Q7Z2Z2 A6NKY5 B7Z6I0 Q9H8Z6,Elongation factor-like GTPase 1,Elongation factor Tu GTP-binding domain-containing protein 1;Elongation factor-like 1;Protein FAM42A;, PF00679;PF14492;PF00009;, GO:1990904;GO:0005525;GO:0003924;GO:0043022;GO:0003746;GO:0046039;GO:0042256;, C:ribonucleoprotein complex;, F:GTP binding; F:GTPase activity; F:ribosome binding; F:translation elongation factor activity;, P:GTP metabolic process; P:mature ribosome assembly;|Q7Z2Z2 A6NKY5 B7Z6I0 Q9H8Z6,Elongation factor-like GTPase 1,Elongation factor Tu GTP-binding domain-containing protein 1;Elongation factor-like 1;Protein FAM42A;, PF00679;PF14492;PF00009;, GO:1990904;GO:0005525;GO:0003924;GO:0043022;GO:0003746;GO:0046039;GO:0042256;, C:ribonucleoprotein complex;, F:GTP binding; F:GTPase activity; F:ribosome binding; F:translation elongation factor activity;, P:GTP metabolic process; P:mature ribosome assembly; scaffold84 indexed_genome mRNA 161421 230766 . + . ID=transcript_12240;Q9Y2A7 O60329 Q53QN5 Q53S94 Q53Y35,Nck-associated protein 1,Membrane-associated protein HEM-2;p125Nap1;, PF09735;, GO:0005829;GO:0070062;GO:0031941;GO:0005925;GO:0016021;GO:0030027;GO:0031258;GO:0001726;GO:0031209;GO:0006915;GO:0016477;GO:0000902;GO:0030031;GO:0007417;GO:0030866;GO:0038096;GO:0048812;GO:0030838;GO:2000601;GO:0010592;GO:0016601;GO:0048010;GO:0016032;, C:cytosol; C:extracellular exosome; C:filamentous actin; C:focal adhesion; C:integral component of membrane; C:lamellipodium; C:lamellipodium membrane; C:ruffle; C:SCAR complex;, , P:apoptotic process; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:central nervous system development; P:cortical actin cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:Rac protein signal transduction; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|Q9Y2A7 O60329 Q53QN5 Q53S94 Q53Y35,Nck-associated protein 1,Membrane-associated protein HEM-2;p125Nap1;, PF09735;, GO:0005829;GO:0070062;GO:0031941;GO:0005925;GO:0016021;GO:0030027;GO:0031258;GO:0001726;GO:0031209;GO:0006915;GO:0016477;GO:0000902;GO:0030031;GO:0007417;GO:0030866;GO:0038096;GO:0048812;GO:0030838;GO:2000601;GO:0010592;GO:0016601;GO:0048010;GO:0016032;, C:cytosol; C:extracellular exosome; C:filamentous actin; C:focal adhesion; C:integral component of membrane; C:lamellipodium; C:lamellipodium membrane; C:ruffle; C:SCAR complex;, , P:apoptotic process; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:central nervous system development; P:cortical actin cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:Rac protein signal transduction; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|Q9Y2A7 O60329 Q53QN5 Q53S94 Q53Y35,Nck-associated protein 1,Membrane-associated protein HEM-2;p125Nap1;, PF09735;, GO:0005829;GO:0070062;GO:0031941;GO:0005925;GO:0016021;GO:0030027;GO:0031258;GO:0001726;GO:0031209;GO:0006915;GO:0016477;GO:0000902;GO:0030031;GO:0007417;GO:0030866;GO:0038096;GO:0048812;GO:0030838;GO:2000601;GO:0010592;GO:0016601;GO:0048010;GO:0016032;, C:cytosol; C:extracellular exosome; C:filamentous actin; C:focal adhesion; C:integral component of membrane; C:lamellipodium; C:lamellipodium membrane; C:ruffle; C:SCAR complex;, , P:apoptotic process; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:central nervous system development; P:cortical actin cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:Rac protein signal transduction; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|Q9Y2A7 O60329 Q53QN5 Q53S94 Q53Y35,Nck-associated protein 1,Membrane-associated protein HEM-2;p125Nap1;, PF09735;, GO:0005829;GO:0070062;GO:0031941;GO:0005925;GO:0016021;GO:0030027;GO:0031258;GO:0001726;GO:0031209;GO:0006915;GO:0016477;GO:0000902;GO:0030031;GO:0007417;GO:0030866;GO:0038096;GO:0048812;GO:0030838;GO:2000601;GO:0010592;GO:0016601;GO:0048010;GO:0016032;, C:cytosol; C:extracellular exosome; C:filamentous actin; C:focal adhesion; C:integral component of membrane; C:lamellipodium; C:lamellipodium membrane; C:ruffle; C:SCAR complex;, , P:apoptotic process; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:central nervous system development; P:cortical actin cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:Rac protein signal transduction; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|Q9Y2A7 O60329 Q53QN5 Q53S94 Q53Y35,Nck-associated protein 1,Membrane-associated protein HEM-2;p125Nap1;, PF09735;, GO:0005829;GO:0070062;GO:0031941;GO:0005925;GO:0016021;GO:0030027;GO:0031258;GO:0001726;GO:0031209;GO:0006915;GO:0016477;GO:0000902;GO:0030031;GO:0007417;GO:0030866;GO:0038096;GO:0048812;GO:0030838;GO:2000601;GO:0010592;GO:0016601;GO:0048010;GO:0016032;, C:cytosol; C:extracellular exosome; C:filamentous actin; C:focal adhesion; C:integral component of membrane; C:lamellipodium; C:lamellipodium membrane; C:ruffle; C:SCAR complex;, , P:apoptotic process; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:central nervous system development; P:cortical actin cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:Rac protein signal transduction; P:vascular endothelial growth factor receptor signaling pathway; P:viral process;|Q9Y2A7 O60329 Q53QN5 Q53S94 Q53Y35,Nck-associated protein 1,Membrane-associated protein HEM-2;p125Nap1;, PF09735;, GO:0005829;GO:0070062;GO:0031941;GO:0005925;GO:0016021;GO:0030027;GO:0031258;GO:0001726;GO:0031209;GO:0006915;GO:0016477;GO:0000902;GO:0030031;GO:0007417;GO:0030866;GO:0038096;GO:0048812;GO:0030838;GO:2000601;GO:0010592;GO:0016601;GO:0048010;GO:0016032;, C:cytosol; C:extracellular exosome; C:filamentous actin; C:focal adhesion; C:integral component of membrane; C:lamellipodium; C:lamellipodium membrane; C:ruffle; C:SCAR complex;, , P:apoptotic process; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:central nervous system development; P:cortical actin cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:Rac protein signal transduction; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; scaffold84 indexed_genome mRNA 278067 311140 . + . ID=transcript_12241;Q92765 O00181 Q99686,Secreted frizzled-related protein 3,Frezzled;Fritz;Frizzled-related protein 1;FrzB-1;, PF01392;PF01759;, GO:0005737;GO:0005615;GO:0016020;GO:0017147;GO:0060070;GO:0090103;GO:0060029;GO:0090090;GO:0061037;GO:0010721;GO:0030308;GO:0008285;GO:0070367;GO:0030178;GO:0014033;GO:0043065;GO:0045600;GO:0001501;GO:0061053;, C:cytoplasm; C:extracellular space; C:membrane;, F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:cochlea morphogenesis; P:convergent extension involved in organogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cartilage development; P:negative regulation of cell development; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of hepatocyte differentiation; P:negative regulation of Wnt signaling pathway; P:neural crest cell differentiation; P:positive regulation of apoptotic process; P:positive regulation of fat cell differentiation; P:skeletal system development; P:somite development; scaffold84 indexed_genome mRNA 372021 427830 . - . ID=transcript_12242;Q96K38 Q96K44 Q96K54 Q9NSY6,DnaJ homolog subfamily C member 10,Endoplasmic reticulum DNA J domain-containing protein 5;Macrothioredoxin;, PF00226;PF00085;, GO:0005783;GO:0034663;GO:0005788;GO:0016020;GO:0001671;GO:0051117;GO:0051087;GO:0015036;GO:0030544;GO:0051787;GO:0016671;GO:0015035;GO:0070059;GO:0001933;GO:0032781;GO:0034975;GO:0034976;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:membrane;, F:ATPase activator activity; F:ATPase binding; F:chaperone binding; F:disulfide oxidoreductase activity; F:Hsp70 protein binding; F:misfolded protein binding; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide oxidoreductase activity;, P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of protein phosphorylation; P:positive regulation of ATPase activity; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent ERAD pathway;|Q96K38 Q96K44 Q96K54 Q9NSY6,DnaJ homolog subfamily C member 10,Endoplasmic reticulum DNA J domain-containing protein 5;Macrothioredoxin;, PF00226;PF00085;, GO:0005783;GO:0034663;GO:0005788;GO:0016020;GO:0001671;GO:0051117;GO:0051087;GO:0015036;GO:0030544;GO:0051787;GO:0016671;GO:0015035;GO:0070059;GO:0001933;GO:0032781;GO:0034975;GO:0034976;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:membrane;, F:ATPase activator activity; F:ATPase binding; F:chaperone binding; F:disulfide oxidoreductase activity; F:Hsp70 protein binding; F:misfolded protein binding; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide oxidoreductase activity;, P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of protein phosphorylation; P:positive regulation of ATPase activity; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent ERAD pathway;|Q96K38 Q96K44 Q96K54 Q9NSY6,DnaJ homolog subfamily C member 10,Endoplasmic reticulum DNA J domain-containing protein 5;Macrothioredoxin;, PF00226;PF00085;, GO:0005783;GO:0034663;GO:0005788;GO:0016020;GO:0001671;GO:0051117;GO:0051087;GO:0015036;GO:0030544;GO:0051787;GO:0016671;GO:0015035;GO:0070059;GO:0001933;GO:0032781;GO:0034975;GO:0034976;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:membrane;, F:ATPase activator activity; F:ATPase binding; F:chaperone binding; F:disulfide oxidoreductase activity; F:Hsp70 protein binding; F:misfolded protein binding; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:protein disulfide oxidoreductase activity;, P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of protein phosphorylation; P:positive regulation of ATPase activity; P:protein folding in endoplasmic reticulum; P:response to endoplasmic reticulum stress; P:ubiquitin-dependent ERAD pathway; scaffold84 indexed_genome mRNA 739502 976948 . + . ID=transcript_12243;Q9C0L4 Q9UFX3,Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A,61 kDa Cam-PDE;hCam-1;, PF00233;PF08499;, GO:0005829;GO:0043025;GO:0005634;GO:0004114;GO:0048101;GO:0005516;GO:0004117;GO:0046872;GO:0046069;GO:0007186;GO:0034391;GO:0048660;GO:0007165;, C:cytosol; C:neuronal cell body; C:nucleus;, F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; F:calmodulin binding; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cGMP catabolic process; P:G protein-coupled receptor signaling pathway; P:regulation of smooth muscle cell apoptotic process; P:regulation of smooth muscle cell proliferation; P:signal transduction;|Q9C0L4 Q9UFX3,Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A,61 kDa Cam-PDE;hCam-1;, PF00233;PF08499;, GO:0005829;GO:0043025;GO:0005634;GO:0004114;GO:0048101;GO:0005516;GO:0004117;GO:0046872;GO:0046069;GO:0007186;GO:0034391;GO:0048660;GO:0007165;, C:cytosol; C:neuronal cell body; C:nucleus;, F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; F:calmodulin binding; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cGMP catabolic process; P:G protein-coupled receptor signaling pathway; P:regulation of smooth muscle cell apoptotic process; P:regulation of smooth muscle cell proliferation; P:signal transduction; scaffold84 indexed_genome mRNA 1226383 1239835 . + . ID=transcript_12244;Q96PW1,Protein ITPRID2 {ECO:0000305},Cleavage signal-1 protein {ECO:0000303|PubMed:1555770};ITPR-interacting domain-containing protein 2 {ECO:0000305};Ki-ras-induced actin-interacting protein {ECO:0000303|PubMed:14673706};Sperm-specific antigen 2;, PF14722;PF14723;, GO:0005829;GO:0005654;GO:0005886;GO:0051015;GO:0005102;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:actin filament binding; F:signaling receptor binding;|Q96PW1,Protein ITPRID2 {ECO:0000305},Cleavage signal-1 protein {ECO:0000303|PubMed:1555770};ITPR-interacting domain-containing protein 2 {ECO:0000305};Ki-ras-induced actin-interacting protein {ECO:0000303|PubMed:14673706};Sperm-specific antigen 2;, PF14722;PF14723;, GO:0005829;GO:0005654;GO:0005886;GO:0051015;GO:0005102;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:actin filament binding; F:signaling receptor binding;|Q96PW1,Protein ITPRID2 {ECO:0000305},Cleavage signal-1 protein {ECO:0000303|PubMed:1555770};ITPR-interacting domain-containing protein 2 {ECO:0000305};Ki-ras-induced actin-interacting protein {ECO:0000303|PubMed:14673706};Sperm-specific antigen 2;, PF14722;PF14723;, GO:0005829;GO:0005654;GO:0005886;GO:0051015;GO:0005102;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:actin filament binding; F:signaling receptor binding; scaffold84 indexed_genome mRNA 1240023 1260949 . - . ID=transcript_12245;Q96PW1,Protein ITPRID2 {ECO:0000305},Cleavage signal-1 protein {ECO:0000303|PubMed:1555770};ITPR-interacting domain-containing protein 2 {ECO:0000305};Ki-ras-induced actin-interacting protein {ECO:0000303|PubMed:14673706};Sperm-specific antigen 2;, PF14722;PF14723;, GO:0005829;GO:0005654;GO:0005886;GO:0051015;GO:0005102;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:actin filament binding; F:signaling receptor binding;|Q96PW1,Protein ITPRID2 {ECO:0000305},Cleavage signal-1 protein {ECO:0000303|PubMed:1555770};ITPR-interacting domain-containing protein 2 {ECO:0000305};Ki-ras-induced actin-interacting protein {ECO:0000303|PubMed:14673706};Sperm-specific antigen 2;, PF14722;PF14723;, GO:0005829;GO:0005654;GO:0005886;GO:0051015;GO:0005102;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:actin filament binding; F:signaling receptor binding;|Q96PW1,Protein ITPRID2 {ECO:0000305},Cleavage signal-1 protein {ECO:0000303|PubMed:1555770};ITPR-interacting domain-containing protein 2 {ECO:0000305};Ki-ras-induced actin-interacting protein {ECO:0000303|PubMed:14673706};Sperm-specific antigen 2;, PF14722;PF14723;, GO:0005829;GO:0005654;GO:0005886;GO:0051015;GO:0005102;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:actin filament binding; F:signaling receptor binding; scaffold84 indexed_genome mRNA 1480059 1484074 . - . ID=transcript_12246;Q13562 B2R9I8 F1T0E1 O00343 Q13340 Q5U095 Q96TH0 Q99455 Q9UEC8,Neurogenic differentiation factor 1,Class A basic helix-loop-helix protein 3;, PF00010;PF12533;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0090575;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0046982;GO:0001102;GO:0000978;GO:1990837;GO:0008134;GO:0035881;GO:0009952;GO:0071333;GO:0021549;GO:0021542;GO:0048562;GO:0031018;GO:0035883;GO:0042593;GO:0048839;GO:0030073;GO:0046426;GO:2000675;GO:0022008;GO:0048666;GO:0030182;GO:0007263;GO:0006913;GO:0003326;GO:0003329;GO:0043065;GO:0045597;GO:0051091;GO:0045666;GO:0045944;GO:2000679;GO:0045893;GO:0071156;GO:0050796;GO:0060730;GO:0006357;GO:0042493;GO:0009749;GO:0023019;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:protein heterodimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:amacrine cell differentiation; P:anterior/posterior pattern specification; P:cellular response to glucose stimulus; P:cerebellum development; P:dentate gyrus development; P:embryonic organ morphogenesis; P:endocrine pancreas development; P:enteroendocrine cell differentiation; P:glucose homeostasis; P:inner ear development; P:insulin secretion; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of type B pancreatic cell apoptotic process; P:neurogenesis; P:neuron development; P:neuron differentiation; P:nitric oxide mediated signal transduction; P:nucleocytoplasmic transport; P:pancreatic A cell fate commitment; P:pancreatic PP cell fate commitment; P:positive regulation of apoptotic process; P:positive regulation of cell differentiation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated; P:regulation of cell cycle arrest; P:regulation of insulin secretion; P:regulation of intestinal epithelial structure maintenance; P:regulation of transcription by RNA polymerase II; P:response to drug; P:response to glucose; P:signal transduction involved in regulation of gene expression; scaffold84 indexed_genome mRNA 1502736 1620115 . + . ID=transcript_12247;Q5DVJ5 Q6UZF6 Q6ZP59,Ceramide kinase-like protein,, PF00781;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005730;GO:0005654;GO:0048471;GO:0001917;GO:0001750;GO:0001727;GO:0003951;GO:0046625;GO:0043066;GO:0016310;GO:0030148;GO:0006665;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment;, F:lipid kinase activity; F:NAD+ kinase activity; F:sphingolipid binding;, P:negative regulation of apoptotic process; P:phosphorylation; P:sphingolipid biosynthetic process; P:sphingolipid metabolic process; scaffold84 indexed_genome mRNA 1620151 1635543 . + . ID=transcript_12248;Q5DVJ5 Q6UZF6 Q6ZP59,Ceramide kinase-like protein,, PF00781;, GO:0005737;GO:0005829;GO:0005783;GO:0005794;GO:0005730;GO:0005654;GO:0048471;GO:0001917;GO:0001750;GO:0001727;GO:0003951;GO:0046625;GO:0043066;GO:0016310;GO:0030148;GO:0006665;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment;, F:lipid kinase activity; F:NAD+ kinase activity; F:sphingolipid binding;, P:negative regulation of apoptotic process; P:phosphorylation; P:sphingolipid biosynthetic process; P:sphingolipid metabolic process;|P13612 D3DPG4 Q7Z4L6,Integrin alpha-4,CD49 antigen-like family member D;Integrin alpha-IV;VLA-4 subunit alpha;, PF01839;PF08441;, GO:0009986;GO:0070062;GO:0005925;GO:0030426;GO:0034668;GO:0034669;GO:0016020;GO:0043025;GO:0005886;GO:0050839;GO:0015026;GO:0001968;GO:0005178;GO:0046872;GO:1990405;GO:0060385;GO:0030183;GO:0140039;GO:0033631;GO:0007160;GO:0003366;GO:1904646;GO:0071345;GO:1990771;GO:0050904;GO:0035987;GO:0030198;GO:0034113;GO:0098657;GO:0007229;GO:0007159;GO:0050900;GO:0050901;GO:0090074;GO:1990138;GO:2000353;GO:1903238;GO:2000406;GO:1905564;GO:0043113;GO:0050776;GO:0034446;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:growth cone; C:integrin alpha4-beta1 complex; C:integrin alpha4-beta7 complex; C:membrane; C:neuronal cell body; C:plasma membrane;, F:cell adhesion molecule binding; F:coreceptor activity; F:fibronectin binding; F:integrin binding; F:metal ion binding; F:protein antigen binding;, P:axonogenesis involved in innervation; P:B cell differentiation; P:cell-cell adhesion in response to extracellular stimulus; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cell-matrix adhesion involved in ameboidal cell migration; P:cellular response to amyloid-beta; P:cellular response to cytokine stimulus; P:clathrin-dependent extracellular exosome endocytosis; P:diapedesis; P:endodermal cell differentiation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:import into cell; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:leukocyte tethering or rolling; P:negative regulation of protein homodimerization activity; P:neuron projection extension; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of leukocyte tethering or rolling; P:positive regulation of T cell migration; P:positive regulation of vascular endothelial cell proliferation; P:receptor clustering; P:regulation of immune response; P:substrate adhesion-dependent cell spreading; scaffold84 indexed_genome mRNA 3148339 3212008 . + . ID=transcript_12249;Q9HCG8 Q05DC2 Q4G135 Q52LF0 Q6PEX2 Q7Z6I0 Q9H5L3 Q9H6Q6,Pre-mRNA-splicing factor CWC22 homolog,Nucampholin homolog;fSAPb;, PF02847;, GO:0071013;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071006;GO:0071007;GO:0071005;GO:0003723;GO:0000398;GO:0048024;, C:catalytic step 2 spliceosome; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 1 spliceosome; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; scaffold84 indexed_genome mRNA 3726675 3730094 . + . ID=transcript_12250;Q569K4 Q49A04 Q6ZMZ7 Q8IY01 Q8N8H2 Q96DK4,Zinc finger protein 385B,Zinc finger protein 533;, , GO:0005634;GO:0003676;GO:0002039;GO:0008270;GO:0072332;, C:nucleus;, F:nucleic acid binding; F:p53 binding; F:zinc ion binding;, P:intrinsic apoptotic signaling pathway by p53 class mediator; scaffold84 indexed_genome mRNA 3983308 4027103 . + . ID=transcript_12251;Q86VW0 Q53R38 Q53SP3 Q5GM69 Q8N6M1 Q96LQ2,SEC14 domain and spectrin repeat-containing protein 1,Huntingtin-interacting protein-like protein;Protein Solo;, PF13716;, GO:0045111;GO:0070300;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1904878;, C:intermediate filament cytoskeleton;, F:phosphatidic acid binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;|Q86VW0 Q53R38 Q53SP3 Q5GM69 Q8N6M1 Q96LQ2,SEC14 domain and spectrin repeat-containing protein 1,Huntingtin-interacting protein-like protein;Protein Solo;, PF13716;, GO:0045111;GO:0070300;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1904878;, C:intermediate filament cytoskeleton;, F:phosphatidic acid binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;|Q86VW0 Q53R38 Q53SP3 Q5GM69 Q8N6M1 Q96LQ2,SEC14 domain and spectrin repeat-containing protein 1,Huntingtin-interacting protein-like protein;Protein Solo;, PF13716;, GO:0045111;GO:0070300;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1904878;, C:intermediate filament cytoskeleton;, F:phosphatidic acid binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;|Q86VW0 Q53R38 Q53SP3 Q5GM69 Q8N6M1 Q96LQ2,SEC14 domain and spectrin repeat-containing protein 1,Huntingtin-interacting protein-like protein;Protein Solo;, PF13716;, GO:0045111;GO:0070300;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1904878;, C:intermediate filament cytoskeleton;, F:phosphatidic acid binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;|Q86VW0 Q53R38 Q53SP3 Q5GM69 Q8N6M1 Q96LQ2,SEC14 domain and spectrin repeat-containing protein 1,Huntingtin-interacting protein-like protein;Protein Solo;, PF13716;, GO:0045111;GO:0070300;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1904878;, C:intermediate filament cytoskeleton;, F:phosphatidic acid binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;|Q86VW0 Q53R38 Q53SP3 Q5GM69 Q8N6M1 Q96LQ2,SEC14 domain and spectrin repeat-containing protein 1,Huntingtin-interacting protein-like protein;Protein Solo;, PF13716;, GO:0045111;GO:0070300;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:1904878;, C:intermediate filament cytoskeleton;, F:phosphatidic acid binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; scaffold84 indexed_genome mRNA 4058362 4272106 . + . ID=transcript_12252;Q6ZP82 H7C0P1 J3KNW6 Q8N8H3,Coiled-coil domain-containing protein 141,Coiled-coil protein associated with myosin II and DISC1 {ECO:0000303|PubMed:20956536};, , GO:0005813;GO:0005737;GO:0043005;GO:0051642;GO:0021799;, C:centrosome; C:cytoplasm; C:neuron projection;, , P:centrosome localization; P:cerebral cortex radially oriented cell migration; scaffold84 indexed_genome mRNA 4308532 4390009 . + . ID=transcript_12253;Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q15772 A8K0G6 A8MRU0 Q27J74 Q695L1 Q6FGA6 Q6ZQW1 Q6ZTL8 Q9P2P9,Striated muscle preferentially expressed protein kinase,Aortic preferentially expressed protein 1;, PF07679;PF00069;, GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0106311;GO:0042692;GO:0007517;GO:0008285;, C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:muscle cell differentiation; P:muscle organ development; P:negative regulation of cell population proliferation;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction; scaffold84 indexed_genome mRNA 4390143 4438024 . + . ID=transcript_12254;Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction; scaffold84 indexed_genome mRNA 4442922 4523993 . + . ID=transcript_12255;Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction; scaffold84 indexed_genome mRNA 4524033 4626681 . - . ID=transcript_12256;Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q9UD97 Q9UP84 Q9Y6L9,Titin,Connectin;Rhabdomyosarcoma antigen MU-RMS-40.14;, PF00041;PF07679;PF00069;PF02818;PF18362;PF09042;, GO:0000794;GO:0005829;GO:0070062;GO:0005576;GO:0031674;GO:0031430;GO:0005865;GO:0030018;GO:0051015;GO:0042805;GO:0005524;GO:0005509;GO:0005516;GO:0019899;GO:0042802;GO:0051371;GO:0002020;GO:0019901;GO:0043621;GO:0106310;GO:0004674;GO:0106311;GO:0004713;GO:0008307;GO:0097493;GO:0031433;GO:0060048;GO:0048739;GO:0003300;GO:0055008;GO:0055003;GO:0035995;GO:0007076;GO:0006936;GO:0030049;GO:0002576;GO:0010628;GO:0050714;GO:0010737;GO:0050790;GO:0045859;GO:0051592;GO:0045214;GO:0048769;GO:0030241;GO:0030240;GO:0006941;, C:condensed nuclear chromosome; C:cytosol; C:extracellular exosome; C:extracellular region; C:I band; C:M band; C:striated muscle thin filament; C:Z disc;, F:actin filament binding; F:actinin binding; F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:enzyme binding; F:identical protein binding; F:muscle alpha-actinin binding; F:protease binding; F:protein kinase binding; F:protein self-association; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity; F:structural constituent of muscle; F:structural molecule activity conferring elasticity; F:telethonin binding;, P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy; P:cardiac muscle tissue morphogenesis; P:cardiac myofibril assembly; P:detection of muscle stretch; P:mitotic chromosome condensation; P:muscle contraction; P:muscle filament sliding; P:platelet degranulation; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein kinase A signaling; P:regulation of catalytic activity; P:regulation of protein kinase activity; P:response to calcium ion; P:sarcomere organization; P:sarcomerogenesis; P:skeletal muscle myosin thick filament assembly; P:skeletal muscle thin filament assembly; P:striated muscle contraction;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold84 indexed_genome mRNA 4626713 4652183 . - . ID=transcript_12257;Q9HB20 Q4ZG69 Q86TQ1 Q9NXT3,Pleckstrin homology domain-containing family A member 3,Phosphatidylinositol-four-phosphate adapter protein 1 {ECO:0000303|PubMed:30659099};, PF00169;, GO:0005829;GO:0005794;GO:0000139;GO:0016020;GO:1902387;GO:1902388;GO:0042802;GO:0070273;GO:0035627;GO:0120009;GO:0006661;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:membrane;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity; F:identical protein binding; F:phosphatidylinositol-4-phosphate binding;, P:ceramide transport; P:intermembrane lipid transfer; P:phosphatidylinositol biosynthetic process; scaffold84 indexed_genome mRNA 4655395 4664517 . + . ID=transcript_12258;Q9Y680 Q4ZG70 Q6V3B2 Q86U65 Q96DA4 Q9Y6B0,Peptidyl-prolyl cis-trans isomerase FKBP7,23 kDa FK506-binding protein;FK506-binding protein 7;Rotamase;, PF13499;PF00254;, GO:0005783;GO:0005788;GO:0005509;GO:0005528;GO:0003755;GO:0018208;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:calcium ion binding; F:FK506 binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:peptidyl-proline modification;|Q9Y680 Q4ZG70 Q6V3B2 Q86U65 Q96DA4 Q9Y6B0,Peptidyl-prolyl cis-trans isomerase FKBP7,23 kDa FK506-binding protein;FK506-binding protein 7;Rotamase;, PF13499;PF00254;, GO:0005783;GO:0005788;GO:0005509;GO:0005528;GO:0003755;GO:0018208;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen;, F:calcium ion binding; F:FK506 binding; F:peptidyl-prolyl cis-trans isomerase activity;, P:peptidyl-proline modification; scaffold84 indexed_genome mRNA 4665908 4672368 . - . ID=transcript_12259;Q0ZLH3 A0PK14 B9EJE2,Pejvakin {ECO:0000303|PubMed:16804542},Autosomal recessive deafness type 59 protein;, PF04598;, GO:0035253;GO:0030864;GO:0005737;GO:0043025;GO:0005778;GO:0120044;GO:0050910;GO:0000425;GO:0097468;GO:1900063;GO:0000302;GO:0007605;GO:0120045;, C:ciliary rootlet; C:cortical actin cytoskeleton; C:cytoplasm; C:neuronal cell body; C:peroxisomal membrane; C:stereocilium base;, , P:detection of mechanical stimulus involved in sensory perception of sound; P:pexophagy; P:programmed cell death in response to reactive oxygen species; P:regulation of peroxisome organization; P:response to reactive oxygen species; P:sensory perception of sound; P:stereocilium maintenance; scaffold84 indexed_genome mRNA 4675132 4690664 . + . ID=transcript_12260;O75569 A8K3I6 Q53G24 Q6X7T5 Q8NDK4,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,PKR-associated protein X;PKR-associating protein X;Protein activator of the interferon-induced protein kinase;Protein kinase, interferon-inducible double-stranded RNA-dependent activator;, PF00035;PF16482;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0048471;GO:0070578;GO:0003725;GO:0008047;GO:0019899;GO:0042802;GO:0070883;GO:0042803;GO:0003723;GO:0034599;GO:0006955;GO:0042474;GO:0010586;GO:0008285;GO:0042473;GO:2001244;GO:0031054;GO:0035196;GO:0030422;GO:0006468;GO:0050821;GO:0009615;GO:0048705;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:RISC-loading complex;, F:double-stranded RNA binding; F:enzyme activator activity; F:enzyme binding; F:identical protein binding; F:pre-miRNA binding; F:protein homodimerization activity; F:RNA binding;, P:cellular response to oxidative stress; P:immune response; P:middle ear morphogenesis; P:miRNA metabolic process; P:negative regulation of cell population proliferation; P:outer ear morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:protein phosphorylation; P:protein stabilization; P:response to virus; P:skeletal system morphogenesis; P:viral process;|O75569 A8K3I6 Q53G24 Q6X7T5 Q8NDK4,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,PKR-associated protein X;PKR-associating protein X;Protein activator of the interferon-induced protein kinase;Protein kinase, interferon-inducible double-stranded RNA-dependent activator;, PF00035;PF16482;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0048471;GO:0070578;GO:0003725;GO:0008047;GO:0019899;GO:0042802;GO:0070883;GO:0042803;GO:0003723;GO:0034599;GO:0006955;GO:0042474;GO:0010586;GO:0008285;GO:0042473;GO:2001244;GO:0031054;GO:0035196;GO:0030422;GO:0006468;GO:0050821;GO:0009615;GO:0048705;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:RISC-loading complex;, F:double-stranded RNA binding; F:enzyme activator activity; F:enzyme binding; F:identical protein binding; F:pre-miRNA binding; F:protein homodimerization activity; F:RNA binding;, P:cellular response to oxidative stress; P:immune response; P:middle ear morphogenesis; P:miRNA metabolic process; P:negative regulation of cell population proliferation; P:outer ear morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:protein phosphorylation; P:protein stabilization; P:response to virus; P:skeletal system morphogenesis; P:viral process;|O75569 A8K3I6 Q53G24 Q6X7T5 Q8NDK4,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,PKR-associated protein X;PKR-associating protein X;Protein activator of the interferon-induced protein kinase;Protein kinase, interferon-inducible double-stranded RNA-dependent activator;, PF00035;PF16482;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0048471;GO:0070578;GO:0003725;GO:0008047;GO:0019899;GO:0042802;GO:0070883;GO:0042803;GO:0003723;GO:0034599;GO:0006955;GO:0042474;GO:0010586;GO:0008285;GO:0042473;GO:2001244;GO:0031054;GO:0035196;GO:0030422;GO:0006468;GO:0050821;GO:0009615;GO:0048705;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:RISC-loading complex;, F:double-stranded RNA binding; F:enzyme activator activity; F:enzyme binding; F:identical protein binding; F:pre-miRNA binding; F:protein homodimerization activity; F:RNA binding;, P:cellular response to oxidative stress; P:immune response; P:middle ear morphogenesis; P:miRNA metabolic process; P:negative regulation of cell population proliferation; P:outer ear morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:protein phosphorylation; P:protein stabilization; P:response to virus; P:skeletal system morphogenesis; P:viral process;|O75569 A8K3I6 Q53G24 Q6X7T5 Q8NDK4,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,PKR-associated protein X;PKR-associating protein X;Protein activator of the interferon-induced protein kinase;Protein kinase, interferon-inducible double-stranded RNA-dependent activator;, PF00035;PF16482;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0048471;GO:0070578;GO:0003725;GO:0008047;GO:0019899;GO:0042802;GO:0070883;GO:0042803;GO:0003723;GO:0034599;GO:0006955;GO:0042474;GO:0010586;GO:0008285;GO:0042473;GO:2001244;GO:0031054;GO:0035196;GO:0030422;GO:0006468;GO:0050821;GO:0009615;GO:0048705;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:RISC-loading complex;, F:double-stranded RNA binding; F:enzyme activator activity; F:enzyme binding; F:identical protein binding; F:pre-miRNA binding; F:protein homodimerization activity; F:RNA binding;, P:cellular response to oxidative stress; P:immune response; P:middle ear morphogenesis; P:miRNA metabolic process; P:negative regulation of cell population proliferation; P:outer ear morphogenesis; P:positive regulation of intrinsic apoptotic signaling pathway; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:protein phosphorylation; P:protein stabilization; P:response to virus; P:skeletal system morphogenesis; P:viral process; scaffold84 indexed_genome mRNA 4711893 4919005 . - . ID=transcript_12261;Q7Z4Q1 Q86V84 Q8N9T0 Q96SR1,Oxysterol-binding protein-related protein 6,, PF01237;PF15409;, GO:0005829;GO:0031901;GO:0005789;GO:0043231;GO:0016020;GO:0031965;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0032374;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:regulation of cholesterol transport;|Q7Z4Q1 Q86V84 Q8N9T0 Q96SR1,Oxysterol-binding protein-related protein 6,, PF01237;PF15409;, GO:0005829;GO:0031901;GO:0005789;GO:0043231;GO:0016020;GO:0031965;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0032374;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:regulation of cholesterol transport;|Q7Z4Q1 Q86V84 Q8N9T0 Q96SR1,Oxysterol-binding protein-related protein 6,, PF01237;PF15409;, GO:0005829;GO:0031901;GO:0005789;GO:0043231;GO:0016020;GO:0031965;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0032374;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:regulation of cholesterol transport;|Q7Z4Q1 Q86V84 Q8N9T0 Q96SR1,Oxysterol-binding protein-related protein 6,, PF01237;PF15409;, GO:0005829;GO:0031901;GO:0005789;GO:0043231;GO:0016020;GO:0031965;GO:0097038;GO:0005886;GO:0015485;GO:0032934;GO:0015248;GO:0006699;GO:0032374;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear membrane; C:perinuclear endoplasmic reticulum; C:plasma membrane;, F:cholesterol binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:regulation of cholesterol transport; scaffold84 indexed_genome mRNA 4977623 4992531 . - . ID=transcript_12262;Q8IUH3 Q6NYL0 Q8NFC9,RNA-binding protein 45,Developmentally-regulated RNA-binding protein 1;RNA-binding motif protein 45;, PF00076;, GO:0005737;GO:0005654;GO:0005634;GO:1990904;GO:0042802;GO:0003723;GO:0030154;GO:0007399;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:identical protein binding; F:RNA binding;, P:cell differentiation; P:nervous system development;|Q8IUH3 Q6NYL0 Q8NFC9,RNA-binding protein 45,Developmentally-regulated RNA-binding protein 1;RNA-binding motif protein 45;, PF00076;, GO:0005737;GO:0005654;GO:0005634;GO:1990904;GO:0042802;GO:0003723;GO:0030154;GO:0007399;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:identical protein binding; F:RNA binding;, P:cell differentiation; P:nervous system development; scaffold84 indexed_genome mRNA 5455389 5457267 . + . ID=transcript_12263;Q8N4P2 Q63HQ1 Q96NE6,Tetratricopeptide repeat protein 30B,, , GO:0005879;GO:0036064;GO:0097542;GO:0005929;GO:0030992;GO:0120170;GO:0042073;GO:0035735;, C:axonemal microtubule; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle B;, F:intraciliary transport particle B binding;, P:intraciliary transport; P:intraciliary transport involved in cilium assembly; scaffold84 indexed_genome mRNA 5523757 5744548 . - . ID=transcript_12264;O00116 A5D8U9 Q2TU35,Alkyldihydroxyacetonephosphate synthase, peroxisomal,Aging-associated gene 5 protein;Alkylglycerone-phosphate synthase;, PF02913;PF01565;, GO:0005829;GO:0016020;GO:0005739;GO:0005730;GO:0005782;GO:0005778;GO:0005777;GO:0008609;GO:0071949;GO:0016491;GO:0008611;GO:0008610;GO:0008104;, C:cytosol; C:membrane; C:mitochondrion; C:nucleolus; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:alkylglycerone-phosphate synthase activity; F:FAD binding; F:oxidoreductase activity;, P:ether lipid biosynthetic process; P:lipid biosynthetic process; P:protein localization;|O00116 A5D8U9 Q2TU35,Alkyldihydroxyacetonephosphate synthase, peroxisomal,Aging-associated gene 5 protein;Alkylglycerone-phosphate synthase;, PF02913;PF01565;, GO:0005829;GO:0016020;GO:0005739;GO:0005730;GO:0005782;GO:0005778;GO:0005777;GO:0008609;GO:0071949;GO:0016491;GO:0008611;GO:0008610;GO:0008104;, C:cytosol; C:membrane; C:mitochondrion; C:nucleolus; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:alkylglycerone-phosphate synthase activity; F:FAD binding; F:oxidoreductase activity;, P:ether lipid biosynthetic process; P:lipid biosynthetic process; P:protein localization; scaffold84 indexed_genome mRNA 5790416 5836809 . - . ID=transcript_12265;Q16236 B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71,Nuclear factor erythroid 2-related factor 2 {ECO:0000303|PubMed:11035812},HEBP1;Nuclear factor, erythroid derived 2, like 2 {ECO:0000303|PubMed:7937919};, PF03131;, GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0005886;GO:0032993;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0019904;GO:0001102;GO:0000978;GO:0043565;GO:0001221;GO:0000976;GO:0046223;GO:0007568;GO:0045454;GO:1904385;GO:0071280;GO:0035690;GO:0071498;GO:0042149;GO:0070301;GO:0071499;GO:0034599;GO:0071356;GO:0030968;GO:0006954;GO:0010667;GO:2000352;GO:1902037;GO:1903206;GO:1902176;GO:1904753;GO:0036499;GO:0045766;GO:0030194;GO:0043536;GO:1903071;GO:0010628;GO:0046326;GO:1903788;GO:0010976;GO:2000379;GO:0045944;GO:0061419;GO:0036091;GO:0036003;GO:0010499;GO:0043161;GO:0016567;GO:0045995;GO:2000121;GO:0006357;GO:0010226;GO:0016032;, C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-DNA complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coregulator binding; F:transcription regulatory region sequence-specific DNA binding;, P:aflatoxin catabolic process; P:aging; P:cell redox homeostasis; P:cellular response to angiotensin; P:cellular response to copper ion; P:cellular response to drug; P:cellular response to fluid shear stress; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to laminar fluid shear stress; P:cellular response to oxidative stress; P:cellular response to tumor necrosis factor; P:endoplasmic reticulum unfolded protein response; P:inflammatory response; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of vascular associated smooth muscle cell migration; P:PERK-mediated unfolded protein response; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of glutathione biosynthetic process; P:positive regulation of neuron projection development; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of embryonic development; P:regulation of removal of superoxide radicals; P:regulation of transcription by RNA polymerase II; P:response to lithium ion; P:viral process;|Q16236 B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71,Nuclear factor erythroid 2-related factor 2 {ECO:0000303|PubMed:11035812},HEBP1;Nuclear factor, erythroid derived 2, like 2 {ECO:0000303|PubMed:7937919};, PF03131;, GO:0005813;GO:0000785;GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0005886;GO:0032993;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0019904;GO:0001102;GO:0000978;GO:0043565;GO:0001221;GO:0000976;GO:0046223;GO:0007568;GO:0045454;GO:1904385;GO:0071280;GO:0035690;GO:0071498;GO:0042149;GO:0070301;GO:0071499;GO:0034599;GO:0071356;GO:0030968;GO:0006954;GO:0010667;GO:2000352;GO:1902037;GO:1903206;GO:1902176;GO:1904753;GO:0036499;GO:0045766;GO:0030194;GO:0043536;GO:1903071;GO:0010628;GO:0046326;GO:1903788;GO:0010976;GO:2000379;GO:0045944;GO:0061419;GO:0036091;GO:0036003;GO:0010499;GO:0043161;GO:0016567;GO:0045995;GO:2000121;GO:0006357;GO:0010226;GO:0016032;, C:centrosome; C:chromatin; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-DNA complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coregulator binding; F:transcription regulatory region sequence-specific DNA binding;, P:aflatoxin catabolic process; P:aging; P:cell redox homeostasis; P:cellular response to angiotensin; P:cellular response to copper ion; P:cellular response to drug; P:cellular response to fluid shear stress; P:cellular response to glucose starvation; P:cellular response to hydrogen peroxide; P:cellular response to laminar fluid shear stress; P:cellular response to oxidative stress; P:cellular response to tumor necrosis factor; P:endoplasmic reticulum unfolded protein response; P:inflammatory response; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of hematopoietic stem cell differentiation; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of vascular associated smooth muscle cell migration; P:PERK-mediated unfolded protein response; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of glutathione biosynthetic process; P:positive regulation of neuron projection development; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of embryonic development; P:regulation of removal of superoxide radicals; P:regulation of transcription by RNA polymerase II; P:response to lithium ion; P:viral process;|P51991 D3DPF4 Q53RW7 Q6URK5,Heterogeneous nuclear ribonucleoprotein A3,, PF00076;, GO:0071013;GO:0005654;GO:0005634;GO:1990904;GO:0003723;GO:0000398;GO:0016070;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:RNA metabolic process; scaffold84 indexed_genome mRNA 6695855 6763577 . - . ID=transcript_12266;O75431 A8JZZ4 Q53S50 Q53SQ2 Q5M7Z6 Q8IZ68,Metaxin-2,Mitochondrial outer membrane import complex protein 2;, PF17171;PF10568;, GO:0005737;GO:0140275;GO:0005741;GO:0005739;GO:0005730;GO:0001401;GO:0007007;GO:0006839;GO:0007005;GO:0015031;, C:cytoplasm; C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:SAM complex;, , P:inner mitochondrial membrane organization; P:mitochondrial transport; P:mitochondrion organization; P:protein transport;|O75431 A8JZZ4 Q53S50 Q53SQ2 Q5M7Z6 Q8IZ68,Metaxin-2,Mitochondrial outer membrane import complex protein 2;, PF17171;PF10568;, GO:0005737;GO:0140275;GO:0005741;GO:0005739;GO:0005730;GO:0001401;GO:0007007;GO:0006839;GO:0007005;GO:0015031;, C:cytoplasm; C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:SAM complex;, , P:inner mitochondrial membrane organization; P:mitochondrial transport; P:mitochondrion organization; P:protein transport;|O75431 A8JZZ4 Q53S50 Q53SQ2 Q5M7Z6 Q8IZ68,Metaxin-2,Mitochondrial outer membrane import complex protein 2;, PF17171;PF10568;, GO:0005737;GO:0140275;GO:0005741;GO:0005739;GO:0005730;GO:0001401;GO:0007007;GO:0006839;GO:0007005;GO:0015031;, C:cytoplasm; C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:nucleolus; C:SAM complex;, , P:inner mitochondrial membrane organization; P:mitochondrial transport; P:mitochondrion organization; P:protein transport; scaffold84 indexed_genome mRNA 6835435 6837650 . - . ID=transcript_12267;Q9GZZ0 B2RAB4,Homeobox protein Hox-D1,Homeobox protein Hox-GG;, PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0048706;GO:0030182;GO:0006357;GO:0019233;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:embryonic skeletal system development; P:neuron differentiation; P:regulation of transcription by RNA polymerase II; P:sensory perception of pain;|Q9GZZ0 B2RAB4,Homeobox protein Hox-D1,Homeobox protein Hox-GG;, PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0048706;GO:0030182;GO:0006357;GO:0019233;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:embryonic skeletal system development; P:neuron differentiation; P:regulation of transcription by RNA polymerase II; P:sensory perception of pain; scaffold85 indexed_genome mRNA 2191148 2518553 . + . ID=transcript_12268;Q9UKZ4 B2RTR5 Q5JZ17,Teneurin-1,Protein Odd Oz/ten-m homolog 1;Tenascin-M1;Teneurin transmembrane protein 1;, PF06484;PF15636;, GO:0005737;GO:0005856;GO:0005783;GO:0005576;GO:0005794;GO:0005887;GO:0043005;GO:0016363;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0050839;GO:0008201;GO:0046982;GO:0042803;GO:0007157;GO:0006955;GO:0008285;GO:0007399;GO:0048666;GO:0007218;GO:0030838;GO:0051491;GO:0090316;GO:0043406;GO:0033138;GO:0006359;, C:cytoplasm; C:cytoskeleton; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:neuron projection; C:nuclear matrix; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:heparin binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:immune response; P:negative regulation of cell population proliferation; P:nervous system development; P:neuron development; P:neuropeptide signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of filopodium assembly; P:positive regulation of intracellular protein transport; P:positive regulation of MAP kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of transcription by RNA polymerase III; scaffold85 indexed_genome mRNA 2778922 2954507 . + . ID=transcript_12269;Q9UKZ4 B2RTR5 Q5JZ17,Teneurin-1,Protein Odd Oz/ten-m homolog 1;Tenascin-M1;Teneurin transmembrane protein 1;, PF06484;PF15636;, GO:0005737;GO:0005856;GO:0005783;GO:0005576;GO:0005794;GO:0005887;GO:0043005;GO:0016363;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0050839;GO:0008201;GO:0046982;GO:0042803;GO:0007157;GO:0006955;GO:0008285;GO:0007399;GO:0048666;GO:0007218;GO:0030838;GO:0051491;GO:0090316;GO:0043406;GO:0033138;GO:0006359;, C:cytoplasm; C:cytoskeleton; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:neuron projection; C:nuclear matrix; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:heparin binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:immune response; P:negative regulation of cell population proliferation; P:nervous system development; P:neuron development; P:neuropeptide signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of filopodium assembly; P:positive regulation of intracellular protein transport; P:positive regulation of MAP kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of transcription by RNA polymerase III;|Q9UKZ4 B2RTR5 Q5JZ17,Teneurin-1,Protein Odd Oz/ten-m homolog 1;Tenascin-M1;Teneurin transmembrane protein 1;, PF06484;PF15636;, GO:0005737;GO:0005856;GO:0005783;GO:0005576;GO:0005794;GO:0005887;GO:0043005;GO:0016363;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0050839;GO:0008201;GO:0046982;GO:0042803;GO:0007157;GO:0006955;GO:0008285;GO:0007399;GO:0048666;GO:0007218;GO:0030838;GO:0051491;GO:0090316;GO:0043406;GO:0033138;GO:0006359;, C:cytoplasm; C:cytoskeleton; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:neuron projection; C:nuclear matrix; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:heparin binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:immune response; P:negative regulation of cell population proliferation; P:nervous system development; P:neuron development; P:neuropeptide signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of filopodium assembly; P:positive regulation of intracellular protein transport; P:positive regulation of MAP kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of transcription by RNA polymerase III;|Q9UKZ4 B2RTR5 Q5JZ17,Teneurin-1,Protein Odd Oz/ten-m homolog 1;Tenascin-M1;Teneurin transmembrane protein 1;, PF06484;PF15636;, GO:0005737;GO:0005856;GO:0005783;GO:0005576;GO:0005794;GO:0005887;GO:0043005;GO:0016363;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0050839;GO:0008201;GO:0046982;GO:0042803;GO:0007157;GO:0006955;GO:0008285;GO:0007399;GO:0048666;GO:0007218;GO:0030838;GO:0051491;GO:0090316;GO:0043406;GO:0033138;GO:0006359;, C:cytoplasm; C:cytoskeleton; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:neuron projection; C:nuclear matrix; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:heparin binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:immune response; P:negative regulation of cell population proliferation; P:nervous system development; P:neuron development; P:neuropeptide signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of filopodium assembly; P:positive regulation of intracellular protein transport; P:positive regulation of MAP kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of transcription by RNA polymerase III; scaffold85 indexed_genome mRNA 3011552 3056835 . + . ID=transcript_12270;Q9UKZ4 B2RTR5 Q5JZ17,Teneurin-1,Protein Odd Oz/ten-m homolog 1;Tenascin-M1;Teneurin transmembrane protein 1;, PF06484;PF15636;, GO:0005737;GO:0005856;GO:0005783;GO:0005576;GO:0005794;GO:0005887;GO:0043005;GO:0016363;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0050839;GO:0008201;GO:0046982;GO:0042803;GO:0007157;GO:0006955;GO:0008285;GO:0007399;GO:0048666;GO:0007218;GO:0030838;GO:0051491;GO:0090316;GO:0043406;GO:0033138;GO:0006359;, C:cytoplasm; C:cytoskeleton; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:neuron projection; C:nuclear matrix; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:heparin binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:immune response; P:negative regulation of cell population proliferation; P:nervous system development; P:neuron development; P:neuropeptide signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of filopodium assembly; P:positive regulation of intracellular protein transport; P:positive regulation of MAP kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of transcription by RNA polymerase III;|Q9UKZ4 B2RTR5 Q5JZ17,Teneurin-1,Protein Odd Oz/ten-m homolog 1;Tenascin-M1;Teneurin transmembrane protein 1;, PF06484;PF15636;, GO:0005737;GO:0005856;GO:0005783;GO:0005576;GO:0005794;GO:0005887;GO:0043005;GO:0016363;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0050839;GO:0008201;GO:0046982;GO:0042803;GO:0007157;GO:0006955;GO:0008285;GO:0007399;GO:0048666;GO:0007218;GO:0030838;GO:0051491;GO:0090316;GO:0043406;GO:0033138;GO:0006359;, C:cytoplasm; C:cytoskeleton; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:neuron projection; C:nuclear matrix; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cell adhesion molecule binding; F:heparin binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:immune response; P:negative regulation of cell population proliferation; P:nervous system development; P:neuron development; P:neuropeptide signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of filopodium assembly; P:positive regulation of intracellular protein transport; P:positive regulation of MAP kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of transcription by RNA polymerase III; scaffold85 indexed_genome mRNA 3060687 3064036 . - . ID=transcript_12271;O60880 A8MSW0 O95383 O95384 O95385 O95386 Q6FGS6 Q9UNR0,SH2 domain-containing protein 1A,Duncan disease SH2-protein;Signaling lymphocytic activation molecule-associated protein;T-cell signal transduction molecule SAP;, PF00017;, GO:0005737;GO:0005829;GO:0002250;GO:0007267;GO:0006968;GO:0006959;GO:0045087;GO:0050860;GO:0045954;GO:0050776;, C:cytoplasm; C:cytosol;, , P:adaptive immune response; P:cell-cell signaling; P:cellular defense response; P:humoral immune response; P:innate immune response; P:negative regulation of T cell receptor signaling pathway; P:positive regulation of natural killer cell mediated cytotoxicity; P:regulation of immune response; scaffold85 indexed_genome mRNA 3280891 3419865 . - . ID=transcript_12272;Q8N3U4 B1AMT5 D3DTF5 O00540 Q5JTI6 Q68DE9 Q9H1N8,Cohesin subunit SA-2,SCC3 homolog 2;Stromal antigen 2;, PF08514;, GO:0000785;GO:0005694;GO:0000775;GO:0008278;GO:0005829;GO:0016020;GO:0097431;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0051321;GO:0090307;GO:0007062;, C:chromatin; C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:cytosol; C:membrane; C:mitotic spindle pole; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cell division; P:meiotic cell cycle; P:mitotic spindle assembly; P:sister chromatid cohesion; scaffold85 indexed_genome mRNA 3458966 3481190 . - . ID=transcript_12273;P98170 D3DTF2 Q9NQ14,E3 ubiquitin-protein ligase XIAP,Baculoviral IAP repeat-containing protein 4;IAP-like protein;Inhibitor of apoptosis protein 3;RING-type E3 ubiquitin transferase XIAP;X-linked inhibitor of apoptosis protein;, PF00653;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005876;GO:0043027;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0006974;GO:0055070;GO:1990001;GO:0043066;GO:0043154;GO:0051402;GO:0090263;GO:1902530;GO:0031398;GO:0030510;GO:0051726;GO:0042127;GO:0050727;GO:0045088;GO:0070424;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle microtubule;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:copper ion homeostasis; P:inhibition of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:neuron apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein linear polyubiquitination; P:positive regulation of protein ubiquitination; P:regulation of BMP signaling pathway; P:regulation of cell cycle; P:regulation of cell population proliferation; P:regulation of inflammatory response; P:regulation of innate immune response; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:Wnt signaling pathway;|P98170 D3DTF2 Q9NQ14,E3 ubiquitin-protein ligase XIAP,Baculoviral IAP repeat-containing protein 4;IAP-like protein;Inhibitor of apoptosis protein 3;RING-type E3 ubiquitin transferase XIAP;X-linked inhibitor of apoptosis protein;, PF00653;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005876;GO:0043027;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0006974;GO:0055070;GO:1990001;GO:0043066;GO:0043154;GO:0051402;GO:0090263;GO:1902530;GO:0031398;GO:0030510;GO:0051726;GO:0042127;GO:0050727;GO:0045088;GO:0070424;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle microtubule;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:copper ion homeostasis; P:inhibition of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:neuron apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein linear polyubiquitination; P:positive regulation of protein ubiquitination; P:regulation of BMP signaling pathway; P:regulation of cell cycle; P:regulation of cell population proliferation; P:regulation of inflammatory response; P:regulation of innate immune response; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:Wnt signaling pathway;|P98170 D3DTF2 Q9NQ14,E3 ubiquitin-protein ligase XIAP,Baculoviral IAP repeat-containing protein 4;IAP-like protein;Inhibitor of apoptosis protein 3;RING-type E3 ubiquitin transferase XIAP;X-linked inhibitor of apoptosis protein;, PF00653;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005876;GO:0043027;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0006974;GO:0055070;GO:1990001;GO:0043066;GO:0043154;GO:0051402;GO:0090263;GO:1902530;GO:0031398;GO:0030510;GO:0051726;GO:0042127;GO:0050727;GO:0045088;GO:0070424;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle microtubule;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:copper ion homeostasis; P:inhibition of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:neuron apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein linear polyubiquitination; P:positive regulation of protein ubiquitination; P:regulation of BMP signaling pathway; P:regulation of cell cycle; P:regulation of cell population proliferation; P:regulation of inflammatory response; P:regulation of innate immune response; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:Wnt signaling pathway;|P84101 A6NL45 B5MCG1 B9A026 O75918 O88891 Q9BZH7,Small EDRK-rich factor 2,Gastric cancer-related protein VRG107;Protein 4F5-related;, PF04419;, GO:0005829;GO:0005634;GO:0031648;, C:cytosol; C:nucleus;, , P:protein destabilization;|P98170 D3DTF2 Q9NQ14,E3 ubiquitin-protein ligase XIAP,Baculoviral IAP repeat-containing protein 4;IAP-like protein;Inhibitor of apoptosis protein 3;RING-type E3 ubiquitin transferase XIAP;X-linked inhibitor of apoptosis protein;, PF00653;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005876;GO:0043027;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0006974;GO:0055070;GO:1990001;GO:0043066;GO:0043154;GO:0051402;GO:0090263;GO:1902530;GO:0031398;GO:0030510;GO:0051726;GO:0042127;GO:0050727;GO:0045088;GO:0070424;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle microtubule;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:copper ion homeostasis; P:inhibition of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:neuron apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein linear polyubiquitination; P:positive regulation of protein ubiquitination; P:regulation of BMP signaling pathway; P:regulation of cell cycle; P:regulation of cell population proliferation; P:regulation of inflammatory response; P:regulation of innate immune response; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:Wnt signaling pathway;|P98170 D3DTF2 Q9NQ14,E3 ubiquitin-protein ligase XIAP,Baculoviral IAP repeat-containing protein 4;IAP-like protein;Inhibitor of apoptosis protein 3;RING-type E3 ubiquitin transferase XIAP;X-linked inhibitor of apoptosis protein;, PF00653;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005876;GO:0043027;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0006974;GO:0055070;GO:1990001;GO:0043066;GO:0043154;GO:0051402;GO:0090263;GO:1902530;GO:0031398;GO:0030510;GO:0051726;GO:0042127;GO:0050727;GO:0045088;GO:0070424;GO:0016055;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle microtubule;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:copper ion homeostasis; P:inhibition of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:neuron apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein linear polyubiquitination; P:positive regulation of protein ubiquitination; P:regulation of BMP signaling pathway; P:regulation of cell cycle; P:regulation of cell population proliferation; P:regulation of inflammatory response; P:regulation of innate immune response; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; P:Wnt signaling pathway; scaffold85 indexed_genome mRNA 3484671 3485335 . + . ID=transcript_12274;Q9BYG5 A2A2A7 Q9Y510,Partitioning defective 6 homolog beta,, PF00564;PF00595;, GO:0016324;GO:0005923;GO:0005938;GO:0005829;GO:0070062;GO:0005634;GO:0005886;GO:0032991;GO:0005080;GO:0007409;GO:0070830;GO:0051301;GO:0007043;GO:0007098;GO:0007163;GO:0065003;GO:0030334;GO:0060341;, C:apical plasma membrane; C:bicellular tight junction; C:cell cortex; C:cytosol; C:extracellular exosome; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:protein kinase C binding;, P:axonogenesis; P:bicellular tight junction assembly; P:cell division; P:cell-cell junction assembly; P:centrosome cycle; P:establishment or maintenance of cell polarity; P:protein-containing complex assembly; P:regulation of cell migration; P:regulation of cellular localization; scaffold85 indexed_genome mRNA 3627660 3711515 . + . ID=transcript_12275;Q8NI27 A6NM50 Q5JZ12 Q6IN92 Q9H8I6,THO complex subunit 2,hTREX120;, PF11262;PF11732;PF16134;, GO:0016607;GO:0005654;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0048699;GO:0031124;GO:0006406;GO:0048666;GO:0016973;GO:0006405;GO:0008380;GO:0046784;, C:nuclear speck; C:nucleoplasm; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:generation of neurons; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:neuron development; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q8NI27 A6NM50 Q5JZ12 Q6IN92 Q9H8I6,THO complex subunit 2,hTREX120;, PF11262;PF11732;PF16134;, GO:0016607;GO:0005654;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0048699;GO:0031124;GO:0006406;GO:0048666;GO:0016973;GO:0006405;GO:0008380;GO:0046784;, C:nuclear speck; C:nucleoplasm; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:generation of neurons; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:neuron development; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q8NI27 A6NM50 Q5JZ12 Q6IN92 Q9H8I6,THO complex subunit 2,hTREX120;, PF11262;PF11732;PF16134;, GO:0016607;GO:0005654;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0048699;GO:0031124;GO:0006406;GO:0048666;GO:0016973;GO:0006405;GO:0008380;GO:0046784;, C:nuclear speck; C:nucleoplasm; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:generation of neurons; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:neuron development; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q8NI27 A6NM50 Q5JZ12 Q6IN92 Q9H8I6,THO complex subunit 2,hTREX120;, PF11262;PF11732;PF16134;, GO:0016607;GO:0005654;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0048699;GO:0031124;GO:0006406;GO:0048666;GO:0016973;GO:0006405;GO:0008380;GO:0046784;, C:nuclear speck; C:nucleoplasm; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:generation of neurons; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:neuron development; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q8NI27 A6NM50 Q5JZ12 Q6IN92 Q9H8I6,THO complex subunit 2,hTREX120;, PF11262;PF11732;PF16134;, GO:0016607;GO:0005654;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0048699;GO:0031124;GO:0006406;GO:0048666;GO:0016973;GO:0006405;GO:0008380;GO:0046784;, C:nuclear speck; C:nucleoplasm; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:generation of neurons; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:neuron development; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus; scaffold85 indexed_genome mRNA 3713807 3725938 . + . ID=transcript_12276;P16591 B2RCR4 B4DSQ2 H2FLB8,Tyrosine-protein kinase Fer,Feline encephalitis virus-related kinase FER;Fujinami poultry sarcoma/Feline sarcoma-related protein Fer;Proto-oncogene c-Fer;Tyrosine kinase 3;p94-Fer;, PF00611;PF07714;PF00017;, GO:0005938;GO:0030054;GO:0042995;GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0005634;GO:0005524;GO:0005154;GO:0008289;GO:0004715;GO:0008157;GO:0004713;GO:0005102;GO:0004714;GO:0031532;GO:0007155;GO:0030154;GO:0008283;GO:0044331;GO:0032869;GO:0036006;GO:0034614;GO:0006935;GO:0019221;GO:0050904;GO:0035426;GO:0038095;GO:0045087;GO:0038028;GO:0070102;GO:0035556;GO:0038109;GO:0000226;GO:0033007;GO:0018108;GO:0048008;GO:0030838;GO:0030335;GO:0008284;GO:0051092;GO:0046777;GO:0006468;GO:0042058;GO:0010762;GO:0010591;GO:0043304;GO:0001932;GO:0032496;GO:0036119;GO:0034446;GO:0007169;GO:0007260;, C:cell cortex; C:cell junction; C:cell projection; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleus;, F:ATP binding; F:epidermal growth factor receptor binding; F:lipid binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase 1 binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton reorganization; P:cell adhesion; P:cell differentiation; P:cell population proliferation; P:cell-cell adhesion mediated by cadherin; P:cellular response to insulin stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cellular response to reactive oxygen species; P:chemotaxis; P:cytokine-mediated signaling pathway; P:diapedesis; P:extracellular matrix-cell signaling; P:Fc-epsilon receptor signaling pathway; P:innate immune response; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:interleukin-6-mediated signaling pathway; P:intracellular signal transduction; P:Kit signaling pathway; P:microtubule cytoskeleton organization; P:negative regulation of mast cell activation involved in immune response; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of fibroblast migration; P:regulation of lamellipodium assembly; P:regulation of mast cell degranulation; P:regulation of protein phosphorylation; P:response to lipopolysaccharide; P:response to platelet-derived growth factor; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:tyrosine phosphorylation of STAT protein;|Q8NI27 A6NM50 Q5JZ12 Q6IN92 Q9H8I6,THO complex subunit 2,hTREX120;, PF11262;PF11732;PF16134;, GO:0016607;GO:0005654;GO:0000347;GO:0000445;GO:0000346;GO:0003729;GO:0048699;GO:0031124;GO:0006406;GO:0048666;GO:0016973;GO:0006405;GO:0008380;GO:0046784;, C:nuclear speck; C:nucleoplasm; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:mRNA binding;, P:generation of neurons; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:neuron development; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|P16591 B2RCR4 B4DSQ2 H2FLB8,Tyrosine-protein kinase Fer,Feline encephalitis virus-related kinase FER;Fujinami poultry sarcoma/Feline sarcoma-related protein Fer;Proto-oncogene c-Fer;Tyrosine kinase 3;p94-Fer;, PF00611;PF07714;PF00017;, GO:0005938;GO:0030054;GO:0042995;GO:0005737;GO:0005856;GO:0005829;GO:0031234;GO:0005634;GO:0005524;GO:0005154;GO:0008289;GO:0004715;GO:0008157;GO:0004713;GO:0005102;GO:0004714;GO:0031532;GO:0007155;GO:0030154;GO:0008283;GO:0044331;GO:0032869;GO:0036006;GO:0034614;GO:0006935;GO:0019221;GO:0050904;GO:0035426;GO:0038095;GO:0045087;GO:0038028;GO:0070102;GO:0035556;GO:0038109;GO:0000226;GO:0033007;GO:0018108;GO:0048008;GO:0030838;GO:0030335;GO:0008284;GO:0051092;GO:0046777;GO:0006468;GO:0042058;GO:0010762;GO:0010591;GO:0043304;GO:0001932;GO:0032496;GO:0036119;GO:0034446;GO:0007169;GO:0007260;, C:cell cortex; C:cell junction; C:cell projection; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleus;, F:ATP binding; F:epidermal growth factor receptor binding; F:lipid binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase 1 binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton reorganization; P:cell adhesion; P:cell differentiation; P:cell population proliferation; P:cell-cell adhesion mediated by cadherin; P:cellular response to insulin stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:cellular response to reactive oxygen species; P:chemotaxis; P:cytokine-mediated signaling pathway; P:diapedesis; P:extracellular matrix-cell signaling; P:Fc-epsilon receptor signaling pathway; P:innate immune response; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:interleukin-6-mediated signaling pathway; P:intracellular signal transduction; P:Kit signaling pathway; P:microtubule cytoskeleton organization; P:negative regulation of mast cell activation involved in immune response; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of fibroblast migration; P:regulation of lamellipodium assembly; P:regulation of mast cell degranulation; P:regulation of protein phosphorylation; P:response to lipopolysaccharide; P:response to platelet-derived growth factor; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:tyrosine phosphorylation of STAT protein; scaffold85 indexed_genome mRNA 3804790 4014182 . - . ID=transcript_12277;P42263 D3DTF1 Q4VXD5 Q4VXD6 Q9HDA0 Q9HDA1 Q9HDA2 Q9P0H1,Glutamate receptor 3,AMPA-selective glutamate receptor 3;GluR-C;GluR-K3;Glutamate receptor ionotropic, AMPA 3;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:0098688;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0015276;GO:0038023;GO:1904315;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P42263 D3DTF1 Q4VXD5 Q4VXD6 Q9HDA0 Q9HDA1 Q9HDA2 Q9P0H1,Glutamate receptor 3,AMPA-selective glutamate receptor 3;GluR-C;GluR-K3;Glutamate receptor ionotropic, AMPA 3;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:0098688;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0015276;GO:0038023;GO:1904315;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P42263 D3DTF1 Q4VXD5 Q4VXD6 Q9HDA0 Q9HDA1 Q9HDA2 Q9P0H1,Glutamate receptor 3,AMPA-selective glutamate receptor 3;GluR-C;GluR-K3;Glutamate receptor ionotropic, AMPA 3;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:0098688;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0015276;GO:0038023;GO:1904315;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P48058 Q86XE8,Glutamate receptor 4,AMPA-selective glutamate receptor 4;GluR-D;Glutamate receptor ionotropic, AMPA 4;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:1903561;GO:0043025;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0038023;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:extracellular vesicle; C:neuronal cell body; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P42263 D3DTF1 Q4VXD5 Q4VXD6 Q9HDA0 Q9HDA1 Q9HDA2 Q9P0H1,Glutamate receptor 3,AMPA-selective glutamate receptor 3;GluR-C;GluR-K3;Glutamate receptor ionotropic, AMPA 3;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:0098688;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0015276;GO:0038023;GO:1904315;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity;|P42263 D3DTF1 Q4VXD5 Q4VXD6 Q9HDA0 Q9HDA1 Q9HDA2 Q9P0H1,Glutamate receptor 3,AMPA-selective glutamate receptor 3;GluR-C;GluR-K3;Glutamate receptor ionotropic, AMPA 3;, PF01094;PF00060;PF10613;, GO:0032281;GO:0043197;GO:0030666;GO:0098688;GO:0005886;GO:0045211;GO:0004971;GO:0001540;GO:0015276;GO:0038023;GO:1904315;GO:0007268;GO:0007215;GO:2000310;, C:AMPA glutamate receptor complex; C:dendritic spine; C:endocytic vesicle membrane; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic membrane;, F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:regulation of NMDA receptor activity; scaffold85 indexed_genome mRNA 6275050 6278827 . + . ID=transcript_12278;Q96EU7 A8K246 Q8WWS3 Q9NZX1,C1GALT1-specific chaperone 1,C38H2-like protein 1;Core 1 beta1,3-galactosyltransferase 2;Core 1 beta3-galactosyltransferase-specific molecular chaperone;, , GO:0070062;GO:0000139;GO:0016021;GO:0016263;GO:0016266;GO:0016267;GO:0030168;GO:0036344;GO:0006493;, C:extracellular exosome; C:Golgi membrane; C:integral component of membrane;, F:glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity;, P:O-glycan processing; P:O-glycan processing, core 1; P:platelet activation; P:platelet morphogenesis; P:protein O-linked glycosylation; scaffold85 indexed_genome mRNA 6287669 6299768 . - . ID=transcript_12279;Q9ULC4 B4DGY2 Q502X6,Malignant T-cell-amplified sequence 1,Multiple copies T-cell malignancies;, PF17832;PF01472;, GO:0005829;GO:0005886;GO:0003743;GO:0007049;GO:0006974;GO:0001731;GO:0075522;GO:0008284;GO:0040008;GO:0032790;GO:0002188;, C:cytosol; C:plasma membrane;, F:translation initiation factor activity;, P:cell cycle; P:cellular response to DNA damage stimulus; P:formation of translation preinitiation complex; P:IRES-dependent viral translational initiation; P:positive regulation of cell population proliferation; P:regulation of growth; P:ribosome disassembly; P:translation reinitiation;|Q9ULC4 B4DGY2 Q502X6,Malignant T-cell-amplified sequence 1,Multiple copies T-cell malignancies;, PF17832;PF01472;, GO:0005829;GO:0005886;GO:0003743;GO:0007049;GO:0006974;GO:0001731;GO:0075522;GO:0008284;GO:0040008;GO:0032790;GO:0002188;, C:cytosol; C:plasma membrane;, F:translation initiation factor activity;, P:cell cycle; P:cellular response to DNA damage stimulus; P:formation of translation preinitiation complex; P:IRES-dependent viral translational initiation; P:positive regulation of cell population proliferation; P:regulation of growth; P:ribosome disassembly; P:translation reinitiation;|Q9ULC4 B4DGY2 Q502X6,Malignant T-cell-amplified sequence 1,Multiple copies T-cell malignancies;, PF17832;PF01472;, GO:0005829;GO:0005886;GO:0003743;GO:0007049;GO:0006974;GO:0001731;GO:0075522;GO:0008284;GO:0040008;GO:0032790;GO:0002188;, C:cytosol; C:plasma membrane;, F:translation initiation factor activity;, P:cell cycle; P:cellular response to DNA damage stimulus; P:formation of translation preinitiation complex; P:IRES-dependent viral translational initiation; P:positive regulation of cell population proliferation; P:regulation of growth; P:ribosome disassembly; P:translation reinitiation; scaffold85 indexed_genome mRNA 6332916 6363860 . + . ID=transcript_12280;Q9UED7,Cullin-4B,, PF00888;PF10557;, GO:0080008;GO:0031465;GO:0031461;GO:0005829;GO:0070062;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0035518;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043687;GO:0010498;GO:0016567;GO:0042254;GO:0031146;GO:0006283;GO:0070914;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein ubiquitination; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:UV-damage excision repair;|Q9UED7,Cullin-4B,, PF00888;PF10557;, GO:0080008;GO:0031465;GO:0031461;GO:0005829;GO:0070062;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0035518;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043687;GO:0010498;GO:0016567;GO:0042254;GO:0031146;GO:0006283;GO:0070914;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein ubiquitination; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:UV-damage excision repair;|Q9UED7,Cullin-4B,, PF00888;PF10557;, GO:0080008;GO:0031465;GO:0031461;GO:0005829;GO:0070062;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0035518;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043687;GO:0010498;GO:0016567;GO:0042254;GO:0031146;GO:0006283;GO:0070914;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein ubiquitination; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:UV-damage excision repair;|Q9UED7,Cullin-4B,, PF00888;PF10557;, GO:0080008;GO:0031465;GO:0031461;GO:0005829;GO:0070062;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0035518;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043687;GO:0010498;GO:0016567;GO:0042254;GO:0031146;GO:0006283;GO:0070914;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein ubiquitination; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:UV-damage excision repair;|Q9UED7,Cullin-4B,, PF00888;PF10557;, GO:0080008;GO:0031465;GO:0031461;GO:0005829;GO:0070062;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0035518;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043687;GO:0010498;GO:0016567;GO:0042254;GO:0031146;GO:0006283;GO:0070914;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein ubiquitination; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:UV-damage excision repair;|Q9UED7,Cullin-4B,, PF00888;PF10557;, GO:0080008;GO:0031465;GO:0031461;GO:0005829;GO:0070062;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0035518;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043687;GO:0010498;GO:0016567;GO:0042254;GO:0031146;GO:0006283;GO:0070914;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein ubiquitination; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:UV-damage excision repair;|Q9UED7,Cullin-4B,, PF00888;PF10557;, GO:0080008;GO:0031465;GO:0031461;GO:0005829;GO:0070062;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0035518;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043687;GO:0010498;GO:0016567;GO:0042254;GO:0031146;GO:0006283;GO:0070914;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4B-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:histone H2A monoubiquitination; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:post-translational protein modification; P:proteasomal protein catabolic process; P:protein ubiquitination; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:transcription-coupled nucleotide-excision repair; P:UV-damage excision repair; scaffold85 indexed_genome mRNA 6416753 6450384 . + . ID=transcript_12281;P13473 A8K4X5 D3DTF0 Q16641 Q6Q3G8 Q96J30 Q99534 Q9UD93,Lysosome-associated membrane glycoprotein 2,CD107 antigen-like family member B;LGP-96 {ECO:0000303|PubMed:8662539};, PF01299;, GO:0044754;GO:0035577;GO:0061742;GO:0070062;GO:0005615;GO:0101003;GO:0097637;GO:0005770;GO:0031902;GO:0043202;GO:1990836;GO:0005765;GO:0005764;GO:0016020;GO:0045121;GO:0048471;GO:0030670;GO:0005886;GO:0031088;GO:0005802;GO:0019899;GO:0019904;GO:0097352;GO:0009267;GO:0061684;GO:0072594;GO:1905146;GO:0046716;GO:0031333;GO:0043312;GO:0002576;GO:0017038;GO:0050821;GO:0006605;GO:0061740;GO:0031647;, C:autolysosome; C:azurophil granule membrane; C:chaperone-mediated autophagy translocation complex; C:extracellular exosome; C:extracellular space; C:ficolin-1-rich granule membrane; C:integral component of autophagosome membrane; C:late endosome; C:late endosome membrane; C:lysosomal lumen; C:lysosomal matrix; C:lysosomal membrane; C:lysosome; C:membrane; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:platelet dense granule membrane; C:trans-Golgi network;, F:enzyme binding; F:protein domain specific binding;, P:autophagosome maturation; P:cellular response to starvation; P:chaperone-mediated autophagy; P:establishment of protein localization to organelle; P:lysosomal protein catabolic process; P:muscle cell cellular homeostasis; P:negative regulation of protein-containing complex assembly; P:neutrophil degranulation; P:platelet degranulation; P:protein import; P:protein stabilization; P:protein targeting; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:regulation of protein stability;|P13473 A8K4X5 D3DTF0 Q16641 Q6Q3G8 Q96J30 Q99534 Q9UD93,Lysosome-associated membrane glycoprotein 2,CD107 antigen-like family member B;LGP-96 {ECO:0000303|PubMed:8662539};, PF01299;, GO:0044754;GO:0035577;GO:0061742;GO:0070062;GO:0005615;GO:0101003;GO:0097637;GO:0005770;GO:0031902;GO:0043202;GO:1990836;GO:0005765;GO:0005764;GO:0016020;GO:0045121;GO:0048471;GO:0030670;GO:0005886;GO:0031088;GO:0005802;GO:0019899;GO:0019904;GO:0097352;GO:0009267;GO:0061684;GO:0072594;GO:1905146;GO:0046716;GO:0031333;GO:0043312;GO:0002576;GO:0017038;GO:0050821;GO:0006605;GO:0061740;GO:0031647;, C:autolysosome; C:azurophil granule membrane; C:chaperone-mediated autophagy translocation complex; C:extracellular exosome; C:extracellular space; C:ficolin-1-rich granule membrane; C:integral component of autophagosome membrane; C:late endosome; C:late endosome membrane; C:lysosomal lumen; C:lysosomal matrix; C:lysosomal membrane; C:lysosome; C:membrane; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:platelet dense granule membrane; C:trans-Golgi network;, F:enzyme binding; F:protein domain specific binding;, P:autophagosome maturation; P:cellular response to starvation; P:chaperone-mediated autophagy; P:establishment of protein localization to organelle; P:lysosomal protein catabolic process; P:muscle cell cellular homeostasis; P:negative regulation of protein-containing complex assembly; P:neutrophil degranulation; P:platelet degranulation; P:protein import; P:protein stabilization; P:protein targeting; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:regulation of protein stability; scaffold85 indexed_genome mRNA 6450406 6453228 . - . ID=transcript_12282;P13473 A8K4X5 D3DTF0 Q16641 Q6Q3G8 Q96J30 Q99534 Q9UD93,Lysosome-associated membrane glycoprotein 2,CD107 antigen-like family member B;LGP-96 {ECO:0000303|PubMed:8662539};, PF01299;, GO:0044754;GO:0035577;GO:0061742;GO:0070062;GO:0005615;GO:0101003;GO:0097637;GO:0005770;GO:0031902;GO:0043202;GO:1990836;GO:0005765;GO:0005764;GO:0016020;GO:0045121;GO:0048471;GO:0030670;GO:0005886;GO:0031088;GO:0005802;GO:0019899;GO:0019904;GO:0097352;GO:0009267;GO:0061684;GO:0072594;GO:1905146;GO:0046716;GO:0031333;GO:0043312;GO:0002576;GO:0017038;GO:0050821;GO:0006605;GO:0061740;GO:0031647;, C:autolysosome; C:azurophil granule membrane; C:chaperone-mediated autophagy translocation complex; C:extracellular exosome; C:extracellular space; C:ficolin-1-rich granule membrane; C:integral component of autophagosome membrane; C:late endosome; C:late endosome membrane; C:lysosomal lumen; C:lysosomal matrix; C:lysosomal membrane; C:lysosome; C:membrane; C:membrane raft; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:platelet dense granule membrane; C:trans-Golgi network;, F:enzyme binding; F:protein domain specific binding;, P:autophagosome maturation; P:cellular response to starvation; P:chaperone-mediated autophagy; P:establishment of protein localization to organelle; P:lysosomal protein catabolic process; P:muscle cell cellular homeostasis; P:negative regulation of protein-containing complex assembly; P:neutrophil degranulation; P:platelet degranulation; P:protein import; P:protein stabilization; P:protein targeting; P:protein targeting to lysosome involved in chaperone-mediated autophagy; P:regulation of protein stability; scaffold85 indexed_genome mRNA 6488744 6508670 . - . ID=transcript_12283;Q9UN42 Q17RR0 Q9UN41,Protein ATP1B4,X,K-ATPase subunit beta-m;X/potassium-transporting ATPase subunit beta-m;, PF00287;, GO:0005887;GO:0005635;GO:0005637;GO:0005890;GO:0022890;GO:0045944;GO:0006813;GO:0006355;GO:0006814;, C:integral component of plasma membrane; C:nuclear envelope; C:nuclear inner membrane; C:sodium:potassium-exchanging ATPase complex;, F:inorganic cation transmembrane transporter activity;, P:positive regulation of transcription by RNA polymerase II; P:potassium ion transport; P:regulation of transcription, DNA-templated; P:sodium ion transport;|Q9UN42 Q17RR0 Q9UN41,Protein ATP1B4,X,K-ATPase subunit beta-m;X/potassium-transporting ATPase subunit beta-m;, PF00287;, GO:0005887;GO:0005635;GO:0005637;GO:0005890;GO:0022890;GO:0045944;GO:0006813;GO:0006355;GO:0006814;, C:integral component of plasma membrane; C:nuclear envelope; C:nuclear inner membrane; C:sodium:potassium-exchanging ATPase complex;, F:inorganic cation transmembrane transporter activity;, P:positive regulation of transcription by RNA polymerase II; P:potassium ion transport; P:regulation of transcription, DNA-templated; P:sodium ion transport;|Q9UN42 Q17RR0 Q9UN41,Protein ATP1B4,X,K-ATPase subunit beta-m;X/potassium-transporting ATPase subunit beta-m;, PF00287;, GO:0005887;GO:0005635;GO:0005637;GO:0005890;GO:0022890;GO:0045944;GO:0006813;GO:0006355;GO:0006814;, C:integral component of plasma membrane; C:nuclear envelope; C:nuclear inner membrane; C:sodium:potassium-exchanging ATPase complex;, F:inorganic cation transmembrane transporter activity;, P:positive regulation of transcription by RNA polymerase II; P:potassium ion transport; P:regulation of transcription, DNA-templated; P:sodium ion transport;|Q9UN42 Q17RR0 Q9UN41,Protein ATP1B4,X,K-ATPase subunit beta-m;X/potassium-transporting ATPase subunit beta-m;, PF00287;, GO:0005887;GO:0005635;GO:0005637;GO:0005890;GO:0022890;GO:0045944;GO:0006813;GO:0006355;GO:0006814;, C:integral component of plasma membrane; C:nuclear envelope; C:nuclear inner membrane; C:sodium:potassium-exchanging ATPase complex;, F:inorganic cation transmembrane transporter activity;, P:positive regulation of transcription by RNA polymerase II; P:potassium ion transport; P:regulation of transcription, DNA-templated; P:sodium ion transport; scaffold85 indexed_genome mRNA 6508736 6509873 . - . ID=transcript_12284;Q9UN42 Q17RR0 Q9UN41,Protein ATP1B4,X,K-ATPase subunit beta-m;X/potassium-transporting ATPase subunit beta-m;, PF00287;, GO:0005887;GO:0005635;GO:0005637;GO:0005890;GO:0022890;GO:0045944;GO:0006813;GO:0006355;GO:0006814;, C:integral component of plasma membrane; C:nuclear envelope; C:nuclear inner membrane; C:sodium:potassium-exchanging ATPase complex;, F:inorganic cation transmembrane transporter activity;, P:positive regulation of transcription by RNA polymerase II; P:potassium ion transport; P:regulation of transcription, DNA-templated; P:sodium ion transport; scaffold85 indexed_genome mRNA 6559167 6608468 . + . ID=transcript_12285;Q5JRV8 A8K0W9 B1APR4 B3KPI6 E9PAR3 Q86Y72 Q9NWN8,Transmembrane protein 255A,Protein FAM70A;, PF14967;, GO:0016021;, C:integral component of membrane; scaffold85 indexed_genome mRNA 6611606 6616515 . - . ID=transcript_12286;Q86T24 B2R5U6 O00319 Q7Z361 Q8IVP6 Q8N3P0,Transcriptional regulator Kaiso,Zinc finger and BTB domain-containing protein 33;, PF00651;, GO:0000785;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0000981;GO:0001227;GO:0046872;GO:0008327;GO:0000978;GO:0043565;GO:1990837;GO:0035556;GO:0045892;GO:0006357;GO:0016055;, C:chromatin; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:methyl-CpG binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:intracellular signal transduction; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway; scaffold86 indexed_genome mRNA 31794 58066 . + . ID=transcript_12287;Q14498 A2RRD3 A5D8W2 B0BLV3 E1P5S0 E1P5S1 Q14499,RNA-binding protein 39 {ECO:0000303|PubMed:28302793},CAPER alpha {ECO:0000303|PubMed:24795046, ECO:0000303|PubMed:28437394};Hepatocellular carcinoma protein 1 {ECO:0000303|PubMed:8227358};RNA-binding motif protein 39;RNA-binding region-containing protein 2;Splicing factor HCC1;, PF15519;PF00076;, GO:0034451;GO:0015630;GO:0016607;GO:0005654;GO:0032991;GO:0003723;GO:0050733;GO:0006397;GO:0048024;GO:0006396;GO:0008380;, C:centriolar satellite; C:microtubule cytoskeleton; C:nuclear speck; C:nucleoplasm; C:protein-containing complex;, F:RNA binding; F:RS domain binding;, P:mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing;|Q14498 A2RRD3 A5D8W2 B0BLV3 E1P5S0 E1P5S1 Q14499,RNA-binding protein 39 {ECO:0000303|PubMed:28302793},CAPER alpha {ECO:0000303|PubMed:24795046, ECO:0000303|PubMed:28437394};Hepatocellular carcinoma protein 1 {ECO:0000303|PubMed:8227358};RNA-binding motif protein 39;RNA-binding region-containing protein 2;Splicing factor HCC1;, PF15519;PF00076;, GO:0034451;GO:0015630;GO:0016607;GO:0005654;GO:0032991;GO:0003723;GO:0050733;GO:0006397;GO:0048024;GO:0006396;GO:0008380;, C:centriolar satellite; C:microtubule cytoskeleton; C:nuclear speck; C:nucleoplasm; C:protein-containing complex;, F:RNA binding; F:RS domain binding;, P:mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing;|Q14498 A2RRD3 A5D8W2 B0BLV3 E1P5S0 E1P5S1 Q14499,RNA-binding protein 39 {ECO:0000303|PubMed:28302793},CAPER alpha {ECO:0000303|PubMed:24795046, ECO:0000303|PubMed:28437394};Hepatocellular carcinoma protein 1 {ECO:0000303|PubMed:8227358};RNA-binding motif protein 39;RNA-binding region-containing protein 2;Splicing factor HCC1;, PF15519;PF00076;, GO:0034451;GO:0015630;GO:0016607;GO:0005654;GO:0032991;GO:0003723;GO:0050733;GO:0006397;GO:0048024;GO:0006396;GO:0008380;, C:centriolar satellite; C:microtubule cytoskeleton; C:nuclear speck; C:nucleoplasm; C:protein-containing complex;, F:RNA binding; F:RS domain binding;, P:mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing;|Q14498 A2RRD3 A5D8W2 B0BLV3 E1P5S0 E1P5S1 Q14499,RNA-binding protein 39 {ECO:0000303|PubMed:28302793},CAPER alpha {ECO:0000303|PubMed:24795046, ECO:0000303|PubMed:28437394};Hepatocellular carcinoma protein 1 {ECO:0000303|PubMed:8227358};RNA-binding motif protein 39;RNA-binding region-containing protein 2;Splicing factor HCC1;, PF15519;PF00076;, GO:0034451;GO:0015630;GO:0016607;GO:0005654;GO:0032991;GO:0003723;GO:0050733;GO:0006397;GO:0048024;GO:0006396;GO:0008380;, C:centriolar satellite; C:microtubule cytoskeleton; C:nuclear speck; C:nucleoplasm; C:protein-containing complex;, F:RNA binding; F:RS domain binding;, P:mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing;|Q14498 A2RRD3 A5D8W2 B0BLV3 E1P5S0 E1P5S1 Q14499,RNA-binding protein 39 {ECO:0000303|PubMed:28302793},CAPER alpha {ECO:0000303|PubMed:24795046, ECO:0000303|PubMed:28437394};Hepatocellular carcinoma protein 1 {ECO:0000303|PubMed:8227358};RNA-binding motif protein 39;RNA-binding region-containing protein 2;Splicing factor HCC1;, PF15519;PF00076;, GO:0034451;GO:0015630;GO:0016607;GO:0005654;GO:0032991;GO:0003723;GO:0050733;GO:0006397;GO:0048024;GO:0006396;GO:0008380;, C:centriolar satellite; C:microtubule cytoskeleton; C:nuclear speck; C:nucleoplasm; C:protein-containing complex;, F:RNA binding; F:RS domain binding;, P:mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing;|Q14498 A2RRD3 A5D8W2 B0BLV3 E1P5S0 E1P5S1 Q14499,RNA-binding protein 39 {ECO:0000303|PubMed:28302793},CAPER alpha {ECO:0000303|PubMed:24795046, ECO:0000303|PubMed:28437394};Hepatocellular carcinoma protein 1 {ECO:0000303|PubMed:8227358};RNA-binding motif protein 39;RNA-binding region-containing protein 2;Splicing factor HCC1;, PF15519;PF00076;, GO:0034451;GO:0015630;GO:0016607;GO:0005654;GO:0032991;GO:0003723;GO:0050733;GO:0006397;GO:0048024;GO:0006396;GO:0008380;, C:centriolar satellite; C:microtubule cytoskeleton; C:nuclear speck; C:nucleoplasm; C:protein-containing complex;, F:RNA binding; F:RS domain binding;, P:mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA processing; P:RNA splicing; scaffold86 indexed_genome mRNA 59325 79262 . + . ID=transcript_12288;Q9Y697 B3KMA5 B4DXK9 E1P5R8 F5GYK5 Q6P0L8 Q9NTZ5 Q9Y481,Cysteine desulfurase, mitochondrial,, PF00266;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0031071;GO:0051536;GO:0046872;GO:0042803;GO:0030170;GO:0044571;GO:0018283;GO:0016226;GO:0006777;GO:0032324;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine desulfurase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:[2Fe-2S] cluster assembly; P:iron incorporation into metallo-sulfur cluster; P:iron-sulfur cluster assembly; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process;|P60602 A7M872 E1P5R9 E9KL28 Q3MHD5 Q5QP16 Q9CQ98 Q9H1N2,Reactive oxygen species modulator 1,Epididymis tissue protein Li 175;Glyrichin;Mitochondrial targeting GxxxG motif protein;Protein MGR2 homolog;, PF10247;, GO:0016021;GO:0005739;GO:0005744;GO:0061844;GO:0034614;GO:0051838;GO:0042742;GO:0050829;GO:0050830;GO:0031640;GO:0008284;GO:2000379;GO:0030150;GO:0045039;GO:0090399;, C:integral component of membrane; C:mitochondrion; C:TIM23 mitochondrial import inner membrane translocase complex;, , P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular response to reactive oxygen species; P:cytolysis by host of symbiont cells; P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:killing of cells of other organism; P:positive regulation of cell population proliferation; P:positive regulation of reactive oxygen species metabolic process; P:protein import into mitochondrial matrix; P:protein insertion into mitochondrial inner membrane; P:replicative senescence;|Q9Y697 B3KMA5 B4DXK9 E1P5R8 F5GYK5 Q6P0L8 Q9NTZ5 Q9Y481,Cysteine desulfurase, mitochondrial,, PF00266;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0031071;GO:0051536;GO:0046872;GO:0042803;GO:0030170;GO:0044571;GO:0018283;GO:0016226;GO:0006777;GO:0032324;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine desulfurase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:[2Fe-2S] cluster assembly; P:iron incorporation into metallo-sulfur cluster; P:iron-sulfur cluster assembly; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process;|Q9Y697 B3KMA5 B4DXK9 E1P5R8 F5GYK5 Q6P0L8 Q9NTZ5 Q9Y481,Cysteine desulfurase, mitochondrial,, PF00266;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0031071;GO:0051536;GO:0046872;GO:0042803;GO:0030170;GO:0044571;GO:0018283;GO:0016226;GO:0006777;GO:0032324;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine desulfurase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:[2Fe-2S] cluster assembly; P:iron incorporation into metallo-sulfur cluster; P:iron-sulfur cluster assembly; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process;|Q9Y697 B3KMA5 B4DXK9 E1P5R8 F5GYK5 Q6P0L8 Q9NTZ5 Q9Y481,Cysteine desulfurase, mitochondrial,, PF00266;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0031071;GO:0051536;GO:0046872;GO:0042803;GO:0030170;GO:0044571;GO:0018283;GO:0016226;GO:0006777;GO:0032324;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine desulfurase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:[2Fe-2S] cluster assembly; P:iron incorporation into metallo-sulfur cluster; P:iron-sulfur cluster assembly; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process;|Q9Y697 B3KMA5 B4DXK9 E1P5R8 F5GYK5 Q6P0L8 Q9NTZ5 Q9Y481,Cysteine desulfurase, mitochondrial,, PF00266;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0031071;GO:0051536;GO:0046872;GO:0042803;GO:0030170;GO:0044571;GO:0018283;GO:0016226;GO:0006777;GO:0032324;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine desulfurase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:[2Fe-2S] cluster assembly; P:iron incorporation into metallo-sulfur cluster; P:iron-sulfur cluster assembly; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process;|Q9Y697 B3KMA5 B4DXK9 E1P5R8 F5GYK5 Q6P0L8 Q9NTZ5 Q9Y481,Cysteine desulfurase, mitochondrial,, PF00266;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0031071;GO:0051536;GO:0046872;GO:0042803;GO:0030170;GO:0044571;GO:0018283;GO:0016226;GO:0006777;GO:0032324;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine desulfurase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:protein homodimerization activity; F:pyridoxal phosphate binding;, P:[2Fe-2S] cluster assembly; P:iron incorporation into metallo-sulfur cluster; P:iron-sulfur cluster assembly; P:Mo-molybdopterin cofactor biosynthetic process; P:molybdopterin cofactor biosynthetic process; scaffold86 indexed_genome mRNA 82137 95726 . - . ID=transcript_12289;Q9NTZ6 B3KRU2 E1P5R6 O94865 Q8N3B1 Q9H196,RNA-binding protein 12,RNA-binding motif protein 12;SH3/WW domain anchor protein in the nucleus;, PF00076;, GO:0005654;GO:1990904;GO:0003723;GO:0043484;, C:nucleoplasm; C:ribonucleoprotein complex;, F:RNA binding;, P:regulation of RNA splicing; scaffold86 indexed_genome mRNA 109622 111600 . - . ID=transcript_12290;Q99829 E1P5Q4 Q6IBL3 Q9H243 Q9NTZ7,Copine-1 {ECO:0000305},Chromobindin 17 {ECO:0000303|PubMed:9430674};Copine I {ECO:0000303|PubMed:9430674, ECO:0000312|HGNC:HGNC:2314};, PF00168;PF07002;, GO:0035577;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0005509;GO:0005544;GO:0004175;GO:0042802;GO:0051059;GO:0001786;GO:0005215;GO:0071277;GO:0046474;GO:0006629;GO:0043392;GO:0010629;GO:1901223;GO:1990138;GO:0043312;GO:0045666;GO:0051897;GO:1903265;GO:0006508;GO:0043122;GO:0016192;, C:azurophil granule membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:endopeptidase activity; F:identical protein binding; F:NF-kappaB binding; F:phosphatidylserine binding; F:transporter activity;, P:cellular response to calcium ion; P:glycerophospholipid biosynthetic process; P:lipid metabolic process; P:negative regulation of DNA binding; P:negative regulation of gene expression; P:negative regulation of NIK/NF-kappaB signaling; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of neuron differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:proteolysis; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:vesicle-mediated transport; scaffold86 indexed_genome mRNA 111779 121690 . + . ID=transcript_12291;Q99829 E1P5Q4 Q6IBL3 Q9H243 Q9NTZ7,Copine-1 {ECO:0000305},Chromobindin 17 {ECO:0000303|PubMed:9430674};Copine I {ECO:0000303|PubMed:9430674, ECO:0000312|HGNC:HGNC:2314};, PF00168;PF07002;, GO:0035577;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0005509;GO:0005544;GO:0004175;GO:0042802;GO:0051059;GO:0001786;GO:0005215;GO:0071277;GO:0046474;GO:0006629;GO:0043392;GO:0010629;GO:1901223;GO:1990138;GO:0043312;GO:0045666;GO:0051897;GO:1903265;GO:0006508;GO:0043122;GO:0016192;, C:azurophil granule membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:endopeptidase activity; F:identical protein binding; F:NF-kappaB binding; F:phosphatidylserine binding; F:transporter activity;, P:cellular response to calcium ion; P:glycerophospholipid biosynthetic process; P:lipid metabolic process; P:negative regulation of DNA binding; P:negative regulation of gene expression; P:negative regulation of NIK/NF-kappaB signaling; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of neuron differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:proteolysis; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:vesicle-mediated transport;|Q99829 E1P5Q4 Q6IBL3 Q9H243 Q9NTZ7,Copine-1 {ECO:0000305},Chromobindin 17 {ECO:0000303|PubMed:9430674};Copine I {ECO:0000303|PubMed:9430674, ECO:0000312|HGNC:HGNC:2314};, PF00168;PF07002;, GO:0035577;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0005509;GO:0005544;GO:0004175;GO:0042802;GO:0051059;GO:0001786;GO:0005215;GO:0071277;GO:0046474;GO:0006629;GO:0043392;GO:0010629;GO:1901223;GO:1990138;GO:0043312;GO:0045666;GO:0051897;GO:1903265;GO:0006508;GO:0043122;GO:0016192;, C:azurophil granule membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:endopeptidase activity; F:identical protein binding; F:NF-kappaB binding; F:phosphatidylserine binding; F:transporter activity;, P:cellular response to calcium ion; P:glycerophospholipid biosynthetic process; P:lipid metabolic process; P:negative regulation of DNA binding; P:negative regulation of gene expression; P:negative regulation of NIK/NF-kappaB signaling; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of neuron differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:proteolysis; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:vesicle-mediated transport;|Q99829 E1P5Q4 Q6IBL3 Q9H243 Q9NTZ7,Copine-1 {ECO:0000305},Chromobindin 17 {ECO:0000303|PubMed:9430674};Copine I {ECO:0000303|PubMed:9430674, ECO:0000312|HGNC:HGNC:2314};, PF00168;PF07002;, GO:0035577;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0005509;GO:0005544;GO:0004175;GO:0042802;GO:0051059;GO:0001786;GO:0005215;GO:0071277;GO:0046474;GO:0006629;GO:0043392;GO:0010629;GO:1901223;GO:1990138;GO:0043312;GO:0045666;GO:0051897;GO:1903265;GO:0006508;GO:0043122;GO:0016192;, C:azurophil granule membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:endopeptidase activity; F:identical protein binding; F:NF-kappaB binding; F:phosphatidylserine binding; F:transporter activity;, P:cellular response to calcium ion; P:glycerophospholipid biosynthetic process; P:lipid metabolic process; P:negative regulation of DNA binding; P:negative regulation of gene expression; P:negative regulation of NIK/NF-kappaB signaling; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of neuron differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:proteolysis; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:vesicle-mediated transport;|Q99829 E1P5Q4 Q6IBL3 Q9H243 Q9NTZ7,Copine-1 {ECO:0000305},Chromobindin 17 {ECO:0000303|PubMed:9430674};Copine I {ECO:0000303|PubMed:9430674, ECO:0000312|HGNC:HGNC:2314};, PF00168;PF07002;, GO:0035577;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0005886;GO:0005509;GO:0005544;GO:0004175;GO:0042802;GO:0051059;GO:0001786;GO:0005215;GO:0071277;GO:0046474;GO:0006629;GO:0043392;GO:0010629;GO:1901223;GO:1990138;GO:0043312;GO:0045666;GO:0051897;GO:1903265;GO:0006508;GO:0043122;GO:0016192;, C:azurophil granule membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:endopeptidase activity; F:identical protein binding; F:NF-kappaB binding; F:phosphatidylserine binding; F:transporter activity;, P:cellular response to calcium ion; P:glycerophospholipid biosynthetic process; P:lipid metabolic process; P:negative regulation of DNA binding; P:negative regulation of gene expression; P:negative regulation of NIK/NF-kappaB signaling; P:neuron projection extension; P:neutrophil degranulation; P:positive regulation of neuron differentiation; P:positive regulation of protein kinase B signaling; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:proteolysis; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:vesicle-mediated transport; scaffold86 indexed_genome mRNA 122112 125009 . - . ID=transcript_12292;Q9NPE6 O43648,Sperm-associated antigen 4 protein,Outer dense fiber-associated protein SPAG4;SUN domain-containing protein 4;, PF07738;, GO:0005737;GO:0005856;GO:0016021;GO:0034993;GO:0031514;GO:0005635;GO:0005637;GO:0043495;GO:0005198;GO:0030154;GO:0006998;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:motile cilium; C:nuclear envelope; C:nuclear inner membrane;, F:protein-membrane adaptor activity; F:structural molecule activity;, P:cell differentiation; P:nuclear envelope organization; P:spermatogenesis;|Q9NPE6 O43648,Sperm-associated antigen 4 protein,Outer dense fiber-associated protein SPAG4;SUN domain-containing protein 4;, PF07738;, GO:0005737;GO:0005856;GO:0016021;GO:0034993;GO:0031514;GO:0005635;GO:0005637;GO:0043495;GO:0005198;GO:0030154;GO:0006998;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:motile cilium; C:nuclear envelope; C:nuclear inner membrane;, F:protein-membrane adaptor activity; F:structural molecule activity;, P:cell differentiation; P:nuclear envelope organization; P:spermatogenesis; scaffold86 indexed_genome mRNA 125119 125693 . + . ID=transcript_12293;Q9NPE6 O43648,Sperm-associated antigen 4 protein,Outer dense fiber-associated protein SPAG4;SUN domain-containing protein 4;, PF07738;, GO:0005737;GO:0005856;GO:0016021;GO:0034993;GO:0031514;GO:0005635;GO:0005637;GO:0043495;GO:0005198;GO:0030154;GO:0006998;GO:0007283;, C:cytoplasm; C:cytoskeleton; C:integral component of membrane; C:meiotic nuclear membrane microtubule tethering complex; C:motile cilium; C:nuclear envelope; C:nuclear inner membrane;, F:protein-membrane adaptor activity; F:structural molecule activity;, P:cell differentiation; P:nuclear envelope organization; P:spermatogenesis; scaffold86 indexed_genome mRNA 173474 177973 . - . ID=transcript_12294;Q9Y282 Q5JWS3 Q6ZWP7 Q9H276 Q9P1L3,Endoplasmic reticulum-Golgi intermediate compartment protein 3,Serologically defined breast cancer antigen NY-BR-84;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0033116;GO:0030176;GO:0030173;GO:0016020;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y282 Q5JWS3 Q6ZWP7 Q9H276 Q9P1L3,Endoplasmic reticulum-Golgi intermediate compartment protein 3,Serologically defined breast cancer antigen NY-BR-84;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0033116;GO:0030176;GO:0030173;GO:0016020;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y282 Q5JWS3 Q6ZWP7 Q9H276 Q9P1L3,Endoplasmic reticulum-Golgi intermediate compartment protein 3,Serologically defined breast cancer antigen NY-BR-84;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0033116;GO:0030176;GO:0030173;GO:0016020;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y282 Q5JWS3 Q6ZWP7 Q9H276 Q9P1L3,Endoplasmic reticulum-Golgi intermediate compartment protein 3,Serologically defined breast cancer antigen NY-BR-84;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0033116;GO:0030176;GO:0030173;GO:0016020;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold86 indexed_genome mRNA 178015 186493 . - . ID=transcript_12295;Q9Y282 Q5JWS3 Q6ZWP7 Q9H276 Q9P1L3,Endoplasmic reticulum-Golgi intermediate compartment protein 3,Serologically defined breast cancer antigen NY-BR-84;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0033116;GO:0030176;GO:0030173;GO:0016020;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y282 Q5JWS3 Q6ZWP7 Q9H276 Q9P1L3,Endoplasmic reticulum-Golgi intermediate compartment protein 3,Serologically defined breast cancer antigen NY-BR-84;, PF07970;PF13850;, GO:0030134;GO:0005783;GO:0033116;GO:0030176;GO:0030173;GO:0016020;GO:0006888;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of Golgi membrane; C:membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold86 indexed_genome mRNA 206734 251512 . + . ID=transcript_12296;Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle;|Q9BV73 E1P5Q3 O14812 O60588 Q9H450,Centrosome-associated protein CEP250,250 kDa centrosomal protein;Centrosomal Nek2-associated protein 1;Centrosomal protein 2;, , GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0070062;GO:0005815;GO:0048471;GO:0001917;GO:0001750;GO:0032991;GO:0008022;GO:0019904;GO:0019901;GO:0010457;GO:0097711;GO:0060271;GO:0050908;GO:0000086;GO:0000278;GO:1905515;GO:1904781;GO:0008104;GO:0033365;GO:0030997;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:extracellular exosome; C:microtubule organizing center; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:photoreceptor outer segment; C:protein-containing complex;, F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding;, P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:detection of light stimulus involved in visual perception; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:non-motile cilium assembly; P:positive regulation of protein localization to centrosome; P:protein localization; P:protein localization to organelle; P:regulation of centriole-centriole cohesion; P:regulation of G2/M transition of mitotic cell cycle; scaffold86 indexed_genome mRNA 277083 277836 . - . ID=transcript_12297;P43026 E1P5Q2 Q96SB1,Growth/differentiation factor 5,Bone morphogenetic protein 14;Cartilage-derived morphogenetic protein 1;Lipopolysaccharide-associated protein 4;Radotermin;, PF00019;PF00688;, GO:0005576;GO:0005615;GO:0005886;GO:0036122;GO:0005125;GO:0008083;GO:0042802;GO:0030509;GO:0007267;GO:0060591;GO:0030326;GO:0035136;GO:0035137;GO:0032331;GO:0050680;GO:2001054;GO:0043524;GO:0043932;GO:0030513;GO:0032332;GO:0045666;GO:0010862;GO:0040014;GO:0060390;GO:0009612;GO:0060395;GO:0007179;, C:extracellular region; C:extracellular space; C:plasma membrane;, F:BMP binding; F:cytokine activity; F:growth factor activity; F:identical protein binding;, P:BMP signaling pathway; P:cell-cell signaling; P:chondroblast differentiation; P:embryonic limb morphogenesis; P:forelimb morphogenesis; P:hindlimb morphogenesis; P:negative regulation of chondrocyte differentiation; P:negative regulation of epithelial cell proliferation; P:negative regulation of mesenchymal cell apoptotic process; P:negative regulation of neuron apoptotic process; P:ossification involved in bone remodeling; P:positive regulation of BMP signaling pathway; P:positive regulation of chondrocyte differentiation; P:positive regulation of neuron differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:regulation of multicellular organism growth; P:regulation of SMAD protein signal transduction; P:response to mechanical stimulus; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; scaffold86 indexed_genome mRNA 289479 382723 . + . ID=transcript_12298;Q9H438 Q9H452 Q9H9K8 Q9H9R5,Ubiquinol-cytochrome-c reductase complex assembly factor 1,Basic FGF-repressed Zic-binding protein;Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog;, PF03981;, GO:0031410;GO:0005743;GO:0034551;GO:0070131;, C:cytoplasmic vesicle; C:mitochondrial inner membrane;, , P:mitochondrial respiratory chain complex III assembly; P:positive regulation of mitochondrial translation;|Q9H438 Q9H452 Q9H9K8 Q9H9R5,Ubiquinol-cytochrome-c reductase complex assembly factor 1,Basic FGF-repressed Zic-binding protein;Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog;, PF03981;, GO:0031410;GO:0005743;GO:0034551;GO:0070131;, C:cytoplasmic vesicle; C:mitochondrial inner membrane;, , P:mitochondrial respiratory chain complex III assembly; P:positive regulation of mitochondrial translation;|Q9H438 Q9H452 Q9H9K8 Q9H9R5,Ubiquinol-cytochrome-c reductase complex assembly factor 1,Basic FGF-repressed Zic-binding protein;Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog;, PF03981;, GO:0031410;GO:0005743;GO:0034551;GO:0070131;, C:cytoplasmic vesicle; C:mitochondrial inner membrane;, , P:mitochondrial respiratory chain complex III assembly; P:positive regulation of mitochondrial translation; scaffold86 indexed_genome mRNA 401954 440652 . + . ID=transcript_12299;P56537 B7ZBG9 Q6IBN8 Q96TD5,Eukaryotic translation initiation factor 6 {ECO:0000255|HAMAP-Rule:MF_03132},B(2)GCN homolog;B4 integrin interactor;CAB;p27(BBP);, PF01912;, GO:0005737;GO:0005829;GO:0070062;GO:0005638;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0043023;GO:0043022;GO:0003743;GO:1902626;GO:0035195;GO:0000460;GO:0000470;GO:0042256;GO:0035278;GO:0045727;GO:0042304;GO:0006110;GO:0045652;GO:2000377;GO:0032868;GO:0000054;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamin filament; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ribosomal large subunit binding; F:ribosome binding; F:translation initiation factor activity;, P:assembly of large subunit precursor of preribosome; P:gene silencing by miRNA; P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:mature ribosome assembly; P:miRNA mediated inhibition of translation; P:positive regulation of translation; P:regulation of fatty acid biosynthetic process; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of reactive oxygen species metabolic process; P:response to insulin; P:ribosomal subunit export from nucleus;|P56537 B7ZBG9 Q6IBN8 Q96TD5,Eukaryotic translation initiation factor 6 {ECO:0000255|HAMAP-Rule:MF_03132},B(2)GCN homolog;B4 integrin interactor;CAB;p27(BBP);, PF01912;, GO:0005737;GO:0005829;GO:0070062;GO:0005638;GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0043023;GO:0043022;GO:0003743;GO:1902626;GO:0035195;GO:0000460;GO:0000470;GO:0042256;GO:0035278;GO:0045727;GO:0042304;GO:0006110;GO:0045652;GO:2000377;GO:0032868;GO:0000054;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:lamin filament; C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, F:ribosomal large subunit binding; F:ribosome binding; F:translation initiation factor activity;, P:assembly of large subunit precursor of preribosome; P:gene silencing by miRNA; P:maturation of 5.8S rRNA; P:maturation of LSU-rRNA; P:mature ribosome assembly; P:miRNA mediated inhibition of translation; P:positive regulation of translation; P:regulation of fatty acid biosynthetic process; P:regulation of glycolytic process; P:regulation of megakaryocyte differentiation; P:regulation of reactive oxygen species metabolic process; P:response to insulin; P:ribosomal subunit export from nucleus;|Q9Y5R2 B7ZBG8 Q9H440,Matrix metalloproteinase-24,Membrane-type matrix metalloproteinase 5;Membrane-type-5 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0070062;GO:0031012;GO:0005887;GO:0032588;GO:0045296;GO:0008047;GO:0004222;GO:0008270;GO:0044331;GO:0098742;GO:0030574;GO:0050965;GO:0030198;GO:0010001;GO:0097150;GO:0006508;, C:extracellular exosome; C:extracellular matrix; C:integral component of plasma membrane; C:trans-Golgi network membrane;, F:cadherin binding; F:enzyme activator activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:collagen catabolic process; P:detection of temperature stimulus involved in sensory perception of pain; P:extracellular matrix organization; P:glial cell differentiation; P:neuronal stem cell population maintenance; P:proteolysis;|Q9Y5R2 B7ZBG8 Q9H440,Matrix metalloproteinase-24,Membrane-type matrix metalloproteinase 5;Membrane-type-5 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0070062;GO:0031012;GO:0005887;GO:0032588;GO:0045296;GO:0008047;GO:0004222;GO:0008270;GO:0044331;GO:0098742;GO:0030574;GO:0050965;GO:0030198;GO:0010001;GO:0097150;GO:0006508;, C:extracellular exosome; C:extracellular matrix; C:integral component of plasma membrane; C:trans-Golgi network membrane;, F:cadherin binding; F:enzyme activator activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:collagen catabolic process; P:detection of temperature stimulus involved in sensory perception of pain; P:extracellular matrix organization; P:glial cell differentiation; P:neuronal stem cell population maintenance; P:proteolysis;|Q9Y5R2 B7ZBG8 Q9H440,Matrix metalloproteinase-24,Membrane-type matrix metalloproteinase 5;Membrane-type-5 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0070062;GO:0031012;GO:0005887;GO:0032588;GO:0045296;GO:0008047;GO:0004222;GO:0008270;GO:0044331;GO:0098742;GO:0030574;GO:0050965;GO:0030198;GO:0010001;GO:0097150;GO:0006508;, C:extracellular exosome; C:extracellular matrix; C:integral component of plasma membrane; C:trans-Golgi network membrane;, F:cadherin binding; F:enzyme activator activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:collagen catabolic process; P:detection of temperature stimulus involved in sensory perception of pain; P:extracellular matrix organization; P:glial cell differentiation; P:neuronal stem cell population maintenance; P:proteolysis;|Q9Y5R2 B7ZBG8 Q9H440,Matrix metalloproteinase-24,Membrane-type matrix metalloproteinase 5;Membrane-type-5 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0070062;GO:0031012;GO:0005887;GO:0032588;GO:0045296;GO:0008047;GO:0004222;GO:0008270;GO:0044331;GO:0098742;GO:0030574;GO:0050965;GO:0030198;GO:0010001;GO:0097150;GO:0006508;, C:extracellular exosome; C:extracellular matrix; C:integral component of plasma membrane; C:trans-Golgi network membrane;, F:cadherin binding; F:enzyme activator activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:collagen catabolic process; P:detection of temperature stimulus involved in sensory perception of pain; P:extracellular matrix organization; P:glial cell differentiation; P:neuronal stem cell population maintenance; P:proteolysis;|Q9Y5R2 B7ZBG8 Q9H440,Matrix metalloproteinase-24,Membrane-type matrix metalloproteinase 5;Membrane-type-5 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0070062;GO:0031012;GO:0005887;GO:0032588;GO:0045296;GO:0008047;GO:0004222;GO:0008270;GO:0044331;GO:0098742;GO:0030574;GO:0050965;GO:0030198;GO:0010001;GO:0097150;GO:0006508;, C:extracellular exosome; C:extracellular matrix; C:integral component of plasma membrane; C:trans-Golgi network membrane;, F:cadherin binding; F:enzyme activator activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:collagen catabolic process; P:detection of temperature stimulus involved in sensory perception of pain; P:extracellular matrix organization; P:glial cell differentiation; P:neuronal stem cell population maintenance; P:proteolysis;|Q9Y5R2 B7ZBG8 Q9H440,Matrix metalloproteinase-24,Membrane-type matrix metalloproteinase 5;Membrane-type-5 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0070062;GO:0031012;GO:0005887;GO:0032588;GO:0045296;GO:0008047;GO:0004222;GO:0008270;GO:0044331;GO:0098742;GO:0030574;GO:0050965;GO:0030198;GO:0010001;GO:0097150;GO:0006508;, C:extracellular exosome; C:extracellular matrix; C:integral component of plasma membrane; C:trans-Golgi network membrane;, F:cadherin binding; F:enzyme activator activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:collagen catabolic process; P:detection of temperature stimulus involved in sensory perception of pain; P:extracellular matrix organization; P:glial cell differentiation; P:neuronal stem cell population maintenance; P:proteolysis;|Q9Y5R2 B7ZBG8 Q9H440,Matrix metalloproteinase-24,Membrane-type matrix metalloproteinase 5;Membrane-type-5 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0070062;GO:0031012;GO:0005887;GO:0032588;GO:0045296;GO:0008047;GO:0004222;GO:0008270;GO:0044331;GO:0098742;GO:0030574;GO:0050965;GO:0030198;GO:0010001;GO:0097150;GO:0006508;, C:extracellular exosome; C:extracellular matrix; C:integral component of plasma membrane; C:trans-Golgi network membrane;, F:cadherin binding; F:enzyme activator activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:collagen catabolic process; P:detection of temperature stimulus involved in sensory perception of pain; P:extracellular matrix organization; P:glial cell differentiation; P:neuronal stem cell population maintenance; P:proteolysis;|Q9Y5R2 B7ZBG8 Q9H440,Matrix metalloproteinase-24,Membrane-type matrix metalloproteinase 5;Membrane-type-5 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0070062;GO:0031012;GO:0005887;GO:0032588;GO:0045296;GO:0008047;GO:0004222;GO:0008270;GO:0044331;GO:0098742;GO:0030574;GO:0050965;GO:0030198;GO:0010001;GO:0097150;GO:0006508;, C:extracellular exosome; C:extracellular matrix; C:integral component of plasma membrane; C:trans-Golgi network membrane;, F:cadherin binding; F:enzyme activator activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:cell-cell adhesion mediated by cadherin; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:collagen catabolic process; P:detection of temperature stimulus involved in sensory perception of pain; P:extracellular matrix organization; P:glial cell differentiation; P:neuronal stem cell population maintenance; P:proteolysis; scaffold86 indexed_genome mRNA 507547 512198 . - . ID=transcript_12300;Q9UNN8 B2RC04 Q14218 Q6IB56 Q96CB3 Q9ULX1,Endothelial protein C receptor,Activated protein C receptor;Endothelial cell protein C receptor;, PF16497;, GO:0009986;GO:0005813;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005887;GO:0048471;GO:0005886;GO:0038023;GO:0007596;GO:0050819;, C:cell surface; C:centrosome; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:signaling receptor activity;, P:blood coagulation; P:negative regulation of coagulation; scaffold86 indexed_genome mRNA 532726 562688 . + . ID=transcript_12301;Q9BV94 B4DTG9 Q6GU33 Q6IA89 Q6UWZ4 Q9H4U0 Q9H886 Q9NTL9 Q9NVE6,ER degradation-enhancing alpha-mannosidase-like protein 2,, PF01532;, GO:0005783;GO:0005788;GO:0044322;GO:0016020;GO:0005509;GO:0004571;GO:0005975;GO:1904382;GO:1904154;GO:0006986;GO:0036511;GO:0036512;GO:0036509;GO:0036510;GO:0097466;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:mannose trimming involved in glycoprotein ERAD pathway; P:positive regulation of retrograde protein transport, ER to cytosol; P:response to unfolded protein; P:trimming of first mannose on A branch; P:trimming of second mannose on A branch; P:trimming of terminal mannose on B branch; P:trimming of terminal mannose on C branch; P:ubiquitin-dependent glycoprotein ERAD pathway; P:viral protein processing;|Q9BV94 B4DTG9 Q6GU33 Q6IA89 Q6UWZ4 Q9H4U0 Q9H886 Q9NTL9 Q9NVE6,ER degradation-enhancing alpha-mannosidase-like protein 2,, PF01532;, GO:0005783;GO:0005788;GO:0044322;GO:0016020;GO:0005509;GO:0004571;GO:0005975;GO:1904382;GO:1904154;GO:0006986;GO:0036511;GO:0036512;GO:0036509;GO:0036510;GO:0097466;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:mannose trimming involved in glycoprotein ERAD pathway; P:positive regulation of retrograde protein transport, ER to cytosol; P:response to unfolded protein; P:trimming of first mannose on A branch; P:trimming of second mannose on A branch; P:trimming of terminal mannose on B branch; P:trimming of terminal mannose on C branch; P:ubiquitin-dependent glycoprotein ERAD pathway; P:viral protein processing;|Q9BV94 B4DTG9 Q6GU33 Q6IA89 Q6UWZ4 Q9H4U0 Q9H886 Q9NTL9 Q9NVE6,ER degradation-enhancing alpha-mannosidase-like protein 2,, PF01532;, GO:0005783;GO:0005788;GO:0044322;GO:0016020;GO:0005509;GO:0004571;GO:0005975;GO:1904382;GO:1904154;GO:0006986;GO:0036511;GO:0036512;GO:0036509;GO:0036510;GO:0097466;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:mannose trimming involved in glycoprotein ERAD pathway; P:positive regulation of retrograde protein transport, ER to cytosol; P:response to unfolded protein; P:trimming of first mannose on A branch; P:trimming of second mannose on A branch; P:trimming of terminal mannose on B branch; P:trimming of terminal mannose on C branch; P:ubiquitin-dependent glycoprotein ERAD pathway; P:viral protein processing;|Q9BV94 B4DTG9 Q6GU33 Q6IA89 Q6UWZ4 Q9H4U0 Q9H886 Q9NTL9 Q9NVE6,ER degradation-enhancing alpha-mannosidase-like protein 2,, PF01532;, GO:0005783;GO:0005788;GO:0044322;GO:0016020;GO:0005509;GO:0004571;GO:0005975;GO:1904382;GO:1904154;GO:0006986;GO:0036511;GO:0036512;GO:0036509;GO:0036510;GO:0097466;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:mannose trimming involved in glycoprotein ERAD pathway; P:positive regulation of retrograde protein transport, ER to cytosol; P:response to unfolded protein; P:trimming of first mannose on A branch; P:trimming of second mannose on A branch; P:trimming of terminal mannose on B branch; P:trimming of terminal mannose on C branch; P:ubiquitin-dependent glycoprotein ERAD pathway; P:viral protein processing;|Q9BV94 B4DTG9 Q6GU33 Q6IA89 Q6UWZ4 Q9H4U0 Q9H886 Q9NTL9 Q9NVE6,ER degradation-enhancing alpha-mannosidase-like protein 2,, PF01532;, GO:0005783;GO:0005788;GO:0044322;GO:0016020;GO:0005509;GO:0004571;GO:0005975;GO:1904382;GO:1904154;GO:0006986;GO:0036511;GO:0036512;GO:0036509;GO:0036510;GO:0097466;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:mannose trimming involved in glycoprotein ERAD pathway; P:positive regulation of retrograde protein transport, ER to cytosol; P:response to unfolded protein; P:trimming of first mannose on A branch; P:trimming of second mannose on A branch; P:trimming of terminal mannose on B branch; P:trimming of terminal mannose on C branch; P:ubiquitin-dependent glycoprotein ERAD pathway; P:viral protein processing; scaffold86 indexed_genome mRNA 569362 578072 . - . ID=transcript_12302;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold86 indexed_genome mRNA 578123 675386 . + . ID=transcript_12303;Q8TEL6 E1P5Q0 E1P5Q1 Q96H82 Q9BVB8 Q9H429 Q9UFS6,Short transient receptor potential channel 4-associated protein,Protein TAP1;TNF-receptor ubiquitous scaffolding/signaling protein;, PF12463;, GO:0031464;GO:0005886;GO:0019902;GO:0070588;GO:0048820;GO:0016567;GO:0006511;, C:Cul4A-RING E3 ubiquitin ligase complex; C:plasma membrane;, F:phosphatase binding;, P:calcium ion transmembrane transport; P:hair follicle maturation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8TEL6 E1P5Q0 E1P5Q1 Q96H82 Q9BVB8 Q9H429 Q9UFS6,Short transient receptor potential channel 4-associated protein,Protein TAP1;TNF-receptor ubiquitous scaffolding/signaling protein;, PF12463;, GO:0031464;GO:0005886;GO:0019902;GO:0070588;GO:0048820;GO:0016567;GO:0006511;, C:Cul4A-RING E3 ubiquitin ligase complex; C:plasma membrane;, F:phosphatase binding;, P:calcium ion transmembrane transport; P:hair follicle maturation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8TEL6 E1P5Q0 E1P5Q1 Q96H82 Q9BVB8 Q9H429 Q9UFS6,Short transient receptor potential channel 4-associated protein,Protein TAP1;TNF-receptor ubiquitous scaffolding/signaling protein;, PF12463;, GO:0031464;GO:0005886;GO:0019902;GO:0070588;GO:0048820;GO:0016567;GO:0006511;, C:Cul4A-RING E3 ubiquitin ligase complex; C:plasma membrane;, F:phosphatase binding;, P:calcium ion transmembrane transport; P:hair follicle maturation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8TEL6 E1P5Q0 E1P5Q1 Q96H82 Q9BVB8 Q9H429 Q9UFS6,Short transient receptor potential channel 4-associated protein,Protein TAP1;TNF-receptor ubiquitous scaffolding/signaling protein;, PF12463;, GO:0031464;GO:0005886;GO:0019902;GO:0070588;GO:0048820;GO:0016567;GO:0006511;, C:Cul4A-RING E3 ubiquitin ligase complex; C:plasma membrane;, F:phosphatase binding;, P:calcium ion transmembrane transport; P:hair follicle maturation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8TEL6 E1P5Q0 E1P5Q1 Q96H82 Q9BVB8 Q9H429 Q9UFS6,Short transient receptor potential channel 4-associated protein,Protein TAP1;TNF-receptor ubiquitous scaffolding/signaling protein;, PF12463;, GO:0031464;GO:0005886;GO:0019902;GO:0070588;GO:0048820;GO:0016567;GO:0006511;, C:Cul4A-RING E3 ubiquitin ligase complex; C:plasma membrane;, F:phosphatase binding;, P:calcium ion transmembrane transport; P:hair follicle maturation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8TEL6 E1P5Q0 E1P5Q1 Q96H82 Q9BVB8 Q9H429 Q9UFS6,Short transient receptor potential channel 4-associated protein,Protein TAP1;TNF-receptor ubiquitous scaffolding/signaling protein;, PF12463;, GO:0031464;GO:0005886;GO:0019902;GO:0070588;GO:0048820;GO:0016567;GO:0006511;, C:Cul4A-RING E3 ubiquitin ligase complex; C:plasma membrane;, F:phosphatase binding;, P:calcium ion transmembrane transport; P:hair follicle maturation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q8TEL6 E1P5Q0 E1P5Q1 Q96H82 Q9BVB8 Q9H429 Q9UFS6,Short transient receptor potential channel 4-associated protein,Protein TAP1;TNF-receptor ubiquitous scaffolding/signaling protein;, PF12463;, GO:0031464;GO:0005886;GO:0019902;GO:0070588;GO:0048820;GO:0016567;GO:0006511;, C:Cul4A-RING E3 ubiquitin ligase complex; C:plasma membrane;, F:phosphatase binding;, P:calcium ion transmembrane transport; P:hair follicle maturation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|P13533 A2RTX1 D9YZU2 Q13943 Q14906 Q14907,Myosin-6,Myosin heavy chain 6;Myosin heavy chain, cardiac muscle alpha isoform;, PF00063;PF02736;PF01576;, GO:0005829;GO:0005859;GO:0030016;GO:0016459;GO:0032982;GO:0030017;GO:0001725;GO:0030018;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0019901;GO:0007512;GO:0046034;GO:0055009;GO:0060048;GO:0048739;GO:0014898;GO:0001701;GO:0006936;GO:0030049;GO:0030239;GO:0006470;GO:0043462;GO:0008217;GO:0008016;GO:0060420;GO:0002027;GO:0002026;GO:0045214;GO:0006941;GO:0055010;GO:0007522;, C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin complex; C:myosin filament; C:sarcomere; C:stress fiber; C:Z disc;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity; F:protein kinase binding;, P:adult heart development; P:ATP metabolic process; P:atrial cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; P:cardiac muscle fiber development; P:cardiac muscle hypertrophy in response to stress; P:in utero embryonic development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:protein dephosphorylation; P:regulation of ATPase activity; P:regulation of blood pressure; P:regulation of heart contraction; P:regulation of heart growth; P:regulation of heart rate; P:regulation of the force of heart contraction; P:sarcomere organization; P:striated muscle contraction; P:ventricular cardiac muscle tissue morphogenesis; P:visceral muscle development;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity;|A7E2Y1 Q5JVW7 Q6NT44 Q6NT57 Q6WG75 Q96I57 Q9NWE2 Q9P216,Myosin-7B,Antigen MLAA-21;Myosin cardiac muscle beta chain;Myosin heavy chain 7B, cardiac muscle beta isoform;Slow A MYH14;, PF00063;PF02736;PF01576;, GO:0097512;GO:0016020;GO:0016459;GO:0032982;GO:0051015;GO:0005524;GO:0003774;, C:cardiac myofibril; C:membrane; C:myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:motor activity; scaffold86 indexed_genome mRNA 684542 710369 . + . ID=transcript_12304;P48637 B2R697 B6F210 E1P5P9 Q4TTD9,Glutathione synthetase,Glutathione synthase;, PF03917;PF03199;, GO:0005829;GO:0070062;GO:0005524;GO:0043295;GO:0004363;GO:0016594;GO:0042802;GO:0000287;GO:0042803;GO:0007568;GO:0006520;GO:0006750;GO:0007399;GO:0043200;GO:0046686;GO:0031667;GO:0006979;GO:0034612;GO:0009410;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:glutathione binding; F:glutathione synthase activity; F:glycine binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity;, P:aging; P:cellular amino acid metabolic process; P:glutathione biosynthetic process; P:nervous system development; P:response to amino acid; P:response to cadmium ion; P:response to nutrient levels; P:response to oxidative stress; P:response to tumor necrosis factor; P:response to xenobiotic stimulus;|P48637 B2R697 B6F210 E1P5P9 Q4TTD9,Glutathione synthetase,Glutathione synthase;, PF03917;PF03199;, GO:0005829;GO:0070062;GO:0005524;GO:0043295;GO:0004363;GO:0016594;GO:0042802;GO:0000287;GO:0042803;GO:0007568;GO:0006520;GO:0006750;GO:0007399;GO:0043200;GO:0046686;GO:0031667;GO:0006979;GO:0034612;GO:0009410;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:glutathione binding; F:glutathione synthase activity; F:glycine binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity;, P:aging; P:cellular amino acid metabolic process; P:glutathione biosynthetic process; P:nervous system development; P:response to amino acid; P:response to cadmium ion; P:response to nutrient levels; P:response to oxidative stress; P:response to tumor necrosis factor; P:response to xenobiotic stimulus; scaffold86 indexed_genome mRNA 710494 714378 . + . ID=transcript_12305;P48637 B2R697 B6F210 E1P5P9 Q4TTD9,Glutathione synthetase,Glutathione synthase;, PF03917;PF03199;, GO:0005829;GO:0070062;GO:0005524;GO:0043295;GO:0004363;GO:0016594;GO:0042802;GO:0000287;GO:0042803;GO:0007568;GO:0006520;GO:0006750;GO:0007399;GO:0043200;GO:0046686;GO:0031667;GO:0006979;GO:0034612;GO:0009410;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:glutathione binding; F:glutathione synthase activity; F:glycine binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity;, P:aging; P:cellular amino acid metabolic process; P:glutathione biosynthetic process; P:nervous system development; P:response to amino acid; P:response to cadmium ion; P:response to nutrient levels; P:response to oxidative stress; P:response to tumor necrosis factor; P:response to xenobiotic stimulus; scaffold86 indexed_genome mRNA 718179 719342 . - . ID=transcript_12306;P48637 B2R697 B6F210 E1P5P9 Q4TTD9,Glutathione synthetase,Glutathione synthase;, PF03917;PF03199;, GO:0005829;GO:0070062;GO:0005524;GO:0043295;GO:0004363;GO:0016594;GO:0042802;GO:0000287;GO:0042803;GO:0007568;GO:0006520;GO:0006750;GO:0007399;GO:0043200;GO:0046686;GO:0031667;GO:0006979;GO:0034612;GO:0009410;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:glutathione binding; F:glutathione synthase activity; F:glycine binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity;, P:aging; P:cellular amino acid metabolic process; P:glutathione biosynthetic process; P:nervous system development; P:response to amino acid; P:response to cadmium ion; P:response to nutrient levels; P:response to oxidative stress; P:response to tumor necrosis factor; P:response to xenobiotic stimulus; scaffold86 indexed_genome mRNA 719764 721059 . + . ID=transcript_12307;P48637 B2R697 B6F210 E1P5P9 Q4TTD9,Glutathione synthetase,Glutathione synthase;, PF03917;PF03199;, GO:0005829;GO:0070062;GO:0005524;GO:0043295;GO:0004363;GO:0016594;GO:0042802;GO:0000287;GO:0042803;GO:0007568;GO:0006520;GO:0006750;GO:0007399;GO:0043200;GO:0046686;GO:0031667;GO:0006979;GO:0034612;GO:0009410;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:glutathione binding; F:glutathione synthase activity; F:glycine binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity;, P:aging; P:cellular amino acid metabolic process; P:glutathione biosynthetic process; P:nervous system development; P:response to amino acid; P:response to cadmium ion; P:response to nutrient levels; P:response to oxidative stress; P:response to tumor necrosis factor; P:response to xenobiotic stimulus;|P48637 B2R697 B6F210 E1P5P9 Q4TTD9,Glutathione synthetase,Glutathione synthase;, PF03917;PF03199;, GO:0005829;GO:0070062;GO:0005524;GO:0043295;GO:0004363;GO:0016594;GO:0042802;GO:0000287;GO:0042803;GO:0007568;GO:0006520;GO:0006750;GO:0007399;GO:0043200;GO:0046686;GO:0031667;GO:0006979;GO:0034612;GO:0009410;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:glutathione binding; F:glutathione synthase activity; F:glycine binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity;, P:aging; P:cellular amino acid metabolic process; P:glutathione biosynthetic process; P:nervous system development; P:response to amino acid; P:response to cadmium ion; P:response to nutrient levels; P:response to oxidative stress; P:response to tumor necrosis factor; P:response to xenobiotic stimulus; scaffold86 indexed_genome mRNA 721412 765921 . - . ID=transcript_12308;Q9NR19 A6NE90 Q5QPH2 Q5QPH3 Q8N238 Q96EL0 Q9NQP7 Q9UJ15,Acetyl-coenzyme A synthetase, cytoplasmic,Acetate--CoA ligase;Acetyl-CoA synthetase;Acetyl-CoA synthetase 1 {ECO:0000250|UniProtKB:Q9QXG4};Acyl-CoA synthetase short-chain family member 2;Acyl-activating enzyme;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0019427;GO:0006069;GO:0008610;GO:0019542;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:lipid biosynthetic process; P:propionate biosynthetic process;|Q9NR19 A6NE90 Q5QPH2 Q5QPH3 Q8N238 Q96EL0 Q9NQP7 Q9UJ15,Acetyl-coenzyme A synthetase, cytoplasmic,Acetate--CoA ligase;Acetyl-CoA synthetase;Acetyl-CoA synthetase 1 {ECO:0000250|UniProtKB:Q9QXG4};Acyl-CoA synthetase short-chain family member 2;Acyl-activating enzyme;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0019427;GO:0006069;GO:0008610;GO:0019542;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:lipid biosynthetic process; P:propionate biosynthetic process;|Q9NR19 A6NE90 Q5QPH2 Q5QPH3 Q8N238 Q96EL0 Q9NQP7 Q9UJ15,Acetyl-coenzyme A synthetase, cytoplasmic,Acetate--CoA ligase;Acetyl-CoA synthetase;Acetyl-CoA synthetase 1 {ECO:0000250|UniProtKB:Q9QXG4};Acyl-CoA synthetase short-chain family member 2;Acyl-activating enzyme;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0019427;GO:0006069;GO:0008610;GO:0019542;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:lipid biosynthetic process; P:propionate biosynthetic process;|Q9NR19 A6NE90 Q5QPH2 Q5QPH3 Q8N238 Q96EL0 Q9NQP7 Q9UJ15,Acetyl-coenzyme A synthetase, cytoplasmic,Acetate--CoA ligase;Acetyl-CoA synthetase;Acetyl-CoA synthetase 1 {ECO:0000250|UniProtKB:Q9QXG4};Acyl-CoA synthetase short-chain family member 2;Acyl-activating enzyme;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0019427;GO:0006069;GO:0008610;GO:0019542;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:lipid biosynthetic process; P:propionate biosynthetic process;|Q9NR19 A6NE90 Q5QPH2 Q5QPH3 Q8N238 Q96EL0 Q9NQP7 Q9UJ15,Acetyl-coenzyme A synthetase, cytoplasmic,Acetate--CoA ligase;Acetyl-CoA synthetase;Acetyl-CoA synthetase 1 {ECO:0000250|UniProtKB:Q9QXG4};Acyl-CoA synthetase short-chain family member 2;Acyl-activating enzyme;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0019427;GO:0006069;GO:0008610;GO:0019542;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:lipid biosynthetic process; P:propionate biosynthetic process;|Q9NR19 A6NE90 Q5QPH2 Q5QPH3 Q8N238 Q96EL0 Q9NQP7 Q9UJ15,Acetyl-coenzyme A synthetase, cytoplasmic,Acetate--CoA ligase;Acetyl-CoA synthetase;Acetyl-CoA synthetase 1 {ECO:0000250|UniProtKB:Q9QXG4};Acyl-CoA synthetase short-chain family member 2;Acyl-activating enzyme;Propionate--CoA ligase;, PF16177;PF00501;PF13193;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005654;GO:0003987;GO:0016208;GO:0005524;GO:0050218;GO:0019413;GO:0019427;GO:0006069;GO:0008610;GO:0019542;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:nucleoplasm;, F:acetate-CoA ligase activity; F:AMP binding; F:ATP binding; F:propionate-CoA ligase activity;, P:acetate biosynthetic process; P:acetyl-CoA biosynthetic process from acetate; P:ethanol oxidation; P:lipid biosynthetic process; P:propionate biosynthetic process; scaffold86 indexed_genome mRNA 770229 793936 . + . ID=transcript_12309;Q9UJ14 Q8N899 Q8NF66 Q9BYP5 Q9BYP6,Glutathione hydrolase 7,Gamma-glutamyltransferase 7;Gamma-glutamyltransferase-like 3;Gamma-glutamyltransferase-like 5;Gamma-glutamyltranspeptidase 7;, , GO:0016021;GO:0005886;GO:0036374;GO:0102953;GO:0103068;GO:0000048;GO:0006750;GO:0006751;GO:1901750;GO:1902883;GO:0032355;GO:0032496;GO:0034612;GO:0007283;, C:integral component of membrane; C:plasma membrane;, F:glutathione hydrolase activity; F:hypoglycin A gamma-glutamyl transpeptidase activity; F:leukotriene C4 gamma-glutamyl transferase activity; F:peptidyltransferase activity;, P:glutathione biosynthetic process; P:glutathione catabolic process; P:leukotriene D4 biosynthetic process; P:negative regulation of response to oxidative stress; P:response to estradiol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:spermatogenesis;|Q9UJ14 Q8N899 Q8NF66 Q9BYP5 Q9BYP6,Glutathione hydrolase 7,Gamma-glutamyltransferase 7;Gamma-glutamyltransferase-like 3;Gamma-glutamyltransferase-like 5;Gamma-glutamyltranspeptidase 7;, , GO:0016021;GO:0005886;GO:0036374;GO:0102953;GO:0103068;GO:0000048;GO:0006750;GO:0006751;GO:1901750;GO:1902883;GO:0032355;GO:0032496;GO:0034612;GO:0007283;, C:integral component of membrane; C:plasma membrane;, F:glutathione hydrolase activity; F:hypoglycin A gamma-glutamyl transpeptidase activity; F:leukotriene C4 gamma-glutamyl transferase activity; F:peptidyltransferase activity;, P:glutathione biosynthetic process; P:glutathione catabolic process; P:leukotriene D4 biosynthetic process; P:negative regulation of response to oxidative stress; P:response to estradiol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:spermatogenesis;|Q9UJ14 Q8N899 Q8NF66 Q9BYP5 Q9BYP6,Glutathione hydrolase 7,Gamma-glutamyltransferase 7;Gamma-glutamyltransferase-like 3;Gamma-glutamyltransferase-like 5;Gamma-glutamyltranspeptidase 7;, , GO:0016021;GO:0005886;GO:0036374;GO:0102953;GO:0103068;GO:0000048;GO:0006750;GO:0006751;GO:1901750;GO:1902883;GO:0032355;GO:0032496;GO:0034612;GO:0007283;, C:integral component of membrane; C:plasma membrane;, F:glutathione hydrolase activity; F:hypoglycin A gamma-glutamyl transpeptidase activity; F:leukotriene C4 gamma-glutamyl transferase activity; F:peptidyltransferase activity;, P:glutathione biosynthetic process; P:glutathione catabolic process; P:leukotriene D4 biosynthetic process; P:negative regulation of response to oxidative stress; P:response to estradiol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:spermatogenesis;|Q9UJ14 Q8N899 Q8NF66 Q9BYP5 Q9BYP6,Glutathione hydrolase 7,Gamma-glutamyltransferase 7;Gamma-glutamyltransferase-like 3;Gamma-glutamyltransferase-like 5;Gamma-glutamyltranspeptidase 7;, , GO:0016021;GO:0005886;GO:0036374;GO:0102953;GO:0103068;GO:0000048;GO:0006750;GO:0006751;GO:1901750;GO:1902883;GO:0032355;GO:0032496;GO:0034612;GO:0007283;, C:integral component of membrane; C:plasma membrane;, F:glutathione hydrolase activity; F:hypoglycin A gamma-glutamyl transpeptidase activity; F:leukotriene C4 gamma-glutamyl transferase activity; F:peptidyltransferase activity;, P:glutathione biosynthetic process; P:glutathione catabolic process; P:leukotriene D4 biosynthetic process; P:negative regulation of response to oxidative stress; P:response to estradiol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:spermatogenesis;|Q9UJ14 Q8N899 Q8NF66 Q9BYP5 Q9BYP6,Glutathione hydrolase 7,Gamma-glutamyltransferase 7;Gamma-glutamyltransferase-like 3;Gamma-glutamyltransferase-like 5;Gamma-glutamyltranspeptidase 7;, , GO:0016021;GO:0005886;GO:0036374;GO:0102953;GO:0103068;GO:0000048;GO:0006750;GO:0006751;GO:1901750;GO:1902883;GO:0032355;GO:0032496;GO:0034612;GO:0007283;, C:integral component of membrane; C:plasma membrane;, F:glutathione hydrolase activity; F:hypoglycin A gamma-glutamyl transpeptidase activity; F:leukotriene C4 gamma-glutamyl transferase activity; F:peptidyltransferase activity;, P:glutathione biosynthetic process; P:glutathione catabolic process; P:leukotriene D4 biosynthetic process; P:negative regulation of response to oxidative stress; P:response to estradiol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:spermatogenesis;|Q9UJ14 Q8N899 Q8NF66 Q9BYP5 Q9BYP6,Glutathione hydrolase 7,Gamma-glutamyltransferase 7;Gamma-glutamyltransferase-like 3;Gamma-glutamyltransferase-like 5;Gamma-glutamyltranspeptidase 7;, , GO:0016021;GO:0005886;GO:0036374;GO:0102953;GO:0103068;GO:0000048;GO:0006750;GO:0006751;GO:1901750;GO:1902883;GO:0032355;GO:0032496;GO:0034612;GO:0007283;, C:integral component of membrane; C:plasma membrane;, F:glutathione hydrolase activity; F:hypoglycin A gamma-glutamyl transpeptidase activity; F:leukotriene C4 gamma-glutamyl transferase activity; F:peptidyltransferase activity;, P:glutathione biosynthetic process; P:glutathione catabolic process; P:leukotriene D4 biosynthetic process; P:negative regulation of response to oxidative stress; P:response to estradiol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:spermatogenesis;|Q9UJ14 Q8N899 Q8NF66 Q9BYP5 Q9BYP6,Glutathione hydrolase 7,Gamma-glutamyltransferase 7;Gamma-glutamyltransferase-like 3;Gamma-glutamyltransferase-like 5;Gamma-glutamyltranspeptidase 7;, , GO:0016021;GO:0005886;GO:0036374;GO:0102953;GO:0103068;GO:0000048;GO:0006750;GO:0006751;GO:1901750;GO:1902883;GO:0032355;GO:0032496;GO:0034612;GO:0007283;, C:integral component of membrane; C:plasma membrane;, F:glutathione hydrolase activity; F:hypoglycin A gamma-glutamyl transpeptidase activity; F:leukotriene C4 gamma-glutamyl transferase activity; F:peptidyltransferase activity;, P:glutathione biosynthetic process; P:glutathione catabolic process; P:leukotriene D4 biosynthetic process; P:negative regulation of response to oxidative stress; P:response to estradiol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:spermatogenesis; scaffold86 indexed_genome mRNA 820756 899464 . + . ID=transcript_12310;Q14686 A6NLF1 B2RMN5 E1P5P7 Q9NTZ9 Q9UH74 Q9UK86,Nuclear receptor coactivator 6,Activating signal cointegrator 2;Amplified in breast cancer protein 3;Cancer-amplified transcriptional coactivator ASC-2;Nuclear receptor coactivator RAP250;Nuclear receptor-activating protein, 250 kDa;Peroxisome proliferator-activated receptor-interacting protein;Thyroid hormone receptor-binding protein;, PF13820;, GO:0005829;GO:0035097;GO:0043231;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0019899;GO:0030331;GO:0051427;GO:0030374;GO:0046965;GO:0046966;GO:0003713;GO:0007420;GO:0006974;GO:0006352;GO:0007507;GO:0030099;GO:0045944;GO:0045893;GO:0019216;GO:0009725;, C:cytosol; C:histone methyltransferase complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:enzyme binding; F:estrogen receptor binding; F:hormone receptor binding; F:nuclear receptor coactivator activity; F:retinoid X receptor binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:brain development; P:cellular response to DNA damage stimulus; P:DNA-templated transcription, initiation; P:heart development; P:myeloid cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:response to hormone;|Q14686 A6NLF1 B2RMN5 E1P5P7 Q9NTZ9 Q9UH74 Q9UK86,Nuclear receptor coactivator 6,Activating signal cointegrator 2;Amplified in breast cancer protein 3;Cancer-amplified transcriptional coactivator ASC-2;Nuclear receptor coactivator RAP250;Nuclear receptor-activating protein, 250 kDa;Peroxisome proliferator-activated receptor-interacting protein;Thyroid hormone receptor-binding protein;, PF13820;, GO:0005829;GO:0035097;GO:0043231;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0019899;GO:0030331;GO:0051427;GO:0030374;GO:0046965;GO:0046966;GO:0003713;GO:0007420;GO:0006974;GO:0006352;GO:0007507;GO:0030099;GO:0045944;GO:0045893;GO:0019216;GO:0009725;, C:cytosol; C:histone methyltransferase complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:enzyme binding; F:estrogen receptor binding; F:hormone receptor binding; F:nuclear receptor coactivator activity; F:retinoid X receptor binding; F:thyroid hormone receptor binding; F:transcription coactivator activity;, P:brain development; P:cellular response to DNA damage stimulus; P:DNA-templated transcription, initiation; P:heart development; P:myeloid cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:response to hormone;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold86 indexed_genome mRNA 900040 909701 . - . ID=transcript_12311;Q8IXH6 A8K8S8 E1P5P6 Q5JX64 Q8IYL5 Q9NU00,Tumor protein p53-inducible nuclear protein 2,Diabetes and obesity-regulated gene;p53-inducible protein U;, PF14839;, GO:0005776;GO:0031410;GO:0005829;GO:0005634;GO:0016605;GO:0043130;GO:0000045;GO:1903828;GO:0001649;GO:0010508;GO:0045893;GO:0001894;GO:0006511;, C:autophagosome; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:PML body;, F:ubiquitin binding;, P:autophagosome assembly; P:negative regulation of cellular protein localization; P:osteoblast differentiation; P:positive regulation of autophagy; P:positive regulation of transcription, DNA-templated; P:tissue homeostasis; P:ubiquitin-dependent protein catabolic process; scaffold86 indexed_genome mRNA 937182 989088 . + . ID=transcript_12312;Q9H490 Q7Z489 Q8N2F2,Phosphatidylinositol glycan anchor biosynthesis class U protein,Cell division cycle protein 91-like 1;GPI transamidase component PIG-U;, , GO:0005789;GO:0042765;GO:0016020;GO:0005886;GO:0016255;GO:0006506;GO:0034394;GO:0046425;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane; C:plasma membrane;, , P:attachment of GPI anchor to protein; P:GPI anchor biosynthetic process; P:protein localization to cell surface; P:regulation of receptor signaling pathway via JAK-STAT; scaffold86 indexed_genome mRNA 998516 1030676 . + . ID=transcript_12313;Q9H490 Q7Z489 Q8N2F2,Phosphatidylinositol glycan anchor biosynthesis class U protein,Cell division cycle protein 91-like 1;GPI transamidase component PIG-U;, , GO:0005789;GO:0042765;GO:0016020;GO:0005886;GO:0016255;GO:0006506;GO:0034394;GO:0046425;, C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane; C:plasma membrane;, , P:attachment of GPI anchor to protein; P:GPI anchor biosynthetic process; P:protein localization to cell surface; P:regulation of receptor signaling pathway via JAK-STAT;|Q9H492 E1P5P4 E1P5P5 Q9BXW5,Microtubule-associated proteins 1A/1B light chain 3A,Autophagy-related protein LC3 A;Autophagy-related ubiquitin-like modifier LC3 A;MAP1 light chain 3-like protein 1;MAP1A/MAP1B light chain 3 A;Microtubule-associated protein 1 light chain 3 alpha;, PF02991;, GO:0044754;GO:0005776;GO:0000421;GO:0005829;GO:0043231;GO:0005770;GO:0005874;GO:0031090;GO:0045202;GO:0008017;GO:0008429;GO:0005543;GO:0031625;GO:0000045;GO:0097352;GO:0000422;GO:0034198;GO:0071280;GO:0070301;GO:0006995;GO:0009267;GO:0016236;GO:0010040;GO:0010288;GO:0043278;, C:autolysosome; C:autophagosome; C:autophagosome membrane; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:microtubule; C:organelle membrane; C:synapse;, F:microtubule binding; F:phosphatidylethanolamine binding; F:phospholipid binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagosome maturation; P:autophagy of mitochondrion; P:cellular response to amino acid starvation; P:cellular response to copper ion; P:cellular response to hydrogen peroxide; P:cellular response to nitrogen starvation; P:cellular response to starvation; P:macroautophagy; P:response to iron(II) ion; P:response to lead ion; P:response to morphine;|Q9H492 E1P5P4 E1P5P5 Q9BXW5,Microtubule-associated proteins 1A/1B light chain 3A,Autophagy-related protein LC3 A;Autophagy-related ubiquitin-like modifier LC3 A;MAP1 light chain 3-like protein 1;MAP1A/MAP1B light chain 3 A;Microtubule-associated protein 1 light chain 3 alpha;, PF02991;, GO:0044754;GO:0005776;GO:0000421;GO:0005829;GO:0043231;GO:0005770;GO:0005874;GO:0031090;GO:0045202;GO:0008017;GO:0008429;GO:0005543;GO:0031625;GO:0000045;GO:0097352;GO:0000422;GO:0034198;GO:0071280;GO:0070301;GO:0006995;GO:0009267;GO:0016236;GO:0010040;GO:0010288;GO:0043278;, C:autolysosome; C:autophagosome; C:autophagosome membrane; C:cytosol; C:intracellular membrane-bounded organelle; C:late endosome; C:microtubule; C:organelle membrane; C:synapse;, F:microtubule binding; F:phosphatidylethanolamine binding; F:phospholipid binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagosome maturation; P:autophagy of mitochondrion; P:cellular response to amino acid starvation; P:cellular response to copper ion; P:cellular response to hydrogen peroxide; P:cellular response to nitrogen starvation; P:cellular response to starvation; P:macroautophagy; P:response to iron(II) ion; P:response to lead ion; P:response to morphine; scaffold86 indexed_genome mRNA 1068983 1171668 . - . ID=transcript_12314;Q9BY75 Q9H451 Q9H4U5,E3 ubiquitin-protein ligase Itchy homolog,Atrophin-1-interacting protein 4;HECT-type E3 ubiquitin transferase Itchy homolog;NFE2-associated polypeptide 1;, PF00168;PF00632;PF00397;, GO:0005737;GO:0031410;GO:0005829;GO:0031901;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005886;GO:0032991;GO:1990763;GO:0045236;GO:0043021;GO:0061630;GO:0044389;GO:0004842;GO:0006915;GO:0051607;GO:0006954;GO:0045087;GO:0043066;GO:0050687;GO:0046329;GO:0032088;GO:0032480;GO:0007219;GO:0070423;GO:0045732;GO:2000646;GO:0043161;GO:0051865;GO:0035519;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0001558;GO:1902036;GO:0090085;GO:0006511;GO:0046718;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:arrestin family protein binding; F:CXCR chemokine receptor binding; F:ribonucleoprotein complex binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein ligase binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:defense response to virus; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of defense response to virus; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:Notch signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of receptor catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell growth; P:regulation of hematopoietic stem cell differentiation; P:regulation of protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral entry into host cell;|Q9BY75 Q9H451 Q9H4U5,E3 ubiquitin-protein ligase Itchy homolog,Atrophin-1-interacting protein 4;HECT-type E3 ubiquitin transferase Itchy homolog;NFE2-associated polypeptide 1;, PF00168;PF00632;PF00397;, GO:0005737;GO:0031410;GO:0005829;GO:0031901;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005886;GO:0032991;GO:1990763;GO:0045236;GO:0043021;GO:0061630;GO:0044389;GO:0004842;GO:0006915;GO:0051607;GO:0006954;GO:0045087;GO:0043066;GO:0050687;GO:0046329;GO:0032088;GO:0032480;GO:0007219;GO:0070423;GO:0045732;GO:2000646;GO:0043161;GO:0051865;GO:0035519;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0001558;GO:1902036;GO:0090085;GO:0006511;GO:0046718;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:arrestin family protein binding; F:CXCR chemokine receptor binding; F:ribonucleoprotein complex binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein ligase binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:defense response to virus; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of defense response to virus; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:Notch signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of receptor catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell growth; P:regulation of hematopoietic stem cell differentiation; P:regulation of protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral entry into host cell;|Q9BY75 Q9H451 Q9H4U5,E3 ubiquitin-protein ligase Itchy homolog,Atrophin-1-interacting protein 4;HECT-type E3 ubiquitin transferase Itchy homolog;NFE2-associated polypeptide 1;, PF00168;PF00632;PF00397;, GO:0005737;GO:0031410;GO:0005829;GO:0031901;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005886;GO:0032991;GO:1990763;GO:0045236;GO:0043021;GO:0061630;GO:0044389;GO:0004842;GO:0006915;GO:0051607;GO:0006954;GO:0045087;GO:0043066;GO:0050687;GO:0046329;GO:0032088;GO:0032480;GO:0007219;GO:0070423;GO:0045732;GO:2000646;GO:0043161;GO:0051865;GO:0035519;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0001558;GO:1902036;GO:0090085;GO:0006511;GO:0046718;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:arrestin family protein binding; F:CXCR chemokine receptor binding; F:ribonucleoprotein complex binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein ligase binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:defense response to virus; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of defense response to virus; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:Notch signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of receptor catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell growth; P:regulation of hematopoietic stem cell differentiation; P:regulation of protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral entry into host cell;|Q9BY75 Q9H451 Q9H4U5,E3 ubiquitin-protein ligase Itchy homolog,Atrophin-1-interacting protein 4;HECT-type E3 ubiquitin transferase Itchy homolog;NFE2-associated polypeptide 1;, PF00168;PF00632;PF00397;, GO:0005737;GO:0031410;GO:0005829;GO:0031901;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005886;GO:0032991;GO:1990763;GO:0045236;GO:0043021;GO:0061630;GO:0044389;GO:0004842;GO:0006915;GO:0051607;GO:0006954;GO:0045087;GO:0043066;GO:0050687;GO:0046329;GO:0032088;GO:0032480;GO:0007219;GO:0070423;GO:0045732;GO:2000646;GO:0043161;GO:0051865;GO:0035519;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0001558;GO:1902036;GO:0090085;GO:0006511;GO:0046718;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:arrestin family protein binding; F:CXCR chemokine receptor binding; F:ribonucleoprotein complex binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein ligase binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:defense response to virus; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of defense response to virus; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:Notch signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of receptor catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell growth; P:regulation of hematopoietic stem cell differentiation; P:regulation of protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral entry into host cell;|Q9BY75 Q9H451 Q9H4U5,E3 ubiquitin-protein ligase Itchy homolog,Atrophin-1-interacting protein 4;HECT-type E3 ubiquitin transferase Itchy homolog;NFE2-associated polypeptide 1;, PF00168;PF00632;PF00397;, GO:0005737;GO:0031410;GO:0005829;GO:0031901;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005886;GO:0032991;GO:1990763;GO:0045236;GO:0043021;GO:0061630;GO:0044389;GO:0004842;GO:0006915;GO:0051607;GO:0006954;GO:0045087;GO:0043066;GO:0050687;GO:0046329;GO:0032088;GO:0032480;GO:0007219;GO:0070423;GO:0045732;GO:2000646;GO:0043161;GO:0051865;GO:0035519;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0001558;GO:1902036;GO:0090085;GO:0006511;GO:0046718;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:arrestin family protein binding; F:CXCR chemokine receptor binding; F:ribonucleoprotein complex binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein ligase binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:defense response to virus; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of defense response to virus; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:Notch signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of receptor catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell growth; P:regulation of hematopoietic stem cell differentiation; P:regulation of protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral entry into host cell;|Q9BY75 Q9H451 Q9H4U5,E3 ubiquitin-protein ligase Itchy homolog,Atrophin-1-interacting protein 4;HECT-type E3 ubiquitin transferase Itchy homolog;NFE2-associated polypeptide 1;, PF00168;PF00632;PF00397;, GO:0005737;GO:0031410;GO:0005829;GO:0031901;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005886;GO:0032991;GO:1990763;GO:0045236;GO:0043021;GO:0061630;GO:0044389;GO:0004842;GO:0006915;GO:0051607;GO:0006954;GO:0045087;GO:0043066;GO:0050687;GO:0046329;GO:0032088;GO:0032480;GO:0007219;GO:0070423;GO:0045732;GO:2000646;GO:0043161;GO:0051865;GO:0035519;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0001558;GO:1902036;GO:0090085;GO:0006511;GO:0046718;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:arrestin family protein binding; F:CXCR chemokine receptor binding; F:ribonucleoprotein complex binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein ligase binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:defense response to virus; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of defense response to virus; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:Notch signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of receptor catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell growth; P:regulation of hematopoietic stem cell differentiation; P:regulation of protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral entry into host cell;|Q9BY75 Q9H451 Q9H4U5,E3 ubiquitin-protein ligase Itchy homolog,Atrophin-1-interacting protein 4;HECT-type E3 ubiquitin transferase Itchy homolog;NFE2-associated polypeptide 1;, PF00168;PF00632;PF00397;, GO:0005737;GO:0031410;GO:0005829;GO:0031901;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005886;GO:0032991;GO:1990763;GO:0045236;GO:0043021;GO:0061630;GO:0044389;GO:0004842;GO:0006915;GO:0051607;GO:0006954;GO:0045087;GO:0043066;GO:0050687;GO:0046329;GO:0032088;GO:0032480;GO:0007219;GO:0070423;GO:0045732;GO:2000646;GO:0043161;GO:0051865;GO:0035519;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0001558;GO:1902036;GO:0090085;GO:0006511;GO:0046718;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:arrestin family protein binding; F:CXCR chemokine receptor binding; F:ribonucleoprotein complex binding; F:ubiquitin protein ligase activity; F:ubiquitin-like protein ligase binding; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:defense response to virus; P:inflammatory response; P:innate immune response; P:negative regulation of apoptotic process; P:negative regulation of defense response to virus; P:negative regulation of JNK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of type I interferon production; P:Notch signaling pathway; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of receptor catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell growth; P:regulation of hematopoietic stem cell differentiation; P:regulation of protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral entry into host cell; scaffold86 indexed_genome mRNA 1242563 1258397 . + . ID=transcript_12315;P23526 A8K307 B3KUN3 E1P5P2 F5H737 Q96A36,Adenosylhomocysteinase,S-adenosyl-L-homocysteine hydrolase;, PF05221;PF00670;, GO:0005829;GO:0070062;GO:0042470;GO:0043005;GO:0005634;GO:0004013;GO:0030554;GO:0042802;GO:0051287;GO:0002439;GO:0042745;GO:0032259;GO:0006730;GO:0001666;GO:0007584;GO:0019510;GO:0033353;GO:0000096;, C:cytosol; C:extracellular exosome; C:melanosome; C:neuron projection; C:nucleus;, F:adenosylhomocysteinase activity; F:adenyl nucleotide binding; F:identical protein binding; F:NAD binding;, P:chronic inflammatory response to antigenic stimulus; P:circadian sleep/wake cycle; P:methylation; P:one-carbon metabolic process; P:response to hypoxia; P:response to nutrient; P:S-adenosylhomocysteine catabolic process; P:S-adenosylmethionine cycle; P:sulfur amino acid metabolic process; scaffold86 indexed_genome mRNA 1456657 1476373 . + . ID=transcript_12316;P20042 Q9BVU0 Q9UJE4,Eukaryotic translation initiation factor 2 subunit 2,Eukaryotic translation initiation factor 2 subunit beta;, PF01873;, GO:0005737;GO:0005829;GO:0005850;GO:0046872;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001732;GO:0001731;GO:0001701;GO:0002176;GO:0008584;GO:0006413;GO:0055085;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2 complex;, F:metal ion binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:formation of translation preinitiation complex; P:in utero embryonic development; P:male germ cell proliferation; P:male gonad development; P:translational initiation; P:transmembrane transport;|P20042 Q9BVU0 Q9UJE4,Eukaryotic translation initiation factor 2 subunit 2,Eukaryotic translation initiation factor 2 subunit beta;, PF01873;, GO:0005737;GO:0005829;GO:0005850;GO:0046872;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001732;GO:0001731;GO:0001701;GO:0002176;GO:0008584;GO:0006413;GO:0055085;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2 complex;, F:metal ion binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:formation of translation preinitiation complex; P:in utero embryonic development; P:male germ cell proliferation; P:male gonad development; P:translational initiation; P:transmembrane transport;|P20042 Q9BVU0 Q9UJE4,Eukaryotic translation initiation factor 2 subunit 2,Eukaryotic translation initiation factor 2 subunit beta;, PF01873;, GO:0005737;GO:0005829;GO:0005850;GO:0046872;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001732;GO:0001731;GO:0001701;GO:0002176;GO:0008584;GO:0006413;GO:0055085;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2 complex;, F:metal ion binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:formation of translation preinitiation complex; P:in utero embryonic development; P:male germ cell proliferation; P:male gonad development; P:translational initiation; P:transmembrane transport;|P20042 Q9BVU0 Q9UJE4,Eukaryotic translation initiation factor 2 subunit 2,Eukaryotic translation initiation factor 2 subunit beta;, PF01873;, GO:0005737;GO:0005829;GO:0005850;GO:0046872;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001732;GO:0001731;GO:0001701;GO:0002176;GO:0008584;GO:0006413;GO:0055085;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2 complex;, F:metal ion binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:formation of translation preinitiation complex; P:in utero embryonic development; P:male germ cell proliferation; P:male gonad development; P:translational initiation; P:transmembrane transport;|P20042 Q9BVU0 Q9UJE4,Eukaryotic translation initiation factor 2 subunit 2,Eukaryotic translation initiation factor 2 subunit beta;, PF01873;, GO:0005737;GO:0005829;GO:0005850;GO:0046872;GO:0003729;GO:0003723;GO:0008135;GO:0003743;GO:0031369;GO:0001732;GO:0001731;GO:0001701;GO:0002176;GO:0008584;GO:0006413;GO:0055085;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2 complex;, F:metal ion binding; F:mRNA binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:formation of translation preinitiation complex; P:in utero embryonic development; P:male germ cell proliferation; P:male gonad development; P:translational initiation; P:transmembrane transport; scaffold86 indexed_genome mRNA 1482799 1566889 . - . ID=transcript_12317;Q9UKM9 Q14621 Q2M365 Q5QPL8 Q9BQX6 Q9UJE3,RNA-binding protein Raly,Autoantigen p542;Heterogeneous nuclear ribonucleoprotein C-like 2;hnRNP associated with lethal yellow protein homolog;, PF00076;, GO:0071013;GO:0005634;GO:0003723;GO:0003712;GO:0042632;GO:0000398;GO:1903506;, C:catalytic step 2 spliceosome; C:nucleus;, F:RNA binding; F:transcription coregulator activity;, P:cholesterol homeostasis; P:mRNA splicing, via spliceosome; P:regulation of nucleic acid-templated transcription;|Q9UKM9 Q14621 Q2M365 Q5QPL8 Q9BQX6 Q9UJE3,RNA-binding protein Raly,Autoantigen p542;Heterogeneous nuclear ribonucleoprotein C-like 2;hnRNP associated with lethal yellow protein homolog;, PF00076;, GO:0071013;GO:0005634;GO:0003723;GO:0003712;GO:0042632;GO:0000398;GO:1903506;, C:catalytic step 2 spliceosome; C:nucleus;, F:RNA binding; F:transcription coregulator activity;, P:cholesterol homeostasis; P:mRNA splicing, via spliceosome; P:regulation of nucleic acid-templated transcription;|Q9UKM9 Q14621 Q2M365 Q5QPL8 Q9BQX6 Q9UJE3,RNA-binding protein Raly,Autoantigen p542;Heterogeneous nuclear ribonucleoprotein C-like 2;hnRNP associated with lethal yellow protein homolog;, PF00076;, GO:0071013;GO:0005634;GO:0003723;GO:0003712;GO:0042632;GO:0000398;GO:1903506;, C:catalytic step 2 spliceosome; C:nucleus;, F:RNA binding; F:transcription coregulator activity;, P:cholesterol homeostasis; P:mRNA splicing, via spliceosome; P:regulation of nucleic acid-templated transcription;|Q9UKM9 Q14621 Q2M365 Q5QPL8 Q9BQX6 Q9UJE3,RNA-binding protein Raly,Autoantigen p542;Heterogeneous nuclear ribonucleoprotein C-like 2;hnRNP associated with lethal yellow protein homolog;, PF00076;, GO:0071013;GO:0005634;GO:0003723;GO:0003712;GO:0042632;GO:0000398;GO:1903506;, C:catalytic step 2 spliceosome; C:nucleus;, F:RNA binding; F:transcription coregulator activity;, P:cholesterol homeostasis; P:mRNA splicing, via spliceosome; P:regulation of nucleic acid-templated transcription;|Q9UKM9 Q14621 Q2M365 Q5QPL8 Q9BQX6 Q9UJE3,RNA-binding protein Raly,Autoantigen p542;Heterogeneous nuclear ribonucleoprotein C-like 2;hnRNP associated with lethal yellow protein homolog;, PF00076;, GO:0071013;GO:0005634;GO:0003723;GO:0003712;GO:0042632;GO:0000398;GO:1903506;, C:catalytic step 2 spliceosome; C:nucleus;, F:RNA binding; F:transcription coregulator activity;, P:cholesterol homeostasis; P:mRNA splicing, via spliceosome; P:regulation of nucleic acid-templated transcription; scaffold86 indexed_genome mRNA 1668915 1714045 . - . ID=transcript_12318;Q9H444 E1P5N4 Q53ZD6,Charged multivesicular body protein 4b,Chromatin-modifying protein 4b;SNF7 homolog associated with Alix 1;SNF7-2;Vacuolar protein sorting-associated protein 32-2;, PF03357;, GO:0005737;GO:0009898;GO:0005829;GO:0005768;GO:0000815;GO:0070062;GO:0031902;GO:0030117;GO:0030496;GO:0005771;GO:0005635;GO:0005634;GO:0031982;GO:0045296;GO:0042802;GO:0042803;GO:0006914;GO:0016197;GO:0010458;GO:0032511;GO:0016236;GO:0036438;GO:0090148;GO:0061952;GO:0000281;GO:0007080;GO:0007084;GO:0036258;GO:1902902;GO:0060548;GO:1901215;GO:0031468;GO:0006997;GO:1902188;GO:0006620;GO:0051258;GO:0010824;GO:1901673;GO:0050792;GO:0090611;GO:0006900;GO:0046755;GO:0039702;GO:0019058;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endosome; C:ESCRT III complex; C:extracellular exosome; C:late endosome membrane; C:membrane coat; C:midbody; C:multivesicular body; C:nuclear envelope; C:nucleus; C:vesicle;, F:cadherin binding; F:identical protein binding; F:protein homodimerization activity;, P:autophagy; P:endosomal transport; P:exit from mitosis; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:macroautophagy; P:maintenance of lens transparency; P:membrane fission; P:midbody abscission; P:mitotic cytokinesis; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of autophagosome assembly; P:negative regulation of cell death; P:negative regulation of neuron death; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of viral release from host cell; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:protein polymerization; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:vesicle budding from membrane; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle;|Q9H444 E1P5N4 Q53ZD6,Charged multivesicular body protein 4b,Chromatin-modifying protein 4b;SNF7 homolog associated with Alix 1;SNF7-2;Vacuolar protein sorting-associated protein 32-2;, PF03357;, GO:0005737;GO:0009898;GO:0005829;GO:0005768;GO:0000815;GO:0070062;GO:0031902;GO:0030117;GO:0030496;GO:0005771;GO:0005635;GO:0005634;GO:0031982;GO:0045296;GO:0042802;GO:0042803;GO:0006914;GO:0016197;GO:0010458;GO:0032511;GO:0016236;GO:0036438;GO:0090148;GO:0061952;GO:0000281;GO:0007080;GO:0007084;GO:0036258;GO:1902902;GO:0060548;GO:1901215;GO:0031468;GO:0006997;GO:1902188;GO:0006620;GO:0051258;GO:0010824;GO:1901673;GO:0050792;GO:0090611;GO:0006900;GO:0046755;GO:0039702;GO:0019058;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endosome; C:ESCRT III complex; C:extracellular exosome; C:late endosome membrane; C:membrane coat; C:midbody; C:multivesicular body; C:nuclear envelope; C:nucleus; C:vesicle;, F:cadherin binding; F:identical protein binding; F:protein homodimerization activity;, P:autophagy; P:endosomal transport; P:exit from mitosis; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:macroautophagy; P:maintenance of lens transparency; P:membrane fission; P:midbody abscission; P:mitotic cytokinesis; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of autophagosome assembly; P:negative regulation of cell death; P:negative regulation of neuron death; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of viral release from host cell; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:protein polymerization; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:vesicle budding from membrane; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle;|Q9H444 E1P5N4 Q53ZD6,Charged multivesicular body protein 4b,Chromatin-modifying protein 4b;SNF7 homolog associated with Alix 1;SNF7-2;Vacuolar protein sorting-associated protein 32-2;, PF03357;, GO:0005737;GO:0009898;GO:0005829;GO:0005768;GO:0000815;GO:0070062;GO:0031902;GO:0030117;GO:0030496;GO:0005771;GO:0005635;GO:0005634;GO:0031982;GO:0045296;GO:0042802;GO:0042803;GO:0006914;GO:0016197;GO:0010458;GO:0032511;GO:0016236;GO:0036438;GO:0090148;GO:0061952;GO:0000281;GO:0007080;GO:0007084;GO:0036258;GO:1902902;GO:0060548;GO:1901215;GO:0031468;GO:0006997;GO:1902188;GO:0006620;GO:0051258;GO:0010824;GO:1901673;GO:0050792;GO:0090611;GO:0006900;GO:0046755;GO:0039702;GO:0019058;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:endosome; C:ESCRT III complex; C:extracellular exosome; C:late endosome membrane; C:membrane coat; C:midbody; C:multivesicular body; C:nuclear envelope; C:nucleus; C:vesicle;, F:cadherin binding; F:identical protein binding; F:protein homodimerization activity;, P:autophagy; P:endosomal transport; P:exit from mitosis; P:late endosome to vacuole transport via multivesicular body sorting pathway; P:macroautophagy; P:maintenance of lens transparency; P:membrane fission; P:midbody abscission; P:mitotic cytokinesis; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of autophagosome assembly; P:negative regulation of cell death; P:negative regulation of neuron death; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of viral release from host cell; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:protein polymerization; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:vesicle budding from membrane; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold86 indexed_genome mRNA 1720862 1748858 . + . ID=transcript_12319;Q9BYN7 A2RUF4 B2RXE5 B7ZM09 Q5JXM8 Q96ST5,Zinc finger protein 341,, PF00096;, GO:0005634;GO:0003677;GO:0001216;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q9BYN7 A2RUF4 B2RXE5 B7ZM09 Q5JXM8 Q96ST5,Zinc finger protein 341,, PF00096;, GO:0005634;GO:0003677;GO:0001216;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q9BYN7 A2RUF4 B2RXE5 B7ZM09 Q5JXM8 Q96ST5,Zinc finger protein 341,, PF00096;, GO:0005634;GO:0003677;GO:0001216;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q9BYN7 A2RUF4 B2RXE5 B7ZM09 Q5JXM8 Q96ST5,Zinc finger protein 341,, PF00096;, GO:0005634;GO:0003677;GO:0001216;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold86 indexed_genome mRNA 1749511 1750208 . + . ID=transcript_12320;Q9BYN7 A2RUF4 B2RXE5 B7ZM09 Q5JXM8 Q96ST5,Zinc finger protein 341,, PF00096;, GO:0005634;GO:0003677;GO:0001216;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold86 indexed_genome mRNA 1752616 1758414 . - . ID=transcript_12321;Q9BYN7 A2RUF4 B2RXE5 B7ZM09 Q5JXM8 Q96ST5,Zinc finger protein 341,, PF00096;, GO:0005634;GO:0003677;GO:0001216;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold86 indexed_genome mRNA 1776276 1790390 . + . ID=transcript_12322;Q9Y6I8 A2A2I7 Q9H0T4,Peroxisomal membrane protein 4,24 kDa peroxisomal intrinsic membrane protein;, , GO:0005829;GO:0016021;GO:0005778;GO:0005777;GO:0045046;, C:cytosol; C:integral component of membrane; C:peroxisomal membrane; C:peroxisome;, , P:protein import into peroxisome membrane; scaffold86 indexed_genome mRNA 1808521 1811341 . + . ID=transcript_12323;Q01094 Q13143 Q92768,Transcription factor E2F1,PBR3;Retinoblastoma-associated protein 1;Retinoblastoma-binding protein 3;pRB-binding protein E2F-1;, PF16421;PF02319;, GO:0005813;GO:0000785;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0035189;GO:0090575;GO:0000987;GO:0003677;GO:0001216;GO:0003700;GO:0000981;GO:0046983;GO:0019901;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0043276;GO:0071398;GO:0071456;GO:1990090;GO:0071466;GO:0000077;GO:0006977;GO:0030900;GO:0000082;GO:0030851;GO:0072332;GO:0008630;GO:1990086;GO:0048255;GO:0043392;GO:0045599;GO:0070345;GO:0070317;GO:0000122;GO:0071930;GO:0045892;GO:0043065;GO:0048146;GO:0010628;GO:0060252;GO:1900740;GO:0045944;GO:0045893;GO:2000045;GO:0006357;GO:0000083;GO:0006355;GO:0007283;GO:0006351;GO:0016032;, C:centrosome; C:chromatin; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:Rb-E2F complex; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:anoikis; P:cellular response to fatty acid; P:cellular response to hypoxia; P:cellular response to nerve growth factor stimulus; P:cellular response to xenobiotic stimulus; P:DNA damage checkpoint; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:forebrain development; P:G1/S transition of mitotic cell cycle; P:granulocyte differentiation; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:lens fiber cell apoptotic process; P:mRNA stabilization; P:negative regulation of DNA binding; P:negative regulation of fat cell differentiation; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of glial cell proliferation; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription, DNA-templated; P:viral process; scaffold86 indexed_genome mRNA 1820837 1842818 . + . ID=transcript_12324;Q9HBW7 Q9HCQ9,N-terminal EF-hand calcium-binding protein 3,Amyloid-beta A4 protein-binding family A member 2-binding protein;Nek2-interacting protein 1;Neuronal calcium-binding protein 3;X11L-binding protein 51;, PF03992;PF13202;, GO:0005737;GO:0005783;GO:0005789;GO:0005794;GO:0000137;GO:0005634;GO:0005509;GO:0019538;GO:0009306;GO:0042984;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:nucleus;, F:calcium ion binding;, P:protein metabolic process; P:protein secretion; P:regulation of amyloid precursor protein biosynthetic process;|Q9HBW7 Q9HCQ9,N-terminal EF-hand calcium-binding protein 3,Amyloid-beta A4 protein-binding family A member 2-binding protein;Nek2-interacting protein 1;Neuronal calcium-binding protein 3;X11L-binding protein 51;, PF03992;PF13202;, GO:0005737;GO:0005783;GO:0005789;GO:0005794;GO:0000137;GO:0005634;GO:0005509;GO:0019538;GO:0009306;GO:0042984;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:nucleus;, F:calcium ion binding;, P:protein metabolic process; P:protein secretion; P:regulation of amyloid precursor protein biosynthetic process;|Q9HBW7 Q9HCQ9,N-terminal EF-hand calcium-binding protein 3,Amyloid-beta A4 protein-binding family A member 2-binding protein;Nek2-interacting protein 1;Neuronal calcium-binding protein 3;X11L-binding protein 51;, PF03992;PF13202;, GO:0005737;GO:0005783;GO:0005789;GO:0005794;GO:0000137;GO:0005634;GO:0005509;GO:0019538;GO:0009306;GO:0042984;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi cis cisterna; C:nucleus;, F:calcium ion binding;, P:protein metabolic process; P:protein secretion; P:regulation of amyloid precursor protein biosynthetic process; scaffold86 indexed_genome mRNA 1850827 1991117 . - . ID=transcript_12325;Q96L00 Q9H436 Q9UJP8 Q9UJP9 Q9UP24,Protein CBFA2T2,ETO homologous on chromosome 20;MTG8-like protein;MTG8-related protein 1;Myeloid translocation-related protein 1;p85;, PF08788;PF07531;PF01753;, GO:0005634;GO:0046872;GO:0003714;GO:0060575;GO:0010977;GO:0045746;GO:0000122;GO:0045892;GO:0010976;GO:0006351;, C:nucleus;, F:metal ion binding; F:transcription corepressor activity;, P:intestinal epithelial cell differentiation; P:negative regulation of neuron projection development; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of neuron projection development; P:transcription, DNA-templated;|Q96L00 Q9H436 Q9UJP8 Q9UJP9 Q9UP24,Protein CBFA2T2,ETO homologous on chromosome 20;MTG8-like protein;MTG8-related protein 1;Myeloid translocation-related protein 1;p85;, PF08788;PF07531;PF01753;, GO:0005634;GO:0046872;GO:0003714;GO:0060575;GO:0010977;GO:0045746;GO:0000122;GO:0045892;GO:0010976;GO:0006351;, C:nucleus;, F:metal ion binding; F:transcription corepressor activity;, P:intestinal epithelial cell differentiation; P:negative regulation of neuron projection development; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of neuron projection development; P:transcription, DNA-templated;|Q96L00 Q9H436 Q9UJP8 Q9UJP9 Q9UP24,Protein CBFA2T2,ETO homologous on chromosome 20;MTG8-like protein;MTG8-related protein 1;Myeloid translocation-related protein 1;p85;, PF08788;PF07531;PF01753;, GO:0005634;GO:0046872;GO:0003714;GO:0060575;GO:0010977;GO:0045746;GO:0000122;GO:0045892;GO:0010976;GO:0006351;, C:nucleus;, F:metal ion binding; F:transcription corepressor activity;, P:intestinal epithelial cell differentiation; P:negative regulation of neuron projection development; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of neuron projection development; P:transcription, DNA-templated;|Q96L00 Q9H436 Q9UJP8 Q9UJP9 Q9UP24,Protein CBFA2T2,ETO homologous on chromosome 20;MTG8-like protein;MTG8-related protein 1;Myeloid translocation-related protein 1;p85;, PF08788;PF07531;PF01753;, GO:0005634;GO:0046872;GO:0003714;GO:0060575;GO:0010977;GO:0045746;GO:0000122;GO:0045892;GO:0010976;GO:0006351;, C:nucleus;, F:metal ion binding; F:transcription corepressor activity;, P:intestinal epithelial cell differentiation; P:negative regulation of neuron projection development; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of neuron projection development; P:transcription, DNA-templated; scaffold86 indexed_genome mRNA 2043806 2082485 . + . ID=transcript_12326;Q13424 A8K7H9 B4DX40 E1P5N1 Q16438,Alpha-1-syntrophin,59 kDa dystrophin-associated protein A1 acidic component 1;Pro-TGF-alpha cytoplasmic domain-interacting protein 1;Syntrophin-1;, PF00595;PF00169;PF18012;, GO:0005737;GO:0005856;GO:0016010;GO:0031594;GO:0045211;GO:0032991;GO:0042383;GO:0045202;GO:0016013;GO:0003779;GO:0051117;GO:0005516;GO:0044325;GO:0050998;GO:0030165;GO:0017080;GO:0005198;GO:0006936;GO:1902083;GO:0007528;GO:0002027;GO:1902305;GO:0003117;GO:0060307;GO:0086005;, C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:neuromuscular junction; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma; C:synapse; C:syntrophin complex;, F:actin binding; F:ATPase binding; F:calmodulin binding; F:ion channel binding; F:nitric-oxide synthase binding; F:PDZ domain binding; F:sodium channel regulator activity; F:structural molecule activity;, P:muscle contraction; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:neuromuscular junction development; P:regulation of heart rate; P:regulation of sodium ion transmembrane transport; P:regulation of vasoconstriction by circulating norepinephrine; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:ventricular cardiac muscle cell action potential;|Q13424 A8K7H9 B4DX40 E1P5N1 Q16438,Alpha-1-syntrophin,59 kDa dystrophin-associated protein A1 acidic component 1;Pro-TGF-alpha cytoplasmic domain-interacting protein 1;Syntrophin-1;, PF00595;PF00169;PF18012;, GO:0005737;GO:0005856;GO:0016010;GO:0031594;GO:0045211;GO:0032991;GO:0042383;GO:0045202;GO:0016013;GO:0003779;GO:0051117;GO:0005516;GO:0044325;GO:0050998;GO:0030165;GO:0017080;GO:0005198;GO:0006936;GO:1902083;GO:0007528;GO:0002027;GO:1902305;GO:0003117;GO:0060307;GO:0086005;, C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:neuromuscular junction; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma; C:synapse; C:syntrophin complex;, F:actin binding; F:ATPase binding; F:calmodulin binding; F:ion channel binding; F:nitric-oxide synthase binding; F:PDZ domain binding; F:sodium channel regulator activity; F:structural molecule activity;, P:muscle contraction; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:neuromuscular junction development; P:regulation of heart rate; P:regulation of sodium ion transmembrane transport; P:regulation of vasoconstriction by circulating norepinephrine; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:ventricular cardiac muscle cell action potential;|Q13424 A8K7H9 B4DX40 E1P5N1 Q16438,Alpha-1-syntrophin,59 kDa dystrophin-associated protein A1 acidic component 1;Pro-TGF-alpha cytoplasmic domain-interacting protein 1;Syntrophin-1;, PF00595;PF00169;PF18012;, GO:0005737;GO:0005856;GO:0016010;GO:0031594;GO:0045211;GO:0032991;GO:0042383;GO:0045202;GO:0016013;GO:0003779;GO:0051117;GO:0005516;GO:0044325;GO:0050998;GO:0030165;GO:0017080;GO:0005198;GO:0006936;GO:1902083;GO:0007528;GO:0002027;GO:1902305;GO:0003117;GO:0060307;GO:0086005;, C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:neuromuscular junction; C:postsynaptic membrane; C:protein-containing complex; C:sarcolemma; C:synapse; C:syntrophin complex;, F:actin binding; F:ATPase binding; F:calmodulin binding; F:ion channel binding; F:nitric-oxide synthase binding; F:PDZ domain binding; F:sodium channel regulator activity; F:structural molecule activity;, P:muscle contraction; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:neuromuscular junction development; P:regulation of heart rate; P:regulation of sodium ion transmembrane transport; P:regulation of vasoconstriction by circulating norepinephrine; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:ventricular cardiac muscle cell action potential;|Q9H859 Q9NZZ9 Q9Y3F0,Mitochondrial tRNA methylthiotransferase CDK5RAP1 {ECO:0000303|PubMed:22422838, ECO:0000303|PubMed:25738458},CDK5 activator-binding protein C42;CDK5 regulatory subunit-associated protein 1;mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase;mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase;, PF04055;PF01938;PF00919;, GO:0005829;GO:0005739;GO:0051539;GO:0046872;GO:0035597;GO:0019901;GO:0044877;GO:0007420;GO:0070900;GO:0045736;GO:0070131;GO:0045903;GO:0045664;, C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:N6-isopentenyladenosine methylthiotransferase activity; F:protein kinase binding; F:protein-containing complex binding;, P:brain development; P:mitochondrial tRNA modification; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of mitochondrial translation; P:positive regulation of translational fidelity; P:regulation of neuron differentiation; scaffold86 indexed_genome mRNA 2088029 2186775 . + . ID=transcript_12327;Q9H859 Q9NZZ9 Q9Y3F0,Mitochondrial tRNA methylthiotransferase CDK5RAP1 {ECO:0000303|PubMed:22422838, ECO:0000303|PubMed:25738458},CDK5 activator-binding protein C42;CDK5 regulatory subunit-associated protein 1;mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase;mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase;, PF04055;PF01938;PF00919;, GO:0005829;GO:0005739;GO:0051539;GO:0046872;GO:0035597;GO:0019901;GO:0044877;GO:0007420;GO:0070900;GO:0045736;GO:0070131;GO:0045903;GO:0045664;, C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:N6-isopentenyladenosine methylthiotransferase activity; F:protein kinase binding; F:protein-containing complex binding;, P:brain development; P:mitochondrial tRNA modification; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of mitochondrial translation; P:positive regulation of translational fidelity; P:regulation of neuron differentiation;|Q9H859 Q9NZZ9 Q9Y3F0,Mitochondrial tRNA methylthiotransferase CDK5RAP1 {ECO:0000303|PubMed:22422838, ECO:0000303|PubMed:25738458},CDK5 activator-binding protein C42;CDK5 regulatory subunit-associated protein 1;mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase;mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase;, PF04055;PF01938;PF00919;, GO:0005829;GO:0005739;GO:0051539;GO:0046872;GO:0035597;GO:0019901;GO:0044877;GO:0007420;GO:0070900;GO:0045736;GO:0070131;GO:0045903;GO:0045664;, C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:N6-isopentenyladenosine methylthiotransferase activity; F:protein kinase binding; F:protein-containing complex binding;, P:brain development; P:mitochondrial tRNA modification; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of mitochondrial translation; P:positive regulation of translational fidelity; P:regulation of neuron differentiation;|Q9H859 Q9NZZ9 Q9Y3F0,Mitochondrial tRNA methylthiotransferase CDK5RAP1 {ECO:0000303|PubMed:22422838, ECO:0000303|PubMed:25738458},CDK5 activator-binding protein C42;CDK5 regulatory subunit-associated protein 1;mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase;mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase;, PF04055;PF01938;PF00919;, GO:0005829;GO:0005739;GO:0051539;GO:0046872;GO:0035597;GO:0019901;GO:0044877;GO:0007420;GO:0070900;GO:0045736;GO:0070131;GO:0045903;GO:0045664;, C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:N6-isopentenyladenosine methylthiotransferase activity; F:protein kinase binding; F:protein-containing complex binding;, P:brain development; P:mitochondrial tRNA modification; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of mitochondrial translation; P:positive regulation of translational fidelity; P:regulation of neuron differentiation;|Q9H859 Q9NZZ9 Q9Y3F0,Mitochondrial tRNA methylthiotransferase CDK5RAP1 {ECO:0000303|PubMed:22422838, ECO:0000303|PubMed:25738458},CDK5 activator-binding protein C42;CDK5 regulatory subunit-associated protein 1;mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase;mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase;, PF04055;PF01938;PF00919;, GO:0005829;GO:0005739;GO:0051539;GO:0046872;GO:0035597;GO:0019901;GO:0044877;GO:0007420;GO:0070900;GO:0045736;GO:0070131;GO:0045903;GO:0045664;, C:cytosol; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:N6-isopentenyladenosine methylthiotransferase activity; F:protein kinase binding; F:protein-containing complex binding;, P:brain development; P:mitochondrial tRNA modification; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of mitochondrial translation; P:positive regulation of translational fidelity; P:regulation of neuron differentiation; scaffold86 indexed_genome mRNA 2924212 2946477 . - . ID=transcript_12328;Q15691 B2R6I7 E1P5M8 Q3KQS8,Microtubule-associated protein RP/EB family member 1,APC-binding protein EB1;End-binding protein 1;, PF00307;PF03271;, GO:0031253;GO:0005813;GO:0036064;GO:0030981;GO:0005881;GO:0005829;GO:0005925;GO:0005794;GO:0005874;GO:0005815;GO:0035371;GO:1905721;GO:0051233;GO:0045296;GO:0042802;GO:0051010;GO:0008022;GO:0019901;GO:0003723;GO:0051301;GO:0016477;GO:0097711;GO:0000086;GO:0001578;GO:0046785;GO:0007052;GO:0031115;GO:1905515;GO:0030335;GO:1903033;GO:0031116;GO:0008104;GO:0071539;GO:0035372;GO:1904825;GO:0010389;GO:0031110;GO:0051225;, C:cell projection membrane; C:centrosome; C:ciliary basal body; C:cortical microtubule cytoskeleton; C:cytoplasmic microtubule; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:microtubule; C:microtubule organizing center; C:microtubule plus-end; C:mitotic spindle astral microtubule end; C:spindle midzone;, F:cadherin binding; F:identical protein binding; F:microtubule plus-end binding; F:protein C-terminus binding; F:protein kinase binding; F:RNA binding;, P:cell division; P:cell migration; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule bundle formation; P:microtubule polymerization; P:mitotic spindle organization; P:negative regulation of microtubule polymerization; P:non-motile cilium assembly; P:positive regulation of cell migration; P:positive regulation of microtubule plus-end binding; P:positive regulation of microtubule polymerization; P:protein localization; P:protein localization to centrosome; P:protein localization to microtubule; P:protein localization to microtubule plus-end; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule polymerization or depolymerization; P:spindle assembly; scaffold86 indexed_genome mRNA 2958770 2959377 . + . ID=transcript_12329;Q9UJQ5 Q9UKA6 Q9UNE5 Q9Y5R9 Q9Y5S0,DNA (cytosine-5)-methyltransferase 3B,DNA methyltransferase HsaIIIB;, PF17980;PF00145;PF00855;, GO:0005654;GO:0005634;GO:0003682;GO:0003886;GO:0003677;GO:0009008;GO:0042826;GO:0046872;GO:0003714;GO:0071549;GO:0071455;GO:0006306;GO:0045814;GO:0051573;GO:0000122;GO:0010628;GO:0051571;GO:0045666;GO:0014823;GO:0031000;GO:0042220;GO:0042493;GO:0032355;GO:0001666;GO:0010212;GO:0009636;GO:0033189;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:DNA-methyltransferase activity; F:histone deacetylase binding; F:metal ion binding; F:transcription corepressor activity;, P:cellular response to dexamethasone stimulus; P:cellular response to hyperoxia; P:DNA methylation; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K9 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of gene expression; P:positive regulation of histone H3-K4 methylation; P:positive regulation of neuron differentiation; P:response to activity; P:response to caffeine; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to hypoxia; P:response to ionizing radiation; P:response to toxic substance; P:response to vitamin A; scaffold86 indexed_genome mRNA 2967016 2977439 . - . ID=transcript_12330;Q9UJQ5 Q9UKA6 Q9UNE5 Q9Y5R9 Q9Y5S0,DNA (cytosine-5)-methyltransferase 3B,DNA methyltransferase HsaIIIB;, PF17980;PF00145;PF00855;, GO:0005654;GO:0005634;GO:0003682;GO:0003886;GO:0003677;GO:0009008;GO:0042826;GO:0046872;GO:0003714;GO:0071549;GO:0071455;GO:0006306;GO:0045814;GO:0051573;GO:0000122;GO:0010628;GO:0051571;GO:0045666;GO:0014823;GO:0031000;GO:0042220;GO:0042493;GO:0032355;GO:0001666;GO:0010212;GO:0009636;GO:0033189;, C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:DNA-methyltransferase activity; F:histone deacetylase binding; F:metal ion binding; F:transcription corepressor activity;, P:cellular response to dexamethasone stimulus; P:cellular response to hyperoxia; P:DNA methylation; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K9 methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of gene expression; P:positive regulation of histone H3-K4 methylation; P:positive regulation of neuron differentiation; P:response to activity; P:response to caffeine; P:response to cocaine; P:response to drug; P:response to estradiol; P:response to hypoxia; P:response to ionizing radiation; P:response to toxic substance; P:response to vitamin A; scaffold86 indexed_genome mRNA 3006997 3030817 . + . ID=transcript_12331;Q86VX2 A2BHJ2 B3KTZ2 Q5JYB0 Q96SI7 Q9BW53,COMM domain-containing protein 7,, PF07258;, GO:0031410;GO:0051059;GO:0032088;GO:0045892;GO:0033209;, C:cytoplasmic vesicle;, F:NF-kappaB binding;, P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription, DNA-templated; P:tumor necrosis factor-mediated signaling pathway;|Q86VX2 A2BHJ2 B3KTZ2 Q5JYB0 Q96SI7 Q9BW53,COMM domain-containing protein 7,, PF07258;, GO:0031410;GO:0051059;GO:0032088;GO:0045892;GO:0033209;, C:cytoplasmic vesicle;, F:NF-kappaB binding;, P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription, DNA-templated; P:tumor necrosis factor-mediated signaling pathway; scaffold86 indexed_genome mRNA 3256582 3261987 . + . ID=transcript_12332;Q96MY1 Q5JYB7 Q6P0Y4 Q9BR34 Q9NQF6,Nucleolar protein 4-like,, , GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm;|Q96MY1 Q5JYB7 Q6P0Y4 Q9BR34 Q9NQF6,Nucleolar protein 4-like,, , GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold86 indexed_genome mRNA 3269270 3280562 . - . ID=transcript_12333;Q8IXJ9 B2RP59 Q5JWS9 Q8IYY7 Q9H466 Q9NQF8 Q9UFJ0 Q9UFP8 Q9Y2I4,Polycomb group protein ASXL1,Additional sex combs-like protein 1;, PF13919;PF05066;PF13922;, GO:0005654;GO:0035517;GO:0003682;GO:0003677;GO:0046872;GO:0042975;GO:0042974;GO:0003713;GO:0009887;GO:0048539;GO:0000902;GO:0072015;GO:0003007;GO:0030097;GO:0048872;GO:0060430;GO:0035522;GO:0045599;GO:0010888;GO:0035359;GO:0048386;GO:0045944;GO:0016579;GO:0035564;GO:0032526;GO:0048538;GO:0006351;, C:nucleoplasm; C:PR-DUB complex;, F:chromatin binding; F:DNA binding; F:metal ion binding; F:peroxisome proliferator activated receptor binding; F:retinoic acid receptor binding; F:transcription coactivator activity;, P:animal organ morphogenesis; P:bone marrow development; P:cell morphogenesis; P:glomerular visceral epithelial cell development; P:heart morphogenesis; P:hemopoiesis; P:homeostasis of number of cells; P:lung saccule development; P:monoubiquitinated histone H2A deubiquitination; P:negative regulation of fat cell differentiation; P:negative regulation of lipid storage; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of retinoic acid receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:regulation of kidney size; P:response to retinoic acid; P:thymus development; P:transcription, DNA-templated; scaffold86 indexed_genome mRNA 3362074 3378703 . - . ID=transcript_12334;O15066 B2RMP4 B4DSR5 E1P5M5,Kinesin-like protein KIF3B,HH0048;Microtubule plus end-directed kinesin motor 3B;, PF00225;, GO:1904115;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0005873;GO:0005819;GO:0005524;GO:0008574;GO:0016887;GO:0120170;GO:0008017;GO:0003777;GO:0031267;GO:0008089;GO:0019886;GO:0007368;GO:0035735;GO:0007018;GO:0007100;GO:0090307;GO:0007052;GO:0072383;GO:0032467;GO:0006890;, C:axon cytoplasm; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:intraciliary transport particle B binding; F:microtubule binding; F:microtubule motor activity; F:small GTPase binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:mitotic centrosome separation; P:mitotic spindle assembly; P:mitotic spindle organization; P:plus-end-directed vesicle transport along microtubule; P:positive regulation of cytokinesis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O15066 B2RMP4 B4DSR5 E1P5M5,Kinesin-like protein KIF3B,HH0048;Microtubule plus end-directed kinesin motor 3B;, PF00225;, GO:1904115;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0005873;GO:0005819;GO:0005524;GO:0008574;GO:0016887;GO:0120170;GO:0008017;GO:0003777;GO:0031267;GO:0008089;GO:0019886;GO:0007368;GO:0035735;GO:0007018;GO:0007100;GO:0090307;GO:0007052;GO:0072383;GO:0032467;GO:0006890;, C:axon cytoplasm; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:intraciliary transport particle B binding; F:microtubule binding; F:microtubule motor activity; F:small GTPase binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:mitotic centrosome separation; P:mitotic spindle assembly; P:mitotic spindle organization; P:plus-end-directed vesicle transport along microtubule; P:positive regulation of cytokinesis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O15066 B2RMP4 B4DSR5 E1P5M5,Kinesin-like protein KIF3B,HH0048;Microtubule plus end-directed kinesin motor 3B;, PF00225;, GO:1904115;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0005873;GO:0005819;GO:0005524;GO:0008574;GO:0016887;GO:0120170;GO:0008017;GO:0003777;GO:0031267;GO:0008089;GO:0019886;GO:0007368;GO:0035735;GO:0007018;GO:0007100;GO:0090307;GO:0007052;GO:0072383;GO:0032467;GO:0006890;, C:axon cytoplasm; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:intraciliary transport particle B binding; F:microtubule binding; F:microtubule motor activity; F:small GTPase binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:mitotic centrosome separation; P:mitotic spindle assembly; P:mitotic spindle organization; P:plus-end-directed vesicle transport along microtubule; P:positive regulation of cytokinesis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold86 indexed_genome mRNA 3378786 3400189 . - . ID=transcript_12335;O15066 B2RMP4 B4DSR5 E1P5M5,Kinesin-like protein KIF3B,HH0048;Microtubule plus end-directed kinesin motor 3B;, PF00225;, GO:1904115;GO:0005813;GO:0097542;GO:0005929;GO:0005829;GO:0070062;GO:0005871;GO:0016939;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0005873;GO:0005819;GO:0005524;GO:0008574;GO:0016887;GO:0120170;GO:0008017;GO:0003777;GO:0031267;GO:0008089;GO:0019886;GO:0007368;GO:0035735;GO:0007018;GO:0007100;GO:0090307;GO:0007052;GO:0072383;GO:0032467;GO:0006890;, C:axon cytoplasm; C:centrosome; C:ciliary tip; C:cilium; C:cytosol; C:extracellular exosome; C:kinesin complex; C:kinesin II complex; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:plus-end kinesin complex; C:spindle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:intraciliary transport particle B binding; F:microtubule binding; F:microtubule motor activity; F:small GTPase binding;, P:anterograde axonal transport; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:determination of left/right symmetry; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; P:mitotic centrosome separation; P:mitotic spindle assembly; P:mitotic spindle organization; P:plus-end-directed vesicle transport along microtubule; P:positive regulation of cytokinesis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold86 indexed_genome mRNA 3426492 3451355 . - . ID=transcript_12336;Q9H488 A8K4R8 E1P5M4 Q14685 Q5W185 Q9BW76,GDP-fucose protein O-fucosyltransferase 1,Peptide-O-fucosyltransferase 1;, PF10250;, GO:0005783;GO:0016020;GO:0008417;GO:0046922;GO:0001525;GO:0006004;GO:0007507;GO:0007399;GO:0007219;GO:0016266;GO:0036066;GO:0006493;GO:0008593;GO:0006355;GO:0001756;, C:endoplasmic reticulum; C:membrane;, F:fucosyltransferase activity; F:peptide-O-fucosyltransferase activity;, P:angiogenesis; P:fucose metabolic process; P:heart development; P:nervous system development; P:Notch signaling pathway; P:O-glycan processing; P:protein O-linked fucosylation; P:protein O-linked glycosylation; P:regulation of Notch signaling pathway; P:regulation of transcription, DNA-templated; P:somitogenesis; scaffold86 indexed_genome mRNA 3461512 3466667 . + . ID=transcript_12337;Q9UPG8 A8K8T5 E1P5M3 Q92584,Zinc finger protein PLAGL2,Pleiomorphic adenoma-like protein 2;, PF00096;, GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0046872;GO:0043565;GO:0034378;GO:0006629;GO:2001244;GO:0009791;GO:0006357;GO:0006351;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:sequence-specific DNA binding;, P:chylomicron assembly; P:lipid metabolic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold86 indexed_genome mRNA 3474748 3507412 . - . ID=transcript_12338;Q92544 B0QYT7 Q9NUA3,Transmembrane 9 superfamily member 4,Tumor cannibalism associated protein 1 {ECO:0000303|PubMed:19893578};, PF02990;, GO:0005769;GO:0005794;GO:0016021;GO:0016020;GO:0007155;GO:0006909;GO:0070863;GO:2000010;GO:0072657;GO:0051453;GO:0001666;GO:0070072;, C:early endosome; C:Golgi apparatus; C:integral component of membrane; C:membrane;, , P:cell adhesion; P:phagocytosis; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to cell surface; P:protein localization to membrane; P:regulation of intracellular pH; P:response to hypoxia; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q92544 B0QYT7 Q9NUA3,Transmembrane 9 superfamily member 4,Tumor cannibalism associated protein 1 {ECO:0000303|PubMed:19893578};, PF02990;, GO:0005769;GO:0005794;GO:0016021;GO:0016020;GO:0007155;GO:0006909;GO:0070863;GO:2000010;GO:0072657;GO:0051453;GO:0001666;GO:0070072;, C:early endosome; C:Golgi apparatus; C:integral component of membrane; C:membrane;, , P:cell adhesion; P:phagocytosis; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to cell surface; P:protein localization to membrane; P:regulation of intracellular pH; P:response to hypoxia; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q92544 B0QYT7 Q9NUA3,Transmembrane 9 superfamily member 4,Tumor cannibalism associated protein 1 {ECO:0000303|PubMed:19893578};, PF02990;, GO:0005769;GO:0005794;GO:0016021;GO:0016020;GO:0007155;GO:0006909;GO:0070863;GO:2000010;GO:0072657;GO:0051453;GO:0001666;GO:0070072;, C:early endosome; C:Golgi apparatus; C:integral component of membrane; C:membrane;, , P:cell adhesion; P:phagocytosis; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to cell surface; P:protein localization to membrane; P:regulation of intracellular pH; P:response to hypoxia; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q92544 B0QYT7 Q9NUA3,Transmembrane 9 superfamily member 4,Tumor cannibalism associated protein 1 {ECO:0000303|PubMed:19893578};, PF02990;, GO:0005769;GO:0005794;GO:0016021;GO:0016020;GO:0007155;GO:0006909;GO:0070863;GO:2000010;GO:0072657;GO:0051453;GO:0001666;GO:0070072;, C:early endosome; C:Golgi apparatus; C:integral component of membrane; C:membrane;, , P:cell adhesion; P:phagocytosis; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to cell surface; P:protein localization to membrane; P:regulation of intracellular pH; P:response to hypoxia; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q92544 B0QYT7 Q9NUA3,Transmembrane 9 superfamily member 4,Tumor cannibalism associated protein 1 {ECO:0000303|PubMed:19893578};, PF02990;, GO:0005769;GO:0005794;GO:0016021;GO:0016020;GO:0007155;GO:0006909;GO:0070863;GO:2000010;GO:0072657;GO:0051453;GO:0001666;GO:0070072;, C:early endosome; C:Golgi apparatus; C:integral component of membrane; C:membrane;, , P:cell adhesion; P:phagocytosis; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to cell surface; P:protein localization to membrane; P:regulation of intracellular pH; P:response to hypoxia; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q92544 B0QYT7 Q9NUA3,Transmembrane 9 superfamily member 4,Tumor cannibalism associated protein 1 {ECO:0000303|PubMed:19893578};, PF02990;, GO:0005769;GO:0005794;GO:0016021;GO:0016020;GO:0007155;GO:0006909;GO:0070863;GO:2000010;GO:0072657;GO:0051453;GO:0001666;GO:0070072;, C:early endosome; C:Golgi apparatus; C:integral component of membrane; C:membrane;, , P:cell adhesion; P:phagocytosis; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to cell surface; P:protein localization to membrane; P:regulation of intracellular pH; P:response to hypoxia; P:vacuolar proton-transporting V-type ATPase complex assembly; scaffold86 indexed_genome mRNA 3539297 3581268 . - . ID=transcript_12339;Q96CC0 Q9H5Y5 Q9NUA4 Q9UMJ5,Tyrosine-protein kinase HCK,Hematopoietic cell kinase;Hemopoietic cell kinase;p59-HCK/p60-HCK;p59Hck;p61Hck;, PF07714;PF00017;PF00018;, GO:0005901;GO:0042995;GO:0005856;GO:0005829;GO:0031234;GO:0005925;GO:0005794;GO:0043231;GO:0005764;GO:0005634;GO:0005886;GO:0030133;GO:0005524;GO:0004715;GO:0001784;GO:0004713;GO:0005102;GO:0004714;GO:0007155;GO:0030154;GO:0019221;GO:0038096;GO:0006954;GO:0045087;GO:0002758;GO:0007229;GO:0060333;GO:0043299;GO:0002522;GO:0031663;GO:0007498;GO:0043066;GO:0002862;GO:0018108;GO:2000251;GO:0030838;GO:0008284;GO:0046777;GO:0006468;GO:0008360;GO:0050690;GO:0051090;GO:0050727;GO:0050764;GO:0071801;GO:0045728;GO:0007169;, C:caveola; C:cell projection; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:nucleus; C:plasma membrane; C:transport vesicle;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell adhesion; P:cell differentiation; P:cytokine-mediated signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inflammatory response; P:innate immune response; P:innate immune response-activating signal transduction; P:integrin-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:leukocyte degranulation; P:leukocyte migration involved in immune response; P:lipopolysaccharide-mediated signaling pathway; P:mesoderm development; P:negative regulation of apoptotic process; P:negative regulation of inflammatory response to antigenic stimulus; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:positive regulation of cell population proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell shape; P:regulation of defense response to virus by virus; P:regulation of DNA-binding transcription factor activity; P:regulation of inflammatory response; P:regulation of phagocytosis; P:regulation of podosome assembly; P:respiratory burst after phagocytosis; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q96CC0 Q9H5Y5 Q9NUA4 Q9UMJ5,Tyrosine-protein kinase HCK,Hematopoietic cell kinase;Hemopoietic cell kinase;p59-HCK/p60-HCK;p59Hck;p61Hck;, PF07714;PF00017;PF00018;, GO:0005901;GO:0042995;GO:0005856;GO:0005829;GO:0031234;GO:0005925;GO:0005794;GO:0043231;GO:0005764;GO:0005634;GO:0005886;GO:0030133;GO:0005524;GO:0004715;GO:0001784;GO:0004713;GO:0005102;GO:0004714;GO:0007155;GO:0030154;GO:0019221;GO:0038096;GO:0006954;GO:0045087;GO:0002758;GO:0007229;GO:0060333;GO:0043299;GO:0002522;GO:0031663;GO:0007498;GO:0043066;GO:0002862;GO:0018108;GO:2000251;GO:0030838;GO:0008284;GO:0046777;GO:0006468;GO:0008360;GO:0050690;GO:0051090;GO:0050727;GO:0050764;GO:0071801;GO:0045728;GO:0007169;, C:caveola; C:cell projection; C:cytoskeleton; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:nucleus; C:plasma membrane; C:transport vesicle;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell adhesion; P:cell differentiation; P:cytokine-mediated signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inflammatory response; P:innate immune response; P:innate immune response-activating signal transduction; P:integrin-mediated signaling pathway; P:interferon-gamma-mediated signaling pathway; P:leukocyte degranulation; P:leukocyte migration involved in immune response; P:lipopolysaccharide-mediated signaling pathway; P:mesoderm development; P:negative regulation of apoptotic process; P:negative regulation of inflammatory response to antigenic stimulus; P:peptidyl-tyrosine phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:positive regulation of cell population proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell shape; P:regulation of defense response to virus by virus; P:regulation of DNA-binding transcription factor activity; P:regulation of inflammatory response; P:regulation of phagocytosis; P:regulation of podosome assembly; P:respiratory burst after phagocytosis; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold86 indexed_genome mRNA 3597767 3614848 . - . ID=transcript_12340;Q9NUG4 Q5JYR9 Q8N5F1 Q8N6G8 Q96MD5,Cerebral cavernous malformations 2 protein-like,, PF16545;|Q9NUG4 Q5JYR9 Q8N5F1 Q8N6G8 Q96MD5,Cerebral cavernous malformations 2 protein-like,, PF16545;|Q9NUG4 Q5JYR9 Q8N5F1 Q8N6G8 Q96MD5,Cerebral cavernous malformations 2 protein-like,, PF16545; scaffold86 indexed_genome mRNA 3627944 3651978 . - . ID=transcript_12341;Q5GH72 Q9NUG5,XK-related protein 7,, PF09815;, GO:0016021;GO:0016020;GO:0005886;GO:1902742;GO:0043652;GO:0070782;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:apoptotic process involved in development; P:engulfment of apoptotic cell; P:phosphatidylserine exposure on apoptotic cell surface; scaffold86 indexed_genome mRNA 3668442 3681669 . + . ID=transcript_12342;Q9NUG6 B2R511 Q96GP3 Q9BUW8,p53 and DNA damage-regulated protein 1,, PF01920;, GO:0005737;GO:0016272;GO:0051082;GO:0006457;, C:cytoplasm; C:prefoldin complex;, F:unfolded protein binding;, P:protein folding;|Q9NUG6 B2R511 Q96GP3 Q9BUW8,p53 and DNA damage-regulated protein 1,, PF01920;, GO:0005737;GO:0016272;GO:0051082;GO:0006457;, C:cytoplasm; C:prefoldin complex;, F:unfolded protein binding;, P:protein folding;|Q3SXZ7 A6NH06 A6NIS5 B3KSG8 Q3SXZ8 Q5JYS3 Q5JYS4,Probable tubulin polyglutamylase TTLL9,Tubulin--tyrosine ligase-like protein 9;, PF03133;, GO:0036064;GO:0005929;GO:0005737;GO:0005874;GO:0005524;GO:0015631;GO:0070740;GO:0030317;GO:0000226;GO:0018095;, C:ciliary basal body; C:cilium; C:cytoplasm; C:microtubule;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:flagellated sperm motility; P:microtubule cytoskeleton organization; P:protein polyglutamylation; scaffold86 indexed_genome mRNA 3682996 3691239 . - . ID=transcript_12343;Q3SXZ7 A6NH06 A6NIS5 B3KSG8 Q3SXZ8 Q5JYS3 Q5JYS4,Probable tubulin polyglutamylase TTLL9,Tubulin--tyrosine ligase-like protein 9;, PF03133;, GO:0036064;GO:0005929;GO:0005737;GO:0005874;GO:0005524;GO:0015631;GO:0070740;GO:0030317;GO:0000226;GO:0018095;, C:ciliary basal body; C:cilium; C:cytoplasm; C:microtubule;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:flagellated sperm motility; P:microtubule cytoskeleton organization; P:protein polyglutamylation;|Q3SXZ7 A6NH06 A6NIS5 B3KSG8 Q3SXZ8 Q5JYS3 Q5JYS4,Probable tubulin polyglutamylase TTLL9,Tubulin--tyrosine ligase-like protein 9;, PF03133;, GO:0036064;GO:0005929;GO:0005737;GO:0005874;GO:0005524;GO:0015631;GO:0070740;GO:0030317;GO:0000226;GO:0018095;, C:ciliary basal body; C:cilium; C:cytoplasm; C:microtubule;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:flagellated sperm motility; P:microtubule cytoskeleton organization; P:protein polyglutamylation; scaffold86 indexed_genome mRNA 3691934 3693261 . - . ID=transcript_12344;Q3SXZ7 A6NH06 A6NIS5 B3KSG8 Q3SXZ8 Q5JYS3 Q5JYS4,Probable tubulin polyglutamylase TTLL9,Tubulin--tyrosine ligase-like protein 9;, PF03133;, GO:0036064;GO:0005929;GO:0005737;GO:0005874;GO:0005524;GO:0015631;GO:0070740;GO:0030317;GO:0000226;GO:0018095;, C:ciliary basal body; C:cilium; C:cytoplasm; C:microtubule;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:flagellated sperm motility; P:microtubule cytoskeleton organization; P:protein polyglutamylation; scaffold86 indexed_genome mRNA 3730422 3731124 . - . ID=transcript_12345;Q9H1R2 A6NH79 A8MVC8 Q5QP62 Q5QP63 Q5QP65 Q6PGN7 Q8N826 Q9BX24,Dual specificity protein phosphatase 15 {ECO:0000312|HGNC:HGNC:16236},VH1-related member Y {ECO:0000303|PubMed:15138252};Vaccinia virus VH1-related dual-specific protein phosphatase Y {ECO:0000305|PubMed:15138252};, , GO:0005829;GO:0005886;GO:0016791;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0016311;GO:0046330;GO:0042127;GO:0007179;, C:cytosol; C:plasma membrane;, F:phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dephosphorylation; P:positive regulation of JNK cascade; P:regulation of cell population proliferation; P:transforming growth factor beta receptor signaling pathway; scaffold86 indexed_genome mRNA 3733680 3734802 . + . ID=transcript_12346;Q9H1R2 A6NH79 A8MVC8 Q5QP62 Q5QP63 Q5QP65 Q6PGN7 Q8N826 Q9BX24,Dual specificity protein phosphatase 15 {ECO:0000312|HGNC:HGNC:16236},VH1-related member Y {ECO:0000303|PubMed:15138252};Vaccinia virus VH1-related dual-specific protein phosphatase Y {ECO:0000305|PubMed:15138252};, , GO:0005829;GO:0005886;GO:0016791;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0016311;GO:0046330;GO:0042127;GO:0007179;, C:cytosol; C:plasma membrane;, F:phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dephosphorylation; P:positive regulation of JNK cascade; P:regulation of cell population proliferation; P:transforming growth factor beta receptor signaling pathway; scaffold86 indexed_genome mRNA 3739971 3753900 . + . ID=transcript_12347;O43638 Q96D28,Forkhead box protein S1,Forkhead-like 18 protein;Forkhead-related transcription factor 10;, PF00250;, GO:0000785;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:0009653;GO:0001568;GO:0030154;GO:0043433;GO:0045892;GO:0050885;GO:0040018;GO:0006357;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:blood vessel development; P:cell differentiation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription, DNA-templated; P:neuromuscular process controlling balance; P:positive regulation of multicellular organism growth; P:regulation of transcription by RNA polymerase II; scaffold86 indexed_genome mRNA 3762711 3777868 . - . ID=transcript_12348;Q9H1R3 Q569L1 Q96I84,Myosin light chain kinase 2, skeletal/cardiac muscle,, PF00069;, GO:0005737;GO:0005634;GO:0030017;GO:0045202;GO:0005524;GO:0005516;GO:0004683;GO:0032027;GO:0004687;GO:0060048;GO:0055008;GO:0007274;GO:0018107;GO:0010628;GO:0046777;GO:0032971;GO:0035914;GO:0014816;GO:0006941;, C:cytoplasm; C:nucleus; C:sarcomere; C:synapse;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:myosin light chain binding; F:myosin light chain kinase activity;, P:cardiac muscle contraction; P:cardiac muscle tissue morphogenesis; P:neuromuscular synaptic transmission; P:peptidyl-threonine phosphorylation; P:positive regulation of gene expression; P:protein autophosphorylation; P:regulation of muscle filament sliding; P:skeletal muscle cell differentiation; P:skeletal muscle satellite cell differentiation; P:striated muscle contraction;|Q9H1R3 Q569L1 Q96I84,Myosin light chain kinase 2, skeletal/cardiac muscle,, PF00069;, GO:0005737;GO:0005634;GO:0030017;GO:0045202;GO:0005524;GO:0005516;GO:0004683;GO:0032027;GO:0004687;GO:0060048;GO:0055008;GO:0007274;GO:0018107;GO:0010628;GO:0046777;GO:0032971;GO:0035914;GO:0014816;GO:0006941;, C:cytoplasm; C:nucleus; C:sarcomere; C:synapse;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:myosin light chain binding; F:myosin light chain kinase activity;, P:cardiac muscle contraction; P:cardiac muscle tissue morphogenesis; P:neuromuscular synaptic transmission; P:peptidyl-threonine phosphorylation; P:positive regulation of gene expression; P:protein autophosphorylation; P:regulation of muscle filament sliding; P:skeletal muscle cell differentiation; P:skeletal muscle satellite cell differentiation; P:striated muscle contraction;|Q9H1R3 Q569L1 Q96I84,Myosin light chain kinase 2, skeletal/cardiac muscle,, PF00069;, GO:0005737;GO:0005634;GO:0030017;GO:0045202;GO:0005524;GO:0005516;GO:0004683;GO:0032027;GO:0004687;GO:0060048;GO:0055008;GO:0007274;GO:0018107;GO:0010628;GO:0046777;GO:0032971;GO:0035914;GO:0014816;GO:0006941;, C:cytoplasm; C:nucleus; C:sarcomere; C:synapse;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:myosin light chain binding; F:myosin light chain kinase activity;, P:cardiac muscle contraction; P:cardiac muscle tissue morphogenesis; P:neuromuscular synaptic transmission; P:peptidyl-threonine phosphorylation; P:positive regulation of gene expression; P:protein autophosphorylation; P:regulation of muscle filament sliding; P:skeletal muscle cell differentiation; P:skeletal muscle satellite cell differentiation; P:striated muscle contraction;|Q9H1R3 Q569L1 Q96I84,Myosin light chain kinase 2, skeletal/cardiac muscle,, PF00069;, GO:0005737;GO:0005634;GO:0030017;GO:0045202;GO:0005524;GO:0005516;GO:0004683;GO:0032027;GO:0004687;GO:0060048;GO:0055008;GO:0007274;GO:0018107;GO:0010628;GO:0046777;GO:0032971;GO:0035914;GO:0014816;GO:0006941;, C:cytoplasm; C:nucleus; C:sarcomere; C:synapse;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:myosin light chain binding; F:myosin light chain kinase activity;, P:cardiac muscle contraction; P:cardiac muscle tissue morphogenesis; P:neuromuscular synaptic transmission; P:peptidyl-threonine phosphorylation; P:positive regulation of gene expression; P:protein autophosphorylation; P:regulation of muscle filament sliding; P:skeletal muscle cell differentiation; P:skeletal muscle satellite cell differentiation; P:striated muscle contraction; scaffold86 indexed_genome mRNA 3791812 3838790 . - . ID=transcript_12349;Q9ULW0 Q96RR5 Q9H1R4 Q9NRA3 Q9UFN9 Q9UL00 Q9Y2M1,Targeting protein for Xklp2,Differentially expressed in cancerous and non-cancerous lung cells 2;Hepatocellular carcinoma-associated antigen 519;Hepatocellular carcinoma-associated antigen 90;Protein fls353;Restricted expression proliferation-associated protein 100;, PF09041;PF06886;PF12214;, GO:0043203;GO:0005829;GO:0045171;GO:0015630;GO:0072686;GO:0005880;GO:0005654;GO:0005634;GO:0005819;GO:0000922;GO:0061676;GO:0008017;GO:0030295;GO:0019901;GO:0032147;GO:0006915;GO:0051301;GO:0007020;GO:0000278;GO:0090307;GO:0007026;GO:0010389;GO:0060236;GO:1901796;, C:axon hillock; C:cytosol; C:intercellular bridge; C:microtubule cytoskeleton; C:mitotic spindle; C:nuclear microtubule; C:nucleoplasm; C:nucleus; C:spindle; C:spindle pole;, F:importin-alpha family protein binding; F:microtubule binding; F:protein kinase activator activity; F:protein kinase binding;, P:activation of protein kinase activity; P:apoptotic process; P:cell division; P:microtubule nucleation; P:mitotic cell cycle; P:mitotic spindle assembly; P:negative regulation of microtubule depolymerization; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:regulation of signal transduction by p53 class mediator; scaffold86 indexed_genome mRNA 3852864 3911685 . + . ID=transcript_12350;Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976,Bcl-2-like protein 1,Apoptosis regulator Bcl-X;, PF00452;PF02180;, GO:0097136;GO:0005813;GO:0005737;GO:0005829;GO:0016021;GO:0005743;GO:0005759;GO:0005741;GO:0005739;GO:0031965;GO:0030672;GO:0051434;GO:0042802;GO:0046982;GO:0042803;GO:0019901;GO:0008637;GO:0019221;GO:0051607;GO:0006897;GO:0097192;GO:0008630;GO:0000165;GO:0007093;GO:2000811;GO:0043066;GO:0010507;GO:1902236;GO:1900118;GO:2001240;GO:1902042;GO:2001243;GO:1902230;GO:1903077;GO:0090201;GO:2001244;GO:0032465;GO:0046902;GO:0051881;GO:0001836;GO:0034097;GO:0019050;, C:Bcl-2 family protein complex; C:centrosome; C:cytoplasm; C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear membrane; C:synaptic vesicle membrane;, F:BH3 domain binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase binding;, P:apoptotic mitochondrial changes; P:cytokine-mediated signaling pathway; P:defense response to virus; P:endocytosis; P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:MAPK cascade; P:mitotic cell cycle checkpoint; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of autophagy; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of execution phase of apoptosis; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of protein localization to plasma membrane; P:negative regulation of release of cytochrome c from mitochondria; P:positive regulation of intrinsic apoptotic signaling pathway; P:regulation of cytokinesis; P:regulation of mitochondrial membrane permeability; P:regulation of mitochondrial membrane potential; P:release of cytochrome c from mitochondria; P:response to cytokine; P:suppression by virus of host apoptotic process; scaffold86 indexed_genome mRNA 3921578 3927001 . - . ID=transcript_12351;Q96KJ9 Q6GTF4 Q9H0Z4,Cytochrome c oxidase subunit 4 isoform 2, mitochondrial,Cytochrome c oxidase subunit IV isoform 2;, PF02936;, GO:0016021;GO:0005751;GO:0004129;GO:0045333;GO:0071456;GO:0006091;GO:0006123;, C:integral component of membrane; C:mitochondrial respiratory chain complex IV;, F:cytochrome-c oxidase activity;, P:cellular respiration; P:cellular response to hypoxia; P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen; scaffold86 indexed_genome mRNA 3945386 3946376 . - . ID=transcript_12352;Q969Z7 Q9H0Z5 Q9H109,DNA-binding protein inhibitor ID-1,Class B basic helix-loop-helix protein 24;Inhibitor of DNA binding 1;Inhibitor of differentiation 1;, PF00010;, GO:0005813;GO:0005794;GO:0005654;GO:0005634;GO:0042802;GO:0070628;GO:0008022;GO:0046983;GO:0047485;GO:0008134;GO:0140416;GO:0001525;GO:0043534;GO:0048514;GO:0007420;GO:0030154;GO:0036164;GO:1903351;GO:0071364;GO:1990090;GO:1901653;GO:0032922;GO:0043066;GO:0120163;GO:0050774;GO:0043392;GO:0043433;GO:0045602;GO:0032091;GO:0000122;GO:0010621;GO:0045892;GO:0030182;GO:0032233;GO:0050679;GO:0010628;GO:1901342;GO:0007179;, C:centrosome; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:proteasome binding; F:protein C-terminus binding; F:protein dimerization activity; F:protein N-terminus binding; F:transcription factor binding; F:transcription regulator inhibitor activity;, P:angiogenesis; P:blood vessel endothelial cell migration; P:blood vessel morphogenesis; P:brain development; P:cell differentiation; P:cell-abiotic substrate adhesion; P:cellular response to dopamine; P:cellular response to epidermal growth factor stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to peptide; P:circadian regulation of gene expression; P:negative regulation of apoptotic process; P:negative regulation of cold-induced thermogenesis; P:negative regulation of dendrite morphogenesis; P:negative regulation of DNA binding; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of endothelial cell differentiation; P:negative regulation of protein binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription by transcription factor localization; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:positive regulation of actin filament bundle assembly; P:positive regulation of epithelial cell proliferation; P:positive regulation of gene expression; P:regulation of vasculature development; P:transforming growth factor beta receptor signaling pathway; scaffold86 indexed_genome mRNA 3967803 4021214 . - . ID=transcript_12353;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q7Z4F2 Q86Y35 Q95H87 Q9H110 Q9H111,Minor histocompatibility antigen H13,Intramembrane protease 1;Presenilin-like protein 3;Signal peptide peptidase;, PF04258;, GO:0009986;GO:0036513;GO:0005783;GO:0005789;GO:0071458;GO:0071556;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0008233;GO:0042803;GO:0031625;GO:0001701;GO:0033619;GO:1904211;GO:0006465;, C:cell surface; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:peptidase activity; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:in utero embryonic development; P:membrane protein proteolysis; P:membrane protein proteolysis involved in retrograde protein transport, ER to cytosol; P:signal peptide processing;|Q7Z4F2 Q86Y35 Q95H87 Q9H110 Q9H111,Minor histocompatibility antigen H13,Intramembrane protease 1;Presenilin-like protein 3;Signal peptide peptidase;, PF04258;, GO:0009986;GO:0036513;GO:0005783;GO:0005789;GO:0071458;GO:0071556;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0008233;GO:0042803;GO:0031625;GO:0001701;GO:0033619;GO:1904211;GO:0006465;, C:cell surface; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:peptidase activity; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:in utero embryonic development; P:membrane protein proteolysis; P:membrane protein proteolysis involved in retrograde protein transport, ER to cytosol; P:signal peptide processing;|Q7Z4F2 Q86Y35 Q95H87 Q9H110 Q9H111,Minor histocompatibility antigen H13,Intramembrane protease 1;Presenilin-like protein 3;Signal peptide peptidase;, PF04258;, GO:0009986;GO:0036513;GO:0005783;GO:0005789;GO:0071458;GO:0071556;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0008233;GO:0042803;GO:0031625;GO:0001701;GO:0033619;GO:1904211;GO:0006465;, C:cell surface; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:peptidase activity; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:in utero embryonic development; P:membrane protein proteolysis; P:membrane protein proteolysis involved in retrograde protein transport, ER to cytosol; P:signal peptide processing;|Q7Z4F2 Q86Y35 Q95H87 Q9H110 Q9H111,Minor histocompatibility antigen H13,Intramembrane protease 1;Presenilin-like protein 3;Signal peptide peptidase;, PF04258;, GO:0009986;GO:0036513;GO:0005783;GO:0005789;GO:0071458;GO:0071556;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0008233;GO:0042803;GO:0031625;GO:0001701;GO:0033619;GO:1904211;GO:0006465;, C:cell surface; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:peptidase activity; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:in utero embryonic development; P:membrane protein proteolysis; P:membrane protein proteolysis involved in retrograde protein transport, ER to cytosol; P:signal peptide processing;|Q7Z4F2 Q86Y35 Q95H87 Q9H110 Q9H111,Minor histocompatibility antigen H13,Intramembrane protease 1;Presenilin-like protein 3;Signal peptide peptidase;, PF04258;, GO:0009986;GO:0036513;GO:0005783;GO:0005789;GO:0071458;GO:0071556;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0008233;GO:0042803;GO:0031625;GO:0001701;GO:0033619;GO:1904211;GO:0006465;, C:cell surface; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:peptidase activity; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:in utero embryonic development; P:membrane protein proteolysis; P:membrane protein proteolysis involved in retrograde protein transport, ER to cytosol; P:signal peptide processing;|Q7Z4F2 Q86Y35 Q95H87 Q9H110 Q9H111,Minor histocompatibility antigen H13,Intramembrane protease 1;Presenilin-like protein 3;Signal peptide peptidase;, PF04258;, GO:0009986;GO:0036513;GO:0005783;GO:0005789;GO:0071458;GO:0071556;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0008233;GO:0042803;GO:0031625;GO:0001701;GO:0033619;GO:1904211;GO:0006465;, C:cell surface; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:peptidase activity; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:in utero embryonic development; P:membrane protein proteolysis; P:membrane protein proteolysis involved in retrograde protein transport, ER to cytosol; P:signal peptide processing;|Q7Z4F2 Q86Y35 Q95H87 Q9H110 Q9H111,Minor histocompatibility antigen H13,Intramembrane protease 1;Presenilin-like protein 3;Signal peptide peptidase;, PF04258;, GO:0009986;GO:0036513;GO:0005783;GO:0005789;GO:0071458;GO:0071556;GO:0016020;GO:0005886;GO:0005791;GO:0042500;GO:0008233;GO:0042803;GO:0031625;GO:0001701;GO:0033619;GO:1904211;GO:0006465;, C:cell surface; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:membrane; C:plasma membrane; C:rough endoplasmic reticulum;, F:aspartic endopeptidase activity, intramembrane cleaving; F:peptidase activity; F:protein homodimerization activity; F:ubiquitin protein ligase binding;, P:in utero embryonic development; P:membrane protein proteolysis; P:membrane protein proteolysis involved in retrograde protein transport, ER to cytosol; P:signal peptide processing; scaffold86 indexed_genome mRNA 4045425 4055079 . - . ID=transcript_12354;O75628 E1P5L1 Q5TZR7 Q5TZR8 Q9NP57,GTP-binding protein REM 1,GTPase-regulating endothelial cell sprouting;Rad and Gem-like GTP-binding protein 1;, PF00071;, GO:0005886;GO:0005246;GO:0005516;GO:0005525;GO:0003924;GO:1901842;GO:0007165;, C:plasma membrane;, F:calcium channel regulator activity; F:calmodulin binding; F:GTP binding; F:GTPase activity;, P:negative regulation of high voltage-gated calcium channel activity; P:signal transduction; scaffold86 indexed_genome mRNA 4381751 4399218 . - . ID=transcript_12355;Q9NUD7 A3KPE0 B2RPH9 Q8N840 Q8NAX5,Uncharacterized protein C20orf96,, PF15397; scaffold86 indexed_genome mRNA 4407043 4408618 . - . ID=transcript_12356;Q9NUD5 Q3B7J3 Q6NT79,Zinc finger CCHC domain-containing protein 3 {ECO:0000305},, PF00098;, GO:0005737;GO:0003690;GO:0003723;GO:0008270;GO:0002218;GO:0071360;GO:0051607;GO:0009597;GO:0045087;GO:1900246;GO:0032481;, C:cytoplasm;, F:double-stranded DNA binding; F:RNA binding; F:zinc ion binding;, P:activation of innate immune response; P:cellular response to exogenous dsRNA; P:defense response to virus; P:detection of virus; P:innate immune response; P:positive regulation of RIG-I signaling pathway; P:positive regulation of type I interferon production; scaffold86 indexed_genome mRNA 4450833 4455900 . + . ID=transcript_12357;Q9GZP1 A8K3B2 Q6FII5 Q9NUD3,Neurensin-2,, , GO:0016021;GO:0043005;GO:0043025;GO:0005886;GO:0030133;GO:0007399;, C:integral component of membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:transport vesicle;, , P:nervous system development; scaffold86 indexed_genome mRNA 4477964 4488249 . + . ID=transcript_12358;Q96RU7 Q53GU4 Q53ZW7 Q6I9Y9 Q8TAI6 Q9H5M8 Q9NUD2,Tribbles homolog 3,Neuronal cell death-inducible putative kinase;SINK;p65-interacting inhibitor of NF-kappa-B;, PF00069;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0031434;GO:0019901;GO:0004860;GO:0003714;GO:0031625;GO:0055106;GO:0032869;GO:0070059;GO:0045599;GO:0045717;GO:0006469;GO:0051898;GO:0000122;GO:0045892;GO:0032436;GO:0032092;GO:0051897;GO:0051443;GO:0006468;GO:0010506;GO:0010827;GO:0043405;GO:0019222;GO:0034976;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:mitogen-activated protein kinase kinase binding; F:protein kinase binding; F:protein kinase inhibitor activity; F:transcription corepressor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase regulator activity;, P:cellular response to insulin stimulus; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of fat cell differentiation; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein kinase B signaling; P:positive regulation of ubiquitin-protein transferase activity; P:protein phosphorylation; P:regulation of autophagy; P:regulation of glucose transmembrane transport; P:regulation of MAP kinase activity; P:regulation of metabolic process; P:response to endoplasmic reticulum stress; scaffold86 indexed_genome mRNA 4488254 4488787 . + . ID=transcript_12359;Q96RU7 Q53GU4 Q53ZW7 Q6I9Y9 Q8TAI6 Q9H5M8 Q9NUD2,Tribbles homolog 3,Neuronal cell death-inducible putative kinase;SINK;p65-interacting inhibitor of NF-kappa-B;, PF00069;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0031434;GO:0019901;GO:0004860;GO:0003714;GO:0031625;GO:0055106;GO:0032869;GO:0070059;GO:0045599;GO:0045717;GO:0006469;GO:0051898;GO:0000122;GO:0045892;GO:0032436;GO:0032092;GO:0051897;GO:0051443;GO:0006468;GO:0010506;GO:0010827;GO:0043405;GO:0019222;GO:0034976;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:mitogen-activated protein kinase kinase binding; F:protein kinase binding; F:protein kinase inhibitor activity; F:transcription corepressor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase regulator activity;, P:cellular response to insulin stimulus; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of fat cell differentiation; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein kinase B signaling; P:positive regulation of ubiquitin-protein transferase activity; P:protein phosphorylation; P:regulation of autophagy; P:regulation of glucose transmembrane transport; P:regulation of MAP kinase activity; P:regulation of metabolic process; P:response to endoplasmic reticulum stress; scaffold86 indexed_genome mRNA 4497025 4513902 . + . ID=transcript_12360;Q9BYM8 O95623 Q86SL2 Q96BS3 Q9BYM9,RanBP-type and C3HC4-type zinc finger-containing protein 1,HBV-associated factor 4;Heme-oxidized IRP2 ubiquitin ligase 1;Hepatitis B virus X-associated protein 4;RING finger protein 54;RING-type E3 ubiquitin transferase HOIL-1 {ECO:0000305};Ubiquitin-conjugating enzyme 7-interacting protein 3;, PF01485;PF13445;, GO:0005829;GO:0071797;GO:0000151;GO:0042802;GO:0046872;GO:0140311;GO:0003713;GO:0043130;GO:0004842;GO:0051220;GO:0007249;GO:0060546;GO:0032088;GO:2001238;GO:0043123;GO:0051092;GO:1901224;GO:0043161;GO:0097039;GO:0000209;GO:0010803;GO:0050852;GO:0016032;, C:cytosol; C:LUBAC complex; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:protein sequestering activity; F:transcription coactivator activity; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:cytoplasmic sequestering of protein; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway; P:viral process;|Q9BYM8 O95623 Q86SL2 Q96BS3 Q9BYM9,RanBP-type and C3HC4-type zinc finger-containing protein 1,HBV-associated factor 4;Heme-oxidized IRP2 ubiquitin ligase 1;Hepatitis B virus X-associated protein 4;RING finger protein 54;RING-type E3 ubiquitin transferase HOIL-1 {ECO:0000305};Ubiquitin-conjugating enzyme 7-interacting protein 3;, PF01485;PF13445;, GO:0005829;GO:0071797;GO:0000151;GO:0042802;GO:0046872;GO:0140311;GO:0003713;GO:0043130;GO:0004842;GO:0051220;GO:0007249;GO:0060546;GO:0032088;GO:2001238;GO:0043123;GO:0051092;GO:1901224;GO:0043161;GO:0097039;GO:0000209;GO:0010803;GO:0050852;GO:0016032;, C:cytosol; C:LUBAC complex; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:protein sequestering activity; F:transcription coactivator activity; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:cytoplasmic sequestering of protein; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway; P:viral process;|Q9BYM8 O95623 Q86SL2 Q96BS3 Q9BYM9,RanBP-type and C3HC4-type zinc finger-containing protein 1,HBV-associated factor 4;Heme-oxidized IRP2 ubiquitin ligase 1;Hepatitis B virus X-associated protein 4;RING finger protein 54;RING-type E3 ubiquitin transferase HOIL-1 {ECO:0000305};Ubiquitin-conjugating enzyme 7-interacting protein 3;, PF01485;PF13445;, GO:0005829;GO:0071797;GO:0000151;GO:0042802;GO:0046872;GO:0140311;GO:0003713;GO:0043130;GO:0004842;GO:0051220;GO:0007249;GO:0060546;GO:0032088;GO:2001238;GO:0043123;GO:0051092;GO:1901224;GO:0043161;GO:0097039;GO:0000209;GO:0010803;GO:0050852;GO:0016032;, C:cytosol; C:LUBAC complex; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:protein sequestering activity; F:transcription coactivator activity; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:cytoplasmic sequestering of protein; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway; P:viral process;|Q9BYM8 O95623 Q86SL2 Q96BS3 Q9BYM9,RanBP-type and C3HC4-type zinc finger-containing protein 1,HBV-associated factor 4;Heme-oxidized IRP2 ubiquitin ligase 1;Hepatitis B virus X-associated protein 4;RING finger protein 54;RING-type E3 ubiquitin transferase HOIL-1 {ECO:0000305};Ubiquitin-conjugating enzyme 7-interacting protein 3;, PF01485;PF13445;, GO:0005829;GO:0071797;GO:0000151;GO:0042802;GO:0046872;GO:0140311;GO:0003713;GO:0043130;GO:0004842;GO:0051220;GO:0007249;GO:0060546;GO:0032088;GO:2001238;GO:0043123;GO:0051092;GO:1901224;GO:0043161;GO:0097039;GO:0000209;GO:0010803;GO:0050852;GO:0016032;, C:cytosol; C:LUBAC complex; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:protein sequestering activity; F:transcription coactivator activity; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:cytoplasmic sequestering of protein; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway; P:viral process;|Q9BYM8 O95623 Q86SL2 Q96BS3 Q9BYM9,RanBP-type and C3HC4-type zinc finger-containing protein 1,HBV-associated factor 4;Heme-oxidized IRP2 ubiquitin ligase 1;Hepatitis B virus X-associated protein 4;RING finger protein 54;RING-type E3 ubiquitin transferase HOIL-1 {ECO:0000305};Ubiquitin-conjugating enzyme 7-interacting protein 3;, PF01485;PF13445;, GO:0005829;GO:0071797;GO:0000151;GO:0042802;GO:0046872;GO:0140311;GO:0003713;GO:0043130;GO:0004842;GO:0051220;GO:0007249;GO:0060546;GO:0032088;GO:2001238;GO:0043123;GO:0051092;GO:1901224;GO:0043161;GO:0097039;GO:0000209;GO:0010803;GO:0050852;GO:0016032;, C:cytosol; C:LUBAC complex; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:protein sequestering activity; F:transcription coactivator activity; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:cytoplasmic sequestering of protein; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway; P:viral process;|Q9BYM8 O95623 Q86SL2 Q96BS3 Q9BYM9,RanBP-type and C3HC4-type zinc finger-containing protein 1,HBV-associated factor 4;Heme-oxidized IRP2 ubiquitin ligase 1;Hepatitis B virus X-associated protein 4;RING finger protein 54;RING-type E3 ubiquitin transferase HOIL-1 {ECO:0000305};Ubiquitin-conjugating enzyme 7-interacting protein 3;, PF01485;PF13445;, GO:0005829;GO:0071797;GO:0000151;GO:0042802;GO:0046872;GO:0140311;GO:0003713;GO:0043130;GO:0004842;GO:0051220;GO:0007249;GO:0060546;GO:0032088;GO:2001238;GO:0043123;GO:0051092;GO:1901224;GO:0043161;GO:0097039;GO:0000209;GO:0010803;GO:0050852;GO:0016032;, C:cytosol; C:LUBAC complex; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:protein sequestering activity; F:transcription coactivator activity; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:cytoplasmic sequestering of protein; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of necroptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein linear polyubiquitination; P:protein polyubiquitination; P:regulation of tumor necrosis factor-mediated signaling pathway; P:T cell receptor signaling pathway; P:viral process; scaffold86 indexed_genome mRNA 4517446 4521982 . - . ID=transcript_12361;Q96BZ9 A8K6I3 B9A6M1 Q5JWQ7 Q6ZSY8 Q96NE1 Q9BYM7 Q9H140,TBC1 domain family member 20,, PF00566;, GO:0005783;GO:0005789;GO:0033116;GO:0030173;GO:0031965;GO:0005096;GO:0031267;GO:0048208;GO:0090110;GO:0006888;GO:0007030;GO:0044829;GO:0046726;GO:1902953;GO:0043547;GO:0019068;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of Golgi membrane; C:nuclear membrane;, F:GTPase activator activity; F:small GTPase binding;, P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:positive regulation by host of viral genome replication; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of GTPase activity; P:virion assembly;|Q96BZ9 A8K6I3 B9A6M1 Q5JWQ7 Q6ZSY8 Q96NE1 Q9BYM7 Q9H140,TBC1 domain family member 20,, PF00566;, GO:0005783;GO:0005789;GO:0033116;GO:0030173;GO:0031965;GO:0005096;GO:0031267;GO:0048208;GO:0090110;GO:0006888;GO:0007030;GO:0044829;GO:0046726;GO:1902953;GO:0043547;GO:0019068;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of Golgi membrane; C:nuclear membrane;, F:GTPase activator activity; F:small GTPase binding;, P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:positive regulation by host of viral genome replication; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of GTPase activity; P:virion assembly; scaffold86 indexed_genome mRNA 4523526 4537329 . + . ID=transcript_12362;Q96BZ9 A8K6I3 B9A6M1 Q5JWQ7 Q6ZSY8 Q96NE1 Q9BYM7 Q9H140,TBC1 domain family member 20,, PF00566;, GO:0005783;GO:0005789;GO:0033116;GO:0030173;GO:0031965;GO:0005096;GO:0031267;GO:0048208;GO:0090110;GO:0006888;GO:0007030;GO:0044829;GO:0046726;GO:1902953;GO:0043547;GO:0019068;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of Golgi membrane; C:nuclear membrane;, F:GTPase activator activity; F:small GTPase binding;, P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:positive regulation by host of viral genome replication; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of GTPase activity; P:virion assembly;|Q96BZ9 A8K6I3 B9A6M1 Q5JWQ7 Q6ZSY8 Q96NE1 Q9BYM7 Q9H140,TBC1 domain family member 20,, PF00566;, GO:0005783;GO:0005789;GO:0033116;GO:0030173;GO:0031965;GO:0005096;GO:0031267;GO:0048208;GO:0090110;GO:0006888;GO:0007030;GO:0044829;GO:0046726;GO:1902953;GO:0043547;GO:0019068;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of Golgi membrane; C:nuclear membrane;, F:GTPase activator activity; F:small GTPase binding;, P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:positive regulation by host of viral genome replication; P:positive regulation by virus of viral protein levels in host cell; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of GTPase activity; P:virion assembly; scaffold86 indexed_genome mRNA 4564826 4568201 . - . ID=transcript_12363;P68400 B4DYS6 D3DVV8 P19138 P20426 Q14013 Q5U065,Casein kinase II subunit alpha,, PF00069;, GO:0005829;GO:0005654;GO:0005634;GO:0016581;GO:0005886;GO:0005956;GO:0016580;GO:0005524;GO:0051879;GO:0042802;GO:0016301;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0061077;GO:0016236;GO:0007076;GO:2001234;GO:0043154;GO:2000059;GO:0018105;GO:0018107;GO:0006656;GO:0030307;GO:0008284;GO:0045732;GO:0030177;GO:0006457;GO:0006468;GO:0051726;GO:1905818;GO:1901796;GO:0048511;GO:0007165;GO:0016055;, C:cytosol; C:nucleoplasm; C:nucleus; C:NuRD complex; C:plasma membrane; C:protein kinase CK2 complex; C:Sin3 complex;, F:ATP binding; F:Hsp90 protein binding; F:identical protein binding; F:kinase activity; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:chaperone-mediated protein folding; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of protein catabolic process; P:positive regulation of Wnt signaling pathway; P:protein folding; P:protein phosphorylation; P:regulation of cell cycle; P:regulation of chromosome separation; P:regulation of signal transduction by p53 class mediator; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway; scaffold86 indexed_genome mRNA 4660363 4666902 . - . ID=transcript_12364;Q12870 Q9NQQ1,Transcription factor 15 {ECO:0000250|UniProtKB:Q60756},Class A basic helix-loop-helix protein 40 {ECO:0000305};Paraxis {ECO:0000250|UniProtKB:Q60756};Protein bHLH-EC2 {ECO:0000303|PubMed:8041747};, PF00010;, GO:0000785;GO:0005634;GO:0090575;GO:0043425;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0046983;GO:0000977;GO:0032502;GO:0043583;GO:0042755;GO:0045198;GO:0060231;GO:0007498;GO:0048644;GO:1902037;GO:0050884;GO:0048339;GO:2000738;GO:0045944;GO:0036342;GO:1903053;GO:0006357;GO:0003016;GO:0048705;GO:0043588;GO:0001756;GO:0019827;, C:chromatin; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:bHLH transcription factor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:protein dimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:developmental process; P:ear development; P:eating behavior; P:establishment of epithelial cell apical/basal polarity; P:mesenchymal to epithelial transition; P:mesoderm development; P:muscle organ morphogenesis; P:negative regulation of hematopoietic stem cell differentiation; P:neuromuscular process controlling posture; P:paraxial mesoderm development; P:positive regulation of stem cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:post-anal tail morphogenesis; P:regulation of extracellular matrix organization; P:regulation of transcription by RNA polymerase II; P:respiratory system process; P:skeletal system morphogenesis; P:skin development; P:somitogenesis; P:stem cell population maintenance; scaffold86 indexed_genome mRNA 4710411 4719266 . - . ID=transcript_12365;Q9BYN0 B2R543 Q8NDM3 Q96AK6,Sulfiredoxin-1,, PF02195;, GO:0005737;GO:0005829;GO:0005524;GO:0016667;GO:0032542;GO:0034599;GO:0006979;, C:cytoplasm; C:cytosol;, F:ATP binding; F:oxidoreductase activity, acting on a sulfur group of donors; F:sulfiredoxin activity;, P:cellular response to oxidative stress; P:response to oxidative stress; scaffold86 indexed_genome mRNA 4857863 4859287 . - . ID=transcript_12366;Q9BQ89 D3DVW2 Q5R1M7,Protein FAM110A,, PF14160;PF14161;, GO:0005737;GO:0005815;GO:0000922;, C:cytoplasm; C:microtubule organizing center; C:spindle pole;|Q9BQ89 D3DVW2 Q5R1M7,Protein FAM110A,, PF14160;PF14161;, GO:0005737;GO:0005815;GO:0000922;, C:cytoplasm; C:microtubule organizing center; C:spindle pole; scaffold86 indexed_genome mRNA 5116438 5165714 . + . ID=transcript_12367;Q92530 A0AVQ9 D3DVW3 Q9H4I1,Proteasome inhibitor PI31 subunit,, PF08577;PF11566;, GO:0005829;GO:0005783;GO:0016020;GO:0005654;GO:0048471;GO:0005839;GO:0004866;GO:0070628;GO:0046982;GO:0042803;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:1901799;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:endoplasmic reticulum; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:proteasome core complex;, F:endopeptidase inhibitor activity; F:proteasome binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of proteasomal protein catabolic process; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q92530 A0AVQ9 D3DVW3 Q9H4I1,Proteasome inhibitor PI31 subunit,, PF08577;PF11566;, GO:0005829;GO:0005783;GO:0016020;GO:0005654;GO:0048471;GO:0005839;GO:0004866;GO:0070628;GO:0046982;GO:0042803;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:1901799;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:endoplasmic reticulum; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:proteasome core complex;, F:endopeptidase inhibitor activity; F:proteasome binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of proteasomal protein catabolic process; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold86 indexed_genome mRNA 5173098 5174339 . - . ID=transcript_12368;Q9NUR3 D3DVW5,Transmembrane protein 74B,, , GO:0016021;, C:integral component of membrane; scaffold86 indexed_genome mRNA 5213962 5256672 . + . ID=transcript_12369;Q9H4I0 B2RXL0 B7ZBB1 B7ZW76 Q5W0X5,Double-strand-break repair protein rad21-like protein 1,, PF04824;PF04825;, GO:0005694;GO:0000800;GO:0030893;GO:0034991;GO:0034990;GO:0005634;GO:0000795;GO:0003682;GO:0009566;GO:0070197;GO:0007064;GO:1990414;GO:0072520;GO:0007283;GO:0007130;, C:chromosome; C:lateral element; C:meiotic cohesin complex; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:fertilization; P:meiotic attachment of telomere to nuclear envelope; P:mitotic sister chromatid cohesion; P:replication-born double-strand break repair via sister chromatid exchange; P:seminiferous tubule development; P:spermatogenesis; P:synaptonemal complex assembly;|Q9H4I0 B2RXL0 B7ZBB1 B7ZW76 Q5W0X5,Double-strand-break repair protein rad21-like protein 1,, PF04824;PF04825;, GO:0005694;GO:0000800;GO:0030893;GO:0034991;GO:0034990;GO:0005634;GO:0000795;GO:0003682;GO:0009566;GO:0070197;GO:0007064;GO:1990414;GO:0072520;GO:0007283;GO:0007130;, C:chromosome; C:lateral element; C:meiotic cohesin complex; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:fertilization; P:meiotic attachment of telomere to nuclear envelope; P:mitotic sister chromatid cohesion; P:replication-born double-strand break repair via sister chromatid exchange; P:seminiferous tubule development; P:spermatogenesis; P:synaptonemal complex assembly;|Q9H4I0 B2RXL0 B7ZBB1 B7ZW76 Q5W0X5,Double-strand-break repair protein rad21-like protein 1,, PF04824;PF04825;, GO:0005694;GO:0000800;GO:0030893;GO:0034991;GO:0034990;GO:0005634;GO:0000795;GO:0003682;GO:0009566;GO:0070197;GO:0007064;GO:1990414;GO:0072520;GO:0007283;GO:0007130;, C:chromosome; C:lateral element; C:meiotic cohesin complex; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:fertilization; P:meiotic attachment of telomere to nuclear envelope; P:mitotic sister chromatid cohesion; P:replication-born double-strand break repair via sister chromatid exchange; P:seminiferous tubule development; P:spermatogenesis; P:synaptonemal complex assembly;|Q9H4I0 B2RXL0 B7ZBB1 B7ZW76 Q5W0X5,Double-strand-break repair protein rad21-like protein 1,, PF04824;PF04825;, GO:0005694;GO:0000800;GO:0030893;GO:0034991;GO:0034990;GO:0005634;GO:0000795;GO:0003682;GO:0009566;GO:0070197;GO:0007064;GO:1990414;GO:0072520;GO:0007283;GO:0007130;, C:chromosome; C:lateral element; C:meiotic cohesin complex; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:fertilization; P:meiotic attachment of telomere to nuclear envelope; P:mitotic sister chromatid cohesion; P:replication-born double-strand break repair via sister chromatid exchange; P:seminiferous tubule development; P:spermatogenesis; P:synaptonemal complex assembly;|Q9H4I0 B2RXL0 B7ZBB1 B7ZW76 Q5W0X5,Double-strand-break repair protein rad21-like protein 1,, PF04824;PF04825;, GO:0005694;GO:0000800;GO:0030893;GO:0034991;GO:0034990;GO:0005634;GO:0000795;GO:0003682;GO:0009566;GO:0070197;GO:0007064;GO:1990414;GO:0072520;GO:0007283;GO:0007130;, C:chromosome; C:lateral element; C:meiotic cohesin complex; C:nuclear meiotic cohesin complex; C:nuclear mitotic cohesin complex; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:fertilization; P:meiotic attachment of telomere to nuclear envelope; P:mitotic sister chromatid cohesion; P:replication-born double-strand break repair via sister chromatid exchange; P:seminiferous tubule development; P:spermatogenesis; P:synaptonemal complex assembly; scaffold86 indexed_genome mRNA 5302185 5309638 . - . ID=transcript_12370;O15079 Q8IYI3,Syntaphilin,, PF15290;, GO:0005737;GO:0005881;GO:0016021;GO:0031966;GO:0005739;GO:0043005;GO:0043025;GO:0042734;GO:0008017;GO:0017075;GO:0007420;GO:0030182;GO:0007269;GO:0016081;, C:cytoplasm; C:cytoplasmic microtubule; C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion; C:neuron projection; C:neuronal cell body; C:presynaptic membrane;, F:microtubule binding; F:syntaxin-1 binding;, P:brain development; P:neuron differentiation; P:neurotransmitter secretion; P:synaptic vesicle docking;|O15079 Q8IYI3,Syntaphilin,, PF15290;, GO:0005737;GO:0005881;GO:0016021;GO:0031966;GO:0005739;GO:0043005;GO:0043025;GO:0042734;GO:0008017;GO:0017075;GO:0007420;GO:0030182;GO:0007269;GO:0016081;, C:cytoplasm; C:cytoplasmic microtubule; C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion; C:neuron projection; C:neuronal cell body; C:presynaptic membrane;, F:microtubule binding; F:syntaxin-1 binding;, P:brain development; P:neuron differentiation; P:neurotransmitter secretion; P:synaptic vesicle docking; scaffold86 indexed_genome mRNA 5356066 5364603 . + . ID=transcript_12371;P62942 D3DVW6 P20071 Q4VC47 Q6FGD9 Q6LEU3 Q9H103 Q9H566,Peptidyl-prolyl cis-trans isomerase FKBP1A,12 kDa FK506-binding protein;Calstabin-1;FK506-binding protein 1A;Immunophilin FKBP12;Rotamase;, PF00254;, GO:0005737;GO:0098562;GO:0005829;GO:0031312;GO:0016020;GO:1990425;GO:0016529;GO:0014802;GO:0030018;GO:0048185;GO:0005528;GO:0044325;GO:0005527;GO:0003755;GO:0046332;GO:0005160;GO:0034713;GO:0006458;GO:1990000;GO:0070588;GO:0061077;GO:0003007;GO:0060347;GO:0032515;GO:1901393;GO:0043123;GO:0032092;GO:0031398;GO:0006457;GO:0022417;GO:0000413;GO:0042026;GO:0032925;GO:1902991;GO:0050776;GO:0032880;GO:0060314;GO:0007183;GO:0097435;GO:0042110;GO:0007179;GO:0055010;, C:cytoplasm; C:cytoplasmic side of membrane; C:cytosol; C:extrinsic component of organelle membrane; C:membrane; C:ryanodine receptor complex; C:sarcoplasmic reticulum; C:terminal cisterna; C:Z disc;, F:activin binding; F:FK506 binding; F:ion channel binding; F:macrolide binding; F:peptidyl-prolyl cis-trans isomerase activity; F:SMAD binding; F:transforming growth factor beta receptor binding; F:type I transforming growth factor beta receptor binding;, P:'de novo' protein folding; P:amyloid fibril formation; P:calcium ion transmembrane transport; P:chaperone-mediated protein folding; P:heart morphogenesis; P:heart trabecula formation; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of transforming growth factor beta1 activation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:protein folding; P:protein maturation by protein folding; P:protein peptidyl-prolyl isomerization; P:protein refolding; P:regulation of activin receptor signaling pathway; P:regulation of amyloid precursor protein catabolic process; P:regulation of immune response; P:regulation of protein localization; P:regulation of ryanodine-sensitive calcium-release channel activity; P:SMAD protein complex assembly; P:supramolecular fiber organization; P:T cell activation; P:transforming growth factor beta receptor signaling pathway; P:ventricular cardiac muscle tissue morphogenesis; scaffold86 indexed_genome mRNA 5395397 5417716 . - . ID=transcript_12372;Q9UNZ2 A2A2L1 B2RD74 Q5JXA4 Q5JXA5 Q7Z533 Q9H102 Q9NVL9 Q9UI06,NSFL1 cofactor p47,UBX domain-containing protein 2C;p97 cofactor p47;, PF08059;PF00789;, GO:0005694;GO:0005829;GO:0005795;GO:0045111;GO:0005654;GO:0005634;GO:0005886;GO:0031616;GO:1990730;GO:0051117;GO:0005543;GO:0043130;GO:0000045;GO:0000132;GO:0007030;GO:0061025;GO:1904780;GO:0031468;GO:0046604;GO:0043161;, C:chromosome; C:cytosol; C:Golgi stack; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle pole centrosome; C:VCP-NSFL1C complex;, F:ATPase binding; F:phospholipid binding; F:ubiquitin binding;, P:autophagosome assembly; P:establishment of mitotic spindle orientation; P:Golgi organization; P:membrane fusion; P:negative regulation of protein localization to centrosome; P:nuclear envelope reassembly; P:positive regulation of mitotic centrosome separation; P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q9UNZ2 A2A2L1 B2RD74 Q5JXA4 Q5JXA5 Q7Z533 Q9H102 Q9NVL9 Q9UI06,NSFL1 cofactor p47,UBX domain-containing protein 2C;p97 cofactor p47;, PF08059;PF00789;, GO:0005694;GO:0005829;GO:0005795;GO:0045111;GO:0005654;GO:0005634;GO:0005886;GO:0031616;GO:1990730;GO:0051117;GO:0005543;GO:0043130;GO:0000045;GO:0000132;GO:0007030;GO:0061025;GO:1904780;GO:0031468;GO:0046604;GO:0043161;, C:chromosome; C:cytosol; C:Golgi stack; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle pole centrosome; C:VCP-NSFL1C complex;, F:ATPase binding; F:phospholipid binding; F:ubiquitin binding;, P:autophagosome assembly; P:establishment of mitotic spindle orientation; P:Golgi organization; P:membrane fusion; P:negative regulation of protein localization to centrosome; P:nuclear envelope reassembly; P:positive regulation of mitotic centrosome separation; P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q9UNZ2 A2A2L1 B2RD74 Q5JXA4 Q5JXA5 Q7Z533 Q9H102 Q9NVL9 Q9UI06,NSFL1 cofactor p47,UBX domain-containing protein 2C;p97 cofactor p47;, PF08059;PF00789;, GO:0005694;GO:0005829;GO:0005795;GO:0045111;GO:0005654;GO:0005634;GO:0005886;GO:0031616;GO:1990730;GO:0051117;GO:0005543;GO:0043130;GO:0000045;GO:0000132;GO:0007030;GO:0061025;GO:1904780;GO:0031468;GO:0046604;GO:0043161;, C:chromosome; C:cytosol; C:Golgi stack; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle pole centrosome; C:VCP-NSFL1C complex;, F:ATPase binding; F:phospholipid binding; F:ubiquitin binding;, P:autophagosome assembly; P:establishment of mitotic spindle orientation; P:Golgi organization; P:membrane fusion; P:negative regulation of protein localization to centrosome; P:nuclear envelope reassembly; P:positive regulation of mitotic centrosome separation; P:proteasome-mediated ubiquitin-dependent protein catabolic process;|Q9UNZ2 A2A2L1 B2RD74 Q5JXA4 Q5JXA5 Q7Z533 Q9H102 Q9NVL9 Q9UI06,NSFL1 cofactor p47,UBX domain-containing protein 2C;p97 cofactor p47;, PF08059;PF00789;, GO:0005694;GO:0005829;GO:0005795;GO:0045111;GO:0005654;GO:0005634;GO:0005886;GO:0031616;GO:1990730;GO:0051117;GO:0005543;GO:0043130;GO:0000045;GO:0000132;GO:0007030;GO:0061025;GO:1904780;GO:0031468;GO:0046604;GO:0043161;, C:chromosome; C:cytosol; C:Golgi stack; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:plasma membrane; C:spindle pole centrosome; C:VCP-NSFL1C complex;, F:ATPase binding; F:phospholipid binding; F:ubiquitin binding;, P:autophagosome assembly; P:establishment of mitotic spindle orientation; P:Golgi organization; P:membrane fusion; P:negative regulation of protein localization to centrosome; P:nuclear envelope reassembly; P:positive regulation of mitotic centrosome separation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; scaffold86 indexed_genome mRNA 5553715 5569971 . + . ID=transcript_12373;Q96KR6 B2RBQ9 E1P5Y7 Q8WVN2 Q9BYL6 Q9H418,Protein FAM210B, mitochondrial {ECO:0000305},, PF06916;, GO:0016021;GO:0031224;GO:0005741;GO:0005739;GO:0071392;GO:0043249;GO:0045648;, C:integral component of membrane; C:intrinsic component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, , P:cellular response to estradiol stimulus; P:erythrocyte maturation; P:positive regulation of erythrocyte differentiation;|O14965 E1P5F9 O60445 O75873 Q9BQD6 Q9UPG5,Aurora kinase A,Aurora 2;Aurora/IPL1-related kinase 1;Breast tumor-amplified kinase;Serine/threonine-protein kinase 15;Serine/threonine-protein kinase 6;Serine/threonine-protein kinase aurora-A;, PF00069;, GO:0043203;GO:0005814;GO:0005813;GO:0032133;GO:0005929;GO:0005829;GO:0042585;GO:0072687;GO:0005874;GO:0015630;GO:0030496;GO:0097431;GO:0005654;GO:0005634;GO:0048471;GO:0045120;GO:0005819;GO:0051233;GO:0031616;GO:0005524;GO:0035174;GO:0046982;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0031625;GO:0031145;GO:0009948;GO:0051301;GO:0051642;GO:0006977;GO:0000086;GO:0097421;GO:0000278;GO:0007100;GO:0007052;GO:0043066;GO:0010972;GO:0010629;GO:0032091;GO:1990138;GO:0018105;GO:0045840;GO:1900195;GO:0032436;GO:0046777;GO:0071539;GO:0006468;GO:0046605;GO:0032465;GO:0010389;GO:0031647;GO:1901796;GO:0009611;GO:0007057;GO:0007051;GO:0006511;, C:axon hillock; C:centriole; C:centrosome; C:chromosome passenger complex; C:cilium; C:cytosol; C:germinal vesicle; C:meiotic spindle; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle pole; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:pronucleus; C:spindle; C:spindle midzone; C:spindle pole centrosome;, F:ATP binding; F:histone serine kinase activity; F:protein heterodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:anterior/posterior axis specification; P:cell division; P:centrosome localization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G2/M transition of mitotic cell cycle; P:liver regeneration; P:mitotic cell cycle; P:mitotic centrosome separation; P:mitotic spindle organization; P:negative regulation of apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of protein binding; P:neuron projection extension; P:peptidyl-serine phosphorylation; P:positive regulation of mitotic nuclear division; P:positive regulation of oocyte maturation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein autophosphorylation; P:protein localization to centrosome; P:protein phosphorylation; P:regulation of centrosome cycle; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of protein stability; P:regulation of signal transduction by p53 class mediator; P:response to wounding; P:spindle assembly involved in female meiosis I; P:spindle organization; P:ubiquitin-dependent protein catabolic process;|O14965 E1P5F9 O60445 O75873 Q9BQD6 Q9UPG5,Aurora kinase A,Aurora 2;Aurora/IPL1-related kinase 1;Breast tumor-amplified kinase;Serine/threonine-protein kinase 15;Serine/threonine-protein kinase 6;Serine/threonine-protein kinase aurora-A;, PF00069;, GO:0043203;GO:0005814;GO:0005813;GO:0032133;GO:0005929;GO:0005829;GO:0042585;GO:0072687;GO:0005874;GO:0015630;GO:0030496;GO:0097431;GO:0005654;GO:0005634;GO:0048471;GO:0045120;GO:0005819;GO:0051233;GO:0031616;GO:0005524;GO:0035174;GO:0046982;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0031625;GO:0031145;GO:0009948;GO:0051301;GO:0051642;GO:0006977;GO:0000086;GO:0097421;GO:0000278;GO:0007100;GO:0007052;GO:0043066;GO:0010972;GO:0010629;GO:0032091;GO:1990138;GO:0018105;GO:0045840;GO:1900195;GO:0032436;GO:0046777;GO:0071539;GO:0006468;GO:0046605;GO:0032465;GO:0010389;GO:0031647;GO:1901796;GO:0009611;GO:0007057;GO:0007051;GO:0006511;, C:axon hillock; C:centriole; C:centrosome; C:chromosome passenger complex; C:cilium; C:cytosol; C:germinal vesicle; C:meiotic spindle; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle pole; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:pronucleus; C:spindle; C:spindle midzone; C:spindle pole centrosome;, F:ATP binding; F:histone serine kinase activity; F:protein heterodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:anterior/posterior axis specification; P:cell division; P:centrosome localization; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G2/M transition of mitotic cell cycle; P:liver regeneration; P:mitotic cell cycle; P:mitotic centrosome separation; P:mitotic spindle organization; P:negative regulation of apoptotic process; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of protein binding; P:neuron projection extension; P:peptidyl-serine phosphorylation; P:positive regulation of mitotic nuclear division; P:positive regulation of oocyte maturation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein autophosphorylation; P:protein localization to centrosome; P:protein phosphorylation; P:regulation of centrosome cycle; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of protein stability; P:regulation of signal transduction by p53 class mediator; P:response to wounding; P:spindle assembly involved in female meiosis I; P:spindle organization; P:ubiquitin-dependent protein catabolic process; scaffold86 indexed_genome mRNA 5576667 5583970 . + . ID=transcript_12374;Q05048 Q5QPD8,Cleavage stimulation factor subunit 1,CF-1 50 kDa subunit;Cleavage stimulation factor 50 kDa subunit;, PF16699;PF00400;, GO:0005848;GO:0005654;GO:0003723;GO:0031124;GO:0000398;GO:0006369;, C:mRNA cleavage stimulating factor complex; C:nucleoplasm;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA splicing, via spliceosome; P:termination of RNA polymerase II transcription; scaffold86 indexed_genome mRNA 5620602 5625446 . + . ID=transcript_12375;Q9NQ75 E1P5Z8 Q5QPD6 Q96K09 Q9BYL5,Cas scaffolding protein family member 4,HEF-like protein;HEF1-EFS-p130Cas-like protein;, PF12026;PF08824;PF14604;, GO:0005737;GO:0005856;GO:0005925;GO:1990782;GO:0090527;GO:0007155;GO:0016477;GO:0030335;GO:0051897;GO:0061098;GO:1900026;GO:0007169;, C:cytoplasm; C:cytoskeleton; C:focal adhesion;, F:protein tyrosine kinase binding;, P:actin filament reorganization; P:cell adhesion; P:cell migration; P:positive regulation of cell migration; P:positive regulation of protein kinase B signaling; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold86 indexed_genome mRNA 5634139 5674671 . + . ID=transcript_12376;Q9BY42 E1P5Z9 Q9BYL7 Q9HCV9 Q9NX29 Q9NZZ8 Q9P002 Q9UHW3,Replication termination factor 2 {ECO:0000305},Replication termination factor 2 domain-containing protein 1 {ECO:0000305};, , GO:0005634;GO:0005657;GO:0003677;GO:0072711;GO:1902979;GO:0097752;GO:0071171;, C:nucleus; C:replication fork;, F:DNA binding;, P:cellular response to hydroxyurea; P:mitotic DNA replication termination; P:regulation of DNA stability; P:site-specific DNA replication termination at RTS1 barrier;|Q6ZNI0 Q9HCV8,Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7,, PF02485;, GO:0000139;GO:0016021;GO:0016757;GO:0006486;, C:Golgi membrane; C:integral component of membrane;, F:transferase activity, transferring glycosyl groups;, P:protein glycosylation;|Q9BY42 E1P5Z9 Q9BYL7 Q9HCV9 Q9NX29 Q9NZZ8 Q9P002 Q9UHW3,Replication termination factor 2 {ECO:0000305},Replication termination factor 2 domain-containing protein 1 {ECO:0000305};, , GO:0005634;GO:0005657;GO:0003677;GO:0072711;GO:1902979;GO:0097752;GO:0071171;, C:nucleus; C:replication fork;, F:DNA binding;, P:cellular response to hydroxyurea; P:mitotic DNA replication termination; P:regulation of DNA stability; P:site-specific DNA replication termination at RTS1 barrier;|Q9BY42 E1P5Z9 Q9BYL7 Q9HCV9 Q9NX29 Q9NZZ8 Q9P002 Q9UHW3,Replication termination factor 2 {ECO:0000305},Replication termination factor 2 domain-containing protein 1 {ECO:0000305};, , GO:0005634;GO:0005657;GO:0003677;GO:0072711;GO:1902979;GO:0097752;GO:0071171;, C:nucleus; C:replication fork;, F:DNA binding;, P:cellular response to hydroxyurea; P:mitotic DNA replication termination; P:regulation of DNA stability; P:site-specific DNA replication termination at RTS1 barrier;|Q9BY42 E1P5Z9 Q9BYL7 Q9HCV9 Q9NX29 Q9NZZ8 Q9P002 Q9UHW3,Replication termination factor 2 {ECO:0000305},Replication termination factor 2 domain-containing protein 1 {ECO:0000305};, , GO:0005634;GO:0005657;GO:0003677;GO:0072711;GO:1902979;GO:0097752;GO:0071171;, C:nucleus; C:replication fork;, F:DNA binding;, P:cellular response to hydroxyurea; P:mitotic DNA replication termination; P:regulation of DNA stability; P:site-specific DNA replication termination at RTS1 barrier;|Q9BY42 E1P5Z9 Q9BYL7 Q9HCV9 Q9NX29 Q9NZZ8 Q9P002 Q9UHW3,Replication termination factor 2 {ECO:0000305},Replication termination factor 2 domain-containing protein 1 {ECO:0000305};, , GO:0005634;GO:0005657;GO:0003677;GO:0072711;GO:1902979;GO:0097752;GO:0071171;, C:nucleus; C:replication fork;, F:DNA binding;, P:cellular response to hydroxyurea; P:mitotic DNA replication termination; P:regulation of DNA stability; P:site-specific DNA replication termination at RTS1 barrier; scaffold86 indexed_genome mRNA 6137123 6226502 . - . ID=transcript_12377;P18075 Q9H512 Q9NTQ7,Bone morphogenetic protein 7,Osteogenic protein 1;, PF00019;PF00688;, GO:0062023;GO:0005576;GO:0005615;GO:0031982;GO:0070700;GO:0005125;GO:0008083;GO:0008201;GO:1905069;GO:0007411;GO:0030509;GO:0060445;GO:0048754;GO:0048738;GO:0060411;GO:0051216;GO:0071773;GO:0071456;GO:0060710;GO:0016358;GO:0048596;GO:0030326;GO:0009880;GO:0060272;GO:0003272;GO:0030855;GO:0001837;GO:0061384;GO:0030902;GO:0048762;GO:0060485;GO:0001707;GO:0001823;GO:0072136;GO:0072133;GO:0001656;GO:0070487;GO:0045786;GO:0060548;GO:0072125;GO:0043407;GO:0072040;GO:0045839;GO:0050768;GO:0045665;GO:0032088;GO:1901223;GO:0045746;GO:0042326;GO:0060686;GO:0010664;GO:0045892;GO:0072134;GO:0021502;GO:0048812;GO:0042475;GO:0001503;GO:0003344;GO:0060037;GO:0043065;GO:0030501;GO:0090336;GO:1905312;GO:1900006;GO:0010718;GO:0010628;GO:0034116;GO:1900106;GO:0045666;GO:0045669;GO:0010862;GO:0010800;GO:0045944;GO:0045893;GO:0034504;GO:0060687;GO:0060393;GO:2000121;GO:0032355;GO:0043434;GO:0033280;GO:0001501;GO:0060395;GO:0043401;GO:0001657;, C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:vesicle;, F:BMP receptor binding; F:cytokine activity; F:growth factor activity; F:heparin binding;, P:allantois development; P:axon guidance; P:BMP signaling pathway; P:branching involved in salivary gland morphogenesis; P:branching morphogenesis of an epithelial tube; P:cardiac muscle tissue development; P:cardiac septum morphogenesis; P:cartilage development; P:cellular response to BMP stimulus; P:cellular response to hypoxia; P:chorio-allantoic fusion; P:dendrite development; P:embryonic camera-type eye morphogenesis; P:embryonic limb morphogenesis; P:embryonic pattern specification; P:embryonic skeletal joint morphogenesis; P:endocardial cushion formation; P:epithelial cell differentiation; P:epithelial to mesenchymal transition; P:heart trabecula morphogenesis; P:hindbrain development; P:mesenchymal cell differentiation; P:mesenchyme development; P:mesoderm formation; P:mesonephros development; P:metanephric mesenchymal cell proliferation involved in metanephros development; P:metanephric mesenchyme morphogenesis; P:metanephros development; P:monocyte aggregation; P:negative regulation of cell cycle; P:negative regulation of cell death; P:negative regulation of glomerular mesangial cell proliferation; P:negative regulation of MAP kinase activity; P:negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis; P:negative regulation of mitotic nuclear division; P:negative regulation of neurogenesis; P:negative regulation of neuron differentiation; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of Notch signaling pathway; P:negative regulation of phosphorylation; P:negative regulation of prostatic bud formation; P:negative regulation of striated muscle cell apoptotic process; P:negative regulation of transcription, DNA-templated; P:nephrogenic mesenchyme morphogenesis; P:neural fold elevation formation; P:neuron projection morphogenesis; P:odontogenesis of dentin-containing tooth; P:ossification; P:pericardium morphogenesis; P:pharyngeal system development; P:positive regulation of apoptotic process; P:positive regulation of bone mineralization; P:positive regulation of brown fat cell differentiation; P:positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis; P:positive regulation of dendrite development; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of hyaluranon cable assembly; P:positive regulation of neuron differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein localization to nucleus; P:regulation of branching involved in prostate gland morphogenesis; P:regulation of pathway-restricted SMAD protein phosphorylation; P:regulation of removal of superoxide radicals; P:response to estradiol; P:response to peptide hormone; P:response to vitamin D; P:skeletal system development; P:SMAD protein signal transduction; P:steroid hormone mediated signaling pathway; P:ureteric bud development; scaffold86 indexed_genome mRNA 6308386 6327541 . + . ID=transcript_12378;P78406 A8K882 O15306 Q3SYL7 Q5TCH8 Q6V708 Q9H100 Q9NQM6,mRNA export factor,Rae1 protein homolog;mRNA-associated protein mrnp 41;, PF00400;, GO:0005737;GO:0001650;GO:0043657;GO:0097431;GO:0005635;GO:0005643;GO:0005654;GO:0005634;GO:0008017;GO:0003723;GO:0043130;GO:0007049;GO:0051301;GO:0075733;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060236;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasm; C:fibrillar center; C:host cell; C:mitotic spindle pole; C:nuclear envelope; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:microtubule binding; F:RNA binding; F:ubiquitin binding;, P:cell cycle; P:cell division; P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mitotic spindle organization; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P78406 A8K882 O15306 Q3SYL7 Q5TCH8 Q6V708 Q9H100 Q9NQM6,mRNA export factor,Rae1 protein homolog;mRNA-associated protein mrnp 41;, PF00400;, GO:0005737;GO:0001650;GO:0043657;GO:0097431;GO:0005635;GO:0005643;GO:0005654;GO:0005634;GO:0008017;GO:0003723;GO:0043130;GO:0007049;GO:0051301;GO:0075733;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060236;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasm; C:fibrillar center; C:host cell; C:mitotic spindle pole; C:nuclear envelope; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:microtubule binding; F:RNA binding; F:ubiquitin binding;, P:cell cycle; P:cell division; P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mitotic spindle organization; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P78406 A8K882 O15306 Q3SYL7 Q5TCH8 Q6V708 Q9H100 Q9NQM6,mRNA export factor,Rae1 protein homolog;mRNA-associated protein mrnp 41;, PF00400;, GO:0005737;GO:0001650;GO:0043657;GO:0097431;GO:0005635;GO:0005643;GO:0005654;GO:0005634;GO:0008017;GO:0003723;GO:0043130;GO:0007049;GO:0051301;GO:0075733;GO:0006406;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060236;GO:0006405;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasm; C:fibrillar center; C:host cell; C:mitotic spindle pole; C:nuclear envelope; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:microtubule binding; F:RNA binding; F:ubiquitin binding;, P:cell cycle; P:cell division; P:intracellular transport of virus; P:mRNA export from nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mitotic spindle organization; P:RNA export from nucleus; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold86 indexed_genome mRNA 6346024 6346783 . + . ID=transcript_12379;Q9H0Z9 A6NDK1 A6NMU6 Q15350 Q15351 Q9BYK3 Q9BYK4,RNA-binding protein 38,CLL-associated antigen KW-5;HSRNASEB;RNA-binding motif protein 38;RNA-binding region-containing protein 1;ssDNA-binding protein SEB4;, PF00076;, GO:0005829;GO:0005634;GO:0003730;GO:0003729;GO:0003723;GO:0070935;GO:0007049;GO:0007050;GO:0030154;GO:0006977;GO:0006978;GO:0006397;GO:0008285;GO:0010830;GO:0043484;GO:0008380;GO:0016032;, C:cytosol; C:nucleus;, F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:cell cycle; P:cell cycle arrest; P:cell differentiation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:mRNA processing; P:negative regulation of cell population proliferation; P:regulation of myotube differentiation; P:regulation of RNA splicing; P:RNA splicing; P:viral process; scaffold86 indexed_genome mRNA 6496497 6502796 . + . ID=transcript_12380;P35558 A8K437 B4DT64 Q8TCA3 Q9UJD2,Phosphoenolpyruvate carboxykinase, cytosolic [GTP] {ECO:0000305},Serine-protein kinase PCK1 {ECO:0000305};, PF00821;PF17297;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005739;GO:0031406;GO:0019003;GO:0005525;GO:0000287;GO:0030145;GO:0004613;GO:0106264;GO:0007568;GO:0071320;GO:0071549;GO:0071332;GO:0071377;GO:0071333;GO:0071456;GO:0032869;GO:0071347;GO:0051365;GO:0071300;GO:0071356;GO:0006094;GO:0042593;GO:0006006;GO:0046327;GO:0070365;GO:0030522;GO:0006107;GO:0018105;GO:0043382;GO:0061402;GO:0019543;GO:0046890;GO:0014823;GO:0032868;GO:0070741;GO:0033993;GO:0032496;GO:1904640;GO:0042594;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrion;, F:carboxylic acid binding; F:GDP binding; F:GTP binding; F:magnesium ion binding; F:manganese ion binding; F:phosphoenolpyruvate carboxykinase (GTP) activity; F:protein serine kinase activity (using GTP as donor);, P:aging; P:cellular response to cAMP; P:cellular response to dexamethasone stimulus; P:cellular response to fructose stimulus; P:cellular response to glucagon stimulus; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to interleukin-1; P:cellular response to potassium ion starvation; P:cellular response to retinoic acid; P:cellular response to tumor necrosis factor; P:gluconeogenesis; P:glucose homeostasis; P:glucose metabolic process; P:glycerol biosynthetic process from pyruvate; P:hepatocyte differentiation; P:intracellular receptor signaling pathway; P:oxaloacetate metabolic process; P:peptidyl-serine phosphorylation; P:positive regulation of memory T cell differentiation; P:positive regulation of transcription from RNA polymerase II promoter in response to acidic pH; P:propionate catabolic process; P:regulation of lipid biosynthetic process; P:response to activity; P:response to insulin; P:response to interleukin-6; P:response to lipid; P:response to lipopolysaccharide; P:response to methionine; P:response to starvation;|P35558 A8K437 B4DT64 Q8TCA3 Q9UJD2,Phosphoenolpyruvate carboxykinase, cytosolic [GTP] {ECO:0000305},Serine-protein kinase PCK1 {ECO:0000305};, PF00821;PF17297;, GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005739;GO:0031406;GO:0019003;GO:0005525;GO:0000287;GO:0030145;GO:0004613;GO:0106264;GO:0007568;GO:0071320;GO:0071549;GO:0071332;GO:0071377;GO:0071333;GO:0071456;GO:0032869;GO:0071347;GO:0051365;GO:0071300;GO:0071356;GO:0006094;GO:0042593;GO:0006006;GO:0046327;GO:0070365;GO:0030522;GO:0006107;GO:0018105;GO:0043382;GO:0061402;GO:0019543;GO:0046890;GO:0014823;GO:0032868;GO:0070741;GO:0033993;GO:0032496;GO:1904640;GO:0042594;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:mitochondrion;, F:carboxylic acid binding; F:GDP binding; F:GTP binding; F:magnesium ion binding; F:manganese ion binding; F:phosphoenolpyruvate carboxykinase (GTP) activity; F:protein serine kinase activity (using GTP as donor);, P:aging; P:cellular response to cAMP; P:cellular response to dexamethasone stimulus; P:cellular response to fructose stimulus; P:cellular response to glucagon stimulus; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to interleukin-1; P:cellular response to potassium ion starvation; P:cellular response to retinoic acid; P:cellular response to tumor necrosis factor; P:gluconeogenesis; P:glucose homeostasis; P:glucose metabolic process; P:glycerol biosynthetic process from pyruvate; P:hepatocyte differentiation; P:intracellular receptor signaling pathway; P:oxaloacetate metabolic process; P:peptidyl-serine phosphorylation; P:positive regulation of memory T cell differentiation; P:positive regulation of transcription from RNA polymerase II promoter in response to acidic pH; P:propionate catabolic process; P:regulation of lipid biosynthetic process; P:response to activity; P:response to insulin; P:response to interleukin-6; P:response to lipid; P:response to lipopolysaccharide; P:response to methionine; P:response to starvation; scaffold86 indexed_genome mRNA 6538885 6543632 . - . ID=transcript_12381;Q9H171 A2A2F7 B3KVA1 F5GYT1 Q5JY39 Q9BYW4,Z-DNA-binding protein 1 {ECO:0000305},DNA-dependent activator of IFN-regulatory factors {ECO:0000303|PubMed:19095800};Tumor stroma and activated macrophage protein DLM-1 {ECO:0000303|PubMed:11842111};, PF02295;, GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0003725;GO:0042802;GO:0003692;GO:0002218;GO:0006915;GO:0051607;GO:0045087;GO:0043065;GO:0050729;GO:0060545;GO:0032481;GO:0060340;GO:0070269;GO:0050727;GO:2000659;GO:0032479;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:identical protein binding; F:left-handed Z-DNA binding;, P:activation of innate immune response; P:apoptotic process; P:defense response to virus; P:innate immune response; P:positive regulation of apoptotic process; P:positive regulation of inflammatory response; P:positive regulation of necroptotic process; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:pyroptosis; P:regulation of inflammatory response; P:regulation of interleukin-1-mediated signaling pathway; P:regulation of type I interferon production; P:viral process;|Q9H171 A2A2F7 B3KVA1 F5GYT1 Q5JY39 Q9BYW4,Z-DNA-binding protein 1 {ECO:0000305},DNA-dependent activator of IFN-regulatory factors {ECO:0000303|PubMed:19095800};Tumor stroma and activated macrophage protein DLM-1 {ECO:0000303|PubMed:11842111};, PF02295;, GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0003725;GO:0042802;GO:0003692;GO:0002218;GO:0006915;GO:0051607;GO:0045087;GO:0043065;GO:0050729;GO:0060545;GO:0032481;GO:0060340;GO:0070269;GO:0050727;GO:2000659;GO:0032479;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:identical protein binding; F:left-handed Z-DNA binding;, P:activation of innate immune response; P:apoptotic process; P:defense response to virus; P:innate immune response; P:positive regulation of apoptotic process; P:positive regulation of inflammatory response; P:positive regulation of necroptotic process; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:pyroptosis; P:regulation of inflammatory response; P:regulation of interleukin-1-mediated signaling pathway; P:regulation of type I interferon production; P:viral process; scaffold86 indexed_genome mRNA 6543986 6546866 . - . ID=transcript_12382;Q9H171 A2A2F7 B3KVA1 F5GYT1 Q5JY39 Q9BYW4,Z-DNA-binding protein 1 {ECO:0000305},DNA-dependent activator of IFN-regulatory factors {ECO:0000303|PubMed:19095800};Tumor stroma and activated macrophage protein DLM-1 {ECO:0000303|PubMed:11842111};, PF02295;, GO:0005737;GO:0005829;GO:0005634;GO:0003677;GO:0003725;GO:0042802;GO:0003692;GO:0002218;GO:0006915;GO:0051607;GO:0045087;GO:0043065;GO:0050729;GO:0060545;GO:0032481;GO:0060340;GO:0070269;GO:0050727;GO:2000659;GO:0032479;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleus;, F:DNA binding; F:double-stranded RNA binding; F:identical protein binding; F:left-handed Z-DNA binding;, P:activation of innate immune response; P:apoptotic process; P:defense response to virus; P:innate immune response; P:positive regulation of apoptotic process; P:positive regulation of inflammatory response; P:positive regulation of necroptotic process; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:pyroptosis; P:regulation of inflammatory response; P:regulation of interleukin-1-mediated signaling pathway; P:regulation of type I interferon production; P:viral process; scaffold87 indexed_genome mRNA 1287125 1422158 . - . ID=transcript_12383;Q6RI45 C9IZ39 C9J3F3 Q2T9J6 Q5JRN1 Q6RI37 Q6RI42 Q6RI44 Q8N916,Bromodomain and WD repeat-containing protein 3,, PF00439;PF00400;, GO:0005634;GO:0007010;GO:0008360;GO:0006357;, C:nucleus;, , P:cytoskeleton organization; P:regulation of cell shape; P:regulation of transcription by RNA polymerase II;|Q6RI45 C9IZ39 C9J3F3 Q2T9J6 Q5JRN1 Q6RI37 Q6RI42 Q6RI44 Q8N916,Bromodomain and WD repeat-containing protein 3,, PF00439;PF00400;, GO:0005634;GO:0007010;GO:0008360;GO:0006357;, C:nucleus;, , P:cytoskeleton organization; P:regulation of cell shape; P:regulation of transcription by RNA polymerase II;|Q6RI45 C9IZ39 C9J3F3 Q2T9J6 Q5JRN1 Q6RI37 Q6RI42 Q6RI44 Q8N916,Bromodomain and WD repeat-containing protein 3,, PF00439;PF00400;, GO:0005634;GO:0007010;GO:0008360;GO:0006357;, C:nucleus;, , P:cytoskeleton organization; P:regulation of cell shape; P:regulation of transcription by RNA polymerase II; scaffold87 indexed_genome mRNA 1682052 1690944 . - . ID=transcript_12384;P82970 Q5JSL1,High mobility group nucleosome-binding domain-containing protein 5,Nucleosome-binding protein 1;, PF01101;, GO:0000785;GO:0005739;GO:0005654;GO:0005634;GO:0003682;GO:0031492;GO:0003723;GO:0006325;GO:0043066;GO:0071157;GO:0008284;GO:0010628;GO:0045893;GO:0006355;, C:chromatin; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:nucleosomal DNA binding; F:RNA binding;, P:chromatin organization; P:negative regulation of apoptotic process; P:negative regulation of cell cycle arrest; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold87 indexed_genome mRNA 1755070 1860183 . + . ID=transcript_12385;O75368 Q3SYL1 Q5JT50 Q6FIE8 Q9H0N8,SH3 domain-binding glutamic acid-rich-like protein,, PF04908;, GO:0005737;GO:0070062;GO:0005615;GO:0005634;GO:0017124;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleus;, F:SH3 domain binding; scaffold87 indexed_genome mRNA 3749290 3750509 . + . ID=transcript_12386;P49335 B2RC71 Q5H9G9 Q99410,POU domain, class 3, transcription factor 4,Brain-specific homeobox/POU domain protein 4;Octamer-binding protein 9;Octamer-binding transcription factor 9;, PF00046;PF00157;, GO:0000785;GO:0005654;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0007420;GO:0090103;GO:2001054;GO:0006357;GO:0007605;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:cochlea morphogenesis; P:negative regulation of mesenchymal cell apoptotic process; P:regulation of transcription by RNA polymerase II; P:sensory perception of sound; scaffold87 indexed_genome mRNA 4303675 4450396 . - . ID=transcript_12387;Q9UK32 B2R854 B7ZL90 Q6FHX2 Q8WX28 Q9H4S6,Ribosomal protein S6 kinase alpha-6,90 kDa ribosomal protein S6 kinase 6;Ribosomal S6 kinase 4;pp90RSK4;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0001650;GO:0005739;GO:0005730;GO:0005654;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0007417;GO:0006978;GO:0045992;GO:0070373;GO:2000381;GO:0018105;GO:0007165;, C:cytoplasm; C:cytosol; C:fibrillar center; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:central nervous system development; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:negative regulation of embryonic development; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of mesoderm development; P:peptidyl-serine phosphorylation; P:signal transduction;|Q9UK32 B2R854 B7ZL90 Q6FHX2 Q8WX28 Q9H4S6,Ribosomal protein S6 kinase alpha-6,90 kDa ribosomal protein S6 kinase 6;Ribosomal S6 kinase 4;pp90RSK4;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0001650;GO:0005739;GO:0005730;GO:0005654;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0007417;GO:0006978;GO:0045992;GO:0070373;GO:2000381;GO:0018105;GO:0007165;, C:cytoplasm; C:cytosol; C:fibrillar center; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:central nervous system development; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:negative regulation of embryonic development; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of mesoderm development; P:peptidyl-serine phosphorylation; P:signal transduction;|Q9UK32 B2R854 B7ZL90 Q6FHX2 Q8WX28 Q9H4S6,Ribosomal protein S6 kinase alpha-6,90 kDa ribosomal protein S6 kinase 6;Ribosomal S6 kinase 4;pp90RSK4;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0001650;GO:0005739;GO:0005730;GO:0005654;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0007417;GO:0006978;GO:0045992;GO:0070373;GO:2000381;GO:0018105;GO:0007165;, C:cytoplasm; C:cytosol; C:fibrillar center; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:central nervous system development; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:negative regulation of embryonic development; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of mesoderm development; P:peptidyl-serine phosphorylation; P:signal transduction;|Q9UK32 B2R854 B7ZL90 Q6FHX2 Q8WX28 Q9H4S6,Ribosomal protein S6 kinase alpha-6,90 kDa ribosomal protein S6 kinase 6;Ribosomal S6 kinase 4;pp90RSK4;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0001650;GO:0005739;GO:0005730;GO:0005654;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0007417;GO:0006978;GO:0045992;GO:0070373;GO:2000381;GO:0018105;GO:0007165;, C:cytoplasm; C:cytosol; C:fibrillar center; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:central nervous system development; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:negative regulation of embryonic development; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of mesoderm development; P:peptidyl-serine phosphorylation; P:signal transduction;|Q9UK32 B2R854 B7ZL90 Q6FHX2 Q8WX28 Q9H4S6,Ribosomal protein S6 kinase alpha-6,90 kDa ribosomal protein S6 kinase 6;Ribosomal S6 kinase 4;pp90RSK4;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0001650;GO:0005739;GO:0005730;GO:0005654;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0007417;GO:0006978;GO:0045992;GO:0070373;GO:2000381;GO:0018105;GO:0007165;, C:cytoplasm; C:cytosol; C:fibrillar center; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:central nervous system development; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:negative regulation of embryonic development; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of mesoderm development; P:peptidyl-serine phosphorylation; P:signal transduction; scaffold87 indexed_genome mRNA 4646024 4646932 . + . ID=transcript_12388;P63136,Endogenous retrovirus group K member 25 Pol protein,HERV-K_11q22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold87 indexed_genome mRNA 4843180 4848287 . - . ID=transcript_12389;Q7Z353 A8K1Y5 B7ZL18 Q5JZB4 Q96NK7,Highly divergent homeobox,, , GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold87 indexed_genome mRNA 5662473 5723912 . + . ID=transcript_12390;Q6UXV4 Q3KNU7 Q5H9D1,MICOS complex subunit MIC27,Apolipoprotein O-like;Protein FAM121A;, PF09769;, GO:0005576;GO:0140275;GO:0061617;GO:0005739;GO:0031093;GO:0001401;GO:0042407;GO:0007007;GO:0002576;, C:extracellular region; C:MIB complex; C:MICOS complex; C:mitochondrion; C:platelet alpha granule lumen; C:SAM complex;, , P:cristae formation; P:inner mitochondrial membrane organization; P:platelet degranulation;|Q6UXV4 Q3KNU7 Q5H9D1,MICOS complex subunit MIC27,Apolipoprotein O-like;Protein FAM121A;, PF09769;, GO:0005576;GO:0140275;GO:0061617;GO:0005739;GO:0031093;GO:0001401;GO:0042407;GO:0007007;GO:0002576;, C:extracellular region; C:MIB complex; C:MICOS complex; C:mitochondrion; C:platelet alpha granule lumen; C:SAM complex;, , P:cristae formation; P:inner mitochondrial membrane organization; P:platelet degranulation;|Q6UXV4 Q3KNU7 Q5H9D1,MICOS complex subunit MIC27,Apolipoprotein O-like;Protein FAM121A;, PF09769;, GO:0005576;GO:0140275;GO:0061617;GO:0005739;GO:0031093;GO:0001401;GO:0042407;GO:0007007;GO:0002576;, C:extracellular region; C:MIB complex; C:MICOS complex; C:mitochondrion; C:platelet alpha granule lumen; C:SAM complex;, , P:cristae formation; P:inner mitochondrial membrane organization; P:platelet degranulation;|Q6UXV4 Q3KNU7 Q5H9D1,MICOS complex subunit MIC27,Apolipoprotein O-like;Protein FAM121A;, PF09769;, GO:0005576;GO:0140275;GO:0061617;GO:0005739;GO:0031093;GO:0001401;GO:0042407;GO:0007007;GO:0002576;, C:extracellular region; C:MIB complex; C:MICOS complex; C:mitochondrion; C:platelet alpha granule lumen; C:SAM complex;, , P:cristae formation; P:inner mitochondrial membrane organization; P:platelet degranulation; scaffold87 indexed_genome mRNA 5961531 5990325 . + . ID=transcript_12391;Q9Y462 B4DSV4 Q6NX42 Q9Y4J6,Zinc finger protein 711,Zinc finger protein 6;, PF00096;PF04704;, GO:0005634;GO:0046872;GO:0043565;GO:0045893;GO:0010468;, C:nucleus;, F:metal ion binding; F:sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of gene expression;|Q9Y462 B4DSV4 Q6NX42 Q9Y4J6,Zinc finger protein 711,Zinc finger protein 6;, PF00096;PF04704;, GO:0005634;GO:0046872;GO:0043565;GO:0045893;GO:0010468;, C:nucleus;, F:metal ion binding; F:sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of gene expression;|Q9Y462 B4DSV4 Q6NX42 Q9Y4J6,Zinc finger protein 711,Zinc finger protein 6;, PF00096;PF04704;, GO:0005634;GO:0046872;GO:0043565;GO:0045893;GO:0010468;, C:nucleus;, F:metal ion binding; F:sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of gene expression;|P17010 B9EG97 O43668 Q8WYJ8,Zinc finger X-chromosomal protein,, PF00096;PF04704;, GO:0005694;GO:0005730;GO:0005654;GO:0043035;GO:0046872;GO:0009566;GO:0048872;GO:0035264;GO:0048599;GO:0001541;GO:0060746;GO:0009791;GO:0006357;GO:0007283;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:chromatin insulator sequence binding; F:metal ion binding;, P:fertilization; P:homeostasis of number of cells; P:multicellular organism growth; P:oocyte development; P:ovarian follicle development; P:parental behavior; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9Y462 B4DSV4 Q6NX42 Q9Y4J6,Zinc finger protein 711,Zinc finger protein 6;, PF00096;PF04704;, GO:0005634;GO:0046872;GO:0043565;GO:0045893;GO:0010468;, C:nucleus;, F:metal ion binding; F:sequence-specific DNA binding;, P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; scaffold88 indexed_genome mRNA 133582 141481 . - . ID=transcript_12392;Q7KZI7 Q15449 Q15524 Q5XGA3 Q68A18 Q96HB3 Q96RG0,Serine/threonine-protein kinase MARK2,ELKL motif kinase 1;MAP/microtubule affinity-regulating kinase 2;PAR1 homolog;PAR1 homolog b;, PF02149;PF00069;PF00627;, GO:0005884;GO:0005737;GO:0030425;GO:0016328;GO:0016020;GO:0097427;GO:0005739;GO:0005654;GO:0005886;GO:0005524;GO:0045296;GO:0008289;GO:0000287;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0048156;GO:0050321;GO:0032147;GO:0000422;GO:0061564;GO:0030010;GO:0071963;GO:0045197;GO:0035556;GO:0000226;GO:0051646;GO:0001764;GO:0018105;GO:0018107;GO:0010976;GO:0046777;GO:0006468;GO:0050770;GO:0051493;GO:1904526;GO:0070507;GO:0016055;, C:actin filament; C:cytoplasm; C:dendrite; C:lateral plasma membrane; C:membrane; C:microtubule bundle; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:lipid binding; F:magnesium ion binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of protein kinase activity; P:autophagy of mitochondrion; P:axon development; P:establishment of cell polarity; P:establishment or maintenance of cell polarity regulating cell shape; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:mitochondrion localization; P:neuron migration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of neuron projection development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cytoskeleton organization; P:regulation of microtubule binding; P:regulation of microtubule cytoskeleton organization; P:Wnt signaling pathway; scaffold88 indexed_genome mRNA 193871 341538 . + . ID=transcript_12393;P42694 I6L9H4,Probable helicase with zinc finger domain,Down-regulated in human cancers protein;, PF13086;PF13087;PF00642;, GO:0005829;GO:0016020;GO:0005634;GO:0043186;GO:0005524;GO:0004386;GO:0046872;GO:0003723;GO:0035194;, C:cytosol; C:membrane; C:nucleus; C:P granule;, F:ATP binding; F:helicase activity; F:metal ion binding; F:RNA binding;, P:post-transcriptional gene silencing by RNA;|P42694 I6L9H4,Probable helicase with zinc finger domain,Down-regulated in human cancers protein;, PF13086;PF13087;PF00642;, GO:0005829;GO:0016020;GO:0005634;GO:0043186;GO:0005524;GO:0004386;GO:0046872;GO:0003723;GO:0035194;, C:cytosol; C:membrane; C:nucleus; C:P granule;, F:ATP binding; F:helicase activity; F:metal ion binding; F:RNA binding;, P:post-transcriptional gene silencing by RNA;|P42694 I6L9H4,Probable helicase with zinc finger domain,Down-regulated in human cancers protein;, PF13086;PF13087;PF00642;, GO:0005829;GO:0016020;GO:0005634;GO:0043186;GO:0005524;GO:0004386;GO:0046872;GO:0003723;GO:0035194;, C:cytosol; C:membrane; C:nucleus; C:P granule;, F:ATP binding; F:helicase activity; F:metal ion binding; F:RNA binding;, P:post-transcriptional gene silencing by RNA;|P42694 I6L9H4,Probable helicase with zinc finger domain,Down-regulated in human cancers protein;, PF13086;PF13087;PF00642;, GO:0005829;GO:0016020;GO:0005634;GO:0043186;GO:0005524;GO:0004386;GO:0046872;GO:0003723;GO:0035194;, C:cytosol; C:membrane; C:nucleus; C:P granule;, F:ATP binding; F:helicase activity; F:metal ion binding; F:RNA binding;, P:post-transcriptional gene silencing by RNA; scaffold88 indexed_genome mRNA 355436 362853 . - . ID=transcript_12394;Q06432 B2R9N3 Q14D59,Voltage-dependent calcium channel gamma-1 subunit,Dihydropyridine-sensitive L-type, skeletal muscle calcium channel subunit gamma;, PF13903;, GO:0005887;GO:1990454;GO:0042383;GO:0030315;GO:0005246;GO:0005245;GO:1902514;GO:0070296;, C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:sarcolemma; C:T-tubule;, F:calcium channel regulator activity; F:voltage-gated calcium channel activity;, P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:sarcoplasmic reticulum calcium ion transport;|Q06432 B2R9N3 Q14D59,Voltage-dependent calcium channel gamma-1 subunit,Dihydropyridine-sensitive L-type, skeletal muscle calcium channel subunit gamma;, PF13903;, GO:0005887;GO:1990454;GO:0042383;GO:0030315;GO:0005246;GO:0005245;GO:1902514;GO:0070296;, C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:sarcolemma; C:T-tubule;, F:calcium channel regulator activity; F:voltage-gated calcium channel activity;, P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:sarcoplasmic reticulum calcium ion transport;|Q06432 B2R9N3 Q14D59,Voltage-dependent calcium channel gamma-1 subunit,Dihydropyridine-sensitive L-type, skeletal muscle calcium channel subunit gamma;, PF13903;, GO:0005887;GO:1990454;GO:0042383;GO:0030315;GO:0005246;GO:0005245;GO:1902514;GO:0070296;, C:integral component of plasma membrane; C:L-type voltage-gated calcium channel complex; C:sarcolemma; C:T-tubule;, F:calcium channel regulator activity; F:voltage-gated calcium channel activity;, P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:sarcoplasmic reticulum calcium ion transport; scaffold88 indexed_genome mRNA 374650 378720 . + . ID=transcript_12395;Q9UBN1 B2RCK0,Voltage-dependent calcium channel gamma-4 subunit,Neuronal voltage-gated calcium channel gamma-4 subunit;Transmembrane AMPAR regulatory protein gamma-4;, PF00822;, GO:0032281;GO:0044297;GO:0009986;GO:0030666;GO:0098978;GO:0005887;GO:0099061;GO:1990454;GO:0005886;GO:0098839;GO:0036477;GO:0005246;GO:0016247;GO:0035255;GO:0005245;GO:0061337;GO:0051899;GO:0099590;GO:0098943;GO:2000969;GO:0051968;GO:0098970;GO:2000311;GO:0098962;GO:0042220;GO:0019226;, C:AMPA glutamate receptor complex; C:cell body; C:cell surface; C:endocytic vesicle membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:postsynaptic density membrane; C:somatodendritic compartment;, F:calcium channel regulator activity; F:channel regulator activity; F:ionotropic glutamate receptor binding; F:voltage-gated calcium channel activity;, P:cardiac conduction; P:membrane depolarization; P:neurotransmitter receptor internalization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of AMPA receptor activity; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic neurotransmitter receptor diffusion trapping; P:regulation of AMPA receptor activity; P:regulation of postsynaptic neurotransmitter receptor activity; P:response to cocaine; P:transmission of nerve impulse; scaffold88 indexed_genome mRNA 774491 787267 . + . ID=transcript_12396;P02749 B2R9M3 Q9UCN7,Beta-2-glycoprotein 1,APC inhibitor;Activated protein C-binding protein;Anticardiolipin cofactor;Apolipoprotein H;Beta-2-glycoprotein I;, PF00084;PF09014;, GO:0009986;GO:0042627;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0031089;GO:0034361;GO:0008201;GO:0042802;GO:0008289;GO:0060230;GO:0005543;GO:0007597;GO:0016525;GO:0030195;GO:0010596;GO:0001937;GO:0051918;GO:0033033;GO:0034392;GO:0031639;GO:0002576;GO:0030194;GO:0051006;GO:0051917;GO:0006641;GO:0034197;, C:cell surface; C:chylomicron; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:platelet dense granule lumen; C:very-low-density lipoprotein particle;, F:heparin binding; F:identical protein binding; F:lipid binding; F:lipoprotein lipase activator activity; F:phospholipid binding;, P:blood coagulation, intrinsic pathway; P:negative regulation of angiogenesis; P:negative regulation of blood coagulation; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of fibrinolysis; P:negative regulation of myeloid cell apoptotic process; P:negative regulation of smooth muscle cell apoptotic process; P:plasminogen activation; P:platelet degranulation; P:positive regulation of blood coagulation; P:positive regulation of lipoprotein lipase activity; P:regulation of fibrinolysis; P:triglyceride metabolic process; P:triglyceride transport;|P02749 B2R9M3 Q9UCN7,Beta-2-glycoprotein 1,APC inhibitor;Activated protein C-binding protein;Anticardiolipin cofactor;Apolipoprotein H;Beta-2-glycoprotein I;, PF00084;PF09014;, GO:0009986;GO:0042627;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0031089;GO:0034361;GO:0008201;GO:0042802;GO:0008289;GO:0060230;GO:0005543;GO:0007597;GO:0016525;GO:0030195;GO:0010596;GO:0001937;GO:0051918;GO:0033033;GO:0034392;GO:0031639;GO:0002576;GO:0030194;GO:0051006;GO:0051917;GO:0006641;GO:0034197;, C:cell surface; C:chylomicron; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:platelet dense granule lumen; C:very-low-density lipoprotein particle;, F:heparin binding; F:identical protein binding; F:lipid binding; F:lipoprotein lipase activator activity; F:phospholipid binding;, P:blood coagulation, intrinsic pathway; P:negative regulation of angiogenesis; P:negative regulation of blood coagulation; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of fibrinolysis; P:negative regulation of myeloid cell apoptotic process; P:negative regulation of smooth muscle cell apoptotic process; P:plasminogen activation; P:platelet degranulation; P:positive regulation of blood coagulation; P:positive regulation of lipoprotein lipase activity; P:regulation of fibrinolysis; P:triglyceride metabolic process; P:triglyceride transport;|P02749 B2R9M3 Q9UCN7,Beta-2-glycoprotein 1,APC inhibitor;Activated protein C-binding protein;Anticardiolipin cofactor;Apolipoprotein H;Beta-2-glycoprotein I;, PF00084;PF09014;, GO:0009986;GO:0042627;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0031089;GO:0034361;GO:0008201;GO:0042802;GO:0008289;GO:0060230;GO:0005543;GO:0007597;GO:0016525;GO:0030195;GO:0010596;GO:0001937;GO:0051918;GO:0033033;GO:0034392;GO:0031639;GO:0002576;GO:0030194;GO:0051006;GO:0051917;GO:0006641;GO:0034197;, C:cell surface; C:chylomicron; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:platelet dense granule lumen; C:very-low-density lipoprotein particle;, F:heparin binding; F:identical protein binding; F:lipid binding; F:lipoprotein lipase activator activity; F:phospholipid binding;, P:blood coagulation, intrinsic pathway; P:negative regulation of angiogenesis; P:negative regulation of blood coagulation; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of fibrinolysis; P:negative regulation of myeloid cell apoptotic process; P:negative regulation of smooth muscle cell apoptotic process; P:plasminogen activation; P:platelet degranulation; P:positive regulation of blood coagulation; P:positive regulation of lipoprotein lipase activity; P:regulation of fibrinolysis; P:triglyceride metabolic process; P:triglyceride transport;|P02749 B2R9M3 Q9UCN7,Beta-2-glycoprotein 1,APC inhibitor;Activated protein C-binding protein;Anticardiolipin cofactor;Apolipoprotein H;Beta-2-glycoprotein I;, PF00084;PF09014;, GO:0009986;GO:0042627;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0034364;GO:0031089;GO:0034361;GO:0008201;GO:0042802;GO:0008289;GO:0060230;GO:0005543;GO:0007597;GO:0016525;GO:0030195;GO:0010596;GO:0001937;GO:0051918;GO:0033033;GO:0034392;GO:0031639;GO:0002576;GO:0030194;GO:0051006;GO:0051917;GO:0006641;GO:0034197;, C:cell surface; C:chylomicron; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:high-density lipoprotein particle; C:platelet dense granule lumen; C:very-low-density lipoprotein particle;, F:heparin binding; F:identical protein binding; F:lipid binding; F:lipoprotein lipase activator activity; F:phospholipid binding;, P:blood coagulation, intrinsic pathway; P:negative regulation of angiogenesis; P:negative regulation of blood coagulation; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of fibrinolysis; P:negative regulation of myeloid cell apoptotic process; P:negative regulation of smooth muscle cell apoptotic process; P:plasminogen activation; P:platelet degranulation; P:positive regulation of blood coagulation; P:positive regulation of lipoprotein lipase activity; P:regulation of fibrinolysis; P:triglyceride metabolic process; P:triglyceride transport; scaffold88 indexed_genome mRNA 808080 1094176 . + . ID=transcript_12397;Q8N8E3 Q6PIB5 Q8NCR4 Q8NFR4,Centrosomal protein of 112 kDa,Coiled-coil domain-containing protein 46;, PF14846;, GO:0005813;GO:0005737;GO:0060077;GO:0005886;GO:0097120;, C:centrosome; C:cytoplasm; C:inhibitory synapse; C:plasma membrane;, , P:receptor localization to synapse;|Q8N8E3 Q6PIB5 Q8NCR4 Q8NFR4,Centrosomal protein of 112 kDa,Coiled-coil domain-containing protein 46;, PF14846;, GO:0005813;GO:0005737;GO:0060077;GO:0005886;GO:0097120;, C:centrosome; C:cytoplasm; C:inhibitory synapse; C:plasma membrane;, , P:receptor localization to synapse;|Q8N8E3 Q6PIB5 Q8NCR4 Q8NFR4,Centrosomal protein of 112 kDa,Coiled-coil domain-containing protein 46;, PF14846;, GO:0005813;GO:0005737;GO:0060077;GO:0005886;GO:0097120;, C:centrosome; C:cytoplasm; C:inhibitory synapse; C:plasma membrane;, , P:receptor localization to synapse; scaffold88 indexed_genome mRNA 1134662 1160783 . + . ID=transcript_12398;Q9Y2T1 Q3MJ88 Q9H3M6 Q9UH84,Axin-2,Axin-like protein;Axis inhibition protein 2;Conductin;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0008013;GO:0019899;GO:0070411;GO:0031625;GO:1904837;GO:0030282;GO:0008283;GO:0034613;GO:0003413;GO:0001957;GO:0043570;GO:0048255;GO:0090090;GO:0008285;GO:0045668;GO:0042476;GO:0090263;GO:0010942;GO:0010718;GO:0001934;GO:0070602;GO:0061181;GO:0032423;GO:0003139;GO:0001756;GO:0016055;, C:beta-catenin destruction complex; C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:ubiquitin protein ligase binding;, P:beta-catenin-TCF complex assembly; P:bone mineralization; P:cell population proliferation; P:cellular protein localization; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:intramembranous ossification; P:maintenance of DNA repeat elements; P:mRNA stabilization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of osteoblast differentiation; P:odontogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell death; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of protein phosphorylation; P:regulation of centromeric sister chromatid cohesion; P:regulation of chondrocyte development; P:regulation of mismatch repair; P:secondary heart field specification; P:somitogenesis; P:Wnt signaling pathway;|Q9Y2T1 Q3MJ88 Q9H3M6 Q9UH84,Axin-2,Axin-like protein;Axis inhibition protein 2;Conductin;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0008013;GO:0019899;GO:0070411;GO:0031625;GO:1904837;GO:0030282;GO:0008283;GO:0034613;GO:0003413;GO:0001957;GO:0043570;GO:0048255;GO:0090090;GO:0008285;GO:0045668;GO:0042476;GO:0090263;GO:0010942;GO:0010718;GO:0001934;GO:0070602;GO:0061181;GO:0032423;GO:0003139;GO:0001756;GO:0016055;, C:beta-catenin destruction complex; C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:ubiquitin protein ligase binding;, P:beta-catenin-TCF complex assembly; P:bone mineralization; P:cell population proliferation; P:cellular protein localization; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:intramembranous ossification; P:maintenance of DNA repeat elements; P:mRNA stabilization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of osteoblast differentiation; P:odontogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell death; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of protein phosphorylation; P:regulation of centromeric sister chromatid cohesion; P:regulation of chondrocyte development; P:regulation of mismatch repair; P:secondary heart field specification; P:somitogenesis; P:Wnt signaling pathway;|Q9Y2T1 Q3MJ88 Q9H3M6 Q9UH84,Axin-2,Axin-like protein;Axis inhibition protein 2;Conductin;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0008013;GO:0019899;GO:0070411;GO:0031625;GO:1904837;GO:0030282;GO:0008283;GO:0034613;GO:0003413;GO:0001957;GO:0043570;GO:0048255;GO:0090090;GO:0008285;GO:0045668;GO:0042476;GO:0090263;GO:0010942;GO:0010718;GO:0001934;GO:0070602;GO:0061181;GO:0032423;GO:0003139;GO:0001756;GO:0016055;, C:beta-catenin destruction complex; C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:ubiquitin protein ligase binding;, P:beta-catenin-TCF complex assembly; P:bone mineralization; P:cell population proliferation; P:cellular protein localization; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:intramembranous ossification; P:maintenance of DNA repeat elements; P:mRNA stabilization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of osteoblast differentiation; P:odontogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell death; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of protein phosphorylation; P:regulation of centromeric sister chromatid cohesion; P:regulation of chondrocyte development; P:regulation of mismatch repair; P:secondary heart field specification; P:somitogenesis; P:Wnt signaling pathway;|Q9Y2T1 Q3MJ88 Q9H3M6 Q9UH84,Axin-2,Axin-like protein;Axis inhibition protein 2;Conductin;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0008013;GO:0019899;GO:0070411;GO:0031625;GO:1904837;GO:0030282;GO:0008283;GO:0034613;GO:0003413;GO:0001957;GO:0043570;GO:0048255;GO:0090090;GO:0008285;GO:0045668;GO:0042476;GO:0090263;GO:0010942;GO:0010718;GO:0001934;GO:0070602;GO:0061181;GO:0032423;GO:0003139;GO:0001756;GO:0016055;, C:beta-catenin destruction complex; C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:ubiquitin protein ligase binding;, P:beta-catenin-TCF complex assembly; P:bone mineralization; P:cell population proliferation; P:cellular protein localization; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:intramembranous ossification; P:maintenance of DNA repeat elements; P:mRNA stabilization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of osteoblast differentiation; P:odontogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell death; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of protein phosphorylation; P:regulation of centromeric sister chromatid cohesion; P:regulation of chondrocyte development; P:regulation of mismatch repair; P:secondary heart field specification; P:somitogenesis; P:Wnt signaling pathway;|Q9Y2T1 Q3MJ88 Q9H3M6 Q9UH84,Axin-2,Axin-like protein;Axis inhibition protein 2;Conductin;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0008013;GO:0019899;GO:0070411;GO:0031625;GO:1904837;GO:0030282;GO:0008283;GO:0034613;GO:0003413;GO:0001957;GO:0043570;GO:0048255;GO:0090090;GO:0008285;GO:0045668;GO:0042476;GO:0090263;GO:0010942;GO:0010718;GO:0001934;GO:0070602;GO:0061181;GO:0032423;GO:0003139;GO:0001756;GO:0016055;, C:beta-catenin destruction complex; C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:ubiquitin protein ligase binding;, P:beta-catenin-TCF complex assembly; P:bone mineralization; P:cell population proliferation; P:cellular protein localization; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:intramembranous ossification; P:maintenance of DNA repeat elements; P:mRNA stabilization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of osteoblast differentiation; P:odontogenesis; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell death; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of protein phosphorylation; P:regulation of centromeric sister chromatid cohesion; P:regulation of chondrocyte development; P:regulation of mismatch repair; P:secondary heart field specification; P:somitogenesis; P:Wnt signaling pathway; scaffold88 indexed_genome mRNA 1333779 1380431 . + . ID=transcript_12399;O75916 A8K3C0 O75573 Q696R2 Q8TD64 Q8TD65 Q9HC32 Q9HC33,Regulator of G-protein signaling 9,, PF00610;PF00631;PF00615;PF18148;, GO:0005737;GO:0098978;GO:0005634;GO:0005886;GO:0098839;GO:0005096;GO:0007212;GO:0007186;GO:0035556;GO:0009968;GO:0007399;GO:1904783;GO:0006457;GO:1905912;GO:0008277;GO:0001975;GO:0032355;GO:0007601;, C:cytoplasm; C:glutamatergic synapse; C:nucleus; C:plasma membrane; C:postsynaptic density membrane;, F:GTPase activator activity;, P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:nervous system development; P:positive regulation of NMDA glutamate receptor activity; P:protein folding; P:regulation of calcium ion export across plasma membrane; P:regulation of G protein-coupled receptor signaling pathway; P:response to amphetamine; P:response to estradiol; P:visual perception;|O75916 A8K3C0 O75573 Q696R2 Q8TD64 Q8TD65 Q9HC32 Q9HC33,Regulator of G-protein signaling 9,, PF00610;PF00631;PF00615;PF18148;, GO:0005737;GO:0098978;GO:0005634;GO:0005886;GO:0098839;GO:0005096;GO:0007212;GO:0007186;GO:0035556;GO:0009968;GO:0007399;GO:1904783;GO:0006457;GO:1905912;GO:0008277;GO:0001975;GO:0032355;GO:0007601;, C:cytoplasm; C:glutamatergic synapse; C:nucleus; C:plasma membrane; C:postsynaptic density membrane;, F:GTPase activator activity;, P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:nervous system development; P:positive regulation of NMDA glutamate receptor activity; P:protein folding; P:regulation of calcium ion export across plasma membrane; P:regulation of G protein-coupled receptor signaling pathway; P:response to amphetamine; P:response to estradiol; P:visual perception;|O75916 A8K3C0 O75573 Q696R2 Q8TD64 Q8TD65 Q9HC32 Q9HC33,Regulator of G-protein signaling 9,, PF00610;PF00631;PF00615;PF18148;, GO:0005737;GO:0098978;GO:0005634;GO:0005886;GO:0098839;GO:0005096;GO:0007212;GO:0007186;GO:0035556;GO:0009968;GO:0007399;GO:1904783;GO:0006457;GO:1905912;GO:0008277;GO:0001975;GO:0032355;GO:0007601;, C:cytoplasm; C:glutamatergic synapse; C:nucleus; C:plasma membrane; C:postsynaptic density membrane;, F:GTPase activator activity;, P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:nervous system development; P:positive regulation of NMDA glutamate receptor activity; P:protein folding; P:regulation of calcium ion export across plasma membrane; P:regulation of G protein-coupled receptor signaling pathway; P:response to amphetamine; P:response to estradiol; P:visual perception; scaffold88 indexed_genome mRNA 1439515 1443023 . - . ID=transcript_12400;Q14344 B2R977 B7Z7R0 F5H1G8 Q8TD70,Guanine nucleotide-binding protein subunit alpha-13,, PF00503;, GO:0031526;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0005834;GO:0042470;GO:0016020;GO:0005634;GO:0005886;GO:0031752;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0031584;GO:0007189;GO:0007188;GO:0007186;GO:1904753;GO:1904706;GO:0030168;GO:0043065;GO:0007204;GO:0051056;GO:0007266;GO:0007165;, C:brush border membrane; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:heterotrimeric G-protein complex; C:melanosome; C:membrane; C:nucleus; C:plasma membrane;, F:D5 dopamine receptor binding; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:activation of phospholipase D activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:signal transduction; scaffold88 indexed_genome mRNA 1471922 1480173 . + . ID=transcript_12401;Q86W34 A6NLD9 B3KR44 Q5XKF1 Q9NZE2,Archaemetzincin-2,Archeobacterial metalloproteinase-like protein 2;, PF07998;, GO:0046872;GO:0008237;, , F:metal ion binding; F:metallopeptidase activity;|Q86W34 A6NLD9 B3KR44 Q5XKF1 Q9NZE2,Archaemetzincin-2,Archeobacterial metalloproteinase-like protein 2;, PF07998;, GO:0046872;GO:0008237;, , F:metal ion binding; F:metallopeptidase activity;|Q86W34 A6NLD9 B3KR44 Q5XKF1 Q9NZE2,Archaemetzincin-2,Archeobacterial metalloproteinase-like protein 2;, PF07998;, GO:0046872;GO:0008237;, , F:metal ion binding; F:metallopeptidase activity;|Q86W34 A6NLD9 B3KR44 Q5XKF1 Q9NZE2,Archaemetzincin-2,Archeobacterial metalloproteinase-like protein 2;, PF07998;, GO:0046872;GO:0008237;, , F:metal ion binding; F:metallopeptidase activity;|Q86W34 A6NLD9 B3KR44 Q5XKF1 Q9NZE2,Archaemetzincin-2,Archeobacterial metalloproteinase-like protein 2;, PF07998;, GO:0046872;GO:0008237;, , F:metal ion binding; F:metallopeptidase activity; scaffold88 indexed_genome mRNA 1487528 1583334 . + . ID=transcript_12402;Q96EG1 Q6UXF2 Q9Y2K4,Arylsulfatase G,, PF00884;, GO:0005783;GO:0005788;GO:0005615;GO:0005764;GO:0004065;GO:0046872;GO:0006790;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular space; C:lysosome;, F:arylsulfatase activity; F:metal ion binding;, P:sulfur compound metabolic process;|O15403 Q6P1X3,Monocarboxylate transporter 7,Monocarboxylate transporter 6;Solute carrier family 16 member 6;, PF07690;, GO:0016021;GO:0005887;GO:0016020;GO:0008028;GO:0015293;GO:0015718;, C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport; scaffold88 indexed_genome mRNA 1587919 1597857 . + . ID=transcript_12403;Q5MNZ9 Q8IXM5 Q9NWF8,WD repeat domain phosphoinositide-interacting protein 1,Atg18 protein homolog;WD40 repeat protein interacting with phosphoinositides of 49 kDa;, , GO:0000421;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0010008;GO:0019898;GO:0000139;GO:0000407;GO:0034045;GO:0005802;GO:0050681;GO:0030331;GO:0080025;GO:0032266;GO:0005102;GO:0000045;GO:0006914;GO:0000422;GO:0044804;GO:0009267;GO:0036498;GO:0016236;GO:0006497;GO:0034497;GO:0048203;, C:autophagosome membrane; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome membrane; C:extrinsic component of membrane; C:Golgi membrane; C:phagophore assembly site; C:phagophore assembly site membrane; C:trans-Golgi network;, F:androgen receptor binding; F:estrogen receptor binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:signaling receptor binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:IRE1-mediated unfolded protein response; P:macroautophagy; P:protein lipidation; P:protein localization to phagophore assembly site; P:vesicle targeting, trans-Golgi to endosome;|Q5MNZ9 Q8IXM5 Q9NWF8,WD repeat domain phosphoinositide-interacting protein 1,Atg18 protein homolog;WD40 repeat protein interacting with phosphoinositides of 49 kDa;, , GO:0000421;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0010008;GO:0019898;GO:0000139;GO:0000407;GO:0034045;GO:0005802;GO:0050681;GO:0030331;GO:0080025;GO:0032266;GO:0005102;GO:0000045;GO:0006914;GO:0000422;GO:0044804;GO:0009267;GO:0036498;GO:0016236;GO:0006497;GO:0034497;GO:0048203;, C:autophagosome membrane; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome membrane; C:extrinsic component of membrane; C:Golgi membrane; C:phagophore assembly site; C:phagophore assembly site membrane; C:trans-Golgi network;, F:androgen receptor binding; F:estrogen receptor binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:signaling receptor binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:IRE1-mediated unfolded protein response; P:macroautophagy; P:protein lipidation; P:protein localization to phagophore assembly site; P:vesicle targeting, trans-Golgi to endosome;|Q5MNZ9 Q8IXM5 Q9NWF8,WD repeat domain phosphoinositide-interacting protein 1,Atg18 protein homolog;WD40 repeat protein interacting with phosphoinositides of 49 kDa;, , GO:0000421;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0010008;GO:0019898;GO:0000139;GO:0000407;GO:0034045;GO:0005802;GO:0050681;GO:0030331;GO:0080025;GO:0032266;GO:0005102;GO:0000045;GO:0006914;GO:0000422;GO:0044804;GO:0009267;GO:0036498;GO:0016236;GO:0006497;GO:0034497;GO:0048203;, C:autophagosome membrane; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome membrane; C:extrinsic component of membrane; C:Golgi membrane; C:phagophore assembly site; C:phagophore assembly site membrane; C:trans-Golgi network;, F:androgen receptor binding; F:estrogen receptor binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:signaling receptor binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:IRE1-mediated unfolded protein response; P:macroautophagy; P:protein lipidation; P:protein localization to phagophore assembly site; P:vesicle targeting, trans-Golgi to endosome;|Q5MNZ9 Q8IXM5 Q9NWF8,WD repeat domain phosphoinositide-interacting protein 1,Atg18 protein homolog;WD40 repeat protein interacting with phosphoinositides of 49 kDa;, , GO:0000421;GO:0030136;GO:0005737;GO:0005856;GO:0005829;GO:0010008;GO:0019898;GO:0000139;GO:0000407;GO:0034045;GO:0005802;GO:0050681;GO:0030331;GO:0080025;GO:0032266;GO:0005102;GO:0000045;GO:0006914;GO:0000422;GO:0044804;GO:0009267;GO:0036498;GO:0016236;GO:0006497;GO:0034497;GO:0048203;, C:autophagosome membrane; C:clathrin-coated vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endosome membrane; C:extrinsic component of membrane; C:Golgi membrane; C:phagophore assembly site; C:phagophore assembly site membrane; C:trans-Golgi network;, F:androgen receptor binding; F:estrogen receptor binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:signaling receptor binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:IRE1-mediated unfolded protein response; P:macroautophagy; P:protein lipidation; P:protein localization to phagophore assembly site; P:vesicle targeting, trans-Golgi to endosome; scaffold88 indexed_genome mRNA 1652308 1687281 . - . ID=transcript_12404;P10644 K7ER48 Q567S7,cAMP-dependent protein kinase type I-alpha regulatory subunit,Tissue-specific extinguisher 1;, PF00027;PF02197;, GO:0005952;GO:0005813;GO:0097546;GO:0005737;GO:0005829;GO:0098978;GO:0016020;GO:0005771;GO:0031594;GO:0031588;GO:0044853;GO:0032991;GO:0097224;GO:0030552;GO:0004862;GO:0008603;GO:0019904;GO:0034236;GO:0031625;GO:0034199;GO:0007596;GO:0060038;GO:0071377;GO:0007268;GO:0007143;GO:0035556;GO:0001707;GO:0046007;GO:2000480;GO:0002862;GO:0045835;GO:0043949;GO:0010738;GO:0006357;GO:0003091;GO:0045214;, C:cAMP-dependent protein kinase complex; C:centrosome; C:ciliary base; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:membrane; C:multivesicular body; C:neuromuscular junction; C:nucleotide-activated protein kinase complex; C:plasma membrane raft; C:protein-containing complex; C:sperm connecting piece;, F:cAMP binding; F:cAMP-dependent protein kinase inhibitor activity; F:cAMP-dependent protein kinase regulator activity; F:protein domain specific binding; F:protein kinase A catalytic subunit binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase A activity; P:blood coagulation; P:cardiac muscle cell proliferation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:female meiotic nuclear division; P:intracellular signal transduction; P:mesoderm formation; P:negative regulation of activated T cell proliferation; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of meiotic nuclear division; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:regulation of transcription by RNA polymerase II; P:renal water homeostasis; P:sarcomere organization;|P10644 K7ER48 Q567S7,cAMP-dependent protein kinase type I-alpha regulatory subunit,Tissue-specific extinguisher 1;, PF00027;PF02197;, GO:0005952;GO:0005813;GO:0097546;GO:0005737;GO:0005829;GO:0098978;GO:0016020;GO:0005771;GO:0031594;GO:0031588;GO:0044853;GO:0032991;GO:0097224;GO:0030552;GO:0004862;GO:0008603;GO:0019904;GO:0034236;GO:0031625;GO:0034199;GO:0007596;GO:0060038;GO:0071377;GO:0007268;GO:0007143;GO:0035556;GO:0001707;GO:0046007;GO:2000480;GO:0002862;GO:0045835;GO:0043949;GO:0010738;GO:0006357;GO:0003091;GO:0045214;, C:cAMP-dependent protein kinase complex; C:centrosome; C:ciliary base; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:membrane; C:multivesicular body; C:neuromuscular junction; C:nucleotide-activated protein kinase complex; C:plasma membrane raft; C:protein-containing complex; C:sperm connecting piece;, F:cAMP binding; F:cAMP-dependent protein kinase inhibitor activity; F:cAMP-dependent protein kinase regulator activity; F:protein domain specific binding; F:protein kinase A catalytic subunit binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase A activity; P:blood coagulation; P:cardiac muscle cell proliferation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:female meiotic nuclear division; P:intracellular signal transduction; P:mesoderm formation; P:negative regulation of activated T cell proliferation; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of meiotic nuclear division; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:regulation of transcription by RNA polymerase II; P:renal water homeostasis; P:sarcomere organization;|P10644 K7ER48 Q567S7,cAMP-dependent protein kinase type I-alpha regulatory subunit,Tissue-specific extinguisher 1;, PF00027;PF02197;, GO:0005952;GO:0005813;GO:0097546;GO:0005737;GO:0005829;GO:0098978;GO:0016020;GO:0005771;GO:0031594;GO:0031588;GO:0044853;GO:0032991;GO:0097224;GO:0030552;GO:0004862;GO:0008603;GO:0019904;GO:0034236;GO:0031625;GO:0034199;GO:0007596;GO:0060038;GO:0071377;GO:0007268;GO:0007143;GO:0035556;GO:0001707;GO:0046007;GO:2000480;GO:0002862;GO:0045835;GO:0043949;GO:0010738;GO:0006357;GO:0003091;GO:0045214;, C:cAMP-dependent protein kinase complex; C:centrosome; C:ciliary base; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:membrane; C:multivesicular body; C:neuromuscular junction; C:nucleotide-activated protein kinase complex; C:plasma membrane raft; C:protein-containing complex; C:sperm connecting piece;, F:cAMP binding; F:cAMP-dependent protein kinase inhibitor activity; F:cAMP-dependent protein kinase regulator activity; F:protein domain specific binding; F:protein kinase A catalytic subunit binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase A activity; P:blood coagulation; P:cardiac muscle cell proliferation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:female meiotic nuclear division; P:intracellular signal transduction; P:mesoderm formation; P:negative regulation of activated T cell proliferation; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of meiotic nuclear division; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:regulation of transcription by RNA polymerase II; P:renal water homeostasis; P:sarcomere organization;|Q96MK3 B2RN47 B2RN49 Q9UF95,Pseudokinase FAM20A {ECO:0000305},, PF06702;, GO:0005737;GO:0005783;GO:0070062;GO:0005615;GO:0005794;GO:0043539;GO:0031214;GO:0055074;GO:0070166;GO:0001934;GO:0006468;GO:0009617;GO:0044691;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular space; C:Golgi apparatus;, F:protein serine/threonine kinase activator activity;, P:biomineral tissue development; P:calcium ion homeostasis; P:enamel mineralization; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:response to bacterium; P:tooth eruption;|Q96MK3 B2RN47 B2RN49 Q9UF95,Pseudokinase FAM20A {ECO:0000305},, PF06702;, GO:0005737;GO:0005783;GO:0070062;GO:0005615;GO:0005794;GO:0043539;GO:0031214;GO:0055074;GO:0070166;GO:0001934;GO:0006468;GO:0009617;GO:0044691;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular space; C:Golgi apparatus;, F:protein serine/threonine kinase activator activity;, P:biomineral tissue development; P:calcium ion homeostasis; P:enamel mineralization; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:response to bacterium; P:tooth eruption;|Q96MK3 B2RN47 B2RN49 Q9UF95,Pseudokinase FAM20A {ECO:0000305},, PF06702;, GO:0005737;GO:0005783;GO:0070062;GO:0005615;GO:0005794;GO:0043539;GO:0031214;GO:0055074;GO:0070166;GO:0001934;GO:0006468;GO:0009617;GO:0044691;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular space; C:Golgi apparatus;, F:protein serine/threonine kinase activator activity;, P:biomineral tissue development; P:calcium ion homeostasis; P:enamel mineralization; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:response to bacterium; P:tooth eruption;|Q96MK3 B2RN47 B2RN49 Q9UF95,Pseudokinase FAM20A {ECO:0000305},, PF06702;, GO:0005737;GO:0005783;GO:0070062;GO:0005615;GO:0005794;GO:0043539;GO:0031214;GO:0055074;GO:0070166;GO:0001934;GO:0006468;GO:0009617;GO:0044691;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular space; C:Golgi apparatus;, F:protein serine/threonine kinase activator activity;, P:biomineral tissue development; P:calcium ion homeostasis; P:enamel mineralization; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:response to bacterium; P:tooth eruption;|Q96MK3 B2RN47 B2RN49 Q9UF95,Pseudokinase FAM20A {ECO:0000305},, PF06702;, GO:0005737;GO:0005783;GO:0070062;GO:0005615;GO:0005794;GO:0043539;GO:0031214;GO:0055074;GO:0070166;GO:0001934;GO:0006468;GO:0009617;GO:0044691;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular space; C:Golgi apparatus;, F:protein serine/threonine kinase activator activity;, P:biomineral tissue development; P:calcium ion homeostasis; P:enamel mineralization; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:response to bacterium; P:tooth eruption;|Q96MK3 B2RN47 B2RN49 Q9UF95,Pseudokinase FAM20A {ECO:0000305},, PF06702;, GO:0005737;GO:0005783;GO:0070062;GO:0005615;GO:0005794;GO:0043539;GO:0031214;GO:0055074;GO:0070166;GO:0001934;GO:0006468;GO:0009617;GO:0044691;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular space; C:Golgi apparatus;, F:protein serine/threonine kinase activator activity;, P:biomineral tissue development; P:calcium ion homeostasis; P:enamel mineralization; P:positive regulation of protein phosphorylation; P:protein phosphorylation; P:response to bacterium; P:tooth eruption; scaffold88 indexed_genome mRNA 1817682 1873122 . - . ID=transcript_12405;Q8IUA7 Q6P655 Q8N2S4 Q8WWZ5 Q96MD8,ATP-binding cassette sub-family A member 9 {ECO:0000305},, PF00005;, GO:0016021;GO:0043231;GO:0005524;GO:0042626;GO:0005319;GO:0006869;, C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport;|Q8IUA7 Q6P655 Q8N2S4 Q8WWZ5 Q96MD8,ATP-binding cassette sub-family A member 9 {ECO:0000305},, PF00005;, GO:0016021;GO:0043231;GO:0005524;GO:0042626;GO:0005319;GO:0006869;, C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport; scaffold88 indexed_genome mRNA 1878009 1938172 . - . ID=transcript_12406;Q8N139 Q6NSH9 Q8N856 Q8WWZ6,ATP-binding cassette sub-family A member 6 {ECO:0000305},, PF00005;, GO:0000139;GO:0016021;GO:0043231;GO:0005654;GO:0005886;GO:0005524;GO:0042626;GO:0005319;GO:0006869;, C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport;|Q8N139 Q6NSH9 Q8N856 Q8WWZ6,ATP-binding cassette sub-family A member 6 {ECO:0000305},, PF00005;, GO:0000139;GO:0016021;GO:0043231;GO:0005654;GO:0005886;GO:0005524;GO:0042626;GO:0005319;GO:0006869;, C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport;|Q8IUA7 Q6P655 Q8N2S4 Q8WWZ5 Q96MD8,ATP-binding cassette sub-family A member 9 {ECO:0000305},, PF00005;, GO:0016021;GO:0043231;GO:0005524;GO:0042626;GO:0005319;GO:0006869;, C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport;|Q8N139 Q6NSH9 Q8N856 Q8WWZ6,ATP-binding cassette sub-family A member 6 {ECO:0000305},, PF00005;, GO:0000139;GO:0016021;GO:0043231;GO:0005654;GO:0005886;GO:0005524;GO:0042626;GO:0005319;GO:0006869;, C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport;|Q8N139 Q6NSH9 Q8N856 Q8WWZ6,ATP-binding cassette sub-family A member 6 {ECO:0000305},, PF00005;, GO:0000139;GO:0016021;GO:0043231;GO:0005654;GO:0005886;GO:0005524;GO:0042626;GO:0005319;GO:0006869;, C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport;|Q8N139 Q6NSH9 Q8N856 Q8WWZ6,ATP-binding cassette sub-family A member 6 {ECO:0000305},, PF00005;, GO:0000139;GO:0016021;GO:0043231;GO:0005654;GO:0005886;GO:0005524;GO:0042626;GO:0005319;GO:0006869;, C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport;|Q8N139 Q6NSH9 Q8N856 Q8WWZ6,ATP-binding cassette sub-family A member 6 {ECO:0000305},, PF00005;, GO:0000139;GO:0016021;GO:0043231;GO:0005654;GO:0005886;GO:0005524;GO:0042626;GO:0005319;GO:0006869;, C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport; scaffold88 indexed_genome mRNA 1947931 1953835 . - . ID=transcript_12407;Q8WWZ4 C9JZH2 C9K035 Q6PIQ6 Q7Z2I9 Q7Z7P7 Q86TD2,ATP-binding cassette sub-family A member 10 {ECO:0000305},, PF00005;, GO:0016021;GO:0043231;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0006869;, C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport; scaffold88 indexed_genome mRNA 1953838 2004139 . - . ID=transcript_12408;O94911 A1L3U3 C9JQE6 Q86WW0,ABC-type organic anion transporter ABCA8,ATP-binding cassette sub-family A member 8 {ECO:0000305};, PF00005;, GO:0016323;GO:0005783;GO:0016021;GO:0043231;GO:0005886;GO:0140359;GO:0008559;GO:0005524;GO:0042626;GO:0005319;GO:0033344;GO:0030301;GO:0006869;GO:0010875;GO:0010874;GO:0006686;GO:0055085;GO:0042908;, C:basolateral plasma membrane; C:endoplasmic reticulum; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol transport; P:lipid transport; P:positive regulation of cholesterol efflux; P:regulation of cholesterol efflux; P:sphingomyelin biosynthetic process; P:transmembrane transport; P:xenobiotic transport;|O94911 A1L3U3 C9JQE6 Q86WW0,ABC-type organic anion transporter ABCA8,ATP-binding cassette sub-family A member 8 {ECO:0000305};, PF00005;, GO:0016323;GO:0005783;GO:0016021;GO:0043231;GO:0005886;GO:0140359;GO:0008559;GO:0005524;GO:0042626;GO:0005319;GO:0033344;GO:0030301;GO:0006869;GO:0010875;GO:0010874;GO:0006686;GO:0055085;GO:0042908;, C:basolateral plasma membrane; C:endoplasmic reticulum; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:ABC-type transporter activity; F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol transport; P:lipid transport; P:positive regulation of cholesterol efflux; P:regulation of cholesterol efflux; P:sphingomyelin biosynthetic process; P:transmembrane transport; P:xenobiotic transport;|Q8WWZ4 C9JZH2 C9K035 Q6PIQ6 Q7Z2I9 Q7Z7P7 Q86TD2,ATP-binding cassette sub-family A member 10 {ECO:0000305},, PF00005;, GO:0016021;GO:0043231;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0006869;, C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport;|Q8WWZ4 C9JZH2 C9K035 Q6PIQ6 Q7Z2I9 Q7Z7P7 Q86TD2,ATP-binding cassette sub-family A member 10 {ECO:0000305},, PF00005;, GO:0016021;GO:0043231;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0006869;, C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:lipid transport; scaffold88 indexed_genome mRNA 2010252 2032501 . + . ID=transcript_12409;Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport;|Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport;|Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport;|Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport;|Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport;|Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport;|Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport;|Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport;|Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport;|Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport; scaffold88 indexed_genome mRNA 2033281 2061784 . - . ID=transcript_12410;Q8WWZ7 Q8IVJ2 Q96LJ1 Q96MS4 Q96PZ9 Q9NY14,Cholesterol transporter ABCA5 {ECO:0000305},ATP-binding cassette sub-family A member 5 {ECO:0000305};, PF00005;, GO:0005794;GO:0000139;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0033344;GO:0042632;GO:0008203;GO:0034375;GO:0006869;GO:0010745;GO:1903064;GO:0010874;GO:0043691;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:high-density lipoprotein particle remodeling; P:lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:positive regulation of reverse cholesterol transport; P:regulation of cholesterol efflux; P:reverse cholesterol transport; scaffold88 indexed_genome mRNA 2119822 2230553 . + . ID=transcript_12411;P52564,Dual specificity mitogen-activated protein kinase kinase 6,MAPK/ERK kinase 6;Stress-activated protein kinase kinase 3;, PF00069;, GO:0005856;GO:0005829;GO:0005654;GO:0005524;GO:0042802;GO:0004708;GO:0019901;GO:0106310;GO:0106311;GO:0004714;GO:0000187;GO:0006915;GO:0060348;GO:0060048;GO:0007050;GO:0072709;GO:0006975;GO:0120163;GO:0070423;GO:0001649;GO:0022602;GO:0043065;GO:0051770;GO:0032308;GO:1901796;GO:0042493;GO:0002931;GO:0007165;, C:cytoskeleton; C:cytosol; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:MAP kinase kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:apoptotic process; P:bone development; P:cardiac muscle contraction; P:cell cycle arrest; P:cellular response to sorbitol; P:DNA damage induced protein phosphorylation; P:negative regulation of cold-induced thermogenesis; P:nucleotide-binding oligomerization domain containing signaling pathway; P:osteoblast differentiation; P:ovulation cycle process; P:positive regulation of apoptotic process; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of prostaglandin secretion; P:regulation of signal transduction by p53 class mediator; P:response to drug; P:response to ischemia; P:signal transduction;|P52564,Dual specificity mitogen-activated protein kinase kinase 6,MAPK/ERK kinase 6;Stress-activated protein kinase kinase 3;, PF00069;, GO:0005856;GO:0005829;GO:0005654;GO:0005524;GO:0042802;GO:0004708;GO:0019901;GO:0106310;GO:0106311;GO:0004714;GO:0000187;GO:0006915;GO:0060348;GO:0060048;GO:0007050;GO:0072709;GO:0006975;GO:0120163;GO:0070423;GO:0001649;GO:0022602;GO:0043065;GO:0051770;GO:0032308;GO:1901796;GO:0042493;GO:0002931;GO:0007165;, C:cytoskeleton; C:cytosol; C:nucleoplasm;, F:ATP binding; F:identical protein binding; F:MAP kinase kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:apoptotic process; P:bone development; P:cardiac muscle contraction; P:cell cycle arrest; P:cellular response to sorbitol; P:DNA damage induced protein phosphorylation; P:negative regulation of cold-induced thermogenesis; P:nucleotide-binding oligomerization domain containing signaling pathway; P:osteoblast differentiation; P:ovulation cycle process; P:positive regulation of apoptotic process; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of prostaglandin secretion; P:regulation of signal transduction by p53 class mediator; P:response to drug; P:response to ischemia; P:signal transduction; scaffold88 indexed_genome mRNA 2661447 2690048 . + . ID=transcript_12412;Q9NPI9,Inward rectifier potassium channel 16,Inward rectifier K(+) channel Kir5.1;Potassium channel, inwardly rectifying subfamily J member 16;, PF01007;PF17655;, GO:0016323;GO:0005886;GO:0008076;GO:0005242;GO:1901381;GO:1990573;GO:0071805;GO:0006813;GO:0034765;, C:basolateral plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:inward rectifier potassium channel activity;, P:positive regulation of potassium ion transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; scaffold88 indexed_genome mRNA 2724748 2732601 . + . ID=transcript_12413;P63252 O15110 P48049,Inward rectifier potassium channel 2,Cardiac inward rectifier potassium channel;Inward rectifier K(+) channel Kir2.1;Potassium channel, inwardly rectifying subfamily J member 2;, PF01007;PF17655;PF08466;, GO:0043197;GO:0005794;GO:0005887;GO:0014704;GO:0031224;GO:0043025;GO:0005886;GO:0005791;GO:0005790;GO:0030315;GO:0008076;GO:0042802;GO:0005242;GO:0005546;GO:0086008;GO:0061337;GO:0086002;GO:0030007;GO:0071260;GO:0015693;GO:0086012;GO:0086011;GO:0086013;GO:1901381;GO:1990573;GO:0071805;GO:0006813;GO:0051289;GO:0086004;GO:0086091;GO:0034765;GO:0060306;GO:0060075;GO:0014861;GO:0055119;GO:0090076;, C:dendritic spine; C:Golgi apparatus; C:integral component of plasma membrane; C:intercalated disc; C:intrinsic component of membrane; C:neuronal cell body; C:plasma membrane; C:rough endoplasmic reticulum; C:smooth endoplasmic reticulum; C:T-tubule; C:voltage-gated potassium channel complex;, F:identical protein binding; F:inward rectifier potassium channel activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization;, P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:magnesium ion transport; P:membrane depolarization during cardiac muscle cell action potential; P:membrane repolarization during action potential; P:membrane repolarization during cardiac muscle cell action potential; P:positive regulation of potassium ion transmembrane transport; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homotetramerization; P:regulation of cardiac muscle cell contraction; P:regulation of heart rate by cardiac conduction; P:regulation of ion transmembrane transport; P:regulation of membrane repolarization; P:regulation of resting membrane potential; P:regulation of skeletal muscle contraction via regulation of action potential; P:relaxation of cardiac muscle; P:relaxation of skeletal muscle; scaffold88 indexed_genome mRNA 4763899 4764498 . + . ID=transcript_12414;Q8N1S5 B2R8H7 Q8WZ81,Zinc transporter ZIP11,Solute carrier family 39 member 11;Zrt- and Irt-like protein 11;, PF02535;, GO:0005737;GO:0005794;GO:0016021;GO:0016020;GO:0005634;GO:0005886;GO:0005385;GO:0071577;, C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:nucleus; C:plasma membrane;, F:zinc ion transmembrane transporter activity;, P:zinc ion transmembrane transport; scaffold88 indexed_genome mRNA 5092935 5099208 . + . ID=transcript_12415;P30874 A8K3Y0 B2R9P7 Q4VBP0 Q96GE0 Q96TF2 Q9BWH1,Somatostatin receptor type 2,SRIF-1;, PF00001;, GO:0005829;GO:0005887;GO:0043005;GO:0005886;GO:0004930;GO:0042923;GO:0030165;GO:0042277;GO:0004994;GO:0007193;GO:0071392;GO:0071385;GO:0021549;GO:0030900;GO:0007186;GO:0007187;GO:0008285;GO:0007218;GO:0030432;GO:0006937;GO:0042594;GO:0007283;, C:cytosol; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:G protein-coupled receptor activity; F:neuropeptide binding; F:PDZ domain binding; F:peptide binding; F:somatostatin receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cellular response to estradiol stimulus; P:cellular response to glucocorticoid stimulus; P:cerebellum development; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:negative regulation of cell population proliferation; P:neuropeptide signaling pathway; P:peristalsis; P:regulation of muscle contraction; P:response to starvation; P:spermatogenesis; scaffold88 indexed_genome mRNA 5125634 5154285 . + . ID=transcript_12416;Q8WTW3 Q9NPV9 Q9P2G6,Conserved oligomeric Golgi complex subunit 1,Component of oligomeric Golgi complex 1;, , GO:0005794;GO:0000139;GO:0017119;GO:0032588;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q8WTW3 Q9NPV9 Q9P2G6,Conserved oligomeric Golgi complex subunit 1,Component of oligomeric Golgi complex 1;, , GO:0005794;GO:0000139;GO:0017119;GO:0032588;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q8WTW3 Q9NPV9 Q9P2G6,Conserved oligomeric Golgi complex subunit 1,Component of oligomeric Golgi complex 1;, , GO:0005794;GO:0000139;GO:0017119;GO:0032588;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:Golgi apparatus; C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold88 indexed_genome mRNA 5154651 5158993 . + . ID=transcript_12417;Q9BSJ5 A8K9X3 Q5JB45 Q6YAU3 Q9H0L9 Q9H5E6 Q9NWN5,Uncharacterized protein C17orf80,Cell migration-inducing gene 3 protein;Human lung cancer oncogene 8 protein;, , GO:0070062;GO:0016021;, C:extracellular exosome; C:integral component of membrane; scaffold88 indexed_genome mRNA 5161872 5162659 . - . ID=transcript_12418;Q9BSJ5 A8K9X3 Q5JB45 Q6YAU3 Q9H0L9 Q9H5E6 Q9NWN5,Uncharacterized protein C17orf80,Cell migration-inducing gene 3 protein;Human lung cancer oncogene 8 protein;, , GO:0070062;GO:0016021;, C:extracellular exosome; C:integral component of membrane; scaffold88 indexed_genome mRNA 5239591 5264433 . - . ID=transcript_12419;Q58EX2 A6NMR8 C9JA57 Q86VY3 Q9NTD2 Q9NVB3 Q9P214,Protein sidekick-2 {ECO:0000250|UniProtKB:Q6V4S5},, PF00041;PF07679;, GO:0016021;GO:0005886;GO:0045202;GO:0060219;GO:0045216;GO:0007156;GO:0010842;GO:0007416;, C:integral component of membrane; C:plasma membrane; C:synapse;, , P:camera-type eye photoreceptor cell differentiation; P:cell-cell junction organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly; scaffold88 indexed_genome mRNA 5272549 5281748 . - . ID=transcript_12420;Q58EX2 A6NMR8 C9JA57 Q86VY3 Q9NTD2 Q9NVB3 Q9P214,Protein sidekick-2 {ECO:0000250|UniProtKB:Q6V4S5},, PF00041;PF07679;, GO:0016021;GO:0005886;GO:0045202;GO:0060219;GO:0045216;GO:0007156;GO:0010842;GO:0007416;, C:integral component of membrane; C:plasma membrane; C:synapse;, , P:camera-type eye photoreceptor cell differentiation; P:cell-cell junction organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly; scaffold88 indexed_genome mRNA 5288974 5298193 . - . ID=transcript_12421;Q58EX2 A6NMR8 C9JA57 Q86VY3 Q9NTD2 Q9NVB3 Q9P214,Protein sidekick-2 {ECO:0000250|UniProtKB:Q6V4S5},, PF00041;PF07679;, GO:0016021;GO:0005886;GO:0045202;GO:0060219;GO:0045216;GO:0007156;GO:0010842;GO:0007416;, C:integral component of membrane; C:plasma membrane; C:synapse;, , P:camera-type eye photoreceptor cell differentiation; P:cell-cell junction organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly;|Q58EX2 A6NMR8 C9JA57 Q86VY3 Q9NTD2 Q9NVB3 Q9P214,Protein sidekick-2 {ECO:0000250|UniProtKB:Q6V4S5},, PF00041;PF07679;, GO:0016021;GO:0005886;GO:0045202;GO:0060219;GO:0045216;GO:0007156;GO:0010842;GO:0007416;, C:integral component of membrane; C:plasma membrane; C:synapse;, , P:camera-type eye photoreceptor cell differentiation; P:cell-cell junction organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly; scaffold88 indexed_genome mRNA 5963412 5966801 . + . ID=transcript_12422;P63173 B2R5A8 P23411,60S ribosomal protein L38,Large ribosomal subunit protein eL38 {ECO:0000303|PubMed:24524803};, PF01781;, GO:0005829;GO:0022625;GO:0033291;GO:0005925;GO:0042788;GO:0014069;GO:0003723;GO:0003735;GO:0034463;GO:0048318;GO:0002181;GO:0042474;GO:0000184;GO:0001503;GO:0006417;GO:0022618;GO:0006364;GO:0007605;GO:0001501;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:eukaryotic 80S initiation complex; C:focal adhesion; C:polysomal ribosome; C:postsynaptic density;, F:RNA binding; F:structural constituent of ribosome;, P:90S preribosome assembly; P:axial mesoderm development; P:cytoplasmic translation; P:middle ear morphogenesis; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ossification; P:regulation of translation; P:ribonucleoprotein complex assembly; P:rRNA processing; P:sensory perception of sound; P:skeletal system development; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold88 indexed_genome mRNA 5977268 5998968 . + . ID=transcript_12423;Q9BSA4 B3KX97 Q3B7H8 Q3B7R9 Q6AWB4 Q8NBB7 Q96PK1,Protein tweety homolog 2,, PF04906;, GO:0034707;GO:0005886;GO:0005229;GO:0072320;, C:chloride channel complex; C:plasma membrane;, F:intracellular calcium activated chloride channel activity; F:volume-sensitive chloride channel activity; scaffold88 indexed_genome mRNA 6004472 6012726 . + . ID=transcript_12424;Q9BSA4 B3KX97 Q3B7H8 Q3B7R9 Q6AWB4 Q8NBB7 Q96PK1,Protein tweety homolog 2,, PF04906;, GO:0034707;GO:0005886;GO:0005229;GO:0072320;, C:chloride channel complex; C:plasma membrane;, F:intracellular calcium activated chloride channel activity; F:volume-sensitive chloride channel activity; scaffold88 indexed_genome mRNA 6042242 6046306 . + . ID=transcript_12425;Q9GZS0 C9J0S6 Q8IUW4 Q9H179 Q9NT53,Dynein intermediate chain 2, axonemal {ECO:0000305},Axonemal dynein intermediate chain 2;, , GO:0005858;GO:0005930;GO:0005874;GO:0036157;GO:0036126;GO:0045504;GO:0045503;GO:0003777;GO:0060271;GO:0003341;GO:0007368;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:microtubule; C:outer dynein arm; C:sperm flagellum;, F:dynein heavy chain binding; F:dynein light chain binding; F:microtubule motor activity;, P:cilium assembly; P:cilium movement; P:determination of left/right symmetry; P:microtubule-based movement; P:outer dynein arm assembly; scaffold88 indexed_genome mRNA 6051892 6066372 . + . ID=transcript_12426;Q2TAC6 A6NLG2 B7ZKR1 Q52M87 Q8N1X8 Q8TAB6,Kinesin-like protein KIF19,, PF00225;, GO:0005930;GO:0005929;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0060404;GO:0007018;GO:0070462;, C:axoneme; C:cilium; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:axonemal microtubule depolymerization; P:microtubule-based movement; P:plus-end specific microtubule depolymerization; scaffold88 indexed_genome mRNA 6066655 6074160 . + . ID=transcript_12427;Q2TAC6 A6NLG2 B7ZKR1 Q52M87 Q8N1X8 Q8TAB6,Kinesin-like protein KIF19,, PF00225;, GO:0005930;GO:0005929;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0060404;GO:0007018;GO:0070462;, C:axoneme; C:cilium; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:axonemal microtubule depolymerization; P:microtubule-based movement; P:plus-end specific microtubule depolymerization;|Q2TAC6 A6NLG2 B7ZKR1 Q52M87 Q8N1X8 Q8TAB6,Kinesin-like protein KIF19,, PF00225;, GO:0005930;GO:0005929;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0060404;GO:0007018;GO:0070462;, C:axoneme; C:cilium; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:axonemal microtubule depolymerization; P:microtubule-based movement; P:plus-end specific microtubule depolymerization;|Q2TAC6 A6NLG2 B7ZKR1 Q52M87 Q8N1X8 Q8TAB6,Kinesin-like protein KIF19,, PF00225;, GO:0005930;GO:0005929;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0060404;GO:0007018;GO:0070462;, C:axoneme; C:cilium; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:axonemal microtubule depolymerization; P:microtubule-based movement; P:plus-end specific microtubule depolymerization;|Q2TAC6 A6NLG2 B7ZKR1 Q52M87 Q8N1X8 Q8TAB6,Kinesin-like protein KIF19,, PF00225;, GO:0005930;GO:0005929;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0060404;GO:0007018;GO:0070462;, C:axoneme; C:cilium; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:axonemal microtubule depolymerization; P:microtubule-based movement; P:plus-end specific microtubule depolymerization; scaffold88 indexed_genome mRNA 6074693 6075463 . + . ID=transcript_12428;Q2TAC6 A6NLG2 B7ZKR1 Q52M87 Q8N1X8 Q8TAB6,Kinesin-like protein KIF19,, PF00225;, GO:0005930;GO:0005929;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0060404;GO:0007018;GO:0070462;, C:axoneme; C:cilium; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:axonemal microtubule depolymerization; P:microtubule-based movement; P:plus-end specific microtubule depolymerization; scaffold88 indexed_genome mRNA 6075497 6077964 . - . ID=transcript_12429;Q2TAC6 A6NLG2 B7ZKR1 Q52M87 Q8N1X8 Q8TAB6,Kinesin-like protein KIF19,, PF00225;, GO:0005930;GO:0005929;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0060404;GO:0007018;GO:0070462;, C:axoneme; C:cilium; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:axonemal microtubule depolymerization; P:microtubule-based movement; P:plus-end specific microtubule depolymerization; scaffold88 indexed_genome mRNA 6148661 6155359 . + . ID=transcript_12430;Q9NQ84 B5BUN4 Q2NL85 Q9NZG5,G-protein coupled receptor family C group 5 member C,Retinoic acid-induced gene 3 protein;, PF00003;, GO:0030659;GO:0070062;GO:0005887;GO:0043231;GO:0005886;GO:0043235;GO:0031982;GO:0004930;GO:0030295;GO:0007186;, C:cytoplasmic vesicle membrane; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:receptor complex; C:vesicle;, F:G protein-coupled receptor activity; F:protein kinase activator activity;, P:G protein-coupled receptor signaling pathway;|Q9NQ84 B5BUN4 Q2NL85 Q9NZG5,G-protein coupled receptor family C group 5 member C,Retinoic acid-induced gene 3 protein;, PF00003;, GO:0030659;GO:0070062;GO:0005887;GO:0043231;GO:0005886;GO:0043235;GO:0031982;GO:0004930;GO:0030295;GO:0007186;, C:cytoplasmic vesicle membrane; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:receptor complex; C:vesicle;, F:G protein-coupled receptor activity; F:protein kinase activator activity;, P:G protein-coupled receptor signaling pathway;|Q9NQ84 B5BUN4 Q2NL85 Q9NZG5,G-protein coupled receptor family C group 5 member C,Retinoic acid-induced gene 3 protein;, PF00003;, GO:0030659;GO:0070062;GO:0005887;GO:0043231;GO:0005886;GO:0043235;GO:0031982;GO:0004930;GO:0030295;GO:0007186;, C:cytoplasmic vesicle membrane; C:extracellular exosome; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:receptor complex; C:vesicle;, F:G protein-coupled receptor activity; F:protein kinase activator activity;, P:G protein-coupled receptor signaling pathway; scaffold88 indexed_genome mRNA 6176229 6195836 . + . ID=transcript_12431;Q9UGN4 A8MW96 O95100 Q9HD97 Q9P0F3 Q9UBK4 Q9UMS9 Q9UMT0,CMRF35-like molecule 8,CD300 antigen-like family member A;CMRF-35-H9;CMRF35-H;IRC1/IRC2;Immunoglobulin superfamily member 12;Inhibitory receptor protein 60;NK inhibitory receptor;, PF07686;, GO:0070062;GO:0101003;GO:0016021;GO:0016020;GO:0005886;GO:0070821;GO:0008429;GO:0001786;GO:0038023;GO:0004888;GO:0007155;GO:1902569;GO:0030889;GO:0050859;GO:1902567;GO:2000417;GO:0048147;GO:0043407;GO:0033007;GO:0043305;GO:0034125;GO:1902564;GO:0051134;GO:0060101;GO:0043312;GO:0032516;GO:0050776;GO:0050856;, C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:phosphatidylethanolamine binding; F:phosphatidylserine binding; F:signaling receptor activity; F:transmembrane signaling receptor activity;, P:cell adhesion; P:negative regulation of activation of Janus kinase activity; P:negative regulation of B cell proliferation; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of eosinophil activation; P:negative regulation of eosinophil migration; P:negative regulation of fibroblast proliferation; P:negative regulation of MAP kinase activity; P:negative regulation of mast cell activation involved in immune response; P:negative regulation of mast cell degranulation; P:negative regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of neutrophil activation; P:negative regulation of NK T cell activation; P:negative regulation of phagocytosis, engulfment; P:neutrophil degranulation; P:positive regulation of phosphoprotein phosphatase activity; P:regulation of immune response; P:regulation of T cell receptor signaling pathway; scaffold88 indexed_genome mRNA 6217453 6228801 . - . ID=transcript_12432;A8K4G0 Q1EG73 Q8IX40 Q8N6D1,CMRF35-like molecule 7,CD300 antigen-like family member B;CMRF35-A2;Immune receptor expressed on myeloid cells 3;Leukocyte mono-Ig-like receptor 5;Triggering receptor expressed on myeloid cells 5;, PF07686;, GO:0016021;GO:0005886;GO:0004888;GO:0045087;GO:0050776;, C:integral component of membrane; C:plasma membrane;, F:transmembrane signaling receptor activity;, P:innate immune response; P:regulation of immune response; scaffold89 indexed_genome mRNA 14424 15319 . - . ID=transcript_12433;A6ZKI3,Retrotransposon Gag-like protein 8C {ECO:0000312|HGNC:HGNC:2569},Mammalian retrotransposon derived protein 8C {ECO:0000312|HGNC:HGNC:2569};, PF16297; scaffold89 indexed_genome mRNA 22681 60900 . - . ID=transcript_12434;A6ZKI3,Retrotransposon Gag-like protein 8C {ECO:0000312|HGNC:HGNC:2569},Mammalian retrotransposon derived protein 8C {ECO:0000312|HGNC:HGNC:2569};, PF16297;|Q9BWD3 A2A2V9 Q8TBU2,Retrotransposon Gag-like protein 8A {ECO:0000312|HGNC:HGNC:24514},Mammalian retrotransposon derived protein 8A;, PF16297;, GO:0005730;, C:nucleolus; scaffold89 indexed_genome mRNA 155522 169039 . - . ID=transcript_12435;Q6P9G9 Q5JRZ7 Q5JRZ8 Q6NZX2 Q8N3Q1 Q8TED7,Zinc finger protein 449,Zinc finger and SCAN domain-containing protein 19;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;GO:0007284;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; P:spermatogonial cell division;|Q6P9G9 Q5JRZ7 Q5JRZ8 Q6NZX2 Q8N3Q1 Q8TED7,Zinc finger protein 449,Zinc finger and SCAN domain-containing protein 19;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;GO:0007284;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; P:spermatogonial cell division; scaffold89 indexed_genome mRNA 189036 198980 . - . ID=transcript_12436;P51815 A6NK62 B3KRI7 Q5JPG0 Q6LDE0,Zinc finger protein 75D,Zinc finger protein 75;Zinc finger protein 82;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II;|P51815 A6NK62 B3KRI7 Q5JPG0 Q6LDE0,Zinc finger protein 75D,Zinc finger protein 75;Zinc finger protein 82;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold89 indexed_genome mRNA 285906 290827 . - . ID=transcript_12437;Q9NQV7 B4DX22 Q27Q50,Histone-lysine N-methyltransferase PRDM9 {ECO:0000305},PR domain zinc finger protein 9;PR domain-containing protein 9;Protein-lysine N-methyltransferase PRDM9 {ECO:0000250|UniProtKB:Q96EQ9};[histone H3]-lysine36 N-trimethyltransferase PRDM9 {ECO:0000305};[histone H3]-lysine4 N-trimethyltransferase PRDM9 {ECO:0000305};[histone H3]-lysine9 N-trimethyltransferase PRDM9 {ECO:0000250|UniProtKB:Q96EQ9};[histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9 {ECO:0000250|UniProtKB:Q96EQ9};[histone H4]-lysine20 N-methyltransferase PRDM9 {ECO:0000250|UniProtKB:Q96EQ9};, PF01352;PF00856;PF09514;PF00096;, GO:0005694;GO:0005654;GO:0005634;GO:0046975;GO:0042800;GO:0018024;GO:0046872;GO:0042803;GO:0010844;GO:0043565;GO:0000976;GO:1990918;GO:0007292;GO:0097676;GO:0097198;GO:0044648;GO:0051568;GO:0097692;GO:0080182;GO:0051567;GO:0007129;GO:0048232;GO:0006311;GO:0043066;GO:0016584;GO:1905516;GO:2001255;GO:1905437;GO:0010845;GO:0010468;GO:0006355;, C:chromosome; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:protein homodimerization activity; F:recombination hotspot binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:double-strand break repair involved in meiotic recombination; P:female gamete generation; P:histone H3-K36 dimethylation; P:histone H3-K36 trimethylation; P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:histone H3-K4 trimethylation; P:histone H3-K9 methylation; P:homologous chromosome pairing at meiosis; P:male gamete generation; P:meiotic gene conversion; P:negative regulation of apoptotic process; P:nucleosome positioning; P:positive regulation of fertilization; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of histone H3-K4 trimethylation; P:positive regulation of reciprocal meiotic recombination; P:regulation of gene expression; P:regulation of transcription, DNA-templated; scaffold89 indexed_genome mRNA 421966 478839 . + . ID=transcript_12438;Q5JSJ4 Q5CZA2 Q6IPS3 Q6ZTU5 Q6ZWE4,Integrator complex subunit 6-like,Protein DDX26B;, PF15300;PF13519;, GO:0032039;GO:0034472;, C:integrator complex;, , P:snRNA 3'-end processing;|Q5JSJ4 Q5CZA2 Q6IPS3 Q6ZTU5 Q6ZWE4,Integrator complex subunit 6-like,Protein DDX26B;, PF15300;PF13519;, GO:0032039;GO:0034472;, C:integrator complex;, , P:snRNA 3'-end processing;|Q5JSJ4 Q5CZA2 Q6IPS3 Q6ZTU5 Q6ZWE4,Integrator complex subunit 6-like,Protein DDX26B;, PF15300;PF13519;, GO:0032039;GO:0034472;, C:integrator complex;, , P:snRNA 3'-end processing;|Q5JSJ4 Q5CZA2 Q6IPS3 Q6ZTU5 Q6ZWE4,Integrator complex subunit 6-like,Protein DDX26B;, PF15300;PF13519;, GO:0032039;GO:0034472;, C:integrator complex;, , P:snRNA 3'-end processing; scaffold89 indexed_genome mRNA 561424 573055 . - . ID=transcript_12439;Q8N4V1 B2R625 B4DIY3 D3DWG7 Q5JPP7,ER membrane protein complex subunit 5 {ECO:0000305|PubMed:29242231},Membrane magnesium transporter 1 {ECO:0000312|HGNC:HGNC:28100};Transmembrane protein 32 {ECO:0000312|HGNC:HGNC:28100};, PF10270;, GO:0005769;GO:0031901;GO:0072546;GO:0005794;GO:0000139;GO:0030176;GO:0016021;GO:0016020;GO:0005886;GO:0015087;GO:0015093;GO:0022890;GO:0015095;GO:0006825;GO:0015693;GO:0045050;GO:0071816;, C:early endosome; C:early endosome membrane; C:EMC complex; C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cobalt ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:inorganic cation transmembrane transporter activity; F:magnesium ion transmembrane transporter activity;, P:copper ion transport; P:magnesium ion transport; P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q8N4V1 B2R625 B4DIY3 D3DWG7 Q5JPP7,ER membrane protein complex subunit 5 {ECO:0000305|PubMed:29242231},Membrane magnesium transporter 1 {ECO:0000312|HGNC:HGNC:28100};Transmembrane protein 32 {ECO:0000312|HGNC:HGNC:28100};, PF10270;, GO:0005769;GO:0031901;GO:0072546;GO:0005794;GO:0000139;GO:0030176;GO:0016021;GO:0016020;GO:0005886;GO:0015087;GO:0015093;GO:0022890;GO:0015095;GO:0006825;GO:0015693;GO:0045050;GO:0071816;, C:early endosome; C:early endosome membrane; C:EMC complex; C:Golgi apparatus; C:Golgi membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cobalt ion transmembrane transporter activity; F:ferrous iron transmembrane transporter activity; F:inorganic cation transmembrane transporter activity; F:magnesium ion transmembrane transporter activity;, P:copper ion transport; P:magnesium ion transport; P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane; scaffold89 indexed_genome mRNA 592283 645840 . + . ID=transcript_12440;Q92581 A6NIQ9 A8K160 B4DU30 B7ZAE0 Q3ZCW7 Q5JPP8 Q5JPP9 Q86VS0,Sodium/hydrogen exchanger 6,Na(+)/H(+) exchanger 6;Solute carrier family 9 member 6;, PF00999;, GO:0031901;GO:0005789;GO:0016021;GO:0043231;GO:0005886;GO:0055037;GO:0055038;GO:0015386;GO:0015385;GO:0048675;GO:0097484;GO:0006811;GO:0048812;GO:0071805;GO:0051453;GO:0098719;, C:early endosome membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:axon extension; P:dendrite extension; P:ion transport; P:neuron projection morphogenesis; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q92581 A6NIQ9 A8K160 B4DU30 B7ZAE0 Q3ZCW7 Q5JPP8 Q5JPP9 Q86VS0,Sodium/hydrogen exchanger 6,Na(+)/H(+) exchanger 6;Solute carrier family 9 member 6;, PF00999;, GO:0031901;GO:0005789;GO:0016021;GO:0043231;GO:0005886;GO:0055037;GO:0055038;GO:0015386;GO:0015385;GO:0048675;GO:0097484;GO:0006811;GO:0048812;GO:0071805;GO:0051453;GO:0098719;, C:early endosome membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:axon extension; P:dendrite extension; P:ion transport; P:neuron projection morphogenesis; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q92581 A6NIQ9 A8K160 B4DU30 B7ZAE0 Q3ZCW7 Q5JPP8 Q5JPP9 Q86VS0,Sodium/hydrogen exchanger 6,Na(+)/H(+) exchanger 6;Solute carrier family 9 member 6;, PF00999;, GO:0031901;GO:0005789;GO:0016021;GO:0043231;GO:0005886;GO:0055037;GO:0055038;GO:0015386;GO:0015385;GO:0048675;GO:0097484;GO:0006811;GO:0048812;GO:0071805;GO:0051453;GO:0098719;, C:early endosome membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:axon extension; P:dendrite extension; P:ion transport; P:neuron projection morphogenesis; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q92581 A6NIQ9 A8K160 B4DU30 B7ZAE0 Q3ZCW7 Q5JPP8 Q5JPP9 Q86VS0,Sodium/hydrogen exchanger 6,Na(+)/H(+) exchanger 6;Solute carrier family 9 member 6;, PF00999;, GO:0031901;GO:0005789;GO:0016021;GO:0043231;GO:0005886;GO:0055037;GO:0055038;GO:0015386;GO:0015385;GO:0048675;GO:0097484;GO:0006811;GO:0048812;GO:0071805;GO:0051453;GO:0098719;, C:early endosome membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:axon extension; P:dendrite extension; P:ion transport; P:neuron projection morphogenesis; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q92581 A6NIQ9 A8K160 B4DU30 B7ZAE0 Q3ZCW7 Q5JPP8 Q5JPP9 Q86VS0,Sodium/hydrogen exchanger 6,Na(+)/H(+) exchanger 6;Solute carrier family 9 member 6;, PF00999;, GO:0031901;GO:0005789;GO:0016021;GO:0043231;GO:0005886;GO:0055037;GO:0055038;GO:0015386;GO:0015385;GO:0048675;GO:0097484;GO:0006811;GO:0048812;GO:0071805;GO:0051453;GO:0098719;, C:early endosome membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:axon extension; P:dendrite extension; P:ion transport; P:neuron projection morphogenesis; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane;|Q92581 A6NIQ9 A8K160 B4DU30 B7ZAE0 Q3ZCW7 Q5JPP8 Q5JPP9 Q86VS0,Sodium/hydrogen exchanger 6,Na(+)/H(+) exchanger 6;Solute carrier family 9 member 6;, PF00999;, GO:0031901;GO:0005789;GO:0016021;GO:0043231;GO:0005886;GO:0055037;GO:0055038;GO:0015386;GO:0015385;GO:0048675;GO:0097484;GO:0006811;GO:0048812;GO:0071805;GO:0051453;GO:0098719;, C:early endosome membrane; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:axon extension; P:dendrite extension; P:ion transport; P:neuron projection morphogenesis; P:potassium ion transmembrane transport; P:regulation of intracellular pH; P:sodium ion import across plasma membrane; scaffold89 indexed_genome mRNA 792990 796061 . - . ID=transcript_12441;Q9NZ40 Q9UKZ8 Q9Y630,Four and a half LIM domains protein 1,Skeletal muscle LIM-protein 1;, PF00412;, GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0044325;GO:0046872;GO:0009887;GO:0030154;GO:0007517;GO:0030308;GO:2000134;GO:0010972;GO:0043268;GO:0003254;GO:1901016;, C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane;, F:ion channel binding; F:metal ion binding;, P:animal organ morphogenesis; P:cell differentiation; P:muscle organ development; P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of G2/M transition of mitotic cell cycle; P:positive regulation of potassium ion transport; P:regulation of membrane depolarization; P:regulation of potassium ion transmembrane transporter activity;|Q9NZ40 Q9UKZ8 Q9Y630,Four and a half LIM domains protein 1,Skeletal muscle LIM-protein 1;, PF00412;, GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0044325;GO:0046872;GO:0009887;GO:0030154;GO:0007517;GO:0030308;GO:2000134;GO:0010972;GO:0043268;GO:0003254;GO:1901016;, C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane;, F:ion channel binding; F:metal ion binding;, P:animal organ morphogenesis; P:cell differentiation; P:muscle organ development; P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of G2/M transition of mitotic cell cycle; P:positive regulation of potassium ion transport; P:regulation of membrane depolarization; P:regulation of potassium ion transmembrane transporter activity;|Q9NZ40 Q9UKZ8 Q9Y630,Four and a half LIM domains protein 1,Skeletal muscle LIM-protein 1;, PF00412;, GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0044325;GO:0046872;GO:0009887;GO:0030154;GO:0007517;GO:0030308;GO:2000134;GO:0010972;GO:0043268;GO:0003254;GO:1901016;, C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane;, F:ion channel binding; F:metal ion binding;, P:animal organ morphogenesis; P:cell differentiation; P:muscle organ development; P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of G2/M transition of mitotic cell cycle; P:positive regulation of potassium ion transport; P:regulation of membrane depolarization; P:regulation of potassium ion transmembrane transporter activity; scaffold89 indexed_genome mRNA 796110 798432 . + . ID=transcript_12442;Q9NZ40 Q9UKZ8 Q9Y630,Four and a half LIM domains protein 1,Skeletal muscle LIM-protein 1;, PF00412;, GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0044325;GO:0046872;GO:0009887;GO:0030154;GO:0007517;GO:0030308;GO:2000134;GO:0010972;GO:0043268;GO:0003254;GO:1901016;, C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane;, F:ion channel binding; F:metal ion binding;, P:animal organ morphogenesis; P:cell differentiation; P:muscle organ development; P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of G2/M transition of mitotic cell cycle; P:positive regulation of potassium ion transport; P:regulation of membrane depolarization; P:regulation of potassium ion transmembrane transporter activity; scaffold89 indexed_genome mRNA 802922 835250 . - . ID=transcript_12443;Q9H9M8,MAP7 domain-containing protein 3,, PF05672;, GO:0005737;GO:0016020;GO:0015630;GO:0005819;GO:0008017;GO:0015631;GO:0000226;GO:0046785;, C:cytoplasm; C:membrane; C:microtubule cytoskeleton; C:spindle;, F:microtubule binding; F:tubulin binding;, P:microtubule cytoskeleton organization; P:microtubule polymerization;|Q9H9M8,MAP7 domain-containing protein 3,, PF05672;, GO:0005737;GO:0016020;GO:0015630;GO:0005819;GO:0008017;GO:0015631;GO:0000226;GO:0046785;, C:cytoplasm; C:membrane; C:microtubule cytoskeleton; C:spindle;, F:microtubule binding; F:tubulin binding;, P:microtubule cytoskeleton organization; P:microtubule polymerization; scaffold89 indexed_genome mRNA 1073441 1091275 . + . ID=transcript_12444;O43719 D3DWG9 Q59G06 Q99730,HIV Tat-specific factor 1,, PF00076;, GO:0005654;GO:0005634;GO:0005686;GO:0005684;GO:0003723;GO:0000398;GO:0032784;GO:0006357;GO:0019079;, C:nucleoplasm; C:nucleus; C:U2 snRNP; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:regulation of DNA-templated transcription, elongation; P:regulation of transcription by RNA polymerase II; P:viral genome replication;|O43719 D3DWG9 Q59G06 Q99730,HIV Tat-specific factor 1,, PF00076;, GO:0005654;GO:0005634;GO:0005686;GO:0005684;GO:0003723;GO:0000398;GO:0032784;GO:0006357;GO:0019079;, C:nucleoplasm; C:nucleus; C:U2 snRNP; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:regulation of DNA-templated transcription, elongation; P:regulation of transcription by RNA polymerase II; P:viral genome replication;|O43719 D3DWG9 Q59G06 Q99730,HIV Tat-specific factor 1,, PF00076;, GO:0005654;GO:0005634;GO:0005686;GO:0005684;GO:0003723;GO:0000398;GO:0032784;GO:0006357;GO:0019079;, C:nucleoplasm; C:nucleus; C:U2 snRNP; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:regulation of DNA-templated transcription, elongation; P:regulation of transcription by RNA polymerase II; P:viral genome replication;|O43719 D3DWG9 Q59G06 Q99730,HIV Tat-specific factor 1,, PF00076;, GO:0005654;GO:0005634;GO:0005686;GO:0005684;GO:0003723;GO:0000398;GO:0032784;GO:0006357;GO:0019079;, C:nucleoplasm; C:nucleus; C:U2 snRNP; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:regulation of DNA-templated transcription, elongation; P:regulation of transcription by RNA polymerase II; P:viral genome replication; scaffold89 indexed_genome mRNA 1126161 1134820 . + . ID=transcript_12445;Q99990 Q5H915,Transcription cofactor vestigial-like protein 1,Protein TONDU;, PF07545;, GO:0005654;GO:0005634;GO:0003713;GO:0006357;GO:0006355;, C:nucleoplasm; C:nucleus;, F:transcription coactivator activity;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold89 indexed_genome mRNA 1256587 1377899 . - . ID=transcript_12446;Q15052 A6NMW9 A8K6S7 B1AL37 Q15396 Q5JQ66 Q7Z3W1 Q86XH0,Rho guanine nucleotide exchange factor 6,Alpha-Pix;COOL-2;PAK-interacting exchange factor alpha;Rac/Cdc42 guanine nucleotide exchange factor 6;, PF16523;PF00307;PF00169;PF00621;PF07653;, GO:0005829;GO:0030027;GO:0005096;GO:0005085;GO:0006915;GO:0007186;GO:0007254;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:lamellipodium;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:JNK cascade; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q15052 A6NMW9 A8K6S7 B1AL37 Q15396 Q5JQ66 Q7Z3W1 Q86XH0,Rho guanine nucleotide exchange factor 6,Alpha-Pix;COOL-2;PAK-interacting exchange factor alpha;Rac/Cdc42 guanine nucleotide exchange factor 6;, PF16523;PF00307;PF00169;PF00621;PF07653;, GO:0005829;GO:0030027;GO:0005096;GO:0005085;GO:0006915;GO:0007186;GO:0007254;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:lamellipodium;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:JNK cascade; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q15052 A6NMW9 A8K6S7 B1AL37 Q15396 Q5JQ66 Q7Z3W1 Q86XH0,Rho guanine nucleotide exchange factor 6,Alpha-Pix;COOL-2;PAK-interacting exchange factor alpha;Rac/Cdc42 guanine nucleotide exchange factor 6;, PF16523;PF00307;PF00169;PF00621;PF07653;, GO:0005829;GO:0030027;GO:0005096;GO:0005085;GO:0006915;GO:0007186;GO:0007254;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:lamellipodium;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:JNK cascade; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q15052 A6NMW9 A8K6S7 B1AL37 Q15396 Q5JQ66 Q7Z3W1 Q86XH0,Rho guanine nucleotide exchange factor 6,Alpha-Pix;COOL-2;PAK-interacting exchange factor alpha;Rac/Cdc42 guanine nucleotide exchange factor 6;, PF16523;PF00307;PF00169;PF00621;PF07653;, GO:0005829;GO:0030027;GO:0005096;GO:0005085;GO:0006915;GO:0007186;GO:0007254;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:lamellipodium;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:apoptotic process; P:G protein-coupled receptor signaling pathway; P:JNK cascade; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; scaffold89 indexed_genome mRNA 1430162 1438773 . - . ID=transcript_12447;P38159 B4E3U4 D3DWH0 E9PG86 Q5JQ67 Q8N8Y7 Q969R3,RNA-binding motif protein, X chromosome,Glycoprotein p43;Heterogeneous nuclear ribonucleoprotein G;, PF08081;PF00076;, GO:0071013;GO:0000791;GO:0070062;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005681;GO:0044530;GO:0003682;GO:0042802;GO:0003729;GO:0019904;GO:0003723;GO:0000978;GO:0003727;GO:0071347;GO:0006509;GO:0006376;GO:0000398;GO:0048025;GO:0001649;GO:0048026;GO:0045944;GO:0051260;GO:0000381;GO:0016070;GO:0006366;, C:catalytic step 2 spliceosome; C:euchromatin; C:extracellular exosome; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex; C:spliceosomal complex; C:supraspliceosomal complex;, F:chromatin binding; F:identical protein binding; F:mRNA binding; F:protein domain specific binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded RNA binding;, P:cellular response to interleukin-1; P:membrane protein ectodomain proteolysis; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:osteoblast differentiation; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:protein homooligomerization; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA metabolic process; P:transcription by RNA polymerase II;|P38159 B4E3U4 D3DWH0 E9PG86 Q5JQ67 Q8N8Y7 Q969R3,RNA-binding motif protein, X chromosome,Glycoprotein p43;Heterogeneous nuclear ribonucleoprotein G;, PF08081;PF00076;, GO:0071013;GO:0000791;GO:0070062;GO:0005615;GO:0016020;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005681;GO:0044530;GO:0003682;GO:0042802;GO:0003729;GO:0019904;GO:0003723;GO:0000978;GO:0003727;GO:0071347;GO:0006509;GO:0006376;GO:0000398;GO:0048025;GO:0001649;GO:0048026;GO:0045944;GO:0051260;GO:0000381;GO:0016070;GO:0006366;, C:catalytic step 2 spliceosome; C:euchromatin; C:extracellular exosome; C:extracellular space; C:membrane; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex; C:spliceosomal complex; C:supraspliceosomal complex;, F:chromatin binding; F:identical protein binding; F:mRNA binding; F:protein domain specific binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:single-stranded RNA binding;, P:cellular response to interleukin-1; P:membrane protein ectodomain proteolysis; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:osteoblast differentiation; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:protein homooligomerization; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA metabolic process; P:transcription by RNA polymerase II; scaffold89 indexed_genome mRNA 2111244 2116863 . + . ID=transcript_12448;O60481 B2CNW4 Q14DE5 Q5JY75,Zinc finger protein ZIC 3,Zinc finger protein 203;Zinc finger protein of the cerebellum 3;, PF00096;PF18366;, GO:0005737;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0009952;GO:0030154;GO:0007417;GO:0071907;GO:0035545;GO:0007368;GO:0071910;GO:0035469;GO:0001947;GO:0030324;GO:0045944;GO:0045893;GO:0006357;GO:0035019;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:cell differentiation; P:central nervous system development; P:determination of digestive tract left/right asymmetry; P:determination of left/right asymmetry in nervous system; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:heart looping; P:lung development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:somatic stem cell population maintenance;|O60481 B2CNW4 Q14DE5 Q5JY75,Zinc finger protein ZIC 3,Zinc finger protein 203;Zinc finger protein of the cerebellum 3;, PF00096;PF18366;, GO:0005737;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0009952;GO:0030154;GO:0007417;GO:0071907;GO:0035545;GO:0007368;GO:0071910;GO:0035469;GO:0001947;GO:0030324;GO:0045944;GO:0045893;GO:0006357;GO:0035019;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior pattern specification; P:cell differentiation; P:central nervous system development; P:determination of digestive tract left/right asymmetry; P:determination of left/right asymmetry in nervous system; P:determination of left/right symmetry; P:determination of liver left/right asymmetry; P:determination of pancreatic left/right asymmetry; P:heart looping; P:lung development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:somatic stem cell population maintenance; scaffold89 indexed_genome mRNA 3002531 3529489 . - . ID=transcript_12449;Q92913 B1AK18 B7Z4M7 B7Z8N0 D3DWH4 O95830 Q9NZH9 Q9NZI0,Fibroblast growth factor 13,Fibroblast growth factor homologous factor 2;, PF00167;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0005576;GO:0030175;GO:0030426;GO:0014704;GO:0016328;GO:0005874;GO:0043005;GO:0005730;GO:0005634;GO:0005886;GO:0048487;GO:0008083;GO:0044325;GO:0008017;GO:0030295;GO:0017080;GO:0007267;GO:0021795;GO:0045200;GO:0021766;GO:1904862;GO:0007612;GO:0000165;GO:0007613;GO:0046785;GO:0048671;GO:0007026;GO:0007399;GO:0001764;GO:0072659;GO:0098909;GO:1905150;GO:0007165;GO:0006814;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular region; C:filopodium; C:growth cone; C:intercalated disc; C:lateral plasma membrane; C:microtubule; C:neuron projection; C:nucleolus; C:nucleus; C:plasma membrane;, F:beta-tubulin binding; F:growth factor activity; F:ion channel binding; F:microtubule binding; F:protein kinase activator activity; F:sodium channel regulator activity;, P:cell-cell signaling; P:cerebral cortex cell migration; P:establishment of neuroblast polarity; P:hippocampus development; P:inhibitory synapse assembly; P:learning; P:MAPK cascade; P:memory; P:microtubule polymerization; P:negative regulation of collateral sprouting; P:negative regulation of microtubule depolymerization; P:nervous system development; P:neuron migration; P:protein localization to plasma membrane; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of voltage-gated sodium channel activity; P:signal transduction; P:sodium ion transport;|Q92913 B1AK18 B7Z4M7 B7Z8N0 D3DWH4 O95830 Q9NZH9 Q9NZI0,Fibroblast growth factor 13,Fibroblast growth factor homologous factor 2;, PF00167;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0005576;GO:0030175;GO:0030426;GO:0014704;GO:0016328;GO:0005874;GO:0043005;GO:0005730;GO:0005634;GO:0005886;GO:0048487;GO:0008083;GO:0044325;GO:0008017;GO:0030295;GO:0017080;GO:0007267;GO:0021795;GO:0045200;GO:0021766;GO:1904862;GO:0007612;GO:0000165;GO:0007613;GO:0046785;GO:0048671;GO:0007026;GO:0007399;GO:0001764;GO:0072659;GO:0098909;GO:1905150;GO:0007165;GO:0006814;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular region; C:filopodium; C:growth cone; C:intercalated disc; C:lateral plasma membrane; C:microtubule; C:neuron projection; C:nucleolus; C:nucleus; C:plasma membrane;, F:beta-tubulin binding; F:growth factor activity; F:ion channel binding; F:microtubule binding; F:protein kinase activator activity; F:sodium channel regulator activity;, P:cell-cell signaling; P:cerebral cortex cell migration; P:establishment of neuroblast polarity; P:hippocampus development; P:inhibitory synapse assembly; P:learning; P:MAPK cascade; P:memory; P:microtubule polymerization; P:negative regulation of collateral sprouting; P:negative regulation of microtubule depolymerization; P:nervous system development; P:neuron migration; P:protein localization to plasma membrane; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of voltage-gated sodium channel activity; P:signal transduction; P:sodium ion transport;|Q92913 B1AK18 B7Z4M7 B7Z8N0 D3DWH4 O95830 Q9NZH9 Q9NZI0,Fibroblast growth factor 13,Fibroblast growth factor homologous factor 2;, PF00167;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0005576;GO:0030175;GO:0030426;GO:0014704;GO:0016328;GO:0005874;GO:0043005;GO:0005730;GO:0005634;GO:0005886;GO:0048487;GO:0008083;GO:0044325;GO:0008017;GO:0030295;GO:0017080;GO:0007267;GO:0021795;GO:0045200;GO:0021766;GO:1904862;GO:0007612;GO:0000165;GO:0007613;GO:0046785;GO:0048671;GO:0007026;GO:0007399;GO:0001764;GO:0072659;GO:0098909;GO:1905150;GO:0007165;GO:0006814;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular region; C:filopodium; C:growth cone; C:intercalated disc; C:lateral plasma membrane; C:microtubule; C:neuron projection; C:nucleolus; C:nucleus; C:plasma membrane;, F:beta-tubulin binding; F:growth factor activity; F:ion channel binding; F:microtubule binding; F:protein kinase activator activity; F:sodium channel regulator activity;, P:cell-cell signaling; P:cerebral cortex cell migration; P:establishment of neuroblast polarity; P:hippocampus development; P:inhibitory synapse assembly; P:learning; P:MAPK cascade; P:memory; P:microtubule polymerization; P:negative regulation of collateral sprouting; P:negative regulation of microtubule depolymerization; P:nervous system development; P:neuron migration; P:protein localization to plasma membrane; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of voltage-gated sodium channel activity; P:signal transduction; P:sodium ion transport; scaffold89 indexed_genome mRNA 3818000 3849864 . + . ID=transcript_12450;P00740 A8K9N4 F2RM36 Q5FBE1 Q5JYJ8,Coagulation factor IX {ECO:0000303|PubMed:3857619},Christmas factor;Plasma thromboplastin component;, PF00008;PF00594;PF00089;, GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0005509;GO:0004175;GO:0004252;GO:0007596;GO:0007597;GO:0006888;GO:0006508;GO:0031638;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane;, F:calcium ion binding; F:endopeptidase activity; F:serine-type endopeptidase activity;, P:blood coagulation; P:blood coagulation, intrinsic pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:proteolysis; P:zymogen activation; scaffold89 indexed_genome mRNA 3870973 3912896 . - . ID=transcript_12451;Q5JYJ4 Q8IUF3 Q8IUF4 Q9UJB3,Proto-oncogene DBL,Proto-oncogene MCF-2;, PF13716;PF00169;PF00621;, GO:0005856;GO:0005829;GO:0016020;GO:0005085;GO:0007186;GO:0035556;GO:0050771;GO:0043065;GO:0051056;, C:cytoskeleton; C:cytosol; C:membrane;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of axonogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q5JYJ4 Q8IUF3 Q8IUF4 Q9UJB3,Proto-oncogene DBL,Proto-oncogene MCF-2;, PF13716;PF00169;PF00621;, GO:0005856;GO:0005829;GO:0016020;GO:0005085;GO:0007186;GO:0035556;GO:0050771;GO:0043065;GO:0051056;, C:cytoskeleton; C:cytosol; C:membrane;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of axonogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; scaffold89 indexed_genome mRNA 4017051 4178169 . - . ID=transcript_12452;Q70IJ9 Q70IK0 Q8WX24,Phospholipid-transporting ATPase IG,ATPase IQ;ATPase class VI type 11C;P4-ATPase flippase complex alpha subunit ATP11C;, PF16212;PF16209;, GO:0005783;GO:0005789;GO:0005887;GO:0005765;GO:0005886;GO:0055037;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0090555;GO:0140346;GO:0034220;GO:0045332;GO:0045579;GO:0002329;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane; C:recycling endosome; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylethanolamine flippase activity; F:phosphatidylserine flippase activity;, P:ion transmembrane transport; P:phospholipid translocation; P:positive regulation of B cell differentiation; P:pre-B cell differentiation;|Q70IJ9 Q70IK0 Q8WX24,Phospholipid-transporting ATPase IG,ATPase IQ;ATPase class VI type 11C;P4-ATPase flippase complex alpha subunit ATP11C;, PF16212;PF16209;, GO:0005783;GO:0005789;GO:0005887;GO:0005765;GO:0005886;GO:0055037;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0090555;GO:0140346;GO:0034220;GO:0045332;GO:0045579;GO:0002329;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane; C:recycling endosome; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylethanolamine flippase activity; F:phosphatidylserine flippase activity;, P:ion transmembrane transport; P:phospholipid translocation; P:positive regulation of B cell differentiation; P:pre-B cell differentiation; scaffold89 indexed_genome mRNA 4429444 4430210 . + . ID=transcript_12453;Q14CZ0,UPF0472 protein C16orf72,, PF15251; scaffold89 indexed_genome mRNA 5381251 5382694 . - . ID=transcript_12454;O95751 Q6IAR6,Protein LDOC1,Leucine zipper protein down-regulated in cancer cells;, PF16297;, GO:0005730;GO:0005654;GO:0005634;GO:0071222;GO:0071225;GO:0008285;, C:nucleolus; C:nucleoplasm; C:nucleus;, , P:cellular response to lipopolysaccharide; P:cellular response to muramyl dipeptide; P:negative regulation of cell population proliferation; scaffold90 indexed_genome mRNA 117414 146897 . + . ID=transcript_12455;Q0VAA2 Q6ZUG6 Q9Y627,Leucine-rich repeat-containing protein 74A {ECO:0000312|HGNC:HGNC:23346},Leucine-rich repeat-containing protein 74 {ECO:0000312|HGNC:HGNC:23346};, PF13516;|Q0VAA2 Q6ZUG6 Q9Y627,Leucine-rich repeat-containing protein 74A {ECO:0000312|HGNC:HGNC:23346},Leucine-rich repeat-containing protein 74 {ECO:0000312|HGNC:HGNC:23346};, PF13516; scaffold90 indexed_genome mRNA 162649 184069 . + . ID=transcript_12456;Q9UNK9 B4DWL7 O94859 Q8NCS9,Protein angel homolog 1,, PF03372;, GO:0005801;GO:0005829;GO:0005783;GO:0005634;GO:0048471;GO:0000175;GO:0008190;GO:0019904;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum; C:nucleus; C:perinuclear region of cytoplasm;, F:3'-5'-exoribonuclease activity; F:eukaryotic initiation factor 4E binding; F:protein domain specific binding;|Q9UNK9 B4DWL7 O94859 Q8NCS9,Protein angel homolog 1,, PF03372;, GO:0005801;GO:0005829;GO:0005783;GO:0005634;GO:0048471;GO:0000175;GO:0008190;GO:0019904;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum; C:nucleus; C:perinuclear region of cytoplasm;, F:3'-5'-exoribonuclease activity; F:eukaryotic initiation factor 4E binding; F:protein domain specific binding;|Q9UNK9 B4DWL7 O94859 Q8NCS9,Protein angel homolog 1,, PF03372;, GO:0005801;GO:0005829;GO:0005783;GO:0005634;GO:0048471;GO:0000175;GO:0008190;GO:0019904;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum; C:nucleus; C:perinuclear region of cytoplasm;, F:3'-5'-exoribonuclease activity; F:eukaryotic initiation factor 4E binding; F:protein domain specific binding;|Q9UNK9 B4DWL7 O94859 Q8NCS9,Protein angel homolog 1,, PF03372;, GO:0005801;GO:0005829;GO:0005783;GO:0005634;GO:0048471;GO:0000175;GO:0008190;GO:0019904;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum; C:nucleus; C:perinuclear region of cytoplasm;, F:3'-5'-exoribonuclease activity; F:eukaryotic initiation factor 4E binding; F:protein domain specific binding;|Q9UNK9 B4DWL7 O94859 Q8NCS9,Protein angel homolog 1,, PF03372;, GO:0005801;GO:0005829;GO:0005783;GO:0005634;GO:0048471;GO:0000175;GO:0008190;GO:0019904;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum; C:nucleus; C:perinuclear region of cytoplasm;, F:3'-5'-exoribonuclease activity; F:eukaryotic initiation factor 4E binding; F:protein domain specific binding; scaffold90 indexed_genome mRNA 187467 210095 . - . ID=transcript_12457;Q7L8A9 Q96H02 Q9UBF4 Q9Y629,Tubulinyl-Tyr carboxypeptidase 1 {ECO:0000305},Tubulin carboxypeptidase 1 {ECO:0000303|PubMed:29146869};Tyrosine carboxypeptidase 1 {ECO:0000305};Vasohibin-1 {ECO:0000303|PubMed:15467828};, PF14822;, GO:0045177;GO:0005737;GO:0005783;GO:0005615;GO:0003779;GO:0004181;GO:0001525;GO:0007050;GO:0060716;GO:0016525;GO:0043537;GO:0010596;GO:0001937;GO:1901491;GO:0006508;GO:0045765;GO:2000772;GO:0009611;, C:apical part of cell; C:cytoplasm; C:endoplasmic reticulum; C:extracellular space;, F:actin binding; F:metallocarboxypeptidase activity;, P:angiogenesis; P:cell cycle arrest; P:labyrinthine layer blood vessel development; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of lymphangiogenesis; P:proteolysis; P:regulation of angiogenesis; P:regulation of cellular senescence; P:response to wounding; scaffold90 indexed_genome mRNA 423135 440030 . - . ID=transcript_12458;O95718 A2VDJ2 B6ZGU4 Q5F0P7 Q5F0P8 Q9HCB4,Steroid hormone receptor ERR2 {ECO:0000305},ERR beta-2;Estrogen receptor-like 2;Estrogen-related receptor beta {ECO:0000303|PubMed:16332939};Nuclear receptor subfamily 3 group B member 2;, PF00104;PF00105;, GO:0000785;GO:0000793;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000987;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0000978;GO:0000993;GO:0043565;GO:1990837;GO:0005496;GO:0003707;GO:0008134;GO:0008270;GO:0043697;GO:0008283;GO:0048839;GO:2000737;GO:0045494;GO:0045725;GO:0045821;GO:1902459;GO:0045944;GO:0071931;GO:0090282;GO:0045893;GO:2000035;GO:0006357;GO:0006355;GO:0017145;GO:0019827;GO:0006367;, C:chromatin; C:condensed chromosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid binding; F:steroid hormone receptor activity; F:transcription factor binding; F:zinc ion binding;, P:cell dedifferentiation; P:cell population proliferation; P:inner ear development; P:negative regulation of stem cell differentiation; P:photoreceptor cell maintenance; P:positive regulation of glycogen biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of stem cell population maintenance; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; P:positive regulation of transcription involved in G2/M transition of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:regulation of stem cell division; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:stem cell division; P:stem cell population maintenance; P:transcription initiation from RNA polymerase II promoter; scaffold90 indexed_genome mRNA 710603 758902 . - . ID=transcript_12459;Q9NWQ4 B3KN42 Q6PEJ7 Q9H3M3 Q9NWH0 Q9ULR8,G patch domain-containing protein 2-like|Q9NWQ4 B3KN42 Q6PEJ7 Q9H3M3 Q9NWH0 Q9ULR8,G patch domain-containing protein 2-like|Q9NWQ4 B3KN42 Q6PEJ7 Q9H3M3 Q9NWH0 Q9ULR8,G patch domain-containing protein 2-like scaffold90 indexed_genome mRNA 846516 977801 . - . ID=transcript_12460;Q96FT9 B3KPT6 B4DZI9 G3V385 O95418 Q9ULA9,Intraflagellar transport protein 43 homolog {ECO:0000305},, PF15305;, GO:0034451;GO:0097542;GO:0005929;GO:0005737;GO:0030991;GO:0015630;GO:0060271;GO:0035721;GO:0035735;, C:centriolar satellite; C:ciliary tip; C:cilium; C:cytoplasm; C:intraciliary transport particle A; C:microtubule cytoskeleton;, , P:cilium assembly; P:intraciliary retrograde transport; P:intraciliary transport involved in cilium assembly;|P10600 Q8WV88,Transforming growth factor beta-3 proprotein,, PF00019;PF00688;, GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0043231;GO:0043025;GO:0005634;GO:0005886;GO:0031093;GO:0030315;GO:0005125;GO:0008083;GO:0042802;GO:0044877;GO:0050431;GO:0034713;GO:0005114;GO:0034714;GO:0000187;GO:0007568;GO:0030509;GO:0045216;GO:0070483;GO:0048565;GO:0048702;GO:0060325;GO:0007565;GO:0060364;GO:0001701;GO:0048839;GO:0048286;GO:0030879;GO:0008285;GO:0010936;GO:0043524;GO:0030512;GO:1904706;GO:0042476;GO:0043932;GO:0002576;GO:0043065;GO:0030501;GO:0051781;GO:0008284;GO:0032967;GO:0010718;GO:0051491;GO:0010862;GO:0050714;GO:0060391;GO:0051496;GO:1905075;GO:0045944;GO:0045893;GO:0042127;GO:0043627;GO:0001666;GO:0034616;GO:0032570;GO:0007435;GO:0062009;GO:0060395;GO:0007179;GO:0042704;GO:0042060;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:neuronal cell body; C:nucleus; C:plasma membrane; C:platelet alpha granule lumen; C:T-tubule;, F:cytokine activity; F:growth factor activity; F:identical protein binding; F:protein-containing complex binding; F:transforming growth factor beta binding; F:type I transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding; F:type III transforming growth factor beta receptor binding;, P:activation of MAPK activity; P:aging; P:BMP signaling pathway; P:cell-cell junction organization; P:detection of hypoxia; P:digestive tract development; P:embryonic neurocranium morphogenesis; P:face morphogenesis; P:female pregnancy; P:frontal suture morphogenesis; P:in utero embryonic development; P:inner ear development; P:lung alveolus development; P:mammary gland development; P:negative regulation of cell population proliferation; P:negative regulation of macrophage cytokine production; P:negative regulation of neuron apoptotic process; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of vascular associated smooth muscle cell proliferation; P:odontogenesis; P:ossification involved in bone remodeling; P:platelet degranulation; P:positive regulation of apoptotic process; P:positive regulation of bone mineralization; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of filopodium assembly; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein secretion; P:positive regulation of SMAD protein signal transduction; P:positive regulation of stress fiber assembly; P:positive regulation of tight junction disassembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell population proliferation; P:response to estrogen; P:response to hypoxia; P:response to laminar fluid shear stress; P:response to progesterone; P:salivary gland morphogenesis; P:secondary palate development; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:uterine wall breakdown; P:wound healing; scaffold90 indexed_genome mRNA 980490 1304766 . - . ID=transcript_12461;Q6EMB2 B9EGH8 B9EGH9 Q9BUB0 Q9H0G4 Q9H7W2 Q9P1V5 Q9UPZ4,Tubulin polyglutamylase TTLL5,SRC1 and TIF2-associated modulatory protein;Tubulin--tyrosine ligase-like protein 5;, PF03133;, GO:0005813;GO:0005929;GO:0005829;GO:0005874;GO:0005634;GO:0005886;GO:0005524;GO:0015631;GO:0070740;GO:0000226;GO:0018095;GO:0060041;, C:centrosome; C:cilium; C:cytosol; C:microtubule; C:nucleus; C:plasma membrane;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:protein polyglutamylation; P:retina development in camera-type eye;|Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated;|Q6EMB2 B9EGH8 B9EGH9 Q9BUB0 Q9H0G4 Q9H7W2 Q9P1V5 Q9UPZ4,Tubulin polyglutamylase TTLL5,SRC1 and TIF2-associated modulatory protein;Tubulin--tyrosine ligase-like protein 5;, PF03133;, GO:0005813;GO:0005929;GO:0005829;GO:0005874;GO:0005634;GO:0005886;GO:0005524;GO:0015631;GO:0070740;GO:0000226;GO:0018095;GO:0060041;, C:centrosome; C:cilium; C:cytosol; C:microtubule; C:nucleus; C:plasma membrane;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:protein polyglutamylation; P:retina development in camera-type eye;|Q6EMB2 B9EGH8 B9EGH9 Q9BUB0 Q9H0G4 Q9H7W2 Q9P1V5 Q9UPZ4,Tubulin polyglutamylase TTLL5,SRC1 and TIF2-associated modulatory protein;Tubulin--tyrosine ligase-like protein 5;, PF03133;, GO:0005813;GO:0005929;GO:0005829;GO:0005874;GO:0005634;GO:0005886;GO:0005524;GO:0015631;GO:0070740;GO:0000226;GO:0018095;GO:0060041;, C:centrosome; C:cilium; C:cytosol; C:microtubule; C:nucleus; C:plasma membrane;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:microtubule cytoskeleton organization; P:protein polyglutamylation; P:retina development in camera-type eye; scaffold90 indexed_genome mRNA 1358108 1367373 . - . ID=transcript_12462;Q9UKR5 Q9P093 Q9UPI2,Ergosterol biosynthetic protein 28 homolog,, PF03694;, GO:0005783;GO:0005789;GO:0016021;GO:0030133;GO:0042802;GO:0030674;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:transport vesicle;, F:identical protein binding; F:protein-macromolecule adaptor activity;, P:sterol biosynthetic process;|Q9UKR5 Q9P093 Q9UPI2,Ergosterol biosynthetic protein 28 homolog,, PF03694;, GO:0005783;GO:0005789;GO:0016021;GO:0030133;GO:0042802;GO:0030674;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:transport vesicle;, F:identical protein binding; F:protein-macromolecule adaptor activity;, P:sterol biosynthetic process; scaffold90 indexed_genome mRNA 1502759 1563243 . - . ID=transcript_12463;Q9UPI3 B7Z485 Q53ZT9 Q96JY3 Q9NX90,Feline leukemia virus subgroup C receptor-related protein 2,Calcium-chelate transporter;, PF07690;, GO:0016021;GO:0005886;GO:0020037;GO:0015232;GO:0097037;, C:integral component of membrane; C:plasma membrane;, F:heme binding; F:heme transmembrane transporter activity;, P:heme export;|Q9UPI3 B7Z485 Q53ZT9 Q96JY3 Q9NX90,Feline leukemia virus subgroup C receptor-related protein 2,Calcium-chelate transporter;, PF07690;, GO:0016021;GO:0005886;GO:0020037;GO:0015232;GO:0097037;, C:integral component of membrane; C:plasma membrane;, F:heme binding; F:heme transmembrane transporter activity;, P:heme export; scaffold90 indexed_genome mRNA 1592565 1614412 . - . ID=transcript_12464;Q16520,Basic leucine zipper transcriptional factor ATF-like,B-cell-activating transcription factor;SF-HT-activated gene 2 protein;, PF00170;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0006974;GO:0019221;GO:0042832;GO:0030330;GO:0060218;GO:0045190;GO:0002320;GO:0043011;GO:0001819;GO:0006357;GO:0072539;GO:0072540;GO:0045064;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:cytokine-mediated signaling pathway; P:defense response to protozoan; P:DNA damage response, signal transduction by p53 class mediator; P:hematopoietic stem cell differentiation; P:isotype switching; P:lymphoid progenitor cell differentiation; P:myeloid dendritic cell differentiation; P:positive regulation of cytokine production; P:regulation of transcription by RNA polymerase II; P:T-helper 17 cell differentiation; P:T-helper 17 cell lineage commitment; P:T-helper 2 cell differentiation; scaffold90 indexed_genome mRNA 1677579 1678695 . + . ID=transcript_12465;Q8WYK2 J3KN58 O95430 Q9UIE4,Jun dimerization protein 2,, PF00170;, GO:0000785;GO:0005634;GO:0003682;GO:0000981;GO:0001227;GO:0044877;GO:0000978;GO:1990837;GO:0045599;GO:0000122;GO:0031065;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of fat cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of histone deacetylation; P:regulation of transcription by RNA polymerase II; scaffold90 indexed_genome mRNA 1834306 1838017 . - . ID=transcript_12466;P01100 A8K4E2 B4DQ65 P18849,Proto-oncogene c-Fos,Cellular oncogene fos;G0/G1 switch regulatory protein 7;, PF00170;, GO:0000785;GO:0005829;GO:0005783;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0032993;GO:0035976;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0044877;GO:0070412;GO:0001102;GO:0000978;GO:0000979;GO:1990837;GO:0008134;GO:0000976;GO:0007568;GO:0071276;GO:0071277;GO:0031668;GO:0032870;GO:0034614;GO:0001661;GO:0019221;GO:0006306;GO:0038095;GO:0007565;GO:0006954;GO:0007399;GO:1901216;GO:0045672;GO:1902895;GO:0045944;GO:0045893;GO:0051090;GO:0006357;GO:0051591;GO:0009409;GO:0051412;GO:0042493;GO:0009629;GO:0035902;GO:0009416;GO:0032496;GO:0035994;GO:0032570;GO:0009636;GO:0035914;GO:0030431;GO:0060395;GO:0006366;GO:0007179;, C:chromatin; C:cytosol; C:endoplasmic reticulum; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription factor AP-1 complex;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein-containing complex binding; F:R-SMAD binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:cellular response to cadmium ion; P:cellular response to calcium ion; P:cellular response to extracellular stimulus; P:cellular response to hormone stimulus; P:cellular response to reactive oxygen species; P:conditioned taste aversion; P:cytokine-mediated signaling pathway; P:DNA methylation; P:Fc-epsilon receptor signaling pathway; P:female pregnancy; P:inflammatory response; P:nervous system development; P:positive regulation of neuron death; P:positive regulation of osteoclast differentiation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription by RNA polymerase II; P:response to cAMP; P:response to cold; P:response to corticosterone; P:response to drug; P:response to gravity; P:response to immobilization stress; P:response to light stimulus; P:response to lipopolysaccharide; P:response to muscle stretch; P:response to progesterone; P:response to toxic substance; P:skeletal muscle cell differentiation; P:sleep; P:SMAD protein signal transduction; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway;|P01100 A8K4E2 B4DQ65 P18849,Proto-oncogene c-Fos,Cellular oncogene fos;G0/G1 switch regulatory protein 7;, PF00170;, GO:0000785;GO:0005829;GO:0005783;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0032993;GO:0035976;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0044877;GO:0070412;GO:0001102;GO:0000978;GO:0000979;GO:1990837;GO:0008134;GO:0000976;GO:0007568;GO:0071276;GO:0071277;GO:0031668;GO:0032870;GO:0034614;GO:0001661;GO:0019221;GO:0006306;GO:0038095;GO:0007565;GO:0006954;GO:0007399;GO:1901216;GO:0045672;GO:1902895;GO:0045944;GO:0045893;GO:0051090;GO:0006357;GO:0051591;GO:0009409;GO:0051412;GO:0042493;GO:0009629;GO:0035902;GO:0009416;GO:0032496;GO:0035994;GO:0032570;GO:0009636;GO:0035914;GO:0030431;GO:0060395;GO:0006366;GO:0007179;, C:chromatin; C:cytosol; C:endoplasmic reticulum; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription factor AP-1 complex;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein-containing complex binding; F:R-SMAD binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:cellular response to cadmium ion; P:cellular response to calcium ion; P:cellular response to extracellular stimulus; P:cellular response to hormone stimulus; P:cellular response to reactive oxygen species; P:conditioned taste aversion; P:cytokine-mediated signaling pathway; P:DNA methylation; P:Fc-epsilon receptor signaling pathway; P:female pregnancy; P:inflammatory response; P:nervous system development; P:positive regulation of neuron death; P:positive regulation of osteoclast differentiation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of DNA-binding transcription factor activity; P:regulation of transcription by RNA polymerase II; P:response to cAMP; P:response to cold; P:response to corticosterone; P:response to drug; P:response to gravity; P:response to immobilization stress; P:response to light stimulus; P:response to lipopolysaccharide; P:response to muscle stretch; P:response to progesterone; P:response to toxic substance; P:skeletal muscle cell differentiation; P:sleep; P:SMAD protein signal transduction; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; scaffold90 indexed_genome mRNA 1915529 1948352 . + . ID=transcript_12467;P49755 B2R605 Q15602 Q16536 Q86TC2 Q86TS5,Transmembrane emp24 domain-containing protein 10,21 kDa transmembrane-trafficking protein;S31I125;S31III125;Tmp-21-I;Transmembrane protein Tmp21;p23;p24 family protein delta-1;p24delta;, PF01105;, GO:0005801;GO:0030137;GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0070765;GO:0005794;GO:0000139;GO:0016021;GO:0042470;GO:0005886;GO:0030667;GO:0030140;GO:0030133;GO:0042589;GO:0008320;GO:0044877;GO:0019905;GO:0048205;GO:0035964;GO:0048208;GO:0106273;GO:0006888;GO:0007030;GO:0006886;GO:0001822;GO:1902960;GO:0032732;GO:0050714;GO:0106272;GO:0045055;GO:1902003;GO:0043279;GO:0006890;GO:0035459;GO:0048199;, C:cis-Golgi network; C:COPI-coated vesicle; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:melanosome; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network transport vesicle; C:transport vesicle; C:zymogen granule membrane;, F:protein transmembrane transporter activity; F:protein-containing complex binding; F:syntaxin binding;, P:COPI coating of Golgi vesicle; P:COPI-coated vesicle budding; P:COPII vesicle coating; P:cytosol to ERGIC protein transport; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:kidney development; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of interleukin-1 production; P:positive regulation of protein secretion; P:protein localization to ERGIC; P:regulated exocytosis; P:regulation of amyloid-beta formation; P:response to alkaloid; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle cargo loading; P:vesicle targeting, to, from or within Golgi; scaffold90 indexed_genome mRNA 1953937 1995713 . - . ID=transcript_12468;Q8TD19 Q52LK6 Q8NCN0 Q8TCY4 Q9UPI4 Q9Y6S4 Q9Y6S5 Q9Y6S6,Serine/threonine-protein kinase Nek9,Nercc1 kinase;Never in mitosis A-related kinase 9;NimA-related kinase 8;, PF00069;PF00415;, GO:0005829;GO:0005634;GO:0005524;GO:0046872;GO:0019901;GO:0106310;GO:0106311;GO:0051301;GO:0007077;GO:0007052;, C:cytosol; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:mitotic nuclear envelope disassembly; P:mitotic spindle organization;|Q8TD19 Q52LK6 Q8NCN0 Q8TCY4 Q9UPI4 Q9Y6S4 Q9Y6S5 Q9Y6S6,Serine/threonine-protein kinase Nek9,Nercc1 kinase;Never in mitosis A-related kinase 9;NimA-related kinase 8;, PF00069;PF00415;, GO:0005829;GO:0005634;GO:0005524;GO:0046872;GO:0019901;GO:0106310;GO:0106311;GO:0051301;GO:0007077;GO:0007052;, C:cytosol; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:mitotic nuclear envelope disassembly; P:mitotic spindle organization;|Q8TD19 Q52LK6 Q8NCN0 Q8TCY4 Q9UPI4 Q9Y6S4 Q9Y6S5 Q9Y6S6,Serine/threonine-protein kinase Nek9,Nercc1 kinase;Never in mitosis A-related kinase 9;NimA-related kinase 8;, PF00069;PF00415;, GO:0005829;GO:0005634;GO:0005524;GO:0046872;GO:0019901;GO:0106310;GO:0106311;GO:0051301;GO:0007077;GO:0007052;, C:cytosol; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:mitotic nuclear envelope disassembly; P:mitotic spindle organization;|Q8TD19 Q52LK6 Q8NCN0 Q8TCY4 Q9UPI4 Q9Y6S4 Q9Y6S5 Q9Y6S6,Serine/threonine-protein kinase Nek9,Nercc1 kinase;Never in mitosis A-related kinase 9;NimA-related kinase 8;, PF00069;PF00415;, GO:0005829;GO:0005634;GO:0005524;GO:0046872;GO:0019901;GO:0106310;GO:0106311;GO:0051301;GO:0007077;GO:0007052;, C:cytosol; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:mitotic nuclear envelope disassembly; P:mitotic spindle organization;|Q8TD19 Q52LK6 Q8NCN0 Q8TCY4 Q9UPI4 Q9Y6S4 Q9Y6S5 Q9Y6S6,Serine/threonine-protein kinase Nek9,Nercc1 kinase;Never in mitosis A-related kinase 9;NimA-related kinase 8;, PF00069;PF00415;, GO:0005829;GO:0005634;GO:0005524;GO:0046872;GO:0019901;GO:0106310;GO:0106311;GO:0051301;GO:0007077;GO:0007052;, C:cytosol; C:nucleus;, F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:mitotic nuclear envelope disassembly; P:mitotic spindle organization; scaffold90 indexed_genome mRNA 1997746 2007272 . - . ID=transcript_12469;Q53FD0 E9PJQ0 Q9BTA8 Q9H5S9,Zinc finger C2HC domain-containing protein 1C,, , GO:0046872;, , F:metal ion binding; scaffold90 indexed_genome mRNA 2017005 2019498 . + . ID=transcript_12470;P07311 A6NDV8 B2R590,Acylphosphatase-1,Acylphosphatase, erythrocyte isozyme;Acylphosphatase, organ-common type isozyme;Acylphosphate phosphohydrolase 1;, PF00708;, GO:0003998;GO:0006796;, , F:acylphosphatase activity;, P:phosphate-containing compound metabolic process; scaffold90 indexed_genome mRNA 2026432 2029740 . + . ID=transcript_12471;Q9UHC1 P49751 Q56DK9 Q9P292 Q9UHC0,DNA mismatch repair protein Mlh3,MutL protein homolog 3;, PF01119;PF08676;, GO:0005712;GO:0001673;GO:0032300;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0019237;GO:0003682;GO:0030983;GO:0003696;GO:0007144;GO:0007140;GO:0006298;GO:0008104;GO:0007131;GO:0007130;, C:chiasma; C:male germ cell nucleus; C:mismatch repair complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:centromeric DNA binding; F:chromatin binding; F:mismatched DNA binding; F:satellite DNA binding;, P:female meiosis I; P:male meiotic nuclear division; P:mismatch repair; P:protein localization; P:reciprocal meiotic recombination; P:synaptonemal complex assembly; scaffold90 indexed_genome mRNA 2029748 2052342 . + . ID=transcript_12472;Q9UHC1 P49751 Q56DK9 Q9P292 Q9UHC0,DNA mismatch repair protein Mlh3,MutL protein homolog 3;, PF01119;PF08676;, GO:0005712;GO:0001673;GO:0032300;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0019237;GO:0003682;GO:0030983;GO:0003696;GO:0007144;GO:0007140;GO:0006298;GO:0008104;GO:0007131;GO:0007130;, C:chiasma; C:male germ cell nucleus; C:mismatch repair complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:centromeric DNA binding; F:chromatin binding; F:mismatched DNA binding; F:satellite DNA binding;, P:female meiosis I; P:male meiotic nuclear division; P:mismatch repair; P:protein localization; P:reciprocal meiotic recombination; P:synaptonemal complex assembly;|Q9UHC1 P49751 Q56DK9 Q9P292 Q9UHC0,DNA mismatch repair protein Mlh3,MutL protein homolog 3;, PF01119;PF08676;, GO:0005712;GO:0001673;GO:0032300;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0019237;GO:0003682;GO:0030983;GO:0003696;GO:0007144;GO:0007140;GO:0006298;GO:0008104;GO:0007131;GO:0007130;, C:chiasma; C:male germ cell nucleus; C:mismatch repair complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:centromeric DNA binding; F:chromatin binding; F:mismatched DNA binding; F:satellite DNA binding;, P:female meiosis I; P:male meiotic nuclear division; P:mismatch repair; P:protein localization; P:reciprocal meiotic recombination; P:synaptonemal complex assembly;|Q9UHC1 P49751 Q56DK9 Q9P292 Q9UHC0,DNA mismatch repair protein Mlh3,MutL protein homolog 3;, PF01119;PF08676;, GO:0005712;GO:0001673;GO:0032300;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0019237;GO:0003682;GO:0030983;GO:0003696;GO:0007144;GO:0007140;GO:0006298;GO:0008104;GO:0007131;GO:0007130;, C:chiasma; C:male germ cell nucleus; C:mismatch repair complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:centromeric DNA binding; F:chromatin binding; F:mismatched DNA binding; F:satellite DNA binding;, P:female meiosis I; P:male meiotic nuclear division; P:mismatch repair; P:protein localization; P:reciprocal meiotic recombination; P:synaptonemal complex assembly;|Q9UHC1 P49751 Q56DK9 Q9P292 Q9UHC0,DNA mismatch repair protein Mlh3,MutL protein homolog 3;, PF01119;PF08676;, GO:0005712;GO:0001673;GO:0032300;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0019237;GO:0003682;GO:0030983;GO:0003696;GO:0007144;GO:0007140;GO:0006298;GO:0008104;GO:0007131;GO:0007130;, C:chiasma; C:male germ cell nucleus; C:mismatch repair complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:centromeric DNA binding; F:chromatin binding; F:mismatched DNA binding; F:satellite DNA binding;, P:female meiosis I; P:male meiotic nuclear division; P:mismatch repair; P:protein localization; P:reciprocal meiotic recombination; P:synaptonemal complex assembly;|Q9UHC1 P49751 Q56DK9 Q9P292 Q9UHC0,DNA mismatch repair protein Mlh3,MutL protein homolog 3;, PF01119;PF08676;, GO:0005712;GO:0001673;GO:0032300;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0019237;GO:0003682;GO:0030983;GO:0003696;GO:0007144;GO:0007140;GO:0006298;GO:0008104;GO:0007131;GO:0007130;, C:chiasma; C:male germ cell nucleus; C:mismatch repair complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:centromeric DNA binding; F:chromatin binding; F:mismatched DNA binding; F:satellite DNA binding;, P:female meiosis I; P:male meiotic nuclear division; P:mismatch repair; P:protein localization; P:reciprocal meiotic recombination; P:synaptonemal complex assembly;|Q9UHC1 P49751 Q56DK9 Q9P292 Q9UHC0,DNA mismatch repair protein Mlh3,MutL protein homolog 3;, PF01119;PF08676;, GO:0005712;GO:0001673;GO:0032300;GO:0005654;GO:0005634;GO:0000795;GO:0005524;GO:0016887;GO:0019237;GO:0003682;GO:0030983;GO:0003696;GO:0007144;GO:0007140;GO:0006298;GO:0008104;GO:0007131;GO:0007130;, C:chiasma; C:male germ cell nucleus; C:mismatch repair complex; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:ATP binding; F:ATPase activity; F:centromeric DNA binding; F:chromatin binding; F:mismatched DNA binding; F:satellite DNA binding;, P:female meiosis I; P:male meiotic nuclear division; P:mismatch repair; P:protein localization; P:reciprocal meiotic recombination; P:synaptonemal complex assembly; scaffold90 indexed_genome mRNA 2052882 2054146 . - . ID=transcript_12473;Q9H1K1 Q6P713 Q99617 Q9H1K2,Iron-sulfur cluster assembly enzyme ISCU, mitochondrial,NifU-like N-terminal domain-containing protein;NifU-like protein;, PF01592;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005634;GO:0051537;GO:0051539;GO:0008198;GO:0005506;GO:0060090;GO:0006879;GO:0016226;GO:1904439;GO:1904234;GO:1902958;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:ferrous iron binding; F:iron ion binding; F:molecular adaptor activity;, P:cellular iron ion homeostasis; P:iron-sulfur cluster assembly; P:negative regulation of iron ion import across plasma membrane; P:positive regulation of aconitate hydratase activity; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; scaffold90 indexed_genome mRNA 2060146 2068066 . - . ID=transcript_12474;P49770 O43201,Translation initiation factor eIF-2B subunit beta,S20I15;S20III15;eIF-2B GDP-GTP exchange factor subunit beta;, PF01008;, GO:0005737;GO:0005829;GO:0005851;GO:0005524;GO:0005525;GO:0003743;GO:0007417;GO:0042552;GO:0014003;GO:0001541;GO:0050790;GO:0006446;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex;, F:ATP binding; F:GTP binding; F:translation initiation factor activity;, P:central nervous system development; P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:regulation of catalytic activity; P:regulation of translational initiation; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|P49770 O43201,Translation initiation factor eIF-2B subunit beta,S20I15;S20III15;eIF-2B GDP-GTP exchange factor subunit beta;, PF01008;, GO:0005737;GO:0005829;GO:0005851;GO:0005524;GO:0005525;GO:0003743;GO:0007417;GO:0042552;GO:0014003;GO:0001541;GO:0050790;GO:0006446;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex;, F:ATP binding; F:GTP binding; F:translation initiation factor activity;, P:central nervous system development; P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:regulation of catalytic activity; P:regulation of translational initiation; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|P49770 O43201,Translation initiation factor eIF-2B subunit beta,S20I15;S20III15;eIF-2B GDP-GTP exchange factor subunit beta;, PF01008;, GO:0005737;GO:0005829;GO:0005851;GO:0005524;GO:0005525;GO:0003743;GO:0007417;GO:0042552;GO:0014003;GO:0001541;GO:0050790;GO:0006446;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex;, F:ATP binding; F:GTP binding; F:translation initiation factor activity;, P:central nervous system development; P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:regulation of catalytic activity; P:regulation of translational initiation; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation;|P49770 O43201,Translation initiation factor eIF-2B subunit beta,S20I15;S20III15;eIF-2B GDP-GTP exchange factor subunit beta;, PF01008;, GO:0005737;GO:0005829;GO:0005851;GO:0005524;GO:0005525;GO:0003743;GO:0007417;GO:0042552;GO:0014003;GO:0001541;GO:0050790;GO:0006446;GO:0009749;GO:0009408;GO:0043434;GO:0050852;GO:0006413;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2B complex;, F:ATP binding; F:GTP binding; F:translation initiation factor activity;, P:central nervous system development; P:myelination; P:oligodendrocyte development; P:ovarian follicle development; P:regulation of catalytic activity; P:regulation of translational initiation; P:response to glucose; P:response to heat; P:response to peptide hormone; P:T cell receptor signaling pathway; P:translational initiation; scaffold90 indexed_genome mRNA 2107131 2114360 . + . ID=transcript_12475;P49763 Q07101 Q9BV78 Q9Y6S8,Placenta growth factor,, PF00341;, GO:0005576;GO:0005615;GO:0016020;GO:0042056;GO:0008083;GO:0008201;GO:0005172;GO:0030154;GO:0007267;GO:0050930;GO:0045766;GO:0051781;GO:0008284;GO:0001938;GO:0060754;GO:0001934;GO:0001666;GO:0007165;GO:0002040;GO:0048010;GO:0038084;, C:extracellular region; C:extracellular space; C:membrane;, F:chemoattractant activity; F:growth factor activity; F:heparin binding; F:vascular endothelial growth factor receptor binding;, P:cell differentiation; P:cell-cell signaling; P:induction of positive chemotaxis; P:positive regulation of angiogenesis; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell proliferation; P:positive regulation of mast cell chemotaxis; P:positive regulation of protein phosphorylation; P:response to hypoxia; P:signal transduction; P:sprouting angiogenesis; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor signaling pathway; scaffold90 indexed_genome mRNA 2145095 2149972 . + . ID=transcript_12476;Q9Y6S9 A6NGM9 Q69YT9 Q6ZMQ6 Q96NR9 Q9BSU9,Ribosomal protein S6 kinase-like 1,, PF04212;PF00069;, GO:0005840;GO:0005524;GO:0106310;GO:0106311;, C:ribosome;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;|Q9Y6S9 A6NGM9 Q69YT9 Q6ZMQ6 Q96NR9 Q9BSU9,Ribosomal protein S6 kinase-like 1,, PF04212;PF00069;, GO:0005840;GO:0005524;GO:0106310;GO:0106311;, C:ribosome;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity; scaffold90 indexed_genome mRNA 2155001 2161109 . + . ID=transcript_12477;Q9Y6S9 A6NGM9 Q69YT9 Q6ZMQ6 Q96NR9 Q9BSU9,Ribosomal protein S6 kinase-like 1,, PF04212;PF00069;, GO:0005840;GO:0005524;GO:0106310;GO:0106311;, C:ribosome;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;|Q9Y6S9 A6NGM9 Q69YT9 Q6ZMQ6 Q96NR9 Q9BSU9,Ribosomal protein S6 kinase-like 1,, PF04212;PF00069;, GO:0005840;GO:0005524;GO:0106310;GO:0106311;, C:ribosome;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity; scaffold90 indexed_genome mRNA 2162244 2182150 . - . ID=transcript_12478;P36957 B7Z5W8 E7ESY5 Q7LDY7 Q9BQ32,Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial,2-oxoglutarate dehydrogenase complex component E2;Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex;E2K;, PF00198;PF00364;, GO:0034451;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0045252;GO:0004149;GO:0016746;GO:0006103;GO:0006091;GO:0106077;GO:0033512;GO:0006554;GO:0006104;GO:0006099;, C:centriolar satellite; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:oxoglutarate dehydrogenase complex;, F:dihydrolipoyllysine-residue succinyltransferase activity; F:transferase activity, transferring acyl groups;, P:2-oxoglutarate metabolic process; P:generation of precursor metabolites and energy; P:histone succinylation; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle;|P36957 B7Z5W8 E7ESY5 Q7LDY7 Q9BQ32,Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial,2-oxoglutarate dehydrogenase complex component E2;Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex;E2K;, PF00198;PF00364;, GO:0034451;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0045252;GO:0004149;GO:0016746;GO:0006103;GO:0006091;GO:0106077;GO:0033512;GO:0006554;GO:0006104;GO:0006099;, C:centriolar satellite; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:oxoglutarate dehydrogenase complex;, F:dihydrolipoyllysine-residue succinyltransferase activity; F:transferase activity, transferring acyl groups;, P:2-oxoglutarate metabolic process; P:generation of precursor metabolites and energy; P:histone succinylation; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle;|P36957 B7Z5W8 E7ESY5 Q7LDY7 Q9BQ32,Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial,2-oxoglutarate dehydrogenase complex component E2;Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex;E2K;, PF00198;PF00364;, GO:0034451;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0045252;GO:0004149;GO:0016746;GO:0006103;GO:0006091;GO:0106077;GO:0033512;GO:0006554;GO:0006104;GO:0006099;, C:centriolar satellite; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:oxoglutarate dehydrogenase complex;, F:dihydrolipoyllysine-residue succinyltransferase activity; F:transferase activity, transferring acyl groups;, P:2-oxoglutarate metabolic process; P:generation of precursor metabolites and energy; P:histone succinylation; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle;|P36957 B7Z5W8 E7ESY5 Q7LDY7 Q9BQ32,Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial,2-oxoglutarate dehydrogenase complex component E2;Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex;E2K;, PF00198;PF00364;, GO:0034451;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0045252;GO:0004149;GO:0016746;GO:0006103;GO:0006091;GO:0106077;GO:0033512;GO:0006554;GO:0006104;GO:0006099;, C:centriolar satellite; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:oxoglutarate dehydrogenase complex;, F:dihydrolipoyllysine-residue succinyltransferase activity; F:transferase activity, transferring acyl groups;, P:2-oxoglutarate metabolic process; P:generation of precursor metabolites and energy; P:histone succinylation; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle;|P36957 B7Z5W8 E7ESY5 Q7LDY7 Q9BQ32,Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial,2-oxoglutarate dehydrogenase complex component E2;Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex;E2K;, PF00198;PF00364;, GO:0034451;GO:0005829;GO:0016020;GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0045252;GO:0004149;GO:0016746;GO:0006103;GO:0006091;GO:0106077;GO:0033512;GO:0006554;GO:0006104;GO:0006099;, C:centriolar satellite; C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:oxoglutarate dehydrogenase complex;, F:dihydrolipoyllysine-residue succinyltransferase activity; F:transferase activity, transferring acyl groups;, P:2-oxoglutarate metabolic process; P:generation of precursor metabolites and energy; P:histone succinylation; P:L-lysine catabolic process to acetyl-CoA via saccharopine; P:lysine catabolic process; P:succinyl-CoA metabolic process; P:tricarboxylic acid cycle; scaffold90 indexed_genome mRNA 2206827 2207469 . - . ID=transcript_12479;Q3B8N5 C9J5W1 Q8N9Q3,Prospero homeobox protein 2,Homeobox prospero-like protein PROX2;, PF05044;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold90 indexed_genome mRNA 2231579 2240912 . - . ID=transcript_12480;P49750 P49752 Q96I64 Q9P1V7,YLP motif-containing protein 1,Nuclear protein ZAP3;ZAP113;, , GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0032204;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:regulation of telomere maintenance;|P49750 P49752 Q96I64 Q9P1V7,YLP motif-containing protein 1,Nuclear protein ZAP3;ZAP113;, , GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0032204;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:regulation of telomere maintenance;|P49750 P49752 Q96I64 Q9P1V7,YLP motif-containing protein 1,Nuclear protein ZAP3;ZAP113;, , GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0032204;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:regulation of telomere maintenance;|P49750 P49752 Q96I64 Q9P1V7,YLP motif-containing protein 1,Nuclear protein ZAP3;ZAP113;, , GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0032204;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:regulation of telomere maintenance; scaffold90 indexed_genome mRNA 2244921 2294337 . - . ID=transcript_12481;P49750 P49752 Q96I64 Q9P1V7,YLP motif-containing protein 1,Nuclear protein ZAP3;ZAP113;, , GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0032204;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:regulation of telomere maintenance; scaffold90 indexed_genome mRNA 2318982 2329393 . - . ID=transcript_12482;Q9Y324 Q86TW8 Q8TBL8,rRNA-processing protein FCF1 homolog,, PF04900;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing;|Q9Y324 Q86TW8 Q8TBL8,rRNA-processing protein FCF1 homolog,, PF04900;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing;|Q9Y324 Q86TW8 Q8TBL8,rRNA-processing protein FCF1 homolog,, PF04900;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing;|Q9Y324 Q86TW8 Q8TBL8,rRNA-processing protein FCF1 homolog,, PF04900;, GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing; scaffold90 indexed_genome mRNA 2329486 2370533 . + . ID=transcript_12483;O15033 B4E2C7 Q7LDY1 Q8IYY9,Apoptosis-resistant E3 ubiquitin protein ligase 1,Apoptosis-resistant HECT-type E3 ubiquitin transferase 1;, PF00630;PF00632;, GO:0005737;GO:0005829;GO:0061630;GO:0004842;GO:0006915;GO:0043066;GO:0045732;GO:0043161;GO:0000209;GO:0016567;GO:0050727;GO:0006511;, C:cytoplasm; C:cytosol;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:positive regulation of protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of inflammatory response; P:ubiquitin-dependent protein catabolic process; scaffold90 indexed_genome mRNA 2416097 2524400 . + . ID=transcript_12484;Q14767 Q99907 Q9NS51,Latent-transforming growth factor beta-binding protein 2,, PF00008;PF07645;PF00683;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005509;GO:0019838;GO:0008201;GO:0050436;GO:0009306;GO:0006605;GO:0097435;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:growth factor binding; F:heparin binding; F:microfibril binding;, P:protein secretion; P:protein targeting; P:supramolecular fiber organization; P:transforming growth factor beta receptor signaling pathway;|Q14767 Q99907 Q9NS51,Latent-transforming growth factor beta-binding protein 2,, PF00008;PF07645;PF00683;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005509;GO:0019838;GO:0008201;GO:0050436;GO:0009306;GO:0006605;GO:0097435;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:growth factor binding; F:heparin binding; F:microfibril binding;, P:protein secretion; P:protein targeting; P:supramolecular fiber organization; P:transforming growth factor beta receptor signaling pathway; scaffold90 indexed_genome mRNA 2524416 2526866 . - . ID=transcript_12485;Q86U28 A6NFF1 A8K3W3 G3V291 Q8IYZ0 Q96BB2,Iron-sulfur cluster assembly 2 homolog, mitochondrial,HESB-like domain-containing protein 1;, PF01521;, GO:0005759;GO:0005739;GO:0051537;GO:0051539;GO:0005506;GO:0016226;GO:0106035;, C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:iron ion binding;, P:iron-sulfur cluster assembly; P:protein maturation by [4Fe-4S] cluster transfer;|Q86U28 A6NFF1 A8K3W3 G3V291 Q8IYZ0 Q96BB2,Iron-sulfur cluster assembly 2 homolog, mitochondrial,HESB-like domain-containing protein 1;, PF01521;, GO:0005759;GO:0005739;GO:0051537;GO:0051539;GO:0005506;GO:0016226;GO:0106035;, C:mitochondrial matrix; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:iron ion binding;, P:iron-sulfur cluster assembly; P:protein maturation by [4Fe-4S] cluster transfer; scaffold90 indexed_genome mRNA 2527139 2536060 . + . ID=transcript_12486;P61916 B4DQV7 Q15668 Q29413,NPC intracellular cholesterol transporter 2 {ECO:0000312|HGNC:HGNC:14537},Epididymal secretory protein E1;Human epididymis-specific protein 1;Niemann-Pick disease type C2 protein {ECO:0000303|PubMed:17018531};, PF02221;, GO:0035578;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0043202;GO:0005764;GO:0015485;GO:0120020;GO:0019899;GO:0032934;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0046836;GO:0032367;GO:0032366;GO:0034383;GO:0043312;GO:0015914;GO:0019747;GO:0009615;GO:0015918;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal lumen; C:lysosome;, F:cholesterol binding; F:cholesterol transfer activity; F:enzyme binding; F:sterol binding;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:glycolipid transport; P:intracellular cholesterol transport; P:intracellular sterol transport; P:low-density lipoprotein particle clearance; P:neutrophil degranulation; P:phospholipid transport; P:regulation of isoprenoid metabolic process; P:response to virus; P:sterol transport;|P61916 B4DQV7 Q15668 Q29413,NPC intracellular cholesterol transporter 2 {ECO:0000312|HGNC:HGNC:14537},Epididymal secretory protein E1;Human epididymis-specific protein 1;Niemann-Pick disease type C2 protein {ECO:0000303|PubMed:17018531};, PF02221;, GO:0035578;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0043202;GO:0005764;GO:0015485;GO:0120020;GO:0019899;GO:0032934;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0046836;GO:0032367;GO:0032366;GO:0034383;GO:0043312;GO:0015914;GO:0019747;GO:0009615;GO:0015918;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal lumen; C:lysosome;, F:cholesterol binding; F:cholesterol transfer activity; F:enzyme binding; F:sterol binding;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:glycolipid transport; P:intracellular cholesterol transport; P:intracellular sterol transport; P:low-density lipoprotein particle clearance; P:neutrophil degranulation; P:phospholipid transport; P:regulation of isoprenoid metabolic process; P:response to virus; P:sterol transport;|P61916 B4DQV7 Q15668 Q29413,NPC intracellular cholesterol transporter 2 {ECO:0000312|HGNC:HGNC:14537},Epididymal secretory protein E1;Human epididymis-specific protein 1;Niemann-Pick disease type C2 protein {ECO:0000303|PubMed:17018531};, PF02221;, GO:0035578;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0043202;GO:0005764;GO:0015485;GO:0120020;GO:0019899;GO:0032934;GO:0033344;GO:0042632;GO:0008203;GO:0030301;GO:0046836;GO:0032367;GO:0032366;GO:0034383;GO:0043312;GO:0015914;GO:0019747;GO:0009615;GO:0015918;, C:azurophil granule lumen; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:lysosomal lumen; C:lysosome;, F:cholesterol binding; F:cholesterol transfer activity; F:enzyme binding; F:sterol binding;, P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:cholesterol transport; P:glycolipid transport; P:intracellular cholesterol transport; P:intracellular sterol transport; P:low-density lipoprotein particle clearance; P:neutrophil degranulation; P:phospholipid transport; P:regulation of isoprenoid metabolic process; P:response to virus; P:sterol transport; scaffold90 indexed_genome mRNA 2668132 2701581 . + . ID=transcript_12487;O14678 A8K5L7 Q6IAQ0 Q96E75,Lysosomal cobalamin transporter ABCD4 {ECO:0000305|PubMed:27456980},ATP-binding cassette sub-family D member 4 {ECO:0000312|HGNC:HGNC:68};PMP70-related protein;Peroxisomal membrane protein 1-like;Peroxisomal membrane protein 69;, PF06472;PF00005;, GO:0043190;GO:0005789;GO:0016021;GO:0005765;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:1990830;GO:0009235;GO:0006635;GO:0015910;GO:0007031;GO:0055085;GO:0042760;, C:ATP-binding cassette (ABC) transporter complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lysosomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity;, P:cellular response to leukemia inhibitory factor; P:cobalamin metabolic process; P:fatty acid beta-oxidation; P:long-chain fatty acid import into peroxisome; P:peroxisome organization; P:transmembrane transport; P:very long-chain fatty acid catabolic process;|O14678 A8K5L7 Q6IAQ0 Q96E75,Lysosomal cobalamin transporter ABCD4 {ECO:0000305|PubMed:27456980},ATP-binding cassette sub-family D member 4 {ECO:0000312|HGNC:HGNC:68};PMP70-related protein;Peroxisomal membrane protein 1-like;Peroxisomal membrane protein 69;, PF06472;PF00005;, GO:0043190;GO:0005789;GO:0016021;GO:0005765;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:1990830;GO:0009235;GO:0006635;GO:0015910;GO:0007031;GO:0055085;GO:0042760;, C:ATP-binding cassette (ABC) transporter complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lysosomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity;, P:cellular response to leukemia inhibitory factor; P:cobalamin metabolic process; P:fatty acid beta-oxidation; P:long-chain fatty acid import into peroxisome; P:peroxisome organization; P:transmembrane transport; P:very long-chain fatty acid catabolic process;|O14678 A8K5L7 Q6IAQ0 Q96E75,Lysosomal cobalamin transporter ABCD4 {ECO:0000305|PubMed:27456980},ATP-binding cassette sub-family D member 4 {ECO:0000312|HGNC:HGNC:68};PMP70-related protein;Peroxisomal membrane protein 1-like;Peroxisomal membrane protein 69;, PF06472;PF00005;, GO:0043190;GO:0005789;GO:0016021;GO:0005765;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:1990830;GO:0009235;GO:0006635;GO:0015910;GO:0007031;GO:0055085;GO:0042760;, C:ATP-binding cassette (ABC) transporter complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lysosomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity;, P:cellular response to leukemia inhibitory factor; P:cobalamin metabolic process; P:fatty acid beta-oxidation; P:long-chain fatty acid import into peroxisome; P:peroxisome organization; P:transmembrane transport; P:very long-chain fatty acid catabolic process;|O14678 A8K5L7 Q6IAQ0 Q96E75,Lysosomal cobalamin transporter ABCD4 {ECO:0000305|PubMed:27456980},ATP-binding cassette sub-family D member 4 {ECO:0000312|HGNC:HGNC:68};PMP70-related protein;Peroxisomal membrane protein 1-like;Peroxisomal membrane protein 69;, PF06472;PF00005;, GO:0043190;GO:0005789;GO:0016021;GO:0005765;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:1990830;GO:0009235;GO:0006635;GO:0015910;GO:0007031;GO:0055085;GO:0042760;, C:ATP-binding cassette (ABC) transporter complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lysosomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity;, P:cellular response to leukemia inhibitory factor; P:cobalamin metabolic process; P:fatty acid beta-oxidation; P:long-chain fatty acid import into peroxisome; P:peroxisome organization; P:transmembrane transport; P:very long-chain fatty acid catabolic process;|O14678 A8K5L7 Q6IAQ0 Q96E75,Lysosomal cobalamin transporter ABCD4 {ECO:0000305|PubMed:27456980},ATP-binding cassette sub-family D member 4 {ECO:0000312|HGNC:HGNC:68};PMP70-related protein;Peroxisomal membrane protein 1-like;Peroxisomal membrane protein 69;, PF06472;PF00005;, GO:0043190;GO:0005789;GO:0016021;GO:0005765;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:1990830;GO:0009235;GO:0006635;GO:0015910;GO:0007031;GO:0055085;GO:0042760;, C:ATP-binding cassette (ABC) transporter complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lysosomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity;, P:cellular response to leukemia inhibitory factor; P:cobalamin metabolic process; P:fatty acid beta-oxidation; P:long-chain fatty acid import into peroxisome; P:peroxisome organization; P:transmembrane transport; P:very long-chain fatty acid catabolic process;|O14678 A8K5L7 Q6IAQ0 Q96E75,Lysosomal cobalamin transporter ABCD4 {ECO:0000305|PubMed:27456980},ATP-binding cassette sub-family D member 4 {ECO:0000312|HGNC:HGNC:68};PMP70-related protein;Peroxisomal membrane protein 1-like;Peroxisomal membrane protein 69;, PF06472;PF00005;, GO:0043190;GO:0005789;GO:0016021;GO:0005765;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:1990830;GO:0009235;GO:0006635;GO:0015910;GO:0007031;GO:0055085;GO:0042760;, C:ATP-binding cassette (ABC) transporter complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lysosomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity;, P:cellular response to leukemia inhibitory factor; P:cobalamin metabolic process; P:fatty acid beta-oxidation; P:long-chain fatty acid import into peroxisome; P:peroxisome organization; P:transmembrane transport; P:very long-chain fatty acid catabolic process;|O14678 A8K5L7 Q6IAQ0 Q96E75,Lysosomal cobalamin transporter ABCD4 {ECO:0000305|PubMed:27456980},ATP-binding cassette sub-family D member 4 {ECO:0000312|HGNC:HGNC:68};PMP70-related protein;Peroxisomal membrane protein 1-like;Peroxisomal membrane protein 69;, PF06472;PF00005;, GO:0043190;GO:0005789;GO:0016021;GO:0005765;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:1990830;GO:0009235;GO:0006635;GO:0015910;GO:0007031;GO:0055085;GO:0042760;, C:ATP-binding cassette (ABC) transporter complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lysosomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity;, P:cellular response to leukemia inhibitory factor; P:cobalamin metabolic process; P:fatty acid beta-oxidation; P:long-chain fatty acid import into peroxisome; P:peroxisome organization; P:transmembrane transport; P:very long-chain fatty acid catabolic process;|O14678 A8K5L7 Q6IAQ0 Q96E75,Lysosomal cobalamin transporter ABCD4 {ECO:0000305|PubMed:27456980},ATP-binding cassette sub-family D member 4 {ECO:0000312|HGNC:HGNC:68};PMP70-related protein;Peroxisomal membrane protein 1-like;Peroxisomal membrane protein 69;, PF06472;PF00005;, GO:0043190;GO:0005789;GO:0016021;GO:0005765;GO:0005778;GO:0005777;GO:0005524;GO:0016887;GO:0042626;GO:0005324;GO:1990830;GO:0009235;GO:0006635;GO:0015910;GO:0007031;GO:0055085;GO:0042760;, C:ATP-binding cassette (ABC) transporter complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lysosomal membrane; C:peroxisomal membrane; C:peroxisome;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:long-chain fatty acid transporter activity;, P:cellular response to leukemia inhibitory factor; P:cobalamin metabolic process; P:fatty acid beta-oxidation; P:long-chain fatty acid import into peroxisome; P:peroxisome organization; P:transmembrane transport; P:very long-chain fatty acid catabolic process; scaffold90 indexed_genome mRNA 2754983 2867429 . - . ID=transcript_12488;Q52LA3,Protein lin-52 homolog,, PF10044;, GO:0070176;GO:0005654;GO:0051726;GO:0006351;, C:DRM complex; C:nucleoplasm;, , P:regulation of cell cycle; P:transcription, DNA-templated; scaffold90 indexed_genome mRNA 2867702 2915378 . + . ID=transcript_12489;Q02252 B2R609 B4DFS8 J3KNU8 Q9UKM8,Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial,Aldehyde dehydrogenase family 6 member A1;, PF00171;, GO:0005759;GO:0005739;GO:0005654;GO:0000062;GO:0018478;GO:0102662;GO:0004491;GO:0003723;GO:0009083;GO:0050873;GO:0006210;GO:0019859;GO:0006574;GO:0006573;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:fatty-acyl-CoA binding; F:malonate-semialdehyde dehydrogenase (acetylating) activity; F:malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity; F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; F:RNA binding;, P:branched-chain amino acid catabolic process; P:brown fat cell differentiation; P:thymine catabolic process; P:thymine metabolic process; P:valine catabolic process; P:valine metabolic process;|Q02252 B2R609 B4DFS8 J3KNU8 Q9UKM8,Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial,Aldehyde dehydrogenase family 6 member A1;, PF00171;, GO:0005759;GO:0005739;GO:0005654;GO:0000062;GO:0018478;GO:0102662;GO:0004491;GO:0003723;GO:0009083;GO:0050873;GO:0006210;GO:0019859;GO:0006574;GO:0006573;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:fatty-acyl-CoA binding; F:malonate-semialdehyde dehydrogenase (acetylating) activity; F:malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity; F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; F:RNA binding;, P:branched-chain amino acid catabolic process; P:brown fat cell differentiation; P:thymine catabolic process; P:thymine metabolic process; P:valine catabolic process; P:valine metabolic process;|Q02252 B2R609 B4DFS8 J3KNU8 Q9UKM8,Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial,Aldehyde dehydrogenase family 6 member A1;, PF00171;, GO:0005759;GO:0005739;GO:0005654;GO:0000062;GO:0018478;GO:0102662;GO:0004491;GO:0003723;GO:0009083;GO:0050873;GO:0006210;GO:0019859;GO:0006574;GO:0006573;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:fatty-acyl-CoA binding; F:malonate-semialdehyde dehydrogenase (acetylating) activity; F:malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity; F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; F:RNA binding;, P:branched-chain amino acid catabolic process; P:brown fat cell differentiation; P:thymine catabolic process; P:thymine metabolic process; P:valine catabolic process; P:valine metabolic process;|Q02252 B2R609 B4DFS8 J3KNU8 Q9UKM8,Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial,Aldehyde dehydrogenase family 6 member A1;, PF00171;, GO:0005759;GO:0005739;GO:0005654;GO:0000062;GO:0018478;GO:0102662;GO:0004491;GO:0003723;GO:0009083;GO:0050873;GO:0006210;GO:0019859;GO:0006574;GO:0006573;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:fatty-acyl-CoA binding; F:malonate-semialdehyde dehydrogenase (acetylating) activity; F:malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity; F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; F:RNA binding;, P:branched-chain amino acid catabolic process; P:brown fat cell differentiation; P:thymine catabolic process; P:thymine metabolic process; P:valine catabolic process; P:valine metabolic process;|Q02252 B2R609 B4DFS8 J3KNU8 Q9UKM8,Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial,Aldehyde dehydrogenase family 6 member A1;, PF00171;, GO:0005759;GO:0005739;GO:0005654;GO:0000062;GO:0018478;GO:0102662;GO:0004491;GO:0003723;GO:0009083;GO:0050873;GO:0006210;GO:0019859;GO:0006574;GO:0006573;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:fatty-acyl-CoA binding; F:malonate-semialdehyde dehydrogenase (acetylating) activity; F:malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity; F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; F:RNA binding;, P:branched-chain amino acid catabolic process; P:brown fat cell differentiation; P:thymine catabolic process; P:thymine metabolic process; P:valine catabolic process; P:valine metabolic process;|Q02252 B2R609 B4DFS8 J3KNU8 Q9UKM8,Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial,Aldehyde dehydrogenase family 6 member A1;, PF00171;, GO:0005759;GO:0005739;GO:0005654;GO:0000062;GO:0018478;GO:0102662;GO:0004491;GO:0003723;GO:0009083;GO:0050873;GO:0006210;GO:0019859;GO:0006574;GO:0006573;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:fatty-acyl-CoA binding; F:malonate-semialdehyde dehydrogenase (acetylating) activity; F:malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity; F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; F:RNA binding;, P:branched-chain amino acid catabolic process; P:brown fat cell differentiation; P:thymine catabolic process; P:thymine metabolic process; P:valine catabolic process; P:valine metabolic process;|Q8ND07 Q0P604 Q9H5P8,Basal body-orientation factor 1 {ECO:0000312|HGNC:HGNC:19855},Coiled-coil domain-containing protein 176;, PF14988;, GO:0036064;GO:0005737;GO:0044458;, C:ciliary basal body; C:cytoplasm;, , P:motile cilium assembly;|Q02252 B2R609 B4DFS8 J3KNU8 Q9UKM8,Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial,Aldehyde dehydrogenase family 6 member A1;, PF00171;, GO:0005759;GO:0005739;GO:0005654;GO:0000062;GO:0018478;GO:0102662;GO:0004491;GO:0003723;GO:0009083;GO:0050873;GO:0006210;GO:0019859;GO:0006574;GO:0006573;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:fatty-acyl-CoA binding; F:malonate-semialdehyde dehydrogenase (acetylating) activity; F:malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity; F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; F:RNA binding;, P:branched-chain amino acid catabolic process; P:brown fat cell differentiation; P:thymine catabolic process; P:thymine metabolic process; P:valine catabolic process; P:valine metabolic process;|Q8ND07 Q0P604 Q9H5P8,Basal body-orientation factor 1 {ECO:0000312|HGNC:HGNC:19855},Coiled-coil domain-containing protein 176;, PF14988;, GO:0036064;GO:0005737;GO:0044458;, C:ciliary basal body; C:cytoplasm;, , P:motile cilium assembly; scaffold90 indexed_genome mRNA 2929254 2968042 . + . ID=transcript_12490;O75356 A1L4C5 Q96RX0,Ectonucleoside triphosphate diphosphohydrolase 5,CD39 antigen-like 4;ER-UDPase;Guanosine-diphosphatase ENTPD5;Nucleoside diphosphatase;Uridine-diphosphatase ENTPD5;, PF01150;, GO:0005783;GO:0005576;GO:0016020;GO:0004382;GO:0017110;GO:0045134;GO:0051084;GO:0046034;GO:0034656;GO:0009134;GO:0045821;GO:0006487;GO:0035590;GO:0014066;, C:endoplasmic reticulum; C:extracellular region; C:membrane;, F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:uridine-diphosphatase activity;, P:'de novo' posttranslational protein folding; P:ATP metabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:positive regulation of glycolytic process; P:protein N-linked glycosylation; P:purinergic nucleotide receptor signaling pathway; P:regulation of phosphatidylinositol 3-kinase signaling;|O75356 A1L4C5 Q96RX0,Ectonucleoside triphosphate diphosphohydrolase 5,CD39 antigen-like 4;ER-UDPase;Guanosine-diphosphatase ENTPD5;Nucleoside diphosphatase;Uridine-diphosphatase ENTPD5;, PF01150;, GO:0005783;GO:0005576;GO:0016020;GO:0004382;GO:0017110;GO:0045134;GO:0051084;GO:0046034;GO:0034656;GO:0009134;GO:0045821;GO:0006487;GO:0035590;GO:0014066;, C:endoplasmic reticulum; C:extracellular region; C:membrane;, F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:uridine-diphosphatase activity;, P:'de novo' posttranslational protein folding; P:ATP metabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:positive regulation of glycolytic process; P:protein N-linked glycosylation; P:purinergic nucleotide receptor signaling pathway; P:regulation of phosphatidylinositol 3-kinase signaling;|O75356 A1L4C5 Q96RX0,Ectonucleoside triphosphate diphosphohydrolase 5,CD39 antigen-like 4;ER-UDPase;Guanosine-diphosphatase ENTPD5;Nucleoside diphosphatase;Uridine-diphosphatase ENTPD5;, PF01150;, GO:0005783;GO:0005576;GO:0016020;GO:0004382;GO:0017110;GO:0045134;GO:0051084;GO:0046034;GO:0034656;GO:0009134;GO:0045821;GO:0006487;GO:0035590;GO:0014066;, C:endoplasmic reticulum; C:extracellular region; C:membrane;, F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:uridine-diphosphatase activity;, P:'de novo' posttranslational protein folding; P:ATP metabolic process; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:positive regulation of glycolytic process; P:protein N-linked glycosylation; P:purinergic nucleotide receptor signaling pathway; P:regulation of phosphatidylinositol 3-kinase signaling;|Q9Y2Z9 B7Z3K8 Q53GG6 Q86U30 Q96CA1 Q96CK2,Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03193},Coenzyme Q10 monooxygenase 6 {ECO:0000255|HAMAP-Rule:MF_03193};, PF01494;, GO:0042995;GO:0031314;GO:0005794;GO:0005739;GO:0071949;GO:0016491;GO:0016709;GO:0016712;GO:0006744;, C:cell projection; C:extrinsic component of mitochondrial inner membrane; C:Golgi apparatus; C:mitochondrion;, F:FAD binding; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;, P:ubiquinone biosynthetic process;|Q9Y2Z9 B7Z3K8 Q53GG6 Q86U30 Q96CA1 Q96CK2,Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03193},Coenzyme Q10 monooxygenase 6 {ECO:0000255|HAMAP-Rule:MF_03193};, PF01494;, GO:0042995;GO:0031314;GO:0005794;GO:0005739;GO:0071949;GO:0016491;GO:0016709;GO:0016712;GO:0006744;, C:cell projection; C:extrinsic component of mitochondrial inner membrane; C:Golgi apparatus; C:mitochondrion;, F:FAD binding; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;, P:ubiquinone biosynthetic process;|Q9Y2Z9 B7Z3K8 Q53GG6 Q86U30 Q96CA1 Q96CK2,Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03193},Coenzyme Q10 monooxygenase 6 {ECO:0000255|HAMAP-Rule:MF_03193};, PF01494;, GO:0042995;GO:0031314;GO:0005794;GO:0005739;GO:0071949;GO:0016491;GO:0016709;GO:0016712;GO:0006744;, C:cell projection; C:extrinsic component of mitochondrial inner membrane; C:Golgi apparatus; C:mitochondrion;, F:FAD binding; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;, P:ubiquinone biosynthetic process;|Q9Y2Z9 B7Z3K8 Q53GG6 Q86U30 Q96CA1 Q96CK2,Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03193},Coenzyme Q10 monooxygenase 6 {ECO:0000255|HAMAP-Rule:MF_03193};, PF01494;, GO:0042995;GO:0031314;GO:0005794;GO:0005739;GO:0071949;GO:0016491;GO:0016709;GO:0016712;GO:0006744;, C:cell projection; C:extrinsic component of mitochondrial inner membrane; C:Golgi apparatus; C:mitochondrion;, F:FAD binding; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;, P:ubiquinone biosynthetic process;|Q9Y2Z9 B7Z3K8 Q53GG6 Q86U30 Q96CA1 Q96CK2,Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03193},Coenzyme Q10 monooxygenase 6 {ECO:0000255|HAMAP-Rule:MF_03193};, PF01494;, GO:0042995;GO:0031314;GO:0005794;GO:0005739;GO:0071949;GO:0016491;GO:0016709;GO:0016712;GO:0006744;, C:cell projection; C:extrinsic component of mitochondrial inner membrane; C:Golgi apparatus; C:mitochondrion;, F:FAD binding; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;, P:ubiquinone biosynthetic process; scaffold90 indexed_genome mRNA 2968273 2983106 . + . ID=transcript_12491;Q96MY7 B7Z882 J3KNA2,Protein FAM161B,, PF10595;, GO:0005881;GO:0015630;GO:0044782;, C:cytoplasmic microtubule; C:microtubule cytoskeleton;, , P:cilium organization;|Q96MY7 B7Z882 J3KNA2,Protein FAM161B,, PF10595;, GO:0005881;GO:0015630;GO:0044782;, C:cytoplasmic microtubule; C:microtubule cytoskeleton;, , P:cilium organization;|Q96MY7 B7Z882 J3KNA2,Protein FAM161B,, PF10595;, GO:0005881;GO:0015630;GO:0044782;, C:cytoplasmic microtubule; C:microtubule cytoskeleton;, , P:cilium organization; scaffold90 indexed_genome mRNA 2983418 3025716 . - . ID=transcript_12492;Q86VK4 B4DDV5 B4DR78 O00153 Q9BQ19,Zinc finger protein 410,Another partner for ARF 1;Zinc finger protein APA-1;, PF00096;, GO:0005634;GO:0046872;GO:1990837;GO:0003712;GO:0006357;, C:nucleus;, F:metal ion binding; F:sequence-specific double-stranded DNA binding; F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II;|Q86VK4 B4DDV5 B4DR78 O00153 Q9BQ19,Zinc finger protein 410,Another partner for ARF 1;Zinc finger protein APA-1;, PF00096;, GO:0005634;GO:0046872;GO:1990837;GO:0003712;GO:0006357;, C:nucleus;, F:metal ion binding; F:sequence-specific double-stranded DNA binding; F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II;|Q86VK4 B4DDV5 B4DR78 O00153 Q9BQ19,Zinc finger protein 410,Another partner for ARF 1;Zinc finger protein APA-1;, PF00096;, GO:0005634;GO:0046872;GO:1990837;GO:0003712;GO:0006357;, C:nucleus;, F:metal ion binding; F:sequence-specific double-stranded DNA binding; F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II;|Q86VK4 B4DDV5 B4DR78 O00153 Q9BQ19,Zinc finger protein 410,Another partner for ARF 1;Zinc finger protein APA-1;, PF00096;, GO:0005634;GO:0046872;GO:1990837;GO:0003712;GO:0006357;, C:nucleus;, F:metal ion binding; F:sequence-specific double-stranded DNA binding; F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II; scaffold90 indexed_genome mRNA 3027167 3052526 . - . ID=transcript_12493;Q8N8N7 Q3L8A4 Q6MZH8,Prostaglandin reductase 2 {ECO:0000305},15-oxoprostaglandin 13-reductase;Zinc-binding alcohol dehydrogenase domain-containing protein 1;, PF16884;PF00107;, GO:0005737;GO:0036132;GO:0047522;GO:0006693;, C:cytoplasm;, F:13-prostaglandin reductase activity; F:15-oxoprostaglandin 13-oxidase activity;, P:prostaglandin metabolic process;|Q7Z569 B4DRM1 B9EGS8 O43238 O75341,BRCA1-associated protein,BRAP2;Impedes mitogenic signal propagation;RING finger protein 52;RING-type E3 ubiquitin transferase BRAP2 {ECO:0000305};Renal carcinoma antigen NY-REN-63;, PF07576;PF13639;PF02148;, GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0000151;GO:0042802;GO:0008139;GO:0003676;GO:0061630;GO:0004842;GO:0008270;GO:0000165;GO:0009968;GO:0016567;GO:0007265;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:ubiquitin ligase complex;, F:identical protein binding; F:nuclear localization sequence binding; F:nucleic acid binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:MAPK cascade; P:negative regulation of signal transduction; P:protein ubiquitination; P:Ras protein signal transduction;|Q7Z569 B4DRM1 B9EGS8 O43238 O75341,BRCA1-associated protein,BRAP2;Impedes mitogenic signal propagation;RING finger protein 52;RING-type E3 ubiquitin transferase BRAP2 {ECO:0000305};Renal carcinoma antigen NY-REN-63;, PF07576;PF13639;PF02148;, GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0000151;GO:0042802;GO:0008139;GO:0003676;GO:0061630;GO:0004842;GO:0008270;GO:0000165;GO:0009968;GO:0016567;GO:0007265;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:ubiquitin ligase complex;, F:identical protein binding; F:nuclear localization sequence binding; F:nucleic acid binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:MAPK cascade; P:negative regulation of signal transduction; P:protein ubiquitination; P:Ras protein signal transduction;|Q8N8N7 Q3L8A4 Q6MZH8,Prostaglandin reductase 2 {ECO:0000305},15-oxoprostaglandin 13-reductase;Zinc-binding alcohol dehydrogenase domain-containing protein 1;, PF16884;PF00107;, GO:0005737;GO:0036132;GO:0047522;GO:0006693;, C:cytoplasm;, F:13-prostaglandin reductase activity; F:15-oxoprostaglandin 13-oxidase activity;, P:prostaglandin metabolic process; scaffold90 indexed_genome mRNA 3131383 3171593 . + . ID=transcript_12494;Q6PJG2 Q6PK13 Q6PK59 Q6ZS23,Mitotic deacetylase-associated SANT domain protein {ECO:0000312|HGNC:HGNC:19853},ELM2 and SANT domain-containing protein 1;, PF01448;, GO:0000118;GO:0005654;GO:0005667;GO:0003677;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q6PJG2 Q6PK13 Q6PK59 Q6ZS23,Mitotic deacetylase-associated SANT domain protein {ECO:0000312|HGNC:HGNC:19853},ELM2 and SANT domain-containing protein 1;, PF01448;, GO:0000118;GO:0005654;GO:0005667;GO:0003677;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q6PJG2 Q6PK13 Q6PK59 Q6ZS23,Mitotic deacetylase-associated SANT domain protein {ECO:0000312|HGNC:HGNC:19853},ELM2 and SANT domain-containing protein 1;, PF01448;, GO:0000118;GO:0005654;GO:0005667;GO:0003677;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q6PJG2 Q6PK13 Q6PK59 Q6ZS23,Mitotic deacetylase-associated SANT domain protein {ECO:0000312|HGNC:HGNC:19853},ELM2 and SANT domain-containing protein 1;, PF01448;, GO:0000118;GO:0005654;GO:0005667;GO:0003677;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q6PJG2 Q6PK13 Q6PK59 Q6ZS23,Mitotic deacetylase-associated SANT domain protein {ECO:0000312|HGNC:HGNC:19853},ELM2 and SANT domain-containing protein 1;, PF01448;, GO:0000118;GO:0005654;GO:0005667;GO:0003677;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q6PJG2 Q6PK13 Q6PK59 Q6ZS23,Mitotic deacetylase-associated SANT domain protein {ECO:0000312|HGNC:HGNC:19853},ELM2 and SANT domain-containing protein 1;, PF01448;, GO:0000118;GO:0005654;GO:0005667;GO:0003677;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q6PJG2 Q6PK13 Q6PK59 Q6ZS23,Mitotic deacetylase-associated SANT domain protein {ECO:0000312|HGNC:HGNC:19853},ELM2 and SANT domain-containing protein 1;, PF01448;, GO:0000118;GO:0005654;GO:0005667;GO:0003677;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:histone deacetylase complex; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold90 indexed_genome mRNA 3173233 3176425 . - . ID=transcript_12495;Q8ND90 A8K4L5 O95144 Q8NG07,Paraneoplastic antigen Ma1,37 kDa neuronal protein;Neuron- and testis-specific protein 1;, PF14893;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0002437;GO:0043065;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm;, , P:inflammatory response to antigenic stimulus; P:positive regulation of apoptotic process; scaffold90 indexed_genome mRNA 3176567 3223518 . - . ID=transcript_12496;Q4LDG9 B2RD38 Q5JPB7 Q9BS43,Dynein light chain 1, axonemal,, , GO:0005737;GO:0005874;GO:0036157;GO:0043014;GO:0045504;GO:0036158;, C:cytoplasm; C:microtubule; C:outer dynein arm;, F:alpha-tubulin binding; F:dynein heavy chain binding;, P:outer dynein arm assembly;|Q4LDG9 B2RD38 Q5JPB7 Q9BS43,Dynein light chain 1, axonemal,, , GO:0005737;GO:0005874;GO:0036157;GO:0043014;GO:0045504;GO:0036158;, C:cytoplasm; C:microtubule; C:outer dynein arm;, F:alpha-tubulin binding; F:dynein heavy chain binding;, P:outer dynein arm assembly;|Q4LDG9 B2RD38 Q5JPB7 Q9BS43,Dynein light chain 1, axonemal,, , GO:0005737;GO:0005874;GO:0036157;GO:0043014;GO:0045504;GO:0036158;, C:cytoplasm; C:microtubule; C:outer dynein arm;, F:alpha-tubulin binding; F:dynein heavy chain binding;, P:outer dynein arm assembly; scaffold90 indexed_genome mRNA 3229850 3236695 . - . ID=transcript_12497;Q86TX2 A1L173 Q3I5F9,Acyl-coenzyme A thioesterase 1 {ECO:0000305|PubMed:16940157},CTE-I;CTE-Ib;Inducible cytosolic acyl-coenzyme A thioester hydrolase;Long chain acyl-CoA thioester hydrolase;Palmitoyl-coenzyme A thioesterase {ECO:0000305|PubMed:16940157};, PF08840;PF04775;, GO:0005829;GO:0047617;GO:0052689;GO:0102991;GO:0016290;GO:0006637;GO:0006631;GO:0001676;GO:0000038;, C:cytosol;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process; P:long-chain fatty acid metabolic process; P:very long-chain fatty acid metabolic process; scaffold90 indexed_genome mRNA 3247193 3247737 . + . ID=transcript_12498;Q8N9L9 Q17RF4 Q5BKT6 Q86TX0 Q86TX1 Q96N88,Peroxisomal succinyl-coenzyme A thioesterase {ECO:0000305|PubMed:16940157},Acyl-coenzyme A thioesterase 4;PTE-2b;Peroxisomal acyl coenzyme A thioester hydrolase Ib;Peroxisomal long-chain acyl-CoA thioesterase Ib;, PF08840;PF04775;, GO:0005829;GO:0005782;GO:0005777;GO:0047617;GO:0052689;GO:0044466;GO:0102991;GO:0016290;GO:0004778;GO:0006637;GO:0043649;GO:0043648;GO:0006633;GO:0006631;GO:0001676;GO:0008104;GO:0032788;GO:0046459;GO:0006104;GO:0032789;GO:0000038;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:glutaryl-CoA hydrolase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity; F:succinyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:dicarboxylic acid catabolic process; P:dicarboxylic acid metabolic process; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:long-chain fatty acid metabolic process; P:protein localization; P:saturated monocarboxylic acid metabolic process; P:short-chain fatty acid metabolic process; P:succinyl-CoA metabolic process; P:unsaturated monocarboxylic acid metabolic process; P:very long-chain fatty acid metabolic process; scaffold90 indexed_genome mRNA 3265053 3267081 . + . ID=transcript_12499;Q86TX2 A1L173 Q3I5F9,Acyl-coenzyme A thioesterase 1 {ECO:0000305|PubMed:16940157},CTE-I;CTE-Ib;Inducible cytosolic acyl-coenzyme A thioester hydrolase;Long chain acyl-CoA thioester hydrolase;Palmitoyl-coenzyme A thioesterase {ECO:0000305|PubMed:16940157};, PF08840;PF04775;, GO:0005829;GO:0047617;GO:0052689;GO:0102991;GO:0016290;GO:0006637;GO:0006631;GO:0001676;GO:0000038;, C:cytosol;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process; P:long-chain fatty acid metabolic process; P:very long-chain fatty acid metabolic process;|P49753 Q3I5F8 Q53EK4 Q9NUX4,Acyl-coenzyme A thioesterase 2, mitochondrial,Acyl-coenzyme A thioester hydrolase 2a;CTE-Ia;Long-chain acyl-CoA thioesterase 2;ZAP128;, PF08840;PF04775;, GO:0005829;GO:0005759;GO:0005739;GO:0005782;GO:0047617;GO:0052689;GO:0102991;GO:0016290;GO:0006637;GO:0006631;GO:0001676;GO:0008104;GO:0000038;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:peroxisomal matrix;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process; P:long-chain fatty acid metabolic process; P:protein localization; P:very long-chain fatty acid metabolic process; scaffold90 indexed_genome mRNA 3321422 3321964 . + . ID=transcript_12500;Q86TX2 A1L173 Q3I5F9,Acyl-coenzyme A thioesterase 1 {ECO:0000305|PubMed:16940157},CTE-I;CTE-Ib;Inducible cytosolic acyl-coenzyme A thioester hydrolase;Long chain acyl-CoA thioester hydrolase;Palmitoyl-coenzyme A thioesterase {ECO:0000305|PubMed:16940157};, PF08840;PF04775;, GO:0005829;GO:0047617;GO:0052689;GO:0102991;GO:0016290;GO:0006637;GO:0006631;GO:0001676;GO:0000038;, C:cytosol;, F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process; P:long-chain fatty acid metabolic process; P:very long-chain fatty acid metabolic process; scaffold90 indexed_genome mRNA 3359759 3362312 . + . ID=transcript_12501;Q9H6W3 B4DT02,Ribosomal oxygenase 1 {ECO:0000312|HGNC:HGNC:20968},60S ribosomal protein L8 histidine hydroxylase;Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66;Histone lysine demethylase NO66;Myc-associated protein with JmjC domain;Nucleolar protein 66;Ribosomal oxygenase NO66;, PF08007;, GO:0005730;GO:0005654;GO:0005634;GO:0016706;GO:0051864;GO:0032453;GO:0005506;GO:0070544;GO:0034720;GO:0045668;GO:0045892;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K4 specific); F:iron ion binding;, P:histone H3-K36 demethylation; P:histone H3-K4 demethylation; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription, DNA-templated; scaffold90 indexed_genome mRNA 3520780 3521671 . - . ID=transcript_12502;Q8WW73 Q9UBG1 Q9UEQ4 Q9UKE8 Q9UKE9 Q9UKF0 Q9UQJ4,Protein numb homolog,Protein S171;, PF06311;PF00640;, GO:0045177;GO:0016323;GO:0005905;GO:0030136;GO:0005737;GO:0005769;GO:0010008;GO:0019897;GO:0005925;GO:0098978;GO:0005634;GO:0005886;GO:0045294;GO:0008013;GO:0045296;GO:0034332;GO:0007409;GO:0021670;GO:1903077;GO:0021849;GO:0030335;GO:0050769;GO:0099149;, C:apical part of cell; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:early endosome; C:endosome membrane; C:extrinsic component of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:plasma membrane;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding;, P:adherens junction organization; P:axonogenesis; P:lateral ventricle development; P:negative regulation of protein localization to plasma membrane; P:neuroblast division in subventricular zone; P:positive regulation of cell migration; P:positive regulation of neurogenesis; P:regulation of postsynaptic neurotransmitter receptor internalization; scaffold90 indexed_genome mRNA 3548490 3550107 . - . ID=transcript_12503;Q8WW73 Q9UBG1 Q9UEQ4 Q9UKE8 Q9UKE9 Q9UKF0 Q9UQJ4,Protein numb homolog,Protein S171;, PF06311;PF00640;, GO:0045177;GO:0016323;GO:0005905;GO:0030136;GO:0005737;GO:0005769;GO:0010008;GO:0019897;GO:0005925;GO:0098978;GO:0005634;GO:0005886;GO:0045294;GO:0008013;GO:0045296;GO:0034332;GO:0007409;GO:0021670;GO:1903077;GO:0021849;GO:0030335;GO:0050769;GO:0099149;, C:apical part of cell; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:early endosome; C:endosome membrane; C:extrinsic component of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:plasma membrane;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding;, P:adherens junction organization; P:axonogenesis; P:lateral ventricle development; P:negative regulation of protein localization to plasma membrane; P:neuroblast division in subventricular zone; P:positive regulation of cell migration; P:positive regulation of neurogenesis; P:regulation of postsynaptic neurotransmitter receptor internalization; scaffold90 indexed_genome mRNA 3550165 3576908 . - . ID=transcript_12504;Q8WW73 Q9UBG1 Q9UEQ4 Q9UKE8 Q9UKE9 Q9UKF0 Q9UQJ4,Protein numb homolog,Protein S171;, PF06311;PF00640;, GO:0045177;GO:0016323;GO:0005905;GO:0030136;GO:0005737;GO:0005769;GO:0010008;GO:0019897;GO:0005925;GO:0098978;GO:0005634;GO:0005886;GO:0045294;GO:0008013;GO:0045296;GO:0034332;GO:0007409;GO:0021670;GO:1903077;GO:0021849;GO:0030335;GO:0050769;GO:0099149;, C:apical part of cell; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:early endosome; C:endosome membrane; C:extrinsic component of plasma membrane; C:focal adhesion; C:glutamatergic synapse; C:nucleus; C:plasma membrane;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding;, P:adherens junction organization; P:axonogenesis; P:lateral ventricle development; P:negative regulation of protein localization to plasma membrane; P:neuroblast division in subventricular zone; P:positive regulation of cell migration; P:positive regulation of neurogenesis; P:regulation of postsynaptic neurotransmitter receptor internalization;|O95428 B4DES8 B4DGE6 Q659F2 Q6UXJ4 Q6ZNM1 Q6ZUJ0 Q7Z681 Q8IVU0,Papilin,, PF05986;PF07679;PF00014;PF08686;PF00090;, GO:0031012;GO:0005576;GO:0004222;GO:0004867;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity; F:serine-type endopeptidase inhibitor activity;, P:extracellular matrix organization; scaffold90 indexed_genome mRNA 3577031 3591374 . - . ID=transcript_12505;O95428 B4DES8 B4DGE6 Q659F2 Q6UXJ4 Q6ZNM1 Q6ZUJ0 Q7Z681 Q8IVU0,Papilin,, PF05986;PF07679;PF00014;PF08686;PF00090;, GO:0031012;GO:0005576;GO:0004222;GO:0004867;GO:0030198;, C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity; F:serine-type endopeptidase inhibitor activity;, P:extracellular matrix organization; scaffold90 indexed_genome mRNA 3604771 3672483 . + . ID=transcript_12506;P49768 B2R6D3 O95465 Q14762 Q15719 Q15720 Q96P33 Q9UIF0,Presenilin-1,Protein S182;, PF01080;, GO:0016235;GO:0016324;GO:0035577;GO:0005938;GO:0030054;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0031901;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0016021;GO:0005887;GO:0099056;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0005739;GO:0031594;GO:0043005;GO:0043025;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005791;GO:0042383;GO:0005790;GO:0008021;GO:0030018;GO:0042500;GO:0004190;GO:0051117;GO:0008013;GO:0045296;GO:0005262;GO:0004175;GO:0070851;GO:0030165;GO:0000186;GO:0042987;GO:0042982;GO:0034205;GO:0050435;GO:0048143;GO:0002265;GO:0000045;GO:0001568;GO:0048854;GO:0021870;GO:0006816;GO:0001708;GO:0098609;GO:1904646;GO:0006974;GO:0021549;GO:0021795;GO:0015871;GO:0021904;GO:0030326;GO:0032469;GO:0048013;GO:0050673;GO:0001947;GO:0002244;GO:0035556;GO:0098712;GO:0007611;GO:0006509;GO:0031293;GO:0007613;GO:0006839;GO:0090647;GO:0043011;GO:0043066;GO:2001234;GO:0050771;GO:1904797;GO:0007175;GO:0010629;GO:0043524;GO:0000122;GO:2000059;GO:0051444;GO:0003407;GO:0051402;GO:0048666;GO:0001764;GO:1990535;GO:0043312;GO:0007220;GO:0035333;GO:1905908;GO:0043065;GO:0043085;GO:0050820;GO:0060999;GO:0010628;GO:0045821;GO:0002038;GO:0043406;GO:0042327;GO:0032436;GO:0032092;GO:0042307;GO:0001921;GO:0045893;GO:0032760;GO:0009791;GO:0006486;GO:0016485;GO:0015031;GO:0060828;GO:0010468;GO:0010975;GO:0042325;GO:0060075;GO:0048167;GO:0051966;GO:0006979;GO:0051208;GO:0048705;GO:0043589;GO:0051563;GO:0001756;GO:0050808;GO:0016080;GO:0002286;GO:0050852;GO:0048538;, C:aggresome; C:apical plasma membrane; C:azurophil granule membrane; C:cell cortex; C:cell junction; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrion; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:rough endoplasmic reticulum; C:sarcolemma; C:smooth endoplasmic reticulum; C:synaptic vesicle; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:aspartic-type endopeptidase activity; F:ATPase binding; F:beta-catenin binding; F:cadherin binding; F:calcium channel activity; F:endopeptidase activity; F:growth factor receptor binding; F:PDZ domain binding;, P:activation of MAPKK activity; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:astrocyte activation; P:astrocyte activation involved in immune response; P:autophagosome assembly; P:blood vessel development; P:brain morphogenesis; P:Cajal-Retzius cell differentiation; P:calcium ion transport; P:cell fate specification; P:cell-cell adhesion; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cerebellum development; P:cerebral cortex cell migration; P:choline transport; P:dorsal/ventral neural tube patterning; P:embryonic limb morphogenesis; P:endoplasmic reticulum calcium ion homeostasis; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:heart looping; P:hematopoietic progenitor cell differentiation; P:intracellular signal transduction; P:L-glutamate import across plasma membrane; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:memory; P:mitochondrial transport; P:modulation of age-related behavioral decline; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of axonogenesis; P:negative regulation of core promoter binding; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-protein transferase activity; P:neural retina development; P:neuron apoptotic process; P:neuron development; P:neuron migration; P:neuron projection maintenance; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid fibril formation; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of coagulation; P:positive regulation of dendritic spine development; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of L-glutamate import across plasma membrane; P:positive regulation of MAP kinase activity; P:positive regulation of phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:positive regulation of receptor recycling; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:post-embryonic development; P:protein glycosylation; P:protein processing; P:protein transport; P:regulation of canonical Wnt signaling pathway; P:regulation of gene expression; P:regulation of neuron projection development; P:regulation of phosphorylation; P:regulation of resting membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, glutamatergic; P:response to oxidative stress; P:sequestering of calcium ion; P:skeletal system morphogenesis; P:skin morphogenesis; P:smooth endoplasmic reticulum calcium ion homeostasis; P:somitogenesis; P:synapse organization; P:synaptic vesicle targeting; P:T cell activation involved in immune response; P:T cell receptor signaling pathway; P:thymus development;|P49768 B2R6D3 O95465 Q14762 Q15719 Q15720 Q96P33 Q9UIF0,Presenilin-1,Protein S182;, PF01080;, GO:0016235;GO:0016324;GO:0035577;GO:0005938;GO:0030054;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0031901;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0016021;GO:0005887;GO:0099056;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0005739;GO:0031594;GO:0043005;GO:0043025;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005791;GO:0042383;GO:0005790;GO:0008021;GO:0030018;GO:0042500;GO:0004190;GO:0051117;GO:0008013;GO:0045296;GO:0005262;GO:0004175;GO:0070851;GO:0030165;GO:0000186;GO:0042987;GO:0042982;GO:0034205;GO:0050435;GO:0048143;GO:0002265;GO:0000045;GO:0001568;GO:0048854;GO:0021870;GO:0006816;GO:0001708;GO:0098609;GO:1904646;GO:0006974;GO:0021549;GO:0021795;GO:0015871;GO:0021904;GO:0030326;GO:0032469;GO:0048013;GO:0050673;GO:0001947;GO:0002244;GO:0035556;GO:0098712;GO:0007611;GO:0006509;GO:0031293;GO:0007613;GO:0006839;GO:0090647;GO:0043011;GO:0043066;GO:2001234;GO:0050771;GO:1904797;GO:0007175;GO:0010629;GO:0043524;GO:0000122;GO:2000059;GO:0051444;GO:0003407;GO:0051402;GO:0048666;GO:0001764;GO:1990535;GO:0043312;GO:0007220;GO:0035333;GO:1905908;GO:0043065;GO:0043085;GO:0050820;GO:0060999;GO:0010628;GO:0045821;GO:0002038;GO:0043406;GO:0042327;GO:0032436;GO:0032092;GO:0042307;GO:0001921;GO:0045893;GO:0032760;GO:0009791;GO:0006486;GO:0016485;GO:0015031;GO:0060828;GO:0010468;GO:0010975;GO:0042325;GO:0060075;GO:0048167;GO:0051966;GO:0006979;GO:0051208;GO:0048705;GO:0043589;GO:0051563;GO:0001756;GO:0050808;GO:0016080;GO:0002286;GO:0050852;GO:0048538;, C:aggresome; C:apical plasma membrane; C:azurophil granule membrane; C:cell cortex; C:cell junction; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrion; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:rough endoplasmic reticulum; C:sarcolemma; C:smooth endoplasmic reticulum; C:synaptic vesicle; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:aspartic-type endopeptidase activity; F:ATPase binding; F:beta-catenin binding; F:cadherin binding; F:calcium channel activity; F:endopeptidase activity; F:growth factor receptor binding; F:PDZ domain binding;, P:activation of MAPKK activity; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:astrocyte activation; P:astrocyte activation involved in immune response; P:autophagosome assembly; P:blood vessel development; P:brain morphogenesis; P:Cajal-Retzius cell differentiation; P:calcium ion transport; P:cell fate specification; P:cell-cell adhesion; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cerebellum development; P:cerebral cortex cell migration; P:choline transport; P:dorsal/ventral neural tube patterning; P:embryonic limb morphogenesis; P:endoplasmic reticulum calcium ion homeostasis; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:heart looping; P:hematopoietic progenitor cell differentiation; P:intracellular signal transduction; P:L-glutamate import across plasma membrane; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:memory; P:mitochondrial transport; P:modulation of age-related behavioral decline; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of axonogenesis; P:negative regulation of core promoter binding; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-protein transferase activity; P:neural retina development; P:neuron apoptotic process; P:neuron development; P:neuron migration; P:neuron projection maintenance; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid fibril formation; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of coagulation; P:positive regulation of dendritic spine development; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of L-glutamate import across plasma membrane; P:positive regulation of MAP kinase activity; P:positive regulation of phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:positive regulation of receptor recycling; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:post-embryonic development; P:protein glycosylation; P:protein processing; P:protein transport; P:regulation of canonical Wnt signaling pathway; P:regulation of gene expression; P:regulation of neuron projection development; P:regulation of phosphorylation; P:regulation of resting membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, glutamatergic; P:response to oxidative stress; P:sequestering of calcium ion; P:skeletal system morphogenesis; P:skin morphogenesis; P:smooth endoplasmic reticulum calcium ion homeostasis; P:somitogenesis; P:synapse organization; P:synaptic vesicle targeting; P:T cell activation involved in immune response; P:T cell receptor signaling pathway; P:thymus development;|P49768 B2R6D3 O95465 Q14762 Q15719 Q15720 Q96P33 Q9UIF0,Presenilin-1,Protein S182;, PF01080;, GO:0016235;GO:0016324;GO:0035577;GO:0005938;GO:0030054;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0031901;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0016021;GO:0005887;GO:0099056;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0005739;GO:0031594;GO:0043005;GO:0043025;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005791;GO:0042383;GO:0005790;GO:0008021;GO:0030018;GO:0042500;GO:0004190;GO:0051117;GO:0008013;GO:0045296;GO:0005262;GO:0004175;GO:0070851;GO:0030165;GO:0000186;GO:0042987;GO:0042982;GO:0034205;GO:0050435;GO:0048143;GO:0002265;GO:0000045;GO:0001568;GO:0048854;GO:0021870;GO:0006816;GO:0001708;GO:0098609;GO:1904646;GO:0006974;GO:0021549;GO:0021795;GO:0015871;GO:0021904;GO:0030326;GO:0032469;GO:0048013;GO:0050673;GO:0001947;GO:0002244;GO:0035556;GO:0098712;GO:0007611;GO:0006509;GO:0031293;GO:0007613;GO:0006839;GO:0090647;GO:0043011;GO:0043066;GO:2001234;GO:0050771;GO:1904797;GO:0007175;GO:0010629;GO:0043524;GO:0000122;GO:2000059;GO:0051444;GO:0003407;GO:0051402;GO:0048666;GO:0001764;GO:1990535;GO:0043312;GO:0007220;GO:0035333;GO:1905908;GO:0043065;GO:0043085;GO:0050820;GO:0060999;GO:0010628;GO:0045821;GO:0002038;GO:0043406;GO:0042327;GO:0032436;GO:0032092;GO:0042307;GO:0001921;GO:0045893;GO:0032760;GO:0009791;GO:0006486;GO:0016485;GO:0015031;GO:0060828;GO:0010468;GO:0010975;GO:0042325;GO:0060075;GO:0048167;GO:0051966;GO:0006979;GO:0051208;GO:0048705;GO:0043589;GO:0051563;GO:0001756;GO:0050808;GO:0016080;GO:0002286;GO:0050852;GO:0048538;, C:aggresome; C:apical plasma membrane; C:azurophil granule membrane; C:cell cortex; C:cell junction; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrion; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:rough endoplasmic reticulum; C:sarcolemma; C:smooth endoplasmic reticulum; C:synaptic vesicle; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:aspartic-type endopeptidase activity; F:ATPase binding; F:beta-catenin binding; F:cadherin binding; F:calcium channel activity; F:endopeptidase activity; F:growth factor receptor binding; F:PDZ domain binding;, P:activation of MAPKK activity; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:astrocyte activation; P:astrocyte activation involved in immune response; P:autophagosome assembly; P:blood vessel development; P:brain morphogenesis; P:Cajal-Retzius cell differentiation; P:calcium ion transport; P:cell fate specification; P:cell-cell adhesion; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cerebellum development; P:cerebral cortex cell migration; P:choline transport; P:dorsal/ventral neural tube patterning; P:embryonic limb morphogenesis; P:endoplasmic reticulum calcium ion homeostasis; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:heart looping; P:hematopoietic progenitor cell differentiation; P:intracellular signal transduction; P:L-glutamate import across plasma membrane; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:memory; P:mitochondrial transport; P:modulation of age-related behavioral decline; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of axonogenesis; P:negative regulation of core promoter binding; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-protein transferase activity; P:neural retina development; P:neuron apoptotic process; P:neuron development; P:neuron migration; P:neuron projection maintenance; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid fibril formation; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of coagulation; P:positive regulation of dendritic spine development; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of L-glutamate import across plasma membrane; P:positive regulation of MAP kinase activity; P:positive regulation of phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:positive regulation of receptor recycling; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:post-embryonic development; P:protein glycosylation; P:protein processing; P:protein transport; P:regulation of canonical Wnt signaling pathway; P:regulation of gene expression; P:regulation of neuron projection development; P:regulation of phosphorylation; P:regulation of resting membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, glutamatergic; P:response to oxidative stress; P:sequestering of calcium ion; P:skeletal system morphogenesis; P:skin morphogenesis; P:smooth endoplasmic reticulum calcium ion homeostasis; P:somitogenesis; P:synapse organization; P:synaptic vesicle targeting; P:T cell activation involved in immune response; P:T cell receptor signaling pathway; P:thymus development;|P49768 B2R6D3 O95465 Q14762 Q15719 Q15720 Q96P33 Q9UIF0,Presenilin-1,Protein S182;, PF01080;, GO:0016235;GO:0016324;GO:0035577;GO:0005938;GO:0030054;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0031901;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0016021;GO:0005887;GO:0099056;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0005739;GO:0031594;GO:0043005;GO:0043025;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005791;GO:0042383;GO:0005790;GO:0008021;GO:0030018;GO:0042500;GO:0004190;GO:0051117;GO:0008013;GO:0045296;GO:0005262;GO:0004175;GO:0070851;GO:0030165;GO:0000186;GO:0042987;GO:0042982;GO:0034205;GO:0050435;GO:0048143;GO:0002265;GO:0000045;GO:0001568;GO:0048854;GO:0021870;GO:0006816;GO:0001708;GO:0098609;GO:1904646;GO:0006974;GO:0021549;GO:0021795;GO:0015871;GO:0021904;GO:0030326;GO:0032469;GO:0048013;GO:0050673;GO:0001947;GO:0002244;GO:0035556;GO:0098712;GO:0007611;GO:0006509;GO:0031293;GO:0007613;GO:0006839;GO:0090647;GO:0043011;GO:0043066;GO:2001234;GO:0050771;GO:1904797;GO:0007175;GO:0010629;GO:0043524;GO:0000122;GO:2000059;GO:0051444;GO:0003407;GO:0051402;GO:0048666;GO:0001764;GO:1990535;GO:0043312;GO:0007220;GO:0035333;GO:1905908;GO:0043065;GO:0043085;GO:0050820;GO:0060999;GO:0010628;GO:0045821;GO:0002038;GO:0043406;GO:0042327;GO:0032436;GO:0032092;GO:0042307;GO:0001921;GO:0045893;GO:0032760;GO:0009791;GO:0006486;GO:0016485;GO:0015031;GO:0060828;GO:0010468;GO:0010975;GO:0042325;GO:0060075;GO:0048167;GO:0051966;GO:0006979;GO:0051208;GO:0048705;GO:0043589;GO:0051563;GO:0001756;GO:0050808;GO:0016080;GO:0002286;GO:0050852;GO:0048538;, C:aggresome; C:apical plasma membrane; C:azurophil granule membrane; C:cell cortex; C:cell junction; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrion; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:rough endoplasmic reticulum; C:sarcolemma; C:smooth endoplasmic reticulum; C:synaptic vesicle; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:aspartic-type endopeptidase activity; F:ATPase binding; F:beta-catenin binding; F:cadherin binding; F:calcium channel activity; F:endopeptidase activity; F:growth factor receptor binding; F:PDZ domain binding;, P:activation of MAPKK activity; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:astrocyte activation; P:astrocyte activation involved in immune response; P:autophagosome assembly; P:blood vessel development; P:brain morphogenesis; P:Cajal-Retzius cell differentiation; P:calcium ion transport; P:cell fate specification; P:cell-cell adhesion; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cerebellum development; P:cerebral cortex cell migration; P:choline transport; P:dorsal/ventral neural tube patterning; P:embryonic limb morphogenesis; P:endoplasmic reticulum calcium ion homeostasis; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:heart looping; P:hematopoietic progenitor cell differentiation; P:intracellular signal transduction; P:L-glutamate import across plasma membrane; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:memory; P:mitochondrial transport; P:modulation of age-related behavioral decline; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of axonogenesis; P:negative regulation of core promoter binding; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-protein transferase activity; P:neural retina development; P:neuron apoptotic process; P:neuron development; P:neuron migration; P:neuron projection maintenance; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid fibril formation; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of coagulation; P:positive regulation of dendritic spine development; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of L-glutamate import across plasma membrane; P:positive regulation of MAP kinase activity; P:positive regulation of phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:positive regulation of receptor recycling; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:post-embryonic development; P:protein glycosylation; P:protein processing; P:protein transport; P:regulation of canonical Wnt signaling pathway; P:regulation of gene expression; P:regulation of neuron projection development; P:regulation of phosphorylation; P:regulation of resting membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, glutamatergic; P:response to oxidative stress; P:sequestering of calcium ion; P:skeletal system morphogenesis; P:skin morphogenesis; P:smooth endoplasmic reticulum calcium ion homeostasis; P:somitogenesis; P:synapse organization; P:synaptic vesicle targeting; P:T cell activation involved in immune response; P:T cell receptor signaling pathway; P:thymus development;|P49768 B2R6D3 O95465 Q14762 Q15719 Q15720 Q96P33 Q9UIF0,Presenilin-1,Protein S182;, PF01080;, GO:0016235;GO:0016324;GO:0035577;GO:0005938;GO:0030054;GO:0009986;GO:0005813;GO:0035253;GO:0043198;GO:0031901;GO:0005783;GO:0005789;GO:0070765;GO:0005794;GO:0000139;GO:0030426;GO:0016021;GO:0005887;GO:0099056;GO:0000776;GO:0005765;GO:0016020;GO:0045121;GO:0005743;GO:0005739;GO:0031594;GO:0043005;GO:0043025;GO:0031965;GO:0005640;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0005791;GO:0042383;GO:0005790;GO:0008021;GO:0030018;GO:0042500;GO:0004190;GO:0051117;GO:0008013;GO:0045296;GO:0005262;GO:0004175;GO:0070851;GO:0030165;GO:0000186;GO:0042987;GO:0042982;GO:0034205;GO:0050435;GO:0048143;GO:0002265;GO:0000045;GO:0001568;GO:0048854;GO:0021870;GO:0006816;GO:0001708;GO:0098609;GO:1904646;GO:0006974;GO:0021549;GO:0021795;GO:0015871;GO:0021904;GO:0030326;GO:0032469;GO:0048013;GO:0050673;GO:0001947;GO:0002244;GO:0035556;GO:0098712;GO:0007611;GO:0006509;GO:0031293;GO:0007613;GO:0006839;GO:0090647;GO:0043011;GO:0043066;GO:2001234;GO:0050771;GO:1904797;GO:0007175;GO:0010629;GO:0043524;GO:0000122;GO:2000059;GO:0051444;GO:0003407;GO:0051402;GO:0048666;GO:0001764;GO:1990535;GO:0043312;GO:0007220;GO:0035333;GO:1905908;GO:0043065;GO:0043085;GO:0050820;GO:0060999;GO:0010628;GO:0045821;GO:0002038;GO:0043406;GO:0042327;GO:0032436;GO:0032092;GO:0042307;GO:0001921;GO:0045893;GO:0032760;GO:0009791;GO:0006486;GO:0016485;GO:0015031;GO:0060828;GO:0010468;GO:0010975;GO:0042325;GO:0060075;GO:0048167;GO:0051966;GO:0006979;GO:0051208;GO:0048705;GO:0043589;GO:0051563;GO:0001756;GO:0050808;GO:0016080;GO:0002286;GO:0050852;GO:0048538;, C:aggresome; C:apical plasma membrane; C:azurophil granule membrane; C:cell cortex; C:cell junction; C:cell surface; C:centrosome; C:ciliary rootlet; C:dendritic shaft; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:kinetochore; C:lysosomal membrane; C:membrane; C:membrane raft; C:mitochondrial inner membrane; C:mitochondrion; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:rough endoplasmic reticulum; C:sarcolemma; C:smooth endoplasmic reticulum; C:synaptic vesicle; C:Z disc;, F:aspartic endopeptidase activity, intramembrane cleaving; F:aspartic-type endopeptidase activity; F:ATPase binding; F:beta-catenin binding; F:cadherin binding; F:calcium channel activity; F:endopeptidase activity; F:growth factor receptor binding; F:PDZ domain binding;, P:activation of MAPKK activity; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:amyloid-beta metabolic process; P:astrocyte activation; P:astrocyte activation involved in immune response; P:autophagosome assembly; P:blood vessel development; P:brain morphogenesis; P:Cajal-Retzius cell differentiation; P:calcium ion transport; P:cell fate specification; P:cell-cell adhesion; P:cellular response to amyloid-beta; P:cellular response to DNA damage stimulus; P:cerebellum development; P:cerebral cortex cell migration; P:choline transport; P:dorsal/ventral neural tube patterning; P:embryonic limb morphogenesis; P:endoplasmic reticulum calcium ion homeostasis; P:ephrin receptor signaling pathway; P:epithelial cell proliferation; P:heart looping; P:hematopoietic progenitor cell differentiation; P:intracellular signal transduction; P:L-glutamate import across plasma membrane; P:learning or memory; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:memory; P:mitochondrial transport; P:modulation of age-related behavioral decline; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of apoptotic signaling pathway; P:negative regulation of axonogenesis; P:negative regulation of core promoter binding; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-protein transferase activity; P:neural retina development; P:neuron apoptotic process; P:neuron development; P:neuron migration; P:neuron projection maintenance; P:neutrophil degranulation; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of amyloid fibril formation; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of coagulation; P:positive regulation of dendritic spine development; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of L-glutamate import across plasma membrane; P:positive regulation of MAP kinase activity; P:positive regulation of phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein import into nucleus; P:positive regulation of receptor recycling; P:positive regulation of transcription, DNA-templated; P:positive regulation of tumor necrosis factor production; P:post-embryonic development; P:protein glycosylation; P:protein processing; P:protein transport; P:regulation of canonical Wnt signaling pathway; P:regulation of gene expression; P:regulation of neuron projection development; P:regulation of phosphorylation; P:regulation of resting membrane potential; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, glutamatergic; P:response to oxidative stress; P:sequestering of calcium ion; P:skeletal system morphogenesis; P:skin morphogenesis; P:smooth endoplasmic reticulum calcium ion homeostasis; P:somitogenesis; P:synapse organization; P:synaptic vesicle targeting; P:T cell activation involved in immune response; P:T cell receptor signaling pathway; P:thymus development; scaffold90 indexed_genome mRNA 3675811 3696990 . - . ID=transcript_12507;Q9UIE9,RNA-binding protein 25,Arg/Glu/Asp-rich protein of 120 kDa;Protein S164;RNA-binding motif protein 25;RNA-binding region-containing protein 7;, PF01480;PF00076;, GO:0005737;GO:0016607;GO:0003729;GO:0003723;GO:0006397;GO:0000381;GO:0042981;GO:0008380;, C:cytoplasm; C:nuclear speck;, F:mRNA binding; F:RNA binding;, P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of apoptotic process; P:RNA splicing;|Q9UIE9,RNA-binding protein 25,Arg/Glu/Asp-rich protein of 120 kDa;Protein S164;RNA-binding motif protein 25;RNA-binding region-containing protein 7;, PF01480;PF00076;, GO:0005737;GO:0016607;GO:0003729;GO:0003723;GO:0006397;GO:0000381;GO:0042981;GO:0008380;, C:cytoplasm; C:nuclear speck;, F:mRNA binding; F:RNA binding;, P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of apoptotic process; P:RNA splicing; scaffold90 indexed_genome mRNA 3697870 3726990 . - . ID=transcript_12508;Q9UIE9,RNA-binding protein 25,Arg/Glu/Asp-rich protein of 120 kDa;Protein S164;RNA-binding motif protein 25;RNA-binding region-containing protein 7;, PF01480;PF00076;, GO:0005737;GO:0016607;GO:0003729;GO:0003723;GO:0006397;GO:0000381;GO:0042981;GO:0008380;, C:cytoplasm; C:nuclear speck;, F:mRNA binding; F:RNA binding;, P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of apoptotic process; P:RNA splicing; scaffold90 indexed_genome mRNA 3753942 3796189 . + . ID=transcript_12509;Q9HBF4 J3KNL9 Q8WYX7 Q96K57 Q9BXP9 Q9HCI3,Zinc finger FYVE domain-containing protein 1,Double FYVE-containing protein 1;SR3;Tandem FYVE fingers-1;, PF01363;, GO:0005776;GO:0005783;GO:0005789;GO:0097629;GO:0005794;GO:0005795;GO:0005811;GO:0044233;GO:0005739;GO:1990462;GO:0048471;GO:0000407;GO:0005545;GO:0005547;GO:0043325;GO:0032266;GO:0008270;GO:0009267;GO:0140042;GO:0016236;GO:0010923;, C:autophagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of omegasome membrane; C:Golgi apparatus; C:Golgi stack; C:lipid droplet; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion; C:omegasome; C:perinuclear region of cytoplasm; C:phagophore assembly site;, F:1-phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:zinc ion binding;, P:cellular response to starvation; P:lipid droplet formation; P:macroautophagy; P:negative regulation of phosphatase activity;|Q9HBF4 J3KNL9 Q8WYX7 Q96K57 Q9BXP9 Q9HCI3,Zinc finger FYVE domain-containing protein 1,Double FYVE-containing protein 1;SR3;Tandem FYVE fingers-1;, PF01363;, GO:0005776;GO:0005783;GO:0005789;GO:0097629;GO:0005794;GO:0005795;GO:0005811;GO:0044233;GO:0005739;GO:1990462;GO:0048471;GO:0000407;GO:0005545;GO:0005547;GO:0043325;GO:0032266;GO:0008270;GO:0009267;GO:0140042;GO:0016236;GO:0010923;, C:autophagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of omegasome membrane; C:Golgi apparatus; C:Golgi stack; C:lipid droplet; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion; C:omegasome; C:perinuclear region of cytoplasm; C:phagophore assembly site;, F:1-phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:zinc ion binding;, P:cellular response to starvation; P:lipid droplet formation; P:macroautophagy; P:negative regulation of phosphatase activity;|Q9HBF4 J3KNL9 Q8WYX7 Q96K57 Q9BXP9 Q9HCI3,Zinc finger FYVE domain-containing protein 1,Double FYVE-containing protein 1;SR3;Tandem FYVE fingers-1;, PF01363;, GO:0005776;GO:0005783;GO:0005789;GO:0097629;GO:0005794;GO:0005795;GO:0005811;GO:0044233;GO:0005739;GO:1990462;GO:0048471;GO:0000407;GO:0005545;GO:0005547;GO:0043325;GO:0032266;GO:0008270;GO:0009267;GO:0140042;GO:0016236;GO:0010923;, C:autophagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of omegasome membrane; C:Golgi apparatus; C:Golgi stack; C:lipid droplet; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion; C:omegasome; C:perinuclear region of cytoplasm; C:phagophore assembly site;, F:1-phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:zinc ion binding;, P:cellular response to starvation; P:lipid droplet formation; P:macroautophagy; P:negative regulation of phosphatase activity;|Q9HBF4 J3KNL9 Q8WYX7 Q96K57 Q9BXP9 Q9HCI3,Zinc finger FYVE domain-containing protein 1,Double FYVE-containing protein 1;SR3;Tandem FYVE fingers-1;, PF01363;, GO:0005776;GO:0005783;GO:0005789;GO:0097629;GO:0005794;GO:0005795;GO:0005811;GO:0044233;GO:0005739;GO:1990462;GO:0048471;GO:0000407;GO:0005545;GO:0005547;GO:0043325;GO:0032266;GO:0008270;GO:0009267;GO:0140042;GO:0016236;GO:0010923;, C:autophagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of omegasome membrane; C:Golgi apparatus; C:Golgi stack; C:lipid droplet; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion; C:omegasome; C:perinuclear region of cytoplasm; C:phagophore assembly site;, F:1-phosphatidylinositol binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:zinc ion binding;, P:cellular response to starvation; P:lipid droplet formation; P:macroautophagy; P:negative regulation of phosphatase activity; scaffold90 indexed_genome mRNA 3806644 3838409 . - . ID=transcript_12510;Q8WV16 B4DUT6 G3V522 Q86U31 Q8IV10 Q96K22 Q9Y4P5,DDB1- and CUL4-associated factor 4,WD repeat-containing protein 21A;, , GO:0080008;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q3SXM0 B3KVI3 Q3ZCW8 Q499Y5 Q9UFI0,DDB1- and CUL4-associated factor 4-like protein 1,WD repeat-containing protein 21B;|Q8WV16 B4DUT6 G3V522 Q86U31 Q8IV10 Q96K22 Q9Y4P5,DDB1- and CUL4-associated factor 4,WD repeat-containing protein 21A;, , GO:0080008;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q8WV16 B4DUT6 G3V522 Q86U31 Q8IV10 Q96K22 Q9Y4P5,DDB1- and CUL4-associated factor 4,WD repeat-containing protein 21A;, , GO:0080008;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q8WV16 B4DUT6 G3V522 Q86U31 Q8IV10 Q96K22 Q9Y4P5,DDB1- and CUL4-associated factor 4,WD repeat-containing protein 21A;, , GO:0080008;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination;|Q8WV16 B4DUT6 G3V522 Q86U31 Q8IV10 Q96K22 Q9Y4P5,DDB1- and CUL4-associated factor 4,WD repeat-containing protein 21A;, , GO:0080008;GO:0005654;GO:0043687;GO:0016567;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:post-translational protein modification; P:protein ubiquitination; scaffold90 indexed_genome mRNA 3908382 3908986 . + . ID=transcript_12511;Q8IV33 A0A088AWM3 O94914 Q6ZNN2,Uncharacterized protein KIAA0825,, PF14906; scaffold90 indexed_genome mRNA 4159815 4161823 . + . ID=transcript_12512;Q92784 A8MSI3 B7Z276 F5H575 Q32UJ0 Q6P9E6 Q6ZT41 Q9H7Y5,Zinc finger protein DPF3,BRG1-associated factor 45C;Zinc finger protein cer-d4;, PF00628;PF14051;, GO:0071565;GO:0005654;GO:0042393;GO:0003712;GO:0008270;GO:0006325;GO:0045892;GO:0007399;GO:0045944;, C:nBAF complex; C:nucleoplasm;, F:histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:chromatin organization; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II; scaffold90 indexed_genome mRNA 4217487 4810953 . - . ID=transcript_12513;Q8TE22 Q9UDS8 Q9UDT0 Q9Y245 Q9Y647,Regulator of G-protein signaling 6,S914;, PF00610;PF00631;PF00615;PF18148;, GO:0005829;GO:0019898;GO:0005634;GO:0005886;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0043547;GO:0008277;, C:cytosol; C:extrinsic component of membrane; C:nucleus; C:plasma membrane;, F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:regulation of G protein-coupled receptor signaling pathway; scaffold90 indexed_genome mRNA 4975914 5114083 . - . ID=transcript_12514;O43166 J3KP19 O95321 Q9UDU4 Q9UNU4,Signal-induced proliferation-associated 1-like protein 1,High-risk human papilloma viruses E6 oncoproteins targeted protein 1;, PF02145;PF11881;, GO:0015629;GO:0005737;GO:0043197;GO:0005886;GO:0014069;GO:0046875;GO:0005096;GO:0031532;GO:0090630;GO:0048013;GO:0050770;GO:0048814;GO:0061001;GO:0043087;GO:0051056;GO:0048167;, C:actin cytoskeleton; C:cytoplasm; C:dendritic spine; C:plasma membrane; C:postsynaptic density;, F:ephrin receptor binding; F:GTPase activator activity;, P:actin cytoskeleton reorganization; P:activation of GTPase activity; P:ephrin receptor signaling pathway; P:regulation of axonogenesis; P:regulation of dendrite morphogenesis; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:regulation of synaptic plasticity;|O43166 J3KP19 O95321 Q9UDU4 Q9UNU4,Signal-induced proliferation-associated 1-like protein 1,High-risk human papilloma viruses E6 oncoproteins targeted protein 1;, PF02145;PF11881;, GO:0015629;GO:0005737;GO:0043197;GO:0005886;GO:0014069;GO:0046875;GO:0005096;GO:0031532;GO:0090630;GO:0048013;GO:0050770;GO:0048814;GO:0061001;GO:0043087;GO:0051056;GO:0048167;, C:actin cytoskeleton; C:cytoplasm; C:dendritic spine; C:plasma membrane; C:postsynaptic density;, F:ephrin receptor binding; F:GTPase activator activity;, P:actin cytoskeleton reorganization; P:activation of GTPase activity; P:ephrin receptor signaling pathway; P:regulation of axonogenesis; P:regulation of dendrite morphogenesis; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:regulation of synaptic plasticity;|O43166 J3KP19 O95321 Q9UDU4 Q9UNU4,Signal-induced proliferation-associated 1-like protein 1,High-risk human papilloma viruses E6 oncoproteins targeted protein 1;, PF02145;PF11881;, GO:0015629;GO:0005737;GO:0043197;GO:0005886;GO:0014069;GO:0046875;GO:0005096;GO:0031532;GO:0090630;GO:0048013;GO:0050770;GO:0048814;GO:0061001;GO:0043087;GO:0051056;GO:0048167;, C:actin cytoskeleton; C:cytoplasm; C:dendritic spine; C:plasma membrane; C:postsynaptic density;, F:ephrin receptor binding; F:GTPase activator activity;, P:actin cytoskeleton reorganization; P:activation of GTPase activity; P:ephrin receptor signaling pathway; P:regulation of axonogenesis; P:regulation of dendrite morphogenesis; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:regulation of synaptic plasticity;|O43166 J3KP19 O95321 Q9UDU4 Q9UNU4,Signal-induced proliferation-associated 1-like protein 1,High-risk human papilloma viruses E6 oncoproteins targeted protein 1;, PF02145;PF11881;, GO:0015629;GO:0005737;GO:0043197;GO:0005886;GO:0014069;GO:0046875;GO:0005096;GO:0031532;GO:0090630;GO:0048013;GO:0050770;GO:0048814;GO:0061001;GO:0043087;GO:0051056;GO:0048167;, C:actin cytoskeleton; C:cytoplasm; C:dendritic spine; C:plasma membrane; C:postsynaptic density;, F:ephrin receptor binding; F:GTPase activator activity;, P:actin cytoskeleton reorganization; P:activation of GTPase activity; P:ephrin receptor signaling pathway; P:regulation of axonogenesis; P:regulation of dendrite morphogenesis; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:regulation of synaptic plasticity; scaffold90 indexed_genome mRNA 5515120 5520408 . - . ID=transcript_12515;Q96RV3 B2RTR6 O94897 Q96AI7 Q9Y2J9,Pecanex-like protein 1 {ECO:0000305},Pecanex homolog protein 1 {ECO:0000312|HGNC:HGNC:19740};, PF05041;, GO:0016021;, C:integral component of membrane; scaffold90 indexed_genome mRNA 5520471 5629955 . - . ID=transcript_12516;Q96RV3 B2RTR6 O94897 Q96AI7 Q9Y2J9,Pecanex-like protein 1 {ECO:0000305},Pecanex homolog protein 1 {ECO:0000312|HGNC:HGNC:19740};, PF05041;, GO:0016021;, C:integral component of membrane;|Q96RV3 B2RTR6 O94897 Q96AI7 Q9Y2J9,Pecanex-like protein 1 {ECO:0000305},Pecanex homolog protein 1 {ECO:0000312|HGNC:HGNC:19740};, PF05041;, GO:0016021;, C:integral component of membrane;|Q96RV3 B2RTR6 O94897 Q96AI7 Q9Y2J9,Pecanex-like protein 1 {ECO:0000305},Pecanex homolog protein 1 {ECO:0000312|HGNC:HGNC:19740};, PF05041;, GO:0016021;, C:integral component of membrane;|Q96RV3 B2RTR6 O94897 Q96AI7 Q9Y2J9,Pecanex-like protein 1 {ECO:0000305},Pecanex homolog protein 1 {ECO:0000312|HGNC:HGNC:19740};, PF05041;, GO:0016021;, C:integral component of membrane; scaffold90 indexed_genome mRNA 5654675 5658661 . + . ID=transcript_12517;Q96RV3 B2RTR6 O94897 Q96AI7 Q9Y2J9,Pecanex-like protein 1 {ECO:0000305},Pecanex homolog protein 1 {ECO:0000312|HGNC:HGNC:19740};, PF05041;, GO:0016021;, C:integral component of membrane; scaffold91 indexed_genome mRNA 430696 485496 . - . ID=transcript_12518;P01138 A1A4E5 Q6FHA0 Q96P60 Q9P2Q8 Q9UKL8,Beta-nerve growth factor {ECO:0000303|PubMed:6688123},, PF00243;, GO:0030424;GO:0005829;GO:0030425;GO:0031904;GO:0005576;GO:0005615;GO:0005796;GO:0008021;GO:0008656;GO:0038177;GO:0008083;GO:0008289;GO:0008191;GO:0005163;GO:0006919;GO:0000186;GO:0008625;GO:0007613;GO:0050804;GO:0043066;GO:0008285;GO:0043154;GO:0043524;GO:0021675;GO:0032455;GO:0038180;GO:0051402;GO:0048812;GO:0048011;GO:0007422;GO:0048015;GO:0043065;GO:0050772;GO:0048672;GO:0043388;GO:0010628;GO:0045666;GO:0033138;GO:0046579;GO:0043281;GO:0045664;GO:0007169;, C:axon; C:cytosol; C:dendrite; C:endosome lumen; C:extracellular region; C:extracellular space; C:Golgi lumen; C:synaptic vesicle;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:death receptor agonist activity; F:growth factor activity; F:lipid binding; F:metalloendopeptidase inhibitor activity; F:nerve growth factor receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of MAPKK activity; P:extrinsic apoptotic signaling pathway via death domain receptors; P:memory; P:modulation of chemical synaptic transmission; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of neuron apoptotic process; P:nerve development; P:nerve growth factor processing; P:nerve growth factor signaling pathway; P:neuron apoptotic process; P:neuron projection morphogenesis; P:neurotrophin TRK receptor signaling pathway; P:peripheral nervous system development; P:phosphatidylinositol-mediated signaling; P:positive regulation of apoptotic process; P:positive regulation of axonogenesis; P:positive regulation of collateral sprouting; P:positive regulation of DNA binding; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of Ras protein signal transduction; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of neuron differentiation; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold91 indexed_genome mRNA 770208 811221 . + . ID=transcript_12519;Q8TAA9 Q5T1D3 Q5T1D4 Q86WG8 Q8N559,Vang-like protein 1,Loop-tail protein 2 homolog;Strabismus 2;Van Gogh-like protein 1;, PF06638;, GO:0016021;GO:0016328;GO:0005886;GO:0007275;GO:0043473;GO:0060071;, C:integral component of membrane; C:lateral plasma membrane; C:plasma membrane;, , P:multicellular organism development; P:pigmentation; P:Wnt signaling pathway, planar cell polarity pathway; scaffold91 indexed_genome mRNA 822757 897515 . - . ID=transcript_12520;O14958 B2R7M6 B4DIB0 Q5T1D2 Q8TBW8,Calsequestrin-2,Calsequestrin, cardiac muscle isoform;, PF01216;, GO:0034704;GO:0005737;GO:0014701;GO:0016529;GO:0033018;GO:0033017;GO:0030018;GO:0005509;GO:0048306;GO:0042803;GO:0060048;GO:0071313;GO:0005513;GO:0034220;GO:1901017;GO:0043267;GO:0060315;GO:0051258;GO:0086029;GO:1903779;GO:0010881;GO:0010649;GO:0002027;GO:0060306;GO:0051279;GO:0010880;GO:0051208;GO:0006941;, C:calcium channel complex; C:cytoplasm; C:junctional sarcoplasmic reticulum membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane; C:Z disc;, F:calcium ion binding; F:calcium-dependent protein binding; F:protein homodimerization activity;, P:cardiac muscle contraction; P:cellular response to caffeine; P:detection of calcium ion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of potassium ion transport; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:protein polymerization; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of heart rate; P:regulation of membrane repolarization; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:sequestering of calcium ion; P:striated muscle contraction;|O14958 B2R7M6 B4DIB0 Q5T1D2 Q8TBW8,Calsequestrin-2,Calsequestrin, cardiac muscle isoform;, PF01216;, GO:0034704;GO:0005737;GO:0014701;GO:0016529;GO:0033018;GO:0033017;GO:0030018;GO:0005509;GO:0048306;GO:0042803;GO:0060048;GO:0071313;GO:0005513;GO:0034220;GO:1901017;GO:0043267;GO:0060315;GO:0051258;GO:0086029;GO:1903779;GO:0010881;GO:0010649;GO:0002027;GO:0060306;GO:0051279;GO:0010880;GO:0051208;GO:0006941;, C:calcium channel complex; C:cytoplasm; C:junctional sarcoplasmic reticulum membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane; C:Z disc;, F:calcium ion binding; F:calcium-dependent protein binding; F:protein homodimerization activity;, P:cardiac muscle contraction; P:cellular response to caffeine; P:detection of calcium ion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of potassium ion transport; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:protein polymerization; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of heart rate; P:regulation of membrane repolarization; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:sequestering of calcium ion; P:striated muscle contraction;|O14958 B2R7M6 B4DIB0 Q5T1D2 Q8TBW8,Calsequestrin-2,Calsequestrin, cardiac muscle isoform;, PF01216;, GO:0034704;GO:0005737;GO:0014701;GO:0016529;GO:0033018;GO:0033017;GO:0030018;GO:0005509;GO:0048306;GO:0042803;GO:0060048;GO:0071313;GO:0005513;GO:0034220;GO:1901017;GO:0043267;GO:0060315;GO:0051258;GO:0086029;GO:1903779;GO:0010881;GO:0010649;GO:0002027;GO:0060306;GO:0051279;GO:0010880;GO:0051208;GO:0006941;, C:calcium channel complex; C:cytoplasm; C:junctional sarcoplasmic reticulum membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane; C:Z disc;, F:calcium ion binding; F:calcium-dependent protein binding; F:protein homodimerization activity;, P:cardiac muscle contraction; P:cellular response to caffeine; P:detection of calcium ion; P:ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of potassium ion transport; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:protein polymerization; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling; P:regulation of heart rate; P:regulation of membrane repolarization; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:sequestering of calcium ion; P:striated muscle contraction; scaffold91 indexed_genome mRNA 959465 962472 . + . ID=transcript_12521;Q02577 Q5T1P6,Helix-loop-helix protein 2,Class A basic helix-loop-helix protein 34;Nescient helix loop helix 2;, PF00010;, GO:0000785;GO:0005634;GO:0005667;GO:0001228;GO:0000981;GO:0046983;GO:0001102;GO:0000978;GO:1990837;GO:0006915;GO:0021535;GO:0007417;GO:0021888;GO:0008584;GO:0060179;GO:0042698;GO:0007422;GO:0051091;GO:0045944;GO:0006357;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:apoptotic process; P:cell migration in hindbrain; P:central nervous system development; P:hypothalamus gonadotrophin-releasing hormone neuron development; P:male gonad development; P:male mating behavior; P:ovulation cycle; P:peripheral nervous system development; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold91 indexed_genome mRNA 1127956 1176942 . + . ID=transcript_12522;Q8IZD6 A8MUR3 Q6UXP5 Q8TAL9 Q9NSH5,Solute carrier family 22 member 15,Fly-like putative transporter 1;, PF00083;, GO:0016021;GO:0022857;GO:0006811;, C:integral component of membrane;, F:transmembrane transporter activity;, P:ion transport; scaffold91 indexed_genome mRNA 1210462 1237972 . + . ID=transcript_12523;Q8N8X9 Q5TDL7,Protein mab-21-like 3,, PF03281;|Q8N8X9 Q5TDL7,Protein mab-21-like 3,, PF03281; scaffold91 indexed_genome mRNA 1517528 1518708 . + . ID=transcript_12524;Q9UJ21,Sodium/potassium-transporting ATPase subunit alpha-1,Sodium pump subunit alpha-1;, PF00689;PF00690;, GO:0016324;GO:0016323;GO:0005901;GO:0005783;GO:0005768;GO:0070062;GO:1903561;GO:0005794;GO:0016021;GO:0014704;GO:0016328;GO:0042470;GO:0016020;GO:0045121;GO:0031090;GO:0060342;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0043531;GO:0030506;GO:0005524;GO:0051087;GO:0005391;GO:0016791;GO:0043548;GO:0030955;GO:0008556;GO:0019904;GO:0046982;GO:0019901;GO:0031402;GO:1990239;GO:0086002;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0060081;GO:0086009;GO:0086013;GO:0031947;GO:0045822;GO:0045823;GO:0045989;GO:1990573;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0002028;GO:0002026;GO:0055119;GO:0042493;GO:1903416;GO:0036376;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:melanosome; C:membrane; C:membrane raft; C:organelle membrane; C:photoreceptor inner segment membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ADP binding; F:ankyrin binding; F:ATP binding; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:phosphatidylinositol 3-kinase binding; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:sodium ion binding; F:steroid hormone binding;, P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:membrane hyperpolarization; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of glucocorticoid biosynthetic process; P:negative regulation of heart contraction; P:positive regulation of heart contraction; P:positive regulation of striated muscle contraction; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to drug; P:response to glycoside; P:sodium ion export across plasma membrane; scaffold91 indexed_genome mRNA 1519388 1519949 . - . ID=transcript_12525;Q9UJ21,Sodium/potassium-transporting ATPase subunit alpha-1,Sodium pump subunit alpha-1;, PF00689;PF00690;, GO:0016324;GO:0016323;GO:0005901;GO:0005783;GO:0005768;GO:0070062;GO:1903561;GO:0005794;GO:0016021;GO:0014704;GO:0016328;GO:0042470;GO:0016020;GO:0045121;GO:0031090;GO:0060342;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0043531;GO:0030506;GO:0005524;GO:0051087;GO:0005391;GO:0016791;GO:0043548;GO:0030955;GO:0008556;GO:0019904;GO:0046982;GO:0019901;GO:0031402;GO:1990239;GO:0086002;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0060081;GO:0086009;GO:0086013;GO:0031947;GO:0045822;GO:0045823;GO:0045989;GO:1990573;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0002028;GO:0002026;GO:0055119;GO:0042493;GO:1903416;GO:0036376;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:melanosome; C:membrane; C:membrane raft; C:organelle membrane; C:photoreceptor inner segment membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ADP binding; F:ankyrin binding; F:ATP binding; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:phosphatidylinositol 3-kinase binding; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:sodium ion binding; F:steroid hormone binding;, P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:membrane hyperpolarization; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of glucocorticoid biosynthetic process; P:negative regulation of heart contraction; P:positive regulation of heart contraction; P:positive regulation of striated muscle contraction; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to drug; P:response to glycoside; P:sodium ion export across plasma membrane; scaffold91 indexed_genome mRNA 1520234 1522340 . - . ID=transcript_12526;Q9UJ21,Sodium/potassium-transporting ATPase subunit alpha-1,Sodium pump subunit alpha-1;, PF00689;PF00690;, GO:0016324;GO:0016323;GO:0005901;GO:0005783;GO:0005768;GO:0070062;GO:1903561;GO:0005794;GO:0016021;GO:0014704;GO:0016328;GO:0042470;GO:0016020;GO:0045121;GO:0031090;GO:0060342;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0043531;GO:0030506;GO:0005524;GO:0051087;GO:0005391;GO:0016791;GO:0043548;GO:0030955;GO:0008556;GO:0019904;GO:0046982;GO:0019901;GO:0031402;GO:1990239;GO:0086002;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0060081;GO:0086009;GO:0086013;GO:0031947;GO:0045822;GO:0045823;GO:0045989;GO:1990573;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0002028;GO:0002026;GO:0055119;GO:0042493;GO:1903416;GO:0036376;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:melanosome; C:membrane; C:membrane raft; C:organelle membrane; C:photoreceptor inner segment membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ADP binding; F:ankyrin binding; F:ATP binding; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:phosphatidylinositol 3-kinase binding; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:sodium ion binding; F:steroid hormone binding;, P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:membrane hyperpolarization; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of glucocorticoid biosynthetic process; P:negative regulation of heart contraction; P:positive regulation of heart contraction; P:positive regulation of striated muscle contraction; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to drug; P:response to glycoside; P:sodium ion export across plasma membrane; scaffold91 indexed_genome mRNA 1522396 1523284 . + . ID=transcript_12527;Q9UJ21,Sodium/potassium-transporting ATPase subunit alpha-1,Sodium pump subunit alpha-1;, PF00689;PF00690;, GO:0016324;GO:0016323;GO:0005901;GO:0005783;GO:0005768;GO:0070062;GO:1903561;GO:0005794;GO:0016021;GO:0014704;GO:0016328;GO:0042470;GO:0016020;GO:0045121;GO:0031090;GO:0060342;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0043531;GO:0030506;GO:0005524;GO:0051087;GO:0005391;GO:0016791;GO:0043548;GO:0030955;GO:0008556;GO:0019904;GO:0046982;GO:0019901;GO:0031402;GO:1990239;GO:0086002;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0060081;GO:0086009;GO:0086013;GO:0031947;GO:0045822;GO:0045823;GO:0045989;GO:1990573;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0002028;GO:0002026;GO:0055119;GO:0042493;GO:1903416;GO:0036376;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:melanosome; C:membrane; C:membrane raft; C:organelle membrane; C:photoreceptor inner segment membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ADP binding; F:ankyrin binding; F:ATP binding; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:phosphatidylinositol 3-kinase binding; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:sodium ion binding; F:steroid hormone binding;, P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:membrane hyperpolarization; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of glucocorticoid biosynthetic process; P:negative regulation of heart contraction; P:positive regulation of heart contraction; P:positive regulation of striated muscle contraction; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to drug; P:response to glycoside; P:sodium ion export across plasma membrane; scaffold91 indexed_genome mRNA 1523432 1524164 . + . ID=transcript_12528;Q9UJ21,Sodium/potassium-transporting ATPase subunit alpha-1,Sodium pump subunit alpha-1;, PF00689;PF00690;, GO:0016324;GO:0016323;GO:0005901;GO:0005783;GO:0005768;GO:0070062;GO:1903561;GO:0005794;GO:0016021;GO:0014704;GO:0016328;GO:0042470;GO:0016020;GO:0045121;GO:0031090;GO:0060342;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0043531;GO:0030506;GO:0005524;GO:0051087;GO:0005391;GO:0016791;GO:0043548;GO:0030955;GO:0008556;GO:0019904;GO:0046982;GO:0019901;GO:0031402;GO:1990239;GO:0086002;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0060081;GO:0086009;GO:0086013;GO:0031947;GO:0045822;GO:0045823;GO:0045989;GO:1990573;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0002028;GO:0002026;GO:0055119;GO:0042493;GO:1903416;GO:0036376;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:melanosome; C:membrane; C:membrane raft; C:organelle membrane; C:photoreceptor inner segment membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ADP binding; F:ankyrin binding; F:ATP binding; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:phosphatidylinositol 3-kinase binding; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:sodium ion binding; F:steroid hormone binding;, P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:membrane hyperpolarization; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of glucocorticoid biosynthetic process; P:negative regulation of heart contraction; P:positive regulation of heart contraction; P:positive regulation of striated muscle contraction; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to drug; P:response to glycoside; P:sodium ion export across plasma membrane; scaffold91 indexed_genome mRNA 1524260 1528893 . - . ID=transcript_12529;Q9UJ21,Sodium/potassium-transporting ATPase subunit alpha-1,Sodium pump subunit alpha-1;, PF00689;PF00690;, GO:0016324;GO:0016323;GO:0005901;GO:0005783;GO:0005768;GO:0070062;GO:1903561;GO:0005794;GO:0016021;GO:0014704;GO:0016328;GO:0042470;GO:0016020;GO:0045121;GO:0031090;GO:0060342;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0005890;GO:0036126;GO:0030315;GO:0043531;GO:0030506;GO:0005524;GO:0051087;GO:0005391;GO:0016791;GO:0043548;GO:0030955;GO:0008556;GO:0019904;GO:0046982;GO:0019901;GO:0031402;GO:1990239;GO:0086002;GO:0086064;GO:0030007;GO:0071260;GO:0071383;GO:0006883;GO:0034220;GO:0060081;GO:0086009;GO:0086013;GO:0031947;GO:0045822;GO:0045823;GO:0045989;GO:1990573;GO:1902600;GO:0008217;GO:1903779;GO:0086004;GO:0002028;GO:0002026;GO:0055119;GO:0042493;GO:1903416;GO:0036376;, C:apical plasma membrane; C:basolateral plasma membrane; C:caveola; C:endoplasmic reticulum; C:endosome; C:extracellular exosome; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:melanosome; C:membrane; C:membrane raft; C:organelle membrane; C:photoreceptor inner segment membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;, F:ADP binding; F:ankyrin binding; F:ATP binding; F:chaperone binding; F:P-type sodium:potassium-exchanging ATPase activity; F:phosphatase activity; F:phosphatidylinositol 3-kinase binding; F:potassium ion binding; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:protein domain specific binding; F:protein heterodimerization activity; F:protein kinase binding; F:sodium ion binding; F:steroid hormone binding;, P:cardiac muscle cell action potential involved in contraction; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to mechanical stimulus; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:membrane hyperpolarization; P:membrane repolarization; P:membrane repolarization during cardiac muscle cell action potential; P:negative regulation of glucocorticoid biosynthetic process; P:negative regulation of heart contraction; P:positive regulation of heart contraction; P:positive regulation of striated muscle contraction; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell contraction; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to drug; P:response to glycoside; P:sodium ion export across plasma membrane; scaffold91 indexed_genome mRNA 1664233 1713697 . - . ID=transcript_12530;P19256 A8K7G5 Q5U053 Q6IB65 Q96KI9,Lymphocyte function-associated antigen 3,Surface glycoprotein LFA-3;, , GO:0009986;GO:0070062;GO:0101003;GO:0005887;GO:0016020;GO:0005886;GO:0030667;GO:0005102;GO:0098609;GO:0071346;GO:0071356;GO:0034113;GO:0050900;GO:0043312;GO:0032757;, C:cell surface; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, F:signaling receptor binding;, P:cell-cell adhesion; P:cellular response to interferon-gamma; P:cellular response to tumor necrosis factor; P:heterotypic cell-cell adhesion; P:leukocyte migration; P:neutrophil degranulation; P:positive regulation of interleukin-8 production; scaffold91 indexed_genome mRNA 1734220 1746156 . - . ID=transcript_12531;O75054 A6NJZ6 A6NMC7,Immunoglobulin superfamily member 3,Glu-Trp-Ile EWI motif-containing protein 3;, PF07686;, GO:0009986;GO:0016021;GO:0032808;, C:cell surface; C:integral component of membrane;, , P:lacrimal gland development; scaffold91 indexed_genome mRNA 1915453 1930163 . + . ID=transcript_12532;P06729 Q96TE5,T-cell surface antigen CD2,Erythrocyte receptor;LFA-2;LFA-3 receptor;Rosette receptor;T-cell surface antigen T11/Leu-5;, PF05790;PF07686;, GO:0046658;GO:0009986;GO:0005911;GO:0009898;GO:0009897;GO:0005576;GO:0005887;GO:0045121;GO:0005886;GO:0032991;GO:0042802;GO:0043621;GO:0030971;GO:0038023;GO:0005102;GO:0006915;GO:0007166;GO:0098609;GO:0034113;GO:0050900;GO:0001766;GO:0030101;GO:0032729;GO:0032757;GO:0030887;GO:0032760;GO:0045580;GO:0042110;, C:anchored component of plasma membrane; C:cell surface; C:cell-cell junction; C:cytoplasmic side of plasma membrane; C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane; C:protein-containing complex;, F:identical protein binding; F:protein self-association; F:receptor tyrosine kinase binding; F:signaling receptor activity; F:signaling receptor binding;, P:apoptotic process; P:cell surface receptor signaling pathway; P:cell-cell adhesion; P:heterotypic cell-cell adhesion; P:leukocyte migration; P:membrane raft polarization; P:natural killer cell activation; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-8 production; P:positive regulation of myeloid dendritic cell activation; P:positive regulation of tumor necrosis factor production; P:regulation of T cell differentiation; P:T cell activation; scaffold91 indexed_genome mRNA 2097742 2145312 . + . ID=transcript_12533;Q9P2B2 Q5VVU9 Q8N2K6,Prostaglandin F2 receptor negative regulator,CD9 partner 1;Glu-Trp-Ile EWI motif-containing protein F;Prostaglandin F2-alpha receptor regulatory protein;Prostaglandin F2-alpha receptor-associated protein;, PF07686;, GO:0009986;GO:0005789;GO:0005794;GO:0016021;GO:0034389;GO:0014905;, C:cell surface; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:lipid droplet organization; P:myoblast fusion involved in skeletal muscle regeneration;|Q9P2B2 Q5VVU9 Q8N2K6,Prostaglandin F2 receptor negative regulator,CD9 partner 1;Glu-Trp-Ile EWI motif-containing protein F;Prostaglandin F2-alpha receptor regulatory protein;Prostaglandin F2-alpha receptor-associated protein;, PF07686;, GO:0009986;GO:0005789;GO:0005794;GO:0016021;GO:0034389;GO:0014905;, C:cell surface; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:lipid droplet organization; P:myoblast fusion involved in skeletal muscle regeneration; scaffold91 indexed_genome mRNA 2219149 2235704 . - . ID=transcript_12534;Q9UNY4 A8K4Q2 O75921 Q5T2K7 Q5VVU8 Q8N6I8,Transcription termination factor 2,Lodestar homolog;RNA polymerase II termination factor;Transcription release factor 2;, PF00271;PF00176;PF06839;, GO:0005829;GO:0005681;GO:0008023;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0008270;GO:0006353;GO:0006397;GO:0008380;GO:0006369;, C:cytosol; C:spliceosomal complex; C:transcription elongation factor complex;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:zinc ion binding;, P:DNA-templated transcription, termination; P:mRNA processing; P:RNA splicing; P:termination of RNA polymerase II transcription; scaffold91 indexed_genome mRNA 2262495 2263338 . + . ID=transcript_12535;Q9UNY4 A8K4Q2 O75921 Q5T2K7 Q5VVU8 Q8N6I8,Transcription termination factor 2,Lodestar homolog;RNA polymerase II termination factor;Transcription release factor 2;, PF00271;PF00176;PF06839;, GO:0005829;GO:0005681;GO:0008023;GO:0005524;GO:0003677;GO:0008094;GO:0004386;GO:0070615;GO:0008270;GO:0006353;GO:0006397;GO:0008380;GO:0006369;, C:cytosol; C:spliceosomal complex; C:transcription elongation factor complex;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity; F:helicase activity; F:nucleosome-dependent ATPase activity; F:zinc ion binding;, P:DNA-templated transcription, termination; P:mRNA processing; P:RNA splicing; P:termination of RNA polymerase II transcription; scaffold91 indexed_genome mRNA 2284370 2293883 . - . ID=transcript_12536;Q9H8W5 Q53GN0 Q5T2K4 Q5T2K5 Q8IYV6,Tripartite motif-containing protein 45,RING finger protein 99;, PF00630;PF00643;PF13445;, GO:0000785;GO:0005829;GO:0045171;GO:0005654;GO:0004842;GO:0008270;GO:0060348;GO:0045893;, C:chromatin; C:cytosol; C:intercellular bridge; C:nucleoplasm;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:bone development; P:positive regulation of transcription, DNA-templated;|Q9H8W5 Q53GN0 Q5T2K4 Q5T2K5 Q8IYV6,Tripartite motif-containing protein 45,RING finger protein 99;, PF00630;PF00643;PF13445;, GO:0000785;GO:0005829;GO:0045171;GO:0005654;GO:0004842;GO:0008270;GO:0060348;GO:0045893;, C:chromatin; C:cytosol; C:intercellular bridge; C:nucleoplasm;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:bone development; P:positive regulation of transcription, DNA-templated;|Q9H8W5 Q53GN0 Q5T2K4 Q5T2K5 Q8IYV6,Tripartite motif-containing protein 45,RING finger protein 99;, PF00630;PF00643;PF13445;, GO:0000785;GO:0005829;GO:0045171;GO:0005654;GO:0004842;GO:0008270;GO:0060348;GO:0045893;, C:chromatin; C:cytosol; C:intercellular bridge; C:nucleoplasm;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:bone development; P:positive regulation of transcription, DNA-templated;|Q9H8W5 Q53GN0 Q5T2K4 Q5T2K5 Q8IYV6,Tripartite motif-containing protein 45,RING finger protein 99;, PF00630;PF00643;PF13445;, GO:0000785;GO:0005829;GO:0045171;GO:0005654;GO:0004842;GO:0008270;GO:0060348;GO:0045893;, C:chromatin; C:cytosol; C:intercellular bridge; C:nucleoplasm;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:bone development; P:positive regulation of transcription, DNA-templated;|Q9H8W5 Q53GN0 Q5T2K4 Q5T2K5 Q8IYV6,Tripartite motif-containing protein 45,RING finger protein 99;, PF00630;PF00643;PF13445;, GO:0000785;GO:0005829;GO:0045171;GO:0005654;GO:0004842;GO:0008270;GO:0060348;GO:0045893;, C:chromatin; C:cytosol; C:intercellular bridge; C:nucleoplasm;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:bone development; P:positive regulation of transcription, DNA-templated; scaffold91 indexed_genome mRNA 2336024 2341688 . - . ID=transcript_12537;Q7Z7D3 Q0GN76 Q45VN0 Q5WPZ3 Q6P097 Q9H6B2,V-set domain-containing T-cell activation inhibitor 1,B7 homolog 4;B7h.5;Immune costimulatory protein B7-H4;Protein B7S1;T-cell costimulatory molecule B7x;, PF07686;, GO:0009897;GO:0016021;GO:0005102;GO:0002250;GO:0043066;GO:0050868;GO:0042130;GO:0001817;GO:0050852;, C:external side of plasma membrane; C:integral component of membrane;, F:signaling receptor binding;, P:adaptive immune response; P:negative regulation of apoptotic process; P:negative regulation of T cell activation; P:negative regulation of T cell proliferation; P:regulation of cytokine production; P:T cell receptor signaling pathway; scaffold91 indexed_genome mRNA 2542908 2695614 . + . ID=transcript_12538;O60476 Q9H510,Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB,Mannosidase alpha class 1A member 2;Processing alpha-1,2-mannosidase IB;, PF01532;, GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005509;GO:0004571;GO:0005975;GO:1904381;GO:0048286;GO:0006491;GO:0006486;GO:0007585;, C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:carbohydrate metabolic process; P:Golgi apparatus mannose trimming; P:lung alveolus development; P:N-glycan processing; P:protein glycosylation; P:respiratory gaseous exchange by respiratory system; scaffold91 indexed_genome mRNA 2767959 2787323 . - . ID=transcript_12539;Q5VWP2 A3KMG2 Q8NE25 Q9NXK0,Terminal nucleotidyltransferase 5C {ECO:0000305},Non-canonical poly(A) polymerase FAM46C {ECO:0000303|PubMed:28931820};, PF07984;, GO:0005737;GO:0005654;GO:0005634;GO:1990817;GO:0003723;GO:0001701;GO:0048255;GO:0016032;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:RNA adenylyltransferase activity; F:RNA binding;, P:in utero embryonic development; P:mRNA stabilization; P:viral process; scaffold91 indexed_genome mRNA 3007464 3069640 . - . ID=transcript_12540;Q9NXN4 Q96DZ0,Ganglioside-induced differentiation-associated protein 2,, PF13716;PF01661;, GO:0005765;GO:0032526;, C:lysosomal membrane;, , P:response to retinoic acid; scaffold91 indexed_genome mRNA 3069930 3108445 . + . ID=transcript_12541;Q9UNX4,WD repeat-containing protein 3,, PF12894;PF04003;PF00400;, GO:0031965;GO:0005730;GO:0005654;GO:0034388;GO:0032040;GO:0003723;GO:0030515;GO:0030490;GO:0006364;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding; F:snoRNA binding;, P:maturation of SSU-rRNA; P:rRNA processing; scaffold91 indexed_genome mRNA 4074451 4124119 . - . ID=transcript_12542;Q96SF7 Q08E76 Q5JT54 Q5T9S7,T-box transcription factor TBX15,T-box transcription factor TBX14;, PF00907;, GO:0000785;GO:0090571;GO:0000981;GO:0001227;GO:0042803;GO:0000978;GO:1990837;GO:0001708;GO:0048701;GO:0006357;, C:chromatin; C:RNA polymerase II transcription repressor complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell fate specification; P:embryonic cranial skeleton morphogenesis; P:regulation of transcription by RNA polymerase II; scaffold91 indexed_genome mRNA 4124172 4195359 . - . ID=transcript_12543;Q96SF7 Q08E76 Q5JT54 Q5T9S7,T-box transcription factor TBX15,T-box transcription factor TBX14;, PF00907;, GO:0000785;GO:0090571;GO:0000981;GO:0001227;GO:0042803;GO:0000978;GO:1990837;GO:0001708;GO:0048701;GO:0006357;, C:chromatin; C:RNA polymerase II transcription repressor complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell fate specification; P:embryonic cranial skeleton morphogenesis; P:regulation of transcription by RNA polymerase II; scaffold91 indexed_genome mRNA 4230216 4251504 . - . ID=transcript_12544;Q9UGM6 B1ALR1 B2R9D4 Q53FT4 Q5VUD2 Q86TQ0,Tryptophan--tRNA ligase, mitochondrial,(Mt)TrpRS;Tryptophanyl-tRNA synthetase;, PF00579;, GO:0005759;GO:0005739;GO:0005654;GO:0005886;GO:0005524;GO:0004830;GO:0070183;GO:0006418;GO:0006436;GO:0001570;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:tryptophan-tRNA ligase activity;, P:mitochondrial tryptophanyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; P:tryptophanyl-tRNA aminoacylation; P:vasculogenesis; scaffold91 indexed_genome mRNA 4565568 4583630 . + . ID=transcript_12545;Q9NYQ3 Q2TU86 Q5QP00 Q9UJS6,Hydroxyacid oxidase 2,(S)-2-hydroxy-acid oxidase, peroxisomal;Cell growth-inhibiting gene 16 protein;Long chain alpha-hydroxy acid oxidase;Long-chain L-2-hydroxy acid oxidase;, PF01070;, GO:0005829;GO:0005782;GO:0005777;GO:0003973;GO:0010181;GO:0052853;GO:0052854;GO:0052852;GO:0009062;GO:0019395;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:(S)-2-hydroxy-acid oxidase activity; F:FMN binding; F:long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity; F:medium-chain-(S)-2-hydroxy-acid oxidase activity; F:very-long-chain-(S)-2-hydroxy-acid oxidase activity;, P:fatty acid catabolic process; P:fatty acid oxidation; P:protein localization;|Q9NYQ3 Q2TU86 Q5QP00 Q9UJS6,Hydroxyacid oxidase 2,(S)-2-hydroxy-acid oxidase, peroxisomal;Cell growth-inhibiting gene 16 protein;Long chain alpha-hydroxy acid oxidase;Long-chain L-2-hydroxy acid oxidase;, PF01070;, GO:0005829;GO:0005782;GO:0005777;GO:0003973;GO:0010181;GO:0052853;GO:0052854;GO:0052852;GO:0009062;GO:0019395;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:(S)-2-hydroxy-acid oxidase activity; F:FMN binding; F:long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity; F:medium-chain-(S)-2-hydroxy-acid oxidase activity; F:very-long-chain-(S)-2-hydroxy-acid oxidase activity;, P:fatty acid catabolic process; P:fatty acid oxidation; P:protein localization;|Q9NYQ3 Q2TU86 Q5QP00 Q9UJS6,Hydroxyacid oxidase 2,(S)-2-hydroxy-acid oxidase, peroxisomal;Cell growth-inhibiting gene 16 protein;Long chain alpha-hydroxy acid oxidase;Long-chain L-2-hydroxy acid oxidase;, PF01070;, GO:0005829;GO:0005782;GO:0005777;GO:0003973;GO:0010181;GO:0052853;GO:0052854;GO:0052852;GO:0009062;GO:0019395;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:(S)-2-hydroxy-acid oxidase activity; F:FMN binding; F:long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity; F:medium-chain-(S)-2-hydroxy-acid oxidase activity; F:very-long-chain-(S)-2-hydroxy-acid oxidase activity;, P:fatty acid catabolic process; P:fatty acid oxidation; P:protein localization;|Q9NYQ3 Q2TU86 Q5QP00 Q9UJS6,Hydroxyacid oxidase 2,(S)-2-hydroxy-acid oxidase, peroxisomal;Cell growth-inhibiting gene 16 protein;Long chain alpha-hydroxy acid oxidase;Long-chain L-2-hydroxy acid oxidase;, PF01070;, GO:0005829;GO:0005782;GO:0005777;GO:0003973;GO:0010181;GO:0052853;GO:0052854;GO:0052852;GO:0009062;GO:0019395;GO:0008104;, C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:(S)-2-hydroxy-acid oxidase activity; F:FMN binding; F:long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity; F:medium-chain-(S)-2-hydroxy-acid oxidase activity; F:very-long-chain-(S)-2-hydroxy-acid oxidase activity;, P:fatty acid catabolic process; P:fatty acid oxidation; P:protein localization; scaffold91 indexed_genome mRNA 4708057 4739475 . + . ID=transcript_12546;O43175 B2RD08 Q5SZU3 Q9BQ01,D-3-phosphoglycerate dehydrogenase,2-oxoglutarate reductase {ECO:0000305};Malate dehydrogenase {ECO:0000305};, PF00389;PF02826;, GO:0005829;GO:0070062;GO:0009055;GO:0030060;GO:0051287;GO:0004617;GO:0007420;GO:0070314;GO:0009448;GO:0021782;GO:0006541;GO:0006544;GO:0006564;GO:0021915;GO:0031175;GO:0010468;GO:0021510;GO:0019530;GO:0006566;, C:cytosol; C:extracellular exosome;, F:electron transfer activity; F:L-malate dehydrogenase activity; F:NAD binding; F:phosphoglycerate dehydrogenase activity;, P:brain development; P:G1 to G0 transition; P:gamma-aminobutyric acid metabolic process; P:glial cell development; P:glutamine metabolic process; P:glycine metabolic process; P:L-serine biosynthetic process; P:neural tube development; P:neuron projection development; P:regulation of gene expression; P:spinal cord development; P:taurine metabolic process; P:threonine metabolic process; scaffold91 indexed_genome mRNA 4744764 4770120 . - . ID=transcript_12547;P54868 B7Z8R3 D3Y5K6 Q5SZU2 Q6IBF4,Hydroxymethylglutaryl-CoA synthase, mitochondrial,3-hydroxy-3-methylglutaryl coenzyme A synthase;, PF08540;PF01154;, GO:0005759;GO:0005739;GO:0004421;GO:0042802;GO:0006084;GO:0006695;GO:0010142;GO:0046951;GO:0019222;, C:mitochondrial matrix; C:mitochondrion;, F:hydroxymethylglutaryl-CoA synthase activity; F:identical protein binding;, P:acetyl-CoA metabolic process; P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process, mevalonate pathway; P:ketone body biosynthetic process; P:regulation of metabolic process;|P54868 B7Z8R3 D3Y5K6 Q5SZU2 Q6IBF4,Hydroxymethylglutaryl-CoA synthase, mitochondrial,3-hydroxy-3-methylglutaryl coenzyme A synthase;, PF08540;PF01154;, GO:0005759;GO:0005739;GO:0004421;GO:0042802;GO:0006084;GO:0006695;GO:0010142;GO:0046951;GO:0019222;, C:mitochondrial matrix; C:mitochondrion;, F:hydroxymethylglutaryl-CoA synthase activity; F:identical protein binding;, P:acetyl-CoA metabolic process; P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process, mevalonate pathway; P:ketone body biosynthetic process; P:regulation of metabolic process;|P54868 B7Z8R3 D3Y5K6 Q5SZU2 Q6IBF4,Hydroxymethylglutaryl-CoA synthase, mitochondrial,3-hydroxy-3-methylglutaryl coenzyme A synthase;, PF08540;PF01154;, GO:0005759;GO:0005739;GO:0004421;GO:0042802;GO:0006084;GO:0006695;GO:0010142;GO:0046951;GO:0019222;, C:mitochondrial matrix; C:mitochondrion;, F:hydroxymethylglutaryl-CoA synthase activity; F:identical protein binding;, P:acetyl-CoA metabolic process; P:cholesterol biosynthetic process; P:farnesyl diphosphate biosynthetic process, mevalonate pathway; P:ketone body biosynthetic process; P:regulation of metabolic process; scaffold91 indexed_genome mRNA 4913507 5087152 . + . ID=transcript_12548;Q04721 Q5T3X7 Q99734 Q9H240,Neurogenic locus notch homolog protein 2 {ECO:0000305},, PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0009986;GO:0005929;GO:0005789;GO:0005576;GO:0000139;GO:0005887;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0043235;GO:0005509;GO:0019899;GO:0051059;GO:0038023;GO:0009887;GO:0006915;GO:0060413;GO:0007411;GO:0046849;GO:0007050;GO:0001709;GO:1990705;GO:0061073;GO:0042742;GO:0030326;GO:0072104;GO:0072015;GO:0001947;GO:0030097;GO:0072574;GO:0006959;GO:0001701;GO:0002437;GO:0035622;GO:0070986;GO:0002315;GO:0002011;GO:0007275;GO:0035264;GO:0043011;GO:0043066;GO:0010629;GO:0045967;GO:0000122;GO:0007399;GO:0061314;GO:0007219;GO:0060674;GO:0043065;GO:0030513;GO:0070374;GO:0010838;GO:0045672;GO:0046579;GO:0072014;GO:0003184;GO:2000249;GO:2001204;GO:0019827;GO:0006367;GO:0042060;, C:cell surface; C:cilium; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:enzyme binding; F:NF-kappaB binding; F:signaling receptor activity;, P:animal organ morphogenesis; P:apoptotic process; P:atrial septum morphogenesis; P:axon guidance; P:bone remodeling; P:cell cycle arrest; P:cell fate determination; P:cholangiocyte proliferation; P:ciliary body morphogenesis; P:defense response to bacterium; P:embryonic limb morphogenesis; P:glomerular capillary formation; P:glomerular visceral epithelial cell development; P:heart looping; P:hemopoiesis; P:hepatocyte proliferation; P:humoral immune response; P:in utero embryonic development; P:inflammatory response to antigenic stimulus; P:intrahepatic bile duct development; P:left/right axis specification; P:marginal zone B cell differentiation; P:morphogenesis of an epithelial sheet; P:multicellular organism development; P:multicellular organism growth; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of growth rate; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:placenta blood vessel development; P:positive regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of keratinocyte proliferation; P:positive regulation of osteoclast differentiation; P:positive regulation of Ras protein signal transduction; P:proximal tubule development; P:pulmonary valve morphogenesis; P:regulation of actin cytoskeleton reorganization; P:regulation of osteoclast development; P:stem cell population maintenance; P:transcription initiation from RNA polymerase II promoter; P:wound healing;|Q04721 Q5T3X7 Q99734 Q9H240,Neurogenic locus notch homolog protein 2 {ECO:0000305},, PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0009986;GO:0005929;GO:0005789;GO:0005576;GO:0000139;GO:0005887;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0043235;GO:0005509;GO:0019899;GO:0051059;GO:0038023;GO:0009887;GO:0006915;GO:0060413;GO:0007411;GO:0046849;GO:0007050;GO:0001709;GO:1990705;GO:0061073;GO:0042742;GO:0030326;GO:0072104;GO:0072015;GO:0001947;GO:0030097;GO:0072574;GO:0006959;GO:0001701;GO:0002437;GO:0035622;GO:0070986;GO:0002315;GO:0002011;GO:0007275;GO:0035264;GO:0043011;GO:0043066;GO:0010629;GO:0045967;GO:0000122;GO:0007399;GO:0061314;GO:0007219;GO:0060674;GO:0043065;GO:0030513;GO:0070374;GO:0010838;GO:0045672;GO:0046579;GO:0072014;GO:0003184;GO:2000249;GO:2001204;GO:0019827;GO:0006367;GO:0042060;, C:cell surface; C:cilium; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:enzyme binding; F:NF-kappaB binding; F:signaling receptor activity;, P:animal organ morphogenesis; P:apoptotic process; P:atrial septum morphogenesis; P:axon guidance; P:bone remodeling; P:cell cycle arrest; P:cell fate determination; P:cholangiocyte proliferation; P:ciliary body morphogenesis; P:defense response to bacterium; P:embryonic limb morphogenesis; P:glomerular capillary formation; P:glomerular visceral epithelial cell development; P:heart looping; P:hemopoiesis; P:hepatocyte proliferation; P:humoral immune response; P:in utero embryonic development; P:inflammatory response to antigenic stimulus; P:intrahepatic bile duct development; P:left/right axis specification; P:marginal zone B cell differentiation; P:morphogenesis of an epithelial sheet; P:multicellular organism development; P:multicellular organism growth; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of growth rate; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:placenta blood vessel development; P:positive regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of keratinocyte proliferation; P:positive regulation of osteoclast differentiation; P:positive regulation of Ras protein signal transduction; P:proximal tubule development; P:pulmonary valve morphogenesis; P:regulation of actin cytoskeleton reorganization; P:regulation of osteoclast development; P:stem cell population maintenance; P:transcription initiation from RNA polymerase II promoter; P:wound healing;|Q04721 Q5T3X7 Q99734 Q9H240,Neurogenic locus notch homolog protein 2 {ECO:0000305},, PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0009986;GO:0005929;GO:0005789;GO:0005576;GO:0000139;GO:0005887;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0043235;GO:0005509;GO:0019899;GO:0051059;GO:0038023;GO:0009887;GO:0006915;GO:0060413;GO:0007411;GO:0046849;GO:0007050;GO:0001709;GO:1990705;GO:0061073;GO:0042742;GO:0030326;GO:0072104;GO:0072015;GO:0001947;GO:0030097;GO:0072574;GO:0006959;GO:0001701;GO:0002437;GO:0035622;GO:0070986;GO:0002315;GO:0002011;GO:0007275;GO:0035264;GO:0043011;GO:0043066;GO:0010629;GO:0045967;GO:0000122;GO:0007399;GO:0061314;GO:0007219;GO:0060674;GO:0043065;GO:0030513;GO:0070374;GO:0010838;GO:0045672;GO:0046579;GO:0072014;GO:0003184;GO:2000249;GO:2001204;GO:0019827;GO:0006367;GO:0042060;, C:cell surface; C:cilium; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:enzyme binding; F:NF-kappaB binding; F:signaling receptor activity;, P:animal organ morphogenesis; P:apoptotic process; P:atrial septum morphogenesis; P:axon guidance; P:bone remodeling; P:cell cycle arrest; P:cell fate determination; P:cholangiocyte proliferation; P:ciliary body morphogenesis; P:defense response to bacterium; P:embryonic limb morphogenesis; P:glomerular capillary formation; P:glomerular visceral epithelial cell development; P:heart looping; P:hemopoiesis; P:hepatocyte proliferation; P:humoral immune response; P:in utero embryonic development; P:inflammatory response to antigenic stimulus; P:intrahepatic bile duct development; P:left/right axis specification; P:marginal zone B cell differentiation; P:morphogenesis of an epithelial sheet; P:multicellular organism development; P:multicellular organism growth; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of growth rate; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:placenta blood vessel development; P:positive regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of keratinocyte proliferation; P:positive regulation of osteoclast differentiation; P:positive regulation of Ras protein signal transduction; P:proximal tubule development; P:pulmonary valve morphogenesis; P:regulation of actin cytoskeleton reorganization; P:regulation of osteoclast development; P:stem cell population maintenance; P:transcription initiation from RNA polymerase II promoter; P:wound healing;|Q04721 Q5T3X7 Q99734 Q9H240,Neurogenic locus notch homolog protein 2 {ECO:0000305},, PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0009986;GO:0005929;GO:0005789;GO:0005576;GO:0000139;GO:0005887;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0043235;GO:0005509;GO:0019899;GO:0051059;GO:0038023;GO:0009887;GO:0006915;GO:0060413;GO:0007411;GO:0046849;GO:0007050;GO:0001709;GO:1990705;GO:0061073;GO:0042742;GO:0030326;GO:0072104;GO:0072015;GO:0001947;GO:0030097;GO:0072574;GO:0006959;GO:0001701;GO:0002437;GO:0035622;GO:0070986;GO:0002315;GO:0002011;GO:0007275;GO:0035264;GO:0043011;GO:0043066;GO:0010629;GO:0045967;GO:0000122;GO:0007399;GO:0061314;GO:0007219;GO:0060674;GO:0043065;GO:0030513;GO:0070374;GO:0010838;GO:0045672;GO:0046579;GO:0072014;GO:0003184;GO:2000249;GO:2001204;GO:0019827;GO:0006367;GO:0042060;, C:cell surface; C:cilium; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:enzyme binding; F:NF-kappaB binding; F:signaling receptor activity;, P:animal organ morphogenesis; P:apoptotic process; P:atrial septum morphogenesis; P:axon guidance; P:bone remodeling; P:cell cycle arrest; P:cell fate determination; P:cholangiocyte proliferation; P:ciliary body morphogenesis; P:defense response to bacterium; P:embryonic limb morphogenesis; P:glomerular capillary formation; P:glomerular visceral epithelial cell development; P:heart looping; P:hemopoiesis; P:hepatocyte proliferation; P:humoral immune response; P:in utero embryonic development; P:inflammatory response to antigenic stimulus; P:intrahepatic bile duct development; P:left/right axis specification; P:marginal zone B cell differentiation; P:morphogenesis of an epithelial sheet; P:multicellular organism development; P:multicellular organism growth; P:myeloid dendritic cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of growth rate; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:placenta blood vessel development; P:positive regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of keratinocyte proliferation; P:positive regulation of osteoclast differentiation; P:positive regulation of Ras protein signal transduction; P:proximal tubule development; P:pulmonary valve morphogenesis; P:regulation of actin cytoskeleton reorganization; P:regulation of osteoclast development; P:stem cell population maintenance; P:transcription initiation from RNA polymerase II promoter; P:wound healing; scaffold91 indexed_genome mRNA 5177930 5200443 . - . ID=transcript_12549;O75396 A8K1G0,Vesicle-trafficking protein SEC22b,ER-Golgi SNARE of 24 kDa;SEC22 vesicle-trafficking protein homolog B;SEC22 vesicle-trafficking protein-like 1;, PF13774;PF00957;, GO:0030137;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0000139;GO:0016021;GO:0042470;GO:0030670;GO:0031201;GO:0008021;GO:0030133;GO:0005484;GO:0019905;GO:0002479;GO:0048208;GO:0006888;GO:1902902;GO:0045732;GO:0015031;GO:0006890;GO:1990668;GO:0048280;, C:COPI-coated vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:melanosome; C:phagocytic vesicle membrane; C:SNARE complex; C:synaptic vesicle; C:transport vesicle;, F:SNAP receptor activity; F:syntaxin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of autophagosome assembly; P:positive regulation of protein catabolic process; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane; P:vesicle fusion with Golgi apparatus;|O75396 A8K1G0,Vesicle-trafficking protein SEC22b,ER-Golgi SNARE of 24 kDa;SEC22 vesicle-trafficking protein homolog B;SEC22 vesicle-trafficking protein-like 1;, PF13774;PF00957;, GO:0030137;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0000139;GO:0016021;GO:0042470;GO:0030670;GO:0031201;GO:0008021;GO:0030133;GO:0005484;GO:0019905;GO:0002479;GO:0048208;GO:0006888;GO:1902902;GO:0045732;GO:0015031;GO:0006890;GO:1990668;GO:0048280;, C:COPI-coated vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:Golgi membrane; C:integral component of membrane; C:melanosome; C:phagocytic vesicle membrane; C:SNARE complex; C:synaptic vesicle; C:transport vesicle;, F:SNAP receptor activity; F:syntaxin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of autophagosome assembly; P:positive regulation of protein catabolic process; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane; P:vesicle fusion with Golgi apparatus; scaffold91 indexed_genome mRNA 5266180 5428258 . + . ID=transcript_12550;Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization; scaffold91 indexed_genome mRNA 5428775 5453679 . + . ID=transcript_12551;Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6P4A8 A8K4E9 Q9BVV3 Q9H625,Phospholipase B-like 1,LAMA-like protein 1;Lamina ancestor homolog 1;Phospholipase B domain-containing protein 1;, PF04916;, GO:0005829;GO:0005576;GO:0005615;GO:0005764;GO:0004620;GO:0036151;GO:0036152;GO:0036149;GO:0009395;GO:0006644;, C:cytosol; C:extracellular region; C:extracellular space; C:lysosome;, F:phospholipase activity;, P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phospholipid catabolic process; P:phospholipid metabolic process;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization;|Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization; scaffold91 indexed_genome mRNA 5492442 5493327 . + . ID=transcript_12552;Q96M43 Q5T483,Neuroblastoma breakpoint family member 4,, PF06758;, GO:0005737;, C:cytoplasm; scaffold92 indexed_genome mRNA 212426 234902 . + . ID=transcript_12553;Q9Y6Q1 D3DUY7 Q9UEQ1 Q9UJA8,Calpain-6,Calpain-like protease X-linked;Calpamodulin;, PF00168;PF01067;PF00648;, GO:0005737;GO:0048471;GO:0005876;GO:0004198;GO:0008017;GO:0001578;GO:0051493;, C:cytoplasm; C:perinuclear region of cytoplasm; C:spindle microtubule;, F:calcium-dependent cysteine-type endopeptidase activity; F:microtubule binding;, P:microtubule bundle formation; P:regulation of cytoskeleton organization;|Q9Y6Q1 D3DUY7 Q9UEQ1 Q9UJA8,Calpain-6,Calpain-like protease X-linked;Calpamodulin;, PF00168;PF01067;PF00648;, GO:0005737;GO:0048471;GO:0005876;GO:0004198;GO:0008017;GO:0001578;GO:0051493;, C:cytoplasm; C:perinuclear region of cytoplasm; C:spindle microtubule;, F:calcium-dependent cysteine-type endopeptidase activity; F:microtubule binding;, P:microtubule bundle formation; P:regulation of cytoskeleton organization; scaffold92 indexed_genome mRNA 234942 236966 . + . ID=transcript_12554;Q9Y6Q1 D3DUY7 Q9UEQ1 Q9UJA8,Calpain-6,Calpain-like protease X-linked;Calpamodulin;, PF00168;PF01067;PF00648;, GO:0005737;GO:0048471;GO:0005876;GO:0004198;GO:0008017;GO:0001578;GO:0051493;, C:cytoplasm; C:perinuclear region of cytoplasm; C:spindle microtubule;, F:calcium-dependent cysteine-type endopeptidase activity; F:microtubule binding;, P:microtubule bundle formation; P:regulation of cytoskeleton organization; scaffold92 indexed_genome mRNA 252903 380339 . - . ID=transcript_12555;Q7Z3Z8 Q8WWK5 Q8WX23 Q9P0J8,Serine/threonine-protein kinase PAK 3,Beta-PAK;Oligophrenin-3;p21-activated kinase 3;, PF00786;PF00069;, GO:0005737;GO:0005829;GO:0005768;GO:0098978;GO:0005886;GO:0014069;GO:0005524;GO:0004708;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0017124;GO:0031267;GO:0032147;GO:0007409;GO:0071407;GO:0016358;GO:0060997;GO:0048013;GO:0061003;GO:2000573;GO:0010763;GO:0043525;GO:0030833;GO:0050770;GO:0002223;GO:0031098;GO:0050808;GO:0031295;GO:0050852;, C:cytoplasm; C:cytosol; C:endosome; C:glutamatergic synapse; C:plasma membrane; C:postsynaptic density;, F:ATP binding; F:MAP kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:SH3 domain binding; F:small GTPase binding;, P:activation of protein kinase activity; P:axonogenesis; P:cellular response to organic cyclic compound; P:dendrite development; P:dendritic spine morphogenesis; P:ephrin receptor signaling pathway; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of DNA biosynthetic process; P:positive regulation of fibroblast migration; P:positive regulation of neuron apoptotic process; P:regulation of actin filament polymerization; P:regulation of axonogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated protein kinase signaling cascade; P:synapse organization; P:T cell costimulation; P:T cell receptor signaling pathway;|Q7Z3Z8 Q8WWK5 Q8WX23 Q9P0J8,Serine/threonine-protein kinase PAK 3,Beta-PAK;Oligophrenin-3;p21-activated kinase 3;, PF00786;PF00069;, GO:0005737;GO:0005829;GO:0005768;GO:0098978;GO:0005886;GO:0014069;GO:0005524;GO:0004708;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0017124;GO:0031267;GO:0032147;GO:0007409;GO:0071407;GO:0016358;GO:0060997;GO:0048013;GO:0061003;GO:2000573;GO:0010763;GO:0043525;GO:0030833;GO:0050770;GO:0002223;GO:0031098;GO:0050808;GO:0031295;GO:0050852;, C:cytoplasm; C:cytosol; C:endosome; C:glutamatergic synapse; C:plasma membrane; C:postsynaptic density;, F:ATP binding; F:MAP kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:SH3 domain binding; F:small GTPase binding;, P:activation of protein kinase activity; P:axonogenesis; P:cellular response to organic cyclic compound; P:dendrite development; P:dendritic spine morphogenesis; P:ephrin receptor signaling pathway; P:positive regulation of dendritic spine morphogenesis; P:positive regulation of DNA biosynthetic process; P:positive regulation of fibroblast migration; P:positive regulation of neuron apoptotic process; P:regulation of actin filament polymerization; P:regulation of axonogenesis; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated protein kinase signaling cascade; P:synapse organization; P:T cell costimulation; P:T cell receptor signaling pathway; scaffold92 indexed_genome mRNA 676824 805410 . + . ID=transcript_12556;Q9BU40 B1AKD0 B4DMP3 D3DUY6 E9PGS5 Q539E4 Q9Y3H7,Chordin-like protein 1,Neuralin-1;Neurogenesin-1;Ventroptin;, PF00093;, GO:0005788;GO:0005576;GO:0030154;GO:0044267;GO:0001654;GO:0007399;GO:0001503;GO:0043687;GO:0038098;, C:endoplasmic reticulum lumen; C:extracellular region;, , P:cell differentiation; P:cellular protein metabolic process; P:eye development; P:nervous system development; P:ossification; P:post-translational protein modification; P:sequestering of BMP from receptor via BMP binding; scaffold92 indexed_genome mRNA 947009 948662 . - . ID=transcript_12557;Q8NET4 Q9P2M8,Retrotransposon Gag-like protein 9 {ECO:0000312|HGNC:HGNC:29245},Retrotransposon gag domain-containing protein 1;Tumor antigen BJ-HCC-23; scaffold92 indexed_genome mRNA 948663 950236 . - . ID=transcript_12558;Q8NET4 Q9P2M8,Retrotransposon Gag-like protein 9 {ECO:0000312|HGNC:HGNC:29245},Retrotransposon gag domain-containing protein 1;Tumor antigen BJ-HCC-23; scaffold92 indexed_genome mRNA 950284 951537 . + . ID=transcript_12559;Q8NET4 Q9P2M8,Retrotransposon Gag-like protein 9 {ECO:0000312|HGNC:HGNC:29245},Retrotransposon gag domain-containing protein 1;Tumor antigen BJ-HCC-23; scaffold92 indexed_genome mRNA 952139 958834 . - . ID=transcript_12560;Q8NET4 Q9P2M8,Retrotransposon Gag-like protein 9 {ECO:0000312|HGNC:HGNC:29245},Retrotransposon gag domain-containing protein 1;Tumor antigen BJ-HCC-23; scaffold92 indexed_genome mRNA 1196964 1198936 . + . ID=transcript_12561;Q9Y4X0 Q5JYV9 Q6P9D8 Q8WX22 Q9UIQ8,AMME syndrome candidate gene 1 protein,, PF01871;, GO:0005739;GO:0005654;GO:0005634;, C:mitochondrion; C:nucleoplasm; C:nucleus; scaffold92 indexed_genome mRNA 1223569 1389965 . - . ID=transcript_12562;Q5U3C3 B3KSQ8 F5H2P2,Transmembrane protein 164,, PF14808;, GO:0016021;, C:integral component of membrane; scaffold92 indexed_genome mRNA 1730045 1767169 . + . ID=transcript_12563;O60488 D3DUY2 O60848 O60849 Q5JWV8,Long-chain-fatty-acid--CoA ligase 4 {ECO:0000305},Arachidonate--CoA ligase {ECO:0000305};Long-chain acyl-CoA synthetase 4;, PF00501;, GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0016021;GO:0005811;GO:0016020;GO:0044233;GO:0005741;GO:0043025;GO:0005778;GO:0005886;GO:0047676;GO:0005524;GO:0004467;GO:0031957;GO:0060996;GO:0060136;GO:0006631;GO:0015908;GO:0008610;GO:0006629;GO:0001676;GO:0035338;GO:0035336;GO:0032307;GO:0030182;GO:0030307;GO:0032024;GO:0070672;GO:0007584;GO:0019432;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:neuronal cell body; C:peroxisomal membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:ATP binding; F:long-chain fatty acid-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:dendritic spine development; P:embryonic process involved in female pregnancy; P:fatty acid metabolic process; P:fatty acid transport; P:lipid biosynthetic process; P:lipid metabolic process; P:long-chain fatty acid metabolic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:long-chain fatty-acyl-CoA metabolic process; P:negative regulation of prostaglandin secretion; P:neuron differentiation; P:positive regulation of cell growth; P:positive regulation of insulin secretion; P:response to interleukin-15; P:response to nutrient; P:triglyceride biosynthetic process; scaffold92 indexed_genome mRNA 1838295 1844641 . - . ID=transcript_12564;Q9Y3M4 Q9Y3M5,NTF2-related export protein 2,Protein p15-2;, PF02136;, GO:0005829;GO:0044613;GO:0005654;GO:0048471;GO:0051028;GO:0006913;GO:0006606;, C:cytosol; C:nuclear pore central transport channel; C:nucleoplasm; C:perinuclear region of cytoplasm;, , P:mRNA transport; P:nucleocytoplasmic transport; P:protein import into nucleus; scaffold92 indexed_genome mRNA 2379629 2431631 . - . ID=transcript_12565;P29400 Q16006 Q16126 Q6LD84 Q7Z700 Q9NUB7,Collagen alpha-5(IV) chain,, PF01413;PF01391;, GO:0005604;GO:0005587;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0031594;GO:0005201;GO:0030020;GO:0030199;GO:0038063;GO:0030198;GO:0007528;, C:basement membrane; C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space; C:neuromuscular junction;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:extracellular matrix organization; P:neuromuscular junction development; scaffold92 indexed_genome mRNA 2891463 2897698 . + . ID=transcript_12566;Q9Y4L4,Collagen alpha-6(IV) chain,, PF01413;PF01391;, GO:0005587;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0007155;GO:0030199;GO:0038063;GO:0030198;, C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:extracellular matrix organization; scaffold92 indexed_genome mRNA 2909318 2913400 . + . ID=transcript_12567;Q9Y4L4,Collagen alpha-6(IV) chain,, PF01413;PF01391;, GO:0005587;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0007155;GO:0030199;GO:0038063;GO:0030198;, C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:extracellular matrix organization; scaffold92 indexed_genome mRNA 2917331 2925243 . + . ID=transcript_12568;Q9Y4L4,Collagen alpha-6(IV) chain,, PF01413;PF01391;, GO:0005587;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0007155;GO:0030199;GO:0038063;GO:0030198;, C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:extracellular matrix organization; scaffold92 indexed_genome mRNA 2930968 2932818 . - . ID=transcript_12569;Q9Y4L4,Collagen alpha-6(IV) chain,, PF01413;PF01391;, GO:0005587;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0007155;GO:0030199;GO:0038063;GO:0030198;, C:collagen type IV trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; P:collagen fibril organization; P:collagen-activated tyrosine kinase receptor signaling pathway; P:extracellular matrix organization; scaffold92 indexed_genome mRNA 2933424 3007821 . - . ID=transcript_12570;Q96KQ1,Cysteine protease ATG4A,AUT-like 2 cysteine endopeptidase;Autophagin-2;Autophagy-related cysteine endopeptidase 2;Autophagy-related protein 4 homolog A;, PF03416;, GO:0005737;GO:0004197;GO:0008234;GO:0006914;GO:0015031;GO:0006508;, C:cytoplasm;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:autophagy; P:protein transport; P:proteolysis; scaffold92 indexed_genome mRNA 3007936 3016374 . + . ID=transcript_12571;O75832 Q5U0B2 Q8IZK9,26S proteasome non-ATPase regulatory subunit 10,26S proteasome regulatory subunit p28;Gankyrin;p28(GANK);, PF00023;PF12796;, GO:0005737;GO:0005829;GO:0045111;GO:0005654;GO:0005634;GO:0000502;GO:0008134;GO:0031145;GO:0002479;GO:0006915;GO:0007253;GO:0038095;GO:0070498;GO:0000165;GO:0043066;GO:0090090;GO:0043518;GO:0010972;GO:0043409;GO:0032088;GO:0090201;GO:0000122;GO:0038061;GO:0090263;GO:0030307;GO:0045737;GO:0032436;GO:0031398;GO:0043687;GO:0036388;GO:0070682;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus; C:proteasome complex;, F:transcription factor binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic process; P:cytoplasmic sequestering of NF-kappaB; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of apoptotic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of MAPK cascade; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of transcription by RNA polymerase II; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome regulatory particle assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold92 indexed_genome mRNA 3153684 3238712 . - . ID=transcript_12572;Q9UJV3 A6NEL8 A6PVI5 Q5JYF5 Q8WWK1 Q9UJR9,Probable E3 ubiquitin-protein ligase MID2,Midin-2;Midline defect 2;Midline-2;RING finger protein 60;RING-type E3 ubiquitin transferase MID2 {ECO:0000305};Tripartite motif-containing protein 1;, PF18568;PF00622;PF00643;PF13445;, GO:0005737;GO:0070062;GO:0005874;GO:0019899;GO:0042802;GO:0008017;GO:0051219;GO:0042803;GO:0003713;GO:0016740;GO:0008270;GO:0045087;GO:0046597;GO:1902187;GO:0032897;GO:0010508;GO:0051091;GO:0043123;GO:0051092;GO:0035372;GO:0016567;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:enzyme binding; F:identical protein binding; F:microtubule binding; F:phosphoprotein binding; F:protein homodimerization activity; F:transcription coactivator activity; F:transferase activity; F:zinc ion binding;, P:innate immune response; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:negative regulation of viral transcription; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein localization to microtubule; P:protein ubiquitination; scaffold92 indexed_genome mRNA 3249437 3402728 . + . ID=transcript_12573;Q9UJV3 A6NEL8 A6PVI5 Q5JYF5 Q8WWK1 Q9UJR9,Probable E3 ubiquitin-protein ligase MID2,Midin-2;Midline defect 2;Midline-2;RING finger protein 60;RING-type E3 ubiquitin transferase MID2 {ECO:0000305};Tripartite motif-containing protein 1;, PF18568;PF00622;PF00643;PF13445;, GO:0005737;GO:0070062;GO:0005874;GO:0019899;GO:0042802;GO:0008017;GO:0051219;GO:0042803;GO:0003713;GO:0016740;GO:0008270;GO:0045087;GO:0046597;GO:1902187;GO:0032897;GO:0010508;GO:0051091;GO:0043123;GO:0051092;GO:0035372;GO:0016567;, C:cytoplasm; C:extracellular exosome; C:microtubule;, F:enzyme binding; F:identical protein binding; F:microtubule binding; F:phosphoprotein binding; F:protein homodimerization activity; F:transcription coactivator activity; F:transferase activity; F:zinc ion binding;, P:innate immune response; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:negative regulation of viral transcription; P:positive regulation of autophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein localization to microtubule; P:protein ubiquitination;|Q99576 Q5H9S3 Q5JRI9 Q6FIH6 Q8NAI1 Q8WVB9 Q9UBN5 Q9UG13,TSC22 domain family protein 3,DSIP-immunoreactive peptide;Delta sleep-inducing peptide immunoreactor;Glucocorticoid-induced leucine zipper protein;TSC-22-like protein;TSC-22-related protein;, PF01166;, GO:0005829;GO:0005634;GO:0034220;GO:0070236;GO:0006357;GO:0006970;, C:cytosol; C:nucleus;, , P:ion transmembrane transport; P:negative regulation of activation-induced cell death of T cells; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress;|Q99576 Q5H9S3 Q5JRI9 Q6FIH6 Q8NAI1 Q8WVB9 Q9UBN5 Q9UG13,TSC22 domain family protein 3,DSIP-immunoreactive peptide;Delta sleep-inducing peptide immunoreactor;Glucocorticoid-induced leucine zipper protein;TSC-22-like protein;TSC-22-related protein;, PF01166;, GO:0005829;GO:0005634;GO:0034220;GO:0070236;GO:0006357;GO:0006970;, C:cytosol; C:nucleus;, , P:ion transmembrane transport; P:negative regulation of activation-induced cell death of T cells; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress;|Q99576 Q5H9S3 Q5JRI9 Q6FIH6 Q8NAI1 Q8WVB9 Q9UBN5 Q9UG13,TSC22 domain family protein 3,DSIP-immunoreactive peptide;Delta sleep-inducing peptide immunoreactor;Glucocorticoid-induced leucine zipper protein;TSC-22-like protein;TSC-22-related protein;, PF01166;, GO:0005829;GO:0005634;GO:0034220;GO:0070236;GO:0006357;GO:0006970;, C:cytosol; C:nucleus;, , P:ion transmembrane transport; P:negative regulation of activation-induced cell death of T cells; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress;|Q99576 Q5H9S3 Q5JRI9 Q6FIH6 Q8NAI1 Q8WVB9 Q9UBN5 Q9UG13,TSC22 domain family protein 3,DSIP-immunoreactive peptide;Delta sleep-inducing peptide immunoreactor;Glucocorticoid-induced leucine zipper protein;TSC-22-like protein;TSC-22-related protein;, PF01166;, GO:0005829;GO:0005634;GO:0034220;GO:0070236;GO:0006357;GO:0006970;, C:cytosol; C:nucleus;, , P:ion transmembrane transport; P:negative regulation of activation-induced cell death of T cells; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress; scaffold92 indexed_genome mRNA 3459938 3488577 . - . ID=transcript_12574;P60891 B1ALA8 B2R6T7 B4DNL6 D3DUX6 P09329,Ribose-phosphate pyrophosphokinase 1,PPRibP;Phosphoribosyl pyrophosphate synthase I;, PF14572;PF13793;, GO:0005737;GO:0005829;GO:0002189;GO:0005524;GO:0042802;GO:0016301;GO:0000287;GO:0042803;GO:0004749;GO:0006015;GO:0046101;GO:0007399;GO:0009116;GO:0006144;GO:0006164;GO:0006221;GO:0009156;GO:0034418;, C:cytoplasm; C:cytosol; C:ribose phosphate diphosphokinase complex;, F:ATP binding; F:identical protein binding; F:kinase activity; F:magnesium ion binding; F:protein homodimerization activity; F:ribose phosphate diphosphokinase activity;, P:5-phosphoribose 1-diphosphate biosynthetic process; P:hypoxanthine biosynthetic process; P:nervous system development; P:nucleoside metabolic process; P:purine nucleobase metabolic process; P:purine nucleotide biosynthetic process; P:pyrimidine nucleotide biosynthetic process; P:ribonucleoside monophosphate biosynthetic process; P:urate biosynthetic process; scaffold92 indexed_genome mRNA 3506658 3507463 . - . ID=transcript_12575;Q5JV73 Q96JK8,FERM and PDZ domain-containing protein 3,, PF00373;PF00595;, GO:0005856;GO:0005886;GO:0030667;GO:0070821;GO:0043312;, C:cytoskeleton; C:plasma membrane; C:secretory granule membrane; C:tertiary granule membrane;, , P:neutrophil degranulation; scaffold92 indexed_genome mRNA 3507963 3508547 . - . ID=transcript_12576;Q5JV73 Q96JK8,FERM and PDZ domain-containing protein 3,, PF00373;PF00595;, GO:0005856;GO:0005886;GO:0030667;GO:0070821;GO:0043312;, C:cytoskeleton; C:plasma membrane; C:secretory granule membrane; C:tertiary granule membrane;, , P:neutrophil degranulation; scaffold92 indexed_genome mRNA 3860898 3905499 . - . ID=transcript_12577;Q9NQM4 D3DUX5 Q86WE1,Dynein assembly factor 6, axonemal {ECO:0000312|HGNC:HGNC:28570},PIH1 domain-containing protein 3 {ECO:0000312|HGNC:HGNC:28570};Sarcoma antigen NY-SAR-97;, PF18201;, GO:0005737;GO:0005802;GO:0051087;GO:0045505;GO:0070286;GO:0003341;GO:0030317;GO:0036159;GO:0036158;, C:cytoplasm; C:trans-Golgi network;, F:chaperone binding; F:dynein intermediate chain binding;, P:axonemal dynein complex assembly; P:cilium movement; P:flagellated sperm motility; P:inner dynein arm assembly; P:outer dynein arm assembly; scaffold92 indexed_genome mRNA 3950040 3989300 . + . ID=transcript_12578;P37198 B3KWU5 Q503A4 Q6GTM2 Q96C43 Q9NSL1,Nuclear pore glycoprotein p62,62 kDa nucleoporin;Nucleoporin Nup62;, PF05064;, GO:0005642;GO:0005813;GO:0005737;GO:0090543;GO:0043657;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044613;GO:0005654;GO:1990904;GO:0000922;GO:0003682;GO:0030544;GO:0051879;GO:0019894;GO:0005543;GO:0044877;GO:0051425;GO:0042169;GO:0030159;GO:0017056;GO:0043130;GO:0007569;GO:0008219;GO:0007166;GO:0098534;GO:0007098;GO:0075733;GO:0007100;GO:0007080;GO:0006406;GO:0043066;GO:0008285;GO:0042059;GO:0043407;GO:0043069;GO:0046580;GO:0046601;GO:0045742;GO:0043123;GO:1903438;GO:0045840;GO:1904781;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060236;GO:0042306;GO:0046578;GO:0009966;GO:0006405;GO:0007283;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:annulate lamellae; C:centrosome; C:cytoplasm; C:Flemming body; C:host cell; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore central transport channel; C:nucleoplasm; C:ribonucleoprotein complex; C:spindle pole;, F:chromatin binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:kinesin binding; F:phospholipid binding; F:protein-containing complex binding; F:PTB domain binding; F:SH2 domain binding; F:signaling receptor complex adaptor activity; F:structural constituent of nuclear pore; F:ubiquitin binding;, P:cell aging; P:cell death; P:cell surface receptor signaling pathway; P:centriole assembly; P:centrosome cycle; P:intracellular transport of virus; P:mitotic centrosome separation; P:mitotic metaphase plate congression; P:mRNA export from nucleus; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of programmed cell death; P:negative regulation of Ras protein signal transduction; P:positive regulation of centriole replication; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of mitotic cytokinetic process; P:positive regulation of mitotic nuclear division; P:positive regulation of protein localization to centrosome; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mitotic spindle organization; P:regulation of protein import into nucleus; P:regulation of Ras protein signal transduction; P:regulation of signal transduction; P:RNA export from nucleus; P:spermatogenesis; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold92 indexed_genome mRNA 3993179 4078492 . + . ID=transcript_12579;Q96IZ5 Q5JSN7 Q5JSN8 Q9H8F7 Q9NV04,RNA-binding protein 41,RNA-binding motif protein 41;, PF00076;, GO:0005689;GO:0097157;GO:0030626;GO:0000398;, C:U12-type spliceosomal complex;, F:pre-mRNA intronic binding; F:U12 snRNA binding;, P:mRNA splicing, via spliceosome; scaffold92 indexed_genome mRNA 4158955 4172071 . + . ID=transcript_12580;Q8TE76 A1YR23 A1YR24 H7BXF1 Q5JUK7 Q96MZ2 Q9HAI7,MORC family CW-type zinc finger protein 4,Zinc finger CW-type coiled-coil domain protein 2;Zinc finger CW-type domain protein 4;, PF17942;PF07496;, GO:0005654;GO:0035064;GO:0008270;, C:nucleoplasm;, F:methylated histone binding; F:zinc ion binding; scaffold92 indexed_genome mRNA 4172084 4240143 . + . ID=transcript_12581;Q8TE76 A1YR23 A1YR24 H7BXF1 Q5JUK7 Q96MZ2 Q9HAI7,MORC family CW-type zinc finger protein 4,Zinc finger CW-type coiled-coil domain protein 2;Zinc finger CW-type domain protein 4;, PF17942;PF07496;, GO:0005654;GO:0035064;GO:0008270;, C:nucleoplasm;, F:methylated histone binding; F:zinc ion binding;|Q8TE76 A1YR23 A1YR24 H7BXF1 Q5JUK7 Q96MZ2 Q9HAI7,MORC family CW-type zinc finger protein 4,Zinc finger CW-type coiled-coil domain protein 2;Zinc finger CW-type domain protein 4;, PF17942;PF07496;, GO:0005654;GO:0035064;GO:0008270;, C:nucleoplasm;, F:methylated histone binding; F:zinc ion binding;|Q8TE76 A1YR23 A1YR24 H7BXF1 Q5JUK7 Q96MZ2 Q9HAI7,MORC family CW-type zinc finger protein 4,Zinc finger CW-type coiled-coil domain protein 2;Zinc finger CW-type domain protein 4;, PF17942;PF07496;, GO:0005654;GO:0035064;GO:0008270;, C:nucleoplasm;, F:methylated histone binding; F:zinc ion binding; scaffold92 indexed_genome mRNA 4253743 4255360 . - . ID=transcript_12582;P57739 B2R6B9,Claudin-2,SP82;, PF00822;, GO:0005923;GO:0005911;GO:0016021;GO:0005886;GO:0042802;GO:0005198;GO:0070830;GO:0016338;GO:0007155;, C:bicellular tight junction; C:cell-cell junction; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:structural molecule activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; scaffold92 indexed_genome mRNA 4317779 4327536 . - . ID=transcript_12583;Q0IIM8 B9A6K5 B9A6K6 Q5JRB7 Q6ZVX5 Q9NXE3,TBC1 domain family member 8B,, PF02893;PF00566;, GO:0005829;GO:0005509;GO:0005096;GO:0090630;GO:0003094;GO:0006886;GO:0016192;, C:cytosol;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:glomerular filtration; P:intracellular protein transport; P:vesicle-mediated transport; scaffold92 indexed_genome mRNA 4328156 4336044 . - . ID=transcript_12584;Q0IIM8 B9A6K5 B9A6K6 Q5JRB7 Q6ZVX5 Q9NXE3,TBC1 domain family member 8B,, PF02893;PF00566;, GO:0005829;GO:0005509;GO:0005096;GO:0090630;GO:0003094;GO:0006886;GO:0016192;, C:cytosol;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:glomerular filtration; P:intracellular protein transport; P:vesicle-mediated transport; scaffold92 indexed_genome mRNA 4366254 4366885 . + . ID=transcript_12585;Q0IIM8 B9A6K5 B9A6K6 Q5JRB7 Q6ZVX5 Q9NXE3,TBC1 domain family member 8B,, PF02893;PF00566;, GO:0005829;GO:0005509;GO:0005096;GO:0090630;GO:0003094;GO:0006886;GO:0016192;, C:cytosol;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:glomerular filtration; P:intracellular protein transport; P:vesicle-mediated transport; scaffold92 indexed_genome mRNA 4371354 4393972 . - . ID=transcript_12586;Q0IIM8 B9A6K5 B9A6K6 Q5JRB7 Q6ZVX5 Q9NXE3,TBC1 domain family member 8B,, PF02893;PF00566;, GO:0005829;GO:0005509;GO:0005096;GO:0090630;GO:0003094;GO:0006886;GO:0016192;, C:cytosol;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:glomerular filtration; P:intracellular protein transport; P:vesicle-mediated transport;|Q0IIM8 B9A6K5 B9A6K6 Q5JRB7 Q6ZVX5 Q9NXE3,TBC1 domain family member 8B,, PF02893;PF00566;, GO:0005829;GO:0005509;GO:0005096;GO:0090630;GO:0003094;GO:0006886;GO:0016192;, C:cytosol;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:glomerular filtration; P:intracellular protein transport; P:vesicle-mediated transport; scaffold92 indexed_genome mRNA 4412129 4469047 . - . ID=transcript_12587;Q8TEB7 A0PJI4 Q6PH80 Q6ZTJ8 Q96RF3 Q9H5E4,E3 ubiquitin-protein ligase RNF128,Gene related to anergy in lymphocytes protein;RING finger protein 128;RING-type E3 ubiquitin transferase RNF128 {ECO:0000305};, PF02225;PF13639;, GO:0005737;GO:0005856;GO:0005829;GO:0005783;GO:0005794;GO:0016021;GO:0005770;GO:0048471;GO:0046872;GO:0061630;GO:0001818;GO:1904352;GO:0016579;GO:0061462;GO:0031647;GO:0006511;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:late endosome; C:perinuclear region of cytoplasm;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:negative regulation of cytokine production; P:positive regulation of protein catabolic process in the vacuole; P:protein deubiquitination; P:protein localization to lysosome; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process; scaffold92 indexed_genome mRNA 4511936 4556358 . - . ID=transcript_12588;Q9NWA6,RPA-related protein RADX {ECO:0000305},RPA-related and RAD51-antagonist, X-chromosome {ECO:0000303|PubMed:28735897};, PF17659;, GO:0016607;GO:0005657;GO:0003723;GO:0003697;GO:2000042;GO:0006282;, C:nuclear speck; C:replication fork;, F:RNA binding; F:single-stranded DNA binding;, P:negative regulation of double-strand break repair via homologous recombination; P:regulation of DNA repair; scaffold92 indexed_genome mRNA 4908501 4913963 . - . ID=transcript_12589;Q00994 B2RD17 D3DXA3 Q5JQT4 Q5JQT5,Protein BEX3 {ECO:0000305},Brain-expressed X-linked protein 3 {ECO:0000312|HGNC:HGNC:13388};Nerve growth factor receptor-associated protein 1;Ovarian granulosa cell 13.0 kDa protein HGR74;p75NTR-associated cell death executor;, PF04538;, GO:0005737;GO:0005829;GO:0005634;GO:0042802;GO:0046872;GO:0005163;GO:0005102;GO:0006919;GO:0006915;GO:0007275;GO:0043154;GO:0043281;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleus;, F:identical protein binding; F:metal ion binding; F:nerve growth factor receptor binding; F:signaling receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:multicellular organism development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:signal transduction;|Q00994 B2RD17 D3DXA3 Q5JQT4 Q5JQT5,Protein BEX3 {ECO:0000305},Brain-expressed X-linked protein 3 {ECO:0000312|HGNC:HGNC:13388};Nerve growth factor receptor-associated protein 1;Ovarian granulosa cell 13.0 kDa protein HGR74;p75NTR-associated cell death executor;, PF04538;, GO:0005737;GO:0005829;GO:0005634;GO:0042802;GO:0046872;GO:0005163;GO:0005102;GO:0006919;GO:0006915;GO:0007275;GO:0043154;GO:0043281;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleus;, F:identical protein binding; F:metal ion binding; F:nerve growth factor receptor binding; F:signaling receptor binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:multicellular organism development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:signal transduction; scaffold92 indexed_genome mRNA 4929507 4931392 . - . ID=transcript_12590;Q9UHQ7 B2R5H6,Transcription elongation factor A protein-like 9 {ECO:0000312|HGNC:HGNC:30084},Transcription elongation factor S-II protein-like 9;WW domain-binding protein 5;, PF04538;, GO:0005634;GO:0050699;, C:nucleus;, F:WW domain binding; scaffold92 indexed_genome mRNA 4981156 4982289 . + . ID=transcript_12591;Q9BXY8 B2R574 D3DXA2 F5H7H5 Q5JVV9,Protein BEX2,Brain-expressed X-linked protein 2;, PF04538;, GO:0005737;GO:0005634;GO:0005102;GO:0006915;GO:0007049;GO:0042981;GO:0051726;GO:0007165;, C:cytoplasm; C:nucleus;, F:signaling receptor binding;, P:apoptotic process; P:cell cycle; P:regulation of apoptotic process; P:regulation of cell cycle; P:signal transduction; scaffold92 indexed_genome mRNA 5019219 5021217 . + . ID=transcript_12592;Q8IYN2,Transcription elongation factor A protein-like 8,Transcription elongation factor S-II protein-like 8;, PF04538;, GO:0005634;GO:0050699;, C:nucleus;, F:WW domain binding; scaffold92 indexed_genome mRNA 5056030 5057640 . - . ID=transcript_12593;Q9NWD9,Protein BEX4 {ECO:0000305},BEX1-like protein 1 {ECO:0000312|HGNC:HGNC:25475};Brain-expressed X-linked protein 4 {ECO:0000303|PubMed:15958283, ECO:0000312|HGNC:HGNC:25475};Nerve growth factor receptor-associated protein 3 {ECO:0000303|PubMed:15958283};, PF04538;, GO:0005737;GO:0005829;GO:0005874;GO:0005654;GO:0005634;GO:0000922;GO:0043014;GO:0042826;GO:0007059;GO:1904428;GO:0030334;GO:0042127;, C:cytoplasm; C:cytosol; C:microtubule; C:nucleoplasm; C:nucleus; C:spindle pole;, F:alpha-tubulin binding; F:histone deacetylase binding;, P:chromosome segregation; P:negative regulation of tubulin deacetylation; P:regulation of cell migration; P:regulation of cell population proliferation; scaffold93 indexed_genome mRNA 441598 458550 . - . ID=transcript_12594;Q9H741 Q53GE8,SREBP regulating gene protein {ECO:0000303|PubMed:32111832},SREBF pathway regulator in Golgi 1 {ECO:0000312|HGNC:HGNC:26128};, PF10218;, GO:0000139;GO:0016021;GO:2000640;, C:Golgi membrane; C:integral component of membrane;, , P:positive regulation of SREBP signaling pathway; scaffold93 indexed_genome mRNA 469842 529084 . + . ID=transcript_12595;Q96EX2 E9PAM7 Q96SU5,RING finger and transmembrane domain-containing protein 2,Transmembrane protein 118;, , GO:0016021;GO:0046872;GO:0061630;GO:1904294;, C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:positive regulation of ERAD pathway;|Q96EX2 E9PAM7 Q96SU5,RING finger and transmembrane domain-containing protein 2,Transmembrane protein 118;, , GO:0016021;GO:0046872;GO:0061630;GO:1904294;, C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:positive regulation of ERAD pathway;|Q96EX2 E9PAM7 Q96SU5,RING finger and transmembrane domain-containing protein 2,Transmembrane protein 118;, , GO:0016021;GO:0046872;GO:0061630;GO:1904294;, C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:positive regulation of ERAD pathway; scaffold93 indexed_genome mRNA 678853 685620 . - . ID=transcript_12596;Q8N3Y1 Q9UK95,F-box/WD repeat-containing protein 8,F-box and WD-40 domain-containing protein 8;F-box only protein 29;, PF12937;, GO:0031467;GO:0005829;GO:0005794;GO:0048471;GO:0019005;GO:0008283;GO:0007030;GO:0060716;GO:0050775;GO:1901485;GO:0043687;GO:0000209;GO:0016567;GO:0060712;, C:Cul7-RING ubiquitin ligase complex; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:SCF ubiquitin ligase complex;, , P:cell population proliferation; P:Golgi organization; P:labyrinthine layer blood vessel development; P:positive regulation of dendrite morphogenesis; P:positive regulation of transcription factor catabolic process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:spongiotrophoblast layer development; scaffold93 indexed_genome mRNA 690482 694310 . + . ID=transcript_12597;Q8N3Y1 Q9UK95,F-box/WD repeat-containing protein 8,F-box and WD-40 domain-containing protein 8;F-box only protein 29;, PF12937;, GO:0031467;GO:0005829;GO:0005794;GO:0048471;GO:0019005;GO:0008283;GO:0007030;GO:0060716;GO:0050775;GO:1901485;GO:0043687;GO:0000209;GO:0016567;GO:0060712;, C:Cul7-RING ubiquitin ligase complex; C:cytosol; C:Golgi apparatus; C:perinuclear region of cytoplasm; C:SCF ubiquitin ligase complex;, , P:cell population proliferation; P:Golgi organization; P:labyrinthine layer blood vessel development; P:positive regulation of dendrite morphogenesis; P:positive regulation of transcription factor catabolic process; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:spongiotrophoblast layer development; scaffold93 indexed_genome mRNA 699093 761159 . - . ID=transcript_12598;Q96BS2 F5H1Y5 Q9NWT9,Calcineurin B homologous protein 3,Tescalcin;, , GO:0005737;GO:0005829;GO:0030027;GO:0005654;GO:0005634;GO:0005886;GO:0001726;GO:0032587;GO:0005509;GO:0000287;GO:0019212;GO:0042803;GO:0004860;GO:0071300;GO:0008584;GO:0030219;GO:0008285;GO:0010628;GO:0030854;GO:0045654;GO:0032417;GO:0045893;GO:0072659;GO:0051604;GO:0050821;GO:0015031;GO:0033628;, C:cytoplasm; C:cytosol; C:lamellipodium; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:calcium ion binding; F:magnesium ion binding; F:phosphatase inhibitor activity; F:protein homodimerization activity; F:protein kinase inhibitor activity;, P:cellular response to retinoic acid; P:male gonad development; P:megakaryocyte differentiation; P:negative regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of granulocyte differentiation; P:positive regulation of megakaryocyte differentiation; P:positive regulation of sodium:proton antiporter activity; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein maturation; P:protein stabilization; P:protein transport; P:regulation of cell adhesion mediated by integrin;|Q96BS2 F5H1Y5 Q9NWT9,Calcineurin B homologous protein 3,Tescalcin;, , GO:0005737;GO:0005829;GO:0030027;GO:0005654;GO:0005634;GO:0005886;GO:0001726;GO:0032587;GO:0005509;GO:0000287;GO:0019212;GO:0042803;GO:0004860;GO:0071300;GO:0008584;GO:0030219;GO:0008285;GO:0010628;GO:0030854;GO:0045654;GO:0032417;GO:0045893;GO:0072659;GO:0051604;GO:0050821;GO:0015031;GO:0033628;, C:cytoplasm; C:cytosol; C:lamellipodium; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:calcium ion binding; F:magnesium ion binding; F:phosphatase inhibitor activity; F:protein homodimerization activity; F:protein kinase inhibitor activity;, P:cellular response to retinoic acid; P:male gonad development; P:megakaryocyte differentiation; P:negative regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of granulocyte differentiation; P:positive regulation of megakaryocyte differentiation; P:positive regulation of sodium:proton antiporter activity; P:positive regulation of transcription, DNA-templated; P:protein localization to plasma membrane; P:protein maturation; P:protein stabilization; P:protein transport; P:regulation of cell adhesion mediated by integrin; scaffold93 indexed_genome mRNA 777306 815833 . - . ID=transcript_12599;O94952 B3KMF0 Q5BJG0 Q9H087,F-box only protein 21,, PF13369;PF08755;, GO:0005829;GO:0000151;GO:0003677;GO:0004842;GO:0043687;GO:0000209;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, F:DNA binding; F:ubiquitin-protein transferase activity;, P:post-translational protein modification; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|O94952 B3KMF0 Q5BJG0 Q9H087,F-box only protein 21,, PF13369;PF08755;, GO:0005829;GO:0000151;GO:0003677;GO:0004842;GO:0043687;GO:0000209;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, F:DNA binding; F:ubiquitin-protein transferase activity;, P:post-translational protein modification; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|O94952 B3KMF0 Q5BJG0 Q9H087,F-box only protein 21,, PF13369;PF08755;, GO:0005829;GO:0000151;GO:0003677;GO:0004842;GO:0043687;GO:0000209;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, F:DNA binding; F:ubiquitin-protein transferase activity;, P:post-translational protein modification; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|O94952 B3KMF0 Q5BJG0 Q9H087,F-box only protein 21,, PF13369;PF08755;, GO:0005829;GO:0000151;GO:0003677;GO:0004842;GO:0043687;GO:0000209;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, F:DNA binding; F:ubiquitin-protein transferase activity;, P:post-translational protein modification; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|O94952 B3KMF0 Q5BJG0 Q9H087,F-box only protein 21,, PF13369;PF08755;, GO:0005829;GO:0000151;GO:0003677;GO:0004842;GO:0043687;GO:0000209;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, F:DNA binding; F:ubiquitin-protein transferase activity;, P:post-translational protein modification; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|O94952 B3KMF0 Q5BJG0 Q9H087,F-box only protein 21,, PF13369;PF08755;, GO:0005829;GO:0000151;GO:0003677;GO:0004842;GO:0043687;GO:0000209;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, F:DNA binding; F:ubiquitin-protein transferase activity;, P:post-translational protein modification; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|O94952 B3KMF0 Q5BJG0 Q9H087,F-box only protein 21,, PF13369;PF08755;, GO:0005829;GO:0000151;GO:0003677;GO:0004842;GO:0043687;GO:0000209;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, F:DNA binding; F:ubiquitin-protein transferase activity;, P:post-translational protein modification; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|O94952 B3KMF0 Q5BJG0 Q9H087,F-box only protein 21,, PF13369;PF08755;, GO:0005829;GO:0000151;GO:0003677;GO:0004842;GO:0043687;GO:0000209;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, F:DNA binding; F:ubiquitin-protein transferase activity;, P:post-translational protein modification; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|O94952 B3KMF0 Q5BJG0 Q9H087,F-box only protein 21,, PF13369;PF08755;, GO:0005829;GO:0000151;GO:0003677;GO:0004842;GO:0043687;GO:0000209;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, F:DNA binding; F:ubiquitin-protein transferase activity;, P:post-translational protein modification; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold93 indexed_genome mRNA 843409 852105 . - . ID=transcript_12600;P29475 E9PH30 O75713,Nitric oxide synthase, brain,Constitutive NOS;NC-NOS;NOS type I;Neuronal NOS;Peptidyl-cysteine S-nitrosylase NOS1;bNOS;, PF00667;PF00258;PF00175;PF02898;PF00595;, GO:0071944;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0045121;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0001917;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0016529;GO:0045202;GO:0012506;GO:0034618;GO:0046870;GO:0048306;GO:0005516;GO:0050660;GO:0010181;GO:0020037;GO:0044325;GO:0050661;GO:0004517;GO:0016491;GO:0016709;GO:0097110;GO:0017080;GO:0034617;GO:0006527;GO:0045454;GO:0071363;GO:0042738;GO:0033555;GO:0006936;GO:0007520;GO:0045776;GO:0051926;GO:0010523;GO:0051346;GO:0043267;GO:0051612;GO:0042136;GO:0006809;GO:0007263;GO:0018119;GO:0031284;GO:0035066;GO:0033138;GO:1902307;GO:0098735;GO:0045944;GO:0045893;GO:1902514;GO:1903779;GO:0055117;GO:0060314;GO:0002028;GO:0009408;GO:0009725;GO:0001666;GO:0032496;GO:0098924;GO:0006941;GO:0042311;, C:cell periphery; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:membrane raft; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:synapse; C:vesicle membrane;, F:arginine binding; F:cadmium ion binding; F:calcium-dependent protein binding; F:calmodulin binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:heme binding; F:ion channel binding; F:NADP binding; F:nitric-oxide synthase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:scaffold protein binding; F:sodium channel regulator activity; F:tetrahydrobiopterin binding;, P:arginine catabolic process; P:cell redox homeostasis; P:cellular response to growth factor stimulus; P:exogenous drug catabolic process; P:multicellular organismal response to stress; P:muscle contraction; P:myoblast fusion; P:negative regulation of blood pressure; P:negative regulation of calcium ion transport; P:negative regulation of calcium ion transport into cytosol; P:negative regulation of hydrolase activity; P:negative regulation of potassium ion transport; P:negative regulation of serotonin uptake; P:neurotransmitter biosynthetic process; P:nitric oxide biosynthetic process; P:nitric oxide mediated signal transduction; P:peptidyl-cysteine S-nitrosylation; P:positive regulation of guanylate cyclase activity; P:positive regulation of histone acetylation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of sodium ion transmembrane transport; P:positive regulation of the force of heart contraction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of sodium ion transport; P:response to heat; P:response to hormone; P:response to hypoxia; P:response to lipopolysaccharide; P:retrograde trans-synaptic signaling by nitric oxide; P:striated muscle contraction; P:vasodilation; scaffold93 indexed_genome mRNA 854414 875229 . - . ID=transcript_12601;P29475 E9PH30 O75713,Nitric oxide synthase, brain,Constitutive NOS;NC-NOS;NOS type I;Neuronal NOS;Peptidyl-cysteine S-nitrosylase NOS1;bNOS;, PF00667;PF00258;PF00175;PF02898;PF00595;, GO:0071944;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0045121;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0001917;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0016529;GO:0045202;GO:0012506;GO:0034618;GO:0046870;GO:0048306;GO:0005516;GO:0050660;GO:0010181;GO:0020037;GO:0044325;GO:0050661;GO:0004517;GO:0016491;GO:0016709;GO:0097110;GO:0017080;GO:0034617;GO:0006527;GO:0045454;GO:0071363;GO:0042738;GO:0033555;GO:0006936;GO:0007520;GO:0045776;GO:0051926;GO:0010523;GO:0051346;GO:0043267;GO:0051612;GO:0042136;GO:0006809;GO:0007263;GO:0018119;GO:0031284;GO:0035066;GO:0033138;GO:1902307;GO:0098735;GO:0045944;GO:0045893;GO:1902514;GO:1903779;GO:0055117;GO:0060314;GO:0002028;GO:0009408;GO:0009725;GO:0001666;GO:0032496;GO:0098924;GO:0006941;GO:0042311;, C:cell periphery; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:membrane raft; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:synapse; C:vesicle membrane;, F:arginine binding; F:cadmium ion binding; F:calcium-dependent protein binding; F:calmodulin binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:heme binding; F:ion channel binding; F:NADP binding; F:nitric-oxide synthase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:scaffold protein binding; F:sodium channel regulator activity; F:tetrahydrobiopterin binding;, P:arginine catabolic process; P:cell redox homeostasis; P:cellular response to growth factor stimulus; P:exogenous drug catabolic process; P:multicellular organismal response to stress; P:muscle contraction; P:myoblast fusion; P:negative regulation of blood pressure; P:negative regulation of calcium ion transport; P:negative regulation of calcium ion transport into cytosol; P:negative regulation of hydrolase activity; P:negative regulation of potassium ion transport; P:negative regulation of serotonin uptake; P:neurotransmitter biosynthetic process; P:nitric oxide biosynthetic process; P:nitric oxide mediated signal transduction; P:peptidyl-cysteine S-nitrosylation; P:positive regulation of guanylate cyclase activity; P:positive regulation of histone acetylation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of sodium ion transmembrane transport; P:positive regulation of the force of heart contraction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of sodium ion transport; P:response to heat; P:response to hormone; P:response to hypoxia; P:response to lipopolysaccharide; P:retrograde trans-synaptic signaling by nitric oxide; P:striated muscle contraction; P:vasodilation; scaffold93 indexed_genome mRNA 880572 928073 . - . ID=transcript_12602;P29475 E9PH30 O75713,Nitric oxide synthase, brain,Constitutive NOS;NC-NOS;NOS type I;Neuronal NOS;Peptidyl-cysteine S-nitrosylase NOS1;bNOS;, PF00667;PF00258;PF00175;PF02898;PF00595;, GO:0071944;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0045121;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0001917;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0016529;GO:0045202;GO:0012506;GO:0034618;GO:0046870;GO:0048306;GO:0005516;GO:0050660;GO:0010181;GO:0020037;GO:0044325;GO:0050661;GO:0004517;GO:0016491;GO:0016709;GO:0097110;GO:0017080;GO:0034617;GO:0006527;GO:0045454;GO:0071363;GO:0042738;GO:0033555;GO:0006936;GO:0007520;GO:0045776;GO:0051926;GO:0010523;GO:0051346;GO:0043267;GO:0051612;GO:0042136;GO:0006809;GO:0007263;GO:0018119;GO:0031284;GO:0035066;GO:0033138;GO:1902307;GO:0098735;GO:0045944;GO:0045893;GO:1902514;GO:1903779;GO:0055117;GO:0060314;GO:0002028;GO:0009408;GO:0009725;GO:0001666;GO:0032496;GO:0098924;GO:0006941;GO:0042311;, C:cell periphery; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:membrane raft; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:synapse; C:vesicle membrane;, F:arginine binding; F:cadmium ion binding; F:calcium-dependent protein binding; F:calmodulin binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:heme binding; F:ion channel binding; F:NADP binding; F:nitric-oxide synthase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:scaffold protein binding; F:sodium channel regulator activity; F:tetrahydrobiopterin binding;, P:arginine catabolic process; P:cell redox homeostasis; P:cellular response to growth factor stimulus; P:exogenous drug catabolic process; P:multicellular organismal response to stress; P:muscle contraction; P:myoblast fusion; P:negative regulation of blood pressure; P:negative regulation of calcium ion transport; P:negative regulation of calcium ion transport into cytosol; P:negative regulation of hydrolase activity; P:negative regulation of potassium ion transport; P:negative regulation of serotonin uptake; P:neurotransmitter biosynthetic process; P:nitric oxide biosynthetic process; P:nitric oxide mediated signal transduction; P:peptidyl-cysteine S-nitrosylation; P:positive regulation of guanylate cyclase activity; P:positive regulation of histone acetylation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of sodium ion transmembrane transport; P:positive regulation of the force of heart contraction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of sodium ion transport; P:response to heat; P:response to hormone; P:response to hypoxia; P:response to lipopolysaccharide; P:retrograde trans-synaptic signaling by nitric oxide; P:striated muscle contraction; P:vasodilation; scaffold93 indexed_genome mRNA 928348 1030880 . - . ID=transcript_12603;P29475 E9PH30 O75713,Nitric oxide synthase, brain,Constitutive NOS;NC-NOS;NOS type I;Neuronal NOS;Peptidyl-cysteine S-nitrosylase NOS1;bNOS;, PF00667;PF00258;PF00175;PF02898;PF00595;, GO:0071944;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0045121;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0001917;GO:0005886;GO:0014069;GO:0032991;GO:0042383;GO:0016529;GO:0045202;GO:0012506;GO:0034618;GO:0046870;GO:0048306;GO:0005516;GO:0050660;GO:0010181;GO:0020037;GO:0044325;GO:0050661;GO:0004517;GO:0016491;GO:0016709;GO:0097110;GO:0017080;GO:0034617;GO:0006527;GO:0045454;GO:0071363;GO:0042738;GO:0033555;GO:0006936;GO:0007520;GO:0045776;GO:0051926;GO:0010523;GO:0051346;GO:0043267;GO:0051612;GO:0042136;GO:0006809;GO:0007263;GO:0018119;GO:0031284;GO:0035066;GO:0033138;GO:1902307;GO:0098735;GO:0045944;GO:0045893;GO:1902514;GO:1903779;GO:0055117;GO:0060314;GO:0002028;GO:0009408;GO:0009725;GO:0001666;GO:0032496;GO:0098924;GO:0006941;GO:0042311;, C:cell periphery; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:membrane raft; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor inner segment; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcolemma; C:sarcoplasmic reticulum; C:synapse; C:vesicle membrane;, F:arginine binding; F:cadmium ion binding; F:calcium-dependent protein binding; F:calmodulin binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:heme binding; F:ion channel binding; F:NADP binding; F:nitric-oxide synthase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:scaffold protein binding; F:sodium channel regulator activity; F:tetrahydrobiopterin binding;, P:arginine catabolic process; P:cell redox homeostasis; P:cellular response to growth factor stimulus; P:exogenous drug catabolic process; P:multicellular organismal response to stress; P:muscle contraction; P:myoblast fusion; P:negative regulation of blood pressure; P:negative regulation of calcium ion transport; P:negative regulation of calcium ion transport into cytosol; P:negative regulation of hydrolase activity; P:negative regulation of potassium ion transport; P:negative regulation of serotonin uptake; P:neurotransmitter biosynthetic process; P:nitric oxide biosynthetic process; P:nitric oxide mediated signal transduction; P:peptidyl-cysteine S-nitrosylation; P:positive regulation of guanylate cyclase activity; P:positive regulation of histone acetylation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of sodium ion transmembrane transport; P:positive regulation of the force of heart contraction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of sodium ion transport; P:response to heat; P:response to hormone; P:response to hypoxia; P:response to lipopolysaccharide; P:retrograde trans-synaptic signaling by nitric oxide; P:striated muscle contraction; P:vasodilation; scaffold93 indexed_genome mRNA 1335223 1421265 . - . ID=transcript_12604;Q6VAB6 A0PJT2 Q3B828 Q8N775,Kinase suppressor of Ras 2,, PF07714;PF13543;, GO:0005737;GO:0005829;GO:0005886;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0019722;GO:0120162;GO:0007265;GO:0007165;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:calcium-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:Ras protein signal transduction; P:signal transduction; scaffold93 indexed_genome mRNA 1455769 1478979 . + . ID=transcript_12605;P40937 A8MZ62 B3KSX8,Replication factor C subunit 5,Activator 1 36 kDa subunit;Activator 1 subunit 5;Replication factor C 36 kDa subunit;, PF00004;PF08542;, GO:0031390;GO:0005663;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003677;GO:0019899;GO:0006287;GO:0042769;GO:0032508;GO:0006281;GO:0006260;GO:0006261;GO:0070987;GO:0042276;GO:0006297;GO:0033683;GO:0006296;GO:1900264;GO:1901796;GO:0032201;GO:0006283;GO:0019985;, C:Ctf18 RFC-like complex; C:DNA replication factor C complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:DNA binding; F:enzyme binding;, P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA duplex unwinding; P:DNA repair; P:DNA replication; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:positive regulation of DNA-directed DNA polymerase activity; P:regulation of signal transduction by p53 class mediator; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold93 indexed_genome mRNA 1494188 1531158 . - . ID=transcript_12606;Q8N0Z9 Q9NWQ7,V-set and immunoglobulin domain-containing protein 10,, PF00047;PF07686;, GO:0005911;GO:0005887;GO:0050839;GO:0098609;, C:cell-cell junction; C:integral component of plasma membrane;, F:cell adhesion molecule binding;, P:cell-cell adhesion; scaffold93 indexed_genome mRNA 1570354 1576695 . + . ID=transcript_12607;P30086 B2R4S1,Phosphatidylethanolamine-binding protein 1,HCNPpp;Neuropolypeptide h3;Prostatic-binding protein;Raf kinase inhibitor protein;, PF01161;, GO:0005829;GO:0070062;GO:0005634;GO:0005524;GO:0019899;GO:0008429;GO:0019901;GO:0003723;GO:0004867;GO:0000165;GO:0043409;, C:cytosol; C:extracellular exosome; C:nucleus;, F:ATP binding; F:enzyme binding; F:phosphatidylethanolamine binding; F:protein kinase binding; F:RNA binding; F:serine-type endopeptidase inhibitor activity;, P:MAPK cascade; P:negative regulation of MAPK cascade;|P30086 B2R4S1,Phosphatidylethanolamine-binding protein 1,HCNPpp;Neuropolypeptide h3;Prostatic-binding protein;Raf kinase inhibitor protein;, PF01161;, GO:0005829;GO:0070062;GO:0005634;GO:0005524;GO:0019899;GO:0008429;GO:0019901;GO:0003723;GO:0004867;GO:0000165;GO:0043409;, C:cytosol; C:extracellular exosome; C:nucleus;, F:ATP binding; F:enzyme binding; F:phosphatidylethanolamine binding; F:protein kinase binding; F:RNA binding; F:serine-type endopeptidase inhibitor activity;, P:MAPK cascade; P:negative regulation of MAPK cascade; scaffold93 indexed_genome mRNA 1583695 1592162 . - . ID=transcript_12608;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold93 indexed_genome mRNA 1592310 1765506 . - . ID=transcript_12609;Q9H2K8 Q658N1 Q8IUM4 Q9HC79 Q9NZM9 Q9UHG7,Serine/threonine-protein kinase TAO3,Cutaneous T-cell lymphoma-associated antigen HD-CL-09;Dendritic cell-derived protein kinase;JNK/SAPK-inhibitory kinase;Jun kinase-inhibitory kinase;Kinase from chicken homolog A;Thousand and one amino acid protein 3;, PF00069;, GO:0005737;GO:0005886;GO:0005524;GO:0004860;GO:0106310;GO:0004674;GO:0106311;GO:0016740;GO:0032147;GO:0006974;GO:0006281;GO:0000165;GO:0007095;GO:0046329;GO:0048812;GO:0046330;GO:0043507;GO:0032874;GO:0046777;GO:0006468;GO:0031098;, C:cytoplasm; C:plasma membrane;, F:ATP binding; F:protein kinase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transferase activity;, P:activation of protein kinase activity; P:cellular response to DNA damage stimulus; P:DNA repair; P:MAPK cascade; P:mitotic G2 DNA damage checkpoint; P:negative regulation of JNK cascade; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:stress-activated protein kinase signaling cascade;|Q9H2K8 Q658N1 Q8IUM4 Q9HC79 Q9NZM9 Q9UHG7,Serine/threonine-protein kinase TAO3,Cutaneous T-cell lymphoma-associated antigen HD-CL-09;Dendritic cell-derived protein kinase;JNK/SAPK-inhibitory kinase;Jun kinase-inhibitory kinase;Kinase from chicken homolog A;Thousand and one amino acid protein 3;, PF00069;, GO:0005737;GO:0005886;GO:0005524;GO:0004860;GO:0106310;GO:0004674;GO:0106311;GO:0016740;GO:0032147;GO:0006974;GO:0006281;GO:0000165;GO:0007095;GO:0046329;GO:0048812;GO:0046330;GO:0043507;GO:0032874;GO:0046777;GO:0006468;GO:0031098;, C:cytoplasm; C:plasma membrane;, F:ATP binding; F:protein kinase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transferase activity;, P:activation of protein kinase activity; P:cellular response to DNA damage stimulus; P:DNA repair; P:MAPK cascade; P:mitotic G2 DNA damage checkpoint; P:negative regulation of JNK cascade; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:stress-activated protein kinase signaling cascade; scaffold93 indexed_genome mRNA 1769219 1805743 . + . ID=transcript_12610;Q9H7L9 Q4KMQ5 Q8N6H0 Q9H8D2,Sin3 histone deacetylase corepressor complex component SDS3,45 kDa Sin3-associated polypeptide;Suppressor of defective silencing 3 protein homolog;, PF08598;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016580;GO:0070822;GO:0019899;GO:0042826;GO:0006915;GO:0016575;GO:0000122;GO:0045892;GO:0043065;GO:0016579;GO:0021762;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:Sin3-type complex;, F:enzyme binding; F:histone deacetylase binding;, P:apoptotic process; P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:protein deubiquitination; P:substantia nigra development;|Q9H7L9 Q4KMQ5 Q8N6H0 Q9H8D2,Sin3 histone deacetylase corepressor complex component SDS3,45 kDa Sin3-associated polypeptide;Suppressor of defective silencing 3 protein homolog;, PF08598;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016580;GO:0070822;GO:0019899;GO:0042826;GO:0006915;GO:0016575;GO:0000122;GO:0045892;GO:0043065;GO:0016579;GO:0021762;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:Sin3-type complex;, F:enzyme binding; F:histone deacetylase binding;, P:apoptotic process; P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:protein deubiquitination; P:substantia nigra development; scaffold93 indexed_genome mRNA 2263284 2425657 . + . ID=transcript_12611;A7MD48 A8K5P6 B2RZH7 Q7Z5F0 Q96JH4,Serine/arginine repetitive matrix protein 4,Medulloblastoma antigen MU-MB-2.76;Neural-specific serine/arginine repetitive splicing factor of 100 kDa;, PF15230;, GO:0005634;GO:0042802;GO:0003729;GO:0030154;GO:0006397;GO:0007399;GO:0042551;GO:0000381;GO:0043484;GO:0008380;GO:0007605;, C:nucleus;, F:identical protein binding; F:mRNA binding;, P:cell differentiation; P:mRNA processing; P:nervous system development; P:neuron maturation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing; P:sensory perception of sound;|A7MD48 A8K5P6 B2RZH7 Q7Z5F0 Q96JH4,Serine/arginine repetitive matrix protein 4,Medulloblastoma antigen MU-MB-2.76;Neural-specific serine/arginine repetitive splicing factor of 100 kDa;, PF15230;, GO:0005634;GO:0042802;GO:0003729;GO:0030154;GO:0006397;GO:0007399;GO:0042551;GO:0000381;GO:0043484;GO:0008380;GO:0007605;, C:nucleus;, F:identical protein binding; F:mRNA binding;, P:cell differentiation; P:mRNA processing; P:nervous system development; P:neuron maturation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing; P:sensory perception of sound; scaffold93 indexed_genome mRNA 2443563 2456886 . - . ID=transcript_12612;Q9UJY1 B2R6A6 Q6FIH3 Q9UKS3,Heat shock protein beta-8,Alpha-crystallin C chain;E2-induced gene 1 protein;Protein kinase H11;Small stress protein-like protein HSP22;, PF00011;, GO:0101031;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0042803;GO:0034620;GO:1905337;GO:0006468;GO:1900034;, C:chaperone complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:protein homodimerization activity;, P:cellular response to unfolded protein; P:positive regulation of aggrephagy; P:protein phosphorylation; P:regulation of cellular response to heat;|Q9UJY1 B2R6A6 Q6FIH3 Q9UKS3,Heat shock protein beta-8,Alpha-crystallin C chain;E2-induced gene 1 protein;Protein kinase H11;Small stress protein-like protein HSP22;, PF00011;, GO:0101031;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0042803;GO:0034620;GO:1905337;GO:0006468;GO:1900034;, C:chaperone complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:protein homodimerization activity;, P:cellular response to unfolded protein; P:positive regulation of aggrephagy; P:protein phosphorylation; P:regulation of cellular response to heat;|Q9UJY1 B2R6A6 Q6FIH3 Q9UKS3,Heat shock protein beta-8,Alpha-crystallin C chain;E2-induced gene 1 protein;Protein kinase H11;Small stress protein-like protein HSP22;, PF00011;, GO:0101031;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0042803;GO:0034620;GO:1905337;GO:0006468;GO:1900034;, C:chaperone complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:protein homodimerization activity;, P:cellular response to unfolded protein; P:positive regulation of aggrephagy; P:protein phosphorylation; P:regulation of cellular response to heat; scaffold93 indexed_genome mRNA 2558216 2690511 . + . ID=transcript_12613;Q8IWA6,Coiled-coil domain-containing protein 60,, PF15769; scaffold93 indexed_genome mRNA 2700091 2723558 . + . ID=transcript_12614;Q8IWA6,Coiled-coil domain-containing protein 60,, PF15769; scaffold93 indexed_genome mRNA 2762497 2805715 . + . ID=transcript_12615;B4DJY2,Transmembrane protein 233,Dispanin subfamily B member 2;Interferon-induced transmembrane domain-containing protein D2;, PF04505;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane; scaffold93 indexed_genome mRNA 2827642 2837806 . + . ID=transcript_12616;Q9Y478 Q9UBV0 Q9UE20 Q9UEX2 Q9Y6V8,5'-AMP-activated protein kinase subunit beta-1,, PF16561;PF04739;, GO:0005737;GO:0005829;GO:0005654;GO:0031588;GO:0005634;GO:0004672;GO:0019901;GO:0007050;GO:0006633;GO:0016236;GO:0035878;GO:0120162;GO:0010628;GO:0006468;GO:0050790;GO:0016241;GO:0080090;GO:1901796;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:protein kinase activity; F:protein kinase binding;, P:cell cycle arrest; P:fatty acid biosynthetic process; P:macroautophagy; P:nail development; P:positive regulation of cold-induced thermogenesis; P:positive regulation of gene expression; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of primary metabolic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction;|Q9Y478 Q9UBV0 Q9UE20 Q9UEX2 Q9Y6V8,5'-AMP-activated protein kinase subunit beta-1,, PF16561;PF04739;, GO:0005737;GO:0005829;GO:0005654;GO:0031588;GO:0005634;GO:0004672;GO:0019901;GO:0007050;GO:0006633;GO:0016236;GO:0035878;GO:0120162;GO:0010628;GO:0006468;GO:0050790;GO:0016241;GO:0080090;GO:1901796;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:protein kinase activity; F:protein kinase binding;, P:cell cycle arrest; P:fatty acid biosynthetic process; P:macroautophagy; P:nail development; P:positive regulation of cold-induced thermogenesis; P:positive regulation of gene expression; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of primary metabolic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction;|Q9Y478 Q9UBV0 Q9UE20 Q9UEX2 Q9Y6V8,5'-AMP-activated protein kinase subunit beta-1,, PF16561;PF04739;, GO:0005737;GO:0005829;GO:0005654;GO:0031588;GO:0005634;GO:0004672;GO:0019901;GO:0007050;GO:0006633;GO:0016236;GO:0035878;GO:0120162;GO:0010628;GO:0006468;GO:0050790;GO:0016241;GO:0080090;GO:1901796;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:protein kinase activity; F:protein kinase binding;, P:cell cycle arrest; P:fatty acid biosynthetic process; P:macroautophagy; P:nail development; P:positive regulation of cold-induced thermogenesis; P:positive regulation of gene expression; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of primary metabolic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction;|Q9Y478 Q9UBV0 Q9UE20 Q9UEX2 Q9Y6V8,5'-AMP-activated protein kinase subunit beta-1,, PF16561;PF04739;, GO:0005737;GO:0005829;GO:0005654;GO:0031588;GO:0005634;GO:0004672;GO:0019901;GO:0007050;GO:0006633;GO:0016236;GO:0035878;GO:0120162;GO:0010628;GO:0006468;GO:0050790;GO:0016241;GO:0080090;GO:1901796;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:protein kinase activity; F:protein kinase binding;, P:cell cycle arrest; P:fatty acid biosynthetic process; P:macroautophagy; P:nail development; P:positive regulation of cold-induced thermogenesis; P:positive regulation of gene expression; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of primary metabolic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction; scaffold93 indexed_genome mRNA 2839271 2877575 . - . ID=transcript_12617;O14578 Q2M5E1 Q6XUH8 Q86UQ9 Q9UPZ7,Citron Rho-interacting kinase,Serine/threonine-protein kinase 21;, PF00780;PF00169;PF00069;, GO:0005737;GO:0005856;GO:0005829;GO:0016020;GO:0005524;GO:0046872;GO:0030165;GO:0019901;GO:0106310;GO:0004674;GO:0030291;GO:0106311;GO:0097110;GO:0017124;GO:0001223;GO:0031032;GO:0048699;GO:0035556;GO:0000278;GO:0000281;GO:0035331;GO:0051402;GO:0018107;GO:0032467;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:membrane;, F:ATP binding; F:metal ion binding; F:PDZ domain binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine kinase inhibitor activity; F:protein threonine kinase activity; F:scaffold protein binding; F:SH3 domain binding; F:transcription coactivator binding;, P:actomyosin structure organization; P:generation of neurons; P:intracellular signal transduction; P:mitotic cell cycle; P:mitotic cytokinesis; P:negative regulation of hippo signaling; P:neuron apoptotic process; P:peptidyl-threonine phosphorylation; P:positive regulation of cytokinesis; scaffold93 indexed_genome mRNA 2881359 2946971 . - . ID=transcript_12618;O14578 Q2M5E1 Q6XUH8 Q86UQ9 Q9UPZ7,Citron Rho-interacting kinase,Serine/threonine-protein kinase 21;, PF00780;PF00169;PF00069;, GO:0005737;GO:0005856;GO:0005829;GO:0016020;GO:0005524;GO:0046872;GO:0030165;GO:0019901;GO:0106310;GO:0004674;GO:0030291;GO:0106311;GO:0097110;GO:0017124;GO:0001223;GO:0031032;GO:0048699;GO:0035556;GO:0000278;GO:0000281;GO:0035331;GO:0051402;GO:0018107;GO:0032467;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:membrane;, F:ATP binding; F:metal ion binding; F:PDZ domain binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine kinase inhibitor activity; F:protein threonine kinase activity; F:scaffold protein binding; F:SH3 domain binding; F:transcription coactivator binding;, P:actomyosin structure organization; P:generation of neurons; P:intracellular signal transduction; P:mitotic cell cycle; P:mitotic cytokinesis; P:negative regulation of hippo signaling; P:neuron apoptotic process; P:peptidyl-threonine phosphorylation; P:positive regulation of cytokinesis;|O14578 Q2M5E1 Q6XUH8 Q86UQ9 Q9UPZ7,Citron Rho-interacting kinase,Serine/threonine-protein kinase 21;, PF00780;PF00169;PF00069;, GO:0005737;GO:0005856;GO:0005829;GO:0016020;GO:0005524;GO:0046872;GO:0030165;GO:0019901;GO:0106310;GO:0004674;GO:0030291;GO:0106311;GO:0097110;GO:0017124;GO:0001223;GO:0031032;GO:0048699;GO:0035556;GO:0000278;GO:0000281;GO:0035331;GO:0051402;GO:0018107;GO:0032467;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:membrane;, F:ATP binding; F:metal ion binding; F:PDZ domain binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine kinase inhibitor activity; F:protein threonine kinase activity; F:scaffold protein binding; F:SH3 domain binding; F:transcription coactivator binding;, P:actomyosin structure organization; P:generation of neurons; P:intracellular signal transduction; P:mitotic cell cycle; P:mitotic cytokinesis; P:negative regulation of hippo signaling; P:neuron apoptotic process; P:peptidyl-threonine phosphorylation; P:positive regulation of cytokinesis;|O14578 Q2M5E1 Q6XUH8 Q86UQ9 Q9UPZ7,Citron Rho-interacting kinase,Serine/threonine-protein kinase 21;, PF00780;PF00169;PF00069;, GO:0005737;GO:0005856;GO:0005829;GO:0016020;GO:0005524;GO:0046872;GO:0030165;GO:0019901;GO:0106310;GO:0004674;GO:0030291;GO:0106311;GO:0097110;GO:0017124;GO:0001223;GO:0031032;GO:0048699;GO:0035556;GO:0000278;GO:0000281;GO:0035331;GO:0051402;GO:0018107;GO:0032467;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:membrane;, F:ATP binding; F:metal ion binding; F:PDZ domain binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine kinase inhibitor activity; F:protein threonine kinase activity; F:scaffold protein binding; F:SH3 domain binding; F:transcription coactivator binding;, P:actomyosin structure organization; P:generation of neurons; P:intracellular signal transduction; P:mitotic cell cycle; P:mitotic cytokinesis; P:negative regulation of hippo signaling; P:neuron apoptotic process; P:peptidyl-threonine phosphorylation; P:positive regulation of cytokinesis; scaffold93 indexed_genome mRNA 3092277 3117386 . + . ID=transcript_12619;Q6ZP65 A8MUC8 B4DWL0 B5MDJ0 O95000,BICD family-like cargo adapter 1,Bicaudal D-related protein 1;Coiled-coil domain-containing protein 64A;, , GO:0005813;GO:0005737;GO:0034452;GO:0031267;GO:0055107;GO:0031175;GO:0047496;, C:centrosome; C:cytoplasm;, F:dynactin binding; F:small GTPase binding;, P:Golgi to secretory granule transport; P:neuron projection development; P:vesicle transport along microtubule; scaffold93 indexed_genome mRNA 3120597 3164317 . - . ID=transcript_12620;Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation;|Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation;|Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation;|Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation;|Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation;|Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation;|Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation;|Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation; scaffold93 indexed_genome mRNA 3166575 3185275 . + . ID=transcript_12621;Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation;|Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation;|Q7Z569 B4DRM1 B9EGS8 O43238 O75341,BRCA1-associated protein,BRAP2;Impedes mitogenic signal propagation;RING finger protein 52;RING-type E3 ubiquitin transferase BRAP2 {ECO:0000305};Renal carcinoma antigen NY-REN-63;, PF07576;PF13639;PF02148;, GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0000151;GO:0042802;GO:0008139;GO:0003676;GO:0061630;GO:0004842;GO:0008270;GO:0000165;GO:0009968;GO:0016567;GO:0007265;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:ubiquitin ligase complex;, F:identical protein binding; F:nuclear localization sequence binding; F:nucleic acid binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:MAPK cascade; P:negative regulation of signal transduction; P:protein ubiquitination; P:Ras protein signal transduction;|Q7Z569 B4DRM1 B9EGS8 O43238 O75341,BRCA1-associated protein,BRAP2;Impedes mitogenic signal propagation;RING finger protein 52;RING-type E3 ubiquitin transferase BRAP2 {ECO:0000305};Renal carcinoma antigen NY-REN-63;, PF07576;PF13639;PF02148;, GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0000151;GO:0042802;GO:0008139;GO:0003676;GO:0061630;GO:0004842;GO:0008270;GO:0000165;GO:0009968;GO:0016567;GO:0007265;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:ubiquitin ligase complex;, F:identical protein binding; F:nuclear localization sequence binding; F:nucleic acid binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:MAPK cascade; P:negative regulation of signal transduction; P:protein ubiquitination; P:Ras protein signal transduction;|Q7Z569 B4DRM1 B9EGS8 O43238 O75341,BRCA1-associated protein,BRAP2;Impedes mitogenic signal propagation;RING finger protein 52;RING-type E3 ubiquitin transferase BRAP2 {ECO:0000305};Renal carcinoma antigen NY-REN-63;, PF07576;PF13639;PF02148;, GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0000151;GO:0042802;GO:0008139;GO:0003676;GO:0061630;GO:0004842;GO:0008270;GO:0000165;GO:0009968;GO:0016567;GO:0007265;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:ubiquitin ligase complex;, F:identical protein binding; F:nuclear localization sequence binding; F:nucleic acid binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:MAPK cascade; P:negative regulation of signal transduction; P:protein ubiquitination; P:Ras protein signal transduction; scaffold93 indexed_genome mRNA 3186633 3187838 . + . ID=transcript_12622;Q7Z569 B4DRM1 B9EGS8 O43238 O75341,BRCA1-associated protein,BRAP2;Impedes mitogenic signal propagation;RING finger protein 52;RING-type E3 ubiquitin transferase BRAP2 {ECO:0000305};Renal carcinoma antigen NY-REN-63;, PF07576;PF13639;PF02148;, GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0000151;GO:0042802;GO:0008139;GO:0003676;GO:0061630;GO:0004842;GO:0008270;GO:0000165;GO:0009968;GO:0016567;GO:0007265;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:ubiquitin ligase complex;, F:identical protein binding; F:nuclear localization sequence binding; F:nucleic acid binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:MAPK cascade; P:negative regulation of signal transduction; P:protein ubiquitination; P:Ras protein signal transduction; scaffold93 indexed_genome mRNA 3188892 3193015 . - . ID=transcript_12623;Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation; scaffold93 indexed_genome mRNA 3193727 3197896 . - . ID=transcript_12624;Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation; scaffold93 indexed_genome mRNA 3204768 3211761 . - . ID=transcript_12625;Q6JQN1 G3XAJ0 Q8N828 Q8NAP2 Q96BX5,Acyl-CoA dehydrogenase family member 10,, PF00441;PF02770;PF02771;PF01636;PF13419;, GO:0005759;GO:0005739;GO:0050660;GO:0016787;GO:0016627;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:hydrolase activity; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:fatty acid beta-oxidation; scaffold93 indexed_genome mRNA 3232131 3259138 . + . ID=transcript_12626;Q7Z569 B4DRM1 B9EGS8 O43238 O75341,BRCA1-associated protein,BRAP2;Impedes mitogenic signal propagation;RING finger protein 52;RING-type E3 ubiquitin transferase BRAP2 {ECO:0000305};Renal carcinoma antigen NY-REN-63;, PF07576;PF13639;PF02148;, GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0000151;GO:0042802;GO:0008139;GO:0003676;GO:0061630;GO:0004842;GO:0008270;GO:0000165;GO:0009968;GO:0016567;GO:0007265;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:ubiquitin ligase complex;, F:identical protein binding; F:nuclear localization sequence binding; F:nucleic acid binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:MAPK cascade; P:negative regulation of signal transduction; P:protein ubiquitination; P:Ras protein signal transduction;|Q7Z569 B4DRM1 B9EGS8 O43238 O75341,BRCA1-associated protein,BRAP2;Impedes mitogenic signal propagation;RING finger protein 52;RING-type E3 ubiquitin transferase BRAP2 {ECO:0000305};Renal carcinoma antigen NY-REN-63;, PF07576;PF13639;PF02148;, GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0000151;GO:0042802;GO:0008139;GO:0003676;GO:0061630;GO:0004842;GO:0008270;GO:0000165;GO:0009968;GO:0016567;GO:0007265;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:ubiquitin ligase complex;, F:identical protein binding; F:nuclear localization sequence binding; F:nucleic acid binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:MAPK cascade; P:negative regulation of signal transduction; P:protein ubiquitination; P:Ras protein signal transduction;|Q7Z569 B4DRM1 B9EGS8 O43238 O75341,BRCA1-associated protein,BRAP2;Impedes mitogenic signal propagation;RING finger protein 52;RING-type E3 ubiquitin transferase BRAP2 {ECO:0000305};Renal carcinoma antigen NY-REN-63;, PF07576;PF13639;PF02148;, GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0000151;GO:0042802;GO:0008139;GO:0003676;GO:0061630;GO:0004842;GO:0008270;GO:0000165;GO:0009968;GO:0016567;GO:0007265;, C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:ubiquitin ligase complex;, F:identical protein binding; F:nuclear localization sequence binding; F:nucleic acid binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:MAPK cascade; P:negative regulation of signal transduction; P:protein ubiquitination; P:Ras protein signal transduction; scaffold93 indexed_genome mRNA 3289148 3410271 . + . ID=transcript_12627;Q99700 A6NLD4 Q24JQ7 Q6ZQZ7 Q99493,Ataxin-2,Spinocerebellar ataxia type 2 protein;Trinucleotide repeat-containing gene 13 protein;, PF06741;PF07145;PF14438;, GO:0005737;GO:0010494;GO:0005829;GO:0005794;GO:0016020;GO:0048471;GO:0005844;GO:1990904;GO:0005802;GO:0005154;GO:0008022;GO:0003723;GO:0002091;GO:0033962;GO:0010603;GO:0006417;GO:0016070;GO:0050658;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:trans-Golgi network;, F:epidermal growth factor receptor binding; F:protein C-terminus binding; F:RNA binding;, P:negative regulation of receptor internalization; P:P-body assembly; P:regulation of cytoplasmic mRNA processing body assembly; P:regulation of translation; P:RNA metabolic process; P:RNA transport; P:stress granule assembly;|Q99700 A6NLD4 Q24JQ7 Q6ZQZ7 Q99493,Ataxin-2,Spinocerebellar ataxia type 2 protein;Trinucleotide repeat-containing gene 13 protein;, PF06741;PF07145;PF14438;, GO:0005737;GO:0010494;GO:0005829;GO:0005794;GO:0016020;GO:0048471;GO:0005844;GO:1990904;GO:0005802;GO:0005154;GO:0008022;GO:0003723;GO:0002091;GO:0033962;GO:0010603;GO:0006417;GO:0016070;GO:0050658;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:trans-Golgi network;, F:epidermal growth factor receptor binding; F:protein C-terminus binding; F:RNA binding;, P:negative regulation of receptor internalization; P:P-body assembly; P:regulation of cytoplasmic mRNA processing body assembly; P:regulation of translation; P:RNA metabolic process; P:RNA transport; P:stress granule assembly;|Q99700 A6NLD4 Q24JQ7 Q6ZQZ7 Q99493,Ataxin-2,Spinocerebellar ataxia type 2 protein;Trinucleotide repeat-containing gene 13 protein;, PF06741;PF07145;PF14438;, GO:0005737;GO:0010494;GO:0005829;GO:0005794;GO:0016020;GO:0048471;GO:0005844;GO:1990904;GO:0005802;GO:0005154;GO:0008022;GO:0003723;GO:0002091;GO:0033962;GO:0010603;GO:0006417;GO:0016070;GO:0050658;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:trans-Golgi network;, F:epidermal growth factor receptor binding; F:protein C-terminus binding; F:RNA binding;, P:negative regulation of receptor internalization; P:P-body assembly; P:regulation of cytoplasmic mRNA processing body assembly; P:regulation of translation; P:RNA metabolic process; P:RNA transport; P:stress granule assembly;|Q99700 A6NLD4 Q24JQ7 Q6ZQZ7 Q99493,Ataxin-2,Spinocerebellar ataxia type 2 protein;Trinucleotide repeat-containing gene 13 protein;, PF06741;PF07145;PF14438;, GO:0005737;GO:0010494;GO:0005829;GO:0005794;GO:0016020;GO:0048471;GO:0005844;GO:1990904;GO:0005802;GO:0005154;GO:0008022;GO:0003723;GO:0002091;GO:0033962;GO:0010603;GO:0006417;GO:0016070;GO:0050658;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:trans-Golgi network;, F:epidermal growth factor receptor binding; F:protein C-terminus binding; F:RNA binding;, P:negative regulation of receptor internalization; P:P-body assembly; P:regulation of cytoplasmic mRNA processing body assembly; P:regulation of translation; P:RNA metabolic process; P:RNA transport; P:stress granule assembly;|Q99700 A6NLD4 Q24JQ7 Q6ZQZ7 Q99493,Ataxin-2,Spinocerebellar ataxia type 2 protein;Trinucleotide repeat-containing gene 13 protein;, PF06741;PF07145;PF14438;, GO:0005737;GO:0010494;GO:0005829;GO:0005794;GO:0016020;GO:0048471;GO:0005844;GO:1990904;GO:0005802;GO:0005154;GO:0008022;GO:0003723;GO:0002091;GO:0033962;GO:0010603;GO:0006417;GO:0016070;GO:0050658;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:Golgi apparatus; C:membrane; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:trans-Golgi network;, F:epidermal growth factor receptor binding; F:protein C-terminus binding; F:RNA binding;, P:negative regulation of receptor internalization; P:P-body assembly; P:regulation of cytoplasmic mRNA processing body assembly; P:regulation of translation; P:RNA metabolic process; P:RNA transport; P:stress granule assembly;|Q9UQQ2 B9EGG5 O95184,SH2B adapter protein 3,Lymphocyte adapter protein;Lymphocyte-specific adapter protein Lnk;Signal transduction protein Lnk;, PF00169;PF08916;PF00017;, GO:0005829;GO:0005886;GO:1990782;GO:0030159;GO:0005173;GO:0005068;GO:0007596;GO:1990869;GO:0036016;GO:0019221;GO:0035162;GO:0048821;GO:0035556;GO:0035855;GO:0035702;GO:0008285;GO:0070100;GO:1900235;GO:0043407;GO:0090331;GO:0051898;GO:0046426;GO:0060761;GO:0042532;GO:0001780;GO:0038163;, C:cytosol; C:plasma membrane;, F:protein tyrosine kinase binding; F:signaling receptor complex adaptor activity; F:stem cell factor receptor binding; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:blood coagulation; P:cellular response to chemokine; P:cellular response to interleukin-3; P:cytokine-mediated signaling pathway; P:embryonic hemopoiesis; P:erythrocyte development; P:intracellular signal transduction; P:megakaryocyte development; P:monocyte homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of Kit signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of platelet aggregation; P:negative regulation of protein kinase B signaling; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of response to cytokine stimulus; P:negative regulation of tyrosine phosphorylation of STAT protein; P:neutrophil homeostasis; P:thrombopoietin-mediated signaling pathway;|Q9UQQ2 B9EGG5 O95184,SH2B adapter protein 3,Lymphocyte adapter protein;Lymphocyte-specific adapter protein Lnk;Signal transduction protein Lnk;, PF00169;PF08916;PF00017;, GO:0005829;GO:0005886;GO:1990782;GO:0030159;GO:0005173;GO:0005068;GO:0007596;GO:1990869;GO:0036016;GO:0019221;GO:0035162;GO:0048821;GO:0035556;GO:0035855;GO:0035702;GO:0008285;GO:0070100;GO:1900235;GO:0043407;GO:0090331;GO:0051898;GO:0046426;GO:0060761;GO:0042532;GO:0001780;GO:0038163;, C:cytosol; C:plasma membrane;, F:protein tyrosine kinase binding; F:signaling receptor complex adaptor activity; F:stem cell factor receptor binding; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:blood coagulation; P:cellular response to chemokine; P:cellular response to interleukin-3; P:cytokine-mediated signaling pathway; P:embryonic hemopoiesis; P:erythrocyte development; P:intracellular signal transduction; P:megakaryocyte development; P:monocyte homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of Kit signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of platelet aggregation; P:negative regulation of protein kinase B signaling; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of response to cytokine stimulus; P:negative regulation of tyrosine phosphorylation of STAT protein; P:neutrophil homeostasis; P:thrombopoietin-mediated signaling pathway; scaffold93 indexed_genome mRNA 3469361 3476457 . + . ID=transcript_12628;Q8N4B1 J3KP50 Q6PJL9 Q96MH8,Sesquipedalian-1 {ECO:0000305|PubMed:20133602},27 kDa inositol polyphosphate phosphatase-interacting protein A;PH domain-containing endocytic trafficking adaptor 1 {ECO:0000305};, PF00169;, GO:0030136;GO:0005829;GO:0005769;GO:0055037;GO:0005802;GO:0042803;GO:0007032;GO:0001881;GO:0042147;, C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:recycling endosome; C:trans-Golgi network;, F:protein homodimerization activity;, P:endosome organization; P:receptor recycling; P:retrograde transport, endosome to Golgi; scaffold93 indexed_genome mRNA 3855032 3860627 . + . ID=transcript_12629;P10916 Q16123,Myosin regulatory light chain 2, ventricular/cardiac muscle isoform {ECO:0000305},Cardiac myosin light chain 2 {ECO:0000303|Ref.3};Myosin light chain 2, slow skeletal/ventricular muscle isoform {ECO:0000250|UniProtKB:Q7M2V4};Ventricular myosin light chain 2 {ECO:0000303|PubMed:2704627};, PF00036;, GO:0031672;GO:0097512;GO:0005856;GO:0005829;GO:0030016;GO:0016459;GO:0030017;GO:0003785;GO:0005509;GO:0032036;GO:0008307;GO:0055003;GO:0060047;GO:0007507;GO:0030049;GO:0030308;GO:0098735;GO:0006942;GO:0002026;GO:0055010;, C:A band; C:cardiac myofibril; C:cytoskeleton; C:cytosol; C:myofibril; C:myosin complex; C:sarcomere;, F:actin monomer binding; F:calcium ion binding; F:myosin heavy chain binding; F:structural constituent of muscle;, P:cardiac myofibril assembly; P:heart contraction; P:heart development; P:muscle filament sliding; P:negative regulation of cell growth; P:positive regulation of the force of heart contraction; P:regulation of striated muscle contraction; P:regulation of the force of heart contraction; P:ventricular cardiac muscle tissue morphogenesis;|P10916 Q16123,Myosin regulatory light chain 2, ventricular/cardiac muscle isoform {ECO:0000305},Cardiac myosin light chain 2 {ECO:0000303|Ref.3};Myosin light chain 2, slow skeletal/ventricular muscle isoform {ECO:0000250|UniProtKB:Q7M2V4};Ventricular myosin light chain 2 {ECO:0000303|PubMed:2704627};, PF00036;, GO:0031672;GO:0097512;GO:0005856;GO:0005829;GO:0030016;GO:0016459;GO:0030017;GO:0003785;GO:0005509;GO:0032036;GO:0008307;GO:0055003;GO:0060047;GO:0007507;GO:0030049;GO:0030308;GO:0098735;GO:0006942;GO:0002026;GO:0055010;, C:A band; C:cardiac myofibril; C:cytoskeleton; C:cytosol; C:myofibril; C:myosin complex; C:sarcomere;, F:actin monomer binding; F:calcium ion binding; F:myosin heavy chain binding; F:structural constituent of muscle;, P:cardiac myofibril assembly; P:heart contraction; P:heart development; P:muscle filament sliding; P:negative regulation of cell growth; P:positive regulation of the force of heart contraction; P:regulation of striated muscle contraction; P:regulation of the force of heart contraction; P:ventricular cardiac muscle tissue morphogenesis; scaffold93 indexed_genome mRNA 3978120 3993564 . + . ID=transcript_12630;P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,Protein phosphatase 1C catalytic subunit;, PF00149;PF16891;, GO:0032154;GO:0000777;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0005925;GO:0098978;GO:0030496;GO:0005741;GO:0005739;GO:0016607;GO:0005730;GO:0005634;GO:0098793;GO:0000164;GO:0032991;GO:0072357;GO:0005521;GO:0046872;GO:0016791;GO:0008022;GO:0019904;GO:0019901;GO:0047485;GO:0008157;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0003723;GO:0051301;GO:0032922;GO:0043153;GO:0005977;GO:0000165;GO:0007052;GO:0030182;GO:0060252;GO:0006470;GO:0042752;GO:0046822;, C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:focal adhesion; C:glutamatergic synapse; C:midbody; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleus; C:presynapse; C:protein phosphatase type 1 complex; C:protein-containing complex; C:PTW/PP1 phosphatase complex;, F:lamin binding; F:metal ion binding; F:phosphatase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein N-terminus binding; F:protein phosphatase 1 binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding; F:RNA binding;, P:cell division; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:glycogen metabolic process; P:MAPK cascade; P:mitotic spindle organization; P:neuron differentiation; P:positive regulation of glial cell proliferation; P:protein dephosphorylation; P:regulation of circadian rhythm; P:regulation of nucleocytoplasmic transport;|P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,Protein phosphatase 1C catalytic subunit;, PF00149;PF16891;, GO:0032154;GO:0000777;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0005925;GO:0098978;GO:0030496;GO:0005741;GO:0005739;GO:0016607;GO:0005730;GO:0005634;GO:0098793;GO:0000164;GO:0032991;GO:0072357;GO:0005521;GO:0046872;GO:0016791;GO:0008022;GO:0019904;GO:0019901;GO:0047485;GO:0008157;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0003723;GO:0051301;GO:0032922;GO:0043153;GO:0005977;GO:0000165;GO:0007052;GO:0030182;GO:0060252;GO:0006470;GO:0042752;GO:0046822;, C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:focal adhesion; C:glutamatergic synapse; C:midbody; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleus; C:presynapse; C:protein phosphatase type 1 complex; C:protein-containing complex; C:PTW/PP1 phosphatase complex;, F:lamin binding; F:metal ion binding; F:phosphatase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein N-terminus binding; F:protein phosphatase 1 binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding; F:RNA binding;, P:cell division; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:glycogen metabolic process; P:MAPK cascade; P:mitotic spindle organization; P:neuron differentiation; P:positive regulation of glial cell proliferation; P:protein dephosphorylation; P:regulation of circadian rhythm; P:regulation of nucleocytoplasmic transport;|P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,Protein phosphatase 1C catalytic subunit;, PF00149;PF16891;, GO:0032154;GO:0000777;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0005925;GO:0098978;GO:0030496;GO:0005741;GO:0005739;GO:0016607;GO:0005730;GO:0005634;GO:0098793;GO:0000164;GO:0032991;GO:0072357;GO:0005521;GO:0046872;GO:0016791;GO:0008022;GO:0019904;GO:0019901;GO:0047485;GO:0008157;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0003723;GO:0051301;GO:0032922;GO:0043153;GO:0005977;GO:0000165;GO:0007052;GO:0030182;GO:0060252;GO:0006470;GO:0042752;GO:0046822;, C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:focal adhesion; C:glutamatergic synapse; C:midbody; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleus; C:presynapse; C:protein phosphatase type 1 complex; C:protein-containing complex; C:PTW/PP1 phosphatase complex;, F:lamin binding; F:metal ion binding; F:phosphatase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein N-terminus binding; F:protein phosphatase 1 binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding; F:RNA binding;, P:cell division; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:glycogen metabolic process; P:MAPK cascade; P:mitotic spindle organization; P:neuron differentiation; P:positive regulation of glial cell proliferation; P:protein dephosphorylation; P:regulation of circadian rhythm; P:regulation of nucleocytoplasmic transport; scaffold93 indexed_genome mRNA 3993654 3997260 . + . ID=transcript_12631;P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,Protein phosphatase 1C catalytic subunit;, PF00149;PF16891;, GO:0032154;GO:0000777;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0005925;GO:0098978;GO:0030496;GO:0005741;GO:0005739;GO:0016607;GO:0005730;GO:0005634;GO:0098793;GO:0000164;GO:0032991;GO:0072357;GO:0005521;GO:0046872;GO:0016791;GO:0008022;GO:0019904;GO:0019901;GO:0047485;GO:0008157;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0003723;GO:0051301;GO:0032922;GO:0043153;GO:0005977;GO:0000165;GO:0007052;GO:0030182;GO:0060252;GO:0006470;GO:0042752;GO:0046822;, C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:focal adhesion; C:glutamatergic synapse; C:midbody; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleus; C:presynapse; C:protein phosphatase type 1 complex; C:protein-containing complex; C:PTW/PP1 phosphatase complex;, F:lamin binding; F:metal ion binding; F:phosphatase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein N-terminus binding; F:protein phosphatase 1 binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding; F:RNA binding;, P:cell division; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:glycogen metabolic process; P:MAPK cascade; P:mitotic spindle organization; P:neuron differentiation; P:positive regulation of glial cell proliferation; P:protein dephosphorylation; P:regulation of circadian rhythm; P:regulation of nucleocytoplasmic transport;|P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,Protein phosphatase 1C catalytic subunit;, PF00149;PF16891;, GO:0032154;GO:0000777;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0005925;GO:0098978;GO:0030496;GO:0005741;GO:0005739;GO:0016607;GO:0005730;GO:0005634;GO:0098793;GO:0000164;GO:0032991;GO:0072357;GO:0005521;GO:0046872;GO:0016791;GO:0008022;GO:0019904;GO:0019901;GO:0047485;GO:0008157;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0003723;GO:0051301;GO:0032922;GO:0043153;GO:0005977;GO:0000165;GO:0007052;GO:0030182;GO:0060252;GO:0006470;GO:0042752;GO:0046822;, C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:focal adhesion; C:glutamatergic synapse; C:midbody; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleus; C:presynapse; C:protein phosphatase type 1 complex; C:protein-containing complex; C:PTW/PP1 phosphatase complex;, F:lamin binding; F:metal ion binding; F:phosphatase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein N-terminus binding; F:protein phosphatase 1 binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding; F:RNA binding;, P:cell division; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:glycogen metabolic process; P:MAPK cascade; P:mitotic spindle organization; P:neuron differentiation; P:positive regulation of glial cell proliferation; P:protein dephosphorylation; P:regulation of circadian rhythm; P:regulation of nucleocytoplasmic transport;|P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,Protein phosphatase 1C catalytic subunit;, PF00149;PF16891;, GO:0032154;GO:0000777;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0005925;GO:0098978;GO:0030496;GO:0005741;GO:0005739;GO:0016607;GO:0005730;GO:0005634;GO:0098793;GO:0000164;GO:0032991;GO:0072357;GO:0005521;GO:0046872;GO:0016791;GO:0008022;GO:0019904;GO:0019901;GO:0047485;GO:0008157;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0003723;GO:0051301;GO:0032922;GO:0043153;GO:0005977;GO:0000165;GO:0007052;GO:0030182;GO:0060252;GO:0006470;GO:0042752;GO:0046822;, C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:focal adhesion; C:glutamatergic synapse; C:midbody; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleus; C:presynapse; C:protein phosphatase type 1 complex; C:protein-containing complex; C:PTW/PP1 phosphatase complex;, F:lamin binding; F:metal ion binding; F:phosphatase activity; F:protein C-terminus binding; F:protein domain specific binding; F:protein kinase binding; F:protein N-terminus binding; F:protein phosphatase 1 binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding; F:RNA binding;, P:cell division; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:glycogen metabolic process; P:MAPK cascade; P:mitotic spindle organization; P:neuron differentiation; P:positive regulation of glial cell proliferation; P:protein dephosphorylation; P:regulation of circadian rhythm; P:regulation of nucleocytoplasmic transport; scaffold93 indexed_genome mRNA 4023430 4057047 . + . ID=transcript_12632;Q96D96 A8MQ37 B4DEB3 F8WCH5 Q6UW11 Q96IS5,Voltage-gated hydrogen channel 1,Hydrogen voltage-gated channel 1;Voltage sensor domain-only protein;, PF00520;PF16799;, GO:0016324;GO:0016021;GO:0005887;GO:0030670;GO:0005886;GO:0030667;GO:0035579;GO:0042802;GO:0022843;GO:0030171;GO:0045454;GO:0071467;GO:0071294;GO:0043312;GO:0032930;GO:1902600;GO:0051453;GO:0034765;GO:0009268;GO:0010043;GO:0035036;, C:apical plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane;, F:identical protein binding; F:voltage-gated cation channel activity; F:voltage-gated proton channel activity;, P:cell redox homeostasis; P:cellular response to pH; P:cellular response to zinc ion; P:neutrophil degranulation; P:positive regulation of superoxide anion generation; P:proton transmembrane transport; P:regulation of intracellular pH; P:regulation of ion transmembrane transport; P:response to pH; P:response to zinc ion; P:sperm-egg recognition;|Q96D96 A8MQ37 B4DEB3 F8WCH5 Q6UW11 Q96IS5,Voltage-gated hydrogen channel 1,Hydrogen voltage-gated channel 1;Voltage sensor domain-only protein;, PF00520;PF16799;, GO:0016324;GO:0016021;GO:0005887;GO:0030670;GO:0005886;GO:0030667;GO:0035579;GO:0042802;GO:0022843;GO:0030171;GO:0045454;GO:0071467;GO:0071294;GO:0043312;GO:0032930;GO:1902600;GO:0051453;GO:0034765;GO:0009268;GO:0010043;GO:0035036;, C:apical plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane;, F:identical protein binding; F:voltage-gated cation channel activity; F:voltage-gated proton channel activity;, P:cell redox homeostasis; P:cellular response to pH; P:cellular response to zinc ion; P:neutrophil degranulation; P:positive regulation of superoxide anion generation; P:proton transmembrane transport; P:regulation of intracellular pH; P:regulation of ion transmembrane transport; P:response to pH; P:response to zinc ion; P:sperm-egg recognition;|Q2MV58 A8MX11 Q49A60 Q6P5X1 Q6UXW2 Q8NAE9 Q96N72 Q9H798,Tectonic-1,, PF07773;, GO:0005856;GO:0005829;GO:0005615;GO:0016020;GO:0036038;GO:0021956;GO:0097711;GO:0060271;GO:0021904;GO:0001701;GO:0001841;GO:1904491;GO:0008589;GO:0021523;GO:0021537;, C:cytoskeleton; C:cytosol; C:extracellular space; C:membrane; C:MKS complex;, , P:central nervous system interneuron axonogenesis; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:dorsal/ventral neural tube patterning; P:in utero embryonic development; P:neural tube formation; P:protein localization to ciliary transition zone; P:regulation of smoothened signaling pathway; P:somatic motor neuron differentiation; P:telencephalon development; scaffold93 indexed_genome mRNA 4058235 4059318 . - . ID=transcript_12633;Q2MV58 A8MX11 Q49A60 Q6P5X1 Q6UXW2 Q8NAE9 Q96N72 Q9H798,Tectonic-1,, PF07773;, GO:0005856;GO:0005829;GO:0005615;GO:0016020;GO:0036038;GO:0021956;GO:0097711;GO:0060271;GO:0021904;GO:0001701;GO:0001841;GO:1904491;GO:0008589;GO:0021523;GO:0021537;, C:cytoskeleton; C:cytosol; C:extracellular space; C:membrane; C:MKS complex;, , P:central nervous system interneuron axonogenesis; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:dorsal/ventral neural tube patterning; P:in utero embryonic development; P:neural tube formation; P:protein localization to ciliary transition zone; P:regulation of smoothened signaling pathway; P:somatic motor neuron differentiation; P:telencephalon development; scaffold93 indexed_genome mRNA 4060119 4081411 . - . ID=transcript_12634;Q2MV58 A8MX11 Q49A60 Q6P5X1 Q6UXW2 Q8NAE9 Q96N72 Q9H798,Tectonic-1,, PF07773;, GO:0005856;GO:0005829;GO:0005615;GO:0016020;GO:0036038;GO:0021956;GO:0097711;GO:0060271;GO:0021904;GO:0001701;GO:0001841;GO:1904491;GO:0008589;GO:0021523;GO:0021537;, C:cytoskeleton; C:cytosol; C:extracellular space; C:membrane; C:MKS complex;, , P:central nervous system interneuron axonogenesis; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:dorsal/ventral neural tube patterning; P:in utero embryonic development; P:neural tube formation; P:protein localization to ciliary transition zone; P:regulation of smoothened signaling pathway; P:somatic motor neuron differentiation; P:telencephalon development;|Q2MV58 A8MX11 Q49A60 Q6P5X1 Q6UXW2 Q8NAE9 Q96N72 Q9H798,Tectonic-1,, PF07773;, GO:0005856;GO:0005829;GO:0005615;GO:0016020;GO:0036038;GO:0021956;GO:0097711;GO:0060271;GO:0021904;GO:0001701;GO:0001841;GO:1904491;GO:0008589;GO:0021523;GO:0021537;, C:cytoskeleton; C:cytosol; C:extracellular space; C:membrane; C:MKS complex;, , P:central nervous system interneuron axonogenesis; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:dorsal/ventral neural tube patterning; P:in utero embryonic development; P:neural tube formation; P:protein localization to ciliary transition zone; P:regulation of smoothened signaling pathway; P:somatic motor neuron differentiation; P:telencephalon development;|Q2MV58 A8MX11 Q49A60 Q6P5X1 Q6UXW2 Q8NAE9 Q96N72 Q9H798,Tectonic-1,, PF07773;, GO:0005856;GO:0005829;GO:0005615;GO:0016020;GO:0036038;GO:0021956;GO:0097711;GO:0060271;GO:0021904;GO:0001701;GO:0001841;GO:1904491;GO:0008589;GO:0021523;GO:0021537;, C:cytoskeleton; C:cytosol; C:extracellular space; C:membrane; C:MKS complex;, , P:central nervous system interneuron axonogenesis; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:dorsal/ventral neural tube patterning; P:in utero embryonic development; P:neural tube formation; P:protein localization to ciliary transition zone; P:regulation of smoothened signaling pathway; P:somatic motor neuron differentiation; P:telencephalon development; scaffold93 indexed_genome mRNA 4137949 4140057 . + . ID=transcript_12635;Q8NI37 B3KWC5 Q68DZ7 Q6UY82,Protein phosphatase PTC7 homolog,T-cell activation protein phosphatase 2C;T-cell activation protein phosphatase 2C-like;, PF07228;, GO:0005759;GO:0005739;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0070262;GO:0010795;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:peptidyl-serine dephosphorylation; P:regulation of ubiquinone biosynthetic process; scaffold93 indexed_genome mRNA 4140107 4148835 . + . ID=transcript_12636;Q8NI37 B3KWC5 Q68DZ7 Q6UY82,Protein phosphatase PTC7 homolog,T-cell activation protein phosphatase 2C;T-cell activation protein phosphatase 2C-like;, PF07228;, GO:0005759;GO:0005739;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0070262;GO:0010795;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:peptidyl-serine dephosphorylation; P:regulation of ubiquinone biosynthetic process;|Q8NI37 B3KWC5 Q68DZ7 Q6UY82,Protein phosphatase PTC7 homolog,T-cell activation protein phosphatase 2C;T-cell activation protein phosphatase 2C-like;, PF07228;, GO:0005759;GO:0005739;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0070262;GO:0010795;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:peptidyl-serine dephosphorylation; P:regulation of ubiquinone biosynthetic process;|Q8NI37 B3KWC5 Q68DZ7 Q6UY82,Protein phosphatase PTC7 homolog,T-cell activation protein phosphatase 2C;T-cell activation protein phosphatase 2C-like;, PF07228;, GO:0005759;GO:0005739;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0070262;GO:0010795;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:peptidyl-serine dephosphorylation; P:regulation of ubiquinone biosynthetic process;|Q8NI37 B3KWC5 Q68DZ7 Q6UY82,Protein phosphatase PTC7 homolog,T-cell activation protein phosphatase 2C;T-cell activation protein phosphatase 2C-like;, PF07228;, GO:0005759;GO:0005739;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0070262;GO:0010795;, C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:peptidyl-serine dephosphorylation; P:regulation of ubiquinone biosynthetic process; scaffold93 indexed_genome mRNA 4157194 4175399 . - . ID=transcript_12637;Q6WBX8 Q5U5K0 Q6NVJ1 Q6ZVT7 Q8N7T9 Q96LI8,Cell cycle checkpoint control protein RAD9B,DNA repair exonuclease rad9 homolog B;, PF04139;, GO:0030896;GO:0005654;GO:0005634;GO:0008408;GO:0071479;GO:0006281;GO:0006260;GO:0000076;GO:0031573;GO:1901796;, C:checkpoint clamp complex; C:nucleoplasm; C:nucleus;, F:3'-5' exonuclease activity;, P:cellular response to ionizing radiation; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:intra-S DNA damage checkpoint; P:regulation of signal transduction by p53 class mediator; scaffold93 indexed_genome mRNA 4175477 4182631 . + . ID=transcript_12638;Q9UBQ0 Q502Y5 Q6FIF8 Q6IAH3 Q9H0W0 Q9NRP1 Q9NRU7,Vacuolar protein sorting-associated protein 29,PEP11 homolog;Vesicle protein sorting 29;, PF12850;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0043231;GO:0005770;GO:0030904;GO:0030906;GO:0046872;GO:0032456;GO:0006886;GO:0042147;GO:1990126;GO:0016032;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:retromer complex; C:retromer, cargo-selective complex;, F:metal ion binding;, P:endocytic recycling; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:viral process; P:Wnt signaling pathway;|Q9UBQ0 Q502Y5 Q6FIF8 Q6IAH3 Q9H0W0 Q9NRP1 Q9NRU7,Vacuolar protein sorting-associated protein 29,PEP11 homolog;Vesicle protein sorting 29;, PF12850;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0043231;GO:0005770;GO:0030904;GO:0030906;GO:0046872;GO:0032456;GO:0006886;GO:0042147;GO:1990126;GO:0016032;GO:0016055;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:retromer complex; C:retromer, cargo-selective complex;, F:metal ion binding;, P:endocytic recycling; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:retrograde transport, endosome to plasma membrane; P:viral process; P:Wnt signaling pathway; scaffold93 indexed_genome mRNA 4182643 4192438 . - . ID=transcript_12639;Q8WUB2 A6NH30 Q99776,Protein FAM216A,, PF15107;|Q8WUB2 A6NH30 Q99776,Protein FAM216A,, PF15107; scaffold93 indexed_genome mRNA 4200923 4206563 . + . ID=transcript_12640;Q9UHW5 B2RC54 D4YWV1 F5H759 Q53FS3 Q6UVZ6 Q7Z3D3 Q8NEI2 Q96HK9,GPN-loop GTPase 3 {ECO:0000303|Ref.2},ATP-binding domain 1 family member C;, PF03029;, GO:0032991;GO:0005525;GO:0003924;, C:protein-containing complex;, F:GTP binding; F:GTPase activity;|Q9UHW5 B2RC54 D4YWV1 F5H759 Q53FS3 Q6UVZ6 Q7Z3D3 Q8NEI2 Q96HK9,GPN-loop GTPase 3 {ECO:0000303|Ref.2},ATP-binding domain 1 family member C;, PF03029;, GO:0032991;GO:0005525;GO:0003924;, C:protein-containing complex;, F:GTP binding; F:GTPase activity;|Q9UHW5 B2RC54 D4YWV1 F5H759 Q53FS3 Q6UVZ6 Q7Z3D3 Q8NEI2 Q96HK9,GPN-loop GTPase 3 {ECO:0000303|Ref.2},ATP-binding domain 1 family member C;, PF03029;, GO:0032991;GO:0005525;GO:0003924;, C:protein-containing complex;, F:GTP binding; F:GTPase activity;|Q9UHW5 B2RC54 D4YWV1 F5H759 Q53FS3 Q6UVZ6 Q7Z3D3 Q8NEI2 Q96HK9,GPN-loop GTPase 3 {ECO:0000303|Ref.2},ATP-binding domain 1 family member C;, PF03029;, GO:0032991;GO:0005525;GO:0003924;, C:protein-containing complex;, F:GTP binding; F:GTPase activity;|Q9UHW5 B2RC54 D4YWV1 F5H759 Q53FS3 Q6UVZ6 Q7Z3D3 Q8NEI2 Q96HK9,GPN-loop GTPase 3 {ECO:0000303|Ref.2},ATP-binding domain 1 family member C;, PF03029;, GO:0032991;GO:0005525;GO:0003924;, C:protein-containing complex;, F:GTP binding; F:GTPase activity;|Q9UHW5 B2RC54 D4YWV1 F5H759 Q53FS3 Q6UVZ6 Q7Z3D3 Q8NEI2 Q96HK9,GPN-loop GTPase 3 {ECO:0000303|Ref.2},ATP-binding domain 1 family member C;, PF03029;, GO:0032991;GO:0005525;GO:0003924;, C:protein-containing complex;, F:GTP binding; F:GTPase activity; scaffold93 indexed_genome mRNA 4215550 4216501 . + . ID=transcript_12641;O15145 O00554,Actin-related protein 2/3 complex subunit 3,Arp2/3 complex 21 kDa subunit;, PF04062;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0031941;GO:0005925;GO:0061850;GO:0030027;GO:0016020;GO:0005634;GO:0035861;GO:0003779;GO:0005200;GO:0070358;GO:0034314;GO:1990090;GO:0048013;GO:0038096;GO:0061024;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:filamentous actin; C:focal adhesion; C:growth cone leading edge; C:lamellipodium; C:membrane; C:nucleus; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:cellular response to nerve growth factor stimulus; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; scaffold93 indexed_genome mRNA 4218542 4220898 . - . ID=transcript_12642;O15145 O00554,Actin-related protein 2/3 complex subunit 3,Arp2/3 complex 21 kDa subunit;, PF04062;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0031941;GO:0005925;GO:0061850;GO:0030027;GO:0016020;GO:0005634;GO:0035861;GO:0003779;GO:0005200;GO:0070358;GO:0034314;GO:1990090;GO:0048013;GO:0038096;GO:0061024;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:filamentous actin; C:focal adhesion; C:growth cone leading edge; C:lamellipodium; C:membrane; C:nucleus; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:cellular response to nerve growth factor stimulus; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization;|O15145 O00554,Actin-related protein 2/3 complex subunit 3,Arp2/3 complex 21 kDa subunit;, PF04062;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0031941;GO:0005925;GO:0061850;GO:0030027;GO:0016020;GO:0005634;GO:0035861;GO:0003779;GO:0005200;GO:0070358;GO:0034314;GO:1990090;GO:0048013;GO:0038096;GO:0061024;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:filamentous actin; C:focal adhesion; C:growth cone leading edge; C:lamellipodium; C:membrane; C:nucleus; C:site of double-strand break;, F:actin binding; F:structural constituent of cytoskeleton;, P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:cellular response to nerve growth factor stimulus; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; scaffold93 indexed_genome mRNA 4236523 4241115 . + . ID=transcript_12643;Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold93 indexed_genome mRNA 4242042 4256438 . + . ID=transcript_12644;Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX3 Q96AC4 Q96GF4 Q9BU24 Q9NT16,Anaphase-promoting complex subunit 7,Cyclosome subunit 7;, PF13181;, GO:0005680;GO:0005737;GO:0005829;GO:0015630;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytoplasm; C:cytosol; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold93 indexed_genome mRNA 4274329 4281450 . - . ID=transcript_12645;P16615 A6NDN7 B4DF05 P16614 Q86VJ2,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 {ECO:0000305},Calcium pump 2;Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0061831;GO:0090534;GO:0005783;GO:0005789;GO:0031234;GO:0005887;GO:0014801;GO:0016020;GO:0048471;GO:0120025;GO:0031095;GO:0032991;GO:0097470;GO:0016529;GO:0033017;GO:0012506;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0086039;GO:0019899;GO:0044325;GO:0031775;GO:0008022;GO:0008553;GO:0044548;GO:0000045;GO:0016240;GO:1990036;GO:0070588;GO:1903515;GO:0014898;GO:0007155;GO:0006874;GO:0034605;GO:0034599;GO:0032469;GO:0008544;GO:0006984;GO:0034220;GO:1990456;GO:0045822;GO:1900121;GO:0140056;GO:0032470;GO:0010460;GO:1903233;GO:1903779;GO:0098909;GO:0086036;GO:0010882;GO:0002026;GO:0055119;GO:0034976;GO:0032496;GO:0070296;GO:0003009;GO:0033292;GO:0014883;, C:apical ectoplasmic specialization; C:calcium ion-transporting ATPase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:longitudinal sarcoplasmic reticulum; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane bounded cell projection; C:platelet dense tubular network membrane; C:protein-containing complex; C:ribbon synapse; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:vesicle membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential; F:enzyme binding; F:ion channel binding; F:lutropin-choriogonadotropic hormone receptor binding; F:protein C-terminus binding; F:proton-exporting ATPase activity, phosphorylative mechanism; F:S100 protein binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport from cytosol to endoplasmic reticulum; P:cardiac muscle hypertrophy in response to stress; P:cell adhesion; P:cellular calcium ion homeostasis; P:cellular response to heat; P:cellular response to oxidative stress; P:endoplasmic reticulum calcium ion homeostasis; P:epidermis development; P:ER-nucleus signaling pathway; P:ion transmembrane transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of heart contraction; P:negative regulation of receptor binding; P:organelle localization by membrane tethering; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of heart rate; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to endoplasmic reticulum stress; P:response to lipopolysaccharide; P:sarcoplasmic reticulum calcium ion transport; P:skeletal muscle contraction; P:T-tubule organization; P:transition between fast and slow fiber;|P16615 A6NDN7 B4DF05 P16614 Q86VJ2,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 {ECO:0000305},Calcium pump 2;Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0061831;GO:0090534;GO:0005783;GO:0005789;GO:0031234;GO:0005887;GO:0014801;GO:0016020;GO:0048471;GO:0120025;GO:0031095;GO:0032991;GO:0097470;GO:0016529;GO:0033017;GO:0012506;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0086039;GO:0019899;GO:0044325;GO:0031775;GO:0008022;GO:0008553;GO:0044548;GO:0000045;GO:0016240;GO:1990036;GO:0070588;GO:1903515;GO:0014898;GO:0007155;GO:0006874;GO:0034605;GO:0034599;GO:0032469;GO:0008544;GO:0006984;GO:0034220;GO:1990456;GO:0045822;GO:1900121;GO:0140056;GO:0032470;GO:0010460;GO:1903233;GO:1903779;GO:0098909;GO:0086036;GO:0010882;GO:0002026;GO:0055119;GO:0034976;GO:0032496;GO:0070296;GO:0003009;GO:0033292;GO:0014883;, C:apical ectoplasmic specialization; C:calcium ion-transporting ATPase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:longitudinal sarcoplasmic reticulum; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane bounded cell projection; C:platelet dense tubular network membrane; C:protein-containing complex; C:ribbon synapse; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:vesicle membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential; F:enzyme binding; F:ion channel binding; F:lutropin-choriogonadotropic hormone receptor binding; F:protein C-terminus binding; F:proton-exporting ATPase activity, phosphorylative mechanism; F:S100 protein binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport from cytosol to endoplasmic reticulum; P:cardiac muscle hypertrophy in response to stress; P:cell adhesion; P:cellular calcium ion homeostasis; P:cellular response to heat; P:cellular response to oxidative stress; P:endoplasmic reticulum calcium ion homeostasis; P:epidermis development; P:ER-nucleus signaling pathway; P:ion transmembrane transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of heart contraction; P:negative regulation of receptor binding; P:organelle localization by membrane tethering; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of heart rate; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to endoplasmic reticulum stress; P:response to lipopolysaccharide; P:sarcoplasmic reticulum calcium ion transport; P:skeletal muscle contraction; P:T-tubule organization; P:transition between fast and slow fiber; scaffold93 indexed_genome mRNA 4284487 4286041 . - . ID=transcript_12646;P16615 A6NDN7 B4DF05 P16614 Q86VJ2,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 {ECO:0000305},Calcium pump 2;Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0061831;GO:0090534;GO:0005783;GO:0005789;GO:0031234;GO:0005887;GO:0014801;GO:0016020;GO:0048471;GO:0120025;GO:0031095;GO:0032991;GO:0097470;GO:0016529;GO:0033017;GO:0012506;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0086039;GO:0019899;GO:0044325;GO:0031775;GO:0008022;GO:0008553;GO:0044548;GO:0000045;GO:0016240;GO:1990036;GO:0070588;GO:1903515;GO:0014898;GO:0007155;GO:0006874;GO:0034605;GO:0034599;GO:0032469;GO:0008544;GO:0006984;GO:0034220;GO:1990456;GO:0045822;GO:1900121;GO:0140056;GO:0032470;GO:0010460;GO:1903233;GO:1903779;GO:0098909;GO:0086036;GO:0010882;GO:0002026;GO:0055119;GO:0034976;GO:0032496;GO:0070296;GO:0003009;GO:0033292;GO:0014883;, C:apical ectoplasmic specialization; C:calcium ion-transporting ATPase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:longitudinal sarcoplasmic reticulum; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane bounded cell projection; C:platelet dense tubular network membrane; C:protein-containing complex; C:ribbon synapse; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:vesicle membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential; F:enzyme binding; F:ion channel binding; F:lutropin-choriogonadotropic hormone receptor binding; F:protein C-terminus binding; F:proton-exporting ATPase activity, phosphorylative mechanism; F:S100 protein binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport from cytosol to endoplasmic reticulum; P:cardiac muscle hypertrophy in response to stress; P:cell adhesion; P:cellular calcium ion homeostasis; P:cellular response to heat; P:cellular response to oxidative stress; P:endoplasmic reticulum calcium ion homeostasis; P:epidermis development; P:ER-nucleus signaling pathway; P:ion transmembrane transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of heart contraction; P:negative regulation of receptor binding; P:organelle localization by membrane tethering; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of heart rate; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to endoplasmic reticulum stress; P:response to lipopolysaccharide; P:sarcoplasmic reticulum calcium ion transport; P:skeletal muscle contraction; P:T-tubule organization; P:transition between fast and slow fiber; scaffold93 indexed_genome mRNA 4289315 4289920 . + . ID=transcript_12647;P16615 A6NDN7 B4DF05 P16614 Q86VJ2,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 {ECO:0000305},Calcium pump 2;Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0061831;GO:0090534;GO:0005783;GO:0005789;GO:0031234;GO:0005887;GO:0014801;GO:0016020;GO:0048471;GO:0120025;GO:0031095;GO:0032991;GO:0097470;GO:0016529;GO:0033017;GO:0012506;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0086039;GO:0019899;GO:0044325;GO:0031775;GO:0008022;GO:0008553;GO:0044548;GO:0000045;GO:0016240;GO:1990036;GO:0070588;GO:1903515;GO:0014898;GO:0007155;GO:0006874;GO:0034605;GO:0034599;GO:0032469;GO:0008544;GO:0006984;GO:0034220;GO:1990456;GO:0045822;GO:1900121;GO:0140056;GO:0032470;GO:0010460;GO:1903233;GO:1903779;GO:0098909;GO:0086036;GO:0010882;GO:0002026;GO:0055119;GO:0034976;GO:0032496;GO:0070296;GO:0003009;GO:0033292;GO:0014883;, C:apical ectoplasmic specialization; C:calcium ion-transporting ATPase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:longitudinal sarcoplasmic reticulum; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane bounded cell projection; C:platelet dense tubular network membrane; C:protein-containing complex; C:ribbon synapse; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:vesicle membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential; F:enzyme binding; F:ion channel binding; F:lutropin-choriogonadotropic hormone receptor binding; F:protein C-terminus binding; F:proton-exporting ATPase activity, phosphorylative mechanism; F:S100 protein binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport from cytosol to endoplasmic reticulum; P:cardiac muscle hypertrophy in response to stress; P:cell adhesion; P:cellular calcium ion homeostasis; P:cellular response to heat; P:cellular response to oxidative stress; P:endoplasmic reticulum calcium ion homeostasis; P:epidermis development; P:ER-nucleus signaling pathway; P:ion transmembrane transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of heart contraction; P:negative regulation of receptor binding; P:organelle localization by membrane tethering; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of heart rate; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to endoplasmic reticulum stress; P:response to lipopolysaccharide; P:sarcoplasmic reticulum calcium ion transport; P:skeletal muscle contraction; P:T-tubule organization; P:transition between fast and slow fiber; scaffold93 indexed_genome mRNA 4300358 4332386 . - . ID=transcript_12648;P16615 A6NDN7 B4DF05 P16614 Q86VJ2,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 {ECO:0000305},Calcium pump 2;Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0061831;GO:0090534;GO:0005783;GO:0005789;GO:0031234;GO:0005887;GO:0014801;GO:0016020;GO:0048471;GO:0120025;GO:0031095;GO:0032991;GO:0097470;GO:0016529;GO:0033017;GO:0012506;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0086039;GO:0019899;GO:0044325;GO:0031775;GO:0008022;GO:0008553;GO:0044548;GO:0000045;GO:0016240;GO:1990036;GO:0070588;GO:1903515;GO:0014898;GO:0007155;GO:0006874;GO:0034605;GO:0034599;GO:0032469;GO:0008544;GO:0006984;GO:0034220;GO:1990456;GO:0045822;GO:1900121;GO:0140056;GO:0032470;GO:0010460;GO:1903233;GO:1903779;GO:0098909;GO:0086036;GO:0010882;GO:0002026;GO:0055119;GO:0034976;GO:0032496;GO:0070296;GO:0003009;GO:0033292;GO:0014883;, C:apical ectoplasmic specialization; C:calcium ion-transporting ATPase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:longitudinal sarcoplasmic reticulum; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane bounded cell projection; C:platelet dense tubular network membrane; C:protein-containing complex; C:ribbon synapse; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:vesicle membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential; F:enzyme binding; F:ion channel binding; F:lutropin-choriogonadotropic hormone receptor binding; F:protein C-terminus binding; F:proton-exporting ATPase activity, phosphorylative mechanism; F:S100 protein binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport from cytosol to endoplasmic reticulum; P:cardiac muscle hypertrophy in response to stress; P:cell adhesion; P:cellular calcium ion homeostasis; P:cellular response to heat; P:cellular response to oxidative stress; P:endoplasmic reticulum calcium ion homeostasis; P:epidermis development; P:ER-nucleus signaling pathway; P:ion transmembrane transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of heart contraction; P:negative regulation of receptor binding; P:organelle localization by membrane tethering; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of heart rate; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to endoplasmic reticulum stress; P:response to lipopolysaccharide; P:sarcoplasmic reticulum calcium ion transport; P:skeletal muscle contraction; P:T-tubule organization; P:transition between fast and slow fiber;|P16615 A6NDN7 B4DF05 P16614 Q86VJ2,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 {ECO:0000305},Calcium pump 2;Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0061831;GO:0090534;GO:0005783;GO:0005789;GO:0031234;GO:0005887;GO:0014801;GO:0016020;GO:0048471;GO:0120025;GO:0031095;GO:0032991;GO:0097470;GO:0016529;GO:0033017;GO:0012506;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0086039;GO:0019899;GO:0044325;GO:0031775;GO:0008022;GO:0008553;GO:0044548;GO:0000045;GO:0016240;GO:1990036;GO:0070588;GO:1903515;GO:0014898;GO:0007155;GO:0006874;GO:0034605;GO:0034599;GO:0032469;GO:0008544;GO:0006984;GO:0034220;GO:1990456;GO:0045822;GO:1900121;GO:0140056;GO:0032470;GO:0010460;GO:1903233;GO:1903779;GO:0098909;GO:0086036;GO:0010882;GO:0002026;GO:0055119;GO:0034976;GO:0032496;GO:0070296;GO:0003009;GO:0033292;GO:0014883;, C:apical ectoplasmic specialization; C:calcium ion-transporting ATPase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:longitudinal sarcoplasmic reticulum; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane bounded cell projection; C:platelet dense tubular network membrane; C:protein-containing complex; C:ribbon synapse; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:vesicle membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential; F:enzyme binding; F:ion channel binding; F:lutropin-choriogonadotropic hormone receptor binding; F:protein C-terminus binding; F:proton-exporting ATPase activity, phosphorylative mechanism; F:S100 protein binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport from cytosol to endoplasmic reticulum; P:cardiac muscle hypertrophy in response to stress; P:cell adhesion; P:cellular calcium ion homeostasis; P:cellular response to heat; P:cellular response to oxidative stress; P:endoplasmic reticulum calcium ion homeostasis; P:epidermis development; P:ER-nucleus signaling pathway; P:ion transmembrane transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of heart contraction; P:negative regulation of receptor binding; P:organelle localization by membrane tethering; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of heart rate; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to endoplasmic reticulum stress; P:response to lipopolysaccharide; P:sarcoplasmic reticulum calcium ion transport; P:skeletal muscle contraction; P:T-tubule organization; P:transition between fast and slow fiber;|P16615 A6NDN7 B4DF05 P16614 Q86VJ2,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 {ECO:0000305},Calcium pump 2;Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0061831;GO:0090534;GO:0005783;GO:0005789;GO:0031234;GO:0005887;GO:0014801;GO:0016020;GO:0048471;GO:0120025;GO:0031095;GO:0032991;GO:0097470;GO:0016529;GO:0033017;GO:0012506;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0086039;GO:0019899;GO:0044325;GO:0031775;GO:0008022;GO:0008553;GO:0044548;GO:0000045;GO:0016240;GO:1990036;GO:0070588;GO:1903515;GO:0014898;GO:0007155;GO:0006874;GO:0034605;GO:0034599;GO:0032469;GO:0008544;GO:0006984;GO:0034220;GO:1990456;GO:0045822;GO:1900121;GO:0140056;GO:0032470;GO:0010460;GO:1903233;GO:1903779;GO:0098909;GO:0086036;GO:0010882;GO:0002026;GO:0055119;GO:0034976;GO:0032496;GO:0070296;GO:0003009;GO:0033292;GO:0014883;, C:apical ectoplasmic specialization; C:calcium ion-transporting ATPase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:longitudinal sarcoplasmic reticulum; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane bounded cell projection; C:platelet dense tubular network membrane; C:protein-containing complex; C:ribbon synapse; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:vesicle membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential; F:enzyme binding; F:ion channel binding; F:lutropin-choriogonadotropic hormone receptor binding; F:protein C-terminus binding; F:proton-exporting ATPase activity, phosphorylative mechanism; F:S100 protein binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport from cytosol to endoplasmic reticulum; P:cardiac muscle hypertrophy in response to stress; P:cell adhesion; P:cellular calcium ion homeostasis; P:cellular response to heat; P:cellular response to oxidative stress; P:endoplasmic reticulum calcium ion homeostasis; P:epidermis development; P:ER-nucleus signaling pathway; P:ion transmembrane transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of heart contraction; P:negative regulation of receptor binding; P:organelle localization by membrane tethering; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of heart rate; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to endoplasmic reticulum stress; P:response to lipopolysaccharide; P:sarcoplasmic reticulum calcium ion transport; P:skeletal muscle contraction; P:T-tubule organization; P:transition between fast and slow fiber;|P16615 A6NDN7 B4DF05 P16614 Q86VJ2,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 {ECO:0000305},Calcium pump 2;Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform;Endoplasmic reticulum class 1/2 Ca(2+) ATPase;, PF00689;PF00690;, GO:0061831;GO:0090534;GO:0005783;GO:0005789;GO:0031234;GO:0005887;GO:0014801;GO:0016020;GO:0048471;GO:0120025;GO:0031095;GO:0032991;GO:0097470;GO:0016529;GO:0033017;GO:0012506;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0086039;GO:0019899;GO:0044325;GO:0031775;GO:0008022;GO:0008553;GO:0044548;GO:0000045;GO:0016240;GO:1990036;GO:0070588;GO:1903515;GO:0014898;GO:0007155;GO:0006874;GO:0034605;GO:0034599;GO:0032469;GO:0008544;GO:0006984;GO:0034220;GO:1990456;GO:0045822;GO:1900121;GO:0140056;GO:0032470;GO:0010460;GO:1903233;GO:1903779;GO:0098909;GO:0086036;GO:0010882;GO:0002026;GO:0055119;GO:0034976;GO:0032496;GO:0070296;GO:0003009;GO:0033292;GO:0014883;, C:apical ectoplasmic specialization; C:calcium ion-transporting ATPase complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:longitudinal sarcoplasmic reticulum; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane bounded cell projection; C:platelet dense tubular network membrane; C:protein-containing complex; C:ribbon synapse; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:vesicle membrane;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential; F:enzyme binding; F:ion channel binding; F:lutropin-choriogonadotropic hormone receptor binding; F:protein C-terminus binding; F:proton-exporting ATPase activity, phosphorylative mechanism; F:S100 protein binding;, P:autophagosome assembly; P:autophagosome membrane docking; P:calcium ion import into sarcoplasmic reticulum; P:calcium ion transmembrane transport; P:calcium ion transport from cytosol to endoplasmic reticulum; P:cardiac muscle hypertrophy in response to stress; P:cell adhesion; P:cellular calcium ion homeostasis; P:cellular response to heat; P:cellular response to oxidative stress; P:endoplasmic reticulum calcium ion homeostasis; P:epidermis development; P:ER-nucleus signaling pathway; P:ion transmembrane transport; P:mitochondrion-endoplasmic reticulum membrane tethering; P:negative regulation of heart contraction; P:negative regulation of receptor binding; P:organelle localization by membrane tethering; P:positive regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of heart rate; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle cell membrane potential; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of the force of heart contraction; P:relaxation of cardiac muscle; P:response to endoplasmic reticulum stress; P:response to lipopolysaccharide; P:sarcoplasmic reticulum calcium ion transport; P:skeletal muscle contraction; P:T-tubule organization; P:transition between fast and slow fiber; scaffold93 indexed_genome mRNA 4388741 4479608 . - . ID=transcript_12649;Q8WYA0 Q2YDY1 Q8NB51 Q9BSV2 Q9UNY8,Intraflagellar transport protein 81 homolog,Carnitine deficiency-associated protein expressed in ventricle 1;, PF18383;, GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030992;GO:0031514;GO:0015631;GO:0060271;GO:0042073;GO:0035735;GO:0008589;GO:0007283;, C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle B; C:motile cilium;, F:tubulin binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:regulation of smoothened signaling pathway; P:spermatogenesis; scaffold93 indexed_genome mRNA 4540025 4575707 . + . ID=transcript_12650;Q4VKI0 Q4VKI1 Q4VKI2 Q4VKI3 Q4VKI4 Q7Z771 Q96EV7,P2X purinoceptor 7,ATP receptor;P2Z receptor;Purinergic receptor;, , GO:0032059;GO:0005737;GO:0005639;GO:0005887;GO:0016020;GO:0005886;GO:0098794;GO:0005524;GO:0004931;GO:0042802;GO:0001530;GO:0001614;GO:0005102;GO:0097190;GO:0032060;GO:0007596;GO:0070588;GO:0035585;GO:0007166;GO:1905114;GO:0071318;GO:0097191;GO:0051899;GO:0045779;GO:0045794;GO:0043409;GO:0017121;GO:0046931;GO:1904172;GO:0030501;GO:0010524;GO:0051495;GO:0010628;GO:0045821;GO:0032731;GO:0034767;GO:0035590;GO:0051709;GO:0002028;GO:0033198;GO:0002931;GO:0019233;, C:bleb; C:cytoplasm; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:postsynapse;, F:ATP binding; F:extracellularly ATP-gated cation channel activity; F:identical protein binding; F:lipopolysaccharide binding; F:purinergic nucleotide receptor activity; F:signaling receptor binding;, P:apoptotic signaling pathway; P:bleb assembly; P:blood coagulation; P:calcium ion transmembrane transport; P:calcium-mediated signaling using extracellular calcium source; P:cell surface receptor signaling pathway; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular response to ATP; P:extrinsic apoptotic signaling pathway; P:membrane depolarization; P:negative regulation of bone resorption; P:negative regulation of cell volume; P:negative regulation of MAPK cascade; P:plasma membrane phospholipid scrambling; P:pore complex assembly; P:positive regulation of bleb assembly; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cytoskeleton organization; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of ion transmembrane transport; P:purinergic nucleotide receptor signaling pathway; P:regulation of killing of cells of other organism; P:regulation of sodium ion transport; P:response to ATP; P:response to ischemia; P:sensory perception of pain;|Q4VKI0 Q4VKI1 Q4VKI2 Q4VKI3 Q4VKI4 Q7Z771 Q96EV7,P2X purinoceptor 7,ATP receptor;P2Z receptor;Purinergic receptor;, , GO:0032059;GO:0005737;GO:0005639;GO:0005887;GO:0016020;GO:0005886;GO:0098794;GO:0005524;GO:0004931;GO:0042802;GO:0001530;GO:0001614;GO:0005102;GO:0097190;GO:0032060;GO:0007596;GO:0070588;GO:0035585;GO:0007166;GO:1905114;GO:0071318;GO:0097191;GO:0051899;GO:0045779;GO:0045794;GO:0043409;GO:0017121;GO:0046931;GO:1904172;GO:0030501;GO:0010524;GO:0051495;GO:0010628;GO:0045821;GO:0032731;GO:0034767;GO:0035590;GO:0051709;GO:0002028;GO:0033198;GO:0002931;GO:0019233;, C:bleb; C:cytoplasm; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:postsynapse;, F:ATP binding; F:extracellularly ATP-gated cation channel activity; F:identical protein binding; F:lipopolysaccharide binding; F:purinergic nucleotide receptor activity; F:signaling receptor binding;, P:apoptotic signaling pathway; P:bleb assembly; P:blood coagulation; P:calcium ion transmembrane transport; P:calcium-mediated signaling using extracellular calcium source; P:cell surface receptor signaling pathway; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular response to ATP; P:extrinsic apoptotic signaling pathway; P:membrane depolarization; P:negative regulation of bone resorption; P:negative regulation of cell volume; P:negative regulation of MAPK cascade; P:plasma membrane phospholipid scrambling; P:pore complex assembly; P:positive regulation of bleb assembly; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cytoskeleton organization; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of ion transmembrane transport; P:purinergic nucleotide receptor signaling pathway; P:regulation of killing of cells of other organism; P:regulation of sodium ion transport; P:response to ATP; P:response to ischemia; P:sensory perception of pain;|Q4VKI0 Q4VKI1 Q4VKI2 Q4VKI3 Q4VKI4 Q7Z771 Q96EV7,P2X purinoceptor 7,ATP receptor;P2Z receptor;Purinergic receptor;, , GO:0032059;GO:0005737;GO:0005639;GO:0005887;GO:0016020;GO:0005886;GO:0098794;GO:0005524;GO:0004931;GO:0042802;GO:0001530;GO:0001614;GO:0005102;GO:0097190;GO:0032060;GO:0007596;GO:0070588;GO:0035585;GO:0007166;GO:1905114;GO:0071318;GO:0097191;GO:0051899;GO:0045779;GO:0045794;GO:0043409;GO:0017121;GO:0046931;GO:1904172;GO:0030501;GO:0010524;GO:0051495;GO:0010628;GO:0045821;GO:0032731;GO:0034767;GO:0035590;GO:0051709;GO:0002028;GO:0033198;GO:0002931;GO:0019233;, C:bleb; C:cytoplasm; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:postsynapse;, F:ATP binding; F:extracellularly ATP-gated cation channel activity; F:identical protein binding; F:lipopolysaccharide binding; F:purinergic nucleotide receptor activity; F:signaling receptor binding;, P:apoptotic signaling pathway; P:bleb assembly; P:blood coagulation; P:calcium ion transmembrane transport; P:calcium-mediated signaling using extracellular calcium source; P:cell surface receptor signaling pathway; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular response to ATP; P:extrinsic apoptotic signaling pathway; P:membrane depolarization; P:negative regulation of bone resorption; P:negative regulation of cell volume; P:negative regulation of MAPK cascade; P:plasma membrane phospholipid scrambling; P:pore complex assembly; P:positive regulation of bleb assembly; P:positive regulation of bone mineralization; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cytoskeleton organization; P:positive regulation of gene expression; P:positive regulation of glycolytic process; P:positive regulation of interleukin-1 beta production; P:positive regulation of ion transmembrane transport; P:purinergic nucleotide receptor signaling pathway; P:regulation of killing of cells of other organism; P:regulation of sodium ion transport; P:response to ATP; P:response to ischemia; P:sensory perception of pain; scaffold93 indexed_genome mRNA 4598735 4620359 . + . ID=transcript_12651;Q99571 E7EPF7 F6RU17 O00450 O14722 Q5U089 Q5U090 Q8N4N1 Q9UBG9,P2X purinoceptor 4,ATP receptor;Purinergic receptor;, , GO:0044297;GO:0030054;GO:0043197;GO:0070062;GO:0005639;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0048471;GO:0005886;GO:0014069;GO:0043195;GO:0005524;GO:0045296;GO:0005507;GO:0004931;GO:0042802;GO:0099604;GO:0001614;GO:0005102;GO:0008270;GO:0097190;GO:0048266;GO:0007596;GO:0070588;GO:0019722;GO:0071318;GO:0071294;GO:0042118;GO:0034220;GO:0051899;GO:1904124;GO:0010614;GO:0019228;GO:0043536;GO:0051928;GO:0010524;GO:0050850;GO:2001028;GO:1904141;GO:0045429;GO:0032308;GO:0051897;GO:0035590;GO:0008217;GO:0055117;GO:0050920;GO:0002028;GO:0055119;GO:0033198;GO:0048678;GO:0034405;GO:0002931;GO:0019233;GO:0050975;GO:0007165;GO:0001894;, C:cell body; C:cell junction; C:dendritic spine; C:extracellular exosome; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:terminal bouton;, F:ATP binding; F:cadherin binding; F:copper ion binding; F:extracellularly ATP-gated cation channel activity; F:identical protein binding; F:ligand-gated calcium channel activity; F:purinergic nucleotide receptor activity; F:signaling receptor binding; F:zinc ion binding;, P:apoptotic signaling pathway; P:behavioral response to pain; P:blood coagulation; P:calcium ion transmembrane transport; P:calcium-mediated signaling; P:cellular response to ATP; P:cellular response to zinc ion; P:endothelial cell activation; P:ion transmembrane transport; P:membrane depolarization; P:microglial cell migration; P:negative regulation of cardiac muscle hypertrophy; P:neuronal action potential; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of calcium ion transport; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of calcium-mediated signaling; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of microglial cell migration; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of prostaglandin secretion; P:positive regulation of protein kinase B signaling; P:purinergic nucleotide receptor signaling pathway; P:regulation of blood pressure; P:regulation of cardiac muscle contraction; P:regulation of chemotaxis; P:regulation of sodium ion transport; P:relaxation of cardiac muscle; P:response to ATP; P:response to axon injury; P:response to fluid shear stress; P:response to ischemia; P:sensory perception of pain; P:sensory perception of touch; P:signal transduction; P:tissue homeostasis;|Q99571 E7EPF7 F6RU17 O00450 O14722 Q5U089 Q5U090 Q8N4N1 Q9UBG9,P2X purinoceptor 4,ATP receptor;Purinergic receptor;, , GO:0044297;GO:0030054;GO:0043197;GO:0070062;GO:0005639;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0048471;GO:0005886;GO:0014069;GO:0043195;GO:0005524;GO:0045296;GO:0005507;GO:0004931;GO:0042802;GO:0099604;GO:0001614;GO:0005102;GO:0008270;GO:0097190;GO:0048266;GO:0007596;GO:0070588;GO:0019722;GO:0071318;GO:0071294;GO:0042118;GO:0034220;GO:0051899;GO:1904124;GO:0010614;GO:0019228;GO:0043536;GO:0051928;GO:0010524;GO:0050850;GO:2001028;GO:1904141;GO:0045429;GO:0032308;GO:0051897;GO:0035590;GO:0008217;GO:0055117;GO:0050920;GO:0002028;GO:0055119;GO:0033198;GO:0048678;GO:0034405;GO:0002931;GO:0019233;GO:0050975;GO:0007165;GO:0001894;, C:cell body; C:cell junction; C:dendritic spine; C:extracellular exosome; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:terminal bouton;, F:ATP binding; F:cadherin binding; F:copper ion binding; F:extracellularly ATP-gated cation channel activity; F:identical protein binding; F:ligand-gated calcium channel activity; F:purinergic nucleotide receptor activity; F:signaling receptor binding; F:zinc ion binding;, P:apoptotic signaling pathway; P:behavioral response to pain; P:blood coagulation; P:calcium ion transmembrane transport; P:calcium-mediated signaling; P:cellular response to ATP; P:cellular response to zinc ion; P:endothelial cell activation; P:ion transmembrane transport; P:membrane depolarization; P:microglial cell migration; P:negative regulation of cardiac muscle hypertrophy; P:neuronal action potential; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of calcium ion transport; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of calcium-mediated signaling; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of microglial cell migration; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of prostaglandin secretion; P:positive regulation of protein kinase B signaling; P:purinergic nucleotide receptor signaling pathway; P:regulation of blood pressure; P:regulation of cardiac muscle contraction; P:regulation of chemotaxis; P:regulation of sodium ion transport; P:relaxation of cardiac muscle; P:response to ATP; P:response to axon injury; P:response to fluid shear stress; P:response to ischemia; P:sensory perception of pain; P:sensory perception of touch; P:signal transduction; P:tissue homeostasis; scaffold93 indexed_genome mRNA 4625434 4656415 . - . ID=transcript_12652;Q8WY06 Q96RP1 Q96RP2 Q96RR3 Q9BWE9 Q9UER3 Q9UES2 Q9Y5N2,Calcium/calmodulin-dependent protein kinase kinase 2,Calcium/calmodulin-dependent protein kinase kinase beta;, PF00069;, GO:0005829;GO:0043005;GO:0005654;GO:0005524;GO:0005509;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0004713;GO:0019722;GO:0061762;GO:0034614;GO:0007268;GO:0000165;GO:1903599;GO:0001934;GO:0045893;GO:0046777;GO:0006468;GO:0045859;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:calcium-mediated signaling; P:CAMKK-AMPK signaling cascade; P:cellular response to reactive oxygen species; P:chemical synaptic transmission; P:MAPK cascade; P:positive regulation of autophagy of mitochondrion; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of protein kinase activity;|Q8WY06 Q96RP1 Q96RP2 Q96RR3 Q9BWE9 Q9UER3 Q9UES2 Q9Y5N2,Calcium/calmodulin-dependent protein kinase kinase 2,Calcium/calmodulin-dependent protein kinase kinase beta;, PF00069;, GO:0005829;GO:0043005;GO:0005654;GO:0005524;GO:0005509;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0004713;GO:0019722;GO:0061762;GO:0034614;GO:0007268;GO:0000165;GO:1903599;GO:0001934;GO:0045893;GO:0046777;GO:0006468;GO:0045859;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:calcium-mediated signaling; P:CAMKK-AMPK signaling cascade; P:cellular response to reactive oxygen species; P:chemical synaptic transmission; P:MAPK cascade; P:positive regulation of autophagy of mitochondrion; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of protein kinase activity;|Q8WY06 Q96RP1 Q96RP2 Q96RR3 Q9BWE9 Q9UER3 Q9UES2 Q9Y5N2,Calcium/calmodulin-dependent protein kinase kinase 2,Calcium/calmodulin-dependent protein kinase kinase beta;, PF00069;, GO:0005829;GO:0043005;GO:0005654;GO:0005524;GO:0005509;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0004713;GO:0019722;GO:0061762;GO:0034614;GO:0007268;GO:0000165;GO:1903599;GO:0001934;GO:0045893;GO:0046777;GO:0006468;GO:0045859;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:calcium-mediated signaling; P:CAMKK-AMPK signaling cascade; P:cellular response to reactive oxygen species; P:chemical synaptic transmission; P:MAPK cascade; P:positive regulation of autophagy of mitochondrion; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of protein kinase activity;|Q8WY06 Q96RP1 Q96RP2 Q96RR3 Q9BWE9 Q9UER3 Q9UES2 Q9Y5N2,Calcium/calmodulin-dependent protein kinase kinase 2,Calcium/calmodulin-dependent protein kinase kinase beta;, PF00069;, GO:0005829;GO:0043005;GO:0005654;GO:0005524;GO:0005509;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0004713;GO:0019722;GO:0061762;GO:0034614;GO:0007268;GO:0000165;GO:1903599;GO:0001934;GO:0045893;GO:0046777;GO:0006468;GO:0045859;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:calcium-mediated signaling; P:CAMKK-AMPK signaling cascade; P:cellular response to reactive oxygen species; P:chemical synaptic transmission; P:MAPK cascade; P:positive regulation of autophagy of mitochondrion; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of protein kinase activity;|Q8WY06 Q96RP1 Q96RP2 Q96RR3 Q9BWE9 Q9UER3 Q9UES2 Q9Y5N2,Calcium/calmodulin-dependent protein kinase kinase 2,Calcium/calmodulin-dependent protein kinase kinase beta;, PF00069;, GO:0005829;GO:0043005;GO:0005654;GO:0005524;GO:0005509;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0004713;GO:0019722;GO:0061762;GO:0034614;GO:0007268;GO:0000165;GO:1903599;GO:0001934;GO:0045893;GO:0046777;GO:0006468;GO:0045859;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:calcium-mediated signaling; P:CAMKK-AMPK signaling cascade; P:cellular response to reactive oxygen species; P:chemical synaptic transmission; P:MAPK cascade; P:positive regulation of autophagy of mitochondrion; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of protein kinase activity;|Q8WY06 Q96RP1 Q96RP2 Q96RR3 Q9BWE9 Q9UER3 Q9UES2 Q9Y5N2,Calcium/calmodulin-dependent protein kinase kinase 2,Calcium/calmodulin-dependent protein kinase kinase beta;, PF00069;, GO:0005829;GO:0043005;GO:0005654;GO:0005524;GO:0005509;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0004713;GO:0019722;GO:0061762;GO:0034614;GO:0007268;GO:0000165;GO:1903599;GO:0001934;GO:0045893;GO:0046777;GO:0006468;GO:0045859;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:calcium-mediated signaling; P:CAMKK-AMPK signaling cascade; P:cellular response to reactive oxygen species; P:chemical synaptic transmission; P:MAPK cascade; P:positive regulation of autophagy of mitochondrion; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of protein kinase activity;|Q8WY06 Q96RP1 Q96RP2 Q96RR3 Q9BWE9 Q9UER3 Q9UES2 Q9Y5N2,Calcium/calmodulin-dependent protein kinase kinase 2,Calcium/calmodulin-dependent protein kinase kinase beta;, PF00069;, GO:0005829;GO:0043005;GO:0005654;GO:0005524;GO:0005509;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0004713;GO:0019722;GO:0061762;GO:0034614;GO:0007268;GO:0000165;GO:1903599;GO:0001934;GO:0045893;GO:0046777;GO:0006468;GO:0045859;, C:cytosol; C:neuron projection; C:nucleoplasm;, F:ATP binding; F:calcium ion binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:protein tyrosine kinase activity;, P:calcium-mediated signaling; P:CAMKK-AMPK signaling cascade; P:cellular response to reactive oxygen species; P:chemical synaptic transmission; P:MAPK cascade; P:positive regulation of autophagy of mitochondrion; P:positive regulation of protein phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of protein kinase activity; scaffold93 indexed_genome mRNA 4686284 4697081 . - . ID=transcript_12653;Q9UJX4 E9PFB2 Q8N4H7 Q9BQD4,Anaphase-promoting complex subunit 5,Cyclosome subunit 5;, PF12862;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX4 E9PFB2 Q8N4H7 Q9BQD4,Anaphase-promoting complex subunit 5,Cyclosome subunit 5;, PF12862;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX4 E9PFB2 Q8N4H7 Q9BQD4,Anaphase-promoting complex subunit 5,Cyclosome subunit 5;, PF12862;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold93 indexed_genome mRNA 4697338 4701259 . - . ID=transcript_12654;Q9UJX4 E9PFB2 Q8N4H7 Q9BQD4,Anaphase-promoting complex subunit 5,Cyclosome subunit 5;, PF12862;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold93 indexed_genome mRNA 4703015 4722265 . + . ID=transcript_12655;Q9UJX4 E9PFB2 Q8N4H7 Q9BQD4,Anaphase-promoting complex subunit 5,Cyclosome subunit 5;, PF12862;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX4 E9PFB2 Q8N4H7 Q9BQD4,Anaphase-promoting complex subunit 5,Cyclosome subunit 5;, PF12862;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX4 E9PFB2 Q8N4H7 Q9BQD4,Anaphase-promoting complex subunit 5,Cyclosome subunit 5;, PF12862;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX4 E9PFB2 Q8N4H7 Q9BQD4,Anaphase-promoting complex subunit 5,Cyclosome subunit 5;, PF12862;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0005819;GO:0019903;GO:0031145;GO:0007049;GO:0051301;GO:0045842;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle;, F:protein phosphatase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold93 indexed_genome mRNA 4753635 4772756 . + . ID=transcript_12656;Q969K3 B7Z933 Q8NG47 Q9H6W8,E3 ubiquitin-protein ligase RNF34 {ECO:0000305},Caspase regulator CARP1 {ECO:0000305};Caspases-8 and -10-associated RING finger protein 1 {ECO:0000303|PubMed:15069192};FYVE-RING finger protein Momo {ECO:0000250|UniProtKB:Q6AYH3};Human RING finger homologous to inhibitor of apoptosis protein {ECO:0000303|PubMed:12118383};RING finger protein 34 {ECO:0000312|HGNC:HGNC:17297};RING finger protein RIFF {ECO:0000303|Ref.2};RING-type E3 ubiquitin transferase RNF34 {ECO:0000305};, , GO:0005737;GO:0005829;GO:0012505;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0046872;GO:0002039;GO:1901981;GO:0061630;GO:0031625;GO:0006915;GO:2001271;GO:1902042;GO:1901797;GO:0035872;GO:0043161;GO:0070936;GO:0016567;GO:2000374;GO:1901796;GO:0006511;, C:cytoplasm; C:cytosol; C:endomembrane system; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:metal ion binding; F:p53 binding; F:phosphatidylinositol phosphate binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of signal transduction by p53 class mediator; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:regulation of oxygen metabolic process; P:regulation of signal transduction by p53 class mediator; P:ubiquitin-dependent protein catabolic process; scaffold93 indexed_genome mRNA 4774830 4840907 . - . ID=transcript_12657;Q8NHM5 A8MRS1 Q1RLM7 Q8NCI2 Q96HC7 Q96SL0 Q96T03 Q9NS96 Q9UF75,Lysine-specific demethylase 2B,CXXC-type zinc finger protein 2;F-box and leucine-rich repeat protein 10;F-box protein FBL10;F-box/LRR-repeat protein 10;JmjC domain-containing histone demethylation protein 1B;Jumonji domain-containing EMSY-interactor methyltransferase motif protein;Protein-containing CXXC domain 2;[Histone-H3]-lysine-36 demethylase 1B;, PF13621;PF00646;PF17811;PF16866;PF02008;, GO:0005694;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0032452;GO:0051864;GO:0000978;GO:0019843;GO:0003712;GO:0045322;GO:0008270;GO:0048596;GO:0030900;GO:0021592;GO:0030902;GO:0035518;GO:0070544;GO:0021993;GO:0021670;GO:0030901;GO:0021555;GO:2000178;GO:0043524;GO:0000122;GO:0030307;GO:1902459;GO:0006482;GO:0006357;GO:0007283;GO:0021678;, C:chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:rRNA binding; F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:embryonic camera-type eye morphogenesis; P:forebrain development; P:fourth ventricle development; P:hindbrain development; P:histone H2A monoubiquitination; P:histone H3-K36 demethylation; P:initiation of neural tube closure; P:lateral ventricle development; P:midbrain development; P:midbrain-hindbrain boundary morphogenesis; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:positive regulation of stem cell population maintenance; P:protein demethylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:third ventricle development;|Q8NHM5 A8MRS1 Q1RLM7 Q8NCI2 Q96HC7 Q96SL0 Q96T03 Q9NS96 Q9UF75,Lysine-specific demethylase 2B,CXXC-type zinc finger protein 2;F-box and leucine-rich repeat protein 10;F-box protein FBL10;F-box/LRR-repeat protein 10;JmjC domain-containing histone demethylation protein 1B;Jumonji domain-containing EMSY-interactor methyltransferase motif protein;Protein-containing CXXC domain 2;[Histone-H3]-lysine-36 demethylase 1B;, PF13621;PF00646;PF17811;PF16866;PF02008;, GO:0005694;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0032452;GO:0051864;GO:0000978;GO:0019843;GO:0003712;GO:0045322;GO:0008270;GO:0048596;GO:0030900;GO:0021592;GO:0030902;GO:0035518;GO:0070544;GO:0021993;GO:0021670;GO:0030901;GO:0021555;GO:2000178;GO:0043524;GO:0000122;GO:0030307;GO:1902459;GO:0006482;GO:0006357;GO:0007283;GO:0021678;, C:chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:rRNA binding; F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:embryonic camera-type eye morphogenesis; P:forebrain development; P:fourth ventricle development; P:hindbrain development; P:histone H2A monoubiquitination; P:histone H3-K36 demethylation; P:initiation of neural tube closure; P:lateral ventricle development; P:midbrain development; P:midbrain-hindbrain boundary morphogenesis; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:positive regulation of stem cell population maintenance; P:protein demethylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:third ventricle development;|Q8NHM5 A8MRS1 Q1RLM7 Q8NCI2 Q96HC7 Q96SL0 Q96T03 Q9NS96 Q9UF75,Lysine-specific demethylase 2B,CXXC-type zinc finger protein 2;F-box and leucine-rich repeat protein 10;F-box protein FBL10;F-box/LRR-repeat protein 10;JmjC domain-containing histone demethylation protein 1B;Jumonji domain-containing EMSY-interactor methyltransferase motif protein;Protein-containing CXXC domain 2;[Histone-H3]-lysine-36 demethylase 1B;, PF13621;PF00646;PF17811;PF16866;PF02008;, GO:0005694;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0032452;GO:0051864;GO:0000978;GO:0019843;GO:0003712;GO:0045322;GO:0008270;GO:0048596;GO:0030900;GO:0021592;GO:0030902;GO:0035518;GO:0070544;GO:0021993;GO:0021670;GO:0030901;GO:0021555;GO:2000178;GO:0043524;GO:0000122;GO:0030307;GO:1902459;GO:0006482;GO:0006357;GO:0007283;GO:0021678;, C:chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:rRNA binding; F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:embryonic camera-type eye morphogenesis; P:forebrain development; P:fourth ventricle development; P:hindbrain development; P:histone H2A monoubiquitination; P:histone H3-K36 demethylation; P:initiation of neural tube closure; P:lateral ventricle development; P:midbrain development; P:midbrain-hindbrain boundary morphogenesis; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:positive regulation of stem cell population maintenance; P:protein demethylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:third ventricle development;|Q8NHM5 A8MRS1 Q1RLM7 Q8NCI2 Q96HC7 Q96SL0 Q96T03 Q9NS96 Q9UF75,Lysine-specific demethylase 2B,CXXC-type zinc finger protein 2;F-box and leucine-rich repeat protein 10;F-box protein FBL10;F-box/LRR-repeat protein 10;JmjC domain-containing histone demethylation protein 1B;Jumonji domain-containing EMSY-interactor methyltransferase motif protein;Protein-containing CXXC domain 2;[Histone-H3]-lysine-36 demethylase 1B;, PF13621;PF00646;PF17811;PF16866;PF02008;, GO:0005694;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0032452;GO:0051864;GO:0000978;GO:0019843;GO:0003712;GO:0045322;GO:0008270;GO:0048596;GO:0030900;GO:0021592;GO:0030902;GO:0035518;GO:0070544;GO:0021993;GO:0021670;GO:0030901;GO:0021555;GO:2000178;GO:0043524;GO:0000122;GO:0030307;GO:1902459;GO:0006482;GO:0006357;GO:0007283;GO:0021678;, C:chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:rRNA binding; F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:embryonic camera-type eye morphogenesis; P:forebrain development; P:fourth ventricle development; P:hindbrain development; P:histone H2A monoubiquitination; P:histone H3-K36 demethylation; P:initiation of neural tube closure; P:lateral ventricle development; P:midbrain development; P:midbrain-hindbrain boundary morphogenesis; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:positive regulation of stem cell population maintenance; P:protein demethylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:third ventricle development; scaffold93 indexed_genome mRNA 4840915 4894243 . - . ID=transcript_12658;Q8NHM5 A8MRS1 Q1RLM7 Q8NCI2 Q96HC7 Q96SL0 Q96T03 Q9NS96 Q9UF75,Lysine-specific demethylase 2B,CXXC-type zinc finger protein 2;F-box and leucine-rich repeat protein 10;F-box protein FBL10;F-box/LRR-repeat protein 10;JmjC domain-containing histone demethylation protein 1B;Jumonji domain-containing EMSY-interactor methyltransferase motif protein;Protein-containing CXXC domain 2;[Histone-H3]-lysine-36 demethylase 1B;, PF13621;PF00646;PF17811;PF16866;PF02008;, GO:0005694;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0032452;GO:0051864;GO:0000978;GO:0019843;GO:0003712;GO:0045322;GO:0008270;GO:0048596;GO:0030900;GO:0021592;GO:0030902;GO:0035518;GO:0070544;GO:0021993;GO:0021670;GO:0030901;GO:0021555;GO:2000178;GO:0043524;GO:0000122;GO:0030307;GO:1902459;GO:0006482;GO:0006357;GO:0007283;GO:0021678;, C:chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:rRNA binding; F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:embryonic camera-type eye morphogenesis; P:forebrain development; P:fourth ventricle development; P:hindbrain development; P:histone H2A monoubiquitination; P:histone H3-K36 demethylation; P:initiation of neural tube closure; P:lateral ventricle development; P:midbrain development; P:midbrain-hindbrain boundary morphogenesis; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:positive regulation of stem cell population maintenance; P:protein demethylation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; P:third ventricle development; scaffold93 indexed_genome mRNA 4926519 4940897 . + . ID=transcript_12659;Q96D31 Q3MHV3 Q6DHX2 Q96BP7 Q96K71,Calcium release-activated calcium channel protein 1,Protein orai-1;Transmembrane protein 142A;, PF07856;, GO:0016323;GO:0034704;GO:0005829;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0044853;GO:0005262;GO:0005516;GO:0042802;GO:0015279;GO:0002250;GO:0070509;GO:0070588;GO:0061180;GO:0045762;GO:0051928;GO:0051924;GO:0002115;, C:basolateral plasma membrane; C:calcium channel complex; C:cytosol; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane; C:plasma membrane raft;, F:calcium channel activity; F:calmodulin binding; F:identical protein binding; F:store-operated calcium channel activity;, P:adaptive immune response; P:calcium ion import; P:calcium ion transmembrane transport; P:mammary gland epithelium development; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion transport; P:regulation of calcium ion transport; P:store-operated calcium entry;|Q96D31 Q3MHV3 Q6DHX2 Q96BP7 Q96K71,Calcium release-activated calcium channel protein 1,Protein orai-1;Transmembrane protein 142A;, PF07856;, GO:0016323;GO:0034704;GO:0005829;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0044853;GO:0005262;GO:0005516;GO:0042802;GO:0015279;GO:0002250;GO:0070509;GO:0070588;GO:0061180;GO:0045762;GO:0051928;GO:0051924;GO:0002115;, C:basolateral plasma membrane; C:calcium channel complex; C:cytosol; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane; C:plasma membrane raft;, F:calcium channel activity; F:calmodulin binding; F:identical protein binding; F:store-operated calcium channel activity;, P:adaptive immune response; P:calcium ion import; P:calcium ion transmembrane transport; P:mammary gland epithelium development; P:positive regulation of adenylate cyclase activity; P:positive regulation of calcium ion transport; P:regulation of calcium ion transport; P:store-operated calcium entry; scaffold93 indexed_genome mRNA 4982563 5043762 . + . ID=transcript_12660;A0PK00 A0PK01 B3KX33,Transmembrane protein 120B {ECO:0000305},, PF07851;, GO:0016021;GO:0016020;GO:0005637;GO:0045444;GO:0034220;GO:0051291;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, , P:fat cell differentiation; P:ion transmembrane transport; P:protein heterooligomerization;|A0PK00 A0PK01 B3KX33,Transmembrane protein 120B {ECO:0000305},, PF07851;, GO:0016021;GO:0016020;GO:0005637;GO:0045444;GO:0034220;GO:0051291;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, , P:fat cell differentiation; P:ion transmembrane transport; P:protein heterooligomerization;|A0PK00 A0PK01 B3KX33,Transmembrane protein 120B {ECO:0000305},, PF07851;, GO:0016021;GO:0016020;GO:0005637;GO:0045444;GO:0034220;GO:0051291;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, , P:fat cell differentiation; P:ion transmembrane transport; P:protein heterooligomerization;|A0PK00 A0PK01 B3KX33,Transmembrane protein 120B {ECO:0000305},, PF07851;, GO:0016021;GO:0016020;GO:0005637;GO:0045444;GO:0034220;GO:0051291;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, , P:fat cell differentiation; P:ion transmembrane transport; P:protein heterooligomerization;|A0PK00 A0PK01 B3KX33,Transmembrane protein 120B {ECO:0000305},, PF07851;, GO:0016021;GO:0016020;GO:0005637;GO:0045444;GO:0034220;GO:0051291;, C:integral component of membrane; C:membrane; C:nuclear inner membrane;, , P:fat cell differentiation; P:ion transmembrane transport; P:protein heterooligomerization;|Q9HBH0 Q8WVB1 Q9NXH6,Rho-related GTP-binding protein RhoF,Rho family GTPase Rif;Rho in filopodia;, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0030667;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0043312;GO:0032956;GO:0008360;GO:0051056;GO:0007264;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:secretory granule membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:neutrophil degranulation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction;|Q9HBH0 Q8WVB1 Q9NXH6,Rho-related GTP-binding protein RhoF,Rho family GTPase Rif;Rho in filopodia;, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0030667;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0043312;GO:0032956;GO:0008360;GO:0051056;GO:0007264;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:secretory granule membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:neutrophil degranulation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction;|Q9HBH0 Q8WVB1 Q9NXH6,Rho-related GTP-binding protein RhoF,Rho family GTPase Rif;Rho in filopodia;, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0070062;GO:0043231;GO:0005886;GO:0030667;GO:0005525;GO:0003924;GO:0019901;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0043312;GO:0032956;GO:0008360;GO:0051056;GO:0007264;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:plasma membrane; C:secretory granule membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:neutrophil degranulation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; scaffold94 indexed_genome mRNA 38879 52662 . + . ID=transcript_12661;P60201 P04400 P06905 Q502Y1 Q6FHZ6,Myelin proteolipid protein,Lipophilin;, PF01275;, GO:0034683;GO:0043209;GO:0005886;GO:0045202;GO:0042802;GO:0019911;GO:0005198;GO:0098990;GO:0014002;GO:0061564;GO:0008366;GO:0022010;GO:0007268;GO:0006954;GO:0042759;GO:0031175;GO:1904427;GO:0030335;GO:0010628;GO:0021762;, C:integrin alphav-beta3 complex; C:myelin sheath; C:plasma membrane; C:synapse;, F:identical protein binding; F:structural constituent of myelin sheath; F:structural molecule activity;, P:AMPA selective glutamate receptor signaling pathway; P:astrocyte development; P:axon development; P:axon ensheathment; P:central nervous system myelination; P:chemical synaptic transmission; P:inflammatory response; P:long-chain fatty acid biosynthetic process; P:neuron projection development; P:positive regulation of calcium ion transmembrane transport; P:positive regulation of cell migration; P:positive regulation of gene expression; P:substantia nigra development;|P60201 P04400 P06905 Q502Y1 Q6FHZ6,Myelin proteolipid protein,Lipophilin;, PF01275;, GO:0034683;GO:0043209;GO:0005886;GO:0045202;GO:0042802;GO:0019911;GO:0005198;GO:0098990;GO:0014002;GO:0061564;GO:0008366;GO:0022010;GO:0007268;GO:0006954;GO:0042759;GO:0031175;GO:1904427;GO:0030335;GO:0010628;GO:0021762;, C:integrin alphav-beta3 complex; C:myelin sheath; C:plasma membrane; C:synapse;, F:identical protein binding; F:structural constituent of myelin sheath; F:structural molecule activity;, P:AMPA selective glutamate receptor signaling pathway; P:astrocyte development; P:axon development; P:axon ensheathment; P:central nervous system myelination; P:chemical synaptic transmission; P:inflammatory response; P:long-chain fatty acid biosynthetic process; P:neuron projection development; P:positive regulation of calcium ion transmembrane transport; P:positive regulation of cell migration; P:positive regulation of gene expression; P:substantia nigra development;|P60201 P04400 P06905 Q502Y1 Q6FHZ6,Myelin proteolipid protein,Lipophilin;, PF01275;, GO:0034683;GO:0043209;GO:0005886;GO:0045202;GO:0042802;GO:0019911;GO:0005198;GO:0098990;GO:0014002;GO:0061564;GO:0008366;GO:0022010;GO:0007268;GO:0006954;GO:0042759;GO:0031175;GO:1904427;GO:0030335;GO:0010628;GO:0021762;, C:integrin alphav-beta3 complex; C:myelin sheath; C:plasma membrane; C:synapse;, F:identical protein binding; F:structural constituent of myelin sheath; F:structural molecule activity;, P:AMPA selective glutamate receptor signaling pathway; P:astrocyte development; P:axon development; P:axon ensheathment; P:central nervous system myelination; P:chemical synaptic transmission; P:inflammatory response; P:long-chain fatty acid biosynthetic process; P:neuron projection development; P:positive regulation of calcium ion transmembrane transport; P:positive regulation of cell migration; P:positive regulation of gene expression; P:substantia nigra development;|P60201 P04400 P06905 Q502Y1 Q6FHZ6,Myelin proteolipid protein,Lipophilin;, PF01275;, GO:0034683;GO:0043209;GO:0005886;GO:0045202;GO:0042802;GO:0019911;GO:0005198;GO:0098990;GO:0014002;GO:0061564;GO:0008366;GO:0022010;GO:0007268;GO:0006954;GO:0042759;GO:0031175;GO:1904427;GO:0030335;GO:0010628;GO:0021762;, C:integrin alphav-beta3 complex; C:myelin sheath; C:plasma membrane; C:synapse;, F:identical protein binding; F:structural constituent of myelin sheath; F:structural molecule activity;, P:AMPA selective glutamate receptor signaling pathway; P:astrocyte development; P:axon development; P:axon ensheathment; P:central nervous system myelination; P:chemical synaptic transmission; P:inflammatory response; P:long-chain fatty acid biosynthetic process; P:neuron projection development; P:positive regulation of calcium ion transmembrane transport; P:positive regulation of cell migration; P:positive regulation of gene expression; P:substantia nigra development; scaffold94 indexed_genome mRNA 92153 97231 . + . ID=transcript_12662;Q9NP90 B2R8M0 Q52LX2,Ras-related protein Rab-9B,Rab-9-like protein;, PF00071;, GO:0005829;GO:0005770;GO:0005764;GO:0045335;GO:0030670;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0003924;GO:0042802;GO:0043312;GO:0015031;GO:0032482;GO:0042147;, C:cytosol; C:late endosome; C:lysosome; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:identical protein binding;, P:neutrophil degranulation; P:protein transport; P:Rab protein signal transduction; P:retrograde transport, endosome to Golgi;|Q9NP90 B2R8M0 Q52LX2,Ras-related protein Rab-9B,Rab-9-like protein;, PF00071;, GO:0005829;GO:0005770;GO:0005764;GO:0045335;GO:0030670;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0003924;GO:0042802;GO:0043312;GO:0015031;GO:0032482;GO:0042147;, C:cytosol; C:late endosome; C:lysosome; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:identical protein binding;, P:neutrophil degranulation; P:protein transport; P:Rab protein signal transduction; P:retrograde transport, endosome to Golgi; scaffold94 indexed_genome mRNA 512788 513941 . + . ID=transcript_12663;Q5H9E4 B2RTT9,Solute carrier family 25 member 53,Mitochondrial carrier triple repeat protein 6;, PF00153;, GO:0016021;GO:0005743;, C:integral component of membrane; C:mitochondrial inner membrane; scaffold94 indexed_genome mRNA 2779667 2908759 . - . ID=transcript_12664;Q9C0H6 B2RTW2 Q9Y3J5,Kelch-like protein 4,, PF07707;PF00651;PF01344;, GO:0034451;GO:0005737;GO:0015630;GO:0003779;, C:centriolar satellite; C:cytoplasm; C:microtubule cytoskeleton;, F:actin binding; scaffold94 indexed_genome mRNA 4602839 4751992 . + . ID=transcript_12665;P24386 A1L4D2 O43732,Rab proteins geranylgeranyltransferase component A 1,Choroideremia protein;Rab escort protein 1;TCD protein;, PF00996;, GO:0005737;GO:0005829;GO:0005634;GO:0005968;GO:0005092;GO:0005096;GO:0004663;GO:0031267;GO:0043687;GO:0018344;GO:0006612;GO:0042981;GO:0007264;GO:0016192;GO:0007601;, C:cytoplasm; C:cytosol; C:nucleus; C:Rab-protein geranylgeranyltransferase complex;, F:GDP-dissociation inhibitor activity; F:GTPase activator activity; F:Rab geranylgeranyltransferase activity; F:small GTPase binding;, P:post-translational protein modification; P:protein geranylgeranylation; P:protein targeting to membrane; P:regulation of apoptotic process; P:small GTPase mediated signal transduction; P:vesicle-mediated transport; P:visual perception; scaffold95 indexed_genome mRNA 112437 113421 . - . ID=transcript_12666;P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold95 indexed_genome mRNA 135185 192000 . - . ID=transcript_12667;Q96RD7 O75968 Q543A0 Q6UW26 Q96AM9 Q96L77 Q96RS5,Pannexin-1,, PF00876;, GO:0032059;GO:0005783;GO:0005789;GO:0005921;GO:0016021;GO:0016020;GO:0005886;GO:0032991;GO:0051015;GO:0005262;GO:0005243;GO:0044325;GO:0022840;GO:0002020;GO:0097110;GO:0005102;GO:0005198;GO:0022829;GO:0006816;GO:0006812;GO:0007267;GO:0048477;GO:0032730;GO:0032731;GO:0033198;GO:0002931;, C:bleb; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:gap junction; C:integral component of membrane; C:membrane; C:plasma membrane; C:protein-containing complex;, F:actin filament binding; F:calcium channel activity; F:gap junction channel activity; F:ion channel binding; F:leak channel activity; F:protease binding; F:scaffold protein binding; F:signaling receptor binding; F:structural molecule activity; F:wide pore channel activity;, P:calcium ion transport; P:cation transport; P:cell-cell signaling; P:oogenesis; P:positive regulation of interleukin-1 alpha production; P:positive regulation of interleukin-1 beta production; P:response to ATP; P:response to ischemia; scaffold95 indexed_genome mRNA 481188 485852 . + . ID=transcript_12668;A8MXK1,V-set and transmembrane domain-containing protein 5,, , GO:0030424;GO:0030425;GO:0016021;GO:0005886;GO:0046847;GO:1904891;GO:0051260;GO:0021517;, C:axon; C:dendrite; C:integral component of membrane; C:plasma membrane;, , P:filopodium assembly; P:positive regulation of excitatory synapse assembly; P:protein homooligomerization; P:ventral spinal cord development; scaffold95 indexed_genome mRNA 492824 524718 . - . ID=transcript_12669;Q9NVC6 B3KN07 Q9HA81 Q9UNP7 Q9Y2W0 Q9Y660,Mediator of RNA polymerase II transcription subunit 17,Activator-recruited cofactor 77 kDa component;Cofactor required for Sp1 transcriptional activation subunit 6;Mediator complex subunit 17;Thyroid hormone receptor-associated protein complex 80 kDa component;Transcriptional coactivator CRSP77;Vitamin D3 receptor-interacting protein complex 80 kDa component;, PF10156;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0005667;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006367;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter;|Q9NVC6 B3KN07 Q9HA81 Q9UNP7 Q9Y2W0 Q9Y660,Mediator of RNA polymerase II transcription subunit 17,Activator-recruited cofactor 77 kDa component;Cofactor required for Sp1 transcriptional activation subunit 6;Mediator complex subunit 17;Thyroid hormone receptor-associated protein complex 80 kDa component;Transcriptional coactivator CRSP77;Vitamin D3 receptor-interacting protein complex 80 kDa component;, PF10156;, GO:0070847;GO:0016592;GO:0016020;GO:0005654;GO:0005634;GO:0005667;GO:0030374;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0045944;GO:0060261;GO:0045893;GO:0006357;GO:0060260;GO:0006367;, C:core mediator complex; C:mediator complex; C:membrane; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:nuclear receptor coactivator activity; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; scaffold95 indexed_genome mRNA 535743 560023 . - . ID=transcript_12670;Q9H0W9 A8K850 Q6FI88 Q6XYB0 Q96EI3 Q96IX1 Q9Y6B4,Ester hydrolase C11orf54,, PF08925;, GO:0070062;GO:0016604;GO:0005654;GO:0005634;GO:0016788;GO:0008270;, C:extracellular exosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:hydrolase activity, acting on ester bonds; F:zinc ion binding; scaffold95 indexed_genome mRNA 562192 628383 . + . ID=transcript_12671;Q9H5J8 Q6I9Y6,TATA box-binding protein-associated factor RNA polymerase I subunit D,RNA polymerase I-specific TBP-associated factor 41 kDa;TATA box-binding protein-associated factor 1D;Transcription initiation factor SL1/TIF-IB subunit D;, PF15333;, GO:0034451;GO:0005829;GO:0072686;GO:0005730;GO:0005654;GO:0005668;GO:0003677;GO:0042802;GO:0045815;GO:0006355;GO:0006363;GO:0006361;, C:centriolar satellite; C:cytosol; C:mitotic spindle; C:nucleolus; C:nucleoplasm; C:RNA polymerase transcription factor SL1 complex;, F:DNA binding; F:identical protein binding;, P:positive regulation of gene expression, epigenetic; P:regulation of transcription, DNA-templated; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter;|Q9H5J8 Q6I9Y6,TATA box-binding protein-associated factor RNA polymerase I subunit D,RNA polymerase I-specific TBP-associated factor 41 kDa;TATA box-binding protein-associated factor 1D;Transcription initiation factor SL1/TIF-IB subunit D;, PF15333;, GO:0034451;GO:0005829;GO:0072686;GO:0005730;GO:0005654;GO:0005668;GO:0003677;GO:0042802;GO:0045815;GO:0006355;GO:0006363;GO:0006361;, C:centriolar satellite; C:cytosol; C:mitotic spindle; C:nucleolus; C:nucleoplasm; C:RNA polymerase transcription factor SL1 complex;, F:DNA binding; F:identical protein binding;, P:positive regulation of gene expression, epigenetic; P:regulation of transcription, DNA-templated; P:termination of RNA polymerase I transcription; P:transcription initiation from RNA polymerase I promoter;|Q9C0D2 C9J5H9 C9JQY8 Q8N7L4 Q8N919 Q8N9B0 Q96LT8,Centrosomal protein of 295 kDa {ECO:0000305},, PF15309;, GO:0005814;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:1990498;GO:0005886;GO:0008017;GO:0007099;GO:1903724;GO:0010825;GO:1904951;GO:1901985;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mitotic spindle microtubule; C:plasma membrane;, F:microtubule binding;, P:centriole replication; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of establishment of protein localization; P:positive regulation of protein acetylation; P:regulation of centriole replication;|Q9C0D2 C9J5H9 C9JQY8 Q8N7L4 Q8N919 Q8N9B0 Q96LT8,Centrosomal protein of 295 kDa {ECO:0000305},, PF15309;, GO:0005814;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:1990498;GO:0005886;GO:0008017;GO:0007099;GO:1903724;GO:0010825;GO:1904951;GO:1901985;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mitotic spindle microtubule; C:plasma membrane;, F:microtubule binding;, P:centriole replication; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of establishment of protein localization; P:positive regulation of protein acetylation; P:regulation of centriole replication;|Q9C0D2 C9J5H9 C9JQY8 Q8N7L4 Q8N919 Q8N9B0 Q96LT8,Centrosomal protein of 295 kDa {ECO:0000305},, PF15309;, GO:0005814;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:1990498;GO:0005886;GO:0008017;GO:0007099;GO:1903724;GO:0010825;GO:1904951;GO:1901985;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mitotic spindle microtubule; C:plasma membrane;, F:microtubule binding;, P:centriole replication; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of establishment of protein localization; P:positive regulation of protein acetylation; P:regulation of centriole replication;|Q9C0D2 C9J5H9 C9JQY8 Q8N7L4 Q8N919 Q8N9B0 Q96LT8,Centrosomal protein of 295 kDa {ECO:0000305},, PF15309;, GO:0005814;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:1990498;GO:0005886;GO:0008017;GO:0007099;GO:1903724;GO:0010825;GO:1904951;GO:1901985;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mitotic spindle microtubule; C:plasma membrane;, F:microtubule binding;, P:centriole replication; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of establishment of protein localization; P:positive regulation of protein acetylation; P:regulation of centriole replication;|Q9C0D2 C9J5H9 C9JQY8 Q8N7L4 Q8N919 Q8N9B0 Q96LT8,Centrosomal protein of 295 kDa {ECO:0000305},, PF15309;, GO:0005814;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:1990498;GO:0005886;GO:0008017;GO:0007099;GO:1903724;GO:0010825;GO:1904951;GO:1901985;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mitotic spindle microtubule; C:plasma membrane;, F:microtubule binding;, P:centriole replication; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of establishment of protein localization; P:positive regulation of protein acetylation; P:regulation of centriole replication;|Q9C0D2 C9J5H9 C9JQY8 Q8N7L4 Q8N919 Q8N9B0 Q96LT8,Centrosomal protein of 295 kDa {ECO:0000305},, PF15309;, GO:0005814;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:1990498;GO:0005886;GO:0008017;GO:0007099;GO:1903724;GO:0010825;GO:1904951;GO:1901985;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mitotic spindle microtubule; C:plasma membrane;, F:microtubule binding;, P:centriole replication; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of establishment of protein localization; P:positive regulation of protein acetylation; P:regulation of centriole replication;|Q9C0D2 C9J5H9 C9JQY8 Q8N7L4 Q8N919 Q8N9B0 Q96LT8,Centrosomal protein of 295 kDa {ECO:0000305},, PF15309;, GO:0005814;GO:0005813;GO:0005737;GO:0005856;GO:0005829;GO:1990498;GO:0005886;GO:0008017;GO:0007099;GO:1903724;GO:0010825;GO:1904951;GO:1901985;GO:0046599;, C:centriole; C:centrosome; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mitotic spindle microtubule; C:plasma membrane;, F:microtubule binding;, P:centriole replication; P:positive regulation of centriole elongation; P:positive regulation of centrosome duplication; P:positive regulation of establishment of protein localization; P:positive regulation of protein acetylation; P:regulation of centriole replication; scaffold95 indexed_genome mRNA 874699 875325 . + . ID=transcript_12672;Q9NRQ5,Single-pass membrane and coiled-coil domain-containing protein 4,Protein FN5;, PF15012;, GO:0016021;, C:integral component of membrane; scaffold95 indexed_genome mRNA 900794 949077 . + . ID=transcript_12673;Q05D60 E9PJR5 Q8NEF1 Q96LL7,Deuterosome assembly protein 1 {ECO:0000312|HGNC:HGNC:26344},Coiled-coil domain-containing protein 67;, PF17045;, GO:0005814;GO:0005737;GO:0098536;GO:0042802;GO:0030030;GO:0007099;GO:0098535;GO:1903251;, C:centriole; C:cytoplasm; C:deuterosome;, F:identical protein binding;, P:cell projection organization; P:centriole replication; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:multi-ciliated epithelial cell differentiation;|Q05D60 E9PJR5 Q8NEF1 Q96LL7,Deuterosome assembly protein 1 {ECO:0000312|HGNC:HGNC:26344},Coiled-coil domain-containing protein 67;, PF17045;, GO:0005814;GO:0005737;GO:0098536;GO:0042802;GO:0030030;GO:0007099;GO:0098535;GO:1903251;, C:centriole; C:cytoplasm; C:deuterosome;, F:identical protein binding;, P:cell projection organization; P:centriole replication; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:multi-ciliated epithelial cell differentiation; scaffold95 indexed_genome mRNA 1176986 1217015 . + . ID=transcript_12674;Q6YBV0 Q86X30 Q8IVM5 Q8N8S6,Proton-coupled amino acid transporter 4,Solute carrier family 36 member 4;, PF01490;, GO:0016021;GO:0005886;GO:0015171;GO:0015180;GO:0015193;GO:0015196;GO:0015293;GO:0003333;GO:0015808;GO:1904271;GO:1904556;GO:0015824;GO:0015827;, C:integral component of membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:L-tryptophan transmembrane transporter activity; F:symporter activity;, P:amino acid transmembrane transport; P:L-alanine transport; P:L-proline import across plasma membrane; P:L-tryptophan transmembrane transport; P:proline transport; P:tryptophan transport;|Q6YBV0 Q86X30 Q8IVM5 Q8N8S6,Proton-coupled amino acid transporter 4,Solute carrier family 36 member 4;, PF01490;, GO:0016021;GO:0005886;GO:0015171;GO:0015180;GO:0015193;GO:0015196;GO:0015293;GO:0003333;GO:0015808;GO:1904271;GO:1904556;GO:0015824;GO:0015827;, C:integral component of membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:L-tryptophan transmembrane transporter activity; F:symporter activity;, P:amino acid transmembrane transport; P:L-alanine transport; P:L-proline import across plasma membrane; P:L-tryptophan transmembrane transport; P:proline transport; P:tryptophan transport; scaffold95 indexed_genome mRNA 1220092 1226596 . - . ID=transcript_12675;Q6YBV0 Q86X30 Q8IVM5 Q8N8S6,Proton-coupled amino acid transporter 4,Solute carrier family 36 member 4;, PF01490;, GO:0016021;GO:0005886;GO:0015171;GO:0015180;GO:0015193;GO:0015196;GO:0015293;GO:0003333;GO:0015808;GO:1904271;GO:1904556;GO:0015824;GO:0015827;, C:integral component of membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:L-tryptophan transmembrane transporter activity; F:symporter activity;, P:amino acid transmembrane transport; P:L-alanine transport; P:L-proline import across plasma membrane; P:L-tryptophan transmembrane transport; P:proline transport; P:tryptophan transport;|Q6YBV0 Q86X30 Q8IVM5 Q8N8S6,Proton-coupled amino acid transporter 4,Solute carrier family 36 member 4;, PF01490;, GO:0016021;GO:0005886;GO:0015171;GO:0015180;GO:0015193;GO:0015196;GO:0015293;GO:0003333;GO:0015808;GO:1904271;GO:1904556;GO:0015824;GO:0015827;, C:integral component of membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-proline transmembrane transporter activity; F:L-tryptophan transmembrane transporter activity; F:symporter activity;, P:amino acid transmembrane transport; P:L-alanine transport; P:L-proline import across plasma membrane; P:L-tryptophan transmembrane transport; P:proline transport; P:tryptophan transport; scaffold95 indexed_genome mRNA 1444976 1476296 . - . ID=transcript_12676;Q8TDW7 B5MDB0 Q96AU6,Protocadherin Fat 3,Cadherin family member 15;FAT tumor suppressor homolog 3;, PF00028;PF02210;, GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0007156;GO:0007275;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold95 indexed_genome mRNA 1508205 1520832 . - . ID=transcript_12677;Q8TDW7 B5MDB0 Q96AU6,Protocadherin Fat 3,Cadherin family member 15;FAT tumor suppressor homolog 3;, PF00028;PF02210;, GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0007156;GO:0007275;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold95 indexed_genome mRNA 1556825 1557374 . - . ID=transcript_12678;Q8TDW7 B5MDB0 Q96AU6,Protocadherin Fat 3,Cadherin family member 15;FAT tumor suppressor homolog 3;, PF00028;PF02210;, GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0007156;GO:0007275;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold95 indexed_genome mRNA 2069184 2069739 . - . ID=transcript_12679;Q8TDW7 B5MDB0 Q96AU6,Protocadherin Fat 3,Cadherin family member 15;FAT tumor suppressor homolog 3;, PF00028;PF02210;, GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0007156;GO:0007275;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold95 indexed_genome mRNA 4310031 4311617 . - . ID=transcript_12680;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold95 indexed_genome mRNA 4346710 4359359 . + . ID=transcript_12681;Q9UHD1 B2R6P8 Q6IN49 Q8WVL9 Q9H3D6,Cysteine and histidine-rich domain-containing protein 1,CHORD domain-containing protein 1;Protein morgana;, PF04968;PF04969;, GO:0043531;GO:0005524;GO:0051879;GO:0008270;GO:0051298;GO:0061077;GO:2000299;GO:1900034;GO:0010824;, , F:ADP binding; F:ATP binding; F:Hsp90 protein binding; F:zinc ion binding;, P:centrosome duplication; P:chaperone-mediated protein folding; P:negative regulation of Rho-dependent protein serine/threonine kinase activity; P:regulation of cellular response to heat; P:regulation of centrosome duplication;|Q9UHD1 B2R6P8 Q6IN49 Q8WVL9 Q9H3D6,Cysteine and histidine-rich domain-containing protein 1,CHORD domain-containing protein 1;Protein morgana;, PF04968;PF04969;, GO:0043531;GO:0005524;GO:0051879;GO:0008270;GO:0051298;GO:0061077;GO:2000299;GO:1900034;GO:0010824;, , F:ADP binding; F:ATP binding; F:Hsp90 protein binding; F:zinc ion binding;, P:centrosome duplication; P:chaperone-mediated protein folding; P:negative regulation of Rho-dependent protein serine/threonine kinase activity; P:regulation of cellular response to heat; P:regulation of centrosome duplication;|Q9UHD1 B2R6P8 Q6IN49 Q8WVL9 Q9H3D6,Cysteine and histidine-rich domain-containing protein 1,CHORD domain-containing protein 1;Protein morgana;, PF04968;PF04969;, GO:0043531;GO:0005524;GO:0051879;GO:0008270;GO:0051298;GO:0061077;GO:2000299;GO:1900034;GO:0010824;, , F:ADP binding; F:ATP binding; F:Hsp90 protein binding; F:zinc ion binding;, P:centrosome duplication; P:chaperone-mediated protein folding; P:negative regulation of Rho-dependent protein serine/threonine kinase activity; P:regulation of cellular response to heat; P:regulation of centrosome duplication; scaffold95 indexed_genome mRNA 4393919 4412449 . - . ID=transcript_12682;Q9Y3Q0 B3KQR4 Q4KKV4 Q4VAM9,N-acetylated-alpha-linked acidic dipeptidase 2,Glutamate carboxypeptidase III;N-acetylated-alpha-linked acidic dipeptidase II;, PF02225;PF04389;PF04253;, GO:0016021;GO:0005886;GO:0004180;GO:0016805;GO:0008239;GO:0046872;GO:0004181;GO:0008236;GO:0009066;GO:0006508;, C:integral component of membrane; C:plasma membrane;, F:carboxypeptidase activity; F:dipeptidase activity; F:dipeptidyl-peptidase activity; F:metal ion binding; F:metallocarboxypeptidase activity; F:serine-type peptidase activity;, P:aspartate family amino acid metabolic process; P:proteolysis; scaffold96 indexed_genome mRNA 42899 44651 . - . ID=transcript_12683;Q96HG1,Small integral membrane protein 10,, PF15118;, GO:0016021;, C:integral component of membrane; scaffold96 indexed_genome mRNA 259319 342231 . + . ID=transcript_12684;Q8NBN4 Q96SJ4,Heparan-sulfate 6-O-sulfotransferase 2 {ECO:0000305},, PF03567;, GO:0000139;GO:0016021;GO:0017095;GO:0006024;GO:0015015;, C:Golgi membrane; C:integral component of membrane;, F:heparan sulfate 6-O-sulfotransferase activity;, P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; scaffold96 indexed_genome mRNA 614307 640257 . + . ID=transcript_12685;Q9UF37,Muscleblind-like protein 3,Cys3His CCG1-required protein;Muscleblind-like X-linked protein;Protein HCHCR;, PF00642;, GO:0005737;GO:0005654;GO:0046872;GO:0003723;GO:0006397;GO:0007275;GO:0045662;GO:0000381;GO:0043484;GO:0008380;, C:cytoplasm; C:nucleoplasm;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:multicellular organism development; P:negative regulation of myoblast differentiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing; scaffold96 indexed_genome mRNA 753191 766283 . + . ID=transcript_12686;Q9Y3L5 B3KWD6 Q5H9H9 Q9BTS0,Ras-related protein Rap-2c,, PF00071;, GO:0005923;GO:0044291;GO:0005737;GO:0005829;GO:0070062;GO:0005886;GO:0055038;GO:0070821;GO:0019003;GO:0005525;GO:0003924;GO:0003713;GO:0090557;GO:0030336;GO:0043312;GO:0031954;GO:0032486;GO:0061097;, C:bicellular tight junction; C:cell-cell contact zone; C:cytoplasm; C:cytosol; C:extracellular exosome; C:plasma membrane; C:recycling endosome membrane; C:tertiary granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:transcription coactivator activity;, P:establishment of endothelial intestinal barrier; P:negative regulation of cell migration; P:neutrophil degranulation; P:positive regulation of protein autophosphorylation; P:Rap protein signal transduction; P:regulation of protein tyrosine kinase activity; scaffold96 indexed_genome mRNA 866172 931681 . - . ID=transcript_12687;Q9P289 B2RAU2 Q3ZB77 Q8NC04 Q9BXC3 Q9BXC4,Serine/threonine-protein kinase 26 {ECO:0000305},MST3 and SOK1-related kinase {ECO:0000303|PubMed:11741893};Mammalian STE20-like protein kinase 4 {ECO:0000303|PubMed:11641781};Serine/threonine-protein kinase MASK {ECO:0000305};, PF00069;, GO:0016324;GO:0071944;GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005798;GO:0016020;GO:0048471;GO:0012506;GO:0005524;GO:0042802;GO:0000287;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0006915;GO:0009267;GO:0030033;GO:0030336;GO:0046777;GO:0006468;GO:0042981;GO:1903205;GO:0042542;, C:apical plasma membrane; C:cell periphery; C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:Golgi-associated vesicle; C:membrane; C:perinuclear region of cytoplasm; C:vesicle membrane;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cellular response to starvation; P:microvillus assembly; P:negative regulation of cell migration; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of hydrogen peroxide-induced cell death; P:response to hydrogen peroxide;|Q9P289 B2RAU2 Q3ZB77 Q8NC04 Q9BXC3 Q9BXC4,Serine/threonine-protein kinase 26 {ECO:0000305},MST3 and SOK1-related kinase {ECO:0000303|PubMed:11741893};Mammalian STE20-like protein kinase 4 {ECO:0000303|PubMed:11641781};Serine/threonine-protein kinase MASK {ECO:0000305};, PF00069;, GO:0016324;GO:0071944;GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005798;GO:0016020;GO:0048471;GO:0012506;GO:0005524;GO:0042802;GO:0000287;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0006915;GO:0009267;GO:0030033;GO:0030336;GO:0046777;GO:0006468;GO:0042981;GO:1903205;GO:0042542;, C:apical plasma membrane; C:cell periphery; C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:Golgi-associated vesicle; C:membrane; C:perinuclear region of cytoplasm; C:vesicle membrane;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cellular response to starvation; P:microvillus assembly; P:negative regulation of cell migration; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of hydrogen peroxide-induced cell death; P:response to hydrogen peroxide;|Q9P289 B2RAU2 Q3ZB77 Q8NC04 Q9BXC3 Q9BXC4,Serine/threonine-protein kinase 26 {ECO:0000305},MST3 and SOK1-related kinase {ECO:0000303|PubMed:11741893};Mammalian STE20-like protein kinase 4 {ECO:0000303|PubMed:11641781};Serine/threonine-protein kinase MASK {ECO:0000305};, PF00069;, GO:0016324;GO:0071944;GO:0005737;GO:0005829;GO:0070062;GO:0005794;GO:0005798;GO:0016020;GO:0048471;GO:0012506;GO:0005524;GO:0042802;GO:0000287;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0006915;GO:0009267;GO:0030033;GO:0030336;GO:0046777;GO:0006468;GO:0042981;GO:1903205;GO:0042542;, C:apical plasma membrane; C:cell periphery; C:cytoplasm; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:Golgi-associated vesicle; C:membrane; C:perinuclear region of cytoplasm; C:vesicle membrane;, F:ATP binding; F:identical protein binding; F:magnesium ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cellular response to starvation; P:microvillus assembly; P:negative regulation of cell migration; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of hydrogen peroxide-induced cell death; P:response to hydrogen peroxide; scaffold96 indexed_genome mRNA 1498556 1499569 . + . ID=transcript_12688;Q8N6C5 B5MEG2 H9KV64 O15070 Q9NTC8,Immunoglobulin superfamily member 1,Immunoglobulin-like domain-containing protein 1;Inhibin-binding protein;Pituitary gland-specific factor 2;p120;, PF00047;PF13895;, GO:0005576;GO:0016021;GO:0016020;GO:0038102;GO:0015026;GO:0034711;GO:0032926;GO:0006355;, C:extracellular region; C:integral component of membrane; C:membrane;, F:activin receptor antagonist activity; F:coreceptor activity; F:inhibin binding;, P:negative regulation of activin receptor signaling pathway; P:regulation of transcription, DNA-templated; scaffold96 indexed_genome mRNA 1499724 1501079 . + . ID=transcript_12689;Q8N6C5 B5MEG2 H9KV64 O15070 Q9NTC8,Immunoglobulin superfamily member 1,Immunoglobulin-like domain-containing protein 1;Inhibin-binding protein;Pituitary gland-specific factor 2;p120;, PF00047;PF13895;, GO:0005576;GO:0016021;GO:0016020;GO:0038102;GO:0015026;GO:0034711;GO:0032926;GO:0006355;, C:extracellular region; C:integral component of membrane; C:membrane;, F:activin receptor antagonist activity; F:coreceptor activity; F:inhibin binding;, P:negative regulation of activin receptor signaling pathway; P:regulation of transcription, DNA-templated; scaffold96 indexed_genome mRNA 1849074 2093026 . + . ID=transcript_12690;Q16206 A8K197 A8K1C2 Q5VTJ1 Q5VTJ2 Q8WUX0 Q9NTP6 Q9UH82,Ecto-NOX disulfide-thiol exchanger 2,APK1 antigen;Cytosolic ovarian carcinoma antigen 1;Tumor-associated hydroquinone oxidase;, PF00076;, GO:0005829;GO:0009897;GO:0005615;GO:0003676;GO:0015035;GO:0022900;GO:0040008;GO:0007624;, C:cytosol; C:external side of plasma membrane; C:extracellular space;, F:nucleic acid binding; F:protein disulfide oxidoreductase activity;, P:electron transport chain; P:regulation of growth; P:ultradian rhythm; scaffold96 indexed_genome mRNA 2093028 2136758 . + . ID=transcript_12691;Q16206 A8K197 A8K1C2 Q5VTJ1 Q5VTJ2 Q8WUX0 Q9NTP6 Q9UH82,Ecto-NOX disulfide-thiol exchanger 2,APK1 antigen;Cytosolic ovarian carcinoma antigen 1;Tumor-associated hydroquinone oxidase;, PF00076;, GO:0005829;GO:0009897;GO:0005615;GO:0003676;GO:0015035;GO:0022900;GO:0040008;GO:0007624;, C:cytosol; C:external side of plasma membrane; C:extracellular space;, F:nucleic acid binding; F:protein disulfide oxidoreductase activity;, P:electron transport chain; P:regulation of growth; P:ultradian rhythm; scaffold96 indexed_genome mRNA 2334934 2349858 . - . ID=transcript_12692;Q9Y388 A8K9Z0 Q5JY82 Q9Y3I8,RNA-binding motif protein, X-linked 2,, PF00076;, GO:0005634;GO:0071011;GO:0005686;GO:0071005;GO:0003723;GO:0000398;, C:nucleus; C:precatalytic spliceosome; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q9Y388 A8K9Z0 Q5JY82 Q9Y3I8,RNA-binding motif protein, X-linked 2,, PF00076;, GO:0005634;GO:0071011;GO:0005686;GO:0071005;GO:0003723;GO:0000398;, C:nucleus; C:precatalytic spliceosome; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q9Y388 A8K9Z0 Q5JY82 Q9Y3I8,RNA-binding motif protein, X-linked 2,, PF00076;, GO:0005634;GO:0071011;GO:0005686;GO:0071005;GO:0003723;GO:0000398;, C:nucleus; C:precatalytic spliceosome; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q9Y388 A8K9Z0 Q5JY82 Q9Y3I8,RNA-binding motif protein, X-linked 2,, PF00076;, GO:0005634;GO:0071011;GO:0005686;GO:0071005;GO:0003723;GO:0000398;, C:nucleus; C:precatalytic spliceosome; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA splicing, via spliceosome; scaffold96 indexed_genome mRNA 2373127 2411131 . - . ID=transcript_12693;O95258 D3DTG2 Q0VDH7 Q9HC60 Q9HC61,Brain mitochondrial carrier protein 1,Mitochondrial uncoupling protein 5;Solute carrier family 25 member 14;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0015297;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0009060;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:1902600;GO:0071422;GO:0008272;GO:0015709;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:aerobic respiration; P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:proton transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:thiosulfate transport;|O95258 D3DTG2 Q0VDH7 Q9HC60 Q9HC61,Brain mitochondrial carrier protein 1,Mitochondrial uncoupling protein 5;Solute carrier family 25 member 14;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0015297;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0009060;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:1902600;GO:0071422;GO:0008272;GO:0015709;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:aerobic respiration; P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:proton transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:thiosulfate transport;|O95258 D3DTG2 Q0VDH7 Q9HC60 Q9HC61,Brain mitochondrial carrier protein 1,Mitochondrial uncoupling protein 5;Solute carrier family 25 member 14;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0015297;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0009060;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:1902600;GO:0071422;GO:0008272;GO:0015709;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:aerobic respiration; P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:proton transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:thiosulfate transport;|O95258 D3DTG2 Q0VDH7 Q9HC60 Q9HC61,Brain mitochondrial carrier protein 1,Mitochondrial uncoupling protein 5;Solute carrier family 25 member 14;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0015297;GO:0015140;GO:0015131;GO:0015141;GO:0015116;GO:0015117;GO:0009060;GO:0071423;GO:0006839;GO:0015729;GO:0035435;GO:1902600;GO:0071422;GO:0008272;GO:0015709;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:antiporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:aerobic respiration; P:malate transmembrane transport; P:mitochondrial transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:proton transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:thiosulfate transport; scaffold96 indexed_genome mRNA 2488018 2537929 . + . ID=transcript_12694;Q8ND82 A8K2V8 Q9NXR3,Zinc finger protein 280C,Suppressor of hairy wing homolog 3;Zinc finger protein 633;, PF13836;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q8ND82 A8K2V8 Q9NXR3,Zinc finger protein 280C,Suppressor of hairy wing homolog 3;Zinc finger protein 633;, PF13836;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q8ND82 A8K2V8 Q9NXR3,Zinc finger protein 280C,Suppressor of hairy wing homolog 3;Zinc finger protein 633;, PF13836;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold96 indexed_genome mRNA 2556579 2600223 . + . ID=transcript_12695;Q14088 Q5JUZ6 Q92465,Ras-related protein Rab-33A,Small GTP-binding protein S10;, PF00071;, GO:0005768;GO:0005794;GO:0000139;GO:0005886;GO:0005525;GO:0003924;GO:0019882;GO:0032482;, C:endosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:antigen processing and presentation; P:Rab protein signal transduction;|Q14088 Q5JUZ6 Q92465,Ras-related protein Rab-33A,Small GTP-binding protein S10;, PF00071;, GO:0005768;GO:0005794;GO:0000139;GO:0005886;GO:0005525;GO:0003924;GO:0019882;GO:0032482;, C:endosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:antigen processing and presentation; P:Rab protein signal transduction;|Q14088 Q5JUZ6 Q92465,Ras-related protein Rab-33A,Small GTP-binding protein S10;, PF00071;, GO:0005768;GO:0005794;GO:0000139;GO:0005886;GO:0005525;GO:0003924;GO:0019882;GO:0032482;, C:endosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:antigen processing and presentation; P:Rab protein signal transduction;|Q14088 Q5JUZ6 Q92465,Ras-related protein Rab-33A,Small GTP-binding protein S10;, PF00071;, GO:0005768;GO:0005794;GO:0000139;GO:0005886;GO:0005525;GO:0003924;GO:0019882;GO:0032482;, C:endosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:antigen processing and presentation; P:Rab protein signal transduction;|Q14088 Q5JUZ6 Q92465,Ras-related protein Rab-33A,Small GTP-binding protein S10;, PF00071;, GO:0005768;GO:0005794;GO:0000139;GO:0005886;GO:0005525;GO:0003924;GO:0019882;GO:0032482;, C:endosome; C:Golgi apparatus; C:Golgi membrane; C:plasma membrane;, F:GTP binding; F:GTPase activity;, P:antigen processing and presentation; P:Rab protein signal transduction;|Q5JUZ7 Q6I9X6 Q9Y3I3 Q9Y3I4,Apoptosis-inducing factor 1, mitochondrial {ECO:0000305},Programmed cell death protein 8;, PF14721;PF07992;, GO:0005829;GO:0005743;GO:0005758;GO:0005739;GO:0005634;GO:0048471;GO:0003677;GO:0071949;GO:0016174;GO:0003954;GO:0016651;GO:0046983;GO:0006919;GO:0006915;GO:0030261;GO:0070059;GO:0033108;GO:0032981;GO:0030182;GO:0043065;GO:0045041;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:FAD binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH dehydrogenase activity; F:oxidoreductase activity, acting on NAD(P)H; F:protein dimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:chromosome condensation; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:mitochondrial respiratory chain complex assembly; P:mitochondrial respiratory chain complex I assembly; P:neuron differentiation; P:positive regulation of apoptotic process; P:protein import into mitochondrial intermembrane space;|Q5JUZ7 Q6I9X6 Q9Y3I3 Q9Y3I4,Apoptosis-inducing factor 1, mitochondrial {ECO:0000305},Programmed cell death protein 8;, PF14721;PF07992;, GO:0005829;GO:0005743;GO:0005758;GO:0005739;GO:0005634;GO:0048471;GO:0003677;GO:0071949;GO:0016174;GO:0003954;GO:0016651;GO:0046983;GO:0006919;GO:0006915;GO:0030261;GO:0070059;GO:0033108;GO:0032981;GO:0030182;GO:0043065;GO:0045041;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:FAD binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH dehydrogenase activity; F:oxidoreductase activity, acting on NAD(P)H; F:protein dimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:chromosome condensation; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:mitochondrial respiratory chain complex assembly; P:mitochondrial respiratory chain complex I assembly; P:neuron differentiation; P:positive regulation of apoptotic process; P:protein import into mitochondrial intermembrane space;|Q5JUZ7 Q6I9X6 Q9Y3I3 Q9Y3I4,Apoptosis-inducing factor 1, mitochondrial {ECO:0000305},Programmed cell death protein 8;, PF14721;PF07992;, GO:0005829;GO:0005743;GO:0005758;GO:0005739;GO:0005634;GO:0048471;GO:0003677;GO:0071949;GO:0016174;GO:0003954;GO:0016651;GO:0046983;GO:0006919;GO:0006915;GO:0030261;GO:0070059;GO:0033108;GO:0032981;GO:0030182;GO:0043065;GO:0045041;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:FAD binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH dehydrogenase activity; F:oxidoreductase activity, acting on NAD(P)H; F:protein dimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:chromosome condensation; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:mitochondrial respiratory chain complex assembly; P:mitochondrial respiratory chain complex I assembly; P:neuron differentiation; P:positive regulation of apoptotic process; P:protein import into mitochondrial intermembrane space;|Q5JUZ7 Q6I9X6 Q9Y3I3 Q9Y3I4,Apoptosis-inducing factor 1, mitochondrial {ECO:0000305},Programmed cell death protein 8;, PF14721;PF07992;, GO:0005829;GO:0005743;GO:0005758;GO:0005739;GO:0005634;GO:0048471;GO:0003677;GO:0071949;GO:0016174;GO:0003954;GO:0016651;GO:0046983;GO:0006919;GO:0006915;GO:0030261;GO:0070059;GO:0033108;GO:0032981;GO:0030182;GO:0043065;GO:0045041;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:FAD binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH dehydrogenase activity; F:oxidoreductase activity, acting on NAD(P)H; F:protein dimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:chromosome condensation; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:mitochondrial respiratory chain complex assembly; P:mitochondrial respiratory chain complex I assembly; P:neuron differentiation; P:positive regulation of apoptotic process; P:protein import into mitochondrial intermembrane space;|Q5JUZ7 Q6I9X6 Q9Y3I3 Q9Y3I4,Apoptosis-inducing factor 1, mitochondrial {ECO:0000305},Programmed cell death protein 8;, PF14721;PF07992;, GO:0005829;GO:0005743;GO:0005758;GO:0005739;GO:0005634;GO:0048471;GO:0003677;GO:0071949;GO:0016174;GO:0003954;GO:0016651;GO:0046983;GO:0006919;GO:0006915;GO:0030261;GO:0070059;GO:0033108;GO:0032981;GO:0030182;GO:0043065;GO:0045041;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:FAD binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH dehydrogenase activity; F:oxidoreductase activity, acting on NAD(P)H; F:protein dimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:chromosome condensation; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:mitochondrial respiratory chain complex assembly; P:mitochondrial respiratory chain complex I assembly; P:neuron differentiation; P:positive regulation of apoptotic process; P:protein import into mitochondrial intermembrane space;|Q5JUZ7 Q6I9X6 Q9Y3I3 Q9Y3I4,Apoptosis-inducing factor 1, mitochondrial {ECO:0000305},Programmed cell death protein 8;, PF14721;PF07992;, GO:0005829;GO:0005743;GO:0005758;GO:0005739;GO:0005634;GO:0048471;GO:0003677;GO:0071949;GO:0016174;GO:0003954;GO:0016651;GO:0046983;GO:0006919;GO:0006915;GO:0030261;GO:0070059;GO:0033108;GO:0032981;GO:0030182;GO:0043065;GO:0045041;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:FAD binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH dehydrogenase activity; F:oxidoreductase activity, acting on NAD(P)H; F:protein dimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:chromosome condensation; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:mitochondrial respiratory chain complex assembly; P:mitochondrial respiratory chain complex I assembly; P:neuron differentiation; P:positive regulation of apoptotic process; P:protein import into mitochondrial intermembrane space;|Q5JUZ7 Q6I9X6 Q9Y3I3 Q9Y3I4,Apoptosis-inducing factor 1, mitochondrial {ECO:0000305},Programmed cell death protein 8;, PF14721;PF07992;, GO:0005829;GO:0005743;GO:0005758;GO:0005739;GO:0005634;GO:0048471;GO:0003677;GO:0071949;GO:0016174;GO:0003954;GO:0016651;GO:0046983;GO:0006919;GO:0006915;GO:0030261;GO:0070059;GO:0033108;GO:0032981;GO:0030182;GO:0043065;GO:0045041;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:FAD binding; F:NAD(P)H oxidase H2O2-forming activity; F:NADH dehydrogenase activity; F:oxidoreductase activity, acting on NAD(P)H; F:protein dimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:chromosome condensation; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:mitochondrial respiratory chain complex assembly; P:mitochondrial respiratory chain complex I assembly; P:neuron differentiation; P:positive regulation of apoptotic process; P:protein import into mitochondrial intermembrane space; scaffold96 indexed_genome mRNA 2613831 2654280 . + . ID=transcript_12696;Q99607 D3DTG1 O60435,ETS-related transcription factor Elf-4,E74-like factor 4;Myeloid Elf-1-like factor;, PF12310;PF00178;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0045087;GO:0001787;GO:0001866;GO:0045944;GO:0045893;GO:0006357;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:innate immune response; P:natural killer cell proliferation; P:NK T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold96 indexed_genome mRNA 2659885 2690551 . - . ID=transcript_12697;Q5H9F3 B5MDQ8 Q5H9F2 Q5H9F4 Q6ZVE0 Q8TEN3 Q9Y528,BCL-6 corepressor-like protein 1,, PF12796;PF15808;PF16553;, GO:0005654;GO:0005886;GO:0006325;, C:nucleoplasm; C:plasma membrane;, , P:chromatin organization; scaffold96 indexed_genome mRNA 2690596 2691223 . - . ID=transcript_12698;Q5H9F3 B5MDQ8 Q5H9F2 Q5H9F4 Q6ZVE0 Q8TEN3 Q9Y528,BCL-6 corepressor-like protein 1,, PF12796;PF15808;PF16553;, GO:0005654;GO:0005886;GO:0006325;, C:nucleoplasm; C:plasma membrane;, , P:chromatin organization; scaffold96 indexed_genome mRNA 2691323 2697374 . + . ID=transcript_12699;Q5H9F3 B5MDQ8 Q5H9F2 Q5H9F4 Q6ZVE0 Q8TEN3 Q9Y528,BCL-6 corepressor-like protein 1,, PF12796;PF15808;PF16553;, GO:0005654;GO:0005886;GO:0006325;, C:nucleoplasm; C:plasma membrane;, , P:chromatin organization;|Q5H9F3 B5MDQ8 Q5H9F2 Q5H9F4 Q6ZVE0 Q8TEN3 Q9Y528,BCL-6 corepressor-like protein 1,, PF12796;PF15808;PF16553;, GO:0005654;GO:0005886;GO:0006325;, C:nucleoplasm; C:plasma membrane;, , P:chromatin organization; scaffold96 indexed_genome mRNA 2766073 2782491 . - . ID=transcript_12700;Q9BVJ6 A8K7A3 A8MVQ1 B4DQ08 E9PEL7 Q5JYF1,U3 small nucleolar RNA-associated protein 14 homolog A,Antigen NY-CO-16;Serologically defined colon cancer antigen 16;, , GO:0005829;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:cytosol; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing;|Q9BVJ6 A8K7A3 A8MVQ1 B4DQ08 E9PEL7 Q5JYF1,U3 small nucleolar RNA-associated protein 14 homolog A,Antigen NY-CO-16;Serologically defined colon cancer antigen 16;, , GO:0005829;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0006364;, C:cytosol; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:rRNA processing;|Q5TAP6 Q5FWG3 Q92555,U3 small nucleolar RNA-associated protein 14 homolog C,, , GO:0005829;GO:0005730;GO:0032040;GO:0030154;GO:0051321;GO:0007275;GO:0006364;GO:0007283;, C:cytosol; C:nucleolus; C:small-subunit processome;, , P:cell differentiation; P:meiotic cell cycle; P:multicellular organism development; P:rRNA processing; P:spermatogenesis; scaffold96 indexed_genome mRNA 2838195 2868877 . + . ID=transcript_12701;Q9NVR6,Palmitoyltransferase ZDHHC9,Zinc finger DHHC domain-containing protein 9;Zinc finger protein 379;Zinc finger protein 380;, PF01529;, GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0031228;GO:0002178;GO:0016409;GO:0019706;GO:0043849;GO:0000165;GO:0018230;GO:0018345;GO:0006612;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:intrinsic component of Golgi membrane; C:palmitoyltransferase complex;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:Ras palmitoyltransferase activity;, P:MAPK cascade; P:peptidyl-L-cysteine S-palmitoylation; P:protein palmitoylation; P:protein targeting to membrane; scaffold96 indexed_genome mRNA 2877508 2891935 . - . ID=transcript_12702;O75995 A6NCH1 A8K7K8 Q5JZ38,SAM and SH3 domain-containing protein 3,SH3 protein expressed in lymphocytes homolog;, PF07647;PF07653;PF12485;, GO:0005737;GO:0005634;GO:0048873;GO:0002821;GO:0030890;GO:0043372;GO:0002639;GO:0032729;GO:0032733;GO:0032743;GO:0032753;GO:0046622;GO:0002726;GO:0042102;GO:0032760;, C:cytoplasm; C:nucleus;, , P:homeostasis of number of cells within a tissue; P:positive regulation of adaptive immune response; P:positive regulation of B cell proliferation; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; P:positive regulation of immunoglobulin production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-4 production; P:positive regulation of organ growth; P:positive regulation of T cell cytokine production; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; scaffold96 indexed_genome mRNA 2899909 2925460 . - . ID=transcript_12703;O43895 A0AV16 O75994,Xaa-Pro aminopeptidase 2,Aminoacylproline aminopeptidase;Membrane-bound aminopeptidase P;X-Pro aminopeptidase 2;, PF01321;PF00557;PF16188;, GO:0031225;GO:0070062;GO:0005576;GO:0016020;GO:0005886;GO:0004177;GO:0046872;GO:0070006;, C:anchored component of membrane; C:extracellular exosome; C:extracellular region; C:membrane; C:plasma membrane;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; scaffold96 indexed_genome mRNA 3070418 3102285 . - . ID=transcript_12704;Q5JQF1 Q5JQF2 Q9UJG5 Q9UMA5,Inositol polyphosphate 5-phosphatase OCRL {ECO:0000305},Inositol polyphosphate 5-phosphatase OCRL-1;Lowe oculocerebrorenal syndrome protein;Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase;, PF03372;PF16726;PF00620;, GO:0005905;GO:0030136;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005795;GO:0005798;GO:0005764;GO:0016020;GO:0005634;GO:0030670;GO:0001750;GO:0005886;GO:0005802;GO:0005096;GO:0052745;GO:0052659;GO:0052658;GO:0004445;GO:0034485;GO:0004439;GO:0031267;GO:0060271;GO:0046855;GO:0043647;GO:0006629;GO:0061024;GO:0006661;GO:0046856;GO:0043087;GO:0051056;GO:0007165;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:Golgi stack; C:Golgi-associated vesicle; C:lysosome; C:membrane; C:nucleus; C:phagocytic vesicle membrane; C:photoreceptor outer segment; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity; F:inositol phosphate phosphatase activity; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:small GTPase binding;, P:cilium assembly; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:lipid metabolic process; P:membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q5JQF1 Q5JQF2 Q9UJG5 Q9UMA5,Inositol polyphosphate 5-phosphatase OCRL {ECO:0000305},Inositol polyphosphate 5-phosphatase OCRL-1;Lowe oculocerebrorenal syndrome protein;Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase;, PF03372;PF16726;PF00620;, GO:0005905;GO:0030136;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005795;GO:0005798;GO:0005764;GO:0016020;GO:0005634;GO:0030670;GO:0001750;GO:0005886;GO:0005802;GO:0005096;GO:0052745;GO:0052659;GO:0052658;GO:0004445;GO:0034485;GO:0004439;GO:0031267;GO:0060271;GO:0046855;GO:0043647;GO:0006629;GO:0061024;GO:0006661;GO:0046856;GO:0043087;GO:0051056;GO:0007165;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:Golgi stack; C:Golgi-associated vesicle; C:lysosome; C:membrane; C:nucleus; C:phagocytic vesicle membrane; C:photoreceptor outer segment; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity; F:inositol phosphate phosphatase activity; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:small GTPase binding;, P:cilium assembly; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:lipid metabolic process; P:membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold96 indexed_genome mRNA 3102316 3119464 . - . ID=transcript_12705;Q5JQF1 Q5JQF2 Q9UJG5 Q9UMA5,Inositol polyphosphate 5-phosphatase OCRL {ECO:0000305},Inositol polyphosphate 5-phosphatase OCRL-1;Lowe oculocerebrorenal syndrome protein;Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase;, PF03372;PF16726;PF00620;, GO:0005905;GO:0030136;GO:0005737;GO:0005829;GO:0005769;GO:0031901;GO:0005795;GO:0005798;GO:0005764;GO:0016020;GO:0005634;GO:0030670;GO:0001750;GO:0005886;GO:0005802;GO:0005096;GO:0052745;GO:0052659;GO:0052658;GO:0004445;GO:0034485;GO:0004439;GO:0031267;GO:0060271;GO:0046855;GO:0043647;GO:0006629;GO:0061024;GO:0006661;GO:0046856;GO:0043087;GO:0051056;GO:0007165;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:cytosol; C:early endosome; C:early endosome membrane; C:Golgi stack; C:Golgi-associated vesicle; C:lysosome; C:membrane; C:nucleus; C:phagocytic vesicle membrane; C:photoreceptor outer segment; C:plasma membrane; C:trans-Golgi network;, F:GTPase activator activity; F:inositol phosphate phosphatase activity; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:small GTPase binding;, P:cilium assembly; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:lipid metabolic process; P:membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold96 indexed_genome mRNA 3137952 3206703 . + . ID=transcript_12706;P28370 Q5JV41 Q5JV42,Probable global transcription activator SNF2L1,ATP-dependent helicase SMARCA1;Nucleosome-remodeling factor subunit SNF2L;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1;, PF13892;PF09110;PF00271;PF09111;PF00176;, GO:0090537;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0036310;GO:0005524;GO:0003677;GO:0004386;GO:0031491;GO:0070615;GO:0008134;GO:0043044;GO:0007420;GO:0006338;GO:0030182;GO:0045944;GO:0045893;, C:CERF complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex;, F:annealing helicase activity; F:ATP binding; F:DNA binding; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:chromatin remodeling; P:neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated;|P28370 Q5JV41 Q5JV42,Probable global transcription activator SNF2L1,ATP-dependent helicase SMARCA1;Nucleosome-remodeling factor subunit SNF2L;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1;, PF13892;PF09110;PF00271;PF09111;PF00176;, GO:0090537;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0036310;GO:0005524;GO:0003677;GO:0004386;GO:0031491;GO:0070615;GO:0008134;GO:0043044;GO:0007420;GO:0006338;GO:0030182;GO:0045944;GO:0045893;, C:CERF complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex;, F:annealing helicase activity; F:ATP binding; F:DNA binding; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:chromatin remodeling; P:neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated;|P28370 Q5JV41 Q5JV42,Probable global transcription activator SNF2L1,ATP-dependent helicase SMARCA1;Nucleosome-remodeling factor subunit SNF2L;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1;, PF13892;PF09110;PF00271;PF09111;PF00176;, GO:0090537;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0036310;GO:0005524;GO:0003677;GO:0004386;GO:0031491;GO:0070615;GO:0008134;GO:0043044;GO:0007420;GO:0006338;GO:0030182;GO:0045944;GO:0045893;, C:CERF complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex;, F:annealing helicase activity; F:ATP binding; F:DNA binding; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:chromatin remodeling; P:neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated;|P28370 Q5JV41 Q5JV42,Probable global transcription activator SNF2L1,ATP-dependent helicase SMARCA1;Nucleosome-remodeling factor subunit SNF2L;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1;, PF13892;PF09110;PF00271;PF09111;PF00176;, GO:0090537;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0036310;GO:0005524;GO:0003677;GO:0004386;GO:0031491;GO:0070615;GO:0008134;GO:0043044;GO:0007420;GO:0006338;GO:0030182;GO:0045944;GO:0045893;, C:CERF complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex;, F:annealing helicase activity; F:ATP binding; F:DNA binding; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:chromatin remodeling; P:neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated;|P28370 Q5JV41 Q5JV42,Probable global transcription activator SNF2L1,ATP-dependent helicase SMARCA1;Nucleosome-remodeling factor subunit SNF2L;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1;, PF13892;PF09110;PF00271;PF09111;PF00176;, GO:0090537;GO:0043231;GO:0005654;GO:0005634;GO:0016589;GO:0036310;GO:0005524;GO:0003677;GO:0004386;GO:0031491;GO:0070615;GO:0008134;GO:0043044;GO:0007420;GO:0006338;GO:0030182;GO:0045944;GO:0045893;, C:CERF complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:NURF complex;, F:annealing helicase activity; F:ATP binding; F:DNA binding; F:helicase activity; F:nucleosome binding; F:nucleosome-dependent ATPase activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:brain development; P:chromatin remodeling; P:neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; scaffold97 indexed_genome mRNA 64499 162509 . - . ID=transcript_12707;P42680 B7ZKZ6 Q3MIS5,Tyrosine-protein kinase Tec,, PF00779;PF00169;PF07714;PF00017;PF00018;, GO:0005856;GO:0005829;GO:0005886;GO:0005524;GO:0046872;GO:0004715;GO:0005543;GO:0004713;GO:0004714;GO:0002250;GO:0050853;GO:0019221;GO:0038095;GO:0007229;GO:0035556;GO:0038083;GO:0018108;GO:0050731;GO:0006468;GO:0010543;GO:0050852;GO:0042246;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:ATP binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phospholipid binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell receptor signaling pathway; P:cytokine-mediated signaling pathway; P:Fc-epsilon receptor signaling pathway; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein phosphorylation; P:regulation of platelet activation; P:T cell receptor signaling pathway; P:tissue regeneration;|P42680 B7ZKZ6 Q3MIS5,Tyrosine-protein kinase Tec,, PF00779;PF00169;PF07714;PF00017;PF00018;, GO:0005856;GO:0005829;GO:0005886;GO:0005524;GO:0046872;GO:0004715;GO:0005543;GO:0004713;GO:0004714;GO:0002250;GO:0050853;GO:0019221;GO:0038095;GO:0007229;GO:0035556;GO:0038083;GO:0018108;GO:0050731;GO:0006468;GO:0010543;GO:0050852;GO:0042246;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:ATP binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phospholipid binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell receptor signaling pathway; P:cytokine-mediated signaling pathway; P:Fc-epsilon receptor signaling pathway; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein phosphorylation; P:regulation of platelet activation; P:T cell receptor signaling pathway; P:tissue regeneration;|P42680 B7ZKZ6 Q3MIS5,Tyrosine-protein kinase Tec,, PF00779;PF00169;PF07714;PF00017;PF00018;, GO:0005856;GO:0005829;GO:0005886;GO:0005524;GO:0046872;GO:0004715;GO:0005543;GO:0004713;GO:0004714;GO:0002250;GO:0050853;GO:0019221;GO:0038095;GO:0007229;GO:0035556;GO:0038083;GO:0018108;GO:0050731;GO:0006468;GO:0010543;GO:0050852;GO:0042246;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:ATP binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phospholipid binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell receptor signaling pathway; P:cytokine-mediated signaling pathway; P:Fc-epsilon receptor signaling pathway; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein phosphorylation; P:regulation of platelet activation; P:T cell receptor signaling pathway; P:tissue regeneration;|P42680 B7ZKZ6 Q3MIS5,Tyrosine-protein kinase Tec,, PF00779;PF00169;PF07714;PF00017;PF00018;, GO:0005856;GO:0005829;GO:0005886;GO:0005524;GO:0046872;GO:0004715;GO:0005543;GO:0004713;GO:0004714;GO:0002250;GO:0050853;GO:0019221;GO:0038095;GO:0007229;GO:0035556;GO:0038083;GO:0018108;GO:0050731;GO:0006468;GO:0010543;GO:0050852;GO:0042246;, C:cytoskeleton; C:cytosol; C:plasma membrane;, F:ATP binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:phospholipid binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell receptor signaling pathway; P:cytokine-mediated signaling pathway; P:Fc-epsilon receptor signaling pathway; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:protein phosphorylation; P:regulation of platelet activation; P:T cell receptor signaling pathway; P:tissue regeneration; scaffold97 indexed_genome mRNA 275849 348786 . + . ID=transcript_12708;Q9P270 A8K4P1 Q8N5R3,SLAIN motif-containing protein 2,, PF15301;, GO:0005813;GO:0005829;GO:0015630;GO:0031122;GO:0007020;GO:0031116;, C:centrosome; C:cytosol; C:microtubule cytoskeleton;, , P:cytoplasmic microtubule organization; P:microtubule nucleation; P:positive regulation of microtubule polymerization;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9P270 A8K4P1 Q8N5R3,SLAIN motif-containing protein 2,, PF15301;, GO:0005813;GO:0005829;GO:0015630;GO:0031122;GO:0007020;GO:0031116;, C:centrosome; C:cytosol; C:microtubule cytoskeleton;, , P:cytoplasmic microtubule organization; P:microtubule nucleation; P:positive regulation of microtubule polymerization; scaffold97 indexed_genome mRNA 406627 532761 . - . ID=transcript_12709;O94915 O95640 Q8WTZ5 Q9NT40,Protein furry homolog-like,ALL1-fused gene from chromosome 4p12 protein;, PF14225;PF14228;PF14222;, GO:0005938;GO:0030427;GO:0000902;GO:0031175;, C:cell cortex; C:site of polarized growth;, , P:cell morphogenesis; P:neuron projection development;|O94915 O95640 Q8WTZ5 Q9NT40,Protein furry homolog-like,ALL1-fused gene from chromosome 4p12 protein;, PF14225;PF14228;PF14222;, GO:0005938;GO:0030427;GO:0000902;GO:0031175;, C:cell cortex; C:site of polarized growth;, , P:cell morphogenesis; P:neuron projection development;|O94915 O95640 Q8WTZ5 Q9NT40,Protein furry homolog-like,ALL1-fused gene from chromosome 4p12 protein;, PF14225;PF14228;PF14222;, GO:0005938;GO:0030427;GO:0000902;GO:0031175;, C:cell cortex; C:site of polarized growth;, , P:cell morphogenesis; P:neuron projection development;|O94915 O95640 Q8WTZ5 Q9NT40,Protein furry homolog-like,ALL1-fused gene from chromosome 4p12 protein;, PF14225;PF14228;PF14222;, GO:0005938;GO:0030427;GO:0000902;GO:0031175;, C:cell cortex; C:site of polarized growth;, , P:cell morphogenesis; P:neuron projection development;|O94915 O95640 Q8WTZ5 Q9NT40,Protein furry homolog-like,ALL1-fused gene from chromosome 4p12 protein;, PF14225;PF14228;PF14222;, GO:0005938;GO:0030427;GO:0000902;GO:0031175;, C:cell cortex; C:site of polarized growth;, , P:cell morphogenesis; P:neuron projection development;|O94915 O95640 Q8WTZ5 Q9NT40,Protein furry homolog-like,ALL1-fused gene from chromosome 4p12 protein;, PF14225;PF14228;PF14222;, GO:0005938;GO:0030427;GO:0000902;GO:0031175;, C:cell cortex; C:site of polarized growth;, , P:cell morphogenesis; P:neuron projection development;|O94915 O95640 Q8WTZ5 Q9NT40,Protein furry homolog-like,ALL1-fused gene from chromosome 4p12 protein;, PF14225;PF14228;PF14222;, GO:0005938;GO:0030427;GO:0000902;GO:0031175;, C:cell cortex; C:site of polarized growth;, , P:cell morphogenesis; P:neuron projection development; scaffold97 indexed_genome mRNA 711306 734565 . + . ID=transcript_12710;Q9NX40 C9K030 G8JLN7 Q9BZE8,OCIA domain-containing protein 1,Ovarian cancer immunoreactive antigen domain containing 1 {ECO:0000303|PubMed:20515946};Ovarian carcinoma immunoreactive antigen;, PF07051;, GO:0005768;GO:0005794;GO:0005764;GO:0016020;GO:0006897;GO:0061484;GO:0046427;GO:2000736;, C:endosome; C:Golgi apparatus; C:lysosome; C:membrane;, , P:endocytosis; P:hematopoietic stem cell homeostasis; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of stem cell differentiation; scaffold97 indexed_genome mRNA 743300 751200 . - . ID=transcript_12711;Q56VL3 B4DPE7 Q8N544,OCIA domain-containing protein 2,Ovarian carcinoma immunoreactive antigen-like protein;, PF07051;, GO:0005768;GO:0005794;GO:0005764;GO:0006897;GO:0061484;GO:0046427;GO:0009617;, C:endosome; C:Golgi apparatus; C:lysosome;, , P:endocytosis; P:hematopoietic stem cell homeostasis; P:positive regulation of receptor signaling pathway via JAK-STAT; P:response to bacterium;|Q56VL3 B4DPE7 Q8N544,OCIA domain-containing protein 2,Ovarian carcinoma immunoreactive antigen-like protein;, PF07051;, GO:0005768;GO:0005794;GO:0005764;GO:0006897;GO:0061484;GO:0046427;GO:0009617;, C:endosome; C:Golgi apparatus; C:lysosome;, , P:endocytosis; P:hematopoietic stem cell homeostasis; P:positive regulation of receptor signaling pathway via JAK-STAT; P:response to bacterium;|Q56VL3 B4DPE7 Q8N544,OCIA domain-containing protein 2,Ovarian carcinoma immunoreactive antigen-like protein;, PF07051;, GO:0005768;GO:0005794;GO:0005764;GO:0006897;GO:0061484;GO:0046427;GO:0009617;, C:endosome; C:Golgi apparatus; C:lysosome;, , P:endocytosis; P:hematopoietic stem cell homeostasis; P:positive regulation of receptor signaling pathway via JAK-STAT; P:response to bacterium;|Q56VL3 B4DPE7 Q8N544,OCIA domain-containing protein 2,Ovarian carcinoma immunoreactive antigen-like protein;, PF07051;, GO:0005768;GO:0005794;GO:0005764;GO:0006897;GO:0061484;GO:0046427;GO:0009617;, C:endosome; C:Golgi apparatus; C:lysosome;, , P:endocytosis; P:hematopoietic stem cell homeostasis; P:positive regulation of receptor signaling pathway via JAK-STAT; P:response to bacterium; scaffold97 indexed_genome mRNA 933692 1020884 . + . ID=transcript_12712;Q92564 B4DH25 Q7Z3F3 Q7Z6B8,DCN1-like protein 4 {ECO:0000305},DCUN1 domain-containing protein 4;Defective in cullin neddylation protein 1-like protein 4;, PF03556;, GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;, C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation;|Q92564 B4DH25 Q7Z3F3 Q7Z6B8,DCN1-like protein 4 {ECO:0000305},DCUN1 domain-containing protein 4;Defective in cullin neddylation protein 1-like protein 4;, PF03556;, GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;, C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation;|Q92564 B4DH25 Q7Z3F3 Q7Z6B8,DCN1-like protein 4 {ECO:0000305},DCUN1 domain-containing protein 4;Defective in cullin neddylation protein 1-like protein 4;, PF03556;, GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;, C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation;|Q92564 B4DH25 Q7Z3F3 Q7Z6B8,DCN1-like protein 4 {ECO:0000305},DCUN1 domain-containing protein 4;Defective in cullin neddylation protein 1-like protein 4;, PF03556;, GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;, C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation;|Q92564 B4DH25 Q7Z3F3 Q7Z6B8,DCN1-like protein 4 {ECO:0000305},DCUN1 domain-containing protein 4;Defective in cullin neddylation protein 1-like protein 4;, PF03556;, GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;, C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation;|Q92564 B4DH25 Q7Z3F3 Q7Z6B8,DCN1-like protein 4 {ECO:0000305},DCUN1 domain-containing protein 4;Defective in cullin neddylation protein 1-like protein 4;, PF03556;, GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;, C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation; scaffold97 indexed_genome mRNA 1105817 1106944 . - . ID=transcript_12713;Q68CR7,Leucine-rich repeat-containing protein 66,, PF00560;PF13855;, GO:0016021;, C:integral component of membrane; scaffold97 indexed_genome mRNA 1109452 1127479 . - . ID=transcript_12714;Q16585 B7Z635 O00661,Beta-sarcoglycan,43 kDa dystrophin-associated glycoprotein;A3b;, PF04790;, GO:0005737;GO:0005856;GO:0016010;GO:0005887;GO:0016012;GO:0042383;GO:0055013;GO:0048747;GO:0007517;GO:0097084;, C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:integral component of plasma membrane; C:sarcoglycan complex; C:sarcolemma;, , P:cardiac muscle cell development; P:muscle fiber development; P:muscle organ development; P:vascular associated smooth muscle cell development;|Q16585 B7Z635 O00661,Beta-sarcoglycan,43 kDa dystrophin-associated glycoprotein;A3b;, PF04790;, GO:0005737;GO:0005856;GO:0016010;GO:0005887;GO:0016012;GO:0042383;GO:0055013;GO:0048747;GO:0007517;GO:0097084;, C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:integral component of plasma membrane; C:sarcoglycan complex; C:sarcolemma;, , P:cardiac muscle cell development; P:muscle fiber development; P:muscle organ development; P:vascular associated smooth muscle cell development; scaffold97 indexed_genome mRNA 1532698 1540857 . - . ID=transcript_12715;P62068 B7Z3Y7 B7Z675 B7Z7S3 G8ACC7 Q80V95 Q9H7U4 Q9H9T8,Ubiquitin carboxyl-terminal hydrolase 46,Deubiquitinating enzyme 46;Ubiquitin thioesterase 46;Ubiquitin-specific-processing protease 46;, PF00443;, GO:0005829;GO:0098978;GO:0005634;GO:0004197;GO:0046872;GO:0004843;GO:0008343;GO:0001662;GO:0048149;GO:0016579;GO:0099149;GO:0032228;GO:0060013;GO:0006511;, C:cytosol; C:glutamatergic synapse; C:nucleus;, F:cysteine-type endopeptidase activity; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity;, P:adult feeding behavior; P:behavioral fear response; P:behavioral response to ethanol; P:protein deubiquitination; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of synaptic transmission, GABAergic; P:righting reflex; P:ubiquitin-dependent protein catabolic process;|P62068 B7Z3Y7 B7Z675 B7Z7S3 G8ACC7 Q80V95 Q9H7U4 Q9H9T8,Ubiquitin carboxyl-terminal hydrolase 46,Deubiquitinating enzyme 46;Ubiquitin thioesterase 46;Ubiquitin-specific-processing protease 46;, PF00443;, GO:0005829;GO:0098978;GO:0005634;GO:0004197;GO:0046872;GO:0004843;GO:0008343;GO:0001662;GO:0048149;GO:0016579;GO:0099149;GO:0032228;GO:0060013;GO:0006511;, C:cytosol; C:glutamatergic synapse; C:nucleus;, F:cysteine-type endopeptidase activity; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity;, P:adult feeding behavior; P:behavioral fear response; P:behavioral response to ethanol; P:protein deubiquitination; P:regulation of postsynaptic neurotransmitter receptor internalization; P:regulation of synaptic transmission, GABAergic; P:righting reflex; P:ubiquitin-dependent protein catabolic process; scaffold97 indexed_genome mRNA 1749430 1752179 . + . ID=transcript_12716;Q9BPW5 B2RC51 Q96KC5,Ras-like protein family member 11B,, PF00071;, GO:0016020;GO:0005525;GO:0003924;GO:0005160;GO:0030512;GO:0007165;, C:membrane;, F:GTP binding; F:GTPase activity; F:transforming growth factor beta receptor binding;, P:negative regulation of transforming growth factor beta receptor signaling pathway; P:signal transduction;|Q9BPW5 B2RC51 Q96KC5,Ras-like protein family member 11B,, PF00071;, GO:0016020;GO:0005525;GO:0003924;GO:0005160;GO:0030512;GO:0007165;, C:membrane;, F:GTP binding; F:GTPase activity; F:transforming growth factor beta receptor binding;, P:negative regulation of transforming growth factor beta receptor signaling pathway; P:signal transduction; scaffold97 indexed_genome mRNA 1756224 2119850 . - . ID=transcript_12717;Q8WU76 Q8N5F3 Q8N8H0 Q96ED3,Sec1 family domain-containing protein 2,Syntaxin-binding protein 1-like 1;, PF00995;, GO:0005886;GO:0030141;GO:0019905;GO:0006886;GO:0006904;GO:0016192;, C:plasma membrane; C:secretory granule;, F:syntaxin binding;, P:intracellular protein transport; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q8WU76 Q8N5F3 Q8N8H0 Q96ED3,Sec1 family domain-containing protein 2,Syntaxin-binding protein 1-like 1;, PF00995;, GO:0005886;GO:0030141;GO:0019905;GO:0006886;GO:0006904;GO:0016192;, C:plasma membrane; C:secretory granule;, F:syntaxin binding;, P:intracellular protein transport; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q8WU76 Q8N5F3 Q8N8H0 Q96ED3,Sec1 family domain-containing protein 2,Syntaxin-binding protein 1-like 1;, PF00995;, GO:0005886;GO:0030141;GO:0019905;GO:0006886;GO:0006904;GO:0016192;, C:plasma membrane; C:secretory granule;, F:syntaxin binding;, P:intracellular protein transport; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport; scaffold97 indexed_genome mRNA 2127201 2292572 . - . ID=transcript_12718;Q9H077,Pre-mRNA 3'-end-processing factor FIP1,FIP1-like 1 protein;Factor interacting with PAP;Rearranged in hypereosinophilia;, PF05182;, GO:0005829;GO:0005847;GO:0005654;GO:0003723;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0098789;GO:0006369;, C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription;|Q9H077,Pre-mRNA 3'-end-processing factor FIP1,FIP1-like 1 protein;Factor interacting with PAP;Rearranged in hypereosinophilia;, PF05182;, GO:0005829;GO:0005847;GO:0005654;GO:0003723;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0098789;GO:0006369;, C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription;|Q8TBB1 Q4W5K7 Q8N4C2 Q96MJ7 Q9BY20,E3 ubiquitin-protein ligase LNX,Ligand of Numb-protein X 1;Numb-binding protein 1;PDZ domain-containing RING finger protein 2;RING-type E3 ubiquitin transferase LNX {ECO:0000305};, PF00595;, GO:0005737;GO:0042802;GO:0046872;GO:0030165;GO:0004842;GO:0006511;, C:cytoplasm;, F:identical protein binding; F:metal ion binding; F:PDZ domain binding; F:ubiquitin-protein transferase activity;, P:ubiquitin-dependent protein catabolic process;|Q8TBB1 Q4W5K7 Q8N4C2 Q96MJ7 Q9BY20,E3 ubiquitin-protein ligase LNX,Ligand of Numb-protein X 1;Numb-binding protein 1;PDZ domain-containing RING finger protein 2;RING-type E3 ubiquitin transferase LNX {ECO:0000305};, PF00595;, GO:0005737;GO:0042802;GO:0046872;GO:0030165;GO:0004842;GO:0006511;, C:cytoplasm;, F:identical protein binding; F:metal ion binding; F:PDZ domain binding; F:ubiquitin-protein transferase activity;, P:ubiquitin-dependent protein catabolic process;|Q8TBB1 Q4W5K7 Q8N4C2 Q96MJ7 Q9BY20,E3 ubiquitin-protein ligase LNX,Ligand of Numb-protein X 1;Numb-binding protein 1;PDZ domain-containing RING finger protein 2;RING-type E3 ubiquitin transferase LNX {ECO:0000305};, PF00595;, GO:0005737;GO:0042802;GO:0046872;GO:0030165;GO:0004842;GO:0006511;, C:cytoplasm;, F:identical protein binding; F:metal ion binding; F:PDZ domain binding; F:ubiquitin-protein transferase activity;, P:ubiquitin-dependent protein catabolic process;|Q8TBB1 Q4W5K7 Q8N4C2 Q96MJ7 Q9BY20,E3 ubiquitin-protein ligase LNX,Ligand of Numb-protein X 1;Numb-binding protein 1;PDZ domain-containing RING finger protein 2;RING-type E3 ubiquitin transferase LNX {ECO:0000305};, PF00595;, GO:0005737;GO:0042802;GO:0046872;GO:0030165;GO:0004842;GO:0006511;, C:cytoplasm;, F:identical protein binding; F:metal ion binding; F:PDZ domain binding; F:ubiquitin-protein transferase activity;, P:ubiquitin-dependent protein catabolic process; scaffold97 indexed_genome mRNA 2300869 2385899 . - . ID=transcript_12719;Q8TBB1 Q4W5K7 Q8N4C2 Q96MJ7 Q9BY20,E3 ubiquitin-protein ligase LNX,Ligand of Numb-protein X 1;Numb-binding protein 1;PDZ domain-containing RING finger protein 2;RING-type E3 ubiquitin transferase LNX {ECO:0000305};, PF00595;, GO:0005737;GO:0042802;GO:0046872;GO:0030165;GO:0004842;GO:0006511;, C:cytoplasm;, F:identical protein binding; F:metal ion binding; F:PDZ domain binding; F:ubiquitin-protein transferase activity;, P:ubiquitin-dependent protein catabolic process; scaffold97 indexed_genome mRNA 2709283 2762897 . - . ID=transcript_12720;Q9UKJ5 B2R639,Cysteine-rich hydrophobic domain-containing protein 2,BrX-like translocated in leukemia;, PF10256;, GO:0005794;GO:0005798;GO:0043231;GO:0005886;, C:Golgi apparatus; C:Golgi-associated vesicle; C:intracellular membrane-bounded organelle; C:plasma membrane; scaffold97 indexed_genome mRNA 2793640 2794306 . - . ID=transcript_12721;Q9BZM3,GS homeobox 2,Genetic-screened homeobox 2;Homeobox protein GSH-2;, PF00046;, GO:0000785;GO:0005737;GO:0005634;GO:0000981;GO:1990837;GO:0021798;GO:0048853;GO:0021575;GO:0048665;GO:0021889;GO:0045747;GO:0048714;GO:0030334;GO:0002087;GO:0021527;GO:0060163;GO:0021978;, C:chromatin; C:cytoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding;, P:forebrain dorsal/ventral pattern formation; P:forebrain morphogenesis; P:hindbrain morphogenesis; P:neuron fate specification; P:olfactory bulb interneuron differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of oligodendrocyte differentiation; P:regulation of cell migration; P:regulation of respiratory gaseous exchange by nervous system process; P:spinal cord association neuron differentiation; P:subpallium neuron fate commitment; P:telencephalon regionalization; scaffold97 indexed_genome mRNA 2884401 2933409 . + . ID=transcript_12722;P16234 B2RE69 E9PBH0 Q6P4H5 Q96KZ7 Q9UD28,Platelet-derived growth factor receptor alpha,Alpha platelet-derived growth factor receptor;Alpha-type platelet-derived growth factor receptor;CD140 antigen-like family member A;CD140a antigen;Platelet-derived growth factor alpha receptor;Platelet-derived growth factor receptor 2;, PF07679;PF07714;, GO:0030054;GO:0005929;GO:0005737;GO:0005789;GO:0009897;GO:0005794;GO:0005887;GO:0031226;GO:0016020;GO:0005902;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0043235;GO:0005524;GO:0019838;GO:0005018;GO:0048407;GO:0005161;GO:0042803;GO:0004672;GO:0044877;GO:0004714;GO:0038085;GO:0005021;GO:0030325;GO:0055003;GO:0001775;GO:0060326;GO:0071230;GO:0034614;GO:0048701;GO:0048557;GO:0048704;GO:0008210;GO:0030198;GO:0060325;GO:0002244;GO:0001701;GO:0033327;GO:0030324;GO:0001553;GO:0030539;GO:0000165;GO:0072277;GO:0007275;GO:0010544;GO:0042475;GO:0018108;GO:0048015;GO:0070527;GO:0048008;GO:0035790;GO:0030335;GO:0008284;GO:0038091;GO:0007204;GO:0070374;GO:0048146;GO:0033674;GO:0043552;GO:0014068;GO:0010863;GO:0051897;GO:0046777;GO:2000249;GO:0050920;GO:2000739;GO:0061298;GO:0060021;GO:0023019;GO:0007169;GO:0016032;GO:0050872;GO:0042060;, C:cell junction; C:cilium; C:cytoplasm; C:endoplasmic reticulum membrane; C:external side of plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:membrane; C:microvillus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:receptor complex;, F:ATP binding; F:growth factor binding; F:platelet-derived growth factor alpha-receptor activity; F:platelet-derived growth factor binding; F:platelet-derived growth factor receptor binding; F:protein homodimerization activity; F:protein kinase activity; F:protein-containing complex binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor binding; F:vascular endothelial growth factor-activated receptor activity;, P:adrenal gland development; P:cardiac myofibril assembly; P:cell activation; P:cell chemotaxis; P:cellular response to amino acid stimulus; P:cellular response to reactive oxygen species; P:embryonic cranial skeleton morphogenesis; P:embryonic digestive tract morphogenesis; P:embryonic skeletal system morphogenesis; P:estrogen metabolic process; P:extracellular matrix organization; P:face morphogenesis; P:hematopoietic progenitor cell differentiation; P:in utero embryonic development; P:Leydig cell differentiation; P:lung development; P:luteinization; P:male genitalia development; P:MAPK cascade; P:metanephric glomerular capillary formation; P:multicellular organism development; P:negative regulation of platelet activation; P:odontogenesis of dentin-containing tooth; P:peptidyl-tyrosine phosphorylation; P:phosphatidylinositol-mediated signaling; P:platelet aggregation; P:platelet-derived growth factor receptor signaling pathway; P:platelet-derived growth factor receptor-alpha signaling pathway; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of kinase activity; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:protein autophosphorylation; P:regulation of actin cytoskeleton reorganization; P:regulation of chemotaxis; P:regulation of mesenchymal stem cell differentiation; P:retina vasculature development in camera-type eye; P:roof of mouth development; P:signal transduction involved in regulation of gene expression; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral process; P:white fat cell differentiation; P:wound healing; scaffold97 indexed_genome mRNA 3316838 3363477 . + . ID=transcript_12723;P10721 B5A956 D5LXN2 D5M931 F5H8F8 Q6IQ28 Q99662 Q9UM99,Mast/stem cell growth factor receptor Kit,Piebald trait protein;Proto-oncogene c-Kit;Tyrosine-protein kinase Kit;p145 c-kit;v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog;, PF00047;PF07714;, GO:0001669;GO:0005911;GO:0009898;GO:0009897;GO:0005615;GO:0001650;GO:0005887;GO:0005886;GO:0043235;GO:0005524;GO:0019955;GO:0046872;GO:0002020;GO:0042803;GO:0004713;GO:0042169;GO:0005020;GO:0004714;GO:0031532;GO:0000187;GO:0030183;GO:0060326;GO:0097067;GO:0019221;GO:0050910;GO:0048565;GO:0035234;GO:0035162;GO:0050673;GO:0030218;GO:0038162;GO:0038093;GO:0008354;GO:0006687;GO:0002244;GO:0035701;GO:0030097;GO:0002327;GO:0006954;GO:0038109;GO:0030032;GO:0002320;GO:0008584;GO:0000165;GO:0002551;GO:0043303;GO:0060374;GO:0070662;GO:0035855;GO:0097326;GO:0030318;GO:0097324;GO:0007275;GO:0002318;GO:0043069;GO:0001541;GO:0018108;GO:0043473;GO:0030335;GO:0008284;GO:1904343;GO:0002732;GO:0051091;GO:0033674;GO:0048170;GO:0043406;GO:0043410;GO:0032765;GO:0045747;GO:0043552;GO:0014068;GO:0010863;GO:0051897;GO:0031274;GO:0120072;GO:0046427;GO:1904349;GO:0042531;GO:1905065;GO:0046777;GO:1904251;GO:0042127;GO:0008360;GO:0006357;GO:0046686;GO:0007165;GO:0048103;GO:0035019;GO:0007286;GO:0007283;GO:0048863;GO:0019827;GO:0030217;GO:0043586;GO:0007169;GO:0008542;, C:acrosomal vesicle; C:cell-cell junction; C:cytoplasmic side of plasma membrane; C:external side of plasma membrane; C:extracellular space; C:fibrillar center; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:cytokine binding; F:metal ion binding; F:protease binding; F:protein homodimerization activity; F:protein tyrosine kinase activity; F:SH2 domain binding; F:stem cell factor receptor activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton reorganization; P:activation of MAPK activity; P:B cell differentiation; P:cell chemotaxis; P:cellular response to thyroid hormone stimulus; P:cytokine-mediated signaling pathway; P:detection of mechanical stimulus involved in sensory perception of sound; P:digestive tract development; P:ectopic germ cell programmed cell death; P:embryonic hemopoiesis; P:epithelial cell proliferation; P:erythrocyte differentiation; P:erythropoietin-mediated signaling pathway; P:Fc receptor signaling pathway; P:germ cell migration; P:glycosphingolipid metabolic process; P:hematopoietic progenitor cell differentiation; P:hematopoietic stem cell migration; P:hemopoiesis; P:immature B cell differentiation; P:inflammatory response; P:Kit signaling pathway; P:lamellipodium assembly; P:lymphoid progenitor cell differentiation; P:male gonad development; P:MAPK cascade; P:mast cell chemotaxis; P:mast cell degranulation; P:mast cell differentiation; P:mast cell proliferation; P:megakaryocyte development; P:melanocyte adhesion; P:melanocyte differentiation; P:melanocyte migration; P:multicellular organism development; P:myeloid progenitor cell differentiation; P:negative regulation of programmed cell death; P:ovarian follicle development; P:peptidyl-tyrosine phosphorylation; P:pigmentation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of colon smooth muscle contraction; P:positive regulation of dendritic cell cytokine production; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of kinase activity; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mast cell cytokine production; P:positive regulation of Notch signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phospholipase C activity; P:positive regulation of protein kinase B signaling; P:positive regulation of pseudopodium assembly; P:positive regulation of pyloric antrum smooth muscle contraction; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of small intestine smooth muscle contraction; P:positive regulation of tyrosine phosphorylation of STAT protein; P:positive regulation of vascular associated smooth muscle cell differentiation; P:protein autophosphorylation; P:regulation of bile acid metabolic process; P:regulation of cell population proliferation; P:regulation of cell shape; P:regulation of transcription by RNA polymerase II; P:response to cadmium ion; P:signal transduction; P:somatic stem cell division; P:somatic stem cell population maintenance; P:spermatid development; P:spermatogenesis; P:stem cell differentiation; P:stem cell population maintenance; P:T cell differentiation; P:tongue development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:visual learning; scaffold97 indexed_genome mRNA 3657368 3702746 . - . ID=transcript_12724;P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178,Vascular endothelial growth factor receptor 2 {ECO:0000305},Fetal liver kinase 1;Kinase insert domain receptor;Protein-tyrosine kinase receptor flk-1;, PF07679;PF00047;PF07714;PF17988;, GO:0030054;GO:0005769;GO:0005783;GO:0005768;GO:0005576;GO:0005794;GO:0005887;GO:0045121;GO:0005634;GO:0005886;GO:0043235;GO:0097443;GO:0005524;GO:0045296;GO:0019838;GO:0051879;GO:0042802;GO:0005178;GO:0004713;GO:0004714;GO:0038085;GO:0005021;GO:0001525;GO:0001569;GO:0035584;GO:0016477;GO:0002042;GO:1904881;GO:0035924;GO:0035162;GO:0045446;GO:0003158;GO:0070371;GO:0030198;GO:0002244;GO:0007275;GO:0043066;GO:2000352;GO:0010629;GO:0038083;GO:0018108;GO:0045766;GO:0043536;GO:0030335;GO:0090050;GO:0008284;GO:0038033;GO:0010595;GO:0001938;GO:0070374;GO:0051894;GO:0033674;GO:0016239;GO:0043410;GO:0051901;GO:0090141;GO:0051770;GO:0014068;GO:0050927;GO:0001934;GO:2001214;GO:0046777;GO:0043491;GO:0008360;GO:0007169;GO:0048010;GO:0036324;GO:0038084;GO:0061042;GO:0001570;GO:0016032;, C:cell junction; C:early endosome; C:endoplasmic reticulum; C:endosome; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:receptor complex; C:sorting endosome;, F:ATP binding; F:cadherin binding; F:growth factor binding; F:Hsp90 protein binding; F:identical protein binding; F:integrin binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor binding; F:vascular endothelial growth factor-activated receptor activity;, P:angiogenesis; P:branching involved in blood vessel morphogenesis; P:calcium-mediated signaling using intracellular calcium source; P:cell migration; P:cell migration involved in sprouting angiogenesis; P:cellular response to hydrogen sulfide; P:cellular response to vascular endothelial growth factor stimulus; P:embryonic hemopoiesis; P:endothelial cell differentiation; P:endothelium development; P:ERK1 and ERK2 cascade; P:extracellular matrix organization; P:hematopoietic progenitor cell differentiation; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of gene expression; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of kinase activity; P:positive regulation of macroautophagy; P:positive regulation of MAPK cascade; P:positive regulation of mitochondrial depolarization; P:positive regulation of mitochondrial fission; P:positive regulation of nitric-oxide synthase biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of positive chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of vasculogenesis; P:protein autophosphorylation; P:protein kinase B signaling; P:regulation of cell shape; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor receptor-2 signaling pathway; P:vascular endothelial growth factor signaling pathway; P:vascular wound healing; P:vasculogenesis; P:viral process; scaffold97 indexed_genome mRNA 3895117 3898559 . + . ID=transcript_12725;Q9H8P0 Q4W5Q6,Polyprenol reductase {ECO:0000305},3-oxo-5-alpha-steroid 4-dehydrogenase 3;Steroid 5-alpha-reductase 2-like;Steroid 5-alpha-reductase 3;, PF02544;, GO:0005783;GO:0005789;GO:0016021;GO:0003865;GO:0047751;GO:0016628;GO:0102389;GO:0006702;GO:0019408;GO:0019348;GO:0006488;GO:0006489;GO:0016095;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; F:cholestenone 5-alpha-reductase activity; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; F:polyprenol reductase activity;, P:androgen biosynthetic process; P:dolichol biosynthetic process; P:dolichol metabolic process; P:dolichol-linked oligosaccharide biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:polyprenol catabolic process;|Q9H8P0 Q4W5Q6,Polyprenol reductase {ECO:0000305},3-oxo-5-alpha-steroid 4-dehydrogenase 3;Steroid 5-alpha-reductase 2-like;Steroid 5-alpha-reductase 3;, PF02544;, GO:0005783;GO:0005789;GO:0016021;GO:0003865;GO:0047751;GO:0016628;GO:0102389;GO:0006702;GO:0019408;GO:0019348;GO:0006488;GO:0006489;GO:0016095;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; F:cholestenone 5-alpha-reductase activity; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; F:polyprenol reductase activity;, P:androgen biosynthetic process; P:dolichol biosynthetic process; P:dolichol metabolic process; P:dolichol-linked oligosaccharide biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:polyprenol catabolic process; scaffold97 indexed_genome mRNA 3920596 3947249 . + . ID=transcript_12726;Q9HC07 A8K3P8 B4DHW1 Q9BTN9 Q9NZ34,Transmembrane protein 165,Transmembrane protein PT27;Transmembrane protein TPARL;, PF01169;, GO:0031901;GO:0010008;GO:0005794;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0032588;GO:0015085;GO:0005384;GO:0046873;GO:0070588;GO:0006874;GO:0032468;GO:0032472;GO:0071421;GO:0006487;GO:0035751;, C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:trans-Golgi network membrane;, F:calcium ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:metal ion transmembrane transporter activity;, P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:Golgi calcium ion homeostasis; P:Golgi calcium ion transport; P:manganese ion transmembrane transport; P:protein N-linked glycosylation; P:regulation of lysosomal lumen pH;|Q9HC07 A8K3P8 B4DHW1 Q9BTN9 Q9NZ34,Transmembrane protein 165,Transmembrane protein PT27;Transmembrane protein TPARL;, PF01169;, GO:0031901;GO:0010008;GO:0005794;GO:0016021;GO:0043231;GO:0031902;GO:0005765;GO:0032588;GO:0015085;GO:0005384;GO:0046873;GO:0070588;GO:0006874;GO:0032468;GO:0032472;GO:0071421;GO:0006487;GO:0035751;, C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:lysosomal membrane; C:trans-Golgi network membrane;, F:calcium ion transmembrane transporter activity; F:manganese ion transmembrane transporter activity; F:metal ion transmembrane transporter activity;, P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:Golgi calcium ion homeostasis; P:Golgi calcium ion transport; P:manganese ion transmembrane transport; P:protein N-linked glycosylation; P:regulation of lysosomal lumen pH; scaffold97 indexed_genome mRNA 3955785 4011343 . - . ID=transcript_12727;O15516 A0AV01 A2I2N9 O14516 Q9UIT8,Circadian locomoter output cycles protein kaput,Class E basic helix-loop-helix protein 8;, PF00010;PF00989;, GO:0000785;GO:0033391;GO:0005694;GO:1990513;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0005667;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0004402;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0071479;GO:0032922;GO:0007623;GO:0000077;GO:2000323;GO:0045892;GO:0009648;GO:0050729;GO:0051092;GO:0045944;GO:0045893;GO:0043161;GO:0006473;GO:0042752;GO:0042634;GO:0050796;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007165;GO:0007283;, C:chromatin; C:chromatoid body; C:chromosome; C:CLOCK-BMAL transcription complex; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:histone acetyltransferase activity; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to ionizing radiation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA damage checkpoint; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of transcription, DNA-templated; P:photoperiodism; P:positive regulation of inflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein acetylation; P:regulation of circadian rhythm; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:signal transduction; P:spermatogenesis;|O15516 A0AV01 A2I2N9 O14516 Q9UIT8,Circadian locomoter output cycles protein kaput,Class E basic helix-loop-helix protein 8;, PF00010;PF00989;, GO:0000785;GO:0033391;GO:0005694;GO:1990513;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0005667;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0004402;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0071479;GO:0032922;GO:0007623;GO:0000077;GO:2000323;GO:0045892;GO:0009648;GO:0050729;GO:0051092;GO:0045944;GO:0045893;GO:0043161;GO:0006473;GO:0042752;GO:0042634;GO:0050796;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007165;GO:0007283;, C:chromatin; C:chromatoid body; C:chromosome; C:CLOCK-BMAL transcription complex; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:histone acetyltransferase activity; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to ionizing radiation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA damage checkpoint; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of transcription, DNA-templated; P:photoperiodism; P:positive regulation of inflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein acetylation; P:regulation of circadian rhythm; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:signal transduction; P:spermatogenesis;|O15516 A0AV01 A2I2N9 O14516 Q9UIT8,Circadian locomoter output cycles protein kaput,Class E basic helix-loop-helix protein 8;, PF00010;PF00989;, GO:0000785;GO:0033391;GO:0005694;GO:1990513;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0005667;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0004402;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0071479;GO:0032922;GO:0007623;GO:0000077;GO:2000323;GO:0045892;GO:0009648;GO:0050729;GO:0051092;GO:0045944;GO:0045893;GO:0043161;GO:0006473;GO:0042752;GO:0042634;GO:0050796;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007165;GO:0007283;, C:chromatin; C:chromatoid body; C:chromosome; C:CLOCK-BMAL transcription complex; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:histone acetyltransferase activity; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to ionizing radiation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA damage checkpoint; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of transcription, DNA-templated; P:photoperiodism; P:positive regulation of inflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein acetylation; P:regulation of circadian rhythm; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:signal transduction; P:spermatogenesis; scaffold97 indexed_genome mRNA 4011351 4087153 . - . ID=transcript_12728;O15516 A0AV01 A2I2N9 O14516 Q9UIT8,Circadian locomoter output cycles protein kaput,Class E basic helix-loop-helix protein 8;, PF00010;PF00989;, GO:0000785;GO:0033391;GO:0005694;GO:1990513;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0005667;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0004402;GO:0046983;GO:0000978;GO:0043565;GO:1990837;GO:0071479;GO:0032922;GO:0007623;GO:0000077;GO:2000323;GO:0045892;GO:0009648;GO:0050729;GO:0051092;GO:0045944;GO:0045893;GO:0043161;GO:0006473;GO:0042752;GO:0042634;GO:0050796;GO:0006357;GO:0006355;GO:2000074;GO:0051775;GO:0007165;GO:0007283;, C:chromatin; C:chromatoid body; C:chromosome; C:CLOCK-BMAL transcription complex; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:histone acetyltransferase activity; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to ionizing radiation; P:circadian regulation of gene expression; P:circadian rhythm; P:DNA damage checkpoint; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of transcription, DNA-templated; P:photoperiodism; P:positive regulation of inflammatory response; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein acetylation; P:regulation of circadian rhythm; P:regulation of hair cycle; P:regulation of insulin secretion; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:regulation of type B pancreatic cell development; P:response to redox state; P:signal transduction; P:spermatogenesis; scaffold97 indexed_genome mRNA 4373203 4430023 . + . ID=transcript_12729;Q9NV70 Q504V4 Q8WUE7 Q96T15 Q9NZE4,Exocyst complex component 1,Exocyst complex component Sec3;, PF15277;PF09763;, GO:0005737;GO:0098592;GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0048471;GO:0005886;GO:0005546;GO:0060271;GO:0051607;GO:0006887;GO:0006893;GO:0048015;GO:0050714;GO:0015031;GO:0016241;GO:0016032;, C:cytoplasm; C:cytoplasmic side of apical plasma membrane; C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:phosphatidylinositol-4,5-bisphosphate binding;, P:cilium assembly; P:defense response to virus; P:exocytosis; P:Golgi to plasma membrane transport; P:phosphatidylinositol-mediated signaling; P:positive regulation of protein secretion; P:protein transport; P:regulation of macroautophagy; P:viral process;|Q9NV70 Q504V4 Q8WUE7 Q96T15 Q9NZE4,Exocyst complex component 1,Exocyst complex component Sec3;, PF15277;PF09763;, GO:0005737;GO:0098592;GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0048471;GO:0005886;GO:0005546;GO:0060271;GO:0051607;GO:0006887;GO:0006893;GO:0048015;GO:0050714;GO:0015031;GO:0016241;GO:0016032;, C:cytoplasm; C:cytoplasmic side of apical plasma membrane; C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:phosphatidylinositol-4,5-bisphosphate binding;, P:cilium assembly; P:defense response to virus; P:exocytosis; P:Golgi to plasma membrane transport; P:phosphatidylinositol-mediated signaling; P:positive regulation of protein secretion; P:protein transport; P:regulation of macroautophagy; P:viral process;|Q9NV70 Q504V4 Q8WUE7 Q96T15 Q9NZE4,Exocyst complex component 1,Exocyst complex component Sec3;, PF15277;PF09763;, GO:0005737;GO:0098592;GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0048471;GO:0005886;GO:0005546;GO:0060271;GO:0051607;GO:0006887;GO:0006893;GO:0048015;GO:0050714;GO:0015031;GO:0016241;GO:0016032;, C:cytoplasm; C:cytoplasmic side of apical plasma membrane; C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:phosphatidylinositol-4,5-bisphosphate binding;, P:cilium assembly; P:defense response to virus; P:exocytosis; P:Golgi to plasma membrane transport; P:phosphatidylinositol-mediated signaling; P:positive regulation of protein secretion; P:protein transport; P:regulation of macroautophagy; P:viral process;|Q9NV70 Q504V4 Q8WUE7 Q96T15 Q9NZE4,Exocyst complex component 1,Exocyst complex component Sec3;, PF15277;PF09763;, GO:0005737;GO:0098592;GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0048471;GO:0005886;GO:0005546;GO:0060271;GO:0051607;GO:0006887;GO:0006893;GO:0048015;GO:0050714;GO:0015031;GO:0016241;GO:0016032;, C:cytoplasm; C:cytoplasmic side of apical plasma membrane; C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:phosphatidylinositol-4,5-bisphosphate binding;, P:cilium assembly; P:defense response to virus; P:exocytosis; P:Golgi to plasma membrane transport; P:phosphatidylinositol-mediated signaling; P:positive regulation of protein secretion; P:protein transport; P:regulation of macroautophagy; P:viral process;|Q9NV70 Q504V4 Q8WUE7 Q96T15 Q9NZE4,Exocyst complex component 1,Exocyst complex component Sec3;, PF15277;PF09763;, GO:0005737;GO:0098592;GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0048471;GO:0005886;GO:0005546;GO:0060271;GO:0051607;GO:0006887;GO:0006893;GO:0048015;GO:0050714;GO:0015031;GO:0016241;GO:0016032;, C:cytoplasm; C:cytoplasmic side of apical plasma membrane; C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:phosphatidylinositol-4,5-bisphosphate binding;, P:cilium assembly; P:defense response to virus; P:exocytosis; P:Golgi to plasma membrane transport; P:phosphatidylinositol-mediated signaling; P:positive regulation of protein secretion; P:protein transport; P:regulation of macroautophagy; P:viral process; scaffold97 indexed_genome mRNA 4469855 4508444 . - . ID=transcript_12730;Q66GS9 B2RMY0 O75130 Q58F25 Q9H8H7,Centrosomal protein of 135 kDa {ECO:0000305},Centrosomal protein 4;, , GO:0005814;GO:0005813;GO:0005829;GO:0008022;GO:0007099;GO:0010457;GO:0097711;GO:0000086;GO:1904951;GO:1902857;GO:0010389;, C:centriole; C:centrosome; C:cytosol;, F:protein C-terminus binding;, P:centriole replication; P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:positive regulation of establishment of protein localization; P:positive regulation of non-motile cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; scaffold97 indexed_genome mRNA 4515747 4541870 . + . ID=transcript_12731;Q66GS9 B2RMY0 O75130 Q58F25 Q9H8H7,Centrosomal protein of 135 kDa {ECO:0000305},Centrosomal protein 4;, , GO:0005814;GO:0005813;GO:0005829;GO:0008022;GO:0007099;GO:0010457;GO:0097711;GO:0000086;GO:1904951;GO:1902857;GO:0010389;, C:centriole; C:centrosome; C:cytosol;, F:protein C-terminus binding;, P:centriole replication; P:centriole-centriole cohesion; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:positive regulation of establishment of protein localization; P:positive regulation of non-motile cilium assembly; P:regulation of G2/M transition of mitotic cell cycle; scaffold98 indexed_genome mRNA 288340 317580 . + . ID=transcript_12732;P35916 A8K6L4 B5A926 Q16067 Q86W07 Q86W08,Vascular endothelial growth factor receptor 3,Fms-like tyrosine kinase 4;Tyrosine-protein kinase receptor FLT4;, PF07679;PF07714;PF17988;, GO:0005829;GO:0005576;GO:0005887;GO:0005654;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042803;GO:0019903;GO:0004714;GO:0005021;GO:0048514;GO:0035924;GO:0002244;GO:0048286;GO:0001945;GO:0001946;GO:0007275;GO:0043066;GO:0018108;GO:0008284;GO:0010595;GO:0001938;GO:0070374;GO:0046330;GO:0033674;GO:0043410;GO:0090037;GO:0001934;GO:0010575;GO:0046777;GO:0060312;GO:0003016;GO:0002040;GO:0007169;GO:0048010;GO:0038084;GO:0001944;, C:cytosol; C:extracellular region; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:protein homodimerization activity; F:protein phosphatase binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor-activated receptor activity;, P:blood vessel morphogenesis; P:cellular response to vascular endothelial growth factor stimulus; P:hematopoietic progenitor cell differentiation; P:lung alveolus development; P:lymph vessel development; P:lymphangiogenesis; P:multicellular organism development; P:negative regulation of apoptotic process; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of JNK cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of protein kinase C signaling; P:positive regulation of protein phosphorylation; P:positive regulation of vascular endothelial growth factor production; P:protein autophosphorylation; P:regulation of blood vessel remodeling; P:respiratory system process; P:sprouting angiogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor signaling pathway; P:vasculature development; scaffold98 indexed_genome mRNA 318605 329187 . + . ID=transcript_12733;P35916 A8K6L4 B5A926 Q16067 Q86W07 Q86W08,Vascular endothelial growth factor receptor 3,Fms-like tyrosine kinase 4;Tyrosine-protein kinase receptor FLT4;, PF07679;PF07714;PF17988;, GO:0005829;GO:0005576;GO:0005887;GO:0005654;GO:0005886;GO:0043235;GO:0005524;GO:0019838;GO:0042803;GO:0019903;GO:0004714;GO:0005021;GO:0048514;GO:0035924;GO:0002244;GO:0048286;GO:0001945;GO:0001946;GO:0007275;GO:0043066;GO:0018108;GO:0008284;GO:0010595;GO:0001938;GO:0070374;GO:0046330;GO:0033674;GO:0043410;GO:0090037;GO:0001934;GO:0010575;GO:0046777;GO:0060312;GO:0003016;GO:0002040;GO:0007169;GO:0048010;GO:0038084;GO:0001944;, C:cytosol; C:extracellular region; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:ATP binding; F:growth factor binding; F:protein homodimerization activity; F:protein phosphatase binding; F:transmembrane receptor protein tyrosine kinase activity; F:vascular endothelial growth factor-activated receptor activity;, P:blood vessel morphogenesis; P:cellular response to vascular endothelial growth factor stimulus; P:hematopoietic progenitor cell differentiation; P:lung alveolus development; P:lymph vessel development; P:lymphangiogenesis; P:multicellular organism development; P:negative regulation of apoptotic process; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of JNK cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of protein kinase C signaling; P:positive regulation of protein phosphorylation; P:positive regulation of vascular endothelial growth factor production; P:protein autophosphorylation; P:regulation of blood vessel remodeling; P:respiratory system process; P:sprouting angiogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor signaling pathway; P:vasculature development; scaffold98 indexed_genome mRNA 366651 444536 . - . ID=transcript_12734;Q9ULM6 A7MD46 D3DWR0,CCR4-NOT transcription complex subunit 6,CCR4 carbon catabolite repression 4-like;Carbon catabolite repressor protein 4 homolog;Cytoplasmic deadenylase;, PF03372;PF13855;, GO:0030014;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0000175;GO:0004532;GO:0046872;GO:0030374;GO:0004535;GO:0003723;GO:0006977;GO:0043928;GO:0035195;GO:0070966;GO:0000289;GO:0008284;GO:0010606;GO:0006417;, C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:3'-5'-exoribonuclease activity; F:exoribonuclease activity; F:metal ion binding; F:nuclear receptor coactivator activity; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:exonucleolytic catabolism of deadenylated mRNA; P:gene silencing by miRNA; P:nuclear-transcribed mRNA catabolic process, no-go decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cell population proliferation; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of translation;|Q9ULM6 A7MD46 D3DWR0,CCR4-NOT transcription complex subunit 6,CCR4 carbon catabolite repression 4-like;Carbon catabolite repressor protein 4 homolog;Cytoplasmic deadenylase;, PF03372;PF13855;, GO:0030014;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0000175;GO:0004532;GO:0046872;GO:0030374;GO:0004535;GO:0003723;GO:0006977;GO:0043928;GO:0035195;GO:0070966;GO:0000289;GO:0008284;GO:0010606;GO:0006417;, C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:3'-5'-exoribonuclease activity; F:exoribonuclease activity; F:metal ion binding; F:nuclear receptor coactivator activity; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:exonucleolytic catabolism of deadenylated mRNA; P:gene silencing by miRNA; P:nuclear-transcribed mRNA catabolic process, no-go decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cell population proliferation; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of translation;|Q9ULM6 A7MD46 D3DWR0,CCR4-NOT transcription complex subunit 6,CCR4 carbon catabolite repression 4-like;Carbon catabolite repressor protein 4 homolog;Cytoplasmic deadenylase;, PF03372;PF13855;, GO:0030014;GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0000175;GO:0004532;GO:0046872;GO:0030374;GO:0004535;GO:0003723;GO:0006977;GO:0043928;GO:0035195;GO:0070966;GO:0000289;GO:0008284;GO:0010606;GO:0006417;, C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:membrane; C:nucleus;, F:3'-5'-exoribonuclease activity; F:exoribonuclease activity; F:metal ion binding; F:nuclear receptor coactivator activity; F:poly(A)-specific ribonuclease activity; F:RNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:exonucleolytic catabolism of deadenylated mRNA; P:gene silencing by miRNA; P:nuclear-transcribed mRNA catabolic process, no-go decay; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cell population proliferation; P:positive regulation of cytoplasmic mRNA processing body assembly; P:regulation of translation; scaffold98 indexed_genome mRNA 630881 673545 . + . ID=transcript_12735;O94808 Q53XM2 Q9BWS4,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2,D-fructose-6-phosphate amidotransferase 2;Glutamine:fructose-6-phosphate amidotransferase 2;Hexosephosphate aminotransferase 2;, PF01380;, GO:0005829;GO:0097367;GO:0004360;GO:1990830;GO:0006112;GO:0006002;GO:0006541;GO:0006487;GO:0006048;GO:0006047;, C:cytosol;, F:carbohydrate derivative binding; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity;, P:cellular response to leukemia inhibitory factor; P:energy reserve metabolic process; P:fructose 6-phosphate metabolic process; P:glutamine metabolic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine biosynthetic process; P:UDP-N-acetylglucosamine metabolic process;|O94808 Q53XM2 Q9BWS4,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2,D-fructose-6-phosphate amidotransferase 2;Glutamine:fructose-6-phosphate amidotransferase 2;Hexosephosphate aminotransferase 2;, PF01380;, GO:0005829;GO:0097367;GO:0004360;GO:1990830;GO:0006112;GO:0006002;GO:0006541;GO:0006487;GO:0006048;GO:0006047;, C:cytosol;, F:carbohydrate derivative binding; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity;, P:cellular response to leukemia inhibitory factor; P:energy reserve metabolic process; P:fructose 6-phosphate metabolic process; P:glutamine metabolic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine biosynthetic process; P:UDP-N-acetylglucosamine metabolic process;|O94808 Q53XM2 Q9BWS4,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2,D-fructose-6-phosphate amidotransferase 2;Glutamine:fructose-6-phosphate amidotransferase 2;Hexosephosphate aminotransferase 2;, PF01380;, GO:0005829;GO:0097367;GO:0004360;GO:1990830;GO:0006112;GO:0006002;GO:0006541;GO:0006487;GO:0006048;GO:0006047;, C:cytosol;, F:carbohydrate derivative binding; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity;, P:cellular response to leukemia inhibitory factor; P:energy reserve metabolic process; P:fructose 6-phosphate metabolic process; P:glutamine metabolic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine biosynthetic process; P:UDP-N-acetylglucosamine metabolic process;|O94808 Q53XM2 Q9BWS4,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2,D-fructose-6-phosphate amidotransferase 2;Glutamine:fructose-6-phosphate amidotransferase 2;Hexosephosphate aminotransferase 2;, PF01380;, GO:0005829;GO:0097367;GO:0004360;GO:1990830;GO:0006112;GO:0006002;GO:0006541;GO:0006487;GO:0006048;GO:0006047;, C:cytosol;, F:carbohydrate derivative binding; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity;, P:cellular response to leukemia inhibitory factor; P:energy reserve metabolic process; P:fructose 6-phosphate metabolic process; P:glutamine metabolic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine biosynthetic process; P:UDP-N-acetylglucosamine metabolic process;|O94808 Q53XM2 Q9BWS4,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2,D-fructose-6-phosphate amidotransferase 2;Glutamine:fructose-6-phosphate amidotransferase 2;Hexosephosphate aminotransferase 2;, PF01380;, GO:0005829;GO:0097367;GO:0004360;GO:1990830;GO:0006112;GO:0006002;GO:0006541;GO:0006487;GO:0006048;GO:0006047;, C:cytosol;, F:carbohydrate derivative binding; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity;, P:cellular response to leukemia inhibitory factor; P:energy reserve metabolic process; P:fructose 6-phosphate metabolic process; P:glutamine metabolic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine biosynthetic process; P:UDP-N-acetylglucosamine metabolic process; scaffold98 indexed_genome mRNA 692499 764825 . + . ID=transcript_12736;Q8N5C5,Mitogen-activated protein kinase 9,JNK-55;Stress-activated protein kinase 1a;Stress-activated protein kinase JNK2;c-Jun N-terminal kinase 2;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0004705;GO:0004707;GO:0106310;GO:0004712;GO:0106311;GO:0008134;GO:0071276;GO:0034614;GO:0038095;GO:0035556;GO:0007254;GO:0018105;GO:2001235;GO:0010628;GO:0010744;GO:0071803;GO:0031398;GO:1901485;GO:0061833;GO:0006468;GO:0042752;GO:0051090;GO:0010468;GO:0048511;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transcription factor binding;, P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of podosome assembly; P:positive regulation of protein ubiquitination; P:positive regulation of transcription factor catabolic process; P:protein localization to tricellular tight junction; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:rhythmic process;|Q8N5C5,Mitogen-activated protein kinase 9,JNK-55;Stress-activated protein kinase 1a;Stress-activated protein kinase JNK2;c-Jun N-terminal kinase 2;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0004705;GO:0004707;GO:0106310;GO:0004712;GO:0106311;GO:0008134;GO:0071276;GO:0034614;GO:0038095;GO:0035556;GO:0007254;GO:0018105;GO:2001235;GO:0010628;GO:0010744;GO:0071803;GO:0031398;GO:1901485;GO:0061833;GO:0006468;GO:0042752;GO:0051090;GO:0010468;GO:0048511;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transcription factor binding;, P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of podosome assembly; P:positive regulation of protein ubiquitination; P:positive regulation of transcription factor catabolic process; P:protein localization to tricellular tight junction; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:rhythmic process;|Q8N5C5,Mitogen-activated protein kinase 9,JNK-55;Stress-activated protein kinase 1a;Stress-activated protein kinase JNK2;c-Jun N-terminal kinase 2;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0004705;GO:0004707;GO:0106310;GO:0004712;GO:0106311;GO:0008134;GO:0071276;GO:0034614;GO:0038095;GO:0035556;GO:0007254;GO:0018105;GO:2001235;GO:0010628;GO:0010744;GO:0071803;GO:0031398;GO:1901485;GO:0061833;GO:0006468;GO:0042752;GO:0051090;GO:0010468;GO:0048511;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transcription factor binding;, P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of podosome assembly; P:positive regulation of protein ubiquitination; P:positive regulation of transcription factor catabolic process; P:protein localization to tricellular tight junction; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:rhythmic process;|Q8N5C5,Mitogen-activated protein kinase 9,JNK-55;Stress-activated protein kinase 1a;Stress-activated protein kinase JNK2;c-Jun N-terminal kinase 2;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0004705;GO:0004707;GO:0106310;GO:0004712;GO:0106311;GO:0008134;GO:0071276;GO:0034614;GO:0038095;GO:0035556;GO:0007254;GO:0018105;GO:2001235;GO:0010628;GO:0010744;GO:0071803;GO:0031398;GO:1901485;GO:0061833;GO:0006468;GO:0042752;GO:0051090;GO:0010468;GO:0048511;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transcription factor binding;, P:cellular response to cadmium ion; P:cellular response to reactive oxygen species; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:peptidyl-serine phosphorylation; P:positive regulation of apoptotic signaling pathway; P:positive regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of podosome assembly; P:positive regulation of protein ubiquitination; P:positive regulation of transcription factor catabolic process; P:protein localization to tricellular tight junction; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:rhythmic process; scaffold98 indexed_genome mRNA 766850 893280 . + . ID=transcript_12737;Q8N431 D3DWQ7 Q7Z4T0 Q8NA49,Ras-GEF domain-containing family member 1C,, PF00617;PF00618;, GO:0005085;GO:0007264;, , F:guanyl-nucleotide exchange factor activity;, P:small GTPase mediated signal transduction;|Q8N431 D3DWQ7 Q7Z4T0 Q8NA49,Ras-GEF domain-containing family member 1C,, PF00617;PF00618;, GO:0005085;GO:0007264;, , F:guanyl-nucleotide exchange factor activity;, P:small GTPase mediated signal transduction;|Q0VAM2 Q0VAM1 Q4W5L7 Q4W5M3 Q96MY8,Ras-GEF domain-containing family member 1B,GPI gamma-4;, PF00617;PF00618;, GO:0005769;GO:0005770;GO:0030496;GO:0005085;GO:0007264;, C:early endosome; C:late endosome; C:midbody;, F:guanyl-nucleotide exchange factor activity;, P:small GTPase mediated signal transduction;|Q8N431 D3DWQ7 Q7Z4T0 Q8NA49,Ras-GEF domain-containing family member 1C,, PF00617;PF00618;, GO:0005085;GO:0007264;, , F:guanyl-nucleotide exchange factor activity;, P:small GTPase mediated signal transduction;|Q8N431 D3DWQ7 Q7Z4T0 Q8NA49,Ras-GEF domain-containing family member 1C,, PF00617;PF00618;, GO:0005085;GO:0007264;, , F:guanyl-nucleotide exchange factor activity;, P:small GTPase mediated signal transduction; scaffold98 indexed_genome mRNA 930622 1073902 . + . ID=transcript_12738;Q86XS8 J3KN31 Q32P32 Q59EL1 Q641P9 Q6P177 Q7L2U2 Q9P0J9,E3 ubiquitin-protein ligase RNF130,Goliath homolog;RING finger protein 130;RING-type E3 ubiquitin transferase RNF130 {ECO:0000305};, PF02225;PF13639;, GO:0005737;GO:0016021;GO:0046872;GO:0061630;GO:0004842;GO:0006915;GO:0012501;GO:0006511;, C:cytoplasm; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:programmed cell death; P:ubiquitin-dependent protein catabolic process;|Q86XS8 J3KN31 Q32P32 Q59EL1 Q641P9 Q6P177 Q7L2U2 Q9P0J9,E3 ubiquitin-protein ligase RNF130,Goliath homolog;RING finger protein 130;RING-type E3 ubiquitin transferase RNF130 {ECO:0000305};, PF02225;PF13639;, GO:0005737;GO:0016021;GO:0046872;GO:0061630;GO:0004842;GO:0006915;GO:0012501;GO:0006511;, C:cytoplasm; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:programmed cell death; P:ubiquitin-dependent protein catabolic process;|Q86XS8 J3KN31 Q32P32 Q59EL1 Q641P9 Q6P177 Q7L2U2 Q9P0J9,E3 ubiquitin-protein ligase RNF130,Goliath homolog;RING finger protein 130;RING-type E3 ubiquitin transferase RNF130 {ECO:0000305};, PF02225;PF13639;, GO:0005737;GO:0016021;GO:0046872;GO:0061630;GO:0004842;GO:0006915;GO:0012501;GO:0006511;, C:cytoplasm; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:programmed cell death; P:ubiquitin-dependent protein catabolic process;|Q86XS8 J3KN31 Q32P32 Q59EL1 Q641P9 Q6P177 Q7L2U2 Q9P0J9,E3 ubiquitin-protein ligase RNF130,Goliath homolog;RING finger protein 130;RING-type E3 ubiquitin transferase RNF130 {ECO:0000305};, PF02225;PF13639;, GO:0005737;GO:0016021;GO:0046872;GO:0061630;GO:0004842;GO:0006915;GO:0012501;GO:0006511;, C:cytoplasm; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:programmed cell death; P:ubiquitin-dependent protein catabolic process; scaffold98 indexed_genome mRNA 1129007 1152451 . + . ID=transcript_12739;Q66K14 D3DWQ5 D3DWQ6 O75163 Q53EY0 Q6MZI2 Q96H49,TBC1 domain family member 9B,, PF02893;PF00566;, GO:0016021;GO:0005509;GO:0005096;GO:0090630;GO:0006886;, C:integral component of membrane;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; scaffold98 indexed_genome mRNA 1154410 1167016 . + . ID=transcript_12740;Q66K14 D3DWQ5 D3DWQ6 O75163 Q53EY0 Q6MZI2 Q96H49,TBC1 domain family member 9B,, PF02893;PF00566;, GO:0016021;GO:0005509;GO:0005096;GO:0090630;GO:0006886;, C:integral component of membrane;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport;|Q66K14 D3DWQ5 D3DWQ6 O75163 Q53EY0 Q6MZI2 Q96H49,TBC1 domain family member 9B,, PF02893;PF00566;, GO:0016021;GO:0005509;GO:0005096;GO:0090630;GO:0006886;, C:integral component of membrane;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport;|Q66K14 D3DWQ5 D3DWQ6 O75163 Q53EY0 Q6MZI2 Q96H49,TBC1 domain family member 9B,, PF02893;PF00566;, GO:0016021;GO:0005509;GO:0005096;GO:0090630;GO:0006886;, C:integral component of membrane;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport;|Q66K14 D3DWQ5 D3DWQ6 O75163 Q53EY0 Q6MZI2 Q96H49,TBC1 domain family member 9B,, PF02893;PF00566;, GO:0016021;GO:0005509;GO:0005096;GO:0090630;GO:0006886;, C:integral component of membrane;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport;|Q66K14 D3DWQ5 D3DWQ6 O75163 Q53EY0 Q6MZI2 Q96H49,TBC1 domain family member 9B,, PF02893;PF00566;, GO:0016021;GO:0005509;GO:0005096;GO:0090630;GO:0006886;, C:integral component of membrane;, F:calcium ion binding; F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; scaffold98 indexed_genome mRNA 1168616 1200466 . + . ID=transcript_12741;Q6NTE8 B5MD09 E9PAK6 Q7Z3D8 Q9BUC1 Q9UN54,MRN complex-interacting protein {ECO:0000312|HGNC:HGNC:30817},MRN-interacting protein {ECO:0000303|PubMed:27568553};, PF15749;, GO:0005654;GO:0005634;GO:0003682;GO:0006974;GO:0006281;GO:0007095;GO:1905168;GO:0045860;GO:0071168;GO:2001032;GO:0010212;, C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2 DNA damage checkpoint; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of protein kinase activity; P:protein localization to chromatin; P:regulation of double-strand break repair via nonhomologous end joining; P:response to ionizing radiation;|Q6NTE8 B5MD09 E9PAK6 Q7Z3D8 Q9BUC1 Q9UN54,MRN complex-interacting protein {ECO:0000312|HGNC:HGNC:30817},MRN-interacting protein {ECO:0000303|PubMed:27568553};, PF15749;, GO:0005654;GO:0005634;GO:0003682;GO:0006974;GO:0006281;GO:0007095;GO:1905168;GO:0045860;GO:0071168;GO:2001032;GO:0010212;, C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:mitotic G2 DNA damage checkpoint; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of protein kinase activity; P:protein localization to chromatin; P:regulation of double-strand break repair via nonhomologous end joining; P:response to ionizing radiation;|Q13501 A6NFN7 B2R661 B3KUW5 Q13446 Q9BUV7 Q9BVS6 Q9UEU1,Sequestosome-1,EBI3-associated protein of 60 kDa;Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa;Ubiquitin-binding protein p62;, PF00564;PF16577;PF00569;, GO:0016235;GO:0044753;GO:0044754;GO:0005776;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0016234;GO:0043231;GO:0005770;GO:0097413;GO:0005739;GO:0005654;GO:0000932;GO:0000407;GO:0016605;GO:0030017;GO:0097225;GO:0019899;GO:0042802;GO:0035255;GO:0070530;GO:0019901;GO:0005080;GO:0004674;GO:0044877;GO:0030971;GO:0042169;GO:0043130;GO:0031625;GO:0008270;GO:0035973;GO:0006915;GO:0006914;GO:0000422;GO:0030154;GO:0016197;GO:0007032;GO:0002376;GO:0070498;GO:0035556;GO:0016236;GO:0000423;GO:0043066;GO:0031397;GO:0000122;GO:0000425;GO:0043065;GO:1900273;GO:1903078;GO:0001934;GO:0045944;GO:0008104;GO:1905719;GO:0043122;GO:0010821;GO:0061635;GO:0046578;GO:0002931;GO:0098780;GO:0061912;GO:0006511;, C:aggresome; C:amphisome; C:autolysosome; C:autophagosome; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:inclusion body; C:intracellular membrane-bounded organelle; C:late endosome; C:Lewy body; C:mitochondrion; C:nucleoplasm; C:P-body; C:phagophore assembly site; C:PML body; C:sarcomere; C:sperm midpiece;, F:enzyme binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:protein kinase binding; F:protein kinase C binding; F:protein serine/threonine kinase activity; F:protein-containing complex binding; F:receptor tyrosine kinase binding; F:SH2 domain binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:aggrephagy; P:apoptotic process; P:autophagy; P:autophagy of mitochondrion; P:cell differentiation; P:endosomal transport; P:endosome organization; P:immune system process; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:macroautophagy; P:mitophagy; P:negative regulation of apoptotic process; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of long-term synaptic potentiation; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein localization; P:protein localization to perinuclear region of cytoplasm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitochondrion organization; P:regulation of protein complex stability; P:regulation of Ras protein signal transduction; P:response to ischemia; P:response to mitochondrial depolarisation; P:selective autophagy; P:ubiquitin-dependent protein catabolic process;|Q13501 A6NFN7 B2R661 B3KUW5 Q13446 Q9BUV7 Q9BVS6 Q9UEU1,Sequestosome-1,EBI3-associated protein of 60 kDa;Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa;Ubiquitin-binding protein p62;, PF00564;PF16577;PF00569;, GO:0016235;GO:0044753;GO:0044754;GO:0005776;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0016234;GO:0043231;GO:0005770;GO:0097413;GO:0005739;GO:0005654;GO:0000932;GO:0000407;GO:0016605;GO:0030017;GO:0097225;GO:0019899;GO:0042802;GO:0035255;GO:0070530;GO:0019901;GO:0005080;GO:0004674;GO:0044877;GO:0030971;GO:0042169;GO:0043130;GO:0031625;GO:0008270;GO:0035973;GO:0006915;GO:0006914;GO:0000422;GO:0030154;GO:0016197;GO:0007032;GO:0002376;GO:0070498;GO:0035556;GO:0016236;GO:0000423;GO:0043066;GO:0031397;GO:0000122;GO:0000425;GO:0043065;GO:1900273;GO:1903078;GO:0001934;GO:0045944;GO:0008104;GO:1905719;GO:0043122;GO:0010821;GO:0061635;GO:0046578;GO:0002931;GO:0098780;GO:0061912;GO:0006511;, C:aggresome; C:amphisome; C:autolysosome; C:autophagosome; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:inclusion body; C:intracellular membrane-bounded organelle; C:late endosome; C:Lewy body; C:mitochondrion; C:nucleoplasm; C:P-body; C:phagophore assembly site; C:PML body; C:sarcomere; C:sperm midpiece;, F:enzyme binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:protein kinase binding; F:protein kinase C binding; F:protein serine/threonine kinase activity; F:protein-containing complex binding; F:receptor tyrosine kinase binding; F:SH2 domain binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:aggrephagy; P:apoptotic process; P:autophagy; P:autophagy of mitochondrion; P:cell differentiation; P:endosomal transport; P:endosome organization; P:immune system process; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:macroautophagy; P:mitophagy; P:negative regulation of apoptotic process; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of long-term synaptic potentiation; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein localization; P:protein localization to perinuclear region of cytoplasm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitochondrion organization; P:regulation of protein complex stability; P:regulation of Ras protein signal transduction; P:response to ischemia; P:response to mitochondrial depolarisation; P:selective autophagy; P:ubiquitin-dependent protein catabolic process;|Q13501 A6NFN7 B2R661 B3KUW5 Q13446 Q9BUV7 Q9BVS6 Q9UEU1,Sequestosome-1,EBI3-associated protein of 60 kDa;Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa;Ubiquitin-binding protein p62;, PF00564;PF16577;PF00569;, GO:0016235;GO:0044753;GO:0044754;GO:0005776;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0016234;GO:0043231;GO:0005770;GO:0097413;GO:0005739;GO:0005654;GO:0000932;GO:0000407;GO:0016605;GO:0030017;GO:0097225;GO:0019899;GO:0042802;GO:0035255;GO:0070530;GO:0019901;GO:0005080;GO:0004674;GO:0044877;GO:0030971;GO:0042169;GO:0043130;GO:0031625;GO:0008270;GO:0035973;GO:0006915;GO:0006914;GO:0000422;GO:0030154;GO:0016197;GO:0007032;GO:0002376;GO:0070498;GO:0035556;GO:0016236;GO:0000423;GO:0043066;GO:0031397;GO:0000122;GO:0000425;GO:0043065;GO:1900273;GO:1903078;GO:0001934;GO:0045944;GO:0008104;GO:1905719;GO:0043122;GO:0010821;GO:0061635;GO:0046578;GO:0002931;GO:0098780;GO:0061912;GO:0006511;, C:aggresome; C:amphisome; C:autolysosome; C:autophagosome; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:inclusion body; C:intracellular membrane-bounded organelle; C:late endosome; C:Lewy body; C:mitochondrion; C:nucleoplasm; C:P-body; C:phagophore assembly site; C:PML body; C:sarcomere; C:sperm midpiece;, F:enzyme binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:protein kinase binding; F:protein kinase C binding; F:protein serine/threonine kinase activity; F:protein-containing complex binding; F:receptor tyrosine kinase binding; F:SH2 domain binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:aggrephagy; P:apoptotic process; P:autophagy; P:autophagy of mitochondrion; P:cell differentiation; P:endosomal transport; P:endosome organization; P:immune system process; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:macroautophagy; P:mitophagy; P:negative regulation of apoptotic process; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of long-term synaptic potentiation; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein localization; P:protein localization to perinuclear region of cytoplasm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitochondrion organization; P:regulation of protein complex stability; P:regulation of Ras protein signal transduction; P:response to ischemia; P:response to mitochondrial depolarisation; P:selective autophagy; P:ubiquitin-dependent protein catabolic process;|Q13501 A6NFN7 B2R661 B3KUW5 Q13446 Q9BUV7 Q9BVS6 Q9UEU1,Sequestosome-1,EBI3-associated protein of 60 kDa;Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa;Ubiquitin-binding protein p62;, PF00564;PF16577;PF00569;, GO:0016235;GO:0044753;GO:0044754;GO:0005776;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0016234;GO:0043231;GO:0005770;GO:0097413;GO:0005739;GO:0005654;GO:0000932;GO:0000407;GO:0016605;GO:0030017;GO:0097225;GO:0019899;GO:0042802;GO:0035255;GO:0070530;GO:0019901;GO:0005080;GO:0004674;GO:0044877;GO:0030971;GO:0042169;GO:0043130;GO:0031625;GO:0008270;GO:0035973;GO:0006915;GO:0006914;GO:0000422;GO:0030154;GO:0016197;GO:0007032;GO:0002376;GO:0070498;GO:0035556;GO:0016236;GO:0000423;GO:0043066;GO:0031397;GO:0000122;GO:0000425;GO:0043065;GO:1900273;GO:1903078;GO:0001934;GO:0045944;GO:0008104;GO:1905719;GO:0043122;GO:0010821;GO:0061635;GO:0046578;GO:0002931;GO:0098780;GO:0061912;GO:0006511;, C:aggresome; C:amphisome; C:autolysosome; C:autophagosome; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:inclusion body; C:intracellular membrane-bounded organelle; C:late endosome; C:Lewy body; C:mitochondrion; C:nucleoplasm; C:P-body; C:phagophore assembly site; C:PML body; C:sarcomere; C:sperm midpiece;, F:enzyme binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:protein kinase binding; F:protein kinase C binding; F:protein serine/threonine kinase activity; F:protein-containing complex binding; F:receptor tyrosine kinase binding; F:SH2 domain binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:aggrephagy; P:apoptotic process; P:autophagy; P:autophagy of mitochondrion; P:cell differentiation; P:endosomal transport; P:endosome organization; P:immune system process; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:macroautophagy; P:mitophagy; P:negative regulation of apoptotic process; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of long-term synaptic potentiation; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein localization; P:protein localization to perinuclear region of cytoplasm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitochondrion organization; P:regulation of protein complex stability; P:regulation of Ras protein signal transduction; P:response to ischemia; P:response to mitochondrial depolarisation; P:selective autophagy; P:ubiquitin-dependent protein catabolic process;|Q13501 A6NFN7 B2R661 B3KUW5 Q13446 Q9BUV7 Q9BVS6 Q9UEU1,Sequestosome-1,EBI3-associated protein of 60 kDa;Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa;Ubiquitin-binding protein p62;, PF00564;PF16577;PF00569;, GO:0016235;GO:0044753;GO:0044754;GO:0005776;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0016234;GO:0043231;GO:0005770;GO:0097413;GO:0005739;GO:0005654;GO:0000932;GO:0000407;GO:0016605;GO:0030017;GO:0097225;GO:0019899;GO:0042802;GO:0035255;GO:0070530;GO:0019901;GO:0005080;GO:0004674;GO:0044877;GO:0030971;GO:0042169;GO:0043130;GO:0031625;GO:0008270;GO:0035973;GO:0006915;GO:0006914;GO:0000422;GO:0030154;GO:0016197;GO:0007032;GO:0002376;GO:0070498;GO:0035556;GO:0016236;GO:0000423;GO:0043066;GO:0031397;GO:0000122;GO:0000425;GO:0043065;GO:1900273;GO:1903078;GO:0001934;GO:0045944;GO:0008104;GO:1905719;GO:0043122;GO:0010821;GO:0061635;GO:0046578;GO:0002931;GO:0098780;GO:0061912;GO:0006511;, C:aggresome; C:amphisome; C:autolysosome; C:autophagosome; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:inclusion body; C:intracellular membrane-bounded organelle; C:late endosome; C:Lewy body; C:mitochondrion; C:nucleoplasm; C:P-body; C:phagophore assembly site; C:PML body; C:sarcomere; C:sperm midpiece;, F:enzyme binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:protein kinase binding; F:protein kinase C binding; F:protein serine/threonine kinase activity; F:protein-containing complex binding; F:receptor tyrosine kinase binding; F:SH2 domain binding; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:aggrephagy; P:apoptotic process; P:autophagy; P:autophagy of mitochondrion; P:cell differentiation; P:endosomal transport; P:endosome organization; P:immune system process; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:macroautophagy; P:mitophagy; P:negative regulation of apoptotic process; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:pexophagy; P:positive regulation of apoptotic process; P:positive regulation of long-term synaptic potentiation; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:protein localization; P:protein localization to perinuclear region of cytoplasm; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mitochondrion organization; P:regulation of protein complex stability; P:regulation of Ras protein signal transduction; P:response to ischemia; P:response to mitochondrial depolarisation; P:selective autophagy; P:ubiquitin-dependent protein catabolic process; scaffold98 indexed_genome mRNA 1243262 1243927 . + . ID=transcript_12742;P62899 B7Z4K2 D3DVJ4 P12947 Q53SQ5 Q6IRZ0 Q6LBJ6,60S ribosomal protein L31,Large ribosomal subunit protein eL31 {ECO:0000303|PubMed:24524803};, PF01198;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold98 indexed_genome mRNA 1262975 1264682 . + . ID=transcript_12743;Q9UQ53 A8MPR0 Q86TF1 Q96GH4 Q9NSK6,Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B,N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb;UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb;, , GO:0005783;GO:0005793;GO:0000139;GO:0005795;GO:0016021;GO:0008375;GO:0008454;GO:0046872;GO:0006491;GO:0006487;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; F:metal ion binding;, P:N-glycan processing; P:protein N-linked glycosylation; P:viral protein processing; scaffold98 indexed_genome mRNA 1264910 1266017 . + . ID=transcript_12744;Q9UQ53 A8MPR0 Q86TF1 Q96GH4 Q9NSK6,Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B,N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb;UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb;, , GO:0005783;GO:0005793;GO:0000139;GO:0005795;GO:0016021;GO:0008375;GO:0008454;GO:0046872;GO:0006491;GO:0006487;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; F:metal ion binding;, P:N-glycan processing; P:protein N-linked glycosylation; P:viral protein processing; scaffold98 indexed_genome mRNA 1266271 1270062 . + . ID=transcript_12745;Q9UQ53 A8MPR0 Q86TF1 Q96GH4 Q9NSK6,Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B,N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb;UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb;, , GO:0005783;GO:0005793;GO:0000139;GO:0005795;GO:0016021;GO:0008375;GO:0008454;GO:0046872;GO:0006491;GO:0006487;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; F:metal ion binding;, P:N-glycan processing; P:protein N-linked glycosylation; P:viral protein processing;|Q9UQ53 A8MPR0 Q86TF1 Q96GH4 Q9NSK6,Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B,N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb;UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb;, , GO:0005783;GO:0005793;GO:0000139;GO:0005795;GO:0016021;GO:0008375;GO:0008454;GO:0046872;GO:0006491;GO:0006487;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; F:metal ion binding;, P:N-glycan processing; P:protein N-linked glycosylation; P:viral protein processing;|Q9UQ53 A8MPR0 Q86TF1 Q96GH4 Q9NSK6,Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B,N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb;UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb;, , GO:0005783;GO:0005793;GO:0000139;GO:0005795;GO:0016021;GO:0008375;GO:0008454;GO:0046872;GO:0006491;GO:0006487;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; F:metal ion binding;, P:N-glycan processing; P:protein N-linked glycosylation; P:viral protein processing;|Q9UQ53 A8MPR0 Q86TF1 Q96GH4 Q9NSK6,Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B,N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb;UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb;, , GO:0005783;GO:0005793;GO:0000139;GO:0005795;GO:0016021;GO:0008375;GO:0008454;GO:0046872;GO:0006491;GO:0006487;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:Golgi stack; C:integral component of membrane;, F:acetylglucosaminyltransferase activity; F:alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; F:metal ion binding;, P:N-glycan processing; P:protein N-linked glycosylation; P:viral protein processing; scaffold98 indexed_genome mRNA 1270080 1274017 . + . ID=transcript_12746;Q16873 Q8N6P0 Q9UC73 Q9UD18,Leukotriene C4 synthase,Glutathione S-transferase LTC4 {ECO:0000305};Leukotriene-C(4) synthase;Leukotriene-C4 synthase;, PF01124;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0005635;GO:0031965;GO:0005640;GO:0008047;GO:0004602;GO:0004364;GO:0042802;GO:0004464;GO:0008289;GO:0019370;GO:0006691;GO:2001301;GO:0019372;GO:0042759;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane;, F:enzyme activator activity; F:glutathione peroxidase activity; F:glutathione transferase activity; F:identical protein binding; F:leukotriene-C4 synthase activity; F:lipid binding;, P:leukotriene biosynthetic process; P:leukotriene metabolic process; P:lipoxin biosynthetic process; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process;|Q16873 Q8N6P0 Q9UC73 Q9UD18,Leukotriene C4 synthase,Glutathione S-transferase LTC4 {ECO:0000305};Leukotriene-C(4) synthase;Leukotriene-C4 synthase;, PF01124;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0005635;GO:0031965;GO:0005640;GO:0008047;GO:0004602;GO:0004364;GO:0042802;GO:0004464;GO:0008289;GO:0019370;GO:0006691;GO:2001301;GO:0019372;GO:0042759;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nuclear envelope; C:nuclear membrane; C:nuclear outer membrane;, F:enzyme activator activity; F:glutathione peroxidase activity; F:glutathione transferase activity; F:identical protein binding; F:leukotriene-C4 synthase activity; F:lipid binding;, P:leukotriene biosynthetic process; P:leukotriene metabolic process; P:lipoxin biosynthetic process; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; scaffold98 indexed_genome mRNA 1298346 1300172 . - . ID=transcript_12747;Q92585 Q9NZ12,Mastermind-like protein 1,, PF09596;, GO:0043231;GO:0002193;GO:0016607;GO:0005654;GO:0005634;GO:0042605;GO:0019901;GO:0003713;GO:0060928;GO:0003162;GO:0045445;GO:0007219;GO:0010831;GO:0045747;GO:0045944;GO:0007221;GO:0006468;GO:0006367;, C:intracellular membrane-bounded organelle; C:MAML1-RBP-Jkappa- ICN1 complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:peptide antigen binding; F:protein kinase binding; F:transcription coactivator activity;, P:atrioventricular node cell development; P:atrioventricular node development; P:myoblast differentiation; P:Notch signaling pathway; P:positive regulation of myotube differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:protein phosphorylation; P:transcription initiation from RNA polymerase II promoter; scaffold98 indexed_genome mRNA 1355271 1387206 . - . ID=transcript_12748;P27824 B2R5V8 B4DGP8 B4E2T8 D3DWQ3 D6R9K3,Calnexin,IP90;Major histocompatibility complex class I antigen-binding protein p88;p90;, PF00262;, GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0071556;GO:0042470;GO:0016020;GO:0044233;GO:0098793;GO:0005509;GO:0030246;GO:0003723;GO:0051082;GO:0019886;GO:0002474;GO:0072583;GO:0030968;GO:0070106;GO:0070757;GO:0006457;GO:0034975;GO:0009306;GO:0048488;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of lumenal side of endoplasmic reticulum membrane; C:melanosome; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:presynapse;, F:calcium ion binding; F:carbohydrate binding; F:RNA binding; F:unfolded protein binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:clathrin-dependent endocytosis; P:endoplasmic reticulum unfolded protein response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein secretion; P:synaptic vesicle endocytosis; P:viral protein processing;|P27824 B2R5V8 B4DGP8 B4E2T8 D3DWQ3 D6R9K3,Calnexin,IP90;Major histocompatibility complex class I antigen-binding protein p88;p90;, PF00262;, GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0071556;GO:0042470;GO:0016020;GO:0044233;GO:0098793;GO:0005509;GO:0030246;GO:0003723;GO:0051082;GO:0019886;GO:0002474;GO:0072583;GO:0030968;GO:0070106;GO:0070757;GO:0006457;GO:0034975;GO:0009306;GO:0048488;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of lumenal side of endoplasmic reticulum membrane; C:melanosome; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:presynapse;, F:calcium ion binding; F:carbohydrate binding; F:RNA binding; F:unfolded protein binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:clathrin-dependent endocytosis; P:endoplasmic reticulum unfolded protein response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein secretion; P:synaptic vesicle endocytosis; P:viral protein processing;|P27824 B2R5V8 B4DGP8 B4E2T8 D3DWQ3 D6R9K3,Calnexin,IP90;Major histocompatibility complex class I antigen-binding protein p88;p90;, PF00262;, GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0071556;GO:0042470;GO:0016020;GO:0044233;GO:0098793;GO:0005509;GO:0030246;GO:0003723;GO:0051082;GO:0019886;GO:0002474;GO:0072583;GO:0030968;GO:0070106;GO:0070757;GO:0006457;GO:0034975;GO:0009306;GO:0048488;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of lumenal side of endoplasmic reticulum membrane; C:melanosome; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:presynapse;, F:calcium ion binding; F:carbohydrate binding; F:RNA binding; F:unfolded protein binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:clathrin-dependent endocytosis; P:endoplasmic reticulum unfolded protein response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein secretion; P:synaptic vesicle endocytosis; P:viral protein processing;|P27824 B2R5V8 B4DGP8 B4E2T8 D3DWQ3 D6R9K3,Calnexin,IP90;Major histocompatibility complex class I antigen-binding protein p88;p90;, PF00262;, GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0071556;GO:0042470;GO:0016020;GO:0044233;GO:0098793;GO:0005509;GO:0030246;GO:0003723;GO:0051082;GO:0019886;GO:0002474;GO:0072583;GO:0030968;GO:0070106;GO:0070757;GO:0006457;GO:0034975;GO:0009306;GO:0048488;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of lumenal side of endoplasmic reticulum membrane; C:melanosome; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:presynapse;, F:calcium ion binding; F:carbohydrate binding; F:RNA binding; F:unfolded protein binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:clathrin-dependent endocytosis; P:endoplasmic reticulum unfolded protein response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein secretion; P:synaptic vesicle endocytosis; P:viral protein processing;|P27824 B2R5V8 B4DGP8 B4E2T8 D3DWQ3 D6R9K3,Calnexin,IP90;Major histocompatibility complex class I antigen-binding protein p88;p90;, PF00262;, GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0071556;GO:0042470;GO:0016020;GO:0044233;GO:0098793;GO:0005509;GO:0030246;GO:0003723;GO:0051082;GO:0019886;GO:0002474;GO:0072583;GO:0030968;GO:0070106;GO:0070757;GO:0006457;GO:0034975;GO:0009306;GO:0048488;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of lumenal side of endoplasmic reticulum membrane; C:melanosome; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:presynapse;, F:calcium ion binding; F:carbohydrate binding; F:RNA binding; F:unfolded protein binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:clathrin-dependent endocytosis; P:endoplasmic reticulum unfolded protein response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein secretion; P:synaptic vesicle endocytosis; P:viral protein processing; scaffold98 indexed_genome mRNA 1400300 1402151 . + . ID=transcript_12749;P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold98 indexed_genome mRNA 1439566 1448652 . + . ID=transcript_12750;P31943 B3KW86 D3DWQ2 Q6IBM4,Heterogeneous nuclear ribonucleoprotein H,, PF00076;PF08080;, GO:0071013;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0042802;GO:0008266;GO:0003723;GO:0008543;GO:0000398;GO:0043484;GO:0016070;GO:0006396;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:identical protein binding; F:poly(U) RNA binding; F:RNA binding;, P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing;|P31943 B3KW86 D3DWQ2 Q6IBM4,Heterogeneous nuclear ribonucleoprotein H,, PF00076;PF08080;, GO:0071013;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0042802;GO:0008266;GO:0003723;GO:0008543;GO:0000398;GO:0043484;GO:0016070;GO:0006396;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:identical protein binding; F:poly(U) RNA binding; F:RNA binding;, P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing;|P31943 B3KW86 D3DWQ2 Q6IBM4,Heterogeneous nuclear ribonucleoprotein H,, PF00076;PF08080;, GO:0071013;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0042802;GO:0008266;GO:0003723;GO:0008543;GO:0000398;GO:0043484;GO:0016070;GO:0006396;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:identical protein binding; F:poly(U) RNA binding; F:RNA binding;, P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing;|P31943 B3KW86 D3DWQ2 Q6IBM4,Heterogeneous nuclear ribonucleoprotein H,, PF00076;PF08080;, GO:0071013;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0042802;GO:0008266;GO:0003723;GO:0008543;GO:0000398;GO:0043484;GO:0016070;GO:0006396;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:identical protein binding; F:poly(U) RNA binding; F:RNA binding;, P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing;|P31943 B3KW86 D3DWQ2 Q6IBM4,Heterogeneous nuclear ribonucleoprotein H,, PF00076;PF08080;, GO:0071013;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0042802;GO:0008266;GO:0003723;GO:0008543;GO:0000398;GO:0043484;GO:0016070;GO:0006396;, C:catalytic step 2 spliceosome; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:identical protein binding; F:poly(U) RNA binding; F:RNA binding;, P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing; scaffold98 indexed_genome mRNA 1449514 1514698 . - . ID=transcript_12751;Q96T51 Q59FF3 Q71S93 Q9H6I3,RUN and FYVE domain-containing protein 1,FYVE-finger protein EIP1;La-binding protein 1;Rab4-interacting protein;Zinc finger FYVE domain-containing protein 12;, PF01363;PF02759;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0043231;GO:0016607;GO:0042802;GO:0008289;GO:0046872;GO:0042169;GO:0017124;GO:0006897;GO:0006661;GO:0015031;GO:0030100;GO:0007264;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nuclear speck;, F:identical protein binding; F:lipid binding; F:metal ion binding; F:SH2 domain binding; F:SH3 domain binding;, P:endocytosis; P:phosphatidylinositol biosynthetic process; P:protein transport; P:regulation of endocytosis; P:small GTPase mediated signal transduction;|Q96T51 Q59FF3 Q71S93 Q9H6I3,RUN and FYVE domain-containing protein 1,FYVE-finger protein EIP1;La-binding protein 1;Rab4-interacting protein;Zinc finger FYVE domain-containing protein 12;, PF01363;PF02759;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0043231;GO:0016607;GO:0042802;GO:0008289;GO:0046872;GO:0042169;GO:0017124;GO:0006897;GO:0006661;GO:0015031;GO:0030100;GO:0007264;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nuclear speck;, F:identical protein binding; F:lipid binding; F:metal ion binding; F:SH2 domain binding; F:SH3 domain binding;, P:endocytosis; P:phosphatidylinositol biosynthetic process; P:protein transport; P:regulation of endocytosis; P:small GTPase mediated signal transduction;|Q96T51 Q59FF3 Q71S93 Q9H6I3,RUN and FYVE domain-containing protein 1,FYVE-finger protein EIP1;La-binding protein 1;Rab4-interacting protein;Zinc finger FYVE domain-containing protein 12;, PF01363;PF02759;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0043231;GO:0016607;GO:0042802;GO:0008289;GO:0046872;GO:0042169;GO:0017124;GO:0006897;GO:0006661;GO:0015031;GO:0030100;GO:0007264;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:intracellular membrane-bounded organelle; C:nuclear speck;, F:identical protein binding; F:lipid binding; F:metal ion binding; F:SH2 domain binding; F:SH3 domain binding;, P:endocytosis; P:phosphatidylinositol biosynthetic process; P:protein transport; P:regulation of endocytosis; P:small GTPase mediated signal transduction;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold98 indexed_genome mRNA 1950917 1951542 . - . ID=transcript_12752;O95450,A disintegrin and metalloproteinase with thrombospondin motifs 2,Procollagen I N-proteinase;Procollagen I/II amino propeptide-processing enzyme;Procollagen N-endopeptidase;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0004222;GO:0008237;GO:0008270;GO:0030574;GO:0030199;GO:0030198;GO:0030324;GO:0016485;GO:0043588;GO:0007283;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:collagen fibril organization; P:extracellular matrix organization; P:lung development; P:protein processing; P:skin development; P:spermatogenesis; scaffold98 indexed_genome mRNA 1964186 1966693 . - . ID=transcript_12753;O95450,A disintegrin and metalloproteinase with thrombospondin motifs 2,Procollagen I N-proteinase;Procollagen I/II amino propeptide-processing enzyme;Procollagen N-endopeptidase;, PF17771;PF05986;PF01562;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0004222;GO:0008237;GO:0008270;GO:0030574;GO:0030199;GO:0030198;GO:0030324;GO:0016485;GO:0043588;GO:0007283;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:collagen fibril organization; P:extracellular matrix organization; P:lung development; P:protein processing; P:skin development; P:spermatogenesis; scaffold98 indexed_genome mRNA 2140571 2161432 . - . ID=transcript_12754;Q8N9F8 Q2M1P2 Q2M323,Zinc finger protein 454,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold98 indexed_genome mRNA 2165574 2177613 . - . ID=transcript_12755;Q6ZN57 A5PLN5 B7ZM23 Q9H6Z6,Zinc finger protein 2 homolog,Zinc finger protein 751;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q96NI8 A1L472 B4DMP1,Zinc finger protein 570,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold98 indexed_genome mRNA 2244678 2248408 . - . ID=transcript_12756;Q5TA31 A6NL57 Q6P2J7 Q6PJR0,E3 ubiquitin-protein ligase RNF187,RING domain AP1 coactivator 1;RING finger protein 187;RING-type E3 ubiquitin transferase RNF187 {ECO:0000305};, PF00097;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046872;GO:0061630;GO:0004842;GO:0045087;GO:0008284;GO:0045893;GO:0043161;GO:0051865;GO:0070936;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:innate immune response; P:positive regulation of cell population proliferation; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:regulation of gene expression;|Q5TA31 A6NL57 Q6P2J7 Q6PJR0,E3 ubiquitin-protein ligase RNF187,RING domain AP1 coactivator 1;RING finger protein 187;RING-type E3 ubiquitin transferase RNF187 {ECO:0000305};, PF00097;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046872;GO:0061630;GO:0004842;GO:0045087;GO:0008284;GO:0045893;GO:0043161;GO:0051865;GO:0070936;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:innate immune response; P:positive regulation of cell population proliferation; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein ubiquitination; P:regulation of gene expression; scaffold98 indexed_genome mRNA 2266168 2266710 . - . ID=transcript_12757;Q96ER3 A6NH05,Protein SAAL1,Synoviocyte proliferation-associated in collagen-induced arthritis protein 1 {ECO:0000303|PubMed:22127701};, , GO:0005654;GO:0005634;GO:1901647;, C:nucleoplasm; C:nucleus;, , P:positive regulation of synoviocyte proliferation; scaffold98 indexed_genome mRNA 2268316 2269934 . - . ID=transcript_12758;Q8N257 A4FU05 Q3ZCP6 Q5TA30,Histone H2B type 3-B,H2B type 12;H2B.U histone 1 {ECO:0000312|HGNC:HGNC:20514};, PF00125;, GO:0005829;GO:0005654;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006334;, C:cytosol; C:nucleoplasm; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:nucleosome assembly; scaffold98 indexed_genome mRNA 2270141 2274868 . - . ID=transcript_12759;P04908 P28001 Q76P63,Histone H2A type 1-B/E,Histone H2A.2;Histone H2A/a;Histone H2A/m;, PF00125;PF16211;, GO:0070062;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006342;GO:0008285;, C:extracellular exosome; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:chromatin silencing; P:negative regulation of cell population proliferation; scaffold98 indexed_genome mRNA 2323744 2327468 . + . ID=transcript_12760;Q96F44 A6NKE2 B2RB82 B3KUS3 B4DX88 Q5VSU1 Q8NCA6 Q9C022,E3 ubiquitin-protein ligase TRIM11,Protein BIA1;RING finger protein 92;RING-type E3 ubiquitin transferase TRIM11 {ECO:0000305};Tripartite motif-containing protein 11;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005654;GO:0019904;GO:0008134;GO:0061630;GO:0008270;GO:0051607;GO:0045087;GO:0050768;GO:0045892;GO:0046597;GO:1902187;GO:0032897;GO:0046598;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:protein domain specific binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:negative regulation of neurogenesis; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:negative regulation of viral transcription; P:positive regulation of viral entry into host cell; P:protein ubiquitination; P:regulation of gene expression;|Q96F44 A6NKE2 B2RB82 B3KUS3 B4DX88 Q5VSU1 Q8NCA6 Q9C022,E3 ubiquitin-protein ligase TRIM11,Protein BIA1;RING finger protein 92;RING-type E3 ubiquitin transferase TRIM11 {ECO:0000305};Tripartite motif-containing protein 11;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005654;GO:0019904;GO:0008134;GO:0061630;GO:0008270;GO:0051607;GO:0045087;GO:0050768;GO:0045892;GO:0046597;GO:1902187;GO:0032897;GO:0046598;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:protein domain specific binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:negative regulation of neurogenesis; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:negative regulation of viral transcription; P:positive regulation of viral entry into host cell; P:protein ubiquitination; P:regulation of gene expression; scaffold98 indexed_genome mRNA 2327503 2332038 . - . ID=transcript_12761;Q96F44 A6NKE2 B2RB82 B3KUS3 B4DX88 Q5VSU1 Q8NCA6 Q9C022,E3 ubiquitin-protein ligase TRIM11,Protein BIA1;RING finger protein 92;RING-type E3 ubiquitin transferase TRIM11 {ECO:0000305};Tripartite motif-containing protein 11;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005654;GO:0019904;GO:0008134;GO:0061630;GO:0008270;GO:0051607;GO:0045087;GO:0050768;GO:0045892;GO:0046597;GO:1902187;GO:0032897;GO:0046598;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:protein domain specific binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:negative regulation of neurogenesis; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:negative regulation of viral transcription; P:positive regulation of viral entry into host cell; P:protein ubiquitination; P:regulation of gene expression;|Q96F44 A6NKE2 B2RB82 B3KUS3 B4DX88 Q5VSU1 Q8NCA6 Q9C022,E3 ubiquitin-protein ligase TRIM11,Protein BIA1;RING finger protein 92;RING-type E3 ubiquitin transferase TRIM11 {ECO:0000305};Tripartite motif-containing protein 11;, PF13765;PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005654;GO:0019904;GO:0008134;GO:0061630;GO:0008270;GO:0051607;GO:0045087;GO:0050768;GO:0045892;GO:0046597;GO:1902187;GO:0032897;GO:0046598;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:protein domain specific binding; F:transcription factor binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:negative regulation of neurogenesis; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:negative regulation of viral transcription; P:positive regulation of viral entry into host cell; P:protein ubiquitination; P:regulation of gene expression; scaffold98 indexed_genome mRNA 2358047 2428565 . - . ID=transcript_12762;Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization;|Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization; scaffold98 indexed_genome mRNA 2437214 2437997 . + . ID=transcript_12763;Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization; scaffold98 indexed_genome mRNA 2441183 2447197 . - . ID=transcript_12764;Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization; scaffold98 indexed_genome mRNA 2466128 2489072 . - . ID=transcript_12765;Q9HCL6,Obscurin,Obscurin-RhoGEF;Obscurin-myosin light chain kinase;, PF00041;PF07679;PF00612;PF00069;PF00621;, GO:0005911;GO:0005829;GO:0005887;GO:0031430;GO:0030016;GO:0016604;GO:0005886;GO:0042383;GO:0030018;GO:0030506;GO:0005524;GO:0005516;GO:0050839;GO:0005085;GO:0046872;GO:0005547;GO:0043325;GO:0032266;GO:0005546;GO:0070273;GO:0010314;GO:0106310;GO:0106311;GO:0008307;GO:0031432;GO:0098609;GO:0007186;GO:0007275;GO:0043065;GO:0036309;GO:0051056;GO:0045214;, C:cell-cell junction; C:cytosol; C:integral component of plasma membrane; C:M band; C:myofibril; C:nuclear body; C:plasma membrane; C:sarcolemma; C:Z disc;, F:ankyrin binding; F:ATP binding; F:calmodulin binding; F:cell adhesion molecule binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:structural constituent of muscle; F:titin binding;, P:cell-cell adhesion; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:protein localization to M-band; P:regulation of small GTPase mediated signal transduction; P:sarcomere organization; scaffold98 indexed_genome mRNA 2627681 2638120 . - . ID=transcript_12766;Q5T440,Putative transferase CAF17, mitochondrial,Iron-sulfur cluster assembly factor homolog;, , GO:0005759;GO:0005739;GO:0003723;GO:0016740;GO:0006783;GO:0016226;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding; F:transferase activity;, P:heme biosynthetic process; P:iron-sulfur cluster assembly; scaffold98 indexed_genome mRNA 2661616 2663917 . - . ID=transcript_12767;Q16774 B1ANH1,Guanylate kinase,GMP kinase;Guanylate kinase 1 {ECO:0000312|HGNC:HGNC:4693};, PF00625;, GO:0005829;GO:0001917;GO:0005524;GO:0004385;GO:0006185;GO:0015949;GO:0006163;GO:0006805;, C:cytosol; C:photoreceptor inner segment;, F:ATP binding; F:guanylate kinase activity;, P:dGDP biosynthetic process; P:nucleobase-containing small molecule interconversion; P:purine nucleotide metabolic process; P:xenobiotic metabolic process; scaffold98 indexed_genome mRNA 2664031 2678323 . - . ID=transcript_12768;Q16774 B1ANH1,Guanylate kinase,GMP kinase;Guanylate kinase 1 {ECO:0000312|HGNC:HGNC:4693};, PF00625;, GO:0005829;GO:0001917;GO:0005524;GO:0004385;GO:0006185;GO:0015949;GO:0006163;GO:0006805;, C:cytosol; C:photoreceptor inner segment;, F:ATP binding; F:guanylate kinase activity;, P:dGDP biosynthetic process; P:nucleobase-containing small molecule interconversion; P:purine nucleotide metabolic process; P:xenobiotic metabolic process;|Q9BU76 Q6P5Y0 Q6ZTZ6 Q6ZWA6 Q8IZH3,Multiple myeloma tumor-associated protein 2,, PF10159;, GO:0005576;GO:1904813;GO:0034774;GO:0003723;GO:0043312;, C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen;, F:RNA binding;, P:neutrophil degranulation;|Q7Z7F7 Q5TBY3 Q5TBY6 Q6UWI8,39S ribosomal protein L55, mitochondrial,Mitochondrial large ribosomal subunit protein bL31m {ECO:0000303|PubMed:27023846};Mitochondrial large ribosomal subunit protein mL55 {ECO:0000303|PubMed:25838379};, PF09776;, GO:0005743;GO:0005762;GO:0005739;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q7Z7F7 Q5TBY3 Q5TBY6 Q6UWI8,39S ribosomal protein L55, mitochondrial,Mitochondrial large ribosomal subunit protein bL31m {ECO:0000303|PubMed:27023846};Mitochondrial large ribosomal subunit protein mL55 {ECO:0000303|PubMed:25838379};, PF09776;, GO:0005743;GO:0005762;GO:0005739;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9BU76 Q6P5Y0 Q6ZTZ6 Q6ZWA6 Q8IZH3,Multiple myeloma tumor-associated protein 2,, PF10159;, GO:0005576;GO:1904813;GO:0034774;GO:0003723;GO:0043312;, C:extracellular region; C:ficolin-1-rich granule lumen; C:secretory granule lumen;, F:RNA binding;, P:neutrophil degranulation; scaffold98 indexed_genome mRNA 2679427 2684230 . - . ID=transcript_12769;P84077 P10947 P32889,ADP-ribosylation factor 1,, PF00025;, GO:0031252;GO:0030137;GO:0005829;GO:0070062;GO:0005925;GO:0098978;GO:0000139;GO:0005770;GO:0043005;GO:0048471;GO:0005778;GO:0005886;GO:0014069;GO:0032991;GO:0030017;GO:0005802;GO:0019003;GO:0005525;GO:0000287;GO:1990583;GO:0019904;GO:0003723;GO:0007015;GO:0019886;GO:0006878;GO:0098586;GO:0097061;GO:0055108;GO:0035722;GO:0006886;GO:0060292;GO:0097212;GO:1990386;GO:0006661;GO:0045956;GO:0060999;GO:0045807;GO:1902953;GO:1902824;GO:0050714;GO:1902307;GO:0006892;GO:0098974;GO:0034315;GO:0050690;GO:1903725;GO:0002090;GO:0070142;GO:0034379;GO:0016192;, C:cell leading edge; C:COPI-coated vesicle; C:cytosol; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:Golgi membrane; C:late endosome; C:neuron projection; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:sarcomere; C:trans-Golgi network;, F:GDP binding; F:GTP binding; F:magnesium ion binding; F:phospholipase D activator activity; F:protein domain specific binding; F:RNA binding;, P:actin filament organization; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular copper ion homeostasis; P:cellular response to virus; P:dendritic spine organization; P:Golgi to transport vesicle transport; P:interleukin-12-mediated signaling pathway; P:intracellular protein transport; P:long-term synaptic depression; P:lysosomal membrane organization; P:mitotic cleavage furrow ingression; P:phosphatidylinositol biosynthetic process; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of dendritic spine development; P:positive regulation of endocytosis; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of late endosome to lysosome transport; P:positive regulation of protein secretion; P:positive regulation of sodium ion transmembrane transport; P:post-Golgi vesicle-mediated transport; P:postsynaptic actin cytoskeleton organization; P:regulation of Arp2/3 complex-mediated actin nucleation; P:regulation of defense response to virus by virus; P:regulation of phospholipid metabolic process; P:regulation of receptor internalization; P:synaptic vesicle budding; P:very-low-density lipoprotein particle assembly; P:vesicle-mediated transport; scaffold98 indexed_genome mRNA 2713336 2758205 . - . ID=transcript_12770;P56704 Q3SY79 Q3SY80 Q969P2,Protein Wnt-3a,, PF00110;, GO:0009986;GO:0031901;GO:0030666;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0098978;GO:0005796;GO:0005886;GO:0098793;GO:1990851;GO:0039706;GO:0005125;GO:0005109;GO:0019904;GO:0048018;GO:0005102;GO:0003713;GO:0090245;GO:0007411;GO:1904886;GO:0090676;GO:0060070;GO:0061317;GO:0045165;GO:0008283;GO:0021846;GO:0033278;GO:0034613;GO:0071300;GO:0010387;GO:0021904;GO:0030198;GO:0001947;GO:0030097;GO:0021766;GO:0001701;GO:0042472;GO:0030879;GO:0050804;GO:0048843;GO:1904339;GO:0045599;GO:0003136;GO:0050768;GO:1901215;GO:0010977;GO:0030182;GO:0001649;GO:0048343;GO:0070527;GO:0030890;GO:0090263;GO:2000081;GO:2000727;GO:0008284;GO:2000049;GO:0048697;GO:0043280;GO:0001819;GO:0061184;GO:0051091;GO:0010628;GO:2000347;GO:0048337;GO:2000179;GO:0033138;GO:0032092;GO:1903078;GO:0001934;GO:0061098;GO:0002092;GO:0048643;GO:0045944;GO:0045893;GO:0036342;GO:0099527;GO:0099054;GO:0070507;GO:1905606;GO:0050807;GO:0062009;GO:0035914;GO:0048103;GO:0021527;GO:0036465;GO:0016055;GO:0021874;GO:1904953;, C:cell surface; C:early endosome membrane; C:endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:glutamatergic synapse; C:Golgi lumen; C:plasma membrane; C:presynapse; C:Wnt-Frizzled-LRP5/6 complex;, F:co-receptor binding; F:cytokine activity; F:frizzled binding; F:protein domain specific binding; F:receptor ligand activity; F:signaling receptor binding; F:transcription coactivator activity;, P:axis elongation involved in somitogenesis; P:axon guidance; P:beta-catenin destruction complex disassembly; P:calcium ion transmembrane transport via low voltage-gated calcium channel; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment; P:cell fate commitment; P:cell population proliferation; P:cell proliferation in forebrain; P:cell proliferation in midbrain; P:cellular protein localization; P:cellular response to retinoic acid; P:COP9 signalosome assembly; P:dorsal/ventral neural tube patterning; P:extracellular matrix organization; P:heart looping; P:hemopoiesis; P:hippocampus development; P:in utero embryonic development; P:inner ear morphogenesis; P:mammary gland development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of dopaminergic neuron differentiation; P:negative regulation of fat cell differentiation; P:negative regulation of heart induction by canonical Wnt signaling pathway; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of neuron projection development; P:neuron differentiation; P:osteoblast differentiation; P:paraxial mesodermal cell fate commitment; P:platelet aggregation; P:positive regulation of B cell proliferation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of cell-cell adhesion mediated by cadherin; P:positive regulation of collateral sprouting in absence of injury; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cytokine production; P:positive regulation of dermatome development; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of gene expression; P:positive regulation of hepatocyte proliferation; P:positive regulation of mesodermal cell fate specification; P:positive regulation of neural precursor cell proliferation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of receptor internalization; P:positive regulation of skeletal muscle tissue development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:post-anal tail morphogenesis; P:postsynapse to nucleus signaling pathway; P:presynapse assembly; P:regulation of microtubule cytoskeleton organization; P:regulation of presynapse assembly; P:regulation of synapse organization; P:secondary palate development; P:skeletal muscle cell differentiation; P:somatic stem cell division; P:spinal cord association neuron differentiation; P:synaptic vesicle recycling; P:Wnt signaling pathway; P:Wnt signaling pathway involved in forebrain neuroblast division; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; scaffold98 indexed_genome mRNA 2832284 2850076 . - . ID=transcript_12771;O14904 A6NLW2 Q2M2J3 Q5VWU0 Q96S50,Protein Wnt-9a,Protein Wnt-14;, PF00110;, GO:0005576;GO:0005615;GO:0005125;GO:0005109;GO:0048018;GO:0060070;GO:0045165;GO:0007267;GO:0071300;GO:0061303;GO:0072498;GO:0061072;GO:0007275;GO:0008285;GO:0032331;GO:0030182;GO:0016055;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:frizzled binding; F:receptor ligand activity;, P:canonical Wnt signaling pathway; P:cell fate commitment; P:cell-cell signaling; P:cellular response to retinoic acid; P:cornea development in camera-type eye; P:embryonic skeletal joint development; P:iris morphogenesis; P:multicellular organism development; P:negative regulation of cell population proliferation; P:negative regulation of chondrocyte differentiation; P:neuron differentiation; P:Wnt signaling pathway;|O14904 A6NLW2 Q2M2J3 Q5VWU0 Q96S50,Protein Wnt-9a,Protein Wnt-14;, PF00110;, GO:0005576;GO:0005615;GO:0005125;GO:0005109;GO:0048018;GO:0060070;GO:0045165;GO:0007267;GO:0071300;GO:0061303;GO:0072498;GO:0061072;GO:0007275;GO:0008285;GO:0032331;GO:0030182;GO:0016055;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:frizzled binding; F:receptor ligand activity;, P:canonical Wnt signaling pathway; P:cell fate commitment; P:cell-cell signaling; P:cellular response to retinoic acid; P:cornea development in camera-type eye; P:embryonic skeletal joint development; P:iris morphogenesis; P:multicellular organism development; P:negative regulation of cell population proliferation; P:negative regulation of chondrocyte differentiation; P:neuron differentiation; P:Wnt signaling pathway; scaffold98 indexed_genome mRNA 3073892 3079586 . + . ID=transcript_12772;Q96FE1 Q96I66 Q96NU3 Q9BT10 Q9BVB2,Synaptosomal-associated protein 47,Epididymis luminal protein 170;Synaptosomal-associated 47 kDa protein;, , GO:0012505;GO:0048471;GO:0005886;GO:0098793;GO:0031201;GO:0005484;GO:0019905;GO:0006887;GO:0031629;GO:0016082;GO:0006906;, C:endomembrane system; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynapse; C:SNARE complex;, F:SNAP receptor activity; F:syntaxin binding;, P:exocytosis; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle priming; P:vesicle fusion; scaffold98 indexed_genome mRNA 3143549 3155164 . + . ID=transcript_12773;Q9H9V9 Q5TBZ1 Q5TBZ6 Q9H970,2-oxoglutarate and iron-dependent oxygenase JMJD4 {ECO:0000303|PubMed:24486019},JmjC domain-containing protein 4;Jumonji domain-containing protein 4;Lysyl-hydroxylase JMJD4 {ECO:0000303|PubMed:24486019};, PF02373;, GO:0005737;GO:0016706;GO:0046872;GO:0045905;GO:0018126;, C:cytoplasm;, F:2-oxoglutarate-dependent dioxygenase activity; F:metal ion binding;, P:positive regulation of translational termination; P:protein hydroxylation;|Q9H9V9 Q5TBZ1 Q5TBZ6 Q9H970,2-oxoglutarate and iron-dependent oxygenase JMJD4 {ECO:0000303|PubMed:24486019},JmjC domain-containing protein 4;Jumonji domain-containing protein 4;Lysyl-hydroxylase JMJD4 {ECO:0000303|PubMed:24486019};, PF02373;, GO:0005737;GO:0016706;GO:0046872;GO:0045905;GO:0018126;, C:cytoplasm;, F:2-oxoglutarate-dependent dioxygenase activity; F:metal ion binding;, P:positive regulation of translational termination; P:protein hydroxylation; scaffold98 indexed_genome mRNA 3206470 3253249 . + . ID=transcript_12774;Q96LW1 A8K0V2 Q5U5Z4,Zinc finger protein 354B,, PF01352;PF00096;PF16622;, GO:0005634;GO:0003682;GO:0000981;GO:0046872;GO:0000978;GO:0000122;GO:0006357;, C:nucleus;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O60765 Q9UNJ8,Zinc finger protein 354A,Transcription factor 17;Zinc finger protein eZNF;, PF01352;PF00096;PF16622;, GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0001822;GO:0000122;GO:0007576;GO:0006357;GO:0051593;GO:0001666;GO:0007605;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:kidney development; P:negative regulation of transcription by RNA polymerase II; P:nucleolar fragmentation; P:regulation of transcription by RNA polymerase II; P:response to folic acid; P:response to hypoxia; P:sensory perception of sound; scaffold98 indexed_genome mRNA 3336237 3336838 . - . ID=transcript_12775;O95178 Q6FGI6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial,Complex I-AGGG;NADH-ubiquinone oxidoreductase AGGG subunit;, PF14813;, GO:0005743;GO:0005747;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold98 indexed_genome mRNA 3396273 3411545 . + . ID=transcript_12776;Q9HD20 B3KPJ2 B3KTA7 Q6NT90 Q6ZMG7 Q9H6C6,Endoplasmic reticulum transmembrane helix translocase {ECO:0000305},Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};, , GO:0005789;GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006874;GO:0034220;GO:0071421;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:manganese ion transmembrane transport; P:protein transport;|Q9HD20 B3KPJ2 B3KTA7 Q6NT90 Q6ZMG7 Q9H6C6,Endoplasmic reticulum transmembrane helix translocase {ECO:0000305},Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};, , GO:0005789;GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006874;GO:0034220;GO:0071421;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:manganese ion transmembrane transport; P:protein transport;|Q9HD20 B3KPJ2 B3KTA7 Q6NT90 Q6ZMG7 Q9H6C6,Endoplasmic reticulum transmembrane helix translocase {ECO:0000305},Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};, , GO:0005789;GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006874;GO:0034220;GO:0071421;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:manganese ion transmembrane transport; P:protein transport;|Q9HD20 B3KPJ2 B3KTA7 Q6NT90 Q6ZMG7 Q9H6C6,Endoplasmic reticulum transmembrane helix translocase {ECO:0000305},Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};, , GO:0005789;GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006874;GO:0034220;GO:0071421;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:manganese ion transmembrane transport; P:protein transport;|Q9HD20 B3KPJ2 B3KTA7 Q6NT90 Q6ZMG7 Q9H6C6,Endoplasmic reticulum transmembrane helix translocase {ECO:0000305},Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};, , GO:0005789;GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006874;GO:0034220;GO:0071421;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:manganese ion transmembrane transport; P:protein transport;|Q9HD20 B3KPJ2 B3KTA7 Q6NT90 Q6ZMG7 Q9H6C6,Endoplasmic reticulum transmembrane helix translocase {ECO:0000305},Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};, , GO:0005789;GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006874;GO:0034220;GO:0071421;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:manganese ion transmembrane transport; P:protein transport;|Q9HD20 B3KPJ2 B3KTA7 Q6NT90 Q6ZMG7 Q9H6C6,Endoplasmic reticulum transmembrane helix translocase {ECO:0000305},Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};, , GO:0005789;GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006874;GO:0034220;GO:0071421;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:manganese ion transmembrane transport; P:protein transport;|Q9HD20 B3KPJ2 B3KTA7 Q6NT90 Q6ZMG7 Q9H6C6,Endoplasmic reticulum transmembrane helix translocase {ECO:0000305},Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};, , GO:0005789;GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006874;GO:0034220;GO:0071421;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:manganese ion transmembrane transport; P:protein transport;|Q9HD20 B3KPJ2 B3KTA7 Q6NT90 Q6ZMG7 Q9H6C6,Endoplasmic reticulum transmembrane helix translocase {ECO:0000305},Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};, , GO:0005789;GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006874;GO:0034220;GO:0071421;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:manganese ion transmembrane transport; P:protein transport;|Q9HD20 B3KPJ2 B3KTA7 Q6NT90 Q6ZMG7 Q9H6C6,Endoplasmic reticulum transmembrane helix translocase {ECO:0000305},Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};, , GO:0005789;GO:0016021;GO:0016020;GO:0005524;GO:0016887;GO:0046872;GO:0006874;GO:0034220;GO:0071421;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:ATP binding; F:ATPase activity; F:metal ion binding;, P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:manganese ion transmembrane transport; P:protein transport; scaffold98 indexed_genome mRNA 3413997 3414601 . + . ID=transcript_12777;Q6R2W3 Q2NKL9 Q5SRJ3 Q8TCN2 Q96MV9 Q96PW3,SCAN domain-containing protein 3,Transposon-derived Buster4 transposase-like protein;Zinc finger BED domain-containing protein 9;, PF02023;, GO:0005737;GO:0005634;GO:0003676;GO:0015074;GO:0045787;GO:0050679;, C:cytoplasm; C:nucleus;, F:nucleic acid binding;, P:DNA integration; P:positive regulation of cell cycle; P:positive regulation of epithelial cell proliferation; scaffold98 indexed_genome mRNA 3417081 3426699 . + . ID=transcript_12778;Q9P107 A0AVN9 B7ZLZ0,GEM-interacting protein,, PF00620;, GO:0005829;GO:0005654;GO:0005886;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0034260;GO:0051056;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:negative regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9P107 A0AVN9 B7ZLZ0,GEM-interacting protein,, PF00620;, GO:0005829;GO:0005654;GO:0005886;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0034260;GO:0051056;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:negative regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9P107 A0AVN9 B7ZLZ0,GEM-interacting protein,, PF00620;, GO:0005829;GO:0005654;GO:0005886;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0034260;GO:0051056;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:negative regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q9P107 A0AVN9 B7ZLZ0,GEM-interacting protein,, PF00620;, GO:0005829;GO:0005654;GO:0005886;GO:0005096;GO:0046872;GO:0090630;GO:0035556;GO:0034260;GO:0051056;, C:cytosol; C:nucleoplasm; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;, P:activation of GTPase activity; P:intracellular signal transduction; P:negative regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold98 indexed_genome mRNA 3432138 3433570 . + . ID=transcript_12779;Q9HBW0 O00543 O43431,Lysophosphatidic acid receptor 2,Lysophosphatidic acid receptor Edg-4;, PF00001;, GO:0009986;GO:0005737;GO:0005887;GO:0005886;GO:0004930;GO:0008289;GO:0070915;GO:0007202;GO:0007189;GO:0007186;GO:0007204;GO:0019222;, C:cell surface; C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:lipid binding; F:lysophosphatidic acid receptor activity;, P:activation of phospholipase C activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:regulation of metabolic process; scaffold98 indexed_genome mRNA 3507612 3508151 . - . ID=transcript_12780;Q8IUL8 Q6NV88 Q8N4A6 Q8WV21,Cartilage intermediate layer protein 2,, PF13330;PF00090;, GO:0070062;GO:0016311;, C:extracellular exosome;, , P:dephosphorylation; scaffold98 indexed_genome mRNA 3516807 3521543 . - . ID=transcript_12781;A6XGL0 A6XGK9 Q4G1C0,YjeF N-terminal domain-containing protein 3 {ECO:0000305},ApoA-I-binding protein 2 {ECO:0000250|UniProtKB:Q1LVI2};, PF03853;, GO:0016020;GO:0005739;GO:0052856;GO:0052857;GO:0071425;GO:0006869;GO:0031580;GO:0016525;GO:0010874;GO:0008593;GO:0002040;, C:membrane; C:mitochondrion;, F:NADHX epimerase activity; F:NADPHX epimerase activity;, P:hematopoietic stem cell proliferation; P:lipid transport; P:membrane raft distribution; P:negative regulation of angiogenesis; P:regulation of cholesterol efflux; P:regulation of Notch signaling pathway; P:sprouting angiogenesis; scaffold98 indexed_genome mRNA 3524440 3534729 . - . ID=transcript_12782;Q9P0J0 B4DF76 K7EK58 Q6PKI0 Q9H2L3 Q9Y327,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13,Cell death regulatory protein GRIM-19;Complex I-B16.6;Gene associated with retinoic and interferon-induced mortality 19 protein;NADH-ubiquinone oxidoreductase B16.6 subunit;, PF06212;, GO:0005737;GO:0016021;GO:0005743;GO:0031966;GO:0005746;GO:0005747;GO:0005739;GO:0005654;GO:0005524;GO:0008137;GO:0003954;GO:0097190;GO:0035458;GO:0071300;GO:0006120;GO:0032981;GO:0030308;GO:2001243;GO:0045892;GO:0043280;GO:0010952;GO:0045732;GO:0045039;GO:0072593;GO:0016032;, C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity;, P:apoptotic signaling pathway; P:cellular response to interferon-beta; P:cellular response to retinoic acid; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription, DNA-templated; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of peptidase activity; P:positive regulation of protein catabolic process; P:protein insertion into mitochondrial inner membrane; P:reactive oxygen species metabolic process; P:viral process;|Q9P0J0 B4DF76 K7EK58 Q6PKI0 Q9H2L3 Q9Y327,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13,Cell death regulatory protein GRIM-19;Complex I-B16.6;Gene associated with retinoic and interferon-induced mortality 19 protein;NADH-ubiquinone oxidoreductase B16.6 subunit;, PF06212;, GO:0005737;GO:0016021;GO:0005743;GO:0031966;GO:0005746;GO:0005747;GO:0005739;GO:0005654;GO:0005524;GO:0008137;GO:0003954;GO:0097190;GO:0035458;GO:0071300;GO:0006120;GO:0032981;GO:0030308;GO:2001243;GO:0045892;GO:0043280;GO:0010952;GO:0045732;GO:0045039;GO:0072593;GO:0016032;, C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respirasome; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:NADH dehydrogenase (ubiquinone) activity; F:NADH dehydrogenase activity;, P:apoptotic signaling pathway; P:cellular response to interferon-beta; P:cellular response to retinoic acid; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:negative regulation of cell growth; P:negative regulation of intrinsic apoptotic signaling pathway; P:negative regulation of transcription, DNA-templated; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of peptidase activity; P:positive regulation of protein catabolic process; P:protein insertion into mitochondrial inner membrane; P:reactive oxygen species metabolic process; P:viral process; scaffold98 indexed_genome mRNA 3541183 3544346 . - . ID=transcript_12783;Q86YP4 B5MC40 Q7L3J2 Q96F28 Q9NPU2 Q9NXS1,Transcriptional repressor p66-alpha,GATA zinc finger domain-containing protein 2A;, PF00320;PF16563;, GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0030674;GO:0043565;GO:0008270;GO:0006306;GO:0000122;GO:0045892;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:protein-macromolecule adaptor activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated;|Q86YP4 B5MC40 Q7L3J2 Q96F28 Q9NPU2 Q9NXS1,Transcriptional repressor p66-alpha,GATA zinc finger domain-containing protein 2A;, PF00320;PF16563;, GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0030674;GO:0043565;GO:0008270;GO:0006306;GO:0000122;GO:0045892;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:protein-macromolecule adaptor activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; scaffold98 indexed_genome mRNA 3544564 3545901 . - . ID=transcript_12784;Q86YP4 B5MC40 Q7L3J2 Q96F28 Q9NPU2 Q9NXS1,Transcriptional repressor p66-alpha,GATA zinc finger domain-containing protein 2A;, PF00320;PF16563;, GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0030674;GO:0043565;GO:0008270;GO:0006306;GO:0000122;GO:0045892;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:protein-macromolecule adaptor activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated;|Q86YP4 B5MC40 Q7L3J2 Q96F28 Q9NPU2 Q9NXS1,Transcriptional repressor p66-alpha,GATA zinc finger domain-containing protein 2A;, PF00320;PF16563;, GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0030674;GO:0043565;GO:0008270;GO:0006306;GO:0000122;GO:0045892;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:protein-macromolecule adaptor activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; scaffold98 indexed_genome mRNA 3545909 3595928 . - . ID=transcript_12785;Q86YP4 B5MC40 Q7L3J2 Q96F28 Q9NPU2 Q9NXS1,Transcriptional repressor p66-alpha,GATA zinc finger domain-containing protein 2A;, PF00320;PF16563;, GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0030674;GO:0043565;GO:0008270;GO:0006306;GO:0000122;GO:0045892;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:protein-macromolecule adaptor activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated;|Q86YP4 B5MC40 Q7L3J2 Q96F28 Q9NPU2 Q9NXS1,Transcriptional repressor p66-alpha,GATA zinc finger domain-containing protein 2A;, PF00320;PF16563;, GO:0016607;GO:0005654;GO:0005634;GO:0016581;GO:0030674;GO:0043565;GO:0008270;GO:0006306;GO:0000122;GO:0045892;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:protein-macromolecule adaptor activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; scaffold98 indexed_genome mRNA 3641747 3661660 . - . ID=transcript_12786;Q9Y6X3 Q66PT1 Q6P3S7 Q6ZTT2 Q9UFX8,MAU2 chromatid cohesion factor homolog,Cohesin loading complex subunit SCC4 homolog;, PF10345;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0090694;GO:0032116;GO:0003690;GO:0047485;GO:0051301;GO:0071921;GO:0034088;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:Scc2-Scc4 cohesin loading complex; C:SMC loading complex;, F:double-stranded DNA binding; F:protein N-terminus binding;, P:cell division; P:cohesin loading; P:maintenance of mitotic sister chromatid cohesion;|Q9Y6X3 Q66PT1 Q6P3S7 Q6ZTT2 Q9UFX8,MAU2 chromatid cohesion factor homolog,Cohesin loading complex subunit SCC4 homolog;, PF10345;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0090694;GO:0032116;GO:0003690;GO:0047485;GO:0051301;GO:0071921;GO:0034088;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:Scc2-Scc4 cohesin loading complex; C:SMC loading complex;, F:double-stranded DNA binding; F:protein N-terminus binding;, P:cell division; P:cohesin loading; P:maintenance of mitotic sister chromatid cohesion;|Q9Y6X3 Q66PT1 Q6P3S7 Q6ZTT2 Q9UFX8,MAU2 chromatid cohesion factor homolog,Cohesin loading complex subunit SCC4 homolog;, PF10345;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0090694;GO:0032116;GO:0003690;GO:0047485;GO:0051301;GO:0071921;GO:0034088;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:Scc2-Scc4 cohesin loading complex; C:SMC loading complex;, F:double-stranded DNA binding; F:protein N-terminus binding;, P:cell division; P:cohesin loading; P:maintenance of mitotic sister chromatid cohesion;|Q9Y6X3 Q66PT1 Q6P3S7 Q6ZTT2 Q9UFX8,MAU2 chromatid cohesion factor homolog,Cohesin loading complex subunit SCC4 homolog;, PF10345;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0090694;GO:0032116;GO:0003690;GO:0047485;GO:0051301;GO:0071921;GO:0034088;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus; C:Scc2-Scc4 cohesin loading complex; C:SMC loading complex;, F:double-stranded DNA binding; F:protein N-terminus binding;, P:cell division; P:cohesin loading; P:maintenance of mitotic sister chromatid cohesion; scaffold98 indexed_genome mRNA 3679046 3708900 . + . ID=transcript_12787;Q8IWZ8 O60378 Q6P3X9 Q8TCQ4 Q8WWT4 Q8WWT5 Q9NTG3,SURP and G-patch domain-containing protein 1,RNA-binding protein RBP;Splicing factor 4;, PF01585;PF01805;, GO:0005654;GO:0005681;GO:0003723;GO:0000398;, C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IWZ8 O60378 Q6P3X9 Q8TCQ4 Q8WWT4 Q8WWT5 Q9NTG3,SURP and G-patch domain-containing protein 1,RNA-binding protein RBP;Splicing factor 4;, PF01585;PF01805;, GO:0005654;GO:0005681;GO:0003723;GO:0000398;, C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IWZ8 O60378 Q6P3X9 Q8TCQ4 Q8WWT4 Q8WWT5 Q9NTG3,SURP and G-patch domain-containing protein 1,RNA-binding protein RBP;Splicing factor 4;, PF01585;PF01805;, GO:0005654;GO:0005681;GO:0003723;GO:0000398;, C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IWZ8 O60378 Q6P3X9 Q8TCQ4 Q8WWT4 Q8WWT5 Q9NTG3,SURP and G-patch domain-containing protein 1,RNA-binding protein RBP;Splicing factor 4;, PF01585;PF01805;, GO:0005654;GO:0005681;GO:0003723;GO:0000398;, C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IWZ8 O60378 Q6P3X9 Q8TCQ4 Q8WWT4 Q8WWT5 Q9NTG3,SURP and G-patch domain-containing protein 1,RNA-binding protein RBP;Splicing factor 4;, PF01585;PF01805;, GO:0005654;GO:0005681;GO:0003723;GO:0000398;, C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IWZ8 O60378 Q6P3X9 Q8TCQ4 Q8WWT4 Q8WWT5 Q9NTG3,SURP and G-patch domain-containing protein 1,RNA-binding protein RBP;Splicing factor 4;, PF01585;PF01805;, GO:0005654;GO:0005681;GO:0003723;GO:0000398;, C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IWZ8 O60378 Q6P3X9 Q8TCQ4 Q8WWT4 Q8WWT5 Q9NTG3,SURP and G-patch domain-containing protein 1,RNA-binding protein RBP;Splicing factor 4;, PF01585;PF01805;, GO:0005654;GO:0005681;GO:0003723;GO:0000398;, C:nucleoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; scaffold98 indexed_genome mRNA 3716834 3719304 . + . ID=transcript_12788;Q9BZW4 Q0IJ64,Transmembrane 6 superfamily member 2,, , GO:0005789;GO:0033116;GO:0016021;GO:0042802;GO:0055088;GO:0006629;GO:0019216;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:integral component of membrane;, F:identical protein binding;, P:lipid homeostasis; P:lipid metabolic process; P:regulation of lipid metabolic process; scaffold98 indexed_genome mRNA 3722495 3728969 . + . ID=transcript_12789;Q86UW8 A5PKW5 Q96PW2,Hyaluronan and proteoglycan link protein 4,Brain link protein 2;, PF07686;PF00193;, GO:0031012;GO:0005576;GO:0005540;GO:0007155;GO:0007417;GO:0001501;, C:extracellular matrix; C:extracellular region;, F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:skeletal system development; scaffold98 indexed_genome mRNA 3732352 3761565 . - . ID=transcript_12790;O14594 Q9UPK6,Neurocan core protein,Chondroitin sulfate proteoglycan 3;, PF00008;PF00059;PF00084;PF07686;PF00193;, GO:0031012;GO:0005576;GO:0005796;GO:0043202;GO:0005509;GO:0030246;GO:0005540;GO:0007155;GO:0007417;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0001501;, C:extracellular matrix; C:extracellular region; C:Golgi lumen; C:lysosomal lumen;, F:calcium ion binding; F:carbohydrate binding; F:hyaluronic acid binding;, P:cell adhesion; P:central nervous system development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:skeletal system development; scaffold98 indexed_genome mRNA 3767990 3808224 . + . ID=transcript_12791;Q86WQ0 A6NGP7 B4DW92,Nuclear receptor 2C2-associated protein,TR4 orphan receptor-associated 16 kDa protein;, , GO:0005654;GO:0006367;, C:nucleoplasm;, , P:transcription initiation from RNA polymerase II promoter;|O14593 O95839 Q24JQ1 Q6FGA8,DNA-binding protein RFXANK,Ankyrin repeat family A protein 1;Regulatory factor X subunit B;Regulatory factor X-associated ankyrin-containing protein;, PF12796;PF13606;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0090575;GO:0003677;GO:0042826;GO:0045944;GO:0007265;GO:0010468;GO:0006357;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:histone deacetylase binding;, P:positive regulation of transcription by RNA polymerase II; P:Ras protein signal transduction; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II;|O14593 O95839 Q24JQ1 Q6FGA8,DNA-binding protein RFXANK,Ankyrin repeat family A protein 1;Regulatory factor X subunit B;Regulatory factor X-associated ankyrin-containing protein;, PF12796;PF13606;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0090575;GO:0003677;GO:0042826;GO:0045944;GO:0007265;GO:0010468;GO:0006357;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:histone deacetylase binding;, P:positive regulation of transcription by RNA polymerase II; P:Ras protein signal transduction; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II;|O14593 O95839 Q24JQ1 Q6FGA8,DNA-binding protein RFXANK,Ankyrin repeat family A protein 1;Regulatory factor X subunit B;Regulatory factor X-associated ankyrin-containing protein;, PF12796;PF13606;, GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0090575;GO:0003677;GO:0042826;GO:0045944;GO:0007265;GO:0010468;GO:0006357;, C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:histone deacetylase binding;, P:positive regulation of transcription by RNA polymerase II; P:Ras protein signal transduction; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II;|Q96FH0 B2RXF9 Q9BT01,BLOC-1-related complex subunit 8 {ECO:0000305},MEF2B neighbor {ECO:0000312|HGNC:HGNC:37247};, PF10167;, GO:0099078;GO:0005765;GO:0007507;, C:BORC complex; C:lysosomal membrane;, , P:heart development;|Q96FH0 B2RXF9 Q9BT01,BLOC-1-related complex subunit 8 {ECO:0000305},MEF2B neighbor {ECO:0000312|HGNC:HGNC:37247};, PF10167;, GO:0099078;GO:0005765;GO:0007507;, C:BORC complex; C:lysosomal membrane;, , P:heart development;|Q96FH0 B2RXF9 Q9BT01,BLOC-1-related complex subunit 8 {ECO:0000305},MEF2B neighbor {ECO:0000312|HGNC:HGNC:37247};, PF10167;, GO:0099078;GO:0005765;GO:0007507;, C:BORC complex; C:lysosomal membrane;, , P:heart development;|Q02080 A0AV80 B4DVH7 B7ZVY1 G5E9M1,Myocyte-specific enhancer factor 2B,RSRFR2;Serum response factor-like protein 2;, PF00319;, GO:0030054;GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0046983;GO:0000978;GO:1990837;GO:0030154;GO:0007517;GO:0045944;GO:0006357;, C:cell junction; C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:muscle organ development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96FH0 B2RXF9 Q9BT01,BLOC-1-related complex subunit 8 {ECO:0000305},MEF2B neighbor {ECO:0000312|HGNC:HGNC:37247};, PF10167;, GO:0099078;GO:0005765;GO:0007507;, C:BORC complex; C:lysosomal membrane;, , P:heart development; scaffold98 indexed_genome mRNA 3816676 3821947 . + . ID=transcript_12792;Q9NX61 B3KUE0 G5E9M6 Q7L2Y1,Transmembrane protein 161A,Adaptive response to oxidative stress protein 29;, PF10268;, GO:0016021;GO:0034599;GO:0034644;GO:1902230;GO:0045739;GO:0032526;, C:integral component of membrane;, , P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of DNA repair; P:response to retinoic acid;|Q9NX61 B3KUE0 G5E9M6 Q7L2Y1,Transmembrane protein 161A,Adaptive response to oxidative stress protein 29;, PF10268;, GO:0016021;GO:0034599;GO:0034644;GO:1902230;GO:0045739;GO:0032526;, C:integral component of membrane;, , P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of DNA repair; P:response to retinoic acid;|Q9NX61 B3KUE0 G5E9M6 Q7L2Y1,Transmembrane protein 161A,Adaptive response to oxidative stress protein 29;, PF10268;, GO:0016021;GO:0034599;GO:0034644;GO:1902230;GO:0045739;GO:0032526;, C:integral component of membrane;, , P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of DNA repair; P:response to retinoic acid; scaffold98 indexed_genome mRNA 3822835 3830042 . + . ID=transcript_12793;Q9NX61 B3KUE0 G5E9M6 Q7L2Y1,Transmembrane protein 161A,Adaptive response to oxidative stress protein 29;, PF10268;, GO:0016021;GO:0034599;GO:0034644;GO:1902230;GO:0045739;GO:0032526;, C:integral component of membrane;, , P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of DNA repair; P:response to retinoic acid;|Q9NX61 B3KUE0 G5E9M6 Q7L2Y1,Transmembrane protein 161A,Adaptive response to oxidative stress protein 29;, PF10268;, GO:0016021;GO:0034599;GO:0034644;GO:1902230;GO:0045739;GO:0032526;, C:integral component of membrane;, , P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of DNA repair; P:response to retinoic acid;|Q9NX61 B3KUE0 G5E9M6 Q7L2Y1,Transmembrane protein 161A,Adaptive response to oxidative stress protein 29;, PF10268;, GO:0016021;GO:0034599;GO:0034644;GO:1902230;GO:0045739;GO:0032526;, C:integral component of membrane;, , P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of DNA repair; P:response to retinoic acid; scaffold98 indexed_genome mRNA 3892294 3902715 . + . ID=transcript_12794;Q6NXE6 B4DI98 O94999 Q9BTH5,Armadillo repeat-containing protein 6,, PF00514;, GO:0005829;GO:0002244;, C:cytosol;, , P:hematopoietic progenitor cell differentiation;|Q6NXE6 B4DI98 O94999 Q9BTH5,Armadillo repeat-containing protein 6,, PF00514;, GO:0005829;GO:0002244;, C:cytosol;, , P:hematopoietic progenitor cell differentiation;|Q6NXE6 B4DI98 O94999 Q9BTH5,Armadillo repeat-containing protein 6,, PF00514;, GO:0005829;GO:0002244;, C:cytosol;, , P:hematopoietic progenitor cell differentiation;|Q6NXE6 B4DI98 O94999 Q9BTH5,Armadillo repeat-containing protein 6,, PF00514;, GO:0005829;GO:0002244;, C:cytosol;, , P:hematopoietic progenitor cell differentiation;|Q6NXE6 B4DI98 O94999 Q9BTH5,Armadillo repeat-containing protein 6,, PF00514;, GO:0005829;GO:0002244;, C:cytosol;, , P:hematopoietic progenitor cell differentiation; scaffold98 indexed_genome mRNA 3910067 3926524 . + . ID=transcript_12795;Q9NSC5 B2RA10 E9PCW9 O14580 O95350 Q9NSB9 Q9NSC0 Q9NSC1,Homer protein homolog 3 {ECO:0000305},, PF00568;, GO:0005737;GO:0005829;GO:0030425;GO:0005886;GO:0014069;GO:0035256;GO:0042802;GO:0007216;GO:0070885;GO:0032703;GO:0006605;GO:2001256;, C:cytoplasm; C:cytosol; C:dendrite; C:plasma membrane; C:postsynaptic density;, F:G protein-coupled glutamate receptor binding; F:identical protein binding;, P:G protein-coupled glutamate receptor signaling pathway; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of interleukin-2 production; P:protein targeting; P:regulation of store-operated calcium entry;|Q9NSC5 B2RA10 E9PCW9 O14580 O95350 Q9NSB9 Q9NSC0 Q9NSC1,Homer protein homolog 3 {ECO:0000305},, PF00568;, GO:0005737;GO:0005829;GO:0030425;GO:0005886;GO:0014069;GO:0035256;GO:0042802;GO:0007216;GO:0070885;GO:0032703;GO:0006605;GO:2001256;, C:cytoplasm; C:cytosol; C:dendrite; C:plasma membrane; C:postsynaptic density;, F:G protein-coupled glutamate receptor binding; F:identical protein binding;, P:G protein-coupled glutamate receptor signaling pathway; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of interleukin-2 production; P:protein targeting; P:regulation of store-operated calcium entry;|Q9Y6V7 E7ENA0 Q53FJ1 Q9BVQ8,Probable ATP-dependent RNA helicase DDX49,DEAD box protein 49;, PF00270;PF00271;, GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0030307;GO:0044357;GO:0006364;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:positive regulation of cell growth; P:regulation of rRNA stability; P:rRNA processing;|Q9Y6V7 E7ENA0 Q53FJ1 Q9BVQ8,Probable ATP-dependent RNA helicase DDX49,DEAD box protein 49;, PF00270;PF00271;, GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0030307;GO:0044357;GO:0006364;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:positive regulation of cell growth; P:regulation of rRNA stability; P:rRNA processing;|Q9Y6V7 E7ENA0 Q53FJ1 Q9BVQ8,Probable ATP-dependent RNA helicase DDX49,DEAD box protein 49;, PF00270;PF00271;, GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0030307;GO:0044357;GO:0006364;, C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:positive regulation of cell growth; P:regulation of rRNA stability; P:rRNA processing; scaffold98 indexed_genome mRNA 3933770 3938308 . + . ID=transcript_12796;O14579 A6NE29 A6NKA3 O76097 Q6IBB8 Q9UGP6,Coatomer subunit epsilon,Epsilon-coat protein;, , GO:0030126;GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0005654;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0015031;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O14579 A6NE29 A6NKA3 O76097 Q6IBB8 Q9UGP6,Coatomer subunit epsilon,Epsilon-coat protein;, , GO:0030126;GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0005654;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0015031;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold98 indexed_genome mRNA 3939469 3941261 . + . ID=transcript_12797;O14579 A6NE29 A6NKA3 O76097 Q6IBB8 Q9UGP6,Coatomer subunit epsilon,Epsilon-coat protein;, , GO:0030126;GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0005654;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0015031;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold98 indexed_genome mRNA 3941516 3967106 . + . ID=transcript_12798;O14579 A6NE29 A6NKA3 O76097 Q6IBB8 Q9UGP6,Coatomer subunit epsilon,Epsilon-coat protein;, , GO:0030126;GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0005654;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0015031;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P27544,Ceramide synthase 1 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 1 {ECO:0000303|PubMed:9872981};Longevity assurance gene 1 protein homolog 1 {ECO:0000250|UniProtKB:P27545};Protein UOG-1 {ECO:0000303|PubMed:2034669};, PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0016410;GO:0050291;GO:0072721;GO:0035690;GO:0036146;GO:0071492;GO:0046513;GO:0051974;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:cellular response to dithiothreitol; P:cellular response to drug; P:cellular response to mycotoxin; P:cellular response to UV-A; P:ceramide biosynthetic process; P:negative regulation of telomerase activity; P:sphingolipid biosynthetic process;|P27544,Ceramide synthase 1 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 1 {ECO:0000303|PubMed:9872981};Longevity assurance gene 1 protein homolog 1 {ECO:0000250|UniProtKB:P27545};Protein UOG-1 {ECO:0000303|PubMed:2034669};, PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0016410;GO:0050291;GO:0072721;GO:0035690;GO:0036146;GO:0071492;GO:0046513;GO:0051974;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:cellular response to dithiothreitol; P:cellular response to drug; P:cellular response to mycotoxin; P:cellular response to UV-A; P:ceramide biosynthetic process; P:negative regulation of telomerase activity; P:sphingolipid biosynthetic process;|P27544,Ceramide synthase 1 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 1 {ECO:0000303|PubMed:9872981};Longevity assurance gene 1 protein homolog 1 {ECO:0000250|UniProtKB:P27545};Protein UOG-1 {ECO:0000303|PubMed:2034669};, PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0016410;GO:0050291;GO:0072721;GO:0035690;GO:0036146;GO:0071492;GO:0046513;GO:0051974;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:cellular response to dithiothreitol; P:cellular response to drug; P:cellular response to mycotoxin; P:cellular response to UV-A; P:ceramide biosynthetic process; P:negative regulation of telomerase activity; P:sphingolipid biosynthetic process;|P27539 O43344,Embryonic growth/differentiation factor 1,, PF00019;, GO:0005615;GO:0005125;GO:0008083;GO:0030509;GO:0010862;GO:0060395;, C:extracellular space;, F:cytokine activity; F:growth factor activity;, P:BMP signaling pathway; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:SMAD protein signal transduction; scaffold98 indexed_genome mRNA 3972957 4173062 . - . ID=transcript_12799;Q92900 O00239 O43343 Q86Z25 Q92842,Regulator of nonsense transcripts 1,ATP-dependent helicase RENT1;Nonsense mRNA reducing factor 1;Up-frameshift suppressor 1 homolog;, PF13086;PF13087;PF18141;PF04851;PF09416;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0035145;GO:0005654;GO:0005634;GO:0000932;GO:0044530;GO:0005524;GO:0003682;GO:0004386;GO:0003723;GO:0003724;GO:0042162;GO:0008270;GO:0061158;GO:0044770;GO:0071347;GO:0071222;GO:0006281;GO:0006260;GO:0009048;GO:0071044;GO:0006406;GO:0000956;GO:0000294;GO:0000184;GO:0061014;GO:0032204;GO:0006449;GO:0032201;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleoplasm; C:nucleus; C:P-body; C:supraspliceosomal complex;, F:ATP binding; F:chromatin binding; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:telomeric DNA binding; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:cell cycle phase transition; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:DNA repair; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:histone mRNA catabolic process; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA catabolic process; P:regulation of telomere maintenance; P:regulation of translational termination; P:telomere maintenance via semi-conservative replication; P:viral process;|Q92900 O00239 O43343 Q86Z25 Q92842,Regulator of nonsense transcripts 1,ATP-dependent helicase RENT1;Nonsense mRNA reducing factor 1;Up-frameshift suppressor 1 homolog;, PF13086;PF13087;PF18141;PF04851;PF09416;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0035145;GO:0005654;GO:0005634;GO:0000932;GO:0044530;GO:0005524;GO:0003682;GO:0004386;GO:0003723;GO:0003724;GO:0042162;GO:0008270;GO:0061158;GO:0044770;GO:0071347;GO:0071222;GO:0006281;GO:0006260;GO:0009048;GO:0071044;GO:0006406;GO:0000956;GO:0000294;GO:0000184;GO:0061014;GO:0032204;GO:0006449;GO:0032201;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleoplasm; C:nucleus; C:P-body; C:supraspliceosomal complex;, F:ATP binding; F:chromatin binding; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:telomeric DNA binding; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:cell cycle phase transition; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:DNA repair; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:histone mRNA catabolic process; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA catabolic process; P:regulation of telomere maintenance; P:regulation of translational termination; P:telomere maintenance via semi-conservative replication; P:viral process;|Q92900 O00239 O43343 Q86Z25 Q92842,Regulator of nonsense transcripts 1,ATP-dependent helicase RENT1;Nonsense mRNA reducing factor 1;Up-frameshift suppressor 1 homolog;, PF13086;PF13087;PF18141;PF04851;PF09416;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0035145;GO:0005654;GO:0005634;GO:0000932;GO:0044530;GO:0005524;GO:0003682;GO:0004386;GO:0003723;GO:0003724;GO:0042162;GO:0008270;GO:0061158;GO:0044770;GO:0071347;GO:0071222;GO:0006281;GO:0006260;GO:0009048;GO:0071044;GO:0006406;GO:0000956;GO:0000294;GO:0000184;GO:0061014;GO:0032204;GO:0006449;GO:0032201;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleoplasm; C:nucleus; C:P-body; C:supraspliceosomal complex;, F:ATP binding; F:chromatin binding; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:telomeric DNA binding; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:cell cycle phase transition; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:DNA repair; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:histone mRNA catabolic process; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA catabolic process; P:regulation of telomere maintenance; P:regulation of translational termination; P:telomere maintenance via semi-conservative replication; P:viral process;|Q92900 O00239 O43343 Q86Z25 Q92842,Regulator of nonsense transcripts 1,ATP-dependent helicase RENT1;Nonsense mRNA reducing factor 1;Up-frameshift suppressor 1 homolog;, PF13086;PF13087;PF18141;PF04851;PF09416;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0035145;GO:0005654;GO:0005634;GO:0000932;GO:0044530;GO:0005524;GO:0003682;GO:0004386;GO:0003723;GO:0003724;GO:0042162;GO:0008270;GO:0061158;GO:0044770;GO:0071347;GO:0071222;GO:0006281;GO:0006260;GO:0009048;GO:0071044;GO:0006406;GO:0000956;GO:0000294;GO:0000184;GO:0061014;GO:0032204;GO:0006449;GO:0032201;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleoplasm; C:nucleus; C:P-body; C:supraspliceosomal complex;, F:ATP binding; F:chromatin binding; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:telomeric DNA binding; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:cell cycle phase transition; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:DNA repair; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:histone mRNA catabolic process; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA catabolic process; P:regulation of telomere maintenance; P:regulation of translational termination; P:telomere maintenance via semi-conservative replication; P:viral process;|Q92900 O00239 O43343 Q86Z25 Q92842,Regulator of nonsense transcripts 1,ATP-dependent helicase RENT1;Nonsense mRNA reducing factor 1;Up-frameshift suppressor 1 homolog;, PF13086;PF13087;PF18141;PF04851;PF09416;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0035145;GO:0005654;GO:0005634;GO:0000932;GO:0044530;GO:0005524;GO:0003682;GO:0004386;GO:0003723;GO:0003724;GO:0042162;GO:0008270;GO:0061158;GO:0044770;GO:0071347;GO:0071222;GO:0006281;GO:0006260;GO:0009048;GO:0071044;GO:0006406;GO:0000956;GO:0000294;GO:0000184;GO:0061014;GO:0032204;GO:0006449;GO:0032201;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleoplasm; C:nucleus; C:P-body; C:supraspliceosomal complex;, F:ATP binding; F:chromatin binding; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:telomeric DNA binding; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:cell cycle phase transition; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:DNA repair; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:histone mRNA catabolic process; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA catabolic process; P:regulation of telomere maintenance; P:regulation of translational termination; P:telomere maintenance via semi-conservative replication; P:viral process;|Q92900 O00239 O43343 Q86Z25 Q92842,Regulator of nonsense transcripts 1,ATP-dependent helicase RENT1;Nonsense mRNA reducing factor 1;Up-frameshift suppressor 1 homolog;, PF13086;PF13087;PF18141;PF04851;PF09416;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0035145;GO:0005654;GO:0005634;GO:0000932;GO:0044530;GO:0005524;GO:0003682;GO:0004386;GO:0003723;GO:0003724;GO:0042162;GO:0008270;GO:0061158;GO:0044770;GO:0071347;GO:0071222;GO:0006281;GO:0006260;GO:0009048;GO:0071044;GO:0006406;GO:0000956;GO:0000294;GO:0000184;GO:0061014;GO:0032204;GO:0006449;GO:0032201;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleoplasm; C:nucleus; C:P-body; C:supraspliceosomal complex;, F:ATP binding; F:chromatin binding; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:telomeric DNA binding; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:cell cycle phase transition; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:DNA repair; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:histone mRNA catabolic process; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA catabolic process; P:regulation of telomere maintenance; P:regulation of translational termination; P:telomere maintenance via semi-conservative replication; P:viral process;|Q92900 O00239 O43343 Q86Z25 Q92842,Regulator of nonsense transcripts 1,ATP-dependent helicase RENT1;Nonsense mRNA reducing factor 1;Up-frameshift suppressor 1 homolog;, PF13086;PF13087;PF18141;PF04851;PF09416;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0035145;GO:0005654;GO:0005634;GO:0000932;GO:0044530;GO:0005524;GO:0003682;GO:0004386;GO:0003723;GO:0003724;GO:0042162;GO:0008270;GO:0061158;GO:0044770;GO:0071347;GO:0071222;GO:0006281;GO:0006260;GO:0009048;GO:0071044;GO:0006406;GO:0000956;GO:0000294;GO:0000184;GO:0061014;GO:0032204;GO:0006449;GO:0032201;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleoplasm; C:nucleus; C:P-body; C:supraspliceosomal complex;, F:ATP binding; F:chromatin binding; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:telomeric DNA binding; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:cell cycle phase transition; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:DNA repair; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:histone mRNA catabolic process; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA catabolic process; P:regulation of telomere maintenance; P:regulation of translational termination; P:telomere maintenance via semi-conservative replication; P:viral process;|Q92900 O00239 O43343 Q86Z25 Q92842,Regulator of nonsense transcripts 1,ATP-dependent helicase RENT1;Nonsense mRNA reducing factor 1;Up-frameshift suppressor 1 homolog;, PF13086;PF13087;PF18141;PF04851;PF09416;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0035145;GO:0005654;GO:0005634;GO:0000932;GO:0044530;GO:0005524;GO:0003682;GO:0004386;GO:0003723;GO:0003724;GO:0042162;GO:0008270;GO:0061158;GO:0044770;GO:0071347;GO:0071222;GO:0006281;GO:0006260;GO:0009048;GO:0071044;GO:0006406;GO:0000956;GO:0000294;GO:0000184;GO:0061014;GO:0032204;GO:0006449;GO:0032201;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleoplasm; C:nucleus; C:P-body; C:supraspliceosomal complex;, F:ATP binding; F:chromatin binding; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:telomeric DNA binding; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:cell cycle phase transition; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:DNA repair; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:histone mRNA catabolic process; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA catabolic process; P:regulation of telomere maintenance; P:regulation of translational termination; P:telomere maintenance via semi-conservative replication; P:viral process;|Q92900 O00239 O43343 Q86Z25 Q92842,Regulator of nonsense transcripts 1,ATP-dependent helicase RENT1;Nonsense mRNA reducing factor 1;Up-frameshift suppressor 1 homolog;, PF13086;PF13087;PF18141;PF04851;PF09416;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0035145;GO:0005654;GO:0005634;GO:0000932;GO:0044530;GO:0005524;GO:0003682;GO:0004386;GO:0003723;GO:0003724;GO:0042162;GO:0008270;GO:0061158;GO:0044770;GO:0071347;GO:0071222;GO:0006281;GO:0006260;GO:0009048;GO:0071044;GO:0006406;GO:0000956;GO:0000294;GO:0000184;GO:0061014;GO:0032204;GO:0006449;GO:0032201;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleoplasm; C:nucleus; C:P-body; C:supraspliceosomal complex;, F:ATP binding; F:chromatin binding; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:telomeric DNA binding; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:cell cycle phase transition; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:DNA repair; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:histone mRNA catabolic process; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA catabolic process; P:regulation of telomere maintenance; P:regulation of translational termination; P:telomere maintenance via semi-conservative replication; P:viral process;|Q92900 O00239 O43343 Q86Z25 Q92842,Regulator of nonsense transcripts 1,ATP-dependent helicase RENT1;Nonsense mRNA reducing factor 1;Up-frameshift suppressor 1 homolog;, PF13086;PF13087;PF18141;PF04851;PF09416;, GO:0000785;GO:0000781;GO:0005737;GO:0005829;GO:0035145;GO:0005654;GO:0005634;GO:0000932;GO:0044530;GO:0005524;GO:0003682;GO:0004386;GO:0003723;GO:0003724;GO:0042162;GO:0008270;GO:0061158;GO:0044770;GO:0071347;GO:0071222;GO:0006281;GO:0006260;GO:0009048;GO:0071044;GO:0006406;GO:0000956;GO:0000294;GO:0000184;GO:0061014;GO:0032204;GO:0006449;GO:0032201;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleoplasm; C:nucleus; C:P-body; C:supraspliceosomal complex;, F:ATP binding; F:chromatin binding; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:telomeric DNA binding; F:zinc ion binding;, P:3'-UTR-mediated mRNA destabilization; P:cell cycle phase transition; P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:DNA repair; P:DNA replication; P:dosage compensation by inactivation of X chromosome; P:histone mRNA catabolic process; P:mRNA export from nucleus; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of mRNA catabolic process; P:regulation of telomere maintenance; P:regulation of translational termination; P:telomere maintenance via semi-conservative replication; P:viral process;|P49747 B4DKJ3 O14592 Q16388 Q16389 Q2NL86 Q8N4T2,Cartilage oligomeric matrix protein,Thrombospondin-5;, PF11598;PF07645;PF02412;PF05735;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0032991;GO:0036122;GO:0005509;GO:0005518;GO:0005201;GO:0043395;GO:0008201;GO:0005178;GO:0002020;GO:0043394;GO:0009887;GO:0010260;GO:0006915;GO:0048844;GO:0030509;GO:0030282;GO:0002063;GO:0035988;GO:0030199;GO:0030198;GO:0003417;GO:0060173;GO:0010259;GO:0035264;GO:0048747;GO:0050881;GO:0043066;GO:1900047;GO:0050905;GO:0070527;GO:1902732;GO:0016485;GO:0009306;GO:0030500;GO:0010468;GO:0006986;GO:0001501;GO:0043588;GO:0035989;GO:0097084;GO:0014829;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:protein-containing complex;, F:BMP binding; F:calcium ion binding; F:collagen binding; F:extracellular matrix structural constituent; F:heparan sulfate proteoglycan binding; F:heparin binding; F:integrin binding; F:protease binding; F:proteoglycan binding;, P:animal organ morphogenesis; P:animal organ senescence; P:apoptotic process; P:artery morphogenesis; P:BMP signaling pathway; P:bone mineralization; P:chondrocyte development; P:chondrocyte proliferation; P:collagen fibril organization; P:extracellular matrix organization; P:growth plate cartilage development; P:limb development; P:multicellular organism aging; P:multicellular organism growth; P:muscle fiber development; P:musculoskeletal movement; P:negative regulation of apoptotic process; P:negative regulation of hemostasis; P:neuromuscular process; P:platelet aggregation; P:positive regulation of chondrocyte proliferation; P:protein processing; P:protein secretion; P:regulation of bone mineralization; P:regulation of gene expression; P:response to unfolded protein; P:skeletal system development; P:skin development; P:tendon development; P:vascular associated smooth muscle cell development; P:vascular associated smooth muscle contraction;|Q96AI8 Q9H801,CREB-regulated transcription coactivator 1,Mucoepidermoid carcinoma translocated protein 1;Transducer of regulated cAMP response element-binding protein 1;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0043025;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0008140;GO:0097009;GO:0043153;GO:0007613;GO:1902631;GO:0032793;GO:1900006;GO:1900273;GO:0045944;GO:0099527;GO:0051289;GO:0048511;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:neuronal cell body; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:entrainment of circadian clock by photoperiod; P:memory; P:negative regulation of membrane hyperpolarization; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of long-term synaptic potentiation; P:positive regulation of transcription by RNA polymerase II; P:postsynapse to nucleus signaling pathway; P:protein homotetramerization; P:rhythmic process; P:viral process;|Q96AI8 Q9H801,CREB-regulated transcription coactivator 1,Mucoepidermoid carcinoma translocated protein 1;Transducer of regulated cAMP response element-binding protein 1;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0043025;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0008140;GO:0097009;GO:0043153;GO:0007613;GO:1902631;GO:0032793;GO:1900006;GO:1900273;GO:0045944;GO:0099527;GO:0051289;GO:0048511;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:neuronal cell body; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:entrainment of circadian clock by photoperiod; P:memory; P:negative regulation of membrane hyperpolarization; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of long-term synaptic potentiation; P:positive regulation of transcription by RNA polymerase II; P:postsynapse to nucleus signaling pathway; P:protein homotetramerization; P:rhythmic process; P:viral process;|Q96AI8 Q9H801,CREB-regulated transcription coactivator 1,Mucoepidermoid carcinoma translocated protein 1;Transducer of regulated cAMP response element-binding protein 1;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0043025;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0008140;GO:0097009;GO:0043153;GO:0007613;GO:1902631;GO:0032793;GO:1900006;GO:1900273;GO:0045944;GO:0099527;GO:0051289;GO:0048511;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:neuronal cell body; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:entrainment of circadian clock by photoperiod; P:memory; P:negative regulation of membrane hyperpolarization; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of long-term synaptic potentiation; P:positive regulation of transcription by RNA polymerase II; P:postsynapse to nucleus signaling pathway; P:protein homotetramerization; P:rhythmic process; P:viral process;|Q96AI8 Q9H801,CREB-regulated transcription coactivator 1,Mucoepidermoid carcinoma translocated protein 1;Transducer of regulated cAMP response element-binding protein 1;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0043025;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0008140;GO:0097009;GO:0043153;GO:0007613;GO:1902631;GO:0032793;GO:1900006;GO:1900273;GO:0045944;GO:0099527;GO:0051289;GO:0048511;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:neuronal cell body; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:entrainment of circadian clock by photoperiod; P:memory; P:negative regulation of membrane hyperpolarization; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of long-term synaptic potentiation; P:positive regulation of transcription by RNA polymerase II; P:postsynapse to nucleus signaling pathway; P:protein homotetramerization; P:rhythmic process; P:viral process;|Q96AI8 Q9H801,CREB-regulated transcription coactivator 1,Mucoepidermoid carcinoma translocated protein 1;Transducer of regulated cAMP response element-binding protein 1;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0043025;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0008140;GO:0097009;GO:0043153;GO:0007613;GO:1902631;GO:0032793;GO:1900006;GO:1900273;GO:0045944;GO:0099527;GO:0051289;GO:0048511;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:neuronal cell body; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:entrainment of circadian clock by photoperiod; P:memory; P:negative regulation of membrane hyperpolarization; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of long-term synaptic potentiation; P:positive regulation of transcription by RNA polymerase II; P:postsynapse to nucleus signaling pathway; P:protein homotetramerization; P:rhythmic process; P:viral process;|Q96AI8 Q9H801,CREB-regulated transcription coactivator 1,Mucoepidermoid carcinoma translocated protein 1;Transducer of regulated cAMP response element-binding protein 1;, PF12886;PF12885;PF12884;, GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0043025;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0008140;GO:0097009;GO:0043153;GO:0007613;GO:1902631;GO:0032793;GO:1900006;GO:1900273;GO:0045944;GO:0099527;GO:0051289;GO:0048511;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:neuronal cell body; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:cAMP response element binding protein binding;, P:energy homeostasis; P:entrainment of circadian clock by photoperiod; P:memory; P:negative regulation of membrane hyperpolarization; P:positive regulation of CREB transcription factor activity; P:positive regulation of dendrite development; P:positive regulation of long-term synaptic potentiation; P:positive regulation of transcription by RNA polymerase II; P:postsynapse to nucleus signaling pathway; P:protein homotetramerization; P:rhythmic process; P:viral process;|Q53HC5 Q8TAP0 Q9NUX3,Kelch-like protein 26,, PF07707;PF00651;PF01344;|Q53HC5 Q8TAP0 Q9NUX3,Kelch-like protein 26,, PF07707;PF00651;PF01344; scaffold98 indexed_genome mRNA 4214830 4217064 . - . ID=transcript_12800;Q9UK28,Transmembrane protein 59-like,Brain-specific membrane-anchored protein;, PF12280;, GO:0000139;GO:0016021;GO:0016020;, C:Golgi membrane; C:integral component of membrane; C:membrane; scaffold98 indexed_genome mRNA 4228735 4234741 . + . ID=transcript_12801;O75462 Q9UHH5,Cytokine receptor-like factor 1,Cytokine-like factor 1;ZcytoR5;, PF09067;PF00041;, GO:0097058;GO:0005829;GO:0009897;GO:0005576;GO:0005615;GO:0043235;GO:0019955;GO:0004896;GO:0019221;GO:0070106;GO:2000672;GO:0043524;GO:0008284;GO:0042531;GO:0001657;, C:CRLF-CLCF1 complex; C:cytosol; C:external side of plasma membrane; C:extracellular region; C:extracellular space; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity;, P:cytokine-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:negative regulation of motor neuron apoptotic process; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of tyrosine phosphorylation of STAT protein; P:ureteric bud development;|O75462 Q9UHH5,Cytokine receptor-like factor 1,Cytokine-like factor 1;ZcytoR5;, PF09067;PF00041;, GO:0097058;GO:0005829;GO:0009897;GO:0005576;GO:0005615;GO:0043235;GO:0019955;GO:0004896;GO:0019221;GO:0070106;GO:2000672;GO:0043524;GO:0008284;GO:0042531;GO:0001657;, C:CRLF-CLCF1 complex; C:cytosol; C:external side of plasma membrane; C:extracellular region; C:extracellular space; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity;, P:cytokine-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:negative regulation of motor neuron apoptotic process; P:negative regulation of neuron apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of tyrosine phosphorylation of STAT protein; P:ureteric bud development; scaffold98 indexed_genome mRNA 4234748 4252770 . - . ID=transcript_12802;Q96EN9 E9PAS0 Q8NAX4 Q9NWI0,Required for excision 1-B domain-containing protein {ECO:0000305},, PF14966;|Q96EN9 E9PAS0 Q8NAX4 Q9NWI0,Required for excision 1-B domain-containing protein {ECO:0000305},, PF14966;|Q8WYN8 Q91887 Q91888 Q9BWD6 Q9BX98 Q9UEF2 Q9UEG1 Q9UEK8 Q9UPK7,Ubiquitin-60S ribosomal protein L40,CEP52;Ubiquitin A-52 residue ribosomal protein fusion product 1;, PF01020;PF00240;, GO:0005737;GO:0005829;GO:0022625;GO:0022627;GO:0030666;GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005615;GO:0043657;GO:0005765;GO:0005741;GO:0005654;GO:0005634;GO:0005886;GO:0031982;GO:0031386;GO:0003735;GO:0031625;GO:0000187;GO:0035973;GO:1990000;GO:0031145;GO:0006464;GO:0019221;GO:0002753;GO:0042769;GO:1904380;GO:0016197;GO:0070987;GO:0042276;GO:0070911;GO:0007249;GO:0070498;GO:0036297;GO:0075733;GO:0007254;GO:0061024;GO:0019941;GO:0052031;GO:0002755;GO:0002756;GO:0043066;GO:0000122;GO:0030512;GO:0000184;GO:0070423;GO:0000715;GO:0000717;GO:0006297;GO:0033683;GO:0006296;GO:0006294;GO:0043065;GO:0051092;GO:0045944;GO:0036388;GO:0016579;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:0043488;GO:0061418;GO:0006364;GO:0006614;GO:0051403;GO:0006283;GO:0007179;GO:0006412;GO:0006413;GO:0019985;GO:0055085;GO:0035666;GO:0019058;GO:0019083;GO:0019081;GO:0019068;GO:0016055;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:cytosolic small ribosomal subunit; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:host cell; C:lysosomal membrane; C:mitochondrial outer membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle;, F:protein tag; F:structural constituent of ribosome; F:ubiquitin protein ligase binding;, P:activation of MAPK activity; P:aggrephagy; P:amyloid fibril formation; P:anaphase-promoting complex-dependent catabolic process; P:cellular protein modification process; P:cytokine-mediated signaling pathway; P:cytoplasmic pattern recognition receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:endoplasmic reticulum mannose trimming; P:endosomal transport; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:global genome nucleotide-excision repair; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:interstrand cross-link repair; P:intracellular transport of virus; P:JNK cascade; P:membrane organization; P:modification-dependent protein catabolic process; P:modulation by symbiont of host defense response; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nucleotide-binding oligomerization domain containing signaling pathway; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly; P:protein deubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:stress-activated MAPK cascade; P:transcription-coupled nucleotide-excision repair; P:transforming growth factor beta receptor signaling pathway; P:translation; P:translational initiation; P:translesion synthesis; P:transmembrane transport; P:TRIF-dependent toll-like receptor signaling pathway; P:viral life cycle; P:viral transcription; P:viral translation; P:virion assembly; P:Wnt signaling pathway;|Q8WYN8 Q91887 Q91888 Q9BWD6 Q9BX98 Q9UEF2 Q9UEG1 Q9UEK8 Q9UPK7,Ubiquitin-60S ribosomal protein L40,CEP52;Ubiquitin A-52 residue ribosomal protein fusion product 1;, PF01020;PF00240;, GO:0005737;GO:0005829;GO:0022625;GO:0022627;GO:0030666;GO:0005783;GO:0005789;GO:0010008;GO:0070062;GO:0005615;GO:0043657;GO:0005765;GO:0005741;GO:0005654;GO:0005634;GO:0005886;GO:0031982;GO:0031386;GO:0003735;GO:0031625;GO:0000187;GO:0035973;GO:1990000;GO:0031145;GO:0006464;GO:0019221;GO:0002753;GO:0042769;GO:1904380;GO:0016197;GO:0070987;GO:0042276;GO:0070911;GO:0007249;GO:0070498;GO:0036297;GO:0075733;GO:0007254;GO:0061024;GO:0019941;GO:0052031;GO:0002755;GO:0002756;GO:0043066;GO:0000122;GO:0030512;GO:0000184;GO:0070423;GO:0000715;GO:0000717;GO:0006297;GO:0033683;GO:0006296;GO:0006294;GO:0043065;GO:0051092;GO:0045944;GO:0036388;GO:0016579;GO:0008104;GO:0000209;GO:0016567;GO:0007096;GO:0043488;GO:0061418;GO:0006364;GO:0006614;GO:0051403;GO:0006283;GO:0007179;GO:0006412;GO:0006413;GO:0019985;GO:0055085;GO:0035666;GO:0019058;GO:0019083;GO:0019081;GO:0019068;GO:0016055;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:cytosolic small ribosomal subunit; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:host cell; C:lysosomal membrane; C:mitochondrial outer membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle;, F:protein tag; F:structural constituent of ribosome; F:ubiquitin protein ligase binding;, P:activation of MAPK activity; P:aggrephagy; P:amyloid fibril formation; P:anaphase-promoting complex-dependent catabolic process; P:cellular protein modification process; P:cytokine-mediated signaling pathway; P:cytoplasmic pattern recognition receptor signaling pathway; P:DNA damage response, detection of DNA damage; P:endoplasmic reticulum mannose trimming; P:endosomal transport; P:error-free translesion synthesis; P:error-prone translesion synthesis; P:global genome nucleotide-excision repair; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-1-mediated signaling pathway; P:interstrand cross-link repair; P:intracellular transport of virus; P:JNK cascade; P:membrane organization; P:modification-dependent protein catabolic process; P:modulation by symbiont of host defense response; P:MyD88-dependent toll-like receptor signaling pathway; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nucleotide-binding oligomerization domain containing signaling pathway; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:positive regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:pre-replicative complex assembly; P:protein deubiquitination; P:protein localization; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:stress-activated MAPK cascade; P:transcription-coupled nucleotide-excision repair; P:transforming growth factor beta receptor signaling pathway; P:translation; P:translational initiation; P:translesion synthesis; P:transmembrane transport; P:TRIF-dependent toll-like receptor signaling pathway; P:viral life cycle; P:viral transcription; P:viral translation; P:virion assembly; P:Wnt signaling pathway;|Q9BQD3 O76098,KxDL motif-containing protein 1,, PF10241;, GO:0099078;GO:0005765;GO:0032418;GO:0016192;, C:BORC complex; C:lysosomal membrane;, , P:lysosome localization; P:vesicle-mediated transport; scaffold98 indexed_genome mRNA 4272686 4282133 . + . ID=transcript_12803;Q14318 C8C9T5 Q53GU3 Q7Z349 Q86YK6,Peptidyl-prolyl cis-trans isomerase FKBP8,38 kDa FK506-binding protein;FK506-binding protein 8;FKBPR38;Rotamase;, PF00254;PF07719;, GO:0005829;GO:0005783;GO:0030176;GO:0016020;GO:0031966;GO:0005739;GO:0032991;GO:0097718;GO:0042802;GO:0046872;GO:0003755;GO:0044183;GO:0006915;GO:0043010;GO:0001708;GO:0021904;GO:0035556;GO:0035264;GO:0043066;GO:0001933;GO:0030513;GO:0006457;GO:0010468;GO:0007224;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion; C:protein-containing complex;, F:disordered domain specific binding; F:identical protein binding; F:metal ion binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein folding chaperone;, P:apoptotic process; P:camera-type eye development; P:cell fate specification; P:dorsal/ventral neural tube patterning; P:intracellular signal transduction; P:multicellular organism growth; P:negative regulation of apoptotic process; P:negative regulation of protein phosphorylation; P:positive regulation of BMP signaling pathway; P:protein folding; P:regulation of gene expression; P:smoothened signaling pathway; P:viral process;|Q14318 C8C9T5 Q53GU3 Q7Z349 Q86YK6,Peptidyl-prolyl cis-trans isomerase FKBP8,38 kDa FK506-binding protein;FK506-binding protein 8;FKBPR38;Rotamase;, PF00254;PF07719;, GO:0005829;GO:0005783;GO:0030176;GO:0016020;GO:0031966;GO:0005739;GO:0032991;GO:0097718;GO:0042802;GO:0046872;GO:0003755;GO:0044183;GO:0006915;GO:0043010;GO:0001708;GO:0021904;GO:0035556;GO:0035264;GO:0043066;GO:0001933;GO:0030513;GO:0006457;GO:0010468;GO:0007224;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion; C:protein-containing complex;, F:disordered domain specific binding; F:identical protein binding; F:metal ion binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein folding chaperone;, P:apoptotic process; P:camera-type eye development; P:cell fate specification; P:dorsal/ventral neural tube patterning; P:intracellular signal transduction; P:multicellular organism growth; P:negative regulation of apoptotic process; P:negative regulation of protein phosphorylation; P:positive regulation of BMP signaling pathway; P:protein folding; P:regulation of gene expression; P:smoothened signaling pathway; P:viral process;|Q14318 C8C9T5 Q53GU3 Q7Z349 Q86YK6,Peptidyl-prolyl cis-trans isomerase FKBP8,38 kDa FK506-binding protein;FK506-binding protein 8;FKBPR38;Rotamase;, PF00254;PF07719;, GO:0005829;GO:0005783;GO:0030176;GO:0016020;GO:0031966;GO:0005739;GO:0032991;GO:0097718;GO:0042802;GO:0046872;GO:0003755;GO:0044183;GO:0006915;GO:0043010;GO:0001708;GO:0021904;GO:0035556;GO:0035264;GO:0043066;GO:0001933;GO:0030513;GO:0006457;GO:0010468;GO:0007224;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion; C:protein-containing complex;, F:disordered domain specific binding; F:identical protein binding; F:metal ion binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein folding chaperone;, P:apoptotic process; P:camera-type eye development; P:cell fate specification; P:dorsal/ventral neural tube patterning; P:intracellular signal transduction; P:multicellular organism growth; P:negative regulation of apoptotic process; P:negative regulation of protein phosphorylation; P:positive regulation of BMP signaling pathway; P:protein folding; P:regulation of gene expression; P:smoothened signaling pathway; P:viral process;|Q14318 C8C9T5 Q53GU3 Q7Z349 Q86YK6,Peptidyl-prolyl cis-trans isomerase FKBP8,38 kDa FK506-binding protein;FK506-binding protein 8;FKBPR38;Rotamase;, PF00254;PF07719;, GO:0005829;GO:0005783;GO:0030176;GO:0016020;GO:0031966;GO:0005739;GO:0032991;GO:0097718;GO:0042802;GO:0046872;GO:0003755;GO:0044183;GO:0006915;GO:0043010;GO:0001708;GO:0021904;GO:0035556;GO:0035264;GO:0043066;GO:0001933;GO:0030513;GO:0006457;GO:0010468;GO:0007224;GO:0016032;, C:cytosol; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:membrane; C:mitochondrial membrane; C:mitochondrion; C:protein-containing complex;, F:disordered domain specific binding; F:identical protein binding; F:metal ion binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein folding chaperone;, P:apoptotic process; P:camera-type eye development; P:cell fate specification; P:dorsal/ventral neural tube patterning; P:intracellular signal transduction; P:multicellular organism growth; P:negative regulation of apoptotic process; P:negative regulation of protein phosphorylation; P:positive regulation of BMP signaling pathway; P:protein folding; P:regulation of gene expression; P:smoothened signaling pathway; P:viral process; scaffold98 indexed_genome mRNA 4350049 4374495 . + . ID=transcript_12804;P55199,RNA polymerase II elongation factor ELL,Eleven-nineteen lysine-rich leukemia protein;, PF10390;PF07303;, GO:0015030;GO:0005829;GO:0035363;GO:0016604;GO:0016607;GO:0005654;GO:0008023;GO:0035327;GO:0019902;GO:0001701;GO:0010923;GO:0032786;GO:0045945;GO:0032968;GO:0042795;GO:0042796;GO:0006366;GO:0006368;, C:Cajal body; C:cytosol; C:histone locus body; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:phosphatase binding;, P:in utero embryonic development; P:negative regulation of phosphatase activity; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P55199,RNA polymerase II elongation factor ELL,Eleven-nineteen lysine-rich leukemia protein;, PF10390;PF07303;, GO:0015030;GO:0005829;GO:0035363;GO:0016604;GO:0016607;GO:0005654;GO:0008023;GO:0035327;GO:0019902;GO:0001701;GO:0010923;GO:0032786;GO:0045945;GO:0032968;GO:0042795;GO:0042796;GO:0006366;GO:0006368;, C:Cajal body; C:cytosol; C:histone locus body; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:phosphatase binding;, P:in utero embryonic development; P:negative regulation of phosphatase activity; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold98 indexed_genome mRNA 4374535 4379492 . + . ID=transcript_12805;P55199,RNA polymerase II elongation factor ELL,Eleven-nineteen lysine-rich leukemia protein;, PF10390;PF07303;, GO:0015030;GO:0005829;GO:0035363;GO:0016604;GO:0016607;GO:0005654;GO:0008023;GO:0035327;GO:0019902;GO:0001701;GO:0010923;GO:0032786;GO:0045945;GO:0032968;GO:0042795;GO:0042796;GO:0006366;GO:0006368;, C:Cajal body; C:cytosol; C:histone locus body; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:phosphatase binding;, P:in utero embryonic development; P:negative regulation of phosphatase activity; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P55199,RNA polymerase II elongation factor ELL,Eleven-nineteen lysine-rich leukemia protein;, PF10390;PF07303;, GO:0015030;GO:0005829;GO:0035363;GO:0016604;GO:0016607;GO:0005654;GO:0008023;GO:0035327;GO:0019902;GO:0001701;GO:0010923;GO:0032786;GO:0045945;GO:0032968;GO:0042795;GO:0042796;GO:0006366;GO:0006368;, C:Cajal body; C:cytosol; C:histone locus body; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:phosphatase binding;, P:in utero embryonic development; P:negative regulation of phosphatase activity; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P55199,RNA polymerase II elongation factor ELL,Eleven-nineteen lysine-rich leukemia protein;, PF10390;PF07303;, GO:0015030;GO:0005829;GO:0035363;GO:0016604;GO:0016607;GO:0005654;GO:0008023;GO:0035327;GO:0019902;GO:0001701;GO:0010923;GO:0032786;GO:0045945;GO:0032968;GO:0042795;GO:0042796;GO:0006366;GO:0006368;, C:Cajal body; C:cytosol; C:histone locus body; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:phosphatase binding;, P:in utero embryonic development; P:negative regulation of phosphatase activity; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|P55199,RNA polymerase II elongation factor ELL,Eleven-nineteen lysine-rich leukemia protein;, PF10390;PF07303;, GO:0015030;GO:0005829;GO:0035363;GO:0016604;GO:0016607;GO:0005654;GO:0008023;GO:0035327;GO:0019902;GO:0001701;GO:0010923;GO:0032786;GO:0045945;GO:0032968;GO:0042795;GO:0042796;GO:0006366;GO:0006368;, C:Cajal body; C:cytosol; C:histone locus body; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:phosphatase binding;, P:in utero embryonic development; P:negative regulation of phosphatase activity; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase III; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold98 indexed_genome mRNA 4382984 4386411 . + . ID=transcript_12806;Q9NPH2 B3KRT1 G5E9U0 Q6NXT5 Q7Z525 Q9BT65 Q9H2Y2 Q9NSU0 Q9NVW7,Inositol-3-phosphate synthase 1,Myo-inositol 1-phosphate synthase;Myo-inositol 1-phosphate synthase A1;, PF01658;PF07994;, GO:0005737;GO:0005829;GO:0004512;GO:0006021;GO:0043647;GO:0008654;, C:cytoplasm; C:cytosol;, F:inositol-3-phosphate synthase activity;, P:inositol biosynthetic process; P:inositol phosphate metabolic process; P:phospholipid biosynthetic process;|Q9NPH2 B3KRT1 G5E9U0 Q6NXT5 Q7Z525 Q9BT65 Q9H2Y2 Q9NSU0 Q9NVW7,Inositol-3-phosphate synthase 1,Myo-inositol 1-phosphate synthase;Myo-inositol 1-phosphate synthase A1;, PF01658;PF07994;, GO:0005737;GO:0005829;GO:0004512;GO:0006021;GO:0043647;GO:0008654;, C:cytoplasm; C:cytosol;, F:inositol-3-phosphate synthase activity;, P:inositol biosynthetic process; P:inositol phosphate metabolic process; P:phospholipid biosynthetic process; scaffold98 indexed_genome mRNA 4386453 4406603 . - . ID=transcript_12807;Q9BWG4 Q9BWW5,Single-stranded DNA-binding protein 4,, , GO:0005634;GO:0003697;GO:0045944;, C:nucleus;, F:single-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II;|Q9BWG4 Q9BWW5,Single-stranded DNA-binding protein 4,, , GO:0005634;GO:0003697;GO:0045944;, C:nucleus;, F:single-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II;|Q9BWG4 Q9BWW5,Single-stranded DNA-binding protein 4,, , GO:0005634;GO:0003697;GO:0045944;, C:nucleus;, F:single-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II;|Q9BWG4 Q9BWW5,Single-stranded DNA-binding protein 4,, , GO:0005634;GO:0003697;GO:0045944;, C:nucleus;, F:single-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; scaffold98 indexed_genome mRNA 4426763 4430471 . + . ID=transcript_12808;Q8N386 Q6IQ00 Q8N9A5,Leucine-rich repeat-containing protein 25,Monocyte and plasmacytoid-activated protein;, , GO:0005737;GO:0016021;, C:cytoplasm; C:integral component of membrane; scaffold98 indexed_genome mRNA 4477449 4514112 . - . ID=transcript_12809;Q9NXJ5 A8K1Q3 Q8IVT1,Pyroglutamyl-peptidase 1,5-oxoprolyl-peptidase;Pyroglutamyl aminopeptidase I;Pyroglutamyl-peptidase I;Pyrrolidone-carboxylate peptidase;, PF01470;, GO:0005829;GO:0016920;GO:0006508;, C:cytosol;, F:pyroglutamyl-peptidase activity;, P:proteolysis;|Q9Y6H1 Q498C3 Q6NZ50,Coiled-coil-helix-coiled-coil-helix domain-containing protein 2,Aging-associated gene 10 protein;HCV NS2 trans-regulated protein;, PF06747;, GO:0005758;GO:0005739;GO:0005634;GO:0043565;GO:0008134;GO:0034599;GO:0007005;GO:1905448;GO:0045944;GO:1900037;, C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus;, F:sequence-specific DNA binding; F:transcription factor binding;, P:cellular response to oxidative stress; P:mitochondrion organization; P:positive regulation of mitochondrial ATP synthesis coupled electron transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of cellular response to hypoxia; scaffold98 indexed_genome mRNA 4535333 4538612 . + . ID=transcript_12810;Q9Y4Z0,U6 snRNA-associated Sm-like protein LSm4,Glycine-rich protein;, PF01423;, GO:0005829;GO:0120115;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0032991;GO:0097526;GO:0071005;GO:0046540;GO:0005688;GO:0042731;GO:0003723;GO:0017070;GO:0043928;GO:0000398;GO:0033962;GO:0008380;GO:0000387;, C:cytosol; C:Lsm2-8 complex; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:protein-containing complex; C:spliceosomal tri-snRNP complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:PH domain binding; F:RNA binding; F:U6 snRNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA splicing, via spliceosome; P:P-body assembly; P:RNA splicing; P:spliceosomal snRNP assembly;|Q9Y4Z0,U6 snRNA-associated Sm-like protein LSm4,Glycine-rich protein;, PF01423;, GO:0005829;GO:0120115;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0032991;GO:0097526;GO:0071005;GO:0046540;GO:0005688;GO:0042731;GO:0003723;GO:0017070;GO:0043928;GO:0000398;GO:0033962;GO:0008380;GO:0000387;, C:cytosol; C:Lsm2-8 complex; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:protein-containing complex; C:spliceosomal tri-snRNP complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:PH domain binding; F:RNA binding; F:U6 snRNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA splicing, via spliceosome; P:P-body assembly; P:RNA splicing; P:spliceosomal snRNP assembly; scaffold98 indexed_genome mRNA 4540543 4541244 . + . ID=transcript_12811;Q9Y4Z0,U6 snRNA-associated Sm-like protein LSm4,Glycine-rich protein;, PF01423;, GO:0005829;GO:0120115;GO:0016020;GO:0005654;GO:0005634;GO:0000932;GO:0032991;GO:0097526;GO:0071005;GO:0046540;GO:0005688;GO:0042731;GO:0003723;GO:0017070;GO:0043928;GO:0000398;GO:0033962;GO:0008380;GO:0000387;, C:cytosol; C:Lsm2-8 complex; C:membrane; C:nucleoplasm; C:nucleus; C:P-body; C:protein-containing complex; C:spliceosomal tri-snRNP complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:PH domain binding; F:RNA binding; F:U6 snRNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA splicing, via spliceosome; P:P-body assembly; P:RNA splicing; P:spliceosomal snRNP assembly; scaffold99 indexed_genome mRNA 233556 255443 . + . ID=transcript_12812;B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process;|B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process;|B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process;|B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process; scaffold99 indexed_genome mRNA 255952 286506 . + . ID=transcript_12813;B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process;|B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process;|B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process;|B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process;|B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process; scaffold99 indexed_genome mRNA 295912 314939 . - . ID=transcript_12814;B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process;|B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process; scaffold99 indexed_genome mRNA 314962 319508 . + . ID=transcript_12815;B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process;|B7ZB57 Q17RC3 Q5JXY9 Q9H5U8,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13,Asparagine-linked glycosylation 13 homolog;Glycosyltransferase 28 domain-containing protein 1;UDP-N-acetylglucosamine transferase subunit ALG13 homolog;, PF04101;PF02338;, GO:0005789;GO:0008234;GO:0004577;GO:0003723;GO:0004843;GO:0006488;, C:endoplasmic reticulum membrane;, F:cysteine-type peptidase activity; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:dolichol-linked oligosaccharide biosynthetic process; scaffold99 indexed_genome mRNA 1109633 1110174 . + . ID=transcript_12816;Q6ZR62 B2RPG1,Retrotransposon Gag-like protein 4 {ECO:0000312|HGNC:HGNC:25214},Mammalian retrotransposon-derived protein 4 {ECO:0000250|UniProtKB:Q3URY0};Zinc finger CCHC domain-containing protein 16;, , GO:0003676;GO:0008270;GO:0050890;GO:0042415;, , F:nucleic acid binding; F:zinc ion binding;, P:cognition; P:norepinephrine metabolic process; scaffold99 indexed_genome mRNA 1517132 1578498 . - . ID=transcript_12817;Q4VCS5 Q504X5 Q9HD27 Q9UPT1,Angiomotin,, PF12240;, GO:0005884;GO:0005923;GO:0030054;GO:0009986;GO:0005737;GO:0031410;GO:0005829;GO:0030139;GO:0009897;GO:0016021;GO:0030027;GO:0005654;GO:0005886;GO:0001726;GO:0001725;GO:0043532;GO:0038023;GO:0030036;GO:0001525;GO:0043534;GO:0042074;GO:0007043;GO:0034613;GO:0006935;GO:0003365;GO:0001702;GO:0035329;GO:0001701;GO:0016525;GO:0034260;GO:0043116;GO:0043536;GO:0045793;GO:0040019;GO:0051496;GO:0030334;GO:0051056;GO:0001570;, C:actin filament; C:bicellular tight junction; C:cell junction; C:cell surface; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle; C:external side of plasma membrane; C:integral component of membrane; C:lamellipodium; C:nucleoplasm; C:plasma membrane; C:ruffle; C:stress fiber;, F:angiostatin binding; F:signaling receptor activity;, P:actin cytoskeleton organization; P:angiogenesis; P:blood vessel endothelial cell migration; P:cell migration involved in gastrulation; P:cell-cell junction assembly; P:cellular protein localization; P:chemotaxis; P:establishment of cell polarity involved in ameboidal cell migration; P:gastrulation with mouth forming second; P:hippo signaling; P:in utero embryonic development; P:negative regulation of angiogenesis; P:negative regulation of GTPase activity; P:negative regulation of vascular permeability; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell size; P:positive regulation of embryonic development; P:positive regulation of stress fiber assembly; P:regulation of cell migration; P:regulation of small GTPase mediated signal transduction; P:vasculogenesis; scaffold99 indexed_genome mRNA 3508484 3519710 . - . ID=transcript_12818;Q14627 A8K7E2 O00667,Interleukin-13 receptor subunit alpha-2,Interleukin-13-binding protein;, PF09240;, GO:0009897;GO:0005576;GO:0005615;GO:0016021;GO:0043235;GO:0019955;GO:0004896;GO:0019221;GO:0016064;GO:0002638;GO:0043305;, C:external side of plasma membrane; C:extracellular region; C:extracellular space; C:integral component of membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity;, P:cytokine-mediated signaling pathway; P:immunoglobulin mediated immune response; P:negative regulation of immunoglobulin production; P:negative regulation of mast cell degranulation; scaffold99 indexed_genome mRNA 3610804 3623329 . - . ID=transcript_12819;Q5VUJ6 F5H2T1 Q08AD5 Q9HA88 Q9P233,Leucine-rich repeat and calponin homology domain-containing protein 2,, PF00307;PF13855;|Q5VUJ6 F5H2T1 Q08AD5 Q9HA88 Q9P233,Leucine-rich repeat and calponin homology domain-containing protein 2,, PF00307;PF13855;|Q5VUJ6 F5H2T1 Q08AD5 Q9HA88 Q9P233,Leucine-rich repeat and calponin homology domain-containing protein 2,, PF00307;PF13855; scaffold99 indexed_genome mRNA 3626549 3716600 . - . ID=transcript_12820;Q5VUJ6 F5H2T1 Q08AD5 Q9HA88 Q9P233,Leucine-rich repeat and calponin homology domain-containing protein 2,, PF00307;PF13855;|Q5VUJ6 F5H2T1 Q08AD5 Q9HA88 Q9P233,Leucine-rich repeat and calponin homology domain-containing protein 2,, PF00307;PF13855; scaffold99 indexed_genome mRNA 4105405 4197069 . + . ID=transcript_12821;P13797 A8K579 B1AQ09 B4DGB4 B7Z6M1 Q86YI6,Plastin-3,T-plastin;, PF00307;PF13499;, GO:0005884;GO:0032432;GO:0005737;GO:0005829;GO:0005886;GO:0051015;GO:0005509;GO:0051017;GO:0051639;GO:0060348;, C:actin filament; C:actin filament bundle; C:cytoplasm; C:cytosol; C:plasma membrane;, F:actin filament binding; F:calcium ion binding;, P:actin filament bundle assembly; P:actin filament network formation; P:bone development;|P13797 A8K579 B1AQ09 B4DGB4 B7Z6M1 Q86YI6,Plastin-3,T-plastin;, PF00307;PF13499;, GO:0005884;GO:0032432;GO:0005737;GO:0005829;GO:0005886;GO:0051015;GO:0005509;GO:0051017;GO:0051639;GO:0060348;, C:actin filament; C:actin filament bundle; C:cytoplasm; C:cytosol; C:plasma membrane;, F:actin filament binding; F:calcium ion binding;, P:actin filament bundle assembly; P:actin filament network formation; P:bone development;|P13797 A8K579 B1AQ09 B4DGB4 B7Z6M1 Q86YI6,Plastin-3,T-plastin;, PF00307;PF13499;, GO:0005884;GO:0032432;GO:0005737;GO:0005829;GO:0005886;GO:0051015;GO:0005509;GO:0051017;GO:0051639;GO:0060348;, C:actin filament; C:actin filament bundle; C:cytoplasm; C:cytosol; C:plasma membrane;, F:actin filament binding; F:calcium ion binding;, P:actin filament bundle assembly; P:actin filament network formation; P:bone development;|P13797 A8K579 B1AQ09 B4DGB4 B7Z6M1 Q86YI6,Plastin-3,T-plastin;, PF00307;PF13499;, GO:0005884;GO:0032432;GO:0005737;GO:0005829;GO:0005886;GO:0051015;GO:0005509;GO:0051017;GO:0051639;GO:0060348;, C:actin filament; C:actin filament bundle; C:cytoplasm; C:cytosol; C:plasma membrane;, F:actin filament binding; F:calcium ion binding;, P:actin filament bundle assembly; P:actin filament network formation; P:bone development; scaffold99 indexed_genome mRNA 4350383 4351849 . - . ID=transcript_12822;Q5JX71 Q05C43,Protein FAM209A,, PF15206;, GO:0070062;GO:0016021;GO:0005634;, C:extracellular exosome; C:integral component of membrane; C:nucleus; scaffold100 indexed_genome mRNA 32681 37474 . + . ID=transcript_12823;P17040 A8K2D0 B1ALI4 B1ALI5 B1ALI6 Q6ZN23 Q96FA9 Q96H84,Zinc finger and SCAN domain-containing protein 20,Zinc finger protein 31;Zinc finger protein 360;Zinc finger protein KOX29;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold100 indexed_genome mRNA 74188 176463 . - . ID=transcript_12824;Q9H4V9 Q9H4W0 Q9H4W1 Q9H4W2 Q9H4W3 Q9H4W4 Q9HCY5 Q9HCY6 Q9HCY7,CUB and sushi domain-containing protein 2,CUB and sushi multiple domains protein 2;, PF00431;PF00084;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q9H4V9 Q9H4W0 Q9H4W1 Q9H4W2 Q9H4W3 Q9H4W4 Q9HCY5 Q9HCY6 Q9HCY7,CUB and sushi domain-containing protein 2,CUB and sushi multiple domains protein 2;, PF00431;PF00084;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q9H4V9 Q9H4W0 Q9H4W1 Q9H4W2 Q9H4W3 Q9H4W4 Q9HCY5 Q9HCY6 Q9HCY7,CUB and sushi domain-containing protein 2,CUB and sushi multiple domains protein 2;, PF00431;PF00084;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold100 indexed_genome mRNA 187426 202884 . - . ID=transcript_12825;Q9H4V9 Q9H4W0 Q9H4W1 Q9H4W2 Q9H4W3 Q9H4W4 Q9HCY5 Q9HCY6 Q9HCY7,CUB and sushi domain-containing protein 2,CUB and sushi multiple domains protein 2;, PF00431;PF00084;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold100 indexed_genome mRNA 293128 309607 . - . ID=transcript_12826;Q9H4V9 Q9H4W0 Q9H4W1 Q9H4W2 Q9H4W3 Q9H4W4 Q9HCY5 Q9HCY6 Q9HCY7,CUB and sushi domain-containing protein 2,CUB and sushi multiple domains protein 2;, PF00431;PF00084;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold100 indexed_genome mRNA 1405182 1407625 . + . ID=transcript_12827;O95377 Q9UPA3,Gap junction beta-5 protein,Connexin-31.1;, PF00029;, GO:0005922;GO:0016021;GO:0005243;GO:0007267;GO:0008544;GO:1905867;GO:0060713;GO:0060708;GO:0060707;, C:connexin complex; C:integral component of membrane;, F:gap junction channel activity;, P:cell-cell signaling; P:epidermis development; P:epididymis development; P:labyrinthine layer morphogenesis; P:spongiotrophoblast differentiation; P:trophoblast giant cell differentiation; scaffold100 indexed_genome mRNA 1447462 1449686 . + . ID=transcript_12828;P35212 A8K698 D3DPR4 Q9P106 Q9UBL1 Q9UNA9 Q9UNB0 Q9UNB1 Q9Y5N7,Gap junction alpha-4 protein,Connexin-37;, PF00029;, GO:0005922;GO:0005921;GO:0005887;GO:0005243;GO:0001568;GO:0006816;GO:0007043;GO:0007267;GO:0003158;GO:0048265;, C:connexin complex; C:gap junction; C:integral component of plasma membrane;, F:gap junction channel activity;, P:blood vessel development; P:calcium ion transport; P:cell-cell junction assembly; P:cell-cell signaling; P:endothelium development; P:response to pain;|P35212 A8K698 D3DPR4 Q9P106 Q9UBL1 Q9UNA9 Q9UNB0 Q9UNB1 Q9Y5N7,Gap junction alpha-4 protein,Connexin-37;, PF00029;, GO:0005922;GO:0005921;GO:0005887;GO:0005243;GO:0001568;GO:0006816;GO:0007043;GO:0007267;GO:0003158;GO:0048265;, C:connexin complex; C:gap junction; C:integral component of plasma membrane;, F:gap junction channel activity;, P:blood vessel development; P:calcium ion transport; P:cell-cell junction assembly; P:cell-cell signaling; P:endothelium development; P:response to pain; scaffold100 indexed_genome mRNA 1494378 1500121 . - . ID=transcript_12829;Q96EX1 D3DPR5 Q49AP7 Q52LP9 Q8NCB4,Small integral membrane protein 12,, PF15990;, GO:0016021;, C:integral component of membrane; scaffold100 indexed_genome mRNA 1506201 1541893 . - . ID=transcript_12830;O95886 Q5TDD5 Q9H3X7,Disks large-associated protein 3,PSD-95/SAP90-binding protein 3;SAP90/PSD-95-associated protein 3;, PF03359;, GO:0098981;GO:0098978;GO:0031594;GO:0005886;GO:0014069;GO:0099572;GO:0001540;GO:0060090;GO:0099563;GO:0098962;GO:0023052;, C:cholinergic synapse; C:glutamatergic synapse; C:neuromuscular junction; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization;, F:amyloid-beta binding; F:molecular adaptor activity;, P:modification of synaptic structure; P:regulation of postsynaptic neurotransmitter receptor activity; P:signaling;|O95886 Q5TDD5 Q9H3X7,Disks large-associated protein 3,PSD-95/SAP90-binding protein 3;SAP90/PSD-95-associated protein 3;, PF03359;, GO:0098981;GO:0098978;GO:0031594;GO:0005886;GO:0014069;GO:0099572;GO:0001540;GO:0060090;GO:0099563;GO:0098962;GO:0023052;, C:cholinergic synapse; C:glutamatergic synapse; C:neuromuscular junction; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization;, F:amyloid-beta binding; F:molecular adaptor activity;, P:modification of synaptic structure; P:regulation of postsynaptic neurotransmitter receptor activity; P:signaling; scaffold100 indexed_genome mRNA 1541898 1547321 . - . ID=transcript_12831;O95886 Q5TDD5 Q9H3X7,Disks large-associated protein 3,PSD-95/SAP90-binding protein 3;SAP90/PSD-95-associated protein 3;, PF03359;, GO:0098981;GO:0098978;GO:0031594;GO:0005886;GO:0014069;GO:0099572;GO:0001540;GO:0060090;GO:0099563;GO:0098962;GO:0023052;, C:cholinergic synapse; C:glutamatergic synapse; C:neuromuscular junction; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization;, F:amyloid-beta binding; F:molecular adaptor activity;, P:modification of synaptic structure; P:regulation of postsynaptic neurotransmitter receptor activity; P:signaling; scaffold100 indexed_genome mRNA 1634800 1637565 . - . ID=transcript_12832;Q8NCS4,Transmembrane protein 35B,ZMYM6 neighbor protein;, PF13564;, GO:0016021;, C:integral component of membrane; scaffold100 indexed_genome mRNA 1642683 1687353 . - . ID=transcript_12833;Q9P2J4,Zinc finger MYM-type protein 6,Transposon-derived Buster2 transposase-like protein;Zinc finger protein 258;, PF14291;PF06467;, GO:0005634;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleus;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q9P2J4,Zinc finger MYM-type protein 6,Transposon-derived Buster2 transposase-like protein;Zinc finger protein 258;, PF14291;PF06467;, GO:0005634;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleus;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q9P2J4,Zinc finger MYM-type protein 6,Transposon-derived Buster2 transposase-like protein;Zinc finger protein 258;, PF14291;PF06467;, GO:0005634;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleus;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q9P2J4,Zinc finger MYM-type protein 6,Transposon-derived Buster2 transposase-like protein;Zinc finger protein 258;, PF14291;PF06467;, GO:0005634;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleus;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis; scaffold100 indexed_genome mRNA 1723312 1749067 . + . ID=transcript_12834;Q5SVZ6 D3DPR7 Q7Z3Q4,Zinc finger MYM-type protein 1,, PF05699;PF14291;PF06467;, GO:0005634;GO:0046983;GO:0008270;, C:nucleus;, F:protein dimerization activity; F:zinc ion binding;|Q5SVZ6 D3DPR7 Q7Z3Q4,Zinc finger MYM-type protein 1,, PF05699;PF14291;PF06467;, GO:0005634;GO:0046983;GO:0008270;, C:nucleus;, F:protein dimerization activity; F:zinc ion binding; scaffold100 indexed_genome mRNA 1775364 1793344 . - . ID=transcript_12835;P23246 P30808 Q5SZ71,Splicing factor, proline- and glutamine-rich,100 kDa DNA-pairing protein;DNA-binding p52/p100 complex, 100 kDa subunit;Polypyrimidine tract-binding protein-associated-splicing factor {ECO:0000303|PubMed:9848648};, PF08075;PF00076;, GO:0000785;GO:0005829;GO:0032839;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0042382;GO:0090575;GO:0003682;GO:0003677;GO:0042826;GO:0003676;GO:0042803;GO:0003723;GO:0000976;GO:0002218;GO:0000380;GO:0098963;GO:0000724;GO:0070932;GO:0045087;GO:0006397;GO:0000398;GO:0033668;GO:0042754;GO:0000122;GO:0045892;GO:1902177;GO:0045876;GO:0045944;GO:0042752;GO:0006355;GO:0048511;GO:0008380;, C:chromatin; C:cytosol; C:dendrite cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:paraspeckles; C:RNA polymerase II transcription regulator complex;, F:chromatin binding; F:DNA binding; F:histone deacetylase binding; F:nucleic acid binding; F:protein homodimerization activity; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:activation of innate immune response; P:alternative mRNA splicing, via spliceosome; P:dendritic transport of messenger ribonucleoprotein complex; P:double-strand break repair via homologous recombination; P:histone H3 deacetylation; P:innate immune response; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of circadian rhythm; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of sister chromatid cohesion; P:positive regulation of transcription by RNA polymerase II; P:regulation of circadian rhythm; P:regulation of transcription, DNA-templated; P:rhythmic process; P:RNA splicing; scaffold100 indexed_genome mRNA 1880638 2028729 . + . ID=transcript_12836;Q5VZL5 A0JP19 A0JP20 O43308 Q5T5E1 Q5T5E2 Q7L3Q4,Zinc finger MYM-type protein 4,Zinc finger protein 262;, PF12012;PF06467;, GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, , F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q5VZL5 A0JP19 A0JP20 O43308 Q5T5E1 Q5T5E2 Q7L3Q4,Zinc finger MYM-type protein 4,Zinc finger protein 262;, PF12012;PF06467;, GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, , F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q5VZL5 A0JP19 A0JP20 O43308 Q5T5E1 Q5T5E2 Q7L3Q4,Zinc finger MYM-type protein 4,Zinc finger protein 262;, PF12012;PF06467;, GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, , F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis;|Q5VZL5 A0JP19 A0JP20 O43308 Q5T5E1 Q5T5E2 Q7L3Q4,Zinc finger MYM-type protein 4,Zinc finger protein 262;, PF12012;PF06467;, GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, , F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis; scaffold100 indexed_genome mRNA 2049501 2155167 . - . ID=transcript_12837;Q8WYZ5 Q96IC3 Q96JJ0 Q9BUW6 Q9H7V0,Dyslexia-associated protein KIAA0319-like protein {ECO:0000305|PubMed:20697954},Adeno-associated virus receptor {ECO:0000303|PubMed:26814968};, , GO:0031410;GO:0005794;GO:0000139;GO:0016021;GO:0005730;GO:0005886;GO:0016032;, C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleolus; C:plasma membrane;, , P:viral process;|Q8WYZ5 Q96IC3 Q96JJ0 Q9BUW6 Q9H7V0,Dyslexia-associated protein KIAA0319-like protein {ECO:0000305|PubMed:20697954},Adeno-associated virus receptor {ECO:0000303|PubMed:26814968};, , GO:0031410;GO:0005794;GO:0000139;GO:0016021;GO:0005730;GO:0005886;GO:0016032;, C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleolus; C:plasma membrane;, , P:viral process;|Q8WYZ5 Q96IC3 Q96JJ0 Q9BUW6 Q9H7V0,Dyslexia-associated protein KIAA0319-like protein {ECO:0000305|PubMed:20697954},Adeno-associated virus receptor {ECO:0000303|PubMed:26814968};, , GO:0031410;GO:0005794;GO:0000139;GO:0016021;GO:0005730;GO:0005886;GO:0016032;, C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleolus; C:plasma membrane;, , P:viral process;|Q8WYZ5 Q96IC3 Q96JJ0 Q9BUW6 Q9H7V0,Dyslexia-associated protein KIAA0319-like protein {ECO:0000305|PubMed:20697954},Adeno-associated virus receptor {ECO:0000303|PubMed:26814968};, , GO:0031410;GO:0005794;GO:0000139;GO:0016021;GO:0005730;GO:0005886;GO:0016032;, C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleolus; C:plasma membrane;, , P:viral process;|Q8WYZ5 Q96IC3 Q96JJ0 Q9BUW6 Q9H7V0,Dyslexia-associated protein KIAA0319-like protein {ECO:0000305|PubMed:20697954},Adeno-associated virus receptor {ECO:0000303|PubMed:26814968};, , GO:0031410;GO:0005794;GO:0000139;GO:0016021;GO:0005730;GO:0005886;GO:0016032;, C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleolus; C:plasma membrane;, , P:viral process;|Q8WYZ5 Q96IC3 Q96JJ0 Q9BUW6 Q9H7V0,Dyslexia-associated protein KIAA0319-like protein {ECO:0000305|PubMed:20697954},Adeno-associated virus receptor {ECO:0000303|PubMed:26814968};, , GO:0031410;GO:0005794;GO:0000139;GO:0016021;GO:0005730;GO:0005886;GO:0016032;, C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleolus; C:plasma membrane;, , P:viral process;|Q8WYZ5 Q96IC3 Q96JJ0 Q9BUW6 Q9H7V0,Dyslexia-associated protein KIAA0319-like protein {ECO:0000305|PubMed:20697954},Adeno-associated virus receptor {ECO:0000303|PubMed:26814968};, , GO:0031410;GO:0005794;GO:0000139;GO:0016021;GO:0005730;GO:0005886;GO:0016032;, C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleolus; C:plasma membrane;, , P:viral process;|Q8WYZ5 Q96IC3 Q96JJ0 Q9BUW6 Q9H7V0,Dyslexia-associated protein KIAA0319-like protein {ECO:0000305|PubMed:20697954},Adeno-associated virus receptor {ECO:0000303|PubMed:26814968};, , GO:0031410;GO:0005794;GO:0000139;GO:0016021;GO:0005730;GO:0005886;GO:0016032;, C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleolus; C:plasma membrane;, , P:viral process;|Q8WYZ5 Q96IC3 Q96JJ0 Q9BUW6 Q9H7V0,Dyslexia-associated protein KIAA0319-like protein {ECO:0000305|PubMed:20697954},Adeno-associated virus receptor {ECO:0000303|PubMed:26814968};, , GO:0031410;GO:0005794;GO:0000139;GO:0016021;GO:0005730;GO:0005886;GO:0016032;, C:cytoplasmic vesicle; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleolus; C:plasma membrane;, , P:viral process;|Q9UBB6 D3DPR9 Q9UBY2 Q9Y4A6 Q9Y4D9,Neurochondrin,, PF05536;, GO:0005829;GO:0030425;GO:0010008;GO:0016020;GO:0043025;GO:0043204;GO:0098794;GO:0045453;GO:0031175;GO:0048168;, C:cytosol; C:dendrite; C:endosome membrane; C:membrane; C:neuronal cell body; C:perikaryon; C:postsynapse;, , P:bone resorption; P:neuron projection development; P:regulation of neuronal synaptic plasticity;|Q9UBB6 D3DPR9 Q9UBY2 Q9Y4A6 Q9Y4D9,Neurochondrin,, PF05536;, GO:0005829;GO:0030425;GO:0010008;GO:0016020;GO:0043025;GO:0043204;GO:0098794;GO:0045453;GO:0031175;GO:0048168;, C:cytosol; C:dendrite; C:endosome membrane; C:membrane; C:neuronal cell body; C:perikaryon; C:postsynapse;, , P:bone resorption; P:neuron projection development; P:regulation of neuronal synaptic plasticity;|Q9UBB6 D3DPR9 Q9UBY2 Q9Y4A6 Q9Y4D9,Neurochondrin,, PF05536;, GO:0005829;GO:0030425;GO:0010008;GO:0016020;GO:0043025;GO:0043204;GO:0098794;GO:0045453;GO:0031175;GO:0048168;, C:cytosol; C:dendrite; C:endosome membrane; C:membrane; C:neuronal cell body; C:perikaryon; C:postsynapse;, , P:bone resorption; P:neuron projection development; P:regulation of neuronal synaptic plasticity;|Q9UBB6 D3DPR9 Q9UBY2 Q9Y4A6 Q9Y4D9,Neurochondrin,, PF05536;, GO:0005829;GO:0030425;GO:0010008;GO:0016020;GO:0043025;GO:0043204;GO:0098794;GO:0045453;GO:0031175;GO:0048168;, C:cytosol; C:dendrite; C:endosome membrane; C:membrane; C:neuronal cell body; C:perikaryon; C:postsynapse;, , P:bone resorption; P:neuron projection development; P:regulation of neuronal synaptic plasticity;|Q9UBB6 D3DPR9 Q9UBY2 Q9Y4A6 Q9Y4D9,Neurochondrin,, PF05536;, GO:0005829;GO:0030425;GO:0010008;GO:0016020;GO:0043025;GO:0043204;GO:0098794;GO:0045453;GO:0031175;GO:0048168;, C:cytosol; C:dendrite; C:endosome membrane; C:membrane; C:neuronal cell body; C:perikaryon; C:postsynapse;, , P:bone resorption; P:neuron projection development; P:regulation of neuronal synaptic plasticity; scaffold100 indexed_genome mRNA 2183835 2217856 . - . ID=transcript_12838;P49721 D3DPS0 P31145 Q9BWZ9,Proteasome subunit beta type-2,Macropain subunit C7-I;Multicatalytic endopeptidase complex subunit C7-I;Proteasome component C7-I;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0014070;GO:0010243;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to organic cyclic compound; P:response to organonitrogen compound; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P49721 D3DPS0 P31145 Q9BWZ9,Proteasome subunit beta type-2,Macropain subunit C7-I;Multicatalytic endopeptidase complex subunit C7-I;Proteasome component C7-I;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0014070;GO:0010243;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to organic cyclic compound; P:response to organonitrogen compound; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold100 indexed_genome mRNA 2301939 2303662 . - . ID=transcript_12839;Q9HAW4 A6NFL4 Q1RMC6 Q2KHM3 Q5VYG0 Q6P6H5 Q8IWI1,Claspin,, , GO:0005794;GO:0005654;GO:0005634;GO:0010997;GO:0000217;GO:0032147;GO:0000077;GO:0006281;GO:0006260;GO:0000076;GO:0033314;GO:0007095;GO:0018105;GO:0016579;, C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:anaphase-promoting complex binding; F:DNA secondary structure binding;, P:activation of protein kinase activity; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:mitotic DNA replication checkpoint; P:mitotic G2 DNA damage checkpoint; P:peptidyl-serine phosphorylation; P:protein deubiquitination; scaffold100 indexed_genome mRNA 2305239 2309964 . - . ID=transcript_12840;Q9HAW4 A6NFL4 Q1RMC6 Q2KHM3 Q5VYG0 Q6P6H5 Q8IWI1,Claspin,, , GO:0005794;GO:0005654;GO:0005634;GO:0010997;GO:0000217;GO:0032147;GO:0000077;GO:0006281;GO:0006260;GO:0000076;GO:0033314;GO:0007095;GO:0018105;GO:0016579;, C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:anaphase-promoting complex binding; F:DNA secondary structure binding;, P:activation of protein kinase activity; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:mitotic DNA replication checkpoint; P:mitotic G2 DNA damage checkpoint; P:peptidyl-serine phosphorylation; P:protein deubiquitination; scaffold100 indexed_genome mRNA 2368612 2402431 . + . ID=transcript_12841;Q9HCK5 A7MD27,Protein argonaute-4 {ECO:0000255|HAMAP-Rule:MF_03033},Argonaute RISC catalytic component 4;Eukaryotic translation initiation factor 2C 4 {ECO:0000255|HAMAP-Rule:MF_03033};, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0016442;GO:0070578;GO:0003725;GO:0035198;GO:0003727;GO:0030522;GO:0008584;GO:0007140;GO:0035280;GO:0035278;GO:0010586;GO:0006402;GO:0043066;GO:0010629;GO:0010628;GO:0035194;GO:0031054;GO:0035196;GO:0022604;GO:0045652;GO:0060260;GO:0010501;GO:0007130;GO:0007223;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleus; C:P-body; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:miRNA binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:male gonad development; P:male meiotic nuclear division; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:miRNA metabolic process; P:mRNA catabolic process; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of gene expression; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of cell morphogenesis; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA secondary structure unwinding; P:synaptonemal complex assembly; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCK5 A7MD27,Protein argonaute-4 {ECO:0000255|HAMAP-Rule:MF_03033},Argonaute RISC catalytic component 4;Eukaryotic translation initiation factor 2C 4 {ECO:0000255|HAMAP-Rule:MF_03033};, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0016442;GO:0070578;GO:0003725;GO:0035198;GO:0003727;GO:0030522;GO:0008584;GO:0007140;GO:0035280;GO:0035278;GO:0010586;GO:0006402;GO:0043066;GO:0010629;GO:0010628;GO:0035194;GO:0031054;GO:0035196;GO:0022604;GO:0045652;GO:0060260;GO:0010501;GO:0007130;GO:0007223;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleus; C:P-body; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:miRNA binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:male gonad development; P:male meiotic nuclear division; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:miRNA metabolic process; P:mRNA catabolic process; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of gene expression; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of cell morphogenesis; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA secondary structure unwinding; P:synaptonemal complex assembly; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCK5 A7MD27,Protein argonaute-4 {ECO:0000255|HAMAP-Rule:MF_03033},Argonaute RISC catalytic component 4;Eukaryotic translation initiation factor 2C 4 {ECO:0000255|HAMAP-Rule:MF_03033};, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0016442;GO:0070578;GO:0003725;GO:0035198;GO:0003727;GO:0030522;GO:0008584;GO:0007140;GO:0035280;GO:0035278;GO:0010586;GO:0006402;GO:0043066;GO:0010629;GO:0010628;GO:0035194;GO:0031054;GO:0035196;GO:0022604;GO:0045652;GO:0060260;GO:0010501;GO:0007130;GO:0007223;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleus; C:P-body; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:miRNA binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:male gonad development; P:male meiotic nuclear division; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:miRNA metabolic process; P:mRNA catabolic process; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of gene expression; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of cell morphogenesis; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA secondary structure unwinding; P:synaptonemal complex assembly; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCK5 A7MD27,Protein argonaute-4 {ECO:0000255|HAMAP-Rule:MF_03033},Argonaute RISC catalytic component 4;Eukaryotic translation initiation factor 2C 4 {ECO:0000255|HAMAP-Rule:MF_03033};, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0016442;GO:0070578;GO:0003725;GO:0035198;GO:0003727;GO:0030522;GO:0008584;GO:0007140;GO:0035280;GO:0035278;GO:0010586;GO:0006402;GO:0043066;GO:0010629;GO:0010628;GO:0035194;GO:0031054;GO:0035196;GO:0022604;GO:0045652;GO:0060260;GO:0010501;GO:0007130;GO:0007223;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleus; C:P-body; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:miRNA binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:male gonad development; P:male meiotic nuclear division; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:miRNA metabolic process; P:mRNA catabolic process; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of gene expression; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of cell morphogenesis; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA secondary structure unwinding; P:synaptonemal complex assembly; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCK5 A7MD27,Protein argonaute-4 {ECO:0000255|HAMAP-Rule:MF_03033},Argonaute RISC catalytic component 4;Eukaryotic translation initiation factor 2C 4 {ECO:0000255|HAMAP-Rule:MF_03033};, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005634;GO:0000932;GO:0016442;GO:0070578;GO:0003725;GO:0035198;GO:0003727;GO:0030522;GO:0008584;GO:0007140;GO:0035280;GO:0035278;GO:0010586;GO:0006402;GO:0043066;GO:0010629;GO:0010628;GO:0035194;GO:0031054;GO:0035196;GO:0022604;GO:0045652;GO:0060260;GO:0010501;GO:0007130;GO:0007223;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleus; C:P-body; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:miRNA binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:male gonad development; P:male meiotic nuclear division; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:miRNA metabolic process; P:mRNA catabolic process; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:positive regulation of gene expression; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of cell morphogenesis; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA secondary structure unwinding; P:synaptonemal complex assembly; P:Wnt signaling pathway, calcium modulating pathway; scaffold100 indexed_genome mRNA 2437253 2466943 . + . ID=transcript_12842;Q9UL18 Q5TA57 Q6P4S0,Protein argonaute-1,Argonaute RISC catalytic component 1;Eukaryotic translation initiation factor 2C 1;Putative RNA-binding protein Q99;, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0005737;GO:0036464;GO:0005829;GO:0005654;GO:0005634;GO:0000932;GO:0005844;GO:1990904;GO:0016442;GO:0070578;GO:0001046;GO:0003725;GO:0035198;GO:0003723;GO:0000993;GO:0003727;GO:0030522;GO:0035280;GO:0035278;GO:0016525;GO:0010629;GO:0000956;GO:0010628;GO:0045944;GO:0035194;GO:0031054;GO:0035196;GO:0060964;GO:0045652;GO:0060260;GO:0090502;GO:0010501;GO:0007223;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nucleoplasm; C:nucleus; C:P-body; C:polysome; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:core promoter sequence-specific DNA binding; F:double-stranded RNA binding; F:miRNA binding; F:RNA binding; F:RNA polymerase II complex binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:negative regulation of angiogenesis; P:negative regulation of gene expression; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:RNA secondary structure unwinding; P:Wnt signaling pathway, calcium modulating pathway;|Q9UL18 Q5TA57 Q6P4S0,Protein argonaute-1,Argonaute RISC catalytic component 1;Eukaryotic translation initiation factor 2C 1;Putative RNA-binding protein Q99;, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0005737;GO:0036464;GO:0005829;GO:0005654;GO:0005634;GO:0000932;GO:0005844;GO:1990904;GO:0016442;GO:0070578;GO:0001046;GO:0003725;GO:0035198;GO:0003723;GO:0000993;GO:0003727;GO:0030522;GO:0035280;GO:0035278;GO:0016525;GO:0010629;GO:0000956;GO:0010628;GO:0045944;GO:0035194;GO:0031054;GO:0035196;GO:0060964;GO:0045652;GO:0060260;GO:0090502;GO:0010501;GO:0007223;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nucleoplasm; C:nucleus; C:P-body; C:polysome; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:core promoter sequence-specific DNA binding; F:double-stranded RNA binding; F:miRNA binding; F:RNA binding; F:RNA polymerase II complex binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:negative regulation of angiogenesis; P:negative regulation of gene expression; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:RNA secondary structure unwinding; P:Wnt signaling pathway, calcium modulating pathway;|Q9UL18 Q5TA57 Q6P4S0,Protein argonaute-1,Argonaute RISC catalytic component 1;Eukaryotic translation initiation factor 2C 1;Putative RNA-binding protein Q99;, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0005737;GO:0036464;GO:0005829;GO:0005654;GO:0005634;GO:0000932;GO:0005844;GO:1990904;GO:0016442;GO:0070578;GO:0001046;GO:0003725;GO:0035198;GO:0003723;GO:0000993;GO:0003727;GO:0030522;GO:0035280;GO:0035278;GO:0016525;GO:0010629;GO:0000956;GO:0010628;GO:0045944;GO:0035194;GO:0031054;GO:0035196;GO:0060964;GO:0045652;GO:0060260;GO:0090502;GO:0010501;GO:0007223;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nucleoplasm; C:nucleus; C:P-body; C:polysome; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:core promoter sequence-specific DNA binding; F:double-stranded RNA binding; F:miRNA binding; F:RNA binding; F:RNA polymerase II complex binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:negative regulation of angiogenesis; P:negative regulation of gene expression; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:RNA secondary structure unwinding; P:Wnt signaling pathway, calcium modulating pathway;|Q9UL18 Q5TA57 Q6P4S0,Protein argonaute-1,Argonaute RISC catalytic component 1;Eukaryotic translation initiation factor 2C 1;Putative RNA-binding protein Q99;, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0005737;GO:0036464;GO:0005829;GO:0005654;GO:0005634;GO:0000932;GO:0005844;GO:1990904;GO:0016442;GO:0070578;GO:0001046;GO:0003725;GO:0035198;GO:0003723;GO:0000993;GO:0003727;GO:0030522;GO:0035280;GO:0035278;GO:0016525;GO:0010629;GO:0000956;GO:0010628;GO:0045944;GO:0035194;GO:0031054;GO:0035196;GO:0060964;GO:0045652;GO:0060260;GO:0090502;GO:0010501;GO:0007223;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nucleoplasm; C:nucleus; C:P-body; C:polysome; C:ribonucleoprotein complex; C:RISC complex; C:RISC-loading complex;, F:core promoter sequence-specific DNA binding; F:double-stranded RNA binding; F:miRNA binding; F:RNA binding; F:RNA polymerase II complex binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:negative regulation of angiogenesis; P:negative regulation of gene expression; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:RNA secondary structure unwinding; P:Wnt signaling pathway, calcium modulating pathway; scaffold100 indexed_genome mRNA 2477240 2592985 . + . ID=transcript_12843;Q9H9G7 B1ALI0 Q5TA55 Q9H1U6,Protein argonaute-3 {ECO:0000255|HAMAP-Rule:MF_03032},Argonaute RISC catalytic component 3;Eukaryotic translation initiation factor 2C 3 {ECO:0000255|HAMAP-Rule:MF_03032};, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0000794;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005654;GO:0000932;GO:0016442;GO:0070578;GO:0003725;GO:0004521;GO:0090624;GO:0046872;GO:0035198;GO:0003723;GO:0003727;GO:0030522;GO:0035280;GO:0035278;GO:0006402;GO:0010629;GO:0010628;GO:1901224;GO:0035194;GO:0031054;GO:0035196;GO:0045652;GO:0072091;GO:0060260;GO:0010501;GO:0007223;, C:condensed nuclear chromosome; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleoplasm; C:P-body; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:endoribonuclease activity; F:endoribonuclease activity, cleaving miRNA-paired mRNA; F:metal ion binding; F:miRNA binding; F:RNA binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:mRNA catabolic process; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of NIK/NF-kappaB signaling; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of stem cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA secondary structure unwinding; P:Wnt signaling pathway, calcium modulating pathway;|Q9H9G7 B1ALI0 Q5TA55 Q9H1U6,Protein argonaute-3 {ECO:0000255|HAMAP-Rule:MF_03032},Argonaute RISC catalytic component 3;Eukaryotic translation initiation factor 2C 3 {ECO:0000255|HAMAP-Rule:MF_03032};, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0000794;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005654;GO:0000932;GO:0016442;GO:0070578;GO:0003725;GO:0004521;GO:0090624;GO:0046872;GO:0035198;GO:0003723;GO:0003727;GO:0030522;GO:0035280;GO:0035278;GO:0006402;GO:0010629;GO:0010628;GO:1901224;GO:0035194;GO:0031054;GO:0035196;GO:0045652;GO:0072091;GO:0060260;GO:0010501;GO:0007223;, C:condensed nuclear chromosome; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleoplasm; C:P-body; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:endoribonuclease activity; F:endoribonuclease activity, cleaving miRNA-paired mRNA; F:metal ion binding; F:miRNA binding; F:RNA binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:mRNA catabolic process; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of NIK/NF-kappaB signaling; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of stem cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA secondary structure unwinding; P:Wnt signaling pathway, calcium modulating pathway;|Q9H9G7 B1ALI0 Q5TA55 Q9H1U6,Protein argonaute-3 {ECO:0000255|HAMAP-Rule:MF_03032},Argonaute RISC catalytic component 3;Eukaryotic translation initiation factor 2C 3 {ECO:0000255|HAMAP-Rule:MF_03032};, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0000794;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005654;GO:0000932;GO:0016442;GO:0070578;GO:0003725;GO:0004521;GO:0090624;GO:0046872;GO:0035198;GO:0003723;GO:0003727;GO:0030522;GO:0035280;GO:0035278;GO:0006402;GO:0010629;GO:0010628;GO:1901224;GO:0035194;GO:0031054;GO:0035196;GO:0045652;GO:0072091;GO:0060260;GO:0010501;GO:0007223;, C:condensed nuclear chromosome; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleoplasm; C:P-body; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:endoribonuclease activity; F:endoribonuclease activity, cleaving miRNA-paired mRNA; F:metal ion binding; F:miRNA binding; F:RNA binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:mRNA catabolic process; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of NIK/NF-kappaB signaling; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of stem cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA secondary structure unwinding; P:Wnt signaling pathway, calcium modulating pathway;|Q9H9G7 B1ALI0 Q5TA55 Q9H1U6,Protein argonaute-3 {ECO:0000255|HAMAP-Rule:MF_03032},Argonaute RISC catalytic component 3;Eukaryotic translation initiation factor 2C 3 {ECO:0000255|HAMAP-Rule:MF_03032};, PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;, GO:0000794;GO:0005737;GO:0036464;GO:0005829;GO:0016020;GO:0005654;GO:0000932;GO:0016442;GO:0070578;GO:0003725;GO:0004521;GO:0090624;GO:0046872;GO:0035198;GO:0003723;GO:0003727;GO:0030522;GO:0035280;GO:0035278;GO:0006402;GO:0010629;GO:0010628;GO:1901224;GO:0035194;GO:0031054;GO:0035196;GO:0045652;GO:0072091;GO:0060260;GO:0010501;GO:0007223;, C:condensed nuclear chromosome; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:membrane; C:nucleoplasm; C:P-body; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:endoribonuclease activity; F:endoribonuclease activity, cleaving miRNA-paired mRNA; F:metal ion binding; F:miRNA binding; F:RNA binding; F:single-stranded RNA binding;, P:intracellular receptor signaling pathway; P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA mediated inhibition of translation; P:mRNA catabolic process; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of NIK/NF-kappaB signaling; P:post-transcriptional gene silencing by RNA; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of megakaryocyte differentiation; P:regulation of stem cell proliferation; P:regulation of transcription initiation from RNA polymerase II promoter; P:RNA secondary structure unwinding; P:Wnt signaling pathway, calcium modulating pathway; scaffold100 indexed_genome mRNA 2615429 2619768 . + . ID=transcript_12844;Q9UIF3 A6NIS6 O60638,Tektin-2,Tektin-t;Testicular tektin;Testicular tektin B1-like protein;, , GO:0005737;GO:0005874;GO:0015630;GO:0005815;GO:0031514;GO:0005634;GO:0060271;GO:0060294;GO:0030317;GO:0036159;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:motile cilium; C:nucleus;, , P:cilium assembly; P:cilium movement involved in cell motility; P:flagellated sperm motility; P:inner dynein arm assembly; scaffold100 indexed_genome mRNA 2620155 2624971 . + . ID=transcript_12845;Q9NX46 Q53G94 Q6IAB8 Q9BY47,ADP-ribose glycohydrolase ARH3 {ECO:0000305},ADP-ribosylhydrolase 3 {ECO:0000303|PubMed:16278211};O-acetyl-ADP-ribose deacetylase ARH3 {ECO:0000305};Poly(ADP-ribose) glycohydrolase ARH3 {ECO:0000305};[Protein ADP-ribosylarginine] hydrolase-like protein 2 {ECO:0000305};[Protein ADP-ribosylserine] hydrolase {ECO:0000305};, PF03747;, GO:0005759;GO:0005739;GO:0016604;GO:0005654;GO:0005634;GO:0090734;GO:0140292;GO:0004553;GO:0000287;GO:0061463;GO:0004649;GO:0006287;GO:0071451;GO:0006281;GO:0140290;, C:mitochondrial matrix; C:mitochondrion; C:nuclear body; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:ADP-ribosylserine hydrolase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:magnesium ion binding; F:O-acetyl-ADP-ribose deacetylase activity; F:poly(ADP-ribose) glycohydrolase activity;, P:base-excision repair, gap-filling; P:cellular response to superoxide; P:DNA repair; P:peptidyl-serine ADP-deribosylation;|Q9NX46 Q53G94 Q6IAB8 Q9BY47,ADP-ribose glycohydrolase ARH3 {ECO:0000305},ADP-ribosylhydrolase 3 {ECO:0000303|PubMed:16278211};O-acetyl-ADP-ribose deacetylase ARH3 {ECO:0000305};Poly(ADP-ribose) glycohydrolase ARH3 {ECO:0000305};[Protein ADP-ribosylarginine] hydrolase-like protein 2 {ECO:0000305};[Protein ADP-ribosylserine] hydrolase {ECO:0000305};, PF03747;, GO:0005759;GO:0005739;GO:0016604;GO:0005654;GO:0005634;GO:0090734;GO:0140292;GO:0004553;GO:0000287;GO:0061463;GO:0004649;GO:0006287;GO:0071451;GO:0006281;GO:0140290;, C:mitochondrial matrix; C:mitochondrion; C:nuclear body; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:ADP-ribosylserine hydrolase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:magnesium ion binding; F:O-acetyl-ADP-ribose deacetylase activity; F:poly(ADP-ribose) glycohydrolase activity;, P:base-excision repair, gap-filling; P:cellular response to superoxide; P:DNA repair; P:peptidyl-serine ADP-deribosylation;|Q9NX46 Q53G94 Q6IAB8 Q9BY47,ADP-ribose glycohydrolase ARH3 {ECO:0000305},ADP-ribosylhydrolase 3 {ECO:0000303|PubMed:16278211};O-acetyl-ADP-ribose deacetylase ARH3 {ECO:0000305};Poly(ADP-ribose) glycohydrolase ARH3 {ECO:0000305};[Protein ADP-ribosylarginine] hydrolase-like protein 2 {ECO:0000305};[Protein ADP-ribosylserine] hydrolase {ECO:0000305};, PF03747;, GO:0005759;GO:0005739;GO:0016604;GO:0005654;GO:0005634;GO:0090734;GO:0140292;GO:0004553;GO:0000287;GO:0061463;GO:0004649;GO:0006287;GO:0071451;GO:0006281;GO:0140290;, C:mitochondrial matrix; C:mitochondrion; C:nuclear body; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:ADP-ribosylserine hydrolase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:magnesium ion binding; F:O-acetyl-ADP-ribose deacetylase activity; F:poly(ADP-ribose) glycohydrolase activity;, P:base-excision repair, gap-filling; P:cellular response to superoxide; P:DNA repair; P:peptidyl-serine ADP-deribosylation;|Q9NX46 Q53G94 Q6IAB8 Q9BY47,ADP-ribose glycohydrolase ARH3 {ECO:0000305},ADP-ribosylhydrolase 3 {ECO:0000303|PubMed:16278211};O-acetyl-ADP-ribose deacetylase ARH3 {ECO:0000305};Poly(ADP-ribose) glycohydrolase ARH3 {ECO:0000305};[Protein ADP-ribosylarginine] hydrolase-like protein 2 {ECO:0000305};[Protein ADP-ribosylserine] hydrolase {ECO:0000305};, PF03747;, GO:0005759;GO:0005739;GO:0016604;GO:0005654;GO:0005634;GO:0090734;GO:0140292;GO:0004553;GO:0000287;GO:0061463;GO:0004649;GO:0006287;GO:0071451;GO:0006281;GO:0140290;, C:mitochondrial matrix; C:mitochondrion; C:nuclear body; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:ADP-ribosylserine hydrolase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:magnesium ion binding; F:O-acetyl-ADP-ribose deacetylase activity; F:poly(ADP-ribose) glycohydrolase activity;, P:base-excision repair, gap-filling; P:cellular response to superoxide; P:DNA repair; P:peptidyl-serine ADP-deribosylation;|Q9NX46 Q53G94 Q6IAB8 Q9BY47,ADP-ribose glycohydrolase ARH3 {ECO:0000305},ADP-ribosylhydrolase 3 {ECO:0000303|PubMed:16278211};O-acetyl-ADP-ribose deacetylase ARH3 {ECO:0000305};Poly(ADP-ribose) glycohydrolase ARH3 {ECO:0000305};[Protein ADP-ribosylarginine] hydrolase-like protein 2 {ECO:0000305};[Protein ADP-ribosylserine] hydrolase {ECO:0000305};, PF03747;, GO:0005759;GO:0005739;GO:0016604;GO:0005654;GO:0005634;GO:0090734;GO:0140292;GO:0004553;GO:0000287;GO:0061463;GO:0004649;GO:0006287;GO:0071451;GO:0006281;GO:0140290;, C:mitochondrial matrix; C:mitochondrion; C:nuclear body; C:nucleoplasm; C:nucleus; C:site of DNA damage;, F:ADP-ribosylserine hydrolase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:magnesium ion binding; F:O-acetyl-ADP-ribose deacetylase activity; F:poly(ADP-ribose) glycohydrolase activity;, P:base-excision repair, gap-filling; P:cellular response to superoxide; P:DNA repair; P:peptidyl-serine ADP-deribosylation; scaffold100 indexed_genome mRNA 2628353 2629600 . + . ID=transcript_12846;P25067 Q5JV31 Q8TEJ5,Collagen alpha-2(VIII) chain,Endothelial collagen;, PF00386;PF01391;, GO:0005604;GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030674;GO:0001525;GO:0048593;GO:0098609;GO:0030199;GO:0050673;GO:0030198;, C:basement membrane; C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:protein-macromolecule adaptor activity;, P:angiogenesis; P:camera-type eye morphogenesis; P:cell-cell adhesion; P:collagen fibril organization; P:epithelial cell proliferation; P:extracellular matrix organization; scaffold100 indexed_genome mRNA 2629625 2650566 . - . ID=transcript_12847;P25067 Q5JV31 Q8TEJ5,Collagen alpha-2(VIII) chain,Endothelial collagen;, PF00386;PF01391;, GO:0005604;GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030674;GO:0001525;GO:0048593;GO:0098609;GO:0030199;GO:0050673;GO:0030198;, C:basement membrane; C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:protein-macromolecule adaptor activity;, P:angiogenesis; P:camera-type eye morphogenesis; P:cell-cell adhesion; P:collagen fibril organization; P:epithelial cell proliferation; P:extracellular matrix organization; scaffold100 indexed_genome mRNA 2659598 2663360 . - . ID=transcript_12848;O43617 A6NDN0 B2RDN2 D3DPS2,Trafficking protein particle complex subunit 3,BET3 homolog;, PF04051;, GO:0033106;GO:0005829;GO:0005783;GO:0005794;GO:0030008;GO:0048208;GO:0006888;GO:0006891;, C:cis-Golgi network membrane; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport;|O43617 A6NDN0 B2RDN2 D3DPS2,Trafficking protein particle complex subunit 3,BET3 homolog;, PF04051;, GO:0033106;GO:0005829;GO:0005783;GO:0005794;GO:0030008;GO:0048208;GO:0006888;GO:0006891;, C:cis-Golgi network membrane; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport;|O43617 A6NDN0 B2RDN2 D3DPS2,Trafficking protein particle complex subunit 3,BET3 homolog;, PF04051;, GO:0033106;GO:0005829;GO:0005783;GO:0005794;GO:0030008;GO:0048208;GO:0006888;GO:0006891;, C:cis-Golgi network membrane; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport;|O43617 A6NDN0 B2RDN2 D3DPS2,Trafficking protein particle complex subunit 3,BET3 homolog;, PF04051;, GO:0033106;GO:0005829;GO:0005783;GO:0005794;GO:0030008;GO:0048208;GO:0006888;GO:0006891;, C:cis-Golgi network membrane; C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; scaffold100 indexed_genome mRNA 2674907 2697466 . + . ID=transcript_12849;Q3KQU3 D3DPS4 Q7L8J5 Q8N905 Q8TAK0 Q9HBQ2 Q9NW29 Q9ULN3,MAP7 domain-containing protein 1,Arginine/proline-rich coiled-coil domain-containing protein 1;Proline/arginine-rich coiled-coil domain-containing protein 1;, PF05672;, GO:0005829;GO:0015630;GO:0005819;GO:0000226;, C:cytosol; C:microtubule cytoskeleton; C:spindle;, , P:microtubule cytoskeleton organization;|Q3KQU3 D3DPS4 Q7L8J5 Q8N905 Q8TAK0 Q9HBQ2 Q9NW29 Q9ULN3,MAP7 domain-containing protein 1,Arginine/proline-rich coiled-coil domain-containing protein 1;Proline/arginine-rich coiled-coil domain-containing protein 1;, PF05672;, GO:0005829;GO:0015630;GO:0005819;GO:0000226;, C:cytosol; C:microtubule cytoskeleton; C:spindle;, , P:microtubule cytoskeleton organization;|Q3KQU3 D3DPS4 Q7L8J5 Q8N905 Q8TAK0 Q9HBQ2 Q9NW29 Q9ULN3,MAP7 domain-containing protein 1,Arginine/proline-rich coiled-coil domain-containing protein 1;Proline/arginine-rich coiled-coil domain-containing protein 1;, PF05672;, GO:0005829;GO:0015630;GO:0005819;GO:0000226;, C:cytosol; C:microtubule cytoskeleton; C:spindle;, , P:microtubule cytoskeleton organization;|Q3KQU3 D3DPS4 Q7L8J5 Q8N905 Q8TAK0 Q9HBQ2 Q9NW29 Q9ULN3,MAP7 domain-containing protein 1,Arginine/proline-rich coiled-coil domain-containing protein 1;Proline/arginine-rich coiled-coil domain-containing protein 1;, PF05672;, GO:0005829;GO:0015630;GO:0005819;GO:0000226;, C:cytosol; C:microtubule cytoskeleton; C:spindle;, , P:microtubule cytoskeleton organization;|Q3KQU3 D3DPS4 Q7L8J5 Q8N905 Q8TAK0 Q9HBQ2 Q9NW29 Q9ULN3,MAP7 domain-containing protein 1,Arginine/proline-rich coiled-coil domain-containing protein 1;Proline/arginine-rich coiled-coil domain-containing protein 1;, PF05672;, GO:0005829;GO:0015630;GO:0005819;GO:0000226;, C:cytosol; C:microtubule cytoskeleton; C:spindle;, , P:microtubule cytoskeleton organization; scaffold100 indexed_genome mRNA 2772051 2787513 . + . ID=transcript_12850;Q9Y2W1 D3DPS5 Q5VTK6,Thyroid hormone receptor-associated protein 3,BCLAF1 and THRAP3 family member 2 {ECO:0000312|HGNC:HGNC:22964};Thyroid hormone receptor-associated protein complex 150 kDa component;, PF15440;, GO:0070062;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0030374;GO:0051219;GO:0003723;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0006397;GO:0048255;GO:0000956;GO:0042753;GO:0048026;GO:0045944;GO:0045893;GO:0000381;GO:0048511;GO:0008380;, C:extracellular exosome; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:nuclear receptor coactivator activity; F:phosphoprotein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:mRNA processing; P:mRNA stabilization; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of circadian rhythm; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of alternative mRNA splicing, via spliceosome; P:rhythmic process; P:RNA splicing;|Q9Y2W1 D3DPS5 Q5VTK6,Thyroid hormone receptor-associated protein 3,BCLAF1 and THRAP3 family member 2 {ECO:0000312|HGNC:HGNC:22964};Thyroid hormone receptor-associated protein complex 150 kDa component;, PF15440;, GO:0070062;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0030374;GO:0051219;GO:0003723;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0006397;GO:0048255;GO:0000956;GO:0042753;GO:0048026;GO:0045944;GO:0045893;GO:0000381;GO:0048511;GO:0008380;, C:extracellular exosome; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:nuclear receptor coactivator activity; F:phosphoprotein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:mRNA processing; P:mRNA stabilization; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of circadian rhythm; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of alternative mRNA splicing, via spliceosome; P:rhythmic process; P:RNA splicing;|Q9Y2W1 D3DPS5 Q5VTK6,Thyroid hormone receptor-associated protein 3,BCLAF1 and THRAP3 family member 2 {ECO:0000312|HGNC:HGNC:22964};Thyroid hormone receptor-associated protein complex 150 kDa component;, PF15440;, GO:0070062;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0030374;GO:0051219;GO:0003723;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0006397;GO:0048255;GO:0000956;GO:0042753;GO:0048026;GO:0045944;GO:0045893;GO:0000381;GO:0048511;GO:0008380;, C:extracellular exosome; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:nuclear receptor coactivator activity; F:phosphoprotein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:mRNA processing; P:mRNA stabilization; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of circadian rhythm; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of alternative mRNA splicing, via spliceosome; P:rhythmic process; P:RNA splicing; scaffold100 indexed_genome mRNA 2787559 2792393 . + . ID=transcript_12851;Q9Y2W1 D3DPS5 Q5VTK6,Thyroid hormone receptor-associated protein 3,BCLAF1 and THRAP3 family member 2 {ECO:0000312|HGNC:HGNC:22964};Thyroid hormone receptor-associated protein complex 150 kDa component;, PF15440;, GO:0070062;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0030374;GO:0051219;GO:0003723;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0006397;GO:0048255;GO:0000956;GO:0042753;GO:0048026;GO:0045944;GO:0045893;GO:0000381;GO:0048511;GO:0008380;, C:extracellular exosome; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:nuclear receptor coactivator activity; F:phosphoprotein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:mRNA processing; P:mRNA stabilization; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of circadian rhythm; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of alternative mRNA splicing, via spliceosome; P:rhythmic process; P:RNA splicing;|Q9Y2W1 D3DPS5 Q5VTK6,Thyroid hormone receptor-associated protein 3,BCLAF1 and THRAP3 family member 2 {ECO:0000312|HGNC:HGNC:22964};Thyroid hormone receptor-associated protein complex 150 kDa component;, PF15440;, GO:0070062;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0030374;GO:0051219;GO:0003723;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0006397;GO:0048255;GO:0000956;GO:0042753;GO:0048026;GO:0045944;GO:0045893;GO:0000381;GO:0048511;GO:0008380;, C:extracellular exosome; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:nuclear receptor coactivator activity; F:phosphoprotein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:mRNA processing; P:mRNA stabilization; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of circadian rhythm; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of alternative mRNA splicing, via spliceosome; P:rhythmic process; P:RNA splicing;|Q9Y2W1 D3DPS5 Q5VTK6,Thyroid hormone receptor-associated protein 3,BCLAF1 and THRAP3 family member 2 {ECO:0000312|HGNC:HGNC:22964};Thyroid hormone receptor-associated protein complex 150 kDa component;, PF15440;, GO:0070062;GO:0016592;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0030374;GO:0051219;GO:0003723;GO:0000978;GO:0046966;GO:0003713;GO:0003712;GO:0042809;GO:0006397;GO:0048255;GO:0000956;GO:0042753;GO:0048026;GO:0045944;GO:0045893;GO:0000381;GO:0048511;GO:0008380;, C:extracellular exosome; C:mediator complex; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:nuclear receptor coactivator activity; F:phosphoprotein binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:thyroid hormone receptor binding; F:transcription coactivator activity; F:transcription coregulator activity; F:vitamin D receptor binding;, P:mRNA processing; P:mRNA stabilization; P:nuclear-transcribed mRNA catabolic process; P:positive regulation of circadian rhythm; P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of alternative mRNA splicing, via spliceosome; P:rhythmic process; P:RNA splicing; scaffold100 indexed_genome mRNA 2793763 2807777 . + . ID=transcript_12852;A4FU49 B4DLI6 D3DPS6 J3KQM5 Q5VTK7 Q86XZ6 Q8N445 Q96DN4 Q9H5W5,SH3 domain-containing protein 21,, PF07653;, GO:0005654;GO:0005886;, C:nucleoplasm; C:plasma membrane; scaffold100 indexed_genome mRNA 2808007 2809087 . - . ID=transcript_12853;Q9NVM1 D3DPS7,Protein eva-1 homolog B,Protein FAM176B;, PF14851;, GO:0016021;, C:integral component of membrane; scaffold100 indexed_genome mRNA 2820797 2857829 . + . ID=transcript_12854;Q9BSA3 Q9H7H6,Serine/threonine-protein kinase 40,SINK-homologous serine/threonine-protein kinase;Sugen kinase 495;, PF00069;, GO:0005829;GO:0005654;GO:0005524;GO:0106310;GO:0106311;GO:0005977;GO:0048286;GO:0060425;GO:0035264;GO:0043066;GO:0010468;GO:0043408;GO:0003016;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:glycogen metabolic process; P:lung alveolus development; P:lung morphogenesis; P:multicellular organism growth; P:negative regulation of apoptotic process; P:regulation of gene expression; P:regulation of MAPK cascade; P:respiratory system process;|Q9BSA3 Q9H7H6,Serine/threonine-protein kinase 40,SINK-homologous serine/threonine-protein kinase;Sugen kinase 495;, PF00069;, GO:0005829;GO:0005654;GO:0005524;GO:0106310;GO:0106311;GO:0005977;GO:0048286;GO:0060425;GO:0035264;GO:0043066;GO:0010468;GO:0043408;GO:0003016;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:glycogen metabolic process; P:lung alveolus development; P:lung morphogenesis; P:multicellular organism growth; P:negative regulation of apoptotic process; P:regulation of gene expression; P:regulation of MAPK cascade; P:respiratory system process;|Q9BSA3 Q9H7H6,Serine/threonine-protein kinase 40,SINK-homologous serine/threonine-protein kinase;Sugen kinase 495;, PF00069;, GO:0005829;GO:0005654;GO:0005524;GO:0106310;GO:0106311;GO:0005977;GO:0048286;GO:0060425;GO:0035264;GO:0043066;GO:0010468;GO:0043408;GO:0003016;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:glycogen metabolic process; P:lung alveolus development; P:lung morphogenesis; P:multicellular organism growth; P:negative regulation of apoptotic process; P:regulation of gene expression; P:regulation of MAPK cascade; P:respiratory system process;|Q9BSA3 Q9H7H6,Serine/threonine-protein kinase 40,SINK-homologous serine/threonine-protein kinase;Sugen kinase 495;, PF00069;, GO:0005829;GO:0005654;GO:0005524;GO:0106310;GO:0106311;GO:0005977;GO:0048286;GO:0060425;GO:0035264;GO:0043066;GO:0010468;GO:0043408;GO:0003016;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:glycogen metabolic process; P:lung alveolus development; P:lung morphogenesis; P:multicellular organism growth; P:negative regulation of apoptotic process; P:regulation of gene expression; P:regulation of MAPK cascade; P:respiratory system process;|Q9BSA3 Q9H7H6,Serine/threonine-protein kinase 40,SINK-homologous serine/threonine-protein kinase;Sugen kinase 495;, PF00069;, GO:0005829;GO:0005654;GO:0005524;GO:0106310;GO:0106311;GO:0005977;GO:0048286;GO:0060425;GO:0035264;GO:0043066;GO:0010468;GO:0043408;GO:0003016;, C:cytosol; C:nucleoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein threonine kinase activity;, P:glycogen metabolic process; P:lung alveolus development; P:lung morphogenesis; P:multicellular organism growth; P:negative regulation of apoptotic process; P:regulation of gene expression; P:regulation of MAPK cascade; P:respiratory system process; scaffold100 indexed_genome mRNA 2863952 2867143 . - . ID=transcript_12855;Q969L4,U7 snRNA-associated Sm-like protein LSm10,, PF01423;, GO:0015030;GO:0016604;GO:0005654;GO:0005683;GO:0071208;GO:0071209;GO:0008334;GO:0006397;GO:1900087;GO:0008380;GO:0006369;, C:Cajal body; C:nuclear body; C:nucleoplasm; C:U7 snRNP;, F:histone pre-mRNA DCP binding; F:U7 snRNA binding;, P:histone mRNA metabolic process; P:mRNA processing; P:positive regulation of G1/S transition of mitotic cell cycle; P:RNA splicing; P:termination of RNA polymerase II transcription; scaffold100 indexed_genome mRNA 2876369 2904819 . - . ID=transcript_12856;Q8WVF1 A6NHM5 A6NHS9 A6NIN9 Q4AEJ0 Q8N7G2 Q8TDF1,Protein OSCP1,Organic solute transport protein 1;Oxidored-nitro domain-containing protein 1;, PF10188;, GO:0009925;GO:0005737;GO:0022857;GO:1990961;, C:basal plasma membrane; C:cytoplasm;, F:transmembrane transporter activity;, P:xenobiotic detoxification by transmembrane export across the plasma membrane;|Q8WVF1 A6NHM5 A6NHS9 A6NIN9 Q4AEJ0 Q8N7G2 Q8TDF1,Protein OSCP1,Organic solute transport protein 1;Oxidored-nitro domain-containing protein 1;, PF10188;, GO:0009925;GO:0005737;GO:0022857;GO:1990961;, C:basal plasma membrane; C:cytoplasm;, F:transmembrane transporter activity;, P:xenobiotic detoxification by transmembrane export across the plasma membrane;|Q8WVF1 A6NHM5 A6NHS9 A6NIN9 Q4AEJ0 Q8N7G2 Q8TDF1,Protein OSCP1,Organic solute transport protein 1;Oxidored-nitro domain-containing protein 1;, PF10188;, GO:0009925;GO:0005737;GO:0022857;GO:1990961;, C:basal plasma membrane; C:cytoplasm;, F:transmembrane transporter activity;, P:xenobiotic detoxification by transmembrane export across the plasma membrane; scaffold100 indexed_genome mRNA 2908172 2915995 . - . ID=transcript_12857;P82914 B2RD82 Q9H2K1,28S ribosomal protein S15, mitochondrial,Mitochondrial small ribosomal subunit protein uS15m {ECO:0000303|PubMed:25838379};, PF00312;, GO:0005743;GO:0005763;GO:0005739;GO:0005730;GO:0005654;GO:0003723;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|P82914 B2RD82 Q9H2K1,28S ribosomal protein S15, mitochondrial,Mitochondrial small ribosomal subunit protein uS15m {ECO:0000303|PubMed:25838379};, PF00312;, GO:0005743;GO:0005763;GO:0005739;GO:0005730;GO:0005654;GO:0003723;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|P82914 B2RD82 Q9H2K1,28S ribosomal protein S15, mitochondrial,Mitochondrial small ribosomal subunit protein uS15m {ECO:0000303|PubMed:25838379};, PF00312;, GO:0005743;GO:0005763;GO:0005739;GO:0005730;GO:0005654;GO:0003723;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold100 indexed_genome mRNA 2917047 2920913 . - . ID=transcript_12858;Q99062,Granulocyte colony-stimulating factor receptor,, PF00041;PF06328;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0051916;GO:0038023;GO:0097186;GO:0007155;GO:0019221;GO:0006952;GO:0030593;GO:0045637;GO:0007165;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:granulocyte colony-stimulating factor binding; F:signaling receptor activity;, P:amelogenesis; P:cell adhesion; P:cytokine-mediated signaling pathway; P:defense response; P:neutrophil chemotaxis; P:regulation of myeloid cell differentiation; P:signal transduction;|Q99062,Granulocyte colony-stimulating factor receptor,, PF00041;PF06328;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0051916;GO:0038023;GO:0097186;GO:0007155;GO:0019221;GO:0006952;GO:0030593;GO:0045637;GO:0007165;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:granulocyte colony-stimulating factor binding; F:signaling receptor activity;, P:amelogenesis; P:cell adhesion; P:cytokine-mediated signaling pathway; P:defense response; P:neutrophil chemotaxis; P:regulation of myeloid cell differentiation; P:signal transduction; scaffold100 indexed_genome mRNA 2921323 2925617 . - . ID=transcript_12859;Q99062,Granulocyte colony-stimulating factor receptor,, PF00041;PF06328;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0051916;GO:0038023;GO:0097186;GO:0007155;GO:0019221;GO:0006952;GO:0030593;GO:0045637;GO:0007165;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:granulocyte colony-stimulating factor binding; F:signaling receptor activity;, P:amelogenesis; P:cell adhesion; P:cytokine-mediated signaling pathway; P:defense response; P:neutrophil chemotaxis; P:regulation of myeloid cell differentiation; P:signal transduction; scaffold100 indexed_genome mRNA 3242831 3305170 . - . ID=transcript_12860;Q13003 A9Z1Z8 B1AMS6 Q13004 Q16136,Glutamate receptor ionotropic, kainate 3,Excitatory amino acid receptor 5;Glutamate receptor 7;, PF01094;PF00060;PF10613;, GO:0030424;GO:0030425;GO:0032839;GO:0098978;GO:0005887;GO:0032983;GO:0043204;GO:0005886;GO:0045211;GO:0042734;GO:0043195;GO:0001640;GO:0008066;GO:0004970;GO:0015277;GO:0015276;GO:0099507;GO:0038023;GO:1904315;GO:0007216;GO:0007215;GO:0050804;GO:0051967;GO:0042391;GO:0035249;, C:axon; C:dendrite; C:dendrite cytoplasm; C:glutamatergic synapse; C:integral component of plasma membrane; C:kainate selective glutamate receptor complex; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:terminal bouton;, F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:glutamate receptor activity; F:ionotropic glutamate receptor activity; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:ligand-gated ion channel activity involved in regulation of presynaptic membrane potential; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:G protein-coupled glutamate receptor signaling pathway; P:glutamate receptor signaling pathway; P:modulation of chemical synaptic transmission; P:negative regulation of synaptic transmission, glutamatergic; P:regulation of membrane potential; P:synaptic transmission, glutamatergic; scaffold100 indexed_genome mRNA 3898527 3905970 . + . ID=transcript_12861;Q5D1E8 D3DPT0 Q6I9Z1 Q9H5P1,Endoribonuclease ZC3H12A {ECO:0000305},Monocyte chemotactic protein-induced protein 1 {ECO:0000303|PubMed:16574901};Regnase-1 {ECO:0000303|PubMed:22037600};Zinc finger CCCH domain-containing protein 12A {ECO:0000312|HGNC:HGNC:26259};, PF18561;PF11977;PF18039;, GO:0005737;GO:0036464;GO:0005856;GO:0042406;GO:0005654;GO:0005634;GO:0000932;GO:0032991;GO:0005791;GO:0030867;GO:0003682;GO:0003677;GO:0004521;GO:0004532;GO:0046872;GO:0035198;GO:0035925;GO:0003730;GO:0003729;GO:0004540;GO:0043022;GO:0003723;GO:0035613;GO:0061158;GO:0001525;GO:0006915;GO:0030154;GO:1990869;GO:0006974;GO:0042149;GO:0071347;GO:1904637;GO:0071222;GO:0034599;GO:1903936;GO:0071356;GO:0098586;GO:0051607;GO:0002757;GO:0006954;GO:0044828;GO:0055118;GO:1900016;GO:0010629;GO:0043124;GO:0032689;GO:0032691;GO:0032715;GO:0043031;GO:0010656;GO:0032088;GO:1901223;GO:0045019;GO:1903799;GO:0001933;GO:2000320;GO:0032720;GO:0007399;GO:0000294;GO:0045766;GO:0010508;GO:0010942;GO:0002230;GO:0010595;GO:1900119;GO:0045600;GO:0010628;GO:0010884;GO:2000627;GO:0061014;GO:1900745;GO:1903003;GO:0042307;GO:2000379;GO:0045944;GO:0051259;GO:0016579;GO:0018215;GO:0010468;GO:0090501;GO:0090502;GO:0050852;GO:0016032;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoskeleton; C:extrinsic component of endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:P-body; C:protein-containing complex; C:rough endoplasmic reticulum; C:rough endoplasmic reticulum membrane;, F:chromatin binding; F:DNA binding; F:endoribonuclease activity; F:exoribonuclease activity; F:metal ion binding; F:miRNA binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:ribonuclease activity; F:ribosome binding; F:RNA binding; F:RNA stem-loop binding;, P:3'-UTR-mediated mRNA destabilization; P:angiogenesis; P:apoptotic process; P:cell differentiation; P:cellular response to chemokine; P:cellular response to DNA damage stimulus; P:cellular response to glucose starvation; P:cellular response to interleukin-1; P:cellular response to ionomycin; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:cellular response to sodium arsenite; P:cellular response to tumor necrosis factor; P:cellular response to virus; P:defense response to virus; P:immune response-activating signal transduction; P:inflammatory response; P:negative regulation by host of viral genome replication; P:negative regulation of cardiac muscle contraction; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of gene expression; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-6 production; P:negative regulation of macrophage activation; P:negative regulation of muscle cell apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of protein phosphorylation; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of tumor necrosis factor production; P:nervous system development; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of cell death; P:positive regulation of defense response to virus by host; P:positive regulation of endothelial cell migration; P:positive regulation of execution phase of apoptosis; P:positive regulation of fat cell differentiation; P:positive regulation of gene expression; P:positive regulation of lipid storage; P:positive regulation of miRNA catabolic process; P:positive regulation of mRNA catabolic process; P:positive regulation of p38MAPK cascade; P:positive regulation of protein deubiquitination; P:positive regulation of protein import into nucleus; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:protein complex oligomerization; P:protein deubiquitination; P:protein phosphopantetheinylation; P:regulation of gene expression; P:RNA phosphodiester bond hydrolysis; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:T cell receptor signaling pathway; P:viral process; scaffold100 indexed_genome mRNA 3906250 3908114 . + . ID=transcript_12862;Q5D1E8 D3DPT0 Q6I9Z1 Q9H5P1,Endoribonuclease ZC3H12A {ECO:0000305},Monocyte chemotactic protein-induced protein 1 {ECO:0000303|PubMed:16574901};Regnase-1 {ECO:0000303|PubMed:22037600};Zinc finger CCCH domain-containing protein 12A {ECO:0000312|HGNC:HGNC:26259};, PF18561;PF11977;PF18039;, GO:0005737;GO:0036464;GO:0005856;GO:0042406;GO:0005654;GO:0005634;GO:0000932;GO:0032991;GO:0005791;GO:0030867;GO:0003682;GO:0003677;GO:0004521;GO:0004532;GO:0046872;GO:0035198;GO:0035925;GO:0003730;GO:0003729;GO:0004540;GO:0043022;GO:0003723;GO:0035613;GO:0061158;GO:0001525;GO:0006915;GO:0030154;GO:1990869;GO:0006974;GO:0042149;GO:0071347;GO:1904637;GO:0071222;GO:0034599;GO:1903936;GO:0071356;GO:0098586;GO:0051607;GO:0002757;GO:0006954;GO:0044828;GO:0055118;GO:1900016;GO:0010629;GO:0043124;GO:0032689;GO:0032691;GO:0032715;GO:0043031;GO:0010656;GO:0032088;GO:1901223;GO:0045019;GO:1903799;GO:0001933;GO:2000320;GO:0032720;GO:0007399;GO:0000294;GO:0045766;GO:0010508;GO:0010942;GO:0002230;GO:0010595;GO:1900119;GO:0045600;GO:0010628;GO:0010884;GO:2000627;GO:0061014;GO:1900745;GO:1903003;GO:0042307;GO:2000379;GO:0045944;GO:0051259;GO:0016579;GO:0018215;GO:0010468;GO:0090501;GO:0090502;GO:0050852;GO:0016032;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoskeleton; C:extrinsic component of endoplasmic reticulum membrane; C:nucleoplasm; C:nucleus; C:P-body; C:protein-containing complex; C:rough endoplasmic reticulum; C:rough endoplasmic reticulum membrane;, F:chromatin binding; F:DNA binding; F:endoribonuclease activity; F:exoribonuclease activity; F:metal ion binding; F:miRNA binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:ribonuclease activity; F:ribosome binding; F:RNA binding; F:RNA stem-loop binding;, P:3'-UTR-mediated mRNA destabilization; P:angiogenesis; P:apoptotic process; P:cell differentiation; P:cellular response to chemokine; P:cellular response to DNA damage stimulus; P:cellular response to glucose starvation; P:cellular response to interleukin-1; P:cellular response to ionomycin; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:cellular response to sodium arsenite; P:cellular response to tumor necrosis factor; P:cellular response to virus; P:defense response to virus; P:immune response-activating signal transduction; P:inflammatory response; P:negative regulation by host of viral genome replication; P:negative regulation of cardiac muscle contraction; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of gene expression; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-6 production; P:negative regulation of macrophage activation; P:negative regulation of muscle cell apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of protein phosphorylation; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of tumor necrosis factor production; P:nervous system development; P:nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of cell death; P:positive regulation of defense response to virus by host; P:positive regulation of endothelial cell migration; P:positive regulation of execution phase of apoptosis; P:positive regulation of fat cell differentiation; P:positive regulation of gene expression; P:positive regulation of lipid storage; P:positive regulation of miRNA catabolic process; P:positive regulation of mRNA catabolic process; P:positive regulation of p38MAPK cascade; P:positive regulation of protein deubiquitination; P:positive regulation of protein import into nucleus; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription by RNA polymerase II; P:protein complex oligomerization; P:protein deubiquitination; P:protein phosphopantetheinylation; P:regulation of gene expression; P:RNA phosphodiester bond hydrolysis; P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:T cell receptor signaling pathway; P:viral process; scaffold100 indexed_genome mRNA 3918435 3940663 . - . ID=transcript_12863;Q9HAF1 B1AK64 Q4F967 Q7Z311 Q86WE3,Chromatin modification-related protein MEAF6,Esa1-associated factor 6 homolog;Sarcoma antigen NY-SAR-91;, PF09340;, GO:0000777;GO:0000776;GO:0070776;GO:1990467;GO:1990468;GO:0035267;GO:0005730;GO:0005654;GO:0043968;GO:0044154;GO:0043972;GO:0043983;GO:0043981;GO:0043982;GO:1901796;, C:condensed chromosome kinetochore; C:kinetochore; C:MOZ/MORF histone acetyltransferase complex; C:NuA3a histone acetyltransferase complex; C:NuA3b histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm;, , P:histone H2A acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:regulation of signal transduction by p53 class mediator;|Q9HAF1 B1AK64 Q4F967 Q7Z311 Q86WE3,Chromatin modification-related protein MEAF6,Esa1-associated factor 6 homolog;Sarcoma antigen NY-SAR-91;, PF09340;, GO:0000777;GO:0000776;GO:0070776;GO:1990467;GO:1990468;GO:0035267;GO:0005730;GO:0005654;GO:0043968;GO:0044154;GO:0043972;GO:0043983;GO:0043981;GO:0043982;GO:1901796;, C:condensed chromosome kinetochore; C:kinetochore; C:MOZ/MORF histone acetyltransferase complex; C:NuA3a histone acetyltransferase complex; C:NuA3b histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm;, , P:histone H2A acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:regulation of signal transduction by p53 class mediator; scaffold100 indexed_genome mRNA 3954333 3967405 . - . ID=transcript_12864;Q8TAD8 Q96SP9 Q9H9T7,Smad nuclear-interacting protein 1,FHA domain-containing protein SNIP1;, PF00498;, GO:0005829;GO:0005654;GO:0005634;GO:0071005;GO:0003729;GO:0003723;GO:0007249;GO:0000398;GO:0035196;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome;, F:mRNA binding; F:RNA binding;, P:I-kappaB kinase/NF-kappaB signaling; P:mRNA splicing, via spliceosome; P:production of miRNAs involved in gene silencing by miRNA; P:regulation of transcription by RNA polymerase II; scaffold100 indexed_genome mRNA 3971379 4001646 . - . ID=transcript_12865;Q13823 Q9BWN7,Nucleolar GTP-binding protein 2,Autoantigen NGP-1;, PF01926;PF08153;, GO:0016020;GO:0005730;GO:0005634;GO:0005525;GO:0003924;GO:0003723;GO:0042254;, C:membrane; C:nucleolus; C:nucleus;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:ribosome biogenesis;|Q13823 Q9BWN7,Nucleolar GTP-binding protein 2,Autoantigen NGP-1;, PF01926;PF08153;, GO:0016020;GO:0005730;GO:0005634;GO:0005525;GO:0003924;GO:0003723;GO:0042254;, C:membrane; C:nucleolus; C:nucleus;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:ribosome biogenesis;|Q13823 Q9BWN7,Nucleolar GTP-binding protein 2,Autoantigen NGP-1;, PF01926;PF08153;, GO:0016020;GO:0005730;GO:0005634;GO:0005525;GO:0003924;GO:0003723;GO:0042254;, C:membrane; C:nucleolus; C:nucleus;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:ribosome biogenesis;|Q13823 Q9BWN7,Nucleolar GTP-binding protein 2,Autoantigen NGP-1;, PF01926;PF08153;, GO:0016020;GO:0005730;GO:0005634;GO:0005525;GO:0003924;GO:0003723;GO:0042254;, C:membrane; C:nucleolus; C:nucleus;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:ribosome biogenesis;|Q13823 Q9BWN7,Nucleolar GTP-binding protein 2,Autoantigen NGP-1;, PF01926;PF08153;, GO:0016020;GO:0005730;GO:0005634;GO:0005525;GO:0003924;GO:0003723;GO:0042254;, C:membrane; C:nucleolus; C:nucleus;, F:GTP binding; F:GTPase activity; F:RNA binding;, P:ribosome biogenesis; scaffold100 indexed_genome mRNA 4018226 4020276 . - . ID=transcript_12866;Q2MKA7 A2A420 Q0H8S6 Q14C72 Q5T0F2 Q8N7L5,R-spondin-1,Roof plate-specific spondin-1;, PF15913;PF00090;, GO:0005576;GO:0005634;GO:0001664;GO:0008201;GO:0005102;GO:0090263;GO:0001934;GO:0030177;GO:0002090;GO:0016055;, C:extracellular region; C:nucleus;, F:G protein-coupled receptor binding; F:heparin binding; F:signaling receptor binding;, P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of protein phosphorylation; P:positive regulation of Wnt signaling pathway; P:regulation of receptor internalization; P:Wnt signaling pathway; scaffold100 indexed_genome mRNA 4086880 4091581 . - . ID=transcript_12867;Q9NX04 D3DPT1 Q8WVD1,Uncharacterized protein C1orf109 {ECO:0000305},, PF15011;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; scaffold100 indexed_genome mRNA 4094193 4095164 . - . ID=transcript_12868;Q9NX04 D3DPT1 Q8WVD1,Uncharacterized protein C1orf109 {ECO:0000305},, PF15011;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; scaffold100 indexed_genome mRNA 4114435 4155757 . - . ID=transcript_12869;Q5JZY3 A4FU89 J3KPB5 Q6NW42,Ephrin type-A receptor 10,, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0005576;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0004714;GO:0005005;GO:0007411;GO:0048013;GO:0007275;GO:0033674;GO:0007169;, C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:ephrin receptor signaling pathway; P:multicellular organism development; P:positive regulation of kinase activity; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q5JZY3 A4FU89 J3KPB5 Q6NW42,Ephrin type-A receptor 10,, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0005576;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0004714;GO:0005005;GO:0007411;GO:0048013;GO:0007275;GO:0033674;GO:0007169;, C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:ephrin receptor signaling pathway; P:multicellular organism development; P:positive regulation of kinase activity; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q5JZY3 A4FU89 J3KPB5 Q6NW42,Ephrin type-A receptor 10,, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0005576;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0004714;GO:0005005;GO:0007411;GO:0048013;GO:0007275;GO:0033674;GO:0007169;, C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:axon guidance; P:ephrin receptor signaling pathway; P:multicellular organism development; P:positive regulation of kinase activity; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold100 indexed_genome mRNA 4192531 4193736 . + . ID=transcript_12870;Q5VSG8 Q6DD86 Q6P497 Q8N5P8 Q96G55 Q96N42,Glycoprotein endo-alpha-1,2-mannosidase-like protein,, PF16317;, GO:0005794;GO:0000139;GO:0016021;GO:0004559;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:alpha-mannosidase activity; scaffold100 indexed_genome mRNA 4197257 4197956 . - . ID=transcript_12871;Q86U90 Q4W4X8 Q6NVW3 Q7L4E4 Q7Z2I4 Q9H5F8,YrdC domain-containing protein, mitochondrial,Dopamine receptor-interacting protein 3;Ischemia/reperfusion-inducible protein homolog;, PF01300;, GO:0005737;GO:0016020;GO:0005739;GO:0003725;GO:0016779;GO:0000049;GO:0051051;GO:0006450;, C:cytoplasm; C:membrane; C:mitochondrion;, F:double-stranded RNA binding; F:nucleotidyltransferase activity; F:tRNA binding;, P:negative regulation of transport; P:regulation of translational fidelity; scaffold100 indexed_genome mRNA 4204930 4247999 . + . ID=transcript_12872;Q6ZSJ8 A2RQF4 E9PQ13 Q56A71,Uncharacterized protein C1orf122,Protein ALAESM;, PF15855;|Q14872 B2RAK6 Q96CB1,Metal regulatory transcription factor 1,MRE-binding transcription factor;Transcription factor MTF-1;, PF00096;, GO:0005737;GO:0005654;GO:0005634;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0046872;GO:0000978;GO:1990837;GO:1990079;GO:0071294;GO:0007417;GO:0045944;GO:0006357;GO:0046686;GO:0010038;GO:0006979;GO:0006351;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cartilage homeostasis; P:cellular response to zinc ion; P:central nervous system development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to cadmium ion; P:response to metal ion; P:response to oxidative stress; P:transcription, DNA-templated;|Q14872 B2RAK6 Q96CB1,Metal regulatory transcription factor 1,MRE-binding transcription factor;Transcription factor MTF-1;, PF00096;, GO:0005737;GO:0005654;GO:0005634;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0035035;GO:0046872;GO:0000978;GO:1990837;GO:1990079;GO:0071294;GO:0007417;GO:0045944;GO:0006357;GO:0046686;GO:0010038;GO:0006979;GO:0006351;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cartilage homeostasis; P:cellular response to zinc ion; P:central nervous system development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to cadmium ion; P:response to metal ion; P:response to oxidative stress; P:transcription, DNA-templated; scaffold100 indexed_genome mRNA 4249558 4302043 . - . ID=transcript_12873;P32019 C9J6U5 Q5VSG9 Q5VSH0 Q5VSH1 Q658Q5 Q6P6D4 Q6PD53 Q86YE1,Type II inositol 1,4,5-trisphosphate 5-phosphatase,75 kDa inositol polyphosphate-5-phosphatase;Phosphoinositide 5-phosphatase;, PF03372;PF16776;PF00620;, GO:0005829;GO:0031901;GO:0005793;GO:0005794;GO:0016021;GO:0016020;GO:0030670;GO:0005886;GO:0052658;GO:0046872;GO:0004439;GO:0030317;GO:0001701;GO:0046855;GO:0043647;GO:0046856;GO:0070613;GO:0051056;GO:0007165;GO:0007283;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane;, F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:flagellated sperm motility; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphatidylinositol dephosphorylation; P:regulation of protein processing; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:spermatogenesis;|P32019 C9J6U5 Q5VSG9 Q5VSH0 Q5VSH1 Q658Q5 Q6P6D4 Q6PD53 Q86YE1,Type II inositol 1,4,5-trisphosphate 5-phosphatase,75 kDa inositol polyphosphate-5-phosphatase;Phosphoinositide 5-phosphatase;, PF03372;PF16776;PF00620;, GO:0005829;GO:0031901;GO:0005793;GO:0005794;GO:0016021;GO:0016020;GO:0030670;GO:0005886;GO:0052658;GO:0046872;GO:0004439;GO:0030317;GO:0001701;GO:0046855;GO:0043647;GO:0046856;GO:0070613;GO:0051056;GO:0007165;GO:0007283;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane;, F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:flagellated sperm motility; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphatidylinositol dephosphorylation; P:regulation of protein processing; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:spermatogenesis;|P32019 C9J6U5 Q5VSG9 Q5VSH0 Q5VSH1 Q658Q5 Q6P6D4 Q6PD53 Q86YE1,Type II inositol 1,4,5-trisphosphate 5-phosphatase,75 kDa inositol polyphosphate-5-phosphatase;Phosphoinositide 5-phosphatase;, PF03372;PF16776;PF00620;, GO:0005829;GO:0031901;GO:0005793;GO:0005794;GO:0016021;GO:0016020;GO:0030670;GO:0005886;GO:0052658;GO:0046872;GO:0004439;GO:0030317;GO:0001701;GO:0046855;GO:0043647;GO:0046856;GO:0070613;GO:0051056;GO:0007165;GO:0007283;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane;, F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:flagellated sperm motility; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphatidylinositol dephosphorylation; P:regulation of protein processing; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:spermatogenesis;|P32019 C9J6U5 Q5VSG9 Q5VSH0 Q5VSH1 Q658Q5 Q6P6D4 Q6PD53 Q86YE1,Type II inositol 1,4,5-trisphosphate 5-phosphatase,75 kDa inositol polyphosphate-5-phosphatase;Phosphoinositide 5-phosphatase;, PF03372;PF16776;PF00620;, GO:0005829;GO:0031901;GO:0005793;GO:0005794;GO:0016021;GO:0016020;GO:0030670;GO:0005886;GO:0052658;GO:0046872;GO:0004439;GO:0030317;GO:0001701;GO:0046855;GO:0043647;GO:0046856;GO:0070613;GO:0051056;GO:0007165;GO:0007283;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane;, F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:flagellated sperm motility; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphatidylinositol dephosphorylation; P:regulation of protein processing; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:spermatogenesis;|P32019 C9J6U5 Q5VSG9 Q5VSH0 Q5VSH1 Q658Q5 Q6P6D4 Q6PD53 Q86YE1,Type II inositol 1,4,5-trisphosphate 5-phosphatase,75 kDa inositol polyphosphate-5-phosphatase;Phosphoinositide 5-phosphatase;, PF03372;PF16776;PF00620;, GO:0005829;GO:0031901;GO:0005793;GO:0005794;GO:0016021;GO:0016020;GO:0030670;GO:0005886;GO:0052658;GO:0046872;GO:0004439;GO:0030317;GO:0001701;GO:0046855;GO:0043647;GO:0046856;GO:0070613;GO:0051056;GO:0007165;GO:0007283;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane;, F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:flagellated sperm motility; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphatidylinositol dephosphorylation; P:regulation of protein processing; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:spermatogenesis;|P32019 C9J6U5 Q5VSG9 Q5VSH0 Q5VSH1 Q658Q5 Q6P6D4 Q6PD53 Q86YE1,Type II inositol 1,4,5-trisphosphate 5-phosphatase,75 kDa inositol polyphosphate-5-phosphatase;Phosphoinositide 5-phosphatase;, PF03372;PF16776;PF00620;, GO:0005829;GO:0031901;GO:0005793;GO:0005794;GO:0016021;GO:0016020;GO:0030670;GO:0005886;GO:0052658;GO:0046872;GO:0004439;GO:0030317;GO:0001701;GO:0046855;GO:0043647;GO:0046856;GO:0070613;GO:0051056;GO:0007165;GO:0007283;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane;, F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:flagellated sperm motility; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphatidylinositol dephosphorylation; P:regulation of protein processing; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:spermatogenesis;|P32019 C9J6U5 Q5VSG9 Q5VSH0 Q5VSH1 Q658Q5 Q6P6D4 Q6PD53 Q86YE1,Type II inositol 1,4,5-trisphosphate 5-phosphatase,75 kDa inositol polyphosphate-5-phosphatase;Phosphoinositide 5-phosphatase;, PF03372;PF16776;PF00620;, GO:0005829;GO:0031901;GO:0005793;GO:0005794;GO:0016021;GO:0016020;GO:0030670;GO:0005886;GO:0052658;GO:0046872;GO:0004439;GO:0030317;GO:0001701;GO:0046855;GO:0043647;GO:0046856;GO:0070613;GO:0051056;GO:0007165;GO:0007283;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane;, F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:flagellated sperm motility; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphatidylinositol dephosphorylation; P:regulation of protein processing; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:spermatogenesis;|P32019 C9J6U5 Q5VSG9 Q5VSH0 Q5VSH1 Q658Q5 Q6P6D4 Q6PD53 Q86YE1,Type II inositol 1,4,5-trisphosphate 5-phosphatase,75 kDa inositol polyphosphate-5-phosphatase;Phosphoinositide 5-phosphatase;, PF03372;PF16776;PF00620;, GO:0005829;GO:0031901;GO:0005793;GO:0005794;GO:0016021;GO:0016020;GO:0030670;GO:0005886;GO:0052658;GO:0046872;GO:0004439;GO:0030317;GO:0001701;GO:0046855;GO:0043647;GO:0046856;GO:0070613;GO:0051056;GO:0007165;GO:0007283;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane;, F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:flagellated sperm motility; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphatidylinositol dephosphorylation; P:regulation of protein processing; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:spermatogenesis;|P32019 C9J6U5 Q5VSG9 Q5VSH0 Q5VSH1 Q658Q5 Q6P6D4 Q6PD53 Q86YE1,Type II inositol 1,4,5-trisphosphate 5-phosphatase,75 kDa inositol polyphosphate-5-phosphatase;Phosphoinositide 5-phosphatase;, PF03372;PF16776;PF00620;, GO:0005829;GO:0031901;GO:0005793;GO:0005794;GO:0016021;GO:0016020;GO:0030670;GO:0005886;GO:0052658;GO:0046872;GO:0004439;GO:0030317;GO:0001701;GO:0046855;GO:0043647;GO:0046856;GO:0070613;GO:0051056;GO:0007165;GO:0007283;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:phagocytic vesicle membrane; C:plasma membrane;, F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:metal ion binding; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:flagellated sperm motility; P:in utero embryonic development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:phosphatidylinositol dephosphorylation; P:regulation of protein processing; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:spermatogenesis; scaffold101 indexed_genome mRNA 223311 266590 . + . ID=transcript_12874;Q8N3T1 A6NMN1 B2R638 F1LIP6 Q86T60 Q96C46 Q96DJ5,Polypeptide N-acetylgalactosaminyltransferase 15,Polypeptide GalNAc transferase-like protein 2;Polypeptide N-acetylgalactosaminyltransferase-like protein 2;Protein-UDP acetylgalactosaminyltransferase-like protein 2;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030133;GO:0030246;GO:0046872;GO:0004653;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing;|Q8N3T1 A6NMN1 B2R638 F1LIP6 Q86T60 Q96C46 Q96DJ5,Polypeptide N-acetylgalactosaminyltransferase 15,Polypeptide GalNAc transferase-like protein 2;Polypeptide N-acetylgalactosaminyltransferase-like protein 2;Protein-UDP acetylgalactosaminyltransferase-like protein 2;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030133;GO:0030246;GO:0046872;GO:0004653;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing;|Q8N3T1 A6NMN1 B2R638 F1LIP6 Q86T60 Q96C46 Q96DJ5,Polypeptide N-acetylgalactosaminyltransferase 15,Polypeptide GalNAc transferase-like protein 2;Polypeptide N-acetylgalactosaminyltransferase-like protein 2;Protein-UDP acetylgalactosaminyltransferase-like protein 2;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030133;GO:0030246;GO:0046872;GO:0004653;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing;|Q8N3T1 A6NMN1 B2R638 F1LIP6 Q86T60 Q96C46 Q96DJ5,Polypeptide N-acetylgalactosaminyltransferase 15,Polypeptide GalNAc transferase-like protein 2;Polypeptide N-acetylgalactosaminyltransferase-like protein 2;Protein-UDP acetylgalactosaminyltransferase-like protein 2;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030133;GO:0030246;GO:0046872;GO:0004653;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing;|Q8N3T1 A6NMN1 B2R638 F1LIP6 Q86T60 Q96C46 Q96DJ5,Polypeptide N-acetylgalactosaminyltransferase 15,Polypeptide GalNAc transferase-like protein 2;Polypeptide N-acetylgalactosaminyltransferase-like protein 2;Protein-UDP acetylgalactosaminyltransferase-like protein 2;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030133;GO:0030246;GO:0046872;GO:0004653;GO:0016266;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:carbohydrate binding; F:metal ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; scaffold101 indexed_genome mRNA 295831 301592 . - . ID=transcript_12875;Q96FX2,DPH3 homolog,CSL-type zinc finger-containing protein 2;DelGEF-interacting protein 1;, PF05207;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046872;GO:0050709;GO:0017183;GO:0051099;GO:0002098;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:metal ion binding;, P:negative regulation of protein secretion; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; P:positive regulation of binding; P:tRNA wobble uridine modification; scaffold101 indexed_genome mRNA 310663 347701 . + . ID=transcript_12876;Q96HP4 Q2HYC7 Q59FA4,Oxidoreductase NAD-binding domain-containing protein 1,, PF00175;, GO:0016491;, , F:oxidoreductase activity;|Q96HP4 Q2HYC7 Q59FA4,Oxidoreductase NAD-binding domain-containing protein 1,, PF00175;, GO:0016491;, , F:oxidoreductase activity;|Q96HP4 Q2HYC7 Q59FA4,Oxidoreductase NAD-binding domain-containing protein 1,, PF00175;, GO:0016491;, , F:oxidoreductase activity;|Q96HP4 Q2HYC7 Q59FA4,Oxidoreductase NAD-binding domain-containing protein 1,, PF00175;, GO:0016491;, , F:oxidoreductase activity; scaffold101 indexed_genome mRNA 987850 1372987 . - . ID=transcript_12877;Q9UPR0 A8K5V4 Q8N498 Q9H8L0 Q9UFP9,Inactive phospholipase C-like protein 2,Phospholipase C-epsilon-2;, PF00168;PF09279;PF16457;PF00388;PF00387;, GO:0005737;GO:0050811;GO:0070679;GO:0004435;GO:0002322;GO:0002337;GO:0007214;GO:0006629;GO:0050859;GO:0120163;GO:0048015;GO:1900122;GO:0033135;GO:0032228;, C:cytoplasm;, F:GABA receptor binding; F:inositol 1,4,5 trisphosphate binding; F:phosphatidylinositol phospholipase C activity;, P:B cell proliferation involved in immune response; P:B-1a B cell differentiation; P:gamma-aminobutyric acid signaling pathway; P:lipid metabolic process; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of cold-induced thermogenesis; P:phosphatidylinositol-mediated signaling; P:positive regulation of receptor binding; P:regulation of peptidyl-serine phosphorylation; P:regulation of synaptic transmission, GABAergic; scaffold101 indexed_genome mRNA 2328314 2403319 . - . ID=transcript_12878;Q01826 B3KXF1 C9JTR6 Q59EQ0,DNA-binding protein SATB1,Special AT-rich sequence-binding protein 1;, PF02376;PF16557;PF00046;PF16534;, GO:0000785;GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0016605;GO:0000981;GO:0001227;GO:0003690;GO:0000978;GO:0000977;GO:0043565;GO:0006325;GO:0006338;GO:0000122;GO:0006357;GO:0016032;, C:chromatin; C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:chromatin remodeling; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:viral process; scaffold101 indexed_genome mRNA 3170777 3417813 . + . ID=transcript_12879;Q96L42 B7Z2I7 Q59GQ6,Potassium voltage-gated channel subfamily H member 8,ELK1;Ether-a-go-go-like potassium channel 3;Voltage-gated potassium channel subunit Kv12.1;, PF00027;PF00520;PF13426;, GO:0005887;GO:0005886;GO:0005249;GO:0071805;GO:0034765;GO:0042391;, C:integral component of plasma membrane; C:plasma membrane;, F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; scaffold101 indexed_genome mRNA 3518949 3567009 . + . ID=transcript_12880;Q96L42 B7Z2I7 Q59GQ6,Potassium voltage-gated channel subfamily H member 8,ELK1;Ether-a-go-go-like potassium channel 3;Voltage-gated potassium channel subunit Kv12.1;, PF00027;PF00520;PF13426;, GO:0005887;GO:0005886;GO:0005249;GO:0071805;GO:0034765;GO:0042391;, C:integral component of plasma membrane; C:plasma membrane;, F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; scaffold101 indexed_genome mRNA 3965176 3993555 . + . ID=transcript_12881;P20339 B4DJA5 Q6FI44,Ras-related protein Rab-5A,, PF00071;, GO:0015629;GO:0098993;GO:0030424;GO:0043679;GO:0030669;GO:0005737;GO:0098559;GO:0005829;GO:0030425;GO:0005769;GO:0031901;GO:0032009;GO:0030139;GO:0012505;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0042470;GO:0045121;GO:0043025;GO:0005654;GO:0045335;GO:0030670;GO:0005886;GO:0098842;GO:0001726;GO:0036477;GO:0008021;GO:0043195;GO:0019003;GO:0005525;GO:0003924;GO:0150093;GO:0007596;GO:0045022;GO:0006897;GO:0006886;GO:0061024;GO:0006909;GO:0006661;GO:0045921;GO:0043687;GO:2000286;GO:2000785;GO:0030100;GO:0051036;GO:0051489;GO:0048169;GO:2000300;GO:0036465;GO:0039694;, C:actin cytoskeleton; C:anchored component of synaptic vesicle membrane; C:axon; C:axon terminus; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytoplasmic side of early endosome membrane; C:cytosol; C:dendrite; C:early endosome; C:early endosome membrane; C:early phagosome; C:endocytic vesicle; C:endomembrane system; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane raft; C:neuronal cell body; C:nucleoplasm; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynaptic early endosome; C:ruffle; C:somatodendritic compartment; C:synaptic vesicle; C:terminal bouton;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:amyloid-beta clearance by transcytosis; P:blood coagulation; P:early endosome to late endosome transport; P:endocytosis; P:intracellular protein transport; P:membrane organization; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:positive regulation of exocytosis; P:post-translational protein modification; P:receptor internalization involved in canonical Wnt signaling pathway; P:regulation of autophagosome assembly; P:regulation of endocytosis; P:regulation of endosome size; P:regulation of filopodium assembly; P:regulation of long-term neuronal synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:synaptic vesicle recycling; P:viral RNA genome replication;|P20339 B4DJA5 Q6FI44,Ras-related protein Rab-5A,, PF00071;, GO:0015629;GO:0098993;GO:0030424;GO:0043679;GO:0030669;GO:0005737;GO:0098559;GO:0005829;GO:0030425;GO:0005769;GO:0031901;GO:0032009;GO:0030139;GO:0012505;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0042470;GO:0045121;GO:0043025;GO:0005654;GO:0045335;GO:0030670;GO:0005886;GO:0098842;GO:0001726;GO:0036477;GO:0008021;GO:0043195;GO:0019003;GO:0005525;GO:0003924;GO:0150093;GO:0007596;GO:0045022;GO:0006897;GO:0006886;GO:0061024;GO:0006909;GO:0006661;GO:0045921;GO:0043687;GO:2000286;GO:2000785;GO:0030100;GO:0051036;GO:0051489;GO:0048169;GO:2000300;GO:0036465;GO:0039694;, C:actin cytoskeleton; C:anchored component of synaptic vesicle membrane; C:axon; C:axon terminus; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytoplasmic side of early endosome membrane; C:cytosol; C:dendrite; C:early endosome; C:early endosome membrane; C:early phagosome; C:endocytic vesicle; C:endomembrane system; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane raft; C:neuronal cell body; C:nucleoplasm; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynaptic early endosome; C:ruffle; C:somatodendritic compartment; C:synaptic vesicle; C:terminal bouton;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:amyloid-beta clearance by transcytosis; P:blood coagulation; P:early endosome to late endosome transport; P:endocytosis; P:intracellular protein transport; P:membrane organization; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:positive regulation of exocytosis; P:post-translational protein modification; P:receptor internalization involved in canonical Wnt signaling pathway; P:regulation of autophagosome assembly; P:regulation of endocytosis; P:regulation of endosome size; P:regulation of filopodium assembly; P:regulation of long-term neuronal synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:synaptic vesicle recycling; P:viral RNA genome replication;|P20339 B4DJA5 Q6FI44,Ras-related protein Rab-5A,, PF00071;, GO:0015629;GO:0098993;GO:0030424;GO:0043679;GO:0030669;GO:0005737;GO:0098559;GO:0005829;GO:0030425;GO:0005769;GO:0031901;GO:0032009;GO:0030139;GO:0012505;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0042470;GO:0045121;GO:0043025;GO:0005654;GO:0045335;GO:0030670;GO:0005886;GO:0098842;GO:0001726;GO:0036477;GO:0008021;GO:0043195;GO:0019003;GO:0005525;GO:0003924;GO:0150093;GO:0007596;GO:0045022;GO:0006897;GO:0006886;GO:0061024;GO:0006909;GO:0006661;GO:0045921;GO:0043687;GO:2000286;GO:2000785;GO:0030100;GO:0051036;GO:0051489;GO:0048169;GO:2000300;GO:0036465;GO:0039694;, C:actin cytoskeleton; C:anchored component of synaptic vesicle membrane; C:axon; C:axon terminus; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:cytoplasmic side of early endosome membrane; C:cytosol; C:dendrite; C:early endosome; C:early endosome membrane; C:early phagosome; C:endocytic vesicle; C:endomembrane system; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane raft; C:neuronal cell body; C:nucleoplasm; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynaptic early endosome; C:ruffle; C:somatodendritic compartment; C:synaptic vesicle; C:terminal bouton;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:amyloid-beta clearance by transcytosis; P:blood coagulation; P:early endosome to late endosome transport; P:endocytosis; P:intracellular protein transport; P:membrane organization; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:positive regulation of exocytosis; P:post-translational protein modification; P:receptor internalization involved in canonical Wnt signaling pathway; P:regulation of autophagosome assembly; P:regulation of endocytosis; P:regulation of endosome size; P:regulation of filopodium assembly; P:regulation of long-term neuronal synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:synaptic vesicle recycling; P:viral RNA genome replication; scaffold101 indexed_genome mRNA 4060130 4132747 . - . ID=transcript_12882;Q92831 Q6NSK1,Histone acetyltransferase KAT2B,Histone acetyltransferase PCAF {ECO:0000303|PubMed:12486002};Lysine acetyltransferase 2B {ECO:0000303|PubMed:27796307};P300/CBP-associated factor {ECO:0000303|PubMed:12486002};Spermidine acetyltransferase KAT2B;, PF00583;PF00439;PF06466;, GO:0031672;GO:0042641;GO:0005671;GO:0005813;GO:0005829;GO:0031674;GO:0000776;GO:0005654;GO:0005634;GO:0000125;GO:0032991;GO:0016407;GO:0003682;GO:0004861;GO:0004145;GO:0004402;GO:0042826;GO:0004468;GO:0061733;GO:0019901;GO:0000977;GO:0003713;GO:0003712;GO:0008134;GO:0007050;GO:0032869;GO:0006338;GO:0007507;GO:0043966;GO:0043970;GO:0018393;GO:0060173;GO:0018076;GO:0008285;GO:0046600;GO:2000233;GO:0007219;GO:0018394;GO:0045815;GO:0045722;GO:0045747;GO:0045944;GO:0007221;GO:0006473;GO:0016579;GO:0045652;GO:0010835;GO:0048511;GO:0006367;GO:0016032;, C:A band; C:actomyosin; C:Ada2/Gcn5/Ada3 transcription activator complex; C:centrosome; C:cytosol; C:I band; C:kinetochore; C:nucleoplasm; C:nucleus; C:PCAF complex; C:protein-containing complex;, F:acetyltransferase activity; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:diamine N-acetyltransferase activity; F:histone acetyltransferase activity; F:histone deacetylase binding; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:peptide-lysine-N-acetyltransferase activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cell cycle arrest; P:cellular response to insulin stimulus; P:chromatin remodeling; P:heart development; P:histone H3 acetylation; P:histone H3-K9 acetylation; P:internal peptidyl-lysine acetylation; P:limb development; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of cell population proliferation; P:negative regulation of centriole replication; P:negative regulation of rRNA processing; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:positive regulation of gene expression, epigenetic; P:positive regulation of gluconeogenesis; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:protein acetylation; P:protein deubiquitination; P:regulation of megakaryocyte differentiation; P:regulation of protein ADP-ribosylation; P:rhythmic process; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q92831 Q6NSK1,Histone acetyltransferase KAT2B,Histone acetyltransferase PCAF {ECO:0000303|PubMed:12486002};Lysine acetyltransferase 2B {ECO:0000303|PubMed:27796307};P300/CBP-associated factor {ECO:0000303|PubMed:12486002};Spermidine acetyltransferase KAT2B;, PF00583;PF00439;PF06466;, GO:0031672;GO:0042641;GO:0005671;GO:0005813;GO:0005829;GO:0031674;GO:0000776;GO:0005654;GO:0005634;GO:0000125;GO:0032991;GO:0016407;GO:0003682;GO:0004861;GO:0004145;GO:0004402;GO:0042826;GO:0004468;GO:0061733;GO:0019901;GO:0000977;GO:0003713;GO:0003712;GO:0008134;GO:0007050;GO:0032869;GO:0006338;GO:0007507;GO:0043966;GO:0043970;GO:0018393;GO:0060173;GO:0018076;GO:0008285;GO:0046600;GO:2000233;GO:0007219;GO:0018394;GO:0045815;GO:0045722;GO:0045747;GO:0045944;GO:0007221;GO:0006473;GO:0016579;GO:0045652;GO:0010835;GO:0048511;GO:0006367;GO:0016032;, C:A band; C:actomyosin; C:Ada2/Gcn5/Ada3 transcription activator complex; C:centrosome; C:cytosol; C:I band; C:kinetochore; C:nucleoplasm; C:nucleus; C:PCAF complex; C:protein-containing complex;, F:acetyltransferase activity; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:diamine N-acetyltransferase activity; F:histone acetyltransferase activity; F:histone deacetylase binding; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:peptide-lysine-N-acetyltransferase activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cell cycle arrest; P:cellular response to insulin stimulus; P:chromatin remodeling; P:heart development; P:histone H3 acetylation; P:histone H3-K9 acetylation; P:internal peptidyl-lysine acetylation; P:limb development; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of cell population proliferation; P:negative regulation of centriole replication; P:negative regulation of rRNA processing; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:positive regulation of gene expression, epigenetic; P:positive regulation of gluconeogenesis; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:protein acetylation; P:protein deubiquitination; P:regulation of megakaryocyte differentiation; P:regulation of protein ADP-ribosylation; P:rhythmic process; P:transcription initiation from RNA polymerase II promoter; P:viral process; scaffold101 indexed_genome mRNA 4132779 4133796 . - . ID=transcript_12883;Q92831 Q6NSK1,Histone acetyltransferase KAT2B,Histone acetyltransferase PCAF {ECO:0000303|PubMed:12486002};Lysine acetyltransferase 2B {ECO:0000303|PubMed:27796307};P300/CBP-associated factor {ECO:0000303|PubMed:12486002};Spermidine acetyltransferase KAT2B;, PF00583;PF00439;PF06466;, GO:0031672;GO:0042641;GO:0005671;GO:0005813;GO:0005829;GO:0031674;GO:0000776;GO:0005654;GO:0005634;GO:0000125;GO:0032991;GO:0016407;GO:0003682;GO:0004861;GO:0004145;GO:0004402;GO:0042826;GO:0004468;GO:0061733;GO:0019901;GO:0000977;GO:0003713;GO:0003712;GO:0008134;GO:0007050;GO:0032869;GO:0006338;GO:0007507;GO:0043966;GO:0043970;GO:0018393;GO:0060173;GO:0018076;GO:0008285;GO:0046600;GO:2000233;GO:0007219;GO:0018394;GO:0045815;GO:0045722;GO:0045747;GO:0045944;GO:0007221;GO:0006473;GO:0016579;GO:0045652;GO:0010835;GO:0048511;GO:0006367;GO:0016032;, C:A band; C:actomyosin; C:Ada2/Gcn5/Ada3 transcription activator complex; C:centrosome; C:cytosol; C:I band; C:kinetochore; C:nucleoplasm; C:nucleus; C:PCAF complex; C:protein-containing complex;, F:acetyltransferase activity; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:diamine N-acetyltransferase activity; F:histone acetyltransferase activity; F:histone deacetylase binding; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:peptide-lysine-N-acetyltransferase activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cell cycle arrest; P:cellular response to insulin stimulus; P:chromatin remodeling; P:heart development; P:histone H3 acetylation; P:histone H3-K9 acetylation; P:internal peptidyl-lysine acetylation; P:limb development; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of cell population proliferation; P:negative regulation of centriole replication; P:negative regulation of rRNA processing; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:positive regulation of gene expression, epigenetic; P:positive regulation of gluconeogenesis; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:protein acetylation; P:protein deubiquitination; P:regulation of megakaryocyte differentiation; P:regulation of protein ADP-ribosylation; P:rhythmic process; P:transcription initiation from RNA polymerase II promoter; P:viral process; scaffold101 indexed_genome mRNA 4139236 4142531 . + . ID=transcript_12884;Q92831 Q6NSK1,Histone acetyltransferase KAT2B,Histone acetyltransferase PCAF {ECO:0000303|PubMed:12486002};Lysine acetyltransferase 2B {ECO:0000303|PubMed:27796307};P300/CBP-associated factor {ECO:0000303|PubMed:12486002};Spermidine acetyltransferase KAT2B;, PF00583;PF00439;PF06466;, GO:0031672;GO:0042641;GO:0005671;GO:0005813;GO:0005829;GO:0031674;GO:0000776;GO:0005654;GO:0005634;GO:0000125;GO:0032991;GO:0016407;GO:0003682;GO:0004861;GO:0004145;GO:0004402;GO:0042826;GO:0004468;GO:0061733;GO:0019901;GO:0000977;GO:0003713;GO:0003712;GO:0008134;GO:0007050;GO:0032869;GO:0006338;GO:0007507;GO:0043966;GO:0043970;GO:0018393;GO:0060173;GO:0018076;GO:0008285;GO:0046600;GO:2000233;GO:0007219;GO:0018394;GO:0045815;GO:0045722;GO:0045747;GO:0045944;GO:0007221;GO:0006473;GO:0016579;GO:0045652;GO:0010835;GO:0048511;GO:0006367;GO:0016032;, C:A band; C:actomyosin; C:Ada2/Gcn5/Ada3 transcription activator complex; C:centrosome; C:cytosol; C:I band; C:kinetochore; C:nucleoplasm; C:nucleus; C:PCAF complex; C:protein-containing complex;, F:acetyltransferase activity; F:chromatin binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:diamine N-acetyltransferase activity; F:histone acetyltransferase activity; F:histone deacetylase binding; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; F:peptide-lysine-N-acetyltransferase activity; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cell cycle arrest; P:cellular response to insulin stimulus; P:chromatin remodeling; P:heart development; P:histone H3 acetylation; P:histone H3-K9 acetylation; P:internal peptidyl-lysine acetylation; P:limb development; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of cell population proliferation; P:negative regulation of centriole replication; P:negative regulation of rRNA processing; P:Notch signaling pathway; P:peptidyl-lysine acetylation; P:positive regulation of gene expression, epigenetic; P:positive regulation of gluconeogenesis; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:protein acetylation; P:protein deubiquitination; P:regulation of megakaryocyte differentiation; P:regulation of protein ADP-ribosylation; P:rhythmic process; P:transcription initiation from RNA polymerase II promoter; P:viral process; scaffold101 indexed_genome mRNA 4164467 4182303 . - . ID=transcript_12885;Q9H275,Shugoshin 1 {ECO:0000312|HGNC:HGNC:25088},Serologically defined breast cancer antigen NY-BR-85;Shugoshin-like 1;, PF07557;PF07558;, GO:0005813;GO:0000775;GO:0000777;GO:0000779;GO:0005829;GO:0000776;GO:0005654;GO:0000922;GO:0019900;GO:0008608;GO:0051301;GO:0010457;GO:0007059;GO:0045143;GO:0045132;GO:0051177;GO:0071962;GO:0000070;GO:0007052;, C:centrosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:condensed chromosome, centromeric region; C:cytosol; C:kinetochore; C:nucleoplasm; C:spindle pole;, F:kinase binding;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:centriole-centriole cohesion; P:chromosome segregation; P:homologous chromosome segregation; P:meiotic chromosome segregation; P:meiotic sister chromatid cohesion; P:mitotic sister chromatid cohesion, centromeric; P:mitotic sister chromatid segregation; P:mitotic spindle organization; scaffold101 indexed_genome mRNA 4247188 4260752 . - . ID=transcript_12886;Q8TC21 B2R8P4 O95015 Q8N9X0,Zinc finger protein 596,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q8TC21 B2R8P4 O95015 Q8N9X0,Zinc finger protein 596,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold102 indexed_genome mRNA 120977 127889 . - . ID=transcript_12887;Q9BV86 A8K4J2 A8K8G7 Q5SZB9 Q9UI28,N-terminal Xaa-Pro-Lys N-methyltransferase 1,Alpha N-terminal protein methyltransferase 1A;Methyltransferase-like protein 11A;N-terminal RCC1 methyltransferase;X-Pro-Lys N-terminal protein methyltransferase 1A;, PF05891;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0042054;GO:0008168;GO:0071885;GO:0008276;GO:0007059;GO:0016571;GO:0018011;GO:0018012;GO:0018013;GO:0018016;GO:0035568;GO:0035572;GO:0035570;GO:0035573;GO:0006480;GO:0007051;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity; F:methyltransferase activity; F:N-terminal protein N-methyltransferase activity; F:protein methyltransferase activity;, P:chromosome segregation; P:histone methylation; P:N-terminal peptidyl-alanine methylation; P:N-terminal peptidyl-alanine trimethylation; P:N-terminal peptidyl-glycine methylation; P:N-terminal peptidyl-proline dimethylation; P:N-terminal peptidyl-proline methylation; P:N-terminal peptidyl-serine dimethylation; P:N-terminal peptidyl-serine methylation; P:N-terminal peptidyl-serine trimethylation; P:N-terminal protein amino acid methylation; P:spindle organization;|Q9BV86 A8K4J2 A8K8G7 Q5SZB9 Q9UI28,N-terminal Xaa-Pro-Lys N-methyltransferase 1,Alpha N-terminal protein methyltransferase 1A;Methyltransferase-like protein 11A;N-terminal RCC1 methyltransferase;X-Pro-Lys N-terminal protein methyltransferase 1A;, PF05891;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0042054;GO:0008168;GO:0071885;GO:0008276;GO:0007059;GO:0016571;GO:0018011;GO:0018012;GO:0018013;GO:0018016;GO:0035568;GO:0035572;GO:0035570;GO:0035573;GO:0006480;GO:0007051;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity; F:methyltransferase activity; F:N-terminal protein N-methyltransferase activity; F:protein methyltransferase activity;, P:chromosome segregation; P:histone methylation; P:N-terminal peptidyl-alanine methylation; P:N-terminal peptidyl-alanine trimethylation; P:N-terminal peptidyl-glycine methylation; P:N-terminal peptidyl-proline dimethylation; P:N-terminal peptidyl-proline methylation; P:N-terminal peptidyl-serine dimethylation; P:N-terminal peptidyl-serine methylation; P:N-terminal peptidyl-serine trimethylation; P:N-terminal protein amino acid methylation; P:spindle organization; scaffold102 indexed_genome mRNA 128042 133296 . - . ID=transcript_12888;Q9NWX5 Q5SZB7 Q9BV15,Ankyrin repeat and SOCS box protein 6,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q9NWX5 Q5SZB7 Q9BV15,Ankyrin repeat and SOCS box protein 6,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q9NWX5 Q5SZB7 Q9BV15,Ankyrin repeat and SOCS box protein 6,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; scaffold102 indexed_genome mRNA 220041 221243 . - . ID=transcript_12889;O14684 O14900 Q5SZC0,Prostaglandin E synthase,Glutathione peroxidase PTGES;Glutathione transferase PTGES;Microsomal glutathione S-transferase 1-like 1 {ECO:0000303|PubMed:10377395};Microsomal prostaglandin E synthase 1 {ECO:0000303|PubMed:12672824};p53-induced gene 12 protein {ECO:0000303|PubMed:9305847};, PF01124;, GO:0005789;GO:0016021;GO:0016020;GO:0005641;GO:0048471;GO:0043295;GO:0004602;GO:0004364;GO:0004667;GO:0050220;GO:0002526;GO:0002544;GO:0019371;GO:0008285;GO:0032308;GO:0001516;GO:0006693;GO:0031620;GO:0050727;GO:0051592;GO:0034097;GO:0032496;GO:0014070;GO:0032526;GO:0019233;GO:0007165;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear envelope lumen; C:perinuclear region of cytoplasm;, F:glutathione binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:prostaglandin-D synthase activity; F:prostaglandin-E synthase activity;, P:acute inflammatory response; P:chronic inflammatory response; P:cyclooxygenase pathway; P:negative regulation of cell population proliferation; P:positive regulation of prostaglandin secretion; P:prostaglandin biosynthetic process; P:prostaglandin metabolic process; P:regulation of fever generation; P:regulation of inflammatory response; P:response to calcium ion; P:response to cytokine; P:response to lipopolysaccharide; P:response to organic cyclic compound; P:response to retinoic acid; P:sensory perception of pain; P:signal transduction; scaffold102 indexed_genome mRNA 292112 299276 . + . ID=transcript_12890;O14657,Torsin-1B,Torsin ATPase-1B;Torsin family 1 member B;, PF06309;, GO:0005783;GO:0005788;GO:0070062;GO:0005635;GO:0031965;GO:0005524;GO:0016887;GO:0042802;GO:0019894;GO:0051085;GO:0007029;GO:0071763;GO:0034504;GO:0006986;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:nuclear envelope; C:nuclear membrane;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:kinesin binding;, P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum organization; P:nuclear membrane organization; P:protein localization to nucleus; P:response to unfolded protein;|O14657,Torsin-1B,Torsin ATPase-1B;Torsin family 1 member B;, PF06309;, GO:0005783;GO:0005788;GO:0070062;GO:0005635;GO:0031965;GO:0005524;GO:0016887;GO:0042802;GO:0019894;GO:0051085;GO:0007029;GO:0071763;GO:0034504;GO:0006986;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:nuclear envelope; C:nuclear membrane;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:kinesin binding;, P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum organization; P:nuclear membrane organization; P:protein localization to nucleus; P:response to unfolded protein;|O14657,Torsin-1B,Torsin ATPase-1B;Torsin family 1 member B;, PF06309;, GO:0005783;GO:0005788;GO:0070062;GO:0005635;GO:0031965;GO:0005524;GO:0016887;GO:0042802;GO:0019894;GO:0051085;GO:0007029;GO:0071763;GO:0034504;GO:0006986;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:nuclear envelope; C:nuclear membrane;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:kinesin binding;, P:chaperone cofactor-dependent protein refolding; P:endoplasmic reticulum organization; P:nuclear membrane organization; P:protein localization to nucleus; P:response to unfolded protein; scaffold102 indexed_genome mRNA 301330 309352 . - . ID=transcript_12891;O14656 B2RB58 Q53Y64 Q96CA0,Torsin-1A,Dystonia 1 protein;Torsin ATPase-1A;Torsin family 1 member A;, PF06309;, GO:0030659;GO:0005856;GO:0005829;GO:0005783;GO:0005788;GO:0070062;GO:0042406;GO:0030426;GO:0043231;GO:0016020;GO:0005635;GO:0031965;GO:0030141;GO:0008021;GO:0005524;GO:0016887;GO:0008092;GO:0042802;GO:0019894;GO:0051787;GO:0051082;GO:0007155;GO:0051085;GO:0061077;GO:0072321;GO:0071712;GO:0045104;GO:0031175;GO:0006998;GO:0071763;GO:0006996;GO:1900244;GO:0000338;GO:0034504;GO:0051584;GO:2000008;GO:0006979;GO:0048489;GO:0044319;, C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extrinsic component of endoplasmic reticulum membrane; C:growth cone; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope; C:nuclear membrane; C:secretory granule; C:synaptic vesicle;, F:ATP binding; F:ATPase activity; F:cytoskeletal protein binding; F:identical protein binding; F:kinesin binding; F:misfolded protein binding; F:unfolded protein binding;, P:cell adhesion; P:chaperone cofactor-dependent protein refolding; P:chaperone-mediated protein folding; P:chaperone-mediated protein transport; P:ER-associated misfolded protein catabolic process; P:intermediate filament cytoskeleton organization; P:neuron projection development; P:nuclear envelope organization; P:nuclear membrane organization; P:organelle organization; P:positive regulation of synaptic vesicle endocytosis; P:protein deneddylation; P:protein localization to nucleus; P:regulation of dopamine uptake involved in synaptic transmission; P:regulation of protein localization to cell surface; P:response to oxidative stress; P:synaptic vesicle transport; P:wound healing, spreading of cells;|O14656 B2RB58 Q53Y64 Q96CA0,Torsin-1A,Dystonia 1 protein;Torsin ATPase-1A;Torsin family 1 member A;, PF06309;, GO:0030659;GO:0005856;GO:0005829;GO:0005783;GO:0005788;GO:0070062;GO:0042406;GO:0030426;GO:0043231;GO:0016020;GO:0005635;GO:0031965;GO:0030141;GO:0008021;GO:0005524;GO:0016887;GO:0008092;GO:0042802;GO:0019894;GO:0051787;GO:0051082;GO:0007155;GO:0051085;GO:0061077;GO:0072321;GO:0071712;GO:0045104;GO:0031175;GO:0006998;GO:0071763;GO:0006996;GO:1900244;GO:0000338;GO:0034504;GO:0051584;GO:2000008;GO:0006979;GO:0048489;GO:0044319;, C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extrinsic component of endoplasmic reticulum membrane; C:growth cone; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope; C:nuclear membrane; C:secretory granule; C:synaptic vesicle;, F:ATP binding; F:ATPase activity; F:cytoskeletal protein binding; F:identical protein binding; F:kinesin binding; F:misfolded protein binding; F:unfolded protein binding;, P:cell adhesion; P:chaperone cofactor-dependent protein refolding; P:chaperone-mediated protein folding; P:chaperone-mediated protein transport; P:ER-associated misfolded protein catabolic process; P:intermediate filament cytoskeleton organization; P:neuron projection development; P:nuclear envelope organization; P:nuclear membrane organization; P:organelle organization; P:positive regulation of synaptic vesicle endocytosis; P:protein deneddylation; P:protein localization to nucleus; P:regulation of dopamine uptake involved in synaptic transmission; P:regulation of protein localization to cell surface; P:response to oxidative stress; P:synaptic vesicle transport; P:wound healing, spreading of cells;|O14656 B2RB58 Q53Y64 Q96CA0,Torsin-1A,Dystonia 1 protein;Torsin ATPase-1A;Torsin family 1 member A;, PF06309;, GO:0030659;GO:0005856;GO:0005829;GO:0005783;GO:0005788;GO:0070062;GO:0042406;GO:0030426;GO:0043231;GO:0016020;GO:0005635;GO:0031965;GO:0030141;GO:0008021;GO:0005524;GO:0016887;GO:0008092;GO:0042802;GO:0019894;GO:0051787;GO:0051082;GO:0007155;GO:0051085;GO:0061077;GO:0072321;GO:0071712;GO:0045104;GO:0031175;GO:0006998;GO:0071763;GO:0006996;GO:1900244;GO:0000338;GO:0034504;GO:0051584;GO:2000008;GO:0006979;GO:0048489;GO:0044319;, C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extrinsic component of endoplasmic reticulum membrane; C:growth cone; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope; C:nuclear membrane; C:secretory granule; C:synaptic vesicle;, F:ATP binding; F:ATPase activity; F:cytoskeletal protein binding; F:identical protein binding; F:kinesin binding; F:misfolded protein binding; F:unfolded protein binding;, P:cell adhesion; P:chaperone cofactor-dependent protein refolding; P:chaperone-mediated protein folding; P:chaperone-mediated protein transport; P:ER-associated misfolded protein catabolic process; P:intermediate filament cytoskeleton organization; P:neuron projection development; P:nuclear envelope organization; P:nuclear membrane organization; P:organelle organization; P:positive regulation of synaptic vesicle endocytosis; P:protein deneddylation; P:protein localization to nucleus; P:regulation of dopamine uptake involved in synaptic transmission; P:regulation of protein localization to cell surface; P:response to oxidative stress; P:synaptic vesicle transport; P:wound healing, spreading of cells;|O14656 B2RB58 Q53Y64 Q96CA0,Torsin-1A,Dystonia 1 protein;Torsin ATPase-1A;Torsin family 1 member A;, PF06309;, GO:0030659;GO:0005856;GO:0005829;GO:0005783;GO:0005788;GO:0070062;GO:0042406;GO:0030426;GO:0043231;GO:0016020;GO:0005635;GO:0031965;GO:0030141;GO:0008021;GO:0005524;GO:0016887;GO:0008092;GO:0042802;GO:0019894;GO:0051787;GO:0051082;GO:0007155;GO:0051085;GO:0061077;GO:0072321;GO:0071712;GO:0045104;GO:0031175;GO:0006998;GO:0071763;GO:0006996;GO:1900244;GO:0000338;GO:0034504;GO:0051584;GO:2000008;GO:0006979;GO:0048489;GO:0044319;, C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extrinsic component of endoplasmic reticulum membrane; C:growth cone; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope; C:nuclear membrane; C:secretory granule; C:synaptic vesicle;, F:ATP binding; F:ATPase activity; F:cytoskeletal protein binding; F:identical protein binding; F:kinesin binding; F:misfolded protein binding; F:unfolded protein binding;, P:cell adhesion; P:chaperone cofactor-dependent protein refolding; P:chaperone-mediated protein folding; P:chaperone-mediated protein transport; P:ER-associated misfolded protein catabolic process; P:intermediate filament cytoskeleton organization; P:neuron projection development; P:nuclear envelope organization; P:nuclear membrane organization; P:organelle organization; P:positive regulation of synaptic vesicle endocytosis; P:protein deneddylation; P:protein localization to nucleus; P:regulation of dopamine uptake involved in synaptic transmission; P:regulation of protein localization to cell surface; P:response to oxidative stress; P:synaptic vesicle transport; P:wound healing, spreading of cells;|O14656 B2RB58 Q53Y64 Q96CA0,Torsin-1A,Dystonia 1 protein;Torsin ATPase-1A;Torsin family 1 member A;, PF06309;, GO:0030659;GO:0005856;GO:0005829;GO:0005783;GO:0005788;GO:0070062;GO:0042406;GO:0030426;GO:0043231;GO:0016020;GO:0005635;GO:0031965;GO:0030141;GO:0008021;GO:0005524;GO:0016887;GO:0008092;GO:0042802;GO:0019894;GO:0051787;GO:0051082;GO:0007155;GO:0051085;GO:0061077;GO:0072321;GO:0071712;GO:0045104;GO:0031175;GO:0006998;GO:0071763;GO:0006996;GO:1900244;GO:0000338;GO:0034504;GO:0051584;GO:2000008;GO:0006979;GO:0048489;GO:0044319;, C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extrinsic component of endoplasmic reticulum membrane; C:growth cone; C:intracellular membrane-bounded organelle; C:membrane; C:nuclear envelope; C:nuclear membrane; C:secretory granule; C:synaptic vesicle;, F:ATP binding; F:ATPase activity; F:cytoskeletal protein binding; F:identical protein binding; F:kinesin binding; F:misfolded protein binding; F:unfolded protein binding;, P:cell adhesion; P:chaperone cofactor-dependent protein refolding; P:chaperone-mediated protein folding; P:chaperone-mediated protein transport; P:ER-associated misfolded protein catabolic process; P:intermediate filament cytoskeleton organization; P:neuron projection development; P:nuclear envelope organization; P:nuclear membrane organization; P:organelle organization; P:positive regulation of synaptic vesicle endocytosis; P:protein deneddylation; P:protein localization to nucleus; P:regulation of dopamine uptake involved in synaptic transmission; P:regulation of protein localization to cell surface; P:response to oxidative stress; P:synaptic vesicle transport; P:wound healing, spreading of cells; scaffold102 indexed_genome mRNA 310182 312804 . + . ID=transcript_12892;Q9NZ63 B3KPX8 Q8WVU6 Q9NT39,Telomere length and silencing protein 1 homolog {ECO:0000250|UniProtKB:Q10148},Hepatocellular carcinoma-associated antigen 59;, PF07052;, GO:0005829;GO:0005654;GO:0005681;GO:0048024;, C:cytosol; C:nucleoplasm; C:spliceosomal complex;, , P:regulation of mRNA splicing, via spliceosome; scaffold102 indexed_genome mRNA 312810 319219 . - . ID=transcript_12893;Q9NZ63 B3KPX8 Q8WVU6 Q9NT39,Telomere length and silencing protein 1 homolog {ECO:0000250|UniProtKB:Q10148},Hepatocellular carcinoma-associated antigen 59;, PF07052;, GO:0005829;GO:0005654;GO:0005681;GO:0048024;, C:cytosol; C:nucleoplasm; C:spliceosomal complex;, , P:regulation of mRNA splicing, via spliceosome;|Q9NZ63 B3KPX8 Q8WVU6 Q9NT39,Telomere length and silencing protein 1 homolog {ECO:0000250|UniProtKB:Q10148},Hepatocellular carcinoma-associated antigen 59;, PF07052;, GO:0005829;GO:0005654;GO:0005681;GO:0048024;, C:cytosol; C:nucleoplasm; C:spliceosomal complex;, , P:regulation of mRNA splicing, via spliceosome;|Q9NZ63 B3KPX8 Q8WVU6 Q9NT39,Telomere length and silencing protein 1 homolog {ECO:0000250|UniProtKB:Q10148},Hepatocellular carcinoma-associated antigen 59;, PF07052;, GO:0005829;GO:0005654;GO:0005681;GO:0048024;, C:cytosol; C:nucleoplasm; C:spliceosomal complex;, , P:regulation of mRNA splicing, via spliceosome; scaffold102 indexed_genome mRNA 319367 359786 . + . ID=transcript_12894;Q9Y2K6 Q541F1 Q8IXQ1 Q96LG5 Q9UQN8 Q9UQP0,Ubiquitin carboxyl-terminal hydrolase 20,Deubiquitinating enzyme 20;Ubiquitin thioesterase 20;Ubiquitin-specific-processing protease 20;VHL-interacting deubiquitinating enzyme 2;, PF06337;PF00443;PF02148;, GO:0005813;GO:0005737;GO:0005829;GO:0048471;GO:0004197;GO:0001664;GO:0004843;GO:0008270;GO:0006897;GO:0016579;GO:0071108;GO:0070536;GO:0008277;GO:0006511;, C:centrosome; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:endocytosis; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q9Y2K6 Q541F1 Q8IXQ1 Q96LG5 Q9UQN8 Q9UQP0,Ubiquitin carboxyl-terminal hydrolase 20,Deubiquitinating enzyme 20;Ubiquitin thioesterase 20;Ubiquitin-specific-processing protease 20;VHL-interacting deubiquitinating enzyme 2;, PF06337;PF00443;PF02148;, GO:0005813;GO:0005737;GO:0005829;GO:0048471;GO:0004197;GO:0001664;GO:0004843;GO:0008270;GO:0006897;GO:0016579;GO:0071108;GO:0070536;GO:0008277;GO:0006511;, C:centrosome; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:endocytosis; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q9Y2K6 Q541F1 Q8IXQ1 Q96LG5 Q9UQN8 Q9UQP0,Ubiquitin carboxyl-terminal hydrolase 20,Deubiquitinating enzyme 20;Ubiquitin thioesterase 20;Ubiquitin-specific-processing protease 20;VHL-interacting deubiquitinating enzyme 2;, PF06337;PF00443;PF02148;, GO:0005813;GO:0005737;GO:0005829;GO:0048471;GO:0004197;GO:0001664;GO:0004843;GO:0008270;GO:0006897;GO:0016579;GO:0071108;GO:0070536;GO:0008277;GO:0006511;, C:centrosome; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:endocytosis; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q9Y2K6 Q541F1 Q8IXQ1 Q96LG5 Q9UQN8 Q9UQP0,Ubiquitin carboxyl-terminal hydrolase 20,Deubiquitinating enzyme 20;Ubiquitin thioesterase 20;Ubiquitin-specific-processing protease 20;VHL-interacting deubiquitinating enzyme 2;, PF06337;PF00443;PF02148;, GO:0005813;GO:0005737;GO:0005829;GO:0048471;GO:0004197;GO:0001664;GO:0004843;GO:0008270;GO:0006897;GO:0016579;GO:0071108;GO:0070536;GO:0008277;GO:0006511;, C:centrosome; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:endocytosis; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process;|Q9Y2K6 Q541F1 Q8IXQ1 Q96LG5 Q9UQN8 Q9UQP0,Ubiquitin carboxyl-terminal hydrolase 20,Deubiquitinating enzyme 20;Ubiquitin thioesterase 20;Ubiquitin-specific-processing protease 20;VHL-interacting deubiquitinating enzyme 2;, PF06337;PF00443;PF02148;, GO:0005813;GO:0005737;GO:0005829;GO:0048471;GO:0004197;GO:0001664;GO:0004843;GO:0008270;GO:0006897;GO:0016579;GO:0071108;GO:0070536;GO:0008277;GO:0006511;, C:centrosome; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm;, F:cysteine-type endopeptidase activity; F:G protein-coupled receptor binding; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:endocytosis; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:regulation of G protein-coupled receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold102 indexed_genome mRNA 365896 441640 . - . ID=transcript_12895;Q9H8H8 Q9NWD1,Formin-binding protein 1,Formin-binding protein 17;, PF00611;PF14604;, GO:0005938;GO:0005905;GO:0031410;GO:0005856;GO:0005829;GO:0043231;GO:0005764;GO:0005886;GO:0042802;GO:0008289;GO:0006897;GO:0061024;GO:0007165;, C:cell cortex; C:clathrin-coated pit; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:lysosome; C:plasma membrane;, F:identical protein binding; F:lipid binding;, P:endocytosis; P:membrane organization; P:signal transduction;|Q9H8H8 Q9NWD1,Formin-binding protein 1,Formin-binding protein 17;, PF00611;PF14604;, GO:0005938;GO:0005905;GO:0031410;GO:0005856;GO:0005829;GO:0043231;GO:0005764;GO:0005886;GO:0042802;GO:0008289;GO:0006897;GO:0061024;GO:0007165;, C:cell cortex; C:clathrin-coated pit; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:lysosome; C:plasma membrane;, F:identical protein binding; F:lipid binding;, P:endocytosis; P:membrane organization; P:signal transduction;|Q9H8H8 Q9NWD1,Formin-binding protein 1,Formin-binding protein 17;, PF00611;PF14604;, GO:0005938;GO:0005905;GO:0031410;GO:0005856;GO:0005829;GO:0043231;GO:0005764;GO:0005886;GO:0042802;GO:0008289;GO:0006897;GO:0061024;GO:0007165;, C:cell cortex; C:clathrin-coated pit; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:intracellular membrane-bounded organelle; C:lysosome; C:plasma membrane;, F:identical protein binding; F:lipid binding;, P:endocytosis; P:membrane organization; P:signal transduction; scaffold102 indexed_genome mRNA 515307 571515 . + . ID=transcript_12896;Q5VW38 A6NJ53 Q2TB81 Q5JPA3 Q5VW39 Q96T26 Q9H658 Q9HCE8,Protein GPR107,Lung seven transmembrane receptor 1;, PF06814;, GO:0030136;GO:0005769;GO:0005794;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0032050;GO:0072583;, C:clathrin-coated vesicle; C:early endosome; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:clathrin heavy chain binding;, P:clathrin-dependent endocytosis;|Q5VW38 A6NJ53 Q2TB81 Q5JPA3 Q5VW39 Q96T26 Q9H658 Q9HCE8,Protein GPR107,Lung seven transmembrane receptor 1;, PF06814;, GO:0030136;GO:0005769;GO:0005794;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0032050;GO:0072583;, C:clathrin-coated vesicle; C:early endosome; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:clathrin heavy chain binding;, P:clathrin-dependent endocytosis;|Q5VW38 A6NJ53 Q2TB81 Q5JPA3 Q5VW39 Q96T26 Q9H658 Q9HCE8,Protein GPR107,Lung seven transmembrane receptor 1;, PF06814;, GO:0030136;GO:0005769;GO:0005794;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0032050;GO:0072583;, C:clathrin-coated vesicle; C:early endosome; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:clathrin heavy chain binding;, P:clathrin-dependent endocytosis; scaffold102 indexed_genome mRNA 632428 648677 . + . ID=transcript_12897;P62166 E9PAY3 P36610 Q9UK26,Neuronal calcium sensor 1,Frequenin homolog;Frequenin-like protein;Frequenin-like ubiquitous protein;, PF00036;PF13499;, GO:0044305;GO:0005737;GO:0030425;GO:0031045;GO:0098978;GO:0005794;GO:0043231;GO:0048471;GO:0005886;GO:0099524;GO:0014069;GO:0099523;GO:0005509;GO:0000287;GO:0019901;GO:0005245;GO:0099626;GO:0048015;GO:0045921;GO:0010975;GO:2000300;, C:calyx of Held; C:cytoplasm; C:dendrite; C:dense core granule; C:glutamatergic synapse; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic density; C:presynaptic cytosol;, F:calcium ion binding; F:magnesium ion binding; F:protein kinase binding; F:voltage-gated calcium channel activity; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:phosphatidylinositol-mediated signaling; P:positive regulation of exocytosis; P:regulation of neuron projection development; P:regulation of synaptic vesicle exocytosis; scaffold102 indexed_genome mRNA 767990 777224 . + . ID=transcript_12898;Q8NDA2 A0A096LP30 Q8N225 Q8TCI8,Hemicentin-2 {ECO:0000305},, PF12662;PF07645;PF07474;PF07679;, GO:0005604;GO:0005938;GO:0030054;GO:0032154;GO:0062023;GO:0031012;GO:0005615;GO:0005509;GO:0050896;, C:basement membrane; C:cell cortex; C:cell junction; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:calcium ion binding;, P:response to stimulus; scaffold102 indexed_genome mRNA 781715 786409 . + . ID=transcript_12899;Q8NDA2 A0A096LP30 Q8N225 Q8TCI8,Hemicentin-2 {ECO:0000305},, PF12662;PF07645;PF07474;PF07679;, GO:0005604;GO:0005938;GO:0030054;GO:0032154;GO:0062023;GO:0031012;GO:0005615;GO:0005509;GO:0050896;, C:basement membrane; C:cell cortex; C:cell junction; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:calcium ion binding;, P:response to stimulus; scaffold102 indexed_genome mRNA 792356 798704 . + . ID=transcript_12900;Q8NDA2 A0A096LP30 Q8N225 Q8TCI8,Hemicentin-2 {ECO:0000305},, PF12662;PF07645;PF07474;PF07679;, GO:0005604;GO:0005938;GO:0030054;GO:0032154;GO:0062023;GO:0031012;GO:0005615;GO:0005509;GO:0050896;, C:basement membrane; C:cell cortex; C:cell junction; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:calcium ion binding;, P:response to stimulus; scaffold102 indexed_genome mRNA 799889 807112 . + . ID=transcript_12901;Q8NDA2 A0A096LP30 Q8N225 Q8TCI8,Hemicentin-2 {ECO:0000305},, PF12662;PF07645;PF07474;PF07679;, GO:0005604;GO:0005938;GO:0030054;GO:0032154;GO:0062023;GO:0031012;GO:0005615;GO:0005509;GO:0050896;, C:basement membrane; C:cell cortex; C:cell junction; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:calcium ion binding;, P:response to stimulus; scaffold102 indexed_genome mRNA 823487 828706 . + . ID=transcript_12902;Q8NDA2 A0A096LP30 Q8N225 Q8TCI8,Hemicentin-2 {ECO:0000305},, PF12662;PF07645;PF07474;PF07679;, GO:0005604;GO:0005938;GO:0030054;GO:0032154;GO:0062023;GO:0031012;GO:0005615;GO:0005509;GO:0050896;, C:basement membrane; C:cell cortex; C:cell junction; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:calcium ion binding;, P:response to stimulus; scaffold102 indexed_genome mRNA 831414 861214 . + . ID=transcript_12903;Q8NDA2 A0A096LP30 Q8N225 Q8TCI8,Hemicentin-2 {ECO:0000305},, PF12662;PF07645;PF07474;PF07679;, GO:0005604;GO:0005938;GO:0030054;GO:0032154;GO:0062023;GO:0031012;GO:0005615;GO:0005509;GO:0050896;, C:basement membrane; C:cell cortex; C:cell junction; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular space;, F:calcium ion binding;, P:response to stimulus; scaffold102 indexed_genome mRNA 877902 932921 . + . ID=transcript_12904;P00966 Q6LDL2 Q86UZ0 Q96GT4,Argininosuccinate synthase {ECO:0000305},Citrulline--aspartate ligase;, PF00764;, GO:0070852;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005764;GO:0005741;GO:0005634;GO:0043204;GO:0016597;GO:0004055;GO:0005524;GO:0042802;GO:0003723;GO:0015643;GO:0006953;GO:0007568;GO:0006526;GO:0000053;GO:0006531;GO:0071418;GO:0071230;GO:0071242;GO:0071320;GO:0071549;GO:0071377;GO:0071346;GO:0071499;GO:0071222;GO:0071400;GO:0071356;GO:0007623;GO:0000052;GO:0060539;GO:0001822;GO:0001889;GO:0007494;GO:1903038;GO:0045429;GO:0042493;GO:0032355;GO:0060416;GO:0010046;GO:0007584;GO:0010043;GO:0000050;, C:cell body fiber; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:lysosome; C:mitochondrial outer membrane; C:nucleus; C:perikaryon;, F:amino acid binding; F:argininosuccinate synthase activity; F:ATP binding; F:identical protein binding; F:RNA binding; F:toxic substance binding;, P:acute-phase response; P:aging; P:arginine biosynthetic process; P:argininosuccinate metabolic process; P:aspartate metabolic process; P:cellular response to amine stimulus; P:cellular response to amino acid stimulus; P:cellular response to ammonium ion; P:cellular response to cAMP; P:cellular response to dexamethasone stimulus; P:cellular response to glucagon stimulus; P:cellular response to interferon-gamma; P:cellular response to laminar fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to oleic acid; P:cellular response to tumor necrosis factor; P:circadian rhythm; P:citrulline metabolic process; P:diaphragm development; P:kidney development; P:liver development; P:midgut development; P:negative regulation of leukocyte cell-cell adhesion; P:positive regulation of nitric oxide biosynthetic process; P:response to drug; P:response to estradiol; P:response to growth hormone; P:response to mycotoxin; P:response to nutrient; P:response to zinc ion; P:urea cycle;|P00966 Q6LDL2 Q86UZ0 Q96GT4,Argininosuccinate synthase {ECO:0000305},Citrulline--aspartate ligase;, PF00764;, GO:0070852;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005764;GO:0005741;GO:0005634;GO:0043204;GO:0016597;GO:0004055;GO:0005524;GO:0042802;GO:0003723;GO:0015643;GO:0006953;GO:0007568;GO:0006526;GO:0000053;GO:0006531;GO:0071418;GO:0071230;GO:0071242;GO:0071320;GO:0071549;GO:0071377;GO:0071346;GO:0071499;GO:0071222;GO:0071400;GO:0071356;GO:0007623;GO:0000052;GO:0060539;GO:0001822;GO:0001889;GO:0007494;GO:1903038;GO:0045429;GO:0042493;GO:0032355;GO:0060416;GO:0010046;GO:0007584;GO:0010043;GO:0000050;, C:cell body fiber; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:lysosome; C:mitochondrial outer membrane; C:nucleus; C:perikaryon;, F:amino acid binding; F:argininosuccinate synthase activity; F:ATP binding; F:identical protein binding; F:RNA binding; F:toxic substance binding;, P:acute-phase response; P:aging; P:arginine biosynthetic process; P:argininosuccinate metabolic process; P:aspartate metabolic process; P:cellular response to amine stimulus; P:cellular response to amino acid stimulus; P:cellular response to ammonium ion; P:cellular response to cAMP; P:cellular response to dexamethasone stimulus; P:cellular response to glucagon stimulus; P:cellular response to interferon-gamma; P:cellular response to laminar fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to oleic acid; P:cellular response to tumor necrosis factor; P:circadian rhythm; P:citrulline metabolic process; P:diaphragm development; P:kidney development; P:liver development; P:midgut development; P:negative regulation of leukocyte cell-cell adhesion; P:positive regulation of nitric oxide biosynthetic process; P:response to drug; P:response to estradiol; P:response to growth hormone; P:response to mycotoxin; P:response to nutrient; P:response to zinc ion; P:urea cycle;|P00966 Q6LDL2 Q86UZ0 Q96GT4,Argininosuccinate synthase {ECO:0000305},Citrulline--aspartate ligase;, PF00764;, GO:0070852;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005764;GO:0005741;GO:0005634;GO:0043204;GO:0016597;GO:0004055;GO:0005524;GO:0042802;GO:0003723;GO:0015643;GO:0006953;GO:0007568;GO:0006526;GO:0000053;GO:0006531;GO:0071418;GO:0071230;GO:0071242;GO:0071320;GO:0071549;GO:0071377;GO:0071346;GO:0071499;GO:0071222;GO:0071400;GO:0071356;GO:0007623;GO:0000052;GO:0060539;GO:0001822;GO:0001889;GO:0007494;GO:1903038;GO:0045429;GO:0042493;GO:0032355;GO:0060416;GO:0010046;GO:0007584;GO:0010043;GO:0000050;, C:cell body fiber; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:lysosome; C:mitochondrial outer membrane; C:nucleus; C:perikaryon;, F:amino acid binding; F:argininosuccinate synthase activity; F:ATP binding; F:identical protein binding; F:RNA binding; F:toxic substance binding;, P:acute-phase response; P:aging; P:arginine biosynthetic process; P:argininosuccinate metabolic process; P:aspartate metabolic process; P:cellular response to amine stimulus; P:cellular response to amino acid stimulus; P:cellular response to ammonium ion; P:cellular response to cAMP; P:cellular response to dexamethasone stimulus; P:cellular response to glucagon stimulus; P:cellular response to interferon-gamma; P:cellular response to laminar fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to oleic acid; P:cellular response to tumor necrosis factor; P:circadian rhythm; P:citrulline metabolic process; P:diaphragm development; P:kidney development; P:liver development; P:midgut development; P:negative regulation of leukocyte cell-cell adhesion; P:positive regulation of nitric oxide biosynthetic process; P:response to drug; P:response to estradiol; P:response to growth hormone; P:response to mycotoxin; P:response to nutrient; P:response to zinc ion; P:urea cycle;|P00966 Q6LDL2 Q86UZ0 Q96GT4,Argininosuccinate synthase {ECO:0000305},Citrulline--aspartate ligase;, PF00764;, GO:0070852;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005764;GO:0005741;GO:0005634;GO:0043204;GO:0016597;GO:0004055;GO:0005524;GO:0042802;GO:0003723;GO:0015643;GO:0006953;GO:0007568;GO:0006526;GO:0000053;GO:0006531;GO:0071418;GO:0071230;GO:0071242;GO:0071320;GO:0071549;GO:0071377;GO:0071346;GO:0071499;GO:0071222;GO:0071400;GO:0071356;GO:0007623;GO:0000052;GO:0060539;GO:0001822;GO:0001889;GO:0007494;GO:1903038;GO:0045429;GO:0042493;GO:0032355;GO:0060416;GO:0010046;GO:0007584;GO:0010043;GO:0000050;, C:cell body fiber; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:lysosome; C:mitochondrial outer membrane; C:nucleus; C:perikaryon;, F:amino acid binding; F:argininosuccinate synthase activity; F:ATP binding; F:identical protein binding; F:RNA binding; F:toxic substance binding;, P:acute-phase response; P:aging; P:arginine biosynthetic process; P:argininosuccinate metabolic process; P:aspartate metabolic process; P:cellular response to amine stimulus; P:cellular response to amino acid stimulus; P:cellular response to ammonium ion; P:cellular response to cAMP; P:cellular response to dexamethasone stimulus; P:cellular response to glucagon stimulus; P:cellular response to interferon-gamma; P:cellular response to laminar fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to oleic acid; P:cellular response to tumor necrosis factor; P:circadian rhythm; P:citrulline metabolic process; P:diaphragm development; P:kidney development; P:liver development; P:midgut development; P:negative regulation of leukocyte cell-cell adhesion; P:positive regulation of nitric oxide biosynthetic process; P:response to drug; P:response to estradiol; P:response to growth hormone; P:response to mycotoxin; P:response to nutrient; P:response to zinc ion; P:urea cycle;|P00966 Q6LDL2 Q86UZ0 Q96GT4,Argininosuccinate synthase {ECO:0000305},Citrulline--aspartate ligase;, PF00764;, GO:0070852;GO:0005737;GO:0005829;GO:0005783;GO:0070062;GO:0005764;GO:0005741;GO:0005634;GO:0043204;GO:0016597;GO:0004055;GO:0005524;GO:0042802;GO:0003723;GO:0015643;GO:0006953;GO:0007568;GO:0006526;GO:0000053;GO:0006531;GO:0071418;GO:0071230;GO:0071242;GO:0071320;GO:0071549;GO:0071377;GO:0071346;GO:0071499;GO:0071222;GO:0071400;GO:0071356;GO:0007623;GO:0000052;GO:0060539;GO:0001822;GO:0001889;GO:0007494;GO:1903038;GO:0045429;GO:0042493;GO:0032355;GO:0060416;GO:0010046;GO:0007584;GO:0010043;GO:0000050;, C:cell body fiber; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:lysosome; C:mitochondrial outer membrane; C:nucleus; C:perikaryon;, F:amino acid binding; F:argininosuccinate synthase activity; F:ATP binding; F:identical protein binding; F:RNA binding; F:toxic substance binding;, P:acute-phase response; P:aging; P:arginine biosynthetic process; P:argininosuccinate metabolic process; P:aspartate metabolic process; P:cellular response to amine stimulus; P:cellular response to amino acid stimulus; P:cellular response to ammonium ion; P:cellular response to cAMP; P:cellular response to dexamethasone stimulus; P:cellular response to glucagon stimulus; P:cellular response to interferon-gamma; P:cellular response to laminar fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to oleic acid; P:cellular response to tumor necrosis factor; P:circadian rhythm; P:citrulline metabolic process; P:diaphragm development; P:kidney development; P:liver development; P:midgut development; P:negative regulation of leukocyte cell-cell adhesion; P:positive regulation of nitric oxide biosynthetic process; P:response to drug; P:response to estradiol; P:response to growth hormone; P:response to mycotoxin; P:response to nutrient; P:response to zinc ion; P:urea cycle; scaffold102 indexed_genome mRNA 988559 1036791 . + . ID=transcript_12905;Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated;|Q96I24 A3KFK8 A3KFL0 Q92946 Q9BVB6,Far upstream element-binding protein 3,, PF00013;, GO:0005737;GO:0016020;GO:0005634;GO:0003729;GO:0003723;GO:0003697;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006351;, C:cytoplasm; C:membrane; C:nucleus;, F:mRNA binding; F:RNA binding; F:single-stranded DNA binding;, P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:transcription, DNA-templated; scaffold102 indexed_genome mRNA 1052749 1721034 . + . ID=transcript_12906;Q5JSZ5 O60270 Q5JSZ7 Q66VZ2 Q68CR0 Q96EI9 Q9H683,Protein PRRC2B,HLA-B-associated transcript 2-like 1;Proline-rich coiled-coil protein 2B;, PF07001;, GO:0003723;GO:0030154;, , F:RNA binding;, P:cell differentiation;|Q13868 A3KFL3 A3KFL4 B4DKK6 Q9NUY4,Exosome complex component RRP4 {ECO:0000305},Exosome component 2;Ribosomal RNA-processing protein 4;, PF14382;PF15985;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008312;GO:0003723;GO:0071034;GO:0043928;GO:0000467;GO:0071035;GO:0071038;GO:0071049;GO:0034427;GO:0071051;GO:0030307;GO:0043488;GO:0006364;GO:0034475;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:7S RNA binding; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyadenylation-dependent snoRNA 3'-end processing; P:positive regulation of cell growth; P:regulation of mRNA stability; P:rRNA processing; P:U4 snRNA 3'-end processing;|Q13868 A3KFL3 A3KFL4 B4DKK6 Q9NUY4,Exosome complex component RRP4 {ECO:0000305},Exosome component 2;Ribosomal RNA-processing protein 4;, PF14382;PF15985;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008312;GO:0003723;GO:0071034;GO:0043928;GO:0000467;GO:0071035;GO:0071038;GO:0071049;GO:0034427;GO:0071051;GO:0030307;GO:0043488;GO:0006364;GO:0034475;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:7S RNA binding; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyadenylation-dependent snoRNA 3'-end processing; P:positive regulation of cell growth; P:regulation of mRNA stability; P:rRNA processing; P:U4 snRNA 3'-end processing;|Q13868 A3KFL3 A3KFL4 B4DKK6 Q9NUY4,Exosome complex component RRP4 {ECO:0000305},Exosome component 2;Ribosomal RNA-processing protein 4;, PF14382;PF15985;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008312;GO:0003723;GO:0071034;GO:0043928;GO:0000467;GO:0071035;GO:0071038;GO:0071049;GO:0034427;GO:0071051;GO:0030307;GO:0043488;GO:0006364;GO:0034475;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:7S RNA binding; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyadenylation-dependent snoRNA 3'-end processing; P:positive regulation of cell growth; P:regulation of mRNA stability; P:rRNA processing; P:U4 snRNA 3'-end processing;|Q13868 A3KFL3 A3KFL4 B4DKK6 Q9NUY4,Exosome complex component RRP4 {ECO:0000305},Exosome component 2;Ribosomal RNA-processing protein 4;, PF14382;PF15985;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0005634;GO:0000175;GO:0008312;GO:0003723;GO:0071034;GO:0043928;GO:0000467;GO:0071035;GO:0071038;GO:0071049;GO:0034427;GO:0071051;GO:0030307;GO:0043488;GO:0006364;GO:0034475;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5'-exoribonuclease activity; F:7S RNA binding; F:RNA binding;, P:CUT catabolic process; P:exonucleolytic catabolism of deadenylated mRNA; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear polyadenylation-dependent tRNA catabolic process; P:nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyadenylation-dependent snoRNA 3'-end processing; P:positive regulation of cell growth; P:regulation of mRNA stability; P:rRNA processing; P:U4 snRNA 3'-end processing;|P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09,Tyrosine-protein kinase ABL1,Abelson murine leukemia viral oncogene homolog 1;Abelson tyrosine-protein kinase 1;Proto-oncogene c-Abl;p150;, PF08919;PF07714;PF00017;PF00018;, GO:0015629;GO:0031252;GO:0005737;GO:0005829;GO:0030425;GO:0005739;GO:0043025;GO:0016604;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0098794;GO:0032991;GO:0051015;GO:0003785;GO:0005524;GO:0000405;GO:0003677;GO:0046875;GO:0000400;GO:0016301;GO:0000287;GO:0030145;GO:0051019;GO:0038191;GO:0004515;GO:0004715;GO:0001784;GO:0070064;GO:0008022;GO:0004672;GO:0005080;GO:0004713;GO:1990837;GO:0042169;GO:0017124;GO:0019905;GO:0003713;GO:0004714;GO:0030036;GO:0090135;GO:0050798;GO:1990051;GO:0046632;GO:0006914;GO:0002322;GO:0050853;GO:0001922;GO:0060020;GO:0007050;GO:0006464;GO:0006974;GO:1903351;GO:0070301;GO:0071222;GO:0034599;GO:0021587;GO:0072359;GO:0048668;GO:0071103;GO:0006975;GO:0006897;GO:0043542;GO:0007173;GO:0045184;GO:0038096;GO:0007229;GO:0008630;GO:0030035;GO:0006298;GO:0051882;GO:0000278;GO:0030514;GO:0022408;GO:2000773;GO:2000352;GO:0070373;GO:0043124;GO:1900272;GO:0045930;GO:1900275;GO:0071901;GO:0051444;GO:0001843;GO:0060563;GO:0050885;GO:0038189;GO:0038083;GO:0018108;GO:0035791;GO:2000251;GO:1904531;GO:0043065;GO:1905555;GO:0090050;GO:0007204;GO:0010595;GO:0070374;GO:0051894;GO:0043123;GO:0032729;GO:0032743;GO:1904528;GO:0045931;GO:0051149;GO:1901216;GO:0033690;GO:0051353;GO:0050731;GO:0001934;GO:0051281;GO:0051496;GO:1900026;GO:0045944;GO:2000096;GO:0009791;GO:0046777;GO:0006468;GO:0032956;GO:2000249;GO:0042981;GO:0010506;GO:0030516;GO:0032489;GO:0030155;GO:2000145;GO:0030100;GO:1903053;GO:1902036;GO:0031113;GO:1905244;GO:2001020;GO:0045580;GO:0006355;GO:0006979;GO:0042770;GO:0048536;GO:0034446;GO:0050852;GO:0048538;GO:0002333;, C:actin cytoskeleton; C:cell leading edge; C:cytoplasm; C:cytosol; C:dendrite; C:mitochondrion; C:neuronal cell body; C:nuclear body; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynapse; C:protein-containing complex;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:bubble DNA binding; F:DNA binding; F:ephrin receptor binding; F:four-way junction DNA binding; F:kinase activity; F:magnesium ion binding; F:manganese ion binding; F:mitogen-activated protein kinase binding; F:neuropilin binding; F:nicotinate-nucleotide adenylyltransferase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase C binding; F:protein tyrosine kinase activity; F:sequence-specific double-stranded DNA binding; F:SH2 domain binding; F:SH3 domain binding; F:syntaxin binding; F:transcription coactivator activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton organization; P:actin filament branching; P:activated T cell proliferation; P:activation of protein kinase C activity; P:alpha-beta T cell differentiation; P:autophagy; P:B cell proliferation involved in immune response; P:B cell receptor signaling pathway; P:B-1 B cell homeostasis; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to dopamine; P:cellular response to hydrogen peroxide; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:cerebellum morphogenesis; P:circulatory system development; P:collateral sprouting; P:DNA conformation change; P:DNA damage induced protein phosphorylation; P:endocytosis; P:endothelial cell migration; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:integrin-mediated signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:microspike assembly; P:mismatch repair; P:mitochondrial depolarization; P:mitotic cell cycle; P:negative regulation of BMP signaling pathway; P:negative regulation of cell-cell adhesion; P:negative regulation of cellular senescence; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mitotic cell cycle; P:negative regulation of phospholipase C activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of ubiquitin-protein transferase activity; P:neural tube closure; P:neuroepithelial cell differentiation; P:neuromuscular process controlling balance; P:neuropilin signaling pathway; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament binding; P:positive regulation of apoptotic process; P:positive regulation of blood vessel branching; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron death; P:positive regulation of osteoblast proliferation; P:positive regulation of oxidoreductase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:post-embryonic development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of axon extension; P:regulation of Cdc42 protein signal transduction; P:regulation of cell adhesion; P:regulation of cell motility; P:regulation of endocytosis; P:regulation of extracellular matrix organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of microtubule polymerization; P:regulation of modification of synaptic structure; P:regulation of response to DNA damage stimulus; P:regulation of T cell differentiation; P:regulation of transcription, DNA-templated; P:response to oxidative stress; P:signal transduction in response to DNA damage; P:spleen development; P:substrate adhesion-dependent cell spreading; P:T cell receptor signaling pathway; P:thymus development; P:transitional one stage B cell differentiation;|P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09,Tyrosine-protein kinase ABL1,Abelson murine leukemia viral oncogene homolog 1;Abelson tyrosine-protein kinase 1;Proto-oncogene c-Abl;p150;, PF08919;PF07714;PF00017;PF00018;, GO:0015629;GO:0031252;GO:0005737;GO:0005829;GO:0030425;GO:0005739;GO:0043025;GO:0016604;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0098794;GO:0032991;GO:0051015;GO:0003785;GO:0005524;GO:0000405;GO:0003677;GO:0046875;GO:0000400;GO:0016301;GO:0000287;GO:0030145;GO:0051019;GO:0038191;GO:0004515;GO:0004715;GO:0001784;GO:0070064;GO:0008022;GO:0004672;GO:0005080;GO:0004713;GO:1990837;GO:0042169;GO:0017124;GO:0019905;GO:0003713;GO:0004714;GO:0030036;GO:0090135;GO:0050798;GO:1990051;GO:0046632;GO:0006914;GO:0002322;GO:0050853;GO:0001922;GO:0060020;GO:0007050;GO:0006464;GO:0006974;GO:1903351;GO:0070301;GO:0071222;GO:0034599;GO:0021587;GO:0072359;GO:0048668;GO:0071103;GO:0006975;GO:0006897;GO:0043542;GO:0007173;GO:0045184;GO:0038096;GO:0007229;GO:0008630;GO:0030035;GO:0006298;GO:0051882;GO:0000278;GO:0030514;GO:0022408;GO:2000773;GO:2000352;GO:0070373;GO:0043124;GO:1900272;GO:0045930;GO:1900275;GO:0071901;GO:0051444;GO:0001843;GO:0060563;GO:0050885;GO:0038189;GO:0038083;GO:0018108;GO:0035791;GO:2000251;GO:1904531;GO:0043065;GO:1905555;GO:0090050;GO:0007204;GO:0010595;GO:0070374;GO:0051894;GO:0043123;GO:0032729;GO:0032743;GO:1904528;GO:0045931;GO:0051149;GO:1901216;GO:0033690;GO:0051353;GO:0050731;GO:0001934;GO:0051281;GO:0051496;GO:1900026;GO:0045944;GO:2000096;GO:0009791;GO:0046777;GO:0006468;GO:0032956;GO:2000249;GO:0042981;GO:0010506;GO:0030516;GO:0032489;GO:0030155;GO:2000145;GO:0030100;GO:1903053;GO:1902036;GO:0031113;GO:1905244;GO:2001020;GO:0045580;GO:0006355;GO:0006979;GO:0042770;GO:0048536;GO:0034446;GO:0050852;GO:0048538;GO:0002333;, C:actin cytoskeleton; C:cell leading edge; C:cytoplasm; C:cytosol; C:dendrite; C:mitochondrion; C:neuronal cell body; C:nuclear body; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynapse; C:protein-containing complex;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:bubble DNA binding; F:DNA binding; F:ephrin receptor binding; F:four-way junction DNA binding; F:kinase activity; F:magnesium ion binding; F:manganese ion binding; F:mitogen-activated protein kinase binding; F:neuropilin binding; F:nicotinate-nucleotide adenylyltransferase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase C binding; F:protein tyrosine kinase activity; F:sequence-specific double-stranded DNA binding; F:SH2 domain binding; F:SH3 domain binding; F:syntaxin binding; F:transcription coactivator activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton organization; P:actin filament branching; P:activated T cell proliferation; P:activation of protein kinase C activity; P:alpha-beta T cell differentiation; P:autophagy; P:B cell proliferation involved in immune response; P:B cell receptor signaling pathway; P:B-1 B cell homeostasis; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to dopamine; P:cellular response to hydrogen peroxide; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:cerebellum morphogenesis; P:circulatory system development; P:collateral sprouting; P:DNA conformation change; P:DNA damage induced protein phosphorylation; P:endocytosis; P:endothelial cell migration; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:integrin-mediated signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:microspike assembly; P:mismatch repair; P:mitochondrial depolarization; P:mitotic cell cycle; P:negative regulation of BMP signaling pathway; P:negative regulation of cell-cell adhesion; P:negative regulation of cellular senescence; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mitotic cell cycle; P:negative regulation of phospholipase C activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of ubiquitin-protein transferase activity; P:neural tube closure; P:neuroepithelial cell differentiation; P:neuromuscular process controlling balance; P:neuropilin signaling pathway; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament binding; P:positive regulation of apoptotic process; P:positive regulation of blood vessel branching; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron death; P:positive regulation of osteoblast proliferation; P:positive regulation of oxidoreductase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:post-embryonic development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of axon extension; P:regulation of Cdc42 protein signal transduction; P:regulation of cell adhesion; P:regulation of cell motility; P:regulation of endocytosis; P:regulation of extracellular matrix organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of microtubule polymerization; P:regulation of modification of synaptic structure; P:regulation of response to DNA damage stimulus; P:regulation of T cell differentiation; P:regulation of transcription, DNA-templated; P:response to oxidative stress; P:signal transduction in response to DNA damage; P:spleen development; P:substrate adhesion-dependent cell spreading; P:T cell receptor signaling pathway; P:thymus development; P:transitional one stage B cell differentiation;|P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09,Tyrosine-protein kinase ABL1,Abelson murine leukemia viral oncogene homolog 1;Abelson tyrosine-protein kinase 1;Proto-oncogene c-Abl;p150;, PF08919;PF07714;PF00017;PF00018;, GO:0015629;GO:0031252;GO:0005737;GO:0005829;GO:0030425;GO:0005739;GO:0043025;GO:0016604;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0098794;GO:0032991;GO:0051015;GO:0003785;GO:0005524;GO:0000405;GO:0003677;GO:0046875;GO:0000400;GO:0016301;GO:0000287;GO:0030145;GO:0051019;GO:0038191;GO:0004515;GO:0004715;GO:0001784;GO:0070064;GO:0008022;GO:0004672;GO:0005080;GO:0004713;GO:1990837;GO:0042169;GO:0017124;GO:0019905;GO:0003713;GO:0004714;GO:0030036;GO:0090135;GO:0050798;GO:1990051;GO:0046632;GO:0006914;GO:0002322;GO:0050853;GO:0001922;GO:0060020;GO:0007050;GO:0006464;GO:0006974;GO:1903351;GO:0070301;GO:0071222;GO:0034599;GO:0021587;GO:0072359;GO:0048668;GO:0071103;GO:0006975;GO:0006897;GO:0043542;GO:0007173;GO:0045184;GO:0038096;GO:0007229;GO:0008630;GO:0030035;GO:0006298;GO:0051882;GO:0000278;GO:0030514;GO:0022408;GO:2000773;GO:2000352;GO:0070373;GO:0043124;GO:1900272;GO:0045930;GO:1900275;GO:0071901;GO:0051444;GO:0001843;GO:0060563;GO:0050885;GO:0038189;GO:0038083;GO:0018108;GO:0035791;GO:2000251;GO:1904531;GO:0043065;GO:1905555;GO:0090050;GO:0007204;GO:0010595;GO:0070374;GO:0051894;GO:0043123;GO:0032729;GO:0032743;GO:1904528;GO:0045931;GO:0051149;GO:1901216;GO:0033690;GO:0051353;GO:0050731;GO:0001934;GO:0051281;GO:0051496;GO:1900026;GO:0045944;GO:2000096;GO:0009791;GO:0046777;GO:0006468;GO:0032956;GO:2000249;GO:0042981;GO:0010506;GO:0030516;GO:0032489;GO:0030155;GO:2000145;GO:0030100;GO:1903053;GO:1902036;GO:0031113;GO:1905244;GO:2001020;GO:0045580;GO:0006355;GO:0006979;GO:0042770;GO:0048536;GO:0034446;GO:0050852;GO:0048538;GO:0002333;, C:actin cytoskeleton; C:cell leading edge; C:cytoplasm; C:cytosol; C:dendrite; C:mitochondrion; C:neuronal cell body; C:nuclear body; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynapse; C:protein-containing complex;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:bubble DNA binding; F:DNA binding; F:ephrin receptor binding; F:four-way junction DNA binding; F:kinase activity; F:magnesium ion binding; F:manganese ion binding; F:mitogen-activated protein kinase binding; F:neuropilin binding; F:nicotinate-nucleotide adenylyltransferase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase C binding; F:protein tyrosine kinase activity; F:sequence-specific double-stranded DNA binding; F:SH2 domain binding; F:SH3 domain binding; F:syntaxin binding; F:transcription coactivator activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton organization; P:actin filament branching; P:activated T cell proliferation; P:activation of protein kinase C activity; P:alpha-beta T cell differentiation; P:autophagy; P:B cell proliferation involved in immune response; P:B cell receptor signaling pathway; P:B-1 B cell homeostasis; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to dopamine; P:cellular response to hydrogen peroxide; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:cerebellum morphogenesis; P:circulatory system development; P:collateral sprouting; P:DNA conformation change; P:DNA damage induced protein phosphorylation; P:endocytosis; P:endothelial cell migration; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:integrin-mediated signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:microspike assembly; P:mismatch repair; P:mitochondrial depolarization; P:mitotic cell cycle; P:negative regulation of BMP signaling pathway; P:negative regulation of cell-cell adhesion; P:negative regulation of cellular senescence; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mitotic cell cycle; P:negative regulation of phospholipase C activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of ubiquitin-protein transferase activity; P:neural tube closure; P:neuroepithelial cell differentiation; P:neuromuscular process controlling balance; P:neuropilin signaling pathway; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament binding; P:positive regulation of apoptotic process; P:positive regulation of blood vessel branching; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron death; P:positive regulation of osteoblast proliferation; P:positive regulation of oxidoreductase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:post-embryonic development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of axon extension; P:regulation of Cdc42 protein signal transduction; P:regulation of cell adhesion; P:regulation of cell motility; P:regulation of endocytosis; P:regulation of extracellular matrix organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of microtubule polymerization; P:regulation of modification of synaptic structure; P:regulation of response to DNA damage stimulus; P:regulation of T cell differentiation; P:regulation of transcription, DNA-templated; P:response to oxidative stress; P:signal transduction in response to DNA damage; P:spleen development; P:substrate adhesion-dependent cell spreading; P:T cell receptor signaling pathway; P:thymus development; P:transitional one stage B cell differentiation;|P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09,Tyrosine-protein kinase ABL1,Abelson murine leukemia viral oncogene homolog 1;Abelson tyrosine-protein kinase 1;Proto-oncogene c-Abl;p150;, PF08919;PF07714;PF00017;PF00018;, GO:0015629;GO:0031252;GO:0005737;GO:0005829;GO:0030425;GO:0005739;GO:0043025;GO:0016604;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0098794;GO:0032991;GO:0051015;GO:0003785;GO:0005524;GO:0000405;GO:0003677;GO:0046875;GO:0000400;GO:0016301;GO:0000287;GO:0030145;GO:0051019;GO:0038191;GO:0004515;GO:0004715;GO:0001784;GO:0070064;GO:0008022;GO:0004672;GO:0005080;GO:0004713;GO:1990837;GO:0042169;GO:0017124;GO:0019905;GO:0003713;GO:0004714;GO:0030036;GO:0090135;GO:0050798;GO:1990051;GO:0046632;GO:0006914;GO:0002322;GO:0050853;GO:0001922;GO:0060020;GO:0007050;GO:0006464;GO:0006974;GO:1903351;GO:0070301;GO:0071222;GO:0034599;GO:0021587;GO:0072359;GO:0048668;GO:0071103;GO:0006975;GO:0006897;GO:0043542;GO:0007173;GO:0045184;GO:0038096;GO:0007229;GO:0008630;GO:0030035;GO:0006298;GO:0051882;GO:0000278;GO:0030514;GO:0022408;GO:2000773;GO:2000352;GO:0070373;GO:0043124;GO:1900272;GO:0045930;GO:1900275;GO:0071901;GO:0051444;GO:0001843;GO:0060563;GO:0050885;GO:0038189;GO:0038083;GO:0018108;GO:0035791;GO:2000251;GO:1904531;GO:0043065;GO:1905555;GO:0090050;GO:0007204;GO:0010595;GO:0070374;GO:0051894;GO:0043123;GO:0032729;GO:0032743;GO:1904528;GO:0045931;GO:0051149;GO:1901216;GO:0033690;GO:0051353;GO:0050731;GO:0001934;GO:0051281;GO:0051496;GO:1900026;GO:0045944;GO:2000096;GO:0009791;GO:0046777;GO:0006468;GO:0032956;GO:2000249;GO:0042981;GO:0010506;GO:0030516;GO:0032489;GO:0030155;GO:2000145;GO:0030100;GO:1903053;GO:1902036;GO:0031113;GO:1905244;GO:2001020;GO:0045580;GO:0006355;GO:0006979;GO:0042770;GO:0048536;GO:0034446;GO:0050852;GO:0048538;GO:0002333;, C:actin cytoskeleton; C:cell leading edge; C:cytoplasm; C:cytosol; C:dendrite; C:mitochondrion; C:neuronal cell body; C:nuclear body; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynapse; C:protein-containing complex;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:bubble DNA binding; F:DNA binding; F:ephrin receptor binding; F:four-way junction DNA binding; F:kinase activity; F:magnesium ion binding; F:manganese ion binding; F:mitogen-activated protein kinase binding; F:neuropilin binding; F:nicotinate-nucleotide adenylyltransferase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase C binding; F:protein tyrosine kinase activity; F:sequence-specific double-stranded DNA binding; F:SH2 domain binding; F:SH3 domain binding; F:syntaxin binding; F:transcription coactivator activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton organization; P:actin filament branching; P:activated T cell proliferation; P:activation of protein kinase C activity; P:alpha-beta T cell differentiation; P:autophagy; P:B cell proliferation involved in immune response; P:B cell receptor signaling pathway; P:B-1 B cell homeostasis; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to dopamine; P:cellular response to hydrogen peroxide; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:cerebellum morphogenesis; P:circulatory system development; P:collateral sprouting; P:DNA conformation change; P:DNA damage induced protein phosphorylation; P:endocytosis; P:endothelial cell migration; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:integrin-mediated signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:microspike assembly; P:mismatch repair; P:mitochondrial depolarization; P:mitotic cell cycle; P:negative regulation of BMP signaling pathway; P:negative regulation of cell-cell adhesion; P:negative regulation of cellular senescence; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mitotic cell cycle; P:negative regulation of phospholipase C activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of ubiquitin-protein transferase activity; P:neural tube closure; P:neuroepithelial cell differentiation; P:neuromuscular process controlling balance; P:neuropilin signaling pathway; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament binding; P:positive regulation of apoptotic process; P:positive regulation of blood vessel branching; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron death; P:positive regulation of osteoblast proliferation; P:positive regulation of oxidoreductase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:post-embryonic development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of axon extension; P:regulation of Cdc42 protein signal transduction; P:regulation of cell adhesion; P:regulation of cell motility; P:regulation of endocytosis; P:regulation of extracellular matrix organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of microtubule polymerization; P:regulation of modification of synaptic structure; P:regulation of response to DNA damage stimulus; P:regulation of T cell differentiation; P:regulation of transcription, DNA-templated; P:response to oxidative stress; P:signal transduction in response to DNA damage; P:spleen development; P:substrate adhesion-dependent cell spreading; P:T cell receptor signaling pathway; P:thymus development; P:transitional one stage B cell differentiation;|P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09,Tyrosine-protein kinase ABL1,Abelson murine leukemia viral oncogene homolog 1;Abelson tyrosine-protein kinase 1;Proto-oncogene c-Abl;p150;, PF08919;PF07714;PF00017;PF00018;, GO:0015629;GO:0031252;GO:0005737;GO:0005829;GO:0030425;GO:0005739;GO:0043025;GO:0016604;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0098794;GO:0032991;GO:0051015;GO:0003785;GO:0005524;GO:0000405;GO:0003677;GO:0046875;GO:0000400;GO:0016301;GO:0000287;GO:0030145;GO:0051019;GO:0038191;GO:0004515;GO:0004715;GO:0001784;GO:0070064;GO:0008022;GO:0004672;GO:0005080;GO:0004713;GO:1990837;GO:0042169;GO:0017124;GO:0019905;GO:0003713;GO:0004714;GO:0030036;GO:0090135;GO:0050798;GO:1990051;GO:0046632;GO:0006914;GO:0002322;GO:0050853;GO:0001922;GO:0060020;GO:0007050;GO:0006464;GO:0006974;GO:1903351;GO:0070301;GO:0071222;GO:0034599;GO:0021587;GO:0072359;GO:0048668;GO:0071103;GO:0006975;GO:0006897;GO:0043542;GO:0007173;GO:0045184;GO:0038096;GO:0007229;GO:0008630;GO:0030035;GO:0006298;GO:0051882;GO:0000278;GO:0030514;GO:0022408;GO:2000773;GO:2000352;GO:0070373;GO:0043124;GO:1900272;GO:0045930;GO:1900275;GO:0071901;GO:0051444;GO:0001843;GO:0060563;GO:0050885;GO:0038189;GO:0038083;GO:0018108;GO:0035791;GO:2000251;GO:1904531;GO:0043065;GO:1905555;GO:0090050;GO:0007204;GO:0010595;GO:0070374;GO:0051894;GO:0043123;GO:0032729;GO:0032743;GO:1904528;GO:0045931;GO:0051149;GO:1901216;GO:0033690;GO:0051353;GO:0050731;GO:0001934;GO:0051281;GO:0051496;GO:1900026;GO:0045944;GO:2000096;GO:0009791;GO:0046777;GO:0006468;GO:0032956;GO:2000249;GO:0042981;GO:0010506;GO:0030516;GO:0032489;GO:0030155;GO:2000145;GO:0030100;GO:1903053;GO:1902036;GO:0031113;GO:1905244;GO:2001020;GO:0045580;GO:0006355;GO:0006979;GO:0042770;GO:0048536;GO:0034446;GO:0050852;GO:0048538;GO:0002333;, C:actin cytoskeleton; C:cell leading edge; C:cytoplasm; C:cytosol; C:dendrite; C:mitochondrion; C:neuronal cell body; C:nuclear body; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynapse; C:protein-containing complex;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:bubble DNA binding; F:DNA binding; F:ephrin receptor binding; F:four-way junction DNA binding; F:kinase activity; F:magnesium ion binding; F:manganese ion binding; F:mitogen-activated protein kinase binding; F:neuropilin binding; F:nicotinate-nucleotide adenylyltransferase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase C binding; F:protein tyrosine kinase activity; F:sequence-specific double-stranded DNA binding; F:SH2 domain binding; F:SH3 domain binding; F:syntaxin binding; F:transcription coactivator activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton organization; P:actin filament branching; P:activated T cell proliferation; P:activation of protein kinase C activity; P:alpha-beta T cell differentiation; P:autophagy; P:B cell proliferation involved in immune response; P:B cell receptor signaling pathway; P:B-1 B cell homeostasis; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to dopamine; P:cellular response to hydrogen peroxide; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:cerebellum morphogenesis; P:circulatory system development; P:collateral sprouting; P:DNA conformation change; P:DNA damage induced protein phosphorylation; P:endocytosis; P:endothelial cell migration; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:integrin-mediated signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:microspike assembly; P:mismatch repair; P:mitochondrial depolarization; P:mitotic cell cycle; P:negative regulation of BMP signaling pathway; P:negative regulation of cell-cell adhesion; P:negative regulation of cellular senescence; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mitotic cell cycle; P:negative regulation of phospholipase C activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of ubiquitin-protein transferase activity; P:neural tube closure; P:neuroepithelial cell differentiation; P:neuromuscular process controlling balance; P:neuropilin signaling pathway; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament binding; P:positive regulation of apoptotic process; P:positive regulation of blood vessel branching; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron death; P:positive regulation of osteoblast proliferation; P:positive regulation of oxidoreductase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:post-embryonic development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of axon extension; P:regulation of Cdc42 protein signal transduction; P:regulation of cell adhesion; P:regulation of cell motility; P:regulation of endocytosis; P:regulation of extracellular matrix organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of microtubule polymerization; P:regulation of modification of synaptic structure; P:regulation of response to DNA damage stimulus; P:regulation of T cell differentiation; P:regulation of transcription, DNA-templated; P:response to oxidative stress; P:signal transduction in response to DNA damage; P:spleen development; P:substrate adhesion-dependent cell spreading; P:T cell receptor signaling pathway; P:thymus development; P:transitional one stage B cell differentiation;|P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09,Tyrosine-protein kinase ABL1,Abelson murine leukemia viral oncogene homolog 1;Abelson tyrosine-protein kinase 1;Proto-oncogene c-Abl;p150;, PF08919;PF07714;PF00017;PF00018;, GO:0015629;GO:0031252;GO:0005737;GO:0005829;GO:0030425;GO:0005739;GO:0043025;GO:0016604;GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0098794;GO:0032991;GO:0051015;GO:0003785;GO:0005524;GO:0000405;GO:0003677;GO:0046875;GO:0000400;GO:0016301;GO:0000287;GO:0030145;GO:0051019;GO:0038191;GO:0004515;GO:0004715;GO:0001784;GO:0070064;GO:0008022;GO:0004672;GO:0005080;GO:0004713;GO:1990837;GO:0042169;GO:0017124;GO:0019905;GO:0003713;GO:0004714;GO:0030036;GO:0090135;GO:0050798;GO:1990051;GO:0046632;GO:0006914;GO:0002322;GO:0050853;GO:0001922;GO:0060020;GO:0007050;GO:0006464;GO:0006974;GO:1903351;GO:0070301;GO:0071222;GO:0034599;GO:0021587;GO:0072359;GO:0048668;GO:0071103;GO:0006975;GO:0006897;GO:0043542;GO:0007173;GO:0045184;GO:0038096;GO:0007229;GO:0008630;GO:0030035;GO:0006298;GO:0051882;GO:0000278;GO:0030514;GO:0022408;GO:2000773;GO:2000352;GO:0070373;GO:0043124;GO:1900272;GO:0045930;GO:1900275;GO:0071901;GO:0051444;GO:0001843;GO:0060563;GO:0050885;GO:0038189;GO:0038083;GO:0018108;GO:0035791;GO:2000251;GO:1904531;GO:0043065;GO:1905555;GO:0090050;GO:0007204;GO:0010595;GO:0070374;GO:0051894;GO:0043123;GO:0032729;GO:0032743;GO:1904528;GO:0045931;GO:0051149;GO:1901216;GO:0033690;GO:0051353;GO:0050731;GO:0001934;GO:0051281;GO:0051496;GO:1900026;GO:0045944;GO:2000096;GO:0009791;GO:0046777;GO:0006468;GO:0032956;GO:2000249;GO:0042981;GO:0010506;GO:0030516;GO:0032489;GO:0030155;GO:2000145;GO:0030100;GO:1903053;GO:1902036;GO:0031113;GO:1905244;GO:2001020;GO:0045580;GO:0006355;GO:0006979;GO:0042770;GO:0048536;GO:0034446;GO:0050852;GO:0048538;GO:0002333;, C:actin cytoskeleton; C:cell leading edge; C:cytoplasm; C:cytosol; C:dendrite; C:mitochondrion; C:neuronal cell body; C:nuclear body; C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynapse; C:protein-containing complex;, F:actin filament binding; F:actin monomer binding; F:ATP binding; F:bubble DNA binding; F:DNA binding; F:ephrin receptor binding; F:four-way junction DNA binding; F:kinase activity; F:magnesium ion binding; F:manganese ion binding; F:mitogen-activated protein kinase binding; F:neuropilin binding; F:nicotinate-nucleotide adenylyltransferase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphotyrosine residue binding; F:proline-rich region binding; F:protein C-terminus binding; F:protein kinase activity; F:protein kinase C binding; F:protein tyrosine kinase activity; F:sequence-specific double-stranded DNA binding; F:SH2 domain binding; F:SH3 domain binding; F:syntaxin binding; F:transcription coactivator activity; F:transmembrane receptor protein tyrosine kinase activity;, P:actin cytoskeleton organization; P:actin filament branching; P:activated T cell proliferation; P:activation of protein kinase C activity; P:alpha-beta T cell differentiation; P:autophagy; P:B cell proliferation involved in immune response; P:B cell receptor signaling pathway; P:B-1 B cell homeostasis; P:Bergmann glial cell differentiation; P:cell cycle arrest; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to dopamine; P:cellular response to hydrogen peroxide; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:cerebellum morphogenesis; P:circulatory system development; P:collateral sprouting; P:DNA conformation change; P:DNA damage induced protein phosphorylation; P:endocytosis; P:endothelial cell migration; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:integrin-mediated signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:microspike assembly; P:mismatch repair; P:mitochondrial depolarization; P:mitotic cell cycle; P:negative regulation of BMP signaling pathway; P:negative regulation of cell-cell adhesion; P:negative regulation of cellular senescence; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mitotic cell cycle; P:negative regulation of phospholipase C activity; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of ubiquitin-protein transferase activity; P:neural tube closure; P:neuroepithelial cell differentiation; P:neuromuscular process controlling balance; P:neuropilin signaling pathway; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament binding; P:positive regulation of apoptotic process; P:positive regulation of blood vessel branching; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell migration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of focal adhesion assembly; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of muscle cell differentiation; P:positive regulation of neuron death; P:positive regulation of osteoblast proliferation; P:positive regulation of oxidoreductase activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:post-embryonic development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of axon extension; P:regulation of Cdc42 protein signal transduction; P:regulation of cell adhesion; P:regulation of cell motility; P:regulation of endocytosis; P:regulation of extracellular matrix organization; P:regulation of hematopoietic stem cell differentiation; P:regulation of microtubule polymerization; P:regulation of modification of synaptic structure; P:regulation of response to DNA damage stimulus; P:regulation of T cell differentiation; P:regulation of transcription, DNA-templated; P:response to oxidative stress; P:signal transduction in response to DNA damage; P:spleen development; P:substrate adhesion-dependent cell spreading; P:T cell receptor signaling pathway; P:thymus development; P:transitional one stage B cell differentiation;|Q9Y6N6 B1APX9 B1APY0 Q59H72,Laminin subunit gamma-3,Laminin-12 subunit gamma;Laminin-14 subunit gamma;Laminin-15 subunit gamma;, PF00052;PF00053;PF00055;, GO:0005604;GO:0031012;GO:0005576;GO:0016020;GO:0005198;GO:0009887;GO:0014002;GO:0016477;GO:0030198;GO:0060041;GO:0034446;GO:0009888;GO:0007601;, C:basement membrane; C:extracellular matrix; C:extracellular region; C:membrane;, F:structural molecule activity;, P:animal organ morphogenesis; P:astrocyte development; P:cell migration; P:extracellular matrix organization; P:retina development in camera-type eye; P:substrate adhesion-dependent cell spreading; P:tissue development; P:visual perception;|Q9Y6N6 B1APX9 B1APY0 Q59H72,Laminin subunit gamma-3,Laminin-12 subunit gamma;Laminin-14 subunit gamma;Laminin-15 subunit gamma;, PF00052;PF00053;PF00055;, GO:0005604;GO:0031012;GO:0005576;GO:0016020;GO:0005198;GO:0009887;GO:0014002;GO:0016477;GO:0030198;GO:0060041;GO:0034446;GO:0009888;GO:0007601;, C:basement membrane; C:extracellular matrix; C:extracellular region; C:membrane;, F:structural molecule activity;, P:animal organ morphogenesis; P:astrocyte development; P:cell migration; P:extracellular matrix organization; P:retina development in camera-type eye; P:substrate adhesion-dependent cell spreading; P:tissue development; P:visual perception;|Q9Y6N6 B1APX9 B1APY0 Q59H72,Laminin subunit gamma-3,Laminin-12 subunit gamma;Laminin-14 subunit gamma;Laminin-15 subunit gamma;, PF00052;PF00053;PF00055;, GO:0005604;GO:0031012;GO:0005576;GO:0016020;GO:0005198;GO:0009887;GO:0014002;GO:0016477;GO:0030198;GO:0060041;GO:0034446;GO:0009888;GO:0007601;, C:basement membrane; C:extracellular matrix; C:extracellular region; C:membrane;, F:structural molecule activity;, P:animal organ morphogenesis; P:astrocyte development; P:cell migration; P:extracellular matrix organization; P:retina development in camera-type eye; P:substrate adhesion-dependent cell spreading; P:tissue development; P:visual perception;|Q9BQI0 B2RBC4 Q6ZR40 Q8NAX7 Q8WU47 Q9H9G0,Allograft inflammatory factor 1-like,Ionized calcium-binding adapter molecule 2;, , GO:0015629;GO:0005737;GO:0070062;GO:0005925;GO:0032991;GO:0032587;GO:0051015;GO:0005509;GO:0051017;GO:0097178;, C:actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:protein-containing complex; C:ruffle membrane;, F:actin filament binding; F:calcium ion binding;, P:actin filament bundle assembly; P:ruffle assembly;|P35658 A6NFQ0 Q15010 Q3KQZ0 Q5JUP7 Q75R47 Q86XD3,Nuclear pore complex protein Nup214,214 kDa nucleoporin;Nucleoporin Nup214;Protein CAN;, PF18617;, GO:1990876;GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005049;GO:0008139;GO:0017056;GO:0075733;GO:0000278;GO:0006406;GO:0006611;GO:0006606;GO:0016925;GO:0051726;GO:1900034;GO:0060964;GO:0006110;GO:0043488;GO:0046822;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasmic side of nuclear pore; C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity; F:nuclear localization sequence binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mRNA stability; P:regulation of nucleocytoplasmic transport; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P35658 A6NFQ0 Q15010 Q3KQZ0 Q5JUP7 Q75R47 Q86XD3,Nuclear pore complex protein Nup214,214 kDa nucleoporin;Nucleoporin Nup214;Protein CAN;, PF18617;, GO:1990876;GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005049;GO:0008139;GO:0017056;GO:0075733;GO:0000278;GO:0006406;GO:0006611;GO:0006606;GO:0016925;GO:0051726;GO:1900034;GO:0060964;GO:0006110;GO:0043488;GO:0046822;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasmic side of nuclear pore; C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity; F:nuclear localization sequence binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mRNA stability; P:regulation of nucleocytoplasmic transport; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P35658 A6NFQ0 Q15010 Q3KQZ0 Q5JUP7 Q75R47 Q86XD3,Nuclear pore complex protein Nup214,214 kDa nucleoporin;Nucleoporin Nup214;Protein CAN;, PF18617;, GO:1990876;GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005049;GO:0008139;GO:0017056;GO:0075733;GO:0000278;GO:0006406;GO:0006611;GO:0006606;GO:0016925;GO:0051726;GO:1900034;GO:0060964;GO:0006110;GO:0043488;GO:0046822;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasmic side of nuclear pore; C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity; F:nuclear localization sequence binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mRNA stability; P:regulation of nucleocytoplasmic transport; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P35658 A6NFQ0 Q15010 Q3KQZ0 Q5JUP7 Q75R47 Q86XD3,Nuclear pore complex protein Nup214,214 kDa nucleoporin;Nucleoporin Nup214;Protein CAN;, PF18617;, GO:1990876;GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005049;GO:0008139;GO:0017056;GO:0075733;GO:0000278;GO:0006406;GO:0006611;GO:0006606;GO:0016925;GO:0051726;GO:1900034;GO:0060964;GO:0006110;GO:0043488;GO:0046822;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasmic side of nuclear pore; C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity; F:nuclear localization sequence binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mRNA stability; P:regulation of nucleocytoplasmic transport; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P35658 A6NFQ0 Q15010 Q3KQZ0 Q5JUP7 Q75R47 Q86XD3,Nuclear pore complex protein Nup214,214 kDa nucleoporin;Nucleoporin Nup214;Protein CAN;, PF18617;, GO:1990876;GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005049;GO:0008139;GO:0017056;GO:0075733;GO:0000278;GO:0006406;GO:0006611;GO:0006606;GO:0016925;GO:0051726;GO:1900034;GO:0060964;GO:0006110;GO:0043488;GO:0046822;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasmic side of nuclear pore; C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity; F:nuclear localization sequence binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mRNA stability; P:regulation of nucleocytoplasmic transport; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P35658 A6NFQ0 Q15010 Q3KQZ0 Q5JUP7 Q75R47 Q86XD3,Nuclear pore complex protein Nup214,214 kDa nucleoporin;Nucleoporin Nup214;Protein CAN;, PF18617;, GO:1990876;GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0005049;GO:0008139;GO:0017056;GO:0075733;GO:0000278;GO:0006406;GO:0006611;GO:0006606;GO:0016925;GO:0051726;GO:1900034;GO:0060964;GO:0006110;GO:0043488;GO:0046822;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytoplasmic side of nuclear pore; C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:nuclear export signal receptor activity; F:nuclear localization sequence binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cell cycle; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mRNA stability; P:regulation of nucleocytoplasmic transport; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q5JUQ0 Q86VQ9 Q9H7P4,Protein FAM78A|Q8NBV4 Q5T6P0 Q96SS7 Q9BRC3,Inactive phospholipid phosphatase 7 {ECO:0000312|HGNC:HGNC:28174},Phosphatidic acid phosphatase type 2 domain-containing protein 3;, PF01569;, GO:0005789;GO:0016021;GO:0016020;GO:0005635;GO:0042392;GO:0010832;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear envelope;, F:sphingosine-1-phosphate phosphatase activity;, P:negative regulation of myotube differentiation;|Q8NBV4 Q5T6P0 Q96SS7 Q9BRC3,Inactive phospholipid phosphatase 7 {ECO:0000312|HGNC:HGNC:28174},Phosphatidic acid phosphatase type 2 domain-containing protein 3;, PF01569;, GO:0005789;GO:0016021;GO:0016020;GO:0005635;GO:0042392;GO:0010832;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear envelope;, F:sphingosine-1-phosphate phosphatase activity;, P:negative regulation of myotube differentiation;|Q8NBV4 Q5T6P0 Q96SS7 Q9BRC3,Inactive phospholipid phosphatase 7 {ECO:0000312|HGNC:HGNC:28174},Phosphatidic acid phosphatase type 2 domain-containing protein 3;, PF01569;, GO:0005789;GO:0016021;GO:0016020;GO:0005635;GO:0042392;GO:0010832;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nuclear envelope;, F:sphingosine-1-phosphate phosphatase activity;, P:negative regulation of myotube differentiation;|Q5JSZ5 O60270 Q5JSZ7 Q66VZ2 Q68CR0 Q96EI9 Q9H683,Protein PRRC2B,HLA-B-associated transcript 2-like 1;Proline-rich coiled-coil protein 2B;, PF07001;, GO:0003723;GO:0030154;, , F:RNA binding;, P:cell differentiation;|Q5JSZ5 O60270 Q5JSZ7 Q66VZ2 Q68CR0 Q96EI9 Q9H683,Protein PRRC2B,HLA-B-associated transcript 2-like 1;Proline-rich coiled-coil protein 2B;, PF07001;, GO:0003723;GO:0030154;, , F:RNA binding;, P:cell differentiation;|Q5JSZ5 O60270 Q5JSZ7 Q66VZ2 Q68CR0 Q96EI9 Q9H683,Protein PRRC2B,HLA-B-associated transcript 2-like 1;Proline-rich coiled-coil protein 2B;, PF07001;, GO:0003723;GO:0030154;, , F:RNA binding;, P:cell differentiation;|Q5JSZ5 O60270 Q5JSZ7 Q66VZ2 Q68CR0 Q96EI9 Q9H683,Protein PRRC2B,HLA-B-associated transcript 2-like 1;Proline-rich coiled-coil protein 2B;, PF07001;, GO:0003723;GO:0030154;, , F:RNA binding;, P:cell differentiation;|Q5JSZ5 O60270 Q5JSZ7 Q66VZ2 Q68CR0 Q96EI9 Q9H683,Protein PRRC2B,HLA-B-associated transcript 2-like 1;Proline-rich coiled-coil protein 2B;, PF07001;, GO:0003723;GO:0030154;, , F:RNA binding;, P:cell differentiation; scaffold102 indexed_genome mRNA 1721831 1745110 . + . ID=transcript_12907;Q9NX82 Q9UNT2,Protein O-mannosyl-transferase 1,Dolichyl-phosphate-mannose--protein mannosyltransferase 1;, PF02815;PF02366;PF16192;, GO:0001669;GO:0005783;GO:0005789;GO:0016021;GO:0016529;GO:0004169;GO:0000030;GO:0046872;GO:0005975;GO:0030198;GO:0007275;GO:1904100;GO:0006493;GO:0035269;, C:acrosomal vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:sarcoplasmic reticulum;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9NX82 Q9UNT2,Protein O-mannosyl-transferase 1,Dolichyl-phosphate-mannose--protein mannosyltransferase 1;, PF02815;PF02366;PF16192;, GO:0001669;GO:0005783;GO:0005789;GO:0016021;GO:0016529;GO:0004169;GO:0000030;GO:0046872;GO:0005975;GO:0030198;GO:0007275;GO:1904100;GO:0006493;GO:0035269;, C:acrosomal vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:sarcoplasmic reticulum;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9NX82 Q9UNT2,Protein O-mannosyl-transferase 1,Dolichyl-phosphate-mannose--protein mannosyltransferase 1;, PF02815;PF02366;PF16192;, GO:0001669;GO:0005783;GO:0005789;GO:0016021;GO:0016529;GO:0004169;GO:0000030;GO:0046872;GO:0005975;GO:0030198;GO:0007275;GO:1904100;GO:0006493;GO:0035269;, C:acrosomal vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:sarcoplasmic reticulum;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9NX82 Q9UNT2,Protein O-mannosyl-transferase 1,Dolichyl-phosphate-mannose--protein mannosyltransferase 1;, PF02815;PF02366;PF16192;, GO:0001669;GO:0005783;GO:0005789;GO:0016021;GO:0016529;GO:0004169;GO:0000030;GO:0046872;GO:0005975;GO:0030198;GO:0007275;GO:1904100;GO:0006493;GO:0035269;, C:acrosomal vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:sarcoplasmic reticulum;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9NX82 Q9UNT2,Protein O-mannosyl-transferase 1,Dolichyl-phosphate-mannose--protein mannosyltransferase 1;, PF02815;PF02366;PF16192;, GO:0001669;GO:0005783;GO:0005789;GO:0016021;GO:0016529;GO:0004169;GO:0000030;GO:0046872;GO:0005975;GO:0030198;GO:0007275;GO:1904100;GO:0006493;GO:0035269;, C:acrosomal vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:sarcoplasmic reticulum;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9NX82 Q9UNT2,Protein O-mannosyl-transferase 1,Dolichyl-phosphate-mannose--protein mannosyltransferase 1;, PF02815;PF02366;PF16192;, GO:0001669;GO:0005783;GO:0005789;GO:0016021;GO:0016529;GO:0004169;GO:0000030;GO:0046872;GO:0005975;GO:0030198;GO:0007275;GO:1904100;GO:0006493;GO:0035269;, C:acrosomal vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:sarcoplasmic reticulum;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9NX82 Q9UNT2,Protein O-mannosyl-transferase 1,Dolichyl-phosphate-mannose--protein mannosyltransferase 1;, PF02815;PF02366;PF16192;, GO:0001669;GO:0005783;GO:0005789;GO:0016021;GO:0016529;GO:0004169;GO:0000030;GO:0046872;GO:0005975;GO:0030198;GO:0007275;GO:1904100;GO:0006493;GO:0035269;, C:acrosomal vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:sarcoplasmic reticulum;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9NX82 Q9UNT2,Protein O-mannosyl-transferase 1,Dolichyl-phosphate-mannose--protein mannosyltransferase 1;, PF02815;PF02366;PF16192;, GO:0001669;GO:0005783;GO:0005789;GO:0016021;GO:0016529;GO:0004169;GO:0000030;GO:0046872;GO:0005975;GO:0030198;GO:0007275;GO:1904100;GO:0006493;GO:0035269;, C:acrosomal vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:sarcoplasmic reticulum;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9NX82 Q9UNT2,Protein O-mannosyl-transferase 1,Dolichyl-phosphate-mannose--protein mannosyltransferase 1;, PF02815;PF02366;PF16192;, GO:0001669;GO:0005783;GO:0005789;GO:0016021;GO:0016529;GO:0004169;GO:0000030;GO:0046872;GO:0005975;GO:0030198;GO:0007275;GO:1904100;GO:0006493;GO:0035269;, C:acrosomal vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:sarcoplasmic reticulum;, F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; F:mannosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of protein O-linked glycosylation; P:protein O-linked glycosylation; P:protein O-linked mannosylation; scaffold102 indexed_genome mRNA 1755314 1781481 . + . ID=transcript_12908;A0A1B0GWB2,Proline rich transmembrane protein 1B {ECO:0000305},, PF04505;, GO:0016021;GO:0016020;, C:integral component of membrane; C:membrane; scaffold102 indexed_genome mRNA 1795403 1916380 . + . ID=transcript_12909;Q13905 Q5JUE4 Q68DL3 Q8IV73,Rap guanine nucleotide exchange factor 1,CRK SH3-binding GNRP;Guanine nucleotide-releasing factor 2;Protein C3G;, PF00617;PF00618;, GO:0005737;GO:0005829;GO:0005769;GO:0043231;GO:0048471;GO:0030670;GO:0032991;GO:0005085;GO:0017124;GO:0090630;GO:0000186;GO:0001568;GO:0098609;GO:0071320;GO:1990090;GO:0019221;GO:0061028;GO:0090090;GO:0070373;GO:2000178;GO:0051898;GO:0046580;GO:0038180;GO:0007399;GO:0048008;GO:0070374;GO:1905451;GO:0043547;GO:0010976;GO:0046579;GO:0032486;GO:1901888;GO:0046328;GO:0007165;GO:0007169;, C:cytoplasm; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:protein-containing complex;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:activation of GTPase activity; P:activation of MAPKK activity; P:blood vessel development; P:cell-cell adhesion; P:cellular response to cAMP; P:cellular response to nerve growth factor stimulus; P:cytokine-mediated signaling pathway; P:establishment of endothelial barrier; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of neural precursor cell proliferation; P:negative regulation of protein kinase B signaling; P:negative regulation of Ras protein signal transduction; P:nerve growth factor signaling pathway; P:nervous system development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of Ras protein signal transduction; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of JNK cascade; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q13905 Q5JUE4 Q68DL3 Q8IV73,Rap guanine nucleotide exchange factor 1,CRK SH3-binding GNRP;Guanine nucleotide-releasing factor 2;Protein C3G;, PF00617;PF00618;, GO:0005737;GO:0005829;GO:0005769;GO:0043231;GO:0048471;GO:0030670;GO:0032991;GO:0005085;GO:0017124;GO:0090630;GO:0000186;GO:0001568;GO:0098609;GO:0071320;GO:1990090;GO:0019221;GO:0061028;GO:0090090;GO:0070373;GO:2000178;GO:0051898;GO:0046580;GO:0038180;GO:0007399;GO:0048008;GO:0070374;GO:1905451;GO:0043547;GO:0010976;GO:0046579;GO:0032486;GO:1901888;GO:0046328;GO:0007165;GO:0007169;, C:cytoplasm; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:protein-containing complex;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:activation of GTPase activity; P:activation of MAPKK activity; P:blood vessel development; P:cell-cell adhesion; P:cellular response to cAMP; P:cellular response to nerve growth factor stimulus; P:cytokine-mediated signaling pathway; P:establishment of endothelial barrier; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of neural precursor cell proliferation; P:negative regulation of protein kinase B signaling; P:negative regulation of Ras protein signal transduction; P:nerve growth factor signaling pathway; P:nervous system development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of Ras protein signal transduction; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of JNK cascade; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q13905 Q5JUE4 Q68DL3 Q8IV73,Rap guanine nucleotide exchange factor 1,CRK SH3-binding GNRP;Guanine nucleotide-releasing factor 2;Protein C3G;, PF00617;PF00618;, GO:0005737;GO:0005829;GO:0005769;GO:0043231;GO:0048471;GO:0030670;GO:0032991;GO:0005085;GO:0017124;GO:0090630;GO:0000186;GO:0001568;GO:0098609;GO:0071320;GO:1990090;GO:0019221;GO:0061028;GO:0090090;GO:0070373;GO:2000178;GO:0051898;GO:0046580;GO:0038180;GO:0007399;GO:0048008;GO:0070374;GO:1905451;GO:0043547;GO:0010976;GO:0046579;GO:0032486;GO:1901888;GO:0046328;GO:0007165;GO:0007169;, C:cytoplasm; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:protein-containing complex;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:activation of GTPase activity; P:activation of MAPKK activity; P:blood vessel development; P:cell-cell adhesion; P:cellular response to cAMP; P:cellular response to nerve growth factor stimulus; P:cytokine-mediated signaling pathway; P:establishment of endothelial barrier; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of neural precursor cell proliferation; P:negative regulation of protein kinase B signaling; P:negative regulation of Ras protein signal transduction; P:nerve growth factor signaling pathway; P:nervous system development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of Ras protein signal transduction; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of JNK cascade; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q13905 Q5JUE4 Q68DL3 Q8IV73,Rap guanine nucleotide exchange factor 1,CRK SH3-binding GNRP;Guanine nucleotide-releasing factor 2;Protein C3G;, PF00617;PF00618;, GO:0005737;GO:0005829;GO:0005769;GO:0043231;GO:0048471;GO:0030670;GO:0032991;GO:0005085;GO:0017124;GO:0090630;GO:0000186;GO:0001568;GO:0098609;GO:0071320;GO:1990090;GO:0019221;GO:0061028;GO:0090090;GO:0070373;GO:2000178;GO:0051898;GO:0046580;GO:0038180;GO:0007399;GO:0048008;GO:0070374;GO:1905451;GO:0043547;GO:0010976;GO:0046579;GO:0032486;GO:1901888;GO:0046328;GO:0007165;GO:0007169;, C:cytoplasm; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:protein-containing complex;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:activation of GTPase activity; P:activation of MAPKK activity; P:blood vessel development; P:cell-cell adhesion; P:cellular response to cAMP; P:cellular response to nerve growth factor stimulus; P:cytokine-mediated signaling pathway; P:establishment of endothelial barrier; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of neural precursor cell proliferation; P:negative regulation of protein kinase B signaling; P:negative regulation of Ras protein signal transduction; P:nerve growth factor signaling pathway; P:nervous system development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of Ras protein signal transduction; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of JNK cascade; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q13905 Q5JUE4 Q68DL3 Q8IV73,Rap guanine nucleotide exchange factor 1,CRK SH3-binding GNRP;Guanine nucleotide-releasing factor 2;Protein C3G;, PF00617;PF00618;, GO:0005737;GO:0005829;GO:0005769;GO:0043231;GO:0048471;GO:0030670;GO:0032991;GO:0005085;GO:0017124;GO:0090630;GO:0000186;GO:0001568;GO:0098609;GO:0071320;GO:1990090;GO:0019221;GO:0061028;GO:0090090;GO:0070373;GO:2000178;GO:0051898;GO:0046580;GO:0038180;GO:0007399;GO:0048008;GO:0070374;GO:1905451;GO:0043547;GO:0010976;GO:0046579;GO:0032486;GO:1901888;GO:0046328;GO:0007165;GO:0007169;, C:cytoplasm; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:protein-containing complex;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:activation of GTPase activity; P:activation of MAPKK activity; P:blood vessel development; P:cell-cell adhesion; P:cellular response to cAMP; P:cellular response to nerve growth factor stimulus; P:cytokine-mediated signaling pathway; P:establishment of endothelial barrier; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of neural precursor cell proliferation; P:negative regulation of protein kinase B signaling; P:negative regulation of Ras protein signal transduction; P:nerve growth factor signaling pathway; P:nervous system development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of Ras protein signal transduction; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of JNK cascade; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q13905 Q5JUE4 Q68DL3 Q8IV73,Rap guanine nucleotide exchange factor 1,CRK SH3-binding GNRP;Guanine nucleotide-releasing factor 2;Protein C3G;, PF00617;PF00618;, GO:0005737;GO:0005829;GO:0005769;GO:0043231;GO:0048471;GO:0030670;GO:0032991;GO:0005085;GO:0017124;GO:0090630;GO:0000186;GO:0001568;GO:0098609;GO:0071320;GO:1990090;GO:0019221;GO:0061028;GO:0090090;GO:0070373;GO:2000178;GO:0051898;GO:0046580;GO:0038180;GO:0007399;GO:0048008;GO:0070374;GO:1905451;GO:0043547;GO:0010976;GO:0046579;GO:0032486;GO:1901888;GO:0046328;GO:0007165;GO:0007169;, C:cytoplasm; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:protein-containing complex;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:activation of GTPase activity; P:activation of MAPKK activity; P:blood vessel development; P:cell-cell adhesion; P:cellular response to cAMP; P:cellular response to nerve growth factor stimulus; P:cytokine-mediated signaling pathway; P:establishment of endothelial barrier; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of neural precursor cell proliferation; P:negative regulation of protein kinase B signaling; P:negative regulation of Ras protein signal transduction; P:nerve growth factor signaling pathway; P:nervous system development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of Ras protein signal transduction; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of JNK cascade; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q13905 Q5JUE4 Q68DL3 Q8IV73,Rap guanine nucleotide exchange factor 1,CRK SH3-binding GNRP;Guanine nucleotide-releasing factor 2;Protein C3G;, PF00617;PF00618;, GO:0005737;GO:0005829;GO:0005769;GO:0043231;GO:0048471;GO:0030670;GO:0032991;GO:0005085;GO:0017124;GO:0090630;GO:0000186;GO:0001568;GO:0098609;GO:0071320;GO:1990090;GO:0019221;GO:0061028;GO:0090090;GO:0070373;GO:2000178;GO:0051898;GO:0046580;GO:0038180;GO:0007399;GO:0048008;GO:0070374;GO:1905451;GO:0043547;GO:0010976;GO:0046579;GO:0032486;GO:1901888;GO:0046328;GO:0007165;GO:0007169;, C:cytoplasm; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:protein-containing complex;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:activation of GTPase activity; P:activation of MAPKK activity; P:blood vessel development; P:cell-cell adhesion; P:cellular response to cAMP; P:cellular response to nerve growth factor stimulus; P:cytokine-mediated signaling pathway; P:establishment of endothelial barrier; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of neural precursor cell proliferation; P:negative regulation of protein kinase B signaling; P:negative regulation of Ras protein signal transduction; P:nerve growth factor signaling pathway; P:nervous system development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of Ras protein signal transduction; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of JNK cascade; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q13905 Q5JUE4 Q68DL3 Q8IV73,Rap guanine nucleotide exchange factor 1,CRK SH3-binding GNRP;Guanine nucleotide-releasing factor 2;Protein C3G;, PF00617;PF00618;, GO:0005737;GO:0005829;GO:0005769;GO:0043231;GO:0048471;GO:0030670;GO:0032991;GO:0005085;GO:0017124;GO:0090630;GO:0000186;GO:0001568;GO:0098609;GO:0071320;GO:1990090;GO:0019221;GO:0061028;GO:0090090;GO:0070373;GO:2000178;GO:0051898;GO:0046580;GO:0038180;GO:0007399;GO:0048008;GO:0070374;GO:1905451;GO:0043547;GO:0010976;GO:0046579;GO:0032486;GO:1901888;GO:0046328;GO:0007165;GO:0007169;, C:cytoplasm; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:protein-containing complex;, F:guanyl-nucleotide exchange factor activity; F:SH3 domain binding;, P:activation of GTPase activity; P:activation of MAPKK activity; P:blood vessel development; P:cell-cell adhesion; P:cellular response to cAMP; P:cellular response to nerve growth factor stimulus; P:cytokine-mediated signaling pathway; P:establishment of endothelial barrier; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of neural precursor cell proliferation; P:negative regulation of protein kinase B signaling; P:negative regulation of Ras protein signal transduction; P:nerve growth factor signaling pathway; P:nervous system development; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of GTPase activity; P:positive regulation of neuron projection development; P:positive regulation of Ras protein signal transduction; P:Rap protein signal transduction; P:regulation of cell junction assembly; P:regulation of JNK cascade; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold102 indexed_genome mRNA 2048019 2260886 . - . ID=transcript_12910;Q6P2C8 O95401 Q4F964 Q5VTA4 Q5VTA5 Q9BU57 Q9NYR4 V9GYV9,Mediator of RNA polymerase II transcription subunit 27,Cofactor required for Sp1 transcriptional activation subunit 8;Mediator complex subunit 27;P37 TRAP/SMCC/PC2 subunit;Transcriptional coactivator CRSP34;, PF11571;, GO:0005829;GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0003713;GO:0006357;GO:0060260;GO:0006367;, C:cytosol; C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:transcription coactivator activity;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter;|Q6P2C8 O95401 Q4F964 Q5VTA4 Q5VTA5 Q9BU57 Q9NYR4 V9GYV9,Mediator of RNA polymerase II transcription subunit 27,Cofactor required for Sp1 transcriptional activation subunit 8;Mediator complex subunit 27;P37 TRAP/SMCC/PC2 subunit;Transcriptional coactivator CRSP34;, PF11571;, GO:0005829;GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0003713;GO:0006357;GO:0060260;GO:0006367;, C:cytosol; C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:transcription coactivator activity;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter;|Q6P2C8 O95401 Q4F964 Q5VTA4 Q5VTA5 Q9BU57 Q9NYR4 V9GYV9,Mediator of RNA polymerase II transcription subunit 27,Cofactor required for Sp1 transcriptional activation subunit 8;Mediator complex subunit 27;P37 TRAP/SMCC/PC2 subunit;Transcriptional coactivator CRSP34;, PF11571;, GO:0005829;GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0003713;GO:0006357;GO:0060260;GO:0006367;, C:cytosol; C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:transcription coactivator activity;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter;|Q6P2C8 O95401 Q4F964 Q5VTA4 Q5VTA5 Q9BU57 Q9NYR4 V9GYV9,Mediator of RNA polymerase II transcription subunit 27,Cofactor required for Sp1 transcriptional activation subunit 8;Mediator complex subunit 27;P37 TRAP/SMCC/PC2 subunit;Transcriptional coactivator CRSP34;, PF11571;, GO:0005829;GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0003713;GO:0006357;GO:0060260;GO:0006367;, C:cytosol; C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:transcription coactivator activity;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter;|Q6P2C8 O95401 Q4F964 Q5VTA4 Q5VTA5 Q9BU57 Q9NYR4 V9GYV9,Mediator of RNA polymerase II transcription subunit 27,Cofactor required for Sp1 transcriptional activation subunit 8;Mediator complex subunit 27;P37 TRAP/SMCC/PC2 subunit;Transcriptional coactivator CRSP34;, PF11571;, GO:0005829;GO:0016592;GO:0005730;GO:0005654;GO:0005634;GO:0005667;GO:0003713;GO:0006357;GO:0060260;GO:0006367;, C:cytosol; C:mediator complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:transcription coactivator activity;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; scaffold102 indexed_genome mRNA 2351125 2419900 . + . ID=transcript_12911;Q96CW9 Q5JUJ2 Q6UXY0 Q96JH0,Netrin-G2 {ECO:0000305},Laminet-2;, PF00053;PF00055;, GO:0046658;GO:0099029;GO:0030424;GO:0005576;GO:0090543;GO:0098978;GO:0045171;GO:0043256;GO:0005886;GO:0098685;GO:0009887;GO:0007409;GO:0070831;GO:0016477;GO:0050804;GO:0098698;GO:2001222;GO:0150011;GO:0010975;GO:1905606;GO:0034446;GO:0099560;GO:0009888;, C:anchored component of plasma membrane; C:anchored component of presynaptic active zone membrane; C:axon; C:extracellular region; C:Flemming body; C:glutamatergic synapse; C:intercellular bridge; C:laminin complex; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, , P:animal organ morphogenesis; P:axonogenesis; P:basement membrane assembly; P:cell migration; P:modulation of chemical synaptic transmission; P:postsynaptic specialization assembly; P:regulation of neuron migration; P:regulation of neuron projection arborization; P:regulation of neuron projection development; P:regulation of presynapse assembly; P:substrate adhesion-dependent cell spreading; P:synaptic membrane adhesion; P:tissue development;|Q96CW9 Q5JUJ2 Q6UXY0 Q96JH0,Netrin-G2 {ECO:0000305},Laminet-2;, PF00053;PF00055;, GO:0046658;GO:0099029;GO:0030424;GO:0005576;GO:0090543;GO:0098978;GO:0045171;GO:0043256;GO:0005886;GO:0098685;GO:0009887;GO:0007409;GO:0070831;GO:0016477;GO:0050804;GO:0098698;GO:2001222;GO:0150011;GO:0010975;GO:1905606;GO:0034446;GO:0099560;GO:0009888;, C:anchored component of plasma membrane; C:anchored component of presynaptic active zone membrane; C:axon; C:extracellular region; C:Flemming body; C:glutamatergic synapse; C:intercellular bridge; C:laminin complex; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, , P:animal organ morphogenesis; P:axonogenesis; P:basement membrane assembly; P:cell migration; P:modulation of chemical synaptic transmission; P:postsynaptic specialization assembly; P:regulation of neuron migration; P:regulation of neuron projection arborization; P:regulation of neuron projection development; P:regulation of presynapse assembly; P:substrate adhesion-dependent cell spreading; P:synaptic membrane adhesion; P:tissue development;|Q96CW9 Q5JUJ2 Q6UXY0 Q96JH0,Netrin-G2 {ECO:0000305},Laminet-2;, PF00053;PF00055;, GO:0046658;GO:0099029;GO:0030424;GO:0005576;GO:0090543;GO:0098978;GO:0045171;GO:0043256;GO:0005886;GO:0098685;GO:0009887;GO:0007409;GO:0070831;GO:0016477;GO:0050804;GO:0098698;GO:2001222;GO:0150011;GO:0010975;GO:1905606;GO:0034446;GO:0099560;GO:0009888;, C:anchored component of plasma membrane; C:anchored component of presynaptic active zone membrane; C:axon; C:extracellular region; C:Flemming body; C:glutamatergic synapse; C:intercellular bridge; C:laminin complex; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, , P:animal organ morphogenesis; P:axonogenesis; P:basement membrane assembly; P:cell migration; P:modulation of chemical synaptic transmission; P:postsynaptic specialization assembly; P:regulation of neuron migration; P:regulation of neuron projection arborization; P:regulation of neuron projection development; P:regulation of presynapse assembly; P:substrate adhesion-dependent cell spreading; P:synaptic membrane adhesion; P:tissue development;|Q96CW9 Q5JUJ2 Q6UXY0 Q96JH0,Netrin-G2 {ECO:0000305},Laminet-2;, PF00053;PF00055;, GO:0046658;GO:0099029;GO:0030424;GO:0005576;GO:0090543;GO:0098978;GO:0045171;GO:0043256;GO:0005886;GO:0098685;GO:0009887;GO:0007409;GO:0070831;GO:0016477;GO:0050804;GO:0098698;GO:2001222;GO:0150011;GO:0010975;GO:1905606;GO:0034446;GO:0099560;GO:0009888;, C:anchored component of plasma membrane; C:anchored component of presynaptic active zone membrane; C:axon; C:extracellular region; C:Flemming body; C:glutamatergic synapse; C:intercellular bridge; C:laminin complex; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, , P:animal organ morphogenesis; P:axonogenesis; P:basement membrane assembly; P:cell migration; P:modulation of chemical synaptic transmission; P:postsynaptic specialization assembly; P:regulation of neuron migration; P:regulation of neuron projection arborization; P:regulation of neuron projection development; P:regulation of presynapse assembly; P:substrate adhesion-dependent cell spreading; P:synaptic membrane adhesion; P:tissue development; scaffold102 indexed_genome mRNA 2438390 2473445 . - . ID=transcript_12912;Q6AZD7 Q7Z3J6 Q8WX33 Q9H9D1 Q9NVP9,Probable helicase senataxin {ECO:0000305},Amyotrophic lateral sclerosis 4 protein;SEN1 homolog {ECO:0000305};Senataxin {ECO:0000303|PubMed:14770181, ECO:0000312|HGNC:HGNC:445};, PF13086;PF13087;, GO:0030424;GO:0000781;GO:0005737;GO:0030426;GO:0045171;GO:0016604;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0042802;GO:0003723;GO:0001147;GO:0030154;GO:0006974;GO:0044344;GO:0070301;GO:0034599;GO:0071300;GO:0007623;GO:0006310;GO:0006353;GO:0006302;GO:0008543;GO:0000165;GO:0006376;GO:0043066;GO:0007399;GO:2000144;GO:0060566;GO:0010976;GO:0033120;GO:2000806;GO:0045944;GO:0043491;GO:0006396;GO:0007283;GO:0006369;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:growth cone; C:intercellular bridge; C:nuclear body; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:identical protein binding; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:cellular response to retinoic acid; P:circadian rhythm; P:DNA recombination; P:DNA-templated transcription, termination; P:double-strand break repair; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:mRNA splice site selection; P:negative regulation of apoptotic process; P:nervous system development; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of DNA-templated transcription, termination; P:positive regulation of neuron projection development; P:positive regulation of RNA splicing; P:positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled; P:positive regulation of transcription by RNA polymerase II; P:protein kinase B signaling; P:RNA processing; P:spermatogenesis; P:termination of RNA polymerase II transcription;|Q6AZD7 Q7Z3J6 Q8WX33 Q9H9D1 Q9NVP9,Probable helicase senataxin {ECO:0000305},Amyotrophic lateral sclerosis 4 protein;SEN1 homolog {ECO:0000305};Senataxin {ECO:0000303|PubMed:14770181, ECO:0000312|HGNC:HGNC:445};, PF13086;PF13087;, GO:0030424;GO:0000781;GO:0005737;GO:0030426;GO:0045171;GO:0016604;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0042802;GO:0003723;GO:0001147;GO:0030154;GO:0006974;GO:0044344;GO:0070301;GO:0034599;GO:0071300;GO:0007623;GO:0006310;GO:0006353;GO:0006302;GO:0008543;GO:0000165;GO:0006376;GO:0043066;GO:0007399;GO:2000144;GO:0060566;GO:0010976;GO:0033120;GO:2000806;GO:0045944;GO:0043491;GO:0006396;GO:0007283;GO:0006369;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:growth cone; C:intercellular bridge; C:nuclear body; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:identical protein binding; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:cellular response to retinoic acid; P:circadian rhythm; P:DNA recombination; P:DNA-templated transcription, termination; P:double-strand break repair; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:mRNA splice site selection; P:negative regulation of apoptotic process; P:nervous system development; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of DNA-templated transcription, termination; P:positive regulation of neuron projection development; P:positive regulation of RNA splicing; P:positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled; P:positive regulation of transcription by RNA polymerase II; P:protein kinase B signaling; P:RNA processing; P:spermatogenesis; P:termination of RNA polymerase II transcription;|Q6AZD7 Q7Z3J6 Q8WX33 Q9H9D1 Q9NVP9,Probable helicase senataxin {ECO:0000305},Amyotrophic lateral sclerosis 4 protein;SEN1 homolog {ECO:0000305};Senataxin {ECO:0000303|PubMed:14770181, ECO:0000312|HGNC:HGNC:445};, PF13086;PF13087;, GO:0030424;GO:0000781;GO:0005737;GO:0030426;GO:0045171;GO:0016604;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0042802;GO:0003723;GO:0001147;GO:0030154;GO:0006974;GO:0044344;GO:0070301;GO:0034599;GO:0071300;GO:0007623;GO:0006310;GO:0006353;GO:0006302;GO:0008543;GO:0000165;GO:0006376;GO:0043066;GO:0007399;GO:2000144;GO:0060566;GO:0010976;GO:0033120;GO:2000806;GO:0045944;GO:0043491;GO:0006396;GO:0007283;GO:0006369;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:growth cone; C:intercellular bridge; C:nuclear body; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:identical protein binding; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:cellular response to retinoic acid; P:circadian rhythm; P:DNA recombination; P:DNA-templated transcription, termination; P:double-strand break repair; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:mRNA splice site selection; P:negative regulation of apoptotic process; P:nervous system development; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of DNA-templated transcription, termination; P:positive regulation of neuron projection development; P:positive regulation of RNA splicing; P:positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled; P:positive regulation of transcription by RNA polymerase II; P:protein kinase B signaling; P:RNA processing; P:spermatogenesis; P:termination of RNA polymerase II transcription;|Q6AZD7 Q7Z3J6 Q8WX33 Q9H9D1 Q9NVP9,Probable helicase senataxin {ECO:0000305},Amyotrophic lateral sclerosis 4 protein;SEN1 homolog {ECO:0000305};Senataxin {ECO:0000303|PubMed:14770181, ECO:0000312|HGNC:HGNC:445};, PF13086;PF13087;, GO:0030424;GO:0000781;GO:0005737;GO:0030426;GO:0045171;GO:0016604;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0042802;GO:0003723;GO:0001147;GO:0030154;GO:0006974;GO:0044344;GO:0070301;GO:0034599;GO:0071300;GO:0007623;GO:0006310;GO:0006353;GO:0006302;GO:0008543;GO:0000165;GO:0006376;GO:0043066;GO:0007399;GO:2000144;GO:0060566;GO:0010976;GO:0033120;GO:2000806;GO:0045944;GO:0043491;GO:0006396;GO:0007283;GO:0006369;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:growth cone; C:intercellular bridge; C:nuclear body; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:identical protein binding; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:cellular response to retinoic acid; P:circadian rhythm; P:DNA recombination; P:DNA-templated transcription, termination; P:double-strand break repair; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:mRNA splice site selection; P:negative regulation of apoptotic process; P:nervous system development; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of DNA-templated transcription, termination; P:positive regulation of neuron projection development; P:positive regulation of RNA splicing; P:positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled; P:positive regulation of transcription by RNA polymerase II; P:protein kinase B signaling; P:RNA processing; P:spermatogenesis; P:termination of RNA polymerase II transcription;|Q6AZD7 Q7Z3J6 Q8WX33 Q9H9D1 Q9NVP9,Probable helicase senataxin {ECO:0000305},Amyotrophic lateral sclerosis 4 protein;SEN1 homolog {ECO:0000305};Senataxin {ECO:0000303|PubMed:14770181, ECO:0000312|HGNC:HGNC:445};, PF13086;PF13087;, GO:0030424;GO:0000781;GO:0005737;GO:0030426;GO:0045171;GO:0016604;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0042802;GO:0003723;GO:0001147;GO:0030154;GO:0006974;GO:0044344;GO:0070301;GO:0034599;GO:0071300;GO:0007623;GO:0006310;GO:0006353;GO:0006302;GO:0008543;GO:0000165;GO:0006376;GO:0043066;GO:0007399;GO:2000144;GO:0060566;GO:0010976;GO:0033120;GO:2000806;GO:0045944;GO:0043491;GO:0006396;GO:0007283;GO:0006369;, C:axon; C:chromosome, telomeric region; C:cytoplasm; C:growth cone; C:intercellular bridge; C:nuclear body; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:identical protein binding; F:RNA binding; F:transcription termination site sequence-specific DNA binding;, P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to oxidative stress; P:cellular response to retinoic acid; P:circadian rhythm; P:DNA recombination; P:DNA-templated transcription, termination; P:double-strand break repair; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:mRNA splice site selection; P:negative regulation of apoptotic process; P:nervous system development; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of DNA-templated transcription, termination; P:positive regulation of neuron projection development; P:positive regulation of RNA splicing; P:positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled; P:positive regulation of transcription by RNA polymerase II; P:protein kinase B signaling; P:RNA processing; P:spermatogenesis; P:termination of RNA polymerase II transcription; scaffold102 indexed_genome mRNA 2542075 2574633 . - . ID=transcript_12913;Q15361 A1L160 Q4VXF3 Q58EY2 Q6P5T5,Transcription termination factor 1,RNA polymerase I termination factor;Transcription termination factor I;, , GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0003677;GO:0044267;GO:0006353;GO:0008156;GO:0006363;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:DNA binding;, P:cellular protein metabolic process; P:DNA-templated transcription, termination; P:negative regulation of DNA replication; P:termination of RNA polymerase I transcription;|Q15361 A1L160 Q4VXF3 Q58EY2 Q6P5T5,Transcription termination factor 1,RNA polymerase I termination factor;Transcription termination factor I;, , GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0003682;GO:0003677;GO:0044267;GO:0006353;GO:0008156;GO:0006363;, C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chromatin binding; F:DNA binding;, P:cellular protein metabolic process; P:DNA-templated transcription, termination; P:negative regulation of DNA replication; P:termination of RNA polymerase I transcription; scaffold102 indexed_genome mRNA 2739272 2742418 . + . ID=transcript_12914;Q9BZE3 Q5T6V2 Q9NY88,BarH-like 1 homeobox protein,, PF00046;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000977;GO:1990837;GO:0030901;GO:0043524;GO:0001764;GO:0006357;GO:0007605;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:midbrain development; P:negative regulation of neuron apoptotic process; P:neuron migration; P:regulation of transcription by RNA polymerase II; P:sensory perception of sound; scaffold102 indexed_genome mRNA 2744273 2746077 . - . ID=transcript_12915;Q9BZE3 Q5T6V2 Q9NY88,BarH-like 1 homeobox protein,, PF00046;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000977;GO:1990837;GO:0030901;GO:0043524;GO:0001764;GO:0006357;GO:0007605;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:midbrain development; P:negative regulation of neuron apoptotic process; P:neuron migration; P:regulation of transcription by RNA polymerase II; P:sensory perception of sound;|Q9BZE3 Q5T6V2 Q9NY88,BarH-like 1 homeobox protein,, PF00046;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000977;GO:1990837;GO:0030901;GO:0043524;GO:0001764;GO:0006357;GO:0007605;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:midbrain development; P:negative regulation of neuron apoptotic process; P:neuron migration; P:regulation of transcription by RNA polymerase II; P:sensory perception of sound; scaffold102 indexed_genome mRNA 2752527 2779859 . - . ID=transcript_12916;Q9H5K6,Probable ATP-dependent RNA helicase DDX31,DEAD box protein 31;Helicain;, PF00270;PF13959;PF00271;, GO:0005794;GO:0043231;GO:0005730;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0042254;, C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:ribosome biogenesis;|Q9H5K6,Probable ATP-dependent RNA helicase DDX31,DEAD box protein 31;Helicain;, PF00270;PF13959;PF00271;, GO:0005794;GO:0043231;GO:0005730;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0042254;, C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:ribosome biogenesis;|Q9H5K6,Probable ATP-dependent RNA helicase DDX31,DEAD box protein 31;Helicain;, PF00270;PF13959;PF00271;, GO:0005794;GO:0043231;GO:0005730;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0042254;, C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:ribosome biogenesis; scaffold102 indexed_genome mRNA 2781905 2827192 . - . ID=transcript_12917;Q9H5K6,Probable ATP-dependent RNA helicase DDX31,DEAD box protein 31;Helicain;, PF00270;PF13959;PF00271;, GO:0005794;GO:0043231;GO:0005730;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0042254;, C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:ribosome biogenesis; scaffold102 indexed_genome mRNA 2827503 2848111 . + . ID=transcript_12918;Q9UKN8 Q5VZJ7,General transcription factor 3C polypeptide 4,TF3C-delta;Transcription factor IIIC 90 kDa subunit;Transcription factor IIIC subunit delta;, PF12657;PF12660;, GO:0005739;GO:0005654;GO:0000127;GO:0003677;GO:0008047;GO:0004402;GO:0042791;GO:0006383;GO:0006384;GO:0042797;, C:mitochondrion; C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding; F:enzyme activator activity; F:histone acetyltransferase activity;, P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III;|Q9UKN8 Q5VZJ7,General transcription factor 3C polypeptide 4,TF3C-delta;Transcription factor IIIC 90 kDa subunit;Transcription factor IIIC subunit delta;, PF12657;PF12660;, GO:0005739;GO:0005654;GO:0000127;GO:0003677;GO:0008047;GO:0004402;GO:0042791;GO:0006383;GO:0006384;GO:0042797;, C:mitochondrion; C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding; F:enzyme activator activity; F:histone acetyltransferase activity;, P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III;|Q9UKN8 Q5VZJ7,General transcription factor 3C polypeptide 4,TF3C-delta;Transcription factor IIIC 90 kDa subunit;Transcription factor IIIC subunit delta;, PF12657;PF12660;, GO:0005739;GO:0005654;GO:0000127;GO:0003677;GO:0008047;GO:0004402;GO:0042791;GO:0006383;GO:0006384;GO:0042797;, C:mitochondrion; C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding; F:enzyme activator activity; F:histone acetyltransferase activity;, P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III;|Q9UKN8 Q5VZJ7,General transcription factor 3C polypeptide 4,TF3C-delta;Transcription factor IIIC 90 kDa subunit;Transcription factor IIIC subunit delta;, PF12657;PF12660;, GO:0005739;GO:0005654;GO:0000127;GO:0003677;GO:0008047;GO:0004402;GO:0042791;GO:0006383;GO:0006384;GO:0042797;, C:mitochondrion; C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding; F:enzyme activator activity; F:histone acetyltransferase activity;, P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III; scaffold102 indexed_genome mRNA 2865993 2953036 . - . ID=transcript_12919;Q96MA6 A8K821 Q8N9W9,Adenylate kinase 8,ATP-AMP transphosphorylase 8;, , GO:0005930;GO:0005737;GO:0005829;GO:0036126;GO:0004017;GO:0005524;GO:0004127;GO:0004550;GO:0015949;GO:0006165;GO:0009142;GO:0021591;, C:axoneme; C:cytoplasm; C:cytosol; C:sperm flagellum;, F:adenylate kinase activity; F:ATP binding; F:cytidylate kinase activity; F:nucleoside diphosphate kinase activity;, P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:ventricular system development; scaffold102 indexed_genome mRNA 2979488 3004489 . - . ID=transcript_12920;Q96MA6 A8K821 Q8N9W9,Adenylate kinase 8,ATP-AMP transphosphorylase 8;, , GO:0005930;GO:0005737;GO:0005829;GO:0036126;GO:0004017;GO:0005524;GO:0004127;GO:0004550;GO:0015949;GO:0006165;GO:0009142;GO:0021591;, C:axoneme; C:cytoplasm; C:cytosol; C:sperm flagellum;, F:adenylate kinase activity; F:ATP binding; F:cytidylate kinase activity; F:nucleoside diphosphate kinase activity;, P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:ventricular system development;|Q96MA6 A8K821 Q8N9W9,Adenylate kinase 8,ATP-AMP transphosphorylase 8;, , GO:0005930;GO:0005737;GO:0005829;GO:0036126;GO:0004017;GO:0005524;GO:0004127;GO:0004550;GO:0015949;GO:0006165;GO:0009142;GO:0021591;, C:axoneme; C:cytoplasm; C:cytosol; C:sperm flagellum;, F:adenylate kinase activity; F:ATP binding; F:cytidylate kinase activity; F:nucleoside diphosphate kinase activity;, P:nucleobase-containing small molecule interconversion; P:nucleoside diphosphate phosphorylation; P:nucleoside triphosphate biosynthetic process; P:ventricular system development; scaffold102 indexed_genome mRNA 3012877 3014680 . + . ID=transcript_12921;Q96E40 Q9UGQ0,Sperm acrosome-associated protein 9,, PF15120;, GO:0001669;GO:0036064;GO:0097546;GO:0005881;GO:0005634;GO:0036126;GO:0048306;, C:acrosomal vesicle; C:ciliary basal body; C:ciliary base; C:cytoplasmic microtubule; C:nucleus; C:sperm flagellum;, F:calcium-dependent protein binding; scaffold102 indexed_genome mRNA 3018337 3059425 . - . ID=transcript_12922;Q92574 B7Z897 Q5VVN5,Hamartin,Tuberous sclerosis 1 protein;, PF04388;, GO:0005938;GO:0101031;GO:0005737;GO:0005856;GO:0005829;GO:0030426;GO:0030027;GO:0005811;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0032991;GO:0033596;GO:0042030;GO:0051087;GO:0032794;GO:0030544;GO:0051879;GO:0047485;GO:0044877;GO:0090630;GO:0002250;GO:0008344;GO:0055007;GO:0030030;GO:0007160;GO:0090650;GO:0021987;GO:0046323;GO:0021766;GO:0001822;GO:0043379;GO:0042552;GO:0032780;GO:0008285;GO:0045792;GO:0034260;GO:0046627;GO:0016242;GO:0010977;GO:1903204;GO:0032007;GO:0017148;GO:0001843;GO:0051894;GO:0016239;GO:0051496;GO:0006813;GO:0050821;GO:0051726;GO:0001952;GO:1901214;GO:0043666;GO:0045859;GO:0051492;GO:0006417;GO:0032868;GO:0006407;GO:0050808;, C:cell cortex; C:chaperone complex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:growth cone; C:lamellipodium; C:lipid droplet; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:TSC1-TSC2 complex;, F:ATPase inhibitor activity; F:chaperone binding; F:GTPase activating protein binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:protein N-terminus binding; F:protein-containing complex binding;, P:activation of GTPase activity; P:adaptive immune response; P:adult locomotory behavior; P:cardiac muscle cell differentiation; P:cell projection organization; P:cell-matrix adhesion; P:cellular response to oxygen-glucose deprivation; P:cerebral cortex development; P:glucose import; P:hippocampus development; P:kidney development; P:memory T cell differentiation; P:myelination; P:negative regulation of ATPase activity; P:negative regulation of cell population proliferation; P:negative regulation of cell size; P:negative regulation of GTPase activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of macroautophagy; P:negative regulation of neuron projection development; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of TOR signaling; P:negative regulation of translation; P:neural tube closure; P:positive regulation of focal adhesion assembly; P:positive regulation of macroautophagy; P:positive regulation of stress fiber assembly; P:potassium ion transport; P:protein stabilization; P:regulation of cell cycle; P:regulation of cell-matrix adhesion; P:regulation of neuron death; P:regulation of phosphoprotein phosphatase activity; P:regulation of protein kinase activity; P:regulation of stress fiber assembly; P:regulation of translation; P:response to insulin; P:rRNA export from nucleus; P:synapse organization;|Q92574 B7Z897 Q5VVN5,Hamartin,Tuberous sclerosis 1 protein;, PF04388;, GO:0005938;GO:0101031;GO:0005737;GO:0005856;GO:0005829;GO:0030426;GO:0030027;GO:0005811;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0032991;GO:0033596;GO:0042030;GO:0051087;GO:0032794;GO:0030544;GO:0051879;GO:0047485;GO:0044877;GO:0090630;GO:0002250;GO:0008344;GO:0055007;GO:0030030;GO:0007160;GO:0090650;GO:0021987;GO:0046323;GO:0021766;GO:0001822;GO:0043379;GO:0042552;GO:0032780;GO:0008285;GO:0045792;GO:0034260;GO:0046627;GO:0016242;GO:0010977;GO:1903204;GO:0032007;GO:0017148;GO:0001843;GO:0051894;GO:0016239;GO:0051496;GO:0006813;GO:0050821;GO:0051726;GO:0001952;GO:1901214;GO:0043666;GO:0045859;GO:0051492;GO:0006417;GO:0032868;GO:0006407;GO:0050808;, C:cell cortex; C:chaperone complex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:growth cone; C:lamellipodium; C:lipid droplet; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:TSC1-TSC2 complex;, F:ATPase inhibitor activity; F:chaperone binding; F:GTPase activating protein binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:protein N-terminus binding; F:protein-containing complex binding;, P:activation of GTPase activity; P:adaptive immune response; P:adult locomotory behavior; P:cardiac muscle cell differentiation; P:cell projection organization; P:cell-matrix adhesion; P:cellular response to oxygen-glucose deprivation; P:cerebral cortex development; P:glucose import; P:hippocampus development; P:kidney development; P:memory T cell differentiation; P:myelination; P:negative regulation of ATPase activity; P:negative regulation of cell population proliferation; P:negative regulation of cell size; P:negative regulation of GTPase activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of macroautophagy; P:negative regulation of neuron projection development; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of TOR signaling; P:negative regulation of translation; P:neural tube closure; P:positive regulation of focal adhesion assembly; P:positive regulation of macroautophagy; P:positive regulation of stress fiber assembly; P:potassium ion transport; P:protein stabilization; P:regulation of cell cycle; P:regulation of cell-matrix adhesion; P:regulation of neuron death; P:regulation of phosphoprotein phosphatase activity; P:regulation of protein kinase activity; P:regulation of stress fiber assembly; P:regulation of translation; P:response to insulin; P:rRNA export from nucleus; P:synapse organization;|Q92574 B7Z897 Q5VVN5,Hamartin,Tuberous sclerosis 1 protein;, PF04388;, GO:0005938;GO:0101031;GO:0005737;GO:0005856;GO:0005829;GO:0030426;GO:0030027;GO:0005811;GO:0016020;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0032991;GO:0033596;GO:0042030;GO:0051087;GO:0032794;GO:0030544;GO:0051879;GO:0047485;GO:0044877;GO:0090630;GO:0002250;GO:0008344;GO:0055007;GO:0030030;GO:0007160;GO:0090650;GO:0021987;GO:0046323;GO:0021766;GO:0001822;GO:0043379;GO:0042552;GO:0032780;GO:0008285;GO:0045792;GO:0034260;GO:0046627;GO:0016242;GO:0010977;GO:1903204;GO:0032007;GO:0017148;GO:0001843;GO:0051894;GO:0016239;GO:0051496;GO:0006813;GO:0050821;GO:0051726;GO:0001952;GO:1901214;GO:0043666;GO:0045859;GO:0051492;GO:0006417;GO:0032868;GO:0006407;GO:0050808;, C:cell cortex; C:chaperone complex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:growth cone; C:lamellipodium; C:lipid droplet; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:TSC1-TSC2 complex;, F:ATPase inhibitor activity; F:chaperone binding; F:GTPase activating protein binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:protein N-terminus binding; F:protein-containing complex binding;, P:activation of GTPase activity; P:adaptive immune response; P:adult locomotory behavior; P:cardiac muscle cell differentiation; P:cell projection organization; P:cell-matrix adhesion; P:cellular response to oxygen-glucose deprivation; P:cerebral cortex development; P:glucose import; P:hippocampus development; P:kidney development; P:memory T cell differentiation; P:myelination; P:negative regulation of ATPase activity; P:negative regulation of cell population proliferation; P:negative regulation of cell size; P:negative regulation of GTPase activity; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of macroautophagy; P:negative regulation of neuron projection development; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of TOR signaling; P:negative regulation of translation; P:neural tube closure; P:positive regulation of focal adhesion assembly; P:positive regulation of macroautophagy; P:positive regulation of stress fiber assembly; P:potassium ion transport; P:protein stabilization; P:regulation of cell cycle; P:regulation of cell-matrix adhesion; P:regulation of neuron death; P:regulation of phosphoprotein phosphatase activity; P:regulation of protein kinase activity; P:regulation of stress fiber assembly; P:regulation of translation; P:response to insulin; P:rRNA export from nucleus; P:synapse organization; scaffold102 indexed_genome mRNA 3127282 3134199 . + . ID=transcript_12923;Q9Y5Q8 A6NI44 A6NJB9 Q5T7U2 Q5T7U3 Q8N2U7 Q8N857 Q96GD9 Q9H4P2,General transcription factor 3C polypeptide 5,TF3C-epsilon;Transcription factor IIIC 63 kDa subunit;Transcription factor IIIC subunit epsilon;, PF09734;PF17682;, GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0035914;GO:0006383;GO:0006384;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:skeletal muscle cell differentiation; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III; scaffold102 indexed_genome mRNA 3135518 3140918 . + . ID=transcript_12924;Q9Y5Q8 A6NI44 A6NJB9 Q5T7U2 Q5T7U3 Q8N2U7 Q8N857 Q96GD9 Q9H4P2,General transcription factor 3C polypeptide 5,TF3C-epsilon;Transcription factor IIIC 63 kDa subunit;Transcription factor IIIC subunit epsilon;, PF09734;PF17682;, GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0035914;GO:0006383;GO:0006384;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:skeletal muscle cell differentiation; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III;|Q9Y5Q8 A6NI44 A6NJB9 Q5T7U2 Q5T7U3 Q8N2U7 Q8N857 Q96GD9 Q9H4P2,General transcription factor 3C polypeptide 5,TF3C-epsilon;Transcription factor IIIC 63 kDa subunit;Transcription factor IIIC subunit epsilon;, PF09734;PF17682;, GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0035914;GO:0006383;GO:0006384;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:skeletal muscle cell differentiation; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III;|Q9Y5Q8 A6NI44 A6NJB9 Q5T7U2 Q5T7U3 Q8N2U7 Q8N857 Q96GD9 Q9H4P2,General transcription factor 3C polypeptide 5,TF3C-epsilon;Transcription factor IIIC 63 kDa subunit;Transcription factor IIIC subunit epsilon;, PF09734;PF17682;, GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0035914;GO:0006383;GO:0006384;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:skeletal muscle cell differentiation; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III;|Q9Y5Q8 A6NI44 A6NJB9 Q5T7U2 Q5T7U3 Q8N2U7 Q8N857 Q96GD9 Q9H4P2,General transcription factor 3C polypeptide 5,TF3C-epsilon;Transcription factor IIIC 63 kDa subunit;Transcription factor IIIC subunit epsilon;, PF09734;PF17682;, GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0035914;GO:0006383;GO:0006384;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:skeletal muscle cell differentiation; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III;|Q9Y5Q8 A6NI44 A6NJB9 Q5T7U2 Q5T7U3 Q8N2U7 Q8N857 Q96GD9 Q9H4P2,General transcription factor 3C polypeptide 5,TF3C-epsilon;Transcription factor IIIC 63 kDa subunit;Transcription factor IIIC subunit epsilon;, PF09734;PF17682;, GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0035914;GO:0006383;GO:0006384;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:skeletal muscle cell differentiation; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III; scaffold102 indexed_genome mRNA 3141765 3142811 . - . ID=transcript_12925;Q9Y5Q8 A6NI44 A6NJB9 Q5T7U2 Q5T7U3 Q8N2U7 Q8N857 Q96GD9 Q9H4P2,General transcription factor 3C polypeptide 5,TF3C-epsilon;Transcription factor IIIC 63 kDa subunit;Transcription factor IIIC subunit epsilon;, PF09734;PF17682;, GO:0005654;GO:0000127;GO:0003677;GO:0042791;GO:0035914;GO:0006383;GO:0006384;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, F:DNA binding;, P:5S class rRNA transcription by RNA polymerase III; P:skeletal muscle cell differentiation; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:tRNA transcription by RNA polymerase III; scaffold102 indexed_genome mRNA 3159693 3160492 . - . ID=transcript_12926;P19835 Q16398 Q5T7U7 Q9UCH1 Q9UP41,Bile salt-activated lipase,Bile salt-stimulated lipase;Bucelipase;Carboxyl ester lipase;Cholesterol esterase;Pancreatic lysophospholipase;Sterol esterase;, PF00135;PF16058;, GO:0009986;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005887;GO:0098793;GO:0045202;GO:0008126;GO:0003824;GO:0008201;GO:0016787;GO:0042043;GO:0038023;GO:0004771;GO:0004806;GO:0046514;GO:0007268;GO:0006707;GO:0009062;GO:0030299;GO:0044258;GO:0044241;GO:0006629;GO:0050804;GO:0007158;GO:0030157;GO:0097104;GO:0097105;GO:0018350;GO:0048488;, C:cell surface; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:presynapse; C:synapse;, F:acetylesterase activity; F:catalytic activity; F:heparin binding; F:hydrolase activity; F:neurexin family protein binding; F:signaling receptor activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:ceramide catabolic process; P:chemical synaptic transmission; P:cholesterol catabolic process; P:fatty acid catabolic process; P:intestinal cholesterol absorption; P:intestinal lipid catabolic process; P:lipid digestion; P:lipid metabolic process; P:modulation of chemical synaptic transmission; P:neuron cell-cell adhesion; P:pancreatic juice secretion; P:postsynaptic membrane assembly; P:presynaptic membrane assembly; P:protein esterification; P:synaptic vesicle endocytosis; scaffold102 indexed_genome mRNA 3167045 3170744 . + . ID=transcript_12927;Q9HAY1 Q9HCT1 Q9P2N8,Ral guanine nucleotide dissociation stimulator,Ral guanine nucleotide exchange factor;, PF00788;PF00617;PF00618;, GO:0005903;GO:0005829;GO:0005634;GO:0030695;GO:0005085;GO:0000165;GO:0007265;, C:brush border; C:cytosol; C:nucleus;, F:GTPase regulator activity; F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:Ras protein signal transduction;|Q9HAY1 Q9HCT1 Q9P2N8,Ral guanine nucleotide dissociation stimulator,Ral guanine nucleotide exchange factor;, PF00788;PF00617;PF00618;, GO:0005903;GO:0005829;GO:0005634;GO:0030695;GO:0005085;GO:0000165;GO:0007265;, C:brush border; C:cytosol; C:nucleus;, F:GTPase regulator activity; F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:Ras protein signal transduction; scaffold102 indexed_genome mRNA 3171059 3180726 . - . ID=transcript_12928;Q9HAY1 Q9HCT1 Q9P2N8,Ral guanine nucleotide dissociation stimulator,Ral guanine nucleotide exchange factor;, PF00788;PF00617;PF00618;, GO:0005903;GO:0005829;GO:0005634;GO:0030695;GO:0005085;GO:0000165;GO:0007265;, C:brush border; C:cytosol; C:nucleus;, F:GTPase regulator activity; F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:Ras protein signal transduction; scaffold102 indexed_genome mRNA 3237401 3238811 . - . ID=transcript_12929;Q9HAY1 Q9HCT1 Q9P2N8,Ral guanine nucleotide dissociation stimulator,Ral guanine nucleotide exchange factor;, PF00788;PF00617;PF00618;, GO:0005903;GO:0005829;GO:0005634;GO:0030695;GO:0005085;GO:0000165;GO:0007265;, C:brush border; C:cytosol; C:nucleus;, F:GTPase regulator activity; F:guanyl-nucleotide exchange factor activity;, P:MAPK cascade; P:Ras protein signal transduction; scaffold102 indexed_genome mRNA 3340035 3340774 . + . ID=transcript_12930;Q8WX39 C9J5F0 Q6JVE7,Epididymal-specific lipocalin-9,MUP-like lipocalin;, PF00061;, GO:0005615;GO:0036094;, C:extracellular space;, F:small molecule binding; scaffold102 indexed_genome mRNA 3380133 3382340 . - . ID=transcript_12931;Q5JUK3 B3KXF7 B7ZVY4 B9EGP2 G5E9V0 Q9P2C5,Potassium channel subfamily T member 1,KCa4.1;, PF03493;PF07885;, GO:0016021;GO:0005886;GO:0005228;GO:0015271;, C:integral component of membrane; C:plasma membrane;, F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity; scaffold102 indexed_genome mRNA 3387940 3388530 . - . ID=transcript_12932;Q5JUK3 B3KXF7 B7ZVY4 B9EGP2 G5E9V0 Q9P2C5,Potassium channel subfamily T member 1,KCa4.1;, PF03493;PF07885;, GO:0016021;GO:0005886;GO:0005228;GO:0015271;, C:integral component of membrane; C:plasma membrane;, F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity; scaffold102 indexed_genome mRNA 3400667 3413124 . + . ID=transcript_12933;Q5T5Y3 A1L4L2 B2REB2 B2REB3 Q70W33 Q8NCY0 Q96E80 Q96FM3 Q9UFJ5,Calmodulin-regulated spectrin-associated protein 1,, PF17095;PF11971;PF08683;, GO:0005737;GO:0005874;GO:0005516;GO:0008017;GO:0051011;GO:0030507;GO:0031122;GO:0007010;GO:0000226;GO:0007026;GO:0031175;GO:0022604;GO:0031113;, C:cytoplasm; C:microtubule;, F:calmodulin binding; F:microtubule binding; F:microtubule minus-end binding; F:spectrin binding;, P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:neuron projection development; P:regulation of cell morphogenesis; P:regulation of microtubule polymerization;|Q5T5Y3 A1L4L2 B2REB2 B2REB3 Q70W33 Q8NCY0 Q96E80 Q96FM3 Q9UFJ5,Calmodulin-regulated spectrin-associated protein 1,, PF17095;PF11971;PF08683;, GO:0005737;GO:0005874;GO:0005516;GO:0008017;GO:0051011;GO:0030507;GO:0031122;GO:0007010;GO:0000226;GO:0007026;GO:0031175;GO:0022604;GO:0031113;, C:cytoplasm; C:microtubule;, F:calmodulin binding; F:microtubule binding; F:microtubule minus-end binding; F:spectrin binding;, P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:neuron projection development; P:regulation of cell morphogenesis; P:regulation of microtubule polymerization;|Q5T5Y3 A1L4L2 B2REB2 B2REB3 Q70W33 Q8NCY0 Q96E80 Q96FM3 Q9UFJ5,Calmodulin-regulated spectrin-associated protein 1,, PF17095;PF11971;PF08683;, GO:0005737;GO:0005874;GO:0005516;GO:0008017;GO:0051011;GO:0030507;GO:0031122;GO:0007010;GO:0000226;GO:0007026;GO:0031175;GO:0022604;GO:0031113;, C:cytoplasm; C:microtubule;, F:calmodulin binding; F:microtubule binding; F:microtubule minus-end binding; F:spectrin binding;, P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:neuron projection development; P:regulation of cell morphogenesis; P:regulation of microtubule polymerization;|Q5T5Y3 A1L4L2 B2REB2 B2REB3 Q70W33 Q8NCY0 Q96E80 Q96FM3 Q9UFJ5,Calmodulin-regulated spectrin-associated protein 1,, PF17095;PF11971;PF08683;, GO:0005737;GO:0005874;GO:0005516;GO:0008017;GO:0051011;GO:0030507;GO:0031122;GO:0007010;GO:0000226;GO:0007026;GO:0031175;GO:0022604;GO:0031113;, C:cytoplasm; C:microtubule;, F:calmodulin binding; F:microtubule binding; F:microtubule minus-end binding; F:spectrin binding;, P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:neuron projection development; P:regulation of cell morphogenesis; P:regulation of microtubule polymerization; scaffold102 indexed_genome mRNA 3463147 3482494 . - . ID=transcript_12934;Q9BSL1 O75500 Q9UMW7,Ubiquitin-associated domain-containing protein 1,E3 ubiquitin-protein ligase subunit KPC2;Glialblastoma cell differentiation-related protein 1;Kip1 ubiquitination-promoting complex protein 2;, PF00627;, GO:0005829;GO:0070062;GO:0005794;GO:0005886;GO:0016567;, C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:plasma membrane;, , P:protein ubiquitination;|Q9BSL1 O75500 Q9UMW7,Ubiquitin-associated domain-containing protein 1,E3 ubiquitin-protein ligase subunit KPC2;Glialblastoma cell differentiation-related protein 1;Kip1 ubiquitination-promoting complex protein 2;, PF00627;, GO:0005829;GO:0070062;GO:0005794;GO:0005886;GO:0016567;, C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:plasma membrane;, , P:protein ubiquitination;|Q9BSL1 O75500 Q9UMW7,Ubiquitin-associated domain-containing protein 1,E3 ubiquitin-protein ligase subunit KPC2;Glialblastoma cell differentiation-related protein 1;Kip1 ubiquitination-promoting complex protein 2;, PF00627;, GO:0005829;GO:0070062;GO:0005794;GO:0005886;GO:0016567;, C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:plasma membrane;, , P:protein ubiquitination;|Q9BSL1 O75500 Q9UMW7,Ubiquitin-associated domain-containing protein 1,E3 ubiquitin-protein ligase subunit KPC2;Glialblastoma cell differentiation-related protein 1;Kip1 ubiquitination-promoting complex protein 2;, PF00627;, GO:0005829;GO:0070062;GO:0005794;GO:0005886;GO:0016567;, C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:plasma membrane;, , P:protein ubiquitination;|Q9BSL1 O75500 Q9UMW7,Ubiquitin-associated domain-containing protein 1,E3 ubiquitin-protein ligase subunit KPC2;Glialblastoma cell differentiation-related protein 1;Kip1 ubiquitination-promoting complex protein 2;, PF00627;, GO:0005829;GO:0070062;GO:0005794;GO:0005886;GO:0016567;, C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:plasma membrane;, , P:protein ubiquitination;|Q9BSL1 O75500 Q9UMW7,Ubiquitin-associated domain-containing protein 1,E3 ubiquitin-protein ligase subunit KPC2;Glialblastoma cell differentiation-related protein 1;Kip1 ubiquitination-promoting complex protein 2;, PF00627;, GO:0005829;GO:0070062;GO:0005794;GO:0005886;GO:0016567;, C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:plasma membrane;, , P:protein ubiquitination; scaffold102 indexed_genome mRNA 3528447 3561778 . - . ID=transcript_12935;Q96BF6,Nucleus accumbens-associated protein 2,BTB/POZ domain-containing protein 14A;Repressor with BTB domain and BEN domain;, PF10523;PF00651;, GO:0000785;GO:0005739;GO:0005730;GO:0005634;GO:0000981;GO:0001227;GO:0042826;GO:0042803;GO:0044877;GO:0000978;GO:0034629;GO:0008285;GO:1900477;GO:0000122;GO:0045892;GO:1902231;GO:0051260;GO:0006357;, C:chromatin; C:mitochondrion; C:nucleolus; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:protein homodimerization activity; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cellular protein-containing complex localization; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:protein homooligomerization; P:regulation of transcription by RNA polymerase II; scaffold102 indexed_genome mRNA 3700979 3716473 . - . ID=transcript_12936;Q6ZRP7 A2CEE0 A6NLB0 Q5TB37 Q7Z7B6 Q86VV7 Q8N3G2,Sulfhydryl oxidase 2,Neuroblastoma-derived sulfhydryl oxidase;Quiescin Q6-like protein 1;, PF04777;PF18371;PF18108;PF00085;, GO:0005615;GO:0005794;GO:0030173;GO:0031965;GO:0005654;GO:0005886;GO:0016971;GO:0003756;GO:0006457;, C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:flavin-linked sulfhydryl oxidase activity; F:protein disulfide isomerase activity;, P:protein folding;|Q6ZRP7 A2CEE0 A6NLB0 Q5TB37 Q7Z7B6 Q86VV7 Q8N3G2,Sulfhydryl oxidase 2,Neuroblastoma-derived sulfhydryl oxidase;Quiescin Q6-like protein 1;, PF04777;PF18371;PF18108;PF00085;, GO:0005615;GO:0005794;GO:0030173;GO:0031965;GO:0005654;GO:0005886;GO:0016971;GO:0003756;GO:0006457;, C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:flavin-linked sulfhydryl oxidase activity; F:protein disulfide isomerase activity;, P:protein folding;|Q6ZRP7 A2CEE0 A6NLB0 Q5TB37 Q7Z7B6 Q86VV7 Q8N3G2,Sulfhydryl oxidase 2,Neuroblastoma-derived sulfhydryl oxidase;Quiescin Q6-like protein 1;, PF04777;PF18371;PF18108;PF00085;, GO:0005615;GO:0005794;GO:0030173;GO:0031965;GO:0005654;GO:0005886;GO:0016971;GO:0003756;GO:0006457;, C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:flavin-linked sulfhydryl oxidase activity; F:protein disulfide isomerase activity;, P:protein folding;|Q6ZRP7 A2CEE0 A6NLB0 Q5TB37 Q7Z7B6 Q86VV7 Q8N3G2,Sulfhydryl oxidase 2,Neuroblastoma-derived sulfhydryl oxidase;Quiescin Q6-like protein 1;, PF04777;PF18371;PF18108;PF00085;, GO:0005615;GO:0005794;GO:0030173;GO:0031965;GO:0005654;GO:0005886;GO:0016971;GO:0003756;GO:0006457;, C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:flavin-linked sulfhydryl oxidase activity; F:protein disulfide isomerase activity;, P:protein folding;|Q6ZRP7 A2CEE0 A6NLB0 Q5TB37 Q7Z7B6 Q86VV7 Q8N3G2,Sulfhydryl oxidase 2,Neuroblastoma-derived sulfhydryl oxidase;Quiescin Q6-like protein 1;, PF04777;PF18371;PF18108;PF00085;, GO:0005615;GO:0005794;GO:0030173;GO:0031965;GO:0005654;GO:0005886;GO:0016971;GO:0003756;GO:0006457;, C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:flavin-linked sulfhydryl oxidase activity; F:protein disulfide isomerase activity;, P:protein folding;|Q6ZRP7 A2CEE0 A6NLB0 Q5TB37 Q7Z7B6 Q86VV7 Q8N3G2,Sulfhydryl oxidase 2,Neuroblastoma-derived sulfhydryl oxidase;Quiescin Q6-like protein 1;, PF04777;PF18371;PF18108;PF00085;, GO:0005615;GO:0005794;GO:0030173;GO:0031965;GO:0005654;GO:0005886;GO:0016971;GO:0003756;GO:0006457;, C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:flavin-linked sulfhydryl oxidase activity; F:protein disulfide isomerase activity;, P:protein folding;|Q6ZRP7 A2CEE0 A6NLB0 Q5TB37 Q7Z7B6 Q86VV7 Q8N3G2,Sulfhydryl oxidase 2,Neuroblastoma-derived sulfhydryl oxidase;Quiescin Q6-like protein 1;, PF04777;PF18371;PF18108;PF00085;, GO:0005615;GO:0005794;GO:0030173;GO:0031965;GO:0005654;GO:0005886;GO:0016971;GO:0003756;GO:0006457;, C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:flavin-linked sulfhydryl oxidase activity; F:protein disulfide isomerase activity;, P:protein folding;|Q6ZRP7 A2CEE0 A6NLB0 Q5TB37 Q7Z7B6 Q86VV7 Q8N3G2,Sulfhydryl oxidase 2,Neuroblastoma-derived sulfhydryl oxidase;Quiescin Q6-like protein 1;, PF04777;PF18371;PF18108;PF00085;, GO:0005615;GO:0005794;GO:0030173;GO:0031965;GO:0005654;GO:0005886;GO:0016971;GO:0003756;GO:0006457;, C:extracellular space; C:Golgi apparatus; C:integral component of Golgi membrane; C:nuclear membrane; C:nucleoplasm; C:plasma membrane;, F:flavin-linked sulfhydryl oxidase activity; F:protein disulfide isomerase activity;, P:protein folding; scaffold102 indexed_genome mRNA 3749333 3771653 . - . ID=transcript_12937;A0A096LP49 Q8N5P7,Coiled-coil domain-containing protein 187 {ECO:0000305},, , GO:0005813;GO:0008017;GO:0034453;, C:centrosome;, F:microtubule binding;, P:microtubule anchoring; scaffold102 indexed_genome mRNA 3771681 3787817 . - . ID=transcript_12938;A0A096LP49 Q8N5P7,Coiled-coil domain-containing protein 187 {ECO:0000305},, , GO:0005813;GO:0008017;GO:0034453;, C:centrosome;, F:microtubule binding;, P:microtubule anchoring; scaffold102 indexed_genome mRNA 3798988 3827197 . + . ID=transcript_12939;Q86YR5 A9Z1X4 B1B0W3 Q86SR5 Q969T1 Q9UFS8,G-protein-signaling modulator 1,Activator of G-protein signaling 3;, PF02188;, GO:0005829;GO:0005789;GO:0000139;GO:0005886;GO:0032991;GO:0005092;GO:0030154;GO:0034260;GO:1905098;GO:0007399;GO:0016239;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:plasma membrane; C:protein-containing complex;, F:GDP-dissociation inhibitor activity;, P:cell differentiation; P:negative regulation of GTPase activity; P:negative regulation of guanyl-nucleotide exchange factor activity; P:nervous system development; P:positive regulation of macroautophagy;|Q86YR5 A9Z1X4 B1B0W3 Q86SR5 Q969T1 Q9UFS8,G-protein-signaling modulator 1,Activator of G-protein signaling 3;, PF02188;, GO:0005829;GO:0005789;GO:0000139;GO:0005886;GO:0032991;GO:0005092;GO:0030154;GO:0034260;GO:1905098;GO:0007399;GO:0016239;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:plasma membrane; C:protein-containing complex;, F:GDP-dissociation inhibitor activity;, P:cell differentiation; P:negative regulation of GTPase activity; P:negative regulation of guanyl-nucleotide exchange factor activity; P:nervous system development; P:positive regulation of macroautophagy;|Q86YR5 A9Z1X4 B1B0W3 Q86SR5 Q969T1 Q9UFS8,G-protein-signaling modulator 1,Activator of G-protein signaling 3;, PF02188;, GO:0005829;GO:0005789;GO:0000139;GO:0005886;GO:0032991;GO:0005092;GO:0030154;GO:0034260;GO:1905098;GO:0007399;GO:0016239;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:plasma membrane; C:protein-containing complex;, F:GDP-dissociation inhibitor activity;, P:cell differentiation; P:negative regulation of GTPase activity; P:negative regulation of guanyl-nucleotide exchange factor activity; P:nervous system development; P:positive regulation of macroautophagy;|Q86YR5 A9Z1X4 B1B0W3 Q86SR5 Q969T1 Q9UFS8,G-protein-signaling modulator 1,Activator of G-protein signaling 3;, PF02188;, GO:0005829;GO:0005789;GO:0000139;GO:0005886;GO:0032991;GO:0005092;GO:0030154;GO:0034260;GO:1905098;GO:0007399;GO:0016239;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:plasma membrane; C:protein-containing complex;, F:GDP-dissociation inhibitor activity;, P:cell differentiation; P:negative regulation of GTPase activity; P:negative regulation of guanyl-nucleotide exchange factor activity; P:nervous system development; P:positive regulation of macroautophagy; scaffold102 indexed_genome mRNA 3827340 3843645 . + . ID=transcript_12940;Q86YR5 A9Z1X4 B1B0W3 Q86SR5 Q969T1 Q9UFS8,G-protein-signaling modulator 1,Activator of G-protein signaling 3;, PF02188;, GO:0005829;GO:0005789;GO:0000139;GO:0005886;GO:0032991;GO:0005092;GO:0030154;GO:0034260;GO:1905098;GO:0007399;GO:0016239;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:plasma membrane; C:protein-containing complex;, F:GDP-dissociation inhibitor activity;, P:cell differentiation; P:negative regulation of GTPase activity; P:negative regulation of guanyl-nucleotide exchange factor activity; P:nervous system development; P:positive regulation of macroautophagy;|Q86YR5 A9Z1X4 B1B0W3 Q86SR5 Q969T1 Q9UFS8,G-protein-signaling modulator 1,Activator of G-protein signaling 3;, PF02188;, GO:0005829;GO:0005789;GO:0000139;GO:0005886;GO:0032991;GO:0005092;GO:0030154;GO:0034260;GO:1905098;GO:0007399;GO:0016239;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:plasma membrane; C:protein-containing complex;, F:GDP-dissociation inhibitor activity;, P:cell differentiation; P:negative regulation of GTPase activity; P:negative regulation of guanyl-nucleotide exchange factor activity; P:nervous system development; P:positive regulation of macroautophagy;|Q9H257 Q5SXM5 Q5SXM6 Q9H854,Caspase recruitment domain-containing protein 9,, PF00619;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0050700;GO:0042802;GO:0042803;GO:0050830;GO:0051607;GO:0007249;GO:0045087;GO:0043280;GO:0043123;GO:0032755;GO:0046330;GO:0032874;GO:0032760;GO:0042981;GO:0032663;GO:0042493;GO:0043330;GO:0009620;GO:0032495;GO:0032494;GO:0002223;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:CARD domain binding; F:identical protein binding; F:protein homodimerization activity;, P:defense response to Gram-positive bacterium; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:innate immune response; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of stress-activated MAPK cascade; P:positive regulation of tumor necrosis factor production; P:regulation of apoptotic process; P:regulation of interleukin-2 production; P:response to drug; P:response to exogenous dsRNA; P:response to fungus; P:response to muramyl dipeptide; P:response to peptidoglycan; P:stimulatory C-type lectin receptor signaling pathway;|Q9H257 Q5SXM5 Q5SXM6 Q9H854,Caspase recruitment domain-containing protein 9,, PF00619;, GO:0005737;GO:0005829;GO:0005886;GO:0032991;GO:0050700;GO:0042802;GO:0042803;GO:0050830;GO:0051607;GO:0007249;GO:0045087;GO:0043280;GO:0043123;GO:0032755;GO:0046330;GO:0032874;GO:0032760;GO:0042981;GO:0032663;GO:0042493;GO:0043330;GO:0009620;GO:0032495;GO:0032494;GO:0002223;, C:cytoplasm; C:cytosol; C:plasma membrane; C:protein-containing complex;, F:CARD domain binding; F:identical protein binding; F:protein homodimerization activity;, P:defense response to Gram-positive bacterium; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:innate immune response; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-6 production; P:positive regulation of JNK cascade; P:positive regulation of stress-activated MAPK cascade; P:positive regulation of tumor necrosis factor production; P:regulation of apoptotic process; P:regulation of interleukin-2 production; P:response to drug; P:response to exogenous dsRNA; P:response to fungus; P:response to muramyl dipeptide; P:response to peptidoglycan; P:stimulatory C-type lectin receptor signaling pathway; scaffold102 indexed_genome mRNA 3845105 3866957 . + . ID=transcript_12941;Q5SXM2 Q9Y6P7,snRNA-activating protein complex subunit 4,Proximal sequence element-binding transcription factor subunit alpha;snRNA-activating protein complex 190 kDa subunit;, PF00249;, GO:0005654;GO:0005634;GO:0019185;GO:0003677;GO:0016251;GO:0000995;GO:0042795;GO:0042796;, C:nucleoplasm; C:nucleus; C:snRNA-activating protein complex;, F:DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase III general transcription initiation factor activity;, P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III;|Q5SXM2 Q9Y6P7,snRNA-activating protein complex subunit 4,Proximal sequence element-binding transcription factor subunit alpha;snRNA-activating protein complex 190 kDa subunit;, PF00249;, GO:0005654;GO:0005634;GO:0019185;GO:0003677;GO:0016251;GO:0000995;GO:0042795;GO:0042796;, C:nucleoplasm; C:nucleus; C:snRNA-activating protein complex;, F:DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase III general transcription initiation factor activity;, P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III;|Q5SXM2 Q9Y6P7,snRNA-activating protein complex subunit 4,Proximal sequence element-binding transcription factor subunit alpha;snRNA-activating protein complex 190 kDa subunit;, PF00249;, GO:0005654;GO:0005634;GO:0019185;GO:0003677;GO:0016251;GO:0000995;GO:0042795;GO:0042796;, C:nucleoplasm; C:nucleus; C:snRNA-activating protein complex;, F:DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase III general transcription initiation factor activity;, P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; scaffold102 indexed_genome mRNA 3883314 3887377 . + . ID=transcript_12942;Q10713 B4DKL3 E7ET61 Q16639 Q5SXM9 Q8N513,Mitochondrial-processing peptidase subunit alpha,Alpha-MPP;Inactive zinc metalloprotease alpha {ECO:0000305};P-55;, PF00675;PF05193;, GO:0005615;GO:0005743;GO:0005759;GO:0005739;GO:0046872;GO:0006851;GO:0006627;, C:extracellular space; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding;, P:mitochondrial calcium ion transmembrane transport; P:protein processing involved in protein targeting to mitochondrion; scaffold102 indexed_genome mRNA 3888089 3891165 . + . ID=transcript_12943;Q10713 B4DKL3 E7ET61 Q16639 Q5SXM9 Q8N513,Mitochondrial-processing peptidase subunit alpha,Alpha-MPP;Inactive zinc metalloprotease alpha {ECO:0000305};P-55;, PF00675;PF05193;, GO:0005615;GO:0005743;GO:0005759;GO:0005739;GO:0046872;GO:0006851;GO:0006627;, C:extracellular space; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding;, P:mitochondrial calcium ion transmembrane transport; P:protein processing involved in protein targeting to mitochondrion;|Q10713 B4DKL3 E7ET61 Q16639 Q5SXM9 Q8N513,Mitochondrial-processing peptidase subunit alpha,Alpha-MPP;Inactive zinc metalloprotease alpha {ECO:0000305};P-55;, PF00675;PF05193;, GO:0005615;GO:0005743;GO:0005759;GO:0005739;GO:0046872;GO:0006851;GO:0006627;, C:extracellular space; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding;, P:mitochondrial calcium ion transmembrane transport; P:protein processing involved in protein targeting to mitochondrion;|Q10713 B4DKL3 E7ET61 Q16639 Q5SXM9 Q8N513,Mitochondrial-processing peptidase subunit alpha,Alpha-MPP;Inactive zinc metalloprotease alpha {ECO:0000305};P-55;, PF00675;PF05193;, GO:0005615;GO:0005743;GO:0005759;GO:0005739;GO:0046872;GO:0006851;GO:0006627;, C:extracellular space; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:metal ion binding;, P:mitochondrial calcium ion transmembrane transport; P:protein processing involved in protein targeting to mitochondrion; scaffold102 indexed_genome mRNA 3892652 3903134 . - . ID=transcript_12944;Q9NRR6 Q15734 Q6PIV5,Phosphatidylinositol polyphosphate 5-phosphatase type IV {ECO:0000305},72 kDa inositol polyphosphate 5-phosphatase;Inositol polyphosphate-5-phosphatase E {ECO:0000303|PubMed:19668216};Phosphatidylinositol 4,5-bisphosphate 5-phosphatase {ECO:0000305};Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase {ECO:0000305};, PF03372;, GO:0005930;GO:0005929;GO:0005829;GO:0005925;GO:0005794;GO:0032580;GO:0005654;GO:0005634;GO:0005886;GO:0001726;GO:0004445;GO:0016314;GO:0034485;GO:0004439;GO:0060271;GO:0046855;GO:0014067;GO:1903565;GO:0017148;GO:0006661;GO:0046856;, C:axoneme; C:cilium; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle;, F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:cilium assembly; P:inositol phosphate dephosphorylation; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein localization to cilium; P:negative regulation of translation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q9NRR6 Q15734 Q6PIV5,Phosphatidylinositol polyphosphate 5-phosphatase type IV {ECO:0000305},72 kDa inositol polyphosphate 5-phosphatase;Inositol polyphosphate-5-phosphatase E {ECO:0000303|PubMed:19668216};Phosphatidylinositol 4,5-bisphosphate 5-phosphatase {ECO:0000305};Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase {ECO:0000305};, PF03372;, GO:0005930;GO:0005929;GO:0005829;GO:0005925;GO:0005794;GO:0032580;GO:0005654;GO:0005634;GO:0005886;GO:0001726;GO:0004445;GO:0016314;GO:0034485;GO:0004439;GO:0060271;GO:0046855;GO:0014067;GO:1903565;GO:0017148;GO:0006661;GO:0046856;, C:axoneme; C:cilium; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle;, F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:cilium assembly; P:inositol phosphate dephosphorylation; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein localization to cilium; P:negative regulation of translation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q9NRR6 Q15734 Q6PIV5,Phosphatidylinositol polyphosphate 5-phosphatase type IV {ECO:0000305},72 kDa inositol polyphosphate 5-phosphatase;Inositol polyphosphate-5-phosphatase E {ECO:0000303|PubMed:19668216};Phosphatidylinositol 4,5-bisphosphate 5-phosphatase {ECO:0000305};Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase {ECO:0000305};, PF03372;, GO:0005930;GO:0005929;GO:0005829;GO:0005925;GO:0005794;GO:0032580;GO:0005654;GO:0005634;GO:0005886;GO:0001726;GO:0004445;GO:0016314;GO:0034485;GO:0004439;GO:0060271;GO:0046855;GO:0014067;GO:1903565;GO:0017148;GO:0006661;GO:0046856;, C:axoneme; C:cilium; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle;, F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:cilium assembly; P:inositol phosphate dephosphorylation; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein localization to cilium; P:negative regulation of translation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation;|Q9NRR6 Q15734 Q6PIV5,Phosphatidylinositol polyphosphate 5-phosphatase type IV {ECO:0000305},72 kDa inositol polyphosphate 5-phosphatase;Inositol polyphosphate-5-phosphatase E {ECO:0000303|PubMed:19668216};Phosphatidylinositol 4,5-bisphosphate 5-phosphatase {ECO:0000305};Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase {ECO:0000305};, PF03372;, GO:0005930;GO:0005929;GO:0005829;GO:0005925;GO:0005794;GO:0032580;GO:0005654;GO:0005634;GO:0005886;GO:0001726;GO:0004445;GO:0016314;GO:0034485;GO:0004439;GO:0060271;GO:0046855;GO:0014067;GO:1903565;GO:0017148;GO:0006661;GO:0046856;, C:axoneme; C:cilium; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle;, F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;, P:cilium assembly; P:inositol phosphate dephosphorylation; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein localization to cilium; P:negative regulation of translation; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; scaffold102 indexed_genome mRNA 3908323 3909318 . - . ID=transcript_12945;O15027 A1YCA4 J3KNL6 Q4G0D7 Q5SXP0 Q5SXP1 Q8N347 Q96HP1,Protein transport protein Sec16A,SEC16 homolog A;, PF12932;PF12931;, GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0005794;GO:0000139;GO:0031090;GO:0048471;GO:0006914;GO:0048208;GO:0007029;GO:0006888;GO:0007030;GO:0043000;GO:0070863;GO:0032527;GO:0070973;GO:0072659;GO:0050821;GO:0034976;GO:0021762;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:organelle membrane; C:perinuclear region of cytoplasm;, , P:autophagy; P:COPII vesicle coating; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi to plasma membrane CFTR protein transport; P:positive regulation of protein exit from endoplasmic reticulum; P:protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein localization to plasma membrane; P:protein stabilization; P:response to endoplasmic reticulum stress; P:substantia nigra development; scaffold102 indexed_genome mRNA 3913513 3915599 . + . ID=transcript_12946;O15027 A1YCA4 J3KNL6 Q4G0D7 Q5SXP0 Q5SXP1 Q8N347 Q96HP1,Protein transport protein Sec16A,SEC16 homolog A;, PF12932;PF12931;, GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0005794;GO:0000139;GO:0031090;GO:0048471;GO:0006914;GO:0048208;GO:0007029;GO:0006888;GO:0007030;GO:0043000;GO:0070863;GO:0032527;GO:0070973;GO:0072659;GO:0050821;GO:0034976;GO:0021762;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:organelle membrane; C:perinuclear region of cytoplasm;, , P:autophagy; P:COPII vesicle coating; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi to plasma membrane CFTR protein transport; P:positive regulation of protein exit from endoplasmic reticulum; P:protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein localization to plasma membrane; P:protein stabilization; P:response to endoplasmic reticulum stress; P:substantia nigra development;|O15027 A1YCA4 J3KNL6 Q4G0D7 Q5SXP0 Q5SXP1 Q8N347 Q96HP1,Protein transport protein Sec16A,SEC16 homolog A;, PF12932;PF12931;, GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0005794;GO:0000139;GO:0031090;GO:0048471;GO:0006914;GO:0048208;GO:0007029;GO:0006888;GO:0007030;GO:0043000;GO:0070863;GO:0032527;GO:0070973;GO:0072659;GO:0050821;GO:0034976;GO:0021762;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:organelle membrane; C:perinuclear region of cytoplasm;, , P:autophagy; P:COPII vesicle coating; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi to plasma membrane CFTR protein transport; P:positive regulation of protein exit from endoplasmic reticulum; P:protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein localization to plasma membrane; P:protein stabilization; P:response to endoplasmic reticulum stress; P:substantia nigra development; scaffold102 indexed_genome mRNA 3920754 3930090 . - . ID=transcript_12947;O15027 A1YCA4 J3KNL6 Q4G0D7 Q5SXP0 Q5SXP1 Q8N347 Q96HP1,Protein transport protein Sec16A,SEC16 homolog A;, PF12932;PF12931;, GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0005794;GO:0000139;GO:0031090;GO:0048471;GO:0006914;GO:0048208;GO:0007029;GO:0006888;GO:0007030;GO:0043000;GO:0070863;GO:0032527;GO:0070973;GO:0072659;GO:0050821;GO:0034976;GO:0021762;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:organelle membrane; C:perinuclear region of cytoplasm;, , P:autophagy; P:COPII vesicle coating; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi to plasma membrane CFTR protein transport; P:positive regulation of protein exit from endoplasmic reticulum; P:protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein localization to plasma membrane; P:protein stabilization; P:response to endoplasmic reticulum stress; P:substantia nigra development;|O15027 A1YCA4 J3KNL6 Q4G0D7 Q5SXP0 Q5SXP1 Q8N347 Q96HP1,Protein transport protein Sec16A,SEC16 homolog A;, PF12932;PF12931;, GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0005794;GO:0000139;GO:0031090;GO:0048471;GO:0006914;GO:0048208;GO:0007029;GO:0006888;GO:0007030;GO:0043000;GO:0070863;GO:0032527;GO:0070973;GO:0072659;GO:0050821;GO:0034976;GO:0021762;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:organelle membrane; C:perinuclear region of cytoplasm;, , P:autophagy; P:COPII vesicle coating; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi to plasma membrane CFTR protein transport; P:positive regulation of protein exit from endoplasmic reticulum; P:protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein localization to plasma membrane; P:protein stabilization; P:response to endoplasmic reticulum stress; P:substantia nigra development;|O15027 A1YCA4 J3KNL6 Q4G0D7 Q5SXP0 Q5SXP1 Q8N347 Q96HP1,Protein transport protein Sec16A,SEC16 homolog A;, PF12932;PF12931;, GO:0005829;GO:0005783;GO:0070971;GO:0005789;GO:0012507;GO:0005794;GO:0000139;GO:0031090;GO:0048471;GO:0006914;GO:0048208;GO:0007029;GO:0006888;GO:0007030;GO:0043000;GO:0070863;GO:0032527;GO:0070973;GO:0072659;GO:0050821;GO:0034976;GO:0021762;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:organelle membrane; C:perinuclear region of cytoplasm;, , P:autophagy; P:COPII vesicle coating; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi to plasma membrane CFTR protein transport; P:positive regulation of protein exit from endoplasmic reticulum; P:protein exit from endoplasmic reticulum; P:protein localization to endoplasmic reticulum exit site; P:protein localization to plasma membrane; P:protein stabilization; P:response to endoplasmic reticulum stress; P:substantia nigra development; scaffold102 indexed_genome mRNA 3963760 3969663 . - . ID=transcript_12948;P46531 Q59ED8 Q5SXM3,Neurogenic locus notch homolog protein 1,Translocation-associated notch protein TAN-1;, PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0001669;GO:0005912;GO:0016324;GO:0009986;GO:0005829;GO:0005789;GO:0005576;GO:0000139;GO:0016021;GO:0002193;GO:0005654;GO:0005634;GO:0005886;GO:0043235;GO:0005509;GO:0031490;GO:0019899;GO:0004857;GO:0042802;GO:0005112;GO:0003713;GO:0004888;GO:0031100;GO:0003180;GO:1902263;GO:0060842;GO:0048708;GO:0003162;GO:0003181;GO:0009912;GO:0007411;GO:0048754;GO:0003209;GO:0003207;GO:0060317;GO:0003214;GO:0060038;GO:0055008;GO:0003213;GO:0003219;GO:0060411;GO:0060948;GO:0003208;GO:0007050;GO:0021515;GO:0001708;GO:0003273;GO:0071372;GO:0035924;GO:0060271;GO:0072044;GO:0007386;GO:0060982;GO:0003182;GO:0003169;GO:0007368;GO:0072017;GO:0035116;GO:0060956;GO:0003203;GO:0003157;GO:0003160;GO:0007492;GO:0001837;GO:0003198;GO:0030900;GO:0007440;GO:0072144;GO:0003241;GO:0031069;GO:0007507;GO:0001947;GO:0061384;GO:0048873;GO:0006959;GO:0006955;GO:0001701;GO:0002437;GO:0030216;GO:0070986;GO:0001889;GO:0030324;GO:0014031;GO:0003192;GO:2000811;GO:0070168;GO:0030514;GO:0045955;GO:0090090;GO:0010614;GO:0043086;GO:0060354;GO:0090051;GO:0008285;GO:0003252;GO:2000048;GO:0010812;GO:0120163;GO:2001027;GO:0003332;GO:0010629;GO:0060253;GO:0045967;GO:0045608;GO:0045662;GO:0010832;GO:0050768;GO:0048715;GO:0030279;GO:0045668;GO:0046533;GO:2000974;GO:2000737;GO:0000122;GO:0045892;GO:0021915;GO:0097150;GO:0061314;GO:0007219;GO:0003270;GO:0048709;GO:0003151;GO:0003344;GO:1903849;GO:1902339;GO:0048711;GO:0030513;GO:0062043;GO:0060045;GO:0030335;GO:0008284;GO:0045603;GO:0050679;GO:0070374;GO:0010628;GO:0045618;GO:0002052;GO:0045747;GO:0046579;GO:0046427;GO:0045944;GO:0061419;GO:0007221;GO:0045893;GO:0045070;GO:0060740;GO:0003184;GO:0060768;GO:1901201;GO:0014807;GO:0003256;GO:0006355;GO:0031960;GO:0032496;GO:0032495;GO:0060528;GO:0035914;GO:0048103;GO:0007283;GO:0002040;GO:0042246;GO:0006367;GO:0035148;GO:0060979;GO:0060843;GO:0060412;GO:0003222;, C:acrosomal vesicle; C:adherens junction; C:apical plasma membrane; C:cell surface; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:MAML1-RBP-Jkappa- ICN1 complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:chromatin DNA binding; F:enzyme binding; F:enzyme inhibitor activity; F:identical protein binding; F:Notch binding; F:transcription coactivator activity; F:transmembrane signaling receptor activity;, P:animal organ regeneration; P:aortic valve morphogenesis; P:apoptotic process involved in embryonic digit morphogenesis; P:arterial endothelial cell differentiation; P:astrocyte differentiation; P:atrioventricular node development; P:atrioventricular valve morphogenesis; P:auditory receptor cell fate commitment; P:axon guidance; P:branching morphogenesis of an epithelial tube; P:cardiac atrium morphogenesis; P:cardiac chamber formation; P:cardiac epithelial to mesenchymal transition; P:cardiac left ventricle morphogenesis; P:cardiac muscle cell proliferation; P:cardiac muscle tissue morphogenesis; P:cardiac right atrium morphogenesis; P:cardiac right ventricle formation; P:cardiac septum morphogenesis; P:cardiac vascular smooth muscle cell development; P:cardiac ventricle morphogenesis; P:cell cycle arrest; P:cell differentiation in spinal cord; P:cell fate specification; P:cell migration involved in endocardial cushion formation; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:cilium assembly; P:collecting duct development; P:compartment pattern specification; P:coronary artery morphogenesis; P:coronary sinus valve morphogenesis; P:coronary vein morphogenesis; P:determination of left/right symmetry; P:distal tubule development; P:embryonic hindlimb morphogenesis; P:endocardial cell differentiation; P:endocardial cushion morphogenesis; P:endocardium development; P:endocardium morphogenesis; P:endoderm development; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:forebrain development; P:foregut morphogenesis; P:glomerular mesangial cell development; P:growth involved in heart morphogenesis; P:hair follicle morphogenesis; P:heart development; P:heart looping; P:heart trabecula morphogenesis; P:homeostasis of number of cells within a tissue; P:humoral immune response; P:immune response; P:in utero embryonic development; P:inflammatory response to antigenic stimulus; P:keratinocyte differentiation; P:left/right axis specification; P:liver development; P:lung development; P:mesenchymal cell development; P:mitral valve formation; P:negative regulation of anoikis; P:negative regulation of biomineral tissue development; P:negative regulation of BMP signaling pathway; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of catalytic activity; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of cell proliferation involved in heart valve morphogenesis; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-substrate adhesion; P:negative regulation of cold-induced thermogenesis; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of extracellular matrix constituent secretion; P:negative regulation of gene expression; P:negative regulation of glial cell proliferation; P:negative regulation of growth rate; P:negative regulation of inner ear auditory receptor cell differentiation; P:negative regulation of myoblast differentiation; P:negative regulation of myotube differentiation; P:negative regulation of neurogenesis; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of ossification; P:negative regulation of osteoblast differentiation; P:negative regulation of photoreceptor cell differentiation; P:negative regulation of pro-B cell differentiation; P:negative regulation of stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation; P:oligodendrocyte differentiation; P:outflow tract morphogenesis; P:pericardium morphogenesis; P:positive regulation of aorta morphogenesis; P:positive regulation of apoptotic process involved in morphogenesis; P:positive regulation of astrocyte differentiation; P:positive regulation of BMP signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell differentiation; P:positive regulation of epithelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of keratinocyte differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of Ras protein signal transduction; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral genome replication; P:prostate gland epithelium morphogenesis; P:pulmonary valve morphogenesis; P:regulation of epithelial cell proliferation involved in prostate gland development; P:regulation of extracellular matrix assembly; P:regulation of somitogenesis; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:regulation of transcription, DNA-templated; P:response to corticosteroid; P:response to lipopolysaccharide; P:response to muramyl dipeptide; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; P:skeletal muscle cell differentiation; P:somatic stem cell division; P:spermatogenesis; P:sprouting angiogenesis; P:tissue regeneration; P:transcription initiation from RNA polymerase II promoter; P:tube formation; P:vasculogenesis involved in coronary vascular morphogenesis; P:venous endothelial cell differentiation; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis; scaffold102 indexed_genome mRNA 3974871 3993450 . - . ID=transcript_12949;P46531 Q59ED8 Q5SXM3,Neurogenic locus notch homolog protein 1,Translocation-associated notch protein TAN-1;, PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0001669;GO:0005912;GO:0016324;GO:0009986;GO:0005829;GO:0005789;GO:0005576;GO:0000139;GO:0016021;GO:0002193;GO:0005654;GO:0005634;GO:0005886;GO:0043235;GO:0005509;GO:0031490;GO:0019899;GO:0004857;GO:0042802;GO:0005112;GO:0003713;GO:0004888;GO:0031100;GO:0003180;GO:1902263;GO:0060842;GO:0048708;GO:0003162;GO:0003181;GO:0009912;GO:0007411;GO:0048754;GO:0003209;GO:0003207;GO:0060317;GO:0003214;GO:0060038;GO:0055008;GO:0003213;GO:0003219;GO:0060411;GO:0060948;GO:0003208;GO:0007050;GO:0021515;GO:0001708;GO:0003273;GO:0071372;GO:0035924;GO:0060271;GO:0072044;GO:0007386;GO:0060982;GO:0003182;GO:0003169;GO:0007368;GO:0072017;GO:0035116;GO:0060956;GO:0003203;GO:0003157;GO:0003160;GO:0007492;GO:0001837;GO:0003198;GO:0030900;GO:0007440;GO:0072144;GO:0003241;GO:0031069;GO:0007507;GO:0001947;GO:0061384;GO:0048873;GO:0006959;GO:0006955;GO:0001701;GO:0002437;GO:0030216;GO:0070986;GO:0001889;GO:0030324;GO:0014031;GO:0003192;GO:2000811;GO:0070168;GO:0030514;GO:0045955;GO:0090090;GO:0010614;GO:0043086;GO:0060354;GO:0090051;GO:0008285;GO:0003252;GO:2000048;GO:0010812;GO:0120163;GO:2001027;GO:0003332;GO:0010629;GO:0060253;GO:0045967;GO:0045608;GO:0045662;GO:0010832;GO:0050768;GO:0048715;GO:0030279;GO:0045668;GO:0046533;GO:2000974;GO:2000737;GO:0000122;GO:0045892;GO:0021915;GO:0097150;GO:0061314;GO:0007219;GO:0003270;GO:0048709;GO:0003151;GO:0003344;GO:1903849;GO:1902339;GO:0048711;GO:0030513;GO:0062043;GO:0060045;GO:0030335;GO:0008284;GO:0045603;GO:0050679;GO:0070374;GO:0010628;GO:0045618;GO:0002052;GO:0045747;GO:0046579;GO:0046427;GO:0045944;GO:0061419;GO:0007221;GO:0045893;GO:0045070;GO:0060740;GO:0003184;GO:0060768;GO:1901201;GO:0014807;GO:0003256;GO:0006355;GO:0031960;GO:0032496;GO:0032495;GO:0060528;GO:0035914;GO:0048103;GO:0007283;GO:0002040;GO:0042246;GO:0006367;GO:0035148;GO:0060979;GO:0060843;GO:0060412;GO:0003222;, C:acrosomal vesicle; C:adherens junction; C:apical plasma membrane; C:cell surface; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:MAML1-RBP-Jkappa- ICN1 complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:chromatin DNA binding; F:enzyme binding; F:enzyme inhibitor activity; F:identical protein binding; F:Notch binding; F:transcription coactivator activity; F:transmembrane signaling receptor activity;, P:animal organ regeneration; P:aortic valve morphogenesis; P:apoptotic process involved in embryonic digit morphogenesis; P:arterial endothelial cell differentiation; P:astrocyte differentiation; P:atrioventricular node development; P:atrioventricular valve morphogenesis; P:auditory receptor cell fate commitment; P:axon guidance; P:branching morphogenesis of an epithelial tube; P:cardiac atrium morphogenesis; P:cardiac chamber formation; P:cardiac epithelial to mesenchymal transition; P:cardiac left ventricle morphogenesis; P:cardiac muscle cell proliferation; P:cardiac muscle tissue morphogenesis; P:cardiac right atrium morphogenesis; P:cardiac right ventricle formation; P:cardiac septum morphogenesis; P:cardiac vascular smooth muscle cell development; P:cardiac ventricle morphogenesis; P:cell cycle arrest; P:cell differentiation in spinal cord; P:cell fate specification; P:cell migration involved in endocardial cushion formation; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:cilium assembly; P:collecting duct development; P:compartment pattern specification; P:coronary artery morphogenesis; P:coronary sinus valve morphogenesis; P:coronary vein morphogenesis; P:determination of left/right symmetry; P:distal tubule development; P:embryonic hindlimb morphogenesis; P:endocardial cell differentiation; P:endocardial cushion morphogenesis; P:endocardium development; P:endocardium morphogenesis; P:endoderm development; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:forebrain development; P:foregut morphogenesis; P:glomerular mesangial cell development; P:growth involved in heart morphogenesis; P:hair follicle morphogenesis; P:heart development; P:heart looping; P:heart trabecula morphogenesis; P:homeostasis of number of cells within a tissue; P:humoral immune response; P:immune response; P:in utero embryonic development; P:inflammatory response to antigenic stimulus; P:keratinocyte differentiation; P:left/right axis specification; P:liver development; P:lung development; P:mesenchymal cell development; P:mitral valve formation; P:negative regulation of anoikis; P:negative regulation of biomineral tissue development; P:negative regulation of BMP signaling pathway; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of catalytic activity; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of cell proliferation involved in heart valve morphogenesis; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-substrate adhesion; P:negative regulation of cold-induced thermogenesis; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of extracellular matrix constituent secretion; P:negative regulation of gene expression; P:negative regulation of glial cell proliferation; P:negative regulation of growth rate; P:negative regulation of inner ear auditory receptor cell differentiation; P:negative regulation of myoblast differentiation; P:negative regulation of myotube differentiation; P:negative regulation of neurogenesis; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of ossification; P:negative regulation of osteoblast differentiation; P:negative regulation of photoreceptor cell differentiation; P:negative regulation of pro-B cell differentiation; P:negative regulation of stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation; P:oligodendrocyte differentiation; P:outflow tract morphogenesis; P:pericardium morphogenesis; P:positive regulation of aorta morphogenesis; P:positive regulation of apoptotic process involved in morphogenesis; P:positive regulation of astrocyte differentiation; P:positive regulation of BMP signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell differentiation; P:positive regulation of epithelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of keratinocyte differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of Ras protein signal transduction; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral genome replication; P:prostate gland epithelium morphogenesis; P:pulmonary valve morphogenesis; P:regulation of epithelial cell proliferation involved in prostate gland development; P:regulation of extracellular matrix assembly; P:regulation of somitogenesis; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:regulation of transcription, DNA-templated; P:response to corticosteroid; P:response to lipopolysaccharide; P:response to muramyl dipeptide; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; P:skeletal muscle cell differentiation; P:somatic stem cell division; P:spermatogenesis; P:sprouting angiogenesis; P:tissue regeneration; P:transcription initiation from RNA polymerase II promoter; P:tube formation; P:vasculogenesis involved in coronary vascular morphogenesis; P:venous endothelial cell differentiation; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis;|P46531 Q59ED8 Q5SXM3,Neurogenic locus notch homolog protein 1,Translocation-associated notch protein TAN-1;, PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0001669;GO:0005912;GO:0016324;GO:0009986;GO:0005829;GO:0005789;GO:0005576;GO:0000139;GO:0016021;GO:0002193;GO:0005654;GO:0005634;GO:0005886;GO:0043235;GO:0005509;GO:0031490;GO:0019899;GO:0004857;GO:0042802;GO:0005112;GO:0003713;GO:0004888;GO:0031100;GO:0003180;GO:1902263;GO:0060842;GO:0048708;GO:0003162;GO:0003181;GO:0009912;GO:0007411;GO:0048754;GO:0003209;GO:0003207;GO:0060317;GO:0003214;GO:0060038;GO:0055008;GO:0003213;GO:0003219;GO:0060411;GO:0060948;GO:0003208;GO:0007050;GO:0021515;GO:0001708;GO:0003273;GO:0071372;GO:0035924;GO:0060271;GO:0072044;GO:0007386;GO:0060982;GO:0003182;GO:0003169;GO:0007368;GO:0072017;GO:0035116;GO:0060956;GO:0003203;GO:0003157;GO:0003160;GO:0007492;GO:0001837;GO:0003198;GO:0030900;GO:0007440;GO:0072144;GO:0003241;GO:0031069;GO:0007507;GO:0001947;GO:0061384;GO:0048873;GO:0006959;GO:0006955;GO:0001701;GO:0002437;GO:0030216;GO:0070986;GO:0001889;GO:0030324;GO:0014031;GO:0003192;GO:2000811;GO:0070168;GO:0030514;GO:0045955;GO:0090090;GO:0010614;GO:0043086;GO:0060354;GO:0090051;GO:0008285;GO:0003252;GO:2000048;GO:0010812;GO:0120163;GO:2001027;GO:0003332;GO:0010629;GO:0060253;GO:0045967;GO:0045608;GO:0045662;GO:0010832;GO:0050768;GO:0048715;GO:0030279;GO:0045668;GO:0046533;GO:2000974;GO:2000737;GO:0000122;GO:0045892;GO:0021915;GO:0097150;GO:0061314;GO:0007219;GO:0003270;GO:0048709;GO:0003151;GO:0003344;GO:1903849;GO:1902339;GO:0048711;GO:0030513;GO:0062043;GO:0060045;GO:0030335;GO:0008284;GO:0045603;GO:0050679;GO:0070374;GO:0010628;GO:0045618;GO:0002052;GO:0045747;GO:0046579;GO:0046427;GO:0045944;GO:0061419;GO:0007221;GO:0045893;GO:0045070;GO:0060740;GO:0003184;GO:0060768;GO:1901201;GO:0014807;GO:0003256;GO:0006355;GO:0031960;GO:0032496;GO:0032495;GO:0060528;GO:0035914;GO:0048103;GO:0007283;GO:0002040;GO:0042246;GO:0006367;GO:0035148;GO:0060979;GO:0060843;GO:0060412;GO:0003222;, C:acrosomal vesicle; C:adherens junction; C:apical plasma membrane; C:cell surface; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:MAML1-RBP-Jkappa- ICN1 complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:chromatin DNA binding; F:enzyme binding; F:enzyme inhibitor activity; F:identical protein binding; F:Notch binding; F:transcription coactivator activity; F:transmembrane signaling receptor activity;, P:animal organ regeneration; P:aortic valve morphogenesis; P:apoptotic process involved in embryonic digit morphogenesis; P:arterial endothelial cell differentiation; P:astrocyte differentiation; P:atrioventricular node development; P:atrioventricular valve morphogenesis; P:auditory receptor cell fate commitment; P:axon guidance; P:branching morphogenesis of an epithelial tube; P:cardiac atrium morphogenesis; P:cardiac chamber formation; P:cardiac epithelial to mesenchymal transition; P:cardiac left ventricle morphogenesis; P:cardiac muscle cell proliferation; P:cardiac muscle tissue morphogenesis; P:cardiac right atrium morphogenesis; P:cardiac right ventricle formation; P:cardiac septum morphogenesis; P:cardiac vascular smooth muscle cell development; P:cardiac ventricle morphogenesis; P:cell cycle arrest; P:cell differentiation in spinal cord; P:cell fate specification; P:cell migration involved in endocardial cushion formation; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:cilium assembly; P:collecting duct development; P:compartment pattern specification; P:coronary artery morphogenesis; P:coronary sinus valve morphogenesis; P:coronary vein morphogenesis; P:determination of left/right symmetry; P:distal tubule development; P:embryonic hindlimb morphogenesis; P:endocardial cell differentiation; P:endocardial cushion morphogenesis; P:endocardium development; P:endocardium morphogenesis; P:endoderm development; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:forebrain development; P:foregut morphogenesis; P:glomerular mesangial cell development; P:growth involved in heart morphogenesis; P:hair follicle morphogenesis; P:heart development; P:heart looping; P:heart trabecula morphogenesis; P:homeostasis of number of cells within a tissue; P:humoral immune response; P:immune response; P:in utero embryonic development; P:inflammatory response to antigenic stimulus; P:keratinocyte differentiation; P:left/right axis specification; P:liver development; P:lung development; P:mesenchymal cell development; P:mitral valve formation; P:negative regulation of anoikis; P:negative regulation of biomineral tissue development; P:negative regulation of BMP signaling pathway; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of catalytic activity; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of cell proliferation involved in heart valve morphogenesis; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-substrate adhesion; P:negative regulation of cold-induced thermogenesis; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of extracellular matrix constituent secretion; P:negative regulation of gene expression; P:negative regulation of glial cell proliferation; P:negative regulation of growth rate; P:negative regulation of inner ear auditory receptor cell differentiation; P:negative regulation of myoblast differentiation; P:negative regulation of myotube differentiation; P:negative regulation of neurogenesis; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of ossification; P:negative regulation of osteoblast differentiation; P:negative regulation of photoreceptor cell differentiation; P:negative regulation of pro-B cell differentiation; P:negative regulation of stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation; P:oligodendrocyte differentiation; P:outflow tract morphogenesis; P:pericardium morphogenesis; P:positive regulation of aorta morphogenesis; P:positive regulation of apoptotic process involved in morphogenesis; P:positive regulation of astrocyte differentiation; P:positive regulation of BMP signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell differentiation; P:positive regulation of epithelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of keratinocyte differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of Ras protein signal transduction; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral genome replication; P:prostate gland epithelium morphogenesis; P:pulmonary valve morphogenesis; P:regulation of epithelial cell proliferation involved in prostate gland development; P:regulation of extracellular matrix assembly; P:regulation of somitogenesis; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:regulation of transcription, DNA-templated; P:response to corticosteroid; P:response to lipopolysaccharide; P:response to muramyl dipeptide; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; P:skeletal muscle cell differentiation; P:somatic stem cell division; P:spermatogenesis; P:sprouting angiogenesis; P:tissue regeneration; P:transcription initiation from RNA polymerase II promoter; P:tube formation; P:vasculogenesis involved in coronary vascular morphogenesis; P:venous endothelial cell differentiation; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis;|P46531 Q59ED8 Q5SXM3,Neurogenic locus notch homolog protein 1,Translocation-associated notch protein TAN-1;, PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0001669;GO:0005912;GO:0016324;GO:0009986;GO:0005829;GO:0005789;GO:0005576;GO:0000139;GO:0016021;GO:0002193;GO:0005654;GO:0005634;GO:0005886;GO:0043235;GO:0005509;GO:0031490;GO:0019899;GO:0004857;GO:0042802;GO:0005112;GO:0003713;GO:0004888;GO:0031100;GO:0003180;GO:1902263;GO:0060842;GO:0048708;GO:0003162;GO:0003181;GO:0009912;GO:0007411;GO:0048754;GO:0003209;GO:0003207;GO:0060317;GO:0003214;GO:0060038;GO:0055008;GO:0003213;GO:0003219;GO:0060411;GO:0060948;GO:0003208;GO:0007050;GO:0021515;GO:0001708;GO:0003273;GO:0071372;GO:0035924;GO:0060271;GO:0072044;GO:0007386;GO:0060982;GO:0003182;GO:0003169;GO:0007368;GO:0072017;GO:0035116;GO:0060956;GO:0003203;GO:0003157;GO:0003160;GO:0007492;GO:0001837;GO:0003198;GO:0030900;GO:0007440;GO:0072144;GO:0003241;GO:0031069;GO:0007507;GO:0001947;GO:0061384;GO:0048873;GO:0006959;GO:0006955;GO:0001701;GO:0002437;GO:0030216;GO:0070986;GO:0001889;GO:0030324;GO:0014031;GO:0003192;GO:2000811;GO:0070168;GO:0030514;GO:0045955;GO:0090090;GO:0010614;GO:0043086;GO:0060354;GO:0090051;GO:0008285;GO:0003252;GO:2000048;GO:0010812;GO:0120163;GO:2001027;GO:0003332;GO:0010629;GO:0060253;GO:0045967;GO:0045608;GO:0045662;GO:0010832;GO:0050768;GO:0048715;GO:0030279;GO:0045668;GO:0046533;GO:2000974;GO:2000737;GO:0000122;GO:0045892;GO:0021915;GO:0097150;GO:0061314;GO:0007219;GO:0003270;GO:0048709;GO:0003151;GO:0003344;GO:1903849;GO:1902339;GO:0048711;GO:0030513;GO:0062043;GO:0060045;GO:0030335;GO:0008284;GO:0045603;GO:0050679;GO:0070374;GO:0010628;GO:0045618;GO:0002052;GO:0045747;GO:0046579;GO:0046427;GO:0045944;GO:0061419;GO:0007221;GO:0045893;GO:0045070;GO:0060740;GO:0003184;GO:0060768;GO:1901201;GO:0014807;GO:0003256;GO:0006355;GO:0031960;GO:0032496;GO:0032495;GO:0060528;GO:0035914;GO:0048103;GO:0007283;GO:0002040;GO:0042246;GO:0006367;GO:0035148;GO:0060979;GO:0060843;GO:0060412;GO:0003222;, C:acrosomal vesicle; C:adherens junction; C:apical plasma membrane; C:cell surface; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:MAML1-RBP-Jkappa- ICN1 complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:receptor complex;, F:calcium ion binding; F:chromatin DNA binding; F:enzyme binding; F:enzyme inhibitor activity; F:identical protein binding; F:Notch binding; F:transcription coactivator activity; F:transmembrane signaling receptor activity;, P:animal organ regeneration; P:aortic valve morphogenesis; P:apoptotic process involved in embryonic digit morphogenesis; P:arterial endothelial cell differentiation; P:astrocyte differentiation; P:atrioventricular node development; P:atrioventricular valve morphogenesis; P:auditory receptor cell fate commitment; P:axon guidance; P:branching morphogenesis of an epithelial tube; P:cardiac atrium morphogenesis; P:cardiac chamber formation; P:cardiac epithelial to mesenchymal transition; P:cardiac left ventricle morphogenesis; P:cardiac muscle cell proliferation; P:cardiac muscle tissue morphogenesis; P:cardiac right atrium morphogenesis; P:cardiac right ventricle formation; P:cardiac septum morphogenesis; P:cardiac vascular smooth muscle cell development; P:cardiac ventricle morphogenesis; P:cell cycle arrest; P:cell differentiation in spinal cord; P:cell fate specification; P:cell migration involved in endocardial cushion formation; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:cilium assembly; P:collecting duct development; P:compartment pattern specification; P:coronary artery morphogenesis; P:coronary sinus valve morphogenesis; P:coronary vein morphogenesis; P:determination of left/right symmetry; P:distal tubule development; P:embryonic hindlimb morphogenesis; P:endocardial cell differentiation; P:endocardial cushion morphogenesis; P:endocardium development; P:endocardium morphogenesis; P:endoderm development; P:epithelial to mesenchymal transition; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:forebrain development; P:foregut morphogenesis; P:glomerular mesangial cell development; P:growth involved in heart morphogenesis; P:hair follicle morphogenesis; P:heart development; P:heart looping; P:heart trabecula morphogenesis; P:homeostasis of number of cells within a tissue; P:humoral immune response; P:immune response; P:in utero embryonic development; P:inflammatory response to antigenic stimulus; P:keratinocyte differentiation; P:left/right axis specification; P:liver development; P:lung development; P:mesenchymal cell development; P:mitral valve formation; P:negative regulation of anoikis; P:negative regulation of biomineral tissue development; P:negative regulation of BMP signaling pathway; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of catalytic activity; P:negative regulation of cell adhesion molecule production; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of cell proliferation involved in heart valve morphogenesis; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-substrate adhesion; P:negative regulation of cold-induced thermogenesis; P:negative regulation of endothelial cell chemotaxis; P:negative regulation of extracellular matrix constituent secretion; P:negative regulation of gene expression; P:negative regulation of glial cell proliferation; P:negative regulation of growth rate; P:negative regulation of inner ear auditory receptor cell differentiation; P:negative regulation of myoblast differentiation; P:negative regulation of myotube differentiation; P:negative regulation of neurogenesis; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of ossification; P:negative regulation of osteoblast differentiation; P:negative regulation of photoreceptor cell differentiation; P:negative regulation of pro-B cell differentiation; P:negative regulation of stem cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube development; P:neuronal stem cell population maintenance; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation; P:oligodendrocyte differentiation; P:outflow tract morphogenesis; P:pericardium morphogenesis; P:positive regulation of aorta morphogenesis; P:positive regulation of apoptotic process involved in morphogenesis; P:positive regulation of astrocyte differentiation; P:positive regulation of BMP signaling pathway; P:positive regulation of cardiac epithelial to mesenchymal transition; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell differentiation; P:positive regulation of epithelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of keratinocyte differentiation; P:positive regulation of neuroblast proliferation; P:positive regulation of Notch signaling pathway; P:positive regulation of Ras protein signal transduction; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral genome replication; P:prostate gland epithelium morphogenesis; P:pulmonary valve morphogenesis; P:regulation of epithelial cell proliferation involved in prostate gland development; P:regulation of extracellular matrix assembly; P:regulation of somitogenesis; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:regulation of transcription, DNA-templated; P:response to corticosteroid; P:response to lipopolysaccharide; P:response to muramyl dipeptide; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; P:skeletal muscle cell differentiation; P:somatic stem cell division; P:spermatogenesis; P:sprouting angiogenesis; P:tissue regeneration; P:transcription initiation from RNA polymerase II promoter; P:tube formation; P:vasculogenesis involved in coronary vascular morphogenesis; P:venous endothelial cell differentiation; P:ventricular septum morphogenesis; P:ventricular trabecula myocardium morphogenesis; scaffold102 indexed_genome mRNA 4126655 4132220 . + . ID=transcript_12950;Q9UHF1 B3KRP0 M9VTX9 Q5M7Y5 Q5VUD5 Q96EG0,Epidermal growth factor-like protein 7,Multiple epidermal growth factor-like domains protein 7;NOTCH4-like protein;Vascular endothelial statin;Zneu1;, PF07974;PF07645;PF07546;, GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0005509;GO:0005102;GO:0048856;GO:0001525;GO:0001568;GO:0007155;GO:0045746;GO:0001938;GO:0001570;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:signaling receptor binding;, P:anatomical structure development; P:angiogenesis; P:blood vessel development; P:cell adhesion; P:negative regulation of Notch signaling pathway; P:positive regulation of endothelial cell proliferation; P:vasculogenesis;|Q9UHF1 B3KRP0 M9VTX9 Q5M7Y5 Q5VUD5 Q96EG0,Epidermal growth factor-like protein 7,Multiple epidermal growth factor-like domains protein 7;NOTCH4-like protein;Vascular endothelial statin;Zneu1;, PF07974;PF07645;PF07546;, GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0005509;GO:0005102;GO:0048856;GO:0001525;GO:0001568;GO:0007155;GO:0045746;GO:0001938;GO:0001570;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:signaling receptor binding;, P:anatomical structure development; P:angiogenesis; P:blood vessel development; P:cell adhesion; P:negative regulation of Notch signaling pathway; P:positive regulation of endothelial cell proliferation; P:vasculogenesis;|Q9UHF1 B3KRP0 M9VTX9 Q5M7Y5 Q5VUD5 Q96EG0,Epidermal growth factor-like protein 7,Multiple epidermal growth factor-like domains protein 7;NOTCH4-like protein;Vascular endothelial statin;Zneu1;, PF07974;PF07645;PF07546;, GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0005509;GO:0005102;GO:0048856;GO:0001525;GO:0001568;GO:0007155;GO:0045746;GO:0001938;GO:0001570;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:signaling receptor binding;, P:anatomical structure development; P:angiogenesis; P:blood vessel development; P:cell adhesion; P:negative regulation of Notch signaling pathway; P:positive regulation of endothelial cell proliferation; P:vasculogenesis;|Q9UHF1 B3KRP0 M9VTX9 Q5M7Y5 Q5VUD5 Q96EG0,Epidermal growth factor-like protein 7,Multiple epidermal growth factor-like domains protein 7;NOTCH4-like protein;Vascular endothelial statin;Zneu1;, PF07974;PF07645;PF07546;, GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0005509;GO:0005102;GO:0048856;GO:0001525;GO:0001568;GO:0007155;GO:0045746;GO:0001938;GO:0001570;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:signaling receptor binding;, P:anatomical structure development; P:angiogenesis; P:blood vessel development; P:cell adhesion; P:negative regulation of Notch signaling pathway; P:positive regulation of endothelial cell proliferation; P:vasculogenesis; scaffold102 indexed_genome mRNA 4169770 4173894 . + . ID=transcript_12951;Q5VUD6 Q5VUD7 Q8N5N0 Q8WYU5,Divergent protein kinase domain 1B {ECO:0000305},Protein FAM69B;, PF12260;PF14875;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane; scaffold103 indexed_genome mRNA 823429 836316 . + . ID=transcript_12952;Q9UHX3 B4DQ96 E7ESD7 E9PBR1 E9PEL6 E9PFQ5 E9PG91 Q8NG96 Q9Y4B1,Adhesion G protein-coupled receptor E2 {ECO:0000303|PubMed:25713288},EGF-like module receptor 2;EGF-like module-containing mucin-like hormone receptor-like 2;, PF00002;PF07645;PF01825;, GO:0016021;GO:0005887;GO:0031256;GO:0005886;GO:0032587;GO:0005509;GO:0035374;GO:0004930;GO:0007189;GO:0007155;GO:0016477;GO:0007166;GO:0007186;GO:0071621;GO:0006954;GO:0043304;, C:integral component of membrane; C:integral component of plasma membrane; C:leading edge membrane; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:chondroitin sulfate binding; F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell migration; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:granulocyte chemotaxis; P:inflammatory response; P:regulation of mast cell degranulation; scaffold103 indexed_genome mRNA 898630 922394 . - . ID=transcript_12953;Q96JL9 Q6P2E6 Q86WS6 Q8TDL0,Zinc finger protein 333,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q96JL9 Q6P2E6 Q86WS6 Q8TDL0,Zinc finger protein 333,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q96JL9 Q6P2E6 Q86WS6 Q8TDL0,Zinc finger protein 333,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 990683 1009512 . + . ID=transcript_12954;Q9BY15,Adhesion G protein-coupled receptor E3 {ECO:0000303|PubMed:25713288},EGF-like module receptor 3;EGF-like module-containing mucin-like hormone receptor-like 3;, PF00002;PF07645;PF16489;PF01825;, GO:0005576;GO:0101003;GO:0016021;GO:0005887;GO:0005886;GO:0030667;GO:0005509;GO:0004930;GO:0007189;GO:0007166;GO:0007186;GO:0043312;, C:extracellular region; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:secretory granule membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:neutrophil degranulation; scaffold103 indexed_genome mRNA 1021988 1037594 . - . ID=transcript_12955;Q6ZS10 A8MX68 B2RTX0 B7ZMM4,C-type lectin domain family 17, member A,Prolectin;, PF00059;, GO:0009986;GO:0016021;GO:0042806;GO:0042802;GO:0005537;GO:0046872;, C:cell surface; C:integral component of membrane;, F:fucose binding; F:identical protein binding; F:mannose binding; F:metal ion binding; scaffold103 indexed_genome mRNA 1054022 1058343 . + . ID=transcript_12956;P17568 Q6ICN9 Q9UI16,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,Cell adhesion protein SQM1;Complex I-B18;NADH-ubiquinone oxidoreductase B18 subunit;, PF05676;, GO:0005743;GO:0005758;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold103 indexed_genome mRNA 1059215 1086763 . - . ID=transcript_12957;Q9NZ01 B2RD55 O75350 Q6IBB2 Q9BWK3 Q9Y6P0,Very-long-chain enoyl-CoA reductase {ECO:0000305},Synaptic glycoprotein SC2;Trans-2,3-enoyl-CoA reductase;, PF02544;, GO:0005783;GO:0005789;GO:0030176;GO:0005634;GO:0016491;GO:0102758;GO:0017099;GO:0030497;GO:0035338;GO:0006665;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:nucleus;, F:oxidoreductase activity; F:very-long-chain enoyl-CoA reductase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:fatty acid elongation; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid metabolic process; P:very long-chain fatty acid biosynthetic process;|Q9NZ01 B2RD55 O75350 Q6IBB2 Q9BWK3 Q9Y6P0,Very-long-chain enoyl-CoA reductase {ECO:0000305},Synaptic glycoprotein SC2;Trans-2,3-enoyl-CoA reductase;, PF02544;, GO:0005783;GO:0005789;GO:0030176;GO:0005634;GO:0016491;GO:0102758;GO:0017099;GO:0030497;GO:0035338;GO:0006665;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:nucleus;, F:oxidoreductase activity; F:very-long-chain enoyl-CoA reductase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:fatty acid elongation; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid metabolic process; P:very long-chain fatty acid biosynthetic process;|Q9NZ01 B2RD55 O75350 Q6IBB2 Q9BWK3 Q9Y6P0,Very-long-chain enoyl-CoA reductase {ECO:0000305},Synaptic glycoprotein SC2;Trans-2,3-enoyl-CoA reductase;, PF02544;, GO:0005783;GO:0005789;GO:0030176;GO:0005634;GO:0016491;GO:0102758;GO:0017099;GO:0030497;GO:0035338;GO:0006665;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:nucleus;, F:oxidoreductase activity; F:very-long-chain enoyl-CoA reductase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:fatty acid elongation; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid metabolic process; P:very long-chain fatty acid biosynthetic process;|Q9NZ01 B2RD55 O75350 Q6IBB2 Q9BWK3 Q9Y6P0,Very-long-chain enoyl-CoA reductase {ECO:0000305},Synaptic glycoprotein SC2;Trans-2,3-enoyl-CoA reductase;, PF02544;, GO:0005783;GO:0005789;GO:0030176;GO:0005634;GO:0016491;GO:0102758;GO:0017099;GO:0030497;GO:0035338;GO:0006665;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:nucleus;, F:oxidoreductase activity; F:very-long-chain enoyl-CoA reductase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:fatty acid elongation; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid metabolic process; P:very long-chain fatty acid biosynthetic process; scaffold103 indexed_genome mRNA 1101159 1104556 . + . ID=transcript_12958;P25685 B4DX52,DnaJ homolog subfamily B member 1,DnaJ protein homolog 1;Heat shock 40 kDa protein 1;Human DnaJ protein 1;, PF00226;PF01556;, GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0014069;GO:0061827;GO:0001671;GO:0051117;GO:0045296;GO:0051087;GO:0030544;GO:0044183;GO:0003714;GO:0051082;GO:0051085;GO:0030900;GO:0090084;GO:0000122;GO:0097201;GO:0032781;GO:1900034;GO:0006986;, C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:postsynaptic density; C:sperm head;, F:ATPase activator activity; F:ATPase binding; F:cadherin binding; F:chaperone binding; F:Hsp70 protein binding; F:protein folding chaperone; F:transcription corepressor activity; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:forebrain development; P:negative regulation of inclusion body assembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of ATPase activity; P:regulation of cellular response to heat; P:response to unfolded protein; scaffold103 indexed_genome mRNA 1118034 1129054 . + . ID=transcript_12959;O14908 A8K4I3 A8MZG3 Q9BTC9,PDZ domain-containing protein GIPC1,GAIP C-terminus-interacting protein;RGS-GAIP-interacting protein;RGS19-interacting protein 1;Synectin;Tax interaction protein 2;, PF00595;, GO:0005903;GO:0005938;GO:0005737;GO:0031410;GO:0005829;GO:0043198;GO:0043197;GO:0030139;GO:0070062;GO:0098978;GO:0016020;GO:0098685;GO:0008021;GO:0012506;GO:0003779;GO:0045296;GO:0042802;GO:0017022;GO:0030165;GO:0005102;GO:0098761;GO:0007268;GO:0043542;GO:0007186;GO:0014047;GO:0032435;GO:0032467;GO:0048023;GO:0030511;GO:0006605;GO:0031647;GO:0048167;GO:2000300;, C:brush border; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic shaft; C:dendritic spine; C:endocytic vesicle; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:vesicle membrane;, F:actin binding; F:cadherin binding; F:identical protein binding; F:myosin binding; F:PDZ domain binding; F:signaling receptor binding;, P:cellular response to interleukin-7; P:chemical synaptic transmission; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:glutamate secretion; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of cytokinesis; P:positive regulation of melanin biosynthetic process; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein targeting; P:regulation of protein stability; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis;|O14908 A8K4I3 A8MZG3 Q9BTC9,PDZ domain-containing protein GIPC1,GAIP C-terminus-interacting protein;RGS-GAIP-interacting protein;RGS19-interacting protein 1;Synectin;Tax interaction protein 2;, PF00595;, GO:0005903;GO:0005938;GO:0005737;GO:0031410;GO:0005829;GO:0043198;GO:0043197;GO:0030139;GO:0070062;GO:0098978;GO:0016020;GO:0098685;GO:0008021;GO:0012506;GO:0003779;GO:0045296;GO:0042802;GO:0017022;GO:0030165;GO:0005102;GO:0098761;GO:0007268;GO:0043542;GO:0007186;GO:0014047;GO:0032435;GO:0032467;GO:0048023;GO:0030511;GO:0006605;GO:0031647;GO:0048167;GO:2000300;, C:brush border; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic shaft; C:dendritic spine; C:endocytic vesicle; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:vesicle membrane;, F:actin binding; F:cadherin binding; F:identical protein binding; F:myosin binding; F:PDZ domain binding; F:signaling receptor binding;, P:cellular response to interleukin-7; P:chemical synaptic transmission; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:glutamate secretion; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of cytokinesis; P:positive regulation of melanin biosynthetic process; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:protein targeting; P:regulation of protein stability; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle exocytosis; scaffold103 indexed_genome mRNA 1137532 1163164 . - . ID=transcript_12960;Q16512 A8K7W5 B2R9R4 B3KVN3 Q15143 Q504U4 Q8IUV5 Q9UD44,Serine/threonine-protein kinase N1,Protease-activated kinase 1;Protein kinase C-like 1;Protein kinase C-like PKN;Protein kinase PKN-alpha;Protein-kinase C-related kinase 1;Serine-threonine protein kinase N;, PF02185;PF00069;PF00433;, GO:0032154;GO:0005737;GO:0005829;GO:0005768;GO:0030496;GO:0005654;GO:0005634;GO:0032991;GO:0050681;GO:0005524;GO:0004698;GO:0003682;GO:0042393;GO:0042826;GO:0035402;GO:0030374;GO:0004672;GO:0004697;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0007257;GO:0001783;GO:0001782;GO:0010631;GO:0035407;GO:0006972;GO:0035556;GO:0030889;GO:0006469;GO:0018105;GO:0006468;GO:0060765;GO:2000145;GO:0002634;GO:0002637;GO:0006357;GO:0003014;GO:0007165;GO:0048536;, C:cleavage furrow; C:cytoplasm; C:cytosol; C:endosome; C:midbody; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:androgen receptor binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:chromatin binding; F:histone binding; F:histone deacetylase binding; F:histone kinase activity (H3-T11 specific); F:nuclear receptor coactivator activity; F:protein kinase activity; F:protein kinase C activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:activation of JUN kinase activity; P:B cell apoptotic process; P:B cell homeostasis; P:epithelial cell migration; P:histone H3-T11 phosphorylation; P:hyperosmotic response; P:intracellular signal transduction; P:negative regulation of B cell proliferation; P:negative regulation of protein kinase activity; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of androgen receptor signaling pathway; P:regulation of cell motility; P:regulation of germinal center formation; P:regulation of immunoglobulin production; P:regulation of transcription by RNA polymerase II; P:renal system process; P:signal transduction; P:spleen development;|Q16512 A8K7W5 B2R9R4 B3KVN3 Q15143 Q504U4 Q8IUV5 Q9UD44,Serine/threonine-protein kinase N1,Protease-activated kinase 1;Protein kinase C-like 1;Protein kinase C-like PKN;Protein kinase PKN-alpha;Protein-kinase C-related kinase 1;Serine-threonine protein kinase N;, PF02185;PF00069;PF00433;, GO:0032154;GO:0005737;GO:0005829;GO:0005768;GO:0030496;GO:0005654;GO:0005634;GO:0032991;GO:0050681;GO:0005524;GO:0004698;GO:0003682;GO:0042393;GO:0042826;GO:0035402;GO:0030374;GO:0004672;GO:0004697;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0007257;GO:0001783;GO:0001782;GO:0010631;GO:0035407;GO:0006972;GO:0035556;GO:0030889;GO:0006469;GO:0018105;GO:0006468;GO:0060765;GO:2000145;GO:0002634;GO:0002637;GO:0006357;GO:0003014;GO:0007165;GO:0048536;, C:cleavage furrow; C:cytoplasm; C:cytosol; C:endosome; C:midbody; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:androgen receptor binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:chromatin binding; F:histone binding; F:histone deacetylase binding; F:histone kinase activity (H3-T11 specific); F:nuclear receptor coactivator activity; F:protein kinase activity; F:protein kinase C activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:activation of JUN kinase activity; P:B cell apoptotic process; P:B cell homeostasis; P:epithelial cell migration; P:histone H3-T11 phosphorylation; P:hyperosmotic response; P:intracellular signal transduction; P:negative regulation of B cell proliferation; P:negative regulation of protein kinase activity; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of androgen receptor signaling pathway; P:regulation of cell motility; P:regulation of germinal center formation; P:regulation of immunoglobulin production; P:regulation of transcription by RNA polymerase II; P:renal system process; P:signal transduction; P:spleen development;|Q16512 A8K7W5 B2R9R4 B3KVN3 Q15143 Q504U4 Q8IUV5 Q9UD44,Serine/threonine-protein kinase N1,Protease-activated kinase 1;Protein kinase C-like 1;Protein kinase C-like PKN;Protein kinase PKN-alpha;Protein-kinase C-related kinase 1;Serine-threonine protein kinase N;, PF02185;PF00069;PF00433;, GO:0032154;GO:0005737;GO:0005829;GO:0005768;GO:0030496;GO:0005654;GO:0005634;GO:0032991;GO:0050681;GO:0005524;GO:0004698;GO:0003682;GO:0042393;GO:0042826;GO:0035402;GO:0030374;GO:0004672;GO:0004697;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0007257;GO:0001783;GO:0001782;GO:0010631;GO:0035407;GO:0006972;GO:0035556;GO:0030889;GO:0006469;GO:0018105;GO:0006468;GO:0060765;GO:2000145;GO:0002634;GO:0002637;GO:0006357;GO:0003014;GO:0007165;GO:0048536;, C:cleavage furrow; C:cytoplasm; C:cytosol; C:endosome; C:midbody; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:androgen receptor binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:chromatin binding; F:histone binding; F:histone deacetylase binding; F:histone kinase activity (H3-T11 specific); F:nuclear receptor coactivator activity; F:protein kinase activity; F:protein kinase C activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:activation of JUN kinase activity; P:B cell apoptotic process; P:B cell homeostasis; P:epithelial cell migration; P:histone H3-T11 phosphorylation; P:hyperosmotic response; P:intracellular signal transduction; P:negative regulation of B cell proliferation; P:negative regulation of protein kinase activity; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of androgen receptor signaling pathway; P:regulation of cell motility; P:regulation of germinal center formation; P:regulation of immunoglobulin production; P:regulation of transcription by RNA polymerase II; P:renal system process; P:signal transduction; P:spleen development;|Q16512 A8K7W5 B2R9R4 B3KVN3 Q15143 Q504U4 Q8IUV5 Q9UD44,Serine/threonine-protein kinase N1,Protease-activated kinase 1;Protein kinase C-like 1;Protein kinase C-like PKN;Protein kinase PKN-alpha;Protein-kinase C-related kinase 1;Serine-threonine protein kinase N;, PF02185;PF00069;PF00433;, GO:0032154;GO:0005737;GO:0005829;GO:0005768;GO:0030496;GO:0005654;GO:0005634;GO:0032991;GO:0050681;GO:0005524;GO:0004698;GO:0003682;GO:0042393;GO:0042826;GO:0035402;GO:0030374;GO:0004672;GO:0004697;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0007257;GO:0001783;GO:0001782;GO:0010631;GO:0035407;GO:0006972;GO:0035556;GO:0030889;GO:0006469;GO:0018105;GO:0006468;GO:0060765;GO:2000145;GO:0002634;GO:0002637;GO:0006357;GO:0003014;GO:0007165;GO:0048536;, C:cleavage furrow; C:cytoplasm; C:cytosol; C:endosome; C:midbody; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:androgen receptor binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:chromatin binding; F:histone binding; F:histone deacetylase binding; F:histone kinase activity (H3-T11 specific); F:nuclear receptor coactivator activity; F:protein kinase activity; F:protein kinase C activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:activation of JUN kinase activity; P:B cell apoptotic process; P:B cell homeostasis; P:epithelial cell migration; P:histone H3-T11 phosphorylation; P:hyperosmotic response; P:intracellular signal transduction; P:negative regulation of B cell proliferation; P:negative regulation of protein kinase activity; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of androgen receptor signaling pathway; P:regulation of cell motility; P:regulation of germinal center formation; P:regulation of immunoglobulin production; P:regulation of transcription by RNA polymerase II; P:renal system process; P:signal transduction; P:spleen development;|Q16512 A8K7W5 B2R9R4 B3KVN3 Q15143 Q504U4 Q8IUV5 Q9UD44,Serine/threonine-protein kinase N1,Protease-activated kinase 1;Protein kinase C-like 1;Protein kinase C-like PKN;Protein kinase PKN-alpha;Protein-kinase C-related kinase 1;Serine-threonine protein kinase N;, PF02185;PF00069;PF00433;, GO:0032154;GO:0005737;GO:0005829;GO:0005768;GO:0030496;GO:0005654;GO:0005634;GO:0032991;GO:0050681;GO:0005524;GO:0004698;GO:0003682;GO:0042393;GO:0042826;GO:0035402;GO:0030374;GO:0004672;GO:0004697;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0007257;GO:0001783;GO:0001782;GO:0010631;GO:0035407;GO:0006972;GO:0035556;GO:0030889;GO:0006469;GO:0018105;GO:0006468;GO:0060765;GO:2000145;GO:0002634;GO:0002637;GO:0006357;GO:0003014;GO:0007165;GO:0048536;, C:cleavage furrow; C:cytoplasm; C:cytosol; C:endosome; C:midbody; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:androgen receptor binding; F:ATP binding; F:calcium-dependent protein kinase C activity; F:chromatin binding; F:histone binding; F:histone deacetylase binding; F:histone kinase activity (H3-T11 specific); F:nuclear receptor coactivator activity; F:protein kinase activity; F:protein kinase C activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:activation of JUN kinase activity; P:B cell apoptotic process; P:B cell homeostasis; P:epithelial cell migration; P:histone H3-T11 phosphorylation; P:hyperosmotic response; P:intracellular signal transduction; P:negative regulation of B cell proliferation; P:negative regulation of protein kinase activity; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of androgen receptor signaling pathway; P:regulation of cell motility; P:regulation of germinal center formation; P:regulation of immunoglobulin production; P:regulation of transcription by RNA polymerase II; P:renal system process; P:signal transduction; P:spleen development; scaffold103 indexed_genome mRNA 1181914 1205784 . + . ID=transcript_12961;O00148 B1Q2N1 Q8N5M0 Q9BVP6 Q9H5W0,ATP-dependent RNA helicase DDX39A,DEAD box protein 39;Nuclear RNA helicase URH49;, PF00270;PF00271;, GO:0005737;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0042802;GO:0003723;GO:0003724;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:cytoplasm; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus;|O00148 B1Q2N1 Q8N5M0 Q9BVP6 Q9H5W0,ATP-dependent RNA helicase DDX39A,DEAD box protein 39;Nuclear RNA helicase URH49;, PF00270;PF00271;, GO:0005737;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0042802;GO:0003723;GO:0003724;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:cytoplasm; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus;|O00148 B1Q2N1 Q8N5M0 Q9BVP6 Q9H5W0,ATP-dependent RNA helicase DDX39A,DEAD box protein 39;Nuclear RNA helicase URH49;, PF00270;PF00271;, GO:0005737;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0042802;GO:0003723;GO:0003724;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:cytoplasm; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:RNA binding; F:RNA helicase activity;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus;|P48960 A8K7Z4 B2RBJ9 O00718 O76101 Q8NG72 Q8TBQ7,Adhesion G protein-coupled receptor E5 {ECO:0000312|HGNC:HGNC:1711},Leukocyte antigen CD97 {ECO:0000303|PubMed:7636245};, PF00002;PF07645;PF01825;, GO:0070062;GO:0005925;GO:0005887;GO:0016020;GO:0005886;GO:0030667;GO:0005509;GO:0004930;GO:0004888;GO:0007189;GO:0007155;GO:0007166;GO:0007267;GO:0007186;GO:0006955;GO:0006954;GO:0043312;, C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, F:calcium ion binding; F:G protein-coupled receptor activity; F:transmembrane signaling receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neutrophil degranulation;|Q9UHX3 B4DQ96 E7ESD7 E9PBR1 E9PEL6 E9PFQ5 E9PG91 Q8NG96 Q9Y4B1,Adhesion G protein-coupled receptor E2 {ECO:0000303|PubMed:25713288},EGF-like module receptor 2;EGF-like module-containing mucin-like hormone receptor-like 2;, PF00002;PF07645;PF01825;, GO:0016021;GO:0005887;GO:0031256;GO:0005886;GO:0032587;GO:0005509;GO:0035374;GO:0004930;GO:0007189;GO:0007155;GO:0016477;GO:0007166;GO:0007186;GO:0071621;GO:0006954;GO:0043304;, C:integral component of membrane; C:integral component of plasma membrane; C:leading edge membrane; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:chondroitin sulfate binding; F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell migration; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:granulocyte chemotaxis; P:inflammatory response; P:regulation of mast cell degranulation;|P48960 A8K7Z4 B2RBJ9 O00718 O76101 Q8NG72 Q8TBQ7,Adhesion G protein-coupled receptor E5 {ECO:0000312|HGNC:HGNC:1711},Leukocyte antigen CD97 {ECO:0000303|PubMed:7636245};, PF00002;PF07645;PF01825;, GO:0070062;GO:0005925;GO:0005887;GO:0016020;GO:0005886;GO:0030667;GO:0005509;GO:0004930;GO:0004888;GO:0007189;GO:0007155;GO:0007166;GO:0007267;GO:0007186;GO:0006955;GO:0006954;GO:0043312;, C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, F:calcium ion binding; F:G protein-coupled receptor activity; F:transmembrane signaling receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neutrophil degranulation;|Q9UHX3 B4DQ96 E7ESD7 E9PBR1 E9PEL6 E9PFQ5 E9PG91 Q8NG96 Q9Y4B1,Adhesion G protein-coupled receptor E2 {ECO:0000303|PubMed:25713288},EGF-like module receptor 2;EGF-like module-containing mucin-like hormone receptor-like 2;, PF00002;PF07645;PF01825;, GO:0016021;GO:0005887;GO:0031256;GO:0005886;GO:0032587;GO:0005509;GO:0035374;GO:0004930;GO:0007189;GO:0007155;GO:0016477;GO:0007166;GO:0007186;GO:0071621;GO:0006954;GO:0043304;, C:integral component of membrane; C:integral component of plasma membrane; C:leading edge membrane; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:chondroitin sulfate binding; F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell migration; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:granulocyte chemotaxis; P:inflammatory response; P:regulation of mast cell degranulation;|Q9UHX3 B4DQ96 E7ESD7 E9PBR1 E9PEL6 E9PFQ5 E9PG91 Q8NG96 Q9Y4B1,Adhesion G protein-coupled receptor E2 {ECO:0000303|PubMed:25713288},EGF-like module receptor 2;EGF-like module-containing mucin-like hormone receptor-like 2;, PF00002;PF07645;PF01825;, GO:0016021;GO:0005887;GO:0031256;GO:0005886;GO:0032587;GO:0005509;GO:0035374;GO:0004930;GO:0007189;GO:0007155;GO:0016477;GO:0007166;GO:0007186;GO:0071621;GO:0006954;GO:0043304;, C:integral component of membrane; C:integral component of plasma membrane; C:leading edge membrane; C:plasma membrane; C:ruffle membrane;, F:calcium ion binding; F:chondroitin sulfate binding; F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell migration; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:granulocyte chemotaxis; P:inflammatory response; P:regulation of mast cell degranulation;|P48960 A8K7Z4 B2RBJ9 O00718 O76101 Q8NG72 Q8TBQ7,Adhesion G protein-coupled receptor E5 {ECO:0000312|HGNC:HGNC:1711},Leukocyte antigen CD97 {ECO:0000303|PubMed:7636245};, PF00002;PF07645;PF01825;, GO:0070062;GO:0005925;GO:0005887;GO:0016020;GO:0005886;GO:0030667;GO:0005509;GO:0004930;GO:0004888;GO:0007189;GO:0007155;GO:0007166;GO:0007267;GO:0007186;GO:0006955;GO:0006954;GO:0043312;, C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:secretory granule membrane;, F:calcium ion binding; F:G protein-coupled receptor activity; F:transmembrane signaling receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neutrophil degranulation; scaffold103 indexed_genome mRNA 1346289 1386070 . + . ID=transcript_12962;O94910 Q96IE7 Q9BU07 Q9HAR3,Adhesion G protein-coupled receptor L1 {ECO:0000312|HGNC:HGNC:20973},Calcium-independent alpha-latrotoxin receptor 1 {ECO:0000250|UniProtKB:O88917};Latrophilin-1 {ECO:0000312|HGNC:HGNC:20973};Lectomedin-2;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0030424;GO:0030426;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0014069;GO:0042734;GO:0045202;GO:0030246;GO:0050839;GO:0004930;GO:0016524;GO:0007189;GO:0035584;GO:0007166;GO:0007186;GO:0007157;GO:0090129;, C:axon; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:presynaptic membrane; C:synapse;, F:carbohydrate binding; F:cell adhesion molecule binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse maturation;|O94910 Q96IE7 Q9BU07 Q9HAR3,Adhesion G protein-coupled receptor L1 {ECO:0000312|HGNC:HGNC:20973},Calcium-independent alpha-latrotoxin receptor 1 {ECO:0000250|UniProtKB:O88917};Latrophilin-1 {ECO:0000312|HGNC:HGNC:20973};Lectomedin-2;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0030424;GO:0030426;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0014069;GO:0042734;GO:0045202;GO:0030246;GO:0050839;GO:0004930;GO:0016524;GO:0007189;GO:0035584;GO:0007166;GO:0007186;GO:0007157;GO:0090129;, C:axon; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:presynaptic membrane; C:synapse;, F:carbohydrate binding; F:cell adhesion molecule binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse maturation;|O94910 Q96IE7 Q9BU07 Q9HAR3,Adhesion G protein-coupled receptor L1 {ECO:0000312|HGNC:HGNC:20973},Calcium-independent alpha-latrotoxin receptor 1 {ECO:0000250|UniProtKB:O88917};Latrophilin-1 {ECO:0000312|HGNC:HGNC:20973};Lectomedin-2;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0030424;GO:0030426;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0014069;GO:0042734;GO:0045202;GO:0030246;GO:0050839;GO:0004930;GO:0016524;GO:0007189;GO:0035584;GO:0007166;GO:0007186;GO:0007157;GO:0090129;, C:axon; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:presynaptic membrane; C:synapse;, F:carbohydrate binding; F:cell adhesion molecule binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse maturation;|O94910 Q96IE7 Q9BU07 Q9HAR3,Adhesion G protein-coupled receptor L1 {ECO:0000312|HGNC:HGNC:20973},Calcium-independent alpha-latrotoxin receptor 1 {ECO:0000250|UniProtKB:O88917};Latrophilin-1 {ECO:0000312|HGNC:HGNC:20973};Lectomedin-2;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0030424;GO:0030426;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0014069;GO:0042734;GO:0045202;GO:0030246;GO:0050839;GO:0004930;GO:0016524;GO:0007189;GO:0035584;GO:0007166;GO:0007186;GO:0007157;GO:0090129;, C:axon; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:presynaptic membrane; C:synapse;, F:carbohydrate binding; F:cell adhesion molecule binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse maturation;|O94910 Q96IE7 Q9BU07 Q9HAR3,Adhesion G protein-coupled receptor L1 {ECO:0000312|HGNC:HGNC:20973},Calcium-independent alpha-latrotoxin receptor 1 {ECO:0000250|UniProtKB:O88917};Latrophilin-1 {ECO:0000312|HGNC:HGNC:20973};Lectomedin-2;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0030424;GO:0030426;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0014069;GO:0042734;GO:0045202;GO:0030246;GO:0050839;GO:0004930;GO:0016524;GO:0007189;GO:0035584;GO:0007166;GO:0007186;GO:0007157;GO:0090129;, C:axon; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:presynaptic membrane; C:synapse;, F:carbohydrate binding; F:cell adhesion molecule binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse maturation; scaffold103 indexed_genome mRNA 1386617 1393616 . - . ID=transcript_12963;O94910 Q96IE7 Q9BU07 Q9HAR3,Adhesion G protein-coupled receptor L1 {ECO:0000312|HGNC:HGNC:20973},Calcium-independent alpha-latrotoxin receptor 1 {ECO:0000250|UniProtKB:O88917};Latrophilin-1 {ECO:0000312|HGNC:HGNC:20973};Lectomedin-2;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0030424;GO:0030426;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0014069;GO:0042734;GO:0045202;GO:0030246;GO:0050839;GO:0004930;GO:0016524;GO:0007189;GO:0035584;GO:0007166;GO:0007186;GO:0007157;GO:0090129;, C:axon; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:presynaptic membrane; C:synapse;, F:carbohydrate binding; F:cell adhesion molecule binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse maturation;|O94910 Q96IE7 Q9BU07 Q9HAR3,Adhesion G protein-coupled receptor L1 {ECO:0000312|HGNC:HGNC:20973},Calcium-independent alpha-latrotoxin receptor 1 {ECO:0000250|UniProtKB:O88917};Latrophilin-1 {ECO:0000312|HGNC:HGNC:20973};Lectomedin-2;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0030424;GO:0030426;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0014069;GO:0042734;GO:0045202;GO:0030246;GO:0050839;GO:0004930;GO:0016524;GO:0007189;GO:0035584;GO:0007166;GO:0007186;GO:0007157;GO:0090129;, C:axon; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:presynaptic membrane; C:synapse;, F:carbohydrate binding; F:cell adhesion molecule binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse maturation;|O94910 Q96IE7 Q9BU07 Q9HAR3,Adhesion G protein-coupled receptor L1 {ECO:0000312|HGNC:HGNC:20973},Calcium-independent alpha-latrotoxin receptor 1 {ECO:0000250|UniProtKB:O88917};Latrophilin-1 {ECO:0000312|HGNC:HGNC:20973};Lectomedin-2;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0030424;GO:0030426;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0014069;GO:0042734;GO:0045202;GO:0030246;GO:0050839;GO:0004930;GO:0016524;GO:0007189;GO:0035584;GO:0007166;GO:0007186;GO:0007157;GO:0090129;, C:axon; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:presynaptic membrane; C:synapse;, F:carbohydrate binding; F:cell adhesion molecule binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse maturation;|O94910 Q96IE7 Q9BU07 Q9HAR3,Adhesion G protein-coupled receptor L1 {ECO:0000312|HGNC:HGNC:20973},Calcium-independent alpha-latrotoxin receptor 1 {ECO:0000250|UniProtKB:O88917};Latrophilin-1 {ECO:0000312|HGNC:HGNC:20973};Lectomedin-2;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0030424;GO:0030426;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0014069;GO:0042734;GO:0045202;GO:0030246;GO:0050839;GO:0004930;GO:0016524;GO:0007189;GO:0035584;GO:0007166;GO:0007186;GO:0007157;GO:0090129;, C:axon; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:presynaptic membrane; C:synapse;, F:carbohydrate binding; F:cell adhesion molecule binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse maturation;|O94910 Q96IE7 Q9BU07 Q9HAR3,Adhesion G protein-coupled receptor L1 {ECO:0000312|HGNC:HGNC:20973},Calcium-independent alpha-latrotoxin receptor 1 {ECO:0000250|UniProtKB:O88917};Latrophilin-1 {ECO:0000312|HGNC:HGNC:20973};Lectomedin-2;, PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;, GO:0030424;GO:0030426;GO:0016021;GO:0005887;GO:0043005;GO:0005886;GO:0014069;GO:0042734;GO:0045202;GO:0030246;GO:0050839;GO:0004930;GO:0016524;GO:0007189;GO:0035584;GO:0007166;GO:0007186;GO:0007157;GO:0090129;, C:axon; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:presynaptic membrane; C:synapse;, F:carbohydrate binding; F:cell adhesion molecule binding; F:G protein-coupled receptor activity; F:latrotoxin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:calcium-mediated signaling using intracellular calcium source; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:positive regulation of synapse maturation; scaffold103 indexed_genome mRNA 1417135 1419812 . - . ID=transcript_12964;Q9NVP2 Q53G51 Q9NVZ0,Histone chaperone ASF1B,Anti-silencing function protein 1 homolog B;CCG1-interacting factor A-II;, PF04729;, GO:0000785;GO:0005654;GO:0032991;GO:0042393;GO:0001835;GO:0030154;GO:0006335;GO:0006336;GO:0007283;, C:chromatin; C:nucleoplasm; C:protein-containing complex;, F:histone binding;, P:blastocyst hatching; P:cell differentiation; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:spermatogenesis; scaffold103 indexed_genome mRNA 1436212 1438501 . - . ID=transcript_12965;P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9,cAMP-dependent protein kinase catalytic subunit alpha,, PF00069;, GO:0001669;GO:0034704;GO:0005952;GO:0005813;GO:0097546;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0016020;GO:0005739;GO:0031594;GO:0016607;GO:0005654;GO:0031588;GO:0005634;GO:0048471;GO:0044853;GO:0036126;GO:0097225;GO:0004679;GO:0005524;GO:0004691;GO:0000287;GO:0030145;GO:0019904;GO:0034237;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0031625;GO:0034199;GO:0002250;GO:0007596;GO:0035584;GO:0086064;GO:0071872;GO:0071377;GO:0071333;GO:0034605;GO:0071374;GO:0007268;GO:0097711;GO:0019221;GO:0000086;GO:0034380;GO:0001707;GO:0050804;GO:0006397;GO:0002862;GO:1901621;GO:0001843;GO:0018105;GO:0018107;GO:0071158;GO:0046827;GO:0046777;GO:0010737;GO:0006468;GO:2000810;GO:1903779;GO:0055117;GO:0010881;GO:0051480;GO:0010389;GO:0002027;GO:0016241;GO:0045667;GO:0061136;GO:0043393;GO:0070613;GO:0060314;GO:0003091;GO:0048240;GO:0002223;, C:acrosomal vesicle; C:calcium channel complex; C:cAMP-dependent protein kinase complex; C:centrosome; C:ciliary base; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:membrane; C:mitochondrion; C:neuromuscular junction; C:nuclear speck; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane raft; C:sperm flagellum; C:sperm midpiece;, F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase activity; F:magnesium ion binding; F:manganese ion binding; F:protein domain specific binding; F:protein kinase A regulatory subunit binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:ubiquitin protein ligase binding;, P:activation of protein kinase A activity; P:adaptive immune response; P:blood coagulation; P:calcium-mediated signaling using intracellular calcium source; P:cell communication by electrical coupling involved in cardiac conduction; P:cellular response to epinephrine stimulus; P:cellular response to glucagon stimulus; P:cellular response to glucose stimulus; P:cellular response to heat; P:cellular response to parathyroid hormone stimulus; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:cytokine-mediated signaling pathway; P:G2/M transition of mitotic cell cycle; P:high-density lipoprotein particle assembly; P:mesoderm formation; P:modulation of chemical synaptic transmission; P:mRNA processing; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; P:neural tube closure; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of cell cycle arrest; P:positive regulation of protein export from nucleus; P:protein autophosphorylation; P:protein kinase A signaling; P:protein phosphorylation; P:regulation of bicellular tight junction assembly; P:regulation of cardiac conduction; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cytosolic calcium ion concentration; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of heart rate; P:regulation of macroautophagy; P:regulation of osteoblast differentiation; P:regulation of proteasomal protein catabolic process; P:regulation of protein binding; P:regulation of protein processing; P:regulation of ryanodine-sensitive calcium-release channel activity; P:renal water homeostasis; P:sperm capacitation; P:stimulatory C-type lectin receptor signaling pathway; scaffold103 indexed_genome mRNA 1445668 1446292 . - . ID=transcript_12966;A6NJJ6,UPF0575 protein C19orf67,, PF11771; scaffold103 indexed_genome mRNA 1446722 1447558 . + . ID=transcript_12967;A6NJJ6,UPF0575 protein C19orf67,, PF11771; scaffold103 indexed_genome mRNA 1447589 1448374 . + . ID=transcript_12968;A6NJJ6,UPF0575 protein C19orf67,, PF11771; scaffold103 indexed_genome mRNA 1452478 1454972 . - . ID=transcript_12969;Q96FF7,Uncharacterized protein MISP3 {ECO:0000305},MISP family member 3 {ECO:0000312|HGNC:HGNC:26963};, PF15304; scaffold103 indexed_genome mRNA 1463949 1469687 . + . ID=transcript_12970;A6NDB9,Paralemmin-3,, , GO:0005737;GO:0005886;GO:0005524;GO:0001960;GO:0032496;GO:0008063;, C:cytoplasm; C:plasma membrane;, F:ATP binding;, P:negative regulation of cytokine-mediated signaling pathway; P:response to lipopolysaccharide; P:Toll signaling pathway; scaffold103 indexed_genome mRNA 1469869 1493304 . - . ID=transcript_12971;Q6UWB1 A0N0L1 O60624,Interleukin-27 receptor subunit alpha,Cytokine receptor WSX-1;Cytokine receptor-like 1;Type I T-cell cytokine receptor;ZcytoR1;, PF00041;, GO:0009897;GO:0005887;GO:0042022;GO:0072536;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0045509;GO:0004888;GO:0007166;GO:0019221;GO:0050830;GO:0006955;GO:0070106;GO:0070757;GO:0032700;GO:0032715;GO:2000408;GO:2000317;GO:0032720;GO:0002829;GO:0042104;GO:0032729;GO:0002827;GO:0048302;, C:external side of plasma membrane; C:integral component of plasma membrane; C:interleukin-12 receptor complex; C:interleukin-23 receptor complex; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-27 receptor activity; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:immune response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-6 production; P:negative regulation of T cell extravasation; P:negative regulation of T-helper 17 type immune response; P:negative regulation of tumor necrosis factor production; P:negative regulation of type 2 immune response; P:positive regulation of activated T cell proliferation; P:positive regulation of interferon-gamma production; P:positive regulation of T-helper 1 type immune response; P:regulation of isotype switching to IgG isotypes;|Q6UWB1 A0N0L1 O60624,Interleukin-27 receptor subunit alpha,Cytokine receptor WSX-1;Cytokine receptor-like 1;Type I T-cell cytokine receptor;ZcytoR1;, PF00041;, GO:0009897;GO:0005887;GO:0042022;GO:0072536;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0045509;GO:0004888;GO:0007166;GO:0019221;GO:0050830;GO:0006955;GO:0070106;GO:0070757;GO:0032700;GO:0032715;GO:2000408;GO:2000317;GO:0032720;GO:0002829;GO:0042104;GO:0032729;GO:0002827;GO:0048302;, C:external side of plasma membrane; C:integral component of plasma membrane; C:interleukin-12 receptor complex; C:interleukin-23 receptor complex; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-27 receptor activity; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:immune response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-6 production; P:negative regulation of T cell extravasation; P:negative regulation of T-helper 17 type immune response; P:negative regulation of tumor necrosis factor production; P:negative regulation of type 2 immune response; P:positive regulation of activated T cell proliferation; P:positive regulation of interferon-gamma production; P:positive regulation of T-helper 1 type immune response; P:regulation of isotype switching to IgG isotypes;|Q6UWB1 A0N0L1 O60624,Interleukin-27 receptor subunit alpha,Cytokine receptor WSX-1;Cytokine receptor-like 1;Type I T-cell cytokine receptor;ZcytoR1;, PF00041;, GO:0009897;GO:0005887;GO:0042022;GO:0072536;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0045509;GO:0004888;GO:0007166;GO:0019221;GO:0050830;GO:0006955;GO:0070106;GO:0070757;GO:0032700;GO:0032715;GO:2000408;GO:2000317;GO:0032720;GO:0002829;GO:0042104;GO:0032729;GO:0002827;GO:0048302;, C:external side of plasma membrane; C:integral component of plasma membrane; C:interleukin-12 receptor complex; C:interleukin-23 receptor complex; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-27 receptor activity; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:immune response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-6 production; P:negative regulation of T cell extravasation; P:negative regulation of T-helper 17 type immune response; P:negative regulation of tumor necrosis factor production; P:negative regulation of type 2 immune response; P:positive regulation of activated T cell proliferation; P:positive regulation of interferon-gamma production; P:positive regulation of T-helper 1 type immune response; P:regulation of isotype switching to IgG isotypes;|Q6UWB1 A0N0L1 O60624,Interleukin-27 receptor subunit alpha,Cytokine receptor WSX-1;Cytokine receptor-like 1;Type I T-cell cytokine receptor;ZcytoR1;, PF00041;, GO:0009897;GO:0005887;GO:0042022;GO:0072536;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0045509;GO:0004888;GO:0007166;GO:0019221;GO:0050830;GO:0006955;GO:0070106;GO:0070757;GO:0032700;GO:0032715;GO:2000408;GO:2000317;GO:0032720;GO:0002829;GO:0042104;GO:0032729;GO:0002827;GO:0048302;, C:external side of plasma membrane; C:integral component of plasma membrane; C:interleukin-12 receptor complex; C:interleukin-23 receptor complex; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-27 receptor activity; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:immune response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-6 production; P:negative regulation of T cell extravasation; P:negative regulation of T-helper 17 type immune response; P:negative regulation of tumor necrosis factor production; P:negative regulation of type 2 immune response; P:positive regulation of activated T cell proliferation; P:positive regulation of interferon-gamma production; P:positive regulation of T-helper 1 type immune response; P:regulation of isotype switching to IgG isotypes;|Q6UWB1 A0N0L1 O60624,Interleukin-27 receptor subunit alpha,Cytokine receptor WSX-1;Cytokine receptor-like 1;Type I T-cell cytokine receptor;ZcytoR1;, PF00041;, GO:0009897;GO:0005887;GO:0042022;GO:0072536;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0045509;GO:0004888;GO:0007166;GO:0019221;GO:0050830;GO:0006955;GO:0070106;GO:0070757;GO:0032700;GO:0032715;GO:2000408;GO:2000317;GO:0032720;GO:0002829;GO:0042104;GO:0032729;GO:0002827;GO:0048302;, C:external side of plasma membrane; C:integral component of plasma membrane; C:interleukin-12 receptor complex; C:interleukin-23 receptor complex; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-27 receptor activity; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:defense response to Gram-positive bacterium; P:immune response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-6 production; P:negative regulation of T cell extravasation; P:negative regulation of T-helper 17 type immune response; P:negative regulation of tumor necrosis factor production; P:negative regulation of type 2 immune response; P:positive regulation of activated T cell proliferation; P:positive regulation of interferon-gamma production; P:positive regulation of T-helper 1 type immune response; P:regulation of isotype switching to IgG isotypes; scaffold103 indexed_genome mRNA 1525544 1536848 . + . ID=transcript_12972;P22670,MHC class II regulatory factor RFX1,Enhancer factor C;Regulatory factor X 1;Transcription factor RFX1;, PF04589;PF02257;, GO:0000785;GO:0043231;GO:0005654;GO:0000981;GO:0000978;GO:1990837;GO:0006955;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:immune response; P:regulation of transcription by RNA polymerase II;|P22670,MHC class II regulatory factor RFX1,Enhancer factor C;Regulatory factor X 1;Transcription factor RFX1;, PF04589;PF02257;, GO:0000785;GO:0043231;GO:0005654;GO:0000981;GO:0000978;GO:1990837;GO:0006955;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:immune response; P:regulation of transcription by RNA polymerase II;|P22670,MHC class II regulatory factor RFX1,Enhancer factor C;Regulatory factor X 1;Transcription factor RFX1;, PF04589;PF02257;, GO:0000785;GO:0043231;GO:0005654;GO:0000981;GO:0000978;GO:1990837;GO:0006955;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:immune response; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 1546247 1546753 . + . ID=transcript_12973;P22670,MHC class II regulatory factor RFX1,Enhancer factor C;Regulatory factor X 1;Transcription factor RFX1;, PF04589;PF02257;, GO:0000785;GO:0043231;GO:0005654;GO:0000981;GO:0000978;GO:1990837;GO:0006955;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:immune response; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 1548251 1555288 . - . ID=transcript_12974;P22670,MHC class II regulatory factor RFX1,Enhancer factor C;Regulatory factor X 1;Transcription factor RFX1;, PF04589;PF02257;, GO:0000785;GO:0043231;GO:0005654;GO:0000981;GO:0000978;GO:1990837;GO:0006955;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:immune response; P:regulation of transcription by RNA polymerase II;|P22670,MHC class II regulatory factor RFX1,Enhancer factor C;Regulatory factor X 1;Transcription factor RFX1;, PF04589;PF02257;, GO:0000785;GO:0043231;GO:0005654;GO:0000981;GO:0000978;GO:1990837;GO:0006955;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:immune response; P:regulation of transcription by RNA polymerase II;|P22670,MHC class II regulatory factor RFX1,Enhancer factor C;Regulatory factor X 1;Transcription factor RFX1;, PF04589;PF02257;, GO:0000785;GO:0043231;GO:0005654;GO:0000981;GO:0000978;GO:1990837;GO:0006955;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:immune response; P:regulation of transcription by RNA polymerase II;|P22670,MHC class II regulatory factor RFX1,Enhancer factor C;Regulatory factor X 1;Transcription factor RFX1;, PF04589;PF02257;, GO:0000785;GO:0043231;GO:0005654;GO:0000981;GO:0000978;GO:1990837;GO:0006955;GO:0006357;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:immune response; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 1555333 1563876 . - . ID=transcript_12975;Q66K64 B3KS86 Q96DW0 Q9BU31,DDB1- and CUL4-associated factor 15 {ECO:0000305},, PF14939;, GO:0080008;GO:0046872;GO:0036094;GO:0002376;GO:0000209;GO:0016567;GO:0032814;, C:Cul4-RING E3 ubiquitin ligase complex;, F:metal ion binding; F:small molecule binding;, P:immune system process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of natural killer cell activation;|Q66K64 B3KS86 Q96DW0 Q9BU31,DDB1- and CUL4-associated factor 15 {ECO:0000305},, PF14939;, GO:0080008;GO:0046872;GO:0036094;GO:0002376;GO:0000209;GO:0016567;GO:0032814;, C:Cul4-RING E3 ubiquitin ligase complex;, F:metal ion binding; F:small molecule binding;, P:immune system process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of natural killer cell activation;|Q66K64 B3KS86 Q96DW0 Q9BU31,DDB1- and CUL4-associated factor 15 {ECO:0000305},, PF14939;, GO:0080008;GO:0046872;GO:0036094;GO:0002376;GO:0000209;GO:0016567;GO:0032814;, C:Cul4-RING E3 ubiquitin ligase complex;, F:metal ion binding; F:small molecule binding;, P:immune system process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of natural killer cell activation;|Q66K64 B3KS86 Q96DW0 Q9BU31,DDB1- and CUL4-associated factor 15 {ECO:0000305},, PF14939;, GO:0080008;GO:0046872;GO:0036094;GO:0002376;GO:0000209;GO:0016567;GO:0032814;, C:Cul4-RING E3 ubiquitin ligase complex;, F:metal ion binding; F:small molecule binding;, P:immune system process; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of natural killer cell activation; scaffold103 indexed_genome mRNA 1581420 1587782 . + . ID=transcript_12976;Q6PEZ8 B7Z564 Q9H5G9,Podocan-like protein 1,, PF13855;, GO:0005615;, C:extracellular space;|Q6PEZ8 B7Z564 Q9H5G9,Podocan-like protein 1,, PF13855;, GO:0005615;, C:extracellular space; scaffold103 indexed_genome mRNA 1588152 1606566 . - . ID=transcript_12977;Q6P1N0 Q7Z435 Q86XV0 Q8NF89 Q9H603 Q9NXI1,Coiled-coil and C2 domain-containing protein 1A,Akt kinase-interacting protein 1;Five prime repressor element under dual repression-binding protein 1;Putative NF-kappa-B-activating protein 023N;, PF00168;, GO:0005829;GO:0070062;GO:0001650;GO:0016020;GO:0005815;GO:0005634;GO:0005886;GO:0045296;GO:0000981;GO:0001227;GO:0000978;GO:1905381;GO:0043123;GO:0006357;, C:cytosol; C:extracellular exosome; C:fibrillar center; C:membrane; C:microtubule organizing center; C:nucleus; C:plasma membrane;, F:cadherin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of snRNA transcription by RNA polymerase II; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of transcription by RNA polymerase II;|Q6P1N0 Q7Z435 Q86XV0 Q8NF89 Q9H603 Q9NXI1,Coiled-coil and C2 domain-containing protein 1A,Akt kinase-interacting protein 1;Five prime repressor element under dual repression-binding protein 1;Putative NF-kappa-B-activating protein 023N;, PF00168;, GO:0005829;GO:0070062;GO:0001650;GO:0016020;GO:0005815;GO:0005634;GO:0005886;GO:0045296;GO:0000981;GO:0001227;GO:0000978;GO:1905381;GO:0043123;GO:0006357;, C:cytosol; C:extracellular exosome; C:fibrillar center; C:membrane; C:microtubule organizing center; C:nucleus; C:plasma membrane;, F:cadherin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of snRNA transcription by RNA polymerase II; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of transcription by RNA polymerase II;|Q6P1N0 Q7Z435 Q86XV0 Q8NF89 Q9H603 Q9NXI1,Coiled-coil and C2 domain-containing protein 1A,Akt kinase-interacting protein 1;Five prime repressor element under dual repression-binding protein 1;Putative NF-kappa-B-activating protein 023N;, PF00168;, GO:0005829;GO:0070062;GO:0001650;GO:0016020;GO:0005815;GO:0005634;GO:0005886;GO:0045296;GO:0000981;GO:0001227;GO:0000978;GO:1905381;GO:0043123;GO:0006357;, C:cytosol; C:extracellular exosome; C:fibrillar center; C:membrane; C:microtubule organizing center; C:nucleus; C:plasma membrane;, F:cadherin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of snRNA transcription by RNA polymerase II; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of transcription by RNA polymerase II;|Q6P1N0 Q7Z435 Q86XV0 Q8NF89 Q9H603 Q9NXI1,Coiled-coil and C2 domain-containing protein 1A,Akt kinase-interacting protein 1;Five prime repressor element under dual repression-binding protein 1;Putative NF-kappa-B-activating protein 023N;, PF00168;, GO:0005829;GO:0070062;GO:0001650;GO:0016020;GO:0005815;GO:0005634;GO:0005886;GO:0045296;GO:0000981;GO:0001227;GO:0000978;GO:1905381;GO:0043123;GO:0006357;, C:cytosol; C:extracellular exosome; C:fibrillar center; C:membrane; C:microtubule organizing center; C:nucleus; C:plasma membrane;, F:cadherin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of snRNA transcription by RNA polymerase II; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 1606655 1627596 . + . ID=transcript_12978;Q0VDD7 Q13411 Q8N825 Q96D63 Q9BU49,Break repair meiotic recombinase recruitment factor 1 {ECO:0000305},Pre-T/NK cell-associated protein 3B3;, PF15710;, GO:0005694;GO:1990918;GO:0007275;GO:0007283;, C:chromosome;, , P:double-strand break repair involved in meiotic recombination; P:multicellular organism development; P:spermatogenesis; scaffold103 indexed_genome mRNA 1629434 1631842 . - . ID=transcript_12979;P60323 Q495E5,Nanos homolog 3,, PF05741;, GO:0005737;GO:0010494;GO:0005634;GO:0000932;GO:0048471;GO:0003729;GO:0003723;GO:0008270;GO:0007281;GO:0007275;GO:2001234;GO:0017148;GO:0048477;GO:1900153;GO:0051726;GO:0006417;GO:0007283;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleus; C:P-body; C:perinuclear region of cytoplasm;, F:mRNA binding; F:RNA binding; F:zinc ion binding;, P:germ cell development; P:multicellular organism development; P:negative regulation of apoptotic signaling pathway; P:negative regulation of translation; P:oogenesis; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:regulation of cell cycle; P:regulation of translation; P:spermatogenesis; scaffold103 indexed_genome mRNA 1664640 1678784 . - . ID=transcript_12980;Q9H7M6,Zinc finger SWIM domain-containing protein 4,, , GO:0031462;GO:0008270;GO:1902667;, C:Cul2-RING ubiquitin ligase complex;, F:zinc ion binding;, P:regulation of axon guidance; scaffold103 indexed_genome mRNA 1693482 1696573 . + . ID=transcript_12981;Q9UNZ5 B2R4J9,Leydig cell tumor 10 kDa protein homolog,, PF09495;|Q9UNZ5 B2R4J9,Leydig cell tumor 10 kDa protein homolog,, PF09495; scaffold103 indexed_genome mRNA 1702336 1703427 . - . ID=transcript_12982;Q9BV20 Q8NDC9,Methylthioribose-1-phosphate isomerase {ECO:0000255|HAMAP-Rule:MF_03119},Mediator of RhoA-dependent invasion;S-methyl-5-thioribose-1-phosphate isomerase {ECO:0000255|HAMAP-Rule:MF_03119};Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein {ECO:0000255|HAMAP-Rule:MF_03119};, PF01008;, GO:0042995;GO:0005829;GO:0001650;GO:0005654;GO:0042802;GO:0046523;GO:0019509;GO:0019284;, C:cell projection; C:cytosol; C:fibrillar center; C:nucleoplasm;, F:identical protein binding; F:S-methyl-5-thioribose-1-phosphate isomerase activity;, P:L-methionine salvage from methylthioadenosine; P:L-methionine salvage from S-adenosylmethionine; scaffold103 indexed_genome mRNA 1704096 1716000 . - . ID=transcript_12983;P13994 Q9BQ72,Coiled-coil domain-containing protein 130,9 kDa protein;, PF04502;, GO:0071014;GO:0005684;GO:0009615;GO:0008380;, C:post-mRNA release spliceosomal complex; C:U2-type spliceosomal complex;, , P:response to virus; P:RNA splicing; scaffold103 indexed_genome mRNA 1963197 2121482 . + . ID=transcript_12984;Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta; scaffold103 indexed_genome mRNA 2139307 2141962 . + . ID=transcript_12985;Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta; scaffold103 indexed_genome mRNA 2146843 2148993 . + . ID=transcript_12986;Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta; scaffold103 indexed_genome mRNA 2156408 2210656 . + . ID=transcript_12987;Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q00975 B1AQK5,Voltage-dependent N-type calcium channel subunit alpha-1B,Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0005524;GO:0005509;GO:0008331;GO:0008022;GO:0005245;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050804;GO:0034765;GO:1904645;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:ATP binding; F:calcium ion binding; F:high voltage-gated calcium channel activity; F:protein C-terminus binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q99793 Q9NS88 Q9UDC4,Voltage-dependent P/Q-type calcium channel subunit alpha-1A {ECO:0000305},Brain calcium channel I {ECO:0000303|PubMed:8988170};Calcium channel, L type, alpha-1 polypeptide isoform 4;Voltage-gated calcium channel subunit alpha Cav2.1;, PF08763;PF16905;PF00520;, GO:0042995;GO:0005737;GO:0016021;GO:0043025;GO:0005634;GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0008331;GO:0046872;GO:0019905;GO:0005245;GO:0070509;GO:0070588;GO:0006816;GO:0008219;GO:1904646;GO:0007268;GO:0051899;GO:0050804;GO:0007204;GO:0050796;GO:0034765;GO:1904645;, C:cell projection; C:cytoplasm; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:syntaxin binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transmembrane transport; P:calcium ion transport; P:cell death; P:cellular response to amyloid-beta; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:positive regulation of cytosolic calcium ion concentration; P:regulation of insulin secretion; P:regulation of ion transmembrane transport; P:response to amyloid-beta; scaffold103 indexed_genome mRNA 2215569 2216490 . + . ID=transcript_12988;Q0P6D6 Q9H8U7,Coiled-coil domain-containing protein 15,, , GO:0005813;, C:centrosome; scaffold103 indexed_genome mRNA 2248853 2253324 . - . ID=transcript_12989;Q9BTL4 Q03827 Q2TAZ2,Immediate early response gene 2 protein,Protein ETR101;, PF05760;, GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0048870;GO:0030182;GO:0045944;GO:0071774;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:cell motility; P:neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:response to fibroblast growth factor; scaffold103 indexed_genome mRNA 2253517 2257901 . + . ID=transcript_12990;O60499 A6NC41 Q6IAP4 Q96AE8,Syntaxin-10,, PF05739;PF09177;, GO:0005829;GO:0012505;GO:0016021;GO:0030285;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0031982;GO:0005484;GO:0000149;GO:0019905;GO:0048193;GO:0006886;GO:0032880;GO:0042147;GO:0048278;GO:0006906;, C:cytosol; C:endomembrane system; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane; C:vesicle;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi vesicle transport; P:intracellular protein transport; P:regulation of protein localization; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion;|O60499 A6NC41 Q6IAP4 Q96AE8,Syntaxin-10,, PF05739;PF09177;, GO:0005829;GO:0012505;GO:0016021;GO:0030285;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0031982;GO:0005484;GO:0000149;GO:0019905;GO:0048193;GO:0006886;GO:0032880;GO:0042147;GO:0048278;GO:0006906;, C:cytosol; C:endomembrane system; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane; C:vesicle;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi vesicle transport; P:intracellular protein transport; P:regulation of protein localization; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion;|O60499 A6NC41 Q6IAP4 Q96AE8,Syntaxin-10,, PF05739;PF09177;, GO:0005829;GO:0012505;GO:0016021;GO:0030285;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0031982;GO:0005484;GO:0000149;GO:0019905;GO:0048193;GO:0006886;GO:0032880;GO:0042147;GO:0048278;GO:0006906;, C:cytosol; C:endomembrane system; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane; C:vesicle;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi vesicle transport; P:intracellular protein transport; P:regulation of protein localization; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion; scaffold103 indexed_genome mRNA 2258042 2264054 . - . ID=transcript_12991;Q96RE7,Nucleus accumbens-associated protein 1,BTB/POZ domain-containing protein 14B;, PF10523;PF00651;, GO:0030054;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0042826;GO:0000978;GO:0045892;GO:0008284;GO:0006357;, C:cell junction; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II;|Q96RE7,Nucleus accumbens-associated protein 1,BTB/POZ domain-containing protein 14B;, PF10523;PF00651;, GO:0030054;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0042826;GO:0000978;GO:0045892;GO:0008284;GO:0006357;, C:cell junction; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 2264990 2266346 . + . ID=transcript_12992;Q96RE7,Nucleus accumbens-associated protein 1,BTB/POZ domain-containing protein 14B;, PF10523;PF00651;, GO:0030054;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0042826;GO:0000978;GO:0045892;GO:0008284;GO:0006357;, C:cell junction; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 2283997 2293445 . + . ID=transcript_12993;Q9NXH9 O76103 Q548Y5 Q8WVA6,tRNA (guanine(26)-N(2))-dimethyltransferase,tRNA 2,2-dimethylguanosine-26 methyltransferase;tRNA(guanine-26,N(2)-N(2)) methyltransferase;tRNA(m(2,2)G26)dimethyltransferase;, PF02005;PF00642;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0004809;GO:0000049;GO:0006400;GO:0002940;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;, P:tRNA modification; P:tRNA N2-guanine methylation;|Q9NXH9 O76103 Q548Y5 Q8WVA6,tRNA (guanine(26)-N(2))-dimethyltransferase,tRNA 2,2-dimethylguanosine-26 methyltransferase;tRNA(guanine-26,N(2)-N(2)) methyltransferase;tRNA(m(2,2)G26)dimethyltransferase;, PF02005;PF00642;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0004809;GO:0000049;GO:0006400;GO:0002940;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;, P:tRNA modification; P:tRNA N2-guanine methylation;|Q9NXH9 O76103 Q548Y5 Q8WVA6,tRNA (guanine(26)-N(2))-dimethyltransferase,tRNA 2,2-dimethylguanosine-26 methyltransferase;tRNA(guanine-26,N(2)-N(2)) methyltransferase;tRNA(m(2,2)G26)dimethyltransferase;, PF02005;PF00642;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0004809;GO:0000049;GO:0006400;GO:0002940;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;, P:tRNA modification; P:tRNA N2-guanine methylation;|Q9NXH9 O76103 Q548Y5 Q8WVA6,tRNA (guanine(26)-N(2))-dimethyltransferase,tRNA 2,2-dimethylguanosine-26 methyltransferase;tRNA(guanine-26,N(2)-N(2)) methyltransferase;tRNA(m(2,2)G26)dimethyltransferase;, PF02005;PF00642;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0004809;GO:0000049;GO:0006400;GO:0002940;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;, P:tRNA modification; P:tRNA N2-guanine methylation;|Q9NXH9 O76103 Q548Y5 Q8WVA6,tRNA (guanine(26)-N(2))-dimethyltransferase,tRNA 2,2-dimethylguanosine-26 methyltransferase;tRNA(guanine-26,N(2)-N(2)) methyltransferase;tRNA(m(2,2)G26)dimethyltransferase;, PF02005;PF00642;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0004809;GO:0000049;GO:0006400;GO:0002940;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;, P:tRNA modification; P:tRNA N2-guanine methylation;|Q9NXH9 O76103 Q548Y5 Q8WVA6,tRNA (guanine(26)-N(2))-dimethyltransferase,tRNA 2,2-dimethylguanosine-26 methyltransferase;tRNA(guanine-26,N(2)-N(2)) methyltransferase;tRNA(m(2,2)G26)dimethyltransferase;, PF02005;PF00642;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0004809;GO:0000049;GO:0006400;GO:0002940;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;, P:tRNA modification; P:tRNA N2-guanine methylation;|Q9NXH9 O76103 Q548Y5 Q8WVA6,tRNA (guanine(26)-N(2))-dimethyltransferase,tRNA 2,2-dimethylguanosine-26 methyltransferase;tRNA(guanine-26,N(2)-N(2)) methyltransferase;tRNA(m(2,2)G26)dimethyltransferase;, PF02005;PF00642;, GO:0005654;GO:0005634;GO:0046872;GO:0003723;GO:0004809;GO:0000049;GO:0006400;GO:0002940;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:RNA binding; F:tRNA (guanine-N2-)-methyltransferase activity; F:tRNA binding;, P:tRNA modification; P:tRNA N2-guanine methylation; scaffold103 indexed_genome mRNA 2294797 2298889 . + . ID=transcript_12994;P12980 O76102,Protein lyl-1,Class A basic helix-loop-helix protein 18;Lymphoblastic leukemia-derived sequence 1;, PF00010;, GO:0000785;GO:0005654;GO:0003677;GO:0000981;GO:0046983;GO:0000978;GO:0030183;GO:0001955;GO:0060216;GO:0045893;GO:0006357;GO:0006355;, C:chromatin; C:nucleoplasm;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:B cell differentiation; P:blood vessel maturation; P:definitive hemopoiesis; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P12980 O76102,Protein lyl-1,Class A basic helix-loop-helix protein 18;Lymphoblastic leukemia-derived sequence 1;, PF00010;, GO:0000785;GO:0005654;GO:0003677;GO:0000981;GO:0046983;GO:0000978;GO:0030183;GO:0001955;GO:0060216;GO:0045893;GO:0006357;GO:0006355;, C:chromatin; C:nucleoplasm;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:B cell differentiation; P:blood vessel maturation; P:definitive hemopoiesis; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold103 indexed_genome mRNA 2300905 2374171 . - . ID=transcript_12995;Q9Y6R8,Nuclear factor 1 X-type,CCAAT-box-binding transcription factor;Nuclear factor I/X;TGGCA-binding protein;, PF00859;PF03165;PF10524;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0006260;GO:0000122;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:DNA replication; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q9Y6R8,Nuclear factor 1 X-type,CCAAT-box-binding transcription factor;Nuclear factor I/X;TGGCA-binding protein;, PF00859;PF03165;PF10524;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0006260;GO:0000122;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:DNA replication; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q9Y6R8,Nuclear factor 1 X-type,CCAAT-box-binding transcription factor;Nuclear factor I/X;TGGCA-binding protein;, PF00859;PF03165;PF10524;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0006260;GO:0000122;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:DNA replication; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q9Y6R8,Nuclear factor 1 X-type,CCAAT-box-binding transcription factor;Nuclear factor I/X;TGGCA-binding protein;, PF00859;PF03165;PF10524;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0006260;GO:0000122;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:DNA replication; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 2439496 2441545 . + . ID=transcript_12996;P54725 K7ESE3 Q59EU8 Q5M7Z1,UV excision repair protein RAD23 homolog A,, PF00627;PF00240;PF09280;, GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0000502;GO:0032991;GO:0003684;GO:0019900;GO:0031593;GO:0070628;GO:0003697;GO:0043130;GO:1990381;GO:0006289;GO:0045787;GO:0032436;GO:0045070;GO:0043161;GO:0031648;GO:0016579;GO:0032434;GO:0016032;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:proteasome complex; C:protein-containing complex;, F:damaged DNA binding; F:kinase binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:single-stranded DNA binding; F:ubiquitin binding; F:ubiquitin-specific protease binding;, P:nucleotide-excision repair; P:positive regulation of cell cycle; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of viral genome replication; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein destabilization; P:protein deubiquitination; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:viral process; scaffold103 indexed_genome mRNA 2446218 2450198 . - . ID=transcript_12997;P27797 Q6IAT4 Q9UDG2,Calreticulin {ECO:0000303|PubMed:9427624},CRP55;Calregulin;Endoplasmic reticulum resident protein 60;HACBP;grp60;, PF00262;, GO:0001669;GO:0009986;GO:0062023;GO:0060473;GO:0005737;GO:0005829;GO:0071682;GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0033116;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005794;GO:0071556;GO:0016020;GO:0042824;GO:0005635;GO:0005634;GO:0048471;GO:0030670;GO:0005844;GO:0033018;GO:0005790;GO:0050681;GO:0005509;GO:0030246;GO:0051087;GO:0001849;GO:0003677;GO:0042562;GO:0005178;GO:0005506;GO:0003729;GO:0042277;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0008270;GO:0002479;GO:0002474;GO:0036500;GO:0055007;GO:0006874;GO:0071285;GO:0090398;GO:0030866;GO:0030968;GO:0042921;GO:0071157;GO:0033144;GO:0045665;GO:0048387;GO:0000122;GO:0045892;GO:0017148;GO:1901164;GO:0002502;GO:0045787;GO:0008284;GO:2000510;GO:0010595;GO:0010628;GO:1901224;GO:0050766;GO:1900026;GO:0006611;GO:0006457;GO:0034975;GO:0034504;GO:0022417;GO:0050821;GO:0006898;GO:0042981;GO:0040020;GO:0006355;GO:0042493;GO:0032355;GO:0033574;GO:0051208;GO:0007283;GO:1990668;, C:acrosomal vesicle; C:cell surface; C:collagen-containing extracellular matrix; C:cortical granule; C:cytoplasm; C:cytosol; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:Golgi apparatus; C:integral component of lumenal side of endoplasmic reticulum membrane; C:membrane; C:MHC class I peptide loading complex; C:nuclear envelope; C:nucleus; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:polysome; C:sarcoplasmic reticulum lumen; C:smooth endoplasmic reticulum;, F:androgen receptor binding; F:calcium ion binding; F:carbohydrate binding; F:chaperone binding; F:complement component C1q complex binding; F:DNA binding; F:hormone binding; F:integrin binding; F:iron ion binding; F:mRNA binding; F:peptide binding; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:ATF6-mediated unfolded protein response; P:cardiac muscle cell differentiation; P:cellular calcium ion homeostasis; P:cellular response to lithium ion; P:cellular senescence; P:cortical actin cytoskeleton organization; P:endoplasmic reticulum unfolded protein response; P:glucocorticoid receptor signaling pathway; P:negative regulation of cell cycle arrest; P:negative regulation of intracellular steroid hormone receptor signaling pathway; P:negative regulation of neuron differentiation; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of trophoblast cell migration; P:peptide antigen assembly with MHC class I protein complex; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of endothelial cell migration; P:positive regulation of gene expression; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of phagocytosis; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein export from nucleus; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein localization to nucleus; P:protein maturation by protein folding; P:protein stabilization; P:receptor-mediated endocytosis; P:regulation of apoptotic process; P:regulation of meiotic nuclear division; P:regulation of transcription, DNA-templated; P:response to drug; P:response to estradiol; P:response to testosterone; P:sequestering of calcium ion; P:spermatogenesis; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;|P27797 Q6IAT4 Q9UDG2,Calreticulin {ECO:0000303|PubMed:9427624},CRP55;Calregulin;Endoplasmic reticulum resident protein 60;HACBP;grp60;, PF00262;, GO:0001669;GO:0009986;GO:0062023;GO:0060473;GO:0005737;GO:0005829;GO:0071682;GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0033116;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0005794;GO:0071556;GO:0016020;GO:0042824;GO:0005635;GO:0005634;GO:0048471;GO:0030670;GO:0005844;GO:0033018;GO:0005790;GO:0050681;GO:0005509;GO:0030246;GO:0051087;GO:0001849;GO:0003677;GO:0042562;GO:0005178;GO:0005506;GO:0003729;GO:0042277;GO:0044183;GO:0003723;GO:0031625;GO:0051082;GO:0008270;GO:0002479;GO:0002474;GO:0036500;GO:0055007;GO:0006874;GO:0071285;GO:0090398;GO:0030866;GO:0030968;GO:0042921;GO:0071157;GO:0033144;GO:0045665;GO:0048387;GO:0000122;GO:0045892;GO:0017148;GO:1901164;GO:0002502;GO:0045787;GO:0008284;GO:2000510;GO:0010595;GO:0010628;GO:1901224;GO:0050766;GO:1900026;GO:0006611;GO:0006457;GO:0034975;GO:0034504;GO:0022417;GO:0050821;GO:0006898;GO:0042981;GO:0040020;GO:0006355;GO:0042493;GO:0032355;GO:0033574;GO:0051208;GO:0007283;GO:1990668;, C:acrosomal vesicle; C:cell surface; C:collagen-containing extracellular matrix; C:cortical granule; C:cytoplasm; C:cytosol; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:Golgi apparatus; C:integral component of lumenal side of endoplasmic reticulum membrane; C:membrane; C:MHC class I peptide loading complex; C:nuclear envelope; C:nucleus; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:polysome; C:sarcoplasmic reticulum lumen; C:smooth endoplasmic reticulum;, F:androgen receptor binding; F:calcium ion binding; F:carbohydrate binding; F:chaperone binding; F:complement component C1q complex binding; F:DNA binding; F:hormone binding; F:integrin binding; F:iron ion binding; F:mRNA binding; F:peptide binding; F:protein folding chaperone; F:RNA binding; F:ubiquitin protein ligase binding; F:unfolded protein binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:antigen processing and presentation of peptide antigen via MHC class I; P:ATF6-mediated unfolded protein response; P:cardiac muscle cell differentiation; P:cellular calcium ion homeostasis; P:cellular response to lithium ion; P:cellular senescence; P:cortical actin cytoskeleton organization; P:endoplasmic reticulum unfolded protein response; P:glucocorticoid receptor signaling pathway; P:negative regulation of cell cycle arrest; P:negative regulation of intracellular steroid hormone receptor signaling pathway; P:negative regulation of neuron differentiation; P:negative regulation of retinoic acid receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of trophoblast cell migration; P:peptide antigen assembly with MHC class I protein complex; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of endothelial cell migration; P:positive regulation of gene expression; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of phagocytosis; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein export from nucleus; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein localization to nucleus; P:protein maturation by protein folding; P:protein stabilization; P:receptor-mediated endocytosis; P:regulation of apoptotic process; P:regulation of meiotic nuclear division; P:regulation of transcription, DNA-templated; P:response to drug; P:response to estradiol; P:response to testosterone; P:sequestering of calcium ion; P:spermatogenesis; P:vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane; scaffold103 indexed_genome mRNA 2455997 2458613 . + . ID=transcript_12998;P15954 Q6NR81,Cytochrome c oxidase subunit 7C, mitochondrial,Cytochrome c oxidase polypeptide VIIc;, PF02935;, GO:0016021;GO:0005743;GO:0005751;GO:0005739;GO:0004129;GO:0006091;GO:0006123;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV; C:mitochondrion;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen; scaffold103 indexed_genome mRNA 2458635 2468414 . + . ID=transcript_12999;Q9Y285 B4E363 Q9NSD8 Q9Y4W8,Phenylalanine--tRNA ligase alpha subunit,CML33;Phenylalanyl-tRNA synthetase alpha subunit;, PF18552;PF18554;PF18553;PF01409;, GO:0005737;GO:0005829;GO:0016020;GO:0009328;GO:0005524;GO:0004826;GO:0003723;GO:0000049;GO:0006432;GO:0051290;GO:0006418;, C:cytoplasm; C:cytosol; C:membrane; C:phenylalanine-tRNA ligase complex;, F:ATP binding; F:phenylalanine-tRNA ligase activity; F:RNA binding; F:tRNA binding;, P:phenylalanyl-tRNA aminoacylation; P:protein heterotetramerization; P:tRNA aminoacylation for protein translation;|Q9Y285 B4E363 Q9NSD8 Q9Y4W8,Phenylalanine--tRNA ligase alpha subunit,CML33;Phenylalanyl-tRNA synthetase alpha subunit;, PF18552;PF18554;PF18553;PF01409;, GO:0005737;GO:0005829;GO:0016020;GO:0009328;GO:0005524;GO:0004826;GO:0003723;GO:0000049;GO:0006432;GO:0051290;GO:0006418;, C:cytoplasm; C:cytosol; C:membrane; C:phenylalanine-tRNA ligase complex;, F:ATP binding; F:phenylalanine-tRNA ligase activity; F:RNA binding; F:tRNA binding;, P:phenylalanyl-tRNA aminoacylation; P:protein heterotetramerization; P:tRNA aminoacylation for protein translation;|Q9Y285 B4E363 Q9NSD8 Q9Y4W8,Phenylalanine--tRNA ligase alpha subunit,CML33;Phenylalanyl-tRNA synthetase alpha subunit;, PF18552;PF18554;PF18553;PF01409;, GO:0005737;GO:0005829;GO:0016020;GO:0009328;GO:0005524;GO:0004826;GO:0003723;GO:0000049;GO:0006432;GO:0051290;GO:0006418;, C:cytoplasm; C:cytosol; C:membrane; C:phenylalanine-tRNA ligase complex;, F:ATP binding; F:phenylalanine-tRNA ligase activity; F:RNA binding; F:tRNA binding;, P:phenylalanyl-tRNA aminoacylation; P:protein heterotetramerization; P:tRNA aminoacylation for protein translation; scaffold103 indexed_genome mRNA 2483405 2492844 . + . ID=transcript_13000;Q6PIF2 B4DYD3,Synaptonemal complex central element protein 2,Central element synaptonemal complex protein 1 {ECO:0000250|UniProtKB:Q505B8};, , GO:0000801;GO:0005694;GO:0005654;GO:0051301;GO:0007130;, C:central element; C:chromosome; C:nucleoplasm;, , P:cell division; P:synaptonemal complex assembly;|Q92947 A8K2Z2 O14719,Glutaryl-CoA dehydrogenase, mitochondrial,, PF00441;PF02770;PF02771;, GO:0005759;GO:0005739;GO:0000062;GO:0050660;GO:0004361;GO:0033539;GO:0046949;GO:0006554;GO:0006568;, C:mitochondrial matrix; C:mitochondrion;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:glutaryl-CoA dehydrogenase activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:fatty-acyl-CoA biosynthetic process; P:lysine catabolic process; P:tryptophan metabolic process;|Q92947 A8K2Z2 O14719,Glutaryl-CoA dehydrogenase, mitochondrial,, PF00441;PF02770;PF02771;, GO:0005759;GO:0005739;GO:0000062;GO:0050660;GO:0004361;GO:0033539;GO:0046949;GO:0006554;GO:0006568;, C:mitochondrial matrix; C:mitochondrion;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:glutaryl-CoA dehydrogenase activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:fatty-acyl-CoA biosynthetic process; P:lysine catabolic process; P:tryptophan metabolic process;|Q92947 A8K2Z2 O14719,Glutaryl-CoA dehydrogenase, mitochondrial,, PF00441;PF02770;PF02771;, GO:0005759;GO:0005739;GO:0000062;GO:0050660;GO:0004361;GO:0033539;GO:0046949;GO:0006554;GO:0006568;, C:mitochondrial matrix; C:mitochondrion;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:glutaryl-CoA dehydrogenase activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:fatty-acyl-CoA biosynthetic process; P:lysine catabolic process; P:tryptophan metabolic process;|Q92947 A8K2Z2 O14719,Glutaryl-CoA dehydrogenase, mitochondrial,, PF00441;PF02770;PF02771;, GO:0005759;GO:0005739;GO:0000062;GO:0050660;GO:0004361;GO:0033539;GO:0046949;GO:0006554;GO:0006568;, C:mitochondrial matrix; C:mitochondrion;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:glutaryl-CoA dehydrogenase activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:fatty-acyl-CoA biosynthetic process; P:lysine catabolic process; P:tryptophan metabolic process;|Q92947 A8K2Z2 O14719,Glutaryl-CoA dehydrogenase, mitochondrial,, PF00441;PF02770;PF02771;, GO:0005759;GO:0005739;GO:0000062;GO:0050660;GO:0004361;GO:0033539;GO:0046949;GO:0006554;GO:0006568;, C:mitochondrial matrix; C:mitochondrion;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:glutaryl-CoA dehydrogenase activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:fatty-acyl-CoA biosynthetic process; P:lysine catabolic process; P:tryptophan metabolic process; scaffold103 indexed_genome mRNA 2500659 2503976 . + . ID=transcript_13001;Q13351 Q6PIJ5 Q92899,Krueppel-like factor 1,Erythroid krueppel-like transcription factor;, PF16832;PF16833;PF00096;, GO:0000785;GO:0005654;GO:0005634;GO:0000987;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0000976;GO:1901653;GO:0030218;GO:0060135;GO:0045893;GO:0006357;GO:0006355;, C:chromatin; C:nucleoplasm; C:nucleus;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to peptide; P:erythrocyte differentiation; P:maternal process involved in female pregnancy; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold103 indexed_genome mRNA 2504648 2507590 . + . ID=transcript_13002;O00115 B2RD06 B7Z4K6 O43910,Deoxyribonuclease-2-alpha,Acid DNase;Deoxyribonuclease II alpha;Lysosomal DNase II;R31240_2;, PF03265;, GO:0070062;GO:0005764;GO:0004531;GO:0003677;GO:0006309;GO:0006259;GO:0030218;GO:0050776;, C:extracellular exosome; C:lysosome;, F:deoxyribonuclease II activity; F:DNA binding;, P:apoptotic DNA fragmentation; P:DNA metabolic process; P:erythrocyte differentiation; P:regulation of immune response; scaffold103 indexed_genome mRNA 2507603 2532109 . - . ID=transcript_13003;Q9Y2H9 O00114 Q8N6X0,Microtubule-associated serine/threonine-protein kinase 1,Syntrophin-associated serine/threonine-protein kinase;, PF08926;PF17820;PF00069;, GO:0030424;GO:0005737;GO:0005856;GO:0030425;GO:0043005;GO:0043025;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0007420;GO:0007010;GO:0035556;GO:0018105;GO:0006468;, C:axon; C:cytoplasm; C:cytoskeleton; C:dendrite; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain development; P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation;|Q9Y2H9 O00114 Q8N6X0,Microtubule-associated serine/threonine-protein kinase 1,Syntrophin-associated serine/threonine-protein kinase;, PF08926;PF17820;PF00069;, GO:0030424;GO:0005737;GO:0005856;GO:0030425;GO:0043005;GO:0043025;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0007420;GO:0007010;GO:0035556;GO:0018105;GO:0006468;, C:axon; C:cytoplasm; C:cytoskeleton; C:dendrite; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain development; P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation;|Q9Y2H9 O00114 Q8N6X0,Microtubule-associated serine/threonine-protein kinase 1,Syntrophin-associated serine/threonine-protein kinase;, PF08926;PF17820;PF00069;, GO:0030424;GO:0005737;GO:0005856;GO:0030425;GO:0043005;GO:0043025;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0007420;GO:0007010;GO:0035556;GO:0018105;GO:0006468;, C:axon; C:cytoplasm; C:cytoskeleton; C:dendrite; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain development; P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation;|Q9Y2H9 O00114 Q8N6X0,Microtubule-associated serine/threonine-protein kinase 1,Syntrophin-associated serine/threonine-protein kinase;, PF08926;PF17820;PF00069;, GO:0030424;GO:0005737;GO:0005856;GO:0030425;GO:0043005;GO:0043025;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0007420;GO:0007010;GO:0035556;GO:0018105;GO:0006468;, C:axon; C:cytoplasm; C:cytoskeleton; C:dendrite; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain development; P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation;|Q9Y2H9 O00114 Q8N6X0,Microtubule-associated serine/threonine-protein kinase 1,Syntrophin-associated serine/threonine-protein kinase;, PF08926;PF17820;PF00069;, GO:0030424;GO:0005737;GO:0005856;GO:0030425;GO:0043005;GO:0043025;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0007420;GO:0007010;GO:0035556;GO:0018105;GO:0006468;, C:axon; C:cytoplasm; C:cytoskeleton; C:dendrite; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain development; P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation; scaffold103 indexed_genome mRNA 2550075 2558471 . - . ID=transcript_13004;O75792 B2RCY1 Q96F11,Ribonuclease H2 subunit A,Aicardi-Goutieres syndrome 4 protein;RNase H(35);Ribonuclease HI large subunit;Ribonuclease HI subunit A;, PF01351;, GO:0005829;GO:0005654;GO:0032299;GO:0046872;GO:0004540;GO:0003723;GO:0004523;GO:0006260;GO:0043137;GO:0006298;GO:0006401;, C:cytosol; C:nucleoplasm; C:ribonuclease H2 complex;, F:metal ion binding; F:ribonuclease activity; F:RNA binding; F:RNA-DNA hybrid ribonuclease activity;, P:DNA replication; P:DNA replication, removal of RNA primer; P:mismatch repair; P:RNA catabolic process;|O75792 B2RCY1 Q96F11,Ribonuclease H2 subunit A,Aicardi-Goutieres syndrome 4 protein;RNase H(35);Ribonuclease HI large subunit;Ribonuclease HI subunit A;, PF01351;, GO:0005829;GO:0005654;GO:0032299;GO:0046872;GO:0004540;GO:0003723;GO:0004523;GO:0006260;GO:0043137;GO:0006298;GO:0006401;, C:cytosol; C:nucleoplasm; C:ribonuclease H2 complex;, F:metal ion binding; F:ribonuclease activity; F:RNA binding; F:RNA-DNA hybrid ribonuclease activity;, P:DNA replication; P:DNA replication, removal of RNA primer; P:mismatch repair; P:RNA catabolic process;|A0A1W2PP97 A0A1W2PP18,Thrombospondin type-1 domain-containing protein 8 {ECO:0000305} scaffold103 indexed_genome mRNA 2558539 2561572 . + . ID=transcript_13005;P32119 A8K0C0 P31945 P32118 P35701 Q6FHG4 Q92763 Q9UC23,Peroxiredoxin-2,Natural killer cell-enhancing factor B;PRP;Thiol-specific antioxidant protein;Thioredoxin peroxidase 1;Thioredoxin-dependent peroxide reductase 1;Thioredoxin-dependent peroxiredoxin 2 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0070062;GO:0016209;GO:0008379;GO:0000187;GO:0045454;GO:0034599;GO:0002357;GO:0048872;GO:0042744;GO:0045321;GO:0043066;GO:2001240;GO:0031665;GO:0032088;GO:0045581;GO:0030194;GO:0042981;GO:0010310;GO:0019430;GO:0002536;GO:0032496;GO:0006979;GO:0042098;GO:0048538;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:antioxidant activity; F:thioredoxin peroxidase activity;, P:activation of MAPK activity; P:cell redox homeostasis; P:cellular response to oxidative stress; P:defense response to tumor cell; P:homeostasis of number of cells; P:hydrogen peroxide catabolic process; P:leukocyte activation; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell differentiation; P:positive regulation of blood coagulation; P:regulation of apoptotic process; P:regulation of hydrogen peroxide metabolic process; P:removal of superoxide radicals; P:respiratory burst involved in inflammatory response; P:response to lipopolysaccharide; P:response to oxidative stress; P:T cell proliferation; P:thymus development;|P32119 A8K0C0 P31945 P32118 P35701 Q6FHG4 Q92763 Q9UC23,Peroxiredoxin-2,Natural killer cell-enhancing factor B;PRP;Thiol-specific antioxidant protein;Thioredoxin peroxidase 1;Thioredoxin-dependent peroxide reductase 1;Thioredoxin-dependent peroxiredoxin 2 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0070062;GO:0016209;GO:0008379;GO:0000187;GO:0045454;GO:0034599;GO:0002357;GO:0048872;GO:0042744;GO:0045321;GO:0043066;GO:2001240;GO:0031665;GO:0032088;GO:0045581;GO:0030194;GO:0042981;GO:0010310;GO:0019430;GO:0002536;GO:0032496;GO:0006979;GO:0042098;GO:0048538;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:antioxidant activity; F:thioredoxin peroxidase activity;, P:activation of MAPK activity; P:cell redox homeostasis; P:cellular response to oxidative stress; P:defense response to tumor cell; P:homeostasis of number of cells; P:hydrogen peroxide catabolic process; P:leukocyte activation; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell differentiation; P:positive regulation of blood coagulation; P:regulation of apoptotic process; P:regulation of hydrogen peroxide metabolic process; P:removal of superoxide radicals; P:respiratory burst involved in inflammatory response; P:response to lipopolysaccharide; P:response to oxidative stress; P:T cell proliferation; P:thymus development; scaffold103 indexed_genome mRNA 2577117 2587490 . + . ID=transcript_13006;Q96ED9 O60562,Protein Hook homolog 2,, PF05622;PF19047;, GO:0005813;GO:0005737;GO:0005829;GO:0070695;GO:0043231;GO:0005874;GO:0051959;GO:0042802;GO:0008017;GO:0031122;GO:0030705;GO:0045022;GO:0006897;GO:0007032;GO:0008333;GO:0007040;GO:0015031;, C:centrosome; C:cytoplasm; C:cytosol; C:FHF complex; C:intracellular membrane-bounded organelle; C:microtubule;, F:dynein light intermediate chain binding; F:identical protein binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:early endosome to late endosome transport; P:endocytosis; P:endosome organization; P:endosome to lysosome transport; P:lysosome organization; P:protein transport;|Q96ED9 O60562,Protein Hook homolog 2,, PF05622;PF19047;, GO:0005813;GO:0005737;GO:0005829;GO:0070695;GO:0043231;GO:0005874;GO:0051959;GO:0042802;GO:0008017;GO:0031122;GO:0030705;GO:0045022;GO:0006897;GO:0007032;GO:0008333;GO:0007040;GO:0015031;, C:centrosome; C:cytoplasm; C:cytosol; C:FHF complex; C:intracellular membrane-bounded organelle; C:microtubule;, F:dynein light intermediate chain binding; F:identical protein binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:early endosome to late endosome transport; P:endocytosis; P:endosome organization; P:endosome to lysosome transport; P:lysosome organization; P:protein transport;|Q96ED9 O60562,Protein Hook homolog 2,, PF05622;PF19047;, GO:0005813;GO:0005737;GO:0005829;GO:0070695;GO:0043231;GO:0005874;GO:0051959;GO:0042802;GO:0008017;GO:0031122;GO:0030705;GO:0045022;GO:0006897;GO:0007032;GO:0008333;GO:0007040;GO:0015031;, C:centrosome; C:cytoplasm; C:cytosol; C:FHF complex; C:intracellular membrane-bounded organelle; C:microtubule;, F:dynein light intermediate chain binding; F:identical protein binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:early endosome to late endosome transport; P:endocytosis; P:endosome organization; P:endosome to lysosome transport; P:lysosome organization; P:protein transport; scaffold103 indexed_genome mRNA 2598071 2606736 . - . ID=transcript_13007;O43681 A6NHP8 A8K740 Q53FC6 Q92849,ATPase GET3 {ECO:0000255|HAMAP-Rule:MF_03112},Arsenical pump-driving ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Arsenite-stimulated ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Guided entry of tail-anchored proteins factor 3, ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Transmembrane domain recognition complex 40 kDa ATPase subunit;hARSA-I;hASNA-I;, PF02374;, GO:0005737;GO:0070062;GO:0043529;GO:0005730;GO:0005654;GO:0015105;GO:0005524;GO:0016887;GO:0046872;GO:0006620;GO:0071816;, C:cytoplasm; C:extracellular exosome; C:GET complex; C:nucleolus; C:nucleoplasm;, F:arsenite transmembrane transporter activity; F:ATP binding; F:ATPase activity; F:metal ion binding;, P:posttranslational protein targeting to endoplasmic reticulum membrane; P:tail-anchored membrane protein insertion into ER membrane;|O43681 A6NHP8 A8K740 Q53FC6 Q92849,ATPase GET3 {ECO:0000255|HAMAP-Rule:MF_03112},Arsenical pump-driving ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Arsenite-stimulated ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Guided entry of tail-anchored proteins factor 3, ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Transmembrane domain recognition complex 40 kDa ATPase subunit;hARSA-I;hASNA-I;, PF02374;, GO:0005737;GO:0070062;GO:0043529;GO:0005730;GO:0005654;GO:0015105;GO:0005524;GO:0016887;GO:0046872;GO:0006620;GO:0071816;, C:cytoplasm; C:extracellular exosome; C:GET complex; C:nucleolus; C:nucleoplasm;, F:arsenite transmembrane transporter activity; F:ATP binding; F:ATPase activity; F:metal ion binding;, P:posttranslational protein targeting to endoplasmic reticulum membrane; P:tail-anchored membrane protein insertion into ER membrane;|O43681 A6NHP8 A8K740 Q53FC6 Q92849,ATPase GET3 {ECO:0000255|HAMAP-Rule:MF_03112},Arsenical pump-driving ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Arsenite-stimulated ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Guided entry of tail-anchored proteins factor 3, ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Transmembrane domain recognition complex 40 kDa ATPase subunit;hARSA-I;hASNA-I;, PF02374;, GO:0005737;GO:0070062;GO:0043529;GO:0005730;GO:0005654;GO:0015105;GO:0005524;GO:0016887;GO:0046872;GO:0006620;GO:0071816;, C:cytoplasm; C:extracellular exosome; C:GET complex; C:nucleolus; C:nucleoplasm;, F:arsenite transmembrane transporter activity; F:ATP binding; F:ATPase activity; F:metal ion binding;, P:posttranslational protein targeting to endoplasmic reticulum membrane; P:tail-anchored membrane protein insertion into ER membrane;|O43681 A6NHP8 A8K740 Q53FC6 Q92849,ATPase GET3 {ECO:0000255|HAMAP-Rule:MF_03112},Arsenical pump-driving ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Arsenite-stimulated ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Guided entry of tail-anchored proteins factor 3, ATPase {ECO:0000255|HAMAP-Rule:MF_03112};Transmembrane domain recognition complex 40 kDa ATPase subunit;hARSA-I;hASNA-I;, PF02374;, GO:0005737;GO:0070062;GO:0043529;GO:0005730;GO:0005654;GO:0015105;GO:0005524;GO:0016887;GO:0046872;GO:0006620;GO:0071816;, C:cytoplasm; C:extracellular exosome; C:GET complex; C:nucleolus; C:nucleoplasm;, F:arsenite transmembrane transporter activity; F:ATP binding; F:ATPase activity; F:metal ion binding;, P:posttranslational protein targeting to endoplasmic reticulum membrane; P:tail-anchored membrane protein insertion into ER membrane; scaffold103 indexed_genome mRNA 2607453 2610951 . + . ID=transcript_13008;Q9BQ61,Telomerase RNA component interacting RNase {ECO:0000303|PubMed:28322335, ECO:0000312|HGNC:HGNC:28424},Exoribonuclease TRIR {ECO:0000305};, , GO:0008408;GO:0008409;GO:0003723;GO:0090503;GO:0016075;, , F:3'-5' exonuclease activity; F:5'-3' exonuclease activity; F:RNA binding;, P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:rRNA catabolic process;|Q9BQ61,Telomerase RNA component interacting RNase {ECO:0000303|PubMed:28322335, ECO:0000312|HGNC:HGNC:28424},Exoribonuclease TRIR {ECO:0000305};, , GO:0008408;GO:0008409;GO:0003723;GO:0090503;GO:0016075;, , F:3'-5' exonuclease activity; F:5'-3' exonuclease activity; F:RNA binding;, P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:rRNA catabolic process; scaffold103 indexed_genome mRNA 2614444 2630324 . + . ID=transcript_13009;O14787 O14655 Q6IN77,Transportin-2,Karyopherin beta-2b;, PF03810;, GO:0005737;GO:0005634;GO:0061608;GO:0008139;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:protein import into nucleus;|O14787 O14655 Q6IN77,Transportin-2,Karyopherin beta-2b;, PF03810;, GO:0005737;GO:0005634;GO:0061608;GO:0008139;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:protein import into nucleus;|O14787 O14655 Q6IN77,Transportin-2,Karyopherin beta-2b;, PF03810;, GO:0005737;GO:0005634;GO:0061608;GO:0008139;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:protein import into nucleus;|O14787 O14655 Q6IN77,Transportin-2,Karyopherin beta-2b;, PF03810;, GO:0005737;GO:0005634;GO:0061608;GO:0008139;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:protein import into nucleus;|O14787 O14655 Q6IN77,Transportin-2,Karyopherin beta-2b;, PF03810;, GO:0005737;GO:0005634;GO:0061608;GO:0008139;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:protein import into nucleus;|O14787 O14655 Q6IN77,Transportin-2,Karyopherin beta-2b;, PF03810;, GO:0005737;GO:0005634;GO:0061608;GO:0008139;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:protein import into nucleus;|O14787 O14655 Q6IN77,Transportin-2,Karyopherin beta-2b;, PF03810;, GO:0005737;GO:0005634;GO:0061608;GO:0008139;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:protein import into nucleus;|O14787 O14655 Q6IN77,Transportin-2,Karyopherin beta-2b;, PF03810;, GO:0005737;GO:0005634;GO:0061608;GO:0008139;GO:0031267;GO:0006606;, C:cytoplasm; C:nucleus;, F:nuclear import signal receptor activity; F:nuclear localization sequence binding; F:small GTPase binding;, P:protein import into nucleus; scaffold103 indexed_genome mRNA 2632845 2640100 . + . ID=transcript_13010;Q5XUX1 B3KVP7 Q9BT89,F-box/WD repeat-containing protein 9,F-box and WD-40 domain-containing protein 9;, PF12937;PF00400;, GO:0005829;GO:0030687;GO:0043687;GO:0000209;, C:cytosol; C:preribosome, large subunit precursor;, , P:post-translational protein modification; P:protein polyubiquitination;|A0A1W2PPG7,Putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 {ECO:0000305},, , GO:0031680;GO:0005834;GO:0031681;GO:0007186;, C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex;, F:G-protein beta-subunit binding;, P:G protein-coupled receptor signaling pathway; scaffold103 indexed_genome mRNA 2642197 2650441 . - . ID=transcript_13011;Q9BRX9 B2RAF1 Q53FT6,WD repeat domain-containing protein 83,Mitogen-activated protein kinase organizer 1;, PF00400;, GO:0071013;GO:0010008;GO:0005681;GO:0090594;GO:0000165;GO:0000398;GO:0043122;GO:0001666;GO:0032496;GO:0000375;, C:catalytic step 2 spliceosome; C:endosome membrane; C:spliceosomal complex;, , P:inflammatory response to wounding; P:MAPK cascade; P:mRNA splicing, via spliceosome; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:response to hypoxia; P:response to lipopolysaccharide; P:RNA splicing, via transesterification reactions;|Q9BRX9 B2RAF1 Q53FT6,WD repeat domain-containing protein 83,Mitogen-activated protein kinase organizer 1;, PF00400;, GO:0071013;GO:0010008;GO:0005681;GO:0090594;GO:0000165;GO:0000398;GO:0043122;GO:0001666;GO:0032496;GO:0000375;, C:catalytic step 2 spliceosome; C:endosome membrane; C:spliceosomal complex;, , P:inflammatory response to wounding; P:MAPK cascade; P:mRNA splicing, via spliceosome; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:response to hypoxia; P:response to lipopolysaccharide; P:RNA splicing, via transesterification reactions;|Q9BRX9 B2RAF1 Q53FT6,WD repeat domain-containing protein 83,Mitogen-activated protein kinase organizer 1;, PF00400;, GO:0071013;GO:0010008;GO:0005681;GO:0090594;GO:0000165;GO:0000398;GO:0043122;GO:0001666;GO:0032496;GO:0000375;, C:catalytic step 2 spliceosome; C:endosome membrane; C:spliceosomal complex;, , P:inflammatory response to wounding; P:MAPK cascade; P:mRNA splicing, via spliceosome; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:response to hypoxia; P:response to lipopolysaccharide; P:RNA splicing, via transesterification reactions; scaffold103 indexed_genome mRNA 2661834 2664258 . + . ID=transcript_13012;Q9Y284 B2R4T8 Q9BVI3,PAT complex subunit Asterix {ECO:0000303|PubMed:32814900},Protein associated with the ER translocon of 10kDa {ECO:0000303|PubMed:12475939};WD repeat domain 83 opposite strand;WDR83 opposite strand;, PF03669;, GO:0016021;, C:integral component of membrane; scaffold103 indexed_genome mRNA 2665091 2680491 . + . ID=transcript_13013;O00754 G5E928 O15330 Q16680 Q93094 Q9BW13,Lysosomal alpha-mannosidase,Lysosomal acid alpha-mannosidase;Mannosidase alpha class 2B member 1;Mannosidase alpha-B;, PF09261;PF17677;PF07748;PF01074;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0043202;GO:0005764;GO:0005654;GO:0005774;GO:0004559;GO:0030246;GO:0046872;GO:0006464;GO:0006013;GO:0043312;GO:0009313;GO:0006517;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:nucleoplasm; C:vacuolar membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:metal ion binding;, P:cellular protein modification process; P:mannose metabolic process; P:neutrophil degranulation; P:oligosaccharide catabolic process; P:protein deglycosylation;|O00754 G5E928 O15330 Q16680 Q93094 Q9BW13,Lysosomal alpha-mannosidase,Lysosomal acid alpha-mannosidase;Mannosidase alpha class 2B member 1;Mannosidase alpha-B;, PF09261;PF17677;PF07748;PF01074;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0043202;GO:0005764;GO:0005654;GO:0005774;GO:0004559;GO:0030246;GO:0046872;GO:0006464;GO:0006013;GO:0043312;GO:0009313;GO:0006517;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:nucleoplasm; C:vacuolar membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:metal ion binding;, P:cellular protein modification process; P:mannose metabolic process; P:neutrophil degranulation; P:oligosaccharide catabolic process; P:protein deglycosylation;|O00754 G5E928 O15330 Q16680 Q93094 Q9BW13,Lysosomal alpha-mannosidase,Lysosomal acid alpha-mannosidase;Mannosidase alpha class 2B member 1;Mannosidase alpha-B;, PF09261;PF17677;PF07748;PF01074;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0043202;GO:0005764;GO:0005654;GO:0005774;GO:0004559;GO:0030246;GO:0046872;GO:0006464;GO:0006013;GO:0043312;GO:0009313;GO:0006517;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:nucleoplasm; C:vacuolar membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:metal ion binding;, P:cellular protein modification process; P:mannose metabolic process; P:neutrophil degranulation; P:oligosaccharide catabolic process; P:protein deglycosylation;|O00754 G5E928 O15330 Q16680 Q93094 Q9BW13,Lysosomal alpha-mannosidase,Lysosomal acid alpha-mannosidase;Mannosidase alpha class 2B member 1;Mannosidase alpha-B;, PF09261;PF17677;PF07748;PF01074;, GO:0035578;GO:0070062;GO:0005576;GO:0005615;GO:0043231;GO:0043202;GO:0005764;GO:0005654;GO:0005774;GO:0004559;GO:0030246;GO:0046872;GO:0006464;GO:0006013;GO:0043312;GO:0009313;GO:0006517;, C:azurophil granule lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:nucleoplasm; C:vacuolar membrane;, F:alpha-mannosidase activity; F:carbohydrate binding; F:metal ion binding;, P:cellular protein modification process; P:mannose metabolic process; P:neutrophil degranulation; P:oligosaccharide catabolic process; P:protein deglycosylation; scaffold103 indexed_genome mRNA 2713701 2751016 . - . ID=transcript_13014;Q3KP31 B7Z586 Q8NC99,Zinc finger protein 791,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q7L945 O14846 Q4KMP9 Q6NT81 Q9BRG4,Zinc finger protein 627,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 2758150 2761571 . - . ID=transcript_13015;Q8N972 A8K4E6,Zinc finger protein 709,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q7L945 O14846 Q4KMP9 Q6NT81 Q9BRG4,Zinc finger protein 627,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 2784460 2785500 . - . ID=transcript_13016;Q9N2K0 O00354 Q96L63 Q9UNM3,HERV-H_2q24.3 provirus ancestral Env polyprotein,Env protein HERV-H/p62;Env protein HERV-H19;Env protein HERV-Hcl.3;Envelope polyprotein;HERV-H/env62;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold103 indexed_genome mRNA 3001923 3002457 . - . ID=transcript_13017;Q3KP31 B7Z586 Q8NC99,Zinc finger protein 791,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 3017354 3030181 . - . ID=transcript_13018;Q8N972 A8K4E6,Zinc finger protein 709,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 3063740 3088888 . - . ID=transcript_13019;Q8WXI7 B5ME49 Q6ZQW5 Q96RK2,Mucin-16 {ECO:0000305},Ovarian cancer-related tumor marker CA125 {ECO:0000303|PubMed:12218296};Ovarian carcinoma antigen CA125 {ECO:0000303|PubMed:11369781};, PF01390;, GO:0070062;GO:0019898;GO:0005796;GO:0016021;GO:0005886;GO:0031982;GO:0007155;GO:0016266;GO:0002223;, C:extracellular exosome; C:extrinsic component of membrane; C:Golgi lumen; C:integral component of membrane; C:plasma membrane; C:vesicle;, , P:cell adhesion; P:O-glycan processing; P:stimulatory C-type lectin receptor signaling pathway; scaffold103 indexed_genome mRNA 3434181 3448484 . + . ID=transcript_13020;Q96PQ6 Q6DCA9 Q96PM0 Q96PM1 Q96PT2 Q9HCI4,Zinc finger protein 317,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 4087371 4088344 . - . ID=transcript_13021;P18124 A8K504 Q15289 Q3KQU0 Q5I0X1 Q6IBM9,60S ribosomal protein L7,Large ribosomal subunit protein uL30 {ECO:0000303|PubMed:24524803};, PF00327;PF08079;, GO:0005737;GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:0014069;GO:1990904;GO:0003677;GO:0042802;GO:0003729;GO:0003723;GO:0003735;GO:0000463;GO:0000184;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:postsynaptic density; C:ribonucleoprotein complex;, F:DNA binding; F:identical protein binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold103 indexed_genome mRNA 4097812 4115524 . - . ID=transcript_13022;Q32M78 Q8N9A1,Zinc finger protein 699,Hangover homolog;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q32M78 Q8N9A1,Zinc finger protein 699,Hangover homolog;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q32M78 Q8N9A1,Zinc finger protein 699,Hangover homolog;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 4118370 4137824 . + . ID=transcript_13023;Q13360 B4DY57 E9PDG0 I3L0I4 Q96ER2,Zinc finger protein 177,, PF01352;PF00096;, GO:0072562;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:1990837;GO:0000122;GO:0006357;, C:blood microparticle; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q13360 B4DY57 E9PDG0 I3L0I4 Q96ER2,Zinc finger protein 177,, PF01352;PF00096;, GO:0072562;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:1990837;GO:0000122;GO:0006357;, C:blood microparticle; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q13360 B4DY57 E9PDG0 I3L0I4 Q96ER2,Zinc finger protein 177,, PF01352;PF00096;, GO:0072562;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:1990837;GO:0000122;GO:0006357;, C:blood microparticle; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 4145465 4186494 . - . ID=transcript_13024;Q9BR84 K7EMG6,Zinc finger protein 559,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96MR9 Q495S9 Q495T1,Zinc finger protein 560,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96MR9 Q495S9 Q495T1,Zinc finger protein 560,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 4199575 4203146 . + . ID=transcript_13025;Q05481 A8K5E1 B7Z6G6,Zinc finger protein 91,Zinc finger protein HPF7;Zinc finger protein HTF10;, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0003700;GO:0000978;GO:0008270;GO:0045892;GO:0070895;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription, DNA-templated; P:negative regulation of transposon integration; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 4205326 4205839 . + . ID=transcript_13026;Q9UQF0 B2RPD4 O95244 O95245 Q8NHY7 Q9NRZ2 Q9NZG3,Syncytin-1,Endogenous retrovirus group W member 1;Env-W;Envelope polyprotein gPr73;Enverin;HERV-7q Envelope protein;HERV-W envelope protein;HERV-W_7q21.2 provirus ancestral Env polyprotein;Syncytin;, PF00429;, GO:0016021;GO:0005886;GO:0009653;GO:0007520;GO:0006949;GO:0000768;, C:integral component of membrane; C:plasma membrane;, , P:anatomical structure morphogenesis; P:myoblast fusion; P:syncytium formation; P:syncytium formation by plasma membrane fusion; scaffold103 indexed_genome mRNA 4244783 4275125 . + . ID=transcript_13027;Q96MR9 Q495S9 Q495T1,Zinc finger protein 560,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q8NG98 A8CAH8 A8CAH9 A8CAI0 A8CAI1 B9EH79,Olfactory receptor 7D4,OR19-B;Odorant receptor family subfamily D member 4RT;Olfactory receptor OR19-7;, PF13853;, GO:0016021;GO:0005886;GO:0004930;GO:0004984;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:olfactory receptor activity; scaffold103 indexed_genome mRNA 4293013 4307765 . + . ID=transcript_13028;Q14584 A0AV90 A4FU85 Q6IQ07 Q6U8A5 Q8IVG3 Q8WVX1 Q96SX9,Zinc finger protein 266,Zinc finger protein HZF1;, PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 4307775 4313019 . - . ID=transcript_13029;Q03923 B9ZVP4 Q6NVI0,Zinc finger protein 85,Zinc finger protein HPF4;Zinc finger protein HTF1;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0006355;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold103 indexed_genome mRNA 4334981 4339442 . - . ID=transcript_13030;Q6ZN57 A5PLN5 B7ZM23 Q9H6Z6,Zinc finger protein 2 homolog,Zinc finger protein 751;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 4364166 4370942 . + . ID=transcript_13031;Q9NXK8 B3KSJ8 Q9H5K4,F-box/LRR-repeat protein 12,F-box and leucine-rich repeat protein 12;F-box protein FBL12;, PF12937;, GO:0005829;GO:0005634;GO:0019005;GO:0043153;GO:0000086;GO:0043687;GO:0000209;GO:0051726;GO:0031146;, C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:post-translational protein modification; P:protein polyubiquitination; P:regulation of cell cycle; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9NXK8 B3KSJ8 Q9H5K4,F-box/LRR-repeat protein 12,F-box and leucine-rich repeat protein 12;F-box protein FBL12;, PF12937;, GO:0005829;GO:0005634;GO:0019005;GO:0043153;GO:0000086;GO:0043687;GO:0000209;GO:0051726;GO:0031146;, C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:post-translational protein modification; P:protein polyubiquitination; P:regulation of cell cycle; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9NXK8 B3KSJ8 Q9H5K4,F-box/LRR-repeat protein 12,F-box and leucine-rich repeat protein 12;F-box protein FBL12;, PF12937;, GO:0005829;GO:0005634;GO:0019005;GO:0043153;GO:0000086;GO:0043687;GO:0000209;GO:0051726;GO:0031146;, C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, , P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:post-translational protein modification; P:protein polyubiquitination; P:regulation of cell cycle; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold103 indexed_genome mRNA 4375365 4377399 . + . ID=transcript_13032;Q9BZL1 Q2NL89,Ubiquitin-like protein 5,, PF00240;, GO:0005737;GO:0005634;GO:0031386;GO:0006464;GO:0000398;GO:1903955;, C:cytoplasm; C:nucleus;, F:protein tag;, P:cellular protein modification process; P:mRNA splicing, via spliceosome; P:positive regulation of protein targeting to mitochondrion; scaffold103 indexed_genome mRNA 4384790 4396957 . + . ID=transcript_13033;Q13526 A8K4V9 Q53X75,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,Peptidyl-prolyl cis-trans isomerase Pin1;Rotamase Pin1;, PF00639;PF00397;, GO:0036064;GO:0005737;GO:0005829;GO:0098978;GO:0030496;GO:0005739;GO:0043005;GO:0016607;GO:0005654;GO:0005634;GO:0099524;GO:0008013;GO:0016859;GO:0032794;GO:0031434;GO:0003774;GO:0003755;GO:0051219;GO:0050815;GO:0050816;GO:0048156;GO:0007049;GO:1902430;GO:2000146;GO:0070373;GO:0043524;GO:0032091;GO:0042177;GO:0030512;GO:0032480;GO:0030182;GO:0090263;GO:0061051;GO:0043547;GO:0043525;GO:0032092;GO:0035307;GO:0001934;GO:0045944;GO:0051443;GO:0000413;GO:0050821;GO:0032465;GO:0010468;GO:0007088;GO:0060393;GO:1900180;GO:0001932;GO:0031647;GO:1901796;GO:0001666;GO:0050808;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:midbody; C:mitochondrion; C:neuron projection; C:nuclear speck; C:nucleoplasm; C:nucleus; C:postsynaptic cytosol;, F:beta-catenin binding; F:cis-trans isomerase activity; F:GTPase activating protein binding; F:mitogen-activated protein kinase kinase binding; F:motor activity; F:peptidyl-prolyl cis-trans isomerase activity; F:phosphoprotein binding; F:phosphoserine residue binding; F:phosphothreonine residue binding; F:tau protein binding;, P:cell cycle; P:negative regulation of amyloid-beta formation; P:negative regulation of cell motility; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of neuron apoptotic process; P:negative regulation of protein binding; P:negative regulation of protein catabolic process; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of type I interferon production; P:neuron differentiation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of GTPase activity; P:positive regulation of neuron apoptotic process; P:positive regulation of protein binding; P:positive regulation of protein dephosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of ubiquitin-protein transferase activity; P:protein peptidyl-prolyl isomerization; P:protein stabilization; P:regulation of cytokinesis; P:regulation of gene expression; P:regulation of mitotic nuclear division; P:regulation of pathway-restricted SMAD protein phosphorylation; P:regulation of protein localization to nucleus; P:regulation of protein phosphorylation; P:regulation of protein stability; P:regulation of signal transduction by p53 class mediator; P:response to hypoxia; P:synapse organization; scaffold103 indexed_genome mRNA 4401194 4408575 . - . ID=transcript_13034;O95897 Q6IMJ3 Q96FC2,Noelin-2,Olfactomedin-2;, PF12308;PF02191;, GO:0032281;GO:0005737;GO:0005576;GO:0005654;GO:0005634;GO:0045202;GO:0051152;GO:0009306;GO:1905174;, C:AMPA glutamate receptor complex; C:cytoplasm; C:extracellular region; C:nucleoplasm; C:nucleus; C:synapse;, , P:positive regulation of smooth muscle cell differentiation; P:protein secretion; P:regulation of vascular associated smooth muscle cell dedifferentiation; scaffold103 indexed_genome mRNA 4495358 4539145 . - . ID=transcript_13035;P25940 Q9NZQ6,Collagen alpha-3(V) chain,, PF01410;PF01391;, GO:0005588;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005518;GO:0005201;GO:0030020;GO:0008201;GO:0043394;GO:0007160;GO:0030199;GO:0030198;GO:0043588;, C:collagen type V trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:collagen binding; F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:heparin binding; F:proteoglycan binding;, P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:skin development;|P25940 Q9NZQ6,Collagen alpha-3(V) chain,, PF01410;PF01391;, GO:0005588;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005518;GO:0005201;GO:0030020;GO:0008201;GO:0043394;GO:0007160;GO:0030199;GO:0030198;GO:0043588;, C:collagen type V trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:collagen binding; F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:heparin binding; F:proteoglycan binding;, P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:skin development;|P25940 Q9NZQ6,Collagen alpha-3(V) chain,, PF01410;PF01391;, GO:0005588;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005518;GO:0005201;GO:0030020;GO:0008201;GO:0043394;GO:0007160;GO:0030199;GO:0030198;GO:0043588;, C:collagen type V trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:collagen binding; F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:heparin binding; F:proteoglycan binding;, P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:skin development;|P25940 Q9NZQ6,Collagen alpha-3(V) chain,, PF01410;PF01391;, GO:0005588;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005518;GO:0005201;GO:0030020;GO:0008201;GO:0043394;GO:0007160;GO:0030199;GO:0030198;GO:0043588;, C:collagen type V trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:collagen binding; F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:heparin binding; F:proteoglycan binding;, P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:skin development;|P25940 Q9NZQ6,Collagen alpha-3(V) chain,, PF01410;PF01391;, GO:0005588;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005518;GO:0005201;GO:0030020;GO:0008201;GO:0043394;GO:0007160;GO:0030199;GO:0030198;GO:0043588;, C:collagen type V trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:collagen binding; F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:heparin binding; F:proteoglycan binding;, P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:skin development; scaffold103 indexed_genome mRNA 4561808 4591845 . + . ID=transcript_13036;P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|Q6ZMU1,Putative protein C3P1,, PF00207;PF07678;, GO:0005615;GO:0004866;, C:extracellular space;, F:endopeptidase inhibitor activity;|Q6ZMU1,Putative protein C3P1,, PF00207;PF07678;, GO:0005615;GO:0004866;, C:extracellular space;, F:endopeptidase inhibitor activity;|Q6ZMU1,Putative protein C3P1,, PF00207;PF07678;, GO:0005615;GO:0004866;, C:extracellular space;, F:endopeptidase inhibitor activity;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning; scaffold103 indexed_genome mRNA 4602680 4607063 . + . ID=transcript_13037;Q9NUL5 A8MQT9 Q4G188 Q8IYH6 Q8N8V1,Shiftless antiviral inhibitor of ribosomal frameshifting protein {ECO:0000305},Interferon-regulated antiviral protein {ECO:0000303|PubMed:27974568};Repressor of yield of DENV protein {ECO:0000303|PubMed:26735137};, PF15135;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000932;GO:0042802;GO:0043022;GO:0003723;GO:1990825;GO:0051607;GO:2001125;GO:0045071;GO:0006449;GO:0035456;GO:0034341;GO:0034340;GO:0034342;GO:0075523;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:P-body;, F:identical protein binding; F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding;, P:defense response to virus; P:negative regulation of translational frameshifting; P:negative regulation of viral genome replication; P:regulation of translational termination; P:response to interferon-beta; P:response to interferon-gamma; P:response to type I interferon; P:response to type III interferon; P:viral translational frameshifting;|Q9NUL5 A8MQT9 Q4G188 Q8IYH6 Q8N8V1,Shiftless antiviral inhibitor of ribosomal frameshifting protein {ECO:0000305},Interferon-regulated antiviral protein {ECO:0000303|PubMed:27974568};Repressor of yield of DENV protein {ECO:0000303|PubMed:26735137};, PF15135;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000932;GO:0042802;GO:0043022;GO:0003723;GO:1990825;GO:0051607;GO:2001125;GO:0045071;GO:0006449;GO:0035456;GO:0034341;GO:0034340;GO:0034342;GO:0075523;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:P-body;, F:identical protein binding; F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding;, P:defense response to virus; P:negative regulation of translational frameshifting; P:negative regulation of viral genome replication; P:regulation of translational termination; P:response to interferon-beta; P:response to interferon-gamma; P:response to type I interferon; P:response to type III interferon; P:viral translational frameshifting;|Q9NUL5 A8MQT9 Q4G188 Q8IYH6 Q8N8V1,Shiftless antiviral inhibitor of ribosomal frameshifting protein {ECO:0000305},Interferon-regulated antiviral protein {ECO:0000303|PubMed:27974568};Repressor of yield of DENV protein {ECO:0000303|PubMed:26735137};, PF15135;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000932;GO:0042802;GO:0043022;GO:0003723;GO:1990825;GO:0051607;GO:2001125;GO:0045071;GO:0006449;GO:0035456;GO:0034341;GO:0034340;GO:0034342;GO:0075523;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:P-body;, F:identical protein binding; F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding;, P:defense response to virus; P:negative regulation of translational frameshifting; P:negative regulation of viral genome replication; P:regulation of translational termination; P:response to interferon-beta; P:response to interferon-gamma; P:response to type I interferon; P:response to type III interferon; P:viral translational frameshifting;|Q9NUL5 A8MQT9 Q4G188 Q8IYH6 Q8N8V1,Shiftless antiviral inhibitor of ribosomal frameshifting protein {ECO:0000305},Interferon-regulated antiviral protein {ECO:0000303|PubMed:27974568};Repressor of yield of DENV protein {ECO:0000303|PubMed:26735137};, PF15135;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000932;GO:0042802;GO:0043022;GO:0003723;GO:1990825;GO:0051607;GO:2001125;GO:0045071;GO:0006449;GO:0035456;GO:0034341;GO:0034340;GO:0034342;GO:0075523;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:P-body;, F:identical protein binding; F:ribosome binding; F:RNA binding; F:sequence-specific mRNA binding;, P:defense response to virus; P:negative regulation of translational frameshifting; P:negative regulation of viral genome replication; P:regulation of translational termination; P:response to interferon-beta; P:response to interferon-gamma; P:response to type I interferon; P:response to type III interferon; P:viral translational frameshifting; scaffold103 indexed_genome mRNA 4607337 4620735 . - . ID=transcript_13038;Q8NI99 A5PKV7 Q9BZZ0,Angiopoietin-related protein 6,Angiopoietin-like protein 6;Angiopoietin-related growth factor;Angiopoietin-related protein 5;, PF00147;, GO:0062023;GO:0070062;GO:0005615;GO:0030141;GO:0005102;GO:0001525;GO:0030154;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space; C:secretory granule;, F:signaling receptor binding;, P:angiogenesis; P:cell differentiation; scaffold103 indexed_genome mRNA 4621387 4625380 . + . ID=transcript_13039;Q9NQ55 C9J3F9 Q9BW97 Q9H170,Suppressor of SWI4 1 homolog,Brix domain-containing protein 3;Peter Pan homolog;, PF04427;, GO:0005730;GO:0005634;GO:0030687;GO:0003723;GO:0019843;GO:0000027;GO:0006364;, C:nucleolus; C:nucleus; C:preribosome, large subunit precursor;, F:RNA binding; F:rRNA binding;, P:ribosomal large subunit assembly; P:rRNA processing; scaffold103 indexed_genome mRNA 4626925 4627987 . + . ID=transcript_13040;Q96G91 B2R8X9 O43190 Q9BYU4 Q9H170,P2Y purinoceptor 11,, PF00001;, GO:0005887;GO:0005886;GO:0045031;GO:0030594;GO:0038023;GO:0007190;GO:0019722;GO:0071318;GO:0006952;GO:0007186;GO:0002862;GO:0023041;GO:0007200;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled ATP receptor activity; F:neurotransmitter receptor activity; F:signaling receptor activity;, P:activation of adenylate cyclase activity; P:calcium-mediated signaling; P:cellular response to ATP; P:defense response; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:neuronal signal transduction; P:phospholipase C-activating G protein-coupled receptor signaling pathway; scaffold103 indexed_genome mRNA 4643379 4687956 . - . ID=transcript_13041;P26358 A0AV63 B7ZLW6 Q9UHG5 Q9ULA2 Q9UMZ6,DNA (cytosine-5)-methyltransferase 1,CXXC-type zinc finger protein 9;DNA methyltransferase HsaI;MCMT;, PF01426;PF06464;PF00145;PF12047;PF02008;, GO:0005654;GO:0005634;GO:0003886;GO:0003677;GO:0009008;GO:1990841;GO:0008270;GO:0006325;GO:0006306;GO:0010216;GO:0010629;GO:0045814;GO:0051573;GO:0000122;GO:1905460;GO:1905931;GO:0090309;GO:0010628;GO:0051571;GO:1904707;GO:0007265;, C:nucleoplasm; C:nucleus;, F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:DNA-methyltransferase activity; F:promoter-specific chromatin binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:maintenance of DNA methylation; P:negative regulation of gene expression; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K9 methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell apoptotic process; P:negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of gene expression; P:positive regulation of histone H3-K4 methylation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:Ras protein signal transduction;|P26358 A0AV63 B7ZLW6 Q9UHG5 Q9ULA2 Q9UMZ6,DNA (cytosine-5)-methyltransferase 1,CXXC-type zinc finger protein 9;DNA methyltransferase HsaI;MCMT;, PF01426;PF06464;PF00145;PF12047;PF02008;, GO:0005654;GO:0005634;GO:0003886;GO:0003677;GO:0009008;GO:1990841;GO:0008270;GO:0006325;GO:0006306;GO:0010216;GO:0010629;GO:0045814;GO:0051573;GO:0000122;GO:1905460;GO:1905931;GO:0090309;GO:0010628;GO:0051571;GO:1904707;GO:0007265;, C:nucleoplasm; C:nucleus;, F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:DNA-methyltransferase activity; F:promoter-specific chromatin binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:maintenance of DNA methylation; P:negative regulation of gene expression; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K9 methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell apoptotic process; P:negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of gene expression; P:positive regulation of histone H3-K4 methylation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:Ras protein signal transduction;|P26358 A0AV63 B7ZLW6 Q9UHG5 Q9ULA2 Q9UMZ6,DNA (cytosine-5)-methyltransferase 1,CXXC-type zinc finger protein 9;DNA methyltransferase HsaI;MCMT;, PF01426;PF06464;PF00145;PF12047;PF02008;, GO:0005654;GO:0005634;GO:0003886;GO:0003677;GO:0009008;GO:1990841;GO:0008270;GO:0006325;GO:0006306;GO:0010216;GO:0010629;GO:0045814;GO:0051573;GO:0000122;GO:1905460;GO:1905931;GO:0090309;GO:0010628;GO:0051571;GO:1904707;GO:0007265;, C:nucleoplasm; C:nucleus;, F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:DNA-methyltransferase activity; F:promoter-specific chromatin binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:maintenance of DNA methylation; P:negative regulation of gene expression; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K9 methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell apoptotic process; P:negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of gene expression; P:positive regulation of histone H3-K4 methylation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:Ras protein signal transduction;|P26358 A0AV63 B7ZLW6 Q9UHG5 Q9ULA2 Q9UMZ6,DNA (cytosine-5)-methyltransferase 1,CXXC-type zinc finger protein 9;DNA methyltransferase HsaI;MCMT;, PF01426;PF06464;PF00145;PF12047;PF02008;, GO:0005654;GO:0005634;GO:0003886;GO:0003677;GO:0009008;GO:1990841;GO:0008270;GO:0006325;GO:0006306;GO:0010216;GO:0010629;GO:0045814;GO:0051573;GO:0000122;GO:1905460;GO:1905931;GO:0090309;GO:0010628;GO:0051571;GO:1904707;GO:0007265;, C:nucleoplasm; C:nucleus;, F:DNA (cytosine-5-)-methyltransferase activity; F:DNA binding; F:DNA-methyltransferase activity; F:promoter-specific chromatin binding; F:zinc ion binding;, P:chromatin organization; P:DNA methylation; P:maintenance of DNA methylation; P:negative regulation of gene expression; P:negative regulation of gene expression, epigenetic; P:negative regulation of histone H3-K9 methylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell apoptotic process; P:negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of gene expression; P:positive regulation of histone H3-K4 methylation; P:positive regulation of vascular associated smooth muscle cell proliferation; P:Ras protein signal transduction; scaffold103 indexed_genome mRNA 4705534 4713245 . - . ID=transcript_13042;O95136 Q86UN8,Sphingosine 1-phosphate receptor 2,Endothelial differentiation G-protein coupled receptor 5;Sphingosine 1-phosphate receptor Edg-5;, PF00001;, GO:0005737;GO:0016021;GO:0005886;GO:0008528;GO:0004930;GO:0001664;GO:0005178;GO:0008289;GO:0038036;GO:0031532;GO:0000187;GO:0007189;GO:0046847;GO:0007186;GO:0090394;GO:0014912;GO:1904706;GO:0008284;GO:1903142;GO:0010800;GO:0019222;GO:0003376;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:G protein-coupled receptor binding; F:integrin binding; F:lipid binding; F:sphingosine-1-phosphate receptor activity;, P:actin cytoskeleton reorganization; P:activation of MAPK activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of establishment of endothelial barrier; P:positive regulation of peptidyl-threonine phosphorylation; P:regulation of metabolic process; P:sphingosine-1-phosphate receptor signaling pathway; scaffold103 indexed_genome mRNA 4727491 4736538 . + . ID=transcript_13043;Q9BYD3 A6NNV7 Q9BW07 Q9H4N2 Q9Y317,39S ribosomal protein L4, mitochondrial,Mitochondrial large ribosomal subunit protein uL4m {ECO:0000303|PubMed:25278503};, PF00573;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q9BYD3 A6NNV7 Q9BW07 Q9H4N2 Q9Y317,39S ribosomal protein L4, mitochondrial,Mitochondrial large ribosomal subunit protein uL4m {ECO:0000303|PubMed:25278503};, PF00573;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q9BYD3 A6NNV7 Q9BW07 Q9H4N2 Q9Y317,39S ribosomal protein L4, mitochondrial,Mitochondrial large ribosomal subunit protein uL4m {ECO:0000303|PubMed:25278503};, PF00573;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold103 indexed_genome mRNA 4769740 4780529 . + . ID=transcript_13044;P05362 B2R6M3 Q5NKV7 Q96B50,Intercellular adhesion molecule 1,Major group rhinovirus receptor;, PF03921;, GO:0009986;GO:0062023;GO:0009897;GO:0070062;GO:0005615;GO:0005925;GO:0001772;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0005178;GO:0038023;GO:0004888;GO:0001618;GO:0002438;GO:0044406;GO:0007155;GO:0033627;GO:0007569;GO:0071312;GO:1904646;GO:0071549;GO:0071333;GO:0071456;GO:0071347;GO:0071354;GO:1990830;GO:0071222;GO:0031669;GO:0071356;GO:0019221;GO:0061028;GO:0090557;GO:0097368;GO:0030198;GO:0007157;GO:0060333;GO:0007159;GO:0050900;GO:0022614;GO:0051926;GO:2000352;GO:1902042;GO:0001541;GO:0030838;GO:0002693;GO:0070374;GO:0043547;GO:1904996;GO:0051092;GO:0045429;GO:0050731;GO:0045907;GO:0046813;GO:0008360;GO:0050776;GO:0001910;GO:1900027;GO:0043200;GO:0001975;GO:0046688;GO:0042493;GO:0045471;GO:0034698;GO:0032868;GO:0010212;GO:0010477;GO:0007605;GO:0002291;GO:0002457;GO:0072683;, C:cell surface; C:collagen-containing extracellular matrix; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:immunological synapse; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:integrin binding; F:signaling receptor activity; F:transmembrane signaling receptor activity; F:virus receptor activity;, P:acute inflammatory response to antigenic stimulus; P:adhesion of symbiont to host; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell aging; P:cellular response to alkaloid; P:cellular response to amyloid-beta; P:cellular response to dexamethasone stimulus; P:cellular response to glucose stimulus; P:cellular response to hypoxia; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to leukemia inhibitory factor; P:cellular response to lipopolysaccharide; P:cellular response to nutrient levels; P:cellular response to tumor necrosis factor; P:cytokine-mediated signaling pathway; P:establishment of endothelial barrier; P:establishment of endothelial intestinal barrier; P:establishment of Sertoli cell barrier; P:extracellular matrix organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:interferon-gamma-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:membrane to membrane docking; P:negative regulation of calcium ion transport; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:ovarian follicle development; P:positive regulation of actin filament polymerization; P:positive regulation of cellular extravasation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of vasoconstriction; P:receptor-mediated virion attachment to host cell; P:regulation of cell shape; P:regulation of immune response; P:regulation of leukocyte mediated cytotoxicity; P:regulation of ruffle assembly; P:response to amino acid; P:response to amphetamine; P:response to copper ion; P:response to drug; P:response to ethanol; P:response to gonadotropin; P:response to insulin; P:response to ionizing radiation; P:response to sulfur dioxide; P:sensory perception of sound; P:T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:T cell antigen processing and presentation; P:T cell extravasation; scaffold103 indexed_genome mRNA 4786424 4788006 . + . ID=transcript_13045;Q9UMF0 Q9Y6F3,Intercellular adhesion molecule 5,Telencephalin;, PF03921;PF13895;, GO:0005887;GO:0005886;GO:0005178;GO:0007155;GO:0098609;GO:0030198;GO:0006909;GO:0050776;, C:integral component of plasma membrane; C:plasma membrane;, F:integrin binding;, P:cell adhesion; P:cell-cell adhesion; P:extracellular matrix organization; P:phagocytosis; P:regulation of immune response; scaffold103 indexed_genome mRNA 4788024 4790155 . + . ID=transcript_13046;Q9UMF0 Q9Y6F3,Intercellular adhesion molecule 5,Telencephalin;, PF03921;PF13895;, GO:0005887;GO:0005886;GO:0005178;GO:0007155;GO:0098609;GO:0030198;GO:0006909;GO:0050776;, C:integral component of plasma membrane; C:plasma membrane;, F:integrin binding;, P:cell adhesion; P:cell-cell adhesion; P:extracellular matrix organization; P:phagocytosis; P:regulation of immune response;|Q9UMF0 Q9Y6F3,Intercellular adhesion molecule 5,Telencephalin;, PF03921;PF13895;, GO:0005887;GO:0005886;GO:0005178;GO:0007155;GO:0098609;GO:0030198;GO:0006909;GO:0050776;, C:integral component of plasma membrane; C:plasma membrane;, F:integrin binding;, P:cell adhesion; P:cell-cell adhesion; P:extracellular matrix organization; P:phagocytosis; P:regulation of immune response; scaffold103 indexed_genome mRNA 4797751 4817256 . - . ID=transcript_13047;Q6P4F2 B7Z6L7 Q8N8B8,Ferredoxin-2, mitochondrial {ECO:0000303|PubMed:20547883},Adrenodoxin-like protein;Ferredoxin-1-like protein;, PF00111;, GO:0005759;GO:0051537;GO:0009055;GO:0046872;GO:0006700;GO:0006124;GO:0016125;, C:mitochondrial matrix;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:metal ion binding;, P:C21-steroid hormone biosynthetic process; P:ferredoxin metabolic process; P:sterol metabolic process;|Q6P4F2 B7Z6L7 Q8N8B8,Ferredoxin-2, mitochondrial {ECO:0000303|PubMed:20547883},Adrenodoxin-like protein;Ferredoxin-1-like protein;, PF00111;, GO:0005759;GO:0051537;GO:0009055;GO:0046872;GO:0006700;GO:0006124;GO:0016125;, C:mitochondrial matrix;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:metal ion binding;, P:C21-steroid hormone biosynthetic process; P:ferredoxin metabolic process; P:sterol metabolic process;|Q6P4F2 B7Z6L7 Q8N8B8,Ferredoxin-2, mitochondrial {ECO:0000303|PubMed:20547883},Adrenodoxin-like protein;Ferredoxin-1-like protein;, PF00111;, GO:0005759;GO:0051537;GO:0009055;GO:0046872;GO:0006700;GO:0006124;GO:0016125;, C:mitochondrial matrix;, F:2 iron, 2 sulfur cluster binding; F:electron transfer activity; F:metal ion binding;, P:C21-steroid hormone biosynthetic process; P:ferredoxin metabolic process; P:sterol metabolic process;|Q8IY67 A6NMU4 Q8IY60 Q8TF24,Ribonucleoprotein PTB-binding 1,Protein raver-1;, PF00076;, GO:0005737;GO:0005634;GO:0003676;GO:0003723;GO:0000398;, C:cytoplasm; C:nucleus;, F:nucleic acid binding; F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IY67 A6NMU4 Q8IY60 Q8TF24,Ribonucleoprotein PTB-binding 1,Protein raver-1;, PF00076;, GO:0005737;GO:0005634;GO:0003676;GO:0003723;GO:0000398;, C:cytoplasm; C:nucleus;, F:nucleic acid binding; F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IY67 A6NMU4 Q8IY60 Q8TF24,Ribonucleoprotein PTB-binding 1,Protein raver-1;, PF00076;, GO:0005737;GO:0005634;GO:0003676;GO:0003723;GO:0000398;, C:cytoplasm; C:nucleus;, F:nucleic acid binding; F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IY67 A6NMU4 Q8IY60 Q8TF24,Ribonucleoprotein PTB-binding 1,Protein raver-1;, PF00076;, GO:0005737;GO:0005634;GO:0003676;GO:0003723;GO:0000398;, C:cytoplasm; C:nucleus;, F:nucleic acid binding; F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IY67 A6NMU4 Q8IY60 Q8TF24,Ribonucleoprotein PTB-binding 1,Protein raver-1;, PF00076;, GO:0005737;GO:0005634;GO:0003676;GO:0003723;GO:0000398;, C:cytoplasm; C:nucleus;, F:nucleic acid binding; F:RNA binding;, P:mRNA splicing, via spliceosome;|Q8IY67 A6NMU4 Q8IY60 Q8TF24,Ribonucleoprotein PTB-binding 1,Protein raver-1;, PF00076;, GO:0005737;GO:0005634;GO:0003676;GO:0003723;GO:0000398;, C:cytoplasm; C:nucleus;, F:nucleic acid binding; F:RNA binding;, P:mRNA splicing, via spliceosome; scaffold103 indexed_genome mRNA 4817300 4819169 . - . ID=transcript_13048;P32942 Q6PD68,Intercellular adhesion molecule 3,CDw50;ICAM-R;, PF03921;, GO:0070062;GO:0005887;GO:0005886;GO:0005178;GO:0005102;GO:0007155;GO:0098609;GO:0030198;GO:0006909;GO:0050776;GO:0002223;, C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:integrin binding; F:signaling receptor binding;, P:cell adhesion; P:cell-cell adhesion; P:extracellular matrix organization; P:phagocytosis; P:regulation of immune response; P:stimulatory C-type lectin receptor signaling pathway;|P32942 Q6PD68,Intercellular adhesion molecule 3,CDw50;ICAM-R;, PF03921;, GO:0070062;GO:0005887;GO:0005886;GO:0005178;GO:0005102;GO:0007155;GO:0098609;GO:0030198;GO:0006909;GO:0050776;GO:0002223;, C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:integrin binding; F:signaling receptor binding;, P:cell adhesion; P:cell-cell adhesion; P:extracellular matrix organization; P:phagocytosis; P:regulation of immune response; P:stimulatory C-type lectin receptor signaling pathway; scaffold103 indexed_genome mRNA 4819192 4819785 . - . ID=transcript_13049;P32942 Q6PD68,Intercellular adhesion molecule 3,CDw50;ICAM-R;, PF03921;, GO:0070062;GO:0005887;GO:0005886;GO:0005178;GO:0005102;GO:0007155;GO:0098609;GO:0030198;GO:0006909;GO:0050776;GO:0002223;, C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:integrin binding; F:signaling receptor binding;, P:cell adhesion; P:cell-cell adhesion; P:extracellular matrix organization; P:phagocytosis; P:regulation of immune response; P:stimulatory C-type lectin receptor signaling pathway; scaffold103 indexed_genome mRNA 4819834 4823615 . - . ID=transcript_13050;P32942 Q6PD68,Intercellular adhesion molecule 3,CDw50;ICAM-R;, PF03921;, GO:0070062;GO:0005887;GO:0005886;GO:0005178;GO:0005102;GO:0007155;GO:0098609;GO:0030198;GO:0006909;GO:0050776;GO:0002223;, C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:integrin binding; F:signaling receptor binding;, P:cell adhesion; P:cell-cell adhesion; P:extracellular matrix organization; P:phagocytosis; P:regulation of immune response; P:stimulatory C-type lectin receptor signaling pathway; scaffold103 indexed_genome mRNA 4831733 4839857 . - . ID=transcript_13051;P29597 Q6QB10 Q96CH0,Non-receptor tyrosine-protein kinase TYK2,, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0005524;GO:0005131;GO:0004715;GO:0004713;GO:0004714;GO:0031702;GO:0019221;GO:0035722;GO:0038155;GO:0070106;GO:0035556;GO:0006468;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:ATP binding; F:growth hormone receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:type 1 angiotensin receptor binding;, P:cytokine-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:intracellular signal transduction; P:protein phosphorylation; P:type I interferon signaling pathway;|P29597 Q6QB10 Q96CH0,Non-receptor tyrosine-protein kinase TYK2,, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0005524;GO:0005131;GO:0004715;GO:0004713;GO:0004714;GO:0031702;GO:0019221;GO:0035722;GO:0038155;GO:0070106;GO:0035556;GO:0006468;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:ATP binding; F:growth hormone receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:type 1 angiotensin receptor binding;, P:cytokine-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:intracellular signal transduction; P:protein phosphorylation; P:type I interferon signaling pathway;|P29597 Q6QB10 Q96CH0,Non-receptor tyrosine-protein kinase TYK2,, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0005524;GO:0005131;GO:0004715;GO:0004713;GO:0004714;GO:0031702;GO:0019221;GO:0035722;GO:0038155;GO:0070106;GO:0035556;GO:0006468;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:ATP binding; F:growth hormone receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:type 1 angiotensin receptor binding;, P:cytokine-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:intracellular signal transduction; P:protein phosphorylation; P:type I interferon signaling pathway; scaffold103 indexed_genome mRNA 4840248 4861339 . - . ID=transcript_13052;P29597 Q6QB10 Q96CH0,Non-receptor tyrosine-protein kinase TYK2,, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0005524;GO:0005131;GO:0004715;GO:0004713;GO:0004714;GO:0031702;GO:0019221;GO:0035722;GO:0038155;GO:0070106;GO:0035556;GO:0006468;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:ATP binding; F:growth hormone receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:type 1 angiotensin receptor binding;, P:cytokine-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:intracellular signal transduction; P:protein phosphorylation; P:type I interferon signaling pathway;|P29597 Q6QB10 Q96CH0,Non-receptor tyrosine-protein kinase TYK2,, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0005524;GO:0005131;GO:0004715;GO:0004713;GO:0004714;GO:0031702;GO:0019221;GO:0035722;GO:0038155;GO:0070106;GO:0035556;GO:0006468;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:ATP binding; F:growth hormone receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:type 1 angiotensin receptor binding;, P:cytokine-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:intracellular signal transduction; P:protein phosphorylation; P:type I interferon signaling pathway;|P29597 Q6QB10 Q96CH0,Non-receptor tyrosine-protein kinase TYK2,, PF18379;PF18377;PF17887;PF07714;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0005524;GO:0005131;GO:0004715;GO:0004713;GO:0004714;GO:0031702;GO:0019221;GO:0035722;GO:0038155;GO:0070106;GO:0035556;GO:0006468;GO:0060337;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:ATP binding; F:growth hormone receptor binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:type 1 angiotensin receptor binding;, P:cytokine-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:interleukin-27-mediated signaling pathway; P:intracellular signal transduction; P:protein phosphorylation; P:type I interferon signaling pathway; scaffold103 indexed_genome mRNA 4877997 4890826 . - . ID=transcript_13053;Q16543 Q53YA2,Hsp90 co-chaperone Cdc37,Hsp90 chaperone protein kinase-targeting subunit;p50Cdc37;, PF08564;PF08565;PF03234;, GO:0101031;GO:0005737;GO:0005829;GO:0070062;GO:1990565;GO:0051087;GO:0031072;GO:0051879;GO:0019900;GO:0019901;GO:0019887;GO:0097110;GO:0051082;GO:0038128;GO:0098779;GO:0010608;GO:0006457;GO:0050821;GO:0006605;GO:0000079;GO:0060334;GO:0060544;GO:0060338;, C:chaperone complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:HSP90-CDC37 chaperone complex;, F:chaperone binding; F:heat shock protein binding; F:Hsp90 protein binding; F:kinase binding; F:protein kinase binding; F:protein kinase regulator activity; F:scaffold protein binding; F:unfolded protein binding;, P:ERBB2 signaling pathway; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:posttranscriptional regulation of gene expression; P:protein folding; P:protein stabilization; P:protein targeting; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of interferon-gamma-mediated signaling pathway; P:regulation of necroptotic process; P:regulation of type I interferon-mediated signaling pathway; scaffold103 indexed_genome mRNA 4919720 4933537 . + . ID=transcript_13054;Q9H3H2,cAMP-specific 3',5'-cyclic phosphodiesterase 4A,DPDE2;PDE46;, PF18100;PF00233;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0004115;GO:0004114;GO:0030552;GO:0046872;GO:0006198;GO:0035690;GO:0007186;GO:0043949;GO:0010738;GO:0007608;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to drug; P:G protein-coupled receptor signaling pathway; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:sensory perception of smell; P:signal transduction; scaffold103 indexed_genome mRNA 4934016 4935658 . - . ID=transcript_13055;Q9H3H2,cAMP-specific 3',5'-cyclic phosphodiesterase 4A,DPDE2;PDE46;, PF18100;PF00233;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0004115;GO:0004114;GO:0030552;GO:0046872;GO:0006198;GO:0035690;GO:0007186;GO:0043949;GO:0010738;GO:0007608;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to drug; P:G protein-coupled receptor signaling pathway; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:sensory perception of smell; P:signal transduction; scaffold103 indexed_genome mRNA 4937787 4950324 . + . ID=transcript_13056;Q9H3H2,cAMP-specific 3',5'-cyclic phosphodiesterase 4A,DPDE2;PDE46;, PF18100;PF00233;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0004115;GO:0004114;GO:0030552;GO:0046872;GO:0006198;GO:0035690;GO:0007186;GO:0043949;GO:0010738;GO:0007608;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to drug; P:G protein-coupled receptor signaling pathway; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:sensory perception of smell; P:signal transduction;|Q9H3H2,cAMP-specific 3',5'-cyclic phosphodiesterase 4A,DPDE2;PDE46;, PF18100;PF00233;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0004115;GO:0004114;GO:0030552;GO:0046872;GO:0006198;GO:0035690;GO:0007186;GO:0043949;GO:0010738;GO:0007608;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to drug; P:G protein-coupled receptor signaling pathway; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:sensory perception of smell; P:signal transduction;|Q9H3H2,cAMP-specific 3',5'-cyclic phosphodiesterase 4A,DPDE2;PDE46;, PF18100;PF00233;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0004115;GO:0004114;GO:0030552;GO:0046872;GO:0006198;GO:0035690;GO:0007186;GO:0043949;GO:0010738;GO:0007608;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to drug; P:G protein-coupled receptor signaling pathway; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:sensory perception of smell; P:signal transduction;|Q9H3H2,cAMP-specific 3',5'-cyclic phosphodiesterase 4A,DPDE2;PDE46;, PF18100;PF00233;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0004115;GO:0004114;GO:0030552;GO:0046872;GO:0006198;GO:0035690;GO:0007186;GO:0043949;GO:0010738;GO:0007608;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to drug; P:G protein-coupled receptor signaling pathway; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:sensory perception of smell; P:signal transduction;|Q9H3H2,cAMP-specific 3',5'-cyclic phosphodiesterase 4A,DPDE2;PDE46;, PF18100;PF00233;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0004115;GO:0004114;GO:0030552;GO:0046872;GO:0006198;GO:0035690;GO:0007186;GO:0043949;GO:0010738;GO:0007608;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to drug; P:G protein-coupled receptor signaling pathway; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:sensory perception of smell; P:signal transduction;|Q9H3H2,cAMP-specific 3',5'-cyclic phosphodiesterase 4A,DPDE2;PDE46;, PF18100;PF00233;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032587;GO:0004115;GO:0004114;GO:0030552;GO:0046872;GO:0006198;GO:0035690;GO:0007186;GO:0043949;GO:0010738;GO:0007608;GO:0007165;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ruffle membrane;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:cAMP binding; F:metal ion binding;, P:cAMP catabolic process; P:cellular response to drug; P:G protein-coupled receptor signaling pathway; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:sensory perception of smell; P:signal transduction; scaffold103 indexed_genome mRNA 4965523 4981618 . - . ID=transcript_13057;Q14145 B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9,Kelch-like ECH-associated protein 1 {ECO:0000303|PubMed:14585973},Cytosolic inhibitor of Nrf2 {ECO:0000303|Ref.1};Kelch-like protein 19 {ECO:0000312|HGNC:HGNC:23177};, PF07707;PF00651;PF01344;, GO:0005884;GO:0034451;GO:0031463;GO:0005737;GO:0005829;GO:0005783;GO:0016234;GO:0030496;GO:0005654;GO:0097718;GO:0042802;GO:0008134;GO:0071353;GO:0034599;GO:0042994;GO:0001701;GO:0043433;GO:0032436;GO:0043687;GO:0016579;GO:0016567;GO:0010506;GO:0045604;GO:0006511;GO:0016032;, C:actin filament; C:centriolar satellite; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:inclusion body; C:midbody; C:nucleoplasm;, F:disordered domain specific binding; F:identical protein binding; F:transcription factor binding;, P:cellular response to interleukin-4; P:cellular response to oxidative stress; P:cytoplasmic sequestering of transcription factor; P:in utero embryonic development; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein deubiquitination; P:protein ubiquitination; P:regulation of autophagy; P:regulation of epidermal cell differentiation; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold103 indexed_genome mRNA 4983099 4988310 . - . ID=transcript_13058;Q9H228 Q6NW11,Sphingosine 1-phosphate receptor 5,Endothelial differentiation G-protein-coupled receptor 8;Sphingosine 1-phosphate receptor Edg-8;, PF00001;, GO:0005737;GO:0016021;GO:0005886;GO:0004930;GO:0038036;GO:0007189;GO:0007186;GO:0019222;GO:0045664;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:sphingosine-1-phosphate receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:regulation of metabolic process; P:regulation of neuron differentiation; scaffold103 indexed_genome mRNA 5012155 5032345 . + . ID=transcript_13059;Q86TL0 Q969K0,Cysteine protease ATG4D,AUT-like 4 cysteine endopeptidase;Autophagin-4;Autophagy-related cysteine endopeptidase 4;Autophagy-related protein 4 homolog D;, PF03416;, GO:0005759;GO:0005739;GO:0005654;GO:0008234;GO:0006915;GO:0006914;GO:0015031;GO:0006508;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:cysteine-type peptidase activity;, P:apoptotic process; P:autophagy; P:protein transport; P:proteolysis;|Q86TL0 Q969K0,Cysteine protease ATG4D,AUT-like 4 cysteine endopeptidase;Autophagin-4;Autophagy-related cysteine endopeptidase 4;Autophagy-related protein 4 homolog D;, PF03416;, GO:0005759;GO:0005739;GO:0005654;GO:0008234;GO:0006915;GO:0006914;GO:0015031;GO:0006508;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:cysteine-type peptidase activity;, P:apoptotic process; P:autophagy; P:protein transport; P:proteolysis;|Q8N9T8 Q2M1R5 Q2M1R7 Q7L5J7 Q96G92 Q9BU50 Q9H6I1 Q9H978,Protein KRI1 homolog,, PF05178;PF12936;, GO:0030686;GO:0005730;GO:0003723;GO:0000447;, C:90S preribosome; C:nucleolus;, F:RNA binding;, P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q86TL0 Q969K0,Cysteine protease ATG4D,AUT-like 4 cysteine endopeptidase;Autophagin-4;Autophagy-related cysteine endopeptidase 4;Autophagy-related protein 4 homolog D;, PF03416;, GO:0005759;GO:0005739;GO:0005654;GO:0008234;GO:0006915;GO:0006914;GO:0015031;GO:0006508;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:cysteine-type peptidase activity;, P:apoptotic process; P:autophagy; P:protein transport; P:proteolysis;|Q8N9T8 Q2M1R5 Q2M1R7 Q7L5J7 Q96G92 Q9BU50 Q9H6I1 Q9H978,Protein KRI1 homolog,, PF05178;PF12936;, GO:0030686;GO:0005730;GO:0003723;GO:0000447;, C:90S preribosome; C:nucleolus;, F:RNA binding;, P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|Q8N9T8 Q2M1R5 Q2M1R7 Q7L5J7 Q96G92 Q9BU50 Q9H6I1 Q9H978,Protein KRI1 homolog,, PF05178;PF12936;, GO:0030686;GO:0005730;GO:0003723;GO:0000447;, C:90S preribosome; C:nucleolus;, F:RNA binding;, P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); scaffold103 indexed_genome mRNA 5033110 5035029 . + . ID=transcript_13060;P55273 Q13102 Q6FGE9,Cyclin-dependent kinase 4 inhibitor D,p19-INK4d;, PF12796;, GO:0097129;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0004861;GO:0019901;GO:0048102;GO:0007050;GO:0000731;GO:0000082;GO:0030308;GO:0008285;GO:0043154;GO:2000134;GO:1902230;GO:0042326;GO:0000079;GO:0032526;GO:0009411;GO:0033280;GO:0007605;, C:cyclin D2-CDK4 complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:protein kinase binding;, P:autophagic cell death; P:cell cycle arrest; P:DNA synthesis involved in DNA repair; P:G1/S transition of mitotic cell cycle; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of phosphorylation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:response to retinoic acid; P:response to UV; P:response to vitamin D; P:sensory perception of sound;|P55273 Q13102 Q6FGE9,Cyclin-dependent kinase 4 inhibitor D,p19-INK4d;, PF12796;, GO:0097129;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0004861;GO:0019901;GO:0048102;GO:0007050;GO:0000731;GO:0000082;GO:0030308;GO:0008285;GO:0043154;GO:2000134;GO:1902230;GO:0042326;GO:0000079;GO:0032526;GO:0009411;GO:0033280;GO:0007605;, C:cyclin D2-CDK4 complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:protein kinase binding;, P:autophagic cell death; P:cell cycle arrest; P:DNA synthesis involved in DNA repair; P:G1/S transition of mitotic cell cycle; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of phosphorylation; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:response to retinoic acid; P:response to UV; P:response to vitamin D; P:sensory perception of sound; scaffold103 indexed_genome mRNA 5036675 5054525 . - . ID=transcript_13061;Q9Y6Q5 B2RDV5 Q9BSI8,AP-1 complex subunit mu-2,AP-mu chain family member mu1B;Adaptor protein complex AP-1 subunit mu-2;Adaptor-related protein complex 1 subunit mu-2;Clathrin assembly protein complex 1 mu-2 medium chain 2;Golgi adaptor HA1/AP1 adaptin mu-2 subunit;Mu-adaptin 2;Mu1B-adaptin;, PF00928;PF01217;, GO:0030131;GO:0030136;GO:0030665;GO:0031410;GO:0030659;GO:0005829;GO:0000139;GO:0043231;GO:0005765;GO:0032588;GO:0035615;GO:0019886;GO:0006892;GO:0006605;GO:0050690;GO:0006903;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:trans-Golgi network membrane;, F:clathrin adaptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:post-Golgi vesicle-mediated transport; P:protein targeting; P:regulation of defense response to virus by virus; P:vesicle targeting; P:vesicle-mediated transport; scaffold103 indexed_genome mRNA 5077216 5092040 . + . ID=transcript_13062;Q9NY68,Choline transporter-like protein 2,Solute carrier family 44 member 2;, PF04515;, GO:0070062;GO:0016021;GO:0005765;GO:0016020;GO:0005739;GO:0005886;GO:0035579;GO:0015220;GO:0022857;GO:0015871;GO:0043312;GO:0006656;GO:0043123;GO:0055085;, C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:specific granule membrane;, F:choline transmembrane transporter activity; F:transmembrane transporter activity;, P:choline transport; P:neutrophil degranulation; P:phosphatidylcholine biosynthetic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:transmembrane transport;|Q9NY68,Choline transporter-like protein 2,Solute carrier family 44 member 2;, PF04515;, GO:0070062;GO:0016021;GO:0005765;GO:0016020;GO:0005739;GO:0005886;GO:0035579;GO:0015220;GO:0022857;GO:0015871;GO:0043312;GO:0006656;GO:0043123;GO:0055085;, C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:specific granule membrane;, F:choline transmembrane transporter activity; F:transmembrane transporter activity;, P:choline transport; P:neutrophil degranulation; P:phosphatidylcholine biosynthetic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:transmembrane transport;|Q9NY68,Choline transporter-like protein 2,Solute carrier family 44 member 2;, PF04515;, GO:0070062;GO:0016021;GO:0005765;GO:0016020;GO:0005739;GO:0005886;GO:0035579;GO:0015220;GO:0022857;GO:0015871;GO:0043312;GO:0006656;GO:0043123;GO:0055085;, C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:specific granule membrane;, F:choline transmembrane transporter activity; F:transmembrane transporter activity;, P:choline transport; P:neutrophil degranulation; P:phosphatidylcholine biosynthetic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:transmembrane transport;|Q9NY68,Choline transporter-like protein 2,Solute carrier family 44 member 2;, PF04515;, GO:0070062;GO:0016021;GO:0005765;GO:0016020;GO:0005739;GO:0005886;GO:0035579;GO:0015220;GO:0022857;GO:0015871;GO:0043312;GO:0006656;GO:0043123;GO:0055085;, C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:specific granule membrane;, F:choline transmembrane transporter activity; F:transmembrane transporter activity;, P:choline transport; P:neutrophil degranulation; P:phosphatidylcholine biosynthetic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:transmembrane transport; scaffold103 indexed_genome mRNA 5118648 5130504 . + . ID=transcript_13063;Q9NRN2 Q9NRN3 Q9NRN4 Q9UMZ9 Q9UN00 Q9UN84 Q9UNA2,Interleukin enhancer-binding factor 3,Double-stranded RNA-binding protein 76;M-phase phosphoprotein 4;Nuclear factor associated with dsRNA;Nuclear factor of activated T-cells 90 kDa;Translational control protein 80;, PF00035;PF07528;, GO:0005737;GO:0005576;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003725;GO:0035925;GO:0003723;GO:0003727;GO:0051607;GO:0045892;GO:0017148;GO:0045071;GO:0045893;GO:0006468;, C:cytoplasm; C:extracellular region; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:double-stranded RNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:single-stranded RNA binding;, P:defense response to virus; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of viral genome replication; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation;|Q9NRN2 Q9NRN3 Q9NRN4 Q9UMZ9 Q9UN00 Q9UN84 Q9UNA2,Interleukin enhancer-binding factor 3,Double-stranded RNA-binding protein 76;M-phase phosphoprotein 4;Nuclear factor associated with dsRNA;Nuclear factor of activated T-cells 90 kDa;Translational control protein 80;, PF00035;PF07528;, GO:0005737;GO:0005576;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003725;GO:0035925;GO:0003723;GO:0003727;GO:0051607;GO:0045892;GO:0017148;GO:0045071;GO:0045893;GO:0006468;, C:cytoplasm; C:extracellular region; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:double-stranded RNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:single-stranded RNA binding;, P:defense response to virus; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of viral genome replication; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation;|Q9NRN2 Q9NRN3 Q9NRN4 Q9UMZ9 Q9UN00 Q9UN84 Q9UNA2,Interleukin enhancer-binding factor 3,Double-stranded RNA-binding protein 76;M-phase phosphoprotein 4;Nuclear factor associated with dsRNA;Nuclear factor of activated T-cells 90 kDa;Translational control protein 80;, PF00035;PF07528;, GO:0005737;GO:0005576;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003725;GO:0035925;GO:0003723;GO:0003727;GO:0051607;GO:0045892;GO:0017148;GO:0045071;GO:0045893;GO:0006468;, C:cytoplasm; C:extracellular region; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:double-stranded RNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:single-stranded RNA binding;, P:defense response to virus; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of viral genome replication; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation;|Q9NRN2 Q9NRN3 Q9NRN4 Q9UMZ9 Q9UN00 Q9UN84 Q9UNA2,Interleukin enhancer-binding factor 3,Double-stranded RNA-binding protein 76;M-phase phosphoprotein 4;Nuclear factor associated with dsRNA;Nuclear factor of activated T-cells 90 kDa;Translational control protein 80;, PF00035;PF07528;, GO:0005737;GO:0005576;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003725;GO:0035925;GO:0003723;GO:0003727;GO:0051607;GO:0045892;GO:0017148;GO:0045071;GO:0045893;GO:0006468;, C:cytoplasm; C:extracellular region; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:double-stranded RNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:single-stranded RNA binding;, P:defense response to virus; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of viral genome replication; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation;|Q9NRN2 Q9NRN3 Q9NRN4 Q9UMZ9 Q9UN00 Q9UN84 Q9UNA2,Interleukin enhancer-binding factor 3,Double-stranded RNA-binding protein 76;M-phase phosphoprotein 4;Nuclear factor associated with dsRNA;Nuclear factor of activated T-cells 90 kDa;Translational control protein 80;, PF00035;PF07528;, GO:0005737;GO:0005576;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003725;GO:0035925;GO:0003723;GO:0003727;GO:0051607;GO:0045892;GO:0017148;GO:0045071;GO:0045893;GO:0006468;, C:cytoplasm; C:extracellular region; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:double-stranded RNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:single-stranded RNA binding;, P:defense response to virus; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of viral genome replication; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation;|Q9NRN2 Q9NRN3 Q9NRN4 Q9UMZ9 Q9UN00 Q9UN84 Q9UNA2,Interleukin enhancer-binding factor 3,Double-stranded RNA-binding protein 76;M-phase phosphoprotein 4;Nuclear factor associated with dsRNA;Nuclear factor of activated T-cells 90 kDa;Translational control protein 80;, PF00035;PF07528;, GO:0005737;GO:0005576;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0003677;GO:0003725;GO:0035925;GO:0003723;GO:0003727;GO:0051607;GO:0045892;GO:0017148;GO:0045071;GO:0045893;GO:0006468;, C:cytoplasm; C:extracellular region; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:double-stranded RNA binding; F:mRNA 3'-UTR AU-rich region binding; F:RNA binding; F:single-stranded RNA binding;, P:defense response to virus; P:negative regulation of transcription, DNA-templated; P:negative regulation of translation; P:negative regulation of viral genome replication; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; scaffold103 indexed_genome mRNA 5147537 5158296 . + . ID=transcript_13064;Q9BXR0 B4DFM7 Q96BQ4 Q9BXQ9,Queuine tRNA-ribosyltransferase catalytic subunit 1 {ECO:0000255|HAMAP-Rule:MF_03218},Guanine insertion enzyme {ECO:0000255|HAMAP-Rule:MF_03218};tRNA-guanine transglycosylase {ECO:0000255|HAMAP-Rule:MF_03218};, PF01702;, GO:0005741;GO:0005634;GO:0032991;GO:0046872;GO:0046982;GO:0042803;GO:0008479;GO:0006400;GO:0101030;, C:mitochondrial outer membrane; C:nucleus; C:protein-containing complex;, F:metal ion binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:queuine tRNA-ribosyltransferase activity;, P:tRNA modification; P:tRNA-guanine transglycosylation; scaffold103 indexed_genome mRNA 5223948 5249013 . + . ID=transcript_13065;P50570 A8K1B6 E7EV30 E9PEQ4 K7ESI9 Q5I0Y0 Q7Z5S3 Q9UPH4,Dynamin-2,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005813;GO:0045334;GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0044327;GO:0030666;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0005794;GO:0000139;GO:0030426;GO:0030027;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0031966;GO:0005634;GO:0048471;GO:0001891;GO:0030670;GO:0005886;GO:0014069;GO:0099092;GO:0098844;GO:0045211;GO:0098793;GO:0032991;GO:0032587;GO:0005802;GO:0031749;GO:0019899;GO:0005525;GO:0003924;GO:0008017;GO:0050998;GO:0036312;GO:0019901;GO:0044877;GO:0017124;GO:0050699;GO:0019886;GO:0071245;GO:1903351;GO:0071732;GO:0071481;GO:0003374;GO:0006897;GO:0002031;GO:0000086;GO:0006893;GO:0044351;GO:0061025;GO:0061024;GO:0000266;GO:1903526;GO:1902856;GO:0030512;GO:0048812;GO:0006909;GO:0043065;GO:2000370;GO:0010592;GO:0045429;GO:0050766;GO:1903408;GO:1900026;GO:0045893;GO:0006892;GO:0098884;GO:0031623;GO:0006898;GO:0030516;GO:1903358;GO:0050999;GO:0035020;GO:0050803;GO:0006355;GO:0042220;GO:0009416;GO:0007165;GO:0007283;GO:0016185;GO:0048489;GO:0033572;, C:axon; C:centrosome; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine head; C:endocytic vesicle membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:lamellipodium; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:phagocytic cup; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynaptic density; C:postsynaptic density, intracellular component; C:postsynaptic endocytic zone membrane; C:postsynaptic membrane; C:presynapse; C:protein-containing complex; C:ruffle membrane; C:trans-Golgi network;, F:D2 dopamine receptor binding; F:enzyme binding; F:GTP binding; F:GTPase activity; F:microtubule binding; F:nitric-oxide synthase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein kinase binding; F:protein-containing complex binding; F:SH3 domain binding; F:WW domain binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular response to carbon monoxide; P:cellular response to dopamine; P:cellular response to nitric oxide; P:cellular response to X-ray; P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:G protein-coupled receptor internalization; P:G2/M transition of mitotic cell cycle; P:Golgi to plasma membrane transport; P:macropinocytosis; P:membrane fusion; P:membrane organization; P:mitochondrial fission; P:negative regulation of membrane tubulation; P:negative regulation of non-motile cilium assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron projection morphogenesis; P:phagocytosis; P:positive regulation of apoptotic process; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of lamellipodium assembly; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of phagocytosis; P:positive regulation of sodium:potassium-exchanging ATPase activity; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:post-Golgi vesicle-mediated transport; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of axon extension; P:regulation of Golgi organization; P:regulation of nitric-oxide synthase activity; P:regulation of Rac protein signal transduction; P:regulation of synapse structure or activity; P:regulation of transcription, DNA-templated; P:response to cocaine; P:response to light stimulus; P:signal transduction; P:spermatogenesis; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:synaptic vesicle transport; P:transferrin transport;|P50570 A8K1B6 E7EV30 E9PEQ4 K7ESI9 Q5I0Y0 Q7Z5S3 Q9UPH4,Dynamin-2,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005813;GO:0045334;GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0044327;GO:0030666;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0005794;GO:0000139;GO:0030426;GO:0030027;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0031966;GO:0005634;GO:0048471;GO:0001891;GO:0030670;GO:0005886;GO:0014069;GO:0099092;GO:0098844;GO:0045211;GO:0098793;GO:0032991;GO:0032587;GO:0005802;GO:0031749;GO:0019899;GO:0005525;GO:0003924;GO:0008017;GO:0050998;GO:0036312;GO:0019901;GO:0044877;GO:0017124;GO:0050699;GO:0019886;GO:0071245;GO:1903351;GO:0071732;GO:0071481;GO:0003374;GO:0006897;GO:0002031;GO:0000086;GO:0006893;GO:0044351;GO:0061025;GO:0061024;GO:0000266;GO:1903526;GO:1902856;GO:0030512;GO:0048812;GO:0006909;GO:0043065;GO:2000370;GO:0010592;GO:0045429;GO:0050766;GO:1903408;GO:1900026;GO:0045893;GO:0006892;GO:0098884;GO:0031623;GO:0006898;GO:0030516;GO:1903358;GO:0050999;GO:0035020;GO:0050803;GO:0006355;GO:0042220;GO:0009416;GO:0007165;GO:0007283;GO:0016185;GO:0048489;GO:0033572;, C:axon; C:centrosome; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine head; C:endocytic vesicle membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:lamellipodium; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:phagocytic cup; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynaptic density; C:postsynaptic density, intracellular component; C:postsynaptic endocytic zone membrane; C:postsynaptic membrane; C:presynapse; C:protein-containing complex; C:ruffle membrane; C:trans-Golgi network;, F:D2 dopamine receptor binding; F:enzyme binding; F:GTP binding; F:GTPase activity; F:microtubule binding; F:nitric-oxide synthase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein kinase binding; F:protein-containing complex binding; F:SH3 domain binding; F:WW domain binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular response to carbon monoxide; P:cellular response to dopamine; P:cellular response to nitric oxide; P:cellular response to X-ray; P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:G protein-coupled receptor internalization; P:G2/M transition of mitotic cell cycle; P:Golgi to plasma membrane transport; P:macropinocytosis; P:membrane fusion; P:membrane organization; P:mitochondrial fission; P:negative regulation of membrane tubulation; P:negative regulation of non-motile cilium assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron projection morphogenesis; P:phagocytosis; P:positive regulation of apoptotic process; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of lamellipodium assembly; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of phagocytosis; P:positive regulation of sodium:potassium-exchanging ATPase activity; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:post-Golgi vesicle-mediated transport; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of axon extension; P:regulation of Golgi organization; P:regulation of nitric-oxide synthase activity; P:regulation of Rac protein signal transduction; P:regulation of synapse structure or activity; P:regulation of transcription, DNA-templated; P:response to cocaine; P:response to light stimulus; P:signal transduction; P:spermatogenesis; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:synaptic vesicle transport; P:transferrin transport;|P50570 A8K1B6 E7EV30 E9PEQ4 K7ESI9 Q5I0Y0 Q7Z5S3 Q9UPH4,Dynamin-2,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005813;GO:0045334;GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0044327;GO:0030666;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0005794;GO:0000139;GO:0030426;GO:0030027;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0031966;GO:0005634;GO:0048471;GO:0001891;GO:0030670;GO:0005886;GO:0014069;GO:0099092;GO:0098844;GO:0045211;GO:0098793;GO:0032991;GO:0032587;GO:0005802;GO:0031749;GO:0019899;GO:0005525;GO:0003924;GO:0008017;GO:0050998;GO:0036312;GO:0019901;GO:0044877;GO:0017124;GO:0050699;GO:0019886;GO:0071245;GO:1903351;GO:0071732;GO:0071481;GO:0003374;GO:0006897;GO:0002031;GO:0000086;GO:0006893;GO:0044351;GO:0061025;GO:0061024;GO:0000266;GO:1903526;GO:1902856;GO:0030512;GO:0048812;GO:0006909;GO:0043065;GO:2000370;GO:0010592;GO:0045429;GO:0050766;GO:1903408;GO:1900026;GO:0045893;GO:0006892;GO:0098884;GO:0031623;GO:0006898;GO:0030516;GO:1903358;GO:0050999;GO:0035020;GO:0050803;GO:0006355;GO:0042220;GO:0009416;GO:0007165;GO:0007283;GO:0016185;GO:0048489;GO:0033572;, C:axon; C:centrosome; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine head; C:endocytic vesicle membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:lamellipodium; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:phagocytic cup; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynaptic density; C:postsynaptic density, intracellular component; C:postsynaptic endocytic zone membrane; C:postsynaptic membrane; C:presynapse; C:protein-containing complex; C:ruffle membrane; C:trans-Golgi network;, F:D2 dopamine receptor binding; F:enzyme binding; F:GTP binding; F:GTPase activity; F:microtubule binding; F:nitric-oxide synthase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein kinase binding; F:protein-containing complex binding; F:SH3 domain binding; F:WW domain binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular response to carbon monoxide; P:cellular response to dopamine; P:cellular response to nitric oxide; P:cellular response to X-ray; P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:G protein-coupled receptor internalization; P:G2/M transition of mitotic cell cycle; P:Golgi to plasma membrane transport; P:macropinocytosis; P:membrane fusion; P:membrane organization; P:mitochondrial fission; P:negative regulation of membrane tubulation; P:negative regulation of non-motile cilium assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron projection morphogenesis; P:phagocytosis; P:positive regulation of apoptotic process; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of lamellipodium assembly; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of phagocytosis; P:positive regulation of sodium:potassium-exchanging ATPase activity; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:post-Golgi vesicle-mediated transport; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of axon extension; P:regulation of Golgi organization; P:regulation of nitric-oxide synthase activity; P:regulation of Rac protein signal transduction; P:regulation of synapse structure or activity; P:regulation of transcription, DNA-templated; P:response to cocaine; P:response to light stimulus; P:signal transduction; P:spermatogenesis; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:synaptic vesicle transport; P:transferrin transport;|P50570 A8K1B6 E7EV30 E9PEQ4 K7ESI9 Q5I0Y0 Q7Z5S3 Q9UPH4,Dynamin-2,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005813;GO:0045334;GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0044327;GO:0030666;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0005794;GO:0000139;GO:0030426;GO:0030027;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0031966;GO:0005634;GO:0048471;GO:0001891;GO:0030670;GO:0005886;GO:0014069;GO:0099092;GO:0098844;GO:0045211;GO:0098793;GO:0032991;GO:0032587;GO:0005802;GO:0031749;GO:0019899;GO:0005525;GO:0003924;GO:0008017;GO:0050998;GO:0036312;GO:0019901;GO:0044877;GO:0017124;GO:0050699;GO:0019886;GO:0071245;GO:1903351;GO:0071732;GO:0071481;GO:0003374;GO:0006897;GO:0002031;GO:0000086;GO:0006893;GO:0044351;GO:0061025;GO:0061024;GO:0000266;GO:1903526;GO:1902856;GO:0030512;GO:0048812;GO:0006909;GO:0043065;GO:2000370;GO:0010592;GO:0045429;GO:0050766;GO:1903408;GO:1900026;GO:0045893;GO:0006892;GO:0098884;GO:0031623;GO:0006898;GO:0030516;GO:1903358;GO:0050999;GO:0035020;GO:0050803;GO:0006355;GO:0042220;GO:0009416;GO:0007165;GO:0007283;GO:0016185;GO:0048489;GO:0033572;, C:axon; C:centrosome; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine head; C:endocytic vesicle membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:lamellipodium; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:phagocytic cup; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynaptic density; C:postsynaptic density, intracellular component; C:postsynaptic endocytic zone membrane; C:postsynaptic membrane; C:presynapse; C:protein-containing complex; C:ruffle membrane; C:trans-Golgi network;, F:D2 dopamine receptor binding; F:enzyme binding; F:GTP binding; F:GTPase activity; F:microtubule binding; F:nitric-oxide synthase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein kinase binding; F:protein-containing complex binding; F:SH3 domain binding; F:WW domain binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular response to carbon monoxide; P:cellular response to dopamine; P:cellular response to nitric oxide; P:cellular response to X-ray; P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:G protein-coupled receptor internalization; P:G2/M transition of mitotic cell cycle; P:Golgi to plasma membrane transport; P:macropinocytosis; P:membrane fusion; P:membrane organization; P:mitochondrial fission; P:negative regulation of membrane tubulation; P:negative regulation of non-motile cilium assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron projection morphogenesis; P:phagocytosis; P:positive regulation of apoptotic process; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of lamellipodium assembly; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of phagocytosis; P:positive regulation of sodium:potassium-exchanging ATPase activity; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:post-Golgi vesicle-mediated transport; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of axon extension; P:regulation of Golgi organization; P:regulation of nitric-oxide synthase activity; P:regulation of Rac protein signal transduction; P:regulation of synapse structure or activity; P:regulation of transcription, DNA-templated; P:response to cocaine; P:response to light stimulus; P:signal transduction; P:spermatogenesis; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:synaptic vesicle transport; P:transferrin transport;|P50570 A8K1B6 E7EV30 E9PEQ4 K7ESI9 Q5I0Y0 Q7Z5S3 Q9UPH4,Dynamin-2,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005813;GO:0045334;GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0044327;GO:0030666;GO:0005768;GO:0070062;GO:0005925;GO:0098978;GO:0005794;GO:0000139;GO:0030426;GO:0030027;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:0031966;GO:0005634;GO:0048471;GO:0001891;GO:0030670;GO:0005886;GO:0014069;GO:0099092;GO:0098844;GO:0045211;GO:0098793;GO:0032991;GO:0032587;GO:0005802;GO:0031749;GO:0019899;GO:0005525;GO:0003924;GO:0008017;GO:0050998;GO:0036312;GO:0019901;GO:0044877;GO:0017124;GO:0050699;GO:0019886;GO:0071245;GO:1903351;GO:0071732;GO:0071481;GO:0003374;GO:0006897;GO:0002031;GO:0000086;GO:0006893;GO:0044351;GO:0061025;GO:0061024;GO:0000266;GO:1903526;GO:1902856;GO:0030512;GO:0048812;GO:0006909;GO:0043065;GO:2000370;GO:0010592;GO:0045429;GO:0050766;GO:1903408;GO:1900026;GO:0045893;GO:0006892;GO:0098884;GO:0031623;GO:0006898;GO:0030516;GO:1903358;GO:0050999;GO:0035020;GO:0050803;GO:0006355;GO:0042220;GO:0009416;GO:0007165;GO:0007283;GO:0016185;GO:0048489;GO:0033572;, C:axon; C:centrosome; C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine head; C:endocytic vesicle membrane; C:endosome; C:extracellular exosome; C:focal adhesion; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:growth cone; C:lamellipodium; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:phagocytic cup; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynaptic density; C:postsynaptic density, intracellular component; C:postsynaptic endocytic zone membrane; C:postsynaptic membrane; C:presynapse; C:protein-containing complex; C:ruffle membrane; C:trans-Golgi network;, F:D2 dopamine receptor binding; F:enzyme binding; F:GTP binding; F:GTPase activity; F:microtubule binding; F:nitric-oxide synthase binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein kinase binding; F:protein-containing complex binding; F:SH3 domain binding; F:WW domain binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cellular response to carbon monoxide; P:cellular response to dopamine; P:cellular response to nitric oxide; P:cellular response to X-ray; P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:G protein-coupled receptor internalization; P:G2/M transition of mitotic cell cycle; P:Golgi to plasma membrane transport; P:macropinocytosis; P:membrane fusion; P:membrane organization; P:mitochondrial fission; P:negative regulation of membrane tubulation; P:negative regulation of non-motile cilium assembly; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neuron projection morphogenesis; P:phagocytosis; P:positive regulation of apoptotic process; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of lamellipodium assembly; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of phagocytosis; P:positive regulation of sodium:potassium-exchanging ATPase activity; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of transcription, DNA-templated; P:post-Golgi vesicle-mediated transport; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of axon extension; P:regulation of Golgi organization; P:regulation of nitric-oxide synthase activity; P:regulation of Rac protein signal transduction; P:regulation of synapse structure or activity; P:regulation of transcription, DNA-templated; P:response to cocaine; P:response to light stimulus; P:signal transduction; P:spermatogenesis; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:synaptic vesicle transport; P:transferrin transport;|Q05193 A6NLM6 Q5SYX0 Q5SYX2 Q6P3T6 Q86VD2,Dynamin-1,, PF01031;PF00350;PF02212;PF00169;, GO:0030424;GO:0005737;GO:0031410;GO:0044327;GO:0070062;GO:0016020;GO:0005874;GO:0015630;GO:0031966;GO:0005654;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0019901;GO:0003723;GO:0003374;GO:0006897;GO:0007032;GO:0048013;GO:0061025;GO:0000266;GO:0098884;GO:0031623;GO:0006898;GO:0050803;GO:0016185;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:dendritic spine head; C:extracellular exosome; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:mitochondrial membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding; F:protein kinase binding; F:RNA binding;, P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:endosome organization; P:ephrin receptor signaling pathway; P:membrane fusion; P:mitochondrial fission; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of synapse structure or activity; P:synaptic vesicle budding from presynaptic endocytic zone membrane;|Q9NQ68 Q9NQN6,Dynamin-3,Dynamin, testicular;T-dynamin;, PF01031;PF00350;PF02212;PF00169;, GO:0061828;GO:0030424;GO:0061829;GO:0005737;GO:0031410;GO:0043197;GO:0044327;GO:0070062;GO:0098978;GO:0005794;GO:0016020;GO:0005874;GO:0015630;GO:0031966;GO:0048471;GO:0005886;GO:0014069;GO:0098844;GO:0098793;GO:0043083;GO:0005525;GO:0003924;GO:0042802;GO:0008017;GO:0050998;GO:0099186;GO:0031798;GO:0031802;GO:0003374;GO:0006897;GO:0046847;GO:0061025;GO:0000266;GO:0061002;GO:0051491;GO:1903423;GO:0098884;GO:0031623;GO:0050803;GO:0007416;GO:0016185;, C:apical tubulobulbar complex; C:axon; C:basal tubulobulbar complex; C:cytoplasm; C:cytoplasmic vesicle; C:dendritic spine; C:dendritic spine head; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:mitochondrial membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic endocytic zone membrane; C:presynapse; C:synaptic cleft;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:microtubule binding; F:nitric-oxide synthase binding; F:structural constituent of postsynapse; F:type 1 metabotropic glutamate receptor binding; F:type 5 metabotropic glutamate receptor binding;, P:dynamin family protein polymerization involved in mitochondrial fission; P:endocytosis; P:filopodium assembly; P:membrane fusion; P:mitochondrial fission; P:negative regulation of dendritic spine morphogenesis; P:positive regulation of filopodium assembly; P:positive regulation of synaptic vesicle recycling; P:postsynaptic neurotransmitter receptor internalization; P:receptor internalization; P:regulation of synapse structure or activity; P:synapse assembly; P:synaptic vesicle budding from presynaptic endocytic zone membrane; scaffold103 indexed_genome mRNA 5249065 5257302 . + . ID=transcript_13066;Q13445,Transmembrane emp24 domain-containing protein 1,Interleukin-1 receptor-like 1 ligand;Putative T1/ST2 receptor-binding protein;p24 family protein gamma-1;, PF01105;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0016021;GO:0005886;GO:0005102;GO:0007267;GO:0006888;GO:0007030;GO:0006886;GO:0007165;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:signaling receptor binding;, P:cell-cell signaling; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:signal transduction; scaffold103 indexed_genome mRNA 5264044 5266542 . + . ID=transcript_13067;A8MVS5 B2RXI3,Protein HIDE1,, PF17737;, GO:0016021;, C:integral component of membrane;|A8MVS5 B2RXI3,Protein HIDE1,, PF17737;, GO:0016021;, C:integral component of membrane;|A8MVS5 B2RXI3,Protein HIDE1,, PF17737;, GO:0016021;, C:integral component of membrane; scaffold103 indexed_genome mRNA 5269692 5274661 . + . ID=transcript_13068;A8MVS5 B2RXI3,Protein HIDE1,, PF17737;, GO:0016021;, C:integral component of membrane; scaffold103 indexed_genome mRNA 5315914 5336482 . + . ID=transcript_13069;Q86X55 A6NN38,Histone-arginine methyltransferase CARM1,Coactivator-associated arginine methyltransferase 1;Protein arginine N-methyltransferase 4;, PF11531;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0042054;GO:0035642;GO:0008469;GO:0070577;GO:0030374;GO:0008276;GO:0016274;GO:0035242;GO:0003713;GO:0000976;GO:0007568;GO:0006977;GO:0034971;GO:0034970;GO:0016571;GO:2000171;GO:0008284;GO:0045600;GO:0033146;GO:0019216;GO:1902415;GO:0006355;GO:0051591;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-R17 specific); F:histone-arginine N-methyltransferase activity; F:lysine-acetylated histone binding; F:nuclear receptor coactivator activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H3-R17 methylation; P:histone H3-R2 methylation; P:histone methylation; P:negative regulation of dendrite development; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:regulation of mRNA binding; P:regulation of transcription, DNA-templated; P:response to cAMP; P:viral process;|Q86X55 A6NN38,Histone-arginine methyltransferase CARM1,Coactivator-associated arginine methyltransferase 1;Protein arginine N-methyltransferase 4;, PF11531;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0042054;GO:0035642;GO:0008469;GO:0070577;GO:0030374;GO:0008276;GO:0016274;GO:0035242;GO:0003713;GO:0000976;GO:0007568;GO:0006977;GO:0034971;GO:0034970;GO:0016571;GO:2000171;GO:0008284;GO:0045600;GO:0033146;GO:0019216;GO:1902415;GO:0006355;GO:0051591;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-R17 specific); F:histone-arginine N-methyltransferase activity; F:lysine-acetylated histone binding; F:nuclear receptor coactivator activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H3-R17 methylation; P:histone H3-R2 methylation; P:histone methylation; P:negative regulation of dendrite development; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:regulation of mRNA binding; P:regulation of transcription, DNA-templated; P:response to cAMP; P:viral process;|Q86X55 A6NN38,Histone-arginine methyltransferase CARM1,Coactivator-associated arginine methyltransferase 1;Protein arginine N-methyltransferase 4;, PF11531;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0042054;GO:0035642;GO:0008469;GO:0070577;GO:0030374;GO:0008276;GO:0016274;GO:0035242;GO:0003713;GO:0000976;GO:0007568;GO:0006977;GO:0034971;GO:0034970;GO:0016571;GO:2000171;GO:0008284;GO:0045600;GO:0033146;GO:0019216;GO:1902415;GO:0006355;GO:0051591;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-R17 specific); F:histone-arginine N-methyltransferase activity; F:lysine-acetylated histone binding; F:nuclear receptor coactivator activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H3-R17 methylation; P:histone H3-R2 methylation; P:histone methylation; P:negative regulation of dendrite development; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:regulation of mRNA binding; P:regulation of transcription, DNA-templated; P:response to cAMP; P:viral process;|Q86X55 A6NN38,Histone-arginine methyltransferase CARM1,Coactivator-associated arginine methyltransferase 1;Protein arginine N-methyltransferase 4;, PF11531;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0042054;GO:0035642;GO:0008469;GO:0070577;GO:0030374;GO:0008276;GO:0016274;GO:0035242;GO:0003713;GO:0000976;GO:0007568;GO:0006977;GO:0034971;GO:0034970;GO:0016571;GO:2000171;GO:0008284;GO:0045600;GO:0033146;GO:0019216;GO:1902415;GO:0006355;GO:0051591;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-R17 specific); F:histone-arginine N-methyltransferase activity; F:lysine-acetylated histone binding; F:nuclear receptor coactivator activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H3-R17 methylation; P:histone H3-R2 methylation; P:histone methylation; P:negative regulation of dendrite development; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:regulation of mRNA binding; P:regulation of transcription, DNA-templated; P:response to cAMP; P:viral process;|Q86X55 A6NN38,Histone-arginine methyltransferase CARM1,Coactivator-associated arginine methyltransferase 1;Protein arginine N-methyltransferase 4;, PF11531;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0042054;GO:0035642;GO:0008469;GO:0070577;GO:0030374;GO:0008276;GO:0016274;GO:0035242;GO:0003713;GO:0000976;GO:0007568;GO:0006977;GO:0034971;GO:0034970;GO:0016571;GO:2000171;GO:0008284;GO:0045600;GO:0033146;GO:0019216;GO:1902415;GO:0006355;GO:0051591;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-R17 specific); F:histone-arginine N-methyltransferase activity; F:lysine-acetylated histone binding; F:nuclear receptor coactivator activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H3-R17 methylation; P:histone H3-R2 methylation; P:histone methylation; P:negative regulation of dendrite development; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:regulation of mRNA binding; P:regulation of transcription, DNA-templated; P:response to cAMP; P:viral process;|Q86X55 A6NN38,Histone-arginine methyltransferase CARM1,Coactivator-associated arginine methyltransferase 1;Protein arginine N-methyltransferase 4;, PF11531;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0042054;GO:0035642;GO:0008469;GO:0070577;GO:0030374;GO:0008276;GO:0016274;GO:0035242;GO:0003713;GO:0000976;GO:0007568;GO:0006977;GO:0034971;GO:0034970;GO:0016571;GO:2000171;GO:0008284;GO:0045600;GO:0033146;GO:0019216;GO:1902415;GO:0006355;GO:0051591;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-R17 specific); F:histone-arginine N-methyltransferase activity; F:lysine-acetylated histone binding; F:nuclear receptor coactivator activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H3-R17 methylation; P:histone H3-R2 methylation; P:histone methylation; P:negative regulation of dendrite development; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:regulation of mRNA binding; P:regulation of transcription, DNA-templated; P:response to cAMP; P:viral process;|Q86X55 A6NN38,Histone-arginine methyltransferase CARM1,Coactivator-associated arginine methyltransferase 1;Protein arginine N-methyltransferase 4;, PF11531;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0042054;GO:0035642;GO:0008469;GO:0070577;GO:0030374;GO:0008276;GO:0016274;GO:0035242;GO:0003713;GO:0000976;GO:0007568;GO:0006977;GO:0034971;GO:0034970;GO:0016571;GO:2000171;GO:0008284;GO:0045600;GO:0033146;GO:0019216;GO:1902415;GO:0006355;GO:0051591;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-R17 specific); F:histone-arginine N-methyltransferase activity; F:lysine-acetylated histone binding; F:nuclear receptor coactivator activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H3-R17 methylation; P:histone H3-R2 methylation; P:histone methylation; P:negative regulation of dendrite development; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:regulation of mRNA binding; P:regulation of transcription, DNA-templated; P:response to cAMP; P:viral process;|Q86X55 A6NN38,Histone-arginine methyltransferase CARM1,Coactivator-associated arginine methyltransferase 1;Protein arginine N-methyltransferase 4;, PF11531;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008013;GO:0042054;GO:0035642;GO:0008469;GO:0070577;GO:0030374;GO:0008276;GO:0016274;GO:0035242;GO:0003713;GO:0000976;GO:0007568;GO:0006977;GO:0034971;GO:0034970;GO:0016571;GO:2000171;GO:0008284;GO:0045600;GO:0033146;GO:0019216;GO:1902415;GO:0006355;GO:0051591;GO:0016032;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:beta-catenin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-R17 specific); F:histone-arginine N-methyltransferase activity; F:lysine-acetylated histone binding; F:nuclear receptor coactivator activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:transcription coactivator activity; F:transcription regulatory region sequence-specific DNA binding;, P:aging; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H3-R17 methylation; P:histone H3-R2 methylation; P:histone methylation; P:negative regulation of dendrite development; P:positive regulation of cell population proliferation; P:positive regulation of fat cell differentiation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of lipid metabolic process; P:regulation of mRNA binding; P:regulation of transcription, DNA-templated; P:response to cAMP; P:viral process; scaffold103 indexed_genome mRNA 5336484 5338178 . + . ID=transcript_13070;Q9BSF4 Q96EY6 Q96IT8,Mitochondrial import inner membrane translocase subunit Tim29 {ECO:0000303|PubMed:27554484},, PF10171;, GO:0016021;GO:0005743;GO:0005758;GO:0042721;GO:0140318;GO:0045039;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:TIM22 mitochondrial import inner membrane insertion complex;, F:protein transporter activity;, P:protein insertion into mitochondrial inner membrane; scaffold103 indexed_genome mRNA 5358736 5359288 . - . ID=transcript_13071;O43313 A8K4H8 Q68DC9,ATM interactor,ATM/ATR-substrate CHK2-interacting zinc finger protein;Zinc finger protein 822;, , GO:0016604;GO:0005634;GO:0001228;GO:0000981;GO:0070840;GO:0046872;GO:0000976;GO:0006974;GO:0044458;GO:1902857;GO:0045944;GO:0045893;GO:0006357;, C:nuclear body; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:dynein complex binding; F:metal ion binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to DNA damage stimulus; P:motile cilium assembly; P:positive regulation of non-motile cilium assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 5416666 5434667 . + . ID=transcript_13072;P51532 B1A8Z4 B1A8Z5 B1A8Z6 B1A8Z7 E9PBR8 O95052 Q9HBD3,Transcription activator BRG1,ATP-dependent helicase SMARCA4;BRG1-associated factor 190A;Mitotic growth and transcription activator;Protein BRG-1;Protein brahma homolog 1;SNF2-beta;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4;, PF07533;PF00439;PF00271;PF07529;PF08880;PF14619;PF00176;, GO:0000785;GO:0005615;GO:0016020;GO:0071565;GO:0071564;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0050681;GO:0005524;GO:0003677;GO:0070182;GO:0008094;GO:0004386;GO:0070577;GO:0070615;GO:0002039;GO:0047485;GO:0003723;GO:0030957;GO:0003713;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0006325;GO:0006338;GO:0038111;GO:0060766;GO:0030308;GO:0000122;GO:0045892;GO:0007399;GO:0003407;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:1902895;GO:0045944;GO:1901838;GO:0045893;GO:0030177;GO:0006357;GO:0001188;, C:chromatin; C:extracellular space; C:membrane; C:nBAF complex; C:npBAF complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:androgen receptor binding; F:ATP binding; F:DNA binding; F:DNA polymerase binding; F:DNA-dependent ATPase activity; F:helicase activity; F:lysine-acetylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding; F:protein N-terminus binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:chromatin organization; P:chromatin remodeling; P:interleukin-7-mediated signaling pathway; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neural retina development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly; scaffold103 indexed_genome mRNA 5440070 5490299 . + . ID=transcript_13073;P51532 B1A8Z4 B1A8Z5 B1A8Z6 B1A8Z7 E9PBR8 O95052 Q9HBD3,Transcription activator BRG1,ATP-dependent helicase SMARCA4;BRG1-associated factor 190A;Mitotic growth and transcription activator;Protein BRG-1;Protein brahma homolog 1;SNF2-beta;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4;, PF07533;PF00439;PF00271;PF07529;PF08880;PF14619;PF00176;, GO:0000785;GO:0005615;GO:0016020;GO:0071565;GO:0071564;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0050681;GO:0005524;GO:0003677;GO:0070182;GO:0008094;GO:0004386;GO:0070577;GO:0070615;GO:0002039;GO:0047485;GO:0003723;GO:0030957;GO:0003713;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0006325;GO:0006338;GO:0038111;GO:0060766;GO:0030308;GO:0000122;GO:0045892;GO:0007399;GO:0003407;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:1902895;GO:0045944;GO:1901838;GO:0045893;GO:0030177;GO:0006357;GO:0001188;, C:chromatin; C:extracellular space; C:membrane; C:nBAF complex; C:npBAF complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:androgen receptor binding; F:ATP binding; F:DNA binding; F:DNA polymerase binding; F:DNA-dependent ATPase activity; F:helicase activity; F:lysine-acetylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding; F:protein N-terminus binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:chromatin organization; P:chromatin remodeling; P:interleukin-7-mediated signaling pathway; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neural retina development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly;|P51532 B1A8Z4 B1A8Z5 B1A8Z6 B1A8Z7 E9PBR8 O95052 Q9HBD3,Transcription activator BRG1,ATP-dependent helicase SMARCA4;BRG1-associated factor 190A;Mitotic growth and transcription activator;Protein BRG-1;Protein brahma homolog 1;SNF2-beta;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4;, PF07533;PF00439;PF00271;PF07529;PF08880;PF14619;PF00176;, GO:0000785;GO:0005615;GO:0016020;GO:0071565;GO:0071564;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0050681;GO:0005524;GO:0003677;GO:0070182;GO:0008094;GO:0004386;GO:0070577;GO:0070615;GO:0002039;GO:0047485;GO:0003723;GO:0030957;GO:0003713;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0006325;GO:0006338;GO:0038111;GO:0060766;GO:0030308;GO:0000122;GO:0045892;GO:0007399;GO:0003407;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:1902895;GO:0045944;GO:1901838;GO:0045893;GO:0030177;GO:0006357;GO:0001188;, C:chromatin; C:extracellular space; C:membrane; C:nBAF complex; C:npBAF complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:androgen receptor binding; F:ATP binding; F:DNA binding; F:DNA polymerase binding; F:DNA-dependent ATPase activity; F:helicase activity; F:lysine-acetylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding; F:protein N-terminus binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:chromatin organization; P:chromatin remodeling; P:interleukin-7-mediated signaling pathway; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neural retina development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly;|P51532 B1A8Z4 B1A8Z5 B1A8Z6 B1A8Z7 E9PBR8 O95052 Q9HBD3,Transcription activator BRG1,ATP-dependent helicase SMARCA4;BRG1-associated factor 190A;Mitotic growth and transcription activator;Protein BRG-1;Protein brahma homolog 1;SNF2-beta;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4;, PF07533;PF00439;PF00271;PF07529;PF08880;PF14619;PF00176;, GO:0000785;GO:0005615;GO:0016020;GO:0071565;GO:0071564;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0050681;GO:0005524;GO:0003677;GO:0070182;GO:0008094;GO:0004386;GO:0070577;GO:0070615;GO:0002039;GO:0047485;GO:0003723;GO:0030957;GO:0003713;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0006325;GO:0006338;GO:0038111;GO:0060766;GO:0030308;GO:0000122;GO:0045892;GO:0007399;GO:0003407;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:1902895;GO:0045944;GO:1901838;GO:0045893;GO:0030177;GO:0006357;GO:0001188;, C:chromatin; C:extracellular space; C:membrane; C:nBAF complex; C:npBAF complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:androgen receptor binding; F:ATP binding; F:DNA binding; F:DNA polymerase binding; F:DNA-dependent ATPase activity; F:helicase activity; F:lysine-acetylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding; F:protein N-terminus binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;, P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:chromatin organization; P:chromatin remodeling; P:interleukin-7-mediated signaling pathway; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neural retina development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly;|Q07020 F8VWC5 Q8WTZ6,60S ribosomal protein L18,Large ribosomal subunit protein eL18 {ECO:0000303|PubMed:24524803};, PF17135;, GO:0005829;GO:0022625;GO:0005783;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:0042788;GO:0005791;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:polysomal ribosome; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold103 indexed_genome mRNA 5523745 5557148 . + . ID=transcript_13074;Q59FQ1 Q9UDH7,Low-density lipoprotein receptor,, PF07645;PF00057;PF00058;, GO:0045177;GO:0016323;GO:0009986;GO:0030669;GO:0005905;GO:0005769;GO:0036020;GO:0010008;GO:0009897;GO:0005794;GO:0005887;GO:0005770;GO:0034362;GO:0005764;GO:0016020;GO:1990666;GO:0005886;GO:0043235;GO:0001540;GO:0005509;GO:0032050;GO:0042802;GO:0030169;GO:0005041;GO:0002020;GO:0030229;GO:0001618;GO:0097242;GO:0150094;GO:0071404;GO:0042632;GO:0070508;GO:0008203;GO:0030301;GO:0034382;GO:0006897;GO:0030299;GO:0006629;GO:0007616;GO:0034383;GO:0061024;GO:1905907;GO:0061889;GO:1903979;GO:0051248;GO:0006909;GO:0015914;GO:0034381;GO:1905167;GO:0010867;GO:0006898;GO:0090118;GO:0010899;GO:0051246;GO:0061771;, C:apical part of cell; C:basolateral plasma membrane; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:early endosome; C:endolysosome membrane; C:endosome membrane; C:external side of plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:low-density lipoprotein particle; C:lysosome; C:membrane; C:PCSK9-LDLR complex; C:plasma membrane; C:receptor complex;, F:amyloid-beta binding; F:calcium ion binding; F:clathrin heavy chain binding; F:identical protein binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:very-low-density lipoprotein particle receptor activity; F:virus receptor activity;, P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol homeostasis; P:cholesterol import; P:cholesterol metabolic process; P:cholesterol transport; P:chylomicron remnant clearance; P:endocytosis; P:intestinal cholesterol absorption; P:lipid metabolic process; P:long-term memory; P:low-density lipoprotein particle clearance; P:membrane organization; P:negative regulation of amyloid fibril formation; P:negative regulation of astrocyte activation; P:negative regulation of microglial cell activation; P:negative regulation of protein metabolic process; P:phagocytosis; P:phospholipid transport; P:plasma lipoprotein particle clearance; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of triglyceride biosynthetic process; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of phosphatidylcholine catabolic process; P:regulation of protein metabolic process; P:response to caloric restriction;|Q59FQ1 Q9UDH7,Low-density lipoprotein receptor,, PF07645;PF00057;PF00058;, GO:0045177;GO:0016323;GO:0009986;GO:0030669;GO:0005905;GO:0005769;GO:0036020;GO:0010008;GO:0009897;GO:0005794;GO:0005887;GO:0005770;GO:0034362;GO:0005764;GO:0016020;GO:1990666;GO:0005886;GO:0043235;GO:0001540;GO:0005509;GO:0032050;GO:0042802;GO:0030169;GO:0005041;GO:0002020;GO:0030229;GO:0001618;GO:0097242;GO:0150094;GO:0071404;GO:0042632;GO:0070508;GO:0008203;GO:0030301;GO:0034382;GO:0006897;GO:0030299;GO:0006629;GO:0007616;GO:0034383;GO:0061024;GO:1905907;GO:0061889;GO:1903979;GO:0051248;GO:0006909;GO:0015914;GO:0034381;GO:1905167;GO:0010867;GO:0006898;GO:0090118;GO:0010899;GO:0051246;GO:0061771;, C:apical part of cell; C:basolateral plasma membrane; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:early endosome; C:endolysosome membrane; C:endosome membrane; C:external side of plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:low-density lipoprotein particle; C:lysosome; C:membrane; C:PCSK9-LDLR complex; C:plasma membrane; C:receptor complex;, F:amyloid-beta binding; F:calcium ion binding; F:clathrin heavy chain binding; F:identical protein binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:very-low-density lipoprotein particle receptor activity; F:virus receptor activity;, P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol homeostasis; P:cholesterol import; P:cholesterol metabolic process; P:cholesterol transport; P:chylomicron remnant clearance; P:endocytosis; P:intestinal cholesterol absorption; P:lipid metabolic process; P:long-term memory; P:low-density lipoprotein particle clearance; P:membrane organization; P:negative regulation of amyloid fibril formation; P:negative regulation of astrocyte activation; P:negative regulation of microglial cell activation; P:negative regulation of protein metabolic process; P:phagocytosis; P:phospholipid transport; P:plasma lipoprotein particle clearance; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of triglyceride biosynthetic process; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of phosphatidylcholine catabolic process; P:regulation of protein metabolic process; P:response to caloric restriction;|Q59FQ1 Q9UDH7,Low-density lipoprotein receptor,, PF07645;PF00057;PF00058;, GO:0045177;GO:0016323;GO:0009986;GO:0030669;GO:0005905;GO:0005769;GO:0036020;GO:0010008;GO:0009897;GO:0005794;GO:0005887;GO:0005770;GO:0034362;GO:0005764;GO:0016020;GO:1990666;GO:0005886;GO:0043235;GO:0001540;GO:0005509;GO:0032050;GO:0042802;GO:0030169;GO:0005041;GO:0002020;GO:0030229;GO:0001618;GO:0097242;GO:0150094;GO:0071404;GO:0042632;GO:0070508;GO:0008203;GO:0030301;GO:0034382;GO:0006897;GO:0030299;GO:0006629;GO:0007616;GO:0034383;GO:0061024;GO:1905907;GO:0061889;GO:1903979;GO:0051248;GO:0006909;GO:0015914;GO:0034381;GO:1905167;GO:0010867;GO:0006898;GO:0090118;GO:0010899;GO:0051246;GO:0061771;, C:apical part of cell; C:basolateral plasma membrane; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:early endosome; C:endolysosome membrane; C:endosome membrane; C:external side of plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:low-density lipoprotein particle; C:lysosome; C:membrane; C:PCSK9-LDLR complex; C:plasma membrane; C:receptor complex;, F:amyloid-beta binding; F:calcium ion binding; F:clathrin heavy chain binding; F:identical protein binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:very-low-density lipoprotein particle receptor activity; F:virus receptor activity;, P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol homeostasis; P:cholesterol import; P:cholesterol metabolic process; P:cholesterol transport; P:chylomicron remnant clearance; P:endocytosis; P:intestinal cholesterol absorption; P:lipid metabolic process; P:long-term memory; P:low-density lipoprotein particle clearance; P:membrane organization; P:negative regulation of amyloid fibril formation; P:negative regulation of astrocyte activation; P:negative regulation of microglial cell activation; P:negative regulation of protein metabolic process; P:phagocytosis; P:phospholipid transport; P:plasma lipoprotein particle clearance; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of triglyceride biosynthetic process; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of phosphatidylcholine catabolic process; P:regulation of protein metabolic process; P:response to caloric restriction;|Q59FQ1 Q9UDH7,Low-density lipoprotein receptor,, PF07645;PF00057;PF00058;, GO:0045177;GO:0016323;GO:0009986;GO:0030669;GO:0005905;GO:0005769;GO:0036020;GO:0010008;GO:0009897;GO:0005794;GO:0005887;GO:0005770;GO:0034362;GO:0005764;GO:0016020;GO:1990666;GO:0005886;GO:0043235;GO:0001540;GO:0005509;GO:0032050;GO:0042802;GO:0030169;GO:0005041;GO:0002020;GO:0030229;GO:0001618;GO:0097242;GO:0150094;GO:0071404;GO:0042632;GO:0070508;GO:0008203;GO:0030301;GO:0034382;GO:0006897;GO:0030299;GO:0006629;GO:0007616;GO:0034383;GO:0061024;GO:1905907;GO:0061889;GO:1903979;GO:0051248;GO:0006909;GO:0015914;GO:0034381;GO:1905167;GO:0010867;GO:0006898;GO:0090118;GO:0010899;GO:0051246;GO:0061771;, C:apical part of cell; C:basolateral plasma membrane; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:early endosome; C:endolysosome membrane; C:endosome membrane; C:external side of plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:low-density lipoprotein particle; C:lysosome; C:membrane; C:PCSK9-LDLR complex; C:plasma membrane; C:receptor complex;, F:amyloid-beta binding; F:calcium ion binding; F:clathrin heavy chain binding; F:identical protein binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:very-low-density lipoprotein particle receptor activity; F:virus receptor activity;, P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol homeostasis; P:cholesterol import; P:cholesterol metabolic process; P:cholesterol transport; P:chylomicron remnant clearance; P:endocytosis; P:intestinal cholesterol absorption; P:lipid metabolic process; P:long-term memory; P:low-density lipoprotein particle clearance; P:membrane organization; P:negative regulation of amyloid fibril formation; P:negative regulation of astrocyte activation; P:negative regulation of microglial cell activation; P:negative regulation of protein metabolic process; P:phagocytosis; P:phospholipid transport; P:plasma lipoprotein particle clearance; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of triglyceride biosynthetic process; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of phosphatidylcholine catabolic process; P:regulation of protein metabolic process; P:response to caloric restriction;|Q59FQ1 Q9UDH7,Low-density lipoprotein receptor,, PF07645;PF00057;PF00058;, GO:0045177;GO:0016323;GO:0009986;GO:0030669;GO:0005905;GO:0005769;GO:0036020;GO:0010008;GO:0009897;GO:0005794;GO:0005887;GO:0005770;GO:0034362;GO:0005764;GO:0016020;GO:1990666;GO:0005886;GO:0043235;GO:0001540;GO:0005509;GO:0032050;GO:0042802;GO:0030169;GO:0005041;GO:0002020;GO:0030229;GO:0001618;GO:0097242;GO:0150094;GO:0071404;GO:0042632;GO:0070508;GO:0008203;GO:0030301;GO:0034382;GO:0006897;GO:0030299;GO:0006629;GO:0007616;GO:0034383;GO:0061024;GO:1905907;GO:0061889;GO:1903979;GO:0051248;GO:0006909;GO:0015914;GO:0034381;GO:1905167;GO:0010867;GO:0006898;GO:0090118;GO:0010899;GO:0051246;GO:0061771;, C:apical part of cell; C:basolateral plasma membrane; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:clathrin-coated pit; C:early endosome; C:endolysosome membrane; C:endosome membrane; C:external side of plasma membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:low-density lipoprotein particle; C:lysosome; C:membrane; C:PCSK9-LDLR complex; C:plasma membrane; C:receptor complex;, F:amyloid-beta binding; F:calcium ion binding; F:clathrin heavy chain binding; F:identical protein binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:very-low-density lipoprotein particle receptor activity; F:virus receptor activity;, P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:cellular response to low-density lipoprotein particle stimulus; P:cholesterol homeostasis; P:cholesterol import; P:cholesterol metabolic process; P:cholesterol transport; P:chylomicron remnant clearance; P:endocytosis; P:intestinal cholesterol absorption; P:lipid metabolic process; P:long-term memory; P:low-density lipoprotein particle clearance; P:membrane organization; P:negative regulation of amyloid fibril formation; P:negative regulation of astrocyte activation; P:negative regulation of microglial cell activation; P:negative regulation of protein metabolic process; P:phagocytosis; P:phospholipid transport; P:plasma lipoprotein particle clearance; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of triglyceride biosynthetic process; P:receptor-mediated endocytosis; P:receptor-mediated endocytosis involved in cholesterol transport; P:regulation of phosphatidylcholine catabolic process; P:regulation of protein metabolic process; P:response to caloric restriction; scaffold103 indexed_genome mRNA 5565642 5567511 . - . ID=transcript_13075;Q8NBT2 B4DZZ7 C9JGC4,Kinetochore protein Spc24,, PF08286;, GO:0000777;GO:0005829;GO:0031262;GO:0005730;GO:0005654;GO:0051301;GO:0007052;, C:condensed chromosome kinetochore; C:cytosol; C:Ndc80 complex; C:nucleolus; C:nucleoplasm;, , P:cell division; P:mitotic spindle organization; scaffold103 indexed_genome mRNA 5579494 5604648 . - . ID=transcript_13076;Q63ZY3 B0I1P4 Q3KQZ3 Q6GUF5 Q9H8S4 Q9NUP0 Q9P210,KN motif and ankyrin repeat domain-containing protein 2,Ankyrin repeat domain-containing protein 25;Matrix-remodeling-associated protein 3;SRC-1-interacting protein;, PF00023;PF12796;PF12075;, GO:0005737;GO:0005739;GO:0006915;GO:0090521;GO:0072073;GO:0008285;GO:2000134;GO:0033147;GO:0043069;GO:0000122;GO:0070563;GO:0035023;, C:cytoplasm; C:mitochondrion;, , P:apoptotic process; P:glomerular visceral epithelial cell migration; P:kidney epithelium development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of programmed cell death; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D receptor signaling pathway; P:regulation of Rho protein signal transduction;|Q63ZY3 B0I1P4 Q3KQZ3 Q6GUF5 Q9H8S4 Q9NUP0 Q9P210,KN motif and ankyrin repeat domain-containing protein 2,Ankyrin repeat domain-containing protein 25;Matrix-remodeling-associated protein 3;SRC-1-interacting protein;, PF00023;PF12796;PF12075;, GO:0005737;GO:0005739;GO:0006915;GO:0090521;GO:0072073;GO:0008285;GO:2000134;GO:0033147;GO:0043069;GO:0000122;GO:0070563;GO:0035023;, C:cytoplasm; C:mitochondrion;, , P:apoptotic process; P:glomerular visceral epithelial cell migration; P:kidney epithelium development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of programmed cell death; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D receptor signaling pathway; P:regulation of Rho protein signal transduction;|Q63ZY3 B0I1P4 Q3KQZ3 Q6GUF5 Q9H8S4 Q9NUP0 Q9P210,KN motif and ankyrin repeat domain-containing protein 2,Ankyrin repeat domain-containing protein 25;Matrix-remodeling-associated protein 3;SRC-1-interacting protein;, PF00023;PF12796;PF12075;, GO:0005737;GO:0005739;GO:0006915;GO:0090521;GO:0072073;GO:0008285;GO:2000134;GO:0033147;GO:0043069;GO:0000122;GO:0070563;GO:0035023;, C:cytoplasm; C:mitochondrion;, , P:apoptotic process; P:glomerular visceral epithelial cell migration; P:kidney epithelium development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of programmed cell death; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D receptor signaling pathway; P:regulation of Rho protein signal transduction;|Q63ZY3 B0I1P4 Q3KQZ3 Q6GUF5 Q9H8S4 Q9NUP0 Q9P210,KN motif and ankyrin repeat domain-containing protein 2,Ankyrin repeat domain-containing protein 25;Matrix-remodeling-associated protein 3;SRC-1-interacting protein;, PF00023;PF12796;PF12075;, GO:0005737;GO:0005739;GO:0006915;GO:0090521;GO:0072073;GO:0008285;GO:2000134;GO:0033147;GO:0043069;GO:0000122;GO:0070563;GO:0035023;, C:cytoplasm; C:mitochondrion;, , P:apoptotic process; P:glomerular visceral epithelial cell migration; P:kidney epithelium development; P:negative regulation of cell population proliferation; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of programmed cell death; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vitamin D receptor signaling pathway; P:regulation of Rho protein signal transduction; scaffold103 indexed_genome mRNA 5610695 5649995 . - . ID=transcript_13077;Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction;|Q96HP0 A6H8X5 Q7Z7P4 Q9P2F2,Dedicator of cytokinesis protein 6,, PF06920;PF14429;PF11878;, GO:0005829;GO:0048471;GO:0005085;GO:0007596;GO:0007264;, C:cytosol; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity;, P:blood coagulation; P:small GTPase mediated signal transduction; scaffold103 indexed_genome mRNA 5722112 5732705 . - . ID=transcript_13078;O95716,Ras-related protein Rab-3D,, PF00071;, GO:0035577;GO:0005881;GO:0005768;GO:0070062;GO:0005886;GO:0099503;GO:0008021;GO:0042588;GO:0005525;GO:0030742;GO:0003924;GO:0031489;GO:0045453;GO:0043312;GO:0018125;GO:1903307;GO:0072659;GO:0009306;GO:0017157;GO:0006904;, C:azurophil granule membrane; C:cytoplasmic microtubule; C:endosome; C:extracellular exosome; C:plasma membrane; C:secretory vesicle; C:synaptic vesicle; C:zymogen granule;, F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity; F:myosin V binding;, P:bone resorption; P:neutrophil degranulation; P:peptidyl-cysteine methylation; P:positive regulation of regulated secretory pathway; P:protein localization to plasma membrane; P:protein secretion; P:regulation of exocytosis; P:vesicle docking involved in exocytosis; scaffold103 indexed_genome mRNA 5734874 5747007 . - . ID=transcript_13079;Q6UW68,Transmembrane protein 205,, PF13664;, GO:0016021;, C:integral component of membrane;|Q6UW68,Transmembrane protein 205,, PF13664;, GO:0016021;, C:integral component of membrane;|P0C7I6 B4DEG3 B4DWR8 B4E133 B7ZAM4,Coiled-coil domain-containing protein 159|P0C7I6 B4DEG3 B4DWR8 B4E133 B7ZAM4,Coiled-coil domain-containing protein 159 scaffold103 indexed_genome mRNA 5747172 5748247 . + . ID=transcript_13080;Q96GM1 Q5CZ76 Q8N1U4 Q9H929,Phospholipid phosphatase-related protein type 2 {ECO:0000305},Lipid phosphate phosphatase-related protein type 2 {ECO:0000303|Ref.2};Plasticity-related gene 4 protein {ECO:0000305|PubMed:14750979};, PF01569;, GO:0005887;GO:0042577;GO:0008195;GO:0046839;GO:0006644;GO:0007165;, C:integral component of plasma membrane;, F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:signal transduction; scaffold103 indexed_genome mRNA 5748599 5753477 . + . ID=transcript_13081;Q96GM1 Q5CZ76 Q8N1U4 Q9H929,Phospholipid phosphatase-related protein type 2 {ECO:0000305},Lipid phosphate phosphatase-related protein type 2 {ECO:0000303|Ref.2};Plasticity-related gene 4 protein {ECO:0000305|PubMed:14750979};, PF01569;, GO:0005887;GO:0042577;GO:0008195;GO:0046839;GO:0006644;GO:0007165;, C:integral component of plasma membrane;, F:lipid phosphatase activity; F:phosphatidate phosphatase activity;, P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:signal transduction; scaffold103 indexed_genome mRNA 5758033 5760438 . + . ID=transcript_13082;Q6NVH7 Q8NAM1,ATPase SWSAP1,SWIM-type zinc finger 7-associated protein 1;SWS1-associated protein 1;ZSWIM7-associated protein 1;, , GO:0005634;GO:0097196;GO:0016887;GO:0003697;GO:0000724;GO:0050821;, C:nucleus; C:Shu complex;, F:ATPase activity; F:single-stranded DNA binding;, P:double-strand break repair via homologous recombination; P:protein stabilization;|Q6NVH7 Q8NAM1,ATPase SWSAP1,SWIM-type zinc finger 7-associated protein 1;SWS1-associated protein 1;ZSWIM7-associated protein 1;, , GO:0005634;GO:0097196;GO:0016887;GO:0003697;GO:0000724;GO:0050821;, C:nucleus; C:Shu complex;, F:ATPase activity; F:single-stranded DNA binding;, P:double-strand break repair via homologous recombination; P:protein stabilization;|Q6NVH7 Q8NAM1,ATPase SWSAP1,SWIM-type zinc finger 7-associated protein 1;SWS1-associated protein 1;ZSWIM7-associated protein 1;, , GO:0005634;GO:0097196;GO:0016887;GO:0003697;GO:0000724;GO:0050821;, C:nucleus; C:Shu complex;, F:ATPase activity; F:single-stranded DNA binding;, P:double-strand break repair via homologous recombination; P:protein stabilization; scaffold103 indexed_genome mRNA 5760870 5766813 . - . ID=transcript_13083;P19235 B2RCG4 Q15443 Q2M205,Erythropoietin receptor,, PF09067;PF00041;, GO:0005576;GO:0005887;GO:0016607;GO:0005886;GO:0004900;GO:0042802;GO:0007420;GO:0046697;GO:0007507;GO:0014068;GO:0046579;GO:0007165;, C:extracellular region; C:integral component of plasma membrane; C:nuclear speck; C:plasma membrane;, F:erythropoietin receptor activity; F:identical protein binding;, P:brain development; P:decidualization; P:heart development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of Ras protein signal transduction; P:signal transduction; scaffold103 indexed_genome mRNA 5770106 5778242 . - . ID=transcript_13084;Q3MIN7 B5ME84 B7ZL22 Q0P6G0,Ral guanine nucleotide dissociation stimulator-like 3,, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0031267;GO:0000165;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:MAPK cascade; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q3MIN7 B5ME84 B7ZL22 Q0P6G0,Ral guanine nucleotide dissociation stimulator-like 3,, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0031267;GO:0000165;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:MAPK cascade; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q3MIN7 B5ME84 B7ZL22 Q0P6G0,Ral guanine nucleotide dissociation stimulator-like 3,, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0031267;GO:0000165;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:MAPK cascade; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q3MIN7 B5ME84 B7ZL22 Q0P6G0,Ral guanine nucleotide dissociation stimulator-like 3,, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0031267;GO:0000165;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:MAPK cascade; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction; scaffold103 indexed_genome mRNA 5779382 5783697 . - . ID=transcript_13085;Q3MIN7 B5ME84 B7ZL22 Q0P6G0,Ral guanine nucleotide dissociation stimulator-like 3,, PF00788;PF00617;PF00618;, GO:0005829;GO:0005085;GO:0031267;GO:0000165;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:small GTPase binding;, P:MAPK cascade; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction; scaffold103 indexed_genome mRNA 5796570 5810992 . + . ID=transcript_13086;P14314 A8K318 Q96BU9 Q96D06 Q9P0W9,Glucosidase 2 subunit beta,80K-H protein {ECO:0000303|PubMed:2793184};Glucosidase II subunit beta;Protein kinase C substrate 60.1 kDa protein heavy chain;, PF13202;PF12999;PF13015;, GO:0005783;GO:0005788;GO:0017177;GO:0043231;GO:0005509;GO:0044325;GO:0051219;GO:0005080;GO:0044267;GO:0035556;GO:0001889;GO:0006491;GO:0043687;GO:0006457;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:glucosidase II complex; C:intracellular membrane-bounded organelle;, F:calcium ion binding; F:ion channel binding; F:phosphoprotein binding; F:protein kinase C binding;, P:cellular protein metabolic process; P:intracellular signal transduction; P:liver development; P:N-glycan processing; P:post-translational protein modification; P:protein folding; P:viral protein processing;|P14314 A8K318 Q96BU9 Q96D06 Q9P0W9,Glucosidase 2 subunit beta,80K-H protein {ECO:0000303|PubMed:2793184};Glucosidase II subunit beta;Protein kinase C substrate 60.1 kDa protein heavy chain;, PF13202;PF12999;PF13015;, GO:0005783;GO:0005788;GO:0017177;GO:0043231;GO:0005509;GO:0044325;GO:0051219;GO:0005080;GO:0044267;GO:0035556;GO:0001889;GO:0006491;GO:0043687;GO:0006457;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:glucosidase II complex; C:intracellular membrane-bounded organelle;, F:calcium ion binding; F:ion channel binding; F:phosphoprotein binding; F:protein kinase C binding;, P:cellular protein metabolic process; P:intracellular signal transduction; P:liver development; P:N-glycan processing; P:post-translational protein modification; P:protein folding; P:viral protein processing;|P14314 A8K318 Q96BU9 Q96D06 Q9P0W9,Glucosidase 2 subunit beta,80K-H protein {ECO:0000303|PubMed:2793184};Glucosidase II subunit beta;Protein kinase C substrate 60.1 kDa protein heavy chain;, PF13202;PF12999;PF13015;, GO:0005783;GO:0005788;GO:0017177;GO:0043231;GO:0005509;GO:0044325;GO:0051219;GO:0005080;GO:0044267;GO:0035556;GO:0001889;GO:0006491;GO:0043687;GO:0006457;GO:0019082;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:glucosidase II complex; C:intracellular membrane-bounded organelle;, F:calcium ion binding; F:ion channel binding; F:phosphoprotein binding; F:protein kinase C binding;, P:cellular protein metabolic process; P:intracellular signal transduction; P:liver development; P:N-glycan processing; P:post-translational protein modification; P:protein folding; P:viral protein processing; scaffold103 indexed_genome mRNA 5812443 5828498 . - . ID=transcript_13087;Q14576 Q16135 Q96CL8 Q96QS9,ELAV-like protein 3,Hu-antigen C;Paraneoplastic cerebellar degeneration-associated antigen;Paraneoplastic limbic encephalitis antigen 21;, PF00076;, GO:1990904;GO:0035925;GO:0030154;GO:0007399;, C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding;, P:cell differentiation; P:nervous system development;|Q14576 Q16135 Q96CL8 Q96QS9,ELAV-like protein 3,Hu-antigen C;Paraneoplastic cerebellar degeneration-associated antigen;Paraneoplastic limbic encephalitis antigen 21;, PF00076;, GO:1990904;GO:0035925;GO:0030154;GO:0007399;, C:ribonucleoprotein complex;, F:mRNA 3'-UTR AU-rich region binding;, P:cell differentiation; P:nervous system development; scaffold103 indexed_genome mRNA 5830653 5834887 . - . ID=transcript_13088;Q96CK0 Q96AS7,Zinc finger protein 653,67 kDa zinc finger protein;Zinc finger protein Zip67;, PF00096;, GO:0005576;GO:0005634;GO:0050682;GO:0003677;GO:0046872;GO:0003712;GO:0003714;GO:0008134;GO:1900116;GO:1903507;GO:0006357;, C:extracellular region; C:nucleus;, F:AF-2 domain binding; F:DNA binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:extracellular negative regulation of signal transduction; P:negative regulation of nucleic acid-templated transcription; P:regulation of transcription by RNA polymerase II;|Q96CK0 Q96AS7,Zinc finger protein 653,67 kDa zinc finger protein;Zinc finger protein Zip67;, PF00096;, GO:0005576;GO:0005634;GO:0050682;GO:0003677;GO:0046872;GO:0003712;GO:0003714;GO:0008134;GO:1900116;GO:1903507;GO:0006357;, C:extracellular region; C:nucleus;, F:AF-2 domain binding; F:DNA binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:extracellular negative regulation of signal transduction; P:negative regulation of nucleic acid-templated transcription; P:regulation of transcription by RNA polymerase II;|Q96CK0 Q96AS7,Zinc finger protein 653,67 kDa zinc finger protein;Zinc finger protein Zip67;, PF00096;, GO:0005576;GO:0005634;GO:0050682;GO:0003677;GO:0046872;GO:0003712;GO:0003714;GO:0008134;GO:1900116;GO:1903507;GO:0006357;, C:extracellular region; C:nucleus;, F:AF-2 domain binding; F:DNA binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:extracellular negative regulation of signal transduction; P:negative regulation of nucleic acid-templated transcription; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 5839582 5844727 . - . ID=transcript_13089;Q96CK0 Q96AS7,Zinc finger protein 653,67 kDa zinc finger protein;Zinc finger protein Zip67;, PF00096;, GO:0005576;GO:0005634;GO:0050682;GO:0003677;GO:0046872;GO:0003712;GO:0003714;GO:0008134;GO:1900116;GO:1903507;GO:0006357;, C:extracellular region; C:nucleus;, F:AF-2 domain binding; F:DNA binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:extracellular negative regulation of signal transduction; P:negative regulation of nucleic acid-templated transcription; P:regulation of transcription by RNA polymerase II;|Q96CK0 Q96AS7,Zinc finger protein 653,67 kDa zinc finger protein;Zinc finger protein Zip67;, PF00096;, GO:0005576;GO:0005634;GO:0050682;GO:0003677;GO:0046872;GO:0003712;GO:0003714;GO:0008134;GO:1900116;GO:1903507;GO:0006357;, C:extracellular region; C:nucleus;, F:AF-2 domain binding; F:DNA binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:extracellular negative regulation of signal transduction; P:negative regulation of nucleic acid-templated transcription; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 5845095 5863214 . + . ID=transcript_13090;Q9BQ95 E9PAN9 K7EMM0 Q96HQ7 Q9NYI1,Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial,Protein SITPEC;, PF06239;PF14784;, GO:0005737;GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005634;GO:0045087;GO:0032981;GO:0051341;GO:0061635;, C:cytoplasm; C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, , P:innate immune response; P:mitochondrial respiratory chain complex I assembly; P:regulation of oxidoreductase activity; P:regulation of protein complex stability;|Q9BQ95 E9PAN9 K7EMM0 Q96HQ7 Q9NYI1,Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial,Protein SITPEC;, PF06239;PF14784;, GO:0005737;GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005634;GO:0045087;GO:0032981;GO:0051341;GO:0061635;, C:cytoplasm; C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, , P:innate immune response; P:mitochondrial respiratory chain complex I assembly; P:regulation of oxidoreductase activity; P:regulation of protein complex stability;|Q9BQ95 E9PAN9 K7EMM0 Q96HQ7 Q9NYI1,Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial,Protein SITPEC;, PF06239;PF14784;, GO:0005737;GO:0005829;GO:0005743;GO:0005739;GO:0005654;GO:0005634;GO:0045087;GO:0032981;GO:0051341;GO:0061635;, C:cytoplasm; C:cytosol; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, , P:innate immune response; P:mitochondrial respiratory chain complex I assembly; P:regulation of oxidoreductase activity; P:regulation of protein complex stability; scaffold103 indexed_genome mRNA 5872221 5875571 . + . ID=transcript_13091;P51911 B2R868 B4DUX6 O00638 Q15416 Q8IY93 Q99438,Calponin-1,Basic calponin;Calponin H1, smooth muscle;, PF00402;PF00307;, GO:0005856;GO:0005925;GO:0003779;GO:0005516;GO:0031032;GO:1904706;GO:0006940;, C:cytoskeleton; C:focal adhesion;, F:actin binding; F:calmodulin binding;, P:actomyosin structure organization; P:negative regulation of vascular associated smooth muscle cell proliferation; P:regulation of smooth muscle contraction;|P51911 B2R868 B4DUX6 O00638 Q15416 Q8IY93 Q99438,Calponin-1,Basic calponin;Calponin H1, smooth muscle;, PF00402;PF00307;, GO:0005856;GO:0005925;GO:0003779;GO:0005516;GO:0031032;GO:1904706;GO:0006940;, C:cytoskeleton; C:focal adhesion;, F:actin binding; F:calmodulin binding;, P:actomyosin structure organization; P:negative regulation of vascular associated smooth muscle cell proliferation; P:regulation of smooth muscle contraction; scaffold103 indexed_genome mRNA 5876011 5880060 . + . ID=transcript_13092;P51911 B2R868 B4DUX6 O00638 Q15416 Q8IY93 Q99438,Calponin-1,Basic calponin;Calponin H1, smooth muscle;, PF00402;PF00307;, GO:0005856;GO:0005925;GO:0003779;GO:0005516;GO:0031032;GO:1904706;GO:0006940;, C:cytoskeleton; C:focal adhesion;, F:actin binding; F:calmodulin binding;, P:actomyosin structure organization; P:negative regulation of vascular associated smooth muscle cell proliferation; P:regulation of smooth muscle contraction;|P51911 B2R868 B4DUX6 O00638 Q15416 Q8IY93 Q99438,Calponin-1,Basic calponin;Calponin H1, smooth muscle;, PF00402;PF00307;, GO:0005856;GO:0005925;GO:0003779;GO:0005516;GO:0031032;GO:1904706;GO:0006940;, C:cytoskeleton; C:focal adhesion;, F:actin binding; F:calmodulin binding;, P:actomyosin structure organization; P:negative regulation of vascular associated smooth muscle cell proliferation; P:regulation of smooth muscle contraction; scaffold103 indexed_genome mRNA 5882508 5890520 . - . ID=transcript_13093;P60002 Q8R1J7 Q96II4,Transcription elongation factor 1 homolog,, PF05129;, GO:0008023;GO:0046872;GO:0000993;GO:0048096;GO:0006368;, C:transcription elongation factor complex;, F:metal ion binding; F:RNA polymerase II complex binding;, P:chromatin-mediated maintenance of transcription; P:transcription elongation from RNA polymerase II promoter; scaffold103 indexed_genome mRNA 5899372 5901941 . - . ID=transcript_13094;P13686 A8K3V2 Q2TAB1 Q6IAS6 Q9UCJ5 Q9UCJ6 Q9UCJ7,Tartrate-resistant acid phosphatase type 5,Tartrate-resistant acid ATPase;Type 5 acid phosphatase;, PF00149;, GO:0005829;GO:0016021;GO:0005764;GO:0003993;GO:0008199;GO:0008198;GO:0045453;GO:0001503;GO:0006771;, C:cytosol; C:integral component of membrane; C:lysosome;, F:acid phosphatase activity; F:ferric iron binding; F:ferrous iron binding;, P:bone resorption; P:ossification; P:riboflavin metabolic process;|P13686 A8K3V2 Q2TAB1 Q6IAS6 Q9UCJ5 Q9UCJ6 Q9UCJ7,Tartrate-resistant acid phosphatase type 5,Tartrate-resistant acid ATPase;Type 5 acid phosphatase;, PF00149;, GO:0005829;GO:0016021;GO:0005764;GO:0003993;GO:0008199;GO:0008198;GO:0045453;GO:0001503;GO:0006771;, C:cytosol; C:integral component of membrane; C:lysosome;, F:acid phosphatase activity; F:ferric iron binding; F:ferrous iron binding;, P:bone resorption; P:ossification; P:riboflavin metabolic process; scaffold103 indexed_genome mRNA 5995082 6022120 . + . ID=transcript_13095;Q96NG5 A8K5F0 B7Z798,Zinc finger protein 558,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96NG5 A8K5F0 B7Z798,Zinc finger protein 558,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96NG5 A8K5F0 B7Z798,Zinc finger protein 558,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold103 indexed_genome mRNA 6060074 6192070 . - . ID=transcript_13096;P06213 Q17RW0 Q59H98 Q9UCB7 Q9UCB8 Q9UCB9,Insulin receptor,, PF00757;PF17870;PF07714;PF01030;, GO:0030424;GO:0005901;GO:0032590;GO:0010008;GO:0009897;GO:0070062;GO:0005899;GO:0005887;GO:0005770;GO:0005764;GO:0016020;GO:0032809;GO:0005886;GO:0043235;GO:0001540;GO:0005524;GO:0038024;GO:0005525;GO:0042802;GO:0043559;GO:0043560;GO:0005009;GO:0031994;GO:0031995;GO:0005159;GO:0043548;GO:0019904;GO:0004713;GO:0044877;GO:0051425;GO:0005198;GO:0004714;GO:0000187;GO:0032147;GO:0032148;GO:0097242;GO:0005975;GO:0032869;GO:0097062;GO:0007186;GO:0042593;GO:0003007;GO:0008286;GO:0007612;GO:0007613;GO:0007275;GO:1990535;GO:0018108;GO:0030335;GO:0008284;GO:0048639;GO:0046326;GO:0045725;GO:0045821;GO:0033674;GO:0043410;GO:0045840;GO:0045429;GO:0014068;GO:0051897;GO:0001934;GO:0043243;GO:0002092;GO:0060267;GO:0046777;GO:0006468;GO:0006898;GO:0045995;GO:0006355;GO:0019087;GO:0007169;GO:0150104;, C:axon; C:caveola; C:dendrite membrane; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:insulin receptor complex; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:membrane; C:neuronal cell body membrane; C:plasma membrane; C:receptor complex;, F:amyloid-beta binding; F:ATP binding; F:cargo receptor activity; F:GTP binding; F:identical protein binding; F:insulin binding; F:insulin receptor substrate binding; F:insulin-activated receptor activity; F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:insulin-like growth factor receptor binding; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:PTB domain binding; F:structural molecule activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:activation of protein kinase activity; P:activation of protein kinase B activity; P:amyloid-beta clearance; P:carbohydrate metabolic process; P:cellular response to insulin stimulus; P:dendritic spine maintenance; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:heart morphogenesis; P:insulin receptor signaling pathway; P:learning; P:memory; P:multicellular organism development; P:neuron projection maintenance; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of developmental growth; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mitotic nuclear division; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex disassembly; P:positive regulation of receptor internalization; P:positive regulation of respiratory burst; P:protein autophosphorylation; P:protein phosphorylation; P:receptor-mediated endocytosis; P:regulation of embryonic development; P:regulation of transcription, DNA-templated; P:transformation of host cell by virus; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:transport across blood-brain barrier;|P06213 Q17RW0 Q59H98 Q9UCB7 Q9UCB8 Q9UCB9,Insulin receptor,, PF00757;PF17870;PF07714;PF01030;, GO:0030424;GO:0005901;GO:0032590;GO:0010008;GO:0009897;GO:0070062;GO:0005899;GO:0005887;GO:0005770;GO:0005764;GO:0016020;GO:0032809;GO:0005886;GO:0043235;GO:0001540;GO:0005524;GO:0038024;GO:0005525;GO:0042802;GO:0043559;GO:0043560;GO:0005009;GO:0031994;GO:0031995;GO:0005159;GO:0043548;GO:0019904;GO:0004713;GO:0044877;GO:0051425;GO:0005198;GO:0004714;GO:0000187;GO:0032147;GO:0032148;GO:0097242;GO:0005975;GO:0032869;GO:0097062;GO:0007186;GO:0042593;GO:0003007;GO:0008286;GO:0007612;GO:0007613;GO:0007275;GO:1990535;GO:0018108;GO:0030335;GO:0008284;GO:0048639;GO:0046326;GO:0045725;GO:0045821;GO:0033674;GO:0043410;GO:0045840;GO:0045429;GO:0014068;GO:0051897;GO:0001934;GO:0043243;GO:0002092;GO:0060267;GO:0046777;GO:0006468;GO:0006898;GO:0045995;GO:0006355;GO:0019087;GO:0007169;GO:0150104;, C:axon; C:caveola; C:dendrite membrane; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:insulin receptor complex; C:integral component of plasma membrane; C:late endosome; C:lysosome; C:membrane; C:neuronal cell body membrane; C:plasma membrane; C:receptor complex;, F:amyloid-beta binding; F:ATP binding; F:cargo receptor activity; F:GTP binding; F:identical protein binding; F:insulin binding; F:insulin receptor substrate binding; F:insulin-activated receptor activity; F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:insulin-like growth factor receptor binding; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:PTB domain binding; F:structural molecule activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:activation of protein kinase activity; P:activation of protein kinase B activity; P:amyloid-beta clearance; P:carbohydrate metabolic process; P:cellular response to insulin stimulus; P:dendritic spine maintenance; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:heart morphogenesis; P:insulin receptor signaling pathway; P:learning; P:memory; P:multicellular organism development; P:neuron projection maintenance; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of developmental growth; P:positive regulation of glucose import; P:positive regulation of glycogen biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mitotic nuclear division; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein-containing complex disassembly; P:positive regulation of receptor internalization; P:positive regulation of respiratory burst; P:protein autophosphorylation; P:protein phosphorylation; P:receptor-mediated endocytosis; P:regulation of embryonic development; P:regulation of transcription, DNA-templated; P:transformation of host cell by virus; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:transport across blood-brain barrier; scaffold103 indexed_genome mRNA 6287335 6355437 . + . ID=transcript_13097;Q6ZSZ5 A8MV62 B5ME81 I3L1I5 O60274 Q6DD92,Rho guanine nucleotide exchange factor 18,114 kDa Rho-specific guanine nucleotide exchange factor;Septin-associated RhoGEF;, PF17838;PF00621;, GO:0045177;GO:0016324;GO:0030054;GO:0005856;GO:0005829;GO:0070062;GO:0005886;GO:0005085;GO:0046872;GO:0030036;GO:0007186;GO:0051497;GO:0043065;GO:0150105;GO:0008360;GO:0035023;GO:0051056;GO:0007264;GO:0007179;, C:apical part of cell; C:apical plasma membrane; C:cell junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:negative regulation of stress fiber assembly; P:positive regulation of apoptotic process; P:protein localization to cell-cell junction; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; P:transforming growth factor beta receptor signaling pathway;|Q6ZSZ5 A8MV62 B5ME81 I3L1I5 O60274 Q6DD92,Rho guanine nucleotide exchange factor 18,114 kDa Rho-specific guanine nucleotide exchange factor;Septin-associated RhoGEF;, PF17838;PF00621;, GO:0045177;GO:0016324;GO:0030054;GO:0005856;GO:0005829;GO:0070062;GO:0005886;GO:0005085;GO:0046872;GO:0030036;GO:0007186;GO:0051497;GO:0043065;GO:0150105;GO:0008360;GO:0035023;GO:0051056;GO:0007264;GO:0007179;, C:apical part of cell; C:apical plasma membrane; C:cell junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding;, P:actin cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:negative regulation of stress fiber assembly; P:positive regulation of apoptotic process; P:protein localization to cell-cell junction; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; P:transforming growth factor beta receptor signaling pathway; scaffold103 indexed_genome mRNA 6356624 6367008 . - . ID=transcript_13098;Q96HA9 Q8NDM0,Peroxisomal membrane protein 11C,Peroxin-11C;Peroxisomal biogenesis factor 11C;Protein PEX11 homolog gamma;, PF05648;, GO:0005779;GO:0031231;GO:0005777;GO:0032991;GO:0016559;GO:0044375;, C:integral component of peroxisomal membrane; C:intrinsic component of peroxisomal membrane; C:peroxisome; C:protein-containing complex;, , P:peroxisome fission; P:regulation of peroxisome size; scaffold103 indexed_genome mRNA 6388780 6389943 . + . ID=transcript_13099;Q8NA69 Q8N115,Testis-expressed protein 45,, PF15373; scaffold103 indexed_genome mRNA 6406020 6416654 . + . ID=transcript_13100;Q9GZU1 D6W647 Q7Z4F7 Q9H292 Q9H4B3 Q9H4B5,Mucolipin-1 {ECO:0000303|PubMed:12459486},MG-2;Mucolipidin {ECO:0000303|PubMed:11013137};Transient receptor potential channel mucolipin 1;, PF08016;, GO:0042995;GO:0010008;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0005654;GO:0001891;GO:0030670;GO:0005886;GO:0043235;GO:0005261;GO:0097682;GO:0099604;GO:0008289;GO:0072345;GO:0002250;GO:0097352;GO:0070588;GO:0006812;GO:0071277;GO:0071467;GO:0034755;GO:0090382;GO:0051289;GO:0033572;, C:cell projection; C:endosome membrane; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:nucleoplasm; C:phagocytic cup; C:phagocytic vesicle membrane; C:plasma membrane; C:receptor complex;, F:cation channel activity; F:intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity; F:ligand-gated calcium channel activity; F:lipid binding; F:NAADP-sensitive calcium-release channel activity;, P:adaptive immune response; P:autophagosome maturation; P:calcium ion transmembrane transport; P:cation transport; P:cellular response to calcium ion; P:cellular response to pH; P:iron ion transmembrane transport; P:phagosome maturation; P:protein homotetramerization; P:transferrin transport;|Q9GZU1 D6W647 Q7Z4F7 Q9H292 Q9H4B3 Q9H4B5,Mucolipin-1 {ECO:0000303|PubMed:12459486},MG-2;Mucolipidin {ECO:0000303|PubMed:11013137};Transient receptor potential channel mucolipin 1;, PF08016;, GO:0042995;GO:0010008;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0005654;GO:0001891;GO:0030670;GO:0005886;GO:0043235;GO:0005261;GO:0097682;GO:0099604;GO:0008289;GO:0072345;GO:0002250;GO:0097352;GO:0070588;GO:0006812;GO:0071277;GO:0071467;GO:0034755;GO:0090382;GO:0051289;GO:0033572;, C:cell projection; C:endosome membrane; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:nucleoplasm; C:phagocytic cup; C:phagocytic vesicle membrane; C:plasma membrane; C:receptor complex;, F:cation channel activity; F:intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity; F:ligand-gated calcium channel activity; F:lipid binding; F:NAADP-sensitive calcium-release channel activity;, P:adaptive immune response; P:autophagosome maturation; P:calcium ion transmembrane transport; P:cation transport; P:cellular response to calcium ion; P:cellular response to pH; P:iron ion transmembrane transport; P:phagosome maturation; P:protein homotetramerization; P:transferrin transport;|Q9GZU1 D6W647 Q7Z4F7 Q9H292 Q9H4B3 Q9H4B5,Mucolipin-1 {ECO:0000303|PubMed:12459486},MG-2;Mucolipidin {ECO:0000303|PubMed:11013137};Transient receptor potential channel mucolipin 1;, PF08016;, GO:0042995;GO:0010008;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0005654;GO:0001891;GO:0030670;GO:0005886;GO:0043235;GO:0005261;GO:0097682;GO:0099604;GO:0008289;GO:0072345;GO:0002250;GO:0097352;GO:0070588;GO:0006812;GO:0071277;GO:0071467;GO:0034755;GO:0090382;GO:0051289;GO:0033572;, C:cell projection; C:endosome membrane; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:nucleoplasm; C:phagocytic cup; C:phagocytic vesicle membrane; C:plasma membrane; C:receptor complex;, F:cation channel activity; F:intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity; F:ligand-gated calcium channel activity; F:lipid binding; F:NAADP-sensitive calcium-release channel activity;, P:adaptive immune response; P:autophagosome maturation; P:calcium ion transmembrane transport; P:cation transport; P:cellular response to calcium ion; P:cellular response to pH; P:iron ion transmembrane transport; P:phagosome maturation; P:protein homotetramerization; P:transferrin transport;|Q9GZU1 D6W647 Q7Z4F7 Q9H292 Q9H4B3 Q9H4B5,Mucolipin-1 {ECO:0000303|PubMed:12459486},MG-2;Mucolipidin {ECO:0000303|PubMed:11013137};Transient receptor potential channel mucolipin 1;, PF08016;, GO:0042995;GO:0010008;GO:0005794;GO:0016021;GO:0005887;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0005654;GO:0001891;GO:0030670;GO:0005886;GO:0043235;GO:0005261;GO:0097682;GO:0099604;GO:0008289;GO:0072345;GO:0002250;GO:0097352;GO:0070588;GO:0006812;GO:0071277;GO:0071467;GO:0034755;GO:0090382;GO:0051289;GO:0033572;, C:cell projection; C:endosome membrane; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:nucleoplasm; C:phagocytic cup; C:phagocytic vesicle membrane; C:plasma membrane; C:receptor complex;, F:cation channel activity; F:intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity; F:ligand-gated calcium channel activity; F:lipid binding; F:NAADP-sensitive calcium-release channel activity;, P:adaptive immune response; P:autophagosome maturation; P:calcium ion transmembrane transport; P:cation transport; P:cellular response to calcium ion; P:cellular response to pH; P:iron ion transmembrane transport; P:phagosome maturation; P:protein homotetramerization; P:transferrin transport; scaffold103 indexed_genome mRNA 6416782 6441204 . + . ID=transcript_13101;Q8IY17 A6NGQ0 B4DFB9 B7Z7T2 F5H5K9 J3KQS3 O60859 Q86W58 Q9UG58,Patatin-like phospholipase domain-containing protein 6 {ECO:0000305},Neuropathy target esterase {ECO:0000303|PubMed:9576844};, PF00027;PF01734;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0004622;GO:0102545;GO:0046475;GO:0046470;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:glycerophospholipid catabolic process; P:phosphatidylcholine metabolic process;|Q8IY17 A6NGQ0 B4DFB9 B7Z7T2 F5H5K9 J3KQS3 O60859 Q86W58 Q9UG58,Patatin-like phospholipase domain-containing protein 6 {ECO:0000305},Neuropathy target esterase {ECO:0000303|PubMed:9576844};, PF00027;PF01734;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0004622;GO:0102545;GO:0046475;GO:0046470;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:glycerophospholipid catabolic process; P:phosphatidylcholine metabolic process;|Q8IY17 A6NGQ0 B4DFB9 B7Z7T2 F5H5K9 J3KQS3 O60859 Q86W58 Q9UG58,Patatin-like phospholipase domain-containing protein 6 {ECO:0000305},Neuropathy target esterase {ECO:0000303|PubMed:9576844};, PF00027;PF01734;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0004622;GO:0102545;GO:0046475;GO:0046470;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:glycerophospholipid catabolic process; P:phosphatidylcholine metabolic process;|Q8IY17 A6NGQ0 B4DFB9 B7Z7T2 F5H5K9 J3KQS3 O60859 Q86W58 Q9UG58,Patatin-like phospholipase domain-containing protein 6 {ECO:0000305},Neuropathy target esterase {ECO:0000303|PubMed:9576844};, PF00027;PF01734;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0004622;GO:0102545;GO:0046475;GO:0046470;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:lysophospholipase activity; F:phosphatidyl phospholipase B activity;, P:glycerophospholipid catabolic process; P:phosphatidylcholine metabolic process; scaffold103 indexed_genome mRNA 6474518 6483054 . + . ID=transcript_13102;Q9P1Y5 Q8NDF1,Calmodulin-regulated spectrin-associated protein 3 {ECO:0000305},Protein Nezha {ECO:0000303|PubMed:23169647};, PF17095;PF11971;PF08683;, GO:0005930;GO:0005813;GO:0036064;GO:0005737;GO:0036449;GO:0031514;GO:0005654;GO:0005915;GO:0051015;GO:0005516;GO:0051011;GO:0030507;GO:0003341;GO:0031122;GO:0009792;GO:0090136;GO:0045198;GO:0030951;GO:0001701;GO:0034453;GO:0000226;GO:0007026;GO:0010923;GO:0031175;GO:0098840;GO:0030334;GO:0051893;GO:1903358;GO:0070507;GO:0031113;GO:0033043;GO:0045218;, C:axoneme; C:centrosome; C:ciliary basal body; C:cytoplasm; C:microtubule minus-end; C:motile cilium; C:nucleoplasm; C:zonula adherens;, F:actin filament binding; F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:cilium movement; P:cytoplasmic microtubule organization; P:embryo development ending in birth or egg hatching; P:epithelial cell-cell adhesion; P:establishment of epithelial cell apical/basal polarity; P:establishment or maintenance of microtubule cytoskeleton polarity; P:in utero embryonic development; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:negative regulation of phosphatase activity; P:neuron projection development; P:protein transport along microtubule; P:regulation of cell migration; P:regulation of focal adhesion assembly; P:regulation of Golgi organization; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule polymerization; P:regulation of organelle organization; P:zonula adherens maintenance;|Q9P1Y5 Q8NDF1,Calmodulin-regulated spectrin-associated protein 3 {ECO:0000305},Protein Nezha {ECO:0000303|PubMed:23169647};, PF17095;PF11971;PF08683;, GO:0005930;GO:0005813;GO:0036064;GO:0005737;GO:0036449;GO:0031514;GO:0005654;GO:0005915;GO:0051015;GO:0005516;GO:0051011;GO:0030507;GO:0003341;GO:0031122;GO:0009792;GO:0090136;GO:0045198;GO:0030951;GO:0001701;GO:0034453;GO:0000226;GO:0007026;GO:0010923;GO:0031175;GO:0098840;GO:0030334;GO:0051893;GO:1903358;GO:0070507;GO:0031113;GO:0033043;GO:0045218;, C:axoneme; C:centrosome; C:ciliary basal body; C:cytoplasm; C:microtubule minus-end; C:motile cilium; C:nucleoplasm; C:zonula adherens;, F:actin filament binding; F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:cilium movement; P:cytoplasmic microtubule organization; P:embryo development ending in birth or egg hatching; P:epithelial cell-cell adhesion; P:establishment of epithelial cell apical/basal polarity; P:establishment or maintenance of microtubule cytoskeleton polarity; P:in utero embryonic development; P:microtubule anchoring; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:negative regulation of phosphatase activity; P:neuron projection development; P:protein transport along microtubule; P:regulation of cell migration; P:regulation of focal adhesion assembly; P:regulation of Golgi organization; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule polymerization; P:regulation of organelle organization; P:zonula adherens maintenance; scaffold103 indexed_genome mRNA 6484243 6492094 . - . ID=transcript_13103;Q9HCS7 Q8TET6 Q96HB0 Q96IW0 Q9NRG6 Q9ULP3,Pre-mRNA-splicing factor SYF1,Protein HCNP;XPA-binding protein 2;, PF13181;, GO:0071013;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0071014;GO:0000974;GO:0071007;GO:0001824;GO:0021987;GO:0000349;GO:0000398;GO:0006351;GO:0006283;, C:catalytic step 2 spliceosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 2 spliceosome;, , P:blastocyst development; P:cerebral cortex development; P:generation of catalytic spliceosome for first transesterification step; P:mRNA splicing, via spliceosome; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|Q9HCS7 Q8TET6 Q96HB0 Q96IW0 Q9NRG6 Q9ULP3,Pre-mRNA-splicing factor SYF1,Protein HCNP;XPA-binding protein 2;, PF13181;, GO:0071013;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0071014;GO:0000974;GO:0071007;GO:0001824;GO:0021987;GO:0000349;GO:0000398;GO:0006351;GO:0006283;, C:catalytic step 2 spliceosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 2 spliceosome;, , P:blastocyst development; P:cerebral cortex development; P:generation of catalytic spliceosome for first transesterification step; P:mRNA splicing, via spliceosome; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|Q9HCS7 Q8TET6 Q96HB0 Q96IW0 Q9NRG6 Q9ULP3,Pre-mRNA-splicing factor SYF1,Protein HCNP;XPA-binding protein 2;, PF13181;, GO:0071013;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0071014;GO:0000974;GO:0071007;GO:0001824;GO:0021987;GO:0000349;GO:0000398;GO:0006351;GO:0006283;, C:catalytic step 2 spliceosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 2 spliceosome;, , P:blastocyst development; P:cerebral cortex development; P:generation of catalytic spliceosome for first transesterification step; P:mRNA splicing, via spliceosome; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; scaffold104 indexed_genome mRNA 66726 81929 . - . ID=transcript_13104;Q9NNW4 Q9UCJ4,Membrane cofactor protein,TLX;Trophoblast leukocyte common antigen;, PF00084;, GO:0009986;GO:0070062;GO:0005925;GO:0002079;GO:0005887;GO:0005886;GO:0045296;GO:0038023;GO:0001618;GO:0002250;GO:0006958;GO:0045087;GO:0010629;GO:0010628;GO:0032733;GO:0043382;GO:0045591;GO:0042102;GO:0071636;GO:0030449;GO:0008593;GO:0035581;GO:0007338;GO:0002456;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:inner acrosomal membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cadherin binding; F:signaling receptor activity; F:virus receptor activity;, P:adaptive immune response; P:complement activation, classical pathway; P:innate immune response; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of interleukin-10 production; P:positive regulation of memory T cell differentiation; P:positive regulation of regulatory T cell differentiation; P:positive regulation of T cell proliferation; P:positive regulation of transforming growth factor beta production; P:regulation of complement activation; P:regulation of Notch signaling pathway; P:sequestering of extracellular ligand from receptor; P:single fertilization; P:T cell mediated immunity;|Q9NNW4 Q9UCJ4,Membrane cofactor protein,TLX;Trophoblast leukocyte common antigen;, PF00084;, GO:0009986;GO:0070062;GO:0005925;GO:0002079;GO:0005887;GO:0005886;GO:0045296;GO:0038023;GO:0001618;GO:0002250;GO:0006958;GO:0045087;GO:0010629;GO:0010628;GO:0032733;GO:0043382;GO:0045591;GO:0042102;GO:0071636;GO:0030449;GO:0008593;GO:0035581;GO:0007338;GO:0002456;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:inner acrosomal membrane; C:integral component of plasma membrane; C:plasma membrane;, F:cadherin binding; F:signaling receptor activity; F:virus receptor activity;, P:adaptive immune response; P:complement activation, classical pathway; P:innate immune response; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of interleukin-10 production; P:positive regulation of memory T cell differentiation; P:positive regulation of regulatory T cell differentiation; P:positive regulation of T cell proliferation; P:positive regulation of transforming growth factor beta production; P:regulation of complement activation; P:regulation of Notch signaling pathway; P:sequestering of extracellular ligand from receptor; P:single fertilization; P:T cell mediated immunity; scaffold104 indexed_genome mRNA 134328 142040 . + . ID=transcript_13105;P36980 Q14310 Q5T9T1,Complement factor H-related protein 2,DDESK59;H factor-like 3;H factor-like protein 2;, PF00084;, GO:0005576;GO:0032991;GO:0042802;GO:0051838;GO:0032091;GO:0030449;, C:extracellular region; C:protein-containing complex;, F:identical protein binding;, P:cytolysis by host of symbiont cells; P:negative regulation of protein binding; P:regulation of complement activation; scaffold104 indexed_genome mRNA 155285 163478 . + . ID=transcript_13106;P05160 A8K3E5 Q5VYL5,Coagulation factor XIII B chain,Fibrin-stabilizing factor B subunit;Protein-glutamine gamma-glutamyltransferase B chain;Transglutaminase B chain;, PF00084;, GO:0005576;GO:0007596;, C:extracellular region;, , P:blood coagulation; scaffold104 indexed_genome mRNA 164073 175847 . - . ID=transcript_13107;P05160 A8K3E5 Q5VYL5,Coagulation factor XIII B chain,Fibrin-stabilizing factor B subunit;Protein-glutamine gamma-glutamyltransferase B chain;Transglutaminase B chain;, PF00084;, GO:0005576;GO:0007596;, C:extracellular region;, , P:blood coagulation;|P05160 A8K3E5 Q5VYL5,Coagulation factor XIII B chain,Fibrin-stabilizing factor B subunit;Protein-glutamine gamma-glutamyltransferase B chain;Transglutaminase B chain;, PF00084;, GO:0005576;GO:0007596;, C:extracellular region;, , P:blood coagulation; scaffold104 indexed_genome mRNA 187322 213742 . + . ID=transcript_13108;P08603 A5PL14 P78435 Q14570 Q2TAZ5 Q38G77 Q5TFM3 Q8N708 Q9NU86,Complement factor H,H factor 1;, PF00084;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0043395;GO:0008201;GO:0042802;GO:0006956;GO:0006957;GO:0030449;GO:1903659;GO:0016032;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:heparan sulfate proteoglycan binding; F:heparin binding; F:identical protein binding;, P:complement activation; P:complement activation, alternative pathway; P:regulation of complement activation; P:regulation of complement-dependent cytotoxicity; P:viral process; scaffold104 indexed_genome mRNA 294142 327008 . - . ID=transcript_13109;Q5SVQ8 A2RUA8 Q6MZT8 Q6ZR25 Q7Z4T1 Q8IZ99,Zinc finger and BTB domain-containing protein 41,, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5SVQ8 A2RUA8 Q6MZT8 Q6ZR25 Q7Z4T1 Q8IZ99,Zinc finger and BTB domain-containing protein 41,, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold104 indexed_genome mRNA 638251 793363 . - . ID=transcript_13110;Q8TBE6 Q9H774 Q9NXU2,DENN domain-containing protein 1B {ECO:0000312|HGNC:HGNC:28404},Connecdenn 2 {ECO:0000303|PubMed:20154091};Protein FAM31B {ECO:0000312|HGNC:HGNC:28404};, PF03455;PF02141;PF03456;, GO:0030136;GO:0005829;GO:0043231;GO:0016607;GO:0005085;GO:1901981;GO:0031267;GO:0032456;GO:0006897;GO:0043547;GO:2000553;GO:0015031;GO:0050776;GO:0050852;, C:clathrin-coated vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytic recycling; P:endocytosis; P:positive regulation of GTPase activity; P:positive regulation of T-helper 2 cell cytokine production; P:protein transport; P:regulation of immune response; P:T cell receptor signaling pathway; scaffold104 indexed_genome mRNA 1296812 1362936 . + . ID=transcript_13111;Q8TDX7 A6NGT8,Serine/threonine-protein kinase Nek7,Never in mitosis A-related kinase 7;, PF00069;, GO:0005737;GO:0005874;GO:0005815;GO:0005654;GO:0000922;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0051973;GO:1904355;GO:0032212;GO:0006468;GO:0007346;GO:0051225;, C:cytoplasm; C:microtubule; C:microtubule organizing center; C:nucleoplasm; C:spindle pole;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein phosphorylation; P:regulation of mitotic cell cycle; P:spindle assembly; scaffold104 indexed_genome mRNA 1732310 1734825 . + . ID=transcript_13112;P08575 A0A0A0MT22 A8K7W6 Q16614 Q9H0Y6 X6R433,Receptor-type tyrosine-protein phosphatase C {ECO:0000305},Leukocyte common antigen;T200;, PF12567;PF00041;PF12453;PF00102;, GO:0032059;GO:0009986;GO:0009898;GO:0009897;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0016020;GO:0098857;GO:0045121;GO:0005886;GO:0030667;GO:0030506;GO:0043395;GO:0008201;GO:0019901;GO:0004725;GO:0005102;GO:0030507;GO:0005001;GO:0000187;GO:0030183;GO:0042100;GO:0050853;GO:0048539;GO:0035584;GO:0044770;GO:0007166;GO:0031668;GO:0051607;GO:0016311;GO:1904155;GO:0002244;GO:0034113;GO:0007159;GO:0001779;GO:0006933;GO:0001960;GO:0070373;GO:0032703;GO:1903979;GO:0031953;GO:0006469;GO:0061099;GO:0001915;GO:0045060;GO:0043312;GO:0044855;GO:0046641;GO:0050857;GO:0030890;GO:0070374;GO:2001238;GO:1905451;GO:0045588;GO:2000473;GO:0002925;GO:0002639;GO:0032743;GO:0048304;GO:0043410;GO:0050731;GO:0045860;GO:1903615;GO:2000648;GO:0001916;GO:0042102;GO:0032760;GO:0045059;GO:0006470;GO:0051726;GO:0010468;GO:0032677;GO:0050764;GO:0061097;GO:0046425;GO:0051209;GO:0010332;GO:0048864;GO:0042110;GO:0030217;GO:0042098;GO:0050852;GO:0016032;, C:bleb; C:cell surface; C:cytoplasmic side of plasma membrane; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:membrane microdomain; C:membrane raft; C:plasma membrane; C:secretory granule membrane;, F:ankyrin binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:spectrin binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:activation of MAPK activity; P:B cell differentiation; P:B cell proliferation; P:B cell receptor signaling pathway; P:bone marrow development; P:calcium-mediated signaling using intracellular calcium source; P:cell cycle phase transition; P:cell surface receptor signaling pathway; P:cellular response to extracellular stimulus; P:defense response to virus; P:dephosphorylation; P:DN2 thymocyte differentiation; P:hematopoietic progenitor cell differentiation; P:heterotypic cell-cell adhesion; P:leukocyte cell-cell adhesion; P:natural killer cell differentiation; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-2 production; P:negative regulation of microglial cell activation; P:negative regulation of protein autophosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of T cell mediated cytotoxicity; P:negative thymic T cell selection; P:neutrophil degranulation; P:plasma membrane raft distribution; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of antigen receptor-mediated signaling pathway; P:positive regulation of B cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of hematopoietic stem cell migration; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-2 production; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein tyrosine phosphatase activity; P:positive regulation of stem cell proliferation; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:positive thymic T cell selection; P:protein dephosphorylation; P:regulation of cell cycle; P:regulation of gene expression; P:regulation of interleukin-8 production; P:regulation of phagocytosis; P:regulation of protein tyrosine kinase activity; P:regulation of receptor signaling pathway via JAK-STAT; P:release of sequestered calcium ion into cytosol; P:response to gamma radiation; P:stem cell development; P:T cell activation; P:T cell differentiation; P:T cell proliferation; P:T cell receptor signaling pathway; P:viral process; scaffold104 indexed_genome mRNA 1761320 1786650 . + . ID=transcript_13113;P08575 A0A0A0MT22 A8K7W6 Q16614 Q9H0Y6 X6R433,Receptor-type tyrosine-protein phosphatase C {ECO:0000305},Leukocyte common antigen;T200;, PF12567;PF00041;PF12453;PF00102;, GO:0032059;GO:0009986;GO:0009898;GO:0009897;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0016020;GO:0098857;GO:0045121;GO:0005886;GO:0030667;GO:0030506;GO:0043395;GO:0008201;GO:0019901;GO:0004725;GO:0005102;GO:0030507;GO:0005001;GO:0000187;GO:0030183;GO:0042100;GO:0050853;GO:0048539;GO:0035584;GO:0044770;GO:0007166;GO:0031668;GO:0051607;GO:0016311;GO:1904155;GO:0002244;GO:0034113;GO:0007159;GO:0001779;GO:0006933;GO:0001960;GO:0070373;GO:0032703;GO:1903979;GO:0031953;GO:0006469;GO:0061099;GO:0001915;GO:0045060;GO:0043312;GO:0044855;GO:0046641;GO:0050857;GO:0030890;GO:0070374;GO:2001238;GO:1905451;GO:0045588;GO:2000473;GO:0002925;GO:0002639;GO:0032743;GO:0048304;GO:0043410;GO:0050731;GO:0045860;GO:1903615;GO:2000648;GO:0001916;GO:0042102;GO:0032760;GO:0045059;GO:0006470;GO:0051726;GO:0010468;GO:0032677;GO:0050764;GO:0061097;GO:0046425;GO:0051209;GO:0010332;GO:0048864;GO:0042110;GO:0030217;GO:0042098;GO:0050852;GO:0016032;, C:bleb; C:cell surface; C:cytoplasmic side of plasma membrane; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:membrane microdomain; C:membrane raft; C:plasma membrane; C:secretory granule membrane;, F:ankyrin binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:spectrin binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:activation of MAPK activity; P:B cell differentiation; P:B cell proliferation; P:B cell receptor signaling pathway; P:bone marrow development; P:calcium-mediated signaling using intracellular calcium source; P:cell cycle phase transition; P:cell surface receptor signaling pathway; P:cellular response to extracellular stimulus; P:defense response to virus; P:dephosphorylation; P:DN2 thymocyte differentiation; P:hematopoietic progenitor cell differentiation; P:heterotypic cell-cell adhesion; P:leukocyte cell-cell adhesion; P:natural killer cell differentiation; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-2 production; P:negative regulation of microglial cell activation; P:negative regulation of protein autophosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of T cell mediated cytotoxicity; P:negative thymic T cell selection; P:neutrophil degranulation; P:plasma membrane raft distribution; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of antigen receptor-mediated signaling pathway; P:positive regulation of B cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of hematopoietic stem cell migration; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-2 production; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein tyrosine phosphatase activity; P:positive regulation of stem cell proliferation; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:positive thymic T cell selection; P:protein dephosphorylation; P:regulation of cell cycle; P:regulation of gene expression; P:regulation of interleukin-8 production; P:regulation of phagocytosis; P:regulation of protein tyrosine kinase activity; P:regulation of receptor signaling pathway via JAK-STAT; P:release of sequestered calcium ion into cytosol; P:response to gamma radiation; P:stem cell development; P:T cell activation; P:T cell differentiation; P:T cell proliferation; P:T cell receptor signaling pathway; P:viral process;|P08575 A0A0A0MT22 A8K7W6 Q16614 Q9H0Y6 X6R433,Receptor-type tyrosine-protein phosphatase C {ECO:0000305},Leukocyte common antigen;T200;, PF12567;PF00041;PF12453;PF00102;, GO:0032059;GO:0009986;GO:0009898;GO:0009897;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0016020;GO:0098857;GO:0045121;GO:0005886;GO:0030667;GO:0030506;GO:0043395;GO:0008201;GO:0019901;GO:0004725;GO:0005102;GO:0030507;GO:0005001;GO:0000187;GO:0030183;GO:0042100;GO:0050853;GO:0048539;GO:0035584;GO:0044770;GO:0007166;GO:0031668;GO:0051607;GO:0016311;GO:1904155;GO:0002244;GO:0034113;GO:0007159;GO:0001779;GO:0006933;GO:0001960;GO:0070373;GO:0032703;GO:1903979;GO:0031953;GO:0006469;GO:0061099;GO:0001915;GO:0045060;GO:0043312;GO:0044855;GO:0046641;GO:0050857;GO:0030890;GO:0070374;GO:2001238;GO:1905451;GO:0045588;GO:2000473;GO:0002925;GO:0002639;GO:0032743;GO:0048304;GO:0043410;GO:0050731;GO:0045860;GO:1903615;GO:2000648;GO:0001916;GO:0042102;GO:0032760;GO:0045059;GO:0006470;GO:0051726;GO:0010468;GO:0032677;GO:0050764;GO:0061097;GO:0046425;GO:0051209;GO:0010332;GO:0048864;GO:0042110;GO:0030217;GO:0042098;GO:0050852;GO:0016032;, C:bleb; C:cell surface; C:cytoplasmic side of plasma membrane; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:membrane microdomain; C:membrane raft; C:plasma membrane; C:secretory granule membrane;, F:ankyrin binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:spectrin binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:activation of MAPK activity; P:B cell differentiation; P:B cell proliferation; P:B cell receptor signaling pathway; P:bone marrow development; P:calcium-mediated signaling using intracellular calcium source; P:cell cycle phase transition; P:cell surface receptor signaling pathway; P:cellular response to extracellular stimulus; P:defense response to virus; P:dephosphorylation; P:DN2 thymocyte differentiation; P:hematopoietic progenitor cell differentiation; P:heterotypic cell-cell adhesion; P:leukocyte cell-cell adhesion; P:natural killer cell differentiation; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-2 production; P:negative regulation of microglial cell activation; P:negative regulation of protein autophosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of T cell mediated cytotoxicity; P:negative thymic T cell selection; P:neutrophil degranulation; P:plasma membrane raft distribution; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of antigen receptor-mediated signaling pathway; P:positive regulation of B cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of hematopoietic stem cell migration; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-2 production; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein tyrosine phosphatase activity; P:positive regulation of stem cell proliferation; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:positive thymic T cell selection; P:protein dephosphorylation; P:regulation of cell cycle; P:regulation of gene expression; P:regulation of interleukin-8 production; P:regulation of phagocytosis; P:regulation of protein tyrosine kinase activity; P:regulation of receptor signaling pathway via JAK-STAT; P:release of sequestered calcium ion into cytosol; P:response to gamma radiation; P:stem cell development; P:T cell activation; P:T cell differentiation; P:T cell proliferation; P:T cell receptor signaling pathway; P:viral process;|P08575 A0A0A0MT22 A8K7W6 Q16614 Q9H0Y6 X6R433,Receptor-type tyrosine-protein phosphatase C {ECO:0000305},Leukocyte common antigen;T200;, PF12567;PF00041;PF12453;PF00102;, GO:0032059;GO:0009986;GO:0009898;GO:0009897;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0016020;GO:0098857;GO:0045121;GO:0005886;GO:0030667;GO:0030506;GO:0043395;GO:0008201;GO:0019901;GO:0004725;GO:0005102;GO:0030507;GO:0005001;GO:0000187;GO:0030183;GO:0042100;GO:0050853;GO:0048539;GO:0035584;GO:0044770;GO:0007166;GO:0031668;GO:0051607;GO:0016311;GO:1904155;GO:0002244;GO:0034113;GO:0007159;GO:0001779;GO:0006933;GO:0001960;GO:0070373;GO:0032703;GO:1903979;GO:0031953;GO:0006469;GO:0061099;GO:0001915;GO:0045060;GO:0043312;GO:0044855;GO:0046641;GO:0050857;GO:0030890;GO:0070374;GO:2001238;GO:1905451;GO:0045588;GO:2000473;GO:0002925;GO:0002639;GO:0032743;GO:0048304;GO:0043410;GO:0050731;GO:0045860;GO:1903615;GO:2000648;GO:0001916;GO:0042102;GO:0032760;GO:0045059;GO:0006470;GO:0051726;GO:0010468;GO:0032677;GO:0050764;GO:0061097;GO:0046425;GO:0051209;GO:0010332;GO:0048864;GO:0042110;GO:0030217;GO:0042098;GO:0050852;GO:0016032;, C:bleb; C:cell surface; C:cytoplasmic side of plasma membrane; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:membrane microdomain; C:membrane raft; C:plasma membrane; C:secretory granule membrane;, F:ankyrin binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:spectrin binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:activation of MAPK activity; P:B cell differentiation; P:B cell proliferation; P:B cell receptor signaling pathway; P:bone marrow development; P:calcium-mediated signaling using intracellular calcium source; P:cell cycle phase transition; P:cell surface receptor signaling pathway; P:cellular response to extracellular stimulus; P:defense response to virus; P:dephosphorylation; P:DN2 thymocyte differentiation; P:hematopoietic progenitor cell differentiation; P:heterotypic cell-cell adhesion; P:leukocyte cell-cell adhesion; P:natural killer cell differentiation; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-2 production; P:negative regulation of microglial cell activation; P:negative regulation of protein autophosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of T cell mediated cytotoxicity; P:negative thymic T cell selection; P:neutrophil degranulation; P:plasma membrane raft distribution; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of antigen receptor-mediated signaling pathway; P:positive regulation of B cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of hematopoietic stem cell migration; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-2 production; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein tyrosine phosphatase activity; P:positive regulation of stem cell proliferation; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:positive thymic T cell selection; P:protein dephosphorylation; P:regulation of cell cycle; P:regulation of gene expression; P:regulation of interleukin-8 production; P:regulation of phagocytosis; P:regulation of protein tyrosine kinase activity; P:regulation of receptor signaling pathway via JAK-STAT; P:release of sequestered calcium ion into cytosol; P:response to gamma radiation; P:stem cell development; P:T cell activation; P:T cell differentiation; P:T cell proliferation; P:T cell receptor signaling pathway; P:viral process; scaffold104 indexed_genome mRNA 2919165 3035463 . + . ID=transcript_13114;O00482 B4E2P3 O95642 Q147U3,Nuclear receptor subfamily 5 group A member 2,Alpha-1-fetoprotein transcription factor;B1-binding factor;CYP7A promoter-binding factor;Hepatocytic transcription factor;Liver receptor homolog 1;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0090575;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0004879;GO:0005543;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0008270;GO:0008206;GO:0097720;GO:1990830;GO:0042632;GO:0009792;GO:0030855;GO:0042592;GO:0009755;GO:0061113;GO:0045944;GO:0045893;GO:0045070;GO:0042127;GO:0006357;GO:0006355;GO:0009888;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:phospholipid binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:bile acid metabolic process; P:calcineurin-mediated signaling; P:cellular response to leukemia inhibitory factor; P:cholesterol homeostasis; P:embryo development ending in birth or egg hatching; P:epithelial cell differentiation; P:homeostatic process; P:hormone-mediated signaling pathway; P:pancreas morphogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral genome replication; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:tissue development; P:transcription initiation from RNA polymerase II promoter; scaffold104 indexed_genome mRNA 3285198 3290166 . - . ID=transcript_13115;Q15058 Q14CI8 Q4G0A5 Q5T1W3,Kinesin-like protein KIF14 {ECO:0000305},, PF00498;PF00225;PF16183;, GO:0005829;GO:0090543;GO:0005871;GO:0016020;GO:0005874;GO:0030496;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0030165;GO:0019901;GO:0015631;GO:0032147;GO:0051301;GO:0021846;GO:0021695;GO:0021685;GO:0021693;GO:0021987;GO:0045184;GO:0021766;GO:0007018;GO:0007080;GO:0043066;GO:0033624;GO:0043524;GO:0021772;GO:0008284;GO:0032467;GO:0043161;GO:0030155;GO:0001558;GO:1903429;GO:0030334;GO:2000045;GO:0010389;GO:0031641;GO:0043523;GO:0032487;GO:0031146;GO:0034446;, C:cytosol; C:Flemming body; C:kinesin complex; C:membrane; C:microtubule; C:midbody; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:PDZ domain binding; F:protein kinase binding; F:tubulin binding;, P:activation of protein kinase activity; P:cell division; P:cell proliferation in forebrain; P:cerebellar cortex development; P:cerebellar granular layer structural organization; P:cerebellar Purkinje cell layer structural organization; P:cerebral cortex development; P:establishment of protein localization; P:hippocampus development; P:microtubule-based movement; P:mitotic metaphase plate congression; P:negative regulation of apoptotic process; P:negative regulation of integrin activation; P:negative regulation of neuron apoptotic process; P:olfactory bulb development; P:positive regulation of cell population proliferation; P:positive regulation of cytokinesis; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell adhesion; P:regulation of cell growth; P:regulation of cell maturation; P:regulation of cell migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of myelination; P:regulation of neuron apoptotic process; P:regulation of Rap protein signal transduction; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:substrate adhesion-dependent cell spreading; scaffold104 indexed_genome mRNA 3290829 3297941 . - . ID=transcript_13116;Q15058 Q14CI8 Q4G0A5 Q5T1W3,Kinesin-like protein KIF14 {ECO:0000305},, PF00498;PF00225;PF16183;, GO:0005829;GO:0090543;GO:0005871;GO:0016020;GO:0005874;GO:0030496;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0030165;GO:0019901;GO:0015631;GO:0032147;GO:0051301;GO:0021846;GO:0021695;GO:0021685;GO:0021693;GO:0021987;GO:0045184;GO:0021766;GO:0007018;GO:0007080;GO:0043066;GO:0033624;GO:0043524;GO:0021772;GO:0008284;GO:0032467;GO:0043161;GO:0030155;GO:0001558;GO:1903429;GO:0030334;GO:2000045;GO:0010389;GO:0031641;GO:0043523;GO:0032487;GO:0031146;GO:0034446;, C:cytosol; C:Flemming body; C:kinesin complex; C:membrane; C:microtubule; C:midbody; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:PDZ domain binding; F:protein kinase binding; F:tubulin binding;, P:activation of protein kinase activity; P:cell division; P:cell proliferation in forebrain; P:cerebellar cortex development; P:cerebellar granular layer structural organization; P:cerebellar Purkinje cell layer structural organization; P:cerebral cortex development; P:establishment of protein localization; P:hippocampus development; P:microtubule-based movement; P:mitotic metaphase plate congression; P:negative regulation of apoptotic process; P:negative regulation of integrin activation; P:negative regulation of neuron apoptotic process; P:olfactory bulb development; P:positive regulation of cell population proliferation; P:positive regulation of cytokinesis; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell adhesion; P:regulation of cell growth; P:regulation of cell maturation; P:regulation of cell migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of myelination; P:regulation of neuron apoptotic process; P:regulation of Rap protein signal transduction; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:substrate adhesion-dependent cell spreading; scaffold104 indexed_genome mRNA 3299243 3309126 . - . ID=transcript_13117;Q15058 Q14CI8 Q4G0A5 Q5T1W3,Kinesin-like protein KIF14 {ECO:0000305},, PF00498;PF00225;PF16183;, GO:0005829;GO:0090543;GO:0005871;GO:0016020;GO:0005874;GO:0030496;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0030165;GO:0019901;GO:0015631;GO:0032147;GO:0051301;GO:0021846;GO:0021695;GO:0021685;GO:0021693;GO:0021987;GO:0045184;GO:0021766;GO:0007018;GO:0007080;GO:0043066;GO:0033624;GO:0043524;GO:0021772;GO:0008284;GO:0032467;GO:0043161;GO:0030155;GO:0001558;GO:1903429;GO:0030334;GO:2000045;GO:0010389;GO:0031641;GO:0043523;GO:0032487;GO:0031146;GO:0034446;, C:cytosol; C:Flemming body; C:kinesin complex; C:membrane; C:microtubule; C:midbody; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:PDZ domain binding; F:protein kinase binding; F:tubulin binding;, P:activation of protein kinase activity; P:cell division; P:cell proliferation in forebrain; P:cerebellar cortex development; P:cerebellar granular layer structural organization; P:cerebellar Purkinje cell layer structural organization; P:cerebral cortex development; P:establishment of protein localization; P:hippocampus development; P:microtubule-based movement; P:mitotic metaphase plate congression; P:negative regulation of apoptotic process; P:negative regulation of integrin activation; P:negative regulation of neuron apoptotic process; P:olfactory bulb development; P:positive regulation of cell population proliferation; P:positive regulation of cytokinesis; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of cell adhesion; P:regulation of cell growth; P:regulation of cell maturation; P:regulation of cell migration; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of myelination; P:regulation of neuron apoptotic process; P:regulation of Rap protein signal transduction; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:substrate adhesion-dependent cell spreading; scaffold104 indexed_genome mRNA 3341003 3355765 . - . ID=transcript_13118;Q5T1V6 Q6PJL2 Q8IVW3 Q9H0W3,Probable ATP-dependent RNA helicase DDX59,DEAD box protein 59;Zinc finger HIT domain-containing protein 5 {ECO:0000303|PubMed:28561026};, PF00270;PF00271;PF04438;, GO:0005737;GO:0005634;GO:0005524;GO:0046872;GO:0003723;GO:0003724;, C:cytoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity;|Q5T1V6 Q6PJL2 Q8IVW3 Q9H0W3,Probable ATP-dependent RNA helicase DDX59,DEAD box protein 59;Zinc finger HIT domain-containing protein 5 {ECO:0000303|PubMed:28561026};, PF00270;PF00271;PF04438;, GO:0005737;GO:0005634;GO:0005524;GO:0046872;GO:0003723;GO:0003724;, C:cytoplasm; C:nucleus;, F:ATP binding; F:metal ion binding; F:RNA binding; F:RNA helicase activity; scaffold104 indexed_genome mRNA 3475979 3479170 . + . ID=transcript_13119;Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization; scaffold104 indexed_genome mRNA 3483107 3495380 . + . ID=transcript_13120;Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization;|Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization;|Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization;|Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization;|Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization; scaffold104 indexed_genome mRNA 3571410 3580274 . - . ID=transcript_13121;O75037 B2RP62 B7ZMI0 Q5T4J3,Kinesin-like protein KIF21B,, PF00225;PF00400;, GO:0031410;GO:0030425;GO:0030426;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytoplasmic vesicle; C:dendrite; C:growth cone; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement;|O75037 B2RP62 B7ZMI0 Q5T4J3,Kinesin-like protein KIF21B,, PF00225;PF00400;, GO:0031410;GO:0030425;GO:0030426;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytoplasmic vesicle; C:dendrite; C:growth cone; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; scaffold104 indexed_genome mRNA 3631201 3701848 . - . ID=transcript_13122;Q13698 A4IF51 B1ALM2 Q12896 Q13934,Voltage-dependent L-type calcium channel subunit alpha-1S,Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle;Voltage-gated calcium channel subunit alpha Cav1.1;, PF08763;PF16905;PF00520;, GO:0005737;GO:0031674;GO:1990454;GO:0005886;GO:0030315;GO:0005891;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0070509;GO:0006816;GO:0071313;GO:0006936;GO:0034765;, C:cytoplasm; C:I band; C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:T-tubule; C:voltage-gated calcium channel complex;, F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:cellular response to caffeine; P:muscle contraction; P:regulation of ion transmembrane transport;|Q13698 A4IF51 B1ALM2 Q12896 Q13934,Voltage-dependent L-type calcium channel subunit alpha-1S,Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle;Voltage-gated calcium channel subunit alpha Cav1.1;, PF08763;PF16905;PF00520;, GO:0005737;GO:0031674;GO:1990454;GO:0005886;GO:0030315;GO:0005891;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0070509;GO:0006816;GO:0071313;GO:0006936;GO:0034765;, C:cytoplasm; C:I band; C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:T-tubule; C:voltage-gated calcium channel complex;, F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:cellular response to caffeine; P:muscle contraction; P:regulation of ion transmembrane transport;|Q13698 A4IF51 B1ALM2 Q12896 Q13934,Voltage-dependent L-type calcium channel subunit alpha-1S,Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle;Voltage-gated calcium channel subunit alpha Cav1.1;, PF08763;PF16905;PF00520;, GO:0005737;GO:0031674;GO:1990454;GO:0005886;GO:0030315;GO:0005891;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0070509;GO:0006816;GO:0071313;GO:0006936;GO:0034765;, C:cytoplasm; C:I band; C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:T-tubule; C:voltage-gated calcium channel complex;, F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:cellular response to caffeine; P:muscle contraction; P:regulation of ion transmembrane transport;|Q13698 A4IF51 B1ALM2 Q12896 Q13934,Voltage-dependent L-type calcium channel subunit alpha-1S,Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle;Voltage-gated calcium channel subunit alpha Cav1.1;, PF08763;PF16905;PF00520;, GO:0005737;GO:0031674;GO:1990454;GO:0005886;GO:0030315;GO:0005891;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0070509;GO:0006816;GO:0071313;GO:0006936;GO:0034765;, C:cytoplasm; C:I band; C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:T-tubule; C:voltage-gated calcium channel complex;, F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:cellular response to caffeine; P:muscle contraction; P:regulation of ion transmembrane transport;|Q13698 A4IF51 B1ALM2 Q12896 Q13934,Voltage-dependent L-type calcium channel subunit alpha-1S,Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle;Voltage-gated calcium channel subunit alpha Cav1.1;, PF08763;PF16905;PF00520;, GO:0005737;GO:0031674;GO:1990454;GO:0005886;GO:0030315;GO:0005891;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0070509;GO:0006816;GO:0071313;GO:0006936;GO:0034765;, C:cytoplasm; C:I band; C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:T-tubule; C:voltage-gated calcium channel complex;, F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:cellular response to caffeine; P:muscle contraction; P:regulation of ion transmembrane transport;|Q13698 A4IF51 B1ALM2 Q12896 Q13934,Voltage-dependent L-type calcium channel subunit alpha-1S,Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle;Voltage-gated calcium channel subunit alpha Cav1.1;, PF08763;PF16905;PF00520;, GO:0005737;GO:0031674;GO:1990454;GO:0005886;GO:0030315;GO:0005891;GO:0005516;GO:0008331;GO:0046872;GO:0005245;GO:0070509;GO:0006816;GO:0071313;GO:0006936;GO:0034765;, C:cytoplasm; C:I band; C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:T-tubule; C:voltage-gated calcium channel complex;, F:calmodulin binding; F:high voltage-gated calcium channel activity; F:metal ion binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:cellular response to caffeine; P:muscle contraction; P:regulation of ion transmembrane transport; scaffold104 indexed_genome mRNA 3728940 3741349 . + . ID=transcript_13123;Q9P0T7 B1ALM6 Q96NQ9 Q9BQF5,Proton-transporting V-type ATPase complex assembly regulator TMEM9 {ECO:0000305|PubMed:30374053},Dermal papilla-derived protein 4 {ECO:0000303|Ref.2};Transmembrane protein 9 {ECO:0000303|PubMed:12359240};, PF05434;, GO:0016021;GO:0045171;GO:0043231;GO:0005770;GO:0005765;GO:0005764;GO:0015630;GO:0072686;GO:0032585;GO:0048388;GO:0007042;GO:0090263;GO:0015031;GO:0070070;GO:0042176;, C:integral component of membrane; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal membrane; C:lysosome; C:microtubule cytoskeleton; C:mitotic spindle; C:multivesicular body membrane;, , P:endosomal lumen acidification; P:lysosomal lumen acidification; P:positive regulation of canonical Wnt signaling pathway; P:protein transport; P:proton-transporting V-type ATPase complex assembly; P:regulation of protein catabolic process;|Q9P0T7 B1ALM6 Q96NQ9 Q9BQF5,Proton-transporting V-type ATPase complex assembly regulator TMEM9 {ECO:0000305|PubMed:30374053},Dermal papilla-derived protein 4 {ECO:0000303|Ref.2};Transmembrane protein 9 {ECO:0000303|PubMed:12359240};, PF05434;, GO:0016021;GO:0045171;GO:0043231;GO:0005770;GO:0005765;GO:0005764;GO:0015630;GO:0072686;GO:0032585;GO:0048388;GO:0007042;GO:0090263;GO:0015031;GO:0070070;GO:0042176;, C:integral component of membrane; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal membrane; C:lysosome; C:microtubule cytoskeleton; C:mitotic spindle; C:multivesicular body membrane;, , P:endosomal lumen acidification; P:lysosomal lumen acidification; P:positive regulation of canonical Wnt signaling pathway; P:protein transport; P:proton-transporting V-type ATPase complex assembly; P:regulation of protein catabolic process;|Q9P0T7 B1ALM6 Q96NQ9 Q9BQF5,Proton-transporting V-type ATPase complex assembly regulator TMEM9 {ECO:0000305|PubMed:30374053},Dermal papilla-derived protein 4 {ECO:0000303|Ref.2};Transmembrane protein 9 {ECO:0000303|PubMed:12359240};, PF05434;, GO:0016021;GO:0045171;GO:0043231;GO:0005770;GO:0005765;GO:0005764;GO:0015630;GO:0072686;GO:0032585;GO:0048388;GO:0007042;GO:0090263;GO:0015031;GO:0070070;GO:0042176;, C:integral component of membrane; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal membrane; C:lysosome; C:microtubule cytoskeleton; C:mitotic spindle; C:multivesicular body membrane;, , P:endosomal lumen acidification; P:lysosomal lumen acidification; P:positive regulation of canonical Wnt signaling pathway; P:protein transport; P:proton-transporting V-type ATPase complex assembly; P:regulation of protein catabolic process; scaffold104 indexed_genome mRNA 3770143 3783032 . + . ID=transcript_13124;Q86VF2 F8WAI1 Q9NT72,Immunoglobulin-like and fibronectin type III domain-containing protein 1,EEF1A2-binding protein 1;KY-interacting protein 1;, PF00041;PF07679;PF18362;, GO:0005634;GO:0045202;GO:0030018;GO:0007156;GO:0010842;GO:0007416;, C:nucleus; C:synapse; C:Z disc;, , P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly;|Q86VF2 F8WAI1 Q9NT72,Immunoglobulin-like and fibronectin type III domain-containing protein 1,EEF1A2-binding protein 1;KY-interacting protein 1;, PF00041;PF07679;PF18362;, GO:0005634;GO:0045202;GO:0030018;GO:0007156;GO:0010842;GO:0007416;, C:nucleus; C:synapse; C:Z disc;, , P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly;|Q86VF2 F8WAI1 Q9NT72,Immunoglobulin-like and fibronectin type III domain-containing protein 1,EEF1A2-binding protein 1;KY-interacting protein 1;, PF00041;PF07679;PF18362;, GO:0005634;GO:0045202;GO:0030018;GO:0007156;GO:0010842;GO:0007416;, C:nucleus; C:synapse; C:Z disc;, , P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly;|Q86VF2 F8WAI1 Q9NT72,Immunoglobulin-like and fibronectin type III domain-containing protein 1,EEF1A2-binding protein 1;KY-interacting protein 1;, PF00041;PF07679;PF18362;, GO:0005634;GO:0045202;GO:0030018;GO:0007156;GO:0010842;GO:0007416;, C:nucleus; C:synapse; C:Z disc;, , P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly;|Q86VF2 F8WAI1 Q9NT72,Immunoglobulin-like and fibronectin type III domain-containing protein 1,EEF1A2-binding protein 1;KY-interacting protein 1;, PF00041;PF07679;PF18362;, GO:0005634;GO:0045202;GO:0030018;GO:0007156;GO:0010842;GO:0007416;, C:nucleus; C:synapse; C:Z disc;, , P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly; scaffold104 indexed_genome mRNA 3788699 3801547 . + . ID=transcript_13125;Q86VF2 F8WAI1 Q9NT72,Immunoglobulin-like and fibronectin type III domain-containing protein 1,EEF1A2-binding protein 1;KY-interacting protein 1;, PF00041;PF07679;PF18362;, GO:0005634;GO:0045202;GO:0030018;GO:0007156;GO:0010842;GO:0007416;, C:nucleus; C:synapse; C:Z disc;, , P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly;|Q86VF2 F8WAI1 Q9NT72,Immunoglobulin-like and fibronectin type III domain-containing protein 1,EEF1A2-binding protein 1;KY-interacting protein 1;, PF00041;PF07679;PF18362;, GO:0005634;GO:0045202;GO:0030018;GO:0007156;GO:0010842;GO:0007416;, C:nucleus; C:synapse; C:Z disc;, , P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly;|Q86VF2 F8WAI1 Q9NT72,Immunoglobulin-like and fibronectin type III domain-containing protein 1,EEF1A2-binding protein 1;KY-interacting protein 1;, PF00041;PF07679;PF18362;, GO:0005634;GO:0045202;GO:0030018;GO:0007156;GO:0010842;GO:0007416;, C:nucleus; C:synapse; C:Z disc;, , P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly;|Q86VF2 F8WAI1 Q9NT72,Immunoglobulin-like and fibronectin type III domain-containing protein 1,EEF1A2-binding protein 1;KY-interacting protein 1;, PF00041;PF07679;PF18362;, GO:0005634;GO:0045202;GO:0030018;GO:0007156;GO:0010842;GO:0007416;, C:nucleus; C:synapse; C:Z disc;, , P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly; scaffold104 indexed_genome mRNA 3904509 3909694 . + . ID=transcript_13126;Q9UHQ9 A0PK21 B2R8E0 O95329 Q53F73 Q8NCL5 Q9UHJ1,NADH-cytochrome b5 reductase 1,Humb5R2;NAD(P)H:quinone oxidoreductase type 3 polypeptide A2;, PF00970;PF00175;, GO:0005789;GO:0070062;GO:0016021;GO:0016020;GO:0005739;GO:0005886;GO:0031092;GO:0004128;GO:0071949;GO:0015701;GO:0002576;GO:0016126;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:platelet alpha granule membrane;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:FAD binding;, P:bicarbonate transport; P:platelet degranulation; P:sterol biosynthetic process;|Q9UHQ9 A0PK21 B2R8E0 O95329 Q53F73 Q8NCL5 Q9UHJ1,NADH-cytochrome b5 reductase 1,Humb5R2;NAD(P)H:quinone oxidoreductase type 3 polypeptide A2;, PF00970;PF00175;, GO:0005789;GO:0070062;GO:0016021;GO:0016020;GO:0005739;GO:0005886;GO:0031092;GO:0004128;GO:0071949;GO:0015701;GO:0002576;GO:0016126;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:platelet alpha granule membrane;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:FAD binding;, P:bicarbonate transport; P:platelet degranulation; P:sterol biosynthetic process;|Q9UHQ9 A0PK21 B2R8E0 O95329 Q53F73 Q8NCL5 Q9UHJ1,NADH-cytochrome b5 reductase 1,Humb5R2;NAD(P)H:quinone oxidoreductase type 3 polypeptide A2;, PF00970;PF00175;, GO:0005789;GO:0070062;GO:0016021;GO:0016020;GO:0005739;GO:0005886;GO:0031092;GO:0004128;GO:0071949;GO:0015701;GO:0002576;GO:0016126;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:platelet alpha granule membrane;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:FAD binding;, P:bicarbonate transport; P:platelet degranulation; P:sterol biosynthetic process;|Q9UHQ9 A0PK21 B2R8E0 O95329 Q53F73 Q8NCL5 Q9UHJ1,NADH-cytochrome b5 reductase 1,Humb5R2;NAD(P)H:quinone oxidoreductase type 3 polypeptide A2;, PF00970;PF00175;, GO:0005789;GO:0070062;GO:0016021;GO:0016020;GO:0005739;GO:0005886;GO:0031092;GO:0004128;GO:0071949;GO:0015701;GO:0002576;GO:0016126;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:platelet alpha granule membrane;, F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:FAD binding;, P:bicarbonate transport; P:platelet degranulation; P:sterol biosynthetic process; scaffold104 indexed_genome mRNA 3925711 3932046 . + . ID=transcript_13127;Q96A54 B3KMB0 Q53HS7 Q53YY6 Q9Y360,Adiponectin receptor protein 1 {ECO:0000303|PubMed:12802337},Progestin and adipoQ receptor family member 1 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member I;, PF03006;, GO:0016021;GO:0031226;GO:0016020;GO:0005886;GO:0097003;GO:0055100;GO:0042802;GO:0046872;GO:0019901;GO:0038023;GO:0033211;GO:0019395;GO:0042593;GO:0009755;GO:0033210;GO:0030308;GO:0010633;GO:0010719;GO:1901223;GO:0046426;GO:0120162;GO:0046628;GO:0046427;GO:0042304;GO:0010906;GO:0019216;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane;, F:adipokinetic hormone receptor activity; F:adiponectin binding; F:identical protein binding; F:metal ion binding; F:protein kinase binding; F:signaling receptor activity;, P:adiponectin-activated signaling pathway; P:fatty acid oxidation; P:glucose homeostasis; P:hormone-mediated signaling pathway; P:leptin-mediated signaling pathway; P:negative regulation of cell growth; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of cold-induced thermogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of fatty acid biosynthetic process; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process;|Q96A54 B3KMB0 Q53HS7 Q53YY6 Q9Y360,Adiponectin receptor protein 1 {ECO:0000303|PubMed:12802337},Progestin and adipoQ receptor family member 1 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member I;, PF03006;, GO:0016021;GO:0031226;GO:0016020;GO:0005886;GO:0097003;GO:0055100;GO:0042802;GO:0046872;GO:0019901;GO:0038023;GO:0033211;GO:0019395;GO:0042593;GO:0009755;GO:0033210;GO:0030308;GO:0010633;GO:0010719;GO:1901223;GO:0046426;GO:0120162;GO:0046628;GO:0046427;GO:0042304;GO:0010906;GO:0019216;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane;, F:adipokinetic hormone receptor activity; F:adiponectin binding; F:identical protein binding; F:metal ion binding; F:protein kinase binding; F:signaling receptor activity;, P:adiponectin-activated signaling pathway; P:fatty acid oxidation; P:glucose homeostasis; P:hormone-mediated signaling pathway; P:leptin-mediated signaling pathway; P:negative regulation of cell growth; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of cold-induced thermogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of fatty acid biosynthetic process; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process;|Q96A54 B3KMB0 Q53HS7 Q53YY6 Q9Y360,Adiponectin receptor protein 1 {ECO:0000303|PubMed:12802337},Progestin and adipoQ receptor family member 1 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member I;, PF03006;, GO:0016021;GO:0031226;GO:0016020;GO:0005886;GO:0097003;GO:0055100;GO:0042802;GO:0046872;GO:0019901;GO:0038023;GO:0033211;GO:0019395;GO:0042593;GO:0009755;GO:0033210;GO:0030308;GO:0010633;GO:0010719;GO:1901223;GO:0046426;GO:0120162;GO:0046628;GO:0046427;GO:0042304;GO:0010906;GO:0019216;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane;, F:adipokinetic hormone receptor activity; F:adiponectin binding; F:identical protein binding; F:metal ion binding; F:protein kinase binding; F:signaling receptor activity;, P:adiponectin-activated signaling pathway; P:fatty acid oxidation; P:glucose homeostasis; P:hormone-mediated signaling pathway; P:leptin-mediated signaling pathway; P:negative regulation of cell growth; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of cold-induced thermogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of fatty acid biosynthetic process; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process;|Q96A54 B3KMB0 Q53HS7 Q53YY6 Q9Y360,Adiponectin receptor protein 1 {ECO:0000303|PubMed:12802337},Progestin and adipoQ receptor family member 1 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member I;, PF03006;, GO:0016021;GO:0031226;GO:0016020;GO:0005886;GO:0097003;GO:0055100;GO:0042802;GO:0046872;GO:0019901;GO:0038023;GO:0033211;GO:0019395;GO:0042593;GO:0009755;GO:0033210;GO:0030308;GO:0010633;GO:0010719;GO:1901223;GO:0046426;GO:0120162;GO:0046628;GO:0046427;GO:0042304;GO:0010906;GO:0019216;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane;, F:adipokinetic hormone receptor activity; F:adiponectin binding; F:identical protein binding; F:metal ion binding; F:protein kinase binding; F:signaling receptor activity;, P:adiponectin-activated signaling pathway; P:fatty acid oxidation; P:glucose homeostasis; P:hormone-mediated signaling pathway; P:leptin-mediated signaling pathway; P:negative regulation of cell growth; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of cold-induced thermogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of fatty acid biosynthetic process; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process;|Q96A54 B3KMB0 Q53HS7 Q53YY6 Q9Y360,Adiponectin receptor protein 1 {ECO:0000303|PubMed:12802337},Progestin and adipoQ receptor family member 1 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member I;, PF03006;, GO:0016021;GO:0031226;GO:0016020;GO:0005886;GO:0097003;GO:0055100;GO:0042802;GO:0046872;GO:0019901;GO:0038023;GO:0033211;GO:0019395;GO:0042593;GO:0009755;GO:0033210;GO:0030308;GO:0010633;GO:0010719;GO:1901223;GO:0046426;GO:0120162;GO:0046628;GO:0046427;GO:0042304;GO:0010906;GO:0019216;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane;, F:adipokinetic hormone receptor activity; F:adiponectin binding; F:identical protein binding; F:metal ion binding; F:protein kinase binding; F:signaling receptor activity;, P:adiponectin-activated signaling pathway; P:fatty acid oxidation; P:glucose homeostasis; P:hormone-mediated signaling pathway; P:leptin-mediated signaling pathway; P:negative regulation of cell growth; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of cold-induced thermogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of fatty acid biosynthetic process; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process;|Q96A54 B3KMB0 Q53HS7 Q53YY6 Q9Y360,Adiponectin receptor protein 1 {ECO:0000303|PubMed:12802337},Progestin and adipoQ receptor family member 1 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member I;, PF03006;, GO:0016021;GO:0031226;GO:0016020;GO:0005886;GO:0097003;GO:0055100;GO:0042802;GO:0046872;GO:0019901;GO:0038023;GO:0033211;GO:0019395;GO:0042593;GO:0009755;GO:0033210;GO:0030308;GO:0010633;GO:0010719;GO:1901223;GO:0046426;GO:0120162;GO:0046628;GO:0046427;GO:0042304;GO:0010906;GO:0019216;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane;, F:adipokinetic hormone receptor activity; F:adiponectin binding; F:identical protein binding; F:metal ion binding; F:protein kinase binding; F:signaling receptor activity;, P:adiponectin-activated signaling pathway; P:fatty acid oxidation; P:glucose homeostasis; P:hormone-mediated signaling pathway; P:leptin-mediated signaling pathway; P:negative regulation of cell growth; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of cold-induced thermogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of fatty acid biosynthetic process; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process;|Q96A54 B3KMB0 Q53HS7 Q53YY6 Q9Y360,Adiponectin receptor protein 1 {ECO:0000303|PubMed:12802337},Progestin and adipoQ receptor family member 1 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member I;, PF03006;, GO:0016021;GO:0031226;GO:0016020;GO:0005886;GO:0097003;GO:0055100;GO:0042802;GO:0046872;GO:0019901;GO:0038023;GO:0033211;GO:0019395;GO:0042593;GO:0009755;GO:0033210;GO:0030308;GO:0010633;GO:0010719;GO:1901223;GO:0046426;GO:0120162;GO:0046628;GO:0046427;GO:0042304;GO:0010906;GO:0019216;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane;, F:adipokinetic hormone receptor activity; F:adiponectin binding; F:identical protein binding; F:metal ion binding; F:protein kinase binding; F:signaling receptor activity;, P:adiponectin-activated signaling pathway; P:fatty acid oxidation; P:glucose homeostasis; P:hormone-mediated signaling pathway; P:leptin-mediated signaling pathway; P:negative regulation of cell growth; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of cold-induced thermogenesis; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of receptor signaling pathway via JAK-STAT; P:regulation of fatty acid biosynthetic process; P:regulation of glucose metabolic process; P:regulation of lipid metabolic process; scaffold104 indexed_genome mRNA 3943294 3965002 . + . ID=transcript_13128;Q53G59 A6NEN8 B7Z7B8 Q9HBX5,Kelch-like protein 12,CUL3-interacting protein 1 {ECO:0000303|Ref.1};DKIR homolog {ECO:0000303|PubMed:15383316};, PF07707;PF00651;PF01344;, GO:0034451;GO:0030127;GO:0030134;GO:0031463;GO:0005829;GO:0043231;GO:0042802;GO:0048208;GO:0006888;GO:0090090;GO:0014032;GO:0014029;GO:0006513;GO:0016055;, C:centriolar satellite; C:COPII vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:intracellular membrane-bounded organelle;, F:identical protein binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of canonical Wnt signaling pathway; P:neural crest cell development; P:neural crest formation; P:protein monoubiquitination; P:Wnt signaling pathway;|Q53G59 A6NEN8 B7Z7B8 Q9HBX5,Kelch-like protein 12,CUL3-interacting protein 1 {ECO:0000303|Ref.1};DKIR homolog {ECO:0000303|PubMed:15383316};, PF07707;PF00651;PF01344;, GO:0034451;GO:0030127;GO:0030134;GO:0031463;GO:0005829;GO:0043231;GO:0042802;GO:0048208;GO:0006888;GO:0090090;GO:0014032;GO:0014029;GO:0006513;GO:0016055;, C:centriolar satellite; C:COPII vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:intracellular membrane-bounded organelle;, F:identical protein binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of canonical Wnt signaling pathway; P:neural crest cell development; P:neural crest formation; P:protein monoubiquitination; P:Wnt signaling pathway;|Q53G59 A6NEN8 B7Z7B8 Q9HBX5,Kelch-like protein 12,CUL3-interacting protein 1 {ECO:0000303|Ref.1};DKIR homolog {ECO:0000303|PubMed:15383316};, PF07707;PF00651;PF01344;, GO:0034451;GO:0030127;GO:0030134;GO:0031463;GO:0005829;GO:0043231;GO:0042802;GO:0048208;GO:0006888;GO:0090090;GO:0014032;GO:0014029;GO:0006513;GO:0016055;, C:centriolar satellite; C:COPII vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:intracellular membrane-bounded organelle;, F:identical protein binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of canonical Wnt signaling pathway; P:neural crest cell development; P:neural crest formation; P:protein monoubiquitination; P:Wnt signaling pathway; scaffold104 indexed_genome mRNA 3972343 3977729 . + . ID=transcript_13129;P47224 B2R4P4 Q92992,Guanine nucleotide exchange factor MSS4,Rab-interacting factor;, PF04421;, GO:0005829;GO:0016020;GO:0005085;GO:0008270;GO:0061025;GO:0006892;GO:0015031;GO:0007264;, C:cytosol; C:membrane;, F:guanyl-nucleotide exchange factor activity; F:zinc ion binding;, P:membrane fusion; P:post-Golgi vesicle-mediated transport; P:protein transport; P:small GTPase mediated signal transduction; scaffold104 indexed_genome mRNA 4015199 4076470 . + . ID=transcript_13130;Q9UGL1 O95811 Q15752 Q9Y3Q5,Lysine-specific demethylase 5B,Cancer/testis antigen 31;Histone demethylase JARID1B;Jumonji/ARID domain-containing protein 1B;PLU-1;Retinoblastoma-binding protein 2 homolog 1;[histone H3]-trimethyl-L-lysine(4) demethylase 5B {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0042393;GO:0032452;GO:0034648;GO:0032453;GO:0034647;GO:1990837;GO:0003714;GO:0008270;GO:0060444;GO:0044344;GO:1990830;GO:0006338;GO:0034720;GO:0070306;GO:0060763;GO:0045892;GO:0010628;GO:0033601;GO:0009791;GO:2000864;GO:0006357;GO:0060992;GO:0048511;GO:0007338;GO:0061038;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:sequence-specific double-stranded DNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:branching involved in mammary gland duct morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:chromatin remodeling; P:histone H3-K4 demethylation; P:lens fiber cell differentiation; P:mammary duct terminal end bud growth; P:negative regulation of transcription, DNA-templated; P:positive regulation of gene expression; P:positive regulation of mammary gland epithelial cell proliferation; P:post-embryonic development; P:regulation of estradiol secretion; P:regulation of transcription by RNA polymerase II; P:response to fungicide; P:rhythmic process; P:single fertilization; P:uterus morphogenesis; scaffold104 indexed_genome mRNA 4076564 4081090 . + . ID=transcript_13131;Q9UGL1 O95811 Q15752 Q9Y3Q5,Lysine-specific demethylase 5B,Cancer/testis antigen 31;Histone demethylase JARID1B;Jumonji/ARID domain-containing protein 1B;PLU-1;Retinoblastoma-binding protein 2 homolog 1;[histone H3]-trimethyl-L-lysine(4) demethylase 5B {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0042393;GO:0032452;GO:0034648;GO:0032453;GO:0034647;GO:1990837;GO:0003714;GO:0008270;GO:0060444;GO:0044344;GO:1990830;GO:0006338;GO:0034720;GO:0070306;GO:0060763;GO:0045892;GO:0010628;GO:0033601;GO:0009791;GO:2000864;GO:0006357;GO:0060992;GO:0048511;GO:0007338;GO:0061038;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:sequence-specific double-stranded DNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:branching involved in mammary gland duct morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:chromatin remodeling; P:histone H3-K4 demethylation; P:lens fiber cell differentiation; P:mammary duct terminal end bud growth; P:negative regulation of transcription, DNA-templated; P:positive regulation of gene expression; P:positive regulation of mammary gland epithelial cell proliferation; P:post-embryonic development; P:regulation of estradiol secretion; P:regulation of transcription by RNA polymerase II; P:response to fungicide; P:rhythmic process; P:single fertilization; P:uterus morphogenesis; scaffold104 indexed_genome mRNA 4081379 4086839 . - . ID=transcript_13132;Q9UGL1 O95811 Q15752 Q9Y3Q5,Lysine-specific demethylase 5B,Cancer/testis antigen 31;Histone demethylase JARID1B;Jumonji/ARID domain-containing protein 1B;PLU-1;Retinoblastoma-binding protein 2 homolog 1;[histone H3]-trimethyl-L-lysine(4) demethylase 5B {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0042393;GO:0032452;GO:0034648;GO:0032453;GO:0034647;GO:1990837;GO:0003714;GO:0008270;GO:0060444;GO:0044344;GO:1990830;GO:0006338;GO:0034720;GO:0070306;GO:0060763;GO:0045892;GO:0010628;GO:0033601;GO:0009791;GO:2000864;GO:0006357;GO:0060992;GO:0048511;GO:0007338;GO:0061038;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:sequence-specific double-stranded DNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:branching involved in mammary gland duct morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:chromatin remodeling; P:histone H3-K4 demethylation; P:lens fiber cell differentiation; P:mammary duct terminal end bud growth; P:negative regulation of transcription, DNA-templated; P:positive regulation of gene expression; P:positive regulation of mammary gland epithelial cell proliferation; P:post-embryonic development; P:regulation of estradiol secretion; P:regulation of transcription by RNA polymerase II; P:response to fungicide; P:rhythmic process; P:single fertilization; P:uterus morphogenesis;|Q9UGL1 O95811 Q15752 Q9Y3Q5,Lysine-specific demethylase 5B,Cancer/testis antigen 31;Histone demethylase JARID1B;Jumonji/ARID domain-containing protein 1B;PLU-1;Retinoblastoma-binding protein 2 homolog 1;[histone H3]-trimethyl-L-lysine(4) demethylase 5B {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0042393;GO:0032452;GO:0034648;GO:0032453;GO:0034647;GO:1990837;GO:0003714;GO:0008270;GO:0060444;GO:0044344;GO:1990830;GO:0006338;GO:0034720;GO:0070306;GO:0060763;GO:0045892;GO:0010628;GO:0033601;GO:0009791;GO:2000864;GO:0006357;GO:0060992;GO:0048511;GO:0007338;GO:0061038;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone binding; F:histone demethylase activity; F:histone demethylase activity (H3-dimethyl-K4 specific); F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:sequence-specific double-stranded DNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:branching involved in mammary gland duct morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to leukemia inhibitory factor; P:chromatin remodeling; P:histone H3-K4 demethylation; P:lens fiber cell differentiation; P:mammary duct terminal end bud growth; P:negative regulation of transcription, DNA-templated; P:positive regulation of gene expression; P:positive regulation of mammary gland epithelial cell proliferation; P:post-embryonic development; P:regulation of estradiol secretion; P:regulation of transcription by RNA polymerase II; P:response to fungicide; P:rhythmic process; P:single fertilization; P:uterus morphogenesis; scaffold105 indexed_genome mRNA 659772 685517 . - . ID=transcript_13133;Q96NR3 B4DQH0 Q0IJ60 Q6P6B8,Patched domain-containing protein 1 {ECO:0000305},, PF02460;, GO:0016021;GO:0016020;GO:0005886;GO:0045202;GO:0007268;GO:0050890;GO:0098976;GO:0098977;GO:0007616;GO:0007614;GO:0007224;GO:0035176;GO:0021794;, C:integral component of membrane; C:membrane; C:plasma membrane; C:synapse;, , P:chemical synaptic transmission; P:cognition; P:excitatory chemical synaptic transmission; P:inhibitory chemical synaptic transmission; P:long-term memory; P:short-term memory; P:smoothened signaling pathway; P:social behavior; P:thalamus development; scaffold105 indexed_genome mRNA 957731 969357 . + . ID=transcript_13134;Q13162 Q6FHT3,Peroxiredoxin-4,Antioxidant enzyme AOE372;Peroxiredoxin IV;Thioredoxin peroxidase AO372;Thioredoxin-dependent peroxide reductase A0372;Thioredoxin-dependent peroxiredoxin 4 {ECO:0000305};, PF10417;PF00578;, GO:0005829;GO:0005783;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0005790;GO:0008379;GO:0045454;GO:0030198;GO:0007252;GO:0008584;GO:2000255;GO:0043312;GO:0018401;GO:0022417;GO:0072593;GO:0006979;GO:0007283;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen; C:smooth endoplasmic reticulum;, F:thioredoxin peroxidase activity;, P:cell redox homeostasis; P:extracellular matrix organization; P:I-kappaB phosphorylation; P:male gonad development; P:negative regulation of male germ cell proliferation; P:neutrophil degranulation; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:protein maturation by protein folding; P:reactive oxygen species metabolic process; P:response to oxidative stress; P:spermatogenesis;|Q13162 Q6FHT3,Peroxiredoxin-4,Antioxidant enzyme AOE372;Peroxiredoxin IV;Thioredoxin peroxidase AO372;Thioredoxin-dependent peroxide reductase A0372;Thioredoxin-dependent peroxiredoxin 4 {ECO:0000305};, PF10417;PF00578;, GO:0005829;GO:0005783;GO:0070062;GO:0005576;GO:1904813;GO:0005634;GO:0034774;GO:0005790;GO:0008379;GO:0045454;GO:0030198;GO:0007252;GO:0008584;GO:2000255;GO:0043312;GO:0018401;GO:0022417;GO:0072593;GO:0006979;GO:0007283;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleus; C:secretory granule lumen; C:smooth endoplasmic reticulum;, F:thioredoxin peroxidase activity;, P:cell redox homeostasis; P:extracellular matrix organization; P:I-kappaB phosphorylation; P:male gonad development; P:negative regulation of male germ cell proliferation; P:neutrophil degranulation; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:protein maturation by protein folding; P:reactive oxygen species metabolic process; P:response to oxidative stress; P:spermatogenesis;|Q06830 B5BU26 D3DPZ8 P35703 Q2V576 Q5T154 Q5T155,Peroxiredoxin-1,Natural killer cell-enhancing factor A;Proliferation-associated gene protein;Thioredoxin peroxidase 2;Thioredoxin-dependent peroxide reductase 2;Thioredoxin-dependent peroxiredoxin 1 {ECO:0000305};, PF10417;PF00578;, GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0042470;GO:0005634;GO:0045296;GO:0004601;GO:0003723;GO:0008379;GO:0008283;GO:0045454;GO:0034599;GO:0042744;GO:0045321;GO:0030101;GO:0019430;GO:0001895;GO:0001501;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:melanosome; C:nucleus;, F:cadherin binding; F:peroxidase activity; F:RNA binding; F:thioredoxin peroxidase activity;, P:cell population proliferation; P:cell redox homeostasis; P:cellular response to oxidative stress; P:hydrogen peroxide catabolic process; P:leukocyte activation; P:natural killer cell activation; P:removal of superoxide radicals; P:retina homeostasis; P:skeletal system development; scaffold105 indexed_genome mRNA 978828 1020174 . + . ID=transcript_13135;Q9Y305 B3KNC9 B7ZM94,Acyl-coenzyme A thioesterase 9, mitochondrial,Acyl-CoA thioester hydrolase 9;, , GO:0005759;GO:0005739;GO:0003986;GO:0047617;GO:0052689;GO:0006637;, C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity;, P:acyl-CoA metabolic process;|Q9Y305 B3KNC9 B7ZM94,Acyl-coenzyme A thioesterase 9, mitochondrial,Acyl-CoA thioester hydrolase 9;, , GO:0005759;GO:0005739;GO:0003986;GO:0047617;GO:0052689;GO:0006637;, C:mitochondrial matrix; C:mitochondrion;, F:acetyl-CoA hydrolase activity; F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity;, P:acyl-CoA metabolic process; scaffold105 indexed_genome mRNA 1059516 1062569 . + . ID=transcript_13136;P21673 Q6ICU9,Diamine acetyltransferase 1 {ECO:0000305},Polyamine N-acetyltransferase 1 {ECO:0000305};Putrescine acetyltransferase {ECO:0000303|PubMed:17516632};Spermidine/spermine N(1)-acetyltransferase 1 {ECO:0000303|PubMed:1652956, ECO:0000303|PubMed:8573111};, PF00583;, GO:0005829;GO:0004145;GO:0042802;GO:0008080;GO:0019809;GO:0001525;GO:0006596;GO:0009447;GO:0032918;, C:cytosol;, F:diamine N-acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:spermidine binding;, P:angiogenesis; P:polyamine biosynthetic process; P:putrescine catabolic process; P:spermidine acetylation;|P21673 Q6ICU9,Diamine acetyltransferase 1 {ECO:0000305},Polyamine N-acetyltransferase 1 {ECO:0000305};Putrescine acetyltransferase {ECO:0000303|PubMed:17516632};Spermidine/spermine N(1)-acetyltransferase 1 {ECO:0000303|PubMed:1652956, ECO:0000303|PubMed:8573111};, PF00583;, GO:0005829;GO:0004145;GO:0042802;GO:0008080;GO:0019809;GO:0001525;GO:0006596;GO:0009447;GO:0032918;, C:cytosol;, F:diamine N-acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:spermidine binding;, P:angiogenesis; P:polyamine biosynthetic process; P:putrescine catabolic process; P:spermidine acetylation;|P21673 Q6ICU9,Diamine acetyltransferase 1 {ECO:0000305},Polyamine N-acetyltransferase 1 {ECO:0000305};Putrescine acetyltransferase {ECO:0000303|PubMed:17516632};Spermidine/spermine N(1)-acetyltransferase 1 {ECO:0000303|PubMed:1652956, ECO:0000303|PubMed:8573111};, PF00583;, GO:0005829;GO:0004145;GO:0042802;GO:0008080;GO:0019809;GO:0001525;GO:0006596;GO:0009447;GO:0032918;, C:cytosol;, F:diamine N-acetyltransferase activity; F:identical protein binding; F:N-acetyltransferase activity; F:spermidine binding;, P:angiogenesis; P:polyamine biosynthetic process; P:putrescine catabolic process; P:spermidine acetylation; scaffold105 indexed_genome mRNA 1102495 1168431 . - . ID=transcript_13137;Q9BUR5 B2R4K9 Q9H3J9,MICOS complex subunit MIC26 {ECO:0000303|PubMed:25764979},Apolipoprotein O;MICOS complex subunit MIC23 {ECO:0000303|PubMed:25781180};Protein FAM121B;, PF09769;, GO:0005829;GO:0005789;GO:0005576;GO:0005615;GO:0000139;GO:0034364;GO:0031305;GO:0034362;GO:0140275;GO:0061617;GO:0005739;GO:0001401;GO:0034361;GO:0042407;GO:0007007;GO:0006869;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:Golgi membrane; C:high-density lipoprotein particle; C:integral component of mitochondrial inner membrane; C:low-density lipoprotein particle; C:MIB complex; C:MICOS complex; C:mitochondrion; C:SAM complex; C:very-low-density lipoprotein particle;, , P:cristae formation; P:inner mitochondrial membrane organization; P:lipid transport; scaffold105 indexed_genome mRNA 1171208 1193590 . + . ID=transcript_13138;Q96LI9,Putative uncharacterized protein CXorf58|Q96LI9,Putative uncharacterized protein CXorf58|Q96LI9,Putative uncharacterized protein CXorf58 scaffold105 indexed_genome mRNA 1241051 1258635 . - . ID=transcript_13139;Q96M94 Q32MN3 Q8NDA3 Q96BM6 Q9C0I6,Kelch-like protein 15,, PF07707;PF00651;PF01344;, GO:0031463;GO:0005634;GO:2000042;GO:0071630;GO:0016567;GO:0006511;, C:Cul3-RING ubiquitin ligase complex; C:nucleus;, , P:negative regulation of double-strand break repair via homologous recombination; P:nuclear protein quality control by the ubiquitin-proteasome system; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold105 indexed_genome mRNA 1295591 1320266 . + . ID=transcript_13140;P41091 A0A024RBY4 A8K2Y2 B2R5N2 B5BTZ4 Q53HK3,Eukaryotic translation initiation factor 2 subunit 3,Eukaryotic translation initiation factor 2 subunit gamma X;, PF09173;PF00009;PF03144;, GO:0005737;GO:0005829;GO:0005850;GO:0070062;GO:0045296;GO:0005525;GO:0003924;GO:0008135;GO:0003743;GO:0000049;GO:0001731;GO:0045903;GO:0006413;GO:0055085;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2 complex; C:extracellular exosome;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:tRNA binding;, P:formation of translation preinitiation complex; P:positive regulation of translational fidelity; P:translational initiation; P:transmembrane transport;|P41091 A0A024RBY4 A8K2Y2 B2R5N2 B5BTZ4 Q53HK3,Eukaryotic translation initiation factor 2 subunit 3,Eukaryotic translation initiation factor 2 subunit gamma X;, PF09173;PF00009;PF03144;, GO:0005737;GO:0005829;GO:0005850;GO:0070062;GO:0045296;GO:0005525;GO:0003924;GO:0008135;GO:0003743;GO:0000049;GO:0001731;GO:0045903;GO:0006413;GO:0055085;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 2 complex; C:extracellular exosome;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:translation factor activity, RNA binding; F:translation initiation factor activity; F:tRNA binding;, P:formation of translation preinitiation complex; P:positive regulation of translational fidelity; P:translational initiation; P:transmembrane transport; scaffold105 indexed_genome mRNA 1394667 1416473 . + . ID=transcript_13141;P17010 B9EG97 O43668 Q8WYJ8,Zinc finger X-chromosomal protein,, PF00096;PF04704;, GO:0005694;GO:0005730;GO:0005654;GO:0043035;GO:0046872;GO:0009566;GO:0048872;GO:0035264;GO:0048599;GO:0001541;GO:0060746;GO:0009791;GO:0006357;GO:0007283;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:chromatin insulator sequence binding; F:metal ion binding;, P:fertilization; P:homeostasis of number of cells; P:multicellular organism growth; P:oocyte development; P:ovarian follicle development; P:parental behavior; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|P17010 B9EG97 O43668 Q8WYJ8,Zinc finger X-chromosomal protein,, PF00096;PF04704;, GO:0005694;GO:0005730;GO:0005654;GO:0043035;GO:0046872;GO:0009566;GO:0048872;GO:0035264;GO:0048599;GO:0001541;GO:0060746;GO:0009791;GO:0006357;GO:0007283;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:chromatin insulator sequence binding; F:metal ion binding;, P:fertilization; P:homeostasis of number of cells; P:multicellular organism growth; P:oocyte development; P:ovarian follicle development; P:parental behavior; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|P17010 B9EG97 O43668 Q8WYJ8,Zinc finger X-chromosomal protein,, PF00096;PF04704;, GO:0005694;GO:0005730;GO:0005654;GO:0043035;GO:0046872;GO:0009566;GO:0048872;GO:0035264;GO:0048599;GO:0001541;GO:0060746;GO:0009791;GO:0006357;GO:0007283;, C:chromosome; C:nucleolus; C:nucleoplasm;, F:chromatin insulator sequence binding; F:metal ion binding;, P:fertilization; P:homeostasis of number of cells; P:multicellular organism growth; P:oocyte development; P:ovarian follicle development; P:parental behavior; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|P08048 B4DVF7 Q14021 Q15558 Q1RME9 Q24JR0 Q96TF3,Zinc finger Y-chromosomal protein,, PF00096;PF04704;, GO:0005730;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0043565;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold105 indexed_genome mRNA 1652813 1737655 . + . ID=transcript_13142;Q15120 B4DXG6,[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial,Pyruvate dehydrogenase kinase isoform 3;, PF10436;PF02518;, GO:0005759;GO:0005739;GO:0005730;GO:0005524;GO:0004672;GO:0004674;GO:0004740;GO:0071398;GO:0071333;GO:0006006;GO:0097411;GO:0018105;GO:0035357;GO:0006468;GO:0010510;GO:0010906;GO:2000377;, C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:ATP binding; F:protein kinase activity; F:protein serine/threonine kinase activity; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity;, P:cellular response to fatty acid; P:cellular response to glucose stimulus; P:glucose metabolic process; P:hypoxia-inducible factor-1alpha signaling pathway; P:peptidyl-serine phosphorylation; P:peroxisome proliferator activated receptor signaling pathway; P:protein phosphorylation; P:regulation of acetyl-CoA biosynthetic process from pyruvate; P:regulation of glucose metabolic process; P:regulation of reactive oxygen species metabolic process; scaffold105 indexed_genome mRNA 1754310 1897830 . - . ID=transcript_13143;Q9Y5K3 A8IX00 B2RCX8 B4DK10 E9PD84 O60621 Q86XC9,Choline-phosphate cytidylyltransferase B,CCT-beta;CTP:phosphocholine cytidylyltransferase B;Phosphorylcholine transferase B;, PF01467;, GO:0005737;GO:0005783;GO:0005789;GO:0004105;GO:0042802;GO:0031210;GO:0006657;GO:0001541;GO:0006656;GO:0007283;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:choline-phosphate cytidylyltransferase activity; F:identical protein binding; F:phosphatidylcholine binding;, P:CDP-choline pathway; P:ovarian follicle development; P:phosphatidylcholine biosynthetic process; P:spermatogenesis; scaffold105 indexed_genome mRNA 1909402 2202941 . + . ID=transcript_13144;P09884 Q86UQ7,DNA polymerase alpha catalytic subunit,DNA polymerase alpha catalytic subunit p180;, PF12254;PF00136;PF03104;PF08996;, GO:0005658;GO:0005829;GO:0005635;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0051539;GO:0003682;GO:0003677;GO:0003688;GO:0003887;GO:0046872;GO:0000166;GO:0019901;GO:0017076;GO:0019103;GO:0003697;GO:0006281;GO:0006260;GO:0006270;GO:0006269;GO:0006271;GO:0000731;GO:0006303;GO:0006273;GO:0006272;GO:1902975;GO:0000083;GO:0032479;GO:0032201;GO:0016032;, C:alpha DNA polymerase:primase complex; C:cytosol; C:nuclear envelope; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:chromatin binding; F:DNA binding; F:DNA replication origin binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding; F:protein kinase binding; F:purine nucleotide binding; F:pyrimidine nucleotide binding; F:single-stranded DNA binding;, P:DNA repair; P:DNA replication; P:DNA replication initiation; P:DNA replication, synthesis of RNA primer; P:DNA strand elongation involved in DNA replication; P:DNA synthesis involved in DNA repair; P:double-strand break repair via nonhomologous end joining; P:lagging strand elongation; P:leading strand elongation; P:mitotic DNA replication initiation; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:regulation of type I interferon production; P:telomere maintenance via semi-conservative replication; P:viral process; scaffold105 indexed_genome mRNA 2222408 2223290 . - . ID=transcript_13145;Q96QS3,Homeobox protein ARX,Aristaless-related homeobox;, PF00046;PF03826;, GO:0000785;GO:0005634;GO:0003682;GO:0000981;GO:0001227;GO:0000978;GO:0000977;GO:1990837;GO:0007411;GO:0021846;GO:0021853;GO:0021800;GO:0021831;GO:0048484;GO:0072148;GO:0021759;GO:0044241;GO:0010628;GO:0046622;GO:0042127;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:axon guidance; P:cell proliferation in forebrain; P:cerebral cortex GABAergic interneuron migration; P:cerebral cortex tangential migration; P:embryonic olfactory bulb interneuron precursor migration; P:enteric nervous system development; P:epithelial cell fate commitment; P:globus pallidus development; P:lipid digestion; P:positive regulation of gene expression; P:positive regulation of organ growth; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; scaffold106 indexed_genome mRNA 1511 55556 . - . ID=transcript_13146;Q96RT8 E9PB12 Q6IQ52 Q96PY8,Gamma-tubulin complex component 5,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT8 E9PB12 Q6IQ52 Q96PY8,Gamma-tubulin complex component 5,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT8 E9PB12 Q6IQ52 Q96PY8,Gamma-tubulin complex component 5,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT8 E9PB12 Q6IQ52 Q96PY8,Gamma-tubulin complex component 5,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT8 E9PB12 Q6IQ52 Q96PY8,Gamma-tubulin complex component 5,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT8 E9PB12 Q6IQ52 Q96PY8,Gamma-tubulin complex component 5,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT8 E9PB12 Q6IQ52 Q96PY8,Gamma-tubulin complex component 5,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT8 E9PB12 Q6IQ52 Q96PY8,Gamma-tubulin complex component 5,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT8 E9PB12 Q6IQ52 Q96PY8,Gamma-tubulin complex component 5,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly; scaffold106 indexed_genome mRNA 60851 68985 . + . ID=transcript_13147;Q96NT0 B4DJ47 Q9BR88,Coiled-coil domain-containing protein 115 {ECO:0000303|PubMed:26833332},, , GO:0030137;GO:0005783;GO:0005793;GO:0005768;GO:0042406;GO:0005764;GO:0016020;GO:0016471;GO:0051082;GO:0006879;GO:0036295;GO:0007042;GO:1905146;GO:0070072;, C:COPI-coated vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome; C:extrinsic component of endoplasmic reticulum membrane; C:lysosome; C:membrane; C:vacuolar proton-transporting V-type ATPase complex;, F:unfolded protein binding;, P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:lysosomal lumen acidification; P:lysosomal protein catabolic process; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q96G21 Q3ZTT3,U3 small nucleolar ribonucleoprotein protein IMP4,Brix domain-containing protein 4;, PF04427;, GO:0001650;GO:0034457;GO:0005730;GO:0005654;GO:0030684;GO:0032040;GO:0042134;GO:0030515;GO:0006364;, C:fibrillar center; C:Mpp10 complex; C:nucleolus; C:nucleoplasm; C:preribosome; C:small-subunit processome;, F:rRNA primary transcript binding; F:snoRNA binding;, P:rRNA processing;|Q96G21 Q3ZTT3,U3 small nucleolar ribonucleoprotein protein IMP4,Brix domain-containing protein 4;, PF04427;, GO:0001650;GO:0034457;GO:0005730;GO:0005654;GO:0030684;GO:0032040;GO:0042134;GO:0030515;GO:0006364;, C:fibrillar center; C:Mpp10 complex; C:nucleolus; C:nucleoplasm; C:preribosome; C:small-subunit processome;, F:rRNA primary transcript binding; F:snoRNA binding;, P:rRNA processing;|Q96G21 Q3ZTT3,U3 small nucleolar ribonucleoprotein protein IMP4,Brix domain-containing protein 4;, PF04427;, GO:0001650;GO:0034457;GO:0005730;GO:0005654;GO:0030684;GO:0032040;GO:0042134;GO:0030515;GO:0006364;, C:fibrillar center; C:Mpp10 complex; C:nucleolus; C:nucleoplasm; C:preribosome; C:small-subunit processome;, F:rRNA primary transcript binding; F:snoRNA binding;, P:rRNA processing; scaffold106 indexed_genome mRNA 79041 80000 . + . ID=transcript_13148;Q99952 B4E1E6 Q53P42,Tyrosine-protein phosphatase non-receptor type 18,Brain-derived phosphatase;, PF00102;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0004726;GO:0004725;GO:0001825;GO:0071345;GO:0038128;GO:1901185;GO:0035335;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:blastocyst formation; P:cellular response to cytokine stimulus; P:ERBB2 signaling pathway; P:negative regulation of ERBB signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; scaffold106 indexed_genome mRNA 95055 98983 . + . ID=transcript_13149;Q99952 B4E1E6 Q53P42,Tyrosine-protein phosphatase non-receptor type 18,Brain-derived phosphatase;, PF00102;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0004726;GO:0004725;GO:0001825;GO:0071345;GO:0038128;GO:1901185;GO:0035335;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:blastocyst formation; P:cellular response to cytokine stimulus; P:ERBB2 signaling pathway; P:negative regulation of ERBB signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation;|Q99952 B4E1E6 Q53P42,Tyrosine-protein phosphatase non-receptor type 18,Brain-derived phosphatase;, PF00102;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0004726;GO:0004725;GO:0001825;GO:0071345;GO:0038128;GO:1901185;GO:0035335;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:blastocyst formation; P:cellular response to cytokine stimulus; P:ERBB2 signaling pathway; P:negative regulation of ERBB signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation;|Q99952 B4E1E6 Q53P42,Tyrosine-protein phosphatase non-receptor type 18,Brain-derived phosphatase;, PF00102;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0004726;GO:0004725;GO:0001825;GO:0071345;GO:0038128;GO:1901185;GO:0035335;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:blastocyst formation; P:cellular response to cytokine stimulus; P:ERBB2 signaling pathway; P:negative regulation of ERBB signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; scaffold106 indexed_genome mRNA 297230 305189 . + . ID=transcript_13150;Q8N944 B7ZLH6,APC membrane recruitment protein 3,Protein FAM123C;, PF09422;, GO:0005886;GO:0008013;GO:0005546;GO:0060828;GO:0016055;, C:plasma membrane;, F:beta-catenin binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q8N944 B7ZLH6,APC membrane recruitment protein 3,Protein FAM123C;, PF09422;, GO:0005886;GO:0008013;GO:0005546;GO:0060828;GO:0016055;, C:plasma membrane;, F:beta-catenin binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold106 indexed_genome mRNA 569657 608867 . + . ID=transcript_13151;Q9NR80 Q9HDC6 Q9UPP0,Rho guanine nucleotide exchange factor 4,APC-stimulated guanine nucleotide exchange factor 1;, PF00169;PF00621;PF00018;, GO:0005829;GO:0032587;GO:0005085;GO:0019904;GO:0046847;GO:0007186;GO:0035556;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; scaffold106 indexed_genome mRNA 743148 753351 . - . ID=transcript_13152;Q9NR80 Q9HDC6 Q9UPP0,Rho guanine nucleotide exchange factor 4,APC-stimulated guanine nucleotide exchange factor 1;, PF00169;PF00621;PF00018;, GO:0005829;GO:0032587;GO:0005085;GO:0019904;GO:0046847;GO:0007186;GO:0035556;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q9NR80 Q9HDC6 Q9UPP0,Rho guanine nucleotide exchange factor 4,APC-stimulated guanine nucleotide exchange factor 1;, PF00169;PF00621;PF00018;, GO:0005829;GO:0032587;GO:0005085;GO:0019904;GO:0046847;GO:0007186;GO:0035556;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q9NR80 Q9HDC6 Q9UPP0,Rho guanine nucleotide exchange factor 4,APC-stimulated guanine nucleotide exchange factor 1;, PF00169;PF00621;PF00018;, GO:0005829;GO:0032587;GO:0005085;GO:0019904;GO:0046847;GO:0007186;GO:0035556;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q9NR80 Q9HDC6 Q9UPP0,Rho guanine nucleotide exchange factor 4,APC-stimulated guanine nucleotide exchange factor 1;, PF00169;PF00621;PF00018;, GO:0005829;GO:0032587;GO:0005085;GO:0019904;GO:0046847;GO:0007186;GO:0035556;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q9NR80 Q9HDC6 Q9UPP0,Rho guanine nucleotide exchange factor 4,APC-stimulated guanine nucleotide exchange factor 1;, PF00169;PF00621;PF00018;, GO:0005829;GO:0032587;GO:0005085;GO:0019904;GO:0046847;GO:0007186;GO:0035556;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction;|Q9NR80 Q9HDC6 Q9UPP0,Rho guanine nucleotide exchange factor 4,APC-stimulated guanine nucleotide exchange factor 1;, PF00169;PF00621;PF00018;, GO:0005829;GO:0032587;GO:0005085;GO:0019904;GO:0046847;GO:0007186;GO:0035556;GO:0030032;GO:0043065;GO:0051056;, C:cytosol; C:ruffle membrane;, F:guanyl-nucleotide exchange factor activity; F:protein domain specific binding;, P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:lamellipodium assembly; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; scaffold106 indexed_genome mRNA 753871 779074 . + . ID=transcript_13153;A1KXE4 Q2TAZ6 Q6NZ40,Myelin-associated neurite-outgrowth inhibitor,p20;, PF14944;, GO:0030424;GO:0070062;GO:0016021;GO:0048471;GO:0005886;, C:axon; C:extracellular exosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;|A1KXE4 Q2TAZ6 Q6NZ40,Myelin-associated neurite-outgrowth inhibitor,p20;, PF14944;, GO:0030424;GO:0070062;GO:0016021;GO:0048471;GO:0005886;, C:axon; C:extracellular exosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;|A1KXE4 Q2TAZ6 Q6NZ40,Myelin-associated neurite-outgrowth inhibitor,p20;, PF14944;, GO:0030424;GO:0070062;GO:0016021;GO:0048471;GO:0005886;, C:axon; C:extracellular exosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; scaffold106 indexed_genome mRNA 783461 784569 . + . ID=transcript_13154;A1KXE4 Q2TAZ6 Q6NZ40,Myelin-associated neurite-outgrowth inhibitor,p20;, PF14944;, GO:0030424;GO:0070062;GO:0016021;GO:0048471;GO:0005886;, C:axon; C:extracellular exosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; scaffold106 indexed_genome mRNA 829851 861234 . + . ID=transcript_13155;Q96CS7 B4DF08 B4DZ66 B8ZZN1 Q53FF1 Q53TH7 Q86W37 Q9BV75 Q9NWK1,Pleckstrin homology domain-containing family B member 2,Evectin-2;, PF00169;, GO:0016021;GO:0055038;GO:0005547;GO:0045595;, C:integral component of membrane; C:recycling endosome membrane;, F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:regulation of cell differentiation;|Q96CS7 B4DF08 B4DZ66 B8ZZN1 Q53FF1 Q53TH7 Q86W37 Q9BV75 Q9NWK1,Pleckstrin homology domain-containing family B member 2,Evectin-2;, PF00169;, GO:0016021;GO:0055038;GO:0005547;GO:0045595;, C:integral component of membrane; C:recycling endosome membrane;, F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:regulation of cell differentiation; scaffold106 indexed_genome mRNA 3124360 3127726 . - . ID=transcript_13156;O60243 B4DEP2 B4DJ29 Q53SL2 Q9BVI1,Heparan-sulfate 6-O-sulfotransferase 1,, PF03567;, GO:0000139;GO:0005887;GO:0017095;GO:0008146;GO:0006024;GO:0015015;GO:0048666;, C:Golgi membrane; C:integral component of plasma membrane;, F:heparan sulfate 6-O-sulfotransferase activity; F:sulfotransferase activity;, P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; P:neuron development; scaffold106 indexed_genome mRNA 3203873 3325734 . - . ID=transcript_13157;Q9NYU2 Q53QP2 Q53SL3 Q8IW30 Q9H8I4,UDP-glucose:glycoprotein glucosyltransferase 1,UDP--Glc:glycoprotein glucosyltransferase;UDP-glucose ceramide glucosyltransferase-like 1;, PF18404;PF18400;PF18401;PF18402;PF18403;PF06427;, GO:0005783;GO:0005788;GO:0044322;GO:0005793;GO:0070062;GO:0032991;GO:0003980;GO:0051082;GO:0051084;GO:1904380;GO:0071712;GO:0018279;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:protein-containing complex;, F:UDP-glucose:glycoprotein glucosyltransferase activity; F:unfolded protein binding;, P:'de novo' posttranslational protein folding; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:protein N-linked glycosylation via asparagine;|Q9NYU2 Q53QP2 Q53SL3 Q8IW30 Q9H8I4,UDP-glucose:glycoprotein glucosyltransferase 1,UDP--Glc:glycoprotein glucosyltransferase;UDP-glucose ceramide glucosyltransferase-like 1;, PF18404;PF18400;PF18401;PF18402;PF18403;PF06427;, GO:0005783;GO:0005788;GO:0044322;GO:0005793;GO:0070062;GO:0032991;GO:0003980;GO:0051082;GO:0051084;GO:1904380;GO:0071712;GO:0018279;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:protein-containing complex;, F:UDP-glucose:glycoprotein glucosyltransferase activity; F:unfolded protein binding;, P:'de novo' posttranslational protein folding; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:protein N-linked glycosylation via asparagine;|Q9NYU2 Q53QP2 Q53SL3 Q8IW30 Q9H8I4,UDP-glucose:glycoprotein glucosyltransferase 1,UDP--Glc:glycoprotein glucosyltransferase;UDP-glucose ceramide glucosyltransferase-like 1;, PF18404;PF18400;PF18401;PF18402;PF18403;PF06427;, GO:0005783;GO:0005788;GO:0044322;GO:0005793;GO:0070062;GO:0032991;GO:0003980;GO:0051082;GO:0051084;GO:1904380;GO:0071712;GO:0018279;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:protein-containing complex;, F:UDP-glucose:glycoprotein glucosyltransferase activity; F:unfolded protein binding;, P:'de novo' posttranslational protein folding; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:protein N-linked glycosylation via asparagine;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9NYU2 Q53QP2 Q53SL3 Q8IW30 Q9H8I4,UDP-glucose:glycoprotein glucosyltransferase 1,UDP--Glc:glycoprotein glucosyltransferase;UDP-glucose ceramide glucosyltransferase-like 1;, PF18404;PF18400;PF18401;PF18402;PF18403;PF06427;, GO:0005783;GO:0005788;GO:0044322;GO:0005793;GO:0070062;GO:0032991;GO:0003980;GO:0051082;GO:0051084;GO:1904380;GO:0071712;GO:0018279;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:protein-containing complex;, F:UDP-glucose:glycoprotein glucosyltransferase activity; F:unfolded protein binding;, P:'de novo' posttranslational protein folding; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:protein N-linked glycosylation via asparagine;|Q9NYU2 Q53QP2 Q53SL3 Q8IW30 Q9H8I4,UDP-glucose:glycoprotein glucosyltransferase 1,UDP--Glc:glycoprotein glucosyltransferase;UDP-glucose ceramide glucosyltransferase-like 1;, PF18404;PF18400;PF18401;PF18402;PF18403;PF06427;, GO:0005783;GO:0005788;GO:0044322;GO:0005793;GO:0070062;GO:0032991;GO:0003980;GO:0051082;GO:0051084;GO:1904380;GO:0071712;GO:0018279;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum quality control compartment; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:protein-containing complex;, F:UDP-glucose:glycoprotein glucosyltransferase activity; F:unfolded protein binding;, P:'de novo' posttranslational protein folding; P:endoplasmic reticulum mannose trimming; P:ER-associated misfolded protein catabolic process; P:protein N-linked glycosylation via asparagine; scaffold106 indexed_genome mRNA 3368335 3444054 . + . ID=transcript_13158;Q9H0E3 B7ZLM3 C9K0X9 Q4ZFV4 Q53T46 Q8WVW4 Q9H9G8,Histone deacetylase complex subunit SAP130,130 kDa Sin3-associated polypeptide;Sin3-associated polypeptide p130;, PF16014;, GO:0016607;GO:0070822;GO:0000122;, C:nuclear speck; C:Sin3-type complex;, , P:negative regulation of transcription by RNA polymerase II;|Q9H0E3 B7ZLM3 C9K0X9 Q4ZFV4 Q53T46 Q8WVW4 Q9H9G8,Histone deacetylase complex subunit SAP130,130 kDa Sin3-associated polypeptide;Sin3-associated polypeptide p130;, PF16014;, GO:0016607;GO:0070822;GO:0000122;, C:nuclear speck; C:Sin3-type complex;, , P:negative regulation of transcription by RNA polymerase II;|Q9H0E3 B7ZLM3 C9K0X9 Q4ZFV4 Q53T46 Q8WVW4 Q9H9G8,Histone deacetylase complex subunit SAP130,130 kDa Sin3-associated polypeptide;Sin3-associated polypeptide p130;, PF16014;, GO:0016607;GO:0070822;GO:0000122;, C:nuclear speck; C:Sin3-type complex;, , P:negative regulation of transcription by RNA polymerase II;|Q9H0E3 B7ZLM3 C9K0X9 Q4ZFV4 Q53T46 Q8WVW4 Q9H9G8,Histone deacetylase complex subunit SAP130,130 kDa Sin3-associated polypeptide;Sin3-associated polypeptide p130;, PF16014;, GO:0016607;GO:0070822;GO:0000122;, C:nuclear speck; C:Sin3-type complex;, , P:negative regulation of transcription by RNA polymerase II;|Q9H0E3 B7ZLM3 C9K0X9 Q4ZFV4 Q53T46 Q8WVW4 Q9H9G8,Histone deacetylase complex subunit SAP130,130 kDa Sin3-associated polypeptide;Sin3-associated polypeptide p130;, PF16014;, GO:0016607;GO:0070822;GO:0000122;, C:nuclear speck; C:Sin3-type complex;, , P:negative regulation of transcription by RNA polymerase II;|Q9H0E3 B7ZLM3 C9K0X9 Q4ZFV4 Q53T46 Q8WVW4 Q9H9G8,Histone deacetylase complex subunit SAP130,130 kDa Sin3-associated polypeptide;Sin3-associated polypeptide p130;, PF16014;, GO:0016607;GO:0070822;GO:0000122;, C:nuclear speck; C:Sin3-type complex;, , P:negative regulation of transcription by RNA polymerase II;|Q9H0E3 B7ZLM3 C9K0X9 Q4ZFV4 Q53T46 Q8WVW4 Q9H9G8,Histone deacetylase complex subunit SAP130,130 kDa Sin3-associated polypeptide;Sin3-associated polypeptide p130;, PF16014;, GO:0016607;GO:0070822;GO:0000122;, C:nuclear speck; C:Sin3-type complex;, , P:negative regulation of transcription by RNA polymerase II; scaffold106 indexed_genome mRNA 3507538 3531374 . + . ID=transcript_13159;Q6DCA0 B4E276,AMMECR1-like protein,, PF01871;, GO:0005634;, C:nucleus;|Q6DCA0 B4E276,AMMECR1-like protein,, PF01871;, GO:0005634;, C:nucleus;|Q6DCA0 B4E276,AMMECR1-like protein,, PF01871;, GO:0005634;, C:nucleus; scaffold106 indexed_genome mRNA 3535798 3548021 . - . ID=transcript_13160;O15514 Q52LT4,DNA-directed RNA polymerase II subunit RPB4,DNA-directed RNA polymerase II subunit D;RNA polymerase II 16 kDa subunit;, PF03874;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000932;GO:0005665;GO:0003899;GO:0000166;GO:0031369;GO:0006370;GO:0008543;GO:0031990;GO:0000398;GO:0048239;GO:0000288;GO:0045948;GO:0050434;GO:0034402;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:P-body; C:RNA polymerase II, core complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:nucleotide binding; F:translation initiation factor binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA export from nucleus in response to heat stress; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of translational initiation; P:positive regulation of viral transcription; P:recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|O15514 Q52LT4,DNA-directed RNA polymerase II subunit RPB4,DNA-directed RNA polymerase II subunit D;RNA polymerase II 16 kDa subunit;, PF03874;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000932;GO:0005665;GO:0003899;GO:0000166;GO:0031369;GO:0006370;GO:0008543;GO:0031990;GO:0000398;GO:0048239;GO:0000288;GO:0045948;GO:0050434;GO:0034402;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:P-body; C:RNA polymerase II, core complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:nucleotide binding; F:translation initiation factor binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA export from nucleus in response to heat stress; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of translational initiation; P:positive regulation of viral transcription; P:recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|O15514 Q52LT4,DNA-directed RNA polymerase II subunit RPB4,DNA-directed RNA polymerase II subunit D;RNA polymerase II 16 kDa subunit;, PF03874;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000932;GO:0005665;GO:0003899;GO:0000166;GO:0031369;GO:0006370;GO:0008543;GO:0031990;GO:0000398;GO:0048239;GO:0000288;GO:0045948;GO:0050434;GO:0034402;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:P-body; C:RNA polymerase II, core complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:nucleotide binding; F:translation initiation factor binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA export from nucleus in response to heat stress; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of translational initiation; P:positive regulation of viral transcription; P:recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|O15514 Q52LT4,DNA-directed RNA polymerase II subunit RPB4,DNA-directed RNA polymerase II subunit D;RNA polymerase II 16 kDa subunit;, PF03874;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000932;GO:0005665;GO:0003899;GO:0000166;GO:0031369;GO:0006370;GO:0008543;GO:0031990;GO:0000398;GO:0048239;GO:0000288;GO:0045948;GO:0050434;GO:0034402;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:P-body; C:RNA polymerase II, core complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:nucleotide binding; F:translation initiation factor binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA export from nucleus in response to heat stress; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of translational initiation; P:positive regulation of viral transcription; P:recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|O15514 Q52LT4,DNA-directed RNA polymerase II subunit RPB4,DNA-directed RNA polymerase II subunit D;RNA polymerase II 16 kDa subunit;, PF03874;, GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0000932;GO:0005665;GO:0003899;GO:0000166;GO:0031369;GO:0006370;GO:0008543;GO:0031990;GO:0000398;GO:0048239;GO:0000288;GO:0045948;GO:0050434;GO:0034402;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:P-body; C:RNA polymerase II, core complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:nucleotide binding; F:translation initiation factor binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA export from nucleus in response to heat stress; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of translational initiation; P:positive regulation of viral transcription; P:recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; scaffold106 indexed_genome mRNA 3583927 3692305 . + . ID=transcript_13161;Q9C0J8 Q05DP8 Q53FG9 Q587J1 Q69YF7 Q6NUQ0 Q9NUL1,pre-mRNA 3' end processing protein WDR33,WD repeat-containing protein 33;WD repeat-containing protein of 146 kDa {ECO:0000303|PubMed:11162572};, PF00400;, GO:0005581;GO:0001650;GO:0005847;GO:0005654;GO:0005634;GO:0003723;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0006301;GO:0007283;GO:0006369;, C:collagen trimer; C:fibrillar center; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:postreplication repair; P:spermatogenesis; P:termination of RNA polymerase II transcription;|Q9C0J8 Q05DP8 Q53FG9 Q587J1 Q69YF7 Q6NUQ0 Q9NUL1,pre-mRNA 3' end processing protein WDR33,WD repeat-containing protein 33;WD repeat-containing protein of 146 kDa {ECO:0000303|PubMed:11162572};, PF00400;, GO:0005581;GO:0001650;GO:0005847;GO:0005654;GO:0005634;GO:0003723;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0006301;GO:0007283;GO:0006369;, C:collagen trimer; C:fibrillar center; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:postreplication repair; P:spermatogenesis; P:termination of RNA polymerase II transcription;|Q9C0J8 Q05DP8 Q53FG9 Q587J1 Q69YF7 Q6NUQ0 Q9NUL1,pre-mRNA 3' end processing protein WDR33,WD repeat-containing protein 33;WD repeat-containing protein of 146 kDa {ECO:0000303|PubMed:11162572};, PF00400;, GO:0005581;GO:0001650;GO:0005847;GO:0005654;GO:0005634;GO:0003723;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0006301;GO:0007283;GO:0006369;, C:collagen trimer; C:fibrillar center; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:postreplication repair; P:spermatogenesis; P:termination of RNA polymerase II transcription;|Q9C0J8 Q05DP8 Q53FG9 Q587J1 Q69YF7 Q6NUQ0 Q9NUL1,pre-mRNA 3' end processing protein WDR33,WD repeat-containing protein 33;WD repeat-containing protein of 146 kDa {ECO:0000303|PubMed:11162572};, PF00400;, GO:0005581;GO:0001650;GO:0005847;GO:0005654;GO:0005634;GO:0003723;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0006301;GO:0007283;GO:0006369;, C:collagen trimer; C:fibrillar center; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:postreplication repair; P:spermatogenesis; P:termination of RNA polymerase II transcription; scaffold106 indexed_genome mRNA 3692312 3699200 . + . ID=transcript_13162;Q9C0J8 Q05DP8 Q53FG9 Q587J1 Q69YF7 Q6NUQ0 Q9NUL1,pre-mRNA 3' end processing protein WDR33,WD repeat-containing protein 33;WD repeat-containing protein of 146 kDa {ECO:0000303|PubMed:11162572};, PF00400;, GO:0005581;GO:0001650;GO:0005847;GO:0005654;GO:0005634;GO:0003723;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0006301;GO:0007283;GO:0006369;, C:collagen trimer; C:fibrillar center; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:postreplication repair; P:spermatogenesis; P:termination of RNA polymerase II transcription;|Q9C0J8 Q05DP8 Q53FG9 Q587J1 Q69YF7 Q6NUQ0 Q9NUL1,pre-mRNA 3' end processing protein WDR33,WD repeat-containing protein 33;WD repeat-containing protein of 146 kDa {ECO:0000303|PubMed:11162572};, PF00400;, GO:0005581;GO:0001650;GO:0005847;GO:0005654;GO:0005634;GO:0003723;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0006301;GO:0007283;GO:0006369;, C:collagen trimer; C:fibrillar center; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:postreplication repair; P:spermatogenesis; P:termination of RNA polymerase II transcription; scaffold106 indexed_genome mRNA 3703899 3709819 . + . ID=transcript_13163;Q587I9 Q8N2P9,Vesicle transport protein SFT2C,SFT2 domain-containing protein 3;, PF04178;, GO:0016021;GO:0015031;GO:0016192;, C:integral component of membrane;, , P:protein transport; P:vesicle-mediated transport; scaffold106 indexed_genome mRNA 3749336 3805317 . + . ID=transcript_13164;Q7Z4I7 A6NLH0 B4DMV1 F5H6E6 Q7Z4I2 Q7Z4I6 Q7Z4I8 Q8NFE7 Q9HA13,LIM and senescent cell antigen-like-containing domain protein 2,LIM-like protein 2;Particularly interesting new Cys-His protein 2;, PF00412;, GO:0005911;GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0046872;GO:0034329;GO:0098609;GO:0045216;GO:0043066;GO:2000346;GO:2000178;GO:2001046;GO:1900026;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane;, F:metal ion binding;, P:cell junction assembly; P:cell-cell adhesion; P:cell-cell junction organization; P:negative regulation of apoptotic process; P:negative regulation of hepatocyte proliferation; P:negative regulation of neural precursor cell proliferation; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of substrate adhesion-dependent cell spreading;|Q7Z4I7 A6NLH0 B4DMV1 F5H6E6 Q7Z4I2 Q7Z4I6 Q7Z4I8 Q8NFE7 Q9HA13,LIM and senescent cell antigen-like-containing domain protein 2,LIM-like protein 2;Particularly interesting new Cys-His protein 2;, PF00412;, GO:0005911;GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0046872;GO:0034329;GO:0098609;GO:0045216;GO:0043066;GO:2000346;GO:2000178;GO:2001046;GO:1900026;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane;, F:metal ion binding;, P:cell junction assembly; P:cell-cell adhesion; P:cell-cell junction organization; P:negative regulation of apoptotic process; P:negative regulation of hepatocyte proliferation; P:negative regulation of neural precursor cell proliferation; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of substrate adhesion-dependent cell spreading;|Q13304 A8K9L0 B2R9X0 Q8N5S7 Q9UDZ6 Q9UE21,Uracil nucleotide/cysteinyl leukotriene receptor,G-protein coupled receptor 17;P2Y-like receptor;R12;, PF00001;, GO:0005887;GO:0005886;GO:0004950;GO:0004930;GO:0033612;GO:0007186;GO:0002862;GO:0048709;GO:0051482;GO:0035025;, C:integral component of plasma membrane; C:plasma membrane;, F:chemokine receptor activity; F:G protein-coupled receptor activity; F:receptor serine/threonine kinase binding;, P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:oligodendrocyte differentiation; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of Rho protein signal transduction;|Q7Z4I7 A6NLH0 B4DMV1 F5H6E6 Q7Z4I2 Q7Z4I6 Q7Z4I8 Q8NFE7 Q9HA13,LIM and senescent cell antigen-like-containing domain protein 2,LIM-like protein 2;Particularly interesting new Cys-His protein 2;, PF00412;, GO:0005911;GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0046872;GO:0034329;GO:0098609;GO:0045216;GO:0043066;GO:2000346;GO:2000178;GO:2001046;GO:1900026;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane;, F:metal ion binding;, P:cell junction assembly; P:cell-cell adhesion; P:cell-cell junction organization; P:negative regulation of apoptotic process; P:negative regulation of hepatocyte proliferation; P:negative regulation of neural precursor cell proliferation; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of substrate adhesion-dependent cell spreading;|Q6PIF6 Q14786 Q8TEE1,Unconventional myosin-VIIb,, PF00373;PF00612;PF00063;PF00784;, GO:0015629;GO:0090651;GO:0005903;GO:0005737;GO:0005902;GO:0016459;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0000146;GO:0007015;GO:1904970;GO:0030154;GO:0007423;GO:0007605;GO:0030050;, C:actin cytoskeleton; C:apical cytoplasm; C:brush border; C:cytoplasm; C:microvillus; C:myosin complex; C:vesicle;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:microfilament motor activity;, P:actin filament organization; P:brush border assembly; P:cell differentiation; P:sensory organ development; P:sensory perception of sound; P:vesicle transport along actin filament; scaffold106 indexed_genome mRNA 3899800 3949073 . + . ID=transcript_13165;Q96ST2 Q2TB65 Q6P157 Q8N3E8 Q96MI7 Q9NV97 Q9NWH8,Protein IWS1 homolog,IWS1-like protein;, PF08711;, GO:0005654;GO:0005634;GO:0006397;GO:0016973;GO:2001253;GO:0090239;GO:0010793;GO:0050684;GO:0008380;GO:0006366;GO:0006368;, C:nucleoplasm; C:nucleus;, , P:mRNA processing; P:poly(A)+ mRNA export from nucleus; P:regulation of histone H3-K36 trimethylation; P:regulation of histone H4 acetylation; P:regulation of mRNA export from nucleus; P:regulation of mRNA processing; P:RNA splicing; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold106 indexed_genome mRNA 4023116 4031537 . - . ID=transcript_13166;Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization; scaffold107 indexed_genome mRNA 134073 146023 . - . ID=transcript_13167;Q8N5F7 Q6IPW6 Q96BQ2 Q9H638,NF-kappa-B-activating protein,, PF06047;, GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0003723;GO:0000122;GO:0045892;GO:0007219;GO:0046638;GO:0010468;, C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:positive regulation of alpha-beta T cell differentiation; P:regulation of gene expression;|Q8N5F7 Q6IPW6 Q96BQ2 Q9H638,NF-kappa-B-activating protein,, PF06047;, GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0003723;GO:0000122;GO:0045892;GO:0007219;GO:0046638;GO:0010468;, C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:RNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway; P:positive regulation of alpha-beta T cell differentiation; P:regulation of gene expression; scaffold107 indexed_genome mRNA 165320 175165 . - . ID=transcript_13168;Q86UN6 A6NNZ0 Q86UN4 Q86UN5,A-kinase anchor protein 14,A-kinase anchor protein 28 kDa;Protein kinase A-anchoring protein 14;, PF14469;, GO:0005930;GO:0005952;GO:0034237;, C:axoneme; C:cAMP-dependent protein kinase complex;, F:protein kinase A regulatory subunit binding; scaffold107 indexed_genome mRNA 177485 181359 . - . ID=transcript_13169;O15239,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1,Complex I-MWFE;NADH-ubiquinone oxidoreductase MWFE subunit;, PF15879;, GO:0016021;GO:0005743;GO:0031966;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O15239,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1,Complex I-MWFE;NADH-ubiquinone oxidoreductase MWFE subunit;, PF15879;, GO:0016021;GO:0005743;GO:0031966;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold107 indexed_genome mRNA 181402 182823 . - . ID=transcript_13170;O15541 B2RBR7,E3 ubiquitin-protein ligase RNF113A,Cwc24 homolog {ECO:0000305};RING finger protein 113A;Zinc finger protein 183 {ECO:0000303|PubMed:9224902};, PF00642;, GO:0016607;GO:0005654;GO:0005634;GO:0071005;GO:0005684;GO:0046872;GO:0061630;GO:0006281;GO:0018276;GO:0000398;GO:0070100;GO:0016567;GO:0034247;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:DNA repair; P:isopeptide cross-linking via N6-glycyl-L-lysine; P:mRNA splicing, via spliceosome; P:negative regulation of chemokine-mediated signaling pathway; P:protein ubiquitination; P:snoRNA splicing; scaffold107 indexed_genome mRNA 215420 230800 . + . ID=transcript_13171;Q9BZI7 D3DWI3 D3DWI4 Q0VAK8 Q9H1J0,Regulator of nonsense transcripts 3B,Nonsense mRNA reducing factor 3B;Up-frameshift suppressor 3 homolog B;Up-frameshift suppressor 3 homolog on chromosome X;, PF03467;, GO:0034451;GO:0005737;GO:0005829;GO:0035145;GO:0005730;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0017056;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0045727;GO:0006405;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:structural constituent of nuclear pore;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:RNA export from nucleus;|Q9BZI7 D3DWI3 D3DWI4 Q0VAK8 Q9H1J0,Regulator of nonsense transcripts 3B,Nonsense mRNA reducing factor 3B;Up-frameshift suppressor 3 homolog B;Up-frameshift suppressor 3 homolog on chromosome X;, PF03467;, GO:0034451;GO:0005737;GO:0005829;GO:0035145;GO:0005730;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0017056;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0045727;GO:0006405;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:structural constituent of nuclear pore;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:RNA export from nucleus;|Q9BZI7 D3DWI3 D3DWI4 Q0VAK8 Q9H1J0,Regulator of nonsense transcripts 3B,Nonsense mRNA reducing factor 3B;Up-frameshift suppressor 3 homolog B;Up-frameshift suppressor 3 homolog on chromosome X;, PF03467;, GO:0034451;GO:0005737;GO:0005829;GO:0035145;GO:0005730;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0017056;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0045727;GO:0006405;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:structural constituent of nuclear pore;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:RNA export from nucleus;|Q9BZI7 D3DWI3 D3DWI4 Q0VAK8 Q9H1J0,Regulator of nonsense transcripts 3B,Nonsense mRNA reducing factor 3B;Up-frameshift suppressor 3 homolog B;Up-frameshift suppressor 3 homolog on chromosome X;, PF03467;, GO:0034451;GO:0005737;GO:0005829;GO:0035145;GO:0005730;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0017056;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0045727;GO:0006405;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding; F:structural constituent of nuclear pore;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; P:RNA export from nucleus; scaffold107 indexed_genome mRNA 248206 248719 . + . ID=transcript_13172;P62891 P02404 P39025 Q9BYF2,60S ribosomal protein L39,Large ribosomal subunit protein eL39 {ECO:0000303|PubMed:24524803};, PF00832;, GO:0005829;GO:0022625;GO:0005615;GO:0042788;GO:0003723;GO:0003735;GO:0019731;GO:0061844;GO:0002181;GO:0050830;GO:0002227;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular space; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:antibacterial humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cytoplasmic translation; P:defense response to Gram-positive bacterium; P:innate immune response in mucosa; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold107 indexed_genome mRNA 278745 279526 . + . ID=transcript_13173;A6NJG2,Ankyrin repeat domain-containing protein SOWAHD,Ankyrin repeat domain-containing protein 58;Protein sosondowah homolog D;, PF12796; scaffold107 indexed_genome mRNA 356396 433530 . + . ID=transcript_13174;Q14141 Q5JTK0 Q969W5 Q96A13 Q96GR1 Q96P86 Q96P87,Septin-6,, PF00735;, GO:0043679;GO:0032153;GO:0032154;GO:0000777;GO:0015630;GO:0030496;GO:0032173;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0008021;GO:0005525;GO:0003924;GO:0060090;GO:0030154;GO:0034613;GO:0060271;GO:0061640;GO:0000281;GO:0007283;GO:0016032;, C:axon terminus; C:cell division site; C:cleavage furrow; C:condensed chromosome kinetochore; C:microtubule cytoskeleton; C:midbody; C:septin collar; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cell differentiation; P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:mitotic cytokinesis; P:spermatogenesis; P:viral process;|Q14141 Q5JTK0 Q969W5 Q96A13 Q96GR1 Q96P86 Q96P87,Septin-6,, PF00735;, GO:0043679;GO:0032153;GO:0032154;GO:0000777;GO:0015630;GO:0030496;GO:0032173;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0008021;GO:0005525;GO:0003924;GO:0060090;GO:0030154;GO:0034613;GO:0060271;GO:0061640;GO:0000281;GO:0007283;GO:0016032;, C:axon terminus; C:cell division site; C:cleavage furrow; C:condensed chromosome kinetochore; C:microtubule cytoskeleton; C:midbody; C:septin collar; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cell differentiation; P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:mitotic cytokinesis; P:spermatogenesis; P:viral process;|Q14141 Q5JTK0 Q969W5 Q96A13 Q96GR1 Q96P86 Q96P87,Septin-6,, PF00735;, GO:0043679;GO:0032153;GO:0032154;GO:0000777;GO:0015630;GO:0030496;GO:0032173;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0008021;GO:0005525;GO:0003924;GO:0060090;GO:0030154;GO:0034613;GO:0060271;GO:0061640;GO:0000281;GO:0007283;GO:0016032;, C:axon terminus; C:cell division site; C:cleavage furrow; C:condensed chromosome kinetochore; C:microtubule cytoskeleton; C:midbody; C:septin collar; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cell differentiation; P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:mitotic cytokinesis; P:spermatogenesis; P:viral process; scaffold107 indexed_genome mRNA 450656 467340 . + . ID=transcript_13175;O15226 G3V1N1 Q4VC41 Q9UJ91,NF-kappa-B-repressing factor,Protein ITBA4;Transcription factor NRF;, PF01585;PF01424;, GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0003723;GO:0000978;GO:0045892;GO:0045944;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; scaffold107 indexed_genome mRNA 468336 477545 . - . ID=transcript_13176;P49459 A6NFE9 A6NGR2 A6NMF5 B2R7R9 D3DWI1 Q4TTG1 Q96FX4,Ubiquitin-conjugating enzyme E2 A,E2 ubiquitin-conjugating enzyme A;RAD6 homolog A;Ubiquitin carrier protein A;Ubiquitin-protein ligase A;, PF00179;, GO:0000785;GO:0005829;GO:0033503;GO:0005654;GO:0001741;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0001835;GO:0006281;GO:0033522;GO:0016574;GO:0060135;GO:0008284;GO:0006301;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0000209;GO:0016567;GO:0009411;GO:0006511;, C:chromatin; C:cytosol; C:HULC complex; C:nucleoplasm; C:XY body;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:blastocyst hatching; P:DNA repair; P:histone H2A ubiquitination; P:histone ubiquitination; P:maternal process involved in female pregnancy; P:positive regulation of cell population proliferation; P:postreplication repair; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:response to UV; P:ubiquitin-dependent protein catabolic process;|P49459 A6NFE9 A6NGR2 A6NMF5 B2R7R9 D3DWI1 Q4TTG1 Q96FX4,Ubiquitin-conjugating enzyme E2 A,E2 ubiquitin-conjugating enzyme A;RAD6 homolog A;Ubiquitin carrier protein A;Ubiquitin-protein ligase A;, PF00179;, GO:0000785;GO:0005829;GO:0033503;GO:0005654;GO:0001741;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0001835;GO:0006281;GO:0033522;GO:0016574;GO:0060135;GO:0008284;GO:0006301;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0000209;GO:0016567;GO:0009411;GO:0006511;, C:chromatin; C:cytosol; C:HULC complex; C:nucleoplasm; C:XY body;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:blastocyst hatching; P:DNA repair; P:histone H2A ubiquitination; P:histone ubiquitination; P:maternal process involved in female pregnancy; P:positive regulation of cell population proliferation; P:postreplication repair; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:response to UV; P:ubiquitin-dependent protein catabolic process; scaffold107 indexed_genome mRNA 487666 501165 . + . ID=transcript_13177;Q9H5V9 A8MPX7 B4DQN2 D3DWH9 F5GWL7 O43351,STING ER exit protein {ECO:0000303|PubMed:32690950},, , GO:0044297;GO:0005737;GO:0005634;GO:0090158;GO:0006888;, C:cell body; C:cytoplasm; C:nucleus;, , P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q9H5V9 A8MPX7 B4DQN2 D3DWH9 F5GWL7 O43351,STING ER exit protein {ECO:0000303|PubMed:32690950},, , GO:0044297;GO:0005737;GO:0005634;GO:0090158;GO:0006888;, C:cell body; C:cytoplasm; C:nucleus;, , P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q9H5V9 A8MPX7 B4DQN2 D3DWH9 F5GWL7 O43351,STING ER exit protein {ECO:0000303|PubMed:32690950},, , GO:0044297;GO:0005737;GO:0005634;GO:0090158;GO:0006888;, C:cell body; C:cytoplasm; C:nucleus;, , P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; scaffold107 indexed_genome mRNA 569766 615403 . - . ID=transcript_13178;Q8WUT9 O75854 Q8N9L5,Solute carrier family 25 member 43,, PF00153;, GO:0016021;GO:0005743;GO:0055085;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:transmembrane transport;|Q8WUT9 O75854 Q8N9L5,Solute carrier family 25 member 43,, PF00153;, GO:0016021;GO:0005743;GO:0055085;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:transmembrane transport; scaffold107 indexed_genome mRNA 797174 804771 . + . ID=transcript_13179;Q02040 Q02832 Q2TB98 Q5JQ74 Q5JQ76 Q8N6U9,A-kinase anchor protein 17A,721P;B-lymphocyte antigen;Protein XE7;Protein kinase A-anchoring protein 17A;Splicing factor, arginine/serine-rich 17A;, , GO:0005829;GO:0016607;GO:0005634;GO:0005681;GO:0051018;GO:0003723;GO:0042113;GO:0006397;GO:0043484;GO:0006355;GO:0008380;GO:0007165;, C:cytosol; C:nuclear speck; C:nucleus; C:spliceosomal complex;, F:protein kinase A binding; F:RNA binding;, P:B cell activation; P:mRNA processing; P:regulation of RNA splicing; P:regulation of transcription, DNA-templated; P:RNA splicing; P:signal transduction; scaffold107 indexed_genome mRNA 809590 817864 . - . ID=transcript_13180;O00264 B7Z1L3 Q9UGJ9,Membrane-associated progesterone receptor component 1,Dap1 {ECO:0000303|PubMed:28396637};IZA {ECO:0000303|PubMed:28396637};, PF00173;, GO:0044297;GO:0012505;GO:0005783;GO:0005887;GO:0016020;GO:0005741;GO:0043005;GO:0043025;GO:0005886;GO:0030868;GO:0035579;GO:0045202;GO:0001540;GO:0020037;GO:0046872;GO:0042803;GO:0005496;GO:0006783;GO:0043312;, C:cell body; C:endomembrane system; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:mitochondrial outer membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:specific granule membrane; C:synapse;, F:amyloid-beta binding; F:heme binding; F:metal ion binding; F:protein homodimerization activity; F:steroid binding;, P:heme biosynthetic process; P:neutrophil degranulation;|O00264 B7Z1L3 Q9UGJ9,Membrane-associated progesterone receptor component 1,Dap1 {ECO:0000303|PubMed:28396637};IZA {ECO:0000303|PubMed:28396637};, PF00173;, GO:0044297;GO:0012505;GO:0005783;GO:0005887;GO:0016020;GO:0005741;GO:0043005;GO:0043025;GO:0005886;GO:0030868;GO:0035579;GO:0045202;GO:0001540;GO:0020037;GO:0046872;GO:0042803;GO:0005496;GO:0006783;GO:0043312;, C:cell body; C:endomembrane system; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:mitochondrial outer membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:specific granule membrane; C:synapse;, F:amyloid-beta binding; F:heme binding; F:metal ion binding; F:protein homodimerization activity; F:steroid binding;, P:heme biosynthetic process; P:neutrophil degranulation;|O00264 B7Z1L3 Q9UGJ9,Membrane-associated progesterone receptor component 1,Dap1 {ECO:0000303|PubMed:28396637};IZA {ECO:0000303|PubMed:28396637};, PF00173;, GO:0044297;GO:0012505;GO:0005783;GO:0005887;GO:0016020;GO:0005741;GO:0043005;GO:0043025;GO:0005886;GO:0030868;GO:0035579;GO:0045202;GO:0001540;GO:0020037;GO:0046872;GO:0042803;GO:0005496;GO:0006783;GO:0043312;, C:cell body; C:endomembrane system; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:mitochondrial outer membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:specific granule membrane; C:synapse;, F:amyloid-beta binding; F:heme binding; F:metal ion binding; F:protein homodimerization activity; F:steroid binding;, P:heme biosynthetic process; P:neutrophil degranulation;|O00264 B7Z1L3 Q9UGJ9,Membrane-associated progesterone receptor component 1,Dap1 {ECO:0000303|PubMed:28396637};IZA {ECO:0000303|PubMed:28396637};, PF00173;, GO:0044297;GO:0012505;GO:0005783;GO:0005887;GO:0016020;GO:0005741;GO:0043005;GO:0043025;GO:0005886;GO:0030868;GO:0035579;GO:0045202;GO:0001540;GO:0020037;GO:0046872;GO:0042803;GO:0005496;GO:0006783;GO:0043312;, C:cell body; C:endomembrane system; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:mitochondrial outer membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:specific granule membrane; C:synapse;, F:amyloid-beta binding; F:heme binding; F:metal ion binding; F:protein homodimerization activity; F:steroid binding;, P:heme biosynthetic process; P:neutrophil degranulation; scaffold107 indexed_genome mRNA 1015461 1054207 . - . ID=transcript_13181;Q496Y0 Q5JPN6 Q8NB00 Q9H647,LON peptidase N-terminal domain and RING finger protein 3,RING finger protein 127;, PF02190;, GO:0046872;, , F:metal ion binding;|Q496Y0 Q5JPN6 Q8NB00 Q9H647,LON peptidase N-terminal domain and RING finger protein 3,RING finger protein 127;, PF02190;, GO:0046872;, , F:metal ion binding;|Q496Y0 Q5JPN6 Q8NB00 Q9H647,LON peptidase N-terminal domain and RING finger protein 3,RING finger protein 127;, PF02190;, GO:0046872;, , F:metal ion binding;|Q496Y0 Q5JPN6 Q8NB00 Q9H647,LON peptidase N-terminal domain and RING finger protein 3,RING finger protein 127;, PF02190;, GO:0046872;, , F:metal ion binding; scaffold107 indexed_genome mRNA 1159139 1162354 . - . ID=transcript_13182;P0CG32,Zinc finger CCHC domain-containing protein 18 {ECO:0000305},, PF14893;, GO:0005634;GO:0046872;, C:nucleus;, F:metal ion binding; scaffold107 indexed_genome mRNA 1194588 1256285 . - . ID=transcript_13183;P78552 O95646 Q5JSL4 Q99656 Q9UDY5,Interleukin-13 receptor subunit alpha-1,Cancer/testis antigen 19;, PF18001;PF09240;, GO:0009897;GO:0005898;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0004923;GO:0007166;GO:0019221;GO:0038165;GO:0008284;, C:external side of plasma membrane; C:interleukin-13 receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:leukemia inhibitory factor receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of cell population proliferation;|P78552 O95646 Q5JSL4 Q99656 Q9UDY5,Interleukin-13 receptor subunit alpha-1,Cancer/testis antigen 19;, PF18001;PF09240;, GO:0009897;GO:0005898;GO:0005886;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0004923;GO:0007166;GO:0019221;GO:0038165;GO:0008284;, C:external side of plasma membrane; C:interleukin-13 receptor complex; C:plasma membrane; C:receptor complex;, F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:leukemia inhibitory factor receptor activity;, P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of cell population proliferation; scaffold107 indexed_genome mRNA 1436891 1437707 . + . ID=transcript_13184;Q5JSL3 A6NMF0 Q66M66 Q6ZUJ5 Q86VU8 Q96MN3,Dedicator of cytokinesis protein 11 {ECO:0000305},Activated Cdc42-associated guanine nucleotide exchange factor;Zizimin-2 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0005085;GO:0001782;GO:0007596;GO:0002315;GO:0051491;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:B cell homeostasis; P:blood coagulation; P:marginal zone B cell differentiation; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction; scaffold107 indexed_genome mRNA 1442313 1581452 . - . ID=transcript_13185;Q5JSL3 A6NMF0 Q66M66 Q6ZUJ5 Q86VU8 Q96MN3,Dedicator of cytokinesis protein 11 {ECO:0000305},Activated Cdc42-associated guanine nucleotide exchange factor;Zizimin-2 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0005085;GO:0001782;GO:0007596;GO:0002315;GO:0051491;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:B cell homeostasis; P:blood coagulation; P:marginal zone B cell differentiation; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q5JSL3 A6NMF0 Q66M66 Q6ZUJ5 Q86VU8 Q96MN3,Dedicator of cytokinesis protein 11 {ECO:0000305},Activated Cdc42-associated guanine nucleotide exchange factor;Zizimin-2 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0005085;GO:0001782;GO:0007596;GO:0002315;GO:0051491;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:B cell homeostasis; P:blood coagulation; P:marginal zone B cell differentiation; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;|Q5JSL3 A6NMF0 Q66M66 Q6ZUJ5 Q86VU8 Q96MN3,Dedicator of cytokinesis protein 11 {ECO:0000305},Activated Cdc42-associated guanine nucleotide exchange factor;Zizimin-2 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0005085;GO:0001782;GO:0007596;GO:0002315;GO:0051491;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:B cell homeostasis; P:blood coagulation; P:marginal zone B cell differentiation; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction; scaffold107 indexed_genome mRNA 1582990 1600461 . - . ID=transcript_13186;Q5JSL3 A6NMF0 Q66M66 Q6ZUJ5 Q86VU8 Q96MN3,Dedicator of cytokinesis protein 11 {ECO:0000305},Activated Cdc42-associated guanine nucleotide exchange factor;Zizimin-2 {ECO:0000305};, PF06920;PF14429;PF11878;PF00169;, GO:0005829;GO:0005085;GO:0001782;GO:0007596;GO:0002315;GO:0051491;GO:0043547;GO:0007264;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:B cell homeostasis; P:blood coagulation; P:marginal zone B cell differentiation; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction; scaffold107 indexed_genome mRNA 1707616 1811599 . - . ID=transcript_13187;Q8NAU8 Q8NHU5 Q9NUV4,WD repeat-containing protein 44,Rabphilin-11;, PF00400;, GO:0005829;GO:0010008;GO:0005794;GO:0048471;, C:cytosol; C:endosome membrane; C:Golgi apparatus; C:perinuclear region of cytoplasm;|Q8NAU8 Q8NHU5 Q9NUV4,WD repeat-containing protein 44,Rabphilin-11;, PF00400;, GO:0005829;GO:0010008;GO:0005794;GO:0048471;, C:cytosol; C:endosome membrane; C:Golgi apparatus; C:perinuclear region of cytoplasm;|Q8NAU8 Q8NHU5 Q9NUV4,WD repeat-containing protein 44,Rabphilin-11;, PF00400;, GO:0005829;GO:0010008;GO:0005794;GO:0048471;, C:cytosol; C:endosome membrane; C:Golgi apparatus; C:perinuclear region of cytoplasm; scaffold107 indexed_genome mRNA 2212679 2235005 . + . ID=transcript_13188;Q9UDN9,Kelch-like protein 13,BTB and kelch domain-containing protein 2;, PF07707;PF00651;PF01344;, GO:0031463;GO:0005829;GO:0030496;GO:0097602;GO:0047485;GO:0007049;GO:0051301;GO:0043687;GO:0016567;GO:0032465;, C:Cul3-RING ubiquitin ligase complex; C:cytosol; C:midbody;, F:cullin family protein binding; F:protein N-terminus binding;, P:cell cycle; P:cell division; P:post-translational protein modification; P:protein ubiquitination; P:regulation of cytokinesis; scaffold107 indexed_genome mRNA 2412873 2413383 . + . ID=transcript_13189;Q92820,Gamma-glutamyl hydrolase,Conjugase;GH;Gamma-Glu-X carboxypeptidase;, PF07722;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0042470;GO:0005634;GO:0035580;GO:1904724;GO:0005773;GO:0008238;GO:0034722;GO:0008242;GO:0043312;GO:0042493;GO:0045471;GO:0032868;GO:0010043;GO:0046900;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:melanosome; C:nucleus; C:specific granule lumen; C:tertiary granule lumen; C:vacuole;, F:exopeptidase activity; F:gamma-glutamyl-peptidase activity; F:omega peptidase activity;, P:neutrophil degranulation; P:response to drug; P:response to ethanol; P:response to insulin; P:response to zinc ion; P:tetrahydrofolylpolyglutamate metabolic process; scaffold107 indexed_genome mRNA 3379753 3406742 . - . ID=transcript_13190;Q9UN76 Q5H942,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),Amino acid transporter ATB0+;Solute carrier family 6 member 14;, PF00209;, GO:0070062;GO:0016021;GO:0005887;GO:0005886;GO:0031982;GO:0022858;GO:0015171;GO:0015293;GO:0032328;GO:0089718;GO:0003333;GO:0006865;GO:0009636;GO:0035725;, C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:vesicle;, F:alanine transmembrane transporter activity; F:amino acid transmembrane transporter activity; F:symporter activity;, P:alanine transport; P:amino acid import across plasma membrane; P:amino acid transmembrane transport; P:amino acid transport; P:response to toxic substance; P:sodium ion transmembrane transport; scaffold108 indexed_genome mRNA 70134 71524 . + . ID=transcript_13191;Q9HCE3 Q4G0V6 Q7L7Z7 Q96QR7 Q9NVJ6,Zinc finger protein 532,, PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding; scaffold108 indexed_genome mRNA 90927 96019 . - . ID=transcript_13192;Q9HCE3 Q4G0V6 Q7L7Z7 Q96QR7 Q9NVJ6,Zinc finger protein 532,, PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding; scaffold108 indexed_genome mRNA 96522 101396 . + . ID=transcript_13193;Q9HCE3 Q4G0V6 Q7L7Z7 Q96QR7 Q9NVJ6,Zinc finger protein 532,, PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding;|Q9HCE3 Q4G0V6 Q7L7Z7 Q96QR7 Q9NVJ6,Zinc finger protein 532,, PF16622;, GO:0005634;GO:0003677;GO:0046872;, C:nucleus;, F:DNA binding; F:metal ion binding; scaffold108 indexed_genome mRNA 216774 217291 . + . ID=transcript_13194;Q9BY50 B2RAA3,Signal peptidase complex catalytic subunit SEC11C,Microsomal signal peptidase 21 kDa subunit;SEC11 homolog C;SEC11-like protein 3;SPC21;, PF00717;, GO:0005789;GO:0016021;GO:0005787;GO:0008233;GO:0004252;GO:0006465;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:signal peptidase complex;, F:peptidase activity; F:serine-type endopeptidase activity;, P:signal peptide processing; scaffold108 indexed_genome mRNA 219948 222745 . - . ID=transcript_13195;Q9BY50 B2RAA3,Signal peptidase complex catalytic subunit SEC11C,Microsomal signal peptidase 21 kDa subunit;SEC11 homolog C;SEC11-like protein 3;SPC21;, PF00717;, GO:0005789;GO:0016021;GO:0005787;GO:0008233;GO:0004252;GO:0006465;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:signal peptidase complex;, F:peptidase activity; F:serine-type endopeptidase activity;, P:signal peptide processing; scaffold108 indexed_genome mRNA 222757 224880 . - . ID=transcript_13196;Q9BY50 B2RAA3,Signal peptidase complex catalytic subunit SEC11C,Microsomal signal peptidase 21 kDa subunit;SEC11 homolog C;SEC11-like protein 3;SPC21;, PF00717;, GO:0005789;GO:0016021;GO:0005787;GO:0008233;GO:0004252;GO:0006465;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:signal peptidase complex;, F:peptidase activity; F:serine-type endopeptidase activity;, P:signal peptide processing; scaffold108 indexed_genome mRNA 338273 356210 . - . ID=transcript_13197;Q9UQG7 Q9UQG8 Q9UQG9 Q9UQH0 Q9UQH1 Q9UQH2,Protein ERGIC-53,ER-Golgi intermediate compartment 53 kDa protein;Gp58;Intracellular mannose-specific lectin MR60;Lectin mannose-binding 1;, PF03388;, GO:0062023;GO:0030134;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0070062;GO:0000139;GO:0016021;GO:0016020;GO:0030017;GO:0005537;GO:0046872;GO:0051082;GO:0007596;GO:0048208;GO:0007029;GO:0006888;GO:0007030;GO:1903215;GO:0010638;GO:0006457;GO:0018279;GO:0015031;, C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:extracellular exosome; C:Golgi membrane; C:integral component of membrane; C:membrane; C:sarcomere;, F:mannose binding; F:metal ion binding; F:unfolded protein binding;, P:blood coagulation; P:COPII vesicle coating; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:negative regulation of protein targeting to mitochondrion; P:positive regulation of organelle organization; P:protein folding; P:protein N-linked glycosylation via asparagine; P:protein transport; scaffold108 indexed_genome mRNA 1940255 2003259 . + . ID=transcript_13198;Q9HBT6 Q495S3,Cadherin-20,, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0016021;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development;|Q9HBT6 Q495S3,Cadherin-20,, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0016021;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:integral component of membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold108 indexed_genome mRNA 2195489 2202646 . + . ID=transcript_13199;Q8N8N0 B3KV99 Q52LA4,E3 ubiquitin-protein ligase RNF152 {ECO:0000305},RING finger protein 152 {ECO:0000312|HGNC:HGNC:26811};RING-type E3 ubiquitin transferase RNF152 {ECO:0000305};, PF14634;, GO:0031301;GO:0005765;GO:0005764;GO:0046872;GO:0031267;GO:0061630;GO:0004842;GO:0006915;GO:0034198;GO:1904262;GO:0010508;GO:0070936;GO:0070534;GO:0016567;, C:integral component of organelle membrane; C:lysosomal membrane; C:lysosome;, F:metal ion binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cellular response to amino acid starvation; P:negative regulation of TORC1 signaling; P:positive regulation of autophagy; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein ubiquitination; scaffold108 indexed_genome mRNA 2380838 2490091 . - . ID=transcript_13200;O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold108 indexed_genome mRNA 2490761 2555651 . + . ID=transcript_13201;Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport;|Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport; scaffold108 indexed_genome mRNA 2557694 2601633 . + . ID=transcript_13202;Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport;|Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport;|Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport; scaffold108 indexed_genome mRNA 2817608 2837731 . + . ID=transcript_13203;Q9C0B9 B2RPG6 Q8N3S1 Q9NXF6,Zinc finger CCHC domain-containing protein 2,, PF00098;, GO:0005737;GO:0003676;GO:0035091;GO:0008270;, C:cytoplasm;, F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding;|Q9C0B9 B2RPG6 Q8N3S1 Q9NXF6,Zinc finger CCHC domain-containing protein 2,, PF00098;, GO:0005737;GO:0003676;GO:0035091;GO:0008270;, C:cytoplasm;, F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding;|Q9C0B9 B2RPG6 Q8N3S1 Q9NXF6,Zinc finger CCHC domain-containing protein 2,, PF00098;, GO:0005737;GO:0003676;GO:0035091;GO:0008270;, C:cytoplasm;, F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding;|Q9C0B9 B2RPG6 Q8N3S1 Q9NXF6,Zinc finger CCHC domain-containing protein 2,, PF00098;, GO:0005737;GO:0003676;GO:0035091;GO:0008270;, C:cytoplasm;, F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding;|Q9C0B9 B2RPG6 Q8N3S1 Q9NXF6,Zinc finger CCHC domain-containing protein 2,, PF00098;, GO:0005737;GO:0003676;GO:0035091;GO:0008270;, C:cytoplasm;, F:nucleic acid binding; F:phosphatidylinositol binding; F:zinc ion binding; scaffold108 indexed_genome mRNA 3146843 3147790 . + . ID=transcript_13204;O60346 A1A4F5 Q641Q7 Q6P4C4 Q6PJI6 Q86TN6 Q96FK2 Q9NUY1,PH domain leucine-rich repeat-containing protein phosphatase 1,Pleckstrin homology domain-containing family E member 1;Suprachiasmatic nucleus circadian oscillatory protein;, PF13516;PF13855;PF00169;PF00481;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0006915;GO:0009649;GO:0051898;GO:0042981;GO:0046328;GO:0043408;GO:1900744;GO:0002667;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:apoptotic process; P:entrainment of circadian clock; P:negative regulation of protein kinase B signaling; P:regulation of apoptotic process; P:regulation of JNK cascade; P:regulation of MAPK cascade; P:regulation of p38MAPK cascade; P:regulation of T cell anergy; P:signal transduction; scaffold108 indexed_genome mRNA 3156733 3159080 . + . ID=transcript_13205;O60346 A1A4F5 Q641Q7 Q6P4C4 Q6PJI6 Q86TN6 Q96FK2 Q9NUY1,PH domain leucine-rich repeat-containing protein phosphatase 1,Pleckstrin homology domain-containing family E member 1;Suprachiasmatic nucleus circadian oscillatory protein;, PF13516;PF13855;PF00169;PF00481;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0006915;GO:0009649;GO:0051898;GO:0042981;GO:0046328;GO:0043408;GO:1900744;GO:0002667;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:apoptotic process; P:entrainment of circadian clock; P:negative regulation of protein kinase B signaling; P:regulation of apoptotic process; P:regulation of JNK cascade; P:regulation of MAPK cascade; P:regulation of p38MAPK cascade; P:regulation of T cell anergy; P:signal transduction; scaffold108 indexed_genome mRNA 3159148 3161727 . - . ID=transcript_13206;O60346 A1A4F5 Q641Q7 Q6P4C4 Q6PJI6 Q86TN6 Q96FK2 Q9NUY1,PH domain leucine-rich repeat-containing protein phosphatase 1,Pleckstrin homology domain-containing family E member 1;Suprachiasmatic nucleus circadian oscillatory protein;, PF13516;PF13855;PF00169;PF00481;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0006915;GO:0009649;GO:0051898;GO:0042981;GO:0046328;GO:0043408;GO:1900744;GO:0002667;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:apoptotic process; P:entrainment of circadian clock; P:negative regulation of protein kinase B signaling; P:regulation of apoptotic process; P:regulation of JNK cascade; P:regulation of MAPK cascade; P:regulation of p38MAPK cascade; P:regulation of T cell anergy; P:signal transduction; scaffold108 indexed_genome mRNA 3484712 3513758 . + . ID=transcript_13207;Q06136 B2R5Y1 B4DMX0,3-ketodihydrosphingosine reductase,3-dehydrosphinganine reductase;Follicular variant translocation protein 1;Short chain dehydrogenase/reductase family 35C member 1;, PF00106;, GO:0005783;GO:0005789;GO:0005615;GO:0016021;GO:0016020;GO:0047560;GO:0006666;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:integral component of membrane; C:membrane;, F:3-dehydrosphinganine reductase activity;, P:3-keto-sphinganine metabolic process; P:sphingolipid biosynthetic process;|Q06136 B2R5Y1 B4DMX0,3-ketodihydrosphingosine reductase,3-dehydrosphinganine reductase;Follicular variant translocation protein 1;Short chain dehydrogenase/reductase family 35C member 1;, PF00106;, GO:0005783;GO:0005789;GO:0005615;GO:0016021;GO:0016020;GO:0047560;GO:0006666;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:integral component of membrane; C:membrane;, F:3-dehydrosphinganine reductase activity;, P:3-keto-sphinganine metabolic process; P:sphingolipid biosynthetic process;|Q06136 B2R5Y1 B4DMX0,3-ketodihydrosphingosine reductase,3-dehydrosphinganine reductase;Follicular variant translocation protein 1;Short chain dehydrogenase/reductase family 35C member 1;, PF00106;, GO:0005783;GO:0005789;GO:0005615;GO:0016021;GO:0016020;GO:0047560;GO:0006666;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:integral component of membrane; C:membrane;, F:3-dehydrosphinganine reductase activity;, P:3-keto-sphinganine metabolic process; P:sphingolipid biosynthetic process; scaffold108 indexed_genome mRNA 3539774 3546388 . - . ID=transcript_13208;O75351 Q69HW4 Q9GZS7,Vacuolar protein sorting-associated protein 4B {ECO:0000305},Cell migration-inducing gene 1 protein;Suppressor of K(+) transport growth defect 1;, PF00004;PF17862;PF04212;PF09336;, GO:0005813;GO:0005737;GO:0005829;GO:0005768;GO:0010008;GO:0070062;GO:0090543;GO:0031902;GO:0005634;GO:0000922;GO:0005524;GO:0016887;GO:0042802;GO:0008568;GO:0008022;GO:0042803;GO:0044877;GO:0030301;GO:0031122;GO:0016197;GO:0032510;GO:1904903;GO:0061738;GO:0016236;GO:0061952;GO:0007080;GO:0036258;GO:0060548;GO:1903542;GO:0006997;GO:1903724;GO:1903543;GO:0010971;GO:1903902;GO:0048524;GO:1902188;GO:0006813;GO:0051261;GO:0015031;GO:0010824;GO:1901673;GO:0050792;GO:0033993;GO:0043162;GO:0090611;GO:0039702;GO:0019058;GO:0019076;, C:centrosome; C:cytoplasm; C:cytosol; C:endosome; C:endosome membrane; C:extracellular exosome; C:Flemming body; C:late endosome membrane; C:nucleus; C:spindle pole;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:microtubule-severing ATPase activity; F:protein C-terminus binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:cholesterol transport; P:cytoplasmic microtubule organization; P:endosomal transport; P:endosome to lysosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:late endosomal microautophagy; P:macroautophagy; P:midbody abscission; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:negative regulation of cell death; P:negative regulation of exosomal secretion; P:nucleus organization; P:positive regulation of centriole elongation; P:positive regulation of exosomal secretion; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of viral life cycle; P:positive regulation of viral process; P:positive regulation of viral release from host cell; P:potassium ion transport; P:protein depolymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:response to lipid; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle; P:viral release from host cell;|O75351 Q69HW4 Q9GZS7,Vacuolar protein sorting-associated protein 4B {ECO:0000305},Cell migration-inducing gene 1 protein;Suppressor of K(+) transport growth defect 1;, PF00004;PF17862;PF04212;PF09336;, GO:0005813;GO:0005737;GO:0005829;GO:0005768;GO:0010008;GO:0070062;GO:0090543;GO:0031902;GO:0005634;GO:0000922;GO:0005524;GO:0016887;GO:0042802;GO:0008568;GO:0008022;GO:0042803;GO:0044877;GO:0030301;GO:0031122;GO:0016197;GO:0032510;GO:1904903;GO:0061738;GO:0016236;GO:0061952;GO:0007080;GO:0036258;GO:0060548;GO:1903542;GO:0006997;GO:1903724;GO:1903543;GO:0010971;GO:1903902;GO:0048524;GO:1902188;GO:0006813;GO:0051261;GO:0015031;GO:0010824;GO:1901673;GO:0050792;GO:0033993;GO:0043162;GO:0090611;GO:0039702;GO:0019058;GO:0019076;, C:centrosome; C:cytoplasm; C:cytosol; C:endosome; C:endosome membrane; C:extracellular exosome; C:Flemming body; C:late endosome membrane; C:nucleus; C:spindle pole;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:microtubule-severing ATPase activity; F:protein C-terminus binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:cholesterol transport; P:cytoplasmic microtubule organization; P:endosomal transport; P:endosome to lysosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:late endosomal microautophagy; P:macroautophagy; P:midbody abscission; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:negative regulation of cell death; P:negative regulation of exosomal secretion; P:nucleus organization; P:positive regulation of centriole elongation; P:positive regulation of exosomal secretion; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of viral life cycle; P:positive regulation of viral process; P:positive regulation of viral release from host cell; P:potassium ion transport; P:protein depolymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:response to lipid; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle; P:viral release from host cell;|O75351 Q69HW4 Q9GZS7,Vacuolar protein sorting-associated protein 4B {ECO:0000305},Cell migration-inducing gene 1 protein;Suppressor of K(+) transport growth defect 1;, PF00004;PF17862;PF04212;PF09336;, GO:0005813;GO:0005737;GO:0005829;GO:0005768;GO:0010008;GO:0070062;GO:0090543;GO:0031902;GO:0005634;GO:0000922;GO:0005524;GO:0016887;GO:0042802;GO:0008568;GO:0008022;GO:0042803;GO:0044877;GO:0030301;GO:0031122;GO:0016197;GO:0032510;GO:1904903;GO:0061738;GO:0016236;GO:0061952;GO:0007080;GO:0036258;GO:0060548;GO:1903542;GO:0006997;GO:1903724;GO:1903543;GO:0010971;GO:1903902;GO:0048524;GO:1902188;GO:0006813;GO:0051261;GO:0015031;GO:0010824;GO:1901673;GO:0050792;GO:0033993;GO:0043162;GO:0090611;GO:0039702;GO:0019058;GO:0019076;, C:centrosome; C:cytoplasm; C:cytosol; C:endosome; C:endosome membrane; C:extracellular exosome; C:Flemming body; C:late endosome membrane; C:nucleus; C:spindle pole;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:microtubule-severing ATPase activity; F:protein C-terminus binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:cholesterol transport; P:cytoplasmic microtubule organization; P:endosomal transport; P:endosome to lysosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:late endosomal microautophagy; P:macroautophagy; P:midbody abscission; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:negative regulation of cell death; P:negative regulation of exosomal secretion; P:nucleus organization; P:positive regulation of centriole elongation; P:positive regulation of exosomal secretion; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of viral life cycle; P:positive regulation of viral process; P:positive regulation of viral release from host cell; P:potassium ion transport; P:protein depolymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:response to lipid; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle; P:viral release from host cell;|O75351 Q69HW4 Q9GZS7,Vacuolar protein sorting-associated protein 4B {ECO:0000305},Cell migration-inducing gene 1 protein;Suppressor of K(+) transport growth defect 1;, PF00004;PF17862;PF04212;PF09336;, GO:0005813;GO:0005737;GO:0005829;GO:0005768;GO:0010008;GO:0070062;GO:0090543;GO:0031902;GO:0005634;GO:0000922;GO:0005524;GO:0016887;GO:0042802;GO:0008568;GO:0008022;GO:0042803;GO:0044877;GO:0030301;GO:0031122;GO:0016197;GO:0032510;GO:1904903;GO:0061738;GO:0016236;GO:0061952;GO:0007080;GO:0036258;GO:0060548;GO:1903542;GO:0006997;GO:1903724;GO:1903543;GO:0010971;GO:1903902;GO:0048524;GO:1902188;GO:0006813;GO:0051261;GO:0015031;GO:0010824;GO:1901673;GO:0050792;GO:0033993;GO:0043162;GO:0090611;GO:0039702;GO:0019058;GO:0019076;, C:centrosome; C:cytoplasm; C:cytosol; C:endosome; C:endosome membrane; C:extracellular exosome; C:Flemming body; C:late endosome membrane; C:nucleus; C:spindle pole;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:microtubule-severing ATPase activity; F:protein C-terminus binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:cholesterol transport; P:cytoplasmic microtubule organization; P:endosomal transport; P:endosome to lysosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:late endosomal microautophagy; P:macroautophagy; P:midbody abscission; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:negative regulation of cell death; P:negative regulation of exosomal secretion; P:nucleus organization; P:positive regulation of centriole elongation; P:positive regulation of exosomal secretion; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of viral life cycle; P:positive regulation of viral process; P:positive regulation of viral release from host cell; P:potassium ion transport; P:protein depolymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:response to lipid; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle; P:viral release from host cell; scaffold108 indexed_genome mRNA 3548072 3551188 . - . ID=transcript_13209;O75351 Q69HW4 Q9GZS7,Vacuolar protein sorting-associated protein 4B {ECO:0000305},Cell migration-inducing gene 1 protein;Suppressor of K(+) transport growth defect 1;, PF00004;PF17862;PF04212;PF09336;, GO:0005813;GO:0005737;GO:0005829;GO:0005768;GO:0010008;GO:0070062;GO:0090543;GO:0031902;GO:0005634;GO:0000922;GO:0005524;GO:0016887;GO:0042802;GO:0008568;GO:0008022;GO:0042803;GO:0044877;GO:0030301;GO:0031122;GO:0016197;GO:0032510;GO:1904903;GO:0061738;GO:0016236;GO:0061952;GO:0007080;GO:0036258;GO:0060548;GO:1903542;GO:0006997;GO:1903724;GO:1903543;GO:0010971;GO:1903902;GO:0048524;GO:1902188;GO:0006813;GO:0051261;GO:0015031;GO:0010824;GO:1901673;GO:0050792;GO:0033993;GO:0043162;GO:0090611;GO:0039702;GO:0019058;GO:0019076;, C:centrosome; C:cytoplasm; C:cytosol; C:endosome; C:endosome membrane; C:extracellular exosome; C:Flemming body; C:late endosome membrane; C:nucleus; C:spindle pole;, F:ATP binding; F:ATPase activity; F:identical protein binding; F:microtubule-severing ATPase activity; F:protein C-terminus binding; F:protein homodimerization activity; F:protein-containing complex binding;, P:cholesterol transport; P:cytoplasmic microtubule organization; P:endosomal transport; P:endosome to lysosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:late endosomal microautophagy; P:macroautophagy; P:midbody abscission; P:mitotic metaphase plate congression; P:multivesicular body assembly; P:negative regulation of cell death; P:negative regulation of exosomal secretion; P:nucleus organization; P:positive regulation of centriole elongation; P:positive regulation of exosomal secretion; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of viral life cycle; P:positive regulation of viral process; P:positive regulation of viral release from host cell; P:potassium ion transport; P:protein depolymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:response to lipid; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle; P:viral release from host cell; scaffold108 indexed_genome mRNA 3896758 3898584 . + . ID=transcript_13210;P05120 Q96E96,Plasminogen activator inhibitor 2,Monocyte Arg-serpin;Placental plasminogen activator inhibitor;Serpin B2;Urokinase inhibitor;, PF00079;, GO:0005737;GO:0005576;GO:0005615;GO:0005886;GO:0004867;GO:0042730;GO:0035722;GO:0043066;GO:0010951;GO:0042060;, C:cytoplasm; C:extracellular region; C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase inhibitor activity;, P:fibrinolysis; P:interleukin-12-mediated signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of endopeptidase activity; P:wound healing; scaffold109 indexed_genome mRNA 75540 77262 . - . ID=transcript_13211;Q9NV56 A8C4L5,MRG/MORF4L-binding protein,MRG-binding protein;Up-regulated in colon cancer 4;, PF07904;, GO:0035267;GO:0005654;GO:0016573;GO:0040008;GO:0006357;, C:NuA4 histone acetyltransferase complex; C:nucleoplasm;, , P:histone acetylation; P:regulation of growth; P:regulation of transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 78144 79349 . - . ID=transcript_13212;Q9NV56 A8C4L5,MRG/MORF4L-binding protein,MRG-binding protein;Up-regulated in colon cancer 4;, PF07904;, GO:0035267;GO:0005654;GO:0016573;GO:0040008;GO:0006357;, C:NuA4 histone acetyltransferase complex; C:nucleoplasm;, , P:histone acetylation; P:regulation of growth; P:regulation of transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 81470 86942 . + . ID=transcript_13213;Q9NZT2 O96029 Q4VXW5 Q96CM2 Q9BQW1 Q9H4H0 Q9H7J5 Q9NZT3 Q9NZT4,Opioid growth factor receptor,Protein 7-60;Zeta-type opioid receptor;, PF04680;PF04664;, GO:0005737;GO:0016020;GO:0005634;GO:0004985;GO:0001558;, C:cytoplasm; C:membrane; C:nucleus;, F:opioid receptor activity;, P:regulation of cell growth;|Q9NZT2 O96029 Q4VXW5 Q96CM2 Q9BQW1 Q9H4H0 Q9H7J5 Q9NZT3 Q9NZT4,Opioid growth factor receptor,Protein 7-60;Zeta-type opioid receptor;, PF04680;PF04664;, GO:0005737;GO:0016020;GO:0005634;GO:0004985;GO:0001558;, C:cytoplasm; C:membrane; C:nucleus;, F:opioid receptor activity;, P:regulation of cell growth; scaffold109 indexed_genome mRNA 87665 89002 . + . ID=transcript_13214;Q9NZT2 O96029 Q4VXW5 Q96CM2 Q9BQW1 Q9H4H0 Q9H7J5 Q9NZT3 Q9NZT4,Opioid growth factor receptor,Protein 7-60;Zeta-type opioid receptor;, PF04680;PF04664;, GO:0005737;GO:0016020;GO:0005634;GO:0004985;GO:0001558;, C:cytoplasm; C:membrane; C:nucleus;, F:opioid receptor activity;, P:regulation of cell growth; scaffold109 indexed_genome mRNA 101763 110163 . + . ID=transcript_13215;Q14050 Q13681 Q9H4G9 Q9UPE2,Collagen alpha-3(IX) chain,, PF01391;, GO:0005604;GO:0005594;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0030199;GO:0030198;GO:0008585;GO:0008584;, C:basement membrane; C:collagen type IX trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength;, P:collagen fibril organization; P:extracellular matrix organization; P:female gonad development; P:male gonad development; scaffold109 indexed_genome mRNA 110663 126498 . - . ID=transcript_13216;Q9UL49 O94771 Q9BYW0,Transcription factor-like 5 protein,Cha transcription factor;HPV-16 E2-binding protein 1;, PF00010;, GO:0000785;GO:0001673;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:1990837;GO:0030154;GO:0007275;GO:0000122;GO:0045595;GO:0042127;GO:0006355;GO:0007283;GO:0006366;, C:chromatin; C:male germ cell nucleus; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription by RNA polymerase II;|Q9UL49 O94771 Q9BYW0,Transcription factor-like 5 protein,Cha transcription factor;HPV-16 E2-binding protein 1;, PF00010;, GO:0000785;GO:0001673;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:1990837;GO:0030154;GO:0007275;GO:0000122;GO:0045595;GO:0042127;GO:0006355;GO:0007283;GO:0006366;, C:chromatin; C:male germ cell nucleus; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription by RNA polymerase II;|Q9UL49 O94771 Q9BYW0,Transcription factor-like 5 protein,Cha transcription factor;HPV-16 E2-binding protein 1;, PF00010;, GO:0000785;GO:0001673;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:1990837;GO:0030154;GO:0007275;GO:0000122;GO:0045595;GO:0042127;GO:0006355;GO:0007283;GO:0006366;, C:chromatin; C:male germ cell nucleus; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription by RNA polymerase II;|Q9UL49 O94771 Q9BYW0,Transcription factor-like 5 protein,Cha transcription factor;HPV-16 E2-binding protein 1;, PF00010;, GO:0000785;GO:0001673;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:1990837;GO:0030154;GO:0007275;GO:0000122;GO:0045595;GO:0042127;GO:0006355;GO:0007283;GO:0006366;, C:chromatin; C:male germ cell nucleus; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription by RNA polymerase II;|Q9UL49 O94771 Q9BYW0,Transcription factor-like 5 protein,Cha transcription factor;HPV-16 E2-binding protein 1;, PF00010;, GO:0000785;GO:0001673;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:1990837;GO:0030154;GO:0007275;GO:0000122;GO:0045595;GO:0042127;GO:0006355;GO:0007283;GO:0006366;, C:chromatin; C:male germ cell nucleus; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription by RNA polymerase II;|Q9UL49 O94771 Q9BYW0,Transcription factor-like 5 protein,Cha transcription factor;HPV-16 E2-binding protein 1;, PF00010;, GO:0000785;GO:0001673;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:1990837;GO:0030154;GO:0007275;GO:0000122;GO:0045595;GO:0042127;GO:0006355;GO:0007283;GO:0006366;, C:chromatin; C:male germ cell nucleus; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of transcription, DNA-templated; P:spermatogenesis; P:transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 143124 167053 . - . ID=transcript_13217;Q9UFB6,Death-inducer obliterator 1,Death-associated transcription factor 1;, PF00628;PF07744;PF07500;, GO:0005737;GO:0005634;GO:0005819;GO:0046872;GO:0003723;GO:0097190;GO:0006351;, C:cytoplasm; C:nucleus; C:spindle;, F:metal ion binding; F:RNA binding;, P:apoptotic signaling pathway; P:transcription, DNA-templated;|Q9UFB6,Death-inducer obliterator 1,Death-associated transcription factor 1;, PF00628;PF07744;PF07500;, GO:0005737;GO:0005634;GO:0005819;GO:0046872;GO:0003723;GO:0097190;GO:0006351;, C:cytoplasm; C:nucleus; C:spindle;, F:metal ion binding; F:RNA binding;, P:apoptotic signaling pathway; P:transcription, DNA-templated;|Q9UFB6,Death-inducer obliterator 1,Death-associated transcription factor 1;, PF00628;PF07744;PF07500;, GO:0005737;GO:0005634;GO:0005819;GO:0046872;GO:0003723;GO:0097190;GO:0006351;, C:cytoplasm; C:nucleus; C:spindle;, F:metal ion binding; F:RNA binding;, P:apoptotic signaling pathway; P:transcription, DNA-templated;|Q9UFB6,Death-inducer obliterator 1,Death-associated transcription factor 1;, PF00628;PF07744;PF07500;, GO:0005737;GO:0005634;GO:0005819;GO:0046872;GO:0003723;GO:0097190;GO:0006351;, C:cytoplasm; C:nucleus; C:spindle;, F:metal ion binding; F:RNA binding;, P:apoptotic signaling pathway; P:transcription, DNA-templated;|Q9UFB6,Death-inducer obliterator 1,Death-associated transcription factor 1;, PF00628;PF07744;PF07500;, GO:0005737;GO:0005634;GO:0005819;GO:0046872;GO:0003723;GO:0097190;GO:0006351;, C:cytoplasm; C:nucleus; C:spindle;, F:metal ion binding; F:RNA binding;, P:apoptotic signaling pathway; P:transcription, DNA-templated;|Q9UFB6,Death-inducer obliterator 1,Death-associated transcription factor 1;, PF00628;PF07744;PF07500;, GO:0005737;GO:0005634;GO:0005819;GO:0046872;GO:0003723;GO:0097190;GO:0006351;, C:cytoplasm; C:nucleus; C:spindle;, F:metal ion binding; F:RNA binding;, P:apoptotic signaling pathway; P:transcription, DNA-templated;|Q9UFB6,Death-inducer obliterator 1,Death-associated transcription factor 1;, PF00628;PF07744;PF07500;, GO:0005737;GO:0005634;GO:0005819;GO:0046872;GO:0003723;GO:0097190;GO:0006351;, C:cytoplasm; C:nucleus; C:spindle;, F:metal ion binding; F:RNA binding;, P:apoptotic signaling pathway; P:transcription, DNA-templated; scaffold109 indexed_genome mRNA 188003 193645 . - . ID=transcript_13218;Q9NWU2 E1P5I3 Q8N5M5,Glucose-induced degradation protein 8 homolog,Two hybrid-associated protein 1 with RanBPM {ECO:0000303|PubMed:28829046};, PF10607;PF08513;, GO:0030054;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0042803;GO:0090263;GO:0008284;GO:0043161;GO:0016055;, C:cell junction; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:protein homodimerization activity;, P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell population proliferation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway;|Q9NWU2 E1P5I3 Q8N5M5,Glucose-induced degradation protein 8 homolog,Two hybrid-associated protein 1 with RanBPM {ECO:0000303|PubMed:28829046};, PF10607;PF08513;, GO:0030054;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0042803;GO:0090263;GO:0008284;GO:0043161;GO:0016055;, C:cell junction; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:protein homodimerization activity;, P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell population proliferation; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway; scaffold109 indexed_genome mRNA 196896 211721 . + . ID=transcript_13219;Q9BYT1 B3KTF2 Q5W198 Q8TB07 Q8TBP4 Q8TEL5 Q9BYT0 Q9BYT2,Solute carrier family 17 member 9,, PF07690;, GO:0042584;GO:0016021;GO:0015217;GO:0005347;GO:0001409;GO:0015866;GO:1904669;GO:0015867;GO:0006887;GO:1903790;, C:chromaffin granule membrane; C:integral component of membrane;, F:ADP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:guanine nucleotide transmembrane transporter activity;, P:ADP transport; P:ATP export; P:ATP transport; P:exocytosis; P:guanine nucleotide transmembrane transport;|Q9BYT1 B3KTF2 Q5W198 Q8TB07 Q8TBP4 Q8TEL5 Q9BYT0 Q9BYT2,Solute carrier family 17 member 9,, PF07690;, GO:0042584;GO:0016021;GO:0015217;GO:0005347;GO:0001409;GO:0015866;GO:1904669;GO:0015867;GO:0006887;GO:1903790;, C:chromaffin granule membrane; C:integral component of membrane;, F:ADP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:guanine nucleotide transmembrane transporter activity;, P:ADP transport; P:ATP export; P:ATP transport; P:exocytosis; P:guanine nucleotide transmembrane transport; scaffold109 indexed_genome mRNA 313906 322816 . - . ID=transcript_13220;Q9BYJ9 Q8N3G5 Q8TBT1 Q96AN4 Q96S57 Q9BTI7 Q9NX79,YTH domain-containing family protein 1 {ECO:0000305},Dermatomyositis associated with cancer putative autoantigen 1 {ECO:0000303|Ref.4};, PF04146;, GO:0005737;GO:0010494;GO:0000932;GO:0003729;GO:1990247;GO:0043022;GO:0003723;GO:0002376;GO:0007612;GO:0007613;GO:0061157;GO:0070925;GO:0045727;GO:0045948;GO:0002577;GO:1902667;GO:1900271;GO:0043488;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:P-body;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:ribosome binding; F:RNA binding;, P:immune system process; P:learning; P:memory; P:mRNA destabilization; P:organelle assembly; P:positive regulation of translation; P:positive regulation of translational initiation; P:regulation of antigen processing and presentation; P:regulation of axon guidance; P:regulation of long-term synaptic potentiation; P:regulation of mRNA stability; P:stress granule assembly;|Q9BYJ9 Q8N3G5 Q8TBT1 Q96AN4 Q96S57 Q9BTI7 Q9NX79,YTH domain-containing family protein 1 {ECO:0000305},Dermatomyositis associated with cancer putative autoantigen 1 {ECO:0000303|Ref.4};, PF04146;, GO:0005737;GO:0010494;GO:0000932;GO:0003729;GO:1990247;GO:0043022;GO:0003723;GO:0002376;GO:0007612;GO:0007613;GO:0061157;GO:0070925;GO:0045727;GO:0045948;GO:0002577;GO:1902667;GO:1900271;GO:0043488;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:P-body;, F:mRNA binding; F:N6-methyladenosine-containing RNA binding; F:ribosome binding; F:RNA binding;, P:immune system process; P:learning; P:memory; P:mRNA destabilization; P:organelle assembly; P:positive regulation of translation; P:positive regulation of translational initiation; P:regulation of antigen processing and presentation; P:regulation of axon guidance; P:regulation of long-term synaptic potentiation; P:regulation of mRNA stability; P:stress granule assembly; scaffold109 indexed_genome mRNA 361686 372184 . + . ID=transcript_13221;Q9NSU3 Q9NVF6 Q9UIL0,ADP-ribosylation factor GTPase-activating protein 1,ADP-ribosylation factor 1 GTPase-activating protein;ARF1-directed GTPase-activating protein;, PF01412;, GO:0005829;GO:0000139;GO:0045202;GO:0005096;GO:0046872;GO:0006888;GO:0036498;GO:0015031;GO:0032012;GO:0030100;GO:0006890;, C:cytosol; C:Golgi membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of endocytosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NSU3 Q9NVF6 Q9UIL0,ADP-ribosylation factor GTPase-activating protein 1,ADP-ribosylation factor 1 GTPase-activating protein;ARF1-directed GTPase-activating protein;, PF01412;, GO:0005829;GO:0000139;GO:0045202;GO:0005096;GO:0046872;GO:0006888;GO:0036498;GO:0015031;GO:0032012;GO:0030100;GO:0006890;, C:cytosol; C:Golgi membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of endocytosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NSU3 Q9NVF6 Q9UIL0,ADP-ribosylation factor GTPase-activating protein 1,ADP-ribosylation factor 1 GTPase-activating protein;ARF1-directed GTPase-activating protein;, PF01412;, GO:0005829;GO:0000139;GO:0045202;GO:0005096;GO:0046872;GO:0006888;GO:0036498;GO:0015031;GO:0032012;GO:0030100;GO:0006890;, C:cytosol; C:Golgi membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of endocytosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NSU3 Q9NVF6 Q9UIL0,ADP-ribosylation factor GTPase-activating protein 1,ADP-ribosylation factor 1 GTPase-activating protein;ARF1-directed GTPase-activating protein;, PF01412;, GO:0005829;GO:0000139;GO:0045202;GO:0005096;GO:0046872;GO:0006888;GO:0036498;GO:0015031;GO:0032012;GO:0030100;GO:0006890;, C:cytosol; C:Golgi membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of endocytosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9NSU3 Q9NVF6 Q9UIL0,ADP-ribosylation factor GTPase-activating protein 1,ADP-ribosylation factor 1 GTPase-activating protein;ARF1-directed GTPase-activating protein;, PF01412;, GO:0005829;GO:0000139;GO:0045202;GO:0005096;GO:0046872;GO:0006888;GO:0036498;GO:0015031;GO:0032012;GO:0030100;GO:0006890;, C:cytosol; C:Golgi membrane; C:synapse;, F:GTPase activator activity; F:metal ion binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein transport; P:regulation of ARF protein signal transduction; P:regulation of endocytosis; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold109 indexed_genome mRNA 438601 487475 . + . ID=transcript_13222;O43526 O43796 O75580 O95845 Q4VXP4 Q4VXR6 Q5VYT8 Q96J59 Q99454,Potassium voltage-gated channel subfamily KQT member 2 {ECO:0000305},KQT-like 2;Neuroblastoma-specific potassium channel subunit alpha KvLQT2;Voltage-gated potassium channel subunit Kv7.2;, PF00520;PF03520;PF11956;, GO:0043194;GO:0016021;GO:0005887;GO:0033268;GO:0005886;GO:0045202;GO:0008076;GO:0030506;GO:0005516;GO:0005251;GO:0005249;GO:0007268;GO:0007399;GO:0071805;GO:0034765;, C:axon initial segment; C:integral component of membrane; C:integral component of plasma membrane; C:node of Ranvier; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:ankyrin binding; F:calmodulin binding; F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:chemical synaptic transmission; P:nervous system development; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport;|O43526 O43796 O75580 O95845 Q4VXP4 Q4VXR6 Q5VYT8 Q96J59 Q99454,Potassium voltage-gated channel subfamily KQT member 2 {ECO:0000305},KQT-like 2;Neuroblastoma-specific potassium channel subunit alpha KvLQT2;Voltage-gated potassium channel subunit Kv7.2;, PF00520;PF03520;PF11956;, GO:0043194;GO:0016021;GO:0005887;GO:0033268;GO:0005886;GO:0045202;GO:0008076;GO:0030506;GO:0005516;GO:0005251;GO:0005249;GO:0007268;GO:0007399;GO:0071805;GO:0034765;, C:axon initial segment; C:integral component of membrane; C:integral component of plasma membrane; C:node of Ranvier; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:ankyrin binding; F:calmodulin binding; F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:chemical synaptic transmission; P:nervous system development; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport;|O43526 O43796 O75580 O95845 Q4VXP4 Q4VXR6 Q5VYT8 Q96J59 Q99454,Potassium voltage-gated channel subfamily KQT member 2 {ECO:0000305},KQT-like 2;Neuroblastoma-specific potassium channel subunit alpha KvLQT2;Voltage-gated potassium channel subunit Kv7.2;, PF00520;PF03520;PF11956;, GO:0043194;GO:0016021;GO:0005887;GO:0033268;GO:0005886;GO:0045202;GO:0008076;GO:0030506;GO:0005516;GO:0005251;GO:0005249;GO:0007268;GO:0007399;GO:0071805;GO:0034765;, C:axon initial segment; C:integral component of membrane; C:integral component of plasma membrane; C:node of Ranvier; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:ankyrin binding; F:calmodulin binding; F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:chemical synaptic transmission; P:nervous system development; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport;|O43526 O43796 O75580 O95845 Q4VXP4 Q4VXR6 Q5VYT8 Q96J59 Q99454,Potassium voltage-gated channel subfamily KQT member 2 {ECO:0000305},KQT-like 2;Neuroblastoma-specific potassium channel subunit alpha KvLQT2;Voltage-gated potassium channel subunit Kv7.2;, PF00520;PF03520;PF11956;, GO:0043194;GO:0016021;GO:0005887;GO:0033268;GO:0005886;GO:0045202;GO:0008076;GO:0030506;GO:0005516;GO:0005251;GO:0005249;GO:0007268;GO:0007399;GO:0071805;GO:0034765;, C:axon initial segment; C:integral component of membrane; C:integral component of plasma membrane; C:node of Ranvier; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:ankyrin binding; F:calmodulin binding; F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:chemical synaptic transmission; P:nervous system development; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport;|O43526 O43796 O75580 O95845 Q4VXP4 Q4VXR6 Q5VYT8 Q96J59 Q99454,Potassium voltage-gated channel subfamily KQT member 2 {ECO:0000305},KQT-like 2;Neuroblastoma-specific potassium channel subunit alpha KvLQT2;Voltage-gated potassium channel subunit Kv7.2;, PF00520;PF03520;PF11956;, GO:0043194;GO:0016021;GO:0005887;GO:0033268;GO:0005886;GO:0045202;GO:0008076;GO:0030506;GO:0005516;GO:0005251;GO:0005249;GO:0007268;GO:0007399;GO:0071805;GO:0034765;, C:axon initial segment; C:integral component of membrane; C:integral component of plasma membrane; C:node of Ranvier; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:ankyrin binding; F:calmodulin binding; F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:chemical synaptic transmission; P:nervous system development; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport;|O43526 O43796 O75580 O95845 Q4VXP4 Q4VXR6 Q5VYT8 Q96J59 Q99454,Potassium voltage-gated channel subfamily KQT member 2 {ECO:0000305},KQT-like 2;Neuroblastoma-specific potassium channel subunit alpha KvLQT2;Voltage-gated potassium channel subunit Kv7.2;, PF00520;PF03520;PF11956;, GO:0043194;GO:0016021;GO:0005887;GO:0033268;GO:0005886;GO:0045202;GO:0008076;GO:0030506;GO:0005516;GO:0005251;GO:0005249;GO:0007268;GO:0007399;GO:0071805;GO:0034765;, C:axon initial segment; C:integral component of membrane; C:integral component of plasma membrane; C:node of Ranvier; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:ankyrin binding; F:calmodulin binding; F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:chemical synaptic transmission; P:nervous system development; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; scaffold109 indexed_genome mRNA 503827 513769 . - . ID=transcript_13223;Q05639 B5BUF3 E1P5J1 P54266 Q0VGC7,Elongation factor 1-alpha 2,Eukaryotic elongation factor 1 A-2;Statin-S1;, PF00009;PF03144;PF03143;, GO:0005737;GO:0098574;GO:0005853;GO:0043025;GO:0045202;GO:0005525;GO:0003924;GO:0019901;GO:0003746;GO:0008135;GO:0043065;GO:0090218;GO:1904714;GO:0051602;GO:0010035;GO:0006412;GO:0006414;, C:cytoplasm; C:cytoplasmic side of lysosomal membrane; C:eukaryotic translation elongation factor 1 complex; C:neuronal cell body; C:synapse;, F:GTP binding; F:GTPase activity; F:protein kinase binding; F:translation elongation factor activity; F:translation factor activity, RNA binding;, P:positive regulation of apoptotic process; P:positive regulation of lipid kinase activity; P:regulation of chaperone-mediated autophagy; P:response to electrical stimulus; P:response to inorganic substance; P:translation; P:translational elongation;|Q05639 B5BUF3 E1P5J1 P54266 Q0VGC7,Elongation factor 1-alpha 2,Eukaryotic elongation factor 1 A-2;Statin-S1;, PF00009;PF03144;PF03143;, GO:0005737;GO:0098574;GO:0005853;GO:0043025;GO:0045202;GO:0005525;GO:0003924;GO:0019901;GO:0003746;GO:0008135;GO:0043065;GO:0090218;GO:1904714;GO:0051602;GO:0010035;GO:0006412;GO:0006414;, C:cytoplasm; C:cytoplasmic side of lysosomal membrane; C:eukaryotic translation elongation factor 1 complex; C:neuronal cell body; C:synapse;, F:GTP binding; F:GTPase activity; F:protein kinase binding; F:translation elongation factor activity; F:translation factor activity, RNA binding;, P:positive regulation of apoptotic process; P:positive regulation of lipid kinase activity; P:regulation of chaperone-mediated autophagy; P:response to electrical stimulus; P:response to inorganic substance; P:translation; P:translational elongation;|Q05639 B5BUF3 E1P5J1 P54266 Q0VGC7,Elongation factor 1-alpha 2,Eukaryotic elongation factor 1 A-2;Statin-S1;, PF00009;PF03144;PF03143;, GO:0005737;GO:0098574;GO:0005853;GO:0043025;GO:0045202;GO:0005525;GO:0003924;GO:0019901;GO:0003746;GO:0008135;GO:0043065;GO:0090218;GO:1904714;GO:0051602;GO:0010035;GO:0006412;GO:0006414;, C:cytoplasm; C:cytoplasmic side of lysosomal membrane; C:eukaryotic translation elongation factor 1 complex; C:neuronal cell body; C:synapse;, F:GTP binding; F:GTPase activity; F:protein kinase binding; F:translation elongation factor activity; F:translation factor activity, RNA binding;, P:positive regulation of apoptotic process; P:positive regulation of lipid kinase activity; P:regulation of chaperone-mediated autophagy; P:response to electrical stimulus; P:response to inorganic substance; P:translation; P:translational elongation;|Q05639 B5BUF3 E1P5J1 P54266 Q0VGC7,Elongation factor 1-alpha 2,Eukaryotic elongation factor 1 A-2;Statin-S1;, PF00009;PF03144;PF03143;, GO:0005737;GO:0098574;GO:0005853;GO:0043025;GO:0045202;GO:0005525;GO:0003924;GO:0019901;GO:0003746;GO:0008135;GO:0043065;GO:0090218;GO:1904714;GO:0051602;GO:0010035;GO:0006412;GO:0006414;, C:cytoplasm; C:cytoplasmic side of lysosomal membrane; C:eukaryotic translation elongation factor 1 complex; C:neuronal cell body; C:synapse;, F:GTP binding; F:GTPase activity; F:protein kinase binding; F:translation elongation factor activity; F:translation factor activity, RNA binding;, P:positive regulation of apoptotic process; P:positive regulation of lipid kinase activity; P:regulation of chaperone-mediated autophagy; P:response to electrical stimulus; P:response to inorganic substance; P:translation; P:translational elongation;|Q05639 B5BUF3 E1P5J1 P54266 Q0VGC7,Elongation factor 1-alpha 2,Eukaryotic elongation factor 1 A-2;Statin-S1;, PF00009;PF03144;PF03143;, GO:0005737;GO:0098574;GO:0005853;GO:0043025;GO:0045202;GO:0005525;GO:0003924;GO:0019901;GO:0003746;GO:0008135;GO:0043065;GO:0090218;GO:1904714;GO:0051602;GO:0010035;GO:0006412;GO:0006414;, C:cytoplasm; C:cytoplasmic side of lysosomal membrane; C:eukaryotic translation elongation factor 1 complex; C:neuronal cell body; C:synapse;, F:GTP binding; F:GTPase activity; F:protein kinase binding; F:translation elongation factor activity; F:translation factor activity, RNA binding;, P:positive regulation of apoptotic process; P:positive regulation of lipid kinase activity; P:regulation of chaperone-mediated autophagy; P:response to electrical stimulus; P:response to inorganic substance; P:translation; P:translational elongation; scaffold109 indexed_genome mRNA 513860 516841 . - . ID=transcript_13224;Q5VTE0,Putative elongation factor 1-alpha-like 3,Eukaryotic elongation factor 1 A-like 3;Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5;, PF00009;PF03144;PF03143;, GO:0005737;GO:0070062;GO:0005615;GO:0005634;GO:0005525;GO:0003924;GO:0003746;GO:0006412;GO:0006414;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleus;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:translation; P:translational elongation;|Q5VTE0,Putative elongation factor 1-alpha-like 3,Eukaryotic elongation factor 1 A-like 3;Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5;, PF00009;PF03144;PF03143;, GO:0005737;GO:0070062;GO:0005615;GO:0005634;GO:0005525;GO:0003924;GO:0003746;GO:0006412;GO:0006414;, C:cytoplasm; C:extracellular exosome; C:extracellular space; C:nucleus;, F:GTP binding; F:GTPase activity; F:translation elongation factor activity;, P:translation; P:translational elongation; scaffold109 indexed_genome mRNA 527658 529298 . + . ID=transcript_13225;Q9H3Y8 E1P5J2 Q4VXP1 Q9H3Y7,Pancreatic progenitor cell differentiation and proliferation factor,Exocrine differentiation and proliferation factor;, PF15060;, GO:0030154;GO:0007275;, , , P:cell differentiation; P:multicellular organism development;|Q9H3Y8 E1P5J2 Q4VXP1 Q9H3Y7,Pancreatic progenitor cell differentiation and proliferation factor,Exocrine differentiation and proliferation factor;, PF15060;, GO:0030154;GO:0007275;, , , P:cell differentiation; P:multicellular organism development; scaffold109 indexed_genome mRNA 539458 542068 . - . ID=transcript_13226;Q9H3Y6,Tyrosine-protein kinase Srms,, PF07714;PF00017;, GO:0005737;GO:0005829;GO:0031234;GO:0005524;GO:0004715;GO:0004713;GO:0005102;GO:0004714;GO:0030154;GO:0045087;GO:0009968;GO:0038083;GO:0018108;GO:0007169;, C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:innate immune response; P:negative regulation of signal transduction; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q9H3Y6,Tyrosine-protein kinase Srms,, PF07714;PF00017;, GO:0005737;GO:0005829;GO:0031234;GO:0005524;GO:0004715;GO:0004713;GO:0005102;GO:0004714;GO:0030154;GO:0045087;GO:0009968;GO:0038083;GO:0018108;GO:0007169;, C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:innate immune response; P:negative regulation of signal transduction; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold109 indexed_genome mRNA 552371 564968 . - . ID=transcript_13227;Q9UKD1 E1P5J3 Q5TDS0 Q9H431 Q9H4X7 Q9H4X8 Q9UF78 Q9ULF1,Glucocorticoid modulatory element-binding protein 2,DNA-binding protein p79PIF;Parvovirus initiation factor p79;, PF01342;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0006357;GO:0006366;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q9UKD1 E1P5J3 Q5TDS0 Q9H431 Q9H4X7 Q9H4X8 Q9UF78 Q9ULF1,Glucocorticoid modulatory element-binding protein 2,DNA-binding protein p79PIF;Parvovirus initiation factor p79;, PF01342;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0006357;GO:0006366;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q9UKD1 E1P5J3 Q5TDS0 Q9H431 Q9H4X7 Q9H4X8 Q9UF78 Q9ULF1,Glucocorticoid modulatory element-binding protein 2,DNA-binding protein p79PIF;Parvovirus initiation factor p79;, PF01342;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0006357;GO:0006366;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 593222 603838 . + . ID=transcript_13228;Q5JTV4 Q9BW37 Q9H402 Q9H4X6 Q9NX25 Q9NZ73 Q9UPR4 Q9Y4R6,Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065},Novel helicase-like;, PF06733;PF13307;, GO:0000781;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003677;GO:0003678;GO:0070182;GO:0046872;GO:0032508;GO:0006281;GO:1902990;GO:0045910;GO:1904430;GO:1904506;GO:1904355;GO:0032206;GO:1904358;GO:1904535;GO:0010569;GO:0031297;GO:0000732;GO:0000723;GO:0043247;GO:0007004;GO:0090657;, C:chromosome, telomeric region; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA polymerase binding; F:metal ion binding;, P:DNA duplex unwinding; P:DNA repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of DNA recombination; P:negative regulation of t-circle formation; P:negative regulation of telomere maintenance in response to DNA damage; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of telomeric loop disassembly; P:regulation of double-strand break repair via homologous recombination; P:replication fork processing; P:strand displacement; P:telomere maintenance; P:telomere maintenance in response to DNA damage; P:telomere maintenance via telomerase; P:telomeric loop disassembly;|Q5JTV4 Q9BW37 Q9H402 Q9H4X6 Q9NX25 Q9NZ73 Q9UPR4 Q9Y4R6,Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065},Novel helicase-like;, PF06733;PF13307;, GO:0000781;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003677;GO:0003678;GO:0070182;GO:0046872;GO:0032508;GO:0006281;GO:1902990;GO:0045910;GO:1904430;GO:1904506;GO:1904355;GO:0032206;GO:1904358;GO:1904535;GO:0010569;GO:0031297;GO:0000732;GO:0000723;GO:0043247;GO:0007004;GO:0090657;, C:chromosome, telomeric region; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA polymerase binding; F:metal ion binding;, P:DNA duplex unwinding; P:DNA repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of DNA recombination; P:negative regulation of t-circle formation; P:negative regulation of telomere maintenance in response to DNA damage; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of telomeric loop disassembly; P:regulation of double-strand break repair via homologous recombination; P:replication fork processing; P:strand displacement; P:telomere maintenance; P:telomere maintenance in response to DNA damage; P:telomere maintenance via telomerase; P:telomeric loop disassembly;|Q5JTV4 Q9BW37 Q9H402 Q9H4X6 Q9NX25 Q9NZ73 Q9UPR4 Q9Y4R6,Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065},Novel helicase-like;, PF06733;PF13307;, GO:0000781;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003677;GO:0003678;GO:0070182;GO:0046872;GO:0032508;GO:0006281;GO:1902990;GO:0045910;GO:1904430;GO:1904506;GO:1904355;GO:0032206;GO:1904358;GO:1904535;GO:0010569;GO:0031297;GO:0000732;GO:0000723;GO:0043247;GO:0007004;GO:0090657;, C:chromosome, telomeric region; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA polymerase binding; F:metal ion binding;, P:DNA duplex unwinding; P:DNA repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of DNA recombination; P:negative regulation of t-circle formation; P:negative regulation of telomere maintenance in response to DNA damage; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of telomeric loop disassembly; P:regulation of double-strand break repair via homologous recombination; P:replication fork processing; P:strand displacement; P:telomere maintenance; P:telomere maintenance in response to DNA damage; P:telomere maintenance via telomerase; P:telomeric loop disassembly; scaffold109 indexed_genome mRNA 603843 612593 . + . ID=transcript_13229;Q5JTV4 Q9BW37 Q9H402 Q9H4X6 Q9NX25 Q9NZ73 Q9UPR4 Q9Y4R6,Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065},Novel helicase-like;, PF06733;PF13307;, GO:0000781;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003677;GO:0003678;GO:0070182;GO:0046872;GO:0032508;GO:0006281;GO:1902990;GO:0045910;GO:1904430;GO:1904506;GO:1904355;GO:0032206;GO:1904358;GO:1904535;GO:0010569;GO:0031297;GO:0000732;GO:0000723;GO:0043247;GO:0007004;GO:0090657;, C:chromosome, telomeric region; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA polymerase binding; F:metal ion binding;, P:DNA duplex unwinding; P:DNA repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of DNA recombination; P:negative regulation of t-circle formation; P:negative regulation of telomere maintenance in response to DNA damage; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of telomeric loop disassembly; P:regulation of double-strand break repair via homologous recombination; P:replication fork processing; P:strand displacement; P:telomere maintenance; P:telomere maintenance in response to DNA damage; P:telomere maintenance via telomerase; P:telomeric loop disassembly;|Q5JTV4 Q9BW37 Q9H402 Q9H4X6 Q9NX25 Q9NZ73 Q9UPR4 Q9Y4R6,Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065},Novel helicase-like;, PF06733;PF13307;, GO:0000781;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003677;GO:0003678;GO:0070182;GO:0046872;GO:0032508;GO:0006281;GO:1902990;GO:0045910;GO:1904430;GO:1904506;GO:1904355;GO:0032206;GO:1904358;GO:1904535;GO:0010569;GO:0031297;GO:0000732;GO:0000723;GO:0043247;GO:0007004;GO:0090657;, C:chromosome, telomeric region; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA polymerase binding; F:metal ion binding;, P:DNA duplex unwinding; P:DNA repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of DNA recombination; P:negative regulation of t-circle formation; P:negative regulation of telomere maintenance in response to DNA damage; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of telomeric loop disassembly; P:regulation of double-strand break repair via homologous recombination; P:replication fork processing; P:strand displacement; P:telomere maintenance; P:telomere maintenance in response to DNA damage; P:telomere maintenance via telomerase; P:telomeric loop disassembly;|Q5JTV4 Q9BW37 Q9H402 Q9H4X6 Q9NX25 Q9NZ73 Q9UPR4 Q9Y4R6,Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065},Novel helicase-like;, PF06733;PF13307;, GO:0000781;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003677;GO:0003678;GO:0070182;GO:0046872;GO:0032508;GO:0006281;GO:1902990;GO:0045910;GO:1904430;GO:1904506;GO:1904355;GO:0032206;GO:1904358;GO:1904535;GO:0010569;GO:0031297;GO:0000732;GO:0000723;GO:0043247;GO:0007004;GO:0090657;, C:chromosome, telomeric region; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA polymerase binding; F:metal ion binding;, P:DNA duplex unwinding; P:DNA repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of DNA recombination; P:negative regulation of t-circle formation; P:negative regulation of telomere maintenance in response to DNA damage; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of telomeric loop disassembly; P:regulation of double-strand break repair via homologous recombination; P:replication fork processing; P:strand displacement; P:telomere maintenance; P:telomere maintenance in response to DNA damage; P:telomere maintenance via telomerase; P:telomeric loop disassembly;|Q5JTV4 Q9BW37 Q9H402 Q9H4X6 Q9NX25 Q9NZ73 Q9UPR4 Q9Y4R6,Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065},Novel helicase-like;, PF06733;PF13307;, GO:0000781;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003677;GO:0003678;GO:0070182;GO:0046872;GO:0032508;GO:0006281;GO:1902990;GO:0045910;GO:1904430;GO:1904506;GO:1904355;GO:0032206;GO:1904358;GO:1904535;GO:0010569;GO:0031297;GO:0000732;GO:0000723;GO:0043247;GO:0007004;GO:0090657;, C:chromosome, telomeric region; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA polymerase binding; F:metal ion binding;, P:DNA duplex unwinding; P:DNA repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of DNA recombination; P:negative regulation of t-circle formation; P:negative regulation of telomere maintenance in response to DNA damage; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of telomeric loop disassembly; P:regulation of double-strand break repair via homologous recombination; P:replication fork processing; P:strand displacement; P:telomere maintenance; P:telomere maintenance in response to DNA damage; P:telomere maintenance via telomerase; P:telomeric loop disassembly;|Q5JTV4 Q9BW37 Q9H402 Q9H4X6 Q9NX25 Q9NZ73 Q9UPR4 Q9Y4R6,Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065},Novel helicase-like;, PF06733;PF13307;, GO:0000781;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003677;GO:0003678;GO:0070182;GO:0046872;GO:0032508;GO:0006281;GO:1902990;GO:0045910;GO:1904430;GO:1904506;GO:1904355;GO:0032206;GO:1904358;GO:1904535;GO:0010569;GO:0031297;GO:0000732;GO:0000723;GO:0043247;GO:0007004;GO:0090657;, C:chromosome, telomeric region; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA polymerase binding; F:metal ion binding;, P:DNA duplex unwinding; P:DNA repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of DNA recombination; P:negative regulation of t-circle formation; P:negative regulation of telomere maintenance in response to DNA damage; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of telomeric loop disassembly; P:regulation of double-strand break repair via homologous recombination; P:replication fork processing; P:strand displacement; P:telomere maintenance; P:telomere maintenance in response to DNA damage; P:telomere maintenance via telomerase; P:telomeric loop disassembly;|Q5JTV4 Q9BW37 Q9H402 Q9H4X6 Q9NX25 Q9NZ73 Q9UPR4 Q9Y4R6,Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065},Novel helicase-like;, PF06733;PF13307;, GO:0000781;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003677;GO:0003678;GO:0070182;GO:0046872;GO:0032508;GO:0006281;GO:1902990;GO:0045910;GO:1904430;GO:1904506;GO:1904355;GO:0032206;GO:1904358;GO:1904535;GO:0010569;GO:0031297;GO:0000732;GO:0000723;GO:0043247;GO:0007004;GO:0090657;, C:chromosome, telomeric region; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA polymerase binding; F:metal ion binding;, P:DNA duplex unwinding; P:DNA repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of DNA recombination; P:negative regulation of t-circle formation; P:negative regulation of telomere maintenance in response to DNA damage; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of telomeric loop disassembly; P:regulation of double-strand break repair via homologous recombination; P:replication fork processing; P:strand displacement; P:telomere maintenance; P:telomere maintenance in response to DNA damage; P:telomere maintenance via telomerase; P:telomeric loop disassembly;|Q5JTV4 Q9BW37 Q9H402 Q9H4X6 Q9NX25 Q9NZ73 Q9UPR4 Q9Y4R6,Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065},Novel helicase-like;, PF06733;PF13307;, GO:0000781;GO:0005654;GO:0005634;GO:0051539;GO:0005524;GO:0003677;GO:0003678;GO:0070182;GO:0046872;GO:0032508;GO:0006281;GO:1902990;GO:0045910;GO:1904430;GO:1904506;GO:1904355;GO:0032206;GO:1904358;GO:1904535;GO:0010569;GO:0031297;GO:0000732;GO:0000723;GO:0043247;GO:0007004;GO:0090657;, C:chromosome, telomeric region; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA polymerase binding; F:metal ion binding;, P:DNA duplex unwinding; P:DNA repair; P:mitotic telomere maintenance via semi-conservative replication; P:negative regulation of DNA recombination; P:negative regulation of t-circle formation; P:negative regulation of telomere maintenance in response to DNA damage; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance; P:positive regulation of telomere maintenance via telomere lengthening; P:positive regulation of telomeric loop disassembly; P:regulation of double-strand break repair via homologous recombination; P:replication fork processing; P:strand displacement; P:telomere maintenance; P:telomere maintenance in response to DNA damage; P:telomere maintenance via telomerase; P:telomeric loop disassembly; scaffold109 indexed_genome mRNA 613034 615648 . + . ID=transcript_13230;O95407,Tumor necrosis factor receptor superfamily member 6B,Decoy receptor 3;Decoy receptor for Fas ligand;M68;, PF00020;, GO:0005576;GO:0005615;GO:0038023;GO:0006915;GO:0043066;GO:0033209;, C:extracellular region; C:extracellular space;, F:signaling receptor activity;, P:apoptotic process; P:negative regulation of apoptotic process; P:tumor necrosis factor-mediated signaling pathway; scaffold109 indexed_genome mRNA 616347 635405 . - . ID=transcript_13231;Q13795 A0A087WY13 B7ZKX7 E1P5J9 Q6IBQ0 V9GYH4,ADP-ribosylation factor-related protein 1,, PF00025;, GO:0005829;GO:0005794;GO:0016020;GO:0005802;GO:0032588;GO:0005525;GO:0003924;GO:0007369;GO:0043001;GO:0006886;GO:0034067;GO:0033365;GO:0042147;GO:0007165;, C:cytosol; C:Golgi apparatus; C:membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:GTP binding; F:GTPase activity;, P:gastrulation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:protein localization to Golgi apparatus; P:protein localization to organelle; P:retrograde transport, endosome to Golgi; P:signal transduction;|Q13795 A0A087WY13 B7ZKX7 E1P5J9 Q6IBQ0 V9GYH4,ADP-ribosylation factor-related protein 1,, PF00025;, GO:0005829;GO:0005794;GO:0016020;GO:0005802;GO:0032588;GO:0005525;GO:0003924;GO:0007369;GO:0043001;GO:0006886;GO:0034067;GO:0033365;GO:0042147;GO:0007165;, C:cytosol; C:Golgi apparatus; C:membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:GTP binding; F:GTPase activity;, P:gastrulation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:protein localization to Golgi apparatus; P:protein localization to organelle; P:retrograde transport, endosome to Golgi; P:signal transduction;|Q13795 A0A087WY13 B7ZKX7 E1P5J9 Q6IBQ0 V9GYH4,ADP-ribosylation factor-related protein 1,, PF00025;, GO:0005829;GO:0005794;GO:0016020;GO:0005802;GO:0032588;GO:0005525;GO:0003924;GO:0007369;GO:0043001;GO:0006886;GO:0034067;GO:0033365;GO:0042147;GO:0007165;, C:cytosol; C:Golgi apparatus; C:membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:GTP binding; F:GTPase activity;, P:gastrulation; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:protein localization to Golgi apparatus; P:protein localization to organelle; P:retrograde transport, endosome to Golgi; P:signal transduction;|Q9H401,Zinc finger CCCH-type with G patch domain-containing protein,G patch domain-containing protein 6;Zinc finger CCCH domain-containing protein 9;Zinc finger and G patch domain-containing protein;, PF01585;PF18044;, GO:0000785;GO:0005654;GO:0005634;GO:0005886;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0007175;GO:0000122;GO:0045892;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 635551 637576 . + . ID=transcript_13232;Q9H400 E1P5K5 E1P5K6 Q5JWJ2 Q6XYB3 Q9NX69,Lck-interacting transmembrane adapter 1,Lck-interacting molecule;, PF15332;, GO:0019815;GO:0005615;GO:0016021;GO:0019901;GO:0002250;GO:0050853;GO:0043122;GO:0043405;GO:1901222;GO:0014066;GO:0051279;GO:0006357;GO:0050852;, C:B cell receptor complex; C:extracellular space; C:integral component of membrane;, F:protein kinase binding;, P:adaptive immune response; P:B cell receptor signaling pathway; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of MAP kinase activity; P:regulation of NIK/NF-kappaB signaling; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of transcription by RNA polymerase II; P:T cell receptor signaling pathway;|Q9H400 E1P5K5 E1P5K6 Q5JWJ2 Q6XYB3 Q9NX69,Lck-interacting transmembrane adapter 1,Lck-interacting molecule;, PF15332;, GO:0019815;GO:0005615;GO:0016021;GO:0019901;GO:0002250;GO:0050853;GO:0043122;GO:0043405;GO:1901222;GO:0014066;GO:0051279;GO:0006357;GO:0050852;, C:B cell receptor complex; C:extracellular space; C:integral component of membrane;, F:protein kinase binding;, P:adaptive immune response; P:B cell receptor signaling pathway; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of MAP kinase activity; P:regulation of NIK/NF-kappaB signaling; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of transcription by RNA polymerase II; P:T cell receptor signaling pathway; scaffold109 indexed_genome mRNA 640254 641630 . + . ID=transcript_13233;Q9NR83 Q2PHL5 Q6F6I6 Q6F6I7 Q6GTK5 Q8TAH5 Q8WVW7 Q96QD3 Q9BV85,SLC2A4 regulator,GLUT4 enhancer factor;Huntington disease gene regulatory region-binding protein 1;, , GO:0005737;GO:0016607;GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;GO:0006355;, C:cytoplasm; C:nuclear speck; C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold109 indexed_genome mRNA 642795 653762 . - . ID=transcript_13234;Q86UZ6 E1P5K9 Q5JWJ3 Q6GMV4 Q9BQK3 Q9H3Z8 Q9H3Z9,Zinc finger and BTB domain-containing protein 46,BTB-ZF protein expressed in effector lymphocytes;BTB/POZ domain-containing protein 4;Zinc finger protein 340;, PF00651;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:2001199;GO:0030853;GO:0045650;GO:0045656;GO:2001200;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of dendritic cell differentiation; P:negative regulation of granulocyte differentiation; P:negative regulation of macrophage differentiation; P:negative regulation of monocyte differentiation; P:positive regulation of dendritic cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 653776 672957 . - . ID=transcript_13235;Q86UZ6 E1P5K9 Q5JWJ3 Q6GMV4 Q9BQK3 Q9H3Z8 Q9H3Z9,Zinc finger and BTB domain-containing protein 46,BTB-ZF protein expressed in effector lymphocytes;BTB/POZ domain-containing protein 4;Zinc finger protein 340;, PF00651;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:2001199;GO:0030853;GO:0045650;GO:0045656;GO:2001200;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of dendritic cell differentiation; P:negative regulation of granulocyte differentiation; P:negative regulation of macrophage differentiation; P:negative regulation of monocyte differentiation; P:positive regulation of dendritic cell differentiation; P:regulation of transcription by RNA polymerase II;|Q86UZ6 E1P5K9 Q5JWJ3 Q6GMV4 Q9BQK3 Q9H3Z8 Q9H3Z9,Zinc finger and BTB domain-containing protein 46,BTB-ZF protein expressed in effector lymphocytes;BTB/POZ domain-containing protein 4;Zinc finger protein 340;, PF00651;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:2001199;GO:0030853;GO:0045650;GO:0045656;GO:2001200;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of dendritic cell differentiation; P:negative regulation of granulocyte differentiation; P:negative regulation of macrophage differentiation; P:negative regulation of monocyte differentiation; P:positive regulation of dendritic cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 719766 735950 . + . ID=transcript_13236;O43399 B4DPJ6 E1P5G7 O43398 Q5JWU5 Q5JWU6 Q5JWU8 Q5U0E0 Q9H3Z6,Tumor protein D54,Tumor protein D52-like 2;, PF04201;, GO:0005737;GO:0048471;GO:0042803;GO:0003723;GO:0005975;GO:0042127;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:RNA binding;, P:carbohydrate metabolic process; P:regulation of cell population proliferation;|O43399 B4DPJ6 E1P5G7 O43398 Q5JWU5 Q5JWU6 Q5JWU8 Q5U0E0 Q9H3Z6,Tumor protein D54,Tumor protein D52-like 2;, PF04201;, GO:0005737;GO:0048471;GO:0042803;GO:0003723;GO:0005975;GO:0042127;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:RNA binding;, P:carbohydrate metabolic process; P:regulation of cell population proliferation;|O43399 B4DPJ6 E1P5G7 O43398 Q5JWU5 Q5JWU6 Q5JWU8 Q5U0E0 Q9H3Z6,Tumor protein D54,Tumor protein D52-like 2;, PF04201;, GO:0005737;GO:0048471;GO:0042803;GO:0003723;GO:0005975;GO:0042127;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:RNA binding;, P:carbohydrate metabolic process; P:regulation of cell population proliferation;|O43399 B4DPJ6 E1P5G7 O43398 Q5JWU5 Q5JWU6 Q5JWU8 Q5U0E0 Q9H3Z6,Tumor protein D54,Tumor protein D52-like 2;, PF04201;, GO:0005737;GO:0048471;GO:0042803;GO:0003723;GO:0005975;GO:0042127;, C:cytoplasm; C:perinuclear region of cytoplasm;, F:protein homodimerization activity; F:RNA binding;, P:carbohydrate metabolic process; P:regulation of cell population proliferation; scaffold109 indexed_genome mRNA 769895 776876 . + . ID=transcript_13237;Q9H3Z4 A8K0M0 B3KY68 E1P5G8 Q9H3Z5 Q9H7H2,DnaJ homolog subfamily C member 5 {ECO:0000305},Ceroid-lipofuscinosis neuronal protein 4 {ECO:0000305};Cysteine string protein {ECO:0000303|PubMed:8764987};, PF00226;, GO:0031225;GO:0098993;GO:0035577;GO:0042584;GO:0061202;GO:0005829;GO:0005794;GO:0043231;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0031594;GO:0005886;GO:0035579;GO:0043008;GO:0061077;GO:0006887;GO:0043524;GO:0007269;GO:0043312;GO:0045055;GO:0098693;GO:0016079;, C:anchored component of membrane; C:anchored component of synaptic vesicle membrane; C:azurophil granule membrane; C:chromaffin granule membrane; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:neuromuscular junction; C:plasma membrane; C:specific granule membrane;, F:ATP-dependent protein binding;, P:chaperone-mediated protein folding; P:exocytosis; P:negative regulation of neuron apoptotic process; P:neurotransmitter secretion; P:neutrophil degranulation; P:regulated exocytosis; P:regulation of synaptic vesicle cycle; P:synaptic vesicle exocytosis;|Q9H3Z4 A8K0M0 B3KY68 E1P5G8 Q9H3Z5 Q9H7H2,DnaJ homolog subfamily C member 5 {ECO:0000305},Ceroid-lipofuscinosis neuronal protein 4 {ECO:0000305};Cysteine string protein {ECO:0000303|PubMed:8764987};, PF00226;, GO:0031225;GO:0098993;GO:0035577;GO:0042584;GO:0061202;GO:0005829;GO:0005794;GO:0043231;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0031594;GO:0005886;GO:0035579;GO:0043008;GO:0061077;GO:0006887;GO:0043524;GO:0007269;GO:0043312;GO:0045055;GO:0098693;GO:0016079;, C:anchored component of membrane; C:anchored component of synaptic vesicle membrane; C:azurophil granule membrane; C:chromaffin granule membrane; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:neuromuscular junction; C:plasma membrane; C:specific granule membrane;, F:ATP-dependent protein binding;, P:chaperone-mediated protein folding; P:exocytosis; P:negative regulation of neuron apoptotic process; P:neurotransmitter secretion; P:neutrophil degranulation; P:regulated exocytosis; P:regulation of synaptic vesicle cycle; P:synaptic vesicle exocytosis;|Q9H3Z4 A8K0M0 B3KY68 E1P5G8 Q9H3Z5 Q9H7H2,DnaJ homolog subfamily C member 5 {ECO:0000305},Ceroid-lipofuscinosis neuronal protein 4 {ECO:0000305};Cysteine string protein {ECO:0000303|PubMed:8764987};, PF00226;, GO:0031225;GO:0098993;GO:0035577;GO:0042584;GO:0061202;GO:0005829;GO:0005794;GO:0043231;GO:0005765;GO:0042470;GO:0016020;GO:0005739;GO:0031594;GO:0005886;GO:0035579;GO:0043008;GO:0061077;GO:0006887;GO:0043524;GO:0007269;GO:0043312;GO:0045055;GO:0098693;GO:0016079;, C:anchored component of membrane; C:anchored component of synaptic vesicle membrane; C:azurophil granule membrane; C:chromaffin granule membrane; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:membrane; C:mitochondrion; C:neuromuscular junction; C:plasma membrane; C:specific granule membrane;, F:ATP-dependent protein binding;, P:chaperone-mediated protein folding; P:exocytosis; P:negative regulation of neuron apoptotic process; P:neurotransmitter secretion; P:neutrophil degranulation; P:regulated exocytosis; P:regulation of synaptic vesicle cycle; P:synaptic vesicle exocytosis; scaffold109 indexed_genome mRNA 781577 793448 . - . ID=transcript_13238;Q9NWZ5 B7Z8N2 Q5JWV0 Q70AQ5 Q8N524 Q9H3Z2,Uridine-cytidine kinase-like 1,, PF00485;, GO:0005829;GO:0005634;GO:0005524;GO:0016301;GO:0004849;GO:0044211;GO:0043097;GO:0044206;GO:0016032;, C:cytosol; C:nucleus;, F:ATP binding; F:kinase activity; F:uridine kinase activity;, P:CTP salvage; P:pyrimidine nucleoside salvage; P:UMP salvage; P:viral process;|Q9NWZ5 B7Z8N2 Q5JWV0 Q70AQ5 Q8N524 Q9H3Z2,Uridine-cytidine kinase-like 1,, PF00485;, GO:0005829;GO:0005634;GO:0005524;GO:0016301;GO:0004849;GO:0044211;GO:0043097;GO:0044206;GO:0016032;, C:cytosol; C:nucleus;, F:ATP binding; F:kinase activity; F:uridine kinase activity;, P:CTP salvage; P:pyrimidine nucleoside salvage; P:UMP salvage; P:viral process; scaffold109 indexed_genome mRNA 793462 801451 . - . ID=transcript_13239;Q96KM6 Q08AK9 Q9ULM4,Zinc finger protein 512B,, , GO:0005654;GO:0003677;GO:0046872;, C:nucleoplasm;, F:DNA binding; F:metal ion binding;|Q96KM6 Q08AK9 Q9ULM4,Zinc finger protein 512B,, , GO:0005654;GO:0003677;GO:0046872;, C:nucleoplasm;, F:DNA binding; F:metal ion binding;|Q96KM6 Q08AK9 Q9ULM4,Zinc finger protein 512B,, , GO:0005654;GO:0003677;GO:0046872;, C:nucleoplasm;, F:DNA binding; F:metal ion binding; scaffold109 indexed_genome mRNA 801741 803542 . - . ID=transcript_13240;Q96KM6 Q08AK9 Q9ULM4,Zinc finger protein 512B,, , GO:0005654;GO:0003677;GO:0046872;, C:nucleoplasm;, F:DNA binding; F:metal ion binding; scaffold109 indexed_genome mRNA 806422 811273 . - . ID=transcript_13241;Q9BYL1,Sterile alpha motif domain-containing protein 10,, PF07647;|Q9BYL1,Sterile alpha motif domain-containing protein 10,, PF07647; scaffold109 indexed_genome mRNA 812590 846718 . + . ID=transcript_13242;O94906 B2RAR5 B3KMC6 O95109 Q5VXS5 Q9H3Z1 Q9H4T9 Q9H4U8 Q9NTE6,Pre-mRNA-processing factor 6,Androgen receptor N-terminal domain-transactivating protein 1;PRP6 homolog;U5 snRNP-associated 102 kDa protein;, PF06424;PF13181;, GO:0071013;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0046540;GO:0005682;GO:0050681;GO:0043021;GO:0003723;GO:0003713;GO:0000398;GO:0045944;GO:0006403;GO:0008380;GO:0000375;GO:0000245;GO:0000244;, C:catalytic step 2 spliceosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:androgen receptor binding; F:ribonucleoprotein complex binding; F:RNA binding; F:transcription coactivator activity;, P:mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:RNA localization; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; P:spliceosomal tri-snRNP complex assembly;|O94906 B2RAR5 B3KMC6 O95109 Q5VXS5 Q9H3Z1 Q9H4T9 Q9H4U8 Q9NTE6,Pre-mRNA-processing factor 6,Androgen receptor N-terminal domain-transactivating protein 1;PRP6 homolog;U5 snRNP-associated 102 kDa protein;, PF06424;PF13181;, GO:0071013;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0046540;GO:0005682;GO:0050681;GO:0043021;GO:0003723;GO:0003713;GO:0000398;GO:0045944;GO:0006403;GO:0008380;GO:0000375;GO:0000245;GO:0000244;, C:catalytic step 2 spliceosome; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:androgen receptor binding; F:ribonucleoprotein complex binding; F:RNA binding; F:transcription coactivator activity;, P:mRNA splicing, via spliceosome; P:positive regulation of transcription by RNA polymerase II; P:RNA localization; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; P:spliceosomal tri-snRNP complex assembly; scaffold109 indexed_genome mRNA 850255 851264 . + . ID=transcript_13243;A0A1B0GTL2,Uncharacterized protein C20orf204 {ECO:0000305} scaffold109 indexed_genome mRNA 871914 879218 . - . ID=transcript_13244;Q15560 B3KNM1 Q8TD37 Q8TD38,Transcription elongation factor A protein 2,Testis-specific S-II;Transcription elongation factor S-II protein 2;Transcription elongation factor TFIIS.l;, PF08711;PF01096;PF07500;, GO:0005813;GO:0005654;GO:0008023;GO:0003677;GO:0008270;GO:0006354;GO:0045944;GO:0032784;, C:centrosome; C:nucleoplasm; C:transcription elongation factor complex;, F:DNA binding; F:zinc ion binding;, P:DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-templated transcription, elongation;|Q15560 B3KNM1 Q8TD37 Q8TD38,Transcription elongation factor A protein 2,Testis-specific S-II;Transcription elongation factor S-II protein 2;Transcription elongation factor TFIIS.l;, PF08711;PF01096;PF07500;, GO:0005813;GO:0005654;GO:0008023;GO:0003677;GO:0008270;GO:0006354;GO:0045944;GO:0032784;, C:centrosome; C:nucleoplasm; C:transcription elongation factor complex;, F:DNA binding; F:zinc ion binding;, P:DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-templated transcription, elongation;|Q15560 B3KNM1 Q8TD37 Q8TD38,Transcription elongation factor A protein 2,Testis-specific S-II;Transcription elongation factor S-II protein 2;Transcription elongation factor TFIIS.l;, PF08711;PF01096;PF07500;, GO:0005813;GO:0005654;GO:0008023;GO:0003677;GO:0008270;GO:0006354;GO:0045944;GO:0032784;, C:centrosome; C:nucleoplasm; C:transcription elongation factor complex;, F:DNA binding; F:zinc ion binding;, P:DNA-templated transcription, elongation; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-templated transcription, elongation; scaffold109 indexed_genome mRNA 879997 882712 . - . ID=transcript_13245;P49795 A8K216 E1P5G9 Q53XN0 Q8TD60,Regulator of G-protein signaling 19,G-alpha-interacting protein;, PF00615;, GO:0005903;GO:0030136;GO:0005794;GO:0016020;GO:0045121;GO:0005886;GO:0001965;GO:0006914;GO:0007186;GO:0009968;GO:0045471;GO:0007264;, C:brush border; C:clathrin-coated vesicle; C:Golgi apparatus; C:membrane; C:membrane raft; C:plasma membrane;, F:G-protein alpha-subunit binding;, P:autophagy; P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:response to ethanol; P:small GTPase mediated signal transduction; scaffold109 indexed_genome mRNA 898101 902178 . + . ID=transcript_13246;P41146 Q8TD34 Q8WYH9 Q9H4K4,Nociceptin receptor,Kappa-type 3 opioid receptor;Orphanin FQ receptor;, PF00001;, GO:0031410;GO:0005887;GO:0043005;GO:0005886;GO:0004930;GO:0042923;GO:0001626;GO:0042277;GO:0007193;GO:0007610;GO:0007186;GO:0007218;GO:0038003;GO:0051482;GO:0007600;GO:0019233;, C:cytoplasmic vesicle; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:G protein-coupled receptor activity; F:neuropeptide binding; F:nociceptin receptor activity; F:peptide binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:behavior; P:G protein-coupled receptor signaling pathway; P:neuropeptide signaling pathway; P:opioid receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:sensory perception; P:sensory perception of pain; scaffold109 indexed_genome mRNA 904716 910583 . + . ID=transcript_13247;P41146 Q8TD34 Q8WYH9 Q9H4K4,Nociceptin receptor,Kappa-type 3 opioid receptor;Orphanin FQ receptor;, PF00001;, GO:0031410;GO:0005887;GO:0043005;GO:0005886;GO:0004930;GO:0042923;GO:0001626;GO:0042277;GO:0007193;GO:0007610;GO:0007186;GO:0007218;GO:0038003;GO:0051482;GO:0007600;GO:0019233;, C:cytoplasmic vesicle; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;, F:G protein-coupled receptor activity; F:neuropeptide binding; F:nociceptin receptor activity; F:peptide binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:behavior; P:G protein-coupled receptor signaling pathway; P:neuropeptide signaling pathway; P:opioid receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:sensory perception; P:sensory perception of pain; scaffold109 indexed_genome mRNA 945754 1007948 . + . ID=transcript_13248;Q01538 E1P5H0 F5H7M8 O94922 Q7Z5W2 Q9UPV2,Myelin transcription factor 1,Myelin transcription factor I;PLPB1;Proteolipid protein-binding protein;, PF08474;PF01530;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0030154;GO:0007399;GO:0006357;GO:0006355;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q01538 E1P5H0 F5H7M8 O94922 Q7Z5W2 Q9UPV2,Myelin transcription factor 1,Myelin transcription factor I;PLPB1;Proteolipid protein-binding protein;, PF08474;PF01530;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0030154;GO:0007399;GO:0006357;GO:0006355;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q01538 E1P5H0 F5H7M8 O94922 Q7Z5W2 Q9UPV2,Myelin transcription factor 1,Myelin transcription factor I;PLPB1;Proteolipid protein-binding protein;, PF08474;PF01530;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0030154;GO:0007399;GO:0006357;GO:0006355;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q01538 E1P5H0 F5H7M8 O94922 Q7Z5W2 Q9UPV2,Myelin transcription factor 1,Myelin transcription factor I;PLPB1;Proteolipid protein-binding protein;, PF08474;PF01530;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0030154;GO:0007399;GO:0006357;GO:0006355;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q01538 E1P5H0 F5H7M8 O94922 Q7Z5W2 Q9UPV2,Myelin transcription factor 1,Myelin transcription factor I;PLPB1;Proteolipid protein-binding protein;, PF08474;PF01530;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0030154;GO:0007399;GO:0006357;GO:0006355;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q01538 E1P5H0 F5H7M8 O94922 Q7Z5W2 Q9UPV2,Myelin transcription factor 1,Myelin transcription factor I;PLPB1;Proteolipid protein-binding protein;, PF08474;PF01530;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0030154;GO:0007399;GO:0006357;GO:0006355;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q01538 E1P5H0 F5H7M8 O94922 Q7Z5W2 Q9UPV2,Myelin transcription factor 1,Myelin transcription factor I;PLPB1;Proteolipid protein-binding protein;, PF08474;PF01530;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0030154;GO:0007399;GO:0006357;GO:0006355;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q01538 E1P5H0 F5H7M8 O94922 Q7Z5W2 Q9UPV2,Myelin transcription factor 1,Myelin transcription factor I;PLPB1;Proteolipid protein-binding protein;, PF08474;PF01530;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0030154;GO:0007399;GO:0006357;GO:0006355;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q01538 E1P5H0 F5H7M8 O94922 Q7Z5W2 Q9UPV2,Myelin transcription factor 1,Myelin transcription factor I;PLPB1;Proteolipid protein-binding protein;, PF08474;PF01530;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0030154;GO:0007399;GO:0006357;GO:0006355;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold109 indexed_genome mRNA 1027728 1037487 . + . ID=transcript_13249;Q9NV79 E1P5H3 Q8IW60 Q9H4K2,Protein-L-isoaspartate O-methyltransferase domain-containing protein 2,, , GO:0005737;GO:0004719;, C:cytoplasm;, F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;|Q9NV79 E1P5H3 Q8IW60 Q9H4K2,Protein-L-isoaspartate O-methyltransferase domain-containing protein 2,, , GO:0005737;GO:0004719;, C:cytoplasm;, F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;|Q9NV79 E1P5H3 Q8IW60 Q9H4K2,Protein-L-isoaspartate O-methyltransferase domain-containing protein 2,, , GO:0005737;GO:0004719;, C:cytoplasm;, F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity; scaffold109 indexed_genome mRNA 1040604 1042750 . - . ID=transcript_13250;Q9NV79 E1P5H3 Q8IW60 Q9H4K2,Protein-L-isoaspartate O-methyltransferase domain-containing protein 2,, , GO:0005737;GO:0004719;, C:cytoplasm;, F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity; scaffold109 indexed_genome mRNA 1407763 1452788 . + . ID=transcript_13251;Q5TFQ8 Q7Z3B9,Signal-regulatory protein beta-1 isoform 3,, PF07654;PF07686;, GO:0016021;, C:integral component of membrane;|Q9UDX2 Q9UIJ6 Q9Y4U9,Tyrosine-protein phosphatase non-receptor type substrate 1,Brain Ig-like molecule with tyrosine-based activation motifs;CD172 antigen-like family member A;Inhibitory receptor SHPS-1;Macrophage fusion receptor;MyD-1 antigen;Signal-regulatory protein alpha-1;Signal-regulatory protein alpha-2;Signal-regulatory protein alpha-3;p84;, PF07654;PF07686;, GO:0009986;GO:0070062;GO:0101003;GO:0005887;GO:0016020;GO:0005886;GO:0070821;GO:0098632;GO:0030695;GO:1990405;GO:0086080;GO:0019903;GO:1990782;GO:0017124;GO:0007155;GO:0016477;GO:0070301;GO:0071346;GO:0071347;GO:0071349;GO:0071222;GO:0050900;GO:0035696;GO:0071650;GO:1900016;GO:0070373;GO:1903720;GO:0050728;GO:0032688;GO:0032715;GO:0046329;GO:0071641;GO:0045019;GO:0050765;GO:0001933;GO:0032720;GO:0043312;GO:0050766;GO:0050870;GO:0010468;GO:0032649;GO:0032651;GO:0032675;GO:0045428;GO:0032680;, C:cell surface; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:tertiary granule membrane;, F:cell-cell adhesion mediator activity; F:GTPase regulator activity; F:protein antigen binding; F:protein binding involved in heterotypic cell-cell adhesion; F:protein phosphatase binding; F:protein tyrosine kinase binding; F:SH3 domain binding;, P:cell adhesion; P:cell migration; P:cellular response to hydrogen peroxide; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to interleukin-12; P:cellular response to lipopolysaccharide; P:leukocyte migration; P:monocyte extravasation; P:negative regulation of chemokine (C-C motif) ligand 5 production; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of I-kappaB phosphorylation; P:negative regulation of inflammatory response; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of JNK cascade; P:negative regulation of macrophage inflammatory protein 1 alpha production; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of phagocytosis; P:negative regulation of protein phosphorylation; P:negative regulation of tumor necrosis factor production; P:neutrophil degranulation; P:positive regulation of phagocytosis; P:positive regulation of T cell activation; P:regulation of gene expression; P:regulation of interferon-gamma production; P:regulation of interleukin-1 beta production; P:regulation of interleukin-6 production; P:regulation of nitric oxide biosynthetic process; P:regulation of tumor necrosis factor production; scaffold109 indexed_genome mRNA 1498188 1499950 . + . ID=transcript_13252;P01213 A8K0Q3,Proenkephalin-B,Beta-neoendorphin-dynorphin;Preprodynorphin;, PF01160;, GO:0043679;GO:0030425;GO:0005576;GO:0043025;GO:0005886;GO:0001515;GO:0031628;GO:0007268;GO:0007186;GO:0007218;GO:0007600;, C:axon terminus; C:dendrite; C:extracellular region; C:neuronal cell body; C:plasma membrane;, F:opioid peptide activity; F:opioid receptor binding;, P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:neuropeptide signaling pathway; P:sensory perception; scaffold109 indexed_genome mRNA 1499982 1501871 . - . ID=transcript_13253;P01213 A8K0Q3,Proenkephalin-B,Beta-neoendorphin-dynorphin;Preprodynorphin;, PF01160;, GO:0043679;GO:0030425;GO:0005576;GO:0043025;GO:0005886;GO:0001515;GO:0031628;GO:0007268;GO:0007186;GO:0007218;GO:0007600;, C:axon terminus; C:dendrite; C:extracellular region; C:neuronal cell body; C:plasma membrane;, F:opioid peptide activity; F:opioid receptor binding;, P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:neuropeptide signaling pathway; P:sensory perception; scaffold109 indexed_genome mRNA 1605296 1628915 . + . ID=transcript_13254;Q8TDR2 B2RBM3 C7ENV8 Q2NKW6 Q5T3R1 Q5T3R2 Q96AB4 Q9BZ06,Serine/threonine-protein kinase 35,CLP-36-interacting kinase 1;PDLIM1-interacting kinase 1;Serine/threonine-protein kinase 35 L1;, PF00069;, GO:0005737;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0051321;, C:cytoplasm; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:meiotic cell cycle; scaffold109 indexed_genome mRNA 2082145 2086701 . + . ID=transcript_13255;Q9BYN5,Transmembrane channel-like protein 2,Transmembrane cochlear-expressed protein 2;, PF07810;, GO:0005887;GO:0032426;GO:0008381;GO:0005245;GO:0050910;GO:1903169;GO:0060005;, C:integral component of plasma membrane; C:stereocilium tip;, F:mechanosensitive ion channel activity; F:voltage-gated calcium channel activity;, P:detection of mechanical stimulus involved in sensory perception of sound; P:regulation of calcium ion transmembrane transport; P:vestibular reflex;|Q9BYN5,Transmembrane channel-like protein 2,Transmembrane cochlear-expressed protein 2;, PF07810;, GO:0005887;GO:0032426;GO:0008381;GO:0005245;GO:0050910;GO:1903169;GO:0060005;, C:integral component of plasma membrane; C:stereocilium tip;, F:mechanosensitive ion channel activity; F:voltage-gated calcium channel activity;, P:detection of mechanical stimulus involved in sensory perception of sound; P:regulation of calcium ion transmembrane transport; P:vestibular reflex; scaffold109 indexed_genome mRNA 2098769 2103160 . + . ID=transcript_13256;O00567 Q2M3T6 Q9NQ05,Nucleolar protein 56,Nucleolar protein 5A;, PF01798;PF08156;, GO:0031428;GO:0005737;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0070761;GO:0032040;GO:0005732;GO:0045296;GO:1990226;GO:0003723;GO:0030515;GO:0006364;, C:box C/D RNP complex; C:cytoplasm; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:pre-snoRNP complex; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:cadherin binding; F:histone methyltransferase binding; F:RNA binding; F:snoRNA binding;, P:rRNA processing;|O00567 Q2M3T6 Q9NQ05,Nucleolar protein 56,Nucleolar protein 5A;, PF01798;PF08156;, GO:0031428;GO:0005737;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0070761;GO:0032040;GO:0005732;GO:0045296;GO:1990226;GO:0003723;GO:0030515;GO:0006364;, C:box C/D RNP complex; C:cytoplasm; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:pre-snoRNP complex; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:cadherin binding; F:histone methyltransferase binding; F:RNA binding; F:snoRNA binding;, P:rRNA processing;|O00567 Q2M3T6 Q9NQ05,Nucleolar protein 56,Nucleolar protein 5A;, PF01798;PF08156;, GO:0031428;GO:0005737;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0070761;GO:0032040;GO:0005732;GO:0045296;GO:1990226;GO:0003723;GO:0030515;GO:0006364;, C:box C/D RNP complex; C:cytoplasm; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:pre-snoRNP complex; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:cadherin binding; F:histone methyltransferase binding; F:RNA binding; F:snoRNA binding;, P:rRNA processing;|O00567 Q2M3T6 Q9NQ05,Nucleolar protein 56,Nucleolar protein 5A;, PF01798;PF08156;, GO:0031428;GO:0005737;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0070761;GO:0032040;GO:0005732;GO:0045296;GO:1990226;GO:0003723;GO:0030515;GO:0006364;, C:box C/D RNP complex; C:cytoplasm; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:pre-snoRNP complex; C:small-subunit processome; C:sno(s)RNA-containing ribonucleoprotein complex;, F:cadherin binding; F:histone methyltransferase binding; F:RNA binding; F:snoRNA binding;, P:rRNA processing; scaffold109 indexed_genome mRNA 2103816 2108777 . + . ID=transcript_13257;Q9UEX0 Q9UG99,Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial,Isocitric dehydrogenase subunit beta;NAD(+)-specific ICDH subunit beta;, PF00180;, GO:0005759;GO:0005739;GO:0005634;GO:0009055;GO:0004449;GO:0000287;GO:0051287;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:electron transfer activity; F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:isocitrate metabolic process; P:tricarboxylic acid cycle;|Q9UEX0 Q9UG99,Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial,Isocitric dehydrogenase subunit beta;NAD(+)-specific ICDH subunit beta;, PF00180;, GO:0005759;GO:0005739;GO:0005634;GO:0009055;GO:0004449;GO:0000287;GO:0051287;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:electron transfer activity; F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:isocitrate metabolic process; P:tricarboxylic acid cycle;|Q9UEX0 Q9UG99,Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial,Isocitric dehydrogenase subunit beta;NAD(+)-specific ICDH subunit beta;, PF00180;, GO:0005759;GO:0005739;GO:0005634;GO:0009055;GO:0004449;GO:0000287;GO:0051287;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:electron transfer activity; F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:isocitrate metabolic process; P:tricarboxylic acid cycle; scaffold109 indexed_genome mRNA 2149682 2196728 . + . ID=transcript_13258;Q9BQW3 Q1MTP7 Q5JY53 Q9NUB6 Q9P2A6,Transcription factor COE4,Early B-cell factor 4;Olf-1/EBF-like 4;, PF16422;PF16423;PF01833;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0046983;GO:0000978;GO:0007275;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II;|Q9H4W6 A0AUY1 Q5T6H9 Q9H4W5,Transcription factor COE3,Early B-cell factor 3;Olf-1/EBF-like 2;, PF16422;PF16423;PF01833;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0046983;GO:0000978;GO:0007275;GO:0045893;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 2196763 2198225 . - . ID=transcript_13259;Q9UH73 Q8IW11,Transcription factor COE1,Early B-cell factor;, PF16422;PF16423;PF01833;, GO:0000785;GO:0005634;GO:0070742;GO:0000981;GO:0046872;GO:0046983;GO:0000978;GO:0007275;GO:0006357;, C:chromatin; C:nucleus;, F:C2H2 zinc finger domain binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 2198605 2201313 . - . ID=transcript_13260;Q9BQW3 Q1MTP7 Q5JY53 Q9NUB6 Q9P2A6,Transcription factor COE4,Early B-cell factor 4;Olf-1/EBF-like 4;, PF16422;PF16423;PF01833;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0046983;GO:0000978;GO:0007275;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 2201322 2204294 . + . ID=transcript_13261;Q9BQW3 Q1MTP7 Q5JY53 Q9NUB6 Q9P2A6,Transcription factor COE4,Early B-cell factor 4;Olf-1/EBF-like 4;, PF16422;PF16423;PF01833;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0046983;GO:0000978;GO:0007275;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II;|Q9BQW3 Q1MTP7 Q5JY53 Q9NUB6 Q9P2A6,Transcription factor COE4,Early B-cell factor 4;Olf-1/EBF-like 4;, PF16422;PF16423;PF01833;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0046983;GO:0000978;GO:0007275;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; scaffold109 indexed_genome mRNA 2237392 2239328 . - . ID=transcript_13262;Q96SM3 Q6P4G8 Q6UW65 Q9NUB5,Probable carboxypeptidase X1,Metallocarboxypeptidase CPX-1;, PF00754;PF00246;, GO:0005615;GO:0004181;GO:0008270;GO:0006518;GO:0016485;, C:extracellular space;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing;|Q96SM3 Q6P4G8 Q6UW65 Q9NUB5,Probable carboxypeptidase X1,Metallocarboxypeptidase CPX-1;, PF00754;PF00246;, GO:0005615;GO:0004181;GO:0008270;GO:0006518;GO:0016485;, C:extracellular space;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing; scaffold109 indexed_genome mRNA 2239497 2243548 . - . ID=transcript_13263;Q96SM3 Q6P4G8 Q6UW65 Q9NUB5,Probable carboxypeptidase X1,Metallocarboxypeptidase CPX-1;, PF00754;PF00246;, GO:0005615;GO:0004181;GO:0008270;GO:0006518;GO:0016485;, C:extracellular space;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing;|Q96SM3 Q6P4G8 Q6UW65 Q9NUB5,Probable carboxypeptidase X1,Metallocarboxypeptidase CPX-1;, PF00754;PF00246;, GO:0005615;GO:0004181;GO:0008270;GO:0006518;GO:0016485;, C:extracellular space;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing; scaffold109 indexed_genome mRNA 2274286 2307116 . + . ID=transcript_13264;Q9H269 Q5JUB1 Q8WU31 Q96EE7 Q96N92 Q9H1Q4 Q9H1Q5,Vacuolar protein sorting-associated protein 16 homolog,, PF04840;PF04841;, GO:0005776;GO:0030424;GO:0030136;GO:0005769;GO:0005768;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0043025;GO:0055037;GO:0003779;GO:0051015;GO:0097352;GO:0016197;GO:0008333;GO:0006886;GO:0035542;GO:0032889;GO:0007033;, C:autophagosome; C:axon; C:clathrin-coated vesicle; C:early endosome; C:endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:recycling endosome;, F:actin binding; F:actin filament binding;, P:autophagosome maturation; P:endosomal transport; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of SNARE complex assembly; P:regulation of vacuole fusion, non-autophagic; P:vacuole organization;|Q9H269 Q5JUB1 Q8WU31 Q96EE7 Q96N92 Q9H1Q4 Q9H1Q5,Vacuolar protein sorting-associated protein 16 homolog,, PF04840;PF04841;, GO:0005776;GO:0030424;GO:0030136;GO:0005769;GO:0005768;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0043025;GO:0055037;GO:0003779;GO:0051015;GO:0097352;GO:0016197;GO:0008333;GO:0006886;GO:0035542;GO:0032889;GO:0007033;, C:autophagosome; C:axon; C:clathrin-coated vesicle; C:early endosome; C:endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:recycling endosome;, F:actin binding; F:actin filament binding;, P:autophagosome maturation; P:endosomal transport; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of SNARE complex assembly; P:regulation of vacuole fusion, non-autophagic; P:vacuole organization;|Q9H269 Q5JUB1 Q8WU31 Q96EE7 Q96N92 Q9H1Q4 Q9H1Q5,Vacuolar protein sorting-associated protein 16 homolog,, PF04840;PF04841;, GO:0005776;GO:0030424;GO:0030136;GO:0005769;GO:0005768;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0043025;GO:0055037;GO:0003779;GO:0051015;GO:0097352;GO:0016197;GO:0008333;GO:0006886;GO:0035542;GO:0032889;GO:0007033;, C:autophagosome; C:axon; C:clathrin-coated vesicle; C:early endosome; C:endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:recycling endosome;, F:actin binding; F:actin filament binding;, P:autophagosome maturation; P:endosomal transport; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of SNARE complex assembly; P:regulation of vacuole fusion, non-autophagic; P:vacuole organization;|Q9H269 Q5JUB1 Q8WU31 Q96EE7 Q96N92 Q9H1Q4 Q9H1Q5,Vacuolar protein sorting-associated protein 16 homolog,, PF04840;PF04841;, GO:0005776;GO:0030424;GO:0030136;GO:0005769;GO:0005768;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0043025;GO:0055037;GO:0003779;GO:0051015;GO:0097352;GO:0016197;GO:0008333;GO:0006886;GO:0035542;GO:0032889;GO:0007033;, C:autophagosome; C:axon; C:clathrin-coated vesicle; C:early endosome; C:endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:recycling endosome;, F:actin binding; F:actin filament binding;, P:autophagosome maturation; P:endosomal transport; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of SNARE complex assembly; P:regulation of vacuole fusion, non-autophagic; P:vacuole organization;|Q9H269 Q5JUB1 Q8WU31 Q96EE7 Q96N92 Q9H1Q4 Q9H1Q5,Vacuolar protein sorting-associated protein 16 homolog,, PF04840;PF04841;, GO:0005776;GO:0030424;GO:0030136;GO:0005769;GO:0005768;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0043025;GO:0055037;GO:0003779;GO:0051015;GO:0097352;GO:0016197;GO:0008333;GO:0006886;GO:0035542;GO:0032889;GO:0007033;, C:autophagosome; C:axon; C:clathrin-coated vesicle; C:early endosome; C:endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:recycling endosome;, F:actin binding; F:actin filament binding;, P:autophagosome maturation; P:endosomal transport; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of SNARE complex assembly; P:regulation of vacuole fusion, non-autophagic; P:vacuole organization;|Q9H269 Q5JUB1 Q8WU31 Q96EE7 Q96N92 Q9H1Q4 Q9H1Q5,Vacuolar protein sorting-associated protein 16 homolog,, PF04840;PF04841;, GO:0005776;GO:0030424;GO:0030136;GO:0005769;GO:0005768;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0043025;GO:0055037;GO:0003779;GO:0051015;GO:0097352;GO:0016197;GO:0008333;GO:0006886;GO:0035542;GO:0032889;GO:0007033;, C:autophagosome; C:axon; C:clathrin-coated vesicle; C:early endosome; C:endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:neuronal cell body; C:recycling endosome;, F:actin binding; F:actin filament binding;, P:autophagosome maturation; P:endosomal transport; P:endosome to lysosome transport; P:intracellular protein transport; P:regulation of SNARE complex assembly; P:regulation of vacuole fusion, non-autophagic; P:vacuole organization; scaffold109 indexed_genome mRNA 2313139 2447322 . + . ID=transcript_13265;P18433 A8K2G8 D3DVX5 Q14513 Q7Z2I2 Q96TD9,Receptor-type tyrosine-protein phosphatase alpha,, PF00102;, GO:0070062;GO:0005925;GO:0005887;GO:0099699;GO:0016020;GO:0005886;GO:0043235;GO:0098685;GO:0004725;GO:0005001;GO:0007411;GO:0008286;GO:0007229;GO:0000165;GO:0050804;GO:0006470;GO:0006468;GO:0051893;, C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:integral component of synaptic membrane; C:membrane; C:plasma membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:axon guidance; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of focal adhesion assembly;|P18433 A8K2G8 D3DVX5 Q14513 Q7Z2I2 Q96TD9,Receptor-type tyrosine-protein phosphatase alpha,, PF00102;, GO:0070062;GO:0005925;GO:0005887;GO:0099699;GO:0016020;GO:0005886;GO:0043235;GO:0098685;GO:0004725;GO:0005001;GO:0007411;GO:0008286;GO:0007229;GO:0000165;GO:0050804;GO:0006470;GO:0006468;GO:0051893;, C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:integral component of synaptic membrane; C:membrane; C:plasma membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:axon guidance; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of focal adhesion assembly; scaffold109 indexed_genome mRNA 2450943 2484003 . + . ID=transcript_13266;P18433 A8K2G8 D3DVX5 Q14513 Q7Z2I2 Q96TD9,Receptor-type tyrosine-protein phosphatase alpha,, PF00102;, GO:0070062;GO:0005925;GO:0005887;GO:0099699;GO:0016020;GO:0005886;GO:0043235;GO:0098685;GO:0004725;GO:0005001;GO:0007411;GO:0008286;GO:0007229;GO:0000165;GO:0050804;GO:0006470;GO:0006468;GO:0051893;, C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:integral component of synaptic membrane; C:membrane; C:plasma membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:axon guidance; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of focal adhesion assembly;|P18433 A8K2G8 D3DVX5 Q14513 Q7Z2I2 Q96TD9,Receptor-type tyrosine-protein phosphatase alpha,, PF00102;, GO:0070062;GO:0005925;GO:0005887;GO:0099699;GO:0016020;GO:0005886;GO:0043235;GO:0098685;GO:0004725;GO:0005001;GO:0007411;GO:0008286;GO:0007229;GO:0000165;GO:0050804;GO:0006470;GO:0006468;GO:0051893;, C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:integral component of synaptic membrane; C:membrane; C:plasma membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:axon guidance; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of focal adhesion assembly;|P18433 A8K2G8 D3DVX5 Q14513 Q7Z2I2 Q96TD9,Receptor-type tyrosine-protein phosphatase alpha,, PF00102;, GO:0070062;GO:0005925;GO:0005887;GO:0099699;GO:0016020;GO:0005886;GO:0043235;GO:0098685;GO:0004725;GO:0005001;GO:0007411;GO:0008286;GO:0007229;GO:0000165;GO:0050804;GO:0006470;GO:0006468;GO:0051893;, C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:integral component of synaptic membrane; C:membrane; C:plasma membrane; C:receptor complex; C:Schaffer collateral - CA1 synapse;, F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:axon guidance; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:MAPK cascade; P:modulation of chemical synaptic transmission; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of focal adhesion assembly; scaffold109 indexed_genome mRNA 2488731 2492084 . + . ID=transcript_13267;Q9BYN8 Q96Q58,28S ribosomal protein S26, mitochondrial,28S ribosomal protein S13, mitochondrial;Mitochondrial small ribosomal subunit protein mS26 {ECO:0000303|PubMed:25838379};, PF14943;, GO:0005743;GO:0005763;GO:0005739;GO:0005654;GO:0003723;GO:0042769;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:RNA binding;, P:DNA damage response, detection of DNA damage; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold109 indexed_genome mRNA 2530549 2547741 . - . ID=transcript_13268;O94941 Q6IAR5 Q86X87 Q9H4J2,RING finger protein 37 {ECO:0000305},RING-type E3 ubiquitin transferase RNF37 {ECO:0000305};U-box domain-containing protein 5 {ECO:0000312|HGNC:HGNC:17777};UbcM4-interacting protein 5 {ECO:0000303|PubMed:10431818};Ubiquitin-conjugating enzyme 7-interacting protein 5 {ECO:0000312|EMBL:CAG33370.1};, PF04564;, GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0046872;GO:0031625;GO:0034450;GO:0000209;, C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase binding; F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination;|O94941 Q6IAR5 Q86X87 Q9H4J2,RING finger protein 37 {ECO:0000305},RING-type E3 ubiquitin transferase RNF37 {ECO:0000305};U-box domain-containing protein 5 {ECO:0000312|HGNC:HGNC:17777};UbcM4-interacting protein 5 {ECO:0000303|PubMed:10431818};Ubiquitin-conjugating enzyme 7-interacting protein 5 {ECO:0000312|EMBL:CAG33370.1};, PF04564;, GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0046872;GO:0031625;GO:0034450;GO:0000209;, C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase binding; F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination;|O94941 Q6IAR5 Q86X87 Q9H4J2,RING finger protein 37 {ECO:0000305},RING-type E3 ubiquitin transferase RNF37 {ECO:0000305};U-box domain-containing protein 5 {ECO:0000312|HGNC:HGNC:17777};UbcM4-interacting protein 5 {ECO:0000303|PubMed:10431818};Ubiquitin-conjugating enzyme 7-interacting protein 5 {ECO:0000312|EMBL:CAG33370.1};, PF04564;, GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0046872;GO:0031625;GO:0034450;GO:0000209;, C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase binding; F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination;|O94941 Q6IAR5 Q86X87 Q9H4J2,RING finger protein 37 {ECO:0000305},RING-type E3 ubiquitin transferase RNF37 {ECO:0000305};U-box domain-containing protein 5 {ECO:0000312|HGNC:HGNC:17777};UbcM4-interacting protein 5 {ECO:0000303|PubMed:10431818};Ubiquitin-conjugating enzyme 7-interacting protein 5 {ECO:0000312|EMBL:CAG33370.1};, PF04564;, GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0046872;GO:0031625;GO:0034450;GO:0000209;, C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase binding; F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination;|O94941 Q6IAR5 Q86X87 Q9H4J2,RING finger protein 37 {ECO:0000305},RING-type E3 ubiquitin transferase RNF37 {ECO:0000305};U-box domain-containing protein 5 {ECO:0000312|HGNC:HGNC:17777};UbcM4-interacting protein 5 {ECO:0000303|PubMed:10431818};Ubiquitin-conjugating enzyme 7-interacting protein 5 {ECO:0000312|EMBL:CAG33370.1};, PF04564;, GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0046872;GO:0031625;GO:0034450;GO:0000209;, C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin protein ligase binding; F:ubiquitin-ubiquitin ligase activity;, P:protein polyubiquitination; scaffold109 indexed_genome mRNA 2568097 2578430 . - . ID=transcript_13269;Q7L8L6 Q96JN3 Q9H5D1 Q9H8Y3,FAST kinase domain-containing protein 5, mitochondrial,, PF06743;PF08368;PF08373;, GO:0042645;GO:0005739;GO:0035770;GO:0003723;GO:0019843;GO:0000963;GO:0006397;GO:0044528;, C:mitochondrial nucleoid; C:mitochondrion; C:ribonucleoprotein granule;, F:RNA binding; F:rRNA binding;, P:mitochondrial RNA processing; P:mRNA processing; P:regulation of mitochondrial mRNA stability; scaffold109 indexed_genome mRNA 2580238 2589993 . - . ID=transcript_13270;O60299 A2A2Q7 D3DVX6 Q8IXX8,Leucine zipper putative tumor suppressor 3 {ECO:0000305},ProSAP-interacting protein 1 {ECO:0000250|UniProtKB:Q8K1Q4};, , GO:0005737;GO:0005856;GO:0043197;GO:0014069;GO:0045202;GO:0061001;, C:cytoplasm; C:cytoskeleton; C:dendritic spine; C:postsynaptic density; C:synapse;, , P:regulation of dendritic spine morphogenesis;|O60299 A2A2Q7 D3DVX6 Q8IXX8,Leucine zipper putative tumor suppressor 3 {ECO:0000305},ProSAP-interacting protein 1 {ECO:0000250|UniProtKB:Q8K1Q4};, , GO:0005737;GO:0005856;GO:0043197;GO:0014069;GO:0045202;GO:0061001;, C:cytoplasm; C:cytoskeleton; C:dendritic spine; C:postsynaptic density; C:synapse;, , P:regulation of dendritic spine morphogenesis; scaffold109 indexed_genome mRNA 2607603 2620137 . - . ID=transcript_13271;Q96HY6 A6NIU5 C9JSZ5 Q9BW47,DDRGK domain-containing protein 1 {ECO:0000305},Dashurin {ECO:0000303|PubMed:20036718};UFM1-binding and PCI domain-containing protein 1 {ECO:0000250|UniProtKB:Q80WW9};, PF09756;, GO:0005737;GO:0005783;GO:0005789;GO:0005730;GO:0001103;GO:0044389;GO:0051216;GO:0043066;GO:0010629;GO:1903895;GO:0032435;GO:1902808;GO:0030335;GO:0008284;GO:0010628;GO:1903721;GO:1905050;GO:0051092;GO:1901800;GO:0032436;GO:1905552;GO:1905636;GO:0045944;GO:1990592;GO:0070972;GO:0071569;GO:0033146;GO:0031647;GO:0034976;GO:0061709;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nucleolus;, F:RNA polymerase II repressing transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cartilage development; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of IRE1-mediated unfolded protein response; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of metallopeptidase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to endoplasmic reticulum; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:protein K69-linked ufmylation; P:protein localization to endoplasmic reticulum; P:protein ufmylation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:reticulophagy;|Q96HY6 A6NIU5 C9JSZ5 Q9BW47,DDRGK domain-containing protein 1 {ECO:0000305},Dashurin {ECO:0000303|PubMed:20036718};UFM1-binding and PCI domain-containing protein 1 {ECO:0000250|UniProtKB:Q80WW9};, PF09756;, GO:0005737;GO:0005783;GO:0005789;GO:0005730;GO:0001103;GO:0044389;GO:0051216;GO:0043066;GO:0010629;GO:1903895;GO:0032435;GO:1902808;GO:0030335;GO:0008284;GO:0010628;GO:1903721;GO:1905050;GO:0051092;GO:1901800;GO:0032436;GO:1905552;GO:1905636;GO:0045944;GO:1990592;GO:0070972;GO:0071569;GO:0033146;GO:0031647;GO:0034976;GO:0061709;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nucleolus;, F:RNA polymerase II repressing transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cartilage development; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of IRE1-mediated unfolded protein response; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of metallopeptidase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to endoplasmic reticulum; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:protein K69-linked ufmylation; P:protein localization to endoplasmic reticulum; P:protein ufmylation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:reticulophagy;|Q96HY6 A6NIU5 C9JSZ5 Q9BW47,DDRGK domain-containing protein 1 {ECO:0000305},Dashurin {ECO:0000303|PubMed:20036718};UFM1-binding and PCI domain-containing protein 1 {ECO:0000250|UniProtKB:Q80WW9};, PF09756;, GO:0005737;GO:0005783;GO:0005789;GO:0005730;GO:0001103;GO:0044389;GO:0051216;GO:0043066;GO:0010629;GO:1903895;GO:0032435;GO:1902808;GO:0030335;GO:0008284;GO:0010628;GO:1903721;GO:1905050;GO:0051092;GO:1901800;GO:0032436;GO:1905552;GO:1905636;GO:0045944;GO:1990592;GO:0070972;GO:0071569;GO:0033146;GO:0031647;GO:0034976;GO:0061709;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:nucleolus;, F:RNA polymerase II repressing transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cartilage development; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of IRE1-mediated unfolded protein response; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of metallopeptidase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to endoplasmic reticulum; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; P:protein K69-linked ufmylation; P:protein localization to endoplasmic reticulum; P:protein ufmylation; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of protein stability; P:response to endoplasmic reticulum stress; P:reticulophagy; scaffold109 indexed_genome mRNA 2623225 2634305 . + . ID=transcript_13272;Q9BY32 A2A2N2 A4UIM5 B2BCH7 O14878 Q5JWH4 Q9BYN1 Q9BYX0 Q9H3H8,Inosine triphosphate pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148},Non-canonical purine NTP pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Non-standard purine NTP pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Nucleoside-triphosphate diphosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Nucleoside-triphosphate pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Putative oncogene protein hlc14-06-p;, PF01725;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0035870;GO:0036218;GO:0042802;GO:0046872;GO:0035529;GO:0047429;GO:0000166;GO:0051276;GO:0009204;GO:0006193;GO:0009143;GO:0006195;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:dITP diphosphatase activity; F:dTTP diphosphatase activity; F:identical protein binding; F:metal ion binding; F:NADH pyrophosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:nucleotide binding;, P:chromosome organization; P:deoxyribonucleoside triphosphate catabolic process; P:ITP catabolic process; P:nucleoside triphosphate catabolic process; P:purine nucleotide catabolic process;|Q9BY32 A2A2N2 A4UIM5 B2BCH7 O14878 Q5JWH4 Q9BYN1 Q9BYX0 Q9H3H8,Inosine triphosphate pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148},Non-canonical purine NTP pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Non-standard purine NTP pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Nucleoside-triphosphate diphosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Nucleoside-triphosphate pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Putative oncogene protein hlc14-06-p;, PF01725;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0035870;GO:0036218;GO:0042802;GO:0046872;GO:0035529;GO:0047429;GO:0000166;GO:0051276;GO:0009204;GO:0006193;GO:0009143;GO:0006195;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:dITP diphosphatase activity; F:dTTP diphosphatase activity; F:identical protein binding; F:metal ion binding; F:NADH pyrophosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:nucleotide binding;, P:chromosome organization; P:deoxyribonucleoside triphosphate catabolic process; P:ITP catabolic process; P:nucleoside triphosphate catabolic process; P:purine nucleotide catabolic process;|Q9BY32 A2A2N2 A4UIM5 B2BCH7 O14878 Q5JWH4 Q9BYN1 Q9BYX0 Q9H3H8,Inosine triphosphate pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148},Non-canonical purine NTP pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Non-standard purine NTP pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Nucleoside-triphosphate diphosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Nucleoside-triphosphate pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Putative oncogene protein hlc14-06-p;, PF01725;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0035870;GO:0036218;GO:0042802;GO:0046872;GO:0035529;GO:0047429;GO:0000166;GO:0051276;GO:0009204;GO:0006193;GO:0009143;GO:0006195;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:dITP diphosphatase activity; F:dTTP diphosphatase activity; F:identical protein binding; F:metal ion binding; F:NADH pyrophosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:nucleotide binding;, P:chromosome organization; P:deoxyribonucleoside triphosphate catabolic process; P:ITP catabolic process; P:nucleoside triphosphate catabolic process; P:purine nucleotide catabolic process;|Q9BY32 A2A2N2 A4UIM5 B2BCH7 O14878 Q5JWH4 Q9BYN1 Q9BYX0 Q9H3H8,Inosine triphosphate pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148},Non-canonical purine NTP pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Non-standard purine NTP pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Nucleoside-triphosphate diphosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Nucleoside-triphosphate pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_03148};Putative oncogene protein hlc14-06-p;, PF01725;, GO:0005737;GO:0005829;GO:0043231;GO:0005654;GO:0035870;GO:0036218;GO:0042802;GO:0046872;GO:0035529;GO:0047429;GO:0000166;GO:0051276;GO:0009204;GO:0006193;GO:0009143;GO:0006195;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:dITP diphosphatase activity; F:dTTP diphosphatase activity; F:identical protein binding; F:metal ion binding; F:NADH pyrophosphatase activity; F:nucleoside-triphosphate diphosphatase activity; F:nucleotide binding;, P:chromosome organization; P:deoxyribonucleoside triphosphate catabolic process; P:ITP catabolic process; P:nucleoside triphosphate catabolic process; P:purine nucleotide catabolic process; scaffold109 indexed_genome mRNA 2635218 2641273 . - . ID=transcript_13273;Q8NBS3 B4DKC8 B4DKX9 G3V1M3 Q2TB62 Q2TB63 Q9BXF4 Q9NTW9,Sodium bicarbonate transporter-like protein 11,Bicarbonate transporter-related protein 1;Sodium borate cotransporter 1;Solute carrier family 4 member 11;, PF00955;, GO:0016324;GO:0016323;GO:0016021;GO:0005886;GO:0012506;GO:0046715;GO:0015301;GO:0015106;GO:0005452;GO:0046983;GO:0015252;GO:0005272;GO:0015293;GO:0022857;GO:0015701;GO:0046713;GO:0030003;GO:0042044;GO:0050801;GO:1902600;GO:0006814;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane; C:vesicle membrane;, F:active borate transmembrane transporter activity; F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:inorganic anion exchanger activity; F:protein dimerization activity; F:proton channel activity; F:sodium channel activity; F:symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:borate transport; P:cellular cation homeostasis; P:fluid transport; P:ion homeostasis; P:proton transmembrane transport; P:sodium ion transport; P:transmembrane transport;|Q8NBS3 B4DKC8 B4DKX9 G3V1M3 Q2TB62 Q2TB63 Q9BXF4 Q9NTW9,Sodium bicarbonate transporter-like protein 11,Bicarbonate transporter-related protein 1;Sodium borate cotransporter 1;Solute carrier family 4 member 11;, PF00955;, GO:0016324;GO:0016323;GO:0016021;GO:0005886;GO:0012506;GO:0046715;GO:0015301;GO:0015106;GO:0005452;GO:0046983;GO:0015252;GO:0005272;GO:0015293;GO:0022857;GO:0015701;GO:0046713;GO:0030003;GO:0042044;GO:0050801;GO:1902600;GO:0006814;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane; C:vesicle membrane;, F:active borate transmembrane transporter activity; F:anion:anion antiporter activity; F:bicarbonate transmembrane transporter activity; F:inorganic anion exchanger activity; F:protein dimerization activity; F:proton channel activity; F:sodium channel activity; F:symporter activity; F:transmembrane transporter activity;, P:bicarbonate transport; P:borate transport; P:cellular cation homeostasis; P:fluid transport; P:ion homeostasis; P:proton transmembrane transport; P:sodium ion transport; P:transmembrane transport; scaffold109 indexed_genome mRNA 2654069 2701691 . - . ID=transcript_13274;Q5TEA3 Q66K86 Q6P2R9 Q9UFX9,Uncharacterized protein C20orf194|Q5TEA3 Q66K86 Q6P2R9 Q9UFX9,Uncharacterized protein C20orf194|Q5TEA3 Q66K86 Q6P2R9 Q9UFX9,Uncharacterized protein C20orf194|Q5TEA3 Q66K86 Q6P2R9 Q9UFX9,Uncharacterized protein C20orf194|Q5TEA3 Q66K86 Q6P2R9 Q9UFX9,Uncharacterized protein C20orf194|Q5TEA3 Q66K86 Q6P2R9 Q9UFX9,Uncharacterized protein C20orf194 scaffold109 indexed_genome mRNA 2725598 2726216 . - . ID=transcript_13275;Q5TEA3 Q66K86 Q6P2R9 Q9UFX9,Uncharacterized protein C20orf194 scaffold109 indexed_genome mRNA 2877657 3058829 . + . ID=transcript_13276;Q9NTQ4 Q9NU01 Q9NZ57 Q9NZ58 Q9UC75 Q9UDF5,Attractin,DPPT-L;Mahogany homolog;, PF00431;PF01344;PF00059;PF01437;, GO:0005604;GO:0005737;GO:0070062;GO:0005615;GO:0005887;GO:0005886;GO:0030246;GO:0038023;GO:0009887;GO:0016477;GO:0021549;GO:0006954;GO:0042552;GO:0043473;GO:0040014;GO:0006979;GO:0034446;GO:0009888;, C:basement membrane; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:carbohydrate binding; F:signaling receptor activity;, P:animal organ morphogenesis; P:cell migration; P:cerebellum development; P:inflammatory response; P:myelination; P:pigmentation; P:regulation of multicellular organism growth; P:response to oxidative stress; P:substrate adhesion-dependent cell spreading; P:tissue development;|Q9NTQ4 Q9NU01 Q9NZ57 Q9NZ58 Q9UC75 Q9UDF5,Attractin,DPPT-L;Mahogany homolog;, PF00431;PF01344;PF00059;PF01437;, GO:0005604;GO:0005737;GO:0070062;GO:0005615;GO:0005887;GO:0005886;GO:0030246;GO:0038023;GO:0009887;GO:0016477;GO:0021549;GO:0006954;GO:0042552;GO:0043473;GO:0040014;GO:0006979;GO:0034446;GO:0009888;, C:basement membrane; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:carbohydrate binding; F:signaling receptor activity;, P:animal organ morphogenesis; P:cell migration; P:cerebellum development; P:inflammatory response; P:myelination; P:pigmentation; P:regulation of multicellular organism growth; P:response to oxidative stress; P:substrate adhesion-dependent cell spreading; P:tissue development;|Q9NTQ4 Q9NU01 Q9NZ57 Q9NZ58 Q9UC75 Q9UDF5,Attractin,DPPT-L;Mahogany homolog;, PF00431;PF01344;PF00059;PF01437;, GO:0005604;GO:0005737;GO:0070062;GO:0005615;GO:0005887;GO:0005886;GO:0030246;GO:0038023;GO:0009887;GO:0016477;GO:0021549;GO:0006954;GO:0042552;GO:0043473;GO:0040014;GO:0006979;GO:0034446;GO:0009888;, C:basement membrane; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:carbohydrate binding; F:signaling receptor activity;, P:animal organ morphogenesis; P:cell migration; P:cerebellum development; P:inflammatory response; P:myelination; P:pigmentation; P:regulation of multicellular organism growth; P:response to oxidative stress; P:substrate adhesion-dependent cell spreading; P:tissue development;|Q9NTQ4 Q9NU01 Q9NZ57 Q9NZ58 Q9UC75 Q9UDF5,Attractin,DPPT-L;Mahogany homolog;, PF00431;PF01344;PF00059;PF01437;, GO:0005604;GO:0005737;GO:0070062;GO:0005615;GO:0005887;GO:0005886;GO:0030246;GO:0038023;GO:0009887;GO:0016477;GO:0021549;GO:0006954;GO:0042552;GO:0043473;GO:0040014;GO:0006979;GO:0034446;GO:0009888;, C:basement membrane; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:carbohydrate binding; F:signaling receptor activity;, P:animal organ morphogenesis; P:cell migration; P:cerebellum development; P:inflammatory response; P:myelination; P:pigmentation; P:regulation of multicellular organism growth; P:response to oxidative stress; P:substrate adhesion-dependent cell spreading; P:tissue development;|Q9NTQ4 Q9NU01 Q9NZ57 Q9NZ58 Q9UC75 Q9UDF5,Attractin,DPPT-L;Mahogany homolog;, PF00431;PF01344;PF00059;PF01437;, GO:0005604;GO:0005737;GO:0070062;GO:0005615;GO:0005887;GO:0005886;GO:0030246;GO:0038023;GO:0009887;GO:0016477;GO:0021549;GO:0006954;GO:0042552;GO:0043473;GO:0040014;GO:0006979;GO:0034446;GO:0009888;, C:basement membrane; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:carbohydrate binding; F:signaling receptor activity;, P:animal organ morphogenesis; P:cell migration; P:cerebellum development; P:inflammatory response; P:myelination; P:pigmentation; P:regulation of multicellular organism growth; P:response to oxidative stress; P:substrate adhesion-dependent cell spreading; P:tissue development; scaffold109 indexed_genome mRNA 3079565 3095998 . - . ID=transcript_13277;Q9BZ11 A0A1K6 Q5JT75 Q5JT76 Q8N0W6,Disintegrin and metalloproteinase domain-containing protein 33,, PF08516;PF00200;PF01562;PF01421;, GO:0016021;GO:0004222;GO:0008270;GO:0006508;, C:integral component of membrane;, F:metalloendopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9BZ11 A0A1K6 Q5JT75 Q5JT76 Q8N0W6,Disintegrin and metalloproteinase domain-containing protein 33,, PF08516;PF00200;PF01562;PF01421;, GO:0016021;GO:0004222;GO:0008270;GO:0006508;, C:integral component of membrane;, F:metalloendopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9BZ11 A0A1K6 Q5JT75 Q5JT76 Q8N0W6,Disintegrin and metalloproteinase domain-containing protein 33,, PF08516;PF00200;PF01562;PF01421;, GO:0016021;GO:0004222;GO:0008270;GO:0006508;, C:integral component of membrane;, F:metalloendopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9BZ11 A0A1K6 Q5JT75 Q5JT76 Q8N0W6,Disintegrin and metalloproteinase domain-containing protein 33,, PF08516;PF00200;PF01562;PF01421;, GO:0016021;GO:0004222;GO:0008270;GO:0006508;, C:integral component of membrane;, F:metalloendopeptidase activity; F:zinc ion binding;, P:proteolysis; scaffold109 indexed_genome mRNA 3105773 3121965 . - . ID=transcript_13278;Q9BZZ2 Q96DL4 Q9GZS5 Q9H1H6 Q9H1H7 Q9H7L7,Sialoadhesin,Sialic acid-binding Ig-like lectin 1;, PF08205;PF07679;PF13895;PF07686;, GO:0005769;GO:0005576;GO:0016021;GO:0005770;GO:0005886;GO:0030246;GO:0046790;GO:0098609;GO:0007160;GO:0075512;GO:0006954;, C:early endosome; C:extracellular region; C:integral component of membrane; C:late endosome; C:plasma membrane;, F:carbohydrate binding; F:virion binding;, P:cell-cell adhesion; P:cell-matrix adhesion; P:clathrin-dependent endocytosis of virus by host cell; P:inflammatory response;|Q9BZZ2 Q96DL4 Q9GZS5 Q9H1H6 Q9H1H7 Q9H7L7,Sialoadhesin,Sialic acid-binding Ig-like lectin 1;, PF08205;PF07679;PF13895;PF07686;, GO:0005769;GO:0005576;GO:0016021;GO:0005770;GO:0005886;GO:0030246;GO:0046790;GO:0098609;GO:0007160;GO:0075512;GO:0006954;, C:early endosome; C:extracellular region; C:integral component of membrane; C:late endosome; C:plasma membrane;, F:carbohydrate binding; F:virion binding;, P:cell-cell adhesion; P:cell-matrix adhesion; P:clathrin-dependent endocytosis of virus by host cell; P:inflammatory response;|Q9BZZ2 Q96DL4 Q9GZS5 Q9H1H6 Q9H1H7 Q9H7L7,Sialoadhesin,Sialic acid-binding Ig-like lectin 1;, PF08205;PF07679;PF13895;PF07686;, GO:0005769;GO:0005576;GO:0016021;GO:0005770;GO:0005886;GO:0030246;GO:0046790;GO:0098609;GO:0007160;GO:0075512;GO:0006954;, C:early endosome; C:extracellular region; C:integral component of membrane; C:late endosome; C:plasma membrane;, F:carbohydrate binding; F:virion binding;, P:cell-cell adhesion; P:cell-matrix adhesion; P:clathrin-dependent endocytosis of virus by host cell; P:inflammatory response;|Q9BZZ2 Q96DL4 Q9GZS5 Q9H1H6 Q9H1H7 Q9H7L7,Sialoadhesin,Sialic acid-binding Ig-like lectin 1;, PF08205;PF07679;PF13895;PF07686;, GO:0005769;GO:0005576;GO:0016021;GO:0005770;GO:0005886;GO:0030246;GO:0046790;GO:0098609;GO:0007160;GO:0075512;GO:0006954;, C:early endosome; C:extracellular region; C:integral component of membrane; C:late endosome; C:plasma membrane;, F:carbohydrate binding; F:virion binding;, P:cell-cell adhesion; P:cell-matrix adhesion; P:clathrin-dependent endocytosis of virus by host cell; P:inflammatory response; scaffold109 indexed_genome mRNA 3122015 3125482 . - . ID=transcript_13279;Q9BZZ2 Q96DL4 Q9GZS5 Q9H1H6 Q9H1H7 Q9H7L7,Sialoadhesin,Sialic acid-binding Ig-like lectin 1;, PF08205;PF07679;PF13895;PF07686;, GO:0005769;GO:0005576;GO:0016021;GO:0005770;GO:0005886;GO:0030246;GO:0046790;GO:0098609;GO:0007160;GO:0075512;GO:0006954;, C:early endosome; C:extracellular region; C:integral component of membrane; C:late endosome; C:plasma membrane;, F:carbohydrate binding; F:virion binding;, P:cell-cell adhesion; P:cell-matrix adhesion; P:clathrin-dependent endocytosis of virus by host cell; P:inflammatory response; scaffold109 indexed_genome mRNA 3147291 3177507 . + . ID=transcript_13280;Q96MM6 D3DVX7 Q2TAK3 Q9BR52,Heat shock 70 kDa protein 12B,, , GO:0005524;, , F:ATP binding;|Q96MM6 D3DVX7 Q2TAK3 Q9BR52,Heat shock 70 kDa protein 12B,, , GO:0005524;, , F:ATP binding;|Q96MM6 D3DVX7 Q2TAK3 Q9BR52,Heat shock 70 kDa protein 12B,, , GO:0005524;, , F:ATP binding;|Q96MM6 D3DVX7 Q2TAK3 Q9BR52,Heat shock 70 kDa protein 12B,, , GO:0005524;, , F:ATP binding;|Q96MM6 D3DVX7 Q2TAK3 Q9BR52,Heat shock 70 kDa protein 12B,, , GO:0005524;, , F:ATP binding;|Q9GZN8 A8K4J0 D3DVX8 Q5JX81 Q9NWX3,UPF0687 protein C20orf27,, PF15006;, GO:0008157;GO:1901224;GO:0030511;, , F:protein phosphatase 1 binding;, P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of transforming growth factor beta receptor signaling pathway;|Q9GZN8 A8K4J0 D3DVX8 Q5JX81 Q9NWX3,UPF0687 protein C20orf27,, PF15006;, GO:0008157;GO:1901224;GO:0030511;, , F:protein phosphatase 1 binding;, P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of transforming growth factor beta receptor signaling pathway;|Q9GZN8 A8K4J0 D3DVX8 Q5JX81 Q9NWX3,UPF0687 protein C20orf27,, PF15006;, GO:0008157;GO:1901224;GO:0030511;, , F:protein phosphatase 1 binding;, P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of transforming growth factor beta receptor signaling pathway; scaffold109 indexed_genome mRNA 3180229 3187134 . + . ID=transcript_13281;P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold109 indexed_genome mRNA 3190960 3199710 . - . ID=transcript_13282;Q9Y4P9 A5YM71 D3DVY0 Q5JX78,Sperm flagellar protein 1,, PF06294;, GO:0097729;GO:0016324;GO:1990716;GO:0005930;GO:0016323;GO:0097542;GO:0005737;GO:0030175;GO:0030027;GO:0005874;GO:0005902;GO:0003779;GO:0008017;GO:1904158;GO:0016477;GO:0003341;GO:0046847;GO:0030032;GO:0001578;GO:0060548;GO:0007026;GO:0051493;GO:2000095;, C:9+2 motile cilium; C:apical plasma membrane; C:axonemal central apparatus; C:axoneme; C:basolateral plasma membrane; C:ciliary tip; C:cytoplasm; C:filopodium; C:lamellipodium; C:microtubule; C:microvillus;, F:actin binding; F:microtubule binding;, P:axonemal central apparatus assembly; P:cell migration; P:cilium movement; P:filopodium assembly; P:lamellipodium assembly; P:microtubule bundle formation; P:negative regulation of cell death; P:negative regulation of microtubule depolymerization; P:regulation of cytoskeleton organization; P:regulation of Wnt signaling pathway, planar cell polarity pathway;|Q9Y4P9 A5YM71 D3DVY0 Q5JX78,Sperm flagellar protein 1,, PF06294;, GO:0097729;GO:0016324;GO:1990716;GO:0005930;GO:0016323;GO:0097542;GO:0005737;GO:0030175;GO:0030027;GO:0005874;GO:0005902;GO:0003779;GO:0008017;GO:1904158;GO:0016477;GO:0003341;GO:0046847;GO:0030032;GO:0001578;GO:0060548;GO:0007026;GO:0051493;GO:2000095;, C:9+2 motile cilium; C:apical plasma membrane; C:axonemal central apparatus; C:axoneme; C:basolateral plasma membrane; C:ciliary tip; C:cytoplasm; C:filopodium; C:lamellipodium; C:microtubule; C:microvillus;, F:actin binding; F:microtubule binding;, P:axonemal central apparatus assembly; P:cell migration; P:cilium movement; P:filopodium assembly; P:lamellipodium assembly; P:microtubule bundle formation; P:negative regulation of cell death; P:negative regulation of microtubule depolymerization; P:regulation of cytoskeleton organization; P:regulation of Wnt signaling pathway, planar cell polarity pathway;|Q9Y4P9 A5YM71 D3DVY0 Q5JX78,Sperm flagellar protein 1,, PF06294;, GO:0097729;GO:0016324;GO:1990716;GO:0005930;GO:0016323;GO:0097542;GO:0005737;GO:0030175;GO:0030027;GO:0005874;GO:0005902;GO:0003779;GO:0008017;GO:1904158;GO:0016477;GO:0003341;GO:0046847;GO:0030032;GO:0001578;GO:0060548;GO:0007026;GO:0051493;GO:2000095;, C:9+2 motile cilium; C:apical plasma membrane; C:axonemal central apparatus; C:axoneme; C:basolateral plasma membrane; C:ciliary tip; C:cytoplasm; C:filopodium; C:lamellipodium; C:microtubule; C:microvillus;, F:actin binding; F:microtubule binding;, P:axonemal central apparatus assembly; P:cell migration; P:cilium movement; P:filopodium assembly; P:lamellipodium assembly; P:microtubule bundle formation; P:negative regulation of cell death; P:negative regulation of microtubule depolymerization; P:regulation of cytoskeleton organization; P:regulation of Wnt signaling pathway, planar cell polarity pathway;|Q9Y4P9 A5YM71 D3DVY0 Q5JX78,Sperm flagellar protein 1,, PF06294;, GO:0097729;GO:0016324;GO:1990716;GO:0005930;GO:0016323;GO:0097542;GO:0005737;GO:0030175;GO:0030027;GO:0005874;GO:0005902;GO:0003779;GO:0008017;GO:1904158;GO:0016477;GO:0003341;GO:0046847;GO:0030032;GO:0001578;GO:0060548;GO:0007026;GO:0051493;GO:2000095;, C:9+2 motile cilium; C:apical plasma membrane; C:axonemal central apparatus; C:axoneme; C:basolateral plasma membrane; C:ciliary tip; C:cytoplasm; C:filopodium; C:lamellipodium; C:microtubule; C:microvillus;, F:actin binding; F:microtubule binding;, P:axonemal central apparatus assembly; P:cell migration; P:cilium movement; P:filopodium assembly; P:lamellipodium assembly; P:microtubule bundle formation; P:negative regulation of cell death; P:negative regulation of microtubule depolymerization; P:regulation of cytoskeleton organization; P:regulation of Wnt signaling pathway, planar cell polarity pathway;|Q9Y4P9 A5YM71 D3DVY0 Q5JX78,Sperm flagellar protein 1,, PF06294;, GO:0097729;GO:0016324;GO:1990716;GO:0005930;GO:0016323;GO:0097542;GO:0005737;GO:0030175;GO:0030027;GO:0005874;GO:0005902;GO:0003779;GO:0008017;GO:1904158;GO:0016477;GO:0003341;GO:0046847;GO:0030032;GO:0001578;GO:0060548;GO:0007026;GO:0051493;GO:2000095;, C:9+2 motile cilium; C:apical plasma membrane; C:axonemal central apparatus; C:axoneme; C:basolateral plasma membrane; C:ciliary tip; C:cytoplasm; C:filopodium; C:lamellipodium; C:microtubule; C:microvillus;, F:actin binding; F:microtubule binding;, P:axonemal central apparatus assembly; P:cell migration; P:cilium movement; P:filopodium assembly; P:lamellipodium assembly; P:microtubule bundle formation; P:negative regulation of cell death; P:negative regulation of microtubule depolymerization; P:regulation of cytoskeleton organization; P:regulation of Wnt signaling pathway, planar cell polarity pathway;|P07199 Q96EI4,Major centromere autoantigen B,Centromere protein B;, PF09026;PF04218;PF03184;PF03221;, GO:0005694;GO:0000775;GO:0000779;GO:0016604;GO:0005654;GO:0005634;GO:0005721;GO:0019237;GO:0003682;GO:0003677;GO:0003696;GO:0043565;, C:chromosome; C:chromosome, centromeric region; C:condensed chromosome, centromeric region; C:nuclear body; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:centromeric DNA binding; F:chromatin binding; F:DNA binding; F:satellite DNA binding; F:sequence-specific DNA binding; scaffold109 indexed_genome mRNA 3216322 3218488 . + . ID=transcript_13283;Q9BRA6,M-phase inducer phosphatase 2,Dual specificity phosphatase Cdc25B;, PF06617;PF00581;, GO:0005813;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000922;GO:0019901;GO:0004725;GO:0051301;GO:0007144;GO:0000086;GO:0000278;GO:0001556;GO:0008284;GO:0032467;GO:0010971;GO:0110032;GO:0045931;GO:0045860;GO:0006468;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle pole;, F:protein kinase binding; F:protein tyrosine phosphatase activity;, P:cell division; P:female meiosis I; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:oocyte maturation; P:positive regulation of cell population proliferation; P:positive regulation of cytokinesis; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of G2/MI transition of meiotic cell cycle; P:positive regulation of mitotic cell cycle; P:positive regulation of protein kinase activity; P:protein phosphorylation; scaffold109 indexed_genome mRNA 3219359 3225777 . + . ID=transcript_13284;Q9BRA6,M-phase inducer phosphatase 2,Dual specificity phosphatase Cdc25B;, PF06617;PF00581;, GO:0005813;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000922;GO:0019901;GO:0004725;GO:0051301;GO:0007144;GO:0000086;GO:0000278;GO:0001556;GO:0008284;GO:0032467;GO:0010971;GO:0110032;GO:0045931;GO:0045860;GO:0006468;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:spindle pole;, F:protein kinase binding; F:protein tyrosine phosphatase activity;, P:cell division; P:female meiosis I; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:oocyte maturation; P:positive regulation of cell population proliferation; P:positive regulation of cytokinesis; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of G2/MI transition of meiotic cell cycle; P:positive regulation of mitotic cell cycle; P:positive regulation of protein kinase activity; P:protein phosphorylation; scaffold109 indexed_genome mRNA 3238270 3242617 . + . ID=transcript_13285;Q9NUS5 B3KSD0 D3DVY7,AP-5 complex subunit sigma-1,Adaptor-related protein complex 5 sigma subunit;, PF15001;, GO:0030119;GO:0005829;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0005654;GO:0000724;GO:0016197;GO:0015031;, C:AP-type membrane coat adaptor complex; C:cytosol; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:nucleoplasm;, , P:double-strand break repair via homologous recombination; P:endosomal transport; P:protein transport; scaffold109 indexed_genome mRNA 3267085 3281434 . + . ID=transcript_13286;Q86VY7 Q9H1H3 Q9H4Y1 Q9H8D3 Q9ULE9,Mitochondrial antiviral-signaling protein {ECO:0000305},CARD adapter inducing interferon beta;Interferon beta promoter stimulator protein 1;Putative NF-kappa-B-activating protein 031N;Virus-induced-signaling adapter;, PF16739;, GO:0016021;GO:0031966;GO:0005741;GO:0005739;GO:0005778;GO:0050700;GO:0019901;GO:0035591;GO:0002218;GO:0071360;GO:0042742;GO:0051607;GO:0045087;GO:0032480;GO:0045071;GO:0071651;GO:0002230;GO:0051091;GO:0043123;GO:0032727;GO:0032728;GO:0032755;GO:0032757;GO:0071660;GO:0002735;GO:0042307;GO:0001934;GO:0060760;GO:0045944;GO:0032760;GO:0060340;GO:1900063;GO:0007165;GO:0016032;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisomal membrane;, F:CARD domain binding; F:protein kinase binding; F:signaling adaptor activity;, P:activation of innate immune response; P:cellular response to exogenous dsRNA; P:defense response to bacterium; P:defense response to virus; P:innate immune response; P:negative regulation of type I interferon production; P:negative regulation of viral genome replication; P:positive regulation of chemokine (C-C motif) ligand 5 production; P:positive regulation of defense response to virus by host; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of IP-10 production; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of protein import into nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of response to cytokine stimulus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon-mediated signaling pathway; P:regulation of peroxisome organization; P:signal transduction; P:viral process; scaffold109 indexed_genome mRNA 3313337 3341757 . + . ID=transcript_13287;Q9BYW5 Q9HAF2,Pantothenate kinase 2, mitochondrial,Pantothenic acid kinase 2;, PF03630;, GO:0005829;GO:0005758;GO:0005739;GO:0005634;GO:0005524;GO:0004594;GO:0009060;GO:0015937;GO:0070584;GO:0015939;GO:0016310;GO:1904251;GO:0019217;GO:0051881;GO:0090207;GO:0007286;, C:cytosol; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus;, F:ATP binding; F:pantothenate kinase activity;, P:aerobic respiration; P:coenzyme A biosynthetic process; P:mitochondrion morphogenesis; P:pantothenate metabolic process; P:phosphorylation; P:regulation of bile acid metabolic process; P:regulation of fatty acid metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of triglyceride metabolic process; P:spermatid development;|Q9BYW5 Q9HAF2,Pantothenate kinase 2, mitochondrial,Pantothenic acid kinase 2;, PF03630;, GO:0005829;GO:0005758;GO:0005739;GO:0005634;GO:0005524;GO:0004594;GO:0009060;GO:0015937;GO:0070584;GO:0015939;GO:0016310;GO:1904251;GO:0019217;GO:0051881;GO:0090207;GO:0007286;, C:cytosol; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus;, F:ATP binding; F:pantothenate kinase activity;, P:aerobic respiration; P:coenzyme A biosynthetic process; P:mitochondrion morphogenesis; P:pantothenate metabolic process; P:phosphorylation; P:regulation of bile acid metabolic process; P:regulation of fatty acid metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of triglyceride metabolic process; P:spermatid development;|Q9BYW5 Q9HAF2,Pantothenate kinase 2, mitochondrial,Pantothenic acid kinase 2;, PF03630;, GO:0005829;GO:0005758;GO:0005739;GO:0005634;GO:0005524;GO:0004594;GO:0009060;GO:0015937;GO:0070584;GO:0015939;GO:0016310;GO:1904251;GO:0019217;GO:0051881;GO:0090207;GO:0007286;, C:cytosol; C:mitochondrial intermembrane space; C:mitochondrion; C:nucleus;, F:ATP binding; F:pantothenate kinase activity;, P:aerobic respiration; P:coenzyme A biosynthetic process; P:mitochondrion morphogenesis; P:pantothenate metabolic process; P:phosphorylation; P:regulation of bile acid metabolic process; P:regulation of fatty acid metabolic process; P:regulation of mitochondrial membrane potential; P:regulation of triglyceride metabolic process; P:spermatid development; scaffold109 indexed_genome mRNA 3346843 3353077 . - . ID=transcript_13288;Q9Y225 D3DVZ2 D3DVZ3 Q9UMH1,RING finger protein 24,, PF13639;, GO:0012505;GO:0005794;GO:0000139;GO:0016021;GO:0061630;GO:0008270;, C:endomembrane system; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:ubiquitin protein ligase activity; F:zinc ion binding;|Q9Y225 D3DVZ2 D3DVZ3 Q9UMH1,RING finger protein 24,, PF13639;, GO:0012505;GO:0005794;GO:0000139;GO:0016021;GO:0061630;GO:0008270;, C:endomembrane system; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:ubiquitin protein ligase activity; F:zinc ion binding; scaffold109 indexed_genome mRNA 3627868 3641648 . + . ID=transcript_13289;Q96LC3 Q96LC4 Q96QT3 Q9BW38 Q9H6H1 Q9NP51 Q9NPY1 Q9NPY2,Spermine oxidase,Polyamine oxidase 1;, PF01593;, GO:0005737;GO:0005829;GO:0043231;GO:0031965;GO:0005654;GO:0005634;GO:0052895;GO:0052894;GO:0016491;GO:0046592;GO:0052901;GO:0006596;GO:0006598;GO:0046208;GO:0006805;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity; F:norspermine:oxygen oxidoreductase activity; F:oxidoreductase activity; F:polyamine oxidase activity; F:spermine:oxygen oxidoreductase (spermidine-forming) activity;, P:polyamine biosynthetic process; P:polyamine catabolic process; P:spermine catabolic process; P:xenobiotic metabolic process;|Q96LC3 Q96LC4 Q96QT3 Q9BW38 Q9H6H1 Q9NP51 Q9NPY1 Q9NPY2,Spermine oxidase,Polyamine oxidase 1;, PF01593;, GO:0005737;GO:0005829;GO:0043231;GO:0031965;GO:0005654;GO:0005634;GO:0052895;GO:0052894;GO:0016491;GO:0046592;GO:0052901;GO:0006596;GO:0006598;GO:0046208;GO:0006805;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity; F:norspermine:oxygen oxidoreductase activity; F:oxidoreductase activity; F:polyamine oxidase activity; F:spermine:oxygen oxidoreductase (spermidine-forming) activity;, P:polyamine biosynthetic process; P:polyamine catabolic process; P:spermine catabolic process; P:xenobiotic metabolic process;|Q96LC3 Q96LC4 Q96QT3 Q9BW38 Q9H6H1 Q9NP51 Q9NPY1 Q9NPY2,Spermine oxidase,Polyamine oxidase 1;, PF01593;, GO:0005737;GO:0005829;GO:0043231;GO:0031965;GO:0005654;GO:0005634;GO:0052895;GO:0052894;GO:0016491;GO:0046592;GO:0052901;GO:0006596;GO:0006598;GO:0046208;GO:0006805;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity; F:norspermine:oxygen oxidoreductase activity; F:oxidoreductase activity; F:polyamine oxidase activity; F:spermine:oxygen oxidoreductase (spermidine-forming) activity;, P:polyamine biosynthetic process; P:polyamine catabolic process; P:spermine catabolic process; P:xenobiotic metabolic process;|Q96LC3 Q96LC4 Q96QT3 Q9BW38 Q9H6H1 Q9NP51 Q9NPY1 Q9NPY2,Spermine oxidase,Polyamine oxidase 1;, PF01593;, GO:0005737;GO:0005829;GO:0043231;GO:0031965;GO:0005654;GO:0005634;GO:0052895;GO:0052894;GO:0016491;GO:0046592;GO:0052901;GO:0006596;GO:0006598;GO:0046208;GO:0006805;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity; F:norspermine:oxygen oxidoreductase activity; F:oxidoreductase activity; F:polyamine oxidase activity; F:spermine:oxygen oxidoreductase (spermidine-forming) activity;, P:polyamine biosynthetic process; P:polyamine catabolic process; P:spermine catabolic process; P:xenobiotic metabolic process; scaffold109 indexed_genome mRNA 3657284 3657789 . + . ID=transcript_13290;P25100 Q9NPY0,Alpha-1D adrenergic receptor,Alpha-1A adrenergic receptor;Alpha-1D adrenoreceptor;Alpha-adrenergic receptor 1a;, PF00001;, GO:0005887;GO:0005886;GO:0004937;GO:0004930;GO:0042802;GO:0071880;GO:0007188;GO:0007267;GO:0007186;GO:0150099;GO:0007200;GO:0008284;GO:0007204;GO:0001996;GO:0043410;GO:0045907;, C:integral component of plasma membrane; C:plasma membrane;, F:alpha1-adrenergic receptor activity; F:G protein-coupled receptor activity; F:identical protein binding;, P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:neuron-glial cell signaling; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of heart rate by epinephrine-norepinephrine; P:positive regulation of MAPK cascade; P:positive regulation of vasoconstriction; scaffold109 indexed_genome mRNA 3788727 3789787 . - . ID=transcript_13291;Q9H1E5 Q8N4P7 Q8NCC1 Q9UJA1 Q9ULQ8,Thioredoxin-related transmembrane protein 4,Thioredoxin domain-containing protein 13;, PF00085;, GO:0016021;GO:0005637;, C:integral component of membrane; C:nuclear inner membrane; scaffold110 indexed_genome mRNA 9812 14085 . - . ID=transcript_13292;Q96BD0 Q9H4T7 Q9H4T8 Q9H8P2 Q9NWX8 Q9UI35 Q9UIG7,Solute carrier organic anion transporter family member 4A1,Colon organic anion transporter;Organic anion transporter polypeptide-related protein 1;Organic anion-transporting polypeptide E;Sodium-independent organic anion transporter E;Solute carrier family 21 member 12;, PF07648;PF03137;, GO:0005887;GO:0005886;GO:0015347;GO:0015349;GO:0043252;, C:integral component of plasma membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity; F:thyroid hormone transmembrane transporter activity;, P:sodium-independent organic anion transport; scaffold110 indexed_genome mRNA 134297 144059 . + . ID=transcript_13293;Q9BWX5 D9ZGF7 Q17RE2 Q86VU4,Transcription factor GATA-5,GATA-binding factor 5;, PF00320;PF05349;, GO:0000785;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0008270;GO:0003180;GO:0007596;GO:0048738;GO:0045165;GO:0071773;GO:0003274;GO:0060575;GO:0010614;GO:0010629;GO:0062000;GO:0010628;GO:0035481;GO:0045944;GO:1901228;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:aortic valve morphogenesis; P:blood coagulation; P:cardiac muscle tissue development; P:cell fate commitment; P:cellular response to BMP stimulus; P:endocardial cushion fusion; P:intestinal epithelial cell differentiation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression; P:positive regulation of cardiac endothelial to mesenchymal transition; P:positive regulation of gene expression; P:positive regulation of Notch signaling pathway involved in heart induction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; P:regulation of transcription by RNA polymerase II;|Q9BWX5 D9ZGF7 Q17RE2 Q86VU4,Transcription factor GATA-5,GATA-binding factor 5;, PF00320;PF05349;, GO:0000785;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0000976;GO:0008270;GO:0003180;GO:0007596;GO:0048738;GO:0045165;GO:0071773;GO:0003274;GO:0060575;GO:0010614;GO:0010629;GO:0062000;GO:0010628;GO:0035481;GO:0045944;GO:1901228;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:aortic valve morphogenesis; P:blood coagulation; P:cardiac muscle tissue development; P:cell fate commitment; P:cellular response to BMP stimulus; P:endocardial cushion fusion; P:intestinal epithelial cell differentiation; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of gene expression; P:positive regulation of cardiac endothelial to mesenchymal transition; P:positive regulation of gene expression; P:positive regulation of Notch signaling pathway involved in heart induction; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; P:regulation of transcription by RNA polymerase II; scaffold110 indexed_genome mRNA 198187 208600 . + . ID=transcript_13294;Q9BTV7 Q5JWL0 Q9BYK0,CDK5 and ABL1 enzyme substrate 2,Interactor with CDK3 2;, PF00134;, GO:0007049;GO:0051301;GO:0051726;, , , P:cell cycle; P:cell division; P:regulation of cell cycle;|Q9BTV7 Q5JWL0 Q9BYK0,CDK5 and ABL1 enzyme substrate 2,Interactor with CDK3 2;, PF00134;, GO:0007049;GO:0051301;GO:0051726;, , , P:cell cycle; P:cell division; P:regulation of cell cycle;|Q9BTV7 Q5JWL0 Q9BYK0,CDK5 and ABL1 enzyme substrate 2,Interactor with CDK3 2;, PF00134;, GO:0007049;GO:0051301;GO:0051726;, , , P:cell cycle; P:cell division; P:regulation of cell cycle;|Q9BTV7 Q5JWL0 Q9BYK0,CDK5 and ABL1 enzyme substrate 2,Interactor with CDK3 2;, PF00134;, GO:0007049;GO:0051301;GO:0051726;, , , P:cell cycle; P:cell division; P:regulation of cell cycle; scaffold110 indexed_genome mRNA 208666 209943 . - . ID=transcript_13295;P63220 P35265,40S ribosomal protein S21,Small ribosomal subunit protein eS21 {ECO:0000303|PubMed:24524803};, PF01249;, GO:0005829;GO:0022627;GO:0005654;GO:0042788;GO:0005791;GO:0015935;GO:0047485;GO:0003723;GO:0003735;GO:0002181;GO:0000447;GO:0000461;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:nucleoplasm; C:polysomal ribosome; C:rough endoplasmic reticulum; C:small ribosomal subunit;, F:protein N-terminus binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold110 indexed_genome mRNA 226063 283341 . + . ID=transcript_13296;O15230 Q5U4N9 Q8TDF8 Q8WZA7 Q9H1P1,Laminin subunit alpha-5,Laminin-10 subunit alpha;Laminin-11 subunit alpha;Laminin-15 subunit alpha;, PF00052;PF00053;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043259;GO:0043260;GO:0005610;GO:0031594;GO:0005634;GO:0043083;GO:0005201;GO:0005178;GO:0009887;GO:0007411;GO:0060445;GO:0001658;GO:0016477;GO:0098609;GO:0060271;GO:0019221;GO:0030198;GO:0001942;GO:0007229;GO:0030324;GO:0001738;GO:0016331;GO:0007517;GO:0001755;GO:0042475;GO:0072659;GO:0030155;GO:0030334;GO:0042127;GO:0045995;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin-10 complex; C:laminin-11 complex; C:laminin-5 complex; C:neuromuscular junction; C:nucleus; C:synaptic cleft;, F:extracellular matrix structural constituent; F:integrin binding;, P:animal organ morphogenesis; P:axon guidance; P:branching involved in salivary gland morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cell migration; P:cell-cell adhesion; P:cilium assembly; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:hair follicle development; P:integrin-mediated signaling pathway; P:lung development; P:morphogenesis of a polarized epithelium; P:morphogenesis of embryonic epithelium; P:muscle organ development; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:protein localization to plasma membrane; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of embryonic development; P:substrate adhesion-dependent cell spreading; P:tissue development;|O15230 Q5U4N9 Q8TDF8 Q8WZA7 Q9H1P1,Laminin subunit alpha-5,Laminin-10 subunit alpha;Laminin-11 subunit alpha;Laminin-15 subunit alpha;, PF00052;PF00053;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043259;GO:0043260;GO:0005610;GO:0031594;GO:0005634;GO:0043083;GO:0005201;GO:0005178;GO:0009887;GO:0007411;GO:0060445;GO:0001658;GO:0016477;GO:0098609;GO:0060271;GO:0019221;GO:0030198;GO:0001942;GO:0007229;GO:0030324;GO:0001738;GO:0016331;GO:0007517;GO:0001755;GO:0042475;GO:0072659;GO:0030155;GO:0030334;GO:0042127;GO:0045995;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin-10 complex; C:laminin-11 complex; C:laminin-5 complex; C:neuromuscular junction; C:nucleus; C:synaptic cleft;, F:extracellular matrix structural constituent; F:integrin binding;, P:animal organ morphogenesis; P:axon guidance; P:branching involved in salivary gland morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cell migration; P:cell-cell adhesion; P:cilium assembly; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:hair follicle development; P:integrin-mediated signaling pathway; P:lung development; P:morphogenesis of a polarized epithelium; P:morphogenesis of embryonic epithelium; P:muscle organ development; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:protein localization to plasma membrane; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of embryonic development; P:substrate adhesion-dependent cell spreading; P:tissue development;|O15230 Q5U4N9 Q8TDF8 Q8WZA7 Q9H1P1,Laminin subunit alpha-5,Laminin-10 subunit alpha;Laminin-11 subunit alpha;Laminin-15 subunit alpha;, PF00052;PF00053;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043259;GO:0043260;GO:0005610;GO:0031594;GO:0005634;GO:0043083;GO:0005201;GO:0005178;GO:0009887;GO:0007411;GO:0060445;GO:0001658;GO:0016477;GO:0098609;GO:0060271;GO:0019221;GO:0030198;GO:0001942;GO:0007229;GO:0030324;GO:0001738;GO:0016331;GO:0007517;GO:0001755;GO:0042475;GO:0072659;GO:0030155;GO:0030334;GO:0042127;GO:0045995;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin-10 complex; C:laminin-11 complex; C:laminin-5 complex; C:neuromuscular junction; C:nucleus; C:synaptic cleft;, F:extracellular matrix structural constituent; F:integrin binding;, P:animal organ morphogenesis; P:axon guidance; P:branching involved in salivary gland morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cell migration; P:cell-cell adhesion; P:cilium assembly; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:hair follicle development; P:integrin-mediated signaling pathway; P:lung development; P:morphogenesis of a polarized epithelium; P:morphogenesis of embryonic epithelium; P:muscle organ development; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:protein localization to plasma membrane; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of embryonic development; P:substrate adhesion-dependent cell spreading; P:tissue development;|O15230 Q5U4N9 Q8TDF8 Q8WZA7 Q9H1P1,Laminin subunit alpha-5,Laminin-10 subunit alpha;Laminin-11 subunit alpha;Laminin-15 subunit alpha;, PF00052;PF00053;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043259;GO:0043260;GO:0005610;GO:0031594;GO:0005634;GO:0043083;GO:0005201;GO:0005178;GO:0009887;GO:0007411;GO:0060445;GO:0001658;GO:0016477;GO:0098609;GO:0060271;GO:0019221;GO:0030198;GO:0001942;GO:0007229;GO:0030324;GO:0001738;GO:0016331;GO:0007517;GO:0001755;GO:0042475;GO:0072659;GO:0030155;GO:0030334;GO:0042127;GO:0045995;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin-10 complex; C:laminin-11 complex; C:laminin-5 complex; C:neuromuscular junction; C:nucleus; C:synaptic cleft;, F:extracellular matrix structural constituent; F:integrin binding;, P:animal organ morphogenesis; P:axon guidance; P:branching involved in salivary gland morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cell migration; P:cell-cell adhesion; P:cilium assembly; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:hair follicle development; P:integrin-mediated signaling pathway; P:lung development; P:morphogenesis of a polarized epithelium; P:morphogenesis of embryonic epithelium; P:muscle organ development; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:protein localization to plasma membrane; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of embryonic development; P:substrate adhesion-dependent cell spreading; P:tissue development;|O15230 Q5U4N9 Q8TDF8 Q8WZA7 Q9H1P1,Laminin subunit alpha-5,Laminin-10 subunit alpha;Laminin-11 subunit alpha;Laminin-15 subunit alpha;, PF00052;PF00053;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043259;GO:0043260;GO:0005610;GO:0031594;GO:0005634;GO:0043083;GO:0005201;GO:0005178;GO:0009887;GO:0007411;GO:0060445;GO:0001658;GO:0016477;GO:0098609;GO:0060271;GO:0019221;GO:0030198;GO:0001942;GO:0007229;GO:0030324;GO:0001738;GO:0016331;GO:0007517;GO:0001755;GO:0042475;GO:0072659;GO:0030155;GO:0030334;GO:0042127;GO:0045995;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin-10 complex; C:laminin-11 complex; C:laminin-5 complex; C:neuromuscular junction; C:nucleus; C:synaptic cleft;, F:extracellular matrix structural constituent; F:integrin binding;, P:animal organ morphogenesis; P:axon guidance; P:branching involved in salivary gland morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cell migration; P:cell-cell adhesion; P:cilium assembly; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:hair follicle development; P:integrin-mediated signaling pathway; P:lung development; P:morphogenesis of a polarized epithelium; P:morphogenesis of embryonic epithelium; P:muscle organ development; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:protein localization to plasma membrane; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of embryonic development; P:substrate adhesion-dependent cell spreading; P:tissue development;|O15230 Q5U4N9 Q8TDF8 Q8WZA7 Q9H1P1,Laminin subunit alpha-5,Laminin-10 subunit alpha;Laminin-11 subunit alpha;Laminin-15 subunit alpha;, PF00052;PF00053;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043259;GO:0043260;GO:0005610;GO:0031594;GO:0005634;GO:0043083;GO:0005201;GO:0005178;GO:0009887;GO:0007411;GO:0060445;GO:0001658;GO:0016477;GO:0098609;GO:0060271;GO:0019221;GO:0030198;GO:0001942;GO:0007229;GO:0030324;GO:0001738;GO:0016331;GO:0007517;GO:0001755;GO:0042475;GO:0072659;GO:0030155;GO:0030334;GO:0042127;GO:0045995;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin-10 complex; C:laminin-11 complex; C:laminin-5 complex; C:neuromuscular junction; C:nucleus; C:synaptic cleft;, F:extracellular matrix structural constituent; F:integrin binding;, P:animal organ morphogenesis; P:axon guidance; P:branching involved in salivary gland morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cell migration; P:cell-cell adhesion; P:cilium assembly; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:hair follicle development; P:integrin-mediated signaling pathway; P:lung development; P:morphogenesis of a polarized epithelium; P:morphogenesis of embryonic epithelium; P:muscle organ development; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:protein localization to plasma membrane; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of embryonic development; P:substrate adhesion-dependent cell spreading; P:tissue development;|O15230 Q5U4N9 Q8TDF8 Q8WZA7 Q9H1P1,Laminin subunit alpha-5,Laminin-10 subunit alpha;Laminin-11 subunit alpha;Laminin-15 subunit alpha;, PF00052;PF00053;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043259;GO:0043260;GO:0005610;GO:0031594;GO:0005634;GO:0043083;GO:0005201;GO:0005178;GO:0009887;GO:0007411;GO:0060445;GO:0001658;GO:0016477;GO:0098609;GO:0060271;GO:0019221;GO:0030198;GO:0001942;GO:0007229;GO:0030324;GO:0001738;GO:0016331;GO:0007517;GO:0001755;GO:0042475;GO:0072659;GO:0030155;GO:0030334;GO:0042127;GO:0045995;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin-10 complex; C:laminin-11 complex; C:laminin-5 complex; C:neuromuscular junction; C:nucleus; C:synaptic cleft;, F:extracellular matrix structural constituent; F:integrin binding;, P:animal organ morphogenesis; P:axon guidance; P:branching involved in salivary gland morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cell migration; P:cell-cell adhesion; P:cilium assembly; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:hair follicle development; P:integrin-mediated signaling pathway; P:lung development; P:morphogenesis of a polarized epithelium; P:morphogenesis of embryonic epithelium; P:muscle organ development; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:protein localization to plasma membrane; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of embryonic development; P:substrate adhesion-dependent cell spreading; P:tissue development;|O15230 Q5U4N9 Q8TDF8 Q8WZA7 Q9H1P1,Laminin subunit alpha-5,Laminin-10 subunit alpha;Laminin-11 subunit alpha;Laminin-15 subunit alpha;, PF00052;PF00053;PF02210;PF06008;PF06009;PF00055;, GO:0005604;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0043259;GO:0043260;GO:0005610;GO:0031594;GO:0005634;GO:0043083;GO:0005201;GO:0005178;GO:0009887;GO:0007411;GO:0060445;GO:0001658;GO:0016477;GO:0098609;GO:0060271;GO:0019221;GO:0030198;GO:0001942;GO:0007229;GO:0030324;GO:0001738;GO:0016331;GO:0007517;GO:0001755;GO:0042475;GO:0072659;GO:0030155;GO:0030334;GO:0042127;GO:0045995;GO:0034446;GO:0009888;, C:basement membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:laminin-10 complex; C:laminin-11 complex; C:laminin-5 complex; C:neuromuscular junction; C:nucleus; C:synaptic cleft;, F:extracellular matrix structural constituent; F:integrin binding;, P:animal organ morphogenesis; P:axon guidance; P:branching involved in salivary gland morphogenesis; P:branching involved in ureteric bud morphogenesis; P:cell migration; P:cell-cell adhesion; P:cilium assembly; P:cytokine-mediated signaling pathway; P:extracellular matrix organization; P:hair follicle development; P:integrin-mediated signaling pathway; P:lung development; P:morphogenesis of a polarized epithelium; P:morphogenesis of embryonic epithelium; P:muscle organ development; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:protein localization to plasma membrane; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of embryonic development; P:substrate adhesion-dependent cell spreading; P:tissue development;|Q16186 A0PKB1 Q96FJ7 Q9H1P2,Proteasomal ubiquitin receptor ADRM1,110 kDa cell membrane glycoprotein;Adhesion-regulating molecule 1;Proteasome regulatory particle non-ATPase 13;Rpn13 homolog;, PF04683;PF16550;, GO:0005829;GO:0005654;GO:0005886;GO:0000502;GO:0008541;GO:0061133;GO:0002020;GO:0070628;GO:0043130;GO:0043248;GO:0016579;GO:0006368;GO:0006511;, C:cytosol; C:nucleoplasm; C:plasma membrane; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex;, F:endopeptidase activator activity; F:protease binding; F:proteasome binding; F:ubiquitin binding;, P:proteasome assembly; P:protein deubiquitination; P:transcription elongation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process;|Q16186 A0PKB1 Q96FJ7 Q9H1P2,Proteasomal ubiquitin receptor ADRM1,110 kDa cell membrane glycoprotein;Adhesion-regulating molecule 1;Proteasome regulatory particle non-ATPase 13;Rpn13 homolog;, PF04683;PF16550;, GO:0005829;GO:0005654;GO:0005886;GO:0000502;GO:0008541;GO:0061133;GO:0002020;GO:0070628;GO:0043130;GO:0043248;GO:0016579;GO:0006368;GO:0006511;, C:cytosol; C:nucleoplasm; C:plasma membrane; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex;, F:endopeptidase activator activity; F:protease binding; F:proteasome binding; F:ubiquitin binding;, P:proteasome assembly; P:protein deubiquitination; P:transcription elongation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process;|Q16186 A0PKB1 Q96FJ7 Q9H1P2,Proteasomal ubiquitin receptor ADRM1,110 kDa cell membrane glycoprotein;Adhesion-regulating molecule 1;Proteasome regulatory particle non-ATPase 13;Rpn13 homolog;, PF04683;PF16550;, GO:0005829;GO:0005654;GO:0005886;GO:0000502;GO:0008541;GO:0061133;GO:0002020;GO:0070628;GO:0043130;GO:0043248;GO:0016579;GO:0006368;GO:0006511;, C:cytosol; C:nucleoplasm; C:plasma membrane; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex;, F:endopeptidase activator activity; F:protease binding; F:proteasome binding; F:ubiquitin binding;, P:proteasome assembly; P:protein deubiquitination; P:transcription elongation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process;|Q16186 A0PKB1 Q96FJ7 Q9H1P2,Proteasomal ubiquitin receptor ADRM1,110 kDa cell membrane glycoprotein;Adhesion-regulating molecule 1;Proteasome regulatory particle non-ATPase 13;Rpn13 homolog;, PF04683;PF16550;, GO:0005829;GO:0005654;GO:0005886;GO:0000502;GO:0008541;GO:0061133;GO:0002020;GO:0070628;GO:0043130;GO:0043248;GO:0016579;GO:0006368;GO:0006511;, C:cytosol; C:nucleoplasm; C:plasma membrane; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex;, F:endopeptidase activator activity; F:protease binding; F:proteasome binding; F:ubiquitin binding;, P:proteasome assembly; P:protein deubiquitination; P:transcription elongation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process;|Q16186 A0PKB1 Q96FJ7 Q9H1P2,Proteasomal ubiquitin receptor ADRM1,110 kDa cell membrane glycoprotein;Adhesion-regulating molecule 1;Proteasome regulatory particle non-ATPase 13;Rpn13 homolog;, PF04683;PF16550;, GO:0005829;GO:0005654;GO:0005886;GO:0000502;GO:0008541;GO:0061133;GO:0002020;GO:0070628;GO:0043130;GO:0043248;GO:0016579;GO:0006368;GO:0006511;, C:cytosol; C:nucleoplasm; C:plasma membrane; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex;, F:endopeptidase activator activity; F:protease binding; F:proteasome binding; F:ubiquitin binding;, P:proteasome assembly; P:protein deubiquitination; P:transcription elongation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process;|Q16186 A0PKB1 Q96FJ7 Q9H1P2,Proteasomal ubiquitin receptor ADRM1,110 kDa cell membrane glycoprotein;Adhesion-regulating molecule 1;Proteasome regulatory particle non-ATPase 13;Rpn13 homolog;, PF04683;PF16550;, GO:0005829;GO:0005654;GO:0005886;GO:0000502;GO:0008541;GO:0061133;GO:0002020;GO:0070628;GO:0043130;GO:0043248;GO:0016579;GO:0006368;GO:0006511;, C:cytosol; C:nucleoplasm; C:plasma membrane; C:proteasome complex; C:proteasome regulatory particle, lid subcomplex;, F:endopeptidase activator activity; F:protease binding; F:proteasome binding; F:ubiquitin binding;, P:proteasome assembly; P:protein deubiquitination; P:transcription elongation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process; scaffold110 indexed_genome mRNA 290850 294657 . - . ID=transcript_13297;Q9H1P3 A8K736 Q6IBT0 Q9BZB1 Q9Y4B8,Oxysterol-binding protein-related protein 2,, PF01237;, GO:0005829;GO:0031234;GO:0043231;GO:0005811;GO:0016020;GO:0015485;GO:0120020;GO:0008526;GO:0005546;GO:0032934;GO:0015248;GO:0006699;GO:0030301;GO:0032367;GO:0015914;GO:0007009;GO:0051289;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidylinositol transfer activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cholesterol transport; P:intracellular cholesterol transport; P:phospholipid transport; P:plasma membrane organization; P:protein homotetramerization; scaffold110 indexed_genome mRNA 294805 327448 . + . ID=transcript_13298;Q9H1P3 A8K736 Q6IBT0 Q9BZB1 Q9Y4B8,Oxysterol-binding protein-related protein 2,, PF01237;, GO:0005829;GO:0031234;GO:0043231;GO:0005811;GO:0016020;GO:0015485;GO:0120020;GO:0008526;GO:0005546;GO:0032934;GO:0015248;GO:0006699;GO:0030301;GO:0032367;GO:0015914;GO:0007009;GO:0051289;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidylinositol transfer activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cholesterol transport; P:intracellular cholesterol transport; P:phospholipid transport; P:plasma membrane organization; P:protein homotetramerization;|Q9H1P3 A8K736 Q6IBT0 Q9BZB1 Q9Y4B8,Oxysterol-binding protein-related protein 2,, PF01237;, GO:0005829;GO:0031234;GO:0043231;GO:0005811;GO:0016020;GO:0015485;GO:0120020;GO:0008526;GO:0005546;GO:0032934;GO:0015248;GO:0006699;GO:0030301;GO:0032367;GO:0015914;GO:0007009;GO:0051289;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidylinositol transfer activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cholesterol transport; P:intracellular cholesterol transport; P:phospholipid transport; P:plasma membrane organization; P:protein homotetramerization;|Q9H1P3 A8K736 Q6IBT0 Q9BZB1 Q9Y4B8,Oxysterol-binding protein-related protein 2,, PF01237;, GO:0005829;GO:0031234;GO:0043231;GO:0005811;GO:0016020;GO:0015485;GO:0120020;GO:0008526;GO:0005546;GO:0032934;GO:0015248;GO:0006699;GO:0030301;GO:0032367;GO:0015914;GO:0007009;GO:0051289;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidylinositol transfer activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cholesterol transport; P:intracellular cholesterol transport; P:phospholipid transport; P:plasma membrane organization; P:protein homotetramerization;|Q9H1P3 A8K736 Q6IBT0 Q9BZB1 Q9Y4B8,Oxysterol-binding protein-related protein 2,, PF01237;, GO:0005829;GO:0031234;GO:0043231;GO:0005811;GO:0016020;GO:0015485;GO:0120020;GO:0008526;GO:0005546;GO:0032934;GO:0015248;GO:0006699;GO:0030301;GO:0032367;GO:0015914;GO:0007009;GO:0051289;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidylinositol transfer activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cholesterol transport; P:intracellular cholesterol transport; P:phospholipid transport; P:plasma membrane organization; P:protein homotetramerization;|Q9H1P3 A8K736 Q6IBT0 Q9BZB1 Q9Y4B8,Oxysterol-binding protein-related protein 2,, PF01237;, GO:0005829;GO:0031234;GO:0043231;GO:0005811;GO:0016020;GO:0015485;GO:0120020;GO:0008526;GO:0005546;GO:0032934;GO:0015248;GO:0006699;GO:0030301;GO:0032367;GO:0015914;GO:0007009;GO:0051289;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane;, F:cholesterol binding; F:cholesterol transfer activity; F:phosphatidylinositol transfer activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:sterol binding; F:sterol transporter activity;, P:bile acid biosynthetic process; P:cholesterol transport; P:intracellular cholesterol transport; P:phospholipid transport; P:plasma membrane organization; P:protein homotetramerization; scaffold110 indexed_genome mRNA 357819 362225 . + . ID=transcript_13299;Q9Y5N1 Q4QRI7 Q9GZX2 Q9H4K8,Histamine H3 receptor,G-protein coupled receptor 97;, PF00001;, GO:0030425;GO:0005887;GO:0005886;GO:0098793;GO:0045202;GO:0016907;GO:0004993;GO:0004969;GO:0030594;GO:0007197;GO:0007268;GO:0050890;GO:0007187;GO:0014050;GO:0014063;GO:0007269;GO:0014061;, C:dendrite; C:integral component of plasma membrane; C:plasma membrane; C:presynapse; C:synapse;, F:G protein-coupled acetylcholine receptor activity; F:G protein-coupled serotonin receptor activity; F:histamine receptor activity; F:neurotransmitter receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway; P:chemical synaptic transmission; P:cognition; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:negative regulation of glutamate secretion; P:negative regulation of serotonin secretion; P:neurotransmitter secretion; P:regulation of norepinephrine secretion; scaffold110 indexed_genome mRNA 370301 371824 . - . ID=transcript_13300;Q9H4K7 A6NDR3 B4DR85 Q96I17 Q9NVG9 Q9UFR4,Mitochondrial ribosome-associated GTPase 2,GTP-binding protein 5;Protein obg homolog 1;, PF01018;PF01926;, GO:0005743;GO:0005759;GO:0005761;GO:0005739;GO:0005525;GO:0003924;GO:0000287;GO:0070129;GO:0044065;GO:0042254;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial ribosome; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:magnesium ion binding;, P:regulation of mitochondrial translation; P:regulation of respiratory system process; P:ribosome biogenesis; scaffold110 indexed_genome mRNA 378405 392035 . - . ID=transcript_13301;Q8NE69 Q9BR55 Q9H4K6,Calcium-responsive transactivator,SS18-like protein 1;SYT homolog 1;, PF05030;, GO:0000777;GO:0005829;GO:0000776;GO:0071565;GO:0016604;GO:0005654;GO:0005634;GO:0003713;GO:0006325;GO:0016358;GO:0050775;GO:0045944;GO:0045893;, C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:nBAF complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity;, P:chromatin organization; P:dendrite development; P:positive regulation of dendrite morphogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated;|Q8NE69 Q9BR55 Q9H4K6,Calcium-responsive transactivator,SS18-like protein 1;SYT homolog 1;, PF05030;, GO:0000777;GO:0005829;GO:0000776;GO:0071565;GO:0016604;GO:0005654;GO:0005634;GO:0003713;GO:0006325;GO:0016358;GO:0050775;GO:0045944;GO:0045893;, C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:nBAF complex; C:nuclear body; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity;, P:chromatin organization; P:dendrite development; P:positive regulation of dendrite morphogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; scaffold110 indexed_genome mRNA 419933 424056 . + . ID=transcript_13302;O14818 B2R515 Q5JXJ2 Q9BR53 Q9H4K5 Q9UEU8,Proteasome subunit alpha type-7,Proteasome subunit RC6-1;Proteasome subunit XAPC7;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0098794;GO:0000502;GO:0005839;GO:0019773;GO:0004175;GO:0042802;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:postsynapse; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex;, F:endopeptidase activity; F:identical protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|O14818 B2R515 Q5JXJ2 Q9BR53 Q9H4K5 Q9UEU8,Proteasome subunit alpha type-7,Proteasome subunit RC6-1;Proteasome subunit XAPC7;, PF00227;PF10584;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0098794;GO:0000502;GO:0005839;GO:0019773;GO:0004175;GO:0042802;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:postsynapse; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, alpha-subunit complex;, F:endopeptidase activity; F:identical protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold110 indexed_genome mRNA 424775 434781 . - . ID=transcript_13303;Q9BX40 Q6PFW8 Q96LH8,Protein LSM14 homolog B,RNA-associated protein 55B {ECO:0000303|PubMed:18723115};, PF09532;PF12701;, GO:0003729;GO:0003723;GO:0007275;GO:0006417;, , F:mRNA binding; F:RNA binding;, P:multicellular organism development; P:regulation of translation;|Q9BX40 Q6PFW8 Q96LH8,Protein LSM14 homolog B,RNA-associated protein 55B {ECO:0000303|PubMed:18723115};, PF09532;PF12701;, GO:0003729;GO:0003723;GO:0007275;GO:0006417;, , F:mRNA binding; F:RNA binding;, P:multicellular organism development; P:regulation of translation;|Q9BX40 Q6PFW8 Q96LH8,Protein LSM14 homolog B,RNA-associated protein 55B {ECO:0000303|PubMed:18723115};, PF09532;PF12701;, GO:0003729;GO:0003723;GO:0007275;GO:0006417;, , F:mRNA binding; F:RNA binding;, P:multicellular organism development; P:regulation of translation;|Q9BX40 Q6PFW8 Q96LH8,Protein LSM14 homolog B,RNA-associated protein 55B {ECO:0000303|PubMed:18723115};, PF09532;PF12701;, GO:0003729;GO:0003723;GO:0007275;GO:0006417;, , F:mRNA binding; F:RNA binding;, P:multicellular organism development; P:regulation of translation; scaffold110 indexed_genome mRNA 470825 532071 . + . ID=transcript_13304;O00268 A6NGD9 Q5TBP6 Q99721 Q9BR40 Q9BX42,Transcription initiation factor TFIID subunit 4,RNA polymerase II TBP-associated factor subunit C;TBP-associated factor 4;Transcription initiation factor TFIID 130 kDa subunit;Transcription initiation factor TFIID 135 kDa subunit;, PF05236;PF07531;, GO:0000785;GO:0005829;GO:0071339;GO:0005654;GO:0032991;GO:0005669;GO:0033276;GO:0017162;GO:0003677;GO:0046982;GO:0006352;GO:0001541;GO:1901796;GO:0006366;GO:0006367;GO:0016032;, C:chromatin; C:cytosol; C:MLL1 complex; C:nucleoplasm; C:protein-containing complex; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:protein heterodimerization activity;, P:DNA-templated transcription, initiation; P:ovarian follicle development; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:viral process;|O00268 A6NGD9 Q5TBP6 Q99721 Q9BR40 Q9BX42,Transcription initiation factor TFIID subunit 4,RNA polymerase II TBP-associated factor subunit C;TBP-associated factor 4;Transcription initiation factor TFIID 130 kDa subunit;Transcription initiation factor TFIID 135 kDa subunit;, PF05236;PF07531;, GO:0000785;GO:0005829;GO:0071339;GO:0005654;GO:0032991;GO:0005669;GO:0033276;GO:0017162;GO:0003677;GO:0046982;GO:0006352;GO:0001541;GO:1901796;GO:0006366;GO:0006367;GO:0016032;, C:chromatin; C:cytosol; C:MLL1 complex; C:nucleoplasm; C:protein-containing complex; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:protein heterodimerization activity;, P:DNA-templated transcription, initiation; P:ovarian follicle development; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:viral process; scaffold110 indexed_genome mRNA 549121 581698 . - . ID=transcript_13305;P55283 B3KWB8 G3V1P8 Q2M208 Q5VZ44 Q9BZ05,Cadherin-4,Retinal cadherin;, PF00028;PF01049;PF08758;, GO:0016342;GO:0005887;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0007411;GO:0007155;GO:0098742;GO:0007157;GO:0007156;GO:0045773;, C:catenin complex; C:integral component of plasma membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:axon guidance; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of axon extension;|P55283 B3KWB8 G3V1P8 Q2M208 Q5VZ44 Q9BZ05,Cadherin-4,Retinal cadherin;, PF00028;PF01049;PF08758;, GO:0016342;GO:0005887;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0007411;GO:0007155;GO:0098742;GO:0007157;GO:0007156;GO:0045773;, C:catenin complex; C:integral component of plasma membrane; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:adherens junction organization; P:axon guidance; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of axon extension; scaffold110 indexed_genome mRNA 1941333 1947532 . - . ID=transcript_13306;Q9NTX9 B3KWH1 Q9NTA3,Protein FAM217B,, PF15344;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold110 indexed_genome mRNA 2007438 2008327 . - . ID=transcript_13307;Q9BX26 A2RUE5 O75763 Q5JX11 Q9NTX8 Q9UG27,Synaptonemal complex protein 2,Synaptonemal complex lateral element protein;, PF18581;PF18584;, GO:0000800;GO:0005634;GO:0000795;GO:0003677;GO:0051301;GO:0007143;GO:0009566;GO:0048808;GO:0007140;GO:0140013;GO:0043066;GO:0007130;, C:lateral element; C:nucleus; C:synaptonemal complex;, F:DNA binding;, P:cell division; P:female meiotic nuclear division; P:fertilization; P:male genitalia morphogenesis; P:male meiotic nuclear division; P:meiotic nuclear division; P:negative regulation of apoptotic process; P:synaptonemal complex assembly; scaffold110 indexed_genome mRNA 2016057 2020759 . + . ID=transcript_13308;Q9BX26 A2RUE5 O75763 Q5JX11 Q9NTX8 Q9UG27,Synaptonemal complex protein 2,Synaptonemal complex lateral element protein;, PF18581;PF18584;, GO:0000800;GO:0005634;GO:0000795;GO:0003677;GO:0051301;GO:0007143;GO:0009566;GO:0048808;GO:0007140;GO:0140013;GO:0043066;GO:0007130;, C:lateral element; C:nucleus; C:synaptonemal complex;, F:DNA binding;, P:cell division; P:female meiotic nuclear division; P:fertilization; P:male genitalia morphogenesis; P:male meiotic nuclear division; P:meiotic nuclear division; P:negative regulation of apoptotic process; P:synaptonemal complex assembly;|Q9BX26 A2RUE5 O75763 Q5JX11 Q9NTX8 Q9UG27,Synaptonemal complex protein 2,Synaptonemal complex lateral element protein;, PF18581;PF18584;, GO:0000800;GO:0005634;GO:0000795;GO:0003677;GO:0051301;GO:0007143;GO:0009566;GO:0048808;GO:0007140;GO:0140013;GO:0043066;GO:0007130;, C:lateral element; C:nucleus; C:synaptonemal complex;, F:DNA binding;, P:cell division; P:female meiotic nuclear division; P:fertilization; P:male genitalia morphogenesis; P:male meiotic nuclear division; P:meiotic nuclear division; P:negative regulation of apoptotic process; P:synaptonemal complex assembly; scaffold110 indexed_genome mRNA 2026854 2214873 . - . ID=transcript_13309;Q96KR7 B1AKX0 B1AN68 B1AN69 B2RB46 Q32P33 Q707P6 Q9H4T4,Phosphatase and actin regulator 3,Scaffold-associated PP1-inhibiting protein;, PF02755;, GO:0016363;GO:0005654;GO:0003779;GO:0008157;GO:0004864;GO:0030036;, C:nuclear matrix; C:nucleoplasm;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin cytoskeleton organization;|Q96KR7 B1AKX0 B1AN68 B1AN69 B2RB46 Q32P33 Q707P6 Q9H4T4,Phosphatase and actin regulator 3,Scaffold-associated PP1-inhibiting protein;, PF02755;, GO:0016363;GO:0005654;GO:0003779;GO:0008157;GO:0004864;GO:0030036;, C:nuclear matrix; C:nucleoplasm;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin cytoskeleton organization;|Q96KR7 B1AKX0 B1AN68 B1AN69 B2RB46 Q32P33 Q707P6 Q9H4T4,Phosphatase and actin regulator 3,Scaffold-associated PP1-inhibiting protein;, PF02755;, GO:0016363;GO:0005654;GO:0003779;GO:0008157;GO:0004864;GO:0030036;, C:nuclear matrix; C:nucleoplasm;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin cytoskeleton organization;|Q96KR7 B1AKX0 B1AN68 B1AN69 B2RB46 Q32P33 Q707P6 Q9H4T4,Phosphatase and actin regulator 3,Scaffold-associated PP1-inhibiting protein;, PF02755;, GO:0016363;GO:0005654;GO:0003779;GO:0008157;GO:0004864;GO:0030036;, C:nuclear matrix; C:nucleoplasm;, F:actin binding; F:protein phosphatase 1 binding; F:protein phosphatase inhibitor activity;, P:actin cytoskeleton organization; scaffold110 indexed_genome mRNA 2404199 2424418 . - . ID=transcript_13310;P14138 E1P5I5 Q03229 Q7Z6D2 Q9UGT7,Endothelin-3,Preproendothelin-3;, PF00322;, GO:0005576;GO:0005615;GO:0031708;GO:0005179;GO:0005102;GO:0008015;GO:0007166;GO:0007267;GO:0006874;GO:0010961;GO:0007186;GO:0048016;GO:0030318;GO:0007275;GO:0001755;GO:0030182;GO:0030593;GO:0030072;GO:0045597;GO:0008284;GO:0010460;GO:0046887;GO:0002690;GO:0043406;GO:0045840;GO:1901381;GO:0060585;GO:0048070;GO:0010468;GO:0003100;GO:0019229;GO:0007165;GO:0042310;GO:0014826;, C:extracellular region; C:extracellular space;, F:endothelin B receptor binding; F:hormone activity; F:signaling receptor binding;, P:blood circulation; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cellular calcium ion homeostasis; P:cellular magnesium ion homeostasis; P:G protein-coupled receptor signaling pathway; P:inositol phosphate-mediated signaling; P:melanocyte differentiation; P:multicellular organism development; P:neural crest cell migration; P:neuron differentiation; P:neutrophil chemotaxis; P:peptide hormone secretion; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of heart rate; P:positive regulation of hormone secretion; P:positive regulation of leukocyte chemotaxis; P:positive regulation of MAP kinase activity; P:positive regulation of mitotic nuclear division; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:regulation of developmental pigmentation; P:regulation of gene expression; P:regulation of systemic arterial blood pressure by endothelin; P:regulation of vasoconstriction; P:signal transduction; P:vasoconstriction; P:vein smooth muscle contraction; scaffold110 indexed_genome mRNA 2424432 2425683 . - . ID=transcript_13311;P14138 E1P5I5 Q03229 Q7Z6D2 Q9UGT7,Endothelin-3,Preproendothelin-3;, PF00322;, GO:0005576;GO:0005615;GO:0031708;GO:0005179;GO:0005102;GO:0008015;GO:0007166;GO:0007267;GO:0006874;GO:0010961;GO:0007186;GO:0048016;GO:0030318;GO:0007275;GO:0001755;GO:0030182;GO:0030593;GO:0030072;GO:0045597;GO:0008284;GO:0010460;GO:0046887;GO:0002690;GO:0043406;GO:0045840;GO:1901381;GO:0060585;GO:0048070;GO:0010468;GO:0003100;GO:0019229;GO:0007165;GO:0042310;GO:0014826;, C:extracellular region; C:extracellular space;, F:endothelin B receptor binding; F:hormone activity; F:signaling receptor binding;, P:blood circulation; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cellular calcium ion homeostasis; P:cellular magnesium ion homeostasis; P:G protein-coupled receptor signaling pathway; P:inositol phosphate-mediated signaling; P:melanocyte differentiation; P:multicellular organism development; P:neural crest cell migration; P:neuron differentiation; P:neutrophil chemotaxis; P:peptide hormone secretion; P:positive regulation of cell differentiation; P:positive regulation of cell population proliferation; P:positive regulation of heart rate; P:positive regulation of hormone secretion; P:positive regulation of leukocyte chemotaxis; P:positive regulation of MAP kinase activity; P:positive regulation of mitotic nuclear division; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:regulation of developmental pigmentation; P:regulation of gene expression; P:regulation of systemic arterial blood pressure by endothelin; P:regulation of vasoconstriction; P:signal transduction; P:vasoconstriction; P:vein smooth muscle contraction; scaffold110 indexed_genome mRNA 2681601 2687494 . + . ID=transcript_13312;Q9Y3B1 E1P5I8 Q5JX17 Q9NUL0,PRELI domain containing protein 3B,Protein slowmo homolog 2;, PF04707;, GO:0005758;GO:1990050;GO:0015914;, C:mitochondrial intermembrane space;, F:phosphatidic acid transfer activity;, P:phospholipid transport;|Q9Y3B1 E1P5I8 Q5JX17 Q9NUL0,PRELI domain containing protein 3B,Protein slowmo homolog 2;, PF04707;, GO:0005758;GO:1990050;GO:0015914;, C:mitochondrial intermembrane space;, F:phosphatidic acid transfer activity;, P:phospholipid transport;|Q9Y3B1 E1P5I8 Q5JX17 Q9NUL0,PRELI domain containing protein 3B,Protein slowmo homolog 2;, PF04707;, GO:0005758;GO:1990050;GO:0015914;, C:mitochondrial intermembrane space;, F:phosphatidic acid transfer activity;, P:phospholipid transport; scaffold110 indexed_genome mRNA 2688831 2689769 . + . ID=transcript_13313;P56381 B2RDD0 E1P5H6 Q53XU6,ATP synthase subunit epsilon, mitochondrial {ECO:0000305},ATP synthase F1 subunit epsilon {ECO:0000312|HGNC:HGNC:838};, PF04627;, GO:0005743;GO:0005759;GO:0005753;GO:0000275;GO:0016787;GO:0046933;GO:0006754;GO:0042407;GO:0042776;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1);, F:hydrolase activity; F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; scaffold110 indexed_genome mRNA 2716114 2735871 . + . ID=transcript_13314;Q9UBR2 B2RC40 O75331 Q9UQV5 Q9UQV6,Cathepsin Z,Cathepsin P;Cathepsin X;, PF00112;, GO:0099738;GO:0062023;GO:0030134;GO:0031410;GO:0005783;GO:0005788;GO:0033116;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005764;GO:0005886;GO:0035580;GO:0004180;GO:0004197;GO:0008234;GO:0002003;GO:0048208;GO:0006888;GO:0010757;GO:0032091;GO:0043312;GO:0006508;GO:0051603;GO:1901214;, C:cell cortex region; C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosome; C:plasma membrane; C:specific granule lumen;, F:carboxypeptidase activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:angiotensin maturation; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of plasminogen activation; P:negative regulation of protein binding; P:neutrophil degranulation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of neuron death;|Q9UBR2 B2RC40 O75331 Q9UQV5 Q9UQV6,Cathepsin Z,Cathepsin P;Cathepsin X;, PF00112;, GO:0099738;GO:0062023;GO:0030134;GO:0031410;GO:0005783;GO:0005788;GO:0033116;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005764;GO:0005886;GO:0035580;GO:0004180;GO:0004197;GO:0008234;GO:0002003;GO:0048208;GO:0006888;GO:0010757;GO:0032091;GO:0043312;GO:0006508;GO:0051603;GO:1901214;, C:cell cortex region; C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosome; C:plasma membrane; C:specific granule lumen;, F:carboxypeptidase activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:angiotensin maturation; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of plasminogen activation; P:negative regulation of protein binding; P:neutrophil degranulation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of neuron death;|Q9UBR2 B2RC40 O75331 Q9UQV5 Q9UQV6,Cathepsin Z,Cathepsin P;Cathepsin X;, PF00112;, GO:0099738;GO:0062023;GO:0030134;GO:0031410;GO:0005783;GO:0005788;GO:0033116;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005764;GO:0005886;GO:0035580;GO:0004180;GO:0004197;GO:0008234;GO:0002003;GO:0048208;GO:0006888;GO:0010757;GO:0032091;GO:0043312;GO:0006508;GO:0051603;GO:1901214;, C:cell cortex region; C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosome; C:plasma membrane; C:specific granule lumen;, F:carboxypeptidase activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:angiotensin maturation; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of plasminogen activation; P:negative regulation of protein binding; P:neutrophil degranulation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of neuron death;|Q9UBR2 B2RC40 O75331 Q9UQV5 Q9UQV6,Cathepsin Z,Cathepsin P;Cathepsin X;, PF00112;, GO:0099738;GO:0062023;GO:0030134;GO:0031410;GO:0005783;GO:0005788;GO:0033116;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005764;GO:0005886;GO:0035580;GO:0004180;GO:0004197;GO:0008234;GO:0002003;GO:0048208;GO:0006888;GO:0010757;GO:0032091;GO:0043312;GO:0006508;GO:0051603;GO:1901214;, C:cell cortex region; C:collagen-containing extracellular matrix; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosome; C:plasma membrane; C:specific granule lumen;, F:carboxypeptidase activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:angiotensin maturation; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of plasminogen activation; P:negative regulation of protein binding; P:neutrophil degranulation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of neuron death;|Q9UGN2 Q9UGN3,Negative elongation factor C/D,TH1-like protein;, PF04858;, GO:0016020;GO:0032021;GO:0005654;GO:0003723;GO:0034244;GO:0050434;GO:0006366;GO:0006368;, C:membrane; C:NELF complex; C:nucleoplasm;, F:RNA binding;, P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9UGN2 Q9UGN3,Negative elongation factor C/D,TH1-like protein;, PF04858;, GO:0016020;GO:0032021;GO:0005654;GO:0003723;GO:0034244;GO:0050434;GO:0006366;GO:0006368;, C:membrane; C:NELF complex; C:nucleoplasm;, F:RNA binding;, P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9UGN2 Q9UGN3,Negative elongation factor C/D,TH1-like protein;, PF04858;, GO:0016020;GO:0032021;GO:0005654;GO:0003723;GO:0034244;GO:0050434;GO:0006366;GO:0006368;, C:membrane; C:NELF complex; C:nucleoplasm;, F:RNA binding;, P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9UGN2 Q9UGN3,Negative elongation factor C/D,TH1-like protein;, PF04858;, GO:0016020;GO:0032021;GO:0005654;GO:0003723;GO:0034244;GO:0050434;GO:0006366;GO:0006368;, C:membrane; C:NELF complex; C:nucleoplasm;, F:RNA binding;, P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9UGN2 Q9UGN3,Negative elongation factor C/D,TH1-like protein;, PF04858;, GO:0016020;GO:0032021;GO:0005654;GO:0003723;GO:0034244;GO:0050434;GO:0006366;GO:0006368;, C:membrane; C:NELF complex; C:nucleoplasm;, F:RNA binding;, P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9UGN2 Q9UGN3,Negative elongation factor C/D,TH1-like protein;, PF04858;, GO:0016020;GO:0032021;GO:0005654;GO:0003723;GO:0034244;GO:0050434;GO:0006366;GO:0006368;, C:membrane; C:NELF complex; C:nucleoplasm;, F:RNA binding;, P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold110 indexed_genome mRNA 2797521 2876351 . - . ID=transcript_13315;Q5JWF2 A2A2S3 E1P5G3 O75684 O75685 Q5JW67 Q5JWF1 Q9NY42,Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas,Adenylate cyclase-stimulating G alpha protein;Extra large alphas protein;, PF00503;, GO:0016324;GO:0005829;GO:0030425;GO:0070062;GO:0005834;GO:0016020;GO:0010856;GO:0031698;GO:0051430;GO:0031748;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0005159;GO:0035255;GO:0046872;GO:0031852;GO:0007191;GO:0007189;GO:0007188;GO:0060348;GO:0051216;GO:0048589;GO:0006306;GO:0048701;GO:0035116;GO:0001958;GO:0006112;GO:0071514;GO:0035264;GO:0070527;GO:0120162;GO:0045669;GO:0045672;GO:0040032;GO:2000828;GO:0042493;GO:0007606;GO:0043588;GO:0001894;, C:apical plasma membrane; C:cytosol; C:dendrite; C:extracellular exosome; C:heterotrimeric G-protein complex; C:membrane;, F:adenylate cyclase activator activity; F:beta-2 adrenergic receptor binding; F:corticotropin-releasing hormone receptor 1 binding; F:D1 dopamine receptor binding; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:insulin-like growth factor receptor binding; F:ionotropic glutamate receptor binding; F:metal ion binding; F:mu-type opioid receptor binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:bone development; P:cartilage development; P:developmental growth; P:DNA methylation; P:embryonic cranial skeleton morphogenesis; P:embryonic hindlimb morphogenesis; P:endochondral ossification; P:energy reserve metabolic process; P:genetic imprinting; P:multicellular organism growth; P:platelet aggregation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoclast differentiation; P:post-embryonic body morphogenesis; P:regulation of parathyroid hormone secretion; P:response to drug; P:sensory perception of chemical stimulus; P:skin development; P:tissue homeostasis;|Q5JWD5 Q6NR75 Q6NXS0 Q8TBC0 Q96H70,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,Adenylate cyclase-stimulating G alpha protein;, PF00503;, GO:0005737;GO:0005829;GO:0070062;GO:0005834;GO:0031224;GO:0016020;GO:0005886;GO:0032588;GO:0010856;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007190;GO:0071880;GO:0007191;GO:0007189;GO:0060348;GO:0071870;GO:0071377;GO:0071380;GO:0050890;GO:0048589;GO:0007186;GO:0060789;GO:0046907;GO:0002862;GO:0070527;GO:0043950;GO:0120162;GO:0043547;GO:0050796;GO:0003091;GO:0007608;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:heterotrimeric G-protein complex; C:intrinsic component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network membrane;, F:adenylate cyclase activator activity; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:bone development; P:cellular response to catecholamine stimulus; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cognition; P:developmental growth; P:G protein-coupled receptor signaling pathway; P:hair follicle placode formation; P:intracellular transport; P:negative regulation of inflammatory response to antigenic stimulus; P:platelet aggregation; P:positive regulation of cAMP-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of GTPase activity; P:regulation of insulin secretion; P:renal water homeostasis; P:sensory perception of smell;|Q5JWF2 A2A2S3 E1P5G3 O75684 O75685 Q5JW67 Q5JWF1 Q9NY42,Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas,Adenylate cyclase-stimulating G alpha protein;Extra large alphas protein;, PF00503;, GO:0016324;GO:0005829;GO:0030425;GO:0070062;GO:0005834;GO:0016020;GO:0010856;GO:0031698;GO:0051430;GO:0031748;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0005159;GO:0035255;GO:0046872;GO:0031852;GO:0007191;GO:0007189;GO:0007188;GO:0060348;GO:0051216;GO:0048589;GO:0006306;GO:0048701;GO:0035116;GO:0001958;GO:0006112;GO:0071514;GO:0035264;GO:0070527;GO:0120162;GO:0045669;GO:0045672;GO:0040032;GO:2000828;GO:0042493;GO:0007606;GO:0043588;GO:0001894;, C:apical plasma membrane; C:cytosol; C:dendrite; C:extracellular exosome; C:heterotrimeric G-protein complex; C:membrane;, F:adenylate cyclase activator activity; F:beta-2 adrenergic receptor binding; F:corticotropin-releasing hormone receptor 1 binding; F:D1 dopamine receptor binding; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:insulin-like growth factor receptor binding; F:ionotropic glutamate receptor binding; F:metal ion binding; F:mu-type opioid receptor binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:bone development; P:cartilage development; P:developmental growth; P:DNA methylation; P:embryonic cranial skeleton morphogenesis; P:embryonic hindlimb morphogenesis; P:endochondral ossification; P:energy reserve metabolic process; P:genetic imprinting; P:multicellular organism growth; P:platelet aggregation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoclast differentiation; P:post-embryonic body morphogenesis; P:regulation of parathyroid hormone secretion; P:response to drug; P:sensory perception of chemical stimulus; P:skin development; P:tissue homeostasis;|Q5JWD5 Q6NR75 Q6NXS0 Q8TBC0 Q96H70,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,Adenylate cyclase-stimulating G alpha protein;, PF00503;, GO:0005737;GO:0005829;GO:0070062;GO:0005834;GO:0031224;GO:0016020;GO:0005886;GO:0032588;GO:0010856;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007190;GO:0071880;GO:0007191;GO:0007189;GO:0060348;GO:0071870;GO:0071377;GO:0071380;GO:0050890;GO:0048589;GO:0007186;GO:0060789;GO:0046907;GO:0002862;GO:0070527;GO:0043950;GO:0120162;GO:0043547;GO:0050796;GO:0003091;GO:0007608;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:heterotrimeric G-protein complex; C:intrinsic component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network membrane;, F:adenylate cyclase activator activity; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:bone development; P:cellular response to catecholamine stimulus; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cognition; P:developmental growth; P:G protein-coupled receptor signaling pathway; P:hair follicle placode formation; P:intracellular transport; P:negative regulation of inflammatory response to antigenic stimulus; P:platelet aggregation; P:positive regulation of cAMP-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of GTPase activity; P:regulation of insulin secretion; P:renal water homeostasis; P:sensory perception of smell;|Q5JWF2 A2A2S3 E1P5G3 O75684 O75685 Q5JW67 Q5JWF1 Q9NY42,Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas,Adenylate cyclase-stimulating G alpha protein;Extra large alphas protein;, PF00503;, GO:0016324;GO:0005829;GO:0030425;GO:0070062;GO:0005834;GO:0016020;GO:0010856;GO:0031698;GO:0051430;GO:0031748;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0005159;GO:0035255;GO:0046872;GO:0031852;GO:0007191;GO:0007189;GO:0007188;GO:0060348;GO:0051216;GO:0048589;GO:0006306;GO:0048701;GO:0035116;GO:0001958;GO:0006112;GO:0071514;GO:0035264;GO:0070527;GO:0120162;GO:0045669;GO:0045672;GO:0040032;GO:2000828;GO:0042493;GO:0007606;GO:0043588;GO:0001894;, C:apical plasma membrane; C:cytosol; C:dendrite; C:extracellular exosome; C:heterotrimeric G-protein complex; C:membrane;, F:adenylate cyclase activator activity; F:beta-2 adrenergic receptor binding; F:corticotropin-releasing hormone receptor 1 binding; F:D1 dopamine receptor binding; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:insulin-like growth factor receptor binding; F:ionotropic glutamate receptor binding; F:metal ion binding; F:mu-type opioid receptor binding;, P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:bone development; P:cartilage development; P:developmental growth; P:DNA methylation; P:embryonic cranial skeleton morphogenesis; P:embryonic hindlimb morphogenesis; P:endochondral ossification; P:energy reserve metabolic process; P:genetic imprinting; P:multicellular organism growth; P:platelet aggregation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoclast differentiation; P:post-embryonic body morphogenesis; P:regulation of parathyroid hormone secretion; P:response to drug; P:sensory perception of chemical stimulus; P:skin development; P:tissue homeostasis;|Q5JWD5 Q6NR75 Q6NXS0 Q8TBC0 Q96H70,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,Adenylate cyclase-stimulating G alpha protein;, PF00503;, GO:0005737;GO:0005829;GO:0070062;GO:0005834;GO:0031224;GO:0016020;GO:0005886;GO:0032588;GO:0010856;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007190;GO:0071880;GO:0007191;GO:0007189;GO:0060348;GO:0071870;GO:0071377;GO:0071380;GO:0050890;GO:0048589;GO:0007186;GO:0060789;GO:0046907;GO:0002862;GO:0070527;GO:0043950;GO:0120162;GO:0043547;GO:0050796;GO:0003091;GO:0007608;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:heterotrimeric G-protein complex; C:intrinsic component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network membrane;, F:adenylate cyclase activator activity; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:bone development; P:cellular response to catecholamine stimulus; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cognition; P:developmental growth; P:G protein-coupled receptor signaling pathway; P:hair follicle placode formation; P:intracellular transport; P:negative regulation of inflammatory response to antigenic stimulus; P:platelet aggregation; P:positive regulation of cAMP-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of GTPase activity; P:regulation of insulin secretion; P:renal water homeostasis; P:sensory perception of smell;|O95467 B2RB88 E1P5G2 O95417,Neuroendocrine secretory protein 55,, PF06390;, GO:0005737;GO:0005576;GO:0005634;GO:0048471;GO:0030133;GO:0007565;GO:0040015;GO:0120162;GO:0009306;GO:0071107;, C:cytoplasm; C:extracellular region; C:nucleus; C:perinuclear region of cytoplasm; C:transport vesicle;, , P:female pregnancy; P:negative regulation of multicellular organism growth; P:positive regulation of cold-induced thermogenesis; P:protein secretion; P:response to parathyroid hormone;|Q5JWD5 Q6NR75 Q6NXS0 Q8TBC0 Q96H70,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,Adenylate cyclase-stimulating G alpha protein;, PF00503;, GO:0005737;GO:0005829;GO:0070062;GO:0005834;GO:0031224;GO:0016020;GO:0005886;GO:0032588;GO:0010856;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007190;GO:0071880;GO:0007191;GO:0007189;GO:0060348;GO:0071870;GO:0071377;GO:0071380;GO:0050890;GO:0048589;GO:0007186;GO:0060789;GO:0046907;GO:0002862;GO:0070527;GO:0043950;GO:0120162;GO:0043547;GO:0050796;GO:0003091;GO:0007608;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:heterotrimeric G-protein complex; C:intrinsic component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network membrane;, F:adenylate cyclase activator activity; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:activation of adenylate cyclase activity; P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:bone development; P:cellular response to catecholamine stimulus; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cognition; P:developmental growth; P:G protein-coupled receptor signaling pathway; P:hair follicle placode formation; P:intracellular transport; P:negative regulation of inflammatory response to antigenic stimulus; P:platelet aggregation; P:positive regulation of cAMP-mediated signaling; P:positive regulation of cold-induced thermogenesis; P:positive regulation of GTPase activity; P:regulation of insulin secretion; P:renal water homeostasis; P:sensory perception of smell; scaffold110 indexed_genome mRNA 3009069 3030374 . - . ID=transcript_13316;Q8WUI2 Q9H1T6 Q9HAI5,Probable aminopeptidase NPEPL1,Aminopeptidase-like 1;, PF18295;PF00883;, GO:0005737;GO:0005634;GO:0030145;GO:0070006;, C:cytoplasm; C:nucleus;, F:manganese ion binding; F:metalloaminopeptidase activity; scaffold110 indexed_genome mRNA 3044345 3051126 . - . ID=transcript_13317;Q9H1T7 Q9H1T8 Q9UIX5,Syntaxin-16,, PF05739;PF00804;, GO:0005737;GO:0005829;GO:0012505;GO:0005925;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0030285;GO:0043231;GO:0016020;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0005484;GO:0000149;GO:0019905;GO:0090161;GO:0006886;GO:0042147;GO:0048278;GO:0006906;, C:cytoplasm; C:cytosol; C:endomembrane system; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi ribbon formation; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion;|Q9H1T7 Q9H1T8 Q9UIX5,Syntaxin-16,, PF05739;PF00804;, GO:0005737;GO:0005829;GO:0012505;GO:0005925;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0030285;GO:0043231;GO:0016020;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0005484;GO:0000149;GO:0019905;GO:0090161;GO:0006886;GO:0042147;GO:0048278;GO:0006906;, C:cytoplasm; C:cytosol; C:endomembrane system; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi ribbon formation; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion;|Q9H1T7 Q9H1T8 Q9UIX5,Syntaxin-16,, PF05739;PF00804;, GO:0005737;GO:0005829;GO:0012505;GO:0005925;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0030285;GO:0043231;GO:0016020;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0005484;GO:0000149;GO:0019905;GO:0090161;GO:0006886;GO:0042147;GO:0048278;GO:0006906;, C:cytoplasm; C:cytosol; C:endomembrane system; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi ribbon formation; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion;|Q9H1T7 Q9H1T8 Q9UIX5,Syntaxin-16,, PF05739;PF00804;, GO:0005737;GO:0005829;GO:0012505;GO:0005925;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0030285;GO:0043231;GO:0016020;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0005484;GO:0000149;GO:0019905;GO:0090161;GO:0006886;GO:0042147;GO:0048278;GO:0006906;, C:cytoplasm; C:cytosol; C:endomembrane system; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi ribbon formation; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion;|Q9H1T7 Q9H1T8 Q9UIX5,Syntaxin-16,, PF05739;PF00804;, GO:0005737;GO:0005829;GO:0012505;GO:0005925;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0030285;GO:0043231;GO:0016020;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0005484;GO:0000149;GO:0019905;GO:0090161;GO:0006886;GO:0042147;GO:0048278;GO:0006906;, C:cytoplasm; C:cytosol; C:endomembrane system; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi ribbon formation; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion; scaffold110 indexed_genome mRNA 3051461 3067398 . - . ID=transcript_13318;Q9H1T7 Q9H1T8 Q9UIX5,Syntaxin-16,, PF05739;PF00804;, GO:0005737;GO:0005829;GO:0012505;GO:0005925;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0030285;GO:0043231;GO:0016020;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0005484;GO:0000149;GO:0019905;GO:0090161;GO:0006886;GO:0042147;GO:0048278;GO:0006906;, C:cytoplasm; C:cytosol; C:endomembrane system; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi ribbon formation; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion;|Q9H1T7 Q9H1T8 Q9UIX5,Syntaxin-16,, PF05739;PF00804;, GO:0005737;GO:0005829;GO:0012505;GO:0005925;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0030285;GO:0043231;GO:0016020;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0005484;GO:0000149;GO:0019905;GO:0090161;GO:0006886;GO:0042147;GO:0048278;GO:0006906;, C:cytoplasm; C:cytosol; C:endomembrane system; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi ribbon formation; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion;|Q9H1T7 Q9H1T8 Q9UIX5,Syntaxin-16,, PF05739;PF00804;, GO:0005737;GO:0005829;GO:0012505;GO:0005925;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0030285;GO:0043231;GO:0016020;GO:0048471;GO:0031201;GO:0005802;GO:0032588;GO:0005484;GO:0000149;GO:0019905;GO:0090161;GO:0006886;GO:0042147;GO:0048278;GO:0006906;, C:cytoplasm; C:cytosol; C:endomembrane system; C:focal adhesion; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:SNARE complex; C:trans-Golgi network; C:trans-Golgi network membrane;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:Golgi ribbon formation; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion; scaffold110 indexed_genome mRNA 3265796 3270707 . + . ID=transcript_13319;O95292 A2A2F2 O95293 Q9P0H0,Vesicle-associated membrane protein-associated protein B/C,, PF00635;, GO:0005737;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005886;GO:0048487;GO:0045296;GO:0019899;GO:0033149;GO:0008017;GO:0046982;GO:0042803;GO:0006874;GO:0090114;GO:0090158;GO:0007029;GO:0006888;GO:0030968;GO:0061817;GO:0036498;GO:0044830;GO:0019048;GO:0044828;GO:0044790;GO:0046725;GO:0044829;GO:0044791;GO:0045070;GO:0030148;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:beta-tubulin binding; F:cadherin binding; F:enzyme binding; F:FFAT motif binding; F:microtubule binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:cellular calcium ion homeostasis; P:COPII-coated vesicle budding; P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum unfolded protein response; P:endoplasmic reticulum-plasma membrane tethering; P:IRE1-mediated unfolded protein response; P:modulation by host of viral RNA genome replication; P:modulation by virus of host process; P:negative regulation by host of viral genome replication; P:negative regulation by host of viral release from host cell; P:negative regulation by virus of viral protein levels in host cell; P:positive regulation by host of viral genome replication; P:positive regulation by host of viral release from host cell; P:positive regulation of viral genome replication; P:sphingolipid biosynthetic process;|O95292 A2A2F2 O95293 Q9P0H0,Vesicle-associated membrane protein-associated protein B/C,, PF00635;, GO:0005737;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005886;GO:0048487;GO:0045296;GO:0019899;GO:0033149;GO:0008017;GO:0046982;GO:0042803;GO:0006874;GO:0090114;GO:0090158;GO:0007029;GO:0006888;GO:0030968;GO:0061817;GO:0036498;GO:0044830;GO:0019048;GO:0044828;GO:0044790;GO:0046725;GO:0044829;GO:0044791;GO:0045070;GO:0030148;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:beta-tubulin binding; F:cadherin binding; F:enzyme binding; F:FFAT motif binding; F:microtubule binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:cellular calcium ion homeostasis; P:COPII-coated vesicle budding; P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum unfolded protein response; P:endoplasmic reticulum-plasma membrane tethering; P:IRE1-mediated unfolded protein response; P:modulation by host of viral RNA genome replication; P:modulation by virus of host process; P:negative regulation by host of viral genome replication; P:negative regulation by host of viral release from host cell; P:negative regulation by virus of viral protein levels in host cell; P:positive regulation by host of viral genome replication; P:positive regulation by host of viral release from host cell; P:positive regulation of viral genome replication; P:sphingolipid biosynthetic process; scaffold110 indexed_genome mRNA 3271160 3271898 . - . ID=transcript_13320;O95292 A2A2F2 O95293 Q9P0H0,Vesicle-associated membrane protein-associated protein B/C,, PF00635;, GO:0005737;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005886;GO:0048487;GO:0045296;GO:0019899;GO:0033149;GO:0008017;GO:0046982;GO:0042803;GO:0006874;GO:0090114;GO:0090158;GO:0007029;GO:0006888;GO:0030968;GO:0061817;GO:0036498;GO:0044830;GO:0019048;GO:0044828;GO:0044790;GO:0046725;GO:0044829;GO:0044791;GO:0045070;GO:0030148;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:beta-tubulin binding; F:cadherin binding; F:enzyme binding; F:FFAT motif binding; F:microtubule binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:cellular calcium ion homeostasis; P:COPII-coated vesicle budding; P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endoplasmic reticulum unfolded protein response; P:endoplasmic reticulum-plasma membrane tethering; P:IRE1-mediated unfolded protein response; P:modulation by host of viral RNA genome replication; P:modulation by virus of host process; P:negative regulation by host of viral genome replication; P:negative regulation by host of viral release from host cell; P:negative regulation by virus of viral protein levels in host cell; P:positive regulation by host of viral genome replication; P:positive regulation by host of viral release from host cell; P:positive regulation of viral genome replication; P:sphingolipid biosynthetic process; scaffold110 indexed_genome mRNA 3339707 3340732 . - . ID=transcript_13321;Q9UL26 B3KR86 E1P605 Q8TF12 Q9H4E6,Ras-related protein Rab-22A,, PF00071;, GO:0015629;GO:0005769;GO:0012505;GO:0010008;GO:0070062;GO:0005770;GO:0045335;GO:0030670;GO:0005886;GO:0001726;GO:0019003;GO:0005525;GO:0003924;GO:0006897;GO:0007032;GO:0006886;GO:0097494;, C:actin cytoskeleton; C:early endosome; C:endomembrane system; C:endosome membrane; C:extracellular exosome; C:late endosome; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:ruffle;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:endocytosis; P:endosome organization; P:intracellular protein transport; P:regulation of vesicle size; scaffold110 indexed_genome mRNA 3423267 3449598 . + . ID=transcript_13322;Q8TF05 Q99774 Q9UNQ7,Serine/threonine-protein phosphatase 4 regulatory subunit 1,, PF02985;PF15017;, GO:0030289;GO:0008287;GO:0019888;GO:0006470;GO:0006468;GO:0007165;, C:protein phosphatase 4 complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:protein dephosphorylation; P:protein phosphorylation; P:signal transduction; scaffold110 indexed_genome mRNA 3450088 3451001 . + . ID=transcript_13323;Q8TF05 Q99774 Q9UNQ7,Serine/threonine-protein phosphatase 4 regulatory subunit 1,, PF02985;PF15017;, GO:0030289;GO:0008287;GO:0019888;GO:0006470;GO:0006468;GO:0007165;, C:protein phosphatase 4 complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:protein dephosphorylation; P:protein phosphorylation; P:signal transduction; scaffold110 indexed_genome mRNA 3452579 3453098 . - . ID=transcript_13324;Q8TF05 Q99774 Q9UNQ7,Serine/threonine-protein phosphatase 4 regulatory subunit 1,, PF02985;PF15017;, GO:0030289;GO:0008287;GO:0019888;GO:0006470;GO:0006468;GO:0007165;, C:protein phosphatase 4 complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:protein dephosphorylation; P:protein phosphorylation; P:signal transduction; scaffold110 indexed_genome mRNA 3455952 3456531 . + . ID=transcript_13325;Q8TF05 Q99774 Q9UNQ7,Serine/threonine-protein phosphatase 4 regulatory subunit 1,, PF02985;PF15017;, GO:0030289;GO:0008287;GO:0019888;GO:0006470;GO:0006468;GO:0007165;, C:protein phosphatase 4 complex; C:protein serine/threonine phosphatase complex;, F:protein phosphatase regulator activity;, P:protein dephosphorylation; P:protein phosphorylation; P:signal transduction; scaffold111 indexed_genome mRNA 52700 167683 . + . ID=transcript_13326;Q9ULE0 A8KA96 Q659C1 Q9BTQ1,Protein WWC3,, , GO:0005829;GO:0019900;GO:0060090;GO:0035331;GO:0046621;GO:0000122;, C:cytosol;, F:kinase binding; F:molecular adaptor activity;, P:negative regulation of hippo signaling; P:negative regulation of organ growth; P:negative regulation of transcription by RNA polymerase II; scaffold111 indexed_genome mRNA 179390 250916 . + . ID=transcript_13327;P51793 A1L3U1 B7Z5Z4 Q9UBU1,H(+)/Cl(-) exchange transporter 4,Chloride channel protein 4;Chloride transporter ClC-4;, PF00571;PF00654;, GO:0005769;GO:0031901;GO:0005789;GO:0010008;GO:0005794;GO:0005887;GO:0031902;GO:0005765;GO:0055037;GO:0055038;GO:0008021;GO:0015297;GO:0005524;GO:0005254;GO:0015299;GO:0005247;GO:0006821;GO:0034220;, C:early endosome; C:early endosome membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:recycling endosome; C:recycling endosome membrane; C:synaptic vesicle;, F:antiporter activity; F:ATP binding; F:chloride channel activity; F:solute:proton antiporter activity; F:voltage-gated chloride channel activity;, P:chloride transport; P:ion transmembrane transport;|P51793 A1L3U1 B7Z5Z4 Q9UBU1,H(+)/Cl(-) exchange transporter 4,Chloride channel protein 4;Chloride transporter ClC-4;, PF00571;PF00654;, GO:0005769;GO:0031901;GO:0005789;GO:0010008;GO:0005794;GO:0005887;GO:0031902;GO:0005765;GO:0055037;GO:0055038;GO:0008021;GO:0015297;GO:0005524;GO:0005254;GO:0015299;GO:0005247;GO:0006821;GO:0034220;, C:early endosome; C:early endosome membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome membrane; C:lysosomal membrane; C:recycling endosome; C:recycling endosome membrane; C:synaptic vesicle;, F:antiporter activity; F:ATP binding; F:chloride channel activity; F:solute:proton antiporter activity; F:voltage-gated chloride channel activity;, P:chloride transport; P:ion transmembrane transport; scaffold111 indexed_genome mRNA 498666 516326 . - . ID=transcript_13328;O15344 B2RCG2 O75361 Q9BZX5,E3 ubiquitin-protein ligase Midline-1,Midin;Putative transcription factor XPRF;RING finger protein 59;RING finger protein Midline-1;RING-type E3 ubiquitin transferase Midline-1 {ECO:0000305};Tripartite motif-containing protein 18;, PF18568;PF00041;PF13765;PF00622;PF00643;PF13445;, GO:0005829;GO:0005874;GO:0005875;GO:0005819;GO:0019899;GO:0042802;GO:0008017;GO:0051219;GO:0042803;GO:0016740;GO:0031625;GO:0008270;GO:0060333;GO:0000226;GO:0007389;GO:0032874;GO:0035372;, C:cytosol; C:microtubule; C:microtubule associated complex; C:spindle;, F:enzyme binding; F:identical protein binding; F:microtubule binding; F:phosphoprotein binding; F:protein homodimerization activity; F:transferase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:interferon-gamma-mediated signaling pathway; P:microtubule cytoskeleton organization; P:pattern specification process; P:positive regulation of stress-activated MAPK cascade; P:protein localization to microtubule; scaffold111 indexed_genome mRNA 516357 578613 . - . ID=transcript_13329;O15344 B2RCG2 O75361 Q9BZX5,E3 ubiquitin-protein ligase Midline-1,Midin;Putative transcription factor XPRF;RING finger protein 59;RING finger protein Midline-1;RING-type E3 ubiquitin transferase Midline-1 {ECO:0000305};Tripartite motif-containing protein 18;, PF18568;PF00041;PF13765;PF00622;PF00643;PF13445;, GO:0005829;GO:0005874;GO:0005875;GO:0005819;GO:0019899;GO:0042802;GO:0008017;GO:0051219;GO:0042803;GO:0016740;GO:0031625;GO:0008270;GO:0060333;GO:0000226;GO:0007389;GO:0032874;GO:0035372;, C:cytosol; C:microtubule; C:microtubule associated complex; C:spindle;, F:enzyme binding; F:identical protein binding; F:microtubule binding; F:phosphoprotein binding; F:protein homodimerization activity; F:transferase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:interferon-gamma-mediated signaling pathway; P:microtubule cytoskeleton organization; P:pattern specification process; P:positive regulation of stress-activated MAPK cascade; P:protein localization to microtubule; scaffold111 indexed_genome mRNA 1178848 1188535 . + . ID=transcript_13330;P53701 B3KUS1 Q502X8,Holocytochrome c-type synthase {ECO:0000305|PubMed:23150584, ECO:0000305|PubMed:8661044},Cytochrome c-type heme lyase {ECO:0000305|PubMed:23150584};, PF01265;, GO:0016020;GO:0005743;GO:0005739;GO:0020037;GO:0004408;GO:0046872;GO:0009887;GO:0018063;, C:membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:heme binding; F:holocytochrome-c synthase activity; F:metal ion binding;, P:animal organ morphogenesis; P:cytochrome c-heme linkage;|P53701 B3KUS1 Q502X8,Holocytochrome c-type synthase {ECO:0000305|PubMed:23150584, ECO:0000305|PubMed:8661044},Cytochrome c-type heme lyase {ECO:0000305|PubMed:23150584};, PF01265;, GO:0016020;GO:0005743;GO:0005739;GO:0020037;GO:0004408;GO:0046872;GO:0009887;GO:0018063;, C:membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:heme binding; F:holocytochrome-c synthase activity; F:metal ion binding;, P:animal organ morphogenesis; P:cytochrome c-heme linkage;|P53701 B3KUS1 Q502X8,Holocytochrome c-type synthase {ECO:0000305|PubMed:23150584, ECO:0000305|PubMed:8661044},Cytochrome c-type heme lyase {ECO:0000305|PubMed:23150584};, PF01265;, GO:0016020;GO:0005743;GO:0005739;GO:0020037;GO:0004408;GO:0046872;GO:0009887;GO:0018063;, C:membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:heme binding; F:holocytochrome-c synthase activity; F:metal ion binding;, P:animal organ morphogenesis; P:cytochrome c-heme linkage; scaffold111 indexed_genome mRNA 1199663 1259489 . - . ID=transcript_13331;O43182 B2RWQ0 O43437 Q9P1B3 Q9UK81 Q9UK82,Rho GTPase-activating protein 6,Rho-type GTPase-activating protein 6;Rho-type GTPase-activating protein RhoGAPX-1;, PF00620;, GO:0015629;GO:0005884;GO:0005737;GO:0005829;GO:0005096;GO:0016004;GO:0043274;GO:0017124;GO:0030041;GO:0007202;GO:0048041;GO:0051895;GO:0051497;GO:0010518;GO:0051056;GO:0007266;, C:actin cytoskeleton; C:actin filament; C:cytoplasm; C:cytosol;, F:GTPase activator activity; F:phospholipase activator activity; F:phospholipase binding; F:SH3 domain binding;, P:actin filament polymerization; P:activation of phospholipase C activity; P:focal adhesion assembly; P:negative regulation of focal adhesion assembly; P:negative regulation of stress fiber assembly; P:positive regulation of phospholipase activity; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold111 indexed_genome mRNA 1806636 1821206 . + . ID=transcript_13332;Q8N5Y2 A6NCU2 A6NHW8 A8K165 B4DUV8 B7Z227 Q9UG70 Q9Y5Z8,Male-specific lethal 3 homolog,Male-specific lethal-3 homolog 1;Male-specific lethal-3 protein-like 1;, PF05712;PF11717;, GO:0000123;GO:0072487;GO:0035267;GO:0005654;GO:0005634;GO:0003677;GO:0046972;GO:0035064;GO:0006342;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0043984;GO:0006355;, C:histone acetyltransferase complex; C:MSL complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone acetyltransferase activity (H4-K16 specific); F:methylated histone binding;, P:chromatin silencing; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:histone H4-K16 acetylation; P:regulation of transcription, DNA-templated;|Q8N5Y2 A6NCU2 A6NHW8 A8K165 B4DUV8 B7Z227 Q9UG70 Q9Y5Z8,Male-specific lethal 3 homolog,Male-specific lethal-3 homolog 1;Male-specific lethal-3 protein-like 1;, PF05712;PF11717;, GO:0000123;GO:0072487;GO:0035267;GO:0005654;GO:0005634;GO:0003677;GO:0046972;GO:0035064;GO:0006342;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0043984;GO:0006355;, C:histone acetyltransferase complex; C:MSL complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone acetyltransferase activity (H4-K16 specific); F:methylated histone binding;, P:chromatin silencing; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:histone H4-K16 acetylation; P:regulation of transcription, DNA-templated;|Q8N5Y2 A6NCU2 A6NHW8 A8K165 B4DUV8 B7Z227 Q9UG70 Q9Y5Z8,Male-specific lethal 3 homolog,Male-specific lethal-3 homolog 1;Male-specific lethal-3 protein-like 1;, PF05712;PF11717;, GO:0000123;GO:0072487;GO:0035267;GO:0005654;GO:0005634;GO:0003677;GO:0046972;GO:0035064;GO:0006342;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0043984;GO:0006355;, C:histone acetyltransferase complex; C:MSL complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone acetyltransferase activity (H4-K16 specific); F:methylated histone binding;, P:chromatin silencing; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:histone H4-K16 acetylation; P:regulation of transcription, DNA-templated;|Q8N5Y2 A6NCU2 A6NHW8 A8K165 B4DUV8 B7Z227 Q9UG70 Q9Y5Z8,Male-specific lethal 3 homolog,Male-specific lethal-3 homolog 1;Male-specific lethal-3 protein-like 1;, PF05712;PF11717;, GO:0000123;GO:0072487;GO:0035267;GO:0005654;GO:0005634;GO:0003677;GO:0046972;GO:0035064;GO:0006342;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0043984;GO:0006355;, C:histone acetyltransferase complex; C:MSL complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone acetyltransferase activity (H4-K16 specific); F:methylated histone binding;, P:chromatin silencing; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:histone H4-K16 acetylation; P:regulation of transcription, DNA-templated; scaffold111 indexed_genome mRNA 2315459 2316122 . + . ID=transcript_13333;Q9UQR0 Q5JXE6 Q86U98 Q8IWD0 Q8NDP2 Q9UGC5,Sex comb on midleg-like protein 2,, PF02820;PF17208;PF00536;PF12140;, GO:0005634;GO:0031519;GO:0003682;GO:0042393;GO:0009653;GO:0045892;, C:nucleus; C:PcG protein complex;, F:chromatin binding; F:histone binding;, P:anatomical structure morphogenesis; P:negative regulation of transcription, DNA-templated; scaffold111 indexed_genome mRNA 2382526 2390220 . + . ID=transcript_13334;Q9UQR0 Q5JXE6 Q86U98 Q8IWD0 Q8NDP2 Q9UGC5,Sex comb on midleg-like protein 2,, PF02820;PF17208;PF00536;PF12140;, GO:0005634;GO:0031519;GO:0003682;GO:0042393;GO:0009653;GO:0045892;, C:nucleus; C:PcG protein complex;, F:chromatin binding; F:histone binding;, P:anatomical structure morphogenesis; P:negative regulation of transcription, DNA-templated;|Q9UQR0 Q5JXE6 Q86U98 Q8IWD0 Q8NDP2 Q9UGC5,Sex comb on midleg-like protein 2,, PF02820;PF17208;PF00536;PF12140;, GO:0005634;GO:0031519;GO:0003682;GO:0042393;GO:0009653;GO:0045892;, C:nucleus; C:PcG protein complex;, F:chromatin binding; F:histone binding;, P:anatomical structure morphogenesis; P:negative regulation of transcription, DNA-templated;|Q9UQR0 Q5JXE6 Q86U98 Q8IWD0 Q8NDP2 Q9UGC5,Sex comb on midleg-like protein 2,, PF02820;PF17208;PF00536;PF12140;, GO:0005634;GO:0031519;GO:0003682;GO:0042393;GO:0009653;GO:0045892;, C:nucleus; C:PcG protein complex;, F:chromatin binding; F:histone binding;, P:anatomical structure morphogenesis; P:negative regulation of transcription, DNA-templated; scaffold111 indexed_genome mRNA 2725430 2790733 . + . ID=transcript_13335;Q9Y5P3 B1B1K2 B4DQM9 E7EMN4 Q8N6X7,Retinoic acid-induced protein 2,, PF15279;, GO:0009792;, , , P:embryo development ending in birth or egg hatching; scaffold111 indexed_genome mRNA 2816879 2823532 . - . ID=transcript_13336;Q9UQR0 Q5JXE6 Q86U98 Q8IWD0 Q8NDP2 Q9UGC5,Sex comb on midleg-like protein 2,, PF02820;PF17208;PF00536;PF12140;, GO:0005634;GO:0031519;GO:0003682;GO:0042393;GO:0009653;GO:0045892;, C:nucleus; C:PcG protein complex;, F:chromatin binding; F:histone binding;, P:anatomical structure morphogenesis; P:negative regulation of transcription, DNA-templated;|Q9UN30 B0FZN6 B2RA08 Q5H968 Q5H969,Sex comb on midleg-like protein 1,, PF00536;, GO:0005634;GO:0003682;GO:0042393;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding;, P:negative regulation of transcription, DNA-templated; scaffold111 indexed_genome mRNA 2838505 2841844 . - . ID=transcript_13337;Q6T4R5 B7ZVX8 E2DH69 Q5J7Q0 Q5J7Q1 Q68DR5,Nance-Horan syndrome protein,Congenital cataracts and dental anomalies protein;, PF15273;, GO:0016324;GO:0005923;GO:0030054;GO:0005925;GO:0005794;GO:0030027;GO:0016604;GO:0030154;GO:0002088;, C:apical plasma membrane; C:bicellular tight junction; C:cell junction; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:nuclear body;, , P:cell differentiation; P:lens development in camera-type eye; scaffold111 indexed_genome mRNA 2842287 2842988 . + . ID=transcript_13338;Q6T4R5 B7ZVX8 E2DH69 Q5J7Q0 Q5J7Q1 Q68DR5,Nance-Horan syndrome protein,Congenital cataracts and dental anomalies protein;, PF15273;, GO:0016324;GO:0005923;GO:0030054;GO:0005925;GO:0005794;GO:0030027;GO:0016604;GO:0030154;GO:0002088;, C:apical plasma membrane; C:bicellular tight junction; C:cell junction; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:nuclear body;, , P:cell differentiation; P:lens development in camera-type eye; scaffold111 indexed_genome mRNA 2843170 2844227 . + . ID=transcript_13339;Q6T4R5 B7ZVX8 E2DH69 Q5J7Q0 Q5J7Q1 Q68DR5,Nance-Horan syndrome protein,Congenital cataracts and dental anomalies protein;, PF15273;, GO:0016324;GO:0005923;GO:0030054;GO:0005925;GO:0005794;GO:0030027;GO:0016604;GO:0030154;GO:0002088;, C:apical plasma membrane; C:bicellular tight junction; C:cell junction; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:nuclear body;, , P:cell differentiation; P:lens development in camera-type eye; scaffold111 indexed_genome mRNA 2844504 2846378 . - . ID=transcript_13340;Q6T4R5 B7ZVX8 E2DH69 Q5J7Q0 Q5J7Q1 Q68DR5,Nance-Horan syndrome protein,Congenital cataracts and dental anomalies protein;, PF15273;, GO:0016324;GO:0005923;GO:0030054;GO:0005925;GO:0005794;GO:0030027;GO:0016604;GO:0030154;GO:0002088;, C:apical plasma membrane; C:bicellular tight junction; C:cell junction; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:nuclear body;, , P:cell differentiation; P:lens development in camera-type eye; scaffold111 indexed_genome mRNA 3370768 3437020 . - . ID=transcript_13341;Q8NFH8 A6PWZ6 O43428 Q5JNZ8 Q8NFI5,RalBP1-associated Eps domain-containing protein 2,Partner of RalBP1;RalBP1-interacting protein 2;, PF12763;, GO:0005829;GO:0005509;GO:0006897;GO:0016197;GO:0007173;GO:0061024;GO:0065003;, C:cytosol;, F:calcium ion binding;, P:endocytosis; P:endosomal transport; P:epidermal growth factor receptor signaling pathway; P:membrane organization; P:protein-containing complex assembly; scaffold111 indexed_genome mRNA 3464436 3542543 . - . ID=transcript_13342;Q8NFH8 A6PWZ6 O43428 Q5JNZ8 Q8NFI5,RalBP1-associated Eps domain-containing protein 2,Partner of RalBP1;RalBP1-interacting protein 2;, PF12763;, GO:0005829;GO:0005509;GO:0006897;GO:0016197;GO:0007173;GO:0061024;GO:0065003;, C:cytosol;, F:calcium ion binding;, P:endocytosis; P:endosomal transport; P:epidermal growth factor receptor signaling pathway; P:membrane organization; P:protein-containing complex assembly; scaffold112 indexed_genome mRNA 6030 15817 . - . ID=transcript_13343;O14641 D3DTN3 Q53XM0,Segment polarity protein dishevelled homolog DVL-2,DSH homolog 2;, PF00610;PF02377;PF00778;PF12316;PF00595;, GO:0016235;GO:0045177;GO:0045334;GO:0005737;GO:0031410;GO:0005829;GO:0016328;GO:0016604;GO:0005654;GO:0005634;GO:0005109;GO:0042802;GO:0019904;GO:0019901;GO:0043621;GO:0030674;GO:0031267;GO:1904886;GO:0060070;GO:0044340;GO:0034613;GO:0090103;GO:0022007;GO:0007507;GO:0035329;GO:0061024;GO:0090090;GO:0001843;GO:0035567;GO:0003151;GO:0090179;GO:0031343;GO:0051091;GO:0043547;GO:0043507;GO:0150012;GO:0001934;GO:0061098;GO:0045944;GO:0006355;GO:0007379;GO:0060071;, C:aggresome; C:apical part of cell; C:clathrin-coated endocytic vesicle; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lateral plasma membrane; C:nuclear body; C:nucleoplasm; C:nucleus;, F:frizzled binding; F:identical protein binding; F:protein domain specific binding; F:protein kinase binding; F:protein self-association; F:protein-macromolecule adaptor activity; F:small GTPase binding;, P:beta-catenin destruction complex disassembly; P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in regulation of cell proliferation; P:cellular protein localization; P:cochlea morphogenesis; P:convergent extension involved in neural plate elongation; P:heart development; P:hippo signaling; P:membrane organization; P:negative regulation of canonical Wnt signaling pathway; P:neural tube closure; P:non-canonical Wnt signaling pathway; P:outflow tract morphogenesis; P:planar cell polarity pathway involved in neural tube closure; P:positive regulation of cell killing; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of GTPase activity; P:positive regulation of JUN kinase activity; P:positive regulation of neuron projection arborization; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:segment specification; P:Wnt signaling pathway, planar cell polarity pathway;|P49748 B4DEB6 F5H2A9 O76056 Q8WUL0,Very long-chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:7668252},, PF00441;PF02770;PF02771;, GO:0031314;GO:0005759;GO:0031966;GO:0042645;GO:0005739;GO:0005730;GO:0005654;GO:0003995;GO:0000062;GO:0050660;GO:0042802;GO:0004466;GO:0017099;GO:0015980;GO:0030855;GO:0006635;GO:0033539;GO:0036498;GO:0045717;GO:0046322;GO:0090181;GO:0009409;GO:0001659;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:acyl-CoA dehydrogenase activity; F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:identical protein binding; F:long-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:energy derivation by oxidation of organic compounds; P:epithelial cell differentiation; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:IRE1-mediated unfolded protein response; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of fatty acid oxidation; P:regulation of cholesterol metabolic process; P:response to cold; P:temperature homeostasis;|P49748 B4DEB6 F5H2A9 O76056 Q8WUL0,Very long-chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:7668252},, PF00441;PF02770;PF02771;, GO:0031314;GO:0005759;GO:0031966;GO:0042645;GO:0005739;GO:0005730;GO:0005654;GO:0003995;GO:0000062;GO:0050660;GO:0042802;GO:0004466;GO:0017099;GO:0015980;GO:0030855;GO:0006635;GO:0033539;GO:0036498;GO:0045717;GO:0046322;GO:0090181;GO:0009409;GO:0001659;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:acyl-CoA dehydrogenase activity; F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:identical protein binding; F:long-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:energy derivation by oxidation of organic compounds; P:epithelial cell differentiation; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:IRE1-mediated unfolded protein response; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of fatty acid oxidation; P:regulation of cholesterol metabolic process; P:response to cold; P:temperature homeostasis;|P49748 B4DEB6 F5H2A9 O76056 Q8WUL0,Very long-chain specific acyl-CoA dehydrogenase, mitochondrial {ECO:0000305|PubMed:7668252},, PF00441;PF02770;PF02771;, GO:0031314;GO:0005759;GO:0031966;GO:0042645;GO:0005739;GO:0005730;GO:0005654;GO:0003995;GO:0000062;GO:0050660;GO:0042802;GO:0004466;GO:0017099;GO:0015980;GO:0030855;GO:0006635;GO:0033539;GO:0036498;GO:0045717;GO:0046322;GO:0090181;GO:0009409;GO:0001659;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:acyl-CoA dehydrogenase activity; F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:identical protein binding; F:long-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:energy derivation by oxidation of organic compounds; P:epithelial cell differentiation; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:IRE1-mediated unfolded protein response; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of fatty acid oxidation; P:regulation of cholesterol metabolic process; P:response to cold; P:temperature homeostasis; scaffold112 indexed_genome mRNA 18335 41196 . + . ID=transcript_13344;P78352 B7Z1S1 G5E939 Q92941 Q9UKK8,Disks large homolog 4,Postsynaptic density protein 95 {ECO:0000305};Synapse-associated protein 90;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:0032281;GO:0030054;GO:0044300;GO:0030863;GO:0005737;GO:0005829;GO:0032839;GO:0043197;GO:0030666;GO:0005783;GO:0060076;GO:0031234;GO:0098978;GO:0044224;GO:0031594;GO:0043005;GO:0044306;GO:0044309;GO:0005886;GO:0014069;GO:0098839;GO:0045211;GO:0045202;GO:0097060;GO:0008021;GO:0033130;GO:0031697;GO:0031748;GO:0035255;GO:0019900;GO:0097109;GO:0031812;GO:0030165;GO:0008022;GO:0019903;GO:0044877;GO:0097110;GO:0097113;GO:0098609;GO:0035865;GO:0007268;GO:0060997;GO:0045184;GO:0007612;GO:0035641;GO:0000165;GO:0002091;GO:0007399;GO:0050885;GO:0007204;GO:2000463;GO:0150012;GO:0061098;GO:0050806;GO:0098970;GO:0035418;GO:0065003;GO:0043113;GO:0097120;GO:2000821;GO:0048169;GO:2000310;GO:0007165;GO:0035176;GO:0016188;GO:0071625;, C:AMPA glutamate receptor complex; C:cell junction; C:cerebellar mossy fiber; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:excitatory synapse; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:juxtaparanode region of axon; C:neuromuscular junction; C:neuron projection; C:neuron projection terminus; C:neuron spine; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic membrane; C:synapse; C:synaptic membrane; C:synaptic vesicle;, F:acetylcholine receptor binding; F:beta-1 adrenergic receptor binding; F:D1 dopamine receptor binding; F:ionotropic glutamate receptor binding; F:kinase binding; F:neuroligin family protein binding; F:P2Y1 nucleotide receptor binding; F:PDZ domain binding; F:protein C-terminus binding; F:protein phosphatase binding; F:protein-containing complex binding; F:scaffold protein binding;, P:AMPA glutamate receptor clustering; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:dendritic spine morphogenesis; P:establishment of protein localization; P:learning; P:locomotory exploration behavior; P:MAPK cascade; P:negative regulation of receptor internalization; P:nervous system development; P:neuromuscular process controlling balance; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron projection arborization; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of synaptic transmission; P:postsynaptic neurotransmitter receptor diffusion trapping; P:protein localization to synapse; P:protein-containing complex assembly; P:receptor clustering; P:receptor localization to synapse; P:regulation of grooming behavior; P:regulation of long-term neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:signal transduction; P:social behavior; P:synaptic vesicle maturation; P:vocalization behavior;|P78352 B7Z1S1 G5E939 Q92941 Q9UKK8,Disks large homolog 4,Postsynaptic density protein 95 {ECO:0000305};Synapse-associated protein 90;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:0032281;GO:0030054;GO:0044300;GO:0030863;GO:0005737;GO:0005829;GO:0032839;GO:0043197;GO:0030666;GO:0005783;GO:0060076;GO:0031234;GO:0098978;GO:0044224;GO:0031594;GO:0043005;GO:0044306;GO:0044309;GO:0005886;GO:0014069;GO:0098839;GO:0045211;GO:0045202;GO:0097060;GO:0008021;GO:0033130;GO:0031697;GO:0031748;GO:0035255;GO:0019900;GO:0097109;GO:0031812;GO:0030165;GO:0008022;GO:0019903;GO:0044877;GO:0097110;GO:0097113;GO:0098609;GO:0035865;GO:0007268;GO:0060997;GO:0045184;GO:0007612;GO:0035641;GO:0000165;GO:0002091;GO:0007399;GO:0050885;GO:0007204;GO:2000463;GO:0150012;GO:0061098;GO:0050806;GO:0098970;GO:0035418;GO:0065003;GO:0043113;GO:0097120;GO:2000821;GO:0048169;GO:2000310;GO:0007165;GO:0035176;GO:0016188;GO:0071625;, C:AMPA glutamate receptor complex; C:cell junction; C:cerebellar mossy fiber; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:excitatory synapse; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:juxtaparanode region of axon; C:neuromuscular junction; C:neuron projection; C:neuron projection terminus; C:neuron spine; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic membrane; C:synapse; C:synaptic membrane; C:synaptic vesicle;, F:acetylcholine receptor binding; F:beta-1 adrenergic receptor binding; F:D1 dopamine receptor binding; F:ionotropic glutamate receptor binding; F:kinase binding; F:neuroligin family protein binding; F:P2Y1 nucleotide receptor binding; F:PDZ domain binding; F:protein C-terminus binding; F:protein phosphatase binding; F:protein-containing complex binding; F:scaffold protein binding;, P:AMPA glutamate receptor clustering; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:dendritic spine morphogenesis; P:establishment of protein localization; P:learning; P:locomotory exploration behavior; P:MAPK cascade; P:negative regulation of receptor internalization; P:nervous system development; P:neuromuscular process controlling balance; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron projection arborization; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of synaptic transmission; P:postsynaptic neurotransmitter receptor diffusion trapping; P:protein localization to synapse; P:protein-containing complex assembly; P:receptor clustering; P:receptor localization to synapse; P:regulation of grooming behavior; P:regulation of long-term neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:signal transduction; P:social behavior; P:synaptic vesicle maturation; P:vocalization behavior;|P78352 B7Z1S1 G5E939 Q92941 Q9UKK8,Disks large homolog 4,Postsynaptic density protein 95 {ECO:0000305};Synapse-associated protein 90;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:0032281;GO:0030054;GO:0044300;GO:0030863;GO:0005737;GO:0005829;GO:0032839;GO:0043197;GO:0030666;GO:0005783;GO:0060076;GO:0031234;GO:0098978;GO:0044224;GO:0031594;GO:0043005;GO:0044306;GO:0044309;GO:0005886;GO:0014069;GO:0098839;GO:0045211;GO:0045202;GO:0097060;GO:0008021;GO:0033130;GO:0031697;GO:0031748;GO:0035255;GO:0019900;GO:0097109;GO:0031812;GO:0030165;GO:0008022;GO:0019903;GO:0044877;GO:0097110;GO:0097113;GO:0098609;GO:0035865;GO:0007268;GO:0060997;GO:0045184;GO:0007612;GO:0035641;GO:0000165;GO:0002091;GO:0007399;GO:0050885;GO:0007204;GO:2000463;GO:0150012;GO:0061098;GO:0050806;GO:0098970;GO:0035418;GO:0065003;GO:0043113;GO:0097120;GO:2000821;GO:0048169;GO:2000310;GO:0007165;GO:0035176;GO:0016188;GO:0071625;, C:AMPA glutamate receptor complex; C:cell junction; C:cerebellar mossy fiber; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:excitatory synapse; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:juxtaparanode region of axon; C:neuromuscular junction; C:neuron projection; C:neuron projection terminus; C:neuron spine; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic membrane; C:synapse; C:synaptic membrane; C:synaptic vesicle;, F:acetylcholine receptor binding; F:beta-1 adrenergic receptor binding; F:D1 dopamine receptor binding; F:ionotropic glutamate receptor binding; F:kinase binding; F:neuroligin family protein binding; F:P2Y1 nucleotide receptor binding; F:PDZ domain binding; F:protein C-terminus binding; F:protein phosphatase binding; F:protein-containing complex binding; F:scaffold protein binding;, P:AMPA glutamate receptor clustering; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:dendritic spine morphogenesis; P:establishment of protein localization; P:learning; P:locomotory exploration behavior; P:MAPK cascade; P:negative regulation of receptor internalization; P:nervous system development; P:neuromuscular process controlling balance; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron projection arborization; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of synaptic transmission; P:postsynaptic neurotransmitter receptor diffusion trapping; P:protein localization to synapse; P:protein-containing complex assembly; P:receptor clustering; P:receptor localization to synapse; P:regulation of grooming behavior; P:regulation of long-term neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:signal transduction; P:social behavior; P:synaptic vesicle maturation; P:vocalization behavior;|P78352 B7Z1S1 G5E939 Q92941 Q9UKK8,Disks large homolog 4,Postsynaptic density protein 95 {ECO:0000305};Synapse-associated protein 90;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:0032281;GO:0030054;GO:0044300;GO:0030863;GO:0005737;GO:0005829;GO:0032839;GO:0043197;GO:0030666;GO:0005783;GO:0060076;GO:0031234;GO:0098978;GO:0044224;GO:0031594;GO:0043005;GO:0044306;GO:0044309;GO:0005886;GO:0014069;GO:0098839;GO:0045211;GO:0045202;GO:0097060;GO:0008021;GO:0033130;GO:0031697;GO:0031748;GO:0035255;GO:0019900;GO:0097109;GO:0031812;GO:0030165;GO:0008022;GO:0019903;GO:0044877;GO:0097110;GO:0097113;GO:0098609;GO:0035865;GO:0007268;GO:0060997;GO:0045184;GO:0007612;GO:0035641;GO:0000165;GO:0002091;GO:0007399;GO:0050885;GO:0007204;GO:2000463;GO:0150012;GO:0061098;GO:0050806;GO:0098970;GO:0035418;GO:0065003;GO:0043113;GO:0097120;GO:2000821;GO:0048169;GO:2000310;GO:0007165;GO:0035176;GO:0016188;GO:0071625;, C:AMPA glutamate receptor complex; C:cell junction; C:cerebellar mossy fiber; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:excitatory synapse; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:juxtaparanode region of axon; C:neuromuscular junction; C:neuron projection; C:neuron projection terminus; C:neuron spine; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic membrane; C:synapse; C:synaptic membrane; C:synaptic vesicle;, F:acetylcholine receptor binding; F:beta-1 adrenergic receptor binding; F:D1 dopamine receptor binding; F:ionotropic glutamate receptor binding; F:kinase binding; F:neuroligin family protein binding; F:P2Y1 nucleotide receptor binding; F:PDZ domain binding; F:protein C-terminus binding; F:protein phosphatase binding; F:protein-containing complex binding; F:scaffold protein binding;, P:AMPA glutamate receptor clustering; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:dendritic spine morphogenesis; P:establishment of protein localization; P:learning; P:locomotory exploration behavior; P:MAPK cascade; P:negative regulation of receptor internalization; P:nervous system development; P:neuromuscular process controlling balance; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron projection arborization; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of synaptic transmission; P:postsynaptic neurotransmitter receptor diffusion trapping; P:protein localization to synapse; P:protein-containing complex assembly; P:receptor clustering; P:receptor localization to synapse; P:regulation of grooming behavior; P:regulation of long-term neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:signal transduction; P:social behavior; P:synaptic vesicle maturation; P:vocalization behavior;|P78352 B7Z1S1 G5E939 Q92941 Q9UKK8,Disks large homolog 4,Postsynaptic density protein 95 {ECO:0000305};Synapse-associated protein 90;, PF00625;PF10608;PF00595;PF10600;PF00018;, GO:0032281;GO:0030054;GO:0044300;GO:0030863;GO:0005737;GO:0005829;GO:0032839;GO:0043197;GO:0030666;GO:0005783;GO:0060076;GO:0031234;GO:0098978;GO:0044224;GO:0031594;GO:0043005;GO:0044306;GO:0044309;GO:0005886;GO:0014069;GO:0098839;GO:0045211;GO:0045202;GO:0097060;GO:0008021;GO:0033130;GO:0031697;GO:0031748;GO:0035255;GO:0019900;GO:0097109;GO:0031812;GO:0030165;GO:0008022;GO:0019903;GO:0044877;GO:0097110;GO:0097113;GO:0098609;GO:0035865;GO:0007268;GO:0060997;GO:0045184;GO:0007612;GO:0035641;GO:0000165;GO:0002091;GO:0007399;GO:0050885;GO:0007204;GO:2000463;GO:0150012;GO:0061098;GO:0050806;GO:0098970;GO:0035418;GO:0065003;GO:0043113;GO:0097120;GO:2000821;GO:0048169;GO:2000310;GO:0007165;GO:0035176;GO:0016188;GO:0071625;, C:AMPA glutamate receptor complex; C:cell junction; C:cerebellar mossy fiber; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite cytoplasm; C:dendritic spine; C:endocytic vesicle membrane; C:endoplasmic reticulum; C:excitatory synapse; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:juxtaparanode region of axon; C:neuromuscular junction; C:neuron projection; C:neuron projection terminus; C:neuron spine; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic membrane; C:synapse; C:synaptic membrane; C:synaptic vesicle;, F:acetylcholine receptor binding; F:beta-1 adrenergic receptor binding; F:D1 dopamine receptor binding; F:ionotropic glutamate receptor binding; F:kinase binding; F:neuroligin family protein binding; F:P2Y1 nucleotide receptor binding; F:PDZ domain binding; F:protein C-terminus binding; F:protein phosphatase binding; F:protein-containing complex binding; F:scaffold protein binding;, P:AMPA glutamate receptor clustering; P:cell-cell adhesion; P:cellular response to potassium ion; P:chemical synaptic transmission; P:dendritic spine morphogenesis; P:establishment of protein localization; P:learning; P:locomotory exploration behavior; P:MAPK cascade; P:negative regulation of receptor internalization; P:nervous system development; P:neuromuscular process controlling balance; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron projection arborization; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of synaptic transmission; P:postsynaptic neurotransmitter receptor diffusion trapping; P:protein localization to synapse; P:protein-containing complex assembly; P:receptor clustering; P:receptor localization to synapse; P:regulation of grooming behavior; P:regulation of long-term neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:signal transduction; P:social behavior; P:synaptic vesicle maturation; P:vocalization behavior; scaffold112 indexed_genome mRNA 51411 56109 . + . ID=transcript_13345;P07306 I3L1X1,Asialoglycoprotein receptor 1,C-type lectin domain family 4 member H1;Hepatic lectin H1;, PF00059;, GO:0005576;GO:0005887;GO:0005886;GO:0004873;GO:0030246;GO:0046872;GO:0031668;GO:0018279;GO:0006898;GO:0016032;, C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:asialoglycoprotein receptor activity; F:carbohydrate binding; F:metal ion binding;, P:cellular response to extracellular stimulus; P:protein N-linked glycosylation via asparagine; P:receptor-mediated endocytosis; P:viral process; scaffold112 indexed_genome mRNA 84463 96270 . + . ID=transcript_13346;P07307 A6NLV8 A8MT12 D3DTM9 D3DTN0 O00448 Q03969,Asialoglycoprotein receptor 2,C-type lectin domain family 4 member H2;Hepatic lectin H2;, PF00059;, GO:0044322;GO:0016021;GO:0048471;GO:0005886;GO:0004873;GO:0030246;GO:0030282;GO:0007166;GO:0055088;GO:0018279;GO:0031647;GO:0016032;, C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:asialoglycoprotein receptor activity; F:carbohydrate binding;, P:bone mineralization; P:cell surface receptor signaling pathway; P:lipid homeostasis; P:protein N-linked glycosylation via asparagine; P:regulation of protein stability; P:viral process;|P07307 A6NLV8 A8MT12 D3DTM9 D3DTN0 O00448 Q03969,Asialoglycoprotein receptor 2,C-type lectin domain family 4 member H2;Hepatic lectin H2;, PF00059;, GO:0044322;GO:0016021;GO:0048471;GO:0005886;GO:0004873;GO:0030246;GO:0030282;GO:0007166;GO:0055088;GO:0018279;GO:0031647;GO:0016032;, C:endoplasmic reticulum quality control compartment; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:asialoglycoprotein receptor activity; F:carbohydrate binding;, P:bone mineralization; P:cell surface receptor signaling pathway; P:lipid homeostasis; P:protein N-linked glycosylation via asparagine; P:regulation of protein stability; P:viral process; scaffold112 indexed_genome mRNA 116360 119133 . + . ID=transcript_13347;Q8NCK7,Monocarboxylate transporter 11,Solute carrier family 16 member 11;, PF07690;, GO:0005789;GO:0016021;GO:0005887;GO:0005886;GO:0008028;GO:0050833;GO:0015293;GO:0006629;GO:0015718;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:monocarboxylic acid transmembrane transporter activity; F:pyruvate transmembrane transporter activity; F:symporter activity;, P:lipid metabolic process; P:monocarboxylic acid transport;|Q8NCK7,Monocarboxylate transporter 11,Solute carrier family 16 member 11;, PF07690;, GO:0005789;GO:0016021;GO:0005887;GO:0005886;GO:0008028;GO:0050833;GO:0015293;GO:0006629;GO:0015718;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:monocarboxylic acid transmembrane transporter activity; F:pyruvate transmembrane transporter activity; F:symporter activity;, P:lipid metabolic process; P:monocarboxylic acid transport; scaffold112 indexed_genome mRNA 119159 122735 . - . ID=transcript_13348;Q7RTY0 A3KMG3 A5PKU5 Q2VP92,Monocarboxylate transporter 13,Solute carrier family 16 member 13;, PF07690;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0005887;GO:0008028;GO:0015293;GO:0015718;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport;|Q7RTY0 A3KMG3 A5PKU5 Q2VP92,Monocarboxylate transporter 13,Solute carrier family 16 member 13;, PF07690;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0005887;GO:0008028;GO:0015293;GO:0015718;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport;|Q7RTY0 A3KMG3 A5PKU5 Q2VP92,Monocarboxylate transporter 13,Solute carrier family 16 member 13;, PF07690;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0005887;GO:0008028;GO:0015293;GO:0015718;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport; scaffold112 indexed_genome mRNA 125038 131516 . - . ID=transcript_13349;Q8N143 Q6PCB4,B-cell CLL/lymphoma 6 member B protein,Bcl6-associated zinc finger protein;Zinc finger protein 62;, PF00651;PF00096;, GO:0005654;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0000122;GO:0045595;GO:0042127;GO:0001817;GO:0002682;GO:0050727;GO:0006357;GO:0042092;, C:nucleoplasm;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of cell differentiation; P:regulation of cell population proliferation; P:regulation of cytokine production; P:regulation of immune system process; P:regulation of inflammatory response; P:regulation of transcription by RNA polymerase II; P:type 2 immune response; scaffold112 indexed_genome mRNA 136604 143051 . + . ID=transcript_13350;Q8IXM2 B4DIV3 C9J4G0 E9PB29,Chromatin complexes subunit BAP18,BPTF-associated protein of 18 kDa;, , GO:0005829;GO:0071339;GO:0005654;GO:0016589;GO:0003677;GO:0042802;GO:0006325;, C:cytosol; C:MLL1 complex; C:nucleoplasm; C:NURF complex;, F:DNA binding; F:identical protein binding;, P:chromatin organization;|Q8IXM2 B4DIV3 C9J4G0 E9PB29,Chromatin complexes subunit BAP18,BPTF-associated protein of 18 kDa;, , GO:0005829;GO:0071339;GO:0005654;GO:0016589;GO:0003677;GO:0042802;GO:0006325;, C:cytosol; C:MLL1 complex; C:nucleoplasm; C:NURF complex;, F:DNA binding; F:identical protein binding;, P:chromatin organization;|Q8IXM2 B4DIV3 C9J4G0 E9PB29,Chromatin complexes subunit BAP18,BPTF-associated protein of 18 kDa;, , GO:0005829;GO:0071339;GO:0005654;GO:0016589;GO:0003677;GO:0042802;GO:0006325;, C:cytosol; C:MLL1 complex; C:nucleoplasm; C:NURF complex;, F:DNA binding; F:identical protein binding;, P:chromatin organization;|Q6P5S7 G3V1Z9 Q502Z2,Ribonuclease kappa,, , GO:0016021;GO:0004521;, C:integral component of membrane;, F:endoribonuclease activity;|Q6P5S7 G3V1Z9 Q502Z2,Ribonuclease kappa,, , GO:0016021;GO:0004521;, C:integral component of membrane;, F:endoribonuclease activity; scaffold112 indexed_genome mRNA 143121 147976 . - . ID=transcript_13351;P18054 O95569 Q6ISF8 Q9UQM4,Polyunsaturated fatty acid lipoxygenase ALOX12 {ECO:0000305},Arachidonate (12S)-lipoxygenase {ECO:0000305|PubMed:17493578};Arachidonate (15S)-lipoxygenase {ECO:0000305|PubMed:17493578};Linoleate (13S)-lipoxygenase {ECO:0000250|UniProtKB:P39655};Lipoxin synthase 12-LO;Platelet-type lipoxygenase 12;, PF00305;PF01477;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0042383;GO:0004052;GO:0050473;GO:0047977;GO:0005506;GO:0016165;GO:0016702;GO:0007568;GO:0019369;GO:0071396;GO:0061436;GO:0019395;GO:0051122;GO:0051121;GO:1901751;GO:0043651;GO:0006629;GO:0034440;GO:2001303;GO:2001306;GO:2001301;GO:0019372;GO:0042759;GO:0010656;GO:0090331;GO:0043065;GO:0043536;GO:0043280;GO:1905956;GO:0010628;GO:0051901;GO:0048661;GO:0042554;GO:0033559;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane; C:sarcolemma;, F:arachidonate 12(S)-lipoxygenase activity; F:arachidonate 15-lipoxygenase activity; F:hepoxilin-epoxide hydrolase activity; F:iron ion binding; F:linoleate 13S-lipoxygenase activity; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;, P:aging; P:arachidonic acid metabolic process; P:cellular response to lipid; P:establishment of skin barrier; P:fatty acid oxidation; P:hepoxilin biosynthetic process; P:hepoxilin metabolic process; P:leukotriene A4 metabolic process; P:linoleic acid metabolic process; P:lipid metabolic process; P:lipid oxidation; P:lipoxin A4 biosynthetic process; P:lipoxin B4 biosynthetic process; P:lipoxin biosynthetic process; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:negative regulation of muscle cell apoptotic process; P:negative regulation of platelet aggregation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of endothelial tube morphogenesis; P:positive regulation of gene expression; P:positive regulation of mitochondrial depolarization; P:positive regulation of smooth muscle cell proliferation; P:superoxide anion generation; P:unsaturated fatty acid metabolic process; scaffold112 indexed_genome mRNA 148198 155743 . - . ID=transcript_13352;P18054 O95569 Q6ISF8 Q9UQM4,Polyunsaturated fatty acid lipoxygenase ALOX12 {ECO:0000305},Arachidonate (12S)-lipoxygenase {ECO:0000305|PubMed:17493578};Arachidonate (15S)-lipoxygenase {ECO:0000305|PubMed:17493578};Linoleate (13S)-lipoxygenase {ECO:0000250|UniProtKB:P39655};Lipoxin synthase 12-LO;Platelet-type lipoxygenase 12;, PF00305;PF01477;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0042383;GO:0004052;GO:0050473;GO:0047977;GO:0005506;GO:0016165;GO:0016702;GO:0007568;GO:0019369;GO:0071396;GO:0061436;GO:0019395;GO:0051122;GO:0051121;GO:1901751;GO:0043651;GO:0006629;GO:0034440;GO:2001303;GO:2001306;GO:2001301;GO:0019372;GO:0042759;GO:0010656;GO:0090331;GO:0043065;GO:0043536;GO:0043280;GO:1905956;GO:0010628;GO:0051901;GO:0048661;GO:0042554;GO:0033559;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane; C:sarcolemma;, F:arachidonate 12(S)-lipoxygenase activity; F:arachidonate 15-lipoxygenase activity; F:hepoxilin-epoxide hydrolase activity; F:iron ion binding; F:linoleate 13S-lipoxygenase activity; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;, P:aging; P:arachidonic acid metabolic process; P:cellular response to lipid; P:establishment of skin barrier; P:fatty acid oxidation; P:hepoxilin biosynthetic process; P:hepoxilin metabolic process; P:leukotriene A4 metabolic process; P:linoleic acid metabolic process; P:lipid metabolic process; P:lipid oxidation; P:lipoxin A4 biosynthetic process; P:lipoxin B4 biosynthetic process; P:lipoxin biosynthetic process; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:negative regulation of muscle cell apoptotic process; P:negative regulation of platelet aggregation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of endothelial tube morphogenesis; P:positive regulation of gene expression; P:positive regulation of mitochondrial depolarization; P:positive regulation of smooth muscle cell proliferation; P:superoxide anion generation; P:unsaturated fatty acid metabolic process; scaffold112 indexed_genome mRNA 155905 156591 . + . ID=transcript_13353;P18054 O95569 Q6ISF8 Q9UQM4,Polyunsaturated fatty acid lipoxygenase ALOX12 {ECO:0000305},Arachidonate (12S)-lipoxygenase {ECO:0000305|PubMed:17493578};Arachidonate (15S)-lipoxygenase {ECO:0000305|PubMed:17493578};Linoleate (13S)-lipoxygenase {ECO:0000250|UniProtKB:P39655};Lipoxin synthase 12-LO;Platelet-type lipoxygenase 12;, PF00305;PF01477;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0042383;GO:0004052;GO:0050473;GO:0047977;GO:0005506;GO:0016165;GO:0016702;GO:0007568;GO:0019369;GO:0071396;GO:0061436;GO:0019395;GO:0051122;GO:0051121;GO:1901751;GO:0043651;GO:0006629;GO:0034440;GO:2001303;GO:2001306;GO:2001301;GO:0019372;GO:0042759;GO:0010656;GO:0090331;GO:0043065;GO:0043536;GO:0043280;GO:1905956;GO:0010628;GO:0051901;GO:0048661;GO:0042554;GO:0033559;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane; C:sarcolemma;, F:arachidonate 12(S)-lipoxygenase activity; F:arachidonate 15-lipoxygenase activity; F:hepoxilin-epoxide hydrolase activity; F:iron ion binding; F:linoleate 13S-lipoxygenase activity; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;, P:aging; P:arachidonic acid metabolic process; P:cellular response to lipid; P:establishment of skin barrier; P:fatty acid oxidation; P:hepoxilin biosynthetic process; P:hepoxilin metabolic process; P:leukotriene A4 metabolic process; P:linoleic acid metabolic process; P:lipid metabolic process; P:lipid oxidation; P:lipoxin A4 biosynthetic process; P:lipoxin B4 biosynthetic process; P:lipoxin biosynthetic process; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:negative regulation of muscle cell apoptotic process; P:negative regulation of platelet aggregation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of endothelial tube morphogenesis; P:positive regulation of gene expression; P:positive regulation of mitochondrial depolarization; P:positive regulation of smooth muscle cell proliferation; P:superoxide anion generation; P:unsaturated fatty acid metabolic process; scaffold112 indexed_genome mRNA 233166 240721 . + . ID=transcript_13354;P16050 A8K2P4 B7ZA11 Q8N6R7 Q99657,Polyunsaturated fatty acid lipoxygenase ALOX15 {ECO:0000305},12/15-lipoxygenase {ECO:0000250|UniProtKB:P39654};Arachidonate 12-lipoxygenase, leukocyte-type {ECO:0000250|UniProtKB:Q02759};Arachidonate 15-lipoxygenase;Arachidonate omega-6 lipoxygenase {ECO:0000303|PubMed:3356688};Hepoxilin A3 synthase Alox15 {ECO:0000250|UniProtKB:Q02759};Linoleate 13S-lipoxygenase;, PF00305;PF01477;, GO:0005829;GO:0031234;GO:0005811;GO:0016020;GO:0005886;GO:0004052;GO:0050473;GO:0051120;GO:0047977;GO:0005506;GO:0016165;GO:0016702;GO:0005546;GO:0043277;GO:0019369;GO:0030282;GO:0071277;GO:0035963;GO:0019221;GO:0019395;GO:0051122;GO:0006954;GO:0006691;GO:0043651;GO:0006629;GO:0034440;GO:2001303;GO:0019372;GO:0042759;GO:0002820;GO:0001503;GO:0006646;GO:0030838;GO:0010811;GO:0070374;GO:0034116;GO:1901074;GO:0050727;GO:0035358;GO:0034976;GO:0042060;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:lipid droplet; C:membrane; C:plasma membrane;, F:arachidonate 12(S)-lipoxygenase activity; F:arachidonate 15-lipoxygenase activity; F:hepoxilin A3 synthase activity; F:hepoxilin-epoxide hydrolase activity; F:iron ion binding; F:linoleate 13S-lipoxygenase activity; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:phosphatidylinositol-4,5-bisphosphate binding;, P:apoptotic cell clearance; P:arachidonic acid metabolic process; P:bone mineralization; P:cellular response to calcium ion; P:cellular response to interleukin-13; P:cytokine-mediated signaling pathway; P:fatty acid oxidation; P:hepoxilin biosynthetic process; P:inflammatory response; P:leukotriene metabolic process; P:linoleic acid metabolic process; P:lipid metabolic process; P:lipid oxidation; P:lipoxin A4 biosynthetic process; P:lipoxygenase pathway; P:long-chain fatty acid biosynthetic process; P:negative regulation of adaptive immune response; P:ossification; P:phosphatidylethanolamine biosynthetic process; P:positive regulation of actin filament polymerization; P:positive regulation of cell-substrate adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heterotypic cell-cell adhesion; P:regulation of engulfment of apoptotic cell; P:regulation of inflammatory response; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:response to endoplasmic reticulum stress; P:wound healing; scaffold112 indexed_genome mRNA 266872 321727 . - . ID=transcript_13355;Q8IZL8 O15450 Q5EGN3 Q6NTE6 Q96FT1 Q9BU60,Proline-, glutamic acid- and leucine-rich protein 1,Modulator of non-genomic activity of estrogen receptor;Transcription factor HMX3;, PF08166;PF08167;, GO:0005737;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0035327;GO:0003682;GO:0003723;GO:0008134;GO:0071391;GO:0045944;GO:0006364;, C:cytoplasm; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:transcriptionally active chromatin;, F:chromatin binding; F:RNA binding; F:transcription factor binding;, P:cellular response to estrogen stimulus; P:positive regulation of transcription by RNA polymerase II; P:rRNA processing;|Q8IZL8 O15450 Q5EGN3 Q6NTE6 Q96FT1 Q9BU60,Proline-, glutamic acid- and leucine-rich protein 1,Modulator of non-genomic activity of estrogen receptor;Transcription factor HMX3;, PF08166;PF08167;, GO:0005737;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0035327;GO:0003682;GO:0003723;GO:0008134;GO:0071391;GO:0045944;GO:0006364;, C:cytoplasm; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:transcriptionally active chromatin;, F:chromatin binding; F:RNA binding; F:transcription factor binding;, P:cellular response to estrogen stimulus; P:positive regulation of transcription by RNA polymerase II; P:rRNA processing;|Q8IZL8 O15450 Q5EGN3 Q6NTE6 Q96FT1 Q9BU60,Proline-, glutamic acid- and leucine-rich protein 1,Modulator of non-genomic activity of estrogen receptor;Transcription factor HMX3;, PF08166;PF08167;, GO:0005737;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0035327;GO:0003682;GO:0003723;GO:0008134;GO:0071391;GO:0045944;GO:0006364;, C:cytoplasm; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:transcriptionally active chromatin;, F:chromatin binding; F:RNA binding; F:transcription factor binding;, P:cellular response to estrogen stimulus; P:positive regulation of transcription by RNA polymerase II; P:rRNA processing;|Q8IZL8 O15450 Q5EGN3 Q6NTE6 Q96FT1 Q9BU60,Proline-, glutamic acid- and leucine-rich protein 1,Modulator of non-genomic activity of estrogen receptor;Transcription factor HMX3;, PF08166;PF08167;, GO:0005737;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0035327;GO:0003682;GO:0003723;GO:0008134;GO:0071391;GO:0045944;GO:0006364;, C:cytoplasm; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:transcriptionally active chromatin;, F:chromatin binding; F:RNA binding; F:transcription factor binding;, P:cellular response to estrogen stimulus; P:positive regulation of transcription by RNA polymerase II; P:rRNA processing;|Q8IZL8 O15450 Q5EGN3 Q6NTE6 Q96FT1 Q9BU60,Proline-, glutamic acid- and leucine-rich protein 1,Modulator of non-genomic activity of estrogen receptor;Transcription factor HMX3;, PF08166;PF08167;, GO:0005737;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0035327;GO:0003682;GO:0003723;GO:0008134;GO:0071391;GO:0045944;GO:0006364;, C:cytoplasm; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:transcriptionally active chromatin;, F:chromatin binding; F:RNA binding; F:transcription factor binding;, P:cellular response to estrogen stimulus; P:positive regulation of transcription by RNA polymerase II; P:rRNA processing;|Q8IZL8 O15450 Q5EGN3 Q6NTE6 Q96FT1 Q9BU60,Proline-, glutamic acid- and leucine-rich protein 1,Modulator of non-genomic activity of estrogen receptor;Transcription factor HMX3;, PF08166;PF08167;, GO:0005737;GO:0016020;GO:0071339;GO:0005730;GO:0005654;GO:0035327;GO:0003682;GO:0003723;GO:0008134;GO:0071391;GO:0045944;GO:0006364;, C:cytoplasm; C:membrane; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:transcriptionally active chromatin;, F:chromatin binding; F:RNA binding; F:transcription factor binding;, P:cellular response to estrogen stimulus; P:positive regulation of transcription by RNA polymerase II; P:rRNA processing;|Q8N7Y2 Q9UEQ6,Beta-arrestin-2,Arrestin beta-2;Non-visual arrestin-3 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0043197;GO:0030139;GO:0005768;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0071889;GO:0031691;GO:0031692;GO:0031701;GO:1990763;GO:0031748;GO:0019899;GO:0031762;GO:0001664;GO:0042802;GO:0051019;GO:0031859;GO:0019904;GO:0043422;GO:0044877;GO:0005102;GO:0031702;GO:0031826;GO:0031625;GO:0007628;GO:0007420;GO:0060326;GO:0002032;GO:0050965;GO:0007212;GO:0060079;GO:0042699;GO:0002031;GO:0007186;GO:0061024;GO:0043154;GO:0034260;GO:0032691;GO:0032695;GO:0032715;GO:0045953;GO:0043524;GO:0032088;GO:0051898;GO:0001933;GO:0031397;GO:0090201;GO:0034392;GO:0034122;GO:0032720;GO:0030168;GO:0051928;GO:2000727;GO:0032967;GO:2000573;GO:1904037;GO:0070374;GO:0010628;GO:0033138;GO:0050731;GO:0051897;GO:0002092;GO:0032226;GO:0043161;GO:0016579;GO:0015031;GO:0016567;GO:0031623;GO:0006366;GO:0007179;GO:0060071;, C:basolateral plasma membrane; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:endocytic vesicle; C:endosome; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:14-3-3 protein binding; F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:arrestin family protein binding; F:D1 dopamine receptor binding; F:enzyme binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:identical protein binding; F:mitogen-activated protein kinase binding; F:platelet activating factor receptor binding; F:protein domain specific binding; F:protein kinase B binding; F:protein-containing complex binding; F:signaling receptor binding; F:type 1 angiotensin receptor binding; F:type 2A serotonin receptor binding; F:ubiquitin protein ligase binding;, P:adult walking behavior; P:brain development; P:cell chemotaxis; P:desensitization of G protein-coupled receptor signaling pathway by arrestin; P:detection of temperature stimulus involved in sensory perception of pain; P:dopamine receptor signaling pathway; P:excitatory postsynaptic potential; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:membrane organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of GTPase activity; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-6 production; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of smooth muscle cell apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:platelet activation; P:positive regulation of calcium ion transport; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of epithelial cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor internalization; P:positive regulation of synaptic transmission, dopaminergic; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein transport; P:protein ubiquitination; P:receptor internalization; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q8N7Y2 Q9UEQ6,Beta-arrestin-2,Arrestin beta-2;Non-visual arrestin-3 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0043197;GO:0030139;GO:0005768;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0071889;GO:0031691;GO:0031692;GO:0031701;GO:1990763;GO:0031748;GO:0019899;GO:0031762;GO:0001664;GO:0042802;GO:0051019;GO:0031859;GO:0019904;GO:0043422;GO:0044877;GO:0005102;GO:0031702;GO:0031826;GO:0031625;GO:0007628;GO:0007420;GO:0060326;GO:0002032;GO:0050965;GO:0007212;GO:0060079;GO:0042699;GO:0002031;GO:0007186;GO:0061024;GO:0043154;GO:0034260;GO:0032691;GO:0032695;GO:0032715;GO:0045953;GO:0043524;GO:0032088;GO:0051898;GO:0001933;GO:0031397;GO:0090201;GO:0034392;GO:0034122;GO:0032720;GO:0030168;GO:0051928;GO:2000727;GO:0032967;GO:2000573;GO:1904037;GO:0070374;GO:0010628;GO:0033138;GO:0050731;GO:0051897;GO:0002092;GO:0032226;GO:0043161;GO:0016579;GO:0015031;GO:0016567;GO:0031623;GO:0006366;GO:0007179;GO:0060071;, C:basolateral plasma membrane; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:endocytic vesicle; C:endosome; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:14-3-3 protein binding; F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:arrestin family protein binding; F:D1 dopamine receptor binding; F:enzyme binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:identical protein binding; F:mitogen-activated protein kinase binding; F:platelet activating factor receptor binding; F:protein domain specific binding; F:protein kinase B binding; F:protein-containing complex binding; F:signaling receptor binding; F:type 1 angiotensin receptor binding; F:type 2A serotonin receptor binding; F:ubiquitin protein ligase binding;, P:adult walking behavior; P:brain development; P:cell chemotaxis; P:desensitization of G protein-coupled receptor signaling pathway by arrestin; P:detection of temperature stimulus involved in sensory perception of pain; P:dopamine receptor signaling pathway; P:excitatory postsynaptic potential; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:membrane organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of GTPase activity; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-6 production; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of smooth muscle cell apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:platelet activation; P:positive regulation of calcium ion transport; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of epithelial cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor internalization; P:positive regulation of synaptic transmission, dopaminergic; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein transport; P:protein ubiquitination; P:receptor internalization; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q8N7Y2 Q9UEQ6,Beta-arrestin-2,Arrestin beta-2;Non-visual arrestin-3 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0043197;GO:0030139;GO:0005768;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0071889;GO:0031691;GO:0031692;GO:0031701;GO:1990763;GO:0031748;GO:0019899;GO:0031762;GO:0001664;GO:0042802;GO:0051019;GO:0031859;GO:0019904;GO:0043422;GO:0044877;GO:0005102;GO:0031702;GO:0031826;GO:0031625;GO:0007628;GO:0007420;GO:0060326;GO:0002032;GO:0050965;GO:0007212;GO:0060079;GO:0042699;GO:0002031;GO:0007186;GO:0061024;GO:0043154;GO:0034260;GO:0032691;GO:0032695;GO:0032715;GO:0045953;GO:0043524;GO:0032088;GO:0051898;GO:0001933;GO:0031397;GO:0090201;GO:0034392;GO:0034122;GO:0032720;GO:0030168;GO:0051928;GO:2000727;GO:0032967;GO:2000573;GO:1904037;GO:0070374;GO:0010628;GO:0033138;GO:0050731;GO:0051897;GO:0002092;GO:0032226;GO:0043161;GO:0016579;GO:0015031;GO:0016567;GO:0031623;GO:0006366;GO:0007179;GO:0060071;, C:basolateral plasma membrane; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:endocytic vesicle; C:endosome; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:14-3-3 protein binding; F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:arrestin family protein binding; F:D1 dopamine receptor binding; F:enzyme binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:identical protein binding; F:mitogen-activated protein kinase binding; F:platelet activating factor receptor binding; F:protein domain specific binding; F:protein kinase B binding; F:protein-containing complex binding; F:signaling receptor binding; F:type 1 angiotensin receptor binding; F:type 2A serotonin receptor binding; F:ubiquitin protein ligase binding;, P:adult walking behavior; P:brain development; P:cell chemotaxis; P:desensitization of G protein-coupled receptor signaling pathway by arrestin; P:detection of temperature stimulus involved in sensory perception of pain; P:dopamine receptor signaling pathway; P:excitatory postsynaptic potential; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:membrane organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of GTPase activity; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-6 production; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of smooth muscle cell apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:platelet activation; P:positive regulation of calcium ion transport; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of epithelial cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor internalization; P:positive regulation of synaptic transmission, dopaminergic; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein transport; P:protein ubiquitination; P:receptor internalization; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q8N7Y2 Q9UEQ6,Beta-arrestin-2,Arrestin beta-2;Non-visual arrestin-3 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0043197;GO:0030139;GO:0005768;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0071889;GO:0031691;GO:0031692;GO:0031701;GO:1990763;GO:0031748;GO:0019899;GO:0031762;GO:0001664;GO:0042802;GO:0051019;GO:0031859;GO:0019904;GO:0043422;GO:0044877;GO:0005102;GO:0031702;GO:0031826;GO:0031625;GO:0007628;GO:0007420;GO:0060326;GO:0002032;GO:0050965;GO:0007212;GO:0060079;GO:0042699;GO:0002031;GO:0007186;GO:0061024;GO:0043154;GO:0034260;GO:0032691;GO:0032695;GO:0032715;GO:0045953;GO:0043524;GO:0032088;GO:0051898;GO:0001933;GO:0031397;GO:0090201;GO:0034392;GO:0034122;GO:0032720;GO:0030168;GO:0051928;GO:2000727;GO:0032967;GO:2000573;GO:1904037;GO:0070374;GO:0010628;GO:0033138;GO:0050731;GO:0051897;GO:0002092;GO:0032226;GO:0043161;GO:0016579;GO:0015031;GO:0016567;GO:0031623;GO:0006366;GO:0007179;GO:0060071;, C:basolateral plasma membrane; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:endocytic vesicle; C:endosome; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:14-3-3 protein binding; F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:arrestin family protein binding; F:D1 dopamine receptor binding; F:enzyme binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:identical protein binding; F:mitogen-activated protein kinase binding; F:platelet activating factor receptor binding; F:protein domain specific binding; F:protein kinase B binding; F:protein-containing complex binding; F:signaling receptor binding; F:type 1 angiotensin receptor binding; F:type 2A serotonin receptor binding; F:ubiquitin protein ligase binding;, P:adult walking behavior; P:brain development; P:cell chemotaxis; P:desensitization of G protein-coupled receptor signaling pathway by arrestin; P:detection of temperature stimulus involved in sensory perception of pain; P:dopamine receptor signaling pathway; P:excitatory postsynaptic potential; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:membrane organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of GTPase activity; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-6 production; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of smooth muscle cell apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:platelet activation; P:positive regulation of calcium ion transport; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of epithelial cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor internalization; P:positive regulation of synaptic transmission, dopaminergic; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein transport; P:protein ubiquitination; P:receptor internalization; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q8N7Y2 Q9UEQ6,Beta-arrestin-2,Arrestin beta-2;Non-visual arrestin-3 {ECO:0000303|PubMed:23886940};, PF02752;PF00339;, GO:0016323;GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0043197;GO:0030139;GO:0005768;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0045211;GO:0071889;GO:0031691;GO:0031692;GO:0031701;GO:1990763;GO:0031748;GO:0019899;GO:0031762;GO:0001664;GO:0042802;GO:0051019;GO:0031859;GO:0019904;GO:0043422;GO:0044877;GO:0005102;GO:0031702;GO:0031826;GO:0031625;GO:0007628;GO:0007420;GO:0060326;GO:0002032;GO:0050965;GO:0007212;GO:0060079;GO:0042699;GO:0002031;GO:0007186;GO:0061024;GO:0043154;GO:0034260;GO:0032691;GO:0032695;GO:0032715;GO:0045953;GO:0043524;GO:0032088;GO:0051898;GO:0001933;GO:0031397;GO:0090201;GO:0034392;GO:0034122;GO:0032720;GO:0030168;GO:0051928;GO:2000727;GO:0032967;GO:2000573;GO:1904037;GO:0070374;GO:0010628;GO:0033138;GO:0050731;GO:0051897;GO:0002092;GO:0032226;GO:0043161;GO:0016579;GO:0015031;GO:0016567;GO:0031623;GO:0006366;GO:0007179;GO:0060071;, C:basolateral plasma membrane; C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendritic spine; C:endocytic vesicle; C:endosome; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:14-3-3 protein binding; F:alpha-1A adrenergic receptor binding; F:alpha-1B adrenergic receptor binding; F:angiotensin receptor binding; F:arrestin family protein binding; F:D1 dopamine receptor binding; F:enzyme binding; F:follicle-stimulating hormone receptor binding; F:G protein-coupled receptor binding; F:identical protein binding; F:mitogen-activated protein kinase binding; F:platelet activating factor receptor binding; F:protein domain specific binding; F:protein kinase B binding; F:protein-containing complex binding; F:signaling receptor binding; F:type 1 angiotensin receptor binding; F:type 2A serotonin receptor binding; F:ubiquitin protein ligase binding;, P:adult walking behavior; P:brain development; P:cell chemotaxis; P:desensitization of G protein-coupled receptor signaling pathway by arrestin; P:detection of temperature stimulus involved in sensory perception of pain; P:dopamine receptor signaling pathway; P:excitatory postsynaptic potential; P:follicle-stimulating hormone signaling pathway; P:G protein-coupled receptor internalization; P:G protein-coupled receptor signaling pathway; P:membrane organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of GTPase activity; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-6 production; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of neuron apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of protein ubiquitination; P:negative regulation of release of cytochrome c from mitochondria; P:negative regulation of smooth muscle cell apoptotic process; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:platelet activation; P:positive regulation of calcium ion transport; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA biosynthetic process; P:positive regulation of epithelial cell apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of receptor internalization; P:positive regulation of synaptic transmission, dopaminergic; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein transport; P:protein ubiquitination; P:receptor internalization; P:transcription by RNA polymerase II; P:transforming growth factor beta receptor signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|Q9P086 Q6NS89,Mediator of RNA polymerase II transcription subunit 11,Mediator complex subunit 11;, PF10280;, GO:0016592;GO:0000151;GO:0003712;GO:0061630;GO:0006357;, C:mediator complex; C:ubiquitin ligase complex;, F:transcription coregulator activity; F:ubiquitin protein ligase activity;, P:regulation of transcription by RNA polymerase II;|Q9P086 Q6NS89,Mediator of RNA polymerase II transcription subunit 11,Mediator complex subunit 11;, PF10280;, GO:0016592;GO:0000151;GO:0003712;GO:0061630;GO:0006357;, C:mediator complex; C:ubiquitin ligase complex;, F:transcription coregulator activity; F:ubiquitin protein ligase activity;, P:regulation of transcription by RNA polymerase II; scaffold112 indexed_genome mRNA 321735 327485 . - . ID=transcript_13356;Q9H2A7 A0N0N4 A8K7U9 B2RCB0 Q8TC80 Q96K63 Q9BXD6 Q9H2F6,C-X-C motif chemokine 16,Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein;Small-inducible cytokine B16;Transmembrane chemokine CXCL16;, , GO:0005576;GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0008009;GO:0005041;GO:0005044;GO:0006935;GO:0007186;GO:0030307;GO:0030335;GO:0006898;GO:0034097;GO:0034341;GO:0034612;GO:0010818;, C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:chemokine activity; F:low-density lipoprotein particle receptor activity; F:scavenger receptor activity;, P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:positive regulation of cell growth; P:positive regulation of cell migration; P:receptor-mediated endocytosis; P:response to cytokine; P:response to interferon-gamma; P:response to tumor necrosis factor; P:T cell chemotaxis;|Q9H2A7 A0N0N4 A8K7U9 B2RCB0 Q8TC80 Q96K63 Q9BXD6 Q9H2F6,C-X-C motif chemokine 16,Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein;Small-inducible cytokine B16;Transmembrane chemokine CXCL16;, , GO:0005576;GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0008009;GO:0005041;GO:0005044;GO:0006935;GO:0007186;GO:0030307;GO:0030335;GO:0006898;GO:0034097;GO:0034341;GO:0034612;GO:0010818;, C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:chemokine activity; F:low-density lipoprotein particle receptor activity; F:scavenger receptor activity;, P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:positive regulation of cell growth; P:positive regulation of cell migration; P:receptor-mediated endocytosis; P:response to cytokine; P:response to interferon-gamma; P:response to tumor necrosis factor; P:T cell chemotaxis;|Q9H091 B4DXY5 I3L296,Zinc finger MYND domain-containing protein 15,, PF01753;, GO:0005737;GO:0005634;GO:0042826;GO:0046872;GO:0045892;GO:0007286;, C:cytoplasm; C:nucleus;, F:histone deacetylase binding; F:metal ion binding;, P:negative regulation of transcription, DNA-templated; P:spermatid development; scaffold112 indexed_genome mRNA 327962 330850 . + . ID=transcript_13357;Q9H091 B4DXY5 I3L296,Zinc finger MYND domain-containing protein 15,, PF01753;, GO:0005737;GO:0005634;GO:0042826;GO:0046872;GO:0045892;GO:0007286;, C:cytoplasm; C:nucleus;, F:histone deacetylase binding; F:metal ion binding;, P:negative regulation of transcription, DNA-templated; P:spermatid development;|Q9H091 B4DXY5 I3L296,Zinc finger MYND domain-containing protein 15,, PF01753;, GO:0005737;GO:0005634;GO:0042826;GO:0046872;GO:0045892;GO:0007286;, C:cytoplasm; C:nucleus;, F:histone deacetylase binding; F:metal ion binding;, P:negative regulation of transcription, DNA-templated; P:spermatid development; scaffold112 indexed_genome mRNA 358886 365344 . + . ID=transcript_13358;O14894 Q17RW9 Q6IB79,Transmembrane 4 L6 family member 5,Tetraspan transmembrane protein L6H;, PF05805;, GO:0016021;GO:0005887;GO:0005765;GO:0005886;GO:0034618;GO:0007049;GO:2000045;, C:integral component of membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane;, F:arginine binding;, P:cell cycle; P:regulation of G1/S transition of mitotic cell cycle; scaffold112 indexed_genome mRNA 366536 368255 . - . ID=transcript_13359;Q7Z5L0 C9JQ15 E9PAU9 E9PGP4 Q3SXP1 Q8IUY1,Vitelline membrane outer layer protein 1 homolog,, PF03762;, GO:0070062;, C:extracellular exosome; scaffold112 indexed_genome mRNA 368303 371821 . + . ID=transcript_13360;A6NH11 A7E2T2,Glycolipid transfer protein domain-containing protein 2,, PF08718;, GO:0005829;GO:0016020;GO:1902387;GO:1902388;GO:0035627;GO:0120009;, C:cytosol; C:membrane;, F:ceramide 1-phosphate binding; F:ceramide 1-phosphate transfer activity;, P:ceramide transport; P:intermembrane lipid transfer; scaffold112 indexed_genome mRNA 374502 377501 . + . ID=transcript_13361;P28072 Q96J55,Proteasome subunit beta type-6,Macropain delta chain;Multicatalytic endopeptidase complex delta chain;Proteasome delta chain;Proteasome subunit Y;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0045296;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:cadherin binding; F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P28072 Q96J55,Proteasome subunit beta type-6,Macropain delta chain;Multicatalytic endopeptidase complex delta chain;Proteasome delta chain;Proteasome subunit Y;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0045296;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:cadherin binding; F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold112 indexed_genome mRNA 388754 398814 . + . ID=transcript_13362;O14939 I3L2C9 O43540 O43579 O43580 Q6PGR0 Q96BY3,Phospholipase D2 {ECO:0000305},Choline phosphatase 2;PLD1C;Phosphatidylcholine-hydrolyzing phospholipase D2;, PF00614;PF13091;PF00787;, GO:0005789;GO:0005886;GO:0098793;GO:0070290;GO:0035091;GO:0004630;GO:0048870;GO:0007010;GO:0038096;GO:0048017;GO:0016042;GO:0006654;GO:0007264;GO:0036465;, C:endoplasmic reticulum membrane; C:plasma membrane; C:presynapse;, F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:phosphatidylinositol binding; F:phospholipase D activity;, P:cell motility; P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inositol lipid-mediated signaling; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:small GTPase mediated signal transduction; P:synaptic vesicle recycling;|O14939 I3L2C9 O43540 O43579 O43580 Q6PGR0 Q96BY3,Phospholipase D2 {ECO:0000305},Choline phosphatase 2;PLD1C;Phosphatidylcholine-hydrolyzing phospholipase D2;, PF00614;PF13091;PF00787;, GO:0005789;GO:0005886;GO:0098793;GO:0070290;GO:0035091;GO:0004630;GO:0048870;GO:0007010;GO:0038096;GO:0048017;GO:0016042;GO:0006654;GO:0007264;GO:0036465;, C:endoplasmic reticulum membrane; C:plasma membrane; C:presynapse;, F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:phosphatidylinositol binding; F:phospholipase D activity;, P:cell motility; P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inositol lipid-mediated signaling; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:small GTPase mediated signal transduction; P:synaptic vesicle recycling; scaffold112 indexed_genome mRNA 398830 406924 . - . ID=transcript_13363;O14939 I3L2C9 O43540 O43579 O43580 Q6PGR0 Q96BY3,Phospholipase D2 {ECO:0000305},Choline phosphatase 2;PLD1C;Phosphatidylcholine-hydrolyzing phospholipase D2;, PF00614;PF13091;PF00787;, GO:0005789;GO:0005886;GO:0098793;GO:0070290;GO:0035091;GO:0004630;GO:0048870;GO:0007010;GO:0038096;GO:0048017;GO:0016042;GO:0006654;GO:0007264;GO:0036465;, C:endoplasmic reticulum membrane; C:plasma membrane; C:presynapse;, F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:phosphatidylinositol binding; F:phospholipase D activity;, P:cell motility; P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inositol lipid-mediated signaling; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:small GTPase mediated signal transduction; P:synaptic vesicle recycling;|O14939 I3L2C9 O43540 O43579 O43580 Q6PGR0 Q96BY3,Phospholipase D2 {ECO:0000305},Choline phosphatase 2;PLD1C;Phosphatidylcholine-hydrolyzing phospholipase D2;, PF00614;PF13091;PF00787;, GO:0005789;GO:0005886;GO:0098793;GO:0070290;GO:0035091;GO:0004630;GO:0048870;GO:0007010;GO:0038096;GO:0048017;GO:0016042;GO:0006654;GO:0007264;GO:0036465;, C:endoplasmic reticulum membrane; C:plasma membrane; C:presynapse;, F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:phosphatidylinositol binding; F:phospholipase D activity;, P:cell motility; P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inositol lipid-mediated signaling; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:small GTPase mediated signal transduction; P:synaptic vesicle recycling;|O14939 I3L2C9 O43540 O43579 O43580 Q6PGR0 Q96BY3,Phospholipase D2 {ECO:0000305},Choline phosphatase 2;PLD1C;Phosphatidylcholine-hydrolyzing phospholipase D2;, PF00614;PF13091;PF00787;, GO:0005789;GO:0005886;GO:0098793;GO:0070290;GO:0035091;GO:0004630;GO:0048870;GO:0007010;GO:0038096;GO:0048017;GO:0016042;GO:0006654;GO:0007264;GO:0036465;, C:endoplasmic reticulum membrane; C:plasma membrane; C:presynapse;, F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:phosphatidylinositol binding; F:phospholipase D activity;, P:cell motility; P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inositol lipid-mediated signaling; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:small GTPase mediated signal transduction; P:synaptic vesicle recycling;|O14939 I3L2C9 O43540 O43579 O43580 Q6PGR0 Q96BY3,Phospholipase D2 {ECO:0000305},Choline phosphatase 2;PLD1C;Phosphatidylcholine-hydrolyzing phospholipase D2;, PF00614;PF13091;PF00787;, GO:0005789;GO:0005886;GO:0098793;GO:0070290;GO:0035091;GO:0004630;GO:0048870;GO:0007010;GO:0038096;GO:0048017;GO:0016042;GO:0006654;GO:0007264;GO:0036465;, C:endoplasmic reticulum membrane; C:plasma membrane; C:presynapse;, F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:phosphatidylinositol binding; F:phospholipase D activity;, P:cell motility; P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inositol lipid-mediated signaling; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:small GTPase mediated signal transduction; P:synaptic vesicle recycling;|O14939 I3L2C9 O43540 O43579 O43580 Q6PGR0 Q96BY3,Phospholipase D2 {ECO:0000305},Choline phosphatase 2;PLD1C;Phosphatidylcholine-hydrolyzing phospholipase D2;, PF00614;PF13091;PF00787;, GO:0005789;GO:0005886;GO:0098793;GO:0070290;GO:0035091;GO:0004630;GO:0048870;GO:0007010;GO:0038096;GO:0048017;GO:0016042;GO:0006654;GO:0007264;GO:0036465;, C:endoplasmic reticulum membrane; C:plasma membrane; C:presynapse;, F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:phosphatidylinositol binding; F:phospholipase D activity;, P:cell motility; P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inositol lipid-mediated signaling; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:small GTPase mediated signal transduction; P:synaptic vesicle recycling;|O14939 I3L2C9 O43540 O43579 O43580 Q6PGR0 Q96BY3,Phospholipase D2 {ECO:0000305},Choline phosphatase 2;PLD1C;Phosphatidylcholine-hydrolyzing phospholipase D2;, PF00614;PF13091;PF00787;, GO:0005789;GO:0005886;GO:0098793;GO:0070290;GO:0035091;GO:0004630;GO:0048870;GO:0007010;GO:0038096;GO:0048017;GO:0016042;GO:0006654;GO:0007264;GO:0036465;, C:endoplasmic reticulum membrane; C:plasma membrane; C:presynapse;, F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:phosphatidylinositol binding; F:phospholipase D activity;, P:cell motility; P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inositol lipid-mediated signaling; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:small GTPase mediated signal transduction; P:synaptic vesicle recycling;|O14939 I3L2C9 O43540 O43579 O43580 Q6PGR0 Q96BY3,Phospholipase D2 {ECO:0000305},Choline phosphatase 2;PLD1C;Phosphatidylcholine-hydrolyzing phospholipase D2;, PF00614;PF13091;PF00787;, GO:0005789;GO:0005886;GO:0098793;GO:0070290;GO:0035091;GO:0004630;GO:0048870;GO:0007010;GO:0038096;GO:0048017;GO:0016042;GO:0006654;GO:0007264;GO:0036465;, C:endoplasmic reticulum membrane; C:plasma membrane; C:presynapse;, F:N-acylphosphatidylethanolamine-specific phospholipase D activity; F:phosphatidylinositol binding; F:phospholipase D activity;, P:cell motility; P:cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:inositol lipid-mediated signaling; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:small GTPase mediated signal transduction; P:synaptic vesicle recycling; scaffold112 indexed_genome mRNA 412921 464574 . + . ID=transcript_13364;Q8N4C8 D3DTK3 D3DTK4 Q5U8Z0 Q9P1X1 Q9P2R8,Misshapen-like kinase 1,GCK family kinase MiNK;MAPK/ERK kinase kinase kinase 6;Misshapen/NIK-related kinase;Mitogen-activated protein kinase kinase kinase kinase 6;, PF00780;PF00069;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005794;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0007268;GO:0048813;GO:0007254;GO:0000165;GO:0007275;GO:0048812;GO:0046330;GO:1900745;GO:0046777;GO:0006468;GO:2000311;GO:0030334;GO:0022407;GO:0001952;GO:0031098;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:Golgi apparatus; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:chemical synaptic transmission; P:dendrite morphogenesis; P:JNK cascade; P:MAPK cascade; P:multicellular organism development; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of AMPA receptor activity; P:regulation of cell migration; P:regulation of cell-cell adhesion; P:regulation of cell-matrix adhesion; P:stress-activated protein kinase signaling cascade;|Q8N4C8 D3DTK3 D3DTK4 Q5U8Z0 Q9P1X1 Q9P2R8,Misshapen-like kinase 1,GCK family kinase MiNK;MAPK/ERK kinase kinase kinase 6;Misshapen/NIK-related kinase;Mitogen-activated protein kinase kinase kinase kinase 6;, PF00780;PF00069;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005794;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0007268;GO:0048813;GO:0007254;GO:0000165;GO:0007275;GO:0048812;GO:0046330;GO:1900745;GO:0046777;GO:0006468;GO:2000311;GO:0030334;GO:0022407;GO:0001952;GO:0031098;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:Golgi apparatus; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:chemical synaptic transmission; P:dendrite morphogenesis; P:JNK cascade; P:MAPK cascade; P:multicellular organism development; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of AMPA receptor activity; P:regulation of cell migration; P:regulation of cell-cell adhesion; P:regulation of cell-matrix adhesion; P:stress-activated protein kinase signaling cascade;|Q8N4C8 D3DTK3 D3DTK4 Q5U8Z0 Q9P1X1 Q9P2R8,Misshapen-like kinase 1,GCK family kinase MiNK;MAPK/ERK kinase kinase kinase 6;Misshapen/NIK-related kinase;Mitogen-activated protein kinase kinase kinase kinase 6;, PF00780;PF00069;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005794;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0007268;GO:0048813;GO:0007254;GO:0000165;GO:0007275;GO:0048812;GO:0046330;GO:1900745;GO:0046777;GO:0006468;GO:2000311;GO:0030334;GO:0022407;GO:0001952;GO:0031098;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:Golgi apparatus; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:chemical synaptic transmission; P:dendrite morphogenesis; P:JNK cascade; P:MAPK cascade; P:multicellular organism development; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of AMPA receptor activity; P:regulation of cell migration; P:regulation of cell-cell adhesion; P:regulation of cell-matrix adhesion; P:stress-activated protein kinase signaling cascade;|Q8N4C8 D3DTK3 D3DTK4 Q5U8Z0 Q9P1X1 Q9P2R8,Misshapen-like kinase 1,GCK family kinase MiNK;MAPK/ERK kinase kinase kinase 6;Misshapen/NIK-related kinase;Mitogen-activated protein kinase kinase kinase kinase 6;, PF00780;PF00069;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005794;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0007268;GO:0048813;GO:0007254;GO:0000165;GO:0007275;GO:0048812;GO:0046330;GO:1900745;GO:0046777;GO:0006468;GO:2000311;GO:0030334;GO:0022407;GO:0001952;GO:0031098;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:Golgi apparatus; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:chemical synaptic transmission; P:dendrite morphogenesis; P:JNK cascade; P:MAPK cascade; P:multicellular organism development; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of AMPA receptor activity; P:regulation of cell migration; P:regulation of cell-cell adhesion; P:regulation of cell-matrix adhesion; P:stress-activated protein kinase signaling cascade;|Q8N4C8 D3DTK3 D3DTK4 Q5U8Z0 Q9P1X1 Q9P2R8,Misshapen-like kinase 1,GCK family kinase MiNK;MAPK/ERK kinase kinase kinase 6;Misshapen/NIK-related kinase;Mitogen-activated protein kinase kinase kinase kinase 6;, PF00780;PF00069;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005794;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0007268;GO:0048813;GO:0007254;GO:0000165;GO:0007275;GO:0048812;GO:0046330;GO:1900745;GO:0046777;GO:0006468;GO:2000311;GO:0030334;GO:0022407;GO:0001952;GO:0031098;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:Golgi apparatus; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:chemical synaptic transmission; P:dendrite morphogenesis; P:JNK cascade; P:MAPK cascade; P:multicellular organism development; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of AMPA receptor activity; P:regulation of cell migration; P:regulation of cell-cell adhesion; P:regulation of cell-matrix adhesion; P:stress-activated protein kinase signaling cascade;|Q8N4C8 D3DTK3 D3DTK4 Q5U8Z0 Q9P1X1 Q9P2R8,Misshapen-like kinase 1,GCK family kinase MiNK;MAPK/ERK kinase kinase kinase 6;Misshapen/NIK-related kinase;Mitogen-activated protein kinase kinase kinase kinase 6;, PF00780;PF00069;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005794;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0007268;GO:0048813;GO:0007254;GO:0000165;GO:0007275;GO:0048812;GO:0046330;GO:1900745;GO:0046777;GO:0006468;GO:2000311;GO:0030334;GO:0022407;GO:0001952;GO:0031098;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:Golgi apparatus; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:chemical synaptic transmission; P:dendrite morphogenesis; P:JNK cascade; P:MAPK cascade; P:multicellular organism development; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of AMPA receptor activity; P:regulation of cell migration; P:regulation of cell-cell adhesion; P:regulation of cell-matrix adhesion; P:stress-activated protein kinase signaling cascade;|Q8N4C8 D3DTK3 D3DTK4 Q5U8Z0 Q9P1X1 Q9P2R8,Misshapen-like kinase 1,GCK family kinase MiNK;MAPK/ERK kinase kinase kinase 6;Misshapen/NIK-related kinase;Mitogen-activated protein kinase kinase kinase kinase 6;, PF00780;PF00069;, GO:0030424;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005794;GO:0014069;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0007268;GO:0048813;GO:0007254;GO:0000165;GO:0007275;GO:0048812;GO:0046330;GO:1900745;GO:0046777;GO:0006468;GO:2000311;GO:0030334;GO:0022407;GO:0001952;GO:0031098;, C:axon; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:Golgi apparatus; C:postsynaptic density;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:chemical synaptic transmission; P:dendrite morphogenesis; P:JNK cascade; P:MAPK cascade; P:multicellular organism development; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of AMPA receptor activity; P:regulation of cell migration; P:regulation of cell-cell adhesion; P:regulation of cell-matrix adhesion; P:stress-activated protein kinase signaling cascade; scaffold112 indexed_genome mRNA 464866 470317 . - . ID=transcript_13365;Q04844 D3DTK6,Acetylcholine receptor subunit epsilon,, PF02931;PF02932;, GO:0005892;GO:0005887;GO:0031594;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0015464;GO:0022848;GO:0008324;GO:0030594;GO:1904315;GO:0007268;GO:0034220;GO:0006936;GO:0050877;GO:0042391;GO:0007165;GO:0007271;, C:acetylcholine-gated channel complex; C:integral component of plasma membrane; C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:cation transmembrane transporter activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:ion transmembrane transport; P:muscle contraction; P:nervous system process; P:regulation of membrane potential; P:signal transduction; P:synaptic transmission, cholinergic;|Q04844 D3DTK6,Acetylcholine receptor subunit epsilon,, PF02931;PF02932;, GO:0005892;GO:0005887;GO:0031594;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0015464;GO:0022848;GO:0008324;GO:0030594;GO:1904315;GO:0007268;GO:0034220;GO:0006936;GO:0050877;GO:0042391;GO:0007165;GO:0007271;, C:acetylcholine-gated channel complex; C:integral component of plasma membrane; C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:cation transmembrane transporter activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:ion transmembrane transport; P:muscle contraction; P:nervous system process; P:regulation of membrane potential; P:signal transduction; P:synaptic transmission, cholinergic;|Q04844 D3DTK6,Acetylcholine receptor subunit epsilon,, PF02931;PF02932;, GO:0005892;GO:0005887;GO:0031594;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0015464;GO:0022848;GO:0008324;GO:0030594;GO:1904315;GO:0007268;GO:0034220;GO:0006936;GO:0050877;GO:0042391;GO:0007165;GO:0007271;, C:acetylcholine-gated channel complex; C:integral component of plasma membrane; C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:cation transmembrane transporter activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:ion transmembrane transport; P:muscle contraction; P:nervous system process; P:regulation of membrane potential; P:signal transduction; P:synaptic transmission, cholinergic;|Q04844 D3DTK6,Acetylcholine receptor subunit epsilon,, PF02931;PF02932;, GO:0005892;GO:0005887;GO:0031594;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0015464;GO:0022848;GO:0008324;GO:0030594;GO:1904315;GO:0007268;GO:0034220;GO:0006936;GO:0050877;GO:0042391;GO:0007165;GO:0007271;, C:acetylcholine-gated channel complex; C:integral component of plasma membrane; C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:cation transmembrane transporter activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:ion transmembrane transport; P:muscle contraction; P:nervous system process; P:regulation of membrane potential; P:signal transduction; P:synaptic transmission, cholinergic;|Q04844 D3DTK6,Acetylcholine receptor subunit epsilon,, PF02931;PF02932;, GO:0005892;GO:0005887;GO:0031594;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0015464;GO:0022848;GO:0008324;GO:0030594;GO:1904315;GO:0007268;GO:0034220;GO:0006936;GO:0050877;GO:0042391;GO:0007165;GO:0007271;, C:acetylcholine-gated channel complex; C:integral component of plasma membrane; C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;, F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:cation transmembrane transporter activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:ion transmembrane transport; P:muscle contraction; P:nervous system process; P:regulation of membrane potential; P:signal transduction; P:synaptic transmission, cholinergic; scaffold112 indexed_genome mRNA 477444 481474 . + . ID=transcript_13366;O00193 B2RD28,Small acidic protein,, PF15477; scaffold112 indexed_genome mRNA 492803 495776 . + . ID=transcript_13367;P07359 E7ES66 Q14441 Q16469 Q8N1F3 Q8NG39 Q9HDC7 Q9UEK1 Q9UQS4,Platelet glycoprotein Ib alpha chain,Antigen CD42b-alpha;, PF13855;PF01462;, GO:0031362;GO:0009986;GO:0070062;GO:0031012;GO:0005615;GO:0005887;GO:0016020;GO:0005886;GO:0015057;GO:0007596;GO:0007597;GO:0007155;GO:0000902;GO:0007166;GO:0042730;GO:0030168;GO:0070527;GO:0030193;GO:0045652;, C:anchored component of external side of plasma membrane; C:cell surface; C:extracellular exosome; C:extracellular matrix; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:thrombin-activated receptor activity;, P:blood coagulation; P:blood coagulation, intrinsic pathway; P:cell adhesion; P:cell morphogenesis; P:cell surface receptor signaling pathway; P:fibrinolysis; P:platelet activation; P:platelet aggregation; P:regulation of blood coagulation; P:regulation of megakaryocyte differentiation; scaffold112 indexed_genome mRNA 495950 502245 . - . ID=transcript_13368;Q02978 F5GY65 O75537 Q969P7,Mitochondrial 2-oxoglutarate/malate carrier protein,Solute carrier family 25 member 11;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0005634;GO:0015297;GO:0015140;GO:0015131;GO:0015367;GO:0003723;GO:0015141;GO:0015116;GO:0015117;GO:0006094;GO:0071423;GO:0015729;GO:0035435;GO:0071422;GO:0008272;GO:0015709;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:antiporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:oxoglutarate:malate antiporter activity; F:RNA binding; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:gluconeogenesis; P:malate transmembrane transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:thiosulfate transport;|Q02978 F5GY65 O75537 Q969P7,Mitochondrial 2-oxoglutarate/malate carrier protein,Solute carrier family 25 member 11;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0005634;GO:0015297;GO:0015140;GO:0015131;GO:0015367;GO:0003723;GO:0015141;GO:0015116;GO:0015117;GO:0006094;GO:0071423;GO:0015729;GO:0035435;GO:0071422;GO:0008272;GO:0015709;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:antiporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:oxoglutarate:malate antiporter activity; F:RNA binding; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:gluconeogenesis; P:malate transmembrane transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:thiosulfate transport;|Q02978 F5GY65 O75537 Q969P7,Mitochondrial 2-oxoglutarate/malate carrier protein,Solute carrier family 25 member 11;, PF00153;, GO:0005887;GO:0005743;GO:0005739;GO:0005634;GO:0015297;GO:0015140;GO:0015131;GO:0015367;GO:0003723;GO:0015141;GO:0015116;GO:0015117;GO:0006094;GO:0071423;GO:0015729;GO:0035435;GO:0071422;GO:0008272;GO:0015709;, C:integral component of plasma membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:antiporter activity; F:malate transmembrane transporter activity; F:oxaloacetate transmembrane transporter activity; F:oxoglutarate:malate antiporter activity; F:RNA binding; F:succinate transmembrane transporter activity; F:sulfate transmembrane transporter activity; F:thiosulfate transmembrane transporter activity;, P:gluconeogenesis; P:malate transmembrane transport; P:oxaloacetate transport; P:phosphate ion transmembrane transport; P:succinate transmembrane transport; P:sulfate transport; P:thiosulfate transport; scaffold112 indexed_genome mRNA 502256 505026 . + . ID=transcript_13369;Q9H6Y7 D3DTK8 Q6XYE0 Q8NDC1 Q9Y3V1,E3 ubiquitin-protein ligase RNF167,RING finger protein 167;RING-type E3 ubiquitin transferase RNF167 {ECO:0000305};RING105;, PF02225;PF13639;, GO:0005737;GO:0012505;GO:0016021;GO:0061630;GO:0004842;GO:0008270;GO:0045786;GO:0000209;GO:0006511;, C:cytoplasm; C:endomembrane system; C:integral component of membrane;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:negative regulation of cell cycle; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9H6Y7 D3DTK8 Q6XYE0 Q8NDC1 Q9Y3V1,E3 ubiquitin-protein ligase RNF167,RING finger protein 167;RING-type E3 ubiquitin transferase RNF167 {ECO:0000305};RING105;, PF02225;PF13639;, GO:0005737;GO:0012505;GO:0016021;GO:0061630;GO:0004842;GO:0008270;GO:0045786;GO:0000209;GO:0006511;, C:cytoplasm; C:endomembrane system; C:integral component of membrane;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:negative regulation of cell cycle; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold112 indexed_genome mRNA 505757 507315 . + . ID=transcript_13370;P07737 Q53Y44,Profilin-1,Epididymis tissue protein Li 184a;Profilin I;, PF00235;, GO:0072562;GO:0005938;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0003779;GO:0003785;GO:0000774;GO:0045296;GO:0005546;GO:0001784;GO:0070064;GO:0003723;GO:0030036;GO:0032232;GO:0030837;GO:0051497;GO:0032233;GO:0030838;GO:0032781;GO:0010634;GO:1900029;GO:0050821;GO:0030833;GO:0060071;, C:blood microparticle; C:cell cortex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus;, F:actin binding; F:actin monomer binding; F:adenyl-nucleotide exchange factor activity; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphotyrosine residue binding; F:proline-rich region binding; F:RNA binding;, P:actin cytoskeleton organization; P:negative regulation of actin filament bundle assembly; P:negative regulation of actin filament polymerization; P:negative regulation of stress fiber assembly; P:positive regulation of actin filament bundle assembly; P:positive regulation of actin filament polymerization; P:positive regulation of ATPase activity; P:positive regulation of epithelial cell migration; P:positive regulation of ruffle assembly; P:protein stabilization; P:regulation of actin filament polymerization; P:Wnt signaling pathway, planar cell polarity pathway;|P07737 Q53Y44,Profilin-1,Epididymis tissue protein Li 184a;Profilin I;, PF00235;, GO:0072562;GO:0005938;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0003779;GO:0003785;GO:0000774;GO:0045296;GO:0005546;GO:0001784;GO:0070064;GO:0003723;GO:0030036;GO:0032232;GO:0030837;GO:0051497;GO:0032233;GO:0030838;GO:0032781;GO:0010634;GO:1900029;GO:0050821;GO:0030833;GO:0060071;, C:blood microparticle; C:cell cortex; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus;, F:actin binding; F:actin monomer binding; F:adenyl-nucleotide exchange factor activity; F:cadherin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphotyrosine residue binding; F:proline-rich region binding; F:RNA binding;, P:actin cytoskeleton organization; P:negative regulation of actin filament bundle assembly; P:negative regulation of actin filament polymerization; P:negative regulation of stress fiber assembly; P:positive regulation of actin filament bundle assembly; P:positive regulation of actin filament polymerization; P:positive regulation of ATPase activity; P:positive regulation of epithelial cell migration; P:positive regulation of ruffle assembly; P:protein stabilization; P:regulation of actin filament polymerization; P:Wnt signaling pathway, planar cell polarity pathway; scaffold112 indexed_genome mRNA 507390 516136 . + . ID=transcript_13371;P13929 B4DUI6 B4DUM6 D3DTL2 E7ENK8 Q96AE2,Beta-enolase,2-phospho-D-glycerate hydro-lyase;Enolase 3;Muscle-specific enolase;Skeletal muscle enolase;, PF00113;PF03952;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0000015;GO:0005886;GO:0042802;GO:0000287;GO:0004634;GO:0044877;GO:0007568;GO:0061621;GO:0006094;GO:0006096;GO:0032889;GO:0042493;GO:0043403;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:phosphopyruvate hydratase complex; C:plasma membrane;, F:identical protein binding; F:magnesium ion binding; F:phosphopyruvate hydratase activity; F:protein-containing complex binding;, P:aging; P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:regulation of vacuole fusion, non-autophagic; P:response to drug; P:skeletal muscle tissue regeneration;|P13929 B4DUI6 B4DUM6 D3DTL2 E7ENK8 Q96AE2,Beta-enolase,2-phospho-D-glycerate hydro-lyase;Enolase 3;Muscle-specific enolase;Skeletal muscle enolase;, PF00113;PF03952;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0000015;GO:0005886;GO:0042802;GO:0000287;GO:0004634;GO:0044877;GO:0007568;GO:0061621;GO:0006094;GO:0006096;GO:0032889;GO:0042493;GO:0043403;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:phosphopyruvate hydratase complex; C:plasma membrane;, F:identical protein binding; F:magnesium ion binding; F:phosphopyruvate hydratase activity; F:protein-containing complex binding;, P:aging; P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:regulation of vacuole fusion, non-autophagic; P:response to drug; P:skeletal muscle tissue regeneration;|P13929 B4DUI6 B4DUM6 D3DTL2 E7ENK8 Q96AE2,Beta-enolase,2-phospho-D-glycerate hydro-lyase;Enolase 3;Muscle-specific enolase;Skeletal muscle enolase;, PF00113;PF03952;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0000015;GO:0005886;GO:0042802;GO:0000287;GO:0004634;GO:0044877;GO:0007568;GO:0061621;GO:0006094;GO:0006096;GO:0032889;GO:0042493;GO:0043403;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:phosphopyruvate hydratase complex; C:plasma membrane;, F:identical protein binding; F:magnesium ion binding; F:phosphopyruvate hydratase activity; F:protein-containing complex binding;, P:aging; P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:regulation of vacuole fusion, non-autophagic; P:response to drug; P:skeletal muscle tissue regeneration;|P13929 B4DUI6 B4DUM6 D3DTL2 E7ENK8 Q96AE2,Beta-enolase,2-phospho-D-glycerate hydro-lyase;Enolase 3;Muscle-specific enolase;Skeletal muscle enolase;, PF00113;PF03952;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0000015;GO:0005886;GO:0042802;GO:0000287;GO:0004634;GO:0044877;GO:0007568;GO:0061621;GO:0006094;GO:0006096;GO:0032889;GO:0042493;GO:0043403;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:phosphopyruvate hydratase complex; C:plasma membrane;, F:identical protein binding; F:magnesium ion binding; F:phosphopyruvate hydratase activity; F:protein-containing complex binding;, P:aging; P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:regulation of vacuole fusion, non-autophagic; P:response to drug; P:skeletal muscle tissue regeneration; scaffold112 indexed_genome mRNA 516951 535420 . - . ID=transcript_13372;O94983 B9EGL0 D3DTL5 E7EWU5 Q7Z6M8 Q8N3V0 Q8NDG4 Q96G17,Calmodulin-binding transcription activator 2,, PF03859;PF01833;, GO:0000785;GO:0005634;GO:0003682;GO:0003690;GO:0042826;GO:0043565;GO:0003713;GO:0003712;GO:0008134;GO:0014898;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:histone deacetylase binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cardiac muscle hypertrophy in response to stress; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O75391 Q96EU5,Sperm-associated antigen 7,, PF01424;, GO:0005634;GO:0003676;, C:nucleus;, F:nucleic acid binding;|O94983 B9EGL0 D3DTL5 E7EWU5 Q7Z6M8 Q8N3V0 Q8NDG4 Q96G17,Calmodulin-binding transcription activator 2,, PF03859;PF01833;, GO:0000785;GO:0005634;GO:0003682;GO:0003690;GO:0042826;GO:0043565;GO:0003713;GO:0003712;GO:0008134;GO:0014898;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:histone deacetylase binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cardiac muscle hypertrophy in response to stress; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O94983 B9EGL0 D3DTL5 E7EWU5 Q7Z6M8 Q8N3V0 Q8NDG4 Q96G17,Calmodulin-binding transcription activator 2,, PF03859;PF01833;, GO:0000785;GO:0005634;GO:0003682;GO:0003690;GO:0042826;GO:0043565;GO:0003713;GO:0003712;GO:0008134;GO:0014898;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:histone deacetylase binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cardiac muscle hypertrophy in response to stress; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O94983 B9EGL0 D3DTL5 E7EWU5 Q7Z6M8 Q8N3V0 Q8NDG4 Q96G17,Calmodulin-binding transcription activator 2,, PF03859;PF01833;, GO:0000785;GO:0005634;GO:0003682;GO:0003690;GO:0042826;GO:0043565;GO:0003713;GO:0003712;GO:0008134;GO:0014898;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:histone deacetylase binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cardiac muscle hypertrophy in response to stress; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O94983 B9EGL0 D3DTL5 E7EWU5 Q7Z6M8 Q8N3V0 Q8NDG4 Q96G17,Calmodulin-binding transcription activator 2,, PF03859;PF01833;, GO:0000785;GO:0005634;GO:0003682;GO:0003690;GO:0042826;GO:0043565;GO:0003713;GO:0003712;GO:0008134;GO:0014898;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:histone deacetylase binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cardiac muscle hypertrophy in response to stress; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O94983 B9EGL0 D3DTL5 E7EWU5 Q7Z6M8 Q8N3V0 Q8NDG4 Q96G17,Calmodulin-binding transcription activator 2,, PF03859;PF01833;, GO:0000785;GO:0005634;GO:0003682;GO:0003690;GO:0042826;GO:0043565;GO:0003713;GO:0003712;GO:0008134;GO:0014898;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:histone deacetylase binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cardiac muscle hypertrophy in response to stress; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O94983 B9EGL0 D3DTL5 E7EWU5 Q7Z6M8 Q8N3V0 Q8NDG4 Q96G17,Calmodulin-binding transcription activator 2,, PF03859;PF01833;, GO:0000785;GO:0005634;GO:0003682;GO:0003690;GO:0042826;GO:0043565;GO:0003713;GO:0003712;GO:0008134;GO:0014898;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:histone deacetylase binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cardiac muscle hypertrophy in response to stress; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|O94983 B9EGL0 D3DTL5 E7EWU5 Q7Z6M8 Q8N3V0 Q8NDG4 Q96G17,Calmodulin-binding transcription activator 2,, PF03859;PF01833;, GO:0000785;GO:0005634;GO:0003682;GO:0003690;GO:0042826;GO:0043565;GO:0003713;GO:0003712;GO:0008134;GO:0014898;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:histone deacetylase binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription factor binding;, P:cardiac muscle hypertrophy in response to stress; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold112 indexed_genome mRNA 546633 547278 . - . ID=transcript_13373;O43896 D3DTL6 O75186 Q5U618,Kinesin-like protein KIF1C,, PF00498;PF00225;PF16183;, GO:0030424;GO:1904115;GO:0030425;GO:0005783;GO:0005794;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0003723;GO:1990048;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0016192;, C:axon; C:axon cytoplasm; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity; F:RNA binding;, P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport; scaffold112 indexed_genome mRNA 551194 554863 . - . ID=transcript_13374;O43896 D3DTL6 O75186 Q5U618,Kinesin-like protein KIF1C,, PF00498;PF00225;PF16183;, GO:0030424;GO:1904115;GO:0030425;GO:0005783;GO:0005794;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0003723;GO:1990048;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0016192;, C:axon; C:axon cytoplasm; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity; F:RNA binding;, P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport; scaffold112 indexed_genome mRNA 555441 556979 . + . ID=transcript_13375;O43896 D3DTL6 O75186 Q5U618,Kinesin-like protein KIF1C,, PF00498;PF00225;PF16183;, GO:0030424;GO:1904115;GO:0030425;GO:0005783;GO:0005794;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0003723;GO:1990048;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0016192;, C:axon; C:axon cytoplasm; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity; F:RNA binding;, P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport; scaffold112 indexed_genome mRNA 558617 560269 . + . ID=transcript_13376;O43896 D3DTL6 O75186 Q5U618,Kinesin-like protein KIF1C,, PF00498;PF00225;PF16183;, GO:0030424;GO:1904115;GO:0030425;GO:0005783;GO:0005794;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0003723;GO:1990048;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0016192;, C:axon; C:axon cytoplasm; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity; F:RNA binding;, P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport; scaffold112 indexed_genome mRNA 603420 611813 . + . ID=transcript_13377;Q96NJ6 A5PLL4,Zinc finger protein 3 homolog,Zinc finger protein 752;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold112 indexed_genome mRNA 617136 621344 . - . ID=transcript_13378;Q9UNY5,Zinc finger protein 232,Zinc finger and SCAN domain-containing protein 11;, PF02023;PF00096;, GO:0005829;GO:0043231;GO:0005654;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold112 indexed_genome mRNA 625837 634560 . - . ID=transcript_13379;Q96JF6 Q6RFS0,Zinc finger protein 594,Zinc finger protein HZF18;, PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold112 indexed_genome mRNA 647467 662568 . - . ID=transcript_13380;Q6UWF3 A6XGL4 B4DLK1 Q96MD0,SLP adapter and CSK-interacting membrane protein,SLP65/SLP76, Csk-interacting membrane protein;, PF15050;, GO:0030175;GO:0001772;GO:0016021;GO:0031256;GO:0016020;GO:0045335;GO:0043235;GO:0001726;GO:0097197;GO:0031259;GO:0060090;GO:0071226;GO:0002720;GO:0002732;GO:0070374;GO:0032735;GO:0032755;GO:0031666;GO:0032874;GO:0034138;GO:0034142;GO:0034154;GO:0038123;, C:filopodium; C:immunological synapse; C:integral component of membrane; C:leading edge membrane; C:membrane; C:phagocytic vesicle; C:receptor complex; C:ruffle; C:tetraspanin-enriched microdomain; C:uropod membrane;, F:molecular adaptor activity;, P:cellular response to molecule of fungal origin; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-6 production; P:positive regulation of lipopolysaccharide-mediated signaling pathway; P:positive regulation of stress-activated MAPK cascade; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 4 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor TLR1:TLR2 signaling pathway; scaffold112 indexed_genome mRNA 758006 761641 . + . ID=transcript_13381;Q15276 B2RAG7 O95369 Q8IVX3,Rab GTPase-binding effector protein 1,Rabaptin-4;Rabaptin-5;Rabaptin-5alpha;Renal carcinoma antigen NY-REN-17;, PF09311;PF03528;, GO:0005769;GO:0031901;GO:0030139;GO:0005768;GO:0043231;GO:0032991;GO:0055037;GO:0008083;GO:0005096;GO:0019904;GO:0042803;GO:0006915;GO:0006897;GO:0006893;GO:0061025;GO:1903441;GO:0015031;GO:0016192;, C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endosome; C:intracellular membrane-bounded organelle; C:protein-containing complex; C:recycling endosome;, F:growth factor activity; F:GTPase activator activity; F:protein domain specific binding; F:protein homodimerization activity;, P:apoptotic process; P:endocytosis; P:Golgi to plasma membrane transport; P:membrane fusion; P:protein localization to ciliary membrane; P:protein transport; P:vesicle-mediated transport; scaffold112 indexed_genome mRNA 765112 765672 . - . ID=transcript_13382;Q15276 B2RAG7 O95369 Q8IVX3,Rab GTPase-binding effector protein 1,Rabaptin-4;Rabaptin-5;Rabaptin-5alpha;Renal carcinoma antigen NY-REN-17;, PF09311;PF03528;, GO:0005769;GO:0031901;GO:0030139;GO:0005768;GO:0043231;GO:0032991;GO:0055037;GO:0008083;GO:0005096;GO:0019904;GO:0042803;GO:0006915;GO:0006897;GO:0006893;GO:0061025;GO:1903441;GO:0015031;GO:0016192;, C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endosome; C:intracellular membrane-bounded organelle; C:protein-containing complex; C:recycling endosome;, F:growth factor activity; F:GTPase activator activity; F:protein domain specific binding; F:protein homodimerization activity;, P:apoptotic process; P:endocytosis; P:Golgi to plasma membrane transport; P:membrane fusion; P:protein localization to ciliary membrane; P:protein transport; P:vesicle-mediated transport; scaffold112 indexed_genome mRNA 790376 791994 . - . ID=transcript_13383;Q15276 B2RAG7 O95369 Q8IVX3,Rab GTPase-binding effector protein 1,Rabaptin-4;Rabaptin-5;Rabaptin-5alpha;Renal carcinoma antigen NY-REN-17;, PF09311;PF03528;, GO:0005769;GO:0031901;GO:0030139;GO:0005768;GO:0043231;GO:0032991;GO:0055037;GO:0008083;GO:0005096;GO:0019904;GO:0042803;GO:0006915;GO:0006897;GO:0006893;GO:0061025;GO:1903441;GO:0015031;GO:0016192;, C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endosome; C:intracellular membrane-bounded organelle; C:protein-containing complex; C:recycling endosome;, F:growth factor activity; F:GTPase activator activity; F:protein domain specific binding; F:protein homodimerization activity;, P:apoptotic process; P:endocytosis; P:Golgi to plasma membrane transport; P:membrane fusion; P:protein localization to ciliary membrane; P:protein transport; P:vesicle-mediated transport; scaffold112 indexed_genome mRNA 794680 799032 . + . ID=transcript_13384;Q15276 B2RAG7 O95369 Q8IVX3,Rab GTPase-binding effector protein 1,Rabaptin-4;Rabaptin-5;Rabaptin-5alpha;Renal carcinoma antigen NY-REN-17;, PF09311;PF03528;, GO:0005769;GO:0031901;GO:0030139;GO:0005768;GO:0043231;GO:0032991;GO:0055037;GO:0008083;GO:0005096;GO:0019904;GO:0042803;GO:0006915;GO:0006897;GO:0006893;GO:0061025;GO:1903441;GO:0015031;GO:0016192;, C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endosome; C:intracellular membrane-bounded organelle; C:protein-containing complex; C:recycling endosome;, F:growth factor activity; F:GTPase activator activity; F:protein domain specific binding; F:protein homodimerization activity;, P:apoptotic process; P:endocytosis; P:Golgi to plasma membrane transport; P:membrane fusion; P:protein localization to ciliary membrane; P:protein transport; P:vesicle-mediated transport; scaffold112 indexed_genome mRNA 803571 825044 . - . ID=transcript_13385;Q99567 D3DTM2 Q9BWE5,Nuclear pore complex protein Nup88,88 kDa nucleoporin;Nucleoporin Nup88;, PF10168;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0017056;GO:0005215;GO:0075733;GO:0000278;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0000055;GO:0000056;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:structural constituent of nuclear pore; F:transporter activity;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q99567 D3DTM2 Q9BWE5,Nuclear pore complex protein Nup88,88 kDa nucleoporin;Nucleoporin Nup88;, PF10168;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0017056;GO:0005215;GO:0075733;GO:0000278;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0000055;GO:0000056;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:structural constituent of nuclear pore; F:transporter activity;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q99567 D3DTM2 Q9BWE5,Nuclear pore complex protein Nup88,88 kDa nucleoporin;Nucleoporin Nup88;, PF10168;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0017056;GO:0005215;GO:0075733;GO:0000278;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0000055;GO:0000056;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:structural constituent of nuclear pore; F:transporter activity;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q99567 D3DTM2 Q9BWE5,Nuclear pore complex protein Nup88,88 kDa nucleoporin;Nucleoporin Nup88;, PF10168;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0017056;GO:0005215;GO:0075733;GO:0000278;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0000055;GO:0000056;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:structural constituent of nuclear pore; F:transporter activity;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q99567 D3DTM2 Q9BWE5,Nuclear pore complex protein Nup88,88 kDa nucleoporin;Nucleoporin Nup88;, PF10168;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0017056;GO:0005215;GO:0075733;GO:0000278;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0000055;GO:0000056;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:structural constituent of nuclear pore; F:transporter activity;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q99567 D3DTM2 Q9BWE5,Nuclear pore complex protein Nup88,88 kDa nucleoporin;Nucleoporin Nup88;, PF10168;, GO:0005829;GO:0043657;GO:0005643;GO:0005654;GO:0017056;GO:0005215;GO:0075733;GO:0000278;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0000055;GO:0000056;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:cytosol; C:host cell; C:nuclear pore; C:nucleoplasm;, F:structural constituent of nuclear pore; F:transporter activity;, P:intracellular transport of virus; P:mitotic cell cycle; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold112 indexed_genome mRNA 825085 837436 . + . ID=transcript_13386;Q4G2Y8 Q6B4V9 Q6B4W0 Q6B4W1 Q6B4W4 Q86X49 Q9BT00,RPA-interacting protein,, PF14768;PF14767;PF14766;, GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0016605;GO:0046872;GO:0044877;GO:0006310;GO:0006281;GO:0006261;GO:0006606;GO:0009411;, C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus; C:PML body;, F:metal ion binding; F:protein-containing complex binding;, P:DNA recombination; P:DNA repair; P:DNA-dependent DNA replication; P:protein import into nucleus; P:response to UV;|Q4G2Y8 Q6B4V9 Q6B4W0 Q6B4W1 Q6B4W4 Q86X49 Q9BT00,RPA-interacting protein,, PF14768;PF14767;PF14766;, GO:0005737;GO:0001650;GO:0005654;GO:0005634;GO:0016605;GO:0046872;GO:0044877;GO:0006310;GO:0006281;GO:0006261;GO:0006606;GO:0009411;, C:cytoplasm; C:fibrillar center; C:nucleoplasm; C:nucleus; C:PML body;, F:metal ion binding; F:protein-containing complex binding;, P:DNA recombination; P:DNA repair; P:DNA-dependent DNA replication; P:protein import into nucleus; P:response to UV;|Q07021 Q2HXR8 Q9NNY8,Complement component 1 Q subcomponent-binding protein, mitochondrial,ASF/SF2-associated protein p32;Glycoprotein gC1qBP;Hyaluronan-binding protein 1;Mitochondrial matrix protein p32;gC1q-R protein;p33;, PF02330;, GO:0009986;GO:0005737;GO:0005829;GO:0005615;GO:0098982;GO:0098978;GO:0016020;GO:0005759;GO:0005739;GO:0005730;GO:0005634;GO:0005886;GO:0048786;GO:0031690;GO:0001849;GO:0005540;GO:0030984;GO:0097177;GO:0003729;GO:0005080;GO:0003714;GO:0008134;GO:0008494;GO:0007597;GO:0006958;GO:0006955;GO:0045087;GO:0097193;GO:0042256;GO:0006397;GO:0050687;GO:0032689;GO:0032695;GO:0039534;GO:0048025;GO:0039536;GO:0000122;GO:0014065;GO:0043065;GO:0045785;GO:2000510;GO:0070131;GO:0090023;GO:0051897;GO:1900026;GO:1901165;GO:0030449;GO:0008380;GO:0016032;, C:cell surface; C:cytoplasm; C:cytosol; C:extracellular space; C:GABA-ergic synapse; C:glutamatergic synapse; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleolus; C:nucleus; C:plasma membrane; C:presynaptic active zone;, F:adrenergic receptor binding; F:complement component C1q complex binding; F:hyaluronic acid binding; F:kininogen binding; F:mitochondrial ribosome binding; F:mRNA binding; F:protein kinase C binding; F:transcription corepressor activity; F:transcription factor binding; F:translation activator activity;, P:blood coagulation, intrinsic pathway; P:complement activation, classical pathway; P:immune response; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:mature ribosome assembly; P:mRNA processing; P:negative regulation of defense response to virus; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-12 production; P:negative regulation of MDA-5 signaling pathway; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of RIG-I signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of mitochondrial translation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein kinase B signaling; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of trophoblast cell migration; P:regulation of complement activation; P:RNA splicing; P:viral process;|Q07021 Q2HXR8 Q9NNY8,Complement component 1 Q subcomponent-binding protein, mitochondrial,ASF/SF2-associated protein p32;Glycoprotein gC1qBP;Hyaluronan-binding protein 1;Mitochondrial matrix protein p32;gC1q-R protein;p33;, PF02330;, GO:0009986;GO:0005737;GO:0005829;GO:0005615;GO:0098982;GO:0098978;GO:0016020;GO:0005759;GO:0005739;GO:0005730;GO:0005634;GO:0005886;GO:0048786;GO:0031690;GO:0001849;GO:0005540;GO:0030984;GO:0097177;GO:0003729;GO:0005080;GO:0003714;GO:0008134;GO:0008494;GO:0007597;GO:0006958;GO:0006955;GO:0045087;GO:0097193;GO:0042256;GO:0006397;GO:0050687;GO:0032689;GO:0032695;GO:0039534;GO:0048025;GO:0039536;GO:0000122;GO:0014065;GO:0043065;GO:0045785;GO:2000510;GO:0070131;GO:0090023;GO:0051897;GO:1900026;GO:1901165;GO:0030449;GO:0008380;GO:0016032;, C:cell surface; C:cytoplasm; C:cytosol; C:extracellular space; C:GABA-ergic synapse; C:glutamatergic synapse; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleolus; C:nucleus; C:plasma membrane; C:presynaptic active zone;, F:adrenergic receptor binding; F:complement component C1q complex binding; F:hyaluronic acid binding; F:kininogen binding; F:mitochondrial ribosome binding; F:mRNA binding; F:protein kinase C binding; F:transcription corepressor activity; F:transcription factor binding; F:translation activator activity;, P:blood coagulation, intrinsic pathway; P:complement activation, classical pathway; P:immune response; P:innate immune response; P:intrinsic apoptotic signaling pathway; P:mature ribosome assembly; P:mRNA processing; P:negative regulation of defense response to virus; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-12 production; P:negative regulation of MDA-5 signaling pathway; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of RIG-I signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of mitochondrial translation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein kinase B signaling; P:positive regulation of substrate adhesion-dependent cell spreading; P:positive regulation of trophoblast cell migration; P:regulation of complement activation; P:RNA splicing; P:viral process; scaffold112 indexed_genome mRNA 839307 859390 . - . ID=transcript_13387;Q9H6R0 B4DHF9 Q4G149 Q5CZ73 Q9H5M9,ATP-dependent RNA helicase DHX33 {ECO:0000305},DEAH box protein 33;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0072559;GO:0005730;GO:0005654;GO:0005634;GO:0033613;GO:0005524;GO:0003725;GO:0003729;GO:0000182;GO:0043023;GO:0003723;GO:0003724;GO:0043410;GO:0051092;GO:1900227;GO:0045943;GO:0032481;GO:0006413;, C:cytoplasm; C:NLRP3 inflammasome complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:ATP binding; F:double-stranded RNA binding; F:mRNA binding; F:rDNA binding; F:ribosomal large subunit binding; F:RNA binding; F:RNA helicase activity;, P:positive regulation of MAPK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of type I interferon production; P:translational initiation;|Q9H6R0 B4DHF9 Q4G149 Q5CZ73 Q9H5M9,ATP-dependent RNA helicase DHX33 {ECO:0000305},DEAH box protein 33;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0072559;GO:0005730;GO:0005654;GO:0005634;GO:0033613;GO:0005524;GO:0003725;GO:0003729;GO:0000182;GO:0043023;GO:0003723;GO:0003724;GO:0043410;GO:0051092;GO:1900227;GO:0045943;GO:0032481;GO:0006413;, C:cytoplasm; C:NLRP3 inflammasome complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:ATP binding; F:double-stranded RNA binding; F:mRNA binding; F:rDNA binding; F:ribosomal large subunit binding; F:RNA binding; F:RNA helicase activity;, P:positive regulation of MAPK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of type I interferon production; P:translational initiation;|Q9H6R0 B4DHF9 Q4G149 Q5CZ73 Q9H5M9,ATP-dependent RNA helicase DHX33 {ECO:0000305},DEAH box protein 33;, PF00270;PF04408;PF00271;PF07717;, GO:0005737;GO:0072559;GO:0005730;GO:0005654;GO:0005634;GO:0033613;GO:0005524;GO:0003725;GO:0003729;GO:0000182;GO:0043023;GO:0003723;GO:0003724;GO:0043410;GO:0051092;GO:1900227;GO:0045943;GO:0032481;GO:0006413;, C:cytoplasm; C:NLRP3 inflammasome complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:ATP binding; F:double-stranded RNA binding; F:mRNA binding; F:rDNA binding; F:ribosomal large subunit binding; F:RNA binding; F:RNA helicase activity;, P:positive regulation of MAPK cascade; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NLRP3 inflammasome complex assembly; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of type I interferon production; P:translational initiation; scaffold112 indexed_genome mRNA 867625 869739 . + . ID=transcript_13388;Q9GZP9 Q9Y3A7,Derlin-2 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 2;Der1-like protein 2 {ECO:0000303|PubMed:15215855};F-LAN-1 {ECO:0000312|EMBL:AAG43049.1};F-LANa {ECO:0000303|PubMed:11500051};, PF04511;, GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0005770;GO:0016020;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:1904380;GO:0030968;GO:1904153;GO:0030307;GO:0008284;GO:0030970;GO:0001967;GO:0030433;GO:0016032;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:late endosome; C:membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:retrograde protein transport, ER to cytosol; P:suckling behavior; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9GZP9 Q9Y3A7,Derlin-2 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 2;Der1-like protein 2 {ECO:0000303|PubMed:15215855};F-LAN-1 {ECO:0000312|EMBL:AAG43049.1};F-LANa {ECO:0000303|PubMed:11500051};, PF04511;, GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0005770;GO:0016020;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:1904380;GO:0030968;GO:1904153;GO:0030307;GO:0008284;GO:0030970;GO:0001967;GO:0030433;GO:0016032;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:late endosome; C:membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:retrograde protein transport, ER to cytosol; P:suckling behavior; P:ubiquitin-dependent ERAD pathway; P:viral process; scaffold112 indexed_genome mRNA 870191 876662 . + . ID=transcript_13389;Q9GZP9 Q9Y3A7,Derlin-2 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 2;Der1-like protein 2 {ECO:0000303|PubMed:15215855};F-LAN-1 {ECO:0000312|EMBL:AAG43049.1};F-LANa {ECO:0000303|PubMed:11500051};, PF04511;, GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0005770;GO:0016020;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:1904380;GO:0030968;GO:1904153;GO:0030307;GO:0008284;GO:0030970;GO:0001967;GO:0030433;GO:0016032;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:late endosome; C:membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:retrograde protein transport, ER to cytosol; P:suckling behavior; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9GZP9 Q9Y3A7,Derlin-2 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 2;Der1-like protein 2 {ECO:0000303|PubMed:15215855};F-LAN-1 {ECO:0000312|EMBL:AAG43049.1};F-LANa {ECO:0000303|PubMed:11500051};, PF04511;, GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0005770;GO:0016020;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:1904380;GO:0030968;GO:1904153;GO:0030307;GO:0008284;GO:0030970;GO:0001967;GO:0030433;GO:0016032;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:late endosome; C:membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:retrograde protein transport, ER to cytosol; P:suckling behavior; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9GZP9 Q9Y3A7,Derlin-2 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 2;Der1-like protein 2 {ECO:0000303|PubMed:15215855};F-LAN-1 {ECO:0000312|EMBL:AAG43049.1};F-LANa {ECO:0000303|PubMed:11500051};, PF04511;, GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0005770;GO:0016020;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:1904380;GO:0030968;GO:1904153;GO:0030307;GO:0008284;GO:0030970;GO:0001967;GO:0030433;GO:0016032;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:late endosome; C:membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:retrograde protein transport, ER to cytosol; P:suckling behavior; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9GZP9 Q9Y3A7,Derlin-2 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 2;Der1-like protein 2 {ECO:0000303|PubMed:15215855};F-LAN-1 {ECO:0000312|EMBL:AAG43049.1};F-LANa {ECO:0000303|PubMed:11500051};, PF04511;, GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0005770;GO:0016020;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:1904380;GO:0030968;GO:1904153;GO:0030307;GO:0008284;GO:0030970;GO:0001967;GO:0030433;GO:0016032;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:late endosome; C:membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:retrograde protein transport, ER to cytosol; P:suckling behavior; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9GZP9 Q9Y3A7,Derlin-2 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 2;Der1-like protein 2 {ECO:0000303|PubMed:15215855};F-LAN-1 {ECO:0000312|EMBL:AAG43049.1};F-LANa {ECO:0000303|PubMed:11500051};, PF04511;, GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0005770;GO:0016020;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:1904380;GO:0030968;GO:1904153;GO:0030307;GO:0008284;GO:0030970;GO:0001967;GO:0030433;GO:0016032;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:late endosome; C:membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:retrograde protein transport, ER to cytosol; P:suckling behavior; P:ubiquitin-dependent ERAD pathway; P:viral process;|Q9GZP9 Q9Y3A7,Derlin-2 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 2;Der1-like protein 2 {ECO:0000303|PubMed:15215855};F-LAN-1 {ECO:0000312|EMBL:AAG43049.1};F-LANa {ECO:0000303|PubMed:11500051};, PF04511;, GO:0005769;GO:0005783;GO:0005789;GO:0044322;GO:0000839;GO:0030176;GO:0005770;GO:0016020;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:1904380;GO:0030968;GO:1904153;GO:0030307;GO:0008284;GO:0030970;GO:0001967;GO:0030433;GO:0016032;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:late endosome; C:membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum mannose trimming; P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:retrograde protein transport, ER to cytosol; P:suckling behavior; P:ubiquitin-dependent ERAD pathway; P:viral process; scaffold112 indexed_genome mRNA 879546 881298 . - . ID=transcript_13390;Q9H081 Q96N24,Protein MIS12 homolog,, PF05859;, GO:0000777;GO:0005829;GO:0000444;GO:0000818;GO:0005634;GO:0051315;GO:0051301;GO:0007059;GO:0051382;GO:0000070;GO:0007052;GO:0034501;, C:condensed chromosome kinetochore; C:cytosol; C:MIS12/MIND type complex; C:nuclear MIS12/MIND complex; C:nucleus;, , P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore assembly; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:protein localization to kinetochore; scaffold112 indexed_genome mRNA 890366 912255 . - . ID=transcript_13391;Q9Y2E0,NACHT, LRR and PYD domains-containing protein 1 {ECO:0000305},Caspase recruitment domain-containing protein 7;Death effector filament-forming ced-4-like apoptosis protein;Nucleotide-binding domain and caspase recruitment domain;, PF00619;PF13553;PF13516;PF05729;PF17776;PF17779;PF02758;, GO:0005829;GO:0061702;GO:0072558;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0008656;GO:0003690;GO:0003725;GO:0019899;GO:0019904;GO:0006919;GO:0140374;GO:0006915;GO:0042742;GO:0051607;GO:0006954;GO:0051402;GO:1904784;GO:0032731;GO:0070269;GO:0042981;GO:0050727;GO:0032495;GO:0097264;GO:0016032;, C:cytosol; C:inflammasome complex; C:NLRP1 inflammasome complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:double-stranded DNA binding; F:double-stranded RNA binding; F:enzyme binding; F:protein domain specific binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:antiviral innate immune response; P:apoptotic process; P:defense response to bacterium; P:defense response to virus; P:inflammatory response; P:neuron apoptotic process; P:NLRP1 inflammasome complex assembly; P:positive regulation of interleukin-1 beta production; P:pyroptosis; P:regulation of apoptotic process; P:regulation of inflammatory response; P:response to muramyl dipeptide; P:self proteolysis; P:viral process; scaffold112 indexed_genome mRNA 912285 923562 . - . ID=transcript_13392;Q9Y2E0,NACHT, LRR and PYD domains-containing protein 1 {ECO:0000305},Caspase recruitment domain-containing protein 7;Death effector filament-forming ced-4-like apoptosis protein;Nucleotide-binding domain and caspase recruitment domain;, PF00619;PF13553;PF13516;PF05729;PF17776;PF17779;PF02758;, GO:0005829;GO:0061702;GO:0072558;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0008656;GO:0003690;GO:0003725;GO:0019899;GO:0019904;GO:0006919;GO:0140374;GO:0006915;GO:0042742;GO:0051607;GO:0006954;GO:0051402;GO:1904784;GO:0032731;GO:0070269;GO:0042981;GO:0050727;GO:0032495;GO:0097264;GO:0016032;, C:cytosol; C:inflammasome complex; C:NLRP1 inflammasome complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:double-stranded DNA binding; F:double-stranded RNA binding; F:enzyme binding; F:protein domain specific binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:antiviral innate immune response; P:apoptotic process; P:defense response to bacterium; P:defense response to virus; P:inflammatory response; P:neuron apoptotic process; P:NLRP1 inflammasome complex assembly; P:positive regulation of interleukin-1 beta production; P:pyroptosis; P:regulation of apoptotic process; P:regulation of inflammatory response; P:response to muramyl dipeptide; P:self proteolysis; P:viral process; scaffold112 indexed_genome mRNA 1267747 1292746 . + . ID=transcript_13393;Q658N2 A8K0N8 D3DTM3 O60276 Q96G45,WSC domain-containing protein 1,, PF00685;PF01822;, GO:0016021;GO:0008146;, C:integral component of membrane;, F:sulfotransferase activity;|Q658N2 A8K0N8 D3DTM3 O60276 Q96G45,WSC domain-containing protein 1,, PF00685;PF01822;, GO:0016021;GO:0008146;, C:integral component of membrane;, F:sulfotransferase activity;|Q658N2 A8K0N8 D3DTM3 O60276 Q96G45,WSC domain-containing protein 1,, PF00685;PF01822;, GO:0016021;GO:0008146;, C:integral component of membrane;, F:sulfotransferase activity;|Q658N2 A8K0N8 D3DTM3 O60276 Q96G45,WSC domain-containing protein 1,, PF00685;PF01822;, GO:0016021;GO:0008146;, C:integral component of membrane;, F:sulfotransferase activity; scaffold112 indexed_genome mRNA 1521721 1534427 . - . ID=transcript_13394;Q9BZ71 A1A5D0 F8WEW5 Q59GH9 Q9NPQ4,Membrane-associated phosphatidylinositol transfer protein 3,Phosphatidylinositol transfer protein, membrane-associated 3;Pyk2 N-terminal domain-interacting receptor 1;, PF02862;, GO:0044297;GO:0042995;GO:0030134;GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0005509;GO:0008289;GO:0004620;GO:0030971;GO:0006661;, C:cell body; C:cell projection; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:calcium ion binding; F:lipid binding; F:phospholipase activity; F:receptor tyrosine kinase binding;, P:phosphatidylinositol biosynthetic process; scaffold112 indexed_genome mRNA 1536560 1598578 . - . ID=transcript_13395;Q9BZ71 A1A5D0 F8WEW5 Q59GH9 Q9NPQ4,Membrane-associated phosphatidylinositol transfer protein 3,Phosphatidylinositol transfer protein, membrane-associated 3;Pyk2 N-terminal domain-interacting receptor 1;, PF02862;, GO:0044297;GO:0042995;GO:0030134;GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0005509;GO:0008289;GO:0004620;GO:0030971;GO:0006661;, C:cell body; C:cell projection; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:calcium ion binding; F:lipid binding; F:phospholipase activity; F:receptor tyrosine kinase binding;, P:phosphatidylinositol biosynthetic process;|Q9BZ71 A1A5D0 F8WEW5 Q59GH9 Q9NPQ4,Membrane-associated phosphatidylinositol transfer protein 3,Phosphatidylinositol transfer protein, membrane-associated 3;Pyk2 N-terminal domain-interacting receptor 1;, PF02862;, GO:0044297;GO:0042995;GO:0030134;GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0005509;GO:0008289;GO:0004620;GO:0030971;GO:0006661;, C:cell body; C:cell projection; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:calcium ion binding; F:lipid binding; F:phospholipase activity; F:receptor tyrosine kinase binding;, P:phosphatidylinositol biosynthetic process;|Q9BZ71 A1A5D0 F8WEW5 Q59GH9 Q9NPQ4,Membrane-associated phosphatidylinositol transfer protein 3,Phosphatidylinositol transfer protein, membrane-associated 3;Pyk2 N-terminal domain-interacting receptor 1;, PF02862;, GO:0044297;GO:0042995;GO:0030134;GO:0005737;GO:0005829;GO:0012505;GO:0016020;GO:0005509;GO:0008289;GO:0004620;GO:0030971;GO:0006661;, C:cell body; C:cell projection; C:COPII-coated ER to Golgi transport vesicle; C:cytoplasm; C:cytosol; C:endomembrane system; C:membrane;, F:calcium ion binding; F:lipid binding; F:phospholipase activity; F:receptor tyrosine kinase binding;, P:phosphatidylinositol biosynthetic process; scaffold112 indexed_genome mRNA 1647265 1689866 . - . ID=transcript_13396;Q2KHM9 A8KA11 B7Z479 O94853 Q05D97 Q2KHN0 Q9UG45,Protein moonraker {ECO:0000303|PubMed:26297806},OFD1- and FOPNL-interacting protein {ECO:0000303|PubMed:26643951};, PF15718;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0007099;GO:0071539;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol;, , P:centriole replication; P:protein localization to centrosome; scaffold112 indexed_genome mRNA 1693966 1701769 . + . ID=transcript_13397;Q9BRA2 A8K7E8,Thioredoxin domain-containing protein 17,14 kDa thioredoxin-related protein;Protein 42-9-9;Thioredoxin-like protein 5;, PF06110;, GO:0005829;GO:0070062;GO:0004601;GO:0047134;GO:0033209;, C:cytosol; C:extracellular exosome;, F:peroxidase activity; F:protein-disulfide reductase activity;, P:tumor necrosis factor-mediated signaling pathway;|Q9BRA2 A8K7E8,Thioredoxin domain-containing protein 17,14 kDa thioredoxin-related protein;Protein 42-9-9;Thioredoxin-like protein 5;, PF06110;, GO:0005829;GO:0070062;GO:0004601;GO:0047134;GO:0033209;, C:cytosol; C:extracellular exosome;, F:peroxidase activity; F:protein-disulfide reductase activity;, P:tumor necrosis factor-mediated signaling pathway; scaffold112 indexed_genome mRNA 1703205 1707815 . - . ID=transcript_13398;A8MU93 D3DTM5,Uncharacterized protein C17orf100 {ECO:0000305} scaffold112 indexed_genome mRNA 1724419 1749851 . - . ID=transcript_13399;Q86YT5 B3KXR0 B7Z4P2 B7ZLB4 F8W7N2 Q6ZMG1,Solute carrier family 13 member 5,Na(+)/citrate cotransporter;Sodium-coupled citrate transporter;Sodium-dependent citrate transporter;, PF00939;, GO:0005829;GO:0016021;GO:0005654;GO:0005886;GO:0015137;GO:0017153;GO:0015141;GO:0098656;GO:0015746;, C:cytosol; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:citrate transmembrane transporter activity; F:sodium:dicarboxylate symporter activity; F:succinate transmembrane transporter activity;, P:anion transmembrane transport; P:citrate transport; scaffold112 indexed_genome mRNA 1770056 1779127 . + . ID=transcript_13400;Q6GPH4 A2T931 A2T932 A8K2L1 A8K9Y3 D3DTM6 Q6MZE8 Q8N557 Q99982,XIAP-associated factor 1,BIRC4-binding protein;, PF18608;, GO:0005829;GO:0005739;GO:0005654;GO:0008270;GO:0006915;GO:0035456;GO:0060337;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:zinc ion binding;, P:apoptotic process; P:response to interferon-beta; P:type I interferon signaling pathway;|Q6GPH4 A2T931 A2T932 A8K2L1 A8K9Y3 D3DTM6 Q6MZE8 Q8N557 Q99982,XIAP-associated factor 1,BIRC4-binding protein;, PF18608;, GO:0005829;GO:0005739;GO:0005654;GO:0008270;GO:0006915;GO:0035456;GO:0060337;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:zinc ion binding;, P:apoptotic process; P:response to interferon-beta; P:type I interferon signaling pathway;|Q6GPH4 A2T931 A2T932 A8K2L1 A8K9Y3 D3DTM6 Q6MZE8 Q8N557 Q99982,XIAP-associated factor 1,BIRC4-binding protein;, PF18608;, GO:0005829;GO:0005739;GO:0005654;GO:0008270;GO:0006915;GO:0035456;GO:0060337;, C:cytosol; C:mitochondrion; C:nucleoplasm;, F:zinc ion binding;, P:apoptotic process; P:response to interferon-beta; P:type I interferon signaling pathway; scaffold112 indexed_genome mRNA 1829854 1842220 . + . ID=transcript_13401;Q2TAL5 Q6ZVK6,Smoothelin-like protein 2,, PF00307;, GO:0031941;GO:0031674;GO:0031430;GO:0005815;GO:0008157;GO:0005523;GO:0030036;GO:0045907;, C:filamentous actin; C:I band; C:M band; C:microtubule organizing center;, F:protein phosphatase 1 binding; F:tropomyosin binding;, P:actin cytoskeleton organization; P:positive regulation of vasoconstriction;|Q2TAL5 Q6ZVK6,Smoothelin-like protein 2,, PF00307;, GO:0031941;GO:0031674;GO:0031430;GO:0005815;GO:0008157;GO:0005523;GO:0030036;GO:0045907;, C:filamentous actin; C:I band; C:M band; C:microtubule organizing center;, F:protein phosphatase 1 binding; F:tropomyosin binding;, P:actin cytoskeleton organization; P:positive regulation of vasoconstriction; scaffold112 indexed_genome mRNA 1866105 1878809 . + . ID=transcript_13402;Q969V4 D3DTM7,Tektin-1,, , GO:0005737;GO:0005874;GO:0015630;GO:0031514;GO:0005634;GO:0060271;GO:0060294;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:motile cilium; C:nucleus;, , P:cilium assembly; P:cilium movement involved in cell motility; scaffold112 indexed_genome mRNA 1893175 1930222 . + . ID=transcript_13403;Q9BQG0 Q86VM3 Q9BW49 Q9P0V5 Q9UF99,Myb-binding protein 1A,, PF04931;, GO:0005737;GO:0043231;GO:0016020;GO:0042564;GO:0005730;GO:0005654;GO:0005634;GO:0070888;GO:0003723;GO:0043565;GO:0003714;GO:0008134;GO:0042149;GO:0032922;GO:0072332;GO:0045892;GO:0001649;GO:2000210;GO:0071158;GO:0045815;GO:0006355;GO:0022904;GO:0042254;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:NLS-dependent protein nuclear import complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:E-box binding; F:RNA binding; F:sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:cellular response to glucose starvation; P:circadian regulation of gene expression; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of transcription, DNA-templated; P:osteoblast differentiation; P:positive regulation of anoikis; P:positive regulation of cell cycle arrest; P:positive regulation of gene expression, epigenetic; P:regulation of transcription, DNA-templated; P:respiratory electron transport chain; P:ribosome biogenesis;|Q9BQG0 Q86VM3 Q9BW49 Q9P0V5 Q9UF99,Myb-binding protein 1A,, PF04931;, GO:0005737;GO:0043231;GO:0016020;GO:0042564;GO:0005730;GO:0005654;GO:0005634;GO:0070888;GO:0003723;GO:0043565;GO:0003714;GO:0008134;GO:0042149;GO:0032922;GO:0072332;GO:0045892;GO:0001649;GO:2000210;GO:0071158;GO:0045815;GO:0006355;GO:0022904;GO:0042254;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:membrane; C:NLS-dependent protein nuclear import complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:E-box binding; F:RNA binding; F:sequence-specific DNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:cellular response to glucose starvation; P:circadian regulation of gene expression; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of transcription, DNA-templated; P:osteoblast differentiation; P:positive regulation of anoikis; P:positive regulation of cell cycle arrest; P:positive regulation of gene expression, epigenetic; P:regulation of transcription, DNA-templated; P:respiratory electron transport chain; P:ribosome biogenesis;|Q8IVW8 B9A1T3,Protein spinster homolog 2 {ECO:0000305},, PF07690;, GO:0010008;GO:0016021;GO:0005886;GO:0046624;GO:0022857;GO:0001782;GO:0060348;GO:0006869;GO:0048535;GO:0072676;GO:0048073;GO:0002920;GO:0030148;GO:0003376;GO:0043029;, C:endosome membrane; C:integral component of membrane; C:plasma membrane;, F:sphingolipid transporter activity; F:transmembrane transporter activity;, P:B cell homeostasis; P:bone development; P:lipid transport; P:lymph node development; P:lymphocyte migration; P:regulation of eye pigmentation; P:regulation of humoral immune response; P:sphingolipid biosynthetic process; P:sphingosine-1-phosphate receptor signaling pathway; P:T cell homeostasis; scaffold112 indexed_genome mRNA 1960654 1992857 . - . ID=transcript_13404;Q6ZMD2 Q8IZ31,Protein spinster homolog 3,, PF07690;, GO:0016021;GO:0022857;GO:0006869;, C:integral component of membrane;, F:transmembrane transporter activity;, P:lipid transport; scaffold112 indexed_genome mRNA 2061366 2165217 . + . ID=transcript_13405;P62253 B2R7P2 D3DTK0 Q99462,Ubiquitin-conjugating enzyme E2 G1,E2 ubiquitin-conjugating enzyme G1;E217K;UBC7;Ubiquitin carrier protein G1;Ubiquitin-protein ligase G1;, PF00179;, GO:0005829;GO:0070062;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0044257;GO:0043161;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P62253 B2R7P2 D3DTK0 Q99462,Ubiquitin-conjugating enzyme E2 G1,E2 ubiquitin-conjugating enzyme G1;E217K;UBC7;Ubiquitin carrier protein G1;Ubiquitin-protein ligase G1;, PF00179;, GO:0005829;GO:0070062;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0044257;GO:0043161;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P62253 B2R7P2 D3DTK0 Q99462,Ubiquitin-conjugating enzyme E2 G1,E2 ubiquitin-conjugating enzyme G1;E217K;UBC7;Ubiquitin carrier protein G1;Ubiquitin-protein ligase G1;, PF00179;, GO:0005829;GO:0070062;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0044257;GO:0043161;GO:0070936;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold112 indexed_genome mRNA 2184171 2226508 . + . ID=transcript_13406;Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi; scaffold112 indexed_genome mRNA 2226538 2239252 . + . ID=transcript_13407;Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi;|Q9P2R3 A8KA65 Q5RKV4 Q9ULG5,Rabankyrin-5 {ECO:0000303|PubMed:15328530},Ankyrin repeat and FYVE domain-containing protein 1;Ankyrin repeats hooked to a zinc finger motif;, PF00023;PF12796;PF00651;PF01363;, GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0070062;GO:0043231;GO:0005765;GO:0044354;GO:0016020;GO:0046872;GO:1901981;GO:0031267;GO:0006897;GO:0016197;GO:0034058;GO:0090160;GO:0048549;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:macropinosome; C:membrane;, F:metal ion binding; F:phosphatidylinositol phosphate binding; F:small GTPase binding;, P:endocytosis; P:endosomal transport; P:endosomal vesicle fusion; P:Golgi to lysosome transport; P:positive regulation of pinocytosis; P:retrograde transport, endosome to Golgi; scaffold112 indexed_genome mRNA 2239260 2247232 . - . ID=transcript_13408;Q8WUJ1 B2R7R6 D3DTJ9 I3L1K2,Neuferricin,Cytochrome b5 domain-containing protein 2;, PF00173;, GO:0012505;GO:0005576;GO:0016020;GO:0020037;GO:0007399;GO:0045666;, C:endomembrane system; C:extracellular region; C:membrane;, F:heme binding;, P:nervous system development; P:positive regulation of neuron differentiation;|Q8WUJ1 B2R7R6 D3DTJ9 I3L1K2,Neuferricin,Cytochrome b5 domain-containing protein 2;, PF00173;, GO:0012505;GO:0005576;GO:0016020;GO:0020037;GO:0007399;GO:0045666;, C:endomembrane system; C:extracellular region; C:membrane;, F:heme binding;, P:nervous system development; P:positive regulation of neuron differentiation; scaffold112 indexed_genome mRNA 2272566 2341157 . + . ID=transcript_13409;O43149 A7MBM5 Q6NXG0 Q6ZRA1 Q6ZSF4 Q9NVB9,Zinc finger ZZ-type and EF-hand domain-containing protein 1,, PF03256;PF00569;, GO:0005509;GO:0008270;, , F:calcium ion binding; F:zinc ion binding;|O43149 A7MBM5 Q6NXG0 Q6ZRA1 Q6ZSF4 Q9NVB9,Zinc finger ZZ-type and EF-hand domain-containing protein 1,, PF03256;PF00569;, GO:0005509;GO:0008270;, , F:calcium ion binding; F:zinc ion binding;|O43149 A7MBM5 Q6NXG0 Q6ZRA1 Q6ZSF4 Q9NVB9,Zinc finger ZZ-type and EF-hand domain-containing protein 1,, PF03256;PF00569;, GO:0005509;GO:0008270;, , F:calcium ion binding; F:zinc ion binding; scaffold112 indexed_genome mRNA 2342641 2347852 . + . ID=transcript_13410;O43149 A7MBM5 Q6NXG0 Q6ZRA1 Q6ZSF4 Q9NVB9,Zinc finger ZZ-type and EF-hand domain-containing protein 1,, PF03256;PF00569;, GO:0005509;GO:0008270;, , F:calcium ion binding; F:zinc ion binding; scaffold112 indexed_genome mRNA 2388451 2412411 . + . ID=transcript_13411;Q8TEX5 Q8TEX6,Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 {ECO:0000305},Calcium pump 3;, PF00689;PF00690;, GO:0005783;GO:0005789;GO:0016021;GO:0031965;GO:0031090;GO:0031095;GO:0016529;GO:0033017;GO:0005524;GO:0016887;GO:0015085;GO:0005388;GO:0030899;GO:0008656;GO:0044325;GO:0046872;GO:0008553;GO:0006919;GO:0070588;GO:0006816;GO:1903515;GO:0006874;GO:0070059;GO:0034220;GO:1900121;GO:1903779;GO:0150104;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear membrane; C:organelle membrane; C:platelet dense tubular network membrane; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:ATPase activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-dependent ATPase activity; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:ion channel binding; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium ion transport from cytosol to endoplasmic reticulum; P:cellular calcium ion homeostasis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:ion transmembrane transport; P:negative regulation of receptor binding; P:regulation of cardiac conduction; P:transport across blood-brain barrier; scaffold112 indexed_genome mRNA 2417134 2432996 . + . ID=transcript_13412;P51575 Q9UK84,P2X purinoceptor 1,ATP receptor;Purinergic receptor;, , GO:0009897;GO:0098978;GO:0005639;GO:0005887;GO:0099055;GO:0099059;GO:0045121;GO:0043005;GO:0005886;GO:0032991;GO:0030667;GO:0035579;GO:0005524;GO:0005261;GO:0008144;GO:0004931;GO:0042802;GO:0044877;GO:0001614;GO:0008270;GO:0006919;GO:0006915;GO:0007596;GO:0046513;GO:0007320;GO:0006811;GO:0019228;GO:0043312;GO:0030168;GO:0043270;GO:0008217;GO:0051924;GO:0099509;GO:2000300;GO:0003056;GO:0033198;GO:0002554;GO:0007165;GO:0035249;, C:external side of plasma membrane; C:glutamatergic synapse; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic active zone membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:protein-containing complex; C:secretory granule membrane; C:specific granule membrane;, F:ATP binding; F:cation channel activity; F:drug binding; F:extracellularly ATP-gated cation channel activity; F:identical protein binding; F:protein-containing complex binding; F:purinergic nucleotide receptor activity; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:blood coagulation; P:ceramide biosynthetic process; P:insemination; P:ion transport; P:neuronal action potential; P:neutrophil degranulation; P:platelet activation; P:positive regulation of ion transport; P:regulation of blood pressure; P:regulation of calcium ion transport; P:regulation of presynaptic cytosolic calcium ion concentration; P:regulation of synaptic vesicle exocytosis; P:regulation of vascular associated smooth muscle contraction; P:response to ATP; P:serotonin secretion by platelet; P:signal transduction; P:synaptic transmission, glutamatergic; scaffold112 indexed_genome mRNA 2433296 2436225 . + . ID=transcript_13413;P51575 Q9UK84,P2X purinoceptor 1,ATP receptor;Purinergic receptor;, , GO:0009897;GO:0098978;GO:0005639;GO:0005887;GO:0099055;GO:0099059;GO:0045121;GO:0043005;GO:0005886;GO:0032991;GO:0030667;GO:0035579;GO:0005524;GO:0005261;GO:0008144;GO:0004931;GO:0042802;GO:0044877;GO:0001614;GO:0008270;GO:0006919;GO:0006915;GO:0007596;GO:0046513;GO:0007320;GO:0006811;GO:0019228;GO:0043312;GO:0030168;GO:0043270;GO:0008217;GO:0051924;GO:0099509;GO:2000300;GO:0003056;GO:0033198;GO:0002554;GO:0007165;GO:0035249;, C:external side of plasma membrane; C:glutamatergic synapse; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic active zone membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:protein-containing complex; C:secretory granule membrane; C:specific granule membrane;, F:ATP binding; F:cation channel activity; F:drug binding; F:extracellularly ATP-gated cation channel activity; F:identical protein binding; F:protein-containing complex binding; F:purinergic nucleotide receptor activity; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:blood coagulation; P:ceramide biosynthetic process; P:insemination; P:ion transport; P:neuronal action potential; P:neutrophil degranulation; P:platelet activation; P:positive regulation of ion transport; P:regulation of blood pressure; P:regulation of calcium ion transport; P:regulation of presynaptic cytosolic calcium ion concentration; P:regulation of synaptic vesicle exocytosis; P:regulation of vascular associated smooth muscle contraction; P:response to ATP; P:serotonin secretion by platelet; P:signal transduction; P:synaptic transmission, glutamatergic; scaffold112 indexed_genome mRNA 2440546 2467664 . + . ID=transcript_13414;Q8N5S9 Q9BQH3,Calcium/calmodulin-dependent protein kinase kinase 1,CaM-kinase IV kinase;Calcium/calmodulin-dependent protein kinase kinase alpha;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0004674;GO:0106311;GO:0007268;GO:0035556;GO:0045860;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:chemical synaptic transmission; P:intracellular signal transduction; P:positive regulation of protein kinase activity;|Q8N5S9 Q9BQH3,Calcium/calmodulin-dependent protein kinase kinase 1,CaM-kinase IV kinase;Calcium/calmodulin-dependent protein kinase kinase alpha;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0004674;GO:0106311;GO:0007268;GO:0035556;GO:0045860;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:chemical synaptic transmission; P:intracellular signal transduction; P:positive regulation of protein kinase activity;|Q8N5S9 Q9BQH3,Calcium/calmodulin-dependent protein kinase kinase 1,CaM-kinase IV kinase;Calcium/calmodulin-dependent protein kinase kinase alpha;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0004674;GO:0106311;GO:0007268;GO:0035556;GO:0045860;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:chemical synaptic transmission; P:intracellular signal transduction; P:positive regulation of protein kinase activity;|Q8N5S9 Q9BQH3,Calcium/calmodulin-dependent protein kinase kinase 1,CaM-kinase IV kinase;Calcium/calmodulin-dependent protein kinase kinase alpha;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0004674;GO:0106311;GO:0007268;GO:0035556;GO:0045860;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:chemical synaptic transmission; P:intracellular signal transduction; P:positive regulation of protein kinase activity;|Q8N5S9 Q9BQH3,Calcium/calmodulin-dependent protein kinase kinase 1,CaM-kinase IV kinase;Calcium/calmodulin-dependent protein kinase kinase alpha;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0004674;GO:0106311;GO:0007268;GO:0035556;GO:0045860;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:chemical synaptic transmission; P:intracellular signal transduction; P:positive regulation of protein kinase activity; scaffold112 indexed_genome mRNA 2476790 2504128 . + . ID=transcript_13415;Q53F19 B3KWG7 Q7L406 Q96FK1 Q9NXZ4,Nuclear cap-binding protein subunit 3 {ECO:0000312|HGNC:HGNC:24612},Protein ELG;, PF10309;, GO:0005737;GO:0016607;GO:0005634;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0006370;GO:0051607;GO:0051028;, C:cytoplasm; C:nuclear speck; C:nucleus; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding;, P:7-methylguanosine mRNA capping; P:defense response to virus; P:mRNA transport;|Q53F19 B3KWG7 Q7L406 Q96FK1 Q9NXZ4,Nuclear cap-binding protein subunit 3 {ECO:0000312|HGNC:HGNC:24612},Protein ELG;, PF10309;, GO:0005737;GO:0016607;GO:0005634;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0006370;GO:0051607;GO:0051028;, C:cytoplasm; C:nuclear speck; C:nucleus; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding;, P:7-methylguanosine mRNA capping; P:defense response to virus; P:mRNA transport;|Q53F19 B3KWG7 Q7L406 Q96FK1 Q9NXZ4,Nuclear cap-binding protein subunit 3 {ECO:0000312|HGNC:HGNC:24612},Protein ELG;, PF10309;, GO:0005737;GO:0016607;GO:0005634;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0006370;GO:0051607;GO:0051028;, C:cytoplasm; C:nuclear speck; C:nucleus; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding;, P:7-methylguanosine mRNA capping; P:defense response to virus; P:mRNA transport;|Q53F19 B3KWG7 Q7L406 Q96FK1 Q9NXZ4,Nuclear cap-binding protein subunit 3 {ECO:0000312|HGNC:HGNC:24612},Protein ELG;, PF10309;, GO:0005737;GO:0016607;GO:0005634;GO:0034518;GO:0003729;GO:0000340;GO:0003723;GO:0000339;GO:0006370;GO:0051607;GO:0051028;, C:cytoplasm; C:nuclear speck; C:nucleus; C:RNA cap binding complex;, F:mRNA binding; F:RNA 7-methylguanosine cap binding; F:RNA binding; F:RNA cap binding;, P:7-methylguanosine mRNA capping; P:defense response to virus; P:mRNA transport; scaffold112 indexed_genome mRNA 2542190 2552681 . + . ID=transcript_13416;P38570 Q17RS6 Q9NZU9,Integrin alpha-E,HML-1 antigen;Integrin alpha-IEL;Mucosal lymphocyte 1 antigen;, PF01839;PF00357;PF08441;PF00092;, GO:0009897;GO:0008305;GO:0005886;GO:0046872;GO:0007155;GO:0030198;GO:0007229;, C:external side of plasma membrane; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; scaffold112 indexed_genome mRNA 2555377 2578021 . + . ID=transcript_13417;P38570 Q17RS6 Q9NZU9,Integrin alpha-E,HML-1 antigen;Integrin alpha-IEL;Mucosal lymphocyte 1 antigen;, PF01839;PF00357;PF08441;PF00092;, GO:0009897;GO:0008305;GO:0005886;GO:0046872;GO:0007155;GO:0030198;GO:0007229;, C:external side of plasma membrane; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway;|P38570 Q17RS6 Q9NZU9,Integrin alpha-E,HML-1 antigen;Integrin alpha-IEL;Mucosal lymphocyte 1 antigen;, PF01839;PF00357;PF08441;PF00092;, GO:0009897;GO:0008305;GO:0005886;GO:0046872;GO:0007155;GO:0030198;GO:0007229;, C:external side of plasma membrane; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway;|P38570 Q17RS6 Q9NZU9,Integrin alpha-E,HML-1 antigen;Integrin alpha-IEL;Mucosal lymphocyte 1 antigen;, PF01839;PF00357;PF08441;PF00092;, GO:0009897;GO:0008305;GO:0005886;GO:0046872;GO:0007155;GO:0030198;GO:0007229;, C:external side of plasma membrane; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway;|P38570 Q17RS6 Q9NZU9,Integrin alpha-E,HML-1 antigen;Integrin alpha-IEL;Mucosal lymphocyte 1 antigen;, PF01839;PF00357;PF08441;PF00092;, GO:0009897;GO:0008305;GO:0005886;GO:0046872;GO:0007155;GO:0030198;GO:0007229;, C:external side of plasma membrane; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; scaffold112 indexed_genome mRNA 2586699 2591067 . + . ID=transcript_13418;Q93086 G5E981 O43450 O75540 Q308M5 Q59F38 Q8IXW4 Q93087 Q9NZV0,P2X purinoceptor 5,ATP receptor;Purinergic receptor;, , GO:0005829;GO:0005639;GO:0005887;GO:0005886;GO:0098794;GO:0005524;GO:0004931;GO:0005216;GO:0001614;GO:0004888;GO:0007596;GO:0007399;GO:0010524;GO:0050850;GO:0033198;GO:0007165;, C:cytosol; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse;, F:ATP binding; F:extracellularly ATP-gated cation channel activity; F:ion channel activity; F:purinergic nucleotide receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:nervous system development; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of calcium-mediated signaling; P:response to ATP; P:signal transduction;|Q93086 G5E981 O43450 O75540 Q308M5 Q59F38 Q8IXW4 Q93087 Q9NZV0,P2X purinoceptor 5,ATP receptor;Purinergic receptor;, , GO:0005829;GO:0005639;GO:0005887;GO:0005886;GO:0098794;GO:0005524;GO:0004931;GO:0005216;GO:0001614;GO:0004888;GO:0007596;GO:0007399;GO:0010524;GO:0050850;GO:0033198;GO:0007165;, C:cytosol; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse;, F:ATP binding; F:extracellularly ATP-gated cation channel activity; F:ion channel activity; F:purinergic nucleotide receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:nervous system development; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of calcium-mediated signaling; P:response to ATP; P:signal transduction; scaffold112 indexed_genome mRNA 2591125 2597460 . + . ID=transcript_13419;Q93086 G5E981 O43450 O75540 Q308M5 Q59F38 Q8IXW4 Q93087 Q9NZV0,P2X purinoceptor 5,ATP receptor;Purinergic receptor;, , GO:0005829;GO:0005639;GO:0005887;GO:0005886;GO:0098794;GO:0005524;GO:0004931;GO:0005216;GO:0001614;GO:0004888;GO:0007596;GO:0007399;GO:0010524;GO:0050850;GO:0033198;GO:0007165;, C:cytosol; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse;, F:ATP binding; F:extracellularly ATP-gated cation channel activity; F:ion channel activity; F:purinergic nucleotide receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:nervous system development; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of calcium-mediated signaling; P:response to ATP; P:signal transduction;|Q93086 G5E981 O43450 O75540 Q308M5 Q59F38 Q8IXW4 Q93087 Q9NZV0,P2X purinoceptor 5,ATP receptor;Purinergic receptor;, , GO:0005829;GO:0005639;GO:0005887;GO:0005886;GO:0098794;GO:0005524;GO:0004931;GO:0005216;GO:0001614;GO:0004888;GO:0007596;GO:0007399;GO:0010524;GO:0050850;GO:0033198;GO:0007165;, C:cytosol; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse;, F:ATP binding; F:extracellularly ATP-gated cation channel activity; F:ion channel activity; F:purinergic nucleotide receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:nervous system development; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of calcium-mediated signaling; P:response to ATP; P:signal transduction;|Q93086 G5E981 O43450 O75540 Q308M5 Q59F38 Q8IXW4 Q93087 Q9NZV0,P2X purinoceptor 5,ATP receptor;Purinergic receptor;, , GO:0005829;GO:0005639;GO:0005887;GO:0005886;GO:0098794;GO:0005524;GO:0004931;GO:0005216;GO:0001614;GO:0004888;GO:0007596;GO:0007399;GO:0010524;GO:0050850;GO:0033198;GO:0007165;, C:cytosol; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse;, F:ATP binding; F:extracellularly ATP-gated cation channel activity; F:ion channel activity; F:purinergic nucleotide receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:nervous system development; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of calcium-mediated signaling; P:response to ATP; P:signal transduction;|Q93086 G5E981 O43450 O75540 Q308M5 Q59F38 Q8IXW4 Q93087 Q9NZV0,P2X purinoceptor 5,ATP receptor;Purinergic receptor;, , GO:0005829;GO:0005639;GO:0005887;GO:0005886;GO:0098794;GO:0005524;GO:0004931;GO:0005216;GO:0001614;GO:0004888;GO:0007596;GO:0007399;GO:0010524;GO:0050850;GO:0033198;GO:0007165;, C:cytosol; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse;, F:ATP binding; F:extracellularly ATP-gated cation channel activity; F:ion channel activity; F:purinergic nucleotide receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:nervous system development; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of calcium-mediated signaling; P:response to ATP; P:signal transduction; scaffold112 indexed_genome mRNA 2604045 2630169 . - . ID=transcript_13420;Q9BV81,ER membrane protein complex subunit 6,Transmembrane protein 93;, PF07019;, GO:0072546;GO:0030176;GO:0016021;GO:0097631;GO:0000045;GO:0045050;GO:0071816;, C:EMC complex; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of omegasome membrane;, , P:autophagosome assembly; P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|O14907 B2RD53 D3DTJ6 Q7LCQ4,Tax1-binding protein 3,Glutaminase-interacting protein 3;Tax interaction protein 1;Tax-interacting protein 1;, PF00595;, GO:0015629;GO:0005737;GO:0005829;GO:0070062;GO:0001650;GO:0043231;GO:0005886;GO:0008013;GO:0008022;GO:0090630;GO:0008285;GO:2000009;GO:0030178;GO:0007266;GO:0016055;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:fibrillar center; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:beta-catenin binding; F:protein C-terminus binding;, P:activation of GTPase activity; P:negative regulation of cell population proliferation; P:negative regulation of protein localization to cell surface; P:negative regulation of Wnt signaling pathway; P:Rho protein signal transduction; P:Wnt signaling pathway;|O14907 B2RD53 D3DTJ6 Q7LCQ4,Tax1-binding protein 3,Glutaminase-interacting protein 3;Tax interaction protein 1;Tax-interacting protein 1;, PF00595;, GO:0015629;GO:0005737;GO:0005829;GO:0070062;GO:0001650;GO:0043231;GO:0005886;GO:0008013;GO:0008022;GO:0090630;GO:0008285;GO:2000009;GO:0030178;GO:0007266;GO:0016055;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:fibrillar center; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:beta-catenin binding; F:protein C-terminus binding;, P:activation of GTPase activity; P:negative regulation of cell population proliferation; P:negative regulation of protein localization to cell surface; P:negative regulation of Wnt signaling pathway; P:Rho protein signal transduction; P:Wnt signaling pathway;|O14907 B2RD53 D3DTJ6 Q7LCQ4,Tax1-binding protein 3,Glutaminase-interacting protein 3;Tax interaction protein 1;Tax-interacting protein 1;, PF00595;, GO:0015629;GO:0005737;GO:0005829;GO:0070062;GO:0001650;GO:0043231;GO:0005886;GO:0008013;GO:0008022;GO:0090630;GO:0008285;GO:2000009;GO:0030178;GO:0007266;GO:0016055;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:fibrillar center; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:beta-catenin binding; F:protein C-terminus binding;, P:activation of GTPase activity; P:negative regulation of cell population proliferation; P:negative regulation of protein localization to cell surface; P:negative regulation of Wnt signaling pathway; P:Rho protein signal transduction; P:Wnt signaling pathway;|O60931 D3DTJ5 Q8IZ01 Q9UNK6,Cystinosin {ECO:0000303|PubMed:9537412},, PF04193;, GO:0070062;GO:0016021;GO:0045111;GO:0043231;GO:0005770;GO:0005765;GO:0005764;GO:0042470;GO:0005886;GO:0005774;GO:0015184;GO:0015295;GO:0007628;GO:0046034;GO:0007420;GO:0006520;GO:0050890;GO:0006749;GO:0007625;GO:0006811;GO:0015811;GO:0002088;GO:0007616;GO:0042438;GO:0010730;GO:0010918;GO:1904263;GO:0048021;GO:0055085;GO:0008542;, C:extracellular exosome; C:integral component of membrane; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal membrane; C:lysosome; C:melanosome; C:plasma membrane; C:vacuolar membrane;, F:L-cystine transmembrane transporter activity; F:solute:proton symporter activity;, P:adult walking behavior; P:ATP metabolic process; P:brain development; P:cellular amino acid metabolic process; P:cognition; P:glutathione metabolic process; P:grooming behavior; P:ion transport; P:L-cystine transport; P:lens development in camera-type eye; P:long-term memory; P:melanin biosynthetic process; P:negative regulation of hydrogen peroxide biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of TORC1 signaling; P:regulation of melanin biosynthetic process; P:transmembrane transport; P:visual learning;|O60931 D3DTJ5 Q8IZ01 Q9UNK6,Cystinosin {ECO:0000303|PubMed:9537412},, PF04193;, GO:0070062;GO:0016021;GO:0045111;GO:0043231;GO:0005770;GO:0005765;GO:0005764;GO:0042470;GO:0005886;GO:0005774;GO:0015184;GO:0015295;GO:0007628;GO:0046034;GO:0007420;GO:0006520;GO:0050890;GO:0006749;GO:0007625;GO:0006811;GO:0015811;GO:0002088;GO:0007616;GO:0042438;GO:0010730;GO:0010918;GO:1904263;GO:0048021;GO:0055085;GO:0008542;, C:extracellular exosome; C:integral component of membrane; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal membrane; C:lysosome; C:melanosome; C:plasma membrane; C:vacuolar membrane;, F:L-cystine transmembrane transporter activity; F:solute:proton symporter activity;, P:adult walking behavior; P:ATP metabolic process; P:brain development; P:cellular amino acid metabolic process; P:cognition; P:glutathione metabolic process; P:grooming behavior; P:ion transport; P:L-cystine transport; P:lens development in camera-type eye; P:long-term memory; P:melanin biosynthetic process; P:negative regulation of hydrogen peroxide biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of TORC1 signaling; P:regulation of melanin biosynthetic process; P:transmembrane transport; P:visual learning;|O60931 D3DTJ5 Q8IZ01 Q9UNK6,Cystinosin {ECO:0000303|PubMed:9537412},, PF04193;, GO:0070062;GO:0016021;GO:0045111;GO:0043231;GO:0005770;GO:0005765;GO:0005764;GO:0042470;GO:0005886;GO:0005774;GO:0015184;GO:0015295;GO:0007628;GO:0046034;GO:0007420;GO:0006520;GO:0050890;GO:0006749;GO:0007625;GO:0006811;GO:0015811;GO:0002088;GO:0007616;GO:0042438;GO:0010730;GO:0010918;GO:1904263;GO:0048021;GO:0055085;GO:0008542;, C:extracellular exosome; C:integral component of membrane; C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal membrane; C:lysosome; C:melanosome; C:plasma membrane; C:vacuolar membrane;, F:L-cystine transmembrane transporter activity; F:solute:proton symporter activity;, P:adult walking behavior; P:ATP metabolic process; P:brain development; P:cellular amino acid metabolic process; P:cognition; P:glutathione metabolic process; P:grooming behavior; P:ion transport; P:L-cystine transport; P:lens development in camera-type eye; P:long-term memory; P:melanin biosynthetic process; P:negative regulation of hydrogen peroxide biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of TORC1 signaling; P:regulation of melanin biosynthetic process; P:transmembrane transport; P:visual learning; scaffold112 indexed_genome mRNA 2630605 2652037 . + . ID=transcript_13421;Q9UHJ6 B2R640 Q8WUH3,Sedoheptulokinase,Carbohydrate kinase-like protein;, PF00370;, GO:0005737;GO:0005829;GO:0005524;GO:0016773;GO:0050277;GO:0005975;GO:0035963;GO:0071353;GO:0071222;GO:0006098;GO:0009052;GO:0016310;GO:0050727;GO:0043030;, C:cytoplasm; C:cytosol;, F:ATP binding; F:phosphotransferase activity, alcohol group as acceptor; F:sedoheptulokinase activity;, P:carbohydrate metabolic process; P:cellular response to interleukin-13; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:phosphorylation; P:regulation of inflammatory response; P:regulation of macrophage activation;|Q9UHJ6 B2R640 Q8WUH3,Sedoheptulokinase,Carbohydrate kinase-like protein;, PF00370;, GO:0005737;GO:0005829;GO:0005524;GO:0016773;GO:0050277;GO:0005975;GO:0035963;GO:0071353;GO:0071222;GO:0006098;GO:0009052;GO:0016310;GO:0050727;GO:0043030;, C:cytoplasm; C:cytosol;, F:ATP binding; F:phosphotransferase activity, alcohol group as acceptor; F:sedoheptulokinase activity;, P:carbohydrate metabolic process; P:cellular response to interleukin-13; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:phosphorylation; P:regulation of inflammatory response; P:regulation of macrophage activation;|Q9UHJ6 B2R640 Q8WUH3,Sedoheptulokinase,Carbohydrate kinase-like protein;, PF00370;, GO:0005737;GO:0005829;GO:0005524;GO:0016773;GO:0050277;GO:0005975;GO:0035963;GO:0071353;GO:0071222;GO:0006098;GO:0009052;GO:0016310;GO:0050727;GO:0043030;, C:cytoplasm; C:cytosol;, F:ATP binding; F:phosphotransferase activity, alcohol group as acceptor; F:sedoheptulokinase activity;, P:carbohydrate metabolic process; P:cellular response to interleukin-13; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:phosphorylation; P:regulation of inflammatory response; P:regulation of macrophage activation;|Q9UHJ6 B2R640 Q8WUH3,Sedoheptulokinase,Carbohydrate kinase-like protein;, PF00370;, GO:0005737;GO:0005829;GO:0005524;GO:0016773;GO:0050277;GO:0005975;GO:0035963;GO:0071353;GO:0071222;GO:0006098;GO:0009052;GO:0016310;GO:0050727;GO:0043030;, C:cytoplasm; C:cytosol;, F:ATP binding; F:phosphotransferase activity, alcohol group as acceptor; F:sedoheptulokinase activity;, P:carbohydrate metabolic process; P:cellular response to interleukin-13; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:phosphorylation; P:regulation of inflammatory response; P:regulation of macrophage activation; scaffold112 indexed_genome mRNA 2733685 2749736 . - . ID=transcript_13422;P45381,Aspartoacylase,Aminoacylase-2;, PF04952;, GO:0005829;GO:0005634;GO:0004046;GO:0019807;GO:0016811;GO:0016788;GO:0042802;GO:0046872;GO:0006533;GO:0009066;GO:0022010;GO:0048714;, C:cytosol; C:nucleus;, F:aminoacylase activity; F:aspartoacylase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:hydrolase activity, acting on ester bonds; F:identical protein binding; F:metal ion binding;, P:aspartate catabolic process; P:aspartate family amino acid metabolic process; P:central nervous system myelination; P:positive regulation of oligodendrocyte differentiation; scaffold112 indexed_genome mRNA 3053417 3056643 . - . ID=transcript_13423;P34982 Q6IFL8 Q96RA4 Q9UM78,Olfactory receptor 1D2,Olfactory receptor 17-4;Olfactory receptor OR17-6;Olfactory receptor-like protein HGMP07E;, PF13853;, GO:0005887;GO:0005886;GO:0004930;GO:0042802;GO:0004984;GO:0006935;GO:0007186;GO:0007608;GO:0007338;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:identical protein binding; F:olfactory receptor activity;, P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:sensory perception of smell; P:single fertilization; scaffold112 indexed_genome mRNA 3067403 3127999 . - . ID=transcript_13424;Q684P5 B2RTY5 Q684P4 Q6AI00 Q6ZVF0 Q9UPW2,Rap1 GTPase-activating protein 2,GTPase-activating Rap/Ran-GAP domain-like protein 4;, PF02145;, GO:0005813;GO:0005737;GO:0005829;GO:0031965;GO:0048471;GO:0005886;GO:0005096;GO:0090630;GO:0002250;GO:0008361;GO:0051056;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:adaptive immune response; P:regulation of cell size; P:regulation of small GTPase mediated signal transduction;|Q684P5 B2RTY5 Q684P4 Q6AI00 Q6ZVF0 Q9UPW2,Rap1 GTPase-activating protein 2,GTPase-activating Rap/Ran-GAP domain-like protein 4;, PF02145;, GO:0005813;GO:0005737;GO:0005829;GO:0031965;GO:0048471;GO:0005886;GO:0005096;GO:0090630;GO:0002250;GO:0008361;GO:0051056;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:adaptive immune response; P:regulation of cell size; P:regulation of small GTPase mediated signal transduction;|Q684P5 B2RTY5 Q684P4 Q6AI00 Q6ZVF0 Q9UPW2,Rap1 GTPase-activating protein 2,GTPase-activating Rap/Ran-GAP domain-like protein 4;, PF02145;, GO:0005813;GO:0005737;GO:0005829;GO:0031965;GO:0048471;GO:0005886;GO:0005096;GO:0090630;GO:0002250;GO:0008361;GO:0051056;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:adaptive immune response; P:regulation of cell size; P:regulation of small GTPase mediated signal transduction;|Q684P5 B2RTY5 Q684P4 Q6AI00 Q6ZVF0 Q9UPW2,Rap1 GTPase-activating protein 2,GTPase-activating Rap/Ran-GAP domain-like protein 4;, PF02145;, GO:0005813;GO:0005737;GO:0005829;GO:0031965;GO:0048471;GO:0005886;GO:0005096;GO:0090630;GO:0002250;GO:0008361;GO:0051056;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:adaptive immune response; P:regulation of cell size; P:regulation of small GTPase mediated signal transduction;|Q684P5 B2RTY5 Q684P4 Q6AI00 Q6ZVF0 Q9UPW2,Rap1 GTPase-activating protein 2,GTPase-activating Rap/Ran-GAP domain-like protein 4;, PF02145;, GO:0005813;GO:0005737;GO:0005829;GO:0031965;GO:0048471;GO:0005886;GO:0005096;GO:0090630;GO:0002250;GO:0008361;GO:0051056;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:adaptive immune response; P:regulation of cell size; P:regulation of small GTPase mediated signal transduction;|Q684P5 B2RTY5 Q684P4 Q6AI00 Q6ZVF0 Q9UPW2,Rap1 GTPase-activating protein 2,GTPase-activating Rap/Ran-GAP domain-like protein 4;, PF02145;, GO:0005813;GO:0005737;GO:0005829;GO:0031965;GO:0048471;GO:0005886;GO:0005096;GO:0090630;GO:0002250;GO:0008361;GO:0051056;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:adaptive immune response; P:regulation of cell size; P:regulation of small GTPase mediated signal transduction;|Q684P5 B2RTY5 Q684P4 Q6AI00 Q6ZVF0 Q9UPW2,Rap1 GTPase-activating protein 2,GTPase-activating Rap/Ran-GAP domain-like protein 4;, PF02145;, GO:0005813;GO:0005737;GO:0005829;GO:0031965;GO:0048471;GO:0005886;GO:0005096;GO:0090630;GO:0002250;GO:0008361;GO:0051056;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:adaptive immune response; P:regulation of cell size; P:regulation of small GTPase mediated signal transduction;|Q684P5 B2RTY5 Q684P4 Q6AI00 Q6ZVF0 Q9UPW2,Rap1 GTPase-activating protein 2,GTPase-activating Rap/Ran-GAP domain-like protein 4;, PF02145;, GO:0005813;GO:0005737;GO:0005829;GO:0031965;GO:0048471;GO:0005886;GO:0005096;GO:0090630;GO:0002250;GO:0008361;GO:0051056;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:adaptive immune response; P:regulation of cell size; P:regulation of small GTPase mediated signal transduction; scaffold112 indexed_genome mRNA 3330247 3333672 . + . ID=transcript_13425;Q53HC0 B3KNQ0 Q9H697,Coiled-coil domain-containing protein 92,Limkain beta-2;, PF14916;, GO:0005814;GO:0005813;GO:0005737;GO:0043231;GO:0005654;GO:0042802;, C:centriole; C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:identical protein binding; scaffold112 indexed_genome mRNA 3341946 3363478 . + . ID=transcript_13426;O75153 Q6AHY2 Q6P3X7 Q6ZUG8 Q8N4U7 Q9BTA3 Q9H979,Clustered mitochondria protein homolog {ECO:0000255|HAMAP-Rule:MF_03013},, PF13236;PF15044;PF12807;, GO:0005737;GO:0003729;GO:0048312;GO:0007005;, C:cytoplasm;, F:mRNA binding;, P:intracellular distribution of mitochondria; P:mitochondrion organization;|O75153 Q6AHY2 Q6P3X7 Q6ZUG8 Q8N4U7 Q9BTA3 Q9H979,Clustered mitochondria protein homolog {ECO:0000255|HAMAP-Rule:MF_03013},, PF13236;PF15044;PF12807;, GO:0005737;GO:0003729;GO:0048312;GO:0007005;, C:cytoplasm;, F:mRNA binding;, P:intracellular distribution of mitochondria; P:mitochondrion organization;|O75153 Q6AHY2 Q6P3X7 Q6ZUG8 Q8N4U7 Q9BTA3 Q9H979,Clustered mitochondria protein homolog {ECO:0000255|HAMAP-Rule:MF_03013},, PF13236;PF15044;PF12807;, GO:0005737;GO:0003729;GO:0048312;GO:0007005;, C:cytoplasm;, F:mRNA binding;, P:intracellular distribution of mitochondria; P:mitochondrion organization;|O75153 Q6AHY2 Q6P3X7 Q6ZUG8 Q8N4U7 Q9BTA3 Q9H979,Clustered mitochondria protein homolog {ECO:0000255|HAMAP-Rule:MF_03013},, PF13236;PF15044;PF12807;, GO:0005737;GO:0003729;GO:0048312;GO:0007005;, C:cytoplasm;, F:mRNA binding;, P:intracellular distribution of mitochondria; P:mitochondrion organization;|O75153 Q6AHY2 Q6P3X7 Q6ZUG8 Q8N4U7 Q9BTA3 Q9H979,Clustered mitochondria protein homolog {ECO:0000255|HAMAP-Rule:MF_03013},, PF13236;PF15044;PF12807;, GO:0005737;GO:0003729;GO:0048312;GO:0007005;, C:cytoplasm;, F:mRNA binding;, P:intracellular distribution of mitochondria; P:mitochondrion organization;|O75153 Q6AHY2 Q6P3X7 Q6ZUG8 Q8N4U7 Q9BTA3 Q9H979,Clustered mitochondria protein homolog {ECO:0000255|HAMAP-Rule:MF_03013},, PF13236;PF15044;PF12807;, GO:0005737;GO:0003729;GO:0048312;GO:0007005;, C:cytoplasm;, F:mRNA binding;, P:intracellular distribution of mitochondria; P:mitochondrion organization;|O75153 Q6AHY2 Q6P3X7 Q6ZUG8 Q8N4U7 Q9BTA3 Q9H979,Clustered mitochondria protein homolog {ECO:0000255|HAMAP-Rule:MF_03013},, PF13236;PF15044;PF12807;, GO:0005737;GO:0003729;GO:0048312;GO:0007005;, C:cytoplasm;, F:mRNA binding;, P:intracellular distribution of mitochondria; P:mitochondrion organization; scaffold112 indexed_genome mRNA 3368743 3436319 . - . ID=transcript_13427;P43034 B2R7Q7 Q8WZ88 Q8WZ89,Platelet-activating factor acetylhydrolase IB subunit beta {ECO:0000255|HAMAP-Rule:MF_03141, ECO:0000305},Lissencephaly-1 protein {ECO:0000255|HAMAP-Rule:MF_03141};PAF acetylhydrolase 45 kDa subunit {ECO:0000255|HAMAP-Rule:MF_03141};PAF-AH alpha {ECO:0000255|HAMAP-Rule:MF_03141};, PF08513;PF00400;, GO:0008247;GO:0000235;GO:1904115;GO:0005938;GO:0005813;GO:0005881;GO:0005829;GO:0070062;GO:0000776;GO:0005875;GO:0031514;GO:0043005;GO:0043025;GO:0005635;GO:0031965;GO:0048471;GO:0045202;GO:0034452;GO:0070840;GO:0008201;GO:0042802;GO:0008017;GO:0051010;GO:0043274;GO:0051219;GO:0046982;GO:0001675;GO:0030036;GO:0008344;GO:0048854;GO:0051301;GO:0021987;GO:0007268;GO:0097711;GO:0021540;GO:0000132;GO:0000086;GO:0007281;GO:0021766;GO:0021819;GO:0007611;GO:0016042;GO:0000226;GO:0031023;GO:0051012;GO:0007017;GO:0007052;GO:0007405;GO:0050885;GO:0001764;GO:0007097;GO:0046469;GO:0038026;GO:0010389;GO:2000574;GO:0008090;GO:0019226;GO:0047496;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:astral microtubule; C:axon cytoplasm; C:cell cortex; C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:kinetochore; C:microtubule associated complex; C:motile cilium; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nuclear membrane; C:perinuclear region of cytoplasm; C:synapse;, F:dynactin binding; F:dynein complex binding; F:heparin binding; F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:phospholipase binding; F:phosphoprotein binding; F:protein heterodimerization activity;, P:acrosome assembly; P:actin cytoskeleton organization; P:adult locomotory behavior; P:brain morphogenesis; P:cell division; P:cerebral cortex development; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:corpus callosum morphogenesis; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:germ cell development; P:hippocampus development; P:layer formation in cerebral cortex; P:learning or memory; P:lipid catabolic process; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:microtubule sliding; P:microtubule-based process; P:mitotic spindle organization; P:neuroblast proliferation; P:neuromuscular process controlling balance; P:neuron migration; P:nuclear migration; P:platelet activating factor metabolic process; P:reelin-mediated signaling pathway; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule motor activity; P:retrograde axonal transport; P:transmission of nerve impulse; P:vesicle transport along microtubule;|P43034 B2R7Q7 Q8WZ88 Q8WZ89,Platelet-activating factor acetylhydrolase IB subunit beta {ECO:0000255|HAMAP-Rule:MF_03141, ECO:0000305},Lissencephaly-1 protein {ECO:0000255|HAMAP-Rule:MF_03141};PAF acetylhydrolase 45 kDa subunit {ECO:0000255|HAMAP-Rule:MF_03141};PAF-AH alpha {ECO:0000255|HAMAP-Rule:MF_03141};, PF08513;PF00400;, GO:0008247;GO:0000235;GO:1904115;GO:0005938;GO:0005813;GO:0005881;GO:0005829;GO:0070062;GO:0000776;GO:0005875;GO:0031514;GO:0043005;GO:0043025;GO:0005635;GO:0031965;GO:0048471;GO:0045202;GO:0034452;GO:0070840;GO:0008201;GO:0042802;GO:0008017;GO:0051010;GO:0043274;GO:0051219;GO:0046982;GO:0001675;GO:0030036;GO:0008344;GO:0048854;GO:0051301;GO:0021987;GO:0007268;GO:0097711;GO:0021540;GO:0000132;GO:0000086;GO:0007281;GO:0021766;GO:0021819;GO:0007611;GO:0016042;GO:0000226;GO:0031023;GO:0051012;GO:0007017;GO:0007052;GO:0007405;GO:0050885;GO:0001764;GO:0007097;GO:0046469;GO:0038026;GO:0010389;GO:2000574;GO:0008090;GO:0019226;GO:0047496;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:astral microtubule; C:axon cytoplasm; C:cell cortex; C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:kinetochore; C:microtubule associated complex; C:motile cilium; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nuclear membrane; C:perinuclear region of cytoplasm; C:synapse;, F:dynactin binding; F:dynein complex binding; F:heparin binding; F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:phospholipase binding; F:phosphoprotein binding; F:protein heterodimerization activity;, P:acrosome assembly; P:actin cytoskeleton organization; P:adult locomotory behavior; P:brain morphogenesis; P:cell division; P:cerebral cortex development; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:corpus callosum morphogenesis; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:germ cell development; P:hippocampus development; P:layer formation in cerebral cortex; P:learning or memory; P:lipid catabolic process; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:microtubule sliding; P:microtubule-based process; P:mitotic spindle organization; P:neuroblast proliferation; P:neuromuscular process controlling balance; P:neuron migration; P:nuclear migration; P:platelet activating factor metabolic process; P:reelin-mediated signaling pathway; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule motor activity; P:retrograde axonal transport; P:transmission of nerve impulse; P:vesicle transport along microtubule;|P43034 B2R7Q7 Q8WZ88 Q8WZ89,Platelet-activating factor acetylhydrolase IB subunit beta {ECO:0000255|HAMAP-Rule:MF_03141, ECO:0000305},Lissencephaly-1 protein {ECO:0000255|HAMAP-Rule:MF_03141};PAF acetylhydrolase 45 kDa subunit {ECO:0000255|HAMAP-Rule:MF_03141};PAF-AH alpha {ECO:0000255|HAMAP-Rule:MF_03141};, PF08513;PF00400;, GO:0008247;GO:0000235;GO:1904115;GO:0005938;GO:0005813;GO:0005881;GO:0005829;GO:0070062;GO:0000776;GO:0005875;GO:0031514;GO:0043005;GO:0043025;GO:0005635;GO:0031965;GO:0048471;GO:0045202;GO:0034452;GO:0070840;GO:0008201;GO:0042802;GO:0008017;GO:0051010;GO:0043274;GO:0051219;GO:0046982;GO:0001675;GO:0030036;GO:0008344;GO:0048854;GO:0051301;GO:0021987;GO:0007268;GO:0097711;GO:0021540;GO:0000132;GO:0000086;GO:0007281;GO:0021766;GO:0021819;GO:0007611;GO:0016042;GO:0000226;GO:0031023;GO:0051012;GO:0007017;GO:0007052;GO:0007405;GO:0050885;GO:0001764;GO:0007097;GO:0046469;GO:0038026;GO:0010389;GO:2000574;GO:0008090;GO:0019226;GO:0047496;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:astral microtubule; C:axon cytoplasm; C:cell cortex; C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:kinetochore; C:microtubule associated complex; C:motile cilium; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nuclear membrane; C:perinuclear region of cytoplasm; C:synapse;, F:dynactin binding; F:dynein complex binding; F:heparin binding; F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:phospholipase binding; F:phosphoprotein binding; F:protein heterodimerization activity;, P:acrosome assembly; P:actin cytoskeleton organization; P:adult locomotory behavior; P:brain morphogenesis; P:cell division; P:cerebral cortex development; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:corpus callosum morphogenesis; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:germ cell development; P:hippocampus development; P:layer formation in cerebral cortex; P:learning or memory; P:lipid catabolic process; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:microtubule sliding; P:microtubule-based process; P:mitotic spindle organization; P:neuroblast proliferation; P:neuromuscular process controlling balance; P:neuron migration; P:nuclear migration; P:platelet activating factor metabolic process; P:reelin-mediated signaling pathway; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule motor activity; P:retrograde axonal transport; P:transmission of nerve impulse; P:vesicle transport along microtubule;|P43034 B2R7Q7 Q8WZ88 Q8WZ89,Platelet-activating factor acetylhydrolase IB subunit beta {ECO:0000255|HAMAP-Rule:MF_03141, ECO:0000305},Lissencephaly-1 protein {ECO:0000255|HAMAP-Rule:MF_03141};PAF acetylhydrolase 45 kDa subunit {ECO:0000255|HAMAP-Rule:MF_03141};PAF-AH alpha {ECO:0000255|HAMAP-Rule:MF_03141};, PF08513;PF00400;, GO:0008247;GO:0000235;GO:1904115;GO:0005938;GO:0005813;GO:0005881;GO:0005829;GO:0070062;GO:0000776;GO:0005875;GO:0031514;GO:0043005;GO:0043025;GO:0005635;GO:0031965;GO:0048471;GO:0045202;GO:0034452;GO:0070840;GO:0008201;GO:0042802;GO:0008017;GO:0051010;GO:0043274;GO:0051219;GO:0046982;GO:0001675;GO:0030036;GO:0008344;GO:0048854;GO:0051301;GO:0021987;GO:0007268;GO:0097711;GO:0021540;GO:0000132;GO:0000086;GO:0007281;GO:0021766;GO:0021819;GO:0007611;GO:0016042;GO:0000226;GO:0031023;GO:0051012;GO:0007017;GO:0007052;GO:0007405;GO:0050885;GO:0001764;GO:0007097;GO:0046469;GO:0038026;GO:0010389;GO:2000574;GO:0008090;GO:0019226;GO:0047496;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:astral microtubule; C:axon cytoplasm; C:cell cortex; C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:kinetochore; C:microtubule associated complex; C:motile cilium; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nuclear membrane; C:perinuclear region of cytoplasm; C:synapse;, F:dynactin binding; F:dynein complex binding; F:heparin binding; F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:phospholipase binding; F:phosphoprotein binding; F:protein heterodimerization activity;, P:acrosome assembly; P:actin cytoskeleton organization; P:adult locomotory behavior; P:brain morphogenesis; P:cell division; P:cerebral cortex development; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:corpus callosum morphogenesis; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:germ cell development; P:hippocampus development; P:layer formation in cerebral cortex; P:learning or memory; P:lipid catabolic process; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:microtubule sliding; P:microtubule-based process; P:mitotic spindle organization; P:neuroblast proliferation; P:neuromuscular process controlling balance; P:neuron migration; P:nuclear migration; P:platelet activating factor metabolic process; P:reelin-mediated signaling pathway; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule motor activity; P:retrograde axonal transport; P:transmission of nerve impulse; P:vesicle transport along microtubule;|P43034 B2R7Q7 Q8WZ88 Q8WZ89,Platelet-activating factor acetylhydrolase IB subunit beta {ECO:0000255|HAMAP-Rule:MF_03141, ECO:0000305},Lissencephaly-1 protein {ECO:0000255|HAMAP-Rule:MF_03141};PAF acetylhydrolase 45 kDa subunit {ECO:0000255|HAMAP-Rule:MF_03141};PAF-AH alpha {ECO:0000255|HAMAP-Rule:MF_03141};, PF08513;PF00400;, GO:0008247;GO:0000235;GO:1904115;GO:0005938;GO:0005813;GO:0005881;GO:0005829;GO:0070062;GO:0000776;GO:0005875;GO:0031514;GO:0043005;GO:0043025;GO:0005635;GO:0031965;GO:0048471;GO:0045202;GO:0034452;GO:0070840;GO:0008201;GO:0042802;GO:0008017;GO:0051010;GO:0043274;GO:0051219;GO:0046982;GO:0001675;GO:0030036;GO:0008344;GO:0048854;GO:0051301;GO:0021987;GO:0007268;GO:0097711;GO:0021540;GO:0000132;GO:0000086;GO:0007281;GO:0021766;GO:0021819;GO:0007611;GO:0016042;GO:0000226;GO:0031023;GO:0051012;GO:0007017;GO:0007052;GO:0007405;GO:0050885;GO:0001764;GO:0007097;GO:0046469;GO:0038026;GO:0010389;GO:2000574;GO:0008090;GO:0019226;GO:0047496;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:astral microtubule; C:axon cytoplasm; C:cell cortex; C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:kinetochore; C:microtubule associated complex; C:motile cilium; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nuclear membrane; C:perinuclear region of cytoplasm; C:synapse;, F:dynactin binding; F:dynein complex binding; F:heparin binding; F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:phospholipase binding; F:phosphoprotein binding; F:protein heterodimerization activity;, P:acrosome assembly; P:actin cytoskeleton organization; P:adult locomotory behavior; P:brain morphogenesis; P:cell division; P:cerebral cortex development; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:corpus callosum morphogenesis; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:germ cell development; P:hippocampus development; P:layer formation in cerebral cortex; P:learning or memory; P:lipid catabolic process; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:microtubule sliding; P:microtubule-based process; P:mitotic spindle organization; P:neuroblast proliferation; P:neuromuscular process controlling balance; P:neuron migration; P:nuclear migration; P:platelet activating factor metabolic process; P:reelin-mediated signaling pathway; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule motor activity; P:retrograde axonal transport; P:transmission of nerve impulse; P:vesicle transport along microtubule;|Q8NHG8,E3 ubiquitin-protein ligase ZNRF2,Protein Ells2;RING finger protein 202;RING-type E3 ubiquitin transferase ZNRF2;Zinc/RING finger protein 2;, PF13639;, GO:0042995;GO:0005737;GO:0030659;GO:0005829;GO:0010008;GO:0001650;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0042734;GO:0032991;GO:0046872;GO:0061630;GO:0000209;, C:cell projection; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome membrane; C:fibrillar center; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:presynaptic membrane; C:protein-containing complex;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:protein polyubiquitination;|Q8NHG8,E3 ubiquitin-protein ligase ZNRF2,Protein Ells2;RING finger protein 202;RING-type E3 ubiquitin transferase ZNRF2;Zinc/RING finger protein 2;, PF13639;, GO:0042995;GO:0005737;GO:0030659;GO:0005829;GO:0010008;GO:0001650;GO:0043231;GO:0005765;GO:0005654;GO:0005886;GO:0042734;GO:0032991;GO:0046872;GO:0061630;GO:0000209;, C:cell projection; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome membrane; C:fibrillar center; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:presynaptic membrane; C:protein-containing complex;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:protein polyubiquitination;|P43034 B2R7Q7 Q8WZ88 Q8WZ89,Platelet-activating factor acetylhydrolase IB subunit beta {ECO:0000255|HAMAP-Rule:MF_03141, ECO:0000305},Lissencephaly-1 protein {ECO:0000255|HAMAP-Rule:MF_03141};PAF acetylhydrolase 45 kDa subunit {ECO:0000255|HAMAP-Rule:MF_03141};PAF-AH alpha {ECO:0000255|HAMAP-Rule:MF_03141};, PF08513;PF00400;, GO:0008247;GO:0000235;GO:1904115;GO:0005938;GO:0005813;GO:0005881;GO:0005829;GO:0070062;GO:0000776;GO:0005875;GO:0031514;GO:0043005;GO:0043025;GO:0005635;GO:0031965;GO:0048471;GO:0045202;GO:0034452;GO:0070840;GO:0008201;GO:0042802;GO:0008017;GO:0051010;GO:0043274;GO:0051219;GO:0046982;GO:0001675;GO:0030036;GO:0008344;GO:0048854;GO:0051301;GO:0021987;GO:0007268;GO:0097711;GO:0021540;GO:0000132;GO:0000086;GO:0007281;GO:0021766;GO:0021819;GO:0007611;GO:0016042;GO:0000226;GO:0031023;GO:0051012;GO:0007017;GO:0007052;GO:0007405;GO:0050885;GO:0001764;GO:0007097;GO:0046469;GO:0038026;GO:0010389;GO:2000574;GO:0008090;GO:0019226;GO:0047496;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:astral microtubule; C:axon cytoplasm; C:cell cortex; C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:kinetochore; C:microtubule associated complex; C:motile cilium; C:neuron projection; C:neuronal cell body; C:nuclear envelope; C:nuclear membrane; C:perinuclear region of cytoplasm; C:synapse;, F:dynactin binding; F:dynein complex binding; F:heparin binding; F:identical protein binding; F:microtubule binding; F:microtubule plus-end binding; F:phospholipase binding; F:phosphoprotein binding; F:protein heterodimerization activity;, P:acrosome assembly; P:actin cytoskeleton organization; P:adult locomotory behavior; P:brain morphogenesis; P:cell division; P:cerebral cortex development; P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:corpus callosum morphogenesis; P:establishment of mitotic spindle orientation; P:G2/M transition of mitotic cell cycle; P:germ cell development; P:hippocampus development; P:layer formation in cerebral cortex; P:learning or memory; P:lipid catabolic process; P:microtubule cytoskeleton organization; P:microtubule organizing center organization; P:microtubule sliding; P:microtubule-based process; P:mitotic spindle organization; P:neuroblast proliferation; P:neuromuscular process controlling balance; P:neuron migration; P:nuclear migration; P:platelet activating factor metabolic process; P:reelin-mediated signaling pathway; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of microtubule motor activity; P:retrograde axonal transport; P:transmission of nerve impulse; P:vesicle transport along microtubule; scaffold112 indexed_genome mRNA 3522175 3585490 . + . ID=transcript_13428;Q86W50 D3DTI8 Q86TE5 Q96T16 Q9BVG7,RNA N6-adenosine-methyltransferase METTL16 {ECO:0000305},Methyltransferase 10 domain-containing protein {ECO:0000303|Ref.14};Methyltransferase-like protein 16 {ECO:0000303|PubMed:27872311};N6-adenosine-methyltransferase METTL16;U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase {ECO:0000305};, PF05971;, GO:0005737;GO:0005634;GO:0052907;GO:0001734;GO:0003723;GO:0035613;GO:0120048;GO:0030629;GO:0006402;GO:0061157;GO:0080009;GO:1905869;GO:0010608;GO:0048024;GO:0070475;GO:0006556;GO:0120049;, C:cytoplasm; C:nucleus;, F:23S rRNA (adenine(1618)-N(6))-methyltransferase activity; F:mRNA (N6-adenosine)-methyltransferase activity; F:RNA binding; F:RNA stem-loop binding; F:U6 snRNA (adenine-(43)-N(6))-methyltransferase activity; F:U6 snRNA 3'-end binding;, P:mRNA catabolic process; P:mRNA destabilization; P:mRNA methylation; P:negative regulation of 3'-UTR-mediated mRNA stabilization; P:posttranscriptional regulation of gene expression; P:regulation of mRNA splicing, via spliceosome; P:rRNA base methylation; P:S-adenosylmethionine biosynthetic process; P:snRNA (adenine-N6)-methylation;|Q86W50 D3DTI8 Q86TE5 Q96T16 Q9BVG7,RNA N6-adenosine-methyltransferase METTL16 {ECO:0000305},Methyltransferase 10 domain-containing protein {ECO:0000303|Ref.14};Methyltransferase-like protein 16 {ECO:0000303|PubMed:27872311};N6-adenosine-methyltransferase METTL16;U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase {ECO:0000305};, PF05971;, GO:0005737;GO:0005634;GO:0052907;GO:0001734;GO:0003723;GO:0035613;GO:0120048;GO:0030629;GO:0006402;GO:0061157;GO:0080009;GO:1905869;GO:0010608;GO:0048024;GO:0070475;GO:0006556;GO:0120049;, C:cytoplasm; C:nucleus;, F:23S rRNA (adenine(1618)-N(6))-methyltransferase activity; F:mRNA (N6-adenosine)-methyltransferase activity; F:RNA binding; F:RNA stem-loop binding; F:U6 snRNA (adenine-(43)-N(6))-methyltransferase activity; F:U6 snRNA 3'-end binding;, P:mRNA catabolic process; P:mRNA destabilization; P:mRNA methylation; P:negative regulation of 3'-UTR-mediated mRNA stabilization; P:posttranscriptional regulation of gene expression; P:regulation of mRNA splicing, via spliceosome; P:rRNA base methylation; P:S-adenosylmethionine biosynthetic process; P:snRNA (adenine-N6)-methylation; scaffold113 indexed_genome mRNA 16418 17350 . - . ID=transcript_13429;Q27J81 Q27J83 Q69YL8 Q6P1X7 Q6PK22 Q86TR7 Q9BRM1 Q9H6N1,Inverted formin-2,HBEBP2-binding protein C;, PF06367;PF06371;PF02181;PF02205;, GO:0048471;GO:0003779;GO:0031267;GO:0030036;GO:0090140;, C:perinuclear region of cytoplasm;, F:actin binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:regulation of mitochondrial fission; scaffold113 indexed_genome mRNA 17434 18982 . - . ID=transcript_13430;Q27J81 Q27J83 Q69YL8 Q6P1X7 Q6PK22 Q86TR7 Q9BRM1 Q9H6N1,Inverted formin-2,HBEBP2-binding protein C;, PF06367;PF06371;PF02181;PF02205;, GO:0048471;GO:0003779;GO:0031267;GO:0030036;GO:0090140;, C:perinuclear region of cytoplasm;, F:actin binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:regulation of mitochondrial fission; scaffold113 indexed_genome mRNA 119950 127939 . + . ID=transcript_13431;Q6ZW26 Q8NA36,Collagen alpha-5(VI) chain,Collagen alpha-1(XXIX) chain;von Willebrand factor A domain-containing protein 4;, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005576;GO:0030020;GO:0007155;, C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular region;, F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion;|Q8N912,Nutritionally-regulated adipose and cardiac enriched protein homolog,, PF15555;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q8N912,Nutritionally-regulated adipose and cardiac enriched protein homolog,, PF15555;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold113 indexed_genome mRNA 536669 537722 . - . ID=transcript_13432;Q86U10 B9EGQ2 Q8IV80,60 kDa lysophospholipase,Lysophospholipase-transacylase {ECO:0000250|UniProtKB:O88202};, PF12796;PF00710;PF17763;, GO:0005829;GO:0003847;GO:0004067;GO:0004622;GO:0102545;GO:0016747;GO:0009066;GO:0016042;, C:cytosol;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:asparaginase activity; F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:transferase activity, transferring acyl groups other than amino-acyl groups;, P:aspartate family amino acid metabolic process; P:lipid catabolic process; scaffold113 indexed_genome mRNA 539364 540269 . + . ID=transcript_13433;Q86U10 B9EGQ2 Q8IV80,60 kDa lysophospholipase,Lysophospholipase-transacylase {ECO:0000250|UniProtKB:O88202};, PF12796;PF00710;PF17763;, GO:0005829;GO:0003847;GO:0004067;GO:0004622;GO:0102545;GO:0016747;GO:0009066;GO:0016042;, C:cytosol;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:asparaginase activity; F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:transferase activity, transferring acyl groups other than amino-acyl groups;, P:aspartate family amino acid metabolic process; P:lipid catabolic process; scaffold113 indexed_genome mRNA 588909 618033 . - . ID=transcript_13434;Q8NDG6 A1A4S7 Q6ZU54 Q8N7T3 Q8N827 Q8N9V5 Q96AS9,ATP-dependent RNA helicase TDRD9 {ECO:0000305},Tudor domain-containing protein 9 {ECO:0000305};, PF00270;PF04408;PF00271;PF00567;, GO:0005737;GO:0005634;GO:0071547;GO:0005524;GO:0016887;GO:0003723;GO:0003724;GO:0030154;GO:0043046;GO:0009566;GO:0031047;GO:0007141;GO:0007140;GO:0007275;GO:0010529;GO:0034587;GO:0007283;, C:cytoplasm; C:nucleus; C:piP-body;, F:ATP binding; F:ATPase activity; F:RNA binding; F:RNA helicase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:fertilization; P:gene silencing by RNA; P:male meiosis I; P:male meiotic nuclear division; P:multicellular organism development; P:negative regulation of transposition; P:piRNA metabolic process; P:spermatogenesis; scaffold113 indexed_genome mRNA 619269 622801 . - . ID=transcript_13435;Q8NDG6 A1A4S7 Q6ZU54 Q8N7T3 Q8N827 Q8N9V5 Q96AS9,ATP-dependent RNA helicase TDRD9 {ECO:0000305},Tudor domain-containing protein 9 {ECO:0000305};, PF00270;PF04408;PF00271;PF00567;, GO:0005737;GO:0005634;GO:0071547;GO:0005524;GO:0016887;GO:0003723;GO:0003724;GO:0030154;GO:0043046;GO:0009566;GO:0031047;GO:0007141;GO:0007140;GO:0007275;GO:0010529;GO:0034587;GO:0007283;, C:cytoplasm; C:nucleus; C:piP-body;, F:ATP binding; F:ATPase activity; F:RNA binding; F:RNA helicase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:fertilization; P:gene silencing by RNA; P:male meiosis I; P:male meiotic nuclear division; P:multicellular organism development; P:negative regulation of transposition; P:piRNA metabolic process; P:spermatogenesis; scaffold113 indexed_genome mRNA 622813 637772 . - . ID=transcript_13436;Q8NDG6 A1A4S7 Q6ZU54 Q8N7T3 Q8N827 Q8N9V5 Q96AS9,ATP-dependent RNA helicase TDRD9 {ECO:0000305},Tudor domain-containing protein 9 {ECO:0000305};, PF00270;PF04408;PF00271;PF00567;, GO:0005737;GO:0005634;GO:0071547;GO:0005524;GO:0016887;GO:0003723;GO:0003724;GO:0030154;GO:0043046;GO:0009566;GO:0031047;GO:0007141;GO:0007140;GO:0007275;GO:0010529;GO:0034587;GO:0007283;, C:cytoplasm; C:nucleus; C:piP-body;, F:ATP binding; F:ATPase activity; F:RNA binding; F:RNA helicase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:fertilization; P:gene silencing by RNA; P:male meiosis I; P:male meiotic nuclear division; P:multicellular organism development; P:negative regulation of transposition; P:piRNA metabolic process; P:spermatogenesis; scaffold113 indexed_genome mRNA 637794 638821 . - . ID=transcript_13437;Q8NDG6 A1A4S7 Q6ZU54 Q8N7T3 Q8N827 Q8N9V5 Q96AS9,ATP-dependent RNA helicase TDRD9 {ECO:0000305},Tudor domain-containing protein 9 {ECO:0000305};, PF00270;PF04408;PF00271;PF00567;, GO:0005737;GO:0005634;GO:0071547;GO:0005524;GO:0016887;GO:0003723;GO:0003724;GO:0030154;GO:0043046;GO:0009566;GO:0031047;GO:0007141;GO:0007140;GO:0007275;GO:0010529;GO:0034587;GO:0007283;, C:cytoplasm; C:nucleus; C:piP-body;, F:ATP binding; F:ATPase activity; F:RNA binding; F:RNA helicase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:fertilization; P:gene silencing by RNA; P:male meiosis I; P:male meiotic nuclear division; P:multicellular organism development; P:negative regulation of transposition; P:piRNA metabolic process; P:spermatogenesis; scaffold113 indexed_genome mRNA 801063 829378 . + . ID=transcript_13438;Q96KQ4 B2RMX5 O94870,Apoptosis-stimulating of p53 protein 1,Protein phosphatase 1 regulatory subunit 13B;, PF12796;PF00018;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0002039;GO:0008134;GO:0072332;GO:0045786;GO:1901216;GO:1900740;GO:0042981;GO:1901796;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:p53 binding; F:transcription factor binding;, P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator;|Q96KQ4 B2RMX5 O94870,Apoptosis-stimulating of p53 protein 1,Protein phosphatase 1 regulatory subunit 13B;, PF12796;PF00018;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0002039;GO:0008134;GO:0072332;GO:0045786;GO:1901216;GO:1900740;GO:0042981;GO:1901796;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:p53 binding; F:transcription factor binding;, P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator; scaffold113 indexed_genome mRNA 831346 839136 . - . ID=transcript_13439;Q96KQ4 B2RMX5 O94870,Apoptosis-stimulating of p53 protein 1,Protein phosphatase 1 regulatory subunit 13B;, PF12796;PF00018;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0002039;GO:0008134;GO:0072332;GO:0045786;GO:1901216;GO:1900740;GO:0042981;GO:1901796;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:p53 binding; F:transcription factor binding;, P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator;|Q96KQ4 B2RMX5 O94870,Apoptosis-stimulating of p53 protein 1,Protein phosphatase 1 regulatory subunit 13B;, PF12796;PF00018;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0002039;GO:0008134;GO:0072332;GO:0045786;GO:1901216;GO:1900740;GO:0042981;GO:1901796;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:p53 binding; F:transcription factor binding;, P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator;|Q96KQ4 B2RMX5 O94870,Apoptosis-stimulating of p53 protein 1,Protein phosphatase 1 regulatory subunit 13B;, PF12796;PF00018;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0002039;GO:0008134;GO:0072332;GO:0045786;GO:1901216;GO:1900740;GO:0042981;GO:1901796;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:p53 binding; F:transcription factor binding;, P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator;|Q96KQ4 B2RMX5 O94870,Apoptosis-stimulating of p53 protein 1,Protein phosphatase 1 regulatory subunit 13B;, PF12796;PF00018;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0002039;GO:0008134;GO:0072332;GO:0045786;GO:1901216;GO:1900740;GO:0042981;GO:1901796;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:p53 binding; F:transcription factor binding;, P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator;|Q96KQ4 B2RMX5 O94870,Apoptosis-stimulating of p53 protein 1,Protein phosphatase 1 regulatory subunit 13B;, PF12796;PF00018;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0002039;GO:0008134;GO:0072332;GO:0045786;GO:1901216;GO:1900740;GO:0042981;GO:1901796;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:p53 binding; F:transcription factor binding;, P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator;|Q96KQ4 B2RMX5 O94870,Apoptosis-stimulating of p53 protein 1,Protein phosphatase 1 regulatory subunit 13B;, PF12796;PF00018;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0002039;GO:0008134;GO:0072332;GO:0045786;GO:1901216;GO:1900740;GO:0042981;GO:1901796;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:p53 binding; F:transcription factor binding;, P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of cell cycle; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of signal transduction by p53 class mediator; scaffold113 indexed_genome mRNA 850039 853984 . - . ID=transcript_13440;O43542 O43568 Q9BU18,DNA repair protein XRCC3,X-ray repair cross-complementing protein 3;, PF08423;, GO:0000781;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033065;GO:0005657;GO:0005524;GO:0003677;GO:0008094;GO:0006974;GO:0006310;GO:0006281;GO:0000724;GO:0045003;GO:0036297;GO:0090267;GO:0010824;GO:0071140;GO:0010033;GO:0090656;GO:0000722;GO:0090737;GO:0090657;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via synthesis-dependent strand annealing; P:interstrand cross-link repair; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of centrosome duplication; P:resolution of mitotic recombination intermediates; P:response to organic substance; P:t-circle formation; P:telomere maintenance via recombination; P:telomere maintenance via telomere trimming; P:telomeric loop disassembly; scaffold113 indexed_genome mRNA 854181 909061 . + . ID=transcript_13441;O43542 O43568 Q9BU18,DNA repair protein XRCC3,X-ray repair cross-complementing protein 3;, PF08423;, GO:0000781;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033065;GO:0005657;GO:0005524;GO:0003677;GO:0008094;GO:0006974;GO:0006310;GO:0006281;GO:0000724;GO:0045003;GO:0036297;GO:0090267;GO:0010824;GO:0071140;GO:0010033;GO:0090656;GO:0000722;GO:0090737;GO:0090657;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via synthesis-dependent strand annealing; P:interstrand cross-link repair; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of centrosome duplication; P:resolution of mitotic recombination intermediates; P:response to organic substance; P:t-circle formation; P:telomere maintenance via recombination; P:telomere maintenance via telomere trimming; P:telomeric loop disassembly;|O43542 O43568 Q9BU18,DNA repair protein XRCC3,X-ray repair cross-complementing protein 3;, PF08423;, GO:0000781;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033065;GO:0005657;GO:0005524;GO:0003677;GO:0008094;GO:0006974;GO:0006310;GO:0006281;GO:0000724;GO:0045003;GO:0036297;GO:0090267;GO:0010824;GO:0071140;GO:0010033;GO:0090656;GO:0000722;GO:0090737;GO:0090657;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via synthesis-dependent strand annealing; P:interstrand cross-link repair; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of centrosome duplication; P:resolution of mitotic recombination intermediates; P:response to organic substance; P:t-circle formation; P:telomere maintenance via recombination; P:telomere maintenance via telomere trimming; P:telomeric loop disassembly;|O43542 O43568 Q9BU18,DNA repair protein XRCC3,X-ray repair cross-complementing protein 3;, PF08423;, GO:0000781;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0048471;GO:0033065;GO:0005657;GO:0005524;GO:0003677;GO:0008094;GO:0006974;GO:0006310;GO:0006281;GO:0000724;GO:0045003;GO:0036297;GO:0090267;GO:0010824;GO:0071140;GO:0010033;GO:0090656;GO:0000722;GO:0090737;GO:0090657;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Rad51C-XRCC3 complex; C:replication fork;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity;, P:cellular response to DNA damage stimulus; P:DNA recombination; P:DNA repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via synthesis-dependent strand annealing; P:interstrand cross-link repair; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:regulation of centrosome duplication; P:resolution of mitotic recombination intermediates; P:response to organic substance; P:t-circle formation; P:telomere maintenance via recombination; P:telomere maintenance via telomere trimming; P:telomeric loop disassembly;|Q96H62,Kinesin light chain 1,, PF13176;, GO:0031410;GO:0005829;GO:0030426;GO:0005871;GO:0016020;GO:0005874;GO:0003774;GO:0019886;GO:0007018;GO:0006890;GO:0035617;GO:0016032;, C:cytoplasmic vesicle; C:cytosol; C:growth cone; C:kinesin complex; C:membrane; C:microtubule;, F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:stress granule disassembly; P:viral process;|Q9NSK0 B3KNY4 B3KPI3 B3KSQ3 B4DME9 Q66K28 Q96EG6,Kinesin light chain 4,Kinesin-like protein 8;, , GO:0005737;GO:0005871;GO:0005874;, C:cytoplasm; C:kinesin complex; C:microtubule;|Q96H62,Kinesin light chain 1,, PF13176;, GO:0031410;GO:0005829;GO:0030426;GO:0005871;GO:0016020;GO:0005874;GO:0003774;GO:0019886;GO:0007018;GO:0006890;GO:0035617;GO:0016032;, C:cytoplasmic vesicle; C:cytosol; C:growth cone; C:kinesin complex; C:membrane; C:microtubule;, F:motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:stress granule disassembly; P:viral process; scaffold113 indexed_genome mRNA 951801 980550 . - . ID=transcript_13442;Q96IL0 H7C2Z1 Q53G28,Cytochrome c oxidase assembly factor 8 {ECO:0000305},Apoptogenic protein 1, mitochondrial;, PF10231;, GO:0099617;GO:0005739;GO:0097193;GO:0033617;GO:1903427;GO:1904960;GO:0050821;GO:0000302;, C:matrix side of mitochondrial inner membrane; C:mitochondrion;, , P:intrinsic apoptotic signaling pathway; P:mitochondrial cytochrome c oxidase assembly; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of cytochrome-c oxidase activity; P:protein stabilization; P:response to reactive oxygen species;|Q96IL0 H7C2Z1 Q53G28,Cytochrome c oxidase assembly factor 8 {ECO:0000305},Apoptogenic protein 1, mitochondrial;, PF10231;, GO:0099617;GO:0005739;GO:0097193;GO:0033617;GO:1903427;GO:1904960;GO:0050821;GO:0000302;, C:matrix side of mitochondrial inner membrane; C:mitochondrion;, , P:intrinsic apoptotic signaling pathway; P:mitochondrial cytochrome c oxidase assembly; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of cytochrome-c oxidase activity; P:protein stabilization; P:response to reactive oxygen species; scaffold113 indexed_genome mRNA 985036 986696 . - . ID=transcript_13443;Q9UL15 O94950 Q86W59,BAG family molecular chaperone regulator 5,Bcl-2-associated athanogene 5;, PF02179;, GO:0005737;GO:0005829;GO:0016234;GO:0016020;GO:0005739;GO:0005634;GO:0048471;GO:0000774;GO:0051087;GO:0031072;GO:0019901;GO:0031625;GO:0007030;GO:0010977;GO:1902176;GO:0032435;GO:0061084;GO:0031397;GO:0051444;GO:0070997;GO:0006457;GO:0050821;GO:1900034;GO:0090083;GO:0051438;, C:cytoplasm; C:cytosol; C:inclusion body; C:membrane; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:heat shock protein binding; F:protein kinase binding; F:ubiquitin protein ligase binding;, P:Golgi organization; P:negative regulation of neuron projection development; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein refolding; P:negative regulation of protein ubiquitination; P:negative regulation of ubiquitin-protein transferase activity; P:neuron death; P:protein folding; P:protein stabilization; P:regulation of cellular response to heat; P:regulation of inclusion body assembly; P:regulation of ubiquitin-protein transferase activity; scaffold113 indexed_genome mRNA 1004939 1018392 . - . ID=transcript_13444;Q96RG1 Q9UMY9 Q9UN34,MAP/microtubule affinity-regulating kinase 3,C-TAK1;Cdc25C-associated protein kinase 1;ELKL motif kinase 2;Protein kinase STK10;Ser/Thr protein kinase PAR-1;Serine/threonine-protein kinase p78;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0035556;GO:0000165;GO:0000226;GO:0035331;GO:0036289;GO:0018105;GO:0032092;GO:0006468;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:intracellular signal transduction; P:MAPK cascade; P:microtubule cytoskeleton organization; P:negative regulation of hippo signaling; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:protein phosphorylation; scaffold113 indexed_genome mRNA 1018400 1108844 . - . ID=transcript_13445;Q96RG1 Q9UMY9 Q9UN34,MAP/microtubule affinity-regulating kinase 3,C-TAK1;Cdc25C-associated protein kinase 1;ELKL motif kinase 2;Protein kinase STK10;Ser/Thr protein kinase PAR-1;Serine/threonine-protein kinase p78;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0035556;GO:0000165;GO:0000226;GO:0035331;GO:0036289;GO:0018105;GO:0032092;GO:0006468;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:intracellular signal transduction; P:MAPK cascade; P:microtubule cytoskeleton organization; P:negative regulation of hippo signaling; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:protein phosphorylation;|Q96RG1 Q9UMY9 Q9UN34,MAP/microtubule affinity-regulating kinase 3,C-TAK1;Cdc25C-associated protein kinase 1;ELKL motif kinase 2;Protein kinase STK10;Ser/Thr protein kinase PAR-1;Serine/threonine-protein kinase p78;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0035556;GO:0000165;GO:0000226;GO:0035331;GO:0036289;GO:0018105;GO:0032092;GO:0006468;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:intracellular signal transduction; P:MAPK cascade; P:microtubule cytoskeleton organization; P:negative regulation of hippo signaling; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:protein phosphorylation;|Q96RG1 Q9UMY9 Q9UN34,MAP/microtubule affinity-regulating kinase 3,C-TAK1;Cdc25C-associated protein kinase 1;ELKL motif kinase 2;Protein kinase STK10;Ser/Thr protein kinase PAR-1;Serine/threonine-protein kinase p78;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0035556;GO:0000165;GO:0000226;GO:0035331;GO:0036289;GO:0018105;GO:0032092;GO:0006468;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:intracellular signal transduction; P:MAPK cascade; P:microtubule cytoskeleton organization; P:negative regulation of hippo signaling; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:protein phosphorylation;|Q9P0L2 D3DTB0 D3DTB1 Q2HIY1 Q5VTF9 Q5VTG0 Q96SW9 Q9P251,Serine/threonine-protein kinase MARK1,MAP/microtubule affinity-regulating kinase 1;PAR1 homolog c;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005856;GO:0030425;GO:0015630;GO:0005886;GO:0005524;GO:0000287;GO:0070300;GO:0005546;GO:0001786;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0007010;GO:0051654;GO:0035556;GO:0000226;GO:0001764;GO:0018105;GO:0006468;GO:0050773;GO:0010975;GO:0016055;, C:cytoplasm; C:cytoskeleton; C:dendrite; C:microtubule cytoskeleton; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:cytoskeleton organization; P:establishment of mitochondrion localization; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:neuron migration; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of dendrite development; P:regulation of neuron projection development; P:Wnt signaling pathway; scaffold113 indexed_genome mRNA 1131295 1142100 . - . ID=transcript_13446;P55010 Q53XB3 Q9H5N2 Q9UG48,Eukaryotic translation initiation factor 5,, PF01873;PF02020;, GO:0005737;GO:0005829;GO:0005886;GO:0045296;GO:0071074;GO:0005092;GO:0005525;GO:0003723;GO:0003743;GO:0090630;GO:0001732;GO:0001731;GO:0006446;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:cadherin binding; F:eukaryotic initiation factor eIF2 binding; F:GDP-dissociation inhibitor activity; F:GTP binding; F:RNA binding; F:translation initiation factor activity;, P:activation of GTPase activity; P:formation of cytoplasmic translation initiation complex; P:formation of translation preinitiation complex; P:regulation of translational initiation;|P55010 Q53XB3 Q9H5N2 Q9UG48,Eukaryotic translation initiation factor 5,, PF01873;PF02020;, GO:0005737;GO:0005829;GO:0005886;GO:0045296;GO:0071074;GO:0005092;GO:0005525;GO:0003723;GO:0003743;GO:0090630;GO:0001732;GO:0001731;GO:0006446;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:cadherin binding; F:eukaryotic initiation factor eIF2 binding; F:GDP-dissociation inhibitor activity; F:GTP binding; F:RNA binding; F:translation initiation factor activity;, P:activation of GTPase activity; P:formation of cytoplasmic translation initiation complex; P:formation of translation preinitiation complex; P:regulation of translational initiation;|P55010 Q53XB3 Q9H5N2 Q9UG48,Eukaryotic translation initiation factor 5,, PF01873;PF02020;, GO:0005737;GO:0005829;GO:0005886;GO:0045296;GO:0071074;GO:0005092;GO:0005525;GO:0003723;GO:0003743;GO:0090630;GO:0001732;GO:0001731;GO:0006446;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:cadherin binding; F:eukaryotic initiation factor eIF2 binding; F:GDP-dissociation inhibitor activity; F:GTP binding; F:RNA binding; F:translation initiation factor activity;, P:activation of GTPase activity; P:formation of cytoplasmic translation initiation complex; P:formation of translation preinitiation complex; P:regulation of translational initiation;|P55010 Q53XB3 Q9H5N2 Q9UG48,Eukaryotic translation initiation factor 5,, PF01873;PF02020;, GO:0005737;GO:0005829;GO:0005886;GO:0045296;GO:0071074;GO:0005092;GO:0005525;GO:0003723;GO:0003743;GO:0090630;GO:0001732;GO:0001731;GO:0006446;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:cadherin binding; F:eukaryotic initiation factor eIF2 binding; F:GDP-dissociation inhibitor activity; F:GTP binding; F:RNA binding; F:translation initiation factor activity;, P:activation of GTPase activity; P:formation of cytoplasmic translation initiation complex; P:formation of translation preinitiation complex; P:regulation of translational initiation; scaffold113 indexed_genome mRNA 1307902 1315303 . - . ID=transcript_13447;Q03169 Q86VI0,Tumor necrosis factor alpha-induced protein 2,Primary response gene B94 protein;, PF06046;, GO:0000145;GO:0005615;GO:0000149;GO:0001525;GO:0030154;GO:0051601;GO:0006887;, C:exocyst; C:extracellular space;, F:SNARE binding;, P:angiogenesis; P:cell differentiation; P:exocyst localization; P:exocytosis; scaffold113 indexed_genome mRNA 1331732 1339725 . - . ID=transcript_13448;Q17RC7 Q14CR2,Exocyst complex component 3-like protein 4,, PF06046;, GO:0000145;GO:0000149;GO:0051601;GO:0006887;, C:exocyst;, F:SNARE binding;, P:exocyst localization; P:exocytosis; scaffold113 indexed_genome mRNA 1342890 1346284 . + . ID=transcript_13449;Q17RC7 Q14CR2,Exocyst complex component 3-like protein 4,, PF06046;, GO:0000145;GO:0000149;GO:0051601;GO:0006887;, C:exocyst;, F:SNARE binding;, P:exocyst localization; P:exocytosis;|Q17RC7 Q14CR2,Exocyst complex component 3-like protein 4,, PF06046;, GO:0000145;GO:0000149;GO:0051601;GO:0006887;, C:exocyst;, F:SNARE binding;, P:exocyst localization; P:exocytosis; scaffold113 indexed_genome mRNA 1353652 1354306 . - . ID=transcript_13450;P10266 P87890 Q14273,Endogenous retrovirus group K member 10 Pol protein,HERV-K10 Pol protein;HERV-K107 Pol protein;HERV-K_5q33.3 provirus ancestral Pol protein;, PF13804;PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold113 indexed_genome mRNA 1460777 1515698 . - . ID=transcript_13451;Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction;|Q9Y5S2 A9JR72 Q2L7A5 Q86TJ1 Q9ULU5,Serine/threonine-protein kinase MRCK beta,CDC42-binding protein kinase beta;DMPK-like beta;Myotonic dystrophy kinase-related CDC42-binding kinase beta;, PF00130;PF00780;PF08826;PF15796;PF00069;, GO:0042641;GO:0031252;GO:0005911;GO:0005737;GO:0005856;GO:0070062;GO:0030027;GO:0005886;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0031532;GO:0031032;GO:0016477;GO:0007010;GO:0007163;GO:0035556;GO:0018107;GO:0006468;GO:0007165;, C:actomyosin; C:cell leading edge; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:lamellipodium; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:cell migration; P:cytoskeleton organization; P:establishment or maintenance of cell polarity; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; P:signal transduction; scaffold113 indexed_genome mRNA 1709090 1729262 . - . ID=transcript_13452;Q9UKL0 J3KN32 Q15044 Q6P2I9 Q86VG5,REST corepressor 1,Protein CoREST;, PF01448;PF00249;, GO:1990391;GO:0000118;GO:0005654;GO:0005634;GO:0005667;GO:0017053;GO:0003682;GO:0019899;GO:0003714;GO:0007596;GO:0030218;GO:0016575;GO:0070933;GO:0045892;GO:0045654;GO:0006357;GO:0016032;, C:DNA repair complex; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex; C:transcription repressor complex;, F:chromatin binding; F:enzyme binding; F:transcription corepressor activity;, P:blood coagulation; P:erythrocyte differentiation; P:histone deacetylation; P:histone H4 deacetylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of megakaryocyte differentiation; P:regulation of transcription by RNA polymerase II; P:viral process;|Q9UKL0 J3KN32 Q15044 Q6P2I9 Q86VG5,REST corepressor 1,Protein CoREST;, PF01448;PF00249;, GO:1990391;GO:0000118;GO:0005654;GO:0005634;GO:0005667;GO:0017053;GO:0003682;GO:0019899;GO:0003714;GO:0007596;GO:0030218;GO:0016575;GO:0070933;GO:0045892;GO:0045654;GO:0006357;GO:0016032;, C:DNA repair complex; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex; C:transcription repressor complex;, F:chromatin binding; F:enzyme binding; F:transcription corepressor activity;, P:blood coagulation; P:erythrocyte differentiation; P:histone deacetylation; P:histone H4 deacetylation; P:negative regulation of transcription, DNA-templated; P:positive regulation of megakaryocyte differentiation; P:regulation of transcription by RNA polymerase II; P:viral process; scaffold113 indexed_genome mRNA 1898928 1905230 . - . ID=transcript_13453;O15040 A5PKY3 A6NFY9 A7E2X3 H0YMM9 Q9UEG6,Tectonin beta-propeller repeat-containing protein 2,WD repeat-containing protein KIAA0329/KIAA0297;, PF06462;PF19193;, GO:0005737;GO:0006914;GO:0032527;, C:cytoplasm;, , P:autophagy; P:protein exit from endoplasmic reticulum;|O15040 A5PKY3 A6NFY9 A7E2X3 H0YMM9 Q9UEG6,Tectonin beta-propeller repeat-containing protein 2,WD repeat-containing protein KIAA0329/KIAA0297;, PF06462;PF19193;, GO:0005737;GO:0006914;GO:0032527;, C:cytoplasm;, , P:autophagy; P:protein exit from endoplasmic reticulum; scaffold113 indexed_genome mRNA 1917268 1918078 . - . ID=transcript_13454;Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold113 indexed_genome mRNA 1938328 1968335 . - . ID=transcript_13455;O15040 A5PKY3 A6NFY9 A7E2X3 H0YMM9 Q9UEG6,Tectonin beta-propeller repeat-containing protein 2,WD repeat-containing protein KIAA0329/KIAA0297;, PF06462;PF19193;, GO:0005737;GO:0006914;GO:0032527;, C:cytoplasm;, , P:autophagy; P:protein exit from endoplasmic reticulum;|O15040 A5PKY3 A6NFY9 A7E2X3 H0YMM9 Q9UEG6,Tectonin beta-propeller repeat-containing protein 2,WD repeat-containing protein KIAA0329/KIAA0297;, PF06462;PF19193;, GO:0005737;GO:0006914;GO:0032527;, C:cytoplasm;, , P:autophagy; P:protein exit from endoplasmic reticulum; scaffold113 indexed_genome mRNA 2006802 2022427 . + . ID=transcript_13456;Q9BW66 F5H7P3 F5H8A7 Q9NPF9,Cyclin-dependent kinase 2-interacting protein,, , GO:0005634;GO:0007049;GO:0051301;GO:0006281;GO:0006260;, C:nucleus;, , P:cell cycle; P:cell division; P:DNA repair; P:DNA replication;|Q9BW66 F5H7P3 F5H8A7 Q9NPF9,Cyclin-dependent kinase 2-interacting protein,, , GO:0005634;GO:0007049;GO:0051301;GO:0006281;GO:0006260;, C:nucleus;, , P:cell cycle; P:cell division; P:DNA repair; P:DNA replication; scaffold113 indexed_genome mRNA 2025047 2032482 . - . ID=transcript_13457;A8K0R7 B3KSD2 Q53FH5 Q6GPI5 Q86TU1 Q9BQ86 Q9NUU3,Zinc finger protein 839,Renal carcinoma antigen NY-REN-50;, PF15961;, GO:0046872;, , F:metal ion binding;|A8K0R7 B3KSD2 Q53FH5 Q6GPI5 Q86TU1 Q9BQ86 Q9NUU3,Zinc finger protein 839,Renal carcinoma antigen NY-REN-50;, PF15961;, GO:0046872;, , F:metal ion binding;|A8K0R7 B3KSD2 Q53FH5 Q6GPI5 Q86TU1 Q9BQ86 Q9NUU3,Zinc finger protein 839,Renal carcinoma antigen NY-REN-50;, PF15961;, GO:0046872;, , F:metal ion binding; scaffold113 indexed_genome mRNA 2033050 2036958 . - . ID=transcript_13458;A8K0R7 B3KSD2 Q53FH5 Q6GPI5 Q86TU1 Q9BQ86 Q9NUU3,Zinc finger protein 839,Renal carcinoma antigen NY-REN-50;, PF15961;, GO:0046872;, , F:metal ion binding; scaffold113 indexed_genome mRNA 2092861 2108953 . + . ID=transcript_13459;Q9UQ07 B2R6Z4 B7Z7P6 E7ER76 E7ERR8 Q92790 Q93067,MAPK/MAK/MRK overlapping kinase,MOK protein kinase;Renal tumor antigen 1;, PF00069;, GO:0097546;GO:0005929;GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004707;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0006468;GO:0010468;GO:0007165;, C:ciliary base; C:cilium; C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:MAP kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:protein phosphorylation; P:regulation of gene expression; P:signal transduction;|Q9UQ07 B2R6Z4 B7Z7P6 E7ER76 E7ERR8 Q92790 Q93067,MAPK/MAK/MRK overlapping kinase,MOK protein kinase;Renal tumor antigen 1;, PF00069;, GO:0097546;GO:0005929;GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004707;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0006468;GO:0010468;GO:0007165;, C:ciliary base; C:cilium; C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:MAP kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:protein phosphorylation; P:regulation of gene expression; P:signal transduction;|Q9UQ07 B2R6Z4 B7Z7P6 E7ER76 E7ERR8 Q92790 Q93067,MAPK/MAK/MRK overlapping kinase,MOK protein kinase;Renal tumor antigen 1;, PF00069;, GO:0097546;GO:0005929;GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004707;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0006468;GO:0010468;GO:0007165;, C:ciliary base; C:cilium; C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:MAP kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:protein phosphorylation; P:regulation of gene expression; P:signal transduction;|Q9UQ07 B2R6Z4 B7Z7P6 E7ER76 E7ERR8 Q92790 Q93067,MAPK/MAK/MRK overlapping kinase,MOK protein kinase;Renal tumor antigen 1;, PF00069;, GO:0097546;GO:0005929;GO:0005737;GO:0005634;GO:0005524;GO:0004693;GO:0004707;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0006468;GO:0010468;GO:0007165;, C:ciliary base; C:cilium; C:cytoplasm; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:MAP kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:protein phosphorylation; P:regulation of gene expression; P:signal transduction; scaffold113 indexed_genome mRNA 2118306 2175472 . - . ID=transcript_13460;Q8WXX2 Q9UF86,WD repeat-containing protein 20,Protein DMR;, PF00400;, GO:0005654;GO:0016579;, C:nucleoplasm;, , P:protein deubiquitination; scaffold113 indexed_genome mRNA 2259666 2321559 . - . ID=transcript_13461;Q14204 B0I1R0 Q6DKQ7 Q8WU28 Q92814 Q9Y4G5,Cytoplasmic dynein 1 heavy chain 1,Cytoplasmic dynein heavy chain 1;Dynein heavy chain, cytosolic;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:1904115;GO:0035578;GO:0005938;GO:0005813;GO:0005868;GO:0005881;GO:0005829;GO:0030286;GO:0070062;GO:0005576;GO:0016020;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003723;GO:0035973;GO:0019886;GO:0051301;GO:0097711;GO:0031122;GO:0006888;GO:0051293;GO:0000086;GO:0007018;GO:0072382;GO:0000278;GO:0007052;GO:0043312;GO:0007097;GO:0033962;GO:0120162;GO:0032388;GO:1905832;GO:0010389;GO:0090235;GO:0060236;GO:0008090;GO:0034063;GO:0019058;, C:axon cytoplasm; C:azurophil granule lumen; C:cell cortex; C:centrosome; C:cytoplasmic dynein complex; C:cytoplasmic microtubule; C:cytosol; C:dynein complex; C:extracellular exosome; C:extracellular region; C:membrane; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:RNA binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of spindle localization; P:G2/M transition of mitotic cell cycle; P:microtubule-based movement; P:minus-end-directed vesicle transport along microtubule; P:mitotic cell cycle; P:mitotic spindle organization; P:neutrophil degranulation; P:nuclear migration; P:P-body assembly; P:positive regulation of cold-induced thermogenesis; P:positive regulation of intracellular transport; P:positive regulation of spindle assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization; P:retrograde axonal transport; P:stress granule assembly; P:viral life cycle;|Q14204 B0I1R0 Q6DKQ7 Q8WU28 Q92814 Q9Y4G5,Cytoplasmic dynein 1 heavy chain 1,Cytoplasmic dynein heavy chain 1;Dynein heavy chain, cytosolic;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:1904115;GO:0035578;GO:0005938;GO:0005813;GO:0005868;GO:0005881;GO:0005829;GO:0030286;GO:0070062;GO:0005576;GO:0016020;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003723;GO:0035973;GO:0019886;GO:0051301;GO:0097711;GO:0031122;GO:0006888;GO:0051293;GO:0000086;GO:0007018;GO:0072382;GO:0000278;GO:0007052;GO:0043312;GO:0007097;GO:0033962;GO:0120162;GO:0032388;GO:1905832;GO:0010389;GO:0090235;GO:0060236;GO:0008090;GO:0034063;GO:0019058;, C:axon cytoplasm; C:azurophil granule lumen; C:cell cortex; C:centrosome; C:cytoplasmic dynein complex; C:cytoplasmic microtubule; C:cytosol; C:dynein complex; C:extracellular exosome; C:extracellular region; C:membrane; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:RNA binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of spindle localization; P:G2/M transition of mitotic cell cycle; P:microtubule-based movement; P:minus-end-directed vesicle transport along microtubule; P:mitotic cell cycle; P:mitotic spindle organization; P:neutrophil degranulation; P:nuclear migration; P:P-body assembly; P:positive regulation of cold-induced thermogenesis; P:positive regulation of intracellular transport; P:positive regulation of spindle assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization; P:retrograde axonal transport; P:stress granule assembly; P:viral life cycle;|Q14204 B0I1R0 Q6DKQ7 Q8WU28 Q92814 Q9Y4G5,Cytoplasmic dynein 1 heavy chain 1,Cytoplasmic dynein heavy chain 1;Dynein heavy chain, cytosolic;, PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:1904115;GO:0035578;GO:0005938;GO:0005813;GO:0005868;GO:0005881;GO:0005829;GO:0030286;GO:0070062;GO:0005576;GO:0016020;GO:0005874;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003723;GO:0035973;GO:0019886;GO:0051301;GO:0097711;GO:0031122;GO:0006888;GO:0051293;GO:0000086;GO:0007018;GO:0072382;GO:0000278;GO:0007052;GO:0043312;GO:0007097;GO:0033962;GO:0120162;GO:0032388;GO:1905832;GO:0010389;GO:0090235;GO:0060236;GO:0008090;GO:0034063;GO:0019058;, C:axon cytoplasm; C:azurophil granule lumen; C:cell cortex; C:centrosome; C:cytoplasmic dynein complex; C:cytoplasmic microtubule; C:cytosol; C:dynein complex; C:extracellular exosome; C:extracellular region; C:membrane; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:RNA binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell division; P:ciliary basal body-plasma membrane docking; P:cytoplasmic microtubule organization; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of spindle localization; P:G2/M transition of mitotic cell cycle; P:microtubule-based movement; P:minus-end-directed vesicle transport along microtubule; P:mitotic cell cycle; P:mitotic spindle organization; P:neutrophil degranulation; P:nuclear migration; P:P-body assembly; P:positive regulation of cold-induced thermogenesis; P:positive regulation of intracellular transport; P:positive regulation of spindle assembly; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of metaphase plate congression; P:regulation of mitotic spindle organization; P:retrograde axonal transport; P:stress granule assembly; P:viral life cycle; scaffold113 indexed_genome mRNA 2361787 2364156 . + . ID=transcript_13462;Q13362 B4DYJ8 B5BUA5 F5GWP3 Q14391 Q15060 Q15174 Q6ZN33,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PP2A B subunit isoform B'-gamma;PP2A B subunit isoform B56-gamma;PP2A B subunit isoform PR61-gamma;PP2A B subunit isoform R5-gamma;Renal carcinoma antigen NY-REN-29;, PF01603;, GO:0000775;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0006977;GO:0042771;GO:0008285;GO:0051898;GO:0043161;GO:0006470;GO:0014066;GO:0031952;GO:1901796;GO:0007165;, C:chromosome, centromeric region; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase B signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signal transduction by p53 class mediator; P:signal transduction; scaffold113 indexed_genome mRNA 2364162 2397970 . - . ID=transcript_13463;Q13362 B4DYJ8 B5BUA5 F5GWP3 Q14391 Q15060 Q15174 Q6ZN33,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PP2A B subunit isoform B'-gamma;PP2A B subunit isoform B56-gamma;PP2A B subunit isoform PR61-gamma;PP2A B subunit isoform R5-gamma;Renal carcinoma antigen NY-REN-29;, PF01603;, GO:0000775;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0006977;GO:0042771;GO:0008285;GO:0051898;GO:0043161;GO:0006470;GO:0014066;GO:0031952;GO:1901796;GO:0007165;, C:chromosome, centromeric region; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase B signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signal transduction by p53 class mediator; P:signal transduction;|Q13362 B4DYJ8 B5BUA5 F5GWP3 Q14391 Q15060 Q15174 Q6ZN33,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PP2A B subunit isoform B'-gamma;PP2A B subunit isoform B56-gamma;PP2A B subunit isoform PR61-gamma;PP2A B subunit isoform R5-gamma;Renal carcinoma antigen NY-REN-29;, PF01603;, GO:0000775;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0006977;GO:0042771;GO:0008285;GO:0051898;GO:0043161;GO:0006470;GO:0014066;GO:0031952;GO:1901796;GO:0007165;, C:chromosome, centromeric region; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase B signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signal transduction by p53 class mediator; P:signal transduction;|Q13362 B4DYJ8 B5BUA5 F5GWP3 Q14391 Q15060 Q15174 Q6ZN33,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PP2A B subunit isoform B'-gamma;PP2A B subunit isoform B56-gamma;PP2A B subunit isoform PR61-gamma;PP2A B subunit isoform R5-gamma;Renal carcinoma antigen NY-REN-29;, PF01603;, GO:0000775;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0006977;GO:0042771;GO:0008285;GO:0051898;GO:0043161;GO:0006470;GO:0014066;GO:0031952;GO:1901796;GO:0007165;, C:chromosome, centromeric region; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase B signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signal transduction by p53 class mediator; P:signal transduction;|Q13362 B4DYJ8 B5BUA5 F5GWP3 Q14391 Q15060 Q15174 Q6ZN33,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PP2A B subunit isoform B'-gamma;PP2A B subunit isoform B56-gamma;PP2A B subunit isoform PR61-gamma;PP2A B subunit isoform R5-gamma;Renal carcinoma antigen NY-REN-29;, PF01603;, GO:0000775;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0006977;GO:0042771;GO:0008285;GO:0051898;GO:0043161;GO:0006470;GO:0014066;GO:0031952;GO:1901796;GO:0007165;, C:chromosome, centromeric region; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of cell population proliferation; P:negative regulation of protein kinase B signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signal transduction by p53 class mediator; P:signal transduction; scaffold114 indexed_genome mRNA 110449 127983 . + . ID=transcript_13464;Q14696 B4DW84 D3DW96 Q969U1,LRP chaperone MESD {ECO:0000305},LDLR chaperone MESD;Mesoderm development LRP chaperone MESD {ECO:0000312|HGNC:HGNC:13520};Mesoderm development candidate 2;Mesoderm development protein;Renal carcinoma antigen NY-REN-61;, PF10185;, GO:0005783;GO:0005886;GO:0042802;GO:0050750;GO:0007498;GO:0001503;GO:0006909;GO:1904395;GO:0006457;GO:0034394;GO:0016055;, C:endoplasmic reticulum; C:plasma membrane;, F:identical protein binding; F:low-density lipoprotein particle receptor binding;, P:mesoderm development; P:ossification; P:phagocytosis; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; P:protein folding; P:protein localization to cell surface; P:Wnt signaling pathway; scaffold114 indexed_genome mRNA 148669 219490 . - . ID=transcript_13465;Q8WUJ3 Q6L9J5 Q9H1K5 Q9NPN9 Q9ULM1,Cell migration-inducing and hyaluronan-binding protein,, PF10162;PF15711;PF13330;, GO:0045334;GO:0005905;GO:0030665;GO:0005737;GO:0005783;GO:0005576;GO:0005634;GO:0005886;GO:0032050;GO:0046923;GO:0005540;GO:0004415;GO:0030213;GO:0030214;GO:0030335;GO:0010800;GO:1900020;GO:0090314;GO:0051281;GO:0007605;, C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:clathrin-coated vesicle membrane; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:nucleus; C:plasma membrane;, F:clathrin heavy chain binding; F:ER retention sequence binding; F:hyaluronic acid binding; F:hyalurononglucosaminidase activity;, P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell migration; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase C activity; P:positive regulation of protein targeting to membrane; P:positive regulation of release of sequestered calcium ion into cytosol; P:sensory perception of sound;|Q8WUJ3 Q6L9J5 Q9H1K5 Q9NPN9 Q9ULM1,Cell migration-inducing and hyaluronan-binding protein,, PF10162;PF15711;PF13330;, GO:0045334;GO:0005905;GO:0030665;GO:0005737;GO:0005783;GO:0005576;GO:0005634;GO:0005886;GO:0032050;GO:0046923;GO:0005540;GO:0004415;GO:0030213;GO:0030214;GO:0030335;GO:0010800;GO:1900020;GO:0090314;GO:0051281;GO:0007605;, C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:clathrin-coated vesicle membrane; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:nucleus; C:plasma membrane;, F:clathrin heavy chain binding; F:ER retention sequence binding; F:hyaluronic acid binding; F:hyalurononglucosaminidase activity;, P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell migration; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase C activity; P:positive regulation of protein targeting to membrane; P:positive regulation of release of sequestered calcium ion into cytosol; P:sensory perception of sound;|Q8WUJ3 Q6L9J5 Q9H1K5 Q9NPN9 Q9ULM1,Cell migration-inducing and hyaluronan-binding protein,, PF10162;PF15711;PF13330;, GO:0045334;GO:0005905;GO:0030665;GO:0005737;GO:0005783;GO:0005576;GO:0005634;GO:0005886;GO:0032050;GO:0046923;GO:0005540;GO:0004415;GO:0030213;GO:0030214;GO:0030335;GO:0010800;GO:1900020;GO:0090314;GO:0051281;GO:0007605;, C:clathrin-coated endocytic vesicle; C:clathrin-coated pit; C:clathrin-coated vesicle membrane; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:nucleus; C:plasma membrane;, F:clathrin heavy chain binding; F:ER retention sequence binding; F:hyaluronic acid binding; F:hyalurononglucosaminidase activity;, P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell migration; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase C activity; P:positive regulation of protein targeting to membrane; P:positive regulation of release of sequestered calcium ion into cytosol; P:sensory perception of sound; scaffold114 indexed_genome mRNA 474059 623214 . - . ID=transcript_13466;Q9HBZ2 B4DIS7 O15024 Q8IYC2,Aryl hydrocarbon receptor nuclear translocator 2,Class E basic helix-loop-helix protein 1;, PF00010;PF00989;PF08447;, GO:0034751;GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0005667;GO:0017162;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0044877;GO:0000978;GO:1990837;GO:0007420;GO:0007417;GO:0001701;GO:0043066;GO:0008284;GO:0045944;GO:0045893;GO:0006357;GO:0006355;GO:0032355;GO:0001666;GO:0006805;, C:aryl hydrocarbon receptor complex; C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:brain development; P:central nervous system development; P:in utero embryonic development; P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to estradiol; P:response to hypoxia; P:xenobiotic metabolic process; scaffold114 indexed_genome mRNA 782392 812031 . - . ID=transcript_13467;P16930 B2R9X1 D3DW95 Q53XA7,Fumarylacetoacetase,Beta-diketonase;Fumarylacetoacetate hydrolase;, PF01557;PF09298;, GO:0005829;GO:0070062;GO:0004334;GO:0046872;GO:0006527;GO:1902000;GO:0006559;GO:0006572;, C:cytosol; C:extracellular exosome;, F:fumarylacetoacetase activity; F:metal ion binding;, P:arginine catabolic process; P:homogentisate catabolic process; P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|P16930 B2R9X1 D3DW95 Q53XA7,Fumarylacetoacetase,Beta-diketonase;Fumarylacetoacetate hydrolase;, PF01557;PF09298;, GO:0005829;GO:0070062;GO:0004334;GO:0046872;GO:0006527;GO:1902000;GO:0006559;GO:0006572;, C:cytosol; C:extracellular exosome;, F:fumarylacetoacetase activity; F:metal ion binding;, P:arginine catabolic process; P:homogentisate catabolic process; P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|P16930 B2R9X1 D3DW95 Q53XA7,Fumarylacetoacetase,Beta-diketonase;Fumarylacetoacetate hydrolase;, PF01557;PF09298;, GO:0005829;GO:0070062;GO:0004334;GO:0046872;GO:0006527;GO:1902000;GO:0006559;GO:0006572;, C:cytosol; C:extracellular exosome;, F:fumarylacetoacetase activity; F:metal ion binding;, P:arginine catabolic process; P:homogentisate catabolic process; P:L-phenylalanine catabolic process; P:tyrosine catabolic process;|P16930 B2R9X1 D3DW95 Q53XA7,Fumarylacetoacetase,Beta-diketonase;Fumarylacetoacetate hydrolase;, PF01557;PF09298;, GO:0005829;GO:0070062;GO:0004334;GO:0046872;GO:0006527;GO:1902000;GO:0006559;GO:0006572;, C:cytosol; C:extracellular exosome;, F:fumarylacetoacetase activity; F:metal ion binding;, P:arginine catabolic process; P:homogentisate catabolic process; P:L-phenylalanine catabolic process; P:tyrosine catabolic process; scaffold114 indexed_genome mRNA 823766 886915 . - . ID=transcript_13468;Q6FIF0 D3DW92 D3DW94 O95792 Q9BQF7 Q9GZY3,AN1-type zinc finger protein 6,Associated with PRK1 protein;Zinc finger A20 domain-containing protein 3;, PF01754;PF01428;, GO:0005829;GO:0003677;GO:0031593;GO:0008270;GO:0006915;GO:0071356;GO:0043066;GO:0008104;GO:0006625;GO:0043122;, C:cytosol;, F:DNA binding; F:polyubiquitin modification-dependent protein binding; F:zinc ion binding;, P:apoptotic process; P:cellular response to tumor necrosis factor; P:negative regulation of apoptotic process; P:protein localization; P:protein targeting to peroxisome; P:regulation of I-kappaB kinase/NF-kappaB signaling;|Q6FIF0 D3DW92 D3DW94 O95792 Q9BQF7 Q9GZY3,AN1-type zinc finger protein 6,Associated with PRK1 protein;Zinc finger A20 domain-containing protein 3;, PF01754;PF01428;, GO:0005829;GO:0003677;GO:0031593;GO:0008270;GO:0006915;GO:0071356;GO:0043066;GO:0008104;GO:0006625;GO:0043122;, C:cytosol;, F:DNA binding; F:polyubiquitin modification-dependent protein binding; F:zinc ion binding;, P:apoptotic process; P:cellular response to tumor necrosis factor; P:negative regulation of apoptotic process; P:protein localization; P:protein targeting to peroxisome; P:regulation of I-kappaB kinase/NF-kappaB signaling;|Q6FIF0 D3DW92 D3DW94 O95792 Q9BQF7 Q9GZY3,AN1-type zinc finger protein 6,Associated with PRK1 protein;Zinc finger A20 domain-containing protein 3;, PF01754;PF01428;, GO:0005829;GO:0003677;GO:0031593;GO:0008270;GO:0006915;GO:0071356;GO:0043066;GO:0008104;GO:0006625;GO:0043122;, C:cytosol;, F:DNA binding; F:polyubiquitin modification-dependent protein binding; F:zinc ion binding;, P:apoptotic process; P:cellular response to tumor necrosis factor; P:negative regulation of apoptotic process; P:protein localization; P:protein targeting to peroxisome; P:regulation of I-kappaB kinase/NF-kappaB signaling;|Q6FIF0 D3DW92 D3DW94 O95792 Q9BQF7 Q9GZY3,AN1-type zinc finger protein 6,Associated with PRK1 protein;Zinc finger A20 domain-containing protein 3;, PF01754;PF01428;, GO:0005829;GO:0003677;GO:0031593;GO:0008270;GO:0006915;GO:0071356;GO:0043066;GO:0008104;GO:0006625;GO:0043122;, C:cytosol;, F:DNA binding; F:polyubiquitin modification-dependent protein binding; F:zinc ion binding;, P:apoptotic process; P:cellular response to tumor necrosis factor; P:negative regulation of apoptotic process; P:protein localization; P:protein targeting to peroxisome; P:regulation of I-kappaB kinase/NF-kappaB signaling;|Q8TCP9 A4D293 A8K3V9 B2RD92 C9J6A8 D6W5T2 Q8N9P3,Protein FAM200A,, , GO:0016021;, C:integral component of membrane; scaffold114 indexed_genome mRNA 929208 930625 . + . ID=transcript_13469;P61566,Endogenous retrovirus group K member 24 Env polyprotein,Envelope polyprotein;HERV-K101 envelope protein;HERV-K_22q11.21 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity; scaffold114 indexed_genome mRNA 945874 956708 . + . ID=transcript_13470;Q16548 Q6FGZ4 Q6FH19 Q86W13 Q99524,Bcl-2-related protein A1,Bcl-2-like protein 5;Hemopoietic-specific early response protein;Protein BFL-1;Protein GRS;, PF00452;, GO:0005741;GO:0051400;GO:0046982;GO:0042803;GO:0044877;GO:0007568;GO:0021987;GO:0097192;GO:0008630;GO:0043066;, C:mitochondrial outer membrane;, F:BH domain binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding;, P:aging; P:cerebral cortex development; P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:negative regulation of apoptotic process; scaffold114 indexed_genome mRNA 968889 984203 . + . ID=transcript_13471;P49914 H3BQ75,5-formyltetrahydrofolate cyclo-ligase,5,10-methenyl-tetrahydrofolate synthetase;, PF01812;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0030272;GO:0005524;GO:0005542;GO:0046872;GO:0046657;GO:0046655;GO:0009396;GO:0015942;GO:0006536;GO:0035999;GO:0046653;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:5-formyltetrahydrofolate cyclo-ligase activity; F:ATP binding; F:folic acid binding; F:metal ion binding;, P:folic acid catabolic process; P:folic acid metabolic process; P:folic acid-containing compound biosynthetic process; P:formate metabolic process; P:glutamate metabolic process; P:tetrahydrofolate interconversion; P:tetrahydrofolate metabolic process; scaffold114 indexed_genome mRNA 1307422 1307963 . + . ID=transcript_13472;Q9UPX6 A7MD43,Major intrinsically disordered Notch2-binding receptor 1 {ECO:0000303|PubMed:29329397},Membrane integral NOTCH2-associated receptor 1;Ubiquitination and mTOR signaling protein {ECO:0000303|PubMed:30080879};, PF06789;, GO:0016021;GO:0005886;GO:0001525;GO:0016525;GO:0030308;GO:0008285;GO:0010977;GO:0031397;GO:0032007;, C:integral component of membrane; C:plasma membrane;, , P:angiogenesis; P:negative regulation of angiogenesis; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of neuron projection development; P:negative regulation of protein ubiquitination; P:negative regulation of TOR signaling; scaffold114 indexed_genome mRNA 1308486 1309315 . + . ID=transcript_13473;Q9UPX6 A7MD43,Major intrinsically disordered Notch2-binding receptor 1 {ECO:0000303|PubMed:29329397},Membrane integral NOTCH2-associated receptor 1;Ubiquitination and mTOR signaling protein {ECO:0000303|PubMed:30080879};, PF06789;, GO:0016021;GO:0005886;GO:0001525;GO:0016525;GO:0030308;GO:0008285;GO:0010977;GO:0031397;GO:0032007;, C:integral component of membrane; C:plasma membrane;, , P:angiogenesis; P:negative regulation of angiogenesis; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of neuron projection development; P:negative regulation of protein ubiquitination; P:negative regulation of TOR signaling; scaffold114 indexed_genome mRNA 1393146 1403865 . - . ID=transcript_13474;Q9Y3Q3 A8K069 B4DN05 Q2T9F8,Transmembrane emp24 domain-containing protein 3,Membrane protein p24B;p24 family protein gamma-4;p26;, PF01105;, GO:0030126;GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0030133;GO:0006888;GO:0007030;GO:0006886;GO:0006890;, C:COPI vesicle coat; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold114 indexed_genome mRNA 1656889 1677289 . + . ID=transcript_13475;P09668 B2RBK0 Q96NY6 Q9BUM7,Pro-cathepsin H,, PF08246;PF00112;, GO:0097208;GO:0062023;GO:0036464;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0005764;GO:0097486;GO:0034774;GO:1904724;GO:0004177;GO:0008656;GO:0004197;GO:0008234;GO:0004175;GO:0030108;GO:0008233;GO:0004252;GO:0070324;GO:0002250;GO:0019882;GO:0010815;GO:0044267;GO:0097067;GO:0060448;GO:0070371;GO:0002764;GO:0033619;GO:0001656;GO:0043066;GO:0010813;GO:0043312;GO:0045766;GO:0030335;GO:0008284;GO:0010634;GO:0010628;GO:0010952;GO:0031648;GO:0006508;GO:0051603;GO:0032526;GO:0043129;GO:0001913;GO:0031638;, C:alveolar lamellar body; C:collagen-containing extracellular matrix; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:lysosome; C:multivesicular body lumen; C:secretory granule lumen; C:tertiary granule lumen;, F:aminopeptidase activity; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:endopeptidase activity; F:HLA-A specific activating MHC class I receptor activity; F:peptidase activity; F:serine-type endopeptidase activity; F:thyroid hormone binding;, P:adaptive immune response; P:antigen processing and presentation; P:bradykinin catabolic process; P:cellular protein metabolic process; P:cellular response to thyroid hormone stimulus; P:dichotomous subdivision of terminal units involved in lung branching; P:ERK1 and ERK2 cascade; P:immune response-regulating signaling pathway; P:membrane protein proteolysis; P:metanephros development; P:negative regulation of apoptotic process; P:neuropeptide catabolic process; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of peptidase activity; P:protein destabilization; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:response to retinoic acid; P:surfactant homeostasis; P:T cell mediated cytotoxicity; P:zymogen activation;|P09668 B2RBK0 Q96NY6 Q9BUM7,Pro-cathepsin H,, PF08246;PF00112;, GO:0097208;GO:0062023;GO:0036464;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0005764;GO:0097486;GO:0034774;GO:1904724;GO:0004177;GO:0008656;GO:0004197;GO:0008234;GO:0004175;GO:0030108;GO:0008233;GO:0004252;GO:0070324;GO:0002250;GO:0019882;GO:0010815;GO:0044267;GO:0097067;GO:0060448;GO:0070371;GO:0002764;GO:0033619;GO:0001656;GO:0043066;GO:0010813;GO:0043312;GO:0045766;GO:0030335;GO:0008284;GO:0010634;GO:0010628;GO:0010952;GO:0031648;GO:0006508;GO:0051603;GO:0032526;GO:0043129;GO:0001913;GO:0031638;, C:alveolar lamellar body; C:collagen-containing extracellular matrix; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:lysosome; C:multivesicular body lumen; C:secretory granule lumen; C:tertiary granule lumen;, F:aminopeptidase activity; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:endopeptidase activity; F:HLA-A specific activating MHC class I receptor activity; F:peptidase activity; F:serine-type endopeptidase activity; F:thyroid hormone binding;, P:adaptive immune response; P:antigen processing and presentation; P:bradykinin catabolic process; P:cellular protein metabolic process; P:cellular response to thyroid hormone stimulus; P:dichotomous subdivision of terminal units involved in lung branching; P:ERK1 and ERK2 cascade; P:immune response-regulating signaling pathway; P:membrane protein proteolysis; P:metanephros development; P:negative regulation of apoptotic process; P:neuropeptide catabolic process; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of peptidase activity; P:protein destabilization; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:response to retinoic acid; P:surfactant homeostasis; P:T cell mediated cytotoxicity; P:zymogen activation;|P09668 B2RBK0 Q96NY6 Q9BUM7,Pro-cathepsin H,, PF08246;PF00112;, GO:0097208;GO:0062023;GO:0036464;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0005764;GO:0097486;GO:0034774;GO:1904724;GO:0004177;GO:0008656;GO:0004197;GO:0008234;GO:0004175;GO:0030108;GO:0008233;GO:0004252;GO:0070324;GO:0002250;GO:0019882;GO:0010815;GO:0044267;GO:0097067;GO:0060448;GO:0070371;GO:0002764;GO:0033619;GO:0001656;GO:0043066;GO:0010813;GO:0043312;GO:0045766;GO:0030335;GO:0008284;GO:0010634;GO:0010628;GO:0010952;GO:0031648;GO:0006508;GO:0051603;GO:0032526;GO:0043129;GO:0001913;GO:0031638;, C:alveolar lamellar body; C:collagen-containing extracellular matrix; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:lysosome; C:multivesicular body lumen; C:secretory granule lumen; C:tertiary granule lumen;, F:aminopeptidase activity; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:endopeptidase activity; F:HLA-A specific activating MHC class I receptor activity; F:peptidase activity; F:serine-type endopeptidase activity; F:thyroid hormone binding;, P:adaptive immune response; P:antigen processing and presentation; P:bradykinin catabolic process; P:cellular protein metabolic process; P:cellular response to thyroid hormone stimulus; P:dichotomous subdivision of terminal units involved in lung branching; P:ERK1 and ERK2 cascade; P:immune response-regulating signaling pathway; P:membrane protein proteolysis; P:metanephros development; P:negative regulation of apoptotic process; P:neuropeptide catabolic process; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of peptidase activity; P:protein destabilization; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:response to retinoic acid; P:surfactant homeostasis; P:T cell mediated cytotoxicity; P:zymogen activation;|P09668 B2RBK0 Q96NY6 Q9BUM7,Pro-cathepsin H,, PF08246;PF00112;, GO:0097208;GO:0062023;GO:0036464;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0005764;GO:0097486;GO:0034774;GO:1904724;GO:0004177;GO:0008656;GO:0004197;GO:0008234;GO:0004175;GO:0030108;GO:0008233;GO:0004252;GO:0070324;GO:0002250;GO:0019882;GO:0010815;GO:0044267;GO:0097067;GO:0060448;GO:0070371;GO:0002764;GO:0033619;GO:0001656;GO:0043066;GO:0010813;GO:0043312;GO:0045766;GO:0030335;GO:0008284;GO:0010634;GO:0010628;GO:0010952;GO:0031648;GO:0006508;GO:0051603;GO:0032526;GO:0043129;GO:0001913;GO:0031638;, C:alveolar lamellar body; C:collagen-containing extracellular matrix; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:lysosome; C:multivesicular body lumen; C:secretory granule lumen; C:tertiary granule lumen;, F:aminopeptidase activity; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:endopeptidase activity; F:HLA-A specific activating MHC class I receptor activity; F:peptidase activity; F:serine-type endopeptidase activity; F:thyroid hormone binding;, P:adaptive immune response; P:antigen processing and presentation; P:bradykinin catabolic process; P:cellular protein metabolic process; P:cellular response to thyroid hormone stimulus; P:dichotomous subdivision of terminal units involved in lung branching; P:ERK1 and ERK2 cascade; P:immune response-regulating signaling pathway; P:membrane protein proteolysis; P:metanephros development; P:negative regulation of apoptotic process; P:neuropeptide catabolic process; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of peptidase activity; P:protein destabilization; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:response to retinoic acid; P:surfactant homeostasis; P:T cell mediated cytotoxicity; P:zymogen activation;|P09668 B2RBK0 Q96NY6 Q9BUM7,Pro-cathepsin H,, PF08246;PF00112;, GO:0097208;GO:0062023;GO:0036464;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0005764;GO:0097486;GO:0034774;GO:1904724;GO:0004177;GO:0008656;GO:0004197;GO:0008234;GO:0004175;GO:0030108;GO:0008233;GO:0004252;GO:0070324;GO:0002250;GO:0019882;GO:0010815;GO:0044267;GO:0097067;GO:0060448;GO:0070371;GO:0002764;GO:0033619;GO:0001656;GO:0043066;GO:0010813;GO:0043312;GO:0045766;GO:0030335;GO:0008284;GO:0010634;GO:0010628;GO:0010952;GO:0031648;GO:0006508;GO:0051603;GO:0032526;GO:0043129;GO:0001913;GO:0031638;, C:alveolar lamellar body; C:collagen-containing extracellular matrix; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:lysosome; C:multivesicular body lumen; C:secretory granule lumen; C:tertiary granule lumen;, F:aminopeptidase activity; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:endopeptidase activity; F:HLA-A specific activating MHC class I receptor activity; F:peptidase activity; F:serine-type endopeptidase activity; F:thyroid hormone binding;, P:adaptive immune response; P:antigen processing and presentation; P:bradykinin catabolic process; P:cellular protein metabolic process; P:cellular response to thyroid hormone stimulus; P:dichotomous subdivision of terminal units involved in lung branching; P:ERK1 and ERK2 cascade; P:immune response-regulating signaling pathway; P:membrane protein proteolysis; P:metanephros development; P:negative regulation of apoptotic process; P:neuropeptide catabolic process; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell migration; P:positive regulation of gene expression; P:positive regulation of peptidase activity; P:protein destabilization; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:response to retinoic acid; P:surfactant homeostasis; P:T cell mediated cytotoxicity; P:zymogen activation; scaffold114 indexed_genome mRNA 1680398 1698210 . - . ID=transcript_13476;Q9NSW5,Mortality factor 4-like protein 1,MORF-related gene 15 protein;Protein MSL3-1;Transcription factor-like protein MRG15;, PF05712;PF11717;, GO:0000123;GO:0035267;GO:0016607;GO:0005654;GO:0016580;GO:0047485;GO:0006342;GO:0000724;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0040008;, C:histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Sin3 complex;, F:protein N-terminus binding;, P:chromatin silencing; P:double-strand break repair via homologous recombination; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:regulation of growth;|Q9NSW5,Mortality factor 4-like protein 1,MORF-related gene 15 protein;Protein MSL3-1;Transcription factor-like protein MRG15;, PF05712;PF11717;, GO:0000123;GO:0035267;GO:0016607;GO:0005654;GO:0016580;GO:0047485;GO:0006342;GO:0000724;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0040008;, C:histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Sin3 complex;, F:protein N-terminus binding;, P:chromatin silencing; P:double-strand break repair via homologous recombination; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:regulation of growth;|Q9NSW5,Mortality factor 4-like protein 1,MORF-related gene 15 protein;Protein MSL3-1;Transcription factor-like protein MRG15;, PF05712;PF11717;, GO:0000123;GO:0035267;GO:0016607;GO:0005654;GO:0016580;GO:0047485;GO:0006342;GO:0000724;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0040008;, C:histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Sin3 complex;, F:protein N-terminus binding;, P:chromatin silencing; P:double-strand break repair via homologous recombination; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:regulation of growth;|Q9NSW5,Mortality factor 4-like protein 1,MORF-related gene 15 protein;Protein MSL3-1;Transcription factor-like protein MRG15;, PF05712;PF11717;, GO:0000123;GO:0035267;GO:0016607;GO:0005654;GO:0016580;GO:0047485;GO:0006342;GO:0000724;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0040008;, C:histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Sin3 complex;, F:protein N-terminus binding;, P:chromatin silencing; P:double-strand break repair via homologous recombination; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:regulation of growth;|Q9NSW5,Mortality factor 4-like protein 1,MORF-related gene 15 protein;Protein MSL3-1;Transcription factor-like protein MRG15;, PF05712;PF11717;, GO:0000123;GO:0035267;GO:0016607;GO:0005654;GO:0016580;GO:0047485;GO:0006342;GO:0000724;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0040008;, C:histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Sin3 complex;, F:protein N-terminus binding;, P:chromatin silencing; P:double-strand break repair via homologous recombination; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:regulation of growth;|Q9NSW5,Mortality factor 4-like protein 1,MORF-related gene 15 protein;Protein MSL3-1;Transcription factor-like protein MRG15;, PF05712;PF11717;, GO:0000123;GO:0035267;GO:0016607;GO:0005654;GO:0016580;GO:0047485;GO:0006342;GO:0000724;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0040008;, C:histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Sin3 complex;, F:protein N-terminus binding;, P:chromatin silencing; P:double-strand break repair via homologous recombination; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:regulation of growth;|Q9NSW5,Mortality factor 4-like protein 1,MORF-related gene 15 protein;Protein MSL3-1;Transcription factor-like protein MRG15;, PF05712;PF11717;, GO:0000123;GO:0035267;GO:0016607;GO:0005654;GO:0016580;GO:0047485;GO:0006342;GO:0000724;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0040008;, C:histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nuclear speck; C:nucleoplasm; C:Sin3 complex;, F:protein N-terminus binding;, P:chromatin silencing; P:double-strand break repair via homologous recombination; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:regulation of growth; scaffold114 indexed_genome mRNA 1835651 1883321 . - . ID=transcript_13477;Q9H0C5 A6NMI8 Q9BX71 Q9NWN4,BTB/POZ domain-containing protein 1,Hepatitis C virus NS5A-transactivated protein 8;, PF07707;PF00651;PF08005;, GO:0036464;GO:0005829;GO:0005654;GO:0000932;GO:0032991;GO:0097602;GO:0042802;GO:0007517;GO:0022008;GO:0043687;GO:0016567;GO:0043393;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nucleoplasm; C:P-body; C:protein-containing complex;, F:cullin family protein binding; F:identical protein binding;, P:muscle organ development; P:neurogenesis; P:post-translational protein modification; P:protein ubiquitination; P:regulation of protein binding;|Q9H0C5 A6NMI8 Q9BX71 Q9NWN4,BTB/POZ domain-containing protein 1,Hepatitis C virus NS5A-transactivated protein 8;, PF07707;PF00651;PF08005;, GO:0036464;GO:0005829;GO:0005654;GO:0000932;GO:0032991;GO:0097602;GO:0042802;GO:0007517;GO:0022008;GO:0043687;GO:0016567;GO:0043393;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nucleoplasm; C:P-body; C:protein-containing complex;, F:cullin family protein binding; F:identical protein binding;, P:muscle organ development; P:neurogenesis; P:post-translational protein modification; P:protein ubiquitination; P:regulation of protein binding;|Q9H0C5 A6NMI8 Q9BX71 Q9NWN4,BTB/POZ domain-containing protein 1,Hepatitis C virus NS5A-transactivated protein 8;, PF07707;PF00651;PF08005;, GO:0036464;GO:0005829;GO:0005654;GO:0000932;GO:0032991;GO:0097602;GO:0042802;GO:0007517;GO:0022008;GO:0043687;GO:0016567;GO:0043393;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nucleoplasm; C:P-body; C:protein-containing complex;, F:cullin family protein binding; F:identical protein binding;, P:muscle organ development; P:neurogenesis; P:post-translational protein modification; P:protein ubiquitination; P:regulation of protein binding;|Q9H0C5 A6NMI8 Q9BX71 Q9NWN4,BTB/POZ domain-containing protein 1,Hepatitis C virus NS5A-transactivated protein 8;, PF07707;PF00651;PF08005;, GO:0036464;GO:0005829;GO:0005654;GO:0000932;GO:0032991;GO:0097602;GO:0042802;GO:0007517;GO:0022008;GO:0043687;GO:0016567;GO:0043393;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nucleoplasm; C:P-body; C:protein-containing complex;, F:cullin family protein binding; F:identical protein binding;, P:muscle organ development; P:neurogenesis; P:post-translational protein modification; P:protein ubiquitination; P:regulation of protein binding; scaffold114 indexed_genome mRNA 1918800 1949592 . + . ID=transcript_13478;Q9BZW5 A8K7T5 H3BU56 Q4U0U5,Transmembrane 6 superfamily member 1,, , GO:0016021;GO:0005765;, C:integral component of membrane; C:lysosomal membrane;|Q9BZW5 A8K7T5 H3BU56 Q4U0U5,Transmembrane 6 superfamily member 1,, , GO:0016021;GO:0005765;, C:integral component of membrane; C:lysosomal membrane;|Q9BZW5 A8K7T5 H3BU56 Q4U0U5,Transmembrane 6 superfamily member 1,, , GO:0016021;GO:0005765;, C:integral component of membrane; C:lysosomal membrane;|P49755 B2R605 Q15602 Q16536 Q86TC2 Q86TS5,Transmembrane emp24 domain-containing protein 10,21 kDa transmembrane-trafficking protein;S31I125;S31III125;Tmp-21-I;Transmembrane protein Tmp21;p23;p24 family protein delta-1;p24delta;, PF01105;, GO:0005801;GO:0030137;GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0070765;GO:0005794;GO:0000139;GO:0016021;GO:0042470;GO:0005886;GO:0030667;GO:0030140;GO:0030133;GO:0042589;GO:0008320;GO:0044877;GO:0019905;GO:0048205;GO:0035964;GO:0048208;GO:0106273;GO:0006888;GO:0007030;GO:0006886;GO:0001822;GO:1902960;GO:0032732;GO:0050714;GO:0106272;GO:0045055;GO:1902003;GO:0043279;GO:0006890;GO:0035459;GO:0048199;, C:cis-Golgi network; C:COPI-coated vesicle; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:melanosome; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network transport vesicle; C:transport vesicle; C:zymogen granule membrane;, F:protein transmembrane transporter activity; F:protein-containing complex binding; F:syntaxin binding;, P:COPI coating of Golgi vesicle; P:COPI-coated vesicle budding; P:COPII vesicle coating; P:cytosol to ERGIC protein transport; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:kidney development; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of interleukin-1 production; P:positive regulation of protein secretion; P:protein localization to ERGIC; P:regulated exocytosis; P:regulation of amyloid-beta formation; P:response to alkaloid; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle cargo loading; P:vesicle targeting, to, from or within Golgi;|Q9BZW5 A8K7T5 H3BU56 Q4U0U5,Transmembrane 6 superfamily member 1,, , GO:0016021;GO:0005765;, C:integral component of membrane; C:lysosomal membrane;|Q9BZW5 A8K7T5 H3BU56 Q4U0U5,Transmembrane 6 superfamily member 1,, , GO:0016021;GO:0005765;, C:integral component of membrane; C:lysosomal membrane; scaffold114 indexed_genome mRNA 1975494 1976057 . - . ID=transcript_13479;Q9Y3E1,Hepatoma-derived growth factor-related protein 3,Hepatoma-derived growth factor 2;, PF00855;, GO:0005829;GO:0005576;GO:0005654;GO:0005634;GO:0003690;GO:0008083;GO:0008017;GO:0003712;GO:0015631;GO:0046785;GO:0007026;GO:0031175;GO:0006357;, C:cytosol; C:extracellular region; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:growth factor activity; F:microtubule binding; F:transcription coregulator activity; F:tubulin binding;, P:microtubule polymerization; P:negative regulation of microtubule depolymerization; P:neuron projection development; P:regulation of transcription by RNA polymerase II; scaffold114 indexed_genome mRNA 2087531 2094439 . - . ID=transcript_13480;Q01954 Q15840,Zinc finger protein basonuclin-1,, , GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0001216;GO:0046872;GO:0000182;GO:0000976;GO:0030154;GO:0008544;GO:0008284;GO:1900195;GO:0045943;GO:0006356;GO:0006355;GO:0007283;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity; F:metal ion binding; F:rDNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:epidermis development; P:positive regulation of cell population proliferation; P:positive regulation of oocyte maturation; P:positive regulation of transcription by RNA polymerase I; P:regulation of transcription by RNA polymerase I; P:regulation of transcription, DNA-templated; P:spermatogenesis; scaffold114 indexed_genome mRNA 2324688 2325535 . + . ID=transcript_13481;Q99963 O43553 O43554,Endophilin-A3,EEN-B2;Endophilin-3;SH3 domain protein 2C;SH3 domain-containing GRB2-like protein 3;, PF03114;PF00018;, GO:0001669;GO:0031901;GO:0098978;GO:0099092;GO:0098845;GO:0098793;GO:0042802;GO:0008289;GO:0008022;GO:0007417;GO:0006897;GO:1900186;GO:0045666;GO:0007165;, C:acrosomal vesicle; C:early endosome membrane; C:glutamatergic synapse; C:postsynaptic density, intracellular component; C:postsynaptic endosome; C:presynapse;, F:identical protein binding; F:lipid binding; F:protein C-terminus binding;, P:central nervous system development; P:endocytosis; P:negative regulation of clathrin-dependent endocytosis; P:positive regulation of neuron differentiation; P:signal transduction; scaffold114 indexed_genome mRNA 2359788 2361084 . - . ID=transcript_13482;Q99963 O43553 O43554,Endophilin-A3,EEN-B2;Endophilin-3;SH3 domain protein 2C;SH3 domain-containing GRB2-like protein 3;, PF03114;PF00018;, GO:0001669;GO:0031901;GO:0098978;GO:0099092;GO:0098845;GO:0098793;GO:0042802;GO:0008289;GO:0008022;GO:0007417;GO:0006897;GO:1900186;GO:0045666;GO:0007165;, C:acrosomal vesicle; C:early endosome membrane; C:glutamatergic synapse; C:postsynaptic density, intracellular component; C:postsynaptic endosome; C:presynapse;, F:identical protein binding; F:lipid binding; F:protein C-terminus binding;, P:central nervous system development; P:endocytosis; P:negative regulation of clathrin-dependent endocytosis; P:positive regulation of neuron differentiation; P:signal transduction;|Q99963 O43553 O43554,Endophilin-A3,EEN-B2;Endophilin-3;SH3 domain protein 2C;SH3 domain-containing GRB2-like protein 3;, PF03114;PF00018;, GO:0001669;GO:0031901;GO:0098978;GO:0099092;GO:0098845;GO:0098793;GO:0042802;GO:0008289;GO:0008022;GO:0007417;GO:0006897;GO:1900186;GO:0045666;GO:0007165;, C:acrosomal vesicle; C:early endosome membrane; C:glutamatergic synapse; C:postsynaptic density, intracellular component; C:postsynaptic endosome; C:presynapse;, F:identical protein binding; F:lipid binding; F:protein C-terminus binding;, P:central nervous system development; P:endocytosis; P:negative regulation of clathrin-dependent endocytosis; P:positive regulation of neuron differentiation; P:signal transduction; scaffold114 indexed_genome mRNA 2565211 2614331 . + . ID=transcript_13483;P82987 A1A566 A1A567 Q9ULI7,ADAMTS-like protein 3,Punctin-2;, PF07679;PF08686;PF00090;, GO:0031012;GO:0005576;GO:0043231;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region; C:intracellular membrane-bounded organelle;, F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold114 indexed_genome mRNA 2629087 2739619 . + . ID=transcript_13484;P82987 A1A566 A1A567 Q9ULI7,ADAMTS-like protein 3,Punctin-2;, PF07679;PF08686;PF00090;, GO:0031012;GO:0005576;GO:0043231;GO:0004222;GO:0030198;, C:extracellular matrix; C:extracellular region; C:intracellular membrane-bounded organelle;, F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold114 indexed_genome mRNA 2785699 2900298 . + . ID=transcript_13485;Q7Z2Z2 A6NKY5 B7Z6I0 Q9H8Z6,Elongation factor-like GTPase 1,Elongation factor Tu GTP-binding domain-containing protein 1;Elongation factor-like 1;Protein FAM42A;, PF00679;PF14492;PF00009;, GO:1990904;GO:0005525;GO:0003924;GO:0043022;GO:0003746;GO:0046039;GO:0042256;, C:ribonucleoprotein complex;, F:GTP binding; F:GTPase activity; F:ribosome binding; F:translation elongation factor activity;, P:GTP metabolic process; P:mature ribosome assembly; scaffold114 indexed_genome mRNA 2978691 2983036 . + . ID=transcript_13486;Q6ZN04 Q4G0W1 Q8IVG2 Q9H0J0,RNA-binding protein MEX3B,RING finger and KH domain-containing protein 3;RING finger protein 195;, PF00013;, GO:0005829;GO:0005654;GO:0000932;GO:0005509;GO:0003723;GO:0046777;GO:0006468;, C:cytosol; C:nucleoplasm; C:P-body;, F:calcium ion binding; F:RNA binding;, P:protein autophosphorylation; P:protein phosphorylation; scaffold115 indexed_genome mRNA 201187 291540 . + . ID=transcript_13487;P12111 A8MT30 B4E3U5 B7ZMJ7 E9PFQ6 E9PGQ9 Q16501 Q53QF4 Q53QF6,Collagen alpha-3(VI) chain,, PF01391;PF00014;PF00092;, GO:0005589;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:1903561;GO:0042383;GO:0030020;GO:0004867;GO:0007155;GO:0030199;GO:0030198;GO:0007517;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:sarcolemma;, F:extracellular matrix structural constituent conferring tensile strength; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:muscle organ development;|P12111 A8MT30 B4E3U5 B7ZMJ7 E9PFQ6 E9PGQ9 Q16501 Q53QF4 Q53QF6,Collagen alpha-3(VI) chain,, PF01391;PF00014;PF00092;, GO:0005589;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:1903561;GO:0042383;GO:0030020;GO:0004867;GO:0007155;GO:0030199;GO:0030198;GO:0007517;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:sarcolemma;, F:extracellular matrix structural constituent conferring tensile strength; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:muscle organ development;|P12111 A8MT30 B4E3U5 B7ZMJ7 E9PFQ6 E9PGQ9 Q16501 Q53QF4 Q53QF6,Collagen alpha-3(VI) chain,, PF01391;PF00014;PF00092;, GO:0005589;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:1903561;GO:0042383;GO:0030020;GO:0004867;GO:0007155;GO:0030199;GO:0030198;GO:0007517;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:sarcolemma;, F:extracellular matrix structural constituent conferring tensile strength; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:muscle organ development;|P12111 A8MT30 B4E3U5 B7ZMJ7 E9PFQ6 E9PGQ9 Q16501 Q53QF4 Q53QF6,Collagen alpha-3(VI) chain,, PF01391;PF00014;PF00092;, GO:0005589;GO:0062023;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:1903561;GO:0042383;GO:0030020;GO:0004867;GO:0007155;GO:0030199;GO:0030198;GO:0007517;, C:collagen type VI trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:sarcolemma;, F:extracellular matrix structural constituent conferring tensile strength; F:serine-type endopeptidase inhibitor activity;, P:cell adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:muscle organ development; scaffold115 indexed_genome mRNA 497484 513716 . - . ID=transcript_13488;Q99627 A8K1H6 Q53QS9,COP9 signalosome complex subunit 8,COP9 homolog;JAB1-containing signalosome subunit 8;, PF10075;, GO:0008180;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0048471;GO:0007250;GO:0010387;GO:0008285;GO:0000715;GO:0043687;GO:0000338;GO:0006468;GO:0006283;, C:COP9 signalosome; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, , P:activation of NF-kappaB-inducing kinase activity; P:COP9 signalosome assembly; P:negative regulation of cell population proliferation; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:protein phosphorylation; P:transcription-coupled nucleotide-excision repair;|Q99627 A8K1H6 Q53QS9,COP9 signalosome complex subunit 8,COP9 homolog;JAB1-containing signalosome subunit 8;, PF10075;, GO:0008180;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0048471;GO:0007250;GO:0010387;GO:0008285;GO:0000715;GO:0043687;GO:0000338;GO:0006468;GO:0006283;, C:COP9 signalosome; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, , P:activation of NF-kappaB-inducing kinase activity; P:COP9 signalosome assembly; P:negative regulation of cell population proliferation; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:protein phosphorylation; P:transcription-coupled nucleotide-excision repair;|Q99627 A8K1H6 Q53QS9,COP9 signalosome complex subunit 8,COP9 homolog;JAB1-containing signalosome subunit 8;, PF10075;, GO:0008180;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0048471;GO:0007250;GO:0010387;GO:0008285;GO:0000715;GO:0043687;GO:0000338;GO:0006468;GO:0006283;, C:COP9 signalosome; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, , P:activation of NF-kappaB-inducing kinase activity; P:COP9 signalosome assembly; P:negative regulation of cell population proliferation; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:protein phosphorylation; P:transcription-coupled nucleotide-excision repair; scaffold115 indexed_genome mRNA 1007453 1019629 . + . ID=transcript_13489;P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986,Atypical chemokine receptor 3,C-X-C chemokine receptor type 7;Chemokine orphan receptor 1;G-protein coupled receptor 159;G-protein coupled receptor RDC1 homolog;, PF00001;, GO:0009986;GO:0005905;GO:0005769;GO:0005768;GO:0009897;GO:0016021;GO:0043231;GO:0005634;GO:0048471;GO:0005886;GO:0055037;GO:0019957;GO:0016493;GO:0019958;GO:0016494;GO:0015026;GO:0005044;GO:0001525;GO:0019722;GO:0007155;GO:0060326;GO:0070098;GO:0007186;GO:0006955;GO:0008285;GO:1902230;GO:0007204;GO:0070374;GO:1905322;GO:0031623;GO:0001570;GO:0016032;, C:cell surface; C:clathrin-coated pit; C:early endosome; C:endosome; C:external side of plasma membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:C-C chemokine binding; F:C-C chemokine receptor activity; F:C-X-C chemokine binding; F:C-X-C chemokine receptor activity; F:coreceptor activity; F:scavenger receptor activity;, P:angiogenesis; P:calcium-mediated signaling; P:cell adhesion; P:cell chemotaxis; P:chemokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:immune response; P:negative regulation of cell population proliferation; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of mesenchymal stem cell migration; P:receptor internalization; P:vasculogenesis; P:viral process; scaffold115 indexed_genome mRNA 1075765 1094031 . + . ID=transcript_13490;Q86XH1 B4DFH9 E7EWQ0 Q4G164 Q53R37 Q53RV3 Q96NS7 Q9H680,Dynein regulatory complex protein 11 {ECO:0000250|UniProtKB:A8IHT2},IQ and AAA domain-containing protein 1;, PF00004;, GO:0005737;GO:0005856;GO:0031514;GO:0005524;GO:0016887;, C:cytoplasm; C:cytoskeleton; C:motile cilium;, F:ATP binding; F:ATPase activity; scaffold115 indexed_genome mRNA 1160246 1215831 . + . ID=transcript_13491;Q86XH1 B4DFH9 E7EWQ0 Q4G164 Q53R37 Q53RV3 Q96NS7 Q9H680,Dynein regulatory complex protein 11 {ECO:0000250|UniProtKB:A8IHT2},IQ and AAA domain-containing protein 1;, PF00004;, GO:0005737;GO:0005856;GO:0031514;GO:0005524;GO:0016887;, C:cytoplasm; C:cytoskeleton; C:motile cilium;, F:ATP binding; F:ATPase activity; scaffold115 indexed_genome mRNA 1303113 1315016 . + . ID=transcript_13492;Q6ZVZ8 B6ZDL7,Ankyrin repeat and SOCS box protein 18,, PF12796;PF07525;, GO:0005829;GO:0035556;GO:0043687;GO:0016567;, C:cytosol;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination; scaffold115 indexed_genome mRNA 1443877 1821062 . - . ID=transcript_13493;Q9UPQ3 B2RTX7 Q541S5 Q6P9D7 Q9NV93,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1,Centaurin-gamma-2;GTP-binding and GTPase-activating protein 1;, PF12796;PF01412;PF00071;, GO:0005737;GO:0005634;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0005543;GO:0015031;, C:cytoplasm; C:nucleus;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:phospholipid binding;, P:protein transport;|Q9UPQ3 B2RTX7 Q541S5 Q6P9D7 Q9NV93,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1,Centaurin-gamma-2;GTP-binding and GTPase-activating protein 1;, PF12796;PF01412;PF00071;, GO:0005737;GO:0005634;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0005543;GO:0015031;, C:cytoplasm; C:nucleus;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:phospholipid binding;, P:protein transport; scaffold115 indexed_genome mRNA 2423497 2444963 . + . ID=transcript_13494;Q9P0V3 O95082 Q309A3 Q53QD0 Q53TD1,SH3 domain-binding protein 4,EH-binding protein 10;Transferrin receptor-trafficking protein;, PF00018;PF07653;PF00791;, GO:0005905;GO:0030136;GO:0005737;GO:0070062;GO:0005634;GO:0005092;GO:0042802;GO:0031267;GO:0071230;GO:0006897;GO:0030308;GO:0008285;GO:0034260;GO:0032007;GO:0010508;GO:0061462;GO:0050790;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:extracellular exosome; C:nucleus;, F:GDP-dissociation inhibitor activity; F:identical protein binding; F:small GTPase binding;, P:cellular response to amino acid stimulus; P:endocytosis; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of GTPase activity; P:negative regulation of TOR signaling; P:positive regulation of autophagy; P:protein localization to lysosome; P:regulation of catalytic activity;|Q9P0V3 O95082 Q309A3 Q53QD0 Q53TD1,SH3 domain-binding protein 4,EH-binding protein 10;Transferrin receptor-trafficking protein;, PF00018;PF07653;PF00791;, GO:0005905;GO:0030136;GO:0005737;GO:0070062;GO:0005634;GO:0005092;GO:0042802;GO:0031267;GO:0071230;GO:0006897;GO:0030308;GO:0008285;GO:0034260;GO:0032007;GO:0010508;GO:0061462;GO:0050790;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:extracellular exosome; C:nucleus;, F:GDP-dissociation inhibitor activity; F:identical protein binding; F:small GTPase binding;, P:cellular response to amino acid stimulus; P:endocytosis; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of GTPase activity; P:negative regulation of TOR signaling; P:positive regulation of autophagy; P:protein localization to lysosome; P:regulation of catalytic activity;|Q9P0V3 O95082 Q309A3 Q53QD0 Q53TD1,SH3 domain-binding protein 4,EH-binding protein 10;Transferrin receptor-trafficking protein;, PF00018;PF07653;PF00791;, GO:0005905;GO:0030136;GO:0005737;GO:0070062;GO:0005634;GO:0005092;GO:0042802;GO:0031267;GO:0071230;GO:0006897;GO:0030308;GO:0008285;GO:0034260;GO:0032007;GO:0010508;GO:0061462;GO:0050790;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:extracellular exosome; C:nucleus;, F:GDP-dissociation inhibitor activity; F:identical protein binding; F:small GTPase binding;, P:cellular response to amino acid stimulus; P:endocytosis; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of GTPase activity; P:negative regulation of TOR signaling; P:positive regulation of autophagy; P:protein localization to lysosome; P:regulation of catalytic activity;|Q9P0V3 O95082 Q309A3 Q53QD0 Q53TD1,SH3 domain-binding protein 4,EH-binding protein 10;Transferrin receptor-trafficking protein;, PF00018;PF07653;PF00791;, GO:0005905;GO:0030136;GO:0005737;GO:0070062;GO:0005634;GO:0005092;GO:0042802;GO:0031267;GO:0071230;GO:0006897;GO:0030308;GO:0008285;GO:0034260;GO:0032007;GO:0010508;GO:0061462;GO:0050790;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasm; C:extracellular exosome; C:nucleus;, F:GDP-dissociation inhibitor activity; F:identical protein binding; F:small GTPase binding;, P:cellular response to amino acid stimulus; P:endocytosis; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of GTPase activity; P:negative regulation of TOR signaling; P:positive regulation of autophagy; P:protein localization to lysosome; P:regulation of catalytic activity; scaffold115 indexed_genome mRNA 2944159 2947725 . - . ID=transcript_13495;P56559 Q4A519 Q53R10 Q9BVN1 Q9UQ34,ADP-ribosylation factor-like protein 4C,ADP-ribosylation factor-like protein 7;ADP-ribosylation factor-like protein LAK;, PF00025;, GO:0005737;GO:0005829;GO:0030175;GO:0005634;GO:0005886;GO:0043014;GO:0005525;GO:0003924;GO:0032456;GO:0006886;GO:0030522;GO:0016192;, C:cytoplasm; C:cytosol; C:filopodium; C:nucleus; C:plasma membrane;, F:alpha-tubulin binding; F:GTP binding; F:GTPase activity;, P:endocytic recycling; P:intracellular protein transport; P:intracellular receptor signaling pathway; P:vesicle-mediated transport; scaffold115 indexed_genome mRNA 3307999 3328325 . - . ID=transcript_13496;Q13103 A4QMV3 Q3B892 Q546M5,Secreted phosphoprotein 24,Secreted phosphoprotein 2;, PF07448;, GO:0062023;GO:0005788;GO:0005576;GO:0031089;GO:0004866;GO:0046849;GO:0044267;GO:0002576;GO:0043687;GO:0001501;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:platelet dense granule lumen;, F:endopeptidase inhibitor activity;, P:bone remodeling; P:cellular protein metabolic process; P:platelet degranulation; P:post-translational protein modification; P:skeletal system development; scaffold115 indexed_genome mRNA 3359253 3368442 . - . ID=transcript_13497;Q7Z2W7 A0AVG2 Q3YFM7 Q6QNH9 Q8TAC3 Q8TDX8 Q9BVK1,Transient receptor potential cation channel subfamily M member 8,Long transient receptor potential channel 6;Transient receptor potential p8;, PF00520;PF18139;, GO:0005789;GO:0009897;GO:0005887;GO:0045121;GO:0005886;GO:0005261;GO:0042802;GO:0099604;GO:0070588;GO:0098655;GO:0006874;GO:0016048;GO:0030001;GO:0120162;GO:0009409;GO:0050955;, C:endoplasmic reticulum membrane; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane;, F:cation channel activity; F:identical protein binding; F:ligand-gated calcium channel activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:cellular calcium ion homeostasis; P:detection of temperature stimulus; P:metal ion transport; P:positive regulation of cold-induced thermogenesis; P:response to cold; P:thermoception; scaffold116 indexed_genome mRNA 108966 115547 . + . ID=transcript_13498;P41587 Q13053 Q15870 Q53Y09 Q6ZN22 Q9UCW0,Vasoactive intestinal polypeptide receptor 2,Helodermin-preferring VIP receptor;Pituitary adenylate cyclase-activating polypeptide type III receptor;VPAC2;, PF00002;PF02793;, GO:0005887;GO:0005886;GO:0008528;GO:0004930;GO:0017046;GO:0004999;GO:0007188;GO:0007166;GO:0007267;GO:0007186;GO:0002862;GO:0007165;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:peptide hormone binding; F:vasoactive intestinal polypeptide receptor activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:signal transduction; scaffold116 indexed_genome mRNA 155340 183652 . - . ID=transcript_13499;Q8WVS4 Q9NW58,Cytoplasmic dynein 2 intermediate chain 1,Dynein 2 intermediate chain 1;WD repeat-containing protein 60;, , GO:0005813;GO:0097546;GO:0097014;GO:0097542;GO:0005929;GO:0005868;GO:0005615;GO:0000242;GO:0045504;GO:0045503;GO:0060271;GO:0048704;GO:0035721;GO:0042073;GO:0035735;GO:0007018;, C:centrosome; C:ciliary base; C:ciliary plasm; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:extracellular space; C:pericentriolar material;, F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium assembly; P:embryonic skeletal system morphogenesis; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement;|Q8WVS4 Q9NW58,Cytoplasmic dynein 2 intermediate chain 1,Dynein 2 intermediate chain 1;WD repeat-containing protein 60;, , GO:0005813;GO:0097546;GO:0097014;GO:0097542;GO:0005929;GO:0005868;GO:0005615;GO:0000242;GO:0045504;GO:0045503;GO:0060271;GO:0048704;GO:0035721;GO:0042073;GO:0035735;GO:0007018;, C:centrosome; C:ciliary base; C:ciliary plasm; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:extracellular space; C:pericentriolar material;, F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium assembly; P:embryonic skeletal system morphogenesis; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement;|Q8WVS4 Q9NW58,Cytoplasmic dynein 2 intermediate chain 1,Dynein 2 intermediate chain 1;WD repeat-containing protein 60;, , GO:0005813;GO:0097546;GO:0097014;GO:0097542;GO:0005929;GO:0005868;GO:0005615;GO:0000242;GO:0045504;GO:0045503;GO:0060271;GO:0048704;GO:0035721;GO:0042073;GO:0035735;GO:0007018;, C:centrosome; C:ciliary base; C:ciliary plasm; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:extracellular space; C:pericentriolar material;, F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium assembly; P:embryonic skeletal system morphogenesis; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement;|Q8WVS4 Q9NW58,Cytoplasmic dynein 2 intermediate chain 1,Dynein 2 intermediate chain 1;WD repeat-containing protein 60;, , GO:0005813;GO:0097546;GO:0097014;GO:0097542;GO:0005929;GO:0005868;GO:0005615;GO:0000242;GO:0045504;GO:0045503;GO:0060271;GO:0048704;GO:0035721;GO:0042073;GO:0035735;GO:0007018;, C:centrosome; C:ciliary base; C:ciliary plasm; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:extracellular space; C:pericentriolar material;, F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium assembly; P:embryonic skeletal system morphogenesis; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement;|Q8WVS4 Q9NW58,Cytoplasmic dynein 2 intermediate chain 1,Dynein 2 intermediate chain 1;WD repeat-containing protein 60;, , GO:0005813;GO:0097546;GO:0097014;GO:0097542;GO:0005929;GO:0005868;GO:0005615;GO:0000242;GO:0045504;GO:0045503;GO:0060271;GO:0048704;GO:0035721;GO:0042073;GO:0035735;GO:0007018;, C:centrosome; C:ciliary base; C:ciliary plasm; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:extracellular space; C:pericentriolar material;, F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium assembly; P:embryonic skeletal system morphogenesis; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement;|Q8WVS4 Q9NW58,Cytoplasmic dynein 2 intermediate chain 1,Dynein 2 intermediate chain 1;WD repeat-containing protein 60;, , GO:0005813;GO:0097546;GO:0097014;GO:0097542;GO:0005929;GO:0005868;GO:0005615;GO:0000242;GO:0045504;GO:0045503;GO:0060271;GO:0048704;GO:0035721;GO:0042073;GO:0035735;GO:0007018;, C:centrosome; C:ciliary base; C:ciliary plasm; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:extracellular space; C:pericentriolar material;, F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium assembly; P:embryonic skeletal system morphogenesis; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement;|Q8WVS4 Q9NW58,Cytoplasmic dynein 2 intermediate chain 1,Dynein 2 intermediate chain 1;WD repeat-containing protein 60;, , GO:0005813;GO:0097546;GO:0097014;GO:0097542;GO:0005929;GO:0005868;GO:0005615;GO:0000242;GO:0045504;GO:0045503;GO:0060271;GO:0048704;GO:0035721;GO:0042073;GO:0035735;GO:0007018;, C:centrosome; C:ciliary base; C:ciliary plasm; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:extracellular space; C:pericentriolar material;, F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium assembly; P:embryonic skeletal system morphogenesis; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; scaffold116 indexed_genome mRNA 183682 200623 . + . ID=transcript_13500;Q8WVS4 Q9NW58,Cytoplasmic dynein 2 intermediate chain 1,Dynein 2 intermediate chain 1;WD repeat-containing protein 60;, , GO:0005813;GO:0097546;GO:0097014;GO:0097542;GO:0005929;GO:0005868;GO:0005615;GO:0000242;GO:0045504;GO:0045503;GO:0060271;GO:0048704;GO:0035721;GO:0042073;GO:0035735;GO:0007018;, C:centrosome; C:ciliary base; C:ciliary plasm; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:extracellular space; C:pericentriolar material;, F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium assembly; P:embryonic skeletal system morphogenesis; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement;|Q8WVS4 Q9NW58,Cytoplasmic dynein 2 intermediate chain 1,Dynein 2 intermediate chain 1;WD repeat-containing protein 60;, , GO:0005813;GO:0097546;GO:0097014;GO:0097542;GO:0005929;GO:0005868;GO:0005615;GO:0000242;GO:0045504;GO:0045503;GO:0060271;GO:0048704;GO:0035721;GO:0042073;GO:0035735;GO:0007018;, C:centrosome; C:ciliary base; C:ciliary plasm; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:extracellular space; C:pericentriolar material;, F:dynein heavy chain binding; F:dynein light chain binding;, P:cilium assembly; P:embryonic skeletal system morphogenesis; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:microtubule-based movement; scaffold116 indexed_genome mRNA 222296 304843 . + . ID=transcript_13501;A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|A0FGR8 A4D229 Q69YJ2 Q6UKI4 Q6ZTU0 Q6ZVU1 Q9BQS0 Q9NW47 Q9ULJ2,Extended synaptotagmin-2 {ECO:0000305},Chr2Syt;, PF00168;PF17047;, GO:0005789;GO:0140268;GO:0031234;GO:0005887;GO:0031227;GO:0016020;GO:0044232;GO:0045296;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0006897;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane; C:organelle membrane contact site;, F:cadherin binding; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endocytosis; P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport; scaffold116 indexed_genome mRNA 326939 386799 . + . ID=transcript_13502;Q86XI2 A4D228 Q7Z3J9 Q8WUG8 Q9BRX6 Q9H8S2 Q9H9K6,Condensin-2 complex subunit G2,Chromosome-associated protein G2;Leucine zipper protein 5;Non-SMC condensin II complex subunit G2;, PF12422;, GO:0000796;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0043425;GO:0035064;GO:0140416;GO:0051301;GO:0030218;GO:0001833;GO:0007076;GO:0000070;GO:0006366;, C:condensin complex; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:bHLH transcription factor binding; F:methylated histone binding; F:transcription regulator inhibitor activity;, P:cell division; P:erythrocyte differentiation; P:inner cell mass cell proliferation; P:mitotic chromosome condensation; P:mitotic sister chromatid segregation; P:transcription by RNA polymerase II;|Q86XI2 A4D228 Q7Z3J9 Q8WUG8 Q9BRX6 Q9H8S2 Q9H9K6,Condensin-2 complex subunit G2,Chromosome-associated protein G2;Leucine zipper protein 5;Non-SMC condensin II complex subunit G2;, PF12422;, GO:0000796;GO:0016020;GO:0016607;GO:0005654;GO:0005634;GO:0043425;GO:0035064;GO:0140416;GO:0051301;GO:0030218;GO:0001833;GO:0007076;GO:0000070;GO:0006366;, C:condensin complex; C:membrane; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:bHLH transcription factor binding; F:methylated histone binding; F:transcription regulator inhibitor activity;, P:cell division; P:erythrocyte differentiation; P:inner cell mass cell proliferation; P:mitotic chromosome condensation; P:mitotic sister chromatid segregation; P:transcription by RNA polymerase II; scaffold116 indexed_genome mRNA 590883 996749 . + . ID=transcript_13503;Q92932 E9PC57 Q8N4I5 Q92662 Q9Y4F8 Q9Y4I6,Receptor-type tyrosine-protein phosphatase N2,Islet cell autoantigen-related protein {ECO:0000303|PubMed:8798755};Phogrin {ECO:0000303|PubMed:25421040, ECO:0000303|PubMed:8878534};, PF11548;PF14948;PF00102;, GO:0005788;GO:0101003;GO:0005887;GO:0030285;GO:0005886;GO:0043235;GO:0030667;GO:0030672;GO:0043195;GO:0005001;GO:0035773;GO:0006629;GO:0034260;GO:0007269;GO:0043312;GO:0006470;, C:endoplasmic reticulum lumen; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:plasma membrane; C:receptor complex; C:secretory granule membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:transmembrane receptor protein tyrosine phosphatase activity;, P:insulin secretion involved in cellular response to glucose stimulus; P:lipid metabolic process; P:negative regulation of GTPase activity; P:neurotransmitter secretion; P:neutrophil degranulation; P:protein dephosphorylation;|Q16849 B4DK12 F5GZS3 Q08319 Q53QD6 Q6NSL1,Receptor-type tyrosine-protein phosphatase-like N,Islet cell antigen 512 {ECO:0000303|PubMed:8144912};Islet cell autoantigen 3;PTP IA-2;, PF11548;PF14948;PF00102;, GO:0043679;GO:0005768;GO:0005794;GO:0016021;GO:0043025;GO:0005634;GO:0043204;GO:0005886;GO:0030141;GO:0045202;GO:0030658;GO:0051020;GO:0030507;GO:0008134;GO:0044389;GO:0019221;GO:1990502;GO:0030073;GO:0035773;GO:0001553;GO:0035335;GO:0045944;GO:1904692;GO:0051591;GO:0043627;GO:0032868;GO:0000302;, C:axon terminus; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:neuronal cell body; C:nucleus; C:perikaryon; C:plasma membrane; C:secretory granule; C:synapse; C:transport vesicle membrane;, F:GTPase binding; F:spectrin binding; F:transcription factor binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:dense core granule maturation; P:insulin secretion; P:insulin secretion involved in cellular response to glucose stimulus; P:luteinization; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type B pancreatic cell proliferation; P:response to cAMP; P:response to estrogen; P:response to insulin; P:response to reactive oxygen species;|Q92932 E9PC57 Q8N4I5 Q92662 Q9Y4F8 Q9Y4I6,Receptor-type tyrosine-protein phosphatase N2,Islet cell autoantigen-related protein {ECO:0000303|PubMed:8798755};Phogrin {ECO:0000303|PubMed:25421040, ECO:0000303|PubMed:8878534};, PF11548;PF14948;PF00102;, GO:0005788;GO:0101003;GO:0005887;GO:0030285;GO:0005886;GO:0043235;GO:0030667;GO:0030672;GO:0043195;GO:0005001;GO:0035773;GO:0006629;GO:0034260;GO:0007269;GO:0043312;GO:0006470;, C:endoplasmic reticulum lumen; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:plasma membrane; C:receptor complex; C:secretory granule membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:transmembrane receptor protein tyrosine phosphatase activity;, P:insulin secretion involved in cellular response to glucose stimulus; P:lipid metabolic process; P:negative regulation of GTPase activity; P:neurotransmitter secretion; P:neutrophil degranulation; P:protein dephosphorylation; scaffold116 indexed_genome mRNA 1034404 1055033 . - . ID=transcript_13504;Q6FIC8 Q75MA2 Q9UIK6,DnaJ homolog subfamily B member 6,HHDJ1;Heat shock protein J2;MRJ;MSJ-1;, PF00226;, GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0048471;GO:0030018;GO:0001671;GO:0051087;GO:0031072;GO:0042802;GO:0051082;GO:0045109;GO:0043154;GO:0090084;GO:0006457;GO:1900034;GO:0032880;, C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Z disc;, F:ATPase activator activity; F:chaperone binding; F:heat shock protein binding; F:identical protein binding; F:unfolded protein binding;, P:intermediate filament organization; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of inclusion body assembly; P:protein folding; P:regulation of cellular response to heat; P:regulation of protein localization;|Q8NHS0 B3KWV7,DnaJ homolog subfamily B member 8,, PF00226;, GO:0005829;GO:0005634;GO:0051087;GO:0044183;GO:0051082;GO:0061077;GO:0090084;, C:cytosol; C:nucleus;, F:chaperone binding; F:protein folding chaperone; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of inclusion body assembly; scaffold116 indexed_genome mRNA 1055652 1060278 . - . ID=transcript_13505;Q8WWF6,DnaJ homolog subfamily B member 3,, PF00226; scaffold116 indexed_genome mRNA 1149585 1150818 . + . ID=transcript_13506;Q15386 A4D235 A6NCP3 Q8TC15 Q96CR4 Q9UDU3,Ubiquitin-protein ligase E3C,HECT-type ubiquitin transferase E3C;HectH2;, PF00632;, GO:0005634;GO:0000502;GO:0061630;GO:0000209;GO:0006511;, C:nucleus; C:proteasome complex;, F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q15386 A4D235 A6NCP3 Q8TC15 Q96CR4 Q9UDU3,Ubiquitin-protein ligase E3C,HECT-type ubiquitin transferase E3C;HectH2;, PF00632;, GO:0005634;GO:0000502;GO:0061630;GO:0000209;GO:0006511;, C:nucleus; C:proteasome complex;, F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold116 indexed_genome mRNA 1190900 1316069 . - . ID=transcript_13507;Q15386 A4D235 A6NCP3 Q8TC15 Q96CR4 Q9UDU3,Ubiquitin-protein ligase E3C,HECT-type ubiquitin transferase E3C;HectH2;, PF00632;, GO:0005634;GO:0000502;GO:0061630;GO:0000209;GO:0006511;, C:nucleus; C:proteasome complex;, F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q15386 A4D235 A6NCP3 Q8TC15 Q96CR4 Q9UDU3,Ubiquitin-protein ligase E3C,HECT-type ubiquitin transferase E3C;HectH2;, PF00632;, GO:0005634;GO:0000502;GO:0061630;GO:0000209;GO:0006511;, C:nucleus; C:proteasome complex;, F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold116 indexed_genome mRNA 1363628 1366958 . + . ID=transcript_13508;Q5C9Z4 Q96I08,Nucleolar MIF4G domain-containing protein 1,SGD1 homolog;, PF02847;PF02854;, GO:0005730;GO:0003723;GO:0048820;GO:0042274;, C:nucleolus;, F:RNA binding;, P:hair follicle maturation; P:ribosomal small subunit biogenesis;|Q5C9Z4 Q96I08,Nucleolar MIF4G domain-containing protein 1,SGD1 homolog;, PF02847;PF02854;, GO:0005730;GO:0003723;GO:0048820;GO:0042274;, C:nucleolus;, F:RNA binding;, P:hair follicle maturation; P:ribosomal small subunit biogenesis; scaffold116 indexed_genome mRNA 1369027 1370190 . + . ID=transcript_13509;Q5C9Z4 Q96I08,Nucleolar MIF4G domain-containing protein 1,SGD1 homolog;, PF02847;PF02854;, GO:0005730;GO:0003723;GO:0048820;GO:0042274;, C:nucleolus;, F:RNA binding;, P:hair follicle maturation; P:ribosomal small subunit biogenesis; scaffold116 indexed_genome mRNA 1421703 1462955 . + . ID=transcript_13510;Q8WVP7 A4D242 Q8N3E3 Q96QZ5 Q9H5N0 Q9HAG9 Q9UDN5 Q9Y6U2,Limb region 1 protein homolog,Differentiation-related gene 14 protein;, PF04791;, GO:0005887;GO:0004888;GO:0007165;, C:integral component of plasma membrane;, F:transmembrane signaling receptor activity;, P:signal transduction;|Q8WVP7 A4D242 Q8N3E3 Q96QZ5 Q9H5N0 Q9HAG9 Q9UDN5 Q9Y6U2,Limb region 1 protein homolog,Differentiation-related gene 14 protein;, PF04791;, GO:0005887;GO:0004888;GO:0007165;, C:integral component of plasma membrane;, F:transmembrane signaling receptor activity;, P:signal transduction; scaffold116 indexed_genome mRNA 1496850 1558779 . + . ID=transcript_13511;Q8WVP7 A4D242 Q8N3E3 Q96QZ5 Q9H5N0 Q9HAG9 Q9UDN5 Q9Y6U2,Limb region 1 protein homolog,Differentiation-related gene 14 protein;, PF04791;, GO:0005887;GO:0004888;GO:0007165;, C:integral component of plasma membrane;, F:transmembrane signaling receptor activity;, P:signal transduction;|Q8WVP7 A4D242 Q8N3E3 Q96QZ5 Q9H5N0 Q9HAG9 Q9UDN5 Q9Y6U2,Limb region 1 protein homolog,Differentiation-related gene 14 protein;, PF04791;, GO:0005887;GO:0004888;GO:0007165;, C:integral component of plasma membrane;, F:transmembrane signaling receptor activity;, P:signal transduction;|Q8WVP7 A4D242 Q8N3E3 Q96QZ5 Q9H5N0 Q9HAG9 Q9UDN5 Q9Y6U2,Limb region 1 protein homolog,Differentiation-related gene 14 protein;, PF04791;, GO:0005887;GO:0004888;GO:0007165;, C:integral component of plasma membrane;, F:transmembrane signaling receptor activity;, P:signal transduction; scaffold116 indexed_genome mRNA 1591289 1603655 . - . ID=transcript_13512;Q9H0A6 Q6FIB3 Q6X7T4 Q8N6V8 Q8TDG0 Q96BM5 Q9Y6U1,RING finger protein 32,, PF00612;PF13639;PF13445;, GO:0016235;GO:0005829;GO:0005768;GO:0016604;GO:0046872;, C:aggresome; C:cytosol; C:endosome; C:nuclear body;, F:metal ion binding; scaffold116 indexed_genome mRNA 2237924 2249674 . - . ID=transcript_13513;Q96EV2 A4D244 B5MC24 Q52LF5 Q75LN9 Q75ML5 Q9NSV0,RNA-binding protein 33,Proline-rich protein 8;RNA-binding motif protein 33;, , GO:0003723;, , F:RNA binding;|Q96EV2 A4D244 B5MC24 Q52LF5 Q75LN9 Q75ML5 Q9NSV0,RNA-binding protein 33,Proline-rich protein 8;RNA-binding motif protein 33;, , GO:0003723;, , F:RNA binding;|Q96EV2 A4D244 B5MC24 Q52LF5 Q75LN9 Q75ML5 Q9NSV0,RNA-binding protein 33,Proline-rich protein 8;RNA-binding motif protein 33;, , GO:0003723;, , F:RNA binding;|Q96EV2 A4D244 B5MC24 Q52LF5 Q75LN9 Q75ML5 Q9NSV0,RNA-binding protein 33,Proline-rich protein 8;RNA-binding motif protein 33;, , GO:0003723;, , F:RNA binding; scaffold116 indexed_genome mRNA 2263175 2348324 . - . ID=transcript_13514;Q96EV2 A4D244 B5MC24 Q52LF5 Q75LN9 Q75ML5 Q9NSV0,RNA-binding protein 33,Proline-rich protein 8;RNA-binding motif protein 33;, , GO:0003723;, , F:RNA binding;|Q96EV2 A4D244 B5MC24 Q52LF5 Q75LN9 Q75ML5 Q9NSV0,RNA-binding protein 33,Proline-rich protein 8;RNA-binding motif protein 33;, , GO:0003723;, , F:RNA binding; scaffold116 indexed_genome mRNA 2442229 2451406 . + . ID=transcript_13515;Q3B7I2 A6NGX3,Protein canopy homolog 1,, PF11938;, GO:0005783;, C:endoplasmic reticulum;|Q3B7I2 A6NGX3,Protein canopy homolog 1,, PF11938;, GO:0005783;, C:endoplasmic reticulum; scaffold116 indexed_genome mRNA 2566302 2579322 . - . ID=transcript_13516;O15503 A4D2N1 A8K6L0 Q53XW8 Q9BUV5,Insulin-induced gene 1 protein {ECO:0000303|PubMed:12202038, ECO:0000303|PubMed:9268630},, PF07281;, GO:0005783;GO:0005789;GO:0032937;GO:0008142;GO:0032869;GO:0036315;GO:0006695;GO:0042632;GO:0060363;GO:0042472;GO:0042474;GO:1901303;GO:0045599;GO:0045717;GO:0070862;GO:0010894;GO:0060021;GO:0032933;GO:0036316;GO:0016126;GO:0006641;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:SREBP-SCAP-Insig complex;, F:oxysterol binding;, P:cellular response to insulin stimulus; P:cellular response to sterol; P:cholesterol biosynthetic process; P:cholesterol homeostasis; P:cranial suture morphogenesis; P:inner ear morphogenesis; P:middle ear morphogenesis; P:negative regulation of cargo loading into COPII-coated vesicle; P:negative regulation of fat cell differentiation; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of protein exit from endoplasmic reticulum; P:negative regulation of steroid biosynthetic process; P:roof of mouth development; P:SREBP signaling pathway; P:SREBP-SCAP complex retention in endoplasmic reticulum; P:sterol biosynthetic process; P:triglyceride metabolic process;|O15503 A4D2N1 A8K6L0 Q53XW8 Q9BUV5,Insulin-induced gene 1 protein {ECO:0000303|PubMed:12202038, ECO:0000303|PubMed:9268630},, PF07281;, GO:0005783;GO:0005789;GO:0032937;GO:0008142;GO:0032869;GO:0036315;GO:0006695;GO:0042632;GO:0060363;GO:0042472;GO:0042474;GO:1901303;GO:0045599;GO:0045717;GO:0070862;GO:0010894;GO:0060021;GO:0032933;GO:0036316;GO:0016126;GO:0006641;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:SREBP-SCAP-Insig complex;, F:oxysterol binding;, P:cellular response to insulin stimulus; P:cellular response to sterol; P:cholesterol biosynthetic process; P:cholesterol homeostasis; P:cranial suture morphogenesis; P:inner ear morphogenesis; P:middle ear morphogenesis; P:negative regulation of cargo loading into COPII-coated vesicle; P:negative regulation of fat cell differentiation; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of protein exit from endoplasmic reticulum; P:negative regulation of steroid biosynthetic process; P:roof of mouth development; P:SREBP signaling pathway; P:SREBP-SCAP complex retention in endoplasmic reticulum; P:sterol biosynthetic process; P:triglyceride metabolic process;|Q9Y5U4 A8K5W8 Q8TBI8,Insulin-induced gene 2 protein {ECO:0000303|PubMed:12242332},, PF07281;, GO:0005783;GO:0005789;GO:0032937;GO:0008142;GO:0032869;GO:0006695;GO:0032933;GO:0036316;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:SREBP-SCAP-Insig complex;, F:oxysterol binding;, P:cellular response to insulin stimulus; P:cholesterol biosynthetic process; P:SREBP signaling pathway; P:SREBP-SCAP complex retention in endoplasmic reticulum; P:sterol biosynthetic process; scaffold116 indexed_genome mRNA 2692919 2707785 . - . ID=transcript_13517;P47898 Q2M2D2,5-hydroxytryptamine receptor 5A,Serotonin receptor 5A;, PF00001;, GO:0030425;GO:0005794;GO:0005887;GO:0099060;GO:0043204;GO:0005886;GO:0005791;GO:0004993;GO:0030594;GO:0051378;GO:0007198;GO:0019933;GO:0007268;GO:0007186;GO:0007187;GO:0021766;GO:0032355;, C:dendrite; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:perikaryon; C:plasma membrane; C:rough endoplasmic reticulum;, F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity; F:serotonin binding;, P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; P:cAMP-mediated signaling; P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:hippocampus development; P:response to estradiol;|P47898 Q2M2D2,5-hydroxytryptamine receptor 5A,Serotonin receptor 5A;, PF00001;, GO:0030425;GO:0005794;GO:0005887;GO:0099060;GO:0043204;GO:0005886;GO:0005791;GO:0004993;GO:0030594;GO:0051378;GO:0007198;GO:0019933;GO:0007268;GO:0007186;GO:0007187;GO:0021766;GO:0032355;, C:dendrite; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:perikaryon; C:plasma membrane; C:rough endoplasmic reticulum;, F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity; F:serotonin binding;, P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; P:cAMP-mediated signaling; P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:hippocampus development; P:response to estradiol;|P47898 Q2M2D2,5-hydroxytryptamine receptor 5A,Serotonin receptor 5A;, PF00001;, GO:0030425;GO:0005794;GO:0005887;GO:0099060;GO:0043204;GO:0005886;GO:0005791;GO:0004993;GO:0030594;GO:0051378;GO:0007198;GO:0019933;GO:0007268;GO:0007186;GO:0007187;GO:0021766;GO:0032355;, C:dendrite; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:perikaryon; C:plasma membrane; C:rough endoplasmic reticulum;, F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity; F:serotonin binding;, P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; P:cAMP-mediated signaling; P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:hippocampus development; P:response to estradiol; scaffold116 indexed_genome mRNA 2757610 2760993 . + . ID=transcript_13518;Q6ZW49 O15404 Q6N099 Q6ZWH9 Q7Z315 Q86UN0 Q8N4P9 Q96HP2,PAX-interacting protein 1,PAX transactivation activation domain-interacting protein;, PF00533;PF12738;PF16770;, GO:0005694;GO:0035097;GO:0044666;GO:0016363;GO:0005654;GO:0005634;GO:0060612;GO:0060717;GO:0030330;GO:0006310;GO:0006303;GO:0043542;GO:0051568;GO:0043433;GO:0035066;GO:0000416;GO:0051571;GO:0045830;GO:0048304;GO:0031398;GO:2001022;GO:0060261;GO:1902749;GO:0010212;GO:0001570;, C:chromosome; C:histone methyltransferase complex; C:MLL3/4 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, , P:adipose tissue development; P:chorion development; P:DNA damage response, signal transduction by p53 class mediator; P:DNA recombination; P:double-strand break repair via nonhomologous end joining; P:endothelial cell migration; P:histone H3-K4 methylation; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone H3-K36 methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of isotype switching; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of protein ubiquitination; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of cell cycle G2/M phase transition; P:response to ionizing radiation; P:vasculogenesis;|Q6ZW49 O15404 Q6N099 Q6ZWH9 Q7Z315 Q86UN0 Q8N4P9 Q96HP2,PAX-interacting protein 1,PAX transactivation activation domain-interacting protein;, PF00533;PF12738;PF16770;, GO:0005694;GO:0035097;GO:0044666;GO:0016363;GO:0005654;GO:0005634;GO:0060612;GO:0060717;GO:0030330;GO:0006310;GO:0006303;GO:0043542;GO:0051568;GO:0043433;GO:0035066;GO:0000416;GO:0051571;GO:0045830;GO:0048304;GO:0031398;GO:2001022;GO:0060261;GO:1902749;GO:0010212;GO:0001570;, C:chromosome; C:histone methyltransferase complex; C:MLL3/4 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, , P:adipose tissue development; P:chorion development; P:DNA damage response, signal transduction by p53 class mediator; P:DNA recombination; P:double-strand break repair via nonhomologous end joining; P:endothelial cell migration; P:histone H3-K4 methylation; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone H3-K36 methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of isotype switching; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of protein ubiquitination; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of cell cycle G2/M phase transition; P:response to ionizing radiation; P:vasculogenesis; scaffold116 indexed_genome mRNA 2768021 2770158 . + . ID=transcript_13519;Q6ZW49 O15404 Q6N099 Q6ZWH9 Q7Z315 Q86UN0 Q8N4P9 Q96HP2,PAX-interacting protein 1,PAX transactivation activation domain-interacting protein;, PF00533;PF12738;PF16770;, GO:0005694;GO:0035097;GO:0044666;GO:0016363;GO:0005654;GO:0005634;GO:0060612;GO:0060717;GO:0030330;GO:0006310;GO:0006303;GO:0043542;GO:0051568;GO:0043433;GO:0035066;GO:0000416;GO:0051571;GO:0045830;GO:0048304;GO:0031398;GO:2001022;GO:0060261;GO:1902749;GO:0010212;GO:0001570;, C:chromosome; C:histone methyltransferase complex; C:MLL3/4 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, , P:adipose tissue development; P:chorion development; P:DNA damage response, signal transduction by p53 class mediator; P:DNA recombination; P:double-strand break repair via nonhomologous end joining; P:endothelial cell migration; P:histone H3-K4 methylation; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone H3-K36 methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of isotype switching; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of protein ubiquitination; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of cell cycle G2/M phase transition; P:response to ionizing radiation; P:vasculogenesis; scaffold116 indexed_genome mRNA 2770793 2771516 . + . ID=transcript_13520;Q6ZW49 O15404 Q6N099 Q6ZWH9 Q7Z315 Q86UN0 Q8N4P9 Q96HP2,PAX-interacting protein 1,PAX transactivation activation domain-interacting protein;, PF00533;PF12738;PF16770;, GO:0005694;GO:0035097;GO:0044666;GO:0016363;GO:0005654;GO:0005634;GO:0060612;GO:0060717;GO:0030330;GO:0006310;GO:0006303;GO:0043542;GO:0051568;GO:0043433;GO:0035066;GO:0000416;GO:0051571;GO:0045830;GO:0048304;GO:0031398;GO:2001022;GO:0060261;GO:1902749;GO:0010212;GO:0001570;, C:chromosome; C:histone methyltransferase complex; C:MLL3/4 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, , P:adipose tissue development; P:chorion development; P:DNA damage response, signal transduction by p53 class mediator; P:DNA recombination; P:double-strand break repair via nonhomologous end joining; P:endothelial cell migration; P:histone H3-K4 methylation; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone H3-K36 methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of isotype switching; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of protein ubiquitination; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of cell cycle G2/M phase transition; P:response to ionizing radiation; P:vasculogenesis; scaffold116 indexed_genome mRNA 2772313 2776092 . - . ID=transcript_13521;Q6ZW49 O15404 Q6N099 Q6ZWH9 Q7Z315 Q86UN0 Q8N4P9 Q96HP2,PAX-interacting protein 1,PAX transactivation activation domain-interacting protein;, PF00533;PF12738;PF16770;, GO:0005694;GO:0035097;GO:0044666;GO:0016363;GO:0005654;GO:0005634;GO:0060612;GO:0060717;GO:0030330;GO:0006310;GO:0006303;GO:0043542;GO:0051568;GO:0043433;GO:0035066;GO:0000416;GO:0051571;GO:0045830;GO:0048304;GO:0031398;GO:2001022;GO:0060261;GO:1902749;GO:0010212;GO:0001570;, C:chromosome; C:histone methyltransferase complex; C:MLL3/4 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, , P:adipose tissue development; P:chorion development; P:DNA damage response, signal transduction by p53 class mediator; P:DNA recombination; P:double-strand break repair via nonhomologous end joining; P:endothelial cell migration; P:histone H3-K4 methylation; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone H3-K36 methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of isotype switching; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of protein ubiquitination; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of cell cycle G2/M phase transition; P:response to ionizing radiation; P:vasculogenesis; scaffold116 indexed_genome mRNA 2776116 2777258 . + . ID=transcript_13522;Q6ZW49 O15404 Q6N099 Q6ZWH9 Q7Z315 Q86UN0 Q8N4P9 Q96HP2,PAX-interacting protein 1,PAX transactivation activation domain-interacting protein;, PF00533;PF12738;PF16770;, GO:0005694;GO:0035097;GO:0044666;GO:0016363;GO:0005654;GO:0005634;GO:0060612;GO:0060717;GO:0030330;GO:0006310;GO:0006303;GO:0043542;GO:0051568;GO:0043433;GO:0035066;GO:0000416;GO:0051571;GO:0045830;GO:0048304;GO:0031398;GO:2001022;GO:0060261;GO:1902749;GO:0010212;GO:0001570;, C:chromosome; C:histone methyltransferase complex; C:MLL3/4 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, , P:adipose tissue development; P:chorion development; P:DNA damage response, signal transduction by p53 class mediator; P:DNA recombination; P:double-strand break repair via nonhomologous end joining; P:endothelial cell migration; P:histone H3-K4 methylation; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone H3-K36 methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of isotype switching; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of protein ubiquitination; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of cell cycle G2/M phase transition; P:response to ionizing radiation; P:vasculogenesis; scaffold116 indexed_genome mRNA 2778515 2781963 . + . ID=transcript_13523;Q6ZW49 O15404 Q6N099 Q6ZWH9 Q7Z315 Q86UN0 Q8N4P9 Q96HP2,PAX-interacting protein 1,PAX transactivation activation domain-interacting protein;, PF00533;PF12738;PF16770;, GO:0005694;GO:0035097;GO:0044666;GO:0016363;GO:0005654;GO:0005634;GO:0060612;GO:0060717;GO:0030330;GO:0006310;GO:0006303;GO:0043542;GO:0051568;GO:0043433;GO:0035066;GO:0000416;GO:0051571;GO:0045830;GO:0048304;GO:0031398;GO:2001022;GO:0060261;GO:1902749;GO:0010212;GO:0001570;, C:chromosome; C:histone methyltransferase complex; C:MLL3/4 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, , P:adipose tissue development; P:chorion development; P:DNA damage response, signal transduction by p53 class mediator; P:DNA recombination; P:double-strand break repair via nonhomologous end joining; P:endothelial cell migration; P:histone H3-K4 methylation; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone H3-K36 methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of isotype switching; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of protein ubiquitination; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of cell cycle G2/M phase transition; P:response to ionizing radiation; P:vasculogenesis;|Q6ZW49 O15404 Q6N099 Q6ZWH9 Q7Z315 Q86UN0 Q8N4P9 Q96HP2,PAX-interacting protein 1,PAX transactivation activation domain-interacting protein;, PF00533;PF12738;PF16770;, GO:0005694;GO:0035097;GO:0044666;GO:0016363;GO:0005654;GO:0005634;GO:0060612;GO:0060717;GO:0030330;GO:0006310;GO:0006303;GO:0043542;GO:0051568;GO:0043433;GO:0035066;GO:0000416;GO:0051571;GO:0045830;GO:0048304;GO:0031398;GO:2001022;GO:0060261;GO:1902749;GO:0010212;GO:0001570;, C:chromosome; C:histone methyltransferase complex; C:MLL3/4 complex; C:nuclear matrix; C:nucleoplasm; C:nucleus;, , P:adipose tissue development; P:chorion development; P:DNA damage response, signal transduction by p53 class mediator; P:DNA recombination; P:double-strand break repair via nonhomologous end joining; P:endothelial cell migration; P:histone H3-K4 methylation; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone H3-K36 methylation; P:positive regulation of histone H3-K4 methylation; P:positive regulation of isotype switching; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of protein ubiquitination; P:positive regulation of response to DNA damage stimulus; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of cell cycle G2/M phase transition; P:response to ionizing radiation; P:vasculogenesis; scaffold116 indexed_genome mRNA 2797447 2801185 . - . ID=transcript_13524;P42658,Dipeptidyl aminopeptidase-like protein 6,DPPX;Dipeptidyl aminopeptidase-related protein;Dipeptidyl peptidase 6;Dipeptidyl peptidase IV-like protein;Dipeptidyl peptidase VI;, PF00930;PF00326;, GO:0016021;GO:0005886;GO:0008076;GO:0015459;GO:0008236;GO:0072659;GO:1901379;, C:integral component of membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:potassium channel regulator activity; F:serine-type peptidase activity;, P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport;|P42658,Dipeptidyl aminopeptidase-like protein 6,DPPX;Dipeptidyl aminopeptidase-related protein;Dipeptidyl peptidase 6;Dipeptidyl peptidase IV-like protein;Dipeptidyl peptidase VI;, PF00930;PF00326;, GO:0016021;GO:0005886;GO:0008076;GO:0015459;GO:0008236;GO:0072659;GO:1901379;, C:integral component of membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:potassium channel regulator activity; F:serine-type peptidase activity;, P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport; scaffold116 indexed_genome mRNA 3136108 3286577 . - . ID=transcript_13525;P42658,Dipeptidyl aminopeptidase-like protein 6,DPPX;Dipeptidyl aminopeptidase-related protein;Dipeptidyl peptidase 6;Dipeptidyl peptidase IV-like protein;Dipeptidyl peptidase VI;, PF00930;PF00326;, GO:0016021;GO:0005886;GO:0008076;GO:0015459;GO:0008236;GO:0072659;GO:1901379;, C:integral component of membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:potassium channel regulator activity; F:serine-type peptidase activity;, P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport; scaffold117 indexed_genome mRNA 13511 210043 . + . ID=transcript_13526;Q9H0Z1 Q9NTS3,Transcriptional regulator ATRX,ATP-dependent helicase ATRX;X-linked helicase II;X-linked nuclear protein;Znf-HX;, PF17981;PF00271;PF00176;, GO:0099115;GO:0000781;GO:0000779;GO:0000792;GO:0016604;GO:0000228;GO:0005654;GO:0005634;GO:0005721;GO:0016605;GO:0005524;GO:0003682;GO:0070087;GO:0003677;GO:0003678;GO:0015616;GO:0042393;GO:0046872;GO:0035064;GO:0070615;GO:0072711;GO:0006338;GO:0070192;GO:0030330;GO:0006306;GO:0006281;GO:0006336;GO:0030900;GO:0000212;GO:0035264;GO:0048239;GO:1904908;GO:1901581;GO:0006334;GO:1900051;GO:0010571;GO:0032206;GO:1901582;GO:0045944;GO:0035128;GO:0070198;GO:1900112;GO:0006355;GO:0031297;GO:0072520;GO:0060009;GO:0007283;, C:chromosome, subtelomeric region; C:chromosome, telomeric region; C:condensed chromosome, centromeric region; C:heterochromatin; C:nuclear body; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:PML body;, F:ATP binding; F:chromatin binding; F:chromo shadow domain binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:histone binding; F:metal ion binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:cellular response to hydroxyurea; P:chromatin remodeling; P:chromosome organization involved in meiotic cell cycle; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:DNA repair; P:DNA replication-independent nucleosome assembly; P:forebrain development; P:meiotic spindle organization; P:multicellular organism growth; P:negative regulation of DNA recombination at telomere; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; P:negative regulation of telomeric RNA transcription from RNA pol II promoter; P:nucleosome assembly; P:positive regulation of histone exchange; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of telomere maintenance; P:positive regulation of telomeric RNA transcription from RNA pol II promoter; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic forelimb morphogenesis; P:protein localization to chromosome, telomeric region; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription, DNA-templated; P:replication fork processing; P:seminiferous tubule development; P:Sertoli cell development; P:spermatogenesis;|Q9H0Z1 Q9NTS3,Transcriptional regulator ATRX,ATP-dependent helicase ATRX;X-linked helicase II;X-linked nuclear protein;Znf-HX;, PF17981;PF00271;PF00176;, GO:0099115;GO:0000781;GO:0000779;GO:0000792;GO:0016604;GO:0000228;GO:0005654;GO:0005634;GO:0005721;GO:0016605;GO:0005524;GO:0003682;GO:0070087;GO:0003677;GO:0003678;GO:0015616;GO:0042393;GO:0046872;GO:0035064;GO:0070615;GO:0072711;GO:0006338;GO:0070192;GO:0030330;GO:0006306;GO:0006281;GO:0006336;GO:0030900;GO:0000212;GO:0035264;GO:0048239;GO:1904908;GO:1901581;GO:0006334;GO:1900051;GO:0010571;GO:0032206;GO:1901582;GO:0045944;GO:0035128;GO:0070198;GO:1900112;GO:0006355;GO:0031297;GO:0072520;GO:0060009;GO:0007283;, C:chromosome, subtelomeric region; C:chromosome, telomeric region; C:condensed chromosome, centromeric region; C:heterochromatin; C:nuclear body; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:PML body;, F:ATP binding; F:chromatin binding; F:chromo shadow domain binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:histone binding; F:metal ion binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:cellular response to hydroxyurea; P:chromatin remodeling; P:chromosome organization involved in meiotic cell cycle; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:DNA repair; P:DNA replication-independent nucleosome assembly; P:forebrain development; P:meiotic spindle organization; P:multicellular organism growth; P:negative regulation of DNA recombination at telomere; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; P:negative regulation of telomeric RNA transcription from RNA pol II promoter; P:nucleosome assembly; P:positive regulation of histone exchange; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of telomere maintenance; P:positive regulation of telomeric RNA transcription from RNA pol II promoter; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic forelimb morphogenesis; P:protein localization to chromosome, telomeric region; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription, DNA-templated; P:replication fork processing; P:seminiferous tubule development; P:Sertoli cell development; P:spermatogenesis;|Q9H0Z1 Q9NTS3,Transcriptional regulator ATRX,ATP-dependent helicase ATRX;X-linked helicase II;X-linked nuclear protein;Znf-HX;, PF17981;PF00271;PF00176;, GO:0099115;GO:0000781;GO:0000779;GO:0000792;GO:0016604;GO:0000228;GO:0005654;GO:0005634;GO:0005721;GO:0016605;GO:0005524;GO:0003682;GO:0070087;GO:0003677;GO:0003678;GO:0015616;GO:0042393;GO:0046872;GO:0035064;GO:0070615;GO:0072711;GO:0006338;GO:0070192;GO:0030330;GO:0006306;GO:0006281;GO:0006336;GO:0030900;GO:0000212;GO:0035264;GO:0048239;GO:1904908;GO:1901581;GO:0006334;GO:1900051;GO:0010571;GO:0032206;GO:1901582;GO:0045944;GO:0035128;GO:0070198;GO:1900112;GO:0006355;GO:0031297;GO:0072520;GO:0060009;GO:0007283;, C:chromosome, subtelomeric region; C:chromosome, telomeric region; C:condensed chromosome, centromeric region; C:heterochromatin; C:nuclear body; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:PML body;, F:ATP binding; F:chromatin binding; F:chromo shadow domain binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:histone binding; F:metal ion binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:cellular response to hydroxyurea; P:chromatin remodeling; P:chromosome organization involved in meiotic cell cycle; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:DNA repair; P:DNA replication-independent nucleosome assembly; P:forebrain development; P:meiotic spindle organization; P:multicellular organism growth; P:negative regulation of DNA recombination at telomere; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; P:negative regulation of telomeric RNA transcription from RNA pol II promoter; P:nucleosome assembly; P:positive regulation of histone exchange; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of telomere maintenance; P:positive regulation of telomeric RNA transcription from RNA pol II promoter; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic forelimb morphogenesis; P:protein localization to chromosome, telomeric region; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription, DNA-templated; P:replication fork processing; P:seminiferous tubule development; P:Sertoli cell development; P:spermatogenesis;|Q9H0Z1 Q9NTS3,Transcriptional regulator ATRX,ATP-dependent helicase ATRX;X-linked helicase II;X-linked nuclear protein;Znf-HX;, PF17981;PF00271;PF00176;, GO:0099115;GO:0000781;GO:0000779;GO:0000792;GO:0016604;GO:0000228;GO:0005654;GO:0005634;GO:0005721;GO:0016605;GO:0005524;GO:0003682;GO:0070087;GO:0003677;GO:0003678;GO:0015616;GO:0042393;GO:0046872;GO:0035064;GO:0070615;GO:0072711;GO:0006338;GO:0070192;GO:0030330;GO:0006306;GO:0006281;GO:0006336;GO:0030900;GO:0000212;GO:0035264;GO:0048239;GO:1904908;GO:1901581;GO:0006334;GO:1900051;GO:0010571;GO:0032206;GO:1901582;GO:0045944;GO:0035128;GO:0070198;GO:1900112;GO:0006355;GO:0031297;GO:0072520;GO:0060009;GO:0007283;, C:chromosome, subtelomeric region; C:chromosome, telomeric region; C:condensed chromosome, centromeric region; C:heterochromatin; C:nuclear body; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:PML body;, F:ATP binding; F:chromatin binding; F:chromo shadow domain binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:histone binding; F:metal ion binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:cellular response to hydroxyurea; P:chromatin remodeling; P:chromosome organization involved in meiotic cell cycle; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:DNA repair; P:DNA replication-independent nucleosome assembly; P:forebrain development; P:meiotic spindle organization; P:multicellular organism growth; P:negative regulation of DNA recombination at telomere; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; P:negative regulation of telomeric RNA transcription from RNA pol II promoter; P:nucleosome assembly; P:positive regulation of histone exchange; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of telomere maintenance; P:positive regulation of telomeric RNA transcription from RNA pol II promoter; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic forelimb morphogenesis; P:protein localization to chromosome, telomeric region; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription, DNA-templated; P:replication fork processing; P:seminiferous tubule development; P:Sertoli cell development; P:spermatogenesis;|Q9H0Z1 Q9NTS3,Transcriptional regulator ATRX,ATP-dependent helicase ATRX;X-linked helicase II;X-linked nuclear protein;Znf-HX;, PF17981;PF00271;PF00176;, GO:0099115;GO:0000781;GO:0000779;GO:0000792;GO:0016604;GO:0000228;GO:0005654;GO:0005634;GO:0005721;GO:0016605;GO:0005524;GO:0003682;GO:0070087;GO:0003677;GO:0003678;GO:0015616;GO:0042393;GO:0046872;GO:0035064;GO:0070615;GO:0072711;GO:0006338;GO:0070192;GO:0030330;GO:0006306;GO:0006281;GO:0006336;GO:0030900;GO:0000212;GO:0035264;GO:0048239;GO:1904908;GO:1901581;GO:0006334;GO:1900051;GO:0010571;GO:0032206;GO:1901582;GO:0045944;GO:0035128;GO:0070198;GO:1900112;GO:0006355;GO:0031297;GO:0072520;GO:0060009;GO:0007283;, C:chromosome, subtelomeric region; C:chromosome, telomeric region; C:condensed chromosome, centromeric region; C:heterochromatin; C:nuclear body; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:PML body;, F:ATP binding; F:chromatin binding; F:chromo shadow domain binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:histone binding; F:metal ion binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:cellular response to hydroxyurea; P:chromatin remodeling; P:chromosome organization involved in meiotic cell cycle; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:DNA repair; P:DNA replication-independent nucleosome assembly; P:forebrain development; P:meiotic spindle organization; P:multicellular organism growth; P:negative regulation of DNA recombination at telomere; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; P:negative regulation of telomeric RNA transcription from RNA pol II promoter; P:nucleosome assembly; P:positive regulation of histone exchange; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of telomere maintenance; P:positive regulation of telomeric RNA transcription from RNA pol II promoter; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic forelimb morphogenesis; P:protein localization to chromosome, telomeric region; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription, DNA-templated; P:replication fork processing; P:seminiferous tubule development; P:Sertoli cell development; P:spermatogenesis; scaffold117 indexed_genome mRNA 230153 292913 . + . ID=transcript_13527;Q9H0Z1 Q9NTS3,Transcriptional regulator ATRX,ATP-dependent helicase ATRX;X-linked helicase II;X-linked nuclear protein;Znf-HX;, PF17981;PF00271;PF00176;, GO:0099115;GO:0000781;GO:0000779;GO:0000792;GO:0016604;GO:0000228;GO:0005654;GO:0005634;GO:0005721;GO:0016605;GO:0005524;GO:0003682;GO:0070087;GO:0003677;GO:0003678;GO:0015616;GO:0042393;GO:0046872;GO:0035064;GO:0070615;GO:0072711;GO:0006338;GO:0070192;GO:0030330;GO:0006306;GO:0006281;GO:0006336;GO:0030900;GO:0000212;GO:0035264;GO:0048239;GO:1904908;GO:1901581;GO:0006334;GO:1900051;GO:0010571;GO:0032206;GO:1901582;GO:0045944;GO:0035128;GO:0070198;GO:1900112;GO:0006355;GO:0031297;GO:0072520;GO:0060009;GO:0007283;, C:chromosome, subtelomeric region; C:chromosome, telomeric region; C:condensed chromosome, centromeric region; C:heterochromatin; C:nuclear body; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:PML body;, F:ATP binding; F:chromatin binding; F:chromo shadow domain binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:histone binding; F:metal ion binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:cellular response to hydroxyurea; P:chromatin remodeling; P:chromosome organization involved in meiotic cell cycle; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:DNA repair; P:DNA replication-independent nucleosome assembly; P:forebrain development; P:meiotic spindle organization; P:multicellular organism growth; P:negative regulation of DNA recombination at telomere; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; P:negative regulation of telomeric RNA transcription from RNA pol II promoter; P:nucleosome assembly; P:positive regulation of histone exchange; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of telomere maintenance; P:positive regulation of telomeric RNA transcription from RNA pol II promoter; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic forelimb morphogenesis; P:protein localization to chromosome, telomeric region; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription, DNA-templated; P:replication fork processing; P:seminiferous tubule development; P:Sertoli cell development; P:spermatogenesis;|Q9H0Z1 Q9NTS3,Transcriptional regulator ATRX,ATP-dependent helicase ATRX;X-linked helicase II;X-linked nuclear protein;Znf-HX;, PF17981;PF00271;PF00176;, GO:0099115;GO:0000781;GO:0000779;GO:0000792;GO:0016604;GO:0000228;GO:0005654;GO:0005634;GO:0005721;GO:0016605;GO:0005524;GO:0003682;GO:0070087;GO:0003677;GO:0003678;GO:0015616;GO:0042393;GO:0046872;GO:0035064;GO:0070615;GO:0072711;GO:0006338;GO:0070192;GO:0030330;GO:0006306;GO:0006281;GO:0006336;GO:0030900;GO:0000212;GO:0035264;GO:0048239;GO:1904908;GO:1901581;GO:0006334;GO:1900051;GO:0010571;GO:0032206;GO:1901582;GO:0045944;GO:0035128;GO:0070198;GO:1900112;GO:0006355;GO:0031297;GO:0072520;GO:0060009;GO:0007283;, C:chromosome, subtelomeric region; C:chromosome, telomeric region; C:condensed chromosome, centromeric region; C:heterochromatin; C:nuclear body; C:nuclear chromosome; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:PML body;, F:ATP binding; F:chromatin binding; F:chromo shadow domain binding; F:DNA binding; F:DNA helicase activity; F:DNA translocase activity; F:histone binding; F:metal ion binding; F:methylated histone binding; F:nucleosome-dependent ATPase activity;, P:cellular response to hydroxyurea; P:chromatin remodeling; P:chromosome organization involved in meiotic cell cycle; P:DNA damage response, signal transduction by p53 class mediator; P:DNA methylation; P:DNA repair; P:DNA replication-independent nucleosome assembly; P:forebrain development; P:meiotic spindle organization; P:multicellular organism growth; P:negative regulation of DNA recombination at telomere; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; P:negative regulation of telomeric RNA transcription from RNA pol II promoter; P:nucleosome assembly; P:positive regulation of histone exchange; P:positive regulation of nuclear cell cycle DNA replication; P:positive regulation of telomere maintenance; P:positive regulation of telomeric RNA transcription from RNA pol II promoter; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic forelimb morphogenesis; P:protein localization to chromosome, telomeric region; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription, DNA-templated; P:replication fork processing; P:seminiferous tubule development; P:Sertoli cell development; P:spermatogenesis; scaffold117 indexed_genome mRNA 313289 316238 . - . ID=transcript_13528;O43320,Fibroblast growth factor 16,, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0009887;GO:0030154;GO:0007267;GO:0008543;GO:0000165;GO:0070349;GO:0008284;GO:2000546;GO:0010628;GO:0051897;GO:0001934;GO:0030334;GO:0009266;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:positive regulation of brown fat cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of gene expression; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:regulation of cell migration; P:response to temperature stimulus; P:signal transduction; scaffold117 indexed_genome mRNA 321329 322787 . + . ID=transcript_13529;O43320,Fibroblast growth factor 16,, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0009887;GO:0030154;GO:0007267;GO:0008543;GO:0000165;GO:0070349;GO:0008284;GO:2000546;GO:0010628;GO:0051897;GO:0001934;GO:0030334;GO:0009266;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:positive regulation of brown fat cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell chemotaxis to fibroblast growth factor; P:positive regulation of gene expression; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:regulation of cell migration; P:response to temperature stimulus; P:signal transduction; scaffold117 indexed_genome mRNA 995948 1002453 . - . ID=transcript_13530;Q9BVG4,Protein PBDC1,Polysaccharide biosynthesis domain-containing protein 1;, PF04669; scaffold117 indexed_genome mRNA 1074712 1077264 . + . ID=transcript_13531;Q8TD90 Q5JSI5,Melanoma-associated antigen E2,Hepatocellular carcinoma-associated protein 3;MAGE-E2 antigen;, PF01454; scaffold117 indexed_genome mRNA 1249570 1386586 . + . ID=transcript_13532;Q96MV8 B3KVG7 Q3SY30 Q6UWH3,Palmitoyltransferase ZDHHC15 {ECO:0000305},Acyltransferase ZDHHC15 {ECO:0000250|UniProtKB:Q8BGJ0};Zinc finger DHHC domain-containing protein 15;, PF01529;, GO:0005783;GO:0005794;GO:0000139;GO:0030173;GO:0098794;GO:0014069;GO:0016409;GO:0019705;GO:0019706;GO:0140439;GO:0008270;GO:0018230;GO:1900006;GO:0072657;GO:0062237;GO:0018345;GO:0140450;GO:0006612;GO:0061001;GO:0016188;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:postsynapse; C:postsynaptic density;, F:palmitoyltransferase activity; F:protein-cysteine S-myristoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity; F:protein-cysteine S-stearoyltransferase activity; F:zinc ion binding;, P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of dendrite development; P:protein localization to membrane; P:protein localization to postsynapse; P:protein palmitoylation; P:protein targeting to Golgi apparatus; P:protein targeting to membrane; P:regulation of dendritic spine morphogenesis; P:synaptic vesicle maturation; scaffold117 indexed_genome mRNA 1444762 1475397 . - . ID=transcript_13533;Q96BW1 Q5JRL1 Q5JRL3 Q68DN0 Q96MW2,Uracil phosphoribosyltransferase homolog,, , GO:0005829;GO:0043231;GO:0005654;GO:0005525;GO:0016301;GO:0007565;GO:0007595;GO:0009116;GO:0032868;GO:0006222;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:GTP binding; F:kinase activity;, P:female pregnancy; P:lactation; P:nucleoside metabolic process; P:response to insulin; P:UMP biosynthetic process; scaffold117 indexed_genome mRNA 1580112 1718987 . + . ID=transcript_13534;O75027 G3XAC4 O75345 Q5VWY7 Q5VWY8 Q9BRE1 Q9UND1 Q9UP01,ATP-binding cassette sub-family B member 7, mitochondrial,ATP-binding cassette transporter 7;, PF00664;PF00005;, GO:0016021;GO:0005743;GO:0005524;GO:0016887;GO:0042626;GO:0015232;GO:0006879;GO:0055085;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:heme transmembrane transporter activity;, P:cellular iron ion homeostasis; P:transmembrane transport;|O75027 G3XAC4 O75345 Q5VWY7 Q5VWY8 Q9BRE1 Q9UND1 Q9UP01,ATP-binding cassette sub-family B member 7, mitochondrial,ATP-binding cassette transporter 7;, PF00664;PF00005;, GO:0016021;GO:0005743;GO:0005524;GO:0016887;GO:0042626;GO:0015232;GO:0006879;GO:0055085;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:heme transmembrane transporter activity;, P:cellular iron ion homeostasis; P:transmembrane transport;|O75027 G3XAC4 O75345 Q5VWY7 Q5VWY8 Q9BRE1 Q9UND1 Q9UP01,ATP-binding cassette sub-family B member 7, mitochondrial,ATP-binding cassette transporter 7;, PF00664;PF00005;, GO:0016021;GO:0005743;GO:0005524;GO:0016887;GO:0042626;GO:0015232;GO:0006879;GO:0055085;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:heme transmembrane transporter activity;, P:cellular iron ion homeostasis; P:transmembrane transport;|O75027 G3XAC4 O75345 Q5VWY7 Q5VWY8 Q9BRE1 Q9UND1 Q9UP01,ATP-binding cassette sub-family B member 7, mitochondrial,ATP-binding cassette transporter 7;, PF00664;PF00005;, GO:0016021;GO:0005743;GO:0005524;GO:0016887;GO:0042626;GO:0015232;GO:0006879;GO:0055085;, C:integral component of membrane; C:mitochondrial inner membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:heme transmembrane transporter activity;, P:cellular iron ion homeostasis; P:transmembrane transport; scaffold117 indexed_genome mRNA 1997176 1998258 . - . ID=transcript_13535;Q5QGS0 A7YY87 Q5JUX9 Q8IVE9,Neurite extension and migration factor {ECO:0000305},XLMR protein related to neurite extension {ECO:0000303|PubMed:24071057};, PF15735;, GO:0005829;GO:0030496;GO:0072686;GO:0005654;GO:0005634;GO:0033629;GO:2000048;GO:0001953;GO:2001223;GO:0007399;, C:cytosol; C:midbody; C:mitotic spindle; C:nucleoplasm; C:nucleus;, , P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron migration; P:nervous system development; scaffold117 indexed_genome mRNA 1999607 2001754 . - . ID=transcript_13536;Q5QGS0 A7YY87 Q5JUX9 Q8IVE9,Neurite extension and migration factor {ECO:0000305},XLMR protein related to neurite extension {ECO:0000303|PubMed:24071057};, PF15735;, GO:0005829;GO:0030496;GO:0072686;GO:0005654;GO:0005634;GO:0033629;GO:2000048;GO:0001953;GO:2001223;GO:0007399;, C:cytosol; C:midbody; C:mitotic spindle; C:nucleoplasm; C:nucleus;, , P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron migration; P:nervous system development; scaffold117 indexed_genome mRNA 2001773 2003296 . - . ID=transcript_13537;Q5QGS0 A7YY87 Q5JUX9 Q8IVE9,Neurite extension and migration factor {ECO:0000305},XLMR protein related to neurite extension {ECO:0000303|PubMed:24071057};, PF15735;, GO:0005829;GO:0030496;GO:0072686;GO:0005654;GO:0005634;GO:0033629;GO:2000048;GO:0001953;GO:2001223;GO:0007399;, C:cytosol; C:midbody; C:mitotic spindle; C:nucleoplasm; C:nucleus;, , P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron migration; P:nervous system development; scaffold117 indexed_genome mRNA 2095330 2114883 . + . ID=transcript_13538;Q9NVW2 B2RBQ1 D3DTE0 Q96D38 Q9Y598,E3 ubiquitin-protein ligase RLIM,LIM domain-interacting RING finger protein;RING finger LIM domain-binding protein;RING finger protein 12;RING-type E3 ubiquitin transferase RLIM {ECO:0000305};Renal carcinoma antigen NY-REN-43;, PF13639;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0017053;GO:0046872;GO:0003714;GO:0061630;GO:0004842;GO:0043433;GO:0000122;GO:0045892;GO:0000209;GO:0016567;GO:0060816;GO:1900095;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:metal ion binding; F:transcription corepressor activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:protein polyubiquitination; P:protein ubiquitination; P:random inactivation of X chromosome; P:regulation of dosage compensation by inactivation of X chromosome; P:ubiquitin-dependent protein catabolic process; scaffold117 indexed_genome mRNA 2145759 2272078 . - . ID=transcript_13539;P36021 Q7Z797,Monocarboxylate transporter 8,Monocarboxylate transporter 7;Solute carrier family 16 member 2;X-linked PEST-containing transporter;, PF07690;, GO:0016324;GO:0016021;GO:0005887;GO:0005886;GO:0015171;GO:0008028;GO:0015293;GO:0015349;GO:0005215;GO:0089718;GO:0006520;GO:0015718;GO:2000178;GO:0043252;GO:0042403;GO:0070327;GO:0150104;, C:apical plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:monocarboxylic acid transmembrane transporter activity; F:symporter activity; F:thyroid hormone transmembrane transporter activity; F:transporter activity;, P:amino acid import across plasma membrane; P:cellular amino acid metabolic process; P:monocarboxylic acid transport; P:negative regulation of neural precursor cell proliferation; P:sodium-independent organic anion transport; P:thyroid hormone metabolic process; P:thyroid hormone transport; P:transport across blood-brain barrier; scaffold117 indexed_genome mRNA 2921040 2957663 . - . ID=transcript_13540;Q5VXU3 A0PJZ2 B0QZ87 B9EGS5 Q5CZ84,Cysteine-rich hydrophobic domain-containing protein 1,Brain X-linked protein;, PF10256;, GO:0031410;GO:0005886;, C:cytoplasmic vesicle; C:plasma membrane;|Q5VXU3 A0PJZ2 B0QZ87 B9EGS5 Q5CZ84,Cysteine-rich hydrophobic domain-containing protein 1,Brain X-linked protein;, PF10256;, GO:0031410;GO:0005886;, C:cytoplasmic vesicle; C:plasma membrane; scaffold117 indexed_genome mRNA 3105344 3107368 . + . ID=transcript_13541;Q9ULW6 B2RE61 B4E161 Q8TAN6,Nucleosome assembly protein 1-like 2,Brain-specific protein, X-linked;, PF00956;, GO:0000785;GO:0005634;GO:0003682;GO:0042393;GO:0006334;GO:0071442;GO:2000617;GO:0045666;GO:2000035;, C:chromatin; C:nucleus;, F:chromatin binding; F:histone binding;, P:nucleosome assembly; P:positive regulation of histone H3-K14 acetylation; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of neuron differentiation; P:regulation of stem cell division; scaffold118 indexed_genome mRNA 395616 400770 . - . ID=transcript_13542;P68104 P04719 P04720 Q6IQ15,Elongation factor 1-alpha 1,Elongation factor Tu;Eukaryotic elongation factor 1 A-1;Leukocyte receptor cluster member 7;, PF00009;PF03144;PF03143;, GO:0030864;GO:0005737;GO:0098574;GO:0005829;GO:0005853;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0016020;GO:0005730;GO:0005634;GO:0005886;GO:0032587;GO:0034774;GO:0005516;GO:0005525;GO:0003924;GO:0019900;GO:0019901;GO:0003723;GO:0003746;GO:0000049;GO:0071364;GO:0043312;GO:1904714;GO:1900022;GO:0006412;GO:0006414;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of lysosomal membrane; C:cytosol; C:eukaryotic translation elongation factor 1 complex; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:membrane; C:nucleolus; C:nucleus; C:plasma membrane; C:ruffle membrane; C:secretory granule lumen;, F:calmodulin binding; F:GTP binding; F:GTPase activity; F:kinase binding; F:protein kinase binding; F:RNA binding; F:translation elongation factor activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:neutrophil degranulation; P:regulation of chaperone-mediated autophagy; P:regulation of D-erythro-sphingosine kinase activity; P:translation; P:translational elongation; scaffold118 indexed_genome mRNA 400998 401569 . - . ID=transcript_13543;Q6PK88 Q86T40 Q86TB2 Q8N3W0 Q8TAY9 Q9HCP2 Q9HCP3 Q9HCP4 Q9HCP5,Myomegalin,Cardiomyopathy-associated protein 2;Phosphodiesterase 4D-interacting protein;, PF07989;PF06758;, GO:0005813;GO:0005737;GO:0005794;GO:0030016;GO:0005634;GO:0019899;GO:0060090;GO:0030953;GO:0034622;GO:0090063;GO:1903358;, C:centrosome; C:cytoplasm; C:Golgi apparatus; C:myofibril; C:nucleus;, F:enzyme binding; F:molecular adaptor activity;, P:astral microtubule organization; P:cellular protein-containing complex assembly; P:positive regulation of microtubule nucleation; P:regulation of Golgi organization; scaffold118 indexed_genome mRNA 441094 449065 . + . ID=transcript_13544;P12314 P12315 Q5QNW7 Q92495 Q92663,High affinity immunoglobulin gamma Fc receptor I,Fc-gamma RI;Fc-gamma RIA;, PF00047;PF13895;, GO:0030669;GO:0031901;GO:0005887;GO:0005886;GO:0019864;GO:0004888;GO:0002479;GO:0007166;GO:0038096;GO:0006955;GO:0060333;GO:0002862;GO:0006911;GO:0061098;GO:0006898;GO:0050776;GO:0007165;, C:clathrin-coated endocytic vesicle membrane; C:early endosome membrane; C:integral component of plasma membrane; C:plasma membrane;, F:IgG binding; F:transmembrane signaling receptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:cell surface receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:phagocytosis, engulfment; P:positive regulation of protein tyrosine kinase activity; P:receptor-mediated endocytosis; P:regulation of immune response; P:signal transduction; scaffold118 indexed_genome mRNA 505373 505909 . + . ID=transcript_13545;Q6FI13 B2R5F0 P20670,Histone H2A type 2-A,H2A-clustered histone 18 {ECO:0000312|HGNC:HGNC:4736};H2A-clustered histone 19 {ECO:0000312|HGNC:HGNC:29668};Histone H2A.2;Histone H2A/o;, PF00125;PF16211;, GO:0070062;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006342;, C:extracellular exosome; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:chromatin silencing; scaffold118 indexed_genome mRNA 523825 538802 . + . ID=transcript_13546;P23527 Q3KPI7 Q8TCV6,Histone H2B type 1-O,H2B-clustered histone 17 {ECO:0000312|HGNC:HGNC:4758};Histone H2B.2;Histone H2B.n;, PF00125;, GO:0005829;GO:0005654;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006334;GO:0016567;, C:cytosol; C:nucleoplasm; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:nucleosome assembly; P:protein ubiquitination;|Q16777 Q6DRA7 Q8IUE5,Histone H2A type 2-C,H2A-clustered histone 20 {ECO:0000312|HGNC:HGNC:4738};Histone H2A-GL101;Histone H2A/q;, PF00125;PF16211;, GO:0070062;GO:0000786;GO:0005634;GO:0003677;GO:0046982;GO:0006342;, C:extracellular exosome; C:nucleosome; C:nucleus;, F:DNA binding; F:protein heterodimerization activity;, P:chromatin silencing;|Q9Y3E2 B2R7K2 D3DUZ4 Q5QNY0,BolA-like protein 1 {ECO:0000305},hBolA {ECO:0000303|PubMed:18548201};, PF01722;, GO:0005739;, C:mitochondrion;|Q9Y3E2 B2R7K2 D3DUZ4 Q5QNY0,BolA-like protein 1 {ECO:0000305},hBolA {ECO:0000303|PubMed:18548201};, PF01722;, GO:0005739;, C:mitochondrion; scaffold118 indexed_genome mRNA 539484 553257 . - . ID=transcript_13547;Q7L0J3 D3DUZ7 O94841 Q5QNX8 Q7Z3L6 Q8NBJ6 Q9BVZ9,Synaptic vesicle glycoprotein 2A,, PF07690;PF00083;, GO:0005911;GO:0030425;GO:0005783;GO:0098982;GO:0098978;GO:0016021;GO:0030285;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0048786;GO:0008021;GO:0030672;GO:0019901;GO:0022857;GO:0006874;GO:0014052;GO:0016082;, C:cell-cell junction; C:dendrite; C:endoplasmic reticulum; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle; C:synaptic vesicle membrane;, F:protein kinase binding; F:transmembrane transporter activity;, P:cellular calcium ion homeostasis; P:regulation of gamma-aminobutyric acid secretion; P:synaptic vesicle priming;|Q7L0J3 D3DUZ7 O94841 Q5QNX8 Q7Z3L6 Q8NBJ6 Q9BVZ9,Synaptic vesicle glycoprotein 2A,, PF07690;PF00083;, GO:0005911;GO:0030425;GO:0005783;GO:0098982;GO:0098978;GO:0016021;GO:0030285;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0048786;GO:0008021;GO:0030672;GO:0019901;GO:0022857;GO:0006874;GO:0014052;GO:0016082;, C:cell-cell junction; C:dendrite; C:endoplasmic reticulum; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle; C:synaptic vesicle membrane;, F:protein kinase binding; F:transmembrane transporter activity;, P:cellular calcium ion homeostasis; P:regulation of gamma-aminobutyric acid secretion; P:synaptic vesicle priming;|Q7L0J3 D3DUZ7 O94841 Q5QNX8 Q7Z3L6 Q8NBJ6 Q9BVZ9,Synaptic vesicle glycoprotein 2A,, PF07690;PF00083;, GO:0005911;GO:0030425;GO:0005783;GO:0098982;GO:0098978;GO:0016021;GO:0030285;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0048786;GO:0008021;GO:0030672;GO:0019901;GO:0022857;GO:0006874;GO:0014052;GO:0016082;, C:cell-cell junction; C:dendrite; C:endoplasmic reticulum; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle; C:synaptic vesicle membrane;, F:protein kinase binding; F:transmembrane transporter activity;, P:cellular calcium ion homeostasis; P:regulation of gamma-aminobutyric acid secretion; P:synaptic vesicle priming;|Q7L0J3 D3DUZ7 O94841 Q5QNX8 Q7Z3L6 Q8NBJ6 Q9BVZ9,Synaptic vesicle glycoprotein 2A,, PF07690;PF00083;, GO:0005911;GO:0030425;GO:0005783;GO:0098982;GO:0098978;GO:0016021;GO:0030285;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0048786;GO:0008021;GO:0030672;GO:0019901;GO:0022857;GO:0006874;GO:0014052;GO:0016082;, C:cell-cell junction; C:dendrite; C:endoplasmic reticulum; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle; C:synaptic vesicle membrane;, F:protein kinase binding; F:transmembrane transporter activity;, P:cellular calcium ion homeostasis; P:regulation of gamma-aminobutyric acid secretion; P:synaptic vesicle priming;|Q7L0J3 D3DUZ7 O94841 Q5QNX8 Q7Z3L6 Q8NBJ6 Q9BVZ9,Synaptic vesicle glycoprotein 2A,, PF07690;PF00083;, GO:0005911;GO:0030425;GO:0005783;GO:0098982;GO:0098978;GO:0016021;GO:0030285;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0048786;GO:0008021;GO:0030672;GO:0019901;GO:0022857;GO:0006874;GO:0014052;GO:0016082;, C:cell-cell junction; C:dendrite; C:endoplasmic reticulum; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle; C:synaptic vesicle membrane;, F:protein kinase binding; F:transmembrane transporter activity;, P:cellular calcium ion homeostasis; P:regulation of gamma-aminobutyric acid secretion; P:synaptic vesicle priming;|Q7L0J3 D3DUZ7 O94841 Q5QNX8 Q7Z3L6 Q8NBJ6 Q9BVZ9,Synaptic vesicle glycoprotein 2A,, PF07690;PF00083;, GO:0005911;GO:0030425;GO:0005783;GO:0098982;GO:0098978;GO:0016021;GO:0030285;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0048786;GO:0008021;GO:0030672;GO:0019901;GO:0022857;GO:0006874;GO:0014052;GO:0016082;, C:cell-cell junction; C:dendrite; C:endoplasmic reticulum; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle; C:synaptic vesicle membrane;, F:protein kinase binding; F:transmembrane transporter activity;, P:cellular calcium ion homeostasis; P:regulation of gamma-aminobutyric acid secretion; P:synaptic vesicle priming;|Q7L0J3 D3DUZ7 O94841 Q5QNX8 Q7Z3L6 Q8NBJ6 Q9BVZ9,Synaptic vesicle glycoprotein 2A,, PF07690;PF00083;, GO:0005911;GO:0030425;GO:0005783;GO:0098982;GO:0098978;GO:0016021;GO:0030285;GO:0031594;GO:0043005;GO:0043025;GO:0005886;GO:0048786;GO:0008021;GO:0030672;GO:0019901;GO:0022857;GO:0006874;GO:0014052;GO:0016082;, C:cell-cell junction; C:dendrite; C:endoplasmic reticulum; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle; C:synaptic vesicle membrane;, F:protein kinase binding; F:transmembrane transporter activity;, P:cellular calcium ion homeostasis; P:regulation of gamma-aminobutyric acid secretion; P:synaptic vesicle priming; scaffold118 indexed_genome mRNA 566249 568170 . - . ID=transcript_13548;Q15427 Q5SZ63,Splicing factor 3B subunit 4,Pre-mRNA-splicing factor SF3b 49 kDa subunit;Spliceosome-associated protein 49;, PF00076;, GO:0005730;GO:0005654;GO:0005634;GO:0005681;GO:0005689;GO:0071005;GO:0003723;GO:1990935;GO:0006397;GO:0000398;GO:0048026;GO:0008380;GO:0000375;, C:nucleolus; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:RNA binding; F:splicing factor binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:positive regulation of mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold118 indexed_genome mRNA 569013 577944 . - . ID=transcript_13549;Q99753,Myotubularin-related protein 11,Cisplatin resistance-associated protein;Inactive phosphatidylinositol 3-phosphatase 11 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0070062;GO:0004438;GO:0046856;, C:cytoplasm; C:extracellular exosome;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation;|Q99753,Myotubularin-related protein 11,Cisplatin resistance-associated protein;Inactive phosphatidylinositol 3-phosphatase 11 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0070062;GO:0004438;GO:0046856;, C:cytoplasm; C:extracellular exosome;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation;|Q99753,Myotubularin-related protein 11,Cisplatin resistance-associated protein;Inactive phosphatidylinositol 3-phosphatase 11 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0070062;GO:0004438;GO:0046856;, C:cytoplasm; C:extracellular exosome;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation;|Q99753,Myotubularin-related protein 11,Cisplatin resistance-associated protein;Inactive phosphatidylinositol 3-phosphatase 11 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0070062;GO:0004438;GO:0046856;, C:cytoplasm; C:extracellular exosome;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation;|Q99753,Myotubularin-related protein 11,Cisplatin resistance-associated protein;Inactive phosphatidylinositol 3-phosphatase 11 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0070062;GO:0004438;GO:0046856;, C:cytoplasm; C:extracellular exosome;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation;|Q99753,Myotubularin-related protein 11,Cisplatin resistance-associated protein;Inactive phosphatidylinositol 3-phosphatase 11 {ECO:0000305};, PF12578;PF06602;, GO:0005737;GO:0070062;GO:0004438;GO:0046856;, C:cytoplasm; C:extracellular exosome;, F:phosphatidylinositol-3-phosphatase activity;, P:phosphatidylinositol dephosphorylation; scaffold118 indexed_genome mRNA 582525 637160 . - . ID=transcript_13550;Q6GQQ9 B7Z643 D3DUZ8 Q5SZ60 Q8WWA7 Q9NQ53 Q9UFF4,OTU domain-containing protein 7B,Cellular zinc finger anti-NF-kappa-B protein {ECO:0000303|PubMed:11463333};Zinc finger A20 domain-containing protein 1;Zinc finger protein Cezanne {ECO:0000305};, PF02338;PF01754;, GO:0005737;GO:0005829;GO:0005634;GO:0008234;GO:0003677;GO:0070530;GO:1990380;GO:0004843;GO:0008270;GO:0002250;GO:0001701;GO:0002385;GO:0043124;GO:0032717;GO:1900181;GO:0000122;GO:0016579;GO:0071947;GO:0035871;GO:0071108;GO:0070536;, C:cytoplasm; C:cytosol; C:nucleus;, F:cysteine-type peptidase activity; F:DNA binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:adaptive immune response; P:in utero embryonic development; P:mucosal immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production; P:negative regulation of protein localization to nucleus; P:negative regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein K11-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination;|Q6GQQ9 B7Z643 D3DUZ8 Q5SZ60 Q8WWA7 Q9NQ53 Q9UFF4,OTU domain-containing protein 7B,Cellular zinc finger anti-NF-kappa-B protein {ECO:0000303|PubMed:11463333};Zinc finger A20 domain-containing protein 1;Zinc finger protein Cezanne {ECO:0000305};, PF02338;PF01754;, GO:0005737;GO:0005829;GO:0005634;GO:0008234;GO:0003677;GO:0070530;GO:1990380;GO:0004843;GO:0008270;GO:0002250;GO:0001701;GO:0002385;GO:0043124;GO:0032717;GO:1900181;GO:0000122;GO:0016579;GO:0071947;GO:0035871;GO:0071108;GO:0070536;, C:cytoplasm; C:cytosol; C:nucleus;, F:cysteine-type peptidase activity; F:DNA binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:adaptive immune response; P:in utero embryonic development; P:mucosal immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production; P:negative regulation of protein localization to nucleus; P:negative regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein K11-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination;|Q6GQQ9 B7Z643 D3DUZ8 Q5SZ60 Q8WWA7 Q9NQ53 Q9UFF4,OTU domain-containing protein 7B,Cellular zinc finger anti-NF-kappa-B protein {ECO:0000303|PubMed:11463333};Zinc finger A20 domain-containing protein 1;Zinc finger protein Cezanne {ECO:0000305};, PF02338;PF01754;, GO:0005737;GO:0005829;GO:0005634;GO:0008234;GO:0003677;GO:0070530;GO:1990380;GO:0004843;GO:0008270;GO:0002250;GO:0001701;GO:0002385;GO:0043124;GO:0032717;GO:1900181;GO:0000122;GO:0016579;GO:0071947;GO:0035871;GO:0071108;GO:0070536;, C:cytoplasm; C:cytosol; C:nucleus;, F:cysteine-type peptidase activity; F:DNA binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:adaptive immune response; P:in utero embryonic development; P:mucosal immune response; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-8 production; P:negative regulation of protein localization to nucleus; P:negative regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; P:protein K11-linked deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; scaffold118 indexed_genome mRNA 696317 761146 . + . ID=transcript_13551;Q9NRW7 D3DUZ9 F5H8K1 Q15715 Q53FR8 Q5T4P6 Q9Y4Z6,Vacuolar protein sorting-associated protein 45,, PF00995;, GO:0010008;GO:0005794;GO:0000139;GO:0016021;GO:0007596;GO:0006886;GO:0016192;, C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:blood coagulation; P:intracellular protein transport; P:vesicle-mediated transport;|Q9NRW7 D3DUZ9 F5H8K1 Q15715 Q53FR8 Q5T4P6 Q9Y4Z6,Vacuolar protein sorting-associated protein 45,, PF00995;, GO:0010008;GO:0005794;GO:0000139;GO:0016021;GO:0007596;GO:0006886;GO:0016192;, C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:blood coagulation; P:intracellular protein transport; P:vesicle-mediated transport;|Q9NRW7 D3DUZ9 F5H8K1 Q15715 Q53FR8 Q5T4P6 Q9Y4Z6,Vacuolar protein sorting-associated protein 45,, PF00995;, GO:0010008;GO:0005794;GO:0000139;GO:0016021;GO:0007596;GO:0006886;GO:0016192;, C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, , P:blood coagulation; P:intracellular protein transport; P:vesicle-mediated transport; scaffold118 indexed_genome mRNA 772135 780110 . - . ID=transcript_13552;Q53GL0 Q336K5 Q8IZ51 Q9NRV3 Q9UL48,Pleckstrin homology domain-containing family O member 1,C-Jun-binding protein;Casein kinase 2-interacting protein 1;Osteoclast maturation-associated gene 120 protein;, PF00169;, GO:0005737;GO:0036195;GO:0005634;GO:0032587;GO:0072673;GO:0007520;GO:0051451;GO:0008360;, C:cytoplasm; C:muscle cell projection membrane; C:nucleus; C:ruffle membrane;, , P:lamellipodium morphogenesis; P:myoblast fusion; P:myoblast migration; P:regulation of cell shape;|Q53GL0 Q336K5 Q8IZ51 Q9NRV3 Q9UL48,Pleckstrin homology domain-containing family O member 1,C-Jun-binding protein;Casein kinase 2-interacting protein 1;Osteoclast maturation-associated gene 120 protein;, PF00169;, GO:0005737;GO:0036195;GO:0005634;GO:0032587;GO:0072673;GO:0007520;GO:0051451;GO:0008360;, C:cytoplasm; C:muscle cell projection membrane; C:nucleus; C:ruffle membrane;, , P:lamellipodium morphogenesis; P:myoblast fusion; P:myoblast migration; P:regulation of cell shape;|Q53GL0 Q336K5 Q8IZ51 Q9NRV3 Q9UL48,Pleckstrin homology domain-containing family O member 1,C-Jun-binding protein;Casein kinase 2-interacting protein 1;Osteoclast maturation-associated gene 120 protein;, PF00169;, GO:0005737;GO:0036195;GO:0005634;GO:0032587;GO:0072673;GO:0007520;GO:0051451;GO:0008360;, C:cytoplasm; C:muscle cell projection membrane; C:nucleus; C:ruffle membrane;, , P:lamellipodium morphogenesis; P:myoblast fusion; P:myoblast migration; P:regulation of cell shape;|Q53GL0 Q336K5 Q8IZ51 Q9NRV3 Q9UL48,Pleckstrin homology domain-containing family O member 1,C-Jun-binding protein;Casein kinase 2-interacting protein 1;Osteoclast maturation-associated gene 120 protein;, PF00169;, GO:0005737;GO:0036195;GO:0005634;GO:0032587;GO:0072673;GO:0007520;GO:0051451;GO:0008360;, C:cytoplasm; C:muscle cell projection membrane; C:nucleus; C:ruffle membrane;, , P:lamellipodium morphogenesis; P:myoblast fusion; P:myoblast migration; P:regulation of cell shape;|Q53GL0 Q336K5 Q8IZ51 Q9NRV3 Q9UL48,Pleckstrin homology domain-containing family O member 1,C-Jun-binding protein;Casein kinase 2-interacting protein 1;Osteoclast maturation-associated gene 120 protein;, PF00169;, GO:0005737;GO:0036195;GO:0005634;GO:0032587;GO:0072673;GO:0007520;GO:0051451;GO:0008360;, C:cytoplasm; C:muscle cell projection membrane; C:nucleus; C:ruffle membrane;, , P:lamellipodium morphogenesis; P:myoblast fusion; P:myoblast migration; P:regulation of cell shape; scaffold118 indexed_genome mRNA 832163 846248 . - . ID=transcript_13553;Q9BTT0 B4E0I6 E9PEA6 Q5TB18 Q5TB20 Q8N1S4 Q8WWW9,Acidic leucine-rich nuclear phosphoprotein 32 family member E,LANP-like protein;, , GO:0031410;GO:0005634;GO:0000812;GO:0042393;GO:0019212;GO:0043486;GO:0042981;, C:cytoplasmic vesicle; C:nucleus; C:Swr1 complex;, F:histone binding; F:phosphatase inhibitor activity;, P:histone exchange; P:regulation of apoptotic process; scaffold118 indexed_genome mRNA 874786 881599 . + . ID=transcript_13554;Q9ULX7 Q5TB24 Q8NCF4,Carbonic anhydrase 14,Carbonate dehydratase XIV;Carbonic anhydrase XIV;, PF00194;, GO:0016021;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;, C:integral component of membrane; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process;|Q9ULX7 Q5TB24 Q8NCF4,Carbonic anhydrase 14,Carbonate dehydratase XIV;Carbonic anhydrase XIV;, PF00194;, GO:0016021;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;, C:integral component of membrane; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process;|Q9ULX7 Q5TB24 Q8NCF4,Carbonic anhydrase 14,Carbonate dehydratase XIV;Carbonic anhydrase XIV;, PF00194;, GO:0016021;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;, C:integral component of membrane; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process;|Q9ULX7 Q5TB24 Q8NCF4,Carbonic anhydrase 14,Carbonate dehydratase XIV;Carbonic anhydrase XIV;, PF00194;, GO:0016021;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;, C:integral component of membrane; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process;|Q9ULX7 Q5TB24 Q8NCF4,Carbonic anhydrase 14,Carbonate dehydratase XIV;Carbonic anhydrase XIV;, PF00194;, GO:0016021;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;, C:integral component of membrane; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process; scaffold118 indexed_genome mRNA 882214 885410 . + . ID=transcript_13555;Q96BI3 B4DQK0 Q5TB22 Q5TB23 Q969R6 Q9BVG0 Q9Y386,Gamma-secretase subunit APH-1A,Aph-1alpha;Presenilin-stabilization factor;, PF06105;, GO:0005769;GO:0005783;GO:0005789;GO:0010008;GO:0070765;GO:0005794;GO:0032580;GO:0016021;GO:0005887;GO:0099056;GO:0016020;GO:0005739;GO:0005886;GO:0008021;GO:0061133;GO:0004175;GO:0019899;GO:0030674;GO:1990000;GO:0042987;GO:0042982;GO:0034205;GO:0048013;GO:0006509;GO:0031293;GO:0001656;GO:0007220;GO:0035333;GO:0007219;GO:0043065;GO:0043085;GO:0010950;GO:0016485;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:synaptic vesicle;, F:endopeptidase activator activity; F:endopeptidase activity; F:enzyme binding; F:protein-macromolecule adaptor activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:ephrin receptor signaling pathway; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:metanephros development; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:Notch signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing;|Q96BI3 B4DQK0 Q5TB22 Q5TB23 Q969R6 Q9BVG0 Q9Y386,Gamma-secretase subunit APH-1A,Aph-1alpha;Presenilin-stabilization factor;, PF06105;, GO:0005769;GO:0005783;GO:0005789;GO:0010008;GO:0070765;GO:0005794;GO:0032580;GO:0016021;GO:0005887;GO:0099056;GO:0016020;GO:0005739;GO:0005886;GO:0008021;GO:0061133;GO:0004175;GO:0019899;GO:0030674;GO:1990000;GO:0042987;GO:0042982;GO:0034205;GO:0048013;GO:0006509;GO:0031293;GO:0001656;GO:0007220;GO:0035333;GO:0007219;GO:0043065;GO:0043085;GO:0010950;GO:0016485;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:synaptic vesicle;, F:endopeptidase activator activity; F:endopeptidase activity; F:enzyme binding; F:protein-macromolecule adaptor activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:ephrin receptor signaling pathway; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:metanephros development; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:Notch signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing;|Q96BI3 B4DQK0 Q5TB22 Q5TB23 Q969R6 Q9BVG0 Q9Y386,Gamma-secretase subunit APH-1A,Aph-1alpha;Presenilin-stabilization factor;, PF06105;, GO:0005769;GO:0005783;GO:0005789;GO:0010008;GO:0070765;GO:0005794;GO:0032580;GO:0016021;GO:0005887;GO:0099056;GO:0016020;GO:0005739;GO:0005886;GO:0008021;GO:0061133;GO:0004175;GO:0019899;GO:0030674;GO:1990000;GO:0042987;GO:0042982;GO:0034205;GO:0048013;GO:0006509;GO:0031293;GO:0001656;GO:0007220;GO:0035333;GO:0007219;GO:0043065;GO:0043085;GO:0010950;GO:0016485;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:membrane; C:mitochondrion; C:plasma membrane; C:synaptic vesicle;, F:endopeptidase activator activity; F:endopeptidase activity; F:enzyme binding; F:protein-macromolecule adaptor activity;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:ephrin receptor signaling pathway; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:metanephros development; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:Notch signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; scaffold118 indexed_genome mRNA 888724 896099 . + . ID=transcript_13556;Q8WWF1 Q9H5P3,Uncharacterized protein C1orf54,, PF15465;, GO:0005576;, C:extracellular region;|Q8WWF1 Q9H5P3,Uncharacterized protein C1orf54,, PF15465;, GO:0005576;, C:extracellular region; scaffold118 indexed_genome mRNA 897870 901293 . + . ID=transcript_13557;Q8N365 B2RD43 D3DV01 Q8N795 Q96MG6,Circadian-associated transcriptional repressor,ChIP-derived repressor of network oscillator;Computationally highlighted repressor of the network oscillator;, PF15673;, GO:0005634;GO:0016605;GO:0070888;GO:0000978;GO:0032922;GO:0045475;GO:0045892;, C:nucleus; C:PML body;, F:E-box binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:locomotor rhythm; P:negative regulation of transcription, DNA-templated; scaffold118 indexed_genome mRNA 906928 919211 . + . ID=transcript_13558;P82921 A0A075B746 Q5TB11 Q9BST6,28S ribosomal protein S21, mitochondrial,Mitochondrial small ribosomal subunit protein bS21m {ECO:0000303|PubMed:25838379};, PF01165;, GO:0005743;GO:0005763;GO:0003723;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold118 indexed_genome mRNA 926515 947373 . + . ID=transcript_13559;O43395 B4DSY9 O43446 Q5VT54,U4/U6 small nuclear ribonucleoprotein Prp3,Pre-mRNA-splicing factor 3;U4/U6 snRNP 90 kDa protein;, PF06544;PF08572;PF01480;, GO:0015030;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0046540;GO:0042802;GO:0003723;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:Cajal body; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:identical protein binding; F:RNA binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|O43395 B4DSY9 O43446 Q5VT54,U4/U6 small nuclear ribonucleoprotein Prp3,Pre-mRNA-splicing factor 3;U4/U6 snRNP 90 kDa protein;, PF06544;PF08572;PF01480;, GO:0015030;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0046540;GO:0042802;GO:0003723;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:Cajal body; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:identical protein binding; F:RNA binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly;|O43395 B4DSY9 O43446 Q5VT54,U4/U6 small nuclear ribonucleoprotein Prp3,Pre-mRNA-splicing factor 3;U4/U6 snRNP 90 kDa protein;, PF06544;PF08572;PF01480;, GO:0015030;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0046540;GO:0042802;GO:0003723;GO:0006397;GO:0000398;GO:0008380;GO:0000375;GO:0000244;, C:Cajal body; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:identical protein binding; F:RNA binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal tri-snRNP complex assembly; scaffold118 indexed_genome mRNA 953610 1034655 . + . ID=transcript_13560;Q9P0D7,Regulation of nuclear pre-mRNA domain-containing protein 2,, PF04818;PF16566;, GO:0005654;GO:0016591;GO:0000993;GO:0031124;GO:0042795;, C:nucleoplasm; C:RNA polymerase II, holoenzyme;, F:RNA polymerase II complex binding;, P:mRNA 3'-end processing; P:snRNA transcription by RNA polymerase II; scaffold118 indexed_genome mRNA 1034805 1040823 . - . ID=transcript_13561;Q9P0D7,Regulation of nuclear pre-mRNA domain-containing protein 2,, PF04818;PF16566;, GO:0005654;GO:0016591;GO:0000993;GO:0031124;GO:0042795;, C:nucleoplasm; C:RNA polymerase II, holoenzyme;, F:RNA polymerase II complex binding;, P:mRNA 3'-end processing; P:snRNA transcription by RNA polymerase II; scaffold118 indexed_genome mRNA 1046856 1066367 . + . ID=transcript_13562;Q9BW92 Q53GW7 Q96I50 Q9H9V2,Threonine--tRNA ligase, mitochondrial,Threonyl-tRNA synthetase;Threonyl-tRNA synthetase-like 1;, PF03129;PF02824;PF00587;PF07973;, GO:0005759;GO:0002161;GO:0005524;GO:0042803;GO:0004829;GO:0070159;GO:0006435;, C:mitochondrial matrix;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:protein homodimerization activity; F:threonine-tRNA ligase activity;, P:mitochondrial threonyl-tRNA aminoacylation; P:threonyl-tRNA aminoacylation;|Q9BW92 Q53GW7 Q96I50 Q9H9V2,Threonine--tRNA ligase, mitochondrial,Threonyl-tRNA synthetase;Threonyl-tRNA synthetase-like 1;, PF03129;PF02824;PF00587;PF07973;, GO:0005759;GO:0002161;GO:0005524;GO:0042803;GO:0004829;GO:0070159;GO:0006435;, C:mitochondrial matrix;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:protein homodimerization activity; F:threonine-tRNA ligase activity;, P:mitochondrial threonyl-tRNA aminoacylation; P:threonyl-tRNA aminoacylation;|Q9BW92 Q53GW7 Q96I50 Q9H9V2,Threonine--tRNA ligase, mitochondrial,Threonyl-tRNA synthetase;Threonyl-tRNA synthetase-like 1;, PF03129;PF02824;PF00587;PF07973;, GO:0005759;GO:0002161;GO:0005524;GO:0042803;GO:0004829;GO:0070159;GO:0006435;, C:mitochondrial matrix;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:protein homodimerization activity; F:threonine-tRNA ligase activity;, P:mitochondrial threonyl-tRNA aminoacylation; P:threonyl-tRNA aminoacylation;|Q9BW92 Q53GW7 Q96I50 Q9H9V2,Threonine--tRNA ligase, mitochondrial,Threonyl-tRNA synthetase;Threonyl-tRNA synthetase-like 1;, PF03129;PF02824;PF00587;PF07973;, GO:0005759;GO:0002161;GO:0005524;GO:0042803;GO:0004829;GO:0070159;GO:0006435;, C:mitochondrial matrix;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:protein homodimerization activity; F:threonine-tRNA ligase activity;, P:mitochondrial threonyl-tRNA aminoacylation; P:threonyl-tRNA aminoacylation;|Q9BW92 Q53GW7 Q96I50 Q9H9V2,Threonine--tRNA ligase, mitochondrial,Threonyl-tRNA synthetase;Threonyl-tRNA synthetase-like 1;, PF03129;PF02824;PF00587;PF07973;, GO:0005759;GO:0002161;GO:0005524;GO:0042803;GO:0004829;GO:0070159;GO:0006435;, C:mitochondrial matrix;, F:aminoacyl-tRNA editing activity; F:ATP binding; F:protein homodimerization activity; F:threonine-tRNA ligase activity;, P:mitochondrial threonyl-tRNA aminoacylation; P:threonyl-tRNA aminoacylation;|Q16610 A8K8S0 B4DW49 B4DY60 O43266 Q5T5G4 Q5T5G5 Q5T5G6 Q8IZ60,Extracellular matrix protein 1,Secretory component p85;, PF05782;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031089;GO:0019899;GO:0005134;GO:0043236;GO:0002020;GO:0008022;GO:0001525;GO:0031214;GO:0002063;GO:0003416;GO:0006954;GO:0030502;GO:0001960;GO:0010466;GO:0001503;GO:0002576;GO:0045766;GO:0001938;GO:0043123;GO:0030500;GO:2000404;GO:0006357;GO:0002828;GO:0007165;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet dense granule lumen;, F:enzyme binding; F:interleukin-2 receptor binding; F:laminin binding; F:protease binding; F:protein C-terminus binding;, P:angiogenesis; P:biomineral tissue development; P:chondrocyte development; P:endochondral bone growth; P:inflammatory response; P:negative regulation of bone mineralization; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of peptidase activity; P:ossification; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of bone mineralization; P:regulation of T cell migration; P:regulation of transcription by RNA polymerase II; P:regulation of type 2 immune response; P:signal transduction;|Q16610 A8K8S0 B4DW49 B4DY60 O43266 Q5T5G4 Q5T5G5 Q5T5G6 Q8IZ60,Extracellular matrix protein 1,Secretory component p85;, PF05782;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031089;GO:0019899;GO:0005134;GO:0043236;GO:0002020;GO:0008022;GO:0001525;GO:0031214;GO:0002063;GO:0003416;GO:0006954;GO:0030502;GO:0001960;GO:0010466;GO:0001503;GO:0002576;GO:0045766;GO:0001938;GO:0043123;GO:0030500;GO:2000404;GO:0006357;GO:0002828;GO:0007165;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet dense granule lumen;, F:enzyme binding; F:interleukin-2 receptor binding; F:laminin binding; F:protease binding; F:protein C-terminus binding;, P:angiogenesis; P:biomineral tissue development; P:chondrocyte development; P:endochondral bone growth; P:inflammatory response; P:negative regulation of bone mineralization; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of peptidase activity; P:ossification; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of bone mineralization; P:regulation of T cell migration; P:regulation of transcription by RNA polymerase II; P:regulation of type 2 immune response; P:signal transduction;|Q16610 A8K8S0 B4DW49 B4DY60 O43266 Q5T5G4 Q5T5G5 Q5T5G6 Q8IZ60,Extracellular matrix protein 1,Secretory component p85;, PF05782;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031089;GO:0019899;GO:0005134;GO:0043236;GO:0002020;GO:0008022;GO:0001525;GO:0031214;GO:0002063;GO:0003416;GO:0006954;GO:0030502;GO:0001960;GO:0010466;GO:0001503;GO:0002576;GO:0045766;GO:0001938;GO:0043123;GO:0030500;GO:2000404;GO:0006357;GO:0002828;GO:0007165;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet dense granule lumen;, F:enzyme binding; F:interleukin-2 receptor binding; F:laminin binding; F:protease binding; F:protein C-terminus binding;, P:angiogenesis; P:biomineral tissue development; P:chondrocyte development; P:endochondral bone growth; P:inflammatory response; P:negative regulation of bone mineralization; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of peptidase activity; P:ossification; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of bone mineralization; P:regulation of T cell migration; P:regulation of transcription by RNA polymerase II; P:regulation of type 2 immune response; P:signal transduction; scaffold118 indexed_genome mRNA 1095452 1104601 . + . ID=transcript_13563;Q6UY14 B2RTT0 F8WAD0 Q5T5F7 Q6IPM6 Q8N643 Q9HBS6,ADAMTS-like protein 4,Thrombospondin repeat-containing protein 1;, PF05986;PF08686;PF00090;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005614;GO:0042802;GO:0004222;GO:0002020;GO:0006915;GO:0002064;GO:0030198;GO:0043065;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:interstitial matrix;, F:identical protein binding; F:metalloendopeptidase activity; F:protease binding;, P:apoptotic process; P:epithelial cell development; P:extracellular matrix organization; P:positive regulation of apoptotic process;|Q6UY14 B2RTT0 F8WAD0 Q5T5F7 Q6IPM6 Q8N643 Q9HBS6,ADAMTS-like protein 4,Thrombospondin repeat-containing protein 1;, PF05986;PF08686;PF00090;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005614;GO:0042802;GO:0004222;GO:0002020;GO:0006915;GO:0002064;GO:0030198;GO:0043065;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:interstitial matrix;, F:identical protein binding; F:metalloendopeptidase activity; F:protease binding;, P:apoptotic process; P:epithelial cell development; P:extracellular matrix organization; P:positive regulation of apoptotic process;|Q6UY14 B2RTT0 F8WAD0 Q5T5F7 Q6IPM6 Q8N643 Q9HBS6,ADAMTS-like protein 4,Thrombospondin repeat-containing protein 1;, PF05986;PF08686;PF00090;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005614;GO:0042802;GO:0004222;GO:0002020;GO:0006915;GO:0002064;GO:0030198;GO:0043065;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:interstitial matrix;, F:identical protein binding; F:metalloendopeptidase activity; F:protease binding;, P:apoptotic process; P:epithelial cell development; P:extracellular matrix organization; P:positive regulation of apoptotic process;|Q6UY14 B2RTT0 F8WAD0 Q5T5F7 Q6IPM6 Q8N643 Q9HBS6,ADAMTS-like protein 4,Thrombospondin repeat-containing protein 1;, PF05986;PF08686;PF00090;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005614;GO:0042802;GO:0004222;GO:0002020;GO:0006915;GO:0002064;GO:0030198;GO:0043065;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:interstitial matrix;, F:identical protein binding; F:metalloendopeptidase activity; F:protease binding;, P:apoptotic process; P:epithelial cell development; P:extracellular matrix organization; P:positive regulation of apoptotic process;|Q6UY14 B2RTT0 F8WAD0 Q5T5F7 Q6IPM6 Q8N643 Q9HBS6,ADAMTS-like protein 4,Thrombospondin repeat-containing protein 1;, PF05986;PF08686;PF00090;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005614;GO:0042802;GO:0004222;GO:0002020;GO:0006915;GO:0002064;GO:0030198;GO:0043065;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:interstitial matrix;, F:identical protein binding; F:metalloendopeptidase activity; F:protease binding;, P:apoptotic process; P:epithelial cell development; P:extracellular matrix organization; P:positive regulation of apoptotic process;|Q6UY14 B2RTT0 F8WAD0 Q5T5F7 Q6IPM6 Q8N643 Q9HBS6,ADAMTS-like protein 4,Thrombospondin repeat-containing protein 1;, PF05986;PF08686;PF00090;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005614;GO:0042802;GO:0004222;GO:0002020;GO:0006915;GO:0002064;GO:0030198;GO:0043065;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:interstitial matrix;, F:identical protein binding; F:metalloendopeptidase activity; F:protease binding;, P:apoptotic process; P:epithelial cell development; P:extracellular matrix organization; P:positive regulation of apoptotic process;|Q6UY14 B2RTT0 F8WAD0 Q5T5F7 Q6IPM6 Q8N643 Q9HBS6,ADAMTS-like protein 4,Thrombospondin repeat-containing protein 1;, PF05986;PF08686;PF00090;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005614;GO:0042802;GO:0004222;GO:0002020;GO:0006915;GO:0002064;GO:0030198;GO:0043065;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:interstitial matrix;, F:identical protein binding; F:metalloendopeptidase activity; F:protease binding;, P:apoptotic process; P:epithelial cell development; P:extracellular matrix organization; P:positive regulation of apoptotic process;|Q6UY14 B2RTT0 F8WAD0 Q5T5F7 Q6IPM6 Q8N643 Q9HBS6,ADAMTS-like protein 4,Thrombospondin repeat-containing protein 1;, PF05986;PF08686;PF00090;, GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005614;GO:0042802;GO:0004222;GO:0002020;GO:0006915;GO:0002064;GO:0030198;GO:0043065;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:interstitial matrix;, F:identical protein binding; F:metalloendopeptidase activity; F:protease binding;, P:apoptotic process; P:epithelial cell development; P:extracellular matrix organization; P:positive regulation of apoptotic process; scaffold118 indexed_genome mRNA 1118874 1123463 . + . ID=transcript_13564;Q9UHR9 Q9UNJ1,Induced myeloid leukemia cell differentiation protein Mcl-1,Bcl-2-like protein 3;Bcl-2-related protein EAT/mcl1;mcl1/EAT;, PF00452;, GO:0097136;GO:0005737;GO:0005829;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0005654;GO:0005634;GO:0051434;GO:0046982;GO:0042803;GO:0008320;GO:0001709;GO:0019725;GO:0019221;GO:0097192;GO:0008630;GO:0007275;GO:2000811;GO:0043066;GO:0010507;GO:2001240;GO:2001243;GO:1903378;GO:2001020;GO:0034097;, C:Bcl-2 family protein complex; C:cytoplasm; C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:BH3 domain binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein transmembrane transporter activity;, P:cell fate determination; P:cellular homeostasis; P:cytokine-mediated signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:multicellular organism development; P:negative regulation of anoikis; P:negative regulation of apoptotic process; P:negative regulation of autophagy; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of intrinsic apoptotic signaling pathway; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:regulation of response to DNA damage stimulus; P:response to cytokine; scaffold118 indexed_genome mRNA 1145403 1151188 . - . ID=transcript_13565;Q6VUC7 Q6VUC8 Q6VUC9 Q6VUD0 Q6VUD1 Q9NRZ0,Alpha-endosulfine,ARPP-19e;, PF04667;, GO:0005737;GO:0005654;GO:0008200;GO:0019212;GO:0019870;GO:0051721;GO:0004864;GO:0019888;GO:0005102;GO:0051301;GO:0000086;GO:0000278;GO:0035308;GO:0050796;GO:0007584;, C:cytoplasm; C:nucleoplasm;, F:ion channel inhibitor activity; F:phosphatase inhibitor activity; F:potassium channel inhibitor activity; F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity; F:signaling receptor binding;, P:cell division; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of protein dephosphorylation; P:regulation of insulin secretion; P:response to nutrient;|Q6VUC7 Q6VUC8 Q6VUC9 Q6VUD0 Q6VUD1 Q9NRZ0,Alpha-endosulfine,ARPP-19e;, PF04667;, GO:0005737;GO:0005654;GO:0008200;GO:0019212;GO:0019870;GO:0051721;GO:0004864;GO:0019888;GO:0005102;GO:0051301;GO:0000086;GO:0000278;GO:0035308;GO:0050796;GO:0007584;, C:cytoplasm; C:nucleoplasm;, F:ion channel inhibitor activity; F:phosphatase inhibitor activity; F:potassium channel inhibitor activity; F:protein phosphatase 2A binding; F:protein phosphatase inhibitor activity; F:protein phosphatase regulator activity; F:signaling receptor binding;, P:cell division; P:G2/M transition of mitotic cell cycle; P:mitotic cell cycle; P:negative regulation of protein dephosphorylation; P:regulation of insulin secretion; P:response to nutrient; scaffold118 indexed_genome mRNA 1161788 1183800 . - . ID=transcript_13566;Q9H4A5 B1AN09 B7Z6N3 Q9NVK0,Golgi phosphoprotein 3-like,GPP34-related protein;, PF05719;, GO:0005829;GO:0005794;GO:0031985;GO:0032580;GO:0000139;GO:0005802;GO:0032588;GO:0070273;GO:0007030;GO:0043001;GO:0048194;GO:0050714;GO:0006890;, C:cytosol; C:Golgi apparatus; C:Golgi cisterna; C:Golgi cisterna membrane; C:Golgi membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:phosphatidylinositol-4-phosphate binding;, P:Golgi organization; P:Golgi to plasma membrane protein transport; P:Golgi vesicle budding; P:positive regulation of protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold118 indexed_genome mRNA 1231986 1286861 . - . ID=transcript_13567;P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3,Cathepsin S,, PF08246;PF00112;, GO:0062023;GO:0036021;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0005770;GO:0043202;GO:0005764;GO:0045335;GO:1904724;GO:0005518;GO:0004197;GO:0001968;GO:0043236;GO:0043394;GO:0002250;GO:0019882;GO:0019886;GO:0048002;GO:0034769;GO:0097067;GO:0030574;GO:0022617;GO:0006955;GO:0043312;GO:2001259;GO:0016485;GO:0006508;GO:0051603;GO:0010447;GO:0002224;, C:collagen-containing extracellular matrix; C:endolysosome lumen; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal lumen; C:lysosome; C:phagocytic vesicle; C:tertiary granule lumen;, F:collagen binding; F:cysteine-type endopeptidase activity; F:fibronectin binding; F:laminin binding; F:proteoglycan binding;, P:adaptive immune response; P:antigen processing and presentation; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen; P:basement membrane disassembly; P:cellular response to thyroid hormone stimulus; P:collagen catabolic process; P:extracellular matrix disassembly; P:immune response; P:neutrophil degranulation; P:positive regulation of cation channel activity; P:protein processing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:response to acidic pH; P:toll-like receptor signaling pathway;|P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3,Cathepsin S,, PF08246;PF00112;, GO:0062023;GO:0036021;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0005770;GO:0043202;GO:0005764;GO:0045335;GO:1904724;GO:0005518;GO:0004197;GO:0001968;GO:0043236;GO:0043394;GO:0002250;GO:0019882;GO:0019886;GO:0048002;GO:0034769;GO:0097067;GO:0030574;GO:0022617;GO:0006955;GO:0043312;GO:2001259;GO:0016485;GO:0006508;GO:0051603;GO:0010447;GO:0002224;, C:collagen-containing extracellular matrix; C:endolysosome lumen; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosomal lumen; C:lysosome; C:phagocytic vesicle; C:tertiary granule lumen;, F:collagen binding; F:cysteine-type endopeptidase activity; F:fibronectin binding; F:laminin binding; F:proteoglycan binding;, P:adaptive immune response; P:antigen processing and presentation; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen; P:basement membrane disassembly; P:cellular response to thyroid hormone stimulus; P:collagen catabolic process; P:extracellular matrix disassembly; P:immune response; P:neutrophil degranulation; P:positive regulation of cation channel activity; P:protein processing; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:response to acidic pH; P:toll-like receptor signaling pathway;|P43235 Q6FHS6,Cathepsin K,Cathepsin O;Cathepsin O2;Cathepsin X;, PF08246;PF00112;, GO:0016324;GO:0036021;GO:0005576;GO:0005615;GO:0043231;GO:0043202;GO:0005764;GO:0005654;GO:0005518;GO:0004197;GO:0008234;GO:0001968;GO:0043394;GO:0000422;GO:0030574;GO:0022617;GO:0006955;GO:0006508;GO:0051603;GO:0045616;GO:0006590;GO:0002224;, C:apical plasma membrane; C:endolysosome lumen; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:nucleoplasm;, F:collagen binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:fibronectin binding; F:proteoglycan binding;, P:autophagy of mitochondrion; P:collagen catabolic process; P:extracellular matrix disassembly; P:immune response; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of keratinocyte differentiation; P:thyroid hormone generation; P:toll-like receptor signaling pathway;|P43235 Q6FHS6,Cathepsin K,Cathepsin O;Cathepsin O2;Cathepsin X;, PF08246;PF00112;, GO:0016324;GO:0036021;GO:0005576;GO:0005615;GO:0043231;GO:0043202;GO:0005764;GO:0005654;GO:0005518;GO:0004197;GO:0008234;GO:0001968;GO:0043394;GO:0000422;GO:0030574;GO:0022617;GO:0006955;GO:0006508;GO:0051603;GO:0045616;GO:0006590;GO:0002224;, C:apical plasma membrane; C:endolysosome lumen; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:nucleoplasm;, F:collagen binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:fibronectin binding; F:proteoglycan binding;, P:autophagy of mitochondrion; P:collagen catabolic process; P:extracellular matrix disassembly; P:immune response; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of keratinocyte differentiation; P:thyroid hormone generation; P:toll-like receptor signaling pathway;|P43235 Q6FHS6,Cathepsin K,Cathepsin O;Cathepsin O2;Cathepsin X;, PF08246;PF00112;, GO:0016324;GO:0036021;GO:0005576;GO:0005615;GO:0043231;GO:0043202;GO:0005764;GO:0005654;GO:0005518;GO:0004197;GO:0008234;GO:0001968;GO:0043394;GO:0000422;GO:0030574;GO:0022617;GO:0006955;GO:0006508;GO:0051603;GO:0045616;GO:0006590;GO:0002224;, C:apical plasma membrane; C:endolysosome lumen; C:extracellular region; C:extracellular space; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:nucleoplasm;, F:collagen binding; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:fibronectin binding; F:proteoglycan binding;, P:autophagy of mitochondrion; P:collagen catabolic process; P:extracellular matrix disassembly; P:immune response; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of keratinocyte differentiation; P:thyroid hormone generation; P:toll-like receptor signaling pathway; scaffold118 indexed_genome mRNA 1286893 1354871 . - . ID=transcript_13568;P27540 B2R9H1 C4AMA1 F8WAP6 Q59ED4 Q5QP39 Q8NDC7,Aryl hydrocarbon receptor nuclear translocator,Class E basic helix-loop-helix protein 2;Dioxin receptor, nuclear translocator;Hypoxia-inducible factor 1-beta;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0090575;GO:0017162;GO:0000987;GO:0003700;GO:0000981;GO:0004879;GO:0046982;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0030154;GO:0001892;GO:0001938;GO:0045648;GO:0045821;GO:0046886;GO:0033235;GO:0045944;GO:0010575;GO:0030949;GO:0006357;GO:0061418;GO:0043619;GO:0001666;GO:0006805;, C:aryl hydrocarbon receptor complex; C:chromatin; C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:cell differentiation; P:embryonic placenta development; P:positive regulation of endothelial cell proliferation; P:positive regulation of erythrocyte differentiation; P:positive regulation of glycolytic process; P:positive regulation of hormone biosynthetic process; P:positive regulation of protein sumoylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to hypoxia; P:xenobiotic metabolic process;|P27540 B2R9H1 C4AMA1 F8WAP6 Q59ED4 Q5QP39 Q8NDC7,Aryl hydrocarbon receptor nuclear translocator,Class E basic helix-loop-helix protein 2;Dioxin receptor, nuclear translocator;Hypoxia-inducible factor 1-beta;, PF00010;PF00989;, GO:0034751;GO:0000785;GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0090575;GO:0017162;GO:0000987;GO:0003700;GO:0000981;GO:0004879;GO:0046982;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0008134;GO:0030154;GO:0001892;GO:0001938;GO:0045648;GO:0045821;GO:0046886;GO:0033235;GO:0045944;GO:0010575;GO:0030949;GO:0006357;GO:0061418;GO:0043619;GO:0001666;GO:0006805;, C:aryl hydrocarbon receptor complex; C:chromatin; C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:aryl hydrocarbon receptor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:cell differentiation; P:embryonic placenta development; P:positive regulation of endothelial cell proliferation; P:positive regulation of erythrocyte differentiation; P:positive regulation of glycolytic process; P:positive regulation of hormone biosynthetic process; P:positive regulation of protein sumoylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; P:response to hypoxia; P:xenobiotic metabolic process; scaffold118 indexed_genome mRNA 1410367 1448978 . + . ID=transcript_13569;Q15047 A6NEW2 Q5SZD8 Q5SZD9 Q5SZE0 Q5SZE7 Q96GM9,Histone-lysine N-methyltransferase SETDB1 {ECO:0000305},ERG-associated protein with SET domain;Histone H3-K9 methyltransferase 4;Lysine N-methyltransferase 1E;SET domain bifurcated 1;, PF18300;PF01429;PF05033;PF00856;PF18358;PF18359;, GO:0005694;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046974;GO:0018024;GO:1990841;GO:0008270;GO:0070828;GO:0051567;GO:0010629;GO:0045869;GO:0090309;GO:0007265;GO:0045471;GO:0033273;, C:chromosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:promoter-specific chromatin binding; F:zinc ion binding;, P:heterochromatin organization; P:histone H3-K9 methylation; P:negative regulation of gene expression; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:Ras protein signal transduction; P:response to ethanol; P:response to vitamin;|Q15047 A6NEW2 Q5SZD8 Q5SZD9 Q5SZE0 Q5SZE7 Q96GM9,Histone-lysine N-methyltransferase SETDB1 {ECO:0000305},ERG-associated protein with SET domain;Histone H3-K9 methyltransferase 4;Lysine N-methyltransferase 1E;SET domain bifurcated 1;, PF18300;PF01429;PF05033;PF00856;PF18358;PF18359;, GO:0005694;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046974;GO:0018024;GO:1990841;GO:0008270;GO:0070828;GO:0051567;GO:0010629;GO:0045869;GO:0090309;GO:0007265;GO:0045471;GO:0033273;, C:chromosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:promoter-specific chromatin binding; F:zinc ion binding;, P:heterochromatin organization; P:histone H3-K9 methylation; P:negative regulation of gene expression; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:Ras protein signal transduction; P:response to ethanol; P:response to vitamin;|Q15047 A6NEW2 Q5SZD8 Q5SZD9 Q5SZE0 Q5SZE7 Q96GM9,Histone-lysine N-methyltransferase SETDB1 {ECO:0000305},ERG-associated protein with SET domain;Histone H3-K9 methyltransferase 4;Lysine N-methyltransferase 1E;SET domain bifurcated 1;, PF18300;PF01429;PF05033;PF00856;PF18358;PF18359;, GO:0005694;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046974;GO:0018024;GO:1990841;GO:0008270;GO:0070828;GO:0051567;GO:0010629;GO:0045869;GO:0090309;GO:0007265;GO:0045471;GO:0033273;, C:chromosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:promoter-specific chromatin binding; F:zinc ion binding;, P:heterochromatin organization; P:histone H3-K9 methylation; P:negative regulation of gene expression; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:Ras protein signal transduction; P:response to ethanol; P:response to vitamin;|Q15047 A6NEW2 Q5SZD8 Q5SZD9 Q5SZE0 Q5SZE7 Q96GM9,Histone-lysine N-methyltransferase SETDB1 {ECO:0000305},ERG-associated protein with SET domain;Histone H3-K9 methyltransferase 4;Lysine N-methyltransferase 1E;SET domain bifurcated 1;, PF18300;PF01429;PF05033;PF00856;PF18358;PF18359;, GO:0005694;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0046974;GO:0018024;GO:1990841;GO:0008270;GO:0070828;GO:0051567;GO:0010629;GO:0045869;GO:0090309;GO:0007265;GO:0045471;GO:0033273;, C:chromosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:promoter-specific chromatin binding; F:zinc ion binding;, P:heterochromatin organization; P:histone H3-K9 methylation; P:negative regulation of gene expression; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:Ras protein signal transduction; P:response to ethanol; P:response to vitamin;|Q96G23 D3DV06 Q5SZE5 Q9HD96 Q9NW79,Ceramide synthase 2 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 2 {ECO:0000303|PubMed:11543633};SP260 {ECO:0000303|PubMed:11543633};Sphingosine N-acyltransferase CERS2 {ECO:0000305};Tumor metastasis-suppressor gene 1 protein {ECO:0000303|Ref.8};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0048681;GO:1900148;GO:1905045;GO:0019216;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:negative regulation of axon regeneration; P:negative regulation of Schwann cell migration; P:negative regulation of Schwann cell proliferation involved in axon regeneration; P:regulation of lipid metabolic process; P:sphingolipid biosynthetic process;|Q96G23 D3DV06 Q5SZE5 Q9HD96 Q9NW79,Ceramide synthase 2 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 2 {ECO:0000303|PubMed:11543633};SP260 {ECO:0000303|PubMed:11543633};Sphingosine N-acyltransferase CERS2 {ECO:0000305};Tumor metastasis-suppressor gene 1 protein {ECO:0000303|Ref.8};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0048681;GO:1900148;GO:1905045;GO:0019216;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:negative regulation of axon regeneration; P:negative regulation of Schwann cell migration; P:negative regulation of Schwann cell proliferation involved in axon regeneration; P:regulation of lipid metabolic process; P:sphingolipid biosynthetic process;|Q96G23 D3DV06 Q5SZE5 Q9HD96 Q9NW79,Ceramide synthase 2 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 2 {ECO:0000303|PubMed:11543633};SP260 {ECO:0000303|PubMed:11543633};Sphingosine N-acyltransferase CERS2 {ECO:0000305};Tumor metastasis-suppressor gene 1 protein {ECO:0000303|Ref.8};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0048681;GO:1900148;GO:1905045;GO:0019216;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:negative regulation of axon regeneration; P:negative regulation of Schwann cell migration; P:negative regulation of Schwann cell proliferation involved in axon regeneration; P:regulation of lipid metabolic process; P:sphingolipid biosynthetic process; scaffold118 indexed_genome mRNA 1456873 1467064 . + . ID=transcript_13570;O76027 Q5SZF1 Q6FI55 Q9BS00 Q9HBJ6,Annexin A9,Annexin XXXI;Annexin-31;Annexin-9;Pemphaxin;, PF00191;, GO:0009986;GO:0005737;GO:0005829;GO:0005615;GO:0005634;GO:0005886;GO:0045202;GO:0031982;GO:0015464;GO:0005262;GO:0005509;GO:0005544;GO:0005546;GO:0001786;GO:0019834;GO:0005543;GO:0002020;GO:0046790;GO:0098609;, C:cell surface; C:cytoplasm; C:cytosol; C:extracellular space; C:nucleus; C:plasma membrane; C:synapse; C:vesicle;, F:acetylcholine receptor activity; F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:phospholipase A2 inhibitor activity; F:phospholipid binding; F:protease binding; F:virion binding;, P:cell-cell adhesion;|O76027 Q5SZF1 Q6FI55 Q9BS00 Q9HBJ6,Annexin A9,Annexin XXXI;Annexin-31;Annexin-9;Pemphaxin;, PF00191;, GO:0009986;GO:0005737;GO:0005829;GO:0005615;GO:0005634;GO:0005886;GO:0045202;GO:0031982;GO:0015464;GO:0005262;GO:0005509;GO:0005544;GO:0005546;GO:0001786;GO:0019834;GO:0005543;GO:0002020;GO:0046790;GO:0098609;, C:cell surface; C:cytoplasm; C:cytosol; C:extracellular space; C:nucleus; C:plasma membrane; C:synapse; C:vesicle;, F:acetylcholine receptor activity; F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:phospholipase A2 inhibitor activity; F:phospholipid binding; F:protease binding; F:virion binding;, P:cell-cell adhesion;|O76027 Q5SZF1 Q6FI55 Q9BS00 Q9HBJ6,Annexin A9,Annexin XXXI;Annexin-31;Annexin-9;Pemphaxin;, PF00191;, GO:0009986;GO:0005737;GO:0005829;GO:0005615;GO:0005634;GO:0005886;GO:0045202;GO:0031982;GO:0015464;GO:0005262;GO:0005509;GO:0005544;GO:0005546;GO:0001786;GO:0019834;GO:0005543;GO:0002020;GO:0046790;GO:0098609;, C:cell surface; C:cytoplasm; C:cytosol; C:extracellular space; C:nucleus; C:plasma membrane; C:synapse; C:vesicle;, F:acetylcholine receptor activity; F:calcium channel activity; F:calcium ion binding; F:calcium-dependent phospholipid binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:phospholipase A2 inhibitor activity; F:phospholipid binding; F:protease binding; F:virion binding;, P:cell-cell adhesion; scaffold118 indexed_genome mRNA 1467478 1477256 . - . ID=transcript_13571;Q9P2F7,Ubiquitin carboxyl-terminal hydrolase MINDY-1 {ECO:0000303|PubMed:27292798},Deubiquitinating enzyme MINDY-1 {ECO:0000303|PubMed:27292798};Protein FAM63A;, PF04424;, GO:0071944;GO:0005829;GO:0016604;GO:0005654;GO:0016807;GO:0036435;GO:1990380;GO:0004843;GO:0071108;, C:cell periphery; C:cytosol; C:nuclear body; C:nucleoplasm;, F:cysteine-type carboxypeptidase activity; F:K48-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein K48-linked deubiquitination;|Q9P2F7,Ubiquitin carboxyl-terminal hydrolase MINDY-1 {ECO:0000303|PubMed:27292798},Deubiquitinating enzyme MINDY-1 {ECO:0000303|PubMed:27292798};Protein FAM63A;, PF04424;, GO:0071944;GO:0005829;GO:0016604;GO:0005654;GO:0016807;GO:0036435;GO:1990380;GO:0004843;GO:0071108;, C:cell periphery; C:cytosol; C:nuclear body; C:nucleoplasm;, F:cysteine-type carboxypeptidase activity; F:K48-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein K48-linked deubiquitination;|Q9P2F7,Ubiquitin carboxyl-terminal hydrolase MINDY-1 {ECO:0000303|PubMed:27292798},Deubiquitinating enzyme MINDY-1 {ECO:0000303|PubMed:27292798};Protein FAM63A;, PF04424;, GO:0071944;GO:0005829;GO:0016604;GO:0005654;GO:0016807;GO:0036435;GO:1990380;GO:0004843;GO:0071108;, C:cell periphery; C:cytosol; C:nuclear body; C:nucleoplasm;, F:cysteine-type carboxypeptidase activity; F:K48-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein K48-linked deubiquitination;|Q9P2F7,Ubiquitin carboxyl-terminal hydrolase MINDY-1 {ECO:0000303|PubMed:27292798},Deubiquitinating enzyme MINDY-1 {ECO:0000303|PubMed:27292798};Protein FAM63A;, PF04424;, GO:0071944;GO:0005829;GO:0016604;GO:0005654;GO:0016807;GO:0036435;GO:1990380;GO:0004843;GO:0071108;, C:cell periphery; C:cytosol; C:nuclear body; C:nucleoplasm;, F:cysteine-type carboxypeptidase activity; F:K48-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein K48-linked deubiquitination;|Q9P2F7,Ubiquitin carboxyl-terminal hydrolase MINDY-1 {ECO:0000303|PubMed:27292798},Deubiquitinating enzyme MINDY-1 {ECO:0000303|PubMed:27292798};Protein FAM63A;, PF04424;, GO:0071944;GO:0005829;GO:0016604;GO:0005654;GO:0016807;GO:0036435;GO:1990380;GO:0004843;GO:0071108;, C:cell periphery; C:cytosol; C:nuclear body; C:nucleoplasm;, F:cysteine-type carboxypeptidase activity; F:K48-linked polyubiquitin modification-dependent protein binding; F:Lys48-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein K48-linked deubiquitination; scaffold118 indexed_genome mRNA 1478280 1496857 . + . ID=transcript_13572;Q9C072 Q9UIV0,Exopolyphosphatase PRUNE1,Drosophila-related expressed sequence 17;HTcD37;Protein prune homolog 1;, PF01368;PF02833;, GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0004309;GO:0004427;GO:0046872;GO:0016791;GO:0015631;GO:0006798;GO:0031113;GO:0050767;, C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus;, F:exopolyphosphatase activity; F:inorganic diphosphatase activity; F:metal ion binding; F:phosphatase activity; F:tubulin binding;, P:polyphosphate catabolic process; P:regulation of microtubule polymerization; P:regulation of neurogenesis;|Q9C072 Q9UIV0,Exopolyphosphatase PRUNE1,Drosophila-related expressed sequence 17;HTcD37;Protein prune homolog 1;, PF01368;PF02833;, GO:0005737;GO:0005829;GO:0005925;GO:0005634;GO:0004309;GO:0004427;GO:0046872;GO:0016791;GO:0015631;GO:0006798;GO:0031113;GO:0050767;, C:cytoplasm; C:cytosol; C:focal adhesion; C:nucleus;, F:exopolyphosphatase activity; F:inorganic diphosphatase activity; F:metal ion binding; F:phosphatase activity; F:tubulin binding;, P:polyphosphate catabolic process; P:regulation of microtubule polymerization; P:regulation of neurogenesis; scaffold118 indexed_genome mRNA 1497362 1506043 . + . ID=transcript_13573;Q7Z465 Q6DK43 Q8TCY7 Q8WYG2,Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein,, PF12496;PF13716;, GO:0005737;GO:0005829;GO:0005634;GO:0004309;GO:0042802;GO:0006915;GO:0008285;GO:0006798;GO:0040009;, C:cytoplasm; C:cytosol; C:nucleus;, F:exopolyphosphatase activity; F:identical protein binding;, P:apoptotic process; P:negative regulation of cell population proliferation; P:polyphosphate catabolic process; P:regulation of growth rate;|Q7Z465 Q6DK43 Q8TCY7 Q8WYG2,Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein,, PF12496;PF13716;, GO:0005737;GO:0005829;GO:0005634;GO:0004309;GO:0042802;GO:0006915;GO:0008285;GO:0006798;GO:0040009;, C:cytoplasm; C:cytosol; C:nucleus;, F:exopolyphosphatase activity; F:identical protein binding;, P:apoptotic process; P:negative regulation of cell population proliferation; P:polyphosphate catabolic process; P:regulation of growth rate; scaffold118 indexed_genome mRNA 1510658 1516794 . - . ID=transcript_13574;Q9NRR8 D3DV12 Q9HB17 Q9NQR2,CDC42 small effector protein 1,CDC42-binding protein SCIP1;Small effector of CDC42 protein 1;, , GO:0030054;GO:0005737;GO:0005856;GO:0005886;GO:0005095;GO:0031267;GO:0006909;GO:0008360;GO:0035023;GO:0007165;, C:cell junction; C:cytoplasm; C:cytoskeleton; C:plasma membrane;, F:GTPase inhibitor activity; F:small GTPase binding;, P:phagocytosis; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:signal transduction;|Q9NRR8 D3DV12 Q9HB17 Q9NQR2,CDC42 small effector protein 1,CDC42-binding protein SCIP1;Small effector of CDC42 protein 1;, , GO:0030054;GO:0005737;GO:0005856;GO:0005886;GO:0005095;GO:0031267;GO:0006909;GO:0008360;GO:0035023;GO:0007165;, C:cell junction; C:cytoplasm; C:cytoskeleton; C:plasma membrane;, F:GTPase inhibitor activity; F:small GTPase binding;, P:phagocytosis; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:signal transduction; scaffold118 indexed_genome mRNA 1519735 1523020 . - . ID=transcript_13575;Q13015,Protein AF1q,, PF15017;, GO:0005829;GO:0005815;GO:0005654;GO:0097191;GO:0097193;GO:0043065;GO:0051901;GO:0090200;GO:0045893;, C:cytosol; C:microtubule organizing center; C:nucleoplasm;, , P:extrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of mitochondrial depolarization; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of transcription, DNA-templated; scaffold118 indexed_genome mRNA 1523079 1547318 . + . ID=transcript_13576;Q8TAK5 B1AVJ8 D3DV14 Q8NAR5,GA-binding protein subunit beta-2,, PF12796;, GO:0005634;GO:0000976;GO:0045944;, C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II;|Q8TAK5 B1AVJ8 D3DV14 Q8NAR5,GA-binding protein subunit beta-2,, PF12796;, GO:0005634;GO:0000976;GO:0045944;, C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II;|Q8TAK5 B1AVJ8 D3DV14 Q8NAR5,GA-binding protein subunit beta-2,, PF12796;, GO:0005634;GO:0000976;GO:0045944;, C:nucleus;, F:transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; scaffold118 indexed_genome mRNA 1558889 1572017 . - . ID=transcript_13577;Q9H3T2 D3DV15 Q5JR71 Q5JR72 Q5JR73 Q8WXT8 Q8WXT9 Q8WXU0 Q96JF8,Semaphorin-6C,Semaphorin-Y;, PF01403;, GO:0009986;GO:0005737;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0030517;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:cell surface; C:cytoplasm; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9H3T2 D3DV15 Q5JR71 Q5JR72 Q5JR73 Q8WXT8 Q8WXT9 Q8WXU0 Q96JF8,Semaphorin-6C,Semaphorin-Y;, PF01403;, GO:0009986;GO:0005737;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0030517;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:cell surface; C:cytoplasm; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9H3T2 D3DV15 Q5JR71 Q5JR72 Q5JR73 Q8WXT8 Q8WXT9 Q8WXU0 Q96JF8,Semaphorin-6C,Semaphorin-Y;, PF01403;, GO:0009986;GO:0005737;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0030517;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:cell surface; C:cytoplasm; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9H3T2 D3DV15 Q5JR71 Q5JR72 Q5JR73 Q8WXT8 Q8WXT9 Q8WXU0 Q96JF8,Semaphorin-6C,Semaphorin-Y;, PF01403;, GO:0009986;GO:0005737;GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0030517;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:cell surface; C:cytoplasm; C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:negative chemotaxis; P:negative regulation of axon extension; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold118 indexed_genome mRNA 1581873 1592174 . + . ID=transcript_13578;Q6P589 Q6I9Y0 Q9H2H7 Q9H5G2,Tumor necrosis factor alpha-induced protein 8-like protein 2,Inflammation factor protein 20;, PF05527;, GO:0005737;GO:0045087;GO:0050728;GO:0050868;GO:0042981;, C:cytoplasm;, , P:innate immune response; P:negative regulation of inflammatory response; P:negative regulation of T cell activation; P:regulation of apoptotic process;|Q96S90 B4DQA1 Q69YX9,LysM and putative peptidoglycan-binding domain-containing protein 1,, PF01476;, GO:0005654;, C:nucleoplasm; scaffold118 indexed_genome mRNA 1592296 1594947 . + . ID=transcript_13579;Q9BWG6 B4DWR1 Q5JR74,Sodium channel modifier 1,, PF15805;PF15803;, GO:0016607;GO:0005634;GO:0019899;GO:0046872;GO:0000380;GO:0008380;, C:nuclear speck; C:nucleus;, F:enzyme binding; F:metal ion binding;, P:alternative mRNA splicing, via spliceosome; P:RNA splicing;|Q9BWG6 B4DWR1 Q5JR74,Sodium channel modifier 1,, PF15805;PF15803;, GO:0016607;GO:0005634;GO:0019899;GO:0046872;GO:0000380;GO:0008380;, C:nuclear speck; C:nucleus;, F:enzyme binding; F:metal ion binding;, P:alternative mRNA splicing, via spliceosome; P:RNA splicing;|Q9BWG6 B4DWR1 Q5JR74,Sodium channel modifier 1,, PF15805;PF15803;, GO:0016607;GO:0005634;GO:0019899;GO:0046872;GO:0000380;GO:0008380;, C:nuclear speck; C:nucleus;, F:enzyme binding; F:metal ion binding;, P:alternative mRNA splicing, via spliceosome; P:RNA splicing;|Q9BWG6 B4DWR1 Q5JR74,Sodium channel modifier 1,, PF15805;PF15803;, GO:0016607;GO:0005634;GO:0019899;GO:0046872;GO:0000380;GO:0008380;, C:nuclear speck; C:nucleus;, F:enzyme binding; F:metal ion binding;, P:alternative mRNA splicing, via spliceosome; P:RNA splicing; scaffold118 indexed_genome mRNA 1595432 1600506 . - . ID=transcript_13580;Q9NZQ9 B7Z6N9 Q5JR83 Q8WVL3 Q9UKH2,Tropomodulin-4,Skeletal muscle tropomodulin;, PF03250;, GO:0005856;GO:0030016;GO:0005865;GO:0051015;GO:0005523;GO:0007015;GO:0006936;GO:0030239;GO:0051694;, C:cytoskeleton; C:myofibril; C:striated muscle thin filament;, F:actin filament binding; F:tropomyosin binding;, P:actin filament organization; P:muscle contraction; P:myofibril assembly; P:pointed-end actin filament capping;|Q9NZQ9 B7Z6N9 Q5JR83 Q8WVL3 Q9UKH2,Tropomodulin-4,Skeletal muscle tropomodulin;, PF03250;, GO:0005856;GO:0030016;GO:0005865;GO:0051015;GO:0005523;GO:0007015;GO:0006936;GO:0030239;GO:0051694;, C:cytoskeleton; C:myofibril; C:striated muscle thin filament;, F:actin filament binding; F:tropomyosin binding;, P:actin filament organization; P:muscle contraction; P:myofibril assembly; P:pointed-end actin filament capping;|Q9NZQ9 B7Z6N9 Q5JR83 Q8WVL3 Q9UKH2,Tropomodulin-4,Skeletal muscle tropomodulin;, PF03250;, GO:0005856;GO:0030016;GO:0005865;GO:0051015;GO:0005523;GO:0007015;GO:0006936;GO:0030239;GO:0051694;, C:cytoskeleton; C:myofibril; C:striated muscle thin filament;, F:actin filament binding; F:tropomyosin binding;, P:actin filament organization; P:muscle contraction; P:myofibril assembly; P:pointed-end actin filament capping; scaffold118 indexed_genome mRNA 1600567 1612204 . - . ID=transcript_13581;Q15906 A6NLK9 A6PW55 Q53GJ2 Q5U0R4,Vacuolar protein sorting-associated protein 72 homolog,Protein YL-1;Transcription factor-like 1;, PF05764;PF08265;, GO:0016607;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042393;GO:0043486;GO:0000122;GO:0035019;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:histone binding;, P:histone exchange; P:negative regulation of transcription by RNA polymerase II; P:somatic stem cell population maintenance; scaffold118 indexed_genome mRNA 1637759 1662587 . + . ID=transcript_13582;Q99755 A8K4Q0 B4DIN0 Q99754 Q99756,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha {ECO:0000305|PubMed:19158393},68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha {ECO:0000303|PubMed:8955136};Phosphatidylinositol 4-phosphate 5-kinase type I alpha {ECO:0000305|PubMed:19158393};, PF01504;, GO:0005829;GO:0005925;GO:0030027;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032587;GO:0016308;GO:0005524;GO:0019900;GO:0031532;GO:0090630;GO:0060326;GO:0016477;GO:0010761;GO:0048041;GO:0006650;GO:0030216;GO:0006909;GO:0006661;GO:0008654;GO:0072659;GO:0014066;GO:0097178;GO:0007165;, C:cytosol; C:focal adhesion; C:lamellipodium; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding; F:kinase binding;, P:actin cytoskeleton reorganization; P:activation of GTPase activity; P:cell chemotaxis; P:cell migration; P:fibroblast migration; P:focal adhesion assembly; P:glycerophospholipid metabolic process; P:keratinocyte differentiation; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:phospholipid biosynthetic process; P:protein localization to plasma membrane; P:regulation of phosphatidylinositol 3-kinase signaling; P:ruffle assembly; P:signal transduction;|A2A3N6 Q6NUK8,Putative PIP5K1A and PSMD4-like protein,, PF01504;PF13519;, GO:0005737;GO:0016307;, C:cytoplasm;, F:phosphatidylinositol phosphate kinase activity;|Q99755 A8K4Q0 B4DIN0 Q99754 Q99756,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha {ECO:0000305|PubMed:19158393},68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha {ECO:0000303|PubMed:8955136};Phosphatidylinositol 4-phosphate 5-kinase type I alpha {ECO:0000305|PubMed:19158393};, PF01504;, GO:0005829;GO:0005925;GO:0030027;GO:0016607;GO:0005654;GO:0005634;GO:0005886;GO:0032587;GO:0016308;GO:0005524;GO:0019900;GO:0031532;GO:0090630;GO:0060326;GO:0016477;GO:0010761;GO:0048041;GO:0006650;GO:0030216;GO:0006909;GO:0006661;GO:0008654;GO:0072659;GO:0014066;GO:0097178;GO:0007165;, C:cytosol; C:focal adhesion; C:lamellipodium; C:nuclear speck; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding; F:kinase binding;, P:actin cytoskeleton reorganization; P:activation of GTPase activity; P:cell chemotaxis; P:cell migration; P:fibroblast migration; P:focal adhesion assembly; P:glycerophospholipid metabolic process; P:keratinocyte differentiation; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:phospholipid biosynthetic process; P:protein localization to plasma membrane; P:regulation of phosphatidylinositol 3-kinase signaling; P:ruffle assembly; P:signal transduction; scaffold118 indexed_genome mRNA 1669367 1678056 . + . ID=transcript_13583;P55036 D3DV16 Q5VWC5 Q9NS92,26S proteasome non-ATPase regulatory subunit 4,26S proteasome regulatory subunit RPN10;26S proteasome regulatory subunit S5A;Antisecretory factor 1;Multiubiquitin chain-binding protein;, PF02809;PF13519;, GO:0005829;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0042802;GO:0031593;GO:0003723;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:identical protein binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P55036 D3DV16 Q5VWC5 Q9NS92,26S proteasome non-ATPase regulatory subunit 4,26S proteasome regulatory subunit RPN10;26S proteasome regulatory subunit S5A;Antisecretory factor 1;Multiubiquitin chain-binding protein;, PF02809;PF13519;, GO:0005829;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0042802;GO:0031593;GO:0003723;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:identical protein binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P55036 D3DV16 Q5VWC5 Q9NS92,26S proteasome non-ATPase regulatory subunit 4,26S proteasome regulatory subunit RPN10;26S proteasome regulatory subunit S5A;Antisecretory factor 1;Multiubiquitin chain-binding protein;, PF02809;PF13519;, GO:0005829;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0042802;GO:0031593;GO:0003723;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:identical protein binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P55036 D3DV16 Q5VWC5 Q9NS92,26S proteasome non-ATPase regulatory subunit 4,26S proteasome regulatory subunit RPN10;26S proteasome regulatory subunit S5A;Antisecretory factor 1;Multiubiquitin chain-binding protein;, PF02809;PF13519;, GO:0005829;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0042802;GO:0031593;GO:0003723;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex;, F:identical protein binding; F:polyubiquitin modification-dependent protein binding; F:RNA binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold118 indexed_genome mRNA 1715247 1723824 . + . ID=transcript_13584;Q8N1G0 D3DV17 Q68DQ8 Q9H937 Q9P2A7,Zinc finger protein 687,, PF00096;PF16622;, GO:0005829;GO:0005654;GO:0003677;GO:0046872;, C:cytosol; C:nucleoplasm;, F:DNA binding; F:metal ion binding; scaffold118 indexed_genome mRNA 1724195 1745976 . - . ID=transcript_13585;Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6,Phosphatidylinositol 4-kinase beta {ECO:0000305},NPIK;PI4K92;PI4KIII {ECO:0000303|PubMed:22124328, ECO:0000303|PubMed:22258260};, PF00454;, GO:0005737;GO:0005829;GO:0005768;GO:0000139;GO:0016020;GO:0005741;GO:0048471;GO:0030867;GO:0004430;GO:0071889;GO:0005524;GO:0052742;GO:0006661;GO:0046854;GO:0048015;GO:0006898;GO:0007165;GO:0016032;, C:cytoplasm; C:cytosol; C:endosome; C:Golgi membrane; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum membrane;, F:1-phosphatidylinositol 4-kinase activity; F:14-3-3 protein binding; F:ATP binding; F:phosphatidylinositol kinase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:receptor-mediated endocytosis; P:signal transduction; P:viral process;|Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6,Phosphatidylinositol 4-kinase beta {ECO:0000305},NPIK;PI4K92;PI4KIII {ECO:0000303|PubMed:22124328, ECO:0000303|PubMed:22258260};, PF00454;, GO:0005737;GO:0005829;GO:0005768;GO:0000139;GO:0016020;GO:0005741;GO:0048471;GO:0030867;GO:0004430;GO:0071889;GO:0005524;GO:0052742;GO:0006661;GO:0046854;GO:0048015;GO:0006898;GO:0007165;GO:0016032;, C:cytoplasm; C:cytosol; C:endosome; C:Golgi membrane; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum membrane;, F:1-phosphatidylinositol 4-kinase activity; F:14-3-3 protein binding; F:ATP binding; F:phosphatidylinositol kinase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:receptor-mediated endocytosis; P:signal transduction; P:viral process;|Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6,Phosphatidylinositol 4-kinase beta {ECO:0000305},NPIK;PI4K92;PI4KIII {ECO:0000303|PubMed:22124328, ECO:0000303|PubMed:22258260};, PF00454;, GO:0005737;GO:0005829;GO:0005768;GO:0000139;GO:0016020;GO:0005741;GO:0048471;GO:0030867;GO:0004430;GO:0071889;GO:0005524;GO:0052742;GO:0006661;GO:0046854;GO:0048015;GO:0006898;GO:0007165;GO:0016032;, C:cytoplasm; C:cytosol; C:endosome; C:Golgi membrane; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum membrane;, F:1-phosphatidylinositol 4-kinase activity; F:14-3-3 protein binding; F:ATP binding; F:phosphatidylinositol kinase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:receptor-mediated endocytosis; P:signal transduction; P:viral process;|Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6,Phosphatidylinositol 4-kinase beta {ECO:0000305},NPIK;PI4K92;PI4KIII {ECO:0000303|PubMed:22124328, ECO:0000303|PubMed:22258260};, PF00454;, GO:0005737;GO:0005829;GO:0005768;GO:0000139;GO:0016020;GO:0005741;GO:0048471;GO:0030867;GO:0004430;GO:0071889;GO:0005524;GO:0052742;GO:0006661;GO:0046854;GO:0048015;GO:0006898;GO:0007165;GO:0016032;, C:cytoplasm; C:cytosol; C:endosome; C:Golgi membrane; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum membrane;, F:1-phosphatidylinositol 4-kinase activity; F:14-3-3 protein binding; F:ATP binding; F:phosphatidylinositol kinase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:receptor-mediated endocytosis; P:signal transduction; P:viral process;|Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6,Phosphatidylinositol 4-kinase beta {ECO:0000305},NPIK;PI4K92;PI4KIII {ECO:0000303|PubMed:22124328, ECO:0000303|PubMed:22258260};, PF00454;, GO:0005737;GO:0005829;GO:0005768;GO:0000139;GO:0016020;GO:0005741;GO:0048471;GO:0030867;GO:0004430;GO:0071889;GO:0005524;GO:0052742;GO:0006661;GO:0046854;GO:0048015;GO:0006898;GO:0007165;GO:0016032;, C:cytoplasm; C:cytosol; C:endosome; C:Golgi membrane; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum membrane;, F:1-phosphatidylinositol 4-kinase activity; F:14-3-3 protein binding; F:ATP binding; F:phosphatidylinositol kinase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:receptor-mediated endocytosis; P:signal transduction; P:viral process;|Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6,Phosphatidylinositol 4-kinase beta {ECO:0000305},NPIK;PI4K92;PI4KIII {ECO:0000303|PubMed:22124328, ECO:0000303|PubMed:22258260};, PF00454;, GO:0005737;GO:0005829;GO:0005768;GO:0000139;GO:0016020;GO:0005741;GO:0048471;GO:0030867;GO:0004430;GO:0071889;GO:0005524;GO:0052742;GO:0006661;GO:0046854;GO:0048015;GO:0006898;GO:0007165;GO:0016032;, C:cytoplasm; C:cytosol; C:endosome; C:Golgi membrane; C:membrane; C:mitochondrial outer membrane; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum membrane;, F:1-phosphatidylinositol 4-kinase activity; F:14-3-3 protein binding; F:ATP binding; F:phosphatidylinositol kinase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:receptor-mediated endocytosis; P:signal transduction; P:viral process; scaffold118 indexed_genome mRNA 1764490 1771811 . - . ID=transcript_13586;P48382 B7Z848 D3DV19 E9PFU4 Q5VWC3,DNA-binding protein RFX5,Regulatory factor X 5;, PF14621;PF18326;PF02257;, GO:0000785;GO:0090575;GO:0001228;GO:0000981;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0000122;GO:0045944;GO:0006357;, C:chromatin; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold118 indexed_genome mRNA 1782430 1791278 . - . ID=transcript_13587;Q13228 A6NML9 A6PVW9 B2RDR3 B4DKP6 B4E1F3 Q49AQ8 Q96GX7,Methanethiol oxidase {ECO:0000303|PubMed:29255262},56 kDa selenium-binding protein;Selenium-binding protein 1;, PF05694;, GO:0005829;GO:0070062;GO:0005615;GO:0001650;GO:0016020;GO:0005730;GO:0018549;GO:0008430;GO:0015031;, C:cytosol; C:extracellular exosome; C:extracellular space; C:fibrillar center; C:membrane; C:nucleolus;, F:methanethiol oxidase activity; F:selenium binding;, P:protein transport; scaffold118 indexed_genome mRNA 1846396 1847002 . - . ID=transcript_13588;P28070 B2R9L3 P31148 Q5SZS5 Q6IBI4 Q969L6,Proteasome subunit beta type-4,26 kDa prosomal protein;Macropain beta chain;Multicatalytic endopeptidase complex beta chain;Proteasome beta chain;Proteasome chain 3;, PF00227;, GO:0036064;GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0004175;GO:0001530;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0002862;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:endopeptidase activity; F:lipopolysaccharide binding; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of inflammatory response to antigenic stimulus; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold118 indexed_genome mRNA 1847108 1848255 . - . ID=transcript_13589;P28070 B2R9L3 P31148 Q5SZS5 Q6IBI4 Q969L6,Proteasome subunit beta type-4,26 kDa prosomal protein;Macropain beta chain;Multicatalytic endopeptidase complex beta chain;Proteasome beta chain;Proteasome chain 3;, PF00227;, GO:0036064;GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0004175;GO:0001530;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0002862;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:ciliary basal body; C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:endopeptidase activity; F:lipopolysaccharide binding; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:negative regulation of inflammatory response to antigenic stimulus; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold118 indexed_genome mRNA 1936050 1960716 . + . ID=transcript_13590;Q9P2M7 A6H8L3 A7MD22 Q5T386 Q9NR25,Cingulin,, PF01576;, GO:0005923;GO:0030054;GO:0016459;GO:0005886;GO:0003779;GO:0045296;GO:0007179;, C:bicellular tight junction; C:cell junction; C:myosin complex; C:plasma membrane;, F:actin binding; F:cadherin binding;, P:transforming growth factor beta receptor signaling pathway;|Q9P2M7 A6H8L3 A7MD22 Q5T386 Q9NR25,Cingulin,, PF01576;, GO:0005923;GO:0030054;GO:0016459;GO:0005886;GO:0003779;GO:0045296;GO:0007179;, C:bicellular tight junction; C:cell junction; C:myosin complex; C:plasma membrane;, F:actin binding; F:cadherin binding;, P:transforming growth factor beta receptor signaling pathway;|Q9P2M7 A6H8L3 A7MD22 Q5T386 Q9NR25,Cingulin,, PF01576;, GO:0005923;GO:0030054;GO:0016459;GO:0005886;GO:0003779;GO:0045296;GO:0007179;, C:bicellular tight junction; C:cell junction; C:myosin complex; C:plasma membrane;, F:actin binding; F:cadherin binding;, P:transforming growth factor beta receptor signaling pathway;|Q9P2M7 A6H8L3 A7MD22 Q5T386 Q9NR25,Cingulin,, PF01576;, GO:0005923;GO:0030054;GO:0016459;GO:0005886;GO:0003779;GO:0045296;GO:0007179;, C:bicellular tight junction; C:cell junction; C:myosin complex; C:plasma membrane;, F:actin binding; F:cadherin binding;, P:transforming growth factor beta receptor signaling pathway;|Q9P2M7 A6H8L3 A7MD22 Q5T386 Q9NR25,Cingulin,, PF01576;, GO:0005923;GO:0030054;GO:0016459;GO:0005886;GO:0003779;GO:0045296;GO:0007179;, C:bicellular tight junction; C:cell junction; C:myosin complex; C:plasma membrane;, F:actin binding; F:cadherin binding;, P:transforming growth factor beta receptor signaling pathway;|Q9P2M7 A6H8L3 A7MD22 Q5T386 Q9NR25,Cingulin,, PF01576;, GO:0005923;GO:0030054;GO:0016459;GO:0005886;GO:0003779;GO:0045296;GO:0007179;, C:bicellular tight junction; C:cell junction; C:myosin complex; C:plasma membrane;, F:actin binding; F:cadherin binding;, P:transforming growth factor beta receptor signaling pathway;|Q9P2M7 A6H8L3 A7MD22 Q5T386 Q9NR25,Cingulin,, PF01576;, GO:0005923;GO:0030054;GO:0016459;GO:0005886;GO:0003779;GO:0045296;GO:0007179;, C:bicellular tight junction; C:cell junction; C:myosin complex; C:plasma membrane;, F:actin binding; F:cadherin binding;, P:transforming growth factor beta receptor signaling pathway; scaffold118 indexed_genome mRNA 2112273 2112792 . + . ID=transcript_13591;Q9H3K8,Sorting nexin-27,, PF00595;PF00787;PF00788;, GO:0005829;GO:0005769;GO:0031901;GO:0005768;GO:0001772;GO:0005654;GO:0035091;GO:0032266;GO:0016197;GO:0008333;GO:0001770;GO:0006886;GO:1990126;GO:0007165;, C:cytosol; C:early endosome; C:early endosome membrane; C:endosome; C:immunological synapse; C:nucleoplasm;, F:phosphatidylinositol binding; F:phosphatidylinositol-3-phosphate binding;, P:endosomal transport; P:endosome to lysosome transport; P:establishment of natural killer cell polarity; P:intracellular protein transport; P:retrograde transport, endosome to plasma membrane; P:signal transduction; scaffold118 indexed_genome mRNA 2123708 2138522 . - . ID=transcript_13592;Q5SZQ8 B7ZKK6 O15414 Q499Y6 Q5SZQ7 Q6NVK0 Q8IZ98 Q9BZC2 Q9HB30,CUGBP Elav-like family member 3,Bruno-like protein 1;CAG repeat protein 4;CUG-BP- and ETR-3-like factor 3;ELAV-type RNA-binding protein 1;Expanded repeat domain protein CAG/CTG 4;RNA-binding protein BRUNOL-1;Trinucleotide repeat-containing gene 4 protein;, PF00076;, GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0036002;GO:0003723;GO:0006376;GO:0048026;GO:0000381;GO:0008380;, C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:pre-mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:positive regulation of mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; scaffold118 indexed_genome mRNA 2173754 2181638 . - . ID=transcript_13593;Q9BYD2 B2RD99 Q5SZR2 Q9BSW8,39S ribosomal protein L9, mitochondrial,Mitochondrial large ribosomal subunit protein bL9m {ECO:0000303|PubMed:25278503};, PF01281;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold118 indexed_genome mRNA 2183785 2184336 . - . ID=transcript_13594;Q9UMX2 E7EUE7 Q6GMR0,Ornithine decarboxylase antizyme 3,, PF02100;, GO:0072562;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008073;GO:1902268;GO:0006596;GO:0045732;GO:0006521;GO:0007283;, C:blood microparticle; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ornithine decarboxylase inhibitor activity;, P:negative regulation of polyamine transmembrane transport; P:polyamine biosynthetic process; P:positive regulation of protein catabolic process; P:regulation of cellular amino acid metabolic process; P:spermatogenesis; scaffold118 indexed_genome mRNA 2184471 2186969 . + . ID=transcript_13595;Q9UMX2 E7EUE7 Q6GMR0,Ornithine decarboxylase antizyme 3,, PF02100;, GO:0072562;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0008073;GO:1902268;GO:0006596;GO:0045732;GO:0006521;GO:0007283;, C:blood microparticle; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ornithine decarboxylase inhibitor activity;, P:negative regulation of polyamine transmembrane transport; P:polyamine biosynthetic process; P:positive regulation of protein catabolic process; P:regulation of cellular amino acid metabolic process; P:spermatogenesis; scaffold118 indexed_genome mRNA 2187004 2210777 . - . ID=transcript_13596;Q9Y2W6 D3DV24 Q5SZR3 Q5SZR5 Q8N582 Q9NYV5,Tudor and KH domain-containing protein,Tudor domain-containing protein 2;, PF00013;PF00567;, GO:0005739;GO:0071546;GO:0071547;GO:0003723;GO:0030154;GO:0043046;GO:0009566;GO:0031047;GO:0007140;GO:0034587;GO:0007283;, C:mitochondrion; C:pi-body; C:piP-body;, F:RNA binding;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:fertilization; P:gene silencing by RNA; P:male meiotic nuclear division; P:piRNA metabolic process; P:spermatogenesis;|Q9Y2W6 D3DV24 Q5SZR3 Q5SZR5 Q8N582 Q9NYV5,Tudor and KH domain-containing protein,Tudor domain-containing protein 2;, PF00013;PF00567;, GO:0005739;GO:0071546;GO:0071547;GO:0003723;GO:0030154;GO:0043046;GO:0009566;GO:0031047;GO:0007140;GO:0034587;GO:0007283;, C:mitochondrion; C:pi-body; C:piP-body;, F:RNA binding;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:fertilization; P:gene silencing by RNA; P:male meiotic nuclear division; P:piRNA metabolic process; P:spermatogenesis; scaffold118 indexed_genome mRNA 2218295 2219850 . - . ID=transcript_13597;Q6UY18,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4,Leucine-rich repeat neuronal protein 6D;, PF07679;PF13855;, GO:0031012;GO:0005615;GO:0016021;, C:extracellular matrix; C:extracellular space; C:integral component of membrane;|Q6UY18,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4,Leucine-rich repeat neuronal protein 6D;, PF07679;PF13855;, GO:0031012;GO:0005615;GO:0016021;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; scaffold118 indexed_genome mRNA 2224568 2234879 . - . ID=transcript_13598;P51449 Q5SZR9 Q8N5V7 Q8NCY8,Nuclear receptor ROR-gamma,Nuclear receptor RZR-gamma;Nuclear receptor subfamily 1 group F member 3;RAR-related orphan receptor C;Retinoid-related orphan receptor-gamma;, PF00104;PF00105;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0098531;GO:0004879;GO:0008142;GO:0000978;GO:1990837;GO:0008270;GO:0060612;GO:0036315;GO:0032922;GO:0019221;GO:0048535;GO:0070244;GO:0000122;GO:0048541;GO:0042753;GO:0045893;GO:0045598;GO:0010906;GO:0019218;GO:0006357;GO:0072539;GO:0042093;GO:0006367;GO:0006805;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:ligand-activated transcription factor activity; F:nuclear receptor activity; F:oxysterol binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:adipose tissue development; P:cellular response to sterol; P:circadian regulation of gene expression; P:cytokine-mediated signaling pathway; P:lymph node development; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:Peyer's patch development; P:positive regulation of circadian rhythm; P:positive regulation of transcription, DNA-templated; P:regulation of fat cell differentiation; P:regulation of glucose metabolic process; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:T-helper 17 cell differentiation; P:T-helper cell differentiation; P:transcription initiation from RNA polymerase II promoter; P:xenobiotic metabolic process;|P51449 Q5SZR9 Q8N5V7 Q8NCY8,Nuclear receptor ROR-gamma,Nuclear receptor RZR-gamma;Nuclear receptor subfamily 1 group F member 3;RAR-related orphan receptor C;Retinoid-related orphan receptor-gamma;, PF00104;PF00105;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0098531;GO:0004879;GO:0008142;GO:0000978;GO:1990837;GO:0008270;GO:0060612;GO:0036315;GO:0032922;GO:0019221;GO:0048535;GO:0070244;GO:0000122;GO:0048541;GO:0042753;GO:0045893;GO:0045598;GO:0010906;GO:0019218;GO:0006357;GO:0072539;GO:0042093;GO:0006367;GO:0006805;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:ligand-activated transcription factor activity; F:nuclear receptor activity; F:oxysterol binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:adipose tissue development; P:cellular response to sterol; P:circadian regulation of gene expression; P:cytokine-mediated signaling pathway; P:lymph node development; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:Peyer's patch development; P:positive regulation of circadian rhythm; P:positive regulation of transcription, DNA-templated; P:regulation of fat cell differentiation; P:regulation of glucose metabolic process; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:T-helper 17 cell differentiation; P:T-helper cell differentiation; P:transcription initiation from RNA polymerase II promoter; P:xenobiotic metabolic process;|P51449 Q5SZR9 Q8N5V7 Q8NCY8,Nuclear receptor ROR-gamma,Nuclear receptor RZR-gamma;Nuclear receptor subfamily 1 group F member 3;RAR-related orphan receptor C;Retinoid-related orphan receptor-gamma;, PF00104;PF00105;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0098531;GO:0004879;GO:0008142;GO:0000978;GO:1990837;GO:0008270;GO:0060612;GO:0036315;GO:0032922;GO:0019221;GO:0048535;GO:0070244;GO:0000122;GO:0048541;GO:0042753;GO:0045893;GO:0045598;GO:0010906;GO:0019218;GO:0006357;GO:0072539;GO:0042093;GO:0006367;GO:0006805;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:ligand-activated transcription factor activity; F:nuclear receptor activity; F:oxysterol binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:adipose tissue development; P:cellular response to sterol; P:circadian regulation of gene expression; P:cytokine-mediated signaling pathway; P:lymph node development; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:Peyer's patch development; P:positive regulation of circadian rhythm; P:positive regulation of transcription, DNA-templated; P:regulation of fat cell differentiation; P:regulation of glucose metabolic process; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:T-helper 17 cell differentiation; P:T-helper cell differentiation; P:transcription initiation from RNA polymerase II promoter; P:xenobiotic metabolic process;|P51449 Q5SZR9 Q8N5V7 Q8NCY8,Nuclear receptor ROR-gamma,Nuclear receptor RZR-gamma;Nuclear receptor subfamily 1 group F member 3;RAR-related orphan receptor C;Retinoid-related orphan receptor-gamma;, PF00104;PF00105;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0098531;GO:0004879;GO:0008142;GO:0000978;GO:1990837;GO:0008270;GO:0060612;GO:0036315;GO:0032922;GO:0019221;GO:0048535;GO:0070244;GO:0000122;GO:0048541;GO:0042753;GO:0045893;GO:0045598;GO:0010906;GO:0019218;GO:0006357;GO:0072539;GO:0042093;GO:0006367;GO:0006805;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:ligand-activated transcription factor activity; F:nuclear receptor activity; F:oxysterol binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:adipose tissue development; P:cellular response to sterol; P:circadian regulation of gene expression; P:cytokine-mediated signaling pathway; P:lymph node development; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:Peyer's patch development; P:positive regulation of circadian rhythm; P:positive regulation of transcription, DNA-templated; P:regulation of fat cell differentiation; P:regulation of glucose metabolic process; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:T-helper 17 cell differentiation; P:T-helper cell differentiation; P:transcription initiation from RNA polymerase II promoter; P:xenobiotic metabolic process;|P51449 Q5SZR9 Q8N5V7 Q8NCY8,Nuclear receptor ROR-gamma,Nuclear receptor RZR-gamma;Nuclear receptor subfamily 1 group F member 3;RAR-related orphan receptor C;Retinoid-related orphan receptor-gamma;, PF00104;PF00105;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0098531;GO:0004879;GO:0008142;GO:0000978;GO:1990837;GO:0008270;GO:0060612;GO:0036315;GO:0032922;GO:0019221;GO:0048535;GO:0070244;GO:0000122;GO:0048541;GO:0042753;GO:0045893;GO:0045598;GO:0010906;GO:0019218;GO:0006357;GO:0072539;GO:0042093;GO:0006367;GO:0006805;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:ligand-activated transcription factor activity; F:nuclear receptor activity; F:oxysterol binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:adipose tissue development; P:cellular response to sterol; P:circadian regulation of gene expression; P:cytokine-mediated signaling pathway; P:lymph node development; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:Peyer's patch development; P:positive regulation of circadian rhythm; P:positive regulation of transcription, DNA-templated; P:regulation of fat cell differentiation; P:regulation of glucose metabolic process; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:T-helper 17 cell differentiation; P:T-helper cell differentiation; P:transcription initiation from RNA polymerase II promoter; P:xenobiotic metabolic process;|P51449 Q5SZR9 Q8N5V7 Q8NCY8,Nuclear receptor ROR-gamma,Nuclear receptor RZR-gamma;Nuclear receptor subfamily 1 group F member 3;RAR-related orphan receptor C;Retinoid-related orphan receptor-gamma;, PF00104;PF00105;, GO:0000785;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0098531;GO:0004879;GO:0008142;GO:0000978;GO:1990837;GO:0008270;GO:0060612;GO:0036315;GO:0032922;GO:0019221;GO:0048535;GO:0070244;GO:0000122;GO:0048541;GO:0042753;GO:0045893;GO:0045598;GO:0010906;GO:0019218;GO:0006357;GO:0072539;GO:0042093;GO:0006367;GO:0006805;, C:chromatin; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:ligand-activated transcription factor activity; F:nuclear receptor activity; F:oxysterol binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:adipose tissue development; P:cellular response to sterol; P:circadian regulation of gene expression; P:cytokine-mediated signaling pathway; P:lymph node development; P:negative regulation of thymocyte apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:Peyer's patch development; P:positive regulation of circadian rhythm; P:positive regulation of transcription, DNA-templated; P:regulation of fat cell differentiation; P:regulation of glucose metabolic process; P:regulation of steroid metabolic process; P:regulation of transcription by RNA polymerase II; P:T-helper 17 cell differentiation; P:T-helper cell differentiation; P:transcription initiation from RNA polymerase II promoter; P:xenobiotic metabolic process; scaffold118 indexed_genome mRNA 2262491 2265125 . + . ID=transcript_13599;P62841 A5D8V9 P11174 Q3KRA1 Q9UDC2,40S ribosomal protein S15,RIG protein;Small ribosomal subunit protein uS19 {ECO:0000303|PubMed:24524803};, PF00203;, GO:0005829;GO:0022627;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0003723;GO:0003735;GO:0000184;GO:0001649;GO:0000028;GO:0042274;GO:0000056;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:osteoblast differentiation; P:ribosomal small subunit assembly; P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold118 indexed_genome mRNA 2316182 2350628 . - . ID=transcript_13600;Q5T1C6 B2RBX2 Q96KR2,Acyl-coenzyme A thioesterase THEM4,Carboxyl-terminal modulator protein;Thioesterase superfamily member 4;, PF03061;, GO:0005829;GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005886;GO:0032587;GO:0102991;GO:0016290;GO:0006637;GO:0006631;GO:0051898;GO:0051897;GO:0043491;GO:1902108;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:ruffle membrane;, F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process; P:negative regulation of protein kinase B signaling; P:positive regulation of protein kinase B signaling; P:protein kinase B signaling; P:regulation of mitochondrial membrane permeability involved in apoptotic process;|Q5T1C6 B2RBX2 Q96KR2,Acyl-coenzyme A thioesterase THEM4,Carboxyl-terminal modulator protein;Thioesterase superfamily member 4;, PF03061;, GO:0005829;GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005886;GO:0032587;GO:0102991;GO:0016290;GO:0006637;GO:0006631;GO:0051898;GO:0051897;GO:0043491;GO:1902108;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:plasma membrane; C:ruffle membrane;, F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity;, P:acyl-CoA metabolic process; P:fatty acid metabolic process; P:negative regulation of protein kinase B signaling; P:positive regulation of protein kinase B signaling; P:protein kinase B signaling; P:regulation of mitochondrial membrane permeability involved in apoptotic process; scaffold118 indexed_genome mRNA 2417834 2419932 . - . ID=transcript_13601;P60903 A8K4V8 P08206 Q5T1C5,Protein S100-A10,Calpactin I light chain;Calpactin-1 light chain;Cellular ligand of annexin II;S100 calcium-binding protein A10;p10 protein;p11;, PF01023;, GO:1990665;GO:0062023;GO:0005737;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0019897;GO:0005509;GO:0048306;GO:0044325;GO:0042803;GO:0001765;GO:0051099;GO:0051894;GO:0043547;GO:0051496;GO:1900026;GO:0072659;GO:0042493;GO:0006900;, C:AnxA2-p11 complex; C:collagen-containing extracellular matrix; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of plasma membrane;, F:calcium ion binding; F:calcium-dependent protein binding; F:ion channel binding; F:protein homodimerization activity;, P:membrane raft assembly; P:positive regulation of binding; P:positive regulation of focal adhesion assembly; P:positive regulation of GTPase activity; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to plasma membrane; P:response to drug; P:vesicle budding from membrane; scaffold118 indexed_genome mRNA 2421740 2434119 . + . ID=transcript_13602;P60903 A8K4V8 P08206 Q5T1C5,Protein S100-A10,Calpactin I light chain;Calpactin-1 light chain;Cellular ligand of annexin II;S100 calcium-binding protein A10;p10 protein;p11;, PF01023;, GO:1990665;GO:0062023;GO:0005737;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0019897;GO:0005509;GO:0048306;GO:0044325;GO:0042803;GO:0001765;GO:0051099;GO:0051894;GO:0043547;GO:0051496;GO:1900026;GO:0072659;GO:0042493;GO:0006900;, C:AnxA2-p11 complex; C:collagen-containing extracellular matrix; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space; C:extrinsic component of plasma membrane;, F:calcium ion binding; F:calcium-dependent protein binding; F:ion channel binding; F:protein homodimerization activity;, P:membrane raft assembly; P:positive regulation of binding; P:positive regulation of focal adhesion assembly; P:positive regulation of GTPase activity; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to plasma membrane; P:response to drug; P:vesicle budding from membrane; scaffold118 indexed_genome mRNA 2456431 2459254 . - . ID=transcript_13603;P31949 Q5VTK0,Protein S100-A11,Calgizzarin;Metastatic lymph node gene 70 protein;Protein S100-C;S100 calcium-binding protein A11;, PF00036;PF01023;, GO:0005912;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0001726;GO:0034774;GO:0098641;GO:0005509;GO:0048306;GO:0042803;GO:0044548;GO:0008285;GO:0008156;GO:0043312;GO:0014911;GO:0007165;, C:adherens junction; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:ruffle; C:secretory granule lumen;, F:cadherin binding involved in cell-cell adhesion; F:calcium ion binding; F:calcium-dependent protein binding; F:protein homodimerization activity; F:S100 protein binding;, P:negative regulation of cell population proliferation; P:negative regulation of DNA replication; P:neutrophil degranulation; P:positive regulation of smooth muscle cell migration; P:signal transduction;|P31949 Q5VTK0,Protein S100-A11,Calgizzarin;Metastatic lymph node gene 70 protein;Protein S100-C;S100 calcium-binding protein A11;, PF00036;PF01023;, GO:0005912;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0001726;GO:0034774;GO:0098641;GO:0005509;GO:0048306;GO:0042803;GO:0044548;GO:0008285;GO:0008156;GO:0043312;GO:0014911;GO:0007165;, C:adherens junction; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:ruffle; C:secretory granule lumen;, F:cadherin binding involved in cell-cell adhesion; F:calcium ion binding; F:calcium-dependent protein binding; F:protein homodimerization activity; F:S100 protein binding;, P:negative regulation of cell population proliferation; P:negative regulation of DNA replication; P:neutrophil degranulation; P:positive regulation of smooth muscle cell migration; P:signal transduction;|P31949 Q5VTK0,Protein S100-A11,Calgizzarin;Metastatic lymph node gene 70 protein;Protein S100-C;S100 calcium-binding protein A11;, PF00036;PF01023;, GO:0005912;GO:0005737;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0001726;GO:0034774;GO:0098641;GO:0005509;GO:0048306;GO:0042803;GO:0044548;GO:0008285;GO:0008156;GO:0043312;GO:0014911;GO:0007165;, C:adherens junction; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus; C:ruffle; C:secretory granule lumen;, F:cadherin binding involved in cell-cell adhesion; F:calcium ion binding; F:calcium-dependent protein binding; F:protein homodimerization activity; F:S100 protein binding;, P:negative regulation of cell population proliferation; P:negative regulation of DNA replication; P:neutrophil degranulation; P:positive regulation of smooth muscle cell migration; P:signal transduction; scaffold119 indexed_genome mRNA 399890 400926 . + . ID=transcript_13604;Q9Y5K3 A8IX00 B2RCX8 B4DK10 E9PD84 O60621 Q86XC9,Choline-phosphate cytidylyltransferase B,CCT-beta;CTP:phosphocholine cytidylyltransferase B;Phosphorylcholine transferase B;, PF01467;, GO:0005737;GO:0005783;GO:0005789;GO:0004105;GO:0042802;GO:0031210;GO:0006657;GO:0001541;GO:0006656;GO:0007283;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:choline-phosphate cytidylyltransferase activity; F:identical protein binding; F:phosphatidylcholine binding;, P:CDP-choline pathway; P:ovarian follicle development; P:phosphatidylcholine biosynthetic process; P:spermatogenesis; scaffold119 indexed_genome mRNA 643588 667203 . - . ID=transcript_13605;P78562 O00678 Q13646 Q2M325 Q93032 Q99827,Phosphate-regulating neutral endopeptidase PHEX,Metalloendopeptidase homolog PEX;Vitamin D-resistant hypophosphatemic rickets protein;X-linked hypophosphatemia protein;, PF01431;PF05649;, GO:0005783;GO:0005794;GO:0005887;GO:0048471;GO:0005886;GO:0004222;GO:0008270;GO:0060348;GO:0030282;GO:0007267;GO:0006464;GO:0071374;GO:0071305;GO:0030324;GO:0042476;GO:0019637;GO:0016485;GO:0006508;GO:0060416;GO:1990418;GO:1904383;GO:0001501;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:metalloendopeptidase activity; F:zinc ion binding;, P:bone development; P:bone mineralization; P:cell-cell signaling; P:cellular protein modification process; P:cellular response to parathyroid hormone stimulus; P:cellular response to vitamin D; P:lung development; P:odontogenesis; P:organophosphate metabolic process; P:protein processing; P:proteolysis; P:response to growth hormone; P:response to insulin-like growth factor stimulus; P:response to sodium phosphate; P:skeletal system development; scaffold119 indexed_genome mRNA 863510 917108 . - . ID=transcript_13606;P52788 A6NHA7 A6NI34 B2R9M0 O00544 Q9UQS1,Spermine synthase,Spermidine aminopropyltransferase;, PF17284;PF17950;, GO:0005829;GO:0070062;GO:0016768;GO:0006555;GO:0006595;GO:0006597;, C:cytosol; C:extracellular exosome;, F:spermine synthase activity;, P:methionine metabolic process; P:polyamine metabolic process; P:spermine biosynthetic process;|P52788 A6NHA7 A6NI34 B2R9M0 O00544 Q9UQS1,Spermine synthase,Spermidine aminopropyltransferase;, PF17284;PF17950;, GO:0005829;GO:0070062;GO:0016768;GO:0006555;GO:0006595;GO:0006597;, C:cytosol; C:extracellular exosome;, F:spermine synthase activity;, P:methionine metabolic process; P:polyamine metabolic process; P:spermine biosynthetic process;|P52788 A6NHA7 A6NI34 B2R9M0 O00544 Q9UQS1,Spermine synthase,Spermidine aminopropyltransferase;, PF17284;PF17950;, GO:0005829;GO:0070062;GO:0016768;GO:0006555;GO:0006595;GO:0006597;, C:cytosol; C:extracellular exosome;, F:spermine synthase activity;, P:methionine metabolic process; P:polyamine metabolic process; P:spermine biosynthetic process; scaffold119 indexed_genome mRNA 977392 989505 . + . ID=transcript_13607;O43462 Q9UM70 Q9UMD3,Membrane-bound transcription factor site-2 protease {ECO:0000305},Endopeptidase S2P {ECO:0000303|PubMed:9659902};Sterol regulatory element-binding proteins intramembrane protease {ECO:0000303|PubMed:9659902};, PF02163;, GO:0005737;GO:0000139;GO:0016021;GO:0046872;GO:0004222;GO:0036500;GO:0070977;GO:0008203;GO:0030968;GO:0031293;GO:0051091;GO:1990440;GO:0045540;GO:1905897;GO:0034976;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:metalloendopeptidase activity;, P:ATF6-mediated unfolded protein response; P:bone maturation; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:membrane protein intracellular domain proteolysis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of cholesterol biosynthetic process; P:regulation of response to endoplasmic reticulum stress; P:response to endoplasmic reticulum stress;|O43462 Q9UM70 Q9UMD3,Membrane-bound transcription factor site-2 protease {ECO:0000305},Endopeptidase S2P {ECO:0000303|PubMed:9659902};Sterol regulatory element-binding proteins intramembrane protease {ECO:0000303|PubMed:9659902};, PF02163;, GO:0005737;GO:0000139;GO:0016021;GO:0046872;GO:0004222;GO:0036500;GO:0070977;GO:0008203;GO:0030968;GO:0031293;GO:0051091;GO:1990440;GO:0045540;GO:1905897;GO:0034976;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:metalloendopeptidase activity;, P:ATF6-mediated unfolded protein response; P:bone maturation; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:membrane protein intracellular domain proteolysis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of cholesterol biosynthetic process; P:regulation of response to endoplasmic reticulum stress; P:response to endoplasmic reticulum stress;|O43462 Q9UM70 Q9UMD3,Membrane-bound transcription factor site-2 protease {ECO:0000305},Endopeptidase S2P {ECO:0000303|PubMed:9659902};Sterol regulatory element-binding proteins intramembrane protease {ECO:0000303|PubMed:9659902};, PF02163;, GO:0005737;GO:0000139;GO:0016021;GO:0046872;GO:0004222;GO:0036500;GO:0070977;GO:0008203;GO:0030968;GO:0031293;GO:0051091;GO:1990440;GO:0045540;GO:1905897;GO:0034976;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:metalloendopeptidase activity;, P:ATF6-mediated unfolded protein response; P:bone maturation; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:membrane protein intracellular domain proteolysis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of cholesterol biosynthetic process; P:regulation of response to endoplasmic reticulum stress; P:response to endoplasmic reticulum stress;|O43462 Q9UM70 Q9UMD3,Membrane-bound transcription factor site-2 protease {ECO:0000305},Endopeptidase S2P {ECO:0000303|PubMed:9659902};Sterol regulatory element-binding proteins intramembrane protease {ECO:0000303|PubMed:9659902};, PF02163;, GO:0005737;GO:0000139;GO:0016021;GO:0046872;GO:0004222;GO:0036500;GO:0070977;GO:0008203;GO:0030968;GO:0031293;GO:0051091;GO:1990440;GO:0045540;GO:1905897;GO:0034976;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:metalloendopeptidase activity;, P:ATF6-mediated unfolded protein response; P:bone maturation; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:membrane protein intracellular domain proteolysis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of cholesterol biosynthetic process; P:regulation of response to endoplasmic reticulum stress; P:response to endoplasmic reticulum stress; scaffold119 indexed_genome mRNA 994292 995417 . - . ID=transcript_13608;O43462 Q9UM70 Q9UMD3,Membrane-bound transcription factor site-2 protease {ECO:0000305},Endopeptidase S2P {ECO:0000303|PubMed:9659902};Sterol regulatory element-binding proteins intramembrane protease {ECO:0000303|PubMed:9659902};, PF02163;, GO:0005737;GO:0000139;GO:0016021;GO:0046872;GO:0004222;GO:0036500;GO:0070977;GO:0008203;GO:0030968;GO:0031293;GO:0051091;GO:1990440;GO:0045540;GO:1905897;GO:0034976;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:metalloendopeptidase activity;, P:ATF6-mediated unfolded protein response; P:bone maturation; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:membrane protein intracellular domain proteolysis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of cholesterol biosynthetic process; P:regulation of response to endoplasmic reticulum stress; P:response to endoplasmic reticulum stress; scaffold119 indexed_genome mRNA 1000175 1002323 . + . ID=transcript_13609;O15391 B2RP10 Q6Q1S4,Transcription factor YY2,Yin and yang 2;Zinc finger protein 631;, PF00096;, GO:0005634;GO:0031519;GO:0005667;GO:0000987;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0045944;GO:0006357;, C:nucleus; C:PcG protein complex; C:transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold119 indexed_genome mRNA 1004786 1022289 . - . ID=transcript_13610;O43462 Q9UM70 Q9UMD3,Membrane-bound transcription factor site-2 protease {ECO:0000305},Endopeptidase S2P {ECO:0000303|PubMed:9659902};Sterol regulatory element-binding proteins intramembrane protease {ECO:0000303|PubMed:9659902};, PF02163;, GO:0005737;GO:0000139;GO:0016021;GO:0046872;GO:0004222;GO:0036500;GO:0070977;GO:0008203;GO:0030968;GO:0031293;GO:0051091;GO:1990440;GO:0045540;GO:1905897;GO:0034976;, C:cytoplasm; C:Golgi membrane; C:integral component of membrane;, F:metal ion binding; F:metalloendopeptidase activity;, P:ATF6-mediated unfolded protein response; P:bone maturation; P:cholesterol metabolic process; P:endoplasmic reticulum unfolded protein response; P:membrane protein intracellular domain proteolysis; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of cholesterol biosynthetic process; P:regulation of response to endoplasmic reticulum stress; P:response to endoplasmic reticulum stress; scaffold119 indexed_genome mRNA 1079620 1130736 . + . ID=transcript_13611;Q9UHP9 B1AWX2,Small muscular protein,Stretch-responsive skeletal muscle protein;, PF15355;, GO:0043034;GO:0031430;GO:0005927;GO:0005634;GO:0006941;, C:costamere; C:M band; C:muscle tendon junction; C:nucleus;, , P:striated muscle contraction; scaffold119 indexed_genome mRNA 1193483 1325528 . - . ID=transcript_13612;Q8N239,Kelch-like protein 34,, PF07707;PF00651;PF01344;, GO:0005615;, C:extracellular space;|Q8WXI2 B4DGR4 B7ZLJ1 B9EG83 E7ESA4 O94976 Q5JPK4 Q5JPN0 Q8WXI1,Connector enhancer of kinase suppressor of ras 2,CNK homolog protein 2;, PF10534;PF06663;PF00595;PF00169;PF00536;, GO:0005737;GO:0070062;GO:0099147;GO:0098978;GO:0043005;GO:0043025;GO:0005886;GO:0042802;GO:0019901;GO:0035556;GO:0099173;GO:0009966;, C:cytoplasm; C:extracellular exosome; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:identical protein binding; F:protein kinase binding;, P:intracellular signal transduction; P:postsynapse organization; P:regulation of signal transduction;|Q8WXI2 B4DGR4 B7ZLJ1 B9EG83 E7ESA4 O94976 Q5JPK4 Q5JPN0 Q8WXI1,Connector enhancer of kinase suppressor of ras 2,CNK homolog protein 2;, PF10534;PF06663;PF00595;PF00169;PF00536;, GO:0005737;GO:0070062;GO:0099147;GO:0098978;GO:0043005;GO:0043025;GO:0005886;GO:0042802;GO:0019901;GO:0035556;GO:0099173;GO:0009966;, C:cytoplasm; C:extracellular exosome; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:identical protein binding; F:protein kinase binding;, P:intracellular signal transduction; P:postsynapse organization; P:regulation of signal transduction; scaffold119 indexed_genome mRNA 1337555 1469693 . - . ID=transcript_13613;Q8WXI2 B4DGR4 B7ZLJ1 B9EG83 E7ESA4 O94976 Q5JPK4 Q5JPN0 Q8WXI1,Connector enhancer of kinase suppressor of ras 2,CNK homolog protein 2;, PF10534;PF06663;PF00595;PF00169;PF00536;, GO:0005737;GO:0070062;GO:0099147;GO:0098978;GO:0043005;GO:0043025;GO:0005886;GO:0042802;GO:0019901;GO:0035556;GO:0099173;GO:0009966;, C:cytoplasm; C:extracellular exosome; C:extrinsic component of postsynaptic density membrane; C:glutamatergic synapse; C:neuron projection; C:neuronal cell body; C:plasma membrane;, F:identical protein binding; F:protein kinase binding;, P:intracellular signal transduction; P:postsynapse organization; P:regulation of signal transduction; scaffold119 indexed_genome mRNA 2412196 2490659 . + . ID=transcript_13614;P51812 B2R9V4 Q4VAP3 Q59H26 Q5JPK8 Q7Z3Z7,Ribosomal protein S6 kinase alpha-3,90 kDa ribosomal protein S6 kinase 3;Insulin-stimulated protein kinase 1;MAP kinase-activated protein kinase 1b;Ribosomal S6 kinase 2;pp90RSK2;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005524;GO:0043027;GO:0000287;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0007049;GO:0007417;GO:0007268;GO:0035556;GO:0043066;GO:0043154;GO:0018105;GO:0045597;GO:0030307;GO:0045944;GO:0043620;GO:0043555;GO:0032496;GO:0007165;GO:0001501;GO:0002224;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:magnesium ion binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:cell cycle; P:central nervous system development; P:chemical synaptic transmission; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:peptidyl-serine phosphorylation; P:positive regulation of cell differentiation; P:positive regulation of cell growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA-templated transcription in response to stress; P:regulation of translation in response to stress; P:response to lipopolysaccharide; P:signal transduction; P:skeletal system development; P:toll-like receptor signaling pathway; scaffold119 indexed_genome mRNA 2493302 2504617 . + . ID=transcript_13615;P47813 B2R5U5 Q0VGC2 Q5JPS5 Q5JPS6,Eukaryotic translation initiation factor 1A, X-chromosomal,Eukaryotic translation initiation factor 4C;, PF01176;, GO:0005829;GO:0003723;GO:0008135;GO:0003743;GO:0006413;GO:0016032;, C:cytosol;, F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:translational initiation; P:viral process;|P47813 B2R5U5 Q0VGC2 Q5JPS5 Q5JPS6,Eukaryotic translation initiation factor 1A, X-chromosomal,Eukaryotic translation initiation factor 4C;, PF01176;, GO:0005829;GO:0003723;GO:0008135;GO:0003743;GO:0006413;GO:0016032;, C:cytosol;, F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:translational initiation; P:viral process; scaffold119 indexed_genome mRNA 2571697 2628941 . + . ID=transcript_13616;Q8N792,MAP7 domain-containing protein 2,, PF05672;, GO:0015630;GO:0000226;, C:microtubule cytoskeleton;, , P:microtubule cytoskeleton organization;|Q8N792,MAP7 domain-containing protein 2,, PF05672;, GO:0015630;GO:0000226;, C:microtubule cytoskeleton;, , P:microtubule cytoskeleton organization;|Q8N792,MAP7 domain-containing protein 2,, PF05672;, GO:0015630;GO:0000226;, C:microtubule cytoskeleton;, , P:microtubule cytoskeleton organization;|Q8N792,MAP7 domain-containing protein 2,, PF05672;, GO:0015630;GO:0000226;, C:microtubule cytoskeleton;, , P:microtubule cytoskeleton organization; scaffold119 indexed_genome mRNA 2644984 2665767 . + . ID=transcript_13617;A2AJT9 A1A4E8 Q5VSM7 Q5VSN1 Q6ZS60 Q8N1W7,BCLAF1 and THRAP3 family member 3 {ECO:0000312|HGNC:HGNC:27413},, PF15440;, GO:0016592;GO:0005739;GO:0003677;GO:0003712;GO:0045944;, C:mediator complex; C:mitochondrion;, F:DNA binding; F:transcription coregulator activity;, P:positive regulation of transcription by RNA polymerase II;|A2AJT9 A1A4E8 Q5VSM7 Q5VSN1 Q6ZS60 Q8N1W7,BCLAF1 and THRAP3 family member 3 {ECO:0000312|HGNC:HGNC:27413},, PF15440;, GO:0016592;GO:0005739;GO:0003677;GO:0003712;GO:0045944;, C:mediator complex; C:mitochondrion;, F:DNA binding; F:transcription coregulator activity;, P:positive regulation of transcription by RNA polymerase II; scaffold119 indexed_genome mRNA 2673434 2689876 . + . ID=transcript_13618;A2AJT9 A1A4E8 Q5VSM7 Q5VSN1 Q6ZS60 Q8N1W7,BCLAF1 and THRAP3 family member 3 {ECO:0000312|HGNC:HGNC:27413},, PF15440;, GO:0016592;GO:0005739;GO:0003677;GO:0003712;GO:0045944;, C:mediator complex; C:mitochondrion;, F:DNA binding; F:transcription coregulator activity;, P:positive regulation of transcription by RNA polymerase II;|A2AJT9 A1A4E8 Q5VSM7 Q5VSN1 Q6ZS60 Q8N1W7,BCLAF1 and THRAP3 family member 3 {ECO:0000312|HGNC:HGNC:27413},, PF15440;, GO:0016592;GO:0005739;GO:0003677;GO:0003712;GO:0045944;, C:mediator complex; C:mitochondrion;, F:DNA binding; F:transcription coregulator activity;, P:positive regulation of transcription by RNA polymerase II;|A2AJT9 A1A4E8 Q5VSM7 Q5VSN1 Q6ZS60 Q8N1W7,BCLAF1 and THRAP3 family member 3 {ECO:0000312|HGNC:HGNC:27413},, PF15440;, GO:0016592;GO:0005739;GO:0003677;GO:0003712;GO:0045944;, C:mediator complex; C:mitochondrion;, F:DNA binding; F:transcription coregulator activity;, P:positive regulation of transcription by RNA polymerase II; scaffold119 indexed_genome mRNA 3040752 3074377 . + . ID=transcript_13619;Q96B97 B7Z1D5 Q5JPT4 Q5JPT5 Q8IWX6 Q8IX98 Q96RN4 Q9NYR0,SH3 domain-containing kinase-binding protein 1,CD2-binding protein 3;Cbl-interacting protein of 85 kDa;Human Src family kinase-binding protein 1;, PF14604;, GO:0005911;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0030139;GO:0005925;GO:0043005;GO:0005886;GO:0045202;GO:0017124;GO:0007015;GO:0006915;GO:0007411;GO:0016477;GO:0007267;GO:0007010;GO:0006897;GO:0061024;GO:0042059;GO:0050871;GO:0008360;, C:cell-cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endocytic vesicle; C:focal adhesion; C:neuron projection; C:plasma membrane; C:synapse;, F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:axon guidance; P:cell migration; P:cell-cell signaling; P:cytoskeleton organization; P:endocytosis; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of B cell activation; P:regulation of cell shape;|Q96B97 B7Z1D5 Q5JPT4 Q5JPT5 Q8IWX6 Q8IX98 Q96RN4 Q9NYR0,SH3 domain-containing kinase-binding protein 1,CD2-binding protein 3;Cbl-interacting protein of 85 kDa;Human Src family kinase-binding protein 1;, PF14604;, GO:0005911;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0030139;GO:0005925;GO:0043005;GO:0005886;GO:0045202;GO:0017124;GO:0007015;GO:0006915;GO:0007411;GO:0016477;GO:0007267;GO:0007010;GO:0006897;GO:0061024;GO:0042059;GO:0050871;GO:0008360;, C:cell-cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endocytic vesicle; C:focal adhesion; C:neuron projection; C:plasma membrane; C:synapse;, F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:axon guidance; P:cell migration; P:cell-cell signaling; P:cytoskeleton organization; P:endocytosis; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of B cell activation; P:regulation of cell shape;|Q96B97 B7Z1D5 Q5JPT4 Q5JPT5 Q8IWX6 Q8IX98 Q96RN4 Q9NYR0,SH3 domain-containing kinase-binding protein 1,CD2-binding protein 3;Cbl-interacting protein of 85 kDa;Human Src family kinase-binding protein 1;, PF14604;, GO:0005911;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0030139;GO:0005925;GO:0043005;GO:0005886;GO:0045202;GO:0017124;GO:0007015;GO:0006915;GO:0007411;GO:0016477;GO:0007267;GO:0007010;GO:0006897;GO:0061024;GO:0042059;GO:0050871;GO:0008360;, C:cell-cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endocytic vesicle; C:focal adhesion; C:neuron projection; C:plasma membrane; C:synapse;, F:SH3 domain binding;, P:actin filament organization; P:apoptotic process; P:axon guidance; P:cell migration; P:cell-cell signaling; P:cytoskeleton organization; P:endocytosis; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of B cell activation; P:regulation of cell shape; scaffold119 indexed_genome mRNA 3143020 3223834 . + . ID=transcript_13620;Q6ZN16 A2AI49 A2AI50 A6NJ61 Q5JPR4 Q6ZMV3,Mitogen-activated protein kinase kinase kinase 15,Apoptosis signal-regulating kinase 3;MAPK/ERK kinase kinase 15;, PF19039;PF13281;PF00069;, GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0000186;, , F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity;|Q6ZN16 A2AI49 A2AI50 A6NJ61 Q5JPR4 Q6ZMV3,Mitogen-activated protein kinase kinase kinase 15,Apoptosis signal-regulating kinase 3;MAPK/ERK kinase kinase 15;, PF19039;PF13281;PF00069;, GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0000186;, , F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity;|Q6ZN16 A2AI49 A2AI50 A6NJ61 Q5JPR4 Q6ZMV3,Mitogen-activated protein kinase kinase kinase 15,Apoptosis signal-regulating kinase 3;MAPK/ERK kinase kinase 15;, PF19039;PF13281;PF00069;, GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0000186;, , F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity; scaffold119 indexed_genome mRNA 3224621 3252980 . + . ID=transcript_13621;Q6ZN16 A2AI49 A2AI50 A6NJ61 Q5JPR4 Q6ZMV3,Mitogen-activated protein kinase kinase kinase 15,Apoptosis signal-regulating kinase 3;MAPK/ERK kinase kinase 15;, PF19039;PF13281;PF00069;, GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0000186;, , F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity;|Q6ZN16 A2AI49 A2AI50 A6NJ61 Q5JPR4 Q6ZMV3,Mitogen-activated protein kinase kinase kinase 15,Apoptosis signal-regulating kinase 3;MAPK/ERK kinase kinase 15;, PF19039;PF13281;PF00069;, GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0000186;, , F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPKK activity;|Q9UBU0 Q9UNG4 Q9UNG5,Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial,PDHE1-A type I;, PF00676;, GO:0005759;GO:0005967;GO:0005739;GO:0005730;GO:0005634;GO:0045254;GO:0004739;GO:0034604;GO:0006086;GO:0006006;GO:0061732;GO:0006090;GO:0006099;, C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleolus; C:nucleus; C:pyruvate dehydrogenase complex;, F:pyruvate dehydrogenase (acetyl-transferring) activity; F:pyruvate dehydrogenase (NAD+) activity;, P:acetyl-CoA biosynthetic process from pyruvate; P:glucose metabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:pyruvate metabolic process; P:tricarboxylic acid cycle;|Q9UBU0 Q9UNG4 Q9UNG5,Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial,PDHE1-A type I;, PF00676;, GO:0005759;GO:0005967;GO:0005739;GO:0005730;GO:0005634;GO:0045254;GO:0004739;GO:0034604;GO:0006086;GO:0006006;GO:0061732;GO:0006090;GO:0006099;, C:mitochondrial matrix; C:mitochondrial pyruvate dehydrogenase complex; C:mitochondrion; C:nucleolus; C:nucleus; C:pyruvate dehydrogenase complex;, F:pyruvate dehydrogenase (acetyl-transferring) activity; F:pyruvate dehydrogenase (NAD+) activity;, P:acetyl-CoA biosynthetic process from pyruvate; P:glucose metabolic process; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; P:pyruvate metabolic process; P:tricarboxylic acid cycle; scaffold120 indexed_genome mRNA 6231 20846 . - . ID=transcript_13622;Q96A49 Q68CP1 Q96C60 Q96JQ6 Q96T20,Synapse-associated protein 1 {ECO:0000305},BSD domain-containing signal transducer and Akt interactor protein {ECO:0000303|PubMed:23300339};, PF03909;, GO:0030424;GO:0005829;GO:0030425;GO:0070062;GO:0031234;GO:0005794;GO:0030426;GO:0005654;GO:0043204;GO:0048471;GO:0045211;GO:0042734;GO:0030154;GO:0071364;GO:0032869;GO:1990314;GO:0036120;GO:0045600;GO:0071902;GO:0038203;, C:axon; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Golgi apparatus; C:growth cone; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:presynaptic membrane;, , P:cell differentiation; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:positive regulation of fat cell differentiation; P:positive regulation of protein serine/threonine kinase activity; P:TORC2 signaling;|Q96A49 Q68CP1 Q96C60 Q96JQ6 Q96T20,Synapse-associated protein 1 {ECO:0000305},BSD domain-containing signal transducer and Akt interactor protein {ECO:0000303|PubMed:23300339};, PF03909;, GO:0030424;GO:0005829;GO:0030425;GO:0070062;GO:0031234;GO:0005794;GO:0030426;GO:0005654;GO:0043204;GO:0048471;GO:0045211;GO:0042734;GO:0030154;GO:0071364;GO:0032869;GO:1990314;GO:0036120;GO:0045600;GO:0071902;GO:0038203;, C:axon; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Golgi apparatus; C:growth cone; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:presynaptic membrane;, , P:cell differentiation; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:positive regulation of fat cell differentiation; P:positive regulation of protein serine/threonine kinase activity; P:TORC2 signaling;|Q96A49 Q68CP1 Q96C60 Q96JQ6 Q96T20,Synapse-associated protein 1 {ECO:0000305},BSD domain-containing signal transducer and Akt interactor protein {ECO:0000303|PubMed:23300339};, PF03909;, GO:0030424;GO:0005829;GO:0030425;GO:0070062;GO:0031234;GO:0005794;GO:0030426;GO:0005654;GO:0043204;GO:0048471;GO:0045211;GO:0042734;GO:0030154;GO:0071364;GO:0032869;GO:1990314;GO:0036120;GO:0045600;GO:0071902;GO:0038203;, C:axon; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Golgi apparatus; C:growth cone; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:presynaptic membrane;, , P:cell differentiation; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:positive regulation of fat cell differentiation; P:positive regulation of protein serine/threonine kinase activity; P:TORC2 signaling;|Q96A49 Q68CP1 Q96C60 Q96JQ6 Q96T20,Synapse-associated protein 1 {ECO:0000305},BSD domain-containing signal transducer and Akt interactor protein {ECO:0000303|PubMed:23300339};, PF03909;, GO:0030424;GO:0005829;GO:0030425;GO:0070062;GO:0031234;GO:0005794;GO:0030426;GO:0005654;GO:0043204;GO:0048471;GO:0045211;GO:0042734;GO:0030154;GO:0071364;GO:0032869;GO:1990314;GO:0036120;GO:0045600;GO:0071902;GO:0038203;, C:axon; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Golgi apparatus; C:growth cone; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:presynaptic membrane;, , P:cell differentiation; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:positive regulation of fat cell differentiation; P:positive regulation of protein serine/threonine kinase activity; P:TORC2 signaling;|Q96A49 Q68CP1 Q96C60 Q96JQ6 Q96T20,Synapse-associated protein 1 {ECO:0000305},BSD domain-containing signal transducer and Akt interactor protein {ECO:0000303|PubMed:23300339};, PF03909;, GO:0030424;GO:0005829;GO:0030425;GO:0070062;GO:0031234;GO:0005794;GO:0030426;GO:0005654;GO:0043204;GO:0048471;GO:0045211;GO:0042734;GO:0030154;GO:0071364;GO:0032869;GO:1990314;GO:0036120;GO:0045600;GO:0071902;GO:0038203;, C:axon; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Golgi apparatus; C:growth cone; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:presynaptic membrane;, , P:cell differentiation; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:positive regulation of fat cell differentiation; P:positive regulation of protein serine/threonine kinase activity; P:TORC2 signaling;|Q96A49 Q68CP1 Q96C60 Q96JQ6 Q96T20,Synapse-associated protein 1 {ECO:0000305},BSD domain-containing signal transducer and Akt interactor protein {ECO:0000303|PubMed:23300339};, PF03909;, GO:0030424;GO:0005829;GO:0030425;GO:0070062;GO:0031234;GO:0005794;GO:0030426;GO:0005654;GO:0043204;GO:0048471;GO:0045211;GO:0042734;GO:0030154;GO:0071364;GO:0032869;GO:1990314;GO:0036120;GO:0045600;GO:0071902;GO:0038203;, C:axon; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Golgi apparatus; C:growth cone; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:presynaptic membrane;, , P:cell differentiation; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:positive regulation of fat cell differentiation; P:positive regulation of protein serine/threonine kinase activity; P:TORC2 signaling;|Q96A49 Q68CP1 Q96C60 Q96JQ6 Q96T20,Synapse-associated protein 1 {ECO:0000305},BSD domain-containing signal transducer and Akt interactor protein {ECO:0000303|PubMed:23300339};, PF03909;, GO:0030424;GO:0005829;GO:0030425;GO:0070062;GO:0031234;GO:0005794;GO:0030426;GO:0005654;GO:0043204;GO:0048471;GO:0045211;GO:0042734;GO:0030154;GO:0071364;GO:0032869;GO:1990314;GO:0036120;GO:0045600;GO:0071902;GO:0038203;, C:axon; C:cytosol; C:dendrite; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:Golgi apparatus; C:growth cone; C:nucleoplasm; C:perikaryon; C:perinuclear region of cytoplasm; C:postsynaptic membrane; C:presynaptic membrane;, , P:cell differentiation; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to platelet-derived growth factor stimulus; P:positive regulation of fat cell differentiation; P:positive regulation of protein serine/threonine kinase activity; P:TORC2 signaling; scaffold120 indexed_genome mRNA 25543 139590 . + . ID=transcript_13623;Q9NRF8 B3KWM2 Q9BRI0 Q9H809 Q9H8K9,CTP synthase 2,CTP synthetase 2;UTP--ammonia ligase 2;, PF06418;PF00117;, GO:0097268;GO:0005737;GO:0005829;GO:0005524;GO:0003883;GO:0042802;GO:0044210;GO:0006241;GO:0006541;GO:0015949;GO:0019856;GO:0006220;, C:cytoophidium; C:cytoplasm; C:cytosol;, F:ATP binding; F:CTP synthase activity; F:identical protein binding;, P:'de novo' CTP biosynthetic process; P:CTP biosynthetic process; P:glutamine metabolic process; P:nucleobase-containing small molecule interconversion; P:pyrimidine nucleobase biosynthetic process; P:pyrimidine nucleotide metabolic process;|P29377 Q5JS49,Protein S100-G,Calbindin-D9k;S100 calcium-binding protein G;Vitamin D-dependent calcium-binding protein, intestinal;, PF00036;PF01023;, GO:0016324;GO:0016323;GO:0005737;GO:0005615;GO:0005509;GO:0048306;GO:0046914;GO:0005499;, C:apical plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:extracellular space;, F:calcium ion binding; F:calcium-dependent protein binding; F:transition metal ion binding; F:vitamin D binding; scaffold120 indexed_genome mRNA 880925 916186 . + . ID=transcript_13624;P56377 B4DSU4 O95326 Q9H2N6,AP-1 complex subunit sigma-2,Adaptor protein complex AP-1 subunit sigma-1B;Adaptor-related protein complex 1 subunit sigma-1B;Clathrin assembly protein complex 1 sigma-1B small chain;Golgi adaptor HA1/AP1 adaptin sigma-1B subunit;Sigma 1B subunit of AP-1 clathrin;Sigma-adaptin 1B;Sigma1B-adaptin;, PF01217;, GO:0030119;GO:0005905;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0032588;GO:0019886;GO:0006886;GO:0006892;GO:0050690;GO:0016192;, C:AP-type membrane coat adaptor complex; C:clathrin-coated pit; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:trans-Golgi network membrane;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|P56377 B4DSU4 O95326 Q9H2N6,AP-1 complex subunit sigma-2,Adaptor protein complex AP-1 subunit sigma-1B;Adaptor-related protein complex 1 subunit sigma-1B;Clathrin assembly protein complex 1 sigma-1B small chain;Golgi adaptor HA1/AP1 adaptin sigma-1B subunit;Sigma 1B subunit of AP-1 clathrin;Sigma-adaptin 1B;Sigma1B-adaptin;, PF01217;, GO:0030119;GO:0005905;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0032588;GO:0019886;GO:0006886;GO:0006892;GO:0050690;GO:0016192;, C:AP-type membrane coat adaptor complex; C:clathrin-coated pit; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:trans-Golgi network membrane;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport; scaffold120 indexed_genome mRNA 919355 925222 . - . ID=transcript_13625;Q15696 Q14D69,U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2,CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2;Renal carcinoma antigen NY-REN-20;U2(RNU2) small nuclear RNA auxiliary factor 1-like 2;U2AF35-related protein;, PF00076;PF00642;, GO:0005654;GO:0005681;GO:0005689;GO:0089701;GO:0042802;GO:0046872;GO:0030628;GO:0000398;GO:0008380;GO:0000245;, C:nucleoplasm; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2AF complex;, F:identical protein binding; F:metal ion binding; F:pre-mRNA 3'-splice site binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly;|Q15696 Q14D69,U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2,CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2;Renal carcinoma antigen NY-REN-20;U2(RNU2) small nuclear RNA auxiliary factor 1-like 2;U2AF35-related protein;, PF00076;PF00642;, GO:0005654;GO:0005681;GO:0005689;GO:0089701;GO:0042802;GO:0046872;GO:0030628;GO:0000398;GO:0008380;GO:0000245;, C:nucleoplasm; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2AF complex;, F:identical protein binding; F:metal ion binding; F:pre-mRNA 3'-splice site binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly;|Q15696 Q14D69,U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2,CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2;Renal carcinoma antigen NY-REN-20;U2(RNU2) small nuclear RNA auxiliary factor 1-like 2;U2AF35-related protein;, PF00076;PF00642;, GO:0005654;GO:0005681;GO:0005689;GO:0089701;GO:0042802;GO:0046872;GO:0030628;GO:0000398;GO:0008380;GO:0000245;, C:nucleoplasm; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2AF complex;, F:identical protein binding; F:metal ion binding; F:pre-mRNA 3'-splice site binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly;|Q15696 Q14D69,U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2,CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2;Renal carcinoma antigen NY-REN-20;U2(RNU2) small nuclear RNA auxiliary factor 1-like 2;U2AF35-related protein;, PF00076;PF00642;, GO:0005654;GO:0005681;GO:0005689;GO:0089701;GO:0042802;GO:0046872;GO:0030628;GO:0000398;GO:0008380;GO:0000245;, C:nucleoplasm; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2AF complex;, F:identical protein binding; F:metal ion binding; F:pre-mRNA 3'-splice site binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly;|Q15696 Q14D69,U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2,CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2;Renal carcinoma antigen NY-REN-20;U2(RNU2) small nuclear RNA auxiliary factor 1-like 2;U2AF35-related protein;, PF00076;PF00642;, GO:0005654;GO:0005681;GO:0005689;GO:0089701;GO:0042802;GO:0046872;GO:0030628;GO:0000398;GO:0008380;GO:0000245;, C:nucleoplasm; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2AF complex;, F:identical protein binding; F:metal ion binding; F:pre-mRNA 3'-splice site binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly; scaffold120 indexed_genome mRNA 929229 942766 . - . ID=transcript_13626;Q15696 Q14D69,U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2,CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2;Renal carcinoma antigen NY-REN-20;U2(RNU2) small nuclear RNA auxiliary factor 1-like 2;U2AF35-related protein;, PF00076;PF00642;, GO:0005654;GO:0005681;GO:0005689;GO:0089701;GO:0042802;GO:0046872;GO:0030628;GO:0000398;GO:0008380;GO:0000245;, C:nucleoplasm; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2AF complex;, F:identical protein binding; F:metal ion binding; F:pre-mRNA 3'-splice site binding;, P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly; scaffold120 indexed_genome mRNA 947819 956493 . - . ID=transcript_13627;Q9Y2D0 A8K4T5,Carbonic anhydrase 5B, mitochondrial,Carbonate dehydratase VB;Carbonic anhydrase VB;, PF00194;, GO:0005737;GO:0005759;GO:0005739;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;GO:0009617;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process; P:response to bacterium; scaffold120 indexed_genome mRNA 1015479 1017261 . - . ID=transcript_13628;Q8N7R1 Q8NDI9,POM121-like protein 12,, , GO:0005643;GO:0008139;GO:0017056;GO:0006606;GO:0006405;, C:nuclear pore;, F:nuclear localization sequence binding; F:structural constituent of nuclear pore;, P:protein import into nucleus; P:RNA export from nucleus; scaffold120 indexed_genome mRNA 1020124 1093648 . + . ID=transcript_13629;Q9HBJ8 B2R9M1 Q6UW07,Collectrin {ECO:0000303|PubMed:21907142},Transmembrane protein 27;, PF16959;, GO:0005737;GO:0070062;GO:0016021;GO:0005886;GO:0042803;GO:0017156;GO:0035773;GO:0051957;GO:0045956;GO:0035774;GO:1905737;GO:0035543;GO:0022898;GO:0035493;, C:cytoplasm; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:protein homodimerization activity;, P:calcium-ion regulated exocytosis; P:insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of amino acid transport; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of L-proline import across plasma membrane; P:positive regulation of SNARE complex assembly; P:regulation of transmembrane transporter activity; P:SNARE complex assembly;|Q9HBJ8 B2R9M1 Q6UW07,Collectrin {ECO:0000303|PubMed:21907142},Transmembrane protein 27;, PF16959;, GO:0005737;GO:0070062;GO:0016021;GO:0005886;GO:0042803;GO:0017156;GO:0035773;GO:0051957;GO:0045956;GO:0035774;GO:1905737;GO:0035543;GO:0022898;GO:0035493;, C:cytoplasm; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:protein homodimerization activity;, P:calcium-ion regulated exocytosis; P:insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of amino acid transport; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of L-proline import across plasma membrane; P:positive regulation of SNARE complex assembly; P:regulation of transmembrane transporter activity; P:SNARE complex assembly;|Q9Y2D0 A8K4T5,Carbonic anhydrase 5B, mitochondrial,Carbonate dehydratase VB;Carbonic anhydrase VB;, PF00194;, GO:0005737;GO:0005759;GO:0005739;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0006730;GO:0009617;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:one-carbon metabolic process; P:response to bacterium; scaffold120 indexed_genome mRNA 1128345 1161444 . + . ID=transcript_13630;Q9BYF1 A0A7D6JAD5 C7ECU1 Q6UWP0 Q86WT0 Q9NRA7 Q9UFZ6,Angiotensin-converting enzyme 2,Angiotensin-converting enzyme homolog {ECO:0000303|PubMed:10924499};Angiotensin-converting enzyme-related carboxypeptidase {ECO:0000303|PubMed:10969042};Metalloprotease MPROT15 {ECO:0000303|Ref.6};, PF16959;PF01401;, GO:0016324;GO:0031526;GO:0009986;GO:0030666;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0016021;GO:0045121;GO:0005886;GO:0004180;GO:0004175;GO:0042802;GO:0004181;GO:0008237;GO:0008241;GO:0001618;GO:0008270;GO:0002003;GO:0003051;GO:0097746;GO:2000272;GO:0051957;GO:0060452;GO:1903598;GO:1905737;GO:2000379;GO:0006508;GO:0046813;GO:1903779;GO:0042127;GO:0001817;GO:0050727;GO:0003081;GO:0022898;GO:0019229;GO:0015827;GO:0046718;, C:apical plasma membrane; C:brush border membrane; C:cell surface; C:endocytic vesicle membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane raft; C:plasma membrane;, F:carboxypeptidase activity; F:endopeptidase activity; F:identical protein binding; F:metallocarboxypeptidase activity; F:metallopeptidase activity; F:peptidyl-dipeptidase activity; F:virus receptor activity; F:zinc ion binding;, P:angiotensin maturation; P:angiotensin-mediated drinking behavior; P:blood vessel diameter maintenance; P:negative regulation of signaling receptor activity; P:positive regulation of amino acid transport; P:positive regulation of cardiac muscle contraction; P:positive regulation of gap junction assembly; P:positive regulation of L-proline import across plasma membrane; P:positive regulation of reactive oxygen species metabolic process; P:proteolysis; P:receptor-mediated virion attachment to host cell; P:regulation of cardiac conduction; P:regulation of cell population proliferation; P:regulation of cytokine production; P:regulation of inflammatory response; P:regulation of systemic arterial blood pressure by renin-angiotensin; P:regulation of transmembrane transporter activity; P:regulation of vasoconstriction; P:tryptophan transport; P:viral entry into host cell; scaffold120 indexed_genome mRNA 1164041 1191768 . - . ID=transcript_13631;P51813 A6NIH9 O60564 Q12871,Cytoplasmic tyrosine-protein kinase BMX,Bone marrow tyrosine kinase gene in chromosome X protein;Epithelial and endothelial tyrosine kinase;NTK38;, PF00779;PF00169;PF07714;PF00017;, GO:0005829;GO:0005654;GO:0005886;GO:0032587;GO:0005524;GO:0046872;GO:0004715;GO:0004713;GO:0004714;GO:0002250;GO:0006915;GO:0050853;GO:0007155;GO:0035556;GO:0007498;GO:0038083;GO:0006661;GO:0046777;GO:0006468;GO:0007165;, C:cytosol; C:nucleoplasm; C:plasma membrane; C:ruffle membrane;, F:ATP binding; F:metal ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:apoptotic process; P:B cell receptor signaling pathway; P:cell adhesion; P:intracellular signal transduction; P:mesoderm development; P:peptidyl-tyrosine autophosphorylation; P:phosphatidylinositol biosynthetic process; P:protein autophosphorylation; P:protein phosphorylation; P:signal transduction; scaffold120 indexed_genome mRNA 1217752 1313706 . + . ID=transcript_13632;O00625 Q5U0G0 Q6FHD2,Pirin,Probable quercetin 2,3-dioxygenase PIR;, PF02678;PF05726;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046872;GO:0008127;GO:0003712;GO:0007586;GO:0030224;GO:0006366;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:quercetin 2,3-dioxygenase activity; F:transcription coregulator activity;, P:digestion; P:monocyte differentiation; P:transcription by RNA polymerase II;|O00625 Q5U0G0 Q6FHD2,Pirin,Probable quercetin 2,3-dioxygenase PIR;, PF02678;PF05726;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0046872;GO:0008127;GO:0003712;GO:0007586;GO:0030224;GO:0006366;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:quercetin 2,3-dioxygenase activity; F:transcription coregulator activity;, P:digestion; P:monocyte differentiation; P:transcription by RNA polymerase II; scaffold120 indexed_genome mRNA 1314088 1355779 . + . ID=transcript_13633;O43915 B2R7Z3,Vascular endothelial growth factor D {ECO:0000312|HGNC:HGNC:3708},c-Fos-induced growth factor;, PF03128;PF00341;, GO:0005576;GO:0005615;GO:0016020;GO:0031093;GO:0042056;GO:0008083;GO:0042802;GO:0005161;GO:0043185;GO:0005172;GO:0008283;GO:0071542;GO:0050930;GO:0002576;GO:0045766;GO:0051781;GO:0008284;GO:0001938;GO:0060754;GO:0001934;GO:0009617;GO:0001666;GO:0002040;GO:0048010;GO:0038084;, C:extracellular region; C:extracellular space; C:membrane; C:platelet alpha granule lumen;, F:chemoattractant activity; F:growth factor activity; F:identical protein binding; F:platelet-derived growth factor receptor binding; F:vascular endothelial growth factor receptor 3 binding; F:vascular endothelial growth factor receptor binding;, P:cell population proliferation; P:dopaminergic neuron differentiation; P:induction of positive chemotaxis; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell proliferation; P:positive regulation of mast cell chemotaxis; P:positive regulation of protein phosphorylation; P:response to bacterium; P:response to hypoxia; P:sprouting angiogenesis; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor signaling pathway;|O43915 B2R7Z3,Vascular endothelial growth factor D {ECO:0000312|HGNC:HGNC:3708},c-Fos-induced growth factor;, PF03128;PF00341;, GO:0005576;GO:0005615;GO:0016020;GO:0031093;GO:0042056;GO:0008083;GO:0042802;GO:0005161;GO:0043185;GO:0005172;GO:0008283;GO:0071542;GO:0050930;GO:0002576;GO:0045766;GO:0051781;GO:0008284;GO:0001938;GO:0060754;GO:0001934;GO:0009617;GO:0001666;GO:0002040;GO:0048010;GO:0038084;, C:extracellular region; C:extracellular space; C:membrane; C:platelet alpha granule lumen;, F:chemoattractant activity; F:growth factor activity; F:identical protein binding; F:platelet-derived growth factor receptor binding; F:vascular endothelial growth factor receptor 3 binding; F:vascular endothelial growth factor receptor binding;, P:cell population proliferation; P:dopaminergic neuron differentiation; P:induction of positive chemotaxis; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell proliferation; P:positive regulation of mast cell chemotaxis; P:positive regulation of protein phosphorylation; P:response to bacterium; P:response to hypoxia; P:sprouting angiogenesis; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor signaling pathway; scaffold120 indexed_genome mRNA 1363287 1366188 . + . ID=transcript_13634;P37287 B4E0V2 Q16025 Q16250,Phosphatidylinositol N-acetylglucosaminyltransferase subunit A {ECO:0000305},GlcNAc-PI synthesis protein;Phosphatidylinositol-glycan biosynthesis class A protein;, PF00534;PF08288;, GO:0005789;GO:0000506;GO:0016021;GO:0016020;GO:0017176;GO:1990830;GO:0006506;GO:0009893;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane; C:membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:cellular response to leukemia inhibitory factor; P:GPI anchor biosynthetic process; P:positive regulation of metabolic process; P:preassembly of GPI anchor in ER membrane; scaffold120 indexed_genome mRNA 1369509 1376840 . + . ID=transcript_13635;P37287 B4E0V2 Q16025 Q16250,Phosphatidylinositol N-acetylglucosaminyltransferase subunit A {ECO:0000305},GlcNAc-PI synthesis protein;Phosphatidylinositol-glycan biosynthesis class A protein;, PF00534;PF08288;, GO:0005789;GO:0000506;GO:0016021;GO:0016020;GO:0017176;GO:1990830;GO:0006506;GO:0009893;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane; C:membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:cellular response to leukemia inhibitory factor; P:GPI anchor biosynthetic process; P:positive regulation of metabolic process; P:preassembly of GPI anchor in ER membrane; scaffold120 indexed_genome mRNA 1388502 1411075 . + . ID=transcript_13636;Q8WXH4 E9PEN1 Q3SYC4 Q7Z667,Ankyrin repeat and SOCS box protein 11,, PF12796;PF07525;, GO:0005829;GO:0005783;GO:0035556;GO:0045732;GO:0043687;GO:0016567;, C:cytosol; C:endoplasmic reticulum;, , P:intracellular signal transduction; P:positive regulation of protein catabolic process; P:post-translational protein modification; P:protein ubiquitination; scaffold120 indexed_genome mRNA 1438431 1448736 . + . ID=transcript_13637;Q96DX5 A8K8A5 Q9BVF5 Q9NWS5 Q9Y4T3,Ankyrin repeat and SOCS box protein 9,, PF12796;PF07525;, GO:0005829;GO:0005739;GO:0035556;GO:0045732;GO:0043687;GO:0016567;, C:cytosol; C:mitochondrion;, , P:intracellular signal transduction; P:positive regulation of protein catabolic process; P:post-translational protein modification; P:protein ubiquitination; scaffold120 indexed_genome mRNA 1743612 1824265 . - . ID=transcript_13638;Q8NHP6 Q8N3H2 Q8NA83,Motile sperm domain-containing protein 2,, PF00650;PF00635;, GO:0005783;GO:0005789;GO:0140284;GO:0005887;GO:0016020;GO:0044232;GO:0005886;GO:0035579;GO:0006935;GO:0043312;GO:0090026;GO:0090023;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of plasma membrane; C:membrane; C:organelle membrane contact site; C:plasma membrane; C:specific granule membrane;, , P:chemotaxis; P:neutrophil degranulation; P:positive regulation of monocyte chemotaxis; P:positive regulation of neutrophil chemotaxis;|Q8NHP6 Q8N3H2 Q8NA83,Motile sperm domain-containing protein 2,, PF00650;PF00635;, GO:0005783;GO:0005789;GO:0140284;GO:0005887;GO:0016020;GO:0044232;GO:0005886;GO:0035579;GO:0006935;GO:0043312;GO:0090026;GO:0090023;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of plasma membrane; C:membrane; C:organelle membrane contact site; C:plasma membrane; C:specific granule membrane;, , P:chemotaxis; P:neutrophil degranulation; P:positive regulation of monocyte chemotaxis; P:positive regulation of neutrophil chemotaxis;|Q8NHP6 Q8N3H2 Q8NA83,Motile sperm domain-containing protein 2,, PF00650;PF00635;, GO:0005783;GO:0005789;GO:0140284;GO:0005887;GO:0016020;GO:0044232;GO:0005886;GO:0035579;GO:0006935;GO:0043312;GO:0090026;GO:0090023;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of plasma membrane; C:membrane; C:organelle membrane contact site; C:plasma membrane; C:specific granule membrane;, , P:chemotaxis; P:neutrophil degranulation; P:positive regulation of monocyte chemotaxis; P:positive regulation of neutrophil chemotaxis;|Q8NHP6 Q8N3H2 Q8NA83,Motile sperm domain-containing protein 2,, PF00650;PF00635;, GO:0005783;GO:0005789;GO:0140284;GO:0005887;GO:0016020;GO:0044232;GO:0005886;GO:0035579;GO:0006935;GO:0043312;GO:0090026;GO:0090023;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-endosome membrane contact site; C:integral component of plasma membrane; C:membrane; C:organelle membrane contact site; C:plasma membrane; C:specific granule membrane;, , P:chemotaxis; P:neutrophil degranulation; P:positive regulation of monocyte chemotaxis; P:positive regulation of neutrophil chemotaxis; scaffold120 indexed_genome mRNA 2620599 2637050 . + . ID=transcript_13639;Q9NWZ8 C4AMC4 Q2LJ66 Q6ZV27,Gem-associated protein 8,Protein FAM51A1;, PF15348;, GO:0005737;GO:0005829;GO:0097504;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0051170;GO:0000387;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, , P:import into nucleus; P:spliceosomal snRNP assembly;|Q9NWZ8 C4AMC4 Q2LJ66 Q6ZV27,Gem-associated protein 8,Protein FAM51A1;, PF15348;, GO:0005737;GO:0005829;GO:0097504;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0051170;GO:0000387;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, , P:import into nucleus; P:spliceosomal snRNP assembly;|Q9NWZ8 C4AMC4 Q2LJ66 Q6ZV27,Gem-associated protein 8,Protein FAM51A1;, PF15348;, GO:0005737;GO:0005829;GO:0097504;GO:0005654;GO:0005634;GO:0032797;GO:0034719;GO:0051170;GO:0000387;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:nucleoplasm; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, , P:import into nucleus; P:spliceosomal snRNP assembly; scaffold120 indexed_genome mRNA 2799271 2863305 . + . ID=transcript_13640;Q13491 O76077 Q86X43 Q8N956,Neuronal membrane glycoprotein M6-b,, PF01275;, GO:0016021;GO:0045121;GO:0005886;GO:0085029;GO:2000009;GO:0051612;GO:0007399;GO:0031175;GO:0001503;GO:0030501;GO:0015031;GO:0032956;GO:0051893;, C:integral component of membrane; C:membrane raft; C:plasma membrane;, , P:extracellular matrix assembly; P:negative regulation of protein localization to cell surface; P:negative regulation of serotonin uptake; P:nervous system development; P:neuron projection development; P:ossification; P:positive regulation of bone mineralization; P:protein transport; P:regulation of actin cytoskeleton organization; P:regulation of focal adhesion assembly;|Q13491 O76077 Q86X43 Q8N956,Neuronal membrane glycoprotein M6-b,, PF01275;, GO:0016021;GO:0045121;GO:0005886;GO:0085029;GO:2000009;GO:0051612;GO:0007399;GO:0031175;GO:0001503;GO:0030501;GO:0015031;GO:0032956;GO:0051893;, C:integral component of membrane; C:membrane raft; C:plasma membrane;, , P:extracellular matrix assembly; P:negative regulation of protein localization to cell surface; P:negative regulation of serotonin uptake; P:nervous system development; P:neuron projection development; P:ossification; P:positive regulation of bone mineralization; P:protein transport; P:regulation of actin cytoskeleton organization; P:regulation of focal adhesion assembly;|Q13491 O76077 Q86X43 Q8N956,Neuronal membrane glycoprotein M6-b,, PF01275;, GO:0016021;GO:0045121;GO:0005886;GO:0085029;GO:2000009;GO:0051612;GO:0007399;GO:0031175;GO:0001503;GO:0030501;GO:0015031;GO:0032956;GO:0051893;, C:integral component of membrane; C:membrane raft; C:plasma membrane;, , P:extracellular matrix assembly; P:negative regulation of protein localization to cell surface; P:negative regulation of serotonin uptake; P:nervous system development; P:neuron projection development; P:ossification; P:positive regulation of bone mineralization; P:protein transport; P:regulation of actin cytoskeleton organization; P:regulation of focal adhesion assembly;|Q13491 O76077 Q86X43 Q8N956,Neuronal membrane glycoprotein M6-b,, PF01275;, GO:0016021;GO:0045121;GO:0005886;GO:0085029;GO:2000009;GO:0051612;GO:0007399;GO:0031175;GO:0001503;GO:0030501;GO:0015031;GO:0032956;GO:0051893;, C:integral component of membrane; C:membrane raft; C:plasma membrane;, , P:extracellular matrix assembly; P:negative regulation of protein localization to cell surface; P:negative regulation of serotonin uptake; P:nervous system development; P:neuron projection development; P:ossification; P:positive regulation of bone mineralization; P:protein transport; P:regulation of actin cytoskeleton organization; P:regulation of focal adhesion assembly; scaffold120 indexed_genome mRNA 2871105 2871989 . - . ID=transcript_13641;O75665 B9ZVU5 O75666 Q4VAK4,Oral-facial-digital syndrome 1 protein,Protein 71-7A;, PF16045;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0005576;GO:0016020;GO:0015630;GO:0031514;GO:0005634;GO:0043014;GO:0043015;GO:0042802;GO:0097711;GO:0060271;GO:0060287;GO:0000086;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:extracellular region; C:membrane; C:microtubule cytoskeleton; C:motile cilium; C:nucleus;, F:alpha-tubulin binding; F:gamma-tubulin binding; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:epithelial cilium movement involved in determination of left/right asymmetry; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; scaffold120 indexed_genome mRNA 2880313 2930672 . - . ID=transcript_13642;O75665 B9ZVU5 O75666 Q4VAK4,Oral-facial-digital syndrome 1 protein,Protein 71-7A;, PF16045;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0005576;GO:0016020;GO:0015630;GO:0031514;GO:0005634;GO:0043014;GO:0043015;GO:0042802;GO:0097711;GO:0060271;GO:0060287;GO:0000086;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:extracellular region; C:membrane; C:microtubule cytoskeleton; C:motile cilium; C:nucleus;, F:alpha-tubulin binding; F:gamma-tubulin binding; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:epithelial cilium movement involved in determination of left/right asymmetry; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|O75665 B9ZVU5 O75666 Q4VAK4,Oral-facial-digital syndrome 1 protein,Protein 71-7A;, PF16045;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0005576;GO:0016020;GO:0015630;GO:0031514;GO:0005634;GO:0043014;GO:0043015;GO:0042802;GO:0097711;GO:0060271;GO:0060287;GO:0000086;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:extracellular region; C:membrane; C:microtubule cytoskeleton; C:motile cilium; C:nucleus;, F:alpha-tubulin binding; F:gamma-tubulin binding; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:epithelial cilium movement involved in determination of left/right asymmetry; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle;|O75665 B9ZVU5 O75666 Q4VAK4,Oral-facial-digital syndrome 1 protein,Protein 71-7A;, PF16045;, GO:0034451;GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0005576;GO:0016020;GO:0015630;GO:0031514;GO:0005634;GO:0043014;GO:0043015;GO:0042802;GO:0097711;GO:0060271;GO:0060287;GO:0000086;GO:0010389;, C:centriolar satellite; C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:extracellular region; C:membrane; C:microtubule cytoskeleton; C:motile cilium; C:nucleus;, F:alpha-tubulin binding; F:gamma-tubulin binding; F:identical protein binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:epithelial cilium movement involved in determination of left/right asymmetry; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; scaffold120 indexed_genome mRNA 2930787 2942786 . + . ID=transcript_13643;P0DI81 A6NEG0 O14582 Q9HD16,Trafficking protein particle complex subunit 2,Sedlin;, PF04628;, GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0043231;GO:0005654;GO:0005634;GO:0048471;GO:0030008;GO:0044325;GO:0008134;GO:0048208;GO:0006888;GO:0006355;GO:0001501;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:TRAPP complex;, F:ion channel binding; F:transcription factor binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:regulation of transcription, DNA-templated; P:skeletal system development;|P0DI81 A6NEG0 O14582 Q9HD16,Trafficking protein particle complex subunit 2,Sedlin;, PF04628;, GO:0005737;GO:0005829;GO:0005783;GO:0005793;GO:0043231;GO:0005654;GO:0005634;GO:0048471;GO:0030008;GO:0044325;GO:0008134;GO:0048208;GO:0006888;GO:0006355;GO:0001501;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:TRAPP complex;, F:ion channel binding; F:transcription factor binding;, P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:regulation of transcription, DNA-templated; P:skeletal system development; scaffold120 indexed_genome mRNA 2946693 2966040 . + . ID=transcript_13644;P51151 A8K390 Q6ICN1,Ras-related protein Rab-9A,, PF00071;, GO:0005829;GO:0005789;GO:0070062;GO:0005770;GO:0005764;GO:0042470;GO:0045335;GO:0030670;GO:0005886;GO:0032588;GO:0030133;GO:0019003;GO:0005525;GO:0003924;GO:0052405;GO:0045921;GO:0015031;GO:0032482;GO:0032880;GO:0042147;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:late endosome; C:lysosome; C:melanosome; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:trans-Golgi network membrane; C:transport vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:negative regulation by host of symbiont molecular function; P:positive regulation of exocytosis; P:protein transport; P:Rab protein signal transduction; P:regulation of protein localization; P:retrograde transport, endosome to Golgi;|P51151 A8K390 Q6ICN1,Ras-related protein Rab-9A,, PF00071;, GO:0005829;GO:0005789;GO:0070062;GO:0005770;GO:0005764;GO:0042470;GO:0045335;GO:0030670;GO:0005886;GO:0032588;GO:0030133;GO:0019003;GO:0005525;GO:0003924;GO:0052405;GO:0045921;GO:0015031;GO:0032482;GO:0032880;GO:0042147;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:late endosome; C:lysosome; C:melanosome; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:trans-Golgi network membrane; C:transport vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:negative regulation by host of symbiont molecular function; P:positive regulation of exocytosis; P:protein transport; P:Rab protein signal transduction; P:regulation of protein localization; P:retrograde transport, endosome to Golgi; scaffold120 indexed_genome mRNA 2988728 2999836 . - . ID=transcript_13645;Q8N8B7 A6NI06 B2RDM3,Transcription elongation factor A N-terminal and central domain-containing protein,TFIIS central domain-containing protein 1;, PF08711;PF07500;, GO:0005634;GO:0006351;, C:nucleus;, , P:transcription, DNA-templated; scaffold120 indexed_genome mRNA 3011553 3014587 . - . ID=transcript_13646;Q8IUX8 B2RCB1 Q6UXJ1 Q8NBV0 Q8WYG3 Q9NY67 Q9NZL7 Q9UFK6,Epidermal growth factor-like protein 6,MAM and EGF domains-containing gene protein;, PF07645;PF00629;, GO:0005604;GO:0005615;GO:0016020;GO:0005509;GO:0005178;GO:0007155;GO:0030154;GO:0030198;GO:0007275;GO:0010811;, C:basement membrane; C:extracellular space; C:membrane;, F:calcium ion binding; F:integrin binding;, P:cell adhesion; P:cell differentiation; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of cell-substrate adhesion; scaffold120 indexed_genome mRNA 3016629 3035786 . - . ID=transcript_13647;Q8IUX8 B2RCB1 Q6UXJ1 Q8NBV0 Q8WYG3 Q9NY67 Q9NZL7 Q9UFK6,Epidermal growth factor-like protein 6,MAM and EGF domains-containing gene protein;, PF07645;PF00629;, GO:0005604;GO:0005615;GO:0016020;GO:0005509;GO:0005178;GO:0007155;GO:0030154;GO:0030198;GO:0007275;GO:0010811;, C:basement membrane; C:extracellular space; C:membrane;, F:calcium ion binding; F:integrin binding;, P:cell adhesion; P:cell differentiation; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of cell-substrate adhesion; scaffold120 indexed_genome mRNA 3035819 3066019 . - . ID=transcript_13648;Q8IUX8 B2RCB1 Q6UXJ1 Q8NBV0 Q8WYG3 Q9NY67 Q9NZL7 Q9UFK6,Epidermal growth factor-like protein 6,MAM and EGF domains-containing gene protein;, PF07645;PF00629;, GO:0005604;GO:0005615;GO:0016020;GO:0005509;GO:0005178;GO:0007155;GO:0030154;GO:0030198;GO:0007275;GO:0010811;, C:basement membrane; C:extracellular space; C:membrane;, F:calcium ion binding; F:integrin binding;, P:cell adhesion; P:cell differentiation; P:extracellular matrix organization; P:multicellular organism development; P:positive regulation of cell-substrate adhesion; scaffold121 indexed_genome mRNA 544823 825755 . + . ID=transcript_13649;Q8N0W4 Q6UX10 Q9ULG0,Neuroligin-4, X-linked,HNLX;, PF00135;, GO:0098985;GO:0009986;GO:0030425;GO:0060076;GO:0016021;GO:0005887;GO:0005886;GO:0098839;GO:0098793;GO:0089717;GO:0098983;GO:0045202;GO:0050839;GO:0031404;GO:0042043;GO:0042803;GO:0097110;GO:0038023;GO:0030534;GO:0003360;GO:0045216;GO:0021549;GO:0007268;GO:0007612;GO:0050804;GO:0090394;GO:0007158;GO:0030182;GO:0035265;GO:0097104;GO:0099054;GO:0097105;GO:0035176;GO:0050808;GO:0048488;GO:0071625;, C:asymmetric, glutamatergic, excitatory synapse; C:cell surface; C:dendrite; C:excitatory synapse; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynaptic density membrane; C:presynapse; C:spanning component of membrane; C:symmetric, GABA-ergic, inhibitory synapse; C:synapse;, F:cell adhesion molecule binding; F:chloride ion binding; F:neurexin family protein binding; F:protein homodimerization activity; F:scaffold protein binding; F:signaling receptor activity;, P:adult behavior; P:brainstem development; P:cell-cell junction organization; P:cerebellum development; P:chemical synaptic transmission; P:learning; P:modulation of chemical synaptic transmission; P:negative regulation of excitatory postsynaptic potential; P:neuron cell-cell adhesion; P:neuron differentiation; P:organ growth; P:postsynaptic membrane assembly; P:presynapse assembly; P:presynaptic membrane assembly; P:social behavior; P:synapse organization; P:synaptic vesicle endocytosis; P:vocalization behavior; scaffold121 indexed_genome mRNA 2854239 2883128 . + . ID=transcript_13650;Q9NR99 Q6P1M7 Q9Y3Y8,Matrix-remodeling-associated protein 5,Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan;, PF07679;PF13855;, GO:0062023;GO:0070062;GO:0005576;GO:0005201;GO:0071559;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:extracellular matrix structural constituent;, P:response to transforming growth factor beta;|Q9NR99 Q6P1M7 Q9Y3Y8,Matrix-remodeling-associated protein 5,Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan;, PF07679;PF13855;, GO:0062023;GO:0070062;GO:0005576;GO:0005201;GO:0071559;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:extracellular matrix structural constituent;, P:response to transforming growth factor beta; scaffold121 indexed_genome mRNA 2985272 3004000 . + . ID=transcript_13651;P51690 Q53FT2 Q53FU8,Arylsulfatase L,Arylsulfatase E;, PF00884;, GO:0005788;GO:0070062;GO:0005794;GO:0005795;GO:0004065;GO:0046872;GO:0001501;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:Golgi apparatus; C:Golgi stack;, F:arylsulfatase activity; F:metal ion binding;, P:skeletal system development;|P51690 Q53FT2 Q53FU8,Arylsulfatase L,Arylsulfatase E;, PF00884;, GO:0005788;GO:0070062;GO:0005794;GO:0005795;GO:0004065;GO:0046872;GO:0001501;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:Golgi apparatus; C:Golgi stack;, F:arylsulfatase activity; F:metal ion binding;, P:skeletal system development; scaffold121 indexed_genome mRNA 3006503 3021712 . + . ID=transcript_13652;P51689 Q9UHJ8,Arylsulfatase D,, PF00884;, GO:0005788;GO:0005764;GO:0004065;GO:0046872;, C:endoplasmic reticulum lumen; C:lysosome;, F:arylsulfatase activity; F:metal ion binding; scaffold121 indexed_genome mRNA 3027023 3039265 . - . ID=transcript_13653;O15488 B7WNN6 O15485 O15486 O15487 O15489 O15490,Glycogenin-2,, PF01501;, GO:0005737;GO:0005829;GO:0008466;GO:0046872;GO:0016757;GO:0102751;GO:0005978;, C:cytoplasm; C:cytosol;, F:glycogenin glucosyltransferase activity; F:metal ion binding; F:transferase activity, transferring glycosyl groups; F:UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity;, P:glycogen biosynthetic process; scaffold121 indexed_genome mRNA 3060126 3080365 . - . ID=transcript_13654;P55808 E9PCH1 Q496N8 Q496N9 Q496P0 Q71BZ5,Glycoprotein Xg,Protein PBDX;, PF12301;, GO:0005887;GO:0034109;GO:2000391;GO:0072683;, C:integral component of plasma membrane;, , P:homotypic cell-cell adhesion; P:positive regulation of neutrophil extravasation; P:T cell extravasation; scaffold121 indexed_genome mRNA 3084139 3106220 . - . ID=transcript_13655;P14209 A6NIW1 O00518 Q6ICV7,CD99 antigen,12E7;E2 antigen;Protein MIC2;T-cell surface glycoprotein E2;, PF12301;, GO:0005737;GO:0005925;GO:0005887;GO:0005886;GO:0034109;GO:2000391;GO:0050776;GO:0072683;, C:cytoplasm; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane;, , P:homotypic cell-cell adhesion; P:positive regulation of neutrophil extravasation; P:regulation of immune response; P:T cell extravasation; scaffold122 indexed_genome mRNA 2207 8774 . - . ID=transcript_13656;P22736 B4DML7 Q15627 Q53Y00 Q6IBU8,Nuclear receptor subfamily 4 group A member 1,Early response protein NAK1;Nuclear hormone receptor NUR/77;Orphan nuclear receptor HMR;Orphan nuclear receptor TR3;ST-59;Testicular receptor 3;, PF00104;PF00105;, GO:0000785;GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0035259;GO:0004879;GO:0046982;GO:0000978;GO:1990837;GO:0008270;GO:0002042;GO:0071376;GO:0044344;GO:0035924;GO:0035767;GO:0045444;GO:0045786;GO:0001938;GO:0045944;GO:0006357;GO:0061469;GO:0007165;GO:0006367;, C:chromatin; C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:nuclear receptor activity; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell migration involved in sprouting angiogenesis; P:cellular response to corticotropin-releasing hormone stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell chemotaxis; P:fat cell differentiation; P:negative regulation of cell cycle; P:positive regulation of endothelial cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of type B pancreatic cell proliferation; P:signal transduction; P:transcription initiation from RNA polymerase II promoter;|P22736 B4DML7 Q15627 Q53Y00 Q6IBU8,Nuclear receptor subfamily 4 group A member 1,Early response protein NAK1;Nuclear hormone receptor NUR/77;Orphan nuclear receptor HMR;Orphan nuclear receptor TR3;ST-59;Testicular receptor 3;, PF00104;PF00105;, GO:0000785;GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0035259;GO:0004879;GO:0046982;GO:0000978;GO:1990837;GO:0008270;GO:0002042;GO:0071376;GO:0044344;GO:0035924;GO:0035767;GO:0045444;GO:0045786;GO:0001938;GO:0045944;GO:0006357;GO:0061469;GO:0007165;GO:0006367;, C:chromatin; C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:nuclear receptor activity; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell migration involved in sprouting angiogenesis; P:cellular response to corticotropin-releasing hormone stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell chemotaxis; P:fat cell differentiation; P:negative regulation of cell cycle; P:positive regulation of endothelial cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of type B pancreatic cell proliferation; P:signal transduction; P:transcription initiation from RNA polymerase II promoter;|P22736 B4DML7 Q15627 Q53Y00 Q6IBU8,Nuclear receptor subfamily 4 group A member 1,Early response protein NAK1;Nuclear hormone receptor NUR/77;Orphan nuclear receptor HMR;Orphan nuclear receptor TR3;ST-59;Testicular receptor 3;, PF00104;PF00105;, GO:0000785;GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0001228;GO:0000981;GO:0035259;GO:0004879;GO:0046982;GO:0000978;GO:1990837;GO:0008270;GO:0002042;GO:0071376;GO:0044344;GO:0035924;GO:0035767;GO:0045444;GO:0045786;GO:0001938;GO:0045944;GO:0006357;GO:0061469;GO:0007165;GO:0006367;, C:chromatin; C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:glucocorticoid receptor binding; F:nuclear receptor activity; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:cell migration involved in sprouting angiogenesis; P:cellular response to corticotropin-releasing hormone stimulus; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial cell chemotaxis; P:fat cell differentiation; P:negative regulation of cell cycle; P:positive regulation of endothelial cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of type B pancreatic cell proliferation; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; scaffold122 indexed_genome mRNA 17171 22744 . - . ID=transcript_13657;Q9BSB4 Q9HAE2 Q9HBN1,Autophagy-related protein 101,, PF07855;, GO:0005829;GO:0005789;GO:0000407;GO:0042802;GO:0044877;GO:0000045;GO:0016236;GO:0016241;, C:cytosol; C:endoplasmic reticulum membrane; C:phagophore assembly site;, F:identical protein binding; F:protein-containing complex binding;, P:autophagosome assembly; P:macroautophagy; P:regulation of macroautophagy;|Q9BSB4 Q9HAE2 Q9HBN1,Autophagy-related protein 101,, PF07855;, GO:0005829;GO:0005789;GO:0000407;GO:0042802;GO:0044877;GO:0000045;GO:0016236;GO:0016241;, C:cytosol; C:endoplasmic reticulum membrane; C:phagophore assembly site;, F:identical protein binding; F:protein-containing complex binding;, P:autophagosome assembly; P:macroautophagy; P:regulation of macroautophagy;|Q9BSB4 Q9HAE2 Q9HBN1,Autophagy-related protein 101,, PF07855;, GO:0005829;GO:0005789;GO:0000407;GO:0042802;GO:0044877;GO:0000045;GO:0016236;GO:0016241;, C:cytosol; C:endoplasmic reticulum membrane; C:phagophore assembly site;, F:identical protein binding; F:protein-containing complex binding;, P:autophagosome assembly; P:macroautophagy; P:regulation of macroautophagy;|Q9BSB4 Q9HAE2 Q9HBN1,Autophagy-related protein 101,, PF07855;, GO:0005829;GO:0005789;GO:0000407;GO:0042802;GO:0044877;GO:0000045;GO:0016236;GO:0016241;, C:cytosol; C:endoplasmic reticulum membrane; C:phagophore assembly site;, F:identical protein binding; F:protein-containing complex binding;, P:autophagosome assembly; P:macroautophagy; P:regulation of macroautophagy; scaffold122 indexed_genome mRNA 73727 97166 . - . ID=transcript_13658;Q6KB66 Q6P1A5 Q7Z3Q0,Keratin, type II cytoskeletal 80,Cytokeratin-80;Keratin-80;Type-II keratin Kb20;, PF00038;, GO:0005737;GO:0005829;GO:0005882;GO:0045111;GO:0045095;GO:0070268;GO:0031424;, C:cytoplasm; C:cytosol; C:intermediate filament; C:intermediate filament cytoskeleton; C:keratin filament;, , P:cornification; P:keratinization; scaffold122 indexed_genome mRNA 144704 154818 . + . ID=transcript_13659;O95678 B4DQU4 Q9NSA9,Keratin, type II cytoskeletal 75,Cytokeratin-75;Keratin-6 hair follicle;Keratin-75;Type II keratin-K6hf;Type-II keratin Kb18;, PF00038;PF16208;, GO:0005829;GO:0070062;GO:0005882;GO:0045095;GO:0005198;GO:0070268;GO:0002244;GO:0031424;, C:cytosol; C:extracellular exosome; C:intermediate filament; C:keratin filament;, F:structural molecule activity;, P:cornification; P:hematopoietic progenitor cell differentiation; P:keratinization;|P13647 Q6PI71 Q6UBJ0 Q8TA91,Keratin, type II cytoskeletal 5,58 kDa cytokeratin;Cytokeratin-5;Keratin-5;Type-II keratin Kb5;, PF00038;PF16208;, GO:0005737;GO:0005829;GO:0070062;GO:0005882;GO:0045095;GO:0016020;GO:0005634;GO:0097110;GO:0005200;GO:0070268;GO:0008544;GO:0031581;GO:0031424;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:intermediate filament; C:keratin filament; C:membrane; C:nucleus;, F:scaffold protein binding; F:structural constituent of cytoskeleton;, P:cornification; P:epidermis development; P:hemidesmosome assembly; P:keratinization;|P08729 Q92676 Q9BUD8 Q9Y3R7,Keratin, type II cytoskeletal 7,Cytokeratin-7;Keratin-7;Sarcolectin;Type-II keratin Kb7;, PF00038;PF16208;, GO:0005737;GO:0005829;GO:0070062;GO:0005882;GO:0045095;GO:0005634;GO:0070268;GO:0031424;GO:0016032;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:intermediate filament; C:keratin filament; C:nucleus;, , P:cornification; P:keratinization; P:viral process;|Q6GMY0 Q6P4C7 Q96J60,Keratin, type II cytoskeletal 8,Cytokeratin-8;Keratin-8;Type-II keratin Kb8;, PF00038;PF16208;, GO:0016327;GO:0005911;GO:0043034;GO:0005737;GO:0005829;GO:0016010;GO:0070062;GO:0005882;GO:0045111;GO:0045095;GO:0016363;GO:0005654;GO:0005634;GO:0042383;GO:0030018;GO:0044877;GO:0097110;GO:0060706;GO:0070268;GO:0097191;GO:0097284;GO:0031424;GO:0051599;GO:0051707;GO:0045214;GO:0033209;GO:0016032;, C:apicolateral plasma membrane; C:cell-cell junction; C:costamere; C:cytoplasm; C:cytosol; C:dystrophin-associated glycoprotein complex; C:extracellular exosome; C:intermediate filament; C:intermediate filament cytoskeleton; C:keratin filament; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:sarcolemma; C:Z disc;, F:protein-containing complex binding; F:scaffold protein binding;, P:cell differentiation involved in embryonic placenta development; P:cornification; P:extrinsic apoptotic signaling pathway; P:hepatocyte apoptotic process; P:keratinization; P:response to hydrostatic pressure; P:response to other organism; P:sarcomere organization; P:tumor necrosis factor-mediated signaling pathway; P:viral process; scaffold122 indexed_genome mRNA 692599 698490 . - . ID=transcript_13660;Q8N1N4 A8K4D6 Q5HYM7 Q7RTT2,Keratin, type II cytoskeletal 78,Cytokeratin-78;Keratin-5b;Keratin-78;Type-II keratin Kb40;, PF00038;PF16208;, GO:0005829;GO:0070062;GO:0005615;GO:0045095;GO:0070268;GO:0031424;, C:cytosol; C:extracellular exosome; C:extracellular space; C:keratin filament;, , P:cornification; P:keratinization;|Q8N1N4 A8K4D6 Q5HYM7 Q7RTT2,Keratin, type II cytoskeletal 78,Cytokeratin-78;Keratin-5b;Keratin-78;Type-II keratin Kb40;, PF00038;PF16208;, GO:0005829;GO:0070062;GO:0005615;GO:0045095;GO:0070268;GO:0031424;, C:cytosol; C:extracellular exosome; C:extracellular space; C:keratin filament;, , P:cornification; P:keratinization; scaffold122 indexed_genome mRNA 735755 743438 . - . ID=transcript_13661;Q6GMY0 Q6P4C7 Q96J60,Keratin, type II cytoskeletal 8,Cytokeratin-8;Keratin-8;Type-II keratin Kb8;, PF00038;PF16208;, GO:0016327;GO:0005911;GO:0043034;GO:0005737;GO:0005829;GO:0016010;GO:0070062;GO:0005882;GO:0045111;GO:0045095;GO:0016363;GO:0005654;GO:0005634;GO:0042383;GO:0030018;GO:0044877;GO:0097110;GO:0060706;GO:0070268;GO:0097191;GO:0097284;GO:0031424;GO:0051599;GO:0051707;GO:0045214;GO:0033209;GO:0016032;, C:apicolateral plasma membrane; C:cell-cell junction; C:costamere; C:cytoplasm; C:cytosol; C:dystrophin-associated glycoprotein complex; C:extracellular exosome; C:intermediate filament; C:intermediate filament cytoskeleton; C:keratin filament; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:sarcolemma; C:Z disc;, F:protein-containing complex binding; F:scaffold protein binding;, P:cell differentiation involved in embryonic placenta development; P:cornification; P:extrinsic apoptotic signaling pathway; P:hepatocyte apoptotic process; P:keratinization; P:response to hydrostatic pressure; P:response to other organism; P:sarcomere organization; P:tumor necrosis factor-mediated signaling pathway; P:viral process; scaffold122 indexed_genome mRNA 779693 783269 . + . ID=transcript_13662;P05783 Q53G38 Q5U0N8 Q9BW26,Keratin, type I cytoskeletal 18,Cell proliferation-inducing gene 46 protein;Cytokeratin-18;Keratin-18;, PF00038;, GO:0005912;GO:0034451;GO:0005737;GO:0005829;GO:0009897;GO:0070062;GO:0005882;GO:0045095;GO:0005815;GO:0005730;GO:0048471;GO:0032991;GO:0098641;GO:0003723;GO:0097110;GO:0005198;GO:0009653;GO:0007049;GO:1902488;GO:0070268;GO:0097191;GO:0043000;GO:0097284;GO:0070365;GO:0045104;GO:0031424;GO:0072497;GO:0043066;GO:0009750;GO:0031667;GO:0033209;GO:0016032;, C:adherens junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:intermediate filament; C:keratin filament; C:microtubule organizing center; C:nucleolus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:cadherin binding involved in cell-cell adhesion; F:RNA binding; F:scaffold protein binding; F:structural molecule activity;, P:anatomical structure morphogenesis; P:cell cycle; P:cholangiocyte apoptotic process; P:cornification; P:extrinsic apoptotic signaling pathway; P:Golgi to plasma membrane CFTR protein transport; P:hepatocyte apoptotic process; P:hepatocyte differentiation; P:intermediate filament cytoskeleton organization; P:keratinization; P:mesenchymal stem cell differentiation; P:negative regulation of apoptotic process; P:response to fructose; P:response to nutrient levels; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|P05783 Q53G38 Q5U0N8 Q9BW26,Keratin, type I cytoskeletal 18,Cell proliferation-inducing gene 46 protein;Cytokeratin-18;Keratin-18;, PF00038;, GO:0005912;GO:0034451;GO:0005737;GO:0005829;GO:0009897;GO:0070062;GO:0005882;GO:0045095;GO:0005815;GO:0005730;GO:0048471;GO:0032991;GO:0098641;GO:0003723;GO:0097110;GO:0005198;GO:0009653;GO:0007049;GO:1902488;GO:0070268;GO:0097191;GO:0043000;GO:0097284;GO:0070365;GO:0045104;GO:0031424;GO:0072497;GO:0043066;GO:0009750;GO:0031667;GO:0033209;GO:0016032;, C:adherens junction; C:centriolar satellite; C:cytoplasm; C:cytosol; C:external side of plasma membrane; C:extracellular exosome; C:intermediate filament; C:keratin filament; C:microtubule organizing center; C:nucleolus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:cadherin binding involved in cell-cell adhesion; F:RNA binding; F:scaffold protein binding; F:structural molecule activity;, P:anatomical structure morphogenesis; P:cell cycle; P:cholangiocyte apoptotic process; P:cornification; P:extrinsic apoptotic signaling pathway; P:Golgi to plasma membrane CFTR protein transport; P:hepatocyte apoptotic process; P:hepatocyte differentiation; P:intermediate filament cytoskeleton organization; P:keratinization; P:mesenchymal stem cell differentiation; P:negative regulation of apoptotic process; P:response to fructose; P:response to nutrient levels; P:tumor necrosis factor-mediated signaling pathway; P:viral process; scaffold122 indexed_genome mRNA 830477 853766 . + . ID=transcript_13663;P23588 B4DS13 Q4G0E3 Q53HQ2 Q6GPH5 Q6IB46 Q8WYK5,Eukaryotic translation initiation factor 4B,, PF00076;, GO:0005829;GO:0016281;GO:0043024;GO:0003723;GO:0033592;GO:0034057;GO:0003743;GO:0097010;GO:0001731;GO:0006446;GO:0006413;, C:cytosol; C:eukaryotic translation initiation factor 4F complex;, F:ribosomal small subunit binding; F:RNA binding; F:RNA strand annealing activity; F:RNA strand-exchange activity; F:translation initiation factor activity;, P:eukaryotic translation initiation factor 4F complex assembly; P:formation of translation preinitiation complex; P:regulation of translational initiation; P:translational initiation;|P23588 B4DS13 Q4G0E3 Q53HQ2 Q6GPH5 Q6IB46 Q8WYK5,Eukaryotic translation initiation factor 4B,, PF00076;, GO:0005829;GO:0016281;GO:0043024;GO:0003723;GO:0033592;GO:0034057;GO:0003743;GO:0097010;GO:0001731;GO:0006446;GO:0006413;, C:cytosol; C:eukaryotic translation initiation factor 4F complex;, F:ribosomal small subunit binding; F:RNA binding; F:RNA strand annealing activity; F:RNA strand-exchange activity; F:translation initiation factor activity;, P:eukaryotic translation initiation factor 4F complex assembly; P:formation of translation preinitiation complex; P:regulation of translational initiation; P:translational initiation; scaffold122 indexed_genome mRNA 859153 888002 . + . ID=transcript_13664;Q8NFG0 Q96P25 Q9NT29 Q9UPS7,Tensin-2,C1 domain-containing phosphatase and tensin homolog;Tensin-like C1 domain-containing phosphatase;, PF08416;PF10409;PF00017;, GO:0005925;GO:0005886;GO:0042802;GO:0019900;GO:0046872;GO:0004725;GO:0019725;GO:0032963;GO:0035556;GO:0001822;GO:0035264;GO:0048871;GO:0008285;GO:0046627;GO:0035335;GO:0014850;, C:focal adhesion; C:plasma membrane;, F:identical protein binding; F:kinase binding; F:metal ion binding; F:protein tyrosine phosphatase activity;, P:cellular homeostasis; P:collagen metabolic process; P:intracellular signal transduction; P:kidney development; P:multicellular organism growth; P:multicellular organismal homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:response to muscle activity;|Q8NFG0 Q96P25 Q9NT29 Q9UPS7,Tensin-2,C1 domain-containing phosphatase and tensin homolog;Tensin-like C1 domain-containing phosphatase;, PF08416;PF10409;PF00017;, GO:0005925;GO:0005886;GO:0042802;GO:0019900;GO:0046872;GO:0004725;GO:0019725;GO:0032963;GO:0035556;GO:0001822;GO:0035264;GO:0048871;GO:0008285;GO:0046627;GO:0035335;GO:0014850;, C:focal adhesion; C:plasma membrane;, F:identical protein binding; F:kinase binding; F:metal ion binding; F:protein tyrosine phosphatase activity;, P:cellular homeostasis; P:collagen metabolic process; P:intracellular signal transduction; P:kidney development; P:multicellular organism growth; P:multicellular organismal homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:response to muscle activity;|Q8NFG0 Q96P25 Q9NT29 Q9UPS7,Tensin-2,C1 domain-containing phosphatase and tensin homolog;Tensin-like C1 domain-containing phosphatase;, PF08416;PF10409;PF00017;, GO:0005925;GO:0005886;GO:0042802;GO:0019900;GO:0046872;GO:0004725;GO:0019725;GO:0032963;GO:0035556;GO:0001822;GO:0035264;GO:0048871;GO:0008285;GO:0046627;GO:0035335;GO:0014850;, C:focal adhesion; C:plasma membrane;, F:identical protein binding; F:kinase binding; F:metal ion binding; F:protein tyrosine phosphatase activity;, P:cellular homeostasis; P:collagen metabolic process; P:intracellular signal transduction; P:kidney development; P:multicellular organism growth; P:multicellular organismal homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:response to muscle activity;|Q8NFG0 Q96P25 Q9NT29 Q9UPS7,Tensin-2,C1 domain-containing phosphatase and tensin homolog;Tensin-like C1 domain-containing phosphatase;, PF08416;PF10409;PF00017;, GO:0005925;GO:0005886;GO:0042802;GO:0019900;GO:0046872;GO:0004725;GO:0019725;GO:0032963;GO:0035556;GO:0001822;GO:0035264;GO:0048871;GO:0008285;GO:0046627;GO:0035335;GO:0014850;, C:focal adhesion; C:plasma membrane;, F:identical protein binding; F:kinase binding; F:metal ion binding; F:protein tyrosine phosphatase activity;, P:cellular homeostasis; P:collagen metabolic process; P:intracellular signal transduction; P:kidney development; P:multicellular organism growth; P:multicellular organismal homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:response to muscle activity;|Q8NFG0 Q96P25 Q9NT29 Q9UPS7,Tensin-2,C1 domain-containing phosphatase and tensin homolog;Tensin-like C1 domain-containing phosphatase;, PF08416;PF10409;PF00017;, GO:0005925;GO:0005886;GO:0042802;GO:0019900;GO:0046872;GO:0004725;GO:0019725;GO:0032963;GO:0035556;GO:0001822;GO:0035264;GO:0048871;GO:0008285;GO:0046627;GO:0035335;GO:0014850;, C:focal adhesion; C:plasma membrane;, F:identical protein binding; F:kinase binding; F:metal ion binding; F:protein tyrosine phosphatase activity;, P:cellular homeostasis; P:collagen metabolic process; P:intracellular signal transduction; P:kidney development; P:multicellular organism growth; P:multicellular organismal homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:response to muscle activity;|Q8NFG0 Q96P25 Q9NT29 Q9UPS7,Tensin-2,C1 domain-containing phosphatase and tensin homolog;Tensin-like C1 domain-containing phosphatase;, PF08416;PF10409;PF00017;, GO:0005925;GO:0005886;GO:0042802;GO:0019900;GO:0046872;GO:0004725;GO:0019725;GO:0032963;GO:0035556;GO:0001822;GO:0035264;GO:0048871;GO:0008285;GO:0046627;GO:0035335;GO:0014850;, C:focal adhesion; C:plasma membrane;, F:identical protein binding; F:kinase binding; F:metal ion binding; F:protein tyrosine phosphatase activity;, P:cellular homeostasis; P:collagen metabolic process; P:intracellular signal transduction; P:kidney development; P:multicellular organism growth; P:multicellular organismal homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:response to muscle activity;|Q8NFG0 Q96P25 Q9NT29 Q9UPS7,Tensin-2,C1 domain-containing phosphatase and tensin homolog;Tensin-like C1 domain-containing phosphatase;, PF08416;PF10409;PF00017;, GO:0005925;GO:0005886;GO:0042802;GO:0019900;GO:0046872;GO:0004725;GO:0019725;GO:0032963;GO:0035556;GO:0001822;GO:0035264;GO:0048871;GO:0008285;GO:0046627;GO:0035335;GO:0014850;, C:focal adhesion; C:plasma membrane;, F:identical protein binding; F:kinase binding; F:metal ion binding; F:protein tyrosine phosphatase activity;, P:cellular homeostasis; P:collagen metabolic process; P:intracellular signal transduction; P:kidney development; P:multicellular organism growth; P:multicellular organismal homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:response to muscle activity;|Q8NCJ5 B9EG99 Q96SK5,SPRY domain-containing protein 3,, PF00622;, GO:0005737;GO:0007166;GO:0007010;, C:cytoplasm;, , P:cell surface receptor signaling pathway; P:cytoskeleton organization;|Q8NCJ5 B9EG99 Q96SK5,SPRY domain-containing protein 3,, PF00622;, GO:0005737;GO:0007166;GO:0007010;, C:cytoplasm;, , P:cell surface receptor signaling pathway; P:cytoskeleton organization;|Q8NCJ5 B9EG99 Q96SK5,SPRY domain-containing protein 3,, PF00622;, GO:0005737;GO:0007166;GO:0007010;, C:cytoplasm;, , P:cell surface receptor signaling pathway; P:cytoskeleton organization;|Q8NCJ5 B9EG99 Q96SK5,SPRY domain-containing protein 3,, PF00622;, GO:0005737;GO:0007166;GO:0007010;, C:cytoplasm;, , P:cell surface receptor signaling pathway; P:cytoskeleton organization;|Q8NCJ5 B9EG99 Q96SK5,SPRY domain-containing protein 3,, PF00622;, GO:0005737;GO:0007166;GO:0007010;, C:cytoplasm;, , P:cell surface receptor signaling pathway; P:cytoskeleton organization; scaffold122 indexed_genome mRNA 894100 898417 . + . ID=transcript_13665;P24592 Q14492,Insulin-like growth factor-binding protein 6 {ECO:0000305},, PF00086;, GO:0005576;GO:0005615;GO:0005794;GO:0042568;GO:0001968;GO:0042802;GO:0031994;GO:0031995;GO:0005102;GO:0000187;GO:0016477;GO:0044267;GO:0090090;GO:0008285;GO:0043567;GO:0007165;, C:extracellular region; C:extracellular space; C:Golgi apparatus; C:insulin-like growth factor binary complex;, F:fibronectin binding; F:identical protein binding; F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:signaling receptor binding;, P:activation of MAPK activity; P:cell migration; P:cellular protein metabolic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:regulation of insulin-like growth factor receptor signaling pathway; P:signal transduction;|P24592 Q14492,Insulin-like growth factor-binding protein 6 {ECO:0000305},, PF00086;, GO:0005576;GO:0005615;GO:0005794;GO:0042568;GO:0001968;GO:0042802;GO:0031994;GO:0031995;GO:0005102;GO:0000187;GO:0016477;GO:0044267;GO:0090090;GO:0008285;GO:0043567;GO:0007165;, C:extracellular region; C:extracellular space; C:Golgi apparatus; C:insulin-like growth factor binary complex;, F:fibronectin binding; F:identical protein binding; F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:signaling receptor binding;, P:activation of MAPK activity; P:cell migration; P:cellular protein metabolic process; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell population proliferation; P:regulation of insulin-like growth factor receptor signaling pathway; P:signal transduction; scaffold122 indexed_genome mRNA 899470 909869 . + . ID=transcript_13666;O75908 F5H7W4 I6L9H9 Q4VB99 Q4VBA1 Q96TD4 Q9UNR2,Sterol O-acyltransferase 2 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase 2;Cholesterol acyltransferase 2;, PF03062;, GO:0005903;GO:0005783;GO:0005789;GO:0016021;GO:0015485;GO:0034736;GO:0000062;GO:0008374;GO:0004772;GO:0016746;GO:0033344;GO:0034435;GO:0042632;GO:0008203;GO:0030299;GO:0034383;GO:0010742;GO:0034379;, C:brush border; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cholesterol binding; F:cholesterol O-acyltransferase activity; F:fatty-acyl-CoA binding; F:O-acyltransferase activity; F:sterol O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:cholesterol efflux; P:cholesterol esterification; P:cholesterol homeostasis; P:cholesterol metabolic process; P:intestinal cholesterol absorption; P:low-density lipoprotein particle clearance; P:macrophage derived foam cell differentiation; P:very-low-density lipoprotein particle assembly;|O75908 F5H7W4 I6L9H9 Q4VB99 Q4VBA1 Q96TD4 Q9UNR2,Sterol O-acyltransferase 2 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase 2;Cholesterol acyltransferase 2;, PF03062;, GO:0005903;GO:0005783;GO:0005789;GO:0016021;GO:0015485;GO:0034736;GO:0000062;GO:0008374;GO:0004772;GO:0016746;GO:0033344;GO:0034435;GO:0042632;GO:0008203;GO:0030299;GO:0034383;GO:0010742;GO:0034379;, C:brush border; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cholesterol binding; F:cholesterol O-acyltransferase activity; F:fatty-acyl-CoA binding; F:O-acyltransferase activity; F:sterol O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:cholesterol efflux; P:cholesterol esterification; P:cholesterol homeostasis; P:cholesterol metabolic process; P:intestinal cholesterol absorption; P:low-density lipoprotein particle clearance; P:macrophage derived foam cell differentiation; P:very-low-density lipoprotein particle assembly;|O75908 F5H7W4 I6L9H9 Q4VB99 Q4VBA1 Q96TD4 Q9UNR2,Sterol O-acyltransferase 2 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase 2;Cholesterol acyltransferase 2;, PF03062;, GO:0005903;GO:0005783;GO:0005789;GO:0016021;GO:0015485;GO:0034736;GO:0000062;GO:0008374;GO:0004772;GO:0016746;GO:0033344;GO:0034435;GO:0042632;GO:0008203;GO:0030299;GO:0034383;GO:0010742;GO:0034379;, C:brush border; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cholesterol binding; F:cholesterol O-acyltransferase activity; F:fatty-acyl-CoA binding; F:O-acyltransferase activity; F:sterol O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:cholesterol efflux; P:cholesterol esterification; P:cholesterol homeostasis; P:cholesterol metabolic process; P:intestinal cholesterol absorption; P:low-density lipoprotein particle clearance; P:macrophage derived foam cell differentiation; P:very-low-density lipoprotein particle assembly;|O75908 F5H7W4 I6L9H9 Q4VB99 Q4VBA1 Q96TD4 Q9UNR2,Sterol O-acyltransferase 2 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase 2;Cholesterol acyltransferase 2;, PF03062;, GO:0005903;GO:0005783;GO:0005789;GO:0016021;GO:0015485;GO:0034736;GO:0000062;GO:0008374;GO:0004772;GO:0016746;GO:0033344;GO:0034435;GO:0042632;GO:0008203;GO:0030299;GO:0034383;GO:0010742;GO:0034379;, C:brush border; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cholesterol binding; F:cholesterol O-acyltransferase activity; F:fatty-acyl-CoA binding; F:O-acyltransferase activity; F:sterol O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:cholesterol efflux; P:cholesterol esterification; P:cholesterol homeostasis; P:cholesterol metabolic process; P:intestinal cholesterol absorption; P:low-density lipoprotein particle clearance; P:macrophage derived foam cell differentiation; P:very-low-density lipoprotein particle assembly;|O75908 F5H7W4 I6L9H9 Q4VB99 Q4VBA1 Q96TD4 Q9UNR2,Sterol O-acyltransferase 2 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase 2;Cholesterol acyltransferase 2;, PF03062;, GO:0005903;GO:0005783;GO:0005789;GO:0016021;GO:0015485;GO:0034736;GO:0000062;GO:0008374;GO:0004772;GO:0016746;GO:0033344;GO:0034435;GO:0042632;GO:0008203;GO:0030299;GO:0034383;GO:0010742;GO:0034379;, C:brush border; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cholesterol binding; F:cholesterol O-acyltransferase activity; F:fatty-acyl-CoA binding; F:O-acyltransferase activity; F:sterol O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:cholesterol efflux; P:cholesterol esterification; P:cholesterol homeostasis; P:cholesterol metabolic process; P:intestinal cholesterol absorption; P:low-density lipoprotein particle clearance; P:macrophage derived foam cell differentiation; P:very-low-density lipoprotein particle assembly;|O75908 F5H7W4 I6L9H9 Q4VB99 Q4VBA1 Q96TD4 Q9UNR2,Sterol O-acyltransferase 2 {ECO:0000305},Acyl-coenzyme A:cholesterol acyltransferase 2;Cholesterol acyltransferase 2;, PF03062;, GO:0005903;GO:0005783;GO:0005789;GO:0016021;GO:0015485;GO:0034736;GO:0000062;GO:0008374;GO:0004772;GO:0016746;GO:0033344;GO:0034435;GO:0042632;GO:0008203;GO:0030299;GO:0034383;GO:0010742;GO:0034379;, C:brush border; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:cholesterol binding; F:cholesterol O-acyltransferase activity; F:fatty-acyl-CoA binding; F:O-acyltransferase activity; F:sterol O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:cholesterol efflux; P:cholesterol esterification; P:cholesterol homeostasis; P:cholesterol metabolic process; P:intestinal cholesterol absorption; P:low-density lipoprotein particle clearance; P:macrophage derived foam cell differentiation; P:very-low-density lipoprotein particle assembly; scaffold122 indexed_genome mRNA 925255 935831 . - . ID=transcript_13667;Q9Y600 A8K0U4 Q4QQH9 Q9UNJ5 Q9Y601,Cysteine sulfinic acid decarboxylase,Aspartate 1-decarboxylase {ECO:0000250|UniProtKB:Q9DBE0};Cysteine-sulfinate decarboxylase;Sulfinoalanine decarboxylase;, PF00282;, GO:0005737;GO:0004068;GO:0030170;GO:0004782;GO:0019449;GO:0019452;GO:0042412;, C:cytoplasm;, F:aspartate 1-decarboxylase activity; F:pyridoxal phosphate binding; F:sulfinoalanine decarboxylase activity;, P:L-cysteine catabolic process to hypotaurine; P:L-cysteine catabolic process to taurine; P:taurine biosynthetic process;|Q9Y600 A8K0U4 Q4QQH9 Q9UNJ5 Q9Y601,Cysteine sulfinic acid decarboxylase,Aspartate 1-decarboxylase {ECO:0000250|UniProtKB:Q9DBE0};Cysteine-sulfinate decarboxylase;Sulfinoalanine decarboxylase;, PF00282;, GO:0005737;GO:0004068;GO:0030170;GO:0004782;GO:0019449;GO:0019452;GO:0042412;, C:cytoplasm;, F:aspartate 1-decarboxylase activity; F:pyridoxal phosphate binding; F:sulfinoalanine decarboxylase activity;, P:L-cysteine catabolic process to hypotaurine; P:L-cysteine catabolic process to taurine; P:taurine biosynthetic process;|Q9Y600 A8K0U4 Q4QQH9 Q9UNJ5 Q9Y601,Cysteine sulfinic acid decarboxylase,Aspartate 1-decarboxylase {ECO:0000250|UniProtKB:Q9DBE0};Cysteine-sulfinate decarboxylase;Sulfinoalanine decarboxylase;, PF00282;, GO:0005737;GO:0004068;GO:0030170;GO:0004782;GO:0019449;GO:0019452;GO:0042412;, C:cytoplasm;, F:aspartate 1-decarboxylase activity; F:pyridoxal phosphate binding; F:sulfinoalanine decarboxylase activity;, P:L-cysteine catabolic process to hypotaurine; P:L-cysteine catabolic process to taurine; P:taurine biosynthetic process;|Q9Y600 A8K0U4 Q4QQH9 Q9UNJ5 Q9Y601,Cysteine sulfinic acid decarboxylase,Aspartate 1-decarboxylase {ECO:0000250|UniProtKB:Q9DBE0};Cysteine-sulfinate decarboxylase;Sulfinoalanine decarboxylase;, PF00282;, GO:0005737;GO:0004068;GO:0030170;GO:0004782;GO:0019449;GO:0019452;GO:0042412;, C:cytoplasm;, F:aspartate 1-decarboxylase activity; F:pyridoxal phosphate binding; F:sulfinoalanine decarboxylase activity;, P:L-cysteine catabolic process to hypotaurine; P:L-cysteine catabolic process to taurine; P:taurine biosynthetic process;|Q9Y600 A8K0U4 Q4QQH9 Q9UNJ5 Q9Y601,Cysteine sulfinic acid decarboxylase,Aspartate 1-decarboxylase {ECO:0000250|UniProtKB:Q9DBE0};Cysteine-sulfinate decarboxylase;Sulfinoalanine decarboxylase;, PF00282;, GO:0005737;GO:0004068;GO:0030170;GO:0004782;GO:0019449;GO:0019452;GO:0042412;, C:cytoplasm;, F:aspartate 1-decarboxylase activity; F:pyridoxal phosphate binding; F:sulfinoalanine decarboxylase activity;, P:L-cysteine catabolic process to hypotaurine; P:L-cysteine catabolic process to taurine; P:taurine biosynthetic process;|Q9Y600 A8K0U4 Q4QQH9 Q9UNJ5 Q9Y601,Cysteine sulfinic acid decarboxylase,Aspartate 1-decarboxylase {ECO:0000250|UniProtKB:Q9DBE0};Cysteine-sulfinate decarboxylase;Sulfinoalanine decarboxylase;, PF00282;, GO:0005737;GO:0004068;GO:0030170;GO:0004782;GO:0019449;GO:0019452;GO:0042412;, C:cytoplasm;, F:aspartate 1-decarboxylase activity; F:pyridoxal phosphate binding; F:sulfinoalanine decarboxylase activity;, P:L-cysteine catabolic process to hypotaurine; P:L-cysteine catabolic process to taurine; P:taurine biosynthetic process;|Q9Y600 A8K0U4 Q4QQH9 Q9UNJ5 Q9Y601,Cysteine sulfinic acid decarboxylase,Aspartate 1-decarboxylase {ECO:0000250|UniProtKB:Q9DBE0};Cysteine-sulfinate decarboxylase;Sulfinoalanine decarboxylase;, PF00282;, GO:0005737;GO:0004068;GO:0030170;GO:0004782;GO:0019449;GO:0019452;GO:0042412;, C:cytoplasm;, F:aspartate 1-decarboxylase activity; F:pyridoxal phosphate binding; F:sulfinoalanine decarboxylase activity;, P:L-cysteine catabolic process to hypotaurine; P:L-cysteine catabolic process to taurine; P:taurine biosynthetic process; scaffold122 indexed_genome mRNA 954037 960254 . - . ID=transcript_13668;Q8NDX6 A8K9M9,Zinc finger protein 740,OriLyt TD-element-binding protein 7;, PF00096;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8NDX6 A8K9M9,Zinc finger protein 740,OriLyt TD-element-binding protein 7;, PF00096;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8NDX6 A8K9M9,Zinc finger protein 740,OriLyt TD-element-binding protein 7;, PF00096;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold122 indexed_genome mRNA 962025 971076 . - . ID=transcript_13669;P26010 Q9UCP7 Q9UCS7,Integrin beta-7,Gut homing receptor beta subunit;, PF07974;PF08725;PF00362;PF17205;, GO:0009986;GO:0070062;GO:0005925;GO:0034669;GO:0008305;GO:0016020;GO:0005886;GO:0043235;GO:0050839;GO:0005178;GO:0046872;GO:0038023;GO:0001618;GO:0007155;GO:0033627;GO:0016477;GO:0007160;GO:0003366;GO:0030198;GO:0034113;GO:0007229;GO:0050901;GO:0043113;GO:0050776;GO:0034446;GO:0072678;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:integrin alpha4-beta7 complex; C:integrin complex; C:membrane; C:plasma membrane; C:receptor complex;, F:cell adhesion molecule binding; F:integrin binding; F:metal ion binding; F:signaling receptor activity; F:virus receptor activity;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:cell-matrix adhesion involved in ameboidal cell migration; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte tethering or rolling; P:receptor clustering; P:regulation of immune response; P:substrate adhesion-dependent cell spreading; P:T cell migration;|P26010 Q9UCP7 Q9UCS7,Integrin beta-7,Gut homing receptor beta subunit;, PF07974;PF08725;PF00362;PF17205;, GO:0009986;GO:0070062;GO:0005925;GO:0034669;GO:0008305;GO:0016020;GO:0005886;GO:0043235;GO:0050839;GO:0005178;GO:0046872;GO:0038023;GO:0001618;GO:0007155;GO:0033627;GO:0016477;GO:0007160;GO:0003366;GO:0030198;GO:0034113;GO:0007229;GO:0050901;GO:0043113;GO:0050776;GO:0034446;GO:0072678;, C:cell surface; C:extracellular exosome; C:focal adhesion; C:integrin alpha4-beta7 complex; C:integrin complex; C:membrane; C:plasma membrane; C:receptor complex;, F:cell adhesion molecule binding; F:integrin binding; F:metal ion binding; F:signaling receptor activity; F:virus receptor activity;, P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-matrix adhesion; P:cell-matrix adhesion involved in ameboidal cell migration; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte tethering or rolling; P:receptor clustering; P:regulation of immune response; P:substrate adhesion-dependent cell spreading; P:T cell migration; scaffold122 indexed_genome mRNA 979733 989549 . - . ID=transcript_13670;Q9H1I3 Q9UJ38,Retinoic acid receptor gamma,Nuclear receptor subfamily 1 group B member 3;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0016021;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0003677;GO:0003700;GO:0000981;GO:0004879;GO:0046965;GO:0000978;GO:1990837;GO:0008270;GO:0009952;GO:0060070;GO:0030154;GO:1990830;GO:0071300;GO:0031076;GO:0048048;GO:0035116;GO:0060324;GO:0002068;GO:0003430;GO:0070384;GO:0009755;GO:0035264;GO:0008285;GO:0032331;GO:0000122;GO:0001843;GO:0043065;GO:0008284;GO:0043068;GO:0045944;GO:0060740;GO:0008361;GO:0031641;GO:0045637;GO:0032526;GO:0048384;GO:0060534;GO:0006367;, C:chromatin; C:cytoplasm; C:integral component of membrane; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anterior/posterior pattern specification; P:canonical Wnt signaling pathway; P:cell differentiation; P:cellular response to leukemia inhibitory factor; P:cellular response to retinoic acid; P:embryonic camera-type eye development; P:embryonic eye morphogenesis; P:embryonic hindlimb morphogenesis; P:face development; P:glandular epithelial cell development; P:growth plate cartilage chondrocyte growth; P:Harderian gland development; P:hormone-mediated signaling pathway; P:multicellular organism growth; P:negative regulation of cell population proliferation; P:negative regulation of chondrocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:neural tube closure; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of programmed cell death; P:positive regulation of transcription by RNA polymerase II; P:prostate gland epithelium morphogenesis; P:regulation of cell size; P:regulation of myelination; P:regulation of myeloid cell differentiation; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:trachea cartilage development; P:transcription initiation from RNA polymerase II promoter;|Q9H1I3 Q9UJ38,Retinoic acid receptor gamma,Nuclear receptor subfamily 1 group B member 3;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0016021;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0003677;GO:0003700;GO:0000981;GO:0004879;GO:0046965;GO:0000978;GO:1990837;GO:0008270;GO:0009952;GO:0060070;GO:0030154;GO:1990830;GO:0071300;GO:0031076;GO:0048048;GO:0035116;GO:0060324;GO:0002068;GO:0003430;GO:0070384;GO:0009755;GO:0035264;GO:0008285;GO:0032331;GO:0000122;GO:0001843;GO:0043065;GO:0008284;GO:0043068;GO:0045944;GO:0060740;GO:0008361;GO:0031641;GO:0045637;GO:0032526;GO:0048384;GO:0060534;GO:0006367;, C:chromatin; C:cytoplasm; C:integral component of membrane; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anterior/posterior pattern specification; P:canonical Wnt signaling pathway; P:cell differentiation; P:cellular response to leukemia inhibitory factor; P:cellular response to retinoic acid; P:embryonic camera-type eye development; P:embryonic eye morphogenesis; P:embryonic hindlimb morphogenesis; P:face development; P:glandular epithelial cell development; P:growth plate cartilage chondrocyte growth; P:Harderian gland development; P:hormone-mediated signaling pathway; P:multicellular organism growth; P:negative regulation of cell population proliferation; P:negative regulation of chondrocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:neural tube closure; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of programmed cell death; P:positive regulation of transcription by RNA polymerase II; P:prostate gland epithelium morphogenesis; P:regulation of cell size; P:regulation of myelination; P:regulation of myeloid cell differentiation; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:trachea cartilage development; P:transcription initiation from RNA polymerase II promoter;|Q9H1I3 Q9UJ38,Retinoic acid receptor gamma,Nuclear receptor subfamily 1 group B member 3;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0016021;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0003677;GO:0003700;GO:0000981;GO:0004879;GO:0046965;GO:0000978;GO:1990837;GO:0008270;GO:0009952;GO:0060070;GO:0030154;GO:1990830;GO:0071300;GO:0031076;GO:0048048;GO:0035116;GO:0060324;GO:0002068;GO:0003430;GO:0070384;GO:0009755;GO:0035264;GO:0008285;GO:0032331;GO:0000122;GO:0001843;GO:0043065;GO:0008284;GO:0043068;GO:0045944;GO:0060740;GO:0008361;GO:0031641;GO:0045637;GO:0032526;GO:0048384;GO:0060534;GO:0006367;, C:chromatin; C:cytoplasm; C:integral component of membrane; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anterior/posterior pattern specification; P:canonical Wnt signaling pathway; P:cell differentiation; P:cellular response to leukemia inhibitory factor; P:cellular response to retinoic acid; P:embryonic camera-type eye development; P:embryonic eye morphogenesis; P:embryonic hindlimb morphogenesis; P:face development; P:glandular epithelial cell development; P:growth plate cartilage chondrocyte growth; P:Harderian gland development; P:hormone-mediated signaling pathway; P:multicellular organism growth; P:negative regulation of cell population proliferation; P:negative regulation of chondrocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:neural tube closure; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of programmed cell death; P:positive regulation of transcription by RNA polymerase II; P:prostate gland epithelium morphogenesis; P:regulation of cell size; P:regulation of myelination; P:regulation of myeloid cell differentiation; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:trachea cartilage development; P:transcription initiation from RNA polymerase II promoter; scaffold122 indexed_genome mRNA 1005088 1009702 . - . ID=transcript_13671;Q9H1I3 Q9UJ38,Retinoic acid receptor gamma,Nuclear receptor subfamily 1 group B member 3;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0016021;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0003677;GO:0003700;GO:0000981;GO:0004879;GO:0046965;GO:0000978;GO:1990837;GO:0008270;GO:0009952;GO:0060070;GO:0030154;GO:1990830;GO:0071300;GO:0031076;GO:0048048;GO:0035116;GO:0060324;GO:0002068;GO:0003430;GO:0070384;GO:0009755;GO:0035264;GO:0008285;GO:0032331;GO:0000122;GO:0001843;GO:0043065;GO:0008284;GO:0043068;GO:0045944;GO:0060740;GO:0008361;GO:0031641;GO:0045637;GO:0032526;GO:0048384;GO:0060534;GO:0006367;, C:chromatin; C:cytoplasm; C:integral component of membrane; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anterior/posterior pattern specification; P:canonical Wnt signaling pathway; P:cell differentiation; P:cellular response to leukemia inhibitory factor; P:cellular response to retinoic acid; P:embryonic camera-type eye development; P:embryonic eye morphogenesis; P:embryonic hindlimb morphogenesis; P:face development; P:glandular epithelial cell development; P:growth plate cartilage chondrocyte growth; P:Harderian gland development; P:hormone-mediated signaling pathway; P:multicellular organism growth; P:negative regulation of cell population proliferation; P:negative regulation of chondrocyte differentiation; P:negative regulation of transcription by RNA polymerase II; P:neural tube closure; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of programmed cell death; P:positive regulation of transcription by RNA polymerase II; P:prostate gland epithelium morphogenesis; P:regulation of cell size; P:regulation of myelination; P:regulation of myeloid cell differentiation; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:trachea cartilage development; P:transcription initiation from RNA polymerase II promoter; scaffold122 indexed_genome mRNA 1023685 1027066 . + . ID=transcript_13672;Q6N075 G3V1N7 Q6NW04 Q8N7W8 Q8NCK0 Q96IA5,Molybdate-anion transporter,Major facilitator superfamily domain-containing protein 5;Molybdate transporter 2 homolog;, PF05631;, GO:0016021;GO:0016020;GO:0005886;GO:0015098;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:molybdate ion transmembrane transporter activity; scaffold122 indexed_genome mRNA 1049950 1053030 . + . ID=transcript_13673;Q14674,Separin,Caspase-like protein ESPL1;Extra spindle poles-like 1 protein;Separase;, , GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005634;GO:0003824;GO:0004197;GO:0008234;GO:0006915;GO:0040001;GO:0045143;GO:0051307;GO:0000212;GO:0000281;GO:0000070;GO:0045875;GO:0045842;, C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleus;, F:catalytic activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:apoptotic process; P:establishment of mitotic spindle localization; P:homologous chromosome segregation; P:meiotic chromosome separation; P:meiotic spindle organization; P:mitotic cytokinesis; P:mitotic sister chromatid segregation; P:negative regulation of sister chromatid cohesion; P:positive regulation of mitotic metaphase/anaphase transition; scaffold122 indexed_genome mRNA 1056243 1059595 . + . ID=transcript_13674;Q99471 A8K9A8 Q54AA8 Q9C083 Q9C084,Prefoldin subunit 5,Myc modulator 1;c-Myc-binding protein Mm-1;, PF02996;, GO:0005737;GO:0005829;GO:0045111;GO:0005634;GO:0016272;GO:0001540;GO:0003714;GO:0051082;GO:1905907;GO:0090090;GO:0045892;GO:0006457;GO:0006355;, C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:nucleus; C:prefoldin complex;, F:amyloid-beta binding; F:transcription corepressor activity; F:unfolded protein binding;, P:negative regulation of amyloid fibril formation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription, DNA-templated; P:protein folding; P:regulation of transcription, DNA-templated;|Q99471 A8K9A8 Q54AA8 Q9C083 Q9C084,Prefoldin subunit 5,Myc modulator 1;c-Myc-binding protein Mm-1;, PF02996;, GO:0005737;GO:0005829;GO:0045111;GO:0005634;GO:0016272;GO:0001540;GO:0003714;GO:0051082;GO:1905907;GO:0090090;GO:0045892;GO:0006457;GO:0006355;, C:cytoplasm; C:cytosol; C:intermediate filament cytoskeleton; C:nucleus; C:prefoldin complex;, F:amyloid-beta binding; F:transcription corepressor activity; F:unfolded protein binding;, P:negative regulation of amyloid fibril formation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription, DNA-templated; P:protein folding; P:regulation of transcription, DNA-templated; scaffold122 indexed_genome mRNA 1059704 1081208 . + . ID=transcript_13675;Q9HB07 Q86UA3,MYG1 exonuclease {ECO:0000305},, PF03690;, GO:0005737;GO:0005759;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0004518;GO:0035641;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus;, F:nuclease activity;, P:locomotory exploration behavior;|Q9HB07 Q86UA3,MYG1 exonuclease {ECO:0000305},, PF03690;, GO:0005737;GO:0005759;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0004518;GO:0035641;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus;, F:nuclease activity;, P:locomotory exploration behavior;|Q9NRG9 Q5JB47 Q9NWI6 Q9UG19,Aladin,Adracalin;, PF00400;, GO:0005813;GO:0005829;GO:0043657;GO:0016020;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0000922;GO:0009566;GO:0075733;GO:0007612;GO:0001578;GO:0090307;GO:0006406;GO:0006913;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0046822;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:centrosome; C:cytosol; C:host cell; C:membrane; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:spindle pole;, , P:fertilization; P:intracellular transport of virus; P:learning; P:microtubule bundle formation; P:mitotic spindle assembly; P:mRNA export from nucleus; P:nucleocytoplasmic transport; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of nucleocytoplasmic transport; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9NRG9 Q5JB47 Q9NWI6 Q9UG19,Aladin,Adracalin;, PF00400;, GO:0005813;GO:0005829;GO:0043657;GO:0016020;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0005654;GO:0005634;GO:0000922;GO:0009566;GO:0075733;GO:0007612;GO:0001578;GO:0090307;GO:0006406;GO:0006913;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0046822;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:centrosome; C:cytosol; C:host cell; C:membrane; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nucleoplasm; C:nucleus; C:spindle pole;, , P:fertilization; P:intracellular transport of virus; P:learning; P:microtubule bundle formation; P:mitotic spindle assembly; P:mRNA export from nucleus; P:nucleocytoplasmic transport; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of nucleocytoplasmic transport; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold122 indexed_genome mRNA 1140230 1173846 . + . ID=transcript_13676;P08047 E4Z9M7 G5E9M8 Q86TN8 Q9H3Q5 Q9NR51 Q9NY21 Q9NYE7,Transcription factor Sp1,, PF00096;, GO:0000785;GO:0005737;GO:0000791;GO:0005654;GO:0005634;GO:0032993;GO:0017053;GO:0043425;GO:0000987;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0003690;GO:0035035;GO:0042826;GO:0071837;GO:0046872;GO:0008022;GO:0042803;GO:0070491;GO:0000978;GO:0001103;GO:0000977;GO:0043565;GO:1990837;GO:0008134;GO:0000976;GO:0032869;GO:0043923;GO:1902004;GO:0045766;GO:0043536;GO:0010628;GO:1904828;GO:0045944;GO:0045893;GO:1905564;GO:0019216;GO:0006357;GO:0006355;GO:0033194;GO:0048511;GO:0042795;GO:0016032;, C:chromatin; C:cytoplasm; C:euchromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription repressor complex;, F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:histone acetyltransferase binding; F:histone deacetylase binding; F:HMG box domain binding; F:metal ion binding; F:protein C-terminus binding; F:protein homodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to insulin stimulus; P:positive regulation by host of viral transcription; P:positive regulation of amyloid-beta formation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of gene expression; P:positive regulation of hydrogen sulfide biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial cell proliferation; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to hydroperoxide; P:rhythmic process; P:snRNA transcription by RNA polymerase II; P:viral process; scaffold122 indexed_genome mRNA 1183279 1184308 . + . ID=transcript_13677;Q16671 A0AVE1 B9EGB7 E9PGD2 F8W1D2 Q13762 Q647K2,Anti-Muellerian hormone type-2 receptor,Anti-Muellerian hormone type II receptor;MIS type II receptor;, PF01064;PF00069;, GO:0048179;GO:0005886;GO:0043235;GO:0048185;GO:0017002;GO:1990272;GO:0005524;GO:0042562;GO:0046872;GO:0004674;GO:0005026;GO:0032924;GO:1990262;GO:0030509;GO:0071363;GO:0008585;GO:0008584;GO:0001880;GO:0006468;GO:0007548;GO:0007179;, C:activin receptor complex; C:plasma membrane; C:receptor complex;, F:activin binding; F:activin-activated receptor activity; F:anti-Mullerian hormone receptor activity; F:ATP binding; F:hormone binding; F:metal ion binding; F:protein serine/threonine kinase activity; F:transforming growth factor beta receptor activity, type II;, P:activin receptor signaling pathway; P:anti-Mullerian hormone signaling pathway; P:BMP signaling pathway; P:cellular response to growth factor stimulus; P:female gonad development; P:male gonad development; P:Mullerian duct regression; P:protein phosphorylation; P:sex differentiation; P:transforming growth factor beta receptor signaling pathway; scaffold122 indexed_genome mRNA 1207062 1208077 . + . ID=transcript_13678;Q9NZ81 Q0V8U0 Q6FIG7 Q6MZP8 Q6NXQ6 Q6PKF9,Proline-rich protein 13,Taxane-resistance protein;, , GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold122 indexed_genome mRNA 1218988 1234008 . + . ID=transcript_13679;Q6IPF4 Q6PKG5,Poly(rC)-binding protein 2,Alpha-CP2;Heterogeneous nuclear ribonucleoprotein E2;, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0014069;GO:1990829;GO:0019899;GO:0003729;GO:0003723;GO:0003697;GO:0031625;GO:0051607;GO:0045087;GO:0075522;GO:0016071;GO:0000398;GO:0050687;GO:0032480;GO:0045944;GO:0043161;GO:0010468;GO:0051252;GO:0016070;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:C-rich single-stranded DNA binding; F:enzyme binding; F:mRNA binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:defense response to virus; P:innate immune response; P:IRES-dependent viral translational initiation; P:mRNA metabolic process; P:mRNA splicing, via spliceosome; P:negative regulation of defense response to virus; P:negative regulation of type I interferon production; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA metabolic process; P:viral RNA genome replication;|Q6IPF4 Q6PKG5,Poly(rC)-binding protein 2,Alpha-CP2;Heterogeneous nuclear ribonucleoprotein E2;, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0014069;GO:1990829;GO:0019899;GO:0003729;GO:0003723;GO:0003697;GO:0031625;GO:0051607;GO:0045087;GO:0075522;GO:0016071;GO:0000398;GO:0050687;GO:0032480;GO:0045944;GO:0043161;GO:0010468;GO:0051252;GO:0016070;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:C-rich single-stranded DNA binding; F:enzyme binding; F:mRNA binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:defense response to virus; P:innate immune response; P:IRES-dependent viral translational initiation; P:mRNA metabolic process; P:mRNA splicing, via spliceosome; P:negative regulation of defense response to virus; P:negative regulation of type I interferon production; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA metabolic process; P:viral RNA genome replication;|Q6IPF4 Q6PKG5,Poly(rC)-binding protein 2,Alpha-CP2;Heterogeneous nuclear ribonucleoprotein E2;, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0014069;GO:1990829;GO:0019899;GO:0003729;GO:0003723;GO:0003697;GO:0031625;GO:0051607;GO:0045087;GO:0075522;GO:0016071;GO:0000398;GO:0050687;GO:0032480;GO:0045944;GO:0043161;GO:0010468;GO:0051252;GO:0016070;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:C-rich single-stranded DNA binding; F:enzyme binding; F:mRNA binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:defense response to virus; P:innate immune response; P:IRES-dependent viral translational initiation; P:mRNA metabolic process; P:mRNA splicing, via spliceosome; P:negative regulation of defense response to virus; P:negative regulation of type I interferon production; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA metabolic process; P:viral RNA genome replication;|Q6IPF4 Q6PKG5,Poly(rC)-binding protein 2,Alpha-CP2;Heterogeneous nuclear ribonucleoprotein E2;, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0014069;GO:1990829;GO:0019899;GO:0003729;GO:0003723;GO:0003697;GO:0031625;GO:0051607;GO:0045087;GO:0075522;GO:0016071;GO:0000398;GO:0050687;GO:0032480;GO:0045944;GO:0043161;GO:0010468;GO:0051252;GO:0016070;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:C-rich single-stranded DNA binding; F:enzyme binding; F:mRNA binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:defense response to virus; P:innate immune response; P:IRES-dependent viral translational initiation; P:mRNA metabolic process; P:mRNA splicing, via spliceosome; P:negative regulation of defense response to virus; P:negative regulation of type I interferon production; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA metabolic process; P:viral RNA genome replication;|Q6IPF4 Q6PKG5,Poly(rC)-binding protein 2,Alpha-CP2;Heterogeneous nuclear ribonucleoprotein E2;, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0014069;GO:1990829;GO:0019899;GO:0003729;GO:0003723;GO:0003697;GO:0031625;GO:0051607;GO:0045087;GO:0075522;GO:0016071;GO:0000398;GO:0050687;GO:0032480;GO:0045944;GO:0043161;GO:0010468;GO:0051252;GO:0016070;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:C-rich single-stranded DNA binding; F:enzyme binding; F:mRNA binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:defense response to virus; P:innate immune response; P:IRES-dependent viral translational initiation; P:mRNA metabolic process; P:mRNA splicing, via spliceosome; P:negative regulation of defense response to virus; P:negative regulation of type I interferon production; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA metabolic process; P:viral RNA genome replication;|Q6IPF4 Q6PKG5,Poly(rC)-binding protein 2,Alpha-CP2;Heterogeneous nuclear ribonucleoprotein E2;, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0014069;GO:1990829;GO:0019899;GO:0003729;GO:0003723;GO:0003697;GO:0031625;GO:0051607;GO:0045087;GO:0075522;GO:0016071;GO:0000398;GO:0050687;GO:0032480;GO:0045944;GO:0043161;GO:0010468;GO:0051252;GO:0016070;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:C-rich single-stranded DNA binding; F:enzyme binding; F:mRNA binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:defense response to virus; P:innate immune response; P:IRES-dependent viral translational initiation; P:mRNA metabolic process; P:mRNA splicing, via spliceosome; P:negative regulation of defense response to virus; P:negative regulation of type I interferon production; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA metabolic process; P:viral RNA genome replication;|Q6IPF4 Q6PKG5,Poly(rC)-binding protein 2,Alpha-CP2;Heterogeneous nuclear ribonucleoprotein E2;, PF00013;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0014069;GO:1990829;GO:0019899;GO:0003729;GO:0003723;GO:0003697;GO:0031625;GO:0051607;GO:0045087;GO:0075522;GO:0016071;GO:0000398;GO:0050687;GO:0032480;GO:0045944;GO:0043161;GO:0010468;GO:0051252;GO:0016070;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus; C:postsynaptic density;, F:C-rich single-stranded DNA binding; F:enzyme binding; F:mRNA binding; F:RNA binding; F:single-stranded DNA binding; F:ubiquitin protein ligase binding;, P:defense response to virus; P:innate immune response; P:IRES-dependent viral translational initiation; P:mRNA metabolic process; P:mRNA splicing, via spliceosome; P:negative regulation of defense response to virus; P:negative regulation of type I interferon production; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of gene expression; P:regulation of RNA metabolic process; P:RNA metabolic process; P:viral RNA genome replication; scaffold122 indexed_genome mRNA 1234023 1245262 . - . ID=transcript_13680;Q12852 B3KSS9 G3V1Y2 Q86VQ5 Q8WY25,Mitogen-activated protein kinase kinase kinase 12,Dual leucine zipper bearing kinase;Leucine-zipper protein kinase;MAPK-upstream kinase;Mixed lineage kinase;, PF07714;, GO:0005737;GO:0005829;GO:0030426;GO:0016020;GO:0005886;GO:0005524;GO:0004706;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0007256;GO:0007257;GO:0016572;GO:0035556;GO:0007254;GO:2000672;GO:0018105;GO:0018107;GO:0070374;GO:0045893;GO:0046777;GO:0006468;, C:cytoplasm; C:cytosol; C:growth cone; C:membrane; C:plasma membrane;, F:ATP binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JNKK activity; P:activation of JUN kinase activity; P:histone phosphorylation; P:intracellular signal transduction; P:JNK cascade; P:negative regulation of motor neuron apoptotic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation;|Q12852 B3KSS9 G3V1Y2 Q86VQ5 Q8WY25,Mitogen-activated protein kinase kinase kinase 12,Dual leucine zipper bearing kinase;Leucine-zipper protein kinase;MAPK-upstream kinase;Mixed lineage kinase;, PF07714;, GO:0005737;GO:0005829;GO:0030426;GO:0016020;GO:0005886;GO:0005524;GO:0004706;GO:0042803;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0007256;GO:0007257;GO:0016572;GO:0035556;GO:0007254;GO:2000672;GO:0018105;GO:0018107;GO:0070374;GO:0045893;GO:0046777;GO:0006468;, C:cytoplasm; C:cytosol; C:growth cone; C:membrane; C:plasma membrane;, F:ATP binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JNKK activity; P:activation of JUN kinase activity; P:histone phosphorylation; P:intracellular signal transduction; P:JNK cascade; P:negative regulation of motor neuron apoptotic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; scaffold122 indexed_genome mRNA 1254194 1259666 . - . ID=transcript_13681;Q15633 Q12878 Q8WY32 Q8WY33 Q9BRY2,RISC-loading complex subunit TARBP2 {ECO:0000255|HAMAP-Rule:MF_03034},TAR RNA-binding protein 2;Trans-activation-responsive RNA-binding protein;, PF00035;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0048471;GO:0016442;GO:0070578;GO:0003725;GO:0019899;GO:0042802;GO:0035198;GO:0070883;GO:0036002;GO:0042803;GO:0047485;GO:0035197;GO:0035280;GO:0010586;GO:0035264;GO:0050689;GO:0006469;GO:0061351;GO:0051149;GO:0045727;GO:0045070;GO:0031054;GO:0035196;GO:0030422;GO:1903798;GO:0090065;GO:0046782;GO:0007338;GO:0035087;GO:0043403;GO:0007286;GO:0030423;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:enzyme binding; F:identical protein binding; F:miRNA binding; F:pre-miRNA binding; F:pre-mRNA binding; F:protein homodimerization activity; F:protein N-terminus binding; F:siRNA binding;, P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA metabolic process; P:multicellular organism growth; P:negative regulation of defense response to virus by host; P:negative regulation of protein kinase activity; P:neural precursor cell proliferation; P:positive regulation of muscle cell differentiation; P:positive regulation of translation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:regulation of production of miRNAs involved in gene silencing by miRNA; P:regulation of production of siRNA involved in RNA interference; P:regulation of viral transcription; P:single fertilization; P:siRNA loading onto RISC involved in RNA interference; P:skeletal muscle tissue regeneration; P:spermatid development; P:targeting of mRNA for destruction involved in RNA interference;|Q15633 Q12878 Q8WY32 Q8WY33 Q9BRY2,RISC-loading complex subunit TARBP2 {ECO:0000255|HAMAP-Rule:MF_03034},TAR RNA-binding protein 2;Trans-activation-responsive RNA-binding protein;, PF00035;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0048471;GO:0016442;GO:0070578;GO:0003725;GO:0019899;GO:0042802;GO:0035198;GO:0070883;GO:0036002;GO:0042803;GO:0047485;GO:0035197;GO:0035280;GO:0010586;GO:0035264;GO:0050689;GO:0006469;GO:0061351;GO:0051149;GO:0045727;GO:0045070;GO:0031054;GO:0035196;GO:0030422;GO:1903798;GO:0090065;GO:0046782;GO:0007338;GO:0035087;GO:0043403;GO:0007286;GO:0030423;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:enzyme binding; F:identical protein binding; F:miRNA binding; F:pre-miRNA binding; F:pre-mRNA binding; F:protein homodimerization activity; F:protein N-terminus binding; F:siRNA binding;, P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA metabolic process; P:multicellular organism growth; P:negative regulation of defense response to virus by host; P:negative regulation of protein kinase activity; P:neural precursor cell proliferation; P:positive regulation of muscle cell differentiation; P:positive regulation of translation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:regulation of production of miRNAs involved in gene silencing by miRNA; P:regulation of production of siRNA involved in RNA interference; P:regulation of viral transcription; P:single fertilization; P:siRNA loading onto RISC involved in RNA interference; P:skeletal muscle tissue regeneration; P:spermatid development; P:targeting of mRNA for destruction involved in RNA interference;|Q15633 Q12878 Q8WY32 Q8WY33 Q9BRY2,RISC-loading complex subunit TARBP2 {ECO:0000255|HAMAP-Rule:MF_03034},TAR RNA-binding protein 2;Trans-activation-responsive RNA-binding protein;, PF00035;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0048471;GO:0016442;GO:0070578;GO:0003725;GO:0019899;GO:0042802;GO:0035198;GO:0070883;GO:0036002;GO:0042803;GO:0047485;GO:0035197;GO:0035280;GO:0010586;GO:0035264;GO:0050689;GO:0006469;GO:0061351;GO:0051149;GO:0045727;GO:0045070;GO:0031054;GO:0035196;GO:0030422;GO:1903798;GO:0090065;GO:0046782;GO:0007338;GO:0035087;GO:0043403;GO:0007286;GO:0030423;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:enzyme binding; F:identical protein binding; F:miRNA binding; F:pre-miRNA binding; F:pre-mRNA binding; F:protein homodimerization activity; F:protein N-terminus binding; F:siRNA binding;, P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA metabolic process; P:multicellular organism growth; P:negative regulation of defense response to virus by host; P:negative regulation of protein kinase activity; P:neural precursor cell proliferation; P:positive regulation of muscle cell differentiation; P:positive regulation of translation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:regulation of production of miRNAs involved in gene silencing by miRNA; P:regulation of production of siRNA involved in RNA interference; P:regulation of viral transcription; P:single fertilization; P:siRNA loading onto RISC involved in RNA interference; P:skeletal muscle tissue regeneration; P:spermatid development; P:targeting of mRNA for destruction involved in RNA interference;|Q15633 Q12878 Q8WY32 Q8WY33 Q9BRY2,RISC-loading complex subunit TARBP2 {ECO:0000255|HAMAP-Rule:MF_03034},TAR RNA-binding protein 2;Trans-activation-responsive RNA-binding protein;, PF00035;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0048471;GO:0016442;GO:0070578;GO:0003725;GO:0019899;GO:0042802;GO:0035198;GO:0070883;GO:0036002;GO:0042803;GO:0047485;GO:0035197;GO:0035280;GO:0010586;GO:0035264;GO:0050689;GO:0006469;GO:0061351;GO:0051149;GO:0045727;GO:0045070;GO:0031054;GO:0035196;GO:0030422;GO:1903798;GO:0090065;GO:0046782;GO:0007338;GO:0035087;GO:0043403;GO:0007286;GO:0030423;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:RISC complex; C:RISC-loading complex;, F:double-stranded RNA binding; F:enzyme binding; F:identical protein binding; F:miRNA binding; F:pre-miRNA binding; F:pre-mRNA binding; F:protein homodimerization activity; F:protein N-terminus binding; F:siRNA binding;, P:miRNA loading onto RISC involved in gene silencing by miRNA; P:miRNA metabolic process; P:multicellular organism growth; P:negative regulation of defense response to virus by host; P:negative regulation of protein kinase activity; P:neural precursor cell proliferation; P:positive regulation of muscle cell differentiation; P:positive regulation of translation; P:positive regulation of viral genome replication; P:pre-miRNA processing; P:production of miRNAs involved in gene silencing by miRNA; P:production of siRNA involved in RNA interference; P:regulation of production of miRNAs involved in gene silencing by miRNA; P:regulation of production of siRNA involved in RNA interference; P:regulation of viral transcription; P:single fertilization; P:siRNA loading onto RISC involved in RNA interference; P:skeletal muscle tissue regeneration; P:spermatid development; P:targeting of mRNA for destruction involved in RNA interference; scaffold122 indexed_genome mRNA 1260083 1265322 . - . ID=transcript_13682;O15130 Q3SXL4,Pro-FMRFamide-related neuropeptide FF,FMRFamide-related peptides;, PF15085;, GO:0043679;GO:0030425;GO:0005576;GO:0005615;GO:0043204;GO:0098794;GO:0031982;GO:0001664;GO:0005184;GO:0005102;GO:0002438;GO:0007268;GO:0060079;GO:0007186;GO:0060135;GO:0032099;GO:0010459;GO:0046676;GO:0007218;GO:0045777;GO:0007204;GO:0003254;GO:0051930;GO:0042493;GO:0043278;GO:0070253;GO:0021510;GO:0030103;, C:axon terminus; C:dendrite; C:extracellular region; C:extracellular space; C:perikaryon; C:postsynapse; C:vesicle;, F:G protein-coupled receptor binding; F:neuropeptide hormone activity; F:signaling receptor binding;, P:acute inflammatory response to antigenic stimulus; P:chemical synaptic transmission; P:excitatory postsynaptic potential; P:G protein-coupled receptor signaling pathway; P:maternal process involved in female pregnancy; P:negative regulation of appetite; P:negative regulation of heart rate; P:negative regulation of insulin secretion; P:neuropeptide signaling pathway; P:positive regulation of blood pressure; P:positive regulation of cytosolic calcium ion concentration; P:regulation of membrane depolarization; P:regulation of sensory perception of pain; P:response to drug; P:response to morphine; P:somatostatin secretion; P:spinal cord development; P:vasopressin secretion; scaffold122 indexed_genome mRNA 1269018 1355703 . - . ID=transcript_13683;P17544 A5D6Y4 B2RMP1 B4DQL4 Q13814 Q8IVR8 Q9UD83,Cyclic AMP-dependent transcription factor ATF-7,Activating transcription factor 7;Transcription factor ATF-A;, PF00170;, GO:0000785;GO:0000781;GO:0005737;GO:0034399;GO:0005654;GO:0005634;GO:0035497;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0046872;GO:0051019;GO:0000978;GO:1990837;GO:0008134;GO:0000122;GO:0006357;GO:0006355;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:metal ion binding; F:mitogen-activated protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:viral process;|P17544 A5D6Y4 B2RMP1 B4DQL4 Q13814 Q8IVR8 Q9UD83,Cyclic AMP-dependent transcription factor ATF-7,Activating transcription factor 7;Transcription factor ATF-A;, PF00170;, GO:0000785;GO:0000781;GO:0005737;GO:0034399;GO:0005654;GO:0005634;GO:0035497;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0046872;GO:0051019;GO:0000978;GO:1990837;GO:0008134;GO:0000122;GO:0006357;GO:0006355;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:metal ion binding; F:mitogen-activated protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:viral process;|P17544 A5D6Y4 B2RMP1 B4DQL4 Q13814 Q8IVR8 Q9UD83,Cyclic AMP-dependent transcription factor ATF-7,Activating transcription factor 7;Transcription factor ATF-A;, PF00170;, GO:0000785;GO:0000781;GO:0005737;GO:0034399;GO:0005654;GO:0005634;GO:0035497;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0046872;GO:0051019;GO:0000978;GO:1990837;GO:0008134;GO:0000122;GO:0006357;GO:0006355;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:metal ion binding; F:mitogen-activated protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:viral process;|P17544 A5D6Y4 B2RMP1 B4DQL4 Q13814 Q8IVR8 Q9UD83,Cyclic AMP-dependent transcription factor ATF-7,Activating transcription factor 7;Transcription factor ATF-A;, PF00170;, GO:0000785;GO:0000781;GO:0005737;GO:0034399;GO:0005654;GO:0005634;GO:0035497;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0046872;GO:0051019;GO:0000978;GO:1990837;GO:0008134;GO:0000122;GO:0006357;GO:0006355;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:metal ion binding; F:mitogen-activated protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:viral process;|P17544 A5D6Y4 B2RMP1 B4DQL4 Q13814 Q8IVR8 Q9UD83,Cyclic AMP-dependent transcription factor ATF-7,Activating transcription factor 7;Transcription factor ATF-A;, PF00170;, GO:0000785;GO:0000781;GO:0005737;GO:0034399;GO:0005654;GO:0005634;GO:0035497;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0046872;GO:0051019;GO:0000978;GO:1990837;GO:0008134;GO:0000122;GO:0006357;GO:0006355;GO:0016032;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:nuclear periphery; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:metal ion binding; F:mitogen-activated protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:viral process; scaffold122 indexed_genome mRNA 1393279 1401712 . - . ID=transcript_13684;Q06055 B3KQQ6,ATP synthase F(0) complex subunit C2, mitochondrial {ECO:0000305},ATP synthase lipid-binding protein;ATP synthase membrane subunit c locus 2 {ECO:0000312|HGNC:HGNC:842};ATP synthase proteolipid P2;ATP synthase proton-transporting mitochondrial F(0) complex subunit C2;ATPase protein 9;ATPase subunit c;, PF00137;, GO:0016021;GO:0005741;GO:0000276;GO:0045263;GO:0008289;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:proton-transporting ATP synthase complex, coupling factor F(o);, F:lipid binding; F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport;|Q06055 B3KQQ6,ATP synthase F(0) complex subunit C2, mitochondrial {ECO:0000305},ATP synthase lipid-binding protein;ATP synthase membrane subunit c locus 2 {ECO:0000312|HGNC:HGNC:842};ATP synthase proteolipid P2;ATP synthase proton-transporting mitochondrial F(0) complex subunit C2;ATPase protein 9;ATPase subunit c;, PF00137;, GO:0016021;GO:0005741;GO:0000276;GO:0045263;GO:0008289;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:proton-transporting ATP synthase complex, coupling factor F(o);, F:lipid binding; F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport;|Q06055 B3KQQ6,ATP synthase F(0) complex subunit C2, mitochondrial {ECO:0000305},ATP synthase lipid-binding protein;ATP synthase membrane subunit c locus 2 {ECO:0000312|HGNC:HGNC:842};ATP synthase proteolipid P2;ATP synthase proton-transporting mitochondrial F(0) complex subunit C2;ATPase protein 9;ATPase subunit c;, PF00137;, GO:0016021;GO:0005741;GO:0000276;GO:0045263;GO:0008289;GO:0046933;GO:0006754;GO:0015986;GO:0042407;GO:0042776;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); C:proton-transporting ATP synthase complex, coupling factor F(o);, F:lipid binding; F:proton-transporting ATP synthase activity, rotational mechanism;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; scaffold122 indexed_genome mRNA 1428047 1441121 . - . ID=transcript_13685;Q9P1Z2 B3KVA8 Q6FI59 Q71RC3 Q86WF8 Q96JU3 Q9H090,Calcium-binding and coiled-coil domain-containing protein 1,Calphoglin;Coiled-coil coactivator protein;Sarcoma antigen NY-SAR-3;, PF07888;PF17751;PF18112;, GO:0000785;GO:0005829;GO:0043231;GO:0005634;GO:0070016;GO:0008013;GO:0003682;GO:0046872;GO:0030374;GO:0008022;GO:0000978;GO:0043565;GO:0003713;GO:0003712;GO:0000976;GO:0030518;GO:0010628;GO:0045944;GO:0045893;GO:0007165;GO:0016055;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:armadillo repeat domain binding; F:beta-catenin binding; F:chromatin binding; F:metal ion binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription regulatory region sequence-specific DNA binding;, P:intracellular steroid hormone receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;|Q9P1Z2 B3KVA8 Q6FI59 Q71RC3 Q86WF8 Q96JU3 Q9H090,Calcium-binding and coiled-coil domain-containing protein 1,Calphoglin;Coiled-coil coactivator protein;Sarcoma antigen NY-SAR-3;, PF07888;PF17751;PF18112;, GO:0000785;GO:0005829;GO:0043231;GO:0005634;GO:0070016;GO:0008013;GO:0003682;GO:0046872;GO:0030374;GO:0008022;GO:0000978;GO:0043565;GO:0003713;GO:0003712;GO:0000976;GO:0030518;GO:0010628;GO:0045944;GO:0045893;GO:0007165;GO:0016055;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:armadillo repeat domain binding; F:beta-catenin binding; F:chromatin binding; F:metal ion binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription regulatory region sequence-specific DNA binding;, P:intracellular steroid hormone receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;|Q9P1Z2 B3KVA8 Q6FI59 Q71RC3 Q86WF8 Q96JU3 Q9H090,Calcium-binding and coiled-coil domain-containing protein 1,Calphoglin;Coiled-coil coactivator protein;Sarcoma antigen NY-SAR-3;, PF07888;PF17751;PF18112;, GO:0000785;GO:0005829;GO:0043231;GO:0005634;GO:0070016;GO:0008013;GO:0003682;GO:0046872;GO:0030374;GO:0008022;GO:0000978;GO:0043565;GO:0003713;GO:0003712;GO:0000976;GO:0030518;GO:0010628;GO:0045944;GO:0045893;GO:0007165;GO:0016055;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:armadillo repeat domain binding; F:beta-catenin binding; F:chromatin binding; F:metal ion binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription regulatory region sequence-specific DNA binding;, P:intracellular steroid hormone receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;|Q9P1Z2 B3KVA8 Q6FI59 Q71RC3 Q86WF8 Q96JU3 Q9H090,Calcium-binding and coiled-coil domain-containing protein 1,Calphoglin;Coiled-coil coactivator protein;Sarcoma antigen NY-SAR-3;, PF07888;PF17751;PF18112;, GO:0000785;GO:0005829;GO:0043231;GO:0005634;GO:0070016;GO:0008013;GO:0003682;GO:0046872;GO:0030374;GO:0008022;GO:0000978;GO:0043565;GO:0003713;GO:0003712;GO:0000976;GO:0030518;GO:0010628;GO:0045944;GO:0045893;GO:0007165;GO:0016055;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:armadillo repeat domain binding; F:beta-catenin binding; F:chromatin binding; F:metal ion binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription regulatory region sequence-specific DNA binding;, P:intracellular steroid hormone receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;|Q9P1Z2 B3KVA8 Q6FI59 Q71RC3 Q86WF8 Q96JU3 Q9H090,Calcium-binding and coiled-coil domain-containing protein 1,Calphoglin;Coiled-coil coactivator protein;Sarcoma antigen NY-SAR-3;, PF07888;PF17751;PF18112;, GO:0000785;GO:0005829;GO:0043231;GO:0005634;GO:0070016;GO:0008013;GO:0003682;GO:0046872;GO:0030374;GO:0008022;GO:0000978;GO:0043565;GO:0003713;GO:0003712;GO:0000976;GO:0030518;GO:0010628;GO:0045944;GO:0045893;GO:0007165;GO:0016055;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:armadillo repeat domain binding; F:beta-catenin binding; F:chromatin binding; F:metal ion binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription regulatory region sequence-specific DNA binding;, P:intracellular steroid hormone receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;|Q9P1Z2 B3KVA8 Q6FI59 Q71RC3 Q86WF8 Q96JU3 Q9H090,Calcium-binding and coiled-coil domain-containing protein 1,Calphoglin;Coiled-coil coactivator protein;Sarcoma antigen NY-SAR-3;, PF07888;PF17751;PF18112;, GO:0000785;GO:0005829;GO:0043231;GO:0005634;GO:0070016;GO:0008013;GO:0003682;GO:0046872;GO:0030374;GO:0008022;GO:0000978;GO:0043565;GO:0003713;GO:0003712;GO:0000976;GO:0030518;GO:0010628;GO:0045944;GO:0045893;GO:0007165;GO:0016055;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:armadillo repeat domain binding; F:beta-catenin binding; F:chromatin binding; F:metal ion binding; F:nuclear receptor coactivator activity; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription coregulator activity; F:transcription regulatory region sequence-specific DNA binding;, P:intracellular steroid hormone receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway; scaffold122 indexed_genome mRNA 1763220 1763801 . - . ID=transcript_13686;P09630 B2RBV2 Q6DK09,Homeobox protein Hox-C6,Homeobox protein CP25;Homeobox protein HHO.C8;Homeobox protein Hox-3C;, PF00046;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0000978;GO:0009952;GO:0048706;GO:0007275;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:anterior/posterior pattern specification; P:embryonic skeletal system development; P:multicellular organism development; P:regulation of transcription by RNA polymerase II; scaffold122 indexed_genome mRNA 1906168 1913302 . - . ID=transcript_13687;Q53HV7 A8K2K9 O95862 Q0D2M0 Q8NB71 Q9BWC8,Single-strand selective monofunctional uracil DNA glycosylase,, , GO:0005829;GO:0001650;GO:0005730;GO:0005654;GO:0003677;GO:0019104;GO:0042802;GO:0000703;GO:0017065;GO:0004844;GO:0006284;GO:0006287;GO:0045008;, C:cytosol; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:DNA N-glycosylase activity; F:identical protein binding; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity; F:single-strand selective uracil DNA N-glycosylase activity; F:uracil DNA N-glycosylase activity;, P:base-excision repair; P:base-excision repair, gap-filling; P:depyrimidination;|Q53HV7 A8K2K9 O95862 Q0D2M0 Q8NB71 Q9BWC8,Single-strand selective monofunctional uracil DNA glycosylase,, , GO:0005829;GO:0001650;GO:0005730;GO:0005654;GO:0003677;GO:0019104;GO:0042802;GO:0000703;GO:0017065;GO:0004844;GO:0006284;GO:0006287;GO:0045008;, C:cytosol; C:fibrillar center; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:DNA N-glycosylase activity; F:identical protein binding; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity; F:single-strand selective uracil DNA N-glycosylase activity; F:uracil DNA N-glycosylase activity;, P:base-excision repair; P:base-excision repair, gap-filling; P:depyrimidination; scaffold122 indexed_genome mRNA 1955316 1984435 . - . ID=transcript_13688;P45973 B2R8T9,Chromobox protein homolog 5,Antigen p25;Heterochromatin protein 1 homolog alpha;, PF00385;PF01393;, GO:0010369;GO:0000781;GO:0000792;GO:0000118;GO:0035097;GO:0000776;GO:0005635;GO:0005730;GO:0005654;GO:0005634;GO:0005721;GO:0032991;GO:1990904;GO:0090734;GO:0017053;GO:0003682;GO:0042826;GO:0042802;GO:0035064;GO:0044877;GO:0030674;GO:0070491;GO:0043021;GO:0007596;GO:0006974;GO:0070317;GO:0000122;GO:0045892;GO:0016032;, C:chromocenter; C:chromosome, telomeric region; C:heterochromatin; C:histone deacetylase complex; C:histone methyltransferase complex; C:kinetochore; C:nuclear envelope; C:nucleolus; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:protein-containing complex; C:ribonucleoprotein complex; C:site of DNA damage; C:transcription repressor complex;, F:chromatin binding; F:histone deacetylase binding; F:identical protein binding; F:methylated histone binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:repressing transcription factor binding; F:ribonucleoprotein complex binding;, P:blood coagulation; P:cellular response to DNA damage stimulus; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:viral process;|P09651 A8K4Z8 Q3MIB7 Q6PJZ7,Heterogeneous nuclear ribonucleoprotein A1,Helix-destabilizing protein;Single-strand RNA-binding protein;hnRNP core protein A1;, PF11627;PF00076;, GO:0071013;GO:0005737;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0005681;GO:0098505;GO:0042802;GO:0035198;GO:0036002;GO:0019904;GO:0003723;GO:0003697;GO:0003727;GO:0061752;GO:0042149;GO:1903936;GO:0008543;GO:0051170;GO:0000398;GO:0051028;GO:0032211;GO:0051168;GO:0032212;GO:0000381;GO:0006405;GO:0016070;GO:0016032;, C:catalytic step 2 spliceosome; C:cytoplasm; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal complex;, F:G-rich strand telomeric DNA binding; F:identical protein binding; F:miRNA binding; F:pre-mRNA binding; F:protein domain specific binding; F:RNA binding; F:single-stranded DNA binding; F:single-stranded RNA binding; F:telomeric repeat-containing RNA binding;, P:cellular response to glucose starvation; P:cellular response to sodium arsenite; P:fibroblast growth factor receptor signaling pathway; P:import into nucleus; P:mRNA splicing, via spliceosome; P:mRNA transport; P:negative regulation of telomere maintenance via telomerase; P:nuclear export; P:positive regulation of telomere maintenance via telomerase; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA metabolic process; P:viral process; scaffold122 indexed_genome mRNA 1984596 1987171 . + . ID=transcript_13689;Q32P51 Q5TBS2,Heterogeneous nuclear ribonucleoprotein A1-like 2,hnRNP core protein A1-like 2;, PF11627;PF00076;, GO:0005737;GO:0005681;GO:0003723;GO:0006397;GO:0051028;GO:0008380;, C:cytoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA transport; P:RNA splicing;|Q32P51 Q5TBS2,Heterogeneous nuclear ribonucleoprotein A1-like 2,hnRNP core protein A1-like 2;, PF11627;PF00076;, GO:0005737;GO:0005681;GO:0003723;GO:0006397;GO:0051028;GO:0008380;, C:cytoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA transport; P:RNA splicing;|Q32P51 Q5TBS2,Heterogeneous nuclear ribonucleoprotein A1-like 2,hnRNP core protein A1-like 2;, PF11627;PF00076;, GO:0005737;GO:0005681;GO:0003723;GO:0006397;GO:0051028;GO:0008380;, C:cytoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA transport; P:RNA splicing; scaffold122 indexed_genome mRNA 1991471 1992535 . - . ID=transcript_13690;Q16621 Q07720 Q6ICV9,Transcription factor NF-E2 45 kDa subunit,Leucine zipper protein NF-E2;Nuclear factor, erythroid-derived 2 45 kDa subunit;p45 NF-E2;, PF03131;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0016605;GO:0032993;GO:0003677;GO:0003700;GO:0000981;GO:0047485;GO:0000978;GO:0043565;GO:1990837;GO:0050699;GO:0007596;GO:0007599;GO:0007275;GO:0006337;GO:0045893;GO:0045652;GO:0006357;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:PML body; C:protein-DNA complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein N-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:WW domain binding;, P:blood coagulation; P:hemostasis; P:multicellular organism development; P:nucleosome disassembly; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation; P:regulation of transcription by RNA polymerase II; scaffold122 indexed_genome mRNA 2025689 2045057 . + . ID=transcript_13691;P61923 B4DDX8 B4DHZ0 F8VS17 F8VWL5 Q549N6 Q9Y3C3,Coatomer subunit zeta-1,Zeta-1-coat protein;, PF01217;, GO:0030126;GO:0005829;GO:0005789;GO:0000139;GO:0030133;GO:0006888;GO:0006891;GO:0006886;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:transport vesicle;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P61923 B4DDX8 B4DHZ0 F8VS17 F8VWL5 Q549N6 Q9Y3C3,Coatomer subunit zeta-1,Zeta-1-coat protein;, PF01217;, GO:0030126;GO:0005829;GO:0005789;GO:0000139;GO:0030133;GO:0006888;GO:0006891;GO:0006886;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:transport vesicle;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P61923 B4DDX8 B4DHZ0 F8VS17 F8VWL5 Q549N6 Q9Y3C3,Coatomer subunit zeta-1,Zeta-1-coat protein;, PF01217;, GO:0030126;GO:0005829;GO:0005789;GO:0000139;GO:0030133;GO:0006888;GO:0006891;GO:0006886;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:transport vesicle;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P61923 B4DDX8 B4DHZ0 F8VS17 F8VWL5 Q549N6 Q9Y3C3,Coatomer subunit zeta-1,Zeta-1-coat protein;, PF01217;, GO:0030126;GO:0005829;GO:0005789;GO:0000139;GO:0030133;GO:0006888;GO:0006891;GO:0006886;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi membrane; C:transport vesicle;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold122 indexed_genome mRNA 2059570 2079192 . - . ID=transcript_13692;Q96PM9 B2RDN5 B4DKH2 F1T0F1 J3KNS3 Q5VH53 Q9H7R6 Q9UFU3,Zinc finger protein 385A,Hematopoietic zinc finger protein;Retinal zinc finger protein;, , GO:0005737;GO:0030425;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0003730;GO:0002039;GO:0003723;GO:0008270;GO:0006915;GO:0006974;GO:0006977;GO:0007599;GO:0007611;GO:0007626;GO:0035855;GO:0010609;GO:1902166;GO:0070889;GO:0030220;GO:1902164;GO:0045600;GO:2000765;GO:1901796;, C:cytoplasm; C:dendrite; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:mRNA 3'-UTR binding; F:p53 binding; F:RNA binding; F:zinc ion binding;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:hemostasis; P:learning or memory; P:locomotory behavior; P:megakaryocyte development; P:mRNA localization resulting in posttranscriptional regulation of gene expression; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:platelet alpha granule organization; P:platelet formation; P:positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:positive regulation of fat cell differentiation; P:regulation of cytoplasmic translation; P:regulation of signal transduction by p53 class mediator;|Q96PM9 B2RDN5 B4DKH2 F1T0F1 J3KNS3 Q5VH53 Q9H7R6 Q9UFU3,Zinc finger protein 385A,Hematopoietic zinc finger protein;Retinal zinc finger protein;, , GO:0005737;GO:0030425;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0003730;GO:0002039;GO:0003723;GO:0008270;GO:0006915;GO:0006974;GO:0006977;GO:0007599;GO:0007611;GO:0007626;GO:0035855;GO:0010609;GO:1902166;GO:0070889;GO:0030220;GO:1902164;GO:0045600;GO:2000765;GO:1901796;, C:cytoplasm; C:dendrite; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:mRNA 3'-UTR binding; F:p53 binding; F:RNA binding; F:zinc ion binding;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:hemostasis; P:learning or memory; P:locomotory behavior; P:megakaryocyte development; P:mRNA localization resulting in posttranscriptional regulation of gene expression; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:platelet alpha granule organization; P:platelet formation; P:positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:positive regulation of fat cell differentiation; P:regulation of cytoplasmic translation; P:regulation of signal transduction by p53 class mediator; scaffold122 indexed_genome mRNA 2088566 2110256 . - . ID=transcript_13693;P08648 Q96HA5,Integrin alpha-5 {ECO:0000305},CD49 antigen-like family member E;Fibronectin receptor subunit alpha;Integrin alpha-F;VLA-5;, PF01839;PF08441;, GO:0071062;GO:0009986;GO:0031410;GO:0005783;GO:0009897;GO:0005925;GO:0005794;GO:0034674;GO:0008305;GO:0005886;GO:0001726;GO:0045202;GO:0005154;GO:0005178;GO:0046872;GO:0005161;GO:0043184;GO:0001618;GO:0001525;GO:0023035;GO:0007155;GO:0033627;GO:0033631;GO:0031589;GO:0007044;GO:0035987;GO:0030198;GO:0007565;GO:0007157;GO:0034113;GO:0007229;GO:0007159;GO:0050900;GO:0007613;GO:2000811;GO:0030335;GO:0010811;GO:0050731;GO:1903672;GO:0030949;GO:0035313;, C:alphav-beta3 integrin-vitronectin complex; C:cell surface; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:external side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:integrin alpha5-beta1 complex; C:integrin complex; C:plasma membrane; C:ruffle; C:synapse;, F:epidermal growth factor receptor binding; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor receptor binding; F:vascular endothelial growth factor receptor 2 binding; F:virus receptor activity;, P:angiogenesis; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell-cell adhesion mediated by integrin; P:cell-substrate adhesion; P:cell-substrate junction assembly; P:endodermal cell differentiation; P:extracellular matrix organization; P:female pregnancy; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:memory; P:negative regulation of anoikis; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:wound healing, spreading of epidermal cells;|P08648 Q96HA5,Integrin alpha-5 {ECO:0000305},CD49 antigen-like family member E;Fibronectin receptor subunit alpha;Integrin alpha-F;VLA-5;, PF01839;PF08441;, GO:0071062;GO:0009986;GO:0031410;GO:0005783;GO:0009897;GO:0005925;GO:0005794;GO:0034674;GO:0008305;GO:0005886;GO:0001726;GO:0045202;GO:0005154;GO:0005178;GO:0046872;GO:0005161;GO:0043184;GO:0001618;GO:0001525;GO:0023035;GO:0007155;GO:0033627;GO:0033631;GO:0031589;GO:0007044;GO:0035987;GO:0030198;GO:0007565;GO:0007157;GO:0034113;GO:0007229;GO:0007159;GO:0050900;GO:0007613;GO:2000811;GO:0030335;GO:0010811;GO:0050731;GO:1903672;GO:0030949;GO:0035313;, C:alphav-beta3 integrin-vitronectin complex; C:cell surface; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:external side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:integrin alpha5-beta1 complex; C:integrin complex; C:plasma membrane; C:ruffle; C:synapse;, F:epidermal growth factor receptor binding; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor receptor binding; F:vascular endothelial growth factor receptor 2 binding; F:virus receptor activity;, P:angiogenesis; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell-cell adhesion mediated by integrin; P:cell-substrate adhesion; P:cell-substrate junction assembly; P:endodermal cell differentiation; P:extracellular matrix organization; P:female pregnancy; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:memory; P:negative regulation of anoikis; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:wound healing, spreading of epidermal cells;|P08648 Q96HA5,Integrin alpha-5 {ECO:0000305},CD49 antigen-like family member E;Fibronectin receptor subunit alpha;Integrin alpha-F;VLA-5;, PF01839;PF08441;, GO:0071062;GO:0009986;GO:0031410;GO:0005783;GO:0009897;GO:0005925;GO:0005794;GO:0034674;GO:0008305;GO:0005886;GO:0001726;GO:0045202;GO:0005154;GO:0005178;GO:0046872;GO:0005161;GO:0043184;GO:0001618;GO:0001525;GO:0023035;GO:0007155;GO:0033627;GO:0033631;GO:0031589;GO:0007044;GO:0035987;GO:0030198;GO:0007565;GO:0007157;GO:0034113;GO:0007229;GO:0007159;GO:0050900;GO:0007613;GO:2000811;GO:0030335;GO:0010811;GO:0050731;GO:1903672;GO:0030949;GO:0035313;, C:alphav-beta3 integrin-vitronectin complex; C:cell surface; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:external side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:integrin alpha5-beta1 complex; C:integrin complex; C:plasma membrane; C:ruffle; C:synapse;, F:epidermal growth factor receptor binding; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor receptor binding; F:vascular endothelial growth factor receptor 2 binding; F:virus receptor activity;, P:angiogenesis; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell-cell adhesion mediated by integrin; P:cell-substrate adhesion; P:cell-substrate junction assembly; P:endodermal cell differentiation; P:extracellular matrix organization; P:female pregnancy; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:memory; P:negative regulation of anoikis; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:wound healing, spreading of epidermal cells;|P08648 Q96HA5,Integrin alpha-5 {ECO:0000305},CD49 antigen-like family member E;Fibronectin receptor subunit alpha;Integrin alpha-F;VLA-5;, PF01839;PF08441;, GO:0071062;GO:0009986;GO:0031410;GO:0005783;GO:0009897;GO:0005925;GO:0005794;GO:0034674;GO:0008305;GO:0005886;GO:0001726;GO:0045202;GO:0005154;GO:0005178;GO:0046872;GO:0005161;GO:0043184;GO:0001618;GO:0001525;GO:0023035;GO:0007155;GO:0033627;GO:0033631;GO:0031589;GO:0007044;GO:0035987;GO:0030198;GO:0007565;GO:0007157;GO:0034113;GO:0007229;GO:0007159;GO:0050900;GO:0007613;GO:2000811;GO:0030335;GO:0010811;GO:0050731;GO:1903672;GO:0030949;GO:0035313;, C:alphav-beta3 integrin-vitronectin complex; C:cell surface; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:external side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:integrin alpha5-beta1 complex; C:integrin complex; C:plasma membrane; C:ruffle; C:synapse;, F:epidermal growth factor receptor binding; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor receptor binding; F:vascular endothelial growth factor receptor 2 binding; F:virus receptor activity;, P:angiogenesis; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell-cell adhesion mediated by integrin; P:cell-substrate adhesion; P:cell-substrate junction assembly; P:endodermal cell differentiation; P:extracellular matrix organization; P:female pregnancy; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:memory; P:negative regulation of anoikis; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:wound healing, spreading of epidermal cells;|P08648 Q96HA5,Integrin alpha-5 {ECO:0000305},CD49 antigen-like family member E;Fibronectin receptor subunit alpha;Integrin alpha-F;VLA-5;, PF01839;PF08441;, GO:0071062;GO:0009986;GO:0031410;GO:0005783;GO:0009897;GO:0005925;GO:0005794;GO:0034674;GO:0008305;GO:0005886;GO:0001726;GO:0045202;GO:0005154;GO:0005178;GO:0046872;GO:0005161;GO:0043184;GO:0001618;GO:0001525;GO:0023035;GO:0007155;GO:0033627;GO:0033631;GO:0031589;GO:0007044;GO:0035987;GO:0030198;GO:0007565;GO:0007157;GO:0034113;GO:0007229;GO:0007159;GO:0050900;GO:0007613;GO:2000811;GO:0030335;GO:0010811;GO:0050731;GO:1903672;GO:0030949;GO:0035313;, C:alphav-beta3 integrin-vitronectin complex; C:cell surface; C:cytoplasmic vesicle; C:endoplasmic reticulum; C:external side of plasma membrane; C:focal adhesion; C:Golgi apparatus; C:integrin alpha5-beta1 complex; C:integrin complex; C:plasma membrane; C:ruffle; C:synapse;, F:epidermal growth factor receptor binding; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor receptor binding; F:vascular endothelial growth factor receptor 2 binding; F:virus receptor activity;, P:angiogenesis; P:CD40 signaling pathway; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell-cell adhesion mediated by integrin; P:cell-substrate adhesion; P:cell-substrate junction assembly; P:endodermal cell differentiation; P:extracellular matrix organization; P:female pregnancy; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:memory; P:negative regulation of anoikis; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:wound healing, spreading of epidermal cells; scaffold122 indexed_genome mRNA 2148236 2195879 . + . ID=transcript_13694;P55160 B4DUT5 Q52LW0,Nck-associated protein 1-like {ECO:0000305},Hematopoietic protein 1 {ECO:0000303|PubMed:1932118};Membrane-associated protein HEM-1;, PF09735;, GO:0005829;GO:0070062;GO:0101003;GO:0005887;GO:0016020;GO:0005886;GO:0031209;GO:0030667;GO:0005096;GO:0030295;GO:0044877;GO:0070358;GO:0001782;GO:0050853;GO:0016477;GO:0000902;GO:0030031;GO:0006935;GO:0030866;GO:0048821;GO:0034101;GO:0038096;GO:0030011;GO:0002262;GO:0043066;GO:0032700;GO:0032715;GO:0035509;GO:0048812;GO:0030593;GO:0043312;GO:0030838;GO:0045579;GO:0030890;GO:0043372;GO:0043378;GO:0033630;GO:0045648;GO:0045588;GO:0045621;GO:0090023;GO:0060100;GO:0042327;GO:0042102;GO:0065003;GO:0042493;GO:0043029;GO:0048010;, C:cytosol; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:SCAR complex; C:secretory granule membrane;, F:GTPase activator activity; F:protein kinase activator activity; F:protein-containing complex binding;, P:actin polymerization-dependent cell motility; P:B cell homeostasis; P:B cell receptor signaling pathway; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:chemotaxis; P:cortical actin cytoskeleton organization; P:erythrocyte development; P:erythrocyte homeostasis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:maintenance of cell polarity; P:myeloid cell homeostasis; P:negative regulation of apoptotic process; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-6 production; P:negative regulation of myosin-light-chain-phosphatase activity; P:neuron projection morphogenesis; P:neutrophil chemotaxis; P:neutrophil degranulation; P:positive regulation of actin filament polymerization; P:positive regulation of B cell differentiation; P:positive regulation of B cell proliferation; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of erythrocyte differentiation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of lymphocyte differentiation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of phagocytosis, engulfment; P:positive regulation of phosphorylation; P:positive regulation of T cell proliferation; P:protein-containing complex assembly; P:response to drug; P:T cell homeostasis; P:vascular endothelial growth factor receptor signaling pathway;|P55160 B4DUT5 Q52LW0,Nck-associated protein 1-like {ECO:0000305},Hematopoietic protein 1 {ECO:0000303|PubMed:1932118};Membrane-associated protein HEM-1;, PF09735;, GO:0005829;GO:0070062;GO:0101003;GO:0005887;GO:0016020;GO:0005886;GO:0031209;GO:0030667;GO:0005096;GO:0030295;GO:0044877;GO:0070358;GO:0001782;GO:0050853;GO:0016477;GO:0000902;GO:0030031;GO:0006935;GO:0030866;GO:0048821;GO:0034101;GO:0038096;GO:0030011;GO:0002262;GO:0043066;GO:0032700;GO:0032715;GO:0035509;GO:0048812;GO:0030593;GO:0043312;GO:0030838;GO:0045579;GO:0030890;GO:0043372;GO:0043378;GO:0033630;GO:0045648;GO:0045588;GO:0045621;GO:0090023;GO:0060100;GO:0042327;GO:0042102;GO:0065003;GO:0042493;GO:0043029;GO:0048010;, C:cytosol; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:SCAR complex; C:secretory granule membrane;, F:GTPase activator activity; F:protein kinase activator activity; F:protein-containing complex binding;, P:actin polymerization-dependent cell motility; P:B cell homeostasis; P:B cell receptor signaling pathway; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:chemotaxis; P:cortical actin cytoskeleton organization; P:erythrocyte development; P:erythrocyte homeostasis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:maintenance of cell polarity; P:myeloid cell homeostasis; P:negative regulation of apoptotic process; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-6 production; P:negative regulation of myosin-light-chain-phosphatase activity; P:neuron projection morphogenesis; P:neutrophil chemotaxis; P:neutrophil degranulation; P:positive regulation of actin filament polymerization; P:positive regulation of B cell differentiation; P:positive regulation of B cell proliferation; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of erythrocyte differentiation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of lymphocyte differentiation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of phagocytosis, engulfment; P:positive regulation of phosphorylation; P:positive regulation of T cell proliferation; P:protein-containing complex assembly; P:response to drug; P:T cell homeostasis; P:vascular endothelial growth factor receptor signaling pathway;|P55160 B4DUT5 Q52LW0,Nck-associated protein 1-like {ECO:0000305},Hematopoietic protein 1 {ECO:0000303|PubMed:1932118};Membrane-associated protein HEM-1;, PF09735;, GO:0005829;GO:0070062;GO:0101003;GO:0005887;GO:0016020;GO:0005886;GO:0031209;GO:0030667;GO:0005096;GO:0030295;GO:0044877;GO:0070358;GO:0001782;GO:0050853;GO:0016477;GO:0000902;GO:0030031;GO:0006935;GO:0030866;GO:0048821;GO:0034101;GO:0038096;GO:0030011;GO:0002262;GO:0043066;GO:0032700;GO:0032715;GO:0035509;GO:0048812;GO:0030593;GO:0043312;GO:0030838;GO:0045579;GO:0030890;GO:0043372;GO:0043378;GO:0033630;GO:0045648;GO:0045588;GO:0045621;GO:0090023;GO:0060100;GO:0042327;GO:0042102;GO:0065003;GO:0042493;GO:0043029;GO:0048010;, C:cytosol; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:SCAR complex; C:secretory granule membrane;, F:GTPase activator activity; F:protein kinase activator activity; F:protein-containing complex binding;, P:actin polymerization-dependent cell motility; P:B cell homeostasis; P:B cell receptor signaling pathway; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:chemotaxis; P:cortical actin cytoskeleton organization; P:erythrocyte development; P:erythrocyte homeostasis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:maintenance of cell polarity; P:myeloid cell homeostasis; P:negative regulation of apoptotic process; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-6 production; P:negative regulation of myosin-light-chain-phosphatase activity; P:neuron projection morphogenesis; P:neutrophil chemotaxis; P:neutrophil degranulation; P:positive regulation of actin filament polymerization; P:positive regulation of B cell differentiation; P:positive regulation of B cell proliferation; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of erythrocyte differentiation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of lymphocyte differentiation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of phagocytosis, engulfment; P:positive regulation of phosphorylation; P:positive regulation of T cell proliferation; P:protein-containing complex assembly; P:response to drug; P:T cell homeostasis; P:vascular endothelial growth factor receptor signaling pathway;|P55160 B4DUT5 Q52LW0,Nck-associated protein 1-like {ECO:0000305},Hematopoietic protein 1 {ECO:0000303|PubMed:1932118};Membrane-associated protein HEM-1;, PF09735;, GO:0005829;GO:0070062;GO:0101003;GO:0005887;GO:0016020;GO:0005886;GO:0031209;GO:0030667;GO:0005096;GO:0030295;GO:0044877;GO:0070358;GO:0001782;GO:0050853;GO:0016477;GO:0000902;GO:0030031;GO:0006935;GO:0030866;GO:0048821;GO:0034101;GO:0038096;GO:0030011;GO:0002262;GO:0043066;GO:0032700;GO:0032715;GO:0035509;GO:0048812;GO:0030593;GO:0043312;GO:0030838;GO:0045579;GO:0030890;GO:0043372;GO:0043378;GO:0033630;GO:0045648;GO:0045588;GO:0045621;GO:0090023;GO:0060100;GO:0042327;GO:0042102;GO:0065003;GO:0042493;GO:0043029;GO:0048010;, C:cytosol; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:SCAR complex; C:secretory granule membrane;, F:GTPase activator activity; F:protein kinase activator activity; F:protein-containing complex binding;, P:actin polymerization-dependent cell motility; P:B cell homeostasis; P:B cell receptor signaling pathway; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:chemotaxis; P:cortical actin cytoskeleton organization; P:erythrocyte development; P:erythrocyte homeostasis; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:maintenance of cell polarity; P:myeloid cell homeostasis; P:negative regulation of apoptotic process; P:negative regulation of interleukin-17 production; P:negative regulation of interleukin-6 production; P:negative regulation of myosin-light-chain-phosphatase activity; P:neuron projection morphogenesis; P:neutrophil chemotaxis; P:neutrophil degranulation; P:positive regulation of actin filament polymerization; P:positive regulation of B cell differentiation; P:positive regulation of B cell proliferation; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of erythrocyte differentiation; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of lymphocyte differentiation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of phagocytosis, engulfment; P:positive regulation of phosphorylation; P:positive regulation of T cell proliferation; P:protein-containing complex assembly; P:response to drug; P:T cell homeostasis; P:vascular endothelial growth factor receptor signaling pathway; scaffold122 indexed_genome mRNA 2200750 2227490 . + . ID=transcript_13695;Q01064 Q92825 Q96KP3,Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B,63 kDa Cam-PDE;, PF00233;PF08499;, GO:0005829;GO:0043025;GO:0004115;GO:0047555;GO:0004114;GO:0048101;GO:0005516;GO:0004117;GO:0046872;GO:0006915;GO:0097011;GO:0036006;GO:0007186;GO:0007626;GO:0030224;GO:0042053;GO:0001505;GO:0001975;GO:0042428;GO:0007165;GO:0008542;, C:cytosol; C:neuronal cell body;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-GMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; F:calmodulin binding; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:apoptotic process; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to macrophage colony-stimulating factor stimulus; P:G protein-coupled receptor signaling pathway; P:locomotory behavior; P:monocyte differentiation; P:regulation of dopamine metabolic process; P:regulation of neurotransmitter levels; P:response to amphetamine; P:serotonin metabolic process; P:signal transduction; P:visual learning; scaffold122 indexed_genome mRNA 2228092 2236418 . - . ID=transcript_13696;Q13522 Q6IB01 Q8TBJ2 Q8WWV2,Protein phosphatase 1 regulatory subunit 1A,Protein phosphatase inhibitor 1;, PF05395;, GO:0005737;GO:0005615;GO:0004865;GO:0005977;GO:0035556;, C:cytoplasm; C:extracellular space;, F:protein serine/threonine phosphatase inhibitor activity;, P:glycogen metabolic process; P:intracellular signal transduction;|Q13522 Q6IB01 Q8TBJ2 Q8WWV2,Protein phosphatase 1 regulatory subunit 1A,Protein phosphatase inhibitor 1;, PF05395;, GO:0005737;GO:0005615;GO:0004865;GO:0005977;GO:0035556;, C:cytoplasm; C:extracellular space;, F:protein serine/threonine phosphatase inhibitor activity;, P:glycogen metabolic process; P:intracellular signal transduction;|Q13522 Q6IB01 Q8TBJ2 Q8WWV2,Protein phosphatase 1 regulatory subunit 1A,Protein phosphatase inhibitor 1;, PF05395;, GO:0005737;GO:0005615;GO:0004865;GO:0005977;GO:0035556;, C:cytoplasm; C:extracellular space;, F:protein serine/threonine phosphatase inhibitor activity;, P:glycogen metabolic process; P:intracellular signal transduction; scaffold122 indexed_genome mRNA 2575537 2582358 . + . ID=transcript_13697;Q9H0E7 B2RDW3,Ubiquitin carboxyl-terminal hydrolase 44,Deubiquitinating enzyme 44;Ubiquitin thioesterase 44;Ubiquitin-specific-processing protease 44;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0008234;GO:0004843;GO:0008270;GO:0007049;GO:0051301;GO:0007059;GO:1904667;GO:0043161;GO:0016579;GO:0090266;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell cycle; P:cell division; P:chromosome segregation; P:negative regulation of ubiquitin protein ligase activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of mitotic cell cycle spindle assembly checkpoint; scaffold122 indexed_genome mRNA 2584886 2588232 . + . ID=transcript_13698;Q9H0E7 B2RDW3,Ubiquitin carboxyl-terminal hydrolase 44,Deubiquitinating enzyme 44;Ubiquitin thioesterase 44;Ubiquitin-specific-processing protease 44;, PF00443;PF02148;, GO:0005737;GO:0005654;GO:0005634;GO:0008234;GO:0004843;GO:0008270;GO:0007049;GO:0051301;GO:0007059;GO:1904667;GO:0043161;GO:0016579;GO:0090266;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:zinc ion binding;, P:cell cycle; P:cell division; P:chromosome segregation; P:negative regulation of ubiquitin protein ligase activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:regulation of mitotic cell cycle spindle assembly checkpoint; scaffold122 indexed_genome mRNA 2588258 2619488 . - . ID=transcript_13699;P50579 B2RDI8 B4DUX5 G3XA91 Q8NB11,Methionine aminopeptidase 2 {ECO:0000255|HAMAP-Rule:MF_03175},Initiation factor 2-associated 67 kDa glycoprotein {ECO:0000255|HAMAP-Rule:MF_03175};Peptidase M {ECO:0000255|HAMAP-Rule:MF_03175};, PF00557;, GO:0005737;GO:0005829;GO:0005886;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0003723;GO:0031365;GO:0018206;GO:0070084;GO:0016485;GO:0022400;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:RNA binding;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal; P:protein processing; P:regulation of rhodopsin mediated signaling pathway;|P50579 B2RDI8 B4DUX5 G3XA91 Q8NB11,Methionine aminopeptidase 2 {ECO:0000255|HAMAP-Rule:MF_03175},Initiation factor 2-associated 67 kDa glycoprotein {ECO:0000255|HAMAP-Rule:MF_03175};Peptidase M {ECO:0000255|HAMAP-Rule:MF_03175};, PF00557;, GO:0005737;GO:0005829;GO:0005886;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0003723;GO:0031365;GO:0018206;GO:0070084;GO:0016485;GO:0022400;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:RNA binding;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal; P:protein processing; P:regulation of rhodopsin mediated signaling pathway;|P50579 B2RDI8 B4DUX5 G3XA91 Q8NB11,Methionine aminopeptidase 2 {ECO:0000255|HAMAP-Rule:MF_03175},Initiation factor 2-associated 67 kDa glycoprotein {ECO:0000255|HAMAP-Rule:MF_03175};Peptidase M {ECO:0000255|HAMAP-Rule:MF_03175};, PF00557;, GO:0005737;GO:0005829;GO:0005886;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0003723;GO:0031365;GO:0018206;GO:0070084;GO:0016485;GO:0022400;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:RNA binding;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal; P:protein processing; P:regulation of rhodopsin mediated signaling pathway;|P50579 B2RDI8 B4DUX5 G3XA91 Q8NB11,Methionine aminopeptidase 2 {ECO:0000255|HAMAP-Rule:MF_03175},Initiation factor 2-associated 67 kDa glycoprotein {ECO:0000255|HAMAP-Rule:MF_03175};Peptidase M {ECO:0000255|HAMAP-Rule:MF_03175};, PF00557;, GO:0005737;GO:0005829;GO:0005886;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0003723;GO:0031365;GO:0018206;GO:0070084;GO:0016485;GO:0022400;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:RNA binding;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal; P:protein processing; P:regulation of rhodopsin mediated signaling pathway;|P50579 B2RDI8 B4DUX5 G3XA91 Q8NB11,Methionine aminopeptidase 2 {ECO:0000255|HAMAP-Rule:MF_03175},Initiation factor 2-associated 67 kDa glycoprotein {ECO:0000255|HAMAP-Rule:MF_03175};Peptidase M {ECO:0000255|HAMAP-Rule:MF_03175};, PF00557;, GO:0005737;GO:0005829;GO:0005886;GO:0004177;GO:0046872;GO:0070006;GO:0008235;GO:0003723;GO:0031365;GO:0018206;GO:0070084;GO:0016485;GO:0022400;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:aminopeptidase activity; F:metal ion binding; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:RNA binding;, P:N-terminal protein amino acid modification; P:peptidyl-methionine modification; P:protein initiator methionine removal; P:protein processing; P:regulation of rhodopsin mediated signaling pathway; scaffold122 indexed_genome mRNA 2765222 2832795 . - . ID=transcript_13700;Q9HBM0 Q6P1Q3 Q9H2F4 Q9H2U5 Q9NT70 Q9NVW0 Q9UF91,Vezatin,, PF12632;, GO:0001669;GO:0005912;GO:0005829;GO:0016021;GO:0005654;GO:0002142;GO:0060171;GO:0017022;GO:0098609;, C:acrosomal vesicle; C:adherens junction; C:cytosol; C:integral component of membrane; C:nucleoplasm; C:stereocilia ankle link complex; C:stereocilium membrane;, F:myosin binding;, P:cell-cell adhesion;|Q9HBM0 Q6P1Q3 Q9H2F4 Q9H2U5 Q9NT70 Q9NVW0 Q9UF91,Vezatin,, PF12632;, GO:0001669;GO:0005912;GO:0005829;GO:0016021;GO:0005654;GO:0002142;GO:0060171;GO:0017022;GO:0098609;, C:acrosomal vesicle; C:adherens junction; C:cytosol; C:integral component of membrane; C:nucleoplasm; C:stereocilia ankle link complex; C:stereocilium membrane;, F:myosin binding;, P:cell-cell adhesion;|Q9HBM0 Q6P1Q3 Q9H2F4 Q9H2U5 Q9NT70 Q9NVW0 Q9UF91,Vezatin,, PF12632;, GO:0001669;GO:0005912;GO:0005829;GO:0016021;GO:0005654;GO:0002142;GO:0060171;GO:0017022;GO:0098609;, C:acrosomal vesicle; C:adherens junction; C:cytosol; C:integral component of membrane; C:nucleoplasm; C:stereocilia ankle link complex; C:stereocilium membrane;, F:myosin binding;, P:cell-cell adhesion; scaffold122 indexed_genome mRNA 2843770 2947429 . + . ID=transcript_13701;Q6ZV73 Q6ZR53 Q7Z2Z7 Q96D44 Q9NUR8 Q9P2I5,FYVE, RhoGEF and PH domain-containing protein 6,Zinc finger FYVE domain-containing protein 24;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity;|Q6ZV73 Q6ZR53 Q7Z2Z7 Q96D44 Q9NUR8 Q9P2I5,FYVE, RhoGEF and PH domain-containing protein 6,Zinc finger FYVE domain-containing protein 24;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity;|Q6ZV73 Q6ZR53 Q7Z2Z7 Q96D44 Q9NUR8 Q9P2I5,FYVE, RhoGEF and PH domain-containing protein 6,Zinc finger FYVE domain-containing protein 24;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;, C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity; scaffold122 indexed_genome mRNA 2972059 2975726 . + . ID=transcript_13702;P13056 A8K5K4 Q15625 Q15626,Nuclear receptor subfamily 2 group C member 1,Orphan nuclear receptor TR2;Testicular receptor 2;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0016605;GO:0003677;GO:0000981;GO:0001227;GO:0042826;GO:0004879;GO:0042803;GO:0000978;GO:1990837;GO:0038023;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0048386;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor activity; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of retinoic acid receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold122 indexed_genome mRNA 2977782 2985773 . + . ID=transcript_13703;P13056 A8K5K4 Q15625 Q15626,Nuclear receptor subfamily 2 group C member 1,Orphan nuclear receptor TR2;Testicular receptor 2;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0016605;GO:0003677;GO:0000981;GO:0001227;GO:0042826;GO:0004879;GO:0042803;GO:0000978;GO:1990837;GO:0038023;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0048386;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor activity; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of retinoic acid receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P13056 A8K5K4 Q15625 Q15626,Nuclear receptor subfamily 2 group C member 1,Orphan nuclear receptor TR2;Testicular receptor 2;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0016605;GO:0003677;GO:0000981;GO:0001227;GO:0042826;GO:0004879;GO:0042803;GO:0000978;GO:1990837;GO:0038023;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0048386;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor activity; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of retinoic acid receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold122 indexed_genome mRNA 2985791 3000649 . + . ID=transcript_13704;P13056 A8K5K4 Q15625 Q15626,Nuclear receptor subfamily 2 group C member 1,Orphan nuclear receptor TR2;Testicular receptor 2;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0016605;GO:0003677;GO:0000981;GO:0001227;GO:0042826;GO:0004879;GO:0042803;GO:0000978;GO:1990837;GO:0038023;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0048386;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor activity; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of retinoic acid receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P13056 A8K5K4 Q15625 Q15626,Nuclear receptor subfamily 2 group C member 1,Orphan nuclear receptor TR2;Testicular receptor 2;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0016605;GO:0003677;GO:0000981;GO:0001227;GO:0042826;GO:0004879;GO:0042803;GO:0000978;GO:1990837;GO:0038023;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0048386;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor activity; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of retinoic acid receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P13056 A8K5K4 Q15625 Q15626,Nuclear receptor subfamily 2 group C member 1,Orphan nuclear receptor TR2;Testicular receptor 2;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0016605;GO:0003677;GO:0000981;GO:0001227;GO:0042826;GO:0004879;GO:0042803;GO:0000978;GO:1990837;GO:0038023;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0048386;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor activity; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of retinoic acid receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P13056 A8K5K4 Q15625 Q15626,Nuclear receptor subfamily 2 group C member 1,Orphan nuclear receptor TR2;Testicular receptor 2;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0016605;GO:0003677;GO:0000981;GO:0001227;GO:0042826;GO:0004879;GO:0042803;GO:0000978;GO:1990837;GO:0038023;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0000122;GO:0048386;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:PML body;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:nuclear receptor activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:signaling receptor activity; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of retinoic acid receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold122 indexed_genome mRNA 3009705 3014645 . - . ID=transcript_13705;Q9UI09 F8VQS7 Q53XX0 Q9BRV6,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12,13 kDa differentiation-associated protein;Complex I-B17.2;NADH-ubiquinone oxidoreductase subunit B17.2;, PF05071;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0008137;GO:0042775;GO:0006120;GO:0032981;GO:0007585;GO:0006979;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:respiratory gaseous exchange by respiratory system; P:response to oxidative stress;|Q9UI09 F8VQS7 Q53XX0 Q9BRV6,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12,13 kDa differentiation-associated protein;Complex I-B17.2;NADH-ubiquinone oxidoreductase subunit B17.2;, PF05071;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0008137;GO:0042775;GO:0006120;GO:0032981;GO:0007585;GO:0006979;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:respiratory gaseous exchange by respiratory system; P:response to oxidative stress; scaffold123 indexed_genome mRNA 854 3663 . - . ID=transcript_13706;Q8IV04 G3V1D6,Carabin,TBC1 domain family member 10C;, PF00566;, GO:0005829;GO:0101003;GO:0031527;GO:0016020;GO:0005886;GO:0005096;GO:0090630;GO:0006886;GO:0050869;GO:0070885;GO:0070373;GO:0043312;GO:0042147;, C:cytosol; C:ficolin-1-rich granule membrane; C:filopodium membrane; C:membrane; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:negative regulation of B cell activation; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of ERK1 and ERK2 cascade; P:neutrophil degranulation; P:retrograde transport, endosome to Golgi; scaffold123 indexed_genome mRNA 5003 6490 . + . ID=transcript_13707;Q8IV04 G3V1D6,Carabin,TBC1 domain family member 10C;, PF00566;, GO:0005829;GO:0101003;GO:0031527;GO:0016020;GO:0005886;GO:0005096;GO:0090630;GO:0006886;GO:0050869;GO:0070885;GO:0070373;GO:0043312;GO:0042147;, C:cytosol; C:ficolin-1-rich granule membrane; C:filopodium membrane; C:membrane; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:negative regulation of B cell activation; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of ERK1 and ERK2 cascade; P:neutrophil degranulation; P:retrograde transport, endosome to Golgi; scaffold123 indexed_genome mRNA 13199 22126 . + . ID=transcript_13708;A5YM72 A8K1M3 B4DFC6 E9PK38 F5H427 Q8N467 Q9P2F3,Carnosine synthase 1,ATP-grasp domain-containing protein 1;, PF18130;, GO:0005829;GO:0005524;GO:0016887;GO:0047730;GO:0102102;GO:0046872;GO:0035499;GO:0006548;, C:cytosol;, F:ATP binding; F:ATPase activity; F:carnosine synthase activity; F:homocarnosine synthase activity; F:metal ion binding;, P:carnosine biosynthetic process; P:histidine catabolic process;|A5YM72 A8K1M3 B4DFC6 E9PK38 F5H427 Q8N467 Q9P2F3,Carnosine synthase 1,ATP-grasp domain-containing protein 1;, PF18130;, GO:0005829;GO:0005524;GO:0016887;GO:0047730;GO:0102102;GO:0046872;GO:0035499;GO:0006548;, C:cytosol;, F:ATP binding; F:ATPase activity; F:carnosine synthase activity; F:homocarnosine synthase activity; F:metal ion binding;, P:carnosine biosynthetic process; P:histidine catabolic process; scaffold123 indexed_genome mRNA 23641 29617 . + . ID=transcript_13709;Q9UBS0 B2RMZ9 B4DML8 O94809 Q9UEC1,Ribosomal protein S6 kinase beta-2,70 kDa ribosomal protein S6 kinase 2;S6 kinase-related kinase;Serine/threonine-protein kinase 14B;p70 ribosomal S6 kinase beta;, PF00069;PF00433;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0042277;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0018105;GO:0045948;GO:0043491;GO:0007165;GO:0031929;GO:0006412;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:peptide binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:peptidyl-serine phosphorylation; P:positive regulation of translational initiation; P:protein kinase B signaling; P:signal transduction; P:TOR signaling; P:translation;|Q9UBS0 B2RMZ9 B4DML8 O94809 Q9UEC1,Ribosomal protein S6 kinase beta-2,70 kDa ribosomal protein S6 kinase 2;S6 kinase-related kinase;Serine/threonine-protein kinase 14B;p70 ribosomal S6 kinase beta;, PF00069;PF00433;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0042277;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0018105;GO:0045948;GO:0043491;GO:0007165;GO:0031929;GO:0006412;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:peptide binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:peptidyl-serine phosphorylation; P:positive regulation of translational initiation; P:protein kinase B signaling; P:signal transduction; P:TOR signaling; P:translation; scaffold123 indexed_genome mRNA 29995 37862 . - . ID=transcript_13710;Q14761 B2R512 O00643 Q6I9S6,Protein tyrosine phosphatase receptor type C-associated protein,CD45-associated protein;Lymphocyte phosphatase-associated phosphoprotein;, PF15713;, GO:0016021;GO:0005886;GO:0006952;, C:integral component of membrane; C:plasma membrane;, , P:defense response;|Q9BR76 B2RD45,Coronin-1B,Coronin-2;, PF08953;PF00400;, GO:0005884;GO:0031252;GO:0071944;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030027;GO:0048471;GO:0005886;GO:0001725;GO:0051015;GO:0071933;GO:0045296;GO:0042802;GO:0030036;GO:0090135;GO:0051017;GO:0007015;GO:0016477;GO:0036120;GO:0035767;GO:0034316;GO:0071672;GO:2000394;GO:1902463;GO:0034315;GO:0031529;GO:0042060;, C:actin filament; C:cell leading edge; C:cell periphery; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane; C:stress fiber;, F:actin filament binding; F:Arp2/3 complex binding; F:cadherin binding; F:identical protein binding;, P:actin cytoskeleton organization; P:actin filament branching; P:actin filament bundle assembly; P:actin filament organization; P:cell migration; P:cellular response to platelet-derived growth factor stimulus; P:endothelial cell chemotaxis; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:negative regulation of smooth muscle cell chemotaxis; P:positive regulation of lamellipodium morphogenesis; P:protein localization to cell leading edge; P:regulation of Arp2/3 complex-mediated actin nucleation; P:ruffle organization; P:wound healing;|Q9BR76 B2RD45,Coronin-1B,Coronin-2;, PF08953;PF00400;, GO:0005884;GO:0031252;GO:0071944;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030027;GO:0048471;GO:0005886;GO:0001725;GO:0051015;GO:0071933;GO:0045296;GO:0042802;GO:0030036;GO:0090135;GO:0051017;GO:0007015;GO:0016477;GO:0036120;GO:0035767;GO:0034316;GO:0071672;GO:2000394;GO:1902463;GO:0034315;GO:0031529;GO:0042060;, C:actin filament; C:cell leading edge; C:cell periphery; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane; C:stress fiber;, F:actin filament binding; F:Arp2/3 complex binding; F:cadherin binding; F:identical protein binding;, P:actin cytoskeleton organization; P:actin filament branching; P:actin filament bundle assembly; P:actin filament organization; P:cell migration; P:cellular response to platelet-derived growth factor stimulus; P:endothelial cell chemotaxis; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:negative regulation of smooth muscle cell chemotaxis; P:positive regulation of lamellipodium morphogenesis; P:protein localization to cell leading edge; P:regulation of Arp2/3 complex-mediated actin nucleation; P:ruffle organization; P:wound healing;|Q9BR76 B2RD45,Coronin-1B,Coronin-2;, PF08953;PF00400;, GO:0005884;GO:0031252;GO:0071944;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030027;GO:0048471;GO:0005886;GO:0001725;GO:0051015;GO:0071933;GO:0045296;GO:0042802;GO:0030036;GO:0090135;GO:0051017;GO:0007015;GO:0016477;GO:0036120;GO:0035767;GO:0034316;GO:0071672;GO:2000394;GO:1902463;GO:0034315;GO:0031529;GO:0042060;, C:actin filament; C:cell leading edge; C:cell periphery; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane; C:stress fiber;, F:actin filament binding; F:Arp2/3 complex binding; F:cadherin binding; F:identical protein binding;, P:actin cytoskeleton organization; P:actin filament branching; P:actin filament bundle assembly; P:actin filament organization; P:cell migration; P:cellular response to platelet-derived growth factor stimulus; P:endothelial cell chemotaxis; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:negative regulation of smooth muscle cell chemotaxis; P:positive regulation of lamellipodium morphogenesis; P:protein localization to cell leading edge; P:regulation of Arp2/3 complex-mediated actin nucleation; P:ruffle organization; P:wound healing;|Q9BR76 B2RD45,Coronin-1B,Coronin-2;, PF08953;PF00400;, GO:0005884;GO:0031252;GO:0071944;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030027;GO:0048471;GO:0005886;GO:0001725;GO:0051015;GO:0071933;GO:0045296;GO:0042802;GO:0030036;GO:0090135;GO:0051017;GO:0007015;GO:0016477;GO:0036120;GO:0035767;GO:0034316;GO:0071672;GO:2000394;GO:1902463;GO:0034315;GO:0031529;GO:0042060;, C:actin filament; C:cell leading edge; C:cell periphery; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lamellipodium; C:perinuclear region of cytoplasm; C:plasma membrane; C:stress fiber;, F:actin filament binding; F:Arp2/3 complex binding; F:cadherin binding; F:identical protein binding;, P:actin cytoskeleton organization; P:actin filament branching; P:actin filament bundle assembly; P:actin filament organization; P:cell migration; P:cellular response to platelet-derived growth factor stimulus; P:endothelial cell chemotaxis; P:negative regulation of Arp2/3 complex-mediated actin nucleation; P:negative regulation of smooth muscle cell chemotaxis; P:positive regulation of lamellipodium morphogenesis; P:protein localization to cell leading edge; P:regulation of Arp2/3 complex-mediated actin nucleation; P:ruffle organization; P:wound healing; scaffold123 indexed_genome mRNA 54492 59246 . - . ID=transcript_13711;Q9H6X4 Q08AK4 Q6PJN3,Transmembrane protein 134,, PF05915;, GO:0005829;GO:0016021;GO:0048471;GO:0016032;, C:cytosol; C:integral component of membrane; C:perinuclear region of cytoplasm;, , P:viral process;|Q9H6X4 Q08AK4 Q6PJN3,Transmembrane protein 134,, PF05915;, GO:0005829;GO:0016021;GO:0048471;GO:0016032;, C:cytosol; C:integral component of membrane; C:perinuclear region of cytoplasm;, , P:viral process; scaffold123 indexed_genome mRNA 70759 85353 . - . ID=transcript_13712;O00562 A6NME4 Q6T7X3 Q8TBN3 Q9BZ73,Membrane-associated phosphatidylinositol transfer protein 1,Drosophila retinal degeneration B homolog;Phosphatidylinositol transfer protein, membrane-associated 1;Pyk2 N-terminal domain-interacting receptor 2;, PF02862;PF02121;, GO:0044297;GO:0032154;GO:0005737;GO:0005829;GO:0005789;GO:0032580;GO:0043231;GO:0005811;GO:0016020;GO:0030496;GO:0005509;GO:0070300;GO:0031210;GO:0008525;GO:0035091;GO:0008526;GO:0030971;GO:0007420;GO:0006629;GO:0006661;GO:0015914;GO:0007602;GO:0015031;, C:cell body; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:midbody;, F:calcium ion binding; F:phosphatidic acid binding; F:phosphatidylcholine binding; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:receptor tyrosine kinase binding;, P:brain development; P:lipid metabolic process; P:phosphatidylinositol biosynthetic process; P:phospholipid transport; P:phototransduction; P:protein transport;|O00562 A6NME4 Q6T7X3 Q8TBN3 Q9BZ73,Membrane-associated phosphatidylinositol transfer protein 1,Drosophila retinal degeneration B homolog;Phosphatidylinositol transfer protein, membrane-associated 1;Pyk2 N-terminal domain-interacting receptor 2;, PF02862;PF02121;, GO:0044297;GO:0032154;GO:0005737;GO:0005829;GO:0005789;GO:0032580;GO:0043231;GO:0005811;GO:0016020;GO:0030496;GO:0005509;GO:0070300;GO:0031210;GO:0008525;GO:0035091;GO:0008526;GO:0030971;GO:0007420;GO:0006629;GO:0006661;GO:0015914;GO:0007602;GO:0015031;, C:cell body; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:midbody;, F:calcium ion binding; F:phosphatidic acid binding; F:phosphatidylcholine binding; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:receptor tyrosine kinase binding;, P:brain development; P:lipid metabolic process; P:phosphatidylinositol biosynthetic process; P:phospholipid transport; P:phototransduction; P:protein transport;|O00562 A6NME4 Q6T7X3 Q8TBN3 Q9BZ73,Membrane-associated phosphatidylinositol transfer protein 1,Drosophila retinal degeneration B homolog;Phosphatidylinositol transfer protein, membrane-associated 1;Pyk2 N-terminal domain-interacting receptor 2;, PF02862;PF02121;, GO:0044297;GO:0032154;GO:0005737;GO:0005829;GO:0005789;GO:0032580;GO:0043231;GO:0005811;GO:0016020;GO:0030496;GO:0005509;GO:0070300;GO:0031210;GO:0008525;GO:0035091;GO:0008526;GO:0030971;GO:0007420;GO:0006629;GO:0006661;GO:0015914;GO:0007602;GO:0015031;, C:cell body; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:midbody;, F:calcium ion binding; F:phosphatidic acid binding; F:phosphatidylcholine binding; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:receptor tyrosine kinase binding;, P:brain development; P:lipid metabolic process; P:phosphatidylinositol biosynthetic process; P:phospholipid transport; P:phototransduction; P:protein transport;|O00562 A6NME4 Q6T7X3 Q8TBN3 Q9BZ73,Membrane-associated phosphatidylinositol transfer protein 1,Drosophila retinal degeneration B homolog;Phosphatidylinositol transfer protein, membrane-associated 1;Pyk2 N-terminal domain-interacting receptor 2;, PF02862;PF02121;, GO:0044297;GO:0032154;GO:0005737;GO:0005829;GO:0005789;GO:0032580;GO:0043231;GO:0005811;GO:0016020;GO:0030496;GO:0005509;GO:0070300;GO:0031210;GO:0008525;GO:0035091;GO:0008526;GO:0030971;GO:0007420;GO:0006629;GO:0006661;GO:0015914;GO:0007602;GO:0015031;, C:cell body; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:midbody;, F:calcium ion binding; F:phosphatidic acid binding; F:phosphatidylcholine binding; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:receptor tyrosine kinase binding;, P:brain development; P:lipid metabolic process; P:phosphatidylinositol biosynthetic process; P:phospholipid transport; P:phototransduction; P:protein transport;|O00562 A6NME4 Q6T7X3 Q8TBN3 Q9BZ73,Membrane-associated phosphatidylinositol transfer protein 1,Drosophila retinal degeneration B homolog;Phosphatidylinositol transfer protein, membrane-associated 1;Pyk2 N-terminal domain-interacting receptor 2;, PF02862;PF02121;, GO:0044297;GO:0032154;GO:0005737;GO:0005829;GO:0005789;GO:0032580;GO:0043231;GO:0005811;GO:0016020;GO:0030496;GO:0005509;GO:0070300;GO:0031210;GO:0008525;GO:0035091;GO:0008526;GO:0030971;GO:0007420;GO:0006629;GO:0006661;GO:0015914;GO:0007602;GO:0015031;, C:cell body; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi cisterna membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:midbody;, F:calcium ion binding; F:phosphatidic acid binding; F:phosphatidylcholine binding; F:phosphatidylcholine transporter activity; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity; F:receptor tyrosine kinase binding;, P:brain development; P:lipid metabolic process; P:phosphatidylinositol biosynthetic process; P:phospholipid transport; P:phototransduction; P:protein transport; scaffold123 indexed_genome mRNA 86979 89333 . - . ID=transcript_13713;O75956,Cyclin-dependent kinase 2-associated protein 2,DOC-1-related protein;, PF09806;, GO:0005737;GO:0005874;GO:0005634;GO:2000134;GO:0070507;GO:2000035;, C:cytoplasm; C:microtubule; C:nucleus;, , P:negative regulation of G1/S transition of mitotic cell cycle; P:regulation of microtubule cytoskeleton organization; P:regulation of stem cell division;|O75956,Cyclin-dependent kinase 2-associated protein 2,DOC-1-related protein;, PF09806;, GO:0005737;GO:0005874;GO:0005634;GO:2000134;GO:0070507;GO:2000035;, C:cytoplasm; C:microtubule; C:nucleus;, , P:negative regulation of G1/S transition of mitotic cell cycle; P:regulation of microtubule cytoskeleton organization; P:regulation of stem cell division; scaffold123 indexed_genome mRNA 108101 110425 . + . ID=transcript_13714;P09211 O00460 Q15690 Q5TZY3,Glutathione S-transferase P {ECO:0000305},GST class-pi;GSTP1-1;, PF14497;PF02798;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005739;GO:0005634;GO:0005886;GO:0034774;GO:0097057;GO:0031982;GO:0035731;GO:0008144;GO:0005504;GO:0043295;GO:0004602;GO:0004364;GO:0008432;GO:0019207;GO:0070026;GO:0035730;GO:0031100;GO:0071460;GO:0071364;GO:0071385;GO:0032869;GO:0071222;GO:0034599;GO:0007417;GO:0035726;GO:1901687;GO:0006749;GO:0051122;GO:0043651;GO:0002674;GO:0043066;GO:0009890;GO:0070373;GO:2001237;GO:0048147;GO:0043124;GO:0032691;GO:0043508;GO:0070664;GO:0043407;GO:0043409;GO:0071638;GO:0051771;GO:0006469;GO:0071672;GO:0032873;GO:0032720;GO:0010804;GO:1904706;GO:0043312;GO:0035732;GO:0014003;GO:0032930;GO:0006693;GO:0070372;GO:0032872;GO:0043200;GO:0032355;GO:0045471;GO:0033591;GO:0000302;GO:0006805;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:mitochondrion; C:nucleus; C:plasma membrane; C:secretory granule lumen; C:TRAF2-GSTP1 complex; C:vesicle;, F:dinitrosyl-iron complex binding; F:drug binding; F:fatty acid binding; F:glutathione binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:JUN kinase binding; F:kinase regulator activity; F:nitric oxide binding; F:S-nitrosoglutathione binding;, P:animal organ regeneration; P:cellular response to cell-matrix adhesion; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucocorticoid stimulus; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:central nervous system development; P:common myeloid progenitor cell proliferation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:hepoxilin biosynthetic process; P:linoleic acid metabolic process; P:negative regulation of acute inflammatory response; P:negative regulation of apoptotic process; P:negative regulation of biosynthetic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-1 beta production; P:negative regulation of JUN kinase activity; P:negative regulation of leukocyte proliferation; P:negative regulation of MAP kinase activity; P:negative regulation of MAPK cascade; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of nitric-oxide synthase biosynthetic process; P:negative regulation of protein kinase activity; P:negative regulation of smooth muscle cell chemotaxis; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:negative regulation of vascular associated smooth muscle cell proliferation; P:neutrophil degranulation; P:nitric oxide storage; P:oligodendrocyte development; P:positive regulation of superoxide anion generation; P:prostaglandin metabolic process; P:regulation of ERK1 and ERK2 cascade; P:regulation of stress-activated MAPK cascade; P:response to amino acid; P:response to estradiol; P:response to ethanol; P:response to L-ascorbic acid; P:response to reactive oxygen species; P:xenobiotic metabolic process; scaffold123 indexed_genome mRNA 145242 160810 . + . ID=transcript_13715;P43353 A3FMP9 Q53XL5 Q8N515 Q96CK8,Aldehyde dehydrogenase family 3 member B1,Aldehyde dehydrogenase 7;, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0005886;GO:0030667;GO:0035579;GO:0031982;GO:0004028;GO:0004030;GO:0018479;GO:0018477;GO:0006066;GO:0046185;GO:0034599;GO:0006068;GO:0006629;GO:0043312;GO:0030148;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane; C:vesicle;, F:3-chloroallyl aldehyde dehydrogenase activity; F:aldehyde dehydrogenase [NAD(P)+] activity; F:benzaldehyde dehydrogenase (NAD+) activity; F:benzaldehyde dehydrogenase (NADP+) activity;, P:alcohol metabolic process; P:aldehyde catabolic process; P:cellular response to oxidative stress; P:ethanol catabolic process; P:lipid metabolic process; P:neutrophil degranulation; P:sphingolipid biosynthetic process;|P43353 A3FMP9 Q53XL5 Q8N515 Q96CK8,Aldehyde dehydrogenase family 3 member B1,Aldehyde dehydrogenase 7;, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0005886;GO:0030667;GO:0035579;GO:0031982;GO:0004028;GO:0004030;GO:0018479;GO:0018477;GO:0006066;GO:0046185;GO:0034599;GO:0006068;GO:0006629;GO:0043312;GO:0030148;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane; C:vesicle;, F:3-chloroallyl aldehyde dehydrogenase activity; F:aldehyde dehydrogenase [NAD(P)+] activity; F:benzaldehyde dehydrogenase (NAD+) activity; F:benzaldehyde dehydrogenase (NADP+) activity;, P:alcohol metabolic process; P:aldehyde catabolic process; P:cellular response to oxidative stress; P:ethanol catabolic process; P:lipid metabolic process; P:neutrophil degranulation; P:sphingolipid biosynthetic process; scaffold123 indexed_genome mRNA 162575 166426 . + . ID=transcript_13716;O00217 B2RB86 Q0VDA8,NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial,Complex I-23kD;NADH-ubiquinone oxidoreductase 23 kDa subunit;TYKY subunit;, PF12838;, GO:0005759;GO:0005747;GO:0005739;GO:0051539;GO:0046872;GO:0008137;GO:0009060;GO:0006120;GO:0032981;GO:0006979;, C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:aerobic respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to oxidative stress;|O00217 B2RB86 Q0VDA8,NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial,Complex I-23kD;NADH-ubiquinone oxidoreductase 23 kDa subunit;TYKY subunit;, PF12838;, GO:0005759;GO:0005747;GO:0005739;GO:0051539;GO:0046872;GO:0008137;GO:0009060;GO:0006120;GO:0032981;GO:0006979;, C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:NADH dehydrogenase (ubiquinone) activity;, P:aerobic respiration; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to oxidative stress; scaffold123 indexed_genome mRNA 169082 181192 . + . ID=transcript_13717;Q13488 O75877 Q8WVC5,V-type proton ATPase 116 kDa subunit a3,Osteoclastic proton pump 116 kDa subunit;T-cell immune regulator 1;T-cell immune response cDNA7 protein;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3;, PF01496;, GO:0016324;GO:0010008;GO:0101003;GO:0005887;GO:0005770;GO:0005765;GO:0005634;GO:0030670;GO:0005886;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0005215;GO:0006915;GO:0000045;GO:0030183;GO:0045453;GO:0006874;GO:0006968;GO:0034198;GO:0071345;GO:0097188;GO:0070166;GO:0030010;GO:0051650;GO:0010467;GO:0061484;GO:0016064;GO:0006954;GO:0008286;GO:0034220;GO:0016236;GO:0035709;GO:0043312;GO:0021554;GO:0001503;GO:0030316;GO:0002158;GO:0090383;GO:0008284;GO:0007039;GO:0033365;GO:1902600;GO:0010468;GO:0050796;GO:0045667;GO:0010155;GO:0010272;GO:0060041;GO:0031529;GO:0030217;GO:0043029;GO:0035711;GO:0044691;GO:0033572;GO:0007035;, C:apical plasma membrane; C:endosome membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:late endosome; C:lysosomal membrane; C:nucleus; C:phagocytic vesicle membrane; C:plasma membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism; F:transporter activity;, P:apoptotic process; P:autophagosome assembly; P:B cell differentiation; P:bone resorption; P:cellular calcium ion homeostasis; P:cellular defense response; P:cellular response to amino acid starvation; P:cellular response to cytokine stimulus; P:dentin mineralization; P:enamel mineralization; P:establishment of cell polarity; P:establishment of vesicle localization; P:gene expression; P:hematopoietic stem cell homeostasis; P:immunoglobulin mediated immune response; P:inflammatory response; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:macroautophagy; P:memory T cell activation; P:neutrophil degranulation; P:optic nerve development; P:ossification; P:osteoclast differentiation; P:osteoclast proliferation; P:phagosome acidification; P:positive regulation of cell population proliferation; P:protein catabolic process in the vacuole; P:protein localization to organelle; P:proton transmembrane transport; P:regulation of gene expression; P:regulation of insulin secretion; P:regulation of osteoblast differentiation; P:regulation of proton transport; P:response to silver ion; P:retina development in camera-type eye; P:ruffle organization; P:T cell differentiation; P:T cell homeostasis; P:T-helper 1 cell activation; P:tooth eruption; P:transferrin transport; P:vacuolar acidification;|Q13488 O75877 Q8WVC5,V-type proton ATPase 116 kDa subunit a3,Osteoclastic proton pump 116 kDa subunit;T-cell immune regulator 1;T-cell immune response cDNA7 protein;Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3;, PF01496;, GO:0016324;GO:0010008;GO:0101003;GO:0005887;GO:0005770;GO:0005765;GO:0005634;GO:0030670;GO:0005886;GO:0016471;GO:0000220;GO:0051117;GO:0046961;GO:0005215;GO:0006915;GO:0000045;GO:0030183;GO:0045453;GO:0006874;GO:0006968;GO:0034198;GO:0071345;GO:0097188;GO:0070166;GO:0030010;GO:0051650;GO:0010467;GO:0061484;GO:0016064;GO:0006954;GO:0008286;GO:0034220;GO:0016236;GO:0035709;GO:0043312;GO:0021554;GO:0001503;GO:0030316;GO:0002158;GO:0090383;GO:0008284;GO:0007039;GO:0033365;GO:1902600;GO:0010468;GO:0050796;GO:0045667;GO:0010155;GO:0010272;GO:0060041;GO:0031529;GO:0030217;GO:0043029;GO:0035711;GO:0044691;GO:0033572;GO:0007035;, C:apical plasma membrane; C:endosome membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:late endosome; C:lysosomal membrane; C:nucleus; C:phagocytic vesicle membrane; C:plasma membrane; C:vacuolar proton-transporting V-type ATPase complex; C:vacuolar proton-transporting V-type ATPase, V0 domain;, F:ATPase binding; F:proton-transporting ATPase activity, rotational mechanism; F:transporter activity;, P:apoptotic process; P:autophagosome assembly; P:B cell differentiation; P:bone resorption; P:cellular calcium ion homeostasis; P:cellular defense response; P:cellular response to amino acid starvation; P:cellular response to cytokine stimulus; P:dentin mineralization; P:enamel mineralization; P:establishment of cell polarity; P:establishment of vesicle localization; P:gene expression; P:hematopoietic stem cell homeostasis; P:immunoglobulin mediated immune response; P:inflammatory response; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:macroautophagy; P:memory T cell activation; P:neutrophil degranulation; P:optic nerve development; P:ossification; P:osteoclast differentiation; P:osteoclast proliferation; P:phagosome acidification; P:positive regulation of cell population proliferation; P:protein catabolic process in the vacuole; P:protein localization to organelle; P:proton transmembrane transport; P:regulation of gene expression; P:regulation of insulin secretion; P:regulation of osteoblast differentiation; P:regulation of proton transport; P:response to silver ion; P:retina development in camera-type eye; P:ruffle organization; P:T cell differentiation; P:T cell homeostasis; P:T-helper 1 cell activation; P:tooth eruption; P:transferrin transport; P:vacuolar acidification; scaffold123 indexed_genome mRNA 183069 211176 . - . ID=transcript_13718;P35790 Q8NE29,Choline kinase alpha,CHETK-alpha;Ethanolamine kinase;, , GO:0005829;GO:0005524;GO:0033265;GO:0004103;GO:0004104;GO:0008144;GO:0004305;GO:0042802;GO:0019695;GO:0006580;GO:0006629;GO:0006869;GO:0006656;GO:0006646;GO:1904681;GO:0009636;, C:cytosol;, F:ATP binding; F:choline binding; F:choline kinase activity; F:cholinesterase activity; F:drug binding; F:ethanolamine kinase activity; F:identical protein binding;, P:choline metabolic process; P:ethanolamine metabolic process; P:lipid metabolic process; P:lipid transport; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:response to 3-methylcholanthrene; P:response to toxic substance;|P35790 Q8NE29,Choline kinase alpha,CHETK-alpha;Ethanolamine kinase;, , GO:0005829;GO:0005524;GO:0033265;GO:0004103;GO:0004104;GO:0008144;GO:0004305;GO:0042802;GO:0019695;GO:0006580;GO:0006629;GO:0006869;GO:0006656;GO:0006646;GO:1904681;GO:0009636;, C:cytosol;, F:ATP binding; F:choline binding; F:choline kinase activity; F:cholinesterase activity; F:drug binding; F:ethanolamine kinase activity; F:identical protein binding;, P:choline metabolic process; P:ethanolamine metabolic process; P:lipid metabolic process; P:lipid transport; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:response to 3-methylcholanthrene; P:response to toxic substance;|P35790 Q8NE29,Choline kinase alpha,CHETK-alpha;Ethanolamine kinase;, , GO:0005829;GO:0005524;GO:0033265;GO:0004103;GO:0004104;GO:0008144;GO:0004305;GO:0042802;GO:0019695;GO:0006580;GO:0006629;GO:0006869;GO:0006656;GO:0006646;GO:1904681;GO:0009636;, C:cytosol;, F:ATP binding; F:choline binding; F:choline kinase activity; F:cholinesterase activity; F:drug binding; F:ethanolamine kinase activity; F:identical protein binding;, P:choline metabolic process; P:ethanolamine metabolic process; P:lipid metabolic process; P:lipid transport; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:response to 3-methylcholanthrene; P:response to toxic substance;|P35790 Q8NE29,Choline kinase alpha,CHETK-alpha;Ethanolamine kinase;, , GO:0005829;GO:0005524;GO:0033265;GO:0004103;GO:0004104;GO:0008144;GO:0004305;GO:0042802;GO:0019695;GO:0006580;GO:0006629;GO:0006869;GO:0006656;GO:0006646;GO:1904681;GO:0009636;, C:cytosol;, F:ATP binding; F:choline binding; F:choline kinase activity; F:cholinesterase activity; F:drug binding; F:ethanolamine kinase activity; F:identical protein binding;, P:choline metabolic process; P:ethanolamine metabolic process; P:lipid metabolic process; P:lipid transport; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:response to 3-methylcholanthrene; P:response to toxic substance; scaffold123 indexed_genome mRNA 211203 240201 . - . ID=transcript_13719;P35790 Q8NE29,Choline kinase alpha,CHETK-alpha;Ethanolamine kinase;, , GO:0005829;GO:0005524;GO:0033265;GO:0004103;GO:0004104;GO:0008144;GO:0004305;GO:0042802;GO:0019695;GO:0006580;GO:0006629;GO:0006869;GO:0006656;GO:0006646;GO:1904681;GO:0009636;, C:cytosol;, F:ATP binding; F:choline binding; F:choline kinase activity; F:cholinesterase activity; F:drug binding; F:ethanolamine kinase activity; F:identical protein binding;, P:choline metabolic process; P:ethanolamine metabolic process; P:lipid metabolic process; P:lipid transport; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:response to 3-methylcholanthrene; P:response to toxic substance; scaffold123 indexed_genome mRNA 274465 279896 . + . ID=transcript_13720;Q9H2K3 Q9NXV3 Q9Y393,Histone-lysine N-methyltransferase KMT5B {ECO:0000305},Lysine N-methyltransferase 5B;Lysine-specific methyltransferase 5B {ECO:0000312|HGNC:HGNC:24283};Suppressor of variegation 4-20 homolog 1;[histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B {ECO:0000305};[histone H4]-lysine20 N-methyltransferase KMT5B {ECO:0000305};, PF00856;, GO:0000779;GO:0005654;GO:0005634;GO:0003682;GO:0042799;GO:0018024;GO:0046872;GO:1904047;GO:0006281;GO:0034772;GO:0034773;GO:0007517;GO:2001034;GO:0045830;, C:condensed chromosome, centromeric region; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H4-K20 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:S-adenosyl-L-methionine binding;, P:DNA repair; P:histone H4-K20 dimethylation; P:histone H4-K20 trimethylation; P:muscle organ development; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching; scaffold123 indexed_genome mRNA 285010 308833 . - . ID=transcript_13721;Q9H2K3 Q9NXV3 Q9Y393,Histone-lysine N-methyltransferase KMT5B {ECO:0000305},Lysine N-methyltransferase 5B;Lysine-specific methyltransferase 5B {ECO:0000312|HGNC:HGNC:24283};Suppressor of variegation 4-20 homolog 1;[histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B {ECO:0000305};[histone H4]-lysine20 N-methyltransferase KMT5B {ECO:0000305};, PF00856;, GO:0000779;GO:0005654;GO:0005634;GO:0003682;GO:0042799;GO:0018024;GO:0046872;GO:1904047;GO:0006281;GO:0034772;GO:0034773;GO:0007517;GO:2001034;GO:0045830;, C:condensed chromosome, centromeric region; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H4-K20 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:S-adenosyl-L-methionine binding;, P:DNA repair; P:histone H4-K20 dimethylation; P:histone H4-K20 trimethylation; P:muscle organ development; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching;|Q9H2K3 Q9NXV3 Q9Y393,Histone-lysine N-methyltransferase KMT5B {ECO:0000305},Lysine N-methyltransferase 5B;Lysine-specific methyltransferase 5B {ECO:0000312|HGNC:HGNC:24283};Suppressor of variegation 4-20 homolog 1;[histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B {ECO:0000305};[histone H4]-lysine20 N-methyltransferase KMT5B {ECO:0000305};, PF00856;, GO:0000779;GO:0005654;GO:0005634;GO:0003682;GO:0042799;GO:0018024;GO:0046872;GO:1904047;GO:0006281;GO:0034772;GO:0034773;GO:0007517;GO:2001034;GO:0045830;, C:condensed chromosome, centromeric region; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H4-K20 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:S-adenosyl-L-methionine binding;, P:DNA repair; P:histone H4-K20 dimethylation; P:histone H4-K20 trimethylation; P:muscle organ development; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching;|Q9H2K3 Q9NXV3 Q9Y393,Histone-lysine N-methyltransferase KMT5B {ECO:0000305},Lysine N-methyltransferase 5B;Lysine-specific methyltransferase 5B {ECO:0000312|HGNC:HGNC:24283};Suppressor of variegation 4-20 homolog 1;[histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B {ECO:0000305};[histone H4]-lysine20 N-methyltransferase KMT5B {ECO:0000305};, PF00856;, GO:0000779;GO:0005654;GO:0005634;GO:0003682;GO:0042799;GO:0018024;GO:0046872;GO:1904047;GO:0006281;GO:0034772;GO:0034773;GO:0007517;GO:2001034;GO:0045830;, C:condensed chromosome, centromeric region; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H4-K20 specific); F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:S-adenosyl-L-methionine binding;, P:DNA repair; P:histone H4-K20 dimethylation; P:histone H4-K20 trimethylation; P:muscle organ development; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching; scaffold123 indexed_genome mRNA 366523 375902 . - . ID=transcript_13722;Q96F05 Q9H2K4,Uncharacterized protein C11orf24,Protein DM4E3;, PF17823;, GO:0005794;GO:0016021;GO:0043231;GO:0005654;GO:0005886;, C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane; scaffold123 indexed_genome mRNA 451447 540066 . + . ID=transcript_13723;O75197 Q96TD6 Q9UES7 Q9UP66,Low-density lipoprotein receptor-related protein 5 {ECO:0000303|PubMed:24706814},Low-density lipoprotein receptor-related protein 7 {ECO:0000250|UniProtKB:Q91VN0};, PF00057;PF00058;, GO:0005783;GO:0016021;GO:0005886;GO:0043235;GO:1990909;GO:1990851;GO:0015026;GO:1904928;GO:0071936;GO:0042813;GO:0017147;GO:0060612;GO:0060033;GO:0009952;GO:1902262;GO:0048539;GO:0060349;GO:0046849;GO:0060444;GO:0060070;GO:0042074;GO:0060764;GO:0042632;GO:0008203;GO:0042733;GO:0006897;GO:0035426;GO:0001702;GO:0006007;GO:0045668;GO:0071901;GO:0110135;GO:0002076;GO:0008284;GO:0051091;GO:0045600;GO:0002053;GO:0045840;GO:0045669;GO:0033690;GO:0045944;GO:0045893;GO:0042981;GO:0008217;GO:0061178;GO:0043434;GO:0009314;GO:0060042;GO:0061304;GO:0035019;GO:1901998;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane; C:receptor complex; C:Wnt signalosome; C:Wnt-Frizzled-LRP5/6 complex;, F:coreceptor activity; F:coreceptor activity involved in canonical Wnt signaling pathway; F:coreceptor activity involved in Wnt signaling pathway; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:adipose tissue development; P:anatomical structure regression; P:anterior/posterior pattern specification; P:apoptotic process involved in blood vessel morphogenesis; P:bone marrow development; P:bone morphogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:canonical Wnt signaling pathway; P:cell migration involved in gastrulation; P:cell-cell signaling involved in mammary gland development; P:cholesterol homeostasis; P:cholesterol metabolic process; P:embryonic digit morphogenesis; P:endocytosis; P:extracellular matrix-cell signaling; P:gastrulation with mouth forming second; P:glucose catabolic process; P:negative regulation of osteoblast differentiation; P:negative regulation of protein serine/threonine kinase activity; P:Norrin signaling pathway; P:osteoblast development; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of fat cell differentiation; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of mitotic nuclear division; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:response to peptide hormone; P:response to radiation; P:retina morphogenesis in camera-type eye; P:retinal blood vessel morphogenesis; P:somatic stem cell population maintenance; P:toxin transport;|O75197 Q96TD6 Q9UES7 Q9UP66,Low-density lipoprotein receptor-related protein 5 {ECO:0000303|PubMed:24706814},Low-density lipoprotein receptor-related protein 7 {ECO:0000250|UniProtKB:Q91VN0};, PF00057;PF00058;, GO:0005783;GO:0016021;GO:0005886;GO:0043235;GO:1990909;GO:1990851;GO:0015026;GO:1904928;GO:0071936;GO:0042813;GO:0017147;GO:0060612;GO:0060033;GO:0009952;GO:1902262;GO:0048539;GO:0060349;GO:0046849;GO:0060444;GO:0060070;GO:0042074;GO:0060764;GO:0042632;GO:0008203;GO:0042733;GO:0006897;GO:0035426;GO:0001702;GO:0006007;GO:0045668;GO:0071901;GO:0110135;GO:0002076;GO:0008284;GO:0051091;GO:0045600;GO:0002053;GO:0045840;GO:0045669;GO:0033690;GO:0045944;GO:0045893;GO:0042981;GO:0008217;GO:0061178;GO:0043434;GO:0009314;GO:0060042;GO:0061304;GO:0035019;GO:1901998;, C:endoplasmic reticulum; C:integral component of membrane; C:plasma membrane; C:receptor complex; C:Wnt signalosome; C:Wnt-Frizzled-LRP5/6 complex;, F:coreceptor activity; F:coreceptor activity involved in canonical Wnt signaling pathway; F:coreceptor activity involved in Wnt signaling pathway; F:Wnt-activated receptor activity; F:Wnt-protein binding;, P:adipose tissue development; P:anatomical structure regression; P:anterior/posterior pattern specification; P:apoptotic process involved in blood vessel morphogenesis; P:bone marrow development; P:bone morphogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:canonical Wnt signaling pathway; P:cell migration involved in gastrulation; P:cell-cell signaling involved in mammary gland development; P:cholesterol homeostasis; P:cholesterol metabolic process; P:embryonic digit morphogenesis; P:endocytosis; P:extracellular matrix-cell signaling; P:gastrulation with mouth forming second; P:glucose catabolic process; P:negative regulation of osteoblast differentiation; P:negative regulation of protein serine/threonine kinase activity; P:Norrin signaling pathway; P:osteoblast development; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of fat cell differentiation; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of mitotic nuclear division; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of apoptotic process; P:regulation of blood pressure; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:response to peptide hormone; P:response to radiation; P:retina morphogenesis in camera-type eye; P:retinal blood vessel morphogenesis; P:somatic stem cell population maintenance; P:toxin transport; scaffold123 indexed_genome mRNA 603187 670839 . + . ID=transcript_13724;Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase;|Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase;|O75170 A6PVG3 B7Z7T3 Q5U5P3 Q7Z2L2 Q7Z5G5 Q7Z731 Q9UGB9,Serine/threonine-protein phosphatase 6 regulatory subunit 2,SAPS domain family member 2;, PF04499;, GO:0005829;GO:0043231;GO:0005634;GO:0019903;GO:0019888;GO:0043666;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:regulation of phosphoprotein phosphatase activity;|Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase;|Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase;|Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase;|Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase;|Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase;|Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase;|Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase;|Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase;|Q9H2K6 Q9HCL4 Q9NUY3,Serine/threonine-protein phosphatase 6 regulatory subunit 3,SAPS domain family member 3;Sporulation-induced transcript 4-associated protein SAPL;, PF04499;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0019903;GO:0019888;GO:0048208;GO:0043666;GO:0007004;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; P:telomere maintenance via telomerase; scaffold123 indexed_genome mRNA 772550 780910 . - . ID=transcript_13725;P50416 Q8TCU0 Q9BWK0,Carnitine O-palmitoyltransferase 1, liver isoform,Carnitine O-palmitoyltransferase I, liver isoform;Carnitine palmitoyltransferase 1A;, PF00755;PF16484;, GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0004095;GO:0042802;GO:1990698;GO:0009437;GO:0006853;GO:0071398;GO:0042755;GO:0030855;GO:0006635;GO:0006631;GO:0006006;GO:0097421;GO:0001676;GO:0032000;GO:0050796;GO:0010883;GO:0043279;GO:0046677;GO:0042493;GO:0045471;GO:0031667;GO:0014070;GO:1904772;GO:0006641;, C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:carnitine O-palmitoyltransferase activity; F:identical protein binding; F:palmitoleoyltransferase activity;, P:carnitine metabolic process; P:carnitine shuttle; P:cellular response to fatty acid; P:eating behavior; P:epithelial cell differentiation; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:glucose metabolic process; P:liver regeneration; P:long-chain fatty acid metabolic process; P:positive regulation of fatty acid beta-oxidation; P:regulation of insulin secretion; P:regulation of lipid storage; P:response to alkaloid; P:response to antibiotic; P:response to drug; P:response to ethanol; P:response to nutrient levels; P:response to organic cyclic compound; P:response to tetrachloromethane; P:triglyceride metabolic process; scaffold123 indexed_genome mRNA 785269 829796 . - . ID=transcript_13726;P50416 Q8TCU0 Q9BWK0,Carnitine O-palmitoyltransferase 1, liver isoform,Carnitine O-palmitoyltransferase I, liver isoform;Carnitine palmitoyltransferase 1A;, PF00755;PF16484;, GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0004095;GO:0042802;GO:1990698;GO:0009437;GO:0006853;GO:0071398;GO:0042755;GO:0030855;GO:0006635;GO:0006631;GO:0006006;GO:0097421;GO:0001676;GO:0032000;GO:0050796;GO:0010883;GO:0043279;GO:0046677;GO:0042493;GO:0045471;GO:0031667;GO:0014070;GO:1904772;GO:0006641;, C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:carnitine O-palmitoyltransferase activity; F:identical protein binding; F:palmitoleoyltransferase activity;, P:carnitine metabolic process; P:carnitine shuttle; P:cellular response to fatty acid; P:eating behavior; P:epithelial cell differentiation; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:glucose metabolic process; P:liver regeneration; P:long-chain fatty acid metabolic process; P:positive regulation of fatty acid beta-oxidation; P:regulation of insulin secretion; P:regulation of lipid storage; P:response to alkaloid; P:response to antibiotic; P:response to drug; P:response to ethanol; P:response to nutrient levels; P:response to organic cyclic compound; P:response to tetrachloromethane; P:triglyceride metabolic process;|P50416 Q8TCU0 Q9BWK0,Carnitine O-palmitoyltransferase 1, liver isoform,Carnitine O-palmitoyltransferase I, liver isoform;Carnitine palmitoyltransferase 1A;, PF00755;PF16484;, GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0004095;GO:0042802;GO:1990698;GO:0009437;GO:0006853;GO:0071398;GO:0042755;GO:0030855;GO:0006635;GO:0006631;GO:0006006;GO:0097421;GO:0001676;GO:0032000;GO:0050796;GO:0010883;GO:0043279;GO:0046677;GO:0042493;GO:0045471;GO:0031667;GO:0014070;GO:1904772;GO:0006641;, C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:carnitine O-palmitoyltransferase activity; F:identical protein binding; F:palmitoleoyltransferase activity;, P:carnitine metabolic process; P:carnitine shuttle; P:cellular response to fatty acid; P:eating behavior; P:epithelial cell differentiation; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:glucose metabolic process; P:liver regeneration; P:long-chain fatty acid metabolic process; P:positive regulation of fatty acid beta-oxidation; P:regulation of insulin secretion; P:regulation of lipid storage; P:response to alkaloid; P:response to antibiotic; P:response to drug; P:response to ethanol; P:response to nutrient levels; P:response to organic cyclic compound; P:response to tetrachloromethane; P:triglyceride metabolic process; scaffold123 indexed_genome mRNA 863133 868659 . + . ID=transcript_13727;Q7Z2W9 A6NKU0 C9JPR2,39S ribosomal protein L21, mitochondrial,Mitochondrial large ribosomal subunit protein bL21m {ECO:0000303|PubMed:25278503};, PF00829;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q7Z2W9 A6NKU0 C9JPR2,39S ribosomal protein L21, mitochondrial,Mitochondrial large ribosomal subunit protein bL21m {ECO:0000303|PubMed:25278503};, PF00829;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q7Z2W9 A6NKU0 C9JPR2,39S ribosomal protein L21, mitochondrial,Mitochondrial large ribosomal subunit protein bL21m {ECO:0000303|PubMed:25278503};, PF00829;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q7Z2W9 A6NKU0 C9JPR2,39S ribosomal protein L21, mitochondrial,Mitochondrial large ribosomal subunit protein bL21m {ECO:0000303|PubMed:25278503};, PF00829;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold123 indexed_genome mRNA 873143 897193 . + . ID=transcript_13728;P38935 A0PJD2 Q00443 Q14177,DNA-binding protein SMUBP-2,ATP-dependent helicase IGHMBP2;Glial factor 1;Immunoglobulin mu-binding protein 2;, PF13086;PF13087;PF01424;PF01428;, GO:0030424;GO:0005737;GO:0030426;GO:0016020;GO:0016604;GO:0005654;GO:0005634;GO:1990904;GO:0043139;GO:0032574;GO:0005524;GO:0003677;GO:0003678;GO:0008094;GO:0042802;GO:0043022;GO:0003723;GO:0008186;GO:0003697;GO:0008134;GO:0000049;GO:0008270;GO:0006310;GO:0006281;GO:0006260;GO:0006412;, C:axon; C:cytoplasm; C:growth cone; C:membrane; C:nuclear body; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:5'-3' DNA helicase activity; F:5'-3' RNA helicase activity; F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA-dependent ATPase activity; F:identical protein binding; F:ribosome binding; F:RNA binding; F:RNA-dependent ATPase activity; F:single-stranded DNA binding; F:transcription factor binding; F:tRNA binding; F:zinc ion binding;, P:DNA recombination; P:DNA repair; P:DNA replication; P:translation; scaffold123 indexed_genome mRNA 959253 968639 . - . ID=transcript_13729;Q96AM1 B3KV43 Q8NBK8,Mas-related G-protein coupled receptor member F,G-protein coupled receptor 140;G-protein coupled receptor 168;, , GO:0016021;GO:0031965;GO:0005886;GO:0004930;GO:0007186;, C:integral component of membrane; C:nuclear membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway;|Q96AM1 B3KV43 Q8NBK8,Mas-related G-protein coupled receptor member F,G-protein coupled receptor 140;G-protein coupled receptor 168;, , GO:0016021;GO:0031965;GO:0005886;GO:0004930;GO:0007186;, C:integral component of membrane; C:nuclear membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; scaffold123 indexed_genome mRNA 990521 1011108 . + . ID=transcript_13730;Q8NHX9 Q9NT82,Two pore calcium channel protein 2 {ECO:0000305},Voltage-dependent calcium channel protein TPC2;, PF00520;, GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0072345;GO:0019901;GO:0005245;GO:0019722;GO:0006874;GO:0034220;GO:0007040;GO:0019065;GO:0010506;GO:0034765;GO:0006939;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:NAADP-sensitive calcium-release channel activity; F:protein kinase binding; F:voltage-gated calcium channel activity;, P:calcium-mediated signaling; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:lysosome organization; P:receptor-mediated endocytosis of virus by host cell; P:regulation of autophagy; P:regulation of ion transmembrane transport; P:smooth muscle contraction;|Q8NHX9 Q9NT82,Two pore calcium channel protein 2 {ECO:0000305},Voltage-dependent calcium channel protein TPC2;, PF00520;, GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0072345;GO:0019901;GO:0005245;GO:0019722;GO:0006874;GO:0034220;GO:0007040;GO:0019065;GO:0010506;GO:0034765;GO:0006939;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:NAADP-sensitive calcium-release channel activity; F:protein kinase binding; F:voltage-gated calcium channel activity;, P:calcium-mediated signaling; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:lysosome organization; P:receptor-mediated endocytosis of virus by host cell; P:regulation of autophagy; P:regulation of ion transmembrane transport; P:smooth muscle contraction; scaffold123 indexed_genome mRNA 1011274 1017614 . + . ID=transcript_13731;Q8NHX9 Q9NT82,Two pore calcium channel protein 2 {ECO:0000305},Voltage-dependent calcium channel protein TPC2;, PF00520;, GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0072345;GO:0019901;GO:0005245;GO:0019722;GO:0006874;GO:0034220;GO:0007040;GO:0019065;GO:0010506;GO:0034765;GO:0006939;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:NAADP-sensitive calcium-release channel activity; F:protein kinase binding; F:voltage-gated calcium channel activity;, P:calcium-mediated signaling; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:lysosome organization; P:receptor-mediated endocytosis of virus by host cell; P:regulation of autophagy; P:regulation of ion transmembrane transport; P:smooth muscle contraction; scaffold123 indexed_genome mRNA 1017746 1022855 . + . ID=transcript_13732;Q8NHX9 Q9NT82,Two pore calcium channel protein 2 {ECO:0000305},Voltage-dependent calcium channel protein TPC2;, PF00520;, GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0072345;GO:0019901;GO:0005245;GO:0019722;GO:0006874;GO:0034220;GO:0007040;GO:0019065;GO:0010506;GO:0034765;GO:0006939;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:NAADP-sensitive calcium-release channel activity; F:protein kinase binding; F:voltage-gated calcium channel activity;, P:calcium-mediated signaling; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:lysosome organization; P:receptor-mediated endocytosis of virus by host cell; P:regulation of autophagy; P:regulation of ion transmembrane transport; P:smooth muscle contraction;|Q8NHX9 Q9NT82,Two pore calcium channel protein 2 {ECO:0000305},Voltage-dependent calcium channel protein TPC2;, PF00520;, GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0072345;GO:0019901;GO:0005245;GO:0019722;GO:0006874;GO:0034220;GO:0007040;GO:0019065;GO:0010506;GO:0034765;GO:0006939;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:NAADP-sensitive calcium-release channel activity; F:protein kinase binding; F:voltage-gated calcium channel activity;, P:calcium-mediated signaling; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:lysosome organization; P:receptor-mediated endocytosis of virus by host cell; P:regulation of autophagy; P:regulation of ion transmembrane transport; P:smooth muscle contraction;|Q8NHX9 Q9NT82,Two pore calcium channel protein 2 {ECO:0000305},Voltage-dependent calcium channel protein TPC2;, PF00520;, GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0072345;GO:0019901;GO:0005245;GO:0019722;GO:0006874;GO:0034220;GO:0007040;GO:0019065;GO:0010506;GO:0034765;GO:0006939;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:NAADP-sensitive calcium-release channel activity; F:protein kinase binding; F:voltage-gated calcium channel activity;, P:calcium-mediated signaling; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:lysosome organization; P:receptor-mediated endocytosis of virus by host cell; P:regulation of autophagy; P:regulation of ion transmembrane transport; P:smooth muscle contraction; scaffold123 indexed_genome mRNA 1488066 1489210 . + . ID=transcript_13733;P24385 Q6LEF0,G1/S-specific cyclin-D1,B-cell lymphoma 1 protein;BCL-1 oncogene;PRAD1 oncogene;, PF02984;PF00134;, GO:0005923;GO:0000307;GO:0005737;GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0017053;GO:0016538;GO:0019899;GO:0042826;GO:0070064;GO:0004672;GO:0019901;GO:0044877;GO:0003714;GO:0008134;GO:0051301;GO:0006974;GO:0019221;GO:0030968;GO:0045444;GO:0000082;GO:0007595;GO:0033327;GO:0097421;GO:0060749;GO:0033598;GO:0044772;GO:0031571;GO:0071157;GO:0030857;GO:0000122;GO:0045787;GO:0045737;GO:1900087;GO:0010971;GO:0033601;GO:0001934;GO:0000320;GO:0000079;GO:0060260;GO:0051592;GO:0051412;GO:0042493;GO:0032355;GO:0043627;GO:0045471;GO:0010039;GO:0044321;GO:0032026;GO:0010243;GO:0070141;GO:0033197;GO:0010165;GO:0016055;, C:bicellular tight junction; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:enzyme binding; F:histone deacetylase binding; F:proline-rich region binding; F:protein kinase activity; F:protein kinase binding; F:protein-containing complex binding; F:transcription corepressor activity; F:transcription factor binding;, P:cell division; P:cellular response to DNA damage stimulus; P:cytokine-mediated signaling pathway; P:endoplasmic reticulum unfolded protein response; P:fat cell differentiation; P:G1/S transition of mitotic cell cycle; P:lactation; P:Leydig cell differentiation; P:liver regeneration; P:mammary gland alveolus development; P:mammary gland epithelial cell proliferation; P:mitotic cell cycle phase transition; P:mitotic G1 DNA damage checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of epithelial cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell cycle; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of mammary gland epithelial cell proliferation; P:positive regulation of protein phosphorylation; P:re-entry into mitotic cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to calcium ion; P:response to corticosterone; P:response to drug; P:response to estradiol; P:response to estrogen; P:response to ethanol; P:response to iron ion; P:response to leptin; P:response to magnesium ion; P:response to organonitrogen compound; P:response to UV-A; P:response to vitamin E; P:response to X-ray; P:Wnt signaling pathway; scaffold123 indexed_genome mRNA 1500881 1508068 . - . ID=transcript_13734;Q8WV07 B2R4R2 Q8NFK0,Protein LTO1 homolog {ECO:0000303|PubMed:23318452, ECO:0000305},Oral cancer-overexpressed protein 1;Tumor-amplified and overexpressed sequence 1;, PF09811;, GO:0005634;GO:0106035;GO:0042273;GO:0000723;GO:0006413;, C:nucleus;, , P:protein maturation by [4Fe-4S] cluster transfer; P:ribosomal large subunit biogenesis; P:telomere maintenance; P:translational initiation;|Q8WV07 B2R4R2 Q8NFK0,Protein LTO1 homolog {ECO:0000303|PubMed:23318452, ECO:0000305},Oral cancer-overexpressed protein 1;Tumor-amplified and overexpressed sequence 1;, PF09811;, GO:0005634;GO:0106035;GO:0042273;GO:0000723;GO:0006413;, C:nucleus;, , P:protein maturation by [4Fe-4S] cluster transfer; P:ribosomal large subunit biogenesis; P:telomere maintenance; P:translational initiation;|Q8WV07 B2R4R2 Q8NFK0,Protein LTO1 homolog {ECO:0000303|PubMed:23318452, ECO:0000305},Oral cancer-overexpressed protein 1;Tumor-amplified and overexpressed sequence 1;, PF09811;, GO:0005634;GO:0106035;GO:0042273;GO:0000723;GO:0006413;, C:nucleus;, , P:protein maturation by [4Fe-4S] cluster transfer; P:ribosomal large subunit biogenesis; P:telomere maintenance; P:translational initiation;|Q8WV07 B2R4R2 Q8NFK0,Protein LTO1 homolog {ECO:0000303|PubMed:23318452, ECO:0000305},Oral cancer-overexpressed protein 1;Tumor-amplified and overexpressed sequence 1;, PF09811;, GO:0005634;GO:0106035;GO:0042273;GO:0000723;GO:0006413;, C:nucleus;, , P:protein maturation by [4Fe-4S] cluster transfer; P:ribosomal large subunit biogenesis; P:telomere maintenance; P:translational initiation; scaffold123 indexed_genome mRNA 1826134 1826777 . - . ID=transcript_13735;O60888 A2AB26 A2BEL4 Q3B784 Q5JXM9 Q5SU05 Q9NYQ9,Protein CutA,Acetylcholinesterase-associated protein;Brain acetylcholinesterase putative membrane anchor;, PF03091;, GO:0070062;GO:0016020;GO:0005507;GO:0019899;GO:0008104;GO:0010038;, C:extracellular exosome; C:membrane;, F:copper ion binding; F:enzyme binding;, P:protein localization; P:response to metal ion; scaffold123 indexed_genome mRNA 1850736 1928009 . + . ID=transcript_13736;Q5XXA6 A8KAM3 Q8IYY8 Q8N7V3,Anoctamin-1,Discovered on gastrointestinal stromal tumors protein 1;Oral cancer overexpressed protein 2;Transmembrane protein 16A;Tumor-amplified and overexpressed sequence 2;, PF16178;PF04547;, GO:0016324;GO:0034707;GO:0005737;GO:0070062;GO:0005887;GO:0045121;GO:0005654;GO:0005886;GO:0005227;GO:0005254;GO:0005229;GO:0015111;GO:0046872;GO:0042803;GO:0005102;GO:0005247;GO:0006812;GO:0034605;GO:1901653;GO:1902476;GO:0006821;GO:0050965;GO:0015705;GO:0034220;GO:0007275;GO:0007200;GO:0035774;GO:0055085;, C:apical plasma membrane; C:chloride channel complex; C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:calcium activated cation channel activity; F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:iodide transmembrane transporter activity; F:metal ion binding; F:protein homodimerization activity; F:signaling receptor binding; F:voltage-gated chloride channel activity;, P:cation transport; P:cellular response to heat; P:cellular response to peptide; P:chloride transmembrane transport; P:chloride transport; P:detection of temperature stimulus involved in sensory perception of pain; P:iodide transport; P:ion transmembrane transport; P:multicellular organism development; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:transmembrane transport;|Q5XXA6 A8KAM3 Q8IYY8 Q8N7V3,Anoctamin-1,Discovered on gastrointestinal stromal tumors protein 1;Oral cancer overexpressed protein 2;Transmembrane protein 16A;Tumor-amplified and overexpressed sequence 2;, PF16178;PF04547;, GO:0016324;GO:0034707;GO:0005737;GO:0070062;GO:0005887;GO:0045121;GO:0005654;GO:0005886;GO:0005227;GO:0005254;GO:0005229;GO:0015111;GO:0046872;GO:0042803;GO:0005102;GO:0005247;GO:0006812;GO:0034605;GO:1901653;GO:1902476;GO:0006821;GO:0050965;GO:0015705;GO:0034220;GO:0007275;GO:0007200;GO:0035774;GO:0055085;, C:apical plasma membrane; C:chloride channel complex; C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:calcium activated cation channel activity; F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:iodide transmembrane transporter activity; F:metal ion binding; F:protein homodimerization activity; F:signaling receptor binding; F:voltage-gated chloride channel activity;, P:cation transport; P:cellular response to heat; P:cellular response to peptide; P:chloride transmembrane transport; P:chloride transport; P:detection of temperature stimulus involved in sensory perception of pain; P:iodide transport; P:ion transmembrane transport; P:multicellular organism development; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:transmembrane transport; scaffold123 indexed_genome mRNA 1929488 1950885 . + . ID=transcript_13737;Q5XXA6 A8KAM3 Q8IYY8 Q8N7V3,Anoctamin-1,Discovered on gastrointestinal stromal tumors protein 1;Oral cancer overexpressed protein 2;Transmembrane protein 16A;Tumor-amplified and overexpressed sequence 2;, PF16178;PF04547;, GO:0016324;GO:0034707;GO:0005737;GO:0070062;GO:0005887;GO:0045121;GO:0005654;GO:0005886;GO:0005227;GO:0005254;GO:0005229;GO:0015111;GO:0046872;GO:0042803;GO:0005102;GO:0005247;GO:0006812;GO:0034605;GO:1901653;GO:1902476;GO:0006821;GO:0050965;GO:0015705;GO:0034220;GO:0007275;GO:0007200;GO:0035774;GO:0055085;, C:apical plasma membrane; C:chloride channel complex; C:cytoplasm; C:extracellular exosome; C:integral component of plasma membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane;, F:calcium activated cation channel activity; F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:iodide transmembrane transporter activity; F:metal ion binding; F:protein homodimerization activity; F:signaling receptor binding; F:voltage-gated chloride channel activity;, P:cation transport; P:cellular response to heat; P:cellular response to peptide; P:chloride transmembrane transport; P:chloride transport; P:detection of temperature stimulus involved in sensory perception of pain; P:iodide transport; P:ion transmembrane transport; P:multicellular organism development; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:transmembrane transport; scaffold123 indexed_genome mRNA 1968139 2039895 . + . ID=transcript_13738;Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization;|Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization;|Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization;|Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization;|F8VP68 Q2M3G8,Liprin-alpha-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2;, PF00536;PF07647;, GO:0030424;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0048786;GO:0099181;GO:0007160;GO:0099519;GO:0006836;GO:0060998;GO:0061001;GO:2000300;GO:0050808;, C:axon; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:presynaptic active zone;, F:structural constituent of presynapse;, P:cell-matrix adhesion; P:dense core granule cytoskeletal transport; P:neurotransmitter transport; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:regulation of synaptic vesicle exocytosis; P:synapse organization;|Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization; scaffold123 indexed_genome mRNA 2040958 2047596 . + . ID=transcript_13739;Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization;|Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization;|Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization; scaffold123 indexed_genome mRNA 2070251 2096544 . + . ID=transcript_13740;Q14247 Q8N707 Q96H99,Src substrate cortactin,Amplaxin;Oncogene EMS1;, PF02218;PF14604;, GO:0005938;GO:0005905;GO:0030864;GO:0030863;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0005925;GO:0005794;GO:0043231;GO:0030027;GO:1990023;GO:0005886;GO:0002102;GO:0001726;GO:0030427;GO:0008076;GO:0051015;GO:0045296;GO:0005522;GO:0031532;GO:0030041;GO:0048870;GO:0097062;GO:0048041;GO:0006886;GO:0097581;GO:0061024;GO:2001237;GO:0048812;GO:0030838;GO:0045987;GO:0006898;GO:0030833;GO:1903146;GO:0030516;GO:0006930;, C:cell cortex; C:clathrin-coated pit; C:cortical actin cytoskeleton; C:cortical cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lamellipodium; C:mitotic spindle midzone; C:plasma membrane; C:podosome; C:ruffle; C:site of polarized growth; C:voltage-gated potassium channel complex;, F:actin filament binding; F:cadherin binding; F:profilin binding;, P:actin cytoskeleton reorganization; P:actin filament polymerization; P:cell motility; P:dendritic spine maintenance; P:focal adhesion assembly; P:intracellular protein transport; P:lamellipodium organization; P:membrane organization; P:negative regulation of extrinsic apoptotic signaling pathway; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of smooth muscle contraction; P:receptor-mediated endocytosis; P:regulation of actin filament polymerization; P:regulation of autophagy of mitochondrion; P:regulation of axon extension; P:substrate-dependent cell migration, cell extension;|Q14247 Q8N707 Q96H99,Src substrate cortactin,Amplaxin;Oncogene EMS1;, PF02218;PF14604;, GO:0005938;GO:0005905;GO:0030864;GO:0030863;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0005925;GO:0005794;GO:0043231;GO:0030027;GO:1990023;GO:0005886;GO:0002102;GO:0001726;GO:0030427;GO:0008076;GO:0051015;GO:0045296;GO:0005522;GO:0031532;GO:0030041;GO:0048870;GO:0097062;GO:0048041;GO:0006886;GO:0097581;GO:0061024;GO:2001237;GO:0048812;GO:0030838;GO:0045987;GO:0006898;GO:0030833;GO:1903146;GO:0030516;GO:0006930;, C:cell cortex; C:clathrin-coated pit; C:cortical actin cytoskeleton; C:cortical cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lamellipodium; C:mitotic spindle midzone; C:plasma membrane; C:podosome; C:ruffle; C:site of polarized growth; C:voltage-gated potassium channel complex;, F:actin filament binding; F:cadherin binding; F:profilin binding;, P:actin cytoskeleton reorganization; P:actin filament polymerization; P:cell motility; P:dendritic spine maintenance; P:focal adhesion assembly; P:intracellular protein transport; P:lamellipodium organization; P:membrane organization; P:negative regulation of extrinsic apoptotic signaling pathway; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of smooth muscle contraction; P:receptor-mediated endocytosis; P:regulation of actin filament polymerization; P:regulation of autophagy of mitochondrion; P:regulation of axon extension; P:substrate-dependent cell migration, cell extension;|Q14247 Q8N707 Q96H99,Src substrate cortactin,Amplaxin;Oncogene EMS1;, PF02218;PF14604;, GO:0005938;GO:0005905;GO:0030864;GO:0030863;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0005925;GO:0005794;GO:0043231;GO:0030027;GO:1990023;GO:0005886;GO:0002102;GO:0001726;GO:0030427;GO:0008076;GO:0051015;GO:0045296;GO:0005522;GO:0031532;GO:0030041;GO:0048870;GO:0097062;GO:0048041;GO:0006886;GO:0097581;GO:0061024;GO:2001237;GO:0048812;GO:0030838;GO:0045987;GO:0006898;GO:0030833;GO:1903146;GO:0030516;GO:0006930;, C:cell cortex; C:clathrin-coated pit; C:cortical actin cytoskeleton; C:cortical cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lamellipodium; C:mitotic spindle midzone; C:plasma membrane; C:podosome; C:ruffle; C:site of polarized growth; C:voltage-gated potassium channel complex;, F:actin filament binding; F:cadherin binding; F:profilin binding;, P:actin cytoskeleton reorganization; P:actin filament polymerization; P:cell motility; P:dendritic spine maintenance; P:focal adhesion assembly; P:intracellular protein transport; P:lamellipodium organization; P:membrane organization; P:negative regulation of extrinsic apoptotic signaling pathway; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of smooth muscle contraction; P:receptor-mediated endocytosis; P:regulation of actin filament polymerization; P:regulation of autophagy of mitochondrion; P:regulation of axon extension; P:substrate-dependent cell migration, cell extension;|Q14247 Q8N707 Q96H99,Src substrate cortactin,Amplaxin;Oncogene EMS1;, PF02218;PF14604;, GO:0005938;GO:0005905;GO:0030864;GO:0030863;GO:0005737;GO:0005856;GO:0005829;GO:0043197;GO:0005925;GO:0005794;GO:0043231;GO:0030027;GO:1990023;GO:0005886;GO:0002102;GO:0001726;GO:0030427;GO:0008076;GO:0051015;GO:0045296;GO:0005522;GO:0031532;GO:0030041;GO:0048870;GO:0097062;GO:0048041;GO:0006886;GO:0097581;GO:0061024;GO:2001237;GO:0048812;GO:0030838;GO:0045987;GO:0006898;GO:0030833;GO:1903146;GO:0030516;GO:0006930;, C:cell cortex; C:clathrin-coated pit; C:cortical actin cytoskeleton; C:cortical cytoskeleton; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendritic spine; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lamellipodium; C:mitotic spindle midzone; C:plasma membrane; C:podosome; C:ruffle; C:site of polarized growth; C:voltage-gated potassium channel complex;, F:actin filament binding; F:cadherin binding; F:profilin binding;, P:actin cytoskeleton reorganization; P:actin filament polymerization; P:cell motility; P:dendritic spine maintenance; P:focal adhesion assembly; P:intracellular protein transport; P:lamellipodium organization; P:membrane organization; P:negative regulation of extrinsic apoptotic signaling pathway; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of smooth muscle contraction; P:receptor-mediated endocytosis; P:regulation of actin filament polymerization; P:regulation of autophagy of mitochondrion; P:regulation of axon extension; P:substrate-dependent cell migration, cell extension; scaffold123 indexed_genome mRNA 2113280 2589312 . - . ID=transcript_13741;Q9UPX8 C0SPG8 C0SPG9 Q3Y8G9 Q52LK2 Q9UKP1,SH3 and multiple ankyrin repeat domains protein 2,Cortactin-binding protein 1;Proline-rich synapse-associated protein 1;, PF17820;PF00536;PF07653;, GO:0016324;GO:0031526;GO:0060170;GO:0005829;GO:0043197;GO:0030426;GO:0043005;GO:0043025;GO:0001917;GO:0001750;GO:0005886;GO:0014069;GO:0035255;GO:0017124;GO:0030160;GO:0030534;GO:0048854;GO:0060997;GO:0007612;GO:0060292;GO:0060291;GO:0035331;GO:0008284;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:2000311;GO:0035176;GO:0007416;GO:0051124;GO:0071625;, C:apical plasma membrane; C:brush border membrane; C:ciliary membrane; C:cytosol; C:dendritic spine; C:growth cone; C:neuron projection; C:neuronal cell body; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding; F:SH3 domain binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:brain morphogenesis; P:dendritic spine morphogenesis; P:learning; P:long-term synaptic depression; P:long-term synaptic potentiation; P:negative regulation of hippo signaling; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse assembly; P:synaptic growth at neuromuscular junction; P:vocalization behavior;|Q9Y566 A8MXP5 B7WNY6 Q9NYW9,SH3 and multiple ankyrin repeat domains protein 1,Somatostatin receptor-interacting protein;, PF12796;PF17820;PF00536;PF07653;, GO:0005829;GO:0030425;GO:0043197;GO:0060076;GO:0016020;GO:0043005;GO:0005886;GO:0014069;GO:0045211;GO:0071532;GO:0042802;GO:0035255;GO:0008022;GO:0044877;GO:0097110;GO:0017124;GO:0031877;GO:0030160;GO:0030534;GO:0008306;GO:0048854;GO:0060997;GO:0050894;GO:0007616;GO:0060291;GO:0032232;GO:0050885;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:0035418;GO:0065003;GO:2000311;GO:0035176;GO:0060074;GO:0051124;GO:0071625;, C:cytosol; C:dendrite; C:dendritic spine; C:excitatory synapse; C:membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:ankyrin repeat binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein-containing complex binding; F:scaffold protein binding; F:SH3 domain binding; F:somatostatin receptor binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:associative learning; P:brain morphogenesis; P:dendritic spine morphogenesis; P:determination of affect; P:long-term memory; P:long-term synaptic potentiation; P:negative regulation of actin filament bundle assembly; P:neuromuscular process controlling balance; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:protein localization to synapse; P:protein-containing complex assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse maturation; P:synaptic growth at neuromuscular junction; P:vocalization behavior;|Q9UPX8 C0SPG8 C0SPG9 Q3Y8G9 Q52LK2 Q9UKP1,SH3 and multiple ankyrin repeat domains protein 2,Cortactin-binding protein 1;Proline-rich synapse-associated protein 1;, PF17820;PF00536;PF07653;, GO:0016324;GO:0031526;GO:0060170;GO:0005829;GO:0043197;GO:0030426;GO:0043005;GO:0043025;GO:0001917;GO:0001750;GO:0005886;GO:0014069;GO:0035255;GO:0017124;GO:0030160;GO:0030534;GO:0048854;GO:0060997;GO:0007612;GO:0060292;GO:0060291;GO:0035331;GO:0008284;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:2000311;GO:0035176;GO:0007416;GO:0051124;GO:0071625;, C:apical plasma membrane; C:brush border membrane; C:ciliary membrane; C:cytosol; C:dendritic spine; C:growth cone; C:neuron projection; C:neuronal cell body; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding; F:SH3 domain binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:brain morphogenesis; P:dendritic spine morphogenesis; P:learning; P:long-term synaptic depression; P:long-term synaptic potentiation; P:negative regulation of hippo signaling; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse assembly; P:synaptic growth at neuromuscular junction; P:vocalization behavior;|Q9UPX8 C0SPG8 C0SPG9 Q3Y8G9 Q52LK2 Q9UKP1,SH3 and multiple ankyrin repeat domains protein 2,Cortactin-binding protein 1;Proline-rich synapse-associated protein 1;, PF17820;PF00536;PF07653;, GO:0016324;GO:0031526;GO:0060170;GO:0005829;GO:0043197;GO:0030426;GO:0043005;GO:0043025;GO:0001917;GO:0001750;GO:0005886;GO:0014069;GO:0035255;GO:0017124;GO:0030160;GO:0030534;GO:0048854;GO:0060997;GO:0007612;GO:0060292;GO:0060291;GO:0035331;GO:0008284;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:2000311;GO:0035176;GO:0007416;GO:0051124;GO:0071625;, C:apical plasma membrane; C:brush border membrane; C:ciliary membrane; C:cytosol; C:dendritic spine; C:growth cone; C:neuron projection; C:neuronal cell body; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding; F:SH3 domain binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:brain morphogenesis; P:dendritic spine morphogenesis; P:learning; P:long-term synaptic depression; P:long-term synaptic potentiation; P:negative regulation of hippo signaling; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse assembly; P:synaptic growth at neuromuscular junction; P:vocalization behavior;|Q9UPX8 C0SPG8 C0SPG9 Q3Y8G9 Q52LK2 Q9UKP1,SH3 and multiple ankyrin repeat domains protein 2,Cortactin-binding protein 1;Proline-rich synapse-associated protein 1;, PF17820;PF00536;PF07653;, GO:0016324;GO:0031526;GO:0060170;GO:0005829;GO:0043197;GO:0030426;GO:0043005;GO:0043025;GO:0001917;GO:0001750;GO:0005886;GO:0014069;GO:0035255;GO:0017124;GO:0030160;GO:0030534;GO:0048854;GO:0060997;GO:0007612;GO:0060292;GO:0060291;GO:0035331;GO:0008284;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:2000311;GO:0035176;GO:0007416;GO:0051124;GO:0071625;, C:apical plasma membrane; C:brush border membrane; C:ciliary membrane; C:cytosol; C:dendritic spine; C:growth cone; C:neuron projection; C:neuronal cell body; C:photoreceptor inner segment; C:photoreceptor outer segment; C:plasma membrane; C:postsynaptic density;, F:ionotropic glutamate receptor binding; F:SH3 domain binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:brain morphogenesis; P:dendritic spine morphogenesis; P:learning; P:long-term synaptic depression; P:long-term synaptic potentiation; P:negative regulation of hippo signaling; P:positive regulation of cell population proliferation; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse assembly; P:synaptic growth at neuromuscular junction; P:vocalization behavior;|Q9Y566 A8MXP5 B7WNY6 Q9NYW9,SH3 and multiple ankyrin repeat domains protein 1,Somatostatin receptor-interacting protein;, PF12796;PF17820;PF00536;PF07653;, GO:0005829;GO:0030425;GO:0043197;GO:0060076;GO:0016020;GO:0043005;GO:0005886;GO:0014069;GO:0045211;GO:0071532;GO:0042802;GO:0035255;GO:0008022;GO:0044877;GO:0097110;GO:0017124;GO:0031877;GO:0030160;GO:0030534;GO:0008306;GO:0048854;GO:0060997;GO:0050894;GO:0007616;GO:0060291;GO:0032232;GO:0050885;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:0035418;GO:0065003;GO:2000311;GO:0035176;GO:0060074;GO:0051124;GO:0071625;, C:cytosol; C:dendrite; C:dendritic spine; C:excitatory synapse; C:membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:ankyrin repeat binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein-containing complex binding; F:scaffold protein binding; F:SH3 domain binding; F:somatostatin receptor binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:associative learning; P:brain morphogenesis; P:dendritic spine morphogenesis; P:determination of affect; P:long-term memory; P:long-term synaptic potentiation; P:negative regulation of actin filament bundle assembly; P:neuromuscular process controlling balance; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:protein localization to synapse; P:protein-containing complex assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse maturation; P:synaptic growth at neuromuscular junction; P:vocalization behavior; scaffold123 indexed_genome mRNA 2808716 2823029 . - . ID=transcript_13742;Q9UBM7 B2R6Z2 O60492 O60717,7-dehydrocholesterol reductase {ECO:0000303|PubMed:9683613},Delta7-sterol reductase {ECO:0000303|PubMed:9465114};Sterol Delta(7)-reductase;Sterol reductase SR-2;, PF01222;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0005640;GO:0047598;GO:0050661;GO:0016627;GO:0009918;GO:0016132;GO:0006695;GO:0033489;GO:0033490;GO:0045540;GO:0019216;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear outer membrane;, F:7-dehydrocholesterol reductase activity; F:NADP binding; F:oxidoreductase activity, acting on the CH-CH group of donors; F:sterol delta7 reductase activity;, P:brassinosteroid biosynthetic process; P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:regulation of cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:sterol biosynthetic process;|Q9UBM7 B2R6Z2 O60492 O60717,7-dehydrocholesterol reductase {ECO:0000303|PubMed:9683613},Delta7-sterol reductase {ECO:0000303|PubMed:9465114};Sterol Delta(7)-reductase;Sterol reductase SR-2;, PF01222;, GO:0005783;GO:0005789;GO:0030176;GO:0016020;GO:0005640;GO:0047598;GO:0050661;GO:0016627;GO:0009918;GO:0016132;GO:0006695;GO:0033489;GO:0033490;GO:0045540;GO:0019216;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nuclear outer membrane;, F:7-dehydrocholesterol reductase activity; F:NADP binding; F:oxidoreductase activity, acting on the CH-CH group of donors; F:sterol delta7 reductase activity;, P:brassinosteroid biosynthetic process; P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:regulation of cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:sterol biosynthetic process; scaffold123 indexed_genome mRNA 2838958 2857447 . + . ID=transcript_13743;Q6IA69 B3KUU4 Q86SN2 Q9HA25 Q9NVM8,Glutamine-dependent NAD(+) synthetase,NAD(+) synthase [glutamine-hydrolyzing];NAD(+) synthetase;, PF00795;PF02540;, GO:0005737;GO:0005829;GO:0005524;GO:0004359;GO:0003952;GO:0034627;GO:0009435;GO:0019674;, C:cytoplasm; C:cytosol;, F:ATP binding; F:glutaminase activity; F:NAD+ synthase (glutamine-hydrolyzing) activity;, P:'de novo' NAD biosynthetic process; P:NAD biosynthetic process; P:NAD metabolic process;|Q6IA69 B3KUU4 Q86SN2 Q9HA25 Q9NVM8,Glutamine-dependent NAD(+) synthetase,NAD(+) synthase [glutamine-hydrolyzing];NAD(+) synthetase;, PF00795;PF02540;, GO:0005737;GO:0005829;GO:0005524;GO:0004359;GO:0003952;GO:0034627;GO:0009435;GO:0019674;, C:cytoplasm; C:cytosol;, F:ATP binding; F:glutaminase activity; F:NAD+ synthase (glutamine-hydrolyzing) activity;, P:'de novo' NAD biosynthetic process; P:NAD biosynthetic process; P:NAD metabolic process; scaffold123 indexed_genome mRNA 2857656 2858888 . - . ID=transcript_13744;Q6IA69 B3KUU4 Q86SN2 Q9HA25 Q9NVM8,Glutamine-dependent NAD(+) synthetase,NAD(+) synthase [glutamine-hydrolyzing];NAD(+) synthetase;, PF00795;PF02540;, GO:0005737;GO:0005829;GO:0005524;GO:0004359;GO:0003952;GO:0034627;GO:0009435;GO:0019674;, C:cytoplasm; C:cytosol;, F:ATP binding; F:glutaminase activity; F:NAD+ synthase (glutamine-hydrolyzing) activity;, P:'de novo' NAD biosynthetic process; P:NAD biosynthetic process; P:NAD metabolic process; scaffold123 indexed_genome mRNA 2859104 2864069 . + . ID=transcript_13745;Q6IA69 B3KUU4 Q86SN2 Q9HA25 Q9NVM8,Glutamine-dependent NAD(+) synthetase,NAD(+) synthase [glutamine-hydrolyzing];NAD(+) synthetase;, PF00795;PF02540;, GO:0005737;GO:0005829;GO:0005524;GO:0004359;GO:0003952;GO:0034627;GO:0009435;GO:0019674;, C:cytoplasm; C:cytosol;, F:ATP binding; F:glutaminase activity; F:NAD+ synthase (glutamine-hydrolyzing) activity;, P:'de novo' NAD biosynthetic process; P:NAD biosynthetic process; P:NAD metabolic process;|Q6IA69 B3KUU4 Q86SN2 Q9HA25 Q9NVM8,Glutamine-dependent NAD(+) synthetase,NAD(+) synthase [glutamine-hydrolyzing];NAD(+) synthetase;, PF00795;PF02540;, GO:0005737;GO:0005829;GO:0005524;GO:0004359;GO:0003952;GO:0034627;GO:0009435;GO:0019674;, C:cytoplasm; C:cytosol;, F:ATP binding; F:glutaminase activity; F:NAD+ synthase (glutamine-hydrolyzing) activity;, P:'de novo' NAD biosynthetic process; P:NAD biosynthetic process; P:NAD metabolic process;|Q6IA69 B3KUU4 Q86SN2 Q9HA25 Q9NVM8,Glutamine-dependent NAD(+) synthetase,NAD(+) synthase [glutamine-hydrolyzing];NAD(+) synthetase;, PF00795;PF02540;, GO:0005737;GO:0005829;GO:0005524;GO:0004359;GO:0003952;GO:0034627;GO:0009435;GO:0019674;, C:cytoplasm; C:cytosol;, F:ATP binding; F:glutaminase activity; F:NAD+ synthase (glutamine-hydrolyzing) activity;, P:'de novo' NAD biosynthetic process; P:NAD biosynthetic process; P:NAD metabolic process; scaffold123 indexed_genome mRNA 2868870 2869431 . + . ID=transcript_13746;Q96LB2 Q4V9L2 Q8TDD8 Q8TDD9,Mas-related G-protein coupled receptor member X1,Sensory neuron-specific G-protein coupled receptor 3/4;, PF00001;, GO:0009986;GO:0016021;GO:0005886;GO:0004930;GO:0004888;GO:0006953;GO:0007166;GO:0007186;GO:1902349;GO:0007165;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:transmembrane signaling receptor activity;, P:acute-phase response; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:response to chloroquine; P:signal transduction; scaffold123 indexed_genome mRNA 3017949 3048309 . + . ID=transcript_13747;Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; scaffold124 indexed_genome mRNA 373073 475459 . - . ID=transcript_13748;Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration;|Q92673 B2RNX7 Q92856,Sortilin-related receptor,Low-density lipoprotein receptor relative with 11 ligand-binding repeats;SorLA-1 {ECO:0000303|PubMed:8940146};Sorting protein-related receptor containing LDLR class A repeats;, PF00041;PF00057;PF00058;PF15902;PF15901;, GO:0009986;GO:0005769;GO:0031901;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0070062;GO:0005615;GO:0005794;GO:0031985;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0005771;GO:0032585;GO:0005641;GO:0097356;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0030658;GO:0001540;GO:0030169;GO:0005041;GO:0042923;GO:0031267;GO:0004888;GO:1990845;GO:1990000;GO:0002024;GO:0038020;GO:1902430;GO:1902960;GO:0030514;GO:0043407;GO:1902963;GO:1902997;GO:0050768;GO:1901215;GO:0032091;GO:0031333;GO:1902948;GO:0010897;GO:0007218;GO:1904179;GO:1902771;GO:1902955;GO:2001137;GO:1902953;GO:1900168;GO:0046628;GO:0045732;GO:0070863;GO:1902966;GO:0006892;GO:0034067;GO:0051604;GO:0045053;GO:0006605;GO:0006622;GO:0006898;GO:0014910;, C:cell surface; C:early endosome; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:Golgi cisterna; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:multivesicular body; C:multivesicular body membrane; C:nuclear envelope lumen; C:perinucleolar compartment; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network; C:transport vesicle membrane;, F:amyloid-beta binding; F:low-density lipoprotein particle binding; F:low-density lipoprotein particle receptor activity; F:neuropeptide binding; F:small GTPase binding; F:transmembrane signaling receptor activity;, P:adaptive thermogenesis; P:amyloid fibril formation; P:diet induced thermogenesis; P:insulin receptor recycling; P:negative regulation of amyloid-beta formation; P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of BMP signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of neurofibrillary tangle assembly; P:negative regulation of neurogenesis; P:negative regulation of neuron death; P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:negative regulation of tau-protein kinase activity; P:negative regulation of triglyceride catabolic process; P:neuropeptide signaling pathway; P:positive regulation of adipose tissue development; P:positive regulation of choline O-acetyltransferase activity; P:positive regulation of early endosome to recycling endosome transport; P:positive regulation of endocytic recycling; P:positive regulation of ER to Golgi vesicle-mediated transport; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of protein catabolic process; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of protein localization to early endosome; P:post-Golgi vesicle-mediated transport; P:protein localization to Golgi apparatus; P:protein maturation; P:protein retention in Golgi apparatus; P:protein targeting; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of smooth muscle cell migration; scaffold124 indexed_genome mRNA 676315 688934 . - . ID=transcript_13749;O75845 O00119 Q6GTM5 Q9UK15,Lathosterol oxidase {ECO:0000305},C-5 sterol desaturase;Delta(7)-sterol 5-desaturase;Delta(7)-sterol C5(6)-desaturase;Lathosterol 5-desaturase;Sterol-C5-desaturase;, PF04116;, GO:0005789;GO:0016021;GO:0016020;GO:0000248;GO:0005506;GO:0050046;GO:0016491;GO:0033489;GO:0033490;GO:0006629;GO:0019216;GO:0016126;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:C-5 sterol desaturase activity; F:iron ion binding; F:lathosterol oxidase activity; F:oxidoreductase activity;, P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:lipid metabolic process; P:regulation of lipid metabolic process; P:sterol biosynthetic process;|O75845 O00119 Q6GTM5 Q9UK15,Lathosterol oxidase {ECO:0000305},C-5 sterol desaturase;Delta(7)-sterol 5-desaturase;Delta(7)-sterol C5(6)-desaturase;Lathosterol 5-desaturase;Sterol-C5-desaturase;, PF04116;, GO:0005789;GO:0016021;GO:0016020;GO:0000248;GO:0005506;GO:0050046;GO:0016491;GO:0033489;GO:0033490;GO:0006629;GO:0019216;GO:0016126;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:C-5 sterol desaturase activity; F:iron ion binding; F:lathosterol oxidase activity; F:oxidoreductase activity;, P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:lipid metabolic process; P:regulation of lipid metabolic process; P:sterol biosynthetic process; scaffold124 indexed_genome mRNA 759867 768014 . - . ID=transcript_13750;O75443,Alpha-tectorin,, PF08742;PF06119;PF01826;PF12714;PF00094;PF00100;, GO:0031225;GO:0062023;GO:0070062;GO:0005576;GO:0005886;GO:0005201;GO:0007160;GO:0007605;, C:anchored component of membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:extracellular matrix structural constituent;, P:cell-matrix adhesion; P:sensory perception of sound; scaffold124 indexed_genome mRNA 775037 779762 . - . ID=transcript_13751;O75443,Alpha-tectorin,, PF08742;PF06119;PF01826;PF12714;PF00094;PF00100;, GO:0031225;GO:0062023;GO:0070062;GO:0005576;GO:0005886;GO:0005201;GO:0007160;GO:0007605;, C:anchored component of membrane; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:extracellular matrix structural constituent;, P:cell-matrix adhesion; P:sensory perception of sound; scaffold124 indexed_genome mRNA 851053 919656 . - . ID=transcript_13752;Q5QJ74 Q0VAN6,Tubulin-specific chaperone cofactor E-like protein,Leucine-rich repeat-containing protein 35;, PF14560;, GO:0005737;GO:0005856;GO:0043014;GO:0000226;GO:0007023;GO:0007021;, C:cytoplasm; C:cytoskeleton;, F:alpha-tubulin binding;, P:microtubule cytoskeleton organization; P:post-chaperonin tubulin folding pathway; P:tubulin complex assembly;|Q5QJ74 Q0VAN6,Tubulin-specific chaperone cofactor E-like protein,Leucine-rich repeat-containing protein 35;, PF14560;, GO:0005737;GO:0005856;GO:0043014;GO:0000226;GO:0007023;GO:0007021;, C:cytoplasm; C:cytoskeleton;, F:alpha-tubulin binding;, P:microtubule cytoskeleton organization; P:post-chaperonin tubulin folding pathway; P:tubulin complex assembly; scaffold124 indexed_genome mRNA 962563 1318061 . - . ID=transcript_13753;Q16099 A8K9L1,Glutamate receptor ionotropic, kainate 4,Excitatory amino acid receptor 1;Glutamate receptor KA-1;, PF01094;PF00060;PF10613;, GO:0098686;GO:0005887;GO:0099055;GO:0099056;GO:0032983;GO:0005886;GO:0045211;GO:0042734;GO:0008066;GO:0015277;GO:0015276;GO:0038023;GO:1904315;GO:0007268;GO:0007215;GO:0050804;GO:0035249;, C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:kainate selective glutamate receptor complex; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane;, F:glutamate receptor activity; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:modulation of chemical synaptic transmission; P:synaptic transmission, glutamatergic;|Q16099 A8K9L1,Glutamate receptor ionotropic, kainate 4,Excitatory amino acid receptor 1;Glutamate receptor KA-1;, PF01094;PF00060;PF10613;, GO:0098686;GO:0005887;GO:0099055;GO:0099056;GO:0032983;GO:0005886;GO:0045211;GO:0042734;GO:0008066;GO:0015277;GO:0015276;GO:0038023;GO:1904315;GO:0007268;GO:0007215;GO:0050804;GO:0035249;, C:hippocampal mossy fiber to CA3 synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:kainate selective glutamate receptor complex; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane;, F:glutamate receptor activity; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:glutamate receptor signaling pathway; P:modulation of chemical synaptic transmission; P:synaptic transmission, glutamatergic; scaffold124 indexed_genome mRNA 1479160 1566907 . - . ID=transcript_13754;Q9NZN5 O15086 Q6P526,Rho guanine nucleotide exchange factor 12,Leukemia-associated RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0007186;GO:0043065;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q9NZN5 O15086 Q6P526,Rho guanine nucleotide exchange factor 12,Leukemia-associated RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0007186;GO:0043065;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q9NZN5 O15086 Q6P526,Rho guanine nucleotide exchange factor 12,Leukemia-associated RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0007186;GO:0043065;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q9NZN5 O15086 Q6P526,Rho guanine nucleotide exchange factor 12,Leukemia-associated RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0007186;GO:0043065;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q9NZN5 O15086 Q6P526,Rho guanine nucleotide exchange factor 12,Leukemia-associated RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0007186;GO:0043065;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q9NZN5 O15086 Q6P526,Rho guanine nucleotide exchange factor 12,Leukemia-associated RhoGEF;, PF00595;PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0001664;GO:0005096;GO:0005085;GO:0007186;GO:0043065;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold124 indexed_genome mRNA 1653140 1657094 . - . ID=transcript_13755;Q6ZRR5 B4DGQ4 B4E230 Q8IZ79,TLC domain-containing protein 5 {ECO:0000305},Transmembrane protein 136;, PF03798;, GO:0016021;, C:integral component of membrane; scaffold124 indexed_genome mRNA 1767236 1768457 . - . ID=transcript_13756;Q86UD1,Out at first protein homolog,HCV NS5A-transactivated protein 13 target protein 2;, PF14941; scaffold124 indexed_genome mRNA 1780408 1780965 . - . ID=transcript_13757;Q3ZCU0 Q8N9C3,Protein GVQW3 {ECO:0000305},GVQW motif-containing protein 3 {ECO:0000305};, PF17906; scaffold124 indexed_genome mRNA 2351608 2368753 . + . ID=transcript_13758;Q15223 O75465 Q2M3D3 Q9HBE6 Q9HBW2,Nectin-1,Herpes virus entry mediator C;Herpesvirus Ig-like receptor;Nectin cell adhesion molecule 1 {ECO:0000312|HGNC:HGNC:9706};Poliovirus receptor-related protein 1;, PF08205;PF07686;, GO:0005912;GO:0043296;GO:0044291;GO:0030425;GO:0005576;GO:0032584;GO:0098686;GO:0016021;GO:0099059;GO:0043231;GO:0016020;GO:0005886;GO:0030246;GO:0050839;GO:0015026;GO:0042802;GO:0042803;GO:0044877;GO:0046790;GO:0001618;GO:0034332;GO:0007411;GO:0007155;GO:0098609;GO:0002934;GO:0070166;GO:0007157;GO:0007156;GO:0006955;GO:0006826;GO:0002089;GO:1902414;GO:0051963;GO:0060041;GO:0046718;GO:0019062;, C:adherens junction; C:apical junction complex; C:cell-cell contact zone; C:dendrite; C:extracellular region; C:growth cone membrane; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, F:carbohydrate binding; F:cell adhesion molecule binding; F:coreceptor activity; F:identical protein binding; F:protein homodimerization activity; F:protein-containing complex binding; F:virion binding; F:virus receptor activity;, P:adherens junction organization; P:axon guidance; P:cell adhesion; P:cell-cell adhesion; P:desmosome organization; P:enamel mineralization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:immune response; P:iron ion transport; P:lens morphogenesis in camera-type eye; P:protein localization to cell junction; P:regulation of synapse assembly; P:retina development in camera-type eye; P:viral entry into host cell; P:virion attachment to host cell; scaffold124 indexed_genome mRNA 2581320 2586998 . + . ID=transcript_13759;P04216 Q16008 Q9NSP1,Thy-1 membrane glycoprotein,CDw90;Thy-1 antigen;, PF00047;, GO:0031362;GO:0016324;GO:0030673;GO:0009986;GO:0030425;GO:0032590;GO:0005783;GO:0009897;GO:0070062;GO:0005576;GO:0005925;GO:0030426;GO:0005887;GO:0045121;GO:0032809;GO:0005886;GO:0034235;GO:0005096;GO:0005178;GO:0019901;GO:0001525;GO:0098609;GO:0007267;GO:0007010;GO:0048041;GO:0007229;GO:0050771;GO:0030336;GO:0070571;GO:0006469;GO:0061099;GO:0050860;GO:0002693;GO:0051894;GO:0043547;GO:0034116;GO:0051281;GO:0050870;GO:0043113;GO:0001952;GO:2000298;GO:0046549;GO:0050852;, C:anchored component of external side of plasma membrane; C:apical plasma membrane; C:axolemma; C:cell surface; C:dendrite; C:dendrite membrane; C:endoplasmic reticulum; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:growth cone; C:integral component of plasma membrane; C:membrane raft; C:neuronal cell body membrane; C:plasma membrane;, F:GPI anchor binding; F:GTPase activator activity; F:integrin binding; F:protein kinase binding;, P:angiogenesis; P:cell-cell adhesion; P:cell-cell signaling; P:cytoskeleton organization; P:focal adhesion assembly; P:integrin-mediated signaling pathway; P:negative regulation of axonogenesis; P:negative regulation of cell migration; P:negative regulation of neuron projection regeneration; P:negative regulation of protein kinase activity; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of T cell receptor signaling pathway; P:positive regulation of cellular extravasation; P:positive regulation of focal adhesion assembly; P:positive regulation of GTPase activity; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of T cell activation; P:receptor clustering; P:regulation of cell-matrix adhesion; P:regulation of Rho-dependent protein serine/threonine kinase activity; P:retinal cone cell development; P:T cell receptor signaling pathway; scaffold124 indexed_genome mRNA 2606940 2628445 . + . ID=transcript_13760;O75604 B0YJB8 E9PPM2 Q8IUM2 Q8IW04 Q96MB9 Q9BQ21,Ubiquitin carboxyl-terminal hydrolase 2,41 kDa ubiquitin-specific protease;Deubiquitinating enzyme 2;Ubiquitin thioesterase 2;Ubiquitin-specific-processing protease 2;, PF00443;, GO:0005813;GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0030332;GO:0004197;GO:0042802;GO:0046872;GO:0004843;GO:0031625;GO:0007049;GO:0048512;GO:0032922;GO:0043153;GO:0045475;GO:0007517;GO:0000122;GO:0045931;GO:0016579;GO:0050821;GO:1901796;GO:0006511;, C:centrosome; C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cyclin binding; F:cysteine-type endopeptidase activity; F:identical protein binding; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin protein ligase binding;, P:cell cycle; P:circadian behavior; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:locomotor rhythm; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of mitotic cell cycle; P:protein deubiquitination; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:ubiquitin-dependent protein catabolic process;|O75604 B0YJB8 E9PPM2 Q8IUM2 Q8IW04 Q96MB9 Q9BQ21,Ubiquitin carboxyl-terminal hydrolase 2,41 kDa ubiquitin-specific protease;Deubiquitinating enzyme 2;Ubiquitin thioesterase 2;Ubiquitin-specific-processing protease 2;, PF00443;, GO:0005813;GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0030332;GO:0004197;GO:0042802;GO:0046872;GO:0004843;GO:0031625;GO:0007049;GO:0048512;GO:0032922;GO:0043153;GO:0045475;GO:0007517;GO:0000122;GO:0045931;GO:0016579;GO:0050821;GO:1901796;GO:0006511;, C:centrosome; C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cyclin binding; F:cysteine-type endopeptidase activity; F:identical protein binding; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin protein ligase binding;, P:cell cycle; P:circadian behavior; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:locomotor rhythm; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of mitotic cell cycle; P:protein deubiquitination; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:ubiquitin-dependent protein catabolic process; scaffold124 indexed_genome mRNA 2628638 2631333 . + . ID=transcript_13761;O75604 B0YJB8 E9PPM2 Q8IUM2 Q8IW04 Q96MB9 Q9BQ21,Ubiquitin carboxyl-terminal hydrolase 2,41 kDa ubiquitin-specific protease;Deubiquitinating enzyme 2;Ubiquitin thioesterase 2;Ubiquitin-specific-processing protease 2;, PF00443;, GO:0005813;GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0030332;GO:0004197;GO:0042802;GO:0046872;GO:0004843;GO:0031625;GO:0007049;GO:0048512;GO:0032922;GO:0043153;GO:0045475;GO:0007517;GO:0000122;GO:0045931;GO:0016579;GO:0050821;GO:1901796;GO:0006511;, C:centrosome; C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cyclin binding; F:cysteine-type endopeptidase activity; F:identical protein binding; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin protein ligase binding;, P:cell cycle; P:circadian behavior; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:locomotor rhythm; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of mitotic cell cycle; P:protein deubiquitination; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:ubiquitin-dependent protein catabolic process;|O75604 B0YJB8 E9PPM2 Q8IUM2 Q8IW04 Q96MB9 Q9BQ21,Ubiquitin carboxyl-terminal hydrolase 2,41 kDa ubiquitin-specific protease;Deubiquitinating enzyme 2;Ubiquitin thioesterase 2;Ubiquitin-specific-processing protease 2;, PF00443;, GO:0005813;GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0030332;GO:0004197;GO:0042802;GO:0046872;GO:0004843;GO:0031625;GO:0007049;GO:0048512;GO:0032922;GO:0043153;GO:0045475;GO:0007517;GO:0000122;GO:0045931;GO:0016579;GO:0050821;GO:1901796;GO:0006511;, C:centrosome; C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:cyclin binding; F:cysteine-type endopeptidase activity; F:identical protein binding; F:metal ion binding; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin protein ligase binding;, P:cell cycle; P:circadian behavior; P:circadian regulation of gene expression; P:entrainment of circadian clock by photoperiod; P:locomotor rhythm; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of mitotic cell cycle; P:protein deubiquitination; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:ubiquitin-dependent protein catabolic process; scaffold124 indexed_genome mRNA 2645649 2647213 . + . ID=transcript_13762;Q9BXJ0 A6NDD3 B0YJ35 Q335M2 Q8N6P2 Q9UFX4,Complement C1q tumor necrosis factor-related protein 5,, PF00386;PF01391;, GO:0042995;GO:0005581;GO:0005615;GO:0005886;, C:cell projection; C:collagen trimer; C:extracellular space; C:plasma membrane; scaffold124 indexed_genome mRNA 2648978 2651828 . - . ID=transcript_13763;Q9BY78 Q542Y8,E3 ubiquitin-protein ligase RNF26 {ECO:0000305},RING finger protein 26 {ECO:0000305};, , GO:0005789;GO:0016021;GO:0061630;GO:0008270;GO:0007032;GO:0050687;GO:0070979;GO:1905719;GO:0016567;GO:0032479;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:endosome organization; P:negative regulation of defense response to virus; P:protein K11-linked ubiquitination; P:protein localization to perinuclear region of cytoplasm; P:protein ubiquitination; P:regulation of type I interferon production; scaffold124 indexed_genome mRNA 2667662 2675903 . + . ID=transcript_13764;P43121 O95812 Q59E86 Q6PHR3 Q6ZTR2,Cell surface glycoprotein MUC18,Cell surface glycoprotein P1H12;Melanoma cell adhesion molecule;Melanoma-associated antigen A32;Melanoma-associated antigen MUC18;S-endo 1 endothelial-associated antigen;, PF08205;PF00047;PF07686;, GO:0009897;GO:0005576;GO:0005615;GO:0005925;GO:0016021;GO:0005634;GO:0005886;GO:0009653;GO:0001525;GO:0007155;GO:0003094;GO:0030335;GO:0061042;, C:external side of plasma membrane; C:extracellular region; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:nucleus; C:plasma membrane;, , P:anatomical structure morphogenesis; P:angiogenesis; P:cell adhesion; P:glomerular filtration; P:positive regulation of cell migration; P:vascular wound healing; scaffold124 indexed_genome mRNA 2681897 2709310 . - . ID=transcript_13765;P22681 A3KMP8,E3 ubiquitin-protein ligase CBL,Casitas B-lineage lymphoma proto-oncogene;Proto-oncogene c-Cbl;RING finger protein 55;RING-type E3 ubiquitin transferase CBL {ECO:0000305};Signal transduction protein CBL;, PF02262;PF02761;PF02762;PF00627;, GO:0005929;GO:0005829;GO:0016600;GO:0005925;GO:0005794;GO:0030426;GO:0045121;GO:0048471;GO:0005886;GO:0045296;GO:0005509;GO:0046875;GO:0005154;GO:0036312;GO:0001784;GO:0030971;GO:0017124;GO:0061630;GO:0004842;GO:0007166;GO:0006974;GO:0071364;GO:1990090;GO:0090650;GO:0036120;GO:0019221;GO:0035635;GO:0007173;GO:0008543;GO:0070102;GO:0008584;GO:0043303;GO:0061024;GO:0043066;GO:0042059;GO:0007175;GO:1901215;GO:0070997;GO:0045742;GO:0014068;GO:0048260;GO:0006513;GO:0000209;GO:0016567;GO:2000583;GO:0032487;GO:0014823;GO:0046677;GO:0045471;GO:0010332;GO:0042594;GO:0033574;GO:0007165;GO:0007179;GO:0006511;, C:cilium; C:cytosol; C:flotillin complex; C:focal adhesion; C:Golgi apparatus; C:growth cone; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cadherin binding; F:calcium ion binding; F:ephrin receptor binding; F:epidermal growth factor receptor binding; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:phosphotyrosine residue binding; F:receptor tyrosine kinase binding; F:SH3 domain binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell surface receptor signaling pathway; P:cellular response to DNA damage stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to oxygen-glucose deprivation; P:cellular response to platelet-derived growth factor stimulus; P:cytokine-mediated signaling pathway; P:entry of bacterium into host cell; P:epidermal growth factor receptor signaling pathway; P:fibroblast growth factor receptor signaling pathway; P:interleukin-6-mediated signaling pathway; P:male gonad development; P:mast cell degranulation; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of neuron death; P:neuron death; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of receptor-mediated endocytosis; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of platelet-derived growth factor receptor-alpha signaling pathway; P:regulation of Rap protein signal transduction; P:response to activity; P:response to antibiotic; P:response to ethanol; P:response to gamma radiation; P:response to starvation; P:response to testosterone; P:signal transduction; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; scaffold124 indexed_genome mRNA 2781974 2796939 . - . ID=transcript_13766;Q86UT6 A8K6Q1 B3KPK2 B3KTA2 Q7RTR3 Q96D51 Q9H724,NLR family member X1,Caterpiller protein 11.3;Nucleotide-binding oligomerization domain protein 26;Nucleotide-binding oligomerization domain protein 5;Nucleotide-binding oligomerization domain protein 9;, PF13516;PF05729;, GO:0030054;GO:0005741;GO:0005739;GO:0005886;GO:0005524;GO:0045087;GO:0035556;GO:0043124;GO:0050728;GO:0045824;GO:0032688;GO:0032715;GO:0039536;GO:0032480;GO:0016032;, C:cell junction; C:mitochondrial outer membrane; C:mitochondrion; C:plasma membrane;, F:ATP binding;, P:innate immune response; P:intracellular signal transduction; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:viral process;|Q86UT6 A8K6Q1 B3KPK2 B3KTA2 Q7RTR3 Q96D51 Q9H724,NLR family member X1,Caterpiller protein 11.3;Nucleotide-binding oligomerization domain protein 26;Nucleotide-binding oligomerization domain protein 5;Nucleotide-binding oligomerization domain protein 9;, PF13516;PF05729;, GO:0030054;GO:0005741;GO:0005739;GO:0005886;GO:0005524;GO:0045087;GO:0035556;GO:0043124;GO:0050728;GO:0045824;GO:0032688;GO:0032715;GO:0039536;GO:0032480;GO:0016032;, C:cell junction; C:mitochondrial outer membrane; C:mitochondrion; C:plasma membrane;, F:ATP binding;, P:innate immune response; P:intracellular signal transduction; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:viral process;|Q86UT6 A8K6Q1 B3KPK2 B3KTA2 Q7RTR3 Q96D51 Q9H724,NLR family member X1,Caterpiller protein 11.3;Nucleotide-binding oligomerization domain protein 26;Nucleotide-binding oligomerization domain protein 5;Nucleotide-binding oligomerization domain protein 9;, PF13516;PF05729;, GO:0030054;GO:0005741;GO:0005739;GO:0005886;GO:0005524;GO:0045087;GO:0035556;GO:0043124;GO:0050728;GO:0045824;GO:0032688;GO:0032715;GO:0039536;GO:0032480;GO:0016032;, C:cell junction; C:mitochondrial outer membrane; C:mitochondrion; C:plasma membrane;, F:ATP binding;, P:innate immune response; P:intracellular signal transduction; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:viral process; scaffold124 indexed_genome mRNA 2803928 2813447 . - . ID=transcript_13767;Q9H172 A8K1B5 Q8WWH0 Q8WWH1 Q8WWH2,ATP-binding cassette sub-family G member 4,, PF01061;PF19055;PF00005;, GO:0010008;GO:0016021;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0042802;GO:0046982;GO:0042803;GO:1990830;GO:0033344;GO:0006869;, C:endosome membrane; C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:cellular response to leukemia inhibitory factor; P:cholesterol efflux; P:lipid transport; scaffold124 indexed_genome mRNA 2813460 2819805 . + . ID=transcript_13768;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q9H172 A8K1B5 Q8WWH0 Q8WWH1 Q8WWH2,ATP-binding cassette sub-family G member 4,, PF01061;PF19055;PF00005;, GO:0010008;GO:0016021;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0042802;GO:0046982;GO:0042803;GO:1990830;GO:0033344;GO:0006869;, C:endosome membrane; C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:cellular response to leukemia inhibitory factor; P:cholesterol efflux; P:lipid transport;|Q9H172 A8K1B5 Q8WWH0 Q8WWH1 Q8WWH2,ATP-binding cassette sub-family G member 4,, PF01061;PF19055;PF00005;, GO:0010008;GO:0016021;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0042802;GO:0046982;GO:0042803;GO:1990830;GO:0033344;GO:0006869;, C:endosome membrane; C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:cellular response to leukemia inhibitory factor; P:cholesterol efflux; P:lipid transport; scaffold124 indexed_genome mRNA 2833788 2834817 . + . ID=transcript_13769;Q9BQA5 B3KPH6 B4DWB4 E9PQF4 Q96E65 Q9Y4M7,Histone H4 transcription factor,Histone nuclear factor P;MBD2-interacting zinc finger protein;Methyl-CpG-binding protein 2-interacting zinc finger protein;, PF00096;, GO:0015030;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0019899;GO:0042393;GO:0046872;GO:0000978;GO:0000977;GO:0000976;GO:0048856;GO:0000077;GO:0006281;GO:0045184;GO:0000082;GO:0001701;GO:0045445;GO:0010629;GO:0045892;GO:0010628;GO:0045944;GO:0045893;GO:0010468;GO:0006357;GO:0000083;GO:0006355;GO:0006351;, C:Cajal body; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:histone binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure development; P:DNA damage checkpoint; P:DNA repair; P:establishment of protein localization; P:G1/S transition of mitotic cell cycle; P:in utero embryonic development; P:myoblast differentiation; P:negative regulation of gene expression; P:negative regulation of transcription, DNA-templated; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold124 indexed_genome mRNA 2845435 2856289 . - . ID=transcript_13770;O14523 Q86UT7 Q86V04 Q8N522 Q8TBN4 Q96G10,Phospholipid transfer protein C2CD2L {ECO:0000305},C2 domain-containing protein 2-like {ECO:0000312|HGNC:HGNC:29000};Transmembrane protein 24 {ECO:0000303|PubMed:28209843};, PF18696;, GO:0032541;GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0043559;GO:0035091;GO:0008526;GO:0035774;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:insulin binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O14523 Q86UT7 Q86V04 Q8N522 Q8TBN4 Q96G10,Phospholipid transfer protein C2CD2L {ECO:0000305},C2 domain-containing protein 2-like {ECO:0000312|HGNC:HGNC:29000};Transmembrane protein 24 {ECO:0000303|PubMed:28209843};, PF18696;, GO:0032541;GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0043559;GO:0035091;GO:0008526;GO:0035774;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:insulin binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O14523 Q86UT7 Q86V04 Q8N522 Q8TBN4 Q96G10,Phospholipid transfer protein C2CD2L {ECO:0000305},C2 domain-containing protein 2-like {ECO:0000312|HGNC:HGNC:29000};Transmembrane protein 24 {ECO:0000303|PubMed:28209843};, PF18696;, GO:0032541;GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0043559;GO:0035091;GO:0008526;GO:0035774;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:insulin binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O14523 Q86UT7 Q86V04 Q8N522 Q8TBN4 Q96G10,Phospholipid transfer protein C2CD2L {ECO:0000305},C2 domain-containing protein 2-like {ECO:0000312|HGNC:HGNC:29000};Transmembrane protein 24 {ECO:0000303|PubMed:28209843};, PF18696;, GO:0032541;GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0043559;GO:0035091;GO:0008526;GO:0035774;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:insulin binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O14523 Q86UT7 Q86V04 Q8N522 Q8TBN4 Q96G10,Phospholipid transfer protein C2CD2L {ECO:0000305},C2 domain-containing protein 2-like {ECO:0000312|HGNC:HGNC:29000};Transmembrane protein 24 {ECO:0000303|PubMed:28209843};, PF18696;, GO:0032541;GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0043559;GO:0035091;GO:0008526;GO:0035774;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:insulin binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;|O14523 Q86UT7 Q86V04 Q8N522 Q8TBN4 Q96G10,Phospholipid transfer protein C2CD2L {ECO:0000305},C2 domain-containing protein 2-like {ECO:0000312|HGNC:HGNC:29000};Transmembrane protein 24 {ECO:0000303|PubMed:28209843};, PF18696;, GO:0032541;GO:0005789;GO:0140268;GO:0016021;GO:0005886;GO:0043559;GO:0035091;GO:0008526;GO:0035774;, C:cortical endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:plasma membrane;, F:insulin binding; F:phosphatidylinositol binding; F:phosphatidylinositol transfer activity;, P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; scaffold124 indexed_genome mRNA 2859892 2865623 . + . ID=transcript_13771;Q9H3H5 O15216 Q86WV9 Q9BWE6,UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase,GlcNAc-1-P transferase {ECO:0000303|PubMed:29459785};N-acetylglucosamine-1-phosphate transferase;, PF00953;, GO:0005789;GO:0030176;GO:0016021;GO:0043231;GO:0016020;GO:0042802;GO:0046872;GO:0008963;GO:0016757;GO:0003975;GO:0003976;GO:0019348;GO:0006488;GO:0006489;GO:0006487;GO:0006047;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:identical protein binding; F:metal ion binding; F:phospho-N-acetylmuramoyl-pentapeptide-transferase activity; F:transferase activity, transferring glycosyl groups; F:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:dolichol metabolic process; P:dolichol-linked oligosaccharide biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine metabolic process;|Q9H3H5 O15216 Q86WV9 Q9BWE6,UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase,GlcNAc-1-P transferase {ECO:0000303|PubMed:29459785};N-acetylglucosamine-1-phosphate transferase;, PF00953;, GO:0005789;GO:0030176;GO:0016021;GO:0043231;GO:0016020;GO:0042802;GO:0046872;GO:0008963;GO:0016757;GO:0003975;GO:0003976;GO:0019348;GO:0006488;GO:0006489;GO:0006487;GO:0006047;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:identical protein binding; F:metal ion binding; F:phospho-N-acetylmuramoyl-pentapeptide-transferase activity; F:transferase activity, transferring glycosyl groups; F:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:dolichol metabolic process; P:dolichol-linked oligosaccharide biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine metabolic process;|Q9H3H5 O15216 Q86WV9 Q9BWE6,UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase,GlcNAc-1-P transferase {ECO:0000303|PubMed:29459785};N-acetylglucosamine-1-phosphate transferase;, PF00953;, GO:0005789;GO:0030176;GO:0016021;GO:0043231;GO:0016020;GO:0042802;GO:0046872;GO:0008963;GO:0016757;GO:0003975;GO:0003976;GO:0019348;GO:0006488;GO:0006489;GO:0006487;GO:0006047;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:identical protein binding; F:metal ion binding; F:phospho-N-acetylmuramoyl-pentapeptide-transferase activity; F:transferase activity, transferring glycosyl groups; F:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:dolichol metabolic process; P:dolichol-linked oligosaccharide biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine metabolic process;|Q9H3H5 O15216 Q86WV9 Q9BWE6,UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase,GlcNAc-1-P transferase {ECO:0000303|PubMed:29459785};N-acetylglucosamine-1-phosphate transferase;, PF00953;, GO:0005789;GO:0030176;GO:0016021;GO:0043231;GO:0016020;GO:0042802;GO:0046872;GO:0008963;GO:0016757;GO:0003975;GO:0003976;GO:0019348;GO:0006488;GO:0006489;GO:0006487;GO:0006047;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:identical protein binding; F:metal ion binding; F:phospho-N-acetylmuramoyl-pentapeptide-transferase activity; F:transferase activity, transferring glycosyl groups; F:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:dolichol metabolic process; P:dolichol-linked oligosaccharide biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine metabolic process;|Q9H3H5 O15216 Q86WV9 Q9BWE6,UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase,GlcNAc-1-P transferase {ECO:0000303|PubMed:29459785};N-acetylglucosamine-1-phosphate transferase;, PF00953;, GO:0005789;GO:0030176;GO:0016021;GO:0043231;GO:0016020;GO:0042802;GO:0046872;GO:0008963;GO:0016757;GO:0003975;GO:0003976;GO:0019348;GO:0006488;GO:0006489;GO:0006487;GO:0006047;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:identical protein binding; F:metal ion binding; F:phospho-N-acetylmuramoyl-pentapeptide-transferase activity; F:transferase activity, transferring glycosyl groups; F:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:dolichol metabolic process; P:dolichol-linked oligosaccharide biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine metabolic process;|Q9H3H5 O15216 Q86WV9 Q9BWE6,UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase,GlcNAc-1-P transferase {ECO:0000303|PubMed:29459785};N-acetylglucosamine-1-phosphate transferase;, PF00953;, GO:0005789;GO:0030176;GO:0016021;GO:0043231;GO:0016020;GO:0042802;GO:0046872;GO:0008963;GO:0016757;GO:0003975;GO:0003976;GO:0019348;GO:0006488;GO:0006489;GO:0006487;GO:0006047;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:identical protein binding; F:metal ion binding; F:phospho-N-acetylmuramoyl-pentapeptide-transferase activity; F:transferase activity, transferring glycosyl groups; F:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:dolichol metabolic process; P:dolichol-linked oligosaccharide biosynthetic process; P:dolichyl diphosphate biosynthetic process; P:protein N-linked glycosylation; P:UDP-N-acetylglucosamine metabolic process; scaffold124 indexed_genome mRNA 2866148 2867830 . + . ID=transcript_13772;P16104 Q4ZGJ7 Q6IAS5,Histone H2AX,Histone H2A.X;, PF00125;PF16211;, GO:0005813;GO:0000794;GO:0070062;GO:0001673;GO:0016607;GO:0005654;GO:0000786;GO:0005634;GO:0005657;GO:0090734;GO:0035861;GO:0001741;GO:0003684;GO:0003677;GO:0019899;GO:0042393;GO:0046982;GO:0006974;GO:0071480;GO:0090398;GO:0021987;GO:0006342;GO:0000077;GO:0006302;GO:0000724;GO:0006303;GO:0051321;GO:0006334;GO:0045739;GO:0010212;GO:0007283;GO:0016032;, C:centrosome; C:condensed nuclear chromosome; C:extracellular exosome; C:male germ cell nucleus; C:nuclear speck; C:nucleoplasm; C:nucleosome; C:nucleus; C:replication fork; C:site of DNA damage; C:site of double-strand break; C:XY body;, F:damaged DNA binding; F:DNA binding; F:enzyme binding; F:histone binding; F:protein heterodimerization activity;, P:cellular response to DNA damage stimulus; P:cellular response to gamma radiation; P:cellular senescence; P:cerebral cortex development; P:chromatin silencing; P:DNA damage checkpoint; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:meiotic cell cycle; P:nucleosome assembly; P:positive regulation of DNA repair; P:response to ionizing radiation; P:spermatogenesis; P:viral process; scaffold124 indexed_genome mRNA 2868154 2875375 . - . ID=transcript_13773;P08397 A8K2L0 G3V1P4 G5EA58 P08396 Q16012,Porphobilinogen deaminase,Hydroxymethylbilane synthase;Pre-uroporphyrinogen synthase;, PF01379;PF03900;, GO:0005737;GO:0005829;GO:0004418;GO:0006783;GO:0018160;GO:0006782;, C:cytoplasm; C:cytosol;, F:hydroxymethylbilane synthase activity;, P:heme biosynthetic process; P:peptidyl-pyrromethane cofactor linkage; P:protoporphyrinogen IX biosynthetic process;|P08397 A8K2L0 G3V1P4 G5EA58 P08396 Q16012,Porphobilinogen deaminase,Hydroxymethylbilane synthase;Pre-uroporphyrinogen synthase;, PF01379;PF03900;, GO:0005737;GO:0005829;GO:0004418;GO:0006783;GO:0018160;GO:0006782;, C:cytoplasm; C:cytosol;, F:hydroxymethylbilane synthase activity;, P:heme biosynthetic process; P:peptidyl-pyrromethane cofactor linkage; P:protoporphyrinogen IX biosynthetic process;|P08397 A8K2L0 G3V1P4 G5EA58 P08396 Q16012,Porphobilinogen deaminase,Hydroxymethylbilane synthase;Pre-uroporphyrinogen synthase;, PF01379;PF03900;, GO:0005737;GO:0005829;GO:0004418;GO:0006783;GO:0018160;GO:0006782;, C:cytoplasm; C:cytosol;, F:hydroxymethylbilane synthase activity;, P:heme biosynthetic process; P:peptidyl-pyrromethane cofactor linkage; P:protoporphyrinogen IX biosynthetic process;|P08397 A8K2L0 G3V1P4 G5EA58 P08396 Q16012,Porphobilinogen deaminase,Hydroxymethylbilane synthase;Pre-uroporphyrinogen synthase;, PF01379;PF03900;, GO:0005737;GO:0005829;GO:0004418;GO:0006783;GO:0018160;GO:0006782;, C:cytoplasm; C:cytosol;, F:hydroxymethylbilane synthase activity;, P:heme biosynthetic process; P:peptidyl-pyrromethane cofactor linkage; P:protoporphyrinogen IX biosynthetic process;|P08397 A8K2L0 G3V1P4 G5EA58 P08396 Q16012,Porphobilinogen deaminase,Hydroxymethylbilane synthase;Pre-uroporphyrinogen synthase;, PF01379;PF03900;, GO:0005737;GO:0005829;GO:0004418;GO:0006783;GO:0018160;GO:0006782;, C:cytoplasm; C:cytosol;, F:hydroxymethylbilane synthase activity;, P:heme biosynthetic process; P:peptidyl-pyrromethane cofactor linkage; P:protoporphyrinogen IX biosynthetic process; scaffold124 indexed_genome mRNA 2877503 2883976 . - . ID=transcript_13774;Q9H270 Q8WY89 Q96EP8 Q9H6D9 Q9HCS6,Vacuolar protein sorting-associated protein 11 homolog,RING finger protein 108;, PF00637;PF12451;, GO:0005776;GO:0030136;GO:0005769;GO:0030139;GO:0005768;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0046872;GO:0000166;GO:0019904;GO:0030674;GO:0019905;GO:0061630;GO:0006914;GO:0034058;GO:0007032;GO:0008333;GO:0006886;GO:0033147;GO:1903364;GO:2000643;GO:1903955;GO:0016567;GO:1902115;GO:0031647;GO:0035542;GO:0007033;GO:0006904;, C:autophagosome; C:clathrin-coated vesicle; C:early endosome; C:endocytic vesicle; C:endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:metal ion binding; F:nucleotide binding; F:protein domain specific binding; F:protein-macromolecule adaptor activity; F:syntaxin binding; F:ubiquitin protein ligase activity;, P:autophagy; P:endosomal vesicle fusion; P:endosome organization; P:endosome to lysosome transport; P:intracellular protein transport; P:negative regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of cellular protein catabolic process; P:positive regulation of early endosome to late endosome transport; P:positive regulation of protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of organelle assembly; P:regulation of protein stability; P:regulation of SNARE complex assembly; P:vacuole organization; P:vesicle docking involved in exocytosis;|Q9H270 Q8WY89 Q96EP8 Q9H6D9 Q9HCS6,Vacuolar protein sorting-associated protein 11 homolog,RING finger protein 108;, PF00637;PF12451;, GO:0005776;GO:0030136;GO:0005769;GO:0030139;GO:0005768;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0046872;GO:0000166;GO:0019904;GO:0030674;GO:0019905;GO:0061630;GO:0006914;GO:0034058;GO:0007032;GO:0008333;GO:0006886;GO:0033147;GO:1903364;GO:2000643;GO:1903955;GO:0016567;GO:1902115;GO:0031647;GO:0035542;GO:0007033;GO:0006904;, C:autophagosome; C:clathrin-coated vesicle; C:early endosome; C:endocytic vesicle; C:endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:metal ion binding; F:nucleotide binding; F:protein domain specific binding; F:protein-macromolecule adaptor activity; F:syntaxin binding; F:ubiquitin protein ligase activity;, P:autophagy; P:endosomal vesicle fusion; P:endosome organization; P:endosome to lysosome transport; P:intracellular protein transport; P:negative regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of cellular protein catabolic process; P:positive regulation of early endosome to late endosome transport; P:positive regulation of protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of organelle assembly; P:regulation of protein stability; P:regulation of SNARE complex assembly; P:vacuole organization; P:vesicle docking involved in exocytosis; scaffold124 indexed_genome mRNA 2885475 2889277 . - . ID=transcript_13775;Q9H270 Q8WY89 Q96EP8 Q9H6D9 Q9HCS6,Vacuolar protein sorting-associated protein 11 homolog,RING finger protein 108;, PF00637;PF12451;, GO:0005776;GO:0030136;GO:0005769;GO:0030139;GO:0005768;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0046872;GO:0000166;GO:0019904;GO:0030674;GO:0019905;GO:0061630;GO:0006914;GO:0034058;GO:0007032;GO:0008333;GO:0006886;GO:0033147;GO:1903364;GO:2000643;GO:1903955;GO:0016567;GO:1902115;GO:0031647;GO:0035542;GO:0007033;GO:0006904;, C:autophagosome; C:clathrin-coated vesicle; C:early endosome; C:endocytic vesicle; C:endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:metal ion binding; F:nucleotide binding; F:protein domain specific binding; F:protein-macromolecule adaptor activity; F:syntaxin binding; F:ubiquitin protein ligase activity;, P:autophagy; P:endosomal vesicle fusion; P:endosome organization; P:endosome to lysosome transport; P:intracellular protein transport; P:negative regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of cellular protein catabolic process; P:positive regulation of early endosome to late endosome transport; P:positive regulation of protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of organelle assembly; P:regulation of protein stability; P:regulation of SNARE complex assembly; P:vacuole organization; P:vesicle docking involved in exocytosis;|Q9H270 Q8WY89 Q96EP8 Q9H6D9 Q9HCS6,Vacuolar protein sorting-associated protein 11 homolog,RING finger protein 108;, PF00637;PF12451;, GO:0005776;GO:0030136;GO:0005769;GO:0030139;GO:0005768;GO:0030897;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0046872;GO:0000166;GO:0019904;GO:0030674;GO:0019905;GO:0061630;GO:0006914;GO:0034058;GO:0007032;GO:0008333;GO:0006886;GO:0033147;GO:1903364;GO:2000643;GO:1903955;GO:0016567;GO:1902115;GO:0031647;GO:0035542;GO:0007033;GO:0006904;, C:autophagosome; C:clathrin-coated vesicle; C:early endosome; C:endocytic vesicle; C:endosome; C:HOPS complex; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;, F:metal ion binding; F:nucleotide binding; F:protein domain specific binding; F:protein-macromolecule adaptor activity; F:syntaxin binding; F:ubiquitin protein ligase activity;, P:autophagy; P:endosomal vesicle fusion; P:endosome organization; P:endosome to lysosome transport; P:intracellular protein transport; P:negative regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of cellular protein catabolic process; P:positive regulation of early endosome to late endosome transport; P:positive regulation of protein targeting to mitochondrion; P:protein ubiquitination; P:regulation of organelle assembly; P:regulation of protein stability; P:regulation of SNARE complex assembly; P:vacuole organization; P:vesicle docking involved in exocytosis; scaffold124 indexed_genome mRNA 2889330 2912730 . + . ID=transcript_13776;Q9Y4L1 A8C1Z0 B7Z909 Q2I204 Q53H25,Hypoxia up-regulated protein 1,150 kDa oxygen-regulated protein;170 kDa glucose-regulated protein;, PF00012;, GO:0071682;GO:0005783;GO:0034663;GO:0005788;GO:0070062;GO:0005576;GO:0005925;GO:0016020;GO:0005790;GO:0005524;GO:0016887;GO:0051087;GO:0051082;GO:0071456;GO:0006888;GO:0036498;GO:1903298;GO:0006898;GO:0034976;GO:0002931;, C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:membrane; C:smooth endoplasmic reticulum;, F:ATP binding; F:ATPase activity; F:chaperone binding; F:unfolded protein binding;, P:cellular response to hypoxia; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; P:receptor-mediated endocytosis; P:response to endoplasmic reticulum stress; P:response to ischemia; scaffold124 indexed_genome mRNA 2920788 2921528 . - . ID=transcript_13777;P02792 B2R4B9 Q6IBT7 Q7Z2W1 Q86WI9 Q8WU07 Q96AU9 Q96CU0 Q9BTZ8,Ferritin light chain,, PF00210;, GO:0044754;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0008043;GO:0016020;GO:0008199;GO:0008198;GO:0042802;GO:0005506;GO:0006879;GO:0006880;GO:0055072;GO:0006826;GO:0043312;GO:0006892;, C:autolysosome; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular ferritin complex; C:membrane;, F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:iron ion binding;, P:cellular iron ion homeostasis; P:intracellular sequestering of iron ion; P:iron ion homeostasis; P:iron ion transport; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; scaffold124 indexed_genome mRNA 2939681 2959357 . + . ID=transcript_13778;O43826 O96016 Q5J7V4 Q9UI19 Q9UNS4,Glucose-6-phosphate exchanger SLC37A4 {ECO:0000305|PubMed:10026167, ECO:0000305|PubMed:21949678},Glucose-5-phosphate transporter;Glucose-6-phosphate translocase {ECO:0000303|PubMed:9428641};Solute carrier family 37 member 4 {ECO:0000312|HGNC:HGNC:4061};Transformation-related gene 19 protein {ECO:0000312|EMBL:AAS00495.1};, PF07690;, GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0061513;GO:0015152;GO:0008643;GO:0006094;GO:0042593;GO:0006006;GO:0015760;GO:0035435;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glucose 6-phosphate:inorganic phosphate antiporter activity; F:glucose-6-phosphate transmembrane transporter activity;, P:carbohydrate transport; P:gluconeogenesis; P:glucose homeostasis; P:glucose metabolic process; P:glucose-6-phosphate transport; P:phosphate ion transmembrane transport;|O43826 O96016 Q5J7V4 Q9UI19 Q9UNS4,Glucose-6-phosphate exchanger SLC37A4 {ECO:0000305|PubMed:10026167, ECO:0000305|PubMed:21949678},Glucose-5-phosphate transporter;Glucose-6-phosphate translocase {ECO:0000303|PubMed:9428641};Solute carrier family 37 member 4 {ECO:0000312|HGNC:HGNC:4061};Transformation-related gene 19 protein {ECO:0000312|EMBL:AAS00495.1};, PF07690;, GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0061513;GO:0015152;GO:0008643;GO:0006094;GO:0042593;GO:0006006;GO:0015760;GO:0035435;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glucose 6-phosphate:inorganic phosphate antiporter activity; F:glucose-6-phosphate transmembrane transporter activity;, P:carbohydrate transport; P:gluconeogenesis; P:glucose homeostasis; P:glucose metabolic process; P:glucose-6-phosphate transport; P:phosphate ion transmembrane transport;|O43826 O96016 Q5J7V4 Q9UI19 Q9UNS4,Glucose-6-phosphate exchanger SLC37A4 {ECO:0000305|PubMed:10026167, ECO:0000305|PubMed:21949678},Glucose-5-phosphate transporter;Glucose-6-phosphate translocase {ECO:0000303|PubMed:9428641};Solute carrier family 37 member 4 {ECO:0000312|HGNC:HGNC:4061};Transformation-related gene 19 protein {ECO:0000312|EMBL:AAS00495.1};, PF07690;, GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0016020;GO:0061513;GO:0015152;GO:0008643;GO:0006094;GO:0042593;GO:0006006;GO:0015760;GO:0035435;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:glucose 6-phosphate:inorganic phosphate antiporter activity; F:glucose-6-phosphate transmembrane transporter activity;, P:carbohydrate transport; P:gluconeogenesis; P:glucose homeostasis; P:glucose metabolic process; P:glucose-6-phosphate transport; P:phosphate ion transmembrane transport;|Q86UT8,Centrosomal AT-AC splicing factor {ECO:0000305},Coiled-coil domain-containing protein 84;, PF14968;, GO:0005813;GO:0005737;GO:0010826;GO:0042176;, C:centrosome; C:cytoplasm;, , P:negative regulation of centrosome duplication; P:regulation of protein catabolic process;|Q9Y296 A8K3A5 B4DME1,Trafficking protein particle complex subunit 4 {ECO:0000305},Hematopoietic stem/progenitor cell protein 172;Synbindin {ECO:0000250|UniProtKB:Q9ES56};TRS23 homolog;, PF04099;, GO:0005829;GO:0030425;GO:0005783;GO:0000139;GO:0005795;GO:0045211;GO:0045202;GO:0008021;GO:0030008;GO:0006914;GO:0048208;GO:0016358;GO:0006888;, C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi membrane; C:Golgi stack; C:postsynaptic membrane; C:synapse; C:synaptic vesicle; C:TRAPP complex;, , P:autophagy; P:COPII vesicle coating; P:dendrite development; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|Q86UT8,Centrosomal AT-AC splicing factor {ECO:0000305},Coiled-coil domain-containing protein 84;, PF14968;, GO:0005813;GO:0005737;GO:0010826;GO:0042176;, C:centrosome; C:cytoplasm;, , P:negative regulation of centrosome duplication; P:regulation of protein catabolic process;|Q86UT8,Centrosomal AT-AC splicing factor {ECO:0000305},Coiled-coil domain-containing protein 84;, PF14968;, GO:0005813;GO:0005737;GO:0010826;GO:0042176;, C:centrosome; C:cytoplasm;, , P:negative regulation of centrosome duplication; P:regulation of protein catabolic process; scaffold125 indexed_genome mRNA 767 50045 . + . ID=transcript_13779;Q08945 Q5BJG8,FACT complex subunit SSRP1,Chromatin-specific transcription elongation factor 80 kDa subunit;Facilitates chromatin transcription complex 80 kDa subunit;Facilitates chromatin transcription complex subunit SSRP1;Recombination signal sequence recognition protein 1;Structure-specific recognition protein 1;T160;, PF00505;PF17292;PF08512;PF03531;, GO:0035101;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:1902275;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:regulation of chromatin organization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q08945 Q5BJG8,FACT complex subunit SSRP1,Chromatin-specific transcription elongation factor 80 kDa subunit;Facilitates chromatin transcription complex 80 kDa subunit;Facilitates chromatin transcription complex subunit SSRP1;Recombination signal sequence recognition protein 1;Structure-specific recognition protein 1;T160;, PF00505;PF17292;PF08512;PF03531;, GO:0035101;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:1902275;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:regulation of chromatin organization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q08945 Q5BJG8,FACT complex subunit SSRP1,Chromatin-specific transcription elongation factor 80 kDa subunit;Facilitates chromatin transcription complex 80 kDa subunit;Facilitates chromatin transcription complex subunit SSRP1;Recombination signal sequence recognition protein 1;Structure-specific recognition protein 1;T160;, PF00505;PF17292;PF08512;PF03531;, GO:0035101;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:1902275;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:regulation of chromatin organization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q08945 Q5BJG8,FACT complex subunit SSRP1,Chromatin-specific transcription elongation factor 80 kDa subunit;Facilitates chromatin transcription complex 80 kDa subunit;Facilitates chromatin transcription complex subunit SSRP1;Recombination signal sequence recognition protein 1;Structure-specific recognition protein 1;T160;, PF00505;PF17292;PF08512;PF03531;, GO:0035101;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:1902275;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:regulation of chromatin organization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q08945 Q5BJG8,FACT complex subunit SSRP1,Chromatin-specific transcription elongation factor 80 kDa subunit;Facilitates chromatin transcription complex 80 kDa subunit;Facilitates chromatin transcription complex subunit SSRP1;Recombination signal sequence recognition protein 1;Structure-specific recognition protein 1;T160;, PF00505;PF17292;PF08512;PF03531;, GO:0035101;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:1902275;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:regulation of chromatin organization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q08945 Q5BJG8,FACT complex subunit SSRP1,Chromatin-specific transcription elongation factor 80 kDa subunit;Facilitates chromatin transcription complex 80 kDa subunit;Facilitates chromatin transcription complex subunit SSRP1;Recombination signal sequence recognition protein 1;Structure-specific recognition protein 1;T160;, PF00505;PF17292;PF08512;PF03531;, GO:0035101;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:1902275;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:regulation of chromatin organization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process;|Q08945 Q5BJG8,FACT complex subunit SSRP1,Chromatin-specific transcription elongation factor 80 kDa subunit;Facilitates chromatin transcription complex 80 kDa subunit;Facilitates chromatin transcription complex subunit SSRP1;Recombination signal sequence recognition protein 1;Structure-specific recognition protein 1;T160;, PF00505;PF17292;PF08512;PF03531;, GO:0035101;GO:0005730;GO:0005654;GO:0003677;GO:0042393;GO:0031491;GO:0003723;GO:0006281;GO:0006260;GO:1902275;GO:1901796;GO:0006366;GO:0006368;GO:0016032;, C:FACT complex; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:histone binding; F:nucleosome binding; F:RNA binding;, P:DNA repair; P:DNA replication; P:regulation of chromatin organization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process; scaffold125 indexed_genome mRNA 100412 103473 . - . ID=transcript_13780;Q8NBI5 B4DNR8 E7EQD2 Q9NSS4,Solute carrier family 43 member 3,Protein FOAP-13;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q8NBI5 B4DNR8 E7EQD2 Q9NSS4,Solute carrier family 43 member 3,Protein FOAP-13;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity;|Q8NBI5 B4DNR8 E7EQD2 Q9NSS4,Solute carrier family 43 member 3,Protein FOAP-13;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold125 indexed_genome mRNA 105708 106598 . - . ID=transcript_13781;Q8NBI5 B4DNR8 E7EQD2 Q9NSS4,Solute carrier family 43 member 3,Protein FOAP-13;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold125 indexed_genome mRNA 106847 109599 . - . ID=transcript_13782;Q8NBI5 B4DNR8 E7EQD2 Q9NSS4,Solute carrier family 43 member 3,Protein FOAP-13;, PF07690;, GO:0016021;GO:0022857;, C:integral component of membrane;, F:transmembrane transporter activity; scaffold125 indexed_genome mRNA 172461 208825 . - . ID=transcript_13783;O75387,Large neutral amino acids transporter small subunit 3,L-type amino acid transporter 3;Prostate cancer overexpressed gene 1 protein;Solute carrier family 43 member 1;, PF07690;, GO:0005887;GO:0005886;GO:0015179;GO:0015175;GO:0006865;GO:0051956;GO:0060358;GO:0015804;, C:integral component of plasma membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:negative regulation of amino acid transport; P:negative regulation of leucine import; P:neutral amino acid transport;|O75387,Large neutral amino acids transporter small subunit 3,L-type amino acid transporter 3;Prostate cancer overexpressed gene 1 protein;Solute carrier family 43 member 1;, PF07690;, GO:0005887;GO:0005886;GO:0015179;GO:0015175;GO:0006865;GO:0051956;GO:0060358;GO:0015804;, C:integral component of plasma membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:negative regulation of amino acid transport; P:negative regulation of leucine import; P:neutral amino acid transport; scaffold125 indexed_genome mRNA 221851 224988 . - . ID=transcript_13784;P62072 A8K136 Q9WV99 Q9WVA0 Q9Y5J8,Mitochondrial import inner membrane translocase subunit Tim10,, PF02953;, GO:0005743;GO:0005758;GO:0042719;GO:0005739;GO:0005744;GO:0051087;GO:0042803;GO:0140318;GO:0008270;GO:0072321;GO:0045039;GO:0006626;GO:0007605;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial intermembrane space protein transporter complex; C:mitochondrion; C:TIM23 mitochondrial import inner membrane translocase complex;, F:chaperone binding; F:protein homodimerization activity; F:protein transporter activity; F:zinc ion binding;, P:chaperone-mediated protein transport; P:protein insertion into mitochondrial inner membrane; P:protein targeting to mitochondrion; P:sensory perception of sound; scaffold125 indexed_genome mRNA 239627 254722 . + . ID=transcript_13785;A8MU46 E9PPJ3,Smoothelin-like protein 1,, PF00307;, GO:0043292;GO:0005737;GO:0031941;GO:0031674;GO:0031430;GO:0005815;GO:0005634;GO:0005516;GO:0051401;GO:0097718;GO:0008157;GO:0043621;GO:0005523;GO:0030036;GO:0048644;GO:0045892;GO:0018105;GO:0045907;GO:0014823;GO:0042493;GO:0042310;, C:contractile fiber; C:cytoplasm; C:filamentous actin; C:I band; C:M band; C:microtubule organizing center; C:nucleus;, F:calmodulin binding; F:CH domain binding; F:disordered domain specific binding; F:protein phosphatase 1 binding; F:protein self-association; F:tropomyosin binding;, P:actin cytoskeleton organization; P:muscle organ morphogenesis; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of vasoconstriction; P:response to activity; P:response to drug; P:vasoconstriction;|A8MU46 E9PPJ3,Smoothelin-like protein 1,, PF00307;, GO:0043292;GO:0005737;GO:0031941;GO:0031674;GO:0031430;GO:0005815;GO:0005634;GO:0005516;GO:0051401;GO:0097718;GO:0008157;GO:0043621;GO:0005523;GO:0030036;GO:0048644;GO:0045892;GO:0018105;GO:0045907;GO:0014823;GO:0042493;GO:0042310;, C:contractile fiber; C:cytoplasm; C:filamentous actin; C:I band; C:M band; C:microtubule organizing center; C:nucleus;, F:calmodulin binding; F:CH domain binding; F:disordered domain specific binding; F:protein phosphatase 1 binding; F:protein self-association; F:tropomyosin binding;, P:actin cytoskeleton organization; P:muscle organ morphogenesis; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of vasoconstriction; P:response to activity; P:response to drug; P:vasoconstriction;|A8MU46 E9PPJ3,Smoothelin-like protein 1,, PF00307;, GO:0043292;GO:0005737;GO:0031941;GO:0031674;GO:0031430;GO:0005815;GO:0005634;GO:0005516;GO:0051401;GO:0097718;GO:0008157;GO:0043621;GO:0005523;GO:0030036;GO:0048644;GO:0045892;GO:0018105;GO:0045907;GO:0014823;GO:0042493;GO:0042310;, C:contractile fiber; C:cytoplasm; C:filamentous actin; C:I band; C:M band; C:microtubule organizing center; C:nucleus;, F:calmodulin binding; F:CH domain binding; F:disordered domain specific binding; F:protein phosphatase 1 binding; F:protein self-association; F:tropomyosin binding;, P:actin cytoskeleton organization; P:muscle organ morphogenesis; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of vasoconstriction; P:response to activity; P:response to drug; P:vasoconstriction; scaffold125 indexed_genome mRNA 288927 300991 . + . ID=transcript_13786;Q7Z455 Q96FE0 Q9UC49 Q9UCF9,Plasma protease C1 inhibitor,C1 esterase inhibitor;C1-inhibiting factor;Serpin G1;, PF00079;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0004867;GO:0008015;GO:0007597;GO:0006958;GO:0042730;GO:0045087;GO:2000267;GO:0001869;GO:0010951;GO:0002576;GO:0030449;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:serine-type endopeptidase inhibitor activity;, P:blood circulation; P:blood coagulation, intrinsic pathway; P:complement activation, classical pathway; P:fibrinolysis; P:innate immune response; P:negative regulation of blood coagulation, intrinsic pathway; P:negative regulation of complement activation, lectin pathway; P:negative regulation of endopeptidase activity; P:platelet degranulation; P:regulation of complement activation;|Q7Z455 Q96FE0 Q9UC49 Q9UCF9,Plasma protease C1 inhibitor,C1 esterase inhibitor;C1-inhibiting factor;Serpin G1;, PF00079;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0004867;GO:0008015;GO:0007597;GO:0006958;GO:0042730;GO:0045087;GO:2000267;GO:0001869;GO:0010951;GO:0002576;GO:0030449;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:serine-type endopeptidase inhibitor activity;, P:blood circulation; P:blood coagulation, intrinsic pathway; P:complement activation, classical pathway; P:fibrinolysis; P:innate immune response; P:negative regulation of blood coagulation, intrinsic pathway; P:negative regulation of complement activation, lectin pathway; P:negative regulation of endopeptidase activity; P:platelet degranulation; P:regulation of complement activation;|Q7Z455 Q96FE0 Q9UC49 Q9UCF9,Plasma protease C1 inhibitor,C1 esterase inhibitor;C1-inhibiting factor;Serpin G1;, PF00079;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0004867;GO:0008015;GO:0007597;GO:0006958;GO:0042730;GO:0045087;GO:2000267;GO:0001869;GO:0010951;GO:0002576;GO:0030449;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:serine-type endopeptidase inhibitor activity;, P:blood circulation; P:blood coagulation, intrinsic pathway; P:complement activation, classical pathway; P:fibrinolysis; P:innate immune response; P:negative regulation of blood coagulation, intrinsic pathway; P:negative regulation of complement activation, lectin pathway; P:negative regulation of endopeptidase activity; P:platelet degranulation; P:regulation of complement activation; scaffold125 indexed_genome mRNA 301008 301927 . + . ID=transcript_13787;Q7Z455 Q96FE0 Q9UC49 Q9UCF9,Plasma protease C1 inhibitor,C1 esterase inhibitor;C1-inhibiting factor;Serpin G1;, PF00079;, GO:0072562;GO:0062023;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0004867;GO:0008015;GO:0007597;GO:0006958;GO:0042730;GO:0045087;GO:2000267;GO:0001869;GO:0010951;GO:0002576;GO:0030449;, C:blood microparticle; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:serine-type endopeptidase inhibitor activity;, P:blood circulation; P:blood coagulation, intrinsic pathway; P:complement activation, classical pathway; P:fibrinolysis; P:innate immune response; P:negative regulation of blood coagulation, intrinsic pathway; P:negative regulation of complement activation, lectin pathway; P:negative regulation of endopeptidase activity; P:platelet degranulation; P:regulation of complement activation; scaffold125 indexed_genome mRNA 327609 333379 . + . ID=transcript_13788;Q96NS1 B3KW92 Q2M3U7 Q65Z98,Protein yippee-like 4,, PF03226;, GO:0005730;GO:0046872;, C:nucleolus;, F:metal ion binding; scaffold125 indexed_genome mRNA 337506 340940 . - . ID=transcript_13789;Q92989 B2R7J6 B4DTI8,Polyribonucleotide 5'-hydroxyl-kinase Clp1 {ECO:0000255|HAMAP-Rule:MF_03035},Polyadenylation factor Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};Polynucleotide kinase Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};Pre-mRNA cleavage complex II protein Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};, PF06807;PF16573;PF16575;, GO:0005829;GO:0005849;GO:0005654;GO:0005634;GO:0000214;GO:0005524;GO:0046404;GO:0051736;GO:0051733;GO:0051731;GO:0021695;GO:0031124;GO:0006378;GO:0000398;GO:0006396;GO:0035087;GO:0030423;GO:0006369;GO:0006388;, C:cytosol; C:mRNA cleavage factor complex; C:nucleoplasm; C:nucleus; C:tRNA-intron endonuclease complex;, F:ATP binding; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; F:ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity; F:polydeoxyribonucleotide kinase activity; F:polynucleotide 5'-hydroxyl-kinase activity;, P:cerebellar cortex development; P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:RNA processing; P:siRNA loading onto RISC involved in RNA interference; P:targeting of mRNA for destruction involved in RNA interference; P:termination of RNA polymerase II transcription; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold125 indexed_genome mRNA 362053 1259366 . + . ID=transcript_13790;Q9C0B5 Q2TGF0 Q6ZMF0 Q8TAK8 Q9H923 Q9UFI7,Palmitoyltransferase ZDHHC5,Zinc finger DHHC domain-containing protein 5;Zinc finger protein 375;, PF01529;, GO:0030425;GO:0016021;GO:0016020;GO:0045335;GO:0005886;GO:0016409;GO:0019706;GO:0062208;GO:1905171;GO:1903078;GO:0018345;, C:dendrite; C:integral component of membrane; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:positive regulation of pattern recognition receptor signaling pathway; P:positive regulation of protein localization to phagocytic vesicle; P:positive regulation of protein localization to plasma membrane; P:protein palmitoylation;|Q9C0B5 Q2TGF0 Q6ZMF0 Q8TAK8 Q9H923 Q9UFI7,Palmitoyltransferase ZDHHC5,Zinc finger DHHC domain-containing protein 5;Zinc finger protein 375;, PF01529;, GO:0030425;GO:0016021;GO:0016020;GO:0045335;GO:0005886;GO:0016409;GO:0019706;GO:0062208;GO:1905171;GO:1903078;GO:0018345;, C:dendrite; C:integral component of membrane; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:positive regulation of pattern recognition receptor signaling pathway; P:positive regulation of protein localization to phagocytic vesicle; P:positive regulation of protein localization to plasma membrane; P:protein palmitoylation;|Q9C0B5 Q2TGF0 Q6ZMF0 Q8TAK8 Q9H923 Q9UFI7,Palmitoyltransferase ZDHHC5,Zinc finger DHHC domain-containing protein 5;Zinc finger protein 375;, PF01529;, GO:0030425;GO:0016021;GO:0016020;GO:0045335;GO:0005886;GO:0016409;GO:0019706;GO:0062208;GO:1905171;GO:1903078;GO:0018345;, C:dendrite; C:integral component of membrane; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:positive regulation of pattern recognition receptor signaling pathway; P:positive regulation of protein localization to phagocytic vesicle; P:positive regulation of protein localization to plasma membrane; P:protein palmitoylation;|Q9C0B5 Q2TGF0 Q6ZMF0 Q8TAK8 Q9H923 Q9UFI7,Palmitoyltransferase ZDHHC5,Zinc finger DHHC domain-containing protein 5;Zinc finger protein 375;, PF01529;, GO:0030425;GO:0016021;GO:0016020;GO:0045335;GO:0005886;GO:0016409;GO:0019706;GO:0062208;GO:1905171;GO:1903078;GO:0018345;, C:dendrite; C:integral component of membrane; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:positive regulation of pattern recognition receptor signaling pathway; P:positive regulation of protein localization to phagocytic vesicle; P:positive regulation of protein localization to plasma membrane; P:protein palmitoylation;|Q9C0B5 Q2TGF0 Q6ZMF0 Q8TAK8 Q9H923 Q9UFI7,Palmitoyltransferase ZDHHC5,Zinc finger DHHC domain-containing protein 5;Zinc finger protein 375;, PF01529;, GO:0030425;GO:0016021;GO:0016020;GO:0045335;GO:0005886;GO:0016409;GO:0019706;GO:0062208;GO:1905171;GO:1903078;GO:0018345;, C:dendrite; C:integral component of membrane; C:membrane; C:phagocytic vesicle; C:plasma membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:positive regulation of pattern recognition receptor signaling pathway; P:positive regulation of protein localization to phagocytic vesicle; P:positive regulation of protein localization to plasma membrane; P:protein palmitoylation;|Q96JP5 A6NHC4 A8MSG7 Q86V47 Q96JP4 Q96QA3,E3 ubiquitin-protein ligase ZFP91,RING-type E3 ubiquitin transferase ZFP91;Zinc finger protein 757;Zinc finger protein 91 homolog;, PF00096;, GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0007250;GO:0070534;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:protein K63-linked ubiquitination; P:regulation of transcription by RNA polymerase II;|A0JLT2 Q8IV02 Q8IZD1,Mediator of RNA polymerase II transcription subunit 19,Lung cancer metastasis-related protein 1;Mediator complex subunit 19;, PF10278;, GO:0016592;GO:0003712;GO:0008134;GO:0045944;, C:mediator complex;, F:transcription coregulator activity; F:transcription factor binding;, P:positive regulation of transcription by RNA polymerase II;|A0JLT2 Q8IV02 Q8IZD1,Mediator of RNA polymerase II transcription subunit 19,Lung cancer metastasis-related protein 1;Mediator complex subunit 19;, PF10278;, GO:0016592;GO:0003712;GO:0008134;GO:0045944;, C:mediator complex;, F:transcription coregulator activity; F:transcription factor binding;, P:positive regulation of transcription by RNA polymerase II;|Q9Y320 B7Z4R4 Q53G73 Q561W0 Q5J7Q7 Q8NBP9 Q9H3L1,Thioredoxin-related transmembrane protein 2,Cell proliferation-inducing gene 26 protein;Thioredoxin domain-containing protein 14;, PF00085;, GO:0005789;GO:0016021;GO:0043227;GO:0044233;GO:0031966;GO:0005739;GO:0015036;GO:0042802;GO:0007420;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane-bounded organelle; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial membrane; C:mitochondrion;, F:disulfide oxidoreductase activity; F:identical protein binding;, P:brain development;|Q9Y320 B7Z4R4 Q53G73 Q561W0 Q5J7Q7 Q8NBP9 Q9H3L1,Thioredoxin-related transmembrane protein 2,Cell proliferation-inducing gene 26 protein;Thioredoxin domain-containing protein 14;, PF00085;, GO:0005789;GO:0016021;GO:0043227;GO:0044233;GO:0031966;GO:0005739;GO:0015036;GO:0042802;GO:0007420;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane-bounded organelle; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial membrane; C:mitochondrion;, F:disulfide oxidoreductase activity; F:identical protein binding;, P:brain development;|Q9Y320 B7Z4R4 Q53G73 Q561W0 Q5J7Q7 Q8NBP9 Q9H3L1,Thioredoxin-related transmembrane protein 2,Cell proliferation-inducing gene 26 protein;Thioredoxin domain-containing protein 14;, PF00085;, GO:0005789;GO:0016021;GO:0043227;GO:0044233;GO:0031966;GO:0005739;GO:0015036;GO:0042802;GO:0007420;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane-bounded organelle; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial membrane; C:mitochondrion;, F:disulfide oxidoreductase activity; F:identical protein binding;, P:brain development;|Q9UP71 Q9UP72 Q9UP73,Catenin delta-1,Cadherin-associated Src substrate;p120 catenin;p120(cas);, PF00514;, GO:0005912;GO:0016342;GO:0005911;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0030426;GO:0098686;GO:0030027;GO:0030496;GO:0005634;GO:0005886;GO:0099092;GO:0098831;GO:0098685;GO:0005915;GO:0045296;GO:0019901;GO:0005102;GO:0034332;GO:0007420;GO:0098609;GO:0044331;GO:0007043;GO:0035635;GO:0090090;GO:0050821;GO:0099072;GO:0016055;, C:adherens junction; C:catenin complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:hippocampal mossy fiber to CA3 synapse; C:lamellipodium; C:midbody; C:nucleus; C:plasma membrane; C:postsynaptic density, intracellular component; C:presynaptic active zone cytoplasmic component; C:Schaffer collateral - CA1 synapse; C:zonula adherens;, F:cadherin binding; F:protein kinase binding; F:signaling receptor binding;, P:adherens junction organization; P:brain development; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell junction assembly; P:entry of bacterium into host cell; P:negative regulation of canonical Wnt signaling pathway; P:protein stabilization; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt signaling pathway;|Q9UP71 Q9UP72 Q9UP73,Catenin delta-1,Cadherin-associated Src substrate;p120 catenin;p120(cas);, PF00514;, GO:0005912;GO:0016342;GO:0005911;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0030426;GO:0098686;GO:0030027;GO:0030496;GO:0005634;GO:0005886;GO:0099092;GO:0098831;GO:0098685;GO:0005915;GO:0045296;GO:0019901;GO:0005102;GO:0034332;GO:0007420;GO:0098609;GO:0044331;GO:0007043;GO:0035635;GO:0090090;GO:0050821;GO:0099072;GO:0016055;, C:adherens junction; C:catenin complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:hippocampal mossy fiber to CA3 synapse; C:lamellipodium; C:midbody; C:nucleus; C:plasma membrane; C:postsynaptic density, intracellular component; C:presynaptic active zone cytoplasmic component; C:Schaffer collateral - CA1 synapse; C:zonula adherens;, F:cadherin binding; F:protein kinase binding; F:signaling receptor binding;, P:adherens junction organization; P:brain development; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell junction assembly; P:entry of bacterium into host cell; P:negative regulation of canonical Wnt signaling pathway; P:protein stabilization; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt signaling pathway;|Q9UP71 Q9UP72 Q9UP73,Catenin delta-1,Cadherin-associated Src substrate;p120 catenin;p120(cas);, PF00514;, GO:0005912;GO:0016342;GO:0005911;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0030426;GO:0098686;GO:0030027;GO:0030496;GO:0005634;GO:0005886;GO:0099092;GO:0098831;GO:0098685;GO:0005915;GO:0045296;GO:0019901;GO:0005102;GO:0034332;GO:0007420;GO:0098609;GO:0044331;GO:0007043;GO:0035635;GO:0090090;GO:0050821;GO:0099072;GO:0016055;, C:adherens junction; C:catenin complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:hippocampal mossy fiber to CA3 synapse; C:lamellipodium; C:midbody; C:nucleus; C:plasma membrane; C:postsynaptic density, intracellular component; C:presynaptic active zone cytoplasmic component; C:Schaffer collateral - CA1 synapse; C:zonula adherens;, F:cadherin binding; F:protein kinase binding; F:signaling receptor binding;, P:adherens junction organization; P:brain development; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell junction assembly; P:entry of bacterium into host cell; P:negative regulation of canonical Wnt signaling pathway; P:protein stabilization; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt signaling pathway;|Q9UP71 Q9UP72 Q9UP73,Catenin delta-1,Cadherin-associated Src substrate;p120 catenin;p120(cas);, PF00514;, GO:0005912;GO:0016342;GO:0005911;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0030426;GO:0098686;GO:0030027;GO:0030496;GO:0005634;GO:0005886;GO:0099092;GO:0098831;GO:0098685;GO:0005915;GO:0045296;GO:0019901;GO:0005102;GO:0034332;GO:0007420;GO:0098609;GO:0044331;GO:0007043;GO:0035635;GO:0090090;GO:0050821;GO:0099072;GO:0016055;, C:adherens junction; C:catenin complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:hippocampal mossy fiber to CA3 synapse; C:lamellipodium; C:midbody; C:nucleus; C:plasma membrane; C:postsynaptic density, intracellular component; C:presynaptic active zone cytoplasmic component; C:Schaffer collateral - CA1 synapse; C:zonula adherens;, F:cadherin binding; F:protein kinase binding; F:signaling receptor binding;, P:adherens junction organization; P:brain development; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell junction assembly; P:entry of bacterium into host cell; P:negative regulation of canonical Wnt signaling pathway; P:protein stabilization; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt signaling pathway;|Q9UP71 Q9UP72 Q9UP73,Catenin delta-1,Cadherin-associated Src substrate;p120 catenin;p120(cas);, PF00514;, GO:0005912;GO:0016342;GO:0005911;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0030426;GO:0098686;GO:0030027;GO:0030496;GO:0005634;GO:0005886;GO:0099092;GO:0098831;GO:0098685;GO:0005915;GO:0045296;GO:0019901;GO:0005102;GO:0034332;GO:0007420;GO:0098609;GO:0044331;GO:0007043;GO:0035635;GO:0090090;GO:0050821;GO:0099072;GO:0016055;, C:adherens junction; C:catenin complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:hippocampal mossy fiber to CA3 synapse; C:lamellipodium; C:midbody; C:nucleus; C:plasma membrane; C:postsynaptic density, intracellular component; C:presynaptic active zone cytoplasmic component; C:Schaffer collateral - CA1 synapse; C:zonula adherens;, F:cadherin binding; F:protein kinase binding; F:signaling receptor binding;, P:adherens junction organization; P:brain development; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell junction assembly; P:entry of bacterium into host cell; P:negative regulation of canonical Wnt signaling pathway; P:protein stabilization; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt signaling pathway;|Q9UP71 Q9UP72 Q9UP73,Catenin delta-1,Cadherin-associated Src substrate;p120 catenin;p120(cas);, PF00514;, GO:0005912;GO:0016342;GO:0005911;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0030426;GO:0098686;GO:0030027;GO:0030496;GO:0005634;GO:0005886;GO:0099092;GO:0098831;GO:0098685;GO:0005915;GO:0045296;GO:0019901;GO:0005102;GO:0034332;GO:0007420;GO:0098609;GO:0044331;GO:0007043;GO:0035635;GO:0090090;GO:0050821;GO:0099072;GO:0016055;, C:adherens junction; C:catenin complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:hippocampal mossy fiber to CA3 synapse; C:lamellipodium; C:midbody; C:nucleus; C:plasma membrane; C:postsynaptic density, intracellular component; C:presynaptic active zone cytoplasmic component; C:Schaffer collateral - CA1 synapse; C:zonula adherens;, F:cadherin binding; F:protein kinase binding; F:signaling receptor binding;, P:adherens junction organization; P:brain development; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell junction assembly; P:entry of bacterium into host cell; P:negative regulation of canonical Wnt signaling pathway; P:protein stabilization; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt signaling pathway;|Q9UP71 Q9UP72 Q9UP73,Catenin delta-1,Cadherin-associated Src substrate;p120 catenin;p120(cas);, PF00514;, GO:0005912;GO:0016342;GO:0005911;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0030426;GO:0098686;GO:0030027;GO:0030496;GO:0005634;GO:0005886;GO:0099092;GO:0098831;GO:0098685;GO:0005915;GO:0045296;GO:0019901;GO:0005102;GO:0034332;GO:0007420;GO:0098609;GO:0044331;GO:0007043;GO:0035635;GO:0090090;GO:0050821;GO:0099072;GO:0016055;, C:adherens junction; C:catenin complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:hippocampal mossy fiber to CA3 synapse; C:lamellipodium; C:midbody; C:nucleus; C:plasma membrane; C:postsynaptic density, intracellular component; C:presynaptic active zone cytoplasmic component; C:Schaffer collateral - CA1 synapse; C:zonula adherens;, F:cadherin binding; F:protein kinase binding; F:signaling receptor binding;, P:adherens junction organization; P:brain development; P:cell-cell adhesion; P:cell-cell adhesion mediated by cadherin; P:cell-cell junction assembly; P:entry of bacterium into host cell; P:negative regulation of canonical Wnt signaling pathway; P:protein stabilization; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt signaling pathway;|O60711 B2R8B4 B4DV71 Q53FW6 Q6FI07,Leupaxin,, PF00412;, GO:0042995;GO:0005737;GO:0005829;GO:0005925;GO:0016020;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0002102;GO:0046872;GO:0003712;GO:0007155;GO:0043542;GO:0050859;GO:0007162;GO:0065003;GO:0033628;GO:0007165;GO:0034446;GO:0007179;, C:cell projection; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:podosome;, F:metal ion binding; F:transcription coregulator activity;, P:cell adhesion; P:endothelial cell migration; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of cell adhesion; P:protein-containing complex assembly; P:regulation of cell adhesion mediated by integrin; P:signal transduction; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway;|O60711 B2R8B4 B4DV71 Q53FW6 Q6FI07,Leupaxin,, PF00412;, GO:0042995;GO:0005737;GO:0005829;GO:0005925;GO:0016020;GO:0016607;GO:0005634;GO:0048471;GO:0005886;GO:0002102;GO:0046872;GO:0003712;GO:0007155;GO:0043542;GO:0050859;GO:0007162;GO:0065003;GO:0033628;GO:0007165;GO:0034446;GO:0007179;, C:cell projection; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane; C:nuclear speck; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:podosome;, F:metal ion binding; F:transcription coregulator activity;, P:cell adhesion; P:endothelial cell migration; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of cell adhesion; P:protein-containing complex assembly; P:regulation of cell adhesion mediated by integrin; P:signal transduction; P:substrate adhesion-dependent cell spreading; P:transforming growth factor beta receptor signaling pathway;|Q96JP5 A6NHC4 A8MSG7 Q86V47 Q96JP4 Q96QA3,E3 ubiquitin-protein ligase ZFP91,RING-type E3 ubiquitin transferase ZFP91;Zinc finger protein 757;Zinc finger protein 91 homolog;, PF00096;, GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0007250;GO:0070534;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:protein K63-linked ubiquitination; P:regulation of transcription by RNA polymerase II;|Q96JP5 A6NHC4 A8MSG7 Q86V47 Q96JP4 Q96QA3,E3 ubiquitin-protein ligase ZFP91,RING-type E3 ubiquitin transferase ZFP91;Zinc finger protein 757;Zinc finger protein 91 homolog;, PF00096;, GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0007250;GO:0070534;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:protein K63-linked ubiquitination; P:regulation of transcription by RNA polymerase II;|Q96JP5 A6NHC4 A8MSG7 Q86V47 Q96JP4 Q96QA3,E3 ubiquitin-protein ligase ZFP91,RING-type E3 ubiquitin transferase ZFP91;Zinc finger protein 757;Zinc finger protein 91 homolog;, PF00096;, GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0007250;GO:0070534;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:protein K63-linked ubiquitination; P:regulation of transcription by RNA polymerase II;|Q96JP5 A6NHC4 A8MSG7 Q86V47 Q96JP4 Q96QA3,E3 ubiquitin-protein ligase ZFP91,RING-type E3 ubiquitin transferase ZFP91;Zinc finger protein 757;Zinc finger protein 91 homolog;, PF00096;, GO:0005730;GO:0005654;GO:0005634;GO:0046872;GO:0004842;GO:0007250;GO:0070534;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:ubiquitin-protein transferase activity;, P:activation of NF-kappaB-inducing kinase activity; P:protein K63-linked ubiquitination; P:regulation of transcription by RNA polymerase II; scaffold125 indexed_genome mRNA 1259836 1260455 . - . ID=transcript_13791;P26441 B2RAB2,Ciliary neurotrophic factor,, PF01110;, GO:0030424;GO:0005737;GO:0005576;GO:0005615;GO:0005127;GO:0005125;GO:0008083;GO:0005138;GO:0044877;GO:0048143;GO:0070120;GO:0019221;GO:0048644;GO:0043524;GO:0046533;GO:0048666;GO:0048680;GO:0008284;GO:0010628;GO:0042531;GO:0046668;GO:0007165;, C:axon; C:cytoplasm; C:extracellular region; C:extracellular space;, F:ciliary neurotrophic factor receptor binding; F:cytokine activity; F:growth factor activity; F:interleukin-6 receptor binding; F:protein-containing complex binding;, P:astrocyte activation; P:ciliary neurotrophic factor-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:muscle organ morphogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of photoreceptor cell differentiation; P:neuron development; P:positive regulation of axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of retinal cell programmed cell death; P:signal transduction; scaffold125 indexed_genome mRNA 1261363 1262186 . + . ID=transcript_13792;P26441 B2RAB2,Ciliary neurotrophic factor,, PF01110;, GO:0030424;GO:0005737;GO:0005576;GO:0005615;GO:0005127;GO:0005125;GO:0008083;GO:0005138;GO:0044877;GO:0048143;GO:0070120;GO:0019221;GO:0048644;GO:0043524;GO:0046533;GO:0048666;GO:0048680;GO:0008284;GO:0010628;GO:0042531;GO:0046668;GO:0007165;, C:axon; C:cytoplasm; C:extracellular region; C:extracellular space;, F:ciliary neurotrophic factor receptor binding; F:cytokine activity; F:growth factor activity; F:interleukin-6 receptor binding; F:protein-containing complex binding;, P:astrocyte activation; P:ciliary neurotrophic factor-mediated signaling pathway; P:cytokine-mediated signaling pathway; P:muscle organ morphogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of photoreceptor cell differentiation; P:neuron development; P:positive regulation of axon regeneration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of retinal cell programmed cell death; P:signal transduction; scaffold125 indexed_genome mRNA 1335900 1366679 . + . ID=transcript_13793;Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process; scaffold125 indexed_genome mRNA 1372342 1373802 . - . ID=transcript_13794;Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process; scaffold125 indexed_genome mRNA 1503950 1506164 . + . ID=transcript_13795;Q6SJ93 B4E2G2 Q6P661,Serine protease FAM111B {ECO:0000305},Cancer-associated nucleoprotein {ECO:0000303|Ref.1};, , GO:0000785;GO:0005634;GO:0008233;GO:0006260;, C:chromatin; C:nucleus;, F:peptidase activity;, P:DNA replication; scaffold125 indexed_genome mRNA 1558212 1559003 . - . ID=transcript_13796;Q9Y2E6 Q0VF38,E3 ubiquitin-protein ligase DTX4,Protein deltex-4;RING finger protein 155;RING-type E3 ubiquitin transferase DTX4 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005829;GO:0005654;GO:0061630;GO:0008270;GO:0007219;GO:0016567;GO:0032479;, C:cytosol; C:nucleoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:Notch signaling pathway; P:protein ubiquitination; P:regulation of type I interferon production; scaffold125 indexed_genome mRNA 1565303 1581671 . + . ID=transcript_13797;Q9Y2E6 Q0VF38,E3 ubiquitin-protein ligase DTX4,Protein deltex-4;RING finger protein 155;RING-type E3 ubiquitin transferase DTX4 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005829;GO:0005654;GO:0061630;GO:0008270;GO:0007219;GO:0016567;GO:0032479;, C:cytosol; C:nucleoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:Notch signaling pathway; P:protein ubiquitination; P:regulation of type I interferon production;|Q9Y2E6 Q0VF38,E3 ubiquitin-protein ligase DTX4,Protein deltex-4;RING finger protein 155;RING-type E3 ubiquitin transferase DTX4 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005829;GO:0005654;GO:0061630;GO:0008270;GO:0007219;GO:0016567;GO:0032479;, C:cytosol; C:nucleoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:Notch signaling pathway; P:protein ubiquitination; P:regulation of type I interferon production; scaffold125 indexed_genome mRNA 1587023 1589669 . + . ID=transcript_13798;Q2M385 Q2M1T6 Q8TEF8,Macrophage-expressed gene 1 protein,Perforin-2 {ECO:0000303|PubMed:23753625};, PF01823;, GO:0031410;GO:0030659;GO:0005576;GO:0016021;GO:0045335;GO:0042742;GO:0050829;GO:0050830;GO:0045087;GO:0035915;, C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:extracellular region; C:integral component of membrane; C:phagocytic vesicle;, , P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:innate immune response; P:pore formation in membrane of other organism; scaffold125 indexed_genome mRNA 1931892 1938192 . - . ID=transcript_13799;P22059 Q6P524,Oxysterol-binding protein 1 {ECO:0000305},, PF01237;PF00169;, GO:0030054;GO:0005737;GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005730;GO:0005654;GO:0097038;GO:0048471;GO:0005886;GO:0005802;GO:0008142;GO:0070273;GO:0019904;GO:0032934;GO:0120015;GO:0015248;GO:0006699;GO:0032367;GO:0015918;, C:cell junction; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleoplasm; C:perinuclear endoplasmic reticulum; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:protein domain specific binding; F:sterol binding; F:sterol transfer activity; F:sterol transporter activity;, P:bile acid biosynthetic process; P:intracellular cholesterol transport; P:sterol transport;|P22059 Q6P524,Oxysterol-binding protein 1 {ECO:0000305},, PF01237;PF00169;, GO:0030054;GO:0005737;GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0043231;GO:0016020;GO:0005730;GO:0005654;GO:0097038;GO:0048471;GO:0005886;GO:0005802;GO:0008142;GO:0070273;GO:0019904;GO:0032934;GO:0120015;GO:0015248;GO:0006699;GO:0032367;GO:0015918;, C:cell junction; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:nucleoplasm; C:perinuclear endoplasmic reticulum; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network;, F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:protein domain specific binding; F:sterol binding; F:sterol transfer activity; F:sterol transporter activity;, P:bile acid biosynthetic process; P:intracellular cholesterol transport; P:sterol transport; scaffold125 indexed_genome mRNA 1991308 2018622 . - . ID=transcript_13800;Q86TB9 B3KXT9 Q2TA86 Q6P166 Q8N9M6 Q8NI63,Protein PAT1 homolog 1,PAT1-like protein 1;Protein PAT1 homolog b;, PF09770;, GO:0036464;GO:0005829;GO:0016607;GO:0000932;GO:0016605;GO:0034046;GO:0008266;GO:0003723;GO:0000290;GO:0043928;GO:0033962;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:P-body; C:PML body;, F:poly(G) binding; F:poly(U) RNA binding; F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:P-body assembly;|Q86TB9 B3KXT9 Q2TA86 Q6P166 Q8N9M6 Q8NI63,Protein PAT1 homolog 1,PAT1-like protein 1;Protein PAT1 homolog b;, PF09770;, GO:0036464;GO:0005829;GO:0016607;GO:0000932;GO:0016605;GO:0034046;GO:0008266;GO:0003723;GO:0000290;GO:0043928;GO:0033962;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:P-body; C:PML body;, F:poly(G) binding; F:poly(U) RNA binding; F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:P-body assembly;|Q86TB9 B3KXT9 Q2TA86 Q6P166 Q8N9M6 Q8NI63,Protein PAT1 homolog 1,PAT1-like protein 1;Protein PAT1 homolog b;, PF09770;, GO:0036464;GO:0005829;GO:0016607;GO:0000932;GO:0016605;GO:0034046;GO:0008266;GO:0003723;GO:0000290;GO:0043928;GO:0033962;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:P-body; C:PML body;, F:poly(G) binding; F:poly(U) RNA binding; F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:P-body assembly;|Q86TB9 B3KXT9 Q2TA86 Q6P166 Q8N9M6 Q8NI63,Protein PAT1 homolog 1,PAT1-like protein 1;Protein PAT1 homolog b;, PF09770;, GO:0036464;GO:0005829;GO:0016607;GO:0000932;GO:0016605;GO:0034046;GO:0008266;GO:0003723;GO:0000290;GO:0043928;GO:0033962;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:P-body; C:PML body;, F:poly(G) binding; F:poly(U) RNA binding; F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:P-body assembly;|Q86TB9 B3KXT9 Q2TA86 Q6P166 Q8N9M6 Q8NI63,Protein PAT1 homolog 1,PAT1-like protein 1;Protein PAT1 homolog b;, PF09770;, GO:0036464;GO:0005829;GO:0016607;GO:0000932;GO:0016605;GO:0034046;GO:0008266;GO:0003723;GO:0000290;GO:0043928;GO:0033962;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:P-body; C:PML body;, F:poly(G) binding; F:poly(U) RNA binding; F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:exonucleolytic catabolism of deadenylated mRNA; P:P-body assembly; scaffold125 indexed_genome mRNA 2127550 2152651 . + . ID=transcript_13801;Q13277 B4DME0 O43750 O43751 Q15360,Syntaxin-3,, PF05739;PF00804;, GO:0016324;GO:0042582;GO:0005911;GO:0030425;GO:0012505;GO:0070062;GO:0098978;GO:0030426;GO:0016021;GO:0030027;GO:0042470;GO:0043005;GO:0005886;GO:0098794;GO:0048787;GO:0098685;GO:0031201;GO:0042581;GO:0008021;GO:0005773;GO:0042589;GO:0050544;GO:0005484;GO:0000149;GO:0019221;GO:0098967;GO:0006887;GO:0006886;GO:0060291;GO:0031175;GO:0045785;GO:0008284;GO:0050921;GO:2000010;GO:1903078;GO:0016081;GO:0031629;GO:0048278;GO:0006906;, C:apical plasma membrane; C:azurophil granule; C:cell-cell junction; C:dendrite; C:endomembrane system; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of membrane; C:lamellipodium; C:melanosome; C:neuron projection; C:plasma membrane; C:postsynapse; C:presynaptic active zone membrane; C:Schaffer collateral - CA1 synapse; C:SNARE complex; C:specific granule; C:synaptic vesicle; C:vacuole; C:zymogen granule membrane;, F:arachidonic acid binding; F:SNAP receptor activity; F:SNARE binding;, P:cytokine-mediated signaling pathway; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:intracellular protein transport; P:long-term synaptic potentiation; P:neuron projection development; P:positive regulation of cell adhesion; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to plasma membrane; P:synaptic vesicle docking; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle fusion;|Q13277 B4DME0 O43750 O43751 Q15360,Syntaxin-3,, PF05739;PF00804;, GO:0016324;GO:0042582;GO:0005911;GO:0030425;GO:0012505;GO:0070062;GO:0098978;GO:0030426;GO:0016021;GO:0030027;GO:0042470;GO:0043005;GO:0005886;GO:0098794;GO:0048787;GO:0098685;GO:0031201;GO:0042581;GO:0008021;GO:0005773;GO:0042589;GO:0050544;GO:0005484;GO:0000149;GO:0019221;GO:0098967;GO:0006887;GO:0006886;GO:0060291;GO:0031175;GO:0045785;GO:0008284;GO:0050921;GO:2000010;GO:1903078;GO:0016081;GO:0031629;GO:0048278;GO:0006906;, C:apical plasma membrane; C:azurophil granule; C:cell-cell junction; C:dendrite; C:endomembrane system; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of membrane; C:lamellipodium; C:melanosome; C:neuron projection; C:plasma membrane; C:postsynapse; C:presynaptic active zone membrane; C:Schaffer collateral - CA1 synapse; C:SNARE complex; C:specific granule; C:synaptic vesicle; C:vacuole; C:zymogen granule membrane;, F:arachidonic acid binding; F:SNAP receptor activity; F:SNARE binding;, P:cytokine-mediated signaling pathway; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; P:exocytosis; P:intracellular protein transport; P:long-term synaptic potentiation; P:neuron projection development; P:positive regulation of cell adhesion; P:positive regulation of cell population proliferation; P:positive regulation of chemotaxis; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to plasma membrane; P:synaptic vesicle docking; P:synaptic vesicle fusion to presynaptic active zone membrane; P:vesicle docking; P:vesicle fusion; scaffold125 indexed_genome mRNA 2156058 2156568 . + . ID=transcript_13802;Q9NX20 Q9BYD0 Q9HB70,39S ribosomal protein L16, mitochondrial,Mitochondrial large ribosomal subunit protein uL16m {ECO:0000303|PubMed:25278503};, PF00252;, GO:0005743;GO:0005762;GO:0005739;GO:0019843;GO:0003735;GO:0032543;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold125 indexed_genome mRNA 2170184 2176921 . - . ID=transcript_13803;P27352 B2RAN8 B4DVZ1,Cobalamin binding intrinsic factor {ECO:0000305},Gastric intrinsic factor {ECO:0000303|PubMed:2071148};Intrinsic factor;, PF01122;PF14478;, GO:0016324;GO:0005768;GO:0005576;GO:0005615;GO:0043202;GO:0005902;GO:0031419;GO:0009235;GO:0015889;GO:0006824;, C:apical plasma membrane; C:endosome; C:extracellular region; C:extracellular space; C:lysosomal lumen; C:microvillus;, F:cobalamin binding;, P:cobalamin metabolic process; P:cobalamin transport; P:cobalt ion transport; scaffold125 indexed_genome mRNA 2446947 2453286 . + . ID=transcript_13804;P11836 A6NMS4 B4DT24 P08984 Q13963,B-lymphocyte antigen CD20,B-lymphocyte surface antigen B1;Bp35;Leukocyte surface antigen Leu-16;Membrane-spanning 4-domains subfamily A member 1;, PF04103;, GO:0009986;GO:0009897;GO:0070062;GO:0005615;GO:0005887;GO:0005654;GO:0005886;GO:0044853;GO:0005154;GO:0042802;GO:0019865;GO:0023026;GO:0042113;GO:0030183;GO:0042100;GO:0050853;GO:1902656;GO:0006959;GO:0051262;GO:0009617;GO:0002115;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:plasma membrane raft;, F:epidermal growth factor receptor binding; F:identical protein binding; F:immunoglobulin binding; F:MHC class II protein complex binding;, P:B cell activation; P:B cell differentiation; P:B cell proliferation; P:B cell receptor signaling pathway; P:calcium ion import into cytosol; P:humoral immune response; P:protein tetramerization; P:response to bacterium; P:store-operated calcium entry; scaffold125 indexed_genome mRNA 2636900 2690204 . - . ID=transcript_13805;P42695 A6NFS2 Q4KMQ9,Condensin-2 complex subunit D3,Non-SMC condensin II complex subunit D3;, PF12717;, GO:0000779;GO:0000796;GO:0016020;GO:0005654;GO:0005721;GO:0003682;GO:0042393;GO:0035064;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome, centromeric region; C:condensin complex; C:membrane; C:nucleoplasm; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:methylated histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|P42695 A6NFS2 Q4KMQ9,Condensin-2 complex subunit D3,Non-SMC condensin II complex subunit D3;, PF12717;, GO:0000779;GO:0000796;GO:0016020;GO:0005654;GO:0005721;GO:0003682;GO:0042393;GO:0035064;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome, centromeric region; C:condensin complex; C:membrane; C:nucleoplasm; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:methylated histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|P42695 A6NFS2 Q4KMQ9,Condensin-2 complex subunit D3,Non-SMC condensin II complex subunit D3;, PF12717;, GO:0000779;GO:0000796;GO:0016020;GO:0005654;GO:0005721;GO:0003682;GO:0042393;GO:0035064;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome, centromeric region; C:condensin complex; C:membrane; C:nucleoplasm; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:methylated histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|P42695 A6NFS2 Q4KMQ9,Condensin-2 complex subunit D3,Non-SMC condensin II complex subunit D3;, PF12717;, GO:0000779;GO:0000796;GO:0016020;GO:0005654;GO:0005721;GO:0003682;GO:0042393;GO:0035064;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome, centromeric region; C:condensin complex; C:membrane; C:nucleoplasm; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:methylated histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|P42695 A6NFS2 Q4KMQ9,Condensin-2 complex subunit D3,Non-SMC condensin II complex subunit D3;, PF12717;, GO:0000779;GO:0000796;GO:0016020;GO:0005654;GO:0005721;GO:0003682;GO:0042393;GO:0035064;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome, centromeric region; C:condensin complex; C:membrane; C:nucleoplasm; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:methylated histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|P42695 A6NFS2 Q4KMQ9,Condensin-2 complex subunit D3,Non-SMC condensin II complex subunit D3;, PF12717;, GO:0000779;GO:0000796;GO:0016020;GO:0005654;GO:0005721;GO:0003682;GO:0042393;GO:0035064;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome, centromeric region; C:condensin complex; C:membrane; C:nucleoplasm; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:methylated histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|P42695 A6NFS2 Q4KMQ9,Condensin-2 complex subunit D3,Non-SMC condensin II complex subunit D3;, PF12717;, GO:0000779;GO:0000796;GO:0016020;GO:0005654;GO:0005721;GO:0003682;GO:0042393;GO:0035064;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome, centromeric region; C:condensin complex; C:membrane; C:nucleoplasm; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:methylated histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation;|P42695 A6NFS2 Q4KMQ9,Condensin-2 complex subunit D3,Non-SMC condensin II complex subunit D3;, PF12717;, GO:0000779;GO:0000796;GO:0016020;GO:0005654;GO:0005721;GO:0003682;GO:0042393;GO:0035064;GO:0051301;GO:0010032;GO:0007076;, C:condensed chromosome, centromeric region; C:condensin complex; C:membrane; C:nucleoplasm; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:methylated histone binding;, P:cell division; P:meiotic chromosome condensation; P:mitotic chromosome condensation; scaffold125 indexed_genome mRNA 2690600 2709178 . + . ID=transcript_13806;Q4G0F5 Q96A55,Vacuolar protein sorting-associated protein 26B,Vesicle protein sorting 26B;, PF03643;, GO:0005829;GO:0005769;GO:0005768;GO:0005770;GO:0045335;GO:0030904;GO:0030906;GO:0071346;GO:0006886;GO:0016241;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:late endosome; C:phagocytic vesicle; C:retromer complex; C:retromer, cargo-selective complex;, , P:cellular response to interferon-gamma; P:intracellular protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi;|Q4G0F5 Q96A55,Vacuolar protein sorting-associated protein 26B,Vesicle protein sorting 26B;, PF03643;, GO:0005829;GO:0005769;GO:0005768;GO:0005770;GO:0045335;GO:0030904;GO:0030906;GO:0071346;GO:0006886;GO:0016241;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:late endosome; C:phagocytic vesicle; C:retromer complex; C:retromer, cargo-selective complex;, , P:cellular response to interferon-gamma; P:intracellular protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi;|Q4G0F5 Q96A55,Vacuolar protein sorting-associated protein 26B,Vesicle protein sorting 26B;, PF03643;, GO:0005829;GO:0005769;GO:0005768;GO:0005770;GO:0045335;GO:0030904;GO:0030906;GO:0071346;GO:0006886;GO:0016241;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:late endosome; C:phagocytic vesicle; C:retromer complex; C:retromer, cargo-selective complex;, , P:cellular response to interferon-gamma; P:intracellular protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi;|Q4G0F5 Q96A55,Vacuolar protein sorting-associated protein 26B,Vesicle protein sorting 26B;, PF03643;, GO:0005829;GO:0005769;GO:0005768;GO:0005770;GO:0045335;GO:0030904;GO:0030906;GO:0071346;GO:0006886;GO:0016241;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:late endosome; C:phagocytic vesicle; C:retromer complex; C:retromer, cargo-selective complex;, , P:cellular response to interferon-gamma; P:intracellular protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi;|Q4G0F5 Q96A55,Vacuolar protein sorting-associated protein 26B,Vesicle protein sorting 26B;, PF03643;, GO:0005829;GO:0005769;GO:0005768;GO:0005770;GO:0045335;GO:0030904;GO:0030906;GO:0071346;GO:0006886;GO:0016241;GO:0042147;, C:cytosol; C:early endosome; C:endosome; C:late endosome; C:phagocytic vesicle; C:retromer complex; C:retromer, cargo-selective complex;, , P:cellular response to interferon-gamma; P:intracellular protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi; scaffold125 indexed_genome mRNA 2709541 2712669 . + . ID=transcript_13807;Q9P016 Q567Q2 Q9H3L4 Q9HC20,Thymocyte nuclear protein 1,Thymocyte protein Thy28;, PF01878;, GO:0005634;, C:nucleus;|Q9P016 Q567Q2 Q9H3L4 Q9HC20,Thymocyte nuclear protein 1,Thymocyte protein Thy28;, PF01878;, GO:0005634;, C:nucleus;|Q9P016 Q567Q2 Q9H3L4 Q9HC20,Thymocyte nuclear protein 1,Thymocyte protein Thy28;, PF01878;, GO:0005634;, C:nucleus; scaffold125 indexed_genome mRNA 2717015 2728766 . + . ID=transcript_13808;Q9UKU7 B7Z5W4 Q6ZWP6 Q9BUS8,Isobutyryl-CoA dehydrogenase, mitochondrial,Activator-recruited cofactor 42 kDa component;Acyl-CoA dehydrogenase family member 8;, PF00441;PF02770;PF02771;, GO:0005759;GO:0003995;GO:0050660;GO:0009083;GO:0006629;GO:0006574;, C:mitochondrial matrix;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding;, P:branched-chain amino acid catabolic process; P:lipid metabolic process; P:valine catabolic process;|Q9UKU7 B7Z5W4 Q6ZWP6 Q9BUS8,Isobutyryl-CoA dehydrogenase, mitochondrial,Activator-recruited cofactor 42 kDa component;Acyl-CoA dehydrogenase family member 8;, PF00441;PF02770;PF02771;, GO:0005759;GO:0003995;GO:0050660;GO:0009083;GO:0006629;GO:0006574;, C:mitochondrial matrix;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding;, P:branched-chain amino acid catabolic process; P:lipid metabolic process; P:valine catabolic process;|Q9UKU7 B7Z5W4 Q6ZWP6 Q9BUS8,Isobutyryl-CoA dehydrogenase, mitochondrial,Activator-recruited cofactor 42 kDa component;Acyl-CoA dehydrogenase family member 8;, PF00441;PF02770;PF02771;, GO:0005759;GO:0003995;GO:0050660;GO:0009083;GO:0006629;GO:0006574;, C:mitochondrial matrix;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding;, P:branched-chain amino acid catabolic process; P:lipid metabolic process; P:valine catabolic process;|Q9UKU7 B7Z5W4 Q6ZWP6 Q9BUS8,Isobutyryl-CoA dehydrogenase, mitochondrial,Activator-recruited cofactor 42 kDa component;Acyl-CoA dehydrogenase family member 8;, PF00441;PF02770;PF02771;, GO:0005759;GO:0003995;GO:0050660;GO:0009083;GO:0006629;GO:0006574;, C:mitochondrial matrix;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding;, P:branched-chain amino acid catabolic process; P:lipid metabolic process; P:valine catabolic process;|Q9UKU7 B7Z5W4 Q6ZWP6 Q9BUS8,Isobutyryl-CoA dehydrogenase, mitochondrial,Activator-recruited cofactor 42 kDa component;Acyl-CoA dehydrogenase family member 8;, PF00441;PF02770;PF02771;, GO:0005759;GO:0003995;GO:0050660;GO:0009083;GO:0006629;GO:0006574;, C:mitochondrial matrix;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding;, P:branched-chain amino acid catabolic process; P:lipid metabolic process; P:valine catabolic process;|Q9UKU7 B7Z5W4 Q6ZWP6 Q9BUS8,Isobutyryl-CoA dehydrogenase, mitochondrial,Activator-recruited cofactor 42 kDa component;Acyl-CoA dehydrogenase family member 8;, PF00441;PF02770;PF02771;, GO:0005759;GO:0003995;GO:0050660;GO:0009083;GO:0006629;GO:0006574;, C:mitochondrial matrix;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding;, P:branched-chain amino acid catabolic process; P:lipid metabolic process; P:valine catabolic process;|Q9UKU7 B7Z5W4 Q6ZWP6 Q9BUS8,Isobutyryl-CoA dehydrogenase, mitochondrial,Activator-recruited cofactor 42 kDa component;Acyl-CoA dehydrogenase family member 8;, PF00441;PF02770;PF02771;, GO:0005759;GO:0003995;GO:0050660;GO:0009083;GO:0006629;GO:0006574;, C:mitochondrial matrix;, F:acyl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding;, P:branched-chain amino acid catabolic process; P:lipid metabolic process; P:valine catabolic process; scaffold125 indexed_genome mRNA 2810977 2816150 . + . ID=transcript_13809;Q8NCI6 A6NEM0 A6NN15 Q6P3S3 Q96FF8,Beta-galactosidase-1-like protein 3,, PF01301;, GO:0005773;GO:0004565;GO:0005975;, C:vacuole;, F:beta-galactosidase activity;, P:carbohydrate metabolic process; scaffold126 indexed_genome mRNA 178 8543 . - . ID=transcript_13810;Q8N135 B2RN53 B9EGS7 Q5M8T1,Leucine-rich repeat LGI family member 4,LGI1-like protein 3;Leucine-rich glioma-inactivated protein 4;, PF03736;PF13855;, GO:0005576;GO:0005615;GO:0008344;GO:0014009;GO:0022011;GO:0042551;GO:0031641;, C:extracellular region; C:extracellular space;, , P:adult locomotory behavior; P:glial cell proliferation; P:myelination in peripheral nervous system; P:neuron maturation; P:regulation of myelination;|Q8N135 B2RN53 B9EGS7 Q5M8T1,Leucine-rich repeat LGI family member 4,LGI1-like protein 3;Leucine-rich glioma-inactivated protein 4;, PF03736;PF13855;, GO:0005576;GO:0005615;GO:0008344;GO:0014009;GO:0022011;GO:0042551;GO:0031641;, C:extracellular region; C:extracellular space;, , P:adult locomotory behavior; P:glial cell proliferation; P:myelination in peripheral nervous system; P:neuron maturation; P:regulation of myelination; scaffold126 indexed_genome mRNA 9169 10967 . - . ID=transcript_13811;Q14802 A6NDE0 C9JDU2 F5H174 F8WB34 Q13211 Q6IB59,FXYD domain-containing ion transport regulator 3,Chloride conductance inducer protein Mat-8;Mammary tumor 8 kDa protein;Phospholemman-like;Sodium/potassium-transporting ATPase subunit FXYD3 {ECO:0000305};, PF02038;, GO:0070062;GO:0005887;GO:0005886;GO:0005254;GO:0099106;GO:0017080;GO:0006821;GO:0034220;GO:0006813;GO:1903779;GO:2000649;GO:0006814;, C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:chloride channel activity; F:ion channel regulator activity; F:sodium channel regulator activity;, P:chloride transport; P:ion transmembrane transport; P:potassium ion transport; P:regulation of cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:sodium ion transport; scaffold126 indexed_genome mRNA 65187 78071 . - . ID=transcript_13812;P05981 B2RDS4,Serine protease hepsin,Transmembrane protease serine 1;, PF09272;PF00089;, GO:0016324;GO:0009986;GO:0005911;GO:0005789;GO:0070062;GO:0016021;GO:0005887;GO:0043025;GO:0005886;GO:0008233;GO:0004252;GO:0070008;GO:0008236;GO:0034769;GO:0090103;GO:0050910;GO:0048012;GO:0043066;GO:0050680;GO:0010719;GO:0097195;GO:0043923;GO:0030307;GO:0010628;GO:2000347;GO:0010756;GO:2000611;GO:0071805;GO:0006508;GO:0008360;GO:0097066;, C:apical plasma membrane; C:cell surface; C:cell-cell junction; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane;, F:peptidase activity; F:serine-type endopeptidase activity; F:serine-type exopeptidase activity; F:serine-type peptidase activity;, P:basement membrane disassembly; P:cochlea morphogenesis; P:detection of mechanical stimulus involved in sensory perception of sound; P:hepatocyte growth factor receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:pilomotor reflex; P:positive regulation by host of viral transcription; P:positive regulation of cell growth; P:positive regulation of gene expression; P:positive regulation of hepatocyte proliferation; P:positive regulation of plasminogen activation; P:positive regulation of thyroid hormone generation; P:potassium ion transmembrane transport; P:proteolysis; P:regulation of cell shape; P:response to thyroid hormone; scaffold126 indexed_genome mRNA 79109 87320 . - . ID=transcript_13813;Q07699 Q5TZZ4 Q6TN97,Sodium channel subunit beta-1,, PF07686;, GO:0005576;GO:0005887;GO:0014704;GO:0033268;GO:0043204;GO:0005886;GO:0030315;GO:0001518;GO:0044325;GO:0019871;GO:0017080;GO:0005244;GO:0005248;GO:0086006;GO:0086062;GO:0007411;GO:0061337;GO:0086002;GO:0060048;GO:0007155;GO:0021966;GO:0040011;GO:0051899;GO:0086012;GO:0086047;GO:0019227;GO:0010976;GO:0010765;GO:0060371;GO:0086091;GO:2000649;GO:0060307;GO:1905150;GO:0046684;GO:0035725;, C:extracellular region; C:integral component of plasma membrane; C:intercalated disc; C:node of Ranvier; C:perikaryon; C:plasma membrane; C:T-tubule; C:voltage-gated sodium channel complex;, F:ion channel binding; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; F:voltage-gated sodium channel activity involved in Purkinje myocyte action potential;, P:axon guidance; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:cell adhesion; P:corticospinal neuron axon guidance; P:locomotion; P:membrane depolarization; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:neuronal action potential propagation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transport; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:regulation of voltage-gated sodium channel activity; P:response to pyrethroid; P:sodium ion transmembrane transport;|Q07699 Q5TZZ4 Q6TN97,Sodium channel subunit beta-1,, PF07686;, GO:0005576;GO:0005887;GO:0014704;GO:0033268;GO:0043204;GO:0005886;GO:0030315;GO:0001518;GO:0044325;GO:0019871;GO:0017080;GO:0005244;GO:0005248;GO:0086006;GO:0086062;GO:0007411;GO:0061337;GO:0086002;GO:0060048;GO:0007155;GO:0021966;GO:0040011;GO:0051899;GO:0086012;GO:0086047;GO:0019227;GO:0010976;GO:0010765;GO:0060371;GO:0086091;GO:2000649;GO:0060307;GO:1905150;GO:0046684;GO:0035725;, C:extracellular region; C:integral component of plasma membrane; C:intercalated disc; C:node of Ranvier; C:perikaryon; C:plasma membrane; C:T-tubule; C:voltage-gated sodium channel complex;, F:ion channel binding; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; F:voltage-gated sodium channel activity involved in Purkinje myocyte action potential;, P:axon guidance; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:cell adhesion; P:corticospinal neuron axon guidance; P:locomotion; P:membrane depolarization; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:neuronal action potential propagation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transport; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:regulation of voltage-gated sodium channel activity; P:response to pyrethroid; P:sodium ion transmembrane transport;|Q07699 Q5TZZ4 Q6TN97,Sodium channel subunit beta-1,, PF07686;, GO:0005576;GO:0005887;GO:0014704;GO:0033268;GO:0043204;GO:0005886;GO:0030315;GO:0001518;GO:0044325;GO:0019871;GO:0017080;GO:0005244;GO:0005248;GO:0086006;GO:0086062;GO:0007411;GO:0061337;GO:0086002;GO:0060048;GO:0007155;GO:0021966;GO:0040011;GO:0051899;GO:0086012;GO:0086047;GO:0019227;GO:0010976;GO:0010765;GO:0060371;GO:0086091;GO:2000649;GO:0060307;GO:1905150;GO:0046684;GO:0035725;, C:extracellular region; C:integral component of plasma membrane; C:intercalated disc; C:node of Ranvier; C:perikaryon; C:plasma membrane; C:T-tubule; C:voltage-gated sodium channel complex;, F:ion channel binding; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; F:voltage-gated sodium channel activity involved in Purkinje myocyte action potential;, P:axon guidance; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:cell adhesion; P:corticospinal neuron axon guidance; P:locomotion; P:membrane depolarization; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:neuronal action potential propagation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transport; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:regulation of voltage-gated sodium channel activity; P:response to pyrethroid; P:sodium ion transmembrane transport;|Q07699 Q5TZZ4 Q6TN97,Sodium channel subunit beta-1,, PF07686;, GO:0005576;GO:0005887;GO:0014704;GO:0033268;GO:0043204;GO:0005886;GO:0030315;GO:0001518;GO:0044325;GO:0019871;GO:0017080;GO:0005244;GO:0005248;GO:0086006;GO:0086062;GO:0007411;GO:0061337;GO:0086002;GO:0060048;GO:0007155;GO:0021966;GO:0040011;GO:0051899;GO:0086012;GO:0086047;GO:0019227;GO:0010976;GO:0010765;GO:0060371;GO:0086091;GO:2000649;GO:0060307;GO:1905150;GO:0046684;GO:0035725;, C:extracellular region; C:integral component of plasma membrane; C:intercalated disc; C:node of Ranvier; C:perikaryon; C:plasma membrane; C:T-tubule; C:voltage-gated sodium channel complex;, F:ion channel binding; F:sodium channel inhibitor activity; F:sodium channel regulator activity; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; F:voltage-gated sodium channel activity involved in Purkinje myocyte action potential;, P:axon guidance; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:cell adhesion; P:corticospinal neuron axon guidance; P:locomotion; P:membrane depolarization; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:neuronal action potential propagation; P:positive regulation of neuron projection development; P:positive regulation of sodium ion transport; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:regulation of voltage-gated sodium channel activity; P:response to pyrethroid; P:sodium ion transmembrane transport; scaffold126 indexed_genome mRNA 94661 110429 . - . ID=transcript_13814;Q96CP6 A6NKY7 Q8NC77 Q9P1Z5,Protein Aster-A {ECO:0000250|UniProtKB:Q8VEF1},GRAM domain-containing protein 1A {ECO:0000305};, PF02893;PF16016;, GO:0005776;GO:0031410;GO:0005829;GO:0140268;GO:0031234;GO:0016021;GO:0031227;GO:0044232;GO:0005886;GO:0015485;GO:0120020;GO:0006914;GO:0071397;, C:autophagosome; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:autophagy; P:cellular response to cholesterol;|Q96CP6 A6NKY7 Q8NC77 Q9P1Z5,Protein Aster-A {ECO:0000250|UniProtKB:Q8VEF1},GRAM domain-containing protein 1A {ECO:0000305};, PF02893;PF16016;, GO:0005776;GO:0031410;GO:0005829;GO:0140268;GO:0031234;GO:0016021;GO:0031227;GO:0044232;GO:0005886;GO:0015485;GO:0120020;GO:0006914;GO:0071397;, C:autophagosome; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:autophagy; P:cellular response to cholesterol;|Q96CP6 A6NKY7 Q8NC77 Q9P1Z5,Protein Aster-A {ECO:0000250|UniProtKB:Q8VEF1},GRAM domain-containing protein 1A {ECO:0000305};, PF02893;PF16016;, GO:0005776;GO:0031410;GO:0005829;GO:0140268;GO:0031234;GO:0016021;GO:0031227;GO:0044232;GO:0005886;GO:0015485;GO:0120020;GO:0006914;GO:0071397;, C:autophagosome; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum-plasma membrane contact site; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of membrane; C:intrinsic component of endoplasmic reticulum membrane; C:organelle membrane contact site; C:plasma membrane;, F:cholesterol binding; F:cholesterol transfer activity;, P:autophagy; P:cellular response to cholesterol; scaffold126 indexed_genome mRNA 160879 193428 . + . ID=transcript_13815;Q3KQV3 B4E333 Q495L1 Q495L3 Q8N932,Zinc finger protein 792,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q3KQV3 B4E333 Q495L1 Q495L3 Q8N932,Zinc finger protein 792,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8TAQ5 B2RDY6 Q96ML5,Zinc finger protein 420,, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0042981;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of apoptotic process; P:regulation of transcription by RNA polymerase II;|A8CG34 A0A075B7F8 A0A087WY75 O75115 Q9Y2N3 Q9Y4S7,Nuclear envelope pore membrane protein POM 121C,Nuclear pore membrane protein 121-2;Pore membrane protein of 121 kDa C;, , GO:0005789;GO:0043657;GO:0016021;GO:0005635;GO:0031965;GO:0005643;GO:0008139;GO:0017056;GO:0075733;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006405;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:endoplasmic reticulum membrane; C:host cell; C:integral component of membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore;, F:nuclear localization sequence binding; F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:RNA export from nucleus; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold126 indexed_genome mRNA 207084 207596 . + . ID=transcript_13816;Q8WUA4 D6W557 Q16632 Q9BWI7,General transcription factor 3C polypeptide 2,TF3C-beta;Transcription factor IIIC 110 kDa subunit;Transcription factor IIIC subunit beta;, PF00400;, GO:0005654;GO:0000127;GO:0042791;GO:0006383;GO:0042797;, C:nucleoplasm; C:transcription factor TFIIIC complex;, , P:5S class rRNA transcription by RNA polymerase III; P:transcription by RNA polymerase III; P:tRNA transcription by RNA polymerase III; scaffold126 indexed_genome mRNA 308209 322490 . + . ID=transcript_13817;Q96NL3 Q569K0 Q5PRG1,Zinc finger protein 599,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold126 indexed_genome mRNA 336864 347715 . + . ID=transcript_13818;Q2M3W8 B7ZKX3 Q49A75,Zinc finger protein 181,HHZ181;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q2M3W8 B7ZKX3 Q49A75,Zinc finger protein 181,HHZ181;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q2M3W8 B7ZKX3 Q49A75,Zinc finger protein 181,HHZ181;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold126 indexed_genome mRNA 888599 908401 . - . ID=transcript_13819;A6NIX2,Wilms tumor protein 1-interacting protein,, PF00412;, GO:0005912;GO:0005634;GO:0000932;GO:0005667;GO:0046872;GO:0003714;GO:0030030;GO:0007010;GO:0035195;GO:0035331;GO:2000637;GO:0022604;GO:0006355;GO:0001666;, C:adherens junction; C:nucleus; C:P-body; C:transcription regulator complex;, F:metal ion binding; F:transcription corepressor activity;, P:cell projection organization; P:cytoskeleton organization; P:gene silencing by miRNA; P:negative regulation of hippo signaling; P:positive regulation of gene silencing by miRNA; P:regulation of cell morphogenesis; P:regulation of transcription, DNA-templated; P:response to hypoxia;|A6NIX2,Wilms tumor protein 1-interacting protein,, PF00412;, GO:0005912;GO:0005634;GO:0000932;GO:0005667;GO:0046872;GO:0003714;GO:0030030;GO:0007010;GO:0035195;GO:0035331;GO:2000637;GO:0022604;GO:0006355;GO:0001666;, C:adherens junction; C:nucleus; C:P-body; C:transcription regulator complex;, F:metal ion binding; F:transcription corepressor activity;, P:cell projection organization; P:cytoskeleton organization; P:gene silencing by miRNA; P:negative regulation of hippo signaling; P:positive regulation of gene silencing by miRNA; P:regulation of cell morphogenesis; P:regulation of transcription, DNA-templated; P:response to hypoxia;|A6NIX2,Wilms tumor protein 1-interacting protein,, PF00412;, GO:0005912;GO:0005634;GO:0000932;GO:0005667;GO:0046872;GO:0003714;GO:0030030;GO:0007010;GO:0035195;GO:0035331;GO:2000637;GO:0022604;GO:0006355;GO:0001666;, C:adherens junction; C:nucleus; C:P-body; C:transcription regulator complex;, F:metal ion binding; F:transcription corepressor activity;, P:cell projection organization; P:cytoskeleton organization; P:gene silencing by miRNA; P:negative regulation of hippo signaling; P:positive regulation of gene silencing by miRNA; P:regulation of cell morphogenesis; P:regulation of transcription, DNA-templated; P:response to hypoxia; scaffold126 indexed_genome mRNA 923257 949638 . - . ID=transcript_13820;Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation;|Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation;|Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation;|Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation;|Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation;|Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation;|Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation;|Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation; scaffold126 indexed_genome mRNA 949684 951103 . + . ID=transcript_13821;Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation; scaffold126 indexed_genome mRNA 951152 951999 . + . ID=transcript_13822;Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation; scaffold126 indexed_genome mRNA 952602 954996 . - . ID=transcript_13823;Q9UBT2 B3KWB9 O95605 Q59H87 Q6IBP6 Q9NTJ1 Q9UED2,SUMO-activating enzyme subunit 2,Anthracycline-associated resistance ARX;Ubiquitin-like 1-activating enzyme E1B;Ubiquitin-like modifier-activating enzyme 2;, PF00899;PF14732;PF16195;, GO:0005737;GO:0005654;GO:0031510;GO:0005524;GO:0000287;GO:0046982;GO:0044388;GO:0019948;GO:0032183;GO:0008134;GO:0016740;GO:0044390;GO:0033235;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:SUMO activating enzyme complex;, F:ATP binding; F:magnesium ion binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:SUMO activating enzyme activity; F:SUMO binding; F:transcription factor binding; F:transferase activity; F:ubiquitin-like protein conjugating enzyme binding;, P:positive regulation of protein sumoylation; P:protein modification by small protein conjugation; P:protein sumoylation; scaffold126 indexed_genome mRNA 969133 977691 . + . ID=transcript_13824;Q9BRP1,Programmed cell death protein 2-like,, PF04194;, GO:0005737;GO:0016020;GO:0007049;, C:cytoplasm; C:membrane;, , P:cell cycle;|Q9BRP1,Programmed cell death protein 2-like,, PF04194;, GO:0005737;GO:0016020;GO:0007049;, C:cytoplasm; C:membrane;, , P:cell cycle;|Q9BRP1,Programmed cell death protein 2-like,, PF04194;, GO:0005737;GO:0016020;GO:0007049;, C:cytoplasm; C:membrane;, , P:cell cycle; scaffold126 indexed_genome mRNA 982114 1019364 . - . ID=transcript_13825;P06744 B4DG39 Q9BRD3 Q9BSK5 Q9UHE6,Glucose-6-phosphate isomerase {ECO:0000303|PubMed:2387591},Autocrine motility factor {ECO:0000303|PubMed:11004567};Neuroleukin {ECO:0000303|PubMed:3352745};Phosphoglucose isomerase {ECO:0000303|PubMed:12163179};Phosphohexose isomerase {ECO:0000303|PubMed:11004567};Sperm antigen 36 {ECO:0000303|PubMed:10727272};, PF00342;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0034774;GO:0005125;GO:0004347;GO:0008083;GO:0048029;GO:0031625;GO:0061621;GO:0005975;GO:0006094;GO:0051156;GO:0006096;GO:0007599;GO:0006959;GO:0043312;GO:0010595;GO:0002639;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane; C:secretory granule lumen;, F:cytokine activity; F:glucose-6-phosphate isomerase activity; F:growth factor activity; F:monosaccharide binding; F:ubiquitin protein ligase binding;, P:canonical glycolysis; P:carbohydrate metabolic process; P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:hemostasis; P:humoral immune response; P:neutrophil degranulation; P:positive regulation of endothelial cell migration; P:positive regulation of immunoglobulin production;|P06744 B4DG39 Q9BRD3 Q9BSK5 Q9UHE6,Glucose-6-phosphate isomerase {ECO:0000303|PubMed:2387591},Autocrine motility factor {ECO:0000303|PubMed:11004567};Neuroleukin {ECO:0000303|PubMed:3352745};Phosphoglucose isomerase {ECO:0000303|PubMed:12163179};Phosphohexose isomerase {ECO:0000303|PubMed:11004567};Sperm antigen 36 {ECO:0000303|PubMed:10727272};, PF00342;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0034774;GO:0005125;GO:0004347;GO:0008083;GO:0048029;GO:0031625;GO:0061621;GO:0005975;GO:0006094;GO:0051156;GO:0006096;GO:0007599;GO:0006959;GO:0043312;GO:0010595;GO:0002639;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane; C:secretory granule lumen;, F:cytokine activity; F:glucose-6-phosphate isomerase activity; F:growth factor activity; F:monosaccharide binding; F:ubiquitin protein ligase binding;, P:canonical glycolysis; P:carbohydrate metabolic process; P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:hemostasis; P:humoral immune response; P:neutrophil degranulation; P:positive regulation of endothelial cell migration; P:positive regulation of immunoglobulin production;|P06744 B4DG39 Q9BRD3 Q9BSK5 Q9UHE6,Glucose-6-phosphate isomerase {ECO:0000303|PubMed:2387591},Autocrine motility factor {ECO:0000303|PubMed:11004567};Neuroleukin {ECO:0000303|PubMed:3352745};Phosphoglucose isomerase {ECO:0000303|PubMed:12163179};Phosphohexose isomerase {ECO:0000303|PubMed:11004567};Sperm antigen 36 {ECO:0000303|PubMed:10727272};, PF00342;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0034774;GO:0005125;GO:0004347;GO:0008083;GO:0048029;GO:0031625;GO:0061621;GO:0005975;GO:0006094;GO:0051156;GO:0006096;GO:0007599;GO:0006959;GO:0043312;GO:0010595;GO:0002639;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane; C:secretory granule lumen;, F:cytokine activity; F:glucose-6-phosphate isomerase activity; F:growth factor activity; F:monosaccharide binding; F:ubiquitin protein ligase binding;, P:canonical glycolysis; P:carbohydrate metabolic process; P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:hemostasis; P:humoral immune response; P:neutrophil degranulation; P:positive regulation of endothelial cell migration; P:positive regulation of immunoglobulin production;|P06744 B4DG39 Q9BRD3 Q9BSK5 Q9UHE6,Glucose-6-phosphate isomerase {ECO:0000303|PubMed:2387591},Autocrine motility factor {ECO:0000303|PubMed:11004567};Neuroleukin {ECO:0000303|PubMed:3352745};Phosphoglucose isomerase {ECO:0000303|PubMed:12163179};Phosphohexose isomerase {ECO:0000303|PubMed:11004567};Sperm antigen 36 {ECO:0000303|PubMed:10727272};, PF00342;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0034774;GO:0005125;GO:0004347;GO:0008083;GO:0048029;GO:0031625;GO:0061621;GO:0005975;GO:0006094;GO:0051156;GO:0006096;GO:0007599;GO:0006959;GO:0043312;GO:0010595;GO:0002639;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane; C:secretory granule lumen;, F:cytokine activity; F:glucose-6-phosphate isomerase activity; F:growth factor activity; F:monosaccharide binding; F:ubiquitin protein ligase binding;, P:canonical glycolysis; P:carbohydrate metabolic process; P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:hemostasis; P:humoral immune response; P:neutrophil degranulation; P:positive regulation of endothelial cell migration; P:positive regulation of immunoglobulin production;|P06744 B4DG39 Q9BRD3 Q9BSK5 Q9UHE6,Glucose-6-phosphate isomerase {ECO:0000303|PubMed:2387591},Autocrine motility factor {ECO:0000303|PubMed:11004567};Neuroleukin {ECO:0000303|PubMed:3352745};Phosphoglucose isomerase {ECO:0000303|PubMed:12163179};Phosphohexose isomerase {ECO:0000303|PubMed:11004567};Sperm antigen 36 {ECO:0000303|PubMed:10727272};, PF00342;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0034774;GO:0005125;GO:0004347;GO:0008083;GO:0048029;GO:0031625;GO:0061621;GO:0005975;GO:0006094;GO:0051156;GO:0006096;GO:0007599;GO:0006959;GO:0043312;GO:0010595;GO:0002639;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane; C:secretory granule lumen;, F:cytokine activity; F:glucose-6-phosphate isomerase activity; F:growth factor activity; F:monosaccharide binding; F:ubiquitin protein ligase binding;, P:canonical glycolysis; P:carbohydrate metabolic process; P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:hemostasis; P:humoral immune response; P:neutrophil degranulation; P:positive regulation of endothelial cell migration; P:positive regulation of immunoglobulin production;|P06744 B4DG39 Q9BRD3 Q9BSK5 Q9UHE6,Glucose-6-phosphate isomerase {ECO:0000303|PubMed:2387591},Autocrine motility factor {ECO:0000303|PubMed:11004567};Neuroleukin {ECO:0000303|PubMed:3352745};Phosphoglucose isomerase {ECO:0000303|PubMed:12163179};Phosphohexose isomerase {ECO:0000303|PubMed:11004567};Sperm antigen 36 {ECO:0000303|PubMed:10727272};, PF00342;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0034774;GO:0005125;GO:0004347;GO:0008083;GO:0048029;GO:0031625;GO:0061621;GO:0005975;GO:0006094;GO:0051156;GO:0006096;GO:0007599;GO:0006959;GO:0043312;GO:0010595;GO:0002639;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane; C:secretory granule lumen;, F:cytokine activity; F:glucose-6-phosphate isomerase activity; F:growth factor activity; F:monosaccharide binding; F:ubiquitin protein ligase binding;, P:canonical glycolysis; P:carbohydrate metabolic process; P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:hemostasis; P:humoral immune response; P:neutrophil degranulation; P:positive regulation of endothelial cell migration; P:positive regulation of immunoglobulin production;|P06744 B4DG39 Q9BRD3 Q9BSK5 Q9UHE6,Glucose-6-phosphate isomerase {ECO:0000303|PubMed:2387591},Autocrine motility factor {ECO:0000303|PubMed:11004567};Neuroleukin {ECO:0000303|PubMed:3352745};Phosphoglucose isomerase {ECO:0000303|PubMed:12163179};Phosphohexose isomerase {ECO:0000303|PubMed:11004567};Sperm antigen 36 {ECO:0000303|PubMed:10727272};, PF00342;, GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005886;GO:0034774;GO:0005125;GO:0004347;GO:0008083;GO:0048029;GO:0031625;GO:0061621;GO:0005975;GO:0006094;GO:0051156;GO:0006096;GO:0007599;GO:0006959;GO:0043312;GO:0010595;GO:0002639;, C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:plasma membrane; C:secretory granule lumen;, F:cytokine activity; F:glucose-6-phosphate isomerase activity; F:growth factor activity; F:monosaccharide binding; F:ubiquitin protein ligase binding;, P:canonical glycolysis; P:carbohydrate metabolic process; P:gluconeogenesis; P:glucose 6-phosphate metabolic process; P:glycolytic process; P:hemostasis; P:humoral immune response; P:neutrophil degranulation; P:positive regulation of endothelial cell migration; P:positive regulation of immunoglobulin production; scaffold126 indexed_genome mRNA 1022627 1032643 . - . ID=transcript_13826;O15063 Q2M3W4,Granule associated Rac and RHOG effector protein 1 {ECO:0000305},, PF15923;, GO:0000932;GO:1905762;GO:0031267;GO:0016601;, C:P-body;, F:CCR4-NOT complex binding; F:small GTPase binding;, P:Rac protein signal transduction;|O15063 Q2M3W4,Granule associated Rac and RHOG effector protein 1 {ECO:0000305},, PF15923;, GO:0000932;GO:1905762;GO:0031267;GO:0016601;, C:P-body;, F:CCR4-NOT complex binding; F:small GTPase binding;, P:Rac protein signal transduction;|O15063 Q2M3W4,Granule associated Rac and RHOG effector protein 1 {ECO:0000305},, PF15923;, GO:0000932;GO:1905762;GO:0031267;GO:0016601;, C:P-body;, F:CCR4-NOT complex binding; F:small GTPase binding;, P:Rac protein signal transduction;|O15063 Q2M3W4,Granule associated Rac and RHOG effector protein 1 {ECO:0000305},, PF15923;, GO:0000932;GO:1905762;GO:0031267;GO:0016601;, C:P-body;, F:CCR4-NOT complex binding; F:small GTPase binding;, P:Rac protein signal transduction; scaffold126 indexed_genome mRNA 1034746 1035820 . - . ID=transcript_13827;O15063 Q2M3W4,Granule associated Rac and RHOG effector protein 1 {ECO:0000305},, PF15923;, GO:0000932;GO:1905762;GO:0031267;GO:0016601;, C:P-body;, F:CCR4-NOT complex binding; F:small GTPase binding;, P:Rac protein signal transduction; scaffold126 indexed_genome mRNA 1120326 1120849 . - . ID=transcript_13828;O15178 E7ERD6 Q4KMP4,T-box transcription factor T {ECO:0000305},Brachyury protein {ECO:0000305};Protein T;, PF00907;, GO:0000785;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001102;GO:0000978;GO:0001085;GO:1990837;GO:0008595;GO:0001708;GO:0003007;GO:0007498;GO:0001707;GO:0043433;GO:0000122;GO:0003257;GO:0090009;GO:0006357;GO:0007165;GO:0001756;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sequence-specific double-stranded DNA binding;, P:anterior/posterior axis specification, embryo; P:cell fate specification; P:heart morphogenesis; P:mesoderm development; P:mesoderm formation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; P:primitive streak formation; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:somitogenesis; scaffold126 indexed_genome mRNA 1139484 1140966 . - . ID=transcript_13829;Q8ND56 B4DTG6 Q76LX7 Q96AR3 Q96K73 Q96SN5 Q9UFR3,Protein LSM14 homolog A {ECO:0000303|PubMed:26339800},Protein FAM61A;Protein SCD6 homolog;Putative alpha-synuclein-binding protein {ECO:0000303|Ref.1};RNA-associated protein 55A {ECO:0000303|PubMed:17074753};, PF09532;PF12701;, GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:1990124;GO:0072686;GO:0000932;GO:0003690;GO:0003725;GO:0003729;GO:0003723;GO:0003727;GO:0090307;GO:0007275;GO:0017148;GO:0033962;GO:0060340;GO:0039529;GO:0034063;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:messenger ribonucleoprotein complex; C:mitotic spindle; C:P-body;, F:double-stranded DNA binding; F:double-stranded RNA binding; F:mRNA binding; F:RNA binding; F:single-stranded RNA binding;, P:mitotic spindle assembly; P:multicellular organism development; P:negative regulation of translation; P:P-body assembly; P:positive regulation of type I interferon-mediated signaling pathway; P:RIG-I signaling pathway; P:stress granule assembly; scaffold126 indexed_genome mRNA 1144231 1145244 . + . ID=transcript_13830;Q8ND56 B4DTG6 Q76LX7 Q96AR3 Q96K73 Q96SN5 Q9UFR3,Protein LSM14 homolog A {ECO:0000303|PubMed:26339800},Protein FAM61A;Protein SCD6 homolog;Putative alpha-synuclein-binding protein {ECO:0000303|Ref.1};RNA-associated protein 55A {ECO:0000303|PubMed:17074753};, PF09532;PF12701;, GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:1990124;GO:0072686;GO:0000932;GO:0003690;GO:0003725;GO:0003729;GO:0003723;GO:0003727;GO:0090307;GO:0007275;GO:0017148;GO:0033962;GO:0060340;GO:0039529;GO:0034063;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:messenger ribonucleoprotein complex; C:mitotic spindle; C:P-body;, F:double-stranded DNA binding; F:double-stranded RNA binding; F:mRNA binding; F:RNA binding; F:single-stranded RNA binding;, P:mitotic spindle assembly; P:multicellular organism development; P:negative regulation of translation; P:P-body assembly; P:positive regulation of type I interferon-mediated signaling pathway; P:RIG-I signaling pathway; P:stress granule assembly; scaffold126 indexed_genome mRNA 1561835 1573153 . - . ID=transcript_13831;Q96SI1 A8K600 Q9BVI6,BTB/POZ domain-containing protein KCTD15,Potassium channel tetramerization domain-containing protein 15;, PF02214;, GO:0042802;GO:0007275;GO:0051260;, , F:identical protein binding;, P:multicellular organism development; P:protein homooligomerization; scaffold126 indexed_genome mRNA 2106884 2159090 . - . ID=transcript_13832;Q9BRR8 Q8IZV6 Q8N3B7 Q9NW94,G patch domain-containing protein 1,Evolutionarily conserved G-patch domain-containing protein;, PF07713;PF01585;, GO:0071013;GO:0005634;GO:0003723;GO:0000398;, C:catalytic step 2 spliceosome; C:nucleus;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q9BRR8 Q8IZV6 Q8N3B7 Q9NW94,G patch domain-containing protein 1,Evolutionarily conserved G-patch domain-containing protein;, PF07713;PF01585;, GO:0071013;GO:0005634;GO:0003723;GO:0000398;, C:catalytic step 2 spliceosome; C:nucleus;, F:RNA binding;, P:mRNA splicing, via spliceosome; scaffold126 indexed_genome mRNA 2207932 2236746 . + . ID=transcript_13833;Q8IUC4 B2RCG8 B3KUY8 B4DUS7 Q8N3T7 Q8N9D6 Q8NE33 Q96RU1,Rhophilin-2,76 kDa RhoB effector protein;GTP-Rho-binding protein 2;p76RBE;, PF03097;PF02185;, GO:0005829;GO:0048471;GO:0007165;, C:cytosol; C:perinuclear region of cytoplasm;, , P:signal transduction;|Q8IUC4 B2RCG8 B3KUY8 B4DUS7 Q8N3T7 Q8N9D6 Q8NE33 Q96RU1,Rhophilin-2,76 kDa RhoB effector protein;GTP-Rho-binding protein 2;p76RBE;, PF03097;PF02185;, GO:0005829;GO:0048471;GO:0007165;, C:cytosol; C:perinuclear region of cytoplasm;, , P:signal transduction; scaffold126 indexed_genome mRNA 2248528 2251994 . - . ID=transcript_13834;Q9BTP7 B3KY46 Q8WUJ7 Q96FX6,Fanconi anemia core complex-associated protein 24 {ECO:0000303|PubMed:17289582, ECO:0000312|HGNC:HGNC:28467},Fanconi anemia-associated protein of 24 kDa;, PF12826;PF17949;, GO:0043240;GO:0043231;GO:0005654;GO:0003682;GO:0003677;GO:0036297;, C:Fanconi anaemia nuclear complex; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:chromatin binding; F:DNA binding;, P:interstrand cross-link repair; scaffold126 indexed_genome mRNA 2252217 2264662 . + . ID=transcript_13835;Q96ST8 B9EGA6 Q8N5J8,Centrosomal protein of 89 kDa,Centrosomal protein 123;Coiled-coil domain-containing protein 123;, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005758;GO:0031514;GO:0097730;GO:0005886;GO:0000922;GO:0045202;GO:0007268;GO:0097711;GO:0060271;GO:0007005;GO:1905515;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:mitochondrial intermembrane space; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:spindle pole; C:synapse;, , P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:mitochondrion organization; P:non-motile cilium assembly; scaffold126 indexed_genome mRNA 2288563 2289382 . - . ID=transcript_13836;Q96ST8 B9EGA6 Q8N5J8,Centrosomal protein of 89 kDa,Centrosomal protein 123;Coiled-coil domain-containing protein 123;, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005758;GO:0031514;GO:0097730;GO:0005886;GO:0000922;GO:0045202;GO:0007268;GO:0097711;GO:0060271;GO:0007005;GO:1905515;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:mitochondrial intermembrane space; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:spindle pole; C:synapse;, , P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:mitochondrion organization; P:non-motile cilium assembly; scaffold126 indexed_genome mRNA 2290464 2321137 . + . ID=transcript_13837;Q96ST8 B9EGA6 Q8N5J8,Centrosomal protein of 89 kDa,Centrosomal protein 123;Coiled-coil domain-containing protein 123;, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005758;GO:0031514;GO:0097730;GO:0005886;GO:0000922;GO:0045202;GO:0007268;GO:0097711;GO:0060271;GO:0007005;GO:1905515;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:mitochondrial intermembrane space; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:spindle pole; C:synapse;, , P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:mitochondrion organization; P:non-motile cilium assembly;|Q96ST8 B9EGA6 Q8N5J8,Centrosomal protein of 89 kDa,Centrosomal protein 123;Coiled-coil domain-containing protein 123;, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005758;GO:0031514;GO:0097730;GO:0005886;GO:0000922;GO:0045202;GO:0007268;GO:0097711;GO:0060271;GO:0007005;GO:1905515;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:mitochondrial intermembrane space; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:spindle pole; C:synapse;, , P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:mitochondrion organization; P:non-motile cilium assembly;|Q96ST8 B9EGA6 Q8N5J8,Centrosomal protein of 89 kDa,Centrosomal protein 123;Coiled-coil domain-containing protein 123;, , GO:0005814;GO:0005813;GO:0097539;GO:0005829;GO:0005758;GO:0031514;GO:0097730;GO:0005886;GO:0000922;GO:0045202;GO:0007268;GO:0097711;GO:0060271;GO:0007005;GO:1905515;, C:centriole; C:centrosome; C:ciliary transition fiber; C:cytosol; C:mitochondrial intermembrane space; C:motile cilium; C:non-motile cilium; C:plasma membrane; C:spindle pole; C:synapse;, , P:chemical synaptic transmission; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:mitochondrion organization; P:non-motile cilium assembly; scaffold126 indexed_genome mRNA 2351242 2371528 . + . ID=transcript_13838;P82251 B2R9A6,b(0,+)-type amino acid transporter 1,Glycoprotein-associated amino acid transporter b0,+AT1;Solute carrier family 7 member 9;, PF13520;, GO:0016324;GO:0031526;GO:0005887;GO:0005886;GO:0015179;GO:0015184;GO:0015175;GO:0042605;GO:0006865;GO:0015811;GO:0050900;GO:0015804;GO:0065003;, C:apical plasma membrane; C:brush border membrane; C:integral component of plasma membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:L-cystine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:peptide antigen binding;, P:amino acid transport; P:L-cystine transport; P:leukocyte migration; P:neutral amino acid transport; P:protein-containing complex assembly; scaffold126 indexed_genome mRNA 2372125 2403791 . - . ID=transcript_13839;Q587J7,Putative ATP-dependent RNA helicase TDRD12,ES cell-associated transcript 8 protein;Tudor domain-containing protein 12;, PF00270;PF00567;, GO:1990923;GO:0005524;GO:0003676;GO:0003724;GO:0030154;GO:0043046;GO:0009566;GO:0031047;GO:0007140;GO:0007275;GO:0034587;GO:0007283;, C:PET complex;, F:ATP binding; F:nucleic acid binding; F:RNA helicase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:fertilization; P:gene silencing by RNA; P:male meiotic nuclear division; P:multicellular organism development; P:piRNA metabolic process; P:spermatogenesis;|Q587J7,Putative ATP-dependent RNA helicase TDRD12,ES cell-associated transcript 8 protein;Tudor domain-containing protein 12;, PF00270;PF00567;, GO:1990923;GO:0005524;GO:0003676;GO:0003724;GO:0030154;GO:0043046;GO:0009566;GO:0031047;GO:0007140;GO:0007275;GO:0034587;GO:0007283;, C:PET complex;, F:ATP binding; F:nucleic acid binding; F:RNA helicase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:fertilization; P:gene silencing by RNA; P:male meiotic nuclear division; P:multicellular organism development; P:piRNA metabolic process; P:spermatogenesis; scaffold126 indexed_genome mRNA 2406003 2456298 . - . ID=transcript_13840;Q587J7,Putative ATP-dependent RNA helicase TDRD12,ES cell-associated transcript 8 protein;Tudor domain-containing protein 12;, PF00270;PF00567;, GO:1990923;GO:0005524;GO:0003676;GO:0003724;GO:0030154;GO:0043046;GO:0009566;GO:0031047;GO:0007140;GO:0007275;GO:0034587;GO:0007283;, C:PET complex;, F:ATP binding; F:nucleic acid binding; F:RNA helicase activity;, P:cell differentiation; P:DNA methylation involved in gamete generation; P:fertilization; P:gene silencing by RNA; P:male meiotic nuclear division; P:multicellular organism development; P:piRNA metabolic process; P:spermatogenesis; scaffold126 indexed_genome mRNA 2462370 2467045 . + . ID=transcript_13841;P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold126 indexed_genome mRNA 2469764 2473848 . + . ID=transcript_13842;A8MXV4,Nucleoside diphosphate-linked moiety X motif 19,, , GO:0005829;GO:0005782;GO:0016787;GO:0046872;GO:0009062;GO:0008104;, C:cytosol; C:peroxisomal matrix;, F:hydrolase activity; F:metal ion binding;, P:fatty acid catabolic process; P:protein localization; scaffold126 indexed_genome mRNA 2498495 2514537 . + . ID=transcript_13843;Q96NW4 Q71MF5 Q86UC3 Q8ND80 Q9H0I4,Ankyrin repeat domain-containing protein 27,VPS9 domain-containing protein;, PF00023;PF12796;PF02204;, GO:0030659;GO:0005829;GO:0005769;GO:0005770;GO:0005764;GO:0042470;GO:0016020;GO:0043005;GO:0005886;GO:0030133;GO:0097422;GO:0005096;GO:0005085;GO:0031267;GO:0000149;GO:0045022;GO:0035646;GO:0035544;GO:0048812;GO:0050775;GO:0010976;GO:0015031;GO:1990126;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:late endosome; C:lysosome; C:melanosome; C:membrane; C:neuron projection; C:plasma membrane; C:transport vesicle; C:tubular endosome;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:SNARE binding;, P:early endosome to late endosome transport; P:endosome to melanosome transport; P:negative regulation of SNARE complex assembly; P:neuron projection morphogenesis; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron projection development; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q96NW4 Q71MF5 Q86UC3 Q8ND80 Q9H0I4,Ankyrin repeat domain-containing protein 27,VPS9 domain-containing protein;, PF00023;PF12796;PF02204;, GO:0030659;GO:0005829;GO:0005769;GO:0005770;GO:0005764;GO:0042470;GO:0016020;GO:0043005;GO:0005886;GO:0030133;GO:0097422;GO:0005096;GO:0005085;GO:0031267;GO:0000149;GO:0045022;GO:0035646;GO:0035544;GO:0048812;GO:0050775;GO:0010976;GO:0015031;GO:1990126;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:late endosome; C:lysosome; C:melanosome; C:membrane; C:neuron projection; C:plasma membrane; C:transport vesicle; C:tubular endosome;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:SNARE binding;, P:early endosome to late endosome transport; P:endosome to melanosome transport; P:negative regulation of SNARE complex assembly; P:neuron projection morphogenesis; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron projection development; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q96NW4 Q71MF5 Q86UC3 Q8ND80 Q9H0I4,Ankyrin repeat domain-containing protein 27,VPS9 domain-containing protein;, PF00023;PF12796;PF02204;, GO:0030659;GO:0005829;GO:0005769;GO:0005770;GO:0005764;GO:0042470;GO:0016020;GO:0043005;GO:0005886;GO:0030133;GO:0097422;GO:0005096;GO:0005085;GO:0031267;GO:0000149;GO:0045022;GO:0035646;GO:0035544;GO:0048812;GO:0050775;GO:0010976;GO:0015031;GO:1990126;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:late endosome; C:lysosome; C:melanosome; C:membrane; C:neuron projection; C:plasma membrane; C:transport vesicle; C:tubular endosome;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:SNARE binding;, P:early endosome to late endosome transport; P:endosome to melanosome transport; P:negative regulation of SNARE complex assembly; P:neuron projection morphogenesis; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron projection development; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q96NW4 Q71MF5 Q86UC3 Q8ND80 Q9H0I4,Ankyrin repeat domain-containing protein 27,VPS9 domain-containing protein;, PF00023;PF12796;PF02204;, GO:0030659;GO:0005829;GO:0005769;GO:0005770;GO:0005764;GO:0042470;GO:0016020;GO:0043005;GO:0005886;GO:0030133;GO:0097422;GO:0005096;GO:0005085;GO:0031267;GO:0000149;GO:0045022;GO:0035646;GO:0035544;GO:0048812;GO:0050775;GO:0010976;GO:0015031;GO:1990126;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:late endosome; C:lysosome; C:melanosome; C:membrane; C:neuron projection; C:plasma membrane; C:transport vesicle; C:tubular endosome;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:SNARE binding;, P:early endosome to late endosome transport; P:endosome to melanosome transport; P:negative regulation of SNARE complex assembly; P:neuron projection morphogenesis; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron projection development; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q96NW4 Q71MF5 Q86UC3 Q8ND80 Q9H0I4,Ankyrin repeat domain-containing protein 27,VPS9 domain-containing protein;, PF00023;PF12796;PF02204;, GO:0030659;GO:0005829;GO:0005769;GO:0005770;GO:0005764;GO:0042470;GO:0016020;GO:0043005;GO:0005886;GO:0030133;GO:0097422;GO:0005096;GO:0005085;GO:0031267;GO:0000149;GO:0045022;GO:0035646;GO:0035544;GO:0048812;GO:0050775;GO:0010976;GO:0015031;GO:1990126;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:late endosome; C:lysosome; C:melanosome; C:membrane; C:neuron projection; C:plasma membrane; C:transport vesicle; C:tubular endosome;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:SNARE binding;, P:early endosome to late endosome transport; P:endosome to melanosome transport; P:negative regulation of SNARE complex assembly; P:neuron projection morphogenesis; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron projection development; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q96NW4 Q71MF5 Q86UC3 Q8ND80 Q9H0I4,Ankyrin repeat domain-containing protein 27,VPS9 domain-containing protein;, PF00023;PF12796;PF02204;, GO:0030659;GO:0005829;GO:0005769;GO:0005770;GO:0005764;GO:0042470;GO:0016020;GO:0043005;GO:0005886;GO:0030133;GO:0097422;GO:0005096;GO:0005085;GO:0031267;GO:0000149;GO:0045022;GO:0035646;GO:0035544;GO:0048812;GO:0050775;GO:0010976;GO:0015031;GO:1990126;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:late endosome; C:lysosome; C:melanosome; C:membrane; C:neuron projection; C:plasma membrane; C:transport vesicle; C:tubular endosome;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:SNARE binding;, P:early endosome to late endosome transport; P:endosome to melanosome transport; P:negative regulation of SNARE complex assembly; P:neuron projection morphogenesis; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron projection development; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q96NW4 Q71MF5 Q86UC3 Q8ND80 Q9H0I4,Ankyrin repeat domain-containing protein 27,VPS9 domain-containing protein;, PF00023;PF12796;PF02204;, GO:0030659;GO:0005829;GO:0005769;GO:0005770;GO:0005764;GO:0042470;GO:0016020;GO:0043005;GO:0005886;GO:0030133;GO:0097422;GO:0005096;GO:0005085;GO:0031267;GO:0000149;GO:0045022;GO:0035646;GO:0035544;GO:0048812;GO:0050775;GO:0010976;GO:0015031;GO:1990126;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:late endosome; C:lysosome; C:melanosome; C:membrane; C:neuron projection; C:plasma membrane; C:transport vesicle; C:tubular endosome;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:SNARE binding;, P:early endosome to late endosome transport; P:endosome to melanosome transport; P:negative regulation of SNARE complex assembly; P:neuron projection morphogenesis; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron projection development; P:protein transport; P:retrograde transport, endosome to plasma membrane; scaffold126 indexed_genome mRNA 2516292 2524659 . - . ID=transcript_13844;O14737 B4DE64 Q53YC9 Q6IB70,Programmed cell death protein 5,TF-1 cell apoptosis-related protein 19;, PF01984;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0010698;GO:0048487;GO:0003677;GO:0008201;GO:0006915;GO:0071560;GO:0008285;GO:1903645;GO:0043065;GO:0043280;GO:0010628;GO:1903638;GO:0090200;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:acetyltransferase activator activity; F:beta-tubulin binding; F:DNA binding; F:heparin binding;, P:apoptotic process; P:cellular response to transforming growth factor beta stimulus; P:negative regulation of cell population proliferation; P:negative regulation of chaperone-mediated protein folding; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of gene expression; P:positive regulation of protein insertion into mitochondrial outer membrane; P:positive regulation of release of cytochrome c from mitochondria;|O14737 B4DE64 Q53YC9 Q6IB70,Programmed cell death protein 5,TF-1 cell apoptosis-related protein 19;, PF01984;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0010698;GO:0048487;GO:0003677;GO:0008201;GO:0006915;GO:0071560;GO:0008285;GO:1903645;GO:0043065;GO:0043280;GO:0010628;GO:1903638;GO:0090200;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:acetyltransferase activator activity; F:beta-tubulin binding; F:DNA binding; F:heparin binding;, P:apoptotic process; P:cellular response to transforming growth factor beta stimulus; P:negative regulation of cell population proliferation; P:negative regulation of chaperone-mediated protein folding; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of gene expression; P:positive regulation of protein insertion into mitochondrial outer membrane; P:positive regulation of release of cytochrome c from mitochondria; scaffold126 indexed_genome mRNA 2615995 2686057 . - . ID=transcript_13845;Q6ZPD9 Q68DC7 Q6ZTB7 Q6ZTS2,Probable C-mannosyltransferase DPY19L3,Dpy-19-like protein 3;Protein dpy-19 homolog 3;, PF10034;, GO:0016021;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;|Q6ZPD9 Q68DC7 Q6ZTB7 Q6ZTS2,Probable C-mannosyltransferase DPY19L3,Dpy-19-like protein 3;Protein dpy-19 homolog 3;, PF10034;, GO:0016021;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan;|Q6ZPD9 Q68DC7 Q6ZTB7 Q6ZTS2,Probable C-mannosyltransferase DPY19L3,Dpy-19-like protein 3;Protein dpy-19 homolog 3;, PF10034;, GO:0016021;GO:0005637;GO:0000030;GO:0018406;, C:integral component of membrane; C:nuclear inner membrane;, F:mannosyltransferase activity;, P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan; scaffold126 indexed_genome mRNA 2708121 2749036 . + . ID=transcript_13846;Q8TCN5 A8K911 Q2TBF1 Q6MZU0 Q9UPR8,Zinc finger protein 507,, PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression;|Q8TCN5 A8K911 Q2TBF1 Q6MZU0 Q9UPR8,Zinc finger protein 507,, PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0045944;GO:0010468;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; scaffold127 indexed_genome mRNA 73612 151472 . - . ID=transcript_13847;P51809 Q53GY7 Q7Z409 Q9H4A7,Vesicle-associated membrane protein 7,Synaptobrevin-like protein 1;Tetanus-insensitive VAMP;, PF13774;PF00957;, GO:0035577;GO:0030669;GO:0005737;GO:0005789;GO:0070062;GO:0030175;GO:0098686;GO:0030285;GO:0043231;GO:0030027;GO:0031902;GO:0005765;GO:0016020;GO:0043005;GO:0048471;GO:0045335;GO:0030670;GO:0005886;GO:0031091;GO:0031143;GO:0030141;GO:0030667;GO:0031201;GO:0005802;GO:0005484;GO:0000149;GO:0019905;GO:0017156;GO:0006888;GO:0008333;GO:0043308;GO:0006887;GO:0061024;GO:0043320;GO:0043312;GO:0006911;GO:1903595;GO:0006892;GO:0015031;GO:0034197;GO:0006906;GO:0048280;GO:0047496;GO:0016192;, C:azurophil granule membrane; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:extracellular exosome; C:filopodium; C:hippocampal mossy fiber to CA3 synapse; C:integral component of synaptic vesicle membrane; C:intracellular membrane-bounded organelle; C:lamellipodium; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:neuron projection; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:platelet alpha granule; C:pseudopodium; C:secretory granule; C:secretory granule membrane; C:SNARE complex; C:trans-Golgi network;, F:SNAP receptor activity; F:SNARE binding; F:syntaxin binding;, P:calcium-ion regulated exocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:endosome to lysosome transport; P:eosinophil degranulation; P:exocytosis; P:membrane organization; P:natural killer cell degranulation; P:neutrophil degranulation; P:phagocytosis, engulfment; P:positive regulation of histamine secretion by mast cell; P:post-Golgi vesicle-mediated transport; P:protein transport; P:triglyceride transport; P:vesicle fusion; P:vesicle fusion with Golgi apparatus; P:vesicle transport along microtubule; P:vesicle-mediated transport;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold127 indexed_genome mRNA 221346 229820 . - . ID=transcript_13848;O43610 A8K0H8,Protein sprouty homolog 3 {ECO:0000305},Sprouty RTK signaling antagonist 3 {ECO:0000312|HGNC:HGNC:11271};Sprouty3 {ECO:0000303|PubMed:30878395};, PF05210;, GO:0005829;GO:0016020;GO:0048513;GO:0061564;GO:0007275;GO:0070373;GO:0040037;GO:0043407;GO:0043409;GO:0150013;GO:0046580;, C:cytosol; C:membrane;, , P:animal organ development; P:axon development; P:multicellular organism development; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of MAPK cascade; P:negative regulation of neuron projection arborization; P:negative regulation of Ras protein signal transduction; scaffold127 indexed_genome mRNA 283823 284850 . - . ID=transcript_13849;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold127 indexed_genome mRNA 375721 376542 . + . ID=transcript_13850;Q9NVH6 A8K6M9 B4E3R3 Q5TZB5 Q6IA90 Q8TBT0,Trimethyllysine dioxygenase, mitochondrial,Epsilon-trimethyllysine 2-oxoglutarate dioxygenase;Epsilon-trimethyllysine hydroxylase;TML hydroxylase;TML-alpha-ketoglutarate dioxygenase;, PF06155;PF02668;, GO:0005759;GO:0005739;GO:0005506;GO:0050353;GO:0045329;GO:0051354;, C:mitochondrial matrix; C:mitochondrion;, F:iron ion binding; F:trimethyllysine dioxygenase activity;, P:carnitine biosynthetic process; P:negative regulation of oxidoreductase activity; scaffold127 indexed_genome mRNA 389693 396420 . - . ID=transcript_13851;Q9NVH6 A8K6M9 B4E3R3 Q5TZB5 Q6IA90 Q8TBT0,Trimethyllysine dioxygenase, mitochondrial,Epsilon-trimethyllysine 2-oxoglutarate dioxygenase;Epsilon-trimethyllysine hydroxylase;TML hydroxylase;TML-alpha-ketoglutarate dioxygenase;, PF06155;PF02668;, GO:0005759;GO:0005739;GO:0005506;GO:0050353;GO:0045329;GO:0051354;, C:mitochondrial matrix; C:mitochondrion;, F:iron ion binding; F:trimethyllysine dioxygenase activity;, P:carnitine biosynthetic process; P:negative regulation of oxidoreductase activity;|Q9NVH6 A8K6M9 B4E3R3 Q5TZB5 Q6IA90 Q8TBT0,Trimethyllysine dioxygenase, mitochondrial,Epsilon-trimethyllysine 2-oxoglutarate dioxygenase;Epsilon-trimethyllysine hydroxylase;TML hydroxylase;TML-alpha-ketoglutarate dioxygenase;, PF06155;PF02668;, GO:0005759;GO:0005739;GO:0005506;GO:0050353;GO:0045329;GO:0051354;, C:mitochondrial matrix; C:mitochondrion;, F:iron ion binding; F:trimethyllysine dioxygenase activity;, P:carnitine biosynthetic process; P:negative regulation of oxidoreductase activity; scaffold127 indexed_genome mRNA 473137 478827 . + . ID=transcript_13852;Q96DA2 Q5JT79 Q8NEX3,Ras-related protein Rab-39B,, PF00071;, GO:0030659;GO:0005794;GO:0000139;GO:0043005;GO:0005886;GO:0031982;GO:0005525;GO:0003924;GO:0031489;GO:0006914;GO:0015031;GO:0032482;GO:0010506;GO:0050808;GO:0016192;, C:cytoplasmic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:neuron projection; C:plasma membrane; C:vesicle;, F:GTP binding; F:GTPase activity; F:myosin V binding;, P:autophagy; P:protein transport; P:Rab protein signal transduction; P:regulation of autophagy; P:synapse organization; P:vesicle-mediated transport; scaffold127 indexed_genome mRNA 492410 516019 . - . ID=transcript_13853;P61758 B2R8L5 B4DWR3 F5H2A7 O55228 Q15765 Q5JT81 Q86X96,Prefoldin subunit 3,HIBBJ46;von Hippel-Lindau-binding protein 1;, PF02996;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005844;GO:0016272;GO:0001540;GO:0015631;GO:0051082;GO:0007017;GO:1905907;GO:0006457;GO:0007021;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:polysome; C:prefoldin complex;, F:amyloid-beta binding; F:tubulin binding; F:unfolded protein binding;, P:microtubule-based process; P:negative regulation of amyloid fibril formation; P:protein folding; P:tubulin complex assembly;|P61758 B2R8L5 B4DWR3 F5H2A7 O55228 Q15765 Q5JT81 Q86X96,Prefoldin subunit 3,HIBBJ46;von Hippel-Lindau-binding protein 1;, PF02996;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005844;GO:0016272;GO:0001540;GO:0015631;GO:0051082;GO:0007017;GO:1905907;GO:0006457;GO:0007021;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:polysome; C:prefoldin complex;, F:amyloid-beta binding; F:tubulin binding; F:unfolded protein binding;, P:microtubule-based process; P:negative regulation of amyloid fibril formation; P:protein folding; P:tubulin complex assembly;|P61758 B2R8L5 B4DWR3 F5H2A7 O55228 Q15765 Q5JT81 Q86X96,Prefoldin subunit 3,HIBBJ46;von Hippel-Lindau-binding protein 1;, PF02996;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005844;GO:0016272;GO:0001540;GO:0015631;GO:0051082;GO:0007017;GO:1905907;GO:0006457;GO:0007021;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:polysome; C:prefoldin complex;, F:amyloid-beta binding; F:tubulin binding; F:unfolded protein binding;, P:microtubule-based process; P:negative regulation of amyloid fibril formation; P:protein folding; P:tubulin complex assembly;|P61758 B2R8L5 B4DWR3 F5H2A7 O55228 Q15765 Q5JT81 Q86X96,Prefoldin subunit 3,HIBBJ46;von Hippel-Lindau-binding protein 1;, PF02996;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005844;GO:0016272;GO:0001540;GO:0015631;GO:0051082;GO:0007017;GO:1905907;GO:0006457;GO:0007021;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:polysome; C:prefoldin complex;, F:amyloid-beta binding; F:tubulin binding; F:unfolded protein binding;, P:microtubule-based process; P:negative regulation of amyloid fibril formation; P:protein folding; P:tubulin complex assembly; scaffold127 indexed_genome mRNA 599067 656294 . - . ID=transcript_13854;Q16107 Q53YX5 Q9BTZ6,Lys-63-specific deubiquitinase BRCC36,BRCA1-A complex subunit BRCC36;BRCA1/BRCA2-containing complex subunit 3;BRCA1/BRCA2-containing complex subunit 36;BRISC complex subunit BRCC36;, PF18110;PF01398;, GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0000152;GO:0005654;GO:0005634;GO:0000922;GO:0000151;GO:0030234;GO:0070122;GO:0046872;GO:0008237;GO:0031593;GO:0004843;GO:0007049;GO:0051301;GO:0006302;GO:0006303;GO:0070537;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0010165;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear ubiquitin ligase complex; C:nucleoplasm; C:nucleus; C:spindle pole; C:ubiquitin ligase complex;, F:enzyme regulator activity; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:polyubiquitin modification-dependent protein binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cell cycle; P:cell division; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H2A K63-linked deubiquitination; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:response to X-ray; P:signal transduction involved in G2 DNA damage checkpoint;|Q16107 Q53YX5 Q9BTZ6,Lys-63-specific deubiquitinase BRCC36,BRCA1-A complex subunit BRCC36;BRCA1/BRCA2-containing complex subunit 3;BRCA1/BRCA2-containing complex subunit 36;BRISC complex subunit BRCC36;, PF18110;PF01398;, GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0000152;GO:0005654;GO:0005634;GO:0000922;GO:0000151;GO:0030234;GO:0070122;GO:0046872;GO:0008237;GO:0031593;GO:0004843;GO:0007049;GO:0051301;GO:0006302;GO:0006303;GO:0070537;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0010165;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear ubiquitin ligase complex; C:nucleoplasm; C:nucleus; C:spindle pole; C:ubiquitin ligase complex;, F:enzyme regulator activity; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:polyubiquitin modification-dependent protein binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cell cycle; P:cell division; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H2A K63-linked deubiquitination; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:response to X-ray; P:signal transduction involved in G2 DNA damage checkpoint;|Q16107 Q53YX5 Q9BTZ6,Lys-63-specific deubiquitinase BRCC36,BRCA1-A complex subunit BRCC36;BRCA1/BRCA2-containing complex subunit 3;BRCA1/BRCA2-containing complex subunit 36;BRISC complex subunit BRCC36;, PF18110;PF01398;, GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0000152;GO:0005654;GO:0005634;GO:0000922;GO:0000151;GO:0030234;GO:0070122;GO:0046872;GO:0008237;GO:0031593;GO:0004843;GO:0007049;GO:0051301;GO:0006302;GO:0006303;GO:0070537;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0010165;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear ubiquitin ligase complex; C:nucleoplasm; C:nucleus; C:spindle pole; C:ubiquitin ligase complex;, F:enzyme regulator activity; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:polyubiquitin modification-dependent protein binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cell cycle; P:cell division; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H2A K63-linked deubiquitination; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:response to X-ray; P:signal transduction involved in G2 DNA damage checkpoint;|Q16107 Q53YX5 Q9BTZ6,Lys-63-specific deubiquitinase BRCC36,BRCA1-A complex subunit BRCC36;BRCA1/BRCA2-containing complex subunit 3;BRCA1/BRCA2-containing complex subunit 36;BRISC complex subunit BRCC36;, PF18110;PF01398;, GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0000152;GO:0005654;GO:0005634;GO:0000922;GO:0000151;GO:0030234;GO:0070122;GO:0046872;GO:0008237;GO:0031593;GO:0004843;GO:0007049;GO:0051301;GO:0006302;GO:0006303;GO:0070537;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0010165;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear ubiquitin ligase complex; C:nucleoplasm; C:nucleus; C:spindle pole; C:ubiquitin ligase complex;, F:enzyme regulator activity; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:polyubiquitin modification-dependent protein binding; F:thiol-dependent ubiquitin-specific protease activity;, P:cell cycle; P:cell division; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H2A K63-linked deubiquitination; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:response to X-ray; P:signal transduction involved in G2 DNA damage checkpoint; scaffold127 indexed_genome mRNA 661301 674045 . + . ID=transcript_13855;P56277 Q5HYP9,Cx9C motif-containing protein 4,Mature T-cell proliferation 1 neighbor protein;Mature T-cell proliferation-1 type A;Protein p8 MTCP-1;, PF08991;, GO:0005758;GO:0005739;, C:mitochondrial intermembrane space; C:mitochondrion;|P56278 Q5HYP2,Protein p13 MTCP-1,Mature T-cell proliferation-1 type B1;, PF01840;, GO:0032991;GO:0019901;GO:0043539;GO:0033138;GO:0071902;, C:protein-containing complex;, F:protein kinase binding; F:protein serine/threonine kinase activator activity;, P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein serine/threonine kinase activity; scaffold127 indexed_genome mRNA 680749 709518 . - . ID=transcript_13856;Q9BWH2 B2R7W5 D3DWY5 Q8NHX8 Q9H2I6,FUN14 domain-containing protein 2,Cervical cancer proto-oncogene 3 protein;Hepatitis C virus core-binding protein 6;, PF04930;, GO:0031307;GO:0005739;GO:0005634;GO:0000422;, C:integral component of mitochondrial outer membrane; C:mitochondrion; C:nucleus;, , P:autophagy of mitochondrion;|Q9BWH2 B2R7W5 D3DWY5 Q8NHX8 Q9H2I6,FUN14 domain-containing protein 2,Cervical cancer proto-oncogene 3 protein;Hepatitis C virus core-binding protein 6;, PF04930;, GO:0031307;GO:0005739;GO:0005634;GO:0000422;, C:integral component of mitochondrial outer membrane; C:mitochondrion; C:nucleus;, , P:autophagy of mitochondrion;|Q9BWH2 B2R7W5 D3DWY5 Q8NHX8 Q9H2I6,FUN14 domain-containing protein 2,Cervical cancer proto-oncogene 3 protein;Hepatitis C virus core-binding protein 6;, PF04930;, GO:0031307;GO:0005739;GO:0005634;GO:0000422;, C:integral component of mitochondrial outer membrane; C:mitochondrion; C:nucleus;, , P:autophagy of mitochondrion; scaffold127 indexed_genome mRNA 728678 869425 . + . ID=transcript_13857;P00451 Q14286 Q5HY69,Coagulation factor VIII,Antihemophilic factor;Procoagulant component;, PF00394;PF07731;PF07732;PF00754;, GO:0030134;GO:0005788;GO:0033116;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0031093;GO:0005507;GO:0016491;GO:0006953;GO:0007596;GO:0007597;GO:0048208;GO:0006888;GO:2000267;GO:0002576;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane; C:platelet alpha granule lumen;, F:copper ion binding; F:oxidoreductase activity;, P:acute-phase response; P:blood coagulation; P:blood coagulation, intrinsic pathway; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of blood coagulation, intrinsic pathway; P:platelet degranulation;|P00451 Q14286 Q5HY69,Coagulation factor VIII,Antihemophilic factor;Procoagulant component;, PF00394;PF07731;PF07732;PF00754;, GO:0030134;GO:0005788;GO:0033116;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0031093;GO:0005507;GO:0016491;GO:0006953;GO:0007596;GO:0007597;GO:0048208;GO:0006888;GO:2000267;GO:0002576;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane; C:platelet alpha granule lumen;, F:copper ion binding; F:oxidoreductase activity;, P:acute-phase response; P:blood coagulation; P:blood coagulation, intrinsic pathway; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of blood coagulation, intrinsic pathway; P:platelet degranulation;|P00451 Q14286 Q5HY69,Coagulation factor VIII,Antihemophilic factor;Procoagulant component;, PF00394;PF07731;PF07732;PF00754;, GO:0030134;GO:0005788;GO:0033116;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0031093;GO:0005507;GO:0016491;GO:0006953;GO:0007596;GO:0007597;GO:0048208;GO:0006888;GO:2000267;GO:0002576;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane; C:platelet alpha granule lumen;, F:copper ion binding; F:oxidoreductase activity;, P:acute-phase response; P:blood coagulation; P:blood coagulation, intrinsic pathway; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of blood coagulation, intrinsic pathway; P:platelet degranulation;|P00451 Q14286 Q5HY69,Coagulation factor VIII,Antihemophilic factor;Procoagulant component;, PF00394;PF07731;PF07732;PF00754;, GO:0030134;GO:0005788;GO:0033116;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:0031093;GO:0005507;GO:0016491;GO:0006953;GO:0007596;GO:0007597;GO:0048208;GO:0006888;GO:2000267;GO:0002576;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane; C:platelet alpha granule lumen;, F:copper ion binding; F:oxidoreductase activity;, P:acute-phase response; P:blood coagulation; P:blood coagulation, intrinsic pathway; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of blood coagulation, intrinsic pathway; P:platelet degranulation; scaffold127 indexed_genome mRNA 883133 910390 . + . ID=transcript_13858;Q00013 B4DZV5 G3XAI1 Q2TSB6 Q5J7V5,55 kDa erythrocyte membrane protein,Membrane protein, palmitoylated 1;, PF00625;PF00595;PF00018;, GO:0034451;GO:0030863;GO:0016020;GO:0005886;GO:0032420;GO:0004385;GO:0090022;GO:0007165;, C:centriolar satellite; C:cortical cytoskeleton; C:membrane; C:plasma membrane; C:stereocilium;, F:guanylate kinase activity;, P:regulation of neutrophil chemotaxis; P:signal transduction;|Q00013 B4DZV5 G3XAI1 Q2TSB6 Q5J7V5,55 kDa erythrocyte membrane protein,Membrane protein, palmitoylated 1;, PF00625;PF00595;PF00018;, GO:0034451;GO:0030863;GO:0016020;GO:0005886;GO:0032420;GO:0004385;GO:0090022;GO:0007165;, C:centriolar satellite; C:cortical cytoskeleton; C:membrane; C:plasma membrane; C:stereocilium;, F:guanylate kinase activity;, P:regulation of neutrophil chemotaxis; P:signal transduction;|Q00013 B4DZV5 G3XAI1 Q2TSB6 Q5J7V5,55 kDa erythrocyte membrane protein,Membrane protein, palmitoylated 1;, PF00625;PF00595;PF00018;, GO:0034451;GO:0030863;GO:0016020;GO:0005886;GO:0032420;GO:0004385;GO:0090022;GO:0007165;, C:centriolar satellite; C:cortical cytoskeleton; C:membrane; C:plasma membrane; C:stereocilium;, F:guanylate kinase activity;, P:regulation of neutrophil chemotaxis; P:signal transduction; scaffold127 indexed_genome mRNA 911172 922945 . - . ID=transcript_13859;O60832 F5BSB3 O43845 Q96G67 Q9Y505,H/ACA ribonucleoprotein complex subunit DKC1,CBF5 homolog;Dyskerin;Nopp140-associated protein of 57 kDa;Nucleolar protein NAP57;Nucleolar protein family A member 4;snoRNP protein DKC1;, PF08068;PF01472;PF16198;PF01509;, GO:0072589;GO:0031429;GO:0090661;GO:0005737;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0034513;GO:0009982;GO:0003723;GO:0003720;GO:0070034;GO:0000495;GO:0000455;GO:1990481;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:1904872;GO:0006396;GO:0006364;GO:0031118;GO:0090666;GO:0031120;GO:0090669;GO:0007004;, C:box H/ACA scaRNP complex; C:box H/ACA snoRNP complex; C:box H/ACA telomerase RNP complex; C:cytoplasm; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:box H/ACA snoRNA binding; F:pseudouridine synthase activity; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:box H/ACA RNA 3'-end processing; P:enzyme-directed rRNA pseudouridine synthesis; P:mRNA pseudouridine synthesis; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:regulation of telomerase RNA localization to Cajal body; P:RNA processing; P:rRNA processing; P:rRNA pseudouridine synthesis; P:scaRNA localization to Cajal body; P:snRNA pseudouridine synthesis; P:telomerase RNA stabilization; P:telomere maintenance via telomerase;|O60832 F5BSB3 O43845 Q96G67 Q9Y505,H/ACA ribonucleoprotein complex subunit DKC1,CBF5 homolog;Dyskerin;Nopp140-associated protein of 57 kDa;Nucleolar protein NAP57;Nucleolar protein family A member 4;snoRNP protein DKC1;, PF08068;PF01472;PF16198;PF01509;, GO:0072589;GO:0031429;GO:0090661;GO:0005737;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0034513;GO:0009982;GO:0003723;GO:0003720;GO:0070034;GO:0000495;GO:0000455;GO:1990481;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:1904872;GO:0006396;GO:0006364;GO:0031118;GO:0090666;GO:0031120;GO:0090669;GO:0007004;, C:box H/ACA scaRNP complex; C:box H/ACA snoRNP complex; C:box H/ACA telomerase RNP complex; C:cytoplasm; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:box H/ACA snoRNA binding; F:pseudouridine synthase activity; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:box H/ACA RNA 3'-end processing; P:enzyme-directed rRNA pseudouridine synthesis; P:mRNA pseudouridine synthesis; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:regulation of telomerase RNA localization to Cajal body; P:RNA processing; P:rRNA processing; P:rRNA pseudouridine synthesis; P:scaRNA localization to Cajal body; P:snRNA pseudouridine synthesis; P:telomerase RNA stabilization; P:telomere maintenance via telomerase;|O60832 F5BSB3 O43845 Q96G67 Q9Y505,H/ACA ribonucleoprotein complex subunit DKC1,CBF5 homolog;Dyskerin;Nopp140-associated protein of 57 kDa;Nucleolar protein NAP57;Nucleolar protein family A member 4;snoRNP protein DKC1;, PF08068;PF01472;PF16198;PF01509;, GO:0072589;GO:0031429;GO:0090661;GO:0005737;GO:0001650;GO:0005730;GO:0005654;GO:0005634;GO:0005697;GO:0034513;GO:0009982;GO:0003723;GO:0003720;GO:0070034;GO:0000495;GO:0000455;GO:1990481;GO:1904851;GO:1904871;GO:0051973;GO:1904874;GO:0032212;GO:1904872;GO:0006396;GO:0006364;GO:0031118;GO:0090666;GO:0031120;GO:0090669;GO:0007004;, C:box H/ACA scaRNP complex; C:box H/ACA snoRNP complex; C:box H/ACA telomerase RNP complex; C:cytoplasm; C:fibrillar center; C:nucleolus; C:nucleoplasm; C:nucleus; C:telomerase holoenzyme complex;, F:box H/ACA snoRNA binding; F:pseudouridine synthase activity; F:RNA binding; F:telomerase activity; F:telomerase RNA binding;, P:box H/ACA RNA 3'-end processing; P:enzyme-directed rRNA pseudouridine synthesis; P:mRNA pseudouridine synthesis; P:positive regulation of establishment of protein localization to telomere; P:positive regulation of protein localization to Cajal body; P:positive regulation of telomerase activity; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of telomere maintenance via telomerase; P:regulation of telomerase RNA localization to Cajal body; P:RNA processing; P:rRNA processing; P:rRNA pseudouridine synthesis; P:scaRNA localization to Cajal body; P:snRNA pseudouridine synthesis; P:telomerase RNA stabilization; P:telomere maintenance via telomerase; scaffold127 indexed_genome mRNA 969215 993827 . + . ID=transcript_13860;Q8WWW8 A6NHF8 E9PB44,GRB2-associated-binding protein 3,GRB2-associated binder 3;Growth factor receptor bound protein 2-associated protein 3;, PF00169;, GO:0030225;, , , P:macrophage differentiation; scaffold127 indexed_genome mRNA 1646395 2089697 . - . ID=transcript_13861;P51654 C9JLE3 G3V1R0 Q2L880 Q2L882,Glypican-3,GTR2-2;Intestinal protein OCI-5;MXR7;, PF01153;, GO:0046658;GO:0009986;GO:0062023;GO:0005788;GO:0005576;GO:0005796;GO:0031226;GO:0043202;GO:0005886;GO:0060422;GO:0009653;GO:0009948;GO:0010171;GO:0030282;GO:0001658;GO:0016477;GO:0042074;GO:0072111;GO:0072203;GO:0044267;GO:0060976;GO:0035116;GO:0006024;GO:0006027;GO:0030324;GO:0072138;GO:0072180;GO:0090090;GO:0050680;GO:0045926;GO:0045879;GO:0030316;GO:0030513;GO:0090263;GO:0045807;GO:0046326;GO:0045732;GO:0045880;GO:2000096;GO:0043687;GO:0060828;GO:2000050;GO:1905475;GO:0009617;GO:0001523;, C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:Golgi lumen; C:intrinsic component of plasma membrane; C:lysosomal lumen; C:plasma membrane;, F:peptidyl-dipeptidase inhibitor activity;, P:anatomical structure morphogenesis; P:anterior/posterior axis specification; P:body morphogenesis; P:bone mineralization; P:branching involved in ureteric bud morphogenesis; P:cell migration; P:cell migration involved in gastrulation; P:cell proliferation involved in kidney development; P:cell proliferation involved in metanephros development; P:cellular protein metabolic process; P:coronary vasculature development; P:embryonic hindlimb morphogenesis; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:lung development; P:mesenchymal cell proliferation involved in ureteric bud development; P:mesonephric duct morphogenesis; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of epithelial cell proliferation; P:negative regulation of growth; P:negative regulation of smoothened signaling pathway; P:osteoclast differentiation; P:positive regulation of BMP signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endocytosis; P:positive regulation of glucose import; P:positive regulation of protein catabolic process; P:positive regulation of smoothened signaling pathway; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; P:post-translational protein modification; P:regulation of canonical Wnt signaling pathway; P:regulation of non-canonical Wnt signaling pathway; P:regulation of protein localization to membrane; P:response to bacterium; P:retinoid metabolic process; scaffold127 indexed_genome mRNA 2277833 2285896 . + . ID=transcript_13862;A6NGH7,Coiled-coil domain-containing protein 160 scaffold127 indexed_genome mRNA 2353057 2406706 . + . ID=transcript_13863;Q8IWS0 A8K230 B4E0G4 D3DTG3 E9PC97 Q5JRC7 Q5JRC8 Q96JK3 Q9BRU0,PHD finger protein 6,PHD-like zinc finger protein;, , GO:0000777;GO:0005730;GO:0005654;GO:0005634;GO:0003677;GO:0019899;GO:0042393;GO:0042826;GO:0046872;GO:0051219;GO:0043021;GO:0003723;GO:0097110;GO:0015631;GO:0000122;GO:0006357;, C:condensed chromosome kinetochore; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA binding; F:enzyme binding; F:histone binding; F:histone deacetylase binding; F:metal ion binding; F:phosphoprotein binding; F:ribonucleoprotein complex binding; F:RNA binding; F:scaffold protein binding; F:tubulin binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold127 indexed_genome mRNA 2441879 2470980 . + . ID=transcript_13864;P00492 A6NHF0 B2R8M9,Hypoxanthine-guanine phosphoribosyltransferase,, PF00156;, GO:0005737;GO:0005829;GO:0070062;GO:0052657;GO:0004422;GO:0042802;GO:0000287;GO:0000166;GO:0006168;GO:0021954;GO:0021895;GO:0048813;GO:0042417;GO:0046038;GO:0032263;GO:0007625;GO:0006178;GO:0046100;GO:0043103;GO:0046040;GO:0032264;GO:0007626;GO:0046651;GO:0045964;GO:0051289;GO:0006164;GO:0006166;GO:0043101;GO:0001975;GO:0021756;GO:0001913;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:guanine phosphoribosyltransferase activity; F:hypoxanthine phosphoribosyltransferase activity; F:identical protein binding; F:magnesium ion binding; F:nucleotide binding;, P:adenine salvage; P:central nervous system neuron development; P:cerebral cortex neuron differentiation; P:dendrite morphogenesis; P:dopamine metabolic process; P:GMP catabolic process; P:GMP salvage; P:grooming behavior; P:guanine salvage; P:hypoxanthine metabolic process; P:hypoxanthine salvage; P:IMP metabolic process; P:IMP salvage; P:locomotory behavior; P:lymphocyte proliferation; P:positive regulation of dopamine metabolic process; P:protein homotetramerization; P:purine nucleotide biosynthetic process; P:purine ribonucleoside salvage; P:purine-containing compound salvage; P:response to amphetamine; P:striatum development; P:T cell mediated cytotoxicity;|P00492 A6NHF0 B2R8M9,Hypoxanthine-guanine phosphoribosyltransferase,, PF00156;, GO:0005737;GO:0005829;GO:0070062;GO:0052657;GO:0004422;GO:0042802;GO:0000287;GO:0000166;GO:0006168;GO:0021954;GO:0021895;GO:0048813;GO:0042417;GO:0046038;GO:0032263;GO:0007625;GO:0006178;GO:0046100;GO:0043103;GO:0046040;GO:0032264;GO:0007626;GO:0046651;GO:0045964;GO:0051289;GO:0006164;GO:0006166;GO:0043101;GO:0001975;GO:0021756;GO:0001913;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:guanine phosphoribosyltransferase activity; F:hypoxanthine phosphoribosyltransferase activity; F:identical protein binding; F:magnesium ion binding; F:nucleotide binding;, P:adenine salvage; P:central nervous system neuron development; P:cerebral cortex neuron differentiation; P:dendrite morphogenesis; P:dopamine metabolic process; P:GMP catabolic process; P:GMP salvage; P:grooming behavior; P:guanine salvage; P:hypoxanthine metabolic process; P:hypoxanthine salvage; P:IMP metabolic process; P:IMP salvage; P:locomotory behavior; P:lymphocyte proliferation; P:positive regulation of dopamine metabolic process; P:protein homotetramerization; P:purine nucleotide biosynthetic process; P:purine ribonucleoside salvage; P:purine-containing compound salvage; P:response to amphetamine; P:striatum development; P:T cell mediated cytotoxicity;|P00492 A6NHF0 B2R8M9,Hypoxanthine-guanine phosphoribosyltransferase,, PF00156;, GO:0005737;GO:0005829;GO:0070062;GO:0052657;GO:0004422;GO:0042802;GO:0000287;GO:0000166;GO:0006168;GO:0021954;GO:0021895;GO:0048813;GO:0042417;GO:0046038;GO:0032263;GO:0007625;GO:0006178;GO:0046100;GO:0043103;GO:0046040;GO:0032264;GO:0007626;GO:0046651;GO:0045964;GO:0051289;GO:0006164;GO:0006166;GO:0043101;GO:0001975;GO:0021756;GO:0001913;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:guanine phosphoribosyltransferase activity; F:hypoxanthine phosphoribosyltransferase activity; F:identical protein binding; F:magnesium ion binding; F:nucleotide binding;, P:adenine salvage; P:central nervous system neuron development; P:cerebral cortex neuron differentiation; P:dendrite morphogenesis; P:dopamine metabolic process; P:GMP catabolic process; P:GMP salvage; P:grooming behavior; P:guanine salvage; P:hypoxanthine metabolic process; P:hypoxanthine salvage; P:IMP metabolic process; P:IMP salvage; P:locomotory behavior; P:lymphocyte proliferation; P:positive regulation of dopamine metabolic process; P:protein homotetramerization; P:purine nucleotide biosynthetic process; P:purine ribonucleoside salvage; P:purine-containing compound salvage; P:response to amphetamine; P:striatum development; P:T cell mediated cytotoxicity; scaffold127 indexed_genome mRNA 2724152 2747264 . - . ID=transcript_13865;Q7Z309 A8K902 Q6PIM2 Q6ZU47 Q6ZV64 Q6ZVE4 Q8TB75,PABIR family member 2 {ECO:0000312|HGNC:HGNC:30490} scaffold127 indexed_genome mRNA 2757667 2760456 . + . ID=transcript_13866;Q6P4D5 F5H036 Q8WVK9,PABIR family member 1 {ECO:0000312|HGNC:HGNC:25202} scaffold128 indexed_genome mRNA 782 20011 . + . ID=transcript_13867;Q8NGA7,Adhesion G protein-coupled receptor E1 {ECO:0000303|PubMed:25713288},EGF-like module receptor 1;EGF-like module-containing mucin-like hormone receptor-like 1;EMR1 hormone receptor;, PF00002;PF12662;PF07645;PF01825;, GO:0005887;GO:0005509;GO:0004930;GO:0002250;GO:0007189;GO:0007155;GO:0007166;GO:0007186;, C:integral component of plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:adaptive immune response; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold128 indexed_genome mRNA 48837 110530 . - . ID=transcript_13868;P15498 B4DVK9 M0QXX6 Q15860,Proto-oncogene vav,, PF00130;PF11971;PF00169;PF00621;PF00017;PF00018;, GO:0005911;GO:0005829;GO:0005886;GO:0005085;GO:0046872;GO:0140031;GO:0001784;GO:0019221;GO:0038095;GO:0038096;GO:0007186;GO:0006955;GO:0007229;GO:0030593;GO:0030168;GO:0043065;GO:0043547;GO:0045954;GO:0051897;GO:0046579;GO:0072593;GO:0008361;GO:0043087;GO:0051056;GO:0007264;GO:0031295;GO:0030217;GO:0048010;, C:cell-cell junction; C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphorylation-dependent protein binding; F:phosphotyrosine residue binding;, P:cytokine-mediated signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:immune response; P:integrin-mediated signaling pathway; P:neutrophil chemotaxis; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of GTPase activity; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of protein kinase B signaling; P:positive regulation of Ras protein signal transduction; P:reactive oxygen species metabolic process; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; P:T cell costimulation; P:T cell differentiation; P:vascular endothelial growth factor receptor signaling pathway;|P15498 B4DVK9 M0QXX6 Q15860,Proto-oncogene vav,, PF00130;PF11971;PF00169;PF00621;PF00017;PF00018;, GO:0005911;GO:0005829;GO:0005886;GO:0005085;GO:0046872;GO:0140031;GO:0001784;GO:0019221;GO:0038095;GO:0038096;GO:0007186;GO:0006955;GO:0007229;GO:0030593;GO:0030168;GO:0043065;GO:0043547;GO:0045954;GO:0051897;GO:0046579;GO:0072593;GO:0008361;GO:0043087;GO:0051056;GO:0007264;GO:0031295;GO:0030217;GO:0048010;, C:cell-cell junction; C:cytosol; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphorylation-dependent protein binding; F:phosphotyrosine residue binding;, P:cytokine-mediated signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:immune response; P:integrin-mediated signaling pathway; P:neutrophil chemotaxis; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of GTPase activity; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of protein kinase B signaling; P:positive regulation of Ras protein signal transduction; P:reactive oxygen species metabolic process; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:small GTPase mediated signal transduction; P:T cell costimulation; P:T cell differentiation; P:vascular endothelial growth factor receptor signaling pathway; scaffold128 indexed_genome mRNA 118040 128514 . + . ID=transcript_13869;Q9BRG2 A8K9R6 B4DRS7 Q9Y2X4,SH2 domain-containing protein 3A,Novel SH2-containing protein 1;, PF00017;, GO:0005085;GO:0001784;GO:0007254;GO:0033138;GO:0007264;, , F:guanyl-nucleotide exchange factor activity; F:phosphotyrosine residue binding;, P:JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:small GTPase mediated signal transduction;|Q9BRG2 A8K9R6 B4DRS7 Q9Y2X4,SH2 domain-containing protein 3A,Novel SH2-containing protein 1;, PF00017;, GO:0005085;GO:0001784;GO:0007254;GO:0033138;GO:0007264;, , F:guanyl-nucleotide exchange factor activity; F:phosphotyrosine residue binding;, P:JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:small GTPase mediated signal transduction; scaffold128 indexed_genome mRNA 128820 138177 . - . ID=transcript_13870;Q8TCY1 Q8TDX3 Q96RJ1,Cdc42-interacting protein 4,Protein Felic;Salt tolerant protein;Thyroid receptor-interacting protein 10;, PF00611;PF00018;, GO:0005938;GO:0042995;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0043231;GO:0005764;GO:0005654;GO:0048471;GO:0001891;GO:0042802;GO:0008289;GO:0030036;GO:0007154;GO:0006897;GO:0061024;GO:0051056;GO:0007165;, C:cell cortex; C:cell projection; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:nucleoplasm; C:perinuclear region of cytoplasm; C:phagocytic cup;, F:identical protein binding; F:lipid binding;, P:actin cytoskeleton organization; P:cell communication; P:endocytosis; P:membrane organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q8TCY1 Q8TDX3 Q96RJ1,Cdc42-interacting protein 4,Protein Felic;Salt tolerant protein;Thyroid receptor-interacting protein 10;, PF00611;PF00018;, GO:0005938;GO:0042995;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0043231;GO:0005764;GO:0005654;GO:0048471;GO:0001891;GO:0042802;GO:0008289;GO:0030036;GO:0007154;GO:0006897;GO:0061024;GO:0051056;GO:0007165;, C:cell cortex; C:cell projection; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:nucleoplasm; C:perinuclear region of cytoplasm; C:phagocytic cup;, F:identical protein binding; F:lipid binding;, P:actin cytoskeleton organization; P:cell communication; P:endocytosis; P:membrane organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q8TCY1 Q8TDX3 Q96RJ1,Cdc42-interacting protein 4,Protein Felic;Salt tolerant protein;Thyroid receptor-interacting protein 10;, PF00611;PF00018;, GO:0005938;GO:0042995;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0043231;GO:0005764;GO:0005654;GO:0048471;GO:0001891;GO:0042802;GO:0008289;GO:0030036;GO:0007154;GO:0006897;GO:0061024;GO:0051056;GO:0007165;, C:cell cortex; C:cell projection; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:nucleoplasm; C:perinuclear region of cytoplasm; C:phagocytic cup;, F:identical protein binding; F:lipid binding;, P:actin cytoskeleton organization; P:cell communication; P:endocytosis; P:membrane organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q8TCY1 Q8TDX3 Q96RJ1,Cdc42-interacting protein 4,Protein Felic;Salt tolerant protein;Thyroid receptor-interacting protein 10;, PF00611;PF00018;, GO:0005938;GO:0042995;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0043231;GO:0005764;GO:0005654;GO:0048471;GO:0001891;GO:0042802;GO:0008289;GO:0030036;GO:0007154;GO:0006897;GO:0061024;GO:0051056;GO:0007165;, C:cell cortex; C:cell projection; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:nucleoplasm; C:perinuclear region of cytoplasm; C:phagocytic cup;, F:identical protein binding; F:lipid binding;, P:actin cytoskeleton organization; P:cell communication; P:endocytosis; P:membrane organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q8TCY1 Q8TDX3 Q96RJ1,Cdc42-interacting protein 4,Protein Felic;Salt tolerant protein;Thyroid receptor-interacting protein 10;, PF00611;PF00018;, GO:0005938;GO:0042995;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005794;GO:0043231;GO:0005764;GO:0005654;GO:0048471;GO:0001891;GO:0042802;GO:0008289;GO:0030036;GO:0007154;GO:0006897;GO:0061024;GO:0051056;GO:0007165;, C:cell cortex; C:cell projection; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lysosome; C:nucleoplasm; C:perinuclear region of cytoplasm; C:phagocytic cup;, F:identical protein binding; F:lipid binding;, P:actin cytoskeleton organization; P:cell communication; P:endocytosis; P:membrane organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold128 indexed_genome mRNA 143345 147858 . + . ID=transcript_13871;Q9NPR9 B9EJD7,Protein GPR108,Lung seven transmembrane receptor 2;, PF06814;, GO:0005794;GO:0016021;GO:0016020;, C:Golgi apparatus; C:integral component of membrane; C:membrane;|Q9NPR9 B9EJD7,Protein GPR108,Lung seven transmembrane receptor 2;, PF06814;, GO:0005794;GO:0016021;GO:0016020;, C:Golgi apparatus; C:integral component of membrane; C:membrane;|Q9NPR9 B9EJD7,Protein GPR108,Lung seven transmembrane receptor 2;, PF06814;, GO:0005794;GO:0016021;GO:0016020;, C:Golgi apparatus; C:integral component of membrane; C:membrane;|Q9NPR9 B9EJD7,Protein GPR108,Lung seven transmembrane receptor 2;, PF06814;, GO:0005794;GO:0016021;GO:0016020;, C:Golgi apparatus; C:integral component of membrane; C:membrane;|Q9NPR9 B9EJD7,Protein GPR108,Lung seven transmembrane receptor 2;, PF06814;, GO:0005794;GO:0016021;GO:0016020;, C:Golgi apparatus; C:integral component of membrane; C:membrane; scaffold128 indexed_genome mRNA 148018 149760 . + . ID=transcript_13872;Q9NPR9 B9EJD7,Protein GPR108,Lung seven transmembrane receptor 2;, PF06814;, GO:0005794;GO:0016021;GO:0016020;, C:Golgi apparatus; C:integral component of membrane; C:membrane;|Q9NPR9 B9EJD7,Protein GPR108,Lung seven transmembrane receptor 2;, PF06814;, GO:0005794;GO:0016021;GO:0016020;, C:Golgi apparatus; C:integral component of membrane; C:membrane; scaffold128 indexed_genome mRNA 157689 194004 . + . ID=transcript_13873;P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning;|P01024 A7E236,Complement C3,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1;, PF00207;PF07703;PF07677;PF01821;PF17790;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0035578;GO:0072562;GO:0009986;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0032991;GO:0034774;GO:0031715;GO:0004866;GO:0005102;GO:0097242;GO:1905114;GO:0044267;GO:0006956;GO:0006957;GO:0006958;GO:0097278;GO:0150062;GO:0006631;GO:0007186;GO:0006955;GO:0006954;GO:0016322;GO:0043312;GO:0035846;GO:0001970;GO:0045766;GO:2000427;GO:0045745;GO:0010828;GO:0010884;GO:0060100;GO:0001934;GO:0048260;GO:0001798;GO:0010575;GO:0043687;GO:0035590;GO:0030449;GO:0050776;GO:0010866;GO:0009617;GO:0007165;GO:0150064;, C:azurophil granule lumen; C:blood microparticle; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:protein-containing complex; C:secretory granule lumen;, F:C5L2 anaphylatoxin chemotactic receptor binding; F:endopeptidase inhibitor activity; F:signaling receptor binding;, P:amyloid-beta clearance; P:cell surface receptor signaling pathway involved in cell-cell signaling; P:cellular protein metabolic process; P:complement activation; P:complement activation, alternative pathway; P:complement activation, classical pathway; P:complement-dependent cytotoxicity; P:complement-mediated synapse pruning; P:fatty acid metabolic process; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:neuron remodeling; P:neutrophil degranulation; P:oviduct epithelium development; P:positive regulation of activation of membrane attack complex; P:positive regulation of angiogenesis; P:positive regulation of apoptotic cell clearance; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of glucose transmembrane transport; P:positive regulation of lipid storage; P:positive regulation of phagocytosis, engulfment; P:positive regulation of protein phosphorylation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of type IIa hypersensitivity; P:positive regulation of vascular endothelial growth factor production; P:post-translational protein modification; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; P:regulation of immune response; P:regulation of triglyceride biosynthetic process; P:response to bacterium; P:signal transduction; P:vertebrate eye-specific patterning; scaffold128 indexed_genome mRNA 219336 222631 . + . ID=transcript_13874;O43557 A8K7M2 C9J5H4 O75476 Q6FHA1 Q8WVF8 Q96LD2,Tumor necrosis factor ligand superfamily member 14,Herpes virus entry mediator ligand;, PF00229;, GO:0005737;GO:0005615;GO:0016021;GO:0005886;GO:0043027;GO:0005125;GO:0042802;GO:0005102;GO:0005164;GO:0006915;GO:0071260;GO:0006955;GO:1901224;GO:0007165;GO:0042110;GO:0031295;GO:0043029;GO:0042098;GO:0033209;, C:cytoplasm; C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:cytokine activity; F:identical protein binding; F:signaling receptor binding; F:tumor necrosis factor receptor binding;, P:apoptotic process; P:cellular response to mechanical stimulus; P:immune response; P:positive regulation of NIK/NF-kappaB signaling; P:signal transduction; P:T cell activation; P:T cell costimulation; P:T cell homeostasis; P:T cell proliferation; P:tumor necrosis factor-mediated signaling pathway; scaffold128 indexed_genome mRNA 353592 357574 . - . ID=transcript_13875;P41273 Q2M3S2,Tumor necrosis factor ligand superfamily member 9,4-1BB ligand;, PF00229;, GO:0005615;GO:0016021;GO:0005886;GO:0005125;GO:0005102;GO:0005164;GO:0032813;GO:0007267;GO:0006955;GO:0042104;GO:0045585;GO:0042981;GO:0042129;GO:0033209;, C:extracellular space; C:integral component of membrane; C:plasma membrane;, F:cytokine activity; F:signaling receptor binding; F:tumor necrosis factor receptor binding; F:tumor necrosis factor receptor superfamily binding;, P:cell-cell signaling; P:immune response; P:positive regulation of activated T cell proliferation; P:positive regulation of cytotoxic T cell differentiation; P:regulation of apoptotic process; P:regulation of T cell proliferation; P:tumor necrosis factor-mediated signaling pathway; scaffold128 indexed_genome mRNA 364603 368217 . + . ID=transcript_13876;O14494 B7ZKN8 G3XA95 O60457 O60463 Q17RZ4,Phospholipid phosphatase 1 {ECO:0000305},Lipid phosphate phosphohydrolase 1;PAP2-alpha;Phosphatidate phosphohydrolase type 2a;Phosphatidic acid phosphatase 2a;, PF01569;, GO:0016324;GO:0005901;GO:0070062;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0106235;GO:0000810;GO:0042577;GO:0008195;GO:0042392;GO:0030521;GO:0006672;GO:0030518;GO:0008285;GO:0046839;GO:0006644;GO:0007205;GO:0019216;GO:0007165;GO:0030148;GO:0006670;, C:apical plasma membrane; C:caveola; C:extracellular exosome; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane;, F:ceramide-1-phosphate phosphatase activity; F:diacylglycerol diphosphate phosphatase activity; F:lipid phosphatase activity; F:phosphatidate phosphatase activity; F:sphingosine-1-phosphate phosphatase activity;, P:androgen receptor signaling pathway; P:ceramide metabolic process; P:intracellular steroid hormone receptor signaling pathway; P:negative regulation of cell population proliferation; P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of lipid metabolic process; P:signal transduction; P:sphingolipid biosynthetic process; P:sphingosine metabolic process; scaffold128 indexed_genome mRNA 369524 378401 . + . ID=transcript_13877;O14495 B2R651 D3DQ52 Q5U0F7 Q96GW0 Q99782,Phospholipid phosphatase 3 {ECO:0000305},Lipid phosphate phosphohydrolase 3;PAP2-beta;Phosphatidate phosphohydrolase type 2b;Phosphatidic acid phosphatase 2b;Vascular endothelial growth factor and type I collagen-inducible protein {ECO:0000303|PubMed:12660161};, PF01569;, GO:0005912;GO:0016323;GO:0070971;GO:0005789;GO:0033116;GO:0005794;GO:0000139;GO:0016021;GO:0005887;GO:0016020;GO:0045121;GO:0005886;GO:0005802;GO:0106235;GO:0005178;GO:0042577;GO:0008195;GO:0042392;GO:0060070;GO:0044329;GO:0044328;GO:0044330;GO:0033631;GO:0006672;GO:0034109;GO:0007229;GO:0001933;GO:0046839;GO:0006644;GO:0051091;GO:0050821;GO:0030111;GO:0006890;GO:0007165;GO:0030148;GO:0006670;, C:adherens junction; C:basolateral plasma membrane; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:plasma membrane; C:trans-Golgi network;, F:ceramide-1-phosphate phosphatase activity; F:integrin binding; F:lipid phosphatase activity; F:phosphatidate phosphatase activity; F:sphingosine-1-phosphate phosphatase activity;, P:canonical Wnt signaling pathway; P:canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion; P:canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration; P:canonical Wnt signaling pathway involved in positive regulation of wound healing; P:cell-cell adhesion mediated by integrin; P:ceramide metabolic process; P:homotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:negative regulation of protein phosphorylation; P:phospholipid dephosphorylation; P:phospholipid metabolic process; P:positive regulation of DNA-binding transcription factor activity; P:protein stabilization; P:regulation of Wnt signaling pathway; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:signal transduction; P:sphingolipid biosynthetic process; P:sphingosine metabolic process;|P04350 B3KQP4 Q969E5,Tubulin beta-4A chain,Tubulin 5 beta;Tubulin beta-4 chain;, PF00091;PF03953;, GO:0005930;GO:0005737;GO:0005829;GO:0070062;GO:0033269;GO:0005874;GO:0043209;GO:0043025;GO:0005634;GO:0005509;GO:0005525;GO:0003924;GO:0005200;GO:0097711;GO:0000086;GO:0000226;GO:0000278;GO:0031115;GO:0010389;, C:axoneme; C:cytoplasm; C:cytosol; C:extracellular exosome; C:internode region of axon; C:microtubule; C:myelin sheath; C:neuronal cell body; C:nucleus;, F:calcium ion binding; F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of microtubule polymerization; P:regulation of G2/M transition of mitotic cell cycle;|P04350 B3KQP4 Q969E5,Tubulin beta-4A chain,Tubulin 5 beta;Tubulin beta-4 chain;, PF00091;PF03953;, GO:0005930;GO:0005737;GO:0005829;GO:0070062;GO:0033269;GO:0005874;GO:0043209;GO:0043025;GO:0005634;GO:0005509;GO:0005525;GO:0003924;GO:0005200;GO:0097711;GO:0000086;GO:0000226;GO:0000278;GO:0031115;GO:0010389;, C:axoneme; C:cytoplasm; C:cytosol; C:extracellular exosome; C:internode region of axon; C:microtubule; C:myelin sheath; C:neuronal cell body; C:nucleus;, F:calcium ion binding; F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of microtubule polymerization; P:regulation of G2/M transition of mitotic cell cycle;|P04350 B3KQP4 Q969E5,Tubulin beta-4A chain,Tubulin 5 beta;Tubulin beta-4 chain;, PF00091;PF03953;, GO:0005930;GO:0005737;GO:0005829;GO:0070062;GO:0033269;GO:0005874;GO:0043209;GO:0043025;GO:0005634;GO:0005509;GO:0005525;GO:0003924;GO:0005200;GO:0097711;GO:0000086;GO:0000226;GO:0000278;GO:0031115;GO:0010389;, C:axoneme; C:cytoplasm; C:cytosol; C:extracellular exosome; C:internode region of axon; C:microtubule; C:myelin sheath; C:neuronal cell body; C:nucleus;, F:calcium ion binding; F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:mitotic cell cycle; P:negative regulation of microtubule polymerization; P:regulation of G2/M transition of mitotic cell cycle; scaffold128 indexed_genome mRNA 388042 399184 . + . ID=transcript_13878;Q8IV53 B4E051 D3PFD4 Q8NDB1 Q9H5Z2,DENN domain-containing protein 1C,Connecdenn 3 {ECO:0000303|PubMed:20154091};Protein FAM31C;, PF03455;PF02141;PF03456;, GO:0005813;GO:0030136;GO:0005829;GO:0043231;GO:0005654;GO:0005085;GO:1901981;GO:0032456;GO:0006897;, C:centrosome; C:clathrin-coated vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol phosphate binding;, P:endocytic recycling; P:endocytosis;|Q8IV53 B4E051 D3PFD4 Q8NDB1 Q9H5Z2,DENN domain-containing protein 1C,Connecdenn 3 {ECO:0000303|PubMed:20154091};Protein FAM31C;, PF03455;PF02141;PF03456;, GO:0005813;GO:0030136;GO:0005829;GO:0043231;GO:0005654;GO:0005085;GO:1901981;GO:0032456;GO:0006897;, C:centrosome; C:clathrin-coated vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol phosphate binding;, P:endocytic recycling; P:endocytosis;|Q8IV53 B4E051 D3PFD4 Q8NDB1 Q9H5Z2,DENN domain-containing protein 1C,Connecdenn 3 {ECO:0000303|PubMed:20154091};Protein FAM31C;, PF03455;PF02141;PF03456;, GO:0005813;GO:0030136;GO:0005829;GO:0043231;GO:0005654;GO:0005085;GO:1901981;GO:0032456;GO:0006897;, C:centrosome; C:clathrin-coated vesicle; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol phosphate binding;, P:endocytic recycling; P:endocytosis; scaffold128 indexed_genome mRNA 401781 415397 . + . ID=transcript_13879;Q9BV35 B4DGB6 Q4LBC2 Q705K3 Q86Y43 Q8N2N4 Q96NQ4,Calcium-binding mitochondrial carrier protein SCaMC-3,Mitochondrial ATP-Mg/Pi carrier protein 2;Mitochondrial Ca(2+)-dependent solute carrier protein 2;Small calcium-binding mitochondrial carrier protein 3;Solute carrier family 25 member 23;, PF13202;PF13499;PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005347;GO:0005509;GO:0036444;GO:0071277;GO:0006851;GO:0051561;GO:1900069;GO:0043457;GO:0002082;GO:0051282;GO:0097274;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:calcium import into the mitochondrion; P:cellular response to calcium ion; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration; P:regulation of cellular hyperosmotic salinity response; P:regulation of cellular respiration; P:regulation of oxidative phosphorylation; P:regulation of sequestering of calcium ion; P:urea homeostasis;|Q9BV35 B4DGB6 Q4LBC2 Q705K3 Q86Y43 Q8N2N4 Q96NQ4,Calcium-binding mitochondrial carrier protein SCaMC-3,Mitochondrial ATP-Mg/Pi carrier protein 2;Mitochondrial Ca(2+)-dependent solute carrier protein 2;Small calcium-binding mitochondrial carrier protein 3;Solute carrier family 25 member 23;, PF13202;PF13499;PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005347;GO:0005509;GO:0036444;GO:0071277;GO:0006851;GO:0051561;GO:1900069;GO:0043457;GO:0002082;GO:0051282;GO:0097274;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:calcium import into the mitochondrion; P:cellular response to calcium ion; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration; P:regulation of cellular hyperosmotic salinity response; P:regulation of cellular respiration; P:regulation of oxidative phosphorylation; P:regulation of sequestering of calcium ion; P:urea homeostasis;|Q9BV35 B4DGB6 Q4LBC2 Q705K3 Q86Y43 Q8N2N4 Q96NQ4,Calcium-binding mitochondrial carrier protein SCaMC-3,Mitochondrial ATP-Mg/Pi carrier protein 2;Mitochondrial Ca(2+)-dependent solute carrier protein 2;Small calcium-binding mitochondrial carrier protein 3;Solute carrier family 25 member 23;, PF13202;PF13499;PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005347;GO:0005509;GO:0036444;GO:0071277;GO:0006851;GO:0051561;GO:1900069;GO:0043457;GO:0002082;GO:0051282;GO:0097274;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:calcium import into the mitochondrion; P:cellular response to calcium ion; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration; P:regulation of cellular hyperosmotic salinity response; P:regulation of cellular respiration; P:regulation of oxidative phosphorylation; P:regulation of sequestering of calcium ion; P:urea homeostasis;|Q9BV35 B4DGB6 Q4LBC2 Q705K3 Q86Y43 Q8N2N4 Q96NQ4,Calcium-binding mitochondrial carrier protein SCaMC-3,Mitochondrial ATP-Mg/Pi carrier protein 2;Mitochondrial Ca(2+)-dependent solute carrier protein 2;Small calcium-binding mitochondrial carrier protein 3;Solute carrier family 25 member 23;, PF13202;PF13499;PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005347;GO:0005509;GO:0036444;GO:0071277;GO:0006851;GO:0051561;GO:1900069;GO:0043457;GO:0002082;GO:0051282;GO:0097274;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP transmembrane transporter activity; F:calcium ion binding;, P:calcium import into the mitochondrion; P:cellular response to calcium ion; P:mitochondrial calcium ion transmembrane transport; P:positive regulation of mitochondrial calcium ion concentration; P:regulation of cellular hyperosmotic salinity response; P:regulation of cellular respiration; P:regulation of oxidative phosphorylation; P:regulation of sequestering of calcium ion; P:urea homeostasis; scaffold128 indexed_genome mRNA 417848 425474 . - . ID=transcript_13880;Q8N5S1 A8MQ40 D6W642 Q8N7R4,Mitochondrial carrier protein SCaMC-3L {ECO:0000305},Mitochondrial ATP-Mg/Pi carrier protein SLC25A41 {ECO:0000305};Small calcium-binding mitochondrial carrier protein 3-like;Solute carrier family 25 member 41;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015217;GO:0005347;GO:0015866;GO:0015867;GO:0140021;GO:1990544;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:ADP transmembrane transporter activity; F:ATP transmembrane transporter activity;, P:ADP transport; P:ATP transport; P:mitochondrial ADP transmembrane transport; P:mitochondrial ATP transmembrane transport;|Q8N5S1 A8MQ40 D6W642 Q8N7R4,Mitochondrial carrier protein SCaMC-3L {ECO:0000305},Mitochondrial ATP-Mg/Pi carrier protein SLC25A41 {ECO:0000305};Small calcium-binding mitochondrial carrier protein 3-like;Solute carrier family 25 member 41;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0015217;GO:0005347;GO:0015866;GO:0015867;GO:0140021;GO:1990544;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:ADP transmembrane transporter activity; F:ATP transmembrane transporter activity;, P:ADP transport; P:ATP transport; P:mitochondrial ADP transmembrane transport; P:mitochondrial ATP transmembrane transport; scaffold128 indexed_genome mRNA 428938 437812 . + . ID=transcript_13881;Q92945 O00301 Q59EZ9 Q5U4P6 Q9UNT5 Q9UQH5,Far upstream element-binding protein 2,KH type-splicing regulatory protein;p75;, PF09005;PF00013;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0035925;GO:0003729;GO:0003723;GO:0061158;GO:0071345;GO:0010586;GO:0006397;GO:0051028;GO:0010989;GO:0045019;GO:0061014;GO:0010468;GO:0043488;GO:0006355;GO:0008380;GO:0000375;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to cytokine stimulus; P:miRNA metabolic process; P:mRNA processing; P:mRNA transport; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of mRNA catabolic process; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of transcription, DNA-templated; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q92945 O00301 Q59EZ9 Q5U4P6 Q9UNT5 Q9UQH5,Far upstream element-binding protein 2,KH type-splicing regulatory protein;p75;, PF09005;PF00013;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0035925;GO:0003729;GO:0003723;GO:0061158;GO:0071345;GO:0010586;GO:0006397;GO:0051028;GO:0010989;GO:0045019;GO:0061014;GO:0010468;GO:0043488;GO:0006355;GO:0008380;GO:0000375;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to cytokine stimulus; P:miRNA metabolic process; P:mRNA processing; P:mRNA transport; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of mRNA catabolic process; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of transcription, DNA-templated; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q92945 O00301 Q59EZ9 Q5U4P6 Q9UNT5 Q9UQH5,Far upstream element-binding protein 2,KH type-splicing regulatory protein;p75;, PF09005;PF00013;, GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0003677;GO:0035925;GO:0003729;GO:0003723;GO:0061158;GO:0071345;GO:0010586;GO:0006397;GO:0051028;GO:0010989;GO:0045019;GO:0061014;GO:0010468;GO:0043488;GO:0006355;GO:0008380;GO:0000375;, C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cellular response to cytokine stimulus; P:miRNA metabolic process; P:mRNA processing; P:mRNA transport; P:negative regulation of low-density lipoprotein particle clearance; P:negative regulation of nitric oxide biosynthetic process; P:positive regulation of mRNA catabolic process; P:regulation of gene expression; P:regulation of mRNA stability; P:regulation of transcription, DNA-templated; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold128 indexed_genome mRNA 451958 456929 . + . ID=transcript_13882;P35269 B2RCS0 Q9BWN0,General transcription factor IIF subunit 1,General transcription factor IIF 74 kDa subunit;Transcription initiation factor IIF subunit alpha;Transcription initiation factor RAP74;, PF05793;, GO:0030054;GO:0043231;GO:0005654;GO:0005634;GO:0032991;GO:0005669;GO:0005674;GO:0003677;GO:0019211;GO:1990841;GO:0019904;GO:0019903;GO:0003723;GO:0016251;GO:0001096;GO:0008134;GO:0006370;GO:0008543;GO:0000398;GO:0032091;GO:0045944;GO:0032968;GO:0050434;GO:0009615;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;, C:cell junction; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription factor TFIID complex; C:transcription factor TFIIF complex;, F:DNA binding; F:phosphatase activator activity; F:promoter-specific chromatin binding; F:protein domain specific binding; F:protein phosphatase binding; F:RNA binding; F:RNA polymerase II general transcription initiation factor activity; F:TFIIF-class transcription factor complex binding; F:transcription factor binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:response to virus; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; scaffold128 indexed_genome mRNA 461335 463434 . - . ID=transcript_13883;Q9BT30 B2R4U9 Q53FF3,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial,Alkylated DNA repair protein alkB homolog 7;Spermatogenesis cell proliferation-related protein;Spermatogenesis-associated protein 11;, PF13532;, GO:0005759;GO:0005739;GO:0051213;GO:0046872;GO:0006974;GO:0006631;GO:0010883;GO:1902445;, C:mitochondrial matrix; C:mitochondrion;, F:dioxygenase activity; F:metal ion binding;, P:cellular response to DNA damage stimulus; P:fatty acid metabolic process; P:regulation of lipid storage; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; scaffold128 indexed_genome mRNA 466714 472939 . - . ID=transcript_13884;Q16740 B2R4W5,ATP-dependent Clp protease proteolytic subunit, mitochondrial,Endopeptidase Clp;, PF00574;, GO:0009368;GO:0005759;GO:0005739;GO:0004176;GO:0051117;GO:0004175;GO:0042802;GO:0008233;GO:0004252;GO:0033619;GO:0006515;GO:0051603;, C:endopeptidase Clp complex; C:mitochondrial matrix; C:mitochondrion;, F:ATP-dependent peptidase activity; F:ATPase binding; F:endopeptidase activity; F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:membrane protein proteolysis; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis involved in cellular protein catabolic process;|Q16740 B2R4W5,ATP-dependent Clp protease proteolytic subunit, mitochondrial,Endopeptidase Clp;, PF00574;, GO:0009368;GO:0005759;GO:0005739;GO:0004176;GO:0051117;GO:0004175;GO:0042802;GO:0008233;GO:0004252;GO:0033619;GO:0006515;GO:0051603;, C:endopeptidase Clp complex; C:mitochondrial matrix; C:mitochondrion;, F:ATP-dependent peptidase activity; F:ATPase binding; F:endopeptidase activity; F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:membrane protein proteolysis; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis involved in cellular protein catabolic process;|Q16740 B2R4W5,ATP-dependent Clp protease proteolytic subunit, mitochondrial,Endopeptidase Clp;, PF00574;, GO:0009368;GO:0005759;GO:0005739;GO:0004176;GO:0051117;GO:0004175;GO:0042802;GO:0008233;GO:0004252;GO:0033619;GO:0006515;GO:0051603;, C:endopeptidase Clp complex; C:mitochondrial matrix; C:mitochondrion;, F:ATP-dependent peptidase activity; F:ATPase binding; F:endopeptidase activity; F:identical protein binding; F:peptidase activity; F:serine-type endopeptidase activity;, P:membrane protein proteolysis; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis involved in cellular protein catabolic process; scaffold128 indexed_genome mRNA 548629 602240 . + . ID=transcript_13885;Q03111 Q14768,Protein ENL,YEATS domain-containing protein 1;, PF17793;PF03366;, GO:0005829;GO:0001650;GO:0005654;GO:0008023;GO:0006469;GO:0006355;GO:0006366;GO:0006368;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:transcription elongation factor complex;, , P:negative regulation of protein kinase activity; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q03111 Q14768,Protein ENL,YEATS domain-containing protein 1;, PF17793;PF03366;, GO:0005829;GO:0001650;GO:0005654;GO:0008023;GO:0006469;GO:0006355;GO:0006366;GO:0006368;, C:cytosol; C:fibrillar center; C:nucleoplasm; C:transcription elongation factor complex;, , P:negative regulation of protein kinase activity; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold128 indexed_genome mRNA 702809 792649 . + . ID=transcript_13886;P48378 A8K581 B3KNC4 Q6IQ44 Q8SNA2,DNA-binding protein RFX2,Regulatory factor X 2;, PF04589;PF02257;, GO:0000785;GO:0005737;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0001675;GO:0060271;GO:0006357;GO:0007286;, C:chromatin; C:cytoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:acrosome assembly; P:cilium assembly; P:regulation of transcription by RNA polymerase II; P:spermatid development; scaffold128 indexed_genome mRNA 806794 858458 . + . ID=transcript_13887;Q9H6Z4 B2RAT8 O60405 O75759 O75760 Q9BT47 Q9UG74,Ran-binding protein 3,, PF00638;, GO:0005737;GO:0005643;GO:0005654;GO:0005634;GO:0070412;GO:0031267;GO:0043547;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:R-SMAD binding; F:small GTPase binding;, P:positive regulation of GTPase activity; P:protein export from nucleus;|Q9H6Z4 B2RAT8 O60405 O75759 O75760 Q9BT47 Q9UG74,Ran-binding protein 3,, PF00638;, GO:0005737;GO:0005643;GO:0005654;GO:0005634;GO:0070412;GO:0031267;GO:0043547;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:R-SMAD binding; F:small GTPase binding;, P:positive regulation of GTPase activity; P:protein export from nucleus;|Q9H6Z4 B2RAT8 O60405 O75759 O75760 Q9BT47 Q9UG74,Ran-binding protein 3,, PF00638;, GO:0005737;GO:0005643;GO:0005654;GO:0005634;GO:0070412;GO:0031267;GO:0043547;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:R-SMAD binding; F:small GTPase binding;, P:positive regulation of GTPase activity; P:protein export from nucleus;|Q9H6Z4 B2RAT8 O60405 O75759 O75760 Q9BT47 Q9UG74,Ran-binding protein 3,, PF00638;, GO:0005737;GO:0005643;GO:0005654;GO:0005634;GO:0070412;GO:0031267;GO:0043547;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:R-SMAD binding; F:small GTPase binding;, P:positive regulation of GTPase activity; P:protein export from nucleus;|Q9H6Z4 B2RAT8 O60405 O75759 O75760 Q9BT47 Q9UG74,Ran-binding protein 3,, PF00638;, GO:0005737;GO:0005643;GO:0005654;GO:0005634;GO:0070412;GO:0031267;GO:0043547;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:R-SMAD binding; F:small GTPase binding;, P:positive regulation of GTPase activity; P:protein export from nucleus;|Q9H6Z4 B2RAT8 O60405 O75759 O75760 Q9BT47 Q9UG74,Ran-binding protein 3,, PF00638;, GO:0005737;GO:0005643;GO:0005654;GO:0005634;GO:0070412;GO:0031267;GO:0043547;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:R-SMAD binding; F:small GTPase binding;, P:positive regulation of GTPase activity; P:protein export from nucleus; scaffold128 indexed_genome mRNA 865253 870629 . + . ID=transcript_13888;Q86Y39 C9JT23 Q6ZS66,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11,Complex I-B14.7;NADH-ubiquinone oxidoreductase subunit B14.7;, , GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, , P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold128 indexed_genome mRNA 904510 905523 . - . ID=transcript_13889;P51993 A6NEX0 D6W637 Q9UND8,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 {ECO:0000305},Fucosyltransferase 6;Fucosyltransferase VI;Galactoside 3-L-fucosyltransferase;, PF17039;PF00852;, GO:0070062;GO:0005576;GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0017083;GO:0046920;GO:0008417;GO:0006672;GO:0036065;GO:0042355;GO:0036071;GO:0009312;GO:0006486;, C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity; F:alpha-(1->3)-fucosyltransferase activity; F:fucosyltransferase activity;, P:ceramide metabolic process; P:fucosylation; P:L-fucose catabolic process; P:N-glycan fucosylation; P:oligosaccharide biosynthetic process; P:protein glycosylation;|Q11128 A8K4X2,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT5;Fucosyltransferase 5;Fucosyltransferase V;Galactoside 3-L-fucosyltransferase;, PF17039;PF00852;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0017060;GO:0017083;GO:0046920;GO:0008417;GO:0005975;GO:0006672;GO:0036065;GO:0042355;GO:0009312;GO:0009311;GO:0006486;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity; F:4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity; F:alpha-(1->3)-fucosyltransferase activity; F:fucosyltransferase activity;, P:carbohydrate metabolic process; P:ceramide metabolic process; P:fucosylation; P:L-fucose catabolic process; P:oligosaccharide biosynthetic process; P:oligosaccharide metabolic process; P:protein glycosylation; scaffold128 indexed_genome mRNA 938413 947380 . + . ID=transcript_13890;Q96G46 Q96HM5 Q9BSU4 Q9H877 Q9NPR1,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like,tRNA-dihydrouridine synthase 3-like;, PF01207;PF18044;, GO:0050660;GO:0046872;GO:0003723;GO:0017150;, , F:flavin adenine dinucleotide binding; F:metal ion binding; F:RNA binding; F:tRNA dihydrouridine synthase activity;|Q96G46 Q96HM5 Q9BSU4 Q9H877 Q9NPR1,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like,tRNA-dihydrouridine synthase 3-like;, PF01207;PF18044;, GO:0050660;GO:0046872;GO:0003723;GO:0017150;, , F:flavin adenine dinucleotide binding; F:metal ion binding; F:RNA binding; F:tRNA dihydrouridine synthase activity;|Q8IZ63 E9PB31,Proline-rich protein 22,, PF15776; scaffold128 indexed_genome mRNA 989668 1003618 . + . ID=transcript_13891;P36776 B3KPH8 D6W635 E5KMH8 F5GZ27 P36777 Q8N8K8 Q9UQ95,Lon protease homolog, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03120},LONHs;Lon protease-like protein {ECO:0000255|HAMAP-Rule:MF_03120};Mitochondrial ATP-dependent protease Lon {ECO:0000255|HAMAP-Rule:MF_03120};Serine protease 15 {ECO:0000255|HAMAP-Rule:MF_03120};, PF00004;PF05362;PF02190;, GO:0005829;GO:0016020;GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0043531;GO:0005524;GO:0004176;GO:0016887;GO:0070182;GO:0051880;GO:0042802;GO:0001018;GO:0043565;GO:0004252;GO:0003697;GO:0003727;GO:0007568;GO:0034599;GO:0051131;GO:0032042;GO:0000002;GO:0007005;GO:0070407;GO:0006515;GO:0051603;GO:0010044;GO:0009725;GO:0001666;, C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm;, F:ADP binding; F:ATP binding; F:ATP-dependent peptidase activity; F:ATPase activity; F:DNA polymerase binding; F:G-quadruplex DNA binding; F:identical protein binding; F:mitochondrial promoter sequence-specific DNA binding; F:sequence-specific DNA binding; F:serine-type endopeptidase activity; F:single-stranded DNA binding; F:single-stranded RNA binding;, P:aging; P:cellular response to oxidative stress; P:chaperone-mediated protein complex assembly; P:mitochondrial DNA metabolic process; P:mitochondrial genome maintenance; P:mitochondrion organization; P:oxidation-dependent protein catabolic process; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis involved in cellular protein catabolic process; P:response to aluminum ion; P:response to hormone; P:response to hypoxia;|P36776 B3KPH8 D6W635 E5KMH8 F5GZ27 P36777 Q8N8K8 Q9UQ95,Lon protease homolog, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03120},LONHs;Lon protease-like protein {ECO:0000255|HAMAP-Rule:MF_03120};Mitochondrial ATP-dependent protease Lon {ECO:0000255|HAMAP-Rule:MF_03120};Serine protease 15 {ECO:0000255|HAMAP-Rule:MF_03120};, PF00004;PF05362;PF02190;, GO:0005829;GO:0016020;GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0043531;GO:0005524;GO:0004176;GO:0016887;GO:0070182;GO:0051880;GO:0042802;GO:0001018;GO:0043565;GO:0004252;GO:0003697;GO:0003727;GO:0007568;GO:0034599;GO:0051131;GO:0032042;GO:0000002;GO:0007005;GO:0070407;GO:0006515;GO:0051603;GO:0010044;GO:0009725;GO:0001666;, C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm;, F:ADP binding; F:ATP binding; F:ATP-dependent peptidase activity; F:ATPase activity; F:DNA polymerase binding; F:G-quadruplex DNA binding; F:identical protein binding; F:mitochondrial promoter sequence-specific DNA binding; F:sequence-specific DNA binding; F:serine-type endopeptidase activity; F:single-stranded DNA binding; F:single-stranded RNA binding;, P:aging; P:cellular response to oxidative stress; P:chaperone-mediated protein complex assembly; P:mitochondrial DNA metabolic process; P:mitochondrial genome maintenance; P:mitochondrion organization; P:oxidation-dependent protein catabolic process; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis involved in cellular protein catabolic process; P:response to aluminum ion; P:response to hormone; P:response to hypoxia; scaffold128 indexed_genome mRNA 1003667 1014484 . - . ID=transcript_13892;P36776 B3KPH8 D6W635 E5KMH8 F5GZ27 P36777 Q8N8K8 Q9UQ95,Lon protease homolog, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03120},LONHs;Lon protease-like protein {ECO:0000255|HAMAP-Rule:MF_03120};Mitochondrial ATP-dependent protease Lon {ECO:0000255|HAMAP-Rule:MF_03120};Serine protease 15 {ECO:0000255|HAMAP-Rule:MF_03120};, PF00004;PF05362;PF02190;, GO:0005829;GO:0016020;GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0043531;GO:0005524;GO:0004176;GO:0016887;GO:0070182;GO:0051880;GO:0042802;GO:0001018;GO:0043565;GO:0004252;GO:0003697;GO:0003727;GO:0007568;GO:0034599;GO:0051131;GO:0032042;GO:0000002;GO:0007005;GO:0070407;GO:0006515;GO:0051603;GO:0010044;GO:0009725;GO:0001666;, C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm;, F:ADP binding; F:ATP binding; F:ATP-dependent peptidase activity; F:ATPase activity; F:DNA polymerase binding; F:G-quadruplex DNA binding; F:identical protein binding; F:mitochondrial promoter sequence-specific DNA binding; F:sequence-specific DNA binding; F:serine-type endopeptidase activity; F:single-stranded DNA binding; F:single-stranded RNA binding;, P:aging; P:cellular response to oxidative stress; P:chaperone-mediated protein complex assembly; P:mitochondrial DNA metabolic process; P:mitochondrial genome maintenance; P:mitochondrion organization; P:oxidation-dependent protein catabolic process; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis involved in cellular protein catabolic process; P:response to aluminum ion; P:response to hormone; P:response to hypoxia;|P36776 B3KPH8 D6W635 E5KMH8 F5GZ27 P36777 Q8N8K8 Q9UQ95,Lon protease homolog, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03120},LONHs;Lon protease-like protein {ECO:0000255|HAMAP-Rule:MF_03120};Mitochondrial ATP-dependent protease Lon {ECO:0000255|HAMAP-Rule:MF_03120};Serine protease 15 {ECO:0000255|HAMAP-Rule:MF_03120};, PF00004;PF05362;PF02190;, GO:0005829;GO:0016020;GO:0005759;GO:0042645;GO:0005739;GO:0005654;GO:0043531;GO:0005524;GO:0004176;GO:0016887;GO:0070182;GO:0051880;GO:0042802;GO:0001018;GO:0043565;GO:0004252;GO:0003697;GO:0003727;GO:0007568;GO:0034599;GO:0051131;GO:0032042;GO:0000002;GO:0007005;GO:0070407;GO:0006515;GO:0051603;GO:0010044;GO:0009725;GO:0001666;, C:cytosol; C:membrane; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleoplasm;, F:ADP binding; F:ATP binding; F:ATP-dependent peptidase activity; F:ATPase activity; F:DNA polymerase binding; F:G-quadruplex DNA binding; F:identical protein binding; F:mitochondrial promoter sequence-specific DNA binding; F:sequence-specific DNA binding; F:serine-type endopeptidase activity; F:single-stranded DNA binding; F:single-stranded RNA binding;, P:aging; P:cellular response to oxidative stress; P:chaperone-mediated protein complex assembly; P:mitochondrial DNA metabolic process; P:mitochondrial genome maintenance; P:mitochondrion organization; P:oxidation-dependent protein catabolic process; P:protein quality control for misfolded or incompletely synthesized proteins; P:proteolysis involved in cellular protein catabolic process; P:response to aluminum ion; P:response to hormone; P:response to hypoxia;|Q9Y3U8 B2R4Y1 D6W634 Q6FIG1 Q9UQF6,60S ribosomal protein L36,Large ribosomal subunit protein eL36 {ECO:0000303|PubMed:24524803};, PF01158;, GO:0005737;GO:0005829;GO:0022625;GO:0016020;GO:0005730;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:membrane; C:nucleolus; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q7Z5J1 Q05D45 Q52LF4 Q7Z5I9 Q7Z5J0 Q7Z5P5 Q7Z5P6 Q7Z5P7 Q7Z5P8,Hydroxysteroid 11-beta-dehydrogenase 1-like protein,11-beta-hydroxysteroid dehydrogenase type 3;Short chain dehydrogenase/reductase family 26C member 2;Short-chain dehydrogenase/reductase 10;, PF00106;, GO:0005576;GO:0043231;GO:0005654;GO:0016491;, C:extracellular region; C:intracellular membrane-bounded organelle; C:nucleoplasm;, F:oxidoreductase activity; scaffold128 indexed_genome mRNA 1016217 1020551 . + . ID=transcript_13893;Q5XKP0 A0A0B4J2A5 K7EKR0 Q86YE5,MICOS complex subunit MIC13 {ECO:0000305},Protein P117 {ECO:0000303|Ref.1};, PF15884;, GO:0140275;GO:0061617;GO:0044284;GO:0005743;GO:0005739;GO:0005654;GO:0001401;GO:0042407;GO:0007007;, C:MIB complex; C:MICOS complex; C:mitochondrial crista junction; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:SAM complex;, , P:cristae formation; P:inner mitochondrial membrane organization;|Q5XKP0 A0A0B4J2A5 K7EKR0 Q86YE5,MICOS complex subunit MIC13 {ECO:0000305},Protein P117 {ECO:0000303|Ref.1};, PF15884;, GO:0140275;GO:0061617;GO:0044284;GO:0005743;GO:0005739;GO:0005654;GO:0001401;GO:0042407;GO:0007007;, C:MIB complex; C:MICOS complex; C:mitochondrial crista junction; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:SAM complex;, , P:cristae formation; P:inner mitochondrial membrane organization; scaffold128 indexed_genome mRNA 1021043 1031707 . + . ID=transcript_13894;Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; scaffold128 indexed_genome mRNA 1031960 1052380 . - . ID=transcript_13895;Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; scaffold128 indexed_genome mRNA 1060370 1080551 . - . ID=transcript_13896;Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II;|Q15424 A0AV56 B7Z5B6 B7ZLP6 F5H0H3 O60406 Q59HH8,Scaffold attachment factor B1,HSP27 estrogen response element-TATA box-binding protein;, PF00076;PF02037;, GO:0030496;GO:0005654;GO:0005634;GO:0003682;GO:0003690;GO:0003723;GO:0000978;GO:0043565;GO:0006325;GO:0030520;GO:0050684;GO:0006357;, C:midbody; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:double-stranded DNA binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:chromatin organization; P:intracellular estrogen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; scaffold128 indexed_genome mRNA 1080761 1090489 . - . ID=transcript_13897;Q14151 B4DKG3 Q8TB13,Scaffold attachment factor B2,, PF00076;PF02037;, GO:0005737;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0043565;GO:0060765;GO:0050684;GO:0006357;GO:0060008;, C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:sequence-specific DNA binding;, P:regulation of androgen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:Sertoli cell differentiation; scaffold128 indexed_genome mRNA 1090907 1109585 . - . ID=transcript_13898;Q14151 B4DKG3 Q8TB13,Scaffold attachment factor B2,, PF00076;PF02037;, GO:0005737;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0043565;GO:0060765;GO:0050684;GO:0006357;GO:0060008;, C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:sequence-specific DNA binding;, P:regulation of androgen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:Sertoli cell differentiation;|Q14151 B4DKG3 Q8TB13,Scaffold attachment factor B2,, PF00076;PF02037;, GO:0005737;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0043565;GO:0060765;GO:0050684;GO:0006357;GO:0060008;, C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:sequence-specific DNA binding;, P:regulation of androgen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:Sertoli cell differentiation;|Q14151 B4DKG3 Q8TB13,Scaffold attachment factor B2,, PF00076;PF02037;, GO:0005737;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0043565;GO:0060765;GO:0050684;GO:0006357;GO:0060008;, C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:sequence-specific DNA binding;, P:regulation of androgen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:Sertoli cell differentiation;|Q14151 B4DKG3 Q8TB13,Scaffold attachment factor B2,, PF00076;PF02037;, GO:0005737;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0043565;GO:0060765;GO:0050684;GO:0006357;GO:0060008;, C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:sequence-specific DNA binding;, P:regulation of androgen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:Sertoli cell differentiation;|Q14151 B4DKG3 Q8TB13,Scaffold attachment factor B2,, PF00076;PF02037;, GO:0005737;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0043565;GO:0060765;GO:0050684;GO:0006357;GO:0060008;, C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:sequence-specific DNA binding;, P:regulation of androgen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:Sertoli cell differentiation;|Q14151 B4DKG3 Q8TB13,Scaffold attachment factor B2,, PF00076;PF02037;, GO:0005737;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0043565;GO:0060765;GO:0050684;GO:0006357;GO:0060008;, C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:sequence-specific DNA binding;, P:regulation of androgen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:Sertoli cell differentiation;|Q14151 B4DKG3 Q8TB13,Scaffold attachment factor B2,, PF00076;PF02037;, GO:0005737;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0043565;GO:0060765;GO:0050684;GO:0006357;GO:0060008;, C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:sequence-specific DNA binding;, P:regulation of androgen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:Sertoli cell differentiation;|Q14151 B4DKG3 Q8TB13,Scaffold attachment factor B2,, PF00076;PF02037;, GO:0005737;GO:0070062;GO:0043231;GO:0016604;GO:0005654;GO:0005634;GO:0042802;GO:0003723;GO:0043565;GO:0060765;GO:0050684;GO:0006357;GO:0060008;, C:cytoplasm; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nuclear body; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; F:sequence-specific DNA binding;, P:regulation of androgen receptor signaling pathway; P:regulation of mRNA processing; P:regulation of transcription by RNA polymerase II; P:Sertoli cell differentiation; scaffold128 indexed_genome mRNA 1354312 1388649 . + . ID=transcript_13899;Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7,Receptor-type tyrosine-protein phosphatase S,Receptor-type tyrosine-protein phosphatase sigma;, PF00041;PF07679;PF00102;, GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;, C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;, P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;|Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7,Receptor-type tyrosine-protein phosphatase S,Receptor-type tyrosine-protein phosphatase sigma;, PF00041;PF07679;PF00102;, GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;, C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;, P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion; scaffold128 indexed_genome mRNA 1391143 1410914 . - . ID=transcript_13900;Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7,Receptor-type tyrosine-protein phosphatase S,Receptor-type tyrosine-protein phosphatase sigma;, PF00041;PF07679;PF00102;, GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;, C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;, P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;|Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7,Receptor-type tyrosine-protein phosphatase S,Receptor-type tyrosine-protein phosphatase sigma;, PF00041;PF07679;PF00102;, GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;, C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;, P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;|Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7,Receptor-type tyrosine-protein phosphatase S,Receptor-type tyrosine-protein phosphatase sigma;, PF00041;PF07679;PF00102;, GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;, C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;, P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;|Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7,Receptor-type tyrosine-protein phosphatase S,Receptor-type tyrosine-protein phosphatase sigma;, PF00041;PF07679;PF00102;, GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;, C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;, P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;|Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7,Receptor-type tyrosine-protein phosphatase S,Receptor-type tyrosine-protein phosphatase sigma;, PF00041;PF07679;PF00102;, GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;, C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;, P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;|Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7,Receptor-type tyrosine-protein phosphatase S,Receptor-type tyrosine-protein phosphatase sigma;, PF00041;PF07679;PF00102;, GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;, C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;, P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion; scaffold128 indexed_genome mRNA 1459691 1462501 . + . ID=transcript_13901;O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation;|O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; scaffold128 indexed_genome mRNA 1462596 1464312 . - . ID=transcript_13902;O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; scaffold128 indexed_genome mRNA 1464548 1486782 . - . ID=transcript_13903;O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation;|O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation;|O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation;|O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; scaffold128 indexed_genome mRNA 1504971 1548787 . - . ID=transcript_13904;O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation;|O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation;|O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation;|O94953 B9EGN8 D6W631 O75274 Q6P3R5 Q9P1V1 Q9UF40,Lysine-specific demethylase 4B,JmjC domain-containing histone demethylation protein 3B;Jumonji domain-containing protein 2B;[histone H3]-trimethyl-L-lysine(9) demethylase 4B {ECO:0000305};, PF02373;PF02375;PF18104;, GO:0035097;GO:0005654;GO:0032452;GO:0051864;GO:0032454;GO:0046872;GO:0006338;GO:0006302;GO:0070544;GO:0033169;, C:histone methyltransferase complex; C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:metal ion binding;, P:chromatin remodeling; P:double-strand break repair; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; scaffold128 indexed_genome mRNA 1602377 1605787 . - . ID=transcript_13905;Q96T88 A0JBR2 A8K024 B2RBA9 Q2HIX7 Q8J022 Q9H6S6 Q9P115 Q9P1U7,E3 ubiquitin-protein ligase UHRF1,Inverted CCAAT box-binding protein of 90 kDa;Nuclear protein 95;Nuclear zinc finger protein Np95;RING finger protein 106;RING-type E3 ubiquitin transferase UHRF1;Transcription factor ICBP90;Ubiquitin-like PHD and RING finger domain-containing protein 1;Ubiquitin-like-containing PHD and RING finger domains protein 1;, PF00628;PF02182;PF12148;PF00240;, GO:0000785;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005657;GO:0000987;GO:0044729;GO:0042393;GO:0042802;GO:0008327;GO:0035064;GO:0031493;GO:0061630;GO:0004842;GO:0008270;GO:0007049;GO:0006281;GO:0010390;GO:0016574;GO:0010216;GO:0000122;GO:0032270;GO:2000373;GO:0045944;GO:0051865;GO:0016567;GO:0050678;GO:0006511;, C:chromatin; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:replication fork;, F:cis-regulatory region sequence-specific DNA binding; F:hemi-methylated DNA-binding; F:histone binding; F:identical protein binding; F:methyl-CpG binding; F:methylated histone binding; F:nucleosomal histone binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cell cycle; P:DNA repair; P:histone monoubiquitination; P:histone ubiquitination; P:maintenance of DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cellular protein metabolic process; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of transcription by RNA polymerase II; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of epithelial cell proliferation; P:ubiquitin-dependent protein catabolic process; scaffold128 indexed_genome mRNA 1616569 1625958 . - . ID=transcript_13906;Q96T88 A0JBR2 A8K024 B2RBA9 Q2HIX7 Q8J022 Q9H6S6 Q9P115 Q9P1U7,E3 ubiquitin-protein ligase UHRF1,Inverted CCAAT box-binding protein of 90 kDa;Nuclear protein 95;Nuclear zinc finger protein Np95;RING finger protein 106;RING-type E3 ubiquitin transferase UHRF1;Transcription factor ICBP90;Ubiquitin-like PHD and RING finger domain-containing protein 1;Ubiquitin-like-containing PHD and RING finger domains protein 1;, PF00628;PF02182;PF12148;PF00240;, GO:0000785;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005657;GO:0000987;GO:0044729;GO:0042393;GO:0042802;GO:0008327;GO:0035064;GO:0031493;GO:0061630;GO:0004842;GO:0008270;GO:0007049;GO:0006281;GO:0010390;GO:0016574;GO:0010216;GO:0000122;GO:0032270;GO:2000373;GO:0045944;GO:0051865;GO:0016567;GO:0050678;GO:0006511;, C:chromatin; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:replication fork;, F:cis-regulatory region sequence-specific DNA binding; F:hemi-methylated DNA-binding; F:histone binding; F:identical protein binding; F:methyl-CpG binding; F:methylated histone binding; F:nucleosomal histone binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cell cycle; P:DNA repair; P:histone monoubiquitination; P:histone ubiquitination; P:maintenance of DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cellular protein metabolic process; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of transcription by RNA polymerase II; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of epithelial cell proliferation; P:ubiquitin-dependent protein catabolic process;|Q96T88 A0JBR2 A8K024 B2RBA9 Q2HIX7 Q8J022 Q9H6S6 Q9P115 Q9P1U7,E3 ubiquitin-protein ligase UHRF1,Inverted CCAAT box-binding protein of 90 kDa;Nuclear protein 95;Nuclear zinc finger protein Np95;RING finger protein 106;RING-type E3 ubiquitin transferase UHRF1;Transcription factor ICBP90;Ubiquitin-like PHD and RING finger domain-containing protein 1;Ubiquitin-like-containing PHD and RING finger domains protein 1;, PF00628;PF02182;PF12148;PF00240;, GO:0000785;GO:0000791;GO:0000792;GO:0016363;GO:0005654;GO:0005634;GO:0005657;GO:0000987;GO:0044729;GO:0042393;GO:0042802;GO:0008327;GO:0035064;GO:0031493;GO:0061630;GO:0004842;GO:0008270;GO:0007049;GO:0006281;GO:0010390;GO:0016574;GO:0010216;GO:0000122;GO:0032270;GO:2000373;GO:0045944;GO:0051865;GO:0016567;GO:0050678;GO:0006511;, C:chromatin; C:euchromatin; C:heterochromatin; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:replication fork;, F:cis-regulatory region sequence-specific DNA binding; F:hemi-methylated DNA-binding; F:histone binding; F:identical protein binding; F:methyl-CpG binding; F:methylated histone binding; F:nucleosomal histone binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:cell cycle; P:DNA repair; P:histone monoubiquitination; P:histone ubiquitination; P:maintenance of DNA methylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cellular protein metabolic process; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of transcription by RNA polymerase II; P:protein autoubiquitination; P:protein ubiquitination; P:regulation of epithelial cell proliferation; P:ubiquitin-dependent protein catabolic process; scaffold128 indexed_genome mRNA 1635086 1637805 . - . ID=transcript_13907;A6NEK1,Arrestin domain-containing protein 5,, PF02752;PF00339;, GO:0005737;GO:1990756;GO:0031625;GO:0015031;, C:cytoplasm;, F:ubiquitin ligase-substrate adaptor activity; F:ubiquitin protein ligase binding;, P:protein transport; scaffold128 indexed_genome mRNA 1673741 1686430 . + . ID=transcript_13908;O60664 A8K4Y9 K7EQF4 Q53G77 Q9BS03 Q9UBD7 Q9UP92,Perilipin-3,47 kDa mannose 6-phosphate receptor-binding protein;Cargo selection protein TIP47;Mannose-6-phosphate receptor-binding protein 1;Placental protein 17;, PF03036;, GO:0005737;GO:0005829;GO:0005768;GO:0010008;GO:0005794;GO:0005811;GO:0016020;GO:0030133;GO:0045296;GO:0019915;GO:0010890;GO:0016192;, C:cytoplasm; C:cytosol; C:endosome; C:endosome membrane; C:Golgi apparatus; C:lipid droplet; C:membrane; C:transport vesicle;, F:cadherin binding;, P:lipid storage; P:positive regulation of sequestering of triglyceride; P:vesicle-mediated transport;|O60664 A8K4Y9 K7EQF4 Q53G77 Q9BS03 Q9UBD7 Q9UP92,Perilipin-3,47 kDa mannose 6-phosphate receptor-binding protein;Cargo selection protein TIP47;Mannose-6-phosphate receptor-binding protein 1;Placental protein 17;, PF03036;, GO:0005737;GO:0005829;GO:0005768;GO:0010008;GO:0005794;GO:0005811;GO:0016020;GO:0030133;GO:0045296;GO:0019915;GO:0010890;GO:0016192;, C:cytoplasm; C:cytosol; C:endosome; C:endosome membrane; C:Golgi apparatus; C:lipid droplet; C:membrane; C:transport vesicle;, F:cadherin binding;, P:lipid storage; P:positive regulation of sequestering of triglyceride; P:vesicle-mediated transport;|O60664 A8K4Y9 K7EQF4 Q53G77 Q9BS03 Q9UBD7 Q9UP92,Perilipin-3,47 kDa mannose 6-phosphate receptor-binding protein;Cargo selection protein TIP47;Mannose-6-phosphate receptor-binding protein 1;Placental protein 17;, PF03036;, GO:0005737;GO:0005829;GO:0005768;GO:0010008;GO:0005794;GO:0005811;GO:0016020;GO:0030133;GO:0045296;GO:0019915;GO:0010890;GO:0016192;, C:cytoplasm; C:cytosol; C:endosome; C:endosome membrane; C:Golgi apparatus; C:lipid droplet; C:membrane; C:transport vesicle;, F:cadherin binding;, P:lipid storage; P:positive regulation of sequestering of triglyceride; P:vesicle-mediated transport; scaffold128 indexed_genome mRNA 1695773 1710522 . + . ID=transcript_13909;Q8IUC6 B3Y691 O75532 Q86XP8 Q96GA0,TIR domain-containing adapter molecule 1,Proline-rich, vinculin and TIR domain-containing protein B;Putative NF-kappa-B-activating protein 502H;Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta;, PF12721;PF17798;, GO:0005776;GO:0005829;GO:0010008;GO:0005739;GO:0097342;GO:0019901;GO:0097190;GO:0071222;GO:0140052;GO:0051607;GO:0007249;GO:0006954;GO:0045087;GO:0031663;GO:0002281;GO:0002756;GO:0070266;GO:0034128;GO:0010508;GO:0030890;GO:0032722;GO:1900017;GO:0010628;GO:0043123;GO:0032728;GO:0032755;GO:0002735;GO:0032816;GO:0051092;GO:0045429;GO:0032092;GO:0031398;GO:0032760;GO:0043254;GO:0043330;GO:0034138;GO:0035666;GO:0016032;, C:autophagosome; C:cytosol; C:endosome membrane; C:mitochondrion; C:ripoptosome;, F:protein kinase binding;, P:apoptotic signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:macrophage activation involved in immune response; P:MyD88-independent toll-like receptor signaling pathway; P:necroptotic process; P:negative regulation of MyD88-independent toll-like receptor signaling pathway; P:positive regulation of autophagy; P:positive regulation of B cell proliferation; P:positive regulation of chemokine production; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of gene expression; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-beta production; P:positive regulation of interleukin-6 production; P:positive regulation of myeloid dendritic cell cytokine production; P:positive regulation of natural killer cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of protein binding; P:positive regulation of protein ubiquitination; P:positive regulation of tumor necrosis factor production; P:regulation of protein-containing complex assembly; P:response to exogenous dsRNA; P:toll-like receptor 3 signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process; scaffold128 indexed_genome mRNA 1723333 1729939 . + . ID=transcript_13910;Q9BSK4 B2RDI3 Q711P8 Q9NPN7 Q9NPW8,Protein fem-1 homolog A,FEM1-alpha;Prostaglandin E receptor 4-associated protein;, PF12796;, GO:0005829;GO:0000151;GO:0031867;GO:0050728;GO:0043687;GO:0016567;GO:0051438;GO:0006511;, C:cytosol; C:ubiquitin ligase complex;, F:EP4 subtype prostaglandin E2 receptor binding;, P:negative regulation of inflammatory response; P:post-translational protein modification; P:protein ubiquitination; P:regulation of ubiquitin-protein transferase activity; P:ubiquitin-dependent protein catabolic process; scaffold128 indexed_genome mRNA 1799020 1836657 . + . ID=transcript_13911;Q8N3F5 Q8WXD8 Q96NT8 Q9BVR3,Dipeptidyl peptidase 9,Dipeptidyl peptidase IV-related protein 2;Dipeptidyl peptidase IX;Dipeptidyl peptidase-like protein 9;, PF00930;PF00326;, GO:0031252;GO:0005829;GO:0005874;GO:0005634;GO:0004177;GO:0008239;GO:0042802;GO:0008236;, C:cell leading edge; C:cytosol; C:microtubule; C:nucleus;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:serine-type peptidase activity;|Q8N3F5 Q8WXD8 Q96NT8 Q9BVR3,Dipeptidyl peptidase 9,Dipeptidyl peptidase IV-related protein 2;Dipeptidyl peptidase IX;Dipeptidyl peptidase-like protein 9;, PF00930;PF00326;, GO:0031252;GO:0005829;GO:0005874;GO:0005634;GO:0004177;GO:0008239;GO:0042802;GO:0008236;, C:cell leading edge; C:cytosol; C:microtubule; C:nucleus;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:serine-type peptidase activity;|Q8N3F5 Q8WXD8 Q96NT8 Q9BVR3,Dipeptidyl peptidase 9,Dipeptidyl peptidase IV-related protein 2;Dipeptidyl peptidase IX;Dipeptidyl peptidase-like protein 9;, PF00930;PF00326;, GO:0031252;GO:0005829;GO:0005874;GO:0005634;GO:0004177;GO:0008239;GO:0042802;GO:0008236;, C:cell leading edge; C:cytosol; C:microtubule; C:nucleus;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:serine-type peptidase activity;|Q8N3F5 Q8WXD8 Q96NT8 Q9BVR3,Dipeptidyl peptidase 9,Dipeptidyl peptidase IV-related protein 2;Dipeptidyl peptidase IX;Dipeptidyl peptidase-like protein 9;, PF00930;PF00326;, GO:0031252;GO:0005829;GO:0005874;GO:0005634;GO:0004177;GO:0008239;GO:0042802;GO:0008236;, C:cell leading edge; C:cytosol; C:microtubule; C:nucleus;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:serine-type peptidase activity;|Q8N3F5 Q8WXD8 Q96NT8 Q9BVR3,Dipeptidyl peptidase 9,Dipeptidyl peptidase IV-related protein 2;Dipeptidyl peptidase IX;Dipeptidyl peptidase-like protein 9;, PF00930;PF00326;, GO:0031252;GO:0005829;GO:0005874;GO:0005634;GO:0004177;GO:0008239;GO:0042802;GO:0008236;, C:cell leading edge; C:cytosol; C:microtubule; C:nucleus;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:serine-type peptidase activity;|Q8N3F5 Q8WXD8 Q96NT8 Q9BVR3,Dipeptidyl peptidase 9,Dipeptidyl peptidase IV-related protein 2;Dipeptidyl peptidase IX;Dipeptidyl peptidase-like protein 9;, PF00930;PF00326;, GO:0031252;GO:0005829;GO:0005874;GO:0005634;GO:0004177;GO:0008239;GO:0042802;GO:0008236;, C:cell leading edge; C:cytosol; C:microtubule; C:nucleus;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:serine-type peptidase activity;|Q8N3F5 Q8WXD8 Q96NT8 Q9BVR3,Dipeptidyl peptidase 9,Dipeptidyl peptidase IV-related protein 2;Dipeptidyl peptidase IX;Dipeptidyl peptidase-like protein 9;, PF00930;PF00326;, GO:0031252;GO:0005829;GO:0005874;GO:0005634;GO:0004177;GO:0008239;GO:0042802;GO:0008236;, C:cell leading edge; C:cytosol; C:microtubule; C:nucleus;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:identical protein binding; F:serine-type peptidase activity; scaffold128 indexed_genome mRNA 1841507 1853649 . + . ID=transcript_13912;Q969H8 D6W628 O75256 O75272 Q9BTK7 Q9NP69,Myeloid-derived growth factor {ECO:0000303|PubMed:25581518, ECO:0000312|HGNC:HGNC:16948},, PF10572;, GO:0005783;GO:0005788;GO:0005793;GO:0005615;GO:0005794;GO:0001525;GO:0006915;GO:0036498;GO:0043066;GO:0045766;GO:0001938;GO:0043410;GO:0014068;GO:0051897;GO:0001934;GO:0045944;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular space; C:Golgi apparatus;, , P:angiogenesis; P:apoptotic process; P:IRE1-mediated unfolded protein response; P:negative regulation of apoptotic process; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II;|Q969H8 D6W628 O75256 O75272 Q9BTK7 Q9NP69,Myeloid-derived growth factor {ECO:0000303|PubMed:25581518, ECO:0000312|HGNC:HGNC:16948},, PF10572;, GO:0005783;GO:0005788;GO:0005793;GO:0005615;GO:0005794;GO:0001525;GO:0006915;GO:0036498;GO:0043066;GO:0045766;GO:0001938;GO:0043410;GO:0014068;GO:0051897;GO:0001934;GO:0045944;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular space; C:Golgi apparatus;, , P:angiogenesis; P:apoptotic process; P:IRE1-mediated unfolded protein response; P:negative regulation of apoptotic process; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; scaffold128 indexed_genome mRNA 1856367 1874996 . - . ID=transcript_13913;Q8WVP5 D6W627,Tumor necrosis factor alpha-induced protein 8-like protein 1,Oxidative stress-regulated gene-beta {ECO:0000303|PubMed:24444419};, PF05527;, GO:0005737;GO:0042802;GO:0032007;GO:0042981;, C:cytoplasm;, F:identical protein binding;, P:negative regulation of TOR signaling; P:regulation of apoptotic process; scaffold128 indexed_genome mRNA 1951039 1962926 . + . ID=transcript_13914;Q9BZV1 D6W626 Q96AH1 Q96IK9 Q9BZV0,UBX domain-containing protein 6 {ECO:0000305},UBX domain-containing protein 1 {ECO:0000303|PubMed:11342112};, PF09409;PF00789;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0019898;GO:0031902;GO:0005765;GO:0005815;GO:0005634;GO:0032991;GO:0032510;GO:0036503;GO:0016236;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:extrinsic component of membrane; C:late endosome membrane; C:lysosomal membrane; C:microtubule organizing center; C:nucleus; C:protein-containing complex;, , P:endosome to lysosome transport via multivesicular body sorting pathway; P:ERAD pathway; P:macroautophagy;|Q9BZV1 D6W626 Q96AH1 Q96IK9 Q9BZV0,UBX domain-containing protein 6 {ECO:0000305},UBX domain-containing protein 1 {ECO:0000303|PubMed:11342112};, PF09409;PF00789;, GO:0005737;GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0019898;GO:0031902;GO:0005765;GO:0005815;GO:0005634;GO:0032991;GO:0032510;GO:0036503;GO:0016236;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:extrinsic component of membrane; C:late endosome membrane; C:lysosomal membrane; C:microtubule organizing center; C:nucleus; C:protein-containing complex;, , P:endosome to lysosome transport via multivesicular body sorting pathway; P:ERAD pathway; P:macroautophagy; scaffold128 indexed_genome mRNA 1964533 1989461 . - . ID=transcript_13915;Q13111 Q6NXG5 Q7Z7K3 Q9UJY8,Chromatin assembly factor 1 subunit A {ECO:0000305},Chromatin assembly factor I p150 subunit;, PF15539;PF15557;PF12253;, GO:0033186;GO:0000785;GO:0005634;GO:0032991;GO:0003682;GO:0070087;GO:0042802;GO:0051082;GO:0007049;GO:0031497;GO:0006281;GO:0006260;GO:0006335;GO:0006334;, C:CAF-1 complex; C:chromatin; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:chromo shadow domain binding; F:identical protein binding; F:unfolded protein binding;, P:cell cycle; P:chromatin assembly; P:DNA repair; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:nucleosome assembly;|Q13111 Q6NXG5 Q7Z7K3 Q9UJY8,Chromatin assembly factor 1 subunit A {ECO:0000305},Chromatin assembly factor I p150 subunit;, PF15539;PF15557;PF12253;, GO:0033186;GO:0000785;GO:0005634;GO:0032991;GO:0003682;GO:0070087;GO:0042802;GO:0051082;GO:0007049;GO:0031497;GO:0006281;GO:0006260;GO:0006335;GO:0006334;, C:CAF-1 complex; C:chromatin; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:chromo shadow domain binding; F:identical protein binding; F:unfolded protein binding;, P:cell cycle; P:chromatin assembly; P:DNA repair; P:DNA replication; P:DNA replication-dependent nucleosome assembly; P:nucleosome assembly; scaffold128 indexed_genome mRNA 1991764 2019266 . + . ID=transcript_13916;Q99961 B4DRA1 E7EVZ4 M0QZV5 Q99668,Endophilin-A2,EEN fusion partner of MLL;Endophilin-2;Extra eleven-nineteen leukemia fusion gene protein;SH3 domain protein 2B;SH3 domain-containing GRB2-like protein 1;, PF03114;PF00018;, GO:0042995;GO:0005737;GO:0005829;GO:0031901;GO:0098978;GO:0098686;GO:0002102;GO:0099092;GO:0098793;GO:0098685;GO:0031697;GO:0045296;GO:0051020;GO:0042802;GO:0044325;GO:0008289;GO:0019902;GO:0008022;GO:0017124;GO:0007417;GO:0098815;GO:1900244;GO:0007165;GO:0016191;, C:cell projection; C:cytoplasm; C:cytosol; C:early endosome membrane; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:podosome; C:postsynaptic density, intracellular component; C:presynapse; C:Schaffer collateral - CA1 synapse;, F:beta-1 adrenergic receptor binding; F:cadherin binding; F:GTPase binding; F:identical protein binding; F:ion channel binding; F:lipid binding; F:phosphatase binding; F:protein C-terminus binding; F:SH3 domain binding;, P:central nervous system development; P:modulation of excitatory postsynaptic potential; P:positive regulation of synaptic vesicle endocytosis; P:signal transduction; P:synaptic vesicle uncoating;|Q99961 B4DRA1 E7EVZ4 M0QZV5 Q99668,Endophilin-A2,EEN fusion partner of MLL;Endophilin-2;Extra eleven-nineteen leukemia fusion gene protein;SH3 domain protein 2B;SH3 domain-containing GRB2-like protein 1;, PF03114;PF00018;, GO:0042995;GO:0005737;GO:0005829;GO:0031901;GO:0098978;GO:0098686;GO:0002102;GO:0099092;GO:0098793;GO:0098685;GO:0031697;GO:0045296;GO:0051020;GO:0042802;GO:0044325;GO:0008289;GO:0019902;GO:0008022;GO:0017124;GO:0007417;GO:0098815;GO:1900244;GO:0007165;GO:0016191;, C:cell projection; C:cytoplasm; C:cytosol; C:early endosome membrane; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:podosome; C:postsynaptic density, intracellular component; C:presynapse; C:Schaffer collateral - CA1 synapse;, F:beta-1 adrenergic receptor binding; F:cadherin binding; F:GTPase binding; F:identical protein binding; F:ion channel binding; F:lipid binding; F:phosphatase binding; F:protein C-terminus binding; F:SH3 domain binding;, P:central nervous system development; P:modulation of excitatory postsynaptic potential; P:positive regulation of synaptic vesicle endocytosis; P:signal transduction; P:synaptic vesicle uncoating; scaffold128 indexed_genome mRNA 2019388 2029190 . - . ID=transcript_13917;Q8N594 Q96SJ0 Q9Y2P1 Q9Y2P2,MPN domain-containing protein {ECO:0000305},, PF01398;PF18755;, GO:0042393;GO:0070122;GO:0046872;GO:0008237;GO:0004843;GO:0003713;GO:0006338;GO:0045944;, , F:histone binding; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:chromatin remodeling; P:positive regulation of transcription by RNA polymerase II;|Q8N594 Q96SJ0 Q9Y2P1 Q9Y2P2,MPN domain-containing protein {ECO:0000305},, PF01398;PF18755;, GO:0042393;GO:0070122;GO:0046872;GO:0008237;GO:0004843;GO:0003713;GO:0006338;GO:0045944;, , F:histone binding; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:chromatin remodeling; P:positive regulation of transcription by RNA polymerase II;|Q8N594 Q96SJ0 Q9Y2P1 Q9Y2P2,MPN domain-containing protein {ECO:0000305},, PF01398;PF18755;, GO:0042393;GO:0070122;GO:0046872;GO:0008237;GO:0004843;GO:0003713;GO:0006338;GO:0045944;, , F:histone binding; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:chromatin remodeling; P:positive regulation of transcription by RNA polymerase II;|Q8N594 Q96SJ0 Q9Y2P1 Q9Y2P2,MPN domain-containing protein {ECO:0000305},, PF01398;PF18755;, GO:0042393;GO:0070122;GO:0046872;GO:0008237;GO:0004843;GO:0003713;GO:0006338;GO:0045944;, , F:histone binding; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:chromatin remodeling; P:positive regulation of transcription by RNA polymerase II;|Q8N594 Q96SJ0 Q9Y2P1 Q9Y2P2,MPN domain-containing protein {ECO:0000305},, PF01398;PF18755;, GO:0042393;GO:0070122;GO:0046872;GO:0008237;GO:0004843;GO:0003713;GO:0006338;GO:0045944;, , F:histone binding; F:isopeptidase activity; F:metal ion binding; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity;, P:chromatin remodeling; P:positive regulation of transcription by RNA polymerase II; scaffold128 indexed_genome mRNA 2034238 2056042 . + . ID=transcript_13918;Q9UGK3 A6NKK3 Q9NXI2,Signal-transducing adaptor protein 2,Breast tumor kinase substrate;, , GO:0005829;GO:0005886;GO:0035591;GO:0042531;, C:cytosol; C:plasma membrane;, F:signaling adaptor activity;, P:positive regulation of tyrosine phosphorylation of STAT protein;|Q9UGK3 A6NKK3 Q9NXI2,Signal-transducing adaptor protein 2,Breast tumor kinase substrate;, , GO:0005829;GO:0005886;GO:0035591;GO:0042531;, C:cytosol; C:plasma membrane;, F:signaling adaptor activity;, P:positive regulation of tyrosine phosphorylation of STAT protein;|Q9BTV5 B2RDT0 Q9BXN0 Q9HAG4,Fibronectin type III and SPRY domain-containing protein 1,MID1-related protein 1;Microtubule-associated protein GLFND;, PF00041;PF00622;, GO:0005813;GO:0032154;GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0008017;GO:0007049;GO:0051301;GO:0031122;GO:0051302;GO:0032465;GO:0060236;, C:centrosome; C:cleavage furrow; C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:microtubule binding;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; P:regulation of cell division; P:regulation of cytokinesis; P:regulation of mitotic spindle organization;|Q9BTV5 B2RDT0 Q9BXN0 Q9HAG4,Fibronectin type III and SPRY domain-containing protein 1,MID1-related protein 1;Microtubule-associated protein GLFND;, PF00041;PF00622;, GO:0005813;GO:0032154;GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0008017;GO:0007049;GO:0051301;GO:0031122;GO:0051302;GO:0032465;GO:0060236;, C:centrosome; C:cleavage furrow; C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:microtubule binding;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; P:regulation of cell division; P:regulation of cytokinesis; P:regulation of mitotic spindle organization;|Q9BTV5 B2RDT0 Q9BXN0 Q9HAG4,Fibronectin type III and SPRY domain-containing protein 1,MID1-related protein 1;Microtubule-associated protein GLFND;, PF00041;PF00622;, GO:0005813;GO:0032154;GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0008017;GO:0007049;GO:0051301;GO:0031122;GO:0051302;GO:0032465;GO:0060236;, C:centrosome; C:cleavage furrow; C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:microtubule binding;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; P:regulation of cell division; P:regulation of cytokinesis; P:regulation of mitotic spindle organization;|Q9BTV5 B2RDT0 Q9BXN0 Q9HAG4,Fibronectin type III and SPRY domain-containing protein 1,MID1-related protein 1;Microtubule-associated protein GLFND;, PF00041;PF00622;, GO:0005813;GO:0032154;GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0008017;GO:0007049;GO:0051301;GO:0031122;GO:0051302;GO:0032465;GO:0060236;, C:centrosome; C:cleavage furrow; C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:microtubule binding;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; P:regulation of cell division; P:regulation of cytokinesis; P:regulation of mitotic spindle organization;|Q9BTV5 B2RDT0 Q9BXN0 Q9HAG4,Fibronectin type III and SPRY domain-containing protein 1,MID1-related protein 1;Microtubule-associated protein GLFND;, PF00041;PF00622;, GO:0005813;GO:0032154;GO:0005737;GO:0005874;GO:0005634;GO:0042802;GO:0008017;GO:0007049;GO:0051301;GO:0031122;GO:0051302;GO:0032465;GO:0060236;, C:centrosome; C:cleavage furrow; C:cytoplasm; C:microtubule; C:nucleus;, F:identical protein binding; F:microtubule binding;, P:cell cycle; P:cell division; P:cytoplasmic microtubule organization; P:regulation of cell division; P:regulation of cytokinesis; P:regulation of mitotic spindle organization; scaffold128 indexed_genome mRNA 2067031 2072193 . - . ID=transcript_13919;Q96IW2 Q96NC2,SH2 domain-containing adapter protein D,, PF00017;, GO:0001784;, , F:phosphotyrosine residue binding;|Q96IW2 Q96NC2,SH2 domain-containing adapter protein D,, PF00017;, GO:0001784;, , F:phosphotyrosine residue binding; scaffold128 indexed_genome mRNA 2079943 2094804 . - . ID=transcript_13920;Q9BW85 O75270 Q9H862 Q9NW16,Splicing factor YJU2 {ECO:0000255|HAMAP-Rule:MF_03226},Coiled-coil domain-containing protein 94 {ECO:0000305};, PF04502;, GO:0071006;GO:0046872;GO:0000349;GO:0043518;GO:0008380;, C:U2-type catalytic step 1 spliceosome;, F:metal ion binding;, P:generation of catalytic spliceosome for first transesterification step; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:RNA splicing; scaffold128 indexed_genome mRNA 2097538 2122812 . - . ID=transcript_13921;Q14213 A0N0N2 O75269,Interleukin-27 subunit beta,Epstein-Barr virus-induced gene 3 protein;, PF00041;, GO:0005788;GO:0009897;GO:0005576;GO:0005615;GO:0005886;GO:0043235;GO:0005125;GO:0019955;GO:0004896;GO:0017046;GO:0019221;GO:0006959;GO:0070106;GO:0070757;GO:0033210;GO:0046641;GO:0032729;GO:0042088;, C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular region; C:extracellular space; C:plasma membrane; C:receptor complex;, F:cytokine activity; F:cytokine binding; F:cytokine receptor activity; F:peptide hormone binding;, P:cytokine-mediated signaling pathway; P:humoral immune response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:leptin-mediated signaling pathway; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of interferon-gamma production; P:T-helper 1 type immune response;|Q14213 A0N0N2 O75269,Interleukin-27 subunit beta,Epstein-Barr virus-induced gene 3 protein;, PF00041;, GO:0005788;GO:0009897;GO:0005576;GO:0005615;GO:0005886;GO:0043235;GO:0005125;GO:0019955;GO:0004896;GO:0017046;GO:0019221;GO:0006959;GO:0070106;GO:0070757;GO:0033210;GO:0046641;GO:0032729;GO:0042088;, C:endoplasmic reticulum lumen; C:external side of plasma membrane; C:extracellular region; C:extracellular space; C:plasma membrane; C:receptor complex;, F:cytokine activity; F:cytokine binding; F:cytokine receptor activity; F:peptide hormone binding;, P:cytokine-mediated signaling pathway; P:humoral immune response; P:interleukin-27-mediated signaling pathway; P:interleukin-35-mediated signaling pathway; P:leptin-mediated signaling pathway; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of interferon-gamma production; P:T-helper 1 type immune response;|Q8TF21 O75268 O95781,Ankyrin repeat domain-containing protein 24,, PF00023;PF12796;|Q8TF21 O75268 O95781,Ankyrin repeat domain-containing protein 24,, PF00023;PF12796; scaffold128 indexed_genome mRNA 2134051 2141342 . + . ID=transcript_13922;Q9UQD1,NAD-dependent protein deacetylase sirtuin-6,Regulatory protein SIR2 homolog 6;SIR2-like protein 6;, PF02146;, GO:0099115;GO:0005737;GO:0005654;GO:0005634;GO:0019213;GO:0004407;GO:0003956;GO:0003950;GO:0070403;GO:0017136;GO:0046969;GO:0003714;GO:0008270;GO:0070932;GO:0000122;GO:1905555;GO:1902732;GO:0031940;GO:0120162;GO:1905549;GO:0032206;GO:1901485;GO:1905564;GO:0003247;GO:0006471;GO:0006476;GO:0010569;GO:0031667;, C:chromosome, subtelomeric region; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:deacetylase activity; F:histone deacetylase activity; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:transcription corepressor activity; F:zinc ion binding;, P:histone H3 deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of blood vessel branching; P:positive regulation of chondrocyte proliferation; P:positive regulation of chromatin silencing at telomere; P:positive regulation of cold-induced thermogenesis; P:positive regulation of subtelomeric heterochromatin assembly; P:positive regulation of telomere maintenance; P:positive regulation of transcription factor catabolic process; P:positive regulation of vascular endothelial cell proliferation; P:post-embryonic cardiac muscle cell growth involved in heart morphogenesis; P:protein ADP-ribosylation; P:protein deacetylation; P:regulation of double-strand break repair via homologous recombination; P:response to nutrient levels;|Q9UQD1,NAD-dependent protein deacetylase sirtuin-6,Regulatory protein SIR2 homolog 6;SIR2-like protein 6;, PF02146;, GO:0099115;GO:0005737;GO:0005654;GO:0005634;GO:0019213;GO:0004407;GO:0003956;GO:0003950;GO:0070403;GO:0017136;GO:0046969;GO:0003714;GO:0008270;GO:0070932;GO:0000122;GO:1905555;GO:1902732;GO:0031940;GO:0120162;GO:1905549;GO:0032206;GO:1901485;GO:1905564;GO:0003247;GO:0006471;GO:0006476;GO:0010569;GO:0031667;, C:chromosome, subtelomeric region; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:deacetylase activity; F:histone deacetylase activity; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:transcription corepressor activity; F:zinc ion binding;, P:histone H3 deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of blood vessel branching; P:positive regulation of chondrocyte proliferation; P:positive regulation of chromatin silencing at telomere; P:positive regulation of cold-induced thermogenesis; P:positive regulation of subtelomeric heterochromatin assembly; P:positive regulation of telomere maintenance; P:positive regulation of transcription factor catabolic process; P:positive regulation of vascular endothelial cell proliferation; P:post-embryonic cardiac muscle cell growth involved in heart morphogenesis; P:protein ADP-ribosylation; P:protein deacetylation; P:regulation of double-strand break repair via homologous recombination; P:response to nutrient levels;|Q9UQD1,NAD-dependent protein deacetylase sirtuin-6,Regulatory protein SIR2 homolog 6;SIR2-like protein 6;, PF02146;, GO:0099115;GO:0005737;GO:0005654;GO:0005634;GO:0019213;GO:0004407;GO:0003956;GO:0003950;GO:0070403;GO:0017136;GO:0046969;GO:0003714;GO:0008270;GO:0070932;GO:0000122;GO:1905555;GO:1902732;GO:0031940;GO:0120162;GO:1905549;GO:0032206;GO:1901485;GO:1905564;GO:0003247;GO:0006471;GO:0006476;GO:0010569;GO:0031667;, C:chromosome, subtelomeric region; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:deacetylase activity; F:histone deacetylase activity; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:transcription corepressor activity; F:zinc ion binding;, P:histone H3 deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of blood vessel branching; P:positive regulation of chondrocyte proliferation; P:positive regulation of chromatin silencing at telomere; P:positive regulation of cold-induced thermogenesis; P:positive regulation of subtelomeric heterochromatin assembly; P:positive regulation of telomere maintenance; P:positive regulation of transcription factor catabolic process; P:positive regulation of vascular endothelial cell proliferation; P:post-embryonic cardiac muscle cell growth involved in heart morphogenesis; P:protein ADP-ribosylation; P:protein deacetylation; P:regulation of double-strand break repair via homologous recombination; P:response to nutrient levels; scaffold128 indexed_genome mRNA 2142979 2154023 . - . ID=transcript_13923;Q68CJ9 B2R7S6 B7ZL69 M0QYW7 Q6ZMC5 Q96TB9,Cyclic AMP-responsive element-binding protein 3-like protein 3,Transcription factor CREB-H;, PF00170;, GO:0000785;GO:0005829;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0016020;GO:0005654;GO:0005634;GO:0035497;GO:0001228;GO:0000981;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:0000976;GO:0030968;GO:0002675;GO:0045944;GO:1990440;GO:0006357;, C:chromatin; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:endoplasmic reticulum unfolded protein response; P:positive regulation of acute inflammatory response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II;|Q68CJ9 B2R7S6 B7ZL69 M0QYW7 Q6ZMC5 Q96TB9,Cyclic AMP-responsive element-binding protein 3-like protein 3,Transcription factor CREB-H;, PF00170;, GO:0000785;GO:0005829;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0016020;GO:0005654;GO:0005634;GO:0035497;GO:0001228;GO:0000981;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:0000976;GO:0030968;GO:0002675;GO:0045944;GO:1990440;GO:0006357;, C:chromatin; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:endoplasmic reticulum unfolded protein response; P:positive regulation of acute inflammatory response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II;|Q68CJ9 B2R7S6 B7ZL69 M0QYW7 Q6ZMC5 Q96TB9,Cyclic AMP-responsive element-binding protein 3-like protein 3,Transcription factor CREB-H;, PF00170;, GO:0000785;GO:0005829;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0016020;GO:0005654;GO:0005634;GO:0035497;GO:0001228;GO:0000981;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:0000976;GO:0030968;GO:0002675;GO:0045944;GO:1990440;GO:0006357;, C:chromatin; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:nucleus;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:endoplasmic reticulum unfolded protein response; P:positive regulation of acute inflammatory response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II; scaffold128 indexed_genome mRNA 2182828 2213748 . + . ID=transcript_13924;P36507,Dual specificity mitogen-activated protein kinase kinase 2,ERK activator kinase 2;MAPK/ERK kinase 2;, PF00069;, GO:0005911;GO:0009898;GO:0005829;GO:0005769;GO:0005783;GO:0005576;GO:0005925;GO:0005794;GO:0005770;GO:0005874;GO:0005739;GO:0005634;GO:0048471;GO:0005778;GO:0005524;GO:0004708;GO:0005078;GO:0046872;GO:0030165;GO:0106310;GO:0043539;GO:0004712;GO:0106311;GO:0097110;GO:0004714;GO:0000187;GO:0000186;GO:0070371;GO:0000165;GO:0010629;GO:0036289;GO:1903800;GO:0071902;GO:0045893;GO:2000641;GO:0090170;GO:0032872;, C:cell-cell junction; C:cytoplasmic side of plasma membrane; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:extracellular region; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:peroxisomal membrane;, F:ATP binding; F:MAP kinase kinase activity; F:MAP-kinase scaffold activity; F:metal ion binding; F:PDZ domain binding; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:activation of MAPKK activity; P:ERK1 and ERK2 cascade; P:MAPK cascade; P:negative regulation of gene expression; P:peptidyl-serine autophosphorylation; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of transcription, DNA-templated; P:regulation of early endosome to late endosome transport; P:regulation of Golgi inheritance; P:regulation of stress-activated MAPK cascade;|P36507,Dual specificity mitogen-activated protein kinase kinase 2,ERK activator kinase 2;MAPK/ERK kinase 2;, PF00069;, GO:0005911;GO:0009898;GO:0005829;GO:0005769;GO:0005783;GO:0005576;GO:0005925;GO:0005794;GO:0005770;GO:0005874;GO:0005739;GO:0005634;GO:0048471;GO:0005778;GO:0005524;GO:0004708;GO:0005078;GO:0046872;GO:0030165;GO:0106310;GO:0043539;GO:0004712;GO:0106311;GO:0097110;GO:0004714;GO:0000187;GO:0000186;GO:0070371;GO:0000165;GO:0010629;GO:0036289;GO:1903800;GO:0071902;GO:0045893;GO:2000641;GO:0090170;GO:0032872;, C:cell-cell junction; C:cytoplasmic side of plasma membrane; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:extracellular region; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:peroxisomal membrane;, F:ATP binding; F:MAP kinase kinase activity; F:MAP-kinase scaffold activity; F:metal ion binding; F:PDZ domain binding; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:scaffold protein binding; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of MAPK activity; P:activation of MAPKK activity; P:ERK1 and ERK2 cascade; P:MAPK cascade; P:negative regulation of gene expression; P:peptidyl-serine autophosphorylation; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of transcription, DNA-templated; P:regulation of early endosome to late endosome transport; P:regulation of Golgi inheritance; P:regulation of stress-activated MAPK cascade; scaffold128 indexed_genome mRNA 2244968 2252087 . + . ID=transcript_13925;O95365 D6W619 O00456 Q14D41 Q5XG86,Zinc finger and BTB domain-containing protein 7A {ECO:0000305},Factor binding IST protein 1 {ECO:0000303|PubMed:9973611};Factor that binds to inducer of short transcripts protein 1;HIV-1 1st-binding protein 1;Leukemia/lymphoma-related factor {ECO:0000303|PubMed:9927193};POZ and Krueppel erythroid myeloid ontogenic factor {ECO:0000303|PubMed:15662416};TTF-I-interacting peptide 21 {ECO:0000312|EMBL:AAB58414.1};Zinc finger protein 857A;, PF00651;PF00096;, GO:0005737;GO:0070418;GO:0005634;GO:0035861;GO:0033613;GO:0050681;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0035035;GO:0046872;GO:0000978;GO:1990837;GO:0046332;GO:0001222;GO:0030183;GO:0006325;GO:0006338;GO:0097680;GO:0043249;GO:0045444;GO:0060766;GO:0045746;GO:0000122;GO:0045892;GO:0030512;GO:0051092;GO:0034504;GO:0000381;GO:0042981;GO:0051090;GO:0006110;GO:0006357;GO:2000677;GO:0006351;, C:cytoplasm; C:DNA-dependent protein kinase complex; C:nucleus; C:site of double-strand break;, F:activating transcription factor binding; F:androgen receptor binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:histone acetyltransferase binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:SMAD binding; F:transcription corepressor binding;, P:B cell differentiation; P:chromatin organization; P:chromatin remodeling; P:double-strand break repair via classical nonhomologous end joining; P:erythrocyte maturation; P:fat cell differentiation; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of NF-kappaB transcription factor activity; P:protein localization to nucleus; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of apoptotic process; P:regulation of DNA-binding transcription factor activity; P:regulation of glycolytic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription regulatory region DNA binding; P:transcription, DNA-templated; scaffold128 indexed_genome mRNA 2265147 2283181 . - . ID=transcript_13926;Q8N2W9 O75926 Q96G19 Q9UN16,E3 SUMO-protein ligase PIAS4,PIASy;Protein inhibitor of activated STAT protein 4;Protein inhibitor of activated STAT protein gamma;RING-type E3 ubiquitin transferase PIAS4 {ECO:0000305};, PF14324;PF02891;, GO:0005737;GO:0016363;GO:0005654;GO:0005634;GO:0016605;GO:1990234;GO:0003677;GO:0008022;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0003714;GO:0031625;GO:0008270;GO:0006302;GO:0006303;GO:0032088;GO:0000122;GO:0045892;GO:0010804;GO:1902231;GO:1902174;GO:0033235;GO:0016925;GO:0006357;GO:0042359;GO:0016055;, C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:PML body; C:transferase complex;, F:DNA binding; F:protein C-terminus binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:transcription corepressor activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of protein sumoylation; P:protein sumoylation; P:regulation of transcription by RNA polymerase II; P:vitamin D metabolic process; P:Wnt signaling pathway;|Q8N2W9 O75926 Q96G19 Q9UN16,E3 SUMO-protein ligase PIAS4,PIASy;Protein inhibitor of activated STAT protein 4;Protein inhibitor of activated STAT protein gamma;RING-type E3 ubiquitin transferase PIAS4 {ECO:0000305};, PF14324;PF02891;, GO:0005737;GO:0016363;GO:0005654;GO:0005634;GO:0016605;GO:1990234;GO:0003677;GO:0008022;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0003714;GO:0031625;GO:0008270;GO:0006302;GO:0006303;GO:0032088;GO:0000122;GO:0045892;GO:0010804;GO:1902231;GO:1902174;GO:0033235;GO:0016925;GO:0006357;GO:0042359;GO:0016055;, C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:PML body; C:transferase complex;, F:DNA binding; F:protein C-terminus binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:transcription corepressor activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of protein sumoylation; P:protein sumoylation; P:regulation of transcription by RNA polymerase II; P:vitamin D metabolic process; P:Wnt signaling pathway;|Q8N2W9 O75926 Q96G19 Q9UN16,E3 SUMO-protein ligase PIAS4,PIASy;Protein inhibitor of activated STAT protein 4;Protein inhibitor of activated STAT protein gamma;RING-type E3 ubiquitin transferase PIAS4 {ECO:0000305};, PF14324;PF02891;, GO:0005737;GO:0016363;GO:0005654;GO:0005634;GO:0016605;GO:1990234;GO:0003677;GO:0008022;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0003714;GO:0031625;GO:0008270;GO:0006302;GO:0006303;GO:0032088;GO:0000122;GO:0045892;GO:0010804;GO:1902231;GO:1902174;GO:0033235;GO:0016925;GO:0006357;GO:0042359;GO:0016055;, C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:PML body; C:transferase complex;, F:DNA binding; F:protein C-terminus binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:transcription corepressor activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; P:positive regulation of keratinocyte apoptotic process; P:positive regulation of protein sumoylation; P:protein sumoylation; P:regulation of transcription by RNA polymerase II; P:vitamin D metabolic process; P:Wnt signaling pathway; scaffold128 indexed_genome mRNA 2320265 2326594 . + . ID=transcript_13927;P13639 B2RMP5 D6W618 Q58J86,Elongation factor 2,, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0016235;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0045121;GO:0005634;GO:0005886;GO:0042788;GO:1990904;GO:0034774;GO:0045202;GO:0008097;GO:0051015;GO:0045296;GO:0005525;GO:0003924;GO:0002039;GO:0019901;GO:0043022;GO:0003723;GO:0003746;GO:0007568;GO:1990416;GO:0014009;GO:0002244;GO:0043312;GO:2000767;GO:0045727;GO:0042493;GO:0034976;GO:0032355;GO:0045471;GO:0051593;GO:0042542;GO:0002931;GO:0035914;GO:0003009;GO:0006414;, C:aggresome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:polysomal ribosome; C:ribonucleoprotein complex; C:secretory granule lumen; C:synapse;, F:5S rRNA binding; F:actin filament binding; F:cadherin binding; F:GTP binding; F:GTPase activity; F:p53 binding; F:protein kinase binding; F:ribosome binding; F:RNA binding; F:translation elongation factor activity;, P:aging; P:cellular response to brain-derived neurotrophic factor stimulus; P:glial cell proliferation; P:hematopoietic progenitor cell differentiation; P:neutrophil degranulation; P:positive regulation of cytoplasmic translation; P:positive regulation of translation; P:response to drug; P:response to endoplasmic reticulum stress; P:response to estradiol; P:response to ethanol; P:response to folic acid; P:response to hydrogen peroxide; P:response to ischemia; P:skeletal muscle cell differentiation; P:skeletal muscle contraction; P:translational elongation;|P13639 B2RMP5 D6W618 Q58J86,Elongation factor 2,, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0016235;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0045121;GO:0005634;GO:0005886;GO:0042788;GO:1990904;GO:0034774;GO:0045202;GO:0008097;GO:0051015;GO:0045296;GO:0005525;GO:0003924;GO:0002039;GO:0019901;GO:0043022;GO:0003723;GO:0003746;GO:0007568;GO:1990416;GO:0014009;GO:0002244;GO:0043312;GO:2000767;GO:0045727;GO:0042493;GO:0034976;GO:0032355;GO:0045471;GO:0051593;GO:0042542;GO:0002931;GO:0035914;GO:0003009;GO:0006414;, C:aggresome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:polysomal ribosome; C:ribonucleoprotein complex; C:secretory granule lumen; C:synapse;, F:5S rRNA binding; F:actin filament binding; F:cadherin binding; F:GTP binding; F:GTPase activity; F:p53 binding; F:protein kinase binding; F:ribosome binding; F:RNA binding; F:translation elongation factor activity;, P:aging; P:cellular response to brain-derived neurotrophic factor stimulus; P:glial cell proliferation; P:hematopoietic progenitor cell differentiation; P:neutrophil degranulation; P:positive regulation of cytoplasmic translation; P:positive regulation of translation; P:response to drug; P:response to endoplasmic reticulum stress; P:response to estradiol; P:response to ethanol; P:response to folic acid; P:response to hydrogen peroxide; P:response to ischemia; P:skeletal muscle cell differentiation; P:skeletal muscle contraction; P:translational elongation;|P13639 B2RMP5 D6W618 Q58J86,Elongation factor 2,, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0016235;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0045121;GO:0005634;GO:0005886;GO:0042788;GO:1990904;GO:0034774;GO:0045202;GO:0008097;GO:0051015;GO:0045296;GO:0005525;GO:0003924;GO:0002039;GO:0019901;GO:0043022;GO:0003723;GO:0003746;GO:0007568;GO:1990416;GO:0014009;GO:0002244;GO:0043312;GO:2000767;GO:0045727;GO:0042493;GO:0034976;GO:0032355;GO:0045471;GO:0051593;GO:0042542;GO:0002931;GO:0035914;GO:0003009;GO:0006414;, C:aggresome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:polysomal ribosome; C:ribonucleoprotein complex; C:secretory granule lumen; C:synapse;, F:5S rRNA binding; F:actin filament binding; F:cadherin binding; F:GTP binding; F:GTPase activity; F:p53 binding; F:protein kinase binding; F:ribosome binding; F:RNA binding; F:translation elongation factor activity;, P:aging; P:cellular response to brain-derived neurotrophic factor stimulus; P:glial cell proliferation; P:hematopoietic progenitor cell differentiation; P:neutrophil degranulation; P:positive regulation of cytoplasmic translation; P:positive regulation of translation; P:response to drug; P:response to endoplasmic reticulum stress; P:response to estradiol; P:response to ethanol; P:response to folic acid; P:response to hydrogen peroxide; P:response to ischemia; P:skeletal muscle cell differentiation; P:skeletal muscle contraction; P:translational elongation;|P13639 B2RMP5 D6W618 Q58J86,Elongation factor 2,, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0016235;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0045121;GO:0005634;GO:0005886;GO:0042788;GO:1990904;GO:0034774;GO:0045202;GO:0008097;GO:0051015;GO:0045296;GO:0005525;GO:0003924;GO:0002039;GO:0019901;GO:0043022;GO:0003723;GO:0003746;GO:0007568;GO:1990416;GO:0014009;GO:0002244;GO:0043312;GO:2000767;GO:0045727;GO:0042493;GO:0034976;GO:0032355;GO:0045471;GO:0051593;GO:0042542;GO:0002931;GO:0035914;GO:0003009;GO:0006414;, C:aggresome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:polysomal ribosome; C:ribonucleoprotein complex; C:secretory granule lumen; C:synapse;, F:5S rRNA binding; F:actin filament binding; F:cadherin binding; F:GTP binding; F:GTPase activity; F:p53 binding; F:protein kinase binding; F:ribosome binding; F:RNA binding; F:translation elongation factor activity;, P:aging; P:cellular response to brain-derived neurotrophic factor stimulus; P:glial cell proliferation; P:hematopoietic progenitor cell differentiation; P:neutrophil degranulation; P:positive regulation of cytoplasmic translation; P:positive regulation of translation; P:response to drug; P:response to endoplasmic reticulum stress; P:response to estradiol; P:response to ethanol; P:response to folic acid; P:response to hydrogen peroxide; P:response to ischemia; P:skeletal muscle cell differentiation; P:skeletal muscle contraction; P:translational elongation; scaffold128 indexed_genome mRNA 2327133 2327877 . + . ID=transcript_13928;P13639 B2RMP5 D6W618 Q58J86,Elongation factor 2,, PF00679;PF14492;PF03764;PF00009;PF03144;, GO:0016235;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0045121;GO:0005634;GO:0005886;GO:0042788;GO:1990904;GO:0034774;GO:0045202;GO:0008097;GO:0051015;GO:0045296;GO:0005525;GO:0003924;GO:0002039;GO:0019901;GO:0043022;GO:0003723;GO:0003746;GO:0007568;GO:1990416;GO:0014009;GO:0002244;GO:0043312;GO:2000767;GO:0045727;GO:0042493;GO:0034976;GO:0032355;GO:0045471;GO:0051593;GO:0042542;GO:0002931;GO:0035914;GO:0003009;GO:0006414;, C:aggresome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:polysomal ribosome; C:ribonucleoprotein complex; C:secretory granule lumen; C:synapse;, F:5S rRNA binding; F:actin filament binding; F:cadherin binding; F:GTP binding; F:GTPase activity; F:p53 binding; F:protein kinase binding; F:ribosome binding; F:RNA binding; F:translation elongation factor activity;, P:aging; P:cellular response to brain-derived neurotrophic factor stimulus; P:glial cell proliferation; P:hematopoietic progenitor cell differentiation; P:neutrophil degranulation; P:positive regulation of cytoplasmic translation; P:positive regulation of translation; P:response to drug; P:response to endoplasmic reticulum stress; P:response to estradiol; P:response to ethanol; P:response to folic acid; P:response to hydrogen peroxide; P:response to ischemia; P:skeletal muscle cell differentiation; P:skeletal muscle contraction; P:translational elongation; scaffold128 indexed_genome mRNA 2330096 2342697 . + . ID=transcript_13929;O43293 A0AVN4 B3KQE2 Q05JY4,Death-associated protein kinase 3,DAP-like kinase;MYPT1 kinase;Zipper-interacting protein kinase;, PF00069;, GO:0005884;GO:0005737;GO:0045121;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0008140;GO:0042802;GO:0043522;GO:0008022;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0006915;GO:0097190;GO:0071346;GO:0006325;GO:0035556;GO:0017148;GO:0030182;GO:0043065;GO:0090263;GO:0030335;GO:2001241;GO:0046777;GO:0006468;GO:2000249;GO:0042981;GO:0010506;GO:2000145;GO:0008360;GO:0051893;GO:0007346;GO:0007088;GO:0043519;GO:0006940;GO:0006355;, C:actin filament; C:cytoplasm; C:membrane raft; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:cAMP response element binding protein binding; F:identical protein binding; F:leucine zipper domain binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to interferon-gamma; P:chromatin organization; P:intracellular signal transduction; P:negative regulation of translation; P:neuron differentiation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell migration; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cell motility; P:regulation of cell shape; P:regulation of focal adhesion assembly; P:regulation of mitotic cell cycle; P:regulation of mitotic nuclear division; P:regulation of myosin II filament organization; P:regulation of smooth muscle contraction; P:regulation of transcription, DNA-templated;|O43293 A0AVN4 B3KQE2 Q05JY4,Death-associated protein kinase 3,DAP-like kinase;MYPT1 kinase;Zipper-interacting protein kinase;, PF00069;, GO:0005884;GO:0005737;GO:0045121;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0008140;GO:0042802;GO:0043522;GO:0008022;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0006915;GO:0097190;GO:0071346;GO:0006325;GO:0035556;GO:0017148;GO:0030182;GO:0043065;GO:0090263;GO:0030335;GO:2001241;GO:0046777;GO:0006468;GO:2000249;GO:0042981;GO:0010506;GO:2000145;GO:0008360;GO:0051893;GO:0007346;GO:0007088;GO:0043519;GO:0006940;GO:0006355;, C:actin filament; C:cytoplasm; C:membrane raft; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:cAMP response element binding protein binding; F:identical protein binding; F:leucine zipper domain binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to interferon-gamma; P:chromatin organization; P:intracellular signal transduction; P:negative regulation of translation; P:neuron differentiation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell migration; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cell motility; P:regulation of cell shape; P:regulation of focal adhesion assembly; P:regulation of mitotic cell cycle; P:regulation of mitotic nuclear division; P:regulation of myosin II filament organization; P:regulation of smooth muscle contraction; P:regulation of transcription, DNA-templated;|P53355 B7ZLD2 B7ZLE7 Q14CQ7 Q1W5W0 Q68CP8 Q6ZRZ3 Q9BTL8,Death-associated protein kinase 1,, PF12796;PF00531;PF00069;, GO:0015629;GO:0005737;GO:0005634;GO:0005886;GO:0005524;GO:0005516;GO:0004683;GO:0005525;GO:0042802;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0017075;GO:0006915;GO:0097190;GO:0071447;GO:0071346;GO:0002357;GO:0035556;GO:0017148;GO:0043065;GO:0010508;GO:0043280;GO:0046777;GO:0006468;GO:0042981;GO:0010506;GO:2000310;, C:actin cytoskeleton; C:cytoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:GTP binding; F:identical protein binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:syntaxin-1 binding;, P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to hydroperoxide; P:cellular response to interferon-gamma; P:defense response to tumor cell; P:intracellular signal transduction; P:negative regulation of translation; P:positive regulation of apoptotic process; P:positive regulation of autophagy; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of NMDA receptor activity;|O43293 A0AVN4 B3KQE2 Q05JY4,Death-associated protein kinase 3,DAP-like kinase;MYPT1 kinase;Zipper-interacting protein kinase;, PF00069;, GO:0005884;GO:0005737;GO:0045121;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0008140;GO:0042802;GO:0043522;GO:0008022;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0006915;GO:0097190;GO:0071346;GO:0006325;GO:0035556;GO:0017148;GO:0030182;GO:0043065;GO:0090263;GO:0030335;GO:2001241;GO:0046777;GO:0006468;GO:2000249;GO:0042981;GO:0010506;GO:2000145;GO:0008360;GO:0051893;GO:0007346;GO:0007088;GO:0043519;GO:0006940;GO:0006355;, C:actin filament; C:cytoplasm; C:membrane raft; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:cAMP response element binding protein binding; F:identical protein binding; F:leucine zipper domain binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to interferon-gamma; P:chromatin organization; P:intracellular signal transduction; P:negative regulation of translation; P:neuron differentiation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell migration; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cell motility; P:regulation of cell shape; P:regulation of focal adhesion assembly; P:regulation of mitotic cell cycle; P:regulation of mitotic nuclear division; P:regulation of myosin II filament organization; P:regulation of smooth muscle contraction; P:regulation of transcription, DNA-templated;|O43293 A0AVN4 B3KQE2 Q05JY4,Death-associated protein kinase 3,DAP-like kinase;MYPT1 kinase;Zipper-interacting protein kinase;, PF00069;, GO:0005884;GO:0005737;GO:0045121;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0008140;GO:0042802;GO:0043522;GO:0008022;GO:0042803;GO:0106310;GO:0004674;GO:0106311;GO:0031267;GO:0006915;GO:0097190;GO:0071346;GO:0006325;GO:0035556;GO:0017148;GO:0030182;GO:0043065;GO:0090263;GO:0030335;GO:2001241;GO:0046777;GO:0006468;GO:2000249;GO:0042981;GO:0010506;GO:2000145;GO:0008360;GO:0051893;GO:0007346;GO:0007088;GO:0043519;GO:0006940;GO:0006355;, C:actin filament; C:cytoplasm; C:membrane raft; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:cAMP response element binding protein binding; F:identical protein binding; F:leucine zipper domain binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:small GTPase binding;, P:apoptotic process; P:apoptotic signaling pathway; P:cellular response to interferon-gamma; P:chromatin organization; P:intracellular signal transduction; P:negative regulation of translation; P:neuron differentiation; P:positive regulation of apoptotic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell migration; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton reorganization; P:regulation of apoptotic process; P:regulation of autophagy; P:regulation of cell motility; P:regulation of cell shape; P:regulation of focal adhesion assembly; P:regulation of mitotic cell cycle; P:regulation of mitotic nuclear division; P:regulation of myosin II filament organization; P:regulation of smooth muscle contraction; P:regulation of transcription, DNA-templated; scaffold128 indexed_genome mRNA 2351373 2357376 . - . ID=transcript_13930;Q9NPI5 B7ZKR3 Q52M81 Q9NZK3,Nicotinamide riboside kinase 2,Integrin beta-1-binding protein 3;Muscle integrin-binding protein;Nicotinic acid riboside kinase 2;Ribosylnicotinamide kinase 2;Ribosylnicotinic acid kinase 2;, , GO:0005829;GO:0043231;GO:0005654;GO:0005886;GO:0005524;GO:0016301;GO:0046872;GO:0050262;GO:0061769;GO:0009435;GO:0019674;GO:0045662;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:kinase activity; F:metal ion binding; F:ribosylnicotinamide kinase activity; F:ribosylnicotinate kinase activity;, P:NAD biosynthetic process; P:NAD metabolic process; P:negative regulation of myoblast differentiation;|Q9NPI5 B7ZKR3 Q52M81 Q9NZK3,Nicotinamide riboside kinase 2,Integrin beta-1-binding protein 3;Muscle integrin-binding protein;Nicotinic acid riboside kinase 2;Ribosylnicotinamide kinase 2;Ribosylnicotinic acid kinase 2;, , GO:0005829;GO:0043231;GO:0005654;GO:0005886;GO:0005524;GO:0016301;GO:0046872;GO:0050262;GO:0061769;GO:0009435;GO:0019674;GO:0045662;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:kinase activity; F:metal ion binding; F:ribosylnicotinamide kinase activity; F:ribosylnicotinate kinase activity;, P:NAD biosynthetic process; P:NAD metabolic process; P:negative regulation of myoblast differentiation;|Q9NPI5 B7ZKR3 Q52M81 Q9NZK3,Nicotinamide riboside kinase 2,Integrin beta-1-binding protein 3;Muscle integrin-binding protein;Nicotinic acid riboside kinase 2;Ribosylnicotinamide kinase 2;Ribosylnicotinic acid kinase 2;, , GO:0005829;GO:0043231;GO:0005654;GO:0005886;GO:0005524;GO:0016301;GO:0046872;GO:0050262;GO:0061769;GO:0009435;GO:0019674;GO:0045662;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:kinase activity; F:metal ion binding; F:ribosylnicotinamide kinase activity; F:ribosylnicotinate kinase activity;, P:NAD biosynthetic process; P:NAD metabolic process; P:negative regulation of myoblast differentiation; scaffold128 indexed_genome mRNA 2365816 2378098 . - . ID=transcript_13931;Q86WG3 Q8NAQ2 Q8TAQ3 Q96HC6 Q96JF5,Caytaxin,Ataxia cayman type protein;BNIP-2-homology;, PF12496;PF13716;, GO:0030424;GO:0005737;GO:0030425;GO:0030426;GO:0031966;GO:0043005;GO:0044306;GO:0048471;GO:0098793;GO:0045202;GO:0004309;GO:0019894;GO:0006915;GO:0048311;GO:2000212;GO:0031175;GO:0006798;GO:0032880;, C:axon; C:cytoplasm; C:dendrite; C:growth cone; C:mitochondrial membrane; C:neuron projection; C:neuron projection terminus; C:perinuclear region of cytoplasm; C:presynapse; C:synapse;, F:exopolyphosphatase activity; F:kinesin binding;, P:apoptotic process; P:mitochondrion distribution; P:negative regulation of glutamate metabolic process; P:neuron projection development; P:polyphosphate catabolic process; P:regulation of protein localization;|Q86WG3 Q8NAQ2 Q8TAQ3 Q96HC6 Q96JF5,Caytaxin,Ataxia cayman type protein;BNIP-2-homology;, PF12496;PF13716;, GO:0030424;GO:0005737;GO:0030425;GO:0030426;GO:0031966;GO:0043005;GO:0044306;GO:0048471;GO:0098793;GO:0045202;GO:0004309;GO:0019894;GO:0006915;GO:0048311;GO:2000212;GO:0031175;GO:0006798;GO:0032880;, C:axon; C:cytoplasm; C:dendrite; C:growth cone; C:mitochondrial membrane; C:neuron projection; C:neuron projection terminus; C:perinuclear region of cytoplasm; C:presynapse; C:synapse;, F:exopolyphosphatase activity; F:kinesin binding;, P:apoptotic process; P:mitochondrion distribution; P:negative regulation of glutamate metabolic process; P:neuron projection development; P:polyphosphate catabolic process; P:regulation of protein localization;|Q86WG3 Q8NAQ2 Q8TAQ3 Q96HC6 Q96JF5,Caytaxin,Ataxia cayman type protein;BNIP-2-homology;, PF12496;PF13716;, GO:0030424;GO:0005737;GO:0030425;GO:0030426;GO:0031966;GO:0043005;GO:0044306;GO:0048471;GO:0098793;GO:0045202;GO:0004309;GO:0019894;GO:0006915;GO:0048311;GO:2000212;GO:0031175;GO:0006798;GO:0032880;, C:axon; C:cytoplasm; C:dendrite; C:growth cone; C:mitochondrial membrane; C:neuron projection; C:neuron projection terminus; C:perinuclear region of cytoplasm; C:presynapse; C:synapse;, F:exopolyphosphatase activity; F:kinesin binding;, P:apoptotic process; P:mitochondrion distribution; P:negative regulation of glutamate metabolic process; P:neuron projection development; P:polyphosphate catabolic process; P:regulation of protein localization; scaffold128 indexed_genome mRNA 2384549 2389578 . - . ID=transcript_13932;Q86WG3 Q8NAQ2 Q8TAQ3 Q96HC6 Q96JF5,Caytaxin,Ataxia cayman type protein;BNIP-2-homology;, PF12496;PF13716;, GO:0030424;GO:0005737;GO:0030425;GO:0030426;GO:0031966;GO:0043005;GO:0044306;GO:0048471;GO:0098793;GO:0045202;GO:0004309;GO:0019894;GO:0006915;GO:0048311;GO:2000212;GO:0031175;GO:0006798;GO:0032880;, C:axon; C:cytoplasm; C:dendrite; C:growth cone; C:mitochondrial membrane; C:neuron projection; C:neuron projection terminus; C:perinuclear region of cytoplasm; C:presynapse; C:synapse;, F:exopolyphosphatase activity; F:kinesin binding;, P:apoptotic process; P:mitochondrion distribution; P:negative regulation of glutamate metabolic process; P:neuron projection development; P:polyphosphate catabolic process; P:regulation of protein localization; scaffold128 indexed_genome mRNA 2419850 2465029 . + . ID=transcript_13933;Q9UPR6 B4DHD0,Zinc finger RNA-binding protein 2,, PF07528;, GO:0003725;GO:0003727;GO:0008270;, , F:double-stranded RNA binding; F:single-stranded RNA binding; F:zinc ion binding;|Q9UPR6 B4DHD0,Zinc finger RNA-binding protein 2,, PF07528;, GO:0003725;GO:0003727;GO:0008270;, , F:double-stranded RNA binding; F:single-stranded RNA binding; F:zinc ion binding;|Q9UPR6 B4DHD0,Zinc finger RNA-binding protein 2,, PF07528;, GO:0003725;GO:0003727;GO:0008270;, , F:double-stranded RNA binding; F:single-stranded RNA binding; F:zinc ion binding;|Q9UPR6 B4DHD0,Zinc finger RNA-binding protein 2,, PF07528;, GO:0003725;GO:0003727;GO:0008270;, , F:double-stranded RNA binding; F:single-stranded RNA binding; F:zinc ion binding;|Q9UPR6 B4DHD0,Zinc finger RNA-binding protein 2,, PF07528;, GO:0003725;GO:0003727;GO:0008270;, , F:double-stranded RNA binding; F:single-stranded RNA binding; F:zinc ion binding;|Q9UPR6 B4DHD0,Zinc finger RNA-binding protein 2,, PF07528;, GO:0003725;GO:0003727;GO:0008270;, , F:double-stranded RNA binding; F:single-stranded RNA binding; F:zinc ion binding; scaffold128 indexed_genome mRNA 2481736 2489529 . + . ID=transcript_13934;P42679 B3KNZ9 Q9NST8,Megakaryocyte-associated tyrosine-protein kinase,CSK homologous kinase;Hematopoietic consensus tyrosine-lacking kinase;Protein kinase HYL;Tyrosine-protein kinase CTK;, PF07714;PF00017;PF00018;, GO:0005829;GO:0016020;GO:0005524;GO:0004715;GO:0004713;GO:0004714;GO:0038128;GO:0008284;GO:0006468;, C:cytosol; C:membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:ERBB2 signaling pathway; P:positive regulation of cell population proliferation; P:protein phosphorylation;|P42679 B3KNZ9 Q9NST8,Megakaryocyte-associated tyrosine-protein kinase,CSK homologous kinase;Hematopoietic consensus tyrosine-lacking kinase;Protein kinase HYL;Tyrosine-protein kinase CTK;, PF07714;PF00017;PF00018;, GO:0005829;GO:0016020;GO:0005524;GO:0004715;GO:0004713;GO:0004714;GO:0038128;GO:0008284;GO:0006468;, C:cytosol; C:membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:ERBB2 signaling pathway; P:positive regulation of cell population proliferation; P:protein phosphorylation; scaffold128 indexed_genome mRNA 2493008 2495547 . + . ID=transcript_13935;Q96IS3,Retina and anterior neural fold homeobox protein 2,Q50-type retinal homeobox protein;Retina and anterior neural fold homeobox-like protein 1;, PF00046;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0045944;GO:0006357;GO:0050896;GO:0007601;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to stimulus; P:visual perception; scaffold128 indexed_genome mRNA 2495983 2498449 . - . ID=transcript_13936;Q6P161,39S ribosomal protein L54, mitochondrial,Mitochondrial large ribosomal subunit protein mL54 {ECO:0000303|PubMed:25838379};, PF08561;, GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold128 indexed_genome mRNA 2500307 2516821 . + . ID=transcript_13937;O96018 O60483 Q9UPZ2,Amyloid-beta A4 precursor protein-binding family A member 3,Adapter protein X11gamma;Neuron-specific X11L2 protein;Neuronal Munc18-1-interacting protein 3;, PF00595;PF00640;, GO:0005737;GO:0043197;GO:0048471;GO:0005886;GO:0001540;GO:0019899;GO:0004857;GO:0007268;GO:0001701;GO:0043086;GO:0015031;GO:0010468;, C:cytoplasm; C:dendritic spine; C:perinuclear region of cytoplasm; C:plasma membrane;, F:amyloid-beta binding; F:enzyme binding; F:enzyme inhibitor activity;, P:chemical synaptic transmission; P:in utero embryonic development; P:negative regulation of catalytic activity; P:protein transport; P:regulation of gene expression;|O95049 A6NFP3 B3KR73 B3KXZ0 B4E2W6 F5H2X0 F5H4S9 K7EK22 Q32N01,Tight junction protein ZO-3,Tight junction protein 3;Zona occludens protein 3;Zonula occludens protein 3;, PF00625;PF00595;PF07653;, GO:0005923;GO:0030054;GO:0005654;GO:0005634;GO:0005886;GO:0050839;GO:0098609;GO:0045216;GO:0090557;GO:0035633;GO:1905605;GO:0150105;, C:bicellular tight junction; C:cell junction; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cell adhesion molecule binding;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction;|O95049 A6NFP3 B3KR73 B3KXZ0 B4E2W6 F5H2X0 F5H4S9 K7EK22 Q32N01,Tight junction protein ZO-3,Tight junction protein 3;Zona occludens protein 3;Zonula occludens protein 3;, PF00625;PF00595;PF07653;, GO:0005923;GO:0030054;GO:0005654;GO:0005634;GO:0005886;GO:0050839;GO:0098609;GO:0045216;GO:0090557;GO:0035633;GO:1905605;GO:0150105;, C:bicellular tight junction; C:cell junction; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cell adhesion molecule binding;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction;|O95049 A6NFP3 B3KR73 B3KXZ0 B4E2W6 F5H2X0 F5H4S9 K7EK22 Q32N01,Tight junction protein ZO-3,Tight junction protein 3;Zona occludens protein 3;Zonula occludens protein 3;, PF00625;PF00595;PF07653;, GO:0005923;GO:0030054;GO:0005654;GO:0005634;GO:0005886;GO:0050839;GO:0098609;GO:0045216;GO:0090557;GO:0035633;GO:1905605;GO:0150105;, C:bicellular tight junction; C:cell junction; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cell adhesion molecule binding;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction; scaffold128 indexed_genome mRNA 2516885 2527834 . - . ID=transcript_13938;O95049 A6NFP3 B3KR73 B3KXZ0 B4E2W6 F5H2X0 F5H4S9 K7EK22 Q32N01,Tight junction protein ZO-3,Tight junction protein 3;Zona occludens protein 3;Zonula occludens protein 3;, PF00625;PF00595;PF07653;, GO:0005923;GO:0030054;GO:0005654;GO:0005634;GO:0005886;GO:0050839;GO:0098609;GO:0045216;GO:0090557;GO:0035633;GO:1905605;GO:0150105;, C:bicellular tight junction; C:cell junction; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:cell adhesion molecule binding;, P:cell-cell adhesion; P:cell-cell junction organization; P:establishment of endothelial intestinal barrier; P:maintenance of blood-brain barrier; P:positive regulation of blood-brain barrier permeability; P:protein localization to cell-cell junction; scaffold128 indexed_genome mRNA 2546312 2594375 . + . ID=transcript_13939;O60331 B7Z9E7 C6GIJ7 C6GIJ8 Q7LE07,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma {ECO:0000305|PubMed:12422219},Type I phosphatidylinositol 4-phosphate 5-kinase gamma {ECO:0000250|UniProtKB:O70161};, PF01504;, GO:0005912;GO:0005829;GO:0010008;GO:0005925;GO:0005654;GO:0001891;GO:0098793;GO:0032587;GO:0001931;GO:0016308;GO:0005524;GO:0030036;GO:0034333;GO:0098609;GO:0072583;GO:0061024;GO:0030593;GO:0006909;GO:0006661;GO:0014066;GO:0048488;GO:0016079;, C:adherens junction; C:cytosol; C:endosome membrane; C:focal adhesion; C:nucleoplasm; C:phagocytic cup; C:presynapse; C:ruffle membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:actin cytoskeleton organization; P:adherens junction assembly; P:cell-cell adhesion; P:clathrin-dependent endocytosis; P:membrane organization; P:neutrophil chemotaxis; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis;|O60331 B7Z9E7 C6GIJ7 C6GIJ8 Q7LE07,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma {ECO:0000305|PubMed:12422219},Type I phosphatidylinositol 4-phosphate 5-kinase gamma {ECO:0000250|UniProtKB:O70161};, PF01504;, GO:0005912;GO:0005829;GO:0010008;GO:0005925;GO:0005654;GO:0001891;GO:0098793;GO:0032587;GO:0001931;GO:0016308;GO:0005524;GO:0030036;GO:0034333;GO:0098609;GO:0072583;GO:0061024;GO:0030593;GO:0006909;GO:0006661;GO:0014066;GO:0048488;GO:0016079;, C:adherens junction; C:cytosol; C:endosome membrane; C:focal adhesion; C:nucleoplasm; C:phagocytic cup; C:presynapse; C:ruffle membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:actin cytoskeleton organization; P:adherens junction assembly; P:cell-cell adhesion; P:clathrin-dependent endocytosis; P:membrane organization; P:neutrophil chemotaxis; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis;|O60331 B7Z9E7 C6GIJ7 C6GIJ8 Q7LE07,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma {ECO:0000305|PubMed:12422219},Type I phosphatidylinositol 4-phosphate 5-kinase gamma {ECO:0000250|UniProtKB:O70161};, PF01504;, GO:0005912;GO:0005829;GO:0010008;GO:0005925;GO:0005654;GO:0001891;GO:0098793;GO:0032587;GO:0001931;GO:0016308;GO:0005524;GO:0030036;GO:0034333;GO:0098609;GO:0072583;GO:0061024;GO:0030593;GO:0006909;GO:0006661;GO:0014066;GO:0048488;GO:0016079;, C:adherens junction; C:cytosol; C:endosome membrane; C:focal adhesion; C:nucleoplasm; C:phagocytic cup; C:presynapse; C:ruffle membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:actin cytoskeleton organization; P:adherens junction assembly; P:cell-cell adhesion; P:clathrin-dependent endocytosis; P:membrane organization; P:neutrophil chemotaxis; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis;|Q7KYT5 Q8NHQ5 Q92749,Phosphatidylinositol 4-phosphate 5-kinase type-1 beta {ECO:0000305|PubMed:8955136},Phosphatidylinositol 4-phosphate 5-kinase type I beta {ECO:0000305|PubMed:8955136};Protein STM-7 {ECO:0000303|PubMed:8841185};Type I phosphatidylinositol 4-phosphate 5-kinase beta {ECO:0000305|PubMed:8955136};, PF01504;, GO:0005829;GO:0012505;GO:0005886;GO:0001931;GO:0016308;GO:0005524;GO:0006661;GO:0014066;, C:cytosol; C:endomembrane system; C:plasma membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling;|O60331 B7Z9E7 C6GIJ7 C6GIJ8 Q7LE07,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma {ECO:0000305|PubMed:12422219},Type I phosphatidylinositol 4-phosphate 5-kinase gamma {ECO:0000250|UniProtKB:O70161};, PF01504;, GO:0005912;GO:0005829;GO:0010008;GO:0005925;GO:0005654;GO:0001891;GO:0098793;GO:0032587;GO:0001931;GO:0016308;GO:0005524;GO:0030036;GO:0034333;GO:0098609;GO:0072583;GO:0061024;GO:0030593;GO:0006909;GO:0006661;GO:0014066;GO:0048488;GO:0016079;, C:adherens junction; C:cytosol; C:endosome membrane; C:focal adhesion; C:nucleoplasm; C:phagocytic cup; C:presynapse; C:ruffle membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:actin cytoskeleton organization; P:adherens junction assembly; P:cell-cell adhesion; P:clathrin-dependent endocytosis; P:membrane organization; P:neutrophil chemotaxis; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis;|O60331 B7Z9E7 C6GIJ7 C6GIJ8 Q7LE07,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma {ECO:0000305|PubMed:12422219},Type I phosphatidylinositol 4-phosphate 5-kinase gamma {ECO:0000250|UniProtKB:O70161};, PF01504;, GO:0005912;GO:0005829;GO:0010008;GO:0005925;GO:0005654;GO:0001891;GO:0098793;GO:0032587;GO:0001931;GO:0016308;GO:0005524;GO:0030036;GO:0034333;GO:0098609;GO:0072583;GO:0061024;GO:0030593;GO:0006909;GO:0006661;GO:0014066;GO:0048488;GO:0016079;, C:adherens junction; C:cytosol; C:endosome membrane; C:focal adhesion; C:nucleoplasm; C:phagocytic cup; C:presynapse; C:ruffle membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:actin cytoskeleton organization; P:adherens junction assembly; P:cell-cell adhesion; P:clathrin-dependent endocytosis; P:membrane organization; P:neutrophil chemotaxis; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis;|O60331 B7Z9E7 C6GIJ7 C6GIJ8 Q7LE07,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma {ECO:0000305|PubMed:12422219},Type I phosphatidylinositol 4-phosphate 5-kinase gamma {ECO:0000250|UniProtKB:O70161};, PF01504;, GO:0005912;GO:0005829;GO:0010008;GO:0005925;GO:0005654;GO:0001891;GO:0098793;GO:0032587;GO:0001931;GO:0016308;GO:0005524;GO:0030036;GO:0034333;GO:0098609;GO:0072583;GO:0061024;GO:0030593;GO:0006909;GO:0006661;GO:0014066;GO:0048488;GO:0016079;, C:adherens junction; C:cytosol; C:endosome membrane; C:focal adhesion; C:nucleoplasm; C:phagocytic cup; C:presynapse; C:ruffle membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:actin cytoskeleton organization; P:adherens junction assembly; P:cell-cell adhesion; P:clathrin-dependent endocytosis; P:membrane organization; P:neutrophil chemotaxis; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis;|O60331 B7Z9E7 C6GIJ7 C6GIJ8 Q7LE07,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma {ECO:0000305|PubMed:12422219},Type I phosphatidylinositol 4-phosphate 5-kinase gamma {ECO:0000250|UniProtKB:O70161};, PF01504;, GO:0005912;GO:0005829;GO:0010008;GO:0005925;GO:0005654;GO:0001891;GO:0098793;GO:0032587;GO:0001931;GO:0016308;GO:0005524;GO:0030036;GO:0034333;GO:0098609;GO:0072583;GO:0061024;GO:0030593;GO:0006909;GO:0006661;GO:0014066;GO:0048488;GO:0016079;, C:adherens junction; C:cytosol; C:endosome membrane; C:focal adhesion; C:nucleoplasm; C:phagocytic cup; C:presynapse; C:ruffle membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:actin cytoskeleton organization; P:adherens junction assembly; P:cell-cell adhesion; P:clathrin-dependent endocytosis; P:membrane organization; P:neutrophil chemotaxis; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis;|O60331 B7Z9E7 C6GIJ7 C6GIJ8 Q7LE07,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma {ECO:0000305|PubMed:12422219},Type I phosphatidylinositol 4-phosphate 5-kinase gamma {ECO:0000250|UniProtKB:O70161};, PF01504;, GO:0005912;GO:0005829;GO:0010008;GO:0005925;GO:0005654;GO:0001891;GO:0098793;GO:0032587;GO:0001931;GO:0016308;GO:0005524;GO:0030036;GO:0034333;GO:0098609;GO:0072583;GO:0061024;GO:0030593;GO:0006909;GO:0006661;GO:0014066;GO:0048488;GO:0016079;, C:adherens junction; C:cytosol; C:endosome membrane; C:focal adhesion; C:nucleoplasm; C:phagocytic cup; C:presynapse; C:ruffle membrane; C:uropod;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:ATP binding;, P:actin cytoskeleton organization; P:adherens junction assembly; P:cell-cell adhesion; P:clathrin-dependent endocytosis; P:membrane organization; P:neutrophil chemotaxis; P:phagocytosis; P:phosphatidylinositol biosynthetic process; P:regulation of phosphatidylinositol 3-kinase signaling; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis; scaffold128 indexed_genome mRNA 2595540 2602999 . + . ID=transcript_13940;Q8WUQ7 A6NNA9 A9UL12 O75229 Q7LE08 Q9BTA6 Q9Y5A4,Cactin,Renal carcinoma antigen NY-REN-24;, PF10312;PF09732;, GO:0071013;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0071347;GO:0071222;GO:0071356;GO:0045087;GO:0045292;GO:0000398;GO:0007275;GO:0043124;GO:0045824;GO:0032688;GO:0032717;GO:0031665;GO:0032088;GO:0001933;GO:0034122;GO:0032720;GO:0060339;GO:0010468;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:innate immune response; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:multicellular organism development; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of innate immune response; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-8 production; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:negative regulation of type I interferon-mediated signaling pathway; P:regulation of gene expression;|Q8WUQ7 A6NNA9 A9UL12 O75229 Q7LE08 Q9BTA6 Q9Y5A4,Cactin,Renal carcinoma antigen NY-REN-24;, PF10312;PF09732;, GO:0071013;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0071347;GO:0071222;GO:0071356;GO:0045087;GO:0045292;GO:0000398;GO:0007275;GO:0043124;GO:0045824;GO:0032688;GO:0032717;GO:0031665;GO:0032088;GO:0001933;GO:0034122;GO:0032720;GO:0060339;GO:0010468;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:innate immune response; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:multicellular organism development; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of innate immune response; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-8 production; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:negative regulation of type I interferon-mediated signaling pathway; P:regulation of gene expression;|Q8WUQ7 A6NNA9 A9UL12 O75229 Q7LE08 Q9BTA6 Q9Y5A4,Cactin,Renal carcinoma antigen NY-REN-24;, PF10312;PF09732;, GO:0071013;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0071347;GO:0071222;GO:0071356;GO:0045087;GO:0045292;GO:0000398;GO:0007275;GO:0043124;GO:0045824;GO:0032688;GO:0032717;GO:0031665;GO:0032088;GO:0001933;GO:0034122;GO:0032720;GO:0060339;GO:0010468;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:innate immune response; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:multicellular organism development; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of innate immune response; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-8 production; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:negative regulation of type I interferon-mediated signaling pathway; P:regulation of gene expression; scaffold128 indexed_genome mRNA 2603637 2607668 . + . ID=transcript_13941;Q8WUQ7 A6NNA9 A9UL12 O75229 Q7LE08 Q9BTA6 Q9Y5A4,Cactin,Renal carcinoma antigen NY-REN-24;, PF10312;PF09732;, GO:0071013;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0071347;GO:0071222;GO:0071356;GO:0045087;GO:0045292;GO:0000398;GO:0007275;GO:0043124;GO:0045824;GO:0032688;GO:0032717;GO:0031665;GO:0032088;GO:0001933;GO:0034122;GO:0032720;GO:0060339;GO:0010468;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:innate immune response; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:multicellular organism development; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of innate immune response; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-8 production; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:negative regulation of type I interferon-mediated signaling pathway; P:regulation of gene expression;|Q8WUQ7 A6NNA9 A9UL12 O75229 Q7LE08 Q9BTA6 Q9Y5A4,Cactin,Renal carcinoma antigen NY-REN-24;, PF10312;PF09732;, GO:0071013;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0071347;GO:0071222;GO:0071356;GO:0045087;GO:0045292;GO:0000398;GO:0007275;GO:0043124;GO:0045824;GO:0032688;GO:0032717;GO:0031665;GO:0032088;GO:0001933;GO:0034122;GO:0032720;GO:0060339;GO:0010468;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:cellular response to interleukin-1; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:innate immune response; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:multicellular organism development; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of innate immune response; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-8 production; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:negative regulation of type I interferon-mediated signaling pathway; P:regulation of gene expression; scaffold128 indexed_genome mRNA 2611789 2623391 . + . ID=transcript_13942;P21731 O75228 Q6DK52 Q9UCY1 Q9UCY2,Thromboxane A2 receptor,Prostanoid TP receptor;, PF00001;, GO:0001669;GO:0005887;GO:0016607;GO:0005886;GO:0004961;GO:0007189;GO:0071222;GO:0007186;GO:0006954;GO:0090051;GO:0045766;GO:0030194;GO:0045777;GO:0007204;GO:0045987;GO:0045907;GO:0050790;GO:0042493;GO:0045471;GO:0007584;GO:0033574;, C:acrosomal vesicle; C:integral component of plasma membrane; C:nuclear speck; C:plasma membrane;, F:thromboxane A2 receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cellular response to lipopolysaccharide; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of blood pressure; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of smooth muscle contraction; P:positive regulation of vasoconstriction; P:regulation of catalytic activity; P:response to drug; P:response to ethanol; P:response to nutrient; P:response to testosterone; scaffold128 indexed_genome mRNA 2623456 2628841 . + . ID=transcript_13943;Q8TF64 O75227,PDZ domain-containing protein GIPC3,, PF00595;|Q8TF64 O75227,PDZ domain-containing protein GIPC3,, PF00595; scaffold128 indexed_genome mRNA 2637322 2643044 . - . ID=transcript_13944;Q9P0W2 A6NMS5 D6W616 Q6IBP8 Q8NBD5 Q9HD21 Q9Y491 Q9Y4A2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related,BRCA2-associated factor 35;HMG box-containing protein 20B;HMG domain-containing protein 2;HMG domain-containing protein HMGX2;Sox-like transcriptional factor;Structural DNA-binding protein BRAF35;, PF00505;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0003677;GO:0007596;GO:0007049;GO:0006325;GO:0033234;GO:0045666;GO:0010468;GO:0035914;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:blood coagulation; P:cell cycle; P:chromatin organization; P:negative regulation of protein sumoylation; P:positive regulation of neuron differentiation; P:regulation of gene expression; P:skeletal muscle cell differentiation;|Q9P0W2 A6NMS5 D6W616 Q6IBP8 Q8NBD5 Q9HD21 Q9Y491 Q9Y4A2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related,BRCA2-associated factor 35;HMG box-containing protein 20B;HMG domain-containing protein 2;HMG domain-containing protein HMGX2;Sox-like transcriptional factor;Structural DNA-binding protein BRAF35;, PF00505;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0003677;GO:0007596;GO:0007049;GO:0006325;GO:0033234;GO:0045666;GO:0010468;GO:0035914;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:blood coagulation; P:cell cycle; P:chromatin organization; P:negative regulation of protein sumoylation; P:positive regulation of neuron differentiation; P:regulation of gene expression; P:skeletal muscle cell differentiation;|Q9P0W2 A6NMS5 D6W616 Q6IBP8 Q8NBD5 Q9HD21 Q9Y491 Q9Y4A2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related,BRCA2-associated factor 35;HMG box-containing protein 20B;HMG domain-containing protein 2;HMG domain-containing protein HMGX2;Sox-like transcriptional factor;Structural DNA-binding protein BRAF35;, PF00505;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0003677;GO:0007596;GO:0007049;GO:0006325;GO:0033234;GO:0045666;GO:0010468;GO:0035914;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:blood coagulation; P:cell cycle; P:chromatin organization; P:negative regulation of protein sumoylation; P:positive regulation of neuron differentiation; P:regulation of gene expression; P:skeletal muscle cell differentiation;|Q9P0W2 A6NMS5 D6W616 Q6IBP8 Q8NBD5 Q9HD21 Q9Y491 Q9Y4A2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related,BRCA2-associated factor 35;HMG box-containing protein 20B;HMG domain-containing protein 2;HMG domain-containing protein HMGX2;Sox-like transcriptional factor;Structural DNA-binding protein BRAF35;, PF00505;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0003677;GO:0007596;GO:0007049;GO:0006325;GO:0033234;GO:0045666;GO:0010468;GO:0035914;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:blood coagulation; P:cell cycle; P:chromatin organization; P:negative regulation of protein sumoylation; P:positive regulation of neuron differentiation; P:regulation of gene expression; P:skeletal muscle cell differentiation;|Q9P0W2 A6NMS5 D6W616 Q6IBP8 Q8NBD5 Q9HD21 Q9Y491 Q9Y4A2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related,BRCA2-associated factor 35;HMG box-containing protein 20B;HMG domain-containing protein 2;HMG domain-containing protein HMGX2;Sox-like transcriptional factor;Structural DNA-binding protein BRAF35;, PF00505;, GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0003677;GO:0007596;GO:0007049;GO:0006325;GO:0033234;GO:0045666;GO:0010468;GO:0035914;, C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:blood coagulation; P:cell cycle; P:chromatin organization; P:negative regulation of protein sumoylation; P:positive regulation of neuron differentiation; P:regulation of gene expression; P:skeletal muscle cell differentiation; scaffold128 indexed_genome mRNA 2657289 2677908 . + . ID=transcript_13945;Q6NUT3 A8MXP7 D6W615 E9PAJ8 Q8N459,Major facilitator superfamily domain-containing protein 12 {ECO:0000305},, , GO:0005887;GO:0005770;GO:0005765;GO:0005764;GO:0042470;GO:0033229;GO:0015293;GO:0008643;GO:1903712;GO:0048022;GO:0071702;GO:0043474;GO:0048021;, C:integral component of plasma membrane; C:late endosome; C:lysosomal membrane; C:lysosome; C:melanosome;, F:cysteine transmembrane transporter activity; F:symporter activity;, P:carbohydrate transport; P:cysteine transmembrane transport; P:negative regulation of melanin biosynthetic process; P:organic substance transport; P:pigment metabolic process involved in pigmentation; P:regulation of melanin biosynthetic process;|Q6NUT3 A8MXP7 D6W615 E9PAJ8 Q8N459,Major facilitator superfamily domain-containing protein 12 {ECO:0000305},, , GO:0005887;GO:0005770;GO:0005765;GO:0005764;GO:0042470;GO:0033229;GO:0015293;GO:0008643;GO:1903712;GO:0048022;GO:0071702;GO:0043474;GO:0048021;, C:integral component of plasma membrane; C:late endosome; C:lysosomal membrane; C:lysosome; C:melanosome;, F:cysteine transmembrane transporter activity; F:symporter activity;, P:carbohydrate transport; P:cysteine transmembrane transport; P:negative regulation of melanin biosynthetic process; P:organic substance transport; P:pigment metabolic process involved in pigmentation; P:regulation of melanin biosynthetic process;|Q6NUT3 A8MXP7 D6W615 E9PAJ8 Q8N459,Major facilitator superfamily domain-containing protein 12 {ECO:0000305},, , GO:0005887;GO:0005770;GO:0005765;GO:0005764;GO:0042470;GO:0033229;GO:0015293;GO:0008643;GO:1903712;GO:0048022;GO:0071702;GO:0043474;GO:0048021;, C:integral component of plasma membrane; C:late endosome; C:lysosomal membrane; C:lysosome; C:melanosome;, F:cysteine transmembrane transporter activity; F:symporter activity;, P:carbohydrate transport; P:cysteine transmembrane transport; P:negative regulation of melanin biosynthetic process; P:organic substance transport; P:pigment metabolic process involved in pigmentation; P:regulation of melanin biosynthetic process;|Q6NUT3 A8MXP7 D6W615 E9PAJ8 Q8N459,Major facilitator superfamily domain-containing protein 12 {ECO:0000305},, , GO:0005887;GO:0005770;GO:0005765;GO:0005764;GO:0042470;GO:0033229;GO:0015293;GO:0008643;GO:1903712;GO:0048022;GO:0071702;GO:0043474;GO:0048021;, C:integral component of plasma membrane; C:late endosome; C:lysosomal membrane; C:lysosome; C:melanosome;, F:cysteine transmembrane transporter activity; F:symporter activity;, P:carbohydrate transport; P:cysteine transmembrane transport; P:negative regulation of melanin biosynthetic process; P:organic substance transport; P:pigment metabolic process involved in pigmentation; P:regulation of melanin biosynthetic process;|Q9UM11 O75869 Q86U66 Q96NW8 Q9UI96 Q9ULH8 Q9UM10 Q9UNQ1 Q9Y2T8,Fizzy-related protein homolog {ECO:0000305},CDC20-like protein 1;Cdh1/Hct1 homolog;, PF12894;PF00400;, GO:0005829;GO:0031965;GO:0005654;GO:0010997;GO:1990757;GO:0031145;GO:0007049;GO:0051301;GO:0006281;GO:0070306;GO:0090344;GO:1905786;GO:0008284;GO:0045732;GO:1904668;GO:0070979;GO:0040020;GO:1901990;GO:0072425;GO:0006511;, C:cytosol; C:nuclear membrane; C:nucleoplasm;, F:anaphase-promoting complex binding; F:ubiquitin ligase activator activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:DNA repair; P:lens fiber cell differentiation; P:negative regulation of cell aging; P:positive regulation of anaphase-promoting complex-dependent catabolic process; P:positive regulation of cell population proliferation; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin protein ligase activity; P:protein K11-linked ubiquitination; P:regulation of meiotic nuclear division; P:regulation of mitotic cell cycle phase transition; P:signal transduction involved in G2 DNA damage checkpoint; P:ubiquitin-dependent protein catabolic process;|Q9UM11 O75869 Q86U66 Q96NW8 Q9UI96 Q9ULH8 Q9UM10 Q9UNQ1 Q9Y2T8,Fizzy-related protein homolog {ECO:0000305},CDC20-like protein 1;Cdh1/Hct1 homolog;, PF12894;PF00400;, GO:0005829;GO:0031965;GO:0005654;GO:0010997;GO:1990757;GO:0031145;GO:0007049;GO:0051301;GO:0006281;GO:0070306;GO:0090344;GO:1905786;GO:0008284;GO:0045732;GO:1904668;GO:0070979;GO:0040020;GO:1901990;GO:0072425;GO:0006511;, C:cytosol; C:nuclear membrane; C:nucleoplasm;, F:anaphase-promoting complex binding; F:ubiquitin ligase activator activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:DNA repair; P:lens fiber cell differentiation; P:negative regulation of cell aging; P:positive regulation of anaphase-promoting complex-dependent catabolic process; P:positive regulation of cell population proliferation; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin protein ligase activity; P:protein K11-linked ubiquitination; P:regulation of meiotic nuclear division; P:regulation of mitotic cell cycle phase transition; P:signal transduction involved in G2 DNA damage checkpoint; P:ubiquitin-dependent protein catabolic process;|Q9UM11 O75869 Q86U66 Q96NW8 Q9UI96 Q9ULH8 Q9UM10 Q9UNQ1 Q9Y2T8,Fizzy-related protein homolog {ECO:0000305},CDC20-like protein 1;Cdh1/Hct1 homolog;, PF12894;PF00400;, GO:0005829;GO:0031965;GO:0005654;GO:0010997;GO:1990757;GO:0031145;GO:0007049;GO:0051301;GO:0006281;GO:0070306;GO:0090344;GO:1905786;GO:0008284;GO:0045732;GO:1904668;GO:0070979;GO:0040020;GO:1901990;GO:0072425;GO:0006511;, C:cytosol; C:nuclear membrane; C:nucleoplasm;, F:anaphase-promoting complex binding; F:ubiquitin ligase activator activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:DNA repair; P:lens fiber cell differentiation; P:negative regulation of cell aging; P:positive regulation of anaphase-promoting complex-dependent catabolic process; P:positive regulation of cell population proliferation; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin protein ligase activity; P:protein K11-linked ubiquitination; P:regulation of meiotic nuclear division; P:regulation of mitotic cell cycle phase transition; P:signal transduction involved in G2 DNA damage checkpoint; P:ubiquitin-dependent protein catabolic process; scaffold128 indexed_genome mRNA 2709073 2718561 . + . ID=transcript_13946;Q9BU89 O75265,Deoxyhypusine hydroxylase {ECO:0000255|HAMAP-Rule:MF_03101, ECO:0000303|PubMed:16533814},Deoxyhypusine dioxygenase {ECO:0000255|HAMAP-Rule:MF_03101};Deoxyhypusine monooxygenase {ECO:0000255|HAMAP-Rule:MF_03101};HEAT-like repeat-containing protein 1 {ECO:0000303|PubMed:19706422};, , GO:0005829;GO:0019135;GO:0005506;GO:0016491;GO:0008612;, C:cytosol;, F:deoxyhypusine monooxygenase activity; F:iron ion binding; F:oxidoreductase activity;, P:peptidyl-lysine modification to peptidyl-hypusine; scaffold128 indexed_genome mRNA 2722700 2728206 . + . ID=transcript_13947;O75264 B9EJF4 Q9P059,Small integral membrane protein 24,, PF15807;, GO:0016021;, C:integral component of membrane; scaffold128 indexed_genome mRNA 2736431 2749317 . - . ID=transcript_13948;Q9UPK0 Q9UPK1,Nuclear factor 1 C-type,CCAAT-box-binding transcription factor;Nuclear factor I/C;TGGCA-binding protein;, PF00859;PF03165;PF10524;, GO:0000785;GO:0001650;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0006260;GO:0000122;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:DNA replication; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|Q9UPK0 Q9UPK1,Nuclear factor 1 C-type,CCAAT-box-binding transcription factor;Nuclear factor I/C;TGGCA-binding protein;, PF00859;PF03165;PF10524;, GO:0000785;GO:0001650;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0006260;GO:0000122;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:DNA replication; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold128 indexed_genome mRNA 2859070 2873087 . - . ID=transcript_13949;Q8N6W0 D6W614 O75253 Q59GP2 Q86VW6 Q9BZC0 Q9NR86,CUGBP Elav-like family member 5,Bruno-like protein 5;CUG-BP- and ETR-3-like factor 5;RNA-binding protein BRUNOL-5;, PF00076;, GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0036002;GO:0003723;GO:0006376;GO:0000381;, C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:pre-mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:regulation of alternative mRNA splicing, via spliceosome;|Q8N6W0 D6W614 O75253 Q59GP2 Q86VW6 Q9BZC0 Q9NR86,CUGBP Elav-like family member 5,Bruno-like protein 5;CUG-BP- and ETR-3-like factor 5;RNA-binding protein BRUNOL-5;, PF00076;, GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0036002;GO:0003723;GO:0006376;GO:0000381;, C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:pre-mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:regulation of alternative mRNA splicing, via spliceosome;|Q8N6W0 D6W614 O75253 Q59GP2 Q86VW6 Q9BZC0 Q9NR86,CUGBP Elav-like family member 5,Bruno-like protein 5;CUG-BP- and ETR-3-like factor 5;RNA-binding protein BRUNOL-5;, PF00076;, GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0036002;GO:0003723;GO:0006376;GO:0000381;, C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:pre-mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:regulation of alternative mRNA splicing, via spliceosome; scaffold128 indexed_genome mRNA 2874811 2876041 . + . ID=transcript_13950;Q8N6W0 D6W614 O75253 Q59GP2 Q86VW6 Q9BZC0 Q9NR86,CUGBP Elav-like family member 5,Bruno-like protein 5;CUG-BP- and ETR-3-like factor 5;RNA-binding protein BRUNOL-5;, PF00076;, GO:0005737;GO:0005634;GO:1990904;GO:0003729;GO:0036002;GO:0003723;GO:0006376;GO:0000381;, C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:mRNA binding; F:pre-mRNA binding; F:RNA binding;, P:mRNA splice site selection; P:regulation of alternative mRNA splicing, via spliceosome; scaffold129 indexed_genome mRNA 88720 95963 . - . ID=transcript_13951;A6NFC5 C9JRE6,Transmembrane protein 235,, PF13903;, GO:0016324;GO:0005783;GO:0016021;, C:apical plasma membrane; C:endoplasmic reticulum; C:integral component of membrane;|A6NFC5 C9JRE6,Transmembrane protein 235,, PF13903;, GO:0016324;GO:0005783;GO:0016021;, C:apical plasma membrane; C:endoplasmic reticulum; C:integral component of membrane; scaffold129 indexed_genome mRNA 113039 119017 . - . ID=transcript_13952;Q63HM1 A2RUB3,Kynurenine formamidase {ECO:0000255|HAMAP-Rule:MF_03014},Arylformamidase {ECO:0000255|HAMAP-Rule:MF_03014};N-formylkynurenine formamidase {ECO:0000255|HAMAP-Rule:MF_03014};, PF07859;, GO:0005737;GO:0005829;GO:0005634;GO:0004061;GO:0016787;GO:0034354;GO:0019441;, C:cytoplasm; C:cytosol; C:nucleus;, F:arylformamidase activity; F:hydrolase activity;, P:'de novo' NAD biosynthetic process from tryptophan; P:tryptophan catabolic process to kynurenine; scaffold129 indexed_genome mRNA 135119 147568 . + . ID=transcript_13953;P04183 B2RC58 Q969V0 Q9UMG9,Thymidine kinase, cytosolic,, PF00265;, GO:0005829;GO:0005524;GO:0042802;GO:0004797;GO:0008270;GO:0071897;GO:0006139;GO:0051289;GO:0043097;GO:0046104;, C:cytosol;, F:ATP binding; F:identical protein binding; F:thymidine kinase activity; F:zinc ion binding;, P:DNA biosynthetic process; P:nucleobase-containing compound metabolic process; P:protein homotetramerization; P:pyrimidine nucleoside salvage; P:thymidine metabolic process; scaffold129 indexed_genome mRNA 148606 150413 . - . ID=transcript_13954;O43760 O43762 Q3KQZ2 Q658S7,Synaptogyrin-2 {ECO:0000305},Cellugyrin {ECO:0000250|UniProtKB:O54980};, PF01284;, GO:0070062;GO:0016021;GO:0005811;GO:0031594;GO:0030672;GO:0045055;GO:0048499;GO:0016032;, C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:neuromuscular junction; C:synaptic vesicle membrane;, , P:regulated exocytosis; P:synaptic vesicle membrane organization; P:viral process;|O43760 O43762 Q3KQZ2 Q658S7,Synaptogyrin-2 {ECO:0000305},Cellugyrin {ECO:0000250|UniProtKB:O54980};, PF01284;, GO:0070062;GO:0016021;GO:0005811;GO:0031594;GO:0030672;GO:0045055;GO:0048499;GO:0016032;, C:extracellular exosome; C:integral component of membrane; C:lipid droplet; C:neuromuscular junction; C:synaptic vesicle membrane;, , P:regulated exocytosis; P:synaptic vesicle membrane organization; P:viral process; scaffold129 indexed_genome mRNA 174312 184052 . - . ID=transcript_13955;Q8IU68 Q2YDC0 Q8IWU7 Q8N358 Q8NF04,Transmembrane channel-like protein 8,Epidermodysplasia verruciformis protein 2;, PF07810;, GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005615;GO:0005794;GO:0005887;GO:0031965;GO:0008381;GO:0140311;GO:0043120;GO:0032091;GO:0031333;GO:0001558;GO:1902041;GO:0055069;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear membrane;, F:mechanosensitive ion channel activity; F:protein sequestering activity; F:tumor necrosis factor binding;, P:negative regulation of protein binding; P:negative regulation of protein-containing complex assembly; P:regulation of cell growth; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:zinc ion homeostasis; scaffold129 indexed_genome mRNA 187082 189187 . + . ID=transcript_13956;Q7Z403 O43284 Q45VJ2 Q8IU98 Q8IUI7 Q8IWU8 Q8TEQ7 Q9HAG5,Transmembrane channel-like protein 6,Epidermodysplasia verruciformis protein 1;Protein LAK-4;, PF07810;, GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0005887;GO:0031965;GO:0005886;GO:0035579;GO:0070821;GO:0008381;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:mechanosensitive ion channel activity;, P:neutrophil degranulation;|Q7Z403 O43284 Q45VJ2 Q8IU98 Q8IUI7 Q8IWU8 Q8TEQ7 Q9HAG5,Transmembrane channel-like protein 6,Epidermodysplasia verruciformis protein 1;Protein LAK-4;, PF07810;, GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0005887;GO:0031965;GO:0005886;GO:0035579;GO:0070821;GO:0008381;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:mechanosensitive ion channel activity;, P:neutrophil degranulation; scaffold129 indexed_genome mRNA 190632 202795 . + . ID=transcript_13957;Q7Z403 O43284 Q45VJ2 Q8IU98 Q8IUI7 Q8IWU8 Q8TEQ7 Q9HAG5,Transmembrane channel-like protein 6,Epidermodysplasia verruciformis protein 1;Protein LAK-4;, PF07810;, GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0005887;GO:0031965;GO:0005886;GO:0035579;GO:0070821;GO:0008381;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:mechanosensitive ion channel activity;, P:neutrophil degranulation;|Q7Z403 O43284 Q45VJ2 Q8IU98 Q8IUI7 Q8IWU8 Q8TEQ7 Q9HAG5,Transmembrane channel-like protein 6,Epidermodysplasia verruciformis protein 1;Protein LAK-4;, PF07810;, GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0005887;GO:0031965;GO:0005886;GO:0035579;GO:0070821;GO:0008381;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:mechanosensitive ion channel activity;, P:neutrophil degranulation;|Q7Z403 O43284 Q45VJ2 Q8IU98 Q8IUI7 Q8IWU8 Q8TEQ7 Q9HAG5,Transmembrane channel-like protein 6,Epidermodysplasia verruciformis protein 1;Protein LAK-4;, PF07810;, GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0005887;GO:0031965;GO:0005886;GO:0035579;GO:0070821;GO:0008381;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:mechanosensitive ion channel activity;, P:neutrophil degranulation;|Q7Z403 O43284 Q45VJ2 Q8IU98 Q8IUI7 Q8IWU8 Q8TEQ7 Q9HAG5,Transmembrane channel-like protein 6,Epidermodysplasia verruciformis protein 1;Protein LAK-4;, PF07810;, GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0005887;GO:0031965;GO:0005886;GO:0035579;GO:0070821;GO:0008381;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:mechanosensitive ion channel activity;, P:neutrophil degranulation;|Q7Z403 O43284 Q45VJ2 Q8IU98 Q8IUI7 Q8IWU8 Q8TEQ7 Q9HAG5,Transmembrane channel-like protein 6,Epidermodysplasia verruciformis protein 1;Protein LAK-4;, PF07810;, GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0005887;GO:0031965;GO:0005886;GO:0035579;GO:0070821;GO:0008381;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:mechanosensitive ion channel activity;, P:neutrophil degranulation;|Q7Z403 O43284 Q45VJ2 Q8IU98 Q8IUI7 Q8IWU8 Q8TEQ7 Q9HAG5,Transmembrane channel-like protein 6,Epidermodysplasia verruciformis protein 1;Protein LAK-4;, PF07810;, GO:0005737;GO:0005783;GO:0005789;GO:0070062;GO:0005794;GO:0005887;GO:0031965;GO:0005886;GO:0035579;GO:0070821;GO:0008381;GO:0043312;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi apparatus; C:integral component of plasma membrane; C:nuclear membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:mechanosensitive ion channel activity;, P:neutrophil degranulation; scaffold129 indexed_genome mRNA 208424 231871 . - . ID=transcript_13958;Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway; scaffold129 indexed_genome mRNA 233282 238316 . - . ID=transcript_13959;Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway; scaffold129 indexed_genome mRNA 239215 342449 . + . ID=transcript_13960;Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway;|Q9HCJ0 G3XAB8 Q86UE5 Q8N3D8 Q96MU9,Trinucleotide repeat-containing gene 6C protein,, PF10427;PF12938;PF16608;PF00627;, GO:0005829;GO:0005654;GO:0000932;GO:0003723;GO:0035195;GO:0030522;GO:0035278;GO:0010629;GO:0010628;GO:1900153;GO:0060213;GO:0035194;GO:0045652;GO:0060260;GO:0007223;, C:cytosol; C:nucleoplasm; C:P-body;, F:RNA binding;, P:gene silencing by miRNA; P:intracellular receptor signaling pathway; P:miRNA mediated inhibition of translation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:post-transcriptional gene silencing by RNA; P:regulation of megakaryocyte differentiation; P:regulation of transcription initiation from RNA polymerase II promoter; P:Wnt signaling pathway, calcium modulating pathway; scaffold129 indexed_genome mRNA 661361 810848 . - . ID=transcript_13961;Q96QF5 Q9HA04 Q9UG40 Q9Y5W4,Septin-9,MLL septin-like fusion protein MSF-A;Ovarian/Breast septin;Septin D1;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0005737;GO:0005874;GO:0015630;GO:0097730;GO:0048471;GO:0031105;GO:0005940;GO:0001725;GO:0045296;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:1902857;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:non-motile cilium; C:perinuclear region of cytoplasm; C:septin complex; C:septin ring; C:stress fiber;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of non-motile cilium assembly;|Q96QF5 Q9HA04 Q9UG40 Q9Y5W4,Septin-9,MLL septin-like fusion protein MSF-A;Ovarian/Breast septin;Septin D1;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0005737;GO:0005874;GO:0015630;GO:0097730;GO:0048471;GO:0031105;GO:0005940;GO:0001725;GO:0045296;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:1902857;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:non-motile cilium; C:perinuclear region of cytoplasm; C:septin complex; C:septin ring; C:stress fiber;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of non-motile cilium assembly;|Q96QF5 Q9HA04 Q9UG40 Q9Y5W4,Septin-9,MLL septin-like fusion protein MSF-A;Ovarian/Breast septin;Septin D1;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0005737;GO:0005874;GO:0015630;GO:0097730;GO:0048471;GO:0031105;GO:0005940;GO:0001725;GO:0045296;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:1902857;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:non-motile cilium; C:perinuclear region of cytoplasm; C:septin complex; C:septin ring; C:stress fiber;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of non-motile cilium assembly;|Q96QF5 Q9HA04 Q9UG40 Q9Y5W4,Septin-9,MLL septin-like fusion protein MSF-A;Ovarian/Breast septin;Septin D1;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0005737;GO:0005874;GO:0015630;GO:0097730;GO:0048471;GO:0031105;GO:0005940;GO:0001725;GO:0045296;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:1902857;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:non-motile cilium; C:perinuclear region of cytoplasm; C:septin complex; C:septin ring; C:stress fiber;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of non-motile cilium assembly;|Q96QF5 Q9HA04 Q9UG40 Q9Y5W4,Septin-9,MLL septin-like fusion protein MSF-A;Ovarian/Breast septin;Septin D1;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0005737;GO:0005874;GO:0015630;GO:0097730;GO:0048471;GO:0031105;GO:0005940;GO:0001725;GO:0045296;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:1902857;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:non-motile cilium; C:perinuclear region of cytoplasm; C:septin complex; C:septin ring; C:stress fiber;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:positive regulation of non-motile cilium assembly; scaffold129 indexed_genome mRNA 985093 1029744 . - . ID=transcript_13962;Q3V5L5 Q6P3S8 Q6P6B3 Q766X5 Q76D04 Q96LS2,Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B,Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase B;GlcNAc-T Vb {ECO:0000303|PubMed:19846580};Mannoside acetylglucosaminyltransferase 5B;N-acetylglucosaminyl-transferase Vb;N-acetylglucosaminyltransferase IX {ECO:0000303|PubMed:14617637};, PF15024;, GO:0005794;GO:0000139;GO:0016021;GO:0030144;GO:0030145;GO:0006487;GO:0018242;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity; F:manganese ion binding;, P:protein N-linked glycosylation; P:protein O-linked glycosylation via serine; scaffold129 indexed_genome mRNA 1099261 1114672 . - . ID=transcript_13963;O43934 O43442 Q9NXI5,UNC93-like protein MFSD11,Major facilitator superfamily domain-containing protein 11;Protein ET;, PF05978;, GO:0016021;, C:integral component of membrane;|O43934 O43442 Q9NXI5,UNC93-like protein MFSD11,Major facilitator superfamily domain-containing protein 11;Protein ET;, PF05978;, GO:0016021;, C:integral component of membrane;|O43934 O43442 Q9NXI5,UNC93-like protein MFSD11,Major facilitator superfamily domain-containing protein 11;Protein ET;, PF05978;, GO:0016021;, C:integral component of membrane;|O43934 O43442 Q9NXI5,UNC93-like protein MFSD11,Major facilitator superfamily domain-containing protein 11;Protein ET;, PF05978;, GO:0016021;, C:integral component of membrane; scaffold129 indexed_genome mRNA 1114709 1127584 . - . ID=transcript_13964;O43934 O43442 Q9NXI5,UNC93-like protein MFSD11,Major facilitator superfamily domain-containing protein 11;Protein ET;, PF05978;, GO:0016021;, C:integral component of membrane;|O43934 O43442 Q9NXI5,UNC93-like protein MFSD11,Major facilitator superfamily domain-containing protein 11;Protein ET;, PF05978;, GO:0016021;, C:integral component of membrane;|Q01130 B3KWD5 B4DN89 H0YG49,Serine/arginine-rich splicing factor 2,Protein PR264;Splicing component, 35 kDa;Splicing factor SC35;Splicing factor, arginine/serine-rich 2;, PF00076;, GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003723;GO:0003714;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0000381;GO:0006405;GO:0008380;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:RNA binding; F:transcription corepressor activity;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; scaffold129 indexed_genome mRNA 1129213 1135333 . - . ID=transcript_13965;Q86XA0 H9ZYJ0 K7EK32,Methyltransferase-like protein 23,, PF10294;, GO:0005737;GO:0016021;GO:0005634;GO:0032991;GO:0031072;GO:0008168;GO:0008134;GO:0050890;GO:0032259;GO:0045944;, C:cytoplasm; C:integral component of membrane; C:nucleus; C:protein-containing complex;, F:heat shock protein binding; F:methyltransferase activity; F:transcription factor binding;, P:cognition; P:methylation; P:positive regulation of transcription by RNA polymerase II;|Q86XA0 H9ZYJ0 K7EK32,Methyltransferase-like protein 23,, PF10294;, GO:0005737;GO:0016021;GO:0005634;GO:0032991;GO:0031072;GO:0008168;GO:0008134;GO:0050890;GO:0032259;GO:0045944;, C:cytoplasm; C:integral component of membrane; C:nucleus; C:protein-containing complex;, F:heat shock protein binding; F:methyltransferase activity; F:transcription factor binding;, P:cognition; P:methylation; P:positive regulation of transcription by RNA polymerase II; scaffold129 indexed_genome mRNA 1135494 1144963 . + . ID=transcript_13966;Q6NYC1 B3KMN8 B4DGX1 Q86VY0 Q8IUM5 Q9Y4E2,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 {ECO:0000305},Histone arginine demethylase JMJD6;JmjC domain-containing protein 6;Jumonji domain-containing protein 6;Lysyl-hydroxylase JMJD6;Peptide-lysine 5-dioxygenase JMJD6;Phosphatidylserine receptor;, PF02373;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:1990904;GO:0032451;GO:0032452;GO:0033746;GO:0033749;GO:0042802;GO:0005506;GO:0035515;GO:0106140;GO:0070815;GO:0003723;GO:0038023;GO:0003727;GO:0140537;GO:0007166;GO:0048821;GO:0007507;GO:0070078;GO:0070079;GO:0001822;GO:0030324;GO:0042116;GO:0006397;GO:0035513;GO:0018395;GO:0045944;GO:0045893;GO:0006482;GO:0051260;GO:0043654;GO:0048024;GO:0060041;GO:0008380;GO:0002040;GO:0033077;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ribonucleoprotein complex;, F:demethylase activity; F:histone demethylase activity; F:histone demethylase activity (H3-R2 specific); F:histone demethylase activity (H4-R3 specific); F:identical protein binding; F:iron ion binding; F:oxidative RNA demethylase activity; F:P-TEFb complex binding; F:peptidyl-lysine 5-dioxygenase activity; F:RNA binding; F:signaling receptor activity; F:single-stranded RNA binding; F:transcription regulator activator activity;, P:cell surface receptor signaling pathway; P:erythrocyte development; P:heart development; P:histone H3-R2 demethylation; P:histone H4-R3 demethylation; P:kidney development; P:lung development; P:macrophage activation; P:mRNA processing; P:oxidative RNA demethylation; P:peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:protein homooligomerization; P:recognition of apoptotic cell; P:regulation of mRNA splicing, via spliceosome; P:retina development in camera-type eye; P:RNA splicing; P:sprouting angiogenesis; P:T cell differentiation in thymus;|Q6NYC1 B3KMN8 B4DGX1 Q86VY0 Q8IUM5 Q9Y4E2,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 {ECO:0000305},Histone arginine demethylase JMJD6;JmjC domain-containing protein 6;Jumonji domain-containing protein 6;Lysyl-hydroxylase JMJD6;Peptide-lysine 5-dioxygenase JMJD6;Phosphatidylserine receptor;, PF02373;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:1990904;GO:0032451;GO:0032452;GO:0033746;GO:0033749;GO:0042802;GO:0005506;GO:0035515;GO:0106140;GO:0070815;GO:0003723;GO:0038023;GO:0003727;GO:0140537;GO:0007166;GO:0048821;GO:0007507;GO:0070078;GO:0070079;GO:0001822;GO:0030324;GO:0042116;GO:0006397;GO:0035513;GO:0018395;GO:0045944;GO:0045893;GO:0006482;GO:0051260;GO:0043654;GO:0048024;GO:0060041;GO:0008380;GO:0002040;GO:0033077;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ribonucleoprotein complex;, F:demethylase activity; F:histone demethylase activity; F:histone demethylase activity (H3-R2 specific); F:histone demethylase activity (H4-R3 specific); F:identical protein binding; F:iron ion binding; F:oxidative RNA demethylase activity; F:P-TEFb complex binding; F:peptidyl-lysine 5-dioxygenase activity; F:RNA binding; F:signaling receptor activity; F:single-stranded RNA binding; F:transcription regulator activator activity;, P:cell surface receptor signaling pathway; P:erythrocyte development; P:heart development; P:histone H3-R2 demethylation; P:histone H4-R3 demethylation; P:kidney development; P:lung development; P:macrophage activation; P:mRNA processing; P:oxidative RNA demethylation; P:peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:protein homooligomerization; P:recognition of apoptotic cell; P:regulation of mRNA splicing, via spliceosome; P:retina development in camera-type eye; P:RNA splicing; P:sprouting angiogenesis; P:T cell differentiation in thymus;|Q6NYC1 B3KMN8 B4DGX1 Q86VY0 Q8IUM5 Q9Y4E2,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 {ECO:0000305},Histone arginine demethylase JMJD6;JmjC domain-containing protein 6;Jumonji domain-containing protein 6;Lysyl-hydroxylase JMJD6;Peptide-lysine 5-dioxygenase JMJD6;Phosphatidylserine receptor;, PF02373;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:1990904;GO:0032451;GO:0032452;GO:0033746;GO:0033749;GO:0042802;GO:0005506;GO:0035515;GO:0106140;GO:0070815;GO:0003723;GO:0038023;GO:0003727;GO:0140537;GO:0007166;GO:0048821;GO:0007507;GO:0070078;GO:0070079;GO:0001822;GO:0030324;GO:0042116;GO:0006397;GO:0035513;GO:0018395;GO:0045944;GO:0045893;GO:0006482;GO:0051260;GO:0043654;GO:0048024;GO:0060041;GO:0008380;GO:0002040;GO:0033077;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ribonucleoprotein complex;, F:demethylase activity; F:histone demethylase activity; F:histone demethylase activity (H3-R2 specific); F:histone demethylase activity (H4-R3 specific); F:identical protein binding; F:iron ion binding; F:oxidative RNA demethylase activity; F:P-TEFb complex binding; F:peptidyl-lysine 5-dioxygenase activity; F:RNA binding; F:signaling receptor activity; F:single-stranded RNA binding; F:transcription regulator activator activity;, P:cell surface receptor signaling pathway; P:erythrocyte development; P:heart development; P:histone H3-R2 demethylation; P:histone H4-R3 demethylation; P:kidney development; P:lung development; P:macrophage activation; P:mRNA processing; P:oxidative RNA demethylation; P:peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:protein homooligomerization; P:recognition of apoptotic cell; P:regulation of mRNA splicing, via spliceosome; P:retina development in camera-type eye; P:RNA splicing; P:sprouting angiogenesis; P:T cell differentiation in thymus;|Q6NYC1 B3KMN8 B4DGX1 Q86VY0 Q8IUM5 Q9Y4E2,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 {ECO:0000305},Histone arginine demethylase JMJD6;JmjC domain-containing protein 6;Jumonji domain-containing protein 6;Lysyl-hydroxylase JMJD6;Peptide-lysine 5-dioxygenase JMJD6;Phosphatidylserine receptor;, PF02373;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:1990904;GO:0032451;GO:0032452;GO:0033746;GO:0033749;GO:0042802;GO:0005506;GO:0035515;GO:0106140;GO:0070815;GO:0003723;GO:0038023;GO:0003727;GO:0140537;GO:0007166;GO:0048821;GO:0007507;GO:0070078;GO:0070079;GO:0001822;GO:0030324;GO:0042116;GO:0006397;GO:0035513;GO:0018395;GO:0045944;GO:0045893;GO:0006482;GO:0051260;GO:0043654;GO:0048024;GO:0060041;GO:0008380;GO:0002040;GO:0033077;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ribonucleoprotein complex;, F:demethylase activity; F:histone demethylase activity; F:histone demethylase activity (H3-R2 specific); F:histone demethylase activity (H4-R3 specific); F:identical protein binding; F:iron ion binding; F:oxidative RNA demethylase activity; F:P-TEFb complex binding; F:peptidyl-lysine 5-dioxygenase activity; F:RNA binding; F:signaling receptor activity; F:single-stranded RNA binding; F:transcription regulator activator activity;, P:cell surface receptor signaling pathway; P:erythrocyte development; P:heart development; P:histone H3-R2 demethylation; P:histone H4-R3 demethylation; P:kidney development; P:lung development; P:macrophage activation; P:mRNA processing; P:oxidative RNA demethylation; P:peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:protein homooligomerization; P:recognition of apoptotic cell; P:regulation of mRNA splicing, via spliceosome; P:retina development in camera-type eye; P:RNA splicing; P:sprouting angiogenesis; P:T cell differentiation in thymus; scaffold129 indexed_genome mRNA 1166054 1180672 . + . ID=transcript_13967;P84157 Q0P5W3,Matrix-remodeling-associated protein 7,, , GO:0062023;GO:0005783;GO:0016021;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:integral component of membrane;|P84157 Q0P5W3,Matrix-remodeling-associated protein 7,, , GO:0062023;GO:0005783;GO:0016021;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:integral component of membrane; scaffold129 indexed_genome mRNA 1266851 1289595 . - . ID=transcript_13968;Q9UJ37 Q12971,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2,GalNAc alpha-2,6-sialyltransferase II;ST6GalNAc II {ECO:0000303|PubMed:10742600};SThM;Sialyltransferase 7B;, PF00777;, GO:0000139;GO:0016021;GO:0001665;GO:0016266;GO:0006486;GO:0006493;GO:1990743;GO:0019082;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity;, P:O-glycan processing; P:protein glycosylation; P:protein O-linked glycosylation; P:protein sialylation; P:viral protein processing;|Q9UJ37 Q12971,Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2,GalNAc alpha-2,6-sialyltransferase II;ST6GalNAc II {ECO:0000303|PubMed:10742600};SThM;Sialyltransferase 7B;, PF00777;, GO:0000139;GO:0016021;GO:0001665;GO:0016266;GO:0006486;GO:0006493;GO:1990743;GO:0019082;, C:Golgi membrane; C:integral component of membrane;, F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity;, P:O-glycan processing; P:protein glycosylation; P:protein O-linked glycosylation; P:protein sialylation; P:viral protein processing; scaffold129 indexed_genome mRNA 1312599 1319281 . + . ID=transcript_13969;Q8WWM9 Q541Y7 Q8N2X5,Cytoglobin,Histoglobin;Stellate cell activation-associated protein;, PF00042;, GO:0005829;GO:0020037;GO:0005506;GO:0019825;GO:0005344;GO:0004601;GO:0015671;GO:0050999;GO:0006979;, C:cytosol;, F:heme binding; F:iron ion binding; F:oxygen binding; F:oxygen carrier activity; F:peroxidase activity;, P:oxygen transport; P:regulation of nitric-oxide synthase activity; P:response to oxidative stress; scaffold129 indexed_genome mRNA 1364616 1378690 . + . ID=transcript_13970;Q6PJF5 A6NEM3 A8K801 Q5U607 Q5YGQ8 Q9H6E9,Inactive rhomboid protein 2,Rhomboid 5 homolog 2;Rhomboid family member 2;Rhomboid veinlet-like protein 5;Rhomboid veinlet-like protein 6;, PF01694;PF12595;, GO:0005789;GO:0005796;GO:0016021;GO:0005886;GO:0019838;GO:0002862;GO:0050709;GO:0015031;GO:0006508;GO:0042058;GO:0050708;, C:endoplasmic reticulum membrane; C:Golgi lumen; C:integral component of membrane; C:plasma membrane;, F:growth factor binding;, P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of protein secretion; P:protein transport; P:proteolysis; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of protein secretion;|Q6PJF5 A6NEM3 A8K801 Q5U607 Q5YGQ8 Q9H6E9,Inactive rhomboid protein 2,Rhomboid 5 homolog 2;Rhomboid family member 2;Rhomboid veinlet-like protein 5;Rhomboid veinlet-like protein 6;, PF01694;PF12595;, GO:0005789;GO:0005796;GO:0016021;GO:0005886;GO:0019838;GO:0002862;GO:0050709;GO:0015031;GO:0006508;GO:0042058;GO:0050708;, C:endoplasmic reticulum membrane; C:Golgi lumen; C:integral component of membrane; C:plasma membrane;, F:growth factor binding;, P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of protein secretion; P:protein transport; P:proteolysis; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of protein secretion; scaffold129 indexed_genome mRNA 1433398 1434781 . + . ID=transcript_13971;Q9H7E4 Q9H9B2,(E3-independent) E2 ubiquitin-conjugating enzyme,E2/E3 hybrid ubiquitin-protein ligase UBE2O;Ubiquitin carrier protein O;Ubiquitin-conjugating enzyme E2 O;Ubiquitin-conjugating enzyme E2 of 230 kDa;Ubiquitin-protein ligase O;, PF00179;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0004869;GO:0003723;GO:0061631;GO:0061630;GO:0004842;GO:0043066;GO:0030513;GO:0070534;GO:0006513;GO:0042147;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity; F:RNA binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:retrograde transport, endosome to Golgi; scaffold129 indexed_genome mRNA 1435251 1441512 . + . ID=transcript_13972;Q9H7E4 Q9H9B2,(E3-independent) E2 ubiquitin-conjugating enzyme,E2/E3 hybrid ubiquitin-protein ligase UBE2O;Ubiquitin carrier protein O;Ubiquitin-conjugating enzyme E2 O;Ubiquitin-conjugating enzyme E2 of 230 kDa;Ubiquitin-protein ligase O;, PF00179;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0004869;GO:0003723;GO:0061631;GO:0061630;GO:0004842;GO:0043066;GO:0030513;GO:0070534;GO:0006513;GO:0042147;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity; F:RNA binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:retrograde transport, endosome to Golgi;|Q9H7E4 Q9H9B2,(E3-independent) E2 ubiquitin-conjugating enzyme,E2/E3 hybrid ubiquitin-protein ligase UBE2O;Ubiquitin carrier protein O;Ubiquitin-conjugating enzyme E2 O;Ubiquitin-conjugating enzyme E2 of 230 kDa;Ubiquitin-protein ligase O;, PF00179;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0004869;GO:0003723;GO:0061631;GO:0061630;GO:0004842;GO:0043066;GO:0030513;GO:0070534;GO:0006513;GO:0042147;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity; F:RNA binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:retrograde transport, endosome to Golgi;|Q9H7E4 Q9H9B2,(E3-independent) E2 ubiquitin-conjugating enzyme,E2/E3 hybrid ubiquitin-protein ligase UBE2O;Ubiquitin carrier protein O;Ubiquitin-conjugating enzyme E2 O;Ubiquitin-conjugating enzyme E2 of 230 kDa;Ubiquitin-protein ligase O;, PF00179;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0004869;GO:0003723;GO:0061631;GO:0061630;GO:0004842;GO:0043066;GO:0030513;GO:0070534;GO:0006513;GO:0042147;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity; F:RNA binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:retrograde transport, endosome to Golgi;|Q9H7E4 Q9H9B2,(E3-independent) E2 ubiquitin-conjugating enzyme,E2/E3 hybrid ubiquitin-protein ligase UBE2O;Ubiquitin carrier protein O;Ubiquitin-conjugating enzyme E2 O;Ubiquitin-conjugating enzyme E2 of 230 kDa;Ubiquitin-protein ligase O;, PF00179;, GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005524;GO:0004869;GO:0003723;GO:0061631;GO:0061630;GO:0004842;GO:0043066;GO:0030513;GO:0070534;GO:0006513;GO:0042147;, C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cysteine-type endopeptidase inhibitor activity; F:RNA binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of apoptotic process; P:positive regulation of BMP signaling pathway; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:retrograde transport, endosome to Golgi; scaffold129 indexed_genome mRNA 1480886 1508070 . + . ID=transcript_13973;Q14558 B2R6M4 Q96H06,Phosphoribosyl pyrophosphate synthase-associated protein 1,39 kDa phosphoribosypyrophosphate synthase-associated protein;, PF14572;PF13793;, GO:0005737;GO:0002189;GO:0004857;GO:0042802;GO:0000287;GO:0004749;GO:0006015;GO:0006139;GO:0006164;, C:cytoplasm; C:ribose phosphate diphosphokinase complex;, F:enzyme inhibitor activity; F:identical protein binding; F:magnesium ion binding; F:ribose phosphate diphosphokinase activity;, P:5-phosphoribose 1-diphosphate biosynthetic process; P:nucleobase-containing compound metabolic process; P:purine nucleotide biosynthetic process;|Q14558 B2R6M4 Q96H06,Phosphoribosyl pyrophosphate synthase-associated protein 1,39 kDa phosphoribosypyrophosphate synthase-associated protein;, PF14572;PF13793;, GO:0005737;GO:0002189;GO:0004857;GO:0042802;GO:0000287;GO:0004749;GO:0006015;GO:0006139;GO:0006164;, C:cytoplasm; C:ribose phosphate diphosphokinase complex;, F:enzyme inhibitor activity; F:identical protein binding; F:magnesium ion binding; F:ribose phosphate diphosphokinase activity;, P:5-phosphoribose 1-diphosphate biosynthetic process; P:nucleobase-containing compound metabolic process; P:purine nucleotide biosynthetic process; scaffold129 indexed_genome mRNA 1536870 1539018 . + . ID=transcript_13974;Q8IYN6,UBA-like domain-containing protein 2 scaffold129 indexed_genome mRNA 1588249 1642902 . + . ID=transcript_13975;Q96PX1 Q8NB72 Q96N56,E3 ubiquitin ligase RNF157 {ECO:0000303|PubMed:25342469},RING finger protein 157;RING-type E3 ubiquitin transferase RNF157 {ECO:0000305};, , GO:0044297;GO:0005737;GO:0005769;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0008333;GO:0043066;GO:0043951;GO:0045744;GO:1903861;GO:0051865;GO:0016567;, C:cell body; C:cytoplasm; C:early endosome; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:endosome to lysosome transport; P:negative regulation of apoptotic process; P:negative regulation of cAMP-mediated signaling; P:negative regulation of G protein-coupled receptor signaling pathway; P:positive regulation of dendrite extension; P:protein autoubiquitination; P:protein ubiquitination;|Q96PX1 Q8NB72 Q96N56,E3 ubiquitin ligase RNF157 {ECO:0000303|PubMed:25342469},RING finger protein 157;RING-type E3 ubiquitin transferase RNF157 {ECO:0000305};, , GO:0044297;GO:0005737;GO:0005769;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0008333;GO:0043066;GO:0043951;GO:0045744;GO:1903861;GO:0051865;GO:0016567;, C:cell body; C:cytoplasm; C:early endosome; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:endosome to lysosome transport; P:negative regulation of apoptotic process; P:negative regulation of cAMP-mediated signaling; P:negative regulation of G protein-coupled receptor signaling pathway; P:positive regulation of dendrite extension; P:protein autoubiquitination; P:protein ubiquitination;|Q96PX1 Q8NB72 Q96N56,E3 ubiquitin ligase RNF157 {ECO:0000303|PubMed:25342469},RING finger protein 157;RING-type E3 ubiquitin transferase RNF157 {ECO:0000305};, , GO:0044297;GO:0005737;GO:0005769;GO:0005634;GO:0005886;GO:0046872;GO:0061630;GO:0008333;GO:0043066;GO:0043951;GO:0045744;GO:1903861;GO:0051865;GO:0016567;, C:cell body; C:cytoplasm; C:early endosome; C:nucleus; C:plasma membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:endosome to lysosome transport; P:negative regulation of apoptotic process; P:negative regulation of cAMP-mediated signaling; P:negative regulation of G protein-coupled receptor signaling pathway; P:positive regulation of dendrite extension; P:protein autoubiquitination; P:protein ubiquitination; scaffold129 indexed_genome mRNA 1644168 1648877 . + . ID=transcript_13976;Q92949 O00630,Forkhead box protein J1 {ECO:0000305},Forkhead-related protein FKHL13 {ECO:0000303|PubMed:9073514};Hepatocyte nuclear factor 3 forkhead homolog 4 {ECO:0000303|PubMed:9530170};, PF00250;, GO:0000785;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0030036;GO:0090630;GO:0035082;GO:0007420;GO:0034613;GO:0002508;GO:0032053;GO:0060271;GO:0007368;GO:0060429;GO:0035089;GO:0072016;GO:0007507;GO:0006959;GO:0060972;GO:0050900;GO:0060428;GO:0035502;GO:0044458;GO:0050869;GO:0002635;GO:0002924;GO:0032715;GO:0032088;GO:0033085;GO:0042130;GO:0000122;GO:0007389;GO:0002897;GO:1901248;GO:0045944;GO:0006357;GO:0007283;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:actin cytoskeleton organization; P:activation of GTPase activity; P:axoneme assembly; P:brain development; P:cellular protein localization; P:central tolerance induction; P:ciliary basal body organization; P:cilium assembly; P:determination of left/right symmetry; P:epithelium development; P:establishment of apical/basal cell polarity; P:glomerular parietal epithelial cell development; P:heart development; P:humoral immune response; P:left/right pattern formation; P:leukocyte migration; P:lung epithelium development; P:metanephric part of ureteric bud development; P:motile cilium assembly; P:negative regulation of B cell activation; P:negative regulation of germinal center formation; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; P:negative regulation of interleukin-6 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of T cell differentiation in thymus; P:negative regulation of T cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:pattern specification process; P:positive regulation of central B cell tolerance induction; P:positive regulation of lung ciliated cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold129 indexed_genome mRNA 1661856 1682892 . + . ID=transcript_13977;Q9UPT5 B5MC69 B8XXP2 Q8ND93 Q8WV91 Q96FF0 Q9H8C3 Q9H9X3 Q9HA32,Exocyst complex component 7,Exocyst complex component Exo70;, PF03081;, GO:0034451;GO:0005829;GO:0000145;GO:0090543;GO:0032584;GO:0016020;GO:0005815;GO:0005886;GO:0060271;GO:0006887;GO:0015031;GO:2000535;GO:0016241;, C:centriolar satellite; C:cytosol; C:exocyst; C:Flemming body; C:growth cone membrane; C:membrane; C:microtubule organizing center; C:plasma membrane;, , P:cilium assembly; P:exocytosis; P:protein transport; P:regulation of entry of bacterium into host cell; P:regulation of macroautophagy;|Q9UPT5 B5MC69 B8XXP2 Q8ND93 Q8WV91 Q96FF0 Q9H8C3 Q9H9X3 Q9HA32,Exocyst complex component 7,Exocyst complex component Exo70;, PF03081;, GO:0034451;GO:0005829;GO:0000145;GO:0090543;GO:0032584;GO:0016020;GO:0005815;GO:0005886;GO:0060271;GO:0006887;GO:0015031;GO:2000535;GO:0016241;, C:centriolar satellite; C:cytosol; C:exocyst; C:Flemming body; C:growth cone membrane; C:membrane; C:microtubule organizing center; C:plasma membrane;, , P:cilium assembly; P:exocytosis; P:protein transport; P:regulation of entry of bacterium into host cell; P:regulation of macroautophagy;|Q9UPT5 B5MC69 B8XXP2 Q8ND93 Q8WV91 Q96FF0 Q9H8C3 Q9H9X3 Q9HA32,Exocyst complex component 7,Exocyst complex component Exo70;, PF03081;, GO:0034451;GO:0005829;GO:0000145;GO:0090543;GO:0032584;GO:0016020;GO:0005815;GO:0005886;GO:0060271;GO:0006887;GO:0015031;GO:2000535;GO:0016241;, C:centriolar satellite; C:cytosol; C:exocyst; C:Flemming body; C:growth cone membrane; C:membrane; C:microtubule organizing center; C:plasma membrane;, , P:cilium assembly; P:exocytosis; P:protein transport; P:regulation of entry of bacterium into host cell; P:regulation of macroautophagy;|Q9UPT5 B5MC69 B8XXP2 Q8ND93 Q8WV91 Q96FF0 Q9H8C3 Q9H9X3 Q9HA32,Exocyst complex component 7,Exocyst complex component Exo70;, PF03081;, GO:0034451;GO:0005829;GO:0000145;GO:0090543;GO:0032584;GO:0016020;GO:0005815;GO:0005886;GO:0060271;GO:0006887;GO:0015031;GO:2000535;GO:0016241;, C:centriolar satellite; C:cytosol; C:exocyst; C:Flemming body; C:growth cone membrane; C:membrane; C:microtubule organizing center; C:plasma membrane;, , P:cilium assembly; P:exocytosis; P:protein transport; P:regulation of entry of bacterium into host cell; P:regulation of macroautophagy;|Q9UPT5 B5MC69 B8XXP2 Q8ND93 Q8WV91 Q96FF0 Q9H8C3 Q9H9X3 Q9HA32,Exocyst complex component 7,Exocyst complex component Exo70;, PF03081;, GO:0034451;GO:0005829;GO:0000145;GO:0090543;GO:0032584;GO:0016020;GO:0005815;GO:0005886;GO:0060271;GO:0006887;GO:0015031;GO:2000535;GO:0016241;, C:centriolar satellite; C:cytosol; C:exocyst; C:Flemming body; C:growth cone membrane; C:membrane; C:microtubule organizing center; C:plasma membrane;, , P:cilium assembly; P:exocytosis; P:protein transport; P:regulation of entry of bacterium into host cell; P:regulation of macroautophagy; scaffold129 indexed_genome mRNA 1694355 1720638 . + . ID=transcript_13978;Q9UHB9 B3KUU5 B3KWY7 G3V1U4 Q8NCJ4 Q8WUK2,Signal recognition particle subunit SRP68,Signal recognition particle 68 kDa protein;, PF16969;, GO:0005829;GO:0005783;GO:0005925;GO:0005730;GO:0005840;GO:0048500;GO:0005786;GO:0008312;GO:0030942;GO:0019904;GO:0003723;GO:0005047;GO:0042493;GO:0006614;, C:cytosol; C:endoplasmic reticulum; C:focal adhesion; C:nucleolus; C:ribosome; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:protein domain specific binding; F:RNA binding; F:signal recognition particle binding;, P:response to drug; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UHB9 B3KUU5 B3KWY7 G3V1U4 Q8NCJ4 Q8WUK2,Signal recognition particle subunit SRP68,Signal recognition particle 68 kDa protein;, PF16969;, GO:0005829;GO:0005783;GO:0005925;GO:0005730;GO:0005840;GO:0048500;GO:0005786;GO:0008312;GO:0030942;GO:0019904;GO:0003723;GO:0005047;GO:0042493;GO:0006614;, C:cytosol; C:endoplasmic reticulum; C:focal adhesion; C:nucleolus; C:ribosome; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:protein domain specific binding; F:RNA binding; F:signal recognition particle binding;, P:response to drug; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UHB9 B3KUU5 B3KWY7 G3V1U4 Q8NCJ4 Q8WUK2,Signal recognition particle subunit SRP68,Signal recognition particle 68 kDa protein;, PF16969;, GO:0005829;GO:0005783;GO:0005925;GO:0005730;GO:0005840;GO:0048500;GO:0005786;GO:0008312;GO:0030942;GO:0019904;GO:0003723;GO:0005047;GO:0042493;GO:0006614;, C:cytosol; C:endoplasmic reticulum; C:focal adhesion; C:nucleolus; C:ribosome; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:protein domain specific binding; F:RNA binding; F:signal recognition particle binding;, P:response to drug; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UHB9 B3KUU5 B3KWY7 G3V1U4 Q8NCJ4 Q8WUK2,Signal recognition particle subunit SRP68,Signal recognition particle 68 kDa protein;, PF16969;, GO:0005829;GO:0005783;GO:0005925;GO:0005730;GO:0005840;GO:0048500;GO:0005786;GO:0008312;GO:0030942;GO:0019904;GO:0003723;GO:0005047;GO:0042493;GO:0006614;, C:cytosol; C:endoplasmic reticulum; C:focal adhesion; C:nucleolus; C:ribosome; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:protein domain specific binding; F:RNA binding; F:signal recognition particle binding;, P:response to drug; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UHB9 B3KUU5 B3KWY7 G3V1U4 Q8NCJ4 Q8WUK2,Signal recognition particle subunit SRP68,Signal recognition particle 68 kDa protein;, PF16969;, GO:0005829;GO:0005783;GO:0005925;GO:0005730;GO:0005840;GO:0048500;GO:0005786;GO:0008312;GO:0030942;GO:0019904;GO:0003723;GO:0005047;GO:0042493;GO:0006614;, C:cytosol; C:endoplasmic reticulum; C:focal adhesion; C:nucleolus; C:ribosome; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:protein domain specific binding; F:RNA binding; F:signal recognition particle binding;, P:response to drug; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UHB9 B3KUU5 B3KWY7 G3V1U4 Q8NCJ4 Q8WUK2,Signal recognition particle subunit SRP68,Signal recognition particle 68 kDa protein;, PF16969;, GO:0005829;GO:0005783;GO:0005925;GO:0005730;GO:0005840;GO:0048500;GO:0005786;GO:0008312;GO:0030942;GO:0019904;GO:0003723;GO:0005047;GO:0042493;GO:0006614;, C:cytosol; C:endoplasmic reticulum; C:focal adhesion; C:nucleolus; C:ribosome; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:protein domain specific binding; F:RNA binding; F:signal recognition particle binding;, P:response to drug; P:SRP-dependent cotranslational protein targeting to membrane;|Q9UHB9 B3KUU5 B3KWY7 G3V1U4 Q8NCJ4 Q8WUK2,Signal recognition particle subunit SRP68,Signal recognition particle 68 kDa protein;, PF16969;, GO:0005829;GO:0005783;GO:0005925;GO:0005730;GO:0005840;GO:0048500;GO:0005786;GO:0008312;GO:0030942;GO:0019904;GO:0003723;GO:0005047;GO:0042493;GO:0006614;, C:cytosol; C:endoplasmic reticulum; C:focal adhesion; C:nucleolus; C:ribosome; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:endoplasmic reticulum signal peptide binding; F:protein domain specific binding; F:RNA binding; F:signal recognition particle binding;, P:response to drug; P:SRP-dependent cotranslational protein targeting to membrane; scaffold129 indexed_genome mRNA 1727165 1745555 . + . ID=transcript_13979;Q92817 A0AUV5,Envoplakin,210 kDa cornified envelope precursor protein;210 kDa paraneoplastic pemphigus antigen;p210;, PF00681;PF17902;, GO:0001533;GO:0005737;GO:0005829;GO:0030057;GO:0070062;GO:0045111;GO:0016020;GO:0045296;GO:0019215;GO:0005198;GO:0070268;GO:0008544;GO:0045104;GO:0030216;GO:0018149;GO:0042060;, C:cornified envelope; C:cytoplasm; C:cytosol; C:desmosome; C:extracellular exosome; C:intermediate filament cytoskeleton; C:membrane;, F:cadherin binding; F:intermediate filament binding; F:structural molecule activity;, P:cornification; P:epidermis development; P:intermediate filament cytoskeleton organization; P:keratinocyte differentiation; P:peptide cross-linking; P:wound healing;|Q92817 A0AUV5,Envoplakin,210 kDa cornified envelope precursor protein;210 kDa paraneoplastic pemphigus antigen;p210;, PF00681;PF17902;, GO:0001533;GO:0005737;GO:0005829;GO:0030057;GO:0070062;GO:0045111;GO:0016020;GO:0045296;GO:0019215;GO:0005198;GO:0070268;GO:0008544;GO:0045104;GO:0030216;GO:0018149;GO:0042060;, C:cornified envelope; C:cytoplasm; C:cytosol; C:desmosome; C:extracellular exosome; C:intermediate filament cytoskeleton; C:membrane;, F:cadherin binding; F:intermediate filament binding; F:structural molecule activity;, P:cornification; P:epidermis development; P:intermediate filament cytoskeleton organization; P:keratinocyte differentiation; P:peptide cross-linking; P:wound healing; scaffold129 indexed_genome mRNA 1745593 1749884 . + . ID=transcript_13980;Q00526,Cyclin-dependent kinase 3,Cell division protein kinase 3;, PF00069;, GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0051301;GO:0008283;GO:0006974;GO:0045023;GO:0000082;GO:0006468;, C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:G0 to G1 transition; P:G1/S transition of mitotic cell cycle; P:protein phosphorylation;|Q00526,Cyclin-dependent kinase 3,Cell division protein kinase 3;, PF00069;, GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0051301;GO:0008283;GO:0006974;GO:0045023;GO:0000082;GO:0006468;, C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:G0 to G1 transition; P:G1/S transition of mitotic cell cycle; P:protein phosphorylation;|Q00526,Cyclin-dependent kinase 3,Cell division protein kinase 3;, PF00069;, GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0051301;GO:0008283;GO:0006974;GO:0045023;GO:0000082;GO:0006468;, C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:G0 to G1 transition; P:G1/S transition of mitotic cell cycle; P:protein phosphorylation;|Q00526,Cyclin-dependent kinase 3,Cell division protein kinase 3;, PF00069;, GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0051301;GO:0008283;GO:0006974;GO:0045023;GO:0000082;GO:0006468;, C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:G0 to G1 transition; P:G1/S transition of mitotic cell cycle; P:protein phosphorylation;|Q00526,Cyclin-dependent kinase 3,Cell division protein kinase 3;, PF00069;, GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0051301;GO:0008283;GO:0006974;GO:0045023;GO:0000082;GO:0006468;, C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell division; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:G0 to G1 transition; P:G1/S transition of mitotic cell cycle; P:protein phosphorylation; scaffold129 indexed_genome mRNA 1764301 1768823 . + . ID=transcript_13981;Q99549 B7Z6F9 Q5JPE5 Q5JTQ0 Q86TK3 Q96MK4 Q9BTP1,M-phase phosphoprotein 8,Two hybrid-associated protein 3 with RanBPM {ECO:0000303|PubMed:12559565};, PF12796;PF00385;, GO:0005737;GO:0005829;GO:0000792;GO:0005730;GO:0005654;GO:0000786;GO:0005634;GO:0005886;GO:0003682;GO:0035064;GO:0045814;GO:0045869;GO:0045892;GO:0090309;GO:0044030;, C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleolus; C:nucleoplasm; C:nucleosome; C:nucleus; C:plasma membrane;, F:chromatin binding; F:methylated histone binding;, P:negative regulation of gene expression, epigenetic; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of transcription, DNA-templated; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:regulation of DNA methylation;|Q9Y5J1 Q9H4N6,U3 small nucleolar RNA-associated protein 18 homolog,WD repeat-containing protein 50;, , GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0034388;GO:0032040;GO:0003723;GO:0006364;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:Pwp2p-containing subcomplex of 90S preribosome; C:small-subunit processome;, F:RNA binding;, P:rRNA processing; scaffold129 indexed_genome mRNA 1772518 1794194 . + . ID=transcript_13982;Q7Z3W5 Q9UD31,Peroxisomal acyl-coenzyme A oxidase 1 {ECO:0000303|PubMed:8117268},Palmitoyl-CoA oxidase {ECO:0000303|PubMed:14702039};Straight-chain acyl-CoA oxidase {ECO:0000303|PubMed:15060085};, PF01756;PF02770;PF14749;, GO:0005829;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0030165;GO:0042803;GO:0047485;GO:0036109;GO:0042632;GO:0033540;GO:0009062;GO:0019395;GO:0006091;GO:0050665;GO:0055088;GO:0006629;GO:0016559;GO:0006693;GO:0008104;GO:0019222;GO:0007283;GO:0140493;GO:0000038;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:PDZ domain binding; F:protein homodimerization activity; F:protein N-terminus binding;, P:alpha-linolenic acid metabolic process; P:cholesterol homeostasis; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:fatty acid oxidation; P:generation of precursor metabolites and energy; P:hydrogen peroxide biosynthetic process; P:lipid homeostasis; P:lipid metabolic process; P:peroxisome fission; P:prostaglandin metabolic process; P:protein localization; P:regulation of metabolic process; P:spermatogenesis; P:very long-chain fatty acid beta-oxidation; P:very long-chain fatty acid metabolic process;|Q7Z3W5 Q9UD31,Peroxisomal acyl-coenzyme A oxidase 1 {ECO:0000303|PubMed:8117268},Palmitoyl-CoA oxidase {ECO:0000303|PubMed:14702039};Straight-chain acyl-CoA oxidase {ECO:0000303|PubMed:15060085};, PF01756;PF02770;PF14749;, GO:0005829;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0030165;GO:0042803;GO:0047485;GO:0036109;GO:0042632;GO:0033540;GO:0009062;GO:0019395;GO:0006091;GO:0050665;GO:0055088;GO:0006629;GO:0016559;GO:0006693;GO:0008104;GO:0019222;GO:0007283;GO:0140493;GO:0000038;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:PDZ domain binding; F:protein homodimerization activity; F:protein N-terminus binding;, P:alpha-linolenic acid metabolic process; P:cholesterol homeostasis; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:fatty acid oxidation; P:generation of precursor metabolites and energy; P:hydrogen peroxide biosynthetic process; P:lipid homeostasis; P:lipid metabolic process; P:peroxisome fission; P:prostaglandin metabolic process; P:protein localization; P:regulation of metabolic process; P:spermatogenesis; P:very long-chain fatty acid beta-oxidation; P:very long-chain fatty acid metabolic process;|Q7Z3W5 Q9UD31,Peroxisomal acyl-coenzyme A oxidase 1 {ECO:0000303|PubMed:8117268},Palmitoyl-CoA oxidase {ECO:0000303|PubMed:14702039};Straight-chain acyl-CoA oxidase {ECO:0000303|PubMed:15060085};, PF01756;PF02770;PF14749;, GO:0005829;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0030165;GO:0042803;GO:0047485;GO:0036109;GO:0042632;GO:0033540;GO:0009062;GO:0019395;GO:0006091;GO:0050665;GO:0055088;GO:0006629;GO:0016559;GO:0006693;GO:0008104;GO:0019222;GO:0007283;GO:0140493;GO:0000038;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:PDZ domain binding; F:protein homodimerization activity; F:protein N-terminus binding;, P:alpha-linolenic acid metabolic process; P:cholesterol homeostasis; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:fatty acid oxidation; P:generation of precursor metabolites and energy; P:hydrogen peroxide biosynthetic process; P:lipid homeostasis; P:lipid metabolic process; P:peroxisome fission; P:prostaglandin metabolic process; P:protein localization; P:regulation of metabolic process; P:spermatogenesis; P:very long-chain fatty acid beta-oxidation; P:very long-chain fatty acid metabolic process;|Q7Z3W5 Q9UD31,Peroxisomal acyl-coenzyme A oxidase 1 {ECO:0000303|PubMed:8117268},Palmitoyl-CoA oxidase {ECO:0000303|PubMed:14702039};Straight-chain acyl-CoA oxidase {ECO:0000303|PubMed:15060085};, PF01756;PF02770;PF14749;, GO:0005829;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0030165;GO:0042803;GO:0047485;GO:0036109;GO:0042632;GO:0033540;GO:0009062;GO:0019395;GO:0006091;GO:0050665;GO:0055088;GO:0006629;GO:0016559;GO:0006693;GO:0008104;GO:0019222;GO:0007283;GO:0140493;GO:0000038;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:PDZ domain binding; F:protein homodimerization activity; F:protein N-terminus binding;, P:alpha-linolenic acid metabolic process; P:cholesterol homeostasis; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:fatty acid oxidation; P:generation of precursor metabolites and energy; P:hydrogen peroxide biosynthetic process; P:lipid homeostasis; P:lipid metabolic process; P:peroxisome fission; P:prostaglandin metabolic process; P:protein localization; P:regulation of metabolic process; P:spermatogenesis; P:very long-chain fatty acid beta-oxidation; P:very long-chain fatty acid metabolic process;|Q7Z3W5 Q9UD31,Peroxisomal acyl-coenzyme A oxidase 1 {ECO:0000303|PubMed:8117268},Palmitoyl-CoA oxidase {ECO:0000303|PubMed:14702039};Straight-chain acyl-CoA oxidase {ECO:0000303|PubMed:15060085};, PF01756;PF02770;PF14749;, GO:0005829;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0030165;GO:0042803;GO:0047485;GO:0036109;GO:0042632;GO:0033540;GO:0009062;GO:0019395;GO:0006091;GO:0050665;GO:0055088;GO:0006629;GO:0016559;GO:0006693;GO:0008104;GO:0019222;GO:0007283;GO:0140493;GO:0000038;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:PDZ domain binding; F:protein homodimerization activity; F:protein N-terminus binding;, P:alpha-linolenic acid metabolic process; P:cholesterol homeostasis; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:fatty acid oxidation; P:generation of precursor metabolites and energy; P:hydrogen peroxide biosynthetic process; P:lipid homeostasis; P:lipid metabolic process; P:peroxisome fission; P:prostaglandin metabolic process; P:protein localization; P:regulation of metabolic process; P:spermatogenesis; P:very long-chain fatty acid beta-oxidation; P:very long-chain fatty acid metabolic process;|Q7Z3W5 Q9UD31,Peroxisomal acyl-coenzyme A oxidase 1 {ECO:0000303|PubMed:8117268},Palmitoyl-CoA oxidase {ECO:0000303|PubMed:14702039};Straight-chain acyl-CoA oxidase {ECO:0000303|PubMed:15060085};, PF01756;PF02770;PF14749;, GO:0005829;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0030165;GO:0042803;GO:0047485;GO:0036109;GO:0042632;GO:0033540;GO:0009062;GO:0019395;GO:0006091;GO:0050665;GO:0055088;GO:0006629;GO:0016559;GO:0006693;GO:0008104;GO:0019222;GO:0007283;GO:0140493;GO:0000038;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:PDZ domain binding; F:protein homodimerization activity; F:protein N-terminus binding;, P:alpha-linolenic acid metabolic process; P:cholesterol homeostasis; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:fatty acid oxidation; P:generation of precursor metabolites and energy; P:hydrogen peroxide biosynthetic process; P:lipid homeostasis; P:lipid metabolic process; P:peroxisome fission; P:prostaglandin metabolic process; P:protein localization; P:regulation of metabolic process; P:spermatogenesis; P:very long-chain fatty acid beta-oxidation; P:very long-chain fatty acid metabolic process;|Q7Z3W5 Q9UD31,Peroxisomal acyl-coenzyme A oxidase 1 {ECO:0000303|PubMed:8117268},Palmitoyl-CoA oxidase {ECO:0000303|PubMed:14702039};Straight-chain acyl-CoA oxidase {ECO:0000303|PubMed:15060085};, PF01756;PF02770;PF14749;, GO:0005829;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016401;GO:0030165;GO:0042803;GO:0047485;GO:0036109;GO:0042632;GO:0033540;GO:0009062;GO:0019395;GO:0006091;GO:0050665;GO:0055088;GO:0006629;GO:0016559;GO:0006693;GO:0008104;GO:0019222;GO:0007283;GO:0140493;GO:0000038;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:palmitoyl-CoA oxidase activity; F:PDZ domain binding; F:protein homodimerization activity; F:protein N-terminus binding;, P:alpha-linolenic acid metabolic process; P:cholesterol homeostasis; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid catabolic process; P:fatty acid oxidation; P:generation of precursor metabolites and energy; P:hydrogen peroxide biosynthetic process; P:lipid homeostasis; P:lipid metabolic process; P:peroxisome fission; P:prostaglandin metabolic process; P:protein localization; P:regulation of metabolic process; P:spermatogenesis; P:very long-chain fatty acid beta-oxidation; P:very long-chain fatty acid metabolic process; scaffold129 indexed_genome mRNA 1797693 1819178 . + . ID=transcript_13983;Q8TES7 B5MEM5 Q96IF6 Q96JG4 Q96MA8,Fas-binding factor 1,Protein albatross;, , GO:0030054;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005829;GO:0000922;GO:0043297;GO:0097711;GO:0060271;GO:0090162;, C:cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cytosol; C:spindle pole;, , P:apical junction assembly; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of epithelial cell polarity;|Q8TES7 B5MEM5 Q96IF6 Q96JG4 Q96MA8,Fas-binding factor 1,Protein albatross;, , GO:0030054;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005829;GO:0000922;GO:0043297;GO:0097711;GO:0060271;GO:0090162;, C:cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cytosol; C:spindle pole;, , P:apical junction assembly; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of epithelial cell polarity;|Q8TES7 B5MEM5 Q96IF6 Q96JG4 Q96MA8,Fas-binding factor 1,Protein albatross;, , GO:0030054;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005829;GO:0000922;GO:0043297;GO:0097711;GO:0060271;GO:0090162;, C:cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cytosol; C:spindle pole;, , P:apical junction assembly; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of epithelial cell polarity;|Q8TES7 B5MEM5 Q96IF6 Q96JG4 Q96MA8,Fas-binding factor 1,Protein albatross;, , GO:0030054;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005829;GO:0000922;GO:0043297;GO:0097711;GO:0060271;GO:0090162;, C:cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cytosol; C:spindle pole;, , P:apical junction assembly; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of epithelial cell polarity;|Q8TES7 B5MEM5 Q96IF6 Q96JG4 Q96MA8,Fas-binding factor 1,Protein albatross;, , GO:0030054;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005829;GO:0000922;GO:0043297;GO:0097711;GO:0060271;GO:0090162;, C:cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cytosol; C:spindle pole;, , P:apical junction assembly; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of epithelial cell polarity;|Q8TES7 B5MEM5 Q96IF6 Q96JG4 Q96MA8,Fas-binding factor 1,Protein albatross;, , GO:0030054;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005829;GO:0000922;GO:0043297;GO:0097711;GO:0060271;GO:0090162;, C:cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cytosol; C:spindle pole;, , P:apical junction assembly; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of epithelial cell polarity;|Q8TES7 B5MEM5 Q96IF6 Q96JG4 Q96MA8,Fas-binding factor 1,Protein albatross;, , GO:0030054;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005829;GO:0000922;GO:0043297;GO:0097711;GO:0060271;GO:0090162;, C:cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cytosol; C:spindle pole;, , P:apical junction assembly; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of epithelial cell polarity;|Q8TES7 B5MEM5 Q96IF6 Q96JG4 Q96MA8,Fas-binding factor 1,Protein albatross;, , GO:0030054;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005829;GO:0000922;GO:0043297;GO:0097711;GO:0060271;GO:0090162;, C:cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cytosol; C:spindle pole;, , P:apical junction assembly; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of epithelial cell polarity;|Q8TES7 B5MEM5 Q96IF6 Q96JG4 Q96MA8,Fas-binding factor 1,Protein albatross;, , GO:0030054;GO:0005814;GO:0005813;GO:0036064;GO:0097539;GO:0005829;GO:0000922;GO:0043297;GO:0097711;GO:0060271;GO:0090162;, C:cell junction; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition fiber; C:cytosol; C:spindle pole;, , P:apical junction assembly; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of epithelial cell polarity; scaffold129 indexed_genome mRNA 1822809 1827749 . + . ID=transcript_13984;Q96DV4 B3KN96 Q96Q66 Q9P0B9,39S ribosomal protein L38, mitochondrial,Mitochondrial large ribosomal subunit protein mL38 {ECO:0000303|PubMed:25278503};, PF01161;, GO:0005743;GO:0005762;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q96DV4 B3KN96 Q96Q66 Q9P0B9,39S ribosomal protein L38, mitochondrial,Mitochondrial large ribosomal subunit protein mL38 {ECO:0000303|PubMed:25278503};, PF01161;, GO:0005743;GO:0005762;GO:0005739;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, , P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold129 indexed_genome mRNA 1836827 1839405 . + . ID=transcript_13985;Q6PJ69 Q4G0F0 Q6DKJ6 Q9BRP6,Tripartite motif-containing protein 65,, PF00622;PF00643;PF00097;, GO:0005829;GO:0005654;GO:0008270;GO:0010508;, C:cytosol; C:nucleoplasm;, F:zinc ion binding;, P:positive regulation of autophagy; scaffold129 indexed_genome mRNA 1850843 1854359 . + . ID=transcript_13986;Q96LD4 Q96AD0 Q96GU5 Q9BRN7,E3 ubiquitin-protein ligase TRIM47 {ECO:0000305},Gene overexpressed in astrocytoma protein;RING finger protein 100;Tripartite motif-containing protein 47 {ECO:0000305};, PF00643;, GO:0005829;GO:0005634;GO:0004842;GO:0008270;GO:0016567;, C:cytosol; C:nucleus;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:protein ubiquitination;|Q96LD4 Q96AD0 Q96GU5 Q9BRN7,E3 ubiquitin-protein ligase TRIM47 {ECO:0000305},Gene overexpressed in astrocytoma protein;RING finger protein 100;Tripartite motif-containing protein 47 {ECO:0000305};, PF00643;, GO:0005829;GO:0005634;GO:0004842;GO:0008270;GO:0016567;, C:cytosol; C:nucleus;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:protein ubiquitination;|Q96LD4 Q96AD0 Q96GU5 Q9BRN7,E3 ubiquitin-protein ligase TRIM47 {ECO:0000305},Gene overexpressed in astrocytoma protein;RING finger protein 100;Tripartite motif-containing protein 47 {ECO:0000305};, PF00643;, GO:0005829;GO:0005634;GO:0004842;GO:0008270;GO:0016567;, C:cytosol; C:nucleus;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:protein ubiquitination; scaffold129 indexed_genome mRNA 1869003 1892541 . + . ID=transcript_13987;Q969T9 B4DFG2 O95638,WW domain-binding protein 2,, PF02893;, GO:0000785;GO:0005737;GO:0005634;GO:0031490;GO:0030331;GO:0000978;GO:0003713;GO:0071391;GO:0045184;GO:0045815;GO:0071442;GO:0033148;GO:0045944;GO:0045893;GO:0050847;GO:0043627;GO:0032570;, C:chromatin; C:cytoplasm; C:nucleus;, F:chromatin DNA binding; F:estrogen receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:cellular response to estrogen stimulus; P:establishment of protein localization; P:positive regulation of gene expression, epigenetic; P:positive regulation of histone H3-K14 acetylation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:progesterone receptor signaling pathway; P:response to estrogen; P:response to progesterone;|Q969T9 B4DFG2 O95638,WW domain-binding protein 2,, PF02893;, GO:0000785;GO:0005737;GO:0005634;GO:0031490;GO:0030331;GO:0000978;GO:0003713;GO:0071391;GO:0045184;GO:0045815;GO:0071442;GO:0033148;GO:0045944;GO:0045893;GO:0050847;GO:0043627;GO:0032570;, C:chromatin; C:cytoplasm; C:nucleus;, F:chromatin DNA binding; F:estrogen receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:cellular response to estrogen stimulus; P:establishment of protein localization; P:positive regulation of gene expression, epigenetic; P:positive regulation of histone H3-K14 acetylation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:progesterone receptor signaling pathway; P:response to estrogen; P:response to progesterone;|Q969T9 B4DFG2 O95638,WW domain-binding protein 2,, PF02893;, GO:0000785;GO:0005737;GO:0005634;GO:0031490;GO:0030331;GO:0000978;GO:0003713;GO:0071391;GO:0045184;GO:0045815;GO:0071442;GO:0033148;GO:0045944;GO:0045893;GO:0050847;GO:0043627;GO:0032570;, C:chromatin; C:cytoplasm; C:nucleus;, F:chromatin DNA binding; F:estrogen receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:cellular response to estrogen stimulus; P:establishment of protein localization; P:positive regulation of gene expression, epigenetic; P:positive regulation of histone H3-K14 acetylation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:progesterone receptor signaling pathway; P:response to estrogen; P:response to progesterone;|Q969T9 B4DFG2 O95638,WW domain-binding protein 2,, PF02893;, GO:0000785;GO:0005737;GO:0005634;GO:0031490;GO:0030331;GO:0000978;GO:0003713;GO:0071391;GO:0045184;GO:0045815;GO:0071442;GO:0033148;GO:0045944;GO:0045893;GO:0050847;GO:0043627;GO:0032570;, C:chromatin; C:cytoplasm; C:nucleus;, F:chromatin DNA binding; F:estrogen receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:cellular response to estrogen stimulus; P:establishment of protein localization; P:positive regulation of gene expression, epigenetic; P:positive regulation of histone H3-K14 acetylation; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:progesterone receptor signaling pathway; P:response to estrogen; P:response to progesterone;|Q70J99 B4DWG9 Q9H7K5,Protein unc-13 homolog D,Munc13-4;, PF00168;PF10540;, GO:0035578;GO:0005829;GO:0070382;GO:0005576;GO:0043231;GO:0005770;GO:0005764;GO:0016020;GO:0055037;GO:0033093;GO:0046872;GO:0031267;GO:0051607;GO:0002467;GO:0002432;GO:0043320;GO:0043312;GO:0006909;GO:0045921;GO:1903307;GO:1900026;GO:0043304;, C:azurophil granule lumen; C:cytosol; C:exocytic vesicle; C:extracellular region; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:membrane; C:recycling endosome; C:Weibel-Palade body;, F:metal ion binding; F:small GTPase binding;, P:defense response to virus; P:germinal center formation; P:granuloma formation; P:natural killer cell degranulation; P:neutrophil degranulation; P:phagocytosis; P:positive regulation of exocytosis; P:positive regulation of regulated secretory pathway; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of mast cell degranulation;|Q70J99 B4DWG9 Q9H7K5,Protein unc-13 homolog D,Munc13-4;, PF00168;PF10540;, GO:0035578;GO:0005829;GO:0070382;GO:0005576;GO:0043231;GO:0005770;GO:0005764;GO:0016020;GO:0055037;GO:0033093;GO:0046872;GO:0031267;GO:0051607;GO:0002467;GO:0002432;GO:0043320;GO:0043312;GO:0006909;GO:0045921;GO:1903307;GO:1900026;GO:0043304;, C:azurophil granule lumen; C:cytosol; C:exocytic vesicle; C:extracellular region; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:membrane; C:recycling endosome; C:Weibel-Palade body;, F:metal ion binding; F:small GTPase binding;, P:defense response to virus; P:germinal center formation; P:granuloma formation; P:natural killer cell degranulation; P:neutrophil degranulation; P:phagocytosis; P:positive regulation of exocytosis; P:positive regulation of regulated secretory pathway; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of mast cell degranulation;|Q70J99 B4DWG9 Q9H7K5,Protein unc-13 homolog D,Munc13-4;, PF00168;PF10540;, GO:0035578;GO:0005829;GO:0070382;GO:0005576;GO:0043231;GO:0005770;GO:0005764;GO:0016020;GO:0055037;GO:0033093;GO:0046872;GO:0031267;GO:0051607;GO:0002467;GO:0002432;GO:0043320;GO:0043312;GO:0006909;GO:0045921;GO:1903307;GO:1900026;GO:0043304;, C:azurophil granule lumen; C:cytosol; C:exocytic vesicle; C:extracellular region; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:membrane; C:recycling endosome; C:Weibel-Palade body;, F:metal ion binding; F:small GTPase binding;, P:defense response to virus; P:germinal center formation; P:granuloma formation; P:natural killer cell degranulation; P:neutrophil degranulation; P:phagocytosis; P:positive regulation of exocytosis; P:positive regulation of regulated secretory pathway; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of mast cell degranulation;|Q70J99 B4DWG9 Q9H7K5,Protein unc-13 homolog D,Munc13-4;, PF00168;PF10540;, GO:0035578;GO:0005829;GO:0070382;GO:0005576;GO:0043231;GO:0005770;GO:0005764;GO:0016020;GO:0055037;GO:0033093;GO:0046872;GO:0031267;GO:0051607;GO:0002467;GO:0002432;GO:0043320;GO:0043312;GO:0006909;GO:0045921;GO:1903307;GO:1900026;GO:0043304;, C:azurophil granule lumen; C:cytosol; C:exocytic vesicle; C:extracellular region; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:membrane; C:recycling endosome; C:Weibel-Palade body;, F:metal ion binding; F:small GTPase binding;, P:defense response to virus; P:germinal center formation; P:granuloma formation; P:natural killer cell degranulation; P:neutrophil degranulation; P:phagocytosis; P:positive regulation of exocytosis; P:positive regulation of regulated secretory pathway; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of mast cell degranulation; scaffold129 indexed_genome mRNA 1892716 1925967 . + . ID=transcript_13988;Q9C0B0,RING finger protein unkempt homolog,Zinc finger CCCH domain-containing protein 5;, PF00642;PF18384;, GO:0005737;GO:0005844;GO:0046872;GO:1990715;GO:1905538;GO:0003723;GO:0048667;GO:0001701;GO:2000766;GO:0001764;, C:cytoplasm; C:polysome;, F:metal ion binding; F:mRNA CDS binding; F:polysome binding; F:RNA binding;, P:cell morphogenesis involved in neuron differentiation; P:in utero embryonic development; P:negative regulation of cytoplasmic translation; P:neuron migration;|Q9C0B0,RING finger protein unkempt homolog,Zinc finger CCCH domain-containing protein 5;, PF00642;PF18384;, GO:0005737;GO:0005844;GO:0046872;GO:1990715;GO:1905538;GO:0003723;GO:0048667;GO:0001701;GO:2000766;GO:0001764;, C:cytoplasm; C:polysome;, F:metal ion binding; F:mRNA CDS binding; F:polysome binding; F:RNA binding;, P:cell morphogenesis involved in neuron differentiation; P:in utero embryonic development; P:negative regulation of cytoplasmic translation; P:neuron migration;|Q9C0B0,RING finger protein unkempt homolog,Zinc finger CCCH domain-containing protein 5;, PF00642;PF18384;, GO:0005737;GO:0005844;GO:0046872;GO:1990715;GO:1905538;GO:0003723;GO:0048667;GO:0001701;GO:2000766;GO:0001764;, C:cytoplasm; C:polysome;, F:metal ion binding; F:mRNA CDS binding; F:polysome binding; F:RNA binding;, P:cell morphogenesis involved in neuron differentiation; P:in utero embryonic development; P:negative regulation of cytoplasmic translation; P:neuron migration;|Q9C0B0,RING finger protein unkempt homolog,Zinc finger CCCH domain-containing protein 5;, PF00642;PF18384;, GO:0005737;GO:0005844;GO:0046872;GO:1990715;GO:1905538;GO:0003723;GO:0048667;GO:0001701;GO:2000766;GO:0001764;, C:cytoplasm; C:polysome;, F:metal ion binding; F:mRNA CDS binding; F:polysome binding; F:RNA binding;, P:cell morphogenesis involved in neuron differentiation; P:in utero embryonic development; P:negative regulation of cytoplasmic translation; P:neuron migration;|Q9C0B0,RING finger protein unkempt homolog,Zinc finger CCCH domain-containing protein 5;, PF00642;PF18384;, GO:0005737;GO:0005844;GO:0046872;GO:1990715;GO:1905538;GO:0003723;GO:0048667;GO:0001701;GO:2000766;GO:0001764;, C:cytoplasm; C:polysome;, F:metal ion binding; F:mRNA CDS binding; F:polysome binding; F:RNA binding;, P:cell morphogenesis involved in neuron differentiation; P:in utero embryonic development; P:negative regulation of cytoplasmic translation; P:neuron migration;|Q9C0B0,RING finger protein unkempt homolog,Zinc finger CCCH domain-containing protein 5;, PF00642;PF18384;, GO:0005737;GO:0005844;GO:0046872;GO:1990715;GO:1905538;GO:0003723;GO:0048667;GO:0001701;GO:2000766;GO:0001764;, C:cytoplasm; C:polysome;, F:metal ion binding; F:mRNA CDS binding; F:polysome binding; F:RNA binding;, P:cell morphogenesis involved in neuron differentiation; P:in utero embryonic development; P:negative regulation of cytoplasmic translation; P:neuron migration;|Q9C0B0,RING finger protein unkempt homolog,Zinc finger CCCH domain-containing protein 5;, PF00642;PF18384;, GO:0005737;GO:0005844;GO:0046872;GO:1990715;GO:1905538;GO:0003723;GO:0048667;GO:0001701;GO:2000766;GO:0001764;, C:cytoplasm; C:polysome;, F:metal ion binding; F:mRNA CDS binding; F:polysome binding; F:RNA binding;, P:cell morphogenesis involved in neuron differentiation; P:in utero embryonic development; P:negative regulation of cytoplasmic translation; P:neuron migration;|Q9C0B0,RING finger protein unkempt homolog,Zinc finger CCCH domain-containing protein 5;, PF00642;PF18384;, GO:0005737;GO:0005844;GO:0046872;GO:1990715;GO:1905538;GO:0003723;GO:0048667;GO:0001701;GO:2000766;GO:0001764;, C:cytoplasm; C:polysome;, F:metal ion binding; F:mRNA CDS binding; F:polysome binding; F:RNA binding;, P:cell morphogenesis involved in neuron differentiation; P:in utero embryonic development; P:negative regulation of cytoplasmic translation; P:neuron migration;|Q9C0B0,RING finger protein unkempt homolog,Zinc finger CCCH domain-containing protein 5;, PF00642;PF18384;, GO:0005737;GO:0005844;GO:0046872;GO:1990715;GO:1905538;GO:0003723;GO:0048667;GO:0001701;GO:2000766;GO:0001764;, C:cytoplasm; C:polysome;, F:metal ion binding; F:mRNA CDS binding; F:polysome binding; F:RNA binding;, P:cell morphogenesis involved in neuron differentiation; P:in utero embryonic development; P:negative regulation of cytoplasmic translation; P:neuron migration; scaffold129 indexed_genome mRNA 1939627 1946414 . + . ID=transcript_13989;P51570 B2RC07 B4E1G6,Galactokinase,Galactose kinase;, PF10509;PF08544;PF00288;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005524;GO:0004335;GO:0005534;GO:0019402;GO:0019388;GO:0006012;GO:0061623;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:ATP binding; F:galactokinase activity; F:galactose binding;, P:galactitol metabolic process; P:galactose catabolic process; P:galactose metabolic process; P:glycolytic process from galactose;|P51570 B2RC07 B4E1G6,Galactokinase,Galactose kinase;, PF10509;PF08544;PF00288;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005524;GO:0004335;GO:0005534;GO:0019402;GO:0019388;GO:0006012;GO:0061623;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:ATP binding; F:galactokinase activity; F:galactose binding;, P:galactitol metabolic process; P:galactose catabolic process; P:galactose metabolic process; P:glycolytic process from galactose;|P51570 B2RC07 B4E1G6,Galactokinase,Galactose kinase;, PF10509;PF08544;PF00288;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005524;GO:0004335;GO:0005534;GO:0019402;GO:0019388;GO:0006012;GO:0061623;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:ATP binding; F:galactokinase activity; F:galactose binding;, P:galactitol metabolic process; P:galactose catabolic process; P:galactose metabolic process; P:glycolytic process from galactose; scaffold129 indexed_genome mRNA 1946527 1948384 . - . ID=transcript_13990;P16144 A0AVL6 O14690 O14691 O15339 O15340 O15341 Q0VF97 Q9UIQ4,Integrin beta-4,GP150;, PF03160;PF07974;PF00041;PF18372;PF07965;PF00362;PF17205;, GO:0009925;GO:0005604;GO:0030054;GO:0031252;GO:0009986;GO:0070062;GO:0005925;GO:0030056;GO:0008305;GO:0031965;GO:0005730;GO:0005886;GO:0043235;GO:0001664;GO:0005178;GO:0006914;GO:0007155;GO:0033627;GO:0016477;GO:0048870;GO:0007160;GO:0030199;GO:0030198;GO:0046847;GO:0031581;GO:0007229;GO:0048333;GO:0035878;GO:0032290;GO:0009611;GO:0043589;GO:0061450;, C:basal plasma membrane; C:basement membrane; C:cell junction; C:cell leading edge; C:cell surface; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:integrin complex; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:receptor complex;, F:G protein-coupled receptor binding; F:integrin binding;, P:autophagy; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell motility; P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:filopodium assembly; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:mesodermal cell differentiation; P:nail development; P:peripheral nervous system myelin formation; P:response to wounding; P:skin morphogenesis; P:trophoblast cell migration;|P16144 A0AVL6 O14690 O14691 O15339 O15340 O15341 Q0VF97 Q9UIQ4,Integrin beta-4,GP150;, PF03160;PF07974;PF00041;PF18372;PF07965;PF00362;PF17205;, GO:0009925;GO:0005604;GO:0030054;GO:0031252;GO:0009986;GO:0070062;GO:0005925;GO:0030056;GO:0008305;GO:0031965;GO:0005730;GO:0005886;GO:0043235;GO:0001664;GO:0005178;GO:0006914;GO:0007155;GO:0033627;GO:0016477;GO:0048870;GO:0007160;GO:0030199;GO:0030198;GO:0046847;GO:0031581;GO:0007229;GO:0048333;GO:0035878;GO:0032290;GO:0009611;GO:0043589;GO:0061450;, C:basal plasma membrane; C:basement membrane; C:cell junction; C:cell leading edge; C:cell surface; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:integrin complex; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:receptor complex;, F:G protein-coupled receptor binding; F:integrin binding;, P:autophagy; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell motility; P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:filopodium assembly; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:mesodermal cell differentiation; P:nail development; P:peripheral nervous system myelin formation; P:response to wounding; P:skin morphogenesis; P:trophoblast cell migration; scaffold129 indexed_genome mRNA 1949021 1972996 . + . ID=transcript_13991;P16144 A0AVL6 O14690 O14691 O15339 O15340 O15341 Q0VF97 Q9UIQ4,Integrin beta-4,GP150;, PF03160;PF07974;PF00041;PF18372;PF07965;PF00362;PF17205;, GO:0009925;GO:0005604;GO:0030054;GO:0031252;GO:0009986;GO:0070062;GO:0005925;GO:0030056;GO:0008305;GO:0031965;GO:0005730;GO:0005886;GO:0043235;GO:0001664;GO:0005178;GO:0006914;GO:0007155;GO:0033627;GO:0016477;GO:0048870;GO:0007160;GO:0030199;GO:0030198;GO:0046847;GO:0031581;GO:0007229;GO:0048333;GO:0035878;GO:0032290;GO:0009611;GO:0043589;GO:0061450;, C:basal plasma membrane; C:basement membrane; C:cell junction; C:cell leading edge; C:cell surface; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:integrin complex; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:receptor complex;, F:G protein-coupled receptor binding; F:integrin binding;, P:autophagy; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell motility; P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:filopodium assembly; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:mesodermal cell differentiation; P:nail development; P:peripheral nervous system myelin formation; P:response to wounding; P:skin morphogenesis; P:trophoblast cell migration;|P16144 A0AVL6 O14690 O14691 O15339 O15340 O15341 Q0VF97 Q9UIQ4,Integrin beta-4,GP150;, PF03160;PF07974;PF00041;PF18372;PF07965;PF00362;PF17205;, GO:0009925;GO:0005604;GO:0030054;GO:0031252;GO:0009986;GO:0070062;GO:0005925;GO:0030056;GO:0008305;GO:0031965;GO:0005730;GO:0005886;GO:0043235;GO:0001664;GO:0005178;GO:0006914;GO:0007155;GO:0033627;GO:0016477;GO:0048870;GO:0007160;GO:0030199;GO:0030198;GO:0046847;GO:0031581;GO:0007229;GO:0048333;GO:0035878;GO:0032290;GO:0009611;GO:0043589;GO:0061450;, C:basal plasma membrane; C:basement membrane; C:cell junction; C:cell leading edge; C:cell surface; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:integrin complex; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:receptor complex;, F:G protein-coupled receptor binding; F:integrin binding;, P:autophagy; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell motility; P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:filopodium assembly; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:mesodermal cell differentiation; P:nail development; P:peripheral nervous system myelin formation; P:response to wounding; P:skin morphogenesis; P:trophoblast cell migration;|P16144 A0AVL6 O14690 O14691 O15339 O15340 O15341 Q0VF97 Q9UIQ4,Integrin beta-4,GP150;, PF03160;PF07974;PF00041;PF18372;PF07965;PF00362;PF17205;, GO:0009925;GO:0005604;GO:0030054;GO:0031252;GO:0009986;GO:0070062;GO:0005925;GO:0030056;GO:0008305;GO:0031965;GO:0005730;GO:0005886;GO:0043235;GO:0001664;GO:0005178;GO:0006914;GO:0007155;GO:0033627;GO:0016477;GO:0048870;GO:0007160;GO:0030199;GO:0030198;GO:0046847;GO:0031581;GO:0007229;GO:0048333;GO:0035878;GO:0032290;GO:0009611;GO:0043589;GO:0061450;, C:basal plasma membrane; C:basement membrane; C:cell junction; C:cell leading edge; C:cell surface; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:integrin complex; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:receptor complex;, F:G protein-coupled receptor binding; F:integrin binding;, P:autophagy; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell motility; P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:filopodium assembly; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:mesodermal cell differentiation; P:nail development; P:peripheral nervous system myelin formation; P:response to wounding; P:skin morphogenesis; P:trophoblast cell migration;|P16144 A0AVL6 O14690 O14691 O15339 O15340 O15341 Q0VF97 Q9UIQ4,Integrin beta-4,GP150;, PF03160;PF07974;PF00041;PF18372;PF07965;PF00362;PF17205;, GO:0009925;GO:0005604;GO:0030054;GO:0031252;GO:0009986;GO:0070062;GO:0005925;GO:0030056;GO:0008305;GO:0031965;GO:0005730;GO:0005886;GO:0043235;GO:0001664;GO:0005178;GO:0006914;GO:0007155;GO:0033627;GO:0016477;GO:0048870;GO:0007160;GO:0030199;GO:0030198;GO:0046847;GO:0031581;GO:0007229;GO:0048333;GO:0035878;GO:0032290;GO:0009611;GO:0043589;GO:0061450;, C:basal plasma membrane; C:basement membrane; C:cell junction; C:cell leading edge; C:cell surface; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:integrin complex; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:receptor complex;, F:G protein-coupled receptor binding; F:integrin binding;, P:autophagy; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell motility; P:cell-matrix adhesion; P:collagen fibril organization; P:extracellular matrix organization; P:filopodium assembly; P:hemidesmosome assembly; P:integrin-mediated signaling pathway; P:mesodermal cell differentiation; P:nail development; P:peripheral nervous system myelin formation; P:response to wounding; P:skin morphogenesis; P:trophoblast cell migration; scaffold129 indexed_genome mRNA 1995893 1997479 . - . ID=transcript_13992;Q9UHR5 B3KML7 Q8N1R5 Q8TDR8 Q96D27,SAP30-binding protein,Transcriptional regulator protein HCNGP;, PF07818;, GO:0045111;GO:0005654;GO:0005634;GO:0006915;GO:0010942;GO:0006355;, C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus;, , P:apoptotic process; P:positive regulation of cell death; P:regulation of transcription, DNA-templated; scaffold129 indexed_genome mRNA 2023103 2052098 . + . ID=transcript_13993;O94762 Q6P4G0 Q9H0B1 Q9P1W7 Q9UNC8,ATP-dependent DNA helicase Q5,DNA helicase, RecQ-like type 5;RecQ protein-like 5;, PF00270;PF00271;PF06959;PF16124;, GO:0005694;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016591;GO:0043138;GO:0005524;GO:0003678;GO:0009378;GO:0042802;GO:0003676;GO:0000993;GO:0051301;GO:0072757;GO:0035690;GO:0051304;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0006268;GO:0000724;GO:0000278;GO:2000042;GO:0034244;GO:1990414;, C:chromosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:four-way junction helicase activity; F:identical protein binding; F:nucleic acid binding; F:RNA polymerase II complex binding;, P:cell division; P:cellular response to camptothecin; P:cellular response to drug; P:chromosome separation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:mitotic cell cycle; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:replication-born double-strand break repair via sister chromatid exchange;|O94762 Q6P4G0 Q9H0B1 Q9P1W7 Q9UNC8,ATP-dependent DNA helicase Q5,DNA helicase, RecQ-like type 5;RecQ protein-like 5;, PF00270;PF00271;PF06959;PF16124;, GO:0005694;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016591;GO:0043138;GO:0005524;GO:0003678;GO:0009378;GO:0042802;GO:0003676;GO:0000993;GO:0051301;GO:0072757;GO:0035690;GO:0051304;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0006268;GO:0000724;GO:0000278;GO:2000042;GO:0034244;GO:1990414;, C:chromosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:four-way junction helicase activity; F:identical protein binding; F:nucleic acid binding; F:RNA polymerase II complex binding;, P:cell division; P:cellular response to camptothecin; P:cellular response to drug; P:chromosome separation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:mitotic cell cycle; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:replication-born double-strand break repair via sister chromatid exchange;|O94762 Q6P4G0 Q9H0B1 Q9P1W7 Q9UNC8,ATP-dependent DNA helicase Q5,DNA helicase, RecQ-like type 5;RecQ protein-like 5;, PF00270;PF00271;PF06959;PF16124;, GO:0005694;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016591;GO:0043138;GO:0005524;GO:0003678;GO:0009378;GO:0042802;GO:0003676;GO:0000993;GO:0051301;GO:0072757;GO:0035690;GO:0051304;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0006268;GO:0000724;GO:0000278;GO:2000042;GO:0034244;GO:1990414;, C:chromosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:four-way junction helicase activity; F:identical protein binding; F:nucleic acid binding; F:RNA polymerase II complex binding;, P:cell division; P:cellular response to camptothecin; P:cellular response to drug; P:chromosome separation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:mitotic cell cycle; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:replication-born double-strand break repair via sister chromatid exchange;|Q71RC9,Small integral membrane protein 5,, PF15831;, GO:0016021;, C:integral component of membrane;|O94762 Q6P4G0 Q9H0B1 Q9P1W7 Q9UNC8,ATP-dependent DNA helicase Q5,DNA helicase, RecQ-like type 5;RecQ protein-like 5;, PF00270;PF00271;PF06959;PF16124;, GO:0005694;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016591;GO:0043138;GO:0005524;GO:0003678;GO:0009378;GO:0042802;GO:0003676;GO:0000993;GO:0051301;GO:0072757;GO:0035690;GO:0051304;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0006268;GO:0000724;GO:0000278;GO:2000042;GO:0034244;GO:1990414;, C:chromosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:four-way junction helicase activity; F:identical protein binding; F:nucleic acid binding; F:RNA polymerase II complex binding;, P:cell division; P:cellular response to camptothecin; P:cellular response to drug; P:chromosome separation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:mitotic cell cycle; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:replication-born double-strand break repair via sister chromatid exchange;|O94762 Q6P4G0 Q9H0B1 Q9P1W7 Q9UNC8,ATP-dependent DNA helicase Q5,DNA helicase, RecQ-like type 5;RecQ protein-like 5;, PF00270;PF00271;PF06959;PF16124;, GO:0005694;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0016591;GO:0043138;GO:0005524;GO:0003678;GO:0009378;GO:0042802;GO:0003676;GO:0000993;GO:0051301;GO:0072757;GO:0035690;GO:0051304;GO:0032508;GO:0006259;GO:0006310;GO:0006281;GO:0006260;GO:0006268;GO:0000724;GO:0000278;GO:2000042;GO:0034244;GO:1990414;, C:chromosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase II, holoenzyme;, F:3'-5' DNA helicase activity; F:ATP binding; F:DNA helicase activity; F:four-way junction helicase activity; F:identical protein binding; F:nucleic acid binding; F:RNA polymerase II complex binding;, P:cell division; P:cellular response to camptothecin; P:cellular response to drug; P:chromosome separation; P:DNA duplex unwinding; P:DNA metabolic process; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:mitotic cell cycle; P:negative regulation of double-strand break repair via homologous recombination; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:replication-born double-strand break repair via sister chromatid exchange; scaffold129 indexed_genome mRNA 2057548 2058407 . - . ID=transcript_13994;Q96JP2 A0A0J9YVZ6,Unconventional myosin-XVB,Myosin XVBP;Unconventional myosin-15B;, PF00063;PF00784;PF07653;, GO:0005737;GO:0016459;GO:0005524;GO:0003774;, C:cytoplasm; C:myosin complex;, F:ATP binding; F:motor activity; scaffold129 indexed_genome mRNA 2091375 2101527 . - . ID=transcript_13995;Q6P1M3 Q14521 Q9BR62,LLGL scribble cell polarity complex component 2,HGL;Lethal(2) giant larvae protein homolog 2;, PF08366;PF00400;, GO:0030864;GO:0005737;GO:0005829;GO:0043231;GO:0005886;GO:0005096;GO:0045159;GO:0030165;GO:0051301;GO:0030866;GO:0051294;GO:0006887;GO:0015820;GO:0032878;GO:0008593;GO:0050708;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase activator activity; F:myosin II binding; F:PDZ domain binding;, P:cell division; P:cortical actin cytoskeleton organization; P:establishment of spindle orientation; P:exocytosis; P:leucine transport; P:regulation of establishment or maintenance of cell polarity; P:regulation of Notch signaling pathway; P:regulation of protein secretion;|Q6P1M3 Q14521 Q9BR62,LLGL scribble cell polarity complex component 2,HGL;Lethal(2) giant larvae protein homolog 2;, PF08366;PF00400;, GO:0030864;GO:0005737;GO:0005829;GO:0043231;GO:0005886;GO:0005096;GO:0045159;GO:0030165;GO:0051301;GO:0030866;GO:0051294;GO:0006887;GO:0015820;GO:0032878;GO:0008593;GO:0050708;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase activator activity; F:myosin II binding; F:PDZ domain binding;, P:cell division; P:cortical actin cytoskeleton organization; P:establishment of spindle orientation; P:exocytosis; P:leucine transport; P:regulation of establishment or maintenance of cell polarity; P:regulation of Notch signaling pathway; P:regulation of protein secretion;|Q6P1M3 Q14521 Q9BR62,LLGL scribble cell polarity complex component 2,HGL;Lethal(2) giant larvae protein homolog 2;, PF08366;PF00400;, GO:0030864;GO:0005737;GO:0005829;GO:0043231;GO:0005886;GO:0005096;GO:0045159;GO:0030165;GO:0051301;GO:0030866;GO:0051294;GO:0006887;GO:0015820;GO:0032878;GO:0008593;GO:0050708;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase activator activity; F:myosin II binding; F:PDZ domain binding;, P:cell division; P:cortical actin cytoskeleton organization; P:establishment of spindle orientation; P:exocytosis; P:leucine transport; P:regulation of establishment or maintenance of cell polarity; P:regulation of Notch signaling pathway; P:regulation of protein secretion;|Q6P1M3 Q14521 Q9BR62,LLGL scribble cell polarity complex component 2,HGL;Lethal(2) giant larvae protein homolog 2;, PF08366;PF00400;, GO:0030864;GO:0005737;GO:0005829;GO:0043231;GO:0005886;GO:0005096;GO:0045159;GO:0030165;GO:0051301;GO:0030866;GO:0051294;GO:0006887;GO:0015820;GO:0032878;GO:0008593;GO:0050708;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase activator activity; F:myosin II binding; F:PDZ domain binding;, P:cell division; P:cortical actin cytoskeleton organization; P:establishment of spindle orientation; P:exocytosis; P:leucine transport; P:regulation of establishment or maintenance of cell polarity; P:regulation of Notch signaling pathway; P:regulation of protein secretion;|Q6P1M3 Q14521 Q9BR62,LLGL scribble cell polarity complex component 2,HGL;Lethal(2) giant larvae protein homolog 2;, PF08366;PF00400;, GO:0030864;GO:0005737;GO:0005829;GO:0043231;GO:0005886;GO:0005096;GO:0045159;GO:0030165;GO:0051301;GO:0030866;GO:0051294;GO:0006887;GO:0015820;GO:0032878;GO:0008593;GO:0050708;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase activator activity; F:myosin II binding; F:PDZ domain binding;, P:cell division; P:cortical actin cytoskeleton organization; P:establishment of spindle orientation; P:exocytosis; P:leucine transport; P:regulation of establishment or maintenance of cell polarity; P:regulation of Notch signaling pathway; P:regulation of protein secretion;|Q6P1M3 Q14521 Q9BR62,LLGL scribble cell polarity complex component 2,HGL;Lethal(2) giant larvae protein homolog 2;, PF08366;PF00400;, GO:0030864;GO:0005737;GO:0005829;GO:0043231;GO:0005886;GO:0005096;GO:0045159;GO:0030165;GO:0051301;GO:0030866;GO:0051294;GO:0006887;GO:0015820;GO:0032878;GO:0008593;GO:0050708;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase activator activity; F:myosin II binding; F:PDZ domain binding;, P:cell division; P:cortical actin cytoskeleton organization; P:establishment of spindle orientation; P:exocytosis; P:leucine transport; P:regulation of establishment or maintenance of cell polarity; P:regulation of Notch signaling pathway; P:regulation of protein secretion; scaffold129 indexed_genome mRNA 2101549 2102605 . - . ID=transcript_13996;Q6P1M3 Q14521 Q9BR62,LLGL scribble cell polarity complex component 2,HGL;Lethal(2) giant larvae protein homolog 2;, PF08366;PF00400;, GO:0030864;GO:0005737;GO:0005829;GO:0043231;GO:0005886;GO:0005096;GO:0045159;GO:0030165;GO:0051301;GO:0030866;GO:0051294;GO:0006887;GO:0015820;GO:0032878;GO:0008593;GO:0050708;, C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTPase activator activity; F:myosin II binding; F:PDZ domain binding;, P:cell division; P:cortical actin cytoskeleton organization; P:establishment of spindle orientation; P:exocytosis; P:leucine transport; P:regulation of establishment or maintenance of cell polarity; P:regulation of Notch signaling pathway; P:regulation of protein secretion; scaffold129 indexed_genome mRNA 2126045 2133207 . - . ID=transcript_13997;Q7Z6J9 Q86WV3 Q86XE4 Q8N9H2,tRNA-splicing endonuclease subunit Sen54,SEN54 homolog;tRNA-intron endonuclease Sen54;, PF12928;, GO:0005730;GO:0005654;GO:0000214;GO:0006397;GO:0006388;GO:0000379;, C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;, , P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage;|Q7Z6J9 Q86WV3 Q86XE4 Q8N9H2,tRNA-splicing endonuclease subunit Sen54,SEN54 homolog;tRNA-intron endonuclease Sen54;, PF12928;, GO:0005730;GO:0005654;GO:0000214;GO:0006397;GO:0006388;GO:0000379;, C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;, , P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage;|Q7Z6J9 Q86WV3 Q86XE4 Q8N9H2,tRNA-splicing endonuclease subunit Sen54,SEN54 homolog;tRNA-intron endonuclease Sen54;, PF12928;, GO:0005730;GO:0005654;GO:0000214;GO:0006397;GO:0006388;GO:0000379;, C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;, , P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage;|Q7Z6J9 Q86WV3 Q86XE4 Q8N9H2,tRNA-splicing endonuclease subunit Sen54,SEN54 homolog;tRNA-intron endonuclease Sen54;, PF12928;, GO:0005730;GO:0005654;GO:0000214;GO:0006397;GO:0006388;GO:0000379;, C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;, , P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage;|Q7Z6J9 Q86WV3 Q86XE4 Q8N9H2,tRNA-splicing endonuclease subunit Sen54,SEN54 homolog;tRNA-intron endonuclease Sen54;, PF12928;, GO:0005730;GO:0005654;GO:0000214;GO:0006397;GO:0006388;GO:0000379;, C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;, , P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage; scaffold129 indexed_genome mRNA 2133462 2170556 . - . ID=transcript_13998;Q8WXE0 B4DTT3 B7Z9H1 Q7LG69 Q9ULT1,Caskin-2,CASK-interacting protein 2;, PF12796;PF16632;PF16600;PF00536;PF07653;, GO:0005737;GO:0016020;, C:cytoplasm; C:membrane;|Q8WXE0 B4DTT3 B7Z9H1 Q7LG69 Q9ULT1,Caskin-2,CASK-interacting protein 2;, PF12796;PF16632;PF16600;PF00536;PF07653;, GO:0005737;GO:0016020;, C:cytoplasm; C:membrane;|Q12767 C9JL75 O75536 Q86XF1,Transmembrane protein 94 {ECO:0000312|HGNC:HGNC:28983},, , GO:0016021;, C:integral component of membrane;|Q12767 C9JL75 O75536 Q86XF1,Transmembrane protein 94 {ECO:0000312|HGNC:HGNC:28983},, , GO:0016021;, C:integral component of membrane;|Q12767 C9JL75 O75536 Q86XF1,Transmembrane protein 94 {ECO:0000312|HGNC:HGNC:28983},, , GO:0016021;, C:integral component of membrane;|Q12767 C9JL75 O75536 Q86XF1,Transmembrane protein 94 {ECO:0000312|HGNC:HGNC:28983},, , GO:0016021;, C:integral component of membrane;|Q12767 C9JL75 O75536 Q86XF1,Transmembrane protein 94 {ECO:0000312|HGNC:HGNC:28983},, , GO:0016021;, C:integral component of membrane;|Q12767 C9JL75 O75536 Q86XF1,Transmembrane protein 94 {ECO:0000312|HGNC:HGNC:28983},, , GO:0016021;, C:integral component of membrane;|Q12767 C9JL75 O75536 Q86XF1,Transmembrane protein 94 {ECO:0000312|HGNC:HGNC:28983},, , GO:0016021;, C:integral component of membrane;|Q12767 C9JL75 O75536 Q86XF1,Transmembrane protein 94 {ECO:0000312|HGNC:HGNC:28983},, , GO:0016021;, C:integral component of membrane; scaffold129 indexed_genome mRNA 2278927 2281534 . + . ID=transcript_13999;P62993 P29354 Q14450 Q63057 Q63059,Growth factor receptor-bound protein 2,Adapter protein GRB2;Protein Ash;SH2/SH3 adapter GRB2;, PF00017;PF00018;, GO:0005911;GO:0008180;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0005794;GO:0070436;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0012506;GO:0046875;GO:0005154;GO:0042802;GO:0043560;GO:0005168;GO:0001784;GO:0019901;GO:0019903;GO:0044877;GO:0030674;GO:0003723;GO:0017124;GO:0031532;GO:0007568;GO:0048646;GO:0007411;GO:0060670;GO:0071479;GO:0019221;GO:0035635;GO:0007173;GO:0038128;GO:0038095;GO:0038096;GO:0008543;GO:0008286;GO:0035723;GO:0050900;GO:0000165;GO:0061024;GO:0042059;GO:0048011;GO:0030838;GO:0051897;GO:0046579;GO:2000379;GO:0007265;GO:0031623;GO:0043408;GO:0042770;GO:0031295;GO:0016032;, C:cell-cell junction; C:COP9 signalosome; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:Golgi apparatus; C:Grb2-EGFR complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle membrane;, F:ephrin receptor binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor substrate binding; F:neurotrophin TRKA receptor binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:SH3 domain binding;, P:actin cytoskeleton reorganization; P:aging; P:anatomical structure formation involved in morphogenesis; P:axon guidance; P:branching involved in labyrinthine layer morphogenesis; P:cellular response to ionizing radiation; P:cytokine-mediated signaling pathway; P:entry of bacterium into host cell; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:interleukin-15-mediated signaling pathway; P:leukocyte migration; P:MAPK cascade; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of protein kinase B signaling; P:positive regulation of Ras protein signal transduction; P:positive regulation of reactive oxygen species metabolic process; P:Ras protein signal transduction; P:receptor internalization; P:regulation of MAPK cascade; P:signal transduction in response to DNA damage; P:T cell costimulation; P:viral process;|P62993 P29354 Q14450 Q63057 Q63059,Growth factor receptor-bound protein 2,Adapter protein GRB2;Protein Ash;SH2/SH3 adapter GRB2;, PF00017;PF00018;, GO:0005911;GO:0008180;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0005794;GO:0070436;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0012506;GO:0046875;GO:0005154;GO:0042802;GO:0043560;GO:0005168;GO:0001784;GO:0019901;GO:0019903;GO:0044877;GO:0030674;GO:0003723;GO:0017124;GO:0031532;GO:0007568;GO:0048646;GO:0007411;GO:0060670;GO:0071479;GO:0019221;GO:0035635;GO:0007173;GO:0038128;GO:0038095;GO:0038096;GO:0008543;GO:0008286;GO:0035723;GO:0050900;GO:0000165;GO:0061024;GO:0042059;GO:0048011;GO:0030838;GO:0051897;GO:0046579;GO:2000379;GO:0007265;GO:0031623;GO:0043408;GO:0042770;GO:0031295;GO:0016032;, C:cell-cell junction; C:COP9 signalosome; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:Golgi apparatus; C:Grb2-EGFR complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle membrane;, F:ephrin receptor binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor substrate binding; F:neurotrophin TRKA receptor binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:SH3 domain binding;, P:actin cytoskeleton reorganization; P:aging; P:anatomical structure formation involved in morphogenesis; P:axon guidance; P:branching involved in labyrinthine layer morphogenesis; P:cellular response to ionizing radiation; P:cytokine-mediated signaling pathway; P:entry of bacterium into host cell; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:interleukin-15-mediated signaling pathway; P:leukocyte migration; P:MAPK cascade; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of protein kinase B signaling; P:positive regulation of Ras protein signal transduction; P:positive regulation of reactive oxygen species metabolic process; P:Ras protein signal transduction; P:receptor internalization; P:regulation of MAPK cascade; P:signal transduction in response to DNA damage; P:T cell costimulation; P:viral process; scaffold129 indexed_genome mRNA 2282798 2286226 . - . ID=transcript_14000;P62993 P29354 Q14450 Q63057 Q63059,Growth factor receptor-bound protein 2,Adapter protein GRB2;Protein Ash;SH2/SH3 adapter GRB2;, PF00017;PF00018;, GO:0005911;GO:0008180;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0005794;GO:0070436;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0012506;GO:0046875;GO:0005154;GO:0042802;GO:0043560;GO:0005168;GO:0001784;GO:0019901;GO:0019903;GO:0044877;GO:0030674;GO:0003723;GO:0017124;GO:0031532;GO:0007568;GO:0048646;GO:0007411;GO:0060670;GO:0071479;GO:0019221;GO:0035635;GO:0007173;GO:0038128;GO:0038095;GO:0038096;GO:0008543;GO:0008286;GO:0035723;GO:0050900;GO:0000165;GO:0061024;GO:0042059;GO:0048011;GO:0030838;GO:0051897;GO:0046579;GO:2000379;GO:0007265;GO:0031623;GO:0043408;GO:0042770;GO:0031295;GO:0016032;, C:cell-cell junction; C:COP9 signalosome; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:Golgi apparatus; C:Grb2-EGFR complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle membrane;, F:ephrin receptor binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor substrate binding; F:neurotrophin TRKA receptor binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:SH3 domain binding;, P:actin cytoskeleton reorganization; P:aging; P:anatomical structure formation involved in morphogenesis; P:axon guidance; P:branching involved in labyrinthine layer morphogenesis; P:cellular response to ionizing radiation; P:cytokine-mediated signaling pathway; P:entry of bacterium into host cell; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:interleukin-15-mediated signaling pathway; P:leukocyte migration; P:MAPK cascade; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of protein kinase B signaling; P:positive regulation of Ras protein signal transduction; P:positive regulation of reactive oxygen species metabolic process; P:Ras protein signal transduction; P:receptor internalization; P:regulation of MAPK cascade; P:signal transduction in response to DNA damage; P:T cell costimulation; P:viral process;|P62993 P29354 Q14450 Q63057 Q63059,Growth factor receptor-bound protein 2,Adapter protein GRB2;Protein Ash;SH2/SH3 adapter GRB2;, PF00017;PF00018;, GO:0005911;GO:0008180;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0005794;GO:0070436;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0012506;GO:0046875;GO:0005154;GO:0042802;GO:0043560;GO:0005168;GO:0001784;GO:0019901;GO:0019903;GO:0044877;GO:0030674;GO:0003723;GO:0017124;GO:0031532;GO:0007568;GO:0048646;GO:0007411;GO:0060670;GO:0071479;GO:0019221;GO:0035635;GO:0007173;GO:0038128;GO:0038095;GO:0038096;GO:0008543;GO:0008286;GO:0035723;GO:0050900;GO:0000165;GO:0061024;GO:0042059;GO:0048011;GO:0030838;GO:0051897;GO:0046579;GO:2000379;GO:0007265;GO:0031623;GO:0043408;GO:0042770;GO:0031295;GO:0016032;, C:cell-cell junction; C:COP9 signalosome; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:Golgi apparatus; C:Grb2-EGFR complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle membrane;, F:ephrin receptor binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor substrate binding; F:neurotrophin TRKA receptor binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:SH3 domain binding;, P:actin cytoskeleton reorganization; P:aging; P:anatomical structure formation involved in morphogenesis; P:axon guidance; P:branching involved in labyrinthine layer morphogenesis; P:cellular response to ionizing radiation; P:cytokine-mediated signaling pathway; P:entry of bacterium into host cell; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:interleukin-15-mediated signaling pathway; P:leukocyte migration; P:MAPK cascade; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of protein kinase B signaling; P:positive regulation of Ras protein signal transduction; P:positive regulation of reactive oxygen species metabolic process; P:Ras protein signal transduction; P:receptor internalization; P:regulation of MAPK cascade; P:signal transduction in response to DNA damage; P:T cell costimulation; P:viral process;|P62993 P29354 Q14450 Q63057 Q63059,Growth factor receptor-bound protein 2,Adapter protein GRB2;Protein Ash;SH2/SH3 adapter GRB2;, PF00017;PF00018;, GO:0005911;GO:0008180;GO:0005737;GO:0005829;GO:0005768;GO:0070062;GO:0005794;GO:0070436;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0012506;GO:0046875;GO:0005154;GO:0042802;GO:0043560;GO:0005168;GO:0001784;GO:0019901;GO:0019903;GO:0044877;GO:0030674;GO:0003723;GO:0017124;GO:0031532;GO:0007568;GO:0048646;GO:0007411;GO:0060670;GO:0071479;GO:0019221;GO:0035635;GO:0007173;GO:0038128;GO:0038095;GO:0038096;GO:0008543;GO:0008286;GO:0035723;GO:0050900;GO:0000165;GO:0061024;GO:0042059;GO:0048011;GO:0030838;GO:0051897;GO:0046579;GO:2000379;GO:0007265;GO:0031623;GO:0043408;GO:0042770;GO:0031295;GO:0016032;, C:cell-cell junction; C:COP9 signalosome; C:cytoplasm; C:cytosol; C:endosome; C:extracellular exosome; C:Golgi apparatus; C:Grb2-EGFR complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:vesicle membrane;, F:ephrin receptor binding; F:epidermal growth factor receptor binding; F:identical protein binding; F:insulin receptor substrate binding; F:neurotrophin TRKA receptor binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:RNA binding; F:SH3 domain binding;, P:actin cytoskeleton reorganization; P:aging; P:anatomical structure formation involved in morphogenesis; P:axon guidance; P:branching involved in labyrinthine layer morphogenesis; P:cellular response to ionizing radiation; P:cytokine-mediated signaling pathway; P:entry of bacterium into host cell; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:interleukin-15-mediated signaling pathway; P:leukocyte migration; P:MAPK cascade; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of actin filament polymerization; P:positive regulation of protein kinase B signaling; P:positive regulation of Ras protein signal transduction; P:positive regulation of reactive oxygen species metabolic process; P:Ras protein signal transduction; P:receptor internalization; P:regulation of MAPK cascade; P:signal transduction in response to DNA damage; P:T cell costimulation; P:viral process; scaffold129 indexed_genome mRNA 2309887 2370661 . + . ID=transcript_14001;Q9HC21 E9PF74 Q6V9R7,Mitochondrial thiamine pyrophosphate carrier,Mitochondrial uncoupling protein 1;Solute carrier family 25 member 19;, PF00153;, GO:0031305;GO:0005743;GO:0005634;GO:0030233;GO:0015234;GO:0030302;GO:0030974;GO:0042723;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:nucleus;, F:deoxynucleotide transmembrane transporter activity; F:thiamine transmembrane transporter activity;, P:deoxynucleotide transport; P:thiamine pyrophosphate transmembrane transport; P:thiamine-containing compound metabolic process;|Q9HC21 E9PF74 Q6V9R7,Mitochondrial thiamine pyrophosphate carrier,Mitochondrial uncoupling protein 1;Solute carrier family 25 member 19;, PF00153;, GO:0031305;GO:0005743;GO:0005634;GO:0030233;GO:0015234;GO:0030302;GO:0030974;GO:0042723;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:nucleus;, F:deoxynucleotide transmembrane transporter activity; F:thiamine transmembrane transporter activity;, P:deoxynucleotide transport; P:thiamine pyrophosphate transmembrane transport; P:thiamine-containing compound metabolic process;|Q9HC21 E9PF74 Q6V9R7,Mitochondrial thiamine pyrophosphate carrier,Mitochondrial uncoupling protein 1;Solute carrier family 25 member 19;, PF00153;, GO:0031305;GO:0005743;GO:0005634;GO:0030233;GO:0015234;GO:0030302;GO:0030974;GO:0042723;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:nucleus;, F:deoxynucleotide transmembrane transporter activity; F:thiamine transmembrane transporter activity;, P:deoxynucleotide transport; P:thiamine pyrophosphate transmembrane transport; P:thiamine-containing compound metabolic process;|Q9HC21 E9PF74 Q6V9R7,Mitochondrial thiamine pyrophosphate carrier,Mitochondrial uncoupling protein 1;Solute carrier family 25 member 19;, PF00153;, GO:0031305;GO:0005743;GO:0005634;GO:0030233;GO:0015234;GO:0030302;GO:0030974;GO:0042723;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:nucleus;, F:deoxynucleotide transmembrane transporter activity; F:thiamine transmembrane transporter activity;, P:deoxynucleotide transport; P:thiamine pyrophosphate transmembrane transport; P:thiamine-containing compound metabolic process;|Q9HC21 E9PF74 Q6V9R7,Mitochondrial thiamine pyrophosphate carrier,Mitochondrial uncoupling protein 1;Solute carrier family 25 member 19;, PF00153;, GO:0031305;GO:0005743;GO:0005634;GO:0030233;GO:0015234;GO:0030302;GO:0030974;GO:0042723;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:nucleus;, F:deoxynucleotide transmembrane transporter activity; F:thiamine transmembrane transporter activity;, P:deoxynucleotide transport; P:thiamine pyrophosphate transmembrane transport; P:thiamine-containing compound metabolic process;|A9UHW6 B4DUM7 Q8N4Q5 Q9HBL5,MIF4G domain-containing protein,SLBP-interacting protein 1;, PF02854;, GO:0005829;GO:0005794;GO:0005730;GO:0042802;GO:0008022;GO:0003723;GO:0008494;GO:0006446;, C:cytosol; C:Golgi apparatus; C:nucleolus;, F:identical protein binding; F:protein C-terminus binding; F:RNA binding; F:translation activator activity;, P:regulation of translational initiation;|A9UHW6 B4DUM7 Q8N4Q5 Q9HBL5,MIF4G domain-containing protein,SLBP-interacting protein 1;, PF02854;, GO:0005829;GO:0005794;GO:0005730;GO:0042802;GO:0008022;GO:0003723;GO:0008494;GO:0006446;, C:cytosol; C:Golgi apparatus; C:nucleolus;, F:identical protein binding; F:protein C-terminus binding; F:RNA binding; F:translation activator activity;, P:regulation of translational initiation;|Q9Y2R9 B2R9N5 Q53GD6,28S ribosomal protein S7, mitochondrial,Mitochondrial small ribosomal subunit protein uS7m {ECO:0000303|PubMed:25838379};bMRP-27a;, PF00177;, GO:0005743;GO:0005763;GO:0005840;GO:0003729;GO:0003723;GO:0019843;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0000028;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:ribosome;, F:mRNA binding; F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:ribosomal small subunit assembly; P:translation;|Q9NZ52 B7Z7E2 B7Z7M9 J3KRN0 Q15017 Q6IS16 Q9UJY3,ADP-ribosylation factor-binding protein GGA3 {ECO:0000305},Golgi-localized, gamma ear-containing, ARF-binding protein 3;, PF02883;PF03127;PF18308;PF00790;, GO:0031901;GO:0010008;GO:0005794;GO:0005764;GO:0032991;GO:0055038;GO:0005802;GO:0044877;GO:0031267;GO:0043130;GO:1990000;GO:0032456;GO:0043001;GO:0006886;GO:1902430;GO:0045732;GO:0031648;GO:0034394;GO:0006622;GO:0031647;, C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:lysosome; C:protein-containing complex; C:recycling endosome membrane; C:trans-Golgi network;, F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin binding;, P:amyloid fibril formation; P:endocytic recycling; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:negative regulation of amyloid-beta formation; P:positive regulation of protein catabolic process; P:protein destabilization; P:protein localization to cell surface; P:protein targeting to lysosome; P:regulation of protein stability;|Q9NZ52 B7Z7E2 B7Z7M9 J3KRN0 Q15017 Q6IS16 Q9UJY3,ADP-ribosylation factor-binding protein GGA3 {ECO:0000305},Golgi-localized, gamma ear-containing, ARF-binding protein 3;, PF02883;PF03127;PF18308;PF00790;, GO:0031901;GO:0010008;GO:0005794;GO:0005764;GO:0032991;GO:0055038;GO:0005802;GO:0044877;GO:0031267;GO:0043130;GO:1990000;GO:0032456;GO:0043001;GO:0006886;GO:1902430;GO:0045732;GO:0031648;GO:0034394;GO:0006622;GO:0031647;, C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:lysosome; C:protein-containing complex; C:recycling endosome membrane; C:trans-Golgi network;, F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin binding;, P:amyloid fibril formation; P:endocytic recycling; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:negative regulation of amyloid-beta formation; P:positive regulation of protein catabolic process; P:protein destabilization; P:protein localization to cell surface; P:protein targeting to lysosome; P:regulation of protein stability;|Q9NZ52 B7Z7E2 B7Z7M9 J3KRN0 Q15017 Q6IS16 Q9UJY3,ADP-ribosylation factor-binding protein GGA3 {ECO:0000305},Golgi-localized, gamma ear-containing, ARF-binding protein 3;, PF02883;PF03127;PF18308;PF00790;, GO:0031901;GO:0010008;GO:0005794;GO:0005764;GO:0032991;GO:0055038;GO:0005802;GO:0044877;GO:0031267;GO:0043130;GO:1990000;GO:0032456;GO:0043001;GO:0006886;GO:1902430;GO:0045732;GO:0031648;GO:0034394;GO:0006622;GO:0031647;, C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:lysosome; C:protein-containing complex; C:recycling endosome membrane; C:trans-Golgi network;, F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin binding;, P:amyloid fibril formation; P:endocytic recycling; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:negative regulation of amyloid-beta formation; P:positive regulation of protein catabolic process; P:protein destabilization; P:protein localization to cell surface; P:protein targeting to lysosome; P:regulation of protein stability;|Q9NZ52 B7Z7E2 B7Z7M9 J3KRN0 Q15017 Q6IS16 Q9UJY3,ADP-ribosylation factor-binding protein GGA3 {ECO:0000305},Golgi-localized, gamma ear-containing, ARF-binding protein 3;, PF02883;PF03127;PF18308;PF00790;, GO:0031901;GO:0010008;GO:0005794;GO:0005764;GO:0032991;GO:0055038;GO:0005802;GO:0044877;GO:0031267;GO:0043130;GO:1990000;GO:0032456;GO:0043001;GO:0006886;GO:1902430;GO:0045732;GO:0031648;GO:0034394;GO:0006622;GO:0031647;, C:early endosome membrane; C:endosome membrane; C:Golgi apparatus; C:lysosome; C:protein-containing complex; C:recycling endosome membrane; C:trans-Golgi network;, F:protein-containing complex binding; F:small GTPase binding; F:ubiquitin binding;, P:amyloid fibril formation; P:endocytic recycling; P:Golgi to plasma membrane protein transport; P:intracellular protein transport; P:negative regulation of amyloid-beta formation; P:positive regulation of protein catabolic process; P:protein destabilization; P:protein localization to cell surface; P:protein targeting to lysosome; P:regulation of protein stability;|Q9BW27 B4DMQ3 B4DPW1 Q8NDI4 Q9H9U1,Nuclear pore complex protein Nup85,85 kDa nucleoporin;FROUNT;Nucleoporin Nup75;Nucleoporin Nup85;Pericentrin-1;, PF07575;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0031080;GO:0005654;GO:0005819;GO:0017056;GO:0075733;GO:0030032;GO:0048246;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore outer ring; C:nucleoplasm; C:spindle;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:lamellipodium assembly; P:macrophage chemotaxis; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BW27 B4DMQ3 B4DPW1 Q8NDI4 Q9H9U1,Nuclear pore complex protein Nup85,85 kDa nucleoporin;FROUNT;Nucleoporin Nup75;Nucleoporin Nup85;Pericentrin-1;, PF07575;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0031080;GO:0005654;GO:0005819;GO:0017056;GO:0075733;GO:0030032;GO:0048246;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore outer ring; C:nucleoplasm; C:spindle;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:lamellipodium assembly; P:macrophage chemotaxis; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BW27 B4DMQ3 B4DPW1 Q8NDI4 Q9H9U1,Nuclear pore complex protein Nup85,85 kDa nucleoporin;FROUNT;Nucleoporin Nup75;Nucleoporin Nup85;Pericentrin-1;, PF07575;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0031080;GO:0005654;GO:0005819;GO:0017056;GO:0075733;GO:0030032;GO:0048246;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore outer ring; C:nucleoplasm; C:spindle;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:lamellipodium assembly; P:macrophage chemotaxis; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BW27 B4DMQ3 B4DPW1 Q8NDI4 Q9H9U1,Nuclear pore complex protein Nup85,85 kDa nucleoporin;FROUNT;Nucleoporin Nup75;Nucleoporin Nup85;Pericentrin-1;, PF07575;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0031080;GO:0005654;GO:0005819;GO:0017056;GO:0075733;GO:0030032;GO:0048246;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore outer ring; C:nucleoplasm; C:spindle;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:lamellipodium assembly; P:macrophage chemotaxis; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BW27 B4DMQ3 B4DPW1 Q8NDI4 Q9H9U1,Nuclear pore complex protein Nup85,85 kDa nucleoporin;FROUNT;Nucleoporin Nup75;Nucleoporin Nup85;Pericentrin-1;, PF07575;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0031080;GO:0005654;GO:0005819;GO:0017056;GO:0075733;GO:0030032;GO:0048246;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore outer ring; C:nucleoplasm; C:spindle;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:lamellipodium assembly; P:macrophage chemotaxis; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BW27 B4DMQ3 B4DPW1 Q8NDI4 Q9H9U1,Nuclear pore complex protein Nup85,85 kDa nucleoporin;FROUNT;Nucleoporin Nup75;Nucleoporin Nup85;Pericentrin-1;, PF07575;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0031080;GO:0005654;GO:0005819;GO:0017056;GO:0075733;GO:0030032;GO:0048246;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore outer ring; C:nucleoplasm; C:spindle;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:lamellipodium assembly; P:macrophage chemotaxis; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BW27 B4DMQ3 B4DPW1 Q8NDI4 Q9H9U1,Nuclear pore complex protein Nup85,85 kDa nucleoporin;FROUNT;Nucleoporin Nup75;Nucleoporin Nup85;Pericentrin-1;, PF07575;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0031080;GO:0005654;GO:0005819;GO:0017056;GO:0075733;GO:0030032;GO:0048246;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore outer ring; C:nucleoplasm; C:spindle;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:lamellipodium assembly; P:macrophage chemotaxis; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BW27 B4DMQ3 B4DPW1 Q8NDI4 Q9H9U1,Nuclear pore complex protein Nup85,85 kDa nucleoporin;FROUNT;Nucleoporin Nup75;Nucleoporin Nup85;Pericentrin-1;, PF07575;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0031080;GO:0005654;GO:0005819;GO:0017056;GO:0075733;GO:0030032;GO:0048246;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore outer ring; C:nucleoplasm; C:spindle;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:lamellipodium assembly; P:macrophage chemotaxis; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q9BW27 B4DMQ3 B4DPW1 Q8NDI4 Q9H9U1,Nuclear pore complex protein Nup85,85 kDa nucleoporin;FROUNT;Nucleoporin Nup75;Nucleoporin Nup85;Pericentrin-1;, PF07575;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0031080;GO:0005654;GO:0005819;GO:0017056;GO:0075733;GO:0030032;GO:0048246;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore outer ring; C:nucleoplasm; C:spindle;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:lamellipodium assembly; P:macrophage chemotaxis; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold129 indexed_genome mRNA 2385535 2392187 . + . ID=transcript_14002;P61956 B2R4I2 P55855 Q32Q42 Q6IPZ6 Q96HK1,Small ubiquitin-related modifier 2 {ECO:0000305},HSMT3 {ECO:0000303|PubMed:8630065};SMT3 homolog 2 {ECO:0000312|HGNC:HGNC:11125};SUMO-3 {ECO:0000303|PubMed:10692421};Sentrin-2 {ECO:0000303|PubMed:9556629};Ubiquitin-like protein SMT3B {ECO:0000305};, PF11976;, GO:0005654;GO:0005634;GO:0016605;GO:0031386;GO:0003723;GO:0031625;GO:0044389;GO:0032436;GO:0016925;, C:nucleoplasm; C:nucleus; C:PML body;, F:protein tag; F:RNA binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein sumoylation;|P61956 B2R4I2 P55855 Q32Q42 Q6IPZ6 Q96HK1,Small ubiquitin-related modifier 2 {ECO:0000305},HSMT3 {ECO:0000303|PubMed:8630065};SMT3 homolog 2 {ECO:0000312|HGNC:HGNC:11125};SUMO-3 {ECO:0000303|PubMed:10692421};Sentrin-2 {ECO:0000303|PubMed:9556629};Ubiquitin-like protein SMT3B {ECO:0000305};, PF11976;, GO:0005654;GO:0005634;GO:0016605;GO:0031386;GO:0003723;GO:0031625;GO:0044389;GO:0032436;GO:0016925;, C:nucleoplasm; C:nucleus; C:PML body;, F:protein tag; F:RNA binding; F:ubiquitin protein ligase binding; F:ubiquitin-like protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein sumoylation; scaffold129 indexed_genome mRNA 2399769 2414775 . + . ID=transcript_14003;Q9UK76 B2R6K3 Q53FG7 Q7Z2D2 Q7Z2F0,Jupiter microtubule associated homolog 1 {ECO:0000312|HGNC:HGNC:14569},Androgen-regulated protein 2;Hematological and neurological expressed 1 protein;, PF17054;, GO:0005737;GO:0031965;GO:0005730;GO:0005654;, C:cytoplasm; C:nuclear membrane; C:nucleolus; C:nucleoplasm; scaffold129 indexed_genome mRNA 2424778 2425658 . + . ID=transcript_14004;Q9H6L4 B4DVA4,Armadillo repeat-containing protein 7,, PF00514; scaffold129 indexed_genome mRNA 2440510 2455300 . - . ID=transcript_14005;O15375 B4E288,Monocarboxylate transporter 6,Monocarboxylate transporter 5;Solute carrier family 16 member 5;, PF07690;, GO:0016021;GO:0005887;GO:0016020;GO:0008028;GO:0015293;GO:0015718;, C:integral component of membrane; C:integral component of plasma membrane; C:membrane;, F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;, P:monocarboxylic acid transport; scaffold129 indexed_genome mRNA 2471673 2475562 . + . ID=transcript_14006;Q6PJ69 Q4G0F0 Q6DKJ6 Q9BRP6,Tripartite motif-containing protein 65,, PF00622;PF00643;PF00097;, GO:0005829;GO:0005654;GO:0008270;GO:0010508;, C:cytosol; C:nucleoplasm;, F:zinc ion binding;, P:positive regulation of autophagy; scaffold129 indexed_genome mRNA 2475793 2479356 . - . ID=transcript_14007;Q96LD4 Q96AD0 Q96GU5 Q9BRN7,E3 ubiquitin-protein ligase TRIM47 {ECO:0000305},Gene overexpressed in astrocytoma protein;RING finger protein 100;Tripartite motif-containing protein 47 {ECO:0000305};, PF00643;, GO:0005829;GO:0005634;GO:0004842;GO:0008270;GO:0016567;, C:cytosol; C:nucleus;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:protein ubiquitination; scaffold129 indexed_genome mRNA 2488856 2496300 . - . ID=transcript_14008;Q14681,BTB/POZ domain-containing protein KCTD2,Potassium channel tetramerization domain-containing protein 2;, PF02214;, GO:0031463;GO:0005737;GO:0097602;GO:0044877;GO:0043161;GO:0051260;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm;, F:cullin family protein binding; F:protein-containing complex binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization;|Q14681,BTB/POZ domain-containing protein KCTD2,Potassium channel tetramerization domain-containing protein 2;, PF02214;, GO:0031463;GO:0005737;GO:0097602;GO:0044877;GO:0043161;GO:0051260;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm;, F:cullin family protein binding; F:protein-containing complex binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; scaffold129 indexed_genome mRNA 2506475 2514348 . - . ID=transcript_14009;O75947 B2R5L6 Q9H3J4,ATP synthase subunit d, mitochondrial {ECO:0000305},ATP synthase peripheral stalk subunit d {ECO:0000305};, PF05873;, GO:0005743;GO:0005753;GO:0000274;GO:0005739;GO:0044877;GO:0015078;GO:0006754;GO:0015986;GO:1901653;GO:0042407;GO:0042776;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase, stator stalk; C:mitochondrion;, F:protein-containing complex binding; F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cellular response to peptide; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport;|O75947 B2R5L6 Q9H3J4,ATP synthase subunit d, mitochondrial {ECO:0000305},ATP synthase peripheral stalk subunit d {ECO:0000305};, PF05873;, GO:0005743;GO:0005753;GO:0000274;GO:0005739;GO:0044877;GO:0015078;GO:0006754;GO:0015986;GO:1901653;GO:0042407;GO:0042776;, C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase, stator stalk; C:mitochondrion;, F:protein-containing complex binding; F:proton transmembrane transporter activity;, P:ATP biosynthetic process; P:ATP synthesis coupled proton transport; P:cellular response to peptide; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; scaffold129 indexed_genome mRNA 2525147 2526078 . + . ID=transcript_14010;Q14197 B2RAD1 Q53HM7 Q53Y11,Peptidyl-tRNA hydrolase ICT1, mitochondrial,39S ribosomal protein L58, mitochondrial {ECO:0000312|HGNC:HGNC:5359};Digestion substraction 1;Immature colon carcinoma transcript 1 protein;Mitochondrial large ribosomal subunit protein mL62 {ECO:0000303|PubMed:27023846};, PF00472;, GO:0005743;GO:0005762;GO:0005759;GO:0005739;GO:0004045;GO:0016150;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial matrix; C:mitochondrion;, F:aminoacyl-tRNA hydrolase activity; F:translation release factor activity, codon nonspecific;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold129 indexed_genome mRNA 2529655 2531062 . + . ID=transcript_14011;Q14197 B2RAD1 Q53HM7 Q53Y11,Peptidyl-tRNA hydrolase ICT1, mitochondrial,39S ribosomal protein L58, mitochondrial {ECO:0000312|HGNC:HGNC:5359};Digestion substraction 1;Immature colon carcinoma transcript 1 protein;Mitochondrial large ribosomal subunit protein mL62 {ECO:0000303|PubMed:27023846};, PF00472;, GO:0005743;GO:0005762;GO:0005759;GO:0005739;GO:0004045;GO:0016150;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial matrix; C:mitochondrion;, F:aminoacyl-tRNA hydrolase activity; F:translation release factor activity, codon nonspecific;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold129 indexed_genome mRNA 2534230 2546192 . - . ID=transcript_14012;Q86X02 B4DFA7 Q15175,Cerebellar degeneration-related protein 2-like,Paraneoplastic 62 kDa antigen;, , GO:0042802;, , F:identical protein binding;|Q86X02 B4DFA7 Q15175,Cerebellar degeneration-related protein 2-like,Paraneoplastic 62 kDa antigen;, , GO:0042802;, , F:identical protein binding;|Q86X02 B4DFA7 Q15175,Cerebellar degeneration-related protein 2-like,Paraneoplastic 62 kDa antigen;, , GO:0042802;, , F:identical protein binding;|Q86X02 B4DFA7 Q15175,Cerebellar degeneration-related protein 2-like,Paraneoplastic 62 kDa antigen;, , GO:0042802;, , F:identical protein binding; scaffold129 indexed_genome mRNA 2556695 2576930 . + . ID=transcript_14013;Q8IV36 Q8N5L6 Q8TE83 Q9NT34,Protein HID1,Down-regulated in multiple cancers 1;HID1 domain-containing protein;Protein hid-1 homolog;, PF12722;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0090498;GO:0005794;GO:0005797;GO:0000138;GO:0016020;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi trans cisterna; C:membrane;|Q8IV36 Q8N5L6 Q8TE83 Q9NT34,Protein HID1,Down-regulated in multiple cancers 1;HID1 domain-containing protein;Protein hid-1 homolog;, PF12722;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0090498;GO:0005794;GO:0005797;GO:0000138;GO:0016020;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi trans cisterna; C:membrane;|Q8IV36 Q8N5L6 Q8TE83 Q9NT34,Protein HID1,Down-regulated in multiple cancers 1;HID1 domain-containing protein;Protein hid-1 homolog;, PF12722;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0090498;GO:0005794;GO:0005797;GO:0000138;GO:0016020;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi trans cisterna; C:membrane;|Q8IV36 Q8N5L6 Q8TE83 Q9NT34,Protein HID1,Down-regulated in multiple cancers 1;HID1 domain-containing protein;Protein hid-1 homolog;, PF12722;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0090498;GO:0005794;GO:0005797;GO:0000138;GO:0016020;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi trans cisterna; C:membrane;|Q8IV36 Q8N5L6 Q8TE83 Q9NT34,Protein HID1,Down-regulated in multiple cancers 1;HID1 domain-containing protein;Protein hid-1 homolog;, PF12722;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0090498;GO:0005794;GO:0005797;GO:0000138;GO:0016020;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi trans cisterna; C:membrane;|Q8IV36 Q8N5L6 Q8TE83 Q9NT34,Protein HID1,Down-regulated in multiple cancers 1;HID1 domain-containing protein;Protein hid-1 homolog;, PF12722;, GO:0005737;GO:0005881;GO:0005829;GO:0070062;GO:0090498;GO:0005794;GO:0005797;GO:0000138;GO:0016020;, C:cytoplasm; C:cytoplasmic microtubule; C:cytosol; C:extracellular exosome; C:extrinsic component of Golgi membrane; C:Golgi apparatus; C:Golgi medial cisterna; C:Golgi trans cisterna; C:membrane; scaffold129 indexed_genome mRNA 2601657 2608583 . + . ID=transcript_14014;Q495M9 Q8N251,Usher syndrome type-1G protein,Scaffold protein containing ankyrin repeats and SAM domain;, PF12796;PF00536;, GO:0015629;GO:0036064;GO:0005829;GO:0032391;GO:0001917;GO:0005886;GO:0042802;GO:0030507;GO:0050957;GO:0042472;GO:0060122;GO:0045494;GO:0050953;GO:0007605;, C:actin cytoskeleton; C:ciliary basal body; C:cytosol; C:photoreceptor connecting cilium; C:photoreceptor inner segment; C:plasma membrane;, F:identical protein binding; F:spectrin binding;, P:equilibrioception; P:inner ear morphogenesis; P:inner ear receptor cell stereocilium organization; P:photoreceptor cell maintenance; P:sensory perception of light stimulus; P:sensory perception of sound; scaffold129 indexed_genome mRNA 2624119 2656573 . + . ID=transcript_14015;Q8N9I5 Q17RQ7 Q6XYE1,Fatty acid desaturase 6,, PF00487;, GO:0016021;GO:0016491;GO:0006633;, C:integral component of membrane;, F:oxidoreductase activity;, P:fatty acid biosynthetic process;|Q8N9I5 Q17RQ7 Q6XYE1,Fatty acid desaturase 6,, PF00487;, GO:0016021;GO:0016491;GO:0006633;, C:integral component of membrane;, F:oxidoreductase activity;, P:fatty acid biosynthetic process; scaffold129 indexed_genome mRNA 2658431 2668859 . + . ID=transcript_14016;Q9BU12,NADPH:adrenodoxin oxidoreductase, mitochondrial,Ferredoxin--NADP(+) reductase;, PF07992;, GO:0005743;GO:0005759;GO:0005739;GO:0004324;GO:0015039;GO:0016491;GO:0006700;GO:0008203;GO:0006124;GO:0006091;GO:0006694;GO:0016125;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ferredoxin-NADP+ reductase activity; F:NADPH-adrenodoxin reductase activity; F:oxidoreductase activity;, P:C21-steroid hormone biosynthetic process; P:cholesterol metabolic process; P:ferredoxin metabolic process; P:generation of precursor metabolites and energy; P:steroid biosynthetic process; P:sterol metabolic process; P:ubiquinone biosynthetic process;|Q9BU12,NADPH:adrenodoxin oxidoreductase, mitochondrial,Ferredoxin--NADP(+) reductase;, PF07992;, GO:0005743;GO:0005759;GO:0005739;GO:0004324;GO:0015039;GO:0016491;GO:0006700;GO:0008203;GO:0006124;GO:0006091;GO:0006694;GO:0016125;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ferredoxin-NADP+ reductase activity; F:NADPH-adrenodoxin reductase activity; F:oxidoreductase activity;, P:C21-steroid hormone biosynthetic process; P:cholesterol metabolic process; P:ferredoxin metabolic process; P:generation of precursor metabolites and energy; P:steroid biosynthetic process; P:sterol metabolic process; P:ubiquinone biosynthetic process;|Q9BU12,NADPH:adrenodoxin oxidoreductase, mitochondrial,Ferredoxin--NADP(+) reductase;, PF07992;, GO:0005743;GO:0005759;GO:0005739;GO:0004324;GO:0015039;GO:0016491;GO:0006700;GO:0008203;GO:0006124;GO:0006091;GO:0006694;GO:0016125;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ferredoxin-NADP+ reductase activity; F:NADPH-adrenodoxin reductase activity; F:oxidoreductase activity;, P:C21-steroid hormone biosynthetic process; P:cholesterol metabolic process; P:ferredoxin metabolic process; P:generation of precursor metabolites and energy; P:steroid biosynthetic process; P:sterol metabolic process; P:ubiquinone biosynthetic process;|Q9BU12,NADPH:adrenodoxin oxidoreductase, mitochondrial,Ferredoxin--NADP(+) reductase;, PF07992;, GO:0005743;GO:0005759;GO:0005739;GO:0004324;GO:0015039;GO:0016491;GO:0006700;GO:0008203;GO:0006124;GO:0006091;GO:0006694;GO:0016125;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ferredoxin-NADP+ reductase activity; F:NADPH-adrenodoxin reductase activity; F:oxidoreductase activity;, P:C21-steroid hormone biosynthetic process; P:cholesterol metabolic process; P:ferredoxin metabolic process; P:generation of precursor metabolites and energy; P:steroid biosynthetic process; P:sterol metabolic process; P:ubiquinone biosynthetic process; scaffold129 indexed_genome mRNA 2669805 2683951 . + . ID=transcript_14017;Q14957 B2RTT1,Glutamate receptor ionotropic, NMDA 2C,Glutamate [NMDA] receptor subunit epsilon-3;N-methyl D-aspartate receptor subtype 2C;, PF01094;PF00060;PF10613;PF10565;, GO:0005789;GO:0098978;GO:0005887;GO:0017146;GO:0005886;GO:0098839;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:1904315;GO:0007420;GO:0097553;GO:0033058;GO:0098976;GO:0060079;GO:0007215;GO:0060291;GO:0042177;GO:0050885;GO:1903539;GO:0048167;GO:0009611;, C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density membrane;, F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:brain development; P:calcium ion transmembrane import into cytosol; P:directional locomotion; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:long-term synaptic potentiation; P:negative regulation of protein catabolic process; P:neuromuscular process controlling balance; P:protein localization to postsynaptic membrane; P:regulation of synaptic plasticity; P:response to wounding;|Q14957 B2RTT1,Glutamate receptor ionotropic, NMDA 2C,Glutamate [NMDA] receptor subunit epsilon-3;N-methyl D-aspartate receptor subtype 2C;, PF01094;PF00060;PF10613;PF10565;, GO:0005789;GO:0098978;GO:0005887;GO:0017146;GO:0005886;GO:0098839;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:1904315;GO:0007420;GO:0097553;GO:0033058;GO:0098976;GO:0060079;GO:0007215;GO:0060291;GO:0042177;GO:0050885;GO:1903539;GO:0048167;GO:0009611;, C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density membrane;, F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:brain development; P:calcium ion transmembrane import into cytosol; P:directional locomotion; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:long-term synaptic potentiation; P:negative regulation of protein catabolic process; P:neuromuscular process controlling balance; P:protein localization to postsynaptic membrane; P:regulation of synaptic plasticity; P:response to wounding;|Q14957 B2RTT1,Glutamate receptor ionotropic, NMDA 2C,Glutamate [NMDA] receptor subunit epsilon-3;N-methyl D-aspartate receptor subtype 2C;, PF01094;PF00060;PF10613;PF10565;, GO:0005789;GO:0098978;GO:0005887;GO:0017146;GO:0005886;GO:0098839;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:1904315;GO:0007420;GO:0097553;GO:0033058;GO:0098976;GO:0060079;GO:0007215;GO:0060291;GO:0042177;GO:0050885;GO:1903539;GO:0048167;GO:0009611;, C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density membrane;, F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:brain development; P:calcium ion transmembrane import into cytosol; P:directional locomotion; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:long-term synaptic potentiation; P:negative regulation of protein catabolic process; P:neuromuscular process controlling balance; P:protein localization to postsynaptic membrane; P:regulation of synaptic plasticity; P:response to wounding;|Q14957 B2RTT1,Glutamate receptor ionotropic, NMDA 2C,Glutamate [NMDA] receptor subunit epsilon-3;N-methyl D-aspartate receptor subtype 2C;, PF01094;PF00060;PF10613;PF10565;, GO:0005789;GO:0098978;GO:0005887;GO:0017146;GO:0005886;GO:0098839;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:1904315;GO:0007420;GO:0097553;GO:0033058;GO:0098976;GO:0060079;GO:0007215;GO:0060291;GO:0042177;GO:0050885;GO:1903539;GO:0048167;GO:0009611;, C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density membrane;, F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:brain development; P:calcium ion transmembrane import into cytosol; P:directional locomotion; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:long-term synaptic potentiation; P:negative regulation of protein catabolic process; P:neuromuscular process controlling balance; P:protein localization to postsynaptic membrane; P:regulation of synaptic plasticity; P:response to wounding;|Q14957 B2RTT1,Glutamate receptor ionotropic, NMDA 2C,Glutamate [NMDA] receptor subunit epsilon-3;N-methyl D-aspartate receptor subtype 2C;, PF01094;PF00060;PF10613;PF10565;, GO:0005789;GO:0098978;GO:0005887;GO:0017146;GO:0005886;GO:0098839;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:1904315;GO:0007420;GO:0097553;GO:0033058;GO:0098976;GO:0060079;GO:0007215;GO:0060291;GO:0042177;GO:0050885;GO:1903539;GO:0048167;GO:0009611;, C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density membrane;, F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:brain development; P:calcium ion transmembrane import into cytosol; P:directional locomotion; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:long-term synaptic potentiation; P:negative regulation of protein catabolic process; P:neuromuscular process controlling balance; P:protein localization to postsynaptic membrane; P:regulation of synaptic plasticity; P:response to wounding;|Q14957 B2RTT1,Glutamate receptor ionotropic, NMDA 2C,Glutamate [NMDA] receptor subunit epsilon-3;N-methyl D-aspartate receptor subtype 2C;, PF01094;PF00060;PF10613;PF10565;, GO:0005789;GO:0098978;GO:0005887;GO:0017146;GO:0005886;GO:0098839;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:1904315;GO:0007420;GO:0097553;GO:0033058;GO:0098976;GO:0060079;GO:0007215;GO:0060291;GO:0042177;GO:0050885;GO:1903539;GO:0048167;GO:0009611;, C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density membrane;, F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:brain development; P:calcium ion transmembrane import into cytosol; P:directional locomotion; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:long-term synaptic potentiation; P:negative regulation of protein catabolic process; P:neuromuscular process controlling balance; P:protein localization to postsynaptic membrane; P:regulation of synaptic plasticity; P:response to wounding; scaffold129 indexed_genome mRNA 2683989 2685510 . + . ID=transcript_14018;Q14957 B2RTT1,Glutamate receptor ionotropic, NMDA 2C,Glutamate [NMDA] receptor subunit epsilon-3;N-methyl D-aspartate receptor subtype 2C;, PF01094;PF00060;PF10613;PF10565;, GO:0005789;GO:0098978;GO:0005887;GO:0017146;GO:0005886;GO:0098839;GO:0022849;GO:0015276;GO:0004972;GO:0038023;GO:1904315;GO:0007420;GO:0097553;GO:0033058;GO:0098976;GO:0060079;GO:0007215;GO:0060291;GO:0042177;GO:0050885;GO:1903539;GO:0048167;GO:0009611;, C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of plasma membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density membrane;, F:glutamate-gated calcium ion channel activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:brain development; P:calcium ion transmembrane import into cytosol; P:directional locomotion; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:glutamate receptor signaling pathway; P:long-term synaptic potentiation; P:negative regulation of protein catabolic process; P:neuromuscular process controlling balance; P:protein localization to postsynaptic membrane; P:regulation of synaptic plasticity; P:response to wounding; scaffold129 indexed_genome mRNA 2690528 2742688 . - . ID=transcript_14019;Q8NE00 Q8TEU1 Q9NT56 Q9NXH1,Transmembrane protein 104,, PF01490;, GO:0016021;, C:integral component of membrane;|Q8NE00 Q8TEU1 Q9NT56 Q9NXH1,Transmembrane protein 104,, PF01490;, GO:0016021;, C:integral component of membrane;|Q8NE00 Q8TEU1 Q9NT56 Q9NXH1,Transmembrane protein 104,, PF01490;, GO:0016021;, C:integral component of membrane; scaffold129 indexed_genome mRNA 2753066 2775956 . + . ID=transcript_14020;Q9BTE0 B2R7F0 Q9BTD0 Q9Y3T3,N-acetyltransferase 9,Embryo brain-specific protein;, PF13302;, GO:0032991;GO:0008080;GO:0006473;, C:protein-containing complex;, F:N-acetyltransferase activity;, P:protein acetylation;|Q9BTE0 B2R7F0 Q9BTD0 Q9Y3T3,N-acetyltransferase 9,Embryo brain-specific protein;, PF13302;, GO:0032991;GO:0008080;GO:0006473;, C:protein-containing complex;, F:N-acetyltransferase activity;, P:protein acetylation;|O14745 B3KY21 O43552 Q86WQ5,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,Ezrin-radixin-moesin-binding phosphoprotein 50;Regulatory cofactor of Na(+)/H(+) exchanger;Sodium-hydrogen exchanger regulatory factor 1;Solute carrier family 9 isoform A3 regulatory factor 1;, PF09007;PF00595;PF17820;, GO:0015629;GO:0016324;GO:0031526;GO:0071944;GO:0005737;GO:0012505;GO:0070062;GO:0030175;GO:0016020;GO:0045121;GO:0005902;GO:0031528;GO:0048471;GO:0098797;GO:0001726;GO:0097225;GO:0032426;GO:0031982;GO:0031698;GO:0008013;GO:0017081;GO:0050780;GO:0015185;GO:0070851;GO:0045159;GO:0030165;GO:0019902;GO:0047485;GO:0043621;GO:0044877;GO:0043495;GO:0005102;GO:0031799;GO:0031800;GO:0030036;GO:0007191;GO:0060088;GO:0032782;GO:0030643;GO:0090660;GO:0044782;GO:0045198;GO:0051683;GO:0051939;GO:0022612;GO:0034635;GO:0098739;GO:0045199;GO:0030033;GO:0002009;GO:0090090;GO:0030336;GO:0008285;GO:0070373;GO:0045930;GO:0014067;GO:0010642;GO:0051898;GO:0032416;GO:0007097;GO:0060158;GO:0007009;GO:2001244;GO:0034767;GO:0072659;GO:0065003;GO:0008360;GO:0008361;GO:0044062;GO:0045859;GO:0032415;GO:0070293;GO:0097291;GO:0003096;GO:0007605;GO:0150104;GO:0016055;, C:actin cytoskeleton; C:apical plasma membrane; C:brush border membrane; C:cell periphery; C:cytoplasm; C:endomembrane system; C:extracellular exosome; C:filopodium; C:membrane; C:membrane raft; C:microvillus; C:microvillus membrane; C:perinuclear region of cytoplasm; C:plasma membrane protein complex; C:ruffle; C:sperm midpiece; C:stereocilium tip; C:vesicle;, F:beta-2 adrenergic receptor binding; F:beta-catenin binding; F:chloride channel regulator activity; F:dopamine receptor binding; F:gamma-aminobutyric acid transmembrane transporter activity; F:growth factor receptor binding; F:myosin II binding; F:PDZ domain binding; F:phosphatase binding; F:protein N-terminus binding; F:protein self-association; F:protein-containing complex binding; F:protein-membrane adaptor activity; F:signaling receptor binding; F:type 2 metabotropic glutamate receptor binding; F:type 3 metabotropic glutamate receptor binding;, P:actin cytoskeleton organization; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:auditory receptor cell stereocilium organization; P:bile acid secretion; P:cellular phosphate ion homeostasis; P:cerebrospinal fluid circulation; P:cilium organization; P:establishment of epithelial cell apical/basal polarity; P:establishment of Golgi localization; P:gamma-aminobutyric acid import; P:gland morphogenesis; P:glutathione transport; P:import across plasma membrane; P:maintenance of epithelial cell apical/basal polarity; P:microvillus assembly; P:morphogenesis of an epithelium; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of mitotic cell cycle; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of protein kinase B signaling; P:negative regulation of sodium:proton antiporter activity; P:nuclear migration; P:phospholipase C-activating dopamine receptor signaling pathway; P:plasma membrane organization; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of ion transmembrane transport; P:protein localization to plasma membrane; P:protein-containing complex assembly; P:regulation of cell shape; P:regulation of cell size; P:regulation of excretion; P:regulation of protein kinase activity; P:regulation of sodium:proton antiporter activity; P:renal absorption; P:renal phosphate ion absorption; P:renal sodium ion transport; P:sensory perception of sound; P:transport across blood-brain barrier; P:Wnt signaling pathway;|O14745 B3KY21 O43552 Q86WQ5,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,Ezrin-radixin-moesin-binding phosphoprotein 50;Regulatory cofactor of Na(+)/H(+) exchanger;Sodium-hydrogen exchanger regulatory factor 1;Solute carrier family 9 isoform A3 regulatory factor 1;, PF09007;PF00595;PF17820;, GO:0015629;GO:0016324;GO:0031526;GO:0071944;GO:0005737;GO:0012505;GO:0070062;GO:0030175;GO:0016020;GO:0045121;GO:0005902;GO:0031528;GO:0048471;GO:0098797;GO:0001726;GO:0097225;GO:0032426;GO:0031982;GO:0031698;GO:0008013;GO:0017081;GO:0050780;GO:0015185;GO:0070851;GO:0045159;GO:0030165;GO:0019902;GO:0047485;GO:0043621;GO:0044877;GO:0043495;GO:0005102;GO:0031799;GO:0031800;GO:0030036;GO:0007191;GO:0060088;GO:0032782;GO:0030643;GO:0090660;GO:0044782;GO:0045198;GO:0051683;GO:0051939;GO:0022612;GO:0034635;GO:0098739;GO:0045199;GO:0030033;GO:0002009;GO:0090090;GO:0030336;GO:0008285;GO:0070373;GO:0045930;GO:0014067;GO:0010642;GO:0051898;GO:0032416;GO:0007097;GO:0060158;GO:0007009;GO:2001244;GO:0034767;GO:0072659;GO:0065003;GO:0008360;GO:0008361;GO:0044062;GO:0045859;GO:0032415;GO:0070293;GO:0097291;GO:0003096;GO:0007605;GO:0150104;GO:0016055;, C:actin cytoskeleton; C:apical plasma membrane; C:brush border membrane; C:cell periphery; C:cytoplasm; C:endomembrane system; C:extracellular exosome; C:filopodium; C:membrane; C:membrane raft; C:microvillus; C:microvillus membrane; C:perinuclear region of cytoplasm; C:plasma membrane protein complex; C:ruffle; C:sperm midpiece; C:stereocilium tip; C:vesicle;, F:beta-2 adrenergic receptor binding; F:beta-catenin binding; F:chloride channel regulator activity; F:dopamine receptor binding; F:gamma-aminobutyric acid transmembrane transporter activity; F:growth factor receptor binding; F:myosin II binding; F:PDZ domain binding; F:phosphatase binding; F:protein N-terminus binding; F:protein self-association; F:protein-containing complex binding; F:protein-membrane adaptor activity; F:signaling receptor binding; F:type 2 metabotropic glutamate receptor binding; F:type 3 metabotropic glutamate receptor binding;, P:actin cytoskeleton organization; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:auditory receptor cell stereocilium organization; P:bile acid secretion; P:cellular phosphate ion homeostasis; P:cerebrospinal fluid circulation; P:cilium organization; P:establishment of epithelial cell apical/basal polarity; P:establishment of Golgi localization; P:gamma-aminobutyric acid import; P:gland morphogenesis; P:glutathione transport; P:import across plasma membrane; P:maintenance of epithelial cell apical/basal polarity; P:microvillus assembly; P:morphogenesis of an epithelium; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of mitotic cell cycle; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of protein kinase B signaling; P:negative regulation of sodium:proton antiporter activity; P:nuclear migration; P:phospholipase C-activating dopamine receptor signaling pathway; P:plasma membrane organization; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of ion transmembrane transport; P:protein localization to plasma membrane; P:protein-containing complex assembly; P:regulation of cell shape; P:regulation of cell size; P:regulation of excretion; P:regulation of protein kinase activity; P:regulation of sodium:proton antiporter activity; P:renal absorption; P:renal phosphate ion absorption; P:renal sodium ion transport; P:sensory perception of sound; P:transport across blood-brain barrier; P:Wnt signaling pathway;|O14745 B3KY21 O43552 Q86WQ5,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,Ezrin-radixin-moesin-binding phosphoprotein 50;Regulatory cofactor of Na(+)/H(+) exchanger;Sodium-hydrogen exchanger regulatory factor 1;Solute carrier family 9 isoform A3 regulatory factor 1;, PF09007;PF00595;PF17820;, GO:0015629;GO:0016324;GO:0031526;GO:0071944;GO:0005737;GO:0012505;GO:0070062;GO:0030175;GO:0016020;GO:0045121;GO:0005902;GO:0031528;GO:0048471;GO:0098797;GO:0001726;GO:0097225;GO:0032426;GO:0031982;GO:0031698;GO:0008013;GO:0017081;GO:0050780;GO:0015185;GO:0070851;GO:0045159;GO:0030165;GO:0019902;GO:0047485;GO:0043621;GO:0044877;GO:0043495;GO:0005102;GO:0031799;GO:0031800;GO:0030036;GO:0007191;GO:0060088;GO:0032782;GO:0030643;GO:0090660;GO:0044782;GO:0045198;GO:0051683;GO:0051939;GO:0022612;GO:0034635;GO:0098739;GO:0045199;GO:0030033;GO:0002009;GO:0090090;GO:0030336;GO:0008285;GO:0070373;GO:0045930;GO:0014067;GO:0010642;GO:0051898;GO:0032416;GO:0007097;GO:0060158;GO:0007009;GO:2001244;GO:0034767;GO:0072659;GO:0065003;GO:0008360;GO:0008361;GO:0044062;GO:0045859;GO:0032415;GO:0070293;GO:0097291;GO:0003096;GO:0007605;GO:0150104;GO:0016055;, C:actin cytoskeleton; C:apical plasma membrane; C:brush border membrane; C:cell periphery; C:cytoplasm; C:endomembrane system; C:extracellular exosome; C:filopodium; C:membrane; C:membrane raft; C:microvillus; C:microvillus membrane; C:perinuclear region of cytoplasm; C:plasma membrane protein complex; C:ruffle; C:sperm midpiece; C:stereocilium tip; C:vesicle;, F:beta-2 adrenergic receptor binding; F:beta-catenin binding; F:chloride channel regulator activity; F:dopamine receptor binding; F:gamma-aminobutyric acid transmembrane transporter activity; F:growth factor receptor binding; F:myosin II binding; F:PDZ domain binding; F:phosphatase binding; F:protein N-terminus binding; F:protein self-association; F:protein-containing complex binding; F:protein-membrane adaptor activity; F:signaling receptor binding; F:type 2 metabotropic glutamate receptor binding; F:type 3 metabotropic glutamate receptor binding;, P:actin cytoskeleton organization; P:adenylate cyclase-activating dopamine receptor signaling pathway; P:auditory receptor cell stereocilium organization; P:bile acid secretion; P:cellular phosphate ion homeostasis; P:cerebrospinal fluid circulation; P:cilium organization; P:establishment of epithelial cell apical/basal polarity; P:establishment of Golgi localization; P:gamma-aminobutyric acid import; P:gland morphogenesis; P:glutathione transport; P:import across plasma membrane; P:maintenance of epithelial cell apical/basal polarity; P:microvillus assembly; P:morphogenesis of an epithelium; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of mitotic cell cycle; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of protein kinase B signaling; P:negative regulation of sodium:proton antiporter activity; P:nuclear migration; P:phospholipase C-activating dopamine receptor signaling pathway; P:plasma membrane organization; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of ion transmembrane transport; P:protein localization to plasma membrane; P:protein-containing complex assembly; P:regulation of cell shape; P:regulation of cell size; P:regulation of excretion; P:regulation of protein kinase activity; P:regulation of sodium:proton antiporter activity; P:renal absorption; P:renal phosphate ion absorption; P:renal sodium ion transport; P:sensory perception of sound; P:transport across blood-brain barrier; P:Wnt signaling pathway; scaffold129 indexed_genome mRNA 2777014 2780649 . - . ID=transcript_14021;Q96AX2 A8MXF5 A8MYT0 Q8IWA7,Ras-related protein Rab-37,, PF00071;, GO:0035577;GO:0005793;GO:0005768;GO:0005794;GO:0005886;GO:0035579;GO:0005525;GO:0003924;GO:0043312;GO:0015031;, C:azurophil granule membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome; C:Golgi apparatus; C:plasma membrane; C:specific granule membrane;, F:GTP binding; F:GTPase activity;, P:neutrophil degranulation; P:protein transport;|Q96AX2 A8MXF5 A8MYT0 Q8IWA7,Ras-related protein Rab-37,, PF00071;, GO:0035577;GO:0005793;GO:0005768;GO:0005794;GO:0005886;GO:0035579;GO:0005525;GO:0003924;GO:0043312;GO:0015031;, C:azurophil granule membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome; C:Golgi apparatus; C:plasma membrane; C:specific granule membrane;, F:GTP binding; F:GTPase activity;, P:neutrophil degranulation; P:protein transport; scaffold129 indexed_genome mRNA 2784515 2785736 . + . ID=transcript_14022;Q96AX2 A8MXF5 A8MYT0 Q8IWA7,Ras-related protein Rab-37,, PF00071;, GO:0035577;GO:0005793;GO:0005768;GO:0005794;GO:0005886;GO:0035579;GO:0005525;GO:0003924;GO:0043312;GO:0015031;, C:azurophil granule membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome; C:Golgi apparatus; C:plasma membrane; C:specific granule membrane;, F:GTP binding; F:GTPase activity;, P:neutrophil degranulation; P:protein transport; scaffold129 indexed_genome mRNA 2793153 2845384 . - . ID=transcript_14023;Q9ULW5 B2RAA6 Q3L6K5 Q6NXS7,Ras-related protein Rab-26,, PF00071;, GO:0098993;GO:0005768;GO:0005794;GO:0000139;GO:0031226;GO:0030667;GO:0019002;GO:0005525;GO:0003924;GO:0035272;GO:0043001;GO:0045055;GO:0017157;GO:0099575;, C:anchored component of synaptic vesicle membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:intrinsic component of plasma membrane; C:secretory granule membrane;, F:GMP binding; F:GTP binding; F:GTPase activity;, P:exocrine system development; P:Golgi to plasma membrane protein transport; P:regulated exocytosis; P:regulation of exocytosis; P:regulation of protein catabolic process at presynapse, modulating synaptic transmission;|Q6UXZ3,CMRF35-like molecule 5 {ECO:0000250|UniProtKB:Q8VCH2},CD300 antigen-like family member D;CMRF35-A4;, PF07686;, GO:0016021;GO:0005886;GO:0004888;GO:0002376;GO:0050776;, C:integral component of membrane; C:plasma membrane;, F:transmembrane signaling receptor activity;, P:immune system process; P:regulation of immune response;|Q8NAF5,CMRF35-like molecule 1,CD300 antigen-like family member F;Immune receptor expressed on myeloid cells 1;Immunoglobulin superfamily member 13;NK inhibitory receptor;, PF07686;, GO:0016021;GO:0005886;GO:0097001;GO:0005136;GO:0001786;GO:0004888;GO:0002376;GO:0035772;GO:2000426;GO:0033004;GO:0034125;GO:2000427;GO:1902216;GO:0050776;GO:0035666;, C:integral component of membrane; C:plasma membrane;, F:ceramide binding; F:interleukin-4 receptor binding; F:phosphatidylserine binding; F:transmembrane signaling receptor activity;, P:immune system process; P:interleukin-13-mediated signaling pathway; P:negative regulation of apoptotic cell clearance; P:negative regulation of mast cell activation; P:negative regulation of MyD88-dependent toll-like receptor signaling pathway; P:positive regulation of apoptotic cell clearance; P:positive regulation of interleukin-4-mediated signaling pathway; P:regulation of immune response; P:TRIF-dependent toll-like receptor signaling pathway; scaffold129 indexed_genome mRNA 2878228 2880313 . + . ID=transcript_14024;Q496F6 B4DNS1 Q7Z7I3,CMRF35-like molecule 2,CD300 antigen-like family member E;CMRF35-A5;Immune receptor expressed on myeloid cells 2;Polymeric immunoglobulin receptor 2;, PF07686;, GO:0016021;GO:0005886;GO:0004888;GO:0045087;GO:0050776;, C:integral component of membrane; C:plasma membrane;, F:transmembrane signaling receptor activity;, P:innate immune response; P:regulation of immune response; scaffold130 indexed_genome mRNA 1384525 1393370 . + . ID=transcript_14025;Q8IW52 Q5JXG3 Q8TCM8 Q96DL3,SLIT and NTRK-like protein 4,, PF13855;, GO:0098978;GO:0016021;GO:0005886;GO:0007409;GO:1905606;GO:0050807;, C:glutamatergic synapse; C:integral component of membrane; C:plasma membrane;, , P:axonogenesis; P:regulation of presynapse assembly; P:regulation of synapse organization; scaffold131 indexed_genome mRNA 1011 3319 . + . ID=transcript_14026;O00168 A8K196,Phospholemman {ECO:0000250|UniProtKB:P56513},FXYD domain-containing ion transport regulator 1 {ECO:0000312|HGNC:HGNC:4025};Sodium/potassium-transporting ATPase subunit FXYD1 {ECO:0000305};, PF02038;, GO:0016324;GO:0005901;GO:0005887;GO:0014704;GO:0005886;GO:0042383;GO:0005890;GO:0030315;GO:0005254;GO:0044325;GO:0099106;GO:0017080;GO:0006821;GO:0034220;GO:0006936;GO:0010734;GO:1903278;GO:0006813;GO:1903779;GO:0086036;GO:0008016;GO:2000649;GO:0006814;, C:apical plasma membrane; C:caveola; C:integral component of plasma membrane; C:intercalated disc; C:plasma membrane; C:sarcolemma; C:sodium:potassium-exchanging ATPase complex; C:T-tubule;, F:chloride channel activity; F:ion channel binding; F:ion channel regulator activity; F:sodium channel regulator activity;, P:chloride transport; P:ion transmembrane transport; P:muscle contraction; P:negative regulation of protein glutathionylation; P:positive regulation of sodium ion export across plasma membrane; P:potassium ion transport; P:regulation of cardiac conduction; P:regulation of cardiac muscle cell membrane potential; P:regulation of heart contraction; P:regulation of sodium ion transmembrane transporter activity; P:sodium ion transport; scaffold131 indexed_genome mRNA 7987 12323 . + . ID=transcript_14027;P58549,FXYD domain-containing ion transport regulator 7,, PF02038;, GO:0016021;GO:0005886;GO:0099106;GO:0017080;GO:0034220;GO:1903779;GO:2000649;, C:integral component of membrane; C:plasma membrane;, F:ion channel regulator activity; F:sodium channel regulator activity;, P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; scaffold131 indexed_genome mRNA 12810 14623 . + . ID=transcript_14028;Q96DB9 B7WNZ8 Q6UW44 Q9HC34 Q9P039,FXYD domain-containing ion transport regulator 5,Dysadherin;, PF02038;, GO:0016021;GO:0003779;GO:0045296;GO:0099106;GO:0017080;GO:0006811;GO:0030033;GO:0046588;GO:2000649;, C:integral component of membrane;, F:actin binding; F:cadherin binding; F:ion channel regulator activity; F:sodium channel regulator activity;, P:ion transport; P:microvillus assembly; P:negative regulation of calcium-dependent cell-cell adhesion; P:regulation of sodium ion transmembrane transporter activity; scaffold131 indexed_genome mRNA 19512 91558 . - . ID=transcript_14029;Q9UQL3,Lipolysis-stimulated lipoprotein receptor,, PF05624;, GO:0042627;GO:0070062;GO:0016021;GO:0034362;GO:0005886;GO:0061689;GO:0034361;GO:0060856;GO:0061436;GO:0001889;GO:0035633;GO:0061833;GO:0019216;GO:1904274;, C:chylomicron; C:extracellular exosome; C:integral component of membrane; C:low-density lipoprotein particle; C:plasma membrane; C:tricellular tight junction; C:very-low-density lipoprotein particle;, , P:establishment of blood-brain barrier; P:establishment of skin barrier; P:liver development; P:maintenance of blood-brain barrier; P:protein localization to tricellular tight junction; P:regulation of lipid metabolic process; P:tricellular tight junction assembly;|Q96DB9 B7WNZ8 Q6UW44 Q9HC34 Q9P039,FXYD domain-containing ion transport regulator 5,Dysadherin;, PF02038;, GO:0016021;GO:0003779;GO:0045296;GO:0099106;GO:0017080;GO:0006811;GO:0030033;GO:0046588;GO:2000649;, C:integral component of membrane;, F:actin binding; F:cadherin binding; F:ion channel regulator activity; F:sodium channel regulator activity;, P:ion transport; P:microvillus assembly; P:negative regulation of calcium-dependent cell-cell adhesion; P:regulation of sodium ion transmembrane transporter activity;|Q17R55 Q8N7G6,Protein FAM187B,Transmembrane protein 162;, , GO:0016021;, C:integral component of membrane;|Q9UQL3,Lipolysis-stimulated lipoprotein receptor,, PF05624;, GO:0042627;GO:0070062;GO:0016021;GO:0034362;GO:0005886;GO:0061689;GO:0034361;GO:0060856;GO:0061436;GO:0001889;GO:0035633;GO:0061833;GO:0019216;GO:1904274;, C:chylomicron; C:extracellular exosome; C:integral component of membrane; C:low-density lipoprotein particle; C:plasma membrane; C:tricellular tight junction; C:very-low-density lipoprotein particle;, , P:establishment of blood-brain barrier; P:establishment of skin barrier; P:liver development; P:maintenance of blood-brain barrier; P:protein localization to tricellular tight junction; P:regulation of lipid metabolic process; P:tricellular tight junction assembly; scaffold131 indexed_genome mRNA 105792 106462 . + . ID=transcript_14030;Q9UQL3,Lipolysis-stimulated lipoprotein receptor,, PF05624;, GO:0042627;GO:0070062;GO:0016021;GO:0034362;GO:0005886;GO:0061689;GO:0034361;GO:0060856;GO:0061436;GO:0001889;GO:0035633;GO:0061833;GO:0019216;GO:1904274;, C:chylomicron; C:extracellular exosome; C:integral component of membrane; C:low-density lipoprotein particle; C:plasma membrane; C:tricellular tight junction; C:very-low-density lipoprotein particle;, , P:establishment of blood-brain barrier; P:establishment of skin barrier; P:liver development; P:maintenance of blood-brain barrier; P:protein localization to tricellular tight junction; P:regulation of lipid metabolic process; P:tricellular tight junction assembly; scaffold131 indexed_genome mRNA 107961 120740 . + . ID=transcript_14031;Q9UQL3,Lipolysis-stimulated lipoprotein receptor,, PF05624;, GO:0042627;GO:0070062;GO:0016021;GO:0034362;GO:0005886;GO:0061689;GO:0034361;GO:0060856;GO:0061436;GO:0001889;GO:0035633;GO:0061833;GO:0019216;GO:1904274;, C:chylomicron; C:extracellular exosome; C:integral component of membrane; C:low-density lipoprotein particle; C:plasma membrane; C:tricellular tight junction; C:very-low-density lipoprotein particle;, , P:establishment of blood-brain barrier; P:establishment of skin barrier; P:liver development; P:maintenance of blood-brain barrier; P:protein localization to tricellular tight junction; P:regulation of lipid metabolic process; P:tricellular tight junction assembly;|Q9UQL3,Lipolysis-stimulated lipoprotein receptor,, PF05624;, GO:0042627;GO:0070062;GO:0016021;GO:0034362;GO:0005886;GO:0061689;GO:0034361;GO:0060856;GO:0061436;GO:0001889;GO:0035633;GO:0061833;GO:0019216;GO:1904274;, C:chylomicron; C:extracellular exosome; C:integral component of membrane; C:low-density lipoprotein particle; C:plasma membrane; C:tricellular tight junction; C:very-low-density lipoprotein particle;, , P:establishment of blood-brain barrier; P:establishment of skin barrier; P:liver development; P:maintenance of blood-brain barrier; P:protein localization to tricellular tight junction; P:regulation of lipid metabolic process; P:tricellular tight junction assembly;|Q9UQL3,Lipolysis-stimulated lipoprotein receptor,, PF05624;, GO:0042627;GO:0070062;GO:0016021;GO:0034362;GO:0005886;GO:0061689;GO:0034361;GO:0060856;GO:0061436;GO:0001889;GO:0035633;GO:0061833;GO:0019216;GO:1904274;, C:chylomicron; C:extracellular exosome; C:integral component of membrane; C:low-density lipoprotein particle; C:plasma membrane; C:tricellular tight junction; C:very-low-density lipoprotein particle;, , P:establishment of blood-brain barrier; P:establishment of skin barrier; P:liver development; P:maintenance of blood-brain barrier; P:protein localization to tricellular tight junction; P:regulation of lipid metabolic process; P:tricellular tight junction assembly;|Q9UQL3,Lipolysis-stimulated lipoprotein receptor,, PF05624;, GO:0042627;GO:0070062;GO:0016021;GO:0034362;GO:0005886;GO:0061689;GO:0034361;GO:0060856;GO:0061436;GO:0001889;GO:0035633;GO:0061833;GO:0019216;GO:1904274;, C:chylomicron; C:extracellular exosome; C:integral component of membrane; C:low-density lipoprotein particle; C:plasma membrane; C:tricellular tight junction; C:very-low-density lipoprotein particle;, , P:establishment of blood-brain barrier; P:establishment of skin barrier; P:liver development; P:maintenance of blood-brain barrier; P:protein localization to tricellular tight junction; P:regulation of lipid metabolic process; P:tricellular tight junction assembly; scaffold131 indexed_genome mRNA 122903 130324 . + . ID=transcript_14032;Q15853 O00671 O00709 Q05750 Q07952 Q15851 Q15852 Q6FI33 Q6YI47,Upstream stimulatory factor 2,Class B basic helix-loop-helix protein 12;FOS-interacting protein;Major late transcription factor 2;Upstream transcription factor 2;, PF00010;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0043425;GO:0003700;GO:0000981;GO:0046982;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0019086;GO:0055088;GO:0045944;GO:0000432;GO:0006357;GO:0000430;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:late viral transcription; P:lipid homeostasis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter by glucose; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter by glucose; scaffold131 indexed_genome mRNA 134251 134815 . - . ID=transcript_14033;P81172 Q1HE14 Q9BY68,Hepcidin {ECO:0000305},Liver-expressed antimicrobial peptide 1;Putative liver tumor regressor;, PF06446;, GO:0045179;GO:0005576;GO:0005615;GO:0014704;GO:0005634;GO:0005507;GO:0005179;GO:0097690;GO:0005102;GO:0006953;GO:0007568;GO:0061844;GO:0006879;GO:1903413;GO:0071354;GO:0071222;GO:0071356;GO:0071481;GO:0042742;GO:0050832;GO:0050829;GO:0050830;GO:0006955;GO:0031640;GO:0097421;GO:0060586;GO:0002262;GO:0045779;GO:0050728;GO:1904479;GO:0032413;GO:1904039;GO:0034760;GO:1904255;GO:0000122;GO:0061051;GO:1903364;GO:0043032;GO:1902916;GO:2000646;GO:0002092;GO:0045944;GO:0007259;GO:0036017;GO:0045471;GO:0010039;GO:1990641;GO:0033189;GO:0010043;, C:apical cortex; C:extracellular region; C:extracellular space; C:intercalated disc; C:nucleus;, F:copper ion binding; F:hormone activity; F:iron ion transmembrane transporter inhibitor activity; F:signaling receptor binding;, P:acute-phase response; P:aging; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cellular iron ion homeostasis; P:cellular response to bile acid; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:cellular response to X-ray; P:defense response to bacterium; P:defense response to fungus; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:immune response; P:killing of cells of other organism; P:liver regeneration; P:multicellular organismal iron ion homeostasis; P:myeloid cell homeostasis; P:negative regulation of bone resorption; P:negative regulation of inflammatory response; P:negative regulation of intestinal absorption; P:negative regulation of ion transmembrane transporter activity; P:negative regulation of iron export across plasma membrane; P:negative regulation of iron ion transmembrane transport; P:negative regulation of iron ion transmembrane transporter activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of cellular protein catabolic process; P:positive regulation of macrophage activation; P:positive regulation of protein polyubiquitination; P:positive regulation of receptor catabolic process; P:positive regulation of receptor internalization; P:positive regulation of transcription by RNA polymerase II; P:receptor signaling pathway via JAK-STAT; P:response to erythropoietin; P:response to ethanol; P:response to iron ion; P:response to iron ion starvation; P:response to vitamin A; P:response to zinc ion; scaffold131 indexed_genome mRNA 143697 144526 . + . ID=transcript_14034;P20916 B7Z2E5 F5GYC0 Q15489 Q567S4,Myelin-associated glycoprotein,Siglec-4a;, PF08205;, GO:0043218;GO:0005737;GO:0005887;GO:0045121;GO:0097453;GO:0043209;GO:0035749;GO:0033270;GO:0005886;GO:0043220;GO:0030246;GO:1905576;GO:0042803;GO:0019901;GO:0033691;GO:0005102;GO:0031103;GO:0007155;GO:0098742;GO:0071260;GO:0022010;GO:0050900;GO:0030517;GO:0050771;GO:0043524;GO:0045665;GO:0010977;GO:0048711;GO:0031643;GO:0021762;GO:0019226;, C:compact myelin; C:cytoplasm; C:integral component of plasma membrane; C:membrane raft; C:mesaxon; C:myelin sheath; C:myelin sheath adaxonal region; C:paranode region of axon; C:plasma membrane; C:Schmidt-Lanterman incisure;, F:carbohydrate binding; F:ganglioside GT1b binding; F:protein homodimerization activity; F:protein kinase binding; F:sialic acid binding; F:signaling receptor binding;, P:axon regeneration; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cellular response to mechanical stimulus; P:central nervous system myelination; P:leukocyte migration; P:negative regulation of axon extension; P:negative regulation of axonogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron differentiation; P:negative regulation of neuron projection development; P:positive regulation of astrocyte differentiation; P:positive regulation of myelination; P:substantia nigra development; P:transmission of nerve impulse; scaffold131 indexed_genome mRNA 155197 157626 . + . ID=transcript_14035;P20916 B7Z2E5 F5GYC0 Q15489 Q567S4,Myelin-associated glycoprotein,Siglec-4a;, PF08205;, GO:0043218;GO:0005737;GO:0005887;GO:0045121;GO:0097453;GO:0043209;GO:0035749;GO:0033270;GO:0005886;GO:0043220;GO:0030246;GO:1905576;GO:0042803;GO:0019901;GO:0033691;GO:0005102;GO:0031103;GO:0007155;GO:0098742;GO:0071260;GO:0022010;GO:0050900;GO:0030517;GO:0050771;GO:0043524;GO:0045665;GO:0010977;GO:0048711;GO:0031643;GO:0021762;GO:0019226;, C:compact myelin; C:cytoplasm; C:integral component of plasma membrane; C:membrane raft; C:mesaxon; C:myelin sheath; C:myelin sheath adaxonal region; C:paranode region of axon; C:plasma membrane; C:Schmidt-Lanterman incisure;, F:carbohydrate binding; F:ganglioside GT1b binding; F:protein homodimerization activity; F:protein kinase binding; F:sialic acid binding; F:signaling receptor binding;, P:axon regeneration; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cellular response to mechanical stimulus; P:central nervous system myelination; P:leukocyte migration; P:negative regulation of axon extension; P:negative regulation of axonogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron differentiation; P:negative regulation of neuron projection development; P:positive regulation of astrocyte differentiation; P:positive regulation of myelination; P:substantia nigra development; P:transmission of nerve impulse;|P20916 B7Z2E5 F5GYC0 Q15489 Q567S4,Myelin-associated glycoprotein,Siglec-4a;, PF08205;, GO:0043218;GO:0005737;GO:0005887;GO:0045121;GO:0097453;GO:0043209;GO:0035749;GO:0033270;GO:0005886;GO:0043220;GO:0030246;GO:1905576;GO:0042803;GO:0019901;GO:0033691;GO:0005102;GO:0031103;GO:0007155;GO:0098742;GO:0071260;GO:0022010;GO:0050900;GO:0030517;GO:0050771;GO:0043524;GO:0045665;GO:0010977;GO:0048711;GO:0031643;GO:0021762;GO:0019226;, C:compact myelin; C:cytoplasm; C:integral component of plasma membrane; C:membrane raft; C:mesaxon; C:myelin sheath; C:myelin sheath adaxonal region; C:paranode region of axon; C:plasma membrane; C:Schmidt-Lanterman incisure;, F:carbohydrate binding; F:ganglioside GT1b binding; F:protein homodimerization activity; F:protein kinase binding; F:sialic acid binding; F:signaling receptor binding;, P:axon regeneration; P:cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cellular response to mechanical stimulus; P:central nervous system myelination; P:leukocyte migration; P:negative regulation of axon extension; P:negative regulation of axonogenesis; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron differentiation; P:negative regulation of neuron projection development; P:positive regulation of astrocyte differentiation; P:positive regulation of myelination; P:substantia nigra development; P:transmission of nerve impulse; scaffold131 indexed_genome mRNA 173035 186520 . + . ID=transcript_14036;Q92872 Q92873 Q9UQA6 Q9UQA7 Q9UQA8 Q9UQA9 Q9UQB0 Q9Y2A6,B-cell receptor CD22,B-lymphocyte cell adhesion molecule;Sialic acid-binding Ig-like lectin 2;T-cell surface antigen Leu-14;, PF08205;PF13895;, GO:0009986;GO:0005737;GO:0005769;GO:0009897;GO:0070062;GO:0016021;GO:0005887;GO:0032809;GO:0005886;GO:0055037;GO:0030246;GO:0042609;GO:0001791;GO:0019903;GO:0033691;GO:0005102;GO:0042113;GO:0007155;GO:0050859;GO:0050849;GO:0002638;GO:0030888;GO:0030100;GO:0050776;, C:cell surface; C:cytoplasm; C:early endosome; C:external side of plasma membrane; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:neuronal cell body membrane; C:plasma membrane; C:recycling endosome;, F:carbohydrate binding; F:CD4 receptor binding; F:IgM binding; F:protein phosphatase binding; F:sialic acid binding; F:signaling receptor binding;, P:B cell activation; P:cell adhesion; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of calcium-mediated signaling; P:negative regulation of immunoglobulin production; P:regulation of B cell proliferation; P:regulation of endocytosis; P:regulation of immune response;|Q92872 Q92873 Q9UQA6 Q9UQA7 Q9UQA8 Q9UQA9 Q9UQB0 Q9Y2A6,B-cell receptor CD22,B-lymphocyte cell adhesion molecule;Sialic acid-binding Ig-like lectin 2;T-cell surface antigen Leu-14;, PF08205;PF13895;, GO:0009986;GO:0005737;GO:0005769;GO:0009897;GO:0070062;GO:0016021;GO:0005887;GO:0032809;GO:0005886;GO:0055037;GO:0030246;GO:0042609;GO:0001791;GO:0019903;GO:0033691;GO:0005102;GO:0042113;GO:0007155;GO:0050859;GO:0050849;GO:0002638;GO:0030888;GO:0030100;GO:0050776;, C:cell surface; C:cytoplasm; C:early endosome; C:external side of plasma membrane; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:neuronal cell body membrane; C:plasma membrane; C:recycling endosome;, F:carbohydrate binding; F:CD4 receptor binding; F:IgM binding; F:protein phosphatase binding; F:sialic acid binding; F:signaling receptor binding;, P:B cell activation; P:cell adhesion; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of calcium-mediated signaling; P:negative regulation of immunoglobulin production; P:regulation of B cell proliferation; P:regulation of endocytosis; P:regulation of immune response; scaffold131 indexed_genome mRNA 196637 197370 . - . ID=transcript_14037;O14843 B2RWM8 Q14CM7,Free fatty acid receptor 3,G-protein coupled receptor 41;, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0008289;GO:0007193;GO:0071398;GO:0007186;GO:0006954;GO:0002385;GO:0045776;GO:0002879;GO:0032722;GO:0002720;GO:0046885;GO:0046626;GO:0014061;GO:0090276;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:lipid binding;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cellular response to fatty acid; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:mucosal immune response; P:negative regulation of blood pressure; P:positive regulation of acute inflammatory response to non-antigenic stimulus; P:positive regulation of chemokine production; P:positive regulation of cytokine production involved in immune response; P:regulation of hormone biosynthetic process; P:regulation of insulin receptor signaling pathway; P:regulation of norepinephrine secretion; P:regulation of peptide hormone secretion; scaffold131 indexed_genome mRNA 302062 311831 . - . ID=transcript_14038;Q96EW8 Q9BSY6,Dermokine,Epidermis-specific secreted protein SK30/SK89;, , GO:0005615;GO:1903575;, C:extracellular space;, , P:cornified envelope assembly; scaffold131 indexed_genome mRNA 322830 345368 . - . ID=transcript_14039;O14556 B2RC82 O60823 Q6JTT9 Q9HCU6,Glyceraldehyde-3-phosphate dehydrogenase, testis-specific,Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2;Spermatogenic glyceraldehyde-3-phosphate dehydrogenase;, PF02800;PF00044;, GO:0005829;GO:0005634;GO:0004365;GO:0051287;GO:0050661;GO:0061621;GO:0030317;GO:0006094;GO:0006096;GO:0045821;, C:cytosol; C:nucleus;, F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; F:NAD binding; F:NADP binding;, P:canonical glycolysis; P:flagellated sperm motility; P:gluconeogenesis; P:glycolytic process; P:positive regulation of glycolytic process;|Q9BVK8 A8MWW0 O75790,Transmembrane protein 147,Protein NIFIE 14;, PF09767;, GO:0005789;GO:0016021;GO:0005886;GO:0032991;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex;|Q9BVK8 A8MWW0 O75790,Transmembrane protein 147,Protein NIFIE 14;, PF09767;, GO:0005789;GO:0016021;GO:0005886;GO:0032991;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:protein-containing complex; scaffold131 indexed_genome mRNA 347951 362213 . - . ID=transcript_14040;P20648 O00738,Potassium-transporting ATPase alpha chain 1,Gastric H(+)/K(+) ATPase subunit alpha;Proton pump;, PF00689;PF00690;PF09040;, GO:0005615;GO:0005887;GO:0005886;GO:0005524;GO:0000287;GO:0005391;GO:0008900;GO:0030007;GO:0006883;GO:0034220;GO:1990573;GO:1902600;GO:0036376;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:P-type sodium:potassium-exchanging ATPase activity; F:potassium:proton exchanging ATPase activity;, P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:sodium ion export across plasma membrane;|P20648 O00738,Potassium-transporting ATPase alpha chain 1,Gastric H(+)/K(+) ATPase subunit alpha;Proton pump;, PF00689;PF00690;PF09040;, GO:0005615;GO:0005887;GO:0005886;GO:0005524;GO:0000287;GO:0005391;GO:0008900;GO:0030007;GO:0006883;GO:0034220;GO:1990573;GO:1902600;GO:0036376;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:P-type sodium:potassium-exchanging ATPase activity; F:potassium:proton exchanging ATPase activity;, P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:sodium ion export across plasma membrane;|P20648 O00738,Potassium-transporting ATPase alpha chain 1,Gastric H(+)/K(+) ATPase subunit alpha;Proton pump;, PF00689;PF00690;PF09040;, GO:0005615;GO:0005887;GO:0005886;GO:0005524;GO:0000287;GO:0005391;GO:0008900;GO:0030007;GO:0006883;GO:0034220;GO:1990573;GO:1902600;GO:0036376;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:ATP binding; F:magnesium ion binding; F:P-type sodium:potassium-exchanging ATPase activity; F:potassium:proton exchanging ATPase activity;, P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:sodium ion export across plasma membrane; scaffold131 indexed_genome mRNA 491805 502632 . + . ID=transcript_14041;O94927 B2RXK1 Q6P2P7 Q7L3D5 Q96CT8,HAUS augmin-like complex subunit 5,, PF14817;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|O94927 B2RXK1 Q6P2P7 Q7L3D5 Q96CT8,HAUS augmin-like complex subunit 5,, PF14817;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|O94927 B2RXK1 Q6P2P7 Q7L3D5 Q96CT8,HAUS augmin-like complex subunit 5,, PF14817;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|O94927 B2RXK1 Q6P2P7 Q7L3D5 Q96CT8,HAUS augmin-like complex subunit 5,, PF14817;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold131 indexed_genome mRNA 508150 515563 . + . ID=transcript_14042;Q9BTD8 O00320 Q8N5R7 Q9BU66,RNA-binding protein 42,RNA-binding motif protein 42;, PF00076;, GO:0005737;GO:0005634;GO:1990904;GO:0003723;GO:0048025;, C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:RNA binding;, P:negative regulation of mRNA splicing, via spliceosome; scaffold131 indexed_genome mRNA 520354 521662 . + . ID=transcript_14043;O00321 A6NFN5 B3KUL0 B9EIN1 Q9UEA0,ETS translocation variant 2,Ets-related protein 71;, PF00178;, GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0001824;GO:0048514;GO:0060803;GO:0030154;GO:0030218;GO:0007219;GO:0001890;GO:0045603;GO:2000382;GO:0006357;GO:0016055;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:blastocyst development; P:blood vessel morphogenesis; P:BMP signaling pathway involved in mesodermal cell fate specification; P:cell differentiation; P:erythrocyte differentiation; P:Notch signaling pathway; P:placenta development; P:positive regulation of endothelial cell differentiation; P:positive regulation of mesoderm development; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway; scaffold131 indexed_genome mRNA 528501 535520 . + . ID=transcript_14044;P14854 B2R5C9 Q6IBL4,Cytochrome c oxidase subunit 6B1,Cytochrome c oxidase subunit VIb isoform 1;, PF02297;, GO:0005743;GO:0005739;GO:0045277;GO:0004129;GO:0006123;GO:0021762;, C:mitochondrial inner membrane; C:mitochondrion; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity;, P:mitochondrial electron transport, cytochrome c to oxygen; P:substantia nigra development;|P14854 B2R5C9 Q6IBL4,Cytochrome c oxidase subunit 6B1,Cytochrome c oxidase subunit VIb isoform 1;, PF02297;, GO:0005743;GO:0005739;GO:0045277;GO:0004129;GO:0006123;GO:0021762;, C:mitochondrial inner membrane; C:mitochondrion; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity;, P:mitochondrial electron transport, cytochrome c to oxygen; P:substantia nigra development; scaffold131 indexed_genome mRNA 579941 580810 . + . ID=transcript_14045;Q9Y2Y4 Q8WVP2,Zinc finger and BTB domain-containing protein 32,FANCC-interacting protein;Fanconi anemia zinc finger protein;Testis zinc finger protein;Zinc finger protein 538;, PF00651;PF00096;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0008270;GO:0000122;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 581887 607726 . - . ID=transcript_14046;Q9UMN6 O15022 O95836 Q96GP2 Q96IP3 Q9UK25 Q9Y668 Q9Y669,Histone-lysine N-methyltransferase 2B,Myeloid/lymphoid or mixed-lineage leukemia protein 4;Trithorax homolog 2;WW domain-binding protein 7;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0035097;GO:0005654;GO:0005634;GO:0042800;GO:0045322;GO:0008270;GO:0044648;GO:0051568;GO:0097692;GO:0045893;GO:0045652;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q9UMN6 O15022 O95836 Q96GP2 Q96IP3 Q9UK25 Q9Y668 Q9Y669,Histone-lysine N-methyltransferase 2B,Myeloid/lymphoid or mixed-lineage leukemia protein 4;Trithorax homolog 2;WW domain-binding protein 7;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0035097;GO:0005654;GO:0005634;GO:0042800;GO:0045322;GO:0008270;GO:0044648;GO:0051568;GO:0097692;GO:0045893;GO:0045652;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q9UMN6 O15022 O95836 Q96GP2 Q96IP3 Q9UK25 Q9Y668 Q9Y669,Histone-lysine N-methyltransferase 2B,Myeloid/lymphoid or mixed-lineage leukemia protein 4;Trithorax homolog 2;WW domain-binding protein 7;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0035097;GO:0005654;GO:0005634;GO:0042800;GO:0045322;GO:0008270;GO:0044648;GO:0051568;GO:0097692;GO:0045893;GO:0045652;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q9UMN6 O15022 O95836 Q96GP2 Q96IP3 Q9UK25 Q9Y668 Q9Y669,Histone-lysine N-methyltransferase 2B,Myeloid/lymphoid or mixed-lineage leukemia protein 4;Trithorax homolog 2;WW domain-binding protein 7;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0035097;GO:0005654;GO:0005634;GO:0042800;GO:0045322;GO:0008270;GO:0044648;GO:0051568;GO:0097692;GO:0045893;GO:0045652;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q9UMN6 O15022 O95836 Q96GP2 Q96IP3 Q9UK25 Q9Y668 Q9Y669,Histone-lysine N-methyltransferase 2B,Myeloid/lymphoid or mixed-lineage leukemia protein 4;Trithorax homolog 2;WW domain-binding protein 7;, PF05965;PF05964;PF00628;PF00856;PF02008;, GO:0035097;GO:0005654;GO:0005634;GO:0042800;GO:0045322;GO:0008270;GO:0044648;GO:0051568;GO:0097692;GO:0045893;GO:0045652;, C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:histone methyltransferase activity (H3-K4 specific); F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 dimethylation; P:histone H3-K4 methylation; P:histone H3-K4 monomethylation; P:positive regulation of transcription, DNA-templated; P:regulation of megakaryocyte differentiation;|Q9H665 Q8N5X0,IGF-like family receptor 1,Transmembrane protein 149;U2 small nuclear RNA auxiliary factor 1-like 4;, , GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q8WU68 A6NKI8 Q56UU3,Splicing factor U2AF 26 kDa subunit,U2 auxiliary factor 26;U2 small nuclear RNA auxiliary factor 1-like protein 4;U2(RNU2) small nuclear RNA auxiliary factor 1-like protein 3;, PF00076;PF00642;, GO:0005737;GO:0016607;GO:0005654;GO:0005681;GO:0089701;GO:0046872;GO:0030628;GO:0031124;GO:0006406;GO:0000398;GO:0006405;, C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:spliceosomal complex; C:U2AF complex;, F:metal ion binding; F:pre-mRNA 3'-splice site binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; scaffold131 indexed_genome mRNA 607966 609258 . + . ID=transcript_14047;Q9NZ42 B2R5L9,Gamma-secretase subunit PEN-2,Presenilin enhancer protein 2;, PF10251;, GO:0005783;GO:0005789;GO:0010008;GO:0070765;GO:0005794;GO:0032580;GO:0016021;GO:0005887;GO:0005886;GO:0061133;GO:0019899;GO:1990000;GO:0042987;GO:0042982;GO:0034205;GO:0048013;GO:0006509;GO:0031293;GO:0007220;GO:0035333;GO:0043065;GO:0043085;GO:0010950;GO:0016485;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:gamma-secretase complex; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:endopeptidase activator activity; F:enzyme binding;, P:amyloid fibril formation; P:amyloid precursor protein catabolic process; P:amyloid precursor protein metabolic process; P:amyloid-beta formation; P:ephrin receptor signaling pathway; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:Notch receptor processing; P:Notch receptor processing, ligand-dependent; P:positive regulation of apoptotic process; P:positive regulation of catalytic activity; P:positive regulation of endopeptidase activity; P:protein processing; scaffold131 indexed_genome mRNA 612015 614087 . - . ID=transcript_14048;Q96GY3 A8KAQ1 O14557 Q7Z2T9,Protein lin-37 homolog,Antolefinin;, PF15306;, GO:0031523;GO:0005654;GO:0017053;GO:0000122;GO:0051726;, C:Myb complex; C:nucleoplasm; C:transcription repressor complex;, , P:negative regulation of transcription by RNA polymerase II; P:regulation of cell cycle; scaffold131 indexed_genome mRNA 614665 617453 . - . ID=transcript_14049;O14558 O14551 Q6NVI3 Q96MG9,Heat shock protein beta-6,Heat shock 20 kDa-like protein p20;, PF00525;PF00011;, GO:0005737;GO:0005829;GO:0005576;GO:0005794;GO:0005730;GO:0005634;GO:0051087;GO:0042803;GO:0005212;GO:0051082;GO:0061077;GO:0010667;GO:0045766;GO:0006937;, C:cytoplasm; C:cytosol; C:extracellular region; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:chaperone binding; F:protein homodimerization activity; F:structural constituent of eye lens; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cardiac muscle cell apoptotic process; P:positive regulation of angiogenesis; P:regulation of muscle contraction;|O14558 O14551 Q6NVI3 Q96MG9,Heat shock protein beta-6,Heat shock 20 kDa-like protein p20;, PF00525;PF00011;, GO:0005737;GO:0005829;GO:0005576;GO:0005794;GO:0005730;GO:0005634;GO:0051087;GO:0042803;GO:0005212;GO:0051082;GO:0061077;GO:0010667;GO:0045766;GO:0006937;, C:cytoplasm; C:cytosol; C:extracellular region; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:chaperone binding; F:protein homodimerization activity; F:structural constituent of eye lens; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cardiac muscle cell apoptotic process; P:positive regulation of angiogenesis; P:regulation of muscle contraction;|O14558 O14551 Q6NVI3 Q96MG9,Heat shock protein beta-6,Heat shock 20 kDa-like protein p20;, PF00525;PF00011;, GO:0005737;GO:0005829;GO:0005576;GO:0005794;GO:0005730;GO:0005634;GO:0051087;GO:0042803;GO:0005212;GO:0051082;GO:0061077;GO:0010667;GO:0045766;GO:0006937;, C:cytoplasm; C:cytosol; C:extracellular region; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:chaperone binding; F:protein homodimerization activity; F:structural constituent of eye lens; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cardiac muscle cell apoptotic process; P:positive regulation of angiogenesis; P:regulation of muscle contraction; scaffold131 indexed_genome mRNA 617993 629873 . + . ID=transcript_14050;Q2NL68 Q8NDI3 Q8WWC8 Q96NL4,Proline and serine-rich protein 3|Q2NL68 Q8NDI3 Q8WWC8 Q96NL4,Proline and serine-rich protein 3|Q2NL68 Q8NDI3 Q8WWC8 Q96NL4,Proline and serine-rich protein 3|Q2NL68 Q8NDI3 Q8WWC8 Q96NL4,Proline and serine-rich protein 3 scaffold131 indexed_genome mRNA 637013 648675 . + . ID=transcript_14051;O14559 O14552 O14560 Q6ZSP6 Q96CP3 Q9NT23,Rho GTPase-activating protein 33,Rho-type GTPase-activating protein 33;Sorting nexin-26;Tc10/CDC42 GTPase-activating protein;, PF00620;PF14604;, GO:0005737;GO:0005829;GO:0043197;GO:0005886;GO:0032991;GO:0005096;GO:0035091;GO:0019901;GO:0015031;GO:0061001;GO:0051056;GO:0009636;GO:0007264;, C:cytoplasm; C:cytosol; C:dendritic spine; C:plasma membrane; C:protein-containing complex;, F:GTPase activator activity; F:phosphatidylinositol binding; F:protein kinase binding;, P:protein transport; P:regulation of dendritic spine morphogenesis; P:regulation of small GTPase mediated signal transduction; P:response to toxic substance; P:small GTPase mediated signal transduction;|O14559 O14552 O14560 Q6ZSP6 Q96CP3 Q9NT23,Rho GTPase-activating protein 33,Rho-type GTPase-activating protein 33;Sorting nexin-26;Tc10/CDC42 GTPase-activating protein;, PF00620;PF14604;, GO:0005737;GO:0005829;GO:0043197;GO:0005886;GO:0032991;GO:0005096;GO:0035091;GO:0019901;GO:0015031;GO:0061001;GO:0051056;GO:0009636;GO:0007264;, C:cytoplasm; C:cytosol; C:dendritic spine; C:plasma membrane; C:protein-containing complex;, F:GTPase activator activity; F:phosphatidylinositol binding; F:protein kinase binding;, P:protein transport; P:regulation of dendritic spine morphogenesis; P:regulation of small GTPase mediated signal transduction; P:response to toxic substance; P:small GTPase mediated signal transduction;|O14559 O14552 O14560 Q6ZSP6 Q96CP3 Q9NT23,Rho GTPase-activating protein 33,Rho-type GTPase-activating protein 33;Sorting nexin-26;Tc10/CDC42 GTPase-activating protein;, PF00620;PF14604;, GO:0005737;GO:0005829;GO:0043197;GO:0005886;GO:0032991;GO:0005096;GO:0035091;GO:0019901;GO:0015031;GO:0061001;GO:0051056;GO:0009636;GO:0007264;, C:cytoplasm; C:cytosol; C:dendritic spine; C:plasma membrane; C:protein-containing complex;, F:GTPase activator activity; F:phosphatidylinositol binding; F:protein kinase binding;, P:protein transport; P:regulation of dendritic spine morphogenesis; P:regulation of small GTPase mediated signal transduction; P:response to toxic substance; P:small GTPase mediated signal transduction;|O14559 O14552 O14560 Q6ZSP6 Q96CP3 Q9NT23,Rho GTPase-activating protein 33,Rho-type GTPase-activating protein 33;Sorting nexin-26;Tc10/CDC42 GTPase-activating protein;, PF00620;PF14604;, GO:0005737;GO:0005829;GO:0043197;GO:0005886;GO:0032991;GO:0005096;GO:0035091;GO:0019901;GO:0015031;GO:0061001;GO:0051056;GO:0009636;GO:0007264;, C:cytoplasm; C:cytosol; C:dendritic spine; C:plasma membrane; C:protein-containing complex;, F:GTPase activator activity; F:phosphatidylinositol binding; F:protein kinase binding;, P:protein transport; P:regulation of dendritic spine morphogenesis; P:regulation of small GTPase mediated signal transduction; P:response to toxic substance; P:small GTPase mediated signal transduction;|O14559 O14552 O14560 Q6ZSP6 Q96CP3 Q9NT23,Rho GTPase-activating protein 33,Rho-type GTPase-activating protein 33;Sorting nexin-26;Tc10/CDC42 GTPase-activating protein;, PF00620;PF14604;, GO:0005737;GO:0005829;GO:0043197;GO:0005886;GO:0032991;GO:0005096;GO:0035091;GO:0019901;GO:0015031;GO:0061001;GO:0051056;GO:0009636;GO:0007264;, C:cytoplasm; C:cytosol; C:dendritic spine; C:plasma membrane; C:protein-containing complex;, F:GTPase activator activity; F:phosphatidylinositol binding; F:protein kinase binding;, P:protein transport; P:regulation of dendritic spine morphogenesis; P:regulation of small GTPase mediated signal transduction; P:response to toxic substance; P:small GTPase mediated signal transduction;|O14559 O14552 O14560 Q6ZSP6 Q96CP3 Q9NT23,Rho GTPase-activating protein 33,Rho-type GTPase-activating protein 33;Sorting nexin-26;Tc10/CDC42 GTPase-activating protein;, PF00620;PF14604;, GO:0005737;GO:0005829;GO:0043197;GO:0005886;GO:0032991;GO:0005096;GO:0035091;GO:0019901;GO:0015031;GO:0061001;GO:0051056;GO:0009636;GO:0007264;, C:cytoplasm; C:cytosol; C:dendritic spine; C:plasma membrane; C:protein-containing complex;, F:GTPase activator activity; F:phosphatidylinositol binding; F:protein kinase binding;, P:protein transport; P:regulation of dendritic spine morphogenesis; P:regulation of small GTPase mediated signal transduction; P:response to toxic substance; P:small GTPase mediated signal transduction; scaffold131 indexed_genome mRNA 657080 673076 . - . ID=transcript_14052;Q9UF12,Hydroxyproline dehydrogenase {ECO:0000303|PubMed:25697095},Kidney and liver proline oxidase 1;Probable proline dehydrogenase 2 {ECO:0000312|HGNC:HGNC:17325};Probable proline oxidase 2;, PF01619;, GO:0005743;GO:0005739;GO:0071949;GO:0016645;GO:0004657;GO:0046487;GO:0006562;GO:0010133;, C:mitochondrial inner membrane; C:mitochondrion;, F:FAD binding; F:oxidoreductase activity, acting on the CH-NH group of donors; F:proline dehydrogenase activity;, P:glyoxylate metabolic process; P:proline catabolic process; P:proline catabolic process to glutamate; scaffold131 indexed_genome mRNA 680459 684404 . - . ID=transcript_14053;O60500 A6NDH2 C3RX61,Nephrin,Renal glomerulus-specific cell adhesion receptor;, PF08205;PF00041;PF07679;, GO:0042995;GO:0005911;GO:0070062;GO:0005925;GO:0005887;GO:0005886;GO:0036057;GO:0050839;GO:0017022;GO:0007155;GO:0098609;GO:0007588;GO:0032836;GO:0072015;GO:0007254;GO:0007520;GO:0030838;GO:0035418;GO:0044062;GO:0007519;, C:cell projection; C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:slit diaphragm;, F:cell adhesion molecule binding; F:myosin binding;, P:cell adhesion; P:cell-cell adhesion; P:excretion; P:glomerular basement membrane development; P:glomerular visceral epithelial cell development; P:JNK cascade; P:myoblast fusion; P:positive regulation of actin filament polymerization; P:protein localization to synapse; P:regulation of excretion; P:skeletal muscle tissue development; scaffold131 indexed_genome mRNA 718935 728520 . + . ID=transcript_14054;P51693 O00113 Q96A92,Amyloid-like protein 1,, PF10515;PF12924;PF12925;PF02177;, GO:0005604;GO:0005794;GO:0016021;GO:0005654;GO:0048471;GO:0005886;GO:0031694;GO:0031695;GO:0031696;GO:0008201;GO:0042802;GO:0046914;GO:0009887;GO:0006915;GO:0007155;GO:0071874;GO:0006897;GO:0030198;GO:0030900;GO:0106072;GO:0007399;, C:basement membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:alpha-2A adrenergic receptor binding; F:alpha-2B adrenergic receptor binding; F:alpha-2C adrenergic receptor binding; F:heparin binding; F:identical protein binding; F:transition metal ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:cell adhesion; P:cellular response to norepinephrine stimulus; P:endocytosis; P:extracellular matrix organization; P:forebrain development; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:nervous system development;|P51693 O00113 Q96A92,Amyloid-like protein 1,, PF10515;PF12924;PF12925;PF02177;, GO:0005604;GO:0005794;GO:0016021;GO:0005654;GO:0048471;GO:0005886;GO:0031694;GO:0031695;GO:0031696;GO:0008201;GO:0042802;GO:0046914;GO:0009887;GO:0006915;GO:0007155;GO:0071874;GO:0006897;GO:0030198;GO:0030900;GO:0106072;GO:0007399;, C:basement membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:alpha-2A adrenergic receptor binding; F:alpha-2B adrenergic receptor binding; F:alpha-2C adrenergic receptor binding; F:heparin binding; F:identical protein binding; F:transition metal ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:cell adhesion; P:cellular response to norepinephrine stimulus; P:endocytosis; P:extracellular matrix organization; P:forebrain development; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:nervous system development;|P51693 O00113 Q96A92,Amyloid-like protein 1,, PF10515;PF12924;PF12925;PF02177;, GO:0005604;GO:0005794;GO:0016021;GO:0005654;GO:0048471;GO:0005886;GO:0031694;GO:0031695;GO:0031696;GO:0008201;GO:0042802;GO:0046914;GO:0009887;GO:0006915;GO:0007155;GO:0071874;GO:0006897;GO:0030198;GO:0030900;GO:0106072;GO:0007399;, C:basement membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:alpha-2A adrenergic receptor binding; F:alpha-2B adrenergic receptor binding; F:alpha-2C adrenergic receptor binding; F:heparin binding; F:identical protein binding; F:transition metal ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:cell adhesion; P:cellular response to norepinephrine stimulus; P:endocytosis; P:extracellular matrix organization; P:forebrain development; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:nervous system development;|P51693 O00113 Q96A92,Amyloid-like protein 1,, PF10515;PF12924;PF12925;PF02177;, GO:0005604;GO:0005794;GO:0016021;GO:0005654;GO:0048471;GO:0005886;GO:0031694;GO:0031695;GO:0031696;GO:0008201;GO:0042802;GO:0046914;GO:0009887;GO:0006915;GO:0007155;GO:0071874;GO:0006897;GO:0030198;GO:0030900;GO:0106072;GO:0007399;, C:basement membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:alpha-2A adrenergic receptor binding; F:alpha-2B adrenergic receptor binding; F:alpha-2C adrenergic receptor binding; F:heparin binding; F:identical protein binding; F:transition metal ion binding;, P:animal organ morphogenesis; P:apoptotic process; P:cell adhesion; P:cellular response to norepinephrine stimulus; P:endocytosis; P:extracellular matrix organization; P:forebrain development; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:nervous system development; scaffold131 indexed_genome mRNA 732143 739164 . - . ID=transcript_14055;Q8NI38 Q8NI39 Q9BRG9,NF-kappa-B inhibitor delta,I-kappa-B-delta;IkappaBNS;T-cell activation NFKB-like protein;TA-NFKBH;, PF00023;PF12796;, GO:0005634;GO:0006954;GO:2000321;GO:0010468;GO:0050852;, C:nucleus;, , P:inflammatory response; P:positive regulation of T-helper 17 cell differentiation; P:regulation of gene expression; P:T cell receptor signaling pathway; scaffold131 indexed_genome mRNA 740246 742680 . + . ID=transcript_14056;Q9UBK5 Q9UBS1 Q9Y3Y0,Hematopoietic cell signal transducer,DNAX-activation protein 10;Membrane protein DAP10;Transmembrane adapter protein KAP10;, PF07213;, GO:0009986;GO:0016021;GO:0005886;GO:0043548;GO:0005102;GO:0014068;GO:0006468;GO:0050776;, C:cell surface; C:integral component of membrane; C:plasma membrane;, F:phosphatidylinositol 3-kinase binding; F:signaling receptor binding;, P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein phosphorylation; P:regulation of immune response; scaffold131 indexed_genome mRNA 771220 827509 . + . ID=transcript_14057;A6NFY7 B2RPM7,Succinate dehydrogenase assembly factor 1, mitochondrial {ECO:0000303|PubMed:19465911},LYR motif-containing protein 8;, PF05347;, GO:0005759;GO:0005739;GO:0034553;, C:mitochondrial matrix; C:mitochondrion;, , P:mitochondrial respiratory chain complex II assembly; scaffold131 indexed_genome mRNA 830431 835611 . + . ID=transcript_14058;Q8N205 A8MRS0 A8MYE3 Q7Z7L3,Nesprin-4,KASH domain-containing protein 4;Nuclear envelope spectrin repeat protein 4;, PF10541;, GO:0031309;GO:0034993;GO:0045198;, C:integral component of nuclear outer membrane; C:meiotic nuclear membrane microtubule tethering complex;, , P:establishment of epithelial cell apical/basal polarity; scaffold131 indexed_genome mRNA 835696 841458 . - . ID=transcript_14059;Q3KRA9 A5LGM8 A6NLP1 A8MU96,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6,Alkylated DNA repair protein alkB homolog 6;, PF13532;, GO:0005737;GO:0005925;GO:0005654;GO:0051213;GO:0046872;, C:cytoplasm; C:focal adhesion; C:nucleoplasm;, F:dioxygenase activity; F:metal ion binding;|Q3KRA9 A5LGM8 A6NLP1 A8MU96,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6,Alkylated DNA repair protein alkB homolog 6;, PF13532;, GO:0005737;GO:0005925;GO:0005654;GO:0051213;GO:0046872;, C:cytoplasm; C:focal adhesion; C:nucleoplasm;, F:dioxygenase activity; F:metal ion binding;|Q3KRA9 A5LGM8 A6NLP1 A8MU96,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6,Alkylated DNA repair protein alkB homolog 6;, PF13532;, GO:0005737;GO:0005925;GO:0005654;GO:0051213;GO:0046872;, C:cytoplasm; C:focal adhesion; C:nucleoplasm;, F:dioxygenase activity; F:metal ion binding;|Q3KRA9 A5LGM8 A6NLP1 A8MU96,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6,Alkylated DNA repair protein alkB homolog 6;, PF13532;, GO:0005737;GO:0005925;GO:0005654;GO:0051213;GO:0046872;, C:cytoplasm; C:focal adhesion; C:nucleoplasm;, F:dioxygenase activity; F:metal ion binding;|Q3KRA9 A5LGM8 A6NLP1 A8MU96,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6,Alkylated DNA repair protein alkB homolog 6;, PF13532;, GO:0005737;GO:0005925;GO:0005654;GO:0051213;GO:0046872;, C:cytoplasm; C:focal adhesion; C:nucleoplasm;, F:dioxygenase activity; F:metal ion binding;|Q3KRA9 A5LGM8 A6NLP1 A8MU96,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6,Alkylated DNA repair protein alkB homolog 6;, PF13532;, GO:0005737;GO:0005925;GO:0005654;GO:0051213;GO:0046872;, C:cytoplasm; C:focal adhesion; C:nucleoplasm;, F:dioxygenase activity; F:metal ion binding; scaffold131 indexed_genome mRNA 841894 855278 . - . ID=transcript_14060;Q96DZ5 A8K0E4 Q8WWL1 Q96C99 Q9UFT7,CAP-Gly domain-containing linker protein 3,Cytoplasmic linker protein 170-related 59 kDa protein;, PF12796;PF01302;, GO:0005737;GO:0005829;GO:0031901;GO:0005795;GO:0045121;GO:0035371;GO:0005634;GO:0005886;GO:0055038;GO:0005802;GO:0032588;GO:0035594;GO:0008017;GO:0051010;GO:0072321;GO:0031122;GO:0045444;GO:0044091;GO:0031115;GO:0018230;GO:0043065;GO:0045807;GO:0010828;GO:1903078;GO:0001934;GO:0010803;, C:cytoplasm; C:cytosol; C:early endosome membrane; C:Golgi stack; C:membrane raft; C:microtubule plus-end; C:nucleus; C:plasma membrane; C:recycling endosome membrane; C:trans-Golgi network; C:trans-Golgi network membrane;, F:ganglioside binding; F:microtubule binding; F:microtubule plus-end binding;, P:chaperone-mediated protein transport; P:cytoplasmic microtubule organization; P:fat cell differentiation; P:membrane biogenesis; P:negative regulation of microtubule polymerization; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of apoptotic process; P:positive regulation of endocytosis; P:positive regulation of glucose transmembrane transport; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:regulation of tumor necrosis factor-mediated signaling pathway; scaffold131 indexed_genome mRNA 856781 872875 . - . ID=transcript_14061;Q8NA92 Q0P5Z7 Q96M21,THAP domain-containing protein 8,, PF05485;, GO:0003677;GO:0046872;, , F:DNA binding; F:metal ion binding; scaffold131 indexed_genome mRNA 884887 889633 . + . ID=transcript_14062;O43379 Q63HP9 Q659D7 Q8NBF7 Q96AD9,WD repeat-containing protein 62,, PF12894;PF00400;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0000922;GO:0007099;GO:0021987;GO:0007052;GO:0022008;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:spindle pole;, , P:centriole replication; P:cerebral cortex development; P:mitotic spindle organization; P:neurogenesis; scaffold131 indexed_genome mRNA 895445 915715 . + . ID=transcript_14063;O43379 Q63HP9 Q659D7 Q8NBF7 Q96AD9,WD repeat-containing protein 62,, PF12894;PF00400;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0000922;GO:0007099;GO:0021987;GO:0007052;GO:0022008;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:spindle pole;, , P:centriole replication; P:cerebral cortex development; P:mitotic spindle organization; P:neurogenesis;|O43379 Q63HP9 Q659D7 Q8NBF7 Q96AD9,WD repeat-containing protein 62,, PF12894;PF00400;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0000922;GO:0007099;GO:0021987;GO:0007052;GO:0022008;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:spindle pole;, , P:centriole replication; P:cerebral cortex development; P:mitotic spindle organization; P:neurogenesis; scaffold131 indexed_genome mRNA 917754 920171 . + . ID=transcript_14064;O43379 Q63HP9 Q659D7 Q8NBF7 Q96AD9,WD repeat-containing protein 62,, PF12894;PF00400;, GO:0034451;GO:0005814;GO:0005813;GO:0005829;GO:0005634;GO:0000922;GO:0007099;GO:0021987;GO:0007052;GO:0022008;, C:centriolar satellite; C:centriole; C:centrosome; C:cytosol; C:nucleus; C:spindle pole;, , P:centriole replication; P:cerebral cortex development; P:mitotic spindle organization; P:neurogenesis; scaffold131 indexed_genome mRNA 925785 927058 . + . ID=transcript_14065;O00110,Putative transcription factor ovo-like protein 3,, PF00096;, GO:0000785;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0009913;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:epidermal cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 927705 937784 . - . ID=transcript_14066;P36954 B2R5J2 Q6NW05,DNA-directed RNA polymerase II subunit RPB9,DNA-directed RNA polymerase II subunit I;RNA polymerase II 14.5 kDa subunit;, PF02150;PF01096;, GO:0005730;GO:0005654;GO:0005634;GO:0005665;GO:0003899;GO:0003676;GO:0008270;GO:0006370;GO:0008543;GO:0001193;GO:0006379;GO:0000398;GO:0048239;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:nucleolus; C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:nucleic acid binding; F:zinc ion binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter; P:mRNA cleavage; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|Q99426 O00111 O00674 O14728 Q6FGY5,Tubulin-folding cofactor B,Cytoskeleton-associated protein 1;Cytoskeleton-associated protein CKAPI;Tubulin-specific chaperone B;, PF01302;PF14560;, GO:0005737;GO:0005829;GO:0005874;GO:0015630;GO:0030154;GO:0007399;, C:cytoplasm; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, , P:cell differentiation; P:nervous system development;|Q99426 O00111 O00674 O14728 Q6FGY5,Tubulin-folding cofactor B,Cytoskeleton-associated protein 1;Cytoskeleton-associated protein CKAPI;Tubulin-specific chaperone B;, PF01302;PF14560;, GO:0005737;GO:0005829;GO:0005874;GO:0015630;GO:0030154;GO:0007399;, C:cytoplasm; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, , P:cell differentiation; P:nervous system development;|Q99426 O00111 O00674 O14728 Q6FGY5,Tubulin-folding cofactor B,Cytoskeleton-associated protein 1;Cytoskeleton-associated protein CKAPI;Tubulin-specific chaperone B;, PF01302;PF14560;, GO:0005737;GO:0005829;GO:0005874;GO:0015630;GO:0030154;GO:0007399;, C:cytoplasm; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, , P:cell differentiation; P:nervous system development;|Q99426 O00111 O00674 O14728 Q6FGY5,Tubulin-folding cofactor B,Cytoskeleton-associated protein 1;Cytoskeleton-associated protein CKAPI;Tubulin-specific chaperone B;, PF01302;PF14560;, GO:0005737;GO:0005829;GO:0005874;GO:0015630;GO:0030154;GO:0007399;, C:cytoplasm; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, , P:cell differentiation; P:nervous system development; scaffold131 indexed_genome mRNA 950609 961844 . + . ID=transcript_14067;P04632 A8K0P1 Q8WTX3 Q96EW0,Calpain small subunit 1,Calcium-activated neutral proteinase small subunit;Calcium-dependent protease small subunit;Calcium-dependent protease small subunit 1;Calpain regulatory subunit;, , GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0005509;GO:0004198;GO:0070268;GO:0022617;GO:0008284;GO:0016241;, C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity;, P:cornification; P:extracellular matrix disassembly; P:positive regulation of cell population proliferation; P:regulation of macroautophagy;|P04632 A8K0P1 Q8WTX3 Q96EW0,Calpain small subunit 1,Calcium-activated neutral proteinase small subunit;Calcium-dependent protease small subunit;Calcium-dependent protease small subunit 1;Calpain regulatory subunit;, , GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0005509;GO:0004198;GO:0070268;GO:0022617;GO:0008284;GO:0016241;, C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity;, P:cornification; P:extracellular matrix disassembly; P:positive regulation of cell population proliferation; P:regulation of macroautophagy;|P04632 A8K0P1 Q8WTX3 Q96EW0,Calpain small subunit 1,Calcium-activated neutral proteinase small subunit;Calcium-dependent protease small subunit;Calcium-dependent protease small subunit 1;Calpain regulatory subunit;, , GO:0005829;GO:0070062;GO:0016020;GO:0005886;GO:0005509;GO:0004198;GO:0070268;GO:0022617;GO:0008284;GO:0016241;, C:cytosol; C:extracellular exosome; C:membrane; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity;, P:cornification; P:extracellular matrix disassembly; P:positive regulation of cell population proliferation; P:regulation of macroautophagy;|P24310,Cytochrome c oxidase subunit 7A1, mitochondrial,Cytochrome c oxidase subunit VIIa-heart;Cytochrome c oxidase subunit VIIa-muscle;, PF02238;, GO:0016021;GO:0005746;GO:0005739;GO:0004129;GO:0006091;GO:0097250;GO:0006119;GO:0002082;, C:integral component of membrane; C:mitochondrial respirasome; C:mitochondrion;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial respirasome assembly; P:oxidative phosphorylation; P:regulation of oxidative phosphorylation;|P24310,Cytochrome c oxidase subunit 7A1, mitochondrial,Cytochrome c oxidase subunit VIIa-heart;Cytochrome c oxidase subunit VIIa-muscle;, PF02238;, GO:0016021;GO:0005746;GO:0005739;GO:0004129;GO:0006091;GO:0097250;GO:0006119;GO:0002082;, C:integral component of membrane; C:mitochondrial respirasome; C:mitochondrion;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial respirasome assembly; P:oxidative phosphorylation; P:regulation of oxidative phosphorylation; scaffold131 indexed_genome mRNA 965974 967490 . + . ID=transcript_14068;P0CF97,Protein FAM200B {ECO:0000305} scaffold131 indexed_genome mRNA 982357 1009846 . - . ID=transcript_14069;Q8N9K5 B3KQ35 Q6NUS2,Zinc finger protein 565,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8N9K5 B3KQ35 Q6NUS2,Zinc finger protein 565,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8N9K5 B3KQ35 Q6NUS2,Zinc finger protein 565,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8N9K5 B3KQ35 Q6NUS2,Zinc finger protein 565,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1017214 1031068 . + . ID=transcript_14070;Q15072 Q2TB94,Zinc finger protein OZF,Only zinc finger protein;Zinc finger protein 146;, PF00096;, GO:0005829;GO:0005730;GO:0005634;GO:0003677;GO:0000981;GO:0008201;GO:0000978;GO:0008270;GO:0006357;GO:0006355;, C:cytosol; C:nucleolus; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:heparin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold131 indexed_genome mRNA 1041160 1081796 . - . ID=transcript_14071;Q8N184 B3KX49 Q6N044,Zinc finger protein 567,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8N184 B3KX49 Q6N044,Zinc finger protein 567,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8N184 B3KX49 Q6N044,Zinc finger protein 567,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8N184 B3KX49 Q6N044,Zinc finger protein 567,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1081799 1098640 . + . ID=transcript_14072;Q8TAF7 A8K9W9 Q6VSF7 Q9ULZ8,Zinc finger protein 461,Gonadotropin-inducible ovary transcription repressor 1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1105748 1136409 . - . ID=transcript_14073;Q96SR6 A3KMP6 A8MT55 C9K0V5 Q53ZY8 Q5JPJ2,Zinc finger protein 382,KRAB/zinc finger suppressor protein 1;Multiple zinc finger and krueppel-associated box protein KS1;, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1155954 1158083 . - . ID=transcript_14074;Q6P280 K7EKE1 Q9H731 Q9HCF7,Zinc finger protein 529,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1160067 1163198 . - . ID=transcript_14075;Q6P280 K7EKE1 Q9H731 Q9HCF7,Zinc finger protein 529,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1169725 1170416 . - . ID=transcript_14076;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold131 indexed_genome mRNA 1175972 1189723 . + . ID=transcript_14077;Q3ZCT1 Q0VF43,Zinc finger protein 260,, PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0007275;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1198575 1227325 . + . ID=transcript_14078;Q969W8 B7ZL95 Q2M3J1,Zinc finger protein 566,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q969W8 B7ZL95 Q2M3J1,Zinc finger protein 566,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1239472 1258878 . + . ID=transcript_14079;Q8N141 Q8NC63 Q8TF53,Zinc finger protein 82 homolog,Zinc finger protein 545;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1267248 1289321 . + . ID=transcript_14080;Q9HCL3 A7MD23,Zinc finger protein 14 homolog,Zinc finger protein 531;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1336450 1361325 . - . ID=transcript_14081;Q3ZCX4 B4DS92 E7ER33 Q6N060 Q8NA64,Zinc finger protein 568,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0000976;GO:0060669;GO:0001701;GO:0000122;GO:0045892;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:embryonic placenta morphogenesis; P:in utero embryonic development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q3ZCX4 B4DS92 E7ER33 Q6N060 Q8NA64,Zinc finger protein 568,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0000976;GO:0060669;GO:0001701;GO:0000122;GO:0045892;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:embryonic placenta morphogenesis; P:in utero embryonic development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1361705 1372700 . + . ID=transcript_14082;Q3KNS6 A0A075B6T0 Q3KNS7 Q6ZNN0 Q7Z657,Zinc finger protein 829,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1426587 1442833 . - . ID=transcript_14083;Q6P3V2 Q8TE95 Q96MV3,Zinc finger protein 585A,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1457060 1468322 . + . ID=transcript_14084;Q8NA42 Q6X2C7,Zinc finger protein 383,, PF01352;PF00096;, GO:0005737;GO:0031965;GO:0005654;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:cytoplasm; C:nuclear membrane; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8NA42 Q6X2C7,Zinc finger protein 383,, PF01352;PF00096;, GO:0005737;GO:0031965;GO:0005654;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:cytoplasm; C:nuclear membrane; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1477969 1490690 . + . ID=transcript_14085;Q8NCK3 B4DSE6 Q96CL0,Zinc finger protein 485,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1506669 1523028 . + . ID=transcript_14086;P10072 A8MRS7 Q6PJD0 Q9BSW9 Q9UM09,Zinc finger protein 875 {ECO:0000305},Krueppel-related zinc finger protein 1;Protein HKR1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0007275;GO:0000122;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P10072 A8MRS7 Q6PJD0 Q9BSW9 Q9UM09,Zinc finger protein 875 {ECO:0000305},Krueppel-related zinc finger protein 1;Protein HKR1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0007275;GO:0000122;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold131 indexed_genome mRNA 1524974 1539999 . + . ID=transcript_14087;Q8NB42 B4DVL5,Zinc finger protein 527,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8NB42 B4DVL5,Zinc finger protein 527,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8NB42 B4DVL5,Zinc finger protein 527,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1549444 1556231 . + . ID=transcript_14088;Q9P2J4,Zinc finger MYM-type protein 6,Transposon-derived Buster2 transposase-like protein;Zinc finger protein 258;, PF14291;PF06467;, GO:0005634;GO:0003677;GO:0008270;GO:0007010;GO:0007275;GO:0022604;, C:nucleus;, F:DNA binding; F:zinc ion binding;, P:cytoskeleton organization; P:multicellular organism development; P:regulation of cell morphogenesis; scaffold131 indexed_genome mRNA 1558687 1583274 . - . ID=transcript_14089;Q5MCW4 A8K1S2 Q15925 Q17RR6 Q96MQ2,Zinc finger protein 569,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5MCW4 A8K1S2 Q15925 Q17RR6 Q96MQ2,Zinc finger protein 569,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5MCW4 A8K1S2 Q15925 Q17RR6 Q96MQ2,Zinc finger protein 569,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1591427 1615836 . + . ID=transcript_14090;Q96NI8 A1L472 B4DMP1,Zinc finger protein 570,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1627820 1654486 . - . ID=transcript_14091;Q8TAQ5 B2RDY6 Q96ML5,Zinc finger protein 420,, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0042981;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of apoptotic process; P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1668459 1669283 . + . ID=transcript_14092;O71037 Q69386 Q9YNA7,Endogenous retrovirus group K member 19 Env polyprotein,EnvK3 protein;Envelope polyprotein;HERV-K(C19) envelope protein;HERV-K_19q11 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity; scaffold131 indexed_genome mRNA 1669400 1670653 . + . ID=transcript_14093;P63132,Endogenous retrovirus group K member 113 Pol protein,HERV-K113 Pol protein;HERV-K_19p13.11 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold131 indexed_genome mRNA 1674417 1677071 . - . ID=transcript_14094;Q7Z3V5 Q2HIY0 Q3ZCU3 Q9NZX7,Zinc finger protein 571,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1700852 1717676 . - . ID=transcript_14095;Q14585,Zinc finger protein 345,Zinc finger protein HZF10;, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:1990837;GO:0000122;GO:0006357;GO:0006359;GO:0006366;GO:0006383;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase III; P:transcription by RNA polymerase II; P:transcription by RNA polymerase III; scaffold131 indexed_genome mRNA 1721448 1735859 . + . ID=transcript_14096;Q6PG37,Zinc finger protein 790,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1750355 1767927 . - . ID=transcript_14097;Q9Y2G7 Q58EY8,Zinc finger protein 30 homolog,Zinc finger protein 745;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9Y2G7 Q58EY8,Zinc finger protein 30 homolog,Zinc finger protein 745;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1819228 1830178 . + . ID=transcript_14098;Q9Y6R6 B9EH00,Zinc finger protein 780B,Zinc finger protein 779;, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8NA42 Q6X2C7,Zinc finger protein 383,, PF01352;PF00096;, GO:0005737;GO:0031965;GO:0005654;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:cytoplasm; C:nuclear membrane; C:nucleoplasm;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1856515 1865936 . + . ID=transcript_14099;Q5HY98 B2RNE0 Q7Z326,Zinc finger protein 766,, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0006355;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:regulation of transcription, DNA-templated;|Q8TAF7 A8K9W9 Q6VSF7 Q9ULZ8,Zinc finger protein 461,Gonadotropin-inducible ovary transcription repressor 1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q3KNS6 A0A075B6T0 Q3KNS7 Q6ZNN0 Q7Z657,Zinc finger protein 829,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q969W8 B7ZL95 Q2M3J1,Zinc finger protein 566,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 1882822 1883578 . - . ID=transcript_14100;Q6ZQQ6 Q9BWV9,WD repeat-containing protein 87,Testis development protein NYD-SP11;, PF00400; scaffold131 indexed_genome mRNA 2074345 2180446 . + . ID=transcript_14101;O60292 Q2TV87,Signal-induced proliferation-associated 1-like protein 3,SPA-1-like protein 3;, PF02145;PF11881;, GO:0045177;GO:0016324;GO:0005737;GO:0005615;GO:0005794;GO:0005654;GO:0005886;GO:0001725;GO:0061689;GO:0005096;GO:0090630;GO:0007010;GO:0003382;GO:0090162;GO:0001654;GO:0002244;GO:0051056;, C:apical part of cell; C:apical plasma membrane; C:cytoplasm; C:extracellular space; C:Golgi apparatus; C:nucleoplasm; C:plasma membrane; C:stress fiber; C:tricellular tight junction;, F:GTPase activator activity;, P:activation of GTPase activity; P:cytoskeleton organization; P:epithelial cell morphogenesis; P:establishment of epithelial cell polarity; P:eye development; P:hematopoietic progenitor cell differentiation; P:regulation of small GTPase mediated signal transduction; scaffold131 indexed_genome mRNA 2185621 2188220 . - . ID=transcript_14102;Q92782 B3KSY8 Q08AJ0,Zinc finger protein neuro-d4,BRG1-associated factor 45B;D4, zinc and double PHD fingers family 1;, PF00628;PF14051;, GO:0005737;GO:0071565;GO:0042393;GO:1990837;GO:0003712;GO:0008270;GO:0006915;GO:0045892;GO:0007399;GO:0045944;, C:cytoplasm; C:nBAF complex;, F:histone binding; F:sequence-specific double-stranded DNA binding; F:transcription coregulator activity; F:zinc ion binding;, P:apoptotic process; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II; scaffold131 indexed_genome mRNA 2221337 2227735 . - . ID=transcript_14103;Q96A00 Q7Z4X7 Q96S54,Protein phosphatase 1 regulatory subunit 14A,17 kDa PKC-potentiated inhibitory protein of PP1;Protein kinase C-potentiated inhibitor protein of 17 kDa;, PF05361;, GO:0005829;GO:0004865;GO:0042325;, C:cytosol;, F:protein serine/threonine phosphatase inhibitor activity;, P:regulation of phosphorylation;|Q96A00 Q7Z4X7 Q96S54,Protein phosphatase 1 regulatory subunit 14A,17 kDa PKC-potentiated inhibitory protein of PP1;Protein kinase C-potentiated inhibitor protein of 17 kDa;, PF05361;, GO:0005829;GO:0004865;GO:0042325;, C:cytosol;, F:protein serine/threonine phosphatase inhibitor activity;, P:regulation of phosphorylation;|Q96A00 Q7Z4X7 Q96S54,Protein phosphatase 1 regulatory subunit 14A,17 kDa PKC-potentiated inhibitory protein of PP1;Protein kinase C-potentiated inhibitor protein of 17 kDa;, PF05361;, GO:0005829;GO:0004865;GO:0042325;, C:cytosol;, F:protein serine/threonine phosphatase inhibitor activity;, P:regulation of phosphorylation;|Q96A00 Q7Z4X7 Q96S54,Protein phosphatase 1 regulatory subunit 14A,17 kDa PKC-potentiated inhibitory protein of PP1;Protein kinase C-potentiated inhibitor protein of 17 kDa;, PF05361;, GO:0005829;GO:0004865;GO:0042325;, C:cytosol;, F:protein serine/threonine phosphatase inhibitor activity;, P:regulation of phosphorylation; scaffold131 indexed_genome mRNA 2236648 2263555 . + . ID=transcript_14104;O43291 A8K667 B4DLU1 O00271 O14895 Q5TZQ3 Q969E0,Kunitz-type protease inhibitor 2,Hepatocyte growth factor activator inhibitor type 2;Placental bikunin;, PF00014;, GO:0005737;GO:0005576;GO:0016021;GO:0005886;GO:0004866;GO:0004867;GO:0071711;GO:0071773;GO:0060672;GO:0007163;GO:2000146;GO:0022408;GO:2000178;GO:0001843;, C:cytoplasm; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:basement membrane organization; P:cellular response to BMP stimulus; P:epithelial cell morphogenesis involved in placental branching; P:establishment or maintenance of cell polarity; P:negative regulation of cell motility; P:negative regulation of cell-cell adhesion; P:negative regulation of neural precursor cell proliferation; P:neural tube closure;|O43291 A8K667 B4DLU1 O00271 O14895 Q5TZQ3 Q969E0,Kunitz-type protease inhibitor 2,Hepatocyte growth factor activator inhibitor type 2;Placental bikunin;, PF00014;, GO:0005737;GO:0005576;GO:0016021;GO:0005886;GO:0004866;GO:0004867;GO:0071711;GO:0071773;GO:0060672;GO:0007163;GO:2000146;GO:0022408;GO:2000178;GO:0001843;, C:cytoplasm; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:basement membrane organization; P:cellular response to BMP stimulus; P:epithelial cell morphogenesis involved in placental branching; P:establishment or maintenance of cell polarity; P:negative regulation of cell motility; P:negative regulation of cell-cell adhesion; P:negative regulation of neural precursor cell proliferation; P:neural tube closure;|O43291 A8K667 B4DLU1 O00271 O14895 Q5TZQ3 Q969E0,Kunitz-type protease inhibitor 2,Hepatocyte growth factor activator inhibitor type 2;Placental bikunin;, PF00014;, GO:0005737;GO:0005576;GO:0016021;GO:0005886;GO:0004866;GO:0004867;GO:0071711;GO:0071773;GO:0060672;GO:0007163;GO:2000146;GO:0022408;GO:2000178;GO:0001843;, C:cytoplasm; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:basement membrane organization; P:cellular response to BMP stimulus; P:epithelial cell morphogenesis involved in placental branching; P:establishment or maintenance of cell polarity; P:negative regulation of cell motility; P:negative regulation of cell-cell adhesion; P:negative regulation of neural precursor cell proliferation; P:neural tube closure; scaffold131 indexed_genome mRNA 2275221 2284714 . - . ID=transcript_14105;Q5BJH7 H7BXS8 Q5JPC2 Q8WY70 Q96C02 Q96IC4,Protein YIF1B {ECO:0000305},YIP1-interacting factor homolog B;, PF03878;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0030173;GO:0006888;GO:0006612;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of Golgi membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein targeting to membrane;|Q5BJH7 H7BXS8 Q5JPC2 Q8WY70 Q96C02 Q96IC4,Protein YIF1B {ECO:0000305},YIP1-interacting factor homolog B;, PF03878;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0030173;GO:0006888;GO:0006612;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of Golgi membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein targeting to membrane;|Q5BJH7 H7BXS8 Q5JPC2 Q8WY70 Q96C02 Q96IC4,Protein YIF1B {ECO:0000305},YIP1-interacting factor homolog B;, PF03878;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0030173;GO:0006888;GO:0006612;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of Golgi membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein targeting to membrane;|Q5BJH7 H7BXS8 Q5JPC2 Q8WY70 Q96C02 Q96IC4,Protein YIF1B {ECO:0000305},YIP1-interacting factor homolog B;, PF03878;, GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0030173;GO:0006888;GO:0006612;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of Golgi membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein targeting to membrane; scaffold131 indexed_genome mRNA 2300311 2301298 . + . ID=transcript_14106;Q9Y257 Q9HB47,Potassium channel subfamily K member 6,Inward rectifying potassium channel protein TWIK-2;TWIK-originated similarity sequence;, PF07885;, GO:0005887;GO:0005886;GO:0008076;GO:0005242;GO:0022841;GO:0061337;GO:0003085;GO:0071805;GO:0006813;GO:0034765;GO:0060075;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:inward rectifier potassium channel activity; F:potassium ion leak channel activity;, P:cardiac conduction; P:negative regulation of systemic arterial blood pressure; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:regulation of resting membrane potential; P:stabilization of membrane potential; scaffold131 indexed_genome mRNA 2307570 2326853 . + . ID=transcript_14107;Q6ZRH7 A6NEG6 Q659E1,Cation channel sperm-associated protein subunit gamma,, PF15064;, GO:0036128;GO:0031514;GO:0005886;GO:0097228;GO:0030154;GO:0007275;GO:0032570;GO:0035036;GO:0007283;, C:CatSper complex; C:motile cilium; C:plasma membrane; C:sperm principal piece;, , P:cell differentiation; P:multicellular organism development; P:response to progesterone; P:sperm-egg recognition; P:spermatogenesis;|Q6ZRH7 A6NEG6 Q659E1,Cation channel sperm-associated protein subunit gamma,, PF15064;, GO:0036128;GO:0031514;GO:0005886;GO:0097228;GO:0030154;GO:0007275;GO:0032570;GO:0035036;GO:0007283;, C:CatSper complex; C:motile cilium; C:plasma membrane; C:sperm principal piece;, , P:cell differentiation; P:multicellular organism development; P:response to progesterone; P:sperm-egg recognition; P:spermatogenesis;|Q6ZRH7 A6NEG6 Q659E1,Cation channel sperm-associated protein subunit gamma,, PF15064;, GO:0036128;GO:0031514;GO:0005886;GO:0097228;GO:0030154;GO:0007275;GO:0032570;GO:0035036;GO:0007283;, C:CatSper complex; C:motile cilium; C:plasma membrane; C:sperm principal piece;, , P:cell differentiation; P:multicellular organism development; P:response to progesterone; P:sperm-egg recognition; P:spermatogenesis; scaffold131 indexed_genome mRNA 2327509 2336783 . + . ID=transcript_14108;Q6ZRH7 A6NEG6 Q659E1,Cation channel sperm-associated protein subunit gamma,, PF15064;, GO:0036128;GO:0031514;GO:0005886;GO:0097228;GO:0030154;GO:0007275;GO:0032570;GO:0035036;GO:0007283;, C:CatSper complex; C:motile cilium; C:plasma membrane; C:sperm principal piece;, , P:cell differentiation; P:multicellular organism development; P:response to progesterone; P:sperm-egg recognition; P:spermatogenesis;|Q6ZRH7 A6NEG6 Q659E1,Cation channel sperm-associated protein subunit gamma,, PF15064;, GO:0036128;GO:0031514;GO:0005886;GO:0097228;GO:0030154;GO:0007275;GO:0032570;GO:0035036;GO:0007283;, C:CatSper complex; C:motile cilium; C:plasma membrane; C:sperm principal piece;, , P:cell differentiation; P:multicellular organism development; P:response to progesterone; P:sperm-egg recognition; P:spermatogenesis; scaffold131 indexed_genome mRNA 2348078 2354518 . + . ID=transcript_14109;P48556 B4DX18 Q6P1L7,26S proteasome non-ATPase regulatory subunit 8,26S proteasome regulatory subunit RPN12;26S proteasome regulatory subunit S14;p31;, PF10075;, GO:0005829;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P48556 B4DX18 Q6P1L7,26S proteasome non-ATPase regulatory subunit 8,26S proteasome regulatory subunit RPN12;26S proteasome regulatory subunit S14;p31;, PF10075;, GO:0005829;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex;, , P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold131 indexed_genome mRNA 2354823 2355375 . - . ID=transcript_14110;Q86UU5 Q7RTU6 Q86UU4 Q8NAA1,Gametogenetin,, PF15685;, GO:0031625;GO:0030154;GO:0006302;GO:0007276;GO:0007275;GO:0007283;, , F:ubiquitin protein ligase binding;, P:cell differentiation; P:double-strand break repair; P:gamete generation; P:multicellular organism development; P:spermatogenesis; scaffold131 indexed_genome mRNA 2372796 2377544 . + . ID=transcript_14111;Q17RN3 A6NMW3 Q66K45,Protein FAM98C,, PF10239;, GO:0072669;, C:tRNA-splicing ligase complex;|Q17RN3 A6NMW3 Q66K45,Protein FAM98C,, PF10239;, GO:0072669;, C:tRNA-splicing ligase complex;|Q17RN3 A6NMW3 Q66K45,Protein FAM98C,, PF10239;, GO:0072669;, C:tRNA-splicing ligase complex; scaffold131 indexed_genome mRNA 2378321 2391939 . - . ID=transcript_14112;Q8N858 Q96QN5 Q96QN6 Q96QN7,RAS guanyl-releasing protein 4,, PF00130;PF00617;, GO:0005829;GO:0016020;GO:0005654;GO:0005886;GO:0005509;GO:0019992;GO:0030742;GO:0005085;GO:0007202;GO:0008283;GO:0000165;GO:0030099;GO:0046579;GO:0008277;GO:0009991;GO:0007264;GO:0007169;, C:cytosol; C:membrane; C:nucleoplasm; C:plasma membrane;, F:calcium ion binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:guanyl-nucleotide exchange factor activity;, P:activation of phospholipase C activity; P:cell population proliferation; P:MAPK cascade; P:myeloid cell differentiation; P:positive regulation of Ras protein signal transduction; P:regulation of G protein-coupled receptor signaling pathway; P:response to extracellular stimulus; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q8N858 Q96QN5 Q96QN6 Q96QN7,RAS guanyl-releasing protein 4,, PF00130;PF00617;, GO:0005829;GO:0016020;GO:0005654;GO:0005886;GO:0005509;GO:0019992;GO:0030742;GO:0005085;GO:0007202;GO:0008283;GO:0000165;GO:0030099;GO:0046579;GO:0008277;GO:0009991;GO:0007264;GO:0007169;, C:cytosol; C:membrane; C:nucleoplasm; C:plasma membrane;, F:calcium ion binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:guanyl-nucleotide exchange factor activity;, P:activation of phospholipase C activity; P:cell population proliferation; P:MAPK cascade; P:myeloid cell differentiation; P:positive regulation of Ras protein signal transduction; P:regulation of G protein-coupled receptor signaling pathway; P:response to extracellular stimulus; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q8N858 Q96QN5 Q96QN6 Q96QN7,RAS guanyl-releasing protein 4,, PF00130;PF00617;, GO:0005829;GO:0016020;GO:0005654;GO:0005886;GO:0005509;GO:0019992;GO:0030742;GO:0005085;GO:0007202;GO:0008283;GO:0000165;GO:0030099;GO:0046579;GO:0008277;GO:0009991;GO:0007264;GO:0007169;, C:cytosol; C:membrane; C:nucleoplasm; C:plasma membrane;, F:calcium ion binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:guanyl-nucleotide exchange factor activity;, P:activation of phospholipase C activity; P:cell population proliferation; P:MAPK cascade; P:myeloid cell differentiation; P:positive regulation of Ras protein signal transduction; P:regulation of G protein-coupled receptor signaling pathway; P:response to extracellular stimulus; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q8N858 Q96QN5 Q96QN6 Q96QN7,RAS guanyl-releasing protein 4,, PF00130;PF00617;, GO:0005829;GO:0016020;GO:0005654;GO:0005886;GO:0005509;GO:0019992;GO:0030742;GO:0005085;GO:0007202;GO:0008283;GO:0000165;GO:0030099;GO:0046579;GO:0008277;GO:0009991;GO:0007264;GO:0007169;, C:cytosol; C:membrane; C:nucleoplasm; C:plasma membrane;, F:calcium ion binding; F:diacylglycerol binding; F:GTP-dependent protein binding; F:guanyl-nucleotide exchange factor activity;, P:activation of phospholipase C activity; P:cell population proliferation; P:MAPK cascade; P:myeloid cell differentiation; P:positive regulation of Ras protein signal transduction; P:regulation of G protein-coupled receptor signaling pathway; P:response to extracellular stimulus; P:small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold131 indexed_genome mRNA 2462765 2464155 . + . ID=transcript_14113;P21817 Q16314 Q16368 Q9NPK1 Q9P1U4,Ryanodine receptor 1,Skeletal muscle calcium release channel;Skeletal muscle ryanodine receptor;Skeletal muscle-type ryanodine receptor;Type 1 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0005938;GO:0005737;GO:0030659;GO:0070062;GO:0031674;GO:0031301;GO:0005887;GO:0014701;GO:0005886;GO:1990425;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0014802;GO:0030018;GO:0005524;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0005245;GO:0006816;GO:0071313;GO:0071277;GO:0034220;GO:0006936;GO:0043931;GO:0003151;GO:0051289;GO:1903779;GO:0051480;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0048741;GO:0043588;, C:calcium channel complex; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:I band; C:integral component of organelle membrane; C:integral component of plasma membrane; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:ryanodine receptor complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:terminal cisterna; C:Z disc;, F:ATP binding; F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity; F:voltage-gated calcium channel activity;, P:calcium ion transport; P:cellular response to caffeine; P:cellular response to calcium ion; P:ion transmembrane transport; P:muscle contraction; P:ossification involved in bone maturation; P:outflow tract morphogenesis; P:protein homotetramerization; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:skeletal muscle fiber development; P:skin development; scaffold131 indexed_genome mRNA 2479453 2486450 . + . ID=transcript_14114;P21817 Q16314 Q16368 Q9NPK1 Q9P1U4,Ryanodine receptor 1,Skeletal muscle calcium release channel;Skeletal muscle ryanodine receptor;Skeletal muscle-type ryanodine receptor;Type 1 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0005938;GO:0005737;GO:0030659;GO:0070062;GO:0031674;GO:0031301;GO:0005887;GO:0014701;GO:0005886;GO:1990425;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0014802;GO:0030018;GO:0005524;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0005245;GO:0006816;GO:0071313;GO:0071277;GO:0034220;GO:0006936;GO:0043931;GO:0003151;GO:0051289;GO:1903779;GO:0051480;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0048741;GO:0043588;, C:calcium channel complex; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:I band; C:integral component of organelle membrane; C:integral component of plasma membrane; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:ryanodine receptor complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:terminal cisterna; C:Z disc;, F:ATP binding; F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity; F:voltage-gated calcium channel activity;, P:calcium ion transport; P:cellular response to caffeine; P:cellular response to calcium ion; P:ion transmembrane transport; P:muscle contraction; P:ossification involved in bone maturation; P:outflow tract morphogenesis; P:protein homotetramerization; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:skeletal muscle fiber development; P:skin development;|P21817 Q16314 Q16368 Q9NPK1 Q9P1U4,Ryanodine receptor 1,Skeletal muscle calcium release channel;Skeletal muscle ryanodine receptor;Skeletal muscle-type ryanodine receptor;Type 1 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0005938;GO:0005737;GO:0030659;GO:0070062;GO:0031674;GO:0031301;GO:0005887;GO:0014701;GO:0005886;GO:1990425;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0014802;GO:0030018;GO:0005524;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0005245;GO:0006816;GO:0071313;GO:0071277;GO:0034220;GO:0006936;GO:0043931;GO:0003151;GO:0051289;GO:1903779;GO:0051480;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0048741;GO:0043588;, C:calcium channel complex; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:I band; C:integral component of organelle membrane; C:integral component of plasma membrane; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:ryanodine receptor complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:terminal cisterna; C:Z disc;, F:ATP binding; F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity; F:voltage-gated calcium channel activity;, P:calcium ion transport; P:cellular response to caffeine; P:cellular response to calcium ion; P:ion transmembrane transport; P:muscle contraction; P:ossification involved in bone maturation; P:outflow tract morphogenesis; P:protein homotetramerization; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:skeletal muscle fiber development; P:skin development; scaffold131 indexed_genome mRNA 2487150 2492182 . + . ID=transcript_14115;P21817 Q16314 Q16368 Q9NPK1 Q9P1U4,Ryanodine receptor 1,Skeletal muscle calcium release channel;Skeletal muscle ryanodine receptor;Skeletal muscle-type ryanodine receptor;Type 1 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0005938;GO:0005737;GO:0030659;GO:0070062;GO:0031674;GO:0031301;GO:0005887;GO:0014701;GO:0005886;GO:1990425;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0014802;GO:0030018;GO:0005524;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0005245;GO:0006816;GO:0071313;GO:0071277;GO:0034220;GO:0006936;GO:0043931;GO:0003151;GO:0051289;GO:1903779;GO:0051480;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0048741;GO:0043588;, C:calcium channel complex; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:I band; C:integral component of organelle membrane; C:integral component of plasma membrane; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:ryanodine receptor complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:terminal cisterna; C:Z disc;, F:ATP binding; F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity; F:voltage-gated calcium channel activity;, P:calcium ion transport; P:cellular response to caffeine; P:cellular response to calcium ion; P:ion transmembrane transport; P:muscle contraction; P:ossification involved in bone maturation; P:outflow tract morphogenesis; P:protein homotetramerization; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:skeletal muscle fiber development; P:skin development; scaffold131 indexed_genome mRNA 2515833 2518718 . + . ID=transcript_14116;P21817 Q16314 Q16368 Q9NPK1 Q9P1U4,Ryanodine receptor 1,Skeletal muscle calcium release channel;Skeletal muscle ryanodine receptor;Skeletal muscle-type ryanodine receptor;Type 1 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0005938;GO:0005737;GO:0030659;GO:0070062;GO:0031674;GO:0031301;GO:0005887;GO:0014701;GO:0005886;GO:1990425;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0014802;GO:0030018;GO:0005524;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0005245;GO:0006816;GO:0071313;GO:0071277;GO:0034220;GO:0006936;GO:0043931;GO:0003151;GO:0051289;GO:1903779;GO:0051480;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0048741;GO:0043588;, C:calcium channel complex; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:I band; C:integral component of organelle membrane; C:integral component of plasma membrane; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:ryanodine receptor complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:terminal cisterna; C:Z disc;, F:ATP binding; F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity; F:voltage-gated calcium channel activity;, P:calcium ion transport; P:cellular response to caffeine; P:cellular response to calcium ion; P:ion transmembrane transport; P:muscle contraction; P:ossification involved in bone maturation; P:outflow tract morphogenesis; P:protein homotetramerization; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:skeletal muscle fiber development; P:skin development; scaffold131 indexed_genome mRNA 2521554 2522212 . - . ID=transcript_14117;P21817 Q16314 Q16368 Q9NPK1 Q9P1U4,Ryanodine receptor 1,Skeletal muscle calcium release channel;Skeletal muscle ryanodine receptor;Skeletal muscle-type ryanodine receptor;Type 1 ryanodine receptor;, PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;, GO:0034704;GO:0005938;GO:0005737;GO:0030659;GO:0070062;GO:0031674;GO:0031301;GO:0005887;GO:0014701;GO:0005886;GO:1990425;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0014802;GO:0030018;GO:0005524;GO:0005262;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0005245;GO:0006816;GO:0071313;GO:0071277;GO:0034220;GO:0006936;GO:0043931;GO:0003151;GO:0051289;GO:1903779;GO:0051480;GO:0051209;GO:0014808;GO:0031000;GO:0001666;GO:0048741;GO:0043588;, C:calcium channel complex; C:cell cortex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:extracellular exosome; C:I band; C:integral component of organelle membrane; C:integral component of plasma membrane; C:junctional sarcoplasmic reticulum membrane; C:plasma membrane; C:ryanodine receptor complex; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:terminal cisterna; C:Z disc;, F:ATP binding; F:calcium channel activity; F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity; F:voltage-gated calcium channel activity;, P:calcium ion transport; P:cellular response to caffeine; P:cellular response to calcium ion; P:ion transmembrane transport; P:muscle contraction; P:ossification involved in bone maturation; P:outflow tract morphogenesis; P:protein homotetramerization; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:release of sequestered calcium ion into cytosol; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:response to caffeine; P:response to hypoxia; P:skeletal muscle fiber development; P:skin development; scaffold131 indexed_genome mRNA 2523620 2530660 . - . ID=transcript_14118;Q92918,Mitogen-activated protein kinase kinase kinase kinase 1,Hematopoietic progenitor kinase;MAPK/ERK kinase kinase kinase 1;, PF00780;PF00069;, GO:0016020;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000185;GO:0008283;GO:1904628;GO:0018105;GO:0046777;GO:0006468;, C:membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:cell population proliferation; P:cellular response to phorbol 13-acetate 12-myristate; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation;|Q92918,Mitogen-activated protein kinase kinase kinase kinase 1,Hematopoietic progenitor kinase;MAPK/ERK kinase kinase kinase 1;, PF00780;PF00069;, GO:0016020;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000185;GO:0008283;GO:1904628;GO:0018105;GO:0046777;GO:0006468;, C:membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:cell population proliferation; P:cellular response to phorbol 13-acetate 12-myristate; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation;|Q92918,Mitogen-activated protein kinase kinase kinase kinase 1,Hematopoietic progenitor kinase;MAPK/ERK kinase kinase kinase 1;, PF00780;PF00069;, GO:0016020;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000185;GO:0008283;GO:1904628;GO:0018105;GO:0046777;GO:0006468;, C:membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:cell population proliferation; P:cellular response to phorbol 13-acetate 12-myristate; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; scaffold131 indexed_genome mRNA 2532010 2540527 . - . ID=transcript_14119;Q92918,Mitogen-activated protein kinase kinase kinase kinase 1,Hematopoietic progenitor kinase;MAPK/ERK kinase kinase kinase 1;, PF00780;PF00069;, GO:0016020;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000185;GO:0008283;GO:1904628;GO:0018105;GO:0046777;GO:0006468;, C:membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:cell population proliferation; P:cellular response to phorbol 13-acetate 12-myristate; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation;|Q92918,Mitogen-activated protein kinase kinase kinase kinase 1,Hematopoietic progenitor kinase;MAPK/ERK kinase kinase kinase 1;, PF00780;PF00069;, GO:0016020;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000185;GO:0008283;GO:1904628;GO:0018105;GO:0046777;GO:0006468;, C:membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:cell population proliferation; P:cellular response to phorbol 13-acetate 12-myristate; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation;|Q92918,Mitogen-activated protein kinase kinase kinase kinase 1,Hematopoietic progenitor kinase;MAPK/ERK kinase kinase kinase 1;, PF00780;PF00069;, GO:0016020;GO:0005524;GO:0008349;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000185;GO:0008283;GO:1904628;GO:0018105;GO:0046777;GO:0006468;, C:membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPKKK activity; P:cell population proliferation; P:cellular response to phorbol 13-acetate 12-myristate; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; scaffold131 indexed_genome mRNA 2541583 2550557 . + . ID=transcript_14120;Q9UBQ5 A8K0I9 B7ZAM9 Q96IQ0 Q9Y6D1,Eukaryotic translation initiation factor 3 subunit K {ECO:0000255|HAMAP-Rule:MF_03010},Eukaryotic translation initiation factor 3 subunit 12 {ECO:0000255|HAMAP-Rule:MF_03010};Muscle-specific gene M9 protein;PLAC-24;eIF-3 p25 {ECO:0000255|HAMAP-Rule:MF_03010};eIF-3 p28;, PF10075;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0005634;GO:0043022;GO:0003743;GO:0001732;GO:0006446;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane; C:nucleus;, F:ribosome binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:regulation of translational initiation; P:translational initiation;|Q9UBQ5 A8K0I9 B7ZAM9 Q96IQ0 Q9Y6D1,Eukaryotic translation initiation factor 3 subunit K {ECO:0000255|HAMAP-Rule:MF_03010},Eukaryotic translation initiation factor 3 subunit 12 {ECO:0000255|HAMAP-Rule:MF_03010};Muscle-specific gene M9 protein;PLAC-24;eIF-3 p25 {ECO:0000255|HAMAP-Rule:MF_03010};eIF-3 p28;, PF10075;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0005634;GO:0043022;GO:0003743;GO:0001732;GO:0006446;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane; C:nucleus;, F:ribosome binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:regulation of translational initiation; P:translational initiation;|Q9UBQ5 A8K0I9 B7ZAM9 Q96IQ0 Q9Y6D1,Eukaryotic translation initiation factor 3 subunit K {ECO:0000255|HAMAP-Rule:MF_03010},Eukaryotic translation initiation factor 3 subunit 12 {ECO:0000255|HAMAP-Rule:MF_03010};Muscle-specific gene M9 protein;PLAC-24;eIF-3 p25 {ECO:0000255|HAMAP-Rule:MF_03010};eIF-3 p28;, PF10075;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0005634;GO:0043022;GO:0003743;GO:0001732;GO:0006446;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane; C:nucleus;, F:ribosome binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:regulation of translational initiation; P:translational initiation;|Q9UBQ5 A8K0I9 B7ZAM9 Q96IQ0 Q9Y6D1,Eukaryotic translation initiation factor 3 subunit K {ECO:0000255|HAMAP-Rule:MF_03010},Eukaryotic translation initiation factor 3 subunit 12 {ECO:0000255|HAMAP-Rule:MF_03010};Muscle-specific gene M9 protein;PLAC-24;eIF-3 p25 {ECO:0000255|HAMAP-Rule:MF_03010};eIF-3 p28;, PF10075;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0005634;GO:0043022;GO:0003743;GO:0001732;GO:0006446;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane; C:nucleus;, F:ribosome binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:regulation of translational initiation; P:translational initiation;|Q9UBQ5 A8K0I9 B7ZAM9 Q96IQ0 Q9Y6D1,Eukaryotic translation initiation factor 3 subunit K {ECO:0000255|HAMAP-Rule:MF_03010},Eukaryotic translation initiation factor 3 subunit 12 {ECO:0000255|HAMAP-Rule:MF_03010};Muscle-specific gene M9 protein;PLAC-24;eIF-3 p25 {ECO:0000255|HAMAP-Rule:MF_03010};eIF-3 p28;, PF10075;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0016020;GO:0005634;GO:0043022;GO:0003743;GO:0001732;GO:0006446;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:membrane; C:nucleus;, F:ribosome binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:regulation of translational initiation; P:translational initiation; scaffold131 indexed_genome mRNA 2564991 2639806 . + . ID=transcript_14121;O43707 A4K467 D6PXK4 O76048,Alpha-actinin-4 {ECO:0000305},Non-muscle alpha-actinin 4 {ECO:0000303|PubMed:10656685};, PF00307;PF08726;PF00435;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0043005;GO:0016604;GO:0005634;GO:0048471;GO:0031093;GO:0032991;GO:0031143;GO:1990904;GO:0001725;GO:0003779;GO:0051015;GO:0005509;GO:0031490;GO:0005178;GO:0044325;GO:0035257;GO:0030374;GO:0001882;GO:0042803;GO:0047485;GO:0042974;GO:0003723;GO:0000977;GO:0003713;GO:1900025;GO:0035357;GO:0002576;GO:0030335;GO:0051272;GO:1901224;GO:0032417;GO:0015031;GO:0042981;GO:1903506;GO:0001666;GO:0048384;GO:0033209;GO:0030050;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:neuron projection; C:nuclear body; C:nucleus; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:protein-containing complex; C:pseudopodium; C:ribonucleoprotein complex; C:stress fiber;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:chromatin DNA binding; F:integrin binding; F:ion channel binding; F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity; F:nucleoside binding; F:protein homodimerization activity; F:protein N-terminus binding; F:retinoic acid receptor binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:negative regulation of substrate adhesion-dependent cell spreading; P:peroxisome proliferator activated receptor signaling pathway; P:platelet degranulation; P:positive regulation of cell migration; P:positive regulation of cellular component movement; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of sodium:proton antiporter activity; P:protein transport; P:regulation of apoptotic process; P:regulation of nucleic acid-templated transcription; P:response to hypoxia; P:retinoic acid receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vesicle transport along actin filament;|O43707 A4K467 D6PXK4 O76048,Alpha-actinin-4 {ECO:0000305},Non-muscle alpha-actinin 4 {ECO:0000303|PubMed:10656685};, PF00307;PF08726;PF00435;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0043005;GO:0016604;GO:0005634;GO:0048471;GO:0031093;GO:0032991;GO:0031143;GO:1990904;GO:0001725;GO:0003779;GO:0051015;GO:0005509;GO:0031490;GO:0005178;GO:0044325;GO:0035257;GO:0030374;GO:0001882;GO:0042803;GO:0047485;GO:0042974;GO:0003723;GO:0000977;GO:0003713;GO:1900025;GO:0035357;GO:0002576;GO:0030335;GO:0051272;GO:1901224;GO:0032417;GO:0015031;GO:0042981;GO:1903506;GO:0001666;GO:0048384;GO:0033209;GO:0030050;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:neuron projection; C:nuclear body; C:nucleus; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:protein-containing complex; C:pseudopodium; C:ribonucleoprotein complex; C:stress fiber;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:chromatin DNA binding; F:integrin binding; F:ion channel binding; F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity; F:nucleoside binding; F:protein homodimerization activity; F:protein N-terminus binding; F:retinoic acid receptor binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:negative regulation of substrate adhesion-dependent cell spreading; P:peroxisome proliferator activated receptor signaling pathway; P:platelet degranulation; P:positive regulation of cell migration; P:positive regulation of cellular component movement; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of sodium:proton antiporter activity; P:protein transport; P:regulation of apoptotic process; P:regulation of nucleic acid-templated transcription; P:response to hypoxia; P:retinoic acid receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vesicle transport along actin filament;|O43707 A4K467 D6PXK4 O76048,Alpha-actinin-4 {ECO:0000305},Non-muscle alpha-actinin 4 {ECO:0000303|PubMed:10656685};, PF00307;PF08726;PF00435;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0043005;GO:0016604;GO:0005634;GO:0048471;GO:0031093;GO:0032991;GO:0031143;GO:1990904;GO:0001725;GO:0003779;GO:0051015;GO:0005509;GO:0031490;GO:0005178;GO:0044325;GO:0035257;GO:0030374;GO:0001882;GO:0042803;GO:0047485;GO:0042974;GO:0003723;GO:0000977;GO:0003713;GO:1900025;GO:0035357;GO:0002576;GO:0030335;GO:0051272;GO:1901224;GO:0032417;GO:0015031;GO:0042981;GO:1903506;GO:0001666;GO:0048384;GO:0033209;GO:0030050;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:neuron projection; C:nuclear body; C:nucleus; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:protein-containing complex; C:pseudopodium; C:ribonucleoprotein complex; C:stress fiber;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:chromatin DNA binding; F:integrin binding; F:ion channel binding; F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity; F:nucleoside binding; F:protein homodimerization activity; F:protein N-terminus binding; F:retinoic acid receptor binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:negative regulation of substrate adhesion-dependent cell spreading; P:peroxisome proliferator activated receptor signaling pathway; P:platelet degranulation; P:positive regulation of cell migration; P:positive regulation of cellular component movement; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of sodium:proton antiporter activity; P:protein transport; P:regulation of apoptotic process; P:regulation of nucleic acid-templated transcription; P:response to hypoxia; P:retinoic acid receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vesicle transport along actin filament;|O43707 A4K467 D6PXK4 O76048,Alpha-actinin-4 {ECO:0000305},Non-muscle alpha-actinin 4 {ECO:0000303|PubMed:10656685};, PF00307;PF08726;PF00435;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0043005;GO:0016604;GO:0005634;GO:0048471;GO:0031093;GO:0032991;GO:0031143;GO:1990904;GO:0001725;GO:0003779;GO:0051015;GO:0005509;GO:0031490;GO:0005178;GO:0044325;GO:0035257;GO:0030374;GO:0001882;GO:0042803;GO:0047485;GO:0042974;GO:0003723;GO:0000977;GO:0003713;GO:1900025;GO:0035357;GO:0002576;GO:0030335;GO:0051272;GO:1901224;GO:0032417;GO:0015031;GO:0042981;GO:1903506;GO:0001666;GO:0048384;GO:0033209;GO:0030050;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:neuron projection; C:nuclear body; C:nucleus; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:protein-containing complex; C:pseudopodium; C:ribonucleoprotein complex; C:stress fiber;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:chromatin DNA binding; F:integrin binding; F:ion channel binding; F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity; F:nucleoside binding; F:protein homodimerization activity; F:protein N-terminus binding; F:retinoic acid receptor binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:negative regulation of substrate adhesion-dependent cell spreading; P:peroxisome proliferator activated receptor signaling pathway; P:platelet degranulation; P:positive regulation of cell migration; P:positive regulation of cellular component movement; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of sodium:proton antiporter activity; P:protein transport; P:regulation of apoptotic process; P:regulation of nucleic acid-templated transcription; P:response to hypoxia; P:retinoic acid receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vesicle transport along actin filament;|O43707 A4K467 D6PXK4 O76048,Alpha-actinin-4 {ECO:0000305},Non-muscle alpha-actinin 4 {ECO:0000303|PubMed:10656685};, PF00307;PF08726;PF00435;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0005925;GO:0043005;GO:0016604;GO:0005634;GO:0048471;GO:0031093;GO:0032991;GO:0031143;GO:1990904;GO:0001725;GO:0003779;GO:0051015;GO:0005509;GO:0031490;GO:0005178;GO:0044325;GO:0035257;GO:0030374;GO:0001882;GO:0042803;GO:0047485;GO:0042974;GO:0003723;GO:0000977;GO:0003713;GO:1900025;GO:0035357;GO:0002576;GO:0030335;GO:0051272;GO:1901224;GO:0032417;GO:0015031;GO:0042981;GO:1903506;GO:0001666;GO:0048384;GO:0033209;GO:0030050;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:focal adhesion; C:neuron projection; C:nuclear body; C:nucleus; C:perinuclear region of cytoplasm; C:platelet alpha granule lumen; C:protein-containing complex; C:pseudopodium; C:ribonucleoprotein complex; C:stress fiber;, F:actin binding; F:actin filament binding; F:calcium ion binding; F:chromatin DNA binding; F:integrin binding; F:ion channel binding; F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity; F:nucleoside binding; F:protein homodimerization activity; F:protein N-terminus binding; F:retinoic acid receptor binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription coactivator activity;, P:negative regulation of substrate adhesion-dependent cell spreading; P:peroxisome proliferator activated receptor signaling pathway; P:platelet degranulation; P:positive regulation of cell migration; P:positive regulation of cellular component movement; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of sodium:proton antiporter activity; P:protein transport; P:regulation of apoptotic process; P:regulation of nucleic acid-templated transcription; P:response to hypoxia; P:retinoic acid receptor signaling pathway; P:tumor necrosis factor-mediated signaling pathway; P:vesicle transport along actin filament; scaffold131 indexed_genome mRNA 2696610 2703469 . - . ID=transcript_14122;P56470,Galectin-4,Antigen NY-CO-27;L-36 lactose-binding protein;Lactose-binding lectin 4;, PF00337;, GO:0062023;GO:0005829;GO:0005615;GO:0005886;GO:0030246;GO:0016936;GO:0007155;, C:collagen-containing extracellular matrix; C:cytosol; C:extracellular space; C:plasma membrane;, F:carbohydrate binding; F:galactoside binding;, P:cell adhesion; scaffold131 indexed_genome mRNA 2703485 2713375 . - . ID=transcript_14123;Q13011 A8K745 Q8WVX0 Q96EZ9,Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial {ECO:0000305},, PF00378;, GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005782;GO:0005777;GO:0051750;GO:0006635;GO:0008104;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:delta3,5-delta2,4-dienoyl-CoA isomerase activity;, P:fatty acid beta-oxidation; P:protein localization;|Q13011 A8K745 Q8WVX0 Q96EZ9,Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial {ECO:0000305},, PF00378;, GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0005782;GO:0005777;GO:0051750;GO:0006635;GO:0008104;, C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion; C:peroxisomal matrix; C:peroxisome;, F:delta3,5-delta2,4-dienoyl-CoA isomerase activity;, P:fatty acid beta-oxidation; P:protein localization; scaffold131 indexed_genome mRNA 2715696 2724110 . - . ID=transcript_14124;P14866 A6ND69 A6NIT8 Q9H3P3,Heterogeneous nuclear ribonucleoprotein L,, PF00076;PF11835;, GO:0005737;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0035770;GO:0003729;GO:0097157;GO:0003723;GO:0000976;GO:0000398;GO:0000381;GO:0043484;GO:0016070;GO:0006396;, C:cytoplasm; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:pre-mRNA intronic binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing;|P14866 A6ND69 A6NIT8 Q9H3P3,Heterogeneous nuclear ribonucleoprotein L,, PF00076;PF11835;, GO:0005737;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0035770;GO:0003729;GO:0097157;GO:0003723;GO:0000976;GO:0000398;GO:0000381;GO:0043484;GO:0016070;GO:0006396;, C:cytoplasm; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:pre-mRNA intronic binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing;|P14866 A6ND69 A6NIT8 Q9H3P3,Heterogeneous nuclear ribonucleoprotein L,, PF00076;PF11835;, GO:0005737;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0035770;GO:0003729;GO:0097157;GO:0003723;GO:0000976;GO:0000398;GO:0000381;GO:0043484;GO:0016070;GO:0006396;, C:cytoplasm; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:pre-mRNA intronic binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing;|P14866 A6ND69 A6NIT8 Q9H3P3,Heterogeneous nuclear ribonucleoprotein L,, PF00076;PF11835;, GO:0005737;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0035770;GO:0003729;GO:0097157;GO:0003723;GO:0000976;GO:0000398;GO:0000381;GO:0043484;GO:0016070;GO:0006396;, C:cytoplasm; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:pre-mRNA intronic binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing;|P14866 A6ND69 A6NIT8 Q9H3P3,Heterogeneous nuclear ribonucleoprotein L,, PF00076;PF11835;, GO:0005737;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0035770;GO:0003729;GO:0097157;GO:0003723;GO:0000976;GO:0000398;GO:0000381;GO:0043484;GO:0016070;GO:0006396;, C:cytoplasm; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:pre-mRNA intronic binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing;|P14866 A6ND69 A6NIT8 Q9H3P3,Heterogeneous nuclear ribonucleoprotein L,, PF00076;PF11835;, GO:0005737;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0035770;GO:0003729;GO:0097157;GO:0003723;GO:0000976;GO:0000398;GO:0000381;GO:0043484;GO:0016070;GO:0006396;, C:cytoplasm; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:pre-mRNA intronic binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing; scaffold131 indexed_genome mRNA 2724873 2725612 . + . ID=transcript_14125;P14866 A6ND69 A6NIT8 Q9H3P3,Heterogeneous nuclear ribonucleoprotein L,, PF00076;PF11835;, GO:0005737;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0035770;GO:0003729;GO:0097157;GO:0003723;GO:0000976;GO:0000398;GO:0000381;GO:0043484;GO:0016070;GO:0006396;, C:cytoplasm; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribonucleoprotein granule;, F:mRNA binding; F:pre-mRNA intronic binding; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA metabolic process; P:RNA processing; scaffold131 indexed_genome mRNA 2734794 2737316 . - . ID=transcript_14126;Q8IXJ6 A8K3V1 B2RB45 O95889 Q924Y7 Q9P0G8 Q9UNT0 Q9Y6E9 U5TP13,NAD-dependent protein deacetylase sirtuin-2,Regulatory protein SIR2 homolog 2;SIR2-like protein 2;, PF02146;, GO:0005814;GO:0005813;GO:0005677;GO:0005694;GO:0000781;GO:0005737;GO:0005829;GO:0097386;GO:0030426;GO:0000792;GO:0044224;GO:0043219;GO:0072687;GO:0005874;GO:0030496;GO:0005739;GO:0072686;GO:0043209;GO:0005730;GO:0005634;GO:0033010;GO:0033270;GO:0043204;GO:0048471;GO:0005886;GO:0043220;GO:0005819;GO:0003682;GO:0035035;GO:0004407;GO:0042826;GO:0003950;GO:0070403;GO:0017136;GO:0046970;GO:0034979;GO:0033558;GO:0008134;GO:0042903;GO:0043130;GO:0008270;GO:0006914;GO:0051301;GO:0044242;GO:0061433;GO:0071872;GO:0035729;GO:0071456;GO:0071219;GO:0034599;GO:0006342;GO:0006348;GO:0048012;GO:0016575;GO:0070932;GO:0070933;GO:0045087;GO:0051321;GO:0007084;GO:0022011;GO:0010507;GO:0008285;GO:1900425;GO:0045599;GO:1900226;GO:0070446;GO:0010801;GO:0042177;GO:2000378;GO:0045843;GO:0000122;GO:0061428;GO:0045892;GO:0034983;GO:0014065;GO:0051987;GO:0051781;GO:0043388;GO:1900119;GO:0045836;GO:1900195;GO:0032436;GO:2000777;GO:0045944;GO:0043161;GO:0006471;GO:0006476;GO:0043491;GO:0000183;GO:0051726;GO:0007096;GO:0031641;GO:0042325;GO:0051775;GO:0021762;GO:0090042;, C:centriole; C:centrosome; C:chromatin silencing complex; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:glial cell projection; C:growth cone; C:heterochromatin; C:juxtaparanode region of axon; C:lateral loop; C:meiotic spindle; C:microtubule; C:midbody; C:mitochondrion; C:mitotic spindle; C:myelin sheath; C:nucleolus; C:nucleus; C:paranodal junction; C:paranode region of axon; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:Schmidt-Lanterman incisure; C:spindle;, F:chromatin binding; F:histone acetyltransferase binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H4-K16 specific); F:NAD-dependent protein deacetylase activity; F:protein deacetylase activity; F:transcription factor binding; F:tubulin deacetylase activity; F:ubiquitin binding; F:zinc ion binding;, P:autophagy; P:cell division; P:cellular lipid catabolic process; P:cellular response to caloric restriction; P:cellular response to epinephrine stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hypoxia; P:cellular response to molecule of bacterial origin; P:cellular response to oxidative stress; P:chromatin silencing; P:chromatin silencing at telomere; P:hepatocyte growth factor receptor signaling pathway; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:innate immune response; P:meiotic cell cycle; P:mitotic nuclear envelope reassembly; P:myelination in peripheral nervous system; P:negative regulation of autophagy; P:negative regulation of cell population proliferation; P:negative regulation of defense response to bacterium; P:negative regulation of fat cell differentiation; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of oligodendrocyte progenitor proliferation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein catabolic process; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of striated muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine deacetylation; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of cell division; P:positive regulation of DNA binding; P:positive regulation of execution phase of apoptosis; P:positive regulation of meiotic nuclear division; P:positive regulation of oocyte maturation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ADP-ribosylation; P:protein deacetylation; P:protein kinase B signaling; P:rDNA heterochromatin assembly; P:regulation of cell cycle; P:regulation of exit from mitosis; P:regulation of myelination; P:regulation of phosphorylation; P:response to redox state; P:substantia nigra development; P:tubulin deacetylation;|Q8IXJ6 A8K3V1 B2RB45 O95889 Q924Y7 Q9P0G8 Q9UNT0 Q9Y6E9 U5TP13,NAD-dependent protein deacetylase sirtuin-2,Regulatory protein SIR2 homolog 2;SIR2-like protein 2;, PF02146;, GO:0005814;GO:0005813;GO:0005677;GO:0005694;GO:0000781;GO:0005737;GO:0005829;GO:0097386;GO:0030426;GO:0000792;GO:0044224;GO:0043219;GO:0072687;GO:0005874;GO:0030496;GO:0005739;GO:0072686;GO:0043209;GO:0005730;GO:0005634;GO:0033010;GO:0033270;GO:0043204;GO:0048471;GO:0005886;GO:0043220;GO:0005819;GO:0003682;GO:0035035;GO:0004407;GO:0042826;GO:0003950;GO:0070403;GO:0017136;GO:0046970;GO:0034979;GO:0033558;GO:0008134;GO:0042903;GO:0043130;GO:0008270;GO:0006914;GO:0051301;GO:0044242;GO:0061433;GO:0071872;GO:0035729;GO:0071456;GO:0071219;GO:0034599;GO:0006342;GO:0006348;GO:0048012;GO:0016575;GO:0070932;GO:0070933;GO:0045087;GO:0051321;GO:0007084;GO:0022011;GO:0010507;GO:0008285;GO:1900425;GO:0045599;GO:1900226;GO:0070446;GO:0010801;GO:0042177;GO:2000378;GO:0045843;GO:0000122;GO:0061428;GO:0045892;GO:0034983;GO:0014065;GO:0051987;GO:0051781;GO:0043388;GO:1900119;GO:0045836;GO:1900195;GO:0032436;GO:2000777;GO:0045944;GO:0043161;GO:0006471;GO:0006476;GO:0043491;GO:0000183;GO:0051726;GO:0007096;GO:0031641;GO:0042325;GO:0051775;GO:0021762;GO:0090042;, C:centriole; C:centrosome; C:chromatin silencing complex; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:glial cell projection; C:growth cone; C:heterochromatin; C:juxtaparanode region of axon; C:lateral loop; C:meiotic spindle; C:microtubule; C:midbody; C:mitochondrion; C:mitotic spindle; C:myelin sheath; C:nucleolus; C:nucleus; C:paranodal junction; C:paranode region of axon; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:Schmidt-Lanterman incisure; C:spindle;, F:chromatin binding; F:histone acetyltransferase binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H4-K16 specific); F:NAD-dependent protein deacetylase activity; F:protein deacetylase activity; F:transcription factor binding; F:tubulin deacetylase activity; F:ubiquitin binding; F:zinc ion binding;, P:autophagy; P:cell division; P:cellular lipid catabolic process; P:cellular response to caloric restriction; P:cellular response to epinephrine stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hypoxia; P:cellular response to molecule of bacterial origin; P:cellular response to oxidative stress; P:chromatin silencing; P:chromatin silencing at telomere; P:hepatocyte growth factor receptor signaling pathway; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:innate immune response; P:meiotic cell cycle; P:mitotic nuclear envelope reassembly; P:myelination in peripheral nervous system; P:negative regulation of autophagy; P:negative regulation of cell population proliferation; P:negative regulation of defense response to bacterium; P:negative regulation of fat cell differentiation; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of oligodendrocyte progenitor proliferation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein catabolic process; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of striated muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine deacetylation; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of cell division; P:positive regulation of DNA binding; P:positive regulation of execution phase of apoptosis; P:positive regulation of meiotic nuclear division; P:positive regulation of oocyte maturation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ADP-ribosylation; P:protein deacetylation; P:protein kinase B signaling; P:rDNA heterochromatin assembly; P:regulation of cell cycle; P:regulation of exit from mitosis; P:regulation of myelination; P:regulation of phosphorylation; P:response to redox state; P:substantia nigra development; P:tubulin deacetylation; scaffold131 indexed_genome mRNA 2744761 2752731 . + . ID=transcript_14127;Q15653 A8K3F4 Q96BJ7,NF-kappa-B inhibitor beta,I-kappa-B-beta;Thyroid receptor-interacting protein 9;, PF12796;, GO:0005829;GO:0005634;GO:0003713;GO:0071222;GO:0007253;GO:0051092;GO:0007165;GO:0006351;, C:cytosol; C:nucleus;, F:transcription coactivator activity;, P:cellular response to lipopolysaccharide; P:cytoplasmic sequestering of NF-kappaB; P:positive regulation of NF-kappaB transcription factor activity; P:signal transduction; P:transcription, DNA-templated;|Q15653 A8K3F4 Q96BJ7,NF-kappa-B inhibitor beta,I-kappa-B-beta;Thyroid receptor-interacting protein 9;, PF12796;, GO:0005829;GO:0005634;GO:0003713;GO:0071222;GO:0007253;GO:0051092;GO:0007165;GO:0006351;, C:cytosol; C:nucleus;, F:transcription coactivator activity;, P:cellular response to lipopolysaccharide; P:cytoplasmic sequestering of NF-kappaB; P:positive regulation of NF-kappaB transcription factor activity; P:signal transduction; P:transcription, DNA-templated; scaffold131 indexed_genome mRNA 2752824 2756517 . - . ID=transcript_14128;I3L3R5,Coiled-coil domain-containing glutamate-rich protein 2,, , GO:0005576;, C:extracellular region; scaffold131 indexed_genome mRNA 2757199 2766923 . - . ID=transcript_14129;Q9NP81 A6NHW7 B4DE10 Q9BVP3,Serine--tRNA ligase, mitochondrial,SerRSmt;Seryl-tRNA synthetase;Seryl-tRNA(Ser/Sec) synthetase;, PF00587;, GO:0005759;GO:0005739;GO:0005524;GO:0003723;GO:0004828;GO:0000049;GO:0070158;GO:0097056;GO:0006434;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:RNA binding; F:serine-tRNA ligase activity; F:tRNA binding;, P:mitochondrial seryl-tRNA aminoacylation; P:selenocysteinyl-tRNA(Sec) biosynthetic process; P:seryl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|Q9NP81 A6NHW7 B4DE10 Q9BVP3,Serine--tRNA ligase, mitochondrial,SerRSmt;Seryl-tRNA synthetase;Seryl-tRNA(Ser/Sec) synthetase;, PF00587;, GO:0005759;GO:0005739;GO:0005524;GO:0003723;GO:0004828;GO:0000049;GO:0070158;GO:0097056;GO:0006434;GO:0006418;, C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:RNA binding; F:serine-tRNA ligase activity; F:tRNA binding;, P:mitochondrial seryl-tRNA aminoacylation; P:selenocysteinyl-tRNA(Sec) biosynthetic process; P:seryl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; scaffold131 indexed_genome mRNA 2773366 2780185 . - . ID=transcript_14130;Q96EF6 Q96LQ4,F-box only protein 17,F-box only protein 26;, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0019005;GO:0006516;GO:0043687;GO:0000209;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex;, , P:glycoprotein catabolic process; P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway;|Q96EF6 Q96LQ4,F-box only protein 17,F-box only protein 26;, PF12937;PF04300;, GO:0005737;GO:0005829;GO:0019005;GO:0006516;GO:0043687;GO:0000209;GO:0031146;GO:0030433;, C:cytoplasm; C:cytosol; C:SCF ubiquitin ligase complex;, , P:glycoprotein catabolic process; P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent ERAD pathway; scaffold132 indexed_genome mRNA 683670 790033 . - . ID=transcript_14131;P61129 A9JR71 Q6ZW96,Zinc finger CCCH domain-containing protein 6,, PF00642;, GO:0000785;GO:0005634;GO:0046872;, C:chromatin; C:nucleus;, F:metal ion binding;|P61129 A9JR71 Q6ZW96,Zinc finger CCCH domain-containing protein 6,, PF00642;, GO:0000785;GO:0005634;GO:0046872;, C:chromatin; C:nucleus;, F:metal ion binding;|P61129 A9JR71 Q6ZW96,Zinc finger CCCH domain-containing protein 6,, PF00642;, GO:0000785;GO:0005634;GO:0046872;, C:chromatin; C:nucleus;, F:metal ion binding; scaffold132 indexed_genome mRNA 841358 868485 . + . ID=transcript_14132;Q8N5P1 Q9BZ75,Zinc finger CCCH domain-containing protein 8,, PF00642;, GO:0015030;GO:0000785;GO:0035363;GO:0016604;GO:0005654;GO:0005634;GO:0008023;GO:0035327;GO:0046872;GO:0003723;GO:0006915;GO:0033085;GO:0045892;GO:0070245;GO:0045945;GO:0046677;GO:0042795;GO:0042796;GO:0043029;, C:Cajal body; C:chromatin; C:histone locus body; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:metal ion binding; F:RNA binding;, P:apoptotic process; P:negative regulation of T cell differentiation in thymus; P:negative regulation of transcription, DNA-templated; P:positive regulation of thymocyte apoptotic process; P:positive regulation of transcription by RNA polymerase III; P:response to antibiotic; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:T cell homeostasis;|Q8N5P1 Q9BZ75,Zinc finger CCCH domain-containing protein 8,, PF00642;, GO:0015030;GO:0000785;GO:0035363;GO:0016604;GO:0005654;GO:0005634;GO:0008023;GO:0035327;GO:0046872;GO:0003723;GO:0006915;GO:0033085;GO:0045892;GO:0070245;GO:0045945;GO:0046677;GO:0042795;GO:0042796;GO:0043029;, C:Cajal body; C:chromatin; C:histone locus body; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:metal ion binding; F:RNA binding;, P:apoptotic process; P:negative regulation of T cell differentiation in thymus; P:negative regulation of transcription, DNA-templated; P:positive regulation of thymocyte apoptotic process; P:positive regulation of transcription by RNA polymerase III; P:response to antibiotic; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:T cell homeostasis;|Q8N5P1 Q9BZ75,Zinc finger CCCH domain-containing protein 8,, PF00642;, GO:0015030;GO:0000785;GO:0035363;GO:0016604;GO:0005654;GO:0005634;GO:0008023;GO:0035327;GO:0046872;GO:0003723;GO:0006915;GO:0033085;GO:0045892;GO:0070245;GO:0045945;GO:0046677;GO:0042795;GO:0042796;GO:0043029;, C:Cajal body; C:chromatin; C:histone locus body; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription elongation factor complex; C:transcriptionally active chromatin;, F:metal ion binding; F:RNA binding;, P:apoptotic process; P:negative regulation of T cell differentiation in thymus; P:negative regulation of transcription, DNA-templated; P:positive regulation of thymocyte apoptotic process; P:positive regulation of transcription by RNA polymerase III; P:response to antibiotic; P:snRNA transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase III; P:T cell homeostasis; scaffold132 indexed_genome mRNA 883973 893719 . + . ID=transcript_14133;Q53RD9 A0JNV1 A0JNV2 Q5H9P5 Q8N9G0,Fibulin-7,, PF00008;PF07645;PF00084;, GO:0031012;GO:0005615;GO:0005925;GO:0005509;GO:0043395;GO:0008201;GO:0007155;GO:0110151;, C:extracellular matrix; C:extracellular space; C:focal adhesion;, F:calcium ion binding; F:heparan sulfate proteoglycan binding; F:heparin binding;, P:cell adhesion; P:positive regulation of biomineralization;|Q53RD9 A0JNV1 A0JNV2 Q5H9P5 Q8N9G0,Fibulin-7,, PF00008;PF07645;PF00084;, GO:0031012;GO:0005615;GO:0005925;GO:0005509;GO:0043395;GO:0008201;GO:0007155;GO:0110151;, C:extracellular matrix; C:extracellular space; C:focal adhesion;, F:calcium ion binding; F:heparan sulfate proteoglycan binding; F:heparin binding;, P:cell adhesion; P:positive regulation of biomineralization; scaffold132 indexed_genome mRNA 953515 954029 . + . ID=transcript_14134;Q96K49 A8K2M9 Q1RLN2 Q53R54,Transmembrane protein 87B {ECO:0000305},, PF06814;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0042147;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, , P:retrograde transport, endosome to Golgi; scaffold132 indexed_genome mRNA 954350 960806 . - . ID=transcript_14135;Q96K49 A8K2M9 Q1RLN2 Q53R54,Transmembrane protein 87B {ECO:0000305},, PF06814;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0042147;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, , P:retrograde transport, endosome to Golgi; scaffold132 indexed_genome mRNA 966945 997768 . - . ID=transcript_14136;Q96K49 A8K2M9 Q1RLN2 Q53R54,Transmembrane protein 87B {ECO:0000305},, PF06814;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0042147;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, , P:retrograde transport, endosome to Golgi;|Q96K49 A8K2M9 Q1RLN2 Q53R54,Transmembrane protein 87B {ECO:0000305},, PF06814;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0042147;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, , P:retrograde transport, endosome to Golgi;|Q96K49 A8K2M9 Q1RLN2 Q53R54,Transmembrane protein 87B {ECO:0000305},, PF06814;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0042147;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, , P:retrograde transport, endosome to Golgi; scaffold132 indexed_genome mRNA 1022255 1141779 . + . ID=transcript_14137;Q12866 Q9HBB4,Tyrosine-protein kinase Mer,Proto-oncogene c-Mer;Receptor tyrosine kinase MerTK;, PF00041;PF00047;PF07714;, GO:0005737;GO:0005615;GO:0005887;GO:0001750;GO:0005886;GO:0043235;GO:0016028;GO:0005524;GO:0004714;GO:0016477;GO:0007166;GO:0007267;GO:0050900;GO:0007275;GO:0001779;GO:0001818;GO:2000107;GO:0051250;GO:0007399;GO:0097350;GO:0006909;GO:0030168;GO:0033674;GO:0050766;GO:0043491;GO:0006468;GO:0060041;GO:0032940;GO:0007283;GO:0034446;GO:0007169;GO:0060068;, C:cytoplasm; C:extracellular space; C:integral component of plasma membrane; C:photoreceptor outer segment; C:plasma membrane; C:receptor complex; C:rhabdomere;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:leukocyte migration; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of cytokine production; P:negative regulation of leukocyte apoptotic process; P:negative regulation of lymphocyte activation; P:nervous system development; P:neutrophil clearance; P:phagocytosis; P:platelet activation; P:positive regulation of kinase activity; P:positive regulation of phagocytosis; P:protein kinase B signaling; P:protein phosphorylation; P:retina development in camera-type eye; P:secretion by cell; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development;|Q12866 Q9HBB4,Tyrosine-protein kinase Mer,Proto-oncogene c-Mer;Receptor tyrosine kinase MerTK;, PF00041;PF00047;PF07714;, GO:0005737;GO:0005615;GO:0005887;GO:0001750;GO:0005886;GO:0043235;GO:0016028;GO:0005524;GO:0004714;GO:0016477;GO:0007166;GO:0007267;GO:0050900;GO:0007275;GO:0001779;GO:0001818;GO:2000107;GO:0051250;GO:0007399;GO:0097350;GO:0006909;GO:0030168;GO:0033674;GO:0050766;GO:0043491;GO:0006468;GO:0060041;GO:0032940;GO:0007283;GO:0034446;GO:0007169;GO:0060068;, C:cytoplasm; C:extracellular space; C:integral component of plasma membrane; C:photoreceptor outer segment; C:plasma membrane; C:receptor complex; C:rhabdomere;, F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell migration; P:cell surface receptor signaling pathway; P:cell-cell signaling; P:leukocyte migration; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of cytokine production; P:negative regulation of leukocyte apoptotic process; P:negative regulation of lymphocyte activation; P:nervous system development; P:neutrophil clearance; P:phagocytosis; P:platelet activation; P:positive regulation of kinase activity; P:positive regulation of phagocytosis; P:protein kinase B signaling; P:protein phosphorylation; P:retina development in camera-type eye; P:secretion by cell; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development; scaffold132 indexed_genome mRNA 1151019 1250396 . + . ID=transcript_14138;Q9H1A4 Q2M3H8 Q9BSE6 Q9H8D0,Anaphase-promoting complex subunit 1,Cyclosome subunit 1;Mitotic checkpoint regulator;Testis-specific gene 24 protein;, PF12859;PF18122;, GO:0005680;GO:0005829;GO:0005654;GO:0060090;GO:0031145;GO:0051301;GO:0007091;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:molecular adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9H1A4 Q2M3H8 Q9BSE6 Q9H8D0,Anaphase-promoting complex subunit 1,Cyclosome subunit 1;Mitotic checkpoint regulator;Testis-specific gene 24 protein;, PF12859;PF18122;, GO:0005680;GO:0005829;GO:0005654;GO:0060090;GO:0031145;GO:0051301;GO:0007091;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:molecular adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9H1A4 Q2M3H8 Q9BSE6 Q9H8D0,Anaphase-promoting complex subunit 1,Cyclosome subunit 1;Mitotic checkpoint regulator;Testis-specific gene 24 protein;, PF12859;PF18122;, GO:0005680;GO:0005829;GO:0005654;GO:0060090;GO:0031145;GO:0051301;GO:0007091;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:molecular adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9H1A4 Q2M3H8 Q9BSE6 Q9H8D0,Anaphase-promoting complex subunit 1,Cyclosome subunit 1;Mitotic checkpoint regulator;Testis-specific gene 24 protein;, PF12859;PF18122;, GO:0005680;GO:0005829;GO:0005654;GO:0060090;GO:0031145;GO:0051301;GO:0007091;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:molecular adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9H1A4 Q2M3H8 Q9BSE6 Q9H8D0,Anaphase-promoting complex subunit 1,Cyclosome subunit 1;Mitotic checkpoint regulator;Testis-specific gene 24 protein;, PF12859;PF18122;, GO:0005680;GO:0005829;GO:0005654;GO:0060090;GO:0031145;GO:0051301;GO:0007091;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:molecular adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9H1A4 Q2M3H8 Q9BSE6 Q9H8D0,Anaphase-promoting complex subunit 1,Cyclosome subunit 1;Mitotic checkpoint regulator;Testis-specific gene 24 protein;, PF12859;PF18122;, GO:0005680;GO:0005829;GO:0005654;GO:0060090;GO:0031145;GO:0051301;GO:0007091;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:molecular adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9H1A4 Q2M3H8 Q9BSE6 Q9H8D0,Anaphase-promoting complex subunit 1,Cyclosome subunit 1;Mitotic checkpoint regulator;Testis-specific gene 24 protein;, PF12859;PF18122;, GO:0005680;GO:0005829;GO:0005654;GO:0060090;GO:0031145;GO:0051301;GO:0007091;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:molecular adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9H1A4 Q2M3H8 Q9BSE6 Q9H8D0,Anaphase-promoting complex subunit 1,Cyclosome subunit 1;Mitotic checkpoint regulator;Testis-specific gene 24 protein;, PF12859;PF18122;, GO:0005680;GO:0005829;GO:0005654;GO:0060090;GO:0031145;GO:0051301;GO:0007091;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:molecular adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9H1A4 Q2M3H8 Q9BSE6 Q9H8D0,Anaphase-promoting complex subunit 1,Cyclosome subunit 1;Mitotic checkpoint regulator;Testis-specific gene 24 protein;, PF12859;PF18122;, GO:0005680;GO:0005829;GO:0005654;GO:0060090;GO:0031145;GO:0051301;GO:0007091;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:molecular adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9H1A4 Q2M3H8 Q9BSE6 Q9H8D0,Anaphase-promoting complex subunit 1,Cyclosome subunit 1;Mitotic checkpoint regulator;Testis-specific gene 24 protein;, PF12859;PF18122;, GO:0005680;GO:0005829;GO:0005654;GO:0060090;GO:0031145;GO:0051301;GO:0007091;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:molecular adaptor activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold132 indexed_genome mRNA 1816402 1861945 . - . ID=transcript_14139;Q8WYM1,Bcl-2-like protein 11,Bcl2-interacting mediator of cell death;, PF08945;PF06773;, GO:0097136;GO:0097141;GO:0097140;GO:0005829;GO:0012505;GO:0019898;GO:0005741;GO:0005739;GO:0008017;GO:0019901;GO:0006919;GO:0006915;GO:1902263;GO:0001783;GO:0001782;GO:0007420;GO:0007160;GO:1904646;GO:0071392;GO:0071385;GO:0019221;GO:0048066;GO:0043583;GO:0097192;GO:0001701;GO:0008630;GO:0001822;GO:0008584;GO:0030879;GO:0007127;GO:0002262;GO:0042475;GO:0043065;GO:0060139;GO:0034263;GO:0045787;GO:0043280;GO:1902237;GO:2000271;GO:2001244;GO:1903896;GO:0043525;GO:0031334;GO:0090200;GO:0048563;GO:0001844;GO:0042981;GO:0048070;GO:0046620;GO:0034976;GO:0007283;GO:0048536;GO:0043029;GO:0070242;GO:0048538;GO:0035148;, C:Bcl-2 family protein complex; C:BIM-BCL-2 complex; C:BIM-BCL-xl complex; C:cytosol; C:endomembrane system; C:extrinsic component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:microtubule binding; F:protein kinase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:apoptotic process involved in embryonic digit morphogenesis; P:B cell apoptotic process; P:B cell homeostasis; P:brain development; P:cell-matrix adhesion; P:cellular response to amyloid-beta; P:cellular response to estradiol stimulus; P:cellular response to glucocorticoid stimulus; P:cytokine-mediated signaling pathway; P:developmental pigmentation; P:ear development; P:extrinsic apoptotic signaling pathway in absence of ligand; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:kidney development; P:male gonad development; P:mammary gland development; P:meiosis I; P:myeloid cell homeostasis; P:odontogenesis of dentin-containing tooth; P:positive regulation of apoptotic process; P:positive regulation of apoptotic process by virus; P:positive regulation of autophagy in response to ER overload; P:positive regulation of cell cycle; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of fibroblast apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of neuron apoptotic process; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:post-embryonic animal organ morphogenesis; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of developmental pigmentation; P:regulation of organ growth; P:response to endoplasmic reticulum stress; P:spermatogenesis; P:spleen development; P:T cell homeostasis; P:thymocyte apoptotic process; P:thymus development; P:tube formation; scaffold132 indexed_genome mRNA 2270015 2289824 . - . ID=transcript_14140;Q00975 B1AQK5,Voltage-dependent N-type calcium channel subunit alpha-1B,Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;, PF08763;PF16905;PF00520;, GO:0005886;GO:0045202;GO:0005891;GO:0001540;GO:0005524;GO:0005509;GO:0008331;GO:0008022;GO:0005245;GO:0070509;GO:0006816;GO:0007268;GO:0051899;GO:0050804;GO:0034765;GO:1904645;, C:plasma membrane; C:synapse; C:voltage-gated calcium channel complex;, F:amyloid-beta binding; F:ATP binding; F:calcium ion binding; F:high voltage-gated calcium channel activity; F:protein C-terminus binding; F:voltage-gated calcium channel activity;, P:calcium ion import; P:calcium ion transport; P:chemical synaptic transmission; P:membrane depolarization; P:modulation of chemical synaptic transmission; P:regulation of ion transmembrane transport; P:response to amyloid-beta;|Q9ULQ1 A7E258 Q86XS9 Q8NC20,Two pore calcium channel protein 1,Voltage-dependent calcium channel protein TPC1;, PF00520;, GO:0005768;GO:0010008;GO:0016021;GO:0005765;GO:0005764;GO:0042802;GO:0015280;GO:0072345;GO:0080025;GO:0042803;GO:0005245;GO:0005248;GO:0034220;GO:0010508;GO:0034765;, C:endosome; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:lysosome;, F:identical protein binding; F:ligand-gated sodium channel activity; F:NAADP-sensitive calcium-release channel activity; F:phosphatidylinositol-3,5-bisphosphate binding; F:protein homodimerization activity; F:voltage-gated calcium channel activity; F:voltage-gated sodium channel activity;, P:ion transmembrane transport; P:positive regulation of autophagy; P:regulation of ion transmembrane transport; scaffold132 indexed_genome mRNA 2333714 2402716 . + . ID=transcript_14141;O15259 O14837,Nephrocystin-1,Juvenile nephronophthisis 1 protein;, PF00018;, GO:0005912;GO:0005923;GO:0005911;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0016020;GO:0031514;GO:0032391;GO:0005198;GO:0030036;GO:0030030;GO:0098609;GO:0097711;GO:0007588;GO:1903348;GO:0090251;GO:0060041;GO:0007165;GO:0048515;GO:0007632;, C:adherens junction; C:bicellular tight junction; C:cell-cell junction; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:membrane; C:motile cilium; C:photoreceptor connecting cilium;, F:structural molecule activity;, P:actin cytoskeleton organization; P:cell projection organization; P:cell-cell adhesion; P:ciliary basal body-plasma membrane docking; P:excretion; P:positive regulation of bicellular tight junction assembly; P:protein localization involved in establishment of planar polarity; P:retina development in camera-type eye; P:signal transduction; P:spermatid differentiation; P:visual behavior;|O15259 O14837,Nephrocystin-1,Juvenile nephronophthisis 1 protein;, PF00018;, GO:0005912;GO:0005923;GO:0005911;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0016020;GO:0031514;GO:0032391;GO:0005198;GO:0030036;GO:0030030;GO:0098609;GO:0097711;GO:0007588;GO:1903348;GO:0090251;GO:0060041;GO:0007165;GO:0048515;GO:0007632;, C:adherens junction; C:bicellular tight junction; C:cell-cell junction; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:membrane; C:motile cilium; C:photoreceptor connecting cilium;, F:structural molecule activity;, P:actin cytoskeleton organization; P:cell projection organization; P:cell-cell adhesion; P:ciliary basal body-plasma membrane docking; P:excretion; P:positive regulation of bicellular tight junction assembly; P:protein localization involved in establishment of planar polarity; P:retina development in camera-type eye; P:signal transduction; P:spermatid differentiation; P:visual behavior;|O15259 O14837,Nephrocystin-1,Juvenile nephronophthisis 1 protein;, PF00018;, GO:0005912;GO:0005923;GO:0005911;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0016020;GO:0031514;GO:0032391;GO:0005198;GO:0030036;GO:0030030;GO:0098609;GO:0097711;GO:0007588;GO:1903348;GO:0090251;GO:0060041;GO:0007165;GO:0048515;GO:0007632;, C:adherens junction; C:bicellular tight junction; C:cell-cell junction; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:membrane; C:motile cilium; C:photoreceptor connecting cilium;, F:structural molecule activity;, P:actin cytoskeleton organization; P:cell projection organization; P:cell-cell adhesion; P:ciliary basal body-plasma membrane docking; P:excretion; P:positive regulation of bicellular tight junction assembly; P:protein localization involved in establishment of planar polarity; P:retina development in camera-type eye; P:signal transduction; P:spermatid differentiation; P:visual behavior; scaffold132 indexed_genome mRNA 2416772 2447999 . + . ID=transcript_14142;Q13021 B3KWR6 Q9BTU0,MAL-like protein,Protein BENE;, PF01284;, GO:0030136;GO:0031410;GO:0000139;GO:0016021;GO:0045121;GO:0005886;GO:0019911;GO:0042632;GO:0042552;, C:clathrin-coated vesicle; C:cytoplasmic vesicle; C:Golgi membrane; C:integral component of membrane; C:membrane raft; C:plasma membrane;, F:structural constituent of myelin sheath;, P:cholesterol homeostasis; P:myelination; scaffold132 indexed_genome mRNA 2483878 2504666 . + . ID=transcript_14143;P21145 Q6FH77,Myelin and lymphocyte protein,T-lymphocyte maturation-associated protein;, PF01284;, GO:0016324;GO:0005783;GO:0019898;GO:0016021;GO:0045121;GO:0008289;GO:0016505;GO:0019911;GO:0045176;GO:0006915;GO:0030154;GO:0007417;GO:0001766;GO:0042552;, C:apical plasma membrane; C:endoplasmic reticulum; C:extrinsic component of membrane; C:integral component of membrane; C:membrane raft;, F:lipid binding; F:peptidase activator activity involved in apoptotic process; F:structural constituent of myelin sheath;, P:apical protein localization; P:apoptotic process; P:cell differentiation; P:central nervous system development; P:membrane raft polarization; P:myelination;|P21145 Q6FH77,Myelin and lymphocyte protein,T-lymphocyte maturation-associated protein;, PF01284;, GO:0016324;GO:0005783;GO:0019898;GO:0016021;GO:0045121;GO:0008289;GO:0016505;GO:0019911;GO:0045176;GO:0006915;GO:0030154;GO:0007417;GO:0001766;GO:0042552;, C:apical plasma membrane; C:endoplasmic reticulum; C:extrinsic component of membrane; C:integral component of membrane; C:membrane raft;, F:lipid binding; F:peptidase activator activity involved in apoptotic process; F:structural constituent of myelin sheath;, P:apical protein localization; P:apoptotic process; P:cell differentiation; P:central nervous system development; P:membrane raft polarization; P:myelination; scaffold132 indexed_genome mRNA 2546705 2570931 . - . ID=transcript_14144;P82675 Q4ZFY5 Q96LJ6 Q9BWI4 Q9BYC4,28S ribosomal protein S5, mitochondrial,Mitochondrial small ribosomal subunit protein uS5m {ECO:0000303|PubMed:25838379};, PF00333;PF03719;, GO:0005743;GO:0005763;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold132 indexed_genome mRNA 2602922 2610167 . + . ID=transcript_14145;Q9BSG1 A8MWV7 B0AZN8 B4DIR4 Q4ZFY6 Q96G44 Q9UMC5,Zinc finger protein 2 {ECO:0000305},Zinc finger protein 2.2;Zinc finger protein 661;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9BSG1 A8MWV7 B0AZN8 B4DIR4 Q4ZFY6 Q96G44 Q9UMC5,Zinc finger protein 2 {ECO:0000305},Zinc finger protein 2.2;Zinc finger protein 661;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9BSG1 A8MWV7 B0AZN8 B4DIR4 Q4ZFY6 Q96G44 Q9UMC5,Zinc finger protein 2 {ECO:0000305},Zinc finger protein 2.2;Zinc finger protein 661;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9BSG1 A8MWV7 B0AZN8 B4DIR4 Q4ZFY6 Q96G44 Q9UMC5,Zinc finger protein 2 {ECO:0000305},Zinc finger protein 2.2;Zinc finger protein 661;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold132 indexed_genome mRNA 2614853 2625141 . + . ID=transcript_14146;Q99676 B2R715 O60792 Q8TBA9,Zinc finger protein 184,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold132 indexed_genome mRNA 2671095 2760278 . + . ID=transcript_14147;Q9Y2W7 H7BY46 Q3YAC3 Q3YAC4 Q53TJ5 Q96T40 Q9UJ84 Q9UJ85,Calsenilin,A-type potassium channel modulatory protein 3;DRE-antagonist modulator;Kv channel-interacting protein 3;, PF13499;PF13833;, GO:0043679;GO:0005829;GO:0030425;GO:0005783;GO:0005794;GO:0005634;GO:0005886;GO:0032993;GO:0008076;GO:0005509;GO:0001227;GO:0044325;GO:0005267;GO:0015459;GO:0000978;GO:0005244;GO:0006915;GO:0061337;GO:0006886;GO:0000122;GO:0072659;GO:1901379;GO:0007165;, C:axon terminus; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:Golgi apparatus; C:nucleus; C:plasma membrane; C:protein-DNA complex; C:voltage-gated potassium channel complex;, F:calcium ion binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:ion channel binding; F:potassium channel activity; F:potassium channel regulator activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:voltage-gated ion channel activity;, P:apoptotic process; P:cardiac conduction; P:intracellular protein transport; P:negative regulation of transcription by RNA polymerase II; P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport; P:signal transduction; scaffold132 indexed_genome mRNA 2776372 2785668 . + . ID=transcript_14148;Q96GK7 Q9Y3B0,Fumarylacetoacetate hydrolase domain-containing protein 2A,, PF01557;, GO:0016836;GO:0016787;GO:0046872;, , F:hydro-lyase activity; F:hydrolase activity; F:metal ion binding;|Q96GK7 Q9Y3B0,Fumarylacetoacetate hydrolase domain-containing protein 2A,, PF01557;, GO:0016836;GO:0016787;GO:0046872;, , F:hydro-lyase activity; F:hydrolase activity; F:metal ion binding;|Q96GK7 Q9Y3B0,Fumarylacetoacetate hydrolase domain-containing protein 2A,, PF01557;, GO:0016836;GO:0016787;GO:0046872;, , F:hydro-lyase activity; F:hydrolase activity; F:metal ion binding; scaffold132 indexed_genome mRNA 2785776 2791400 . - . ID=transcript_14149;Q6NUI2 Q6P2E4 Q6ZNI3 Q6ZNI5 Q6ZWJ4,Glycerol-3-phosphate acyltransferase 2, mitochondrial {ECO:0000305},1-acylglycerol-3-phosphate O-acyltransferase GPAT2 {ECO:0000250|UniProtKB:Q14DK4};xGPAT1 {ECO:0000250|UniProtKB:Q14DK4};, , GO:0016021;GO:0031966;GO:0005741;GO:0005739;GO:0003841;GO:0004366;GO:0102420;GO:0016024;GO:0006631;GO:0006072;GO:0006654;GO:0008654;GO:1990511;GO:0019432;, C:integral component of membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:glycerol-3-phosphate O-acyltransferase activity; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity;, P:CDP-diacylglycerol biosynthetic process; P:fatty acid metabolic process; P:glycerol-3-phosphate metabolic process; P:phosphatidic acid biosynthetic process; P:phospholipid biosynthetic process; P:piRNA biosynthetic process; P:triglyceride biosynthetic process; scaffold133 indexed_genome mRNA 80253 136756 . + . ID=transcript_14150;O95180 B5ME00 F8WFD1 O95802 Q8WWI6 Q96QI6 Q96RZ9 Q9NYY4 Q9NYY5,Voltage-dependent T-type calcium channel subunit alpha-1H,Low-voltage-activated calcium channel alpha1 3.2 subunit;Voltage-gated calcium channel subunit alpha Cav3.2;, PF00520;, GO:0016021;GO:0005887;GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0046872;GO:0097110;GO:0005244;GO:0005248;GO:0032342;GO:0070509;GO:0032870;GO:0035865;GO:0034651;GO:0098662;GO:0086010;GO:0006936;GO:0007517;GO:0007520;GO:0019228;GO:2000344;GO:0045956;GO:0008016;GO:0034765;GO:0042391;, C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:metal ion binding; F:scaffold protein binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:aldosterone biosynthetic process; P:calcium ion import; P:cellular response to hormone stimulus; P:cellular response to potassium ion; P:cortisol biosynthetic process; P:inorganic cation transmembrane transport; P:membrane depolarization during action potential; P:muscle contraction; P:muscle organ development; P:myoblast fusion; P:neuronal action potential; P:positive regulation of acrosome reaction; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of heart contraction; P:regulation of ion transmembrane transport; P:regulation of membrane potential;|O95180 B5ME00 F8WFD1 O95802 Q8WWI6 Q96QI6 Q96RZ9 Q9NYY4 Q9NYY5,Voltage-dependent T-type calcium channel subunit alpha-1H,Low-voltage-activated calcium channel alpha1 3.2 subunit;Voltage-gated calcium channel subunit alpha Cav3.2;, PF00520;, GO:0016021;GO:0005887;GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0046872;GO:0097110;GO:0005244;GO:0005248;GO:0032342;GO:0070509;GO:0032870;GO:0035865;GO:0034651;GO:0098662;GO:0086010;GO:0006936;GO:0007517;GO:0007520;GO:0019228;GO:2000344;GO:0045956;GO:0008016;GO:0034765;GO:0042391;, C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:metal ion binding; F:scaffold protein binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:aldosterone biosynthetic process; P:calcium ion import; P:cellular response to hormone stimulus; P:cellular response to potassium ion; P:cortisol biosynthetic process; P:inorganic cation transmembrane transport; P:membrane depolarization during action potential; P:muscle contraction; P:muscle organ development; P:myoblast fusion; P:neuronal action potential; P:positive regulation of acrosome reaction; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of heart contraction; P:regulation of ion transmembrane transport; P:regulation of membrane potential;|O95180 B5ME00 F8WFD1 O95802 Q8WWI6 Q96QI6 Q96RZ9 Q9NYY4 Q9NYY5,Voltage-dependent T-type calcium channel subunit alpha-1H,Low-voltage-activated calcium channel alpha1 3.2 subunit;Voltage-gated calcium channel subunit alpha Cav3.2;, PF00520;, GO:0016021;GO:0005887;GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0046872;GO:0097110;GO:0005244;GO:0005248;GO:0032342;GO:0070509;GO:0032870;GO:0035865;GO:0034651;GO:0098662;GO:0086010;GO:0006936;GO:0007517;GO:0007520;GO:0019228;GO:2000344;GO:0045956;GO:0008016;GO:0034765;GO:0042391;, C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:metal ion binding; F:scaffold protein binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:aldosterone biosynthetic process; P:calcium ion import; P:cellular response to hormone stimulus; P:cellular response to potassium ion; P:cortisol biosynthetic process; P:inorganic cation transmembrane transport; P:membrane depolarization during action potential; P:muscle contraction; P:muscle organ development; P:myoblast fusion; P:neuronal action potential; P:positive regulation of acrosome reaction; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of heart contraction; P:regulation of ion transmembrane transport; P:regulation of membrane potential;|O95180 B5ME00 F8WFD1 O95802 Q8WWI6 Q96QI6 Q96RZ9 Q9NYY4 Q9NYY5,Voltage-dependent T-type calcium channel subunit alpha-1H,Low-voltage-activated calcium channel alpha1 3.2 subunit;Voltage-gated calcium channel subunit alpha Cav3.2;, PF00520;, GO:0016021;GO:0005887;GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0046872;GO:0097110;GO:0005244;GO:0005248;GO:0032342;GO:0070509;GO:0032870;GO:0035865;GO:0034651;GO:0098662;GO:0086010;GO:0006936;GO:0007517;GO:0007520;GO:0019228;GO:2000344;GO:0045956;GO:0008016;GO:0034765;GO:0042391;, C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:metal ion binding; F:scaffold protein binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:aldosterone biosynthetic process; P:calcium ion import; P:cellular response to hormone stimulus; P:cellular response to potassium ion; P:cortisol biosynthetic process; P:inorganic cation transmembrane transport; P:membrane depolarization during action potential; P:muscle contraction; P:muscle organ development; P:myoblast fusion; P:neuronal action potential; P:positive regulation of acrosome reaction; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of heart contraction; P:regulation of ion transmembrane transport; P:regulation of membrane potential;|O95180 B5ME00 F8WFD1 O95802 Q8WWI6 Q96QI6 Q96RZ9 Q9NYY4 Q9NYY5,Voltage-dependent T-type calcium channel subunit alpha-1H,Low-voltage-activated calcium channel alpha1 3.2 subunit;Voltage-gated calcium channel subunit alpha Cav3.2;, PF00520;, GO:0016021;GO:0005887;GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0046872;GO:0097110;GO:0005244;GO:0005248;GO:0032342;GO:0070509;GO:0032870;GO:0035865;GO:0034651;GO:0098662;GO:0086010;GO:0006936;GO:0007517;GO:0007520;GO:0019228;GO:2000344;GO:0045956;GO:0008016;GO:0034765;GO:0042391;, C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:metal ion binding; F:scaffold protein binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:aldosterone biosynthetic process; P:calcium ion import; P:cellular response to hormone stimulus; P:cellular response to potassium ion; P:cortisol biosynthetic process; P:inorganic cation transmembrane transport; P:membrane depolarization during action potential; P:muscle contraction; P:muscle organ development; P:myoblast fusion; P:neuronal action potential; P:positive regulation of acrosome reaction; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of heart contraction; P:regulation of ion transmembrane transport; P:regulation of membrane potential;|O95180 B5ME00 F8WFD1 O95802 Q8WWI6 Q96QI6 Q96RZ9 Q9NYY4 Q9NYY5,Voltage-dependent T-type calcium channel subunit alpha-1H,Low-voltage-activated calcium channel alpha1 3.2 subunit;Voltage-gated calcium channel subunit alpha Cav3.2;, PF00520;, GO:0016021;GO:0005887;GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0046872;GO:0097110;GO:0005244;GO:0005248;GO:0032342;GO:0070509;GO:0032870;GO:0035865;GO:0034651;GO:0098662;GO:0086010;GO:0006936;GO:0007517;GO:0007520;GO:0019228;GO:2000344;GO:0045956;GO:0008016;GO:0034765;GO:0042391;, C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:metal ion binding; F:scaffold protein binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:aldosterone biosynthetic process; P:calcium ion import; P:cellular response to hormone stimulus; P:cellular response to potassium ion; P:cortisol biosynthetic process; P:inorganic cation transmembrane transport; P:membrane depolarization during action potential; P:muscle contraction; P:muscle organ development; P:myoblast fusion; P:neuronal action potential; P:positive regulation of acrosome reaction; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of heart contraction; P:regulation of ion transmembrane transport; P:regulation of membrane potential;|O95180 B5ME00 F8WFD1 O95802 Q8WWI6 Q96QI6 Q96RZ9 Q9NYY4 Q9NYY5,Voltage-dependent T-type calcium channel subunit alpha-1H,Low-voltage-activated calcium channel alpha1 3.2 subunit;Voltage-gated calcium channel subunit alpha Cav3.2;, PF00520;, GO:0016021;GO:0005887;GO:0043005;GO:0005891;GO:0001518;GO:0008332;GO:0046872;GO:0097110;GO:0005244;GO:0005248;GO:0032342;GO:0070509;GO:0032870;GO:0035865;GO:0034651;GO:0098662;GO:0086010;GO:0006936;GO:0007517;GO:0007520;GO:0019228;GO:2000344;GO:0045956;GO:0008016;GO:0034765;GO:0042391;, C:integral component of membrane; C:integral component of plasma membrane; C:neuron projection; C:voltage-gated calcium channel complex; C:voltage-gated sodium channel complex;, F:low voltage-gated calcium channel activity; F:metal ion binding; F:scaffold protein binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity;, P:aldosterone biosynthetic process; P:calcium ion import; P:cellular response to hormone stimulus; P:cellular response to potassium ion; P:cortisol biosynthetic process; P:inorganic cation transmembrane transport; P:membrane depolarization during action potential; P:muscle contraction; P:muscle organ development; P:myoblast fusion; P:neuronal action potential; P:positive regulation of acrosome reaction; P:positive regulation of calcium ion-dependent exocytosis; P:regulation of heart contraction; P:regulation of ion transmembrane transport; P:regulation of membrane potential; scaffold133 indexed_genome mRNA 184568 197026 . + . ID=transcript_14151;P63279 D3DU69 P50550 Q15698 Q59GX1 Q86VB3,SUMO-conjugating enzyme UBC9,RING-type E3 SUMO transferase UBC9;SUMO-protein ligase;Ubiquitin carrier protein 9;Ubiquitin carrier protein I;Ubiquitin-conjugating enzyme E2 I;Ubiquitin-protein ligase I;p18;, PF00179;, GO:0005737;GO:0005829;GO:0005635;GO:0005654;GO:0005634;GO:0016605;GO:1990356;GO:0000795;GO:1990234;GO:0005524;GO:0019899;GO:0071535;GO:0003723;GO:0044388;GO:0061656;GO:0019789;GO:0001221;GO:0008134;GO:0051301;GO:0006464;GO:0007059;GO:0007084;GO:0000122;GO:0045892;GO:1903755;GO:0016925;GO:0006511;GO:0019082;, C:cytoplasm; C:cytosol; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:PML body; C:sumoylated E2 ligase complex; C:synaptonemal complex; C:transferase complex;, F:ATP binding; F:enzyme binding; F:RING-like zinc finger domain binding; F:RNA binding; F:small protein activating enzyme binding; F:SUMO conjugating enzyme activity; F:SUMO transferase activity; F:transcription coregulator binding; F:transcription factor binding;, P:cell division; P:cellular protein modification process; P:chromosome segregation; P:mitotic nuclear envelope reassembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of SUMO transferase activity; P:protein sumoylation; P:ubiquitin-dependent protein catabolic process; P:viral protein processing;|P63279 D3DU69 P50550 Q15698 Q59GX1 Q86VB3,SUMO-conjugating enzyme UBC9,RING-type E3 SUMO transferase UBC9;SUMO-protein ligase;Ubiquitin carrier protein 9;Ubiquitin carrier protein I;Ubiquitin-conjugating enzyme E2 I;Ubiquitin-protein ligase I;p18;, PF00179;, GO:0005737;GO:0005829;GO:0005635;GO:0005654;GO:0005634;GO:0016605;GO:1990356;GO:0000795;GO:1990234;GO:0005524;GO:0019899;GO:0071535;GO:0003723;GO:0044388;GO:0061656;GO:0019789;GO:0001221;GO:0008134;GO:0051301;GO:0006464;GO:0007059;GO:0007084;GO:0000122;GO:0045892;GO:1903755;GO:0016925;GO:0006511;GO:0019082;, C:cytoplasm; C:cytosol; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:PML body; C:sumoylated E2 ligase complex; C:synaptonemal complex; C:transferase complex;, F:ATP binding; F:enzyme binding; F:RING-like zinc finger domain binding; F:RNA binding; F:small protein activating enzyme binding; F:SUMO conjugating enzyme activity; F:SUMO transferase activity; F:transcription coregulator binding; F:transcription factor binding;, P:cell division; P:cellular protein modification process; P:chromosome segregation; P:mitotic nuclear envelope reassembly; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of SUMO transferase activity; P:protein sumoylation; P:ubiquitin-dependent protein catabolic process; P:viral protein processing; scaffold133 indexed_genome mRNA 210263 221856 . + . ID=transcript_14152;H3BVI3 H7C2Q1 O94839 Q2M226 Q658J2 Q76N05 Q96RZ3 Q9UJK1,BAI1-associated protein 3 {ECO:0000303|PubMed:9790924},Brain-specific angiogenesis inhibitor I-associated protein 3 {ECO:0000303|PubMed:9790924};, PF00168;, GO:0005829;GO:0031902;GO:0005886;GO:0098793;GO:0055038;GO:0032588;GO:0005509;GO:0005543;GO:0000149;GO:0019905;GO:1990502;GO:0006887;GO:0007186;GO:0035774;GO:0001956;GO:1905413;GO:0032228;GO:0042147;, C:cytosol; C:late endosome membrane; C:plasma membrane; C:presynapse; C:recycling endosome membrane; C:trans-Golgi network membrane;, F:calcium ion binding; F:phospholipid binding; F:SNARE binding; F:syntaxin binding;, P:dense core granule maturation; P:exocytosis; P:G protein-coupled receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of neurotransmitter secretion; P:regulation of dense core granule exocytosis; P:regulation of synaptic transmission, GABAergic; P:retrograde transport, endosome to Golgi;|Q9UJK0 Q6PJT8,18S rRNA aminocarboxypropyltransferase {ECO:0000305},20S S rRNA accumulation protein 3 homolog {ECO:0000303|PubMed:27084949};, PF04034;PF04068;, GO:0005829;GO:1904047;GO:0016740;GO:0000455;GO:0030490;GO:0000154;, C:cytosol;, F:S-adenosyl-L-methionine binding; F:transferase activity;, P:enzyme-directed rRNA pseudouridine synthesis; P:maturation of SSU-rRNA; P:rRNA modification;|Q9UJK0 Q6PJT8,18S rRNA aminocarboxypropyltransferase {ECO:0000305},20S S rRNA accumulation protein 3 homolog {ECO:0000303|PubMed:27084949};, PF04034;PF04068;, GO:0005829;GO:1904047;GO:0016740;GO:0000455;GO:0030490;GO:0000154;, C:cytosol;, F:S-adenosyl-L-methionine binding; F:transferase activity;, P:enzyme-directed rRNA pseudouridine synthesis; P:maturation of SSU-rRNA; P:rRNA modification; scaffold133 indexed_genome mRNA 222305 237019 . + . ID=transcript_14153;Q9UJJ9 B2R556 Q6XYD7 Q96L13,N-acetylglucosamine-1-phosphotransferase subunit gamma,GlcNAc-1-phosphotransferase subunit gamma;UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma;, PF13015;, GO:0070062;GO:0005794;GO:0000139;GO:0042803;GO:0003976;GO:0046835;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane;, F:protein homodimerization activity; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:carbohydrate phosphorylation;|Q9UJJ9 B2R556 Q6XYD7 Q96L13,N-acetylglucosamine-1-phosphotransferase subunit gamma,GlcNAc-1-phosphotransferase subunit gamma;UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma;, PF13015;, GO:0070062;GO:0005794;GO:0000139;GO:0042803;GO:0003976;GO:0046835;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane;, F:protein homodimerization activity; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:carbohydrate phosphorylation;|Q9UJJ9 B2R556 Q6XYD7 Q96L13,N-acetylglucosamine-1-phosphotransferase subunit gamma,GlcNAc-1-phosphotransferase subunit gamma;UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma;, PF13015;, GO:0070062;GO:0005794;GO:0000139;GO:0042803;GO:0003976;GO:0046835;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane;, F:protein homodimerization activity; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:carbohydrate phosphorylation;|Q9UJJ9 B2R556 Q6XYD7 Q96L13,N-acetylglucosamine-1-phosphotransferase subunit gamma,GlcNAc-1-phosphotransferase subunit gamma;UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma;, PF13015;, GO:0070062;GO:0005794;GO:0000139;GO:0042803;GO:0003976;GO:0046835;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane;, F:protein homodimerization activity; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;, P:carbohydrate phosphorylation; scaffold133 indexed_genome mRNA 237259 239597 . + . ID=transcript_14154;Q9H9P5 B0QYN6 B1GXI8 Q96EV1 Q96RZ1 Q9BWL5 Q9H5K0 Q9UJJ8,Putative E3 ubiquitin-protein ligase UNKL,RING finger protein unkempt-like;Zinc finger CCCH domain-containing protein 5-like;, PF00642;PF18384;, GO:0005829;GO:0005634;GO:0046872;GO:0016740;GO:0000209;, C:cytosol; C:nucleus;, F:metal ion binding; F:transferase activity;, P:protein polyubiquitination; scaffold133 indexed_genome mRNA 251932 272413 . - . ID=transcript_14155;Q9H9P5 B0QYN6 B1GXI8 Q96EV1 Q96RZ1 Q9BWL5 Q9H5K0 Q9UJJ8,Putative E3 ubiquitin-protein ligase UNKL,RING finger protein unkempt-like;Zinc finger CCCH domain-containing protein 5-like;, PF00642;PF18384;, GO:0005829;GO:0005634;GO:0046872;GO:0016740;GO:0000209;, C:cytosol; C:nucleus;, F:metal ion binding; F:transferase activity;, P:protein polyubiquitination;|Q9H9P5 B0QYN6 B1GXI8 Q96EV1 Q96RZ1 Q9BWL5 Q9H5K0 Q9UJJ8,Putative E3 ubiquitin-protein ligase UNKL,RING finger protein unkempt-like;Zinc finger CCCH domain-containing protein 5-like;, PF00642;PF18384;, GO:0005829;GO:0005634;GO:0046872;GO:0016740;GO:0000209;, C:cytosol; C:nucleus;, F:metal ion binding; F:transferase activity;, P:protein polyubiquitination; scaffold133 indexed_genome mRNA 277780 279063 . + . ID=transcript_14156;Q4G0I0 Q96RZ0,Protein CCSMST1,, PF15013;, GO:0016021;, C:integral component of membrane; scaffold133 indexed_genome mRNA 286344 287823 . + . ID=transcript_14157;A0A1W2PR82 Q96RY9,Protein PERCC1 {ECO:0000305},Proline and glutamage-rich protein with a coiled coil domain {ECO:0000303|PubMed:31217582};, , GO:0048546;GO:0035883;, , , P:digestive tract morphogenesis; P:enteroendocrine cell differentiation; scaffold133 indexed_genome mRNA 287870 291182 . - . ID=transcript_14158;A6NI56 G9JV18,Coiled-coil domain-containing protein 154 {ECO:0000305},, PF15450;, GO:0005769;, C:early endosome; scaffold133 indexed_genome mRNA 292132 295307 . - . ID=transcript_14159;A6NI56 G9JV18,Coiled-coil domain-containing protein 154 {ECO:0000305},, PF15450;, GO:0005769;, C:early endosome;|A6NI56 G9JV18,Coiled-coil domain-containing protein 154 {ECO:0000305},, PF15450;, GO:0005769;, C:early endosome; scaffold133 indexed_genome mRNA 299278 300061 . - . ID=transcript_14160;P51798 A6NEJ7 A8K5T9 A8K7X1 B3KPN3 E9PDB9 Q9NYX5,H(+)/Cl(-) exchange transporter 7,Chloride channel 7 alpha subunit;Chloride channel protein 7;, PF00571;PF00654;, GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0005654;GO:0015297;GO:0005524;GO:0005254;GO:0015108;GO:0005247;GO:0034220;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:nucleoplasm;, F:antiporter activity; F:ATP binding; F:chloride channel activity; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:ion transmembrane transport; scaffold133 indexed_genome mRNA 300871 310321 . - . ID=transcript_14161;P51798 A6NEJ7 A8K5T9 A8K7X1 B3KPN3 E9PDB9 Q9NYX5,H(+)/Cl(-) exchange transporter 7,Chloride channel 7 alpha subunit;Chloride channel protein 7;, PF00571;PF00654;, GO:0016021;GO:0043231;GO:0005765;GO:0016020;GO:0005654;GO:0015297;GO:0005524;GO:0005254;GO:0015108;GO:0005247;GO:0034220;, C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:nucleoplasm;, F:antiporter activity; F:ATP binding; F:chloride channel activity; F:chloride transmembrane transporter activity; F:voltage-gated chloride channel activity;, P:ion transmembrane transport; scaffold133 indexed_genome mRNA 334083 360016 . + . ID=transcript_14162;Q9Y4R8 D3DU73 O75168 Q7LDV4 Q9BR21,Telomere length regulation protein TEL2 homolog,Protein clk-2 homolog;, PF10193;, GO:0070209;GO:0000781;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0034399;GO:0005634;GO:0031931;GO:0031932;GO:0051879;GO:0060090;GO:0019901;GO:0044877;GO:0042162;GO:0071902;GO:1904263;GO:1904515;GO:0050821;GO:0032006;GO:0007004;, C:ASTRA complex; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear periphery; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:Hsp90 protein binding; F:molecular adaptor activity; F:protein kinase binding; F:protein-containing complex binding; F:telomeric DNA binding;, P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein stabilization; P:regulation of TOR signaling; P:telomere maintenance via telomerase;|Q9Y4R8 D3DU73 O75168 Q7LDV4 Q9BR21,Telomere length regulation protein TEL2 homolog,Protein clk-2 homolog;, PF10193;, GO:0070209;GO:0000781;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0034399;GO:0005634;GO:0031931;GO:0031932;GO:0051879;GO:0060090;GO:0019901;GO:0044877;GO:0042162;GO:0071902;GO:1904263;GO:1904515;GO:0050821;GO:0032006;GO:0007004;, C:ASTRA complex; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear periphery; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:Hsp90 protein binding; F:molecular adaptor activity; F:protein kinase binding; F:protein-containing complex binding; F:telomeric DNA binding;, P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein stabilization; P:regulation of TOR signaling; P:telomere maintenance via telomerase;|Q9Y4R8 D3DU73 O75168 Q7LDV4 Q9BR21,Telomere length regulation protein TEL2 homolog,Protein clk-2 homolog;, PF10193;, GO:0070209;GO:0000781;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0034399;GO:0005634;GO:0031931;GO:0031932;GO:0051879;GO:0060090;GO:0019901;GO:0044877;GO:0042162;GO:0071902;GO:1904263;GO:1904515;GO:0050821;GO:0032006;GO:0007004;, C:ASTRA complex; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear periphery; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:Hsp90 protein binding; F:molecular adaptor activity; F:protein kinase binding; F:protein-containing complex binding; F:telomeric DNA binding;, P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein stabilization; P:regulation of TOR signaling; P:telomere maintenance via telomerase;|Q9Y4R8 D3DU73 O75168 Q7LDV4 Q9BR21,Telomere length regulation protein TEL2 homolog,Protein clk-2 homolog;, PF10193;, GO:0070209;GO:0000781;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0034399;GO:0005634;GO:0031931;GO:0031932;GO:0051879;GO:0060090;GO:0019901;GO:0044877;GO:0042162;GO:0071902;GO:1904263;GO:1904515;GO:0050821;GO:0032006;GO:0007004;, C:ASTRA complex; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear periphery; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:Hsp90 protein binding; F:molecular adaptor activity; F:protein kinase binding; F:protein-containing complex binding; F:telomeric DNA binding;, P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein stabilization; P:regulation of TOR signaling; P:telomere maintenance via telomerase;|Q9Y4R8 D3DU73 O75168 Q7LDV4 Q9BR21,Telomere length regulation protein TEL2 homolog,Protein clk-2 homolog;, PF10193;, GO:0070209;GO:0000781;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0034399;GO:0005634;GO:0031931;GO:0031932;GO:0051879;GO:0060090;GO:0019901;GO:0044877;GO:0042162;GO:0071902;GO:1904263;GO:1904515;GO:0050821;GO:0032006;GO:0007004;, C:ASTRA complex; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear periphery; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:Hsp90 protein binding; F:molecular adaptor activity; F:protein kinase binding; F:protein-containing complex binding; F:telomeric DNA binding;, P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein stabilization; P:regulation of TOR signaling; P:telomere maintenance via telomerase;|Q9Y4R8 D3DU73 O75168 Q7LDV4 Q9BR21,Telomere length regulation protein TEL2 homolog,Protein clk-2 homolog;, PF10193;, GO:0070209;GO:0000781;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0034399;GO:0005634;GO:0031931;GO:0031932;GO:0051879;GO:0060090;GO:0019901;GO:0044877;GO:0042162;GO:0071902;GO:1904263;GO:1904515;GO:0050821;GO:0032006;GO:0007004;, C:ASTRA complex; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear periphery; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:Hsp90 protein binding; F:molecular adaptor activity; F:protein kinase binding; F:protein-containing complex binding; F:telomeric DNA binding;, P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein stabilization; P:regulation of TOR signaling; P:telomere maintenance via telomerase;|Q9Y4R8 D3DU73 O75168 Q7LDV4 Q9BR21,Telomere length regulation protein TEL2 homolog,Protein clk-2 homolog;, PF10193;, GO:0070209;GO:0000781;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0034399;GO:0005634;GO:0031931;GO:0031932;GO:0051879;GO:0060090;GO:0019901;GO:0044877;GO:0042162;GO:0071902;GO:1904263;GO:1904515;GO:0050821;GO:0032006;GO:0007004;, C:ASTRA complex; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear periphery; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:Hsp90 protein binding; F:molecular adaptor activity; F:protein kinase binding; F:protein-containing complex binding; F:telomeric DNA binding;, P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein stabilization; P:regulation of TOR signaling; P:telomere maintenance via telomerase;|Q9Y4R8 D3DU73 O75168 Q7LDV4 Q9BR21,Telomere length regulation protein TEL2 homolog,Protein clk-2 homolog;, PF10193;, GO:0070209;GO:0000781;GO:0005737;GO:0005829;GO:0016020;GO:0016604;GO:0034399;GO:0005634;GO:0031931;GO:0031932;GO:0051879;GO:0060090;GO:0019901;GO:0044877;GO:0042162;GO:0071902;GO:1904263;GO:1904515;GO:0050821;GO:0032006;GO:0007004;, C:ASTRA complex; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:membrane; C:nuclear body; C:nuclear periphery; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:Hsp90 protein binding; F:molecular adaptor activity; F:protein kinase binding; F:protein-containing complex binding; F:telomeric DNA binding;, P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of TORC1 signaling; P:positive regulation of TORC2 signaling; P:protein stabilization; P:regulation of TOR signaling; P:telomere maintenance via telomerase;|Q96RY7 A2A2A8 D3DU75 O60332 Q9UG52,Intraflagellar transport protein 140 homolog {ECO:0000305},WD and tetratricopeptide repeats protein 2;, , GO:0005930;GO:0005814;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0032391;GO:0001750;GO:0060271;GO:0007368;GO:1990403;GO:0031076;GO:0048701;GO:0042733;GO:0007507;GO:0035721;GO:0042073;GO:0035735;GO:0021532;GO:1905515;GO:0035845;GO:0061512;GO:1902017;GO:0008589;, C:axoneme; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cilium assembly; P:determination of left/right symmetry; P:embryonic brain development; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic digit morphogenesis; P:heart development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:neural tube patterning; P:non-motile cilium assembly; P:photoreceptor cell outer segment organization; P:protein localization to cilium; P:regulation of cilium assembly; P:regulation of smoothened signaling pathway;|Q96RY7 A2A2A8 D3DU75 O60332 Q9UG52,Intraflagellar transport protein 140 homolog {ECO:0000305},WD and tetratricopeptide repeats protein 2;, , GO:0005930;GO:0005814;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0032391;GO:0001750;GO:0060271;GO:0007368;GO:1990403;GO:0031076;GO:0048701;GO:0042733;GO:0007507;GO:0035721;GO:0042073;GO:0035735;GO:0021532;GO:1905515;GO:0035845;GO:0061512;GO:1902017;GO:0008589;, C:axoneme; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cilium assembly; P:determination of left/right symmetry; P:embryonic brain development; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic digit morphogenesis; P:heart development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:neural tube patterning; P:non-motile cilium assembly; P:photoreceptor cell outer segment organization; P:protein localization to cilium; P:regulation of cilium assembly; P:regulation of smoothened signaling pathway;|Q96RY7 A2A2A8 D3DU75 O60332 Q9UG52,Intraflagellar transport protein 140 homolog {ECO:0000305},WD and tetratricopeptide repeats protein 2;, , GO:0005930;GO:0005814;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0032391;GO:0001750;GO:0060271;GO:0007368;GO:1990403;GO:0031076;GO:0048701;GO:0042733;GO:0007507;GO:0035721;GO:0042073;GO:0035735;GO:0021532;GO:1905515;GO:0035845;GO:0061512;GO:1902017;GO:0008589;, C:axoneme; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cilium assembly; P:determination of left/right symmetry; P:embryonic brain development; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic digit morphogenesis; P:heart development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:neural tube patterning; P:non-motile cilium assembly; P:photoreceptor cell outer segment organization; P:protein localization to cilium; P:regulation of cilium assembly; P:regulation of smoothened signaling pathway; scaffold133 indexed_genome mRNA 366699 373807 . + . ID=transcript_14163;Q9BSN7 D3DU76 Q3KRC1 Q9H7G5,Transmembrane protein 204,Claudin-like protein 24;, , GO:0005912;GO:0016021;GO:0005886;GO:0001945;GO:0030947;GO:0051145;, C:adherens junction; C:integral component of membrane; C:plasma membrane;, , P:lymph vessel development; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:smooth muscle cell differentiation; scaffold133 indexed_genome mRNA 375013 402592 . - . ID=transcript_14164;Q96RY7 A2A2A8 D3DU75 O60332 Q9UG52,Intraflagellar transport protein 140 homolog {ECO:0000305},WD and tetratricopeptide repeats protein 2;, , GO:0005930;GO:0005814;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0032391;GO:0001750;GO:0060271;GO:0007368;GO:1990403;GO:0031076;GO:0048701;GO:0042733;GO:0007507;GO:0035721;GO:0042073;GO:0035735;GO:0021532;GO:1905515;GO:0035845;GO:0061512;GO:1902017;GO:0008589;, C:axoneme; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cilium assembly; P:determination of left/right symmetry; P:embryonic brain development; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic digit morphogenesis; P:heart development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:neural tube patterning; P:non-motile cilium assembly; P:photoreceptor cell outer segment organization; P:protein localization to cilium; P:regulation of cilium assembly; P:regulation of smoothened signaling pathway;|Q96RY7 A2A2A8 D3DU75 O60332 Q9UG52,Intraflagellar transport protein 140 homolog {ECO:0000305},WD and tetratricopeptide repeats protein 2;, , GO:0005930;GO:0005814;GO:0005813;GO:0036064;GO:0097542;GO:0005929;GO:0030991;GO:0032391;GO:0001750;GO:0060271;GO:0007368;GO:1990403;GO:0031076;GO:0048701;GO:0042733;GO:0007507;GO:0035721;GO:0042073;GO:0035735;GO:0021532;GO:1905515;GO:0035845;GO:0061512;GO:1902017;GO:0008589;, C:axoneme; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary tip; C:cilium; C:intraciliary transport particle A; C:photoreceptor connecting cilium; C:photoreceptor outer segment;, , P:cilium assembly; P:determination of left/right symmetry; P:embryonic brain development; P:embryonic camera-type eye development; P:embryonic cranial skeleton morphogenesis; P:embryonic digit morphogenesis; P:heart development; P:intraciliary retrograde transport; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:neural tube patterning; P:non-motile cilium assembly; P:photoreceptor cell outer segment organization; P:protein localization to cilium; P:regulation of cilium assembly; P:regulation of smoothened signaling pathway; scaffold133 indexed_genome mRNA 435552 452171 . + . ID=transcript_14165;Q96RY5 A8MZL1 B1AJY1 Q8NDN1 Q9P2C1,Protein cramped-like {ECO:0000305},Cramped chromatin regulator homolog 1 {ECO:0000312|HGNC:HGNC:14122};Hematological and neurological expressed 1-like protein;, , GO:0005634;GO:0003682;GO:0003677;GO:0007389;, C:nucleus;, F:chromatin binding; F:DNA binding;, P:pattern specification process;|Q96RY5 A8MZL1 B1AJY1 Q8NDN1 Q9P2C1,Protein cramped-like {ECO:0000305},Cramped chromatin regulator homolog 1 {ECO:0000312|HGNC:HGNC:14122};Hematological and neurological expressed 1-like protein;, , GO:0005634;GO:0003682;GO:0003677;GO:0007389;, C:nucleus;, F:chromatin binding; F:DNA binding;, P:pattern specification process; scaffold133 indexed_genome mRNA 452923 462340 . + . ID=transcript_14166;Q96RY5 A8MZL1 B1AJY1 Q8NDN1 Q9P2C1,Protein cramped-like {ECO:0000305},Cramped chromatin regulator homolog 1 {ECO:0000312|HGNC:HGNC:14122};Hematological and neurological expressed 1-like protein;, , GO:0005634;GO:0003682;GO:0003677;GO:0007389;, C:nucleus;, F:chromatin binding; F:DNA binding;, P:pattern specification process;|Q96RY5 A8MZL1 B1AJY1 Q8NDN1 Q9P2C1,Protein cramped-like {ECO:0000305},Cramped chromatin regulator homolog 1 {ECO:0000312|HGNC:HGNC:14122};Hematological and neurological expressed 1-like protein;, , GO:0005634;GO:0003682;GO:0003677;GO:0007389;, C:nucleus;, F:chromatin binding; F:DNA binding;, P:pattern specification process;|Q96RY5 A8MZL1 B1AJY1 Q8NDN1 Q9P2C1,Protein cramped-like {ECO:0000305},Cramped chromatin regulator homolog 1 {ECO:0000312|HGNC:HGNC:14122};Hematological and neurological expressed 1-like protein;, , GO:0005634;GO:0003682;GO:0003677;GO:0007389;, C:nucleus;, F:chromatin binding; F:DNA binding;, P:pattern specification process;|Q96RY5 A8MZL1 B1AJY1 Q8NDN1 Q9P2C1,Protein cramped-like {ECO:0000305},Cramped chromatin regulator homolog 1 {ECO:0000312|HGNC:HGNC:14122};Hematological and neurological expressed 1-like protein;, , GO:0005634;GO:0003682;GO:0003677;GO:0007389;, C:nucleus;, F:chromatin binding; F:DNA binding;, P:pattern specification process;|Q96RY5 A8MZL1 B1AJY1 Q8NDN1 Q9P2C1,Protein cramped-like {ECO:0000305},Cramped chromatin regulator homolog 1 {ECO:0000312|HGNC:HGNC:14122};Hematological and neurological expressed 1-like protein;, , GO:0005634;GO:0003682;GO:0003677;GO:0007389;, C:nucleus;, F:chromatin binding; F:DNA binding;, P:pattern specification process; scaffold133 indexed_genome mRNA 471665 479408 . + . ID=transcript_14167;Q9H910 B1AJY2 B4DLH4 Q6EIC7,Jupiter microtubule associated homolog 2 {ECO:0000312|HGNC:HGNC:14137},Hematological and neurological expressed 1-like protein {ECO:0000303|PubMed:15094197};, PF17054;, GO:0005829;GO:0005634;GO:0005886;, C:cytosol; C:nucleus; C:plasma membrane;|Q9H910 B1AJY2 B4DLH4 Q6EIC7,Jupiter microtubule associated homolog 2 {ECO:0000312|HGNC:HGNC:14137},Hematological and neurological expressed 1-like protein {ECO:0000303|PubMed:15094197};, PF17054;, GO:0005829;GO:0005634;GO:0005886;, C:cytosol; C:nucleus; C:plasma membrane; scaffold133 indexed_genome mRNA 484470 530001 . + . ID=transcript_14168;Q9UPT6 A2A2B3 A7E2B3 Q96RY4 Q9H4I4 Q9H7P1 Q9NUG0,C-Jun-amino-terminal kinase-interacting protein 3,JNK MAP kinase scaffold protein 3;Mitogen-activated protein kinase 8-interacting protein 3;, PF16471;PF09744;, GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0031410;GO:0030425;GO:0000139;GO:0030426;GO:0048471;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0099641;GO:0061564;GO:0031103;GO:0046328;GO:0016192;, C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:Golgi membrane; C:growth cone; C:perinuclear region of cytoplasm;, F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:anterograde axonal protein transport; P:axon development; P:axon regeneration; P:regulation of JNK cascade; P:vesicle-mediated transport;|Q9UPT6 A2A2B3 A7E2B3 Q96RY4 Q9H4I4 Q9H7P1 Q9NUG0,C-Jun-amino-terminal kinase-interacting protein 3,JNK MAP kinase scaffold protein 3;Mitogen-activated protein kinase 8-interacting protein 3;, PF16471;PF09744;, GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0031410;GO:0030425;GO:0000139;GO:0030426;GO:0048471;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0099641;GO:0061564;GO:0031103;GO:0046328;GO:0016192;, C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:Golgi membrane; C:growth cone; C:perinuclear region of cytoplasm;, F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:anterograde axonal protein transport; P:axon development; P:axon regeneration; P:regulation of JNK cascade; P:vesicle-mediated transport;|Q9UPT6 A2A2B3 A7E2B3 Q96RY4 Q9H4I4 Q9H7P1 Q9NUG0,C-Jun-amino-terminal kinase-interacting protein 3,JNK MAP kinase scaffold protein 3;Mitogen-activated protein kinase 8-interacting protein 3;, PF16471;PF09744;, GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0031410;GO:0030425;GO:0000139;GO:0030426;GO:0048471;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0099641;GO:0061564;GO:0031103;GO:0046328;GO:0016192;, C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:Golgi membrane; C:growth cone; C:perinuclear region of cytoplasm;, F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:anterograde axonal protein transport; P:axon development; P:axon regeneration; P:regulation of JNK cascade; P:vesicle-mediated transport;|Q9UPT6 A2A2B3 A7E2B3 Q96RY4 Q9H4I4 Q9H7P1 Q9NUG0,C-Jun-amino-terminal kinase-interacting protein 3,JNK MAP kinase scaffold protein 3;Mitogen-activated protein kinase 8-interacting protein 3;, PF16471;PF09744;, GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0031410;GO:0030425;GO:0000139;GO:0030426;GO:0048471;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0099641;GO:0061564;GO:0031103;GO:0046328;GO:0016192;, C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:Golgi membrane; C:growth cone; C:perinuclear region of cytoplasm;, F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:anterograde axonal protein transport; P:axon development; P:axon regeneration; P:regulation of JNK cascade; P:vesicle-mediated transport;|Q9UPT6 A2A2B3 A7E2B3 Q96RY4 Q9H4I4 Q9H7P1 Q9NUG0,C-Jun-amino-terminal kinase-interacting protein 3,JNK MAP kinase scaffold protein 3;Mitogen-activated protein kinase 8-interacting protein 3;, PF16471;PF09744;, GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0031410;GO:0030425;GO:0000139;GO:0030426;GO:0048471;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0099641;GO:0061564;GO:0031103;GO:0046328;GO:0016192;, C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:Golgi membrane; C:growth cone; C:perinuclear region of cytoplasm;, F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:anterograde axonal protein transport; P:axon development; P:axon regeneration; P:regulation of JNK cascade; P:vesicle-mediated transport;|Q9UPT6 A2A2B3 A7E2B3 Q96RY4 Q9H4I4 Q9H7P1 Q9NUG0,C-Jun-amino-terminal kinase-interacting protein 3,JNK MAP kinase scaffold protein 3;Mitogen-activated protein kinase 8-interacting protein 3;, PF16471;PF09744;, GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0031410;GO:0030425;GO:0000139;GO:0030426;GO:0048471;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0099641;GO:0061564;GO:0031103;GO:0046328;GO:0016192;, C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:Golgi membrane; C:growth cone; C:perinuclear region of cytoplasm;, F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:anterograde axonal protein transport; P:axon development; P:axon regeneration; P:regulation of JNK cascade; P:vesicle-mediated transport;|Q9UPT6 A2A2B3 A7E2B3 Q96RY4 Q9H4I4 Q9H7P1 Q9NUG0,C-Jun-amino-terminal kinase-interacting protein 3,JNK MAP kinase scaffold protein 3;Mitogen-activated protein kinase 8-interacting protein 3;, PF16471;PF09744;, GO:0030424;GO:1904115;GO:0044297;GO:0005737;GO:0031410;GO:0030425;GO:0000139;GO:0030426;GO:0048471;GO:0008432;GO:0019894;GO:0005078;GO:0030159;GO:0007257;GO:0099641;GO:0061564;GO:0031103;GO:0046328;GO:0016192;, C:axon; C:axon cytoplasm; C:cell body; C:cytoplasm; C:cytoplasmic vesicle; C:dendrite; C:Golgi membrane; C:growth cone; C:perinuclear region of cytoplasm;, F:JUN kinase binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:signaling receptor complex adaptor activity;, P:activation of JUN kinase activity; P:anterograde axonal protein transport; P:axon development; P:axon regeneration; P:regulation of JNK cascade; P:vesicle-mediated transport; scaffold133 indexed_genome mRNA 530005 531266 . - . ID=transcript_14169;Q13232 Q9BWH4,Nucleoside diphosphate kinase 3,DR-nm23;Nucleoside diphosphate kinase C;nm23-H3;, PF00334;, GO:0005829;GO:0005524;GO:0046872;GO:0004550;GO:0006915;GO:0006241;GO:0006183;GO:0015949;GO:0006228;, C:cytosol;, F:ATP binding; F:metal ion binding; F:nucleoside diphosphate kinase activity;, P:apoptotic process; P:CTP biosynthetic process; P:GTP biosynthetic process; P:nucleobase-containing small molecule interconversion; P:UTP biosynthetic process; scaffold133 indexed_genome mRNA 531497 540939 . + . ID=transcript_14170;A4GXA9 Q8TEP2 Q96RY3,Probable crossover junction endonuclease EME2,, PF02732;, GO:0048476;GO:0005634;GO:0003677;GO:0004519;GO:0006302;GO:0031573;GO:0031297;GO:0000712;, C:Holliday junction resolvase complex; C:nucleus;, F:DNA binding; F:endonuclease activity;, P:double-strand break repair; P:intra-S DNA damage checkpoint; P:replication fork processing; P:resolution of meiotic recombination intermediates;|A4GXA9 Q8TEP2 Q96RY3,Probable crossover junction endonuclease EME2,, PF02732;, GO:0048476;GO:0005634;GO:0003677;GO:0004519;GO:0006302;GO:0031573;GO:0031297;GO:0000712;, C:Holliday junction resolvase complex; C:nucleus;, F:DNA binding; F:endonuclease activity;, P:double-strand break repair; P:intra-S DNA damage checkpoint; P:replication fork processing; P:resolution of meiotic recombination intermediates;|Q6PJ21 D3DU78 Q49A96 Q86X18 Q8WXK5 Q96IE6 Q96RY2,SPRY domain-containing SOCS box protein 3,, PF00622;, GO:0005829;GO:0019005;GO:0043687;GO:0043161;GO:0016567;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q6PJ21 D3DU78 Q49A96 Q86X18 Q8WXK5 Q96IE6 Q96RY2,SPRY domain-containing SOCS box protein 3,, PF00622;, GO:0005829;GO:0019005;GO:0043687;GO:0043161;GO:0016567;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q6PJ21 D3DU78 Q49A96 Q86X18 Q8WXK5 Q96IE6 Q96RY2,SPRY domain-containing SOCS box protein 3,, PF00622;, GO:0005829;GO:0019005;GO:0043687;GO:0043161;GO:0016567;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination;|Q6PJ21 D3DU78 Q49A96 Q86X18 Q8WXK5 Q96IE6 Q96RY2,SPRY domain-containing SOCS box protein 3,, PF00622;, GO:0005829;GO:0019005;GO:0043687;GO:0043161;GO:0016567;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; scaffold133 indexed_genome mRNA 542225 547217 . + . ID=transcript_14171;Q9Y5Y2 D3DU80 Q9NWB2,Cytosolic Fe-S cluster assembly factor NUBP2 {ECO:0000255|HAMAP-Rule:MF_03039},Nucleotide-binding protein 2 {ECO:0000255|HAMAP-Rule:MF_03039};, PF10609;, GO:0005814;GO:0005929;GO:0005829;GO:0005634;GO:0031616;GO:0051539;GO:0005524;GO:0016887;GO:0051536;GO:0046872;GO:0000166;GO:0030030;GO:0016226;, C:centriole; C:cilium; C:cytosol; C:nucleus; C:spindle pole centrosome;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:nucleotide binding;, P:cell projection organization; P:iron-sulfur cluster assembly;|Q9Y5Y2 D3DU80 Q9NWB2,Cytosolic Fe-S cluster assembly factor NUBP2 {ECO:0000255|HAMAP-Rule:MF_03039},Nucleotide-binding protein 2 {ECO:0000255|HAMAP-Rule:MF_03039};, PF10609;, GO:0005814;GO:0005929;GO:0005829;GO:0005634;GO:0031616;GO:0051539;GO:0005524;GO:0016887;GO:0051536;GO:0046872;GO:0000166;GO:0030030;GO:0016226;, C:centriole; C:cilium; C:cytosol; C:nucleus; C:spindle pole centrosome;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:nucleotide binding;, P:cell projection organization; P:iron-sulfur cluster assembly;|Q9Y5Y2 D3DU80 Q9NWB2,Cytosolic Fe-S cluster assembly factor NUBP2 {ECO:0000255|HAMAP-Rule:MF_03039},Nucleotide-binding protein 2 {ECO:0000255|HAMAP-Rule:MF_03039};, PF10609;, GO:0005814;GO:0005929;GO:0005829;GO:0005634;GO:0031616;GO:0051539;GO:0005524;GO:0016887;GO:0051536;GO:0046872;GO:0000166;GO:0030030;GO:0016226;, C:centriole; C:cilium; C:cytosol; C:nucleus; C:spindle pole centrosome;, F:4 iron, 4 sulfur cluster binding; F:ATP binding; F:ATPase activity; F:iron-sulfur cluster binding; F:metal ion binding; F:nucleotide binding;, P:cell projection organization; P:iron-sulfur cluster assembly; scaffold133 indexed_genome mRNA 547948 554718 . + . ID=transcript_14172;P35858 B4DZY8 E9PGU3,Insulin-like growth factor-binding protein complex acid labile subunit,, PF13855;PF01462;, GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0042567;GO:0005520;GO:0007155;GO:0044267;GO:0007165;, C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:insulin-like growth factor ternary complex;, F:insulin-like growth factor binding;, P:cell adhesion; P:cellular protein metabolic process; P:signal transduction; scaffold133 indexed_genome mRNA 558515 571548 . - . ID=transcript_14173;Q16775 A8K290 B4DP33 B4DRA7 E7EN93,Hydroxyacylglutathione hydrolase, mitochondrial {ECO:0000303|PubMed:15117945},Glyoxalase II;, PF16123;PF00753;, GO:0005737;GO:0005829;GO:0005759;GO:0004416;GO:0046872;GO:0006750;GO:0019243;GO:0006090;, C:cytoplasm; C:cytosol; C:mitochondrial matrix;, F:hydroxyacylglutathione hydrolase activity; F:metal ion binding;, P:glutathione biosynthetic process; P:methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione; P:pyruvate metabolic process;|Q16775 A8K290 B4DP33 B4DRA7 E7EN93,Hydroxyacylglutathione hydrolase, mitochondrial {ECO:0000303|PubMed:15117945},Glyoxalase II;, PF16123;PF00753;, GO:0005737;GO:0005829;GO:0005759;GO:0004416;GO:0046872;GO:0006750;GO:0019243;GO:0006090;, C:cytoplasm; C:cytosol; C:mitochondrial matrix;, F:hydroxyacylglutathione hydrolase activity; F:metal ion binding;, P:glutathione biosynthetic process; P:methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione; P:pyruvate metabolic process; scaffold133 indexed_genome mRNA 572116 573356 . - . ID=transcript_14174;Q6P587 B1AK40 B1AK41 Q6FIC7 Q96RY1 Q9H0N6,Acylpyruvase FAHD1, mitochondrial,Fumarylacetoacetate hydrolase domain-containing protein 1;Oxaloacetate decarboxylase;YisK-like protein;, PF01557;, GO:0005829;GO:0005759;GO:0005739;GO:0005654;GO:0018773;GO:0047621;GO:0034545;GO:0046872;GO:0008948;GO:0006099;, C:cytosol; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:acetylpyruvate hydrolase activity; F:acylpyruvate hydrolase activity; F:fumarylpyruvate hydrolase activity; F:metal ion binding; F:oxaloacetate decarboxylase activity;, P:tricarboxylic acid cycle; scaffold133 indexed_genome mRNA 582627 614840 . - . ID=transcript_14175;Q8N635 B1AK39 C9J0S1 Q96RY0,Meiosis-specific with OB domain-containing protein {ECO:0000305},, , GO:0005694;GO:0005737;GO:0005634;GO:0003682;GO:0008310;GO:0003697;GO:0000724;GO:0007144;GO:0009566;GO:0007129;GO:0007141;GO:0007140;GO:0000712;, C:chromosome; C:cytoplasm; C:nucleus;, F:chromatin binding; F:single-stranded DNA 3'-5' exodeoxyribonuclease activity; F:single-stranded DNA binding;, P:double-strand break repair via homologous recombination; P:female meiosis I; P:fertilization; P:homologous chromosome pairing at meiosis; P:male meiosis I; P:male meiotic nuclear division; P:resolution of meiotic recombination intermediates; scaffold133 indexed_genome mRNA 682524 696493 . - . ID=transcript_14176;Q92901,60S ribosomal protein L3-like,Large ribosomal subunit protein uL3-like;, PF00297;, GO:0022625;GO:0016020;GO:0005840;GO:0003723;GO:0003735;GO:0000027;GO:0006412;, C:cytosolic large ribosomal subunit; C:membrane; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:ribosomal large subunit assembly; P:translation;|Q9NZV6 Q96RX6 Q9BTV2 Q9P0B1,Methionine-R-sulfoxide reductase B1,Selenoprotein X;, PF01641;, GO:0005856;GO:0005829;GO:0005634;GO:0003779;GO:0033745;GO:0033743;GO:0008270;GO:0030041;GO:0045087;GO:0030091;, C:cytoskeleton; C:cytosol; C:nucleus;, F:actin binding; F:L-methionine-(R)-S-oxide reductase activity; F:peptide-methionine (R)-S-oxide reductase activity; F:zinc ion binding;, P:actin filament polymerization; P:innate immune response; P:protein repair;|Q92901,60S ribosomal protein L3-like,Large ribosomal subunit protein uL3-like;, PF00297;, GO:0022625;GO:0016020;GO:0005840;GO:0003723;GO:0003735;GO:0000027;GO:0006412;, C:cytosolic large ribosomal subunit; C:membrane; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:ribosomal large subunit assembly; P:translation; scaffold133 indexed_genome mRNA 698378 700701 . + . ID=transcript_14177;O96000 Q96II6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10,Complex I-PDSW;NADH-ubiquinone oxidoreductase PDSW subunit;, PF10249;, GO:0005743;GO:0005747;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O96000 Q96II6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10,Complex I-PDSW;NADH-ubiquinone oxidoreductase PDSW subunit;, PF10249;, GO:0005743;GO:0005747;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold133 indexed_genome mRNA 702175 702903 . - . ID=transcript_14178;P15880 B2R5G0 D3DU82 Q3MIB1,40S ribosomal protein S2,40S ribosomal protein S4;Protein LLRep3;Small ribosomal subunit protein uS5 {ECO:0000303|PubMed:24524803};, PF00333;PF03719;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0005634;GO:0045296;GO:0019899;GO:0017134;GO:0003729;GO:0003723;GO:0003735;GO:0000184;GO:0051443;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:nucleus;, F:cadherin binding; F:enzyme binding; F:fibroblast growth factor binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of ubiquitin-protein transferase activity; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold133 indexed_genome mRNA 715734 722630 . + . ID=transcript_14179;Q12788 Q59GD6 Q8IVB7 Q96A78,Transducin beta-like protein 3,WD repeat-containing protein SAZD;, PF08625;PF00400;, GO:0030686;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0034511;GO:0000480;GO:0000472;GO:0006364;, C:90S preribosome; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding; F:U3 snoRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q12788 Q59GD6 Q8IVB7 Q96A78,Transducin beta-like protein 3,WD repeat-containing protein SAZD;, PF08625;PF00400;, GO:0030686;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0034511;GO:0000480;GO:0000472;GO:0006364;, C:90S preribosome; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding; F:U3 snoRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:rRNA processing;|Q8NFA2 Q86YM1 Q8NFA3 Q96B73,NADPH oxidase organizer 1,NADPH oxidase regulatory protein;Nox organizer 1;Nox-organizing protein 1;SH3 and PX domain-containing protein 5;, PF14604;, GO:0005737;GO:0043020;GO:0005886;GO:0019899;GO:0060090;GO:0035091;GO:0005543;GO:0016176;GO:0022617;GO:0031343;GO:0010310;GO:0060263;GO:0006801;, C:cytoplasm; C:NADPH oxidase complex; C:plasma membrane;, F:enzyme binding; F:molecular adaptor activity; F:phosphatidylinositol binding; F:phospholipid binding; F:superoxide-generating NADPH oxidase activator activity;, P:extracellular matrix disassembly; P:positive regulation of cell killing; P:regulation of hydrogen peroxide metabolic process; P:regulation of respiratory burst; P:superoxide metabolic process; scaffold133 indexed_genome mRNA 722873 723652 . - . ID=transcript_14180;Q8NFA2 Q86YM1 Q8NFA3 Q96B73,NADPH oxidase organizer 1,NADPH oxidase regulatory protein;Nox organizer 1;Nox-organizing protein 1;SH3 and PX domain-containing protein 5;, PF14604;, GO:0005737;GO:0043020;GO:0005886;GO:0019899;GO:0060090;GO:0035091;GO:0005543;GO:0016176;GO:0022617;GO:0031343;GO:0010310;GO:0060263;GO:0006801;, C:cytoplasm; C:NADPH oxidase complex; C:plasma membrane;, F:enzyme binding; F:molecular adaptor activity; F:phosphatidylinositol binding; F:phospholipid binding; F:superoxide-generating NADPH oxidase activator activity;, P:extracellular matrix disassembly; P:positive regulation of cell killing; P:regulation of hydrogen peroxide metabolic process; P:regulation of respiratory burst; P:superoxide metabolic process; scaffold133 indexed_genome mRNA 731953 744177 . + . ID=transcript_14181;O43761 B2R9S0,Synaptogyrin-3 {ECO:0000305},, PF01284;, GO:0016021;GO:0031594;GO:0008021;GO:0030672;GO:0032411;GO:0045055;GO:0021762;, C:integral component of membrane; C:neuromuscular junction; C:synaptic vesicle; C:synaptic vesicle membrane;, , P:positive regulation of transporter activity; P:regulated exocytosis; P:substantia nigra development;|Q86UK7 Q8IW49 Q8N3D9 Q96FG3 Q9H7J3,E3 ubiquitin-protein ligase ZNF598 {ECO:0000305},Zinc finger protein 598 {ECO:0000312|HGNC:HGNC:28079};, , GO:0046872;GO:0043022;GO:0003723;GO:0061630;GO:0006513;GO:0016567;GO:0072344;, , F:metal ion binding; F:ribosome binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein monoubiquitination; P:protein ubiquitination; P:rescue of stalled ribosome;|Q86UK7 Q8IW49 Q8N3D9 Q96FG3 Q9H7J3,E3 ubiquitin-protein ligase ZNF598 {ECO:0000305},Zinc finger protein 598 {ECO:0000312|HGNC:HGNC:28079};, , GO:0046872;GO:0043022;GO:0003723;GO:0061630;GO:0006513;GO:0016567;GO:0072344;, , F:metal ion binding; F:ribosome binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein monoubiquitination; P:protein ubiquitination; P:rescue of stalled ribosome;|Q86UK7 Q8IW49 Q8N3D9 Q96FG3 Q9H7J3,E3 ubiquitin-protein ligase ZNF598 {ECO:0000305},Zinc finger protein 598 {ECO:0000312|HGNC:HGNC:28079};, , GO:0046872;GO:0043022;GO:0003723;GO:0061630;GO:0006513;GO:0016567;GO:0072344;, , F:metal ion binding; F:ribosome binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein monoubiquitination; P:protein ubiquitination; P:rescue of stalled ribosome;|Q86UK7 Q8IW49 Q8N3D9 Q96FG3 Q9H7J3,E3 ubiquitin-protein ligase ZNF598 {ECO:0000305},Zinc finger protein 598 {ECO:0000312|HGNC:HGNC:28079};, , GO:0046872;GO:0043022;GO:0003723;GO:0061630;GO:0006513;GO:0016567;GO:0072344;, , F:metal ion binding; F:ribosome binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein monoubiquitination; P:protein ubiquitination; P:rescue of stalled ribosome;|Q86UK7 Q8IW49 Q8N3D9 Q96FG3 Q9H7J3,E3 ubiquitin-protein ligase ZNF598 {ECO:0000305},Zinc finger protein 598 {ECO:0000312|HGNC:HGNC:28079};, , GO:0046872;GO:0043022;GO:0003723;GO:0061630;GO:0006513;GO:0016567;GO:0072344;, , F:metal ion binding; F:ribosome binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein monoubiquitination; P:protein ubiquitination; P:rescue of stalled ribosome;|Q86UK7 Q8IW49 Q8N3D9 Q96FG3 Q9H7J3,E3 ubiquitin-protein ligase ZNF598 {ECO:0000305},Zinc finger protein 598 {ECO:0000312|HGNC:HGNC:28079};, , GO:0046872;GO:0043022;GO:0003723;GO:0061630;GO:0006513;GO:0016567;GO:0072344;, , F:metal ion binding; F:ribosome binding; F:RNA binding; F:ubiquitin protein ligase activity;, P:protein monoubiquitination; P:protein ubiquitination; P:rescue of stalled ribosome; scaffold133 indexed_genome mRNA 766352 773318 . + . ID=transcript_14182;Q15599 D3DU84 D3DU85 H3BSV6 O00272 O00556 Q3KQY7,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,NHE3 kinase A regulatory protein E3KARP;SRY-interacting protein 1;Sodium-hydrogen exchanger regulatory factor 2;Solute carrier family 9 isoform A3 regulatory factor 2;Tyrosine kinase activator protein 1;, PF09007;PF00595;, GO:0016324;GO:0012505;GO:0070062;GO:0005925;GO:0005634;GO:0005886;GO:0008013;GO:0045296;GO:0042802;GO:0019902;GO:0008022;GO:0043495;GO:0005102;GO:0031799;GO:0031800;GO:0072659;GO:0065003;, C:apical plasma membrane; C:endomembrane system; C:extracellular exosome; C:focal adhesion; C:nucleus; C:plasma membrane;, F:beta-catenin binding; F:cadherin binding; F:identical protein binding; F:phosphatase binding; F:protein C-terminus binding; F:protein-membrane adaptor activity; F:signaling receptor binding; F:type 2 metabotropic glutamate receptor binding; F:type 3 metabotropic glutamate receptor binding;, P:protein localization to plasma membrane; P:protein-containing complex assembly;|Q15599 D3DU84 D3DU85 H3BSV6 O00272 O00556 Q3KQY7,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,NHE3 kinase A regulatory protein E3KARP;SRY-interacting protein 1;Sodium-hydrogen exchanger regulatory factor 2;Solute carrier family 9 isoform A3 regulatory factor 2;Tyrosine kinase activator protein 1;, PF09007;PF00595;, GO:0016324;GO:0012505;GO:0070062;GO:0005925;GO:0005634;GO:0005886;GO:0008013;GO:0045296;GO:0042802;GO:0019902;GO:0008022;GO:0043495;GO:0005102;GO:0031799;GO:0031800;GO:0072659;GO:0065003;, C:apical plasma membrane; C:endomembrane system; C:extracellular exosome; C:focal adhesion; C:nucleus; C:plasma membrane;, F:beta-catenin binding; F:cadherin binding; F:identical protein binding; F:phosphatase binding; F:protein C-terminus binding; F:protein-membrane adaptor activity; F:signaling receptor binding; F:type 2 metabotropic glutamate receptor binding; F:type 3 metabotropic glutamate receptor binding;, P:protein localization to plasma membrane; P:protein-containing complex assembly;|Q15599 D3DU84 D3DU85 H3BSV6 O00272 O00556 Q3KQY7,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,NHE3 kinase A regulatory protein E3KARP;SRY-interacting protein 1;Sodium-hydrogen exchanger regulatory factor 2;Solute carrier family 9 isoform A3 regulatory factor 2;Tyrosine kinase activator protein 1;, PF09007;PF00595;, GO:0016324;GO:0012505;GO:0070062;GO:0005925;GO:0005634;GO:0005886;GO:0008013;GO:0045296;GO:0042802;GO:0019902;GO:0008022;GO:0043495;GO:0005102;GO:0031799;GO:0031800;GO:0072659;GO:0065003;, C:apical plasma membrane; C:endomembrane system; C:extracellular exosome; C:focal adhesion; C:nucleus; C:plasma membrane;, F:beta-catenin binding; F:cadherin binding; F:identical protein binding; F:phosphatase binding; F:protein C-terminus binding; F:protein-membrane adaptor activity; F:signaling receptor binding; F:type 2 metabotropic glutamate receptor binding; F:type 3 metabotropic glutamate receptor binding;, P:protein localization to plasma membrane; P:protein-containing complex assembly;|Q15599 D3DU84 D3DU85 H3BSV6 O00272 O00556 Q3KQY7,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,NHE3 kinase A regulatory protein E3KARP;SRY-interacting protein 1;Sodium-hydrogen exchanger regulatory factor 2;Solute carrier family 9 isoform A3 regulatory factor 2;Tyrosine kinase activator protein 1;, PF09007;PF00595;, GO:0016324;GO:0012505;GO:0070062;GO:0005925;GO:0005634;GO:0005886;GO:0008013;GO:0045296;GO:0042802;GO:0019902;GO:0008022;GO:0043495;GO:0005102;GO:0031799;GO:0031800;GO:0072659;GO:0065003;, C:apical plasma membrane; C:endomembrane system; C:extracellular exosome; C:focal adhesion; C:nucleus; C:plasma membrane;, F:beta-catenin binding; F:cadherin binding; F:identical protein binding; F:phosphatase binding; F:protein C-terminus binding; F:protein-membrane adaptor activity; F:signaling receptor binding; F:type 2 metabotropic glutamate receptor binding; F:type 3 metabotropic glutamate receptor binding;, P:protein localization to plasma membrane; P:protein-containing complex assembly; scaffold133 indexed_genome mRNA 774001 779343 . - . ID=transcript_14183;P78549 Q1MVR1 Q99566 Q99794 Q9BPX2,Endonuclease III-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03183},Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase {ECO:0000255|HAMAP-Rule:MF_03183};, PF00633;PF00730;, GO:0005739;GO:0005654;GO:0005634;GO:0051539;GO:0140078;GO:0003684;GO:0019104;GO:0003906;GO:0003690;GO:0004519;GO:0046872;GO:0000703;GO:0006285;GO:0006287;GO:0045008;GO:0006296;, C:mitochondrion; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA N-glycosylase activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA binding; F:endonuclease activity; F:metal ion binding; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity;, P:base-excision repair, AP site formation; P:base-excision repair, gap-filling; P:depyrimidination; P:nucleotide-excision repair, DNA incision, 5'-to lesion;|P78549 Q1MVR1 Q99566 Q99794 Q9BPX2,Endonuclease III-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03183},Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase {ECO:0000255|HAMAP-Rule:MF_03183};, PF00633;PF00730;, GO:0005739;GO:0005654;GO:0005634;GO:0051539;GO:0140078;GO:0003684;GO:0019104;GO:0003906;GO:0003690;GO:0004519;GO:0046872;GO:0000703;GO:0006285;GO:0006287;GO:0045008;GO:0006296;, C:mitochondrion; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA N-glycosylase activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA binding; F:endonuclease activity; F:metal ion binding; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity;, P:base-excision repair, AP site formation; P:base-excision repair, gap-filling; P:depyrimidination; P:nucleotide-excision repair, DNA incision, 5'-to lesion;|P78549 Q1MVR1 Q99566 Q99794 Q9BPX2,Endonuclease III-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03183},Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase {ECO:0000255|HAMAP-Rule:MF_03183};, PF00633;PF00730;, GO:0005739;GO:0005654;GO:0005634;GO:0051539;GO:0140078;GO:0003684;GO:0019104;GO:0003906;GO:0003690;GO:0004519;GO:0046872;GO:0000703;GO:0006285;GO:0006287;GO:0045008;GO:0006296;, C:mitochondrion; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA N-glycosylase activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA binding; F:endonuclease activity; F:metal ion binding; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity;, P:base-excision repair, AP site formation; P:base-excision repair, gap-filling; P:depyrimidination; P:nucleotide-excision repair, DNA incision, 5'-to lesion;|P78549 Q1MVR1 Q99566 Q99794 Q9BPX2,Endonuclease III-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03183},Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase {ECO:0000255|HAMAP-Rule:MF_03183};, PF00633;PF00730;, GO:0005739;GO:0005654;GO:0005634;GO:0051539;GO:0140078;GO:0003684;GO:0019104;GO:0003906;GO:0003690;GO:0004519;GO:0046872;GO:0000703;GO:0006285;GO:0006287;GO:0045008;GO:0006296;, C:mitochondrion; C:nucleoplasm; C:nucleus;, F:4 iron, 4 sulfur cluster binding; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; F:damaged DNA binding; F:DNA N-glycosylase activity; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA binding; F:endonuclease activity; F:metal ion binding; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity;, P:base-excision repair, AP site formation; P:base-excision repair, gap-filling; P:depyrimidination; P:nucleotide-excision repair, DNA incision, 5'-to lesion; scaffold133 indexed_genome mRNA 784732 802655 . - . ID=transcript_14184;Q8TAZ1,Tuberin,Tuberous sclerosis 2 protein;, PF11864;PF02145;PF03542;, GO:0005737;GO:0005829;GO:0005794;GO:0005764;GO:0016020;GO:0005634;GO:0048471;GO:0014069;GO:0033596;GO:0005096;GO:0051879;GO:0019902;GO:0042803;GO:0031267;GO:0043276;GO:0006897;GO:0007507;GO:0048009;GO:0008285;GO:0046627;GO:1901525;GO:0014067;GO:0006469;GO:0051898;GO:0032007;GO:0030178;GO:0001843;GO:0050918;GO:0016239;GO:0006606;GO:0043491;GO:0008104;GO:0051726;GO:0030100;GO:0046626;GO:0051056;GO:0016192;GO:0016032;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:lysosome; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:TSC1-TSC2 complex;, F:GTPase activator activity; F:Hsp90 protein binding; F:phosphatase binding; F:protein homodimerization activity; F:small GTPase binding;, P:anoikis; P:endocytosis; P:heart development; P:insulin-like growth factor receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of mitophagy; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of Wnt signaling pathway; P:neural tube closure; P:positive chemotaxis; P:positive regulation of macroautophagy; P:protein import into nucleus; P:protein kinase B signaling; P:protein localization; P:regulation of cell cycle; P:regulation of endocytosis; P:regulation of insulin receptor signaling pathway; P:regulation of small GTPase mediated signal transduction; P:vesicle-mediated transport; P:viral process;|Q8TAZ1,Tuberin,Tuberous sclerosis 2 protein;, PF11864;PF02145;PF03542;, GO:0005737;GO:0005829;GO:0005794;GO:0005764;GO:0016020;GO:0005634;GO:0048471;GO:0014069;GO:0033596;GO:0005096;GO:0051879;GO:0019902;GO:0042803;GO:0031267;GO:0043276;GO:0006897;GO:0007507;GO:0048009;GO:0008285;GO:0046627;GO:1901525;GO:0014067;GO:0006469;GO:0051898;GO:0032007;GO:0030178;GO:0001843;GO:0050918;GO:0016239;GO:0006606;GO:0043491;GO:0008104;GO:0051726;GO:0030100;GO:0046626;GO:0051056;GO:0016192;GO:0016032;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:lysosome; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:TSC1-TSC2 complex;, F:GTPase activator activity; F:Hsp90 protein binding; F:phosphatase binding; F:protein homodimerization activity; F:small GTPase binding;, P:anoikis; P:endocytosis; P:heart development; P:insulin-like growth factor receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of mitophagy; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of Wnt signaling pathway; P:neural tube closure; P:positive chemotaxis; P:positive regulation of macroautophagy; P:protein import into nucleus; P:protein kinase B signaling; P:protein localization; P:regulation of cell cycle; P:regulation of endocytosis; P:regulation of insulin receptor signaling pathway; P:regulation of small GTPase mediated signal transduction; P:vesicle-mediated transport; P:viral process;|Q8TAZ1,Tuberin,Tuberous sclerosis 2 protein;, PF11864;PF02145;PF03542;, GO:0005737;GO:0005829;GO:0005794;GO:0005764;GO:0016020;GO:0005634;GO:0048471;GO:0014069;GO:0033596;GO:0005096;GO:0051879;GO:0019902;GO:0042803;GO:0031267;GO:0043276;GO:0006897;GO:0007507;GO:0048009;GO:0008285;GO:0046627;GO:1901525;GO:0014067;GO:0006469;GO:0051898;GO:0032007;GO:0030178;GO:0001843;GO:0050918;GO:0016239;GO:0006606;GO:0043491;GO:0008104;GO:0051726;GO:0030100;GO:0046626;GO:0051056;GO:0016192;GO:0016032;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:lysosome; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:TSC1-TSC2 complex;, F:GTPase activator activity; F:Hsp90 protein binding; F:phosphatase binding; F:protein homodimerization activity; F:small GTPase binding;, P:anoikis; P:endocytosis; P:heart development; P:insulin-like growth factor receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of mitophagy; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of Wnt signaling pathway; P:neural tube closure; P:positive chemotaxis; P:positive regulation of macroautophagy; P:protein import into nucleus; P:protein kinase B signaling; P:protein localization; P:regulation of cell cycle; P:regulation of endocytosis; P:regulation of insulin receptor signaling pathway; P:regulation of small GTPase mediated signal transduction; P:vesicle-mediated transport; P:viral process;|Q8TAZ1,Tuberin,Tuberous sclerosis 2 protein;, PF11864;PF02145;PF03542;, GO:0005737;GO:0005829;GO:0005794;GO:0005764;GO:0016020;GO:0005634;GO:0048471;GO:0014069;GO:0033596;GO:0005096;GO:0051879;GO:0019902;GO:0042803;GO:0031267;GO:0043276;GO:0006897;GO:0007507;GO:0048009;GO:0008285;GO:0046627;GO:1901525;GO:0014067;GO:0006469;GO:0051898;GO:0032007;GO:0030178;GO:0001843;GO:0050918;GO:0016239;GO:0006606;GO:0043491;GO:0008104;GO:0051726;GO:0030100;GO:0046626;GO:0051056;GO:0016192;GO:0016032;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:lysosome; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:TSC1-TSC2 complex;, F:GTPase activator activity; F:Hsp90 protein binding; F:phosphatase binding; F:protein homodimerization activity; F:small GTPase binding;, P:anoikis; P:endocytosis; P:heart development; P:insulin-like growth factor receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of mitophagy; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of Wnt signaling pathway; P:neural tube closure; P:positive chemotaxis; P:positive regulation of macroautophagy; P:protein import into nucleus; P:protein kinase B signaling; P:protein localization; P:regulation of cell cycle; P:regulation of endocytosis; P:regulation of insulin receptor signaling pathway; P:regulation of small GTPase mediated signal transduction; P:vesicle-mediated transport; P:viral process; scaffold133 indexed_genome mRNA 804160 844912 . + . ID=transcript_14185;Q8TAZ1,Tuberin,Tuberous sclerosis 2 protein;, PF11864;PF02145;PF03542;, GO:0005737;GO:0005829;GO:0005794;GO:0005764;GO:0016020;GO:0005634;GO:0048471;GO:0014069;GO:0033596;GO:0005096;GO:0051879;GO:0019902;GO:0042803;GO:0031267;GO:0043276;GO:0006897;GO:0007507;GO:0048009;GO:0008285;GO:0046627;GO:1901525;GO:0014067;GO:0006469;GO:0051898;GO:0032007;GO:0030178;GO:0001843;GO:0050918;GO:0016239;GO:0006606;GO:0043491;GO:0008104;GO:0051726;GO:0030100;GO:0046626;GO:0051056;GO:0016192;GO:0016032;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:lysosome; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:TSC1-TSC2 complex;, F:GTPase activator activity; F:Hsp90 protein binding; F:phosphatase binding; F:protein homodimerization activity; F:small GTPase binding;, P:anoikis; P:endocytosis; P:heart development; P:insulin-like growth factor receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of mitophagy; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of Wnt signaling pathway; P:neural tube closure; P:positive chemotaxis; P:positive regulation of macroautophagy; P:protein import into nucleus; P:protein kinase B signaling; P:protein localization; P:regulation of cell cycle; P:regulation of endocytosis; P:regulation of insulin receptor signaling pathway; P:regulation of small GTPase mediated signal transduction; P:vesicle-mediated transport; P:viral process;|Q8TAZ1,Tuberin,Tuberous sclerosis 2 protein;, PF11864;PF02145;PF03542;, GO:0005737;GO:0005829;GO:0005794;GO:0005764;GO:0016020;GO:0005634;GO:0048471;GO:0014069;GO:0033596;GO:0005096;GO:0051879;GO:0019902;GO:0042803;GO:0031267;GO:0043276;GO:0006897;GO:0007507;GO:0048009;GO:0008285;GO:0046627;GO:1901525;GO:0014067;GO:0006469;GO:0051898;GO:0032007;GO:0030178;GO:0001843;GO:0050918;GO:0016239;GO:0006606;GO:0043491;GO:0008104;GO:0051726;GO:0030100;GO:0046626;GO:0051056;GO:0016192;GO:0016032;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:lysosome; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:TSC1-TSC2 complex;, F:GTPase activator activity; F:Hsp90 protein binding; F:phosphatase binding; F:protein homodimerization activity; F:small GTPase binding;, P:anoikis; P:endocytosis; P:heart development; P:insulin-like growth factor receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of mitophagy; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of Wnt signaling pathway; P:neural tube closure; P:positive chemotaxis; P:positive regulation of macroautophagy; P:protein import into nucleus; P:protein kinase B signaling; P:protein localization; P:regulation of cell cycle; P:regulation of endocytosis; P:regulation of insulin receptor signaling pathway; P:regulation of small GTPase mediated signal transduction; P:vesicle-mediated transport; P:viral process;|Q8TAZ1,Tuberin,Tuberous sclerosis 2 protein;, PF11864;PF02145;PF03542;, GO:0005737;GO:0005829;GO:0005794;GO:0005764;GO:0016020;GO:0005634;GO:0048471;GO:0014069;GO:0033596;GO:0005096;GO:0051879;GO:0019902;GO:0042803;GO:0031267;GO:0043276;GO:0006897;GO:0007507;GO:0048009;GO:0008285;GO:0046627;GO:1901525;GO:0014067;GO:0006469;GO:0051898;GO:0032007;GO:0030178;GO:0001843;GO:0050918;GO:0016239;GO:0006606;GO:0043491;GO:0008104;GO:0051726;GO:0030100;GO:0046626;GO:0051056;GO:0016192;GO:0016032;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:lysosome; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic density; C:TSC1-TSC2 complex;, F:GTPase activator activity; F:Hsp90 protein binding; F:phosphatase binding; F:protein homodimerization activity; F:small GTPase binding;, P:anoikis; P:endocytosis; P:heart development; P:insulin-like growth factor receptor signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of mitophagy; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:negative regulation of Wnt signaling pathway; P:neural tube closure; P:positive chemotaxis; P:positive regulation of macroautophagy; P:protein import into nucleus; P:protein kinase B signaling; P:protein localization; P:regulation of cell cycle; P:regulation of endocytosis; P:regulation of insulin receptor signaling pathway; P:regulation of small GTPase mediated signal transduction; P:vesicle-mediated transport; P:viral process;|P98161 Q15140 Q15141,Polycystin-1 {ECO:0000305},Autosomal dominant polycystic kidney disease 1 protein;, PF00059;PF13855;PF00801;PF08016;PF01477;PF02010;PF01822;, GO:0016323;GO:0034704;GO:0034703;GO:0009986;GO:0060170;GO:0005929;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0005887;GO:0016328;GO:0031514;GO:0005634;GO:0005886;GO:0002133;GO:0005262;GO:0030246;GO:0044325;GO:0019904;GO:0019901;GO:0042813;GO:0009653;GO:0048754;GO:0070588;GO:0007161;GO:0001502;GO:0051216;GO:0007050;GO:0198738;GO:0007160;GO:0060271;GO:0042994;GO:0050982;GO:0048565;GO:0001892;GO:0030010;GO:0048806;GO:0007507;GO:0007156;GO:0001701;GO:0001822;GO:0001889;GO:0060428;GO:0036303;GO:0072177;GO:0072164;GO:0072218;GO:0072205;GO:0072287;GO:0072237;GO:0021915;GO:0018105;GO:0060674;GO:0045737;GO:0007204;GO:0032092;GO:0045944;GO:0006611;GO:0051290;GO:0007259;GO:0030155;GO:2000045;GO:0060236;GO:0061136;GO:0034405;GO:0043588;GO:0021510;, C:basolateral plasma membrane; C:calcium channel complex; C:cation channel complex; C:cell surface; C:ciliary membrane; C:cilium; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lateral plasma membrane; C:motile cilium; C:nucleus; C:plasma membrane; C:polycystin complex;, F:calcium channel activity; F:carbohydrate binding; F:ion channel binding; F:protein domain specific binding; F:protein kinase binding; F:Wnt-activated receptor activity;, P:anatomical structure morphogenesis; P:branching morphogenesis of an epithelial tube; P:calcium ion transmembrane transport; P:calcium-independent cell-matrix adhesion; P:cartilage condensation; P:cartilage development; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cell-matrix adhesion; P:cilium assembly; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:digestive tract development; P:embryonic placenta development; P:establishment of cell polarity; P:genitalia development; P:heart development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:in utero embryonic development; P:kidney development; P:liver development; P:lung epithelium development; P:lymph vessel morphogenesis; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric collecting duct development; P:metanephric distal tubule morphogenesis; P:metanephric proximal tubule development; P:neural tube development; P:peptidyl-serine phosphorylation; P:placenta blood vessel development; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:protein export from nucleus; P:protein heterotetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of cell adhesion; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:regulation of proteasomal protein catabolic process; P:response to fluid shear stress; P:skin development; P:spinal cord development;|P98161 Q15140 Q15141,Polycystin-1 {ECO:0000305},Autosomal dominant polycystic kidney disease 1 protein;, PF00059;PF13855;PF00801;PF08016;PF01477;PF02010;PF01822;, GO:0016323;GO:0034704;GO:0034703;GO:0009986;GO:0060170;GO:0005929;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0005887;GO:0016328;GO:0031514;GO:0005634;GO:0005886;GO:0002133;GO:0005262;GO:0030246;GO:0044325;GO:0019904;GO:0019901;GO:0042813;GO:0009653;GO:0048754;GO:0070588;GO:0007161;GO:0001502;GO:0051216;GO:0007050;GO:0198738;GO:0007160;GO:0060271;GO:0042994;GO:0050982;GO:0048565;GO:0001892;GO:0030010;GO:0048806;GO:0007507;GO:0007156;GO:0001701;GO:0001822;GO:0001889;GO:0060428;GO:0036303;GO:0072177;GO:0072164;GO:0072218;GO:0072205;GO:0072287;GO:0072237;GO:0021915;GO:0018105;GO:0060674;GO:0045737;GO:0007204;GO:0032092;GO:0045944;GO:0006611;GO:0051290;GO:0007259;GO:0030155;GO:2000045;GO:0060236;GO:0061136;GO:0034405;GO:0043588;GO:0021510;, C:basolateral plasma membrane; C:calcium channel complex; C:cation channel complex; C:cell surface; C:ciliary membrane; C:cilium; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lateral plasma membrane; C:motile cilium; C:nucleus; C:plasma membrane; C:polycystin complex;, F:calcium channel activity; F:carbohydrate binding; F:ion channel binding; F:protein domain specific binding; F:protein kinase binding; F:Wnt-activated receptor activity;, P:anatomical structure morphogenesis; P:branching morphogenesis of an epithelial tube; P:calcium ion transmembrane transport; P:calcium-independent cell-matrix adhesion; P:cartilage condensation; P:cartilage development; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cell-matrix adhesion; P:cilium assembly; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:digestive tract development; P:embryonic placenta development; P:establishment of cell polarity; P:genitalia development; P:heart development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:in utero embryonic development; P:kidney development; P:liver development; P:lung epithelium development; P:lymph vessel morphogenesis; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric collecting duct development; P:metanephric distal tubule morphogenesis; P:metanephric proximal tubule development; P:neural tube development; P:peptidyl-serine phosphorylation; P:placenta blood vessel development; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:protein export from nucleus; P:protein heterotetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of cell adhesion; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:regulation of proteasomal protein catabolic process; P:response to fluid shear stress; P:skin development; P:spinal cord development;|P98161 Q15140 Q15141,Polycystin-1 {ECO:0000305},Autosomal dominant polycystic kidney disease 1 protein;, PF00059;PF13855;PF00801;PF08016;PF01477;PF02010;PF01822;, GO:0016323;GO:0034704;GO:0034703;GO:0009986;GO:0060170;GO:0005929;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0005887;GO:0016328;GO:0031514;GO:0005634;GO:0005886;GO:0002133;GO:0005262;GO:0030246;GO:0044325;GO:0019904;GO:0019901;GO:0042813;GO:0009653;GO:0048754;GO:0070588;GO:0007161;GO:0001502;GO:0051216;GO:0007050;GO:0198738;GO:0007160;GO:0060271;GO:0042994;GO:0050982;GO:0048565;GO:0001892;GO:0030010;GO:0048806;GO:0007507;GO:0007156;GO:0001701;GO:0001822;GO:0001889;GO:0060428;GO:0036303;GO:0072177;GO:0072164;GO:0072218;GO:0072205;GO:0072287;GO:0072237;GO:0021915;GO:0018105;GO:0060674;GO:0045737;GO:0007204;GO:0032092;GO:0045944;GO:0006611;GO:0051290;GO:0007259;GO:0030155;GO:2000045;GO:0060236;GO:0061136;GO:0034405;GO:0043588;GO:0021510;, C:basolateral plasma membrane; C:calcium channel complex; C:cation channel complex; C:cell surface; C:ciliary membrane; C:cilium; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lateral plasma membrane; C:motile cilium; C:nucleus; C:plasma membrane; C:polycystin complex;, F:calcium channel activity; F:carbohydrate binding; F:ion channel binding; F:protein domain specific binding; F:protein kinase binding; F:Wnt-activated receptor activity;, P:anatomical structure morphogenesis; P:branching morphogenesis of an epithelial tube; P:calcium ion transmembrane transport; P:calcium-independent cell-matrix adhesion; P:cartilage condensation; P:cartilage development; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cell-matrix adhesion; P:cilium assembly; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:digestive tract development; P:embryonic placenta development; P:establishment of cell polarity; P:genitalia development; P:heart development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:in utero embryonic development; P:kidney development; P:liver development; P:lung epithelium development; P:lymph vessel morphogenesis; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric collecting duct development; P:metanephric distal tubule morphogenesis; P:metanephric proximal tubule development; P:neural tube development; P:peptidyl-serine phosphorylation; P:placenta blood vessel development; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:protein export from nucleus; P:protein heterotetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of cell adhesion; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:regulation of proteasomal protein catabolic process; P:response to fluid shear stress; P:skin development; P:spinal cord development;|P98161 Q15140 Q15141,Polycystin-1 {ECO:0000305},Autosomal dominant polycystic kidney disease 1 protein;, PF00059;PF13855;PF00801;PF08016;PF01477;PF02010;PF01822;, GO:0016323;GO:0034704;GO:0034703;GO:0009986;GO:0060170;GO:0005929;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0005887;GO:0016328;GO:0031514;GO:0005634;GO:0005886;GO:0002133;GO:0005262;GO:0030246;GO:0044325;GO:0019904;GO:0019901;GO:0042813;GO:0009653;GO:0048754;GO:0070588;GO:0007161;GO:0001502;GO:0051216;GO:0007050;GO:0198738;GO:0007160;GO:0060271;GO:0042994;GO:0050982;GO:0048565;GO:0001892;GO:0030010;GO:0048806;GO:0007507;GO:0007156;GO:0001701;GO:0001822;GO:0001889;GO:0060428;GO:0036303;GO:0072177;GO:0072164;GO:0072218;GO:0072205;GO:0072287;GO:0072237;GO:0021915;GO:0018105;GO:0060674;GO:0045737;GO:0007204;GO:0032092;GO:0045944;GO:0006611;GO:0051290;GO:0007259;GO:0030155;GO:2000045;GO:0060236;GO:0061136;GO:0034405;GO:0043588;GO:0021510;, C:basolateral plasma membrane; C:calcium channel complex; C:cation channel complex; C:cell surface; C:ciliary membrane; C:cilium; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lateral plasma membrane; C:motile cilium; C:nucleus; C:plasma membrane; C:polycystin complex;, F:calcium channel activity; F:carbohydrate binding; F:ion channel binding; F:protein domain specific binding; F:protein kinase binding; F:Wnt-activated receptor activity;, P:anatomical structure morphogenesis; P:branching morphogenesis of an epithelial tube; P:calcium ion transmembrane transport; P:calcium-independent cell-matrix adhesion; P:cartilage condensation; P:cartilage development; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cell-matrix adhesion; P:cilium assembly; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:digestive tract development; P:embryonic placenta development; P:establishment of cell polarity; P:genitalia development; P:heart development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:in utero embryonic development; P:kidney development; P:liver development; P:lung epithelium development; P:lymph vessel morphogenesis; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric collecting duct development; P:metanephric distal tubule morphogenesis; P:metanephric proximal tubule development; P:neural tube development; P:peptidyl-serine phosphorylation; P:placenta blood vessel development; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:protein export from nucleus; P:protein heterotetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of cell adhesion; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:regulation of proteasomal protein catabolic process; P:response to fluid shear stress; P:skin development; P:spinal cord development;|P98161 Q15140 Q15141,Polycystin-1 {ECO:0000305},Autosomal dominant polycystic kidney disease 1 protein;, PF00059;PF13855;PF00801;PF08016;PF01477;PF02010;PF01822;, GO:0016323;GO:0034704;GO:0034703;GO:0009986;GO:0060170;GO:0005929;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0005887;GO:0016328;GO:0031514;GO:0005634;GO:0005886;GO:0002133;GO:0005262;GO:0030246;GO:0044325;GO:0019904;GO:0019901;GO:0042813;GO:0009653;GO:0048754;GO:0070588;GO:0007161;GO:0001502;GO:0051216;GO:0007050;GO:0198738;GO:0007160;GO:0060271;GO:0042994;GO:0050982;GO:0048565;GO:0001892;GO:0030010;GO:0048806;GO:0007507;GO:0007156;GO:0001701;GO:0001822;GO:0001889;GO:0060428;GO:0036303;GO:0072177;GO:0072164;GO:0072218;GO:0072205;GO:0072287;GO:0072237;GO:0021915;GO:0018105;GO:0060674;GO:0045737;GO:0007204;GO:0032092;GO:0045944;GO:0006611;GO:0051290;GO:0007259;GO:0030155;GO:2000045;GO:0060236;GO:0061136;GO:0034405;GO:0043588;GO:0021510;, C:basolateral plasma membrane; C:calcium channel complex; C:cation channel complex; C:cell surface; C:ciliary membrane; C:cilium; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lateral plasma membrane; C:motile cilium; C:nucleus; C:plasma membrane; C:polycystin complex;, F:calcium channel activity; F:carbohydrate binding; F:ion channel binding; F:protein domain specific binding; F:protein kinase binding; F:Wnt-activated receptor activity;, P:anatomical structure morphogenesis; P:branching morphogenesis of an epithelial tube; P:calcium ion transmembrane transport; P:calcium-independent cell-matrix adhesion; P:cartilage condensation; P:cartilage development; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cell-matrix adhesion; P:cilium assembly; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:digestive tract development; P:embryonic placenta development; P:establishment of cell polarity; P:genitalia development; P:heart development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:in utero embryonic development; P:kidney development; P:liver development; P:lung epithelium development; P:lymph vessel morphogenesis; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric collecting duct development; P:metanephric distal tubule morphogenesis; P:metanephric proximal tubule development; P:neural tube development; P:peptidyl-serine phosphorylation; P:placenta blood vessel development; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:protein export from nucleus; P:protein heterotetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of cell adhesion; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:regulation of proteasomal protein catabolic process; P:response to fluid shear stress; P:skin development; P:spinal cord development;|P98161 Q15140 Q15141,Polycystin-1 {ECO:0000305},Autosomal dominant polycystic kidney disease 1 protein;, PF00059;PF13855;PF00801;PF08016;PF01477;PF02010;PF01822;, GO:0016323;GO:0034704;GO:0034703;GO:0009986;GO:0060170;GO:0005929;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0005887;GO:0016328;GO:0031514;GO:0005634;GO:0005886;GO:0002133;GO:0005262;GO:0030246;GO:0044325;GO:0019904;GO:0019901;GO:0042813;GO:0009653;GO:0048754;GO:0070588;GO:0007161;GO:0001502;GO:0051216;GO:0007050;GO:0198738;GO:0007160;GO:0060271;GO:0042994;GO:0050982;GO:0048565;GO:0001892;GO:0030010;GO:0048806;GO:0007507;GO:0007156;GO:0001701;GO:0001822;GO:0001889;GO:0060428;GO:0036303;GO:0072177;GO:0072164;GO:0072218;GO:0072205;GO:0072287;GO:0072237;GO:0021915;GO:0018105;GO:0060674;GO:0045737;GO:0007204;GO:0032092;GO:0045944;GO:0006611;GO:0051290;GO:0007259;GO:0030155;GO:2000045;GO:0060236;GO:0061136;GO:0034405;GO:0043588;GO:0021510;, C:basolateral plasma membrane; C:calcium channel complex; C:cation channel complex; C:cell surface; C:ciliary membrane; C:cilium; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lateral plasma membrane; C:motile cilium; C:nucleus; C:plasma membrane; C:polycystin complex;, F:calcium channel activity; F:carbohydrate binding; F:ion channel binding; F:protein domain specific binding; F:protein kinase binding; F:Wnt-activated receptor activity;, P:anatomical structure morphogenesis; P:branching morphogenesis of an epithelial tube; P:calcium ion transmembrane transport; P:calcium-independent cell-matrix adhesion; P:cartilage condensation; P:cartilage development; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cell-matrix adhesion; P:cilium assembly; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:digestive tract development; P:embryonic placenta development; P:establishment of cell polarity; P:genitalia development; P:heart development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:in utero embryonic development; P:kidney development; P:liver development; P:lung epithelium development; P:lymph vessel morphogenesis; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric collecting duct development; P:metanephric distal tubule morphogenesis; P:metanephric proximal tubule development; P:neural tube development; P:peptidyl-serine phosphorylation; P:placenta blood vessel development; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:protein export from nucleus; P:protein heterotetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of cell adhesion; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:regulation of proteasomal protein catabolic process; P:response to fluid shear stress; P:skin development; P:spinal cord development;|P98161 Q15140 Q15141,Polycystin-1 {ECO:0000305},Autosomal dominant polycystic kidney disease 1 protein;, PF00059;PF13855;PF00801;PF08016;PF01477;PF02010;PF01822;, GO:0016323;GO:0034704;GO:0034703;GO:0009986;GO:0060170;GO:0005929;GO:0005737;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0030660;GO:0016021;GO:0005887;GO:0016328;GO:0031514;GO:0005634;GO:0005886;GO:0002133;GO:0005262;GO:0030246;GO:0044325;GO:0019904;GO:0019901;GO:0042813;GO:0009653;GO:0048754;GO:0070588;GO:0007161;GO:0001502;GO:0051216;GO:0007050;GO:0198738;GO:0007160;GO:0060271;GO:0042994;GO:0050982;GO:0048565;GO:0001892;GO:0030010;GO:0048806;GO:0007507;GO:0007156;GO:0001701;GO:0001822;GO:0001889;GO:0060428;GO:0036303;GO:0072177;GO:0072164;GO:0072218;GO:0072205;GO:0072287;GO:0072237;GO:0021915;GO:0018105;GO:0060674;GO:0045737;GO:0007204;GO:0032092;GO:0045944;GO:0006611;GO:0051290;GO:0007259;GO:0030155;GO:2000045;GO:0060236;GO:0061136;GO:0034405;GO:0043588;GO:0021510;, C:basolateral plasma membrane; C:calcium channel complex; C:cation channel complex; C:cell surface; C:ciliary membrane; C:cilium; C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane; C:integral component of plasma membrane; C:lateral plasma membrane; C:motile cilium; C:nucleus; C:plasma membrane; C:polycystin complex;, F:calcium channel activity; F:carbohydrate binding; F:ion channel binding; F:protein domain specific binding; F:protein kinase binding; F:Wnt-activated receptor activity;, P:anatomical structure morphogenesis; P:branching morphogenesis of an epithelial tube; P:calcium ion transmembrane transport; P:calcium-independent cell-matrix adhesion; P:cartilage condensation; P:cartilage development; P:cell cycle arrest; P:cell-cell signaling by wnt; P:cell-matrix adhesion; P:cilium assembly; P:cytoplasmic sequestering of transcription factor; P:detection of mechanical stimulus; P:digestive tract development; P:embryonic placenta development; P:establishment of cell polarity; P:genitalia development; P:heart development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:in utero embryonic development; P:kidney development; P:liver development; P:lung epithelium development; P:lymph vessel morphogenesis; P:mesonephric duct development; P:mesonephric tubule development; P:metanephric ascending thin limb development; P:metanephric collecting duct development; P:metanephric distal tubule morphogenesis; P:metanephric proximal tubule development; P:neural tube development; P:peptidyl-serine phosphorylation; P:placenta blood vessel development; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:protein export from nucleus; P:protein heterotetramerization; P:receptor signaling pathway via JAK-STAT; P:regulation of cell adhesion; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of mitotic spindle organization; P:regulation of proteasomal protein catabolic process; P:response to fluid shear stress; P:skin development; P:spinal cord development; scaffold133 indexed_genome mRNA 880391 885271 . + . ID=transcript_14186;Q9ULW5 B2RAA6 Q3L6K5 Q6NXS7,Ras-related protein Rab-26,, PF00071;, GO:0098993;GO:0005768;GO:0005794;GO:0000139;GO:0031226;GO:0030667;GO:0019002;GO:0005525;GO:0003924;GO:0035272;GO:0043001;GO:0045055;GO:0017157;GO:0099575;, C:anchored component of synaptic vesicle membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:intrinsic component of plasma membrane; C:secretory granule membrane;, F:GMP binding; F:GTP binding; F:GTPase activity;, P:exocrine system development; P:Golgi to plasma membrane protein transport; P:regulated exocytosis; P:regulation of exocytosis; P:regulation of protein catabolic process at presynapse, modulating synaptic transmission;|Q9ULW5 B2RAA6 Q3L6K5 Q6NXS7,Ras-related protein Rab-26,, PF00071;, GO:0098993;GO:0005768;GO:0005794;GO:0000139;GO:0031226;GO:0030667;GO:0019002;GO:0005525;GO:0003924;GO:0035272;GO:0043001;GO:0045055;GO:0017157;GO:0099575;, C:anchored component of synaptic vesicle membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:intrinsic component of plasma membrane; C:secretory granule membrane;, F:GMP binding; F:GTP binding; F:GTPase activity;, P:exocrine system development; P:Golgi to plasma membrane protein transport; P:regulated exocytosis; P:regulation of exocytosis; P:regulation of protein catabolic process at presynapse, modulating synaptic transmission;|Q9ULW5 B2RAA6 Q3L6K5 Q6NXS7,Ras-related protein Rab-26,, PF00071;, GO:0098993;GO:0005768;GO:0005794;GO:0000139;GO:0031226;GO:0030667;GO:0019002;GO:0005525;GO:0003924;GO:0035272;GO:0043001;GO:0045055;GO:0017157;GO:0099575;, C:anchored component of synaptic vesicle membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:intrinsic component of plasma membrane; C:secretory granule membrane;, F:GMP binding; F:GTP binding; F:GTPase activity;, P:exocrine system development; P:Golgi to plasma membrane protein transport; P:regulated exocytosis; P:regulation of exocytosis; P:regulation of protein catabolic process at presynapse, modulating synaptic transmission;|Q9ULW5 B2RAA6 Q3L6K5 Q6NXS7,Ras-related protein Rab-26,, PF00071;, GO:0098993;GO:0005768;GO:0005794;GO:0000139;GO:0031226;GO:0030667;GO:0019002;GO:0005525;GO:0003924;GO:0035272;GO:0043001;GO:0045055;GO:0017157;GO:0099575;, C:anchored component of synaptic vesicle membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:intrinsic component of plasma membrane; C:secretory granule membrane;, F:GMP binding; F:GTP binding; F:GTPase activity;, P:exocrine system development; P:Golgi to plasma membrane protein transport; P:regulated exocytosis; P:regulation of exocytosis; P:regulation of protein catabolic process at presynapse, modulating synaptic transmission; scaffold133 indexed_genome mRNA 902715 922514 . + . ID=transcript_14187;Q6Q0C0 Q9H073,E3 ubiquitin-protein ligase TRAF7,RING finger and WD repeat-containing protein 1;RING finger protein 119;RING-type E3 ubiquitin transferase TRAF7 {ECO:0000305};TNF receptor-associated factor 7;, PF00400;PF13445;, GO:0031410;GO:0043231;GO:0005730;GO:0005886;GO:0000151;GO:0004842;GO:0008270;GO:0000185;GO:0006915;GO:0007219;GO:2001235;GO:0043410;GO:0016567;GO:0070372;GO:0000027;, C:cytoplasmic vesicle; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of MAPKKK activity; P:apoptotic process; P:Notch signaling pathway; P:positive regulation of apoptotic signaling pathway; P:positive regulation of MAPK cascade; P:protein ubiquitination; P:regulation of ERK1 and ERK2 cascade; P:ribosomal large subunit assembly;|Q6Q0C0 Q9H073,E3 ubiquitin-protein ligase TRAF7,RING finger and WD repeat-containing protein 1;RING finger protein 119;RING-type E3 ubiquitin transferase TRAF7 {ECO:0000305};TNF receptor-associated factor 7;, PF00400;PF13445;, GO:0031410;GO:0043231;GO:0005730;GO:0005886;GO:0000151;GO:0004842;GO:0008270;GO:0000185;GO:0006915;GO:0007219;GO:2001235;GO:0043410;GO:0016567;GO:0070372;GO:0000027;, C:cytoplasmic vesicle; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of MAPKKK activity; P:apoptotic process; P:Notch signaling pathway; P:positive regulation of apoptotic signaling pathway; P:positive regulation of MAPK cascade; P:protein ubiquitination; P:regulation of ERK1 and ERK2 cascade; P:ribosomal large subunit assembly;|Q6Q0C0 Q9H073,E3 ubiquitin-protein ligase TRAF7,RING finger and WD repeat-containing protein 1;RING finger protein 119;RING-type E3 ubiquitin transferase TRAF7 {ECO:0000305};TNF receptor-associated factor 7;, PF00400;PF13445;, GO:0031410;GO:0043231;GO:0005730;GO:0005886;GO:0000151;GO:0004842;GO:0008270;GO:0000185;GO:0006915;GO:0007219;GO:2001235;GO:0043410;GO:0016567;GO:0070372;GO:0000027;, C:cytoplasmic vesicle; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of MAPKKK activity; P:apoptotic process; P:Notch signaling pathway; P:positive regulation of apoptotic signaling pathway; P:positive regulation of MAPK cascade; P:protein ubiquitination; P:regulation of ERK1 and ERK2 cascade; P:ribosomal large subunit assembly;|Q6Q0C0 Q9H073,E3 ubiquitin-protein ligase TRAF7,RING finger and WD repeat-containing protein 1;RING finger protein 119;RING-type E3 ubiquitin transferase TRAF7 {ECO:0000305};TNF receptor-associated factor 7;, PF00400;PF13445;, GO:0031410;GO:0043231;GO:0005730;GO:0005886;GO:0000151;GO:0004842;GO:0008270;GO:0000185;GO:0006915;GO:0007219;GO:2001235;GO:0043410;GO:0016567;GO:0070372;GO:0000027;, C:cytoplasmic vesicle; C:intracellular membrane-bounded organelle; C:nucleolus; C:plasma membrane; C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of MAPKKK activity; P:apoptotic process; P:Notch signaling pathway; P:positive regulation of apoptotic signaling pathway; P:positive regulation of MAPK cascade; P:protein ubiquitination; P:regulation of ERK1 and ERK2 cascade; P:ribosomal large subunit assembly; scaffold133 indexed_genome mRNA 922632 943033 . - . ID=transcript_14188;Q8WXD9 Q9P2P0,Caskin-1,CASK-interacting protein 1;, PF12796;PF16632;PF16600;PF00536;PF07653;, GO:0005737;GO:0016020;GO:0042802;GO:0007165;, C:cytoplasm; C:membrane;, F:identical protein binding;, P:signal transduction;|Q8WXD9 Q9P2P0,Caskin-1,CASK-interacting protein 1;, PF12796;PF16632;PF16600;PF00536;PF07653;, GO:0005737;GO:0016020;GO:0042802;GO:0007165;, C:cytoplasm; C:membrane;, F:identical protein binding;, P:signal transduction; scaffold133 indexed_genome mRNA 949370 953902 . - . ID=transcript_14189;Q9BVC4 B3KMM4 B4DY00 D3DU88 Q5M800 Q86Y18 Q8WUI5 Q9HA66 Q9UJV6,Target of rapamycin complex subunit LST8,G protein beta subunit-like;Mammalian lethal with SEC13 protein 8;, PF00400;, GO:0005737;GO:0005829;GO:0005654;GO:0031931;GO:0031932;GO:0043539;GO:0032148;GO:0007050;GO:0034198;GO:0032008;GO:0032956;GO:1900034;GO:0016241;GO:1901796;GO:0031929;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:TORC1 complex; C:TORC2 complex;, F:protein serine/threonine kinase activator activity;, P:activation of protein kinase B activity; P:cell cycle arrest; P:cellular response to amino acid starvation; P:positive regulation of TOR signaling; P:regulation of actin cytoskeleton organization; P:regulation of cellular response to heat; P:regulation of macroautophagy; P:regulation of signal transduction by p53 class mediator; P:TOR signaling; P:TORC1 signaling; scaffold133 indexed_genome mRNA 953931 954625 . - . ID=transcript_14190;Q6PL45 C9J7K2 Q8IXU9,BRICHOS domain-containing protein 5,, PF04089;, GO:0005615;GO:0016021;GO:0042127;, C:extracellular space; C:integral component of membrane;, , P:regulation of cell population proliferation; scaffold133 indexed_genome mRNA 955476 1002193 . - . ID=transcript_14191;A6NDG6,Glycerol-3-phosphate phosphatase {ECO:0000305},Aspartate-based ubiquitous Mg(2+)-dependent phosphatase {ECO:0000303|PubMed:26755581};Phosphoglycolate phosphatase {ECO:0000303|PubMed:215071};, PF13344;, GO:0005737;GO:0000121;GO:0043136;GO:0000287;GO:0098519;GO:0016791;GO:0008967;GO:0004725;GO:0016311;GO:0006114;GO:0006650;GO:0045721;GO:0035335;, C:cytoplasm;, F:glycerol-1-phosphatase activity; F:glycerol-3-phosphatase activity; F:magnesium ion binding; F:nucleotide phosphatase activity, acting on free nucleotides; F:phosphatase activity; F:phosphoglycolate phosphatase activity; F:protein tyrosine phosphatase activity;, P:dephosphorylation; P:glycerol biosynthetic process; P:glycerophospholipid metabolic process; P:negative regulation of gluconeogenesis; P:peptidyl-tyrosine dephosphorylation;|Q66K89 A8K2R4 O00146,Transcription factor E4F1,E4F transcription factor 1;Putative E3 ubiquitin-protein ligase E4F1;RING-type E3 ubiquitin transferase E4F1 {ECO:0000305};Transcription factor E4F;p120E4F;p50E4F;, PF00096;, GO:0005737;GO:0005654;GO:0005819;GO:0035497;GO:0001228;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:0016740;GO:0051301;GO:0006260;GO:0071850;GO:0000122;GO:0045944;GO:0016567;GO:0010564;GO:0040008;GO:0009794;GO:0006357;GO:0016032;, C:cytoplasm; C:nucleoplasm; C:spindle;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transferase activity;, P:cell division; P:DNA replication; P:mitotic cell cycle arrest; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein ubiquitination; P:regulation of cell cycle process; P:regulation of growth; P:regulation of mitotic cell cycle, embryonic; P:regulation of transcription by RNA polymerase II; P:viral process;|Q66K89 A8K2R4 O00146,Transcription factor E4F1,E4F transcription factor 1;Putative E3 ubiquitin-protein ligase E4F1;RING-type E3 ubiquitin transferase E4F1 {ECO:0000305};Transcription factor E4F;p120E4F;p50E4F;, PF00096;, GO:0005737;GO:0005654;GO:0005819;GO:0035497;GO:0001228;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:0016740;GO:0051301;GO:0006260;GO:0071850;GO:0000122;GO:0045944;GO:0016567;GO:0010564;GO:0040008;GO:0009794;GO:0006357;GO:0016032;, C:cytoplasm; C:nucleoplasm; C:spindle;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transferase activity;, P:cell division; P:DNA replication; P:mitotic cell cycle arrest; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein ubiquitination; P:regulation of cell cycle process; P:regulation of growth; P:regulation of mitotic cell cycle, embryonic; P:regulation of transcription by RNA polymerase II; P:viral process;|Q66K89 A8K2R4 O00146,Transcription factor E4F1,E4F transcription factor 1;Putative E3 ubiquitin-protein ligase E4F1;RING-type E3 ubiquitin transferase E4F1 {ECO:0000305};Transcription factor E4F;p120E4F;p50E4F;, PF00096;, GO:0005737;GO:0005654;GO:0005819;GO:0035497;GO:0001228;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:0016740;GO:0051301;GO:0006260;GO:0071850;GO:0000122;GO:0045944;GO:0016567;GO:0010564;GO:0040008;GO:0009794;GO:0006357;GO:0016032;, C:cytoplasm; C:nucleoplasm; C:spindle;, F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transferase activity;, P:cell division; P:DNA replication; P:mitotic cell cycle arrest; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein ubiquitination; P:regulation of cell cycle process; P:regulation of growth; P:regulation of mitotic cell cycle, embryonic; P:regulation of transcription by RNA polymerase II; P:viral process;|P42126 A8K512 Q13290 Q7Z2L6 Q7Z2L7 Q9BUB8 Q9BW05 Q9UDG6,Enoyl-CoA delta isomerase 1, mitochondrial,3,2-trans-enoyl-CoA isomerase;Delta(3),Delta(2)-enoyl-CoA isomerase;Dodecenoyl-CoA isomerase;, PF00378;, GO:0005759;GO:0005739;GO:0004165;GO:0004300;GO:0016863;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:dodecenoyl-CoA delta-isomerase activity; F:enoyl-CoA hydratase activity; F:intramolecular oxidoreductase activity, transposing C=C bonds;, P:fatty acid beta-oxidation;|P42126 A8K512 Q13290 Q7Z2L6 Q7Z2L7 Q9BUB8 Q9BW05 Q9UDG6,Enoyl-CoA delta isomerase 1, mitochondrial,3,2-trans-enoyl-CoA isomerase;Delta(3),Delta(2)-enoyl-CoA isomerase;Dodecenoyl-CoA isomerase;, PF00378;, GO:0005759;GO:0005739;GO:0004165;GO:0004300;GO:0016863;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:dodecenoyl-CoA delta-isomerase activity; F:enoyl-CoA hydratase activity; F:intramolecular oxidoreductase activity, transposing C=C bonds;, P:fatty acid beta-oxidation;|P42126 A8K512 Q13290 Q7Z2L6 Q7Z2L7 Q9BUB8 Q9BW05 Q9UDG6,Enoyl-CoA delta isomerase 1, mitochondrial,3,2-trans-enoyl-CoA isomerase;Delta(3),Delta(2)-enoyl-CoA isomerase;Dodecenoyl-CoA isomerase;, PF00378;, GO:0005759;GO:0005739;GO:0004165;GO:0004300;GO:0016863;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:dodecenoyl-CoA delta-isomerase activity; F:enoyl-CoA hydratase activity; F:intramolecular oxidoreductase activity, transposing C=C bonds;, P:fatty acid beta-oxidation;|Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response;|P42126 A8K512 Q13290 Q7Z2L6 Q7Z2L7 Q9BUB8 Q9BW05 Q9UDG6,Enoyl-CoA delta isomerase 1, mitochondrial,3,2-trans-enoyl-CoA isomerase;Delta(3),Delta(2)-enoyl-CoA isomerase;Dodecenoyl-CoA isomerase;, PF00378;, GO:0005759;GO:0005739;GO:0004165;GO:0004300;GO:0016863;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:dodecenoyl-CoA delta-isomerase activity; F:enoyl-CoA hydratase activity; F:intramolecular oxidoreductase activity, transposing C=C bonds;, P:fatty acid beta-oxidation;|Q15287 A8K1P0 B4DDU8 B4DZU7 B7ZA17 O75308 Q32P25 Q8WY42 Q9NYG3,RNA-binding protein with serine-rich domain 1,SR-related protein LDC2;, PF00076;, GO:0061574;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003730;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0048025;GO:0000184;GO:0043065;GO:0000381;GO:0006405;GO:0008380;GO:0006351;, C:ASAP complex; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:mRNA 3'-UTR binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; P:transcription, DNA-templated;|Q15287 A8K1P0 B4DDU8 B4DZU7 B7ZA17 O75308 Q32P25 Q8WY42 Q9NYG3,RNA-binding protein with serine-rich domain 1,SR-related protein LDC2;, PF00076;, GO:0061574;GO:0005737;GO:0005829;GO:0016607;GO:0005654;GO:0005634;GO:0003730;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0048025;GO:0000184;GO:0043065;GO:0000381;GO:0006405;GO:0008380;GO:0006351;, C:ASAP complex; C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:mRNA 3'-UTR binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA splicing; P:transcription, DNA-templated; scaffold133 indexed_genome mRNA 1008291 1039962 . - . ID=transcript_14192;Q99758 B2RU09 Q54A95 Q6P5P9 Q92473,Phospholipid-transporting ATPase ABCA3 {ECO:0000305},ABC-C transporter;ATP-binding cassette sub-family A member 3 {ECO:0000305};ATP-binding cassette transporter 3;Xenobiotic-transporting ATPase ABCA3 {ECO:0000305};, PF00005;, GO:0097208;GO:0097233;GO:0030659;GO:0005615;GO:0016021;GO:0043231;GO:0042599;GO:0097232;GO:0005770;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0140345;GO:0120019;GO:0044267;GO:0046618;GO:0006855;GO:0006869;GO:0030324;GO:0070925;GO:0046470;GO:0046471;GO:0055091;GO:0015914;GO:0010875;GO:1902995;GO:2001140;GO:0032464;GO:0046890;GO:0150172;GO:0042493;GO:0051384;GO:0043129;GO:0042908;, C:alveolar lamellar body; C:alveolar lamellar body membrane; C:cytoplasmic vesicle membrane; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lamellar body; C:lamellar body membrane; C:late endosome; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity; F:phosphatidylcholine flippase activity; F:phosphatidylcholine transfer activity;, P:cellular protein metabolic process; P:drug export; P:drug transmembrane transport; P:lipid transport; P:lung development; P:organelle assembly; P:phosphatidylcholine metabolic process; P:phosphatidylglycerol metabolic process; P:phospholipid homeostasis; P:phospholipid transport; P:positive regulation of cholesterol efflux; P:positive regulation of phospholipid efflux; P:positive regulation of phospholipid transport; P:positive regulation of protein homooligomerization; P:regulation of lipid biosynthetic process; P:regulation of phosphatidylcholine metabolic process; P:response to drug; P:response to glucocorticoid; P:surfactant homeostasis; P:xenobiotic transport;|Q99758 B2RU09 Q54A95 Q6P5P9 Q92473,Phospholipid-transporting ATPase ABCA3 {ECO:0000305},ABC-C transporter;ATP-binding cassette sub-family A member 3 {ECO:0000305};ATP-binding cassette transporter 3;Xenobiotic-transporting ATPase ABCA3 {ECO:0000305};, PF00005;, GO:0097208;GO:0097233;GO:0030659;GO:0005615;GO:0016021;GO:0043231;GO:0042599;GO:0097232;GO:0005770;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0140345;GO:0120019;GO:0044267;GO:0046618;GO:0006855;GO:0006869;GO:0030324;GO:0070925;GO:0046470;GO:0046471;GO:0055091;GO:0015914;GO:0010875;GO:1902995;GO:2001140;GO:0032464;GO:0046890;GO:0150172;GO:0042493;GO:0051384;GO:0043129;GO:0042908;, C:alveolar lamellar body; C:alveolar lamellar body membrane; C:cytoplasmic vesicle membrane; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lamellar body; C:lamellar body membrane; C:late endosome; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity; F:phosphatidylcholine flippase activity; F:phosphatidylcholine transfer activity;, P:cellular protein metabolic process; P:drug export; P:drug transmembrane transport; P:lipid transport; P:lung development; P:organelle assembly; P:phosphatidylcholine metabolic process; P:phosphatidylglycerol metabolic process; P:phospholipid homeostasis; P:phospholipid transport; P:positive regulation of cholesterol efflux; P:positive regulation of phospholipid efflux; P:positive regulation of phospholipid transport; P:positive regulation of protein homooligomerization; P:regulation of lipid biosynthetic process; P:regulation of phosphatidylcholine metabolic process; P:response to drug; P:response to glucocorticoid; P:surfactant homeostasis; P:xenobiotic transport;|Q99758 B2RU09 Q54A95 Q6P5P9 Q92473,Phospholipid-transporting ATPase ABCA3 {ECO:0000305},ABC-C transporter;ATP-binding cassette sub-family A member 3 {ECO:0000305};ATP-binding cassette transporter 3;Xenobiotic-transporting ATPase ABCA3 {ECO:0000305};, PF00005;, GO:0097208;GO:0097233;GO:0030659;GO:0005615;GO:0016021;GO:0043231;GO:0042599;GO:0097232;GO:0005770;GO:0005886;GO:0008559;GO:0005524;GO:0016887;GO:0042626;GO:0005319;GO:0140345;GO:0120019;GO:0044267;GO:0046618;GO:0006855;GO:0006869;GO:0030324;GO:0070925;GO:0046470;GO:0046471;GO:0055091;GO:0015914;GO:0010875;GO:1902995;GO:2001140;GO:0032464;GO:0046890;GO:0150172;GO:0042493;GO:0051384;GO:0043129;GO:0042908;, C:alveolar lamellar body; C:alveolar lamellar body membrane; C:cytoplasmic vesicle membrane; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lamellar body; C:lamellar body membrane; C:late endosome; C:plasma membrane;, F:ABC-type xenobiotic transporter activity; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:lipid transporter activity; F:phosphatidylcholine flippase activity; F:phosphatidylcholine transfer activity;, P:cellular protein metabolic process; P:drug export; P:drug transmembrane transport; P:lipid transport; P:lung development; P:organelle assembly; P:phosphatidylcholine metabolic process; P:phosphatidylglycerol metabolic process; P:phospholipid homeostasis; P:phospholipid transport; P:positive regulation of cholesterol efflux; P:positive regulation of phospholipid efflux; P:positive regulation of phospholipid transport; P:positive regulation of protein homooligomerization; P:regulation of lipid biosynthetic process; P:regulation of phosphatidylcholine metabolic process; P:response to drug; P:response to glucocorticoid; P:surfactant homeostasis; P:xenobiotic transport; scaffold133 indexed_genome mRNA 1173863 1178671 . + . ID=transcript_14193;P41002 B2R8H3 Q96EG9,Cyclin-F,F-box only protein 1;, PF02984;PF00134;PF00646;, GO:0030054;GO:0005814;GO:0005813;GO:0000307;GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0016538;GO:0051301;GO:0044772;GO:0010826;GO:0001890;GO:0043687;GO:0000209;GO:0016567;GO:0000320;GO:0000079;GO:0031146;, C:cell junction; C:centriole; C:centrosome; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:mitotic cell cycle phase transition; P:negative regulation of centrosome duplication; P:placenta development; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:re-entry into mitotic cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|P41002 B2R8H3 Q96EG9,Cyclin-F,F-box only protein 1;, PF02984;PF00134;PF00646;, GO:0030054;GO:0005814;GO:0005813;GO:0000307;GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0016538;GO:0051301;GO:0044772;GO:0010826;GO:0001890;GO:0043687;GO:0000209;GO:0016567;GO:0000320;GO:0000079;GO:0031146;, C:cell junction; C:centriole; C:centrosome; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:mitotic cell cycle phase transition; P:negative regulation of centrosome duplication; P:placenta development; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:re-entry into mitotic cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold133 indexed_genome mRNA 1178713 1182168 . + . ID=transcript_14194;P41002 B2R8H3 Q96EG9,Cyclin-F,F-box only protein 1;, PF02984;PF00134;PF00646;, GO:0030054;GO:0005814;GO:0005813;GO:0000307;GO:0005737;GO:0005829;GO:0005634;GO:0019005;GO:0016538;GO:0051301;GO:0044772;GO:0010826;GO:0001890;GO:0043687;GO:0000209;GO:0016567;GO:0000320;GO:0000079;GO:0031146;, C:cell junction; C:centriole; C:centrosome; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:cell division; P:mitotic cell cycle phase transition; P:negative regulation of centrosome duplication; P:placenta development; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:re-entry into mitotic cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold133 indexed_genome mRNA 1182898 1187654 . + . ID=transcript_14195;Q7L2K0 B4DXD7 Q96H61 Q9H872,Tubulin epsilon and delta complex protein 2 {ECO:0000305},, PF15764;, GO:0005814;GO:0005929;GO:0005737;GO:0045880;, C:centriole; C:cilium; C:cytoplasm;, , P:positive regulation of smoothened signaling pathway;|Q7L2K0 B4DXD7 Q96H61 Q9H872,Tubulin epsilon and delta complex protein 2 {ECO:0000305},, PF15764;, GO:0005814;GO:0005929;GO:0005737;GO:0045880;, C:centriole; C:cilium; C:cytoplasm;, , P:positive regulation of smoothened signaling pathway;|Q7L2K0 B4DXD7 Q96H61 Q9H872,Tubulin epsilon and delta complex protein 2 {ECO:0000305},, PF15764;, GO:0005814;GO:0005929;GO:0005737;GO:0045880;, C:centriole; C:cilium; C:cytoplasm;, , P:positive regulation of smoothened signaling pathway;|Q7L2K0 B4DXD7 Q96H61 Q9H872,Tubulin epsilon and delta complex protein 2 {ECO:0000305},, PF15764;, GO:0005814;GO:0005929;GO:0005737;GO:0045880;, C:centriole; C:cilium; C:cytoplasm;, , P:positive regulation of smoothened signaling pathway;|Q7L2K0 B4DXD7 Q96H61 Q9H872,Tubulin epsilon and delta complex protein 2 {ECO:0000305},, PF15764;, GO:0005814;GO:0005929;GO:0005737;GO:0045880;, C:centriole; C:cilium; C:cytoplasm;, , P:positive regulation of smoothened signaling pathway; scaffold133 indexed_genome mRNA 1211587 1220306 . + . ID=transcript_14196;Q9ULP9 A0JNW3 B9A6M6 Q2KJ08,TBC1 domain family member 24,, PF00566;PF07534;, GO:0030054;GO:0005737;GO:0030659;GO:0031594;GO:0005886;GO:0043195;GO:0005096;GO:0036475;GO:0031175;, C:cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:neuromuscular junction; C:plasma membrane; C:terminal bouton;, F:GTPase activator activity;, P:neuron death in response to oxidative stress; P:neuron projection development;|Q9ULP9 A0JNW3 B9A6M6 Q2KJ08,TBC1 domain family member 24,, PF00566;PF07534;, GO:0030054;GO:0005737;GO:0030659;GO:0031594;GO:0005886;GO:0043195;GO:0005096;GO:0036475;GO:0031175;, C:cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:neuromuscular junction; C:plasma membrane; C:terminal bouton;, F:GTPase activator activity;, P:neuron death in response to oxidative stress; P:neuron projection development; scaffold133 indexed_genome mRNA 1237886 1241982 . - . ID=transcript_14197;P27449 Q6FH26,V-type proton ATPase 16 kDa proteolipid subunit,Vacuolar proton pump 16 kDa proteolipid subunit;, PF00137;, GO:0035577;GO:0010008;GO:0070062;GO:0101003;GO:0005925;GO:0016021;GO:0005765;GO:0030670;GO:0005886;GO:0033179;GO:0070821;GO:0046933;GO:0046961;GO:0031625;GO:0034198;GO:0008286;GO:0034220;GO:0043312;GO:0090383;GO:0030177;GO:1902600;GO:0016241;GO:0033572;GO:0016032;, C:azurophil granule membrane; C:endosome membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integral component of membrane; C:lysosomal membrane; C:phagocytic vesicle membrane; C:plasma membrane; C:proton-transporting V-type ATPase, V0 domain; C:tertiary granule membrane;, F:proton-transporting ATP synthase activity, rotational mechanism; F:proton-transporting ATPase activity, rotational mechanism; F:ubiquitin protein ligase binding;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:neutrophil degranulation; P:phagosome acidification; P:positive regulation of Wnt signaling pathway; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:viral process; scaffold133 indexed_genome mRNA 1242968 1251031 . + . ID=transcript_14198;Q9Y303 B4DL77 Q8WV54,N-acetylglucosamine-6-phosphate deacetylase {ECO:0000305|PubMed:22692205},Amidohydrolase domain-containing protein 2 {ECO:0000305};, PF01979;, GO:0005829;GO:0005634;GO:0046872;GO:0047419;GO:0008448;GO:0005975;GO:0006046;GO:0019262;GO:0006048;, C:cytosol; C:nucleus;, F:metal ion binding; F:N-acetylgalactosamine-6-phosphate deacetylase activity; F:N-acetylglucosamine-6-phosphate deacetylase activity;, P:carbohydrate metabolic process; P:N-acetylglucosamine catabolic process; P:N-acetylneuraminate catabolic process; P:UDP-N-acetylglucosamine biosynthetic process; scaffold133 indexed_genome mRNA 1286143 1324149 . + . ID=transcript_14199;O15530 H0Y4Z0 Q59EH6 Q6FI20 Q8IV52 Q9BRD5,3-phosphoinositide-dependent protein kinase 1,, PF14593;PF00069;, GO:0042995;GO:0005737;GO:0031410;GO:0005829;GO:0005925;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0004676;GO:0005524;GO:0005158;GO:0016004;GO:0043274;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0032148;GO:0019722;GO:0016477;GO:1990416;GO:0071364;GO:0032869;GO:0007173;GO:0097191;GO:0038095;GO:0048041;GO:0006972;GO:0035556;GO:0010667;GO:2000352;GO:0043524;GO:0006469;GO:0034122;GO:0030512;GO:0018105;GO:0018107;GO:0030168;GO:0045766;GO:0043536;GO:0010518;GO:0051897;GO:1903078;GO:0051281;GO:1903672;GO:1905564;GO:0046777;GO:0006468;GO:0043122;GO:0043304;GO:1901796;GO:0002223;GO:0031295;GO:0050852;GO:0003323;, C:cell projection; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:focal adhesion; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase activity; F:ATP binding; F:insulin receptor binding; F:phospholipase activator activity; F:phospholipase binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:activation of protein kinase B activity; P:calcium-mediated signaling; P:cell migration; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:epidermal growth factor receptor signaling pathway; P:extrinsic apoptotic signaling pathway; P:Fc-epsilon receptor signaling pathway; P:focal adhesion assembly; P:hyperosmotic response; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:negative regulation of protein kinase activity; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mast cell degranulation; P:regulation of signal transduction by p53 class mediator; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; P:type B pancreatic cell development;|Q6A1A2,Putative 3-phosphoinositide-dependent protein kinase 2,3-phosphoinositide-dependent protein kinase 2 pseudogene {ECO:0000305};, PF00069;, GO:0005737;GO:0016020;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0035556;GO:0018105;, C:cytoplasm; C:membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:intracellular signal transduction; P:peptidyl-serine phosphorylation;|O15530 H0Y4Z0 Q59EH6 Q6FI20 Q8IV52 Q9BRD5,3-phosphoinositide-dependent protein kinase 1,, PF14593;PF00069;, GO:0042995;GO:0005737;GO:0031410;GO:0005829;GO:0005925;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0004676;GO:0005524;GO:0005158;GO:0016004;GO:0043274;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0032148;GO:0019722;GO:0016477;GO:1990416;GO:0071364;GO:0032869;GO:0007173;GO:0097191;GO:0038095;GO:0048041;GO:0006972;GO:0035556;GO:0010667;GO:2000352;GO:0043524;GO:0006469;GO:0034122;GO:0030512;GO:0018105;GO:0018107;GO:0030168;GO:0045766;GO:0043536;GO:0010518;GO:0051897;GO:1903078;GO:0051281;GO:1903672;GO:1905564;GO:0046777;GO:0006468;GO:0043122;GO:0043304;GO:1901796;GO:0002223;GO:0031295;GO:0050852;GO:0003323;, C:cell projection; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:focal adhesion; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase activity; F:ATP binding; F:insulin receptor binding; F:phospholipase activator activity; F:phospholipase binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:activation of protein kinase B activity; P:calcium-mediated signaling; P:cell migration; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:epidermal growth factor receptor signaling pathway; P:extrinsic apoptotic signaling pathway; P:Fc-epsilon receptor signaling pathway; P:focal adhesion assembly; P:hyperosmotic response; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:negative regulation of protein kinase activity; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mast cell degranulation; P:regulation of signal transduction by p53 class mediator; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; P:type B pancreatic cell development;|O15530 H0Y4Z0 Q59EH6 Q6FI20 Q8IV52 Q9BRD5,3-phosphoinositide-dependent protein kinase 1,, PF14593;PF00069;, GO:0042995;GO:0005737;GO:0031410;GO:0005829;GO:0005925;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0004676;GO:0005524;GO:0005158;GO:0016004;GO:0043274;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0032148;GO:0019722;GO:0016477;GO:1990416;GO:0071364;GO:0032869;GO:0007173;GO:0097191;GO:0038095;GO:0048041;GO:0006972;GO:0035556;GO:0010667;GO:2000352;GO:0043524;GO:0006469;GO:0034122;GO:0030512;GO:0018105;GO:0018107;GO:0030168;GO:0045766;GO:0043536;GO:0010518;GO:0051897;GO:1903078;GO:0051281;GO:1903672;GO:1905564;GO:0046777;GO:0006468;GO:0043122;GO:0043304;GO:1901796;GO:0002223;GO:0031295;GO:0050852;GO:0003323;, C:cell projection; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:focal adhesion; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase activity; F:ATP binding; F:insulin receptor binding; F:phospholipase activator activity; F:phospholipase binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:activation of protein kinase B activity; P:calcium-mediated signaling; P:cell migration; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:epidermal growth factor receptor signaling pathway; P:extrinsic apoptotic signaling pathway; P:Fc-epsilon receptor signaling pathway; P:focal adhesion assembly; P:hyperosmotic response; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:negative regulation of protein kinase activity; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mast cell degranulation; P:regulation of signal transduction by p53 class mediator; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; P:type B pancreatic cell development;|O15530 H0Y4Z0 Q59EH6 Q6FI20 Q8IV52 Q9BRD5,3-phosphoinositide-dependent protein kinase 1,, PF14593;PF00069;, GO:0042995;GO:0005737;GO:0031410;GO:0005829;GO:0005925;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0004676;GO:0005524;GO:0005158;GO:0016004;GO:0043274;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0032148;GO:0019722;GO:0016477;GO:1990416;GO:0071364;GO:0032869;GO:0007173;GO:0097191;GO:0038095;GO:0048041;GO:0006972;GO:0035556;GO:0010667;GO:2000352;GO:0043524;GO:0006469;GO:0034122;GO:0030512;GO:0018105;GO:0018107;GO:0030168;GO:0045766;GO:0043536;GO:0010518;GO:0051897;GO:1903078;GO:0051281;GO:1903672;GO:1905564;GO:0046777;GO:0006468;GO:0043122;GO:0043304;GO:1901796;GO:0002223;GO:0031295;GO:0050852;GO:0003323;, C:cell projection; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:focal adhesion; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase activity; F:ATP binding; F:insulin receptor binding; F:phospholipase activator activity; F:phospholipase binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:activation of protein kinase B activity; P:calcium-mediated signaling; P:cell migration; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:epidermal growth factor receptor signaling pathway; P:extrinsic apoptotic signaling pathway; P:Fc-epsilon receptor signaling pathway; P:focal adhesion assembly; P:hyperosmotic response; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:negative regulation of protein kinase activity; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mast cell degranulation; P:regulation of signal transduction by p53 class mediator; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; P:type B pancreatic cell development;|O15530 H0Y4Z0 Q59EH6 Q6FI20 Q8IV52 Q9BRD5,3-phosphoinositide-dependent protein kinase 1,, PF14593;PF00069;, GO:0042995;GO:0005737;GO:0031410;GO:0005829;GO:0005925;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0004676;GO:0005524;GO:0005158;GO:0016004;GO:0043274;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0032148;GO:0019722;GO:0016477;GO:1990416;GO:0071364;GO:0032869;GO:0007173;GO:0097191;GO:0038095;GO:0048041;GO:0006972;GO:0035556;GO:0010667;GO:2000352;GO:0043524;GO:0006469;GO:0034122;GO:0030512;GO:0018105;GO:0018107;GO:0030168;GO:0045766;GO:0043536;GO:0010518;GO:0051897;GO:1903078;GO:0051281;GO:1903672;GO:1905564;GO:0046777;GO:0006468;GO:0043122;GO:0043304;GO:1901796;GO:0002223;GO:0031295;GO:0050852;GO:0003323;, C:cell projection; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:focal adhesion; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density;, F:3-phosphoinositide-dependent protein kinase activity; F:ATP binding; F:insulin receptor binding; F:phospholipase activator activity; F:phospholipase binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:activation of protein kinase B activity; P:calcium-mediated signaling; P:cell migration; P:cellular response to brain-derived neurotrophic factor stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:epidermal growth factor receptor signaling pathway; P:extrinsic apoptotic signaling pathway; P:Fc-epsilon receptor signaling pathway; P:focal adhesion assembly; P:hyperosmotic response; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of neuron apoptotic process; P:negative regulation of protein kinase activity; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of sprouting angiogenesis; P:positive regulation of vascular endothelial cell proliferation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mast cell degranulation; P:regulation of signal transduction by p53 class mediator; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; P:type B pancreatic cell development; scaffold133 indexed_genome mRNA 1335907 1337901 . - . ID=transcript_14200;Q9NXV2 D3DU96,BTB/POZ domain-containing protein KCTD5,, PF02214;, GO:0031463;GO:0005737;GO:0005829;GO:0005634;GO:0097602;GO:0042802;GO:0044877;GO:0043161;GO:0051260;GO:0016032;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleus;, F:cullin family protein binding; F:identical protein binding; F:protein-containing complex binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:viral process; scaffold133 indexed_genome mRNA 1338116 1339872 . - . ID=transcript_14201;Q9NXV2 D3DU96,BTB/POZ domain-containing protein KCTD5,, PF02214;, GO:0031463;GO:0005737;GO:0005829;GO:0005634;GO:0097602;GO:0042802;GO:0044877;GO:0043161;GO:0051260;GO:0016032;, C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:nucleus;, F:cullin family protein binding; F:identical protein binding; F:protein-containing complex binding;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:viral process; scaffold133 indexed_genome mRNA 1397800 1402418 . + . ID=transcript_14202;Q9GZN4 O43342 Q6UXE0,Brain-specific serine protease 4,Serine protease 22;Serine protease 26;Tryptase epsilon;, PF00089;, GO:0005615;GO:0016504;GO:0004252;GO:0010952;GO:0006508;, C:extracellular space;, F:peptidase activator activity; F:serine-type endopeptidase activity;, P:positive regulation of peptidase activity; P:proteolysis; scaffold133 indexed_genome mRNA 1474956 1476423 . - . ID=transcript_14203;Q7RTY9,Serine protease 41,Testis serine protease 1;, PF00089;, GO:0031225;GO:0005576;GO:0043229;GO:0005886;GO:0004252;GO:0017080;, C:anchored component of membrane; C:extracellular region; C:intracellular organelle; C:plasma membrane;, F:serine-type endopeptidase activity; F:sodium channel regulator activity;|Q9Y6M0 Q9NS34 Q9P2V6,Testisin,Eosinophil serine protease 1;Serine protease 21;, PF00089;, GO:0031225;GO:0005737;GO:0005576;GO:0005615;GO:0016020;GO:0005886;GO:0004252;GO:0008236;GO:0006508;GO:0007283;, C:anchored component of membrane; C:cytoplasm; C:extracellular region; C:extracellular space; C:membrane; C:plasma membrane;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:proteolysis; P:spermatogenesis;|Q7RTY9,Serine protease 41,Testis serine protease 1;, PF00089;, GO:0031225;GO:0005576;GO:0043229;GO:0005886;GO:0004252;GO:0017080;, C:anchored component of membrane; C:extracellular region; C:intracellular organelle; C:plasma membrane;, F:serine-type endopeptidase activity; F:sodium channel regulator activity; scaffold133 indexed_genome mRNA 1493681 1496380 . - . ID=transcript_14204;Q15370 B7WPD3,Elongin-B,Elongin 18 kDa subunit;RNA polymerase II transcription factor SIII subunit B;SIII p18;Transcription elongation factor B polypeptide 2;, PF00240;, GO:0031462;GO:0031466;GO:0005829;GO:0070449;GO:0005654;GO:0030891;GO:0031625;GO:0032436;GO:0043687;GO:0016567;GO:0065003;GO:0061418;GO:0006366;GO:0006368;GO:0016032;, C:Cul2-RING ubiquitin ligase complex; C:Cul5-RING ubiquitin ligase complex; C:cytosol; C:elongin complex; C:nucleoplasm; C:VCB complex;, F:ubiquitin protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein ubiquitination; P:protein-containing complex assembly; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:viral process; scaffold133 indexed_genome mRNA 1496699 1512774 . - . ID=transcript_14205;Q96GY7 Q9P0G1 Q9UHA8 Q9UQ36 Q9UQ37 Q9UQ38 Q9UQ40,Serine/arginine repetitive matrix protein 2,300 kDa nuclear matrix antigen;Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa;Splicing coactivator subunit SRm300;Tax-responsive enhancer element-binding protein 803;, PF08312;, GO:0015030;GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071007;GO:0071005;GO:0070742;GO:0003729;GO:0047485;GO:0003723;GO:0000398;, C:Cajal body; C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:C2H2 zinc finger domain binding; F:mRNA binding; F:protein N-terminus binding; F:RNA binding;, P:mRNA splicing, via spliceosome;|Q96GY7 Q9P0G1 Q9UHA8 Q9UQ36 Q9UQ37 Q9UQ38 Q9UQ40,Serine/arginine repetitive matrix protein 2,300 kDa nuclear matrix antigen;Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa;Splicing coactivator subunit SRm300;Tax-responsive enhancer element-binding protein 803;, PF08312;, GO:0015030;GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071007;GO:0071005;GO:0070742;GO:0003729;GO:0047485;GO:0003723;GO:0000398;, C:Cajal body; C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:C2H2 zinc finger domain binding; F:mRNA binding; F:protein N-terminus binding; F:RNA binding;, P:mRNA splicing, via spliceosome;|Q96GY7 Q9P0G1 Q9UHA8 Q9UQ36 Q9UQ37 Q9UQ38 Q9UQ40,Serine/arginine repetitive matrix protein 2,300 kDa nuclear matrix antigen;Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa;Splicing coactivator subunit SRm300;Tax-responsive enhancer element-binding protein 803;, PF08312;, GO:0015030;GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071007;GO:0071005;GO:0070742;GO:0003729;GO:0047485;GO:0003723;GO:0000398;, C:Cajal body; C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:C2H2 zinc finger domain binding; F:mRNA binding; F:protein N-terminus binding; F:RNA binding;, P:mRNA splicing, via spliceosome;|Q96GY7 Q9P0G1 Q9UHA8 Q9UQ36 Q9UQ37 Q9UQ38 Q9UQ40,Serine/arginine repetitive matrix protein 2,300 kDa nuclear matrix antigen;Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa;Splicing coactivator subunit SRm300;Tax-responsive enhancer element-binding protein 803;, PF08312;, GO:0015030;GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071007;GO:0071005;GO:0070742;GO:0003729;GO:0047485;GO:0003723;GO:0000398;, C:Cajal body; C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:C2H2 zinc finger domain binding; F:mRNA binding; F:protein N-terminus binding; F:RNA binding;, P:mRNA splicing, via spliceosome;|Q96GY7 Q9P0G1 Q9UHA8 Q9UQ36 Q9UQ37 Q9UQ38 Q9UQ40,Serine/arginine repetitive matrix protein 2,300 kDa nuclear matrix antigen;Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa;Splicing coactivator subunit SRm300;Tax-responsive enhancer element-binding protein 803;, PF08312;, GO:0015030;GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071007;GO:0071005;GO:0070742;GO:0003729;GO:0047485;GO:0003723;GO:0000398;, C:Cajal body; C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome;, F:C2H2 zinc finger domain binding; F:mRNA binding; F:protein N-terminus binding; F:RNA binding;, P:mRNA splicing, via spliceosome; scaffold133 indexed_genome mRNA 1545457 1546558 . + . ID=transcript_14206;Q96CP2,FLYWCH family member 2,, PF15423;, GO:0003723;, , F:RNA binding; scaffold133 indexed_genome mRNA 1554885 1621616 . + . ID=transcript_14207;Q4VC44 D3DUA1 Q6ZSQ1 Q8WV62 Q9BQG6 Q9BUS5 Q9HCM0,FLYWCH-type zinc finger-containing protein 1,, PF04500;PF15423;, GO:0005829;GO:0016604;GO:0005654;GO:0003677;GO:0046872;, C:cytosol; C:nuclear body; C:nucleoplasm;, F:DNA binding; F:metal ion binding;|Q8NCW0 B4DXF6 I3L2S2 Q8N2J4 Q8NCW1 Q96GL8 Q9BTP9,Kremen protein 2,Dickkopf receptor 2;Kringle domain-containing transmembrane protein 2;Kringle-containing protein marking the eye and the nose;, PF00431;PF00051;PF01822;, GO:0031901;GO:0016021;GO:0005886;GO:0060173;GO:0090090;GO:0030279;GO:0016055;, C:early endosome membrane; C:integral component of membrane; C:plasma membrane;, , P:limb development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of ossification; P:Wnt signaling pathway; scaffold133 indexed_genome mRNA 1641392 1642886 . + . ID=transcript_14208;O95484,Claudin-9,, PF00822;, GO:0005923;GO:0030054;GO:0016021;GO:0043231;GO:0005886;GO:0042802;GO:0005198;GO:0001618;GO:0070830;GO:0016338;GO:0007155;, C:bicellular tight junction; C:cell junction; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:identical protein binding; F:structural molecule activity; F:virus receptor activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; scaffold133 indexed_genome mRNA 1643120 1644101 . + . ID=transcript_14209;P56747 B3KQP9 D3DUA5,Claudin-6,Skullin;, PF00822;, GO:0016327;GO:0005923;GO:0016021;GO:0005886;GO:0042802;GO:0005198;GO:0001618;GO:0070830;GO:0016338;GO:0007155;, C:apicolateral plasma membrane; C:bicellular tight junction; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:structural molecule activity; F:virus receptor activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; scaffold133 indexed_genome mRNA 1652021 1654094 . + . ID=transcript_14210;Q9NP84 D3DUA6 Q9HCS0,Tumor necrosis factor receptor superfamily member 12A,Fibroblast growth factor-inducible immediate-early response protein 14;Tweak-receptor;, PF12191;, GO:0016021;GO:0005886;GO:0001525;GO:0006915;GO:0007155;GO:0030154;GO:0043065;GO:2001238;GO:0061041;GO:0033209;, C:integral component of membrane; C:plasma membrane;, , P:angiogenesis; P:apoptotic process; P:cell adhesion; P:cell differentiation; P:positive regulation of apoptotic process; P:positive regulation of extrinsic apoptotic signaling pathway; P:regulation of wound healing; P:tumor necrosis factor-mediated signaling pathway; scaffold133 indexed_genome mRNA 1654249 1658792 . - . ID=transcript_14211;Q9NWW0 D3DUA7 Q68EN7,Host cell factor C1 regulator 1,HCF-1 beta-propeller-interacting protein;, PF15226;, GO:0005737;GO:0005654;, C:cytoplasm; C:nucleoplasm;|Q9NWW0 D3DUA7 Q68EN7,Host cell factor C1 regulator 1,HCF-1 beta-propeller-interacting protein;, PF15226;, GO:0005737;GO:0005654;, C:cytoplasm; C:nucleoplasm;|Q86W42 B2RA85 Q8NBR1 Q9BTV9,THO complex subunit 6 homolog,Functional spliceosome-associated protein 35;WD repeat-containing protein 58;, PF00400;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003723;GO:0006915;GO:0007417;GO:0031124;GO:0006406;GO:0043066;GO:0006405;GO:0008380;GO:0046784;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:RNA binding;, P:apoptotic process; P:central nervous system development; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of apoptotic process; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q86W42 B2RA85 Q8NBR1 Q9BTV9,THO complex subunit 6 homolog,Functional spliceosome-associated protein 35;WD repeat-containing protein 58;, PF00400;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003723;GO:0006915;GO:0007417;GO:0031124;GO:0006406;GO:0043066;GO:0006405;GO:0008380;GO:0046784;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:RNA binding;, P:apoptotic process; P:central nervous system development; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of apoptotic process; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus;|Q86W42 B2RA85 Q8NBR1 Q9BTV9,THO complex subunit 6 homolog,Functional spliceosome-associated protein 35;WD repeat-containing protein 58;, PF00400;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0000347;GO:0000445;GO:0000346;GO:0003723;GO:0006915;GO:0007417;GO:0031124;GO:0006406;GO:0043066;GO:0006405;GO:0008380;GO:0046784;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:THO complex; C:THO complex part of transcription export complex; C:transcription export complex;, F:RNA binding;, P:apoptotic process; P:central nervous system development; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:negative regulation of apoptotic process; P:RNA export from nucleus; P:RNA splicing; P:viral mRNA export from host cell nucleus; scaffold133 indexed_genome mRNA 1659419 1666334 . - . ID=transcript_14212;A1A5D9 Q658L9,BICD family-like cargo adapter 2,Bicaudal D-related protein 2;Coiled-coil domain-containing protein 64B;, , GO:0005737;GO:0055107;GO:0047496;, C:cytoplasm;, , P:Golgi to secretory granule transport; P:vesicle transport along microtubule; scaffold133 indexed_genome mRNA 1689938 1697993 . + . ID=transcript_14213;Q9NPA2 D3DUA8 Q9H3Q0,Matrix metalloproteinase-25,Leukolysin;Membrane-type matrix metalloproteinase 6;Membrane-type-6 matrix metalloproteinase;, PF00045;PF00413;PF01471;, GO:0031225;GO:0031012;GO:0005576;GO:0016020;GO:0005886;GO:0035579;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0060022;GO:0006954;GO:0043312;GO:0006508;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:membrane; C:plasma membrane; C:specific granule membrane;, F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:hard palate development; P:inflammatory response; P:neutrophil degranulation; P:proteolysis;|Q9NPA2 D3DUA8 Q9H3Q0,Matrix metalloproteinase-25,Leukolysin;Membrane-type matrix metalloproteinase 6;Membrane-type-6 matrix metalloproteinase;, PF00045;PF00413;PF01471;, GO:0031225;GO:0031012;GO:0005576;GO:0016020;GO:0005886;GO:0035579;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0060022;GO:0006954;GO:0043312;GO:0006508;, C:anchored component of membrane; C:extracellular matrix; C:extracellular region; C:membrane; C:plasma membrane; C:specific granule membrane;, F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:hard palate development; P:inflammatory response; P:neutrophil degranulation; P:proteolysis; scaffold133 indexed_genome mRNA 1741627 1750179 . + . ID=transcript_14214;O95201 A8MZK0 D3DUB4 Q9BU95,Zinc finger protein 205,Zinc finger protein 210;, PF01352;PF00096;, GO:0005739;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0010729;GO:1901030;GO:0006357;GO:0006355;, C:mitochondrion; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hydrogen peroxide biosynthetic process; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|O95201 A8MZK0 D3DUB4 Q9BU95,Zinc finger protein 205,Zinc finger protein 210;, PF01352;PF00096;, GO:0005739;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0010729;GO:1901030;GO:0006357;GO:0006355;, C:mitochondrion; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hydrogen peroxide biosynthetic process; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|O95201 A8MZK0 D3DUB4 Q9BU95,Zinc finger protein 205,Zinc finger protein 210;, PF01352;PF00096;, GO:0005739;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0010729;GO:1901030;GO:0006357;GO:0006355;, C:mitochondrion; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hydrogen peroxide biosynthetic process; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|O95201 A8MZK0 D3DUB4 Q9BU95,Zinc finger protein 205,Zinc finger protein 210;, PF01352;PF00096;, GO:0005739;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0010729;GO:1901030;GO:0006357;GO:0006355;, C:mitochondrion; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of hydrogen peroxide biosynthetic process; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold133 indexed_genome mRNA 1757484 1762614 . + . ID=transcript_14215;O14771 A8K1B9 B4DMG6 Q96IS1,Zinc finger protein 213,Putative transcription factor CR53;Zinc finger protein with KRAB and SCAN domains 21;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|O14771 A8K1B9 B4DMG6 Q96IS1,Zinc finger protein 213,Putative transcription factor CR53;Zinc finger protein with KRAB and SCAN domains 21;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold133 indexed_genome mRNA 1772962 1775443 . + . ID=transcript_14216;P31944 O95823 Q3SYC9,Caspase-14,, , GO:0005737;GO:0005829;GO:0045095;GO:0005739;GO:0005654;GO:0005634;GO:0004197;GO:0097200;GO:0070268;GO:0008544;GO:0031424;, C:cytoplasm; C:cytosol; C:keratin filament; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis;, P:cornification; P:epidermis development; P:keratinization; scaffold133 indexed_genome mRNA 1796482 1797362 . - . ID=transcript_14217;P87889 P10263 P10264 Q69385 Q9UKH6,Endogenous retrovirus group K member 10 Gag polyprotein,HERV-K10 Gag protein;HERV-K107 Gag protein;HERV-K_5q33.3 provirus ancestral Gag polyprotein;, PF02337;PF00607;PF00098;, GO:0005886;GO:0003676;GO:0005198;GO:0008270;GO:0016032;, C:plasma membrane;, F:nucleic acid binding; F:structural molecule activity; F:zinc ion binding;, P:viral process; scaffold133 indexed_genome mRNA 1857706 1863348 . + . ID=transcript_14218;Q8NGR9 A3KFM2 B2RNY4 Q6IF17 Q96RA3,Olfactory receptor 1N2,Olfactory receptor OR9-23;, PF13853;, GO:0016021;GO:0005730;GO:0005654;GO:0005886;GO:0004930;GO:0004984;, C:integral component of membrane; C:nucleolus; C:nucleoplasm; C:plasma membrane;, F:G protein-coupled receptor activity; F:olfactory receptor activity; scaffold133 indexed_genome mRNA 1866885 1877608 . - . ID=transcript_14219;P98182 D3DUB7 D3DUB8 O15361 Q5XKM5 Q7Z5V1,Zinc finger protein 200,, PF00096;, GO:0005634;GO:0046872;, C:nucleus;, F:metal ion binding;|P98182 D3DUB7 D3DUB8 O15361 Q5XKM5 Q7Z5V1,Zinc finger protein 200,, PF00096;, GO:0005634;GO:0046872;, C:nucleus;, F:metal ion binding; scaffold133 indexed_genome mRNA 1882157 1884789 . - . ID=transcript_14220;O15553 D3DUC0 F5H0Q3 Q3MJ84 Q96PN4 Q96PN5,Pyrin,Marenostrin;, PF13765;PF02758;PF00622;PF00643;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0030027;GO:0005874;GO:0005875;GO:0005654;GO:0005634;GO:0001726;GO:0003779;GO:0042802;GO:0061630;GO:0008270;GO:0006954;GO:0045087;GO:1900016;GO:0050728;GO:0032691;GO:0032695;GO:0071641;GO:1900226;GO:0010508;GO:2001056;GO:0016567;GO:0035590;GO:0010468;GO:0034341;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:nucleoplasm; C:nucleus; C:ruffle;, F:actin binding; F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:inflammatory response; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of inflammatory response; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of macrophage inflammatory protein 1 alpha production; P:negative regulation of NLRP3 inflammasome complex assembly; P:positive regulation of autophagy; P:positive regulation of cysteine-type endopeptidase activity; P:protein ubiquitination; P:purinergic nucleotide receptor signaling pathway; P:regulation of gene expression; P:response to interferon-gamma;|O15553 D3DUC0 F5H0Q3 Q3MJ84 Q96PN4 Q96PN5,Pyrin,Marenostrin;, PF13765;PF02758;PF00622;PF00643;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0030027;GO:0005874;GO:0005875;GO:0005654;GO:0005634;GO:0001726;GO:0003779;GO:0042802;GO:0061630;GO:0008270;GO:0006954;GO:0045087;GO:1900016;GO:0050728;GO:0032691;GO:0032695;GO:0071641;GO:1900226;GO:0010508;GO:2001056;GO:0016567;GO:0035590;GO:0010468;GO:0034341;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:nucleoplasm; C:nucleus; C:ruffle;, F:actin binding; F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:inflammatory response; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of inflammatory response; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of macrophage inflammatory protein 1 alpha production; P:negative regulation of NLRP3 inflammasome complex assembly; P:positive regulation of autophagy; P:positive regulation of cysteine-type endopeptidase activity; P:protein ubiquitination; P:purinergic nucleotide receptor signaling pathway; P:regulation of gene expression; P:response to interferon-gamma; scaffold133 indexed_genome mRNA 1885835 1896669 . - . ID=transcript_14221;O15553 D3DUC0 F5H0Q3 Q3MJ84 Q96PN4 Q96PN5,Pyrin,Marenostrin;, PF13765;PF02758;PF00622;PF00643;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0030027;GO:0005874;GO:0005875;GO:0005654;GO:0005634;GO:0001726;GO:0003779;GO:0042802;GO:0061630;GO:0008270;GO:0006954;GO:0045087;GO:1900016;GO:0050728;GO:0032691;GO:0032695;GO:0071641;GO:1900226;GO:0010508;GO:2001056;GO:0016567;GO:0035590;GO:0010468;GO:0034341;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:nucleoplasm; C:nucleus; C:ruffle;, F:actin binding; F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:inflammatory response; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of inflammatory response; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of macrophage inflammatory protein 1 alpha production; P:negative regulation of NLRP3 inflammasome complex assembly; P:positive regulation of autophagy; P:positive regulation of cysteine-type endopeptidase activity; P:protein ubiquitination; P:purinergic nucleotide receptor signaling pathway; P:regulation of gene expression; P:response to interferon-gamma;|O15553 D3DUC0 F5H0Q3 Q3MJ84 Q96PN4 Q96PN5,Pyrin,Marenostrin;, PF13765;PF02758;PF00622;PF00643;, GO:0005776;GO:0005737;GO:0031410;GO:0005829;GO:0030027;GO:0005874;GO:0005875;GO:0005654;GO:0005634;GO:0001726;GO:0003779;GO:0042802;GO:0061630;GO:0008270;GO:0006954;GO:0045087;GO:1900016;GO:0050728;GO:0032691;GO:0032695;GO:0071641;GO:1900226;GO:0010508;GO:2001056;GO:0016567;GO:0035590;GO:0010468;GO:0034341;, C:autophagosome; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lamellipodium; C:microtubule; C:microtubule associated complex; C:nucleoplasm; C:nucleus; C:ruffle;, F:actin binding; F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:inflammatory response; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of inflammatory response; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of macrophage inflammatory protein 1 alpha production; P:negative regulation of NLRP3 inflammasome complex assembly; P:positive regulation of autophagy; P:positive regulation of cysteine-type endopeptidase activity; P:protein ubiquitination; P:purinergic nucleotide receptor signaling pathway; P:regulation of gene expression; P:response to interferon-gamma; scaffold133 indexed_genome mRNA 1925236 1932820 . + . ID=transcript_14222;O14978 B2R634 O43387 Q96H95,Zinc finger protein 263 {ECO:0000312|HGNC:HGNC:13056},Zinc finger protein FPM315 {ECO:0000312|HGNC:HGNC:13056};Zinc finger protein with KRAB and SCAN domains 12 {ECO:0000312|HGNC:HGNC:13056};, PF01352;PF02023;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:0045944;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|O14978 B2R634 O43387 Q96H95,Zinc finger protein 263 {ECO:0000312|HGNC:HGNC:13056},Zinc finger protein FPM315 {ECO:0000312|HGNC:HGNC:13056};Zinc finger protein with KRAB and SCAN domains 12 {ECO:0000312|HGNC:HGNC:13056};, PF01352;PF02023;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:0045944;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|O14978 B2R634 O43387 Q96H95,Zinc finger protein 263 {ECO:0000312|HGNC:HGNC:13056},Zinc finger protein FPM315 {ECO:0000312|HGNC:HGNC:13056};Zinc finger protein with KRAB and SCAN domains 12 {ECO:0000312|HGNC:HGNC:13056};, PF01352;PF02023;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:0045944;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold133 indexed_genome mRNA 1970296 1977747 . + . ID=transcript_14223;Q96N20 Q0VDI8 Q92669,Zinc finger protein 75A,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:1990837;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold133 indexed_genome mRNA 1978823 1979797 . - . ID=transcript_14224;Q8N3J9 B3KP97 Q15914 Q3ZCQ7,Zinc finger protein 664,Zinc finger protein 176 {ECO:0000312|HGNC:HGNC:25406};Zinc finger protein from organ of Corti;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold133 indexed_genome mRNA 2028796 2035341 . + . ID=transcript_14225;Q15697 Q53Y68 Q9BQ34,Zinc finger protein 174,AW-1;Zinc finger and SCAN domain-containing protein 8;, PF02023;PF00096;, GO:0015629;GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0003700;GO:0000981;GO:0046872;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0000122;GO:0045892;GO:0006357;, C:actin cytoskeleton; C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q15697 Q53Y68 Q9BQ34,Zinc finger protein 174,AW-1;Zinc finger and SCAN domain-containing protein 8;, PF02023;PF00096;, GO:0015629;GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0003700;GO:0000981;GO:0046872;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0000122;GO:0045892;GO:0006357;, C:actin cytoskeleton; C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold133 indexed_genome mRNA 2043521 2045497 . + . ID=transcript_14226;Q96LX8,Zinc finger protein 597,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold133 indexed_genome mRNA 2073082 2086205 . + . ID=transcript_14227;Q9H7X0 B3KRQ0 B4DLZ0 B4DPZ8 B4DYC4 D3DUC2 E7EQ65 Q6IA31 Q6UX26,N-alpha-acetyltransferase 60 {ECO:0000303|PubMed:25732826, ECO:0000312|HGNC:HGNC:25875},Histone acetyltransferase type B protein 4 {ECO:0000303|PubMed:21981917};N-acetyltransferase 15;N-alpha-acetyltransferase F;, PF00583;, GO:0000139;GO:0010485;GO:0004402;GO:0004596;GO:0042803;GO:0008283;GO:0007059;GO:0043966;GO:0043967;GO:0017196;GO:0006474;GO:0006334;, C:Golgi membrane;, F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:peptide alpha-N-acetyltransferase activity; F:protein homodimerization activity;, P:cell population proliferation; P:chromosome segregation; P:histone H3 acetylation; P:histone H4 acetylation; P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:nucleosome assembly;|Q9H7X0 B3KRQ0 B4DLZ0 B4DPZ8 B4DYC4 D3DUC2 E7EQ65 Q6IA31 Q6UX26,N-alpha-acetyltransferase 60 {ECO:0000303|PubMed:25732826, ECO:0000312|HGNC:HGNC:25875},Histone acetyltransferase type B protein 4 {ECO:0000303|PubMed:21981917};N-acetyltransferase 15;N-alpha-acetyltransferase F;, PF00583;, GO:0000139;GO:0010485;GO:0004402;GO:0004596;GO:0042803;GO:0008283;GO:0007059;GO:0043966;GO:0043967;GO:0017196;GO:0006474;GO:0006334;, C:Golgi membrane;, F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:peptide alpha-N-acetyltransferase activity; F:protein homodimerization activity;, P:cell population proliferation; P:chromosome segregation; P:histone H3 acetylation; P:histone H4 acetylation; P:N-terminal peptidyl-methionine acetylation; P:N-terminal protein amino acid acetylation; P:nucleosome assembly; scaffold133 indexed_genome mRNA 2091879 2098214 . + . ID=transcript_14228;Q96AJ1 O75138 Q65ZA3 Q9H8R4 Q9H8T1,Clusterin-associated protein 1,Qilin {ECO:0000303|PubMed:15530380};, PF10234;, GO:0005813;GO:0097542;GO:0005929;GO:0043231;GO:0030992;GO:0005654;GO:0060271;GO:0035735;, C:centrosome; C:ciliary tip; C:cilium; C:intracellular membrane-bounded organelle; C:intraciliary transport particle B; C:nucleoplasm;, , P:cilium assembly; P:intraciliary transport involved in cilium assembly;|Q96AJ1 O75138 Q65ZA3 Q9H8R4 Q9H8T1,Clusterin-associated protein 1,Qilin {ECO:0000303|PubMed:15530380};, PF10234;, GO:0005813;GO:0097542;GO:0005929;GO:0043231;GO:0030992;GO:0005654;GO:0060271;GO:0035735;, C:centrosome; C:ciliary tip; C:cilium; C:intracellular membrane-bounded organelle; C:intraciliary transport particle B; C:nucleoplasm;, , P:cilium assembly; P:intraciliary transport involved in cilium assembly;|P52758 Q6FHU9 Q6IBG0,2-iminobutanoate/2-iminopropanoate deaminase {ECO:0000305|PubMed:22094463},14.5 kDa translational inhibitor protein {ECO:0000303|PubMed:8973653};Heat-responsive protein 12 {ECO:0000312|HGNC:HGNC:16897};Reactive intermediate imine deaminase A homolog {ECO:0000312|HGNC:HGNC:16897};Translation inhibitor L-PSP ribonuclease {ECO:0000250|UniProtKB:P52759};UK114 antigen homolog {ECO:0000305|PubMed:20817725};, PF01042;, GO:0005737;GO:0005829;GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0005777;GO:0120242;GO:0120243;GO:0019239;GO:0016892;GO:0003729;GO:0003723;GO:0019518;GO:0006402;GO:0061157;GO:0017148;GO:1901565;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:peroxisome;, F:2-iminobutanoate deaminase activity; F:2-iminopropanoate deaminase activity; F:deaminase activity; F:endoribonuclease activity, producing 3'-phosphomonoesters; F:mRNA binding; F:RNA binding;, P:L-threonine catabolic process to glycine; P:mRNA catabolic process; P:mRNA destabilization; P:negative regulation of translation; P:organonitrogen compound catabolic process; scaffold133 indexed_genome mRNA 2098833 2119081 . + . ID=transcript_14229;Q96AJ1 O75138 Q65ZA3 Q9H8R4 Q9H8T1,Clusterin-associated protein 1,Qilin {ECO:0000303|PubMed:15530380};, PF10234;, GO:0005813;GO:0097542;GO:0005929;GO:0043231;GO:0030992;GO:0005654;GO:0060271;GO:0035735;, C:centrosome; C:ciliary tip; C:cilium; C:intracellular membrane-bounded organelle; C:intraciliary transport particle B; C:nucleoplasm;, , P:cilium assembly; P:intraciliary transport involved in cilium assembly;|Q96AJ1 O75138 Q65ZA3 Q9H8R4 Q9H8T1,Clusterin-associated protein 1,Qilin {ECO:0000303|PubMed:15530380};, PF10234;, GO:0005813;GO:0097542;GO:0005929;GO:0043231;GO:0030992;GO:0005654;GO:0060271;GO:0035735;, C:centrosome; C:ciliary tip; C:cilium; C:intracellular membrane-bounded organelle; C:intraciliary transport particle B; C:nucleoplasm;, , P:cilium assembly; P:intraciliary transport involved in cilium assembly;|Q96AJ1 O75138 Q65ZA3 Q9H8R4 Q9H8T1,Clusterin-associated protein 1,Qilin {ECO:0000303|PubMed:15530380};, PF10234;, GO:0005813;GO:0097542;GO:0005929;GO:0043231;GO:0030992;GO:0005654;GO:0060271;GO:0035735;, C:centrosome; C:ciliary tip; C:cilium; C:intracellular membrane-bounded organelle; C:intraciliary transport particle B; C:nucleoplasm;, , P:cilium assembly; P:intraciliary transport involved in cilium assembly;|Q6PKC3 O95887 Q6PJA6 Q8N2Q4 Q96K45 Q96K53,Thioredoxin domain-containing protein 11,EF-hand-binding protein 1;, PF00085;, GO:0005789;GO:0016021;, C:endoplasmic reticulum membrane; C:integral component of membrane;|Q96AJ1 O75138 Q65ZA3 Q9H8R4 Q9H8T1,Clusterin-associated protein 1,Qilin {ECO:0000303|PubMed:15530380};, PF10234;, GO:0005813;GO:0097542;GO:0005929;GO:0043231;GO:0030992;GO:0005654;GO:0060271;GO:0035735;, C:centrosome; C:ciliary tip; C:cilium; C:intracellular membrane-bounded organelle; C:intraciliary transport particle B; C:nucleoplasm;, , P:cilium assembly; P:intraciliary transport involved in cilium assembly;|Q96AJ1 O75138 Q65ZA3 Q9H8R4 Q9H8T1,Clusterin-associated protein 1,Qilin {ECO:0000303|PubMed:15530380};, PF10234;, GO:0005813;GO:0097542;GO:0005929;GO:0043231;GO:0030992;GO:0005654;GO:0060271;GO:0035735;, C:centrosome; C:ciliary tip; C:cilium; C:intracellular membrane-bounded organelle; C:intraciliary transport particle B; C:nucleoplasm;, , P:cilium assembly; P:intraciliary transport involved in cilium assembly; scaffold133 indexed_genome mRNA 2124262 2129968 . - . ID=transcript_14230;Q7RTR2 Q5EY36 Q8NF48 Q8NI01 Q8NI02 Q8TEL3,NLR family CARD domain-containing protein 3,CARD15-like protein;Caterpiller protein 16.2 {ECO:0000303|PubMed:15705585};NACHT, LRR and CARD domains-containing protein 3;Nucleotide-binding oligomerization domain protein 3;, PF13516;PF05729;PF17776;PF17779;, GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0048471;GO:0005524;GO:0036312;GO:0007249;GO:0035556;GO:1900016;GO:0050680;GO:0048147;GO:0043124;GO:0050728;GO:0045824;GO:0032687;GO:0032688;GO:0032715;GO:0032088;GO:1901223;GO:1900226;GO:0014067;GO:0032720;GO:0042110;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm;, F:ATP binding; F:phosphatidylinositol 3-kinase regulatory subunit binding;, P:I-kappaB kinase/NF-kappaB signaling; P:intracellular signal transduction; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of epithelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of tumor necrosis factor production; P:T cell activation;|Q7RTR2 Q5EY36 Q8NF48 Q8NI01 Q8NI02 Q8TEL3,NLR family CARD domain-containing protein 3,CARD15-like protein;Caterpiller protein 16.2 {ECO:0000303|PubMed:15705585};NACHT, LRR and CARD domains-containing protein 3;Nucleotide-binding oligomerization domain protein 3;, PF13516;PF05729;PF17776;PF17779;, GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0048471;GO:0005524;GO:0036312;GO:0007249;GO:0035556;GO:1900016;GO:0050680;GO:0048147;GO:0043124;GO:0050728;GO:0045824;GO:0032687;GO:0032688;GO:0032715;GO:0032088;GO:1901223;GO:1900226;GO:0014067;GO:0032720;GO:0042110;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm;, F:ATP binding; F:phosphatidylinositol 3-kinase regulatory subunit binding;, P:I-kappaB kinase/NF-kappaB signaling; P:intracellular signal transduction; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of epithelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of tumor necrosis factor production; P:T cell activation; scaffold133 indexed_genome mRNA 2131100 2137367 . - . ID=transcript_14231;Q7RTR2 Q5EY36 Q8NF48 Q8NI01 Q8NI02 Q8TEL3,NLR family CARD domain-containing protein 3,CARD15-like protein;Caterpiller protein 16.2 {ECO:0000303|PubMed:15705585};NACHT, LRR and CARD domains-containing protein 3;Nucleotide-binding oligomerization domain protein 3;, PF13516;PF05729;PF17776;PF17779;, GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0048471;GO:0005524;GO:0036312;GO:0007249;GO:0035556;GO:1900016;GO:0050680;GO:0048147;GO:0043124;GO:0050728;GO:0045824;GO:0032687;GO:0032688;GO:0032715;GO:0032088;GO:1901223;GO:1900226;GO:0014067;GO:0032720;GO:0042110;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm;, F:ATP binding; F:phosphatidylinositol 3-kinase regulatory subunit binding;, P:I-kappaB kinase/NF-kappaB signaling; P:intracellular signal transduction; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of epithelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of tumor necrosis factor production; P:T cell activation; scaffold133 indexed_genome mRNA 2154807 2173991 . - . ID=transcript_14232;Q8IY92 Q69YT8 Q8TF15 Q96JP1,Structure-specific endonuclease subunit SLX4,BTB/POZ domain-containing protein 12;, PF00651;PF09494;, GO:0030054;GO:0000781;GO:0005829;GO:0005654;GO:0033557;GO:0003677;GO:0008047;GO:0019899;GO:0046872;GO:0010792;GO:0006281;GO:0006260;GO:0000724;GO:0036297;GO:0000706;GO:1904357;GO:0006289;GO:1904431;GO:0000712;GO:0072429;GO:0090656;GO:0061820;, C:cell junction; C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:Slx1-Slx4 complex;, F:DNA binding; F:enzyme activator activity; F:enzyme binding; F:metal ion binding;, P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:meiotic DNA double-strand break processing; P:negative regulation of telomere maintenance via telomere lengthening; P:nucleotide-excision repair; P:positive regulation of t-circle formation; P:resolution of meiotic recombination intermediates; P:response to intra-S DNA damage checkpoint signaling; P:t-circle formation; P:telomeric D-loop disassembly;|Q8IY92 Q69YT8 Q8TF15 Q96JP1,Structure-specific endonuclease subunit SLX4,BTB/POZ domain-containing protein 12;, PF00651;PF09494;, GO:0030054;GO:0000781;GO:0005829;GO:0005654;GO:0033557;GO:0003677;GO:0008047;GO:0019899;GO:0046872;GO:0010792;GO:0006281;GO:0006260;GO:0000724;GO:0036297;GO:0000706;GO:1904357;GO:0006289;GO:1904431;GO:0000712;GO:0072429;GO:0090656;GO:0061820;, C:cell junction; C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:Slx1-Slx4 complex;, F:DNA binding; F:enzyme activator activity; F:enzyme binding; F:metal ion binding;, P:DNA double-strand break processing involved in repair via single-strand annealing; P:DNA repair; P:DNA replication; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:meiotic DNA double-strand break processing; P:negative regulation of telomere maintenance via telomere lengthening; P:nucleotide-excision repair; P:positive regulation of t-circle formation; P:resolution of meiotic recombination intermediates; P:response to intra-S DNA damage checkpoint signaling; P:t-circle formation; P:telomeric D-loop disassembly; scaffold133 indexed_genome mRNA 2200419 2256734 . + . ID=transcript_14233;P24855 B4DV35 Q14UU9 Q14UV0,Deoxyribonuclease-1,Deoxyribonuclease I;, PF03372;, GO:0070062;GO:0005576;GO:0005635;GO:0005634;GO:0003779;GO:0004530;GO:0003677;GO:0006915;GO:0006308;GO:0000737;GO:0002283;GO:0002673;GO:0070948;, C:extracellular exosome; C:extracellular region; C:nuclear envelope; C:nucleus;, F:actin binding; F:deoxyribonuclease I activity; F:DNA binding;, P:apoptotic process; P:DNA catabolic process; P:DNA catabolic process, endonucleolytic; P:neutrophil activation involved in immune response; P:regulation of acute inflammatory response; P:regulation of neutrophil mediated cytotoxicity;|P24855 B4DV35 Q14UU9 Q14UV0,Deoxyribonuclease-1,Deoxyribonuclease I;, PF03372;, GO:0070062;GO:0005576;GO:0005635;GO:0005634;GO:0003779;GO:0004530;GO:0003677;GO:0006915;GO:0006308;GO:0000737;GO:0002283;GO:0002673;GO:0070948;, C:extracellular exosome; C:extracellular region; C:nuclear envelope; C:nucleus;, F:actin binding; F:deoxyribonuclease I activity; F:DNA binding;, P:apoptotic process; P:DNA catabolic process; P:DNA catabolic process, endonucleolytic; P:neutrophil activation involved in immune response; P:regulation of acute inflammatory response; P:regulation of neutrophil mediated cytotoxicity;|Q12931 B4DR68 D3DUC8 F5H897 O43642 O75235 Q9UHL5,Heat shock protein 75 kDa, mitochondrial,TNFR-associated protein 1;Tumor necrosis factor type 1 receptor-associated protein;, PF00183;, GO:0016020;GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005524;GO:0016887;GO:0019901;GO:0003723;GO:0005164;GO:0051082;GO:0061077;GO:1901856;GO:1903751;GO:1903427;GO:0006457;GO:0009386;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:protein kinase binding; F:RNA binding; F:tumor necrosis factor receptor binding; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cellular respiration; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of reactive oxygen species biosynthetic process; P:protein folding; P:translational attenuation;|Q12931 B4DR68 D3DUC8 F5H897 O43642 O75235 Q9UHL5,Heat shock protein 75 kDa, mitochondrial,TNFR-associated protein 1;Tumor necrosis factor type 1 receptor-associated protein;, PF00183;, GO:0016020;GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005524;GO:0016887;GO:0019901;GO:0003723;GO:0005164;GO:0051082;GO:0061077;GO:1901856;GO:1903751;GO:1903427;GO:0006457;GO:0009386;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:protein kinase binding; F:RNA binding; F:tumor necrosis factor receptor binding; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cellular respiration; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of reactive oxygen species biosynthetic process; P:protein folding; P:translational attenuation;|Q12931 B4DR68 D3DUC8 F5H897 O43642 O75235 Q9UHL5,Heat shock protein 75 kDa, mitochondrial,TNFR-associated protein 1;Tumor necrosis factor type 1 receptor-associated protein;, PF00183;, GO:0016020;GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005524;GO:0016887;GO:0019901;GO:0003723;GO:0005164;GO:0051082;GO:0061077;GO:1901856;GO:1903751;GO:1903427;GO:0006457;GO:0009386;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:protein kinase binding; F:RNA binding; F:tumor necrosis factor receptor binding; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cellular respiration; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of reactive oxygen species biosynthetic process; P:protein folding; P:translational attenuation;|Q12931 B4DR68 D3DUC8 F5H897 O43642 O75235 Q9UHL5,Heat shock protein 75 kDa, mitochondrial,TNFR-associated protein 1;Tumor necrosis factor type 1 receptor-associated protein;, PF00183;, GO:0016020;GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005524;GO:0016887;GO:0019901;GO:0003723;GO:0005164;GO:0051082;GO:0061077;GO:1901856;GO:1903751;GO:1903427;GO:0006457;GO:0009386;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:protein kinase binding; F:RNA binding; F:tumor necrosis factor receptor binding; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cellular respiration; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of reactive oxygen species biosynthetic process; P:protein folding; P:translational attenuation;|Q12931 B4DR68 D3DUC8 F5H897 O43642 O75235 Q9UHL5,Heat shock protein 75 kDa, mitochondrial,TNFR-associated protein 1;Tumor necrosis factor type 1 receptor-associated protein;, PF00183;, GO:0016020;GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005524;GO:0016887;GO:0019901;GO:0003723;GO:0005164;GO:0051082;GO:0061077;GO:1901856;GO:1903751;GO:1903427;GO:0006457;GO:0009386;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:protein kinase binding; F:RNA binding; F:tumor necrosis factor receptor binding; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cellular respiration; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of reactive oxygen species biosynthetic process; P:protein folding; P:translational attenuation;|Q12931 B4DR68 D3DUC8 F5H897 O43642 O75235 Q9UHL5,Heat shock protein 75 kDa, mitochondrial,TNFR-associated protein 1;Tumor necrosis factor type 1 receptor-associated protein;, PF00183;, GO:0016020;GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005654;GO:0005524;GO:0016887;GO:0019901;GO:0003723;GO:0005164;GO:0051082;GO:0061077;GO:1901856;GO:1903751;GO:1903427;GO:0006457;GO:0009386;, C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:protein kinase binding; F:RNA binding; F:tumor necrosis factor receptor binding; F:unfolded protein binding;, P:chaperone-mediated protein folding; P:negative regulation of cellular respiration; P:negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:negative regulation of reactive oxygen species biosynthetic process; P:protein folding; P:translational attenuation; scaffold133 indexed_genome mRNA 2265744 2275303 . - . ID=transcript_14234;Q92793 D3DUC9 O00147 Q16376 Q4LE28,CREB-binding protein,Histone lysine acetyltransferase CREBBP;Protein-lysine acetyltransferase CREBBP;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0000785;GO:0005737;GO:0000123;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016407;GO:0003682;GO:0031490;GO:0003684;GO:0004402;GO:0043426;GO:0002039;GO:0061733;GO:0001102;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:1904837;GO:0034644;GO:0042733;GO:0016573;GO:1990258;GO:0042592;GO:0018076;GO:0000122;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0065003;GO:0042981;GO:1900034;GO:0019216;GO:0045637;GO:0008589;GO:0061418;GO:0006355;GO:0001666;GO:0048511;GO:0007165;GO:0002223;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:histone acetyltransferase complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:acetyltransferase activity; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:histone acetyltransferase activity; F:MRF binding; F:p53 binding; F:peptide-lysine-N-acetyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:embryonic digit morphogenesis; P:histone acetylation; P:histone glutamine methylation; P:homeostatic process; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of lipid metabolic process; P:regulation of myeloid cell differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:rhythmic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q92793 D3DUC9 O00147 Q16376 Q4LE28,CREB-binding protein,Histone lysine acetyltransferase CREBBP;Protein-lysine acetyltransferase CREBBP;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0000785;GO:0005737;GO:0000123;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016407;GO:0003682;GO:0031490;GO:0003684;GO:0004402;GO:0043426;GO:0002039;GO:0061733;GO:0001102;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:1904837;GO:0034644;GO:0042733;GO:0016573;GO:1990258;GO:0042592;GO:0018076;GO:0000122;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0065003;GO:0042981;GO:1900034;GO:0019216;GO:0045637;GO:0008589;GO:0061418;GO:0006355;GO:0001666;GO:0048511;GO:0007165;GO:0002223;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:histone acetyltransferase complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:acetyltransferase activity; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:histone acetyltransferase activity; F:MRF binding; F:p53 binding; F:peptide-lysine-N-acetyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:embryonic digit morphogenesis; P:histone acetylation; P:histone glutamine methylation; P:homeostatic process; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of lipid metabolic process; P:regulation of myeloid cell differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:rhythmic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q92793 D3DUC9 O00147 Q16376 Q4LE28,CREB-binding protein,Histone lysine acetyltransferase CREBBP;Protein-lysine acetyltransferase CREBBP;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0000785;GO:0005737;GO:0000123;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016407;GO:0003682;GO:0031490;GO:0003684;GO:0004402;GO:0043426;GO:0002039;GO:0061733;GO:0001102;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:1904837;GO:0034644;GO:0042733;GO:0016573;GO:1990258;GO:0042592;GO:0018076;GO:0000122;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0065003;GO:0042981;GO:1900034;GO:0019216;GO:0045637;GO:0008589;GO:0061418;GO:0006355;GO:0001666;GO:0048511;GO:0007165;GO:0002223;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:histone acetyltransferase complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:acetyltransferase activity; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:histone acetyltransferase activity; F:MRF binding; F:p53 binding; F:peptide-lysine-N-acetyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:embryonic digit morphogenesis; P:histone acetylation; P:histone glutamine methylation; P:homeostatic process; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of lipid metabolic process; P:regulation of myeloid cell differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:rhythmic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process; scaffold133 indexed_genome mRNA 2275642 2383807 . + . ID=transcript_14235;Q92793 D3DUC9 O00147 Q16376 Q4LE28,CREB-binding protein,Histone lysine acetyltransferase CREBBP;Protein-lysine acetyltransferase CREBBP;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0000785;GO:0005737;GO:0000123;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016407;GO:0003682;GO:0031490;GO:0003684;GO:0004402;GO:0043426;GO:0002039;GO:0061733;GO:0001102;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:1904837;GO:0034644;GO:0042733;GO:0016573;GO:1990258;GO:0042592;GO:0018076;GO:0000122;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0065003;GO:0042981;GO:1900034;GO:0019216;GO:0045637;GO:0008589;GO:0061418;GO:0006355;GO:0001666;GO:0048511;GO:0007165;GO:0002223;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:histone acetyltransferase complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:acetyltransferase activity; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:histone acetyltransferase activity; F:MRF binding; F:p53 binding; F:peptide-lysine-N-acetyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:embryonic digit morphogenesis; P:histone acetylation; P:histone glutamine methylation; P:homeostatic process; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of lipid metabolic process; P:regulation of myeloid cell differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:rhythmic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q92793 D3DUC9 O00147 Q16376 Q4LE28,CREB-binding protein,Histone lysine acetyltransferase CREBBP;Protein-lysine acetyltransferase CREBBP;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0000785;GO:0005737;GO:0000123;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016407;GO:0003682;GO:0031490;GO:0003684;GO:0004402;GO:0043426;GO:0002039;GO:0061733;GO:0001102;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:1904837;GO:0034644;GO:0042733;GO:0016573;GO:1990258;GO:0042592;GO:0018076;GO:0000122;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0065003;GO:0042981;GO:1900034;GO:0019216;GO:0045637;GO:0008589;GO:0061418;GO:0006355;GO:0001666;GO:0048511;GO:0007165;GO:0002223;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:histone acetyltransferase complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:acetyltransferase activity; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:histone acetyltransferase activity; F:MRF binding; F:p53 binding; F:peptide-lysine-N-acetyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:embryonic digit morphogenesis; P:histone acetylation; P:histone glutamine methylation; P:homeostatic process; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of lipid metabolic process; P:regulation of myeloid cell differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:rhythmic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q92793 D3DUC9 O00147 Q16376 Q4LE28,CREB-binding protein,Histone lysine acetyltransferase CREBBP;Protein-lysine acetyltransferase CREBBP;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0000785;GO:0005737;GO:0000123;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016407;GO:0003682;GO:0031490;GO:0003684;GO:0004402;GO:0043426;GO:0002039;GO:0061733;GO:0001102;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:1904837;GO:0034644;GO:0042733;GO:0016573;GO:1990258;GO:0042592;GO:0018076;GO:0000122;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0065003;GO:0042981;GO:1900034;GO:0019216;GO:0045637;GO:0008589;GO:0061418;GO:0006355;GO:0001666;GO:0048511;GO:0007165;GO:0002223;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:histone acetyltransferase complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:acetyltransferase activity; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:histone acetyltransferase activity; F:MRF binding; F:p53 binding; F:peptide-lysine-N-acetyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:embryonic digit morphogenesis; P:histone acetylation; P:histone glutamine methylation; P:homeostatic process; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of lipid metabolic process; P:regulation of myeloid cell differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:rhythmic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q92793 D3DUC9 O00147 Q16376 Q4LE28,CREB-binding protein,Histone lysine acetyltransferase CREBBP;Protein-lysine acetyltransferase CREBBP;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0000785;GO:0005737;GO:0000123;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016407;GO:0003682;GO:0031490;GO:0003684;GO:0004402;GO:0043426;GO:0002039;GO:0061733;GO:0001102;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:1904837;GO:0034644;GO:0042733;GO:0016573;GO:1990258;GO:0042592;GO:0018076;GO:0000122;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0065003;GO:0042981;GO:1900034;GO:0019216;GO:0045637;GO:0008589;GO:0061418;GO:0006355;GO:0001666;GO:0048511;GO:0007165;GO:0002223;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:histone acetyltransferase complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:acetyltransferase activity; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:histone acetyltransferase activity; F:MRF binding; F:p53 binding; F:peptide-lysine-N-acetyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:embryonic digit morphogenesis; P:histone acetylation; P:histone glutamine methylation; P:homeostatic process; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of lipid metabolic process; P:regulation of myeloid cell differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:rhythmic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q92793 D3DUC9 O00147 Q16376 Q4LE28,CREB-binding protein,Histone lysine acetyltransferase CREBBP;Protein-lysine acetyltransferase CREBBP;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0000785;GO:0005737;GO:0000123;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016407;GO:0003682;GO:0031490;GO:0003684;GO:0004402;GO:0043426;GO:0002039;GO:0061733;GO:0001102;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:1904837;GO:0034644;GO:0042733;GO:0016573;GO:1990258;GO:0042592;GO:0018076;GO:0000122;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0065003;GO:0042981;GO:1900034;GO:0019216;GO:0045637;GO:0008589;GO:0061418;GO:0006355;GO:0001666;GO:0048511;GO:0007165;GO:0002223;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:histone acetyltransferase complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:acetyltransferase activity; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:histone acetyltransferase activity; F:MRF binding; F:p53 binding; F:peptide-lysine-N-acetyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:embryonic digit morphogenesis; P:histone acetylation; P:histone glutamine methylation; P:homeostatic process; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of lipid metabolic process; P:regulation of myeloid cell differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:rhythmic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process;|Q92793 D3DUC9 O00147 Q16376 Q4LE28,CREB-binding protein,Histone lysine acetyltransferase CREBBP;Protein-lysine acetyltransferase CREBBP;, PF00439;PF09030;PF06001;PF08214;PF02172;PF02135;PF00569;, GO:0000785;GO:0005737;GO:0000123;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0016407;GO:0003682;GO:0031490;GO:0003684;GO:0004402;GO:0043426;GO:0002039;GO:0061733;GO:0001102;GO:0001085;GO:0003713;GO:0003714;GO:0008134;GO:0008270;GO:1904837;GO:0034644;GO:0042733;GO:0016573;GO:1990258;GO:0042592;GO:0018076;GO:0000122;GO:0007219;GO:0045747;GO:0045944;GO:0007221;GO:0045893;GO:0030511;GO:0032481;GO:0006473;GO:0031648;GO:0065003;GO:0042981;GO:1900034;GO:0019216;GO:0045637;GO:0008589;GO:0061418;GO:0006355;GO:0001666;GO:0048511;GO:0007165;GO:0002223;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:histone acetyltransferase complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:acetyltransferase activity; F:chromatin binding; F:chromatin DNA binding; F:damaged DNA binding; F:histone acetyltransferase activity; F:MRF binding; F:p53 binding; F:peptide-lysine-N-acetyltransferase activity; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:beta-catenin-TCF complex assembly; P:cellular response to UV; P:embryonic digit morphogenesis; P:histone acetylation; P:histone glutamine methylation; P:homeostatic process; P:N-terminal peptidyl-lysine acetylation; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:positive regulation of transcription, DNA-templated; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of type I interferon production; P:protein acetylation; P:protein destabilization; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of lipid metabolic process; P:regulation of myeloid cell differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:rhythmic process; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; P:viral process; scaffold133 indexed_genome mRNA 2464965 2562980 . - . ID=transcript_14236;O60503 A7E2V5 A7E2X2 D3DUD1 O60273 Q4ZHT9 Q4ZIR5 Q9BWT4 Q9UGP2,Adenylate cyclase type 9 {ECO:0000303|PubMed:9628827},ATP pyrophosphate-lyase 9;Adenylate cyclase type IX {ECO:0000303|PubMed:10987815};Adenylyl cyclase 9;, PF00211;, GO:0030424;GO:0030425;GO:0016021;GO:0005887;GO:0005886;GO:0004016;GO:0005524;GO:0046872;GO:0007190;GO:0034199;GO:0071880;GO:0007189;GO:0007193;GO:0006171;GO:0071377;GO:0007186;GO:0001701;GO:0002862;GO:0003091;GO:0007165;, C:axon; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:adenylate cyclase activity; F:ATP binding; F:metal ion binding;, P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating adrenergic receptor signaling pathway; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cAMP biosynthetic process; P:cellular response to glucagon stimulus; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:negative regulation of inflammatory response to antigenic stimulus; P:renal water homeostasis; P:signal transduction; scaffold133 indexed_genome mRNA 2612445 2624574 . - . ID=transcript_14237;Q86TD4 B4DYT9,Sarcalumenin,, PF00350;PF16880;, GO:0043231;GO:0033018;GO:0033017;GO:0005525;GO:0006897;GO:0016197;, C:intracellular membrane-bounded organelle; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:GTP binding;, P:endocytosis; P:endosomal transport;|Q86TD4 B4DYT9,Sarcalumenin,, PF00350;PF16880;, GO:0043231;GO:0033018;GO:0033017;GO:0005525;GO:0006897;GO:0016197;, C:intracellular membrane-bounded organelle; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:GTP binding;, P:endocytosis; P:endosomal transport;|Q86TD4 B4DYT9,Sarcalumenin,, PF00350;PF16880;, GO:0043231;GO:0033018;GO:0033017;GO:0005525;GO:0006897;GO:0016197;, C:intracellular membrane-bounded organelle; C:sarcoplasmic reticulum lumen; C:sarcoplasmic reticulum membrane;, F:GTP binding;, P:endocytosis; P:endosomal transport; scaffold133 indexed_genome mRNA 2659041 2679270 . + . ID=transcript_14238;Q01664 O60409,Transcription factor AP-4,Activating enhancer-binding protein 4;Class C basic helix-loop-helix protein 41;, PF00010;, GO:0000785;GO:0005739;GO:0005654;GO:0005634;GO:0017053;GO:0003677;GO:0001228;GO:0000981;GO:0070888;GO:0042826;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0071549;GO:0006978;GO:0043922;GO:0071157;GO:0008285;GO:0045736;GO:0043392;GO:0045892;GO:0043923;GO:0043065;GO:2001269;GO:0045893;GO:0065003;GO:1901990;GO:0006357;, C:chromatin; C:mitochondrion; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:histone deacetylase binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to dexamethasone stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:negative regulation by host of viral transcription; P:negative regulation of cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of DNA binding; P:negative regulation of transcription, DNA-templated; P:positive regulation by host of viral transcription; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:regulation of mitotic cell cycle phase transition; P:regulation of transcription by RNA polymerase II;|Q01664 O60409,Transcription factor AP-4,Activating enhancer-binding protein 4;Class C basic helix-loop-helix protein 41;, PF00010;, GO:0000785;GO:0005739;GO:0005654;GO:0005634;GO:0017053;GO:0003677;GO:0001228;GO:0000981;GO:0070888;GO:0042826;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0071549;GO:0006978;GO:0043922;GO:0071157;GO:0008285;GO:0045736;GO:0043392;GO:0045892;GO:0043923;GO:0043065;GO:2001269;GO:0045893;GO:0065003;GO:1901990;GO:0006357;, C:chromatin; C:mitochondrion; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:histone deacetylase binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to dexamethasone stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:negative regulation by host of viral transcription; P:negative regulation of cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of DNA binding; P:negative regulation of transcription, DNA-templated; P:positive regulation by host of viral transcription; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:regulation of mitotic cell cycle phase transition; P:regulation of transcription by RNA polymerase II; scaffold133 indexed_genome mRNA 2727780 2728868 . + . ID=transcript_14239;Q9BZE0 B3KX84,Zinc finger protein GLIS2,GLI-similar 2;Neuronal Krueppel-like protein;, PF00096;, GO:0005737;GO:0097730;GO:0016607;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0000976;GO:0061005;GO:0007417;GO:0061484;GO:0043433;GO:0045879;GO:0000122;GO:0045892;GO:1900182;GO:0045944;GO:0045893;GO:0006357;GO:0060994;, C:cytoplasm; C:non-motile cilium; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell differentiation involved in kidney development; P:central nervous system development; P:hematopoietic stem cell homeostasis; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of smoothened signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of protein localization to nucleus; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter involved in kidney development; scaffold133 indexed_genome mRNA 2732178 2736484 . - . ID=transcript_14240;Q9Y3D7 Q6I9Z3 Q9H5X3,Mitochondrial import inner membrane translocase subunit TIM16,Mitochondria-associated granulocyte macrophage CSF-signaling molecule;Presequence translocated-associated motor subunit PAM16;, , GO:0031314;GO:0005759;GO:0001405;GO:0032991;GO:0005744;GO:0032780;GO:0001503;GO:0030150;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:PAM complex, Tim23 associated import motor; C:protein-containing complex; C:TIM23 mitochondrial import inner membrane translocase complex;, , P:negative regulation of ATPase activity; P:ossification; P:protein import into mitochondrial matrix;|Q9Y3D7 Q6I9Z3 Q9H5X3,Mitochondrial import inner membrane translocase subunit TIM16,Mitochondria-associated granulocyte macrophage CSF-signaling molecule;Presequence translocated-associated motor subunit PAM16;, , GO:0031314;GO:0005759;GO:0001405;GO:0032991;GO:0005744;GO:0032780;GO:0001503;GO:0030150;, C:extrinsic component of mitochondrial inner membrane; C:mitochondrial matrix; C:PAM complex, Tim23 associated import motor; C:protein-containing complex; C:TIM23 mitochondrial import inner membrane translocase complex;, , P:negative regulation of ATPase activity; P:ossification; P:protein import into mitochondrial matrix; scaffold133 indexed_genome mRNA 2740358 2745011 . - . ID=transcript_14241;P57737 B4DFD6 B4DL18 I3L416 Q17RK4,Coronin-7,70 kDa WD repeat tumor rejection antigen homolog;, PF08953;PF00400;, GO:0031410;GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005802;GO:0003779;GO:0051015;GO:0007015;GO:0030041;GO:0006895;GO:0015031;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network;, F:actin binding; F:actin filament binding;, P:actin filament organization; P:actin filament polymerization; P:Golgi to endosome transport; P:protein transport;|P57737 B4DFD6 B4DL18 I3L416 Q17RK4,Coronin-7,70 kDa WD repeat tumor rejection antigen homolog;, PF08953;PF00400;, GO:0031410;GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005802;GO:0003779;GO:0051015;GO:0007015;GO:0030041;GO:0006895;GO:0015031;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network;, F:actin binding; F:actin filament binding;, P:actin filament organization; P:actin filament polymerization; P:Golgi to endosome transport; P:protein transport;|P57737 B4DFD6 B4DL18 I3L416 Q17RK4,Coronin-7,70 kDa WD repeat tumor rejection antigen homolog;, PF08953;PF00400;, GO:0031410;GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005802;GO:0003779;GO:0051015;GO:0007015;GO:0030041;GO:0006895;GO:0015031;, C:cytoplasmic vesicle; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network;, F:actin binding; F:actin filament binding;, P:actin filament organization; P:actin filament polymerization; P:Golgi to endosome transport; P:protein transport; scaffold135 indexed_genome mRNA 187032 189194 . + . ID=transcript_14242;Q8IXX5 A8K5W1 Q6NW15 Q96E06,Transmembrane protein 183A,, , GO:0016021;, C:integral component of membrane; scaffold135 indexed_genome mRNA 190778 202277 . + . ID=transcript_14243;Q1AE95 Q1AE97,Transmembrane protein 183B,, , GO:0016021;, C:integral component of membrane;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q1AE95 Q1AE97,Transmembrane protein 183B,, , GO:0016021;, C:integral component of membrane;|Q1AE95 Q1AE97,Transmembrane protein 183B,, , GO:0016021;, C:integral component of membrane;|Q1AE95 Q1AE97,Transmembrane protein 183B,, , GO:0016021;, C:integral component of membrane; scaffold135 indexed_genome mRNA 205038 228265 . + . ID=transcript_14244;O75335 A2RUJ5 B1APN8 B1N949 B7ZM43 O94971,Liprin-alpha-4,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;, PF00536;PF07647;, GO:0009986;GO:0005829;GO:0048786;GO:0045202;GO:0006836;GO:0050808;, C:cell surface; C:cytosol; C:presynaptic active zone; C:synapse;, , P:neurotransmitter transport; P:synapse organization;|O75335 A2RUJ5 B1APN8 B1N949 B7ZM43 O94971,Liprin-alpha-4,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;, PF00536;PF07647;, GO:0009986;GO:0005829;GO:0048786;GO:0045202;GO:0006836;GO:0050808;, C:cell surface; C:cytosol; C:presynaptic active zone; C:synapse;, , P:neurotransmitter transport; P:synapse organization; scaffold135 indexed_genome mRNA 233732 259508 . + . ID=transcript_14245;O75335 A2RUJ5 B1APN8 B1N949 B7ZM43 O94971,Liprin-alpha-4,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;, PF00536;PF07647;, GO:0009986;GO:0005829;GO:0048786;GO:0045202;GO:0006836;GO:0050808;, C:cell surface; C:cytosol; C:presynaptic active zone; C:synapse;, , P:neurotransmitter transport; P:synapse organization;|O75335 A2RUJ5 B1APN8 B1N949 B7ZM43 O94971,Liprin-alpha-4,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;, PF00536;PF07647;, GO:0009986;GO:0005829;GO:0048786;GO:0045202;GO:0006836;GO:0050808;, C:cell surface; C:cytosol; C:presynaptic active zone; C:synapse;, , P:neurotransmitter transport; P:synapse organization;|F8VP68 Q2M3G8,Liprin-alpha-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2;, PF00536;PF07647;, GO:0030424;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0048786;GO:0099181;GO:0007160;GO:0099519;GO:0006836;GO:0060998;GO:0061001;GO:2000300;GO:0050808;, C:axon; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:presynaptic active zone;, F:structural constituent of presynapse;, P:cell-matrix adhesion; P:dense core granule cytoskeletal transport; P:neurotransmitter transport; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:regulation of synaptic vesicle exocytosis; P:synapse organization;|F8VP68 Q2M3G8,Liprin-alpha-2,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2;, PF00536;PF07647;, GO:0030424;GO:0009986;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0048786;GO:0099181;GO:0007160;GO:0099519;GO:0006836;GO:0060998;GO:0061001;GO:2000300;GO:0050808;, C:axon; C:cell surface; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:presynaptic active zone;, F:structural constituent of presynapse;, P:cell-matrix adhesion; P:dense core granule cytoskeletal transport; P:neurotransmitter transport; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:regulation of synaptic vesicle exocytosis; P:synapse organization;|O75335 A2RUJ5 B1APN8 B1N949 B7ZM43 O94971,Liprin-alpha-4,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;, PF00536;PF07647;, GO:0009986;GO:0005829;GO:0048786;GO:0045202;GO:0006836;GO:0050808;, C:cell surface; C:cytosol; C:presynaptic active zone; C:synapse;, , P:neurotransmitter transport; P:synapse organization;|O75335 A2RUJ5 B1APN8 B1N949 B7ZM43 O94971,Liprin-alpha-4,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;, PF00536;PF07647;, GO:0009986;GO:0005829;GO:0048786;GO:0045202;GO:0006836;GO:0050808;, C:cell surface; C:cytosol; C:presynaptic active zone; C:synapse;, , P:neurotransmitter transport; P:synapse organization;|O75335 A2RUJ5 B1APN8 B1N949 B7ZM43 O94971,Liprin-alpha-4,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;, PF00536;PF07647;, GO:0009986;GO:0005829;GO:0048786;GO:0045202;GO:0006836;GO:0050808;, C:cell surface; C:cytosol; C:presynaptic active zone; C:synapse;, , P:neurotransmitter transport; P:synapse organization;|O75335 A2RUJ5 B1APN8 B1N949 B7ZM43 O94971,Liprin-alpha-4,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;, PF00536;PF07647;, GO:0009986;GO:0005829;GO:0048786;GO:0045202;GO:0006836;GO:0050808;, C:cell surface; C:cytosol; C:presynaptic active zone; C:synapse;, , P:neurotransmitter transport; P:synapse organization;|O75335 A2RUJ5 B1APN8 B1N949 B7ZM43 O94971,Liprin-alpha-4,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;, PF00536;PF07647;, GO:0009986;GO:0005829;GO:0048786;GO:0045202;GO:0006836;GO:0050808;, C:cell surface; C:cytosol; C:presynaptic active zone; C:synapse;, , P:neurotransmitter transport; P:synapse organization;|O75335 A2RUJ5 B1APN8 B1N949 B7ZM43 O94971,Liprin-alpha-4,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;, PF00536;PF07647;, GO:0009986;GO:0005829;GO:0048786;GO:0045202;GO:0006836;GO:0050808;, C:cell surface; C:cytosol; C:presynaptic active zone; C:synapse;, , P:neurotransmitter transport; P:synapse organization; scaffold135 indexed_genome mRNA 266751 269519 . - . ID=transcript_14246;P15173 Q53XW6,Myogenin,Class C basic helix-loop-helix protein 3;Myogenic factor 4;, PF01586;PF00010;, GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0005667;GO:0031490;GO:0001228;GO:0003700;GO:0000981;GO:0070888;GO:0046983;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0007049;GO:0071392;GO:0071363;GO:0071285;GO:0071259;GO:0071300;GO:0071356;GO:0042693;GO:0045445;GO:0008285;GO:0045820;GO:0001503;GO:0071158;GO:0014737;GO:0051149;GO:0045663;GO:0010831;GO:1903862;GO:0048743;GO:0045944;GO:1901739;GO:0014842;GO:0006357;GO:0014894;GO:0014878;GO:0009629;GO:0014873;GO:0014732;GO:0035914;GO:0048741;GO:0007519;GO:0043403;GO:0014891;, C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:transcription regulator complex;, F:chromatin DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell cycle; P:cellular response to estradiol stimulus; P:cellular response to growth factor stimulus; P:cellular response to lithium ion; P:cellular response to magnetism; P:cellular response to retinoic acid; P:cellular response to tumor necrosis factor; P:muscle cell fate commitment; P:myoblast differentiation; P:negative regulation of cell population proliferation; P:negative regulation of glycolytic process; P:ossification; P:positive regulation of cell cycle arrest; P:positive regulation of muscle atrophy; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of myotube differentiation; P:positive regulation of oxidative phosphorylation; P:positive regulation of skeletal muscle fiber development; P:positive regulation of transcription by RNA polymerase II; P:regulation of myoblast fusion; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to denervation involved in regulation of muscle adaptation; P:response to electrical stimulus involved in regulation of muscle adaptation; P:response to gravity; P:response to muscle activity involved in regulation of muscle adaptation; P:skeletal muscle atrophy; P:skeletal muscle cell differentiation; P:skeletal muscle fiber development; P:skeletal muscle tissue development; P:skeletal muscle tissue regeneration; P:striated muscle atrophy; scaffold135 indexed_genome mRNA 369922 418427 . + . ID=transcript_14247;P30542 A6NFY5 A6NGP4 A8K1L3 B3KXQ4 D2CGD0 Q6FHK3 Q8TAM8,Adenosine receptor A1,, PF00001;, GO:0030673;GO:0016323;GO:0044305;GO:0043197;GO:0005783;GO:0005887;GO:0099055;GO:0099056;GO:0043025;GO:0005886;GO:0014069;GO:0048786;GO:0043195;GO:0001609;GO:0001664;GO:0031683;GO:0031072;GO:0032795;GO:0099582;GO:0046982;GO:0001883;GO:0000186;GO:0007193;GO:0097190;GO:0007267;GO:0050890;GO:0050965;GO:0060079;GO:0055089;GO:0007186;GO:0006954;GO:0016042;GO:0002674;GO:0043066;GO:0008285;GO:0042323;GO:0014050;GO:0045822;GO:0046888;GO:0002686;GO:0050995;GO:1900453;GO:1900272;GO:0070256;GO:0032900;GO:0035814;GO:0032229;GO:0051967;GO:0003085;GO:0007399;GO:0006909;GO:0045741;GO:0050996;GO:1901216;GO:0032244;GO:0002793;GO:0043268;GO:0035307;GO:0003084;GO:0006612;GO:0086004;GO:0003093;GO:0002087;GO:0051930;GO:0060087;GO:0001666;GO:0007165;GO:0001659;GO:0070328;, C:axolemma; C:basolateral plasma membrane; C:calyx of Held; C:dendritic spine; C:endoplasmic reticulum; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:presynaptic active zone; C:terminal bouton;, F:G protein-coupled adenosine receptor activity; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:heat shock protein binding; F:heterotrimeric G-protein binding; F:neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:protein heterodimerization activity; F:purine nucleoside binding;, P:activation of MAPKK activity; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:apoptotic signaling pathway; P:cell-cell signaling; P:cognition; P:detection of temperature stimulus involved in sensory perception of pain; P:excitatory postsynaptic potential; P:fatty acid homeostasis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lipid catabolic process; P:negative regulation of acute inflammatory response; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of circadian sleep/wake cycle, non-REM sleep; P:negative regulation of glutamate secretion; P:negative regulation of heart contraction; P:negative regulation of hormone secretion; P:negative regulation of leukocyte migration; P:negative regulation of lipid catabolic process; P:negative regulation of long-term synaptic depression; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mucus secretion; P:negative regulation of neurotrophin production; P:negative regulation of renal sodium excretion; P:negative regulation of synaptic transmission, GABAergic; P:negative regulation of synaptic transmission, glutamatergic; P:negative regulation of systemic arterial blood pressure; P:nervous system development; P:phagocytosis; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of lipid catabolic process; P:positive regulation of neuron death; P:positive regulation of nucleoside transport; P:positive regulation of peptide secretion; P:positive regulation of potassium ion transport; P:positive regulation of protein dephosphorylation; P:positive regulation of systemic arterial blood pressure; P:protein targeting to membrane; P:regulation of cardiac muscle cell contraction; P:regulation of glomerular filtration; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of sensory perception of pain; P:relaxation of vascular associated smooth muscle; P:response to hypoxia; P:signal transduction; P:temperature homeostasis; P:triglyceride homeostasis;|P30542 A6NFY5 A6NGP4 A8K1L3 B3KXQ4 D2CGD0 Q6FHK3 Q8TAM8,Adenosine receptor A1,, PF00001;, GO:0030673;GO:0016323;GO:0044305;GO:0043197;GO:0005783;GO:0005887;GO:0099055;GO:0099056;GO:0043025;GO:0005886;GO:0014069;GO:0048786;GO:0043195;GO:0001609;GO:0001664;GO:0031683;GO:0031072;GO:0032795;GO:0099582;GO:0046982;GO:0001883;GO:0000186;GO:0007193;GO:0097190;GO:0007267;GO:0050890;GO:0050965;GO:0060079;GO:0055089;GO:0007186;GO:0006954;GO:0016042;GO:0002674;GO:0043066;GO:0008285;GO:0042323;GO:0014050;GO:0045822;GO:0046888;GO:0002686;GO:0050995;GO:1900453;GO:1900272;GO:0070256;GO:0032900;GO:0035814;GO:0032229;GO:0051967;GO:0003085;GO:0007399;GO:0006909;GO:0045741;GO:0050996;GO:1901216;GO:0032244;GO:0002793;GO:0043268;GO:0035307;GO:0003084;GO:0006612;GO:0086004;GO:0003093;GO:0002087;GO:0051930;GO:0060087;GO:0001666;GO:0007165;GO:0001659;GO:0070328;, C:axolemma; C:basolateral plasma membrane; C:calyx of Held; C:dendritic spine; C:endoplasmic reticulum; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:presynaptic active zone; C:terminal bouton;, F:G protein-coupled adenosine receptor activity; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:heat shock protein binding; F:heterotrimeric G-protein binding; F:neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:protein heterodimerization activity; F:purine nucleoside binding;, P:activation of MAPKK activity; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:apoptotic signaling pathway; P:cell-cell signaling; P:cognition; P:detection of temperature stimulus involved in sensory perception of pain; P:excitatory postsynaptic potential; P:fatty acid homeostasis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lipid catabolic process; P:negative regulation of acute inflammatory response; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of circadian sleep/wake cycle, non-REM sleep; P:negative regulation of glutamate secretion; P:negative regulation of heart contraction; P:negative regulation of hormone secretion; P:negative regulation of leukocyte migration; P:negative regulation of lipid catabolic process; P:negative regulation of long-term synaptic depression; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mucus secretion; P:negative regulation of neurotrophin production; P:negative regulation of renal sodium excretion; P:negative regulation of synaptic transmission, GABAergic; P:negative regulation of synaptic transmission, glutamatergic; P:negative regulation of systemic arterial blood pressure; P:nervous system development; P:phagocytosis; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of lipid catabolic process; P:positive regulation of neuron death; P:positive regulation of nucleoside transport; P:positive regulation of peptide secretion; P:positive regulation of potassium ion transport; P:positive regulation of protein dephosphorylation; P:positive regulation of systemic arterial blood pressure; P:protein targeting to membrane; P:regulation of cardiac muscle cell contraction; P:regulation of glomerular filtration; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of sensory perception of pain; P:relaxation of vascular associated smooth muscle; P:response to hypoxia; P:signal transduction; P:temperature homeostasis; P:triglyceride homeostasis;|P30542 A6NFY5 A6NGP4 A8K1L3 B3KXQ4 D2CGD0 Q6FHK3 Q8TAM8,Adenosine receptor A1,, PF00001;, GO:0030673;GO:0016323;GO:0044305;GO:0043197;GO:0005783;GO:0005887;GO:0099055;GO:0099056;GO:0043025;GO:0005886;GO:0014069;GO:0048786;GO:0043195;GO:0001609;GO:0001664;GO:0031683;GO:0031072;GO:0032795;GO:0099582;GO:0046982;GO:0001883;GO:0000186;GO:0007193;GO:0097190;GO:0007267;GO:0050890;GO:0050965;GO:0060079;GO:0055089;GO:0007186;GO:0006954;GO:0016042;GO:0002674;GO:0043066;GO:0008285;GO:0042323;GO:0014050;GO:0045822;GO:0046888;GO:0002686;GO:0050995;GO:1900453;GO:1900272;GO:0070256;GO:0032900;GO:0035814;GO:0032229;GO:0051967;GO:0003085;GO:0007399;GO:0006909;GO:0045741;GO:0050996;GO:1901216;GO:0032244;GO:0002793;GO:0043268;GO:0035307;GO:0003084;GO:0006612;GO:0086004;GO:0003093;GO:0002087;GO:0051930;GO:0060087;GO:0001666;GO:0007165;GO:0001659;GO:0070328;, C:axolemma; C:basolateral plasma membrane; C:calyx of Held; C:dendritic spine; C:endoplasmic reticulum; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:presynaptic active zone; C:terminal bouton;, F:G protein-coupled adenosine receptor activity; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:heat shock protein binding; F:heterotrimeric G-protein binding; F:neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:protein heterodimerization activity; F:purine nucleoside binding;, P:activation of MAPKK activity; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:apoptotic signaling pathway; P:cell-cell signaling; P:cognition; P:detection of temperature stimulus involved in sensory perception of pain; P:excitatory postsynaptic potential; P:fatty acid homeostasis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lipid catabolic process; P:negative regulation of acute inflammatory response; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of circadian sleep/wake cycle, non-REM sleep; P:negative regulation of glutamate secretion; P:negative regulation of heart contraction; P:negative regulation of hormone secretion; P:negative regulation of leukocyte migration; P:negative regulation of lipid catabolic process; P:negative regulation of long-term synaptic depression; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mucus secretion; P:negative regulation of neurotrophin production; P:negative regulation of renal sodium excretion; P:negative regulation of synaptic transmission, GABAergic; P:negative regulation of synaptic transmission, glutamatergic; P:negative regulation of systemic arterial blood pressure; P:nervous system development; P:phagocytosis; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of lipid catabolic process; P:positive regulation of neuron death; P:positive regulation of nucleoside transport; P:positive regulation of peptide secretion; P:positive regulation of potassium ion transport; P:positive regulation of protein dephosphorylation; P:positive regulation of systemic arterial blood pressure; P:protein targeting to membrane; P:regulation of cardiac muscle cell contraction; P:regulation of glomerular filtration; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of sensory perception of pain; P:relaxation of vascular associated smooth muscle; P:response to hypoxia; P:signal transduction; P:temperature homeostasis; P:triglyceride homeostasis;|P30542 A6NFY5 A6NGP4 A8K1L3 B3KXQ4 D2CGD0 Q6FHK3 Q8TAM8,Adenosine receptor A1,, PF00001;, GO:0030673;GO:0016323;GO:0044305;GO:0043197;GO:0005783;GO:0005887;GO:0099055;GO:0099056;GO:0043025;GO:0005886;GO:0014069;GO:0048786;GO:0043195;GO:0001609;GO:0001664;GO:0031683;GO:0031072;GO:0032795;GO:0099582;GO:0046982;GO:0001883;GO:0000186;GO:0007193;GO:0097190;GO:0007267;GO:0050890;GO:0050965;GO:0060079;GO:0055089;GO:0007186;GO:0006954;GO:0016042;GO:0002674;GO:0043066;GO:0008285;GO:0042323;GO:0014050;GO:0045822;GO:0046888;GO:0002686;GO:0050995;GO:1900453;GO:1900272;GO:0070256;GO:0032900;GO:0035814;GO:0032229;GO:0051967;GO:0003085;GO:0007399;GO:0006909;GO:0045741;GO:0050996;GO:1901216;GO:0032244;GO:0002793;GO:0043268;GO:0035307;GO:0003084;GO:0006612;GO:0086004;GO:0003093;GO:0002087;GO:0051930;GO:0060087;GO:0001666;GO:0007165;GO:0001659;GO:0070328;, C:axolemma; C:basolateral plasma membrane; C:calyx of Held; C:dendritic spine; C:endoplasmic reticulum; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:presynaptic active zone; C:terminal bouton;, F:G protein-coupled adenosine receptor activity; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:heat shock protein binding; F:heterotrimeric G-protein binding; F:neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:protein heterodimerization activity; F:purine nucleoside binding;, P:activation of MAPKK activity; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:apoptotic signaling pathway; P:cell-cell signaling; P:cognition; P:detection of temperature stimulus involved in sensory perception of pain; P:excitatory postsynaptic potential; P:fatty acid homeostasis; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:lipid catabolic process; P:negative regulation of acute inflammatory response; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of circadian sleep/wake cycle, non-REM sleep; P:negative regulation of glutamate secretion; P:negative regulation of heart contraction; P:negative regulation of hormone secretion; P:negative regulation of leukocyte migration; P:negative regulation of lipid catabolic process; P:negative regulation of long-term synaptic depression; P:negative regulation of long-term synaptic potentiation; P:negative regulation of mucus secretion; P:negative regulation of neurotrophin production; P:negative regulation of renal sodium excretion; P:negative regulation of synaptic transmission, GABAergic; P:negative regulation of synaptic transmission, glutamatergic; P:negative regulation of systemic arterial blood pressure; P:nervous system development; P:phagocytosis; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of lipid catabolic process; P:positive regulation of neuron death; P:positive regulation of nucleoside transport; P:positive regulation of peptide secretion; P:positive regulation of potassium ion transport; P:positive regulation of protein dephosphorylation; P:positive regulation of systemic arterial blood pressure; P:protein targeting to membrane; P:regulation of cardiac muscle cell contraction; P:regulation of glomerular filtration; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of sensory perception of pain; P:relaxation of vascular associated smooth muscle; P:response to hypoxia; P:signal transduction; P:temperature homeostasis; P:triglyceride homeostasis;|Q13203 Q16886 Q86YC5,Myosin-binding protein H,H-protein;, PF00041;PF07679;, GO:0032982;GO:0008307;GO:0007155;GO:0006942;, C:myosin filament;, F:structural constituent of muscle;, P:cell adhesion; P:regulation of striated muscle contraction; scaffold135 indexed_genome mRNA 419610 426256 . - . ID=transcript_14248;P36222 B2R7B0 P30923 Q8IVA4 Q96HI7,Chitinase-3-like protein 1,39 kDa synovial protein;Cartilage glycoprotein 39;YKL-40;, PF00704;, GO:0005737;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0048471;GO:0035580;GO:0030246;GO:0008061;GO:0005201;GO:0007250;GO:0006915;GO:0005975;GO:0051216;GO:0071347;GO:0071356;GO:0006032;GO:0006954;GO:0030324;GO:0043312;GO:0045766;GO:0070374;GO:0032757;GO:0010800;GO:0051897;GO:0070555;GO:0070741;GO:0009612;GO:0034612;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:perinuclear region of cytoplasm; C:specific granule lumen;, F:carbohydrate binding; F:chitin binding; F:extracellular matrix structural constituent;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic process; P:carbohydrate metabolic process; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chitin catabolic process; P:inflammatory response; P:lung development; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of interleukin-8 production; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase B signaling; P:response to interleukin-1; P:response to interleukin-6; P:response to mechanical stimulus; P:response to tumor necrosis factor;|P36222 B2R7B0 P30923 Q8IVA4 Q96HI7,Chitinase-3-like protein 1,39 kDa synovial protein;Cartilage glycoprotein 39;YKL-40;, PF00704;, GO:0005737;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0048471;GO:0035580;GO:0030246;GO:0008061;GO:0005201;GO:0007250;GO:0006915;GO:0005975;GO:0051216;GO:0071347;GO:0071356;GO:0006032;GO:0006954;GO:0030324;GO:0043312;GO:0045766;GO:0070374;GO:0032757;GO:0010800;GO:0051897;GO:0070555;GO:0070741;GO:0009612;GO:0034612;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:perinuclear region of cytoplasm; C:specific granule lumen;, F:carbohydrate binding; F:chitin binding; F:extracellular matrix structural constituent;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic process; P:carbohydrate metabolic process; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chitin catabolic process; P:inflammatory response; P:lung development; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of interleukin-8 production; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase B signaling; P:response to interleukin-1; P:response to interleukin-6; P:response to mechanical stimulus; P:response to tumor necrosis factor;|P36222 B2R7B0 P30923 Q8IVA4 Q96HI7,Chitinase-3-like protein 1,39 kDa synovial protein;Cartilage glycoprotein 39;YKL-40;, PF00704;, GO:0005737;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0048471;GO:0035580;GO:0030246;GO:0008061;GO:0005201;GO:0007250;GO:0006915;GO:0005975;GO:0051216;GO:0071347;GO:0071356;GO:0006032;GO:0006954;GO:0030324;GO:0043312;GO:0045766;GO:0070374;GO:0032757;GO:0010800;GO:0051897;GO:0070555;GO:0070741;GO:0009612;GO:0034612;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:perinuclear region of cytoplasm; C:specific granule lumen;, F:carbohydrate binding; F:chitin binding; F:extracellular matrix structural constituent;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic process; P:carbohydrate metabolic process; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chitin catabolic process; P:inflammatory response; P:lung development; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of interleukin-8 production; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase B signaling; P:response to interleukin-1; P:response to interleukin-6; P:response to mechanical stimulus; P:response to tumor necrosis factor;|P36222 B2R7B0 P30923 Q8IVA4 Q96HI7,Chitinase-3-like protein 1,39 kDa synovial protein;Cartilage glycoprotein 39;YKL-40;, PF00704;, GO:0005737;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0048471;GO:0035580;GO:0030246;GO:0008061;GO:0005201;GO:0007250;GO:0006915;GO:0005975;GO:0051216;GO:0071347;GO:0071356;GO:0006032;GO:0006954;GO:0030324;GO:0043312;GO:0045766;GO:0070374;GO:0032757;GO:0010800;GO:0051897;GO:0070555;GO:0070741;GO:0009612;GO:0034612;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:perinuclear region of cytoplasm; C:specific granule lumen;, F:carbohydrate binding; F:chitin binding; F:extracellular matrix structural constituent;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic process; P:carbohydrate metabolic process; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chitin catabolic process; P:inflammatory response; P:lung development; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of interleukin-8 production; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase B signaling; P:response to interleukin-1; P:response to interleukin-6; P:response to mechanical stimulus; P:response to tumor necrosis factor; scaffold135 indexed_genome mRNA 426289 430966 . - . ID=transcript_14249;P36222 B2R7B0 P30923 Q8IVA4 Q96HI7,Chitinase-3-like protein 1,39 kDa synovial protein;Cartilage glycoprotein 39;YKL-40;, PF00704;, GO:0005737;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0048471;GO:0035580;GO:0030246;GO:0008061;GO:0005201;GO:0007250;GO:0006915;GO:0005975;GO:0051216;GO:0071347;GO:0071356;GO:0006032;GO:0006954;GO:0030324;GO:0043312;GO:0045766;GO:0070374;GO:0032757;GO:0010800;GO:0051897;GO:0070555;GO:0070741;GO:0009612;GO:0034612;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:perinuclear region of cytoplasm; C:specific granule lumen;, F:carbohydrate binding; F:chitin binding; F:extracellular matrix structural constituent;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic process; P:carbohydrate metabolic process; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chitin catabolic process; P:inflammatory response; P:lung development; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of interleukin-8 production; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase B signaling; P:response to interleukin-1; P:response to interleukin-6; P:response to mechanical stimulus; P:response to tumor necrosis factor;|P36222 B2R7B0 P30923 Q8IVA4 Q96HI7,Chitinase-3-like protein 1,39 kDa synovial protein;Cartilage glycoprotein 39;YKL-40;, PF00704;, GO:0005737;GO:0005783;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0048471;GO:0035580;GO:0030246;GO:0008061;GO:0005201;GO:0007250;GO:0006915;GO:0005975;GO:0051216;GO:0071347;GO:0071356;GO:0006032;GO:0006954;GO:0030324;GO:0043312;GO:0045766;GO:0070374;GO:0032757;GO:0010800;GO:0051897;GO:0070555;GO:0070741;GO:0009612;GO:0034612;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:perinuclear region of cytoplasm; C:specific granule lumen;, F:carbohydrate binding; F:chitin binding; F:extracellular matrix structural constituent;, P:activation of NF-kappaB-inducing kinase activity; P:apoptotic process; P:carbohydrate metabolic process; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chitin catabolic process; P:inflammatory response; P:lung development; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of interleukin-8 production; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase B signaling; P:response to interleukin-1; P:response to interleukin-6; P:response to mechanical stimulus; P:response to tumor necrosis factor; scaffold135 indexed_genome mRNA 519144 523937 . + . ID=transcript_14250;P78543 A0A024R986 Q3KR25 Q5VUT0,Protein BTG2,BTG family member 2;NGF-inducible anti-proliferative protein PC3;, PF07742;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0003714;GO:0009952;GO:0008306;GO:0006974;GO:0021954;GO:0021542;GO:0006977;GO:0006281;GO:0008285;GO:0045930;GO:2000178;GO:0043524;GO:0000122;GO:0017148;GO:0031175;GO:0060213;GO:0006479;GO:0051602;GO:0009612;GO:0014070;GO:0043434;GO:0035914;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:transcription corepressor activity;, P:anterior/posterior pattern specification; P:associative learning; P:cellular response to DNA damage stimulus; P:central nervous system neuron development; P:dentate gyrus development; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA repair; P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:neuron projection development; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:protein methylation; P:response to electrical stimulus; P:response to mechanical stimulus; P:response to organic cyclic compound; P:response to peptide hormone; P:skeletal muscle cell differentiation;|P78543 A0A024R986 Q3KR25 Q5VUT0,Protein BTG2,BTG family member 2;NGF-inducible anti-proliferative protein PC3;, PF07742;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0003714;GO:0009952;GO:0008306;GO:0006974;GO:0021954;GO:0021542;GO:0006977;GO:0006281;GO:0008285;GO:0045930;GO:2000178;GO:0043524;GO:0000122;GO:0017148;GO:0031175;GO:0060213;GO:0006479;GO:0051602;GO:0009612;GO:0014070;GO:0043434;GO:0035914;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:transcription corepressor activity;, P:anterior/posterior pattern specification; P:associative learning; P:cellular response to DNA damage stimulus; P:central nervous system neuron development; P:dentate gyrus development; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:DNA repair; P:negative regulation of cell population proliferation; P:negative regulation of mitotic cell cycle; P:negative regulation of neural precursor cell proliferation; P:negative regulation of neuron apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of translation; P:neuron projection development; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:protein methylation; P:response to electrical stimulus; P:response to mechanical stimulus; P:response to organic cyclic compound; P:response to peptide hormone; P:skeletal muscle cell differentiation; scaffold135 indexed_genome mRNA 544436 545157 . + . ID=transcript_14251;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold135 indexed_genome mRNA 554257 564329 . - . ID=transcript_14252;Q06828 Q15331 Q8IV47,Fibromodulin,Collagen-binding 59 kDa protein;Keratan sulfate proteoglycan fibromodulin;, PF13855;PF01462;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0043202;GO:0030199;GO:0018146;GO:0042340;GO:0007181;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:lysosomal lumen;, , P:collagen fibril organization; P:keratan sulfate biosynthetic process; P:keratan sulfate catabolic process; P:transforming growth factor beta receptor complex assembly; scaffold135 indexed_genome mRNA 689141 703579 . + . ID=transcript_14253;P51888 Q6FG38,Prolargin,Proline-arginine-rich end leucine-rich repeat protein;, PF00560;PF13855;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:1903561;GO:0005796;GO:0043202;GO:0005201;GO:0030021;GO:0008201;GO:0007569;GO:0018146;GO:0042340;GO:0001501;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:Golgi lumen; C:lysosomal lumen;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring compression resistance; F:heparin binding;, P:cell aging; P:keratan sulfate biosynthetic process; P:keratan sulfate catabolic process; P:skeletal system development; scaffold135 indexed_genome mRNA 898990 951795 . + . ID=transcript_14254;P23634 B1APW5 B1APW6 Q13450 Q13452 Q13455 Q16817 Q7Z3S1,Plasma membrane calcium-transporting ATPase 4 {ECO:0000305},Matrix-remodeling-associated protein 1;Plasma membrane calcium ATPase isoform 4;Plasma membrane calcium pump isoform 4;, PF12424;PF00689;PF00690;, GO:0016323;GO:0005901;GO:0098978;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0043005;GO:0005886;GO:0032991;GO:0036126;GO:0097228;GO:0030315;GO:0030018;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:0048306;GO:0005516;GO:0046872;GO:0050998;GO:0036487;GO:0030165;GO:0019901;GO:0030346;GO:0097110;GO:0017080;GO:1901660;GO:0098703;GO:0097553;GO:0070588;GO:0006874;GO:1905145;GO:0071872;GO:0030317;GO:0021766;GO:0034220;GO:0140199;GO:0016525;GO:1900082;GO:0043537;GO:0070885;GO:1903243;GO:1902548;GO:1903249;GO:0010629;GO:0045019;GO:0010751;GO:0051001;GO:1902083;GO:0098736;GO:0003407;GO:2000481;GO:0033138;GO:1903078;GO:1903779;GO:1902806;GO:0051480;GO:1902305;GO:0006357;GO:0051599;GO:0007283;GO:0150104;GO:0014832;, C:basolateral plasma membrane; C:caveola; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:protein-containing complex; C:sperm flagellum; C:sperm principal piece; C:T-tubule; C:Z disc;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-dependent protein binding; F:calmodulin binding; F:metal ion binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase inhibitor activity; F:PDZ domain binding; F:protein kinase binding; F:protein phosphatase 2B binding; F:scaffold protein binding; F:sodium channel regulator activity;, P:calcium ion export; P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:cellular response to acetylcholine; P:cellular response to epinephrine stimulus; P:flagellated sperm motility; P:hippocampus development; P:ion transmembrane transport; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:negative regulation of angiogenesis; P:negative regulation of arginine catabolic process; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of cellular response to vascular endothelial growth factor stimulus; P:negative regulation of citrulline biosynthetic process; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric oxide mediated signal transduction; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of the force of heart contraction; P:neural retina development; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein localization to plasma membrane; P:regulation of cardiac conduction; P:regulation of cell cycle G1/S phase transition; P:regulation of cytosolic calcium ion concentration; P:regulation of sodium ion transmembrane transport; P:regulation of transcription by RNA polymerase II; P:response to hydrostatic pressure; P:spermatogenesis; P:transport across blood-brain barrier; P:urinary bladder smooth muscle contraction;|P23634 B1APW5 B1APW6 Q13450 Q13452 Q13455 Q16817 Q7Z3S1,Plasma membrane calcium-transporting ATPase 4 {ECO:0000305},Matrix-remodeling-associated protein 1;Plasma membrane calcium ATPase isoform 4;Plasma membrane calcium pump isoform 4;, PF12424;PF00689;PF00690;, GO:0016323;GO:0005901;GO:0098978;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0043005;GO:0005886;GO:0032991;GO:0036126;GO:0097228;GO:0030315;GO:0030018;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:0048306;GO:0005516;GO:0046872;GO:0050998;GO:0036487;GO:0030165;GO:0019901;GO:0030346;GO:0097110;GO:0017080;GO:1901660;GO:0098703;GO:0097553;GO:0070588;GO:0006874;GO:1905145;GO:0071872;GO:0030317;GO:0021766;GO:0034220;GO:0140199;GO:0016525;GO:1900082;GO:0043537;GO:0070885;GO:1903243;GO:1902548;GO:1903249;GO:0010629;GO:0045019;GO:0010751;GO:0051001;GO:1902083;GO:0098736;GO:0003407;GO:2000481;GO:0033138;GO:1903078;GO:1903779;GO:1902806;GO:0051480;GO:1902305;GO:0006357;GO:0051599;GO:0007283;GO:0150104;GO:0014832;, C:basolateral plasma membrane; C:caveola; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:protein-containing complex; C:sperm flagellum; C:sperm principal piece; C:T-tubule; C:Z disc;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-dependent protein binding; F:calmodulin binding; F:metal ion binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase inhibitor activity; F:PDZ domain binding; F:protein kinase binding; F:protein phosphatase 2B binding; F:scaffold protein binding; F:sodium channel regulator activity;, P:calcium ion export; P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:cellular response to acetylcholine; P:cellular response to epinephrine stimulus; P:flagellated sperm motility; P:hippocampus development; P:ion transmembrane transport; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:negative regulation of angiogenesis; P:negative regulation of arginine catabolic process; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of cellular response to vascular endothelial growth factor stimulus; P:negative regulation of citrulline biosynthetic process; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric oxide mediated signal transduction; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of the force of heart contraction; P:neural retina development; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein localization to plasma membrane; P:regulation of cardiac conduction; P:regulation of cell cycle G1/S phase transition; P:regulation of cytosolic calcium ion concentration; P:regulation of sodium ion transmembrane transport; P:regulation of transcription by RNA polymerase II; P:response to hydrostatic pressure; P:spermatogenesis; P:transport across blood-brain barrier; P:urinary bladder smooth muscle contraction;|P23634 B1APW5 B1APW6 Q13450 Q13452 Q13455 Q16817 Q7Z3S1,Plasma membrane calcium-transporting ATPase 4 {ECO:0000305},Matrix-remodeling-associated protein 1;Plasma membrane calcium ATPase isoform 4;Plasma membrane calcium pump isoform 4;, PF12424;PF00689;PF00690;, GO:0016323;GO:0005901;GO:0098978;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0043005;GO:0005886;GO:0032991;GO:0036126;GO:0097228;GO:0030315;GO:0030018;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:0048306;GO:0005516;GO:0046872;GO:0050998;GO:0036487;GO:0030165;GO:0019901;GO:0030346;GO:0097110;GO:0017080;GO:1901660;GO:0098703;GO:0097553;GO:0070588;GO:0006874;GO:1905145;GO:0071872;GO:0030317;GO:0021766;GO:0034220;GO:0140199;GO:0016525;GO:1900082;GO:0043537;GO:0070885;GO:1903243;GO:1902548;GO:1903249;GO:0010629;GO:0045019;GO:0010751;GO:0051001;GO:1902083;GO:0098736;GO:0003407;GO:2000481;GO:0033138;GO:1903078;GO:1903779;GO:1902806;GO:0051480;GO:1902305;GO:0006357;GO:0051599;GO:0007283;GO:0150104;GO:0014832;, C:basolateral plasma membrane; C:caveola; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:protein-containing complex; C:sperm flagellum; C:sperm principal piece; C:T-tubule; C:Z disc;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-dependent protein binding; F:calmodulin binding; F:metal ion binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase inhibitor activity; F:PDZ domain binding; F:protein kinase binding; F:protein phosphatase 2B binding; F:scaffold protein binding; F:sodium channel regulator activity;, P:calcium ion export; P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:cellular response to acetylcholine; P:cellular response to epinephrine stimulus; P:flagellated sperm motility; P:hippocampus development; P:ion transmembrane transport; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:negative regulation of angiogenesis; P:negative regulation of arginine catabolic process; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of cellular response to vascular endothelial growth factor stimulus; P:negative regulation of citrulline biosynthetic process; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric oxide mediated signal transduction; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of the force of heart contraction; P:neural retina development; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein localization to plasma membrane; P:regulation of cardiac conduction; P:regulation of cell cycle G1/S phase transition; P:regulation of cytosolic calcium ion concentration; P:regulation of sodium ion transmembrane transport; P:regulation of transcription by RNA polymerase II; P:response to hydrostatic pressure; P:spermatogenesis; P:transport across blood-brain barrier; P:urinary bladder smooth muscle contraction;|P23634 B1APW5 B1APW6 Q13450 Q13452 Q13455 Q16817 Q7Z3S1,Plasma membrane calcium-transporting ATPase 4 {ECO:0000305},Matrix-remodeling-associated protein 1;Plasma membrane calcium ATPase isoform 4;Plasma membrane calcium pump isoform 4;, PF12424;PF00689;PF00690;, GO:0016323;GO:0005901;GO:0098978;GO:0005887;GO:0099059;GO:0043231;GO:0016020;GO:0045121;GO:0043005;GO:0005886;GO:0032991;GO:0036126;GO:0097228;GO:0030315;GO:0030018;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:0048306;GO:0005516;GO:0046872;GO:0050998;GO:0036487;GO:0030165;GO:0019901;GO:0030346;GO:0097110;GO:0017080;GO:1901660;GO:0098703;GO:0097553;GO:0070588;GO:0006874;GO:1905145;GO:0071872;GO:0030317;GO:0021766;GO:0034220;GO:0140199;GO:0016525;GO:1900082;GO:0043537;GO:0070885;GO:1903243;GO:1902548;GO:1903249;GO:0010629;GO:0045019;GO:0010751;GO:0051001;GO:1902083;GO:0098736;GO:0003407;GO:2000481;GO:0033138;GO:1903078;GO:1903779;GO:1902806;GO:0051480;GO:1902305;GO:0006357;GO:0051599;GO:0007283;GO:0150104;GO:0014832;, C:basolateral plasma membrane; C:caveola; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:protein-containing complex; C:sperm flagellum; C:sperm principal piece; C:T-tubule; C:Z disc;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-dependent protein binding; F:calmodulin binding; F:metal ion binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase inhibitor activity; F:PDZ domain binding; F:protein kinase binding; F:protein phosphatase 2B binding; F:scaffold protein binding; F:sodium channel regulator activity;, P:calcium ion export; P:calcium ion import across plasma membrane; P:calcium ion transmembrane import into cytosol; P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:cellular response to acetylcholine; P:cellular response to epinephrine stimulus; P:flagellated sperm motility; P:hippocampus development; P:ion transmembrane transport; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; P:negative regulation of angiogenesis; P:negative regulation of arginine catabolic process; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cardiac muscle hypertrophy in response to stress; P:negative regulation of cellular response to vascular endothelial growth factor stimulus; P:negative regulation of citrulline biosynthetic process; P:negative regulation of gene expression; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of nitric oxide mediated signal transduction; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of peptidyl-cysteine S-nitrosylation; P:negative regulation of the force of heart contraction; P:neural retina development; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein localization to plasma membrane; P:regulation of cardiac conduction; P:regulation of cell cycle G1/S phase transition; P:regulation of cytosolic calcium ion concentration; P:regulation of sodium ion transmembrane transport; P:regulation of transcription by RNA polymerase II; P:response to hydrostatic pressure; P:spermatogenesis; P:transport across blood-brain barrier; P:urinary bladder smooth muscle contraction; scaffold135 indexed_genome mRNA 971296 972185 . + . ID=transcript_14255;Q8IWV1 B7Z744 J3KP69 Q6NSZ6 Q9NXB4,Lymphocyte transmembrane adapter 1,Linker for activation of X cells;Membrane-associated adapter protein LAX;, PF15681;, GO:0005829;GO:0005794;GO:0016021;GO:0016020;GO:0005886;GO:0019901;GO:0042169;GO:0002250;GO:0050851;GO:0042113;GO:0006955;GO:0000188;GO:0035556;GO:0046649;GO:0050868;, C:cytosol; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:plasma membrane;, F:protein kinase binding; F:SH2 domain binding;, P:adaptive immune response; P:antigen receptor-mediated signaling pathway; P:B cell activation; P:immune response; P:inactivation of MAPK activity; P:intracellular signal transduction; P:lymphocyte activation; P:negative regulation of T cell activation; scaffold135 indexed_genome mRNA 1058012 1065152 . + . ID=transcript_14256;P86452,Zinc finger BED domain-containing protein 6 {ECO:0000303|PubMed:20016685},, PF05699;PF02892;, GO:0000785;GO:0005737;GO:0005730;GO:0005634;GO:0000981;GO:0046872;GO:0046983;GO:0000976;GO:0001835;GO:0060548;GO:0051148;GO:0000122;GO:0045892;GO:0045787;GO:0061178;GO:0006357;GO:0003309;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:protein dimerization activity; F:transcription regulatory region sequence-specific DNA binding;, P:blastocyst hatching; P:negative regulation of cell death; P:negative regulation of muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II; P:type B pancreatic cell differentiation; scaffold135 indexed_genome mRNA 1065256 1124075 . + . ID=transcript_14257;O75152 Q6AHY4 Q6AHY9 Q6AW79 Q6AWA1 Q6PJK4 Q86XZ7,Zinc finger CCCH domain-containing protein 11A,, PF15663;, GO:0005654;GO:0046872;GO:0003729;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0006405;, C:nucleoplasm;, F:metal ion binding; F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|P62304 B2R5B9 P08578 Q15498 Q5BKT2,Small nuclear ribonucleoprotein E,Sm protein E;, PF01423;, GO:0071013;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0034715;GO:0071011;GO:0030532;GO:0034719;GO:0005681;GO:0005697;GO:0005685;GO:0005689;GO:0005686;GO:0071007;GO:0071005;GO:0005687;GO:0046540;GO:0005682;GO:0005683;GO:0003723;GO:0042633;GO:0008334;GO:0051170;GO:0000398;GO:0000245;GO:0000387;GO:0006369;, C:catalytic step 2 spliceosome; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:precatalytic spliceosome; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal complex; C:telomerase holoenzyme complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:U7 snRNP;, F:RNA binding;, P:hair cycle; P:histone mRNA metabolic process; P:import into nucleus; P:mRNA splicing, via spliceosome; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly; P:termination of RNA polymerase II transcription;|A0A1B0GTU1,Zinc finger CCCH domain-containing protein 11B {ECO:0000305},, PF15663;, GO:0046872;GO:0003729;GO:0016973;, , F:metal ion binding; F:mRNA binding;, P:poly(A)+ mRNA export from nucleus;|O75152 Q6AHY4 Q6AHY9 Q6AW79 Q6AWA1 Q6PJK4 Q86XZ7,Zinc finger CCCH domain-containing protein 11A,, PF15663;, GO:0005654;GO:0046872;GO:0003729;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0006405;, C:nucleoplasm;, F:metal ion binding; F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; scaffold135 indexed_genome mRNA 1378957 1380104 . + . ID=transcript_14258;Q9UN79 B4E2B0 O95275 O95826 Q3KQV7 Q5SXX1 Q9UHW7,Transcription factor SOX-13,Islet cell antigen 12;SRY (Sex determining region Y)-box 13;Type 1 diabetes autoantigen ICA12;, PF00505;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001217;GO:0001227;GO:0042802;GO:0000978;GO:0043565;GO:0000976;GO:0009653;GO:0045165;GO:0042492;GO:0090090;GO:0000122;GO:0045892;GO:0090336;GO:0045588;GO:0006357;GO:0006355;GO:0021529;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell fate commitment; P:gamma-delta T cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of brown fat cell differentiation; P:positive regulation of gamma-delta T cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spinal cord oligodendrocyte cell differentiation; scaffold135 indexed_genome mRNA 1382644 1383894 . - . ID=transcript_14259;Q9UN79 B4E2B0 O95275 O95826 Q3KQV7 Q5SXX1 Q9UHW7,Transcription factor SOX-13,Islet cell antigen 12;SRY (Sex determining region Y)-box 13;Type 1 diabetes autoantigen ICA12;, PF00505;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001217;GO:0001227;GO:0042802;GO:0000978;GO:0043565;GO:0000976;GO:0009653;GO:0045165;GO:0042492;GO:0090090;GO:0000122;GO:0045892;GO:0090336;GO:0045588;GO:0006357;GO:0006355;GO:0021529;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell fate commitment; P:gamma-delta T cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of brown fat cell differentiation; P:positive regulation of gamma-delta T cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spinal cord oligodendrocyte cell differentiation; scaffold135 indexed_genome mRNA 1389623 1393583 . + . ID=transcript_14260;Q9UN79 B4E2B0 O95275 O95826 Q3KQV7 Q5SXX1 Q9UHW7,Transcription factor SOX-13,Islet cell antigen 12;SRY (Sex determining region Y)-box 13;Type 1 diabetes autoantigen ICA12;, PF00505;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001217;GO:0001227;GO:0042802;GO:0000978;GO:0043565;GO:0000976;GO:0009653;GO:0045165;GO:0042492;GO:0090090;GO:0000122;GO:0045892;GO:0090336;GO:0045588;GO:0006357;GO:0006355;GO:0021529;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell fate commitment; P:gamma-delta T cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of brown fat cell differentiation; P:positive regulation of gamma-delta T cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spinal cord oligodendrocyte cell differentiation;|Q9UN79 B4E2B0 O95275 O95826 Q3KQV7 Q5SXX1 Q9UHW7,Transcription factor SOX-13,Islet cell antigen 12;SRY (Sex determining region Y)-box 13;Type 1 diabetes autoantigen ICA12;, PF00505;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001217;GO:0001227;GO:0042802;GO:0000978;GO:0043565;GO:0000976;GO:0009653;GO:0045165;GO:0042492;GO:0090090;GO:0000122;GO:0045892;GO:0090336;GO:0045588;GO:0006357;GO:0006355;GO:0021529;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell fate commitment; P:gamma-delta T cell differentiation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of brown fat cell differentiation; P:positive regulation of gamma-delta T cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spinal cord oligodendrocyte cell differentiation; scaffold135 indexed_genome mRNA 1396649 1412891 . - . ID=transcript_14261;Q9NVF9 B7Z7K1 Q5SXX5 Q68CK3 Q96G05,Ethanolamine kinase 2,Ethanolamine kinase-like protein;, , GO:0005829;GO:0005524;GO:0004305;GO:0001701;GO:0035264;GO:0006646;GO:0001890;GO:0009791;, C:cytosol;, F:ATP binding; F:ethanolamine kinase activity;, P:in utero embryonic development; P:multicellular organism growth; P:phosphatidylethanolamine biosynthetic process; P:placenta development; P:post-embryonic development;|Q9NVF9 B7Z7K1 Q5SXX5 Q68CK3 Q96G05,Ethanolamine kinase 2,Ethanolamine kinase-like protein;, , GO:0005829;GO:0005524;GO:0004305;GO:0001701;GO:0035264;GO:0006646;GO:0001890;GO:0009791;, C:cytosol;, F:ATP binding; F:ethanolamine kinase activity;, P:in utero embryonic development; P:multicellular organism growth; P:phosphatidylethanolamine biosynthetic process; P:placenta development; P:post-embryonic development;|Q9NVF9 B7Z7K1 Q5SXX5 Q68CK3 Q96G05,Ethanolamine kinase 2,Ethanolamine kinase-like protein;, , GO:0005829;GO:0005524;GO:0004305;GO:0001701;GO:0035264;GO:0006646;GO:0001890;GO:0009791;, C:cytosol;, F:ATP binding; F:ethanolamine kinase activity;, P:in utero embryonic development; P:multicellular organism growth; P:phosphatidylethanolamine biosynthetic process; P:placenta development; P:post-embryonic development;|Q9NVF9 B7Z7K1 Q5SXX5 Q68CK3 Q96G05,Ethanolamine kinase 2,Ethanolamine kinase-like protein;, , GO:0005829;GO:0005524;GO:0004305;GO:0001701;GO:0035264;GO:0006646;GO:0001890;GO:0009791;, C:cytosol;, F:ATP binding; F:ethanolamine kinase activity;, P:in utero embryonic development; P:multicellular organism growth; P:phosphatidylethanolamine biosynthetic process; P:placenta development; P:post-embryonic development;|Q9NVF9 B7Z7K1 Q5SXX5 Q68CK3 Q96G05,Ethanolamine kinase 2,Ethanolamine kinase-like protein;, , GO:0005829;GO:0005524;GO:0004305;GO:0001701;GO:0035264;GO:0006646;GO:0001890;GO:0009791;, C:cytosol;, F:ATP binding; F:ethanolamine kinase activity;, P:in utero embryonic development; P:multicellular organism growth; P:phosphatidylethanolamine biosynthetic process; P:placenta development; P:post-embryonic development; scaffold135 indexed_genome mRNA 1454633 1458112 . - . ID=transcript_14262;Q6ZVE7,Vesicle transport protein GOT1A,Golgi transport 1 homolog A;hGOT1b;, PF04178;, GO:0005783;GO:0000137;GO:0000139;GO:0016021;GO:0016020;GO:0005635;GO:0005802;GO:0006888;GO:0015031;, C:endoplasmic reticulum; C:Golgi cis cisterna; C:Golgi membrane; C:integral component of membrane; C:membrane; C:nuclear envelope; C:trans-Golgi network;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; scaffold135 indexed_genome mRNA 1481633 1488622 . - . ID=transcript_14263;Q9Y2H5 A7MD51 Q5VTI6,Pleckstrin homology domain-containing family A member 6,Phosphoinositol 3-phosphate-binding protein 3;, PF00169;|Q9Y2H5 A7MD51 Q5VTI6,Pleckstrin homology domain-containing family A member 6,Phosphoinositol 3-phosphate-binding protein 3;, PF00169;|Q9Y2H5 A7MD51 Q5VTI6,Pleckstrin homology domain-containing family A member 6,Phosphoinositol 3-phosphate-binding protein 3;, PF00169; scaffold135 indexed_genome mRNA 1489665 1608700 . - . ID=transcript_14264;Q9Y2H5 A7MD51 Q5VTI6,Pleckstrin homology domain-containing family A member 6,Phosphoinositol 3-phosphate-binding protein 3;, PF00169;|Q9Y2H5 A7MD51 Q5VTI6,Pleckstrin homology domain-containing family A member 6,Phosphoinositol 3-phosphate-binding protein 3;, PF00169;|Q9Y2H5 A7MD51 Q5VTI6,Pleckstrin homology domain-containing family A member 6,Phosphoinositol 3-phosphate-binding protein 3;, PF00169;|Q9BVR4 Q9C0H7 Q9H924 Q9NVK8,Pleckstrin homology domain-containing family A member 5,Phosphoinositol 3-phosphate-binding protein 2;, PF00169;PF00397;, GO:0005829;GO:0098978;GO:0016020;GO:0005654;GO:0014069;GO:0080025;GO:0032266;GO:0070273;GO:0010314;GO:0061458;, C:cytosol; C:glutamatergic synapse; C:membrane; C:nucleoplasm; C:postsynaptic density;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:reproductive system development; scaffold135 indexed_genome mRNA 1638966 1641796 . - . ID=transcript_14265;Q5SWA1 Q53GQ4 Q658M2 Q6P156 Q96SN1,Protein phosphatase 1 regulatory subunit 15B,, PF10472;PF10488;, GO:0005783;GO:0000164;GO:0019888;GO:0006983;GO:1903912;GO:1903898;GO:0001933;GO:0070262;GO:0032516;GO:0034976;GO:0042542;, C:endoplasmic reticulum; C:protein phosphatase type 1 complex;, F:protein phosphatase regulator activity;, P:ER overload response; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of protein phosphorylation; P:peptidyl-serine dephosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:response to endoplasmic reticulum stress; P:response to hydrogen peroxide; scaffold135 indexed_genome mRNA 1641828 1645054 . - . ID=transcript_14266;Q5SWA1 Q53GQ4 Q658M2 Q6P156 Q96SN1,Protein phosphatase 1 regulatory subunit 15B,, PF10472;PF10488;, GO:0005783;GO:0000164;GO:0019888;GO:0006983;GO:1903912;GO:1903898;GO:0001933;GO:0070262;GO:0032516;GO:0034976;GO:0042542;, C:endoplasmic reticulum; C:protein phosphatase type 1 complex;, F:protein phosphatase regulator activity;, P:ER overload response; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of protein phosphorylation; P:peptidyl-serine dephosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:response to endoplasmic reticulum stress; P:response to hydrogen peroxide; scaffold135 indexed_genome mRNA 1653630 1687521 . - . ID=transcript_14267;O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling;|O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling;|O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling;|O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling;|O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling;|O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling;|O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling;|O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling;|O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling; scaffold135 indexed_genome mRNA 1689628 1704293 . - . ID=transcript_14268;O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling;|O00750 O95666 Q5SW99,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,C2-PI3K;Phosphoinositide 3-kinase-C2-beta;, PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;, GO:0005737;GO:0005829;GO:0030139;GO:0005783;GO:0043231;GO:0016020;GO:0005654;GO:0005942;GO:0005886;GO:0016303;GO:0035005;GO:0005524;GO:0001727;GO:0035091;GO:0052742;GO:1905037;GO:0016477;GO:0009267;GO:0014065;GO:0006661;GO:0046854;GO:0036092;GO:0048015;GO:0043491;, C:cytoplasm; C:cytosol; C:endocytic vesicle; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:phosphatidylinositol 3-kinase complex; C:plasma membrane;, F:1-phosphatidylinositol-3-kinase activity; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; F:ATP binding; F:lipid kinase activity; F:phosphatidylinositol binding; F:phosphatidylinositol kinase activity;, P:autophagosome organization; P:cell migration; P:cellular response to starvation; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-3-phosphate biosynthetic process; P:phosphatidylinositol-mediated signaling; P:protein kinase B signaling; scaffold135 indexed_genome mRNA 1741123 1766271 . + . ID=transcript_14269;O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83,Protein Mdm4,Double minute 4 protein;Mdm2-like p53-binding protein;Protein Mdmx;p53-binding protein Mdm4;, PF02201;PF00641;, GO:0005654;GO:0005634;GO:0019899;GO:0008270;GO:0003283;GO:0003181;GO:0071456;GO:0030330;GO:0006977;GO:0003203;GO:0003170;GO:0043066;GO:0071157;GO:0008285;GO:0042177;GO:0000122;GO:0045944;GO:0016579;GO:0050821;GO:0065003;GO:1901796;GO:0006357;GO:0003281;, C:nucleoplasm; C:nucleus;, F:enzyme binding; F:zinc ion binding;, P:atrial septum development; P:atrioventricular valve morphogenesis; P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:endocardial cushion morphogenesis; P:heart valve development; P:negative regulation of apoptotic process; P:negative regulation of cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of protein catabolic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein stabilization; P:protein-containing complex assembly; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:ventricular septum development; scaffold135 indexed_genome mRNA 1767924 1785418 . + . ID=transcript_14270;O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83,Protein Mdm4,Double minute 4 protein;Mdm2-like p53-binding protein;Protein Mdmx;p53-binding protein Mdm4;, PF02201;PF00641;, GO:0005654;GO:0005634;GO:0019899;GO:0008270;GO:0003283;GO:0003181;GO:0071456;GO:0030330;GO:0006977;GO:0003203;GO:0003170;GO:0043066;GO:0071157;GO:0008285;GO:0042177;GO:0000122;GO:0045944;GO:0016579;GO:0050821;GO:0065003;GO:1901796;GO:0006357;GO:0003281;, C:nucleoplasm; C:nucleus;, F:enzyme binding; F:zinc ion binding;, P:atrial septum development; P:atrioventricular valve morphogenesis; P:cellular response to hypoxia; P:DNA damage response, signal transduction by p53 class mediator; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:endocardial cushion morphogenesis; P:heart valve development; P:negative regulation of apoptotic process; P:negative regulation of cell cycle arrest; P:negative regulation of cell population proliferation; P:negative regulation of protein catabolic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein stabilization; P:protein-containing complex assembly; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:ventricular septum development; scaffold135 indexed_genome mRNA 1845061 1847556 . + . ID=transcript_14271;O75325 B2R624 Q5T0Y0 Q6UXM0 Q8N182,Leucine-rich repeat neuronal protein 2,Glioma amplified on chromosome 1 protein;Leucine-rich repeat neuronal protein 5;, PF07679;PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0038023;GO:0007155;GO:0007165;, C:extracellular matrix; C:extracellular space; C:integral component of membrane;, F:signaling receptor activity;, P:cell adhesion; P:signal transduction; scaffold135 indexed_genome mRNA 2222688 2274729 . + . ID=transcript_14272;Q68DH3 Q6ZQV6 Q7Z3K1 Q96HT1 Q96K50,Neurofascin,, PF13882;PF00041;PF07679;PF00047;, GO:0043194;GO:0030425;GO:0101003;GO:0005925;GO:0005887;GO:0033268;GO:0033010;GO:0005886;GO:0097454;GO:0019904;GO:0007411;GO:0007155;GO:0042552;GO:0043312;GO:0007422;GO:0072659;GO:0050808;GO:0019226;, C:axon initial segment; C:dendrite; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integral component of plasma membrane; C:node of Ranvier; C:paranodal junction; C:plasma membrane; C:Schwann cell microvillus;, F:protein domain specific binding;, P:axon guidance; P:cell adhesion; P:myelination; P:neutrophil degranulation; P:peripheral nervous system development; P:protein localization to plasma membrane; P:synapse organization; P:transmission of nerve impulse;|Q68DH3 Q6ZQV6 Q7Z3K1 Q96HT1 Q96K50,Neurofascin,, PF13882;PF00041;PF07679;PF00047;, GO:0043194;GO:0030425;GO:0101003;GO:0005925;GO:0005887;GO:0033268;GO:0033010;GO:0005886;GO:0097454;GO:0019904;GO:0007411;GO:0007155;GO:0042552;GO:0043312;GO:0007422;GO:0072659;GO:0050808;GO:0019226;, C:axon initial segment; C:dendrite; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integral component of plasma membrane; C:node of Ranvier; C:paranodal junction; C:plasma membrane; C:Schwann cell microvillus;, F:protein domain specific binding;, P:axon guidance; P:cell adhesion; P:myelination; P:neutrophil degranulation; P:peripheral nervous system development; P:protein localization to plasma membrane; P:synapse organization; P:transmission of nerve impulse;|Q68DH3 Q6ZQV6 Q7Z3K1 Q96HT1 Q96K50,Neurofascin,, PF13882;PF00041;PF07679;PF00047;, GO:0043194;GO:0030425;GO:0101003;GO:0005925;GO:0005887;GO:0033268;GO:0033010;GO:0005886;GO:0097454;GO:0019904;GO:0007411;GO:0007155;GO:0042552;GO:0043312;GO:0007422;GO:0072659;GO:0050808;GO:0019226;, C:axon initial segment; C:dendrite; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integral component of plasma membrane; C:node of Ranvier; C:paranodal junction; C:plasma membrane; C:Schwann cell microvillus;, F:protein domain specific binding;, P:axon guidance; P:cell adhesion; P:myelination; P:neutrophil degranulation; P:peripheral nervous system development; P:protein localization to plasma membrane; P:synapse organization; P:transmission of nerve impulse;|Q68DH3 Q6ZQV6 Q7Z3K1 Q96HT1 Q96K50,Neurofascin,, PF13882;PF00041;PF07679;PF00047;, GO:0043194;GO:0030425;GO:0101003;GO:0005925;GO:0005887;GO:0033268;GO:0033010;GO:0005886;GO:0097454;GO:0019904;GO:0007411;GO:0007155;GO:0042552;GO:0043312;GO:0007422;GO:0072659;GO:0050808;GO:0019226;, C:axon initial segment; C:dendrite; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integral component of plasma membrane; C:node of Ranvier; C:paranodal junction; C:plasma membrane; C:Schwann cell microvillus;, F:protein domain specific binding;, P:axon guidance; P:cell adhesion; P:myelination; P:neutrophil degranulation; P:peripheral nervous system development; P:protein localization to plasma membrane; P:synapse organization; P:transmission of nerve impulse;|Q68DH3 Q6ZQV6 Q7Z3K1 Q96HT1 Q96K50,Neurofascin,, PF13882;PF00041;PF07679;PF00047;, GO:0043194;GO:0030425;GO:0101003;GO:0005925;GO:0005887;GO:0033268;GO:0033010;GO:0005886;GO:0097454;GO:0019904;GO:0007411;GO:0007155;GO:0042552;GO:0043312;GO:0007422;GO:0072659;GO:0050808;GO:0019226;, C:axon initial segment; C:dendrite; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integral component of plasma membrane; C:node of Ranvier; C:paranodal junction; C:plasma membrane; C:Schwann cell microvillus;, F:protein domain specific binding;, P:axon guidance; P:cell adhesion; P:myelination; P:neutrophil degranulation; P:peripheral nervous system development; P:protein localization to plasma membrane; P:synapse organization; P:transmission of nerve impulse; scaffold135 indexed_genome mRNA 2275795 2282538 . + . ID=transcript_14273;Q68DH3 Q6ZQV6 Q7Z3K1 Q96HT1 Q96K50,Neurofascin,, PF13882;PF00041;PF07679;PF00047;, GO:0043194;GO:0030425;GO:0101003;GO:0005925;GO:0005887;GO:0033268;GO:0033010;GO:0005886;GO:0097454;GO:0019904;GO:0007411;GO:0007155;GO:0042552;GO:0043312;GO:0007422;GO:0072659;GO:0050808;GO:0019226;, C:axon initial segment; C:dendrite; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integral component of plasma membrane; C:node of Ranvier; C:paranodal junction; C:plasma membrane; C:Schwann cell microvillus;, F:protein domain specific binding;, P:axon guidance; P:cell adhesion; P:myelination; P:neutrophil degranulation; P:peripheral nervous system development; P:protein localization to plasma membrane; P:synapse organization; P:transmission of nerve impulse; scaffold135 indexed_genome mRNA 2283781 2287191 . + . ID=transcript_14274;Q68DH3 Q6ZQV6 Q7Z3K1 Q96HT1 Q96K50,Neurofascin,, PF13882;PF00041;PF07679;PF00047;, GO:0043194;GO:0030425;GO:0101003;GO:0005925;GO:0005887;GO:0033268;GO:0033010;GO:0005886;GO:0097454;GO:0019904;GO:0007411;GO:0007155;GO:0042552;GO:0043312;GO:0007422;GO:0072659;GO:0050808;GO:0019226;, C:axon initial segment; C:dendrite; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integral component of plasma membrane; C:node of Ranvier; C:paranodal junction; C:plasma membrane; C:Schwann cell microvillus;, F:protein domain specific binding;, P:axon guidance; P:cell adhesion; P:myelination; P:neutrophil degranulation; P:peripheral nervous system development; P:protein localization to plasma membrane; P:synapse organization; P:transmission of nerve impulse; scaffold135 indexed_genome mRNA 2287262 2297734 . + . ID=transcript_14275;Q68DH3 Q6ZQV6 Q7Z3K1 Q96HT1 Q96K50,Neurofascin,, PF13882;PF00041;PF07679;PF00047;, GO:0043194;GO:0030425;GO:0101003;GO:0005925;GO:0005887;GO:0033268;GO:0033010;GO:0005886;GO:0097454;GO:0019904;GO:0007411;GO:0007155;GO:0042552;GO:0043312;GO:0007422;GO:0072659;GO:0050808;GO:0019226;, C:axon initial segment; C:dendrite; C:ficolin-1-rich granule membrane; C:focal adhesion; C:integral component of plasma membrane; C:node of Ranvier; C:paranodal junction; C:plasma membrane; C:Schwann cell microvillus;, F:protein domain specific binding;, P:axon guidance; P:cell adhesion; P:myelination; P:neutrophil degranulation; P:peripheral nervous system development; P:protein localization to plasma membrane; P:synapse organization; P:transmission of nerve impulse; scaffold135 indexed_genome mRNA 2332676 2349074 . + . ID=transcript_14276;Q02246 P78432 Q5T054,Contactin-2,Axonal glycoprotein TAG-1;Axonin-1;Transient axonal glycoprotein 1;, PF00041;PF07679;, GO:0099025;GO:0030424;GO:0044224;GO:0043209;GO:0033268;GO:0005886;GO:0045202;GO:0098632;GO:0042802;GO:0007411;GO:0007155;GO:0045163;GO:0070593;GO:0007156;GO:0097090;GO:0071205;, C:anchored component of postsynaptic membrane; C:axon; C:juxtaparanode region of axon; C:myelin sheath; C:node of Ranvier; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:identical protein binding;, P:axon guidance; P:cell adhesion; P:clustering of voltage-gated potassium channels; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:presynaptic membrane organization; P:protein localization to juxtaparanode region of axon;|Q02246 P78432 Q5T054,Contactin-2,Axonal glycoprotein TAG-1;Axonin-1;Transient axonal glycoprotein 1;, PF00041;PF07679;, GO:0099025;GO:0030424;GO:0044224;GO:0043209;GO:0033268;GO:0005886;GO:0045202;GO:0098632;GO:0042802;GO:0007411;GO:0007155;GO:0045163;GO:0070593;GO:0007156;GO:0097090;GO:0071205;, C:anchored component of postsynaptic membrane; C:axon; C:juxtaparanode region of axon; C:myelin sheath; C:node of Ranvier; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:identical protein binding;, P:axon guidance; P:cell adhesion; P:clustering of voltage-gated potassium channels; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:presynaptic membrane organization; P:protein localization to juxtaparanode region of axon;|Q02246 P78432 Q5T054,Contactin-2,Axonal glycoprotein TAG-1;Axonin-1;Transient axonal glycoprotein 1;, PF00041;PF07679;, GO:0099025;GO:0030424;GO:0044224;GO:0043209;GO:0033268;GO:0005886;GO:0045202;GO:0098632;GO:0042802;GO:0007411;GO:0007155;GO:0045163;GO:0070593;GO:0007156;GO:0097090;GO:0071205;, C:anchored component of postsynaptic membrane; C:axon; C:juxtaparanode region of axon; C:myelin sheath; C:node of Ranvier; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:identical protein binding;, P:axon guidance; P:cell adhesion; P:clustering of voltage-gated potassium channels; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:presynaptic membrane organization; P:protein localization to juxtaparanode region of axon;|Q02246 P78432 Q5T054,Contactin-2,Axonal glycoprotein TAG-1;Axonin-1;Transient axonal glycoprotein 1;, PF00041;PF07679;, GO:0099025;GO:0030424;GO:0044224;GO:0043209;GO:0033268;GO:0005886;GO:0045202;GO:0098632;GO:0042802;GO:0007411;GO:0007155;GO:0045163;GO:0070593;GO:0007156;GO:0097090;GO:0071205;, C:anchored component of postsynaptic membrane; C:axon; C:juxtaparanode region of axon; C:myelin sheath; C:node of Ranvier; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:identical protein binding;, P:axon guidance; P:cell adhesion; P:clustering of voltage-gated potassium channels; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:presynaptic membrane organization; P:protein localization to juxtaparanode region of axon;|Q02246 P78432 Q5T054,Contactin-2,Axonal glycoprotein TAG-1;Axonin-1;Transient axonal glycoprotein 1;, PF00041;PF07679;, GO:0099025;GO:0030424;GO:0044224;GO:0043209;GO:0033268;GO:0005886;GO:0045202;GO:0098632;GO:0042802;GO:0007411;GO:0007155;GO:0045163;GO:0070593;GO:0007156;GO:0097090;GO:0071205;, C:anchored component of postsynaptic membrane; C:axon; C:juxtaparanode region of axon; C:myelin sheath; C:node of Ranvier; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:identical protein binding;, P:axon guidance; P:cell adhesion; P:clustering of voltage-gated potassium channels; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:presynaptic membrane organization; P:protein localization to juxtaparanode region of axon;|Q02246 P78432 Q5T054,Contactin-2,Axonal glycoprotein TAG-1;Axonin-1;Transient axonal glycoprotein 1;, PF00041;PF07679;, GO:0099025;GO:0030424;GO:0044224;GO:0043209;GO:0033268;GO:0005886;GO:0045202;GO:0098632;GO:0042802;GO:0007411;GO:0007155;GO:0045163;GO:0070593;GO:0007156;GO:0097090;GO:0071205;, C:anchored component of postsynaptic membrane; C:axon; C:juxtaparanode region of axon; C:myelin sheath; C:node of Ranvier; C:plasma membrane; C:synapse;, F:cell-cell adhesion mediator activity; F:identical protein binding;, P:axon guidance; P:cell adhesion; P:clustering of voltage-gated potassium channels; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:presynaptic membrane organization; P:protein localization to juxtaparanode region of axon; scaffold135 indexed_genome mRNA 2351952 2394729 . - . ID=transcript_14277;Q15291 A8K272 Q7Z6D8 Q8NDZ7,Retinoblastoma-binding protein 5,Retinoblastoma-binding protein RBQ-3;, PF00400;, GO:0035097;GO:0071339;GO:0044666;GO:0005730;GO:0005654;GO:0005634;GO:0048188;GO:0035064;GO:0000976;GO:1904837;GO:0006974;GO:0051568;GO:0043687;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL1 complex; C:MLL3/4 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:methylated histone binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:histone H3-K4 methylation; P:post-translational protein modification; P:regulation of megakaryocyte differentiation; P:response to estrogen;|O15488 B7WNN6 O15485 O15486 O15487 O15489 O15490,Glycogenin-2,, PF01501;, GO:0005737;GO:0005829;GO:0008466;GO:0046872;GO:0016757;GO:0102751;GO:0005978;, C:cytoplasm; C:cytosol;, F:glycogenin glucosyltransferase activity; F:metal ion binding; F:transferase activity, transferring glycosyl groups; F:UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity;, P:glycogen biosynthetic process;|Q15291 A8K272 Q7Z6D8 Q8NDZ7,Retinoblastoma-binding protein 5,Retinoblastoma-binding protein RBQ-3;, PF00400;, GO:0035097;GO:0071339;GO:0044666;GO:0005730;GO:0005654;GO:0005634;GO:0048188;GO:0035064;GO:0000976;GO:1904837;GO:0006974;GO:0051568;GO:0043687;GO:0045652;GO:0043627;, C:histone methyltransferase complex; C:MLL1 complex; C:MLL3/4 complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:methylated histone binding; F:transcription regulatory region sequence-specific DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to DNA damage stimulus; P:histone H3-K4 methylation; P:post-translational protein modification; P:regulation of megakaryocyte differentiation; P:response to estrogen; scaffold135 indexed_genome mRNA 2407303 2408754 . + . ID=transcript_14278;Q99623 B4DP75 Q2YDA4 Q7KYU3 Q92978,Prohibitin-2,B-cell receptor-associated protein BAP37;D-prohibitin;Repressor of estrogen receptor activity;, PF01145;, GO:0030424;GO:0071944;GO:0009986;GO:0005737;GO:0098982;GO:0098978;GO:0005743;GO:0005741;GO:0035632;GO:0005739;GO:0016363;GO:0005634;GO:0005886;GO:0014069;GO:0048786;GO:0032991;GO:0033218;GO:0030331;GO:0042802;GO:0008022;GO:0046982;GO:0042803;GO:0047485;GO:0046625;GO:0007202;GO:1990051;GO:0140374;GO:0042113;GO:0023035;GO:0016477;GO:0071456;GO:0071300;GO:0039520;GO:0060749;GO:0060744;GO:0006851;GO:0007005;GO:0000423;GO:0043066;GO:0043433;GO:0033147;GO:0033600;GO:0045892;GO:1902808;GO:0051091;GO:0070374;GO:0031536;GO:0002639;GO:1901224;GO:0006606;GO:0050821;GO:0060762;GO:1900208;GO:1904959;GO:0009611;GO:0039529;GO:0007062;, C:axon; C:cell periphery; C:cell surface; C:cytoplasm; C:GABA-ergic synapse; C:glutamatergic synapse; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrial prohibitin complex; C:mitochondrion; C:nuclear matrix; C:nucleus; C:plasma membrane; C:postsynaptic density; C:presynaptic active zone; C:protein-containing complex;, F:amide binding; F:estrogen receptor binding; F:identical protein binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein N-terminus binding; F:sphingolipid binding;, P:activation of phospholipase C activity; P:activation of protein kinase C activity; P:antiviral innate immune response; P:B cell activation; P:CD40 signaling pathway; P:cell migration; P:cellular response to hypoxia; P:cellular response to retinoic acid; P:induction by virus of host autophagy; P:mammary gland alveolus development; P:mammary gland branching involved in thelarche; P:mitochondrial calcium ion transmembrane transport; P:mitochondrion organization; P:mitophagy; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of mammary gland epithelial cell proliferation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exit from mitosis; P:positive regulation of immunoglobulin production; P:positive regulation of NIK/NF-kappaB signaling; P:protein import into nucleus; P:protein stabilization; P:regulation of branching involved in mammary gland duct morphogenesis; P:regulation of cardiolipin metabolic process; P:regulation of cytochrome-c oxidase activity; P:response to wounding; P:RIG-I signaling pathway; P:sister chromatid cohesion; scaffold135 indexed_genome mRNA 2436529 2441030 . - . ID=transcript_14279;Q6XUX3 B7ZL64 O75060 Q17R94 Q5RKT0 Q6IN87 Q6P997 Q86Y03 Q9P1S5,Dual serine/threonine and tyrosine protein kinase,Dusty protein kinase;RIP-homologous kinase;Receptor-interacting serine/threonine-protein kinase 5;Sugen kinase 496;, PF07714;, GO:0016324;GO:0016323;GO:0030054;GO:0005737;GO:0005524;GO:0106310;GO:0004712;GO:0106311;GO:0004714;GO:0044344;GO:0043066;GO:0070374;GO:0045743;GO:0033674;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cellular response to fibroblast growth factor stimulus; P:negative regulation of apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of kinase activity; scaffold135 indexed_genome mRNA 2442085 2486401 . - . ID=transcript_14280;Q6XUX3 B7ZL64 O75060 Q17R94 Q5RKT0 Q6IN87 Q6P997 Q86Y03 Q9P1S5,Dual serine/threonine and tyrosine protein kinase,Dusty protein kinase;RIP-homologous kinase;Receptor-interacting serine/threonine-protein kinase 5;Sugen kinase 496;, PF07714;, GO:0016324;GO:0016323;GO:0030054;GO:0005737;GO:0005524;GO:0106310;GO:0004712;GO:0106311;GO:0004714;GO:0044344;GO:0043066;GO:0070374;GO:0045743;GO:0033674;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cellular response to fibroblast growth factor stimulus; P:negative regulation of apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of kinase activity;|Q6XUX3 B7ZL64 O75060 Q17R94 Q5RKT0 Q6IN87 Q6P997 Q86Y03 Q9P1S5,Dual serine/threonine and tyrosine protein kinase,Dusty protein kinase;RIP-homologous kinase;Receptor-interacting serine/threonine-protein kinase 5;Sugen kinase 496;, PF07714;, GO:0016324;GO:0016323;GO:0030054;GO:0005737;GO:0005524;GO:0106310;GO:0004712;GO:0106311;GO:0004714;GO:0044344;GO:0043066;GO:0070374;GO:0045743;GO:0033674;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cellular response to fibroblast growth factor stimulus; P:negative regulation of apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of kinase activity;|Q6XUX3 B7ZL64 O75060 Q17R94 Q5RKT0 Q6IN87 Q6P997 Q86Y03 Q9P1S5,Dual serine/threonine and tyrosine protein kinase,Dusty protein kinase;RIP-homologous kinase;Receptor-interacting serine/threonine-protein kinase 5;Sugen kinase 496;, PF07714;, GO:0016324;GO:0016323;GO:0030054;GO:0005737;GO:0005524;GO:0106310;GO:0004712;GO:0106311;GO:0004714;GO:0044344;GO:0043066;GO:0070374;GO:0045743;GO:0033674;, C:apical plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cellular response to fibroblast growth factor stimulus; P:negative regulation of apoptotic process; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of kinase activity; scaffold135 indexed_genome mRNA 2510387 2548258 . + . ID=transcript_14281;O75069 A2RRH3 B2RAX5 B3KTM7 B7Z1P7 Q6ZN09 Q7Z6C6,Transmembrane and coiled-coil domains protein 2 {ECO:0000303|PubMed:21593558},Cerebral protein 11 {ECO:0000303|Ref.2};, PF10267;, GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0042982;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:amyloid precursor protein metabolic process;|O75069 A2RRH3 B2RAX5 B3KTM7 B7Z1P7 Q6ZN09 Q7Z6C6,Transmembrane and coiled-coil domains protein 2 {ECO:0000303|PubMed:21593558},Cerebral protein 11 {ECO:0000303|Ref.2};, PF10267;, GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0042982;, C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:amyloid precursor protein metabolic process; scaffold135 indexed_genome mRNA 2567573 2569309 . + . ID=transcript_14282;Q9H093,NUAK family SNF1-like kinase 2,Omphalocele kinase 2;SNF1/AMP kinase-related kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0006915;GO:0042149;GO:0035556;GO:0043066;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:apoptotic process; P:cellular response to glucose starvation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:protein phosphorylation; scaffold135 indexed_genome mRNA 2569352 2570586 . + . ID=transcript_14283;Q9H093,NUAK family SNF1-like kinase 2,Omphalocele kinase 2;SNF1/AMP kinase-related kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0006915;GO:0042149;GO:0035556;GO:0043066;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:apoptotic process; P:cellular response to glucose starvation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:protein phosphorylation; scaffold135 indexed_genome mRNA 2572338 2572918 . - . ID=transcript_14284;Q9H093,NUAK family SNF1-like kinase 2,Omphalocele kinase 2;SNF1/AMP kinase-related kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0006915;GO:0042149;GO:0035556;GO:0043066;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:apoptotic process; P:cellular response to glucose starvation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:protein phosphorylation; scaffold135 indexed_genome mRNA 2574317 2586910 . - . ID=transcript_14285;Q9H093,NUAK family SNF1-like kinase 2,Omphalocele kinase 2;SNF1/AMP kinase-related kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0030036;GO:0006915;GO:0042149;GO:0035556;GO:0043066;GO:0006468;, C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton organization; P:apoptotic process; P:cellular response to glucose starvation; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:protein phosphorylation; scaffold135 indexed_genome mRNA 2601689 2608558 . - . ID=transcript_14286;Q8IYD2 B3KU70 Q9NVG5,Kelch domain-containing protein 8A,Substitute for delta-EGFR expression 1;, PF01344;|Q8IYD2 B3KU70 Q9NVG5,Kelch domain-containing protein 8A,Substitute for delta-EGFR expression 1;, PF01344;|Q8IYD2 B3KU70 Q9NVG5,Kelch domain-containing protein 8A,Substitute for delta-EGFR expression 1;, PF01344; scaffold135 indexed_genome mRNA 2669232 2676180 . - . ID=transcript_14287;Q68G75 Q6L9T9 Q6L9U0 Q6L9U1 Q6L9U2 Q6L9U3 Q6L9U4,LEM domain-containing protein 1,Cancer/testis antigen 50;LEM domain protein 1;, PF03020;, GO:0016021;, C:integral component of membrane; scaffold136 indexed_genome mRNA 71941 87384 . + . ID=transcript_14288;O15013 O14665 Q2KHR8 Q68D55 Q8IWD9 Q8IY77,Rho guanine nucleotide exchange factor 10,, PF00621;, GO:0005813;GO:0005829;GO:0005085;GO:0019894;GO:0030036;GO:0090630;GO:0051298;GO:0090307;GO:0022011;GO:0051496;GO:0035023;, C:centrosome; C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:kinesin binding;, P:actin cytoskeleton organization; P:activation of GTPase activity; P:centrosome duplication; P:mitotic spindle assembly; P:myelination in peripheral nervous system; P:positive regulation of stress fiber assembly; P:regulation of Rho protein signal transduction; scaffold136 indexed_genome mRNA 87754 131754 . - . ID=transcript_14289;O15013 O14665 Q2KHR8 Q68D55 Q8IWD9 Q8IY77,Rho guanine nucleotide exchange factor 10,, PF00621;, GO:0005813;GO:0005829;GO:0005085;GO:0019894;GO:0030036;GO:0090630;GO:0051298;GO:0090307;GO:0022011;GO:0051496;GO:0035023;, C:centrosome; C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:kinesin binding;, P:actin cytoskeleton organization; P:activation of GTPase activity; P:centrosome duplication; P:mitotic spindle assembly; P:myelination in peripheral nervous system; P:positive regulation of stress fiber assembly; P:regulation of Rho protein signal transduction;|O15013 O14665 Q2KHR8 Q68D55 Q8IWD9 Q8IY77,Rho guanine nucleotide exchange factor 10,, PF00621;, GO:0005813;GO:0005829;GO:0005085;GO:0019894;GO:0030036;GO:0090630;GO:0051298;GO:0090307;GO:0022011;GO:0051496;GO:0035023;, C:centrosome; C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:kinesin binding;, P:actin cytoskeleton organization; P:activation of GTPase activity; P:centrosome duplication; P:mitotic spindle assembly; P:myelination in peripheral nervous system; P:positive regulation of stress fiber assembly; P:regulation of Rho protein signal transduction;|O15013 O14665 Q2KHR8 Q68D55 Q8IWD9 Q8IY77,Rho guanine nucleotide exchange factor 10,, PF00621;, GO:0005813;GO:0005829;GO:0005085;GO:0019894;GO:0030036;GO:0090630;GO:0051298;GO:0090307;GO:0022011;GO:0051496;GO:0035023;, C:centrosome; C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:kinesin binding;, P:actin cytoskeleton organization; P:activation of GTPase activity; P:centrosome duplication; P:mitotic spindle assembly; P:myelination in peripheral nervous system; P:positive regulation of stress fiber assembly; P:regulation of Rho protein signal transduction;|O15013 O14665 Q2KHR8 Q68D55 Q8IWD9 Q8IY77,Rho guanine nucleotide exchange factor 10,, PF00621;, GO:0005813;GO:0005829;GO:0005085;GO:0019894;GO:0030036;GO:0090630;GO:0051298;GO:0090307;GO:0022011;GO:0051496;GO:0035023;, C:centrosome; C:cytosol;, F:guanyl-nucleotide exchange factor activity; F:kinesin binding;, P:actin cytoskeleton organization; P:activation of GTPase activity; P:centrosome duplication; P:mitotic spindle assembly; P:myelination in peripheral nervous system; P:positive regulation of stress fiber assembly; P:regulation of Rho protein signal transduction; scaffold136 indexed_genome mRNA 191901 234513 . + . ID=transcript_14290;P54296 Q7Z3Y2,Myomesin-2,165 kDa connectin-associated protein;165 kDa titin-associated protein;M-protein;Myomesin family member 2;, PF00041;PF07679;, GO:0031430;GO:0005739;GO:0032982;GO:0051015;GO:0019900;GO:0008307;GO:0002074;GO:0006936;, C:M band; C:mitochondrion; C:myosin filament;, F:actin filament binding; F:kinase binding; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction;|P54296 Q7Z3Y2,Myomesin-2,165 kDa connectin-associated protein;165 kDa titin-associated protein;M-protein;Myomesin family member 2;, PF00041;PF07679;, GO:0031430;GO:0005739;GO:0032982;GO:0051015;GO:0019900;GO:0008307;GO:0002074;GO:0006936;, C:M band; C:mitochondrion; C:myosin filament;, F:actin filament binding; F:kinase binding; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction;|P54296 Q7Z3Y2,Myomesin-2,165 kDa connectin-associated protein;165 kDa titin-associated protein;M-protein;Myomesin family member 2;, PF00041;PF07679;, GO:0031430;GO:0005739;GO:0032982;GO:0051015;GO:0019900;GO:0008307;GO:0002074;GO:0006936;, C:M band; C:mitochondrion; C:myosin filament;, F:actin filament binding; F:kinase binding; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction; scaffold136 indexed_genome mRNA 234599 253534 . + . ID=transcript_14291;P54296 Q7Z3Y2,Myomesin-2,165 kDa connectin-associated protein;165 kDa titin-associated protein;M-protein;Myomesin family member 2;, PF00041;PF07679;, GO:0031430;GO:0005739;GO:0032982;GO:0051015;GO:0019900;GO:0008307;GO:0002074;GO:0006936;, C:M band; C:mitochondrion; C:myosin filament;, F:actin filament binding; F:kinase binding; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction;|P54296 Q7Z3Y2,Myomesin-2,165 kDa connectin-associated protein;165 kDa titin-associated protein;M-protein;Myomesin family member 2;, PF00041;PF07679;, GO:0031430;GO:0005739;GO:0032982;GO:0051015;GO:0019900;GO:0008307;GO:0002074;GO:0006936;, C:M band; C:mitochondrion; C:myosin filament;, F:actin filament binding; F:kinase binding; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction;|P54296 Q7Z3Y2,Myomesin-2,165 kDa connectin-associated protein;165 kDa titin-associated protein;M-protein;Myomesin family member 2;, PF00041;PF07679;, GO:0031430;GO:0005739;GO:0032982;GO:0051015;GO:0019900;GO:0008307;GO:0002074;GO:0006936;, C:M band; C:mitochondrion; C:myosin filament;, F:actin filament binding; F:kinase binding; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction;|P54296 Q7Z3Y2,Myomesin-2,165 kDa connectin-associated protein;165 kDa titin-associated protein;M-protein;Myomesin family member 2;, PF00041;PF07679;, GO:0031430;GO:0005739;GO:0032982;GO:0051015;GO:0019900;GO:0008307;GO:0002074;GO:0006936;, C:M band; C:mitochondrion; C:myosin filament;, F:actin filament binding; F:kinase binding; F:structural constituent of muscle;, P:extraocular skeletal muscle development; P:muscle contraction; scaffold136 indexed_genome mRNA 880686 881327 . - . ID=transcript_14292;Q96PZ7 A0A0U1RQY1 Q0H0J5 Q96QU9 Q96RM4,CUB and sushi domain-containing protein 1,CUB and sushi multiple domains protein 1;, PF00431;PF00084;, GO:0016021;, C:integral component of membrane; scaffold136 indexed_genome mRNA 990616 992112 . - . ID=transcript_14293;Q9P1A6 A1QCF8 A1QCF9 A5D8Y2 O14488 O14664 Q9P1A7,Disks large-associated protein 2 {ECO:0000305},PSD-95/SAP90-binding protein 2;SAP90/PSD-95-associated protein 2;, PF03359;, GO:0098978;GO:0005883;GO:0005886;GO:0014069;GO:0099572;GO:0060090;GO:0007270;GO:0098962;, C:glutamatergic synapse; C:neurofilament; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization;, F:molecular adaptor activity;, P:neuron-neuron synaptic transmission; P:regulation of postsynaptic neurotransmitter receptor activity; scaffold137 indexed_genome mRNA 71155 72441 . - . ID=transcript_14294;P42658,Dipeptidyl aminopeptidase-like protein 6,DPPX;Dipeptidyl aminopeptidase-related protein;Dipeptidyl peptidase 6;Dipeptidyl peptidase IV-like protein;Dipeptidyl peptidase VI;, PF00930;PF00326;, GO:0016021;GO:0005886;GO:0008076;GO:0015459;GO:0008236;GO:0072659;GO:1901379;, C:integral component of membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:potassium channel regulator activity; F:serine-type peptidase activity;, P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport; scaffold137 indexed_genome mRNA 331617 332388 . + . ID=transcript_14295;Q6TTV4 Q86YR9 Q9P236,Inactive dipeptidyl peptidase 10,Dipeptidyl peptidase IV-related protein 3;Dipeptidyl peptidase X;Dipeptidyl peptidase-like protein 2;, PF00930;PF00326;, GO:0016020;GO:0005886;GO:0008076;GO:0044325;GO:0015459;GO:0008236;GO:1903078;GO:0072659;GO:1901379;, C:membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:ion channel binding; F:potassium channel regulator activity; F:serine-type peptidase activity;, P:positive regulation of protein localization to plasma membrane; P:protein localization to plasma membrane; P:regulation of potassium ion transmembrane transport; scaffold137 indexed_genome mRNA 598881 1395369 . + . ID=transcript_14296;Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation;|Q9P1U1 A8MTG1 B4DFW4 Q7Z526 Q96BT2,Actin-related protein 3B,ARP3-beta;Actin-like protein 3B;Actin-related protein ARP4;, PF00022;, GO:0042995;GO:0005737;GO:0005856;GO:0070062;GO:0003779;GO:0005524;, C:cell projection; C:cytoplasm; C:cytoskeleton; C:extracellular exosome;, F:actin binding; F:ATP binding;|Q9P1U1 A8MTG1 B4DFW4 Q7Z526 Q96BT2,Actin-related protein 3B,ARP3-beta;Actin-like protein 3B;Actin-related protein ARP4;, PF00022;, GO:0042995;GO:0005737;GO:0005856;GO:0070062;GO:0003779;GO:0005524;, C:cell projection; C:cytoplasm; C:cytoskeleton; C:extracellular exosome;, F:actin binding; F:ATP binding;|Q9C0K3 Q5CZI4,Actin-related protein 3C,Actin-related protein 11;, PF00022;, GO:0070062;GO:0003779;GO:0005524;, C:extracellular exosome;, F:actin binding; F:ATP binding;|O43543 B2R925,DNA repair protein XRCC2,X-ray repair cross-complementing protein 2;, PF08423;, GO:0005813;GO:0005737;GO:0043231;GO:0005654;GO:0033063;GO:0005657;GO:0005524;GO:0003677;GO:0008094;GO:0007098;GO:0006281;GO:0000724;GO:0001701;GO:0051321;GO:0000278;GO:0035264;GO:0043524;GO:0050769;GO:2000269;GO:0010332;GO:0010165;GO:0001756;GO:0042148;, C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; C:replication fork;, F:ATP binding; F:DNA binding; F:DNA-dependent ATPase activity;, P:centrosome cycle; P:DNA repair; P:double-strand break repair via homologous recombination; P:in utero embryonic development; P:meiotic cell cycle; P:mitotic cell cycle; P:multicellular organism growth; P:negative regulation of neuron apoptotic process; P:positive regulation of neurogenesis; P:regulation of fibroblast apoptotic process; P:response to gamma radiation; P:response to X-ray; P:somitogenesis; P:strand invasion; scaffold137 indexed_genome mRNA 1406738 1502398 . + . ID=transcript_14297;Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation;|Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation;|Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation;|Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation;|Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation;|Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation;|Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation;|Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation;|Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation;|Q8NEZ4 Q8NC02 Q8NDF6 Q9H9P4 Q9NR13 Q9P222 Q9UDR7,Histone-lysine N-methyltransferase 2C,Homologous to ALR protein;Myeloid/lymphoid or mixed-lineage leukemia protein 3;, PF05965;PF05964;PF00628;PF00856;, GO:0035097;GO:0044666;GO:0005654;GO:0005634;GO:0003677;GO:0042393;GO:0042054;GO:0042800;GO:0046872;GO:0003723;GO:0003713;GO:0016746;GO:0097692;GO:0045944;GO:0045652;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus;, F:DNA binding; F:histone binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K4 specific); F:metal ion binding; F:RNA binding; F:transcription coactivator activity; F:transferase activity, transferring acyl groups;, P:histone H3-K4 monomethylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of megakaryocyte differentiation; scaffold137 indexed_genome mRNA 1510444 1538037 . - . ID=transcript_14298;Q8NCW6 B3KWF4 Q6PCD1 Q9H6C2 Q9H6Z5 Q9UDR8,Polypeptide N-acetylgalactosaminyltransferase 11,Polypeptide GalNAc transferase 11;Protein-UDP acetylgalactosaminyltransferase 11;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0005112;GO:0004653;GO:0060271;GO:0007368;GO:0007220;GO:0061314;GO:0016266;GO:0018243;GO:0008593;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:Notch binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:cilium assembly; P:determination of left/right symmetry; P:Notch receptor processing; P:Notch signaling involved in heart development; P:O-glycan processing; P:protein O-linked glycosylation via threonine; P:regulation of Notch signaling pathway;|Q8NCW6 B3KWF4 Q6PCD1 Q9H6C2 Q9H6Z5 Q9UDR8,Polypeptide N-acetylgalactosaminyltransferase 11,Polypeptide GalNAc transferase 11;Protein-UDP acetylgalactosaminyltransferase 11;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0005112;GO:0004653;GO:0060271;GO:0007368;GO:0007220;GO:0061314;GO:0016266;GO:0018243;GO:0008593;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:Notch binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:cilium assembly; P:determination of left/right symmetry; P:Notch receptor processing; P:Notch signaling involved in heart development; P:O-glycan processing; P:protein O-linked glycosylation via threonine; P:regulation of Notch signaling pathway;|Q8NCW6 B3KWF4 Q6PCD1 Q9H6C2 Q9H6Z5 Q9UDR8,Polypeptide N-acetylgalactosaminyltransferase 11,Polypeptide GalNAc transferase 11;Protein-UDP acetylgalactosaminyltransferase 11;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0005112;GO:0004653;GO:0060271;GO:0007368;GO:0007220;GO:0061314;GO:0016266;GO:0018243;GO:0008593;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:Notch binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:cilium assembly; P:determination of left/right symmetry; P:Notch receptor processing; P:Notch signaling involved in heart development; P:O-glycan processing; P:protein O-linked glycosylation via threonine; P:regulation of Notch signaling pathway;|Q8NCW6 B3KWF4 Q6PCD1 Q9H6C2 Q9H6Z5 Q9UDR8,Polypeptide N-acetylgalactosaminyltransferase 11,Polypeptide GalNAc transferase 11;Protein-UDP acetylgalactosaminyltransferase 11;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11;, PF00535;PF00652;, GO:0005794;GO:0000139;GO:0016021;GO:0030246;GO:0046872;GO:0005112;GO:0004653;GO:0060271;GO:0007368;GO:0007220;GO:0061314;GO:0016266;GO:0018243;GO:0008593;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:carbohydrate binding; F:metal ion binding; F:Notch binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:cilium assembly; P:determination of left/right symmetry; P:Notch receptor processing; P:Notch signaling involved in heart development; P:O-glycan processing; P:protein O-linked glycosylation via threonine; P:regulation of Notch signaling pathway; scaffold137 indexed_genome mRNA 1969119 1982309 . + . ID=transcript_14299;Q9UGJ0 Q53Y07 Q6NUI0 Q75MP4 Q9NUZ9 Q9UDN8 Q9ULX8,5'-AMP-activated protein kinase subunit gamma-2,H91620p;, PF00571;, GO:0005737;GO:0005829;GO:0005615;GO:0005654;GO:0031588;GO:0005634;GO:0043531;GO:0016208;GO:0004679;GO:0005524;GO:0004862;GO:0008603;GO:0008607;GO:0030295;GO:0019901;GO:0019887;GO:0006754;GO:0006853;GO:0007050;GO:0042149;GO:0006633;GO:0005977;GO:0035556;GO:0016236;GO:0006469;GO:0010800;GO:0045860;GO:0006468;GO:0050790;GO:0042304;GO:0019217;GO:0046320;GO:0046324;GO:0006110;GO:0016241;GO:1901796;GO:0016126;, C:cytoplasm; C:cytosol; C:extracellular space; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:ADP binding; F:AMP binding; F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase inhibitor activity; F:cAMP-dependent protein kinase regulator activity; F:phosphorylase kinase regulator activity; F:protein kinase activator activity; F:protein kinase binding; F:protein kinase regulator activity;, P:ATP biosynthetic process; P:carnitine shuttle; P:cell cycle arrest; P:cellular response to glucose starvation; P:fatty acid biosynthetic process; P:glycogen metabolic process; P:intracellular signal transduction; P:macroautophagy; P:negative regulation of protein kinase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase activity; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of fatty acid biosynthetic process; P:regulation of fatty acid metabolic process; P:regulation of fatty acid oxidation; P:regulation of glucose import; P:regulation of glycolytic process; P:regulation of macroautophagy; P:regulation of signal transduction by p53 class mediator; P:sterol biosynthetic process; scaffold137 indexed_genome mRNA 1985240 1990035 . + . ID=transcript_14300;Q9UGJ0 Q53Y07 Q6NUI0 Q75MP4 Q9NUZ9 Q9UDN8 Q9ULX8,5'-AMP-activated protein kinase subunit gamma-2,H91620p;, PF00571;, GO:0005737;GO:0005829;GO:0005615;GO:0005654;GO:0031588;GO:0005634;GO:0043531;GO:0016208;GO:0004679;GO:0005524;GO:0004862;GO:0008603;GO:0008607;GO:0030295;GO:0019901;GO:0019887;GO:0006754;GO:0006853;GO:0007050;GO:0042149;GO:0006633;GO:0005977;GO:0035556;GO:0016236;GO:0006469;GO:0010800;GO:0045860;GO:0006468;GO:0050790;GO:0042304;GO:0019217;GO:0046320;GO:0046324;GO:0006110;GO:0016241;GO:1901796;GO:0016126;, C:cytoplasm; C:cytosol; C:extracellular space; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:ADP binding; F:AMP binding; F:AMP-activated protein kinase activity; F:ATP binding; F:cAMP-dependent protein kinase inhibitor activity; F:cAMP-dependent protein kinase regulator activity; F:phosphorylase kinase regulator activity; F:protein kinase activator activity; F:protein kinase binding; F:protein kinase regulator activity;, P:ATP biosynthetic process; P:carnitine shuttle; P:cell cycle arrest; P:cellular response to glucose starvation; P:fatty acid biosynthetic process; P:glycogen metabolic process; P:intracellular signal transduction; P:macroautophagy; P:negative regulation of protein kinase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein kinase activity; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of fatty acid biosynthetic process; P:regulation of fatty acid metabolic process; P:regulation of fatty acid oxidation; P:regulation of glucose import; P:regulation of glycolytic process; P:regulation of macroautophagy; P:regulation of signal transduction by p53 class mediator; P:sterol biosynthetic process; scaffold137 indexed_genome mRNA 2064871 2086269 . + . ID=transcript_14301;Q15382 B3KWN6 D3DX13 Q53Y56 Q99444,GTP-binding protein Rheb,Ras homolog enriched in brain;, PF00071;, GO:0005829;GO:0005789;GO:0070062;GO:0000139;GO:0005765;GO:0016020;GO:0005886;GO:0014069;GO:0005681;GO:0019003;GO:0005525;GO:0003924;GO:0000287;GO:0019901;GO:0007050;GO:0034198;GO:0120163;GO:0048714;GO:0032008;GO:0016241;GO:2000074;GO:0007165;GO:0007264;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:postsynaptic density; C:spliceosomal complex;, F:GDP binding; F:GTP binding; F:GTPase activity; F:magnesium ion binding; F:protein kinase binding;, P:cell cycle arrest; P:cellular response to amino acid starvation; P:negative regulation of cold-induced thermogenesis; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of TOR signaling; P:regulation of macroautophagy; P:regulation of type B pancreatic cell development; P:signal transduction; P:small GTPase mediated signal transduction;|Q15382 B3KWN6 D3DX13 Q53Y56 Q99444,GTP-binding protein Rheb,Ras homolog enriched in brain;, PF00071;, GO:0005829;GO:0005789;GO:0070062;GO:0000139;GO:0005765;GO:0016020;GO:0005886;GO:0014069;GO:0005681;GO:0019003;GO:0005525;GO:0003924;GO:0000287;GO:0019901;GO:0007050;GO:0034198;GO:0120163;GO:0048714;GO:0032008;GO:0016241;GO:2000074;GO:0007165;GO:0007264;, C:cytosol; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:postsynaptic density; C:spliceosomal complex;, F:GDP binding; F:GTP binding; F:GTPase activity; F:magnesium ion binding; F:protein kinase binding;, P:cell cycle arrest; P:cellular response to amino acid starvation; P:negative regulation of cold-induced thermogenesis; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of TOR signaling; P:regulation of macroautophagy; P:regulation of type B pancreatic cell development; P:signal transduction; P:small GTPase mediated signal transduction; scaffold137 indexed_genome mRNA 2126435 2127453 . + . ID=transcript_14302;Q86TI4 B4DJF1 C9JAJ5 C9JXE3 Q3KNT1 Q6ZUS8,WD repeat-containing protein 86,, PF00400; scaffold137 indexed_genome mRNA 2156487 2165482 . - . ID=transcript_14303;Q9Y5A7 O95422 Q75MR9 Q8IX22 Q9BXR2,NEDD8 ultimate buster 1,Negative regulator of ubiquitin-like proteins 1;Renal carcinoma antigen NY-REN-18;, PF00627;PF18037;, GO:0005829;GO:0005730;GO:0005654;GO:0032436;GO:0043687;GO:0016567;GO:2000058;GO:0034341;GO:0034612;GO:0006511;, C:cytosol; C:nucleolus; C:nucleoplasm;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of ubiquitin-dependent protein catabolic process; P:response to interferon-gamma; P:response to tumor necrosis factor; P:ubiquitin-dependent protein catabolic process;|Q9Y5A7 O95422 Q75MR9 Q8IX22 Q9BXR2,NEDD8 ultimate buster 1,Negative regulator of ubiquitin-like proteins 1;Renal carcinoma antigen NY-REN-18;, PF00627;PF18037;, GO:0005829;GO:0005730;GO:0005654;GO:0032436;GO:0043687;GO:0016567;GO:2000058;GO:0034341;GO:0034612;GO:0006511;, C:cytosol; C:nucleolus; C:nucleoplasm;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of ubiquitin-dependent protein catabolic process; P:response to interferon-gamma; P:response to tumor necrosis factor; P:ubiquitin-dependent protein catabolic process;|Q9Y5A7 O95422 Q75MR9 Q8IX22 Q9BXR2,NEDD8 ultimate buster 1,Negative regulator of ubiquitin-like proteins 1;Renal carcinoma antigen NY-REN-18;, PF00627;PF18037;, GO:0005829;GO:0005730;GO:0005654;GO:0032436;GO:0043687;GO:0016567;GO:2000058;GO:0034341;GO:0034612;GO:0006511;, C:cytosol; C:nucleolus; C:nucleoplasm;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of ubiquitin-dependent protein catabolic process; P:response to interferon-gamma; P:response to tumor necrosis factor; P:ubiquitin-dependent protein catabolic process; scaffold137 indexed_genome mRNA 2167047 2390020 . - . ID=transcript_14304;Q9Y5A7 O95422 Q75MR9 Q8IX22 Q9BXR2,NEDD8 ultimate buster 1,Negative regulator of ubiquitin-like proteins 1;Renal carcinoma antigen NY-REN-18;, PF00627;PF18037;, GO:0005829;GO:0005730;GO:0005654;GO:0032436;GO:0043687;GO:0016567;GO:2000058;GO:0034341;GO:0034612;GO:0006511;, C:cytosol; C:nucleolus; C:nucleoplasm;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of ubiquitin-dependent protein catabolic process; P:response to interferon-gamma; P:response to tumor necrosis factor; P:ubiquitin-dependent protein catabolic process;|Q9Y5A7 O95422 Q75MR9 Q8IX22 Q9BXR2,NEDD8 ultimate buster 1,Negative regulator of ubiquitin-like proteins 1;Renal carcinoma antigen NY-REN-18;, PF00627;PF18037;, GO:0005829;GO:0005730;GO:0005654;GO:0032436;GO:0043687;GO:0016567;GO:2000058;GO:0034341;GO:0034612;GO:0006511;, C:cytosol; C:nucleolus; C:nucleoplasm;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of ubiquitin-dependent protein catabolic process; P:response to interferon-gamma; P:response to tumor necrosis factor; P:ubiquitin-dependent protein catabolic process;|Q6STE5 D3DX10 Q2YD86 Q75MJ2 Q75MR8 Q92926 Q9BUH1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3,60 kDa BRG-1/Brm-associated factor subunit C;BRG1-associated factor 60C;, PF02201;, GO:0000785;GO:0005737;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003682;GO:0035257;GO:0016922;GO:0030374;GO:0005102;GO:0003713;GO:0008134;GO:0003219;GO:0006338;GO:0042692;GO:0003407;GO:0006337;GO:0010971;GO:0002052;GO:0051152;GO:0045944;GO:0045893;GO:0019216;GO:0043393;GO:0006357;GO:0003139;, C:chromatin; C:cytoplasm; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:signaling receptor binding; F:transcription coactivator activity; F:transcription factor binding;, P:cardiac right ventricle formation; P:chromatin remodeling; P:muscle cell differentiation; P:neural retina development; P:nucleosome disassembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of neuroblast proliferation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of protein binding; P:regulation of transcription by RNA polymerase II; P:secondary heart field specification;|Q6STE5 D3DX10 Q2YD86 Q75MJ2 Q75MR8 Q92926 Q9BUH1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3,60 kDa BRG-1/Brm-associated factor subunit C;BRG1-associated factor 60C;, PF02201;, GO:0000785;GO:0005737;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003682;GO:0035257;GO:0016922;GO:0030374;GO:0005102;GO:0003713;GO:0008134;GO:0003219;GO:0006338;GO:0042692;GO:0003407;GO:0006337;GO:0010971;GO:0002052;GO:0051152;GO:0045944;GO:0045893;GO:0019216;GO:0043393;GO:0006357;GO:0003139;, C:chromatin; C:cytoplasm; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:signaling receptor binding; F:transcription coactivator activity; F:transcription factor binding;, P:cardiac right ventricle formation; P:chromatin remodeling; P:muscle cell differentiation; P:neural retina development; P:nucleosome disassembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of neuroblast proliferation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of protein binding; P:regulation of transcription by RNA polymerase II; P:secondary heart field specification;|Q6STE5 D3DX10 Q2YD86 Q75MJ2 Q75MR8 Q92926 Q9BUH1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3,60 kDa BRG-1/Brm-associated factor subunit C;BRG1-associated factor 60C;, PF02201;, GO:0000785;GO:0005737;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003682;GO:0035257;GO:0016922;GO:0030374;GO:0005102;GO:0003713;GO:0008134;GO:0003219;GO:0006338;GO:0042692;GO:0003407;GO:0006337;GO:0010971;GO:0002052;GO:0051152;GO:0045944;GO:0045893;GO:0019216;GO:0043393;GO:0006357;GO:0003139;, C:chromatin; C:cytoplasm; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:signaling receptor binding; F:transcription coactivator activity; F:transcription factor binding;, P:cardiac right ventricle formation; P:chromatin remodeling; P:muscle cell differentiation; P:neural retina development; P:nucleosome disassembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of neuroblast proliferation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of protein binding; P:regulation of transcription by RNA polymerase II; P:secondary heart field specification;|Q6STE5 D3DX10 Q2YD86 Q75MJ2 Q75MR8 Q92926 Q9BUH1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3,60 kDa BRG-1/Brm-associated factor subunit C;BRG1-associated factor 60C;, PF02201;, GO:0000785;GO:0005737;GO:0071565;GO:0071564;GO:0005654;GO:0005634;GO:0016514;GO:0003682;GO:0035257;GO:0016922;GO:0030374;GO:0005102;GO:0003713;GO:0008134;GO:0003219;GO:0006338;GO:0042692;GO:0003407;GO:0006337;GO:0010971;GO:0002052;GO:0051152;GO:0045944;GO:0045893;GO:0019216;GO:0043393;GO:0006357;GO:0003139;, C:chromatin; C:cytoplasm; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:nuclear hormone receptor binding; F:nuclear receptor binding; F:nuclear receptor coactivator activity; F:signaling receptor binding; F:transcription coactivator activity; F:transcription factor binding;, P:cardiac right ventricle formation; P:chromatin remodeling; P:muscle cell differentiation; P:neural retina development; P:nucleosome disassembly; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of neuroblast proliferation; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of protein binding; P:regulation of transcription by RNA polymerase II; P:secondary heart field specification;|Q9P2E5 B2DBD8 Q6P2I4 Q6UXD2,Chondroitin sulfate glucuronyltransferase,CSGlcA-T;Chondroitin glucuronyltransferase;Chondroitin polymerizing factor 2;Chondroitin synthase 3;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase;, PF05679;, GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0008376;GO:0047238;GO:0050510;GO:0030206;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity;, P:chondroitin sulfate biosynthetic process;|Q9P2E5 B2DBD8 Q6P2I4 Q6UXD2,Chondroitin sulfate glucuronyltransferase,CSGlcA-T;Chondroitin glucuronyltransferase;Chondroitin polymerizing factor 2;Chondroitin synthase 3;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase;, PF05679;, GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0008376;GO:0047238;GO:0050510;GO:0030206;, C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity;, P:chondroitin sulfate biosynthetic process;|Q9UG63 O60864 Q75MJ0 Q75MJ1 Q96TE8,ATP-binding cassette sub-family F member 2,Iron-inhibited ABC transporter 2;, PF00005;PF12848;, GO:0016020;GO:0005524;GO:0016887;, C:membrane;, F:ATP binding; F:ATPase activity;|Q9UG63 O60864 Q75MJ0 Q75MJ1 Q96TE8,ATP-binding cassette sub-family F member 2,Iron-inhibited ABC transporter 2;, PF00005;PF12848;, GO:0016020;GO:0005524;GO:0016887;, C:membrane;, F:ATP binding; F:ATPase activity;|Q9UG63 O60864 Q75MJ0 Q75MJ1 Q96TE8,ATP-binding cassette sub-family F member 2,Iron-inhibited ABC transporter 2;, PF00005;PF12848;, GO:0016020;GO:0005524;GO:0016887;, C:membrane;, F:ATP binding; F:ATPase activity;|Q8WXI3 A0AVH0 Q6ZUL6,Ankyrin repeat and SOCS box protein 10,, PF12796;PF07525;, GO:0005737;GO:0005829;GO:0005634;GO:0035556;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:nucleus;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q8WXI3 A0AVH0 Q6ZUL6,Ankyrin repeat and SOCS box protein 10,, PF12796;PF07525;, GO:0005737;GO:0005829;GO:0005634;GO:0035556;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:nucleus;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q8WXI3 A0AVH0 Q6ZUL6,Ankyrin repeat and SOCS box protein 10,, PF12796;PF07525;, GO:0005737;GO:0005829;GO:0005634;GO:0035556;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:nucleus;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q8WXI3 A0AVH0 Q6ZUL6,Ankyrin repeat and SOCS box protein 10,, PF12796;PF07525;, GO:0005737;GO:0005829;GO:0005634;GO:0035556;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:nucleus;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q8WXI3 A0AVH0 Q6ZUL6,Ankyrin repeat and SOCS box protein 10,, PF12796;PF07525;, GO:0005737;GO:0005829;GO:0005634;GO:0035556;GO:0043687;GO:0016567;, C:cytoplasm; C:cytosol; C:nucleus;, , P:intracellular signal transduction; P:post-translational protein modification; P:protein ubiquitination;|Q14549,Homeobox protein GBX-1,Gastrulation and brain-specific homeobox protein 1;, PF00046;, GO:0000785;GO:0005634;GO:0000981;GO:0000977;GO:0007628;GO:0048663;GO:0019230;GO:0051960;GO:0006357;GO:0097374;GO:0021522;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:adult walking behavior; P:neuron fate commitment; P:proprioception; P:regulation of nervous system development; P:regulation of transcription by RNA polymerase II; P:sensory neuron axon guidance; P:spinal cord motor neuron differentiation;|Q96P47 B3KNZ8 E9PAL8 Q59EN0 Q96RK3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3,CRAM-associated GTPase;Centaurin-gamma-3;MR1-interacting protein;, PF12796;PF01412;PF00071;, GO:0071944;GO:0005737;GO:0016020;GO:0005634;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031593;GO:0034614;GO:0043161;GO:0007165;, C:cell periphery; C:cytoplasm; C:membrane; C:nucleus;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:polyubiquitin modification-dependent protein binding;, P:cellular response to reactive oxygen species; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction;|Q96P47 B3KNZ8 E9PAL8 Q59EN0 Q96RK3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3,CRAM-associated GTPase;Centaurin-gamma-3;MR1-interacting protein;, PF12796;PF01412;PF00071;, GO:0071944;GO:0005737;GO:0016020;GO:0005634;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031593;GO:0034614;GO:0043161;GO:0007165;, C:cell periphery; C:cytoplasm; C:membrane; C:nucleus;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:polyubiquitin modification-dependent protein binding;, P:cellular response to reactive oxygen species; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction;|Q96P47 B3KNZ8 E9PAL8 Q59EN0 Q96RK3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3,CRAM-associated GTPase;Centaurin-gamma-3;MR1-interacting protein;, PF12796;PF01412;PF00071;, GO:0071944;GO:0005737;GO:0016020;GO:0005634;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031593;GO:0034614;GO:0043161;GO:0007165;, C:cell periphery; C:cytoplasm; C:membrane; C:nucleus;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:polyubiquitin modification-dependent protein binding;, P:cellular response to reactive oxygen species; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction;|Q96P47 B3KNZ8 E9PAL8 Q59EN0 Q96RK3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3,CRAM-associated GTPase;Centaurin-gamma-3;MR1-interacting protein;, PF12796;PF01412;PF00071;, GO:0071944;GO:0005737;GO:0016020;GO:0005634;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031593;GO:0034614;GO:0043161;GO:0007165;, C:cell periphery; C:cytoplasm; C:membrane; C:nucleus;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:polyubiquitin modification-dependent protein binding;, P:cellular response to reactive oxygen species; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction;|Q96P47 B3KNZ8 E9PAL8 Q59EN0 Q96RK3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3,CRAM-associated GTPase;Centaurin-gamma-3;MR1-interacting protein;, PF12796;PF01412;PF00071;, GO:0071944;GO:0005737;GO:0016020;GO:0005634;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031593;GO:0034614;GO:0043161;GO:0007165;, C:cell periphery; C:cytoplasm; C:membrane; C:nucleus;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:polyubiquitin modification-dependent protein binding;, P:cellular response to reactive oxygen species; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction;|Q96P47 B3KNZ8 E9PAL8 Q59EN0 Q96RK3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3,CRAM-associated GTPase;Centaurin-gamma-3;MR1-interacting protein;, PF12796;PF01412;PF00071;, GO:0071944;GO:0005737;GO:0016020;GO:0005634;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031593;GO:0034614;GO:0043161;GO:0007165;, C:cell periphery; C:cytoplasm; C:membrane; C:nucleus;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:polyubiquitin modification-dependent protein binding;, P:cellular response to reactive oxygen species; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction;|Q96P47 B3KNZ8 E9PAL8 Q59EN0 Q96RK3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3,CRAM-associated GTPase;Centaurin-gamma-3;MR1-interacting protein;, PF12796;PF01412;PF00071;, GO:0071944;GO:0005737;GO:0016020;GO:0005634;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031593;GO:0034614;GO:0043161;GO:0007165;, C:cell periphery; C:cytoplasm; C:membrane; C:nucleus;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:polyubiquitin modification-dependent protein binding;, P:cellular response to reactive oxygen species; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction;|Q96P47 B3KNZ8 E9PAL8 Q59EN0 Q96RK3,Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3,CRAM-associated GTPase;Centaurin-gamma-3;MR1-interacting protein;, PF12796;PF01412;PF00071;, GO:0071944;GO:0005737;GO:0016020;GO:0005634;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031593;GO:0034614;GO:0043161;GO:0007165;, C:cell periphery; C:cytoplasm; C:membrane; C:nucleus;, F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:polyubiquitin modification-dependent protein binding;, P:cellular response to reactive oxygen species; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction; scaffold137 indexed_genome mRNA 2397736 2398652 . - . ID=transcript_14305;P05387 Q6FG96,60S acidic ribosomal protein P2,Large ribosomal subunit protein P2 {ECO:0000303|PubMed:24524803};Renal carcinoma antigen NY-REN-44;, , GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0003735;GO:0002182;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane;, F:structural constituent of ribosome;, P:cytoplasmic translational elongation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold137 indexed_genome mRNA 2430665 2432449 . + . ID=transcript_14306;Q9BVT8 D3DX06 Q53AQ2,Transmembrane and ubiquitin-like domain-containing protein 1,Dendritic cell-derived ubiquitin-like protein;Hepatocyte odd protein shuttling protein;Ubiquitin-like protein SB144;, PF00240;, GO:0016021;GO:0005815;GO:0005730;GO:0045211;GO:0055037;GO:0030433;, C:integral component of membrane; C:microtubule organizing center; C:nucleolus; C:postsynaptic membrane; C:recycling endosome;, , P:ubiquitin-dependent ERAD pathway; scaffold137 indexed_genome mRNA 2432474 2458520 . - . ID=transcript_14307;Q14296 A8K867 F8VTW9 Q59EM8 Q8IVA0,Fas-activated serine/threonine kinase,, PF06743;PF08368;PF08373;, GO:0005759;GO:0005524;GO:0033867;GO:0004674;GO:0003723;GO:0097190;GO:0006468;GO:0044528;GO:0043484;, C:mitochondrial matrix;, F:ATP binding; F:Fas-activated serine/threonine kinase activity; F:protein serine/threonine kinase activity; F:RNA binding;, P:apoptotic signaling pathway; P:protein phosphorylation; P:regulation of mitochondrial mRNA stability; P:regulation of RNA splicing;|Q14296 A8K867 F8VTW9 Q59EM8 Q8IVA0,Fas-activated serine/threonine kinase,, PF06743;PF08368;PF08373;, GO:0005759;GO:0005524;GO:0033867;GO:0004674;GO:0003723;GO:0097190;GO:0006468;GO:0044528;GO:0043484;, C:mitochondrial matrix;, F:ATP binding; F:Fas-activated serine/threonine kinase activity; F:protein serine/threonine kinase activity; F:RNA binding;, P:apoptotic signaling pathway; P:protein phosphorylation; P:regulation of mitochondrial mRNA stability; P:regulation of RNA splicing;|P04920 B2R6T0 B4DIT0 D3DX05 F8W682 Q45EY5 Q969L3,Anion exchange protein 2,Non-erythroid band 3-like protein;Solute carrier family 4 member 2;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0005925;GO:0016021;GO:0016020;GO:0005886;GO:0008509;GO:0015301;GO:0019899;GO:0005452;GO:0022857;GO:0006820;GO:0015701;GO:0048565;GO:0050801;GO:0051453;GO:0007283;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:focal adhesion; C:integral component of membrane; C:membrane; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:enzyme binding; F:inorganic anion exchanger activity; F:transmembrane transporter activity;, P:anion transport; P:bicarbonate transport; P:digestive tract development; P:ion homeostasis; P:regulation of intracellular pH; P:spermatogenesis; P:transmembrane transport;|P04920 B2R6T0 B4DIT0 D3DX05 F8W682 Q45EY5 Q969L3,Anion exchange protein 2,Non-erythroid band 3-like protein;Solute carrier family 4 member 2;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0005925;GO:0016021;GO:0016020;GO:0005886;GO:0008509;GO:0015301;GO:0019899;GO:0005452;GO:0022857;GO:0006820;GO:0015701;GO:0048565;GO:0050801;GO:0051453;GO:0007283;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:focal adhesion; C:integral component of membrane; C:membrane; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:enzyme binding; F:inorganic anion exchanger activity; F:transmembrane transporter activity;, P:anion transport; P:bicarbonate transport; P:digestive tract development; P:ion homeostasis; P:regulation of intracellular pH; P:spermatogenesis; P:transmembrane transport;|P04920 B2R6T0 B4DIT0 D3DX05 F8W682 Q45EY5 Q969L3,Anion exchange protein 2,Non-erythroid band 3-like protein;Solute carrier family 4 member 2;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0005925;GO:0016021;GO:0016020;GO:0005886;GO:0008509;GO:0015301;GO:0019899;GO:0005452;GO:0022857;GO:0006820;GO:0015701;GO:0048565;GO:0050801;GO:0051453;GO:0007283;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:focal adhesion; C:integral component of membrane; C:membrane; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:enzyme binding; F:inorganic anion exchanger activity; F:transmembrane transporter activity;, P:anion transport; P:bicarbonate transport; P:digestive tract development; P:ion homeostasis; P:regulation of intracellular pH; P:spermatogenesis; P:transmembrane transport;|P04920 B2R6T0 B4DIT0 D3DX05 F8W682 Q45EY5 Q969L3,Anion exchange protein 2,Non-erythroid band 3-like protein;Solute carrier family 4 member 2;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0005925;GO:0016021;GO:0016020;GO:0005886;GO:0008509;GO:0015301;GO:0019899;GO:0005452;GO:0022857;GO:0006820;GO:0015701;GO:0048565;GO:0050801;GO:0051453;GO:0007283;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:focal adhesion; C:integral component of membrane; C:membrane; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:enzyme binding; F:inorganic anion exchanger activity; F:transmembrane transporter activity;, P:anion transport; P:bicarbonate transport; P:digestive tract development; P:ion homeostasis; P:regulation of intracellular pH; P:spermatogenesis; P:transmembrane transport;|P04920 B2R6T0 B4DIT0 D3DX05 F8W682 Q45EY5 Q969L3,Anion exchange protein 2,Non-erythroid band 3-like protein;Solute carrier family 4 member 2;, PF07565;PF00955;, GO:0016324;GO:0016323;GO:0005925;GO:0016021;GO:0016020;GO:0005886;GO:0008509;GO:0015301;GO:0019899;GO:0005452;GO:0022857;GO:0006820;GO:0015701;GO:0048565;GO:0050801;GO:0051453;GO:0007283;GO:0055085;, C:apical plasma membrane; C:basolateral plasma membrane; C:focal adhesion; C:integral component of membrane; C:membrane; C:plasma membrane;, F:anion transmembrane transporter activity; F:anion:anion antiporter activity; F:enzyme binding; F:inorganic anion exchanger activity; F:transmembrane transporter activity;, P:anion transport; P:bicarbonate transport; P:digestive tract development; P:ion homeostasis; P:regulation of intracellular pH; P:spermatogenesis; P:transmembrane transport; scaffold137 indexed_genome mRNA 2460121 2463084 . + . ID=transcript_14308;Q00535 A1XKG3,Cyclin-dependent-like kinase 5,Cell division protein kinase 5;Serine/threonine-protein kinase PSSALRE;Tau protein kinase II catalytic subunit;, PF00069;, GO:0030424;GO:0030054;GO:0005737;GO:0005829;GO:0030425;GO:0030175;GO:0098978;GO:0030426;GO:0030027;GO:0016020;GO:0005874;GO:0031594;GO:0043005;GO:0043025;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0098793;GO:0016533;GO:0098685;GO:0030549;GO:0005524;GO:0004693;GO:0046875;GO:0005176;GO:0043125;GO:0051879;GO:0016301;GO:0002039;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0099635;GO:0048675;GO:0007409;GO:0048148;GO:0070509;GO:0051301;GO:0007160;GO:1904646;GO:0021954;GO:0021697;GO:0007268;GO:0022038;GO:0030866;GO:0048813;GO:0060079;GO:0021766;GO:0016572;GO:0006886;GO:0021819;GO:0000226;GO:0007005;GO:0008045;GO:0030517;GO:0045786;GO:1901215;GO:0046826;GO:0031397;GO:0045861;GO:0031914;GO:0045892;GO:0051402;GO:0030182;GO:0001764;GO:0031175;GO:0006913;GO:0048709;GO:0018105;GO:0018107;GO:0016310;GO:2000251;GO:0045956;GO:0034352;GO:0043525;GO:0032092;GO:0045860;GO:0090314;GO:1901387;GO:0046777;GO:0035418;GO:0006468;GO:0032801;GO:0043113;GO:0042981;GO:0071156;GO:0030334;GO:0061001;GO:0016241;GO:1903076;GO:1901796;GO:0048167;GO:0051966;GO:1903421;GO:0000083;GO:0009611;GO:0048511;GO:0014044;GO:0019233;GO:0042501;GO:0007519;GO:0007416;GO:0098883;GO:0001963;GO:0035249;GO:0048488;GO:0016079;GO:0048489;GO:0008542;, C:axon; C:cell junction; C:cytoplasm; C:cytosol; C:dendrite; C:filopodium; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:membrane; C:microtubule; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:presynapse; C:protein kinase 5 complex; C:Schaffer collateral - CA1 synapse;, F:acetylcholine receptor activator activity; F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:ephrin receptor binding; F:ErbB-2 class receptor binding; F:ErbB-3 class receptor binding; F:Hsp90 protein binding; F:kinase activity; F:p53 binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;, P:axon extension; P:axonogenesis; P:behavioral response to cocaine; P:calcium ion import; P:cell division; P:cell-matrix adhesion; P:cellular response to amyloid-beta; P:central nervous system neuron development; P:cerebellar cortex formation; P:chemical synaptic transmission; P:corpus callosum development; P:cortical actin cytoskeleton organization; P:dendrite morphogenesis; P:excitatory postsynaptic potential; P:hippocampus development; P:histone phosphorylation; P:intracellular protein transport; P:layer formation in cerebral cortex; P:microtubule cytoskeleton organization; P:mitochondrion organization; P:motor neuron axon guidance; P:negative regulation of axon extension; P:negative regulation of cell cycle; P:negative regulation of neuron death; P:negative regulation of protein export from nucleus; P:negative regulation of protein ubiquitination; P:negative regulation of proteolysis; P:negative regulation of synaptic plasticity; P:negative regulation of transcription, DNA-templated; P:neuron apoptotic process; P:neuron differentiation; P:neuron migration; P:neuron projection development; P:nucleocytoplasmic transport; P:oligodendrocyte differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of glial cell apoptotic process; P:positive regulation of neuron apoptotic process; P:positive regulation of protein binding; P:positive regulation of protein kinase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of voltage-gated calcium channel activity; P:protein autophosphorylation; P:protein localization to synapse; P:protein phosphorylation; P:receptor catabolic process; P:receptor clustering; P:regulation of apoptotic process; P:regulation of cell cycle arrest; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:regulation of macroautophagy; P:regulation of protein localization to plasma membrane; P:regulation of signal transduction by p53 class mediator; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, glutamatergic; P:regulation of synaptic vesicle recycling; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:response to wounding; P:rhythmic process; P:Schwann cell development; P:sensory perception of pain; P:serine phosphorylation of STAT protein; P:skeletal muscle tissue development; P:synapse assembly; P:synapse pruning; P:synaptic transmission, dopaminergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis; P:synaptic vesicle transport; P:visual learning;|Q00535 A1XKG3,Cyclin-dependent-like kinase 5,Cell division protein kinase 5;Serine/threonine-protein kinase PSSALRE;Tau protein kinase II catalytic subunit;, PF00069;, GO:0030424;GO:0030054;GO:0005737;GO:0005829;GO:0030425;GO:0030175;GO:0098978;GO:0030426;GO:0030027;GO:0016020;GO:0005874;GO:0031594;GO:0043005;GO:0043025;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0098793;GO:0016533;GO:0098685;GO:0030549;GO:0005524;GO:0004693;GO:0046875;GO:0005176;GO:0043125;GO:0051879;GO:0016301;GO:0002039;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0099635;GO:0048675;GO:0007409;GO:0048148;GO:0070509;GO:0051301;GO:0007160;GO:1904646;GO:0021954;GO:0021697;GO:0007268;GO:0022038;GO:0030866;GO:0048813;GO:0060079;GO:0021766;GO:0016572;GO:0006886;GO:0021819;GO:0000226;GO:0007005;GO:0008045;GO:0030517;GO:0045786;GO:1901215;GO:0046826;GO:0031397;GO:0045861;GO:0031914;GO:0045892;GO:0051402;GO:0030182;GO:0001764;GO:0031175;GO:0006913;GO:0048709;GO:0018105;GO:0018107;GO:0016310;GO:2000251;GO:0045956;GO:0034352;GO:0043525;GO:0032092;GO:0045860;GO:0090314;GO:1901387;GO:0046777;GO:0035418;GO:0006468;GO:0032801;GO:0043113;GO:0042981;GO:0071156;GO:0030334;GO:0061001;GO:0016241;GO:1903076;GO:1901796;GO:0048167;GO:0051966;GO:1903421;GO:0000083;GO:0009611;GO:0048511;GO:0014044;GO:0019233;GO:0042501;GO:0007519;GO:0007416;GO:0098883;GO:0001963;GO:0035249;GO:0048488;GO:0016079;GO:0048489;GO:0008542;, C:axon; C:cell junction; C:cytoplasm; C:cytosol; C:dendrite; C:filopodium; C:glutamatergic synapse; C:growth cone; C:lamellipodium; C:membrane; C:microtubule; C:neuromuscular junction; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:presynapse; C:protein kinase 5 complex; C:Schaffer collateral - CA1 synapse;, F:acetylcholine receptor activator activity; F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:ephrin receptor binding; F:ErbB-2 class receptor binding; F:ErbB-3 class receptor binding; F:Hsp90 protein binding; F:kinase activity; F:p53 binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;, P:axon extension; P:axonogenesis; P:behavioral response to cocaine; P:calcium ion import; P:cell division; P:cell-matrix adhesion; P:cellular response to amyloid-beta; P:central nervous system neuron development; P:cerebellar cortex formation; P:chemical synaptic transmission; P:corpus callosum development; P:cortical actin cytoskeleton organization; P:dendrite morphogenesis; P:excitatory postsynaptic potential; P:hippocampus development; P:histone phosphorylation; P:intracellular protein transport; P:layer formation in cerebral cortex; P:microtubule cytoskeleton organization; P:mitochondrion organization; P:motor neuron axon guidance; P:negative regulation of axon extension; P:negative regulation of cell cycle; P:negative regulation of neuron death; P:negative regulation of protein export from nucleus; P:negative regulation of protein ubiquitination; P:negative regulation of proteolysis; P:negative regulation of synaptic plasticity; P:negative regulation of transcription, DNA-templated; P:neuron apoptotic process; P:neuron differentiation; P:neuron migration; P:neuron projection development; P:nucleocytoplasmic transport; P:oligodendrocyte differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphorylation; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of glial cell apoptotic process; P:positive regulation of neuron apoptotic process; P:positive regulation of protein binding; P:positive regulation of protein kinase activity; P:positive regulation of protein targeting to membrane; P:positive regulation of voltage-gated calcium channel activity; P:protein autophosphorylation; P:protein localization to synapse; P:protein phosphorylation; P:receptor catabolic process; P:receptor clustering; P:regulation of apoptotic process; P:regulation of cell cycle arrest; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:regulation of macroautophagy; P:regulation of protein localization to plasma membrane; P:regulation of signal transduction by p53 class mediator; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, glutamatergic; P:regulation of synaptic vesicle recycling; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:response to wounding; P:rhythmic process; P:Schwann cell development; P:sensory perception of pain; P:serine phosphorylation of STAT protein; P:skeletal muscle tissue development; P:synapse assembly; P:synapse pruning; P:synaptic transmission, dopaminergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle endocytosis; P:synaptic vesicle exocytosis; P:synaptic vesicle transport; P:visual learning; scaffold137 indexed_genome mRNA 2464511 2469677 . - . ID=transcript_14309;Q9UHC3 B2R9V0 O60263 O75906 Q59FN9 Q9UER8 Q9UHC4,Acid-sensing ion channel 3,Amiloride-sensitive cation channel 3;Neuronal amiloride-sensitive cation channel 3;Testis sodium channel 1;, PF00858;, GO:0005887;GO:0048471;GO:0005886;GO:0044736;GO:0005261;GO:0042931;GO:0015280;GO:0005272;GO:0050968;GO:0050966;GO:0050965;GO:0034220;GO:0010447;GO:0009408;GO:0007600;GO:0050915;GO:0007165;GO:0035725;, C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:acid-sensing ion channel activity; F:cation channel activity; F:enterobactin transmembrane transporter activity; F:ligand-gated sodium channel activity; F:sodium channel activity;, P:detection of chemical stimulus involved in sensory perception of pain; P:detection of mechanical stimulus involved in sensory perception of pain; P:detection of temperature stimulus involved in sensory perception of pain; P:ion transmembrane transport; P:response to acidic pH; P:response to heat; P:sensory perception; P:sensory perception of sour taste; P:signal transduction; P:sodium ion transmembrane transport;|Q9UHC3 B2R9V0 O60263 O75906 Q59FN9 Q9UER8 Q9UHC4,Acid-sensing ion channel 3,Amiloride-sensitive cation channel 3;Neuronal amiloride-sensitive cation channel 3;Testis sodium channel 1;, PF00858;, GO:0005887;GO:0048471;GO:0005886;GO:0044736;GO:0005261;GO:0042931;GO:0015280;GO:0005272;GO:0050968;GO:0050966;GO:0050965;GO:0034220;GO:0010447;GO:0009408;GO:0007600;GO:0050915;GO:0007165;GO:0035725;, C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:acid-sensing ion channel activity; F:cation channel activity; F:enterobactin transmembrane transporter activity; F:ligand-gated sodium channel activity; F:sodium channel activity;, P:detection of chemical stimulus involved in sensory perception of pain; P:detection of mechanical stimulus involved in sensory perception of pain; P:detection of temperature stimulus involved in sensory perception of pain; P:ion transmembrane transport; P:response to acidic pH; P:response to heat; P:sensory perception; P:sensory perception of sour taste; P:signal transduction; P:sodium ion transmembrane transport;|Q9UHC3 B2R9V0 O60263 O75906 Q59FN9 Q9UER8 Q9UHC4,Acid-sensing ion channel 3,Amiloride-sensitive cation channel 3;Neuronal amiloride-sensitive cation channel 3;Testis sodium channel 1;, PF00858;, GO:0005887;GO:0048471;GO:0005886;GO:0044736;GO:0005261;GO:0042931;GO:0015280;GO:0005272;GO:0050968;GO:0050966;GO:0050965;GO:0034220;GO:0010447;GO:0009408;GO:0007600;GO:0050915;GO:0007165;GO:0035725;, C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:acid-sensing ion channel activity; F:cation channel activity; F:enterobactin transmembrane transporter activity; F:ligand-gated sodium channel activity; F:sodium channel activity;, P:detection of chemical stimulus involved in sensory perception of pain; P:detection of mechanical stimulus involved in sensory perception of pain; P:detection of temperature stimulus involved in sensory perception of pain; P:ion transmembrane transport; P:response to acidic pH; P:response to heat; P:sensory perception; P:sensory perception of sour taste; P:signal transduction; P:sodium ion transmembrane transport; scaffold137 indexed_genome mRNA 2469711 2487059 . - . ID=transcript_14310;Q9NUT2 A5D8W3 B2RBL8 B3KND2 B4DG02 G3XAP3 O95787 Q53GM0,Mitochondrial potassium channel ATP-binding subunit {ECO:0000305},ATP-binding cassette sub-family B member 8, mitochondrial {ECO:0000303|PubMed:25944712};Mitochondrial ATP-binding cassette 1 {ECO:0000303|PubMed:9878413};Mitochondrial sulfonylurea-receptor {ECO:0000303|PubMed:31435016};, PF00664;PF00005;, GO:0043190;GO:0016021;GO:0062157;GO:0005743;GO:0031966;GO:0005739;GO:0005730;GO:0005654;GO:0005524;GO:0016887;GO:0042626;GO:0071805;GO:0055085;, C:ATP-binding cassette (ABC) transporter complex; C:integral component of membrane; C:mitochondrial ATP-gated potassium channel complex; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:potassium ion transmembrane transport; P:transmembrane transport;|Q9NUT2 A5D8W3 B2RBL8 B3KND2 B4DG02 G3XAP3 O95787 Q53GM0,Mitochondrial potassium channel ATP-binding subunit {ECO:0000305},ATP-binding cassette sub-family B member 8, mitochondrial {ECO:0000303|PubMed:25944712};Mitochondrial ATP-binding cassette 1 {ECO:0000303|PubMed:9878413};Mitochondrial sulfonylurea-receptor {ECO:0000303|PubMed:31435016};, PF00664;PF00005;, GO:0043190;GO:0016021;GO:0062157;GO:0005743;GO:0031966;GO:0005739;GO:0005730;GO:0005654;GO:0005524;GO:0016887;GO:0042626;GO:0071805;GO:0055085;, C:ATP-binding cassette (ABC) transporter complex; C:integral component of membrane; C:mitochondrial ATP-gated potassium channel complex; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:potassium ion transmembrane transport; P:transmembrane transport;|Q9NUT2 A5D8W3 B2RBL8 B3KND2 B4DG02 G3XAP3 O95787 Q53GM0,Mitochondrial potassium channel ATP-binding subunit {ECO:0000305},ATP-binding cassette sub-family B member 8, mitochondrial {ECO:0000303|PubMed:25944712};Mitochondrial ATP-binding cassette 1 {ECO:0000303|PubMed:9878413};Mitochondrial sulfonylurea-receptor {ECO:0000303|PubMed:31435016};, PF00664;PF00005;, GO:0043190;GO:0016021;GO:0062157;GO:0005743;GO:0031966;GO:0005739;GO:0005730;GO:0005654;GO:0005524;GO:0016887;GO:0042626;GO:0071805;GO:0055085;, C:ATP-binding cassette (ABC) transporter complex; C:integral component of membrane; C:mitochondrial ATP-gated potassium channel complex; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity;, P:potassium ion transmembrane transport; P:transmembrane transport; scaffold137 indexed_genome mRNA 2490172 2493841 . + . ID=transcript_14311;Q674R7 A1A5D3 Q6JRW5 Q8N8I8,Autophagy-related protein 9B,APG9-like 2;Nitric oxide synthase 3-overlapping antisense gene protein;, PF04109;, GO:0005776;GO:0000421;GO:0031410;GO:0016021;GO:0000407;GO:0000045;GO:0000422;GO:0044805;GO:0034497;, C:autophagosome; C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:phagophore assembly site;, , P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:protein localization to phagophore assembly site; scaffold137 indexed_genome mRNA 2494477 2506520 . + . ID=transcript_14312;Q548C1 Q6GSL5 Q9UDC6,Nitric oxide synthase, endothelial,Constitutive NOS;EC-NOS;Endothelial NOS;NOS type III;, PF00667;PF00258;PF00175;PF02898;, GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0030666;GO:0005794;GO:0000139;GO:0005634;GO:0005886;GO:0012506;GO:0003785;GO:0034618;GO:0046870;GO:0005516;GO:0050660;GO:0010181;GO:0020037;GO:0050661;GO:0004517;GO:0016491;GO:0016709;GO:0034617;GO:0003180;GO:0006527;GO:0097746;GO:0001974;GO:0045454;GO:0003203;GO:0043542;GO:0048873;GO:0007005;GO:0070168;GO:0045776;GO:0008285;GO:1902042;GO:0014740;GO:0010544;GO:0006809;GO:0007263;GO:0045766;GO:0043536;GO:0010628;GO:0031284;GO:0045747;GO:0003184;GO:0008217;GO:0031644;GO:0050999;GO:0003100;GO:0019430;GO:0034405;GO:0009408;GO:0009725;GO:0032496;GO:0014806;GO:0046146;GO:0042311;, C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endocytic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:nucleus; C:plasma membrane; C:vesicle membrane;, F:actin monomer binding; F:arginine binding; F:cadmium ion binding; F:calmodulin binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:heme binding; F:NADP binding; F:nitric-oxide synthase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:tetrahydrobiopterin binding;, P:aortic valve morphogenesis; P:arginine catabolic process; P:blood vessel diameter maintenance; P:blood vessel remodeling; P:cell redox homeostasis; P:endocardial cushion morphogenesis; P:endothelial cell migration; P:homeostasis of number of cells within a tissue; P:mitochondrion organization; P:negative regulation of biomineral tissue development; P:negative regulation of blood pressure; P:negative regulation of cell population proliferation; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of muscle hyperplasia; P:negative regulation of platelet activation; P:nitric oxide biosynthetic process; P:nitric oxide mediated signal transduction; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of gene expression; P:positive regulation of guanylate cyclase activity; P:positive regulation of Notch signaling pathway; P:pulmonary valve morphogenesis; P:regulation of blood pressure; P:regulation of nervous system process; P:regulation of nitric-oxide synthase activity; P:regulation of systemic arterial blood pressure by endothelin; P:removal of superoxide radicals; P:response to fluid shear stress; P:response to heat; P:response to hormone; P:response to lipopolysaccharide; P:smooth muscle hyperplasia; P:tetrahydrobiopterin metabolic process; P:vasodilation;|Q548C1 Q6GSL5 Q9UDC6,Nitric oxide synthase, endothelial,Constitutive NOS;EC-NOS;Endothelial NOS;NOS type III;, PF00667;PF00258;PF00175;PF02898;, GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0030666;GO:0005794;GO:0000139;GO:0005634;GO:0005886;GO:0012506;GO:0003785;GO:0034618;GO:0046870;GO:0005516;GO:0050660;GO:0010181;GO:0020037;GO:0050661;GO:0004517;GO:0016491;GO:0016709;GO:0034617;GO:0003180;GO:0006527;GO:0097746;GO:0001974;GO:0045454;GO:0003203;GO:0043542;GO:0048873;GO:0007005;GO:0070168;GO:0045776;GO:0008285;GO:1902042;GO:0014740;GO:0010544;GO:0006809;GO:0007263;GO:0045766;GO:0043536;GO:0010628;GO:0031284;GO:0045747;GO:0003184;GO:0008217;GO:0031644;GO:0050999;GO:0003100;GO:0019430;GO:0034405;GO:0009408;GO:0009725;GO:0032496;GO:0014806;GO:0046146;GO:0042311;, C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endocytic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:nucleus; C:plasma membrane; C:vesicle membrane;, F:actin monomer binding; F:arginine binding; F:cadmium ion binding; F:calmodulin binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:heme binding; F:NADP binding; F:nitric-oxide synthase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:tetrahydrobiopterin binding;, P:aortic valve morphogenesis; P:arginine catabolic process; P:blood vessel diameter maintenance; P:blood vessel remodeling; P:cell redox homeostasis; P:endocardial cushion morphogenesis; P:endothelial cell migration; P:homeostasis of number of cells within a tissue; P:mitochondrion organization; P:negative regulation of biomineral tissue development; P:negative regulation of blood pressure; P:negative regulation of cell population proliferation; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of muscle hyperplasia; P:negative regulation of platelet activation; P:nitric oxide biosynthetic process; P:nitric oxide mediated signal transduction; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of gene expression; P:positive regulation of guanylate cyclase activity; P:positive regulation of Notch signaling pathway; P:pulmonary valve morphogenesis; P:regulation of blood pressure; P:regulation of nervous system process; P:regulation of nitric-oxide synthase activity; P:regulation of systemic arterial blood pressure by endothelin; P:removal of superoxide radicals; P:response to fluid shear stress; P:response to heat; P:response to hormone; P:response to lipopolysaccharide; P:smooth muscle hyperplasia; P:tetrahydrobiopterin metabolic process; P:vasodilation; scaffold137 indexed_genome mRNA 2507764 2514823 . - . ID=transcript_14313;Q548C1 Q6GSL5 Q9UDC6,Nitric oxide synthase, endothelial,Constitutive NOS;EC-NOS;Endothelial NOS;NOS type III;, PF00667;PF00258;PF00175;PF02898;, GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0030666;GO:0005794;GO:0000139;GO:0005634;GO:0005886;GO:0012506;GO:0003785;GO:0034618;GO:0046870;GO:0005516;GO:0050660;GO:0010181;GO:0020037;GO:0050661;GO:0004517;GO:0016491;GO:0016709;GO:0034617;GO:0003180;GO:0006527;GO:0097746;GO:0001974;GO:0045454;GO:0003203;GO:0043542;GO:0048873;GO:0007005;GO:0070168;GO:0045776;GO:0008285;GO:1902042;GO:0014740;GO:0010544;GO:0006809;GO:0007263;GO:0045766;GO:0043536;GO:0010628;GO:0031284;GO:0045747;GO:0003184;GO:0008217;GO:0031644;GO:0050999;GO:0003100;GO:0019430;GO:0034405;GO:0009408;GO:0009725;GO:0032496;GO:0014806;GO:0046146;GO:0042311;, C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:endocytic vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:nucleus; C:plasma membrane; C:vesicle membrane;, F:actin monomer binding; F:arginine binding; F:cadmium ion binding; F:calmodulin binding; F:flavin adenine dinucleotide binding; F:FMN binding; F:heme binding; F:NADP binding; F:nitric-oxide synthase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:tetrahydrobiopterin binding;, P:aortic valve morphogenesis; P:arginine catabolic process; P:blood vessel diameter maintenance; P:blood vessel remodeling; P:cell redox homeostasis; P:endocardial cushion morphogenesis; P:endothelial cell migration; P:homeostasis of number of cells within a tissue; P:mitochondrion organization; P:negative regulation of biomineral tissue development; P:negative regulation of blood pressure; P:negative regulation of cell population proliferation; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of muscle hyperplasia; P:negative regulation of platelet activation; P:nitric oxide biosynthetic process; P:nitric oxide mediated signal transduction; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of gene expression; P:positive regulation of guanylate cyclase activity; P:positive regulation of Notch signaling pathway; P:pulmonary valve morphogenesis; P:regulation of blood pressure; P:regulation of nervous system process; P:regulation of nitric-oxide synthase activity; P:regulation of systemic arterial blood pressure by endothelin; P:removal of superoxide radicals; P:response to fluid shear stress; P:response to heat; P:response to hormone; P:response to lipopolysaccharide; P:smooth muscle hyperplasia; P:tetrahydrobiopterin metabolic process; P:vasodilation; scaffold138 indexed_genome mRNA 273373 304036 . - . ID=transcript_14314;Q5H9M0 D3DUX2 Q49AS5 Q8N2C0 Q96MT6,PWWP domain-containing DNA repair factor 3B {ECO:0000305},Mutated melanoma-associated antigen 1-like protein 1;PWWP domain-containing protein MUM1L1;, PF00855;, GO:0070062;, C:extracellular exosome; scaffold138 indexed_genome mRNA 384035 390120 . + . ID=transcript_14315;P05543 D3DUX1,Thyroxine-binding globulin,Serpin A7;T4-binding globulin;, PF00079;, GO:0070062;GO:0005576;GO:0005615;GO:0004867;GO:0010951;GO:0070327;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity; P:thyroid hormone transport;|P05543 D3DUX1,Thyroxine-binding globulin,Serpin A7;T4-binding globulin;, PF00079;, GO:0070062;GO:0005576;GO:0005615;GO:0004867;GO:0010951;GO:0070327;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity; P:thyroid hormone transport;|P05543 D3DUX1,Thyroxine-binding globulin,Serpin A7;T4-binding globulin;, PF00079;, GO:0070062;GO:0005576;GO:0005615;GO:0004867;GO:0010951;GO:0070327;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity; P:thyroid hormone transport;|P05543 D3DUX1,Thyroxine-binding globulin,Serpin A7;T4-binding globulin;, PF00079;, GO:0070062;GO:0005576;GO:0005615;GO:0004867;GO:0010951;GO:0070327;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:serine-type endopeptidase inhibitor activity;, P:negative regulation of endopeptidase activity; P:thyroid hormone transport; scaffold138 indexed_genome mRNA 456501 499701 . - . ID=transcript_14316;Q7Z2Y5 Q32ND6 Q5H9K2 Q6ZMP2,Nik-related protein kinase,, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0000165;GO:0048812;GO:0031098;, C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:MAPK cascade; P:neuron projection morphogenesis; P:stress-activated protein kinase signaling cascade; scaffold138 indexed_genome mRNA 503100 579663 . - . ID=transcript_14317;Q7Z2Y5 Q32ND6 Q5H9K2 Q6ZMP2,Nik-related protein kinase,, PF00780;PF00069;, GO:0005737;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0032147;GO:0000165;GO:0048812;GO:0031098;, C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:activation of protein kinase activity; P:MAPK cascade; P:neuron projection morphogenesis; P:stress-activated protein kinase signaling cascade; scaffold138 indexed_genome mRNA 2436163 2462517 . - . ID=transcript_14318;Q6PEV8 Q8WVP6 Q96AV3,Protein FAM199X,, PF15814; scaffold139 indexed_genome mRNA 308 7887 . + . ID=transcript_14319;Q8WVR3 A4D2A9 D6W5U4 Q9BQJ1 Q9BUB6 Q9NV47,Trafficking protein particle complex subunit 14,Microtubule-associated protein 11 {ECO:0000303|PubMed:30715179};, PF15806;, GO:0034451;GO:0043231;GO:0030496;GO:0072686;GO:0005886;GO:1990071;GO:0043014;GO:0060271;GO:0042127;, C:centriolar satellite; C:intracellular membrane-bounded organelle; C:midbody; C:mitotic spindle; C:plasma membrane; C:TRAPPII protein complex;, F:alpha-tubulin binding;, P:cilium assembly; P:regulation of cell population proliferation;|Q8WVR3 A4D2A9 D6W5U4 Q9BQJ1 Q9BUB6 Q9NV47,Trafficking protein particle complex subunit 14,Microtubule-associated protein 11 {ECO:0000303|PubMed:30715179};, PF15806;, GO:0034451;GO:0043231;GO:0030496;GO:0072686;GO:0005886;GO:1990071;GO:0043014;GO:0060271;GO:0042127;, C:centriolar satellite; C:intracellular membrane-bounded organelle; C:midbody; C:mitotic spindle; C:plasma membrane; C:TRAPPII protein complex;, F:alpha-tubulin binding;, P:cilium assembly; P:regulation of cell population proliferation;|Q0VGL1,Ragulator complex protein LAMTOR4,Late endosomal/lysosomal adaptor and MAPK and MTOR activator 4;, , GO:0043231;GO:0005765;GO:0005764;GO:0071986;GO:0007050;GO:0034198;GO:0071230;GO:0032008;GO:0061462;GO:0050790;GO:0008361;GO:0016241;, C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:Ragulator complex;, , P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:positive regulation of TOR signaling; P:protein localization to lysosome; P:regulation of catalytic activity; P:regulation of cell size; P:regulation of macroautophagy;|Q0VGL1,Ragulator complex protein LAMTOR4,Late endosomal/lysosomal adaptor and MAPK and MTOR activator 4;, , GO:0043231;GO:0005765;GO:0005764;GO:0071986;GO:0007050;GO:0034198;GO:0071230;GO:0032008;GO:0061462;GO:0050790;GO:0008361;GO:0016241;, C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:Ragulator complex;, , P:cell cycle arrest; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:positive regulation of TOR signaling; P:protein localization to lysosome; P:regulation of catalytic activity; P:regulation of cell size; P:regulation of macroautophagy; scaffold139 indexed_genome mRNA 88713 90329 . + . ID=transcript_14320;A4D2B0 Q8N5X8,Metallo-beta-lactamase domain-containing protein 1,, PF00753;, GO:0016787;GO:0046872;, , F:hydrolase activity; F:metal ion binding; scaffold139 indexed_genome mRNA 90958 93087 . - . ID=transcript_14321;Q8N129 Q8WUN9,Protein canopy homolog 4,, PF11938;, GO:0005576;GO:0005102;GO:1903078;, C:extracellular region;, F:signaling receptor binding;, P:positive regulation of protein localization to plasma membrane; scaffold139 indexed_genome mRNA 94364 96058 . + . ID=transcript_14322;Q8N129 Q8WUN9,Protein canopy homolog 4,, PF11938;, GO:0005576;GO:0005102;GO:1903078;, C:extracellular region;, F:signaling receptor binding;, P:positive regulation of protein localization to plasma membrane; scaffold139 indexed_genome mRNA 96072 106269 . + . ID=transcript_14323;P49848 A4D2B2 A4D2B3 B4DT11 D6W5U2 Q6AI29,Transcription initiation factor TFIID subunit 6,RNA polymerase II TBP-associated factor subunit E;Transcription initiation factor TFIID 70 kDa subunit;Transcription initiation factor TFIID 80 kDa subunit;, PF02969;PF07571;, GO:0005829;GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0000124;GO:0046695;GO:0005669;GO:0033276;GO:0017162;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006915;GO:0006352;GO:0016573;GO:0045786;GO:0008285;GO:0043065;GO:2001244;GO:0045944;GO:0060261;GO:1901796;GO:0042795;GO:0006366;GO:0006367;, C:cytosol; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SAGA complex; C:SLIK (SAGA-like) complex; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:apoptotic process; P:DNA-templated transcription, initiation; P:histone acetylation; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of signal transduction by p53 class mediator; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P49848 A4D2B2 A4D2B3 B4DT11 D6W5U2 Q6AI29,Transcription initiation factor TFIID subunit 6,RNA polymerase II TBP-associated factor subunit E;Transcription initiation factor TFIID 70 kDa subunit;Transcription initiation factor TFIID 80 kDa subunit;, PF02969;PF07571;, GO:0005829;GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0000124;GO:0046695;GO:0005669;GO:0033276;GO:0017162;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006915;GO:0006352;GO:0016573;GO:0045786;GO:0008285;GO:0043065;GO:2001244;GO:0045944;GO:0060261;GO:1901796;GO:0042795;GO:0006366;GO:0006367;, C:cytosol; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SAGA complex; C:SLIK (SAGA-like) complex; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:apoptotic process; P:DNA-templated transcription, initiation; P:histone acetylation; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of signal transduction by p53 class mediator; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P49848 A4D2B2 A4D2B3 B4DT11 D6W5U2 Q6AI29,Transcription initiation factor TFIID subunit 6,RNA polymerase II TBP-associated factor subunit E;Transcription initiation factor TFIID 70 kDa subunit;Transcription initiation factor TFIID 80 kDa subunit;, PF02969;PF07571;, GO:0005829;GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0000124;GO:0046695;GO:0005669;GO:0033276;GO:0017162;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006915;GO:0006352;GO:0016573;GO:0045786;GO:0008285;GO:0043065;GO:2001244;GO:0045944;GO:0060261;GO:1901796;GO:0042795;GO:0006366;GO:0006367;, C:cytosol; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SAGA complex; C:SLIK (SAGA-like) complex; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:apoptotic process; P:DNA-templated transcription, initiation; P:histone acetylation; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of signal transduction by p53 class mediator; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|P49848 A4D2B2 A4D2B3 B4DT11 D6W5U2 Q6AI29,Transcription initiation factor TFIID subunit 6,RNA polymerase II TBP-associated factor subunit E;Transcription initiation factor TFIID 70 kDa subunit;Transcription initiation factor TFIID 80 kDa subunit;, PF02969;PF07571;, GO:0005829;GO:0071339;GO:0005654;GO:0005634;GO:0032991;GO:0000124;GO:0046695;GO:0005669;GO:0033276;GO:0017162;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006915;GO:0006352;GO:0016573;GO:0045786;GO:0008285;GO:0043065;GO:2001244;GO:0045944;GO:0060261;GO:1901796;GO:0042795;GO:0006366;GO:0006367;, C:cytosol; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SAGA complex; C:SLIK (SAGA-like) complex; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:aryl hydrocarbon receptor binding; F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:apoptotic process; P:DNA-templated transcription, initiation; P:histone acetylation; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:positive regulation of apoptotic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:regulation of signal transduction by p53 class mediator; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|O00189 D6W5U1 Q8WV65 Q9UHK9,AP-4 complex subunit mu-1 {ECO:0000305},AP-4 adaptor complex mu subunit;Adaptor-related protein complex 4 subunit mu-1;Mu subunit of AP-4;Mu-adaptin-related protein 2;Mu4-adaptin;, PF00928;PF01217;, GO:0030124;GO:0030131;GO:0031410;GO:0005829;GO:0005769;GO:0031904;GO:0070062;GO:0043231;GO:0005802;GO:0032588;GO:0019904;GO:0006895;GO:0090160;GO:0006886;GO:0006892;GO:0008104;GO:1903361;GO:0006605;GO:0006622;GO:0016192;, C:AP-4 adaptor complex; C:clathrin adaptor complex; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:endosome lumen; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:trans-Golgi network; C:trans-Golgi network membrane;, F:protein domain specific binding;, P:Golgi to endosome transport; P:Golgi to lysosome transport; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:protein localization; P:protein localization to basolateral plasma membrane; P:protein targeting; P:protein targeting to lysosome; P:vesicle-mediated transport;|O00189 D6W5U1 Q8WV65 Q9UHK9,AP-4 complex subunit mu-1 {ECO:0000305},AP-4 adaptor complex mu subunit;Adaptor-related protein complex 4 subunit mu-1;Mu subunit of AP-4;Mu-adaptin-related protein 2;Mu4-adaptin;, PF00928;PF01217;, GO:0030124;GO:0030131;GO:0031410;GO:0005829;GO:0005769;GO:0031904;GO:0070062;GO:0043231;GO:0005802;GO:0032588;GO:0019904;GO:0006895;GO:0090160;GO:0006886;GO:0006892;GO:0008104;GO:1903361;GO:0006605;GO:0006622;GO:0016192;, C:AP-4 adaptor complex; C:clathrin adaptor complex; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:endosome lumen; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:trans-Golgi network; C:trans-Golgi network membrane;, F:protein domain specific binding;, P:Golgi to endosome transport; P:Golgi to lysosome transport; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:protein localization; P:protein localization to basolateral plasma membrane; P:protein targeting; P:protein targeting to lysosome; P:vesicle-mediated transport; scaffold139 indexed_genome mRNA 107315 117211 . + . ID=transcript_14324;P33993 A4D2A1 A4D2A2 E9PGN9 Q15076 Q96D34 Q96GL1,DNA replication licensing factor MCM7,CDC47 homolog;P1.1-MCM3;, PF00493;PF17855;PF14551;PF17207;, GO:0000785;GO:0000781;GO:0071162;GO:0005829;GO:0042555;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0003678;GO:0003688;GO:0003697;GO:0008283;GO:0006974;GO:0071364;GO:0071466;GO:0006260;GO:0006270;GO:0006271;GO:0006268;GO:0000727;GO:0036388;GO:0006267;GO:0042325;GO:0042493;, C:chromatin; C:chromosome, telomeric region; C:CMG complex; C:cytosol; C:MCM complex; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA helicase activity; F:DNA replication origin binding; F:single-stranded DNA binding;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to xenobiotic stimulus; P:DNA replication; P:DNA replication initiation; P:DNA strand elongation involved in DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via break-induced replication; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; P:regulation of phosphorylation; P:response to drug;|P33993 A4D2A1 A4D2A2 E9PGN9 Q15076 Q96D34 Q96GL1,DNA replication licensing factor MCM7,CDC47 homolog;P1.1-MCM3;, PF00493;PF17855;PF14551;PF17207;, GO:0000785;GO:0000781;GO:0071162;GO:0005829;GO:0042555;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0003678;GO:0003688;GO:0003697;GO:0008283;GO:0006974;GO:0071364;GO:0071466;GO:0006260;GO:0006270;GO:0006271;GO:0006268;GO:0000727;GO:0036388;GO:0006267;GO:0042325;GO:0042493;, C:chromatin; C:chromosome, telomeric region; C:CMG complex; C:cytosol; C:MCM complex; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA helicase activity; F:DNA replication origin binding; F:single-stranded DNA binding;, P:cell population proliferation; P:cellular response to DNA damage stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to xenobiotic stimulus; P:DNA replication; P:DNA replication initiation; P:DNA strand elongation involved in DNA replication; P:DNA unwinding involved in DNA replication; P:double-strand break repair via break-induced replication; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; P:regulation of phosphorylation; P:response to drug;|Q7L5N1 A4D2A3 O15387,COP9 signalosome complex subunit 6,JAB1-containing signalosome subunit 6;MOV34 homolog;Vpr-interacting protein;, PF01398;PF13012;, GO:0008180;GO:0005829;GO:0005654;GO:0048471;GO:0070122;GO:0000715;GO:0043687;GO:0000338;GO:0006283;GO:0016032;, C:COP9 signalosome; C:cytosol; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:isopeptidase activity;, P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q7L5N1 A4D2A3 O15387,COP9 signalosome complex subunit 6,JAB1-containing signalosome subunit 6;MOV34 homolog;Vpr-interacting protein;, PF01398;PF13012;, GO:0008180;GO:0005829;GO:0005654;GO:0048471;GO:0070122;GO:0000715;GO:0043687;GO:0000338;GO:0006283;GO:0016032;, C:COP9 signalosome; C:cytosol; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:isopeptidase activity;, P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair; P:viral process; scaffold139 indexed_genome mRNA 126203 134101 . + . ID=transcript_14325;P17036 D6W5U0 P13683 Q9HBR4 Q9NNX8 Q9NXJ1 Q9UC15 Q9UC16,Zinc finger protein 3,Zinc finger protein HF.12;Zinc finger protein HZF3.1;Zinc finger protein KOX25;, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0001227;GO:0042802;GO:0000977;GO:0008270;GO:0030154;GO:0045321;GO:0007275;GO:0000122;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:leukocyte activation; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold139 indexed_genome mRNA 143928 148328 . - . ID=transcript_14326;Q9Y5A6 A4D2A6 D6W5T9 Q9H0B5,Zinc finger and SCAN domain-containing protein 21,Renal carcinoma antigen NY-REN-21;Zinc finger protein 38 homolog;, PF02023;PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0007141;GO:0045944;GO:0006357;GO:0006355;GO:0007283;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:male meiosis I; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis;|Q9Y5A6 A4D2A6 D6W5T9 Q9H0B5,Zinc finger and SCAN domain-containing protein 21,Renal carcinoma antigen NY-REN-21;Zinc finger protein 38 homolog;, PF02023;PF00096;, GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0007141;GO:0045944;GO:0006357;GO:0006355;GO:0007283;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:male meiosis I; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis; scaffold139 indexed_genome mRNA 155562 175484 . - . ID=transcript_14327;P17029 A4D294 P52745 Q2M1U1 Q8TBW5 Q8TEK7,Zinc finger protein with KRAB and SCAN domains 1,Zinc finger protein 139;Zinc finger protein 36;Zinc finger protein KOX18;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P17029 A4D294 P52745 Q2M1U1 Q8TBW5 Q8TEK7,Zinc finger protein with KRAB and SCAN domains 1,Zinc finger protein 139;Zinc finger protein 36;Zinc finger protein KOX18;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold139 indexed_genome mRNA 217095 223870 . + . ID=transcript_14328;Q9C037 A4D298 Q75MK1 Q96F06 Q9C036,E3 ubiquitin-protein ligase TRIM4,RING finger protein 87;RING-type E3 ubiquitin transferase TRIM4 {ECO:0000305};Tripartite motif-containing protein 4;, PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005886;GO:0042802;GO:0061630;GO:0008270;GO:0045087;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:protein ubiquitination; P:regulation of gene expression;|Q9C037 A4D298 Q75MK1 Q96F06 Q9C036,E3 ubiquitin-protein ligase TRIM4,RING finger protein 87;RING-type E3 ubiquitin transferase TRIM4 {ECO:0000305};Tripartite motif-containing protein 4;, PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005886;GO:0042802;GO:0061630;GO:0008270;GO:0045087;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:protein ubiquitination; P:regulation of gene expression; scaffold139 indexed_genome mRNA 223903 235447 . + . ID=transcript_14329;Q9C037 A4D298 Q75MK1 Q96F06 Q9C036,E3 ubiquitin-protein ligase TRIM4,RING finger protein 87;RING-type E3 ubiquitin transferase TRIM4 {ECO:0000305};Tripartite motif-containing protein 4;, PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005886;GO:0042802;GO:0061630;GO:0008270;GO:0045087;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:protein ubiquitination; P:regulation of gene expression;|Q9C037 A4D298 Q75MK1 Q96F06 Q9C036,E3 ubiquitin-protein ligase TRIM4,RING finger protein 87;RING-type E3 ubiquitin transferase TRIM4 {ECO:0000305};Tripartite motif-containing protein 4;, PF00622;PF00643;, GO:0005737;GO:0005829;GO:0005886;GO:0042802;GO:0061630;GO:0008270;GO:0045087;GO:0016567;GO:0010468;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:identical protein binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:innate immune response; P:protein ubiquitination; P:regulation of gene expression; scaffold139 indexed_genome mRNA 250984 611301 . - . ID=transcript_14330;P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|P20815 A4D289 B7Z5I7 Q53WY8 Q75MV0 Q9HB56,Cytochrome P450 3A5 {ECO:0000303|PubMed:11502729},CYPIIIA5;Cytochrome P450-PCN3 {ECO:0000303|PubMed:2732228};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0008401;GO:0008395;GO:0050649;GO:0046222;GO:0009822;GO:0042737;GO:0008210;GO:0002933;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:drug catabolic process; P:estrogen metabolic process; P:lipid hydroxylation; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|P20815 A4D289 B7Z5I7 Q53WY8 Q75MV0 Q9HB56,Cytochrome P450 3A5 {ECO:0000303|PubMed:11502729},CYPIIIA5;Cytochrome P450-PCN3 {ECO:0000303|PubMed:2732228};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0008401;GO:0008395;GO:0050649;GO:0046222;GO:0009822;GO:0042737;GO:0008210;GO:0002933;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:drug catabolic process; P:estrogen metabolic process; P:lipid hydroxylation; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|Q9HB55 Q495Y1 Q75MK2 Q75MK3 Q9HB52 Q9HB53 Q9HB54 Q9HB57,Cytochrome P450 3A43,, PF00067;, GO:0005789;GO:0070330;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0008395;GO:0050649;GO:0070989;GO:0008202;, C:endoplasmic reticulum membrane;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:oxidative demethylation; P:steroid metabolic process;|P27635 A3KQT0 D3DWW6 Q16470 Q2HXT7 Q53FH7 Q6FGN8 Q8TDA5,60S ribosomal protein L10 {ECO:0000305},Laminin receptor homolog;Large ribosomal subunit protein uL16 {ECO:0000303|PubMed:24524803};Protein QM;Ribosomal protein L10 {ECO:0000312|HGNC:HGNC:10298};Tumor suppressor QM;, PF00252;, GO:0005829;GO:0022625;GO:0005783;GO:0016020;GO:0005634;GO:0032991;GO:0003723;GO:0003735;GO:0045182;GO:1990403;GO:0043066;GO:0000122;GO:0000184;GO:0006417;GO:0000027;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:membrane; C:nucleus; C:protein-containing complex;, F:RNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:embryonic brain development; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translation; P:ribosomal large subunit assembly; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|Q5FWF6 A4D282 A6NH61 Q6ZMZ9,Zinc finger protein 789,, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P20815 A4D289 B7Z5I7 Q53WY8 Q75MV0 Q9HB56,Cytochrome P450 3A5 {ECO:0000303|PubMed:11502729},CYPIIIA5;Cytochrome P450-PCN3 {ECO:0000303|PubMed:2732228};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0008401;GO:0008395;GO:0050649;GO:0046222;GO:0009822;GO:0042737;GO:0008210;GO:0002933;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:drug catabolic process; P:estrogen metabolic process; P:lipid hydroxylation; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P20815 A4D289 B7Z5I7 Q53WY8 Q75MV0 Q9HB56,Cytochrome P450 3A5 {ECO:0000303|PubMed:11502729},CYPIIIA5;Cytochrome P450-PCN3 {ECO:0000303|PubMed:2732228};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0008401;GO:0008395;GO:0050649;GO:0046222;GO:0009822;GO:0042737;GO:0008210;GO:0002933;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:drug catabolic process; P:estrogen metabolic process; P:lipid hydroxylation; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P20815 A4D289 B7Z5I7 Q53WY8 Q75MV0 Q9HB56,Cytochrome P450 3A5 {ECO:0000303|PubMed:11502729},CYPIIIA5;Cytochrome P450-PCN3 {ECO:0000303|PubMed:2732228};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0008401;GO:0008395;GO:0050649;GO:0046222;GO:0009822;GO:0042737;GO:0008210;GO:0002933;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:drug catabolic process; P:estrogen metabolic process; P:lipid hydroxylation; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|P20815 A4D289 B7Z5I7 Q53WY8 Q75MV0 Q9HB56,Cytochrome P450 3A5 {ECO:0000303|PubMed:11502729},CYPIIIA5;Cytochrome P450-PCN3 {ECO:0000303|PubMed:2732228};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0008401;GO:0008395;GO:0050649;GO:0046222;GO:0009822;GO:0042737;GO:0008210;GO:0002933;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:drug catabolic process; P:estrogen metabolic process; P:lipid hydroxylation; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|P24462 A4D288 Q9H241,Cytochrome P450 3A7 {ECO:0000303|PubMed:17178770},CYPIIIA7;Cytochrome P450-HFLA {ECO:0000303|PubMed:2492179};P450HLp2 {ECO:0000303|PubMed:2492179};, PF00067;, GO:0005789;GO:0062183;GO:0070330;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0019825;GO:0008401;GO:0008395;GO:0050649;GO:0008210;GO:0002933;GO:0070989;GO:0042573;GO:0042572;GO:0006694;GO:0008202;GO:0006805;, C:endoplasmic reticulum membrane;, F:all-trans retinoic acid 18-hydroxylase activity; F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:estrogen metabolic process; P:lipid hydroxylation; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid biosynthetic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P20815 A4D289 B7Z5I7 Q53WY8 Q75MV0 Q9HB56,Cytochrome P450 3A5 {ECO:0000303|PubMed:11502729},CYPIIIA5;Cytochrome P450-PCN3 {ECO:0000303|PubMed:2732228};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0008401;GO:0008395;GO:0050649;GO:0046222;GO:0009822;GO:0042737;GO:0008210;GO:0002933;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:drug catabolic process; P:estrogen metabolic process; P:lipid hydroxylation; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P20815 A4D289 B7Z5I7 Q53WY8 Q75MV0 Q9HB56,Cytochrome P450 3A5 {ECO:0000303|PubMed:11502729},CYPIIIA5;Cytochrome P450-PCN3 {ECO:0000303|PubMed:2732228};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0008401;GO:0008395;GO:0050649;GO:0046222;GO:0009822;GO:0042737;GO:0008210;GO:0002933;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:drug catabolic process; P:estrogen metabolic process; P:lipid hydroxylation; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P20815 A4D289 B7Z5I7 Q53WY8 Q75MV0 Q9HB56,Cytochrome P450 3A5 {ECO:0000303|PubMed:11502729},CYPIIIA5;Cytochrome P450-PCN3 {ECO:0000303|PubMed:2732228};, PF00067;, GO:0005789;GO:0043231;GO:0070330;GO:0101020;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0008401;GO:0008395;GO:0050649;GO:0046222;GO:0009822;GO:0042737;GO:0008210;GO:0002933;GO:0070989;GO:0042573;GO:0042572;GO:0008202;GO:0006805;, C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:aromatase activity; F:estrogen 16-alpha-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:retinoic acid 4-hydroxylase activity; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:drug catabolic process; P:estrogen metabolic process; P:lipid hydroxylation; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process;|P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|P08684 P05184 Q16757 Q9UK50,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842},1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};1,8-cineole 2-exo-monooxygenase;Albendazole monooxygenase (sulfoxide-forming);Albendazole sulfoxidase;CYPIIIA3;CYPIIIA4;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450 3A3;Cytochrome P450 HLp {ECO:0000303|PubMed:3460094};Cytochrome P450 NF-25;Cytochrome P450-PCN1;Nifedipine oxidase;Quinine 3-monooxygenase;, PF00067;, GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0102320;GO:0062181;GO:0062188;GO:0062189;GO:0062187;GO:0070330;GO:0034875;GO:0019899;GO:0101020;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0019825;GO:0050591;GO:0008401;GO:0005496;GO:0008395;GO:0050649;GO:0070576;GO:0030343;GO:0046222;GO:0009822;GO:0008209;GO:0008203;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0002933;GO:0006629;GO:0042759;GO:0016098;GO:0070989;GO:0042573;GO:0042572;GO:0006706;GO:0008202;GO:0042369;GO:0042359;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:1,8-cineole 2-exo-monooxygenase activity; F:1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity; F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:aromatase activity; F:caffeine oxidase activity; F:enzyme binding; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxygen binding; F:quinine 3-monooxygenase activity; F:retinoic acid 4-hydroxylase activity; F:steroid binding; F:steroid hydroxylase activity; F:testosterone 6-beta-hydroxylase activity; F:vitamin D 24-hydroxylase activity; F:vitamin D3 25-hydroxylase activity;, P:aflatoxin metabolic process; P:alkaloid catabolic process; P:androgen metabolic process; P:cholesterol metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:lipid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:oxidative demethylation; P:retinoic acid metabolic process; P:retinol metabolic process; P:steroid catabolic process; P:steroid metabolic process; P:vitamin D catabolic process; P:vitamin D metabolic process; P:xenobiotic metabolic process;|Q6NSZ9 A4D290 D6W5T5 Q14C82 Q14C99 Q5EBM9 Q6DJZ0 Q6N032 Q6ZML3,Zinc finger and SCAN domain-containing protein 25,Zinc finger protein 498;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P0DP42,Transmembrane protein 225B {ECO:0000312|HGNC:HGNC:53075},, , GO:0016021;GO:0010923;, C:integral component of membrane;, , P:negative regulation of phosphatase activity;|P0DP42,Transmembrane protein 225B {ECO:0000312|HGNC:HGNC:53075},, , GO:0016021;GO:0010923;, C:integral component of membrane;, , P:negative regulation of phosphatase activity;|P0DP42,Transmembrane protein 225B {ECO:0000312|HGNC:HGNC:53075},, , GO:0016021;GO:0010923;, C:integral component of membrane;, , P:negative regulation of phosphatase activity;|Q6ZN57 A5PLN5 B7ZM23 Q9H6Z6,Zinc finger protein 2 homolog,Zinc finger protein 751;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9BQ85,Zinc finger protein 655,Vav-interacting Krueppel-like protein;, PF00096;, GO:0005737;GO:0005730;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:2000134;GO:0006357;, C:cytoplasm; C:nucleolus; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of G1/S transition of mitotic cell cycle; P:regulation of transcription by RNA polymerase II;|P17036 D6W5U0 P13683 Q9HBR4 Q9NNX8 Q9NXJ1 Q9UC15 Q9UC16,Zinc finger protein 3,Zinc finger protein HF.12;Zinc finger protein HZF3.1;Zinc finger protein KOX25;, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0001227;GO:0042802;GO:0000977;GO:0008270;GO:0030154;GO:0045321;GO:0007275;GO:0000122;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:leukocyte activation; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9BQ85,Zinc finger protein 655,Vav-interacting Krueppel-like protein;, PF00096;, GO:0005737;GO:0005730;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:2000134;GO:0006357;, C:cytoplasm; C:nucleolus; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of G1/S transition of mitotic cell cycle; P:regulation of transcription by RNA polymerase II;|Q5FWF6 A4D282 A6NH61 Q6ZMZ9,Zinc finger protein 789,, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5FWF6 A4D282 A6NH61 Q6ZMZ9,Zinc finger protein 789,, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold139 indexed_genome mRNA 613897 625466 . - . ID=transcript_14331;Q9Y2L8 A4D280 D6W5S9,Zinc finger protein with KRAB and SCAN domains 5,Zinc finger protein 95 homolog;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold139 indexed_genome mRNA 628412 630206 . - . ID=transcript_14332;Q9Y2L8 A4D280 D6W5S9,Zinc finger protein with KRAB and SCAN domains 5,Zinc finger protein 95 homolog;, PF01352;PF02023;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0008270;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold139 indexed_genome mRNA 634953 637928 . + . ID=transcript_14333;Q53GI3 A4D281 Q05DA6 Q6P5X9 Q8TB27 Q9HA37 Q9UD51,Zinc finger protein 394,Zinc finger protein with KRAB and SCAN domains 14;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q53GI3 A4D281 Q05DA6 Q6P5X9 Q8TB27 Q9HA37 Q9UD51,Zinc finger protein 394,Zinc finger protein with KRAB and SCAN domains 14;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q53GI3 A4D281 Q05DA6 Q6P5X9 Q8TB27 Q9HA37 Q9UD51,Zinc finger protein 394,Zinc finger protein with KRAB and SCAN domains 14;, PF01352;PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold139 indexed_genome mRNA 665479 670541 . + . ID=transcript_14334;P56134 C9J8H9 F8W7V3 O76079 Q6IBB3 Q96L83 Q9BTI8,ATP synthase subunit f, mitochondrial {ECO:0000305},ATP synthase membrane subunit f {ECO:0000305};, PF10206;, GO:0016021;GO:0005743;GO:0005753;GO:0005739;GO:0031965;GO:0005634;GO:0045263;GO:0006754;GO:0042407;GO:0042776;GO:1902600;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrion; C:nuclear membrane; C:nucleus; C:proton-transporting ATP synthase complex, coupling factor F(o);, , P:ATP biosynthetic process; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:proton transmembrane transport;|P56134 C9J8H9 F8W7V3 O76079 Q6IBB3 Q96L83 Q9BTI8,ATP synthase subunit f, mitochondrial {ECO:0000305},ATP synthase membrane subunit f {ECO:0000305};, PF10206;, GO:0016021;GO:0005743;GO:0005753;GO:0005739;GO:0031965;GO:0005634;GO:0045263;GO:0006754;GO:0042407;GO:0042776;GO:1902600;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrion; C:nuclear membrane; C:nucleus; C:proton-transporting ATP synthase complex, coupling factor F(o);, , P:ATP biosynthetic process; P:cristae formation; P:mitochondrial ATP synthesis coupled proton transport; P:proton transmembrane transport; scaffold139 indexed_genome mRNA 671109 697220 . - . ID=transcript_14335;O75127 Q3ZB78 Q66K60 Q9UDV2,Pentatricopeptide repeat-containing protein 1, mitochondrial,, PF13812;PF17177;, GO:0005759;GO:0005739;GO:0003723;GO:0000049;GO:0042780;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding; F:tRNA binding;, P:tRNA 3'-end processing;|O95639 D6W5S8 Q6FGE6 Q86TF8 Q9BTW6,Cleavage and polyadenylation specificity factor subunit 4,Cleavage and polyadenylation specificity factor 30 kDa subunit;NS1 effector domain-binding protein 1;No arches homolog;, PF00642;PF15663;PF00098;, GO:0043231;GO:0005847;GO:0005654;GO:0003723;GO:1990837;GO:0008270;GO:0046778;GO:0031124;GO:0006406;GO:0000398;GO:0098789;GO:0006369;GO:0006388;, C:intracellular membrane-bounded organelle; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:RNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:modification by virus of host mRNA processing; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; P:tRNA splicing, via endonucleolytic cleavage and ligation;|O75127 Q3ZB78 Q66K60 Q9UDV2,Pentatricopeptide repeat-containing protein 1, mitochondrial,, PF13812;PF17177;, GO:0005759;GO:0005739;GO:0003723;GO:0000049;GO:0042780;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding; F:tRNA binding;, P:tRNA 3'-end processing;|O75127 Q3ZB78 Q66K60 Q9UDV2,Pentatricopeptide repeat-containing protein 1, mitochondrial,, PF13812;PF17177;, GO:0005759;GO:0005739;GO:0003723;GO:0000049;GO:0042780;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding; F:tRNA binding;, P:tRNA 3'-end processing; scaffold139 indexed_genome mRNA 698926 726167 . + . ID=transcript_14336;O75127 Q3ZB78 Q66K60 Q9UDV2,Pentatricopeptide repeat-containing protein 1, mitochondrial,, PF13812;PF17177;, GO:0005759;GO:0005739;GO:0003723;GO:0000049;GO:0042780;, C:mitochondrial matrix; C:mitochondrion;, F:RNA binding; F:tRNA binding;, P:tRNA 3'-end processing;|P41223 A4D274 B7Z4S9 D6W5S6 Q6IB53 Q9UDV1,Protein BUD31 homolog {ECO:0000303|PubMed:25091737},Protein EDG-2 {ECO:0000303|PubMed:7841202};Protein G10 homolog {ECO:0000303|PubMed:7841202};, PF01125;, GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0035257;GO:0030374;GO:0000398;GO:2000825;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity;, P:mRNA splicing, via spliceosome; P:positive regulation of androgen receptor activity;|P41223 A4D274 B7Z4S9 D6W5S6 Q6IB53 Q9UDV1,Protein BUD31 homolog {ECO:0000303|PubMed:25091737},Protein EDG-2 {ECO:0000303|PubMed:7841202};Protein G10 homolog {ECO:0000303|PubMed:7841202};, PF01125;, GO:0005654;GO:0005634;GO:0005681;GO:0071007;GO:0035257;GO:0030374;GO:0000398;GO:2000825;, C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type catalytic step 2 spliceosome;, F:nuclear hormone receptor binding; F:nuclear receptor coactivator activity;, P:mRNA splicing, via spliceosome; P:positive regulation of androgen receptor activity;|Q13442 D6W5S5 Q92906,28 kDa heat- and acid-stable phosphoprotein,PDGF-associated protein;PDGFA-associated protein 1;, PF10252;, GO:0005829;GO:0005576;GO:1904813;GO:0005886;GO:0003723;GO:0043312;GO:0007165;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:plasma membrane;, F:RNA binding;, P:neutrophil degranulation; P:signal transduction;|Q13442 D6W5S5 Q92906,28 kDa heat- and acid-stable phosphoprotein,PDGF-associated protein;PDGFA-associated protein 1;, PF10252;, GO:0005829;GO:0005576;GO:1904813;GO:0005886;GO:0003723;GO:0043312;GO:0007165;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:plasma membrane;, F:RNA binding;, P:neutrophil degranulation; P:signal transduction; scaffold139 indexed_genome mRNA 727623 729538 . + . ID=transcript_14337;O15143 Q9BU00,Actin-related protein 2/3 complex subunit 1B,Arp2/3 complex 41 kDa subunit;p41-ARC;, PF00400;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0005925;GO:0005634;GO:0036284;GO:0003779;GO:0044877;GO:0005200;GO:0034314;GO:0048013;GO:0038096;GO:0032355;GO:0043627;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:focal adhesion; C:nucleus; C:tubulobulbar complex;, F:actin binding; F:protein-containing complex binding; F:structural constituent of cytoskeleton;, P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:response to estradiol; P:response to estrogen; scaffold139 indexed_genome mRNA 729560 733836 . - . ID=transcript_14338;O15143 Q9BU00,Actin-related protein 2/3 complex subunit 1B,Arp2/3 complex 41 kDa subunit;p41-ARC;, PF00400;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0005925;GO:0005634;GO:0036284;GO:0003779;GO:0044877;GO:0005200;GO:0034314;GO:0048013;GO:0038096;GO:0032355;GO:0043627;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:focal adhesion; C:nucleus; C:tubulobulbar complex;, F:actin binding; F:protein-containing complex binding; F:structural constituent of cytoskeleton;, P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:response to estradiol; P:response to estrogen; scaffold139 indexed_genome mRNA 749813 756478 . - . ID=transcript_14339;Q92747 A4D276 B4DLQ7 D6W5S1 Q7Z5U8 Q86WU5 Q8IXQ0,Actin-related protein 2/3 complex subunit 1A,SOP2-like protein;, PF00400;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0005634;GO:0035861;GO:0003779;GO:0051015;GO:0030036;GO:0034314;GO:0048013;GO:0038096;GO:0061024;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:nucleus; C:site of double-strand break;, F:actin binding; F:actin filament binding;, P:actin cytoskeleton organization; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization;|Q92747 A4D276 B4DLQ7 D6W5S1 Q7Z5U8 Q86WU5 Q8IXQ0,Actin-related protein 2/3 complex subunit 1A,SOP2-like protein;, PF00400;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0005634;GO:0035861;GO:0003779;GO:0051015;GO:0030036;GO:0034314;GO:0048013;GO:0038096;GO:0061024;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:nucleus; C:site of double-strand break;, F:actin binding; F:actin filament binding;, P:actin cytoskeleton organization; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization;|Q92747 A4D276 B4DLQ7 D6W5S1 Q7Z5U8 Q86WU5 Q8IXQ0,Actin-related protein 2/3 complex subunit 1A,SOP2-like protein;, PF00400;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0005634;GO:0035861;GO:0003779;GO:0051015;GO:0030036;GO:0034314;GO:0048013;GO:0038096;GO:0061024;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:nucleus; C:site of double-strand break;, F:actin binding; F:actin filament binding;, P:actin cytoskeleton organization; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; scaffold139 indexed_genome mRNA 756494 760176 . - . ID=transcript_14340;Q92747 A4D276 B4DLQ7 D6W5S1 Q7Z5U8 Q86WU5 Q8IXQ0,Actin-related protein 2/3 complex subunit 1A,SOP2-like protein;, PF00400;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0005634;GO:0035861;GO:0003779;GO:0051015;GO:0030036;GO:0034314;GO:0048013;GO:0038096;GO:0061024;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:nucleus; C:site of double-strand break;, F:actin binding; F:actin filament binding;, P:actin cytoskeleton organization; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization;|Q92747 A4D276 B4DLQ7 D6W5S1 Q7Z5U8 Q86WU5 Q8IXQ0,Actin-related protein 2/3 complex subunit 1A,SOP2-like protein;, PF00400;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0005634;GO:0035861;GO:0003779;GO:0051015;GO:0030036;GO:0034314;GO:0048013;GO:0038096;GO:0061024;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:nucleus; C:site of double-strand break;, F:actin binding; F:actin filament binding;, P:actin cytoskeleton organization; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; scaffold139 indexed_genome mRNA 762745 767013 . - . ID=transcript_14341;Q92747 A4D276 B4DLQ7 D6W5S1 Q7Z5U8 Q86WU5 Q8IXQ0,Actin-related protein 2/3 complex subunit 1A,SOP2-like protein;, PF00400;, GO:0015629;GO:0005885;GO:0005829;GO:0070062;GO:0005634;GO:0035861;GO:0003779;GO:0051015;GO:0030036;GO:0034314;GO:0048013;GO:0038096;GO:0061024;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:cytosol; C:extracellular exosome; C:nucleus; C:site of double-strand break;, F:actin binding; F:actin filament binding;, P:actin cytoskeleton organization; P:Arp2/3 complex-mediated actin nucleation; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:membrane organization; scaffold139 indexed_genome mRNA 965070 966641 . + . ID=transcript_14342;Q9HCE7 A4D279 B7ZMB6 B9EGV3 O75853 Q547Q3 Q9UJT8,E3 ubiquitin-protein ligase SMURF1,HECT-type E3 ubiquitin transferase SMURF1;SMAD ubiquitination regulatory factor 1;SMAD-specific E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF00397;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0043025;GO:0005654;GO:0005886;GO:0048185;GO:0070411;GO:0005543;GO:0070412;GO:0061630;GO:0004842;GO:0030509;GO:0030154;GO:0007398;GO:0061736;GO:0030514;GO:0030512;GO:1903861;GO:0045732;GO:2000060;GO:0043161;GO:0006611;GO:0034394;GO:0072659;GO:0000209;GO:0071211;GO:0016567;GO:0032801;GO:0061753;GO:0007179;GO:0006511;GO:0030579;GO:0060071;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuronal cell body; C:nucleoplasm; C:plasma membrane;, F:activin binding; F:I-SMAD binding; F:phospholipid binding; F:R-SMAD binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:BMP signaling pathway; P:cell differentiation; P:ectoderm development; P:engulfment of target by autophagosome; P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of dendrite extension; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin-dependent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein export from nucleus; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein polyubiquitination; P:protein targeting to vacuole involved in autophagy; P:protein ubiquitination; P:receptor catabolic process; P:substrate localization to autophagosome; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HCE7 A4D279 B7ZMB6 B9EGV3 O75853 Q547Q3 Q9UJT8,E3 ubiquitin-protein ligase SMURF1,HECT-type E3 ubiquitin transferase SMURF1;SMAD ubiquitination regulatory factor 1;SMAD-specific E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF00397;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0043025;GO:0005654;GO:0005886;GO:0048185;GO:0070411;GO:0005543;GO:0070412;GO:0061630;GO:0004842;GO:0030509;GO:0030154;GO:0007398;GO:0061736;GO:0030514;GO:0030512;GO:1903861;GO:0045732;GO:2000060;GO:0043161;GO:0006611;GO:0034394;GO:0072659;GO:0000209;GO:0071211;GO:0016567;GO:0032801;GO:0061753;GO:0007179;GO:0006511;GO:0030579;GO:0060071;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuronal cell body; C:nucleoplasm; C:plasma membrane;, F:activin binding; F:I-SMAD binding; F:phospholipid binding; F:R-SMAD binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:BMP signaling pathway; P:cell differentiation; P:ectoderm development; P:engulfment of target by autophagosome; P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of dendrite extension; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin-dependent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein export from nucleus; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein polyubiquitination; P:protein targeting to vacuole involved in autophagy; P:protein ubiquitination; P:receptor catabolic process; P:substrate localization to autophagosome; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold139 indexed_genome mRNA 966681 967679 . - . ID=transcript_14343;Q9HCE7 A4D279 B7ZMB6 B9EGV3 O75853 Q547Q3 Q9UJT8,E3 ubiquitin-protein ligase SMURF1,HECT-type E3 ubiquitin transferase SMURF1;SMAD ubiquitination regulatory factor 1;SMAD-specific E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF00397;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0043025;GO:0005654;GO:0005886;GO:0048185;GO:0070411;GO:0005543;GO:0070412;GO:0061630;GO:0004842;GO:0030509;GO:0030154;GO:0007398;GO:0061736;GO:0030514;GO:0030512;GO:1903861;GO:0045732;GO:2000060;GO:0043161;GO:0006611;GO:0034394;GO:0072659;GO:0000209;GO:0071211;GO:0016567;GO:0032801;GO:0061753;GO:0007179;GO:0006511;GO:0030579;GO:0060071;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuronal cell body; C:nucleoplasm; C:plasma membrane;, F:activin binding; F:I-SMAD binding; F:phospholipid binding; F:R-SMAD binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:BMP signaling pathway; P:cell differentiation; P:ectoderm development; P:engulfment of target by autophagosome; P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of dendrite extension; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin-dependent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein export from nucleus; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein polyubiquitination; P:protein targeting to vacuole involved in autophagy; P:protein ubiquitination; P:receptor catabolic process; P:substrate localization to autophagosome; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold139 indexed_genome mRNA 968204 978753 . - . ID=transcript_14344;Q9HCE7 A4D279 B7ZMB6 B9EGV3 O75853 Q547Q3 Q9UJT8,E3 ubiquitin-protein ligase SMURF1,HECT-type E3 ubiquitin transferase SMURF1;SMAD ubiquitination regulatory factor 1;SMAD-specific E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF00397;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0043025;GO:0005654;GO:0005886;GO:0048185;GO:0070411;GO:0005543;GO:0070412;GO:0061630;GO:0004842;GO:0030509;GO:0030154;GO:0007398;GO:0061736;GO:0030514;GO:0030512;GO:1903861;GO:0045732;GO:2000060;GO:0043161;GO:0006611;GO:0034394;GO:0072659;GO:0000209;GO:0071211;GO:0016567;GO:0032801;GO:0061753;GO:0007179;GO:0006511;GO:0030579;GO:0060071;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuronal cell body; C:nucleoplasm; C:plasma membrane;, F:activin binding; F:I-SMAD binding; F:phospholipid binding; F:R-SMAD binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:BMP signaling pathway; P:cell differentiation; P:ectoderm development; P:engulfment of target by autophagosome; P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of dendrite extension; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin-dependent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein export from nucleus; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein polyubiquitination; P:protein targeting to vacuole involved in autophagy; P:protein ubiquitination; P:receptor catabolic process; P:substrate localization to autophagosome; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HCE7 A4D279 B7ZMB6 B9EGV3 O75853 Q547Q3 Q9UJT8,E3 ubiquitin-protein ligase SMURF1,HECT-type E3 ubiquitin transferase SMURF1;SMAD ubiquitination regulatory factor 1;SMAD-specific E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF00397;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0043025;GO:0005654;GO:0005886;GO:0048185;GO:0070411;GO:0005543;GO:0070412;GO:0061630;GO:0004842;GO:0030509;GO:0030154;GO:0007398;GO:0061736;GO:0030514;GO:0030512;GO:1903861;GO:0045732;GO:2000060;GO:0043161;GO:0006611;GO:0034394;GO:0072659;GO:0000209;GO:0071211;GO:0016567;GO:0032801;GO:0061753;GO:0007179;GO:0006511;GO:0030579;GO:0060071;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuronal cell body; C:nucleoplasm; C:plasma membrane;, F:activin binding; F:I-SMAD binding; F:phospholipid binding; F:R-SMAD binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:BMP signaling pathway; P:cell differentiation; P:ectoderm development; P:engulfment of target by autophagosome; P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of dendrite extension; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin-dependent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein export from nucleus; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein polyubiquitination; P:protein targeting to vacuole involved in autophagy; P:protein ubiquitination; P:receptor catabolic process; P:substrate localization to autophagosome; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9HCE7 A4D279 B7ZMB6 B9EGV3 O75853 Q547Q3 Q9UJT8,E3 ubiquitin-protein ligase SMURF1,HECT-type E3 ubiquitin transferase SMURF1;SMAD ubiquitination regulatory factor 1;SMAD-specific E3 ubiquitin-protein ligase 1;, PF00168;PF00632;PF00397;, GO:0030424;GO:0005737;GO:0005829;GO:0070062;GO:0043025;GO:0005654;GO:0005886;GO:0048185;GO:0070411;GO:0005543;GO:0070412;GO:0061630;GO:0004842;GO:0030509;GO:0030154;GO:0007398;GO:0061736;GO:0030514;GO:0030512;GO:1903861;GO:0045732;GO:2000060;GO:0043161;GO:0006611;GO:0034394;GO:0072659;GO:0000209;GO:0071211;GO:0016567;GO:0032801;GO:0061753;GO:0007179;GO:0006511;GO:0030579;GO:0060071;, C:axon; C:cytoplasm; C:cytosol; C:extracellular exosome; C:neuronal cell body; C:nucleoplasm; C:plasma membrane;, F:activin binding; F:I-SMAD binding; F:phospholipid binding; F:R-SMAD binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:BMP signaling pathway; P:cell differentiation; P:ectoderm development; P:engulfment of target by autophagosome; P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of dendrite extension; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin-dependent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein export from nucleus; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein polyubiquitination; P:protein targeting to vacuole involved in autophagy; P:protein ubiquitination; P:receptor catabolic process; P:substrate localization to autophagosome; P:transforming growth factor beta receptor signaling pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold139 indexed_genome mRNA 1007154 1058509 . + . ID=transcript_14345;Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated; scaffold139 indexed_genome mRNA 1059024 1070242 . - . ID=transcript_14346;Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated;|Q9Y4A5 A4D265 O75218 Q9Y631 Q9Y6H4,Transformation/transcription domain-associated protein,350/400 kDa PCAF-associated factor;STAF40;Tra1 homolog;, PF02259;PF00454;, GO:0005794;GO:0035267;GO:0005654;GO:0005634;GO:0000125;GO:0000124;GO:0030914;GO:0000812;GO:0033276;GO:0003712;GO:1904837;GO:0006281;GO:0016573;GO:0016578;GO:0043968;GO:0043967;GO:0016310;GO:0016579;GO:0006355;, C:Golgi apparatus; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:PCAF complex; C:SAGA complex; C:STAGA complex; C:Swr1 complex; C:transcription factor TFTC complex;, F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:DNA repair; P:histone acetylation; P:histone deubiquitination; P:histone H2A acetylation; P:histone H4 acetylation; P:phosphorylation; P:protein deubiquitination; P:regulation of transcription, DNA-templated; scaffold139 indexed_genome mRNA 1096515 1107298 . + . ID=transcript_14347;Q8N3G9 A4D266 B7Z364 Q8IY46 Q8N0W9 Q8N3R2,Transmembrane protein 130,, , GO:0005794;GO:0000139;GO:0005887;, C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane;|Q8N3G9 A4D266 B7Z364 Q8IY46 Q8N0W9 Q8N3R2,Transmembrane protein 130,, , GO:0005794;GO:0000139;GO:0005887;, C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; scaffold139 indexed_genome mRNA 1225691 1232127 . - . ID=transcript_14348;P47972 A4D267 Q86XV7 Q96G70,Neuronal pentraxin-2,Neuronal pentraxin II;, PF00354;, GO:0005576;GO:0098978;GO:0030246;GO:0046872;GO:0008306;GO:0007268;GO:0098962;, C:extracellular region; C:glutamatergic synapse;, F:carbohydrate binding; F:metal ion binding;, P:associative learning; P:chemical synaptic transmission; P:regulation of postsynaptic neurotransmitter receptor activity; scaffold139 indexed_genome mRNA 1389173 1467359 . + . ID=transcript_14349;Q9UHR4 A4D268 Q75L21 Q75L22 Q96CV4 Q9H5F5 Q9Y2M8,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1,Insulin receptor tyrosine kinase substrate;, PF08397;PF14604;, GO:0005912;GO:0005856;GO:0005829;GO:0070062;GO:0005654;GO:0005886;GO:0003779;GO:0098641;GO:0070064;GO:0051764;GO:0051017;GO:0007009;GO:2000251;GO:0030838;GO:0046626;GO:0009617;, C:adherens junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:plasma membrane;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:proline-rich region binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:plasma membrane organization; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:regulation of insulin receptor signaling pathway; P:response to bacterium;|Q9UHR4 A4D268 Q75L21 Q75L22 Q96CV4 Q9H5F5 Q9Y2M8,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1,Insulin receptor tyrosine kinase substrate;, PF08397;PF14604;, GO:0005912;GO:0005856;GO:0005829;GO:0070062;GO:0005654;GO:0005886;GO:0003779;GO:0098641;GO:0070064;GO:0051764;GO:0051017;GO:0007009;GO:2000251;GO:0030838;GO:0046626;GO:0009617;, C:adherens junction; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:plasma membrane;, F:actin binding; F:cadherin binding involved in cell-cell adhesion; F:proline-rich region binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:plasma membrane organization; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:regulation of insulin receptor signaling pathway; P:response to bacterium;|O95415 D6W5R8 F5GXW6 Q8WV52 Q9UIC6,Brain protein I3,pRGR2;, PF10164;, GO:0035577;GO:0016021;GO:0005634;GO:0048471;GO:0005886;GO:0042802;GO:0043312;, C:azurophil granule membrane; C:integral component of membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding;, P:neutrophil degranulation;|O95415 D6W5R8 F5GXW6 Q8WV52 Q9UIC6,Brain protein I3,pRGR2;, PF10164;, GO:0035577;GO:0016021;GO:0005634;GO:0048471;GO:0005886;GO:0042802;GO:0043312;, C:azurophil granule membrane; C:integral component of membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding;, P:neutrophil degranulation; scaffold139 indexed_genome mRNA 1470657 1472858 . - . ID=transcript_14350;O95415 D6W5R8 F5GXW6 Q8WV52 Q9UIC6,Brain protein I3,pRGR2;, PF10164;, GO:0035577;GO:0016021;GO:0005634;GO:0048471;GO:0005886;GO:0042802;GO:0043312;, C:azurophil granule membrane; C:integral component of membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:identical protein binding;, P:neutrophil degranulation; scaffold139 indexed_genome mRNA 1492647 1505330 . + . ID=transcript_14351;Q7Z6L1 A8KAD1 B3KPZ1 C9J024 F5GX57 Q96EB0 Q9P2I9 Q9UFR6,Tectonin beta-propeller repeat-containing protein 1,, PF06462;PF06398;PF19193;, GO:0000421;GO:0031410;GO:0016021;GO:0043231;GO:0005765;GO:0005654;GO:0032266;GO:0097352;GO:0006914;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome maturation; P:autophagy;|Q7Z6L1 A8KAD1 B3KPZ1 C9J024 F5GX57 Q96EB0 Q9P2I9 Q9UFR6,Tectonin beta-propeller repeat-containing protein 1,, PF06462;PF06398;PF19193;, GO:0000421;GO:0031410;GO:0016021;GO:0043231;GO:0005765;GO:0005654;GO:0032266;GO:0097352;GO:0006914;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome maturation; P:autophagy;|Q7Z6L1 A8KAD1 B3KPZ1 C9J024 F5GX57 Q96EB0 Q9P2I9 Q9UFR6,Tectonin beta-propeller repeat-containing protein 1,, PF06462;PF06398;PF19193;, GO:0000421;GO:0031410;GO:0016021;GO:0043231;GO:0005765;GO:0005654;GO:0032266;GO:0097352;GO:0006914;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome maturation; P:autophagy; scaffold139 indexed_genome mRNA 1508183 1519164 . - . ID=transcript_14352;Q7Z6L1 A8KAD1 B3KPZ1 C9J024 F5GX57 Q96EB0 Q9P2I9 Q9UFR6,Tectonin beta-propeller repeat-containing protein 1,, PF06462;PF06398;PF19193;, GO:0000421;GO:0031410;GO:0016021;GO:0043231;GO:0005765;GO:0005654;GO:0032266;GO:0097352;GO:0006914;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome maturation; P:autophagy;|Q7Z6L1 A8KAD1 B3KPZ1 C9J024 F5GX57 Q96EB0 Q9P2I9 Q9UFR6,Tectonin beta-propeller repeat-containing protein 1,, PF06462;PF06398;PF19193;, GO:0000421;GO:0031410;GO:0016021;GO:0043231;GO:0005765;GO:0005654;GO:0032266;GO:0097352;GO:0006914;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome maturation; P:autophagy;|Q7Z6L1 A8KAD1 B3KPZ1 C9J024 F5GX57 Q96EB0 Q9P2I9 Q9UFR6,Tectonin beta-propeller repeat-containing protein 1,, PF06462;PF06398;PF19193;, GO:0000421;GO:0031410;GO:0016021;GO:0043231;GO:0005765;GO:0005654;GO:0032266;GO:0097352;GO:0006914;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome maturation; P:autophagy; scaffold139 indexed_genome mRNA 1519407 1520097 . + . ID=transcript_14353;Q7Z6L1 A8KAD1 B3KPZ1 C9J024 F5GX57 Q96EB0 Q9P2I9 Q9UFR6,Tectonin beta-propeller repeat-containing protein 1,, PF06462;PF06398;PF19193;, GO:0000421;GO:0031410;GO:0016021;GO:0043231;GO:0005765;GO:0005654;GO:0032266;GO:0097352;GO:0006914;, C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:nucleoplasm;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome maturation; P:autophagy; scaffold139 indexed_genome mRNA 1520920 1523784 . - . ID=transcript_14354;Q7RTS1 A4D271 Q14DE4,Class A basic helix-loop-helix protein 15,Class B basic helix-loop-helix protein 8;Muscle, intestine and stomach expression 1;, PF00010;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0046983;GO:0000978;GO:1990837;GO:0019722;GO:0048469;GO:0007267;GO:0042149;GO:0030968;GO:0007186;GO:0042593;GO:0007030;GO:0048312;GO:0006851;GO:0010832;GO:0030182;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:calcium-mediated signaling; P:cell maturation; P:cell-cell signaling; P:cellular response to glucose starvation; P:endoplasmic reticulum unfolded protein response; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:Golgi organization; P:intracellular distribution of mitochondria; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of myotube differentiation; P:neuron differentiation; P:regulation of transcription by RNA polymerase II; scaffold139 indexed_genome mRNA 1529415 1574441 . - . ID=transcript_14355;Q8IWU2 A4D272 Q75MG7 Q9UPS3,Serine/threonine-protein kinase LMTK2,Apoptosis-associated tyrosine kinase 2;Brain-enriched kinase;CDK5/p35-regulated kinase;Kinase/phosphatase/inhibitor 2;Lemur tyrosine kinase 2;Serine/threonine-protein kinase KPI-2;, PF07714;, GO:0005829;GO:0005769;GO:0005794;GO:0030426;GO:0016021;GO:0005887;GO:0043025;GO:0048471;GO:0043235;GO:0055037;GO:0005524;GO:0070853;GO:0004864;GO:0106310;GO:0004674;GO:0106311;GO:0007409;GO:0045022;GO:0032456;GO:0007275;GO:0018105;GO:0018107;GO:0018108;GO:0033674;GO:0046777;GO:0006468;GO:0001881;GO:0033572;GO:0007169;, C:cytosol; C:early endosome; C:Golgi apparatus; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:receptor complex; C:recycling endosome;, F:ATP binding; F:myosin VI binding; F:protein phosphatase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axonogenesis; P:early endosome to late endosome transport; P:endocytic recycling; P:multicellular organism development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:receptor recycling; P:transferrin transport; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q8IWU2 A4D272 Q75MG7 Q9UPS3,Serine/threonine-protein kinase LMTK2,Apoptosis-associated tyrosine kinase 2;Brain-enriched kinase;CDK5/p35-regulated kinase;Kinase/phosphatase/inhibitor 2;Lemur tyrosine kinase 2;Serine/threonine-protein kinase KPI-2;, PF07714;, GO:0005829;GO:0005769;GO:0005794;GO:0030426;GO:0016021;GO:0005887;GO:0043025;GO:0048471;GO:0043235;GO:0055037;GO:0005524;GO:0070853;GO:0004864;GO:0106310;GO:0004674;GO:0106311;GO:0007409;GO:0045022;GO:0032456;GO:0007275;GO:0018105;GO:0018107;GO:0018108;GO:0033674;GO:0046777;GO:0006468;GO:0001881;GO:0033572;GO:0007169;, C:cytosol; C:early endosome; C:Golgi apparatus; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:receptor complex; C:recycling endosome;, F:ATP binding; F:myosin VI binding; F:protein phosphatase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axonogenesis; P:early endosome to late endosome transport; P:endocytic recycling; P:multicellular organism development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:receptor recycling; P:transferrin transport; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold139 indexed_genome mRNA 1679365 1710677 . + . ID=transcript_14356;P86791 A2RU45 O95766 Q9UG65 Q9Y359,Vacuolar fusion protein CCZ1 homolog,, PF19031;PF19032;PF19033;, GO:0005829;GO:0043231;GO:0005765;GO:0035658;GO:0005085;GO:0016192;, C:cytosol; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:Mon1-Ccz1 complex;, F:guanyl-nucleotide exchange factor activity;, P:vesicle-mediated transport;|P86791 A2RU45 O95766 Q9UG65 Q9Y359,Vacuolar fusion protein CCZ1 homolog,, PF19031;PF19032;PF19033;, GO:0005829;GO:0043231;GO:0005765;GO:0035658;GO:0005085;GO:0016192;, C:cytosol; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:Mon1-Ccz1 complex;, F:guanyl-nucleotide exchange factor activity;, P:vesicle-mediated transport;|P86791 A2RU45 O95766 Q9UG65 Q9Y359,Vacuolar fusion protein CCZ1 homolog,, PF19031;PF19032;PF19033;, GO:0005829;GO:0043231;GO:0005765;GO:0035658;GO:0005085;GO:0016192;, C:cytosol; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:Mon1-Ccz1 complex;, F:guanyl-nucleotide exchange factor activity;, P:vesicle-mediated transport;|P86791 A2RU45 O95766 Q9UG65 Q9Y359,Vacuolar fusion protein CCZ1 homolog,, PF19031;PF19032;PF19033;, GO:0005829;GO:0043231;GO:0005765;GO:0035658;GO:0005085;GO:0016192;, C:cytosol; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:Mon1-Ccz1 complex;, F:guanyl-nucleotide exchange factor activity;, P:vesicle-mediated transport;|P86791 A2RU45 O95766 Q9UG65 Q9Y359,Vacuolar fusion protein CCZ1 homolog,, PF19031;PF19032;PF19033;, GO:0005829;GO:0043231;GO:0005765;GO:0035658;GO:0005085;GO:0016192;, C:cytosol; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:Mon1-Ccz1 complex;, F:guanyl-nucleotide exchange factor activity;, P:vesicle-mediated transport;|P0C881 A6NMW7 Q86ST9 Q8NE68,Radial spoke head 10 homolog B,, PF02493;|P86791 A2RU45 O95766 Q9UG65 Q9Y359,Vacuolar fusion protein CCZ1 homolog,, PF19031;PF19032;PF19033;, GO:0005829;GO:0043231;GO:0005765;GO:0035658;GO:0005085;GO:0016192;, C:cytosol; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:Mon1-Ccz1 complex;, F:guanyl-nucleotide exchange factor activity;, P:vesicle-mediated transport;|P86791 A2RU45 O95766 Q9UG65 Q9Y359,Vacuolar fusion protein CCZ1 homolog,, PF19031;PF19032;PF19033;, GO:0005829;GO:0043231;GO:0005765;GO:0035658;GO:0005085;GO:0016192;, C:cytosol; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:Mon1-Ccz1 complex;, F:guanyl-nucleotide exchange factor activity;, P:vesicle-mediated transport;|P0C881 A6NMW7 Q86ST9 Q8NE68,Radial spoke head 10 homolog B,, PF02493; scaffold139 indexed_genome mRNA 1712006 1731620 . - . ID=transcript_14357;P0C881 A6NMW7 Q86ST9 Q8NE68,Radial spoke head 10 homolog B,, PF02493; scaffold139 indexed_genome mRNA 1734143 1754504 . - . ID=transcript_14358;P54278 B2R610 Q52LH6 Q5FBW9 Q5FBX1 Q5FBX2 Q75MR2,Mismatch repair endonuclease PMS2 {ECO:0000305},DNA mismatch repair protein PMS2;PMS1 protein homolog 2;, PF01119;PF08676;, GO:0036464;GO:0005829;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0003677;GO:0004519;GO:0032138;GO:0006298;GO:0042493;GO:0016446;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:DNA binding; F:endonuclease activity; F:single base insertion or deletion binding;, P:mismatch repair; P:response to drug; P:somatic hypermutation of immunoglobulin genes;|P54278 B2R610 Q52LH6 Q5FBW9 Q5FBX1 Q5FBX2 Q75MR2,Mismatch repair endonuclease PMS2 {ECO:0000305},DNA mismatch repair protein PMS2;PMS1 protein homolog 2;, PF01119;PF08676;, GO:0036464;GO:0005829;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0003677;GO:0004519;GO:0032138;GO:0006298;GO:0042493;GO:0016446;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:DNA binding; F:endonuclease activity; F:single base insertion or deletion binding;, P:mismatch repair; P:response to drug; P:somatic hypermutation of immunoglobulin genes;|P54278 B2R610 Q52LH6 Q5FBW9 Q5FBX1 Q5FBX2 Q75MR2,Mismatch repair endonuclease PMS2 {ECO:0000305},DNA mismatch repair protein PMS2;PMS1 protein homolog 2;, PF01119;PF08676;, GO:0036464;GO:0005829;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0003677;GO:0004519;GO:0032138;GO:0006298;GO:0042493;GO:0016446;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:DNA binding; F:endonuclease activity; F:single base insertion or deletion binding;, P:mismatch repair; P:response to drug; P:somatic hypermutation of immunoglobulin genes;|P54278 B2R610 Q52LH6 Q5FBW9 Q5FBX1 Q5FBX2 Q75MR2,Mismatch repair endonuclease PMS2 {ECO:0000305},DNA mismatch repair protein PMS2;PMS1 protein homolog 2;, PF01119;PF08676;, GO:0036464;GO:0005829;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0003677;GO:0004519;GO:0032138;GO:0006298;GO:0042493;GO:0016446;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:DNA binding; F:endonuclease activity; F:single base insertion or deletion binding;, P:mismatch repair; P:response to drug; P:somatic hypermutation of immunoglobulin genes;|P54278 B2R610 Q52LH6 Q5FBW9 Q5FBX1 Q5FBX2 Q75MR2,Mismatch repair endonuclease PMS2 {ECO:0000305},DNA mismatch repair protein PMS2;PMS1 protein homolog 2;, PF01119;PF08676;, GO:0036464;GO:0005829;GO:0032300;GO:0032389;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0003677;GO:0004519;GO:0032138;GO:0006298;GO:0042493;GO:0016446;, C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:DNA binding; F:endonuclease activity; F:single base insertion or deletion binding;, P:mismatch repair; P:response to drug; P:somatic hypermutation of immunoglobulin genes;|Q13401 A6NG70 Q3MJ29,Putative postmeiotic segregation increased 2-like protein 3,PMS2-related protein 3;Postmeiotic segregation increased 2-like protein 9;Postmeiotic segregation increased protein 5;Putative postmeiotic segregation increased 2 pseudogene 3;, PF01352;, GO:0032300;GO:0016887;GO:0006298;GO:0006355;, C:mismatch repair complex;, F:ATPase activity;, P:mismatch repair; P:regulation of transcription, DNA-templated;|Q13670,Putative postmeiotic segregation increased 2-like protein 11,PMS2-related protein 6;Putative postmeiotic segregation increased 2 pseudogene 11;, , GO:0032300;GO:0016887;GO:0016301;GO:0006298;, C:mismatch repair complex;, F:ATPase activity; F:kinase activity;, P:mismatch repair; scaffold139 indexed_genome mRNA 1759940 1789551 . + . ID=transcript_14359;Q13155 F8W950 Q75MR1 Q96CZ5 Q9P1L2,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2,Multisynthase complex auxiliary component p38;Protein JTV-1;, PF16780;PF00043;PF18569;, GO:0017101;GO:0005829;GO:0016020;GO:0005634;GO:0060090;GO:0006915;GO:0008285;GO:1903632;GO:1901216;GO:0031398;GO:0065003;GO:0006418;GO:0060510;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytosol; C:membrane; C:nucleus;, F:molecular adaptor activity;, P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of aminoacyl-tRNA ligase activity; P:positive regulation of neuron death; P:positive regulation of protein ubiquitination; P:protein-containing complex assembly; P:tRNA aminoacylation for protein translation; P:type II pneumocyte differentiation;|Q13155 F8W950 Q75MR1 Q96CZ5 Q9P1L2,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2,Multisynthase complex auxiliary component p38;Protein JTV-1;, PF16780;PF00043;PF18569;, GO:0017101;GO:0005829;GO:0016020;GO:0005634;GO:0060090;GO:0006915;GO:0008285;GO:1903632;GO:1901216;GO:0031398;GO:0065003;GO:0006418;GO:0060510;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytosol; C:membrane; C:nucleus;, F:molecular adaptor activity;, P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of aminoacyl-tRNA ligase activity; P:positive regulation of neuron death; P:positive regulation of protein ubiquitination; P:protein-containing complex assembly; P:tRNA aminoacylation for protein translation; P:type II pneumocyte differentiation;|Q13155 F8W950 Q75MR1 Q96CZ5 Q9P1L2,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2,Multisynthase complex auxiliary component p38;Protein JTV-1;, PF16780;PF00043;PF18569;, GO:0017101;GO:0005829;GO:0016020;GO:0005634;GO:0060090;GO:0006915;GO:0008285;GO:1903632;GO:1901216;GO:0031398;GO:0065003;GO:0006418;GO:0060510;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytosol; C:membrane; C:nucleus;, F:molecular adaptor activity;, P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of aminoacyl-tRNA ligase activity; P:positive regulation of neuron death; P:positive regulation of protein ubiquitination; P:protein-containing complex assembly; P:tRNA aminoacylation for protein translation; P:type II pneumocyte differentiation;|Q9UHG4,Eukaryotic translation initiation factor 2-alpha kinase 1 {ECO:0000305},Heme-controlled repressor;Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase {ECO:0000303|Ref.3};Heme-regulated inhibitor {ECO:0000303|PubMed:11101152};Hemin-sensitive initiation factor 2-alpha kinase {ECO:0000303|Ref.2};, PF00069;, GO:0005737;GO:0005524;GO:0004694;GO:0020037;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0002526;GO:0140468;GO:0140467;GO:0055072;GO:0030225;GO:0008285;GO:0046986;GO:0045993;GO:0006909;GO:0046777;GO:0046501;GO:0010999;GO:1990641;, C:cytoplasm;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:heme binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:acute inflammatory response; P:HRI-mediated signaling; P:integrated stress response signaling; P:iron ion homeostasis; P:macrophage differentiation; P:negative regulation of cell population proliferation; P:negative regulation of hemoglobin biosynthetic process; P:negative regulation of translational initiation by iron; P:phagocytosis; P:protein autophosphorylation; P:protoporphyrinogen IX metabolic process; P:regulation of eIF2 alpha phosphorylation by heme; P:response to iron ion starvation;|Q9UHG4,Eukaryotic translation initiation factor 2-alpha kinase 1 {ECO:0000305},Heme-controlled repressor;Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase {ECO:0000303|Ref.3};Heme-regulated inhibitor {ECO:0000303|PubMed:11101152};Hemin-sensitive initiation factor 2-alpha kinase {ECO:0000303|Ref.2};, PF00069;, GO:0005737;GO:0005524;GO:0004694;GO:0020037;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0002526;GO:0140468;GO:0140467;GO:0055072;GO:0030225;GO:0008285;GO:0046986;GO:0045993;GO:0006909;GO:0046777;GO:0046501;GO:0010999;GO:1990641;, C:cytoplasm;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:heme binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:acute inflammatory response; P:HRI-mediated signaling; P:integrated stress response signaling; P:iron ion homeostasis; P:macrophage differentiation; P:negative regulation of cell population proliferation; P:negative regulation of hemoglobin biosynthetic process; P:negative regulation of translational initiation by iron; P:phagocytosis; P:protein autophosphorylation; P:protoporphyrinogen IX metabolic process; P:regulation of eIF2 alpha phosphorylation by heme; P:response to iron ion starvation;|A6NGH8,Ankyrin repeat domain-containing protein 61,, PF12796;, GO:0005654;, C:nucleoplasm;|Q9UHG4,Eukaryotic translation initiation factor 2-alpha kinase 1 {ECO:0000305},Heme-controlled repressor;Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase {ECO:0000303|Ref.3};Heme-regulated inhibitor {ECO:0000303|PubMed:11101152};Hemin-sensitive initiation factor 2-alpha kinase {ECO:0000303|Ref.2};, PF00069;, GO:0005737;GO:0005524;GO:0004694;GO:0020037;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0002526;GO:0140468;GO:0140467;GO:0055072;GO:0030225;GO:0008285;GO:0046986;GO:0045993;GO:0006909;GO:0046777;GO:0046501;GO:0010999;GO:1990641;, C:cytoplasm;, F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:heme binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:acute inflammatory response; P:HRI-mediated signaling; P:integrated stress response signaling; P:iron ion homeostasis; P:macrophage differentiation; P:negative regulation of cell population proliferation; P:negative regulation of hemoglobin biosynthetic process; P:negative regulation of translational initiation by iron; P:phagocytosis; P:protein autophosphorylation; P:protoporphyrinogen IX metabolic process; P:regulation of eIF2 alpha phosphorylation by heme; P:response to iron ion starvation; scaffold139 indexed_genome mRNA 1822424 1854740 . + . ID=transcript_14360;Q9H9J4 A2RUE3 B5MDA5 Q0VIN8 Q3C166 Q6P9B4,Ubiquitin carboxyl-terminal hydrolase 42,Deubiquitinating enzyme 42;Ubiquitin thioesterase 42;Ubiquitin-specific-processing protease 42;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0030154;GO:0016579;GO:0042981;GO:0007283;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell differentiation; P:protein deubiquitination; P:regulation of apoptotic process; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process;|Q9H9J4 A2RUE3 B5MDA5 Q0VIN8 Q3C166 Q6P9B4,Ubiquitin carboxyl-terminal hydrolase 42,Deubiquitinating enzyme 42;Ubiquitin thioesterase 42;Ubiquitin-specific-processing protease 42;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0030154;GO:0016579;GO:0042981;GO:0007283;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell differentiation; P:protein deubiquitination; P:regulation of apoptotic process; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process;|Q9H9J4 A2RUE3 B5MDA5 Q0VIN8 Q3C166 Q6P9B4,Ubiquitin carboxyl-terminal hydrolase 42,Deubiquitinating enzyme 42;Ubiquitin thioesterase 42;Ubiquitin-specific-processing protease 42;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0030154;GO:0016579;GO:0042981;GO:0007283;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell differentiation; P:protein deubiquitination; P:regulation of apoptotic process; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process;|Q9H9J4 A2RUE3 B5MDA5 Q0VIN8 Q3C166 Q6P9B4,Ubiquitin carboxyl-terminal hydrolase 42,Deubiquitinating enzyme 42;Ubiquitin thioesterase 42;Ubiquitin-specific-processing protease 42;, PF00443;, GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0004843;GO:0030154;GO:0016579;GO:0042981;GO:0007283;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:cell differentiation; P:protein deubiquitination; P:regulation of apoptotic process; P:spermatogenesis; P:ubiquitin-dependent protein catabolic process; scaffold139 indexed_genome mRNA 1972867 1995566 . + . ID=transcript_14361;Q7Z4H9 Q75ML2 Q8NA52 Q9BRR7,Protein FAM220A,STAT3-interacting protein as a repressor;, PF15487;, GO:0005634;GO:0097677;GO:0000122;GO:0006470;, C:nucleus;, F:STAT family protein binding;, P:negative regulation of transcription by RNA polymerase II; P:protein dephosphorylation; scaffold139 indexed_genome mRNA 2031774 2041703 . + . ID=transcript_14362;P63000 O95501 P15154 Q3Y4D3 Q5JAA8 Q9BTB4,Ras-related C3 botulinum toxin substrate 1 {ECO:0000305},Cell migration-inducing gene 5 protein;Ras-like protein TC25;p21-Rac1;, PF00071;, GO:0005938;GO:0042995;GO:0005737;GO:0036464;GO:0031410;GO:0005856;GO:0005829;GO:0043197;GO:0005789;GO:0070062;GO:0031234;GO:0101003;GO:0005925;GO:0098978;GO:0000139;GO:0043231;GO:0030027;GO:0042470;GO:0016020;GO:0005886;GO:0098794;GO:0055038;GO:0032587;GO:0030667;GO:0005802;GO:0051117;GO:0019899;GO:0005525;GO:0003924;GO:0042826;GO:0019901;GO:0044877;GO:0051022;GO:0031996;GO:0030036;GO:0007015;GO:0030041;GO:0009653;GO:0007596;GO:0045453;GO:0007155;GO:0048870;GO:0008283;GO:0030031;GO:0007160;GO:0071260;GO:0030865;GO:0043652;GO:0048013;GO:0007163;GO:0038095;GO:0038096;GO:0048012;GO:0006954;GO:0035556;GO:0030032;GO:0051668;GO:0002551;GO:0008045;GO:0010764;GO:0032707;GO:0048261;GO:0001764;GO:0043312;GO:0031343;GO:0010811;GO:0045740;GO:0010595;GO:0051894;GO:0035774;GO:0010592;GO:0031116;GO:0090023;GO:0051897;GO:0001934;GO:0035025;GO:0051496;GO:1900026;GO:0016601;GO:0032956;GO:0030334;GO:0008360;GO:0008361;GO:0050690;GO:0010310;GO:0010591;GO:1902622;GO:0045428;GO:0060263;GO:0051056;GO:0051492;GO:0009611;GO:0097178;GO:0031529;GO:0071526;GO:0003376;GO:0034446;GO:0031295;GO:0048010;GO:0060071;, C:cell cortex; C:cell projection; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:ficolin-1-rich granule membrane; C:focal adhesion; C:glutamatergic synapse; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lamellipodium; C:melanosome; C:membrane; C:plasma membrane; C:postsynapse; C:recycling endosome membrane; C:ruffle membrane; C:secretory granule membrane; C:trans-Golgi network;, F:ATPase binding; F:enzyme binding; F:GTP binding; F:GTPase activity; F:histone deacetylase binding; F:protein kinase binding; F:protein-containing complex binding; F:Rho GDP-dissociation inhibitor binding; F:thioesterase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:actin filament polymerization; P:anatomical structure morphogenesis; P:blood coagulation; P:bone resorption; P:cell adhesion; P:cell motility; P:cell population proliferation; P:cell projection assembly; P:cell-matrix adhesion; P:cellular response to mechanical stimulus; P:cortical cytoskeleton organization; P:engulfment of apoptotic cell; P:ephrin receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:hepatocyte growth factor receptor signaling pathway; P:inflammatory response; P:intracellular signal transduction; P:lamellipodium assembly; P:localization within membrane; P:mast cell chemotaxis; P:motor neuron axon guidance; P:negative regulation of fibroblast migration; P:negative regulation of interleukin-23 production; P:negative regulation of receptor-mediated endocytosis; P:neuron migration; P:neutrophil degranulation; P:positive regulation of cell killing; P:positive regulation of cell-substrate adhesion; P:positive regulation of DNA replication; P:positive regulation of endothelial cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lamellipodium assembly; P:positive regulation of microtubule polymerization; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of Rho protein signal transduction; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:Rac protein signal transduction; P:regulation of actin cytoskeleton organization; P:regulation of cell migration; P:regulation of cell shape; P:regulation of cell size; P:regulation of defense response to virus by virus; P:regulation of hydrogen peroxide metabolic process; P:regulation of lamellipodium assembly; P:regulation of neutrophil migration; P:regulation of nitric oxide biosynthetic process; P:regulation of respiratory burst; P:regulation of small GTPase mediated signal transduction; P:regulation of stress fiber assembly; P:response to wounding; P:ruffle assembly; P:ruffle organization; P:semaphorin-plexin signaling pathway; P:sphingosine-1-phosphate receptor signaling pathway; P:substrate adhesion-dependent cell spreading; P:T cell costimulation; P:vascular endothelial growth factor receptor signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway;|P63000 O95501 P15154 Q3Y4D3 Q5JAA8 Q9BTB4,Ras-related C3 botulinum toxin substrate 1 {ECO:0000305},Cell migration-inducing gene 5 protein;Ras-like protein TC25;p21-Rac1;, PF00071;, GO:0005938;GO:0042995;GO:0005737;GO:0036464;GO:0031410;GO:0005856;GO:0005829;GO:0043197;GO:0005789;GO:0070062;GO:0031234;GO:0101003;GO:0005925;GO:0098978;GO:0000139;GO:0043231;GO:0030027;GO:0042470;GO:0016020;GO:0005886;GO:0098794;GO:0055038;GO:0032587;GO:0030667;GO:0005802;GO:0051117;GO:0019899;GO:0005525;GO:0003924;GO:0042826;GO:0019901;GO:0044877;GO:0051022;GO:0031996;GO:0030036;GO:0007015;GO:0030041;GO:0009653;GO:0007596;GO:0045453;GO:0007155;GO:0048870;GO:0008283;GO:0030031;GO:0007160;GO:0071260;GO:0030865;GO:0043652;GO:0048013;GO:0007163;GO:0038095;GO:0038096;GO:0048012;GO:0006954;GO:0035556;GO:0030032;GO:0051668;GO:0002551;GO:0008045;GO:0010764;GO:0032707;GO:0048261;GO:0001764;GO:0043312;GO:0031343;GO:0010811;GO:0045740;GO:0010595;GO:0051894;GO:0035774;GO:0010592;GO:0031116;GO:0090023;GO:0051897;GO:0001934;GO:0035025;GO:0051496;GO:1900026;GO:0016601;GO:0032956;GO:0030334;GO:0008360;GO:0008361;GO:0050690;GO:0010310;GO:0010591;GO:1902622;GO:0045428;GO:0060263;GO:0051056;GO:0051492;GO:0009611;GO:0097178;GO:0031529;GO:0071526;GO:0003376;GO:0034446;GO:0031295;GO:0048010;GO:0060071;, C:cell cortex; C:cell projection; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:dendritic spine; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extrinsic component of cytoplasmic side of plasma membrane; C:ficolin-1-rich granule membrane; C:focal adhesion; C:glutamatergic synapse; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lamellipodium; C:melanosome; C:membrane; C:plasma membrane; C:postsynapse; C:recycling endosome membrane; C:ruffle membrane; C:secretory granule membrane; C:trans-Golgi network;, F:ATPase binding; F:enzyme binding; F:GTP binding; F:GTPase activity; F:histone deacetylase binding; F:protein kinase binding; F:protein-containing complex binding; F:Rho GDP-dissociation inhibitor binding; F:thioesterase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:actin filament polymerization; P:anatomical structure morphogenesis; P:blood coagulation; P:bone resorption; P:cell adhesion; P:cell motility; P:cell population proliferation; P:cell projection assembly; P:cell-matrix adhesion; P:cellular response to mechanical stimulus; P:cortical cytoskeleton organization; P:engulfment of apoptotic cell; P:ephrin receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:hepatocyte growth factor receptor signaling pathway; P:inflammatory response; P:intracellular signal transduction; P:lamellipodium assembly; P:localization within membrane; P:mast cell chemotaxis; P:motor neuron axon guidance; P:negative regulation of fibroblast migration; P:negative regulation of interleukin-23 production; P:negative regulation of receptor-mediated endocytosis; P:neuron migration; P:neutrophil degranulation; P:positive regulation of cell killing; P:positive regulation of cell-substrate adhesion; P:positive regulation of DNA replication; P:positive regulation of endothelial cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lamellipodium assembly; P:positive regulation of microtubule polymerization; P:positive regulation of neutrophil chemotaxis; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of Rho protein signal transduction; P:positive regulation of stress fiber assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:Rac protein signal transduction; P:regulation of actin cytoskeleton organization; P:regulation of cell migration; P:regulation of cell shape; P:regulation of cell size; P:regulation of defense response to virus by virus; P:regulation of hydrogen peroxide metabolic process; P:regulation of lamellipodium assembly; P:regulation of neutrophil migration; P:regulation of nitric oxide biosynthetic process; P:regulation of respiratory burst; P:regulation of small GTPase mediated signal transduction; P:regulation of stress fiber assembly; P:response to wounding; P:ruffle assembly; P:ruffle organization; P:semaphorin-plexin signaling pathway; P:sphingosine-1-phosphate receptor signaling pathway; P:substrate adhesion-dependent cell spreading; P:T cell costimulation; P:vascular endothelial growth factor receptor signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold139 indexed_genome mRNA 2043252 2065248 . - . ID=transcript_14363;Q8NCG7 A4D2P3 B3KV90 B4DQU0 Q6PIX3 Q8N2N2 Q8N9S1 Q8TED3 Q8WXE6,Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053},KCCR13L;PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};, PF01764;, GO:0016021;GO:0005765;GO:0005654;GO:0005886;GO:0045211;GO:0016298;GO:0046872;GO:0004806;GO:0019369;GO:0071926;GO:0007216;GO:0016042;GO:0007405;GO:0022008;GO:0042136;GO:0010898;GO:0001516;GO:0050727;GO:0098921;, C:integral component of membrane; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane;, F:lipase activity; F:metal ion binding; F:triglyceride lipase activity;, P:arachidonic acid metabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:lipid catabolic process; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:positive regulation of triglyceride catabolic process; P:prostaglandin biosynthetic process; P:regulation of inflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q8NCG7 A4D2P3 B3KV90 B4DQU0 Q6PIX3 Q8N2N2 Q8N9S1 Q8TED3 Q8WXE6,Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053},KCCR13L;PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};, PF01764;, GO:0016021;GO:0005765;GO:0005654;GO:0005886;GO:0045211;GO:0016298;GO:0046872;GO:0004806;GO:0019369;GO:0071926;GO:0007216;GO:0016042;GO:0007405;GO:0022008;GO:0042136;GO:0010898;GO:0001516;GO:0050727;GO:0098921;, C:integral component of membrane; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane;, F:lipase activity; F:metal ion binding; F:triglyceride lipase activity;, P:arachidonic acid metabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:lipid catabolic process; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:positive regulation of triglyceride catabolic process; P:prostaglandin biosynthetic process; P:regulation of inflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q8NCG7 A4D2P3 B3KV90 B4DQU0 Q6PIX3 Q8N2N2 Q8N9S1 Q8TED3 Q8WXE6,Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053},KCCR13L;PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};, PF01764;, GO:0016021;GO:0005765;GO:0005654;GO:0005886;GO:0045211;GO:0016298;GO:0046872;GO:0004806;GO:0019369;GO:0071926;GO:0007216;GO:0016042;GO:0007405;GO:0022008;GO:0042136;GO:0010898;GO:0001516;GO:0050727;GO:0098921;, C:integral component of membrane; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane;, F:lipase activity; F:metal ion binding; F:triglyceride lipase activity;, P:arachidonic acid metabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:lipid catabolic process; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:positive regulation of triglyceride catabolic process; P:prostaglandin biosynthetic process; P:regulation of inflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q8NCG7 A4D2P3 B3KV90 B4DQU0 Q6PIX3 Q8N2N2 Q8N9S1 Q8TED3 Q8WXE6,Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053},KCCR13L;PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};, PF01764;, GO:0016021;GO:0005765;GO:0005654;GO:0005886;GO:0045211;GO:0016298;GO:0046872;GO:0004806;GO:0019369;GO:0071926;GO:0007216;GO:0016042;GO:0007405;GO:0022008;GO:0042136;GO:0010898;GO:0001516;GO:0050727;GO:0098921;, C:integral component of membrane; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane;, F:lipase activity; F:metal ion binding; F:triglyceride lipase activity;, P:arachidonic acid metabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:lipid catabolic process; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:positive regulation of triglyceride catabolic process; P:prostaglandin biosynthetic process; P:regulation of inflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q8NCG7 A4D2P3 B3KV90 B4DQU0 Q6PIX3 Q8N2N2 Q8N9S1 Q8TED3 Q8WXE6,Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053},KCCR13L;PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};, PF01764;, GO:0016021;GO:0005765;GO:0005654;GO:0005886;GO:0045211;GO:0016298;GO:0046872;GO:0004806;GO:0019369;GO:0071926;GO:0007216;GO:0016042;GO:0007405;GO:0022008;GO:0042136;GO:0010898;GO:0001516;GO:0050727;GO:0098921;, C:integral component of membrane; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane;, F:lipase activity; F:metal ion binding; F:triglyceride lipase activity;, P:arachidonic acid metabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:lipid catabolic process; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:positive regulation of triglyceride catabolic process; P:prostaglandin biosynthetic process; P:regulation of inflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q8NCG7 A4D2P3 B3KV90 B4DQU0 Q6PIX3 Q8N2N2 Q8N9S1 Q8TED3 Q8WXE6,Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053},KCCR13L;PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};, PF01764;, GO:0016021;GO:0005765;GO:0005654;GO:0005886;GO:0045211;GO:0016298;GO:0046872;GO:0004806;GO:0019369;GO:0071926;GO:0007216;GO:0016042;GO:0007405;GO:0022008;GO:0042136;GO:0010898;GO:0001516;GO:0050727;GO:0098921;, C:integral component of membrane; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane;, F:lipase activity; F:metal ion binding; F:triglyceride lipase activity;, P:arachidonic acid metabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:lipid catabolic process; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:positive regulation of triglyceride catabolic process; P:prostaglandin biosynthetic process; P:regulation of inflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q8NCG7 A4D2P3 B3KV90 B4DQU0 Q6PIX3 Q8N2N2 Q8N9S1 Q8TED3 Q8WXE6,Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053},KCCR13L;PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};, PF01764;, GO:0016021;GO:0005765;GO:0005654;GO:0005886;GO:0045211;GO:0016298;GO:0046872;GO:0004806;GO:0019369;GO:0071926;GO:0007216;GO:0016042;GO:0007405;GO:0022008;GO:0042136;GO:0010898;GO:0001516;GO:0050727;GO:0098921;, C:integral component of membrane; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane;, F:lipase activity; F:metal ion binding; F:triglyceride lipase activity;, P:arachidonic acid metabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:lipid catabolic process; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:positive regulation of triglyceride catabolic process; P:prostaglandin biosynthetic process; P:regulation of inflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q8NCG7 A4D2P3 B3KV90 B4DQU0 Q6PIX3 Q8N2N2 Q8N9S1 Q8TED3 Q8WXE6,Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053},KCCR13L;PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};, PF01764;, GO:0016021;GO:0005765;GO:0005654;GO:0005886;GO:0045211;GO:0016298;GO:0046872;GO:0004806;GO:0019369;GO:0071926;GO:0007216;GO:0016042;GO:0007405;GO:0022008;GO:0042136;GO:0010898;GO:0001516;GO:0050727;GO:0098921;, C:integral component of membrane; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane;, F:lipase activity; F:metal ion binding; F:triglyceride lipase activity;, P:arachidonic acid metabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:lipid catabolic process; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:positive regulation of triglyceride catabolic process; P:prostaglandin biosynthetic process; P:regulation of inflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q8NCG7 A4D2P3 B3KV90 B4DQU0 Q6PIX3 Q8N2N2 Q8N9S1 Q8TED3 Q8WXE6,Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053},KCCR13L;PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};, PF01764;, GO:0016021;GO:0005765;GO:0005654;GO:0005886;GO:0045211;GO:0016298;GO:0046872;GO:0004806;GO:0019369;GO:0071926;GO:0007216;GO:0016042;GO:0007405;GO:0022008;GO:0042136;GO:0010898;GO:0001516;GO:0050727;GO:0098921;, C:integral component of membrane; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane;, F:lipase activity; F:metal ion binding; F:triglyceride lipase activity;, P:arachidonic acid metabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:lipid catabolic process; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:positive regulation of triglyceride catabolic process; P:prostaglandin biosynthetic process; P:regulation of inflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q8NCG7 A4D2P3 B3KV90 B4DQU0 Q6PIX3 Q8N2N2 Q8N9S1 Q8TED3 Q8WXE6,Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053},KCCR13L;PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};, PF01764;, GO:0016021;GO:0005765;GO:0005654;GO:0005886;GO:0045211;GO:0016298;GO:0046872;GO:0004806;GO:0019369;GO:0071926;GO:0007216;GO:0016042;GO:0007405;GO:0022008;GO:0042136;GO:0010898;GO:0001516;GO:0050727;GO:0098921;, C:integral component of membrane; C:lysosomal membrane; C:nucleoplasm; C:plasma membrane; C:postsynaptic membrane;, F:lipase activity; F:metal ion binding; F:triglyceride lipase activity;, P:arachidonic acid metabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:lipid catabolic process; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:positive regulation of triglyceride catabolic process; P:prostaglandin biosynthetic process; P:regulation of inflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid; scaffold139 indexed_genome mRNA 2073174 2089405 . - . ID=transcript_14364;P33947 A4D2P4 Q6IPC5 Q96E30,ER lumen protein-retaining receptor 2,ERD2-like protein 1;KDEL endoplasmic reticulum protein retention receptor 2;, PF00810;, GO:0005801;GO:0030663;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0030133;GO:0046923;GO:0005046;GO:0006888;GO:0006621;GO:0015031;GO:0006890;, C:cis-Golgi network; C:COPI-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:ER retention sequence binding; F:KDEL sequence binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein retention in ER lumen; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P33947 A4D2P4 Q6IPC5 Q96E30,ER lumen protein-retaining receptor 2,ERD2-like protein 1;KDEL endoplasmic reticulum protein retention receptor 2;, PF00810;, GO:0005801;GO:0030663;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0030133;GO:0046923;GO:0005046;GO:0006888;GO:0006621;GO:0015031;GO:0006890;, C:cis-Golgi network; C:COPI-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:ER retention sequence binding; F:KDEL sequence binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein retention in ER lumen; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P33947 A4D2P4 Q6IPC5 Q96E30,ER lumen protein-retaining receptor 2,ERD2-like protein 1;KDEL endoplasmic reticulum protein retention receptor 2;, PF00810;, GO:0005801;GO:0030663;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0030133;GO:0046923;GO:0005046;GO:0006888;GO:0006621;GO:0015031;GO:0006890;, C:cis-Golgi network; C:COPI-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:ER retention sequence binding; F:KDEL sequence binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein retention in ER lumen; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P33947 A4D2P4 Q6IPC5 Q96E30,ER lumen protein-retaining receptor 2,ERD2-like protein 1;KDEL endoplasmic reticulum protein retention receptor 2;, PF00810;, GO:0005801;GO:0030663;GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0030133;GO:0046923;GO:0005046;GO:0006888;GO:0006621;GO:0015031;GO:0006890;, C:cis-Golgi network; C:COPI-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:ER retention sequence binding; F:KDEL sequence binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein retention in ER lumen; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold139 indexed_genome mRNA 2120926 2125415 . + . ID=transcript_14365;A4D2P6,Delphilin,Glutamate receptor, ionotropic, delta 2-interacting protein 1;, PF02181;PF00595;, GO:0045211;GO:0060292;, C:postsynaptic membrane;, , P:long-term synaptic depression; scaffold139 indexed_genome mRNA 2125927 2134398 . - . ID=transcript_14366;A4D2P6,Delphilin,Glutamate receptor, ionotropic, delta 2-interacting protein 1;, PF02181;PF00595;, GO:0045211;GO:0060292;, C:postsynaptic membrane;, , P:long-term synaptic depression; scaffold139 indexed_genome mRNA 2169621 2171043 . - . ID=transcript_14367;Q9NPG8 A4D2N9 Q53EV7 Q6FIB5 Q9H0R9,Palmitoyltransferase ZDHHC4 {ECO:0000305},Zinc finger DHHC domain-containing protein 4 {ECO:0000312|HGNC:HGNC:18471};Zinc finger protein 374;, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0019706;GO:0018230;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein targeting to membrane; scaffold139 indexed_genome mRNA 2171368 2176941 . + . ID=transcript_14368;Q9NPG8 A4D2N9 Q53EV7 Q6FIB5 Q9H0R9,Palmitoyltransferase ZDHHC4 {ECO:0000305},Zinc finger DHHC domain-containing protein 4 {ECO:0000312|HGNC:HGNC:18471};Zinc finger protein 374;, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0019706;GO:0018230;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein targeting to membrane;|Q9NPG8 A4D2N9 Q53EV7 Q6FIB5 Q9H0R9,Palmitoyltransferase ZDHHC4 {ECO:0000305},Zinc finger DHHC domain-containing protein 4 {ECO:0000312|HGNC:HGNC:18471};Zinc finger protein 374;, PF01529;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0019706;GO:0018230;GO:0006612;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein targeting to membrane; scaffold139 indexed_genome mRNA 2185705 2187370 . + . ID=transcript_14369;Q96N11 Q9BQ43,Uncharacterized protein C7orf26,, PF14964; scaffold139 indexed_genome mRNA 2187401 2188636 . + . ID=transcript_14370;Q96N11 Q9BQ43,Uncharacterized protein C7orf26,, PF14964; scaffold139 indexed_genome mRNA 2188970 2193861 . + . ID=transcript_14371;Q96N11 Q9BQ43,Uncharacterized protein C7orf26,, PF14964;|Q96N11 Q9BQ43,Uncharacterized protein C7orf26,, PF14964;|Q96N11 Q9BQ43,Uncharacterized protein C7orf26,, PF14964; scaffold139 indexed_genome mRNA 2258214 2287952 . + . ID=transcript_14372;P17014 A8MYC4 A8WFQ8 B2RNQ7 B4DF45 Q6N016 Q8NHZ0 Q9H9P0 Q9ULZ6,Zinc finger protein 12,Gonadotropin-inducible ovary transcription repressor 3;Zinc finger protein 325;Zinc finger protein KOX3;, PF01352;PF00096;, GO:0005813;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0045892;GO:0006357;, C:centrosome; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|P17032 B3KRQ3 D3DRZ3 Q96B88,Zinc finger protein 37A,Zinc finger protein KOX21;, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold139 indexed_genome mRNA 2305541 2319091 . + . ID=transcript_14373;Q9NYW8 A6NDF2 A8KAK4 B2RN44 B9EGS1 F8W6M7,RB-associated KRAB zinc finger protein,RB-associated KRAB repressor;Zinc finger protein 769;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0000977;GO:0008270;GO:0045892;GO:0006357;GO:0006355;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold139 indexed_genome mRNA 2378211 2479119 . + . ID=transcript_14374;Q9NWF9 Q6Y691 Q75ML7 Q7Z2H7 Q7Z7C1 Q8NHW7 Q9NYT1,E3 ubiquitin-protein ligase RNF216,RING finger protein 216;RING-type E3 ubiquitin transferase RNF216 {ECO:0000305};Triad domain-containing protein 3;Ubiquitin-conjugating enzyme 7-interacting protein 1;Zinc finger protein inhibiting NF-kappa-B;, , GO:0005829;GO:0098978;GO:0005654;GO:0005634;GO:0098843;GO:0098685;GO:0046872;GO:0061630;GO:0006915;GO:0032480;GO:0043161;GO:0099546;GO:0070936;GO:0050691;GO:0032648;GO:0016032;, C:cytosol; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynaptic endocytic zone; C:Schaffer collateral - CA1 synapse;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:apoptotic process; P:negative regulation of type I interferon production; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein catabolic process, modulating synaptic transmission; P:protein K48-linked ubiquitination; P:regulation of defense response to virus by host; P:regulation of interferon-beta production; P:viral process; scaffold139 indexed_genome mRNA 2491619 2494370 . + . ID=transcript_14375;Q9NWF9 Q6Y691 Q75ML7 Q7Z2H7 Q7Z7C1 Q8NHW7 Q9NYT1,E3 ubiquitin-protein ligase RNF216,RING finger protein 216;RING-type E3 ubiquitin transferase RNF216 {ECO:0000305};Triad domain-containing protein 3;Ubiquitin-conjugating enzyme 7-interacting protein 1;Zinc finger protein inhibiting NF-kappa-B;, , GO:0005829;GO:0098978;GO:0005654;GO:0005634;GO:0098843;GO:0098685;GO:0046872;GO:0061630;GO:0006915;GO:0032480;GO:0043161;GO:0099546;GO:0070936;GO:0050691;GO:0032648;GO:0016032;, C:cytosol; C:glutamatergic synapse; C:nucleoplasm; C:nucleus; C:postsynaptic endocytic zone; C:Schaffer collateral - CA1 synapse;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:apoptotic process; P:negative regulation of type I interferon production; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein catabolic process, modulating synaptic transmission; P:protein K48-linked ubiquitination; P:regulation of defense response to virus by host; P:regulation of interferon-beta production; P:viral process; scaffold139 indexed_genome mRNA 2505437 2514791 . - . ID=transcript_14376;Q16658 A6NI89 B2RE97 Q96IC5 Q96IH1 Q9BRF1,Fascin,55 kDa actin-bundling protein;Singed-like protein;p55;, PF06268;, GO:0015629;GO:0005938;GO:0031253;GO:0005911;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0030175;GO:0030426;GO:0030027;GO:0044393;GO:0005902;GO:0002102;GO:0001726;GO:0001725;GO:0003779;GO:0051015;GO:0045296;GO:0008144;GO:0030674;GO:0003723;GO:0030036;GO:0051017;GO:0016477;GO:0048870;GO:0007043;GO:0019221;GO:0035089;GO:0007163;GO:0030035;GO:0030046;GO:0090091;GO:0051491;GO:0010592;GO:0071803;GO:0032956;GO:0032534;, C:actin cytoskeleton; C:cell cortex; C:cell projection membrane; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:filopodium; C:growth cone; C:lamellipodium; C:microspike; C:microvillus; C:podosome; C:ruffle; C:stress fiber;, F:actin binding; F:actin filament binding; F:cadherin binding; F:drug binding; F:protein-macromolecule adaptor activity; F:RNA binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:cell migration; P:cell motility; P:cell-cell junction assembly; P:cytokine-mediated signaling pathway; P:establishment of apical/basal cell polarity; P:establishment or maintenance of cell polarity; P:microspike assembly; P:parallel actin filament bundle assembly; P:positive regulation of extracellular matrix disassembly; P:positive regulation of filopodium assembly; P:positive regulation of lamellipodium assembly; P:positive regulation of podosome assembly; P:regulation of actin cytoskeleton organization; P:regulation of microvillus assembly;|Q16658 A6NI89 B2RE97 Q96IC5 Q96IH1 Q9BRF1,Fascin,55 kDa actin-bundling protein;Singed-like protein;p55;, PF06268;, GO:0015629;GO:0005938;GO:0031253;GO:0005911;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0030175;GO:0030426;GO:0030027;GO:0044393;GO:0005902;GO:0002102;GO:0001726;GO:0001725;GO:0003779;GO:0051015;GO:0045296;GO:0008144;GO:0030674;GO:0003723;GO:0030036;GO:0051017;GO:0016477;GO:0048870;GO:0007043;GO:0019221;GO:0035089;GO:0007163;GO:0030035;GO:0030046;GO:0090091;GO:0051491;GO:0010592;GO:0071803;GO:0032956;GO:0032534;, C:actin cytoskeleton; C:cell cortex; C:cell projection membrane; C:cell-cell junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:filopodium; C:growth cone; C:lamellipodium; C:microspike; C:microvillus; C:podosome; C:ruffle; C:stress fiber;, F:actin binding; F:actin filament binding; F:cadherin binding; F:drug binding; F:protein-macromolecule adaptor activity; F:RNA binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:cell migration; P:cell motility; P:cell-cell junction assembly; P:cytokine-mediated signaling pathway; P:establishment of apical/basal cell polarity; P:establishment or maintenance of cell polarity; P:microspike assembly; P:parallel actin filament bundle assembly; P:positive regulation of extracellular matrix disassembly; P:positive regulation of filopodium assembly; P:positive regulation of lamellipodium assembly; P:positive regulation of podosome assembly; P:regulation of actin cytoskeleton organization; P:regulation of microvillus assembly; scaffold140 indexed_genome mRNA 73733 79900 . + . ID=transcript_14377;Q96EK2 B0QYW3 B0QYW4 B3KRU4 B7Z4F8 Q5TFL2 Q6ICC0,PHD finger protein 21B,, PF00628;, GO:0046872;, , F:metal ion binding; scaffold140 indexed_genome mRNA 93590 95043 . - . ID=transcript_14378;Q9NSG0 Q9NVX8 Q9NXL1 Q9UH20,Rho GTPase-activating protein 8,Rho-type GTPase-activating protein 8;, PF13716;PF00620;, GO:0005829;GO:0005096;GO:0070374;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:positive regulation of ERK1 and ERK2 cascade; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold140 indexed_genome mRNA 108398 125649 . - . ID=transcript_14379;Q9NSG0 Q9NVX8 Q9NXL1 Q9UH20,Rho GTPase-activating protein 8,Rho-type GTPase-activating protein 8;, PF13716;PF00620;, GO:0005829;GO:0005096;GO:0070374;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity;, P:positive regulation of ERK1 and ERK2 cascade; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold140 indexed_genome mRNA 160544 161499 . - . ID=transcript_14380;Q5XKJ6 Q96RW1 Q96RW2 Q9HA49 Q9HC46 Q9NSG0 Q9NVX8 Q9NXL1 Q9UH20,Proline-rich protein 5,Protein observed with Rictor-1;, PF08539;, GO:0005829;GO:0031932;GO:0032148;GO:0007049;GO:0014068;GO:1901796;GO:0038203;, C:cytosol; C:TORC2 complex;, , P:activation of protein kinase B activity; P:cell cycle; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:regulation of signal transduction by p53 class mediator; P:TORC2 signaling; scaffold140 indexed_genome mRNA 335181 341322 . + . ID=transcript_14381;Q6ICC9 Q6ZTR1,Retrotransposon Gag-like protein 6 {ECO:0000312|HGNC:HGNC:13343},Leucine zipper protein down-regulated in cancer cells-like;Mammalian retrotransposon-derived protein 6 {ECO:0000250|UniProtKB:Q505G4};Protein LDOC1L {ECO:0000305};, PF16297; scaffold140 indexed_genome mRNA 559095 586180 . - . ID=transcript_14382;Q9HBI0 B4DDW5 E7EVM6 Q9BQX5 Q9NSG1,Gamma-parvin,, PF00307;, GO:0015629;GO:0005737;GO:0005856;GO:0005925;GO:0005886;GO:0003779;GO:0031532;GO:0030031;GO:0007160;GO:0007163;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:focal adhesion; C:plasma membrane;, F:actin binding;, P:actin cytoskeleton reorganization; P:cell projection assembly; P:cell-matrix adhesion; P:establishment or maintenance of cell polarity; P:substrate adhesion-dependent cell spreading;|Q9HBI0 B4DDW5 E7EVM6 Q9BQX5 Q9NSG1,Gamma-parvin,, PF00307;, GO:0015629;GO:0005737;GO:0005856;GO:0005925;GO:0005886;GO:0003779;GO:0031532;GO:0030031;GO:0007160;GO:0007163;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:focal adhesion; C:plasma membrane;, F:actin binding;, P:actin cytoskeleton reorganization; P:cell projection assembly; P:cell-matrix adhesion; P:establishment or maintenance of cell polarity; P:substrate adhesion-dependent cell spreading; scaffold140 indexed_genome mRNA 596458 650035 . - . ID=transcript_14383;Q9Y368 Q9Y3L6 Q9Y3L7,Beta-parvin,Affixin;, PF00307;, GO:0015629;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0005886;GO:0030018;GO:0003779;GO:0031532;GO:0030031;GO:0007163;GO:0071963;GO:0030032;GO:0034446;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:plasma membrane; C:Z disc;, F:actin binding;, P:actin cytoskeleton reorganization; P:cell projection assembly; P:establishment or maintenance of cell polarity; P:establishment or maintenance of cell polarity regulating cell shape; P:lamellipodium assembly; P:substrate adhesion-dependent cell spreading; scaffold140 indexed_genome mRNA 740695 771100 . - . ID=transcript_14384;Q9Y512 Q53HC4 Q56VW7 Q969Y9 Q96I46 Q9NW85 Q9UQM9,Sorting and assembly machinery component 50 homolog,Transformation-related gene 3 protein;, PF01103;, GO:0070062;GO:0016021;GO:0140275;GO:0005741;GO:0005739;GO:0001401;GO:0034622;GO:0042407;GO:0007007;GO:0033108;GO:0045040;, C:extracellular exosome; C:integral component of membrane; C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:SAM complex;, , P:cellular protein-containing complex assembly; P:cristae formation; P:inner mitochondrial membrane organization; P:mitochondrial respiratory chain complex assembly; P:protein insertion into mitochondrial outer membrane;|Q9Y512 Q53HC4 Q56VW7 Q969Y9 Q96I46 Q9NW85 Q9UQM9,Sorting and assembly machinery component 50 homolog,Transformation-related gene 3 protein;, PF01103;, GO:0070062;GO:0016021;GO:0140275;GO:0005741;GO:0005739;GO:0001401;GO:0034622;GO:0042407;GO:0007007;GO:0033108;GO:0045040;, C:extracellular exosome; C:integral component of membrane; C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:SAM complex;, , P:cellular protein-containing complex assembly; P:cristae formation; P:inner mitochondrial membrane organization; P:mitochondrial respiratory chain complex assembly; P:protein insertion into mitochondrial outer membrane;|Q9Y512 Q53HC4 Q56VW7 Q969Y9 Q96I46 Q9NW85 Q9UQM9,Sorting and assembly machinery component 50 homolog,Transformation-related gene 3 protein;, PF01103;, GO:0070062;GO:0016021;GO:0140275;GO:0005741;GO:0005739;GO:0001401;GO:0034622;GO:0042407;GO:0007007;GO:0033108;GO:0045040;, C:extracellular exosome; C:integral component of membrane; C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:SAM complex;, , P:cellular protein-containing complex assembly; P:cristae formation; P:inner mitochondrial membrane organization; P:mitochondrial respiratory chain complex assembly; P:protein insertion into mitochondrial outer membrane;|Q9Y512 Q53HC4 Q56VW7 Q969Y9 Q96I46 Q9NW85 Q9UQM9,Sorting and assembly machinery component 50 homolog,Transformation-related gene 3 protein;, PF01103;, GO:0070062;GO:0016021;GO:0140275;GO:0005741;GO:0005739;GO:0001401;GO:0034622;GO:0042407;GO:0007007;GO:0033108;GO:0045040;, C:extracellular exosome; C:integral component of membrane; C:MIB complex; C:mitochondrial outer membrane; C:mitochondrion; C:SAM complex;, , P:cellular protein-containing complex assembly; P:cristae formation; P:inner mitochondrial membrane organization; P:mitochondrial respiratory chain complex assembly; P:protein insertion into mitochondrial outer membrane; scaffold140 indexed_genome mRNA 776554 797695 . - . ID=transcript_14385;Q9NST1 B0QYI0 B2RCL3 B3KW00 Q6P1A1 Q96CB4,1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 {ECO:0000305|PubMed:22560221},Acylglycerol transacylase {ECO:0000303|PubMed:15364929};Adiponutrin {ECO:0000303|PubMed:22560221};Calcium-independent phospholipase A2-epsilon {ECO:0000303|PubMed:15364929};Lysophosphatidic acid acyltransferase {ECO:0000303|PubMed:22560221};Patatin-like phospholipase domain-containing protein 3 {ECO:0000303|PubMed:19224197};, PF01734;, GO:0005737;GO:0005789;GO:0016021;GO:0005811;GO:0016020;GO:0003841;GO:0051265;GO:0036042;GO:0042171;GO:0035727;GO:0051264;GO:0004623;GO:0004806;GO:0036155;GO:1905243;GO:0032869;GO:0006650;GO:0034389;GO:0055088;GO:0001676;GO:0006654;GO:0009744;GO:0036153;GO:0019432;GO:0019433;GO:0050872;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:diolein transacylation activity; F:long-chain fatty acyl-CoA binding; F:lysophosphatidic acid acyltransferase activity; F:lysophosphatidic acid binding; F:mono-olein transacylation activity; F:phospholipase A2 activity; F:triglyceride lipase activity;, P:acylglycerol acyl-chain remodeling; P:cellular response to 3,3',5-triiodo-L-thyronine; P:cellular response to insulin stimulus; P:glycerophospholipid metabolic process; P:lipid droplet organization; P:lipid homeostasis; P:long-chain fatty acid metabolic process; P:phosphatidic acid biosynthetic process; P:response to sucrose; P:triglyceride acyl-chain remodeling; P:triglyceride biosynthetic process; P:triglyceride catabolic process; P:white fat cell differentiation;|Q9NST1 B0QYI0 B2RCL3 B3KW00 Q6P1A1 Q96CB4,1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 {ECO:0000305|PubMed:22560221},Acylglycerol transacylase {ECO:0000303|PubMed:15364929};Adiponutrin {ECO:0000303|PubMed:22560221};Calcium-independent phospholipase A2-epsilon {ECO:0000303|PubMed:15364929};Lysophosphatidic acid acyltransferase {ECO:0000303|PubMed:22560221};Patatin-like phospholipase domain-containing protein 3 {ECO:0000303|PubMed:19224197};, PF01734;, GO:0005737;GO:0005789;GO:0016021;GO:0005811;GO:0016020;GO:0003841;GO:0051265;GO:0036042;GO:0042171;GO:0035727;GO:0051264;GO:0004623;GO:0004806;GO:0036155;GO:1905243;GO:0032869;GO:0006650;GO:0034389;GO:0055088;GO:0001676;GO:0006654;GO:0009744;GO:0036153;GO:0019432;GO:0019433;GO:0050872;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:diolein transacylation activity; F:long-chain fatty acyl-CoA binding; F:lysophosphatidic acid acyltransferase activity; F:lysophosphatidic acid binding; F:mono-olein transacylation activity; F:phospholipase A2 activity; F:triglyceride lipase activity;, P:acylglycerol acyl-chain remodeling; P:cellular response to 3,3',5-triiodo-L-thyronine; P:cellular response to insulin stimulus; P:glycerophospholipid metabolic process; P:lipid droplet organization; P:lipid homeostasis; P:long-chain fatty acid metabolic process; P:phosphatidic acid biosynthetic process; P:response to sucrose; P:triglyceride acyl-chain remodeling; P:triglyceride biosynthetic process; P:triglyceride catabolic process; P:white fat cell differentiation; scaffold140 indexed_genome mRNA 867260 867767 . - . ID=transcript_14386;Q9BR01 B2R7N3 O43728,Sulfotransferase 4A1,Brain sulfotransferase-like protein;Nervous system sulfotransferase;, PF00685;, GO:0005737;GO:0005829;GO:0042802;GO:0008146;GO:0050427;GO:0008202;GO:0051923;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:steroid metabolic process; P:sulfation; scaffold140 indexed_genome mRNA 870061 871066 . + . ID=transcript_14387;Q9BR01 B2R7N3 O43728,Sulfotransferase 4A1,Brain sulfotransferase-like protein;Nervous system sulfotransferase;, PF00685;, GO:0005737;GO:0005829;GO:0042802;GO:0008146;GO:0050427;GO:0008202;GO:0051923;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:steroid metabolic process; P:sulfation; scaffold140 indexed_genome mRNA 874697 879960 . - . ID=transcript_14388;Q9BR01 B2R7N3 O43728,Sulfotransferase 4A1,Brain sulfotransferase-like protein;Nervous system sulfotransferase;, PF00685;, GO:0005737;GO:0005829;GO:0042802;GO:0008146;GO:0050427;GO:0008202;GO:0051923;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:steroid metabolic process; P:sulfation;|Q9BR01 B2R7N3 O43728,Sulfotransferase 4A1,Brain sulfotransferase-like protein;Nervous system sulfotransferase;, PF00685;, GO:0005737;GO:0005829;GO:0042802;GO:0008146;GO:0050427;GO:0008202;GO:0051923;, C:cytoplasm; C:cytosol;, F:identical protein binding; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:steroid metabolic process; P:sulfation; scaffold140 indexed_genome mRNA 1080470 1096886 . + . ID=transcript_14389;Q5THR3 A8K8P6 A8K8Y3 B0QYI4 B0QYI6 Q5U5T6 Q9BY88 Q9H5C4 Q9NSF5,EF-hand calcium-binding domain-containing protein 6,CAP-binding protein complex-interacting protein 1;DJ-1-binding protein;, PF08976;PF13499;PF13833;, GO:0005654;GO:0005509;, C:nucleoplasm;, F:calcium ion binding;|Q5THR3 A8K8P6 A8K8Y3 B0QYI4 B0QYI6 Q5U5T6 Q9BY88 Q9H5C4 Q9NSF5,EF-hand calcium-binding domain-containing protein 6,CAP-binding protein complex-interacting protein 1;DJ-1-binding protein;, PF08976;PF13499;PF13833;, GO:0005654;GO:0005509;, C:nucleoplasm;, F:calcium ion binding; scaffold140 indexed_genome mRNA 1392012 1408447 . + . ID=transcript_14390;Q8IWY4 Q5R336,Signal peptide, CUB and EGF-like domain-containing protein 1,, PF12662;PF00431;PF12947;PF07645;PF07699;, GO:0009986;GO:0009897;GO:0005615;GO:0019897;GO:0005886;GO:0005509;GO:0042802;GO:0007512;GO:0007596;GO:0045446;GO:0022617;GO:0006954;GO:0045880;GO:0009791;GO:0007165;, C:cell surface; C:external side of plasma membrane; C:extracellular space; C:extrinsic component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:identical protein binding;, P:adult heart development; P:blood coagulation; P:endothelial cell differentiation; P:extracellular matrix disassembly; P:inflammatory response; P:positive regulation of smoothened signaling pathway; P:post-embryonic development; P:signal transduction; scaffold140 indexed_genome mRNA 1423284 1441257 . + . ID=transcript_14391;Q14166 Q20WK5 Q9UGU3,Tubulin--tyrosine ligase-like protein 12,Inactive tubulin--tyrosine ligase-like protein 12 {ECO:0000305};, PF03133;, GO:0005737;GO:0005815;GO:0030496;GO:0005634;GO:0005819;GO:0005524;GO:1990889;GO:0015631;GO:0034968;GO:0045087;GO:0060339;GO:0018215;GO:0007346;, C:cytoplasm; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle;, F:ATP binding; F:H4K20me3 modified histone binding; F:tubulin binding;, P:histone lysine methylation; P:innate immune response; P:negative regulation of type I interferon-mediated signaling pathway; P:protein phosphopantetheinylation; P:regulation of mitotic cell cycle; scaffold140 indexed_genome mRNA 1442586 1454964 . - . ID=transcript_14392;P30536 Q53Y59 Q6ICF9 Q96TF6,Translocator protein,Mitochondrial benzodiazepine receptor;PKBS;Peripheral-type benzodiazepine receptor;, PF03073;, GO:0005829;GO:0005783;GO:0070062;GO:0016021;GO:0043231;GO:0005741;GO:0005739;GO:0005497;GO:0008503;GO:0015485;GO:0044325;GO:0030325;GO:0007568;GO:0006820;GO:0048266;GO:0006700;GO:0071476;GO:0071222;GO:0071294;GO:0006821;GO:0060242;GO:0008347;GO:0006783;GO:0006869;GO:0072656;GO:1903579;GO:1903147;GO:0060253;GO:0045019;GO:0031397;GO:0032720;GO:0014012;GO:0043065;GO:0051928;GO:0060252;GO:0051901;GO:0010940;GO:2000379;GO:0006626;GO:0042127;GO:0032374;GO:0050810;GO:0042493;GO:0010042;GO:0032570;GO:0033574;GO:0010266;GO:0008202;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrial outer membrane; C:mitochondrion;, F:androgen binding; F:benzodiazepine receptor activity; F:cholesterol binding; F:ion channel binding;, P:adrenal gland development; P:aging; P:anion transport; P:behavioral response to pain; P:C21-steroid hormone biosynthetic process; P:cellular hypotonic response; P:cellular response to lipopolysaccharide; P:cellular response to zinc ion; P:chloride transport; P:contact inhibition; P:glial cell migration; P:heme biosynthetic process; P:lipid transport; P:maintenance of protein location in mitochondrion; P:negative regulation of ATP metabolic process; P:negative regulation of autophagy of mitochondrion; P:negative regulation of glial cell proliferation; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of protein ubiquitination; P:negative regulation of tumor necrosis factor production; P:peripheral nervous system axon regeneration; P:positive regulation of apoptotic process; P:positive regulation of calcium ion transport; P:positive regulation of glial cell proliferation; P:positive regulation of mitochondrial depolarization; P:positive regulation of necrotic cell death; P:positive regulation of reactive oxygen species metabolic process; P:protein targeting to mitochondrion; P:regulation of cell population proliferation; P:regulation of cholesterol transport; P:regulation of steroid biosynthetic process; P:response to drug; P:response to manganese ion; P:response to progesterone; P:response to testosterone; P:response to vitamin B1; P:steroid metabolic process;|P30536 Q53Y59 Q6ICF9 Q96TF6,Translocator protein,Mitochondrial benzodiazepine receptor;PKBS;Peripheral-type benzodiazepine receptor;, PF03073;, GO:0005829;GO:0005783;GO:0070062;GO:0016021;GO:0043231;GO:0005741;GO:0005739;GO:0005497;GO:0008503;GO:0015485;GO:0044325;GO:0030325;GO:0007568;GO:0006820;GO:0048266;GO:0006700;GO:0071476;GO:0071222;GO:0071294;GO:0006821;GO:0060242;GO:0008347;GO:0006783;GO:0006869;GO:0072656;GO:1903579;GO:1903147;GO:0060253;GO:0045019;GO:0031397;GO:0032720;GO:0014012;GO:0043065;GO:0051928;GO:0060252;GO:0051901;GO:0010940;GO:2000379;GO:0006626;GO:0042127;GO:0032374;GO:0050810;GO:0042493;GO:0010042;GO:0032570;GO:0033574;GO:0010266;GO:0008202;, C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrial outer membrane; C:mitochondrion;, F:androgen binding; F:benzodiazepine receptor activity; F:cholesterol binding; F:ion channel binding;, P:adrenal gland development; P:aging; P:anion transport; P:behavioral response to pain; P:C21-steroid hormone biosynthetic process; P:cellular hypotonic response; P:cellular response to lipopolysaccharide; P:cellular response to zinc ion; P:chloride transport; P:contact inhibition; P:glial cell migration; P:heme biosynthetic process; P:lipid transport; P:maintenance of protein location in mitochondrion; P:negative regulation of ATP metabolic process; P:negative regulation of autophagy of mitochondrion; P:negative regulation of glial cell proliferation; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of protein ubiquitination; P:negative regulation of tumor necrosis factor production; P:peripheral nervous system axon regeneration; P:positive regulation of apoptotic process; P:positive regulation of calcium ion transport; P:positive regulation of glial cell proliferation; P:positive regulation of mitochondrial depolarization; P:positive regulation of necrotic cell death; P:positive regulation of reactive oxygen species metabolic process; P:protein targeting to mitochondrion; P:regulation of cell population proliferation; P:regulation of cholesterol transport; P:regulation of steroid biosynthetic process; P:response to drug; P:response to manganese ion; P:response to progesterone; P:response to testosterone; P:response to vitamin B1; P:steroid metabolic process; scaffold140 indexed_genome mRNA 1464601 1477216 . + . ID=transcript_14393;Q8IVS2 B0QY72 O95510 O95511,Malonyl-CoA-acyl carrier protein transacylase, mitochondrial {ECO:0000305},Mitochondrial malonyl CoA:ACP acyltransferase;Mitochondrial malonyltransferase;[Acyl-carrier-protein] malonyltransferase;, PF00698;, GO:0005759;GO:0005739;GO:0004314;GO:0004312;GO:0003723;GO:0006635;GO:0006633;, C:mitochondrial matrix; C:mitochondrion;, F:[acyl-carrier-protein] S-malonyltransferase activity; F:fatty acid synthase activity; F:RNA binding;, P:fatty acid beta-oxidation; P:fatty acid biosynthetic process; scaffold140 indexed_genome mRNA 1480130 1483238 . - . ID=transcript_14394;Q13323 Q16582 Q6FH93,Bcl-2-interacting killer,Apoptosis inducer NBK;BIP1;BP4;, PF12201;, GO:0012505;GO:0016021;GO:0031966;GO:0008637;GO:0006915;GO:0008584;GO:0031334;GO:0090200;GO:0042981;, C:endomembrane system; C:integral component of membrane; C:mitochondrial membrane;, , P:apoptotic mitochondrial changes; P:apoptotic process; P:male gonad development; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:regulation of apoptotic process; scaffold140 indexed_genome mRNA 1529524 1561509 . + . ID=transcript_14395;O95922 B2RDS7 Q9BR27 Q9NRS9 Q9UMU0,Probable tubulin polyglutamylase TTLL1,Tubulin polyglutamylase complex subunit 3;Tubulin--tyrosine ligase-like protein 1;, PF03133;, GO:0036064;GO:0005929;GO:0005737;GO:0005576;GO:0005874;GO:0005524;GO:0015631;GO:0070740;GO:0021702;GO:0002395;GO:0000226;GO:0120197;GO:0018095;GO:0120222;GO:0007288;, C:ciliary basal body; C:cilium; C:cytoplasm; C:extracellular region; C:microtubule;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:cerebellar Purkinje cell differentiation; P:immune response in nasopharyngeal-associated lymphoid tissue; P:microtubule cytoskeleton organization; P:mucociliary clearance; P:protein polyglutamylation; P:regulation of blastocyst development; P:sperm axoneme assembly;|O95922 B2RDS7 Q9BR27 Q9NRS9 Q9UMU0,Probable tubulin polyglutamylase TTLL1,Tubulin polyglutamylase complex subunit 3;Tubulin--tyrosine ligase-like protein 1;, PF03133;, GO:0036064;GO:0005929;GO:0005737;GO:0005576;GO:0005874;GO:0005524;GO:0015631;GO:0070740;GO:0021702;GO:0002395;GO:0000226;GO:0120197;GO:0018095;GO:0120222;GO:0007288;, C:ciliary basal body; C:cilium; C:cytoplasm; C:extracellular region; C:microtubule;, F:ATP binding; F:tubulin binding; F:tubulin-glutamic acid ligase activity;, P:cerebellar Purkinje cell differentiation; P:immune response in nasopharyngeal-associated lymphoid tissue; P:microtubule cytoskeleton organization; P:mucociliary clearance; P:protein polyglutamylation; P:regulation of blastocyst development; P:sperm axoneme assembly; scaffold140 indexed_genome mRNA 1675655 1695539 . + . ID=transcript_14396;Q9UNF0 O95921 Q96HV9 Q9H0D3 Q9NPN1 Q9Y4V2,Protein kinase C and casein kinase substrate in neurons protein 2,Syndapin-2;Syndapin-II;, PF00611;PF00018;, GO:0005901;GO:0005911;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0019898;GO:0005925;GO:0098978;GO:0043231;GO:0016607;GO:0005886;GO:0055038;GO:0032587;GO:0045296;GO:0008092;GO:0042802;GO:0070300;GO:0005543;GO:0005215;GO:0030036;GO:0070836;GO:0072584;GO:0048858;GO:0007010;GO:0061024;GO:0050804;GO:0045806;GO:0097320;GO:0036010;GO:0030100;, C:caveola; C:cell-cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:extrinsic component of membrane; C:focal adhesion; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nuclear speck; C:plasma membrane; C:recycling endosome membrane; C:ruffle membrane;, F:cadherin binding; F:cytoskeletal protein binding; F:identical protein binding; F:phosphatidic acid binding; F:phospholipid binding; F:transporter activity;, P:actin cytoskeleton organization; P:caveola assembly; P:caveolin-mediated endocytosis; P:cell projection morphogenesis; P:cytoskeleton organization; P:membrane organization; P:modulation of chemical synaptic transmission; P:negative regulation of endocytosis; P:plasma membrane tubulation; P:protein localization to endosome; P:regulation of endocytosis;|Q9BY11 Q9P2G8,Protein kinase C and casein kinase substrate in neurons protein 1,Syndapin-1;, PF00611;PF14604;, GO:0043679;GO:0030137;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005768;GO:0048471;GO:0098684;GO:0005886;GO:0098833;GO:0032587;GO:0045202;GO:0008092;GO:0042802;GO:0005543;GO:0007015;GO:0007010;GO:0045806;GO:0048812;GO:0097320;GO:1900006;GO:0072657;GO:0072659;GO:0030100;GO:0048488;, C:axon terminus; C:COPI-coated vesicle; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:endosome; C:perinuclear region of cytoplasm; C:photoreceptor ribbon synapse; C:plasma membrane; C:presynaptic endocytic zone; C:ruffle membrane; C:synapse;, F:cytoskeletal protein binding; F:identical protein binding; F:phospholipid binding;, P:actin filament organization; P:cytoskeleton organization; P:negative regulation of endocytosis; P:neuron projection morphogenesis; P:plasma membrane tubulation; P:positive regulation of dendrite development; P:protein localization to membrane; P:protein localization to plasma membrane; P:regulation of endocytosis; P:synaptic vesicle endocytosis;|Q9UNF0 O95921 Q96HV9 Q9H0D3 Q9NPN1 Q9Y4V2,Protein kinase C and casein kinase substrate in neurons protein 2,Syndapin-2;Syndapin-II;, PF00611;PF00018;, GO:0005901;GO:0005911;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0019898;GO:0005925;GO:0098978;GO:0043231;GO:0016607;GO:0005886;GO:0055038;GO:0032587;GO:0045296;GO:0008092;GO:0042802;GO:0070300;GO:0005543;GO:0005215;GO:0030036;GO:0070836;GO:0072584;GO:0048858;GO:0007010;GO:0061024;GO:0050804;GO:0045806;GO:0097320;GO:0036010;GO:0030100;, C:caveola; C:cell-cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:extrinsic component of membrane; C:focal adhesion; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nuclear speck; C:plasma membrane; C:recycling endosome membrane; C:ruffle membrane;, F:cadherin binding; F:cytoskeletal protein binding; F:identical protein binding; F:phosphatidic acid binding; F:phospholipid binding; F:transporter activity;, P:actin cytoskeleton organization; P:caveola assembly; P:caveolin-mediated endocytosis; P:cell projection morphogenesis; P:cytoskeleton organization; P:membrane organization; P:modulation of chemical synaptic transmission; P:negative regulation of endocytosis; P:plasma membrane tubulation; P:protein localization to endosome; P:regulation of endocytosis;|Q9UNF0 O95921 Q96HV9 Q9H0D3 Q9NPN1 Q9Y4V2,Protein kinase C and casein kinase substrate in neurons protein 2,Syndapin-2;Syndapin-II;, PF00611;PF00018;, GO:0005901;GO:0005911;GO:0005737;GO:0030659;GO:0005856;GO:0005829;GO:0005769;GO:0005768;GO:0070062;GO:0019898;GO:0005925;GO:0098978;GO:0043231;GO:0016607;GO:0005886;GO:0055038;GO:0032587;GO:0045296;GO:0008092;GO:0042802;GO:0070300;GO:0005543;GO:0005215;GO:0030036;GO:0070836;GO:0072584;GO:0048858;GO:0007010;GO:0061024;GO:0050804;GO:0045806;GO:0097320;GO:0036010;GO:0030100;, C:caveola; C:cell-cell junction; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytoskeleton; C:cytosol; C:early endosome; C:endosome; C:extracellular exosome; C:extrinsic component of membrane; C:focal adhesion; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nuclear speck; C:plasma membrane; C:recycling endosome membrane; C:ruffle membrane;, F:cadherin binding; F:cytoskeletal protein binding; F:identical protein binding; F:phosphatidic acid binding; F:phospholipid binding; F:transporter activity;, P:actin cytoskeleton organization; P:caveola assembly; P:caveolin-mediated endocytosis; P:cell projection morphogenesis; P:cytoskeleton organization; P:membrane organization; P:modulation of chemical synaptic transmission; P:negative regulation of endocytosis; P:plasma membrane tubulation; P:protein localization to endosome; P:regulation of endocytosis; scaffold140 indexed_genome mRNA 1708438 1759866 . + . ID=transcript_14397;Q9NP61 E9PB03 Q9BSC6 Q9H9J0 Q9NT10 Q9NUP5 Q9Y4V3 Q9Y4V4,ADP-ribosylation factor GTPase-activating protein 3,, PF01412;, GO:0005829;GO:0005794;GO:0000139;GO:0016020;GO:0005096;GO:0046872;GO:0048205;GO:0006888;GO:0006886;GO:0009306;GO:0006890;GO:0016192;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:membrane;, F:GTPase activator activity; F:metal ion binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport;|Q9NP61 E9PB03 Q9BSC6 Q9H9J0 Q9NT10 Q9NUP5 Q9Y4V3 Q9Y4V4,ADP-ribosylation factor GTPase-activating protein 3,, PF01412;, GO:0005829;GO:0005794;GO:0000139;GO:0016020;GO:0005096;GO:0046872;GO:0048205;GO:0006888;GO:0006886;GO:0009306;GO:0006890;GO:0016192;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:membrane;, F:GTPase activator activity; F:metal ion binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle-mediated transport; scaffold140 indexed_genome mRNA 1844031 1847157 . + . ID=transcript_14398;Q9NPC4 B2R7C4 Q9P1X5,Lactosylceramide 4-alpha-galactosyltransferase,Alpha-1,4-N-acetylglucosaminyltransferase;Alpha-1,4-galactosyltransferase;Alpha4Gal-T1;CD77 synthase;Globotriaosylceramide synthase;P1/Pk synthase;UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase;, PF04572;PF04488;, GO:0030173;GO:0016020;GO:0008378;GO:0050512;GO:0015643;GO:0016758;GO:0001576;GO:0006688;GO:0007009;, C:integral component of Golgi membrane; C:membrane;, F:galactosyltransferase activity; F:lactosylceramide 4-alpha-galactosyltransferase activity; F:toxic substance binding; F:transferase activity, transferring hexosyl groups;, P:globoside biosynthetic process; P:glycosphingolipid biosynthetic process; P:plasma membrane organization; scaffold140 indexed_genome mRNA 1896306 1919479 . + . ID=transcript_14399;Q9UL56,NADH-cytochrome b5 reductase 3,Diaphorase-1;, PF00970;PF00175;, GO:0035578;GO:0005737;GO:0005783;GO:0005789;GO:0005576;GO:0005833;GO:0005811;GO:0016020;GO:0005741;GO:0005739;GO:1903958;GO:0043531;GO:0016208;GO:0004128;GO:0071949;GO:0051287;GO:0008015;GO:0006695;GO:0019852;GO:0043312;GO:0006809;GO:0006805;, C:azurophil granule lumen; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:hemoglobin complex; C:lipid droplet; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nitric-oxide synthase complex;, F:ADP binding; F:AMP binding; F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:FAD binding; F:NAD binding;, P:blood circulation; P:cholesterol biosynthetic process; P:L-ascorbic acid metabolic process; P:neutrophil degranulation; P:nitric oxide biosynthetic process; P:xenobiotic metabolic process;|Q9UL56,NADH-cytochrome b5 reductase 3,Diaphorase-1;, PF00970;PF00175;, GO:0035578;GO:0005737;GO:0005783;GO:0005789;GO:0005576;GO:0005833;GO:0005811;GO:0016020;GO:0005741;GO:0005739;GO:1903958;GO:0043531;GO:0016208;GO:0004128;GO:0071949;GO:0051287;GO:0008015;GO:0006695;GO:0019852;GO:0043312;GO:0006809;GO:0006805;, C:azurophil granule lumen; C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:hemoglobin complex; C:lipid droplet; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nitric-oxide synthase complex;, F:ADP binding; F:AMP binding; F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:FAD binding; F:NAD binding;, P:blood circulation; P:cholesterol biosynthetic process; P:L-ascorbic acid metabolic process; P:neutrophil degranulation; P:nitric oxide biosynthetic process; P:xenobiotic metabolic process; scaffold140 indexed_genome mRNA 1930809 1942317 . + . ID=transcript_14400;Q9BY77 A8K6F8 A8K6V9 Q009A7 Q5H972 Q6PGN6 Q7Z6Z0 Q9NSP5 Q9NSP6,Polymerase delta-interacting protein 3,46 kDa DNA polymerase delta interaction protein;S6K1 Aly/REF-like target;, PF00076;, GO:0005737;GO:0036464;GO:0005829;GO:0016607;GO:0005654;GO:0044877;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0045727;GO:0006405;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:nucleoplasm;, F:protein-containing complex binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:positive regulation of translation; P:RNA export from nucleus;|Q9BY77 A8K6F8 A8K6V9 Q009A7 Q5H972 Q6PGN6 Q7Z6Z0 Q9NSP5 Q9NSP6,Polymerase delta-interacting protein 3,46 kDa DNA polymerase delta interaction protein;S6K1 Aly/REF-like target;, PF00076;, GO:0005737;GO:0036464;GO:0005829;GO:0016607;GO:0005654;GO:0044877;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0045727;GO:0006405;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:nucleoplasm;, F:protein-containing complex binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:positive regulation of translation; P:RNA export from nucleus;|Q9BY77 A8K6F8 A8K6V9 Q009A7 Q5H972 Q6PGN6 Q7Z6Z0 Q9NSP5 Q9NSP6,Polymerase delta-interacting protein 3,46 kDa DNA polymerase delta interaction protein;S6K1 Aly/REF-like target;, PF00076;, GO:0005737;GO:0036464;GO:0005829;GO:0016607;GO:0005654;GO:0044877;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0045727;GO:0006405;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:nucleoplasm;, F:protein-containing complex binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:positive regulation of translation; P:RNA export from nucleus;|Q9BY77 A8K6F8 A8K6V9 Q009A7 Q5H972 Q6PGN6 Q7Z6Z0 Q9NSP5 Q9NSP6,Polymerase delta-interacting protein 3,46 kDa DNA polymerase delta interaction protein;S6K1 Aly/REF-like target;, PF00076;, GO:0005737;GO:0036464;GO:0005829;GO:0016607;GO:0005654;GO:0044877;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0045727;GO:0006405;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:nucleoplasm;, F:protein-containing complex binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:positive regulation of translation; P:RNA export from nucleus;|Q9BY77 A8K6F8 A8K6V9 Q009A7 Q5H972 Q6PGN6 Q7Z6Z0 Q9NSP5 Q9NSP6,Polymerase delta-interacting protein 3,46 kDa DNA polymerase delta interaction protein;S6K1 Aly/REF-like target;, PF00076;, GO:0005737;GO:0036464;GO:0005829;GO:0016607;GO:0005654;GO:0044877;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0045727;GO:0006405;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:nucleoplasm;, F:protein-containing complex binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:positive regulation of translation; P:RNA export from nucleus;|Q9BY77 A8K6F8 A8K6V9 Q009A7 Q5H972 Q6PGN6 Q7Z6Z0 Q9NSP5 Q9NSP6,Polymerase delta-interacting protein 3,46 kDa DNA polymerase delta interaction protein;S6K1 Aly/REF-like target;, PF00076;, GO:0005737;GO:0036464;GO:0005829;GO:0016607;GO:0005654;GO:0044877;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0045727;GO:0006405;, C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:nuclear speck; C:nucleoplasm;, F:protein-containing complex binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:positive regulation of translation; P:RNA export from nucleus; scaffold140 indexed_genome mRNA 1947172 1951291 . + . ID=transcript_14401;Q8NEY6 Q9Y3H5,Ribosomal RNA-processing protein 7 homolog A,Gastric cancer antigen Zg14;, PF17799;PF12923;, GO:0032545;GO:0005737;GO:0005654;GO:0034456;GO:0003723;GO:0001825;GO:0000028;GO:0006364;, C:CURI complex; C:cytoplasm; C:nucleoplasm; C:UTP-C complex;, F:RNA binding;, P:blastocyst formation; P:ribosomal small subunit assembly; P:rRNA processing; scaffold140 indexed_genome mRNA 1971920 1974898 . + . ID=transcript_14402;Q9NQF3 Q5JZ95 Q9UH21,Serine hydrolase-like protein,, PF00561;, GO:0016787;, , F:hydrolase activity; scaffold140 indexed_genome mRNA 2038854 2073927 . + . ID=transcript_14403;Q8NET5 B0QYD0 Q20WL2 Q5JZ96 Q8IUY8 Q8TEM8,NFAT activation molecule 1,Calcineurin/NFAT-activating ITAM-containing protein;NFAT-activating protein with ITAM motif 1;, , GO:0035577;GO:0016021;GO:0045121;GO:0005886;GO:0004888;GO:0030183;GO:0050853;GO:0006954;GO:0035556;GO:0043312;GO:0050861;GO:0001819;GO:0051091;GO:0045577;GO:0007165;, C:azurophil granule membrane; C:integral component of membrane; C:membrane raft; C:plasma membrane;, F:transmembrane signaling receptor activity;, P:B cell differentiation; P:B cell receptor signaling pathway; P:inflammatory response; P:intracellular signal transduction; P:neutrophil degranulation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of cytokine production; P:positive regulation of DNA-binding transcription factor activity; P:regulation of B cell differentiation; P:signal transduction; scaffold140 indexed_genome mRNA 2250586 2296979 . + . ID=transcript_14404;Q9UGU0 A9JX12 O14528 Q13078 Q4V353 Q9H4M0,Transcription factor 20,Nuclear factor SPBP;Protein AR1;Stromelysin-1 PDGF-responsive element-binding protein;, , GO:0016604;GO:0005654;GO:0005634;GO:0003677;GO:0046872;GO:0003723;GO:0045944;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA binding; F:metal ion binding; F:RNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold140 indexed_genome mRNA 2303658 2310305 . + . ID=transcript_14405;A0A087X1C5 Q6XP50,Putative cytochrome P450 2D7 {ECO:0000305},, PF00067;, GO:0005737;GO:0016021;GO:0043231;GO:0005739;GO:0070330;GO:0020037;GO:0005506;GO:0016712;GO:0008395;GO:0019369;GO:0042738;GO:0006082;GO:0006805;, C:cytoplasm; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:aromatase activity; F:heme binding; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:arachidonic acid metabolic process; P:exogenous drug catabolic process; P:organic acid metabolic process; P:xenobiotic metabolic process;|P10635 Q16752 Q2XND6 Q2XND7 Q2XNE0 Q6B012 Q6NXU8,Cytochrome P450 2D6 {ECO:0000303|PubMed:18698000},CYPIID6;Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};Cytochrome P450-DB1;Debrisoquine 4-hydroxylase;, PF00067;, GO:0005737;GO:0005783;GO:0005789;GO:0043231;GO:0005739;GO:0062188;GO:0062189;GO:0062187;GO:0020037;GO:0005506;GO:0004497;GO:0016491;GO:0016712;GO:0008395;GO:0009822;GO:0009820;GO:0019369;GO:0008203;GO:0009804;GO:0042737;GO:0017144;GO:0008210;GO:0042738;GO:0046483;GO:0033076;GO:0042759;GO:0016098;GO:0051100;GO:0090350;GO:0006082;GO:0070989;GO:0042572;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:mitochondrion;, F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:alkaloid catabolic process; P:alkaloid metabolic process; P:arachidonic acid metabolic process; P:cholesterol metabolic process; P:coumarin metabolic process; P:drug catabolic process; P:drug metabolic process; P:estrogen metabolic process; P:exogenous drug catabolic process; P:heterocycle metabolic process; P:isoquinoline alkaloid metabolic process; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:negative regulation of binding; P:negative regulation of cellular organofluorine metabolic process; P:organic acid metabolic process; P:oxidative demethylation; P:retinol metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process; scaffold140 indexed_genome mRNA 2339640 2356560 . + . ID=transcript_14406;P56556 B2RE54 O43675 Q6FGW0 Q6IBT8 Q6IC39,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 {ECO:0000305},Complex I-B14;LYR motif-containing protein 6;NADH-ubiquinone oxidoreductase B14 subunit;, PF05347;, GO:0005743;GO:0031966;GO:0005747;GO:0008137;GO:0006120;GO:0032981;GO:0006979;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to oxidative stress;|P56556 B2RE54 O43675 Q6FGW0 Q6IBT8 Q6IC39,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 {ECO:0000305},Complex I-B14;LYR motif-containing protein 6;NADH-ubiquinone oxidoreductase B14 subunit;, PF05347;, GO:0005743;GO:0031966;GO:0005747;GO:0008137;GO:0006120;GO:0032981;GO:0006979;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to oxidative stress;|P56556 B2RE54 O43675 Q6FGW0 Q6IBT8 Q6IC39,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 {ECO:0000305},Complex I-B14;LYR motif-containing protein 6;NADH-ubiquinone oxidoreductase B14 subunit;, PF05347;, GO:0005743;GO:0031966;GO:0005747;GO:0008137;GO:0006120;GO:0032981;GO:0006979;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to oxidative stress;|Q9H4I9 B2R5D1 Q8TAB9,Essential MCU regulator, mitochondrial {ECO:0000303|PubMed:24231807},Single-pass membrane protein with aspartate-rich tail 1, mitochondrial {ECO:0000312|HGNC:HGNC:25055};, PF10161;, GO:0031305;GO:0005743;GO:0005759;GO:0005739;GO:0005654;GO:1990246;GO:0036444;GO:0051560;GO:0006851;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:uniplex complex;, , P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport;|Q6ICB4 Q3SXQ3 Q8N6L9,Sesquipedalian-2 {ECO:0000305|PubMed:20133602},27 kDa inositol polyphosphate phosphatase interacting protein B;PH domain-containing endocytic trafficking adaptor 2 {ECO:0000305};, PF00169;, GO:0030136;GO:0005829;GO:0005769;GO:0055037;GO:0005802;GO:0042803;GO:0007032;GO:0001881;GO:0042147;, C:clathrin-coated vesicle; C:cytosol; C:early endosome; C:recycling endosome; C:trans-Golgi network;, F:protein homodimerization activity;, P:endosome organization; P:receptor recycling; P:retrograde transport, endosome to Golgi; scaffold140 indexed_genome mRNA 2360601 2367807 . + . ID=transcript_14407;P17050,Alpha-N-acetylgalactosaminidase {ECO:0000305},Alpha-galactosidase B;, PF16499;PF17450;, GO:0005737;GO:0070062;GO:0005764;GO:0004557;GO:0008456;GO:0042803;GO:0016052;GO:0019377;GO:0016139;GO:0046477;GO:0009311;, C:cytoplasm; C:extracellular exosome; C:lysosome;, F:alpha-galactosidase activity; F:alpha-N-acetylgalactosaminidase activity; F:protein homodimerization activity;, P:carbohydrate catabolic process; P:glycolipid catabolic process; P:glycoside catabolic process; P:glycosylceramide catabolic process; P:oligosaccharide metabolic process;|P17050,Alpha-N-acetylgalactosaminidase {ECO:0000305},Alpha-galactosidase B;, PF16499;PF17450;, GO:0005737;GO:0070062;GO:0005764;GO:0004557;GO:0008456;GO:0042803;GO:0016052;GO:0019377;GO:0016139;GO:0046477;GO:0009311;, C:cytoplasm; C:extracellular exosome; C:lysosome;, F:alpha-galactosidase activity; F:alpha-N-acetylgalactosaminidase activity; F:protein homodimerization activity;, P:carbohydrate catabolic process; P:glycolipid catabolic process; P:glycoside catabolic process; P:glycosylceramide catabolic process; P:oligosaccharide metabolic process;|P17050,Alpha-N-acetylgalactosaminidase {ECO:0000305},Alpha-galactosidase B;, PF16499;PF17450;, GO:0005737;GO:0070062;GO:0005764;GO:0004557;GO:0008456;GO:0042803;GO:0016052;GO:0019377;GO:0016139;GO:0046477;GO:0009311;, C:cytoplasm; C:extracellular exosome; C:lysosome;, F:alpha-galactosidase activity; F:alpha-N-acetylgalactosaminidase activity; F:protein homodimerization activity;, P:carbohydrate catabolic process; P:glycolipid catabolic process; P:glycoside catabolic process; P:glycosylceramide catabolic process; P:oligosaccharide metabolic process; scaffold140 indexed_genome mRNA 2386302 2386825 . + . ID=transcript_14408;Q9HCL3 A7MD23,Zinc finger protein 14 homolog,Zinc finger protein 531;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold140 indexed_genome mRNA 2408059 2414263 . - . ID=transcript_14409;Q9UH03 B1AHR0 Q2NKJ7 Q59GF7 Q6IBZ6 Q8N3P3 Q9HD35,Neuronal-specific septin-3,, PF00735;, GO:0032153;GO:0015630;GO:0043005;GO:0098793;GO:0099569;GO:0031105;GO:0005940;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0061640;, C:cell division site; C:microtubule cytoskeleton; C:neuron projection; C:presynapse; C:presynaptic cytoskeleton; C:septin complex; C:septin ring;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis;|Q9UH03 B1AHR0 Q2NKJ7 Q59GF7 Q6IBZ6 Q8N3P3 Q9HD35,Neuronal-specific septin-3,, PF00735;, GO:0032153;GO:0015630;GO:0043005;GO:0098793;GO:0099569;GO:0031105;GO:0005940;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0061640;, C:cell division site; C:microtubule cytoskeleton; C:neuron projection; C:presynapse; C:presynaptic cytoskeleton; C:septin complex; C:septin ring;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; scaffold140 indexed_genome mRNA 2415422 2427886 . - . ID=transcript_14410;Q9UH03 B1AHR0 Q2NKJ7 Q59GF7 Q6IBZ6 Q8N3P3 Q9HD35,Neuronal-specific septin-3,, PF00735;, GO:0032153;GO:0015630;GO:0043005;GO:0098793;GO:0099569;GO:0031105;GO:0005940;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0061640;, C:cell division site; C:microtubule cytoskeleton; C:neuron projection; C:presynapse; C:presynaptic cytoskeleton; C:septin complex; C:septin ring;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis;|Q9UH03 B1AHR0 Q2NKJ7 Q59GF7 Q6IBZ6 Q8N3P3 Q9HD35,Neuronal-specific septin-3,, PF00735;, GO:0032153;GO:0015630;GO:0043005;GO:0098793;GO:0099569;GO:0031105;GO:0005940;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0061640;, C:cell division site; C:microtubule cytoskeleton; C:neuron projection; C:presynapse; C:presynaptic cytoskeleton; C:septin complex; C:septin ring;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; scaffold140 indexed_genome mRNA 2456351 2467892 . + . ID=transcript_14411;Q9NSP4 A7LM22 B1AHQ9 Q6I9W3,Centromere protein M,Interphase centromere complex protein 39;Proliferation-associated nuclear element protein 1;, PF11111;, GO:0000777;GO:0005829;GO:0005654;GO:0034080;GO:0007052;, C:condensed chromosome kinetochore; C:cytosol; C:nucleoplasm;, , P:CENP-A containing nucleosome assembly; P:mitotic spindle organization;|Q9NSP4 A7LM22 B1AHQ9 Q6I9W3,Centromere protein M,Interphase centromere complex protein 39;Proliferation-associated nuclear element protein 1;, PF11111;, GO:0000777;GO:0005829;GO:0005654;GO:0034080;GO:0007052;, C:condensed chromosome kinetochore; C:cytosol; C:nucleoplasm;, , P:CENP-A containing nucleosome assembly; P:mitotic spindle organization;|Q9NSP4 A7LM22 B1AHQ9 Q6I9W3,Centromere protein M,Interphase centromere complex protein 39;Proliferation-associated nuclear element protein 1;, PF11111;, GO:0000777;GO:0005829;GO:0005654;GO:0034080;GO:0007052;, C:condensed chromosome kinetochore; C:cytosol; C:nucleoplasm;, , P:CENP-A containing nucleosome assembly; P:mitotic spindle organization;|Q9NSP4 A7LM22 B1AHQ9 Q6I9W3,Centromere protein M,Interphase centromere complex protein 39;Proliferation-associated nuclear element protein 1;, PF11111;, GO:0000777;GO:0005829;GO:0005654;GO:0034080;GO:0007052;, C:condensed chromosome kinetochore; C:cytosol; C:nucleoplasm;, , P:CENP-A containing nucleosome assembly; P:mitotic spindle organization; scaffold141 indexed_genome mRNA 208237 209309 . - . ID=transcript_14412;Q9NP77 Q9BZS6 Q9H933,RNA polymerase II subunit A C-terminal domain phosphatase SSU72,, PF04722;, GO:0005829;GO:0005847;GO:0005654;GO:0106306;GO:0106307;GO:0008420;GO:0070940;GO:0006378;GO:0006369;, C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:dephosphorylation of RNA polymerase II C-terminal domain; P:mRNA polyadenylation; P:termination of RNA polymerase II transcription; scaffold141 indexed_genome mRNA 374663 402450 . + . ID=transcript_14413;Q8TAG5 A4D2E9 B5MC94,V-set and transmembrane domain-containing protein 2A {ECO:0000312|HGNC:HGNC:28499},, PF07686;, GO:0005576;GO:0016021;GO:0042802;GO:0030154;GO:0071773;GO:0090336;GO:0010628;GO:0010884;GO:0070352;, C:extracellular region; C:integral component of membrane;, F:identical protein binding;, P:cell differentiation; P:cellular response to BMP stimulus; P:positive regulation of brown fat cell differentiation; P:positive regulation of gene expression; P:positive regulation of lipid storage; P:positive regulation of white fat cell proliferation;|Q8TAG5 A4D2E9 B5MC94,V-set and transmembrane domain-containing protein 2A {ECO:0000312|HGNC:HGNC:28499},, PF07686;, GO:0005576;GO:0016021;GO:0042802;GO:0030154;GO:0071773;GO:0090336;GO:0010628;GO:0010884;GO:0070352;, C:extracellular region; C:integral component of membrane;, F:identical protein binding;, P:cell differentiation; P:cellular response to BMP stimulus; P:positive regulation of brown fat cell differentiation; P:positive regulation of gene expression; P:positive regulation of lipid storage; P:positive regulation of white fat cell proliferation;|Q8TAG5 A4D2E9 B5MC94,V-set and transmembrane domain-containing protein 2A {ECO:0000312|HGNC:HGNC:28499},, PF07686;, GO:0005576;GO:0016021;GO:0042802;GO:0030154;GO:0071773;GO:0090336;GO:0010628;GO:0010884;GO:0070352;, C:extracellular region; C:integral component of membrane;, F:identical protein binding;, P:cell differentiation; P:cellular response to BMP stimulus; P:positive regulation of brown fat cell differentiation; P:positive regulation of gene expression; P:positive regulation of lipid storage; P:positive regulation of white fat cell proliferation;|Q8TAG5 A4D2E9 B5MC94,V-set and transmembrane domain-containing protein 2A {ECO:0000312|HGNC:HGNC:28499},, PF07686;, GO:0005576;GO:0016021;GO:0042802;GO:0030154;GO:0071773;GO:0090336;GO:0010628;GO:0010884;GO:0070352;, C:extracellular region; C:integral component of membrane;, F:identical protein binding;, P:cell differentiation; P:cellular response to BMP stimulus; P:positive regulation of brown fat cell differentiation; P:positive regulation of gene expression; P:positive regulation of lipid storage; P:positive regulation of white fat cell proliferation; scaffold142 indexed_genome mRNA 50820 52837 . + . ID=transcript_14414;P63128 Q9UKH4,Endogenous retrovirus group K member 9 Pol protein,HERV-K(C6) Gag-Pol protein;HERV-K109 Gag-Pol protein;HERV-K_6q14.1 provirus ancestral Gag-Pol polyprotein;, PF00692;PF01585;PF02337;PF00607;PF00077;PF00078;PF00098;, GO:0005886;GO:0004190;GO:0003887;GO:0003723;GO:0003964;GO:0004523;GO:0005198;GO:0008270;GO:0016032;, C:plasma membrane;, F:aspartic-type endopeptidase activity; F:DNA-directed DNA polymerase activity; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:structural molecule activity; F:zinc ion binding;, P:viral process; scaffold142 indexed_genome mRNA 79107 94031 . + . ID=transcript_14415;Q5HY98 B2RNE0 Q7Z326,Zinc finger protein 766,, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0046872;GO:0006355;, C:nucleus;, F:DNA binding; F:metal ion binding;, P:regulation of transcription, DNA-templated; scaffold142 indexed_genome mRNA 113484 115925 . + . ID=transcript_14416;Q96SE7 B3KU77 B9EG59 G5E9N4 Q8TCN1,Zinc finger protein 347,Zinc finger protein 1111;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 123221 124694 . - . ID=transcript_14417;P10266 P87890 Q14273,Endogenous retrovirus group K member 10 Pol protein,HERV-K10 Pol protein;HERV-K107 Pol protein;HERV-K_5q33.3 provirus ancestral Pol protein;, PF13804;PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold142 indexed_genome mRNA 126278 126829 . + . ID=transcript_14418;P61567,Endogenous retrovirus group K member 7 Env polyprotein,Envelope polyprotein;HERV-K(III) envelope protein;HERV-K102 envelope protein;HERV-K_1q22 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity; scaffold142 indexed_genome mRNA 128307 129172 . - . ID=transcript_14419;P61566,Endogenous retrovirus group K member 24 Env polyprotein,Envelope polyprotein;HERV-K101 envelope protein;HERV-K_22q11.21 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity; scaffold142 indexed_genome mRNA 129447 132696 . + . ID=transcript_14420;P63132,Endogenous retrovirus group K member 113 Pol protein,HERV-K113 Pol protein;HERV-K_19p13.11 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold142 indexed_genome mRNA 140621 144406 . + . ID=transcript_14421;P35754 B2R4L2 Q3KQS1 Q6ICT1,Glutaredoxin-1,Thioltransferase-1;, PF00462;, GO:0005829;GO:0070062;GO:0005634;GO:0009055;GO:0015038;GO:0097573;GO:0047485;GO:0015949;GO:0045838;GO:2000651;GO:0080058;, C:cytosol; C:extracellular exosome; C:nucleus;, F:electron transfer activity; F:glutathione disulfide oxidoreductase activity; F:glutathione oxidoreductase activity; F:protein N-terminus binding;, P:nucleobase-containing small molecule interconversion; P:positive regulation of membrane potential; P:positive regulation of sodium ion transmembrane transporter activity; P:protein deglutathionylation; scaffold142 indexed_genome mRNA 156805 169117 . - . ID=transcript_14422;Q9H7R5 A8K5T8,Zinc finger protein 665,Zinc finger protein 160-like;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 186745 187343 . + . ID=transcript_14423;Q76KX8 Q76KX9,Zinc finger protein 534,KRAB domain only protein 3;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 302761 315009 . - . ID=transcript_14424;Q96SE7 B3KU77 B9EG59 G5E9N4 Q8TCN1,Zinc finger protein 347,Zinc finger protein 1111;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 442351 442947 . - . ID=transcript_14425;P63133,Endogenous retrovirus group K member 8 Pol protein,HERV-K115 Pol protein;HERV-K_8p23.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold142 indexed_genome mRNA 631625 632157 . + . ID=transcript_14426;Q3ZCX4 B4DS92 E7ER33 Q6N060 Q8NA64,Zinc finger protein 568,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0000976;GO:0060669;GO:0001701;GO:0000122;GO:0045892;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:embryonic placenta morphogenesis; P:in utero embryonic development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 634127 644603 . - . ID=transcript_14427;Q8WV37 Q5JPG9 Q6P0Q4 Q8N1M5,Zinc finger protein 480,, PF01352;PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 646009 647718 . - . ID=transcript_14428;Q14590 B4DTQ7 O14898 O14899 Q17RR8,Zinc finger protein 235,Zinc finger protein 270;Zinc finger protein 93 homolog;Zinc finger protein HZF6;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 647765 655696 . - . ID=transcript_14429;Q9HCG1 Q14589 Q504Q8 Q96JC5 Q9BVY9 Q9H7N6,Zinc finger protein 160,Zinc finger protein HZF5;Zinc finger protein Kr18;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0030097;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:hemopoiesis; P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 674952 683709 . + . ID=transcript_14430;Q9H7R5 A8K5T8,Zinc finger protein 665,Zinc finger protein 160-like;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 689756 712235 . + . ID=transcript_14431;Q09FC8 F5H287 Q09FC7 Q09FC9 Q09FD0 Q6NSZ2 Q6P3S0 Q9NUR2,Zinc finger protein 415,, PF00096;, GO:0005737;GO:0001650;GO:0015630;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytoplasm; C:fibrillar center; C:microtubule cytoskeleton; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9H7R5 A8K5T8,Zinc finger protein 665,Zinc finger protein 160-like;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 732574 737999 . + . ID=transcript_14432;Q08AN1 B3KRV1 Q0P658 Q658V7,Zinc finger protein 616,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9H7R5 A8K5T8,Zinc finger protein 665,Zinc finger protein 160-like;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 760692 761374 . - . ID=transcript_14433;Q9H7R5 A8K5T8,Zinc finger protein 665,Zinc finger protein 160-like;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 790480 797501 . + . ID=transcript_14434;Q86XU0,Zinc finger protein 677,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 809277 813874 . - . ID=transcript_14435;Q96SE7 B3KU77 B9EG59 G5E9N4 Q8TCN1,Zinc finger protein 347,Zinc finger protein 1111;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 816505 818531 . + . ID=transcript_14436;Q76KX8 Q76KX9,Zinc finger protein 534,KRAB domain only protein 3;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8WV37 Q5JPG9 Q6P0Q4 Q8N1M5,Zinc finger protein 480,, PF01352;PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 1382000 1395937 . + . ID=transcript_14437;Q8TAQ5 B2RDY6 Q96ML5,Zinc finger protein 420,, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0042981;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of apoptotic process; P:regulation of transcription by RNA polymerase II;|B4DX44,Zinc finger protein 736,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q96SE7 B3KU77 B9EG59 G5E9N4 Q8TCN1,Zinc finger protein 347,Zinc finger protein 1111;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold142 indexed_genome mRNA 1429344 1434275 . - . ID=transcript_14438;Q32P51 Q5TBS2,Heterogeneous nuclear ribonucleoprotein A1-like 2,hnRNP core protein A1-like 2;, PF11627;PF00076;, GO:0005737;GO:0005681;GO:0003723;GO:0006397;GO:0051028;GO:0008380;, C:cytoplasm; C:spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA transport; P:RNA splicing; scaffold142 indexed_genome mRNA 1445317 1459652 . - . ID=transcript_14439;Q9NQX6 Q96GJ4,Zinc finger protein 331,C2H2-like zinc finger protein rearranged in thyroid adenomas;Zinc finger protein 361;Zinc finger protein 463;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated;|Q9NQX6 Q96GJ4,Zinc finger protein 331,C2H2-like zinc finger protein rearranged in thyroid adenomas;Zinc finger protein 361;Zinc finger protein 463;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated; scaffold142 indexed_genome mRNA 1806527 1808492 . - . ID=transcript_14440;Q8WY07 D3DVU7 Q5JQR2 Q8N185 Q8NCA7 Q96SZ7,Cationic amino acid transporter 3,Cationic amino acid transporter y+;Solute carrier family 7 member 3;, PF13520;PF13906;, GO:0016021;GO:0005886;GO:0015171;GO:0015181;GO:0061459;GO:0015189;GO:0000064;GO:0006865;GO:0097638;GO:0097639;GO:0097640;GO:1903352;GO:0150104;, C:integral component of membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:arginine transmembrane transporter activity; F:L-arginine transmembrane transporter activity; F:L-lysine transmembrane transporter activity; F:L-ornithine transmembrane transporter activity;, P:amino acid transport; P:L-arginine import across plasma membrane; P:L-lysine import across plasma membrane; P:L-ornithine import across plasma membrane; P:L-ornithine transmembrane transport; P:transport across blood-brain barrier; scaffold142 indexed_genome mRNA 1906409 1923280 . - . ID=transcript_14441;Q8WXS5 Q9BXT0 Q9BY23,Voltage-dependent calcium channel gamma-8 subunit,Neuronal voltage-gated calcium channel gamma-8 subunit;Transmembrane AMPAR regulatory protein gamma-8;, PF00822;, GO:0032281;GO:0030666;GO:1990454;GO:0005886;GO:0014069;GO:0098839;GO:0005891;GO:0005246;GO:0016247;GO:0005245;GO:0006816;GO:0061337;GO:0099590;GO:0098943;GO:0051968;GO:0098970;GO:2000311;GO:0019226;, C:AMPA glutamate receptor complex; C:endocytic vesicle membrane; C:L-type voltage-gated calcium channel complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic density membrane; C:voltage-gated calcium channel complex;, F:calcium channel regulator activity; F:channel regulator activity; F:voltage-gated calcium channel activity;, P:calcium ion transport; P:cardiac conduction; P:neurotransmitter receptor internalization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic neurotransmitter receptor diffusion trapping; P:regulation of AMPA receptor activity; P:transmission of nerve impulse; scaffold142 indexed_genome mRNA 1934489 1950330 . - . ID=transcript_14442;P62955 Q52LL8 Q8VBX3 Q8WXS6 Q9BXT1,Voltage-dependent calcium channel gamma-7 subunit,Neuronal voltage-gated calcium channel gamma-7 subunit;Transmembrane AMPAR regulatory protein gamma-7;, PF13903;, GO:0032281;GO:0044300;GO:0005769;GO:0098978;GO:0099061;GO:1990454;GO:0043025;GO:0005886;GO:0098839;GO:0005891;GO:0005246;GO:0016247;GO:0005245;GO:0006816;GO:0061337;GO:0099590;GO:0098943;GO:1903861;GO:0051968;GO:0098970;GO:2000311;GO:0043488;GO:0019226;, C:AMPA glutamate receptor complex; C:cerebellar mossy fiber; C:early endosome; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:L-type voltage-gated calcium channel complex; C:neuronal cell body; C:plasma membrane; C:postsynaptic density membrane; C:voltage-gated calcium channel complex;, F:calcium channel regulator activity; F:channel regulator activity; F:voltage-gated calcium channel activity;, P:calcium ion transport; P:cardiac conduction; P:neurotransmitter receptor internalization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of dendrite extension; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic neurotransmitter receptor diffusion trapping; P:regulation of AMPA receptor activity; P:regulation of mRNA stability; P:transmission of nerve impulse; scaffold142 indexed_genome mRNA 1954924 1973860 . - . ID=transcript_14443;P05129 B7Z8Q0,Protein kinase C gamma type,, PF00130;PF00168;PF00069;PF00433;, GO:0044305;GO:0005911;GO:0005829;GO:0030425;GO:0005634;GO:0048471;GO:0005886;GO:0099524;GO:0014069;GO:0099523;GO:0097060;GO:0005524;GO:0004698;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0008270;GO:0007268;GO:0007635;GO:0060384;GO:0035556;GO:0007611;GO:0043524;GO:1901799;GO:0042177;GO:0031397;GO:0018105;GO:0016310;GO:0030168;GO:0032425;GO:0099171;GO:0046777;GO:0006468;GO:0042752;GO:0050764;GO:0032095;GO:2000300;GO:0043278;GO:0048265;GO:1990911;GO:0048511;, C:calyx of Held; C:cell-cell junction; C:cytosol; C:dendrite; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic density; C:presynaptic cytosol; C:synaptic membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:chemical synaptic transmission; P:chemosensory behavior; P:innervation; P:intracellular signal transduction; P:learning or memory; P:negative regulation of neuron apoptotic process; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of protein catabolic process; P:negative regulation of protein ubiquitination; P:peptidyl-serine phosphorylation; P:phosphorylation; P:platelet activation; P:positive regulation of mismatch repair; P:presynaptic modulation of chemical synaptic transmission; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of phagocytosis; P:regulation of response to food; P:regulation of synaptic vesicle exocytosis; P:response to morphine; P:response to pain; P:response to psychosocial stress; P:rhythmic process;|P05129 B7Z8Q0,Protein kinase C gamma type,, PF00130;PF00168;PF00069;PF00433;, GO:0044305;GO:0005911;GO:0005829;GO:0030425;GO:0005634;GO:0048471;GO:0005886;GO:0099524;GO:0014069;GO:0099523;GO:0097060;GO:0005524;GO:0004698;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0008270;GO:0007268;GO:0007635;GO:0060384;GO:0035556;GO:0007611;GO:0043524;GO:1901799;GO:0042177;GO:0031397;GO:0018105;GO:0016310;GO:0030168;GO:0032425;GO:0099171;GO:0046777;GO:0006468;GO:0042752;GO:0050764;GO:0032095;GO:2000300;GO:0043278;GO:0048265;GO:1990911;GO:0048511;, C:calyx of Held; C:cell-cell junction; C:cytosol; C:dendrite; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic cytosol; C:postsynaptic density; C:presynaptic cytosol; C:synaptic membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:zinc ion binding;, P:chemical synaptic transmission; P:chemosensory behavior; P:innervation; P:intracellular signal transduction; P:learning or memory; P:negative regulation of neuron apoptotic process; P:negative regulation of proteasomal protein catabolic process; P:negative regulation of protein catabolic process; P:negative regulation of protein ubiquitination; P:peptidyl-serine phosphorylation; P:phosphorylation; P:platelet activation; P:positive regulation of mismatch repair; P:presynaptic modulation of chemical synaptic transmission; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of phagocytosis; P:regulation of response to food; P:regulation of synaptic vesicle exocytosis; P:response to morphine; P:response to pain; P:response to psychosocial stress; P:rhythmic process; scaffold143 indexed_genome mRNA 121998 126691 . + . ID=transcript_14444;Q9Y4D2 A0A024R517 A7E233 Q6WQJ0,Diacylglycerol lipase-alpha,Neural stem cell-derived dendrite regulator {ECO:0000303|Ref.1};Sn1-specific diacylglycerol lipase alpha {ECO:0000303|PubMed:14610053};, PF01764;, GO:0032590;GO:0032591;GO:0031901;GO:0099055;GO:0005886;GO:0098839;GO:0045211;GO:0043196;GO:0016787;GO:0046872;GO:0019369;GO:0046340;GO:0071926;GO:0007216;GO:0007405;GO:0022008;GO:0042136;GO:0150077;GO:0098921;, C:dendrite membrane; C:dendritic spine membrane; C:early endosome membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:postsynaptic density membrane; C:postsynaptic membrane; C:varicosity;, F:hydrolase activity; F:metal ion binding;, P:arachidonic acid metabolic process; P:diacylglycerol catabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:regulation of neuroinflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid; scaffold143 indexed_genome mRNA 129454 147774 . + . ID=transcript_14445;Q9Y4D2 A0A024R517 A7E233 Q6WQJ0,Diacylglycerol lipase-alpha,Neural stem cell-derived dendrite regulator {ECO:0000303|Ref.1};Sn1-specific diacylglycerol lipase alpha {ECO:0000303|PubMed:14610053};, PF01764;, GO:0032590;GO:0032591;GO:0031901;GO:0099055;GO:0005886;GO:0098839;GO:0045211;GO:0043196;GO:0016787;GO:0046872;GO:0019369;GO:0046340;GO:0071926;GO:0007216;GO:0007405;GO:0022008;GO:0042136;GO:0150077;GO:0098921;, C:dendrite membrane; C:dendritic spine membrane; C:early endosome membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:postsynaptic density membrane; C:postsynaptic membrane; C:varicosity;, F:hydrolase activity; F:metal ion binding;, P:arachidonic acid metabolic process; P:diacylglycerol catabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:regulation of neuroinflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q9Y4D2 A0A024R517 A7E233 Q6WQJ0,Diacylglycerol lipase-alpha,Neural stem cell-derived dendrite regulator {ECO:0000303|Ref.1};Sn1-specific diacylglycerol lipase alpha {ECO:0000303|PubMed:14610053};, PF01764;, GO:0032590;GO:0032591;GO:0031901;GO:0099055;GO:0005886;GO:0098839;GO:0045211;GO:0043196;GO:0016787;GO:0046872;GO:0019369;GO:0046340;GO:0071926;GO:0007216;GO:0007405;GO:0022008;GO:0042136;GO:0150077;GO:0098921;, C:dendrite membrane; C:dendritic spine membrane; C:early endosome membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:postsynaptic density membrane; C:postsynaptic membrane; C:varicosity;, F:hydrolase activity; F:metal ion binding;, P:arachidonic acid metabolic process; P:diacylglycerol catabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:regulation of neuroinflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid;|Q9Y4D2 A0A024R517 A7E233 Q6WQJ0,Diacylglycerol lipase-alpha,Neural stem cell-derived dendrite regulator {ECO:0000303|Ref.1};Sn1-specific diacylglycerol lipase alpha {ECO:0000303|PubMed:14610053};, PF01764;, GO:0032590;GO:0032591;GO:0031901;GO:0099055;GO:0005886;GO:0098839;GO:0045211;GO:0043196;GO:0016787;GO:0046872;GO:0019369;GO:0046340;GO:0071926;GO:0007216;GO:0007405;GO:0022008;GO:0042136;GO:0150077;GO:0098921;, C:dendrite membrane; C:dendritic spine membrane; C:early endosome membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:postsynaptic density membrane; C:postsynaptic membrane; C:varicosity;, F:hydrolase activity; F:metal ion binding;, P:arachidonic acid metabolic process; P:diacylglycerol catabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:regulation of neuroinflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid; scaffold143 indexed_genome mRNA 147819 151596 . + . ID=transcript_14446;Q9Y4D2 A0A024R517 A7E233 Q6WQJ0,Diacylglycerol lipase-alpha,Neural stem cell-derived dendrite regulator {ECO:0000303|Ref.1};Sn1-specific diacylglycerol lipase alpha {ECO:0000303|PubMed:14610053};, PF01764;, GO:0032590;GO:0032591;GO:0031901;GO:0099055;GO:0005886;GO:0098839;GO:0045211;GO:0043196;GO:0016787;GO:0046872;GO:0019369;GO:0046340;GO:0071926;GO:0007216;GO:0007405;GO:0022008;GO:0042136;GO:0150077;GO:0098921;, C:dendrite membrane; C:dendritic spine membrane; C:early endosome membrane; C:integral component of postsynaptic membrane; C:plasma membrane; C:postsynaptic density membrane; C:postsynaptic membrane; C:varicosity;, F:hydrolase activity; F:metal ion binding;, P:arachidonic acid metabolic process; P:diacylglycerol catabolic process; P:endocannabinoid signaling pathway; P:G protein-coupled glutamate receptor signaling pathway; P:neuroblast proliferation; P:neurogenesis; P:neurotransmitter biosynthetic process; P:regulation of neuroinflammatory response; P:retrograde trans-synaptic signaling by endocannabinoid; scaffold143 indexed_genome mRNA 180006 198014 . + . ID=transcript_14447;Q9Y2G1 O43582 Q9P1Q6,Myelin regulatory factor,Myelin gene regulatory factor;, PF13887;PF13888;PF05224;PF13884;, GO:0005829;GO:0005789;GO:0005794;GO:0016021;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0042802;GO:0008233;GO:0043565;GO:0032286;GO:0022010;GO:0014003;GO:0048709;GO:0031643;GO:0045893;GO:0016540;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:peptidase activity; F:sequence-specific DNA binding;, P:central nervous system myelin maintenance; P:central nervous system myelination; P:oligodendrocyte development; P:oligodendrocyte differentiation; P:positive regulation of myelination; P:positive regulation of transcription, DNA-templated; P:protein autoprocessing;|Q9Y2G1 O43582 Q9P1Q6,Myelin regulatory factor,Myelin gene regulatory factor;, PF13887;PF13888;PF05224;PF13884;, GO:0005829;GO:0005789;GO:0005794;GO:0016021;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0042802;GO:0008233;GO:0043565;GO:0032286;GO:0022010;GO:0014003;GO:0048709;GO:0031643;GO:0045893;GO:0016540;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:peptidase activity; F:sequence-specific DNA binding;, P:central nervous system myelin maintenance; P:central nervous system myelination; P:oligodendrocyte development; P:oligodendrocyte differentiation; P:positive regulation of myelination; P:positive regulation of transcription, DNA-templated; P:protein autoprocessing;|Q9Y2G1 O43582 Q9P1Q6,Myelin regulatory factor,Myelin gene regulatory factor;, PF13887;PF13888;PF05224;PF13884;, GO:0005829;GO:0005789;GO:0005794;GO:0016021;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0042802;GO:0008233;GO:0043565;GO:0032286;GO:0022010;GO:0014003;GO:0048709;GO:0031643;GO:0045893;GO:0016540;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:peptidase activity; F:sequence-specific DNA binding;, P:central nervous system myelin maintenance; P:central nervous system myelination; P:oligodendrocyte development; P:oligodendrocyte differentiation; P:positive regulation of myelination; P:positive regulation of transcription, DNA-templated; P:protein autoprocessing;|Q9Y2G1 O43582 Q9P1Q6,Myelin regulatory factor,Myelin gene regulatory factor;, PF13887;PF13888;PF05224;PF13884;, GO:0005829;GO:0005789;GO:0005794;GO:0016021;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0042802;GO:0008233;GO:0043565;GO:0032286;GO:0022010;GO:0014003;GO:0048709;GO:0031643;GO:0045893;GO:0016540;, C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:peptidase activity; F:sequence-specific DNA binding;, P:central nervous system myelin maintenance; P:central nervous system myelination; P:oligodendrocyte development; P:oligodendrocyte differentiation; P:positive regulation of myelination; P:positive regulation of transcription, DNA-templated; P:protein autoprocessing; scaffold143 indexed_genome mRNA 199686 200813 . + . ID=transcript_14448;P61165 A8K6L8 Q9D953 Q9Y2Q7,Transmembrane protein 258,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258;, PF05251;, GO:0005783;GO:0016021;GO:0043227;GO:0034998;GO:0032991;GO:0006487;, C:endoplasmic reticulum; C:integral component of membrane; C:membrane-bounded organelle; C:oligosaccharyltransferase I complex; C:protein-containing complex;, , P:protein N-linked glycosylation; scaffold143 indexed_genome mRNA 202526 207055 . + . ID=transcript_14449;P39748,Flap endonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03140},DNase IV;Flap structure-specific endonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03140};Maturation factor 1;, PF00867;PF00752;, GO:0000781;GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0008409;GO:0017108;GO:0003684;GO:0003677;GO:0003690;GO:0008309;GO:0004519;GO:0004527;GO:0048256;GO:0000287;GO:0030145;GO:0004523;GO:0006287;GO:0006281;GO:0006260;GO:0043137;GO:0006302;GO:0000724;GO:0007613;GO:0090305;GO:0045876;GO:0032201;GO:0009650;, C:chromosome, telomeric region; C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:5'-3' exonuclease activity; F:5'-flap endonuclease activity; F:damaged DNA binding; F:DNA binding; F:double-stranded DNA binding; F:double-stranded DNA exodeoxyribonuclease activity; F:endonuclease activity; F:exonuclease activity; F:flap endonuclease activity; F:magnesium ion binding; F:manganese ion binding; F:RNA-DNA hybrid ribonuclease activity;, P:base-excision repair, gap-filling; P:DNA repair; P:DNA replication; P:DNA replication, removal of RNA primer; P:double-strand break repair; P:double-strand break repair via homologous recombination; P:memory; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of sister chromatid cohesion; P:telomere maintenance via semi-conservative replication; P:UV protection; scaffold143 indexed_genome mRNA 211738 223885 . - . ID=transcript_14450;Q96T10 Q9NRP8 Q9NYX1,Acyl-CoA (8-3)-desaturase {ECO:0000305},Delta(5) fatty acid desaturase;Fatty acid desaturase 1 {ECO:0000303|PubMed:10860662};, PF00173;PF00487;, GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005739;GO:0062076;GO:0000248;GO:0016213;GO:0016491;GO:0036109;GO:0007267;GO:0009267;GO:0046456;GO:0043651;GO:0042759;GO:0008654;GO:0045595;GO:0019222;GO:0006355;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion;, F:acyl-CoA delta5-desaturase activity; F:C-5 sterol desaturase activity; F:linoleoyl-CoA desaturase activity; F:oxidoreductase activity;, P:alpha-linolenic acid metabolic process; P:cell-cell signaling; P:cellular response to starvation; P:icosanoid biosynthetic process; P:linoleic acid metabolic process; P:long-chain fatty acid biosynthetic process; P:phospholipid biosynthetic process; P:regulation of cell differentiation; P:regulation of metabolic process; P:regulation of transcription, DNA-templated; P:unsaturated fatty acid biosynthetic process;|Q96T10 Q9NRP8 Q9NYX1,Acyl-CoA (8-3)-desaturase {ECO:0000305},Delta(5) fatty acid desaturase;Fatty acid desaturase 1 {ECO:0000303|PubMed:10860662};, PF00173;PF00487;, GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005739;GO:0062076;GO:0000248;GO:0016213;GO:0016491;GO:0036109;GO:0007267;GO:0009267;GO:0046456;GO:0043651;GO:0042759;GO:0008654;GO:0045595;GO:0019222;GO:0006355;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion;, F:acyl-CoA delta5-desaturase activity; F:C-5 sterol desaturase activity; F:linoleoyl-CoA desaturase activity; F:oxidoreductase activity;, P:alpha-linolenic acid metabolic process; P:cell-cell signaling; P:cellular response to starvation; P:icosanoid biosynthetic process; P:linoleic acid metabolic process; P:long-chain fatty acid biosynthetic process; P:phospholipid biosynthetic process; P:regulation of cell differentiation; P:regulation of metabolic process; P:regulation of transcription, DNA-templated; P:unsaturated fatty acid biosynthetic process; scaffold143 indexed_genome mRNA 304576 305643 . + . ID=transcript_14451;Q9BXR3 Q6KH04 Q9BXR4 Q9UKH5 Q9UP31 Q9WIK9 Q9WJR4,Endogenous retrovirus group K member 6 Pol protein,HERV-K(C7) Pol protein;HERV-K(HML-2.HOM) Pol protein;HERV-K108 Pol protein;HERV-K_7p22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold143 indexed_genome mRNA 323859 390310 . + . ID=transcript_14452;O95864 A8K2M6 B7Z634 Q6MZQ7 Q96H07 Q96SV8 Q9H3G3 Q9Y3X4,Acyl-CoA 6-desaturase {ECO:0000305|PubMed:12713571},Delta(6) fatty acid desaturase;Fatty acid desaturase 2 {ECO:0000303|PubMed:10860662};, PF00173;PF00487;, GO:0005789;GO:0005887;GO:0016020;GO:0016213;GO:0004768;GO:0036109;GO:0043651;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:linoleoyl-CoA desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:alpha-linolenic acid metabolic process; P:linoleic acid metabolic process; P:unsaturated fatty acid biosynthetic process;|Q9Y5Q0 O60426,Fatty acid desaturase 3 {ECO:0000250|UniProtKB:Q8K1P9},Delta(13) fatty acid desaturase {ECO:0000250|UniProtKB:Q8K1P9};, PF00173;PF00487;, GO:0005789;GO:0016021;GO:0016020;GO:0016491;GO:0006665;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:oxidoreductase activity;, P:sphingolipid metabolic process; P:unsaturated fatty acid biosynthetic process;|O95864 A8K2M6 B7Z634 Q6MZQ7 Q96H07 Q96SV8 Q9H3G3 Q9Y3X4,Acyl-CoA 6-desaturase {ECO:0000305|PubMed:12713571},Delta(6) fatty acid desaturase;Fatty acid desaturase 2 {ECO:0000303|PubMed:10860662};, PF00173;PF00487;, GO:0005789;GO:0005887;GO:0016020;GO:0016213;GO:0004768;GO:0036109;GO:0043651;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:linoleoyl-CoA desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:alpha-linolenic acid metabolic process; P:linoleic acid metabolic process; P:unsaturated fatty acid biosynthetic process;|O95864 A8K2M6 B7Z634 Q6MZQ7 Q96H07 Q96SV8 Q9H3G3 Q9Y3X4,Acyl-CoA 6-desaturase {ECO:0000305|PubMed:12713571},Delta(6) fatty acid desaturase;Fatty acid desaturase 2 {ECO:0000303|PubMed:10860662};, PF00173;PF00487;, GO:0005789;GO:0005887;GO:0016020;GO:0016213;GO:0004768;GO:0036109;GO:0043651;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:linoleoyl-CoA desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:alpha-linolenic acid metabolic process; P:linoleic acid metabolic process; P:unsaturated fatty acid biosynthetic process;|O95864 A8K2M6 B7Z634 Q6MZQ7 Q96H07 Q96SV8 Q9H3G3 Q9Y3X4,Acyl-CoA 6-desaturase {ECO:0000305|PubMed:12713571},Delta(6) fatty acid desaturase;Fatty acid desaturase 2 {ECO:0000303|PubMed:10860662};, PF00173;PF00487;, GO:0005789;GO:0005887;GO:0016020;GO:0016213;GO:0004768;GO:0036109;GO:0043651;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:linoleoyl-CoA desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:alpha-linolenic acid metabolic process; P:linoleic acid metabolic process; P:unsaturated fatty acid biosynthetic process;|O95864 A8K2M6 B7Z634 Q6MZQ7 Q96H07 Q96SV8 Q9H3G3 Q9Y3X4,Acyl-CoA 6-desaturase {ECO:0000305|PubMed:12713571},Delta(6) fatty acid desaturase;Fatty acid desaturase 2 {ECO:0000303|PubMed:10860662};, PF00173;PF00487;, GO:0005789;GO:0005887;GO:0016020;GO:0016213;GO:0004768;GO:0036109;GO:0043651;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:linoleoyl-CoA desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:alpha-linolenic acid metabolic process; P:linoleic acid metabolic process; P:unsaturated fatty acid biosynthetic process;|O95864 A8K2M6 B7Z634 Q6MZQ7 Q96H07 Q96SV8 Q9H3G3 Q9Y3X4,Acyl-CoA 6-desaturase {ECO:0000305|PubMed:12713571},Delta(6) fatty acid desaturase;Fatty acid desaturase 2 {ECO:0000303|PubMed:10860662};, PF00173;PF00487;, GO:0005789;GO:0005887;GO:0016020;GO:0016213;GO:0004768;GO:0036109;GO:0043651;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:linoleoyl-CoA desaturase activity; F:stearoyl-CoA 9-desaturase activity;, P:alpha-linolenic acid metabolic process; P:linoleic acid metabolic process; P:unsaturated fatty acid biosynthetic process;|Q9Y5Q0 O60426,Fatty acid desaturase 3 {ECO:0000250|UniProtKB:Q8K1P9},Delta(13) fatty acid desaturase {ECO:0000250|UniProtKB:Q8K1P9};, PF00173;PF00487;, GO:0005789;GO:0016021;GO:0016020;GO:0016491;GO:0006665;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:oxidoreductase activity;, P:sphingolipid metabolic process; P:unsaturated fatty acid biosynthetic process; scaffold143 indexed_genome mRNA 398625 409089 . - . ID=transcript_14453;Q8TBN0 Q86V32 Q9P1Q8,Guanine nucleotide exchange factor for Rab-3A,Rab-3A-interacting-like protein 1;Rabin3-like 1;, PF06428;, GO:0005829;GO:0070319;GO:0005085;GO:0042802;GO:0006887;GO:0015031;, C:cytosol; C:Golgi to plasma membrane transport vesicle;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:exocytosis; P:protein transport;|Q8TBN0 Q86V32 Q9P1Q8,Guanine nucleotide exchange factor for Rab-3A,Rab-3A-interacting-like protein 1;Rabin3-like 1;, PF06428;, GO:0005829;GO:0070319;GO:0005085;GO:0042802;GO:0006887;GO:0015031;, C:cytosol; C:Golgi to plasma membrane transport vesicle;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:exocytosis; P:protein transport;|Q8TBN0 Q86V32 Q9P1Q8,Guanine nucleotide exchange factor for Rab-3A,Rab-3A-interacting-like protein 1;Rabin3-like 1;, PF06428;, GO:0005829;GO:0070319;GO:0005085;GO:0042802;GO:0006887;GO:0015031;, C:cytosol; C:Golgi to plasma membrane transport vesicle;, F:guanyl-nucleotide exchange factor activity; F:identical protein binding;, P:exocytosis; P:protein transport; scaffold143 indexed_genome mRNA 576534 600528 . + . ID=transcript_14454;Q9NQS7 A8MQD2 Q5Y192,Inner centromere protein,, PF03941;PF12178;, GO:0000801;GO:0010369;GO:0032133;GO:0000775;GO:0000793;GO:0000777;GO:0005829;GO:0000776;GO:0000800;GO:1990385;GO:0005874;GO:0030496;GO:0016604;GO:0005654;GO:0005634;GO:0005721;GO:0032991;GO:0005819;GO:0043539;GO:0007059;GO:0016572;GO:0010032;GO:0051257;GO:0051310;GO:0000281;GO:0000070;GO:0007052;GO:0071902;GO:1902412;, C:central element; C:chromocenter; C:chromosome passenger complex; C:chromosome, centromeric region; C:condensed chromosome; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:lateral element; C:meiotic spindle midzone; C:microtubule; C:midbody; C:nuclear body; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin; C:protein-containing complex; C:spindle;, F:protein serine/threonine kinase activator activity;, P:chromosome segregation; P:histone phosphorylation; P:meiotic chromosome condensation; P:meiotic spindle midzone assembly; P:metaphase plate congression; P:mitotic cytokinesis; P:mitotic sister chromatid segregation; P:mitotic spindle organization; P:positive regulation of protein serine/threonine kinase activity; P:regulation of mitotic cytokinesis; scaffold143 indexed_genome mRNA 659939 663518 . + . ID=transcript_14455;Q13296 A1A522 Q86WH8,Mammaglobin-A,Mammaglobin-1;Secretoglobin family 2A member 2;, PF01099;, GO:0005615;GO:0030521;, C:extracellular space;, , P:androgen receptor signaling pathway; scaffold143 indexed_genome mRNA 695800 717394 . + . ID=transcript_14456;Q7L266 B2R7Q0 Q567Q4 Q6P1P0 Q8NI34 Q9H6F7,Isoaspartyl peptidase/L-asparaginase,Asparaginase-like protein 1 {ECO:0000303|PubMed:19839645};Beta-aspartyl-peptidase {ECO:0000303|PubMed:19839645};Isoaspartyl dipeptidase;L-asparagine amidohydrolase;, PF01112;, GO:0005737;GO:0005829;GO:0005634;GO:0001917;GO:0004067;GO:0008798;GO:0033345;GO:0006558;, C:cytoplasm; C:cytosol; C:nucleus; C:photoreceptor inner segment;, F:asparaginase activity; F:beta-aspartyl-peptidase activity;, P:asparagine catabolic process via L-aspartate; P:L-phenylalanine metabolic process;|Q7L266 B2R7Q0 Q567Q4 Q6P1P0 Q8NI34 Q9H6F7,Isoaspartyl peptidase/L-asparaginase,Asparaginase-like protein 1 {ECO:0000303|PubMed:19839645};Beta-aspartyl-peptidase {ECO:0000303|PubMed:19839645};Isoaspartyl dipeptidase;L-asparagine amidohydrolase;, PF01112;, GO:0005737;GO:0005829;GO:0005634;GO:0001917;GO:0004067;GO:0008798;GO:0033345;GO:0006558;, C:cytoplasm; C:cytosol; C:nucleus; C:photoreceptor inner segment;, F:asparaginase activity; F:beta-aspartyl-peptidase activity;, P:asparagine catabolic process via L-aspartate; P:L-phenylalanine metabolic process;|Q7L266 B2R7Q0 Q567Q4 Q6P1P0 Q8NI34 Q9H6F7,Isoaspartyl peptidase/L-asparaginase,Asparaginase-like protein 1 {ECO:0000303|PubMed:19839645};Beta-aspartyl-peptidase {ECO:0000303|PubMed:19839645};Isoaspartyl dipeptidase;L-asparagine amidohydrolase;, PF01112;, GO:0005737;GO:0005829;GO:0005634;GO:0001917;GO:0004067;GO:0008798;GO:0033345;GO:0006558;, C:cytoplasm; C:cytosol; C:nucleus; C:photoreceptor inner segment;, F:asparaginase activity; F:beta-aspartyl-peptidase activity;, P:asparagine catabolic process via L-aspartate; P:L-phenylalanine metabolic process;|Q7L266 B2R7Q0 Q567Q4 Q6P1P0 Q8NI34 Q9H6F7,Isoaspartyl peptidase/L-asparaginase,Asparaginase-like protein 1 {ECO:0000303|PubMed:19839645};Beta-aspartyl-peptidase {ECO:0000303|PubMed:19839645};Isoaspartyl dipeptidase;L-asparagine amidohydrolase;, PF01112;, GO:0005737;GO:0005829;GO:0005634;GO:0001917;GO:0004067;GO:0008798;GO:0033345;GO:0006558;, C:cytoplasm; C:cytosol; C:nucleus; C:photoreceptor inner segment;, F:asparaginase activity; F:beta-aspartyl-peptidase activity;, P:asparagine catabolic process via L-aspartate; P:L-phenylalanine metabolic process; scaffold143 indexed_genome mRNA 756795 835336 . - . ID=transcript_14457;Q09666 A1A586,Neuroblast differentiation-associated protein AHNAK,Desmoyokin;, , GO:0015629;GO:0044291;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0005765;GO:0016020;GO:0005634;GO:0005886;GO:0042383;GO:0030315;GO:0031982;GO:0045296;GO:0042802;GO:0003723;GO:0044548;GO:0097493;GO:0043484;GO:1901385;, C:actin cytoskeleton; C:cell-cell contact zone; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lysosomal membrane; C:membrane; C:nucleus; C:plasma membrane; C:sarcolemma; C:T-tubule; C:vesicle;, F:cadherin binding; F:identical protein binding; F:RNA binding; F:S100 protein binding; F:structural molecule activity conferring elasticity;, P:regulation of RNA splicing; P:regulation of voltage-gated calcium channel activity;|Q09666 A1A586,Neuroblast differentiation-associated protein AHNAK,Desmoyokin;, , GO:0015629;GO:0044291;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0005765;GO:0016020;GO:0005634;GO:0005886;GO:0042383;GO:0030315;GO:0031982;GO:0045296;GO:0042802;GO:0003723;GO:0044548;GO:0097493;GO:0043484;GO:1901385;, C:actin cytoskeleton; C:cell-cell contact zone; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lysosomal membrane; C:membrane; C:nucleus; C:plasma membrane; C:sarcolemma; C:T-tubule; C:vesicle;, F:cadherin binding; F:identical protein binding; F:RNA binding; F:S100 protein binding; F:structural molecule activity conferring elasticity;, P:regulation of RNA splicing; P:regulation of voltage-gated calcium channel activity;|Q09666 A1A586,Neuroblast differentiation-associated protein AHNAK,Desmoyokin;, , GO:0015629;GO:0044291;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0005765;GO:0016020;GO:0005634;GO:0005886;GO:0042383;GO:0030315;GO:0031982;GO:0045296;GO:0042802;GO:0003723;GO:0044548;GO:0097493;GO:0043484;GO:1901385;, C:actin cytoskeleton; C:cell-cell contact zone; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lysosomal membrane; C:membrane; C:nucleus; C:plasma membrane; C:sarcolemma; C:T-tubule; C:vesicle;, F:cadherin binding; F:identical protein binding; F:RNA binding; F:S100 protein binding; F:structural molecule activity conferring elasticity;, P:regulation of RNA splicing; P:regulation of voltage-gated calcium channel activity; scaffold143 indexed_genome mRNA 854851 864323 . - . ID=transcript_14458;P26641 B4DTG2 Q6PJ62 Q6PK31 Q96CU2 Q9P196,Elongation factor 1-gamma,eEF-1B gamma;, PF00647;PF00043;PF02798;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0045296;GO:0003746;GO:0006749;GO:0009615;GO:0006414;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:cadherin binding; F:translation elongation factor activity;, P:glutathione metabolic process; P:response to virus; P:translational elongation;|P26641 B4DTG2 Q6PJ62 Q6PK31 Q96CU2 Q9P196,Elongation factor 1-gamma,eEF-1B gamma;, PF00647;PF00043;PF02798;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005634;GO:0045296;GO:0003746;GO:0006749;GO:0009615;GO:0006414;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleus;, F:cadherin binding; F:translation elongation factor activity;, P:glutathione metabolic process; P:response to virus; P:translational elongation; scaffold143 indexed_genome mRNA 865273 875376 . - . ID=transcript_14459;Q9H6E5 A1A527 A8K995 Q2NL65 Q7L583 Q9H6H7,Speckle targeted PIP5K1A-regulated poly(A) polymerase,RNA-binding motif protein 21;U6 snRNA-specific terminal uridylyltransferase 1;, PF03828;PF00076;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0019899;GO:0046872;GO:0003730;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0017070;GO:0006378;GO:0006397;GO:0098789;GO:0016180;GO:0034477;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:enzyme binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:U6 snRNA binding;, P:mRNA polyadenylation; P:mRNA processing; P:pre-mRNA cleavage required for polyadenylation; P:snRNA processing; P:U6 snRNA 3'-end processing;|Q9H6E5 A1A527 A8K995 Q2NL65 Q7L583 Q9H6H7,Speckle targeted PIP5K1A-regulated poly(A) polymerase,RNA-binding motif protein 21;U6 snRNA-specific terminal uridylyltransferase 1;, PF03828;PF00076;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0019899;GO:0046872;GO:0003730;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0017070;GO:0006378;GO:0006397;GO:0098789;GO:0016180;GO:0034477;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:enzyme binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:U6 snRNA binding;, P:mRNA polyadenylation; P:mRNA processing; P:pre-mRNA cleavage required for polyadenylation; P:snRNA processing; P:U6 snRNA 3'-end processing;|Q9H6E5 A1A527 A8K995 Q2NL65 Q7L583 Q9H6H7,Speckle targeted PIP5K1A-regulated poly(A) polymerase,RNA-binding motif protein 21;U6 snRNA-specific terminal uridylyltransferase 1;, PF03828;PF00076;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0019899;GO:0046872;GO:0003730;GO:0016779;GO:0004652;GO:0003723;GO:0050265;GO:0017070;GO:0006378;GO:0006397;GO:0098789;GO:0016180;GO:0034477;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:enzyme binding; F:metal ion binding; F:mRNA 3'-UTR binding; F:nucleotidyltransferase activity; F:polynucleotide adenylyltransferase activity; F:RNA binding; F:RNA uridylyltransferase activity; F:U6 snRNA binding;, P:mRNA polyadenylation; P:mRNA processing; P:pre-mRNA cleavage required for polyadenylation; P:snRNA processing; P:U6 snRNA 3'-end processing; scaffold143 indexed_genome mRNA 877308 896839 . - . ID=transcript_14460;O94776 Q68DB1 Q9UQB5,Metastasis-associated protein MTA2,Metastasis-associated 1-like 1;p53 target protein in deacetylase complex;, PF01426;PF01448;PF00320;PF17226;, GO:0000785;GO:0000118;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0005667;GO:0003682;GO:0004407;GO:0042826;GO:0001103;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0043044;GO:0006333;GO:0006306;GO:0016575;GO:0000122;GO:0045944;GO:0010762;GO:1901796;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:transcription regulator complex;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:chromatin assembly or disassembly; P:DNA methylation; P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of fibroblast migration; P:regulation of signal transduction by p53 class mediator;|O94776 Q68DB1 Q9UQB5,Metastasis-associated protein MTA2,Metastasis-associated 1-like 1;p53 target protein in deacetylase complex;, PF01426;PF01448;PF00320;PF17226;, GO:0000785;GO:0000118;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0005667;GO:0003682;GO:0004407;GO:0042826;GO:0001103;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0043044;GO:0006333;GO:0006306;GO:0016575;GO:0000122;GO:0045944;GO:0010762;GO:1901796;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:transcription regulator complex;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:chromatin assembly or disassembly; P:DNA methylation; P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of fibroblast migration; P:regulation of signal transduction by p53 class mediator;|O94776 Q68DB1 Q9UQB5,Metastasis-associated protein MTA2,Metastasis-associated 1-like 1;p53 target protein in deacetylase complex;, PF01426;PF01448;PF00320;PF17226;, GO:0000785;GO:0000118;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0005667;GO:0003682;GO:0004407;GO:0042826;GO:0001103;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0043044;GO:0006333;GO:0006306;GO:0016575;GO:0000122;GO:0045944;GO:0010762;GO:1901796;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:transcription regulator complex;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:chromatin assembly or disassembly; P:DNA methylation; P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of fibroblast migration; P:regulation of signal transduction by p53 class mediator;|Q32P44 Q6ZQW7 Q8NA55,Echinoderm microtubule-associated protein-like 3,, PF03451;PF00400;, GO:0005737;GO:0015630;GO:0030496;GO:1990498;GO:0005634;GO:0005819;GO:0005876;GO:0008017;GO:0051301;GO:0000226;GO:0007080;GO:1901673;, C:cytoplasm; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle microtubule; C:nucleus; C:spindle; C:spindle microtubule;, F:microtubule binding;, P:cell division; P:microtubule cytoskeleton organization; P:mitotic metaphase plate congression; P:regulation of mitotic spindle assembly;|O94776 Q68DB1 Q9UQB5,Metastasis-associated protein MTA2,Metastasis-associated 1-like 1;p53 target protein in deacetylase complex;, PF01426;PF01448;PF00320;PF17226;, GO:0000785;GO:0000118;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0005667;GO:0003682;GO:0004407;GO:0042826;GO:0001103;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0043044;GO:0006333;GO:0006306;GO:0016575;GO:0000122;GO:0045944;GO:0010762;GO:1901796;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:transcription regulator complex;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:chromatin assembly or disassembly; P:DNA methylation; P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of fibroblast migration; P:regulation of signal transduction by p53 class mediator;|O94776 Q68DB1 Q9UQB5,Metastasis-associated protein MTA2,Metastasis-associated 1-like 1;p53 target protein in deacetylase complex;, PF01426;PF01448;PF00320;PF17226;, GO:0000785;GO:0000118;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0005667;GO:0003682;GO:0004407;GO:0042826;GO:0001103;GO:0001085;GO:0043565;GO:0003713;GO:0003714;GO:0008270;GO:0043044;GO:0006333;GO:0006306;GO:0016575;GO:0000122;GO:0045944;GO:0010762;GO:1901796;, C:chromatin; C:histone deacetylase complex; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:transcription regulator complex;, F:chromatin binding; F:histone deacetylase activity; F:histone deacetylase binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:chromatin assembly or disassembly; P:DNA methylation; P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of fibroblast migration; P:regulation of signal transduction by p53 class mediator;|Q32P44 Q6ZQW7 Q8NA55,Echinoderm microtubule-associated protein-like 3,, PF03451;PF00400;, GO:0005737;GO:0015630;GO:0030496;GO:1990498;GO:0005634;GO:0005819;GO:0005876;GO:0008017;GO:0051301;GO:0000226;GO:0007080;GO:1901673;, C:cytoplasm; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle microtubule; C:nucleus; C:spindle; C:spindle microtubule;, F:microtubule binding;, P:cell division; P:microtubule cytoskeleton organization; P:mitotic metaphase plate congression; P:regulation of mitotic spindle assembly;|Q32P44 Q6ZQW7 Q8NA55,Echinoderm microtubule-associated protein-like 3,, PF03451;PF00400;, GO:0005737;GO:0015630;GO:0030496;GO:1990498;GO:0005634;GO:0005819;GO:0005876;GO:0008017;GO:0051301;GO:0000226;GO:0007080;GO:1901673;, C:cytoplasm; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle microtubule; C:nucleus; C:spindle; C:spindle microtubule;, F:microtubule binding;, P:cell division; P:microtubule cytoskeleton organization; P:mitotic metaphase plate congression; P:regulation of mitotic spindle assembly;|Q32P44 Q6ZQW7 Q8NA55,Echinoderm microtubule-associated protein-like 3,, PF03451;PF00400;, GO:0005737;GO:0015630;GO:0030496;GO:1990498;GO:0005634;GO:0005819;GO:0005876;GO:0008017;GO:0051301;GO:0000226;GO:0007080;GO:1901673;, C:cytoplasm; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle microtubule; C:nucleus; C:spindle; C:spindle microtubule;, F:microtubule binding;, P:cell division; P:microtubule cytoskeleton organization; P:mitotic metaphase plate congression; P:regulation of mitotic spindle assembly; scaffold143 indexed_genome mRNA 900062 903238 . + . ID=transcript_14461;O94766 B7ZAB3 Q96I06 Q9UEP0,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,Beta-1,3-glucuronyltransferase 3;Glucuronosyltransferase I;UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase;, PF03360;, GO:0005801;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0015018;GO:0015020;GO:0046872;GO:0072542;GO:0005975;GO:0050650;GO:0050651;GO:0006024;GO:0030203;GO:0015012;GO:0043085;GO:0090316;GO:0006486;, C:cis-Golgi network; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; F:glucuronosyltransferase activity; F:metal ion binding; F:protein phosphatase activator activity;, P:carbohydrate metabolic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:dermatan sulfate proteoglycan biosynthetic process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:positive regulation of catalytic activity; P:positive regulation of intracellular protein transport; P:protein glycosylation; scaffold143 indexed_genome mRNA 903325 905114 . - . ID=transcript_14462;O94766 B7ZAB3 Q96I06 Q9UEP0,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,Beta-1,3-glucuronyltransferase 3;Glucuronosyltransferase I;UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase;, PF03360;, GO:0005801;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0015018;GO:0015020;GO:0046872;GO:0072542;GO:0005975;GO:0050650;GO:0050651;GO:0006024;GO:0030203;GO:0015012;GO:0043085;GO:0090316;GO:0006486;, C:cis-Golgi network; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; F:glucuronosyltransferase activity; F:metal ion binding; F:protein phosphatase activator activity;, P:carbohydrate metabolic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:dermatan sulfate proteoglycan biosynthetic process; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:heparan sulfate proteoglycan biosynthetic process; P:positive regulation of catalytic activity; P:positive regulation of intracellular protein transport; P:protein glycosylation; scaffold143 indexed_genome mRNA 907816 919722 . - . ID=transcript_14463;Q14697 A6NC20 Q8WTS9 Q9P0X0,Neutral alpha-glucosidase AB,Alpha-glucosidase 2;Glucosidase II subunit alpha {ECO:0000303|PubMed:27259053};, PF13802;PF01055;, GO:0005788;GO:0070062;GO:0017177;GO:0005794;GO:0043231;GO:0042470;GO:0016020;GO:0090599;GO:0030246;GO:0033919;GO:0004553;GO:0003723;GO:0005975;GO:0006491;GO:0006457;GO:0019082;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:glucosidase II complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane;, F:alpha-glucosidase activity; F:carbohydrate binding; F:glucan 1,3-alpha-glucosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:RNA binding;, P:carbohydrate metabolic process; P:N-glycan processing; P:protein folding; P:viral protein processing;|Q14697 A6NC20 Q8WTS9 Q9P0X0,Neutral alpha-glucosidase AB,Alpha-glucosidase 2;Glucosidase II subunit alpha {ECO:0000303|PubMed:27259053};, PF13802;PF01055;, GO:0005788;GO:0070062;GO:0017177;GO:0005794;GO:0043231;GO:0042470;GO:0016020;GO:0090599;GO:0030246;GO:0033919;GO:0004553;GO:0003723;GO:0005975;GO:0006491;GO:0006457;GO:0019082;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:glucosidase II complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane;, F:alpha-glucosidase activity; F:carbohydrate binding; F:glucan 1,3-alpha-glucosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:RNA binding;, P:carbohydrate metabolic process; P:N-glycan processing; P:protein folding; P:viral protein processing;|Q14697 A6NC20 Q8WTS9 Q9P0X0,Neutral alpha-glucosidase AB,Alpha-glucosidase 2;Glucosidase II subunit alpha {ECO:0000303|PubMed:27259053};, PF13802;PF01055;, GO:0005788;GO:0070062;GO:0017177;GO:0005794;GO:0043231;GO:0042470;GO:0016020;GO:0090599;GO:0030246;GO:0033919;GO:0004553;GO:0003723;GO:0005975;GO:0006491;GO:0006457;GO:0019082;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:glucosidase II complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane;, F:alpha-glucosidase activity; F:carbohydrate binding; F:glucan 1,3-alpha-glucosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:RNA binding;, P:carbohydrate metabolic process; P:N-glycan processing; P:protein folding; P:viral protein processing;|Q14697 A6NC20 Q8WTS9 Q9P0X0,Neutral alpha-glucosidase AB,Alpha-glucosidase 2;Glucosidase II subunit alpha {ECO:0000303|PubMed:27259053};, PF13802;PF01055;, GO:0005788;GO:0070062;GO:0017177;GO:0005794;GO:0043231;GO:0042470;GO:0016020;GO:0090599;GO:0030246;GO:0033919;GO:0004553;GO:0003723;GO:0005975;GO:0006491;GO:0006457;GO:0019082;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:glucosidase II complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane;, F:alpha-glucosidase activity; F:carbohydrate binding; F:glucan 1,3-alpha-glucosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:RNA binding;, P:carbohydrate metabolic process; P:N-glycan processing; P:protein folding; P:viral protein processing;|Q14697 A6NC20 Q8WTS9 Q9P0X0,Neutral alpha-glucosidase AB,Alpha-glucosidase 2;Glucosidase II subunit alpha {ECO:0000303|PubMed:27259053};, PF13802;PF01055;, GO:0005788;GO:0070062;GO:0017177;GO:0005794;GO:0043231;GO:0042470;GO:0016020;GO:0090599;GO:0030246;GO:0033919;GO:0004553;GO:0003723;GO:0005975;GO:0006491;GO:0006457;GO:0019082;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:glucosidase II complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane;, F:alpha-glucosidase activity; F:carbohydrate binding; F:glucan 1,3-alpha-glucosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:RNA binding;, P:carbohydrate metabolic process; P:N-glycan processing; P:protein folding; P:viral protein processing;|Q14697 A6NC20 Q8WTS9 Q9P0X0,Neutral alpha-glucosidase AB,Alpha-glucosidase 2;Glucosidase II subunit alpha {ECO:0000303|PubMed:27259053};, PF13802;PF01055;, GO:0005788;GO:0070062;GO:0017177;GO:0005794;GO:0043231;GO:0042470;GO:0016020;GO:0090599;GO:0030246;GO:0033919;GO:0004553;GO:0003723;GO:0005975;GO:0006491;GO:0006457;GO:0019082;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:glucosidase II complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane;, F:alpha-glucosidase activity; F:carbohydrate binding; F:glucan 1,3-alpha-glucosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:RNA binding;, P:carbohydrate metabolic process; P:N-glycan processing; P:protein folding; P:viral protein processing;|Q14697 A6NC20 Q8WTS9 Q9P0X0,Neutral alpha-glucosidase AB,Alpha-glucosidase 2;Glucosidase II subunit alpha {ECO:0000303|PubMed:27259053};, PF13802;PF01055;, GO:0005788;GO:0070062;GO:0017177;GO:0005794;GO:0043231;GO:0042470;GO:0016020;GO:0090599;GO:0030246;GO:0033919;GO:0004553;GO:0003723;GO:0005975;GO:0006491;GO:0006457;GO:0019082;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:glucosidase II complex; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane;, F:alpha-glucosidase activity; F:carbohydrate binding; F:glucan 1,3-alpha-glucosidase activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:RNA binding;, P:carbohydrate metabolic process; P:N-glycan processing; P:protein folding; P:viral protein processing; scaffold143 indexed_genome mRNA 922940 927740 . + . ID=transcript_14464;Q6P9B9 Q8N6W5 Q9C0G5,Integrator complex subunit 5,, PF14838;PF14837;, GO:0005737;GO:0005829;GO:0016021;GO:0032039;GO:0016020;GO:0031965;GO:0005654;GO:0005634;GO:0034472;GO:0016180;GO:0042795;, C:cytoplasm; C:cytosol; C:integral component of membrane; C:integrator complex; C:membrane; C:nuclear membrane; C:nucleoplasm; C:nucleus;, , P:snRNA 3'-end processing; P:snRNA processing; P:snRNA transcription by RNA polymerase II; scaffold143 indexed_genome mRNA 932720 935496 . - . ID=transcript_14465;E9PRG8 A0A0B4J220,Uncharacterized protein C11orf98 {ECO:0000305},, PF17719;|E9PRG8 A0A0B4J220,Uncharacterized protein C11orf98 {ECO:0000305},, PF17719; scaffold143 indexed_genome mRNA 935648 937149 . + . ID=transcript_14466;A8MUP2 B7Z4C1,Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial {ECO:0000303|PubMed:28887308, ECO:0000305},Methyltransferase-like protein 12, mitochondrial {ECO:0000312|HGNC:HGNC:33113};, PF13847;, GO:0005739;GO:0016278;GO:0016279;GO:0018027;GO:0018026;GO:0018023;GO:0006479;, C:mitochondrion;, F:lysine N-methyltransferase activity; F:protein-lysine N-methyltransferase activity;, P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:protein methylation; scaffold143 indexed_genome mRNA 940579 942348 . + . ID=transcript_14467;Q6UW78 Q5FVD5,Ubiquinol-cytochrome-c reductase complex assembly factor 3 {ECO:0000312|HGNC:HGNC:34399},Assembly factor CBP4 homolog {ECO:0000303|PubMed:25008109};, PF15141;, GO:0005829;GO:0031305;GO:0005739;GO:0005654;GO:1901612;GO:0070300;GO:0006754;GO:0042407;GO:0006122;GO:0034551;, C:cytosol; C:integral component of mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm;, F:cardiolipin binding; F:phosphatidic acid binding;, P:ATP biosynthetic process; P:cristae formation; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:mitochondrial respiratory chain complex III assembly; scaffold143 indexed_genome mRNA 943185 945840 . - . ID=transcript_14468;Q04323 Q9BV93 Q9BVV5,UBX domain-containing protein 1,SAPK substrate protein 1;UBA/UBX 33.3 kDa protein;, PF00627;PF00789;, GO:0005737;GO:0005829;GO:0030425;GO:0005783;GO:0043025;GO:0005654;GO:0034098;GO:0051117;GO:0036435;GO:0071796;GO:0031593;GO:1904855;GO:0043130;GO:0031625;GO:0006302;GO:1904293;GO:0032435;GO:1903094;GO:0031397;GO:2000157;GO:0043161;GO:0006457;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:neuronal cell body; C:nucleoplasm; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:ATPase binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:K6-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome regulatory particle binding; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:double-strand break repair; P:negative regulation of ERAD pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein K48-linked deubiquitination; P:negative regulation of protein ubiquitination; P:negative regulation of ubiquitin-specific protease activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein folding; P:viral process;|Q04323 Q9BV93 Q9BVV5,UBX domain-containing protein 1,SAPK substrate protein 1;UBA/UBX 33.3 kDa protein;, PF00627;PF00789;, GO:0005737;GO:0005829;GO:0030425;GO:0005783;GO:0043025;GO:0005654;GO:0034098;GO:0051117;GO:0036435;GO:0071796;GO:0031593;GO:1904855;GO:0043130;GO:0031625;GO:0006302;GO:1904293;GO:0032435;GO:1903094;GO:0031397;GO:2000157;GO:0043161;GO:0006457;GO:0016032;, C:cytoplasm; C:cytosol; C:dendrite; C:endoplasmic reticulum; C:neuronal cell body; C:nucleoplasm; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:ATPase binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:K6-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome regulatory particle binding; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:double-strand break repair; P:negative regulation of ERAD pathway; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein K48-linked deubiquitination; P:negative regulation of protein ubiquitination; P:negative regulation of ubiquitin-specific protease activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein folding; P:viral process; scaffold143 indexed_genome mRNA 952872 964566 . - . ID=transcript_14469;Q96G97 G3XAE4 Q567S1 Q96SV1 Q9BSQ0,Seipin,Bernardinelli-Seip congenital lipodystrophy type 2 protein;, PF06775;, GO:0005789;GO:0030176;GO:0005811;GO:0005543;GO:0045444;GO:0016042;GO:0140042;GO:0034389;GO:0019915;GO:0050995;GO:0120162;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:lipid droplet;, F:phospholipid binding;, P:fat cell differentiation; P:lipid catabolic process; P:lipid droplet formation; P:lipid droplet organization; P:lipid storage; P:negative regulation of lipid catabolic process; P:positive regulation of cold-induced thermogenesis;|Q96G97 G3XAE4 Q567S1 Q96SV1 Q9BSQ0,Seipin,Bernardinelli-Seip congenital lipodystrophy type 2 protein;, PF06775;, GO:0005789;GO:0030176;GO:0005811;GO:0005543;GO:0045444;GO:0016042;GO:0140042;GO:0034389;GO:0019915;GO:0050995;GO:0120162;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:lipid droplet;, F:phospholipid binding;, P:fat cell differentiation; P:lipid catabolic process; P:lipid droplet formation; P:lipid droplet organization; P:lipid storage; P:negative regulation of lipid catabolic process; P:positive regulation of cold-induced thermogenesis;|Q96G97 G3XAE4 Q567S1 Q96SV1 Q9BSQ0,Seipin,Bernardinelli-Seip congenital lipodystrophy type 2 protein;, PF06775;, GO:0005789;GO:0030176;GO:0005811;GO:0005543;GO:0045444;GO:0016042;GO:0140042;GO:0034389;GO:0019915;GO:0050995;GO:0120162;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:lipid droplet;, F:phospholipid binding;, P:fat cell differentiation; P:lipid catabolic process; P:lipid droplet formation; P:lipid droplet organization; P:lipid storage; P:negative regulation of lipid catabolic process; P:positive regulation of cold-induced thermogenesis;|Q96G97 G3XAE4 Q567S1 Q96SV1 Q9BSQ0,Seipin,Bernardinelli-Seip congenital lipodystrophy type 2 protein;, PF06775;, GO:0005789;GO:0030176;GO:0005811;GO:0005543;GO:0045444;GO:0016042;GO:0140042;GO:0034389;GO:0019915;GO:0050995;GO:0120162;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:lipid droplet;, F:phospholipid binding;, P:fat cell differentiation; P:lipid catabolic process; P:lipid droplet formation; P:lipid droplet organization; P:lipid storage; P:negative regulation of lipid catabolic process; P:positive regulation of cold-induced thermogenesis; scaffold143 indexed_genome mRNA 964729 967787 . + . ID=transcript_14470;P63215 B2R4S7 P29798 Q61014,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3,, PF00631;, GO:0044297;GO:0030425;GO:0031680;GO:0005834;GO:0005886;GO:0014069;GO:0031681;GO:0003924;GO:0000187;GO:0007186;GO:0007204;, C:cell body; C:dendrite; C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:plasma membrane; C:postsynaptic density;, F:G-protein beta-subunit binding; F:GTPase activity;, P:activation of MAPK activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration;|P63215 B2R4S7 P29798 Q61014,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3,, PF00631;, GO:0044297;GO:0030425;GO:0031680;GO:0005834;GO:0005886;GO:0014069;GO:0031681;GO:0003924;GO:0000187;GO:0007186;GO:0007204;, C:cell body; C:dendrite; C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:plasma membrane; C:postsynaptic density;, F:G-protein beta-subunit binding; F:GTPase activity;, P:activation of MAPK activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; scaffold143 indexed_genome mRNA 972971 981987 . - . ID=transcript_14471;Q1KMD3 Q8N3B3,Heterogeneous nuclear ribonucleoprotein U-like protein 2,Scaffold-attachment factor A2;, PF02037;PF00622;, GO:0016020;GO:0005654;GO:0005634;GO:0003723;, C:membrane; C:nucleoplasm; C:nucleus;, F:RNA binding;|Q1KMD3 Q8N3B3,Heterogeneous nuclear ribonucleoprotein U-like protein 2,Scaffold-attachment factor A2;, PF02037;PF00622;, GO:0016020;GO:0005654;GO:0005634;GO:0003723;, C:membrane; C:nucleoplasm; C:nucleus;, F:RNA binding;|Q1KMD3 Q8N3B3,Heterogeneous nuclear ribonucleoprotein U-like protein 2,Scaffold-attachment factor A2;, PF02037;PF00622;, GO:0016020;GO:0005654;GO:0005634;GO:0003723;, C:membrane; C:nucleoplasm; C:nucleus;, F:RNA binding;|Q1KMD3 Q8N3B3,Heterogeneous nuclear ribonucleoprotein U-like protein 2,Scaffold-attachment factor A2;, PF02037;PF00622;, GO:0016020;GO:0005654;GO:0005634;GO:0003723;, C:membrane; C:nucleoplasm; C:nucleus;, F:RNA binding; scaffold143 indexed_genome mRNA 987979 996896 . + . ID=transcript_14472;Q8N5M4 Q8WYY7,Tetratricopeptide repeat protein 9C,, PF07719; scaffold143 indexed_genome mRNA 999182 1001480 . - . ID=transcript_14473;Q9H5J0,Zinc finger and BTB domain-containing protein 3,, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold143 indexed_genome mRNA 1001750 1002425 . + . ID=transcript_14474;Q9H5J0,Zinc finger and BTB domain-containing protein 3,, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold143 indexed_genome mRNA 1028249 1031533 . + . ID=transcript_14475;P62487 B2R5C0 P52433 Q2M1Z4,DNA-directed RNA polymerase II subunit RPB7,DNA-directed RNA polymerase II subunit G;RNA polymerase II 19 kDa subunit;, PF00575;PF03876;, GO:0005654;GO:0005634;GO:0000932;GO:0005665;GO:0003899;GO:0003697;GO:0003727;GO:0031369;GO:0006370;GO:0006915;GO:0008543;GO:0000398;GO:0048239;GO:0000291;GO:0060213;GO:0045948;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:nucleoplasm; C:nucleus; C:P-body; C:RNA polymerase II, core complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding; F:single-stranded RNA binding; F:translation initiation factor binding;, P:7-methylguanosine mRNA capping; P:apoptotic process; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of translational initiation; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; scaffold143 indexed_genome mRNA 1034483 1048846 . + . ID=transcript_14476;Q9Y6J9 B2RAT0 Q96HA6,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L,PCAF-associated factor 65-alpha;, PF02969;PF07571;, GO:0070062;GO:0000118;GO:0005654;GO:0005634;GO:0000124;GO:0046695;GO:0030914;GO:0005669;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006338;GO:0016573;GO:0043966;GO:0045944;GO:1904672;GO:0006357;GO:0006355;GO:0006367;, C:extracellular exosome; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:SAGA complex; C:SLIK (SAGA-like) complex; C:STAGA complex; C:transcription factor TFIID complex;, F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:chromatin remodeling; P:histone acetylation; P:histone H3 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of somatic stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y6J9 B2RAT0 Q96HA6,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L,PCAF-associated factor 65-alpha;, PF02969;PF07571;, GO:0070062;GO:0000118;GO:0005654;GO:0005634;GO:0000124;GO:0046695;GO:0030914;GO:0005669;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006338;GO:0016573;GO:0043966;GO:0045944;GO:1904672;GO:0006357;GO:0006355;GO:0006367;, C:extracellular exosome; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:SAGA complex; C:SLIK (SAGA-like) complex; C:STAGA complex; C:transcription factor TFIID complex;, F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:chromatin remodeling; P:histone acetylation; P:histone H3 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of somatic stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y6J9 B2RAT0 Q96HA6,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L,PCAF-associated factor 65-alpha;, PF02969;PF07571;, GO:0070062;GO:0000118;GO:0005654;GO:0005634;GO:0000124;GO:0046695;GO:0030914;GO:0005669;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006338;GO:0016573;GO:0043966;GO:0045944;GO:1904672;GO:0006357;GO:0006355;GO:0006367;, C:extracellular exosome; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:SAGA complex; C:SLIK (SAGA-like) complex; C:STAGA complex; C:transcription factor TFIID complex;, F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:chromatin remodeling; P:histone acetylation; P:histone H3 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of somatic stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y6J9 B2RAT0 Q96HA6,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L,PCAF-associated factor 65-alpha;, PF02969;PF07571;, GO:0070062;GO:0000118;GO:0005654;GO:0005634;GO:0000124;GO:0046695;GO:0030914;GO:0005669;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006338;GO:0016573;GO:0043966;GO:0045944;GO:1904672;GO:0006357;GO:0006355;GO:0006367;, C:extracellular exosome; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:SAGA complex; C:SLIK (SAGA-like) complex; C:STAGA complex; C:transcription factor TFIID complex;, F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:chromatin remodeling; P:histone acetylation; P:histone H3 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of somatic stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y6J9 B2RAT0 Q96HA6,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L,PCAF-associated factor 65-alpha;, PF02969;PF07571;, GO:0070062;GO:0000118;GO:0005654;GO:0005634;GO:0000124;GO:0046695;GO:0030914;GO:0005669;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006338;GO:0016573;GO:0043966;GO:0045944;GO:1904672;GO:0006357;GO:0006355;GO:0006367;, C:extracellular exosome; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:SAGA complex; C:SLIK (SAGA-like) complex; C:STAGA complex; C:transcription factor TFIID complex;, F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:chromatin remodeling; P:histone acetylation; P:histone H3 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of somatic stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y6J9 B2RAT0 Q96HA6,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L,PCAF-associated factor 65-alpha;, PF02969;PF07571;, GO:0070062;GO:0000118;GO:0005654;GO:0005634;GO:0000124;GO:0046695;GO:0030914;GO:0005669;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006338;GO:0016573;GO:0043966;GO:0045944;GO:1904672;GO:0006357;GO:0006355;GO:0006367;, C:extracellular exosome; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:SAGA complex; C:SLIK (SAGA-like) complex; C:STAGA complex; C:transcription factor TFIID complex;, F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:chromatin remodeling; P:histone acetylation; P:histone H3 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of somatic stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q9Y6J9 B2RAT0 Q96HA6,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L,PCAF-associated factor 65-alpha;, PF02969;PF07571;, GO:0070062;GO:0000118;GO:0005654;GO:0005634;GO:0000124;GO:0046695;GO:0030914;GO:0005669;GO:0003677;GO:0046982;GO:0016251;GO:0003713;GO:0006338;GO:0016573;GO:0043966;GO:0045944;GO:1904672;GO:0006357;GO:0006355;GO:0006367;, C:extracellular exosome; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:SAGA complex; C:SLIK (SAGA-like) complex; C:STAGA complex; C:transcription factor TFIID complex;, F:DNA binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription coactivator activity;, P:chromatin remodeling; P:histone acetylation; P:histone H3 acetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of somatic stem cell population maintenance; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter;|Q7Z7N9,Transmembrane protein 179B,, , GO:0035577;GO:0101003;GO:0016021;GO:0016607;GO:0005730;GO:0005886;GO:0030667;GO:0043312;, C:azurophil granule membrane; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:nuclear speck; C:nucleolus; C:plasma membrane; C:secretory granule membrane;, , P:neutrophil degranulation;|A0PJW6 Q504S0 Q86YD4 Q8WUC5 Q96HG0,Transmembrane protein 223,, , GO:0016021;GO:0007399;, C:integral component of membrane;, , P:nervous system development;|Q7Z7N9,Transmembrane protein 179B,, , GO:0035577;GO:0101003;GO:0016021;GO:0016607;GO:0005730;GO:0005886;GO:0030667;GO:0043312;, C:azurophil granule membrane; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:nuclear speck; C:nucleolus; C:plasma membrane; C:secretory granule membrane;, , P:neutrophil degranulation; scaffold143 indexed_genome mRNA 1048967 1060554 . - . ID=transcript_14477;Q9UBU9 B4E269 Q99799 Q9UQL2,Nuclear RNA export factor 1,Tip-associated protein;Tip-associating protein;mRNA export factor TAP;, PF02136;PF09162;PF03943;, GO:0005737;GO:0010494;GO:0005829;GO:0042405;GO:0005643;GO:0016607;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0006406;GO:0016973;GO:0006405;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear inclusion body; C:nuclear pore; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; P:viral process;|Q9UBU9 B4E269 Q99799 Q9UQL2,Nuclear RNA export factor 1,Tip-associated protein;Tip-associating protein;mRNA export factor TAP;, PF02136;PF09162;PF03943;, GO:0005737;GO:0010494;GO:0005829;GO:0042405;GO:0005643;GO:0016607;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0006406;GO:0016973;GO:0006405;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear inclusion body; C:nuclear pore; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; P:viral process;|Q9UBU9 B4E269 Q99799 Q9UQL2,Nuclear RNA export factor 1,Tip-associated protein;Tip-associating protein;mRNA export factor TAP;, PF02136;PF09162;PF03943;, GO:0005737;GO:0010494;GO:0005829;GO:0042405;GO:0005643;GO:0016607;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0006406;GO:0016973;GO:0006405;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear inclusion body; C:nuclear pore; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; P:viral process;|Q9UBU9 B4E269 Q99799 Q9UQL2,Nuclear RNA export factor 1,Tip-associated protein;Tip-associating protein;mRNA export factor TAP;, PF02136;PF09162;PF03943;, GO:0005737;GO:0010494;GO:0005829;GO:0042405;GO:0005643;GO:0016607;GO:0005654;GO:0005634;GO:0003729;GO:0003723;GO:0006406;GO:0016973;GO:0006405;GO:0016032;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear inclusion body; C:nuclear pore; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:RNA export from nucleus; P:viral process; scaffold143 indexed_genome mRNA 1060734 1090906 . - . ID=transcript_14478;Q13190 B2R8T2 F8W8Q9 Q5U0D4 Q7Z3T6 Q9BUG1,Syntaxin-5,, PF05739;PF11416;, GO:0005829;GO:0012505;GO:0005789;GO:0033116;GO:0012507;GO:0005794;GO:0000139;GO:0016021;GO:0031201;GO:0031982;GO:0045296;GO:0047485;GO:0005484;GO:0000149;GO:0048208;GO:0034498;GO:0006888;GO:0090166;GO:0006886;GO:0045732;GO:0045048;GO:1903358;GO:0042147;GO:0048278;GO:0006906;GO:0048280;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:SNARE complex; C:vesicle;, F:cadherin binding; F:protein N-terminus binding; F:SNAP receptor activity; F:SNARE binding;, P:COPII vesicle coating; P:early endosome to Golgi transport; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi disassembly; P:intracellular protein transport; P:positive regulation of protein catabolic process; P:protein insertion into ER membrane; P:regulation of Golgi organization; P:retrograde transport, endosome to Golgi; P:vesicle docking; P:vesicle fusion; P:vesicle fusion with Golgi apparatus; scaffold143 indexed_genome mRNA 1092174 1099970 . - . ID=transcript_14479;Q6RFH5 A8K8G5 Q9BRC9 Q9H6X8 Q9NVY2,WD repeat-containing protein 74,NOP seven-associated protein 1;, PF00400;, GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0001825;GO:0042273;GO:0016070;GO:0006364;, C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, , P:blastocyst formation; P:ribosomal large subunit biogenesis; P:RNA metabolic process; P:rRNA processing;|Q6RFH5 A8K8G5 Q9BRC9 Q9H6X8 Q9NVY2,WD repeat-containing protein 74,NOP seven-associated protein 1;, PF00400;, GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0001825;GO:0042273;GO:0016070;GO:0006364;, C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, , P:blastocyst formation; P:ribosomal large subunit biogenesis; P:RNA metabolic process; P:rRNA processing;|Q6RFH5 A8K8G5 Q9BRC9 Q9H6X8 Q9NVY2,WD repeat-containing protein 74,NOP seven-associated protein 1;, PF00400;, GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0001825;GO:0042273;GO:0016070;GO:0006364;, C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, , P:blastocyst formation; P:ribosomal large subunit biogenesis; P:RNA metabolic process; P:rRNA processing;|Q6RFH5 A8K8G5 Q9BRC9 Q9H6X8 Q9NVY2,WD repeat-containing protein 74,NOP seven-associated protein 1;, PF00400;, GO:0005730;GO:0005654;GO:0005634;GO:0030687;GO:0001825;GO:0042273;GO:0016070;GO:0006364;, C:nucleolus; C:nucleoplasm; C:nucleus; C:preribosome, large subunit precursor;, , P:blastocyst formation; P:ribosomal large subunit biogenesis; P:RNA metabolic process; P:rRNA processing; scaffold143 indexed_genome mRNA 1110073 1138519 . + . ID=transcript_14480;P08195 Q13543,4F2 cell-surface antigen heavy chain {ECO:0000303|PubMed:3476959},4F2 heavy chain antigen;Lymphocyte activation antigen 4F2 large subunit;Solute carrier family 3 member 2;, PF00128;PF16028;, GO:1990184;GO:0016324;GO:0009925;GO:0016323;GO:0030054;GO:0009986;GO:0070062;GO:0016021;GO:0005765;GO:0042470;GO:0016020;GO:0005654;GO:0005886;GO:0015173;GO:0045296;GO:0005432;GO:0003824;GO:0003725;GO:0015180;GO:0015190;GO:0015175;GO:0003723;GO:0006865;GO:0006816;GO:0005975;GO:1904273;GO:1902475;GO:1903801;GO:0098713;GO:0050900;GO:0015823;GO:0043330;GO:0015827;, C:amino acid transport complex; C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:aromatic amino acid transmembrane transporter activity; F:cadherin binding; F:calcium:sodium antiporter activity; F:catalytic activity; F:double-stranded RNA binding; F:L-alanine transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:RNA binding;, P:amino acid transport; P:calcium ion transport; P:carbohydrate metabolic process; P:L-alanine import across plasma membrane; P:L-alpha-amino acid transmembrane transport; P:L-leucine import across plasma membrane; P:leucine import across plasma membrane; P:leukocyte migration; P:phenylalanine transport; P:response to exogenous dsRNA; P:tryptophan transport;|P08195 Q13543,4F2 cell-surface antigen heavy chain {ECO:0000303|PubMed:3476959},4F2 heavy chain antigen;Lymphocyte activation antigen 4F2 large subunit;Solute carrier family 3 member 2;, PF00128;PF16028;, GO:1990184;GO:0016324;GO:0009925;GO:0016323;GO:0030054;GO:0009986;GO:0070062;GO:0016021;GO:0005765;GO:0042470;GO:0016020;GO:0005654;GO:0005886;GO:0015173;GO:0045296;GO:0005432;GO:0003824;GO:0003725;GO:0015180;GO:0015190;GO:0015175;GO:0003723;GO:0006865;GO:0006816;GO:0005975;GO:1904273;GO:1902475;GO:1903801;GO:0098713;GO:0050900;GO:0015823;GO:0043330;GO:0015827;, C:amino acid transport complex; C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:aromatic amino acid transmembrane transporter activity; F:cadherin binding; F:calcium:sodium antiporter activity; F:catalytic activity; F:double-stranded RNA binding; F:L-alanine transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:RNA binding;, P:amino acid transport; P:calcium ion transport; P:carbohydrate metabolic process; P:L-alanine import across plasma membrane; P:L-alpha-amino acid transmembrane transport; P:L-leucine import across plasma membrane; P:leucine import across plasma membrane; P:leukocyte migration; P:phenylalanine transport; P:response to exogenous dsRNA; P:tryptophan transport;|P08195 Q13543,4F2 cell-surface antigen heavy chain {ECO:0000303|PubMed:3476959},4F2 heavy chain antigen;Lymphocyte activation antigen 4F2 large subunit;Solute carrier family 3 member 2;, PF00128;PF16028;, GO:1990184;GO:0016324;GO:0009925;GO:0016323;GO:0030054;GO:0009986;GO:0070062;GO:0016021;GO:0005765;GO:0042470;GO:0016020;GO:0005654;GO:0005886;GO:0015173;GO:0045296;GO:0005432;GO:0003824;GO:0003725;GO:0015180;GO:0015190;GO:0015175;GO:0003723;GO:0006865;GO:0006816;GO:0005975;GO:1904273;GO:1902475;GO:1903801;GO:0098713;GO:0050900;GO:0015823;GO:0043330;GO:0015827;, C:amino acid transport complex; C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:aromatic amino acid transmembrane transporter activity; F:cadherin binding; F:calcium:sodium antiporter activity; F:catalytic activity; F:double-stranded RNA binding; F:L-alanine transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:RNA binding;, P:amino acid transport; P:calcium ion transport; P:carbohydrate metabolic process; P:L-alanine import across plasma membrane; P:L-alpha-amino acid transmembrane transport; P:L-leucine import across plasma membrane; P:leucine import across plasma membrane; P:leukocyte migration; P:phenylalanine transport; P:response to exogenous dsRNA; P:tryptophan transport;|P08195 Q13543,4F2 cell-surface antigen heavy chain {ECO:0000303|PubMed:3476959},4F2 heavy chain antigen;Lymphocyte activation antigen 4F2 large subunit;Solute carrier family 3 member 2;, PF00128;PF16028;, GO:1990184;GO:0016324;GO:0009925;GO:0016323;GO:0030054;GO:0009986;GO:0070062;GO:0016021;GO:0005765;GO:0042470;GO:0016020;GO:0005654;GO:0005886;GO:0015173;GO:0045296;GO:0005432;GO:0003824;GO:0003725;GO:0015180;GO:0015190;GO:0015175;GO:0003723;GO:0006865;GO:0006816;GO:0005975;GO:1904273;GO:1902475;GO:1903801;GO:0098713;GO:0050900;GO:0015823;GO:0043330;GO:0015827;, C:amino acid transport complex; C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:lysosomal membrane; C:melanosome; C:membrane; C:nucleoplasm; C:plasma membrane;, F:aromatic amino acid transmembrane transporter activity; F:cadherin binding; F:calcium:sodium antiporter activity; F:catalytic activity; F:double-stranded RNA binding; F:L-alanine transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:RNA binding;, P:amino acid transport; P:calcium ion transport; P:carbohydrate metabolic process; P:L-alanine import across plasma membrane; P:L-alpha-amino acid transmembrane transport; P:L-leucine import across plasma membrane; P:leucine import across plasma membrane; P:leukocyte migration; P:phenylalanine transport; P:response to exogenous dsRNA; P:tryptophan transport; scaffold143 indexed_genome mRNA 1161300 1161821 . + . ID=transcript_14481;P11229 Q96RH1,Muscarinic acetylcholine receptor M1,, PF00001;, GO:0043679;GO:0098981;GO:0030425;GO:0098978;GO:0005887;GO:0099061;GO:0099056;GO:0016020;GO:0005886;GO:0098685;GO:0045202;GO:0016907;GO:0004993;GO:0030594;GO:0099529;GO:0004435;GO:0007197;GO:0007268;GO:0050890;GO:0007213;GO:0007186;GO:0007187;GO:0007399;GO:0007274;GO:0007207;GO:0090316;GO:0043270;GO:0007205;GO:0060251;GO:0040012;GO:0046541;GO:0007165;, C:axon terminus; C:cholinergic synapse; C:dendrite; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse; C:synapse;, F:G protein-coupled acetylcholine receptor activity; F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity; F:neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; F:phosphatidylinositol phospholipase C activity;, P:adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway; P:chemical synaptic transmission; P:cognition; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:nervous system development; P:neuromuscular synaptic transmission; P:phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway; P:positive regulation of intracellular protein transport; P:positive regulation of ion transport; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of glial cell proliferation; P:regulation of locomotion; P:saliva secretion; P:signal transduction; scaffold143 indexed_genome mRNA 1235709 1237481 . - . ID=transcript_14482;Q8TCC7 B4DPH7 F5GWA8 F5H5J1 O95820 Q59EW9 Q96TC1,Solute carrier family 22 member 8,Organic anion transporter 3;, PF00083;, GO:0016324;GO:0016323;GO:0070062;GO:0016021;GO:0005886;GO:0005452;GO:0009636;GO:0150104;, C:apical plasma membrane; C:basolateral plasma membrane; C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:inorganic anion exchanger activity;, P:response to toxic substance; P:transport across blood-brain barrier; scaffold143 indexed_genome mRNA 1349686 1378875 . - . ID=transcript_14483;Q63ZE4 Q68CJ0,Solute carrier family 22 member 10,Organic anion transporter 5;, PF00083;, GO:0016021;GO:0022857;GO:0015711;, C:integral component of membrane;, F:transmembrane transporter activity;, P:organic anion transport;|Q63ZE4 Q68CJ0,Solute carrier family 22 member 10,Organic anion transporter 5;, PF00083;, GO:0016021;GO:0022857;GO:0015711;, C:integral component of membrane;, F:transmembrane transporter activity;, P:organic anion transport;|Q63ZE4 Q68CJ0,Solute carrier family 22 member 10,Organic anion transporter 5;, PF00083;, GO:0016021;GO:0022857;GO:0015711;, C:integral component of membrane;, F:transmembrane transporter activity;, P:organic anion transport; scaffold143 indexed_genome mRNA 1450313 1460381 . + . ID=transcript_14484;Q63ZE4 Q68CJ0,Solute carrier family 22 member 10,Organic anion transporter 5;, PF00083;, GO:0016021;GO:0022857;GO:0015711;, C:integral component of membrane;, F:transmembrane transporter activity;, P:organic anion transport; scaffold143 indexed_genome mRNA 1475083 1491581 . + . ID=transcript_14485;Q63ZE4 Q68CJ0,Solute carrier family 22 member 10,Organic anion transporter 5;, PF00083;, GO:0016021;GO:0022857;GO:0015711;, C:integral component of membrane;, F:transmembrane transporter activity;, P:organic anion transport; scaffold143 indexed_genome mRNA 1491590 1496350 . + . ID=transcript_14486;Q63ZE4 Q68CJ0,Solute carrier family 22 member 10,Organic anion transporter 5;, PF00083;, GO:0016021;GO:0022857;GO:0015711;, C:integral component of membrane;, F:transmembrane transporter activity;, P:organic anion transport; scaffold143 indexed_genome mRNA 1542455 1793950 . + . ID=transcript_14487;P46108 A8MWE8 B0LPE8 D3DTH6 Q96GA9 Q96HJ0,Adapter molecule crk,Proto-oncogene c-Crk;p38;, PF00017;PF00018;PF07653;, GO:0015629;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0045121;GO:0005634;GO:0005886;GO:0032991;GO:0008092;GO:0046875;GO:0005159;GO:0019900;GO:0001784;GO:0045309;GO:0043621;GO:1990782;GO:0097110;GO:0042169;GO:0017124;GO:0035591;GO:0030159;GO:0031625;GO:0030036;GO:0090630;GO:0000186;GO:0060326;GO:1990859;GO:1990314;GO:1990090;GO:0071732;GO:0071560;GO:0098749;GO:0021987;GO:0019221;GO:0016358;GO:0048013;GO:0030010;GO:0038096;GO:0035685;GO:0021766;GO:0006629;GO:2000146;GO:0045953;GO:0061045;GO:0001764;GO:0030307;GO:0014911;GO:1900026;GO:0038026;GO:0032956;GO:0033628;GO:0008360;GO:0050773;GO:0043087;GO:1902531;GO:0043393;GO:0035020;GO:0009966;GO:2000404;GO:0006357;GO:0061847;GO:0035728;GO:0042542;GO:0001878;GO:0048010;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:membrane raft; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:cytoskeletal protein binding; F:ephrin receptor binding; F:insulin-like growth factor receptor binding; F:kinase binding; F:phosphotyrosine residue binding; F:protein phosphorylated amino acid binding; F:protein self-association; F:protein tyrosine kinase binding; F:scaffold protein binding; F:SH2 domain binding; F:SH3 domain binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity; F:ubiquitin protein ligase binding;, P:actin cytoskeleton organization; P:activation of GTPase activity; P:activation of MAPKK activity; P:cell chemotaxis; P:cellular response to endothelin; P:cellular response to insulin-like growth factor stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to nitric oxide; P:cellular response to transforming growth factor beta stimulus; P:cerebellar neuron development; P:cerebral cortex development; P:cytokine-mediated signaling pathway; P:dendrite development; P:ephrin receptor signaling pathway; P:establishment of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:helper T cell diapedesis; P:hippocampus development; P:lipid metabolic process; P:negative regulation of cell motility; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of wound healing; P:neuron migration; P:positive regulation of cell growth; P:positive regulation of smooth muscle cell migration; P:positive regulation of substrate adhesion-dependent cell spreading; P:reelin-mediated signaling pathway; P:regulation of actin cytoskeleton organization; P:regulation of cell adhesion mediated by integrin; P:regulation of cell shape; P:regulation of dendrite development; P:regulation of GTPase activity; P:regulation of intracellular signal transduction; P:regulation of protein binding; P:regulation of Rac protein signal transduction; P:regulation of signal transduction; P:regulation of T cell migration; P:regulation of transcription by RNA polymerase II; P:response to cholecystokinin; P:response to hepatocyte growth factor; P:response to hydrogen peroxide; P:response to yeast; P:vascular endothelial growth factor receptor signaling pathway;|Q6T423 A4FU27,Solute carrier family 22 member 25,Organic anion transporter UST6;, PF07690;, GO:0016021;GO:0022857;GO:0015711;, C:integral component of membrane;, F:transmembrane transporter activity;, P:organic anion transport;|Q6T423 A4FU27,Solute carrier family 22 member 25,Organic anion transporter UST6;, PF07690;, GO:0016021;GO:0022857;GO:0015711;, C:integral component of membrane;, F:transmembrane transporter activity;, P:organic anion transport;|Q6T423 A4FU27,Solute carrier family 22 member 25,Organic anion transporter UST6;, PF07690;, GO:0016021;GO:0022857;GO:0015711;, C:integral component of membrane;, F:transmembrane transporter activity;, P:organic anion transport;|Q8N4F4 A0A087WWM3 C9JC66,Steroid transmembrane transporter SLC22A24 {ECO:0000303|PubMed:31553721},Solute carrier family 22 member 24 {ECO:0000312|HGNC:HGNC:28542};, PF00083;, GO:0016021;GO:0022857;GO:0015711;GO:0008202;GO:0035382;, C:integral component of membrane;, F:transmembrane transporter activity;, P:organic anion transport; P:steroid metabolic process; P:sterol transmembrane transport; scaffold143 indexed_genome mRNA 1799167 1799851 . + . ID=transcript_14488;P53816 B2R7Q4 B7XAK5 Q3SYI3 Q9HDD1,Phospholipase A and acyltransferase 3 {ECO:0000312|HGNC:HGNC:17825},Adipose-specific phospholipase A2 {ECO:0000303|PubMed:22923616};Group XVI phospholipase A1/A2 {ECO:0000312|HGNC:HGNC:17825};H-rev 107 protein homolog {ECO:0000303|PubMed:9771974};HRAS-like suppressor 1;HRAS-like suppressor 3 {ECO:0000303|PubMed:17374643};HREV107-3;Renal carcinoma antigen NY-REN-65 {ECO:0000303|PubMed:10508479};, PF04970;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0048471;GO:0005778;GO:0005777;GO:0005886;GO:0052740;GO:0016410;GO:0052739;GO:0008970;GO:0004623;GO:0102567;GO:0102568;GO:0046485;GO:0016042;GO:0070292;GO:0045786;GO:0007031;GO:0036151;GO:0036152;GO:0036149;GO:0036150;GO:0008654;GO:0006644;GO:1904177;GO:0009617;GO:0006641;GO:0016032;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:peroxisome; C:plasma membrane;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:N-acyltransferase activity; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:ether lipid metabolic process; P:lipid catabolic process; P:N-acylphosphatidylethanolamine metabolic process; P:negative regulation of cell cycle; P:peroxisome organization; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:phospholipid biosynthetic process; P:phospholipid metabolic process; P:regulation of adipose tissue development; P:response to bacterium; P:triglyceride metabolic process; P:viral process; scaffold143 indexed_genome mRNA 1834344 1872446 . - . ID=transcript_14489;Q8NHH9 B7Z1X2 B7Z7X8 Q4ZG30 Q7Z630 Q8NHH8 Q9H5M7,Atlastin-2,ADP-ribosylation factor-like protein 6-interacting protein 2;, PF02263;PF02841;, GO:0005783;GO:0005789;GO:0098826;GO:0016021;GO:0016020;GO:0005525;GO:0003924;GO:0042802;GO:0007029;GO:1990809;GO:0007030;GO:0051260;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network membrane; C:integral component of membrane; C:membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:endoplasmic reticulum organization; P:endoplasmic reticulum tubular network membrane organization; P:Golgi organization; P:protein homooligomerization;|Q6DD88 Q8N7W5 Q9H8Q5 Q9UFL1,Atlastin-3,, PF02263;PF02841;, GO:0005783;GO:0005789;GO:0071782;GO:0098826;GO:0016021;GO:0016020;GO:0005525;GO:0003924;GO:0042802;GO:0007029;GO:0007030;GO:1903373;GO:0051260;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum tubular network; C:endoplasmic reticulum tubular network membrane; C:integral component of membrane; C:membrane;, F:GTP binding; F:GTPase activity; F:identical protein binding;, P:endoplasmic reticulum organization; P:Golgi organization; P:positive regulation of endoplasmic reticulum tubular network organization; P:protein homooligomerization; scaffold143 indexed_genome mRNA 1878920 1936036 . + . ID=transcript_14490;Q5UEP2 Q6T930 Q7RTM7 Q7RTM8 Q7RTN3,Reticulon-3,Homolog of ASY protein;Neuroendocrine-specific protein-like 2;Neuroendocrine-specific protein-like II;, PF02453;, GO:0005783;GO:0005789;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0045202;GO:0006915;GO:0071787;GO:0071786;GO:1902430;GO:0016192;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:synapse;, , P:apoptotic process; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network organization; P:negative regulation of amyloid-beta formation; P:vesicle-mediated transport; P:viral process;|Q5UEP2 Q6T930 Q7RTM7 Q7RTM8 Q7RTN3,Reticulon-3,Homolog of ASY protein;Neuroendocrine-specific protein-like 2;Neuroendocrine-specific protein-like II;, PF02453;, GO:0005783;GO:0005789;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0045202;GO:0006915;GO:0071787;GO:0071786;GO:1902430;GO:0016192;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:synapse;, , P:apoptotic process; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network organization; P:negative regulation of amyloid-beta formation; P:vesicle-mediated transport; P:viral process;|Q5UEP2 Q6T930 Q7RTM7 Q7RTM8 Q7RTN3,Reticulon-3,Homolog of ASY protein;Neuroendocrine-specific protein-like 2;Neuroendocrine-specific protein-like II;, PF02453;, GO:0005783;GO:0005789;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0045202;GO:0006915;GO:0071787;GO:0071786;GO:1902430;GO:0016192;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:synapse;, , P:apoptotic process; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network organization; P:negative regulation of amyloid-beta formation; P:vesicle-mediated transport; P:viral process; scaffold143 indexed_genome mRNA 1936095 1940197 . + . ID=transcript_14491;Q5UEP2 Q6T930 Q7RTM7 Q7RTM8 Q7RTN3,Reticulon-3,Homolog of ASY protein;Neuroendocrine-specific protein-like 2;Neuroendocrine-specific protein-like II;, PF02453;, GO:0005783;GO:0005789;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0045202;GO:0006915;GO:0071787;GO:0071786;GO:1902430;GO:0016192;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:synapse;, , P:apoptotic process; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network organization; P:negative regulation of amyloid-beta formation; P:vesicle-mediated transport; P:viral process;|Q5UEP2 Q6T930 Q7RTM7 Q7RTM8 Q7RTN3,Reticulon-3,Homolog of ASY protein;Neuroendocrine-specific protein-like 2;Neuroendocrine-specific protein-like II;, PF02453;, GO:0005783;GO:0005789;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0005886;GO:0045202;GO:0006915;GO:0071787;GO:0071786;GO:1902430;GO:0016192;GO:0016032;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:synapse;, , P:apoptotic process; P:endoplasmic reticulum tubular network formation; P:endoplasmic reticulum tubular network organization; P:negative regulation of amyloid-beta formation; P:vesicle-mediated transport; P:viral process; scaffold143 indexed_genome mRNA 2000648 2014136 . + . ID=transcript_14492;Q9BUA3 Q68CV7 Q6PHS2 Q96IH0,Spindlin interactor and repressor of chromatin-binding protein {ECO:0000305},SPIN1-docking protein {ECO:0000303|PubMed:29061846};, PF18658;, GO:0045892;, , , P:negative regulation of transcription, DNA-templated;|Q9BUA3 Q68CV7 Q6PHS2 Q96IH0,Spindlin interactor and repressor of chromatin-binding protein {ECO:0000305},SPIN1-docking protein {ECO:0000303|PubMed:29061846};, PF18658;, GO:0045892;, , , P:negative regulation of transcription, DNA-templated; scaffold143 indexed_genome mRNA 2055861 2080543 . + . ID=transcript_14493;Q7KZI7 Q15449 Q15524 Q5XGA3 Q68A18 Q96HB3 Q96RG0,Serine/threonine-protein kinase MARK2,ELKL motif kinase 1;MAP/microtubule affinity-regulating kinase 2;PAR1 homolog;PAR1 homolog b;, PF02149;PF00069;PF00627;, GO:0005884;GO:0005737;GO:0030425;GO:0016328;GO:0016020;GO:0097427;GO:0005739;GO:0005654;GO:0005886;GO:0005524;GO:0045296;GO:0008289;GO:0000287;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0048156;GO:0050321;GO:0032147;GO:0000422;GO:0061564;GO:0030010;GO:0071963;GO:0045197;GO:0035556;GO:0000226;GO:0051646;GO:0001764;GO:0018105;GO:0018107;GO:0010976;GO:0046777;GO:0006468;GO:0050770;GO:0051493;GO:1904526;GO:0070507;GO:0016055;, C:actin filament; C:cytoplasm; C:dendrite; C:lateral plasma membrane; C:membrane; C:microtubule bundle; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:lipid binding; F:magnesium ion binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of protein kinase activity; P:autophagy of mitochondrion; P:axon development; P:establishment of cell polarity; P:establishment or maintenance of cell polarity regulating cell shape; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:mitochondrion localization; P:neuron migration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of neuron projection development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cytoskeleton organization; P:regulation of microtubule binding; P:regulation of microtubule cytoskeleton organization; P:Wnt signaling pathway;|Q7KZI7 Q15449 Q15524 Q5XGA3 Q68A18 Q96HB3 Q96RG0,Serine/threonine-protein kinase MARK2,ELKL motif kinase 1;MAP/microtubule affinity-regulating kinase 2;PAR1 homolog;PAR1 homolog b;, PF02149;PF00069;PF00627;, GO:0005884;GO:0005737;GO:0030425;GO:0016328;GO:0016020;GO:0097427;GO:0005739;GO:0005654;GO:0005886;GO:0005524;GO:0045296;GO:0008289;GO:0000287;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0048156;GO:0050321;GO:0032147;GO:0000422;GO:0061564;GO:0030010;GO:0071963;GO:0045197;GO:0035556;GO:0000226;GO:0051646;GO:0001764;GO:0018105;GO:0018107;GO:0010976;GO:0046777;GO:0006468;GO:0050770;GO:0051493;GO:1904526;GO:0070507;GO:0016055;, C:actin filament; C:cytoplasm; C:dendrite; C:lateral plasma membrane; C:membrane; C:microtubule bundle; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:lipid binding; F:magnesium ion binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of protein kinase activity; P:autophagy of mitochondrion; P:axon development; P:establishment of cell polarity; P:establishment or maintenance of cell polarity regulating cell shape; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:mitochondrion localization; P:neuron migration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of neuron projection development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cytoskeleton organization; P:regulation of microtubule binding; P:regulation of microtubule cytoskeleton organization; P:Wnt signaling pathway;|Q7KZI7 Q15449 Q15524 Q5XGA3 Q68A18 Q96HB3 Q96RG0,Serine/threonine-protein kinase MARK2,ELKL motif kinase 1;MAP/microtubule affinity-regulating kinase 2;PAR1 homolog;PAR1 homolog b;, PF02149;PF00069;PF00627;, GO:0005884;GO:0005737;GO:0030425;GO:0016328;GO:0016020;GO:0097427;GO:0005739;GO:0005654;GO:0005886;GO:0005524;GO:0045296;GO:0008289;GO:0000287;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0048156;GO:0050321;GO:0032147;GO:0000422;GO:0061564;GO:0030010;GO:0071963;GO:0045197;GO:0035556;GO:0000226;GO:0051646;GO:0001764;GO:0018105;GO:0018107;GO:0010976;GO:0046777;GO:0006468;GO:0050770;GO:0051493;GO:1904526;GO:0070507;GO:0016055;, C:actin filament; C:cytoplasm; C:dendrite; C:lateral plasma membrane; C:membrane; C:microtubule bundle; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:lipid binding; F:magnesium ion binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of protein kinase activity; P:autophagy of mitochondrion; P:axon development; P:establishment of cell polarity; P:establishment or maintenance of cell polarity regulating cell shape; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:mitochondrion localization; P:neuron migration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of neuron projection development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cytoskeleton organization; P:regulation of microtubule binding; P:regulation of microtubule cytoskeleton organization; P:Wnt signaling pathway;|Q96RG1 Q9UMY9 Q9UN34,MAP/microtubule affinity-regulating kinase 3,C-TAK1;Cdc25C-associated protein kinase 1;ELKL motif kinase 2;Protein kinase STK10;Ser/Thr protein kinase PAR-1;Serine/threonine-protein kinase p78;, PF02149;PF00069;PF00627;, GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005886;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0035556;GO:0000165;GO:0000226;GO:0035331;GO:0036289;GO:0018105;GO:0032092;GO:0006468;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:plasma membrane;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:intracellular signal transduction; P:MAPK cascade; P:microtubule cytoskeleton organization; P:negative regulation of hippo signaling; P:peptidyl-serine autophosphorylation; P:peptidyl-serine phosphorylation; P:positive regulation of protein binding; P:protein phosphorylation;|Q7KZI7 Q15449 Q15524 Q5XGA3 Q68A18 Q96HB3 Q96RG0,Serine/threonine-protein kinase MARK2,ELKL motif kinase 1;MAP/microtubule affinity-regulating kinase 2;PAR1 homolog;PAR1 homolog b;, PF02149;PF00069;PF00627;, GO:0005884;GO:0005737;GO:0030425;GO:0016328;GO:0016020;GO:0097427;GO:0005739;GO:0005654;GO:0005886;GO:0005524;GO:0045296;GO:0008289;GO:0000287;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0048156;GO:0050321;GO:0032147;GO:0000422;GO:0061564;GO:0030010;GO:0071963;GO:0045197;GO:0035556;GO:0000226;GO:0051646;GO:0001764;GO:0018105;GO:0018107;GO:0010976;GO:0046777;GO:0006468;GO:0050770;GO:0051493;GO:1904526;GO:0070507;GO:0016055;, C:actin filament; C:cytoplasm; C:dendrite; C:lateral plasma membrane; C:membrane; C:microtubule bundle; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:lipid binding; F:magnesium ion binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of protein kinase activity; P:autophagy of mitochondrion; P:axon development; P:establishment of cell polarity; P:establishment or maintenance of cell polarity regulating cell shape; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:mitochondrion localization; P:neuron migration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of neuron projection development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cytoskeleton organization; P:regulation of microtubule binding; P:regulation of microtubule cytoskeleton organization; P:Wnt signaling pathway;|Q7KZI7 Q15449 Q15524 Q5XGA3 Q68A18 Q96HB3 Q96RG0,Serine/threonine-protein kinase MARK2,ELKL motif kinase 1;MAP/microtubule affinity-regulating kinase 2;PAR1 homolog;PAR1 homolog b;, PF02149;PF00069;PF00627;, GO:0005884;GO:0005737;GO:0030425;GO:0016328;GO:0016020;GO:0097427;GO:0005739;GO:0005654;GO:0005886;GO:0005524;GO:0045296;GO:0008289;GO:0000287;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0048156;GO:0050321;GO:0032147;GO:0000422;GO:0061564;GO:0030010;GO:0071963;GO:0045197;GO:0035556;GO:0000226;GO:0051646;GO:0001764;GO:0018105;GO:0018107;GO:0010976;GO:0046777;GO:0006468;GO:0050770;GO:0051493;GO:1904526;GO:0070507;GO:0016055;, C:actin filament; C:cytoplasm; C:dendrite; C:lateral plasma membrane; C:membrane; C:microtubule bundle; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:lipid binding; F:magnesium ion binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of protein kinase activity; P:autophagy of mitochondrion; P:axon development; P:establishment of cell polarity; P:establishment or maintenance of cell polarity regulating cell shape; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:mitochondrion localization; P:neuron migration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of neuron projection development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cytoskeleton organization; P:regulation of microtubule binding; P:regulation of microtubule cytoskeleton organization; P:Wnt signaling pathway; scaffold143 indexed_genome mRNA 2080735 2086673 . - . ID=transcript_14494;Q7KZI7 Q15449 Q15524 Q5XGA3 Q68A18 Q96HB3 Q96RG0,Serine/threonine-protein kinase MARK2,ELKL motif kinase 1;MAP/microtubule affinity-regulating kinase 2;PAR1 homolog;PAR1 homolog b;, PF02149;PF00069;PF00627;, GO:0005884;GO:0005737;GO:0030425;GO:0016328;GO:0016020;GO:0097427;GO:0005739;GO:0005654;GO:0005886;GO:0005524;GO:0045296;GO:0008289;GO:0000287;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0048156;GO:0050321;GO:0032147;GO:0000422;GO:0061564;GO:0030010;GO:0071963;GO:0045197;GO:0035556;GO:0000226;GO:0051646;GO:0001764;GO:0018105;GO:0018107;GO:0010976;GO:0046777;GO:0006468;GO:0050770;GO:0051493;GO:1904526;GO:0070507;GO:0016055;, C:actin filament; C:cytoplasm; C:dendrite; C:lateral plasma membrane; C:membrane; C:microtubule bundle; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:lipid binding; F:magnesium ion binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of protein kinase activity; P:autophagy of mitochondrion; P:axon development; P:establishment of cell polarity; P:establishment or maintenance of cell polarity regulating cell shape; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:mitochondrion localization; P:neuron migration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of neuron projection development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cytoskeleton organization; P:regulation of microtubule binding; P:regulation of microtubule cytoskeleton organization; P:Wnt signaling pathway;|Q7KZI7 Q15449 Q15524 Q5XGA3 Q68A18 Q96HB3 Q96RG0,Serine/threonine-protein kinase MARK2,ELKL motif kinase 1;MAP/microtubule affinity-regulating kinase 2;PAR1 homolog;PAR1 homolog b;, PF02149;PF00069;PF00627;, GO:0005884;GO:0005737;GO:0030425;GO:0016328;GO:0016020;GO:0097427;GO:0005739;GO:0005654;GO:0005886;GO:0005524;GO:0045296;GO:0008289;GO:0000287;GO:0030295;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0048156;GO:0050321;GO:0032147;GO:0000422;GO:0061564;GO:0030010;GO:0071963;GO:0045197;GO:0035556;GO:0000226;GO:0051646;GO:0001764;GO:0018105;GO:0018107;GO:0010976;GO:0046777;GO:0006468;GO:0050770;GO:0051493;GO:1904526;GO:0070507;GO:0016055;, C:actin filament; C:cytoplasm; C:dendrite; C:lateral plasma membrane; C:membrane; C:microtubule bundle; C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:cadherin binding; F:lipid binding; F:magnesium ion binding; F:protein kinase activator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:tau protein binding; F:tau-protein kinase activity;, P:activation of protein kinase activity; P:autophagy of mitochondrion; P:axon development; P:establishment of cell polarity; P:establishment or maintenance of cell polarity regulating cell shape; P:establishment or maintenance of epithelial cell apical/basal polarity; P:intracellular signal transduction; P:microtubule cytoskeleton organization; P:mitochondrion localization; P:neuron migration; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of neuron projection development; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of cytoskeleton organization; P:regulation of microtubule binding; P:regulation of microtubule cytoskeleton organization; P:Wnt signaling pathway; scaffold143 indexed_genome mRNA 2087086 2091865 . - . ID=transcript_14495;Q8IZ40 Q96FP3,REST corepressor 2,, PF01448;PF00249;, GO:0000118;GO:0005667;GO:0019899;GO:0003714;GO:0016575;GO:0045892;GO:0006357;, C:histone deacetylase complex; C:transcription regulator complex;, F:enzyme binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold143 indexed_genome mRNA 2111949 2124695 . + . ID=transcript_14496;Q86UY6 B4DR03 B4DU10 Q5HYL5 Q9H897,N-alpha-acetyltransferase 40 {ECO:0000303|PubMed:19660095, ECO:0000312|HGNC:HGNC:25845},N-acetyltransferase 11;N-alpha-acetyltransferase D {ECO:0000303|PubMed:25619998};Protein acetyltransferase 1 {ECO:0000303|PubMed:19695338};, PF00583;, GO:0034451;GO:0005829;GO:0005654;GO:0005634;GO:0043998;GO:0010485;GO:1990189;GO:0043968;GO:0043967;GO:0006629;GO:0006474;, C:centriolar satellite; C:cytosol; C:nucleoplasm; C:nucleus;, F:H2A histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:peptide-serine-N-acetyltransferase activity;, P:histone H2A acetylation; P:histone H4 acetylation; P:lipid metabolic process; P:N-terminal protein amino acid acetylation;|Q86UY6 B4DR03 B4DU10 Q5HYL5 Q9H897,N-alpha-acetyltransferase 40 {ECO:0000303|PubMed:19660095, ECO:0000312|HGNC:HGNC:25845},N-acetyltransferase 11;N-alpha-acetyltransferase D {ECO:0000303|PubMed:25619998};Protein acetyltransferase 1 {ECO:0000303|PubMed:19695338};, PF00583;, GO:0034451;GO:0005829;GO:0005654;GO:0005634;GO:0043998;GO:0010485;GO:1990189;GO:0043968;GO:0043967;GO:0006629;GO:0006474;, C:centriolar satellite; C:cytosol; C:nucleoplasm; C:nucleus;, F:H2A histone acetyltransferase activity; F:H4 histone acetyltransferase activity; F:peptide-serine-N-acetyltransferase activity;, P:histone H2A acetylation; P:histone H4 acetylation; P:lipid metabolic process; P:N-terminal protein amino acid acetylation; scaffold143 indexed_genome mRNA 2127136 2128438 . + . ID=transcript_14497;P63267 B2R7E7 B4E315 D6W5H8 E9PG30 P12718 Q504R1 Q6FI22,Actin, gamma-enteric smooth muscle,Alpha-actin-3;Gamma-2-actin;Smooth muscle gamma-actin;, PF00022;, GO:0072562;GO:0044297;GO:0071944;GO:0005737;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0030027;GO:0032982;GO:0005524;GO:0090131;GO:0006936;GO:0010628;, C:blood microparticle; C:cell body; C:cell periphery; C:cytoplasm; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:lamellipodium; C:myosin filament;, F:ATP binding;, P:mesenchyme migration; P:muscle contraction; P:positive regulation of gene expression; scaffold143 indexed_genome mRNA 2137778 2139559 . - . ID=transcript_14498;P10176 P15955,Cytochrome c oxidase subunit 8A, mitochondrial,Cytochrome c oxidase polypeptide VIII-liver/heart;Cytochrome c oxidase subunit 8-2;, PF02285;, GO:0016021;GO:0005743;GO:0005739;GO:0045277;GO:0004129;GO:0006091;GO:0006123;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen; scaffold143 indexed_genome mRNA 2150307 2153416 . + . ID=transcript_14499;Q96FW1 Q32Q78 Q96II3 Q9NXQ4 Q9P0B8,Ubiquitin thioesterase OTUB1,Deubiquitinating enzyme OTUB1;OTU domain-containing ubiquitin aldehyde-binding protein 1;Otubain-1;Ubiquitin-specific-processing protease OTUB1;, PF10275;, GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0019784;GO:0004843;GO:0043130;GO:0031625;GO:0002250;GO:0006974;GO:0006281;GO:2000780;GO:1901315;GO:0016579;GO:0071108;, C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:NEDD8-specific protease activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:ubiquitin protein ligase binding;, P:adaptive immune response; P:cellular response to DNA damage stimulus; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:protein deubiquitination; P:protein K48-linked deubiquitination; scaffold143 indexed_genome mRNA 2153886 2154595 . + . ID=transcript_14500;Q9BQ69 Q9UH96,ADP-ribose glycohydrolase MACROD1 {ECO:0000305},MACRO domain-containing protein 1 {ECO:0000303|PubMed:23474712};O-acetyl-ADP-ribose deacetylase MACROD1;Protein LRP16;[Protein ADP-ribosylaspartate] hydrolase MACROD1 {ECO:0000305};[Protein ADP-ribosylglutamate] hydrolase MACROD1 {ECO:0000305};, PF01661;, GO:0005654;GO:0005634;GO:0140293;GO:0019213;GO:0016798;GO:0006974;GO:0140291;GO:0051725;GO:0042278;, C:nucleoplasm; C:nucleus;, F:ADP-ribosylglutamate hydrolase activity; F:deacetylase activity; F:hydrolase activity, acting on glycosyl bonds;, P:cellular response to DNA damage stimulus; P:peptidyl-glutamate ADP-deribosylation; P:protein de-ADP-ribosylation; P:purine nucleoside metabolic process; scaffold143 indexed_genome mRNA 2154717 2156083 . - . ID=transcript_14501;Q9BQ69 Q9UH96,ADP-ribose glycohydrolase MACROD1 {ECO:0000305},MACRO domain-containing protein 1 {ECO:0000303|PubMed:23474712};O-acetyl-ADP-ribose deacetylase MACROD1;Protein LRP16;[Protein ADP-ribosylaspartate] hydrolase MACROD1 {ECO:0000305};[Protein ADP-ribosylglutamate] hydrolase MACROD1 {ECO:0000305};, PF01661;, GO:0005654;GO:0005634;GO:0140293;GO:0019213;GO:0016798;GO:0006974;GO:0140291;GO:0051725;GO:0042278;, C:nucleoplasm; C:nucleus;, F:ADP-ribosylglutamate hydrolase activity; F:deacetylase activity; F:hydrolase activity, acting on glycosyl bonds;, P:cellular response to DNA damage stimulus; P:peptidyl-glutamate ADP-deribosylation; P:protein de-ADP-ribosylation; P:purine nucleoside metabolic process; scaffold143 indexed_genome mRNA 2266994 2268417 . + . ID=transcript_14502;Q9NZU1 Q8WVA2,Leucine-rich repeat transmembrane protein FLRT1,Fibronectin-like domain-containing leucine-rich transmembrane protein 1;, PF13855;PF01462;, GO:0005911;GO:0031410;GO:0030659;GO:0005789;GO:0031012;GO:0005615;GO:0005925;GO:0005887;GO:0044306;GO:0032809;GO:0048471;GO:0005886;GO:0030674;GO:0007155;GO:0016358;GO:0008543;GO:1990138;, C:cell-cell junction; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:endoplasmic reticulum membrane; C:extracellular matrix; C:extracellular space; C:focal adhesion; C:integral component of plasma membrane; C:neuron projection terminus; C:neuronal cell body membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:protein-macromolecule adaptor activity;, P:cell adhesion; P:dendrite development; P:fibroblast growth factor receptor signaling pathway; P:neuron projection extension; scaffold143 indexed_genome mRNA 2322868 2324102 . - . ID=transcript_14503;P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold143 indexed_genome mRNA 2325339 2326219 . + . ID=transcript_14504;Q9P2P1 Q6P153 Q86TR3 Q9HAC4,Protein NYNRIN,NYN domain and retroviral integrase catalytic domain-containing protein;Protein cousin of GIN1;, PF17921;PF11977;PF17919;, GO:0036464;GO:0016021;GO:0005634;GO:0004521;GO:0003729;GO:0015074;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:integral component of membrane; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:DNA integration; P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold143 indexed_genome mRNA 2337983 2349894 . + . ID=transcript_14505;P31948 B4DM70 F5H0T1 G3XAD8 Q3ZCU9 Q5TZU9,Stress-induced-phosphoprotein 1,Hsc70/Hsp90-organizing protein;Renal carcinoma antigen NY-REN-11;Transformation-sensitive protein IEF SSP 3521;, PF17830;PF07719;PF13181;, GO:0101031;GO:0005829;GO:0005794;GO:0005634;GO:0032991;GO:0051087;GO:0030544;GO:0051879;GO:0008022;GO:0003723;GO:0098761;, C:chaperone complex; C:cytosol; C:Golgi apparatus; C:nucleus; C:protein-containing complex;, F:chaperone binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:protein C-terminus binding; F:RNA binding;, P:cellular response to interleukin-7;|P31948 B4DM70 F5H0T1 G3XAD8 Q3ZCU9 Q5TZU9,Stress-induced-phosphoprotein 1,Hsc70/Hsp90-organizing protein;Renal carcinoma antigen NY-REN-11;Transformation-sensitive protein IEF SSP 3521;, PF17830;PF07719;PF13181;, GO:0101031;GO:0005829;GO:0005794;GO:0005634;GO:0032991;GO:0051087;GO:0030544;GO:0051879;GO:0008022;GO:0003723;GO:0098761;, C:chaperone complex; C:cytosol; C:Golgi apparatus; C:nucleus; C:protein-containing complex;, F:chaperone binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:protein C-terminus binding; F:RNA binding;, P:cellular response to interleukin-7;|P31948 B4DM70 F5H0T1 G3XAD8 Q3ZCU9 Q5TZU9,Stress-induced-phosphoprotein 1,Hsc70/Hsp90-organizing protein;Renal carcinoma antigen NY-REN-11;Transformation-sensitive protein IEF SSP 3521;, PF17830;PF07719;PF13181;, GO:0101031;GO:0005829;GO:0005794;GO:0005634;GO:0032991;GO:0051087;GO:0030544;GO:0051879;GO:0008022;GO:0003723;GO:0098761;, C:chaperone complex; C:cytosol; C:Golgi apparatus; C:nucleus; C:protein-containing complex;, F:chaperone binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:protein C-terminus binding; F:RNA binding;, P:cellular response to interleukin-7;|P31948 B4DM70 F5H0T1 G3XAD8 Q3ZCU9 Q5TZU9,Stress-induced-phosphoprotein 1,Hsc70/Hsp90-organizing protein;Renal carcinoma antigen NY-REN-11;Transformation-sensitive protein IEF SSP 3521;, PF17830;PF07719;PF13181;, GO:0101031;GO:0005829;GO:0005794;GO:0005634;GO:0032991;GO:0051087;GO:0030544;GO:0051879;GO:0008022;GO:0003723;GO:0098761;, C:chaperone complex; C:cytosol; C:Golgi apparatus; C:nucleus; C:protein-containing complex;, F:chaperone binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:protein C-terminus binding; F:RNA binding;, P:cellular response to interleukin-7;|P31948 B4DM70 F5H0T1 G3XAD8 Q3ZCU9 Q5TZU9,Stress-induced-phosphoprotein 1,Hsc70/Hsp90-organizing protein;Renal carcinoma antigen NY-REN-11;Transformation-sensitive protein IEF SSP 3521;, PF17830;PF07719;PF13181;, GO:0101031;GO:0005829;GO:0005794;GO:0005634;GO:0032991;GO:0051087;GO:0030544;GO:0051879;GO:0008022;GO:0003723;GO:0098761;, C:chaperone complex; C:cytosol; C:Golgi apparatus; C:nucleus; C:protein-containing complex;, F:chaperone binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:protein C-terminus binding; F:RNA binding;, P:cellular response to interleukin-7; scaffold143 indexed_genome mRNA 2351917 2371688 . + . ID=transcript_14506;Q86UX7 Q8IUA1 Q8N207 Q9BT48,Fermitin family homolog 3,Kindlin-3;MIG2-like protein;Unc-112-related protein 2;, PF00373;PF18124;PF00169;, GO:0042995;GO:0030055;GO:0070062;GO:0005576;GO:0016020;GO:0031093;GO:0002102;GO:0005178;GO:0007160;GO:0033622;GO:0007229;GO:0007159;GO:0070527;GO:0002576;GO:0030335;GO:0033632;GO:0034446;, C:cell projection; C:cell-substrate junction; C:extracellular exosome; C:extracellular region; C:membrane; C:platelet alpha granule lumen; C:podosome;, F:integrin binding;, P:cell-matrix adhesion; P:integrin activation; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:platelet aggregation; P:platelet degranulation; P:positive regulation of cell migration; P:regulation of cell-cell adhesion mediated by integrin; P:substrate adhesion-dependent cell spreading;|Q86UX7 Q8IUA1 Q8N207 Q9BT48,Fermitin family homolog 3,Kindlin-3;MIG2-like protein;Unc-112-related protein 2;, PF00373;PF18124;PF00169;, GO:0042995;GO:0030055;GO:0070062;GO:0005576;GO:0016020;GO:0031093;GO:0002102;GO:0005178;GO:0007160;GO:0033622;GO:0007229;GO:0007159;GO:0070527;GO:0002576;GO:0030335;GO:0033632;GO:0034446;, C:cell projection; C:cell-substrate junction; C:extracellular exosome; C:extracellular region; C:membrane; C:platelet alpha granule lumen; C:podosome;, F:integrin binding;, P:cell-matrix adhesion; P:integrin activation; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:platelet aggregation; P:platelet degranulation; P:positive regulation of cell migration; P:regulation of cell-cell adhesion mediated by integrin; P:substrate adhesion-dependent cell spreading;|Q86UX7 Q8IUA1 Q8N207 Q9BT48,Fermitin family homolog 3,Kindlin-3;MIG2-like protein;Unc-112-related protein 2;, PF00373;PF18124;PF00169;, GO:0042995;GO:0030055;GO:0070062;GO:0005576;GO:0016020;GO:0031093;GO:0002102;GO:0005178;GO:0007160;GO:0033622;GO:0007229;GO:0007159;GO:0070527;GO:0002576;GO:0030335;GO:0033632;GO:0034446;, C:cell projection; C:cell-substrate junction; C:extracellular exosome; C:extracellular region; C:membrane; C:platelet alpha granule lumen; C:podosome;, F:integrin binding;, P:cell-matrix adhesion; P:integrin activation; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:platelet aggregation; P:platelet degranulation; P:positive regulation of cell migration; P:regulation of cell-cell adhesion mediated by integrin; P:substrate adhesion-dependent cell spreading;|Q86UX7 Q8IUA1 Q8N207 Q9BT48,Fermitin family homolog 3,Kindlin-3;MIG2-like protein;Unc-112-related protein 2;, PF00373;PF18124;PF00169;, GO:0042995;GO:0030055;GO:0070062;GO:0005576;GO:0016020;GO:0031093;GO:0002102;GO:0005178;GO:0007160;GO:0033622;GO:0007229;GO:0007159;GO:0070527;GO:0002576;GO:0030335;GO:0033632;GO:0034446;, C:cell projection; C:cell-substrate junction; C:extracellular exosome; C:extracellular region; C:membrane; C:platelet alpha granule lumen; C:podosome;, F:integrin binding;, P:cell-matrix adhesion; P:integrin activation; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:platelet aggregation; P:platelet degranulation; P:positive regulation of cell migration; P:regulation of cell-cell adhesion mediated by integrin; P:substrate adhesion-dependent cell spreading;|Q86TN4 A8MU17 A8MYC9 F5H2B2 Q9BSB9,tRNA 2'-phosphotransferase 1,, PF01885;, GO:0003950;GO:0000215;GO:0045859;GO:0008033;GO:0006388;, , F:NAD+ ADP-ribosyltransferase activity; F:tRNA 2'-phosphotransferase activity;, P:regulation of protein kinase activity; P:tRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q86TN4 A8MU17 A8MYC9 F5H2B2 Q9BSB9,tRNA 2'-phosphotransferase 1,, PF01885;, GO:0003950;GO:0000215;GO:0045859;GO:0008033;GO:0006388;, , F:NAD+ ADP-ribosyltransferase activity; F:tRNA 2'-phosphotransferase activity;, P:regulation of protein kinase activity; P:tRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q86TN4 A8MU17 A8MYC9 F5H2B2 Q9BSB9,tRNA 2'-phosphotransferase 1,, PF01885;, GO:0003950;GO:0000215;GO:0045859;GO:0008033;GO:0006388;, , F:NAD+ ADP-ribosyltransferase activity; F:tRNA 2'-phosphotransferase activity;, P:regulation of protein kinase activity; P:tRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q86TN4 A8MU17 A8MYC9 F5H2B2 Q9BSB9,tRNA 2'-phosphotransferase 1,, PF01885;, GO:0003950;GO:0000215;GO:0045859;GO:0008033;GO:0006388;, , F:NAD+ ADP-ribosyltransferase activity; F:tRNA 2'-phosphotransferase activity;, P:regulation of protein kinase activity; P:tRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold143 indexed_genome mRNA 2371814 2383118 . + . ID=transcript_14507;Q9BRQ3 C9JY06 Q71RD5,Uridine diphosphate glucose pyrophosphatase NUDT22,Nucleoside diphosphate-linked moiety X motif 22;, , GO:0005654;GO:0052751;GO:0046872;GO:0008768;, C:nucleoplasm;, F:GDP-mannose hydrolase activity; F:metal ion binding; F:UDP-sugar diphosphatase activity;|Q9BRQ3 C9JY06 Q71RD5,Uridine diphosphate glucose pyrophosphatase NUDT22,Nucleoside diphosphate-linked moiety X motif 22;, , GO:0005654;GO:0052751;GO:0046872;GO:0008768;, C:nucleoplasm;, F:GDP-mannose hydrolase activity; F:metal ion binding; F:UDP-sugar diphosphatase activity;|Q9NNZ3 O14716,DnaJ homolog subfamily C member 4,DnaJ-like protein HSPF2;Multiple endocrine neoplasia type 1 candidate protein number 18;, PF00226;, GO:0016021;GO:0016020;GO:0051082;GO:0006457;GO:0006986;, C:integral component of membrane; C:membrane;, F:unfolded protein binding;, P:protein folding; P:response to unfolded protein;|Q9NNZ3 O14716,DnaJ homolog subfamily C member 4,DnaJ-like protein HSPF2;Multiple endocrine neoplasia type 1 candidate protein number 18;, PF00226;, GO:0016021;GO:0016020;GO:0051082;GO:0006457;GO:0006986;, C:integral component of membrane; C:membrane;, F:unfolded protein binding;, P:protein folding; P:response to unfolded protein;|P49765 Q16528,Vascular endothelial growth factor B,VEGF-related factor;, PF00341;, GO:0005576;GO:0005615;GO:0016020;GO:0031093;GO:0042056;GO:0008083;GO:0008201;GO:0042802;GO:0043183;GO:0005172;GO:0060048;GO:0060976;GO:0050930;GO:0043066;GO:0010629;GO:0043524;GO:0002576;GO:0045766;GO:0051781;GO:0001938;GO:0070374;GO:0060754;GO:0050731;GO:0051897;GO:0001934;GO:0030949;GO:0035470;GO:0006493;GO:0042493;GO:0001666;GO:0002040;GO:0048010;GO:0038084;, C:extracellular region; C:extracellular space; C:membrane; C:platelet alpha granule lumen;, F:chemoattractant activity; F:growth factor activity; F:heparin binding; F:identical protein binding; F:vascular endothelial growth factor receptor 1 binding; F:vascular endothelial growth factor receptor binding;, P:cardiac muscle contraction; P:coronary vasculature development; P:induction of positive chemotaxis; P:negative regulation of apoptotic process; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of cell division; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of mast cell chemotaxis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:positive regulation of vascular wound healing; P:protein O-linked glycosylation; P:response to drug; P:response to hypoxia; P:sprouting angiogenesis; P:vascular endothelial growth factor receptor signaling pathway; P:vascular endothelial growth factor signaling pathway; scaffold144 indexed_genome mRNA 79703 84041 . - . ID=transcript_14508;P10073 Q15922 Q7Z3L8,Zinc finger and SCAN domain-containing protein 22,Krueppel-related zinc finger protein 2;Protein HKR2;Zinc finger protein 50;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 94817 96306 . - . ID=transcript_14509;O75554 B7Z4M2 Q32P29,WW domain-binding protein 4,Formin-binding protein 21 {ECO:0000303|PubMed:19592703};WW domain-containing-binding protein 4;, PF00397;PF06220;, GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0071005;GO:0070064;GO:0003723;GO:0008270;GO:0045292;GO:0000398;GO:0008380;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:U2-type precatalytic spliceosome;, F:proline-rich region binding; F:RNA binding; F:zinc ion binding;, P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:RNA splicing; scaffold144 indexed_genome mRNA 100417 109677 . + . ID=transcript_14510;P28698 M0QXU0 Q7Z729 Q96I71 Q9NRY0 Q9UBW2,Myeloid zinc finger 1,Zinc finger and SCAN domain-containing protein 6;Zinc finger protein 42;, PF02023;PF00096;, GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0042803;GO:0000978;GO:0000976;GO:0000122;GO:0045944;GO:0006355;, C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|P28698 M0QXU0 Q7Z729 Q96I71 Q9NRY0 Q9UBW2,Myeloid zinc finger 1,Zinc finger and SCAN domain-containing protein 6;Zinc finger protein 42;, PF02023;PF00096;, GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0042803;GO:0000978;GO:0000976;GO:0000122;GO:0045944;GO:0006355;, C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold144 indexed_genome mRNA 114537 118088 . + . ID=transcript_14511;O43633 B2R4W6 Q3ZTT0,Charged multivesicular body protein 2a,Chromatin-modifying protein 2a;Putative breast adenocarcinoma marker BC-2;Vacuolar protein sorting-associated protein 2-1;, PF03357;, GO:0005829;GO:0000815;GO:0070062;GO:0031902;GO:0016020;GO:0030117;GO:0005771;GO:0005635;GO:0031210;GO:0019904;GO:0016197;GO:0032509;GO:1904903;GO:0045184;GO:0010458;GO:0045324;GO:0016236;GO:0010324;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0060548;GO:1903723;GO:0031468;GO:0006997;GO:1903543;GO:1902188;GO:0006892;GO:0051260;GO:0051258;GO:0015031;GO:0010824;GO:1901673;GO:0050792;GO:0039702;GO:0019058;, C:cytosol; C:ESCRT III complex; C:extracellular exosome; C:late endosome membrane; C:membrane; C:membrane coat; C:multivesicular body; C:nuclear envelope;, F:phosphatidylcholine binding; F:protein domain specific binding;, P:endosomal transport; P:endosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:establishment of protein localization; P:exit from mitosis; P:late endosome to vacuole transport; P:macroautophagy; P:membrane invagination; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of cell death; P:negative regulation of centriole elongation; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of exosomal secretion; P:positive regulation of viral release from host cell; P:post-Golgi vesicle-mediated transport; P:protein homooligomerization; P:protein polymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:viral budding via host ESCRT complex; P:viral life cycle;|O43633 B2R4W6 Q3ZTT0,Charged multivesicular body protein 2a,Chromatin-modifying protein 2a;Putative breast adenocarcinoma marker BC-2;Vacuolar protein sorting-associated protein 2-1;, PF03357;, GO:0005829;GO:0000815;GO:0070062;GO:0031902;GO:0016020;GO:0030117;GO:0005771;GO:0005635;GO:0031210;GO:0019904;GO:0016197;GO:0032509;GO:1904903;GO:0045184;GO:0010458;GO:0045324;GO:0016236;GO:0010324;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0060548;GO:1903723;GO:0031468;GO:0006997;GO:1903543;GO:1902188;GO:0006892;GO:0051260;GO:0051258;GO:0015031;GO:0010824;GO:1901673;GO:0050792;GO:0039702;GO:0019058;, C:cytosol; C:ESCRT III complex; C:extracellular exosome; C:late endosome membrane; C:membrane; C:membrane coat; C:multivesicular body; C:nuclear envelope;, F:phosphatidylcholine binding; F:protein domain specific binding;, P:endosomal transport; P:endosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:establishment of protein localization; P:exit from mitosis; P:late endosome to vacuole transport; P:macroautophagy; P:membrane invagination; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of cell death; P:negative regulation of centriole elongation; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of exosomal secretion; P:positive regulation of viral release from host cell; P:post-Golgi vesicle-mediated transport; P:protein homooligomerization; P:protein polymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:viral budding via host ESCRT complex; P:viral life cycle;|O43633 B2R4W6 Q3ZTT0,Charged multivesicular body protein 2a,Chromatin-modifying protein 2a;Putative breast adenocarcinoma marker BC-2;Vacuolar protein sorting-associated protein 2-1;, PF03357;, GO:0005829;GO:0000815;GO:0070062;GO:0031902;GO:0016020;GO:0030117;GO:0005771;GO:0005635;GO:0031210;GO:0019904;GO:0016197;GO:0032509;GO:1904903;GO:0045184;GO:0010458;GO:0045324;GO:0016236;GO:0010324;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0060548;GO:1903723;GO:0031468;GO:0006997;GO:1903543;GO:1902188;GO:0006892;GO:0051260;GO:0051258;GO:0015031;GO:0010824;GO:1901673;GO:0050792;GO:0039702;GO:0019058;, C:cytosol; C:ESCRT III complex; C:extracellular exosome; C:late endosome membrane; C:membrane; C:membrane coat; C:multivesicular body; C:nuclear envelope;, F:phosphatidylcholine binding; F:protein domain specific binding;, P:endosomal transport; P:endosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:establishment of protein localization; P:exit from mitosis; P:late endosome to vacuole transport; P:macroautophagy; P:membrane invagination; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of cell death; P:negative regulation of centriole elongation; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of exosomal secretion; P:positive regulation of viral release from host cell; P:post-Golgi vesicle-mediated transport; P:protein homooligomerization; P:protein polymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:viral budding via host ESCRT complex; P:viral life cycle;|O43633 B2R4W6 Q3ZTT0,Charged multivesicular body protein 2a,Chromatin-modifying protein 2a;Putative breast adenocarcinoma marker BC-2;Vacuolar protein sorting-associated protein 2-1;, PF03357;, GO:0005829;GO:0000815;GO:0070062;GO:0031902;GO:0016020;GO:0030117;GO:0005771;GO:0005635;GO:0031210;GO:0019904;GO:0016197;GO:0032509;GO:1904903;GO:0045184;GO:0010458;GO:0045324;GO:0016236;GO:0010324;GO:0061952;GO:0007080;GO:0007084;GO:0036258;GO:0060548;GO:1903723;GO:0031468;GO:0006997;GO:1903543;GO:1902188;GO:0006892;GO:0051260;GO:0051258;GO:0015031;GO:0010824;GO:1901673;GO:0050792;GO:0039702;GO:0019058;, C:cytosol; C:ESCRT III complex; C:extracellular exosome; C:late endosome membrane; C:membrane; C:membrane coat; C:multivesicular body; C:nuclear envelope;, F:phosphatidylcholine binding; F:protein domain specific binding;, P:endosomal transport; P:endosome transport via multivesicular body sorting pathway; P:ESCRT III complex disassembly; P:establishment of protein localization; P:exit from mitosis; P:late endosome to vacuole transport; P:macroautophagy; P:membrane invagination; P:midbody abscission; P:mitotic metaphase plate congression; P:mitotic nuclear envelope reassembly; P:multivesicular body assembly; P:negative regulation of cell death; P:negative regulation of centriole elongation; P:nuclear envelope reassembly; P:nucleus organization; P:positive regulation of exosomal secretion; P:positive regulation of viral release from host cell; P:post-Golgi vesicle-mediated transport; P:protein homooligomerization; P:protein polymerization; P:protein transport; P:regulation of centrosome duplication; P:regulation of mitotic spindle assembly; P:regulation of viral process; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold144 indexed_genome mRNA 118685 124523 . - . ID=transcript_14512;Q13263 O00677 Q7Z632 Q93040 Q96IM1,Transcription intermediary factor 1-beta,E3 SUMO-protein ligase TRIM28;KRAB-associated protein 1;KRAB-interacting protein 1;Nuclear corepressor KAP-1;RING finger protein 96;RING-type E3 ubiquitin transferase TIF1-beta {ECO:0000305};Tripartite motif-containing protein 28;, PF00628;PF00643;PF14634;, GO:0000785;GO:0000791;GO:0000792;GO:0005654;GO:0005634;GO:0032991;GO:0090575;GO:0003682;GO:0070087;GO:0003677;GO:0035851;GO:1990841;GO:0004672;GO:0003723;GO:0019789;GO:0003713;GO:0003714;GO:0031625;GO:0004842;GO:0008270;GO:0006325;GO:0060028;GO:0043045;GO:0006281;GO:0007566;GO:0060669;GO:0001837;GO:0045087;GO:1901536;GO:0045869;GO:0000122;GO:0045892;GO:1902187;GO:0043388;GO:0090309;GO:0045739;GO:0042307;GO:0045893;GO:0046777;GO:0016925;GO:0007265;GO:2000653;GO:0060260;GO:0016032;, C:chromatin; C:euchromatin; C:heterochromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:RNA polymerase II transcription regulator complex;, F:chromatin binding; F:chromo shadow domain binding; F:DNA binding; F:Krueppel-associated box domain binding; F:promoter-specific chromatin binding; F:protein kinase activity; F:RNA binding; F:SUMO transferase activity; F:transcription coactivator activity; F:transcription corepressor activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:chromatin organization; P:convergent extension involved in axis elongation; P:DNA methylation involved in embryo development; P:DNA repair; P:embryo implantation; P:embryonic placenta morphogenesis; P:epithelial to mesenchymal transition; P:innate immune response; P:negative regulation of DNA demethylation; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of viral release from host cell; P:positive regulation of DNA binding; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of DNA repair; P:positive regulation of protein import into nucleus; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein sumoylation; P:Ras protein signal transduction; P:regulation of genetic imprinting; P:regulation of transcription initiation from RNA polymerase II promoter; P:viral process; scaffold144 indexed_genome mRNA 163282 164886 . + . ID=transcript_14513;Q9Y2P5 B3KVP6 B4DPQ1,Bile acyl-CoA synthetase {ECO:0000303|PubMed:11980911},Bile acid-CoA ligase {ECO:0000250|UniProtKB:Q9ES38};Cholate--CoA ligase {ECO:0000303|PubMed:10749848};Fatty acid transport protein 5 {ECO:0000303|PubMed:20530735};Fatty-acid-coenzyme A ligase, very long-chain 3;Solute carrier family 27 member 5;Very long-chain acyl-CoA synthetase homolog 2 {ECO:0000303|PubMed:10479480, ECO:0000303|PubMed:10749848};Very long-chain acyl-CoA synthetase-related protein {ECO:0000250|UniProtKB:Q4LDG0};, PF00501;PF13193;, GO:0009925;GO:0005783;GO:0005789;GO:0030176;GO:0032991;GO:0005524;GO:0047747;GO:0015245;GO:0005324;GO:0004467;GO:0016491;GO:0044877;GO:0031957;GO:0015721;GO:0006699;GO:0046951;GO:0015911;GO:0006642;GO:0000038;, C:basal plasma membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:protein-containing complex;, F:ATP binding; F:cholate-CoA ligase activity; F:fatty acid transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:oxidoreductase activity; F:protein-containing complex binding; F:very long-chain fatty acid-CoA ligase activity;, P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:ketone body biosynthetic process; P:long-chain fatty acid import across plasma membrane; P:triglyceride mobilization; P:very long-chain fatty acid metabolic process; scaffold144 indexed_genome mRNA 165032 166021 . + . ID=transcript_14514;Q9Y2P5 B3KVP6 B4DPQ1,Bile acyl-CoA synthetase {ECO:0000303|PubMed:11980911},Bile acid-CoA ligase {ECO:0000250|UniProtKB:Q9ES38};Cholate--CoA ligase {ECO:0000303|PubMed:10749848};Fatty acid transport protein 5 {ECO:0000303|PubMed:20530735};Fatty-acid-coenzyme A ligase, very long-chain 3;Solute carrier family 27 member 5;Very long-chain acyl-CoA synthetase homolog 2 {ECO:0000303|PubMed:10479480, ECO:0000303|PubMed:10749848};Very long-chain acyl-CoA synthetase-related protein {ECO:0000250|UniProtKB:Q4LDG0};, PF00501;PF13193;, GO:0009925;GO:0005783;GO:0005789;GO:0030176;GO:0032991;GO:0005524;GO:0047747;GO:0015245;GO:0005324;GO:0004467;GO:0016491;GO:0044877;GO:0031957;GO:0015721;GO:0006699;GO:0046951;GO:0015911;GO:0006642;GO:0000038;, C:basal plasma membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:protein-containing complex;, F:ATP binding; F:cholate-CoA ligase activity; F:fatty acid transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:oxidoreductase activity; F:protein-containing complex binding; F:very long-chain fatty acid-CoA ligase activity;, P:bile acid and bile salt transport; P:bile acid biosynthetic process; P:ketone body biosynthetic process; P:long-chain fatty acid import across plasma membrane; P:triglyceride mobilization; P:very long-chain fatty acid metabolic process; scaffold144 indexed_genome mRNA 173756 176105 . - . ID=transcript_14515;Q9NWS9 Q96AF5,Zinc finger protein 446,Zinc finger protein with KRAB and SCAN domains 20;, PF01352;PF02023;PF00096;, GO:0000785;GO:0005615;GO:0005634;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0006357;, C:chromatin; C:extracellular space; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 204449 209754 . + . ID=transcript_14516;P52740 Q32MI9,Zinc finger protein 132,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 212148 216585 . + . ID=transcript_14517;Q8IVC4 A8K203,Zinc finger protein 584,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 217615 219871 . - . ID=transcript_14518;Q8IVC4 A8K203,Zinc finger protein 584,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 232448 240643 . - . ID=transcript_14519;P46782 B2R4T2 Q96BN0,40S ribosomal protein S5,Small ribosomal subunit protein uS7 {ECO:0000303|PubMed:24524803};, PF00177;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:1990904;GO:0005840;GO:0003729;GO:0003723;GO:0019843;GO:0003735;GO:0000184;GO:0006450;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:ribonucleoprotein complex; C:ribosome;, F:mRNA binding; F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translational fidelity; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P46782 B2R4T2 Q96BN0,40S ribosomal protein S5,Small ribosomal subunit protein uS7 {ECO:0000303|PubMed:24524803};, PF00177;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:1990904;GO:0005840;GO:0003729;GO:0003723;GO:0019843;GO:0003735;GO:0000184;GO:0006450;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:ribonucleoprotein complex; C:ribosome;, F:mRNA binding; F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translational fidelity; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P46782 B2R4T2 Q96BN0,40S ribosomal protein S5,Small ribosomal subunit protein uS7 {ECO:0000303|PubMed:24524803};, PF00177;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:1990904;GO:0005840;GO:0003729;GO:0003723;GO:0019843;GO:0003735;GO:0000184;GO:0006450;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:ribonucleoprotein complex; C:ribosome;, F:mRNA binding; F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of translational fidelity; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold144 indexed_genome mRNA 251474 269120 . + . ID=transcript_14520;P04217 A8K052 Q68CK0 Q8IYJ6 Q96P39,Alpha-1B-glycoprotein,Alpha-1-B glycoprotein;, PF13895;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0031093;GO:0034774;GO:0043312;GO:0002576;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:platelet alpha granule lumen; C:secretory granule lumen;, , P:neutrophil degranulation; P:platelet degranulation;|P04217 A8K052 Q68CK0 Q8IYJ6 Q96P39,Alpha-1B-glycoprotein,Alpha-1-B glycoprotein;, PF13895;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0031093;GO:0034774;GO:0043312;GO:0002576;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:platelet alpha granule lumen; C:secretory granule lumen;, , P:neutrophil degranulation; P:platelet degranulation;|P10073 Q15922 Q7Z3L8,Zinc finger and SCAN domain-containing protein 22,Krueppel-related zinc finger protein 2;Protein HKR2;Zinc finger protein 50;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P04217 A8K052 Q68CK0 Q8IYJ6 Q96P39,Alpha-1B-glycoprotein,Alpha-1-B glycoprotein;, PF13895;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0031093;GO:0034774;GO:0043312;GO:0002576;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:platelet alpha granule lumen; C:secretory granule lumen;, , P:neutrophil degranulation; P:platelet degranulation;|P10073 Q15922 Q7Z3L8,Zinc finger and SCAN domain-containing protein 22,Krueppel-related zinc finger protein 2;Protein HKR2;Zinc finger protein 50;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 273649 274202 . + . ID=transcript_14521;P62244 P39027 P39031 Q3MHD9 Q8C023 Q9BV24,40S ribosomal protein S15a,Small ribosomal subunit protein uS8 {ECO:0000303|PubMed:24524803};, PF00410;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0003723;GO:0003735;GO:0000184;GO:0045787;GO:0008284;GO:0009615;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:response to virus; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold144 indexed_genome mRNA 274930 292077 . - . ID=transcript_14522;P17098 Q6PI99,Zinc finger protein 8,Zinc finger protein HF.18;, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0000978;GO:0008270;GO:0030509;GO:0000122;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 300212 300778 . - . ID=transcript_14523;Q6NX49 A8K6J1 Q9UEX4,Zinc finger protein 544,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 301157 308799 . - . ID=transcript_14524;Q6NX49 A8K6J1 Q9UEX4,Zinc finger protein 544,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 315159 315868 . - . ID=transcript_14525;Q8WXB4 A8KAN2 Q8NE04 Q96JH5,Zinc finger protein 606,Zinc finger protein 328;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 317516 325560 . - . ID=transcript_14526;Q96GC6 Q53XU4 Q6MZG1 Q8WY37 Q8WY38 Q92969 Q9UII0 Q9UII1,Neurotrophin receptor-interacting factor homolog,Zinc finger protein 274;Zinc finger protein HFB101;Zinc finger protein with KRAB and SCAN domains 19;Zinc finger protein zfp2;, PF01352;PF02023;PF00096;, GO:0005737;GO:0005730;GO:0003682;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:1900112;GO:0006357;GO:0006355;, C:cytoplasm; C:nucleolus;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q96GC6 Q53XU4 Q6MZG1 Q8WY37 Q8WY38 Q92969 Q9UII0 Q9UII1,Neurotrophin receptor-interacting factor homolog,Zinc finger protein 274;Zinc finger protein HFB101;Zinc finger protein with KRAB and SCAN domains 19;Zinc finger protein zfp2;, PF01352;PF02023;PF00096;, GO:0005737;GO:0005730;GO:0003682;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:1900112;GO:0006357;GO:0006355;, C:cytoplasm; C:nucleolus;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold144 indexed_genome mRNA 337716 341334 . - . ID=transcript_14527;Q96GC6 Q53XU4 Q6MZG1 Q8WY37 Q8WY38 Q92969 Q9UII0 Q9UII1,Neurotrophin receptor-interacting factor homolog,Zinc finger protein 274;Zinc finger protein HFB101;Zinc finger protein with KRAB and SCAN domains 19;Zinc finger protein zfp2;, PF01352;PF02023;PF00096;, GO:0005737;GO:0005730;GO:0003682;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:1900112;GO:0006357;GO:0006355;, C:cytoplasm; C:nucleolus;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q96GC6 Q53XU4 Q6MZG1 Q8WY37 Q8WY38 Q92969 Q9UII0 Q9UII1,Neurotrophin receptor-interacting factor homolog,Zinc finger protein 274;Zinc finger protein HFB101;Zinc finger protein with KRAB and SCAN domains 19;Zinc finger protein zfp2;, PF01352;PF02023;PF00096;, GO:0005737;GO:0005730;GO:0003682;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:1990837;GO:0000122;GO:1900112;GO:0006357;GO:0006355;, C:cytoplasm; C:nucleolus;, F:chromatin binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of histone H3-K9 trimethylation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold144 indexed_genome mRNA 346604 349972 . + . ID=transcript_14528;B4DU55,Zinc finger protein 879,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 351077 363936 . + . ID=transcript_14529;Q86UD4 B3KR32 Q9H9R7,Zinc finger protein 329,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 373740 378106 . - . ID=transcript_14530;P52742 B4DHH9 E9PEV2 F5GYY9 I3L0B3 Q5U5L3 Q8N1I7,Zinc finger protein 135,Zinc finger protein 61;Zinc finger protein 78-like 1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0007010;GO:0022604;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cytoskeleton organization; P:regulation of cell morphogenesis; P:regulation of transcription by RNA polymerase II;|P52742 B4DHH9 E9PEV2 F5GYY9 I3L0B3 Q5U5L3 Q8N1I7,Zinc finger protein 135,Zinc finger protein 61;Zinc finger protein 78-like 1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0007010;GO:0022604;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cytoskeleton organization; P:regulation of cell morphogenesis; P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 387886 389109 . + . ID=transcript_14531;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold144 indexed_genome mRNA 390803 413009 . + . ID=transcript_14532;Q8WXB4 A8KAN2 Q8NE04 Q96JH5,Zinc finger protein 606,Zinc finger protein 328;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8WXB4 A8KAN2 Q8NE04 Q96JH5,Zinc finger protein 606,Zinc finger protein 328;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8WXB4 A8KAN2 Q8NE04 Q96JH5,Zinc finger protein 606,Zinc finger protein 328;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 418398 419746 . + . ID=transcript_14533;Q8NEA5,Uncharacterized protein C19orf18,, PF17686;, GO:0070062;GO:0016021;, C:extracellular exosome; C:integral component of membrane; scaffold144 indexed_genome mRNA 419786 444812 . + . ID=transcript_14534;Q8NEA5,Uncharacterized protein C19orf18,, PF17686;, GO:0070062;GO:0016021;, C:extracellular exosome; C:integral component of membrane;|Q8NEA5,Uncharacterized protein C19orf18,, PF17686;, GO:0070062;GO:0016021;, C:extracellular exosome; C:integral component of membrane; scaffold144 indexed_genome mRNA 474511 486415 . + . ID=transcript_14535;Q9Y2P7 B2RA92 Q53Y85 Q9BV71,Zinc finger protein 256,Bone marrow zinc finger 3;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0045892;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|B7Z6K7 A6NF35,Zinc finger protein 814,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 494374 498581 . + . ID=transcript_14536;B7Z6K7 A6NF35,Zinc finger protein 814,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 509722 522072 . - . ID=transcript_14537;Q9Y2P7 B2RA92 Q53Y85 Q9BV71,Zinc finger protein 256,Bone marrow zinc finger 3;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0045892;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 532631 566201 . - . ID=transcript_14538;Q9H707 B3KUE9 Q6P5A6,Zinc finger protein 552,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 600725 627198 . + . ID=transcript_14539;A8MQ14,Zinc finger protein 850,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 646246 646902 . - . ID=transcript_14540;Q9Y2P7 B2RA92 Q53Y85 Q9BV71,Zinc finger protein 256,Bone marrow zinc finger 3;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0045892;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 647677 648255 . - . ID=transcript_14541;Q96JF6 Q6RFS0,Zinc finger protein 594,Zinc finger protein HZF18;, PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 651129 652565 . + . ID=transcript_14542;Q9N2K0 O00354 Q96L63 Q9UNM3,HERV-H_2q24.3 provirus ancestral Env polyprotein,Env protein HERV-H/p62;Env protein HERV-H19;Env protein HERV-Hcl.3;Envelope polyprotein;HERV-H/env62;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold144 indexed_genome mRNA 652584 653658 . - . ID=transcript_14543;Q9P2P1 Q6P153 Q86TR3 Q9HAC4,Protein NYNRIN,NYN domain and retroviral integrase catalytic domain-containing protein;Protein cousin of GIN1;, PF17921;PF11977;PF17919;, GO:0036464;GO:0016021;GO:0005634;GO:0004521;GO:0003729;GO:0015074;GO:0090502;, C:cytoplasmic ribonucleoprotein granule; C:integral component of membrane; C:nucleus;, F:endoribonuclease activity; F:mRNA binding;, P:DNA integration; P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold144 indexed_genome mRNA 654695 657439 . + . ID=transcript_14544;Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response; scaffold144 indexed_genome mRNA 674401 708842 . + . ID=transcript_14545;Q59EG4 Q59G36 Q5EBL6,Zinc finger protein 211,Zinc finger protein C2H2-25;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 721391 725956 . + . ID=transcript_14546;Q13106 A7MCY3 Q8IVG7 Q8NAR0,Zinc finger protein 154,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q68DY9 A6NJK9 B4DH56 B4DYS0,Zinc finger protein 772,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 730537 731522 . + . ID=transcript_14547;B7Z6K7 A6NF35,Zinc finger protein 814,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 731695 734785 . + . ID=transcript_14548;Q96RE9 A8MY91 B3KU35 B4DU78 F5GWS1 Q06DQ3 Q17RP3 Q5H9N5,Zinc finger protein 300,, PF01352;PF00096;, GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0043565;GO:0045944;GO:0006357;, C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 737865 738574 . + . ID=transcript_14549;O43674 Q561V6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial,Complex I-SGDH;NADH-ubiquinone oxidoreductase SGDH subunit;, PF09781;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0005654;GO:0008137;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion; C:nucleoplasm;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold144 indexed_genome mRNA 740174 750951 . - . ID=transcript_14550;Q7Z340 B4DU22 P17034 Q8N246 Q9BRY1,Zinc finger protein 551,Zinc finger protein KOX23;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 769943 778929 . - . ID=transcript_14551;Q59EG4 Q59G36 Q5EBL6,Zinc finger protein 211,Zinc finger protein C2H2-25;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 809386 818117 . + . ID=transcript_14552;Q59EG4 Q59G36 Q5EBL6,Zinc finger protein 211,Zinc finger protein C2H2-25;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 818138 834328 . - . ID=transcript_14553;Q9Y2P7 B2RA92 Q53Y85 Q9BV71,Zinc finger protein 256,Bone marrow zinc finger 3;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0045892;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q3SY52 O43339 Q3SY51 Q3SY53,Zinc finger protein interacting with ribonucleoprotein K,Zinc finger protein 762;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 843848 851916 . + . ID=transcript_14554;Q59EG4 Q59G36 Q5EBL6,Zinc finger protein 211,Zinc finger protein C2H2-25;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 855107 884135 . - . ID=transcript_14555;Q8TF45 Q2M1S2 Q670L5 Q96N18,Zinc finger protein 418,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 889613 891912 . + . ID=transcript_14556;Q9H707 B3KUE9 Q6P5A6,Zinc finger protein 552,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 892123 895774 . - . ID=transcript_14557;Q9H7R5 A8K5T8,Zinc finger protein 665,Zinc finger protein 160-like;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 899945 900983 . - . ID=transcript_14558;Q59EG4 Q59G36 Q5EBL6,Zinc finger protein 211,Zinc finger protein C2H2-25;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 932489 937158 . - . ID=transcript_14559;Q9GZP7 B3KSV5 Q7Z5H8 Q7Z5H9,Vomeronasal type-1 receptor 1,G-protein coupled receptor GPCR24;V1r-like receptor 1;V3r-related gene protein;Vomeronasal olfactory receptor chromosome 19 subtype I member 1;, PF03402;, GO:0016021;GO:0005886;GO:0016503;GO:0019236;, C:integral component of membrane; C:plasma membrane;, F:pheromone receptor activity;, P:response to pheromone; scaffold144 indexed_genome mRNA 951938 972178 . - . ID=transcript_14560;P52741 Q9Y4B2,Zinc finger protein 134,, PF00096;, GO:0005654;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8TAW3 A6NF07 Q9H5E9,Zinc finger protein 671,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8TAW3 A6NF07 Q9H5E9,Zinc finger protein 671,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q3KQV3 B4E333 Q495L1 Q495L3 Q8N932,Zinc finger protein 792,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q7Z340 B4DU22 P17034 Q8N246 Q9BRY1,Zinc finger protein 551,Zinc finger protein KOX23;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q6P9A1 O43340 Q9P220,Zinc finger protein 530,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1018645 1032479 . + . ID=transcript_14561;Q6P9A3 B3KV91 O43336 Q8NAR4,Zinc finger protein 549,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9BWM5 Q9NWW8,Zinc finger protein 416,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1038171 1047077 . + . ID=transcript_14562;Q6P9A3 B3KV91 O43336 Q8NAR4,Zinc finger protein 549,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q6P9A3 B3KV91 O43336 Q8NAR4,Zinc finger protein 549,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1054568 1090384 . + . ID=transcript_14563;Q7Z398 B3KVF6 O43337 Q7Z6D7 Q8NE45,Zinc finger protein 550,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q96HQ0 B4DXU7 B4E348 B7ZA41 E9PCP4 E9PED0 E9PET3 E9PFX9 Q9H5P0,Zinc finger protein 419,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q6PK81 Q96DL8,Zinc finger protein 773,Zinc finger protein 419B;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q96NL3 Q569K0 Q5PRG1,Zinc finger protein 599,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1106761 1110898 . - . ID=transcript_14564;Q6PK81 Q96DL8,Zinc finger protein 773,Zinc finger protein 419B;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1120994 1128649 . + . ID=transcript_14565;Q68DY9 A6NJK9 B4DH56 B4DYS0,Zinc finger protein 772,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1141775 1148927 . + . ID=transcript_14566;Q8IVP9 A8K5Z9 Q96NC4,Zinc finger protein 547,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8NEK5 Q96M05,Zinc finger protein 548,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1150952 1152736 . - . ID=transcript_14567;Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response; scaffold144 indexed_genome mRNA 1155205 1162115 . + . ID=transcript_14568;Q9HCX3,Zinc finger protein 304 {ECO:0000312|HGNC:HGNC:13505},KRAB-containing zinc finger protein {ECO:0000303|PubMed:12051768};, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:1990841;GO:0000978;GO:0001525;GO:0006325;GO:0007229;GO:2000811;GO:0035562;GO:0045766;GO:0030335;GO:0090309;GO:0050679;GO:1902466;GO:1900114;GO:0045944;GO:0007265;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:chromatin organization; P:integrin-mediated signaling pathway; P:negative regulation of anoikis; P:negative regulation of chromatin binding; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of epithelial cell proliferation; P:positive regulation of histone H3-K27 trimethylation; P:positive regulation of histone H3-K9 trimethylation; P:positive regulation of transcription by RNA polymerase II; P:Ras protein signal transduction; P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1162259 1172236 . - . ID=transcript_14569;Q8NEK5 Q96M05,Zinc finger protein 548,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1179285 1189677 . - . ID=transcript_14570;Q8NEK5 Q96M05,Zinc finger protein 548,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1196335 1199457 . + . ID=transcript_14571;P17021 B3KXU2 B3KY20 Q8N7M1 Q8N893 Q8TF54,Zinc finger protein 17,Zinc finger protein HPF3;Zinc finger protein KOX10;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1199490 1201116 . + . ID=transcript_14572;P13682 B2RBU6 Q53Y54 Q96D01,Zinc finger protein 35,Zinc finger protein HF.10;, PF00096;, GO:0005634;GO:0048471;GO:0003677;GO:0003700;GO:0000981;GO:0046872;GO:0000977;GO:0043565;GO:0071300;GO:0006357;GO:0006355;GO:0007283;, C:nucleus; C:perinuclear region of cytoplasm;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:cellular response to retinoic acid; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:spermatogenesis; scaffold144 indexed_genome mRNA 1203624 1208571 . + . ID=transcript_14573;Q96HQ0 B4DXU7 B4E348 B7ZA41 E9PCP4 E9PED0 E9PET3 E9PFX9 Q9H5P0,Zinc finger protein 419,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1208862 1215654 . - . ID=transcript_14574;Q13106 A7MCY3 Q8IVG7 Q8NAR0,Zinc finger protein 154,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1215688 1226485 . + . ID=transcript_14575;Q6PK81 Q96DL8,Zinc finger protein 773,Zinc finger protein 419B;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1291344 1292346 . + . ID=transcript_14576;Q9HCX3,Zinc finger protein 304 {ECO:0000312|HGNC:HGNC:13505},KRAB-containing zinc finger protein {ECO:0000303|PubMed:12051768};, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:1990841;GO:0000978;GO:0001525;GO:0006325;GO:0007229;GO:2000811;GO:0035562;GO:0045766;GO:0030335;GO:0090309;GO:0050679;GO:1902466;GO:1900114;GO:0045944;GO:0007265;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:angiogenesis; P:chromatin organization; P:integrin-mediated signaling pathway; P:negative regulation of anoikis; P:negative regulation of chromatin binding; P:positive regulation of angiogenesis; P:positive regulation of cell migration; P:positive regulation of DNA methylation-dependent heterochromatin assembly; P:positive regulation of epithelial cell proliferation; P:positive regulation of histone H3-K27 trimethylation; P:positive regulation of histone H3-K9 trimethylation; P:positive regulation of transcription by RNA polymerase II; P:Ras protein signal transduction; P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1299797 1301335 . + . ID=transcript_14577;Q5CZA5 B4DNM5,Zinc finger protein 805,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1318430 1323434 . + . ID=transcript_14578;Q5CZA5 B4DNM5,Zinc finger protein 805,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1323564 1338033 . - . ID=transcript_14579;Q5CZA5 B4DNM5,Zinc finger protein 805,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1340493 1344671 . - . ID=transcript_14580;Q9UQB9 O60681 O75442 Q6AZY8 Q6DLZ0 Q9UPK5,Aurora kinase C,Aurora 3;Aurora/IPL1-related kinase 3;Aurora/IPL1/Eg2 protein 2;Serine/threonine-protein kinase 13;Serine/threonine-protein kinase aurora-C;, PF00069;, GO:0032133;GO:0000775;GO:0000793;GO:0005737;GO:0030496;GO:0005634;GO:0005819;GO:0005876;GO:0051233;GO:0031616;GO:0005524;GO:0035174;GO:0004672;GO:0106310;GO:0004712;GO:0106311;GO:0008608;GO:0051301;GO:0016570;GO:0051321;GO:0051256;GO:0007052;GO:0048599;GO:0032467;GO:0006468;GO:0032465;GO:0007283;, C:chromosome passenger complex; C:chromosome, centromeric region; C:condensed chromosome; C:cytoplasm; C:midbody; C:nucleus; C:spindle; C:spindle microtubule; C:spindle midzone; C:spindle pole centrosome;, F:ATP binding; F:histone serine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:histone modification; P:meiotic cell cycle; P:mitotic spindle midzone assembly; P:mitotic spindle organization; P:oocyte development; P:positive regulation of cytokinesis; P:protein phosphorylation; P:regulation of cytokinesis; P:spermatogenesis;|Q9UQB9 O60681 O75442 Q6AZY8 Q6DLZ0 Q9UPK5,Aurora kinase C,Aurora 3;Aurora/IPL1-related kinase 3;Aurora/IPL1/Eg2 protein 2;Serine/threonine-protein kinase 13;Serine/threonine-protein kinase aurora-C;, PF00069;, GO:0032133;GO:0000775;GO:0000793;GO:0005737;GO:0030496;GO:0005634;GO:0005819;GO:0005876;GO:0051233;GO:0031616;GO:0005524;GO:0035174;GO:0004672;GO:0106310;GO:0004712;GO:0106311;GO:0008608;GO:0051301;GO:0016570;GO:0051321;GO:0051256;GO:0007052;GO:0048599;GO:0032467;GO:0006468;GO:0032465;GO:0007283;, C:chromosome passenger complex; C:chromosome, centromeric region; C:condensed chromosome; C:cytoplasm; C:midbody; C:nucleus; C:spindle; C:spindle microtubule; C:spindle midzone; C:spindle pole centrosome;, F:ATP binding; F:histone serine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:histone modification; P:meiotic cell cycle; P:mitotic spindle midzone assembly; P:mitotic spindle organization; P:oocyte development; P:positive regulation of cytokinesis; P:protein phosphorylation; P:regulation of cytokinesis; P:spermatogenesis;|Q9UQB9 O60681 O75442 Q6AZY8 Q6DLZ0 Q9UPK5,Aurora kinase C,Aurora 3;Aurora/IPL1-related kinase 3;Aurora/IPL1/Eg2 protein 2;Serine/threonine-protein kinase 13;Serine/threonine-protein kinase aurora-C;, PF00069;, GO:0032133;GO:0000775;GO:0000793;GO:0005737;GO:0030496;GO:0005634;GO:0005819;GO:0005876;GO:0051233;GO:0031616;GO:0005524;GO:0035174;GO:0004672;GO:0106310;GO:0004712;GO:0106311;GO:0008608;GO:0051301;GO:0016570;GO:0051321;GO:0051256;GO:0007052;GO:0048599;GO:0032467;GO:0006468;GO:0032465;GO:0007283;, C:chromosome passenger complex; C:chromosome, centromeric region; C:condensed chromosome; C:cytoplasm; C:midbody; C:nucleus; C:spindle; C:spindle microtubule; C:spindle midzone; C:spindle pole centrosome;, F:ATP binding; F:histone serine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:histone modification; P:meiotic cell cycle; P:mitotic spindle midzone assembly; P:mitotic spindle organization; P:oocyte development; P:positive regulation of cytokinesis; P:protein phosphorylation; P:regulation of cytokinesis; P:spermatogenesis; scaffold144 indexed_genome mRNA 1359104 1375478 . - . ID=transcript_14581;O43296 A8K8Y9 Q9P1V0,Zinc finger protein 264,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|O43296 A8K8Y9 Q9P1V0,Zinc finger protein 264,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1656236 1664890 . + . ID=transcript_14582;Q9GZU2 A7E2B8 B4DIM4 C9JP50 P78418 Q5H9P9 Q7Z7H7 Q8TF75 Q9GZY2,Paternally-expressed gene 3 protein,Zinc finger and SCAN domain-containing protein 24;, PF02023;PF00096;, GO:0005776;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0006915;GO:0000122;GO:0045944;GO:0010468;GO:0006357;, C:autophagosome; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II;|Q9GZU2 A7E2B8 B4DIM4 C9JP50 P78418 Q5H9P9 Q7Z7H7 Q8TF75 Q9GZY2,Paternally-expressed gene 3 protein,Zinc finger and SCAN domain-containing protein 24;, PF02023;PF00096;, GO:0005776;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0006915;GO:0000122;GO:0045944;GO:0010468;GO:0006357;, C:autophagosome; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1859215 1880597 . + . ID=transcript_14583;Q8NHY6 A0JNV6 K7ES88 Q8NHU8 Q9BY30 Q9P2B6,Zinc finger protein 28 homolog,Krueppel-like zinc finger factor X6;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1882072 1894254 . + . ID=transcript_14584;Q6ECI4 A8MTW0 B9EGU1 Q6ZPA1 Q9Y2N9,Zinc finger protein 470,Chondrogenesis zinc finger protein 1;, PF01352;PF00096;, GO:0016604;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1903098 1938603 . + . ID=transcript_14585;Q9NQZ8 Q15919 Q9UC09 Q9UQD3,Endothelial zinc finger protein induced by tumor necrosis factor alpha,Zinc finger protein 71;, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P0DL12,Small integral membrane protein 17,, , GO:0016021;, C:integral component of membrane; scaffold144 indexed_genome mRNA 1946584 1962472 . - . ID=transcript_14586;Q9BX82 B4DF32 O75260 Q08AD6 Q08AD7 Q8N3V1 Q9P2F1,Zinc finger protein 471,EZFIT-related protein 1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q6ECI4 A8MTW0 B9EGU1 Q6ZPA1 Q9Y2N9,Zinc finger protein 470,Chondrogenesis zinc finger protein 1;, PF01352;PF00096;, GO:0016604;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1968409 1969206 . - . ID=transcript_14587;Q96NI8 A1L472 B4DMP1,Zinc finger protein 570,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 1971016 1972669 . + . ID=transcript_14588;Q9HCL3 A7MD23,Zinc finger protein 14 homolog,Zinc finger protein 531;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 2009220 2028080 . + . ID=transcript_14589;Q96ND8 O14850 Q2NKK3,Zinc finger protein 583,Zinc finger protein L3-5;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 2032512 2047821 . - . ID=transcript_14590;Q5HYK9 B2RMS6 B9EK36 Q6B093 Q9H807,Zinc finger protein 667,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5HYK9 B2RMS6 B9EK36 Q6B093 Q9H807,Zinc finger protein 667,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q5HYK9 B2RMS6 B9EK36 Q6B093 Q9H807,Zinc finger protein 667,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 2132339 2137559 . + . ID=transcript_14591;Q8N0Y2 Q8TEQ9 Q8WU35 Q9NUU1,Zinc finger protein 444,Endothelial zinc finger protein 2;Zinc finger and SCAN domain-containing protein 17;, PF02023;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 2158655 2161081 . - . ID=transcript_14592;Q6DD87 A0A087WUD1 O00455,Zinc finger protein 787,TTF-I-interacting peptide 20;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0043565;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold144 indexed_genome mRNA 2312222 2313097 . - . ID=transcript_14593;Q8WWY3 E7ESA8 F1T0A4 F1T0A5 Q17RB4 Q8N7F9 Q9H271 Q9Y439,U4/U6 small nuclear ribonucleoprotein Prp31,Pre-mRNA-processing factor 31;Serologically defined breast cancer antigen NY-BR-99;U4/U6 snRNP 61 kDa protein;, PF01798;PF09785;, GO:0015030;GO:0071339;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0097526;GO:0071005;GO:0005684;GO:0005687;GO:0046540;GO:0005690;GO:0042802;GO:0043021;GO:0003723;GO:0070990;GO:0030621;GO:0030622;GO:0000398;GO:0071166;GO:0000244;, C:Cajal body; C:MLL1 complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:spliceosomal tri-snRNP complex; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U4atac snRNP;, F:identical protein binding; F:ribonucleoprotein complex binding; F:RNA binding; F:snRNP binding; F:U4 snRNA binding; F:U4atac snRNA binding;, P:mRNA splicing, via spliceosome; P:ribonucleoprotein complex localization; P:spliceosomal tri-snRNP complex assembly; scaffold144 indexed_genome mRNA 2319530 2327526 . + . ID=transcript_14594;P0C1Z6 G5E9B5,TCF3 fusion partner,INO80 complex subunit F;Protein FB1;, , GO:0005737;GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0097190;GO:0006310;GO:0006281;GO:0043065;GO:0016579;, C:cytoplasm; C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:apoptotic signaling pathway; P:DNA recombination; P:DNA repair; P:positive regulation of apoptotic process; P:protein deubiquitination;|P0C1Z6 G5E9B5,TCF3 fusion partner,INO80 complex subunit F;Protein FB1;, , GO:0005737;GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0097190;GO:0006310;GO:0006281;GO:0043065;GO:0016579;, C:cytoplasm; C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:apoptotic signaling pathway; P:DNA recombination; P:DNA repair; P:positive regulation of apoptotic process; P:protein deubiquitination;|P0C1Z6 G5E9B5,TCF3 fusion partner,INO80 complex subunit F;Protein FB1;, , GO:0005737;GO:0031011;GO:0005654;GO:0005634;GO:0003677;GO:0097190;GO:0006310;GO:0006281;GO:0043065;GO:0016579;, C:cytoplasm; C:Ino80 complex; C:nucleoplasm; C:nucleus;, F:DNA binding;, P:apoptotic signaling pathway; P:DNA recombination; P:DNA repair; P:positive regulation of apoptotic process; P:protein deubiquitination; scaffold144 indexed_genome mRNA 2338553 2343785 . + . ID=transcript_14595;Q8IYS5 B7WNS2 Q5GRG5 Q8N763 Q8NHL4 Q8WXQ0 Q8WXQ1 Q8WXQ2,Osteoclast-associated immunoglobulin-like receptor,Polymeric immunoglobulin receptor 3;, PF13895;, GO:0070062;GO:0005576;GO:0016021;GO:0005886;GO:0035580;GO:1904724;GO:0038064;GO:0043312;GO:0030316;GO:0050776;, C:extracellular exosome; C:extracellular region; C:integral component of membrane; C:plasma membrane; C:specific granule lumen; C:tertiary granule lumen;, F:collagen receptor activity;, P:neutrophil degranulation; P:osteoclast differentiation; P:regulation of immune response; scaffold145 indexed_genome mRNA 267691 269688 . - . ID=transcript_14596;Q9UPT9 A0JNS3 Q2NLE2 Q6MZY4 Q8TBS8 Q96IW5,Ubiquitin carboxyl-terminal hydrolase 22,Deubiquitinating enzyme 22;Ubiquitin thioesterase 22;Ubiquitin-specific-processing protease 22;, PF00443;PF02148;, GO:0005654;GO:0000124;GO:0008234;GO:0019899;GO:0030374;GO:0004843;GO:0003713;GO:0008270;GO:0007049;GO:0009792;GO:0016578;GO:0043967;GO:0016574;GO:0045931;GO:0045893;GO:0016579;GO:0006511;, C:nucleoplasm; C:SAGA complex;, F:cysteine-type peptidase activity; F:enzyme binding; F:nuclear receptor coactivator activity; F:thiol-dependent ubiquitin-specific protease activity; F:transcription coactivator activity; F:zinc ion binding;, P:cell cycle; P:embryo development ending in birth or egg hatching; P:histone deubiquitination; P:histone H4 acetylation; P:histone ubiquitination; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold145 indexed_genome mRNA 484932 493809 . + . ID=transcript_14597;P51795 A1L475 B3KPN6 Q5JQD5 Q7RTN8,H(+)/Cl(-) exchange transporter 5,Chloride channel protein 5;Chloride transporter ClC-5;, PF00571;PF00654;, GO:0045177;GO:0005829;GO:0005769;GO:0010008;GO:0005794;GO:0000139;GO:0005887;GO:0005765;GO:0016020;GO:0005886;GO:0008021;GO:0005524;GO:0005254;GO:0042802;GO:0015299;GO:0005247;GO:0006897;GO:0007588;GO:0034220;, C:apical part of cell; C:cytosol; C:early endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:synaptic vesicle;, F:ATP binding; F:chloride channel activity; F:identical protein binding; F:solute:proton antiporter activity; F:voltage-gated chloride channel activity;, P:endocytosis; P:excretion; P:ion transmembrane transport; scaffold145 indexed_genome mRNA 499719 510090 . + . ID=transcript_14598;P51795 A1L475 B3KPN6 Q5JQD5 Q7RTN8,H(+)/Cl(-) exchange transporter 5,Chloride channel protein 5;Chloride transporter ClC-5;, PF00571;PF00654;, GO:0045177;GO:0005829;GO:0005769;GO:0010008;GO:0005794;GO:0000139;GO:0005887;GO:0005765;GO:0016020;GO:0005886;GO:0008021;GO:0005524;GO:0005254;GO:0042802;GO:0015299;GO:0005247;GO:0006897;GO:0007588;GO:0034220;, C:apical part of cell; C:cytosol; C:early endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:synaptic vesicle;, F:ATP binding; F:chloride channel activity; F:identical protein binding; F:solute:proton antiporter activity; F:voltage-gated chloride channel activity;, P:endocytosis; P:excretion; P:ion transmembrane transport;|P51795 A1L475 B3KPN6 Q5JQD5 Q7RTN8,H(+)/Cl(-) exchange transporter 5,Chloride channel protein 5;Chloride transporter ClC-5;, PF00571;PF00654;, GO:0045177;GO:0005829;GO:0005769;GO:0010008;GO:0005794;GO:0000139;GO:0005887;GO:0005765;GO:0016020;GO:0005886;GO:0008021;GO:0005524;GO:0005254;GO:0042802;GO:0015299;GO:0005247;GO:0006897;GO:0007588;GO:0034220;, C:apical part of cell; C:cytosol; C:early endosome; C:endosome membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:plasma membrane; C:synaptic vesicle;, F:ATP binding; F:chloride channel activity; F:identical protein binding; F:solute:proton antiporter activity; F:voltage-gated chloride channel activity;, P:endocytosis; P:excretion; P:ion transmembrane transport; scaffold145 indexed_genome mRNA 601328 605999 . - . ID=transcript_14599;Q5JQC9 A0AV85 O60904 O95246 Q5JQD1 Q5JQD2 Q5JQD3,A-kinase anchor protein 4,A-kinase anchor protein 82 kDa;Major sperm fibrous sheath protein;Protein kinase A-anchoring protein 4;, PF05716;PF10522;, GO:0005952;GO:0005737;GO:0005856;GO:0031514;GO:0005634;GO:0048471;GO:0097224;GO:0097229;GO:0035686;GO:0097225;GO:0097228;GO:0030018;GO:0051018;GO:0045184;GO:0030317;GO:0044458;GO:0008104;GO:0007165;GO:0007338;GO:0007178;, C:cAMP-dependent protein kinase complex; C:cytoplasm; C:cytoskeleton; C:motile cilium; C:nucleus; C:perinuclear region of cytoplasm; C:sperm connecting piece; C:sperm end piece; C:sperm fibrous sheath; C:sperm midpiece; C:sperm principal piece; C:Z disc;, F:protein kinase A binding;, P:establishment of protein localization; P:flagellated sperm motility; P:motile cilium assembly; P:protein localization; P:signal transduction; P:single fertilization; P:transmembrane receptor protein serine/threonine kinase signaling pathway; scaffold145 indexed_genome mRNA 631706 675652 . + . ID=transcript_14600;Q8WWL7 B1AQI5 B1AQI6 Q96SB5 Q96SB6 Q96SB7 Q9NT38,G2/mitotic-specific cyclin-B3,, PF02984;PF00134;, GO:0005813;GO:0000307;GO:0005737;GO:0016607;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0051321;GO:0044772;GO:0000079;GO:0010389;, C:centrosome; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nuclear speck; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:meiotic cell cycle; P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of G2/M transition of mitotic cell cycle;|Q8WWL7 B1AQI5 B1AQI6 Q96SB5 Q96SB6 Q96SB7 Q9NT38,G2/mitotic-specific cyclin-B3,, PF02984;PF00134;, GO:0005813;GO:0000307;GO:0005737;GO:0016607;GO:0005634;GO:0016538;GO:0019901;GO:0051301;GO:0051321;GO:0044772;GO:0000079;GO:0010389;, C:centrosome; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nuclear speck; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding;, P:cell division; P:meiotic cell cycle; P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of G2/M transition of mitotic cell cycle; scaffold145 indexed_genome mRNA 1081319 1135547 . - . ID=transcript_14601;Q9ULL8 A7E2X9 D6RFW0 Q96LA0,Protein Shroom4,Second homolog of apical protein;, PF08687;PF00595;, GO:0005884;GO:0005912;GO:0043296;GO:0016324;GO:0009925;GO:0030864;GO:0005737;GO:0009898;GO:0005925;GO:0043231;GO:0005654;GO:0001725;GO:0051015;GO:0045159;GO:0030036;GO:0007015;GO:0007420;GO:0050890;, C:actin filament; C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:basal plasma membrane; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:stress fiber;, F:actin filament binding; F:myosin II binding;, P:actin cytoskeleton organization; P:actin filament organization; P:brain development; P:cognition;|Q9ULL8 A7E2X9 D6RFW0 Q96LA0,Protein Shroom4,Second homolog of apical protein;, PF08687;PF00595;, GO:0005884;GO:0005912;GO:0043296;GO:0016324;GO:0009925;GO:0030864;GO:0005737;GO:0009898;GO:0005925;GO:0043231;GO:0005654;GO:0001725;GO:0051015;GO:0045159;GO:0030036;GO:0007015;GO:0007420;GO:0050890;, C:actin filament; C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:basal plasma membrane; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:stress fiber;, F:actin filament binding; F:myosin II binding;, P:actin cytoskeleton organization; P:actin filament organization; P:brain development; P:cognition;|Q9ULL8 A7E2X9 D6RFW0 Q96LA0,Protein Shroom4,Second homolog of apical protein;, PF08687;PF00595;, GO:0005884;GO:0005912;GO:0043296;GO:0016324;GO:0009925;GO:0030864;GO:0005737;GO:0009898;GO:0005925;GO:0043231;GO:0005654;GO:0001725;GO:0051015;GO:0045159;GO:0030036;GO:0007015;GO:0007420;GO:0050890;, C:actin filament; C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:basal plasma membrane; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:stress fiber;, F:actin filament binding; F:myosin II binding;, P:actin cytoskeleton organization; P:actin filament organization; P:brain development; P:cognition;|Q9ULL8 A7E2X9 D6RFW0 Q96LA0,Protein Shroom4,Second homolog of apical protein;, PF08687;PF00595;, GO:0005884;GO:0005912;GO:0043296;GO:0016324;GO:0009925;GO:0030864;GO:0005737;GO:0009898;GO:0005925;GO:0043231;GO:0005654;GO:0001725;GO:0051015;GO:0045159;GO:0030036;GO:0007015;GO:0007420;GO:0050890;, C:actin filament; C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:basal plasma membrane; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:stress fiber;, F:actin filament binding; F:myosin II binding;, P:actin cytoskeleton organization; P:actin filament organization; P:brain development; P:cognition;|Q9ULL8 A7E2X9 D6RFW0 Q96LA0,Protein Shroom4,Second homolog of apical protein;, PF08687;PF00595;, GO:0005884;GO:0005912;GO:0043296;GO:0016324;GO:0009925;GO:0030864;GO:0005737;GO:0009898;GO:0005925;GO:0043231;GO:0005654;GO:0001725;GO:0051015;GO:0045159;GO:0030036;GO:0007015;GO:0007420;GO:0050890;, C:actin filament; C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:basal plasma membrane; C:cortical actin cytoskeleton; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:focal adhesion; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:stress fiber;, F:actin filament binding; F:myosin II binding;, P:actin cytoskeleton organization; P:actin filament organization; P:brain development; P:cognition; scaffold145 indexed_genome mRNA 1669603 1674900 . - . ID=transcript_14602;Q96G61 Q9NVN0,Diphosphoinositol polyphosphate phosphohydrolase 3-beta {ECO:0000305},Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-beta;Diadenosine hexaphosphate hydrolase (AMP-forming);Nucleoside diphosphate-linked moiety X motif 11;hAps1;, PF00293;, GO:0005737;GO:0005829;GO:0005634;GO:0034431;GO:0034432;GO:0008486;GO:0000298;GO:0052842;GO:0052840;GO:0050072;GO:0046872;GO:1901911;GO:1901909;GO:1901907;GO:0071543;GO:0043647;, C:cytoplasm; C:cytosol; C:nucleus;, F:bis(5'-adenosyl)-hexaphosphatase activity; F:bis(5'-adenosyl)-pentaphosphatase activity; F:diphosphoinositol-polyphosphate diphosphatase activity; F:endopolyphosphatase activity; F:inositol diphosphate pentakisphosphate diphosphatase activity; F:inositol diphosphate tetrakisphosphate diphosphatase activity; F:m7G(5')pppN diphosphatase activity; F:metal ion binding;, P:adenosine 5'-(hexahydrogen pentaphosphate) catabolic process; P:diadenosine hexaphosphate catabolic process; P:diadenosine pentaphosphate catabolic process; P:diphosphoinositol polyphosphate metabolic process; P:inositol phosphate metabolic process; scaffold145 indexed_genome mRNA 2001801 2004342 . - . ID=transcript_14603;Q8IYD1 Q9H909 Q9NVY0 Q9NY44,Eukaryotic peptide chain release factor GTP-binding subunit ERF3B,G1 to S phase transition protein 2 homolog;, PF00009;PF03143;PF07145;, GO:0005829;GO:0018444;GO:0005525;GO:0003924;GO:0003723;GO:0003747;GO:0007049;GO:0002184;GO:0000184;GO:0006412;, C:cytosol; C:translation release factor complex;, F:GTP binding; F:GTPase activity; F:RNA binding; F:translation release factor activity;, P:cell cycle; P:cytoplasmic translational termination; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:translation; scaffold145 indexed_genome mRNA 2112125 2112886 . + . ID=transcript_14604;Q8NCK3 B4DSE6 Q96CL0,Zinc finger protein 485,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold145 indexed_genome mRNA 2147176 2153306 . + . ID=transcript_14605;Q9Y5V3 Q5VSH6 Q8IZ84 Q8WY92 Q9H352 Q9HBT4 Q9UF36,Melanoma-associated antigen D1,MAGE tumor antigen CCF;MAGE-D1 antigen;Neurotrophin receptor-interacting MAGE homolog;, PF01454;, GO:0000785;GO:0005737;GO:0005634;GO:0005886;GO:0032991;GO:0042802;GO:0032922;GO:0050680;GO:0042981;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:identical protein binding;, P:circadian regulation of gene expression; P:negative regulation of epithelial cell proliferation; P:regulation of apoptotic process; P:regulation of transcription, DNA-templated;|Q9Y5V3 Q5VSH6 Q8IZ84 Q8WY92 Q9H352 Q9HBT4 Q9UF36,Melanoma-associated antigen D1,MAGE tumor antigen CCF;MAGE-D1 antigen;Neurotrophin receptor-interacting MAGE homolog;, PF01454;, GO:0000785;GO:0005737;GO:0005634;GO:0005886;GO:0032991;GO:0042802;GO:0032922;GO:0050680;GO:0042981;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:identical protein binding;, P:circadian regulation of gene expression; P:negative regulation of epithelial cell proliferation; P:regulation of apoptotic process; P:regulation of transcription, DNA-templated;|Q9Y5V3 Q5VSH6 Q8IZ84 Q8WY92 Q9H352 Q9HBT4 Q9UF36,Melanoma-associated antigen D1,MAGE tumor antigen CCF;MAGE-D1 antigen;Neurotrophin receptor-interacting MAGE homolog;, PF01454;, GO:0000785;GO:0005737;GO:0005634;GO:0005886;GO:0032991;GO:0042802;GO:0032922;GO:0050680;GO:0042981;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:identical protein binding;, P:circadian regulation of gene expression; P:negative regulation of epithelial cell proliferation; P:regulation of apoptotic process; P:regulation of transcription, DNA-templated;|Q9Y5V3 Q5VSH6 Q8IZ84 Q8WY92 Q9H352 Q9HBT4 Q9UF36,Melanoma-associated antigen D1,MAGE tumor antigen CCF;MAGE-D1 antigen;Neurotrophin receptor-interacting MAGE homolog;, PF01454;, GO:0000785;GO:0005737;GO:0005634;GO:0005886;GO:0032991;GO:0042802;GO:0032922;GO:0050680;GO:0042981;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:identical protein binding;, P:circadian regulation of gene expression; P:negative regulation of epithelial cell proliferation; P:regulation of apoptotic process; P:regulation of transcription, DNA-templated; scaffold145 indexed_genome mRNA 2358959 2366488 . - . ID=transcript_14606;Q96JG8 A8K093 Q5HYN6 Q8WXW4 Q9BQ84 Q9BVH1 Q9BYH3 Q9BYH4 Q9H217,Melanoma-associated antigen D4,MAGE-D4 antigen;MAGE-E1 antigen;, PF01454;|Q96JG8 A8K093 Q5HYN6 Q8WXW4 Q9BQ84 Q9BVH1 Q9BYH3 Q9BYH4 Q9H217,Melanoma-associated antigen D4,MAGE-D4 antigen;MAGE-E1 antigen;, PF01454; scaffold146 indexed_genome mRNA 2153827 2180218 . + . ID=transcript_14607;P0DMC3,Apelin receptor early endogenous ligand {ECO:0000312|HGNC:HGNC:48925},Protein Elabela {ECO:0000250|UniProtKB:P0DMC2};Protein Toddler {ECO:0000250|UniProtKB:P0DMC2};, , GO:0005576;GO:0005615;GO:0031704;GO:0005179;GO:0007512;GO:0001525;GO:0060183;GO:0090134;GO:0060976;GO:0035050;GO:0007492;GO:0007507;GO:0090133;GO:0007509;GO:0060674;GO:0045766;GO:1903589;GO:0070374;GO:1904022;GO:0045823;GO:1901165;GO:0001570;, C:extracellular region; C:extracellular space;, F:apelin receptor binding; F:hormone activity;, P:adult heart development; P:angiogenesis; P:apelin receptor signaling pathway; P:cell migration involved in mesendoderm migration; P:coronary vasculature development; P:embryonic heart tube development; P:endoderm development; P:heart development; P:mesendoderm migration; P:mesoderm migration involved in gastrulation; P:placenta blood vessel development; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of G protein-coupled receptor internalization; P:positive regulation of heart contraction; P:positive regulation of trophoblast cell migration; P:vasculogenesis;|P0DMC3,Apelin receptor early endogenous ligand {ECO:0000312|HGNC:HGNC:48925},Protein Elabela {ECO:0000250|UniProtKB:P0DMC2};Protein Toddler {ECO:0000250|UniProtKB:P0DMC2};, , GO:0005576;GO:0005615;GO:0031704;GO:0005179;GO:0007512;GO:0001525;GO:0060183;GO:0090134;GO:0060976;GO:0035050;GO:0007492;GO:0007507;GO:0090133;GO:0007509;GO:0060674;GO:0045766;GO:1903589;GO:0070374;GO:1904022;GO:0045823;GO:1901165;GO:0001570;, C:extracellular region; C:extracellular space;, F:apelin receptor binding; F:hormone activity;, P:adult heart development; P:angiogenesis; P:apelin receptor signaling pathway; P:cell migration involved in mesendoderm migration; P:coronary vasculature development; P:embryonic heart tube development; P:endoderm development; P:heart development; P:mesendoderm migration; P:mesoderm migration involved in gastrulation; P:placenta blood vessel development; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of G protein-coupled receptor internalization; P:positive regulation of heart contraction; P:positive regulation of trophoblast cell migration; P:vasculogenesis; scaffold146 indexed_genome mRNA 2215602 2216905 . + . ID=transcript_14608;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold146 indexed_genome mRNA 2237172 2237909 . + . ID=transcript_14609;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold146 indexed_genome mRNA 2249513 2257216 . - . ID=transcript_14610;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold147 indexed_genome mRNA 75071 110292 . - . ID=transcript_14611;Q86VB7 C9JIG2 Q07898 Q07899 Q07900 Q07901 Q2VLH7,Scavenger receptor cysteine-rich type 1 protein M130,Hemoglobin scavenger receptor;, PF00530;, GO:0005829;GO:0030666;GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0005044;GO:0006953;GO:0002862;GO:0006898;, C:cytosol; C:endocytic vesicle membrane; C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:scavenger receptor activity;, P:acute-phase response; P:negative regulation of inflammatory response to antigenic stimulus; P:receptor-mediated endocytosis;|Q86VB7 C9JIG2 Q07898 Q07899 Q07900 Q07901 Q2VLH7,Scavenger receptor cysteine-rich type 1 protein M130,Hemoglobin scavenger receptor;, PF00530;, GO:0005829;GO:0030666;GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0005044;GO:0006953;GO:0002862;GO:0006898;, C:cytosol; C:endocytic vesicle membrane; C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:scavenger receptor activity;, P:acute-phase response; P:negative regulation of inflammatory response to antigenic stimulus; P:receptor-mediated endocytosis; scaffold147 indexed_genome mRNA 244899 260698 . - . ID=transcript_14612;Q6EIG7 A2RUK3,C-type lectin domain family 6 member A {ECO:0000305},C-type lectin superfamily member 10;Dendritic cell-associated C-type lectin 2;, PF00059;, GO:0016021;GO:0005886;GO:0005509;GO:0030246;GO:0005537;GO:0002250;GO:0050832;GO:0045087;GO:0001819;GO:0043123;GO:0002223;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:carbohydrate binding; F:mannose binding;, P:adaptive immune response; P:defense response to fungus; P:innate immune response; P:positive regulation of cytokine production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:stimulatory C-type lectin receptor signaling pathway; scaffold147 indexed_genome mRNA 272142 275447 . - . ID=transcript_14613;Q9UMR7 Q17R69 Q8WXW9 Q9H2Z9 Q9NS33 Q9UI34,C-type lectin domain family 4 member A {ECO:0000305},C-type lectin DDB27;C-type lectin superfamily member 6;Dendritic cell immunoreceptor;Lectin-like immunoreceptor;, PF00059;, GO:0005887;GO:0005886;GO:0005509;GO:0030246;GO:0005537;GO:0004888;GO:0002250;GO:0042590;GO:0036037;GO:0007155;GO:0007166;GO:0045087;GO:0001818;GO:0032720;GO:0002470;GO:0002223;GO:0016032;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:carbohydrate binding; F:mannose binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; P:CD8-positive, alpha-beta T cell activation; P:cell adhesion; P:cell surface receptor signaling pathway; P:innate immune response; P:negative regulation of cytokine production; P:negative regulation of tumor necrosis factor production; P:plasmacytoid dendritic cell antigen processing and presentation; P:stimulatory C-type lectin receptor signaling pathway; P:viral process; scaffold147 indexed_genome mRNA 299373 305703 . - . ID=transcript_14614;Q8NC96 Q2NL73 Q5XG95 Q6NWY6 Q8N153 Q8NCB0 Q9BU52 Q9Y407,Adaptin ear-binding coat-associated protein 1,NECAP endocytosis-associated protein 1;, PF07933;, GO:0030125;GO:0005905;GO:0005829;GO:0006897;GO:0061024;GO:0015031;GO:0016192;, C:clathrin vesicle coat; C:clathrin-coated pit; C:cytosol;, , P:endocytosis; P:membrane organization; P:protein transport; P:vesicle-mediated transport;|Q8NC96 Q2NL73 Q5XG95 Q6NWY6 Q8N153 Q8NCB0 Q9BU52 Q9Y407,Adaptin ear-binding coat-associated protein 1,NECAP endocytosis-associated protein 1;, PF07933;, GO:0030125;GO:0005905;GO:0005829;GO:0006897;GO:0061024;GO:0015031;GO:0016192;, C:clathrin vesicle coat; C:clathrin-coated pit; C:cytosol;, , P:endocytosis; P:membrane organization; P:protein transport; P:vesicle-mediated transport; scaffold147 indexed_genome mRNA 333706 335530 . - . ID=transcript_14615;Q16581 O43771 Q92868,C3a anaphylatoxin chemotactic receptor,, PF00001;, GO:0035577;GO:0005887;GO:0005886;GO:0035579;GO:0004876;GO:0004875;GO:0004930;GO:0008015;GO:0006935;GO:0002430;GO:0007186;GO:0006954;GO:0043312;GO:0007200;GO:0045766;GO:0007204;GO:0051482;GO:0010759;GO:0090023;GO:0010575;GO:0035590;GO:0030449;, C:azurophil granule membrane; C:integral component of plasma membrane; C:plasma membrane; C:specific granule membrane;, F:complement component C3a receptor activity; F:complement receptor activity; F:G protein-coupled receptor activity;, P:blood circulation; P:chemotaxis; P:complement receptor mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:neutrophil degranulation; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of macrophage chemotaxis; P:positive regulation of neutrophil chemotaxis; P:positive regulation of vascular endothelial growth factor production; P:purinergic nucleotide receptor signaling pathway; P:regulation of complement activation; scaffold147 indexed_genome mRNA 340493 349740 . - . ID=transcript_14616;Q9P0K8 A0AVK4 B2RMP3 Q96PS9 Q9NSN5,Forkhead box protein J2,Fork head homologous X;, PF00250;, GO:0000785;GO:0001650;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0000978;GO:0043565;GO:1990837;GO:0007141;GO:0016525;GO:0110059;GO:0045944;GO:0045893;GO:1904707;GO:0006357;GO:0007283;, C:chromatin; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:male meiosis I; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9P0K8 A0AVK4 B2RMP3 Q96PS9 Q9NSN5,Forkhead box protein J2,Fork head homologous X;, PF00250;, GO:0000785;GO:0001650;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0000978;GO:0043565;GO:1990837;GO:0007141;GO:0016525;GO:0110059;GO:0045944;GO:0045893;GO:1904707;GO:0006357;GO:0007283;, C:chromatin; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:male meiosis I; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9P0K8 A0AVK4 B2RMP3 Q96PS9 Q9NSN5,Forkhead box protein J2,Fork head homologous X;, PF00250;, GO:0000785;GO:0001650;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0000978;GO:0043565;GO:1990837;GO:0007141;GO:0016525;GO:0110059;GO:0045944;GO:0045893;GO:1904707;GO:0006357;GO:0007283;, C:chromatin; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:male meiosis I; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular associated smooth muscle cell proliferation; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold147 indexed_genome mRNA 453830 466525 . + . ID=transcript_14617;P11169 B2R606 D3DUU6 Q6I9U2 Q9UG15,Solute carrier family 2, facilitated glucose transporter member 3 {ECO:0000305},Glucose transporter type 3, brain {ECO:0000303|PubMed:9477959};, PF00083;, GO:0042995;GO:0070062;GO:0101003;GO:0016021;GO:0005887;GO:0043204;GO:0005886;GO:0030667;GO:0035579;GO:0070821;GO:0005536;GO:0005355;GO:0005975;GO:0098708;GO:1904659;GO:0019852;GO:0043312;GO:0150104;, C:cell projection; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:integral component of plasma membrane; C:perikaryon; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane; C:tertiary granule membrane;, F:glucose binding; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:glucose import across plasma membrane; P:glucose transmembrane transport; P:L-ascorbic acid metabolic process; P:neutrophil degranulation; P:transport across blood-brain barrier;|Q8TDB8 B3KVB5 B3KWW7 B7Z844 B7ZAC3 Q6UY84 Q8TDB9,Solute carrier family 2, facilitated glucose transporter member 14 {ECO:0000305},Glucose transporter type 14 {ECO:0000303|PubMed:12504846};, PF00083;, GO:0016021;GO:0005634;GO:0005886;GO:0033300;GO:0005355;GO:0030154;GO:0070837;GO:1904659;GO:0007275;GO:0007283;, C:integral component of membrane; C:nucleus; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:cell differentiation; P:dehydroascorbic acid transport; P:glucose transmembrane transport; P:multicellular organism development; P:spermatogenesis;|P11169 B2R606 D3DUU6 Q6I9U2 Q9UG15,Solute carrier family 2, facilitated glucose transporter member 3 {ECO:0000305},Glucose transporter type 3, brain {ECO:0000303|PubMed:9477959};, PF00083;, GO:0042995;GO:0070062;GO:0101003;GO:0016021;GO:0005887;GO:0043204;GO:0005886;GO:0030667;GO:0035579;GO:0070821;GO:0005536;GO:0005355;GO:0005975;GO:0098708;GO:1904659;GO:0019852;GO:0043312;GO:0150104;, C:cell projection; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:integral component of plasma membrane; C:perikaryon; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane; C:tertiary granule membrane;, F:glucose binding; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:glucose import across plasma membrane; P:glucose transmembrane transport; P:L-ascorbic acid metabolic process; P:neutrophil degranulation; P:transport across blood-brain barrier;|P11169 B2R606 D3DUU6 Q6I9U2 Q9UG15,Solute carrier family 2, facilitated glucose transporter member 3 {ECO:0000305},Glucose transporter type 3, brain {ECO:0000303|PubMed:9477959};, PF00083;, GO:0042995;GO:0070062;GO:0101003;GO:0016021;GO:0005887;GO:0043204;GO:0005886;GO:0030667;GO:0035579;GO:0070821;GO:0005536;GO:0005355;GO:0005975;GO:0098708;GO:1904659;GO:0019852;GO:0043312;GO:0150104;, C:cell projection; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:integral component of plasma membrane; C:perikaryon; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane; C:tertiary granule membrane;, F:glucose binding; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:glucose import across plasma membrane; P:glucose transmembrane transport; P:L-ascorbic acid metabolic process; P:neutrophil degranulation; P:transport across blood-brain barrier;|P11169 B2R606 D3DUU6 Q6I9U2 Q9UG15,Solute carrier family 2, facilitated glucose transporter member 3 {ECO:0000305},Glucose transporter type 3, brain {ECO:0000303|PubMed:9477959};, PF00083;, GO:0042995;GO:0070062;GO:0101003;GO:0016021;GO:0005887;GO:0043204;GO:0005886;GO:0030667;GO:0035579;GO:0070821;GO:0005536;GO:0005355;GO:0005975;GO:0098708;GO:1904659;GO:0019852;GO:0043312;GO:0150104;, C:cell projection; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of membrane; C:integral component of plasma membrane; C:perikaryon; C:plasma membrane; C:secretory granule membrane; C:specific granule membrane; C:tertiary granule membrane;, F:glucose binding; F:glucose transmembrane transporter activity;, P:carbohydrate metabolic process; P:glucose import across plasma membrane; P:glucose transmembrane transport; P:L-ascorbic acid metabolic process; P:neutrophil degranulation; P:transport across blood-brain barrier;|Q8TDB8 B3KVB5 B3KWW7 B7Z844 B7ZAC3 Q6UY84 Q8TDB9,Solute carrier family 2, facilitated glucose transporter member 14 {ECO:0000305},Glucose transporter type 14 {ECO:0000303|PubMed:12504846};, PF00083;, GO:0016021;GO:0005634;GO:0005886;GO:0033300;GO:0005355;GO:0030154;GO:0070837;GO:1904659;GO:0007275;GO:0007283;, C:integral component of membrane; C:nucleus; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:cell differentiation; P:dehydroascorbic acid transport; P:glucose transmembrane transport; P:multicellular organism development; P:spermatogenesis; scaffold147 indexed_genome mRNA 559576 560569 . + . ID=transcript_14618;Q86XS8 J3KN31 Q32P32 Q59EL1 Q641P9 Q6P177 Q7L2U2 Q9P0J9,E3 ubiquitin-protein ligase RNF130,Goliath homolog;RING finger protein 130;RING-type E3 ubiquitin transferase RNF130 {ECO:0000305};, PF02225;PF13639;, GO:0005737;GO:0016021;GO:0046872;GO:0061630;GO:0004842;GO:0006915;GO:0012501;GO:0006511;, C:cytoplasm; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:programmed cell death; P:ubiquitin-dependent protein catabolic process; scaffold147 indexed_genome mRNA 683478 704975 . - . ID=transcript_14619;Q13361 B0AZL6 D3DUV1 Q7Z490,Microfibrillar-associated protein 5,MP25;Microfibril-associated glycoprotein 2;, PF05507;, GO:0062023;GO:0005576;GO:0001527;GO:0005201;GO:0060216;GO:0048048;GO:0030198;GO:0097435;, C:collagen-containing extracellular matrix; C:extracellular region; C:microfibril;, F:extracellular matrix structural constituent;, P:definitive hemopoiesis; P:embryonic eye morphogenesis; P:extracellular matrix organization; P:supramolecular fiber organization;|Q13361 B0AZL6 D3DUV1 Q7Z490,Microfibrillar-associated protein 5,MP25;Microfibril-associated glycoprotein 2;, PF05507;, GO:0062023;GO:0005576;GO:0001527;GO:0005201;GO:0060216;GO:0048048;GO:0030198;GO:0097435;, C:collagen-containing extracellular matrix; C:extracellular region; C:microfibril;, F:extracellular matrix structural constituent;, P:definitive hemopoiesis; P:embryonic eye morphogenesis; P:extracellular matrix organization; P:supramolecular fiber organization;|Q13361 B0AZL6 D3DUV1 Q7Z490,Microfibrillar-associated protein 5,MP25;Microfibril-associated glycoprotein 2;, PF05507;, GO:0062023;GO:0005576;GO:0001527;GO:0005201;GO:0060216;GO:0048048;GO:0030198;GO:0097435;, C:collagen-containing extracellular matrix; C:extracellular region; C:microfibril;, F:extracellular matrix structural constituent;, P:definitive hemopoiesis; P:embryonic eye morphogenesis; P:extracellular matrix organization; P:supramolecular fiber organization; scaffold147 indexed_genome mRNA 755461 766823 . + . ID=transcript_14620;Q9ULI2 B7Z834 D3DUV2 Q8N4P4 Q8WTW6,Beta-citrylglutamate synthase B,N-acetyl-aspartylglutamate synthetase B;Ribosomal protein S6 modification-like protein B;, PF08443;, GO:0005737;GO:0005829;GO:0005524;GO:0072591;GO:0016879;GO:0046872;GO:0072590;GO:0006464;GO:0009064;, C:cytoplasm; C:cytosol;, F:ATP binding; F:citrate-L-glutamate ligase activity; F:ligase activity, forming carbon-nitrogen bonds; F:metal ion binding; F:N-acetyl-L-aspartate-L-glutamate ligase activity;, P:cellular protein modification process; P:glutamine family amino acid metabolic process; scaffold147 indexed_genome mRNA 863489 888112 . + . ID=transcript_14621;P78364 D3DUV4 Q8WVM3 Q9BU63,Polyhomeotic-like protein 1,Early development regulatory protein 1;, PF00536;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0008270;GO:0016574;GO:0007275;GO:0070317;GO:0045892;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:zinc ion binding;, P:histone ubiquitination; P:multicellular organism development; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated;|P78364 D3DUV4 Q8WVM3 Q9BU63,Polyhomeotic-like protein 1,Early development regulatory protein 1;, PF00536;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0008270;GO:0016574;GO:0007275;GO:0070317;GO:0045892;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:zinc ion binding;, P:histone ubiquitination; P:multicellular organism development; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated;|P78364 D3DUV4 Q8WVM3 Q9BU63,Polyhomeotic-like protein 1,Early development regulatory protein 1;, PF00536;, GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0003677;GO:0042393;GO:0008270;GO:0016574;GO:0007275;GO:0070317;GO:0045892;, C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:DNA binding; F:histone binding; F:zinc ion binding;, P:histone ubiquitination; P:multicellular organism development; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription, DNA-templated; scaffold147 indexed_genome mRNA 888122 903761 . - . ID=transcript_14622;P20645 A8K528 D3DUV5,Cation-dependent mannose-6-phosphate receptor,46 kDa mannose 6-phosphate receptor;, PF02157;, GO:0030669;GO:0005768;GO:0005887;GO:0005770;GO:0005765;GO:0016020;GO:0048471;GO:0005886;GO:0005802;GO:0032588;GO:0030133;GO:0019904;GO:1905394;GO:0004888;GO:0008333;GO:0007041;GO:0061024;GO:0006622;GO:0006898;GO:0033299;, C:clathrin-coated endocytic vesicle membrane; C:endosome; C:integral component of plasma membrane; C:late endosome; C:lysosomal membrane; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:transport vesicle;, F:protein domain specific binding; F:retromer complex binding; F:transmembrane signaling receptor activity;, P:endosome to lysosome transport; P:lysosomal transport; P:membrane organization; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:secretion of lysosomal enzymes;|P20645 A8K528 D3DUV5,Cation-dependent mannose-6-phosphate receptor,46 kDa mannose 6-phosphate receptor;, PF02157;, GO:0030669;GO:0005768;GO:0005887;GO:0005770;GO:0005765;GO:0016020;GO:0048471;GO:0005886;GO:0005802;GO:0032588;GO:0030133;GO:0019904;GO:1905394;GO:0004888;GO:0008333;GO:0007041;GO:0061024;GO:0006622;GO:0006898;GO:0033299;, C:clathrin-coated endocytic vesicle membrane; C:endosome; C:integral component of plasma membrane; C:late endosome; C:lysosomal membrane; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:transport vesicle;, F:protein domain specific binding; F:retromer complex binding; F:transmembrane signaling receptor activity;, P:endosome to lysosome transport; P:lysosomal transport; P:membrane organization; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:secretion of lysosomal enzymes;|Q9NP50 D3DUV8 Q9BSZ8,SIN3-HDAC complex-associated factor {ECO:0000312|HGNC:HGNC:30702},Protein FAM60A;Tera protein homolog;, PF15396;, GO:0016580;GO:0045596;GO:0030336;GO:0008284;, C:Sin3 complex;, , P:negative regulation of cell differentiation; P:negative regulation of cell migration; P:positive regulation of cell population proliferation;|P62753 P08227 P10660 Q4VBY7 Q8N6Z7,40S ribosomal protein S6 {ECO:0000303|PubMed:29563586},Phosphoprotein NP33;Small ribosomal subunit protein eS6 {ECO:0000303|PubMed:24524803};, PF01092;, GO:0044297;GO:0036464;GO:0005829;GO:0022627;GO:0030425;GO:0005783;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005844;GO:1990904;GO:0015935;GO:0019901;GO:0003723;GO:0003735;GO:0006924;GO:0048821;GO:0000082;GO:0007369;GO:0042593;GO:0022605;GO:0043066;GO:0000184;GO:0001890;GO:0043065;GO:0008284;GO:0042274;GO:0006364;GO:0006614;GO:0033077;GO:0002309;GO:0031929;GO:0006412;GO:0006413;GO:0019083;, C:cell body; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic small ribosomal subunit; C:dendrite; C:endoplasmic reticulum; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:polysome; C:ribonucleoprotein complex; C:small ribosomal subunit;, F:protein kinase binding; F:RNA binding; F:structural constituent of ribosome;, P:activation-induced cell death of T cells; P:erythrocyte development; P:G1/S transition of mitotic cell cycle; P:gastrulation; P:glucose homeostasis; P:mammalian oogenesis stage; P:negative regulation of apoptotic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:placenta development; P:positive regulation of apoptotic process; P:positive regulation of cell population proliferation; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:T cell differentiation in thymus; P:T cell proliferation involved in immune response; P:TOR signaling; P:translation; P:translational initiation; P:viral transcription; scaffold147 indexed_genome mRNA 1013606 1014189 . + . ID=transcript_14623;P01023 Q13677 Q59F47 Q5QTS0 Q68DN2 Q6PIY3 Q6PN97,Alpha-2-macroglobulin,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5;, PF00207;PF07703;PF07677;PF01835;PF17791;PF17789;PF07678;, GO:0072562;GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0048306;GO:0004866;GO:0019899;GO:0019838;GO:0019966;GO:0019959;GO:0002020;GO:0004867;GO:0005102;GO:0043120;GO:0022617;GO:2000267;GO:0001869;GO:0002576;GO:0051056;GO:0048863;, C:blood microparticle; C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:calcium-dependent protein binding; F:endopeptidase inhibitor activity; F:enzyme binding; F:growth factor binding; F:interleukin-1 binding; F:interleukin-8 binding; F:protease binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding; F:tumor necrosis factor binding;, P:extracellular matrix disassembly; P:negative regulation of blood coagulation, intrinsic pathway; P:negative regulation of complement activation, lectin pathway; P:platelet degranulation; P:regulation of small GTPase mediated signal transduction; P:stem cell differentiation; scaffold147 indexed_genome mRNA 1016827 1057231 . - . ID=transcript_14624;P01023 Q13677 Q59F47 Q5QTS0 Q68DN2 Q6PIY3 Q6PN97,Alpha-2-macroglobulin,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5;, PF00207;PF07703;PF07677;PF01835;PF17791;PF17789;PF07678;, GO:0072562;GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0048306;GO:0004866;GO:0019899;GO:0019838;GO:0019966;GO:0019959;GO:0002020;GO:0004867;GO:0005102;GO:0043120;GO:0022617;GO:2000267;GO:0001869;GO:0002576;GO:0051056;GO:0048863;, C:blood microparticle; C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:calcium-dependent protein binding; F:endopeptidase inhibitor activity; F:enzyme binding; F:growth factor binding; F:interleukin-1 binding; F:interleukin-8 binding; F:protease binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding; F:tumor necrosis factor binding;, P:extracellular matrix disassembly; P:negative regulation of blood coagulation, intrinsic pathway; P:negative regulation of complement activation, lectin pathway; P:platelet degranulation; P:regulation of small GTPase mediated signal transduction; P:stem cell differentiation; scaffold147 indexed_genome mRNA 1095403 1151157 . - . ID=transcript_14625;P01023 Q13677 Q59F47 Q5QTS0 Q68DN2 Q6PIY3 Q6PN97,Alpha-2-macroglobulin,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5;, PF00207;PF07703;PF07677;PF01835;PF17791;PF17789;PF07678;, GO:0072562;GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0048306;GO:0004866;GO:0019899;GO:0019838;GO:0019966;GO:0019959;GO:0002020;GO:0004867;GO:0005102;GO:0043120;GO:0022617;GO:2000267;GO:0001869;GO:0002576;GO:0051056;GO:0048863;, C:blood microparticle; C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:calcium-dependent protein binding; F:endopeptidase inhibitor activity; F:enzyme binding; F:growth factor binding; F:interleukin-1 binding; F:interleukin-8 binding; F:protease binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding; F:tumor necrosis factor binding;, P:extracellular matrix disassembly; P:negative regulation of blood coagulation, intrinsic pathway; P:negative regulation of complement activation, lectin pathway; P:platelet degranulation; P:regulation of small GTPase mediated signal transduction; P:stem cell differentiation;|P20742 A6ND27 Q15273 Q2NKL2 Q7M4N7,Pregnancy zone protein,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6;, PF00207;PF07703;PF07677;PF01835;PF17791;PF17789;PF07678;, GO:0072562;GO:0070062;GO:0005576;GO:0004866;GO:0002020;GO:0004867;GO:0007565;, C:blood microparticle; C:extracellular exosome; C:extracellular region;, F:endopeptidase inhibitor activity; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:female pregnancy;|P20742 A6ND27 Q15273 Q2NKL2 Q7M4N7,Pregnancy zone protein,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6;, PF00207;PF07703;PF07677;PF01835;PF17791;PF17789;PF07678;, GO:0072562;GO:0070062;GO:0005576;GO:0004866;GO:0002020;GO:0004867;GO:0007565;, C:blood microparticle; C:extracellular exosome; C:extracellular region;, F:endopeptidase inhibitor activity; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:female pregnancy;|P01023 Q13677 Q59F47 Q5QTS0 Q68DN2 Q6PIY3 Q6PN97,Alpha-2-macroglobulin,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5;, PF00207;PF07703;PF07677;PF01835;PF17791;PF17789;PF07678;, GO:0072562;GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0048306;GO:0004866;GO:0019899;GO:0019838;GO:0019966;GO:0019959;GO:0002020;GO:0004867;GO:0005102;GO:0043120;GO:0022617;GO:2000267;GO:0001869;GO:0002576;GO:0051056;GO:0048863;, C:blood microparticle; C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:calcium-dependent protein binding; F:endopeptidase inhibitor activity; F:enzyme binding; F:growth factor binding; F:interleukin-1 binding; F:interleukin-8 binding; F:protease binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding; F:tumor necrosis factor binding;, P:extracellular matrix disassembly; P:negative regulation of blood coagulation, intrinsic pathway; P:negative regulation of complement activation, lectin pathway; P:platelet degranulation; P:regulation of small GTPase mediated signal transduction; P:stem cell differentiation;|P20742 A6ND27 Q15273 Q2NKL2 Q7M4N7,Pregnancy zone protein,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6;, PF00207;PF07703;PF07677;PF01835;PF17791;PF17789;PF07678;, GO:0072562;GO:0070062;GO:0005576;GO:0004866;GO:0002020;GO:0004867;GO:0007565;, C:blood microparticle; C:extracellular exosome; C:extracellular region;, F:endopeptidase inhibitor activity; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:female pregnancy;|P20742 A6ND27 Q15273 Q2NKL2 Q7M4N7,Pregnancy zone protein,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6;, PF00207;PF07703;PF07677;PF01835;PF17791;PF17789;PF07678;, GO:0072562;GO:0070062;GO:0005576;GO:0004866;GO:0002020;GO:0004867;GO:0007565;, C:blood microparticle; C:extracellular exosome; C:extracellular region;, F:endopeptidase inhibitor activity; F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:female pregnancy;|P01023 Q13677 Q59F47 Q5QTS0 Q68DN2 Q6PIY3 Q6PN97,Alpha-2-macroglobulin,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5;, PF00207;PF07703;PF07677;PF01835;PF17791;PF17789;PF07678;, GO:0072562;GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0031093;GO:0048306;GO:0004866;GO:0019899;GO:0019838;GO:0019966;GO:0019959;GO:0002020;GO:0004867;GO:0005102;GO:0043120;GO:0022617;GO:2000267;GO:0001869;GO:0002576;GO:0051056;GO:0048863;, C:blood microparticle; C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:calcium-dependent protein binding; F:endopeptidase inhibitor activity; F:enzyme binding; F:growth factor binding; F:interleukin-1 binding; F:interleukin-8 binding; F:protease binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding; F:tumor necrosis factor binding;, P:extracellular matrix disassembly; P:negative regulation of blood coagulation, intrinsic pathway; P:negative regulation of complement activation, lectin pathway; P:platelet degranulation; P:regulation of small GTPase mediated signal transduction; P:stem cell differentiation; scaffold147 indexed_genome mRNA 1173874 1180222 . - . ID=transcript_14626;Q6IE37,Ovostatin homolog 1,, PF00207;PF07703;PF07677;PF17791;PF17789;PF07678;, GO:0005615;GO:0004867;, C:extracellular space;, F:serine-type endopeptidase inhibitor activity; scaffold147 indexed_genome mRNA 1190978 1200319 . + . ID=transcript_14627;Q6IE37,Ovostatin homolog 1,, PF00207;PF07703;PF07677;PF17791;PF17789;PF07678;, GO:0005615;GO:0004867;, C:extracellular space;, F:serine-type endopeptidase inhibitor activity; scaffold147 indexed_genome mRNA 1306070 1313882 . - . ID=transcript_14628;Q12918 Q24K24,Killer cell lectin-like receptor subfamily B member 1,C-type lectin domain family 5 member B;HNKR-P1a;Natural killer cell surface protein P1A;, PF00059;, GO:0016021;GO:0005886;GO:0030246;GO:0004888;GO:0007166;GO:0050776;, C:integral component of membrane; C:plasma membrane;, F:carbohydrate binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:regulation of immune response; scaffold147 indexed_genome mRNA 1340549 1349941 . + . ID=transcript_14629;Q9UHP7 D6CI39 D6CI40 D6CI41 Q6YID5 Q8WUP7 Q9HD37 Q9HD38,C-type lectin domain family 2 member D,Lectin-like NK cell receptor;Lectin-like transcript 1;Osteoclast inhibitory lectin;, PF00059;, GO:0009986;GO:0005783;GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0030246;GO:0046703;GO:0004888;GO:0007166;GO:0050776;, C:cell surface; C:endoplasmic reticulum; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:carbohydrate binding; F:natural killer cell lectin-like receptor binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:regulation of immune response;|Q9UHP7 D6CI39 D6CI40 D6CI41 Q6YID5 Q8WUP7 Q9HD37 Q9HD38,C-type lectin domain family 2 member D,Lectin-like NK cell receptor;Lectin-like transcript 1;Osteoclast inhibitory lectin;, PF00059;, GO:0009986;GO:0005783;GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0030246;GO:0046703;GO:0004888;GO:0007166;GO:0050776;, C:cell surface; C:endoplasmic reticulum; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:carbohydrate binding; F:natural killer cell lectin-like receptor binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:regulation of immune response;|Q9UHP7 D6CI39 D6CI40 D6CI41 Q6YID5 Q8WUP7 Q9HD37 Q9HD38,C-type lectin domain family 2 member D,Lectin-like NK cell receptor;Lectin-like transcript 1;Osteoclast inhibitory lectin;, PF00059;, GO:0009986;GO:0005783;GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0030246;GO:0046703;GO:0004888;GO:0007166;GO:0050776;, C:cell surface; C:endoplasmic reticulum; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:carbohydrate binding; F:natural killer cell lectin-like receptor binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:regulation of immune response; scaffold147 indexed_genome mRNA 1464218 1480111 . - . ID=transcript_14630;Q9NZS2 A0A0C4DGY9 Q4KMT5 Q96PR2 Q96PR3 Q9NZS1,Killer cell lectin-like receptor subfamily F member 1,Activating coreceptor NKp80;C-type lectin domain family 5 member C;, PF00059;, GO:0005887;GO:0016020;GO:0005886;GO:0030246;GO:0032393;GO:0004888;GO:0007166;GO:0050776;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:carbohydrate binding; F:MHC class I receptor activity; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:regulation of immune response; scaffold147 indexed_genome mRNA 1499742 1506387 . - . ID=transcript_14631;Q07108,Early activation antigen CD69,Activation inducer molecule;BL-AC/P26;C-type lectin domain family 2 member C;EA1;Early T-cell activation antigen p60;GP32/28;Leukocyte surface antigen Leu-23;MLR-3;, PF00059;, GO:0009897;GO:0005887;GO:0032991;GO:0005509;GO:0030246;GO:0042802;GO:0004888;, C:external side of plasma membrane; C:integral component of plasma membrane; C:protein-containing complex;, F:calcium ion binding; F:carbohydrate binding; F:identical protein binding; F:transmembrane signaling receptor activity; scaffold147 indexed_genome mRNA 1559011 1563922 . + . ID=transcript_14632;Q9NZS2 A0A0C4DGY9 Q4KMT5 Q96PR2 Q96PR3 Q9NZS1,Killer cell lectin-like receptor subfamily F member 1,Activating coreceptor NKp80;C-type lectin domain family 5 member C;, PF00059;, GO:0005887;GO:0016020;GO:0005886;GO:0030246;GO:0032393;GO:0004888;GO:0007166;GO:0050776;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:carbohydrate binding; F:MHC class I receptor activity; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:regulation of immune response; scaffold147 indexed_genome mRNA 1627456 1638930 . - . ID=transcript_14633;Q9UHP7 D6CI39 D6CI40 D6CI41 Q6YID5 Q8WUP7 Q9HD37 Q9HD38,C-type lectin domain family 2 member D,Lectin-like NK cell receptor;Lectin-like transcript 1;Osteoclast inhibitory lectin;, PF00059;, GO:0009986;GO:0005783;GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0030246;GO:0046703;GO:0004888;GO:0007166;GO:0050776;, C:cell surface; C:endoplasmic reticulum; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:carbohydrate binding; F:natural killer cell lectin-like receptor binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:regulation of immune response; scaffold147 indexed_genome mRNA 1655891 1671988 . - . ID=transcript_14634;Q9UHP7 D6CI39 D6CI40 D6CI41 Q6YID5 Q8WUP7 Q9HD37 Q9HD38,C-type lectin domain family 2 member D,Lectin-like NK cell receptor;Lectin-like transcript 1;Osteoclast inhibitory lectin;, PF00059;, GO:0009986;GO:0005783;GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0030246;GO:0046703;GO:0004888;GO:0007166;GO:0050776;, C:cell surface; C:endoplasmic reticulum; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:carbohydrate binding; F:natural killer cell lectin-like receptor binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:regulation of immune response;|Q9UHP7 D6CI39 D6CI40 D6CI41 Q6YID5 Q8WUP7 Q9HD37 Q9HD38,C-type lectin domain family 2 member D,Lectin-like NK cell receptor;Lectin-like transcript 1;Osteoclast inhibitory lectin;, PF00059;, GO:0009986;GO:0005783;GO:0009897;GO:0005887;GO:0016020;GO:0005886;GO:0030246;GO:0046703;GO:0004888;GO:0007166;GO:0050776;, C:cell surface; C:endoplasmic reticulum; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:carbohydrate binding; F:natural killer cell lectin-like receptor binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:regulation of immune response; scaffold147 indexed_genome mRNA 1672601 1673138 . - . ID=transcript_14635;P19784,Casein kinase II subunit alpha',, PF00069;, GO:0001669;GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005956;GO:0005524;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0021987;GO:0097421;GO:0016236;GO:0007076;GO:2001234;GO:2000059;GO:0018105;GO:0018107;GO:0006656;GO:1903955;GO:0006457;GO:1903146;GO:0051726;GO:1905818;GO:1901796;GO:0007283;GO:0016055;, C:acrosomal vesicle; C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein kinase CK2 complex;, F:ATP binding; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:cerebral cortex development; P:liver regeneration; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of protein targeting to mitochondrion; P:protein folding; P:regulation of autophagy of mitochondrion; P:regulation of cell cycle; P:regulation of chromosome separation; P:regulation of signal transduction by p53 class mediator; P:spermatogenesis; P:Wnt signaling pathway; scaffold147 indexed_genome mRNA 1693039 1711805 . - . ID=transcript_14636;Q92478 B2R9U1 Q8IZE9 Q9BS74 Q9UQB4,C-type lectin domain family 2 member B,Activation-induced C-type lectin;C-type lectin superfamily member 2;IFN-alpha-2b-inducing-related protein 1;, PF00059;, GO:0009897;GO:0005887;GO:0005886;GO:0030246;GO:0042802;GO:0050776;, C:external side of plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:carbohydrate binding; F:identical protein binding;, P:regulation of immune response; scaffold147 indexed_genome mRNA 1806460 1818917 . - . ID=transcript_14637;Q5QGZ9 B2RA16 Q6P4H1 Q6RH77 Q6RH78 Q8TDQ6,C-type lectin domain family 12 member A,C-type lectin-like molecule 1;Dendritic cell-associated lectin 2;Myeloid inhibitory C-type lectin-like receptor;, PF00059;, GO:0016021;GO:0005886;GO:0035579;GO:0070821;GO:0030246;GO:0030545;GO:0043312;, C:integral component of membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:carbohydrate binding; F:receptor regulator activity;, P:neutrophil degranulation;|Q5QGZ9 B2RA16 Q6P4H1 Q6RH77 Q6RH78 Q8TDQ6,C-type lectin domain family 12 member A,C-type lectin-like molecule 1;Dendritic cell-associated lectin 2;Myeloid inhibitory C-type lectin-like receptor;, PF00059;, GO:0016021;GO:0005886;GO:0035579;GO:0070821;GO:0030246;GO:0030545;GO:0043312;, C:integral component of membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:carbohydrate binding; F:receptor regulator activity;, P:neutrophil degranulation; scaffold147 indexed_genome mRNA 1855638 1865688 . + . ID=transcript_14638;Q6UXN8 B0ZBM2,C-type lectin domain family 9 member A,, PF00059;, GO:0009986;GO:0016021;GO:0030246;GO:0001819;GO:0006898;, C:cell surface; C:integral component of membrane;, F:carbohydrate binding;, P:positive regulation of cytokine production; P:receptor-mediated endocytosis; scaffold147 indexed_genome mRNA 1871564 1893331 . - . ID=transcript_14639;Q8NC01 Q8IUW7 Q9NZH3,C-type lectin domain family 1 member A,C-type lectin-like receptor 1;, PF00059;, GO:0005887;GO:0005622;GO:0030246;GO:0004888;GO:0007166;GO:0006952;, C:integral component of plasma membrane; C:intracellular anatomical structure;, F:carbohydrate binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:defense response;|Q8NC01 Q8IUW7 Q9NZH3,C-type lectin domain family 1 member A,C-type lectin-like receptor 1;, PF00059;, GO:0005887;GO:0005622;GO:0030246;GO:0004888;GO:0007166;GO:0006952;, C:integral component of plasma membrane; C:intracellular anatomical structure;, F:carbohydrate binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:defense response; scaffold147 indexed_genome mRNA 1929920 1958644 . + . ID=transcript_14640;P78380 A8K7V9 B4DI48 G3V1I4 Q2PP00 Q7Z484,Oxidized low-density lipoprotein receptor 1,C-type lectin domain family 8 member A;Lectin-like oxidized LDL receptor 1;Lectin-type oxidized LDL receptor 1;, PF00059;PF08391;, GO:0005576;GO:0005887;GO:0043231;GO:0016020;GO:0045121;GO:0005654;GO:0005886;GO:0043235;GO:0035579;GO:0070821;GO:0030246;GO:0042802;GO:0005041;GO:0008015;GO:0008219;GO:0006954;GO:0007159;GO:0050900;GO:0042157;GO:0043312;GO:0006508;, C:extracellular region; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:membrane raft; C:nucleoplasm; C:plasma membrane; C:receptor complex; C:specific granule membrane; C:tertiary granule membrane;, F:carbohydrate binding; F:identical protein binding; F:low-density lipoprotein particle receptor activity;, P:blood circulation; P:cell death; P:inflammatory response; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:lipoprotein metabolic process; P:neutrophil degranulation; P:proteolysis; scaffold147 indexed_genome mRNA 1972011 1981433 . + . ID=transcript_14641;Q9H0R8 B4E0Y7 Q6FIE6,Gamma-aminobutyric acid receptor-associated protein-like 1,Early estrogen-regulated protein;GABA(A) receptor-associated protein-like 1;Glandular epithelial cell protein 1;, PF02991;, GO:0005776;GO:0000421;GO:0044297;GO:0030659;GO:0005829;GO:0032839;GO:0032590;GO:0005783;GO:0005794;GO:0005874;GO:0048487;GO:0050811;GO:0030957;GO:0031625;GO:0000045;GO:0097352;GO:0000422;GO:0006995;GO:0016236;, C:autophagosome; C:autophagosome membrane; C:cell body; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite cytoplasm; C:dendrite membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:microtubule;, F:beta-tubulin binding; F:GABA receptor binding; F:Tat protein binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagosome maturation; P:autophagy of mitochondrion; P:cellular response to nitrogen starvation; P:macroautophagy;|Q9H0R8 B4E0Y7 Q6FIE6,Gamma-aminobutyric acid receptor-associated protein-like 1,Early estrogen-regulated protein;GABA(A) receptor-associated protein-like 1;Glandular epithelial cell protein 1;, PF02991;, GO:0005776;GO:0000421;GO:0044297;GO:0030659;GO:0005829;GO:0032839;GO:0032590;GO:0005783;GO:0005794;GO:0005874;GO:0048487;GO:0050811;GO:0030957;GO:0031625;GO:0000045;GO:0097352;GO:0000422;GO:0006995;GO:0016236;, C:autophagosome; C:autophagosome membrane; C:cell body; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite cytoplasm; C:dendrite membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:microtubule;, F:beta-tubulin binding; F:GABA receptor binding; F:Tat protein binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagosome maturation; P:autophagy of mitochondrion; P:cellular response to nitrogen starvation; P:macroautophagy; scaffold147 indexed_genome mRNA 1997428 2003721 . + . ID=transcript_14642;P78527 P78528 Q13327 Q13337 Q14175 Q59H99 Q7Z611 Q96SE6 Q9UME3,DNA-dependent protein kinase catalytic subunit,DNPK1;p460;, PF02259;PF02260;PF08163;PF00454;, GO:0000781;GO:0005829;GO:0005958;GO:0016020;GO:0070419;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:0032040;GO:0005667;GO:0005524;GO:0004677;GO:0003690;GO:0019899;GO:0019904;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0008134;GO:0034511;GO:0002218;GO:0002326;GO:0007420;GO:0006464;GO:0006974;GO:0032869;GO:0006302;GO:0097681;GO:0006303;GO:0035234;GO:0007507;GO:0033152;GO:0045087;GO:0008630;GO:0000460;GO:0043066;GO:2000773;GO:0002638;GO:0001933;GO:2001229;GO:0018105;GO:0018107;GO:0043065;GO:0048639;GO:2001034;GO:0045648;GO:0048146;GO:0045621;GO:1905221;GO:0045944;GO:0045727;GO:0032481;GO:0002328;GO:0031648;GO:0006468;GO:0016567;GO:0042752;GO:0050678;GO:1902036;GO:0048660;GO:0014823;GO:0010332;GO:0048511;GO:0072431;GO:0034462;GO:0001756;GO:0048536;GO:0033077;GO:0002360;GO:0033153;GO:0016233;GO:0000723;GO:0048538;, C:chromosome, telomeric region; C:cytosol; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:membrane; C:nonhomologous end joining complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:small-subunit processome; C:transcription regulator complex;, F:ATP binding; F:DNA-dependent protein kinase activity; F:double-stranded DNA binding; F:enzyme binding; F:protein domain specific binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:transcription factor binding; F:U3 snoRNA binding;, P:activation of innate immune response; P:B cell lineage commitment; P:brain development; P:cellular protein modification process; P:cellular response to DNA damage stimulus; P:cellular response to insulin stimulus; P:double-strand break repair; P:double-strand break repair via alternative nonhomologous end joining; P:double-strand break repair via nonhomologous end joining; P:ectopic germ cell programmed cell death; P:heart development; P:immunoglobulin V(D)J recombination; P:innate immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:maturation of 5.8S rRNA; P:negative regulation of apoptotic process; P:negative regulation of cellular senescence; P:negative regulation of immunoglobulin production; P:negative regulation of protein phosphorylation; P:negative regulation of response to gamma radiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of developmental growth; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of erythrocyte differentiation; P:positive regulation of fibroblast proliferation; P:positive regulation of lymphocyte differentiation; P:positive regulation of platelet formation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation; P:positive regulation of type I interferon production; P:pro-B cell differentiation; P:protein destabilization; P:protein phosphorylation; P:protein ubiquitination; P:regulation of circadian rhythm; P:regulation of epithelial cell proliferation; P:regulation of hematopoietic stem cell differentiation; P:regulation of smooth muscle cell proliferation; P:response to activity; P:response to gamma radiation; P:rhythmic process; P:signal transduction involved in mitotic G1 DNA damage checkpoint; P:small-subunit processome assembly; P:somitogenesis; P:spleen development; P:T cell differentiation in thymus; P:T cell lineage commitment; P:T cell receptor V(D)J recombination; P:telomere capping; P:telomere maintenance; P:thymus development;|Q13241 O43321 O43773 Q9UBE3 Q9UEQ0,Natural killer cells antigen CD94,KP43;Killer cell lectin-like receptor subfamily D member 1;NK cell receptor;, PF00059;, GO:0005887;GO:0005886;GO:0043235;GO:0030246;GO:0062082;GO:0023024;GO:0023030;GO:1990405;GO:0004888;GO:0002250;GO:0007166;GO:0045087;GO:0002228;GO:0045953;GO:0001915;GO:0045954;GO:0050776;GO:0002223;, C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:carbohydrate binding; F:HLA-E specific inhibitory MHC class Ib receptor activity; F:MHC class I protein complex binding; F:MHC class Ib protein binding, via antigen binding groove; F:protein antigen binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:cell surface receptor signaling pathway; P:innate immune response; P:natural killer cell mediated immunity; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of T cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity; P:regulation of immune response; P:stimulatory C-type lectin receptor signaling pathway; scaffold147 indexed_genome mRNA 2076429 2081908 . + . ID=transcript_14643;Q13241 O43321 O43773 Q9UBE3 Q9UEQ0,Natural killer cells antigen CD94,KP43;Killer cell lectin-like receptor subfamily D member 1;NK cell receptor;, PF00059;, GO:0005887;GO:0005886;GO:0043235;GO:0030246;GO:0062082;GO:0023024;GO:0023030;GO:1990405;GO:0004888;GO:0002250;GO:0007166;GO:0045087;GO:0002228;GO:0045953;GO:0001915;GO:0045954;GO:0050776;GO:0002223;, C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:carbohydrate binding; F:HLA-E specific inhibitory MHC class Ib receptor activity; F:MHC class I protein complex binding; F:MHC class Ib protein binding, via antigen binding groove; F:protein antigen binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:cell surface receptor signaling pathway; P:innate immune response; P:natural killer cell mediated immunity; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of T cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity; P:regulation of immune response; P:stimulatory C-type lectin receptor signaling pathway; scaffold148 indexed_genome mRNA 10700 47506 . + . ID=transcript_14644;Q8NFB2 B3KTZ3 Q3SYH1 Q96CW3 Q96KE8,Transmembrane protein 185A,Protein FAM11A;, PF10269;, GO:0030425;GO:0016021;, C:dendrite; C:integral component of membrane; scaffold148 indexed_genome mRNA 58044 62368 . + . ID=transcript_14645;Q8NFB2 B3KTZ3 Q3SYH1 Q96CW3 Q96KE8,Transmembrane protein 185A,Protein FAM11A;, PF10269;, GO:0030425;GO:0016021;, C:dendrite; C:integral component of membrane;|Q8NFB2 B3KTZ3 Q3SYH1 Q96CW3 Q96KE8,Transmembrane protein 185A,Protein FAM11A;, PF10269;, GO:0030425;GO:0016021;, C:dendrite; C:integral component of membrane;|Q9H7F4 A8K1G5 Q53T33 Q66K44 Q8IZ77,Transmembrane protein 185B,Protein FAM11B;, PF10269;, GO:0016021;, C:integral component of membrane; scaffold148 indexed_genome mRNA 113279 132491 . + . ID=transcript_14646;P22304 D3DWT4 Q14604 Q9BRM3,Iduronate 2-sulfatase,Alpha-L-iduronate sulfate sulfatase;, PF00884;, GO:0043202;GO:0005764;GO:0005509;GO:0004423;GO:0008484;GO:0030207;GO:0006027;, C:lysosomal lumen; C:lysosome;, F:calcium ion binding; F:iduronate-2-sulfatase activity; F:sulfuric ester hydrolase activity;, P:chondroitin sulfate catabolic process; P:glycosaminoglycan catabolic process;|P22304 D3DWT4 Q14604 Q9BRM3,Iduronate 2-sulfatase,Alpha-L-iduronate sulfate sulfatase;, PF00884;, GO:0043202;GO:0005764;GO:0005509;GO:0004423;GO:0008484;GO:0030207;GO:0006027;, C:lysosomal lumen; C:lysosome;, F:calcium ion binding; F:iduronate-2-sulfatase activity; F:sulfuric ester hydrolase activity;, P:chondroitin sulfate catabolic process; P:glycosaminoglycan catabolic process;|P22304 D3DWT4 Q14604 Q9BRM3,Iduronate 2-sulfatase,Alpha-L-iduronate sulfate sulfatase;, PF00884;, GO:0043202;GO:0005764;GO:0005509;GO:0004423;GO:0008484;GO:0030207;GO:0006027;, C:lysosomal lumen; C:lysosome;, F:calcium ion binding; F:iduronate-2-sulfatase activity; F:sulfuric ester hydrolase activity;, P:chondroitin sulfate catabolic process; P:glycosaminoglycan catabolic process;|P22304 D3DWT4 Q14604 Q9BRM3,Iduronate 2-sulfatase,Alpha-L-iduronate sulfate sulfatase;, PF00884;, GO:0043202;GO:0005764;GO:0005509;GO:0004423;GO:0008484;GO:0030207;GO:0006027;, C:lysosomal lumen; C:lysosome;, F:calcium ion binding; F:iduronate-2-sulfatase activity; F:sulfuric ester hydrolase activity;, P:chondroitin sulfate catabolic process; P:glycosaminoglycan catabolic process;|P22304 D3DWT4 Q14604 Q9BRM3,Iduronate 2-sulfatase,Alpha-L-iduronate sulfate sulfatase;, PF00884;, GO:0043202;GO:0005764;GO:0005509;GO:0004423;GO:0008484;GO:0030207;GO:0006027;, C:lysosomal lumen; C:lysosome;, F:calcium ion binding; F:iduronate-2-sulfatase activity; F:sulfuric ester hydrolase activity;, P:chondroitin sulfate catabolic process; P:glycosaminoglycan catabolic process;|P22304 D3DWT4 Q14604 Q9BRM3,Iduronate 2-sulfatase,Alpha-L-iduronate sulfate sulfatase;, PF00884;, GO:0043202;GO:0005764;GO:0005509;GO:0004423;GO:0008484;GO:0030207;GO:0006027;, C:lysosomal lumen; C:lysosome;, F:calcium ion binding; F:iduronate-2-sulfatase activity; F:sulfuric ester hydrolase activity;, P:chondroitin sulfate catabolic process; P:glycosaminoglycan catabolic process; scaffold148 indexed_genome mRNA 436987 471356 . - . ID=transcript_14647;Q13521 Q14323 Q7Z2F7 Q7Z400 Q9UNA5,AF4/FMR2 family member 2,Fragile X E mental retardation syndrome protein;Fragile X mental retardation 2 protein;Protein Ox19;, PF18876;PF18875;, GO:0016607;GO:0002151;GO:0007420;GO:0007611;GO:0006397;GO:0010629;GO:0035063;GO:0010468;GO:0043484;GO:0008380;, C:nuclear speck;, F:G-quadruplex RNA binding;, P:brain development; P:learning or memory; P:mRNA processing; P:negative regulation of gene expression; P:nuclear speck organization; P:regulation of gene expression; P:regulation of RNA splicing; P:RNA splicing; scaffold148 indexed_genome mRNA 784977 794275 . - . ID=transcript_14648;Q13521 Q14323 Q7Z2F7 Q7Z400 Q9UNA5,AF4/FMR2 family member 2,Fragile X E mental retardation syndrome protein;Fragile X mental retardation 2 protein;Protein Ox19;, PF18876;PF18875;, GO:0016607;GO:0002151;GO:0007420;GO:0007611;GO:0006397;GO:0010629;GO:0035063;GO:0010468;GO:0043484;GO:0008380;, C:nuclear speck;, F:G-quadruplex RNA binding;, P:brain development; P:learning or memory; P:mRNA processing; P:negative regulation of gene expression; P:nuclear speck organization; P:regulation of gene expression; P:regulation of RNA splicing; P:RNA splicing; scaffold148 indexed_genome mRNA 1430401 1461398 . - . ID=transcript_14649;Q06787 A6NNH4 D3DWT0 D3DWT1 D3DWT2 G8JL90 Q16578 Q5PQZ6 Q99054,Synaptic functional regulator FMR1 {ECO:0000305},Fragile X mental retardation protein 1 {ECO:0000312|HGNC:HGNC:3775};, PF05641;PF16098;PF12235;PF00013;PF17904;PF18336;, GO:0030424;GO:0043679;GO:0015030;GO:0042995;GO:0010369;GO:0005694;GO:0000775;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0030425;GO:1902737;GO:0043197;GO:0044326;GO:0019897;GO:0032433;GO:0097386;GO:0030426;GO:1990812;GO:0016020;GO:1990124;GO:0005845;GO:0043005;GO:0043025;GO:0071598;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0005844;GO:0098794;GO:0014069;GO:0045211;GO:0098793;GO:0042734;GO:1990904;GO:0045202;GO:0003682;GO:0070840;GO:0002151;GO:0042802;GO:0044325;GO:0035064;GO:0008017;GO:0035198;GO:0003730;GO:0048027;GO:0003729;GO:0034046;GO:0008266;GO:0046982;GO:0042803;GO:0043022;GO:0003723;GO:0035613;GO:0033592;GO:1990825;GO:0035197;GO:0031369;GO:0045182;GO:0030371;GO:0006974;GO:0072711;GO:0034644;GO:0098586;GO:0031047;GO:0007215;GO:0044830;GO:0006397;GO:0051028;GO:2000766;GO:1900453;GO:1902373;GO:2000301;GO:0017148;GO:0045947;GO:1901386;GO:0007399;GO:0060999;GO:0051491;GO:2000637;GO:0033129;GO:1901254;GO:1902416;GO:1901800;GO:0001934;GO:0002092;GO:2001022;GO:0045727;GO:0000381;GO:0060998;GO:0051489;GO:0060964;GO:0043488;GO:0098908;GO:0046928;GO:0008380;GO:0016032;, C:axon; C:axon terminus; C:Cajal body; C:cell projection; C:chromocenter; C:chromosome; C:chromosome, centromeric region; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:extrinsic component of plasma membrane; C:filopodium tip; C:glial cell projection; C:growth cone; C:growth cone filopodium; C:membrane; C:messenger ribonucleoprotein complex; C:mRNA cap binding complex; C:neuron projection; C:neuronal cell body; C:neuronal ribonucleoprotein granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:polysome; C:postsynapse; C:postsynaptic density; C:postsynaptic membrane; C:presynapse; C:presynaptic membrane; C:ribonucleoprotein complex; C:synapse;, F:chromatin binding; F:dynein complex binding; F:G-quadruplex RNA binding; F:identical protein binding; F:ion channel binding; F:methylated histone binding; F:microtubule binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:mRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:ribosome binding; F:RNA binding; F:RNA stem-loop binding; F:RNA strand annealing activity; F:sequence-specific mRNA binding; F:siRNA binding; F:translation initiation factor binding; F:translation regulator activity; F:translation repressor activity;, P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to UV; P:cellular response to virus; P:gene silencing by RNA; P:glutamate receptor signaling pathway; P:modulation by host of viral RNA genome replication; P:mRNA processing; P:mRNA transport; P:negative regulation of cytoplasmic translation; P:negative regulation of long-term synaptic depression; P:negative regulation of mRNA catabolic process; P:negative regulation of synaptic vesicle exocytosis; P:negative regulation of translation; P:negative regulation of translational initiation; P:negative regulation of voltage-gated calcium channel activity; P:nervous system development; P:positive regulation of dendritic spine development; P:positive regulation of filopodium assembly; P:positive regulation of gene silencing by miRNA; P:positive regulation of histone phosphorylation; P:positive regulation of intracellular transport of viral material; P:positive regulation of mRNA binding; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of receptor internalization; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of dendritic spine development; P:regulation of filopodium assembly; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of neuronal action potential; P:regulation of neurotransmitter secretion; P:RNA splicing; P:viral process;|Q06787 A6NNH4 D3DWT0 D3DWT1 D3DWT2 G8JL90 Q16578 Q5PQZ6 Q99054,Synaptic functional regulator FMR1 {ECO:0000305},Fragile X mental retardation protein 1 {ECO:0000312|HGNC:HGNC:3775};, PF05641;PF16098;PF12235;PF00013;PF17904;PF18336;, GO:0030424;GO:0043679;GO:0015030;GO:0042995;GO:0010369;GO:0005694;GO:0000775;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0030425;GO:1902737;GO:0043197;GO:0044326;GO:0019897;GO:0032433;GO:0097386;GO:0030426;GO:1990812;GO:0016020;GO:1990124;GO:0005845;GO:0043005;GO:0043025;GO:0071598;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0005844;GO:0098794;GO:0014069;GO:0045211;GO:0098793;GO:0042734;GO:1990904;GO:0045202;GO:0003682;GO:0070840;GO:0002151;GO:0042802;GO:0044325;GO:0035064;GO:0008017;GO:0035198;GO:0003730;GO:0048027;GO:0003729;GO:0034046;GO:0008266;GO:0046982;GO:0042803;GO:0043022;GO:0003723;GO:0035613;GO:0033592;GO:1990825;GO:0035197;GO:0031369;GO:0045182;GO:0030371;GO:0006974;GO:0072711;GO:0034644;GO:0098586;GO:0031047;GO:0007215;GO:0044830;GO:0006397;GO:0051028;GO:2000766;GO:1900453;GO:1902373;GO:2000301;GO:0017148;GO:0045947;GO:1901386;GO:0007399;GO:0060999;GO:0051491;GO:2000637;GO:0033129;GO:1901254;GO:1902416;GO:1901800;GO:0001934;GO:0002092;GO:2001022;GO:0045727;GO:0000381;GO:0060998;GO:0051489;GO:0060964;GO:0043488;GO:0098908;GO:0046928;GO:0008380;GO:0016032;, C:axon; C:axon terminus; C:Cajal body; C:cell projection; C:chromocenter; C:chromosome; C:chromosome, centromeric region; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:extrinsic component of plasma membrane; C:filopodium tip; C:glial cell projection; C:growth cone; C:growth cone filopodium; C:membrane; C:messenger ribonucleoprotein complex; C:mRNA cap binding complex; C:neuron projection; C:neuronal cell body; C:neuronal ribonucleoprotein granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:polysome; C:postsynapse; C:postsynaptic density; C:postsynaptic membrane; C:presynapse; C:presynaptic membrane; C:ribonucleoprotein complex; C:synapse;, F:chromatin binding; F:dynein complex binding; F:G-quadruplex RNA binding; F:identical protein binding; F:ion channel binding; F:methylated histone binding; F:microtubule binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:mRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:ribosome binding; F:RNA binding; F:RNA stem-loop binding; F:RNA strand annealing activity; F:sequence-specific mRNA binding; F:siRNA binding; F:translation initiation factor binding; F:translation regulator activity; F:translation repressor activity;, P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to UV; P:cellular response to virus; P:gene silencing by RNA; P:glutamate receptor signaling pathway; P:modulation by host of viral RNA genome replication; P:mRNA processing; P:mRNA transport; P:negative regulation of cytoplasmic translation; P:negative regulation of long-term synaptic depression; P:negative regulation of mRNA catabolic process; P:negative regulation of synaptic vesicle exocytosis; P:negative regulation of translation; P:negative regulation of translational initiation; P:negative regulation of voltage-gated calcium channel activity; P:nervous system development; P:positive regulation of dendritic spine development; P:positive regulation of filopodium assembly; P:positive regulation of gene silencing by miRNA; P:positive regulation of histone phosphorylation; P:positive regulation of intracellular transport of viral material; P:positive regulation of mRNA binding; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of receptor internalization; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of dendritic spine development; P:regulation of filopodium assembly; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of neuronal action potential; P:regulation of neurotransmitter secretion; P:RNA splicing; P:viral process;|Q06787 A6NNH4 D3DWT0 D3DWT1 D3DWT2 G8JL90 Q16578 Q5PQZ6 Q99054,Synaptic functional regulator FMR1 {ECO:0000305},Fragile X mental retardation protein 1 {ECO:0000312|HGNC:HGNC:3775};, PF05641;PF16098;PF12235;PF00013;PF17904;PF18336;, GO:0030424;GO:0043679;GO:0015030;GO:0042995;GO:0010369;GO:0005694;GO:0000775;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0030425;GO:1902737;GO:0043197;GO:0044326;GO:0019897;GO:0032433;GO:0097386;GO:0030426;GO:1990812;GO:0016020;GO:1990124;GO:0005845;GO:0043005;GO:0043025;GO:0071598;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0005844;GO:0098794;GO:0014069;GO:0045211;GO:0098793;GO:0042734;GO:1990904;GO:0045202;GO:0003682;GO:0070840;GO:0002151;GO:0042802;GO:0044325;GO:0035064;GO:0008017;GO:0035198;GO:0003730;GO:0048027;GO:0003729;GO:0034046;GO:0008266;GO:0046982;GO:0042803;GO:0043022;GO:0003723;GO:0035613;GO:0033592;GO:1990825;GO:0035197;GO:0031369;GO:0045182;GO:0030371;GO:0006974;GO:0072711;GO:0034644;GO:0098586;GO:0031047;GO:0007215;GO:0044830;GO:0006397;GO:0051028;GO:2000766;GO:1900453;GO:1902373;GO:2000301;GO:0017148;GO:0045947;GO:1901386;GO:0007399;GO:0060999;GO:0051491;GO:2000637;GO:0033129;GO:1901254;GO:1902416;GO:1901800;GO:0001934;GO:0002092;GO:2001022;GO:0045727;GO:0000381;GO:0060998;GO:0051489;GO:0060964;GO:0043488;GO:0098908;GO:0046928;GO:0008380;GO:0016032;, C:axon; C:axon terminus; C:Cajal body; C:cell projection; C:chromocenter; C:chromosome; C:chromosome, centromeric region; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:extrinsic component of plasma membrane; C:filopodium tip; C:glial cell projection; C:growth cone; C:growth cone filopodium; C:membrane; C:messenger ribonucleoprotein complex; C:mRNA cap binding complex; C:neuron projection; C:neuronal cell body; C:neuronal ribonucleoprotein granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:polysome; C:postsynapse; C:postsynaptic density; C:postsynaptic membrane; C:presynapse; C:presynaptic membrane; C:ribonucleoprotein complex; C:synapse;, F:chromatin binding; F:dynein complex binding; F:G-quadruplex RNA binding; F:identical protein binding; F:ion channel binding; F:methylated histone binding; F:microtubule binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:mRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:ribosome binding; F:RNA binding; F:RNA stem-loop binding; F:RNA strand annealing activity; F:sequence-specific mRNA binding; F:siRNA binding; F:translation initiation factor binding; F:translation regulator activity; F:translation repressor activity;, P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to UV; P:cellular response to virus; P:gene silencing by RNA; P:glutamate receptor signaling pathway; P:modulation by host of viral RNA genome replication; P:mRNA processing; P:mRNA transport; P:negative regulation of cytoplasmic translation; P:negative regulation of long-term synaptic depression; P:negative regulation of mRNA catabolic process; P:negative regulation of synaptic vesicle exocytosis; P:negative regulation of translation; P:negative regulation of translational initiation; P:negative regulation of voltage-gated calcium channel activity; P:nervous system development; P:positive regulation of dendritic spine development; P:positive regulation of filopodium assembly; P:positive regulation of gene silencing by miRNA; P:positive regulation of histone phosphorylation; P:positive regulation of intracellular transport of viral material; P:positive regulation of mRNA binding; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of receptor internalization; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of dendritic spine development; P:regulation of filopodium assembly; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of neuronal action potential; P:regulation of neurotransmitter secretion; P:RNA splicing; P:viral process;|Q06787 A6NNH4 D3DWT0 D3DWT1 D3DWT2 G8JL90 Q16578 Q5PQZ6 Q99054,Synaptic functional regulator FMR1 {ECO:0000305},Fragile X mental retardation protein 1 {ECO:0000312|HGNC:HGNC:3775};, PF05641;PF16098;PF12235;PF00013;PF17904;PF18336;, GO:0030424;GO:0043679;GO:0015030;GO:0042995;GO:0010369;GO:0005694;GO:0000775;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0030425;GO:1902737;GO:0043197;GO:0044326;GO:0019897;GO:0032433;GO:0097386;GO:0030426;GO:1990812;GO:0016020;GO:1990124;GO:0005845;GO:0043005;GO:0043025;GO:0071598;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0005844;GO:0098794;GO:0014069;GO:0045211;GO:0098793;GO:0042734;GO:1990904;GO:0045202;GO:0003682;GO:0070840;GO:0002151;GO:0042802;GO:0044325;GO:0035064;GO:0008017;GO:0035198;GO:0003730;GO:0048027;GO:0003729;GO:0034046;GO:0008266;GO:0046982;GO:0042803;GO:0043022;GO:0003723;GO:0035613;GO:0033592;GO:1990825;GO:0035197;GO:0031369;GO:0045182;GO:0030371;GO:0006974;GO:0072711;GO:0034644;GO:0098586;GO:0031047;GO:0007215;GO:0044830;GO:0006397;GO:0051028;GO:2000766;GO:1900453;GO:1902373;GO:2000301;GO:0017148;GO:0045947;GO:1901386;GO:0007399;GO:0060999;GO:0051491;GO:2000637;GO:0033129;GO:1901254;GO:1902416;GO:1901800;GO:0001934;GO:0002092;GO:2001022;GO:0045727;GO:0000381;GO:0060998;GO:0051489;GO:0060964;GO:0043488;GO:0098908;GO:0046928;GO:0008380;GO:0016032;, C:axon; C:axon terminus; C:Cajal body; C:cell projection; C:chromocenter; C:chromosome; C:chromosome, centromeric region; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:extrinsic component of plasma membrane; C:filopodium tip; C:glial cell projection; C:growth cone; C:growth cone filopodium; C:membrane; C:messenger ribonucleoprotein complex; C:mRNA cap binding complex; C:neuron projection; C:neuronal cell body; C:neuronal ribonucleoprotein granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:polysome; C:postsynapse; C:postsynaptic density; C:postsynaptic membrane; C:presynapse; C:presynaptic membrane; C:ribonucleoprotein complex; C:synapse;, F:chromatin binding; F:dynein complex binding; F:G-quadruplex RNA binding; F:identical protein binding; F:ion channel binding; F:methylated histone binding; F:microtubule binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:mRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:ribosome binding; F:RNA binding; F:RNA stem-loop binding; F:RNA strand annealing activity; F:sequence-specific mRNA binding; F:siRNA binding; F:translation initiation factor binding; F:translation regulator activity; F:translation repressor activity;, P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to UV; P:cellular response to virus; P:gene silencing by RNA; P:glutamate receptor signaling pathway; P:modulation by host of viral RNA genome replication; P:mRNA processing; P:mRNA transport; P:negative regulation of cytoplasmic translation; P:negative regulation of long-term synaptic depression; P:negative regulation of mRNA catabolic process; P:negative regulation of synaptic vesicle exocytosis; P:negative regulation of translation; P:negative regulation of translational initiation; P:negative regulation of voltage-gated calcium channel activity; P:nervous system development; P:positive regulation of dendritic spine development; P:positive regulation of filopodium assembly; P:positive regulation of gene silencing by miRNA; P:positive regulation of histone phosphorylation; P:positive regulation of intracellular transport of viral material; P:positive regulation of mRNA binding; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of receptor internalization; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of dendritic spine development; P:regulation of filopodium assembly; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of neuronal action potential; P:regulation of neurotransmitter secretion; P:RNA splicing; P:viral process;|Q06787 A6NNH4 D3DWT0 D3DWT1 D3DWT2 G8JL90 Q16578 Q5PQZ6 Q99054,Synaptic functional regulator FMR1 {ECO:0000305},Fragile X mental retardation protein 1 {ECO:0000312|HGNC:HGNC:3775};, PF05641;PF16098;PF12235;PF00013;PF17904;PF18336;, GO:0030424;GO:0043679;GO:0015030;GO:0042995;GO:0010369;GO:0005694;GO:0000775;GO:0005737;GO:0036464;GO:0010494;GO:0005829;GO:0030425;GO:1902737;GO:0043197;GO:0044326;GO:0019897;GO:0032433;GO:0097386;GO:0030426;GO:1990812;GO:0016020;GO:1990124;GO:0005845;GO:0043005;GO:0043025;GO:0071598;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0005844;GO:0098794;GO:0014069;GO:0045211;GO:0098793;GO:0042734;GO:1990904;GO:0045202;GO:0003682;GO:0070840;GO:0002151;GO:0042802;GO:0044325;GO:0035064;GO:0008017;GO:0035198;GO:0003730;GO:0048027;GO:0003729;GO:0034046;GO:0008266;GO:0046982;GO:0042803;GO:0043022;GO:0003723;GO:0035613;GO:0033592;GO:1990825;GO:0035197;GO:0031369;GO:0045182;GO:0030371;GO:0006974;GO:0072711;GO:0034644;GO:0098586;GO:0031047;GO:0007215;GO:0044830;GO:0006397;GO:0051028;GO:2000766;GO:1900453;GO:1902373;GO:2000301;GO:0017148;GO:0045947;GO:1901386;GO:0007399;GO:0060999;GO:0051491;GO:2000637;GO:0033129;GO:1901254;GO:1902416;GO:1901800;GO:0001934;GO:0002092;GO:2001022;GO:0045727;GO:0000381;GO:0060998;GO:0051489;GO:0060964;GO:0043488;GO:0098908;GO:0046928;GO:0008380;GO:0016032;, C:axon; C:axon terminus; C:Cajal body; C:cell projection; C:chromocenter; C:chromosome; C:chromosome, centromeric region; C:cytoplasm; C:cytoplasmic ribonucleoprotein granule; C:cytoplasmic stress granule; C:cytosol; C:dendrite; C:dendritic filopodium; C:dendritic spine; C:dendritic spine neck; C:extrinsic component of plasma membrane; C:filopodium tip; C:glial cell projection; C:growth cone; C:growth cone filopodium; C:membrane; C:messenger ribonucleoprotein complex; C:mRNA cap binding complex; C:neuron projection; C:neuronal cell body; C:neuronal ribonucleoprotein granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:polysome; C:postsynapse; C:postsynaptic density; C:postsynaptic membrane; C:presynapse; C:presynaptic membrane; C:ribonucleoprotein complex; C:synapse;, F:chromatin binding; F:dynein complex binding; F:G-quadruplex RNA binding; F:identical protein binding; F:ion channel binding; F:methylated histone binding; F:microtubule binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:mRNA binding; F:poly(G) binding; F:poly(U) RNA binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:ribosome binding; F:RNA binding; F:RNA stem-loop binding; F:RNA strand annealing activity; F:sequence-specific mRNA binding; F:siRNA binding; F:translation initiation factor binding; F:translation regulator activity; F:translation repressor activity;, P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:cellular response to UV; P:cellular response to virus; P:gene silencing by RNA; P:glutamate receptor signaling pathway; P:modulation by host of viral RNA genome replication; P:mRNA processing; P:mRNA transport; P:negative regulation of cytoplasmic translation; P:negative regulation of long-term synaptic depression; P:negative regulation of mRNA catabolic process; P:negative regulation of synaptic vesicle exocytosis; P:negative regulation of translation; P:negative regulation of translational initiation; P:negative regulation of voltage-gated calcium channel activity; P:nervous system development; P:positive regulation of dendritic spine development; P:positive regulation of filopodium assembly; P:positive regulation of gene silencing by miRNA; P:positive regulation of histone phosphorylation; P:positive regulation of intracellular transport of viral material; P:positive regulation of mRNA binding; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of receptor internalization; P:positive regulation of response to DNA damage stimulus; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of dendritic spine development; P:regulation of filopodium assembly; P:regulation of gene silencing by miRNA; P:regulation of mRNA stability; P:regulation of neuronal action potential; P:regulation of neurotransmitter secretion; P:RNA splicing; P:viral process; scaffold149 indexed_genome mRNA 128659 130671 . + . ID=transcript_14650;Q7L0Q8 B1AKN1 Q59FE9 Q8TDQ2,Rho-related GTP-binding protein RhoU,CDC42-like GTPase 1;GTP-binding protein-like 1;Rho GTPase-like protein ARHU;Ryu GTPase;Wnt-1 responsive Cdc42 homolog 1;, PF00071;, GO:0042995;GO:0005829;GO:0005925;GO:0000139;GO:0005886;GO:0002102;GO:0005525;GO:0003924;GO:0046872;GO:0032488;GO:0016477;GO:0030031;GO:0019221;GO:0007010;GO:0006897;GO:1903955;GO:0008360;GO:0051056;, C:cell projection; C:cytosol; C:focal adhesion; C:Golgi membrane; C:plasma membrane; C:podosome;, F:GTP binding; F:GTPase activity; F:metal ion binding;, P:Cdc42 protein signal transduction; P:cell migration; P:cell projection assembly; P:cytokine-mediated signaling pathway; P:cytoskeleton organization; P:endocytosis; P:positive regulation of protein targeting to mitochondrion; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; scaffold149 indexed_genome mRNA 633094 651163 . + . ID=transcript_14651;P20338 Q5T7P7 Q9BQ44,Ras-related protein Rab-4A,, PF00071;, GO:0098993;GO:0030659;GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0032593;GO:0043231;GO:0048471;GO:0005886;GO:0098837;GO:0055038;GO:0031982;GO:0001671;GO:0051117;GO:0019003;GO:0005525;GO:0003924;GO:0035255;GO:0019905;GO:0019882;GO:0006661;GO:0015031;GO:0032482;GO:0030100;, C:anchored component of synaptic vesicle membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:insulin-responsive compartment; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic recycling endosome; C:recycling endosome membrane; C:vesicle;, F:ATPase activator activity; F:ATPase binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ionotropic glutamate receptor binding; F:syntaxin binding;, P:antigen processing and presentation; P:phosphatidylinositol biosynthetic process; P:protein transport; P:Rab protein signal transduction; P:regulation of endocytosis;|P20338 Q5T7P7 Q9BQ44,Ras-related protein Rab-4A,, PF00071;, GO:0098993;GO:0030659;GO:0005829;GO:0031901;GO:0005768;GO:0070062;GO:0032593;GO:0043231;GO:0048471;GO:0005886;GO:0098837;GO:0055038;GO:0031982;GO:0001671;GO:0051117;GO:0019003;GO:0005525;GO:0003924;GO:0035255;GO:0019905;GO:0019882;GO:0006661;GO:0015031;GO:0032482;GO:0030100;, C:anchored component of synaptic vesicle membrane; C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome membrane; C:endosome; C:extracellular exosome; C:insulin-responsive compartment; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic recycling endosome; C:recycling endosome membrane; C:vesicle;, F:ATPase activator activity; F:ATPase binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ionotropic glutamate receptor binding; F:syntaxin binding;, P:antigen processing and presentation; P:phosphatidylinositol biosynthetic process; P:protein transport; P:Rab protein signal transduction; P:regulation of endocytosis; scaffold149 indexed_genome mRNA 662938 663572 . - . ID=transcript_14652;Q8NCC5 Q6PIU7 Q86SS4 Q9BQG7,Sugar phosphate exchanger 3,Solute carrier family 37 member 3;, PF07690;, GO:0030176;GO:0022857;GO:0008643;GO:0015712;, C:integral component of endoplasmic reticulum membrane;, F:transmembrane transporter activity;, P:carbohydrate transport; P:hexose phosphate transport; scaffold149 indexed_genome mRNA 664223 664767 . + . ID=transcript_14653;Q8NCC5 Q6PIU7 Q86SS4 Q9BQG7,Sugar phosphate exchanger 3,Solute carrier family 37 member 3;, PF07690;, GO:0030176;GO:0022857;GO:0008643;GO:0015712;, C:integral component of endoplasmic reticulum membrane;, F:transmembrane transporter activity;, P:carbohydrate transport; P:hexose phosphate transport; scaffold149 indexed_genome mRNA 671477 700520 . - . ID=transcript_14654;Q6IQ19 A8K5X2 Q6P9G2 Q6ZW85 Q8IXU1 Q96BM2,Centriole, cilia and spindle-associated protein,, PF15748;, GO:0030424;GO:0005930;GO:0005814;GO:0005813;GO:0036064;GO:0035869;GO:0005929;GO:0072686;GO:0061673;GO:0005819;GO:0008017;GO:0007049;GO:0051301;GO:1990755;GO:0007275;GO:0060296;GO:0045995;GO:1901673;, C:axon; C:axoneme; C:centriole; C:centrosome; C:ciliary basal body; C:ciliary transition zone; C:cilium; C:mitotic spindle; C:mitotic spindle astral microtubule; C:spindle;, F:microtubule binding;, P:cell cycle; P:cell division; P:mitotic spindle microtubule depolymerization; P:multicellular organism development; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of embryonic development; P:regulation of mitotic spindle assembly; scaffold149 indexed_genome mRNA 707393 708455 . - . ID=transcript_14655;Q9BQE6 Q96NA4,LBH domain-containing protein 1 {ECO:0000305},, PF15317;, GO:0005634;GO:0045893;, C:nucleus;, , P:positive regulation of transcription, DNA-templated; scaffold149 indexed_genome mRNA 735741 737554 . + . ID=transcript_14656;P63132,Endogenous retrovirus group K member 113 Pol protein,HERV-K113 Pol protein;HERV-K_19p13.11 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold149 indexed_genome mRNA 788100 789194 . - . ID=transcript_14657;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold149 indexed_genome mRNA 800743 802175 . - . ID=transcript_14658;P68133 P02568 P99020 Q5T8M9,Actin, alpha skeletal muscle,Alpha-actin-1;, PF00022;, GO:0015629;GO:0005884;GO:0072562;GO:0044297;GO:0005829;GO:0005869;GO:0070062;GO:0005615;GO:0030175;GO:0030027;GO:0030017;GO:0001725;GO:0005865;GO:0043531;GO:0005524;GO:0017022;GO:0005200;GO:0071417;GO:0090131;GO:0006936;GO:0030049;GO:0010628;GO:0009991;GO:0010226;GO:0009612;GO:0048545;GO:0043503;GO:0048741;GO:0030240;, C:actin cytoskeleton; C:actin filament; C:blood microparticle; C:cell body; C:cytosol; C:dynactin complex; C:extracellular exosome; C:extracellular space; C:filopodium; C:lamellipodium; C:sarcomere; C:stress fiber; C:striated muscle thin filament;, F:ADP binding; F:ATP binding; F:myosin binding; F:structural constituent of cytoskeleton;, P:cellular response to organonitrogen compound; P:mesenchyme migration; P:muscle contraction; P:muscle filament sliding; P:positive regulation of gene expression; P:response to extracellular stimulus; P:response to lithium ion; P:response to mechanical stimulus; P:response to steroid hormone; P:skeletal muscle fiber adaptation; P:skeletal muscle fiber development; P:skeletal muscle thin filament assembly; scaffold149 indexed_genome mRNA 805445 865802 . - . ID=transcript_14659;Q8WUM0 B2RAZ8 Q5T8N0 Q9H9W2 Q9NV71 Q9NVC4,Nuclear pore complex protein Nup133,133 kDa nucleoporin;Nucleoporin Nup133;, PF03177;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0021915;GO:0022008;GO:0006999;GO:0048339;GO:0016973;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0061053;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:neural tube development; P:neurogenesis; P:nuclear pore organization; P:paraxial mesoderm development; P:poly(A)+ mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:somite development; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8WUM0 B2RAZ8 Q5T8N0 Q9H9W2 Q9NV71 Q9NVC4,Nuclear pore complex protein Nup133,133 kDa nucleoporin;Nucleoporin Nup133;, PF03177;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0021915;GO:0022008;GO:0006999;GO:0048339;GO:0016973;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0061053;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:neural tube development; P:neurogenesis; P:nuclear pore organization; P:paraxial mesoderm development; P:poly(A)+ mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:somite development; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8WUM0 B2RAZ8 Q5T8N0 Q9H9W2 Q9NV71 Q9NVC4,Nuclear pore complex protein Nup133,133 kDa nucleoporin;Nucleoporin Nup133;, PF03177;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0021915;GO:0022008;GO:0006999;GO:0048339;GO:0016973;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0061053;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:neural tube development; P:neurogenesis; P:nuclear pore organization; P:paraxial mesoderm development; P:poly(A)+ mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:somite development; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription;|Q8WUM0 B2RAZ8 Q5T8N0 Q9H9W2 Q9NV71 Q9NVC4,Nuclear pore complex protein Nup133,133 kDa nucleoporin;Nucleoporin Nup133;, PF03177;, GO:0000777;GO:0005829;GO:0043657;GO:0016020;GO:0005635;GO:0031965;GO:0005643;GO:0031080;GO:0017056;GO:0075733;GO:0007084;GO:0007052;GO:0006406;GO:0072006;GO:0021915;GO:0022008;GO:0006999;GO:0048339;GO:0016973;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0061053;GO:0000972;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:condensed chromosome kinetochore; C:cytosol; C:host cell; C:membrane; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore outer ring;, F:structural constituent of nuclear pore;, P:intracellular transport of virus; P:mitotic nuclear envelope reassembly; P:mitotic spindle organization; P:mRNA export from nucleus; P:nephron development; P:neural tube development; P:neurogenesis; P:nuclear pore organization; P:paraxial mesoderm development; P:poly(A)+ mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:somite development; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold149 indexed_genome mRNA 871474 880590 . - . ID=transcript_14660;Q9NRK6 Q13040 Q6P1Q8 Q9H3V0,ATP-binding cassette sub-family B member 10, mitochondrial,ATP-binding cassette transporter 10;Mitochondrial ATP-binding cassette 2;, PF00664;PF00005;, GO:0032592;GO:0005743;GO:0005524;GO:0016887;GO:0042626;GO:0042802;GO:0006839;, C:integral component of mitochondrial membrane; C:mitochondrial inner membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:identical protein binding;, P:mitochondrial transport; scaffold149 indexed_genome mRNA 894733 895347 . + . ID=transcript_14661;Q9NRK6 Q13040 Q6P1Q8 Q9H3V0,ATP-binding cassette sub-family B member 10, mitochondrial,ATP-binding cassette transporter 10;Mitochondrial ATP-binding cassette 2;, PF00664;PF00005;, GO:0032592;GO:0005743;GO:0005524;GO:0016887;GO:0042626;GO:0042802;GO:0006839;, C:integral component of mitochondrial membrane; C:mitochondrial inner membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:identical protein binding;, P:mitochondrial transport; scaffold149 indexed_genome mRNA 951806 954399 . - . ID=transcript_14662;O75529 Q5TDI5 Q5TDI6 Q8IW31,TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L {ECO:0000305},PCAF-associated factor 65 beta;, PF04494;PF00400;, GO:0036464;GO:0016607;GO:0005634;GO:0030914;GO:0033276;GO:0003713;GO:0043966;GO:1904672;GO:0006355;GO:0006366;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of somatic stem cell population maintenance; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II;|O75529 Q5TDI5 Q5TDI6 Q8IW31,TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L {ECO:0000305},PCAF-associated factor 65 beta;, PF04494;PF00400;, GO:0036464;GO:0016607;GO:0005634;GO:0030914;GO:0033276;GO:0003713;GO:0043966;GO:1904672;GO:0006355;GO:0006366;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of somatic stem cell population maintenance; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; scaffold149 indexed_genome mRNA 957344 957855 . + . ID=transcript_14663;O75529 Q5TDI5 Q5TDI6 Q8IW31,TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L {ECO:0000305},PCAF-associated factor 65 beta;, PF04494;PF00400;, GO:0036464;GO:0016607;GO:0005634;GO:0030914;GO:0033276;GO:0003713;GO:0043966;GO:1904672;GO:0006355;GO:0006366;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleus; C:STAGA complex; C:transcription factor TFTC complex;, F:transcription coactivator activity;, P:histone H3 acetylation; P:regulation of somatic stem cell population maintenance; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; scaffold149 indexed_genome mRNA 988450 1014973 . + . ID=transcript_14664;Q14146 Q5VYC9,Unhealthy ribosome biogenesis protein 2 homolog,, PF10441;, GO:0016235;GO:0030496;GO:0005730;GO:0042254;, C:aggresome; C:midbody; C:nucleolus;, , P:ribosome biogenesis;|Q14146 Q5VYC9,Unhealthy ribosome biogenesis protein 2 homolog,, PF10441;, GO:0016235;GO:0030496;GO:0005730;GO:0042254;, C:aggresome; C:midbody; C:nucleolus;, , P:ribosome biogenesis;|Q14146 Q5VYC9,Unhealthy ribosome biogenesis protein 2 homolog,, PF10441;, GO:0016235;GO:0030496;GO:0005730;GO:0042254;, C:aggresome; C:midbody; C:nucleolus;, , P:ribosome biogenesis; scaffold149 indexed_genome mRNA 1620645 1621923 . - . ID=transcript_14665;Q10471 A8K1Y3 B7Z8V8 C5HU00 Q9NPY4,Polypeptide N-acetylgalactosaminyltransferase 2,Polypeptide GalNAc transferase 2;Protein-UDP acetylgalactosaminyltransferase 2;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2;, PF00535;PF00652;, GO:0005789;GO:0005576;GO:0005794;GO:0032580;GO:0000139;GO:0005795;GO:0030173;GO:0016020;GO:0048471;GO:0030246;GO:0030145;GO:0004653;GO:0016266;GO:0051604;GO:0006493;GO:0018242;GO:0018243;, C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi stack; C:integral component of Golgi membrane; C:membrane; C:perinuclear region of cytoplasm;, F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein maturation; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine; scaffold149 indexed_genome mRNA 1623523 1651097 . + . ID=transcript_14666;Q10471 A8K1Y3 B7Z8V8 C5HU00 Q9NPY4,Polypeptide N-acetylgalactosaminyltransferase 2,Polypeptide GalNAc transferase 2;Protein-UDP acetylgalactosaminyltransferase 2;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2;, PF00535;PF00652;, GO:0005789;GO:0005576;GO:0005794;GO:0032580;GO:0000139;GO:0005795;GO:0030173;GO:0016020;GO:0048471;GO:0030246;GO:0030145;GO:0004653;GO:0016266;GO:0051604;GO:0006493;GO:0018242;GO:0018243;, C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi stack; C:integral component of Golgi membrane; C:membrane; C:perinuclear region of cytoplasm;, F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein maturation; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q10471 A8K1Y3 B7Z8V8 C5HU00 Q9NPY4,Polypeptide N-acetylgalactosaminyltransferase 2,Polypeptide GalNAc transferase 2;Protein-UDP acetylgalactosaminyltransferase 2;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2;, PF00535;PF00652;, GO:0005789;GO:0005576;GO:0005794;GO:0032580;GO:0000139;GO:0005795;GO:0030173;GO:0016020;GO:0048471;GO:0030246;GO:0030145;GO:0004653;GO:0016266;GO:0051604;GO:0006493;GO:0018242;GO:0018243;, C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi stack; C:integral component of Golgi membrane; C:membrane; C:perinuclear region of cytoplasm;, F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein maturation; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q10471 A8K1Y3 B7Z8V8 C5HU00 Q9NPY4,Polypeptide N-acetylgalactosaminyltransferase 2,Polypeptide GalNAc transferase 2;Protein-UDP acetylgalactosaminyltransferase 2;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2;, PF00535;PF00652;, GO:0005789;GO:0005576;GO:0005794;GO:0032580;GO:0000139;GO:0005795;GO:0030173;GO:0016020;GO:0048471;GO:0030246;GO:0030145;GO:0004653;GO:0016266;GO:0051604;GO:0006493;GO:0018242;GO:0018243;, C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi stack; C:integral component of Golgi membrane; C:membrane; C:perinuclear region of cytoplasm;, F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein maturation; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine;|Q10471 A8K1Y3 B7Z8V8 C5HU00 Q9NPY4,Polypeptide N-acetylgalactosaminyltransferase 2,Polypeptide GalNAc transferase 2;Protein-UDP acetylgalactosaminyltransferase 2;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2;, PF00535;PF00652;, GO:0005789;GO:0005576;GO:0005794;GO:0032580;GO:0000139;GO:0005795;GO:0030173;GO:0016020;GO:0048471;GO:0030246;GO:0030145;GO:0004653;GO:0016266;GO:0051604;GO:0006493;GO:0018242;GO:0018243;, C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:Golgi stack; C:integral component of Golgi membrane; C:membrane; C:perinuclear region of cytoplasm;, F:carbohydrate binding; F:manganese ion binding; F:polypeptide N-acetylgalactosaminyltransferase activity;, P:O-glycan processing; P:protein maturation; P:protein O-linked glycosylation; P:protein O-linked glycosylation via serine; P:protein O-linked glycosylation via threonine; scaffold150 indexed_genome mRNA 4451 5558 . + . ID=transcript_14667;B6SEH8,Endogenous retrovirus group V member 1 Env polyprotein,HERV-V_19q13.41 provirus ancestral Env polyprotein 1;, PF00429;, GO:0016021;, C:integral component of membrane; scaffold150 indexed_genome mRNA 7084 8199 . + . ID=transcript_14668;B6SEH9,Endogenous retrovirus group V member 2 Env polyprotein,HERV-V_19q13.41 provirus ancestral Env polyprotein 2;, PF00429;, GO:0016021;, C:integral component of membrane; scaffold150 indexed_genome mRNA 11670 40721 . + . ID=transcript_14669;Q8NCN5 A7E298 A8K8Y7 B3KSE1 Q6AI20 Q6AWC9,Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial,, PF01266;PF16350;PF01571;PF08669;, GO:0005737;GO:0005759;GO:0005739;GO:0016491;GO:0010510;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:oxidoreductase activity;, P:regulation of acetyl-CoA biosynthetic process from pyruvate; scaffold150 indexed_genome mRNA 94394 95073 . + . ID=transcript_14670;Q8NCF0 Q8IUW8,C-type lectin domain family 18 member C,Mannose receptor-like protein 3;, PF00188;PF00059;, GO:0005783;GO:0005768;GO:0005615;GO:0005794;GO:0030247;, C:endoplasmic reticulum; C:endosome; C:extracellular space; C:Golgi apparatus;, F:polysaccharide binding; scaffold150 indexed_genome mRNA 96019 99088 . + . ID=transcript_14671;A5D8T8 A8K1G9 Q6DCB3 Q7Z5K9 Q96HH2,C-type lectin domain family 18 member A,Mannose receptor-like protein 2;, PF00188;PF00059;, GO:0005783;GO:0005768;GO:0005615;GO:0005794;GO:0030247;, C:endoplasmic reticulum; C:endosome; C:extracellular space; C:Golgi apparatus;, F:polysaccharide binding; scaffold150 indexed_genome mRNA 102176 103540 . + . ID=transcript_14672;Q9HB71 B2ZWH2 B3KSF1 O60666 Q5R370 Q5R371,Calcyclin-binding protein,S100A6-binding protein;Siah-interacting protein;, PF04969;PF05002;PF09032;, GO:0030877;GO:0044297;GO:0005829;GO:0070062;GO:0043005;GO:0005641;GO:0005654;GO:0005634;GO:0019005;GO:0019904;GO:0042803;GO:0044548;GO:0015631;GO:0031625;GO:0007568;GO:0055007;GO:0071277;GO:1990830;GO:0007507;GO:0060548;GO:0045740;GO:0060416;, C:beta-catenin destruction complex; C:cell body; C:cytosol; C:extracellular exosome; C:neuron projection; C:nuclear envelope lumen; C:nucleoplasm; C:nucleus; C:SCF ubiquitin ligase complex;, F:protein domain specific binding; F:protein homodimerization activity; F:S100 protein binding; F:tubulin binding; F:ubiquitin protein ligase binding;, P:aging; P:cardiac muscle cell differentiation; P:cellular response to calcium ion; P:cellular response to leukemia inhibitory factor; P:heart development; P:negative regulation of cell death; P:positive regulation of DNA replication; P:response to growth hormone; scaffold150 indexed_genome mRNA 110586 115174 . + . ID=transcript_14673;Q86SE5 B3KTH2 G3V129 Q6ZW87 Q8N1C2,RNA-binding Raly-like protein,Heterogeneous nuclear ribonucleoprotein C-like 3;, PF00076;, GO:0005654;GO:0005634;GO:0042802;GO:0003723;, C:nucleoplasm; C:nucleus;, F:identical protein binding; F:RNA binding; scaffold150 indexed_genome mRNA 119336 135725 . - . ID=transcript_14674;P49588 A6NF14 B4DR45 Q53GV7 Q96FA0,Alanine--tRNA ligase, cytoplasmic {ECO:0000255|HAMAP-Rule:MF_03133},Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};Renal carcinoma antigen NY-REN-42;, PF02272;PF01411;PF07973;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0004813;GO:0016597;GO:0002161;GO:0005524;GO:0002196;GO:0000049;GO:0008270;GO:0006419;GO:0006418;GO:0006400;GO:0008033;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:alanine-tRNA ligase activity; F:amino acid binding; F:aminoacyl-tRNA editing activity; F:ATP binding; F:Ser-tRNA(Ala) hydrolase activity; F:tRNA binding; F:zinc ion binding;, P:alanyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; P:tRNA modification; P:tRNA processing;|P49588 A6NF14 B4DR45 Q53GV7 Q96FA0,Alanine--tRNA ligase, cytoplasmic {ECO:0000255|HAMAP-Rule:MF_03133},Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};Renal carcinoma antigen NY-REN-42;, PF02272;PF01411;PF07973;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0004813;GO:0016597;GO:0002161;GO:0005524;GO:0002196;GO:0000049;GO:0008270;GO:0006419;GO:0006418;GO:0006400;GO:0008033;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:alanine-tRNA ligase activity; F:amino acid binding; F:aminoacyl-tRNA editing activity; F:ATP binding; F:Ser-tRNA(Ala) hydrolase activity; F:tRNA binding; F:zinc ion binding;, P:alanyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; P:tRNA modification; P:tRNA processing;|P49588 A6NF14 B4DR45 Q53GV7 Q96FA0,Alanine--tRNA ligase, cytoplasmic {ECO:0000255|HAMAP-Rule:MF_03133},Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};Renal carcinoma antigen NY-REN-42;, PF02272;PF01411;PF07973;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0004813;GO:0016597;GO:0002161;GO:0005524;GO:0002196;GO:0000049;GO:0008270;GO:0006419;GO:0006418;GO:0006400;GO:0008033;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:alanine-tRNA ligase activity; F:amino acid binding; F:aminoacyl-tRNA editing activity; F:ATP binding; F:Ser-tRNA(Ala) hydrolase activity; F:tRNA binding; F:zinc ion binding;, P:alanyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; P:tRNA modification; P:tRNA processing;|P49588 A6NF14 B4DR45 Q53GV7 Q96FA0,Alanine--tRNA ligase, cytoplasmic {ECO:0000255|HAMAP-Rule:MF_03133},Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};Renal carcinoma antigen NY-REN-42;, PF02272;PF01411;PF07973;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0004813;GO:0016597;GO:0002161;GO:0005524;GO:0002196;GO:0000049;GO:0008270;GO:0006419;GO:0006418;GO:0006400;GO:0008033;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:alanine-tRNA ligase activity; F:amino acid binding; F:aminoacyl-tRNA editing activity; F:ATP binding; F:Ser-tRNA(Ala) hydrolase activity; F:tRNA binding; F:zinc ion binding;, P:alanyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; P:tRNA modification; P:tRNA processing;|P49588 A6NF14 B4DR45 Q53GV7 Q96FA0,Alanine--tRNA ligase, cytoplasmic {ECO:0000255|HAMAP-Rule:MF_03133},Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};Renal carcinoma antigen NY-REN-42;, PF02272;PF01411;PF07973;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0004813;GO:0016597;GO:0002161;GO:0005524;GO:0002196;GO:0000049;GO:0008270;GO:0006419;GO:0006418;GO:0006400;GO:0008033;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:alanine-tRNA ligase activity; F:amino acid binding; F:aminoacyl-tRNA editing activity; F:ATP binding; F:Ser-tRNA(Ala) hydrolase activity; F:tRNA binding; F:zinc ion binding;, P:alanyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; P:tRNA modification; P:tRNA processing;|P49588 A6NF14 B4DR45 Q53GV7 Q96FA0,Alanine--tRNA ligase, cytoplasmic {ECO:0000255|HAMAP-Rule:MF_03133},Alanyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_03133};Renal carcinoma antigen NY-REN-42;, PF02272;PF01411;PF07973;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005739;GO:0004813;GO:0016597;GO:0002161;GO:0005524;GO:0002196;GO:0000049;GO:0008270;GO:0006419;GO:0006418;GO:0006400;GO:0008033;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:mitochondrion;, F:alanine-tRNA ligase activity; F:amino acid binding; F:aminoacyl-tRNA editing activity; F:ATP binding; F:Ser-tRNA(Ala) hydrolase activity; F:tRNA binding; F:zinc ion binding;, P:alanyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; P:tRNA modification; P:tRNA processing; scaffold150 indexed_genome mRNA 142174 160630 . + . ID=transcript_14675;Q9UMR2 B3KNE9 B4DXS6 E7EMK4 Q6FIB7 Q6IAE0 Q96KE7 Q9H0U0,ATP-dependent RNA helicase DDX19B,DEAD box RNA helicase DEAD5;DEAD box protein 19B;, PF00270;PF00271;, GO:0005737;GO:0010494;GO:0070062;GO:0016020;GO:0005635;GO:0005643;GO:0005654;GO:0005634;GO:0005524;GO:0004386;GO:0003723;GO:0003724;GO:0006406;GO:0016973;, C:cytoplasm; C:cytoplasmic stress granule; C:extracellular exosome; C:membrane; C:nuclear envelope; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:ATP binding; F:helicase activity; F:RNA binding; F:RNA helicase activity;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus;|Q9UMR2 B3KNE9 B4DXS6 E7EMK4 Q6FIB7 Q6IAE0 Q96KE7 Q9H0U0,ATP-dependent RNA helicase DDX19B,DEAD box RNA helicase DEAD5;DEAD box protein 19B;, PF00270;PF00271;, GO:0005737;GO:0010494;GO:0070062;GO:0016020;GO:0005635;GO:0005643;GO:0005654;GO:0005634;GO:0005524;GO:0004386;GO:0003723;GO:0003724;GO:0006406;GO:0016973;, C:cytoplasm; C:cytoplasmic stress granule; C:extracellular exosome; C:membrane; C:nuclear envelope; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:ATP binding; F:helicase activity; F:RNA binding; F:RNA helicase activity;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus;|Q9UMR2 B3KNE9 B4DXS6 E7EMK4 Q6FIB7 Q6IAE0 Q96KE7 Q9H0U0,ATP-dependent RNA helicase DDX19B,DEAD box RNA helicase DEAD5;DEAD box protein 19B;, PF00270;PF00271;, GO:0005737;GO:0010494;GO:0070062;GO:0016020;GO:0005635;GO:0005643;GO:0005654;GO:0005634;GO:0005524;GO:0004386;GO:0003723;GO:0003724;GO:0006406;GO:0016973;, C:cytoplasm; C:cytoplasmic stress granule; C:extracellular exosome; C:membrane; C:nuclear envelope; C:nuclear pore; C:nucleoplasm; C:nucleus;, F:ATP binding; F:helicase activity; F:RNA binding; F:RNA helicase activity;, P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus;|Q9NUU7 B2RPL0 B4DRZ7 Q53FM0,ATP-dependent RNA helicase DDX19A,DDX19-like protein;DEAD box protein 19A;, PF00270;PF00271;, GO:0010494;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0016973;, C:cytoplasmic stress granule; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:poly(A)+ mRNA export from nucleus;|Q9NUU7 B2RPL0 B4DRZ7 Q53FM0,ATP-dependent RNA helicase DDX19A,DDX19-like protein;DEAD box protein 19A;, PF00270;PF00271;, GO:0010494;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0016973;, C:cytoplasmic stress granule; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:poly(A)+ mRNA export from nucleus; scaffold150 indexed_genome mRNA 177631 186749 . + . ID=transcript_14676;Q9NUU7 B2RPL0 B4DRZ7 Q53FM0,ATP-dependent RNA helicase DDX19A,DDX19-like protein;DEAD box protein 19A;, PF00270;PF00271;, GO:0010494;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0016973;, C:cytoplasmic stress granule; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:poly(A)+ mRNA export from nucleus;|Q9NUU7 B2RPL0 B4DRZ7 Q53FM0,ATP-dependent RNA helicase DDX19A,DDX19-like protein;DEAD box protein 19A;, PF00270;PF00271;, GO:0010494;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0016973;, C:cytoplasmic stress granule; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:poly(A)+ mRNA export from nucleus; scaffold150 indexed_genome mRNA 188615 190058 . + . ID=transcript_14677;Q9NUU7 B2RPL0 B4DRZ7 Q53FM0,ATP-dependent RNA helicase DDX19A,DDX19-like protein;DEAD box protein 19A;, PF00270;PF00271;, GO:0010494;GO:0016020;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0003724;GO:0016973;, C:cytoplasmic stress granule; C:membrane; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:poly(A)+ mRNA export from nucleus; scaffold150 indexed_genome mRNA 197506 206948 . + . ID=transcript_14678;Q16842 O00654,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2,Gal-NAc6S;Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase {ECO:0000303|PubMed:9266697};Monosialoganglioside sialyltransferase;ST3Gal II {ECO:0000303|PubMed:8920913};ST3GalA.2;Sialyltransferase 4B;, PF00777;, GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0003836;GO:0047288;GO:0042803;GO:0010706;GO:0010707;GO:0009247;GO:0009101;GO:0018146;GO:0030259;GO:0016266;GO:0009312;GO:0006486;GO:1990743;GO:0097503;GO:0019082;, C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; F:monosialoganglioside sialyltransferase activity; F:protein homodimerization activity;, P:ganglioside biosynthetic process via lactosylceramide; P:globoside biosynthetic process via lactosylceramide; P:glycolipid biosynthetic process; P:glycoprotein biosynthetic process; P:keratan sulfate biosynthetic process; P:lipid glycosylation; P:O-glycan processing; P:oligosaccharide biosynthetic process; P:protein glycosylation; P:protein sialylation; P:sialylation; P:viral protein processing; scaffold150 indexed_genome mRNA 207134 212000 . - . ID=transcript_14679;Q16842 O00654,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2,Gal-NAc6S;Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase {ECO:0000303|PubMed:9266697};Monosialoganglioside sialyltransferase;ST3Gal II {ECO:0000303|PubMed:8920913};ST3GalA.2;Sialyltransferase 4B;, PF00777;, GO:0005576;GO:0032580;GO:0000139;GO:0016021;GO:0003836;GO:0047288;GO:0042803;GO:0010706;GO:0010707;GO:0009247;GO:0009101;GO:0018146;GO:0030259;GO:0016266;GO:0009312;GO:0006486;GO:1990743;GO:0097503;GO:0019082;, C:extracellular region; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane;, F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; F:monosialoganglioside sialyltransferase activity; F:protein homodimerization activity;, P:ganglioside biosynthetic process via lactosylceramide; P:globoside biosynthetic process via lactosylceramide; P:glycolipid biosynthetic process; P:glycoprotein biosynthetic process; P:keratan sulfate biosynthetic process; P:lipid glycosylation; P:O-glycan processing; P:oligosaccharide biosynthetic process; P:protein glycosylation; P:protein sialylation; P:sialylation; P:viral protein processing; scaffold150 indexed_genome mRNA 261153 303447 . - . ID=transcript_14680;Q8N0W3 Q5PSM3 Q5XKL6 Q6ZRA0 Q96MT9,L-fucose kinase {ECO:0000305},, PF07959;PF08544;PF00288;, GO:0005829;GO:0005524;GO:0050201;GO:0046835;GO:0042352;GO:1903350;, C:cytosol;, F:ATP binding; F:fucokinase activity;, P:carbohydrate phosphorylation; P:GDP-L-fucose salvage; P:response to dopamine;|Q8N0W3 Q5PSM3 Q5XKL6 Q6ZRA0 Q96MT9,L-fucose kinase {ECO:0000305},, PF07959;PF08544;PF00288;, GO:0005829;GO:0005524;GO:0050201;GO:0046835;GO:0042352;GO:1903350;, C:cytosol;, F:ATP binding; F:fucokinase activity;, P:carbohydrate phosphorylation; P:GDP-L-fucose salvage; P:response to dopamine;|Q8N0W3 Q5PSM3 Q5XKL6 Q6ZRA0 Q96MT9,L-fucose kinase {ECO:0000305},, PF07959;PF08544;PF00288;, GO:0005829;GO:0005524;GO:0050201;GO:0046835;GO:0042352;GO:1903350;, C:cytosol;, F:ATP binding; F:fucokinase activity;, P:carbohydrate phosphorylation; P:GDP-L-fucose salvage; P:response to dopamine;|Q8N0W3 Q5PSM3 Q5XKL6 Q6ZRA0 Q96MT9,L-fucose kinase {ECO:0000305},, PF07959;PF08544;PF00288;, GO:0005829;GO:0005524;GO:0050201;GO:0046835;GO:0042352;GO:1903350;, C:cytosol;, F:ATP binding; F:fucokinase activity;, P:carbohydrate phosphorylation; P:GDP-L-fucose salvage; P:response to dopamine;|Q8N0W3 Q5PSM3 Q5XKL6 Q6ZRA0 Q96MT9,L-fucose kinase {ECO:0000305},, PF07959;PF08544;PF00288;, GO:0005829;GO:0005524;GO:0050201;GO:0046835;GO:0042352;GO:1903350;, C:cytosol;, F:ATP binding; F:fucokinase activity;, P:carbohydrate phosphorylation; P:GDP-L-fucose salvage; P:response to dopamine;|Q8N0W3 Q5PSM3 Q5XKL6 Q6ZRA0 Q96MT9,L-fucose kinase {ECO:0000305},, PF07959;PF08544;PF00288;, GO:0005829;GO:0005524;GO:0050201;GO:0046835;GO:0042352;GO:1903350;, C:cytosol;, F:ATP binding; F:fucokinase activity;, P:carbohydrate phosphorylation; P:GDP-L-fucose salvage; P:response to dopamine;|Q8N0W3 Q5PSM3 Q5XKL6 Q6ZRA0 Q96MT9,L-fucose kinase {ECO:0000305},, PF07959;PF08544;PF00288;, GO:0005829;GO:0005524;GO:0050201;GO:0046835;GO:0042352;GO:1903350;, C:cytosol;, F:ATP binding; F:fucokinase activity;, P:carbohydrate phosphorylation; P:GDP-L-fucose salvage; P:response to dopamine;|Q8N0W3 Q5PSM3 Q5XKL6 Q6ZRA0 Q96MT9,L-fucose kinase {ECO:0000305},, PF07959;PF08544;PF00288;, GO:0005829;GO:0005524;GO:0050201;GO:0046835;GO:0042352;GO:1903350;, C:cytosol;, F:ATP binding; F:fucokinase activity;, P:carbohydrate phosphorylation; P:GDP-L-fucose salvage; P:response to dopamine;|Q8N0W3 Q5PSM3 Q5XKL6 Q6ZRA0 Q96MT9,L-fucose kinase {ECO:0000305},, PF07959;PF08544;PF00288;, GO:0005829;GO:0005524;GO:0050201;GO:0046835;GO:0042352;GO:1903350;, C:cytosol;, F:ATP binding; F:fucokinase activity;, P:carbohydrate phosphorylation; P:GDP-L-fucose salvage; P:response to dopamine;|Q9H9E3 B4DMN8 C9JS23 Q96D40 Q9BRF0 Q9BVZ2 Q9H5Y4 Q9Y3W3,Conserved oligomeric Golgi complex subunit 4,Component of oligomeric Golgi complex 4;, PF08318;, GO:0005829;GO:0000139;GO:0017119;GO:0032588;GO:0042802;GO:0006888;GO:0007030;GO:0048213;GO:0015031;GO:0006890;, C:cytosol; C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, F:identical protein binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi vesicle prefusion complex stabilization; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9H9E3 B4DMN8 C9JS23 Q96D40 Q9BRF0 Q9BVZ2 Q9H5Y4 Q9Y3W3,Conserved oligomeric Golgi complex subunit 4,Component of oligomeric Golgi complex 4;, PF08318;, GO:0005829;GO:0000139;GO:0017119;GO:0032588;GO:0042802;GO:0006888;GO:0007030;GO:0048213;GO:0015031;GO:0006890;, C:cytosol; C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, F:identical protein binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi vesicle prefusion complex stabilization; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9H9E3 B4DMN8 C9JS23 Q96D40 Q9BRF0 Q9BVZ2 Q9H5Y4 Q9Y3W3,Conserved oligomeric Golgi complex subunit 4,Component of oligomeric Golgi complex 4;, PF08318;, GO:0005829;GO:0000139;GO:0017119;GO:0032588;GO:0042802;GO:0006888;GO:0007030;GO:0048213;GO:0015031;GO:0006890;, C:cytosol; C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, F:identical protein binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi vesicle prefusion complex stabilization; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9H9E3 B4DMN8 C9JS23 Q96D40 Q9BRF0 Q9BVZ2 Q9H5Y4 Q9Y3W3,Conserved oligomeric Golgi complex subunit 4,Component of oligomeric Golgi complex 4;, PF08318;, GO:0005829;GO:0000139;GO:0017119;GO:0032588;GO:0042802;GO:0006888;GO:0007030;GO:0048213;GO:0015031;GO:0006890;, C:cytosol; C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, F:identical protein binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi vesicle prefusion complex stabilization; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9H9E3 B4DMN8 C9JS23 Q96D40 Q9BRF0 Q9BVZ2 Q9H5Y4 Q9Y3W3,Conserved oligomeric Golgi complex subunit 4,Component of oligomeric Golgi complex 4;, PF08318;, GO:0005829;GO:0000139;GO:0017119;GO:0032588;GO:0042802;GO:0006888;GO:0007030;GO:0048213;GO:0015031;GO:0006890;, C:cytosol; C:Golgi membrane; C:Golgi transport complex; C:trans-Golgi network membrane;, F:identical protein binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi vesicle prefusion complex stabilization; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold150 indexed_genome mRNA 303712 344055 . + . ID=transcript_14681;Q15393 Q6NTI8 Q96GC0 Q9BPY2 Q9UFX7 Q9UJ29,Splicing factor 3B subunit 3,Pre-mRNA-splicing factor SF3b 130 kDa subunit;STAF130;Spliceosome-associated protein 130;, PF03178;PF10433;, GO:0071013;GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0071005;GO:0003676;GO:0044877;GO:0000398;GO:0042177;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:nucleic acid binding; F:protein-containing complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of protein catabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q9NRJ1,Protein MOST-1,, , GO:0005737;GO:0005789;GO:0005634;GO:0043066;GO:0008284;, C:cytoplasm; C:endoplasmic reticulum membrane; C:nucleus;, , P:negative regulation of apoptotic process; P:positive regulation of cell population proliferation;|Q15393 Q6NTI8 Q96GC0 Q9BPY2 Q9UFX7 Q9UJ29,Splicing factor 3B subunit 3,Pre-mRNA-splicing factor SF3b 130 kDa subunit;STAF130;Spliceosome-associated protein 130;, PF03178;PF10433;, GO:0071013;GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0071005;GO:0003676;GO:0044877;GO:0000398;GO:0042177;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:nucleic acid binding; F:protein-containing complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of protein catabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q15393 Q6NTI8 Q96GC0 Q9BPY2 Q9UFX7 Q9UJ29,Splicing factor 3B subunit 3,Pre-mRNA-splicing factor SF3b 130 kDa subunit;STAF130;Spliceosome-associated protein 130;, PF03178;PF10433;, GO:0071013;GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0071005;GO:0003676;GO:0044877;GO:0000398;GO:0042177;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:nucleic acid binding; F:protein-containing complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of protein catabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q15393 Q6NTI8 Q96GC0 Q9BPY2 Q9UFX7 Q9UJ29,Splicing factor 3B subunit 3,Pre-mRNA-splicing factor SF3b 130 kDa subunit;STAF130;Spliceosome-associated protein 130;, PF03178;PF10433;, GO:0071013;GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0071005;GO:0003676;GO:0044877;GO:0000398;GO:0042177;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:nucleic acid binding; F:protein-containing complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of protein catabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q15393 Q6NTI8 Q96GC0 Q9BPY2 Q9UFX7 Q9UJ29,Splicing factor 3B subunit 3,Pre-mRNA-splicing factor SF3b 130 kDa subunit;STAF130;Spliceosome-associated protein 130;, PF03178;PF10433;, GO:0071013;GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0071005;GO:0003676;GO:0044877;GO:0000398;GO:0042177;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:nucleic acid binding; F:protein-containing complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of protein catabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q15393 Q6NTI8 Q96GC0 Q9BPY2 Q9UFX7 Q9UJ29,Splicing factor 3B subunit 3,Pre-mRNA-splicing factor SF3b 130 kDa subunit;STAF130;Spliceosome-associated protein 130;, PF03178;PF10433;, GO:0071013;GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0071005;GO:0003676;GO:0044877;GO:0000398;GO:0042177;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:nucleic acid binding; F:protein-containing complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of protein catabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q15393 Q6NTI8 Q96GC0 Q9BPY2 Q9UFX7 Q9UJ29,Splicing factor 3B subunit 3,Pre-mRNA-splicing factor SF3b 130 kDa subunit;STAF130;Spliceosome-associated protein 130;, PF03178;PF10433;, GO:0071013;GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0071005;GO:0003676;GO:0044877;GO:0000398;GO:0042177;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:nucleic acid binding; F:protein-containing complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of protein catabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q15393 Q6NTI8 Q96GC0 Q9BPY2 Q9UFX7 Q9UJ29,Splicing factor 3B subunit 3,Pre-mRNA-splicing factor SF3b 130 kDa subunit;STAF130;Spliceosome-associated protein 130;, PF03178;PF10433;, GO:0071013;GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0071005;GO:0003676;GO:0044877;GO:0000398;GO:0042177;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:nucleic acid binding; F:protein-containing complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of protein catabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q15393 Q6NTI8 Q96GC0 Q9BPY2 Q9UFX7 Q9UJ29,Splicing factor 3B subunit 3,Pre-mRNA-splicing factor SF3b 130 kDa subunit;STAF130;Spliceosome-associated protein 130;, PF03178;PF10433;, GO:0071013;GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0071005;GO:0003676;GO:0044877;GO:0000398;GO:0042177;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:nucleic acid binding; F:protein-containing complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of protein catabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions;|Q15393 Q6NTI8 Q96GC0 Q9BPY2 Q9UFX7 Q9UJ29,Splicing factor 3B subunit 3,Pre-mRNA-splicing factor SF3b 130 kDa subunit;STAF130;Spliceosome-associated protein 130;, PF03178;PF10433;, GO:0071013;GO:0005730;GO:0005654;GO:0005634;GO:0005689;GO:0071005;GO:0003676;GO:0044877;GO:0000398;GO:0042177;GO:0008380;GO:0000375;, C:catalytic step 2 spliceosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome;, F:nucleic acid binding; F:protein-containing complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of protein catabolic process; P:RNA splicing; P:RNA splicing, via transesterification reactions; scaffold150 indexed_genome mRNA 362587 411570 . + . ID=transcript_14682;Q6ZMJ4 B2RC28 B2Z4A8 B2ZC70 Q8N6L2,Interleukin-34,, PF15036;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0042802;GO:0005157;GO:0019221;GO:0006954;GO:0045087;GO:0061514;GO:0061518;GO:0008284;GO:0010628;GO:0010759;GO:0045651;GO:0120041;GO:0043406;GO:0045657;GO:0048714;GO:0001934;GO:0061098;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:identical protein binding; F:macrophage colony-stimulating factor receptor binding;, P:cytokine-mediated signaling pathway; P:inflammatory response; P:innate immune response; P:interleukin-34-mediated signaling pathway; P:microglial cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage differentiation; P:positive regulation of macrophage proliferation; P:positive regulation of MAP kinase activity; P:positive regulation of monocyte differentiation; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity;|Q6ZMJ4 B2RC28 B2Z4A8 B2ZC70 Q8N6L2,Interleukin-34,, PF15036;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0042802;GO:0005157;GO:0019221;GO:0006954;GO:0045087;GO:0061514;GO:0061518;GO:0008284;GO:0010628;GO:0010759;GO:0045651;GO:0120041;GO:0043406;GO:0045657;GO:0048714;GO:0001934;GO:0061098;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:identical protein binding; F:macrophage colony-stimulating factor receptor binding;, P:cytokine-mediated signaling pathway; P:inflammatory response; P:innate immune response; P:interleukin-34-mediated signaling pathway; P:microglial cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage differentiation; P:positive regulation of macrophage proliferation; P:positive regulation of MAP kinase activity; P:positive regulation of monocyte differentiation; P:positive regulation of oligodendrocyte differentiation; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; scaffold150 indexed_genome mRNA 415091 426374 . - . ID=transcript_14683;Q765P7 A6NJI7 Q9BUA8,Protein MTSS 2 {ECO:0000305},Actin-bundling with BAIAP2 homology protein 1;MTSS1-like protein;, PF08397;, GO:0030864;GO:0030027;GO:0032587;GO:0003785;GO:0005096;GO:0005546;GO:0031267;GO:0090630;GO:0036120;GO:0097581;GO:0007009;GO:0097178;, C:cortical actin cytoskeleton; C:lamellipodium; C:ruffle membrane;, F:actin monomer binding; F:GTPase activator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding;, P:activation of GTPase activity; P:cellular response to platelet-derived growth factor stimulus; P:lamellipodium organization; P:plasma membrane organization; P:ruffle assembly;|Q765P7 A6NJI7 Q9BUA8,Protein MTSS 2 {ECO:0000305},Actin-bundling with BAIAP2 homology protein 1;MTSS1-like protein;, PF08397;, GO:0030864;GO:0030027;GO:0032587;GO:0003785;GO:0005096;GO:0005546;GO:0031267;GO:0090630;GO:0036120;GO:0097581;GO:0007009;GO:0097178;, C:cortical actin cytoskeleton; C:lamellipodium; C:ruffle membrane;, F:actin monomer binding; F:GTPase activator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding;, P:activation of GTPase activity; P:cellular response to platelet-derived growth factor stimulus; P:lamellipodium organization; P:plasma membrane organization; P:ruffle assembly;|Q765P7 A6NJI7 Q9BUA8,Protein MTSS 2 {ECO:0000305},Actin-bundling with BAIAP2 homology protein 1;MTSS1-like protein;, PF08397;, GO:0030864;GO:0030027;GO:0032587;GO:0003785;GO:0005096;GO:0005546;GO:0031267;GO:0090630;GO:0036120;GO:0097581;GO:0007009;GO:0097178;, C:cortical actin cytoskeleton; C:lamellipodium; C:ruffle membrane;, F:actin monomer binding; F:GTPase activator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding;, P:activation of GTPase activity; P:cellular response to platelet-derived growth factor stimulus; P:lamellipodium organization; P:plasma membrane organization; P:ruffle assembly;|Q765P7 A6NJI7 Q9BUA8,Protein MTSS 2 {ECO:0000305},Actin-bundling with BAIAP2 homology protein 1;MTSS1-like protein;, PF08397;, GO:0030864;GO:0030027;GO:0032587;GO:0003785;GO:0005096;GO:0005546;GO:0031267;GO:0090630;GO:0036120;GO:0097581;GO:0007009;GO:0097178;, C:cortical actin cytoskeleton; C:lamellipodium; C:ruffle membrane;, F:actin monomer binding; F:GTPase activator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding;, P:activation of GTPase activity; P:cellular response to platelet-derived growth factor stimulus; P:lamellipodium organization; P:plasma membrane organization; P:ruffle assembly;|Q765P7 A6NJI7 Q9BUA8,Protein MTSS 2 {ECO:0000305},Actin-bundling with BAIAP2 homology protein 1;MTSS1-like protein;, PF08397;, GO:0030864;GO:0030027;GO:0032587;GO:0003785;GO:0005096;GO:0005546;GO:0031267;GO:0090630;GO:0036120;GO:0097581;GO:0007009;GO:0097178;, C:cortical actin cytoskeleton; C:lamellipodium; C:ruffle membrane;, F:actin monomer binding; F:GTPase activator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding;, P:activation of GTPase activity; P:cellular response to platelet-derived growth factor stimulus; P:lamellipodium organization; P:plasma membrane organization; P:ruffle assembly;|Q765P7 A6NJI7 Q9BUA8,Protein MTSS 2 {ECO:0000305},Actin-bundling with BAIAP2 homology protein 1;MTSS1-like protein;, PF08397;, GO:0030864;GO:0030027;GO:0032587;GO:0003785;GO:0005096;GO:0005546;GO:0031267;GO:0090630;GO:0036120;GO:0097581;GO:0007009;GO:0097178;, C:cortical actin cytoskeleton; C:lamellipodium; C:ruffle membrane;, F:actin monomer binding; F:GTPase activator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding;, P:activation of GTPase activity; P:cellular response to platelet-derived growth factor stimulus; P:lamellipodium organization; P:plasma membrane organization; P:ruffle assembly; scaffold150 indexed_genome mRNA 427490 432097 . - . ID=transcript_14684;Q765P7 A6NJI7 Q9BUA8,Protein MTSS 2 {ECO:0000305},Actin-bundling with BAIAP2 homology protein 1;MTSS1-like protein;, PF08397;, GO:0030864;GO:0030027;GO:0032587;GO:0003785;GO:0005096;GO:0005546;GO:0031267;GO:0090630;GO:0036120;GO:0097581;GO:0007009;GO:0097178;, C:cortical actin cytoskeleton; C:lamellipodium; C:ruffle membrane;, F:actin monomer binding; F:GTPase activator activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:small GTPase binding;, P:activation of GTPase activity; P:cellular response to platelet-derived growth factor stimulus; P:lamellipodium organization; P:plasma membrane organization; P:ruffle assembly; scaffold150 indexed_genome mRNA 432736 508448 . - . ID=transcript_14685;Q08AM6 B3KPJ5 B3KSM8 Q13174 Q6IA12 Q7L4Y1 Q9BW96 Q9H6V6,Protein VAC14 homolog,Tax1-binding protein 2;, PF11916;, GO:0005829;GO:0031901;GO:0005783;GO:0010008;GO:0000306;GO:0000139;GO:0043231;GO:0031902;GO:0070772;GO:0042802;GO:0038023;GO:0006661;GO:0033674;GO:0007165;GO:0016032;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum; C:endosome membrane; C:extrinsic component of vacuolar membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:PAS complex;, F:identical protein binding; F:signaling receptor activity;, P:phosphatidylinositol biosynthetic process; P:positive regulation of kinase activity; P:signal transduction; P:viral process;|Q08AM6 B3KPJ5 B3KSM8 Q13174 Q6IA12 Q7L4Y1 Q9BW96 Q9H6V6,Protein VAC14 homolog,Tax1-binding protein 2;, PF11916;, GO:0005829;GO:0031901;GO:0005783;GO:0010008;GO:0000306;GO:0000139;GO:0043231;GO:0031902;GO:0070772;GO:0042802;GO:0038023;GO:0006661;GO:0033674;GO:0007165;GO:0016032;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum; C:endosome membrane; C:extrinsic component of vacuolar membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:PAS complex;, F:identical protein binding; F:signaling receptor activity;, P:phosphatidylinositol biosynthetic process; P:positive regulation of kinase activity; P:signal transduction; P:viral process;|Q08AM6 B3KPJ5 B3KSM8 Q13174 Q6IA12 Q7L4Y1 Q9BW96 Q9H6V6,Protein VAC14 homolog,Tax1-binding protein 2;, PF11916;, GO:0005829;GO:0031901;GO:0005783;GO:0010008;GO:0000306;GO:0000139;GO:0043231;GO:0031902;GO:0070772;GO:0042802;GO:0038023;GO:0006661;GO:0033674;GO:0007165;GO:0016032;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum; C:endosome membrane; C:extrinsic component of vacuolar membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:PAS complex;, F:identical protein binding; F:signaling receptor activity;, P:phosphatidylinositol biosynthetic process; P:positive regulation of kinase activity; P:signal transduction; P:viral process;|Q08AM6 B3KPJ5 B3KSM8 Q13174 Q6IA12 Q7L4Y1 Q9BW96 Q9H6V6,Protein VAC14 homolog,Tax1-binding protein 2;, PF11916;, GO:0005829;GO:0031901;GO:0005783;GO:0010008;GO:0000306;GO:0000139;GO:0043231;GO:0031902;GO:0070772;GO:0042802;GO:0038023;GO:0006661;GO:0033674;GO:0007165;GO:0016032;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum; C:endosome membrane; C:extrinsic component of vacuolar membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:PAS complex;, F:identical protein binding; F:signaling receptor activity;, P:phosphatidylinositol biosynthetic process; P:positive regulation of kinase activity; P:signal transduction; P:viral process;|Q08AM6 B3KPJ5 B3KSM8 Q13174 Q6IA12 Q7L4Y1 Q9BW96 Q9H6V6,Protein VAC14 homolog,Tax1-binding protein 2;, PF11916;, GO:0005829;GO:0031901;GO:0005783;GO:0010008;GO:0000306;GO:0000139;GO:0043231;GO:0031902;GO:0070772;GO:0042802;GO:0038023;GO:0006661;GO:0033674;GO:0007165;GO:0016032;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum; C:endosome membrane; C:extrinsic component of vacuolar membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:PAS complex;, F:identical protein binding; F:signaling receptor activity;, P:phosphatidylinositol biosynthetic process; P:positive regulation of kinase activity; P:signal transduction; P:viral process;|Q08AM6 B3KPJ5 B3KSM8 Q13174 Q6IA12 Q7L4Y1 Q9BW96 Q9H6V6,Protein VAC14 homolog,Tax1-binding protein 2;, PF11916;, GO:0005829;GO:0031901;GO:0005783;GO:0010008;GO:0000306;GO:0000139;GO:0043231;GO:0031902;GO:0070772;GO:0042802;GO:0038023;GO:0006661;GO:0033674;GO:0007165;GO:0016032;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum; C:endosome membrane; C:extrinsic component of vacuolar membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:PAS complex;, F:identical protein binding; F:signaling receptor activity;, P:phosphatidylinositol biosynthetic process; P:positive regulation of kinase activity; P:signal transduction; P:viral process;|Q08AM6 B3KPJ5 B3KSM8 Q13174 Q6IA12 Q7L4Y1 Q9BW96 Q9H6V6,Protein VAC14 homolog,Tax1-binding protein 2;, PF11916;, GO:0005829;GO:0031901;GO:0005783;GO:0010008;GO:0000306;GO:0000139;GO:0043231;GO:0031902;GO:0070772;GO:0042802;GO:0038023;GO:0006661;GO:0033674;GO:0007165;GO:0016032;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum; C:endosome membrane; C:extrinsic component of vacuolar membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:PAS complex;, F:identical protein binding; F:signaling receptor activity;, P:phosphatidylinositol biosynthetic process; P:positive regulation of kinase activity; P:signal transduction; P:viral process;|Q08AM6 B3KPJ5 B3KSM8 Q13174 Q6IA12 Q7L4Y1 Q9BW96 Q9H6V6,Protein VAC14 homolog,Tax1-binding protein 2;, PF11916;, GO:0005829;GO:0031901;GO:0005783;GO:0010008;GO:0000306;GO:0000139;GO:0043231;GO:0031902;GO:0070772;GO:0042802;GO:0038023;GO:0006661;GO:0033674;GO:0007165;GO:0016032;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum; C:endosome membrane; C:extrinsic component of vacuolar membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:PAS complex;, F:identical protein binding; F:signaling receptor activity;, P:phosphatidylinositol biosynthetic process; P:positive regulation of kinase activity; P:signal transduction; P:viral process;|Q08AM6 B3KPJ5 B3KSM8 Q13174 Q6IA12 Q7L4Y1 Q9BW96 Q9H6V6,Protein VAC14 homolog,Tax1-binding protein 2;, PF11916;, GO:0005829;GO:0031901;GO:0005783;GO:0010008;GO:0000306;GO:0000139;GO:0043231;GO:0031902;GO:0070772;GO:0042802;GO:0038023;GO:0006661;GO:0033674;GO:0007165;GO:0016032;, C:cytosol; C:early endosome membrane; C:endoplasmic reticulum; C:endosome membrane; C:extrinsic component of vacuolar membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:PAS complex;, F:identical protein binding; F:signaling receptor activity;, P:phosphatidylinositol biosynthetic process; P:positive regulation of kinase activity; P:signal transduction; P:viral process; scaffold150 indexed_genome mRNA 512340 550719 . + . ID=transcript_14686;P59045 C9JSF5 Q2TV85 Q2TV86 Q53ZZ0 Q8NBF5,NACHT, LRR and PYD domains-containing protein 11,Nucleotide-binding oligomerization domain protein 17;PAAD-and NACHT domain-containing protein 10;PYRIN-containing APAF1-like protein 6;, PF13516;PF05729;PF17776;PF17779;PF02758;, GO:0005524;GO:0016715;GO:0003723;, , F:ATP binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen; F:RNA binding; scaffold150 indexed_genome mRNA 906119 917337 . + . ID=transcript_14687;P47985 A8K519 Q6NVX5 Q9UPH2,Cytochrome b-c1 complex subunit Rieske, mitochondrial,Complex III subunit 5;Cytochrome b-c1 complex subunit 5;Rieske iron-sulfur protein;Rieske protein UQCRFS1 {ECO:0000305};Ubiquinol-cytochrome c reductase iron-sulfur subunit;, PF00355;PF09165;PF02921;, GO:0016021;GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0051537;GO:0046872;GO:0016491;GO:0008121;GO:0006122;GO:0034551;GO:0022904;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding; F:oxidoreductase activity; F:ubiquinol-cytochrome-c reductase activity;, P:mitochondrial electron transport, ubiquinol to cytochrome c; P:mitochondrial respiratory chain complex III assembly; P:respiratory electron transport chain;|P47985 A8K519 Q6NVX5 Q9UPH2,Cytochrome b-c1 complex subunit Rieske, mitochondrial,Complex III subunit 5;Cytochrome b-c1 complex subunit 5;Rieske iron-sulfur protein;Rieske protein UQCRFS1 {ECO:0000305};Ubiquinol-cytochrome c reductase iron-sulfur subunit;, PF00355;PF09165;PF02921;, GO:0016021;GO:0005743;GO:0005750;GO:0005751;GO:0005739;GO:0051537;GO:0046872;GO:0016491;GO:0008121;GO:0006122;GO:0034551;GO:0022904;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrial respiratory chain complex IV; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding; F:oxidoreductase activity; F:ubiquinol-cytochrome-c reductase activity;, P:mitochondrial electron transport, ubiquinol to cytochrome c; P:mitochondrial respiratory chain complex III assembly; P:respiratory electron transport chain; scaffold150 indexed_genome mRNA 1477480 1478230 . + . ID=transcript_14688;Q9Y696 Q9UFW9 Q9UQJ6,Chloride intracellular channel protein 4,Intracellular chloride ion channel protein p64H1;, , GO:0015629;GO:0045177;GO:0009986;GO:0005911;GO:0005813;GO:0034707;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0005902;GO:0030496;GO:0005739;GO:0016363;GO:0005634;GO:0048471;GO:0005886;GO:0005254;GO:0005244;GO:0001525;GO:0048754;GO:0030154;GO:0071277;GO:0006821;GO:0001886;GO:0035088;GO:0009566;GO:0030216;GO:0035264;GO:0030336;GO:0051493;GO:0034765;GO:0061299;GO:0007035;, C:actin cytoskeleton; C:apical part of cell; C:cell surface; C:cell-cell junction; C:centrosome; C:chloride channel complex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:microvillus; C:midbody; C:mitochondrion; C:nuclear matrix; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:chloride channel activity; F:voltage-gated ion channel activity;, P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:cell differentiation; P:cellular response to calcium ion; P:chloride transport; P:endothelial cell morphogenesis; P:establishment or maintenance of apical/basal cell polarity; P:fertilization; P:keratinocyte differentiation; P:multicellular organism growth; P:negative regulation of cell migration; P:regulation of cytoskeleton organization; P:regulation of ion transmembrane transport; P:retina vasculature morphogenesis in camera-type eye; P:vacuolar acidification; scaffold150 indexed_genome mRNA 1483582 1485318 . + . ID=transcript_14689;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold150 indexed_genome mRNA 1502396 1511144 . - . ID=transcript_14690;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold150 indexed_genome mRNA 1539329 1545107 . + . ID=transcript_14691;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport;|Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold150 indexed_genome mRNA 1547250 1558792 . - . ID=transcript_14692;P01019 Q16358 Q16359 Q96F91,Angiotensinogen,Serpin A8;, PF00079;, GO:0072562;GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0008083;GO:0005179;GO:0048018;GO:0004867;GO:0017080;GO:0016176;GO:0031702;GO:0031703;GO:0000187;GO:0038166;GO:0001974;GO:0007267;GO:0007186;GO:0007199;GO:0001822;GO:0034374;GO:0002034;GO:0010951;GO:0010629;GO:0043407;GO:0051387;GO:2000650;GO:0007263;GO:0007200;GO:0010536;GO:0090190;GO:0010613;GO:0032270;GO:0010873;GO:0001819;GO:0010595;GO:0045742;GO:2001238;GO:0048146;GO:1903598;GO:0050729;GO:0010744;GO:1902632;GO:0033864;GO:0051092;GO:0050731;GO:0014068;GO:0061098;GO:2000379;GO:0045893;GO:0008217;GO:0002016;GO:1903779;GO:0001558;GO:0042127;GO:1901201;GO:0019222;GO:0002019;GO:0035813;GO:0019229;GO:0003014;GO:0002018;GO:0014873;GO:0042310;, C:blood microparticle; C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:growth factor activity; F:hormone activity; F:receptor ligand activity; F:serine-type endopeptidase inhibitor activity; F:sodium channel regulator activity; F:superoxide-generating NADPH oxidase activator activity; F:type 1 angiotensin receptor binding; F:type 2 angiotensin receptor binding;, P:activation of MAPK activity; P:angiotensin-activated signaling pathway; P:blood vessel remodeling; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; P:kidney development; P:low-density lipoprotein particle remodeling; P:maintenance of blood vessel diameter homeostasis by renin-angiotensin; P:negative regulation of endopeptidase activity; P:negative regulation of gene expression; P:negative regulation of MAP kinase activity; P:negative regulation of neurotrophin TRK receptor signaling pathway; P:negative regulation of sodium ion transmembrane transporter activity; P:nitric oxide mediated signal transduction; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of activation of Janus kinase activity; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol esterification; P:positive regulation of cytokine production; P:positive regulation of endothelial cell migration; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of fibroblast proliferation; P:positive regulation of gap junction assembly; P:positive regulation of inflammatory response; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of membrane hyperpolarization; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription, DNA-templated; P:regulation of blood pressure; P:regulation of blood volume by renin-angiotensin; P:regulation of cardiac conduction; P:regulation of cell growth; P:regulation of cell population proliferation; P:regulation of extracellular matrix assembly; P:regulation of metabolic process; P:regulation of renal output by angiotensin; P:regulation of renal sodium excretion; P:regulation of vasoconstriction; P:renal system process; P:renin-angiotensin regulation of aldosterone production; P:response to muscle activity involved in regulation of muscle adaptation; P:vasoconstriction;|P01019 Q16358 Q16359 Q96F91,Angiotensinogen,Serpin A8;, PF00079;, GO:0072562;GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0008083;GO:0005179;GO:0048018;GO:0004867;GO:0017080;GO:0016176;GO:0031702;GO:0031703;GO:0000187;GO:0038166;GO:0001974;GO:0007267;GO:0007186;GO:0007199;GO:0001822;GO:0034374;GO:0002034;GO:0010951;GO:0010629;GO:0043407;GO:0051387;GO:2000650;GO:0007263;GO:0007200;GO:0010536;GO:0090190;GO:0010613;GO:0032270;GO:0010873;GO:0001819;GO:0010595;GO:0045742;GO:2001238;GO:0048146;GO:1903598;GO:0050729;GO:0010744;GO:1902632;GO:0033864;GO:0051092;GO:0050731;GO:0014068;GO:0061098;GO:2000379;GO:0045893;GO:0008217;GO:0002016;GO:1903779;GO:0001558;GO:0042127;GO:1901201;GO:0019222;GO:0002019;GO:0035813;GO:0019229;GO:0003014;GO:0002018;GO:0014873;GO:0042310;, C:blood microparticle; C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:growth factor activity; F:hormone activity; F:receptor ligand activity; F:serine-type endopeptidase inhibitor activity; F:sodium channel regulator activity; F:superoxide-generating NADPH oxidase activator activity; F:type 1 angiotensin receptor binding; F:type 2 angiotensin receptor binding;, P:activation of MAPK activity; P:angiotensin-activated signaling pathway; P:blood vessel remodeling; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; P:kidney development; P:low-density lipoprotein particle remodeling; P:maintenance of blood vessel diameter homeostasis by renin-angiotensin; P:negative regulation of endopeptidase activity; P:negative regulation of gene expression; P:negative regulation of MAP kinase activity; P:negative regulation of neurotrophin TRK receptor signaling pathway; P:negative regulation of sodium ion transmembrane transporter activity; P:nitric oxide mediated signal transduction; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of activation of Janus kinase activity; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol esterification; P:positive regulation of cytokine production; P:positive regulation of endothelial cell migration; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of fibroblast proliferation; P:positive regulation of gap junction assembly; P:positive regulation of inflammatory response; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of membrane hyperpolarization; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription, DNA-templated; P:regulation of blood pressure; P:regulation of blood volume by renin-angiotensin; P:regulation of cardiac conduction; P:regulation of cell growth; P:regulation of cell population proliferation; P:regulation of extracellular matrix assembly; P:regulation of metabolic process; P:regulation of renal output by angiotensin; P:regulation of renal sodium excretion; P:regulation of vasoconstriction; P:renal system process; P:renin-angiotensin regulation of aldosterone production; P:response to muscle activity involved in regulation of muscle adaptation; P:vasoconstriction;|P01019 Q16358 Q16359 Q96F91,Angiotensinogen,Serpin A8;, PF00079;, GO:0072562;GO:0062023;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0008083;GO:0005179;GO:0048018;GO:0004867;GO:0017080;GO:0016176;GO:0031702;GO:0031703;GO:0000187;GO:0038166;GO:0001974;GO:0007267;GO:0007186;GO:0007199;GO:0001822;GO:0034374;GO:0002034;GO:0010951;GO:0010629;GO:0043407;GO:0051387;GO:2000650;GO:0007263;GO:0007200;GO:0010536;GO:0090190;GO:0010613;GO:0032270;GO:0010873;GO:0001819;GO:0010595;GO:0045742;GO:2001238;GO:0048146;GO:1903598;GO:0050729;GO:0010744;GO:1902632;GO:0033864;GO:0051092;GO:0050731;GO:0014068;GO:0061098;GO:2000379;GO:0045893;GO:0008217;GO:0002016;GO:1903779;GO:0001558;GO:0042127;GO:1901201;GO:0019222;GO:0002019;GO:0035813;GO:0019229;GO:0003014;GO:0002018;GO:0014873;GO:0042310;, C:blood microparticle; C:collagen-containing extracellular matrix; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:growth factor activity; F:hormone activity; F:receptor ligand activity; F:serine-type endopeptidase inhibitor activity; F:sodium channel regulator activity; F:superoxide-generating NADPH oxidase activator activity; F:type 1 angiotensin receptor binding; F:type 2 angiotensin receptor binding;, P:activation of MAPK activity; P:angiotensin-activated signaling pathway; P:blood vessel remodeling; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; P:kidney development; P:low-density lipoprotein particle remodeling; P:maintenance of blood vessel diameter homeostasis by renin-angiotensin; P:negative regulation of endopeptidase activity; P:negative regulation of gene expression; P:negative regulation of MAP kinase activity; P:negative regulation of neurotrophin TRK receptor signaling pathway; P:negative regulation of sodium ion transmembrane transporter activity; P:nitric oxide mediated signal transduction; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of activation of Janus kinase activity; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cardiac muscle hypertrophy; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol esterification; P:positive regulation of cytokine production; P:positive regulation of endothelial cell migration; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of fibroblast proliferation; P:positive regulation of gap junction assembly; P:positive regulation of inflammatory response; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of membrane hyperpolarization; P:positive regulation of NAD(P)H oxidase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of reactive oxygen species metabolic process; P:positive regulation of transcription, DNA-templated; P:regulation of blood pressure; P:regulation of blood volume by renin-angiotensin; P:regulation of cardiac conduction; P:regulation of cell growth; P:regulation of cell population proliferation; P:regulation of extracellular matrix assembly; P:regulation of metabolic process; P:regulation of renal output by angiotensin; P:regulation of renal sodium excretion; P:regulation of vasoconstriction; P:renal system process; P:renin-angiotensin regulation of aldosterone production; P:response to muscle activity involved in regulation of muscle adaptation; P:vasoconstriction; scaffold150 indexed_genome mRNA 1659317 1659949 . - . ID=transcript_14693;P08865 P11085 P12030 Q16471 Q6IPD1 Q6IPD2 Q6NSD1 Q6NXQ8 Q86VC0,40S ribosomal protein SA {ECO:0000255|HAMAP-Rule:MF_03016},37 kDa laminin receptor precursor {ECO:0000255|HAMAP-Rule:MF_03016};37/67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};67 kDa laminin receptor {ECO:0000255|HAMAP-Rule:MF_03016};Colon carcinoma laminin-binding protein;Laminin receptor 1 {ECO:0000255|HAMAP-Rule:MF_03016};Laminin-binding protein precursor p40 {ECO:0000255|HAMAP-Rule:MF_03016};Multidrug resistance-associated protein MGr1-Ag;NEM/1CHD4;Small ribosomal subunit protein uS2 {ECO:0000303|PubMed:24524803};, PF16122;PF00318;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0043236;GO:0005055;GO:0043022;GO:0003723;GO:0003735;GO:0001618;GO:0007155;GO:0002181;GO:0000184;GO:0000028;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:laminin binding; F:laminin receptor activity; F:ribosome binding; F:RNA binding; F:structural constituent of ribosome; F:virus receptor activity;, P:cell adhesion; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit assembly; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold150 indexed_genome mRNA 1990101 1992001 . + . ID=transcript_14694;Q15116 O00517 Q8IX89,Programmed cell death protein 1 {ECO:0000303|PubMed:7851902},, PF07686;, GO:0009897;GO:0016021;GO:0005886;GO:0002250;GO:0006915;GO:0006959;GO:0007275;GO:0050777;GO:0070234;GO:0050776;GO:0031295;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane;, , P:adaptive immune response; P:apoptotic process; P:humoral immune response; P:multicellular organism development; P:negative regulation of immune response; P:positive regulation of T cell apoptotic process; P:regulation of immune response; P:T cell costimulation; scaffold151 indexed_genome mRNA 1906 13166 . - . ID=transcript_14695;P56192 B3KVK7 Q14895 Q53H14 Q96A15 Q96BZ0 Q9NSE0,Methionine--tRNA ligase, cytoplasmic,Methionyl-tRNA synthetase;, PF00043;PF18485;PF09334;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005524;GO:0004825;GO:0000049;GO:0071364;GO:0032869;GO:0036120;GO:0009267;GO:0006431;GO:1901838;GO:0009303;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus;, F:ATP binding; F:methionine-tRNA ligase activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to starvation; P:methionyl-tRNA aminoacylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription; P:tRNA aminoacylation for protein translation;|P56192 B3KVK7 Q14895 Q53H14 Q96A15 Q96BZ0 Q9NSE0,Methionine--tRNA ligase, cytoplasmic,Methionyl-tRNA synthetase;, PF00043;PF18485;PF09334;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005524;GO:0004825;GO:0000049;GO:0071364;GO:0032869;GO:0036120;GO:0009267;GO:0006431;GO:1901838;GO:0009303;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus;, F:ATP binding; F:methionine-tRNA ligase activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to starvation; P:methionyl-tRNA aminoacylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription; P:tRNA aminoacylation for protein translation;|P56192 B3KVK7 Q14895 Q53H14 Q96A15 Q96BZ0 Q9NSE0,Methionine--tRNA ligase, cytoplasmic,Methionyl-tRNA synthetase;, PF00043;PF18485;PF09334;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005524;GO:0004825;GO:0000049;GO:0071364;GO:0032869;GO:0036120;GO:0009267;GO:0006431;GO:1901838;GO:0009303;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus;, F:ATP binding; F:methionine-tRNA ligase activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to starvation; P:methionyl-tRNA aminoacylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription; P:tRNA aminoacylation for protein translation;|P56192 B3KVK7 Q14895 Q53H14 Q96A15 Q96BZ0 Q9NSE0,Methionine--tRNA ligase, cytoplasmic,Methionyl-tRNA synthetase;, PF00043;PF18485;PF09334;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005524;GO:0004825;GO:0000049;GO:0071364;GO:0032869;GO:0036120;GO:0009267;GO:0006431;GO:1901838;GO:0009303;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus;, F:ATP binding; F:methionine-tRNA ligase activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to starvation; P:methionyl-tRNA aminoacylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription; P:tRNA aminoacylation for protein translation; scaffold151 indexed_genome mRNA 13673 16337 . + . ID=transcript_14696;P56192 B3KVK7 Q14895 Q53H14 Q96A15 Q96BZ0 Q9NSE0,Methionine--tRNA ligase, cytoplasmic,Methionyl-tRNA synthetase;, PF00043;PF18485;PF09334;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005524;GO:0004825;GO:0000049;GO:0071364;GO:0032869;GO:0036120;GO:0009267;GO:0006431;GO:1901838;GO:0009303;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus;, F:ATP binding; F:methionine-tRNA ligase activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to starvation; P:methionyl-tRNA aminoacylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription; P:tRNA aminoacylation for protein translation; scaffold151 indexed_genome mRNA 16359 226891 . - . ID=transcript_14697;P56192 B3KVK7 Q14895 Q53H14 Q96A15 Q96BZ0 Q9NSE0,Methionine--tRNA ligase, cytoplasmic,Methionyl-tRNA synthetase;, PF00043;PF18485;PF09334;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005524;GO:0004825;GO:0000049;GO:0071364;GO:0032869;GO:0036120;GO:0009267;GO:0006431;GO:1901838;GO:0009303;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus;, F:ATP binding; F:methionine-tRNA ligase activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to starvation; P:methionyl-tRNA aminoacylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription; P:tRNA aminoacylation for protein translation;|P56192 B3KVK7 Q14895 Q53H14 Q96A15 Q96BZ0 Q9NSE0,Methionine--tRNA ligase, cytoplasmic,Methionyl-tRNA synthetase;, PF00043;PF18485;PF09334;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005524;GO:0004825;GO:0000049;GO:0071364;GO:0032869;GO:0036120;GO:0009267;GO:0006431;GO:1901838;GO:0009303;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus;, F:ATP binding; F:methionine-tRNA ligase activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to starvation; P:methionyl-tRNA aminoacylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription; P:tRNA aminoacylation for protein translation;|P56192 B3KVK7 Q14895 Q53H14 Q96A15 Q96BZ0 Q9NSE0,Methionine--tRNA ligase, cytoplasmic,Methionyl-tRNA synthetase;, PF00043;PF18485;PF09334;PF00458;, GO:0017101;GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005730;GO:0005524;GO:0004825;GO:0000049;GO:0071364;GO:0032869;GO:0036120;GO:0009267;GO:0006431;GO:1901838;GO:0009303;GO:0006418;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleolus;, F:ATP binding; F:methionine-tRNA ligase activity; F:tRNA binding;, P:cellular response to epidermal growth factor stimulus; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to starvation; P:methionyl-tRNA aminoacylation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:rRNA transcription; P:tRNA aminoacylation for protein translation;|Q9BRR9 B4DVI3 E9PDX9 Q8NAF3 Q8TCJ3 Q8WYR0 Q96EZ2 Q96S74,Rho GTPase-activating protein 9,Rho-type GTPase-activating protein 9;, PF00169;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0005576;GO:0034774;GO:0005096;GO:0005547;GO:0043312;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular region; C:secretory granule lumen;, F:GTPase activator activity; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:neutrophil degranulation; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9Y2K5 B7ZL65 Q2M1T9 Q3ZCT5,R3H domain-containing protein 2,, PF01424;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|Q9BRR9 B4DVI3 E9PDX9 Q8NAF3 Q8TCJ3 Q8WYR0 Q96EZ2 Q96S74,Rho GTPase-activating protein 9,Rho-type GTPase-activating protein 9;, PF00169;PF00620;PF00018;, GO:0005737;GO:0005829;GO:0005576;GO:0034774;GO:0005096;GO:0005547;GO:0043312;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:extracellular region; C:secretory granule lumen;, F:GTPase activator activity; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:neutrophil degranulation; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|P08151 D0EUY3 E9PQQ9 F5H6H8 Q8TDN9,Zinc finger protein GLI1,Glioma-associated oncogene;Oncogene GLI;, PF00096;, GO:0005930;GO:0097546;GO:0097542;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0000981;GO:0046872;GO:0008017;GO:0000978;GO:0000977;GO:0043565;GO:0000976;GO:0060070;GO:0021696;GO:0048546;GO:0009953;GO:0009913;GO:0097421;GO:0030324;GO:0090090;GO:0060032;GO:0001649;GO:0021983;GO:0060045;GO:1902808;GO:0030335;GO:0008284;GO:0045740;GO:0045880;GO:0045944;GO:0045893;GO:0030850;GO:0009954;GO:2000345;GO:0045667;GO:0008589;GO:0006357;GO:0009611;GO:0007224;GO:0021938;GO:0007283;GO:0007418;, C:axoneme; C:ciliary base; C:ciliary tip; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:microtubule binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:canonical Wnt signaling pathway; P:cerebellar cortex morphogenesis; P:digestive tract morphogenesis; P:dorsal/ventral pattern formation; P:epidermal cell differentiation; P:liver regeneration; P:lung development; P:negative regulation of canonical Wnt signaling pathway; P:notochord regression; P:osteoblast differentiation; P:pituitary gland development; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of DNA replication; P:positive regulation of smoothened signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:proximal/distal pattern formation; P:regulation of hepatocyte proliferation; P:regulation of osteoblast differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to wounding; P:smoothened signaling pathway; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; P:spermatogenesis; P:ventral midline development;|P08151 D0EUY3 E9PQQ9 F5H6H8 Q8TDN9,Zinc finger protein GLI1,Glioma-associated oncogene;Oncogene GLI;, PF00096;, GO:0005930;GO:0097546;GO:0097542;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0000981;GO:0046872;GO:0008017;GO:0000978;GO:0000977;GO:0043565;GO:0000976;GO:0060070;GO:0021696;GO:0048546;GO:0009953;GO:0009913;GO:0097421;GO:0030324;GO:0090090;GO:0060032;GO:0001649;GO:0021983;GO:0060045;GO:1902808;GO:0030335;GO:0008284;GO:0045740;GO:0045880;GO:0045944;GO:0045893;GO:0030850;GO:0009954;GO:2000345;GO:0045667;GO:0008589;GO:0006357;GO:0009611;GO:0007224;GO:0021938;GO:0007283;GO:0007418;, C:axoneme; C:ciliary base; C:ciliary tip; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:microtubule binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:canonical Wnt signaling pathway; P:cerebellar cortex morphogenesis; P:digestive tract morphogenesis; P:dorsal/ventral pattern formation; P:epidermal cell differentiation; P:liver regeneration; P:lung development; P:negative regulation of canonical Wnt signaling pathway; P:notochord regression; P:osteoblast differentiation; P:pituitary gland development; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of DNA replication; P:positive regulation of smoothened signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:proximal/distal pattern formation; P:regulation of hepatocyte proliferation; P:regulation of osteoblast differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to wounding; P:smoothened signaling pathway; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; P:spermatogenesis; P:ventral midline development;|P08151 D0EUY3 E9PQQ9 F5H6H8 Q8TDN9,Zinc finger protein GLI1,Glioma-associated oncogene;Oncogene GLI;, PF00096;, GO:0005930;GO:0097546;GO:0097542;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0000981;GO:0046872;GO:0008017;GO:0000978;GO:0000977;GO:0043565;GO:0000976;GO:0060070;GO:0021696;GO:0048546;GO:0009953;GO:0009913;GO:0097421;GO:0030324;GO:0090090;GO:0060032;GO:0001649;GO:0021983;GO:0060045;GO:1902808;GO:0030335;GO:0008284;GO:0045740;GO:0045880;GO:0045944;GO:0045893;GO:0030850;GO:0009954;GO:2000345;GO:0045667;GO:0008589;GO:0006357;GO:0009611;GO:0007224;GO:0021938;GO:0007283;GO:0007418;, C:axoneme; C:ciliary base; C:ciliary tip; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:microtubule binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:canonical Wnt signaling pathway; P:cerebellar cortex morphogenesis; P:digestive tract morphogenesis; P:dorsal/ventral pattern formation; P:epidermal cell differentiation; P:liver regeneration; P:lung development; P:negative regulation of canonical Wnt signaling pathway; P:notochord regression; P:osteoblast differentiation; P:pituitary gland development; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of DNA replication; P:positive regulation of smoothened signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:proximal/distal pattern formation; P:regulation of hepatocyte proliferation; P:regulation of osteoblast differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to wounding; P:smoothened signaling pathway; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; P:spermatogenesis; P:ventral midline development;|P08151 D0EUY3 E9PQQ9 F5H6H8 Q8TDN9,Zinc finger protein GLI1,Glioma-associated oncogene;Oncogene GLI;, PF00096;, GO:0005930;GO:0097546;GO:0097542;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0000981;GO:0046872;GO:0008017;GO:0000978;GO:0000977;GO:0043565;GO:0000976;GO:0060070;GO:0021696;GO:0048546;GO:0009953;GO:0009913;GO:0097421;GO:0030324;GO:0090090;GO:0060032;GO:0001649;GO:0021983;GO:0060045;GO:1902808;GO:0030335;GO:0008284;GO:0045740;GO:0045880;GO:0045944;GO:0045893;GO:0030850;GO:0009954;GO:2000345;GO:0045667;GO:0008589;GO:0006357;GO:0009611;GO:0007224;GO:0021938;GO:0007283;GO:0007418;, C:axoneme; C:ciliary base; C:ciliary tip; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:microtubule binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:canonical Wnt signaling pathway; P:cerebellar cortex morphogenesis; P:digestive tract morphogenesis; P:dorsal/ventral pattern formation; P:epidermal cell differentiation; P:liver regeneration; P:lung development; P:negative regulation of canonical Wnt signaling pathway; P:notochord regression; P:osteoblast differentiation; P:pituitary gland development; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of DNA replication; P:positive regulation of smoothened signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:proximal/distal pattern formation; P:regulation of hepatocyte proliferation; P:regulation of osteoblast differentiation; P:regulation of smoothened signaling pathway; P:regulation of transcription by RNA polymerase II; P:response to wounding; P:smoothened signaling pathway; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; P:spermatogenesis; P:ventral midline development;|P58166,Inhibin beta E chain,Activin beta-E chain;, PF00019;, GO:0062023;GO:0005615;GO:0005125;GO:0008083;GO:0005179;GO:0010862;GO:0060395;, C:collagen-containing extracellular matrix; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:hormone activity;, P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:SMAD protein signal transduction;|P55103 A1L3Y2,Inhibin beta C chain,Activin beta-C chain;, PF00019;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005179;GO:0005160;GO:0010862;GO:0060395;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:transforming growth factor beta receptor binding;, P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:SMAD protein signal transduction;|P55103 A1L3Y2,Inhibin beta C chain,Activin beta-C chain;, PF00019;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005179;GO:0005160;GO:0010862;GO:0060395;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:transforming growth factor beta receptor binding;, P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:SMAD protein signal transduction;|P55103 A1L3Y2,Inhibin beta C chain,Activin beta-C chain;, PF00019;, GO:0005576;GO:0005615;GO:0005125;GO:0008083;GO:0005179;GO:0005160;GO:0010862;GO:0060395;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:growth factor activity; F:hormone activity; F:transforming growth factor beta receptor binding;, P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:SMAD protein signal transduction;|Q9Y2K5 B7ZL65 Q2M1T9 Q3ZCT5,R3H domain-containing protein 2,, PF01424;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|Q9Y2K5 B7ZL65 Q2M1T9 Q3ZCT5,R3H domain-containing protein 2,, PF01424;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|Q9Y2K5 B7ZL65 Q2M1T9 Q3ZCT5,R3H domain-containing protein 2,, PF01424;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|Q9Y2K5 B7ZL65 Q2M1T9 Q3ZCT5,R3H domain-containing protein 2,, PF01424;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|Q9Y2K5 B7ZL65 Q2M1T9 Q3ZCT5,R3H domain-containing protein 2,, PF01424;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding; scaffold151 indexed_genome mRNA 226923 234159 . - . ID=transcript_14698;Q9Y2K5 B7ZL65 Q2M1T9 Q3ZCT5,R3H domain-containing protein 2,, PF01424;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|Q9Y2K5 B7ZL65 Q2M1T9 Q3ZCT5,R3H domain-containing protein 2,, PF01424;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding;|Q9Y2K5 B7ZL65 Q2M1T9 Q3ZCT5,R3H domain-containing protein 2,, PF01424;, GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding; scaffold151 indexed_genome mRNA 236366 242356 . + . ID=transcript_14699;Q96MF2 B4DUK9 Q96HU5,SH3 and cysteine-rich domain-containing protein 3,, PF00130;PF00018;PF07653;, GO:0005829;GO:0031234;GO:0005654;GO:0045202;GO:0030315;GO:0005891;GO:0042802;GO:0046872;GO:0035556;GO:0007274;GO:1903078;GO:1901387;GO:0003009;GO:0048741;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleoplasm; C:synapse; C:T-tubule; C:voltage-gated calcium channel complex;, F:identical protein binding; F:metal ion binding;, P:intracellular signal transduction; P:neuromuscular synaptic transmission; P:positive regulation of protein localization to plasma membrane; P:positive regulation of voltage-gated calcium channel activity; P:skeletal muscle contraction; P:skeletal muscle fiber development;|Q96MF2 B4DUK9 Q96HU5,SH3 and cysteine-rich domain-containing protein 3,, PF00130;PF00018;PF07653;, GO:0005829;GO:0031234;GO:0005654;GO:0045202;GO:0030315;GO:0005891;GO:0042802;GO:0046872;GO:0035556;GO:0007274;GO:1903078;GO:1901387;GO:0003009;GO:0048741;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleoplasm; C:synapse; C:T-tubule; C:voltage-gated calcium channel complex;, F:identical protein binding; F:metal ion binding;, P:intracellular signal transduction; P:neuromuscular synaptic transmission; P:positive regulation of protein localization to plasma membrane; P:positive regulation of voltage-gated calcium channel activity; P:skeletal muscle contraction; P:skeletal muscle fiber development;|Q96MF2 B4DUK9 Q96HU5,SH3 and cysteine-rich domain-containing protein 3,, PF00130;PF00018;PF07653;, GO:0005829;GO:0031234;GO:0005654;GO:0045202;GO:0030315;GO:0005891;GO:0042802;GO:0046872;GO:0035556;GO:0007274;GO:1903078;GO:1901387;GO:0003009;GO:0048741;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleoplasm; C:synapse; C:T-tubule; C:voltage-gated calcium channel complex;, F:identical protein binding; F:metal ion binding;, P:intracellular signal transduction; P:neuromuscular synaptic transmission; P:positive regulation of protein localization to plasma membrane; P:positive regulation of voltage-gated calcium channel activity; P:skeletal muscle contraction; P:skeletal muscle fiber development;|Q96MF2 B4DUK9 Q96HU5,SH3 and cysteine-rich domain-containing protein 3,, PF00130;PF00018;PF07653;, GO:0005829;GO:0031234;GO:0005654;GO:0045202;GO:0030315;GO:0005891;GO:0042802;GO:0046872;GO:0035556;GO:0007274;GO:1903078;GO:1901387;GO:0003009;GO:0048741;, C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:nucleoplasm; C:synapse; C:T-tubule; C:voltage-gated calcium channel complex;, F:identical protein binding; F:metal ion binding;, P:intracellular signal transduction; P:neuromuscular synaptic transmission; P:positive regulation of protein localization to plasma membrane; P:positive regulation of voltage-gated calcium channel activity; P:skeletal muscle contraction; P:skeletal muscle fiber development; scaffold151 indexed_genome mRNA 247717 258467 . + . ID=transcript_14700;Q9NRX3 Q6IAH9,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2,NADH-ubiquinone oxidoreductase MLRQ subunit homolog;, PF06522;, GO:0005751;GO:0022900;GO:1902600;, C:mitochondrial respiratory chain complex IV;, , P:electron transport chain; P:proton transmembrane transport;|P34897 B7Z9F1 E7EQ19 E7EU43 O00740 Q8N1A5,Serine hydroxymethyltransferase, mitochondrial,Glycine hydroxymethyltransferase;Serine methylase;, PF00464;, GO:0070552;GO:0005737;GO:0005829;GO:0070062;GO:0015630;GO:0005743;GO:0005758;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0003682;GO:0050897;GO:0004372;GO:0008732;GO:0048027;GO:0042803;GO:0030170;GO:0070905;GO:0000900;GO:0008270;GO:0046655;GO:0019264;GO:0006544;GO:0006564;GO:0006565;GO:0006563;GO:0006730;GO:0008284;GO:0051289;GO:0070536;GO:0051262;GO:0009113;GO:1903715;GO:0070129;GO:0002082;GO:0034340;GO:0035999;GO:0046653;, C:BRISC complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:chromatin binding; F:cobalt ion binding; F:glycine hydroxymethyltransferase activity; F:L-allo-threonine aldolase activity; F:mRNA 5'-UTR binding; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:serine binding; F:translation repressor activity, mRNA regulatory element binding; F:zinc ion binding;, P:folic acid metabolic process; P:glycine biosynthetic process from serine; P:glycine metabolic process; P:L-serine biosynthetic process; P:L-serine catabolic process; P:L-serine metabolic process; P:one-carbon metabolic process; P:positive regulation of cell population proliferation; P:protein homotetramerization; P:protein K63-linked deubiquitination; P:protein tetramerization; P:purine nucleobase biosynthetic process; P:regulation of aerobic respiration; P:regulation of mitochondrial translation; P:regulation of oxidative phosphorylation; P:response to type I interferon; P:tetrahydrofolate interconversion; P:tetrahydrofolate metabolic process;|P34897 B7Z9F1 E7EQ19 E7EU43 O00740 Q8N1A5,Serine hydroxymethyltransferase, mitochondrial,Glycine hydroxymethyltransferase;Serine methylase;, PF00464;, GO:0070552;GO:0005737;GO:0005829;GO:0070062;GO:0015630;GO:0005743;GO:0005758;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0003682;GO:0050897;GO:0004372;GO:0008732;GO:0048027;GO:0042803;GO:0030170;GO:0070905;GO:0000900;GO:0008270;GO:0046655;GO:0019264;GO:0006544;GO:0006564;GO:0006565;GO:0006563;GO:0006730;GO:0008284;GO:0051289;GO:0070536;GO:0051262;GO:0009113;GO:1903715;GO:0070129;GO:0002082;GO:0034340;GO:0035999;GO:0046653;, C:BRISC complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:chromatin binding; F:cobalt ion binding; F:glycine hydroxymethyltransferase activity; F:L-allo-threonine aldolase activity; F:mRNA 5'-UTR binding; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:serine binding; F:translation repressor activity, mRNA regulatory element binding; F:zinc ion binding;, P:folic acid metabolic process; P:glycine biosynthetic process from serine; P:glycine metabolic process; P:L-serine biosynthetic process; P:L-serine catabolic process; P:L-serine metabolic process; P:one-carbon metabolic process; P:positive regulation of cell population proliferation; P:protein homotetramerization; P:protein K63-linked deubiquitination; P:protein tetramerization; P:purine nucleobase biosynthetic process; P:regulation of aerobic respiration; P:regulation of mitochondrial translation; P:regulation of oxidative phosphorylation; P:response to type I interferon; P:tetrahydrofolate interconversion; P:tetrahydrofolate metabolic process;|P34897 B7Z9F1 E7EQ19 E7EU43 O00740 Q8N1A5,Serine hydroxymethyltransferase, mitochondrial,Glycine hydroxymethyltransferase;Serine methylase;, PF00464;, GO:0070552;GO:0005737;GO:0005829;GO:0070062;GO:0015630;GO:0005743;GO:0005758;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0003682;GO:0050897;GO:0004372;GO:0008732;GO:0048027;GO:0042803;GO:0030170;GO:0070905;GO:0000900;GO:0008270;GO:0046655;GO:0019264;GO:0006544;GO:0006564;GO:0006565;GO:0006563;GO:0006730;GO:0008284;GO:0051289;GO:0070536;GO:0051262;GO:0009113;GO:1903715;GO:0070129;GO:0002082;GO:0034340;GO:0035999;GO:0046653;, C:BRISC complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:chromatin binding; F:cobalt ion binding; F:glycine hydroxymethyltransferase activity; F:L-allo-threonine aldolase activity; F:mRNA 5'-UTR binding; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:serine binding; F:translation repressor activity, mRNA regulatory element binding; F:zinc ion binding;, P:folic acid metabolic process; P:glycine biosynthetic process from serine; P:glycine metabolic process; P:L-serine biosynthetic process; P:L-serine catabolic process; P:L-serine metabolic process; P:one-carbon metabolic process; P:positive regulation of cell population proliferation; P:protein homotetramerization; P:protein K63-linked deubiquitination; P:protein tetramerization; P:purine nucleobase biosynthetic process; P:regulation of aerobic respiration; P:regulation of mitochondrial translation; P:regulation of oxidative phosphorylation; P:response to type I interferon; P:tetrahydrofolate interconversion; P:tetrahydrofolate metabolic process;|P34897 B7Z9F1 E7EQ19 E7EU43 O00740 Q8N1A5,Serine hydroxymethyltransferase, mitochondrial,Glycine hydroxymethyltransferase;Serine methylase;, PF00464;, GO:0070552;GO:0005737;GO:0005829;GO:0070062;GO:0015630;GO:0005743;GO:0005758;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0003682;GO:0050897;GO:0004372;GO:0008732;GO:0048027;GO:0042803;GO:0030170;GO:0070905;GO:0000900;GO:0008270;GO:0046655;GO:0019264;GO:0006544;GO:0006564;GO:0006565;GO:0006563;GO:0006730;GO:0008284;GO:0051289;GO:0070536;GO:0051262;GO:0009113;GO:1903715;GO:0070129;GO:0002082;GO:0034340;GO:0035999;GO:0046653;, C:BRISC complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:chromatin binding; F:cobalt ion binding; F:glycine hydroxymethyltransferase activity; F:L-allo-threonine aldolase activity; F:mRNA 5'-UTR binding; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:serine binding; F:translation repressor activity, mRNA regulatory element binding; F:zinc ion binding;, P:folic acid metabolic process; P:glycine biosynthetic process from serine; P:glycine metabolic process; P:L-serine biosynthetic process; P:L-serine catabolic process; P:L-serine metabolic process; P:one-carbon metabolic process; P:positive regulation of cell population proliferation; P:protein homotetramerization; P:protein K63-linked deubiquitination; P:protein tetramerization; P:purine nucleobase biosynthetic process; P:regulation of aerobic respiration; P:regulation of mitochondrial translation; P:regulation of oxidative phosphorylation; P:response to type I interferon; P:tetrahydrofolate interconversion; P:tetrahydrofolate metabolic process;|P34897 B7Z9F1 E7EQ19 E7EU43 O00740 Q8N1A5,Serine hydroxymethyltransferase, mitochondrial,Glycine hydroxymethyltransferase;Serine methylase;, PF00464;, GO:0070552;GO:0005737;GO:0005829;GO:0070062;GO:0015630;GO:0005743;GO:0005758;GO:0005759;GO:0042645;GO:0005739;GO:0005634;GO:0003682;GO:0050897;GO:0004372;GO:0008732;GO:0048027;GO:0042803;GO:0030170;GO:0070905;GO:0000900;GO:0008270;GO:0046655;GO:0019264;GO:0006544;GO:0006564;GO:0006565;GO:0006563;GO:0006730;GO:0008284;GO:0051289;GO:0070536;GO:0051262;GO:0009113;GO:1903715;GO:0070129;GO:0002082;GO:0034340;GO:0035999;GO:0046653;, C:BRISC complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrion; C:nucleus;, F:chromatin binding; F:cobalt ion binding; F:glycine hydroxymethyltransferase activity; F:L-allo-threonine aldolase activity; F:mRNA 5'-UTR binding; F:protein homodimerization activity; F:pyridoxal phosphate binding; F:serine binding; F:translation repressor activity, mRNA regulatory element binding; F:zinc ion binding;, P:folic acid metabolic process; P:glycine biosynthetic process from serine; P:glycine metabolic process; P:L-serine biosynthetic process; P:L-serine catabolic process; P:L-serine metabolic process; P:one-carbon metabolic process; P:positive regulation of cell population proliferation; P:protein homotetramerization; P:protein K63-linked deubiquitination; P:protein tetramerization; P:purine nucleobase biosynthetic process; P:regulation of aerobic respiration; P:regulation of mitochondrial translation; P:regulation of oxidative phosphorylation; P:response to type I interferon; P:tetrahydrofolate interconversion; P:tetrahydrofolate metabolic process; scaffold151 indexed_genome mRNA 275207 280407 . - . ID=transcript_14701;Q07954 Q2PP12 Q86SW0 Q8IVG8,Prolow-density lipoprotein receptor-related protein 1 {ECO:0000305},Alpha-2-macroglobulin receptor {ECO:0000303|PubMed:26142438};Apolipoprotein E receptor;, PF12662;PF16472;PF07645;PF00057;PF00058;, GO:0045177;GO:0044295;GO:0016323;GO:0005905;GO:0030136;GO:0005856;GO:0030425;GO:0005769;GO:0030666;GO:0005925;GO:0032593;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0005634;GO:0005886;GO:0098797;GO:0150051;GO:0043235;GO:0016964;GO:0001540;GO:0034185;GO:0030226;GO:0005509;GO:0038024;GO:0032050;GO:0015026;GO:0043395;GO:0070325;GO:0005041;GO:0002020;GO:0044877;GO:0003723;GO:0005044;GO:0038023;GO:0007568;GO:0097242;GO:0150094;GO:0150093;GO:0035909;GO:0043277;GO:0002265;GO:0008283;GO:0044242;GO:1904646;GO:0021987;GO:0061642;GO:0006629;GO:0042157;GO:0042953;GO:0007041;GO:0051481;GO:0051895;GO:1905049;GO:0043524;GO:0010977;GO:2000587;GO:0014912;GO:0030178;GO:0006909;GO:1900223;GO:0048691;GO:0010942;GO:2000343;GO:0010875;GO:1904109;GO:0048694;GO:0007204;GO:0045807;GO:0070374;GO:0035774;GO:0032370;GO:1905167;GO:0050766;GO:0032092;GO:1903078;GO:1900149;GO:1904300;GO:1904754;GO:0007205;GO:0031623;GO:0006898;GO:0032956;GO:0032374;GO:0010715;GO:0032429;GO:0001523;GO:0045056;GO:0150104;, C:apical part of cell; C:axonal growth cone; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoskeleton; C:dendrite; C:early endosome; C:endocytic vesicle membrane; C:focal adhesion; C:insulin-responsive compartment; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:plasma membrane protein complex; C:postsynaptic Golgi apparatus; C:receptor complex;, F:alpha-2 macroglobulin receptor activity; F:amyloid-beta binding; F:apolipoprotein binding; F:apolipoprotein receptor activity; F:calcium ion binding; F:cargo receptor activity; F:clathrin heavy chain binding; F:coreceptor activity; F:heparan sulfate proteoglycan binding; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:protein-containing complex binding; F:RNA binding; F:scavenger receptor activity; F:signaling receptor activity;, P:aging; P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta clearance by transcytosis; P:aorta morphogenesis; P:apoptotic cell clearance; P:astrocyte activation involved in immune response; P:cell population proliferation; P:cellular lipid catabolic process; P:cellular response to amyloid-beta; P:cerebral cortex development; P:chemoattraction of axon; P:lipid metabolic process; P:lipoprotein metabolic process; P:lipoprotein transport; P:lysosomal transport; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of focal adhesion assembly; P:negative regulation of metallopeptidase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron projection development; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of Wnt signaling pathway; P:phagocytosis; P:positive regulation of amyloid-beta clearance; P:positive regulation of axon extension involved in regeneration; P:positive regulation of cell death; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol import; P:positive regulation of collateral sprouting of injured axon; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lipid transport; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of phagocytosis; P:positive regulation of protein binding; P:positive regulation of protein localization to plasma membrane; P:positive regulation of Schwann cell migration; P:positive regulation of transcytosis; P:positive regulation of vascular associated smooth muscle cell migration; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of cholesterol transport; P:regulation of extracellular matrix disassembly; P:regulation of phospholipase A2 activity; P:retinoid metabolic process; P:transcytosis; P:transport across blood-brain barrier;|Q07954 Q2PP12 Q86SW0 Q8IVG8,Prolow-density lipoprotein receptor-related protein 1 {ECO:0000305},Alpha-2-macroglobulin receptor {ECO:0000303|PubMed:26142438};Apolipoprotein E receptor;, PF12662;PF16472;PF07645;PF00057;PF00058;, GO:0045177;GO:0044295;GO:0016323;GO:0005905;GO:0030136;GO:0005856;GO:0030425;GO:0005769;GO:0030666;GO:0005925;GO:0032593;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0005634;GO:0005886;GO:0098797;GO:0150051;GO:0043235;GO:0016964;GO:0001540;GO:0034185;GO:0030226;GO:0005509;GO:0038024;GO:0032050;GO:0015026;GO:0043395;GO:0070325;GO:0005041;GO:0002020;GO:0044877;GO:0003723;GO:0005044;GO:0038023;GO:0007568;GO:0097242;GO:0150094;GO:0150093;GO:0035909;GO:0043277;GO:0002265;GO:0008283;GO:0044242;GO:1904646;GO:0021987;GO:0061642;GO:0006629;GO:0042157;GO:0042953;GO:0007041;GO:0051481;GO:0051895;GO:1905049;GO:0043524;GO:0010977;GO:2000587;GO:0014912;GO:0030178;GO:0006909;GO:1900223;GO:0048691;GO:0010942;GO:2000343;GO:0010875;GO:1904109;GO:0048694;GO:0007204;GO:0045807;GO:0070374;GO:0035774;GO:0032370;GO:1905167;GO:0050766;GO:0032092;GO:1903078;GO:1900149;GO:1904300;GO:1904754;GO:0007205;GO:0031623;GO:0006898;GO:0032956;GO:0032374;GO:0010715;GO:0032429;GO:0001523;GO:0045056;GO:0150104;, C:apical part of cell; C:axonal growth cone; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoskeleton; C:dendrite; C:early endosome; C:endocytic vesicle membrane; C:focal adhesion; C:insulin-responsive compartment; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:plasma membrane protein complex; C:postsynaptic Golgi apparatus; C:receptor complex;, F:alpha-2 macroglobulin receptor activity; F:amyloid-beta binding; F:apolipoprotein binding; F:apolipoprotein receptor activity; F:calcium ion binding; F:cargo receptor activity; F:clathrin heavy chain binding; F:coreceptor activity; F:heparan sulfate proteoglycan binding; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:protein-containing complex binding; F:RNA binding; F:scavenger receptor activity; F:signaling receptor activity;, P:aging; P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta clearance by transcytosis; P:aorta morphogenesis; P:apoptotic cell clearance; P:astrocyte activation involved in immune response; P:cell population proliferation; P:cellular lipid catabolic process; P:cellular response to amyloid-beta; P:cerebral cortex development; P:chemoattraction of axon; P:lipid metabolic process; P:lipoprotein metabolic process; P:lipoprotein transport; P:lysosomal transport; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of focal adhesion assembly; P:negative regulation of metallopeptidase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron projection development; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of Wnt signaling pathway; P:phagocytosis; P:positive regulation of amyloid-beta clearance; P:positive regulation of axon extension involved in regeneration; P:positive regulation of cell death; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol import; P:positive regulation of collateral sprouting of injured axon; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lipid transport; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of phagocytosis; P:positive regulation of protein binding; P:positive regulation of protein localization to plasma membrane; P:positive regulation of Schwann cell migration; P:positive regulation of transcytosis; P:positive regulation of vascular associated smooth muscle cell migration; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of cholesterol transport; P:regulation of extracellular matrix disassembly; P:regulation of phospholipase A2 activity; P:retinoid metabolic process; P:transcytosis; P:transport across blood-brain barrier;|Q07954 Q2PP12 Q86SW0 Q8IVG8,Prolow-density lipoprotein receptor-related protein 1 {ECO:0000305},Alpha-2-macroglobulin receptor {ECO:0000303|PubMed:26142438};Apolipoprotein E receptor;, PF12662;PF16472;PF07645;PF00057;PF00058;, GO:0045177;GO:0044295;GO:0016323;GO:0005905;GO:0030136;GO:0005856;GO:0030425;GO:0005769;GO:0030666;GO:0005925;GO:0032593;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0005634;GO:0005886;GO:0098797;GO:0150051;GO:0043235;GO:0016964;GO:0001540;GO:0034185;GO:0030226;GO:0005509;GO:0038024;GO:0032050;GO:0015026;GO:0043395;GO:0070325;GO:0005041;GO:0002020;GO:0044877;GO:0003723;GO:0005044;GO:0038023;GO:0007568;GO:0097242;GO:0150094;GO:0150093;GO:0035909;GO:0043277;GO:0002265;GO:0008283;GO:0044242;GO:1904646;GO:0021987;GO:0061642;GO:0006629;GO:0042157;GO:0042953;GO:0007041;GO:0051481;GO:0051895;GO:1905049;GO:0043524;GO:0010977;GO:2000587;GO:0014912;GO:0030178;GO:0006909;GO:1900223;GO:0048691;GO:0010942;GO:2000343;GO:0010875;GO:1904109;GO:0048694;GO:0007204;GO:0045807;GO:0070374;GO:0035774;GO:0032370;GO:1905167;GO:0050766;GO:0032092;GO:1903078;GO:1900149;GO:1904300;GO:1904754;GO:0007205;GO:0031623;GO:0006898;GO:0032956;GO:0032374;GO:0010715;GO:0032429;GO:0001523;GO:0045056;GO:0150104;, C:apical part of cell; C:axonal growth cone; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoskeleton; C:dendrite; C:early endosome; C:endocytic vesicle membrane; C:focal adhesion; C:insulin-responsive compartment; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:plasma membrane protein complex; C:postsynaptic Golgi apparatus; C:receptor complex;, F:alpha-2 macroglobulin receptor activity; F:amyloid-beta binding; F:apolipoprotein binding; F:apolipoprotein receptor activity; F:calcium ion binding; F:cargo receptor activity; F:clathrin heavy chain binding; F:coreceptor activity; F:heparan sulfate proteoglycan binding; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:protein-containing complex binding; F:RNA binding; F:scavenger receptor activity; F:signaling receptor activity;, P:aging; P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta clearance by transcytosis; P:aorta morphogenesis; P:apoptotic cell clearance; P:astrocyte activation involved in immune response; P:cell population proliferation; P:cellular lipid catabolic process; P:cellular response to amyloid-beta; P:cerebral cortex development; P:chemoattraction of axon; P:lipid metabolic process; P:lipoprotein metabolic process; P:lipoprotein transport; P:lysosomal transport; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of focal adhesion assembly; P:negative regulation of metallopeptidase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron projection development; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of Wnt signaling pathway; P:phagocytosis; P:positive regulation of amyloid-beta clearance; P:positive regulation of axon extension involved in regeneration; P:positive regulation of cell death; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol import; P:positive regulation of collateral sprouting of injured axon; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lipid transport; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of phagocytosis; P:positive regulation of protein binding; P:positive regulation of protein localization to plasma membrane; P:positive regulation of Schwann cell migration; P:positive regulation of transcytosis; P:positive regulation of vascular associated smooth muscle cell migration; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of cholesterol transport; P:regulation of extracellular matrix disassembly; P:regulation of phospholipase A2 activity; P:retinoid metabolic process; P:transcytosis; P:transport across blood-brain barrier; scaffold151 indexed_genome mRNA 281012 281708 . + . ID=transcript_14702;Q07954 Q2PP12 Q86SW0 Q8IVG8,Prolow-density lipoprotein receptor-related protein 1 {ECO:0000305},Alpha-2-macroglobulin receptor {ECO:0000303|PubMed:26142438};Apolipoprotein E receptor;, PF12662;PF16472;PF07645;PF00057;PF00058;, GO:0045177;GO:0044295;GO:0016323;GO:0005905;GO:0030136;GO:0005856;GO:0030425;GO:0005769;GO:0030666;GO:0005925;GO:0032593;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0005634;GO:0005886;GO:0098797;GO:0150051;GO:0043235;GO:0016964;GO:0001540;GO:0034185;GO:0030226;GO:0005509;GO:0038024;GO:0032050;GO:0015026;GO:0043395;GO:0070325;GO:0005041;GO:0002020;GO:0044877;GO:0003723;GO:0005044;GO:0038023;GO:0007568;GO:0097242;GO:0150094;GO:0150093;GO:0035909;GO:0043277;GO:0002265;GO:0008283;GO:0044242;GO:1904646;GO:0021987;GO:0061642;GO:0006629;GO:0042157;GO:0042953;GO:0007041;GO:0051481;GO:0051895;GO:1905049;GO:0043524;GO:0010977;GO:2000587;GO:0014912;GO:0030178;GO:0006909;GO:1900223;GO:0048691;GO:0010942;GO:2000343;GO:0010875;GO:1904109;GO:0048694;GO:0007204;GO:0045807;GO:0070374;GO:0035774;GO:0032370;GO:1905167;GO:0050766;GO:0032092;GO:1903078;GO:1900149;GO:1904300;GO:1904754;GO:0007205;GO:0031623;GO:0006898;GO:0032956;GO:0032374;GO:0010715;GO:0032429;GO:0001523;GO:0045056;GO:0150104;, C:apical part of cell; C:axonal growth cone; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoskeleton; C:dendrite; C:early endosome; C:endocytic vesicle membrane; C:focal adhesion; C:insulin-responsive compartment; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:plasma membrane protein complex; C:postsynaptic Golgi apparatus; C:receptor complex;, F:alpha-2 macroglobulin receptor activity; F:amyloid-beta binding; F:apolipoprotein binding; F:apolipoprotein receptor activity; F:calcium ion binding; F:cargo receptor activity; F:clathrin heavy chain binding; F:coreceptor activity; F:heparan sulfate proteoglycan binding; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:protein-containing complex binding; F:RNA binding; F:scavenger receptor activity; F:signaling receptor activity;, P:aging; P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta clearance by transcytosis; P:aorta morphogenesis; P:apoptotic cell clearance; P:astrocyte activation involved in immune response; P:cell population proliferation; P:cellular lipid catabolic process; P:cellular response to amyloid-beta; P:cerebral cortex development; P:chemoattraction of axon; P:lipid metabolic process; P:lipoprotein metabolic process; P:lipoprotein transport; P:lysosomal transport; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of focal adhesion assembly; P:negative regulation of metallopeptidase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron projection development; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of Wnt signaling pathway; P:phagocytosis; P:positive regulation of amyloid-beta clearance; P:positive regulation of axon extension involved in regeneration; P:positive regulation of cell death; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol import; P:positive regulation of collateral sprouting of injured axon; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lipid transport; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of phagocytosis; P:positive regulation of protein binding; P:positive regulation of protein localization to plasma membrane; P:positive regulation of Schwann cell migration; P:positive regulation of transcytosis; P:positive regulation of vascular associated smooth muscle cell migration; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of cholesterol transport; P:regulation of extracellular matrix disassembly; P:regulation of phospholipase A2 activity; P:retinoid metabolic process; P:transcytosis; P:transport across blood-brain barrier; scaffold151 indexed_genome mRNA 282551 285702 . - . ID=transcript_14703;Q07954 Q2PP12 Q86SW0 Q8IVG8,Prolow-density lipoprotein receptor-related protein 1 {ECO:0000305},Alpha-2-macroglobulin receptor {ECO:0000303|PubMed:26142438};Apolipoprotein E receptor;, PF12662;PF16472;PF07645;PF00057;PF00058;, GO:0045177;GO:0044295;GO:0016323;GO:0005905;GO:0030136;GO:0005856;GO:0030425;GO:0005769;GO:0030666;GO:0005925;GO:0032593;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0005634;GO:0005886;GO:0098797;GO:0150051;GO:0043235;GO:0016964;GO:0001540;GO:0034185;GO:0030226;GO:0005509;GO:0038024;GO:0032050;GO:0015026;GO:0043395;GO:0070325;GO:0005041;GO:0002020;GO:0044877;GO:0003723;GO:0005044;GO:0038023;GO:0007568;GO:0097242;GO:0150094;GO:0150093;GO:0035909;GO:0043277;GO:0002265;GO:0008283;GO:0044242;GO:1904646;GO:0021987;GO:0061642;GO:0006629;GO:0042157;GO:0042953;GO:0007041;GO:0051481;GO:0051895;GO:1905049;GO:0043524;GO:0010977;GO:2000587;GO:0014912;GO:0030178;GO:0006909;GO:1900223;GO:0048691;GO:0010942;GO:2000343;GO:0010875;GO:1904109;GO:0048694;GO:0007204;GO:0045807;GO:0070374;GO:0035774;GO:0032370;GO:1905167;GO:0050766;GO:0032092;GO:1903078;GO:1900149;GO:1904300;GO:1904754;GO:0007205;GO:0031623;GO:0006898;GO:0032956;GO:0032374;GO:0010715;GO:0032429;GO:0001523;GO:0045056;GO:0150104;, C:apical part of cell; C:axonal growth cone; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoskeleton; C:dendrite; C:early endosome; C:endocytic vesicle membrane; C:focal adhesion; C:insulin-responsive compartment; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:plasma membrane protein complex; C:postsynaptic Golgi apparatus; C:receptor complex;, F:alpha-2 macroglobulin receptor activity; F:amyloid-beta binding; F:apolipoprotein binding; F:apolipoprotein receptor activity; F:calcium ion binding; F:cargo receptor activity; F:clathrin heavy chain binding; F:coreceptor activity; F:heparan sulfate proteoglycan binding; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:protein-containing complex binding; F:RNA binding; F:scavenger receptor activity; F:signaling receptor activity;, P:aging; P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta clearance by transcytosis; P:aorta morphogenesis; P:apoptotic cell clearance; P:astrocyte activation involved in immune response; P:cell population proliferation; P:cellular lipid catabolic process; P:cellular response to amyloid-beta; P:cerebral cortex development; P:chemoattraction of axon; P:lipid metabolic process; P:lipoprotein metabolic process; P:lipoprotein transport; P:lysosomal transport; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of focal adhesion assembly; P:negative regulation of metallopeptidase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron projection development; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of Wnt signaling pathway; P:phagocytosis; P:positive regulation of amyloid-beta clearance; P:positive regulation of axon extension involved in regeneration; P:positive regulation of cell death; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol import; P:positive regulation of collateral sprouting of injured axon; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lipid transport; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of phagocytosis; P:positive regulation of protein binding; P:positive regulation of protein localization to plasma membrane; P:positive regulation of Schwann cell migration; P:positive regulation of transcytosis; P:positive regulation of vascular associated smooth muscle cell migration; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of cholesterol transport; P:regulation of extracellular matrix disassembly; P:regulation of phospholipase A2 activity; P:retinoid metabolic process; P:transcytosis; P:transport across blood-brain barrier;|Q07954 Q2PP12 Q86SW0 Q8IVG8,Prolow-density lipoprotein receptor-related protein 1 {ECO:0000305},Alpha-2-macroglobulin receptor {ECO:0000303|PubMed:26142438};Apolipoprotein E receptor;, PF12662;PF16472;PF07645;PF00057;PF00058;, GO:0045177;GO:0044295;GO:0016323;GO:0005905;GO:0030136;GO:0005856;GO:0030425;GO:0005769;GO:0030666;GO:0005925;GO:0032593;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0005634;GO:0005886;GO:0098797;GO:0150051;GO:0043235;GO:0016964;GO:0001540;GO:0034185;GO:0030226;GO:0005509;GO:0038024;GO:0032050;GO:0015026;GO:0043395;GO:0070325;GO:0005041;GO:0002020;GO:0044877;GO:0003723;GO:0005044;GO:0038023;GO:0007568;GO:0097242;GO:0150094;GO:0150093;GO:0035909;GO:0043277;GO:0002265;GO:0008283;GO:0044242;GO:1904646;GO:0021987;GO:0061642;GO:0006629;GO:0042157;GO:0042953;GO:0007041;GO:0051481;GO:0051895;GO:1905049;GO:0043524;GO:0010977;GO:2000587;GO:0014912;GO:0030178;GO:0006909;GO:1900223;GO:0048691;GO:0010942;GO:2000343;GO:0010875;GO:1904109;GO:0048694;GO:0007204;GO:0045807;GO:0070374;GO:0035774;GO:0032370;GO:1905167;GO:0050766;GO:0032092;GO:1903078;GO:1900149;GO:1904300;GO:1904754;GO:0007205;GO:0031623;GO:0006898;GO:0032956;GO:0032374;GO:0010715;GO:0032429;GO:0001523;GO:0045056;GO:0150104;, C:apical part of cell; C:axonal growth cone; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoskeleton; C:dendrite; C:early endosome; C:endocytic vesicle membrane; C:focal adhesion; C:insulin-responsive compartment; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:plasma membrane protein complex; C:postsynaptic Golgi apparatus; C:receptor complex;, F:alpha-2 macroglobulin receptor activity; F:amyloid-beta binding; F:apolipoprotein binding; F:apolipoprotein receptor activity; F:calcium ion binding; F:cargo receptor activity; F:clathrin heavy chain binding; F:coreceptor activity; F:heparan sulfate proteoglycan binding; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:protein-containing complex binding; F:RNA binding; F:scavenger receptor activity; F:signaling receptor activity;, P:aging; P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta clearance by transcytosis; P:aorta morphogenesis; P:apoptotic cell clearance; P:astrocyte activation involved in immune response; P:cell population proliferation; P:cellular lipid catabolic process; P:cellular response to amyloid-beta; P:cerebral cortex development; P:chemoattraction of axon; P:lipid metabolic process; P:lipoprotein metabolic process; P:lipoprotein transport; P:lysosomal transport; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of focal adhesion assembly; P:negative regulation of metallopeptidase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron projection development; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of Wnt signaling pathway; P:phagocytosis; P:positive regulation of amyloid-beta clearance; P:positive regulation of axon extension involved in regeneration; P:positive regulation of cell death; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol import; P:positive regulation of collateral sprouting of injured axon; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lipid transport; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of phagocytosis; P:positive regulation of protein binding; P:positive regulation of protein localization to plasma membrane; P:positive regulation of Schwann cell migration; P:positive regulation of transcytosis; P:positive regulation of vascular associated smooth muscle cell migration; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of cholesterol transport; P:regulation of extracellular matrix disassembly; P:regulation of phospholipase A2 activity; P:retinoid metabolic process; P:transcytosis; P:transport across blood-brain barrier;|Q07954 Q2PP12 Q86SW0 Q8IVG8,Prolow-density lipoprotein receptor-related protein 1 {ECO:0000305},Alpha-2-macroglobulin receptor {ECO:0000303|PubMed:26142438};Apolipoprotein E receptor;, PF12662;PF16472;PF07645;PF00057;PF00058;, GO:0045177;GO:0044295;GO:0016323;GO:0005905;GO:0030136;GO:0005856;GO:0030425;GO:0005769;GO:0030666;GO:0005925;GO:0032593;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0005634;GO:0005886;GO:0098797;GO:0150051;GO:0043235;GO:0016964;GO:0001540;GO:0034185;GO:0030226;GO:0005509;GO:0038024;GO:0032050;GO:0015026;GO:0043395;GO:0070325;GO:0005041;GO:0002020;GO:0044877;GO:0003723;GO:0005044;GO:0038023;GO:0007568;GO:0097242;GO:0150094;GO:0150093;GO:0035909;GO:0043277;GO:0002265;GO:0008283;GO:0044242;GO:1904646;GO:0021987;GO:0061642;GO:0006629;GO:0042157;GO:0042953;GO:0007041;GO:0051481;GO:0051895;GO:1905049;GO:0043524;GO:0010977;GO:2000587;GO:0014912;GO:0030178;GO:0006909;GO:1900223;GO:0048691;GO:0010942;GO:2000343;GO:0010875;GO:1904109;GO:0048694;GO:0007204;GO:0045807;GO:0070374;GO:0035774;GO:0032370;GO:1905167;GO:0050766;GO:0032092;GO:1903078;GO:1900149;GO:1904300;GO:1904754;GO:0007205;GO:0031623;GO:0006898;GO:0032956;GO:0032374;GO:0010715;GO:0032429;GO:0001523;GO:0045056;GO:0150104;, C:apical part of cell; C:axonal growth cone; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoskeleton; C:dendrite; C:early endosome; C:endocytic vesicle membrane; C:focal adhesion; C:insulin-responsive compartment; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:plasma membrane protein complex; C:postsynaptic Golgi apparatus; C:receptor complex;, F:alpha-2 macroglobulin receptor activity; F:amyloid-beta binding; F:apolipoprotein binding; F:apolipoprotein receptor activity; F:calcium ion binding; F:cargo receptor activity; F:clathrin heavy chain binding; F:coreceptor activity; F:heparan sulfate proteoglycan binding; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:protein-containing complex binding; F:RNA binding; F:scavenger receptor activity; F:signaling receptor activity;, P:aging; P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta clearance by transcytosis; P:aorta morphogenesis; P:apoptotic cell clearance; P:astrocyte activation involved in immune response; P:cell population proliferation; P:cellular lipid catabolic process; P:cellular response to amyloid-beta; P:cerebral cortex development; P:chemoattraction of axon; P:lipid metabolic process; P:lipoprotein metabolic process; P:lipoprotein transport; P:lysosomal transport; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of focal adhesion assembly; P:negative regulation of metallopeptidase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron projection development; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of Wnt signaling pathway; P:phagocytosis; P:positive regulation of amyloid-beta clearance; P:positive regulation of axon extension involved in regeneration; P:positive regulation of cell death; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol import; P:positive regulation of collateral sprouting of injured axon; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lipid transport; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of phagocytosis; P:positive regulation of protein binding; P:positive regulation of protein localization to plasma membrane; P:positive regulation of Schwann cell migration; P:positive regulation of transcytosis; P:positive regulation of vascular associated smooth muscle cell migration; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of cholesterol transport; P:regulation of extracellular matrix disassembly; P:regulation of phospholipase A2 activity; P:retinoid metabolic process; P:transcytosis; P:transport across blood-brain barrier; scaffold151 indexed_genome mRNA 317618 319297 . - . ID=transcript_14704;Q07954 Q2PP12 Q86SW0 Q8IVG8,Prolow-density lipoprotein receptor-related protein 1 {ECO:0000305},Alpha-2-macroglobulin receptor {ECO:0000303|PubMed:26142438};Apolipoprotein E receptor;, PF12662;PF16472;PF07645;PF00057;PF00058;, GO:0045177;GO:0044295;GO:0016323;GO:0005905;GO:0030136;GO:0005856;GO:0030425;GO:0005769;GO:0030666;GO:0005925;GO:0032593;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0005634;GO:0005886;GO:0098797;GO:0150051;GO:0043235;GO:0016964;GO:0001540;GO:0034185;GO:0030226;GO:0005509;GO:0038024;GO:0032050;GO:0015026;GO:0043395;GO:0070325;GO:0005041;GO:0002020;GO:0044877;GO:0003723;GO:0005044;GO:0038023;GO:0007568;GO:0097242;GO:0150094;GO:0150093;GO:0035909;GO:0043277;GO:0002265;GO:0008283;GO:0044242;GO:1904646;GO:0021987;GO:0061642;GO:0006629;GO:0042157;GO:0042953;GO:0007041;GO:0051481;GO:0051895;GO:1905049;GO:0043524;GO:0010977;GO:2000587;GO:0014912;GO:0030178;GO:0006909;GO:1900223;GO:0048691;GO:0010942;GO:2000343;GO:0010875;GO:1904109;GO:0048694;GO:0007204;GO:0045807;GO:0070374;GO:0035774;GO:0032370;GO:1905167;GO:0050766;GO:0032092;GO:1903078;GO:1900149;GO:1904300;GO:1904754;GO:0007205;GO:0031623;GO:0006898;GO:0032956;GO:0032374;GO:0010715;GO:0032429;GO:0001523;GO:0045056;GO:0150104;, C:apical part of cell; C:axonal growth cone; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoskeleton; C:dendrite; C:early endosome; C:endocytic vesicle membrane; C:focal adhesion; C:insulin-responsive compartment; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:plasma membrane protein complex; C:postsynaptic Golgi apparatus; C:receptor complex;, F:alpha-2 macroglobulin receptor activity; F:amyloid-beta binding; F:apolipoprotein binding; F:apolipoprotein receptor activity; F:calcium ion binding; F:cargo receptor activity; F:clathrin heavy chain binding; F:coreceptor activity; F:heparan sulfate proteoglycan binding; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:protein-containing complex binding; F:RNA binding; F:scavenger receptor activity; F:signaling receptor activity;, P:aging; P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta clearance by transcytosis; P:aorta morphogenesis; P:apoptotic cell clearance; P:astrocyte activation involved in immune response; P:cell population proliferation; P:cellular lipid catabolic process; P:cellular response to amyloid-beta; P:cerebral cortex development; P:chemoattraction of axon; P:lipid metabolic process; P:lipoprotein metabolic process; P:lipoprotein transport; P:lysosomal transport; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of focal adhesion assembly; P:negative regulation of metallopeptidase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron projection development; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of Wnt signaling pathway; P:phagocytosis; P:positive regulation of amyloid-beta clearance; P:positive regulation of axon extension involved in regeneration; P:positive regulation of cell death; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol import; P:positive regulation of collateral sprouting of injured axon; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lipid transport; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of phagocytosis; P:positive regulation of protein binding; P:positive regulation of protein localization to plasma membrane; P:positive regulation of Schwann cell migration; P:positive regulation of transcytosis; P:positive regulation of vascular associated smooth muscle cell migration; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of cholesterol transport; P:regulation of extracellular matrix disassembly; P:regulation of phospholipase A2 activity; P:retinoid metabolic process; P:transcytosis; P:transport across blood-brain barrier;|Q07954 Q2PP12 Q86SW0 Q8IVG8,Prolow-density lipoprotein receptor-related protein 1 {ECO:0000305},Alpha-2-macroglobulin receptor {ECO:0000303|PubMed:26142438};Apolipoprotein E receptor;, PF12662;PF16472;PF07645;PF00057;PF00058;, GO:0045177;GO:0044295;GO:0016323;GO:0005905;GO:0030136;GO:0005856;GO:0030425;GO:0005769;GO:0030666;GO:0005925;GO:0032593;GO:0005887;GO:0005765;GO:0016020;GO:0043025;GO:0005634;GO:0005886;GO:0098797;GO:0150051;GO:0043235;GO:0016964;GO:0001540;GO:0034185;GO:0030226;GO:0005509;GO:0038024;GO:0032050;GO:0015026;GO:0043395;GO:0070325;GO:0005041;GO:0002020;GO:0044877;GO:0003723;GO:0005044;GO:0038023;GO:0007568;GO:0097242;GO:0150094;GO:0150093;GO:0035909;GO:0043277;GO:0002265;GO:0008283;GO:0044242;GO:1904646;GO:0021987;GO:0061642;GO:0006629;GO:0042157;GO:0042953;GO:0007041;GO:0051481;GO:0051895;GO:1905049;GO:0043524;GO:0010977;GO:2000587;GO:0014912;GO:0030178;GO:0006909;GO:1900223;GO:0048691;GO:0010942;GO:2000343;GO:0010875;GO:1904109;GO:0048694;GO:0007204;GO:0045807;GO:0070374;GO:0035774;GO:0032370;GO:1905167;GO:0050766;GO:0032092;GO:1903078;GO:1900149;GO:1904300;GO:1904754;GO:0007205;GO:0031623;GO:0006898;GO:0032956;GO:0032374;GO:0010715;GO:0032429;GO:0001523;GO:0045056;GO:0150104;, C:apical part of cell; C:axonal growth cone; C:basolateral plasma membrane; C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoskeleton; C:dendrite; C:early endosome; C:endocytic vesicle membrane; C:focal adhesion; C:insulin-responsive compartment; C:integral component of plasma membrane; C:lysosomal membrane; C:membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:plasma membrane protein complex; C:postsynaptic Golgi apparatus; C:receptor complex;, F:alpha-2 macroglobulin receptor activity; F:amyloid-beta binding; F:apolipoprotein binding; F:apolipoprotein receptor activity; F:calcium ion binding; F:cargo receptor activity; F:clathrin heavy chain binding; F:coreceptor activity; F:heparan sulfate proteoglycan binding; F:lipoprotein particle receptor binding; F:low-density lipoprotein particle receptor activity; F:protease binding; F:protein-containing complex binding; F:RNA binding; F:scavenger receptor activity; F:signaling receptor activity;, P:aging; P:amyloid-beta clearance; P:amyloid-beta clearance by cellular catabolic process; P:amyloid-beta clearance by transcytosis; P:aorta morphogenesis; P:apoptotic cell clearance; P:astrocyte activation involved in immune response; P:cell population proliferation; P:cellular lipid catabolic process; P:cellular response to amyloid-beta; P:cerebral cortex development; P:chemoattraction of axon; P:lipid metabolic process; P:lipoprotein metabolic process; P:lipoprotein transport; P:lysosomal transport; P:negative regulation of cytosolic calcium ion concentration; P:negative regulation of focal adhesion assembly; P:negative regulation of metallopeptidase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron projection development; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; P:negative regulation of smooth muscle cell migration; P:negative regulation of Wnt signaling pathway; P:phagocytosis; P:positive regulation of amyloid-beta clearance; P:positive regulation of axon extension involved in regeneration; P:positive regulation of cell death; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol import; P:positive regulation of collateral sprouting of injured axon; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of lipid transport; P:positive regulation of lysosomal protein catabolic process; P:positive regulation of phagocytosis; P:positive regulation of protein binding; P:positive regulation of protein localization to plasma membrane; P:positive regulation of Schwann cell migration; P:positive regulation of transcytosis; P:positive regulation of vascular associated smooth muscle cell migration; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:receptor internalization; P:receptor-mediated endocytosis; P:regulation of actin cytoskeleton organization; P:regulation of cholesterol transport; P:regulation of extracellular matrix disassembly; P:regulation of phospholipase A2 activity; P:retinoid metabolic process; P:transcytosis; P:transport across blood-brain barrier; scaffold151 indexed_genome mRNA 370470 384765 . + . ID=transcript_14705;P42226 A8K316 B7ZA27 F5GXI9 Q5FBW5 Q71UP4,Signal transducer and activator of transcription 6,IL-4 Stat;, PF00017;PF14596;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0019903;GO:0000978;GO:0000977;GO:0019221;GO:0006952;GO:0060397;GO:0035771;GO:0120162;GO:0045944;GO:0032481;GO:0007259;GO:0042127;GO:0006357;GO:0043434;GO:0007165;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-4-mediated signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:signal transduction;|P42226 A8K316 B7ZA27 F5GXI9 Q5FBW5 Q71UP4,Signal transducer and activator of transcription 6,IL-4 Stat;, PF00017;PF14596;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0019903;GO:0000978;GO:0000977;GO:0019221;GO:0006952;GO:0060397;GO:0035771;GO:0120162;GO:0045944;GO:0032481;GO:0007259;GO:0042127;GO:0006357;GO:0043434;GO:0007165;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-4-mediated signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:signal transduction;|P42226 A8K316 B7ZA27 F5GXI9 Q5FBW5 Q71UP4,Signal transducer and activator of transcription 6,IL-4 Stat;, PF00017;PF14596;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0019903;GO:0000978;GO:0000977;GO:0019221;GO:0006952;GO:0060397;GO:0035771;GO:0120162;GO:0045944;GO:0032481;GO:0007259;GO:0042127;GO:0006357;GO:0043434;GO:0007165;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-4-mediated signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:signal transduction;|P42226 A8K316 B7ZA27 F5GXI9 Q5FBW5 Q71UP4,Signal transducer and activator of transcription 6,IL-4 Stat;, PF00017;PF14596;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0019903;GO:0000978;GO:0000977;GO:0019221;GO:0006952;GO:0060397;GO:0035771;GO:0120162;GO:0045944;GO:0032481;GO:0007259;GO:0042127;GO:0006357;GO:0043434;GO:0007165;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-4-mediated signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:signal transduction;|P42226 A8K316 B7ZA27 F5GXI9 Q5FBW5 Q71UP4,Signal transducer and activator of transcription 6,IL-4 Stat;, PF00017;PF14596;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0019903;GO:0000978;GO:0000977;GO:0019221;GO:0006952;GO:0060397;GO:0035771;GO:0120162;GO:0045944;GO:0032481;GO:0007259;GO:0042127;GO:0006357;GO:0043434;GO:0007165;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-4-mediated signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:signal transduction;|P42226 A8K316 B7ZA27 F5GXI9 Q5FBW5 Q71UP4,Signal transducer and activator of transcription 6,IL-4 Stat;, PF00017;PF14596;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0019903;GO:0000978;GO:0000977;GO:0019221;GO:0006952;GO:0060397;GO:0035771;GO:0120162;GO:0045944;GO:0032481;GO:0007259;GO:0042127;GO:0006357;GO:0043434;GO:0007165;, C:chromatin; C:cytosol; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein phosphatase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cytokine-mediated signaling pathway; P:defense response; P:growth hormone receptor signaling pathway via JAK-STAT; P:interleukin-4-mediated signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:signal transduction; scaffold151 indexed_genome mRNA 386426 387661 . - . ID=transcript_14706;Q15742 B2RAK3 O76006 Q14797,NGFI-A-binding protein 2,EGR-1-binding protein 2;Melanoma-associated delayed early response protein;, PF04904;PF04905;, GO:0005654;GO:0005634;GO:0042802;GO:0003712;GO:0003714;GO:0008134;GO:0001958;GO:0042552;GO:0016480;GO:0007399;GO:1902949;GO:0045682;GO:0006355;GO:0014037;, C:nucleoplasm; C:nucleus;, F:identical protein binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:endochondral ossification; P:myelination; P:negative regulation of transcription by RNA polymerase III; P:nervous system development; P:positive regulation of tau-protein kinase activity; P:regulation of epidermis development; P:regulation of transcription, DNA-templated; P:Schwann cell differentiation; scaffold151 indexed_genome mRNA 388254 389731 . + . ID=transcript_14707;Q15742 B2RAK3 O76006 Q14797,NGFI-A-binding protein 2,EGR-1-binding protein 2;Melanoma-associated delayed early response protein;, PF04904;PF04905;, GO:0005654;GO:0005634;GO:0042802;GO:0003712;GO:0003714;GO:0008134;GO:0001958;GO:0042552;GO:0016480;GO:0007399;GO:1902949;GO:0045682;GO:0006355;GO:0014037;, C:nucleoplasm; C:nucleus;, F:identical protein binding; F:transcription coregulator activity; F:transcription corepressor activity; F:transcription factor binding;, P:endochondral ossification; P:myelination; P:negative regulation of transcription by RNA polymerase III; P:nervous system development; P:positive regulation of tau-protein kinase activity; P:regulation of epidermis development; P:regulation of transcription, DNA-templated; P:Schwann cell differentiation; scaffold151 indexed_genome mRNA 399433 416634 . + . ID=transcript_14708;O14524 Q17R72 Q68DH0 Q6IQ25,Nuclear envelope integral membrane protein 1,, PF10225;, GO:0016021;GO:0005635;GO:0005637;GO:0071763;, C:integral component of membrane; C:nuclear envelope; C:nuclear inner membrane;, , P:nuclear membrane organization;|O14524 Q17R72 Q68DH0 Q6IQ25,Nuclear envelope integral membrane protein 1,, PF10225;, GO:0016021;GO:0005635;GO:0005637;GO:0071763;, C:integral component of membrane; C:nuclear envelope; C:nuclear inner membrane;, , P:nuclear membrane organization;|O14524 Q17R72 Q68DH0 Q6IQ25,Nuclear envelope integral membrane protein 1,, PF10225;, GO:0016021;GO:0005635;GO:0005637;GO:0071763;, C:integral component of membrane; C:nuclear envelope; C:nuclear inner membrane;, , P:nuclear membrane organization;|O14524 Q17R72 Q68DH0 Q6IQ25,Nuclear envelope integral membrane protein 1,, PF10225;, GO:0016021;GO:0005635;GO:0005637;GO:0071763;, C:integral component of membrane; C:nuclear envelope; C:nuclear inner membrane;, , P:nuclear membrane organization; scaffold151 indexed_genome mRNA 481478 484497 . + . ID=transcript_14709;O15060 A7MD38 Q9UD98,Zinc finger and BTB domain-containing protein 39,, PF00651;PF00096;, GO:0005654;GO:0001227;GO:0046872;GO:0000978;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold151 indexed_genome mRNA 489994 491920 . - . ID=transcript_14710;O15218,G-protein coupled receptor 182,, PF00001;, GO:0016021;GO:0005886;GO:0004930;GO:0004888;GO:0007166;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; scaffold151 indexed_genome mRNA 529245 531225 . + . ID=transcript_14711;O75452 Q9UNV2,Retinol dehydrogenase 16,Human epidermal retinol dehydrogenase {ECO:0000303|PubMed:10329026};Microsomal NAD(+)-dependent retinol dehydrogenase 4 {ECO:0000303|PubMed:12534290};Short chain dehydrogenase/reductase family 9C member 8 {ECO:0000303|PubMed:19027726};Sterol/retinol dehydrogenase;, PF00106;, GO:0005789;GO:0016021;GO:0043231;GO:0047044;GO:0047023;GO:0009055;GO:0042802;GO:0004745;GO:0006629;GO:0042572;GO:0008202;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:electron transfer activity; F:identical protein binding; F:retinol dehydrogenase activity;, P:lipid metabolic process; P:retinol metabolic process; P:steroid metabolic process; scaffold151 indexed_genome mRNA 548537 555293 . + . ID=transcript_14712;O75452 Q9UNV2,Retinol dehydrogenase 16,Human epidermal retinol dehydrogenase {ECO:0000303|PubMed:10329026};Microsomal NAD(+)-dependent retinol dehydrogenase 4 {ECO:0000303|PubMed:12534290};Short chain dehydrogenase/reductase family 9C member 8 {ECO:0000303|PubMed:19027726};Sterol/retinol dehydrogenase;, PF00106;, GO:0005789;GO:0016021;GO:0043231;GO:0047044;GO:0047023;GO:0009055;GO:0042802;GO:0004745;GO:0006629;GO:0042572;GO:0008202;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:electron transfer activity; F:identical protein binding; F:retinol dehydrogenase activity;, P:lipid metabolic process; P:retinol metabolic process; P:steroid metabolic process;|O75452 Q9UNV2,Retinol dehydrogenase 16,Human epidermal retinol dehydrogenase {ECO:0000303|PubMed:10329026};Microsomal NAD(+)-dependent retinol dehydrogenase 4 {ECO:0000303|PubMed:12534290};Short chain dehydrogenase/reductase family 9C member 8 {ECO:0000303|PubMed:19027726};Sterol/retinol dehydrogenase;, PF00106;, GO:0005789;GO:0016021;GO:0043231;GO:0047044;GO:0047023;GO:0009055;GO:0042802;GO:0004745;GO:0006629;GO:0042572;GO:0008202;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:electron transfer activity; F:identical protein binding; F:retinol dehydrogenase activity;, P:lipid metabolic process; P:retinol metabolic process; P:steroid metabolic process;|O75452 Q9UNV2,Retinol dehydrogenase 16,Human epidermal retinol dehydrogenase {ECO:0000303|PubMed:10329026};Microsomal NAD(+)-dependent retinol dehydrogenase 4 {ECO:0000303|PubMed:12534290};Short chain dehydrogenase/reductase family 9C member 8 {ECO:0000303|PubMed:19027726};Sterol/retinol dehydrogenase;, PF00106;, GO:0005789;GO:0016021;GO:0043231;GO:0047044;GO:0047023;GO:0009055;GO:0042802;GO:0004745;GO:0006629;GO:0042572;GO:0008202;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:electron transfer activity; F:identical protein binding; F:retinol dehydrogenase activity;, P:lipid metabolic process; P:retinol metabolic process; P:steroid metabolic process; scaffold151 indexed_genome mRNA 678152 687675 . - . ID=transcript_14713;O14756 O43275,17-beta-hydroxysteroid dehydrogenase type 6,3-alpha->beta-hydroxysteroid epimerase;Oxidative 3-alpha hydroxysteroid dehydrogenase;Short chain dehydrogenase/reductase family 9C member 6;, PF00106;, GO:0031901;GO:0005783;GO:0044594;GO:0072582;GO:0047024;GO:0047044;GO:0047023;GO:0003824;GO:0009055;GO:0016491;GO:0004745;GO:0047045;GO:0047035;GO:0006702;GO:0006710;GO:0062175;, C:early endosome membrane; C:endoplasmic reticulum;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:catalytic activity; F:electron transfer activity; F:oxidoreductase activity; F:retinol dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:androgen biosynthetic process; P:androgen catabolic process; P:brexanolone catabolic process;|O14756 O43275,17-beta-hydroxysteroid dehydrogenase type 6,3-alpha->beta-hydroxysteroid epimerase;Oxidative 3-alpha hydroxysteroid dehydrogenase;Short chain dehydrogenase/reductase family 9C member 6;, PF00106;, GO:0031901;GO:0005783;GO:0044594;GO:0072582;GO:0047024;GO:0047044;GO:0047023;GO:0003824;GO:0009055;GO:0016491;GO:0004745;GO:0047045;GO:0047035;GO:0006702;GO:0006710;GO:0062175;, C:early endosome membrane; C:endoplasmic reticulum;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:catalytic activity; F:electron transfer activity; F:oxidoreductase activity; F:retinol dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:androgen biosynthetic process; P:androgen catabolic process; P:brexanolone catabolic process;|O14756 O43275,17-beta-hydroxysteroid dehydrogenase type 6,3-alpha->beta-hydroxysteroid epimerase;Oxidative 3-alpha hydroxysteroid dehydrogenase;Short chain dehydrogenase/reductase family 9C member 6;, PF00106;, GO:0031901;GO:0005783;GO:0044594;GO:0072582;GO:0047024;GO:0047044;GO:0047023;GO:0003824;GO:0009055;GO:0016491;GO:0004745;GO:0047045;GO:0047035;GO:0006702;GO:0006710;GO:0062175;, C:early endosome membrane; C:endoplasmic reticulum;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:catalytic activity; F:electron transfer activity; F:oxidoreductase activity; F:retinol dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:androgen biosynthetic process; P:androgen catabolic process; P:brexanolone catabolic process;|O14756 O43275,17-beta-hydroxysteroid dehydrogenase type 6,3-alpha->beta-hydroxysteroid epimerase;Oxidative 3-alpha hydroxysteroid dehydrogenase;Short chain dehydrogenase/reductase family 9C member 6;, PF00106;, GO:0031901;GO:0005783;GO:0044594;GO:0072582;GO:0047024;GO:0047044;GO:0047023;GO:0003824;GO:0009055;GO:0016491;GO:0004745;GO:0047045;GO:0047035;GO:0006702;GO:0006710;GO:0062175;, C:early endosome membrane; C:endoplasmic reticulum;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:catalytic activity; F:electron transfer activity; F:oxidoreductase activity; F:retinol dehydrogenase activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity; F:testosterone dehydrogenase (NAD+) activity;, P:androgen biosynthetic process; P:androgen catabolic process; P:brexanolone catabolic process; scaffold151 indexed_genome mRNA 715497 734843 . + . ID=transcript_14714;P49642,DNA primase small subunit,DNA primase 49 kDa subunit;, PF01896;, GO:0005658;GO:0016020;GO:0005654;GO:0003896;GO:0046872;GO:0006270;GO:0006269;GO:0032201;, C:alpha DNA polymerase:primase complex; C:membrane; C:nucleoplasm;, F:DNA primase activity; F:metal ion binding;, P:DNA replication initiation; P:DNA replication, synthesis of RNA primer; P:telomere maintenance via semi-conservative replication;|P49642,DNA primase small subunit,DNA primase 49 kDa subunit;, PF01896;, GO:0005658;GO:0016020;GO:0005654;GO:0003896;GO:0046872;GO:0006270;GO:0006269;GO:0032201;, C:alpha DNA polymerase:primase complex; C:membrane; C:nucleoplasm;, F:DNA primase activity; F:metal ion binding;, P:DNA replication initiation; P:DNA replication, synthesis of RNA primer; P:telomere maintenance via semi-conservative replication;|P49642,DNA primase small subunit,DNA primase 49 kDa subunit;, PF01896;, GO:0005658;GO:0016020;GO:0005654;GO:0003896;GO:0046872;GO:0006270;GO:0006269;GO:0032201;, C:alpha DNA polymerase:primase complex; C:membrane; C:nucleoplasm;, F:DNA primase activity; F:metal ion binding;, P:DNA replication initiation; P:DNA replication, synthesis of RNA primer; P:telomere maintenance via semi-conservative replication;|P49642,DNA primase small subunit,DNA primase 49 kDa subunit;, PF01896;, GO:0005658;GO:0016020;GO:0005654;GO:0003896;GO:0046872;GO:0006270;GO:0006269;GO:0032201;, C:alpha DNA polymerase:primase complex; C:membrane; C:nucleoplasm;, F:DNA primase activity; F:metal ion binding;, P:DNA replication initiation; P:DNA replication, synthesis of RNA primer; P:telomere maintenance via semi-conservative replication; scaffold151 indexed_genome mRNA 736608 744997 . + . ID=transcript_14715;Q13765 A8MTN7 B2R4P8 F8VU71 Q3KQV4 Q53A18 Q53G46,Nascent polypeptide-associated complex subunit alpha,Alpha-NAC;, PF19026;PF01849;, GO:0005737;GO:0070062;GO:0005854;GO:0005634;GO:0003677;GO:0003713;GO:0003231;GO:0061384;GO:0010664;GO:1901227;GO:2000138;GO:0048633;GO:1901228;GO:0015031;GO:0048742;GO:0043403;GO:0006412;GO:0042060;, C:cytoplasm; C:extracellular exosome; C:nascent polypeptide-associated complex; C:nucleus;, F:DNA binding; F:transcription coactivator activity;, P:cardiac ventricle development; P:heart trabecula morphogenesis; P:negative regulation of striated muscle cell apoptotic process; P:negative regulation of transcription from RNA polymerase II promoter involved in heart development; P:positive regulation of cell proliferation involved in heart morphogenesis; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; P:protein transport; P:regulation of skeletal muscle fiber development; P:skeletal muscle tissue regeneration; P:translation; P:wound healing;|Q13765 A8MTN7 B2R4P8 F8VU71 Q3KQV4 Q53A18 Q53G46,Nascent polypeptide-associated complex subunit alpha,Alpha-NAC;, PF19026;PF01849;, GO:0005737;GO:0070062;GO:0005854;GO:0005634;GO:0003677;GO:0003713;GO:0003231;GO:0061384;GO:0010664;GO:1901227;GO:2000138;GO:0048633;GO:1901228;GO:0015031;GO:0048742;GO:0043403;GO:0006412;GO:0042060;, C:cytoplasm; C:extracellular exosome; C:nascent polypeptide-associated complex; C:nucleus;, F:DNA binding; F:transcription coactivator activity;, P:cardiac ventricle development; P:heart trabecula morphogenesis; P:negative regulation of striated muscle cell apoptotic process; P:negative regulation of transcription from RNA polymerase II promoter involved in heart development; P:positive regulation of cell proliferation involved in heart morphogenesis; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; P:protein transport; P:regulation of skeletal muscle fiber development; P:skeletal muscle tissue regeneration; P:translation; P:wound healing; scaffold151 indexed_genome mRNA 745496 746523 . + . ID=transcript_14716;Q13765 A8MTN7 B2R4P8 F8VU71 Q3KQV4 Q53A18 Q53G46,Nascent polypeptide-associated complex subunit alpha,Alpha-NAC;, PF19026;PF01849;, GO:0005737;GO:0070062;GO:0005854;GO:0005634;GO:0003677;GO:0003713;GO:0003231;GO:0061384;GO:0010664;GO:1901227;GO:2000138;GO:0048633;GO:1901228;GO:0015031;GO:0048742;GO:0043403;GO:0006412;GO:0042060;, C:cytoplasm; C:extracellular exosome; C:nascent polypeptide-associated complex; C:nucleus;, F:DNA binding; F:transcription coactivator activity;, P:cardiac ventricle development; P:heart trabecula morphogenesis; P:negative regulation of striated muscle cell apoptotic process; P:negative regulation of transcription from RNA polymerase II promoter involved in heart development; P:positive regulation of cell proliferation involved in heart morphogenesis; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; P:protein transport; P:regulation of skeletal muscle fiber development; P:skeletal muscle tissue regeneration; P:translation; P:wound healing; scaffold151 indexed_genome mRNA 779136 799118 . + . ID=transcript_14717;Q15185 A8K7D0 B4DHP2 B4DP11 B4DP21 Q8WU70,Prostaglandin E synthase 3,Cytosolic prostaglandin E2 synthase;Hsp90 co-chaperone;Progesterone receptor complex p23;Telomerase-binding protein p23;, PF04969;, GO:0101031;GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0005697;GO:0051087;GO:0070182;GO:0051879;GO:0050220;GO:0003720;GO:0051082;GO:0051085;GO:0051131;GO:0019371;GO:0042327;GO:0051973;GO:0001516;GO:0006457;GO:0050821;GO:1900034;GO:0007165;GO:1905323;GO:0000723;GO:0007004;GO:0006805;, C:chaperone complex; C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:telomerase holoenzyme complex;, F:chaperone binding; F:DNA polymerase binding; F:Hsp90 protein binding; F:prostaglandin-E synthase activity; F:telomerase activity; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:chaperone-mediated protein complex assembly; P:cyclooxygenase pathway; P:positive regulation of phosphorylation; P:positive regulation of telomerase activity; P:prostaglandin biosynthetic process; P:protein folding; P:protein stabilization; P:regulation of cellular response to heat; P:signal transduction; P:telomerase holoenzyme complex assembly; P:telomere maintenance; P:telomere maintenance via telomerase; P:xenobiotic metabolic process;|Q15185 A8K7D0 B4DHP2 B4DP11 B4DP21 Q8WU70,Prostaglandin E synthase 3,Cytosolic prostaglandin E2 synthase;Hsp90 co-chaperone;Progesterone receptor complex p23;Telomerase-binding protein p23;, PF04969;, GO:0101031;GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0032991;GO:0005697;GO:0051087;GO:0070182;GO:0051879;GO:0050220;GO:0003720;GO:0051082;GO:0051085;GO:0051131;GO:0019371;GO:0042327;GO:0051973;GO:0001516;GO:0006457;GO:0050821;GO:1900034;GO:0007165;GO:1905323;GO:0000723;GO:0007004;GO:0006805;, C:chaperone complex; C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:telomerase holoenzyme complex;, F:chaperone binding; F:DNA polymerase binding; F:Hsp90 protein binding; F:prostaglandin-E synthase activity; F:telomerase activity; F:unfolded protein binding;, P:chaperone cofactor-dependent protein refolding; P:chaperone-mediated protein complex assembly; P:cyclooxygenase pathway; P:positive regulation of phosphorylation; P:positive regulation of telomerase activity; P:prostaglandin biosynthetic process; P:protein folding; P:protein stabilization; P:regulation of cellular response to heat; P:signal transduction; P:telomerase holoenzyme complex assembly; P:telomere maintenance; P:telomere maintenance via telomerase; P:xenobiotic metabolic process; scaffold151 indexed_genome mRNA 806023 811361 . - . ID=transcript_14718;P06576 A8K4X0 Q14283,ATP synthase subunit beta, mitochondrial {ECO:0000305},ATP synthase F1 subunit beta {ECO:0000312|HGNC:HGNC:830};, PF00006;PF02874;, GO:0009986;GO:0070062;GO:0016020;GO:0005759;GO:0031966;GO:0042645;GO:0005753;GO:0005754;GO:0005739;GO:0005634;GO:0005886;GO:0045259;GO:0045261;GO:0043532;GO:0005524;GO:0042288;GO:0046933;GO:0046961;GO:0001525;GO:0006754;GO:0098761;GO:0042407;GO:0006091;GO:0006629;GO:0042776;GO:0007005;GO:0006933;GO:0001649;GO:0043536;GO:1902600;GO:0051453;, C:cell surface; C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase, catalytic core; C:mitochondrion; C:nucleus; C:plasma membrane; C:proton-transporting ATP synthase complex; C:proton-transporting ATP synthase complex, catalytic core F(1);, F:angiostatin binding; F:ATP binding; F:MHC class I protein binding; F:proton-transporting ATP synthase activity, rotational mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:angiogenesis; P:ATP biosynthetic process; P:cellular response to interleukin-7; P:cristae formation; P:generation of precursor metabolites and energy; P:lipid metabolic process; P:mitochondrial ATP synthesis coupled proton transport; P:mitochondrion organization; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:osteoblast differentiation; P:positive regulation of blood vessel endothelial cell migration; P:proton transmembrane transport; P:regulation of intracellular pH;|P06576 A8K4X0 Q14283,ATP synthase subunit beta, mitochondrial {ECO:0000305},ATP synthase F1 subunit beta {ECO:0000312|HGNC:HGNC:830};, PF00006;PF02874;, GO:0009986;GO:0070062;GO:0016020;GO:0005759;GO:0031966;GO:0042645;GO:0005753;GO:0005754;GO:0005739;GO:0005634;GO:0005886;GO:0045259;GO:0045261;GO:0043532;GO:0005524;GO:0042288;GO:0046933;GO:0046961;GO:0001525;GO:0006754;GO:0098761;GO:0042407;GO:0006091;GO:0006629;GO:0042776;GO:0007005;GO:0006933;GO:0001649;GO:0043536;GO:1902600;GO:0051453;, C:cell surface; C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase, catalytic core; C:mitochondrion; C:nucleus; C:plasma membrane; C:proton-transporting ATP synthase complex; C:proton-transporting ATP synthase complex, catalytic core F(1);, F:angiostatin binding; F:ATP binding; F:MHC class I protein binding; F:proton-transporting ATP synthase activity, rotational mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:angiogenesis; P:ATP biosynthetic process; P:cellular response to interleukin-7; P:cristae formation; P:generation of precursor metabolites and energy; P:lipid metabolic process; P:mitochondrial ATP synthesis coupled proton transport; P:mitochondrion organization; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:osteoblast differentiation; P:positive regulation of blood vessel endothelial cell migration; P:proton transmembrane transport; P:regulation of intracellular pH;|P06576 A8K4X0 Q14283,ATP synthase subunit beta, mitochondrial {ECO:0000305},ATP synthase F1 subunit beta {ECO:0000312|HGNC:HGNC:830};, PF00006;PF02874;, GO:0009986;GO:0070062;GO:0016020;GO:0005759;GO:0031966;GO:0042645;GO:0005753;GO:0005754;GO:0005739;GO:0005634;GO:0005886;GO:0045259;GO:0045261;GO:0043532;GO:0005524;GO:0042288;GO:0046933;GO:0046961;GO:0001525;GO:0006754;GO:0098761;GO:0042407;GO:0006091;GO:0006629;GO:0042776;GO:0007005;GO:0006933;GO:0001649;GO:0043536;GO:1902600;GO:0051453;, C:cell surface; C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase, catalytic core; C:mitochondrion; C:nucleus; C:plasma membrane; C:proton-transporting ATP synthase complex; C:proton-transporting ATP synthase complex, catalytic core F(1);, F:angiostatin binding; F:ATP binding; F:MHC class I protein binding; F:proton-transporting ATP synthase activity, rotational mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:angiogenesis; P:ATP biosynthetic process; P:cellular response to interleukin-7; P:cristae formation; P:generation of precursor metabolites and energy; P:lipid metabolic process; P:mitochondrial ATP synthesis coupled proton transport; P:mitochondrion organization; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:osteoblast differentiation; P:positive regulation of blood vessel endothelial cell migration; P:proton transmembrane transport; P:regulation of intracellular pH;|P06576 A8K4X0 Q14283,ATP synthase subunit beta, mitochondrial {ECO:0000305},ATP synthase F1 subunit beta {ECO:0000312|HGNC:HGNC:830};, PF00006;PF02874;, GO:0009986;GO:0070062;GO:0016020;GO:0005759;GO:0031966;GO:0042645;GO:0005753;GO:0005754;GO:0005739;GO:0005634;GO:0005886;GO:0045259;GO:0045261;GO:0043532;GO:0005524;GO:0042288;GO:0046933;GO:0046961;GO:0001525;GO:0006754;GO:0098761;GO:0042407;GO:0006091;GO:0006629;GO:0042776;GO:0007005;GO:0006933;GO:0001649;GO:0043536;GO:1902600;GO:0051453;, C:cell surface; C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial nucleoid; C:mitochondrial proton-transporting ATP synthase complex; C:mitochondrial proton-transporting ATP synthase, catalytic core; C:mitochondrion; C:nucleus; C:plasma membrane; C:proton-transporting ATP synthase complex; C:proton-transporting ATP synthase complex, catalytic core F(1);, F:angiostatin binding; F:ATP binding; F:MHC class I protein binding; F:proton-transporting ATP synthase activity, rotational mechanism; F:proton-transporting ATPase activity, rotational mechanism;, P:angiogenesis; P:ATP biosynthetic process; P:cellular response to interleukin-7; P:cristae formation; P:generation of precursor metabolites and energy; P:lipid metabolic process; P:mitochondrial ATP synthesis coupled proton transport; P:mitochondrion organization; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:osteoblast differentiation; P:positive regulation of blood vessel endothelial cell migration; P:proton transmembrane transport; P:regulation of intracellular pH; scaffold151 indexed_genome mRNA 813165 849296 . + . ID=transcript_14719;Q9UIF9 B3KN66 O00536 O15030 Q68DI8 Q96H26,Bromodomain adjacent to zinc finger domain protein 2A,Transcription termination factor I-interacting protein 5;hWALp3;, PF00439;PF02791;PF01429;PF00628;PF15612;PF15613;, GO:0005677;GO:0005829;GO:0016607;GO:0005730;GO:0033553;GO:0003677;GO:0042393;GO:0070577;GO:0046872;GO:0016922;GO:0003723;GO:0006338;GO:0006306;GO:0016575;GO:0000183;GO:0006355;GO:0001188;GO:0006351;, C:chromatin silencing complex; C:cytosol; C:nuclear speck; C:nucleolus; C:rDNA heterochromatin;, F:DNA binding; F:histone binding; F:lysine-acetylated histone binding; F:metal ion binding; F:nuclear receptor binding; F:RNA binding;, P:chromatin remodeling; P:DNA methylation; P:histone deacetylation; P:rDNA heterochromatin assembly; P:regulation of transcription, DNA-templated; P:RNA polymerase I preinitiation complex assembly; P:transcription, DNA-templated;|Q9UIF9 B3KN66 O00536 O15030 Q68DI8 Q96H26,Bromodomain adjacent to zinc finger domain protein 2A,Transcription termination factor I-interacting protein 5;hWALp3;, PF00439;PF02791;PF01429;PF00628;PF15612;PF15613;, GO:0005677;GO:0005829;GO:0016607;GO:0005730;GO:0033553;GO:0003677;GO:0042393;GO:0070577;GO:0046872;GO:0016922;GO:0003723;GO:0006338;GO:0006306;GO:0016575;GO:0000183;GO:0006355;GO:0001188;GO:0006351;, C:chromatin silencing complex; C:cytosol; C:nuclear speck; C:nucleolus; C:rDNA heterochromatin;, F:DNA binding; F:histone binding; F:lysine-acetylated histone binding; F:metal ion binding; F:nuclear receptor binding; F:RNA binding;, P:chromatin remodeling; P:DNA methylation; P:histone deacetylation; P:rDNA heterochromatin assembly; P:regulation of transcription, DNA-templated; P:RNA polymerase I preinitiation complex assembly; P:transcription, DNA-templated; scaffold151 indexed_genome mRNA 849949 857827 . + . ID=transcript_14720;Q9UIF9 B3KN66 O00536 O15030 Q68DI8 Q96H26,Bromodomain adjacent to zinc finger domain protein 2A,Transcription termination factor I-interacting protein 5;hWALp3;, PF00439;PF02791;PF01429;PF00628;PF15612;PF15613;, GO:0005677;GO:0005829;GO:0016607;GO:0005730;GO:0033553;GO:0003677;GO:0042393;GO:0070577;GO:0046872;GO:0016922;GO:0003723;GO:0006338;GO:0006306;GO:0016575;GO:0000183;GO:0006355;GO:0001188;GO:0006351;, C:chromatin silencing complex; C:cytosol; C:nuclear speck; C:nucleolus; C:rDNA heterochromatin;, F:DNA binding; F:histone binding; F:lysine-acetylated histone binding; F:metal ion binding; F:nuclear receptor binding; F:RNA binding;, P:chromatin remodeling; P:DNA methylation; P:histone deacetylation; P:rDNA heterochromatin assembly; P:regulation of transcription, DNA-templated; P:RNA polymerase I preinitiation complex assembly; P:transcription, DNA-templated;|Q9UIF9 B3KN66 O00536 O15030 Q68DI8 Q96H26,Bromodomain adjacent to zinc finger domain protein 2A,Transcription termination factor I-interacting protein 5;hWALp3;, PF00439;PF02791;PF01429;PF00628;PF15612;PF15613;, GO:0005677;GO:0005829;GO:0016607;GO:0005730;GO:0033553;GO:0003677;GO:0042393;GO:0070577;GO:0046872;GO:0016922;GO:0003723;GO:0006338;GO:0006306;GO:0016575;GO:0000183;GO:0006355;GO:0001188;GO:0006351;, C:chromatin silencing complex; C:cytosol; C:nuclear speck; C:nucleolus; C:rDNA heterochromatin;, F:DNA binding; F:histone binding; F:lysine-acetylated histone binding; F:metal ion binding; F:nuclear receptor binding; F:RNA binding;, P:chromatin remodeling; P:DNA methylation; P:histone deacetylation; P:rDNA heterochromatin assembly; P:regulation of transcription, DNA-templated; P:RNA polymerase I preinitiation complex assembly; P:transcription, DNA-templated;|Q9UIF9 B3KN66 O00536 O15030 Q68DI8 Q96H26,Bromodomain adjacent to zinc finger domain protein 2A,Transcription termination factor I-interacting protein 5;hWALp3;, PF00439;PF02791;PF01429;PF00628;PF15612;PF15613;, GO:0005677;GO:0005829;GO:0016607;GO:0005730;GO:0033553;GO:0003677;GO:0042393;GO:0070577;GO:0046872;GO:0016922;GO:0003723;GO:0006338;GO:0006306;GO:0016575;GO:0000183;GO:0006355;GO:0001188;GO:0006351;, C:chromatin silencing complex; C:cytosol; C:nuclear speck; C:nucleolus; C:rDNA heterochromatin;, F:DNA binding; F:histone binding; F:lysine-acetylated histone binding; F:metal ion binding; F:nuclear receptor binding; F:RNA binding;, P:chromatin remodeling; P:DNA methylation; P:histone deacetylation; P:rDNA heterochromatin assembly; P:regulation of transcription, DNA-templated; P:RNA polymerase I preinitiation complex assembly; P:transcription, DNA-templated;|Q9UIF9 B3KN66 O00536 O15030 Q68DI8 Q96H26,Bromodomain adjacent to zinc finger domain protein 2A,Transcription termination factor I-interacting protein 5;hWALp3;, PF00439;PF02791;PF01429;PF00628;PF15612;PF15613;, GO:0005677;GO:0005829;GO:0016607;GO:0005730;GO:0033553;GO:0003677;GO:0042393;GO:0070577;GO:0046872;GO:0016922;GO:0003723;GO:0006338;GO:0006306;GO:0016575;GO:0000183;GO:0006355;GO:0001188;GO:0006351;, C:chromatin silencing complex; C:cytosol; C:nuclear speck; C:nucleolus; C:rDNA heterochromatin;, F:DNA binding; F:histone binding; F:lysine-acetylated histone binding; F:metal ion binding; F:nuclear receptor binding; F:RNA binding;, P:chromatin remodeling; P:DNA methylation; P:histone deacetylation; P:rDNA heterochromatin assembly; P:regulation of transcription, DNA-templated; P:RNA polymerase I preinitiation complex assembly; P:transcription, DNA-templated; scaffold151 indexed_genome mRNA 863182 932625 . - . ID=transcript_14721;Q15434,RNA-binding motif, single-stranded-interacting protein 2,Suppressor of CDC2 with RNA-binding motif 3;, PF00076;, GO:0005829;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0006396;, C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:RNA processing;|Q15434,RNA-binding motif, single-stranded-interacting protein 2,Suppressor of CDC2 with RNA-binding motif 3;, PF00076;, GO:0005829;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0006396;, C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:RNA processing;|Q15434,RNA-binding motif, single-stranded-interacting protein 2,Suppressor of CDC2 with RNA-binding motif 3;, PF00076;, GO:0005829;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0006396;, C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:RNA processing; scaffold151 indexed_genome mRNA 932795 947212 . + . ID=transcript_14722;Q9UI32 B7Z8Q9 Q8IX91 Q9NYY2 Q9UI31,Glutaminase liver isoform, mitochondrial,L-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005759;GO:0005739;GO:0004359;GO:0006520;GO:0006537;GO:0006543;GO:0009064;GO:0006836;GO:0072593;GO:0042981;, C:mitochondrial matrix; C:mitochondrion;, F:glutaminase activity;, P:cellular amino acid metabolic process; P:glutamate biosynthetic process; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:reactive oxygen species metabolic process; P:regulation of apoptotic process;|Q9UI32 B7Z8Q9 Q8IX91 Q9NYY2 Q9UI31,Glutaminase liver isoform, mitochondrial,L-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005759;GO:0005739;GO:0004359;GO:0006520;GO:0006537;GO:0006543;GO:0009064;GO:0006836;GO:0072593;GO:0042981;, C:mitochondrial matrix; C:mitochondrion;, F:glutaminase activity;, P:cellular amino acid metabolic process; P:glutamate biosynthetic process; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:reactive oxygen species metabolic process; P:regulation of apoptotic process;|Q9UI32 B7Z8Q9 Q8IX91 Q9NYY2 Q9UI31,Glutaminase liver isoform, mitochondrial,L-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005759;GO:0005739;GO:0004359;GO:0006520;GO:0006537;GO:0006543;GO:0009064;GO:0006836;GO:0072593;GO:0042981;, C:mitochondrial matrix; C:mitochondrion;, F:glutaminase activity;, P:cellular amino acid metabolic process; P:glutamate biosynthetic process; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:reactive oxygen species metabolic process; P:regulation of apoptotic process;|Q9UI32 B7Z8Q9 Q8IX91 Q9NYY2 Q9UI31,Glutaminase liver isoform, mitochondrial,L-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005759;GO:0005739;GO:0004359;GO:0006520;GO:0006537;GO:0006543;GO:0009064;GO:0006836;GO:0072593;GO:0042981;, C:mitochondrial matrix; C:mitochondrion;, F:glutaminase activity;, P:cellular amino acid metabolic process; P:glutamate biosynthetic process; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:reactive oxygen species metabolic process; P:regulation of apoptotic process;|Q9UI32 B7Z8Q9 Q8IX91 Q9NYY2 Q9UI31,Glutaminase liver isoform, mitochondrial,L-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005759;GO:0005739;GO:0004359;GO:0006520;GO:0006537;GO:0006543;GO:0009064;GO:0006836;GO:0072593;GO:0042981;, C:mitochondrial matrix; C:mitochondrion;, F:glutaminase activity;, P:cellular amino acid metabolic process; P:glutamate biosynthetic process; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:reactive oxygen species metabolic process; P:regulation of apoptotic process;|Q9UI32 B7Z8Q9 Q8IX91 Q9NYY2 Q9UI31,Glutaminase liver isoform, mitochondrial,L-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005759;GO:0005739;GO:0004359;GO:0006520;GO:0006537;GO:0006543;GO:0009064;GO:0006836;GO:0072593;GO:0042981;, C:mitochondrial matrix; C:mitochondrion;, F:glutaminase activity;, P:cellular amino acid metabolic process; P:glutamate biosynthetic process; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:reactive oxygen species metabolic process; P:regulation of apoptotic process;|Q8WW59 A8K7A5,SPRY domain-containing protein 4,, PF00622;, GO:0005634;, C:nucleus;|Q9UI32 B7Z8Q9 Q8IX91 Q9NYY2 Q9UI31,Glutaminase liver isoform, mitochondrial,L-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005759;GO:0005739;GO:0004359;GO:0006520;GO:0006537;GO:0006543;GO:0009064;GO:0006836;GO:0072593;GO:0042981;, C:mitochondrial matrix; C:mitochondrion;, F:glutaminase activity;, P:cellular amino acid metabolic process; P:glutamate biosynthetic process; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:reactive oxygen species metabolic process; P:regulation of apoptotic process;|Q9UI32 B7Z8Q9 Q8IX91 Q9NYY2 Q9UI31,Glutaminase liver isoform, mitochondrial,L-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005759;GO:0005739;GO:0004359;GO:0006520;GO:0006537;GO:0006543;GO:0009064;GO:0006836;GO:0072593;GO:0042981;, C:mitochondrial matrix; C:mitochondrion;, F:glutaminase activity;, P:cellular amino acid metabolic process; P:glutamate biosynthetic process; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:reactive oxygen species metabolic process; P:regulation of apoptotic process;|Q9UI32 B7Z8Q9 Q8IX91 Q9NYY2 Q9UI31,Glutaminase liver isoform, mitochondrial,L-glutaminase;L-glutamine amidohydrolase;, PF12796;PF17959;PF04960;, GO:0005759;GO:0005739;GO:0004359;GO:0006520;GO:0006537;GO:0006543;GO:0009064;GO:0006836;GO:0072593;GO:0042981;, C:mitochondrial matrix; C:mitochondrion;, F:glutaminase activity;, P:cellular amino acid metabolic process; P:glutamate biosynthetic process; P:glutamine catabolic process; P:glutamine family amino acid metabolic process; P:neurotransmitter transport; P:reactive oxygen species metabolic process; P:regulation of apoptotic process; scaffold151 indexed_genome mRNA 966416 969757 . + . ID=transcript_14723;Q9UNS1 B2ZAV0 O94802 Q86VM1 Q8IWH3,Protein timeless homolog,, PF04821;PF05029;, GO:0000785;GO:0005654;GO:0005634;GO:0031298;GO:0035861;GO:0003677;GO:0048754;GO:0044770;GO:0051301;GO:1904976;GO:0072719;GO:0006974;GO:0072711;GO:0007623;GO:0009582;GO:0006281;GO:0006260;GO:0000076;GO:0030324;GO:0002009;GO:0000122;GO:0045892;GO:2000781;GO:1905168;GO:0042752;GO:0043111;GO:0048478;, C:chromatin; C:nucleoplasm; C:nucleus; C:replication fork protection complex; C:site of double-strand break;, F:DNA binding;, P:branching morphogenesis of an epithelial tube; P:cell cycle phase transition; P:cell division; P:cellular response to bleomycin; P:cellular response to cisplatin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:circadian rhythm; P:detection of abiotic stimulus; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:lung development; P:morphogenesis of an epithelium; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:regulation of circadian rhythm; P:replication fork arrest; P:replication fork protection; scaffold151 indexed_genome mRNA 970409 977865 . + . ID=transcript_14724;Q9UNS1 B2ZAV0 O94802 Q86VM1 Q8IWH3,Protein timeless homolog,, PF04821;PF05029;, GO:0000785;GO:0005654;GO:0005634;GO:0031298;GO:0035861;GO:0003677;GO:0048754;GO:0044770;GO:0051301;GO:1904976;GO:0072719;GO:0006974;GO:0072711;GO:0007623;GO:0009582;GO:0006281;GO:0006260;GO:0000076;GO:0030324;GO:0002009;GO:0000122;GO:0045892;GO:2000781;GO:1905168;GO:0042752;GO:0043111;GO:0048478;, C:chromatin; C:nucleoplasm; C:nucleus; C:replication fork protection complex; C:site of double-strand break;, F:DNA binding;, P:branching morphogenesis of an epithelial tube; P:cell cycle phase transition; P:cell division; P:cellular response to bleomycin; P:cellular response to cisplatin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:circadian rhythm; P:detection of abiotic stimulus; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:lung development; P:morphogenesis of an epithelium; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:regulation of circadian rhythm; P:replication fork arrest; P:replication fork protection;|Q9UNS1 B2ZAV0 O94802 Q86VM1 Q8IWH3,Protein timeless homolog,, PF04821;PF05029;, GO:0000785;GO:0005654;GO:0005634;GO:0031298;GO:0035861;GO:0003677;GO:0048754;GO:0044770;GO:0051301;GO:1904976;GO:0072719;GO:0006974;GO:0072711;GO:0007623;GO:0009582;GO:0006281;GO:0006260;GO:0000076;GO:0030324;GO:0002009;GO:0000122;GO:0045892;GO:2000781;GO:1905168;GO:0042752;GO:0043111;GO:0048478;, C:chromatin; C:nucleoplasm; C:nucleus; C:replication fork protection complex; C:site of double-strand break;, F:DNA binding;, P:branching morphogenesis of an epithelial tube; P:cell cycle phase transition; P:cell division; P:cellular response to bleomycin; P:cellular response to cisplatin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:circadian rhythm; P:detection of abiotic stimulus; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:lung development; P:morphogenesis of an epithelium; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:regulation of circadian rhythm; P:replication fork arrest; P:replication fork protection;|Q9UNS1 B2ZAV0 O94802 Q86VM1 Q8IWH3,Protein timeless homolog,, PF04821;PF05029;, GO:0000785;GO:0005654;GO:0005634;GO:0031298;GO:0035861;GO:0003677;GO:0048754;GO:0044770;GO:0051301;GO:1904976;GO:0072719;GO:0006974;GO:0072711;GO:0007623;GO:0009582;GO:0006281;GO:0006260;GO:0000076;GO:0030324;GO:0002009;GO:0000122;GO:0045892;GO:2000781;GO:1905168;GO:0042752;GO:0043111;GO:0048478;, C:chromatin; C:nucleoplasm; C:nucleus; C:replication fork protection complex; C:site of double-strand break;, F:DNA binding;, P:branching morphogenesis of an epithelial tube; P:cell cycle phase transition; P:cell division; P:cellular response to bleomycin; P:cellular response to cisplatin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:circadian rhythm; P:detection of abiotic stimulus; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:lung development; P:morphogenesis of an epithelium; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:regulation of circadian rhythm; P:replication fork arrest; P:replication fork protection; scaffold151 indexed_genome mRNA 978125 982976 . + . ID=transcript_14725;Q9UNS1 B2ZAV0 O94802 Q86VM1 Q8IWH3,Protein timeless homolog,, PF04821;PF05029;, GO:0000785;GO:0005654;GO:0005634;GO:0031298;GO:0035861;GO:0003677;GO:0048754;GO:0044770;GO:0051301;GO:1904976;GO:0072719;GO:0006974;GO:0072711;GO:0007623;GO:0009582;GO:0006281;GO:0006260;GO:0000076;GO:0030324;GO:0002009;GO:0000122;GO:0045892;GO:2000781;GO:1905168;GO:0042752;GO:0043111;GO:0048478;, C:chromatin; C:nucleoplasm; C:nucleus; C:replication fork protection complex; C:site of double-strand break;, F:DNA binding;, P:branching morphogenesis of an epithelial tube; P:cell cycle phase transition; P:cell division; P:cellular response to bleomycin; P:cellular response to cisplatin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:circadian rhythm; P:detection of abiotic stimulus; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:lung development; P:morphogenesis of an epithelium; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:regulation of circadian rhythm; P:replication fork arrest; P:replication fork protection;|Q9UNS1 B2ZAV0 O94802 Q86VM1 Q8IWH3,Protein timeless homolog,, PF04821;PF05029;, GO:0000785;GO:0005654;GO:0005634;GO:0031298;GO:0035861;GO:0003677;GO:0048754;GO:0044770;GO:0051301;GO:1904976;GO:0072719;GO:0006974;GO:0072711;GO:0007623;GO:0009582;GO:0006281;GO:0006260;GO:0000076;GO:0030324;GO:0002009;GO:0000122;GO:0045892;GO:2000781;GO:1905168;GO:0042752;GO:0043111;GO:0048478;, C:chromatin; C:nucleoplasm; C:nucleus; C:replication fork protection complex; C:site of double-strand break;, F:DNA binding;, P:branching morphogenesis of an epithelial tube; P:cell cycle phase transition; P:cell division; P:cellular response to bleomycin; P:cellular response to cisplatin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:circadian rhythm; P:detection of abiotic stimulus; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:lung development; P:morphogenesis of an epithelium; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:regulation of circadian rhythm; P:replication fork arrest; P:replication fork protection;|Q9UNS1 B2ZAV0 O94802 Q86VM1 Q8IWH3,Protein timeless homolog,, PF04821;PF05029;, GO:0000785;GO:0005654;GO:0005634;GO:0031298;GO:0035861;GO:0003677;GO:0048754;GO:0044770;GO:0051301;GO:1904976;GO:0072719;GO:0006974;GO:0072711;GO:0007623;GO:0009582;GO:0006281;GO:0006260;GO:0000076;GO:0030324;GO:0002009;GO:0000122;GO:0045892;GO:2000781;GO:1905168;GO:0042752;GO:0043111;GO:0048478;, C:chromatin; C:nucleoplasm; C:nucleus; C:replication fork protection complex; C:site of double-strand break;, F:DNA binding;, P:branching morphogenesis of an epithelial tube; P:cell cycle phase transition; P:cell division; P:cellular response to bleomycin; P:cellular response to cisplatin; P:cellular response to DNA damage stimulus; P:cellular response to hydroxyurea; P:circadian rhythm; P:detection of abiotic stimulus; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:lung development; P:morphogenesis of an epithelium; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of double-strand break repair; P:positive regulation of double-strand break repair via homologous recombination; P:regulation of circadian rhythm; P:replication fork arrest; P:replication fork protection; scaffold151 indexed_genome mRNA 1000313 1002291 . + . ID=transcript_14726;Q13790 Q8TC13,Apolipoprotein F,Lipid transfer inhibitor protein;, PF15148;, GO:0005615;GO:0034364;GO:0034362;GO:0015485;GO:0005319;GO:0005102;GO:0008203;GO:0006629;GO:0006869;, C:extracellular space; C:high-density lipoprotein particle; C:low-density lipoprotein particle;, F:cholesterol binding; F:lipid transporter activity; F:signaling receptor binding;, P:cholesterol metabolic process; P:lipid metabolic process; P:lipid transport; scaffold151 indexed_genome mRNA 1003520 1014269 . - . ID=transcript_14727;P52630 B4DLC7 G3V2M6 Q16430 Q16431 Q9UDL4,Signal transducer and activator of transcription 2,p113;, PF00017;PF12188;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0005886;GO:0000981;GO:0042802;GO:0000978;GO:0044389;GO:0019221;GO:0006952;GO:0051607;GO:0007259;GO:0042127;GO:0090140;GO:0001932;GO:0006357;GO:0043434;GO:0060337;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:defense response; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of mitochondrial fission; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:type I interferon signaling pathway; P:viral process;|P52630 B4DLC7 G3V2M6 Q16430 Q16431 Q9UDL4,Signal transducer and activator of transcription 2,p113;, PF00017;PF12188;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0005886;GO:0000981;GO:0042802;GO:0000978;GO:0044389;GO:0019221;GO:0006952;GO:0051607;GO:0007259;GO:0042127;GO:0090140;GO:0001932;GO:0006357;GO:0043434;GO:0060337;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:defense response; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of mitochondrial fission; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:type I interferon signaling pathway; P:viral process;|P52630 B4DLC7 G3V2M6 Q16430 Q16431 Q9UDL4,Signal transducer and activator of transcription 2,p113;, PF00017;PF12188;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0005886;GO:0000981;GO:0042802;GO:0000978;GO:0044389;GO:0019221;GO:0006952;GO:0051607;GO:0007259;GO:0042127;GO:0090140;GO:0001932;GO:0006357;GO:0043434;GO:0060337;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:defense response; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of mitochondrial fission; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:type I interferon signaling pathway; P:viral process;|P52630 B4DLC7 G3V2M6 Q16430 Q16431 Q9UDL4,Signal transducer and activator of transcription 2,p113;, PF00017;PF12188;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0005886;GO:0000981;GO:0042802;GO:0000978;GO:0044389;GO:0019221;GO:0006952;GO:0051607;GO:0007259;GO:0042127;GO:0090140;GO:0001932;GO:0006357;GO:0043434;GO:0060337;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:defense response; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of mitochondrial fission; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:type I interferon signaling pathway; P:viral process;|P52630 B4DLC7 G3V2M6 Q16430 Q16431 Q9UDL4,Signal transducer and activator of transcription 2,p113;, PF00017;PF12188;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0005886;GO:0000981;GO:0042802;GO:0000978;GO:0044389;GO:0019221;GO:0006952;GO:0051607;GO:0007259;GO:0042127;GO:0090140;GO:0001932;GO:0006357;GO:0043434;GO:0060337;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:defense response; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of mitochondrial fission; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:type I interferon signaling pathway; P:viral process;|P52630 B4DLC7 G3V2M6 Q16430 Q16431 Q9UDL4,Signal transducer and activator of transcription 2,p113;, PF00017;PF12188;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0005886;GO:0000981;GO:0042802;GO:0000978;GO:0044389;GO:0019221;GO:0006952;GO:0051607;GO:0007259;GO:0042127;GO:0090140;GO:0001932;GO:0006357;GO:0043434;GO:0060337;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:defense response; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of mitochondrial fission; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:type I interferon signaling pathway; P:viral process;|P52630 B4DLC7 G3V2M6 Q16430 Q16431 Q9UDL4,Signal transducer and activator of transcription 2,p113;, PF00017;PF12188;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0005886;GO:0000981;GO:0042802;GO:0000978;GO:0044389;GO:0019221;GO:0006952;GO:0051607;GO:0007259;GO:0042127;GO:0090140;GO:0001932;GO:0006357;GO:0043434;GO:0060337;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:defense response; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of mitochondrial fission; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:type I interferon signaling pathway; P:viral process; scaffold151 indexed_genome mRNA 1014414 1019999 . + . ID=transcript_14728;P52630 B4DLC7 G3V2M6 Q16430 Q16431 Q9UDL4,Signal transducer and activator of transcription 2,p113;, PF00017;PF12188;PF01017;PF02864;PF02865;, GO:0000785;GO:0005829;GO:0005654;GO:0005886;GO:0000981;GO:0042802;GO:0000978;GO:0044389;GO:0019221;GO:0006952;GO:0051607;GO:0007259;GO:0042127;GO:0090140;GO:0001932;GO:0006357;GO:0043434;GO:0060337;GO:0016032;, C:chromatin; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:ubiquitin-like protein ligase binding;, P:cytokine-mediated signaling pathway; P:defense response; P:defense response to virus; P:receptor signaling pathway via JAK-STAT; P:regulation of cell population proliferation; P:regulation of mitochondrial fission; P:regulation of protein phosphorylation; P:regulation of transcription by RNA polymerase II; P:response to peptide hormone; P:type I interferon signaling pathway; P:viral process;|Q9NPF7 Q6NZ80 Q6NZ82 Q9H2A5,Interleukin-23 subunit alpha,Interleukin-23 subunit p19;, PF16649;, GO:0005788;GO:0005576;GO:0070743;GO:0005125;GO:0045519;GO:0019221;GO:0050829;GO:0051607;GO:0006954;GO:0045087;GO:0038155;GO:0032693;GO:0042104;GO:0010536;GO:0002230;GO:0032725;GO:0050729;GO:0032729;GO:0032733;GO:0032735;GO:0032740;GO:0043382;GO:0032816;GO:0032819;GO:0090023;GO:1901224;GO:0051135;GO:0051142;GO:0045672;GO:0001916;GO:0042102;GO:0002827;GO:2000330;GO:2000318;GO:0034105;GO:0045944;GO:0032760;GO:0042531;GO:0042509;GO:0042098;GO:0048771;, C:endoplasmic reticulum lumen; C:extracellular region; C:interleukin-23 complex;, F:cytokine activity; F:interleukin-23 receptor binding;, P:cytokine-mediated signaling pathway; P:defense response to Gram-negative bacterium; P:defense response to virus; P:inflammatory response; P:innate immune response; P:interleukin-23-mediated signaling pathway; P:negative regulation of interleukin-10 production; P:positive regulation of activated T cell proliferation; P:positive regulation of activation of Janus kinase activity; P:positive regulation of defense response to virus by host; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of inflammatory response; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of memory T cell differentiation; P:positive regulation of natural killer cell activation; P:positive regulation of natural killer cell proliferation; P:positive regulation of neutrophil chemotaxis; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of NK T cell activation; P:positive regulation of NK T cell proliferation; P:positive regulation of osteoclast differentiation; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of T cell proliferation; P:positive regulation of T-helper 1 type immune response; P:positive regulation of T-helper 17 cell lineage commitment; P:positive regulation of T-helper 17 type immune response; P:positive regulation of tissue remodeling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of tyrosine phosphorylation of STAT protein; P:T cell proliferation; P:tissue remodeling; scaffold151 indexed_genome mRNA 1023055 1037571 . + . ID=transcript_14729;Q504Q3 O75189 Q76E12 Q8IVE1,PAN2-PAN3 deadenylation complex catalytic subunit PAN2 {ECO:0000255|HAMAP-Rule:MF_03182},Inactive ubiquitin carboxyl-terminal hydrolase 52 {ECO:0000255|HAMAP-Rule:MF_03182};PAB1P-dependent poly(A)-specific ribonuclease {ECO:0000255|HAMAP-Rule:MF_03182};Poly(A)-nuclease deadenylation complex subunit 2 {ECO:0000255|HAMAP-Rule:MF_03182};, PF00929;PF13423;, GO:0005829;GO:0005634;GO:0000932;GO:0031251;GO:0000175;GO:0046872;GO:0003676;GO:0004535;GO:0006397;GO:0000289;GO:0010606;GO:0018215;GO:0006508;, C:cytosol; C:nucleus; C:P-body; C:PAN complex;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:nucleic acid binding; F:poly(A)-specific ribonuclease activity;, P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:protein phosphopantetheinylation; P:proteolysis;|Q504Q3 O75189 Q76E12 Q8IVE1,PAN2-PAN3 deadenylation complex catalytic subunit PAN2 {ECO:0000255|HAMAP-Rule:MF_03182},Inactive ubiquitin carboxyl-terminal hydrolase 52 {ECO:0000255|HAMAP-Rule:MF_03182};PAB1P-dependent poly(A)-specific ribonuclease {ECO:0000255|HAMAP-Rule:MF_03182};Poly(A)-nuclease deadenylation complex subunit 2 {ECO:0000255|HAMAP-Rule:MF_03182};, PF00929;PF13423;, GO:0005829;GO:0005634;GO:0000932;GO:0031251;GO:0000175;GO:0046872;GO:0003676;GO:0004535;GO:0006397;GO:0000289;GO:0010606;GO:0018215;GO:0006508;, C:cytosol; C:nucleus; C:P-body; C:PAN complex;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:nucleic acid binding; F:poly(A)-specific ribonuclease activity;, P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:protein phosphopantetheinylation; P:proteolysis;|Q504Q3 O75189 Q76E12 Q8IVE1,PAN2-PAN3 deadenylation complex catalytic subunit PAN2 {ECO:0000255|HAMAP-Rule:MF_03182},Inactive ubiquitin carboxyl-terminal hydrolase 52 {ECO:0000255|HAMAP-Rule:MF_03182};PAB1P-dependent poly(A)-specific ribonuclease {ECO:0000255|HAMAP-Rule:MF_03182};Poly(A)-nuclease deadenylation complex subunit 2 {ECO:0000255|HAMAP-Rule:MF_03182};, PF00929;PF13423;, GO:0005829;GO:0005634;GO:0000932;GO:0031251;GO:0000175;GO:0046872;GO:0003676;GO:0004535;GO:0006397;GO:0000289;GO:0010606;GO:0018215;GO:0006508;, C:cytosol; C:nucleus; C:P-body; C:PAN complex;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:nucleic acid binding; F:poly(A)-specific ribonuclease activity;, P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:protein phosphopantetheinylation; P:proteolysis;|Q504Q3 O75189 Q76E12 Q8IVE1,PAN2-PAN3 deadenylation complex catalytic subunit PAN2 {ECO:0000255|HAMAP-Rule:MF_03182},Inactive ubiquitin carboxyl-terminal hydrolase 52 {ECO:0000255|HAMAP-Rule:MF_03182};PAB1P-dependent poly(A)-specific ribonuclease {ECO:0000255|HAMAP-Rule:MF_03182};Poly(A)-nuclease deadenylation complex subunit 2 {ECO:0000255|HAMAP-Rule:MF_03182};, PF00929;PF13423;, GO:0005829;GO:0005634;GO:0000932;GO:0031251;GO:0000175;GO:0046872;GO:0003676;GO:0004535;GO:0006397;GO:0000289;GO:0010606;GO:0018215;GO:0006508;, C:cytosol; C:nucleus; C:P-body; C:PAN complex;, F:3'-5'-exoribonuclease activity; F:metal ion binding; F:nucleic acid binding; F:poly(A)-specific ribonuclease activity;, P:mRNA processing; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cytoplasmic mRNA processing body assembly; P:protein phosphopantetheinylation; P:proteolysis; scaffold151 indexed_genome mRNA 1038399 1044186 . + . ID=transcript_14730;Q9Y2B0 B2R7B9 Q9UHE9,Protein canopy homolog 2,MIR-interacting saposin-like protein;Putative secreted protein Zsig9;Transmembrane protein 4;, PF11938;, GO:0005783;GO:0010629;GO:1905599;GO:0010988;, C:endoplasmic reticulum;, , P:negative regulation of gene expression; P:positive regulation of low-density lipoprotein receptor activity; P:regulation of low-density lipoprotein particle clearance;|Q9Y2B0 B2R7B9 Q9UHE9,Protein canopy homolog 2,MIR-interacting saposin-like protein;Putative secreted protein Zsig9;Transmembrane protein 4;, PF11938;, GO:0005783;GO:0010629;GO:1905599;GO:0010988;, C:endoplasmic reticulum;, , P:negative regulation of gene expression; P:positive regulation of low-density lipoprotein receptor activity; P:regulation of low-density lipoprotein particle clearance;|Q9Y2B0 B2R7B9 Q9UHE9,Protein canopy homolog 2,MIR-interacting saposin-like protein;Putative secreted protein Zsig9;Transmembrane protein 4;, PF11938;, GO:0005783;GO:0010629;GO:1905599;GO:0010988;, C:endoplasmic reticulum;, , P:negative regulation of gene expression; P:positive regulation of low-density lipoprotein receptor activity; P:regulation of low-density lipoprotein particle clearance;|Q9Y2B0 B2R7B9 Q9UHE9,Protein canopy homolog 2,MIR-interacting saposin-like protein;Putative secreted protein Zsig9;Transmembrane protein 4;, PF11938;, GO:0005783;GO:0010629;GO:1905599;GO:0010988;, C:endoplasmic reticulum;, , P:negative regulation of gene expression; P:positive regulation of low-density lipoprotein receptor activity; P:regulation of low-density lipoprotein particle clearance; scaffold151 indexed_genome mRNA 1050134 1076196 . + . ID=transcript_14731;O75390 Q71UT9 Q7KZH0 Q96FZ8 Q9BWN8,Citrate synthase, mitochondrial,Citrate (Si)-synthase;, PF00285;, GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0004108;GO:0003723;GO:0005975;GO:0006101;GO:0006099;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:citrate (Si)-synthase activity; F:RNA binding;, P:carbohydrate metabolic process; P:citrate metabolic process; P:tricarboxylic acid cycle;|O75390 Q71UT9 Q7KZH0 Q96FZ8 Q9BWN8,Citrate synthase, mitochondrial,Citrate (Si)-synthase;, PF00285;, GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0004108;GO:0003723;GO:0005975;GO:0006101;GO:0006099;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:citrate (Si)-synthase activity; F:RNA binding;, P:carbohydrate metabolic process; P:citrate metabolic process; P:tricarboxylic acid cycle;|O75390 Q71UT9 Q7KZH0 Q96FZ8 Q9BWN8,Citrate synthase, mitochondrial,Citrate (Si)-synthase;, PF00285;, GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0004108;GO:0003723;GO:0005975;GO:0006101;GO:0006099;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:citrate (Si)-synthase activity; F:RNA binding;, P:carbohydrate metabolic process; P:citrate metabolic process; P:tricarboxylic acid cycle;|O75390 Q71UT9 Q7KZH0 Q96FZ8 Q9BWN8,Citrate synthase, mitochondrial,Citrate (Si)-synthase;, PF00285;, GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0004108;GO:0003723;GO:0005975;GO:0006101;GO:0006099;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:citrate (Si)-synthase activity; F:RNA binding;, P:carbohydrate metabolic process; P:citrate metabolic process; P:tricarboxylic acid cycle;|O75390 Q71UT9 Q7KZH0 Q96FZ8 Q9BWN8,Citrate synthase, mitochondrial,Citrate (Si)-synthase;, PF00285;, GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0004108;GO:0003723;GO:0005975;GO:0006101;GO:0006099;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:citrate (Si)-synthase activity; F:RNA binding;, P:carbohydrate metabolic process; P:citrate metabolic process; P:tricarboxylic acid cycle;|O75390 Q71UT9 Q7KZH0 Q96FZ8 Q9BWN8,Citrate synthase, mitochondrial,Citrate (Si)-synthase;, PF00285;, GO:0070062;GO:0005759;GO:0005739;GO:0005634;GO:0004108;GO:0003723;GO:0005975;GO:0006101;GO:0006099;, C:extracellular exosome; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:citrate (Si)-synthase activity; F:RNA binding;, P:carbohydrate metabolic process; P:citrate metabolic process; P:tricarboxylic acid cycle;|Q96MF6 Q6GMR6 Q6UWB9 Q86X16 Q8TAL2 Q96MF1 Q9BUP4,Coenzyme Q-binding protein COQ10 homolog A, mitochondrial,, PF03364;, GO:0005743;GO:0005739;GO:0048039;GO:0045333;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:ubiquinone binding;, P:cellular respiration; P:ubiquinone biosynthetic process;|Q96MF6 Q6GMR6 Q6UWB9 Q86X16 Q8TAL2 Q96MF1 Q9BUP4,Coenzyme Q-binding protein COQ10 homolog A, mitochondrial,, PF03364;, GO:0005743;GO:0005739;GO:0048039;GO:0045333;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:ubiquinone binding;, P:cellular respiration; P:ubiquinone biosynthetic process;|Q96MF6 Q6GMR6 Q6UWB9 Q86X16 Q8TAL2 Q96MF1 Q9BUP4,Coenzyme Q-binding protein COQ10 homolog A, mitochondrial,, PF03364;, GO:0005743;GO:0005739;GO:0048039;GO:0045333;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:ubiquinone binding;, P:cellular respiration; P:ubiquinone biosynthetic process;|Q96MF6 Q6GMR6 Q6UWB9 Q86X16 Q8TAL2 Q96MF1 Q9BUP4,Coenzyme Q-binding protein COQ10 homolog A, mitochondrial,, PF03364;, GO:0005743;GO:0005739;GO:0048039;GO:0045333;GO:0006744;, C:mitochondrial inner membrane; C:mitochondrion;, F:ubiquinone binding;, P:cellular respiration; P:ubiquinone biosynthetic process; scaffold151 indexed_genome mRNA 1082200 1109671 . + . ID=transcript_14732;Q8NB46 A6NE79 B1Q2K2,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C,Ankyrin repeat domain-containing protein 52;, PF00023;PF12796;|Q8NB46 A6NE79 B1Q2K2,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C,Ankyrin repeat domain-containing protein 52;, PF00023;PF12796;|Q8NB46 A6NE79 B1Q2K2,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C,Ankyrin repeat domain-containing protein 52;, PF00023;PF12796;|Q8NB46 A6NE79 B1Q2K2,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C,Ankyrin repeat domain-containing protein 52;, PF00023;PF12796;|Q8NB46 A6NE79 B1Q2K2,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C,Ankyrin repeat domain-containing protein 52;, PF00023;PF12796;|Q8NB46 A6NE79 B1Q2K2,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C,Ankyrin repeat domain-containing protein 52;, PF00023;PF12796;|Q8NB46 A6NE79 B1Q2K2,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C,Ankyrin repeat domain-containing protein 52;, PF00023;PF12796;|Q6ZMH5 B2R808 Q8N6Y3,Zinc transporter ZIP5,Solute carrier family 39 member 5;Zrt- and Irt-like protein 5;, PF02535;, GO:0016323;GO:0070062;GO:0005887;GO:0005385;GO:0030509;GO:0034224;GO:0006882;GO:0001654;GO:0070315;GO:0061351;GO:0048026;GO:0071578;, C:basolateral plasma membrane; C:extracellular exosome; C:integral component of plasma membrane;, F:zinc ion transmembrane transporter activity;, P:BMP signaling pathway; P:cellular response to zinc ion starvation; P:cellular zinc ion homeostasis; P:eye development; P:G1 to G0 transition involved in cell differentiation; P:neural precursor cell proliferation; P:positive regulation of mRNA splicing, via spliceosome; P:zinc ion import across plasma membrane;|Q9BQ15 A6NDF8 Q6XYC8,SOSS complex subunit B1,Nucleic acid-binding protein 2;Oligonucleotide/oligosaccharide-binding fold-containing protein 2B;Sensor of single-strand DNA complex subunit B1;Sensor of ssDNA subunit B1;Single-stranded DNA-binding protein 1;, PF01336;, GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0003677;GO:0070182;GO:0098505;GO:0003697;GO:0006974;GO:0006281;GO:0000724;GO:0070200;GO:0044818;GO:1904355;GO:0010212;GO:0042795;, C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, F:DNA binding; F:DNA polymerase binding; F:G-rich strand telomeric DNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:double-strand break repair via homologous recombination; P:establishment of protein localization to telomere; P:mitotic G2/M transition checkpoint; P:positive regulation of telomere capping; P:response to ionizing radiation; P:snRNA transcription by RNA polymerase II;|Q9BQ15 A6NDF8 Q6XYC8,SOSS complex subunit B1,Nucleic acid-binding protein 2;Oligonucleotide/oligosaccharide-binding fold-containing protein 2B;Sensor of single-strand DNA complex subunit B1;Sensor of ssDNA subunit B1;Single-stranded DNA-binding protein 1;, PF01336;, GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0003677;GO:0070182;GO:0098505;GO:0003697;GO:0006974;GO:0006281;GO:0000724;GO:0070200;GO:0044818;GO:1904355;GO:0010212;GO:0042795;, C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, F:DNA binding; F:DNA polymerase binding; F:G-rich strand telomeric DNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:double-strand break repair via homologous recombination; P:establishment of protein localization to telomere; P:mitotic G2/M transition checkpoint; P:positive regulation of telomere capping; P:response to ionizing radiation; P:snRNA transcription by RNA polymerase II;|Q9BQ15 A6NDF8 Q6XYC8,SOSS complex subunit B1,Nucleic acid-binding protein 2;Oligonucleotide/oligosaccharide-binding fold-containing protein 2B;Sensor of single-strand DNA complex subunit B1;Sensor of ssDNA subunit B1;Single-stranded DNA-binding protein 1;, PF01336;, GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0003677;GO:0070182;GO:0098505;GO:0003697;GO:0006974;GO:0006281;GO:0000724;GO:0070200;GO:0044818;GO:1904355;GO:0010212;GO:0042795;, C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, F:DNA binding; F:DNA polymerase binding; F:G-rich strand telomeric DNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:double-strand break repair via homologous recombination; P:establishment of protein localization to telomere; P:mitotic G2/M transition checkpoint; P:positive regulation of telomere capping; P:response to ionizing radiation; P:snRNA transcription by RNA polymerase II;|Q9BQ15 A6NDF8 Q6XYC8,SOSS complex subunit B1,Nucleic acid-binding protein 2;Oligonucleotide/oligosaccharide-binding fold-containing protein 2B;Sensor of single-strand DNA complex subunit B1;Sensor of ssDNA subunit B1;Single-stranded DNA-binding protein 1;, PF01336;, GO:0000781;GO:0005829;GO:0005654;GO:0005634;GO:0035861;GO:0070876;GO:0003677;GO:0070182;GO:0098505;GO:0003697;GO:0006974;GO:0006281;GO:0000724;GO:0070200;GO:0044818;GO:1904355;GO:0010212;GO:0042795;, C:chromosome, telomeric region; C:cytosol; C:nucleoplasm; C:nucleus; C:site of double-strand break; C:SOSS complex;, F:DNA binding; F:DNA polymerase binding; F:G-rich strand telomeric DNA binding; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:double-strand break repair via homologous recombination; P:establishment of protein localization to telomere; P:mitotic G2/M transition checkpoint; P:positive regulation of telomere capping; P:response to ionizing radiation; P:snRNA transcription by RNA polymerase II; scaffold151 indexed_genome mRNA 1110304 1141255 . + . ID=transcript_14733;Q9H4P4 A6NFW0 B2RBT8 O75598,E3 ubiquitin-protein ligase NRDP1,RING finger protein 41;RING-type E3 ubiquitin transferase NRDP1 {ECO:0000305};, PF08941;, GO:0005829;GO:0071782;GO:0048471;GO:0005128;GO:0042802;GO:0005135;GO:0019904;GO:0030971;GO:0031267;GO:0061630;GO:0004842;GO:0008270;GO:0006914;GO:0097191;GO:0030336;GO:0008285;GO:1901525;GO:0051091;GO:0045732;GO:2000379;GO:0010498;GO:0051865;GO:0000209;GO:0016567;GO:2000114;GO:0045619;GO:0043408;GO:0045637;GO:0051896;GO:2000377;, C:cytosol; C:endoplasmic reticulum tubular network; C:perinuclear region of cytoplasm;, F:erythropoietin receptor binding; F:identical protein binding; F:interleukin-3 receptor binding; F:protein domain specific binding; F:receptor tyrosine kinase binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:autophagy; P:extrinsic apoptotic signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of mitophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of protein catabolic process; P:positive regulation of reactive oxygen species metabolic process; P:proteasomal protein catabolic process; P:protein autoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of establishment of cell polarity; P:regulation of lymphocyte differentiation; P:regulation of MAPK cascade; P:regulation of myeloid cell differentiation; P:regulation of protein kinase B signaling; P:regulation of reactive oxygen species metabolic process;|Q9H4P4 A6NFW0 B2RBT8 O75598,E3 ubiquitin-protein ligase NRDP1,RING finger protein 41;RING-type E3 ubiquitin transferase NRDP1 {ECO:0000305};, PF08941;, GO:0005829;GO:0071782;GO:0048471;GO:0005128;GO:0042802;GO:0005135;GO:0019904;GO:0030971;GO:0031267;GO:0061630;GO:0004842;GO:0008270;GO:0006914;GO:0097191;GO:0030336;GO:0008285;GO:1901525;GO:0051091;GO:0045732;GO:2000379;GO:0010498;GO:0051865;GO:0000209;GO:0016567;GO:2000114;GO:0045619;GO:0043408;GO:0045637;GO:0051896;GO:2000377;, C:cytosol; C:endoplasmic reticulum tubular network; C:perinuclear region of cytoplasm;, F:erythropoietin receptor binding; F:identical protein binding; F:interleukin-3 receptor binding; F:protein domain specific binding; F:receptor tyrosine kinase binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:autophagy; P:extrinsic apoptotic signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of mitophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of protein catabolic process; P:positive regulation of reactive oxygen species metabolic process; P:proteasomal protein catabolic process; P:protein autoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of establishment of cell polarity; P:regulation of lymphocyte differentiation; P:regulation of MAPK cascade; P:regulation of myeloid cell differentiation; P:regulation of protein kinase B signaling; P:regulation of reactive oxygen species metabolic process;|Q9H4P4 A6NFW0 B2RBT8 O75598,E3 ubiquitin-protein ligase NRDP1,RING finger protein 41;RING-type E3 ubiquitin transferase NRDP1 {ECO:0000305};, PF08941;, GO:0005829;GO:0071782;GO:0048471;GO:0005128;GO:0042802;GO:0005135;GO:0019904;GO:0030971;GO:0031267;GO:0061630;GO:0004842;GO:0008270;GO:0006914;GO:0097191;GO:0030336;GO:0008285;GO:1901525;GO:0051091;GO:0045732;GO:2000379;GO:0010498;GO:0051865;GO:0000209;GO:0016567;GO:2000114;GO:0045619;GO:0043408;GO:0045637;GO:0051896;GO:2000377;, C:cytosol; C:endoplasmic reticulum tubular network; C:perinuclear region of cytoplasm;, F:erythropoietin receptor binding; F:identical protein binding; F:interleukin-3 receptor binding; F:protein domain specific binding; F:receptor tyrosine kinase binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:autophagy; P:extrinsic apoptotic signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of mitophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of protein catabolic process; P:positive regulation of reactive oxygen species metabolic process; P:proteasomal protein catabolic process; P:protein autoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of establishment of cell polarity; P:regulation of lymphocyte differentiation; P:regulation of MAPK cascade; P:regulation of myeloid cell differentiation; P:regulation of protein kinase B signaling; P:regulation of reactive oxygen species metabolic process;|Q9H4P4 A6NFW0 B2RBT8 O75598,E3 ubiquitin-protein ligase NRDP1,RING finger protein 41;RING-type E3 ubiquitin transferase NRDP1 {ECO:0000305};, PF08941;, GO:0005829;GO:0071782;GO:0048471;GO:0005128;GO:0042802;GO:0005135;GO:0019904;GO:0030971;GO:0031267;GO:0061630;GO:0004842;GO:0008270;GO:0006914;GO:0097191;GO:0030336;GO:0008285;GO:1901525;GO:0051091;GO:0045732;GO:2000379;GO:0010498;GO:0051865;GO:0000209;GO:0016567;GO:2000114;GO:0045619;GO:0043408;GO:0045637;GO:0051896;GO:2000377;, C:cytosol; C:endoplasmic reticulum tubular network; C:perinuclear region of cytoplasm;, F:erythropoietin receptor binding; F:identical protein binding; F:interleukin-3 receptor binding; F:protein domain specific binding; F:receptor tyrosine kinase binding; F:small GTPase binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:autophagy; P:extrinsic apoptotic signaling pathway; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of mitophagy; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of protein catabolic process; P:positive regulation of reactive oxygen species metabolic process; P:proteasomal protein catabolic process; P:protein autoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of establishment of cell polarity; P:regulation of lymphocyte differentiation; P:regulation of MAPK cascade; P:regulation of myeloid cell differentiation; P:regulation of protein kinase B signaling; P:regulation of reactive oxygen species metabolic process; scaffold151 indexed_genome mRNA 1156655 1173225 . + . ID=transcript_14734;Q8TAQ2 F8VTJ5 Q59GV3 Q92923 Q96E12 Q96GY4,SWI/SNF complex subunit SMARCC2,BRG1-associated factor 170;SWI/SNF complex 170 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0032991;GO:0016514;GO:0042393;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0007399;GO:0006337;GO:0045893;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:protein-containing complex; C:SWI/SNF complex;, F:histone binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q8TAQ2 F8VTJ5 Q59GV3 Q92923 Q96E12 Q96GY4,SWI/SNF complex subunit SMARCC2,BRG1-associated factor 170;SWI/SNF complex 170 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0032991;GO:0016514;GO:0042393;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0007399;GO:0006337;GO:0045893;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:protein-containing complex; C:SWI/SNF complex;, F:histone binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q8TAQ2 F8VTJ5 Q59GV3 Q92923 Q96E12 Q96GY4,SWI/SNF complex subunit SMARCC2,BRG1-associated factor 170;SWI/SNF complex 170 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0032991;GO:0016514;GO:0042393;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0007399;GO:0006337;GO:0045893;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:protein-containing complex; C:SWI/SNF complex;, F:histone binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q8TAQ2 F8VTJ5 Q59GV3 Q92923 Q96E12 Q96GY4,SWI/SNF complex subunit SMARCC2,BRG1-associated factor 170;SWI/SNF complex 170 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0032991;GO:0016514;GO:0042393;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0007399;GO:0006337;GO:0045893;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:protein-containing complex; C:SWI/SNF complex;, F:histone binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q8TAQ2 F8VTJ5 Q59GV3 Q92923 Q96E12 Q96GY4,SWI/SNF complex subunit SMARCC2,BRG1-associated factor 170;SWI/SNF complex 170 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0032991;GO:0016514;GO:0042393;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0007399;GO:0006337;GO:0045893;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:protein-containing complex; C:SWI/SNF complex;, F:histone binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q8TAQ2 F8VTJ5 Q59GV3 Q92923 Q96E12 Q96GY4,SWI/SNF complex subunit SMARCC2,BRG1-associated factor 170;SWI/SNF complex 170 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0032991;GO:0016514;GO:0042393;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0007399;GO:0006337;GO:0045893;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:protein-containing complex; C:SWI/SNF complex;, F:histone binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q8TAQ2 F8VTJ5 Q59GV3 Q92923 Q96E12 Q96GY4,SWI/SNF complex subunit SMARCC2,BRG1-associated factor 170;SWI/SNF complex 170 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0032991;GO:0016514;GO:0042393;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0007399;GO:0006337;GO:0045893;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:protein-containing complex; C:SWI/SNF complex;, F:histone binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q8TAQ2 F8VTJ5 Q59GV3 Q92923 Q96E12 Q96GY4,SWI/SNF complex subunit SMARCC2,BRG1-associated factor 170;SWI/SNF complex 170 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0032991;GO:0016514;GO:0042393;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0007399;GO:0006337;GO:0045893;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:protein-containing complex; C:SWI/SNF complex;, F:histone binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q8TAQ2 F8VTJ5 Q59GV3 Q92923 Q96E12 Q96GY4,SWI/SNF complex subunit SMARCC2,BRG1-associated factor 170;SWI/SNF complex 170 kDa subunit;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2;, PF00249;PF04433;PF16495;PF16496;PF16498;, GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0032991;GO:0016514;GO:0042393;GO:0003713;GO:0043044;GO:0006338;GO:0045892;GO:0007399;GO:0006337;GO:0045893;GO:0006357;, C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:protein-containing complex; C:SWI/SNF complex;, F:histone binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin remodeling; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:nucleosome disassembly; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold151 indexed_genome mRNA 1175132 1177961 . - . ID=transcript_14735;P14649,Myosin light chain 6B,Myosin light chain 1 slow-twitch muscle A isoform;Smooth muscle and nonmuscle myosin light chain alkali 6B;, , GO:0005829;GO:0070062;GO:0005859;GO:0016459;GO:0016461;GO:0005509;GO:0003774;GO:0008307;GO:0006936;GO:0030049;GO:0007519;, C:cytosol; C:extracellular exosome; C:muscle myosin complex; C:myosin complex; C:unconventional myosin complex;, F:calcium ion binding; F:motor activity; F:structural constituent of muscle;, P:muscle contraction; P:muscle filament sliding; P:skeletal muscle tissue development;|P60660 P16475 P24572 P24573 Q12790 Q561V9 Q6IAZ0 Q6IPY5,Myosin light polypeptide 6,17 kDa myosin light chain;Myosin light chain 3;Myosin light chain alkali 3;Smooth muscle and nonmuscle myosin light chain alkali 6;, , GO:0005903;GO:0005829;GO:0070062;GO:0016020;GO:0016459;GO:0016461;GO:0031982;GO:0030898;GO:0005509;GO:0003774;GO:0008307;GO:0006936;GO:0030049;GO:0007519;, C:brush border; C:cytosol; C:extracellular exosome; C:membrane; C:myosin complex; C:unconventional myosin complex; C:vesicle;, F:actin-dependent ATPase activity; F:calcium ion binding; F:motor activity; F:structural constituent of muscle;, P:muscle contraction; P:muscle filament sliding; P:skeletal muscle tissue development; scaffold151 indexed_genome mRNA 1178478 1181805 . - . ID=transcript_14736;P14649,Myosin light chain 6B,Myosin light chain 1 slow-twitch muscle A isoform;Smooth muscle and nonmuscle myosin light chain alkali 6B;, , GO:0005829;GO:0070062;GO:0005859;GO:0016459;GO:0016461;GO:0005509;GO:0003774;GO:0008307;GO:0006936;GO:0030049;GO:0007519;, C:cytosol; C:extracellular exosome; C:muscle myosin complex; C:myosin complex; C:unconventional myosin complex;, F:calcium ion binding; F:motor activity; F:structural constituent of muscle;, P:muscle contraction; P:muscle filament sliding; P:skeletal muscle tissue development;|P14649,Myosin light chain 6B,Myosin light chain 1 slow-twitch muscle A isoform;Smooth muscle and nonmuscle myosin light chain alkali 6B;, , GO:0005829;GO:0070062;GO:0005859;GO:0016459;GO:0016461;GO:0005509;GO:0003774;GO:0008307;GO:0006936;GO:0030049;GO:0007519;, C:cytosol; C:extracellular exosome; C:muscle myosin complex; C:myosin complex; C:unconventional myosin complex;, F:calcium ion binding; F:motor activity; F:structural constituent of muscle;, P:muscle contraction; P:muscle filament sliding; P:skeletal muscle tissue development;|P60660 P16475 P24572 P24573 Q12790 Q561V9 Q6IAZ0 Q6IPY5,Myosin light polypeptide 6,17 kDa myosin light chain;Myosin light chain 3;Myosin light chain alkali 3;Smooth muscle and nonmuscle myosin light chain alkali 6;, , GO:0005903;GO:0005829;GO:0070062;GO:0016020;GO:0016459;GO:0016461;GO:0031982;GO:0030898;GO:0005509;GO:0003774;GO:0008307;GO:0006936;GO:0030049;GO:0007519;, C:brush border; C:cytosol; C:extracellular exosome; C:membrane; C:myosin complex; C:unconventional myosin complex; C:vesicle;, F:actin-dependent ATPase activity; F:calcium ion binding; F:motor activity; F:structural constituent of muscle;, P:muscle contraction; P:muscle filament sliding; P:skeletal muscle tissue development; scaffold151 indexed_genome mRNA 1191579 1198654 . - . ID=transcript_14737;P60866 B2R4F4 B4DW28 P17075 Q5M8S9,40S ribosomal protein S20,Small ribosomal subunit protein uS10 {ECO:0000303|PubMed:24524803};, PF00338;, GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0015935;GO:0003723;GO:0003735;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q9BSJ8 A0FGR7 A8K2S2 O94848 Q6PJN4 Q9H6J1 Q9H6W2 Q9Y416,Extended synaptotagmin-1 {ECO:0000305},Membrane-bound C2 domain-containing protein;, PF00168;PF17047;, GO:0005783;GO:0005789;GO:0031234;GO:0030176;GO:0031227;GO:0016020;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of endoplasmic reticulum membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|Q9BSJ8 A0FGR7 A8K2S2 O94848 Q6PJN4 Q9H6J1 Q9H6W2 Q9Y416,Extended synaptotagmin-1 {ECO:0000305},Membrane-bound C2 domain-containing protein;, PF00168;PF17047;, GO:0005783;GO:0005789;GO:0031234;GO:0030176;GO:0031227;GO:0016020;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of endoplasmic reticulum membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|Q9BSJ8 A0FGR7 A8K2S2 O94848 Q6PJN4 Q9H6J1 Q9H6W2 Q9Y416,Extended synaptotagmin-1 {ECO:0000305},Membrane-bound C2 domain-containing protein;, PF00168;PF17047;, GO:0005783;GO:0005789;GO:0031234;GO:0030176;GO:0031227;GO:0016020;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of endoplasmic reticulum membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|Q9BSJ8 A0FGR7 A8K2S2 O94848 Q6PJN4 Q9H6J1 Q9H6W2 Q9Y416,Extended synaptotagmin-1 {ECO:0000305},Membrane-bound C2 domain-containing protein;, PF00168;PF17047;, GO:0005783;GO:0005789;GO:0031234;GO:0030176;GO:0031227;GO:0016020;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of endoplasmic reticulum membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|Q9BSJ8 A0FGR7 A8K2S2 O94848 Q6PJN4 Q9H6J1 Q9H6W2 Q9Y416,Extended synaptotagmin-1 {ECO:0000305},Membrane-bound C2 domain-containing protein;, PF00168;PF17047;, GO:0005783;GO:0005789;GO:0031234;GO:0030176;GO:0031227;GO:0016020;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of endoplasmic reticulum membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport; scaffold151 indexed_genome mRNA 1199503 1207062 . + . ID=transcript_14738;Q9BSJ8 A0FGR7 A8K2S2 O94848 Q6PJN4 Q9H6J1 Q9H6W2 Q9Y416,Extended synaptotagmin-1 {ECO:0000305},Membrane-bound C2 domain-containing protein;, PF00168;PF17047;, GO:0005783;GO:0005789;GO:0031234;GO:0030176;GO:0031227;GO:0016020;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of endoplasmic reticulum membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|Q9BSJ8 A0FGR7 A8K2S2 O94848 Q6PJN4 Q9H6J1 Q9H6W2 Q9Y416,Extended synaptotagmin-1 {ECO:0000305},Membrane-bound C2 domain-containing protein;, PF00168;PF17047;, GO:0005783;GO:0005789;GO:0031234;GO:0030176;GO:0031227;GO:0016020;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of endoplasmic reticulum membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|Q9BSJ8 A0FGR7 A8K2S2 O94848 Q6PJN4 Q9H6J1 Q9H6W2 Q9Y416,Extended synaptotagmin-1 {ECO:0000305},Membrane-bound C2 domain-containing protein;, PF00168;PF17047;, GO:0005783;GO:0005789;GO:0031234;GO:0030176;GO:0031227;GO:0016020;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of endoplasmic reticulum membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport;|Q9BSJ8 A0FGR7 A8K2S2 O94848 Q6PJN4 Q9H6J1 Q9H6W2 Q9Y416,Extended synaptotagmin-1 {ECO:0000305},Membrane-bound C2 domain-containing protein;, PF00168;PF17047;, GO:0005783;GO:0005789;GO:0031234;GO:0030176;GO:0031227;GO:0016020;GO:0005509;GO:0005544;GO:0042802;GO:0031210;GO:0008429;GO:0035091;GO:0061817;GO:0006687;GO:0006869;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; C:integral component of endoplasmic reticulum membrane; C:intrinsic component of endoplasmic reticulum membrane; C:membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:identical protein binding; F:phosphatidylcholine binding; F:phosphatidylethanolamine binding; F:phosphatidylinositol binding;, P:endoplasmic reticulum-plasma membrane tethering; P:glycosphingolipid metabolic process; P:lipid transport; scaffold151 indexed_genome mRNA 1224105 1232444 . + . ID=transcript_14739;Q9UQ80 O43846 Q9UM59,Proliferation-associated protein 2G4,Cell cycle protein p38-2G4 homolog;ErbB3-binding protein 1;, PF00557;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0005634;GO:0003676;GO:0003723;GO:0003714;GO:0031625;GO:0043066;GO:0045892;GO:0043312;GO:0045597;GO:0006417;GO:0006364;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:nucleus;, F:nucleic acid binding; F:RNA binding; F:transcription corepressor activity; F:ubiquitin protein ligase binding;, P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of cell differentiation; P:regulation of translation; P:rRNA processing;|Q9UQ80 O43846 Q9UM59,Proliferation-associated protein 2G4,Cell cycle protein p38-2G4 homolog;ErbB3-binding protein 1;, PF00557;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0005634;GO:0003676;GO:0003723;GO:0003714;GO:0031625;GO:0043066;GO:0045892;GO:0043312;GO:0045597;GO:0006417;GO:0006364;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:nucleus;, F:nucleic acid binding; F:RNA binding; F:transcription corepressor activity; F:ubiquitin protein ligase binding;, P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of cell differentiation; P:regulation of translation; P:rRNA processing;|Q9UQ80 O43846 Q9UM59,Proliferation-associated protein 2G4,Cell cycle protein p38-2G4 homolog;ErbB3-binding protein 1;, PF00557;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0005634;GO:0003676;GO:0003723;GO:0003714;GO:0031625;GO:0043066;GO:0045892;GO:0043312;GO:0045597;GO:0006417;GO:0006364;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:nucleus;, F:nucleic acid binding; F:RNA binding; F:transcription corepressor activity; F:ubiquitin protein ligase binding;, P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of cell differentiation; P:regulation of translation; P:rRNA processing;|Q9UQ80 O43846 Q9UM59,Proliferation-associated protein 2G4,Cell cycle protein p38-2G4 homolog;ErbB3-binding protein 1;, PF00557;, GO:0035578;GO:0005737;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0005634;GO:0003676;GO:0003723;GO:0003714;GO:0031625;GO:0043066;GO:0045892;GO:0043312;GO:0045597;GO:0006417;GO:0006364;, C:azurophil granule lumen; C:cytoplasm; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:nucleus;, F:nucleic acid binding; F:RNA binding; F:transcription corepressor activity; F:ubiquitin protein ligase binding;, P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:neutrophil degranulation; P:positive regulation of cell differentiation; P:regulation of translation; P:rRNA processing; scaffold151 indexed_genome mRNA 1233183 1243928 . - . ID=transcript_14740;P21860 A8K6L6 B4DIK7 B4DV32 E9PDT8 Q9BUD7,Receptor tyrosine-protein kinase erbB-3,Proto-oncogene-like protein c-ErbB-3;Tyrosine kinase-type cell surface receptor HER3;, PF00757;PF14843;PF07714;PF01030;, GO:0016324;GO:0009925;GO:0016323;GO:0038143;GO:0005615;GO:0005887;GO:0016328;GO:0005886;GO:0043235;GO:0005524;GO:0043125;GO:0019838;GO:0042802;GO:0038132;GO:0038131;GO:0046982;GO:0030296;GO:0004714;GO:0004888;GO:0031625;GO:0021545;GO:0003197;GO:0038128;GO:0097192;GO:0007507;GO:0000165;GO:0007275;GO:0007162;GO:0043524;GO:0051048;GO:0009968;GO:0007399;GO:0051402;GO:0007422;GO:0014065;GO:0070886;GO:0055025;GO:0008284;GO:0010628;GO:0033674;GO:0014068;GO:0051897;GO:0061098;GO:2000145;GO:0042127;GO:0014037;GO:0007165;GO:0007169;GO:0042060;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:ERBB3:ERBB2 complex; C:extracellular space; C:integral component of plasma membrane; C:lateral plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ErbB-3 class receptor binding; F:growth factor binding; F:identical protein binding; F:neuregulin binding; F:neuregulin receptor activity; F:protein heterodimerization activity; F:protein tyrosine kinase activator activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane signaling receptor activity; F:ubiquitin protein ligase binding;, P:cranial nerve development; P:endocardial cushion development; P:ERBB2 signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:heart development; P:MAPK cascade; P:multicellular organism development; P:negative regulation of cell adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of secretion; P:negative regulation of signal transduction; P:nervous system development; P:neuron apoptotic process; P:peripheral nervous system development; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cardiac muscle tissue development; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell motility; P:regulation of cell population proliferation; P:Schwann cell differentiation; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing; scaffold151 indexed_genome mRNA 1244527 1254391 . - . ID=transcript_14741;P21860 A8K6L6 B4DIK7 B4DV32 E9PDT8 Q9BUD7,Receptor tyrosine-protein kinase erbB-3,Proto-oncogene-like protein c-ErbB-3;Tyrosine kinase-type cell surface receptor HER3;, PF00757;PF14843;PF07714;PF01030;, GO:0016324;GO:0009925;GO:0016323;GO:0038143;GO:0005615;GO:0005887;GO:0016328;GO:0005886;GO:0043235;GO:0005524;GO:0043125;GO:0019838;GO:0042802;GO:0038132;GO:0038131;GO:0046982;GO:0030296;GO:0004714;GO:0004888;GO:0031625;GO:0021545;GO:0003197;GO:0038128;GO:0097192;GO:0007507;GO:0000165;GO:0007275;GO:0007162;GO:0043524;GO:0051048;GO:0009968;GO:0007399;GO:0051402;GO:0007422;GO:0014065;GO:0070886;GO:0055025;GO:0008284;GO:0010628;GO:0033674;GO:0014068;GO:0051897;GO:0061098;GO:2000145;GO:0042127;GO:0014037;GO:0007165;GO:0007169;GO:0042060;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:ERBB3:ERBB2 complex; C:extracellular space; C:integral component of plasma membrane; C:lateral plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ErbB-3 class receptor binding; F:growth factor binding; F:identical protein binding; F:neuregulin binding; F:neuregulin receptor activity; F:protein heterodimerization activity; F:protein tyrosine kinase activator activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane signaling receptor activity; F:ubiquitin protein ligase binding;, P:cranial nerve development; P:endocardial cushion development; P:ERBB2 signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:heart development; P:MAPK cascade; P:multicellular organism development; P:negative regulation of cell adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of secretion; P:negative regulation of signal transduction; P:nervous system development; P:neuron apoptotic process; P:peripheral nervous system development; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cardiac muscle tissue development; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell motility; P:regulation of cell population proliferation; P:Schwann cell differentiation; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing;|P21860 A8K6L6 B4DIK7 B4DV32 E9PDT8 Q9BUD7,Receptor tyrosine-protein kinase erbB-3,Proto-oncogene-like protein c-ErbB-3;Tyrosine kinase-type cell surface receptor HER3;, PF00757;PF14843;PF07714;PF01030;, GO:0016324;GO:0009925;GO:0016323;GO:0038143;GO:0005615;GO:0005887;GO:0016328;GO:0005886;GO:0043235;GO:0005524;GO:0043125;GO:0019838;GO:0042802;GO:0038132;GO:0038131;GO:0046982;GO:0030296;GO:0004714;GO:0004888;GO:0031625;GO:0021545;GO:0003197;GO:0038128;GO:0097192;GO:0007507;GO:0000165;GO:0007275;GO:0007162;GO:0043524;GO:0051048;GO:0009968;GO:0007399;GO:0051402;GO:0007422;GO:0014065;GO:0070886;GO:0055025;GO:0008284;GO:0010628;GO:0033674;GO:0014068;GO:0051897;GO:0061098;GO:2000145;GO:0042127;GO:0014037;GO:0007165;GO:0007169;GO:0042060;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:ERBB3:ERBB2 complex; C:extracellular space; C:integral component of plasma membrane; C:lateral plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ErbB-3 class receptor binding; F:growth factor binding; F:identical protein binding; F:neuregulin binding; F:neuregulin receptor activity; F:protein heterodimerization activity; F:protein tyrosine kinase activator activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane signaling receptor activity; F:ubiquitin protein ligase binding;, P:cranial nerve development; P:endocardial cushion development; P:ERBB2 signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:heart development; P:MAPK cascade; P:multicellular organism development; P:negative regulation of cell adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of secretion; P:negative regulation of signal transduction; P:nervous system development; P:neuron apoptotic process; P:peripheral nervous system development; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cardiac muscle tissue development; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell motility; P:regulation of cell population proliferation; P:Schwann cell differentiation; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing;|P21860 A8K6L6 B4DIK7 B4DV32 E9PDT8 Q9BUD7,Receptor tyrosine-protein kinase erbB-3,Proto-oncogene-like protein c-ErbB-3;Tyrosine kinase-type cell surface receptor HER3;, PF00757;PF14843;PF07714;PF01030;, GO:0016324;GO:0009925;GO:0016323;GO:0038143;GO:0005615;GO:0005887;GO:0016328;GO:0005886;GO:0043235;GO:0005524;GO:0043125;GO:0019838;GO:0042802;GO:0038132;GO:0038131;GO:0046982;GO:0030296;GO:0004714;GO:0004888;GO:0031625;GO:0021545;GO:0003197;GO:0038128;GO:0097192;GO:0007507;GO:0000165;GO:0007275;GO:0007162;GO:0043524;GO:0051048;GO:0009968;GO:0007399;GO:0051402;GO:0007422;GO:0014065;GO:0070886;GO:0055025;GO:0008284;GO:0010628;GO:0033674;GO:0014068;GO:0051897;GO:0061098;GO:2000145;GO:0042127;GO:0014037;GO:0007165;GO:0007169;GO:0042060;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:ERBB3:ERBB2 complex; C:extracellular space; C:integral component of plasma membrane; C:lateral plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ErbB-3 class receptor binding; F:growth factor binding; F:identical protein binding; F:neuregulin binding; F:neuregulin receptor activity; F:protein heterodimerization activity; F:protein tyrosine kinase activator activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane signaling receptor activity; F:ubiquitin protein ligase binding;, P:cranial nerve development; P:endocardial cushion development; P:ERBB2 signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:heart development; P:MAPK cascade; P:multicellular organism development; P:negative regulation of cell adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of secretion; P:negative regulation of signal transduction; P:nervous system development; P:neuron apoptotic process; P:peripheral nervous system development; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cardiac muscle tissue development; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell motility; P:regulation of cell population proliferation; P:Schwann cell differentiation; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing;|P21860 A8K6L6 B4DIK7 B4DV32 E9PDT8 Q9BUD7,Receptor tyrosine-protein kinase erbB-3,Proto-oncogene-like protein c-ErbB-3;Tyrosine kinase-type cell surface receptor HER3;, PF00757;PF14843;PF07714;PF01030;, GO:0016324;GO:0009925;GO:0016323;GO:0038143;GO:0005615;GO:0005887;GO:0016328;GO:0005886;GO:0043235;GO:0005524;GO:0043125;GO:0019838;GO:0042802;GO:0038132;GO:0038131;GO:0046982;GO:0030296;GO:0004714;GO:0004888;GO:0031625;GO:0021545;GO:0003197;GO:0038128;GO:0097192;GO:0007507;GO:0000165;GO:0007275;GO:0007162;GO:0043524;GO:0051048;GO:0009968;GO:0007399;GO:0051402;GO:0007422;GO:0014065;GO:0070886;GO:0055025;GO:0008284;GO:0010628;GO:0033674;GO:0014068;GO:0051897;GO:0061098;GO:2000145;GO:0042127;GO:0014037;GO:0007165;GO:0007169;GO:0042060;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:ERBB3:ERBB2 complex; C:extracellular space; C:integral component of plasma membrane; C:lateral plasma membrane; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ErbB-3 class receptor binding; F:growth factor binding; F:identical protein binding; F:neuregulin binding; F:neuregulin receptor activity; F:protein heterodimerization activity; F:protein tyrosine kinase activator activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane signaling receptor activity; F:ubiquitin protein ligase binding;, P:cranial nerve development; P:endocardial cushion development; P:ERBB2 signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:heart development; P:MAPK cascade; P:multicellular organism development; P:negative regulation of cell adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of secretion; P:negative regulation of signal transduction; P:nervous system development; P:neuron apoptotic process; P:peripheral nervous system development; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of calcineurin-NFAT signaling cascade; P:positive regulation of cardiac muscle tissue development; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of kinase activity; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell motility; P:regulation of cell population proliferation; P:Schwann cell differentiation; P:signal transduction; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:wound healing; scaffold151 indexed_genome mRNA 1289684 1290354 . - . ID=transcript_14742;P09651 A8K4Z8 Q3MIB7 Q6PJZ7,Heterogeneous nuclear ribonucleoprotein A1,Helix-destabilizing protein;Single-strand RNA-binding protein;hnRNP core protein A1;, PF11627;PF00076;, GO:0071013;GO:0005737;GO:0070062;GO:0016020;GO:0005654;GO:0005634;GO:1990904;GO:0005681;GO:0098505;GO:0042802;GO:0035198;GO:0036002;GO:0019904;GO:0003723;GO:0003697;GO:0003727;GO:0061752;GO:0042149;GO:1903936;GO:0008543;GO:0051170;GO:0000398;GO:0051028;GO:0032211;GO:0051168;GO:0032212;GO:0000381;GO:0006405;GO:0016070;GO:0016032;, C:catalytic step 2 spliceosome; C:cytoplasm; C:extracellular exosome; C:membrane; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal complex;, F:G-rich strand telomeric DNA binding; F:identical protein binding; F:miRNA binding; F:pre-mRNA binding; F:protein domain specific binding; F:RNA binding; F:single-stranded DNA binding; F:single-stranded RNA binding; F:telomeric repeat-containing RNA binding;, P:cellular response to glucose starvation; P:cellular response to sodium arsenite; P:fibroblast growth factor receptor signaling pathway; P:import into nucleus; P:mRNA splicing, via spliceosome; P:mRNA transport; P:negative regulation of telomere maintenance via telomerase; P:nuclear export; P:positive regulation of telomere maintenance via telomerase; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA export from nucleus; P:RNA metabolic process; P:viral process; scaffold151 indexed_genome mRNA 1294906 1298698 . - . ID=transcript_14743;P62854 P02383 P70394 Q06722 Q3MHD8 Q6IRY4,40S ribosomal protein S26,Small ribosomal subunit protein eS26 {ECO:0000303|PubMed:24524803};, PF01283;, GO:0098556;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0042788;GO:0015935;GO:0045296;GO:0003729;GO:0003723;GO:0003735;GO:0002181;GO:0033119;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic side of rough endoplasmic reticulum membrane; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:polysomal ribosome; C:small ribosomal subunit;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:negative regulation of RNA splicing; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62854 P02383 P70394 Q06722 Q3MHD8 Q6IRY4,40S ribosomal protein S26,Small ribosomal subunit protein eS26 {ECO:0000303|PubMed:24524803};, PF01283;, GO:0098556;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0042788;GO:0015935;GO:0045296;GO:0003729;GO:0003723;GO:0003735;GO:0002181;GO:0033119;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic side of rough endoplasmic reticulum membrane; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:polysomal ribosome; C:small ribosomal subunit;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:negative regulation of RNA splicing; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62854 P02383 P70394 Q06722 Q3MHD8 Q6IRY4,40S ribosomal protein S26,Small ribosomal subunit protein eS26 {ECO:0000303|PubMed:24524803};, PF01283;, GO:0098556;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0042788;GO:0015935;GO:0045296;GO:0003729;GO:0003723;GO:0003735;GO:0002181;GO:0033119;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic side of rough endoplasmic reticulum membrane; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:polysomal ribosome; C:small ribosomal subunit;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:negative regulation of RNA splicing; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62854 P02383 P70394 Q06722 Q3MHD8 Q6IRY4,40S ribosomal protein S26,Small ribosomal subunit protein eS26 {ECO:0000303|PubMed:24524803};, PF01283;, GO:0098556;GO:0005829;GO:0022627;GO:0070062;GO:0016020;GO:0005654;GO:0042788;GO:0015935;GO:0045296;GO:0003729;GO:0003723;GO:0003735;GO:0002181;GO:0033119;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasmic side of rough endoplasmic reticulum membrane; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:membrane; C:nucleoplasm; C:polysomal ribosome; C:small ribosomal subunit;, F:cadherin binding; F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:negative regulation of RNA splicing; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold151 indexed_genome mRNA 1307095 1315409 . - . ID=transcript_14744;Q9H2S9 Q96JP3,Zinc finger protein Eos,Ikaros family zinc finger protein 4;, PF00096;, GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0043425;GO:0003700;GO:0019904;GO:0000978;GO:0008270;GO:0045892;GO:0045944;GO:0051260;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:protein homooligomerization; P:regulation of transcription by RNA polymerase II;|Q9H2S9 Q96JP3,Zinc finger protein Eos,Ikaros family zinc finger protein 4;, PF00096;, GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0043425;GO:0003700;GO:0019904;GO:0000978;GO:0008270;GO:0045892;GO:0045944;GO:0051260;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:protein homooligomerization; P:regulation of transcription by RNA polymerase II;|Q9H2S9 Q96JP3,Zinc finger protein Eos,Ikaros family zinc finger protein 4;, PF00096;, GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0043425;GO:0003700;GO:0019904;GO:0000978;GO:0008270;GO:0045892;GO:0045944;GO:0051260;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:protein homooligomerization; P:regulation of transcription by RNA polymerase II; scaffold151 indexed_genome mRNA 1315421 1317784 . - . ID=transcript_14745;Q9H2S9 Q96JP3,Zinc finger protein Eos,Ikaros family zinc finger protein 4;, PF00096;, GO:0016604;GO:0005654;GO:0005634;GO:0032991;GO:0043425;GO:0003700;GO:0019904;GO:0000978;GO:0008270;GO:0045892;GO:0045944;GO:0051260;GO:0006357;, C:nuclear body; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:bHLH transcription factor binding; F:DNA-binding transcription factor activity; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:protein homooligomerization; P:regulation of transcription by RNA polymerase II; scaffold151 indexed_genome mRNA 1329838 1332752 . - . ID=transcript_14746;P51687,Sulfite oxidase, mitochondrial,, PF00173;PF03404;PF00174;, GO:0005758;GO:0005759;GO:0005739;GO:0020037;GO:0030151;GO:0043546;GO:0008482;GO:0070221;GO:0006790;, C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion;, F:heme binding; F:molybdenum ion binding; F:molybdopterin cofactor binding; F:sulfite oxidase activity;, P:sulfide oxidation, using sulfide:quinone oxidoreductase; P:sulfur compound metabolic process; scaffold151 indexed_genome mRNA 1337052 1342345 . - . ID=transcript_14747;P61020 A8K982 B4DKD7 P35239 P35277 Q6PIK9 Q86TH0 Q8IXL2,Ras-related protein Rab-5B,, PF00071;, GO:0098993;GO:0005769;GO:0031901;GO:0030139;GO:0012505;GO:0005768;GO:0070062;GO:0043231;GO:0042470;GO:0016020;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0030742;GO:0003924;GO:0019882;GO:0006897;GO:0007032;GO:0006886;GO:0043312;GO:0048227;GO:0030100;, C:anchored component of synaptic vesicle membrane; C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endomembrane system; C:endosome; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity;, P:antigen processing and presentation; P:endocytosis; P:endosome organization; P:intracellular protein transport; P:neutrophil degranulation; P:plasma membrane to endosome transport; P:regulation of endocytosis;|P61020 A8K982 B4DKD7 P35239 P35277 Q6PIK9 Q86TH0 Q8IXL2,Ras-related protein Rab-5B,, PF00071;, GO:0098993;GO:0005769;GO:0031901;GO:0030139;GO:0012505;GO:0005768;GO:0070062;GO:0043231;GO:0042470;GO:0016020;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0030742;GO:0003924;GO:0019882;GO:0006897;GO:0007032;GO:0006886;GO:0043312;GO:0048227;GO:0030100;, C:anchored component of synaptic vesicle membrane; C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endomembrane system; C:endosome; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:melanosome; C:membrane; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activity;, P:antigen processing and presentation; P:endocytosis; P:endosome organization; P:intracellular protein transport; P:neutrophil degranulation; P:plasma membrane to endosome transport; P:regulation of endocytosis; scaffold151 indexed_genome mRNA 1355851 1357289 . - . ID=transcript_14748;P24941 A8K7C6 O75100,Cyclin-dependent kinase 2,Cell division protein kinase 2;p33 protein kinase;, PF00069;, GO:0015030;GO:0005813;GO:0097123;GO:0097124;GO:0097134;GO:0097135;GO:0000307;GO:0005737;GO:0005829;GO:0005768;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0097472;GO:0004693;GO:0046872;GO:0019904;GO:0106310;GO:0004674;GO:0106311;GO:0031145;GO:0051301;GO:0071732;GO:0007099;GO:0051298;GO:0006281;GO:0006260;GO:0006270;GO:0000082;GO:0000086;GO:0030851;GO:0016572;GO:0051321;GO:0031571;GO:0018105;GO:0008284;GO:0006468;GO:0007265;GO:0010389;GO:0010468;GO:0060968;GO:1901796;GO:0007165;GO:0007004;, C:Cajal body; C:centrosome; C:cyclin A1-CDK2 complex; C:cyclin A2-CDK2 complex; C:cyclin E1-CDK2 complex; C:cyclin E2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:endosome; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein kinase activity; F:cyclin-dependent protein serine/threonine kinase activity; F:metal ion binding; F:protein domain specific binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:cellular response to nitric oxide; P:centriole replication; P:centrosome duplication; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:granulocyte differentiation; P:histone phosphorylation; P:meiotic cell cycle; P:mitotic G1 DNA damage checkpoint; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:Ras protein signal transduction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gene expression; P:regulation of gene silencing; P:regulation of signal transduction by p53 class mediator; P:signal transduction; P:telomere maintenance via telomerase; scaffold151 indexed_genome mRNA 1358902 1359625 . + . ID=transcript_14749;P24941 A8K7C6 O75100,Cyclin-dependent kinase 2,Cell division protein kinase 2;p33 protein kinase;, PF00069;, GO:0015030;GO:0005813;GO:0097123;GO:0097124;GO:0097134;GO:0097135;GO:0000307;GO:0005737;GO:0005829;GO:0005768;GO:0005654;GO:0005634;GO:0005524;GO:0030332;GO:0097472;GO:0004693;GO:0046872;GO:0019904;GO:0106310;GO:0004674;GO:0106311;GO:0031145;GO:0051301;GO:0071732;GO:0007099;GO:0051298;GO:0006281;GO:0006260;GO:0006270;GO:0000082;GO:0000086;GO:0030851;GO:0016572;GO:0051321;GO:0031571;GO:0018105;GO:0008284;GO:0006468;GO:0007265;GO:0010389;GO:0010468;GO:0060968;GO:1901796;GO:0007165;GO:0007004;, C:Cajal body; C:centrosome; C:cyclin A1-CDK2 complex; C:cyclin A2-CDK2 complex; C:cyclin E1-CDK2 complex; C:cyclin E2-CDK2 complex; C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:endosome; C:nucleoplasm; C:nucleus;, F:ATP binding; F:cyclin binding; F:cyclin-dependent protein kinase activity; F:cyclin-dependent protein serine/threonine kinase activity; F:metal ion binding; F:protein domain specific binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:cellular response to nitric oxide; P:centriole replication; P:centrosome duplication; P:DNA repair; P:DNA replication; P:DNA replication initiation; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:granulocyte differentiation; P:histone phosphorylation; P:meiotic cell cycle; P:mitotic G1 DNA damage checkpoint; P:peptidyl-serine phosphorylation; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:Ras protein signal transduction; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of gene expression; P:regulation of gene silencing; P:regulation of signal transduction by p53 class mediator; P:signal transduction; P:telomere maintenance via telomerase; scaffold151 indexed_genome mRNA 1362573 1363269 . + . ID=transcript_14750;P40967 B3KS57 B7Z6D7 Q12763 Q14448 Q14817 Q16565,Melanocyte protein PMEL,ME20-M;Melanocyte protein Pmel 17;Melanocytes lineage-specific antigen GP100;Melanoma-associated ME20 antigen;P1;P100;Premelanosome protein;Silver locus protein homolog;, PF00801;, GO:0005783;GO:0005789;GO:0005576;GO:0005794;GO:0005887;GO:0042470;GO:0032585;GO:0005886;GO:0042802;GO:0042438;GO:0032438;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:melanosome; C:multivesicular body membrane; C:plasma membrane;, F:identical protein binding;, P:melanin biosynthetic process; P:melanosome organization; scaffold151 indexed_genome mRNA 1365505 1369166 . + . ID=transcript_14751;P40967 B3KS57 B7Z6D7 Q12763 Q14448 Q14817 Q16565,Melanocyte protein PMEL,ME20-M;Melanocyte protein Pmel 17;Melanocytes lineage-specific antigen GP100;Melanoma-associated ME20 antigen;P1;P100;Premelanosome protein;Silver locus protein homolog;, PF00801;, GO:0005783;GO:0005789;GO:0005576;GO:0005794;GO:0005887;GO:0042470;GO:0032585;GO:0005886;GO:0042802;GO:0042438;GO:0032438;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:melanosome; C:multivesicular body membrane; C:plasma membrane;, F:identical protein binding;, P:melanin biosynthetic process; P:melanosome organization; scaffold151 indexed_genome mRNA 1369174 1392664 . - . ID=transcript_14752;P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2,Diacylglycerol kinase alpha,80 kDa diacylglycerol kinase;Diglyceride kinase alpha;, PF00130;PF14513;PF00609;PF00781;, GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0016301;GO:0008289;GO:0003951;GO:0005543;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0006654;GO:0030168;GO:0007205;, C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid binding; F:NAD+ kinase activity; F:phospholipid binding;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway;|P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2,Diacylglycerol kinase alpha,80 kDa diacylglycerol kinase;Diglyceride kinase alpha;, PF00130;PF14513;PF00609;PF00781;, GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0016301;GO:0008289;GO:0003951;GO:0005543;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0006654;GO:0030168;GO:0007205;, C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid binding; F:NAD+ kinase activity; F:phospholipid binding;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway;|P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2,Diacylglycerol kinase alpha,80 kDa diacylglycerol kinase;Diglyceride kinase alpha;, PF00130;PF14513;PF00609;PF00781;, GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0016301;GO:0008289;GO:0003951;GO:0005543;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0006654;GO:0030168;GO:0007205;, C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid binding; F:NAD+ kinase activity; F:phospholipid binding;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway;|P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2,Diacylglycerol kinase alpha,80 kDa diacylglycerol kinase;Diglyceride kinase alpha;, PF00130;PF14513;PF00609;PF00781;, GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0016301;GO:0008289;GO:0003951;GO:0005543;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0006654;GO:0030168;GO:0007205;, C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid binding; F:NAD+ kinase activity; F:phospholipid binding;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway;|P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2,Diacylglycerol kinase alpha,80 kDa diacylglycerol kinase;Diglyceride kinase alpha;, PF00130;PF14513;PF00609;PF00781;, GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0016301;GO:0008289;GO:0003951;GO:0005543;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0006654;GO:0030168;GO:0007205;, C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid binding; F:NAD+ kinase activity; F:phospholipid binding;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway;|P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2,Diacylglycerol kinase alpha,80 kDa diacylglycerol kinase;Diglyceride kinase alpha;, PF00130;PF14513;PF00609;PF00781;, GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0016301;GO:0008289;GO:0003951;GO:0005543;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0006654;GO:0030168;GO:0007205;, C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid binding; F:NAD+ kinase activity; F:phospholipid binding;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway;|P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2,Diacylglycerol kinase alpha,80 kDa diacylglycerol kinase;Diglyceride kinase alpha;, PF00130;PF14513;PF00609;PF00781;, GO:0005829;GO:0016020;GO:0005886;GO:0005524;GO:0005509;GO:0004143;GO:0016301;GO:0008289;GO:0003951;GO:0005543;GO:0046339;GO:0046486;GO:0035556;GO:0046834;GO:0006654;GO:0030168;GO:0007205;, C:cytosol; C:membrane; C:plasma membrane;, F:ATP binding; F:calcium ion binding; F:diacylglycerol kinase activity; F:kinase activity; F:lipid binding; F:NAD+ kinase activity; F:phospholipid binding;, P:diacylglycerol metabolic process; P:glycerolipid metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:phosphatidic acid biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; scaffold151 indexed_genome mRNA 1412322 1414368 . + . ID=transcript_14753;Q9BRP8 B6ZDM5 Q8IXJ8 Q8N8E7,Partner of Y14 and mago {ECO:0000250|UniProtKB:P82804},PYM homolog 1 exon junction complex-associated factor {ECO:0000312|HGNC:HGNC:30258};Protein wibg homolog;, PF09282;, GO:0030054;GO:0005737;GO:0005829;GO:0035145;GO:0005730;GO:0005654;GO:0043022;GO:0003723;GO:1903259;GO:0000184;GO:0045727;, C:cell junction; C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:nucleolus; C:nucleoplasm;, F:ribosome binding; F:RNA binding;, P:exon-exon junction complex disassembly; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; scaffold151 indexed_genome mRNA 1441396 1447297 . + . ID=transcript_14754;Q99542 B4E030 O15278 O95606 Q99580,Matrix metalloproteinase-19,Matrix metalloproteinase RASI;Matrix metalloproteinase-18;, PF00045;PF00413;PF01471;, GO:0031012;GO:0005576;GO:0005615;GO:0004222;GO:0008270;GO:0001525;GO:0030154;GO:0030574;GO:0022617;GO:0030198;GO:0001554;GO:0001541;GO:0001542;GO:0006508;GO:0051591;GO:0009725;, C:extracellular matrix; C:extracellular region; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:angiogenesis; P:cell differentiation; P:collagen catabolic process; P:extracellular matrix disassembly; P:extracellular matrix organization; P:luteolysis; P:ovarian follicle development; P:ovulation from ovarian follicle; P:proteolysis; P:response to cAMP; P:response to hormone;|Q99542 B4E030 O15278 O95606 Q99580,Matrix metalloproteinase-19,Matrix metalloproteinase RASI;Matrix metalloproteinase-18;, PF00045;PF00413;PF01471;, GO:0031012;GO:0005576;GO:0005615;GO:0004222;GO:0008270;GO:0001525;GO:0030154;GO:0030574;GO:0022617;GO:0030198;GO:0001554;GO:0001541;GO:0001542;GO:0006508;GO:0051591;GO:0009725;, C:extracellular matrix; C:extracellular region; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:angiogenesis; P:cell differentiation; P:collagen catabolic process; P:extracellular matrix disassembly; P:extracellular matrix organization; P:luteolysis; P:ovarian follicle development; P:ovulation from ovarian follicle; P:proteolysis; P:response to cAMP; P:response to hormone; scaffold151 indexed_genome mRNA 1447709 1451967 . - . ID=transcript_14755;Q66K66,Transmembrane protein 198,, PF13886;, GO:0031410;GO:0016021;GO:0005886;GO:0007275;GO:0090263;GO:0016055;, C:cytoplasmic vesicle; C:integral component of membrane; C:plasma membrane;, , P:multicellular organism development; P:positive regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q66K66,Transmembrane protein 198,, PF13886;, GO:0031410;GO:0016021;GO:0005886;GO:0007275;GO:0090263;GO:0016055;, C:cytoplasmic vesicle; C:integral component of membrane; C:plasma membrane;, , P:multicellular organism development; P:positive regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway;|Q66K66,Transmembrane protein 198,, PF13886;, GO:0031410;GO:0016021;GO:0005886;GO:0007275;GO:0090263;GO:0016055;, C:cytoplasmic vesicle; C:integral component of membrane; C:plasma membrane;, , P:multicellular organism development; P:positive regulation of canonical Wnt signaling pathway; P:Wnt signaling pathway; scaffold151 indexed_genome mRNA 1453563 1462733 . - . ID=transcript_14756;Q6Y2X3 A5YM67 Q17RY2 Q66K17 Q96N59 Q96T63,DnaJ homolog subfamily C member 14,DnaJ protein homolog 3;Dopamine receptor-interacting protein of 78 kDa;Human DnaJ protein 3;, PF00226;PF14901;, GO:0005789;GO:0016021;GO:0016020;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:protein transport;|Q6Y2X3 A5YM67 Q17RY2 Q66K17 Q96N59 Q96T63,DnaJ homolog subfamily C member 14,DnaJ protein homolog 3;Dopamine receptor-interacting protein of 78 kDa;Human DnaJ protein 3;, PF00226;PF14901;, GO:0005789;GO:0016021;GO:0016020;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:protein transport;|Q6Y2X3 A5YM67 Q17RY2 Q66K17 Q96N59 Q96T63,DnaJ homolog subfamily C member 14,DnaJ protein homolog 3;Dopamine receptor-interacting protein of 78 kDa;Human DnaJ protein 3;, PF00226;PF14901;, GO:0005789;GO:0016021;GO:0016020;GO:0015031;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:protein transport;|Q53FV1 B2RA58 Q7Z4E5 Q8NFX0 Q9P004,ORM1-like protein 2,Adoplin-2;, PF04061;, GO:0005783;GO:0016021;GO:0035339;GO:0090156;GO:0006672;GO:1900060;, C:endoplasmic reticulum; C:integral component of membrane; C:SPOTS complex;, , P:cellular sphingolipid homeostasis; P:ceramide metabolic process; P:negative regulation of ceramide biosynthetic process;|Q53FV1 B2RA58 Q7Z4E5 Q8NFX0 Q9P004,ORM1-like protein 2,Adoplin-2;, PF04061;, GO:0005783;GO:0016021;GO:0035339;GO:0090156;GO:0006672;GO:1900060;, C:endoplasmic reticulum; C:integral component of membrane; C:SPOTS complex;, , P:cellular sphingolipid homeostasis; P:ceramide metabolic process; P:negative regulation of ceramide biosynthetic process; scaffold151 indexed_genome mRNA 1463057 1510509 . + . ID=transcript_14757;P82979 A8K393 Q9P066,SAP domain-containing ribonucleoprotein,Cytokine-induced protein of 29 kDa;Nuclear protein Hcc-1;Proliferation-associated cytokine-inducible protein CIP29;, PF02037;, GO:0036464;GO:0016607;GO:0005654;GO:0005634;GO:0000346;GO:0003677;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0006417;GO:0006405;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:transcription export complex;, F:DNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:regulation of translation; P:RNA export from nucleus;|P82979 A8K393 Q9P066,SAP domain-containing ribonucleoprotein,Cytokine-induced protein of 29 kDa;Nuclear protein Hcc-1;Proliferation-associated cytokine-inducible protein CIP29;, PF02037;, GO:0036464;GO:0016607;GO:0005654;GO:0005634;GO:0000346;GO:0003677;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0006417;GO:0006405;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:transcription export complex;, F:DNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:regulation of translation; P:RNA export from nucleus;|P82979 A8K393 Q9P066,SAP domain-containing ribonucleoprotein,Cytokine-induced protein of 29 kDa;Nuclear protein Hcc-1;Proliferation-associated cytokine-inducible protein CIP29;, PF02037;, GO:0036464;GO:0016607;GO:0005654;GO:0005634;GO:0000346;GO:0003677;GO:0003723;GO:0031124;GO:0006406;GO:0016973;GO:0006417;GO:0006405;, C:cytoplasmic ribonucleoprotein granule; C:nuclear speck; C:nucleoplasm; C:nucleus; C:transcription export complex;, F:DNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:poly(A)+ mRNA export from nucleus; P:regulation of translation; P:RNA export from nucleus;|O15342 B2R557 D3DQM1 Q6IBE8,V-type proton ATPase subunit e 1,V-ATPase 9.2 kDa membrane accessory protein;V-ATPase M9.2 subunit;Vacuolar proton pump subunit e 1;, PF05493;, GO:0010008;GO:0016021;GO:0005765;GO:0030670;GO:0033179;GO:0042625;GO:0016787;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0055085;GO:0007035;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:phagocytic vesicle membrane; C:proton-transporting V-type ATPase, V0 domain;, F:ATPase-coupled ion transmembrane transporter activity; F:hydrolase activity; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:transmembrane transport; P:vacuolar acidification; scaffold151 indexed_genome mRNA 1516861 1524315 . - . ID=transcript_14758;O95390 Q9UID1 Q9UID2,Growth/differentiation factor 11 {ECO:0000303|PubMed:10391213},Bone morphogenetic protein 11 {ECO:0000303|PubMed:10075854};, PF00019;PF00688;, GO:0005615;GO:0043231;GO:0005654;GO:0032991;GO:0005125;GO:0008083;GO:0048593;GO:0048469;GO:0007498;GO:0001656;GO:0008285;GO:0045665;GO:0007399;GO:0031016;GO:0010862;GO:0060021;GO:0001501;GO:0060395;GO:0021512;GO:0001657;, C:extracellular space; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:protein-containing complex;, F:cytokine activity; F:growth factor activity;, P:camera-type eye morphogenesis; P:cell maturation; P:mesoderm development; P:metanephros development; P:negative regulation of cell population proliferation; P:negative regulation of neuron differentiation; P:nervous system development; P:pancreas development; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:roof of mouth development; P:skeletal system development; P:SMAD protein signal transduction; P:spinal cord anterior/posterior patterning; P:ureteric bud development;|O95390 Q9UID1 Q9UID2,Growth/differentiation factor 11 {ECO:0000303|PubMed:10391213},Bone morphogenetic protein 11 {ECO:0000303|PubMed:10075854};, PF00019;PF00688;, GO:0005615;GO:0043231;GO:0005654;GO:0032991;GO:0005125;GO:0008083;GO:0048593;GO:0048469;GO:0007498;GO:0001656;GO:0008285;GO:0045665;GO:0007399;GO:0031016;GO:0010862;GO:0060021;GO:0001501;GO:0060395;GO:0021512;GO:0001657;, C:extracellular space; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:protein-containing complex;, F:cytokine activity; F:growth factor activity;, P:camera-type eye morphogenesis; P:cell maturation; P:mesoderm development; P:metanephros development; P:negative regulation of cell population proliferation; P:negative regulation of neuron differentiation; P:nervous system development; P:pancreas development; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:roof of mouth development; P:skeletal system development; P:SMAD protein signal transduction; P:spinal cord anterior/posterior patterning; P:ureteric bud development;|O95390 Q9UID1 Q9UID2,Growth/differentiation factor 11 {ECO:0000303|PubMed:10391213},Bone morphogenetic protein 11 {ECO:0000303|PubMed:10075854};, PF00019;PF00688;, GO:0005615;GO:0043231;GO:0005654;GO:0032991;GO:0005125;GO:0008083;GO:0048593;GO:0048469;GO:0007498;GO:0001656;GO:0008285;GO:0045665;GO:0007399;GO:0031016;GO:0010862;GO:0060021;GO:0001501;GO:0060395;GO:0021512;GO:0001657;, C:extracellular space; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:protein-containing complex;, F:cytokine activity; F:growth factor activity;, P:camera-type eye morphogenesis; P:cell maturation; P:mesoderm development; P:metanephros development; P:negative regulation of cell population proliferation; P:negative regulation of neuron differentiation; P:nervous system development; P:pancreas development; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:roof of mouth development; P:skeletal system development; P:SMAD protein signal transduction; P:spinal cord anterior/posterior patterning; P:ureteric bud development; scaffold151 indexed_genome mRNA 1538992 1555396 . + . ID=transcript_14759;Q92781 O00179 Q8TAI2,Retinol dehydrogenase 5,11-cis retinol dehydrogenase {ECO:0000303|PubMed:8884265};9-cis retinol dehydrogenase;Short chain dehydrogenase/reductase family 9C member 5 {ECO:0000303|PubMed:19027726};, PF00106;, GO:0044297;GO:0005788;GO:0005789;GO:0016021;GO:0047044;GO:0047023;GO:0042803;GO:0004745;GO:0050896;GO:0001523;GO:0042572;GO:0008202;GO:0007601;, C:cell body; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:androsterone dehydrogenase activity; F:protein homodimerization activity; F:retinol dehydrogenase activity;, P:response to stimulus; P:retinoid metabolic process; P:retinol metabolic process; P:steroid metabolic process; P:visual perception;|P78537 A1L4Q9 Q6NZ45,Biogenesis of lysosome-related organelles complex 1 subunit 1,GCN5-like protein 1;Protein RT14;, PF06320;, GO:1904115;GO:0031083;GO:0099078;GO:0005829;GO:0005615;GO:0005765;GO:0005758;GO:0005759;GO:0009060;GO:0008089;GO:0048490;GO:0016197;GO:0032418;GO:0032438;GO:0031175;GO:0018394;GO:0060155;GO:0006892;, C:axon cytoplasm; C:BLOC-1 complex; C:BORC complex; C:cytosol; C:extracellular space; C:lysosomal membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix;, , P:aerobic respiration; P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endosomal transport; P:lysosome localization; P:melanosome organization; P:neuron projection development; P:peptidyl-lysine acetylation; P:platelet dense granule organization; P:post-Golgi vesicle-mediated transport;|P78537 A1L4Q9 Q6NZ45,Biogenesis of lysosome-related organelles complex 1 subunit 1,GCN5-like protein 1;Protein RT14;, PF06320;, GO:1904115;GO:0031083;GO:0099078;GO:0005829;GO:0005615;GO:0005765;GO:0005758;GO:0005759;GO:0009060;GO:0008089;GO:0048490;GO:0016197;GO:0032418;GO:0032438;GO:0031175;GO:0018394;GO:0060155;GO:0006892;, C:axon cytoplasm; C:BLOC-1 complex; C:BORC complex; C:cytosol; C:extracellular space; C:lysosomal membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix;, , P:aerobic respiration; P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endosomal transport; P:lysosome localization; P:melanosome organization; P:neuron projection development; P:peptidyl-lysine acetylation; P:platelet dense granule organization; P:post-Golgi vesicle-mediated transport; scaffold151 indexed_genome mRNA 1557580 1582799 . + . ID=transcript_14760;Q13683 B4E3U0 C9JMD3 C9JMZ6 O43197 Q86W93 Q9NY89 Q9UET0 Q9UEV2,Integrin alpha-7,, PF01839;PF08441;, GO:0009986;GO:0008305;GO:0005886;GO:0046872;GO:0007160;GO:0035987;GO:0030198;GO:0034113;GO:0007229;GO:0007517;GO:0008360;, C:cell surface; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell-matrix adhesion; P:endodermal cell differentiation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:muscle organ development; P:regulation of cell shape;|Q13683 B4E3U0 C9JMD3 C9JMZ6 O43197 Q86W93 Q9NY89 Q9UET0 Q9UEV2,Integrin alpha-7,, PF01839;PF08441;, GO:0009986;GO:0008305;GO:0005886;GO:0046872;GO:0007160;GO:0035987;GO:0030198;GO:0034113;GO:0007229;GO:0007517;GO:0008360;, C:cell surface; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell-matrix adhesion; P:endodermal cell differentiation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:muscle organ development; P:regulation of cell shape;|Q13683 B4E3U0 C9JMD3 C9JMZ6 O43197 Q86W93 Q9NY89 Q9UET0 Q9UEV2,Integrin alpha-7,, PF01839;PF08441;, GO:0009986;GO:0008305;GO:0005886;GO:0046872;GO:0007160;GO:0035987;GO:0030198;GO:0034113;GO:0007229;GO:0007517;GO:0008360;, C:cell surface; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell-matrix adhesion; P:endodermal cell differentiation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:muscle organ development; P:regulation of cell shape;|Q13683 B4E3U0 C9JMD3 C9JMZ6 O43197 Q86W93 Q9NY89 Q9UET0 Q9UEV2,Integrin alpha-7,, PF01839;PF08441;, GO:0009986;GO:0008305;GO:0005886;GO:0046872;GO:0007160;GO:0035987;GO:0030198;GO:0034113;GO:0007229;GO:0007517;GO:0008360;, C:cell surface; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell-matrix adhesion; P:endodermal cell differentiation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:muscle organ development; P:regulation of cell shape;|Q13683 B4E3U0 C9JMD3 C9JMZ6 O43197 Q86W93 Q9NY89 Q9UET0 Q9UEV2,Integrin alpha-7,, PF01839;PF08441;, GO:0009986;GO:0008305;GO:0005886;GO:0046872;GO:0007160;GO:0035987;GO:0030198;GO:0034113;GO:0007229;GO:0007517;GO:0008360;, C:cell surface; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell-matrix adhesion; P:endodermal cell differentiation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:muscle organ development; P:regulation of cell shape;|Q13683 B4E3U0 C9JMD3 C9JMZ6 O43197 Q86W93 Q9NY89 Q9UET0 Q9UEV2,Integrin alpha-7,, PF01839;PF08441;, GO:0009986;GO:0008305;GO:0005886;GO:0046872;GO:0007160;GO:0035987;GO:0030198;GO:0034113;GO:0007229;GO:0007517;GO:0008360;, C:cell surface; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell-matrix adhesion; P:endodermal cell differentiation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:muscle organ development; P:regulation of cell shape;|Q13683 B4E3U0 C9JMD3 C9JMZ6 O43197 Q86W93 Q9NY89 Q9UET0 Q9UEV2,Integrin alpha-7,, PF01839;PF08441;, GO:0009986;GO:0008305;GO:0005886;GO:0046872;GO:0007160;GO:0035987;GO:0030198;GO:0034113;GO:0007229;GO:0007517;GO:0008360;, C:cell surface; C:integrin complex; C:plasma membrane;, F:metal ion binding;, P:cell-matrix adhesion; P:endodermal cell differentiation; P:extracellular matrix organization; P:heterotypic cell-cell adhesion; P:integrin-mediated signaling pathway; P:muscle organ development; P:regulation of cell shape;|Q6UX53 A8K247 Q8WUI1,Methyltransferase-like protein 7B,, PF08241;, GO:0008168;GO:0032259;, , F:methyltransferase activity;, P:methylation;|Q6UX53 A8K247 Q8WUI1,Methyltransferase-like protein 7B,, PF08241;, GO:0008168;GO:0032259;, , F:methyltransferase activity;, P:methylation; scaffold152 indexed_genome mRNA 324686 388507 . - . ID=transcript_14761;O60312 Q4G0S9 Q969I4,Phospholipid-transporting ATPase VA,ATPase class V type 10A;Aminophospholipid translocase VA;P4-ATPase flippase complex alpha subunit ATP10A;, PF16212;PF16209;, GO:0005783;GO:0005789;GO:0016021;GO:0005887;GO:1990531;GO:0005886;GO:0005524;GO:0140326;GO:0140351;GO:0000287;GO:0140345;GO:0034220;GO:0045332;GO:1903527;GO:0008360;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:glycosylceramide flippase activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;, P:ion transmembrane transport; P:phospholipid translocation; P:positive regulation of membrane tubulation; P:regulation of cell shape; scaffold152 indexed_genome mRNA 663822 666628 . + . ID=transcript_14762;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold152 indexed_genome mRNA 717748 754252 . + . ID=transcript_14763;Q9UEP9,Ubiquitin-protein ligase E3A,E6AP ubiquitin-protein ligase {ECO:0000303|PubMed:17108031};HECT-type ubiquitin transferase E3A;Human papillomavirus E6-associated protein {ECO:0000303|PubMed:8380895};Oncogenic protein-associated protein E6-AP {ECO:0000303|PubMed:8380895};Renal carcinoma antigen NY-REN-54;, PF16558;PF00632;, GO:0005829;GO:0005634;GO:0000502;GO:0046872;GO:0003713;GO:0061630;GO:0004842;GO:0030521;GO:0007420;GO:1990416;GO:0061002;GO:0001541;GO:1905528;GO:0014068;GO:0031398;GO:0045944;GO:0050847;GO:0060736;GO:0051865;GO:0070936;GO:0006508;GO:0042752;GO:2000058;GO:0042220;GO:0042542;GO:0032570;GO:0048511;GO:0035037;GO:0006511;GO:0016032;, C:cytosol; C:nucleus; C:proteasome complex;, F:metal ion binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:androgen receptor signaling pathway; P:brain development; P:cellular response to brain-derived neurotrophic factor stimulus; P:negative regulation of dendritic spine morphogenesis; P:ovarian follicle development; P:positive regulation of Golgi lumen acidification; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:progesterone receptor signaling pathway; P:prostate gland growth; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:proteolysis; P:regulation of circadian rhythm; P:regulation of ubiquitin-dependent protein catabolic process; P:response to cocaine; P:response to hydrogen peroxide; P:response to progesterone; P:rhythmic process; P:sperm entry; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9UEP9,Ubiquitin-protein ligase E3A,E6AP ubiquitin-protein ligase {ECO:0000303|PubMed:17108031};HECT-type ubiquitin transferase E3A;Human papillomavirus E6-associated protein {ECO:0000303|PubMed:8380895};Oncogenic protein-associated protein E6-AP {ECO:0000303|PubMed:8380895};Renal carcinoma antigen NY-REN-54;, PF16558;PF00632;, GO:0005829;GO:0005634;GO:0000502;GO:0046872;GO:0003713;GO:0061630;GO:0004842;GO:0030521;GO:0007420;GO:1990416;GO:0061002;GO:0001541;GO:1905528;GO:0014068;GO:0031398;GO:0045944;GO:0050847;GO:0060736;GO:0051865;GO:0070936;GO:0006508;GO:0042752;GO:2000058;GO:0042220;GO:0042542;GO:0032570;GO:0048511;GO:0035037;GO:0006511;GO:0016032;, C:cytosol; C:nucleus; C:proteasome complex;, F:metal ion binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:androgen receptor signaling pathway; P:brain development; P:cellular response to brain-derived neurotrophic factor stimulus; P:negative regulation of dendritic spine morphogenesis; P:ovarian follicle development; P:positive regulation of Golgi lumen acidification; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:progesterone receptor signaling pathway; P:prostate gland growth; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:proteolysis; P:regulation of circadian rhythm; P:regulation of ubiquitin-dependent protein catabolic process; P:response to cocaine; P:response to hydrogen peroxide; P:response to progesterone; P:rhythmic process; P:sperm entry; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9UEP9,Ubiquitin-protein ligase E3A,E6AP ubiquitin-protein ligase {ECO:0000303|PubMed:17108031};HECT-type ubiquitin transferase E3A;Human papillomavirus E6-associated protein {ECO:0000303|PubMed:8380895};Oncogenic protein-associated protein E6-AP {ECO:0000303|PubMed:8380895};Renal carcinoma antigen NY-REN-54;, PF16558;PF00632;, GO:0005829;GO:0005634;GO:0000502;GO:0046872;GO:0003713;GO:0061630;GO:0004842;GO:0030521;GO:0007420;GO:1990416;GO:0061002;GO:0001541;GO:1905528;GO:0014068;GO:0031398;GO:0045944;GO:0050847;GO:0060736;GO:0051865;GO:0070936;GO:0006508;GO:0042752;GO:2000058;GO:0042220;GO:0042542;GO:0032570;GO:0048511;GO:0035037;GO:0006511;GO:0016032;, C:cytosol; C:nucleus; C:proteasome complex;, F:metal ion binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:androgen receptor signaling pathway; P:brain development; P:cellular response to brain-derived neurotrophic factor stimulus; P:negative regulation of dendritic spine morphogenesis; P:ovarian follicle development; P:positive regulation of Golgi lumen acidification; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:progesterone receptor signaling pathway; P:prostate gland growth; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:proteolysis; P:regulation of circadian rhythm; P:regulation of ubiquitin-dependent protein catabolic process; P:response to cocaine; P:response to hydrogen peroxide; P:response to progesterone; P:rhythmic process; P:sperm entry; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold152 indexed_genome mRNA 760872 775017 . + . ID=transcript_14764;Q9UEP9,Ubiquitin-protein ligase E3A,E6AP ubiquitin-protein ligase {ECO:0000303|PubMed:17108031};HECT-type ubiquitin transferase E3A;Human papillomavirus E6-associated protein {ECO:0000303|PubMed:8380895};Oncogenic protein-associated protein E6-AP {ECO:0000303|PubMed:8380895};Renal carcinoma antigen NY-REN-54;, PF16558;PF00632;, GO:0005829;GO:0005634;GO:0000502;GO:0046872;GO:0003713;GO:0061630;GO:0004842;GO:0030521;GO:0007420;GO:1990416;GO:0061002;GO:0001541;GO:1905528;GO:0014068;GO:0031398;GO:0045944;GO:0050847;GO:0060736;GO:0051865;GO:0070936;GO:0006508;GO:0042752;GO:2000058;GO:0042220;GO:0042542;GO:0032570;GO:0048511;GO:0035037;GO:0006511;GO:0016032;, C:cytosol; C:nucleus; C:proteasome complex;, F:metal ion binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:androgen receptor signaling pathway; P:brain development; P:cellular response to brain-derived neurotrophic factor stimulus; P:negative regulation of dendritic spine morphogenesis; P:ovarian follicle development; P:positive regulation of Golgi lumen acidification; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:progesterone receptor signaling pathway; P:prostate gland growth; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:proteolysis; P:regulation of circadian rhythm; P:regulation of ubiquitin-dependent protein catabolic process; P:response to cocaine; P:response to hydrogen peroxide; P:response to progesterone; P:rhythmic process; P:sperm entry; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9UEP9,Ubiquitin-protein ligase E3A,E6AP ubiquitin-protein ligase {ECO:0000303|PubMed:17108031};HECT-type ubiquitin transferase E3A;Human papillomavirus E6-associated protein {ECO:0000303|PubMed:8380895};Oncogenic protein-associated protein E6-AP {ECO:0000303|PubMed:8380895};Renal carcinoma antigen NY-REN-54;, PF16558;PF00632;, GO:0005829;GO:0005634;GO:0000502;GO:0046872;GO:0003713;GO:0061630;GO:0004842;GO:0030521;GO:0007420;GO:1990416;GO:0061002;GO:0001541;GO:1905528;GO:0014068;GO:0031398;GO:0045944;GO:0050847;GO:0060736;GO:0051865;GO:0070936;GO:0006508;GO:0042752;GO:2000058;GO:0042220;GO:0042542;GO:0032570;GO:0048511;GO:0035037;GO:0006511;GO:0016032;, C:cytosol; C:nucleus; C:proteasome complex;, F:metal ion binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:androgen receptor signaling pathway; P:brain development; P:cellular response to brain-derived neurotrophic factor stimulus; P:negative regulation of dendritic spine morphogenesis; P:ovarian follicle development; P:positive regulation of Golgi lumen acidification; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:progesterone receptor signaling pathway; P:prostate gland growth; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:proteolysis; P:regulation of circadian rhythm; P:regulation of ubiquitin-dependent protein catabolic process; P:response to cocaine; P:response to hydrogen peroxide; P:response to progesterone; P:rhythmic process; P:sperm entry; P:ubiquitin-dependent protein catabolic process; P:viral process;|Q9UEP9,Ubiquitin-protein ligase E3A,E6AP ubiquitin-protein ligase {ECO:0000303|PubMed:17108031};HECT-type ubiquitin transferase E3A;Human papillomavirus E6-associated protein {ECO:0000303|PubMed:8380895};Oncogenic protein-associated protein E6-AP {ECO:0000303|PubMed:8380895};Renal carcinoma antigen NY-REN-54;, PF16558;PF00632;, GO:0005829;GO:0005634;GO:0000502;GO:0046872;GO:0003713;GO:0061630;GO:0004842;GO:0030521;GO:0007420;GO:1990416;GO:0061002;GO:0001541;GO:1905528;GO:0014068;GO:0031398;GO:0045944;GO:0050847;GO:0060736;GO:0051865;GO:0070936;GO:0006508;GO:0042752;GO:2000058;GO:0042220;GO:0042542;GO:0032570;GO:0048511;GO:0035037;GO:0006511;GO:0016032;, C:cytosol; C:nucleus; C:proteasome complex;, F:metal ion binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:androgen receptor signaling pathway; P:brain development; P:cellular response to brain-derived neurotrophic factor stimulus; P:negative regulation of dendritic spine morphogenesis; P:ovarian follicle development; P:positive regulation of Golgi lumen acidification; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:progesterone receptor signaling pathway; P:prostate gland growth; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:proteolysis; P:regulation of circadian rhythm; P:regulation of ubiquitin-dependent protein catabolic process; P:response to cocaine; P:response to hydrogen peroxide; P:response to progesterone; P:rhythmic process; P:sperm entry; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold152 indexed_genome mRNA 1116838 1134386 . - . ID=transcript_14765;P63162 B3KVR1 P14648 P17135 Q0D2Q5,Small nuclear ribonucleoprotein-associated protein N,Sm protein D;Sm protein N;Tissue-specific-splicing protein;, PF01423;, GO:0071013;GO:0005737;GO:0005654;GO:0030532;GO:0005681;GO:0005685;GO:0005686;GO:0071004;GO:0005687;GO:0046540;GO:0005682;GO:0003723;GO:0000398;GO:0009725;GO:0008380;, C:catalytic step 2 spliceosome; C:cytoplasm; C:nucleoplasm; C:small nuclear ribonucleoprotein complex; C:spliceosomal complex; C:U1 snRNP; C:U2 snRNP; C:U2-type prespliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:response to hormone; P:RNA splicing;|P14678 Q15490 Q6IB35 Q9UIS5,Small nuclear ribonucleoprotein-associated proteins B and B',Sm protein B/B';, PF01423;, GO:0071013;GO:0005737;GO:0005829;GO:0071204;GO:0034709;GO:0005654;GO:0005634;GO:0030532;GO:0034719;GO:0005681;GO:0005697;GO:0005685;GO:0005689;GO:0005686;GO:0071007;GO:0071005;GO:0071004;GO:0005687;GO:0046540;GO:0005682;GO:0005683;GO:0071208;GO:0003723;GO:0070034;GO:1990446;GO:1990447;GO:0007420;GO:0008334;GO:0051170;GO:0000398;GO:0006479;GO:0008380;GO:0000387;GO:0006369;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:histone pre-mRNA 3'end processing complex; C:methylosome; C:nucleoplasm; C:nucleus; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal complex; C:telomerase holoenzyme complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:U7 snRNP;, F:histone pre-mRNA DCP binding; F:RNA binding; F:telomerase RNA binding; F:U1 snRNP binding; F:U2 snRNP binding;, P:brain development; P:histone mRNA metabolic process; P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein methylation; P:RNA splicing; P:spliceosomal snRNP assembly; P:termination of RNA polymerase II transcription;|P63162 B3KVR1 P14648 P17135 Q0D2Q5,Small nuclear ribonucleoprotein-associated protein N,Sm protein D;Sm protein N;Tissue-specific-splicing protein;, PF01423;, GO:0071013;GO:0005737;GO:0005654;GO:0030532;GO:0005681;GO:0005685;GO:0005686;GO:0071004;GO:0005687;GO:0046540;GO:0005682;GO:0003723;GO:0000398;GO:0009725;GO:0008380;, C:catalytic step 2 spliceosome; C:cytoplasm; C:nucleoplasm; C:small nuclear ribonucleoprotein complex; C:spliceosomal complex; C:U1 snRNP; C:U2 snRNP; C:U2-type prespliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:response to hormone; P:RNA splicing;|P63162 B3KVR1 P14648 P17135 Q0D2Q5,Small nuclear ribonucleoprotein-associated protein N,Sm protein D;Sm protein N;Tissue-specific-splicing protein;, PF01423;, GO:0071013;GO:0005737;GO:0005654;GO:0030532;GO:0005681;GO:0005685;GO:0005686;GO:0071004;GO:0005687;GO:0046540;GO:0005682;GO:0003723;GO:0000398;GO:0009725;GO:0008380;, C:catalytic step 2 spliceosome; C:cytoplasm; C:nucleoplasm; C:small nuclear ribonucleoprotein complex; C:spliceosomal complex; C:U1 snRNP; C:U2 snRNP; C:U2-type prespliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:RNA binding;, P:mRNA splicing, via spliceosome; P:response to hormone; P:RNA splicing;|Q9Y675 A6NCW2,SNRPN upstream reading frame protein,, PF07192;, GO:0016607;GO:0005634;, C:nuclear speck; C:nucleus; scaffold152 indexed_genome mRNA 1712381 1714054 . + . ID=transcript_14766;Q99608 B2R6Z5,Necdin,, PF01454;, GO:0042995;GO:0005813;GO:0005829;GO:0005654;GO:0043204;GO:0032991;GO:0001228;GO:0043015;GO:1990841;GO:0000978;GO:0048675;GO:0007413;GO:0007417;GO:0019221;GO:0071514;GO:0008347;GO:0048871;GO:0008285;GO:0043433;GO:0000122;GO:0001764;GO:0048011;GO:0090312;GO:0009791;GO:0040008;GO:0003016;GO:0019233;, C:cell projection; C:centrosome; C:cytosol; C:nucleoplasm; C:perikaryon; C:protein-containing complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:gamma-tubulin binding; F:promoter-specific chromatin binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:axon extension; P:axonal fasciculation; P:central nervous system development; P:cytokine-mediated signaling pathway; P:genetic imprinting; P:glial cell migration; P:multicellular organismal homeostasis; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:neuron migration; P:neurotrophin TRK receptor signaling pathway; P:positive regulation of protein deacetylation; P:post-embryonic development; P:regulation of growth; P:respiratory system process; P:sensory perception of pain; scaffold152 indexed_genome mRNA 1753545 1754422 . - . ID=transcript_14767;Q9UJ55 H0YDD5,MAGE-like protein 2,Necdin-like protein 1;Protein nM15;, PF01454;, GO:0005829;GO:0005769;GO:0005768;GO:0005634;GO:0004842;GO:0034314;GO:0045892;GO:0051127;GO:0070534;GO:0042752;GO:0042147;GO:0048511;, C:cytosol; C:early endosome; C:endosome; C:nucleus;, F:ubiquitin-protein transferase activity;, P:Arp2/3 complex-mediated actin nucleation; P:negative regulation of transcription, DNA-templated; P:positive regulation of actin nucleation; P:protein K63-linked ubiquitination; P:regulation of circadian rhythm; P:retrograde transport, endosome to Golgi; P:rhythmic process; scaffold152 indexed_genome mRNA 1754901 1757797 . - . ID=transcript_14768;Q9UJ55 H0YDD5,MAGE-like protein 2,Necdin-like protein 1;Protein nM15;, PF01454;, GO:0005829;GO:0005769;GO:0005768;GO:0005634;GO:0004842;GO:0034314;GO:0045892;GO:0051127;GO:0070534;GO:0042752;GO:0042147;GO:0048511;, C:cytosol; C:early endosome; C:endosome; C:nucleus;, F:ubiquitin-protein transferase activity;, P:Arp2/3 complex-mediated actin nucleation; P:negative regulation of transcription, DNA-templated; P:positive regulation of actin nucleation; P:protein K63-linked ubiquitination; P:regulation of circadian rhythm; P:retrograde transport, endosome to Golgi; P:rhythmic process; scaffold153 indexed_genome mRNA 665864 669234 . + . ID=transcript_14769;Q13495 B2RCQ4 B4DG93 B9EGA5,Mastermind-like domain-containing protein 1,F18;Protein CG1;, , GO:0005813;GO:0005794;GO:0016604;GO:0005654;GO:0008584;GO:0006357;, C:centrosome; C:Golgi apparatus; C:nuclear body; C:nucleoplasm;, , P:male gonad development; P:regulation of transcription by RNA polymerase II; scaffold153 indexed_genome mRNA 692979 701349 . + . ID=transcript_14770;Q13495 B2RCQ4 B4DG93 B9EGA5,Mastermind-like domain-containing protein 1,F18;Protein CG1;, , GO:0005813;GO:0005794;GO:0016604;GO:0005654;GO:0008584;GO:0006357;, C:centrosome; C:Golgi apparatus; C:nuclear body; C:nucleoplasm;, , P:male gonad development; P:regulation of transcription by RNA polymerase II; scaffold153 indexed_genome mRNA 776027 844384 . + . ID=transcript_14771;Q13496 A6NDB1 B7Z491 F2Z330 Q8NEL1,Myotubularin {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;, PF02893;PF06602;, GO:0005737;GO:0005829;GO:0030175;GO:0031674;GO:0005770;GO:0005886;GO:0001726;GO:0019215;GO:0035091;GO:0052629;GO:0004438;GO:0004721;GO:0004725;GO:0008333;GO:0045109;GO:0048311;GO:0070584;GO:0046716;GO:1902902;GO:0032435;GO:0051898;GO:0032007;GO:0006661;GO:0046856;GO:0048633;GO:0006470;GO:0015031;GO:0044088;, C:cytoplasm; C:cytosol; C:filopodium; C:I band; C:late endosome; C:plasma membrane; C:ruffle;, F:intermediate filament binding; F:phosphatidylinositol binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;, P:endosome to lysosome transport; P:intermediate filament organization; P:mitochondrion distribution; P:mitochondrion morphogenesis; P:muscle cell cellular homeostasis; P:negative regulation of autophagosome assembly; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein kinase B signaling; P:negative regulation of TOR signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of skeletal muscle tissue growth; P:protein dephosphorylation; P:protein transport; P:regulation of vacuole organization; scaffold153 indexed_genome mRNA 876561 937894 . + . ID=transcript_14772;Q13613 A0A024RC07 Q9UBX6 Q9UEM0 Q9UQD5,Myotubularin-related protein 1 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;, PF02893;PF06602;, GO:0005737;GO:0005829;GO:0005886;GO:0052629;GO:0004438;GO:0042803;GO:0004725;GO:0006661;GO:0046856;GO:0060304;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein homodimerization activity; F:protein tyrosine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:regulation of phosphatidylinositol dephosphorylation;|Q13613 A0A024RC07 Q9UBX6 Q9UEM0 Q9UQD5,Myotubularin-related protein 1 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;, PF02893;PF06602;, GO:0005737;GO:0005829;GO:0005886;GO:0052629;GO:0004438;GO:0042803;GO:0004725;GO:0006661;GO:0046856;GO:0060304;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein homodimerization activity; F:protein tyrosine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:regulation of phosphatidylinositol dephosphorylation;|Q13613 A0A024RC07 Q9UBX6 Q9UEM0 Q9UQD5,Myotubularin-related protein 1 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;, PF02893;PF06602;, GO:0005737;GO:0005829;GO:0005886;GO:0052629;GO:0004438;GO:0042803;GO:0004725;GO:0006661;GO:0046856;GO:0060304;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein homodimerization activity; F:protein tyrosine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:regulation of phosphatidylinositol dephosphorylation;|Q13613 A0A024RC07 Q9UBX6 Q9UEM0 Q9UQD5,Myotubularin-related protein 1 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;, PF02893;PF06602;, GO:0005737;GO:0005829;GO:0005886;GO:0052629;GO:0004438;GO:0042803;GO:0004725;GO:0006661;GO:0046856;GO:0060304;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein homodimerization activity; F:protein tyrosine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:regulation of phosphatidylinositol dephosphorylation;|Q13613 A0A024RC07 Q9UBX6 Q9UEM0 Q9UQD5,Myotubularin-related protein 1 {ECO:0000305},Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;, PF02893;PF06602;, GO:0005737;GO:0005829;GO:0005886;GO:0052629;GO:0004438;GO:0042803;GO:0004725;GO:0006661;GO:0046856;GO:0060304;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein homodimerization activity; F:protein tyrosine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:regulation of phosphatidylinositol dephosphorylation;|Q8TCZ1 Q9BQG9,CD99 antigen-like protein 2,MIC2-like protein 1;, PF12301;, GO:0005912;GO:0009986;GO:0005925;GO:0016021;GO:0005886;GO:0007155;GO:0050904;GO:2000391;GO:2000409;, C:adherens junction; C:cell surface; C:focal adhesion; C:integral component of membrane; C:plasma membrane;, , P:cell adhesion; P:diapedesis; P:positive regulation of neutrophil extravasation; P:positive regulation of T cell extravasation;|Q8TCZ1 Q9BQG9,CD99 antigen-like protein 2,MIC2-like protein 1;, PF12301;, GO:0005912;GO:0009986;GO:0005925;GO:0016021;GO:0005886;GO:0007155;GO:0050904;GO:2000391;GO:2000409;, C:adherens junction; C:cell surface; C:focal adhesion; C:integral component of membrane; C:plasma membrane;, , P:cell adhesion; P:diapedesis; P:positive regulation of neutrophil extravasation; P:positive regulation of T cell extravasation; scaffold153 indexed_genome mRNA 1393657 1406633 . + . ID=transcript_14773;Q3ZAQ7 A6NKV7 B3KUA9,Vacuolar ATPase assembly integral membrane protein VMA21 {ECO:0000255|HAMAP-Rule:MF_03058},Myopathy with excessive autophagy protein;, PF09446;, GO:0005789;GO:0033116;GO:0012507;GO:0016021;GO:0005764;GO:0005773;GO:0043462;GO:0070072;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:integral component of membrane; C:lysosome; C:vacuole;, , P:regulation of ATPase activity; P:vacuolar proton-transporting V-type ATPase complex assembly;|Q3ZAQ7 A6NKV7 B3KUA9,Vacuolar ATPase assembly integral membrane protein VMA21 {ECO:0000255|HAMAP-Rule:MF_03058},Myopathy with excessive autophagy protein;, PF09446;, GO:0005789;GO:0033116;GO:0012507;GO:0016021;GO:0005764;GO:0005773;GO:0043462;GO:0070072;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:integral component of membrane; C:lysosome; C:vacuole;, , P:regulation of ATPase activity; P:vacuolar proton-transporting V-type ATPase complex assembly; scaffold153 indexed_genome mRNA 1681702 1686307 . + . ID=transcript_14774;Q9BZD7 A1A523 A1A575 Q8N2N6,Transmembrane gamma-carboxyglutamic acid protein 3,Proline-rich gamma-carboxyglutamic acid protein 3;, PF00594;, GO:0005576;GO:0016021;GO:0005509;, C:extracellular region; C:integral component of membrane;, F:calcium ion binding; scaffold154 indexed_genome mRNA 33867 49962 . - . ID=transcript_14775;Q8IW93 A6NJ04 Q5TEV2 Q6PJQ4 Q8N244,Rho guanine nucleotide exchange factor 19,Ephexin-2;, PF00621;PF14604;, GO:0005829;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0043065;GO:0032956;GO:0051056;GO:0060071;GO:0042060;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing;|Q8IW93 A6NJ04 Q5TEV2 Q6PJQ4 Q8N244,Rho guanine nucleotide exchange factor 19,Ephexin-2;, PF00621;PF14604;, GO:0005829;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0043065;GO:0032956;GO:0051056;GO:0060071;GO:0042060;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing;|Q8IW93 A6NJ04 Q5TEV2 Q6PJQ4 Q8N244,Rho guanine nucleotide exchange factor 19,Ephexin-2;, PF00621;PF14604;, GO:0005829;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0043065;GO:0032956;GO:0051056;GO:0060071;GO:0042060;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing;|Q8IW93 A6NJ04 Q5TEV2 Q6PJQ4 Q8N244,Rho guanine nucleotide exchange factor 19,Ephexin-2;, PF00621;PF14604;, GO:0005829;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0043065;GO:0032956;GO:0051056;GO:0060071;GO:0042060;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing;|Q8IW93 A6NJ04 Q5TEV2 Q6PJQ4 Q8N244,Rho guanine nucleotide exchange factor 19,Ephexin-2;, PF00621;PF14604;, GO:0005829;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0043065;GO:0032956;GO:0051056;GO:0060071;GO:0042060;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing;|Q8IW93 A6NJ04 Q5TEV2 Q6PJQ4 Q8N244,Rho guanine nucleotide exchange factor 19,Ephexin-2;, PF00621;PF14604;, GO:0005829;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0043065;GO:0032956;GO:0051056;GO:0060071;GO:0042060;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing;|Q8IW93 A6NJ04 Q5TEV2 Q6PJQ4 Q8N244,Rho guanine nucleotide exchange factor 19,Ephexin-2;, PF00621;PF14604;, GO:0005829;GO:0005096;GO:0005085;GO:0090630;GO:0007186;GO:0043065;GO:0032956;GO:0051056;GO:0060071;GO:0042060;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; P:wound healing; scaffold154 indexed_genome mRNA 67211 72029 . - . ID=transcript_14776;Q9BU20 Q5TEV7,Ciliogenesis and planar polarity effector 2 {ECO:0000305},REM2- and Rab-like small GTPase 1 {ECO:0000250|UniProtKB:Q6GNL4};, PF00071;, GO:0036064;GO:0005737;GO:0005525;GO:0003924;GO:0034613;GO:0060271;GO:0006887;GO:0015031;GO:0017157;GO:0031338;, C:ciliary basal body; C:cytoplasm;, F:GTP binding; F:GTPase activity;, P:cellular protein localization; P:cilium assembly; P:exocytosis; P:protein transport; P:regulation of exocytosis; P:regulation of vesicle fusion; scaffold154 indexed_genome mRNA 81718 171138 . + . ID=transcript_14777;Q6P3S6 B3KP30 Q5TEU8 Q86XI0 Q8N3N4 Q8N5F8 Q9BRM0 Q9P2L4,F-box only protein 42,Just one F-box and Kelch domain-containing protein;, PF12937;PF07646;|Q6P3S6 B3KP30 Q5TEU8 Q86XI0 Q8N3N4 Q8N5F8 Q9BRM0 Q9P2L4,F-box only protein 42,Just one F-box and Kelch domain-containing protein;, PF12937;PF07646;|Q6P3S6 B3KP30 Q5TEU8 Q86XI0 Q8N3N4 Q8N5F8 Q9BRM0 Q9P2L4,F-box only protein 42,Just one F-box and Kelch domain-containing protein;, PF12937;PF07646;|Q6P3S6 B3KP30 Q5TEU8 Q86XI0 Q8N3N4 Q8N5F8 Q9BRM0 Q9P2L4,F-box only protein 42,Just one F-box and Kelch domain-containing protein;, PF12937;PF07646;|Q6P3S6 B3KP30 Q5TEU8 Q86XI0 Q8N3N4 Q8N5F8 Q9BRM0 Q9P2L4,F-box only protein 42,Just one F-box and Kelch domain-containing protein;, PF12937;PF07646;|Q6P3S6 B3KP30 Q5TEU8 Q86XI0 Q8N3N4 Q8N5F8 Q9BRM0 Q9P2L4,F-box only protein 42,Just one F-box and Kelch domain-containing protein;, PF12937;PF07646;|Q6P3S6 B3KP30 Q5TEU8 Q86XI0 Q8N3N4 Q8N5F8 Q9BRM0 Q9P2L4,F-box only protein 42,Just one F-box and Kelch domain-containing protein;, PF12937;PF07646; scaffold154 indexed_genome mRNA 190507 195175 . - . ID=transcript_14778;P63132,Endogenous retrovirus group K member 113 Pol protein,HERV-K113 Pol protein;HERV-K_19p13.11 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold154 indexed_genome mRNA 215075 219354 . + . ID=transcript_14779;Q7Z422 A8MXJ2 C9K0U0 Q7Z424 Q8IVM2 Q8TBV3 Q9Y403,SUZ domain-containing protein 1,Putative MAPK-activating protein PM18/PM20/PM22;, PF12752;PF12901; scaffold154 indexed_genome mRNA 220767 221972 . - . ID=transcript_14780;Q7Z572 B9EK40 F5GXP5,Spermatogenesis-associated protein 21,, , GO:0005509;, , F:calcium ion binding; scaffold154 indexed_genome mRNA 269583 282187 . - . ID=transcript_14781;Q9NVZ3 B4DY19 E9PGQ8 Q5VSU4 Q5VSU5 Q9H7L1 Q9H8L1,Adaptin ear-binding coat-associated protein 2,NECAP endocytosis-associated protein 2;, PF07933;, GO:0030125;GO:0005905;GO:0006897;GO:0015031;GO:0016192;, C:clathrin vesicle coat; C:clathrin-coated pit;, , P:endocytosis; P:protein transport; P:vesicle-mediated transport; scaffold154 indexed_genome mRNA 304731 323754 . - . ID=transcript_14782;Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle;|Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle;|Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle;|Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle;|Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle;|Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle; scaffold154 indexed_genome mRNA 325637 346739 . + . ID=transcript_14783;Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle;|Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle;|Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle;|Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle;|Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle;|Q5TZA2 Q2VHY3 Q66GT7 Q7Z2L4 Q7Z5D7,Rootletin,Ciliary rootlet coiled-coil protein;, , GO:0097729;GO:0015629;GO:0005814;GO:0005813;GO:0035253;GO:0005829;GO:0070062;GO:0001917;GO:0005886;GO:0120219;GO:0003779;GO:0019894;GO:0005200;GO:0005198;GO:0010457;GO:0007098;GO:0032053;GO:0010669;GO:0051656;GO:0045494;GO:0045724;GO:1903566;GO:0008104;GO:0033365;, C:9+2 motile cilium; C:actin cytoskeleton; C:centriole; C:centrosome; C:ciliary rootlet; C:cytosol; C:extracellular exosome; C:photoreceptor inner segment; C:plasma membrane; C:subapical part of cell;, F:actin binding; F:kinesin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:centriole-centriole cohesion; P:centrosome cycle; P:ciliary basal body organization; P:epithelial structure maintenance; P:establishment of organelle localization; P:photoreceptor cell maintenance; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein localization; P:protein localization to organelle; scaffold154 indexed_genome mRNA 347928 354258 . - . ID=transcript_14784;P55001 Q53X60 Q5JXY0,Microfibrillar-associated protein 2,Microfibril-associated glycoprotein 1;, PF05507;PF01549;, GO:0062023;GO:0005576;GO:0001527;GO:0048048;GO:0030198;GO:0120162;GO:0048050;, C:collagen-containing extracellular matrix; C:extracellular region; C:microfibril;, , P:embryonic eye morphogenesis; P:extracellular matrix organization; P:positive regulation of cold-induced thermogenesis; P:post-embryonic eye morphogenesis;|P55001 Q53X60 Q5JXY0,Microfibrillar-associated protein 2,Microfibril-associated glycoprotein 1;, PF05507;PF01549;, GO:0062023;GO:0005576;GO:0001527;GO:0048048;GO:0030198;GO:0120162;GO:0048050;, C:collagen-containing extracellular matrix; C:extracellular region; C:microfibril;, , P:embryonic eye morphogenesis; P:extracellular matrix organization; P:positive regulation of cold-induced thermogenesis; P:post-embryonic eye morphogenesis;|P55001 Q53X60 Q5JXY0,Microfibrillar-associated protein 2,Microfibril-associated glycoprotein 1;, PF05507;PF01549;, GO:0062023;GO:0005576;GO:0001527;GO:0048048;GO:0030198;GO:0120162;GO:0048050;, C:collagen-containing extracellular matrix; C:extracellular region; C:microfibril;, , P:embryonic eye morphogenesis; P:extracellular matrix organization; P:positive regulation of cold-induced thermogenesis; P:post-embryonic eye morphogenesis;|P55001 Q53X60 Q5JXY0,Microfibrillar-associated protein 2,Microfibril-associated glycoprotein 1;, PF05507;PF01549;, GO:0062023;GO:0005576;GO:0001527;GO:0048048;GO:0030198;GO:0120162;GO:0048050;, C:collagen-containing extracellular matrix; C:extracellular region; C:microfibril;, , P:embryonic eye morphogenesis; P:extracellular matrix organization; P:positive regulation of cold-induced thermogenesis; P:post-embryonic eye morphogenesis; scaffold154 indexed_genome mRNA 357075 375608 . - . ID=transcript_14785;Q9NQ11 O75700 Q5JXY1 Q5JXY2 Q6S9Z9,Polyamine-transporting ATPase 13A2 {ECO:0000305|PubMed:31996848},, PF12409;, GO:0005776;GO:0000421;GO:1905103;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0005771;GO:0032585;GO:0043005;GO:0043025;GO:0030133;GO:0031982;GO:0012506;GO:0015417;GO:0005524;GO:0016887;GO:1903135;GO:0030145;GO:0070300;GO:0080025;GO:0008270;GO:1905037;GO:0061909;GO:0006914;GO:0006874;GO:0030003;GO:0006879;GO:0071287;GO:0034599;GO:0071294;GO:0006882;GO:0097734;GO:0034220;GO:0055088;GO:0007041;GO:1905166;GO:1901215;GO:1990938;GO:1902047;GO:1903543;GO:0010628;GO:0050714;GO:0046777;GO:0061462;GO:0016243;GO:1903146;GO:1904714;GO:0052548;GO:1905123;GO:0033157;GO:1905165;GO:0016241;GO:0010821;GO:1900180;GO:2000152;GO:1903710;GO:0055069;, C:autophagosome; C:autophagosome membrane; C:integral component of lysosomal membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:multivesicular body; C:multivesicular body membrane; C:neuron projection; C:neuronal cell body; C:transport vesicle; C:vesicle; C:vesicle membrane;, F:ABC-type polyamine transporter activity; F:ATP binding; F:ATPase activity; F:cupric ion binding; F:manganese ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:zinc ion binding;, P:autophagosome organization; P:autophagosome-lysosome fusion; P:autophagy; P:cellular calcium ion homeostasis; P:cellular cation homeostasis; P:cellular iron ion homeostasis; P:cellular response to manganese ion; P:cellular response to oxidative stress; P:cellular response to zinc ion; P:cellular zinc ion homeostasis; P:extracellular exosome biogenesis; P:ion transmembrane transport; P:lipid homeostasis; P:lysosomal transport; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of neuron death; P:peptidyl-aspartic acid autophosphorylation; P:polyamine transmembrane transport; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein autophosphorylation; P:protein localization to lysosome; P:regulation of autophagosome size; P:regulation of autophagy of mitochondrion; P:regulation of chaperone-mediated autophagy; P:regulation of endopeptidase activity; P:regulation of glucosylceramidase activity; P:regulation of intracellular protein transport; P:regulation of lysosomal protein catabolic process; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of protein localization to nucleus; P:regulation of ubiquitin-specific protease activity; P:spermine transmembrane transport; P:zinc ion homeostasis;|Q9NQ11 O75700 Q5JXY1 Q5JXY2 Q6S9Z9,Polyamine-transporting ATPase 13A2 {ECO:0000305|PubMed:31996848},, PF12409;, GO:0005776;GO:0000421;GO:1905103;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0005771;GO:0032585;GO:0043005;GO:0043025;GO:0030133;GO:0031982;GO:0012506;GO:0015417;GO:0005524;GO:0016887;GO:1903135;GO:0030145;GO:0070300;GO:0080025;GO:0008270;GO:1905037;GO:0061909;GO:0006914;GO:0006874;GO:0030003;GO:0006879;GO:0071287;GO:0034599;GO:0071294;GO:0006882;GO:0097734;GO:0034220;GO:0055088;GO:0007041;GO:1905166;GO:1901215;GO:1990938;GO:1902047;GO:1903543;GO:0010628;GO:0050714;GO:0046777;GO:0061462;GO:0016243;GO:1903146;GO:1904714;GO:0052548;GO:1905123;GO:0033157;GO:1905165;GO:0016241;GO:0010821;GO:1900180;GO:2000152;GO:1903710;GO:0055069;, C:autophagosome; C:autophagosome membrane; C:integral component of lysosomal membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:multivesicular body; C:multivesicular body membrane; C:neuron projection; C:neuronal cell body; C:transport vesicle; C:vesicle; C:vesicle membrane;, F:ABC-type polyamine transporter activity; F:ATP binding; F:ATPase activity; F:cupric ion binding; F:manganese ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:zinc ion binding;, P:autophagosome organization; P:autophagosome-lysosome fusion; P:autophagy; P:cellular calcium ion homeostasis; P:cellular cation homeostasis; P:cellular iron ion homeostasis; P:cellular response to manganese ion; P:cellular response to oxidative stress; P:cellular response to zinc ion; P:cellular zinc ion homeostasis; P:extracellular exosome biogenesis; P:ion transmembrane transport; P:lipid homeostasis; P:lysosomal transport; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of neuron death; P:peptidyl-aspartic acid autophosphorylation; P:polyamine transmembrane transport; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein autophosphorylation; P:protein localization to lysosome; P:regulation of autophagosome size; P:regulation of autophagy of mitochondrion; P:regulation of chaperone-mediated autophagy; P:regulation of endopeptidase activity; P:regulation of glucosylceramidase activity; P:regulation of intracellular protein transport; P:regulation of lysosomal protein catabolic process; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of protein localization to nucleus; P:regulation of ubiquitin-specific protease activity; P:spermine transmembrane transport; P:zinc ion homeostasis;|Q9NQ11 O75700 Q5JXY1 Q5JXY2 Q6S9Z9,Polyamine-transporting ATPase 13A2 {ECO:0000305|PubMed:31996848},, PF12409;, GO:0005776;GO:0000421;GO:1905103;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0005771;GO:0032585;GO:0043005;GO:0043025;GO:0030133;GO:0031982;GO:0012506;GO:0015417;GO:0005524;GO:0016887;GO:1903135;GO:0030145;GO:0070300;GO:0080025;GO:0008270;GO:1905037;GO:0061909;GO:0006914;GO:0006874;GO:0030003;GO:0006879;GO:0071287;GO:0034599;GO:0071294;GO:0006882;GO:0097734;GO:0034220;GO:0055088;GO:0007041;GO:1905166;GO:1901215;GO:1990938;GO:1902047;GO:1903543;GO:0010628;GO:0050714;GO:0046777;GO:0061462;GO:0016243;GO:1903146;GO:1904714;GO:0052548;GO:1905123;GO:0033157;GO:1905165;GO:0016241;GO:0010821;GO:1900180;GO:2000152;GO:1903710;GO:0055069;, C:autophagosome; C:autophagosome membrane; C:integral component of lysosomal membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:multivesicular body; C:multivesicular body membrane; C:neuron projection; C:neuronal cell body; C:transport vesicle; C:vesicle; C:vesicle membrane;, F:ABC-type polyamine transporter activity; F:ATP binding; F:ATPase activity; F:cupric ion binding; F:manganese ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:zinc ion binding;, P:autophagosome organization; P:autophagosome-lysosome fusion; P:autophagy; P:cellular calcium ion homeostasis; P:cellular cation homeostasis; P:cellular iron ion homeostasis; P:cellular response to manganese ion; P:cellular response to oxidative stress; P:cellular response to zinc ion; P:cellular zinc ion homeostasis; P:extracellular exosome biogenesis; P:ion transmembrane transport; P:lipid homeostasis; P:lysosomal transport; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of neuron death; P:peptidyl-aspartic acid autophosphorylation; P:polyamine transmembrane transport; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein autophosphorylation; P:protein localization to lysosome; P:regulation of autophagosome size; P:regulation of autophagy of mitochondrion; P:regulation of chaperone-mediated autophagy; P:regulation of endopeptidase activity; P:regulation of glucosylceramidase activity; P:regulation of intracellular protein transport; P:regulation of lysosomal protein catabolic process; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of protein localization to nucleus; P:regulation of ubiquitin-specific protease activity; P:spermine transmembrane transport; P:zinc ion homeostasis;|Q9NQ11 O75700 Q5JXY1 Q5JXY2 Q6S9Z9,Polyamine-transporting ATPase 13A2 {ECO:0000305|PubMed:31996848},, PF12409;, GO:0005776;GO:0000421;GO:1905103;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0005771;GO:0032585;GO:0043005;GO:0043025;GO:0030133;GO:0031982;GO:0012506;GO:0015417;GO:0005524;GO:0016887;GO:1903135;GO:0030145;GO:0070300;GO:0080025;GO:0008270;GO:1905037;GO:0061909;GO:0006914;GO:0006874;GO:0030003;GO:0006879;GO:0071287;GO:0034599;GO:0071294;GO:0006882;GO:0097734;GO:0034220;GO:0055088;GO:0007041;GO:1905166;GO:1901215;GO:1990938;GO:1902047;GO:1903543;GO:0010628;GO:0050714;GO:0046777;GO:0061462;GO:0016243;GO:1903146;GO:1904714;GO:0052548;GO:1905123;GO:0033157;GO:1905165;GO:0016241;GO:0010821;GO:1900180;GO:2000152;GO:1903710;GO:0055069;, C:autophagosome; C:autophagosome membrane; C:integral component of lysosomal membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:multivesicular body; C:multivesicular body membrane; C:neuron projection; C:neuronal cell body; C:transport vesicle; C:vesicle; C:vesicle membrane;, F:ABC-type polyamine transporter activity; F:ATP binding; F:ATPase activity; F:cupric ion binding; F:manganese ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:zinc ion binding;, P:autophagosome organization; P:autophagosome-lysosome fusion; P:autophagy; P:cellular calcium ion homeostasis; P:cellular cation homeostasis; P:cellular iron ion homeostasis; P:cellular response to manganese ion; P:cellular response to oxidative stress; P:cellular response to zinc ion; P:cellular zinc ion homeostasis; P:extracellular exosome biogenesis; P:ion transmembrane transport; P:lipid homeostasis; P:lysosomal transport; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of neuron death; P:peptidyl-aspartic acid autophosphorylation; P:polyamine transmembrane transport; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein autophosphorylation; P:protein localization to lysosome; P:regulation of autophagosome size; P:regulation of autophagy of mitochondrion; P:regulation of chaperone-mediated autophagy; P:regulation of endopeptidase activity; P:regulation of glucosylceramidase activity; P:regulation of intracellular protein transport; P:regulation of lysosomal protein catabolic process; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of protein localization to nucleus; P:regulation of ubiquitin-specific protease activity; P:spermine transmembrane transport; P:zinc ion homeostasis;|Q9NQ11 O75700 Q5JXY1 Q5JXY2 Q6S9Z9,Polyamine-transporting ATPase 13A2 {ECO:0000305|PubMed:31996848},, PF12409;, GO:0005776;GO:0000421;GO:1905103;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0005771;GO:0032585;GO:0043005;GO:0043025;GO:0030133;GO:0031982;GO:0012506;GO:0015417;GO:0005524;GO:0016887;GO:1903135;GO:0030145;GO:0070300;GO:0080025;GO:0008270;GO:1905037;GO:0061909;GO:0006914;GO:0006874;GO:0030003;GO:0006879;GO:0071287;GO:0034599;GO:0071294;GO:0006882;GO:0097734;GO:0034220;GO:0055088;GO:0007041;GO:1905166;GO:1901215;GO:1990938;GO:1902047;GO:1903543;GO:0010628;GO:0050714;GO:0046777;GO:0061462;GO:0016243;GO:1903146;GO:1904714;GO:0052548;GO:1905123;GO:0033157;GO:1905165;GO:0016241;GO:0010821;GO:1900180;GO:2000152;GO:1903710;GO:0055069;, C:autophagosome; C:autophagosome membrane; C:integral component of lysosomal membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:multivesicular body; C:multivesicular body membrane; C:neuron projection; C:neuronal cell body; C:transport vesicle; C:vesicle; C:vesicle membrane;, F:ABC-type polyamine transporter activity; F:ATP binding; F:ATPase activity; F:cupric ion binding; F:manganese ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:zinc ion binding;, P:autophagosome organization; P:autophagosome-lysosome fusion; P:autophagy; P:cellular calcium ion homeostasis; P:cellular cation homeostasis; P:cellular iron ion homeostasis; P:cellular response to manganese ion; P:cellular response to oxidative stress; P:cellular response to zinc ion; P:cellular zinc ion homeostasis; P:extracellular exosome biogenesis; P:ion transmembrane transport; P:lipid homeostasis; P:lysosomal transport; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of neuron death; P:peptidyl-aspartic acid autophosphorylation; P:polyamine transmembrane transport; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein autophosphorylation; P:protein localization to lysosome; P:regulation of autophagosome size; P:regulation of autophagy of mitochondrion; P:regulation of chaperone-mediated autophagy; P:regulation of endopeptidase activity; P:regulation of glucosylceramidase activity; P:regulation of intracellular protein transport; P:regulation of lysosomal protein catabolic process; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of protein localization to nucleus; P:regulation of ubiquitin-specific protease activity; P:spermine transmembrane transport; P:zinc ion homeostasis;|Q9NQ11 O75700 Q5JXY1 Q5JXY2 Q6S9Z9,Polyamine-transporting ATPase 13A2 {ECO:0000305|PubMed:31996848},, PF12409;, GO:0005776;GO:0000421;GO:1905103;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0005771;GO:0032585;GO:0043005;GO:0043025;GO:0030133;GO:0031982;GO:0012506;GO:0015417;GO:0005524;GO:0016887;GO:1903135;GO:0030145;GO:0070300;GO:0080025;GO:0008270;GO:1905037;GO:0061909;GO:0006914;GO:0006874;GO:0030003;GO:0006879;GO:0071287;GO:0034599;GO:0071294;GO:0006882;GO:0097734;GO:0034220;GO:0055088;GO:0007041;GO:1905166;GO:1901215;GO:1990938;GO:1902047;GO:1903543;GO:0010628;GO:0050714;GO:0046777;GO:0061462;GO:0016243;GO:1903146;GO:1904714;GO:0052548;GO:1905123;GO:0033157;GO:1905165;GO:0016241;GO:0010821;GO:1900180;GO:2000152;GO:1903710;GO:0055069;, C:autophagosome; C:autophagosome membrane; C:integral component of lysosomal membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:multivesicular body; C:multivesicular body membrane; C:neuron projection; C:neuronal cell body; C:transport vesicle; C:vesicle; C:vesicle membrane;, F:ABC-type polyamine transporter activity; F:ATP binding; F:ATPase activity; F:cupric ion binding; F:manganese ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:zinc ion binding;, P:autophagosome organization; P:autophagosome-lysosome fusion; P:autophagy; P:cellular calcium ion homeostasis; P:cellular cation homeostasis; P:cellular iron ion homeostasis; P:cellular response to manganese ion; P:cellular response to oxidative stress; P:cellular response to zinc ion; P:cellular zinc ion homeostasis; P:extracellular exosome biogenesis; P:ion transmembrane transport; P:lipid homeostasis; P:lysosomal transport; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of neuron death; P:peptidyl-aspartic acid autophosphorylation; P:polyamine transmembrane transport; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein autophosphorylation; P:protein localization to lysosome; P:regulation of autophagosome size; P:regulation of autophagy of mitochondrion; P:regulation of chaperone-mediated autophagy; P:regulation of endopeptidase activity; P:regulation of glucosylceramidase activity; P:regulation of intracellular protein transport; P:regulation of lysosomal protein catabolic process; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of protein localization to nucleus; P:regulation of ubiquitin-specific protease activity; P:spermine transmembrane transport; P:zinc ion homeostasis;|Q9NQ11 O75700 Q5JXY1 Q5JXY2 Q6S9Z9,Polyamine-transporting ATPase 13A2 {ECO:0000305|PubMed:31996848},, PF12409;, GO:0005776;GO:0000421;GO:1905103;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0005771;GO:0032585;GO:0043005;GO:0043025;GO:0030133;GO:0031982;GO:0012506;GO:0015417;GO:0005524;GO:0016887;GO:1903135;GO:0030145;GO:0070300;GO:0080025;GO:0008270;GO:1905037;GO:0061909;GO:0006914;GO:0006874;GO:0030003;GO:0006879;GO:0071287;GO:0034599;GO:0071294;GO:0006882;GO:0097734;GO:0034220;GO:0055088;GO:0007041;GO:1905166;GO:1901215;GO:1990938;GO:1902047;GO:1903543;GO:0010628;GO:0050714;GO:0046777;GO:0061462;GO:0016243;GO:1903146;GO:1904714;GO:0052548;GO:1905123;GO:0033157;GO:1905165;GO:0016241;GO:0010821;GO:1900180;GO:2000152;GO:1903710;GO:0055069;, C:autophagosome; C:autophagosome membrane; C:integral component of lysosomal membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:multivesicular body; C:multivesicular body membrane; C:neuron projection; C:neuronal cell body; C:transport vesicle; C:vesicle; C:vesicle membrane;, F:ABC-type polyamine transporter activity; F:ATP binding; F:ATPase activity; F:cupric ion binding; F:manganese ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:zinc ion binding;, P:autophagosome organization; P:autophagosome-lysosome fusion; P:autophagy; P:cellular calcium ion homeostasis; P:cellular cation homeostasis; P:cellular iron ion homeostasis; P:cellular response to manganese ion; P:cellular response to oxidative stress; P:cellular response to zinc ion; P:cellular zinc ion homeostasis; P:extracellular exosome biogenesis; P:ion transmembrane transport; P:lipid homeostasis; P:lysosomal transport; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of neuron death; P:peptidyl-aspartic acid autophosphorylation; P:polyamine transmembrane transport; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein autophosphorylation; P:protein localization to lysosome; P:regulation of autophagosome size; P:regulation of autophagy of mitochondrion; P:regulation of chaperone-mediated autophagy; P:regulation of endopeptidase activity; P:regulation of glucosylceramidase activity; P:regulation of intracellular protein transport; P:regulation of lysosomal protein catabolic process; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of protein localization to nucleus; P:regulation of ubiquitin-specific protease activity; P:spermine transmembrane transport; P:zinc ion homeostasis;|Q9NQ11 O75700 Q5JXY1 Q5JXY2 Q6S9Z9,Polyamine-transporting ATPase 13A2 {ECO:0000305|PubMed:31996848},, PF12409;, GO:0005776;GO:0000421;GO:1905103;GO:0016021;GO:0005770;GO:0043202;GO:0005765;GO:0005764;GO:0005771;GO:0032585;GO:0043005;GO:0043025;GO:0030133;GO:0031982;GO:0012506;GO:0015417;GO:0005524;GO:0016887;GO:1903135;GO:0030145;GO:0070300;GO:0080025;GO:0008270;GO:1905037;GO:0061909;GO:0006914;GO:0006874;GO:0030003;GO:0006879;GO:0071287;GO:0034599;GO:0071294;GO:0006882;GO:0097734;GO:0034220;GO:0055088;GO:0007041;GO:1905166;GO:1901215;GO:1990938;GO:1902047;GO:1903543;GO:0010628;GO:0050714;GO:0046777;GO:0061462;GO:0016243;GO:1903146;GO:1904714;GO:0052548;GO:1905123;GO:0033157;GO:1905165;GO:0016241;GO:0010821;GO:1900180;GO:2000152;GO:1903710;GO:0055069;, C:autophagosome; C:autophagosome membrane; C:integral component of lysosomal membrane; C:integral component of membrane; C:late endosome; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:multivesicular body; C:multivesicular body membrane; C:neuron projection; C:neuronal cell body; C:transport vesicle; C:vesicle; C:vesicle membrane;, F:ABC-type polyamine transporter activity; F:ATP binding; F:ATPase activity; F:cupric ion binding; F:manganese ion binding; F:phosphatidic acid binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:zinc ion binding;, P:autophagosome organization; P:autophagosome-lysosome fusion; P:autophagy; P:cellular calcium ion homeostasis; P:cellular cation homeostasis; P:cellular iron ion homeostasis; P:cellular response to manganese ion; P:cellular response to oxidative stress; P:cellular response to zinc ion; P:cellular zinc ion homeostasis; P:extracellular exosome biogenesis; P:ion transmembrane transport; P:lipid homeostasis; P:lysosomal transport; P:negative regulation of lysosomal protein catabolic process; P:negative regulation of neuron death; P:peptidyl-aspartic acid autophosphorylation; P:polyamine transmembrane transport; P:positive regulation of exosomal secretion; P:positive regulation of gene expression; P:positive regulation of protein secretion; P:protein autophosphorylation; P:protein localization to lysosome; P:regulation of autophagosome size; P:regulation of autophagy of mitochondrion; P:regulation of chaperone-mediated autophagy; P:regulation of endopeptidase activity; P:regulation of glucosylceramidase activity; P:regulation of intracellular protein transport; P:regulation of lysosomal protein catabolic process; P:regulation of macroautophagy; P:regulation of mitochondrion organization; P:regulation of protein localization to nucleus; P:regulation of ubiquitin-specific protease activity; P:spermine transmembrane transport; P:zinc ion homeostasis; scaffold154 indexed_genome mRNA 393143 423491 . - . ID=transcript_14786;P21912 B2R545 Q0QEY7 Q9NQ12,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial,Iron-sulfur subunit of complex II;, PF13085;, GO:0005743;GO:0031966;GO:0005749;GO:0005739;GO:0005654;GO:0005886;GO:0051537;GO:0051538;GO:0051539;GO:0009055;GO:0046872;GO:0008177;GO:0048039;GO:0009060;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:2 iron, 2 sulfur cluster binding; F:3 iron, 4 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:succinate dehydrogenase (ubiquinone) activity; F:ubiquinone binding;, P:aerobic respiration; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle;|P21912 B2R545 Q0QEY7 Q9NQ12,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial,Iron-sulfur subunit of complex II;, PF13085;, GO:0005743;GO:0031966;GO:0005749;GO:0005739;GO:0005654;GO:0005886;GO:0051537;GO:0051538;GO:0051539;GO:0009055;GO:0046872;GO:0008177;GO:0048039;GO:0009060;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:2 iron, 2 sulfur cluster binding; F:3 iron, 4 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:succinate dehydrogenase (ubiquinone) activity; F:ubiquinone binding;, P:aerobic respiration; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle;|P21912 B2R545 Q0QEY7 Q9NQ12,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial,Iron-sulfur subunit of complex II;, PF13085;, GO:0005743;GO:0031966;GO:0005749;GO:0005739;GO:0005654;GO:0005886;GO:0051537;GO:0051538;GO:0051539;GO:0009055;GO:0046872;GO:0008177;GO:0048039;GO:0009060;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:2 iron, 2 sulfur cluster binding; F:3 iron, 4 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:succinate dehydrogenase (ubiquinone) activity; F:ubiquinone binding;, P:aerobic respiration; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle;|P21912 B2R545 Q0QEY7 Q9NQ12,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial,Iron-sulfur subunit of complex II;, PF13085;, GO:0005743;GO:0031966;GO:0005749;GO:0005739;GO:0005654;GO:0005886;GO:0051537;GO:0051538;GO:0051539;GO:0009055;GO:0046872;GO:0008177;GO:0048039;GO:0009060;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:2 iron, 2 sulfur cluster binding; F:3 iron, 4 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:succinate dehydrogenase (ubiquinone) activity; F:ubiquinone binding;, P:aerobic respiration; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle;|P21912 B2R545 Q0QEY7 Q9NQ12,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial,Iron-sulfur subunit of complex II;, PF13085;, GO:0005743;GO:0031966;GO:0005749;GO:0005739;GO:0005654;GO:0005886;GO:0051537;GO:0051538;GO:0051539;GO:0009055;GO:0046872;GO:0008177;GO:0048039;GO:0009060;GO:0022904;GO:0006105;GO:0006099;, C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); C:mitochondrion; C:nucleoplasm; C:plasma membrane;, F:2 iron, 2 sulfur cluster binding; F:3 iron, 4 sulfur cluster binding; F:4 iron, 4 sulfur cluster binding; F:electron transfer activity; F:metal ion binding; F:succinate dehydrogenase (ubiquinone) activity; F:ubiquinone binding;, P:aerobic respiration; P:respiratory electron transport chain; P:succinate metabolic process; P:tricarboxylic acid cycle; scaffold154 indexed_genome mRNA 446200 515655 . - . ID=transcript_14787;Q9Y2J8 Q96DA7 Q9UPN2,Protein-arginine deiminase type-2,PAD-H19;Peptidylarginine deiminase II {ECO:0000303|PubMed:12392711};Protein-arginine deiminase type II;, PF03068;PF08527;PF08526;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005634;GO:0035327;GO:0005509;GO:0030331;GO:0042803;GO:0004668;GO:1990830;GO:0006325;GO:0048096;GO:0036414;GO:0036413;GO:0030520;GO:0070100;GO:1901624;GO:0043312;GO:0018101;GO:0010848;GO:0021762;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleus; C:transcriptionally active chromatin;, F:calcium ion binding; F:estrogen receptor binding; F:protein homodimerization activity; F:protein-arginine deiminase activity;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:chromatin-mediated maintenance of transcription; P:histone citrullination; P:histone H3-R26 citrullination; P:intracellular estrogen receptor signaling pathway; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of lymphocyte chemotaxis; P:neutrophil degranulation; P:protein citrullination; P:regulation of chromatin disassembly; P:substantia nigra development;|Q9Y2J8 Q96DA7 Q9UPN2,Protein-arginine deiminase type-2,PAD-H19;Peptidylarginine deiminase II {ECO:0000303|PubMed:12392711};Protein-arginine deiminase type II;, PF03068;PF08527;PF08526;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005634;GO:0035327;GO:0005509;GO:0030331;GO:0042803;GO:0004668;GO:1990830;GO:0006325;GO:0048096;GO:0036414;GO:0036413;GO:0030520;GO:0070100;GO:1901624;GO:0043312;GO:0018101;GO:0010848;GO:0021762;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleus; C:transcriptionally active chromatin;, F:calcium ion binding; F:estrogen receptor binding; F:protein homodimerization activity; F:protein-arginine deiminase activity;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:chromatin-mediated maintenance of transcription; P:histone citrullination; P:histone H3-R26 citrullination; P:intracellular estrogen receptor signaling pathway; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of lymphocyte chemotaxis; P:neutrophil degranulation; P:protein citrullination; P:regulation of chromatin disassembly; P:substantia nigra development;|Q9Y2J8 Q96DA7 Q9UPN2,Protein-arginine deiminase type-2,PAD-H19;Peptidylarginine deiminase II {ECO:0000303|PubMed:12392711};Protein-arginine deiminase type II;, PF03068;PF08527;PF08526;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005634;GO:0035327;GO:0005509;GO:0030331;GO:0042803;GO:0004668;GO:1990830;GO:0006325;GO:0048096;GO:0036414;GO:0036413;GO:0030520;GO:0070100;GO:1901624;GO:0043312;GO:0018101;GO:0010848;GO:0021762;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleus; C:transcriptionally active chromatin;, F:calcium ion binding; F:estrogen receptor binding; F:protein homodimerization activity; F:protein-arginine deiminase activity;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:chromatin-mediated maintenance of transcription; P:histone citrullination; P:histone H3-R26 citrullination; P:intracellular estrogen receptor signaling pathway; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of lymphocyte chemotaxis; P:neutrophil degranulation; P:protein citrullination; P:regulation of chromatin disassembly; P:substantia nigra development;|Q9Y2J8 Q96DA7 Q9UPN2,Protein-arginine deiminase type-2,PAD-H19;Peptidylarginine deiminase II {ECO:0000303|PubMed:12392711};Protein-arginine deiminase type II;, PF03068;PF08527;PF08526;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005634;GO:0035327;GO:0005509;GO:0030331;GO:0042803;GO:0004668;GO:1990830;GO:0006325;GO:0048096;GO:0036414;GO:0036413;GO:0030520;GO:0070100;GO:1901624;GO:0043312;GO:0018101;GO:0010848;GO:0021762;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleus; C:transcriptionally active chromatin;, F:calcium ion binding; F:estrogen receptor binding; F:protein homodimerization activity; F:protein-arginine deiminase activity;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:chromatin-mediated maintenance of transcription; P:histone citrullination; P:histone H3-R26 citrullination; P:intracellular estrogen receptor signaling pathway; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of lymphocyte chemotaxis; P:neutrophil degranulation; P:protein citrullination; P:regulation of chromatin disassembly; P:substantia nigra development;|Q9Y2J8 Q96DA7 Q9UPN2,Protein-arginine deiminase type-2,PAD-H19;Peptidylarginine deiminase II {ECO:0000303|PubMed:12392711};Protein-arginine deiminase type II;, PF03068;PF08527;PF08526;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005634;GO:0035327;GO:0005509;GO:0030331;GO:0042803;GO:0004668;GO:1990830;GO:0006325;GO:0048096;GO:0036414;GO:0036413;GO:0030520;GO:0070100;GO:1901624;GO:0043312;GO:0018101;GO:0010848;GO:0021762;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleus; C:transcriptionally active chromatin;, F:calcium ion binding; F:estrogen receptor binding; F:protein homodimerization activity; F:protein-arginine deiminase activity;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:chromatin-mediated maintenance of transcription; P:histone citrullination; P:histone H3-R26 citrullination; P:intracellular estrogen receptor signaling pathway; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of lymphocyte chemotaxis; P:neutrophil degranulation; P:protein citrullination; P:regulation of chromatin disassembly; P:substantia nigra development;|Q9Y2J8 Q96DA7 Q9UPN2,Protein-arginine deiminase type-2,PAD-H19;Peptidylarginine deiminase II {ECO:0000303|PubMed:12392711};Protein-arginine deiminase type II;, PF03068;PF08527;PF08526;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005634;GO:0035327;GO:0005509;GO:0030331;GO:0042803;GO:0004668;GO:1990830;GO:0006325;GO:0048096;GO:0036414;GO:0036413;GO:0030520;GO:0070100;GO:1901624;GO:0043312;GO:0018101;GO:0010848;GO:0021762;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nucleus; C:transcriptionally active chromatin;, F:calcium ion binding; F:estrogen receptor binding; F:protein homodimerization activity; F:protein-arginine deiminase activity;, P:cellular response to leukemia inhibitory factor; P:chromatin organization; P:chromatin-mediated maintenance of transcription; P:histone citrullination; P:histone H3-R26 citrullination; P:intracellular estrogen receptor signaling pathway; P:negative regulation of chemokine-mediated signaling pathway; P:negative regulation of lymphocyte chemotaxis; P:neutrophil degranulation; P:protein citrullination; P:regulation of chromatin disassembly; P:substantia nigra development; scaffold154 indexed_genome mRNA 629811 650846 . + . ID=transcript_14788;Q9ULW8 Q58EY7 Q70SX5,Protein-arginine deiminase type-3,Peptidylarginine deiminase III;Protein-arginine deiminase type III;, PF03068;PF08527;PF08526;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0042802;GO:0004668;GO:0006325;GO:0036414;GO:0018101;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:identical protein binding; F:protein-arginine deiminase activity;, P:chromatin organization; P:histone citrullination; P:protein citrullination;|Q9ULW8 Q58EY7 Q70SX5,Protein-arginine deiminase type-3,Peptidylarginine deiminase III;Protein-arginine deiminase type III;, PF03068;PF08527;PF08526;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0042802;GO:0004668;GO:0006325;GO:0036414;GO:0018101;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:identical protein binding; F:protein-arginine deiminase activity;, P:chromatin organization; P:histone citrullination; P:protein citrullination;|Q9ULW8 Q58EY7 Q70SX5,Protein-arginine deiminase type-3,Peptidylarginine deiminase III;Protein-arginine deiminase type III;, PF03068;PF08527;PF08526;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0042802;GO:0004668;GO:0006325;GO:0036414;GO:0018101;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:identical protein binding; F:protein-arginine deiminase activity;, P:chromatin organization; P:histone citrullination; P:protein citrullination;|Q9ULW8 Q58EY7 Q70SX5,Protein-arginine deiminase type-3,Peptidylarginine deiminase III;Protein-arginine deiminase type III;, PF03068;PF08527;PF08526;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0042802;GO:0004668;GO:0006325;GO:0036414;GO:0018101;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:identical protein binding; F:protein-arginine deiminase activity;, P:chromatin organization; P:histone citrullination; P:protein citrullination;|Q9ULW8 Q58EY7 Q70SX5,Protein-arginine deiminase type-3,Peptidylarginine deiminase III;Protein-arginine deiminase type III;, PF03068;PF08527;PF08526;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0042802;GO:0004668;GO:0006325;GO:0036414;GO:0018101;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:identical protein binding; F:protein-arginine deiminase activity;, P:chromatin organization; P:histone citrullination; P:protein citrullination;|Q9ULW8 Q58EY7 Q70SX5,Protein-arginine deiminase type-3,Peptidylarginine deiminase III;Protein-arginine deiminase type III;, PF03068;PF08527;PF08526;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0042802;GO:0004668;GO:0006325;GO:0036414;GO:0018101;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:identical protein binding; F:protein-arginine deiminase activity;, P:chromatin organization; P:histone citrullination; P:protein citrullination;|Q9ULW8 Q58EY7 Q70SX5,Protein-arginine deiminase type-3,Peptidylarginine deiminase III;Protein-arginine deiminase type III;, PF03068;PF08527;PF08526;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0042802;GO:0004668;GO:0006325;GO:0036414;GO:0018101;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:identical protein binding; F:protein-arginine deiminase activity;, P:chromatin organization; P:histone citrullination; P:protein citrullination;|Q9ULW8 Q58EY7 Q70SX5,Protein-arginine deiminase type-3,Peptidylarginine deiminase III;Protein-arginine deiminase type III;, PF03068;PF08527;PF08526;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0042802;GO:0004668;GO:0006325;GO:0036414;GO:0018101;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:identical protein binding; F:protein-arginine deiminase activity;, P:chromatin organization; P:histone citrullination; P:protein citrullination; scaffold154 indexed_genome mRNA 728345 744695 . - . ID=transcript_14789;Q9P258 Q8IVL9 Q9BSN6 Q9NPV8,Protein RCC2,RCC1-like protein TD-60 {ECO:0000303|PubMed:12919680};Telophase disk protein of 60 kDa {ECO:0000303|PubMed:1939370};, PF00415;, GO:0034506;GO:0005829;GO:0031901;GO:0005874;GO:0030496;GO:1990023;GO:0005730;GO:0005886;GO:0005085;GO:0008017;GO:0019904;GO:0019901;GO:0003723;GO:0031267;GO:0090630;GO:0051301;GO:0072356;GO:0045184;GO:0048041;GO:0007229;GO:0007052;GO:0051895;GO:0034260;GO:1900025;GO:0051987;GO:0010971;GO:0030334;GO:0010762;GO:1900027;, C:chromosome, centromeric core domain; C:cytosol; C:early endosome membrane; C:microtubule; C:midbody; C:mitotic spindle midzone; C:nucleolus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:protein domain specific binding; F:protein kinase binding; F:RNA binding; F:small GTPase binding;, P:activation of GTPase activity; P:cell division; P:chromosome passenger complex localization to kinetochore; P:establishment of protein localization; P:focal adhesion assembly; P:integrin-mediated signaling pathway; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of GTPase activity; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of G2/M transition of mitotic cell cycle; P:regulation of cell migration; P:regulation of fibroblast migration; P:regulation of ruffle assembly;|Q9P258 Q8IVL9 Q9BSN6 Q9NPV8,Protein RCC2,RCC1-like protein TD-60 {ECO:0000303|PubMed:12919680};Telophase disk protein of 60 kDa {ECO:0000303|PubMed:1939370};, PF00415;, GO:0034506;GO:0005829;GO:0031901;GO:0005874;GO:0030496;GO:1990023;GO:0005730;GO:0005886;GO:0005085;GO:0008017;GO:0019904;GO:0019901;GO:0003723;GO:0031267;GO:0090630;GO:0051301;GO:0072356;GO:0045184;GO:0048041;GO:0007229;GO:0007052;GO:0051895;GO:0034260;GO:1900025;GO:0051987;GO:0010971;GO:0030334;GO:0010762;GO:1900027;, C:chromosome, centromeric core domain; C:cytosol; C:early endosome membrane; C:microtubule; C:midbody; C:mitotic spindle midzone; C:nucleolus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:protein domain specific binding; F:protein kinase binding; F:RNA binding; F:small GTPase binding;, P:activation of GTPase activity; P:cell division; P:chromosome passenger complex localization to kinetochore; P:establishment of protein localization; P:focal adhesion assembly; P:integrin-mediated signaling pathway; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of GTPase activity; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of G2/M transition of mitotic cell cycle; P:regulation of cell migration; P:regulation of fibroblast migration; P:regulation of ruffle assembly;|Q9P258 Q8IVL9 Q9BSN6 Q9NPV8,Protein RCC2,RCC1-like protein TD-60 {ECO:0000303|PubMed:12919680};Telophase disk protein of 60 kDa {ECO:0000303|PubMed:1939370};, PF00415;, GO:0034506;GO:0005829;GO:0031901;GO:0005874;GO:0030496;GO:1990023;GO:0005730;GO:0005886;GO:0005085;GO:0008017;GO:0019904;GO:0019901;GO:0003723;GO:0031267;GO:0090630;GO:0051301;GO:0072356;GO:0045184;GO:0048041;GO:0007229;GO:0007052;GO:0051895;GO:0034260;GO:1900025;GO:0051987;GO:0010971;GO:0030334;GO:0010762;GO:1900027;, C:chromosome, centromeric core domain; C:cytosol; C:early endosome membrane; C:microtubule; C:midbody; C:mitotic spindle midzone; C:nucleolus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:protein domain specific binding; F:protein kinase binding; F:RNA binding; F:small GTPase binding;, P:activation of GTPase activity; P:cell division; P:chromosome passenger complex localization to kinetochore; P:establishment of protein localization; P:focal adhesion assembly; P:integrin-mediated signaling pathway; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of GTPase activity; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of G2/M transition of mitotic cell cycle; P:regulation of cell migration; P:regulation of fibroblast migration; P:regulation of ruffle assembly;|Q9P258 Q8IVL9 Q9BSN6 Q9NPV8,Protein RCC2,RCC1-like protein TD-60 {ECO:0000303|PubMed:12919680};Telophase disk protein of 60 kDa {ECO:0000303|PubMed:1939370};, PF00415;, GO:0034506;GO:0005829;GO:0031901;GO:0005874;GO:0030496;GO:1990023;GO:0005730;GO:0005886;GO:0005085;GO:0008017;GO:0019904;GO:0019901;GO:0003723;GO:0031267;GO:0090630;GO:0051301;GO:0072356;GO:0045184;GO:0048041;GO:0007229;GO:0007052;GO:0051895;GO:0034260;GO:1900025;GO:0051987;GO:0010971;GO:0030334;GO:0010762;GO:1900027;, C:chromosome, centromeric core domain; C:cytosol; C:early endosome membrane; C:microtubule; C:midbody; C:mitotic spindle midzone; C:nucleolus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:protein domain specific binding; F:protein kinase binding; F:RNA binding; F:small GTPase binding;, P:activation of GTPase activity; P:cell division; P:chromosome passenger complex localization to kinetochore; P:establishment of protein localization; P:focal adhesion assembly; P:integrin-mediated signaling pathway; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of GTPase activity; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of G2/M transition of mitotic cell cycle; P:regulation of cell migration; P:regulation of fibroblast migration; P:regulation of ruffle assembly; scaffold154 indexed_genome mRNA 747443 750622 . + . ID=transcript_14790;Q9P258 Q8IVL9 Q9BSN6 Q9NPV8,Protein RCC2,RCC1-like protein TD-60 {ECO:0000303|PubMed:12919680};Telophase disk protein of 60 kDa {ECO:0000303|PubMed:1939370};, PF00415;, GO:0034506;GO:0005829;GO:0031901;GO:0005874;GO:0030496;GO:1990023;GO:0005730;GO:0005886;GO:0005085;GO:0008017;GO:0019904;GO:0019901;GO:0003723;GO:0031267;GO:0090630;GO:0051301;GO:0072356;GO:0045184;GO:0048041;GO:0007229;GO:0007052;GO:0051895;GO:0034260;GO:1900025;GO:0051987;GO:0010971;GO:0030334;GO:0010762;GO:1900027;, C:chromosome, centromeric core domain; C:cytosol; C:early endosome membrane; C:microtubule; C:midbody; C:mitotic spindle midzone; C:nucleolus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:microtubule binding; F:protein domain specific binding; F:protein kinase binding; F:RNA binding; F:small GTPase binding;, P:activation of GTPase activity; P:cell division; P:chromosome passenger complex localization to kinetochore; P:establishment of protein localization; P:focal adhesion assembly; P:integrin-mediated signaling pathway; P:mitotic spindle organization; P:negative regulation of focal adhesion assembly; P:negative regulation of GTPase activity; P:negative regulation of substrate adhesion-dependent cell spreading; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of G2/M transition of mitotic cell cycle; P:regulation of cell migration; P:regulation of fibroblast migration; P:regulation of ruffle assembly; scaffold154 indexed_genome mRNA 866134 873104 . + . ID=transcript_14791;Q9NVT3,Rho guanine nucleotide exchange factor 10-like protein,GrinchGEF;, PF00621;, GO:0005829;GO:0005096;GO:0005085;GO:0030036;GO:0051496;GO:0032933;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:positive regulation of stress fiber assembly; P:SREBP signaling pathway;|Q9NVT3,Rho guanine nucleotide exchange factor 10-like protein,GrinchGEF;, PF00621;, GO:0005829;GO:0005096;GO:0005085;GO:0030036;GO:0051496;GO:0032933;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:positive regulation of stress fiber assembly; P:SREBP signaling pathway; scaffold154 indexed_genome mRNA 873455 945186 . + . ID=transcript_14792;Q9NVT3,Rho guanine nucleotide exchange factor 10-like protein,GrinchGEF;, PF00621;, GO:0005829;GO:0005096;GO:0005085;GO:0030036;GO:0051496;GO:0032933;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:positive regulation of stress fiber assembly; P:SREBP signaling pathway;|Q9NVT3,Rho guanine nucleotide exchange factor 10-like protein,GrinchGEF;, PF00621;, GO:0005829;GO:0005096;GO:0005085;GO:0030036;GO:0051496;GO:0032933;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:positive regulation of stress fiber assembly; P:SREBP signaling pathway;|Q9NVT3,Rho guanine nucleotide exchange factor 10-like protein,GrinchGEF;, PF00621;, GO:0005829;GO:0005096;GO:0005085;GO:0030036;GO:0051496;GO:0032933;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:positive regulation of stress fiber assembly; P:SREBP signaling pathway;|Q9NVT3,Rho guanine nucleotide exchange factor 10-like protein,GrinchGEF;, PF00621;, GO:0005829;GO:0005096;GO:0005085;GO:0030036;GO:0051496;GO:0032933;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:positive regulation of stress fiber assembly; P:SREBP signaling pathway;|Q9NVT3,Rho guanine nucleotide exchange factor 10-like protein,GrinchGEF;, PF00621;, GO:0005829;GO:0005096;GO:0005085;GO:0030036;GO:0051496;GO:0032933;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:positive regulation of stress fiber assembly; P:SREBP signaling pathway;|Q9NVT3,Rho guanine nucleotide exchange factor 10-like protein,GrinchGEF;, PF00621;, GO:0005829;GO:0005096;GO:0005085;GO:0030036;GO:0051496;GO:0032933;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:positive regulation of stress fiber assembly; P:SREBP signaling pathway;|Q9NVT3,Rho guanine nucleotide exchange factor 10-like protein,GrinchGEF;, PF00621;, GO:0005829;GO:0005096;GO:0005085;GO:0030036;GO:0051496;GO:0032933;, C:cytosol;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:positive regulation of stress fiber assembly; P:SREBP signaling pathway; scaffold155 indexed_genome mRNA 137 970 . - . ID=transcript_14793;Q8NES3 B3KTY6 B5MCR5 O00589 Q96C39 Q9UJW5,Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase;, PF02434;, GO:0005576;GO:1903561;GO:0000139;GO:0030173;GO:0008375;GO:0046872;GO:0033829;GO:0009887;GO:0002315;GO:1902367;GO:0008593;GO:0014807;GO:0001756;GO:0030217;, C:extracellular region; C:extracellular vesicle; C:Golgi membrane; C:integral component of Golgi membrane;, F:acetylglucosaminyltransferase activity; F:metal ion binding; F:O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity;, P:animal organ morphogenesis; P:marginal zone B cell differentiation; P:negative regulation of Notch signaling pathway involved in somitogenesis; P:regulation of Notch signaling pathway; P:regulation of somitogenesis; P:somitogenesis; P:T cell differentiation; scaffold155 indexed_genome mRNA 1024 4074 . - . ID=transcript_14794;Q8NES3 B3KTY6 B5MCR5 O00589 Q96C39 Q9UJW5,Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase;, PF02434;, GO:0005576;GO:1903561;GO:0000139;GO:0030173;GO:0008375;GO:0046872;GO:0033829;GO:0009887;GO:0002315;GO:1902367;GO:0008593;GO:0014807;GO:0001756;GO:0030217;, C:extracellular region; C:extracellular vesicle; C:Golgi membrane; C:integral component of Golgi membrane;, F:acetylglucosaminyltransferase activity; F:metal ion binding; F:O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity;, P:animal organ morphogenesis; P:marginal zone B cell differentiation; P:negative regulation of Notch signaling pathway involved in somitogenesis; P:regulation of Notch signaling pathway; P:regulation of somitogenesis; P:somitogenesis; P:T cell differentiation; scaffold155 indexed_genome mRNA 21502 24384 . - . ID=transcript_14795;Q9C0H2 A4D201 B7WP98 Q6L749 Q6ZVG3 Q8TEG6,Protein tweety homolog 3,, PF04906;, GO:0034707;GO:0070062;GO:0005886;GO:0005254;GO:0005229;GO:0072320;GO:0006821;GO:0034220;, C:chloride channel complex; C:extracellular exosome; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:volume-sensitive chloride channel activity;, P:chloride transport; P:ion transmembrane transport;|Q9C0H2 A4D201 B7WP98 Q6L749 Q6ZVG3 Q8TEG6,Protein tweety homolog 3,, PF04906;, GO:0034707;GO:0070062;GO:0005886;GO:0005254;GO:0005229;GO:0072320;GO:0006821;GO:0034220;, C:chloride channel complex; C:extracellular exosome; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:volume-sensitive chloride channel activity;, P:chloride transport; P:ion transmembrane transport; scaffold155 indexed_genome mRNA 25621 27650 . - . ID=transcript_14796;Q9C0H2 A4D201 B7WP98 Q6L749 Q6ZVG3 Q8TEG6,Protein tweety homolog 3,, PF04906;, GO:0034707;GO:0070062;GO:0005886;GO:0005254;GO:0005229;GO:0072320;GO:0006821;GO:0034220;, C:chloride channel complex; C:extracellular exosome; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:volume-sensitive chloride channel activity;, P:chloride transport; P:ion transmembrane transport; scaffold155 indexed_genome mRNA 51998 77335 . + . ID=transcript_14797;Q6IPM2 Q4G0P7 Q6P7T4 Q9H0H7 Q9UPX7,IQ domain-containing protein E,, PF00612;, GO:0060170;GO:0005929;GO:0035108;, C:ciliary membrane; C:cilium;, , P:limb morphogenesis;|Q6IPM2 Q4G0P7 Q6P7T4 Q9H0H7 Q9UPX7,IQ domain-containing protein E,, PF00612;, GO:0060170;GO:0005929;GO:0035108;, C:ciliary membrane; C:cilium;, , P:limb morphogenesis;|Q6IPM2 Q4G0P7 Q6P7T4 Q9H0H7 Q9UPX7,IQ domain-containing protein E,, PF00612;, GO:0060170;GO:0005929;GO:0035108;, C:ciliary membrane; C:cilium;, , P:limb morphogenesis;|Q6IPM2 Q4G0P7 Q6P7T4 Q9H0H7 Q9UPX7,IQ domain-containing protein E,, PF00612;, GO:0060170;GO:0005929;GO:0035108;, C:ciliary membrane; C:cilium;, , P:limb morphogenesis;|Q6IPM2 Q4G0P7 Q6P7T4 Q9H0H7 Q9UPX7,IQ domain-containing protein E,, PF00612;, GO:0060170;GO:0005929;GO:0035108;, C:ciliary membrane; C:cilium;, , P:limb morphogenesis; scaffold155 indexed_genome mRNA 99103 108913 . + . ID=transcript_14798;Q6PJG6 A4D200 C9JY24 Q8IW85 Q8IZ43 Q8WVR8 Q96IV9 Q9H7J8 Q9UFA3,BRCA1-associated ATM activator 1,BRCA1-associated protein required for ATM activation protein 1;, PF02985;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0006915;GO:0016477;GO:0008283;GO:0006974;GO:0006006;GO:0051646;GO:0030307;GO:0001934;GO:0010212;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, , P:apoptotic process; P:cell migration; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:glucose metabolic process; P:mitochondrion localization; P:positive regulation of cell growth; P:positive regulation of protein phosphorylation; P:response to ionizing radiation;|Q6PJG6 A4D200 C9JY24 Q8IW85 Q8IZ43 Q8WVR8 Q96IV9 Q9H7J8 Q9UFA3,BRCA1-associated ATM activator 1,BRCA1-associated protein required for ATM activation protein 1;, PF02985;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0006915;GO:0016477;GO:0008283;GO:0006974;GO:0006006;GO:0051646;GO:0030307;GO:0001934;GO:0010212;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, , P:apoptotic process; P:cell migration; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:glucose metabolic process; P:mitochondrion localization; P:positive regulation of cell growth; P:positive regulation of protein phosphorylation; P:response to ionizing radiation;|Q6PJG6 A4D200 C9JY24 Q8IW85 Q8IZ43 Q8WVR8 Q96IV9 Q9H7J8 Q9UFA3,BRCA1-associated ATM activator 1,BRCA1-associated protein required for ATM activation protein 1;, PF02985;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0006915;GO:0016477;GO:0008283;GO:0006974;GO:0006006;GO:0051646;GO:0030307;GO:0001934;GO:0010212;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, , P:apoptotic process; P:cell migration; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:glucose metabolic process; P:mitochondrion localization; P:positive regulation of cell growth; P:positive regulation of protein phosphorylation; P:response to ionizing radiation;|Q6PJG6 A4D200 C9JY24 Q8IW85 Q8IZ43 Q8WVR8 Q96IV9 Q9H7J8 Q9UFA3,BRCA1-associated ATM activator 1,BRCA1-associated protein required for ATM activation protein 1;, PF02985;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0006915;GO:0016477;GO:0008283;GO:0006974;GO:0006006;GO:0051646;GO:0030307;GO:0001934;GO:0010212;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, , P:apoptotic process; P:cell migration; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:glucose metabolic process; P:mitochondrion localization; P:positive regulation of cell growth; P:positive regulation of protein phosphorylation; P:response to ionizing radiation;|Q6PJG6 A4D200 C9JY24 Q8IW85 Q8IZ43 Q8WVR8 Q96IV9 Q9H7J8 Q9UFA3,BRCA1-associated ATM activator 1,BRCA1-associated protein required for ATM activation protein 1;, PF02985;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0006915;GO:0016477;GO:0008283;GO:0006974;GO:0006006;GO:0051646;GO:0030307;GO:0001934;GO:0010212;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, , P:apoptotic process; P:cell migration; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:glucose metabolic process; P:mitochondrion localization; P:positive regulation of cell growth; P:positive regulation of protein phosphorylation; P:response to ionizing radiation;|Q6PJG6 A4D200 C9JY24 Q8IW85 Q8IZ43 Q8WVR8 Q96IV9 Q9H7J8 Q9UFA3,BRCA1-associated ATM activator 1,BRCA1-associated protein required for ATM activation protein 1;, PF02985;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0006915;GO:0016477;GO:0008283;GO:0006974;GO:0006006;GO:0051646;GO:0030307;GO:0001934;GO:0010212;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, , P:apoptotic process; P:cell migration; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:glucose metabolic process; P:mitochondrion localization; P:positive regulation of cell growth; P:positive regulation of protein phosphorylation; P:response to ionizing radiation;|Q6PJG6 A4D200 C9JY24 Q8IW85 Q8IZ43 Q8WVR8 Q96IV9 Q9H7J8 Q9UFA3,BRCA1-associated ATM activator 1,BRCA1-associated protein required for ATM activation protein 1;, PF02985;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0006915;GO:0016477;GO:0008283;GO:0006974;GO:0006006;GO:0051646;GO:0030307;GO:0001934;GO:0010212;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, , P:apoptotic process; P:cell migration; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:glucose metabolic process; P:mitochondrion localization; P:positive regulation of cell growth; P:positive regulation of protein phosphorylation; P:response to ionizing radiation;|Q6PJG6 A4D200 C9JY24 Q8IW85 Q8IZ43 Q8WVR8 Q96IV9 Q9H7J8 Q9UFA3,BRCA1-associated ATM activator 1,BRCA1-associated protein required for ATM activation protein 1;, PF02985;, GO:0005737;GO:0016020;GO:0005654;GO:0005634;GO:0006915;GO:0016477;GO:0008283;GO:0006974;GO:0006006;GO:0051646;GO:0030307;GO:0001934;GO:0010212;, C:cytoplasm; C:membrane; C:nucleoplasm; C:nucleus;, , P:apoptotic process; P:cell migration; P:cell population proliferation; P:cellular response to DNA damage stimulus; P:glucose metabolic process; P:mitochondrion localization; P:positive regulation of cell growth; P:positive regulation of protein phosphorylation; P:response to ionizing radiation; scaffold155 indexed_genome mRNA 112336 138125 . + . ID=transcript_14799;Q400G9 B3KRS0 Q8TF51,Archaemetzincin-1,Archeobacterial metalloproteinase-like protein 1;, , GO:0046872;GO:0008237;, , F:metal ion binding; F:metallopeptidase activity;|Q400G9 B3KRS0 Q8TF51,Archaemetzincin-1,Archeobacterial metalloproteinase-like protein 1;, , GO:0046872;GO:0008237;, , F:metal ion binding; F:metallopeptidase activity; scaffold155 indexed_genome mRNA 144082 175835 . - . ID=transcript_14800;Q03113 A4D204 B3KXS2 B7Z3F7 Q2T9L1 Q5PPR5 Q86UM8 Q8TD71 Q9UDU9,Guanine nucleotide-binding protein subunit alpha-12,, PF00503;, GO:0031526;GO:0005737;GO:0005925;GO:0005834;GO:0016328;GO:0005886;GO:0031752;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0007188;GO:0007596;GO:0007186;GO:1904753;GO:1904706;GO:0030168;GO:0010762;GO:0032434;GO:0032006;GO:0042493;GO:0007266;, C:brush border membrane; C:cytoplasm; C:focal adhesion; C:heterotrimeric G-protein complex; C:lateral plasma membrane; C:plasma membrane;, F:D5 dopamine receptor binding; F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:blood coagulation; P:G protein-coupled receptor signaling pathway; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:platelet activation; P:regulation of fibroblast migration; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of TOR signaling; P:response to drug; P:Rho protein signal transduction; scaffold155 indexed_genome mRNA 268140 296833 . - . ID=transcript_14801;Q9BXL7 A4D1Z7 Q2NKN7 Q548H3,Caspase recruitment domain-containing protein 11,CARD-containing MAGUK protein 1;, PF00619;, GO:0032449;GO:0005737;GO:0005829;GO:0070062;GO:0001772;GO:0045121;GO:0005886;GO:0050700;GO:0004385;GO:0030183;GO:0042100;GO:0038095;GO:0048872;GO:0007249;GO:0030890;GO:0043123;GO:0032743;GO:0051092;GO:0042102;GO:0050862;GO:0042981;GO:0045577;GO:0045580;GO:0002223;GO:0031295;GO:0050852;GO:0045061;GO:0038202;, C:CBM complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:immunological synapse; C:membrane raft; C:plasma membrane;, F:CARD domain binding; F:guanylate kinase activity;, P:B cell differentiation; P:B cell proliferation; P:Fc-epsilon receptor signaling pathway; P:homeostasis of number of cells; P:I-kappaB kinase/NF-kappaB signaling; P:positive regulation of B cell proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-2 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T cell proliferation; P:positive regulation of T cell receptor signaling pathway; P:regulation of apoptotic process; P:regulation of B cell differentiation; P:regulation of T cell differentiation; P:stimulatory C-type lectin receptor signaling pathway; P:T cell costimulation; P:T cell receptor signaling pathway; P:thymic T cell selection; P:TORC1 signaling; scaffold155 indexed_genome mRNA 856382 1213183 . - . ID=transcript_14802;Q7Z5N4 Q8TEN9 Q8TEP5 Q96N44,Protein sidekick-1 {ECO:0000303|PubMed:15213259},, PF00041;PF07679;, GO:0016021;GO:0005886;GO:0045202;GO:0042802;GO:0048148;GO:0045216;GO:0007156;GO:0060998;GO:0010842;GO:0007416;, C:integral component of membrane; C:plasma membrane; C:synapse;, F:identical protein binding;, P:behavioral response to cocaine; P:cell-cell junction organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:regulation of dendritic spine development; P:retina layer formation; P:synapse assembly; scaffold155 indexed_genome mRNA 1225447 1280255 . + . ID=transcript_14803;Q7Z5N4 Q8TEN9 Q8TEP5 Q96N44,Protein sidekick-1 {ECO:0000303|PubMed:15213259},, PF00041;PF07679;, GO:0016021;GO:0005886;GO:0045202;GO:0042802;GO:0048148;GO:0045216;GO:0007156;GO:0060998;GO:0010842;GO:0007416;, C:integral component of membrane; C:plasma membrane; C:synapse;, F:identical protein binding;, P:behavioral response to cocaine; P:cell-cell junction organization; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:regulation of dendritic spine development; P:retina layer formation; P:synapse assembly; scaffold155 indexed_genome mRNA 1464625 1521781 . + . ID=transcript_14804;P85037,Forkhead box protein K1 {ECO:0000303|PubMed:15202027, ECO:0000303|PubMed:15289879},Myocyte nuclear factor {ECO:0000303|PubMed:15289879};, PF00498;PF00250;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0071889;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0000976;GO:0061621;GO:0030154;GO:0001678;GO:0007517;GO:0010507;GO:0045892;GO:0045893;GO:0016579;GO:0010906;GO:0006357;GO:0042594;GO:0016032;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:canonical glycolysis; P:cell differentiation; P:cellular glucose homeostasis; P:muscle organ development; P:negative regulation of autophagy; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of glucose metabolic process; P:regulation of transcription by RNA polymerase II; P:response to starvation; P:viral process;|P85037,Forkhead box protein K1 {ECO:0000303|PubMed:15202027, ECO:0000303|PubMed:15289879},Myocyte nuclear factor {ECO:0000303|PubMed:15289879};, PF00498;PF00250;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0071889;GO:0003700;GO:0000981;GO:0001227;GO:0000978;GO:1990837;GO:0000976;GO:0061621;GO:0030154;GO:0001678;GO:0007517;GO:0010507;GO:0045892;GO:0045893;GO:0016579;GO:0010906;GO:0006357;GO:0042594;GO:0016032;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:14-3-3 protein binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:canonical glycolysis; P:cell differentiation; P:cellular glucose homeostasis; P:muscle organ development; P:negative regulation of autophagy; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:regulation of glucose metabolic process; P:regulation of transcription by RNA polymerase II; P:response to starvation; P:viral process; scaffold155 indexed_genome mRNA 1536946 1539218 . + . ID=transcript_14805;O43299 Q8N3X2 Q96H80,AP-5 complex subunit zeta-1,Adaptor-related protein complex 5 zeta subunit;, PF14764;, GO:0044599;GO:0030119;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0000724;GO:0016197;GO:0015031;, C:AP-5 adaptor complex; C:AP-type membrane coat adaptor complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, , P:double-strand break repair via homologous recombination; P:endosomal transport; P:protein transport;|O43299 Q8N3X2 Q96H80,AP-5 complex subunit zeta-1,Adaptor-related protein complex 5 zeta subunit;, PF14764;, GO:0044599;GO:0030119;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0000724;GO:0016197;GO:0015031;, C:AP-5 adaptor complex; C:AP-type membrane coat adaptor complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, , P:double-strand break repair via homologous recombination; P:endosomal transport; P:protein transport; scaffold155 indexed_genome mRNA 1539967 1549155 . + . ID=transcript_14806;O43299 Q8N3X2 Q96H80,AP-5 complex subunit zeta-1,Adaptor-related protein complex 5 zeta subunit;, PF14764;, GO:0044599;GO:0030119;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0000724;GO:0016197;GO:0015031;, C:AP-5 adaptor complex; C:AP-type membrane coat adaptor complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, , P:double-strand break repair via homologous recombination; P:endosomal transport; P:protein transport;|O43299 Q8N3X2 Q96H80,AP-5 complex subunit zeta-1,Adaptor-related protein complex 5 zeta subunit;, PF14764;, GO:0044599;GO:0030119;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0000724;GO:0016197;GO:0015031;, C:AP-5 adaptor complex; C:AP-type membrane coat adaptor complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, , P:double-strand break repair via homologous recombination; P:endosomal transport; P:protein transport;|Q9NWC4,Ras-associating and dilute domain-containing protein,, PF01843;PF00595;PF00788;, GO:0005874;GO:0032991;GO:0007275;GO:0007165;GO:0034446;, C:microtubule; C:protein-containing complex;, , P:multicellular organism development; P:signal transduction; P:substrate adhesion-dependent cell spreading;|O43299 Q8N3X2 Q96H80,AP-5 complex subunit zeta-1,Adaptor-related protein complex 5 zeta subunit;, PF14764;, GO:0044599;GO:0030119;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0000724;GO:0016197;GO:0015031;, C:AP-5 adaptor complex; C:AP-type membrane coat adaptor complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, , P:double-strand break repair via homologous recombination; P:endosomal transport; P:protein transport;|O43299 Q8N3X2 Q96H80,AP-5 complex subunit zeta-1,Adaptor-related protein complex 5 zeta subunit;, PF14764;, GO:0044599;GO:0030119;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0000724;GO:0016197;GO:0015031;, C:AP-5 adaptor complex; C:AP-type membrane coat adaptor complex; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, , P:double-strand break repair via homologous recombination; P:endosomal transport; P:protein transport; scaffold155 indexed_genome mRNA 1557936 1603264 . - . ID=transcript_14807;Q9NWC4,Ras-associating and dilute domain-containing protein,, PF01843;PF00595;PF00788;, GO:0005874;GO:0032991;GO:0007275;GO:0007165;GO:0034446;, C:microtubule; C:protein-containing complex;, , P:multicellular organism development; P:signal transduction; P:substrate adhesion-dependent cell spreading;|Q9NWC4,Ras-associating and dilute domain-containing protein,, PF01843;PF00595;PF00788;, GO:0005874;GO:0032991;GO:0007275;GO:0007165;GO:0034446;, C:microtubule; C:protein-containing complex;, , P:multicellular organism development; P:signal transduction; P:substrate adhesion-dependent cell spreading;|Q9NWC4,Ras-associating and dilute domain-containing protein,, PF01843;PF00595;PF00788;, GO:0005874;GO:0032991;GO:0007275;GO:0007165;GO:0034446;, C:microtubule; C:protein-containing complex;, , P:multicellular organism development; P:signal transduction; P:substrate adhesion-dependent cell spreading;|P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription;|P51003 Q86SX4 Q86TV0 Q8IYF5 Q9BVU2,Poly(A) polymerase alpha,Polynucleotide adenylyltransferase alpha;, PF01909;PF04928;PF04926;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0030145;GO:0004652;GO:0003723;GO:0031124;GO:0006378;GO:0000398;GO:0031440;GO:0043631;GO:0006369;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:manganese ion binding; F:polynucleotide adenylyltransferase activity; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:regulation of mRNA 3'-end processing; P:RNA polyadenylation; P:termination of RNA polymerase II transcription; scaffold155 indexed_genome mRNA 1629345 1644581 . - . ID=transcript_14808;Q8IY49 B5MBW4 Q6NVU5 Q6TCH0,Monocyte to macrophage differentiation factor 2,Progestin and adipoQ receptor family member 10 {ECO:0000303|PubMed:16044242};Progestin and adipoQ receptor family member X;, PF03006;, GO:0000139;GO:0016021;GO:0048471;GO:0004672;GO:0045666;GO:0045860;GO:0046579;GO:0032880;, C:Golgi membrane; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:protein kinase activity;, P:positive regulation of neuron differentiation; P:positive regulation of protein kinase activity; P:positive regulation of Ras protein signal transduction; P:regulation of protein localization; scaffold155 indexed_genome mRNA 1702725 1727472 . + . ID=transcript_14809;Q9Y4P8 B3KNC2 Q5MNZ8 Q6FI96 Q75L50 Q96IE4 Q9Y364,WD repeat domain phosphoinositide-interacting protein 2 {ECO:0000305},WIPI49-like protein 2;, , GO:0005829;GO:0019898;GO:0005654;GO:0000407;GO:0034045;GO:0032991;GO:0080025;GO:0032266;GO:0010314;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0016236;GO:0006497;GO:0061739;GO:0034497;GO:0098792;, C:cytosol; C:extrinsic component of membrane; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane; C:protein-containing complex;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:macroautophagy; P:protein lipidation; P:protein lipidation involved in autophagosome assembly; P:protein localization to phagophore assembly site; P:xenophagy;|Q9Y4P8 B3KNC2 Q5MNZ8 Q6FI96 Q75L50 Q96IE4 Q9Y364,WD repeat domain phosphoinositide-interacting protein 2 {ECO:0000305},WIPI49-like protein 2;, , GO:0005829;GO:0019898;GO:0005654;GO:0000407;GO:0034045;GO:0032991;GO:0080025;GO:0032266;GO:0010314;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0016236;GO:0006497;GO:0061739;GO:0034497;GO:0098792;, C:cytosol; C:extrinsic component of membrane; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane; C:protein-containing complex;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:macroautophagy; P:protein lipidation; P:protein lipidation involved in autophagosome assembly; P:protein localization to phagophore assembly site; P:xenophagy;|Q9Y4P8 B3KNC2 Q5MNZ8 Q6FI96 Q75L50 Q96IE4 Q9Y364,WD repeat domain phosphoinositide-interacting protein 2 {ECO:0000305},WIPI49-like protein 2;, , GO:0005829;GO:0019898;GO:0005654;GO:0000407;GO:0034045;GO:0032991;GO:0080025;GO:0032266;GO:0010314;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0016236;GO:0006497;GO:0061739;GO:0034497;GO:0098792;, C:cytosol; C:extrinsic component of membrane; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane; C:protein-containing complex;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:macroautophagy; P:protein lipidation; P:protein lipidation involved in autophagosome assembly; P:protein localization to phagophore assembly site; P:xenophagy;|Q9Y4P8 B3KNC2 Q5MNZ8 Q6FI96 Q75L50 Q96IE4 Q9Y364,WD repeat domain phosphoinositide-interacting protein 2 {ECO:0000305},WIPI49-like protein 2;, , GO:0005829;GO:0019898;GO:0005654;GO:0000407;GO:0034045;GO:0032991;GO:0080025;GO:0032266;GO:0010314;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0016236;GO:0006497;GO:0061739;GO:0034497;GO:0098792;, C:cytosol; C:extrinsic component of membrane; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane; C:protein-containing complex;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:macroautophagy; P:protein lipidation; P:protein lipidation involved in autophagosome assembly; P:protein localization to phagophore assembly site; P:xenophagy;|Q9Y4P8 B3KNC2 Q5MNZ8 Q6FI96 Q75L50 Q96IE4 Q9Y364,WD repeat domain phosphoinositide-interacting protein 2 {ECO:0000305},WIPI49-like protein 2;, , GO:0005829;GO:0019898;GO:0005654;GO:0000407;GO:0034045;GO:0032991;GO:0080025;GO:0032266;GO:0010314;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0016236;GO:0006497;GO:0061739;GO:0034497;GO:0098792;, C:cytosol; C:extrinsic component of membrane; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane; C:protein-containing complex;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:macroautophagy; P:protein lipidation; P:protein lipidation involved in autophagosome assembly; P:protein localization to phagophore assembly site; P:xenophagy;|Q9Y4P8 B3KNC2 Q5MNZ8 Q6FI96 Q75L50 Q96IE4 Q9Y364,WD repeat domain phosphoinositide-interacting protein 2 {ECO:0000305},WIPI49-like protein 2;, , GO:0005829;GO:0019898;GO:0005654;GO:0000407;GO:0034045;GO:0032991;GO:0080025;GO:0032266;GO:0010314;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0016236;GO:0006497;GO:0061739;GO:0034497;GO:0098792;, C:cytosol; C:extrinsic component of membrane; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane; C:protein-containing complex;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:macroautophagy; P:protein lipidation; P:protein lipidation involved in autophagosome assembly; P:protein localization to phagophore assembly site; P:xenophagy;|Q9Y4P8 B3KNC2 Q5MNZ8 Q6FI96 Q75L50 Q96IE4 Q9Y364,WD repeat domain phosphoinositide-interacting protein 2 {ECO:0000305},WIPI49-like protein 2;, , GO:0005829;GO:0019898;GO:0005654;GO:0000407;GO:0034045;GO:0032991;GO:0080025;GO:0032266;GO:0010314;GO:0000045;GO:0000422;GO:0044804;GO:0009267;GO:0016236;GO:0006497;GO:0061739;GO:0034497;GO:0098792;, C:cytosol; C:extrinsic component of membrane; C:nucleoplasm; C:phagophore assembly site; C:phagophore assembly site membrane; C:protein-containing complex;, F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:macroautophagy; P:protein lipidation; P:protein lipidation involved in autophagosome assembly; P:protein localization to phagophore assembly site; P:xenophagy; scaffold155 indexed_genome mRNA 1763489 1775482 . + . ID=transcript_14810;Q7RTT9 Q6PJ08 Q86WY8 Q8NAR3 Q8NBM2,Equilibrative nucleoside transporter 4,Plasma membrane monoamine transporter;Solute carrier family 29 member 4;, PF01733;, GO:0016324;GO:0016323;GO:0016021;GO:0005886;GO:0098793;GO:0008324;GO:0015562;GO:0008504;GO:0005326;GO:0005337;GO:0005342;GO:0015101;GO:0019534;GO:0042910;GO:0098655;GO:0090494;GO:0051625;GO:0140115;GO:0001692;GO:0051615;GO:0015844;GO:0006836;GO:0051620;GO:1903825;GO:0015695;GO:0051610;GO:1901998;GO:0150104;GO:0042908;, C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane; C:presynapse;, F:cation transmembrane transporter activity; F:efflux transmembrane transporter activity; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:organic acid transmembrane transporter activity; F:organic cation transmembrane transporter activity; F:toxin transmembrane transporter activity; F:xenobiotic transmembrane transporter activity;, P:cation transmembrane transport; P:dopamine uptake; P:epinephrine uptake; P:export across plasma membrane; P:histamine metabolic process; P:histamine uptake; P:monoamine transport; P:neurotransmitter transport; P:norepinephrine uptake; P:organic acid transmembrane transport; P:organic cation transport; P:serotonin uptake; P:toxin transport; P:transport across blood-brain barrier; P:xenobiotic transport; scaffold155 indexed_genome mRNA 1778576 1799750 . - . ID=transcript_14811;O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding;|O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding;|O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding;|O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding;|O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding;|O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding;|O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding;|O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding; scaffold155 indexed_genome mRNA 1799998 1812121 . - . ID=transcript_14812;O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding;|O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding;|O15417 A8MX41 Q96JH1 Q96K91,Trinucleotide repeat-containing gene 18 protein,Long CAG trinucleotide repeat-containing gene 79 protein;, PF01426;, GO:0005829;GO:0005739;GO:0031965;GO:0005654;GO:0003682;, C:cytosol; C:mitochondrion; C:nuclear membrane; C:nucleoplasm;, F:chromatin binding; scaffold156 indexed_genome mRNA 1137366 1163132 . - . ID=transcript_14813;P48664 Q8N753,Excitatory amino acid transporter 4,Sodium-dependent glutamate/aspartate transporter;Solute carrier family 1 member 6;, PF00375;, GO:0098978;GO:0005794;GO:0005887;GO:0099056;GO:0045111;GO:0016020;GO:0098796;GO:0005886;GO:0005314;GO:0015183;GO:0046872;GO:0015810;GO:0007268;GO:0006811;GO:0098712;GO:0015813;GO:0006836;GO:0001504;GO:0042391;, C:glutamatergic synapse; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intermediate filament cytoskeleton; C:membrane; C:membrane protein complex; C:plasma membrane;, F:high-affinity glutamate transmembrane transporter activity; F:L-aspartate transmembrane transporter activity; F:metal ion binding;, P:aspartate transmembrane transport; P:chemical synaptic transmission; P:ion transport; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:neurotransmitter uptake; P:regulation of membrane potential;|P48664 Q8N753,Excitatory amino acid transporter 4,Sodium-dependent glutamate/aspartate transporter;Solute carrier family 1 member 6;, PF00375;, GO:0098978;GO:0005794;GO:0005887;GO:0099056;GO:0045111;GO:0016020;GO:0098796;GO:0005886;GO:0005314;GO:0015183;GO:0046872;GO:0015810;GO:0007268;GO:0006811;GO:0098712;GO:0015813;GO:0006836;GO:0001504;GO:0042391;, C:glutamatergic synapse; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intermediate filament cytoskeleton; C:membrane; C:membrane protein complex; C:plasma membrane;, F:high-affinity glutamate transmembrane transporter activity; F:L-aspartate transmembrane transporter activity; F:metal ion binding;, P:aspartate transmembrane transport; P:chemical synaptic transmission; P:ion transport; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:neurotransmitter uptake; P:regulation of membrane potential;|P48664 Q8N753,Excitatory amino acid transporter 4,Sodium-dependent glutamate/aspartate transporter;Solute carrier family 1 member 6;, PF00375;, GO:0098978;GO:0005794;GO:0005887;GO:0099056;GO:0045111;GO:0016020;GO:0098796;GO:0005886;GO:0005314;GO:0015183;GO:0046872;GO:0015810;GO:0007268;GO:0006811;GO:0098712;GO:0015813;GO:0006836;GO:0001504;GO:0042391;, C:glutamatergic synapse; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intermediate filament cytoskeleton; C:membrane; C:membrane protein complex; C:plasma membrane;, F:high-affinity glutamate transmembrane transporter activity; F:L-aspartate transmembrane transporter activity; F:metal ion binding;, P:aspartate transmembrane transport; P:chemical synaptic transmission; P:ion transport; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:neurotransmitter uptake; P:regulation of membrane potential;|P48664 Q8N753,Excitatory amino acid transporter 4,Sodium-dependent glutamate/aspartate transporter;Solute carrier family 1 member 6;, PF00375;, GO:0098978;GO:0005794;GO:0005887;GO:0099056;GO:0045111;GO:0016020;GO:0098796;GO:0005886;GO:0005314;GO:0015183;GO:0046872;GO:0015810;GO:0007268;GO:0006811;GO:0098712;GO:0015813;GO:0006836;GO:0001504;GO:0042391;, C:glutamatergic synapse; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intermediate filament cytoskeleton; C:membrane; C:membrane protein complex; C:plasma membrane;, F:high-affinity glutamate transmembrane transporter activity; F:L-aspartate transmembrane transporter activity; F:metal ion binding;, P:aspartate transmembrane transport; P:chemical synaptic transmission; P:ion transport; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:neurotransmitter uptake; P:regulation of membrane potential;|P48664 Q8N753,Excitatory amino acid transporter 4,Sodium-dependent glutamate/aspartate transporter;Solute carrier family 1 member 6;, PF00375;, GO:0098978;GO:0005794;GO:0005887;GO:0099056;GO:0045111;GO:0016020;GO:0098796;GO:0005886;GO:0005314;GO:0015183;GO:0046872;GO:0015810;GO:0007268;GO:0006811;GO:0098712;GO:0015813;GO:0006836;GO:0001504;GO:0042391;, C:glutamatergic synapse; C:Golgi apparatus; C:integral component of plasma membrane; C:integral component of presynaptic membrane; C:intermediate filament cytoskeleton; C:membrane; C:membrane protein complex; C:plasma membrane;, F:high-affinity glutamate transmembrane transporter activity; F:L-aspartate transmembrane transporter activity; F:metal ion binding;, P:aspartate transmembrane transport; P:chemical synaptic transmission; P:ion transport; P:L-glutamate import across plasma membrane; P:L-glutamate transmembrane transport; P:neurotransmitter transport; P:neurotransmitter uptake; P:regulation of membrane potential; scaffold156 indexed_genome mRNA 1296472 1302983 . + . ID=transcript_14814;Q6ZW31 Q7L2I8 Q8N6J2 Q9H8K4,Rho GTPase-activating protein SYDE1,Synapse defective protein 1 homolog 1;, PF00620;, GO:0005829;GO:0005096;GO:0030695;GO:0031532;GO:0090630;GO:0016477;GO:1901165;GO:0051493;GO:0051056;GO:0007165;, C:cytosol;, F:GTPase activator activity; F:GTPase regulator activity;, P:actin cytoskeleton reorganization; P:activation of GTPase activity; P:cell migration; P:positive regulation of trophoblast cell migration; P:regulation of cytoskeleton organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold156 indexed_genome mRNA 1303137 1315651 . - . ID=transcript_14815;A1L0T0 O43341 Q96F08 Q99651 Q9BWN5 Q9UEB2,2-hydroxyacyl-CoA lyase 2 {ECO:0000303|PubMed:28289220},Acetolactate synthase-like protein;IlvB-like protein;, PF02775;PF00205;PF02776;, GO:0005948;GO:0005789;GO:0016021;GO:0016020;GO:0003984;GO:0050660;GO:0016829;GO:0000287;GO:0030976;GO:0001561;GO:0009097;GO:0009099;, C:acetolactate synthase complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:acetolactate synthase activity; F:flavin adenine dinucleotide binding; F:lyase activity; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:isoleucine biosynthetic process; P:valine biosynthetic process;|A1L0T0 O43341 Q96F08 Q99651 Q9BWN5 Q9UEB2,2-hydroxyacyl-CoA lyase 2 {ECO:0000303|PubMed:28289220},Acetolactate synthase-like protein;IlvB-like protein;, PF02775;PF00205;PF02776;, GO:0005948;GO:0005789;GO:0016021;GO:0016020;GO:0003984;GO:0050660;GO:0016829;GO:0000287;GO:0030976;GO:0001561;GO:0009097;GO:0009099;, C:acetolactate synthase complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:acetolactate synthase activity; F:flavin adenine dinucleotide binding; F:lyase activity; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:isoleucine biosynthetic process; P:valine biosynthetic process;|A1L0T0 O43341 Q96F08 Q99651 Q9BWN5 Q9UEB2,2-hydroxyacyl-CoA lyase 2 {ECO:0000303|PubMed:28289220},Acetolactate synthase-like protein;IlvB-like protein;, PF02775;PF00205;PF02776;, GO:0005948;GO:0005789;GO:0016021;GO:0016020;GO:0003984;GO:0050660;GO:0016829;GO:0000287;GO:0030976;GO:0001561;GO:0009097;GO:0009099;, C:acetolactate synthase complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:acetolactate synthase activity; F:flavin adenine dinucleotide binding; F:lyase activity; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:isoleucine biosynthetic process; P:valine biosynthetic process;|A1L0T0 O43341 Q96F08 Q99651 Q9BWN5 Q9UEB2,2-hydroxyacyl-CoA lyase 2 {ECO:0000303|PubMed:28289220},Acetolactate synthase-like protein;IlvB-like protein;, PF02775;PF00205;PF02776;, GO:0005948;GO:0005789;GO:0016021;GO:0016020;GO:0003984;GO:0050660;GO:0016829;GO:0000287;GO:0030976;GO:0001561;GO:0009097;GO:0009099;, C:acetolactate synthase complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:acetolactate synthase activity; F:flavin adenine dinucleotide binding; F:lyase activity; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:isoleucine biosynthetic process; P:valine biosynthetic process;|A1L0T0 O43341 Q96F08 Q99651 Q9BWN5 Q9UEB2,2-hydroxyacyl-CoA lyase 2 {ECO:0000303|PubMed:28289220},Acetolactate synthase-like protein;IlvB-like protein;, PF02775;PF00205;PF02776;, GO:0005948;GO:0005789;GO:0016021;GO:0016020;GO:0003984;GO:0050660;GO:0016829;GO:0000287;GO:0030976;GO:0001561;GO:0009097;GO:0009099;, C:acetolactate synthase complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:acetolactate synthase activity; F:flavin adenine dinucleotide binding; F:lyase activity; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:isoleucine biosynthetic process; P:valine biosynthetic process;|A1L0T0 O43341 Q96F08 Q99651 Q9BWN5 Q9UEB2,2-hydroxyacyl-CoA lyase 2 {ECO:0000303|PubMed:28289220},Acetolactate synthase-like protein;IlvB-like protein;, PF02775;PF00205;PF02776;, GO:0005948;GO:0005789;GO:0016021;GO:0016020;GO:0003984;GO:0050660;GO:0016829;GO:0000287;GO:0030976;GO:0001561;GO:0009097;GO:0009099;, C:acetolactate synthase complex; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:acetolactate synthase activity; F:flavin adenine dinucleotide binding; F:lyase activity; F:magnesium ion binding; F:thiamine pyrophosphate binding;, P:fatty acid alpha-oxidation; P:isoleucine biosynthetic process; P:valine biosynthetic process; scaffold156 indexed_genome mRNA 1398291 1398942 . - . ID=transcript_14816;Q9UM47 Q9UEB3 Q9UPL3 Q9Y6L8,Neurogenic locus notch homolog protein 3,, PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;, GO:0015629;GO:0009986;GO:0005829;GO:0005789;GO:0005576;GO:0000139;GO:0016021;GO:0005654;GO:0005886;GO:0043235;GO:0045296;GO:0005509;GO:0042802;GO:0038023;GO:0007411;GO:0045746;GO:0007219;GO:0007221;GO:0050793;GO:0006367;, C:actin cytoskeleton; C:cell surface; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:nucleoplasm; C:plasma membrane; C:receptor complex;, F:cadherin binding; F:calcium ion binding; F:identical protein binding; F:signaling receptor activity;, P:axon guidance; P:negative regulation of Notch signaling pathway; P:Notch signaling pathway; P:positive regulation of transcription of Notch receptor target; P:regulation of developmental process; P:transcription initiation from RNA polymerase II promoter; scaffold156 indexed_genome mRNA 1422736 1428890 . - . ID=transcript_14817;Q9H6B9 A3KMR3,Epoxide hydrolase 3,Abhydrolase domain-containing protein 9;, PF12697;, GO:0005783;GO:0016021;GO:0043231;GO:0016020;GO:0004301;GO:0016787;GO:0097176;GO:0006629;, C:endoplasmic reticulum; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:epoxide hydrolase activity; F:hydrolase activity;, P:epoxide metabolic process; P:lipid metabolic process;|Q9H6B9 A3KMR3,Epoxide hydrolase 3,Abhydrolase domain-containing protein 9;, PF12697;, GO:0005783;GO:0016021;GO:0043231;GO:0016020;GO:0004301;GO:0016787;GO:0097176;GO:0006629;, C:endoplasmic reticulum; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:epoxide hydrolase activity; F:hydrolase activity;, P:epoxide metabolic process; P:lipid metabolic process;|Q9H6B9 A3KMR3,Epoxide hydrolase 3,Abhydrolase domain-containing protein 9;, PF12697;, GO:0005783;GO:0016021;GO:0043231;GO:0016020;GO:0004301;GO:0016787;GO:0097176;GO:0006629;, C:endoplasmic reticulum; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:epoxide hydrolase activity; F:hydrolase activity;, P:epoxide metabolic process; P:lipid metabolic process; scaffold156 indexed_genome mRNA 1432503 1436949 . - . ID=transcript_14818;O60885 O60433 Q4G0X8 Q86YS8 Q96PD3,Bromodomain-containing protein 4,Protein HUNK1;, PF17035;PF17105;PF00439;, GO:0005694;GO:0000794;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0070577;GO:0106140;GO:0002039;GO:0099122;GO:0008353;GO:0003713;GO:0003712;GO:0006974;GO:0006325;GO:0006338;GO:0043922;GO:2000002;GO:0010971;GO:2001255;GO:0043123;GO:0045944;GO:0032968;GO:0045893;GO:0050727;GO:1901407;GO:0000083;GO:0016032;, C:chromosome; C:condensed nuclear chromosome; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:lysine-acetylated histone binding; F:P-TEFb complex binding; F:p53 binding; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription coactivator activity; F:transcription coregulator activity;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromatin remodeling; P:negative regulation by host of viral transcription; P:negative regulation of DNA damage checkpoint; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of inflammatory response; P:regulation of phosphorylation of RNA polymerase II C-terminal domain; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:viral process;|O60885 O60433 Q4G0X8 Q86YS8 Q96PD3,Bromodomain-containing protein 4,Protein HUNK1;, PF17035;PF17105;PF00439;, GO:0005694;GO:0000794;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0070577;GO:0106140;GO:0002039;GO:0099122;GO:0008353;GO:0003713;GO:0003712;GO:0006974;GO:0006325;GO:0006338;GO:0043922;GO:2000002;GO:0010971;GO:2001255;GO:0043123;GO:0045944;GO:0032968;GO:0045893;GO:0050727;GO:1901407;GO:0000083;GO:0016032;, C:chromosome; C:condensed nuclear chromosome; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:lysine-acetylated histone binding; F:P-TEFb complex binding; F:p53 binding; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription coactivator activity; F:transcription coregulator activity;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromatin remodeling; P:negative regulation by host of viral transcription; P:negative regulation of DNA damage checkpoint; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of inflammatory response; P:regulation of phosphorylation of RNA polymerase II C-terminal domain; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:viral process; scaffold156 indexed_genome mRNA 1438910 1525647 . - . ID=transcript_14819;O60885 O60433 Q4G0X8 Q86YS8 Q96PD3,Bromodomain-containing protein 4,Protein HUNK1;, PF17035;PF17105;PF00439;, GO:0005694;GO:0000794;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0070577;GO:0106140;GO:0002039;GO:0099122;GO:0008353;GO:0003713;GO:0003712;GO:0006974;GO:0006325;GO:0006338;GO:0043922;GO:2000002;GO:0010971;GO:2001255;GO:0043123;GO:0045944;GO:0032968;GO:0045893;GO:0050727;GO:1901407;GO:0000083;GO:0016032;, C:chromosome; C:condensed nuclear chromosome; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:lysine-acetylated histone binding; F:P-TEFb complex binding; F:p53 binding; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription coactivator activity; F:transcription coregulator activity;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromatin remodeling; P:negative regulation by host of viral transcription; P:negative regulation of DNA damage checkpoint; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of inflammatory response; P:regulation of phosphorylation of RNA polymerase II C-terminal domain; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:viral process;|O60885 O60433 Q4G0X8 Q86YS8 Q96PD3,Bromodomain-containing protein 4,Protein HUNK1;, PF17035;PF17105;PF00439;, GO:0005694;GO:0000794;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0070577;GO:0106140;GO:0002039;GO:0099122;GO:0008353;GO:0003713;GO:0003712;GO:0006974;GO:0006325;GO:0006338;GO:0043922;GO:2000002;GO:0010971;GO:2001255;GO:0043123;GO:0045944;GO:0032968;GO:0045893;GO:0050727;GO:1901407;GO:0000083;GO:0016032;, C:chromosome; C:condensed nuclear chromosome; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:lysine-acetylated histone binding; F:P-TEFb complex binding; F:p53 binding; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription coactivator activity; F:transcription coregulator activity;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromatin remodeling; P:negative regulation by host of viral transcription; P:negative regulation of DNA damage checkpoint; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of inflammatory response; P:regulation of phosphorylation of RNA polymerase II C-terminal domain; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:viral process;|O60885 O60433 Q4G0X8 Q86YS8 Q96PD3,Bromodomain-containing protein 4,Protein HUNK1;, PF17035;PF17105;PF00439;, GO:0005694;GO:0000794;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0070577;GO:0106140;GO:0002039;GO:0099122;GO:0008353;GO:0003713;GO:0003712;GO:0006974;GO:0006325;GO:0006338;GO:0043922;GO:2000002;GO:0010971;GO:2001255;GO:0043123;GO:0045944;GO:0032968;GO:0045893;GO:0050727;GO:1901407;GO:0000083;GO:0016032;, C:chromosome; C:condensed nuclear chromosome; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:lysine-acetylated histone binding; F:P-TEFb complex binding; F:p53 binding; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription coactivator activity; F:transcription coregulator activity;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromatin remodeling; P:negative regulation by host of viral transcription; P:negative regulation of DNA damage checkpoint; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of inflammatory response; P:regulation of phosphorylation of RNA polymerase II C-terminal domain; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:viral process;|O60885 O60433 Q4G0X8 Q86YS8 Q96PD3,Bromodomain-containing protein 4,Protein HUNK1;, PF17035;PF17105;PF00439;, GO:0005694;GO:0000794;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0070577;GO:0106140;GO:0002039;GO:0099122;GO:0008353;GO:0003713;GO:0003712;GO:0006974;GO:0006325;GO:0006338;GO:0043922;GO:2000002;GO:0010971;GO:2001255;GO:0043123;GO:0045944;GO:0032968;GO:0045893;GO:0050727;GO:1901407;GO:0000083;GO:0016032;, C:chromosome; C:condensed nuclear chromosome; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:lysine-acetylated histone binding; F:P-TEFb complex binding; F:p53 binding; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription coactivator activity; F:transcription coregulator activity;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromatin remodeling; P:negative regulation by host of viral transcription; P:negative regulation of DNA damage checkpoint; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of inflammatory response; P:regulation of phosphorylation of RNA polymerase II C-terminal domain; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:viral process;|O60885 O60433 Q4G0X8 Q86YS8 Q96PD3,Bromodomain-containing protein 4,Protein HUNK1;, PF17035;PF17105;PF00439;, GO:0005694;GO:0000794;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0070577;GO:0106140;GO:0002039;GO:0099122;GO:0008353;GO:0003713;GO:0003712;GO:0006974;GO:0006325;GO:0006338;GO:0043922;GO:2000002;GO:0010971;GO:2001255;GO:0043123;GO:0045944;GO:0032968;GO:0045893;GO:0050727;GO:1901407;GO:0000083;GO:0016032;, C:chromosome; C:condensed nuclear chromosome; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:lysine-acetylated histone binding; F:P-TEFb complex binding; F:p53 binding; F:RNA polymerase II C-terminal domain binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription coactivator activity; F:transcription coregulator activity;, P:cellular response to DNA damage stimulus; P:chromatin organization; P:chromatin remodeling; P:negative regulation by host of viral transcription; P:negative regulation of DNA damage checkpoint; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of histone H3-K36 trimethylation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of transcription, DNA-templated; P:regulation of inflammatory response; P:regulation of phosphorylation of RNA polymerase II C-terminal domain; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:viral process; scaffold156 indexed_genome mRNA 1535735 1552836 . - . ID=transcript_14820;O43823,A-kinase anchor protein 8,A-kinase anchor protein 95 kDa;, PF04988;, GO:0000793;GO:0001939;GO:0005794;GO:0016020;GO:0005739;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0003690;GO:0042826;GO:0051059;GO:0034237;GO:0003723;GO:0008270;GO:0044839;GO:0071222;GO:0071380;GO:0045087;GO:0000278;GO:0007076;GO:0032720;GO:0031065;GO:0015031;GO:0033127;GO:0007165;, C:condensed chromosome; C:female pronucleus; C:Golgi apparatus; C:membrane; C:mitochondrion; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:histone deacetylase binding; F:NF-kappaB binding; F:protein kinase A regulatory subunit binding; F:RNA binding; F:zinc ion binding;, P:cell cycle G2/M phase transition; P:cellular response to lipopolysaccharide; P:cellular response to prostaglandin E stimulus; P:innate immune response; P:mitotic cell cycle; P:mitotic chromosome condensation; P:negative regulation of tumor necrosis factor production; P:positive regulation of histone deacetylation; P:protein transport; P:regulation of histone phosphorylation; P:signal transduction;|O43823,A-kinase anchor protein 8,A-kinase anchor protein 95 kDa;, PF04988;, GO:0000793;GO:0001939;GO:0005794;GO:0016020;GO:0005739;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0003690;GO:0042826;GO:0051059;GO:0034237;GO:0003723;GO:0008270;GO:0044839;GO:0071222;GO:0071380;GO:0045087;GO:0000278;GO:0007076;GO:0032720;GO:0031065;GO:0015031;GO:0033127;GO:0007165;, C:condensed chromosome; C:female pronucleus; C:Golgi apparatus; C:membrane; C:mitochondrion; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:histone deacetylase binding; F:NF-kappaB binding; F:protein kinase A regulatory subunit binding; F:RNA binding; F:zinc ion binding;, P:cell cycle G2/M phase transition; P:cellular response to lipopolysaccharide; P:cellular response to prostaglandin E stimulus; P:innate immune response; P:mitotic cell cycle; P:mitotic chromosome condensation; P:negative regulation of tumor necrosis factor production; P:positive regulation of histone deacetylation; P:protein transport; P:regulation of histone phosphorylation; P:signal transduction;|O43823,A-kinase anchor protein 8,A-kinase anchor protein 95 kDa;, PF04988;, GO:0000793;GO:0001939;GO:0005794;GO:0016020;GO:0005739;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0003690;GO:0042826;GO:0051059;GO:0034237;GO:0003723;GO:0008270;GO:0044839;GO:0071222;GO:0071380;GO:0045087;GO:0000278;GO:0007076;GO:0032720;GO:0031065;GO:0015031;GO:0033127;GO:0007165;, C:condensed chromosome; C:female pronucleus; C:Golgi apparatus; C:membrane; C:mitochondrion; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:histone deacetylase binding; F:NF-kappaB binding; F:protein kinase A regulatory subunit binding; F:RNA binding; F:zinc ion binding;, P:cell cycle G2/M phase transition; P:cellular response to lipopolysaccharide; P:cellular response to prostaglandin E stimulus; P:innate immune response; P:mitotic cell cycle; P:mitotic chromosome condensation; P:negative regulation of tumor necrosis factor production; P:positive regulation of histone deacetylation; P:protein transport; P:regulation of histone phosphorylation; P:signal transduction;|O43823,A-kinase anchor protein 8,A-kinase anchor protein 95 kDa;, PF04988;, GO:0000793;GO:0001939;GO:0005794;GO:0016020;GO:0005739;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0003690;GO:0042826;GO:0051059;GO:0034237;GO:0003723;GO:0008270;GO:0044839;GO:0071222;GO:0071380;GO:0045087;GO:0000278;GO:0007076;GO:0032720;GO:0031065;GO:0015031;GO:0033127;GO:0007165;, C:condensed chromosome; C:female pronucleus; C:Golgi apparatus; C:membrane; C:mitochondrion; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded DNA binding; F:histone deacetylase binding; F:NF-kappaB binding; F:protein kinase A regulatory subunit binding; F:RNA binding; F:zinc ion binding;, P:cell cycle G2/M phase transition; P:cellular response to lipopolysaccharide; P:cellular response to prostaglandin E stimulus; P:innate immune response; P:mitotic cell cycle; P:mitotic chromosome condensation; P:negative regulation of tumor necrosis factor production; P:positive regulation of histone deacetylation; P:protein transport; P:regulation of histone phosphorylation; P:signal transduction; scaffold156 indexed_genome mRNA 1553680 1584750 . - . ID=transcript_14821;Q9ULX6 B4DJ74 B5BU90 O94792 Q96J58 Q9NRQ0 Q9UGM0,A-kinase anchor protein 8-like,Helicase A-binding protein 95;Homologous to AKAP95 protein;Neighbor of A-kinase-anchoring protein 95;, PF04988;, GO:0000785;GO:0005737;GO:0016363;GO:0016607;GO:0005634;GO:0016605;GO:1990904;GO:0017151;GO:0003677;GO:0042826;GO:0005521;GO:0046872;GO:0034237;GO:0003723;GO:0044839;GO:0007076;GO:0006397;GO:0051081;GO:0031065;GO:0045944;GO:0033127;GO:0010793;GO:0008380;GO:0016032;, C:chromatin; C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleus; C:PML body; C:ribonucleoprotein complex;, F:DEAD/H-box RNA helicase binding; F:DNA binding; F:histone deacetylase binding; F:lamin binding; F:metal ion binding; F:protein kinase A regulatory subunit binding; F:RNA binding;, P:cell cycle G2/M phase transition; P:mitotic chromosome condensation; P:mRNA processing; P:nuclear envelope disassembly; P:positive regulation of histone deacetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of histone phosphorylation; P:regulation of mRNA export from nucleus; P:RNA splicing; P:viral process;|Q9ULX6 B4DJ74 B5BU90 O94792 Q96J58 Q9NRQ0 Q9UGM0,A-kinase anchor protein 8-like,Helicase A-binding protein 95;Homologous to AKAP95 protein;Neighbor of A-kinase-anchoring protein 95;, PF04988;, GO:0000785;GO:0005737;GO:0016363;GO:0016607;GO:0005634;GO:0016605;GO:1990904;GO:0017151;GO:0003677;GO:0042826;GO:0005521;GO:0046872;GO:0034237;GO:0003723;GO:0044839;GO:0007076;GO:0006397;GO:0051081;GO:0031065;GO:0045944;GO:0033127;GO:0010793;GO:0008380;GO:0016032;, C:chromatin; C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleus; C:PML body; C:ribonucleoprotein complex;, F:DEAD/H-box RNA helicase binding; F:DNA binding; F:histone deacetylase binding; F:lamin binding; F:metal ion binding; F:protein kinase A regulatory subunit binding; F:RNA binding;, P:cell cycle G2/M phase transition; P:mitotic chromosome condensation; P:mRNA processing; P:nuclear envelope disassembly; P:positive regulation of histone deacetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of histone phosphorylation; P:regulation of mRNA export from nucleus; P:RNA splicing; P:viral process;|Q9ULX6 B4DJ74 B5BU90 O94792 Q96J58 Q9NRQ0 Q9UGM0,A-kinase anchor protein 8-like,Helicase A-binding protein 95;Homologous to AKAP95 protein;Neighbor of A-kinase-anchoring protein 95;, PF04988;, GO:0000785;GO:0005737;GO:0016363;GO:0016607;GO:0005634;GO:0016605;GO:1990904;GO:0017151;GO:0003677;GO:0042826;GO:0005521;GO:0046872;GO:0034237;GO:0003723;GO:0044839;GO:0007076;GO:0006397;GO:0051081;GO:0031065;GO:0045944;GO:0033127;GO:0010793;GO:0008380;GO:0016032;, C:chromatin; C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleus; C:PML body; C:ribonucleoprotein complex;, F:DEAD/H-box RNA helicase binding; F:DNA binding; F:histone deacetylase binding; F:lamin binding; F:metal ion binding; F:protein kinase A regulatory subunit binding; F:RNA binding;, P:cell cycle G2/M phase transition; P:mitotic chromosome condensation; P:mRNA processing; P:nuclear envelope disassembly; P:positive regulation of histone deacetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of histone phosphorylation; P:regulation of mRNA export from nucleus; P:RNA splicing; P:viral process;|Q9ULX6 B4DJ74 B5BU90 O94792 Q96J58 Q9NRQ0 Q9UGM0,A-kinase anchor protein 8-like,Helicase A-binding protein 95;Homologous to AKAP95 protein;Neighbor of A-kinase-anchoring protein 95;, PF04988;, GO:0000785;GO:0005737;GO:0016363;GO:0016607;GO:0005634;GO:0016605;GO:1990904;GO:0017151;GO:0003677;GO:0042826;GO:0005521;GO:0046872;GO:0034237;GO:0003723;GO:0044839;GO:0007076;GO:0006397;GO:0051081;GO:0031065;GO:0045944;GO:0033127;GO:0010793;GO:0008380;GO:0016032;, C:chromatin; C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleus; C:PML body; C:ribonucleoprotein complex;, F:DEAD/H-box RNA helicase binding; F:DNA binding; F:histone deacetylase binding; F:lamin binding; F:metal ion binding; F:protein kinase A regulatory subunit binding; F:RNA binding;, P:cell cycle G2/M phase transition; P:mitotic chromosome condensation; P:mRNA processing; P:nuclear envelope disassembly; P:positive regulation of histone deacetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of histone phosphorylation; P:regulation of mRNA export from nucleus; P:RNA splicing; P:viral process;|Q9ULX6 B4DJ74 B5BU90 O94792 Q96J58 Q9NRQ0 Q9UGM0,A-kinase anchor protein 8-like,Helicase A-binding protein 95;Homologous to AKAP95 protein;Neighbor of A-kinase-anchoring protein 95;, PF04988;, GO:0000785;GO:0005737;GO:0016363;GO:0016607;GO:0005634;GO:0016605;GO:1990904;GO:0017151;GO:0003677;GO:0042826;GO:0005521;GO:0046872;GO:0034237;GO:0003723;GO:0044839;GO:0007076;GO:0006397;GO:0051081;GO:0031065;GO:0045944;GO:0033127;GO:0010793;GO:0008380;GO:0016032;, C:chromatin; C:cytoplasm; C:nuclear matrix; C:nuclear speck; C:nucleus; C:PML body; C:ribonucleoprotein complex;, F:DEAD/H-box RNA helicase binding; F:DNA binding; F:histone deacetylase binding; F:lamin binding; F:metal ion binding; F:protein kinase A regulatory subunit binding; F:RNA binding;, P:cell cycle G2/M phase transition; P:mitotic chromosome condensation; P:mRNA processing; P:nuclear envelope disassembly; P:positive regulation of histone deacetylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of histone phosphorylation; P:regulation of mRNA export from nucleus; P:RNA splicing; P:viral process; scaffold156 indexed_genome mRNA 1587497 1590634 . - . ID=transcript_14822;Q96IG5 Q96SQ6 Q9BUR8 Q9NPT1,Protein Wiz,Widely-interspaced zinc finger-containing protein;Zinc finger protein 803;, , GO:0070062;GO:0030496;GO:0005654;GO:0005634;GO:0000981;GO:1990226;GO:0046872;GO:0044877;GO:0000978;GO:0001226;GO:0010571;GO:0050821;GO:0006357;, C:extracellular exosome; C:midbody; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone methyltransferase binding; F:metal ion binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding;, P:positive regulation of nuclear cell cycle DNA replication; P:protein stabilization; P:regulation of transcription by RNA polymerase II; scaffold156 indexed_genome mRNA 1590703 1603823 . - . ID=transcript_14823;Q96IG5 Q96SQ6 Q9BUR8 Q9NPT1,Protein Wiz,Widely-interspaced zinc finger-containing protein;Zinc finger protein 803;, , GO:0070062;GO:0030496;GO:0005654;GO:0005634;GO:0000981;GO:1990226;GO:0046872;GO:0044877;GO:0000978;GO:0001226;GO:0010571;GO:0050821;GO:0006357;, C:extracellular exosome; C:midbody; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone methyltransferase binding; F:metal ion binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding;, P:positive regulation of nuclear cell cycle DNA replication; P:protein stabilization; P:regulation of transcription by RNA polymerase II;|Q96IG5 Q96SQ6 Q9BUR8 Q9NPT1,Protein Wiz,Widely-interspaced zinc finger-containing protein;Zinc finger protein 803;, , GO:0070062;GO:0030496;GO:0005654;GO:0005634;GO:0000981;GO:1990226;GO:0046872;GO:0044877;GO:0000978;GO:0001226;GO:0010571;GO:0050821;GO:0006357;, C:extracellular exosome; C:midbody; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone methyltransferase binding; F:metal ion binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding;, P:positive regulation of nuclear cell cycle DNA replication; P:protein stabilization; P:regulation of transcription by RNA polymerase II; scaffold156 indexed_genome mRNA 1603827 1604869 . + . ID=transcript_14824;Q96IG5 Q96SQ6 Q9BUR8 Q9NPT1,Protein Wiz,Widely-interspaced zinc finger-containing protein;Zinc finger protein 803;, , GO:0070062;GO:0030496;GO:0005654;GO:0005634;GO:0000981;GO:1990226;GO:0046872;GO:0044877;GO:0000978;GO:0001226;GO:0010571;GO:0050821;GO:0006357;, C:extracellular exosome; C:midbody; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone methyltransferase binding; F:metal ion binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding;, P:positive regulation of nuclear cell cycle DNA replication; P:protein stabilization; P:regulation of transcription by RNA polymerase II; scaffold156 indexed_genome mRNA 1618136 1624584 . - . ID=transcript_14825;Q86YV0 Q8N2T9 Q9H735,RAS protein activator like-3,, PF00616;, GO:0005938;GO:0005737;GO:0098562;GO:0005829;GO:0070062;GO:0016020;GO:0005096;GO:0042802;GO:0000165;GO:0046580;GO:0051142;, C:cell cortex; C:cytoplasm; C:cytoplasmic side of membrane; C:cytosol; C:extracellular exosome; C:membrane;, F:GTPase activator activity; F:identical protein binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:positive regulation of NK T cell proliferation;|Q86YV0 Q8N2T9 Q9H735,RAS protein activator like-3,, PF00616;, GO:0005938;GO:0005737;GO:0098562;GO:0005829;GO:0070062;GO:0016020;GO:0005096;GO:0042802;GO:0000165;GO:0046580;GO:0051142;, C:cell cortex; C:cytoplasm; C:cytoplasmic side of membrane; C:cytosol; C:extracellular exosome; C:membrane;, F:GTPase activator activity; F:identical protein binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:positive regulation of NK T cell proliferation; scaffold156 indexed_genome mRNA 1627674 1633275 . - . ID=transcript_14826;Q96PD5 A8K050 A8K8C7 B2RMZ2 B7ZM33 Q68CK1 Q96N74 Q9UC60,N-acetylmuramoyl-L-alanine amidase,Peptidoglycan recognition protein 2;Peptidoglycan recognition protein long;, PF01510;, GO:0070062;GO:0005576;GO:0016020;GO:0008745;GO:0042834;GO:0016019;GO:0008270;GO:0019730;GO:0051701;GO:0050830;GO:0016045;GO:0045087;GO:0032689;GO:0032827;GO:0001519;GO:0009253;GO:0050727;, C:extracellular exosome; C:extracellular region; C:membrane;, F:N-acetylmuramoyl-L-alanine amidase activity; F:peptidoglycan binding; F:peptidoglycan immune receptor activity; F:zinc ion binding;, P:antimicrobial humoral response; P:biological process involved in interaction with host; P:defense response to Gram-positive bacterium; P:detection of bacterium; P:innate immune response; P:negative regulation of interferon-gamma production; P:negative regulation of natural killer cell differentiation involved in immune response; P:peptide amidation; P:peptidoglycan catabolic process; P:regulation of inflammatory response; scaffold156 indexed_genome mRNA 1697693 1705332 . + . ID=transcript_14827;Q6NT55 Q8N8H4,Cytochrome P450 4F22 {ECO:0000303|PubMed:26056268},, PF00067;, GO:0005789;GO:0016021;GO:0020037;GO:0005506;GO:0004497;GO:0016705;GO:0046513;GO:0006690;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;, P:ceramide biosynthetic process; P:icosanoid metabolic process; scaffold156 indexed_genome mRNA 1724773 1756713 . + . ID=transcript_14828;Q08477 B7Z8Z3 O60634 Q5U740,Cytochrome P450 4F3,20-hydroxyeicosatetraenoic acid synthase {ECO:0000303|PubMed:11461919};CYPIVF3;Cytochrome P450-LTB-omega;Docosahexaenoic acid omega-hydroxylase CYP4F3 {ECO:0000305|PubMed:16820285};Leukotriene-B(4) 20-monooxygenase 2;Leukotriene-B(4) omega-hydroxylase 2;, PF00067;, GO:0005789;GO:0016021;GO:0043231;GO:0008391;GO:0070330;GO:0102207;GO:0020037;GO:0005506;GO:0050051;GO:0004497;GO:0019369;GO:0006690;GO:0036101;GO:0006691;GO:0042361;GO:0042376;GO:0042377;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid monooxygenase activity; F:aromatase activity; F:docosanoate omega-hydroxylase activity; F:heme binding; F:iron ion binding; F:leukotriene-B4 20-monooxygenase activity; F:monooxygenase activity;, P:arachidonic acid metabolic process; P:icosanoid metabolic process; P:leukotriene B4 catabolic process; P:leukotriene metabolic process; P:menaquinone catabolic process; P:phylloquinone catabolic process; P:vitamin K catabolic process; scaffold156 indexed_genome mRNA 1851798 1865811 . + . ID=transcript_14829;P78329 A0A024R7K3 A8K425 B4DV75 Q16677 Q6NWT4 Q6NWT6 Q9NNZ0 Q9UIU8,Cytochrome P450 4F2 {ECO:0000303|PubMed:20861217},20-hydroxyeicosatetraenoic acid synthase {ECO:0000303|PubMed:10660572};Arachidonic acid omega-hydroxylase {ECO:0000303|PubMed:10660572};CYPIVF2;Cytochrome P450-LTB-omega;Docosahexaenoic acid omega-hydroxylase;Leukotriene-B(4) 20-monooxygenase 1;Leukotriene-B(4) omega-hydroxylase 1 {ECO:0000305};Phylloquinone omega-hydroxylase CYP4F2 {ECO:0000305};, PF00067;, GO:0016324;GO:0005737;GO:0005789;GO:0043231;GO:0018685;GO:0052871;GO:0008392;GO:0008391;GO:0052869;GO:0070330;GO:0102207;GO:0020037;GO:0005506;GO:0050051;GO:0016709;GO:0052872;GO:0019369;GO:0007596;GO:0017144;GO:0019373;GO:0006690;GO:0036101;GO:0006691;GO:0001676;GO:0042361;GO:0032304;GO:0097267;GO:0042376;GO:0032305;GO:0003095;GO:0008217;GO:0003091;GO:0055078;GO:0000038;GO:0042360;GO:0042377;, C:apical plasma membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:alkane 1-monooxygenase activity; F:alpha-tocopherol omega-hydroxylase activity; F:arachidonic acid epoxygenase activity; F:arachidonic acid monooxygenase activity; F:arachidonic acid omega-hydroxylase activity; F:aromatase activity; F:docosanoate omega-hydroxylase activity; F:heme binding; F:iron ion binding; F:leukotriene-B4 20-monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:tocotrienol omega-hydroxylase activity;, P:arachidonic acid metabolic process; P:blood coagulation; P:drug metabolic process; P:epoxygenase P450 pathway; P:icosanoid metabolic process; P:leukotriene B4 catabolic process; P:leukotriene metabolic process; P:long-chain fatty acid metabolic process; P:menaquinone catabolic process; P:negative regulation of icosanoid secretion; P:omega-hydroxylase P450 pathway; P:phylloquinone catabolic process; P:positive regulation of icosanoid secretion; P:pressure natriuresis; P:regulation of blood pressure; P:renal water homeostasis; P:sodium ion homeostasis; P:very long-chain fatty acid metabolic process; P:vitamin E metabolic process; P:vitamin K catabolic process;|P78329 A0A024R7K3 A8K425 B4DV75 Q16677 Q6NWT4 Q6NWT6 Q9NNZ0 Q9UIU8,Cytochrome P450 4F2 {ECO:0000303|PubMed:20861217},20-hydroxyeicosatetraenoic acid synthase {ECO:0000303|PubMed:10660572};Arachidonic acid omega-hydroxylase {ECO:0000303|PubMed:10660572};CYPIVF2;Cytochrome P450-LTB-omega;Docosahexaenoic acid omega-hydroxylase;Leukotriene-B(4) 20-monooxygenase 1;Leukotriene-B(4) omega-hydroxylase 1 {ECO:0000305};Phylloquinone omega-hydroxylase CYP4F2 {ECO:0000305};, PF00067;, GO:0016324;GO:0005737;GO:0005789;GO:0043231;GO:0018685;GO:0052871;GO:0008392;GO:0008391;GO:0052869;GO:0070330;GO:0102207;GO:0020037;GO:0005506;GO:0050051;GO:0016709;GO:0052872;GO:0019369;GO:0007596;GO:0017144;GO:0019373;GO:0006690;GO:0036101;GO:0006691;GO:0001676;GO:0042361;GO:0032304;GO:0097267;GO:0042376;GO:0032305;GO:0003095;GO:0008217;GO:0003091;GO:0055078;GO:0000038;GO:0042360;GO:0042377;, C:apical plasma membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:alkane 1-monooxygenase activity; F:alpha-tocopherol omega-hydroxylase activity; F:arachidonic acid epoxygenase activity; F:arachidonic acid monooxygenase activity; F:arachidonic acid omega-hydroxylase activity; F:aromatase activity; F:docosanoate omega-hydroxylase activity; F:heme binding; F:iron ion binding; F:leukotriene-B4 20-monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:tocotrienol omega-hydroxylase activity;, P:arachidonic acid metabolic process; P:blood coagulation; P:drug metabolic process; P:epoxygenase P450 pathway; P:icosanoid metabolic process; P:leukotriene B4 catabolic process; P:leukotriene metabolic process; P:long-chain fatty acid metabolic process; P:menaquinone catabolic process; P:negative regulation of icosanoid secretion; P:omega-hydroxylase P450 pathway; P:phylloquinone catabolic process; P:positive regulation of icosanoid secretion; P:pressure natriuresis; P:regulation of blood pressure; P:renal water homeostasis; P:sodium ion homeostasis; P:very long-chain fatty acid metabolic process; P:vitamin E metabolic process; P:vitamin K catabolic process; scaffold156 indexed_genome mRNA 1883186 1899294 . + . ID=transcript_14830;P78329 A0A024R7K3 A8K425 B4DV75 Q16677 Q6NWT4 Q6NWT6 Q9NNZ0 Q9UIU8,Cytochrome P450 4F2 {ECO:0000303|PubMed:20861217},20-hydroxyeicosatetraenoic acid synthase {ECO:0000303|PubMed:10660572};Arachidonic acid omega-hydroxylase {ECO:0000303|PubMed:10660572};CYPIVF2;Cytochrome P450-LTB-omega;Docosahexaenoic acid omega-hydroxylase;Leukotriene-B(4) 20-monooxygenase 1;Leukotriene-B(4) omega-hydroxylase 1 {ECO:0000305};Phylloquinone omega-hydroxylase CYP4F2 {ECO:0000305};, PF00067;, GO:0016324;GO:0005737;GO:0005789;GO:0043231;GO:0018685;GO:0052871;GO:0008392;GO:0008391;GO:0052869;GO:0070330;GO:0102207;GO:0020037;GO:0005506;GO:0050051;GO:0016709;GO:0052872;GO:0019369;GO:0007596;GO:0017144;GO:0019373;GO:0006690;GO:0036101;GO:0006691;GO:0001676;GO:0042361;GO:0032304;GO:0097267;GO:0042376;GO:0032305;GO:0003095;GO:0008217;GO:0003091;GO:0055078;GO:0000038;GO:0042360;GO:0042377;, C:apical plasma membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:alkane 1-monooxygenase activity; F:alpha-tocopherol omega-hydroxylase activity; F:arachidonic acid epoxygenase activity; F:arachidonic acid monooxygenase activity; F:arachidonic acid omega-hydroxylase activity; F:aromatase activity; F:docosanoate omega-hydroxylase activity; F:heme binding; F:iron ion binding; F:leukotriene-B4 20-monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:tocotrienol omega-hydroxylase activity;, P:arachidonic acid metabolic process; P:blood coagulation; P:drug metabolic process; P:epoxygenase P450 pathway; P:icosanoid metabolic process; P:leukotriene B4 catabolic process; P:leukotriene metabolic process; P:long-chain fatty acid metabolic process; P:menaquinone catabolic process; P:negative regulation of icosanoid secretion; P:omega-hydroxylase P450 pathway; P:phylloquinone catabolic process; P:positive regulation of icosanoid secretion; P:pressure natriuresis; P:regulation of blood pressure; P:renal water homeostasis; P:sodium ion homeostasis; P:very long-chain fatty acid metabolic process; P:vitamin E metabolic process; P:vitamin K catabolic process; scaffold157 indexed_genome mRNA 4594 6279 . - . ID=transcript_14831;P20749,B-cell lymphoma 3 protein,Proto-oncogene BCL3;, PF00023;PF12796;, GO:0032996;GO:0033257;GO:0005737;GO:0005829;GO:0043231;GO:0030496;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030674;GO:0003713;GO:0008134;GO:0019730;GO:0006974;GO:0042742;GO:0042832;GO:0030330;GO:0030198;GO:0002268;GO:0002467;GO:0002455;GO:0007249;GO:0042771;GO:0051457;GO:0002315;GO:0043066;GO:0032717;GO:0046426;GO:0045892;GO:0032720;GO:0032729;GO:0032733;GO:0045944;GO:0045893;GO:0045727;GO:0042981;GO:0051101;GO:1901222;GO:0010225;GO:0009615;GO:0048536;GO:0042088;GO:0045064;GO:0006351;, C:Bcl3-Bcl10 complex; C:Bcl3/NF-kappaB2 complex; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:midbody; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:protein-macromolecule adaptor activity; F:transcription coactivator activity; F:transcription factor binding;, P:antimicrobial humoral response; P:cellular response to DNA damage stimulus; P:defense response to bacterium; P:defense response to protozoan; P:DNA damage response, signal transduction by p53 class mediator; P:extracellular matrix organization; P:follicular dendritic cell differentiation; P:germinal center formation; P:humoral immune response mediated by circulating immunoglobulin; P:I-kappaB kinase/NF-kappaB signaling; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:maintenance of protein location in nucleus; P:marginal zone B cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of interleukin-8 production; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:regulation of apoptotic process; P:regulation of DNA binding; P:regulation of NIK/NF-kappaB signaling; P:response to UV-C; P:response to virus; P:spleen development; P:T-helper 1 type immune response; P:T-helper 2 cell differentiation; P:transcription, DNA-templated; scaffold157 indexed_genome mRNA 7778 9122 . + . ID=transcript_14832;P20749,B-cell lymphoma 3 protein,Proto-oncogene BCL3;, PF00023;PF12796;, GO:0032996;GO:0033257;GO:0005737;GO:0005829;GO:0043231;GO:0030496;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030674;GO:0003713;GO:0008134;GO:0019730;GO:0006974;GO:0042742;GO:0042832;GO:0030330;GO:0030198;GO:0002268;GO:0002467;GO:0002455;GO:0007249;GO:0042771;GO:0051457;GO:0002315;GO:0043066;GO:0032717;GO:0046426;GO:0045892;GO:0032720;GO:0032729;GO:0032733;GO:0045944;GO:0045893;GO:0045727;GO:0042981;GO:0051101;GO:1901222;GO:0010225;GO:0009615;GO:0048536;GO:0042088;GO:0045064;GO:0006351;, C:Bcl3-Bcl10 complex; C:Bcl3/NF-kappaB2 complex; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:midbody; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:protein-macromolecule adaptor activity; F:transcription coactivator activity; F:transcription factor binding;, P:antimicrobial humoral response; P:cellular response to DNA damage stimulus; P:defense response to bacterium; P:defense response to protozoan; P:DNA damage response, signal transduction by p53 class mediator; P:extracellular matrix organization; P:follicular dendritic cell differentiation; P:germinal center formation; P:humoral immune response mediated by circulating immunoglobulin; P:I-kappaB kinase/NF-kappaB signaling; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:maintenance of protein location in nucleus; P:marginal zone B cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of interleukin-8 production; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:regulation of apoptotic process; P:regulation of DNA binding; P:regulation of NIK/NF-kappaB signaling; P:response to UV-C; P:response to virus; P:spleen development; P:T-helper 1 type immune response; P:T-helper 2 cell differentiation; P:transcription, DNA-templated;|P20749,B-cell lymphoma 3 protein,Proto-oncogene BCL3;, PF00023;PF12796;, GO:0032996;GO:0033257;GO:0005737;GO:0005829;GO:0043231;GO:0030496;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0030674;GO:0003713;GO:0008134;GO:0019730;GO:0006974;GO:0042742;GO:0042832;GO:0030330;GO:0030198;GO:0002268;GO:0002467;GO:0002455;GO:0007249;GO:0042771;GO:0051457;GO:0002315;GO:0043066;GO:0032717;GO:0046426;GO:0045892;GO:0032720;GO:0032729;GO:0032733;GO:0045944;GO:0045893;GO:0045727;GO:0042981;GO:0051101;GO:1901222;GO:0010225;GO:0009615;GO:0048536;GO:0042088;GO:0045064;GO:0006351;, C:Bcl3-Bcl10 complex; C:Bcl3/NF-kappaB2 complex; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:midbody; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:protein-macromolecule adaptor activity; F:transcription coactivator activity; F:transcription factor binding;, P:antimicrobial humoral response; P:cellular response to DNA damage stimulus; P:defense response to bacterium; P:defense response to protozoan; P:DNA damage response, signal transduction by p53 class mediator; P:extracellular matrix organization; P:follicular dendritic cell differentiation; P:germinal center formation; P:humoral immune response mediated by circulating immunoglobulin; P:I-kappaB kinase/NF-kappaB signaling; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:maintenance of protein location in nucleus; P:marginal zone B cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of interleukin-8 production; P:negative regulation of receptor signaling pathway via JAK-STAT; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-10 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:regulation of apoptotic process; P:regulation of DNA binding; P:regulation of NIK/NF-kappaB signaling; P:response to UV-C; P:response to virus; P:spleen development; P:T-helper 1 type immune response; P:T-helper 2 cell differentiation; P:transcription, DNA-templated; scaffold157 indexed_genome mRNA 19561 22914 . - . ID=transcript_14833;Q9ULV8 Q8N1E5 Q9Y5Z2 Q9Y5Z3,E3 ubiquitin-protein ligase CBL-C,RING finger protein 57;RING-type E3 ubiquitin transferase CBL-C {ECO:0000305};SH3-binding protein CBL-3;SH3-binding protein CBL-C;Signal transduction protein CBL-C;, PF02262;PF02761;PF02762;, GO:0045121;GO:0005886;GO:0005509;GO:0005154;GO:0001784;GO:0030971;GO:0017124;GO:0061630;GO:0008270;GO:0007166;GO:0042059;GO:0007175;GO:0043407;GO:0016567;GO:0007165;GO:0006511;, C:membrane raft; C:plasma membrane;, F:calcium ion binding; F:epidermal growth factor receptor binding; F:phosphotyrosine residue binding; F:receptor tyrosine kinase binding; F:SH3 domain binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of MAP kinase activity; P:protein ubiquitination; P:signal transduction; P:ubiquitin-dependent protein catabolic process; scaffold157 indexed_genome mRNA 24483 32594 . + . ID=transcript_14834;Q9ULV8 Q8N1E5 Q9Y5Z2 Q9Y5Z3,E3 ubiquitin-protein ligase CBL-C,RING finger protein 57;RING-type E3 ubiquitin transferase CBL-C {ECO:0000305};SH3-binding protein CBL-3;SH3-binding protein CBL-C;Signal transduction protein CBL-C;, PF02262;PF02761;PF02762;, GO:0045121;GO:0005886;GO:0005509;GO:0005154;GO:0001784;GO:0030971;GO:0017124;GO:0061630;GO:0008270;GO:0007166;GO:0042059;GO:0007175;GO:0043407;GO:0016567;GO:0007165;GO:0006511;, C:membrane raft; C:plasma membrane;, F:calcium ion binding; F:epidermal growth factor receptor binding; F:phosphotyrosine residue binding; F:receptor tyrosine kinase binding; F:SH3 domain binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of MAP kinase activity; P:protein ubiquitination; P:signal transduction; P:ubiquitin-dependent protein catabolic process;|Q9ULV8 Q8N1E5 Q9Y5Z2 Q9Y5Z3,E3 ubiquitin-protein ligase CBL-C,RING finger protein 57;RING-type E3 ubiquitin transferase CBL-C {ECO:0000305};SH3-binding protein CBL-3;SH3-binding protein CBL-C;Signal transduction protein CBL-C;, PF02262;PF02761;PF02762;, GO:0045121;GO:0005886;GO:0005509;GO:0005154;GO:0001784;GO:0030971;GO:0017124;GO:0061630;GO:0008270;GO:0007166;GO:0042059;GO:0007175;GO:0043407;GO:0016567;GO:0007165;GO:0006511;, C:membrane raft; C:plasma membrane;, F:calcium ion binding; F:epidermal growth factor receptor binding; F:phosphotyrosine residue binding; F:receptor tyrosine kinase binding; F:SH3 domain binding; F:ubiquitin protein ligase activity; F:zinc ion binding;, P:cell surface receptor signaling pathway; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity; P:negative regulation of MAP kinase activity; P:protein ubiquitination; P:signal transduction; P:ubiquitin-dependent protein catabolic process; scaffold157 indexed_genome mRNA 54065 54719 . - . ID=transcript_14835;P50895 A8MYF9 A9YWT5 A9YWT6 Q86VC7,Basal cell adhesion molecule,Auberger B antigen;B-CAM cell surface glycoprotein;F8/G253 antigen;Lutheran antigen;Lutheran blood group glycoprotein;, PF08205;PF13895;PF07686;, GO:0062023;GO:0009897;GO:0070062;GO:0005576;GO:0005887;GO:0005886;GO:0043236;GO:0005055;GO:0008022;GO:0004888;GO:0007155;GO:0007160;GO:0007165;, C:collagen-containing extracellular matrix; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:laminin binding; F:laminin receptor activity; F:protein C-terminus binding; F:transmembrane signaling receptor activity;, P:cell adhesion; P:cell-matrix adhesion; P:signal transduction; scaffold157 indexed_genome mRNA 70116 102803 . + . ID=transcript_14836;Q92692 A8K5L5 O75455 Q6IBI6 Q96J29,Nectin-2,Herpes virus entry mediator B;Nectin cell adhesion molecule 2 {ECO:0000312|HGNC:HGNC:9707};Poliovirus receptor-related protein 2;, PF08205;PF07686;, GO:0043296;GO:0009986;GO:0044291;GO:0005911;GO:0070062;GO:0005925;GO:0016021;GO:0005886;GO:0005915;GO:0050839;GO:0015026;GO:0042802;GO:0042803;GO:0001618;GO:0001675;GO:0034332;GO:0044406;GO:0032990;GO:0044782;GO:0046814;GO:0007010;GO:0051654;GO:0009566;GO:0019064;GO:0007156;GO:0002891;GO:0033005;GO:0045954;GO:0002860;GO:0050862;GO:0050776;GO:0046596;GO:0030382;GO:0007286;GO:0007289;GO:0042271;GO:0060370;, C:apical junction complex; C:cell surface; C:cell-cell contact zone; C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:plasma membrane; C:zonula adherens;, F:cell adhesion molecule binding; F:coreceptor activity; F:identical protein binding; F:protein homodimerization activity; F:virus receptor activity;, P:acrosome assembly; P:adherens junction organization; P:adhesion of symbiont to host; P:cell part morphogenesis; P:cilium organization; P:coreceptor-mediated virion attachment to host cell; P:cytoskeleton organization; P:establishment of mitochondrion localization; P:fertilization; P:fusion of virus membrane with host plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of immunoglobulin mediated immune response; P:positive regulation of mast cell activation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:positive regulation of T cell receptor signaling pathway; P:regulation of immune response; P:regulation of viral entry into host cell; P:sperm mitochondrion organization; P:spermatid development; P:spermatid nucleus differentiation; P:susceptibility to natural killer cell mediated cytotoxicity; P:susceptibility to T cell mediated cytotoxicity;|Q92692 A8K5L5 O75455 Q6IBI6 Q96J29,Nectin-2,Herpes virus entry mediator B;Nectin cell adhesion molecule 2 {ECO:0000312|HGNC:HGNC:9707};Poliovirus receptor-related protein 2;, PF08205;PF07686;, GO:0043296;GO:0009986;GO:0044291;GO:0005911;GO:0070062;GO:0005925;GO:0016021;GO:0005886;GO:0005915;GO:0050839;GO:0015026;GO:0042802;GO:0042803;GO:0001618;GO:0001675;GO:0034332;GO:0044406;GO:0032990;GO:0044782;GO:0046814;GO:0007010;GO:0051654;GO:0009566;GO:0019064;GO:0007156;GO:0002891;GO:0033005;GO:0045954;GO:0002860;GO:0050862;GO:0050776;GO:0046596;GO:0030382;GO:0007286;GO:0007289;GO:0042271;GO:0060370;, C:apical junction complex; C:cell surface; C:cell-cell contact zone; C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:plasma membrane; C:zonula adherens;, F:cell adhesion molecule binding; F:coreceptor activity; F:identical protein binding; F:protein homodimerization activity; F:virus receptor activity;, P:acrosome assembly; P:adherens junction organization; P:adhesion of symbiont to host; P:cell part morphogenesis; P:cilium organization; P:coreceptor-mediated virion attachment to host cell; P:cytoskeleton organization; P:establishment of mitochondrion localization; P:fertilization; P:fusion of virus membrane with host plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of immunoglobulin mediated immune response; P:positive regulation of mast cell activation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:positive regulation of T cell receptor signaling pathway; P:regulation of immune response; P:regulation of viral entry into host cell; P:sperm mitochondrion organization; P:spermatid development; P:spermatid nucleus differentiation; P:susceptibility to natural killer cell mediated cytotoxicity; P:susceptibility to T cell mediated cytotoxicity;|Q92692 A8K5L5 O75455 Q6IBI6 Q96J29,Nectin-2,Herpes virus entry mediator B;Nectin cell adhesion molecule 2 {ECO:0000312|HGNC:HGNC:9707};Poliovirus receptor-related protein 2;, PF08205;PF07686;, GO:0043296;GO:0009986;GO:0044291;GO:0005911;GO:0070062;GO:0005925;GO:0016021;GO:0005886;GO:0005915;GO:0050839;GO:0015026;GO:0042802;GO:0042803;GO:0001618;GO:0001675;GO:0034332;GO:0044406;GO:0032990;GO:0044782;GO:0046814;GO:0007010;GO:0051654;GO:0009566;GO:0019064;GO:0007156;GO:0002891;GO:0033005;GO:0045954;GO:0002860;GO:0050862;GO:0050776;GO:0046596;GO:0030382;GO:0007286;GO:0007289;GO:0042271;GO:0060370;, C:apical junction complex; C:cell surface; C:cell-cell contact zone; C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:plasma membrane; C:zonula adherens;, F:cell adhesion molecule binding; F:coreceptor activity; F:identical protein binding; F:protein homodimerization activity; F:virus receptor activity;, P:acrosome assembly; P:adherens junction organization; P:adhesion of symbiont to host; P:cell part morphogenesis; P:cilium organization; P:coreceptor-mediated virion attachment to host cell; P:cytoskeleton organization; P:establishment of mitochondrion localization; P:fertilization; P:fusion of virus membrane with host plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of immunoglobulin mediated immune response; P:positive regulation of mast cell activation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:positive regulation of T cell receptor signaling pathway; P:regulation of immune response; P:regulation of viral entry into host cell; P:sperm mitochondrion organization; P:spermatid development; P:spermatid nucleus differentiation; P:susceptibility to natural killer cell mediated cytotoxicity; P:susceptibility to T cell mediated cytotoxicity;|Q92692 A8K5L5 O75455 Q6IBI6 Q96J29,Nectin-2,Herpes virus entry mediator B;Nectin cell adhesion molecule 2 {ECO:0000312|HGNC:HGNC:9707};Poliovirus receptor-related protein 2;, PF08205;PF07686;, GO:0043296;GO:0009986;GO:0044291;GO:0005911;GO:0070062;GO:0005925;GO:0016021;GO:0005886;GO:0005915;GO:0050839;GO:0015026;GO:0042802;GO:0042803;GO:0001618;GO:0001675;GO:0034332;GO:0044406;GO:0032990;GO:0044782;GO:0046814;GO:0007010;GO:0051654;GO:0009566;GO:0019064;GO:0007156;GO:0002891;GO:0033005;GO:0045954;GO:0002860;GO:0050862;GO:0050776;GO:0046596;GO:0030382;GO:0007286;GO:0007289;GO:0042271;GO:0060370;, C:apical junction complex; C:cell surface; C:cell-cell contact zone; C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:plasma membrane; C:zonula adherens;, F:cell adhesion molecule binding; F:coreceptor activity; F:identical protein binding; F:protein homodimerization activity; F:virus receptor activity;, P:acrosome assembly; P:adherens junction organization; P:adhesion of symbiont to host; P:cell part morphogenesis; P:cilium organization; P:coreceptor-mediated virion attachment to host cell; P:cytoskeleton organization; P:establishment of mitochondrion localization; P:fertilization; P:fusion of virus membrane with host plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of immunoglobulin mediated immune response; P:positive regulation of mast cell activation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:positive regulation of T cell receptor signaling pathway; P:regulation of immune response; P:regulation of viral entry into host cell; P:sperm mitochondrion organization; P:spermatid development; P:spermatid nucleus differentiation; P:susceptibility to natural killer cell mediated cytotoxicity; P:susceptibility to T cell mediated cytotoxicity;|Q92692 A8K5L5 O75455 Q6IBI6 Q96J29,Nectin-2,Herpes virus entry mediator B;Nectin cell adhesion molecule 2 {ECO:0000312|HGNC:HGNC:9707};Poliovirus receptor-related protein 2;, PF08205;PF07686;, GO:0043296;GO:0009986;GO:0044291;GO:0005911;GO:0070062;GO:0005925;GO:0016021;GO:0005886;GO:0005915;GO:0050839;GO:0015026;GO:0042802;GO:0042803;GO:0001618;GO:0001675;GO:0034332;GO:0044406;GO:0032990;GO:0044782;GO:0046814;GO:0007010;GO:0051654;GO:0009566;GO:0019064;GO:0007156;GO:0002891;GO:0033005;GO:0045954;GO:0002860;GO:0050862;GO:0050776;GO:0046596;GO:0030382;GO:0007286;GO:0007289;GO:0042271;GO:0060370;, C:apical junction complex; C:cell surface; C:cell-cell contact zone; C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:plasma membrane; C:zonula adherens;, F:cell adhesion molecule binding; F:coreceptor activity; F:identical protein binding; F:protein homodimerization activity; F:virus receptor activity;, P:acrosome assembly; P:adherens junction organization; P:adhesion of symbiont to host; P:cell part morphogenesis; P:cilium organization; P:coreceptor-mediated virion attachment to host cell; P:cytoskeleton organization; P:establishment of mitochondrion localization; P:fertilization; P:fusion of virus membrane with host plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of immunoglobulin mediated immune response; P:positive regulation of mast cell activation; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:positive regulation of T cell receptor signaling pathway; P:regulation of immune response; P:regulation of viral entry into host cell; P:sperm mitochondrion organization; P:spermatid development; P:spermatid nucleus differentiation; P:susceptibility to natural killer cell mediated cytotoxicity; P:susceptibility to T cell mediated cytotoxicity; scaffold157 indexed_genome mRNA 104424 115949 . + . ID=transcript_14837;O96008 A0A024R0P9 Q86VW4 Q8WY09 Q8WY10 Q8WY11 Q9BR95,Mitochondrial import receptor subunit TOM40 homolog,Protein Haymaker;Translocase of outer membrane 40 kDa subunit homolog;p38.5;, PF01459;, GO:0005829;GO:0016021;GO:0031307;GO:0044233;GO:0005743;GO:0005741;GO:0005742;GO:0005739;GO:0046930;GO:0015288;GO:0008320;GO:0016236;GO:0030150;GO:0006626;, C:cytosol; C:integral component of membrane; C:integral component of mitochondrial outer membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrial outer membrane translocase complex; C:mitochondrion; C:pore complex;, F:porin activity; F:protein transmembrane transporter activity;, P:macroautophagy; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; scaffold157 indexed_genome mRNA 127394 128241 . + . ID=transcript_14838;P02649 B2RC15 C0JYY5 Q9P2S4,Apolipoprotein E {ECO:0000305},, PF01442;, GO:0072562;GO:0042627;GO:0030669;GO:0062023;GO:0005737;GO:0030425;GO:0034365;GO:0005769;GO:0071682;GO:0005783;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:1903561;GO:0098978;GO:0005794;GO:0034364;GO:0034363;GO:1990777;GO:0034362;GO:0016020;GO:0043025;GO:0005634;GO:0005886;GO:0043083;GO:0034361;GO:0001540;GO:0016209;GO:0120020;GO:0043395;GO:0008201;GO:0042802;GO:0008289;GO:0005319;GO:0071813;GO:0050750;GO:0046911;GO:0060228;GO:0005543;GO:0046983;GO:0042803;GO:0044877;GO:0005102;GO:0005198;GO:0048156;GO:0070326;GO:0097113;GO:0042982;GO:0048844;GO:0006874;GO:0044267;GO:0019934;GO:0006707;GO:0033344;GO:0042632;GO:0008203;GO:0034378;GO:0034382;GO:0034371;GO:0007010;GO:0055089;GO:0007186;GO:0010467;GO:0034380;GO:0034384;GO:0034375;GO:0071831;GO:0030522;GO:0046907;GO:0010877;GO:0042158;GO:0042159;GO:0035641;GO:0015909;GO:0007616;GO:0034374;GO:0051651;GO:1905907;GO:1902430;GO:0030195;GO:0043537;GO:0090090;GO:0032269;GO:0045541;GO:0090370;GO:0061000;GO:1902951;GO:0010596;GO:0001937;GO:0010629;GO:0050728;GO:0051055;GO:1903001;GO:1900272;GO:0043407;GO:0043524;GO:1901215;GO:0010977;GO:1902999;GO:0010544;GO:1901627;GO:0050709;GO:0090209;GO:0031175;GO:0007263;GO:0097114;GO:0033700;GO:0044794;GO:1905908;GO:1900223;GO:1902004;GO:0010875;GO:0010873;GO:0060999;GO:1902952;GO:0045807;GO:0070374;GO:1905855;GO:1905860;GO:0046889;GO:1903002;GO:0032805;GO:0051044;GO:1902998;GO:1901216;GO:0010976;GO:0051000;GO:1902995;GO:1901631;GO:0045893;GO:0043687;GO:0017038;GO:0006898;GO:1905906;GO:1902991;GO:1900221;GO:0030516;GO:2000822;GO:0032489;GO:1905890;GO:0090181;GO:0045088;GO:1901214;GO:0048168;GO:0061136;GO:0051246;GO:0043254;GO:1902947;GO:0006357;GO:0061771;GO:0002021;GO:0000302;GO:0001523;GO:0043691;GO:0007271;GO:0070328;GO:0006641;GO:0071830;GO:0042311;GO:0034447;GO:0034372;GO:0019068;, C:blood microparticle; C:chylomicron; C:clathrin-coated endocytic vesicle membrane; C:collagen-containing extracellular matrix; C:cytoplasm; C:dendrite; C:discoidal high-density lipoprotein particle; C:early endosome; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:extracellular vesicle; C:glutamatergic synapse; C:Golgi apparatus; C:high-density lipoprotein particle; C:intermediate-density lipoprotein particle; C:lipoprotein particle; C:low-density lipoprotein particle; C:membrane; C:neuronal cell body; C:nucleus; C:plasma membrane; C:synaptic cleft; C:very-low-density lipoprotein particle;, F:amyloid-beta binding; F:antioxidant activity; F:cholesterol transfer activity; F:heparan sulfate proteoglycan binding; F:heparin binding; F:identical protein binding; F:lipid binding; F:lipid transporter activity; F:lipoprotein particle binding; F:low-density lipoprotein particle receptor binding; F:metal chelating activity; F:phosphatidylcholine-sterol O-acyltransferase activator activity; F:phospholipid binding; F:protein dimerization activity; F:protein homodimerization activity; F:protein-containing complex binding; F:signaling receptor binding; F:structural molecule activity; F:tau protein binding; F:very-low-density lipoprotein particle receptor binding;, P:AMPA glutamate receptor clustering; P:amyloid precursor protein metabolic process; P:artery morphogenesis; P:cellular calcium ion homeostasis; P:cellular protein metabolic process; P:cGMP-mediated signaling; P:cholesterol catabolic process; P:cholesterol efflux; P:cholesterol homeostasis; P:cholesterol metabolic process; P:chylomicron assembly; P:chylomicron remnant clearance; P:chylomicron remodeling; P:cytoskeleton organization; P:fatty acid homeostasis; P:G protein-coupled receptor signaling pathway; P:gene expression; P:high-density lipoprotein particle assembly; P:high-density lipoprotein particle clearance; P:high-density lipoprotein particle remodeling; P:intermediate-density lipoprotein particle clearance; P:intracellular receptor signaling pathway; P:intracellular transport; P:lipid transport involved in lipid storage; P:lipoprotein biosynthetic process; P:lipoprotein catabolic process; P:locomotory exploration behavior; P:long-chain fatty acid transport; P:long-term memory; P:low-density lipoprotein particle remodeling; P:maintenance of location in cell; P:negative regulation of amyloid fibril formation; P:negative regulation of amyloid-beta formation; P:negative regulation of blood coagulation; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cellular protein metabolic process; P:negative regulation of cholesterol biosynthetic process; P:negative regulation of cholesterol efflux; P:negative regulation of dendritic spine development; P:negative regulation of dendritic spine maintenance; P:negative regulation of endothelial cell migration; P:negative regulation of endothelial cell proliferation; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of lipid biosynthetic process; P:negative regulation of lipid transport across blood-brain barrier; P:negative regulation of long-term synaptic potentiation; P:negative regulation of MAP kinase activity; P:negative regulation of neuron apoptotic process; P:negative regulation of neuron death; P:negative regulation of neuron projection development; P:negative regulation of phospholipid efflux; P:negative regulation of platelet activation; P:negative regulation of postsynaptic membrane organization; P:negative regulation of protein secretion; P:negative regulation of triglyceride metabolic process; P:neuron projection development; P:nitric oxide mediated signal transduction; P:NMDA glutamate receptor clustering; P:phospholipid efflux; P:positive regulation by host of viral process; P:positive regulation of amyloid fibril formation; P:positive regulation of amyloid-beta clearance; P:positive regulation of amyloid-beta formation; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol esterification; P:positive regulation of dendritic spine development; P:positive regulation of dendritic spine maintenance; P:positive regulation of endocytosis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of heparan sulfate binding; P:positive regulation of heparan sulfate proteoglycan binding; P:positive regulation of lipid biosynthetic process; P:positive regulation of lipid transport across blood-brain barrier; P:positive regulation of low-density lipoprotein particle receptor catabolic process; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of neurofibrillary tangle assembly; P:positive regulation of neuron death; P:positive regulation of neuron projection development; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of phospholipid efflux; P:positive regulation of presynaptic membrane organization; P:positive regulation of transcription, DNA-templated; P:post-translational protein modification; P:protein import; P:receptor-mediated endocytosis; P:regulation of amyloid fibril formation; P:regulation of amyloid precursor protein catabolic process; P:regulation of amyloid-beta clearance; P:regulation of axon extension; P:regulation of behavioral fear response; P:regulation of Cdc42 protein signal transduction; P:regulation of cellular response to very-low-density lipoprotein particle stimulus; P:regulation of cholesterol metabolic process; P:regulation of innate immune response; P:regulation of neuron death; P:regulation of neuronal synaptic plasticity; P:regulation of proteasomal protein catabolic process; P:regulation of protein metabolic process; P:regulation of protein-containing complex assembly; P:regulation of tau-protein kinase activity; P:regulation of transcription by RNA polymerase II; P:response to caloric restriction; P:response to dietary excess; P:response to reactive oxygen species; P:retinoid metabolic process; P:reverse cholesterol transport; P:synaptic transmission, cholinergic; P:triglyceride homeostasis; P:triglyceride metabolic process; P:triglyceride-rich lipoprotein particle clearance; P:vasodilation; P:very-low-density lipoprotein particle clearance; P:very-low-density lipoprotein particle remodeling; P:virion assembly; scaffold157 indexed_genome mRNA 132374 179070 . + . ID=transcript_14839;O96005 B3KQH2 B4DDS3 B4E2X9 B7Z9X9 F5H8J3 Q53ET6 Q9BSS5,Cleft lip and palate transmembrane protein 1,, PF05602;, GO:0012505;GO:0009897;GO:0005887;GO:0016020;GO:0030154;GO:0007275;GO:0033081;, C:endomembrane system; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane;, , P:cell differentiation; P:multicellular organism development; P:regulation of T cell differentiation in thymus;|P55056 B3KWY6 Q53YY8,Apolipoprotein C-IV,Apolipoprotein C4;, PF15119;, GO:0005576;GO:0034364;GO:0034361;GO:0005319;GO:0030522;GO:0006629;GO:0010890;GO:0070328;GO:0034379;GO:0034447;, C:extracellular region; C:high-density lipoprotein particle; C:very-low-density lipoprotein particle;, F:lipid transporter activity;, P:intracellular receptor signaling pathway; P:lipid metabolic process; P:positive regulation of sequestering of triglyceride; P:triglyceride homeostasis; P:very-low-density lipoprotein particle assembly; P:very-low-density lipoprotein particle clearance;|O96005 B3KQH2 B4DDS3 B4E2X9 B7Z9X9 F5H8J3 Q53ET6 Q9BSS5,Cleft lip and palate transmembrane protein 1,, PF05602;, GO:0012505;GO:0009897;GO:0005887;GO:0016020;GO:0030154;GO:0007275;GO:0033081;, C:endomembrane system; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane;, , P:cell differentiation; P:multicellular organism development; P:regulation of T cell differentiation in thymus;|O96005 B3KQH2 B4DDS3 B4E2X9 B7Z9X9 F5H8J3 Q53ET6 Q9BSS5,Cleft lip and palate transmembrane protein 1,, PF05602;, GO:0012505;GO:0009897;GO:0005887;GO:0016020;GO:0030154;GO:0007275;GO:0033081;, C:endomembrane system; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane;, , P:cell differentiation; P:multicellular organism development; P:regulation of T cell differentiation in thymus; scaffold157 indexed_genome mRNA 183571 211464 . + . ID=transcript_14840;Q01201 Q6GTX7 Q9UEI7,Transcription factor RelB,I-Rel;, PF16180;PF16181;PF16179;PF00554;, GO:0000785;GO:0005829;GO:0005815;GO:0005654;GO:0005634;GO:0032991;GO:0017053;GO:0000981;GO:0042802;GO:0019901;GO:0000978;GO:0019882;GO:0071470;GO:0032922;GO:0007249;GO:0006954;GO:0045087;GO:0030098;GO:0043011;GO:0032688;GO:0045892;GO:0038061;GO:0010628;GO:0006357;GO:0034097;GO:0002223;GO:0045063;, C:chromatin; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription repressor complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:antigen processing and presentation; P:cellular response to osmotic stress; P:circadian regulation of gene expression; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:lymphocyte differentiation; P:myeloid dendritic cell differentiation; P:negative regulation of interferon-beta production; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:response to cytokine; P:stimulatory C-type lectin receptor signaling pathway; P:T-helper 1 cell differentiation;|Q01201 Q6GTX7 Q9UEI7,Transcription factor RelB,I-Rel;, PF16180;PF16181;PF16179;PF00554;, GO:0000785;GO:0005829;GO:0005815;GO:0005654;GO:0005634;GO:0032991;GO:0017053;GO:0000981;GO:0042802;GO:0019901;GO:0000978;GO:0019882;GO:0071470;GO:0032922;GO:0007249;GO:0006954;GO:0045087;GO:0030098;GO:0043011;GO:0032688;GO:0045892;GO:0038061;GO:0010628;GO:0006357;GO:0034097;GO:0002223;GO:0045063;, C:chromatin; C:cytosol; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription repressor complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:antigen processing and presentation; P:cellular response to osmotic stress; P:circadian regulation of gene expression; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:lymphocyte differentiation; P:myeloid dendritic cell differentiation; P:negative regulation of interferon-beta production; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:positive regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:response to cytokine; P:stimulatory C-type lectin receptor signaling pathway; P:T-helper 1 cell differentiation; scaffold157 indexed_genome mRNA 211635 226656 . + . ID=transcript_14841;Q8N2M8 B4DDT8 F8WAG9 O96026 Q6UW71 Q96DX2,CLK4-associating serine/arginine rich protein,Splicing factor, arginine/serine-rich 16;Suppressor of white-apricot homolog 2;, PF09750;, GO:0005654;GO:0006397;GO:0008380;, C:nucleoplasm;, , P:mRNA processing; P:RNA splicing;|Q8N2M8 B4DDT8 F8WAG9 O96026 Q6UW71 Q96DX2,CLK4-associating serine/arginine rich protein,Splicing factor, arginine/serine-rich 16;Suppressor of white-apricot homolog 2;, PF09750;, GO:0005654;GO:0006397;GO:0008380;, C:nucleoplasm;, , P:mRNA processing; P:RNA splicing; scaffold157 indexed_genome mRNA 232819 236580 . + . ID=transcript_14842;Q8N2M8 B4DDT8 F8WAG9 O96026 Q6UW71 Q96DX2,CLK4-associating serine/arginine rich protein,Splicing factor, arginine/serine-rich 16;Suppressor of white-apricot homolog 2;, PF09750;, GO:0005654;GO:0006397;GO:0008380;, C:nucleoplasm;, , P:mRNA processing; P:RNA splicing; scaffold157 indexed_genome mRNA 237195 238110 . - . ID=transcript_14843;Q8WUU4,Zinc finger protein 296,Zinc finger protein 342;, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:1990837;GO:0008134;GO:0000122;GO:0045944;GO:0006357;GO:0007283;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold157 indexed_genome mRNA 238123 241952 . + . ID=transcript_14844;Q8WUU4,Zinc finger protein 296,Zinc finger protein 342;, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:1990837;GO:0008134;GO:0000122;GO:0045944;GO:0006357;GO:0007283;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold157 indexed_genome mRNA 250661 254764 . + . ID=transcript_14845;Q9H840 Q6IA34,Gem-associated protein 7,SIP3;, PF11095;PF12901;, GO:0005737;GO:0005829;GO:0097504;GO:0016604;GO:0005654;GO:0120114;GO:0032797;GO:0034719;GO:0051170;GO:0000398;GO:0000387;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:nuclear body; C:nucleoplasm; C:Sm-like protein family complex; C:SMN complex; C:SMN-Sm protein complex;, , P:import into nucleus; P:mRNA splicing, via spliceosome; P:spliceosomal snRNP assembly;|Q9H840 Q6IA34,Gem-associated protein 7,SIP3;, PF11095;PF12901;, GO:0005737;GO:0005829;GO:0097504;GO:0016604;GO:0005654;GO:0120114;GO:0032797;GO:0034719;GO:0051170;GO:0000398;GO:0000387;, C:cytoplasm; C:cytosol; C:Gemini of coiled bodies; C:nuclear body; C:nucleoplasm; C:Sm-like protein family complex; C:SMN complex; C:SMN-Sm protein complex;, , P:import into nucleus; P:mRNA splicing, via spliceosome; P:spliceosomal snRNP assembly; scaffold157 indexed_genome mRNA 290033 296874 . + . ID=transcript_14846;O75864 B5MDA4 Q8IWK3 Q8TF16,Protein phosphatase 1 regulatory subunit 37,Leucine-rich repeat-containing protein 68;, PF13516;, GO:0004864;GO:0010923;, , F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity;|O75864 B5MDA4 Q8IWK3 Q8TF16,Protein phosphatase 1 regulatory subunit 37,Leucine-rich repeat-containing protein 68;, PF13516;, GO:0004864;GO:0010923;, , F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity;|O75864 B5MDA4 Q8IWK3 Q8TF16,Protein phosphatase 1 regulatory subunit 37,Leucine-rich repeat-containing protein 68;, PF13516;, GO:0004864;GO:0010923;, , F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity;|O75864 B5MDA4 Q8IWK3 Q8TF16,Protein phosphatase 1 regulatory subunit 37,Leucine-rich repeat-containing protein 68;, PF13516;, GO:0004864;GO:0010923;, , F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity; scaffold157 indexed_genome mRNA 301096 305981 . - . ID=transcript_14847;Q17RQ9 B7ZLG6 D6RH15 Q8N2A2,NTPase KAP family P-loop domain-containing protein 1,, PF07693;, GO:0016021;, C:integral component of membrane; scaffold157 indexed_genome mRNA 311714 321532 . - . ID=transcript_14848;O75865 K7ERB1 K7ERQ4 Q9BQ45 Q9P092,Trafficking protein particle complex subunit 6A {ECO:0000303|PubMed:19416478},, PF04051;, GO:0005801;GO:0005829;GO:0005783;GO:0005802;GO:0030008;GO:0048208;GO:0006888;GO:1903232;GO:0043087;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum; C:trans-Golgi network; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:melanosome assembly; P:regulation of GTPase activity;|O75865 K7ERB1 K7ERQ4 Q9BQ45 Q9P092,Trafficking protein particle complex subunit 6A {ECO:0000303|PubMed:19416478},, PF04051;, GO:0005801;GO:0005829;GO:0005783;GO:0005802;GO:0030008;GO:0048208;GO:0006888;GO:1903232;GO:0043087;, C:cis-Golgi network; C:cytosol; C:endoplasmic reticulum; C:trans-Golgi network; C:TRAPP complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:melanosome assembly; P:regulation of GTPase activity; scaffold157 indexed_genome mRNA 325124 327611 . - . ID=transcript_14849;Q6QNY0 B2RXB8,Biogenesis of lysosome-related organelles complex 1 subunit 3,, PF15753;, GO:1904115;GO:0031083;GO:0005829;GO:0030133;GO:0008320;GO:0008089;GO:0048490;GO:0035646;GO:0001654;GO:0032438;GO:0032402;GO:0031175;GO:0043473;GO:0030168;GO:0060155;GO:0032816;GO:0006892;GO:0042493;GO:0033299;, C:axon cytoplasm; C:BLOC-1 complex; C:cytosol; C:transport vesicle;, F:protein transmembrane transporter activity;, P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:endosome to melanosome transport; P:eye development; P:melanosome organization; P:melanosome transport; P:neuron projection development; P:pigmentation; P:platelet activation; P:platelet dense granule organization; P:positive regulation of natural killer cell activation; P:post-Golgi vesicle-mediated transport; P:response to drug; P:secretion of lysosomal enzymes; scaffold157 indexed_genome mRNA 360189 373707 . + . ID=transcript_14850;P37058 Q5U0Q6,Testosterone 17-beta-dehydrogenase 3 {ECO:0000305},17-beta-hydroxysteroid dehydrogenase type 3;Estradiol 17-beta-dehydrogenase 2;Short chain dehydrogenase/reductase family 12C member 2;Testicular 17-beta-hydroxysteroid dehydrogenase;, PF00106;, GO:0005783;GO:0005789;GO:0043231;GO:0072582;GO:0047045;GO:0006702;GO:0030539;GO:0006694;GO:0061370;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; F:testosterone 17-beta-dehydrogenase (NADP+) activity;, P:androgen biosynthetic process; P:male genitalia development; P:steroid biosynthetic process; P:testosterone biosynthetic process;|Q3SXM5 B4DSL2 D3DUL4 Q3SXM4 Q8NC98 Q9BY22,Inactive hydroxysteroid dehydrogenase-like protein 1,Short chain dehydrogenase/reductase family 12C member 3;, PF00106;, GO:0045111;GO:0043231;GO:0005739;, C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:mitochondrion; scaffold157 indexed_genome mRNA 375315 375849 . + . ID=transcript_14851;P28749 A8K2W5 Q4VXA0 Q8N5K6 Q9H1L5 Q9H1M1,Retinoblastoma-like protein 1,107 kDa retinoblastoma-associated protein;pRb1;, PF11934;PF01858;PF01857;, GO:0000785;GO:0005654;GO:0005667;GO:1990841;GO:0001102;GO:0000977;GO:0008134;GO:0007049;GO:0030154;GO:0006325;GO:2000773;GO:2000134;GO:0010629;GO:0000122;GO:0045944;GO:0051302;GO:0043550;GO:0016032;, C:chromatin; C:nucleoplasm; C:transcription regulator complex;, F:promoter-specific chromatin binding; F:RNA polymerase II activating transcription factor binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:cell cycle; P:cell differentiation; P:chromatin organization; P:negative regulation of cellular senescence; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of gene expression; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell division; P:regulation of lipid kinase activity; P:viral process; scaffold157 indexed_genome mRNA 387859 404734 . - . ID=transcript_14852;Q2M3D2 Q8N9W2 Q96GV2,Exocyst complex component 3-like protein 2,HBV X-transactivated gene 7 protein;HBV XAg-transactivated protein 7;, PF06046;, GO:0000145;GO:0000149;GO:0051601;GO:0006887;, C:exocyst;, F:SNARE binding;, P:exocyst localization; P:exocytosis; scaffold157 indexed_genome mRNA 417377 418070 . + . ID=transcript_14853;Q96L34 Q8NG37 Q96JG7 Q96SQ2 Q9BYD8,MAP/microtubule affinity-regulating kinase 4,MAP/microtubule affinity-regulating kinase-like 1;, PF02149;PF00069;PF00627;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0030425;GO:0000930;GO:0015630;GO:0005815;GO:0030496;GO:0043005;GO:0005524;GO:0043015;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0043130;GO:0007049;GO:0051301;GO:0097711;GO:0044782;GO:0035556;GO:0001578;GO:0000226;GO:0007399;GO:0045724;GO:0043068;GO:1904781;GO:0006468;GO:0046605;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:dendrite; C:gamma-tubulin complex; C:microtubule cytoskeleton; C:microtubule organizing center; C:midbody; C:neuron projection;, F:ATP binding; F:gamma-tubulin binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:ubiquitin binding;, P:cell cycle; P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:intracellular signal transduction; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of programmed cell death; P:positive regulation of protein localization to centrosome; P:protein phosphorylation; P:regulation of centrosome cycle; scaffold157 indexed_genome mRNA 418137 435831 . + . ID=transcript_14854;Q96L34 Q8NG37 Q96JG7 Q96SQ2 Q9BYD8,MAP/microtubule affinity-regulating kinase 4,MAP/microtubule affinity-regulating kinase-like 1;, PF02149;PF00069;PF00627;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0030425;GO:0000930;GO:0015630;GO:0005815;GO:0030496;GO:0043005;GO:0005524;GO:0043015;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0043130;GO:0007049;GO:0051301;GO:0097711;GO:0044782;GO:0035556;GO:0001578;GO:0000226;GO:0007399;GO:0045724;GO:0043068;GO:1904781;GO:0006468;GO:0046605;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:dendrite; C:gamma-tubulin complex; C:microtubule cytoskeleton; C:microtubule organizing center; C:midbody; C:neuron projection;, F:ATP binding; F:gamma-tubulin binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:ubiquitin binding;, P:cell cycle; P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:intracellular signal transduction; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of programmed cell death; P:positive regulation of protein localization to centrosome; P:protein phosphorylation; P:regulation of centrosome cycle;|Q96L34 Q8NG37 Q96JG7 Q96SQ2 Q9BYD8,MAP/microtubule affinity-regulating kinase 4,MAP/microtubule affinity-regulating kinase-like 1;, PF02149;PF00069;PF00627;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0030425;GO:0000930;GO:0015630;GO:0005815;GO:0030496;GO:0043005;GO:0005524;GO:0043015;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0043130;GO:0007049;GO:0051301;GO:0097711;GO:0044782;GO:0035556;GO:0001578;GO:0000226;GO:0007399;GO:0045724;GO:0043068;GO:1904781;GO:0006468;GO:0046605;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:dendrite; C:gamma-tubulin complex; C:microtubule cytoskeleton; C:microtubule organizing center; C:midbody; C:neuron projection;, F:ATP binding; F:gamma-tubulin binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:ubiquitin binding;, P:cell cycle; P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:intracellular signal transduction; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of programmed cell death; P:positive regulation of protein localization to centrosome; P:protein phosphorylation; P:regulation of centrosome cycle;|Q96L34 Q8NG37 Q96JG7 Q96SQ2 Q9BYD8,MAP/microtubule affinity-regulating kinase 4,MAP/microtubule affinity-regulating kinase-like 1;, PF02149;PF00069;PF00627;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0030425;GO:0000930;GO:0015630;GO:0005815;GO:0030496;GO:0043005;GO:0005524;GO:0043015;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0043130;GO:0007049;GO:0051301;GO:0097711;GO:0044782;GO:0035556;GO:0001578;GO:0000226;GO:0007399;GO:0045724;GO:0043068;GO:1904781;GO:0006468;GO:0046605;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:dendrite; C:gamma-tubulin complex; C:microtubule cytoskeleton; C:microtubule organizing center; C:midbody; C:neuron projection;, F:ATP binding; F:gamma-tubulin binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:ubiquitin binding;, P:cell cycle; P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:intracellular signal transduction; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of programmed cell death; P:positive regulation of protein localization to centrosome; P:protein phosphorylation; P:regulation of centrosome cycle;|Q96L34 Q8NG37 Q96JG7 Q96SQ2 Q9BYD8,MAP/microtubule affinity-regulating kinase 4,MAP/microtubule affinity-regulating kinase-like 1;, PF02149;PF00069;PF00627;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0030425;GO:0000930;GO:0015630;GO:0005815;GO:0030496;GO:0043005;GO:0005524;GO:0043015;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0043130;GO:0007049;GO:0051301;GO:0097711;GO:0044782;GO:0035556;GO:0001578;GO:0000226;GO:0007399;GO:0045724;GO:0043068;GO:1904781;GO:0006468;GO:0046605;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:dendrite; C:gamma-tubulin complex; C:microtubule cytoskeleton; C:microtubule organizing center; C:midbody; C:neuron projection;, F:ATP binding; F:gamma-tubulin binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:ubiquitin binding;, P:cell cycle; P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:intracellular signal transduction; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of programmed cell death; P:positive regulation of protein localization to centrosome; P:protein phosphorylation; P:regulation of centrosome cycle; scaffold157 indexed_genome mRNA 437981 442873 . + . ID=transcript_14855;Q96L34 Q8NG37 Q96JG7 Q96SQ2 Q9BYD8,MAP/microtubule affinity-regulating kinase 4,MAP/microtubule affinity-regulating kinase-like 1;, PF02149;PF00069;PF00627;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0030425;GO:0000930;GO:0015630;GO:0005815;GO:0030496;GO:0043005;GO:0005524;GO:0043015;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0043130;GO:0007049;GO:0051301;GO:0097711;GO:0044782;GO:0035556;GO:0001578;GO:0000226;GO:0007399;GO:0045724;GO:0043068;GO:1904781;GO:0006468;GO:0046605;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:dendrite; C:gamma-tubulin complex; C:microtubule cytoskeleton; C:microtubule organizing center; C:midbody; C:neuron projection;, F:ATP binding; F:gamma-tubulin binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:ubiquitin binding;, P:cell cycle; P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:intracellular signal transduction; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of programmed cell death; P:positive regulation of protein localization to centrosome; P:protein phosphorylation; P:regulation of centrosome cycle;|Q96L34 Q8NG37 Q96JG7 Q96SQ2 Q9BYD8,MAP/microtubule affinity-regulating kinase 4,MAP/microtubule affinity-regulating kinase-like 1;, PF02149;PF00069;PF00627;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0030425;GO:0000930;GO:0015630;GO:0005815;GO:0030496;GO:0043005;GO:0005524;GO:0043015;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0043130;GO:0007049;GO:0051301;GO:0097711;GO:0044782;GO:0035556;GO:0001578;GO:0000226;GO:0007399;GO:0045724;GO:0043068;GO:1904781;GO:0006468;GO:0046605;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:dendrite; C:gamma-tubulin complex; C:microtubule cytoskeleton; C:microtubule organizing center; C:midbody; C:neuron projection;, F:ATP binding; F:gamma-tubulin binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:ubiquitin binding;, P:cell cycle; P:cell division; P:ciliary basal body-plasma membrane docking; P:cilium organization; P:intracellular signal transduction; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:nervous system development; P:positive regulation of cilium assembly; P:positive regulation of programmed cell death; P:positive regulation of protein localization to centrosome; P:protein phosphorylation; P:regulation of centrosome cycle; scaffold157 indexed_genome mRNA 445277 453495 . - . ID=transcript_14856;P06732 Q96QL9,Creatine kinase M-type,Creatine kinase M chain;Creatine phosphokinase M-type {ECO:0000305};M-CK;, PF00217;PF02807;, GO:0005829;GO:0005615;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0046314;, C:cytosol; C:extracellular space;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:phosphocreatine biosynthetic process;|P06732 Q96QL9,Creatine kinase M-type,Creatine kinase M chain;Creatine phosphokinase M-type {ECO:0000305};M-CK;, PF00217;PF02807;, GO:0005829;GO:0005615;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0046314;, C:cytosol; C:extracellular space;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:phosphocreatine biosynthetic process;|P06732 Q96QL9,Creatine kinase M-type,Creatine kinase M chain;Creatine phosphokinase M-type {ECO:0000305};M-CK;, PF00217;PF02807;, GO:0005829;GO:0005615;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0046314;, C:cytosol; C:extracellular space;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:phosphocreatine biosynthetic process;|P06732 Q96QL9,Creatine kinase M-type,Creatine kinase M chain;Creatine phosphokinase M-type {ECO:0000305};M-CK;, PF00217;PF02807;, GO:0005829;GO:0005615;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0046314;, C:cytosol; C:extracellular space;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:phosphocreatine biosynthetic process;|P06732 Q96QL9,Creatine kinase M-type,Creatine kinase M chain;Creatine phosphokinase M-type {ECO:0000305};M-CK;, PF00217;PF02807;, GO:0005829;GO:0005615;GO:0005524;GO:0004111;GO:0016301;GO:0006600;GO:0046314;, C:cytosol; C:extracellular space;, F:ATP binding; F:creatine kinase activity; F:kinase activity;, P:creatine metabolic process; P:phosphocreatine biosynthetic process; scaffold157 indexed_genome mRNA 474023 491563 . - . ID=transcript_14857;P18074 Q2TB78 Q2YDY2 Q7KZU6 Q8N721,General transcription and DNA repair factor IIH helicase subunit XPD,Basic transcription factor 2 80 kDa subunit;CXPD;DNA excision repair protein ERCC-2;DNA repair protein complementing XP-D cells;TFIIH basal transcription factor complex 80 kDa subunit;Xeroderma pigmentosum group D-complementing protein;, PF06733;PF06777;PF13307;, GO:0070516;GO:0005737;GO:0005829;GO:0071817;GO:0005654;GO:0005634;GO:0005819;GO:0005669;GO:0000439;GO:0005675;GO:0051539;GO:0043139;GO:0005524;GO:0003684;GO:0003678;GO:0046872;GO:0008022;GO:0047485;GO:0030674;GO:0006370;GO:0007568;GO:0006915;GO:0030282;GO:0008283;GO:0032289;GO:0007059;GO:0040016;GO:0048568;GO:0043249;GO:0030198;GO:0070911;GO:0035315;GO:0048820;GO:0060218;GO:0001701;GO:0000462;GO:0035264;GO:0006289;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0043388;GO:0045951;GO:0009791;GO:1901990;GO:0001666;GO:0006979;GO:0009411;GO:0021510;GO:0006363;GO:0006366;GO:0006362;GO:0006368;GO:0006361;GO:0006367;GO:0006283;GO:0009650;GO:0016032;, C:CAK-ERCC2 complex; C:cytoplasm; C:cytosol; C:MMXD complex; C:nucleoplasm; C:nucleus; C:spindle; C:transcription factor TFIID complex; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex;, F:4 iron, 4 sulfur cluster binding; F:5'-3' DNA helicase activity; F:ATP binding; F:damaged DNA binding; F:DNA helicase activity; F:metal ion binding; F:protein C-terminus binding; F:protein N-terminus binding; F:protein-macromolecule adaptor activity;, P:7-methylguanosine mRNA capping; P:aging; P:apoptotic process; P:bone mineralization; P:cell population proliferation; P:central nervous system myelin formation; P:chromosome segregation; P:embryonic cleavage; P:embryonic organ development; P:erythrocyte maturation; P:extracellular matrix organization; P:global genome nucleotide-excision repair; P:hair cell differentiation; P:hair follicle maturation; P:hematopoietic stem cell differentiation; P:in utero embryonic development; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:multicellular organism growth; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of DNA binding; P:positive regulation of mitotic recombination; P:post-embryonic development; P:regulation of mitotic cell cycle phase transition; P:response to hypoxia; P:response to oxidative stress; P:response to UV; P:spinal cord development; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase I promoter; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; P:UV protection; P:viral process; scaffold157 indexed_genome mRNA 500185 500710 . - . ID=transcript_14858;Q8WUF5 Q2PNZ9 Q5DU71 Q5I1X4 Q6P1R7 Q6PKF8 Q9Y290,RelA-associated inhibitor,Inhibitor of ASPP protein;NFkB-interacting protein 1;PPP1R13B-like protein;, PF12796;PF14604;, GO:0030054;GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0045296;GO:0042802;GO:0003714;GO:0008134;GO:0006915;GO:0060048;GO:0003215;GO:0031076;GO:0042633;GO:0035264;GO:0048871;GO:0000122;GO:0045597;GO:0009791;GO:1901796;GO:0006357;GO:0006351;GO:0003229;, C:cell junction; C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:cadherin binding; F:identical protein binding; F:transcription corepressor activity; F:transcription factor binding;, P:apoptotic process; P:cardiac muscle contraction; P:cardiac right ventricle morphogenesis; P:embryonic camera-type eye development; P:hair cycle; P:multicellular organism growth; P:multicellular organismal homeostasis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell differentiation; P:post-embryonic development; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:ventricular cardiac muscle tissue development; scaffold157 indexed_genome mRNA 502911 532149 . + . ID=transcript_14859;Q8WUF5 Q2PNZ9 Q5DU71 Q5I1X4 Q6P1R7 Q6PKF8 Q9Y290,RelA-associated inhibitor,Inhibitor of ASPP protein;NFkB-interacting protein 1;PPP1R13B-like protein;, PF12796;PF14604;, GO:0030054;GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0045296;GO:0042802;GO:0003714;GO:0008134;GO:0006915;GO:0060048;GO:0003215;GO:0031076;GO:0042633;GO:0035264;GO:0048871;GO:0000122;GO:0045597;GO:0009791;GO:1901796;GO:0006357;GO:0006351;GO:0003229;, C:cell junction; C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:cadherin binding; F:identical protein binding; F:transcription corepressor activity; F:transcription factor binding;, P:apoptotic process; P:cardiac muscle contraction; P:cardiac right ventricle morphogenesis; P:embryonic camera-type eye development; P:hair cycle; P:multicellular organism growth; P:multicellular organismal homeostasis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell differentiation; P:post-embryonic development; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:ventricular cardiac muscle tissue development;|Q8WUF5 Q2PNZ9 Q5DU71 Q5I1X4 Q6P1R7 Q6PKF8 Q9Y290,RelA-associated inhibitor,Inhibitor of ASPP protein;NFkB-interacting protein 1;PPP1R13B-like protein;, PF12796;PF14604;, GO:0030054;GO:0005829;GO:0045171;GO:0005654;GO:0005634;GO:0045296;GO:0042802;GO:0003714;GO:0008134;GO:0006915;GO:0060048;GO:0003215;GO:0031076;GO:0042633;GO:0035264;GO:0048871;GO:0000122;GO:0045597;GO:0009791;GO:1901796;GO:0006357;GO:0006351;GO:0003229;, C:cell junction; C:cytosol; C:intercellular bridge; C:nucleoplasm; C:nucleus;, F:cadherin binding; F:identical protein binding; F:transcription corepressor activity; F:transcription factor binding;, P:apoptotic process; P:cardiac muscle contraction; P:cardiac right ventricle morphogenesis; P:embryonic camera-type eye development; P:hair cycle; P:multicellular organism growth; P:multicellular organismal homeostasis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell differentiation; P:post-embryonic development; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; P:ventricular cardiac muscle tissue development;|P07992 B2RC01 B3KRR0 Q7Z7F5 Q96S40,DNA excision repair protein ERCC-1,, PF03834;, GO:0000781;GO:0005737;GO:0070522;GO:0005654;GO:0000109;GO:0000110;GO:0003684;GO:0004519;GO:1990841;GO:0008022;GO:0019904;GO:0003697;GO:0001094;GO:0008283;GO:0006310;GO:0006281;GO:0006303;GO:0048568;GO:0070911;GO:0036297;GO:0045190;GO:0008584;GO:0000710;GO:0006312;GO:0010259;GO:0035264;GO:1905765;GO:0032205;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006293;GO:0048477;GO:1904431;GO:0060261;GO:0035166;GO:0000720;GO:0090399;GO:0046686;GO:0035902;GO:0007584;GO:0006979;GO:0009744;GO:0010165;GO:0007283;GO:0006949;GO:0090656;GO:0061819;GO:0006283;GO:0009650;GO:0070914;, C:chromosome, telomeric region; C:cytoplasm; C:ERCC4-ERCC1 complex; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 1 complex;, F:damaged DNA binding; F:endonuclease activity; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein domain specific binding; F:single-stranded DNA binding; F:TFIID-class transcription factor complex binding;, P:cell population proliferation; P:DNA recombination; P:DNA repair; P:double-strand break repair via nonhomologous end joining; P:embryonic organ development; P:global genome nucleotide-excision repair; P:interstrand cross-link repair; P:isotype switching; P:male gonad development; P:meiotic mismatch repair; P:mitotic recombination; P:multicellular organism aging; P:multicellular organism growth; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of telomere maintenance; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex stabilization; P:oogenesis; P:positive regulation of t-circle formation; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:post-embryonic hemopoiesis; P:pyrimidine dimer repair by nucleotide-excision repair; P:replicative senescence; P:response to cadmium ion; P:response to immobilization stress; P:response to nutrient; P:response to oxidative stress; P:response to sucrose; P:response to X-ray; P:spermatogenesis; P:syncytium formation; P:t-circle formation; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:UV protection; P:UV-damage excision repair;|P07992 B2RC01 B3KRR0 Q7Z7F5 Q96S40,DNA excision repair protein ERCC-1,, PF03834;, GO:0000781;GO:0005737;GO:0070522;GO:0005654;GO:0000109;GO:0000110;GO:0003684;GO:0004519;GO:1990841;GO:0008022;GO:0019904;GO:0003697;GO:0001094;GO:0008283;GO:0006310;GO:0006281;GO:0006303;GO:0048568;GO:0070911;GO:0036297;GO:0045190;GO:0008584;GO:0000710;GO:0006312;GO:0010259;GO:0035264;GO:1905765;GO:0032205;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006293;GO:0048477;GO:1904431;GO:0060261;GO:0035166;GO:0000720;GO:0090399;GO:0046686;GO:0035902;GO:0007584;GO:0006979;GO:0009744;GO:0010165;GO:0007283;GO:0006949;GO:0090656;GO:0061819;GO:0006283;GO:0009650;GO:0070914;, C:chromosome, telomeric region; C:cytoplasm; C:ERCC4-ERCC1 complex; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 1 complex;, F:damaged DNA binding; F:endonuclease activity; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein domain specific binding; F:single-stranded DNA binding; F:TFIID-class transcription factor complex binding;, P:cell population proliferation; P:DNA recombination; P:DNA repair; P:double-strand break repair via nonhomologous end joining; P:embryonic organ development; P:global genome nucleotide-excision repair; P:interstrand cross-link repair; P:isotype switching; P:male gonad development; P:meiotic mismatch repair; P:mitotic recombination; P:multicellular organism aging; P:multicellular organism growth; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of telomere maintenance; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex stabilization; P:oogenesis; P:positive regulation of t-circle formation; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:post-embryonic hemopoiesis; P:pyrimidine dimer repair by nucleotide-excision repair; P:replicative senescence; P:response to cadmium ion; P:response to immobilization stress; P:response to nutrient; P:response to oxidative stress; P:response to sucrose; P:response to X-ray; P:spermatogenesis; P:syncytium formation; P:t-circle formation; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:UV protection; P:UV-damage excision repair;|P07992 B2RC01 B3KRR0 Q7Z7F5 Q96S40,DNA excision repair protein ERCC-1,, PF03834;, GO:0000781;GO:0005737;GO:0070522;GO:0005654;GO:0000109;GO:0000110;GO:0003684;GO:0004519;GO:1990841;GO:0008022;GO:0019904;GO:0003697;GO:0001094;GO:0008283;GO:0006310;GO:0006281;GO:0006303;GO:0048568;GO:0070911;GO:0036297;GO:0045190;GO:0008584;GO:0000710;GO:0006312;GO:0010259;GO:0035264;GO:1905765;GO:0032205;GO:0006289;GO:0033683;GO:0006295;GO:0006296;GO:0006293;GO:0048477;GO:1904431;GO:0060261;GO:0035166;GO:0000720;GO:0090399;GO:0046686;GO:0035902;GO:0007584;GO:0006979;GO:0009744;GO:0010165;GO:0007283;GO:0006949;GO:0090656;GO:0061819;GO:0006283;GO:0009650;GO:0070914;, C:chromosome, telomeric region; C:cytoplasm; C:ERCC4-ERCC1 complex; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleotide-excision repair factor 1 complex;, F:damaged DNA binding; F:endonuclease activity; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:protein domain specific binding; F:single-stranded DNA binding; F:TFIID-class transcription factor complex binding;, P:cell population proliferation; P:DNA recombination; P:DNA repair; P:double-strand break repair via nonhomologous end joining; P:embryonic organ development; P:global genome nucleotide-excision repair; P:interstrand cross-link repair; P:isotype switching; P:male gonad development; P:meiotic mismatch repair; P:mitotic recombination; P:multicellular organism aging; P:multicellular organism growth; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of telomere maintenance; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex stabilization; P:oogenesis; P:positive regulation of t-circle formation; P:positive regulation of transcription initiation from RNA polymerase II promoter; P:post-embryonic hemopoiesis; P:pyrimidine dimer repair by nucleotide-excision repair; P:replicative senescence; P:response to cadmium ion; P:response to immobilization stress; P:response to nutrient; P:response to oxidative stress; P:response to sucrose; P:response to X-ray; P:spermatogenesis; P:syncytium formation; P:t-circle formation; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:UV protection; P:UV-damage excision repair; scaffold157 indexed_genome mRNA 567079 569487 . - . ID=transcript_14860;A8VJG9 E7EPR6 E9PHJ3 K7EMJ6 Q49AD7,Protein fosB,G0/G1 switch regulatory protein 3;, PF00170;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0071277;GO:0032870;GO:0007565;GO:0000122;GO:0006357;GO:0051591;GO:0051412;GO:0042493;GO:0009612;GO:0043278;GO:0032570;GO:0006366;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:cellular response to calcium ion; P:cellular response to hormone stimulus; P:female pregnancy; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to cAMP; P:response to corticosterone; P:response to drug; P:response to mechanical stimulus; P:response to morphine; P:response to progesterone; P:transcription by RNA polymerase II;|A8VJG9 E7EPR6 E9PHJ3 K7EMJ6 Q49AD7,Protein fosB,G0/G1 switch regulatory protein 3;, PF00170;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0071277;GO:0032870;GO:0007565;GO:0000122;GO:0006357;GO:0051591;GO:0051412;GO:0042493;GO:0009612;GO:0043278;GO:0032570;GO:0006366;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:cellular response to calcium ion; P:cellular response to hormone stimulus; P:female pregnancy; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to cAMP; P:response to corticosterone; P:response to drug; P:response to mechanical stimulus; P:response to morphine; P:response to progesterone; P:transcription by RNA polymerase II; scaffold157 indexed_genome mRNA 576786 582258 . - . ID=transcript_14861;O75298 O60509 Q7RTM6 Q7RTN1 Q7RTN2,Reticulon-2,Neuroendocrine-specific protein-like 1;Neuroendocrine-specific protein-like I;, PF02453;, GO:0009986;GO:0005783;GO:0030176;GO:0005882;GO:0033017;GO:0030315;GO:0014802;GO:0030018;GO:0010467;GO:0065002;GO:1902430;GO:0046324;, C:cell surface; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:intermediate filament; C:sarcoplasmic reticulum membrane; C:T-tubule; C:terminal cisterna; C:Z disc;, , P:gene expression; P:intracellular protein transmembrane transport; P:negative regulation of amyloid-beta formation; P:regulation of glucose import;|O75298 O60509 Q7RTM6 Q7RTN1 Q7RTN2,Reticulon-2,Neuroendocrine-specific protein-like 1;Neuroendocrine-specific protein-like I;, PF02453;, GO:0009986;GO:0005783;GO:0030176;GO:0005882;GO:0033017;GO:0030315;GO:0014802;GO:0030018;GO:0010467;GO:0065002;GO:1902430;GO:0046324;, C:cell surface; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:intermediate filament; C:sarcoplasmic reticulum membrane; C:T-tubule; C:terminal cisterna; C:Z disc;, , P:gene expression; P:intracellular protein transmembrane transport; P:negative regulation of amyloid-beta formation; P:regulation of glucose import;|O75298 O60509 Q7RTM6 Q7RTN1 Q7RTN2,Reticulon-2,Neuroendocrine-specific protein-like 1;Neuroendocrine-specific protein-like I;, PF02453;, GO:0009986;GO:0005783;GO:0030176;GO:0005882;GO:0033017;GO:0030315;GO:0014802;GO:0030018;GO:0010467;GO:0065002;GO:1902430;GO:0046324;, C:cell surface; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:intermediate filament; C:sarcoplasmic reticulum membrane; C:T-tubule; C:terminal cisterna; C:Z disc;, , P:gene expression; P:intracellular protein transmembrane transport; P:negative regulation of amyloid-beta formation; P:regulation of glucose import;|O75298 O60509 Q7RTM6 Q7RTN1 Q7RTN2,Reticulon-2,Neuroendocrine-specific protein-like 1;Neuroendocrine-specific protein-like I;, PF02453;, GO:0009986;GO:0005783;GO:0030176;GO:0005882;GO:0033017;GO:0030315;GO:0014802;GO:0030018;GO:0010467;GO:0065002;GO:1902430;GO:0046324;, C:cell surface; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:intermediate filament; C:sarcoplasmic reticulum membrane; C:T-tubule; C:terminal cisterna; C:Z disc;, , P:gene expression; P:intracellular protein transmembrane transport; P:negative regulation of amyloid-beta formation; P:regulation of glucose import; scaffold157 indexed_genome mRNA 587562 589931 . + . ID=transcript_14862;Q8N819 Q6P662,Probable protein phosphatase 1N,, PF00481;PF07830;, GO:0005829;GO:0005634;GO:0000287;GO:0030145;GO:0106306;GO:0106307;GO:0043124;GO:0090263;, C:cytosol; C:nucleus;, F:magnesium ion binding; F:manganese ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; scaffold157 indexed_genome mRNA 593430 606444 . + . ID=transcript_14863;P50552 B2RBT9 Q6PIZ1 Q93035,Vasodilator-stimulated phosphoprotein,, PF08776;PF00568;, GO:0015629;GO:0005923;GO:0005829;GO:0070062;GO:0031527;GO:0005925;GO:0031258;GO:0005886;GO:0003779;GO:0045296;GO:0005522;GO:0017124;GO:0030036;GO:0008154;GO:0007411;GO:0034329;GO:0001843;GO:0030838;GO:0051289;, C:actin cytoskeleton; C:bicellular tight junction; C:cytosol; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:lamellipodium membrane; C:plasma membrane;, F:actin binding; F:cadherin binding; F:profilin binding; F:SH3 domain binding;, P:actin cytoskeleton organization; P:actin polymerization or depolymerization; P:axon guidance; P:cell junction assembly; P:neural tube closure; P:positive regulation of actin filament polymerization; P:protein homotetramerization;|P50552 B2RBT9 Q6PIZ1 Q93035,Vasodilator-stimulated phosphoprotein,, PF08776;PF00568;, GO:0015629;GO:0005923;GO:0005829;GO:0070062;GO:0031527;GO:0005925;GO:0031258;GO:0005886;GO:0003779;GO:0045296;GO:0005522;GO:0017124;GO:0030036;GO:0008154;GO:0007411;GO:0034329;GO:0001843;GO:0030838;GO:0051289;, C:actin cytoskeleton; C:bicellular tight junction; C:cytosol; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:lamellipodium membrane; C:plasma membrane;, F:actin binding; F:cadherin binding; F:profilin binding; F:SH3 domain binding;, P:actin cytoskeleton organization; P:actin polymerization or depolymerization; P:axon guidance; P:cell junction assembly; P:neural tube closure; P:positive regulation of actin filament polymerization; P:protein homotetramerization;|P50552 B2RBT9 Q6PIZ1 Q93035,Vasodilator-stimulated phosphoprotein,, PF08776;PF00568;, GO:0015629;GO:0005923;GO:0005829;GO:0070062;GO:0031527;GO:0005925;GO:0031258;GO:0005886;GO:0003779;GO:0045296;GO:0005522;GO:0017124;GO:0030036;GO:0008154;GO:0007411;GO:0034329;GO:0001843;GO:0030838;GO:0051289;, C:actin cytoskeleton; C:bicellular tight junction; C:cytosol; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:lamellipodium membrane; C:plasma membrane;, F:actin binding; F:cadherin binding; F:profilin binding; F:SH3 domain binding;, P:actin cytoskeleton organization; P:actin polymerization or depolymerization; P:axon guidance; P:cell junction assembly; P:neural tube closure; P:positive regulation of actin filament polymerization; P:protein homotetramerization;|P50552 B2RBT9 Q6PIZ1 Q93035,Vasodilator-stimulated phosphoprotein,, PF08776;PF00568;, GO:0015629;GO:0005923;GO:0005829;GO:0070062;GO:0031527;GO:0005925;GO:0031258;GO:0005886;GO:0003779;GO:0045296;GO:0005522;GO:0017124;GO:0030036;GO:0008154;GO:0007411;GO:0034329;GO:0001843;GO:0030838;GO:0051289;, C:actin cytoskeleton; C:bicellular tight junction; C:cytosol; C:extracellular exosome; C:filopodium membrane; C:focal adhesion; C:lamellipodium membrane; C:plasma membrane;, F:actin binding; F:cadherin binding; F:profilin binding; F:SH3 domain binding;, P:actin cytoskeleton organization; P:actin polymerization or depolymerization; P:axon guidance; P:cell junction assembly; P:neural tube closure; P:positive regulation of actin filament polymerization; P:protein homotetramerization; scaffold157 indexed_genome mRNA 612692 679479 . - . ID=transcript_14864;Q9H6K4 Q6P384 Q8N784,Optic atrophy 3 protein,, PF07047;, GO:0005739;GO:0019216;GO:0050896;GO:0007601;, C:mitochondrion;, , P:regulation of lipid metabolic process; P:response to stimulus; P:visual perception;|Q9H6K4 Q6P384 Q8N784,Optic atrophy 3 protein,, PF07047;, GO:0005739;GO:0019216;GO:0050896;GO:0007601;, C:mitochondrion;, , P:regulation of lipid metabolic process; P:response to stimulus; P:visual perception; scaffold157 indexed_genome mRNA 683169 685454 . + . ID=transcript_14865;P46093 A8K3T3 B0M0K1 Q6NWM4,G-protein coupled receptor 4,G-protein coupled receptor 6C.l {ECO:0000303|PubMed:7498459};, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0007189;GO:0060055;GO:0007186;GO:0072144;GO:0016525;GO:0007200;GO:0051482;GO:0050729;GO:0035025;GO:0030155;GO:0043114;GO:0010447;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:angiogenesis involved in wound healing; P:G protein-coupled receptor signaling pathway; P:glomerular mesangial cell development; P:negative regulation of angiogenesis; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of inflammatory response; P:positive regulation of Rho protein signal transduction; P:regulation of cell adhesion; P:regulation of vascular permeability; P:response to acidic pH;|P46093 A8K3T3 B0M0K1 Q6NWM4,G-protein coupled receptor 4,G-protein coupled receptor 6C.l {ECO:0000303|PubMed:7498459};, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0007189;GO:0060055;GO:0007186;GO:0072144;GO:0016525;GO:0007200;GO:0051482;GO:0050729;GO:0035025;GO:0030155;GO:0043114;GO:0010447;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:angiogenesis involved in wound healing; P:G protein-coupled receptor signaling pathway; P:glomerular mesangial cell development; P:negative regulation of angiogenesis; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of inflammatory response; P:positive regulation of Rho protein signal transduction; P:regulation of cell adhesion; P:regulation of vascular permeability; P:response to acidic pH; scaffold157 indexed_genome mRNA 700811 725133 . - . ID=transcript_14866;O95834 B7Z3I2 B7Z3Q9 K7ERL7 Q59EN8 Q8N5A2 Q9UG50,Echinoderm microtubule-associated protein-like 2,, PF03451;PF00400;, GO:0005737;GO:0005874;GO:0005875;GO:0005819;GO:0008017;GO:0008022;GO:0005102;GO:0015631;GO:0000226;GO:0031115;GO:0010968;GO:0007605;GO:0007601;, C:cytoplasm; C:microtubule; C:microtubule associated complex; C:spindle;, F:microtubule binding; F:protein C-terminus binding; F:signaling receptor binding; F:tubulin binding;, P:microtubule cytoskeleton organization; P:negative regulation of microtubule polymerization; P:regulation of microtubule nucleation; P:sensory perception of sound; P:visual perception;|O95834 B7Z3I2 B7Z3Q9 K7ERL7 Q59EN8 Q8N5A2 Q9UG50,Echinoderm microtubule-associated protein-like 2,, PF03451;PF00400;, GO:0005737;GO:0005874;GO:0005875;GO:0005819;GO:0008017;GO:0008022;GO:0005102;GO:0015631;GO:0000226;GO:0031115;GO:0010968;GO:0007605;GO:0007601;, C:cytoplasm; C:microtubule; C:microtubule associated complex; C:spindle;, F:microtubule binding; F:protein C-terminus binding; F:signaling receptor binding; F:tubulin binding;, P:microtubule cytoskeleton organization; P:negative regulation of microtubule polymerization; P:regulation of microtubule nucleation; P:sensory perception of sound; P:visual perception;|O95834 B7Z3I2 B7Z3Q9 K7ERL7 Q59EN8 Q8N5A2 Q9UG50,Echinoderm microtubule-associated protein-like 2,, PF03451;PF00400;, GO:0005737;GO:0005874;GO:0005875;GO:0005819;GO:0008017;GO:0008022;GO:0005102;GO:0015631;GO:0000226;GO:0031115;GO:0010968;GO:0007605;GO:0007601;, C:cytoplasm; C:microtubule; C:microtubule associated complex; C:spindle;, F:microtubule binding; F:protein C-terminus binding; F:signaling receptor binding; F:tubulin binding;, P:microtubule cytoskeleton organization; P:negative regulation of microtubule polymerization; P:regulation of microtubule nucleation; P:sensory perception of sound; P:visual perception;|O95834 B7Z3I2 B7Z3Q9 K7ERL7 Q59EN8 Q8N5A2 Q9UG50,Echinoderm microtubule-associated protein-like 2,, PF03451;PF00400;, GO:0005737;GO:0005874;GO:0005875;GO:0005819;GO:0008017;GO:0008022;GO:0005102;GO:0015631;GO:0000226;GO:0031115;GO:0010968;GO:0007605;GO:0007601;, C:cytoplasm; C:microtubule; C:microtubule associated complex; C:spindle;, F:microtubule binding; F:protein C-terminus binding; F:signaling receptor binding; F:tubulin binding;, P:microtubule cytoskeleton organization; P:negative regulation of microtubule polymerization; P:regulation of microtubule nucleation; P:sensory perception of sound; P:visual perception;|O95834 B7Z3I2 B7Z3Q9 K7ERL7 Q59EN8 Q8N5A2 Q9UG50,Echinoderm microtubule-associated protein-like 2,, PF03451;PF00400;, GO:0005737;GO:0005874;GO:0005875;GO:0005819;GO:0008017;GO:0008022;GO:0005102;GO:0015631;GO:0000226;GO:0031115;GO:0010968;GO:0007605;GO:0007601;, C:cytoplasm; C:microtubule; C:microtubule associated complex; C:spindle;, F:microtubule binding; F:protein C-terminus binding; F:signaling receptor binding; F:tubulin binding;, P:microtubule cytoskeleton organization; P:negative regulation of microtubule polymerization; P:regulation of microtubule nucleation; P:sensory perception of sound; P:visual perception;|O95834 B7Z3I2 B7Z3Q9 K7ERL7 Q59EN8 Q8N5A2 Q9UG50,Echinoderm microtubule-associated protein-like 2,, PF03451;PF00400;, GO:0005737;GO:0005874;GO:0005875;GO:0005819;GO:0008017;GO:0008022;GO:0005102;GO:0015631;GO:0000226;GO:0031115;GO:0010968;GO:0007605;GO:0007601;, C:cytoplasm; C:microtubule; C:microtubule associated complex; C:spindle;, F:microtubule binding; F:protein C-terminus binding; F:signaling receptor binding; F:tubulin binding;, P:microtubule cytoskeleton organization; P:negative regulation of microtubule polymerization; P:regulation of microtubule nucleation; P:sensory perception of sound; P:visual perception; scaffold157 indexed_genome mRNA 752104 758242 . + . ID=transcript_14867;Q9NXS2 Q53HE4 Q96F74,Glutaminyl-peptide cyclotransferase-like protein,Golgi-resident glutaminyl-peptide cyclotransferase;isoQC;, PF04389;, GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0016603;GO:0008270;GO:0017186;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane;, F:glutaminyl-peptide cyclotransferase activity; F:zinc ion binding;, P:peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase; scaffold157 indexed_genome mRNA 761350 765303 . + . ID=transcript_14868;Q6PJ61,F-box only protein 46,F-box only protein 34-like;, PF12937; scaffold157 indexed_genome mRNA 798944 823786 . - . ID=transcript_14869;Q09013 E5KR08 Q16205 Q6P5Z6,Myotonin-protein kinase,DM-kinase;DM1 protein kinase;DMPK;Myotonic dystrophy protein kinase;, PF08826;PF00069;, GO:0005829;GO:0005789;GO:0031307;GO:0031965;GO:0005640;GO:0005886;GO:0033017;GO:0005524;GO:0046872;GO:0017020;GO:0106310;GO:0004674;GO:0106311;GO:0006874;GO:0035556;GO:0010657;GO:0006998;GO:0018105;GO:0006468;GO:1903779;GO:0014853;GO:0008016;GO:0010830;GO:0014722;GO:0002028;GO:0051823;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of mitochondrial outer membrane; C:nuclear membrane; C:nuclear outer membrane; C:plasma membrane; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:metal ion binding; F:myosin phosphatase regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular calcium ion homeostasis; P:intracellular signal transduction; P:muscle cell apoptotic process; P:nuclear envelope organization; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of cardiac conduction; P:regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction; P:regulation of heart contraction; P:regulation of myotube differentiation; P:regulation of skeletal muscle contraction by calcium ion signaling; P:regulation of sodium ion transport; P:regulation of synapse structural plasticity;|Q09013 E5KR08 Q16205 Q6P5Z6,Myotonin-protein kinase,DM-kinase;DM1 protein kinase;DMPK;Myotonic dystrophy protein kinase;, PF08826;PF00069;, GO:0005829;GO:0005789;GO:0031307;GO:0031965;GO:0005640;GO:0005886;GO:0033017;GO:0005524;GO:0046872;GO:0017020;GO:0106310;GO:0004674;GO:0106311;GO:0006874;GO:0035556;GO:0010657;GO:0006998;GO:0018105;GO:0006468;GO:1903779;GO:0014853;GO:0008016;GO:0010830;GO:0014722;GO:0002028;GO:0051823;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of mitochondrial outer membrane; C:nuclear membrane; C:nuclear outer membrane; C:plasma membrane; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:metal ion binding; F:myosin phosphatase regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular calcium ion homeostasis; P:intracellular signal transduction; P:muscle cell apoptotic process; P:nuclear envelope organization; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of cardiac conduction; P:regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction; P:regulation of heart contraction; P:regulation of myotube differentiation; P:regulation of skeletal muscle contraction by calcium ion signaling; P:regulation of sodium ion transport; P:regulation of synapse structural plasticity;|Q09013 E5KR08 Q16205 Q6P5Z6,Myotonin-protein kinase,DM-kinase;DM1 protein kinase;DMPK;Myotonic dystrophy protein kinase;, PF08826;PF00069;, GO:0005829;GO:0005789;GO:0031307;GO:0031965;GO:0005640;GO:0005886;GO:0033017;GO:0005524;GO:0046872;GO:0017020;GO:0106310;GO:0004674;GO:0106311;GO:0006874;GO:0035556;GO:0010657;GO:0006998;GO:0018105;GO:0006468;GO:1903779;GO:0014853;GO:0008016;GO:0010830;GO:0014722;GO:0002028;GO:0051823;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of mitochondrial outer membrane; C:nuclear membrane; C:nuclear outer membrane; C:plasma membrane; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:metal ion binding; F:myosin phosphatase regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular calcium ion homeostasis; P:intracellular signal transduction; P:muscle cell apoptotic process; P:nuclear envelope organization; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of cardiac conduction; P:regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction; P:regulation of heart contraction; P:regulation of myotube differentiation; P:regulation of skeletal muscle contraction by calcium ion signaling; P:regulation of sodium ion transport; P:regulation of synapse structural plasticity;|Q09013 E5KR08 Q16205 Q6P5Z6,Myotonin-protein kinase,DM-kinase;DM1 protein kinase;DMPK;Myotonic dystrophy protein kinase;, PF08826;PF00069;, GO:0005829;GO:0005789;GO:0031307;GO:0031965;GO:0005640;GO:0005886;GO:0033017;GO:0005524;GO:0046872;GO:0017020;GO:0106310;GO:0004674;GO:0106311;GO:0006874;GO:0035556;GO:0010657;GO:0006998;GO:0018105;GO:0006468;GO:1903779;GO:0014853;GO:0008016;GO:0010830;GO:0014722;GO:0002028;GO:0051823;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of mitochondrial outer membrane; C:nuclear membrane; C:nuclear outer membrane; C:plasma membrane; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:metal ion binding; F:myosin phosphatase regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular calcium ion homeostasis; P:intracellular signal transduction; P:muscle cell apoptotic process; P:nuclear envelope organization; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of cardiac conduction; P:regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction; P:regulation of heart contraction; P:regulation of myotube differentiation; P:regulation of skeletal muscle contraction by calcium ion signaling; P:regulation of sodium ion transport; P:regulation of synapse structural plasticity;|Q09013 E5KR08 Q16205 Q6P5Z6,Myotonin-protein kinase,DM-kinase;DM1 protein kinase;DMPK;Myotonic dystrophy protein kinase;, PF08826;PF00069;, GO:0005829;GO:0005789;GO:0031307;GO:0031965;GO:0005640;GO:0005886;GO:0033017;GO:0005524;GO:0046872;GO:0017020;GO:0106310;GO:0004674;GO:0106311;GO:0006874;GO:0035556;GO:0010657;GO:0006998;GO:0018105;GO:0006468;GO:1903779;GO:0014853;GO:0008016;GO:0010830;GO:0014722;GO:0002028;GO:0051823;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of mitochondrial outer membrane; C:nuclear membrane; C:nuclear outer membrane; C:plasma membrane; C:sarcoplasmic reticulum membrane;, F:ATP binding; F:metal ion binding; F:myosin phosphatase regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular calcium ion homeostasis; P:intracellular signal transduction; P:muscle cell apoptotic process; P:nuclear envelope organization; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of cardiac conduction; P:regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction; P:regulation of heart contraction; P:regulation of myotube differentiation; P:regulation of skeletal muscle contraction by calcium ion signaling; P:regulation of sodium ion transport; P:regulation of synapse structural plasticity; scaffold157 indexed_genome mRNA 823796 830908 . - . ID=transcript_14870;Q09019,Dystrophia myotonica WD repeat-containing protein,Dystrophia myotonica-containing WD repeat motif protein;Protein 59;Protein DMR-N9;, PF00400;, GO:0030425;GO:0005634;GO:0043204;, C:dendrite; C:nucleus; C:perikaryon;|Q09019,Dystrophia myotonica WD repeat-containing protein,Dystrophia myotonica-containing WD repeat motif protein;Protein 59;Protein DMR-N9;, PF00400;, GO:0030425;GO:0005634;GO:0043204;, C:dendrite; C:nucleus; C:perikaryon; scaffold157 indexed_genome mRNA 859769 863344 . - . ID=transcript_14871;Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription;|Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription; scaffold157 indexed_genome mRNA 863386 893440 . - . ID=transcript_14872;Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription;|Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription;|Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription;|Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription;|Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription;|Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription;|Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription;|Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription;|Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription;|Q92797 O00521 O00689 O00733 Q59GT5 Q8N2U5,Symplekin,, PF11935;PF12295;, GO:0005923;GO:0005737;GO:0005856;GO:0005829;GO:0005847;GO:0016604;GO:0097165;GO:0005654;GO:0005886;GO:0007155;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0032091;GO:0035307;GO:0006369;, C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:mRNA cleavage and polyadenylation specificity factor complex; C:nuclear body; C:nuclear stress granule; C:nucleoplasm; C:plasma membrane;, , P:cell adhesion; P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:negative regulation of protein binding; P:positive regulation of protein dephosphorylation; P:termination of RNA polymerase II transcription; scaffold157 indexed_genome mRNA 894290 900796 . + . ID=transcript_14873;P55318 A9LYI5 Q53F16 Q9UMW9,Hepatocyte nuclear factor 3-gamma,Fork head-related protein FKH H3;Forkhead box protein A3;Transcription factor 3G;, PF00250;PF08430;, GO:0015629;GO:0000785;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0019904;GO:0000978;GO:1990837;GO:0008134;GO:0000976;GO:0009653;GO:0030154;GO:0001678;GO:0009267;GO:0006325;GO:0061484;GO:0007275;GO:0045944;GO:0006357;GO:0007283;, C:actin cytoskeleton; C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:cell differentiation; P:cellular glucose homeostasis; P:cellular response to starvation; P:chromatin organization; P:hematopoietic stem cell homeostasis; P:multicellular organism development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold157 indexed_genome mRNA 908325 910683 . - . ID=transcript_14874;Q8IU81 Q53EL7 Q6DC95 Q9BRZ9 Q9Y4P4,Interferon regulatory factor 2-binding protein 1,Probable E3 ubiquitin-protein ligase IRF2BP1;Probable RING-type E3 ubiquitin transferase IRF2BP1 {ECO:0000305};, PF11261;PF00097;, GO:0005654;GO:0005634;GO:0046872;GO:0003714;GO:0008134;GO:0061630;GO:0000122;GO:0000209;GO:0006357;, C:nucleoplasm; C:nucleus;, F:metal ion binding; F:transcription corepressor activity; F:transcription factor binding; F:ubiquitin protein ligase activity;, P:negative regulation of transcription by RNA polymerase II; P:protein polyubiquitination; P:regulation of transcription by RNA polymerase II; scaffold157 indexed_genome mRNA 956142 972148 . - . ID=transcript_14875;Q9UNW9 O43267 Q9UEA1,RNA-binding protein Nova-2,Astrocytic NOVA1-like RNA-binding protein;Neuro-oncological ventral antigen 2;, PF00013;, GO:0005737;GO:0005634;GO:0003729;GO:0003723;GO:0000398;GO:0120163;GO:0000381;GO:0010468;GO:0051252;, C:cytoplasm; C:nucleus;, F:mRNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of cold-induced thermogenesis; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of RNA metabolic process; scaffold157 indexed_genome mRNA 1006047 1018898 . + . ID=transcript_14876;Q9Y6R9 C8CAP4 Q9HDB6,Centrosomal protein CCDC61 {ECO:0000303|PubMed:30354798},Coiled-coil domain-containing protein 61;VFL3 homolog {ECO:0000303|PubMed:31789463, ECO:0000303|PubMed:32375023};, , GO:0034451;GO:0120103;GO:0005813;GO:0036064;GO:0005737;GO:0005815;GO:0042802;GO:0008017;GO:0030030;GO:0098534;GO:0090307;, C:centriolar satellite; C:centriolar subdistal appendage; C:centrosome; C:ciliary basal body; C:cytoplasm; C:microtubule organizing center;, F:identical protein binding; F:microtubule binding;, P:cell projection organization; P:centriole assembly; P:mitotic spindle assembly;|Q9Y6R9 C8CAP4 Q9HDB6,Centrosomal protein CCDC61 {ECO:0000303|PubMed:30354798},Coiled-coil domain-containing protein 61;VFL3 homolog {ECO:0000303|PubMed:31789463, ECO:0000303|PubMed:32375023};, , GO:0034451;GO:0120103;GO:0005813;GO:0036064;GO:0005737;GO:0005815;GO:0042802;GO:0008017;GO:0030030;GO:0098534;GO:0090307;, C:centriolar satellite; C:centriolar subdistal appendage; C:centrosome; C:ciliary basal body; C:cytoplasm; C:microtubule organizing center;, F:identical protein binding; F:microtubule binding;, P:cell projection organization; P:centriole assembly; P:mitotic spindle assembly; scaffold157 indexed_genome mRNA 1068316 1116773 . + . ID=transcript_14877;Q9HAI2,Hypoxia-inducible factor 3-alpha {ECO:0000303|PubMed:11573933},Basic-helix-loop-helix-PAS protein MOP7;Class E basic helix-loop-helix protein 17;HIF3-alpha-1;Inhibitory PAS domain protein;Member of PAS protein 7;PAS domain-containing protein 7;, PF11413;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0005739;GO:0016607;GO:0005654;GO:0005886;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0001525;GO:0006915;GO:0043687;GO:0016567;GO:0006357;GO:0061418;GO:0006366;, C:chromatin; C:cytosol; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:apoptotic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:transcription by RNA polymerase II;|Q9HAI2,Hypoxia-inducible factor 3-alpha {ECO:0000303|PubMed:11573933},Basic-helix-loop-helix-PAS protein MOP7;Class E basic helix-loop-helix protein 17;HIF3-alpha-1;Inhibitory PAS domain protein;Member of PAS protein 7;PAS domain-containing protein 7;, PF11413;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0005739;GO:0016607;GO:0005654;GO:0005886;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0001525;GO:0006915;GO:0043687;GO:0016567;GO:0006357;GO:0061418;GO:0006366;, C:chromatin; C:cytosol; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:apoptotic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:transcription by RNA polymerase II;|Q9HAI2,Hypoxia-inducible factor 3-alpha {ECO:0000303|PubMed:11573933},Basic-helix-loop-helix-PAS protein MOP7;Class E basic helix-loop-helix protein 17;HIF3-alpha-1;Inhibitory PAS domain protein;Member of PAS protein 7;PAS domain-containing protein 7;, PF11413;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0005739;GO:0016607;GO:0005654;GO:0005886;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0001525;GO:0006915;GO:0043687;GO:0016567;GO:0006357;GO:0061418;GO:0006366;, C:chromatin; C:cytosol; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:apoptotic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:transcription by RNA polymerase II;|Q9HAI2,Hypoxia-inducible factor 3-alpha {ECO:0000303|PubMed:11573933},Basic-helix-loop-helix-PAS protein MOP7;Class E basic helix-loop-helix protein 17;HIF3-alpha-1;Inhibitory PAS domain protein;Member of PAS protein 7;PAS domain-containing protein 7;, PF11413;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0005739;GO:0016607;GO:0005654;GO:0005886;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0001525;GO:0006915;GO:0043687;GO:0016567;GO:0006357;GO:0061418;GO:0006366;, C:chromatin; C:cytosol; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:apoptotic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:transcription by RNA polymerase II;|Q9HAI2,Hypoxia-inducible factor 3-alpha {ECO:0000303|PubMed:11573933},Basic-helix-loop-helix-PAS protein MOP7;Class E basic helix-loop-helix protein 17;HIF3-alpha-1;Inhibitory PAS domain protein;Member of PAS protein 7;PAS domain-containing protein 7;, PF11413;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0005739;GO:0016607;GO:0005654;GO:0005886;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0001525;GO:0006915;GO:0043687;GO:0016567;GO:0006357;GO:0061418;GO:0006366;, C:chromatin; C:cytosol; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:apoptotic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:transcription by RNA polymerase II;|Q9HAI2,Hypoxia-inducible factor 3-alpha {ECO:0000303|PubMed:11573933},Basic-helix-loop-helix-PAS protein MOP7;Class E basic helix-loop-helix protein 17;HIF3-alpha-1;Inhibitory PAS domain protein;Member of PAS protein 7;PAS domain-containing protein 7;, PF11413;PF00989;PF08447;, GO:0000785;GO:0005829;GO:0005739;GO:0016607;GO:0005654;GO:0005886;GO:0000981;GO:0046983;GO:0000978;GO:0000977;GO:0001525;GO:0006915;GO:0043687;GO:0016567;GO:0006357;GO:0061418;GO:0006366;, C:chromatin; C:cytosol; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:plasma membrane;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:apoptotic process; P:post-translational protein modification; P:protein ubiquitination; P:regulation of transcription by RNA polymerase II; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:transcription by RNA polymerase II;|P53041 Q16722 Q53XV2,Serine/threonine-protein phosphatase 5,Protein phosphatase T;, PF00149;PF08321;PF00515;, GO:0101031;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0032991;GO:1990635;GO:0043531;GO:0005524;GO:0001965;GO:0051879;GO:0042802;GO:0008289;GO:0046872;GO:0008017;GO:0016791;GO:0004721;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0003723;GO:0048156;GO:0071276;GO:0070301;GO:0006302;GO:0016576;GO:0000165;GO:0000278;GO:1901215;GO:0001933;GO:0070262;GO:0035970;GO:2000324;GO:0043123;GO:0006470;GO:1904550;GO:0010288;GO:0043278;GO:0006351;, C:chaperone complex; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:proximal dendrite;, F:ADP binding; F:ATP binding; F:G-protein alpha-subunit binding; F:Hsp90 protein binding; F:identical protein binding; F:lipid binding; F:metal ion binding; F:microtubule binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding; F:RNA binding; F:tau protein binding;, P:cellular response to cadmium ion; P:cellular response to hydrogen peroxide; P:double-strand break repair; P:histone dephosphorylation; P:MAPK cascade; P:mitotic cell cycle; P:negative regulation of neuron death; P:negative regulation of protein phosphorylation; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of glucocorticoid receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein dephosphorylation; P:response to arachidonic acid; P:response to lead ion; P:response to morphine; P:transcription, DNA-templated;|E7EU14 B3KSW5,Protein PPP5D1,PPP5 TPR repeat domain-containing protein 1;, PF08321;|P53041 Q16722 Q53XV2,Serine/threonine-protein phosphatase 5,Protein phosphatase T;, PF00149;PF08321;PF00515;, GO:0101031;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0032991;GO:1990635;GO:0043531;GO:0005524;GO:0001965;GO:0051879;GO:0042802;GO:0008289;GO:0046872;GO:0008017;GO:0016791;GO:0004721;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0003723;GO:0048156;GO:0071276;GO:0070301;GO:0006302;GO:0016576;GO:0000165;GO:0000278;GO:1901215;GO:0001933;GO:0070262;GO:0035970;GO:2000324;GO:0043123;GO:0006470;GO:1904550;GO:0010288;GO:0043278;GO:0006351;, C:chaperone complex; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:proximal dendrite;, F:ADP binding; F:ATP binding; F:G-protein alpha-subunit binding; F:Hsp90 protein binding; F:identical protein binding; F:lipid binding; F:metal ion binding; F:microtubule binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding; F:RNA binding; F:tau protein binding;, P:cellular response to cadmium ion; P:cellular response to hydrogen peroxide; P:double-strand break repair; P:histone dephosphorylation; P:MAPK cascade; P:mitotic cell cycle; P:negative regulation of neuron death; P:negative regulation of protein phosphorylation; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of glucocorticoid receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein dephosphorylation; P:response to arachidonic acid; P:response to lead ion; P:response to morphine; P:transcription, DNA-templated;|P53041 Q16722 Q53XV2,Serine/threonine-protein phosphatase 5,Protein phosphatase T;, PF00149;PF08321;PF00515;, GO:0101031;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0032991;GO:1990635;GO:0043531;GO:0005524;GO:0001965;GO:0051879;GO:0042802;GO:0008289;GO:0046872;GO:0008017;GO:0016791;GO:0004721;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0003723;GO:0048156;GO:0071276;GO:0070301;GO:0006302;GO:0016576;GO:0000165;GO:0000278;GO:1901215;GO:0001933;GO:0070262;GO:0035970;GO:2000324;GO:0043123;GO:0006470;GO:1904550;GO:0010288;GO:0043278;GO:0006351;, C:chaperone complex; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:proximal dendrite;, F:ADP binding; F:ATP binding; F:G-protein alpha-subunit binding; F:Hsp90 protein binding; F:identical protein binding; F:lipid binding; F:metal ion binding; F:microtubule binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding; F:RNA binding; F:tau protein binding;, P:cellular response to cadmium ion; P:cellular response to hydrogen peroxide; P:double-strand break repair; P:histone dephosphorylation; P:MAPK cascade; P:mitotic cell cycle; P:negative regulation of neuron death; P:negative regulation of protein phosphorylation; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of glucocorticoid receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein dephosphorylation; P:response to arachidonic acid; P:response to lead ion; P:response to morphine; P:transcription, DNA-templated;|P53041 Q16722 Q53XV2,Serine/threonine-protein phosphatase 5,Protein phosphatase T;, PF00149;PF08321;PF00515;, GO:0101031;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0032991;GO:1990635;GO:0043531;GO:0005524;GO:0001965;GO:0051879;GO:0042802;GO:0008289;GO:0046872;GO:0008017;GO:0016791;GO:0004721;GO:0106306;GO:0004722;GO:0106307;GO:0044877;GO:0003723;GO:0048156;GO:0071276;GO:0070301;GO:0006302;GO:0016576;GO:0000165;GO:0000278;GO:1901215;GO:0001933;GO:0070262;GO:0035970;GO:2000324;GO:0043123;GO:0006470;GO:1904550;GO:0010288;GO:0043278;GO:0006351;, C:chaperone complex; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:protein-containing complex; C:proximal dendrite;, F:ADP binding; F:ATP binding; F:G-protein alpha-subunit binding; F:Hsp90 protein binding; F:identical protein binding; F:lipid binding; F:metal ion binding; F:microtubule binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein-containing complex binding; F:RNA binding; F:tau protein binding;, P:cellular response to cadmium ion; P:cellular response to hydrogen peroxide; P:double-strand break repair; P:histone dephosphorylation; P:MAPK cascade; P:mitotic cell cycle; P:negative regulation of neuron death; P:negative regulation of protein phosphorylation; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of glucocorticoid receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein dephosphorylation; P:response to arachidonic acid; P:response to lead ion; P:response to morphine; P:transcription, DNA-templated; scaffold157 indexed_genome mRNA 1151089 1152923 . + . ID=transcript_14878;Q86V59 A8K2F3 Q5U638 Q8N3H4 Q9NVE8,Paraneoplastic antigen-like protein 8A {ECO:0000312|HGNC:HGNC:25578},PNMA-like protein 1;, PF14893; scaffold157 indexed_genome mRNA 1194749 1197356 . + . ID=transcript_14879;Q9H0W5 Q8TB26,Coiled-coil domain-containing protein 8,, PF14893;, GO:1990393;GO:0005813;GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0000226;GO:0010923;GO:0043687;GO:0007088;, C:3M complex; C:centrosome; C:cytoplasm; C:cytosol; C:nucleoplasm; C:plasma membrane;, , P:microtubule cytoskeleton organization; P:negative regulation of phosphatase activity; P:post-translational protein modification; P:regulation of mitotic nuclear division; scaffold157 indexed_genome mRNA 1245082 1254149 . + . ID=transcript_14880;Q96HK3,Calmodulin-1 {ECO:0000312|HGNC:HGNC:1442},, PF13499;, GO:0034704;GO:1902494;GO:0005813;GO:0005737;GO:0005829;GO:0005576;GO:0030426;GO:0031966;GO:0043209;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0030017;GO:0005876;GO:0000922;GO:0030672;GO:0031982;GO:0008076;GO:0010856;GO:0008179;GO:0019855;GO:0005509;GO:0048306;GO:0097718;GO:0030234;GO:0044325;GO:0031997;GO:0050998;GO:0030235;GO:0043548;GO:0019904;GO:0019901;GO:0072542;GO:0043539;GO:0031432;GO:0031800;GO:0007190;GO:0016240;GO:0007268;GO:0005513;GO:0090151;GO:0038095;GO:0007186;GO:0000086;GO:0005980;GO:0043647;GO:0000165;GO:1990456;GO:0006936;GO:1901842;GO:0010801;GO:0060315;GO:0140056;GO:0002576;GO:0051343;GO:0043388;GO:0051000;GO:0010800;GO:0032516;GO:0031954;GO:0035307;GO:0071902;GO:0060316;GO:0098901;GO:0055117;GO:0010881;GO:1901844;GO:0032465;GO:0002027;GO:0050999;GO:0010880;GO:0022400;GO:0060314;GO:1900242;GO:2000300;GO:0001975;GO:0051592;GO:0051412;GO:0021762;GO:0046146;GO:0016032;GO:0007223;, C:calcium channel complex; C:catalytic complex; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular region; C:growth cone; C:mitochondrial membrane; C:myelin sheath; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:sarcomere; C:spindle microtubule; C:spindle pole; C:synaptic vesicle membrane; C:vesicle; C:voltage-gated potassium channel complex;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium-dependent protein binding; F:disordered domain specific binding; F:enzyme regulator activity; F:ion channel binding; F:N-terminal myristoylation domain binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase activator activity; F:protein serine/threonine kinase activator activity; F:titin binding; F:type 3 metabotropic glutamate receptor binding;, P:activation of adenylate cyclase activity; P:autophagosome membrane docking; P:chemical synaptic transmission; P:detection of calcium ion; P:establishment of protein localization to mitochondrial membrane; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:glycogen catabolic process; P:inositol phosphate metabolic process; P:MAPK cascade; P:mitochondrion-endoplasmic reticulum membrane tethering; P:muscle contraction; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:organelle localization by membrane tethering; P:platelet degranulation; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of DNA binding; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytokinesis; P:regulation of heart rate; P:regulation of nitric-oxide synthase activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of rhodopsin mediated signaling pathway; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic vesicle endocytosis; P:regulation of synaptic vesicle exocytosis; P:response to amphetamine; P:response to calcium ion; P:response to corticosterone; P:substantia nigra development; P:tetrahydrobiopterin metabolic process; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q96HK3,Calmodulin-1 {ECO:0000312|HGNC:HGNC:1442},, PF13499;, GO:0034704;GO:1902494;GO:0005813;GO:0005737;GO:0005829;GO:0005576;GO:0030426;GO:0031966;GO:0043209;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0030017;GO:0005876;GO:0000922;GO:0030672;GO:0031982;GO:0008076;GO:0010856;GO:0008179;GO:0019855;GO:0005509;GO:0048306;GO:0097718;GO:0030234;GO:0044325;GO:0031997;GO:0050998;GO:0030235;GO:0043548;GO:0019904;GO:0019901;GO:0072542;GO:0043539;GO:0031432;GO:0031800;GO:0007190;GO:0016240;GO:0007268;GO:0005513;GO:0090151;GO:0038095;GO:0007186;GO:0000086;GO:0005980;GO:0043647;GO:0000165;GO:1990456;GO:0006936;GO:1901842;GO:0010801;GO:0060315;GO:0140056;GO:0002576;GO:0051343;GO:0043388;GO:0051000;GO:0010800;GO:0032516;GO:0031954;GO:0035307;GO:0071902;GO:0060316;GO:0098901;GO:0055117;GO:0010881;GO:1901844;GO:0032465;GO:0002027;GO:0050999;GO:0010880;GO:0022400;GO:0060314;GO:1900242;GO:2000300;GO:0001975;GO:0051592;GO:0051412;GO:0021762;GO:0046146;GO:0016032;GO:0007223;, C:calcium channel complex; C:catalytic complex; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular region; C:growth cone; C:mitochondrial membrane; C:myelin sheath; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:sarcomere; C:spindle microtubule; C:spindle pole; C:synaptic vesicle membrane; C:vesicle; C:voltage-gated potassium channel complex;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium-dependent protein binding; F:disordered domain specific binding; F:enzyme regulator activity; F:ion channel binding; F:N-terminal myristoylation domain binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase activator activity; F:protein serine/threonine kinase activator activity; F:titin binding; F:type 3 metabotropic glutamate receptor binding;, P:activation of adenylate cyclase activity; P:autophagosome membrane docking; P:chemical synaptic transmission; P:detection of calcium ion; P:establishment of protein localization to mitochondrial membrane; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:glycogen catabolic process; P:inositol phosphate metabolic process; P:MAPK cascade; P:mitochondrion-endoplasmic reticulum membrane tethering; P:muscle contraction; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:organelle localization by membrane tethering; P:platelet degranulation; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of DNA binding; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytokinesis; P:regulation of heart rate; P:regulation of nitric-oxide synthase activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of rhodopsin mediated signaling pathway; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic vesicle endocytosis; P:regulation of synaptic vesicle exocytosis; P:response to amphetamine; P:response to calcium ion; P:response to corticosterone; P:substantia nigra development; P:tetrahydrobiopterin metabolic process; P:viral process; P:Wnt signaling pathway, calcium modulating pathway;|Q96HK3,Calmodulin-1 {ECO:0000312|HGNC:HGNC:1442},, PF13499;, GO:0034704;GO:1902494;GO:0005813;GO:0005737;GO:0005829;GO:0005576;GO:0030426;GO:0031966;GO:0043209;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0030017;GO:0005876;GO:0000922;GO:0030672;GO:0031982;GO:0008076;GO:0010856;GO:0008179;GO:0019855;GO:0005509;GO:0048306;GO:0097718;GO:0030234;GO:0044325;GO:0031997;GO:0050998;GO:0030235;GO:0043548;GO:0019904;GO:0019901;GO:0072542;GO:0043539;GO:0031432;GO:0031800;GO:0007190;GO:0016240;GO:0007268;GO:0005513;GO:0090151;GO:0038095;GO:0007186;GO:0000086;GO:0005980;GO:0043647;GO:0000165;GO:1990456;GO:0006936;GO:1901842;GO:0010801;GO:0060315;GO:0140056;GO:0002576;GO:0051343;GO:0043388;GO:0051000;GO:0010800;GO:0032516;GO:0031954;GO:0035307;GO:0071902;GO:0060316;GO:0098901;GO:0055117;GO:0010881;GO:1901844;GO:0032465;GO:0002027;GO:0050999;GO:0010880;GO:0022400;GO:0060314;GO:1900242;GO:2000300;GO:0001975;GO:0051592;GO:0051412;GO:0021762;GO:0046146;GO:0016032;GO:0007223;, C:calcium channel complex; C:catalytic complex; C:centrosome; C:cytoplasm; C:cytosol; C:extracellular region; C:growth cone; C:mitochondrial membrane; C:myelin sheath; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:sarcomere; C:spindle microtubule; C:spindle pole; C:synaptic vesicle membrane; C:vesicle; C:voltage-gated potassium channel complex;, F:adenylate cyclase activator activity; F:adenylate cyclase binding; F:calcium channel inhibitor activity; F:calcium ion binding; F:calcium-dependent protein binding; F:disordered domain specific binding; F:enzyme regulator activity; F:ion channel binding; F:N-terminal myristoylation domain binding; F:nitric-oxide synthase binding; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol 3-kinase binding; F:protein domain specific binding; F:protein kinase binding; F:protein phosphatase activator activity; F:protein serine/threonine kinase activator activity; F:titin binding; F:type 3 metabotropic glutamate receptor binding;, P:activation of adenylate cyclase activity; P:autophagosome membrane docking; P:chemical synaptic transmission; P:detection of calcium ion; P:establishment of protein localization to mitochondrial membrane; P:Fc-epsilon receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G2/M transition of mitotic cell cycle; P:glycogen catabolic process; P:inositol phosphate metabolic process; P:MAPK cascade; P:mitochondrion-endoplasmic reticulum membrane tethering; P:muscle contraction; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:organelle localization by membrane tethering; P:platelet degranulation; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:positive regulation of DNA binding; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of protein autophosphorylation; P:positive regulation of protein dephosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of cardiac muscle cell action potential; P:regulation of cardiac muscle contraction; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:regulation of cytokinesis; P:regulation of heart rate; P:regulation of nitric-oxide synthase activity; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:regulation of rhodopsin mediated signaling pathway; P:regulation of ryanodine-sensitive calcium-release channel activity; P:regulation of synaptic vesicle endocytosis; P:regulation of synaptic vesicle exocytosis; P:response to amphetamine; P:response to calcium ion; P:response to corticosterone; P:substantia nigra development; P:tetrahydrobiopterin metabolic process; P:viral process; P:Wnt signaling pathway, calcium modulating pathway; scaffold157 indexed_genome mRNA 1259674 1263448 . - . ID=transcript_14881;P43119,Prostacyclin receptor,Prostaglandin I2 receptor;Prostanoid IP receptor;, PF00001;, GO:0005829;GO:0005887;GO:0005886;GO:0016501;GO:0007189;GO:0007267;GO:0007186;GO:0007187;GO:0006954;GO:0002862;GO:0010642;GO:0048662;GO:0007204;GO:0050790;GO:0032496;, C:cytosol; C:integral component of plasma membrane; C:plasma membrane;, F:prostacyclin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:inflammatory response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of cytosolic calcium ion concentration; P:regulation of catalytic activity; P:response to lipopolysaccharide;|P43119,Prostacyclin receptor,Prostaglandin I2 receptor;Prostanoid IP receptor;, PF00001;, GO:0005829;GO:0005887;GO:0005886;GO:0016501;GO:0007189;GO:0007267;GO:0007186;GO:0007187;GO:0006954;GO:0002862;GO:0010642;GO:0048662;GO:0007204;GO:0050790;GO:0032496;, C:cytosol; C:integral component of plasma membrane; C:plasma membrane;, F:prostacyclin receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:inflammatory response; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of platelet-derived growth factor receptor signaling pathway; P:negative regulation of smooth muscle cell proliferation; P:positive regulation of cytosolic calcium ion concentration; P:regulation of catalytic activity; P:response to lipopolysaccharide; scaffold157 indexed_genome mRNA 1299264 1331514 . - . ID=transcript_14882;Q9BZL6 B4DTS2 M0QZW1 M0R2R2 Q8NCK8 Q8TB08 Q9P0T6 Q9Y3X8,Serine/threonine-protein kinase D2,nPKC-D2;, PF00130;PF00069;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0004698;GO:0046872;GO:0004672;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0002250;GO:0001525;GO:0007155;GO:0008219;GO:0035924;GO:0061154;GO:0035556;GO:0018105;GO:0018107;GO:0045766;GO:0043536;GO:0045785;GO:0032793;GO:2000573;GO:0051091;GO:2001028;GO:0038033;GO:0010595;GO:0001938;GO:0070374;GO:0045743;GO:1901727;GO:0032743;GO:0032757;GO:1902533;GO:0051092;GO:0033138;GO:0050862;GO:0045944;GO:0030949;GO:0046777;GO:0089700;GO:0006468;GO:0030148;GO:0050852;GO:0048010;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:metal ion binding; F:protein kinase activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adaptive immune response; P:angiogenesis; P:cell adhesion; P:cell death; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial tube morphogenesis; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell adhesion; P:positive regulation of CREB transcription factor activity; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of histone deacetylase activity; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-8 production; P:positive regulation of intracellular signal transduction; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein kinase D signaling; P:protein phosphorylation; P:sphingolipid biosynthetic process; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q9BZL6 B4DTS2 M0QZW1 M0R2R2 Q8NCK8 Q8TB08 Q9P0T6 Q9Y3X8,Serine/threonine-protein kinase D2,nPKC-D2;, PF00130;PF00069;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0004698;GO:0046872;GO:0004672;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0002250;GO:0001525;GO:0007155;GO:0008219;GO:0035924;GO:0061154;GO:0035556;GO:0018105;GO:0018107;GO:0045766;GO:0043536;GO:0045785;GO:0032793;GO:2000573;GO:0051091;GO:2001028;GO:0038033;GO:0010595;GO:0001938;GO:0070374;GO:0045743;GO:1901727;GO:0032743;GO:0032757;GO:1902533;GO:0051092;GO:0033138;GO:0050862;GO:0045944;GO:0030949;GO:0046777;GO:0089700;GO:0006468;GO:0030148;GO:0050852;GO:0048010;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:metal ion binding; F:protein kinase activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adaptive immune response; P:angiogenesis; P:cell adhesion; P:cell death; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial tube morphogenesis; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell adhesion; P:positive regulation of CREB transcription factor activity; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of histone deacetylase activity; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-8 production; P:positive regulation of intracellular signal transduction; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein kinase D signaling; P:protein phosphorylation; P:sphingolipid biosynthetic process; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q15139 A6NL64 B2RAF6,Serine/threonine-protein kinase D1,Protein kinase C mu type;Protein kinase D;nPKC-D1;nPKC-mu;, PF00130;PF00169;PF00069;, GO:0000421;GO:0005829;GO:0005794;GO:0005886;GO:0005802;GO:0005524;GO:0004698;GO:0042802;GO:0016301;GO:0046872;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0001525;GO:0006915;GO:0030154;GO:0034198;GO:0071447;GO:0034599;GO:0035924;GO:0007030;GO:0048193;GO:0006954;GO:0045087;GO:0007229;GO:0035556;GO:0060548;GO:0045806;GO:0007399;GO:0018105;GO:0018107;GO:0045766;GO:0010508;GO:0043536;GO:0032793;GO:2001028;GO:0038033;GO:0010595;GO:0001938;GO:1901727;GO:0043123;GO:0010976;GO:0051092;GO:0045669;GO:0033138;GO:0043552;GO:0045944;GO:0046777;GO:0089700;GO:0006468;GO:0007265;GO:2001044;GO:0010837;GO:0031647;GO:0007165;GO:0030148;GO:0048010;, C:autophagosome membrane; C:cytosol; C:Golgi apparatus; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:identical protein binding; F:kinase activity; F:metal ion binding; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:angiogenesis; P:apoptotic process; P:cell differentiation; P:cellular response to amino acid starvation; P:cellular response to hydroperoxide; P:cellular response to oxidative stress; P:cellular response to vascular endothelial growth factor stimulus; P:Golgi organization; P:Golgi vesicle transport; P:inflammatory response; P:innate immune response; P:integrin-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cell death; P:negative regulation of endocytosis; P:nervous system development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of autophagy; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of CREB transcription factor activity; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of histone deacetylase activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of neuron projection development; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of osteoblast differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of transcription by RNA polymerase II; P:protein autophosphorylation; P:protein kinase D signaling; P:protein phosphorylation; P:Ras protein signal transduction; P:regulation of integrin-mediated signaling pathway; P:regulation of keratinocyte proliferation; P:regulation of protein stability; P:signal transduction; P:sphingolipid biosynthetic process; P:vascular endothelial growth factor receptor signaling pathway;|Q9BZL6 B4DTS2 M0QZW1 M0R2R2 Q8NCK8 Q8TB08 Q9P0T6 Q9Y3X8,Serine/threonine-protein kinase D2,nPKC-D2;, PF00130;PF00069;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0004698;GO:0046872;GO:0004672;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0002250;GO:0001525;GO:0007155;GO:0008219;GO:0035924;GO:0061154;GO:0035556;GO:0018105;GO:0018107;GO:0045766;GO:0043536;GO:0045785;GO:0032793;GO:2000573;GO:0051091;GO:2001028;GO:0038033;GO:0010595;GO:0001938;GO:0070374;GO:0045743;GO:1901727;GO:0032743;GO:0032757;GO:1902533;GO:0051092;GO:0033138;GO:0050862;GO:0045944;GO:0030949;GO:0046777;GO:0089700;GO:0006468;GO:0030148;GO:0050852;GO:0048010;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:metal ion binding; F:protein kinase activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adaptive immune response; P:angiogenesis; P:cell adhesion; P:cell death; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial tube morphogenesis; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell adhesion; P:positive regulation of CREB transcription factor activity; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of histone deacetylase activity; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-8 production; P:positive regulation of intracellular signal transduction; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein kinase D signaling; P:protein phosphorylation; P:sphingolipid biosynthetic process; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|Q9BZL6 B4DTS2 M0QZW1 M0R2R2 Q8NCK8 Q8TB08 Q9P0T6 Q9Y3X8,Serine/threonine-protein kinase D2,nPKC-D2;, PF00130;PF00069;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0004698;GO:0046872;GO:0004672;GO:0005080;GO:0106310;GO:0004674;GO:0106311;GO:0002250;GO:0001525;GO:0007155;GO:0008219;GO:0035924;GO:0061154;GO:0035556;GO:0018105;GO:0018107;GO:0045766;GO:0043536;GO:0045785;GO:0032793;GO:2000573;GO:0051091;GO:2001028;GO:0038033;GO:0010595;GO:0001938;GO:0070374;GO:0045743;GO:1901727;GO:0032743;GO:0032757;GO:1902533;GO:0051092;GO:0033138;GO:0050862;GO:0045944;GO:0030949;GO:0046777;GO:0089700;GO:0006468;GO:0030148;GO:0050852;GO:0048010;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:calcium-dependent protein kinase C activity; F:metal ion binding; F:protein kinase activity; F:protein kinase C binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:adaptive immune response; P:angiogenesis; P:cell adhesion; P:cell death; P:cellular response to vascular endothelial growth factor stimulus; P:endothelial tube morphogenesis; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell adhesion; P:positive regulation of CREB transcription factor activity; P:positive regulation of DNA biosynthetic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of histone deacetylase activity; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-8 production; P:positive regulation of intracellular signal transduction; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein kinase D signaling; P:protein phosphorylation; P:sphingolipid biosynthetic process; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold157 indexed_genome mRNA 1333938 1366693 . - . ID=transcript_14883;Q9NRL3 A0A024R0V2 B4DQH7 F8VYA6 Q8NE53,Striatin-4,Zinedin;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0043197;GO:0090443;GO:0016020;GO:0070016;GO:0005516;GO:0051721;GO:0044877;, C:cytoplasm; C:dendrite; C:dendritic spine; C:FAR/SIN/STRIPAK complex; C:membrane;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding;|Q9NRL3 A0A024R0V2 B4DQH7 F8VYA6 Q8NE53,Striatin-4,Zinedin;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0043197;GO:0090443;GO:0016020;GO:0070016;GO:0005516;GO:0051721;GO:0044877;, C:cytoplasm; C:dendrite; C:dendritic spine; C:FAR/SIN/STRIPAK complex; C:membrane;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding;|Q9NRL3 A0A024R0V2 B4DQH7 F8VYA6 Q8NE53,Striatin-4,Zinedin;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0043197;GO:0090443;GO:0016020;GO:0070016;GO:0005516;GO:0051721;GO:0044877;, C:cytoplasm; C:dendrite; C:dendritic spine; C:FAR/SIN/STRIPAK complex; C:membrane;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding;|Q9NRL3 A0A024R0V2 B4DQH7 F8VYA6 Q8NE53,Striatin-4,Zinedin;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0043197;GO:0090443;GO:0016020;GO:0070016;GO:0005516;GO:0051721;GO:0044877;, C:cytoplasm; C:dendrite; C:dendritic spine; C:FAR/SIN/STRIPAK complex; C:membrane;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding;|Q9NRL3 A0A024R0V2 B4DQH7 F8VYA6 Q8NE53,Striatin-4,Zinedin;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0043197;GO:0090443;GO:0016020;GO:0070016;GO:0005516;GO:0051721;GO:0044877;, C:cytoplasm; C:dendrite; C:dendritic spine; C:FAR/SIN/STRIPAK complex; C:membrane;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding;|Q9NRL3 A0A024R0V2 B4DQH7 F8VYA6 Q8NE53,Striatin-4,Zinedin;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0043197;GO:0090443;GO:0016020;GO:0070016;GO:0005516;GO:0051721;GO:0044877;, C:cytoplasm; C:dendrite; C:dendritic spine; C:FAR/SIN/STRIPAK complex; C:membrane;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding;|Q9NRL3 A0A024R0V2 B4DQH7 F8VYA6 Q8NE53,Striatin-4,Zinedin;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0043197;GO:0090443;GO:0016020;GO:0070016;GO:0005516;GO:0051721;GO:0044877;, C:cytoplasm; C:dendrite; C:dendritic spine; C:FAR/SIN/STRIPAK complex; C:membrane;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding;|Q9NRL3 A0A024R0V2 B4DQH7 F8VYA6 Q8NE53,Striatin-4,Zinedin;, PF08232;PF00400;, GO:0005737;GO:0030425;GO:0043197;GO:0090443;GO:0016020;GO:0070016;GO:0005516;GO:0051721;GO:0044877;, C:cytoplasm; C:dendrite; C:dendritic spine; C:FAR/SIN/STRIPAK complex; C:membrane;, F:armadillo repeat domain binding; F:calmodulin binding; F:protein phosphatase 2A binding; F:protein-containing complex binding;|Q9H9S5 A8K5G7,Fukutin-related protein {ECO:0000303|PubMed:11592034},Ribitol-5-phosphate transferase {ECO:0000303|PubMed:26923585};, PF04991;, GO:0005829;GO:0005615;GO:0005794;GO:0000139;GO:0016021;GO:0005654;GO:0005791;GO:0042383;GO:0002162;GO:0042802;GO:0016740;GO:0035269;GO:0016485;, C:cytosol; C:extracellular space; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nucleoplasm; C:rough endoplasmic reticulum; C:sarcolemma;, F:dystroglycan binding; F:identical protein binding; F:transferase activity;, P:protein O-linked mannosylation; P:protein processing; scaffold157 indexed_genome mRNA 1374636 1386221 . - . ID=transcript_14884;Q9BWQ3 Q9UNP2,Neutral amino acid transporter B(0),Baboon M7 virus receptor;RD114/simian type D retrovirus receptor;Sodium-dependent neutral amino acid transporter type 2;Solute carrier family 1 member 5;, PF00375;, GO:0009925;GO:0070062;GO:0016021;GO:0005887;GO:0042470;GO:0016020;GO:0005886;GO:0015183;GO:0015186;GO:0015194;GO:0046872;GO:0015175;GO:0038023;GO:0015293;GO:0001618;GO:0006865;GO:0010585;GO:0006868;GO:0140009;GO:1903803;GO:0015804;GO:0070207;GO:0150104;, C:basal plasma membrane; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:L-aspartate transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:metal ion binding; F:neutral amino acid transmembrane transporter activity; F:signaling receptor activity; F:symporter activity; F:virus receptor activity;, P:amino acid transport; P:glutamine secretion; P:glutamine transport; P:L-aspartate import across plasma membrane; P:L-glutamine import across plasma membrane; P:neutral amino acid transport; P:protein homotrimerization; P:transport across blood-brain barrier;|Q9BWQ3 Q9UNP2,Neutral amino acid transporter B(0),Baboon M7 virus receptor;RD114/simian type D retrovirus receptor;Sodium-dependent neutral amino acid transporter type 2;Solute carrier family 1 member 5;, PF00375;, GO:0009925;GO:0070062;GO:0016021;GO:0005887;GO:0042470;GO:0016020;GO:0005886;GO:0015183;GO:0015186;GO:0015194;GO:0046872;GO:0015175;GO:0038023;GO:0015293;GO:0001618;GO:0006865;GO:0010585;GO:0006868;GO:0140009;GO:1903803;GO:0015804;GO:0070207;GO:0150104;, C:basal plasma membrane; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:L-aspartate transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:metal ion binding; F:neutral amino acid transmembrane transporter activity; F:signaling receptor activity; F:symporter activity; F:virus receptor activity;, P:amino acid transport; P:glutamine secretion; P:glutamine transport; P:L-aspartate import across plasma membrane; P:L-glutamine import across plasma membrane; P:neutral amino acid transport; P:protein homotrimerization; P:transport across blood-brain barrier;|Q9BWQ3 Q9UNP2,Neutral amino acid transporter B(0),Baboon M7 virus receptor;RD114/simian type D retrovirus receptor;Sodium-dependent neutral amino acid transporter type 2;Solute carrier family 1 member 5;, PF00375;, GO:0009925;GO:0070062;GO:0016021;GO:0005887;GO:0042470;GO:0016020;GO:0005886;GO:0015183;GO:0015186;GO:0015194;GO:0046872;GO:0015175;GO:0038023;GO:0015293;GO:0001618;GO:0006865;GO:0010585;GO:0006868;GO:0140009;GO:1903803;GO:0015804;GO:0070207;GO:0150104;, C:basal plasma membrane; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:L-aspartate transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:metal ion binding; F:neutral amino acid transmembrane transporter activity; F:signaling receptor activity; F:symporter activity; F:virus receptor activity;, P:amino acid transport; P:glutamine secretion; P:glutamine transport; P:L-aspartate import across plasma membrane; P:L-glutamine import across plasma membrane; P:neutral amino acid transport; P:protein homotrimerization; P:transport across blood-brain barrier;|Q9BWQ3 Q9UNP2,Neutral amino acid transporter B(0),Baboon M7 virus receptor;RD114/simian type D retrovirus receptor;Sodium-dependent neutral amino acid transporter type 2;Solute carrier family 1 member 5;, PF00375;, GO:0009925;GO:0070062;GO:0016021;GO:0005887;GO:0042470;GO:0016020;GO:0005886;GO:0015183;GO:0015186;GO:0015194;GO:0046872;GO:0015175;GO:0038023;GO:0015293;GO:0001618;GO:0006865;GO:0010585;GO:0006868;GO:0140009;GO:1903803;GO:0015804;GO:0070207;GO:0150104;, C:basal plasma membrane; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:L-aspartate transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:metal ion binding; F:neutral amino acid transmembrane transporter activity; F:signaling receptor activity; F:symporter activity; F:virus receptor activity;, P:amino acid transport; P:glutamine secretion; P:glutamine transport; P:L-aspartate import across plasma membrane; P:L-glutamine import across plasma membrane; P:neutral amino acid transport; P:protein homotrimerization; P:transport across blood-brain barrier;|Q9BWQ3 Q9UNP2,Neutral amino acid transporter B(0),Baboon M7 virus receptor;RD114/simian type D retrovirus receptor;Sodium-dependent neutral amino acid transporter type 2;Solute carrier family 1 member 5;, PF00375;, GO:0009925;GO:0070062;GO:0016021;GO:0005887;GO:0042470;GO:0016020;GO:0005886;GO:0015183;GO:0015186;GO:0015194;GO:0046872;GO:0015175;GO:0038023;GO:0015293;GO:0001618;GO:0006865;GO:0010585;GO:0006868;GO:0140009;GO:1903803;GO:0015804;GO:0070207;GO:0150104;, C:basal plasma membrane; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:melanosome; C:membrane; C:plasma membrane;, F:L-aspartate transmembrane transporter activity; F:L-glutamine transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:metal ion binding; F:neutral amino acid transmembrane transporter activity; F:signaling receptor activity; F:symporter activity; F:virus receptor activity;, P:amino acid transport; P:glutamine secretion; P:glutamine transport; P:L-aspartate import across plasma membrane; P:L-glutamine import across plasma membrane; P:neutral amino acid transport; P:protein homotrimerization; P:transport across blood-brain barrier; scaffold157 indexed_genome mRNA 1431219 1437801 . - . ID=transcript_14885;P53680 B2R4Z4 O75977 Q6PK67,AP-2 complex subunit sigma,Adaptor protein complex AP-2 subunit sigma;Adaptor-related protein complex 2 subunit sigma;Clathrin assembly protein 2 sigma small chain;Clathrin coat assembly protein AP17;Clathrin coat-associated protein AP17;HA2 17 kDa subunit;Plasma membrane adaptor AP-2 17 kDa protein;Sigma2-adaptin;, PF01217;, GO:0030122;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0043231;GO:0005886;GO:0035615;GO:0019886;GO:0048268;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0050690;GO:0030100;GO:0016192;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:clathrin adaptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:regulation of defense response to virus by virus; P:regulation of endocytosis; P:vesicle-mediated transport; P:Wnt signaling pathway, planar cell polarity pathway;|P53680 B2R4Z4 O75977 Q6PK67,AP-2 complex subunit sigma,Adaptor protein complex AP-2 subunit sigma;Adaptor-related protein complex 2 subunit sigma;Clathrin assembly protein 2 sigma small chain;Clathrin coat assembly protein AP17;Clathrin coat-associated protein AP17;HA2 17 kDa subunit;Plasma membrane adaptor AP-2 17 kDa protein;Sigma2-adaptin;, PF01217;, GO:0030122;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0043231;GO:0005886;GO:0035615;GO:0019886;GO:0048268;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0050690;GO:0030100;GO:0016192;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:clathrin adaptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:regulation of defense response to virus by virus; P:regulation of endocytosis; P:vesicle-mediated transport; P:Wnt signaling pathway, planar cell polarity pathway; scaffold157 indexed_genome mRNA 1489996 1562968 . + . ID=transcript_14886;Q9NRY4 A7E2A4 Q14452 Q9C0E1,Rho GTPase-activating protein 35 {ECO:0000312|HGNC:HGNC:4591},Glucocorticoid receptor DNA-binding factor 1;Glucocorticoid receptor repression factor 1;Rho GAP p190A;, PF01846;PF00071;PF00620;PF16512;, GO:0015629;GO:0036064;GO:0005829;GO:0005634;GO:0005886;GO:0003677;GO:0005525;GO:0005096;GO:0003924;GO:0005543;GO:0007411;GO:0007413;GO:0043010;GO:0016477;GO:0031668;GO:0021955;GO:0030950;GO:0030900;GO:0030879;GO:0035024;GO:0043116;GO:0001843;GO:0097485;GO:0045724;GO:0010976;GO:0032956;GO:0008064;GO:0050770;GO:0008360;GO:0051056;GO:0007165;GO:0044319;, C:actin cytoskeleton; C:ciliary basal body; C:cytosol; C:nucleus; C:plasma membrane;, F:DNA binding; F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:phospholipid binding;, P:axon guidance; P:axonal fasciculation; P:camera-type eye development; P:cell migration; P:cellular response to extracellular stimulus; P:central nervous system neuron axonogenesis; P:establishment or maintenance of actin cytoskeleton polarity; P:forebrain development; P:mammary gland development; P:negative regulation of Rho protein signal transduction; P:negative regulation of vascular permeability; P:neural tube closure; P:neuron projection guidance; P:positive regulation of cilium assembly; P:positive regulation of neuron projection development; P:regulation of actin cytoskeleton organization; P:regulation of actin polymerization or depolymerization; P:regulation of axonogenesis; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:wound healing, spreading of cells;|Q9NRY4 A7E2A4 Q14452 Q9C0E1,Rho GTPase-activating protein 35 {ECO:0000312|HGNC:HGNC:4591},Glucocorticoid receptor DNA-binding factor 1;Glucocorticoid receptor repression factor 1;Rho GAP p190A;, PF01846;PF00071;PF00620;PF16512;, GO:0015629;GO:0036064;GO:0005829;GO:0005634;GO:0005886;GO:0003677;GO:0005525;GO:0005096;GO:0003924;GO:0005543;GO:0007411;GO:0007413;GO:0043010;GO:0016477;GO:0031668;GO:0021955;GO:0030950;GO:0030900;GO:0030879;GO:0035024;GO:0043116;GO:0001843;GO:0097485;GO:0045724;GO:0010976;GO:0032956;GO:0008064;GO:0050770;GO:0008360;GO:0051056;GO:0007165;GO:0044319;, C:actin cytoskeleton; C:ciliary basal body; C:cytosol; C:nucleus; C:plasma membrane;, F:DNA binding; F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:phospholipid binding;, P:axon guidance; P:axonal fasciculation; P:camera-type eye development; P:cell migration; P:cellular response to extracellular stimulus; P:central nervous system neuron axonogenesis; P:establishment or maintenance of actin cytoskeleton polarity; P:forebrain development; P:mammary gland development; P:negative regulation of Rho protein signal transduction; P:negative regulation of vascular permeability; P:neural tube closure; P:neuron projection guidance; P:positive regulation of cilium assembly; P:positive regulation of neuron projection development; P:regulation of actin cytoskeleton organization; P:regulation of actin polymerization or depolymerization; P:regulation of axonogenesis; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:wound healing, spreading of cells; scaffold157 indexed_genome mRNA 1594869 1597517 . + . ID=transcript_14887;Q99742 B4DR69 Q99632 Q9BY83,Neuronal PAS domain-containing protein 1,Basic-helix-loop-helix-PAS protein MOP5;Class E basic helix-loop-helix protein 11;Member of PAS protein 5;PAS domain-containing protein 5;, PF00010;PF00989;PF08447;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0046982;GO:0000977;GO:0007417;GO:0042711;GO:0000122;GO:0045892;GO:0006357;GO:0001964;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:central nervous system development; P:maternal behavior; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:startle response; scaffold157 indexed_genome mRNA 1597651 1599582 . - . ID=transcript_14888;Q9NX00 Q9BU41,Transmembrane protein 160,, , GO:0016021;, C:integral component of membrane;|Q9NX00 Q9BU41,Transmembrane protein 160,, , GO:0016021;, C:integral component of membrane; scaffold157 indexed_genome mRNA 1620851 1656980 . - . ID=transcript_14889;Q9UPT8 Q9Y420,Zinc finger CCCH domain-containing protein 4,, PF00642;PF18044;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0003723;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA binding;|Q9UPT8 Q9Y420,Zinc finger CCCH domain-containing protein 4,, PF00642;PF18044;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0003723;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA binding;|Q9UPT8 Q9Y420,Zinc finger CCCH domain-containing protein 4,, PF00642;PF18044;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0003723;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA binding; scaffold157 indexed_genome mRNA 1683315 1734052 . - . ID=transcript_14890;Q9UBE0 B2RDP5 B3KMQ2 F5GXX7 G3XAK6 O95717 Q9P020,SUMO-activating enzyme subunit 1,Ubiquitin-like 1-activating enzyme E1A;, PF00899;, GO:0005737;GO:0005654;GO:0005634;GO:0031510;GO:0043008;GO:0008047;GO:0008022;GO:0046982;GO:0044388;GO:0004839;GO:0033235;GO:1903955;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:SUMO activating enzyme complex;, F:ATP-dependent protein binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:ubiquitin activating enzyme activity;, P:positive regulation of protein sumoylation; P:positive regulation of protein targeting to mitochondrion; P:protein modification by small protein conjugation; P:protein sumoylation;|Q9UBE0 B2RDP5 B3KMQ2 F5GXX7 G3XAK6 O95717 Q9P020,SUMO-activating enzyme subunit 1,Ubiquitin-like 1-activating enzyme E1A;, PF00899;, GO:0005737;GO:0005654;GO:0005634;GO:0031510;GO:0043008;GO:0008047;GO:0008022;GO:0046982;GO:0044388;GO:0004839;GO:0033235;GO:1903955;GO:0032446;GO:0016925;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:SUMO activating enzyme complex;, F:ATP-dependent protein binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein heterodimerization activity; F:small protein activating enzyme binding; F:ubiquitin activating enzyme activity;, P:positive regulation of protein sumoylation; P:positive regulation of protein targeting to mitochondrion; P:protein modification by small protein conjugation; P:protein sumoylation; scaffold157 indexed_genome mRNA 1738259 1740721 . + . ID=transcript_14891;Q9BXH1 B9EGI3 O00171 Q96PG9,Bcl-2-binding component 3, isoforms 1/2,JFY-1;p53 up-regulated modulator of apoptosis;, PF15826;, GO:0005829;GO:0005783;GO:0005741;GO:0005739;GO:0006919;GO:0097190;GO:0006974;GO:0071456;GO:0008340;GO:0097194;GO:0070059;GO:0032471;GO:0045926;GO:2001056;GO:1902237;GO:2001244;GO:1903896;GO:0043525;GO:0032464;GO:1900740;GO:0031334;GO:0090200;GO:0070245;GO:0001844;GO:0042981;GO:0001836;GO:0051209;GO:0034976;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial outer membrane; C:mitochondrion;, , P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic signaling pathway; P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:determination of adult lifespan; P:execution phase of apoptosis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of growth; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of neuron apoptotic process; P:positive regulation of protein homooligomerization; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of thymocyte apoptotic process; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:release of cytochrome c from mitochondria; P:release of sequestered calcium ion into cytosol; P:response to endoplasmic reticulum stress;|Q96PG8,Bcl-2-binding component 3, isoforms 3/4,JFY-1;p53 up-regulated modulator of apoptosis;, , GO:0005739;GO:0051117;GO:0006919;GO:0006915;GO:0097194;GO:0070059;GO:2001244;GO:1900740;GO:0090200;GO:0001836;, C:mitochondrion;, F:ATPase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:execution phase of apoptosis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of release of cytochrome c from mitochondria; P:release of cytochrome c from mitochondria; scaffold157 indexed_genome mRNA 1742228 1743426 . + . ID=transcript_14892;Q9BXH1 B9EGI3 O00171 Q96PG9,Bcl-2-binding component 3, isoforms 1/2,JFY-1;p53 up-regulated modulator of apoptosis;, PF15826;, GO:0005829;GO:0005783;GO:0005741;GO:0005739;GO:0006919;GO:0097190;GO:0006974;GO:0071456;GO:0008340;GO:0097194;GO:0070059;GO:0032471;GO:0045926;GO:2001056;GO:1902237;GO:2001244;GO:1903896;GO:0043525;GO:0032464;GO:1900740;GO:0031334;GO:0090200;GO:0070245;GO:0001844;GO:0042981;GO:0001836;GO:0051209;GO:0034976;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial outer membrane; C:mitochondrion;, , P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic signaling pathway; P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:determination of adult lifespan; P:execution phase of apoptosis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of growth; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of neuron apoptotic process; P:positive regulation of protein homooligomerization; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of thymocyte apoptotic process; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:release of cytochrome c from mitochondria; P:release of sequestered calcium ion into cytosol; P:response to endoplasmic reticulum stress; scaffold157 indexed_genome mRNA 1766941 1776796 . + . ID=transcript_14893;Q9Y3X0,Coiled-coil domain-containing protein 9,, PF15266;, GO:0003723;, , F:RNA binding;|Q9Y3X0,Coiled-coil domain-containing protein 9,, PF15266;, GO:0003723;, , F:RNA binding;|Q9Y3X0,Coiled-coil domain-containing protein 9,, PF15266;, GO:0003723;, , F:RNA binding;|Q9Y3X0,Coiled-coil domain-containing protein 9,, PF15266;, GO:0003723;, , F:RNA binding;|Q9Y3X0,Coiled-coil domain-containing protein 9,, PF15266;, GO:0003723;, , F:RNA binding;|Q9Y3X0,Coiled-coil domain-containing protein 9,, PF15266;, GO:0003723;, , F:RNA binding;|Q9Y3X0,Coiled-coil domain-containing protein 9,, PF15266;, GO:0003723;, , F:RNA binding; scaffold158 indexed_genome mRNA 440847 442058 . + . ID=transcript_14894;P23352 B2RPF8,Anosmin-1 {ECO:0000303|PubMed:8832397, ECO:0000312|HGNC:HGNC:6211},Adhesion molecule-like X-linked;Kallmann syndrome protein {ECO:0000303|PubMed:1913827};, PF17869;PF00041;PF00095;, GO:0009986;GO:0031012;GO:0005576;GO:0005615;GO:0005886;GO:0005201;GO:0008201;GO:0004867;GO:0007411;GO:0007155;GO:0006935;GO:0008543;GO:0030182;, C:cell surface; C:extracellular matrix; C:extracellular region; C:extracellular space; C:plasma membrane;, F:extracellular matrix structural constituent; F:heparin binding; F:serine-type endopeptidase inhibitor activity;, P:axon guidance; P:cell adhesion; P:chemotaxis; P:fibroblast growth factor receptor signaling pathway; P:neuron differentiation; scaffold158 indexed_genome mRNA 1460426 1512995 . + . ID=transcript_14895;O60907 A8K044 A8K4J7 Q86UY2,F-box-like/WD repeat-containing protein TBL1X,SMAP55;Transducin beta-like protein 1X;Transducin-beta-like protein 1, X-linked;, PF08513;PF00400;, GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0008013;GO:0042393;GO:0042802;GO:0008022;GO:0019904;GO:0003714;GO:0008134;GO:0000976;GO:0016575;GO:0030522;GO:0000122;GO:0090263;GO:0045944;GO:0045893;GO:0043161;GO:0050821;GO:0006508;GO:0019216;GO:0006357;GO:0007605;GO:0006367;, C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:beta-catenin binding; F:histone binding; F:identical protein binding; F:protein C-terminus binding; F:protein domain specific binding; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:histone deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein stabilization; P:proteolysis; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:sensory perception of sound; P:transcription initiation from RNA polymerase II promoter;|O60907 A8K044 A8K4J7 Q86UY2,F-box-like/WD repeat-containing protein TBL1X,SMAP55;Transducin beta-like protein 1X;Transducin-beta-like protein 1, X-linked;, PF08513;PF00400;, GO:0000118;GO:0072686;GO:0005654;GO:0005634;GO:0017053;GO:0008013;GO:0042393;GO:0042802;GO:0008022;GO:0019904;GO:0003714;GO:0008134;GO:0000976;GO:0016575;GO:0030522;GO:0000122;GO:0090263;GO:0045944;GO:0045893;GO:0043161;GO:0050821;GO:0006508;GO:0019216;GO:0006357;GO:0007605;GO:0006367;, C:histone deacetylase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:beta-catenin binding; F:histone binding; F:identical protein binding; F:protein C-terminus binding; F:protein domain specific binding; F:transcription corepressor activity; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:histone deacetylation; P:intracellular receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein stabilization; P:proteolysis; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:sensory perception of sound; P:transcription initiation from RNA polymerase II promoter;|Q9BQ87 A1L4B3,F-box-like/WD repeat-containing protein TBL1Y,Transducin beta-like protein 1Y;Transducin-beta-like protein 1, Y-linked;, PF08513;PF00400;, GO:0000118;GO:0005654;GO:0005634;GO:0003714;GO:0016575;GO:0006357;, C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:transcription corepressor activity;, P:histone deacetylation; P:regulation of transcription by RNA polymerase II; scaffold158 indexed_genome mRNA 1579311 1672700 . + . ID=transcript_14896;Q13796 B9EIQ7,Protein Shroom2,Apical-like protein;Protein APXL;, PF08688;PF08687;PF00595;, GO:0005912;GO:0043296;GO:0016324;GO:0005923;GO:0005737;GO:0005856;GO:0070062;GO:0005874;GO:0005886;GO:0003779;GO:0051015;GO:0008013;GO:0015280;GO:0007015;GO:0045176;GO:0007420;GO:0043010;GO:0048593;GO:0016477;GO:0043482;GO:0043583;GO:0032401;GO:0008057;GO:0002089;GO:0032438;, C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:microtubule; C:plasma membrane;, F:actin binding; F:actin filament binding; F:beta-catenin binding; F:ligand-gated sodium channel activity;, P:actin filament organization; P:apical protein localization; P:brain development; P:camera-type eye development; P:camera-type eye morphogenesis; P:cell migration; P:cellular pigment accumulation; P:ear development; P:establishment of melanosome localization; P:eye pigment granule organization; P:lens morphogenesis in camera-type eye; P:melanosome organization; scaffold158 indexed_genome mRNA 1720651 1722965 . + . ID=transcript_14897;Q13796 B9EIQ7,Protein Shroom2,Apical-like protein;Protein APXL;, PF08688;PF08687;PF00595;, GO:0005912;GO:0043296;GO:0016324;GO:0005923;GO:0005737;GO:0005856;GO:0070062;GO:0005874;GO:0005886;GO:0003779;GO:0051015;GO:0008013;GO:0015280;GO:0007015;GO:0045176;GO:0007420;GO:0043010;GO:0048593;GO:0016477;GO:0043482;GO:0043583;GO:0032401;GO:0008057;GO:0002089;GO:0032438;, C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton; C:extracellular exosome; C:microtubule; C:plasma membrane;, F:actin binding; F:actin filament binding; F:beta-catenin binding; F:ligand-gated sodium channel activity;, P:actin filament organization; P:apical protein localization; P:brain development; P:camera-type eye development; P:camera-type eye morphogenesis; P:cell migration; P:cellular pigment accumulation; P:ear development; P:establishment of melanosome localization; P:eye pigment granule organization; P:lens morphogenesis in camera-type eye; P:melanosome organization; scaffold159 indexed_genome mRNA 376713 412264 . - . ID=transcript_14898;O95299 Q8WXC9,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial,Complex I-42kD;NADH-ubiquinone oxidoreductase 42 kDa subunit;, PF01712;, GO:0005737;GO:0005743;GO:0005759;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O95299 Q8WXC9,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial,Complex I-42kD;NADH-ubiquinone oxidoreductase 42 kDa subunit;, PF01712;, GO:0005737;GO:0005743;GO:0005759;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O95299 Q8WXC9,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial,Complex I-42kD;NADH-ubiquinone oxidoreductase 42 kDa subunit;, PF01712;, GO:0005737;GO:0005743;GO:0005759;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O95299 Q8WXC9,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial,Complex I-42kD;NADH-ubiquinone oxidoreductase 42 kDa subunit;, PF01712;, GO:0005737;GO:0005743;GO:0005759;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|O95299 Q8WXC9,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial,Complex I-42kD;NADH-ubiquinone oxidoreductase 42 kDa subunit;, PF01712;, GO:0005737;GO:0005743;GO:0005759;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:cytoplasm; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold159 indexed_genome mRNA 682968 687940 . - . ID=transcript_14899;Q8WXC6 Q8N110,COP9 signalosome complex subunit 9 {ECO:0000305},CSN acidic protein {ECO:0000303|PubMed:26456823};Myeloma-overexpressed gene 2 protein {ECO:0000303|Ref.1};, PF15004;, GO:0000785;GO:0008180;GO:0005737;GO:0005654;GO:0005634;GO:0034644;GO:0051220;GO:2000435;GO:0008284;, C:chromatin; C:COP9 signalosome; C:cytoplasm; C:nucleoplasm; C:nucleus;, , P:cellular response to UV; P:cytoplasmic sequestering of protein; P:negative regulation of protein neddylation; P:positive regulation of cell population proliferation;|Q8WXC6 Q8N110,COP9 signalosome complex subunit 9 {ECO:0000305},CSN acidic protein {ECO:0000303|PubMed:26456823};Myeloma-overexpressed gene 2 protein {ECO:0000303|Ref.1};, PF15004;, GO:0000785;GO:0008180;GO:0005737;GO:0005654;GO:0005634;GO:0034644;GO:0051220;GO:2000435;GO:0008284;, C:chromatin; C:COP9 signalosome; C:cytoplasm; C:nucleoplasm; C:nucleus;, , P:cellular response to UV; P:cytoplasmic sequestering of protein; P:negative regulation of protein neddylation; P:positive regulation of cell population proliferation; scaffold159 indexed_genome mRNA 913185 915305 . + . ID=transcript_14900;P35052 B3KTD1 Q53QM4,Glypican-1,, PF01153;, GO:0046658;GO:0009986;GO:0062023;GO:0005829;GO:0005768;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0031226;GO:0043202;GO:0045121;GO:0005654;GO:0005886;GO:0045202;GO:0005507;GO:0017134;GO:0043236;GO:0007411;GO:0016477;GO:0006024;GO:0006027;GO:0030200;GO:0050900;GO:0032288;GO:0040037;GO:2001016;GO:1905475;GO:0001523;GO:0014037;, C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytosol; C:endosome; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:intrinsic component of plasma membrane; C:lysosomal lumen; C:membrane raft; C:nucleoplasm; C:plasma membrane; C:synapse;, F:copper ion binding; F:fibroblast growth factor binding; F:laminin binding;, P:axon guidance; P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:heparan sulfate proteoglycan catabolic process; P:leukocyte migration; P:myelin assembly; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of skeletal muscle cell differentiation; P:regulation of protein localization to membrane; P:retinoid metabolic process; P:Schwann cell differentiation; scaffold159 indexed_genome mRNA 917588 919111 . - . ID=transcript_14901;P35052 B3KTD1 Q53QM4,Glypican-1,, PF01153;, GO:0046658;GO:0009986;GO:0062023;GO:0005829;GO:0005768;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0031226;GO:0043202;GO:0045121;GO:0005654;GO:0005886;GO:0045202;GO:0005507;GO:0017134;GO:0043236;GO:0007411;GO:0016477;GO:0006024;GO:0006027;GO:0030200;GO:0050900;GO:0032288;GO:0040037;GO:2001016;GO:1905475;GO:0001523;GO:0014037;, C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytosol; C:endosome; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:intrinsic component of plasma membrane; C:lysosomal lumen; C:membrane raft; C:nucleoplasm; C:plasma membrane; C:synapse;, F:copper ion binding; F:fibroblast growth factor binding; F:laminin binding;, P:axon guidance; P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:heparan sulfate proteoglycan catabolic process; P:leukocyte migration; P:myelin assembly; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of skeletal muscle cell differentiation; P:regulation of protein localization to membrane; P:retinoid metabolic process; P:Schwann cell differentiation;|P35052 B3KTD1 Q53QM4,Glypican-1,, PF01153;, GO:0046658;GO:0009986;GO:0062023;GO:0005829;GO:0005768;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0031226;GO:0043202;GO:0045121;GO:0005654;GO:0005886;GO:0045202;GO:0005507;GO:0017134;GO:0043236;GO:0007411;GO:0016477;GO:0006024;GO:0006027;GO:0030200;GO:0050900;GO:0032288;GO:0040037;GO:2001016;GO:1905475;GO:0001523;GO:0014037;, C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:cytosol; C:endosome; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:intrinsic component of plasma membrane; C:lysosomal lumen; C:membrane raft; C:nucleoplasm; C:plasma membrane; C:synapse;, F:copper ion binding; F:fibroblast growth factor binding; F:laminin binding;, P:axon guidance; P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:heparan sulfate proteoglycan catabolic process; P:leukocyte migration; P:myelin assembly; P:negative regulation of fibroblast growth factor receptor signaling pathway; P:positive regulation of skeletal muscle cell differentiation; P:regulation of protein localization to membrane; P:retinoid metabolic process; P:Schwann cell differentiation; scaffold159 indexed_genome mRNA 964507 969593 . - . ID=transcript_14902;Q9P2S6 B2RB78 Q4ZFV3 Q8IYX5 Q8NDK5 Q9H0V8 Q9NX10,Ankyrin repeat and MYND domain-containing protein 1,Testis-specific ankyrin-like protein 1;Zinc finger MYND domain-containing protein 13;, PF00023;PF12796;PF02493;PF01753;, GO:0046872;, , F:metal ion binding; scaffold159 indexed_genome mRNA 970585 971351 . + . ID=transcript_14903;Q9P2S6 B2RB78 Q4ZFV3 Q8IYX5 Q8NDK5 Q9H0V8 Q9NX10,Ankyrin repeat and MYND domain-containing protein 1,Testis-specific ankyrin-like protein 1;Zinc finger MYND domain-containing protein 13;, PF00023;PF12796;PF02493;PF01753;, GO:0046872;, , F:metal ion binding; scaffold159 indexed_genome mRNA 972579 975833 . - . ID=transcript_14904;Q9P2S6 B2RB78 Q4ZFV3 Q8IYX5 Q8NDK5 Q9H0V8 Q9NX10,Ankyrin repeat and MYND domain-containing protein 1,Testis-specific ankyrin-like protein 1;Zinc finger MYND domain-containing protein 13;, PF00023;PF12796;PF02493;PF01753;, GO:0046872;, , F:metal ion binding; scaffold159 indexed_genome mRNA 981972 986150 . + . ID=transcript_14905;Q4G0W2,Dual specificity phosphatase 28,, , GO:0016791;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0016311;, , F:phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:dephosphorylation; scaffold159 indexed_genome mRNA 991501 998888 . - . ID=transcript_14906;Q9HAU8 Q5XKC3 Q6NX56 Q96AC9 Q9H033 Q9NVD0,Aminopeptidase RNPEPL1 {ECO:0000305|PubMed:19508204},Arginyl aminopeptidase-like 1 {ECO:0000312|HGNC:HGNC:10079};Methionyl aminopeptidase {ECO:0000305|PubMed:19508204};, PF09127;PF01433;, GO:0070006;GO:0008270;GO:0006508;, , F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9HAU8 Q5XKC3 Q6NX56 Q96AC9 Q9H033 Q9NVD0,Aminopeptidase RNPEPL1 {ECO:0000305|PubMed:19508204},Arginyl aminopeptidase-like 1 {ECO:0000312|HGNC:HGNC:10079};Methionyl aminopeptidase {ECO:0000305|PubMed:19508204};, PF09127;PF01433;, GO:0070006;GO:0008270;GO:0006508;, , F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9HAU8 Q5XKC3 Q6NX56 Q96AC9 Q9H033 Q9NVD0,Aminopeptidase RNPEPL1 {ECO:0000305|PubMed:19508204},Arginyl aminopeptidase-like 1 {ECO:0000312|HGNC:HGNC:10079};Methionyl aminopeptidase {ECO:0000305|PubMed:19508204};, PF09127;PF01433;, GO:0070006;GO:0008270;GO:0006508;, , F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9HAU8 Q5XKC3 Q6NX56 Q96AC9 Q9H033 Q9NVD0,Aminopeptidase RNPEPL1 {ECO:0000305|PubMed:19508204},Arginyl aminopeptidase-like 1 {ECO:0000312|HGNC:HGNC:10079};Methionyl aminopeptidase {ECO:0000305|PubMed:19508204};, PF09127;PF01433;, GO:0070006;GO:0008270;GO:0006508;, , F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9HAU8 Q5XKC3 Q6NX56 Q96AC9 Q9H033 Q9NVD0,Aminopeptidase RNPEPL1 {ECO:0000305|PubMed:19508204},Arginyl aminopeptidase-like 1 {ECO:0000312|HGNC:HGNC:10079};Methionyl aminopeptidase {ECO:0000305|PubMed:19508204};, PF09127;PF01433;, GO:0070006;GO:0008270;GO:0006508;, , F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis; scaffold159 indexed_genome mRNA 1007908 1013290 . - . ID=transcript_14907;Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport; scaffold159 indexed_genome mRNA 1013651 1014552 . + . ID=transcript_14908;Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport; scaffold159 indexed_genome mRNA 1018123 1077941 . - . ID=transcript_14909;Q9P280,Kinesin-like protein KIF1B,, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0031410;GO:0030659;GO:0030425;GO:0005871;GO:0005874;GO:0005875;GO:0005739;GO:0043005;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0019900;GO:0019894;GO:0008017;GO:0003777;GO:0097110;GO:0008089;GO:1990048;GO:0006915;GO:1990090;GO:0030705;GO:0032418;GO:0007018;GO:0007274;GO:0007270;GO:0010628;GO:1990778;GO:1904647;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:dendrite; C:kinesin complex; C:microtubule; C:microtubule associated complex; C:mitochondrion; C:neuron projection; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:kinase binding; F:kinesin binding; F:microtubule binding; F:microtubule motor activity; F:scaffold protein binding;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:apoptotic process; P:cellular response to nerve growth factor stimulus; P:cytoskeleton-dependent intracellular transport; P:lysosome localization; P:microtubule-based movement; P:neuromuscular synaptic transmission; P:neuron-neuron synaptic transmission; P:positive regulation of gene expression; P:protein localization to cell periphery; P:response to rotenone; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport; scaffold159 indexed_genome mRNA 1103885 1113427 . + . ID=transcript_14910;P21549 Q53QU6,Serine--pyruvate aminotransferase,Alanine--glyoxylate aminotransferase;, PF00266;, GO:0005829;GO:0043231;GO:0005759;GO:0005782;GO:0005777;GO:0008453;GO:0016597;GO:0042802;GO:0042803;GO:0043621;GO:0030170;GO:0004760;GO:0008483;GO:0019752;GO:0019265;GO:0009436;GO:0046487;GO:0042853;GO:0019448;GO:0008104;GO:0042866;GO:0051591;GO:0051384;, C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:peroxisomal matrix; C:peroxisome;, F:alanine-glyoxylate transaminase activity; F:amino acid binding; F:identical protein binding; F:protein homodimerization activity; F:protein self-association; F:pyridoxal phosphate binding; F:serine-pyruvate transaminase activity; F:transaminase activity;, P:carboxylic acid metabolic process; P:glycine biosynthetic process, by transamination of glyoxylate; P:glyoxylate catabolic process; P:glyoxylate metabolic process; P:L-alanine catabolic process; P:L-cysteine catabolic process; P:protein localization; P:pyruvate biosynthetic process; P:response to cAMP; P:response to glucocorticoid;|P21549 Q53QU6,Serine--pyruvate aminotransferase,Alanine--glyoxylate aminotransferase;, PF00266;, GO:0005829;GO:0043231;GO:0005759;GO:0005782;GO:0005777;GO:0008453;GO:0016597;GO:0042802;GO:0042803;GO:0043621;GO:0030170;GO:0004760;GO:0008483;GO:0019752;GO:0019265;GO:0009436;GO:0046487;GO:0042853;GO:0019448;GO:0008104;GO:0042866;GO:0051591;GO:0051384;, C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:peroxisomal matrix; C:peroxisome;, F:alanine-glyoxylate transaminase activity; F:amino acid binding; F:identical protein binding; F:protein homodimerization activity; F:protein self-association; F:pyridoxal phosphate binding; F:serine-pyruvate transaminase activity; F:transaminase activity;, P:carboxylic acid metabolic process; P:glycine biosynthetic process, by transamination of glyoxylate; P:glyoxylate catabolic process; P:glyoxylate metabolic process; P:L-alanine catabolic process; P:L-cysteine catabolic process; P:protein localization; P:pyruvate biosynthetic process; P:response to cAMP; P:response to glucocorticoid; scaffold159 indexed_genome mRNA 1115931 1124754 . - . ID=transcript_14911;Q08AI8 B3KPP9 H7BXM3 Q08AI9 Q53QU5 Q9H622,Protein mab-21-like 4 {ECO:0000305},, PF03281;|Q08AI8 B3KPP9 H7BXM3 Q08AI9 Q53QU5 Q9H622,Protein mab-21-like 4 {ECO:0000305},, PF03281; scaffold159 indexed_genome mRNA 1194602 1195269 . - . ID=transcript_14912;Q8N7Z2 A0A087WU96,Golgin subfamily A member 6-like protein 1 scaffold159 indexed_genome mRNA 1237302 1258933 . + . ID=transcript_14913;Q8TER0 B5MDC3 B7WNK6 B7WPM0 Q336F4 Q336F5 Q8N369 Q8TEP7,Sushi, nidogen and EGF-like domain-containing protein 1,Insulin-responsive sequence DNA-binding protein 1;, PF00008;PF00041;PF12661;PF06119;, GO:0005576;GO:0005509;GO:0005112;GO:0007160;, C:extracellular region;, F:calcium ion binding; F:Notch binding;, P:cell-matrix adhesion;|Q8TER0 B5MDC3 B7WNK6 B7WPM0 Q336F4 Q336F5 Q8N369 Q8TEP7,Sushi, nidogen and EGF-like domain-containing protein 1,Insulin-responsive sequence DNA-binding protein 1;, PF00008;PF00041;PF12661;PF06119;, GO:0005576;GO:0005509;GO:0005112;GO:0007160;, C:extracellular region;, F:calcium ion binding; F:Notch binding;, P:cell-matrix adhesion; scaffold159 indexed_genome mRNA 1260116 1265080 . + . ID=transcript_14914;Q8TER0 B5MDC3 B7WNK6 B7WPM0 Q336F4 Q336F5 Q8N369 Q8TEP7,Sushi, nidogen and EGF-like domain-containing protein 1,Insulin-responsive sequence DNA-binding protein 1;, PF00008;PF00041;PF12661;PF06119;, GO:0005576;GO:0005509;GO:0005112;GO:0007160;, C:extracellular region;, F:calcium ion binding; F:Notch binding;, P:cell-matrix adhesion; scaffold159 indexed_genome mRNA 1265106 1266640 . + . ID=transcript_14915;Q8TER0 B5MDC3 B7WNK6 B7WPM0 Q336F4 Q336F5 Q8N369 Q8TEP7,Sushi, nidogen and EGF-like domain-containing protein 1,Insulin-responsive sequence DNA-binding protein 1;, PF00008;PF00041;PF12661;PF06119;, GO:0005576;GO:0005509;GO:0005112;GO:0007160;, C:extracellular region;, F:calcium ion binding; F:Notch binding;, P:cell-matrix adhesion; scaffold159 indexed_genome mRNA 1266678 1288519 . + . ID=transcript_14916;Q8TER0 B5MDC3 B7WNK6 B7WPM0 Q336F4 Q336F5 Q8N369 Q8TEP7,Sushi, nidogen and EGF-like domain-containing protein 1,Insulin-responsive sequence DNA-binding protein 1;, PF00008;PF00041;PF12661;PF06119;, GO:0005576;GO:0005509;GO:0005112;GO:0007160;, C:extracellular region;, F:calcium ion binding; F:Notch binding;, P:cell-matrix adhesion;|Q8TER0 B5MDC3 B7WNK6 B7WPM0 Q336F4 Q336F5 Q8N369 Q8TEP7,Sushi, nidogen and EGF-like domain-containing protein 1,Insulin-responsive sequence DNA-binding protein 1;, PF00008;PF00041;PF12661;PF06119;, GO:0005576;GO:0005509;GO:0005112;GO:0007160;, C:extracellular region;, F:calcium ion binding; F:Notch binding;, P:cell-matrix adhesion;|Q7Z6M4 A8K6K0 Q9P0E0,Transcription termination factor 4, mitochondrial,Mitochondrial transcription termination factor 4;mTERF domain-containing protein 2;, PF02536;, GO:0005829;GO:0005762;GO:0005759;GO:0005739;GO:0003690;GO:0019843;GO:0043010;GO:0007507;GO:0006390;GO:0006626;GO:0006355;GO:0042255;GO:0031167;, C:cytosol; C:mitochondrial large ribosomal subunit; C:mitochondrial matrix; C:mitochondrion;, F:double-stranded DNA binding; F:rRNA binding;, P:camera-type eye development; P:heart development; P:mitochondrial transcription; P:protein targeting to mitochondrion; P:regulation of transcription, DNA-templated; P:ribosome assembly; P:rRNA methylation; scaffold159 indexed_genome mRNA 1292411 1308190 . - . ID=transcript_14917;Q96RG2 G5E9F1 Q05BE4 Q68DY3 Q6GSJ5 Q86XH6 Q99763 Q9UFR7,PAS domain-containing serine/threonine-protein kinase,, PF13426;PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0035091;GO:0106310;GO:0004674;GO:0106311;GO:0097009;GO:0035556;GO:0045719;GO:0045727;GO:0046777;GO:0006468;GO:0070092;GO:0043576;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:phosphatidylinositol binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:energy homeostasis; P:intracellular signal transduction; P:negative regulation of glycogen biosynthetic process; P:positive regulation of translation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of glucagon secretion; P:regulation of respiratory gaseous exchange;|Q96RG2 G5E9F1 Q05BE4 Q68DY3 Q6GSJ5 Q86XH6 Q99763 Q9UFR7,PAS domain-containing serine/threonine-protein kinase,, PF13426;PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0035091;GO:0106310;GO:0004674;GO:0106311;GO:0097009;GO:0035556;GO:0045719;GO:0045727;GO:0046777;GO:0006468;GO:0070092;GO:0043576;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:phosphatidylinositol binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:energy homeostasis; P:intracellular signal transduction; P:negative regulation of glycogen biosynthetic process; P:positive regulation of translation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of glucagon secretion; P:regulation of respiratory gaseous exchange;|Q96RG2 G5E9F1 Q05BE4 Q68DY3 Q6GSJ5 Q86XH6 Q99763 Q9UFR7,PAS domain-containing serine/threonine-protein kinase,, PF13426;PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0035091;GO:0106310;GO:0004674;GO:0106311;GO:0097009;GO:0035556;GO:0045719;GO:0045727;GO:0046777;GO:0006468;GO:0070092;GO:0043576;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:phosphatidylinositol binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:energy homeostasis; P:intracellular signal transduction; P:negative regulation of glycogen biosynthetic process; P:positive regulation of translation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of glucagon secretion; P:regulation of respiratory gaseous exchange;|Q96RG2 G5E9F1 Q05BE4 Q68DY3 Q6GSJ5 Q86XH6 Q99763 Q9UFR7,PAS domain-containing serine/threonine-protein kinase,, PF13426;PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0035091;GO:0106310;GO:0004674;GO:0106311;GO:0097009;GO:0035556;GO:0045719;GO:0045727;GO:0046777;GO:0006468;GO:0070092;GO:0043576;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:phosphatidylinositol binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:energy homeostasis; P:intracellular signal transduction; P:negative regulation of glycogen biosynthetic process; P:positive regulation of translation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of glucagon secretion; P:regulation of respiratory gaseous exchange;|Q96RG2 G5E9F1 Q05BE4 Q68DY3 Q6GSJ5 Q86XH6 Q99763 Q9UFR7,PAS domain-containing serine/threonine-protein kinase,, PF13426;PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0035091;GO:0106310;GO:0004674;GO:0106311;GO:0097009;GO:0035556;GO:0045719;GO:0045727;GO:0046777;GO:0006468;GO:0070092;GO:0043576;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:phosphatidylinositol binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:energy homeostasis; P:intracellular signal transduction; P:negative regulation of glycogen biosynthetic process; P:positive regulation of translation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of glucagon secretion; P:regulation of respiratory gaseous exchange; scaffold159 indexed_genome mRNA 1311791 1319407 . + . ID=transcript_14918;Q96RG2 G5E9F1 Q05BE4 Q68DY3 Q6GSJ5 Q86XH6 Q99763 Q9UFR7,PAS domain-containing serine/threonine-protein kinase,, PF13426;PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0035091;GO:0106310;GO:0004674;GO:0106311;GO:0097009;GO:0035556;GO:0045719;GO:0045727;GO:0046777;GO:0006468;GO:0070092;GO:0043576;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:phosphatidylinositol binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:energy homeostasis; P:intracellular signal transduction; P:negative regulation of glycogen biosynthetic process; P:positive regulation of translation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of glucagon secretion; P:regulation of respiratory gaseous exchange;|Q96RG2 G5E9F1 Q05BE4 Q68DY3 Q6GSJ5 Q86XH6 Q99763 Q9UFR7,PAS domain-containing serine/threonine-protein kinase,, PF13426;PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0035091;GO:0106310;GO:0004674;GO:0106311;GO:0097009;GO:0035556;GO:0045719;GO:0045727;GO:0046777;GO:0006468;GO:0070092;GO:0043576;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:phosphatidylinositol binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:energy homeostasis; P:intracellular signal transduction; P:negative regulation of glycogen biosynthetic process; P:positive regulation of translation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of glucagon secretion; P:regulation of respiratory gaseous exchange; scaffold159 indexed_genome mRNA 1326166 1348432 . + . ID=transcript_14919;Q15435 B4DFD4 B5MCY6 Q9UQE5 Q9UQE6 Q9Y6K4,Protein phosphatase 1 regulatory subunit 7,Protein phosphatase 1 regulatory subunit 22;, , GO:0005694;GO:0005737;GO:0070062;GO:0005634;GO:0030234;GO:0019888;GO:0035307;, C:chromosome; C:cytoplasm; C:extracellular exosome; C:nucleus;, F:enzyme regulator activity; F:protein phosphatase regulator activity;, P:positive regulation of protein dephosphorylation;|Q15435 B4DFD4 B5MCY6 Q9UQE5 Q9UQE6 Q9Y6K4,Protein phosphatase 1 regulatory subunit 7,Protein phosphatase 1 regulatory subunit 22;, , GO:0005694;GO:0005737;GO:0070062;GO:0005634;GO:0030234;GO:0019888;GO:0035307;, C:chromosome; C:cytoplasm; C:extracellular exosome; C:nucleus;, F:enzyme regulator activity; F:protein phosphatase regulator activity;, P:positive regulation of protein dephosphorylation;|Q15435 B4DFD4 B5MCY6 Q9UQE5 Q9UQE6 Q9Y6K4,Protein phosphatase 1 regulatory subunit 7,Protein phosphatase 1 regulatory subunit 22;, , GO:0005694;GO:0005737;GO:0070062;GO:0005634;GO:0030234;GO:0019888;GO:0035307;, C:chromosome; C:cytoplasm; C:extracellular exosome; C:nucleus;, F:enzyme regulator activity; F:protein phosphatase regulator activity;, P:positive regulation of protein dephosphorylation; scaffold159 indexed_genome mRNA 1383184 1409197 . - . ID=transcript_14920;Q00341 B4DTQ2 E7EM71 Q53QU2 Q9UCY3,Vigilin,High density lipoprotein-binding protein;, PF00013;, GO:0005737;GO:0005829;GO:0034364;GO:0005634;GO:0005886;GO:0005844;GO:0045296;GO:0008289;GO:0003729;GO:0003723;GO:0008203;GO:0034384;GO:0006869;, C:cytoplasm; C:cytosol; C:high-density lipoprotein particle; C:nucleus; C:plasma membrane; C:polysome;, F:cadherin binding; F:lipid binding; F:mRNA binding; F:RNA binding;, P:cholesterol metabolic process; P:high-density lipoprotein particle clearance; P:lipid transport;|Q00341 B4DTQ2 E7EM71 Q53QU2 Q9UCY3,Vigilin,High density lipoprotein-binding protein;, PF00013;, GO:0005737;GO:0005829;GO:0034364;GO:0005634;GO:0005886;GO:0005844;GO:0045296;GO:0008289;GO:0003729;GO:0003723;GO:0008203;GO:0034384;GO:0006869;, C:cytoplasm; C:cytosol; C:high-density lipoprotein particle; C:nucleus; C:plasma membrane; C:polysome;, F:cadherin binding; F:lipid binding; F:mRNA binding; F:RNA binding;, P:cholesterol metabolic process; P:high-density lipoprotein particle clearance; P:lipid transport;|Q00341 B4DTQ2 E7EM71 Q53QU2 Q9UCY3,Vigilin,High density lipoprotein-binding protein;, PF00013;, GO:0005737;GO:0005829;GO:0034364;GO:0005634;GO:0005886;GO:0005844;GO:0045296;GO:0008289;GO:0003729;GO:0003723;GO:0008203;GO:0034384;GO:0006869;, C:cytoplasm; C:cytosol; C:high-density lipoprotein particle; C:nucleus; C:plasma membrane; C:polysome;, F:cadherin binding; F:lipid binding; F:mRNA binding; F:RNA binding;, P:cholesterol metabolic process; P:high-density lipoprotein particle clearance; P:lipid transport;|Q00341 B4DTQ2 E7EM71 Q53QU2 Q9UCY3,Vigilin,High density lipoprotein-binding protein;, PF00013;, GO:0005737;GO:0005829;GO:0034364;GO:0005634;GO:0005886;GO:0005844;GO:0045296;GO:0008289;GO:0003729;GO:0003723;GO:0008203;GO:0034384;GO:0006869;, C:cytoplasm; C:cytosol; C:high-density lipoprotein particle; C:nucleus; C:plasma membrane; C:polysome;, F:cadherin binding; F:lipid binding; F:mRNA binding; F:RNA binding;, P:cholesterol metabolic process; P:high-density lipoprotein particle clearance; P:lipid transport;|Q00341 B4DTQ2 E7EM71 Q53QU2 Q9UCY3,Vigilin,High density lipoprotein-binding protein;, PF00013;, GO:0005737;GO:0005829;GO:0034364;GO:0005634;GO:0005886;GO:0005844;GO:0045296;GO:0008289;GO:0003729;GO:0003723;GO:0008203;GO:0034384;GO:0006869;, C:cytoplasm; C:cytosol; C:high-density lipoprotein particle; C:nucleus; C:plasma membrane; C:polysome;, F:cadherin binding; F:lipid binding; F:mRNA binding; F:RNA binding;, P:cholesterol metabolic process; P:high-density lipoprotein particle clearance; P:lipid transport;|Q00341 B4DTQ2 E7EM71 Q53QU2 Q9UCY3,Vigilin,High density lipoprotein-binding protein;, PF00013;, GO:0005737;GO:0005829;GO:0034364;GO:0005634;GO:0005886;GO:0005844;GO:0045296;GO:0008289;GO:0003729;GO:0003723;GO:0008203;GO:0034384;GO:0006869;, C:cytoplasm; C:cytosol; C:high-density lipoprotein particle; C:nucleus; C:plasma membrane; C:polysome;, F:cadherin binding; F:lipid binding; F:mRNA binding; F:RNA binding;, P:cholesterol metabolic process; P:high-density lipoprotein particle clearance; P:lipid transport;|Q00341 B4DTQ2 E7EM71 Q53QU2 Q9UCY3,Vigilin,High density lipoprotein-binding protein;, PF00013;, GO:0005737;GO:0005829;GO:0034364;GO:0005634;GO:0005886;GO:0005844;GO:0045296;GO:0008289;GO:0003729;GO:0003723;GO:0008203;GO:0034384;GO:0006869;, C:cytoplasm; C:cytosol; C:high-density lipoprotein particle; C:nucleus; C:plasma membrane; C:polysome;, F:cadherin binding; F:lipid binding; F:mRNA binding; F:RNA binding;, P:cholesterol metabolic process; P:high-density lipoprotein particle clearance; P:lipid transport; scaffold159 indexed_genome mRNA 1451905 1470976 . + . ID=transcript_14921;Q15019 B4DGE8 Q14132 Q53QU3 Q8IUK9 Q96CB0,Septin-2,Neural precursor cell expressed developmentally down-regulated protein 5;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0060170;GO:0032154;GO:0000777;GO:0005737;GO:0000145;GO:0070062;GO:0045171;GO:0015630;GO:0030496;GO:0097730;GO:0005654;GO:0005634;GO:0048471;GO:0032391;GO:0005886;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0008021;GO:0045296;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0060271;GO:0061640;GO:0031175;GO:0017157;GO:0007224;GO:0007283;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:ciliary membrane; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:exocyst; C:extracellular exosome; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:non-motile cilium; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor connecting cilium; C:plasma membrane; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:synaptic vesicle;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:neuron projection development; P:regulation of exocytosis; P:smoothened signaling pathway; P:spermatogenesis;|Q15019 B4DGE8 Q14132 Q53QU3 Q8IUK9 Q96CB0,Septin-2,Neural precursor cell expressed developmentally down-regulated protein 5;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0060170;GO:0032154;GO:0000777;GO:0005737;GO:0000145;GO:0070062;GO:0045171;GO:0015630;GO:0030496;GO:0097730;GO:0005654;GO:0005634;GO:0048471;GO:0032391;GO:0005886;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0008021;GO:0045296;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0060271;GO:0061640;GO:0031175;GO:0017157;GO:0007224;GO:0007283;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:ciliary membrane; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:exocyst; C:extracellular exosome; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:non-motile cilium; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor connecting cilium; C:plasma membrane; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:synaptic vesicle;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:neuron projection development; P:regulation of exocytosis; P:smoothened signaling pathway; P:spermatogenesis;|Q15019 B4DGE8 Q14132 Q53QU3 Q8IUK9 Q96CB0,Septin-2,Neural precursor cell expressed developmentally down-regulated protein 5;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0060170;GO:0032154;GO:0000777;GO:0005737;GO:0000145;GO:0070062;GO:0045171;GO:0015630;GO:0030496;GO:0097730;GO:0005654;GO:0005634;GO:0048471;GO:0032391;GO:0005886;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0008021;GO:0045296;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0060271;GO:0061640;GO:0031175;GO:0017157;GO:0007224;GO:0007283;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:ciliary membrane; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:exocyst; C:extracellular exosome; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:non-motile cilium; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor connecting cilium; C:plasma membrane; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:synaptic vesicle;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:neuron projection development; P:regulation of exocytosis; P:smoothened signaling pathway; P:spermatogenesis;|Q15019 B4DGE8 Q14132 Q53QU3 Q8IUK9 Q96CB0,Septin-2,Neural precursor cell expressed developmentally down-regulated protein 5;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0060170;GO:0032154;GO:0000777;GO:0005737;GO:0000145;GO:0070062;GO:0045171;GO:0015630;GO:0030496;GO:0097730;GO:0005654;GO:0005634;GO:0048471;GO:0032391;GO:0005886;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0008021;GO:0045296;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0060271;GO:0061640;GO:0031175;GO:0017157;GO:0007224;GO:0007283;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:ciliary membrane; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:exocyst; C:extracellular exosome; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:non-motile cilium; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor connecting cilium; C:plasma membrane; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:synaptic vesicle;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:neuron projection development; P:regulation of exocytosis; P:smoothened signaling pathway; P:spermatogenesis;|Q15019 B4DGE8 Q14132 Q53QU3 Q8IUK9 Q96CB0,Septin-2,Neural precursor cell expressed developmentally down-regulated protein 5;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0060170;GO:0032154;GO:0000777;GO:0005737;GO:0000145;GO:0070062;GO:0045171;GO:0015630;GO:0030496;GO:0097730;GO:0005654;GO:0005634;GO:0048471;GO:0032391;GO:0005886;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0008021;GO:0045296;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0060271;GO:0061640;GO:0031175;GO:0017157;GO:0007224;GO:0007283;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:ciliary membrane; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:exocyst; C:extracellular exosome; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:non-motile cilium; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor connecting cilium; C:plasma membrane; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:synaptic vesicle;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:neuron projection development; P:regulation of exocytosis; P:smoothened signaling pathway; P:spermatogenesis;|Q15019 B4DGE8 Q14132 Q53QU3 Q8IUK9 Q96CB0,Septin-2,Neural precursor cell expressed developmentally down-regulated protein 5;, PF00735;, GO:0015629;GO:0005930;GO:0032153;GO:0060170;GO:0032154;GO:0000777;GO:0005737;GO:0000145;GO:0070062;GO:0045171;GO:0015630;GO:0030496;GO:0097730;GO:0005654;GO:0005634;GO:0048471;GO:0032391;GO:0005886;GO:0031105;GO:0005940;GO:0097227;GO:0005819;GO:0008021;GO:0045296;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0060271;GO:0061640;GO:0031175;GO:0017157;GO:0007224;GO:0007283;, C:actin cytoskeleton; C:axoneme; C:cell division site; C:ciliary membrane; C:cleavage furrow; C:condensed chromosome kinetochore; C:cytoplasm; C:exocyst; C:extracellular exosome; C:intercellular bridge; C:microtubule cytoskeleton; C:midbody; C:non-motile cilium; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:photoreceptor connecting cilium; C:plasma membrane; C:septin complex; C:septin ring; C:sperm annulus; C:spindle; C:synaptic vesicle;, F:cadherin binding; F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cilium assembly; P:cytoskeleton-dependent cytokinesis; P:neuron projection development; P:regulation of exocytosis; P:smoothened signaling pathway; P:spermatogenesis;|P62891 P02404 P39025 Q9BYF2,60S ribosomal protein L39,Large ribosomal subunit protein eL39 {ECO:0000303|PubMed:24524803};, PF00832;, GO:0005829;GO:0022625;GO:0005615;GO:0042788;GO:0003723;GO:0003735;GO:0019731;GO:0061844;GO:0002181;GO:0050830;GO:0002227;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular space; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:antibacterial humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cytoplasmic translation; P:defense response to Gram-positive bacterium; P:innate immune response in mucosa; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold159 indexed_genome mRNA 1485041 1563630 . + . ID=transcript_14922;O94887 B7Z6J8 F5GZ84 Q53QM5 Q8WU27 Q9UFE7,FERM, ARHGEF and pleckstrin domain-containing protein 2,FERM domain-including RhoGEF;FERM, RhoGEF and pleckstrin domain-containing protein 2;Pleckstrin homology domain-containing family C member 3;, PF08736;PF09380;PF00373;PF09379;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0008092;GO:0005085;GO:0031532;GO:0007155;GO:0022405;GO:0016322;GO:0030316;GO:0071800;GO:0016601;GO:0033623;GO:0071526;, C:cytoplasm; C:cytoskeleton; C:cytosol;, F:cytoskeletal protein binding; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton reorganization; P:cell adhesion; P:hair cycle process; P:neuron remodeling; P:osteoclast differentiation; P:podosome assembly; P:Rac protein signal transduction; P:regulation of integrin activation; P:semaphorin-plexin signaling pathway;|O94887 B7Z6J8 F5GZ84 Q53QM5 Q8WU27 Q9UFE7,FERM, ARHGEF and pleckstrin domain-containing protein 2,FERM domain-including RhoGEF;FERM, RhoGEF and pleckstrin domain-containing protein 2;Pleckstrin homology domain-containing family C member 3;, PF08736;PF09380;PF00373;PF09379;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0008092;GO:0005085;GO:0031532;GO:0007155;GO:0022405;GO:0016322;GO:0030316;GO:0071800;GO:0016601;GO:0033623;GO:0071526;, C:cytoplasm; C:cytoskeleton; C:cytosol;, F:cytoskeletal protein binding; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton reorganization; P:cell adhesion; P:hair cycle process; P:neuron remodeling; P:osteoclast differentiation; P:podosome assembly; P:Rac protein signal transduction; P:regulation of integrin activation; P:semaphorin-plexin signaling pathway;|O94887 B7Z6J8 F5GZ84 Q53QM5 Q8WU27 Q9UFE7,FERM, ARHGEF and pleckstrin domain-containing protein 2,FERM domain-including RhoGEF;FERM, RhoGEF and pleckstrin domain-containing protein 2;Pleckstrin homology domain-containing family C member 3;, PF08736;PF09380;PF00373;PF09379;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0008092;GO:0005085;GO:0031532;GO:0007155;GO:0022405;GO:0016322;GO:0030316;GO:0071800;GO:0016601;GO:0033623;GO:0071526;, C:cytoplasm; C:cytoskeleton; C:cytosol;, F:cytoskeletal protein binding; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton reorganization; P:cell adhesion; P:hair cycle process; P:neuron remodeling; P:osteoclast differentiation; P:podosome assembly; P:Rac protein signal transduction; P:regulation of integrin activation; P:semaphorin-plexin signaling pathway;|O94887 B7Z6J8 F5GZ84 Q53QM5 Q8WU27 Q9UFE7,FERM, ARHGEF and pleckstrin domain-containing protein 2,FERM domain-including RhoGEF;FERM, RhoGEF and pleckstrin domain-containing protein 2;Pleckstrin homology domain-containing family C member 3;, PF08736;PF09380;PF00373;PF09379;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0008092;GO:0005085;GO:0031532;GO:0007155;GO:0022405;GO:0016322;GO:0030316;GO:0071800;GO:0016601;GO:0033623;GO:0071526;, C:cytoplasm; C:cytoskeleton; C:cytosol;, F:cytoskeletal protein binding; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton reorganization; P:cell adhesion; P:hair cycle process; P:neuron remodeling; P:osteoclast differentiation; P:podosome assembly; P:Rac protein signal transduction; P:regulation of integrin activation; P:semaphorin-plexin signaling pathway; scaffold159 indexed_genome mRNA 1563728 1578411 . + . ID=transcript_14923;O94887 B7Z6J8 F5GZ84 Q53QM5 Q8WU27 Q9UFE7,FERM, ARHGEF and pleckstrin domain-containing protein 2,FERM domain-including RhoGEF;FERM, RhoGEF and pleckstrin domain-containing protein 2;Pleckstrin homology domain-containing family C member 3;, PF08736;PF09380;PF00373;PF09379;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0008092;GO:0005085;GO:0031532;GO:0007155;GO:0022405;GO:0016322;GO:0030316;GO:0071800;GO:0016601;GO:0033623;GO:0071526;, C:cytoplasm; C:cytoskeleton; C:cytosol;, F:cytoskeletal protein binding; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton reorganization; P:cell adhesion; P:hair cycle process; P:neuron remodeling; P:osteoclast differentiation; P:podosome assembly; P:Rac protein signal transduction; P:regulation of integrin activation; P:semaphorin-plexin signaling pathway;|O94887 B7Z6J8 F5GZ84 Q53QM5 Q8WU27 Q9UFE7,FERM, ARHGEF and pleckstrin domain-containing protein 2,FERM domain-including RhoGEF;FERM, RhoGEF and pleckstrin domain-containing protein 2;Pleckstrin homology domain-containing family C member 3;, PF08736;PF09380;PF00373;PF09379;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0008092;GO:0005085;GO:0031532;GO:0007155;GO:0022405;GO:0016322;GO:0030316;GO:0071800;GO:0016601;GO:0033623;GO:0071526;, C:cytoplasm; C:cytoskeleton; C:cytosol;, F:cytoskeletal protein binding; F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton reorganization; P:cell adhesion; P:hair cycle process; P:neuron remodeling; P:osteoclast differentiation; P:podosome assembly; P:Rac protein signal transduction; P:regulation of integrin activation; P:semaphorin-plexin signaling pathway;|O00506 A8K6Z3 A8K7D2 B7Z9K1 Q15522 Q5BJF1,Serine/threonine-protein kinase 25,Ste20-like kinase;Sterile 20/oxidant stress-response kinase 1;, PF00069;, GO:0005737;GO:0070062;GO:0000139;GO:0005524;GO:0046872;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0051683;GO:0007163;GO:0051645;GO:0090168;GO:0036481;GO:0050772;GO:0032874;GO:0046777;GO:0006468;GO:0042542;GO:0006979;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:Golgi membrane;, F:ATP binding; F:metal ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:establishment of Golgi localization; P:establishment or maintenance of cell polarity; P:Golgi localization; P:Golgi reassembly; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:positive regulation of axonogenesis; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:response to hydrogen peroxide; P:response to oxidative stress; P:signal transduction;|O00506 A8K6Z3 A8K7D2 B7Z9K1 Q15522 Q5BJF1,Serine/threonine-protein kinase 25,Ste20-like kinase;Sterile 20/oxidant stress-response kinase 1;, PF00069;, GO:0005737;GO:0070062;GO:0000139;GO:0005524;GO:0046872;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0051683;GO:0007163;GO:0051645;GO:0090168;GO:0036481;GO:0050772;GO:0032874;GO:0046777;GO:0006468;GO:0042542;GO:0006979;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:Golgi membrane;, F:ATP binding; F:metal ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:establishment of Golgi localization; P:establishment or maintenance of cell polarity; P:Golgi localization; P:Golgi reassembly; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:positive regulation of axonogenesis; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:response to hydrogen peroxide; P:response to oxidative stress; P:signal transduction;|O00506 A8K6Z3 A8K7D2 B7Z9K1 Q15522 Q5BJF1,Serine/threonine-protein kinase 25,Ste20-like kinase;Sterile 20/oxidant stress-response kinase 1;, PF00069;, GO:0005737;GO:0070062;GO:0000139;GO:0005524;GO:0046872;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0051683;GO:0007163;GO:0051645;GO:0090168;GO:0036481;GO:0050772;GO:0032874;GO:0046777;GO:0006468;GO:0042542;GO:0006979;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:Golgi membrane;, F:ATP binding; F:metal ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:establishment of Golgi localization; P:establishment or maintenance of cell polarity; P:Golgi localization; P:Golgi reassembly; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:positive regulation of axonogenesis; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:response to hydrogen peroxide; P:response to oxidative stress; P:signal transduction;|O00506 A8K6Z3 A8K7D2 B7Z9K1 Q15522 Q5BJF1,Serine/threonine-protein kinase 25,Ste20-like kinase;Sterile 20/oxidant stress-response kinase 1;, PF00069;, GO:0005737;GO:0070062;GO:0000139;GO:0005524;GO:0046872;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0051683;GO:0007163;GO:0051645;GO:0090168;GO:0036481;GO:0050772;GO:0032874;GO:0046777;GO:0006468;GO:0042542;GO:0006979;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:Golgi membrane;, F:ATP binding; F:metal ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:establishment of Golgi localization; P:establishment or maintenance of cell polarity; P:Golgi localization; P:Golgi reassembly; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:positive regulation of axonogenesis; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:response to hydrogen peroxide; P:response to oxidative stress; P:signal transduction; scaffold159 indexed_genome mRNA 1578560 1582062 . - . ID=transcript_14924;O00506 A8K6Z3 A8K7D2 B7Z9K1 Q15522 Q5BJF1,Serine/threonine-protein kinase 25,Ste20-like kinase;Sterile 20/oxidant stress-response kinase 1;, PF00069;, GO:0005737;GO:0070062;GO:0000139;GO:0005524;GO:0046872;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0051683;GO:0007163;GO:0051645;GO:0090168;GO:0036481;GO:0050772;GO:0032874;GO:0046777;GO:0006468;GO:0042542;GO:0006979;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:Golgi membrane;, F:ATP binding; F:metal ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:establishment of Golgi localization; P:establishment or maintenance of cell polarity; P:Golgi localization; P:Golgi reassembly; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:positive regulation of axonogenesis; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:response to hydrogen peroxide; P:response to oxidative stress; P:signal transduction;|O00506 A8K6Z3 A8K7D2 B7Z9K1 Q15522 Q5BJF1,Serine/threonine-protein kinase 25,Ste20-like kinase;Sterile 20/oxidant stress-response kinase 1;, PF00069;, GO:0005737;GO:0070062;GO:0000139;GO:0005524;GO:0046872;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0051683;GO:0007163;GO:0051645;GO:0090168;GO:0036481;GO:0050772;GO:0032874;GO:0046777;GO:0006468;GO:0042542;GO:0006979;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:Golgi membrane;, F:ATP binding; F:metal ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:establishment of Golgi localization; P:establishment or maintenance of cell polarity; P:Golgi localization; P:Golgi reassembly; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:positive regulation of axonogenesis; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:response to hydrogen peroxide; P:response to oxidative stress; P:signal transduction;|O00506 A8K6Z3 A8K7D2 B7Z9K1 Q15522 Q5BJF1,Serine/threonine-protein kinase 25,Ste20-like kinase;Sterile 20/oxidant stress-response kinase 1;, PF00069;, GO:0005737;GO:0070062;GO:0000139;GO:0005524;GO:0046872;GO:0042803;GO:0004672;GO:0106310;GO:0106311;GO:0051683;GO:0007163;GO:0051645;GO:0090168;GO:0036481;GO:0050772;GO:0032874;GO:0046777;GO:0006468;GO:0042542;GO:0006979;GO:0007165;, C:cytoplasm; C:extracellular exosome; C:Golgi membrane;, F:ATP binding; F:metal ion binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:establishment of Golgi localization; P:establishment or maintenance of cell polarity; P:Golgi localization; P:Golgi reassembly; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; P:positive regulation of axonogenesis; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:response to hydrogen peroxide; P:response to oxidative stress; P:signal transduction; scaffold159 indexed_genome mRNA 1617690 1663097 . + . ID=transcript_14925;Q9UMX3,Bcl-2-related ovarian killer protein {ECO:0000303|PubMed:11034351},Bcl-2-like protein 9;, PF00452;, GO:0033106;GO:0005737;GO:0031901;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0016020;GO:0005743;GO:0031966;GO:0005741;GO:0005739;GO:0005640;GO:0005634;GO:0055038;GO:0032588;GO:0051400;GO:0046982;GO:0042803;GO:0044877;GO:0005102;GO:0031625;GO:0006919;GO:0008635;GO:0006915;GO:0007420;GO:0006921;GO:0097192;GO:0072332;GO:0008630;GO:0008584;GO:0051902;GO:1901029;GO:0060546;GO:0043524;GO:0051402;GO:0048709;GO:0043065;GO:1902237;GO:1900119;GO:2001244;GO:1901030;GO:1903899;GO:0051259;GO:0010506;GO:1901382;GO:0051480;GO:1904708;GO:0001836;, C:cis-Golgi network membrane; C:cytoplasm; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear outer membrane; C:nucleus; C:recycling endosome membrane; C:trans-Golgi network membrane;, F:BH domain binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding; F:signaling receptor binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:apoptotic process; P:brain development; P:cellular component disassembly involved in execution phase of apoptosis; P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:male gonad development; P:negative regulation of mitochondrial depolarization; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:negative regulation of necroptotic process; P:negative regulation of neuron apoptotic process; P:neuron apoptotic process; P:oligodendrocyte differentiation; P:positive regulation of apoptotic process; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of execution phase of apoptosis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of PERK-mediated unfolded protein response; P:protein complex oligomerization; P:regulation of autophagy; P:regulation of chorionic trophoblast cell proliferation; P:regulation of cytosolic calcium ion concentration; P:regulation of granulosa cell apoptotic process; P:release of cytochrome c from mitochondria;|Q9UMX3,Bcl-2-related ovarian killer protein {ECO:0000303|PubMed:11034351},Bcl-2-like protein 9;, PF00452;, GO:0033106;GO:0005737;GO:0031901;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0016020;GO:0005743;GO:0031966;GO:0005741;GO:0005739;GO:0005640;GO:0005634;GO:0055038;GO:0032588;GO:0051400;GO:0046982;GO:0042803;GO:0044877;GO:0005102;GO:0031625;GO:0006919;GO:0008635;GO:0006915;GO:0007420;GO:0006921;GO:0097192;GO:0072332;GO:0008630;GO:0008584;GO:0051902;GO:1901029;GO:0060546;GO:0043524;GO:0051402;GO:0048709;GO:0043065;GO:1902237;GO:1900119;GO:2001244;GO:1901030;GO:1903899;GO:0051259;GO:0010506;GO:1901382;GO:0051480;GO:1904708;GO:0001836;, C:cis-Golgi network membrane; C:cytoplasm; C:early endosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear outer membrane; C:nucleus; C:recycling endosome membrane; C:trans-Golgi network membrane;, F:BH domain binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding; F:signaling receptor binding; F:ubiquitin protein ligase binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:apoptotic process; P:brain development; P:cellular component disassembly involved in execution phase of apoptosis; P:extrinsic apoptotic signaling pathway in absence of ligand; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:male gonad development; P:negative regulation of mitochondrial depolarization; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:negative regulation of necroptotic process; P:negative regulation of neuron apoptotic process; P:neuron apoptotic process; P:oligodendrocyte differentiation; P:positive regulation of apoptotic process; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of execution phase of apoptosis; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of PERK-mediated unfolded protein response; P:protein complex oligomerization; P:regulation of autophagy; P:regulation of chorionic trophoblast cell proliferation; P:regulation of cytosolic calcium ion concentration; P:regulation of granulosa cell apoptotic process; P:release of cytochrome c from mitochondria;|Q8WY91 Q53NU7 Q6GRN0 Q6IPJ3 Q9NW26 Q9Y325,Peroxynitrite isomerase THAP4 {ECO:0000305|PubMed:30524950},THAP domain-containing protein 4 {ECO:0000312|HGNC:HGNC:23187};, PF08768;PF05485;, GO:0003677;GO:0020037;GO:0042802;GO:0046872;GO:0070026;GO:0062213;GO:0042126;GO:0006570;, , F:DNA binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:nitric oxide binding; F:peroxynitrite isomerase activity;, P:nitrate metabolic process; P:tyrosine metabolic process;|Q8WY91 Q53NU7 Q6GRN0 Q6IPJ3 Q9NW26 Q9Y325,Peroxynitrite isomerase THAP4 {ECO:0000305|PubMed:30524950},THAP domain-containing protein 4 {ECO:0000312|HGNC:HGNC:23187};, PF08768;PF05485;, GO:0003677;GO:0020037;GO:0042802;GO:0046872;GO:0070026;GO:0062213;GO:0042126;GO:0006570;, , F:DNA binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:nitric oxide binding; F:peroxynitrite isomerase activity;, P:nitrate metabolic process; P:tyrosine metabolic process;|Q8WY91 Q53NU7 Q6GRN0 Q6IPJ3 Q9NW26 Q9Y325,Peroxynitrite isomerase THAP4 {ECO:0000305|PubMed:30524950},THAP domain-containing protein 4 {ECO:0000312|HGNC:HGNC:23187};, PF08768;PF05485;, GO:0003677;GO:0020037;GO:0042802;GO:0046872;GO:0070026;GO:0062213;GO:0042126;GO:0006570;, , F:DNA binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:nitric oxide binding; F:peroxynitrite isomerase activity;, P:nitrate metabolic process; P:tyrosine metabolic process; scaffold159 indexed_genome mRNA 1685582 1694896 . + . ID=transcript_14926;Q9Y4P1 B7WNK2 Q53NU4 Q6ZUV8 Q8WYM9 Q96K07 Q96K96 Q96SZ1 Q9Y2F2,Cysteine protease ATG4B,AUT-like 1 cysteine endopeptidase;Autophagin-1;Autophagy-related cysteine endopeptidase 1;Autophagy-related protein 4 homolog B;, PF03416;, GO:0005829;GO:0004197;GO:0008234;GO:0004175;GO:0006914;GO:0016236;GO:0045732;GO:0051697;GO:0015031;GO:0006508;, C:cytosol;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:endopeptidase activity;, P:autophagy; P:macroautophagy; P:positive regulation of protein catabolic process; P:protein delipidation; P:protein transport; P:proteolysis;|Q9Y4P1 B7WNK2 Q53NU4 Q6ZUV8 Q8WYM9 Q96K07 Q96K96 Q96SZ1 Q9Y2F2,Cysteine protease ATG4B,AUT-like 1 cysteine endopeptidase;Autophagin-1;Autophagy-related cysteine endopeptidase 1;Autophagy-related protein 4 homolog B;, PF03416;, GO:0005829;GO:0004197;GO:0008234;GO:0004175;GO:0006914;GO:0016236;GO:0045732;GO:0051697;GO:0015031;GO:0006508;, C:cytosol;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:endopeptidase activity;, P:autophagy; P:macroautophagy; P:positive regulation of protein catabolic process; P:protein delipidation; P:protein transport; P:proteolysis;|Q9Y4P1 B7WNK2 Q53NU4 Q6ZUV8 Q8WYM9 Q96K07 Q96K96 Q96SZ1 Q9Y2F2,Cysteine protease ATG4B,AUT-like 1 cysteine endopeptidase;Autophagin-1;Autophagy-related cysteine endopeptidase 1;Autophagy-related protein 4 homolog B;, PF03416;, GO:0005829;GO:0004197;GO:0008234;GO:0004175;GO:0006914;GO:0016236;GO:0045732;GO:0051697;GO:0015031;GO:0006508;, C:cytosol;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:endopeptidase activity;, P:autophagy; P:macroautophagy; P:positive regulation of protein catabolic process; P:protein delipidation; P:protein transport; P:proteolysis;|Q9Y4P1 B7WNK2 Q53NU4 Q6ZUV8 Q8WYM9 Q96K07 Q96K96 Q96SZ1 Q9Y2F2,Cysteine protease ATG4B,AUT-like 1 cysteine endopeptidase;Autophagin-1;Autophagy-related cysteine endopeptidase 1;Autophagy-related protein 4 homolog B;, PF03416;, GO:0005829;GO:0004197;GO:0008234;GO:0004175;GO:0006914;GO:0016236;GO:0045732;GO:0051697;GO:0015031;GO:0006508;, C:cytosol;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:endopeptidase activity;, P:autophagy; P:macroautophagy; P:positive regulation of protein catabolic process; P:protein delipidation; P:protein transport; P:proteolysis;|Q9Y4P1 B7WNK2 Q53NU4 Q6ZUV8 Q8WYM9 Q96K07 Q96K96 Q96SZ1 Q9Y2F2,Cysteine protease ATG4B,AUT-like 1 cysteine endopeptidase;Autophagin-1;Autophagy-related cysteine endopeptidase 1;Autophagy-related protein 4 homolog B;, PF03416;, GO:0005829;GO:0004197;GO:0008234;GO:0004175;GO:0006914;GO:0016236;GO:0045732;GO:0051697;GO:0015031;GO:0006508;, C:cytosol;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity; F:endopeptidase activity;, P:autophagy; P:macroautophagy; P:positive regulation of protein catabolic process; P:protein delipidation; P:protein transport; P:proteolysis; scaffold159 indexed_genome mRNA 1695142 1696725 . + . ID=transcript_14927;P23919 B7ZW70 Q6FGX1 Q9BUX4,Thymidylate kinase,dTMP kinase;, PF02223;, GO:0005737;GO:0005829;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0005524;GO:0004550;GO:0004798;GO:0009041;GO:0071363;GO:0006233;GO:0006235;GO:0006227;GO:0045445;GO:0015949;GO:0046686;GO:0043627;GO:0046105;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:ATP binding; F:nucleoside diphosphate kinase activity; F:thymidylate kinase activity; F:uridylate kinase activity;, P:cellular response to growth factor stimulus; P:dTDP biosynthetic process; P:dTTP biosynthetic process; P:dUDP biosynthetic process; P:myoblast differentiation; P:nucleobase-containing small molecule interconversion; P:response to cadmium ion; P:response to estrogen; P:thymidine biosynthetic process; scaffold159 indexed_genome mRNA 1697986 1703403 . - . ID=transcript_14928;P23919 B7ZW70 Q6FGX1 Q9BUX4,Thymidylate kinase,dTMP kinase;, PF02223;, GO:0005737;GO:0005829;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0005524;GO:0004550;GO:0004798;GO:0009041;GO:0071363;GO:0006233;GO:0006235;GO:0006227;GO:0045445;GO:0015949;GO:0046686;GO:0043627;GO:0046105;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:ATP binding; F:nucleoside diphosphate kinase activity; F:thymidylate kinase activity; F:uridylate kinase activity;, P:cellular response to growth factor stimulus; P:dTDP biosynthetic process; P:dTTP biosynthetic process; P:dUDP biosynthetic process; P:myoblast differentiation; P:nucleobase-containing small molecule interconversion; P:response to cadmium ion; P:response to estrogen; P:thymidine biosynthetic process;|P23919 B7ZW70 Q6FGX1 Q9BUX4,Thymidylate kinase,dTMP kinase;, PF02223;, GO:0005737;GO:0005829;GO:0005758;GO:0005759;GO:0005739;GO:0005634;GO:0005524;GO:0004550;GO:0004798;GO:0009041;GO:0071363;GO:0006233;GO:0006235;GO:0006227;GO:0045445;GO:0015949;GO:0046686;GO:0043627;GO:0046105;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:ATP binding; F:nucleoside diphosphate kinase activity; F:thymidylate kinase activity; F:uridylate kinase activity;, P:cellular response to growth factor stimulus; P:dTDP biosynthetic process; P:dTTP biosynthetic process; P:dUDP biosynthetic process; P:myoblast differentiation; P:nucleobase-containing small molecule interconversion; P:response to cadmium ion; P:response to estrogen; P:thymidine biosynthetic process; scaffold159 indexed_genome mRNA 1713087 1713985 . + . ID=transcript_14929;Q8WYH8 A8K1P3 Q53NU6 Q57Z54 Q9BS30,Inhibitor of growth protein 5,p28ING5;, PF12998;, GO:0005694;GO:0000123;GO:0070776;GO:0005654;GO:0005634;GO:0003682;GO:0046872;GO:0035064;GO:0006260;GO:0043966;GO:0044154;GO:0043967;GO:0008285;GO:0045926;GO:0043065;GO:2001235;GO:0045893;GO:0006473;GO:1901796;, C:chromosome; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:metal ion binding; F:methylated histone binding;, P:DNA replication; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H4 acetylation; P:negative regulation of cell population proliferation; P:negative regulation of growth; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of transcription, DNA-templated; P:protein acetylation; P:regulation of signal transduction by p53 class mediator; scaffold159 indexed_genome mRNA 1717614 1721127 . + . ID=transcript_14930;Q8WYH8 A8K1P3 Q53NU6 Q57Z54 Q9BS30,Inhibitor of growth protein 5,p28ING5;, PF12998;, GO:0005694;GO:0000123;GO:0070776;GO:0005654;GO:0005634;GO:0003682;GO:0046872;GO:0035064;GO:0006260;GO:0043966;GO:0044154;GO:0043967;GO:0008285;GO:0045926;GO:0043065;GO:2001235;GO:0045893;GO:0006473;GO:1901796;, C:chromosome; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:metal ion binding; F:methylated histone binding;, P:DNA replication; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H4 acetylation; P:negative regulation of cell population proliferation; P:negative regulation of growth; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of transcription, DNA-templated; P:protein acetylation; P:regulation of signal transduction by p53 class mediator; scaffold159 indexed_genome mRNA 1723217 1725431 . + . ID=transcript_14931;Q8WYH8 A8K1P3 Q53NU6 Q57Z54 Q9BS30,Inhibitor of growth protein 5,p28ING5;, PF12998;, GO:0005694;GO:0000123;GO:0070776;GO:0005654;GO:0005634;GO:0003682;GO:0046872;GO:0035064;GO:0006260;GO:0043966;GO:0044154;GO:0043967;GO:0008285;GO:0045926;GO:0043065;GO:2001235;GO:0045893;GO:0006473;GO:1901796;, C:chromosome; C:histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:metal ion binding; F:methylated histone binding;, P:DNA replication; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H4 acetylation; P:negative regulation of cell population proliferation; P:negative regulation of growth; P:positive regulation of apoptotic process; P:positive regulation of apoptotic signaling pathway; P:positive regulation of transcription, DNA-templated; P:protein acetylation; P:regulation of signal transduction by p53 class mediator; scaffold159 indexed_genome mRNA 1745166 1747650 . + . ID=transcript_14932;Q8N465 B4E3L6 E7ENP2 Q6IQ24 Q8N5Q8,D-2-hydroxyglutarate dehydrogenase, mitochondrial,, PF02913;PF01565;, GO:0005759;GO:0005739;GO:0051990;GO:0071949;GO:0006103;GO:0044267;GO:0032025;GO:0010042;GO:0010043;, C:mitochondrial matrix; C:mitochondrion;, F:(R)-2-hydroxyglutarate dehydrogenase activity; F:FAD binding;, P:2-oxoglutarate metabolic process; P:cellular protein metabolic process; P:response to cobalt ion; P:response to manganese ion; P:response to zinc ion;|Q8N465 B4E3L6 E7ENP2 Q6IQ24 Q8N5Q8,D-2-hydroxyglutarate dehydrogenase, mitochondrial,, PF02913;PF01565;, GO:0005759;GO:0005739;GO:0051990;GO:0071949;GO:0006103;GO:0044267;GO:0032025;GO:0010042;GO:0010043;, C:mitochondrial matrix; C:mitochondrion;, F:(R)-2-hydroxyglutarate dehydrogenase activity; F:FAD binding;, P:2-oxoglutarate metabolic process; P:cellular protein metabolic process; P:response to cobalt ion; P:response to manganese ion; P:response to zinc ion; scaffold160 indexed_genome mRNA 1086077 1088761 . + . ID=transcript_14933;A8MWK0,Putative fatty acid desaturase 2-like protein FADS2B,Fatty acid desaturase 2 pseudogene 1;Fatty acid desaturase 2B, pseudogene {ECO:0000312|HGNC:HGNC:43618};, PF00173;PF00487;, GO:0005789;GO:0016021;GO:0046872;GO:0016491;GO:0006636;, C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:oxidoreductase activity;, P:unsaturated fatty acid biosynthetic process; scaffold160 indexed_genome mRNA 1686654 1691876 . - . ID=transcript_14934;Q9C0C2 A7E2F8 Q6PJ35 Q6ZV74,182 kDa tankyrase-1-binding protein,, PF15327;, GO:0015629;GO:0005912;GO:0030014;GO:0005737;GO:0005829;GO:0000792;GO:0005634;GO:0005886;GO:0071532;GO:0045296;GO:0019899;GO:0044877;GO:0071479;GO:0006977;GO:0006302;GO:0000289;GO:0033138;GO:0010800;GO:0031954;GO:0007004;, C:actin cytoskeleton; C:adherens junction; C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleus; C:plasma membrane;, F:ankyrin repeat binding; F:cadherin binding; F:enzyme binding; F:protein-containing complex binding;, P:cellular response to ionizing radiation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:double-strand break repair; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein autophosphorylation; P:telomere maintenance via telomerase;|Q9C0C2 A7E2F8 Q6PJ35 Q6ZV74,182 kDa tankyrase-1-binding protein,, PF15327;, GO:0015629;GO:0005912;GO:0030014;GO:0005737;GO:0005829;GO:0000792;GO:0005634;GO:0005886;GO:0071532;GO:0045296;GO:0019899;GO:0044877;GO:0071479;GO:0006977;GO:0006302;GO:0000289;GO:0033138;GO:0010800;GO:0031954;GO:0007004;, C:actin cytoskeleton; C:adherens junction; C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleus; C:plasma membrane;, F:ankyrin repeat binding; F:cadherin binding; F:enzyme binding; F:protein-containing complex binding;, P:cellular response to ionizing radiation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:double-strand break repair; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein autophosphorylation; P:telomere maintenance via telomerase; scaffold160 indexed_genome mRNA 1695096 1698979 . + . ID=transcript_14935;Q9C0C2 A7E2F8 Q6PJ35 Q6ZV74,182 kDa tankyrase-1-binding protein,, PF15327;, GO:0015629;GO:0005912;GO:0030014;GO:0005737;GO:0005829;GO:0000792;GO:0005634;GO:0005886;GO:0071532;GO:0045296;GO:0019899;GO:0044877;GO:0071479;GO:0006977;GO:0006302;GO:0000289;GO:0033138;GO:0010800;GO:0031954;GO:0007004;, C:actin cytoskeleton; C:adherens junction; C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleus; C:plasma membrane;, F:ankyrin repeat binding; F:cadherin binding; F:enzyme binding; F:protein-containing complex binding;, P:cellular response to ionizing radiation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:double-strand break repair; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein autophosphorylation; P:telomere maintenance via telomerase;|Q9C0C2 A7E2F8 Q6PJ35 Q6ZV74,182 kDa tankyrase-1-binding protein,, PF15327;, GO:0015629;GO:0005912;GO:0030014;GO:0005737;GO:0005829;GO:0000792;GO:0005634;GO:0005886;GO:0071532;GO:0045296;GO:0019899;GO:0044877;GO:0071479;GO:0006977;GO:0006302;GO:0000289;GO:0033138;GO:0010800;GO:0031954;GO:0007004;, C:actin cytoskeleton; C:adherens junction; C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleus; C:plasma membrane;, F:ankyrin repeat binding; F:cadherin binding; F:enzyme binding; F:protein-containing complex binding;, P:cellular response to ionizing radiation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:double-strand break repair; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein autophosphorylation; P:telomere maintenance via telomerase; scaffold161 indexed_genome mRNA 338384 348481 . - . ID=transcript_14936;Q96FJ2 B2R5B4,Dynein light chain 2, cytoplasmic,8 kDa dynein light chain b;Dynein light chain LC8-type 2;, PF01221;, GO:0097731;GO:0005813;GO:0097542;GO:0005929;GO:0005868;GO:0005829;GO:0030286;GO:0098978;GO:0016020;GO:0005874;GO:0031475;GO:0005634;GO:0005886;GO:0098794;GO:0014069;GO:0045505;GO:0051959;GO:0042802;GO:0044877;GO:0097110;GO:0035973;GO:0019886;GO:0060271;GO:0006888;GO:0035735;GO:0016236;GO:0007052;GO:2000582;GO:0019058;, C:9+0 non-motile cilium; C:centrosome; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:cytosol; C:dynein complex; C:glutamatergic synapse; C:membrane; C:microtubule; C:myosin V complex; C:nucleus; C:plasma membrane; C:postsynapse; C:postsynaptic density;, F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:identical protein binding; F:protein-containing complex binding; F:scaffold protein binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intraciliary transport involved in cilium assembly; P:macroautophagy; P:mitotic spindle organization; P:positive regulation of ATP-dependent microtubule motor activity, plus-end-directed; P:viral life cycle;|Q96FJ2 B2R5B4,Dynein light chain 2, cytoplasmic,8 kDa dynein light chain b;Dynein light chain LC8-type 2;, PF01221;, GO:0097731;GO:0005813;GO:0097542;GO:0005929;GO:0005868;GO:0005829;GO:0030286;GO:0098978;GO:0016020;GO:0005874;GO:0031475;GO:0005634;GO:0005886;GO:0098794;GO:0014069;GO:0045505;GO:0051959;GO:0042802;GO:0044877;GO:0097110;GO:0035973;GO:0019886;GO:0060271;GO:0006888;GO:0035735;GO:0016236;GO:0007052;GO:2000582;GO:0019058;, C:9+0 non-motile cilium; C:centrosome; C:ciliary tip; C:cilium; C:cytoplasmic dynein complex; C:cytosol; C:dynein complex; C:glutamatergic synapse; C:membrane; C:microtubule; C:myosin V complex; C:nucleus; C:plasma membrane; C:postsynapse; C:postsynaptic density;, F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:identical protein binding; F:protein-containing complex binding; F:scaffold protein binding;, P:aggrephagy; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cilium assembly; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intraciliary transport involved in cilium assembly; P:macroautophagy; P:mitotic spindle organization; P:positive regulation of ATP-dependent microtubule motor activity, plus-end-directed; P:viral life cycle; scaffold161 indexed_genome mRNA 426111 445786 . + . ID=transcript_14937;Q07955 B2R6Z7 D3DTZ3 Q13809,Serine/arginine-rich splicing factor 1,Alternative-splicing factor 1;Splicing factor, arginine/serine-rich 1;pre-mRNA-splicing factor SF2, P33 subunit;, PF00076;, GO:0071013;GO:0005737;GO:0016607;GO:0005654;GO:0005634;GO:0044547;GO:0003729;GO:0003723;GO:0000380;GO:0031124;GO:0000395;GO:0006406;GO:0006397;GO:0006376;GO:0000398;GO:0006405;, C:catalytic step 2 spliceosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA topoisomerase binding; F:mRNA binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:mRNA 3'-end processing; P:mRNA 5'-splice site recognition; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:RNA export from nucleus; scaffold161 indexed_genome mRNA 454436 466089 . + . ID=transcript_14938;Q14119,Vascular endothelial zinc finger 1,Putative transcription factor DB1;Zinc finger protein 161;, PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000977;GO:0001525;GO:0006968;GO:0001885;GO:0045603;GO:0045944;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:cellular defense response; P:endothelial cell development; P:positive regulation of endothelial cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14119,Vascular endothelial zinc finger 1,Putative transcription factor DB1;Zinc finger protein 161;, PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000977;GO:0001525;GO:0006968;GO:0001885;GO:0045603;GO:0045944;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:cellular defense response; P:endothelial cell development; P:positive regulation of endothelial cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14119,Vascular endothelial zinc finger 1,Putative transcription factor DB1;Zinc finger protein 161;, PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000977;GO:0001525;GO:0006968;GO:0001885;GO:0045603;GO:0045944;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:cellular defense response; P:endothelial cell development; P:positive regulation of endothelial cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14119,Vascular endothelial zinc finger 1,Putative transcription factor DB1;Zinc finger protein 161;, PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000977;GO:0001525;GO:0006968;GO:0001885;GO:0045603;GO:0045944;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:cellular defense response; P:endothelial cell development; P:positive regulation of endothelial cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14119,Vascular endothelial zinc finger 1,Putative transcription factor DB1;Zinc finger protein 161;, PF00096;, GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000977;GO:0001525;GO:0006968;GO:0001885;GO:0045603;GO:0045944;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:angiogenesis; P:cellular defense response; P:endothelial cell development; P:positive regulation of endothelial cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold161 indexed_genome mRNA 571723 581471 . + . ID=transcript_14939;Q9NWM3 D3DTZ2 Q9NWD0,CUE domain-containing protein 1,, PF02845;, GO:0043130;, , F:ubiquitin binding; scaffold161 indexed_genome mRNA 596481 601251 . + . ID=transcript_14940;Q9Y3D9 B2R6V3 Q96Q24 Q9BWH8 Q9P053,28S ribosomal protein S23, mitochondrial,Mitochondrial small ribosomal subunit protein mS23;, PF10484;, GO:0005743;GO:0005739;GO:0031965;GO:0005840;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrion; C:nuclear membrane; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination;|Q9Y3D9 B2R6V3 Q96Q24 Q9BWH8 Q9P053,28S ribosomal protein S23, mitochondrial,Mitochondrial small ribosomal subunit protein mS23;, PF10484;, GO:0005743;GO:0005739;GO:0031965;GO:0005840;GO:0003723;GO:0003735;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrion; C:nuclear membrane; C:ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold161 indexed_genome mRNA 743554 771349 . - . ID=transcript_14941;Q96DH6 Q7Z6M7 Q8N9T4,RNA-binding protein Musashi homolog 2,, PF00076;, GO:0005737;GO:0005829;GO:0043231;GO:0005844;GO:0042802;GO:0003723;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:polysome;, F:identical protein binding; F:RNA binding;|Q96DH6 Q7Z6M7 Q8N9T4,RNA-binding protein Musashi homolog 2,, PF00076;, GO:0005737;GO:0005829;GO:0043231;GO:0005844;GO:0042802;GO:0003723;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:polysome;, F:identical protein binding; F:RNA binding; scaffold161 indexed_genome mRNA 1136050 1149426 . + . ID=transcript_14942;P17568 Q6ICN9 Q9UI16,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,Cell adhesion protein SQM1;Complex I-B18;NADH-ubiquinone oxidoreductase B18 subunit;, PF05676;, GO:0005743;GO:0005758;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold161 indexed_genome mRNA 1263944 1276560 . - . ID=transcript_14943;Q92667 A8K8Q1 D3DTZ0 Q13320 Q9BW14,A-kinase anchor protein 1, mitochondrial,A-kinase anchor protein 149 kDa;Dual specificity A-kinase-anchoring protein 1;Protein kinase A-anchoring protein 1;Spermatid A-kinase anchor protein 84;, PF00013;PF00567;, GO:0005829;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0034237;GO:0003723;GO:0140374;GO:0006915;GO:0007596;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein kinase A regulatory subunit binding; F:RNA binding;, P:antiviral innate immune response; P:apoptotic process; P:blood coagulation;|Q92667 A8K8Q1 D3DTZ0 Q13320 Q9BW14,A-kinase anchor protein 1, mitochondrial,A-kinase anchor protein 149 kDa;Dual specificity A-kinase-anchoring protein 1;Protein kinase A-anchoring protein 1;Spermatid A-kinase anchor protein 84;, PF00013;PF00567;, GO:0005829;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0034237;GO:0003723;GO:0140374;GO:0006915;GO:0007596;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein kinase A regulatory subunit binding; F:RNA binding;, P:antiviral innate immune response; P:apoptotic process; P:blood coagulation;|Q92667 A8K8Q1 D3DTZ0 Q13320 Q9BW14,A-kinase anchor protein 1, mitochondrial,A-kinase anchor protein 149 kDa;Dual specificity A-kinase-anchoring protein 1;Protein kinase A-anchoring protein 1;Spermatid A-kinase anchor protein 84;, PF00013;PF00567;, GO:0005829;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0034237;GO:0003723;GO:0140374;GO:0006915;GO:0007596;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein kinase A regulatory subunit binding; F:RNA binding;, P:antiviral innate immune response; P:apoptotic process; P:blood coagulation;|Q92667 A8K8Q1 D3DTZ0 Q13320 Q9BW14,A-kinase anchor protein 1, mitochondrial,A-kinase anchor protein 149 kDa;Dual specificity A-kinase-anchoring protein 1;Protein kinase A-anchoring protein 1;Spermatid A-kinase anchor protein 84;, PF00013;PF00567;, GO:0005829;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0034237;GO:0003723;GO:0140374;GO:0006915;GO:0007596;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein kinase A regulatory subunit binding; F:RNA binding;, P:antiviral innate immune response; P:apoptotic process; P:blood coagulation;|Q92667 A8K8Q1 D3DTZ0 Q13320 Q9BW14,A-kinase anchor protein 1, mitochondrial,A-kinase anchor protein 149 kDa;Dual specificity A-kinase-anchoring protein 1;Protein kinase A-anchoring protein 1;Spermatid A-kinase anchor protein 84;, PF00013;PF00567;, GO:0005829;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0034237;GO:0003723;GO:0140374;GO:0006915;GO:0007596;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein kinase A regulatory subunit binding; F:RNA binding;, P:antiviral innate immune response; P:apoptotic process; P:blood coagulation;|Q92667 A8K8Q1 D3DTZ0 Q13320 Q9BW14,A-kinase anchor protein 1, mitochondrial,A-kinase anchor protein 149 kDa;Dual specificity A-kinase-anchoring protein 1;Protein kinase A-anchoring protein 1;Spermatid A-kinase anchor protein 84;, PF00013;PF00567;, GO:0005829;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0034237;GO:0003723;GO:0140374;GO:0006915;GO:0007596;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein kinase A regulatory subunit binding; F:RNA binding;, P:antiviral innate immune response; P:apoptotic process; P:blood coagulation;|Q92667 A8K8Q1 D3DTZ0 Q13320 Q9BW14,A-kinase anchor protein 1, mitochondrial,A-kinase anchor protein 149 kDa;Dual specificity A-kinase-anchoring protein 1;Protein kinase A-anchoring protein 1;Spermatid A-kinase anchor protein 84;, PF00013;PF00567;, GO:0005829;GO:0016021;GO:0016020;GO:0005741;GO:0005739;GO:0034237;GO:0003723;GO:0140374;GO:0006915;GO:0007596;, C:cytosol; C:integral component of membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:protein kinase A regulatory subunit binding; F:RNA binding;, P:antiviral innate immune response; P:apoptotic process; P:blood coagulation; scaffold161 indexed_genome mRNA 1381728 1412952 . - . ID=transcript_14944;Q9HB40 Q96A94 Q9H3F0,Retinoid-inducible serine carboxypeptidase,Serine carboxypeptidase 1;, PF00450;, GO:0005829;GO:0070062;GO:0004185;GO:0097746;GO:0045776;GO:0042573;, C:cytosol; C:extracellular exosome;, F:serine-type carboxypeptidase activity;, P:blood vessel diameter maintenance; P:negative regulation of blood pressure; P:retinoic acid metabolic process;|Q9HB40 Q96A94 Q9H3F0,Retinoid-inducible serine carboxypeptidase,Serine carboxypeptidase 1;, PF00450;, GO:0005829;GO:0070062;GO:0004185;GO:0097746;GO:0045776;GO:0042573;, C:cytosol; C:extracellular exosome;, F:serine-type carboxypeptidase activity;, P:blood vessel diameter maintenance; P:negative regulation of blood pressure; P:retinoic acid metabolic process; scaffold161 indexed_genome mRNA 1450510 1459718 . - . ID=transcript_14945;P38432 B2R931,Coilin,p80-coilin;, PF15862;, GO:0015030;GO:0001650;GO:0016020;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0042802;GO:0008022;GO:0030619;GO:0030620;GO:0000387;, C:Cajal body; C:fibrillar center; C:membrane; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:protein C-terminus binding; F:U1 snRNA binding; F:U2 snRNA binding;, P:spliceosomal snRNP assembly;|P38432 B2R931,Coilin,p80-coilin;, PF15862;, GO:0015030;GO:0001650;GO:0016020;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0042802;GO:0008022;GO:0030619;GO:0030620;GO:0000387;, C:Cajal body; C:fibrillar center; C:membrane; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:protein C-terminus binding; F:U1 snRNA binding; F:U2 snRNA binding;, P:spliceosomal snRNP assembly;|P38432 B2R931,Coilin,p80-coilin;, PF15862;, GO:0015030;GO:0001650;GO:0016020;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0042802;GO:0008022;GO:0030619;GO:0030620;GO:0000387;, C:Cajal body; C:fibrillar center; C:membrane; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:protein C-terminus binding; F:U1 snRNA binding; F:U2 snRNA binding;, P:spliceosomal snRNP assembly;|P38432 B2R931,Coilin,p80-coilin;, PF15862;, GO:0015030;GO:0001650;GO:0016020;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0042802;GO:0008022;GO:0030619;GO:0030620;GO:0000387;, C:Cajal body; C:fibrillar center; C:membrane; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:protein C-terminus binding; F:U1 snRNA binding; F:U2 snRNA binding;, P:spliceosomal snRNP assembly; scaffold161 indexed_genome mRNA 1492829 1512272 . + . ID=transcript_14946;Q14258,E3 ubiquitin/ISG15 ligase TRIM25,Estrogen-responsive finger protein {ECO:0000303|PubMed:8248217};RING finger protein 147;RING-type E3 ubiquitin transferase;RING-type E3 ubiquitin transferase TRIM25 {ECO:0000305};Tripartite motif-containing protein 25;Ubiquitin/ISG15-conjugating enzyme TRIM25;Zinc finger protein 147;, PF13765;PF00622;, GO:0010494;GO:0005829;GO:0016604;GO:0005654;GO:0045296;GO:0016874;GO:0046872;GO:0039552;GO:0003723;GO:0003713;GO:0061630;GO:1990830;GO:0051607;GO:0045087;GO:0060333;GO:0032480;GO:0046597;GO:1902187;GO:0051091;GO:0043123;GO:0051092;GO:0006513;GO:0032880;GO:0046596;GO:1902186;GO:0043627;GO:0033280;GO:0019985;GO:0030433;GO:0006511;GO:0016032;, C:cytoplasmic stress granule; C:cytosol; C:nuclear body; C:nucleoplasm;, F:cadherin binding; F:ligase activity; F:metal ion binding; F:RIG-I binding; F:RNA binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity;, P:cellular response to leukemia inhibitory factor; P:defense response to virus; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:negative regulation of type I interferon production; P:negative regulation of viral entry into host cell; P:negative regulation of viral release from host cell; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:protein monoubiquitination; P:regulation of protein localization; P:regulation of viral entry into host cell; P:regulation of viral release from host cell; P:response to estrogen; P:response to vitamin D; P:translesion synthesis; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold161 indexed_genome mRNA 1557530 1585899 . - . ID=transcript_14947;P52429 Q8TBM4 Q9UKQ3,Diacylglycerol kinase epsilon,Diglyceride kinase epsilon;, PF00130;PF00609;PF00781;, GO:0005737;GO:0005829;GO:0098978;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0005524;GO:0004143;GO:0016301;GO:0046872;GO:0003951;GO:0046339;GO:0035556;GO:0046834;GO:0050804;GO:0006654;GO:0006661;GO:0030168;GO:0007205;, C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:diacylglycerol kinase activity; F:kinase activity; F:metal ion binding; F:NAD+ kinase activity;, P:diacylglycerol metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:modulation of chemical synaptic transmission; P:phosphatidic acid biosynthetic process; P:phosphatidylinositol biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway;|P52429 Q8TBM4 Q9UKQ3,Diacylglycerol kinase epsilon,Diglyceride kinase epsilon;, PF00130;PF00609;PF00781;, GO:0005737;GO:0005829;GO:0098978;GO:0016021;GO:0016020;GO:0005654;GO:0005886;GO:0005524;GO:0004143;GO:0016301;GO:0046872;GO:0003951;GO:0046339;GO:0035556;GO:0046834;GO:0050804;GO:0006654;GO:0006661;GO:0030168;GO:0007205;, C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:integral component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:ATP binding; F:diacylglycerol kinase activity; F:kinase activity; F:metal ion binding; F:NAD+ kinase activity;, P:diacylglycerol metabolic process; P:intracellular signal transduction; P:lipid phosphorylation; P:modulation of chemical synaptic transmission; P:phosphatidic acid biosynthetic process; P:phosphatidylinositol biosynthetic process; P:platelet activation; P:protein kinase C-activating G protein-coupled receptor signaling pathway; scaffold162 indexed_genome mRNA 126104 145751 . - . ID=transcript_14948;Q8TBG4 B7Z1Y0 E9PBY0 Q9H174,Ethanolamine-phosphate phospho-lyase,Alanine--glyoxylate aminotransferase 2-like 1;, PF00202;, GO:0005759;GO:0050459;GO:0030170;GO:0008483;GO:0006646;, C:mitochondrial matrix;, F:ethanolamine-phosphate phospho-lyase activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:phosphatidylethanolamine biosynthetic process;|Q8TBG4 B7Z1Y0 E9PBY0 Q9H174,Ethanolamine-phosphate phospho-lyase,Alanine--glyoxylate aminotransferase 2-like 1;, PF00202;, GO:0005759;GO:0050459;GO:0030170;GO:0008483;GO:0006646;, C:mitochondrial matrix;, F:ethanolamine-phosphate phospho-lyase activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:phosphatidylethanolamine biosynthetic process;|Q8TBG4 B7Z1Y0 E9PBY0 Q9H174,Ethanolamine-phosphate phospho-lyase,Alanine--glyoxylate aminotransferase 2-like 1;, PF00202;, GO:0005759;GO:0050459;GO:0030170;GO:0008483;GO:0006646;, C:mitochondrial matrix;, F:ethanolamine-phosphate phospho-lyase activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:phosphatidylethanolamine biosynthetic process;|Q8TBG4 B7Z1Y0 E9PBY0 Q9H174,Ethanolamine-phosphate phospho-lyase,Alanine--glyoxylate aminotransferase 2-like 1;, PF00202;, GO:0005759;GO:0050459;GO:0030170;GO:0008483;GO:0006646;, C:mitochondrial matrix;, F:ethanolamine-phosphate phospho-lyase activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:phosphatidylethanolamine biosynthetic process;|Q8TBG4 B7Z1Y0 E9PBY0 Q9H174,Ethanolamine-phosphate phospho-lyase,Alanine--glyoxylate aminotransferase 2-like 1;, PF00202;, GO:0005759;GO:0050459;GO:0030170;GO:0008483;GO:0006646;, C:mitochondrial matrix;, F:ethanolamine-phosphate phospho-lyase activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:phosphatidylethanolamine biosynthetic process;|Q8TBG4 B7Z1Y0 E9PBY0 Q9H174,Ethanolamine-phosphate phospho-lyase,Alanine--glyoxylate aminotransferase 2-like 1;, PF00202;, GO:0005759;GO:0050459;GO:0030170;GO:0008483;GO:0006646;, C:mitochondrial matrix;, F:ethanolamine-phosphate phospho-lyase activity; F:pyridoxal phosphate binding; F:transaminase activity;, P:phosphatidylethanolamine biosynthetic process; scaffold162 indexed_genome mRNA 786505 873371 . + . ID=transcript_14949;O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure;|O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure;|O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure;|O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure;|O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure;|O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure;|O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure;|O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure;|O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure;|O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure;|O95487 B7ZKM8 B7ZKN4 Q0VG08,Protein transport protein Sec24B {ECO:0000305},SEC24-related protein B;, PF00626;PF08033;PF04815;PF04811;PF04810;, GO:0030127;GO:0005829;GO:0070971;GO:0005789;GO:0012507;GO:0000149;GO:0008270;GO:0019886;GO:0002474;GO:0035909;GO:0060088;GO:0021747;GO:0048208;GO:0090110;GO:0060982;GO:0006888;GO:0006886;GO:0060463;GO:0001843;GO:0003151;GO:0061156;GO:1901301;GO:0090178;, C:COPII vesicle coat; C:cytosol; C:endoplasmic reticulum exit site; C:endoplasmic reticulum membrane; C:ER to Golgi transport vesicle membrane;, F:SNARE binding; F:zinc ion binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:antigen processing and presentation of peptide antigen via MHC class I; P:aorta morphogenesis; P:auditory receptor cell stereocilium organization; P:cochlear nucleus development; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:coronary artery morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:lung lobe morphogenesis; P:neural tube closure; P:outflow tract morphogenesis; P:pulmonary artery morphogenesis; P:regulation of cargo loading into COPII-coated vesicle; P:regulation of establishment of planar polarity involved in neural tube closure; scaffold162 indexed_genome mRNA 982060 984639 . + . ID=transcript_14950;Q9NWR8 A8K4Y3 Q6IAC1,Calcium uniporter regulatory subunit MCUb, mitochondrial {ECO:0000305},Coiled-coil domain-containing protein 109B {ECO:0000305};, PF04678;, GO:0034704;GO:0031305;GO:0043231;GO:0031224;GO:0005743;GO:0005739;GO:0005654;GO:1990246;GO:0019855;GO:0036444;GO:0051560;GO:0006851;, C:calcium channel complex; C:integral component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:uniplex complex;, F:calcium channel inhibitor activity;, P:calcium import into the mitochondrion; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; scaffold162 indexed_genome mRNA 987314 994119 . - . ID=transcript_14951;P55212 Q9BQE7,Caspase-6,Apoptotic protease Mch-2;, , GO:0005737;GO:0005829;GO:0005654;GO:0004197;GO:0097153;GO:0097200;GO:0008234;GO:0042802;GO:0006915;GO:0072734;GO:0030855;GO:0097194;GO:0006508;GO:0042981;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:cysteine-type peptidase activity; F:identical protein binding;, P:apoptotic process; P:cellular response to staurosporine; P:epithelial cell differentiation; P:execution phase of apoptosis; P:proteolysis; P:regulation of apoptotic process;|P55212 Q9BQE7,Caspase-6,Apoptotic protease Mch-2;, , GO:0005737;GO:0005829;GO:0005654;GO:0004197;GO:0097153;GO:0097200;GO:0008234;GO:0042802;GO:0006915;GO:0072734;GO:0030855;GO:0097194;GO:0006508;GO:0042981;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:cysteine-type peptidase activity; F:identical protein binding;, P:apoptotic process; P:cellular response to staurosporine; P:epithelial cell differentiation; P:execution phase of apoptosis; P:proteolysis; P:regulation of apoptotic process;|P55212 Q9BQE7,Caspase-6,Apoptotic protease Mch-2;, , GO:0005737;GO:0005829;GO:0005654;GO:0004197;GO:0097153;GO:0097200;GO:0008234;GO:0042802;GO:0006915;GO:0072734;GO:0030855;GO:0097194;GO:0006508;GO:0042981;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:cysteine-type peptidase activity; F:identical protein binding;, P:apoptotic process; P:cellular response to staurosporine; P:epithelial cell differentiation; P:execution phase of apoptosis; P:proteolysis; P:regulation of apoptotic process;|P55212 Q9BQE7,Caspase-6,Apoptotic protease Mch-2;, , GO:0005737;GO:0005829;GO:0005654;GO:0004197;GO:0097153;GO:0097200;GO:0008234;GO:0042802;GO:0006915;GO:0072734;GO:0030855;GO:0097194;GO:0006508;GO:0042981;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:cysteine-type peptidase activity; F:identical protein binding;, P:apoptotic process; P:cellular response to staurosporine; P:epithelial cell differentiation; P:execution phase of apoptosis; P:proteolysis; P:regulation of apoptotic process;|P55212 Q9BQE7,Caspase-6,Apoptotic protease Mch-2;, , GO:0005737;GO:0005829;GO:0005654;GO:0004197;GO:0097153;GO:0097200;GO:0008234;GO:0042802;GO:0006915;GO:0072734;GO:0030855;GO:0097194;GO:0006508;GO:0042981;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:cysteine-type endopeptidase activity; F:cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:cysteine-type peptidase activity; F:identical protein binding;, P:apoptotic process; P:cellular response to staurosporine; P:epithelial cell differentiation; P:execution phase of apoptosis; P:proteolysis; P:regulation of apoptotic process; scaffold162 indexed_genome mRNA 1015652 1026502 . - . ID=transcript_14952;Q9BZM1 Q9BZ89,Group XIIA secretory phospholipase A2,Phosphatidylcholine 2-acylhydrolase 12A;, PF06951;, GO:0005737;GO:0005576;GO:0005509;GO:0047498;GO:0004623;GO:0102567;GO:0102568;GO:0050482;GO:0016042;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036149;GO:0036150;, C:cytoplasm; C:extracellular region;, F:calcium ion binding; F:calcium-dependent phospholipase A2 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:arachidonic acid secretion; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling;|Q9BZM1 Q9BZ89,Group XIIA secretory phospholipase A2,Phosphatidylcholine 2-acylhydrolase 12A;, PF06951;, GO:0005737;GO:0005576;GO:0005509;GO:0047498;GO:0004623;GO:0102567;GO:0102568;GO:0050482;GO:0016042;GO:0006654;GO:0036151;GO:0036152;GO:0036148;GO:0036149;GO:0036150;, C:cytoplasm; C:extracellular region;, F:calcium ion binding; F:calcium-dependent phospholipase A2 activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);, P:arachidonic acid secretion; P:lipid catabolic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylglycerol acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; scaffold162 indexed_genome mRNA 1042886 1090007 . - . ID=transcript_14953;P05156 O60442,Complement factor I,C3B/C4B inactivator;, PF00057;PF00530;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0046872;GO:0005044;GO:0004252;GO:0006958;GO:0045087;GO:0030449;GO:0016032;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane;, F:metal ion binding; F:scavenger receptor activity; F:serine-type endopeptidase activity;, P:complement activation, classical pathway; P:innate immune response; P:regulation of complement activation; P:viral process;|P05156 O60442,Complement factor I,C3B/C4B inactivator;, PF00057;PF00530;PF00089;, GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0046872;GO:0005044;GO:0004252;GO:0006958;GO:0045087;GO:0030449;GO:0016032;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane;, F:metal ion binding; F:scavenger receptor activity; F:serine-type endopeptidase activity;, P:complement activation, classical pathway; P:innate immune response; P:regulation of complement activation; P:viral process; scaffold162 indexed_genome mRNA 1102817 1106057 . + . ID=transcript_14954;Q9NY12 Q5MJQ2,H/ACA ribonucleoprotein complex subunit 1,Nucleolar protein family A member 1;snoRNP protein GAR1;, PF04410;, GO:0072589;GO:0031429;GO:0090661;GO:0000781;GO:0001650;GO:0005654;GO:0005697;GO:0034513;GO:0003723;GO:0070034;GO:0031118;GO:0000454;GO:0007004;, C:box H/ACA scaRNP complex; C:box H/ACA snoRNP complex; C:box H/ACA telomerase RNP complex; C:chromosome, telomeric region; C:fibrillar center; C:nucleoplasm; C:telomerase holoenzyme complex;, F:box H/ACA snoRNA binding; F:RNA binding; F:telomerase RNA binding;, P:rRNA pseudouridine synthesis; P:snoRNA guided rRNA pseudouridine synthesis; P:telomere maintenance via telomerase;|Q9NY12 Q5MJQ2,H/ACA ribonucleoprotein complex subunit 1,Nucleolar protein family A member 1;snoRNP protein GAR1;, PF04410;, GO:0072589;GO:0031429;GO:0090661;GO:0000781;GO:0001650;GO:0005654;GO:0005697;GO:0034513;GO:0003723;GO:0070034;GO:0031118;GO:0000454;GO:0007004;, C:box H/ACA scaRNP complex; C:box H/ACA snoRNP complex; C:box H/ACA telomerase RNP complex; C:chromosome, telomeric region; C:fibrillar center; C:nucleoplasm; C:telomerase holoenzyme complex;, F:box H/ACA snoRNA binding; F:RNA binding; F:telomerase RNA binding;, P:rRNA pseudouridine synthesis; P:snoRNA guided rRNA pseudouridine synthesis; P:telomere maintenance via telomerase; scaffold162 indexed_genome mRNA 1106878 1110628 . + . ID=transcript_14955;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold162 indexed_genome mRNA 1115373 1116446 . + . ID=transcript_14956;O14718 A1A4V2 Q7RTS4,Visual pigment-like receptor peropsin,, PF00001;, GO:0005887;GO:0001750;GO:0008020;GO:0004930;GO:0071482;GO:0007186;GO:0007602;GO:0018298;GO:0007601;, C:integral component of plasma membrane; C:photoreceptor outer segment;, F:G protein-coupled photoreceptor activity; F:G protein-coupled receptor activity;, P:cellular response to light stimulus; P:G protein-coupled receptor signaling pathway; P:phototransduction; P:protein-chromophore linkage; P:visual perception; scaffold162 indexed_genome mRNA 1123456 1125609 . + . ID=transcript_14957;O14718 A1A4V2 Q7RTS4,Visual pigment-like receptor peropsin,, PF00001;, GO:0005887;GO:0001750;GO:0008020;GO:0004930;GO:0071482;GO:0007186;GO:0007602;GO:0018298;GO:0007601;, C:integral component of plasma membrane; C:photoreceptor outer segment;, F:G protein-coupled photoreceptor activity; F:G protein-coupled receptor activity;, P:cellular response to light stimulus; P:G protein-coupled receptor signaling pathway; P:phototransduction; P:protein-chromophore linkage; P:visual perception; scaffold162 indexed_genome mRNA 1126332 1129148 . + . ID=transcript_14958;O14718 A1A4V2 Q7RTS4,Visual pigment-like receptor peropsin,, PF00001;, GO:0005887;GO:0001750;GO:0008020;GO:0004930;GO:0071482;GO:0007186;GO:0007602;GO:0018298;GO:0007601;, C:integral component of plasma membrane; C:photoreceptor outer segment;, F:G protein-coupled photoreceptor activity; F:G protein-coupled receptor activity;, P:cellular response to light stimulus; P:G protein-coupled receptor signaling pathway; P:phototransduction; P:protein-chromophore linkage; P:visual perception; scaffold162 indexed_genome mRNA 1264112 1282909 . + . ID=transcript_14959;P01133 B4DRK7 E7EVD2 E9PBF0 Q52LZ6,Pro-epidermal growth factor,, PF00008;PF07645;PF00058;, GO:0030669;GO:0070062;GO:0005576;GO:0005615;GO:0016021;GO:0005765;GO:0005886;GO:0031093;GO:0005509;GO:0005154;GO:0008083;GO:0005085;GO:0030297;GO:0000187;GO:0000186;GO:0001525;GO:0048754;GO:0007173;GO:0038029;GO:0038128;GO:0070371;GO:0060749;GO:0000165;GO:0061024;GO:0090370;GO:0042059;GO:1901185;GO:0045746;GO:0051048;GO:0018108;GO:0002576;GO:0090263;GO:0030335;GO:0008284;GO:0021940;GO:0043388;GO:0045740;GO:0010595;GO:0001938;GO:0045741;GO:1905278;GO:0010628;GO:1900127;GO:0043406;GO:0043410;GO:0045840;GO:0010800;GO:0014068;GO:0042327;GO:0051897;GO:1902966;GO:0002092;GO:0045893;GO:2000060;GO:0090279;GO:2000145;GO:2000008;GO:0046425;GO:0007165;, C:clathrin-coated endocytic vesicle membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane; C:platelet alpha granule lumen;, F:calcium ion binding; F:epidermal growth factor receptor binding; F:growth factor activity; F:guanyl-nucleotide exchange factor activity; F:transmembrane receptor protein tyrosine kinase activator activity;, P:activation of MAPK activity; P:activation of MAPKK activity; P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:epidermal growth factor receptor signaling pathway; P:epidermal growth factor receptor signaling pathway via MAPK cascade; P:ERBB2 signaling pathway; P:ERK1 and ERK2 cascade; P:mammary gland alveolus development; P:MAPK cascade; P:membrane organization; P:negative regulation of cholesterol efflux; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of ERBB signaling pathway; P:negative regulation of Notch signaling pathway; P:negative regulation of secretion; P:peptidyl-tyrosine phosphorylation; P:platelet degranulation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cerebellar granule cell precursor proliferation; P:positive regulation of DNA binding; P:positive regulation of DNA replication; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of epithelial tube formation; P:positive regulation of gene expression; P:positive regulation of hyaluronan biosynthetic process; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mitotic nuclear division; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to early endosome; P:positive regulation of receptor internalization; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin-dependent protein catabolic process; P:regulation of calcium ion import; P:regulation of cell motility; P:regulation of protein localization to cell surface; P:regulation of receptor signaling pathway via JAK-STAT; P:signal transduction; scaffold162 indexed_genome mRNA 1339956 1478823 . - . ID=transcript_14960;Q9H5J4 Q4W5L0 Q8NCD1,Elongation of very long chain fatty acids protein 6 {ECO:0000255|HAMAP-Rule:MF_03206, ECO:0000305},3-keto acyl-CoA synthase ELOVL6 {ECO:0000255|HAMAP-Rule:MF_03206};ELOVL fatty acid elongase 6 {ECO:0000255|HAMAP-Rule:MF_03206};Fatty acid elongase 2;Fatty acyl-CoA elongase;Long-chain fatty-acyl elongase;Very long chain 3-ketoacyl-CoA synthase 6 {ECO:0000255|HAMAP-Rule:MF_03206};Very long chain 3-oxoacyl-CoA synthase 6 {ECO:0000255|HAMAP-Rule:MF_03206};, PF01151;, GO:0005783;GO:0005789;GO:0009923;GO:0030176;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0034625;GO:0034626;GO:0019367;GO:0042759;GO:0035338;GO:0120162;GO:0019216;GO:0030148;GO:0006636;GO:0042761;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:fatty acid elongase complex; C:integral component of endoplasmic reticulum membrane;, F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;, P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:long-chain fatty acid biosynthetic process; P:long-chain fatty-acyl-CoA biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:regulation of lipid metabolic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process; scaffold163 indexed_genome mRNA 60848 89530 . - . ID=transcript_14961;Q92599 A6NC65 A6NKP6 F6W7K9 Q8IX36 Q8IX37 Q9BVB3,Septin-8 {ECO:0000305},, PF00735;, GO:0030424;GO:0032153;GO:0015630;GO:0098793;GO:0031105;GO:0005940;GO:0030672;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:0033157;GO:0031647;GO:0035542;, C:axon; C:cell division site; C:microtubule cytoskeleton; C:presynapse; C:septin complex; C:septin ring; C:synaptic vesicle membrane;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:regulation of intracellular protein transport; P:regulation of protein stability; P:regulation of SNARE complex assembly;|Q92599 A6NC65 A6NKP6 F6W7K9 Q8IX36 Q8IX37 Q9BVB3,Septin-8 {ECO:0000305},, PF00735;, GO:0030424;GO:0032153;GO:0015630;GO:0098793;GO:0031105;GO:0005940;GO:0030672;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:0033157;GO:0031647;GO:0035542;, C:axon; C:cell division site; C:microtubule cytoskeleton; C:presynapse; C:septin complex; C:septin ring; C:synaptic vesicle membrane;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:regulation of intracellular protein transport; P:regulation of protein stability; P:regulation of SNARE complex assembly;|Q92599 A6NC65 A6NKP6 F6W7K9 Q8IX36 Q8IX37 Q9BVB3,Septin-8 {ECO:0000305},, PF00735;, GO:0030424;GO:0032153;GO:0015630;GO:0098793;GO:0031105;GO:0005940;GO:0030672;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:0033157;GO:0031647;GO:0035542;, C:axon; C:cell division site; C:microtubule cytoskeleton; C:presynapse; C:septin complex; C:septin ring; C:synaptic vesicle membrane;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:regulation of intracellular protein transport; P:regulation of protein stability; P:regulation of SNARE complex assembly;|Q92599 A6NC65 A6NKP6 F6W7K9 Q8IX36 Q8IX37 Q9BVB3,Septin-8 {ECO:0000305},, PF00735;, GO:0030424;GO:0032153;GO:0015630;GO:0098793;GO:0031105;GO:0005940;GO:0030672;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:0033157;GO:0031647;GO:0035542;, C:axon; C:cell division site; C:microtubule cytoskeleton; C:presynapse; C:septin complex; C:septin ring; C:synaptic vesicle membrane;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:regulation of intracellular protein transport; P:regulation of protein stability; P:regulation of SNARE complex assembly;|Q92599 A6NC65 A6NKP6 F6W7K9 Q8IX36 Q8IX37 Q9BVB3,Septin-8 {ECO:0000305},, PF00735;, GO:0030424;GO:0032153;GO:0015630;GO:0098793;GO:0031105;GO:0005940;GO:0030672;GO:0005525;GO:0003924;GO:0060090;GO:0034613;GO:0061640;GO:0033157;GO:0031647;GO:0035542;, C:axon; C:cell division site; C:microtubule cytoskeleton; C:presynapse; C:septin complex; C:septin ring; C:synaptic vesicle membrane;, F:GTP binding; F:GTPase activity; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:regulation of intracellular protein transport; P:regulation of protein stability; P:regulation of SNARE complex assembly;|Q6ZMN8 B2RNE2 B7ZMB7 B7ZMB8,Cyclin-I2,, PF00134;, GO:0000307;GO:0005737;GO:0005634;GO:0016538;GO:0044772;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold163 indexed_genome mRNA 89579 95371 . - . ID=transcript_14962;Q6ZMN8 B2RNE2 B7ZMB7 B7ZMB8,Cyclin-I2,, PF00134;, GO:0000307;GO:0005737;GO:0005634;GO:0016538;GO:0044772;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity;|Q6ZMN8 B2RNE2 B7ZMB7 B7ZMB8,Cyclin-I2,, PF00134;, GO:0000307;GO:0005737;GO:0005634;GO:0016538;GO:0044772;GO:0000079;, C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:mitotic cell cycle phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold163 indexed_genome mRNA 280817 284603 . + . ID=transcript_14963;Q9P0U4 B2RC03 Q8N2W4 Q96BC8 Q9P2V7,CXXC-type zinc finger protein 1,CpG-binding protein;PHD finger and CXXC domain-containing protein 1;, PF00628;PF12269;PF02008;, GO:0005829;GO:0035097;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0000987;GO:0035064;GO:0045322;GO:0008270;GO:0051568;GO:0036498;GO:0045893;GO:0006355;, C:cytosol; C:histone methyltransferase complex; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:cis-regulatory region sequence-specific DNA binding; F:methylated histone binding; F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 methylation; P:IRE1-mediated unfolded protein response; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold163 indexed_genome mRNA 452369 452918 . + . ID=transcript_14964;Q9UBK9 A0A0C4DFR8 B2R561 Q5JZG3 Q9Y6E5,Protein UXT,Androgen receptor trapped clone 27 protein {ECO:0000303|PubMed:11854421};Ubiquitously expressed transcript protein;, PF02996;, GO:0005813;GO:0000785;GO:0005737;GO:0005856;GO:0005654;GO:0005634;GO:0000922;GO:0048487;GO:0003682;GO:0008017;GO:0003712;GO:0003714;GO:0006915;GO:0007098;GO:0000226;GO:0047497;GO:0070317;GO:0000122;, C:centrosome; C:chromatin; C:cytoplasm; C:cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle pole;, F:beta-tubulin binding; F:chromatin binding; F:microtubule binding; F:transcription coregulator activity; F:transcription corepressor activity;, P:apoptotic process; P:centrosome cycle; P:microtubule cytoskeleton organization; P:mitochondrion transport along microtubule; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; scaffold163 indexed_genome mRNA 456110 458848 . - . ID=transcript_14965;Q9UBK9 A0A0C4DFR8 B2R561 Q5JZG3 Q9Y6E5,Protein UXT,Androgen receptor trapped clone 27 protein {ECO:0000303|PubMed:11854421};Ubiquitously expressed transcript protein;, PF02996;, GO:0005813;GO:0000785;GO:0005737;GO:0005856;GO:0005654;GO:0005634;GO:0000922;GO:0048487;GO:0003682;GO:0008017;GO:0003712;GO:0003714;GO:0006915;GO:0007098;GO:0000226;GO:0047497;GO:0070317;GO:0000122;, C:centrosome; C:chromatin; C:cytoplasm; C:cytoskeleton; C:nucleoplasm; C:nucleus; C:spindle pole;, F:beta-tubulin binding; F:chromatin binding; F:microtubule binding; F:transcription coregulator activity; F:transcription corepressor activity;, P:apoptotic process; P:centrosome cycle; P:microtubule cytoskeleton organization; P:mitochondrion transport along microtubule; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; scaffold163 indexed_genome mRNA 459250 474808 . + . ID=transcript_14966;P19419 B2R7H4 O75606 O95058 Q969X8 Q9UJM4,ETS domain-containing protein Elk-1,, PF00178;, GO:0043679;GO:0000785;GO:0030425;GO:0005739;GO:0043025;GO:0005654;GO:0005634;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0030374;GO:0000978;GO:0001085;GO:1990837;GO:0000976;GO:0030154;GO:0071480;GO:0071394;GO:0010467;GO:0001889;GO:0030324;GO:1901216;GO:0045944;GO:0045893;GO:0006357;GO:0071774;GO:0009416;, C:axon terminus; C:chromatin; C:dendrite; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor coactivator activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:cellular response to gamma radiation; P:cellular response to testosterone stimulus; P:gene expression; P:liver development; P:lung development; P:positive regulation of neuron death; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to fibroblast growth factor; P:response to light stimulus; scaffold163 indexed_genome mRNA 478914 479749 . + . ID=transcript_14967;P27918 O15134 O15135 O15136 O75826,Properdin,Complement factor P;, PF00090;, GO:0005788;GO:0005576;GO:0005615;GO:0035580;GO:1904724;GO:0006956;GO:0006957;GO:0042742;GO:0006955;GO:0043312;GO:0030449;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:specific granule lumen; C:tertiary granule lumen;, , P:complement activation; P:complement activation, alternative pathway; P:defense response to bacterium; P:immune response; P:neutrophil degranulation; P:regulation of complement activation; scaffold163 indexed_genome mRNA 480159 484428 . + . ID=transcript_14968;P27918 O15134 O15135 O15136 O75826,Properdin,Complement factor P;, PF00090;, GO:0005788;GO:0005576;GO:0005615;GO:0035580;GO:1904724;GO:0006956;GO:0006957;GO:0042742;GO:0006955;GO:0043312;GO:0030449;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:specific granule lumen; C:tertiary granule lumen;, , P:complement activation; P:complement activation, alternative pathway; P:defense response to bacterium; P:immune response; P:neutrophil degranulation; P:regulation of complement activation; scaffold163 indexed_genome mRNA 487844 548539 . + . ID=transcript_14969;P17600 B1AJQ1 O75825 Q5H9A9,Synapsin-1,Brain protein 4.1;Synapsin I;, PF02078;PF02750;PF10581;, GO:0098993;GO:0030424;GO:0005856;GO:0005829;GO:0030425;GO:0098850;GO:0005794;GO:0014069;GO:0048786;GO:0098685;GO:0008021;GO:0030672;GO:0000795;GO:0003779;GO:0005524;GO:0048306;GO:0042802;GO:0019901;GO:0005215;GO:0007268;GO:0048666;GO:0007269;GO:0046928;GO:0098693;GO:2000300;GO:0050808;GO:0097091;, C:anchored component of synaptic vesicle membrane; C:axon; C:cytoskeleton; C:cytosol; C:dendrite; C:extrinsic component of synaptic vesicle membrane; C:Golgi apparatus; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane; C:synaptonemal complex;, F:actin binding; F:ATP binding; F:calcium-dependent protein binding; F:identical protein binding; F:protein kinase binding; F:transporter activity;, P:chemical synaptic transmission; P:neuron development; P:neurotransmitter secretion; P:regulation of neurotransmitter secretion; P:regulation of synaptic vesicle cycle; P:regulation of synaptic vesicle exocytosis; P:synapse organization; P:synaptic vesicle clustering;|P01033 Q14252 Q9UCU1,Metalloproteinase inhibitor 1,Erythroid-potentiating activity;Fibroblast collagenase inhibitor;Tissue inhibitor of metalloproteinases 1;, PF00965;, GO:0005604;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031093;GO:0005125;GO:0008083;GO:0008191;GO:0030414;GO:0002020;GO:0008270;GO:0007568;GO:0051216;GO:0001775;GO:0044267;GO:0071492;GO:0002248;GO:0019221;GO:0022617;GO:0043066;GO:0043086;GO:0010951;GO:0051045;GO:1905049;GO:1901164;GO:0002576;GO:0008284;GO:0043687;GO:2001044;GO:0034097;GO:0009725;GO:0010033;GO:0043434;, C:basement membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:cytokine activity; F:growth factor activity; F:metalloendopeptidase inhibitor activity; F:peptidase inhibitor activity; F:protease binding; F:zinc ion binding;, P:aging; P:cartilage development; P:cell activation; P:cellular protein metabolic process; P:cellular response to UV-A; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:extracellular matrix disassembly; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of endopeptidase activity; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of metallopeptidase activity; P:negative regulation of trophoblast cell migration; P:platelet degranulation; P:positive regulation of cell population proliferation; P:post-translational protein modification; P:regulation of integrin-mediated signaling pathway; P:response to cytokine; P:response to hormone; P:response to organic substance; P:response to peptide hormone;|P01033 Q14252 Q9UCU1,Metalloproteinase inhibitor 1,Erythroid-potentiating activity;Fibroblast collagenase inhibitor;Tissue inhibitor of metalloproteinases 1;, PF00965;, GO:0005604;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031093;GO:0005125;GO:0008083;GO:0008191;GO:0030414;GO:0002020;GO:0008270;GO:0007568;GO:0051216;GO:0001775;GO:0044267;GO:0071492;GO:0002248;GO:0019221;GO:0022617;GO:0043066;GO:0043086;GO:0010951;GO:0051045;GO:1905049;GO:1901164;GO:0002576;GO:0008284;GO:0043687;GO:2001044;GO:0034097;GO:0009725;GO:0010033;GO:0043434;, C:basement membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:cytokine activity; F:growth factor activity; F:metalloendopeptidase inhibitor activity; F:peptidase inhibitor activity; F:protease binding; F:zinc ion binding;, P:aging; P:cartilage development; P:cell activation; P:cellular protein metabolic process; P:cellular response to UV-A; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:extracellular matrix disassembly; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of endopeptidase activity; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of metallopeptidase activity; P:negative regulation of trophoblast cell migration; P:platelet degranulation; P:positive regulation of cell population proliferation; P:post-translational protein modification; P:regulation of integrin-mediated signaling pathway; P:response to cytokine; P:response to hormone; P:response to organic substance; P:response to peptide hormone;|P01033 Q14252 Q9UCU1,Metalloproteinase inhibitor 1,Erythroid-potentiating activity;Fibroblast collagenase inhibitor;Tissue inhibitor of metalloproteinases 1;, PF00965;, GO:0005604;GO:0005788;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0031093;GO:0005125;GO:0008083;GO:0008191;GO:0030414;GO:0002020;GO:0008270;GO:0007568;GO:0051216;GO:0001775;GO:0044267;GO:0071492;GO:0002248;GO:0019221;GO:0022617;GO:0043066;GO:0043086;GO:0010951;GO:0051045;GO:1905049;GO:1901164;GO:0002576;GO:0008284;GO:0043687;GO:2001044;GO:0034097;GO:0009725;GO:0010033;GO:0043434;, C:basement membrane; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:cytokine activity; F:growth factor activity; F:metalloendopeptidase inhibitor activity; F:peptidase inhibitor activity; F:protease binding; F:zinc ion binding;, P:aging; P:cartilage development; P:cell activation; P:cellular protein metabolic process; P:cellular response to UV-A; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:extracellular matrix disassembly; P:negative regulation of apoptotic process; P:negative regulation of catalytic activity; P:negative regulation of endopeptidase activity; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of metallopeptidase activity; P:negative regulation of trophoblast cell migration; P:platelet degranulation; P:positive regulation of cell population proliferation; P:post-translational protein modification; P:regulation of integrin-mediated signaling pathway; P:response to cytokine; P:response to hormone; P:response to organic substance; P:response to peptide hormone;|P17600 B1AJQ1 O75825 Q5H9A9,Synapsin-1,Brain protein 4.1;Synapsin I;, PF02078;PF02750;PF10581;, GO:0098993;GO:0030424;GO:0005856;GO:0005829;GO:0030425;GO:0098850;GO:0005794;GO:0014069;GO:0048786;GO:0098685;GO:0008021;GO:0030672;GO:0000795;GO:0003779;GO:0005524;GO:0048306;GO:0042802;GO:0019901;GO:0005215;GO:0007268;GO:0048666;GO:0007269;GO:0046928;GO:0098693;GO:2000300;GO:0050808;GO:0097091;, C:anchored component of synaptic vesicle membrane; C:axon; C:cytoskeleton; C:cytosol; C:dendrite; C:extrinsic component of synaptic vesicle membrane; C:Golgi apparatus; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane; C:synaptonemal complex;, F:actin binding; F:ATP binding; F:calcium-dependent protein binding; F:identical protein binding; F:protein kinase binding; F:transporter activity;, P:chemical synaptic transmission; P:neuron development; P:neurotransmitter secretion; P:regulation of neurotransmitter secretion; P:regulation of synaptic vesicle cycle; P:regulation of synaptic vesicle exocytosis; P:synapse organization; P:synaptic vesicle clustering;|P17600 B1AJQ1 O75825 Q5H9A9,Synapsin-1,Brain protein 4.1;Synapsin I;, PF02078;PF02750;PF10581;, GO:0098993;GO:0030424;GO:0005856;GO:0005829;GO:0030425;GO:0098850;GO:0005794;GO:0014069;GO:0048786;GO:0098685;GO:0008021;GO:0030672;GO:0000795;GO:0003779;GO:0005524;GO:0048306;GO:0042802;GO:0019901;GO:0005215;GO:0007268;GO:0048666;GO:0007269;GO:0046928;GO:0098693;GO:2000300;GO:0050808;GO:0097091;, C:anchored component of synaptic vesicle membrane; C:axon; C:cytoskeleton; C:cytosol; C:dendrite; C:extrinsic component of synaptic vesicle membrane; C:Golgi apparatus; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane; C:synaptonemal complex;, F:actin binding; F:ATP binding; F:calcium-dependent protein binding; F:identical protein binding; F:protein kinase binding; F:transporter activity;, P:chemical synaptic transmission; P:neuron development; P:neurotransmitter secretion; P:regulation of neurotransmitter secretion; P:regulation of synaptic vesicle cycle; P:regulation of synaptic vesicle exocytosis; P:synapse organization; P:synaptic vesicle clustering;|P17600 B1AJQ1 O75825 Q5H9A9,Synapsin-1,Brain protein 4.1;Synapsin I;, PF02078;PF02750;PF10581;, GO:0098993;GO:0030424;GO:0005856;GO:0005829;GO:0030425;GO:0098850;GO:0005794;GO:0014069;GO:0048786;GO:0098685;GO:0008021;GO:0030672;GO:0000795;GO:0003779;GO:0005524;GO:0048306;GO:0042802;GO:0019901;GO:0005215;GO:0007268;GO:0048666;GO:0007269;GO:0046928;GO:0098693;GO:2000300;GO:0050808;GO:0097091;, C:anchored component of synaptic vesicle membrane; C:axon; C:cytoskeleton; C:cytosol; C:dendrite; C:extrinsic component of synaptic vesicle membrane; C:Golgi apparatus; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane; C:synaptonemal complex;, F:actin binding; F:ATP binding; F:calcium-dependent protein binding; F:identical protein binding; F:protein kinase binding; F:transporter activity;, P:chemical synaptic transmission; P:neuron development; P:neurotransmitter secretion; P:regulation of neurotransmitter secretion; P:regulation of synaptic vesicle cycle; P:regulation of synaptic vesicle exocytosis; P:synapse organization; P:synaptic vesicle clustering;|P17600 B1AJQ1 O75825 Q5H9A9,Synapsin-1,Brain protein 4.1;Synapsin I;, PF02078;PF02750;PF10581;, GO:0098993;GO:0030424;GO:0005856;GO:0005829;GO:0030425;GO:0098850;GO:0005794;GO:0014069;GO:0048786;GO:0098685;GO:0008021;GO:0030672;GO:0000795;GO:0003779;GO:0005524;GO:0048306;GO:0042802;GO:0019901;GO:0005215;GO:0007268;GO:0048666;GO:0007269;GO:0046928;GO:0098693;GO:2000300;GO:0050808;GO:0097091;, C:anchored component of synaptic vesicle membrane; C:axon; C:cytoskeleton; C:cytosol; C:dendrite; C:extrinsic component of synaptic vesicle membrane; C:Golgi apparatus; C:postsynaptic density; C:presynaptic active zone; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane; C:synaptonemal complex;, F:actin binding; F:ATP binding; F:calcium-dependent protein binding; F:identical protein binding; F:protein kinase binding; F:transporter activity;, P:chemical synaptic transmission; P:neuron development; P:neurotransmitter secretion; P:regulation of neurotransmitter secretion; P:regulation of synaptic vesicle cycle; P:regulation of synaptic vesicle exocytosis; P:synapse organization; P:synaptic vesicle clustering;|P10398 P07557 Q5H9B2 Q5H9B3,Serine/threonine-protein kinase A-Raf,Proto-oncogene A-Raf;Proto-oncogene A-Raf-1;Proto-oncogene Pks;, PF00130;PF07714;PF02196;, GO:0005829;GO:0005739;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006464;GO:0000165;GO:0043066;GO:0033138;GO:0032434;GO:0032006;, C:cytosol; C:mitochondrion;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular protein modification process; P:MAPK cascade; P:negative regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of TOR signaling;|P10398 P07557 Q5H9B2 Q5H9B3,Serine/threonine-protein kinase A-Raf,Proto-oncogene A-Raf;Proto-oncogene A-Raf-1;Proto-oncogene Pks;, PF00130;PF07714;PF02196;, GO:0005829;GO:0005739;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006464;GO:0000165;GO:0043066;GO:0033138;GO:0032434;GO:0032006;, C:cytosol; C:mitochondrion;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular protein modification process; P:MAPK cascade; P:negative regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of TOR signaling; scaffold163 indexed_genome mRNA 548628 552741 . - . ID=transcript_14970;P10398 P07557 Q5H9B2 Q5H9B3,Serine/threonine-protein kinase A-Raf,Proto-oncogene A-Raf;Proto-oncogene A-Raf-1;Proto-oncogene Pks;, PF00130;PF07714;PF02196;, GO:0005829;GO:0005739;GO:0005524;GO:0004709;GO:0046872;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006464;GO:0000165;GO:0043066;GO:0033138;GO:0032434;GO:0032006;, C:cytosol; C:mitochondrion;, F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cellular protein modification process; P:MAPK cascade; P:negative regulation of apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:regulation of TOR signaling; scaffold163 indexed_genome mRNA 661971 699781 . + . ID=transcript_14971;Q9UMV9 Q9UMW0 Q9UMW1,Zinc finger protein 41,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold163 indexed_genome mRNA 721023 725451 . - . ID=transcript_14972;P51786 Q96LE9,Zinc finger protein 157,Zinc finger protein HZF22;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold163 indexed_genome mRNA 818970 833812 . - . ID=transcript_14973;P51784 B2RTX1 Q8IUG6 Q9BWE1,Ubiquitin carboxyl-terminal hydrolase 11,Deubiquitinating enzyme 11;Ubiquitin thioesterase 11;Ubiquitin-specific-processing protease 11;, PF06337;PF14836;PF00443;PF14533;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0001226;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA polymerase II transcription corepressor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|P51784 B2RTX1 Q8IUG6 Q9BWE1,Ubiquitin carboxyl-terminal hydrolase 11,Deubiquitinating enzyme 11;Ubiquitin thioesterase 11;Ubiquitin-specific-processing protease 11;, PF06337;PF14836;PF00443;PF14533;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0001226;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA polymerase II transcription corepressor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|P51784 B2RTX1 Q8IUG6 Q9BWE1,Ubiquitin carboxyl-terminal hydrolase 11,Deubiquitinating enzyme 11;Ubiquitin thioesterase 11;Ubiquitin-specific-processing protease 11;, PF06337;PF14836;PF00443;PF14533;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0001226;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA polymerase II transcription corepressor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|P51784 B2RTX1 Q8IUG6 Q9BWE1,Ubiquitin carboxyl-terminal hydrolase 11,Deubiquitinating enzyme 11;Ubiquitin thioesterase 11;Ubiquitin-specific-processing protease 11;, PF06337;PF14836;PF00443;PF14533;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0001226;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA polymerase II transcription corepressor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|P51784 B2RTX1 Q8IUG6 Q9BWE1,Ubiquitin carboxyl-terminal hydrolase 11,Deubiquitinating enzyme 11;Ubiquitin thioesterase 11;Ubiquitin-specific-processing protease 11;, PF06337;PF14836;PF00443;PF14533;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0001226;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA polymerase II transcription corepressor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|P51784 B2RTX1 Q8IUG6 Q9BWE1,Ubiquitin carboxyl-terminal hydrolase 11,Deubiquitinating enzyme 11;Ubiquitin thioesterase 11;Ubiquitin-specific-processing protease 11;, PF06337;PF14836;PF00443;PF14533;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0001226;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA polymerase II transcription corepressor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|P51784 B2RTX1 Q8IUG6 Q9BWE1,Ubiquitin carboxyl-terminal hydrolase 11,Deubiquitinating enzyme 11;Ubiquitin thioesterase 11;Ubiquitin-specific-processing protease 11;, PF06337;PF14836;PF00443;PF14533;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0001226;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA polymerase II transcription corepressor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process;|P51784 B2RTX1 Q8IUG6 Q9BWE1,Ubiquitin carboxyl-terminal hydrolase 11,Deubiquitinating enzyme 11;Ubiquitin thioesterase 11;Ubiquitin-specific-processing protease 11;, PF06337;PF14836;PF00443;PF14533;, GO:0005694;GO:0005829;GO:0005654;GO:0005634;GO:0004197;GO:0001226;GO:0004843;GO:0016579;GO:0006511;GO:0016032;, C:chromosome; C:cytosol; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA polymerase II transcription corepressor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; P:viral process; scaffold163 indexed_genome mRNA 836654 847485 . - . ID=transcript_14974;Q00536 A8K280 B7Z7C8 J3KN74 J3KQP7,Cyclin-dependent kinase 16,Cell division protein kinase 16;PCTAIRE-motif protein kinase 1;Serine/threonine-protein kinase PCTAIRE-1;, PF00069;, GO:0005737;GO:0005829;GO:0031234;GO:0015630;GO:0043005;GO:0005634;GO:0005886;GO:0008021;GO:0005524;GO:0004693;GO:0106310;GO:0004674;GO:0106311;GO:0006887;GO:0030252;GO:0031175;GO:0006468;GO:0061178;GO:0000083;GO:0007283;, C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:microtubule cytoskeleton; C:neuron projection; C:nucleus; C:plasma membrane; C:synaptic vesicle;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:exocytosis; P:growth hormone secretion; P:neuron projection development; P:protein phosphorylation; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:spermatogenesis;|Q00536 A8K280 B7Z7C8 J3KN74 J3KQP7,Cyclin-dependent kinase 16,Cell division protein kinase 16;PCTAIRE-motif protein kinase 1;Serine/threonine-protein kinase PCTAIRE-1;, PF00069;, GO:0005737;GO:0005829;GO:0031234;GO:0015630;GO:0043005;GO:0005634;GO:0005886;GO:0008021;GO:0005524;GO:0004693;GO:0106310;GO:0004674;GO:0106311;GO:0006887;GO:0030252;GO:0031175;GO:0006468;GO:0061178;GO:0000083;GO:0007283;, C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:microtubule cytoskeleton; C:neuron projection; C:nucleus; C:plasma membrane; C:synaptic vesicle;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:exocytosis; P:growth hormone secretion; P:neuron projection development; P:protein phosphorylation; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:spermatogenesis;|Q00536 A8K280 B7Z7C8 J3KN74 J3KQP7,Cyclin-dependent kinase 16,Cell division protein kinase 16;PCTAIRE-motif protein kinase 1;Serine/threonine-protein kinase PCTAIRE-1;, PF00069;, GO:0005737;GO:0005829;GO:0031234;GO:0015630;GO:0043005;GO:0005634;GO:0005886;GO:0008021;GO:0005524;GO:0004693;GO:0106310;GO:0004674;GO:0106311;GO:0006887;GO:0030252;GO:0031175;GO:0006468;GO:0061178;GO:0000083;GO:0007283;, C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:microtubule cytoskeleton; C:neuron projection; C:nucleus; C:plasma membrane; C:synaptic vesicle;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:exocytosis; P:growth hormone secretion; P:neuron projection development; P:protein phosphorylation; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:spermatogenesis; scaffold163 indexed_genome mRNA 854208 874124 . - . ID=transcript_14975;P22314 Q5JRR8 Q96E13,Ubiquitin-like modifier-activating enzyme 1,Protein A1S9;Ubiquitin-activating enzyme E1;, PF16191;PF16190;PF09358;PF00899;PF10585;, GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0004839;GO:0006974;GO:0032446;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:ubiquitin activating enzyme activity;, P:cellular response to DNA damage stimulus; P:protein modification by small protein conjugation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P22314 Q5JRR8 Q96E13,Ubiquitin-like modifier-activating enzyme 1,Protein A1S9;Ubiquitin-activating enzyme E1;, PF16191;PF16190;PF09358;PF00899;PF10585;, GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0004839;GO:0006974;GO:0032446;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:ubiquitin activating enzyme activity;, P:cellular response to DNA damage stimulus; P:protein modification by small protein conjugation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P22314 Q5JRR8 Q96E13,Ubiquitin-like modifier-activating enzyme 1,Protein A1S9;Ubiquitin-activating enzyme E1;, PF16191;PF16190;PF09358;PF00899;PF10585;, GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0004839;GO:0006974;GO:0032446;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:ubiquitin activating enzyme activity;, P:cellular response to DNA damage stimulus; P:protein modification by small protein conjugation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P22314 Q5JRR8 Q96E13,Ubiquitin-like modifier-activating enzyme 1,Protein A1S9;Ubiquitin-activating enzyme E1;, PF16191;PF16190;PF09358;PF00899;PF10585;, GO:0005737;GO:0005829;GO:0070062;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003723;GO:0004839;GO:0006974;GO:0032446;GO:0016567;GO:0006511;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:RNA binding; F:ubiquitin activating enzyme activity;, P:cellular response to DNA damage stimulus; P:protein modification by small protein conjugation; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold163 indexed_genome mRNA 883550 912174 . - . ID=transcript_14976;P98175 A0A0A0MR66 C4AM81 Q14136 Q5JRR2 Q9BTE4 Q9BTX0 Q9NTB1,RNA-binding protein 10 {ECO:0000305},G patch domain-containing protein 9;RNA-binding motif protein 10;RNA-binding protein S1-1 {ECO:0000250|UniProtKB:P70501};, PF01585;PF17780;PF00076;PF00641;, GO:0016607;GO:0005634;GO:0032991;GO:0042802;GO:0046872;GO:0035198;GO:0003723;GO:0070935;GO:0000398;GO:0008285;GO:0048025;GO:0000122;GO:0034393;GO:0000381;, C:nuclear speck; C:nucleus; C:protein-containing complex;, F:identical protein binding; F:metal ion binding; F:miRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of smooth muscle cell apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome;|P98175 A0A0A0MR66 C4AM81 Q14136 Q5JRR2 Q9BTE4 Q9BTX0 Q9NTB1,RNA-binding protein 10 {ECO:0000305},G patch domain-containing protein 9;RNA-binding motif protein 10;RNA-binding protein S1-1 {ECO:0000250|UniProtKB:P70501};, PF01585;PF17780;PF00076;PF00641;, GO:0016607;GO:0005634;GO:0032991;GO:0042802;GO:0046872;GO:0035198;GO:0003723;GO:0070935;GO:0000398;GO:0008285;GO:0048025;GO:0000122;GO:0034393;GO:0000381;, C:nuclear speck; C:nucleus; C:protein-containing complex;, F:identical protein binding; F:metal ion binding; F:miRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of smooth muscle cell apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome;|P98175 A0A0A0MR66 C4AM81 Q14136 Q5JRR2 Q9BTE4 Q9BTX0 Q9NTB1,RNA-binding protein 10 {ECO:0000305},G patch domain-containing protein 9;RNA-binding motif protein 10;RNA-binding protein S1-1 {ECO:0000250|UniProtKB:P70501};, PF01585;PF17780;PF00076;PF00641;, GO:0016607;GO:0005634;GO:0032991;GO:0042802;GO:0046872;GO:0035198;GO:0003723;GO:0070935;GO:0000398;GO:0008285;GO:0048025;GO:0000122;GO:0034393;GO:0000381;, C:nuclear speck; C:nucleus; C:protein-containing complex;, F:identical protein binding; F:metal ion binding; F:miRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of smooth muscle cell apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome;|P98175 A0A0A0MR66 C4AM81 Q14136 Q5JRR2 Q9BTE4 Q9BTX0 Q9NTB1,RNA-binding protein 10 {ECO:0000305},G patch domain-containing protein 9;RNA-binding motif protein 10;RNA-binding protein S1-1 {ECO:0000250|UniProtKB:P70501};, PF01585;PF17780;PF00076;PF00641;, GO:0016607;GO:0005634;GO:0032991;GO:0042802;GO:0046872;GO:0035198;GO:0003723;GO:0070935;GO:0000398;GO:0008285;GO:0048025;GO:0000122;GO:0034393;GO:0000381;, C:nuclear speck; C:nucleus; C:protein-containing complex;, F:identical protein binding; F:metal ion binding; F:miRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of smooth muscle cell apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome;|P98175 A0A0A0MR66 C4AM81 Q14136 Q5JRR2 Q9BTE4 Q9BTX0 Q9NTB1,RNA-binding protein 10 {ECO:0000305},G patch domain-containing protein 9;RNA-binding motif protein 10;RNA-binding protein S1-1 {ECO:0000250|UniProtKB:P70501};, PF01585;PF17780;PF00076;PF00641;, GO:0016607;GO:0005634;GO:0032991;GO:0042802;GO:0046872;GO:0035198;GO:0003723;GO:0070935;GO:0000398;GO:0008285;GO:0048025;GO:0000122;GO:0034393;GO:0000381;, C:nuclear speck; C:nucleus; C:protein-containing complex;, F:identical protein binding; F:metal ion binding; F:miRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of smooth muscle cell apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome;|P98175 A0A0A0MR66 C4AM81 Q14136 Q5JRR2 Q9BTE4 Q9BTX0 Q9NTB1,RNA-binding protein 10 {ECO:0000305},G patch domain-containing protein 9;RNA-binding motif protein 10;RNA-binding protein S1-1 {ECO:0000250|UniProtKB:P70501};, PF01585;PF17780;PF00076;PF00641;, GO:0016607;GO:0005634;GO:0032991;GO:0042802;GO:0046872;GO:0035198;GO:0003723;GO:0070935;GO:0000398;GO:0008285;GO:0048025;GO:0000122;GO:0034393;GO:0000381;, C:nuclear speck; C:nucleus; C:protein-containing complex;, F:identical protein binding; F:metal ion binding; F:miRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of smooth muscle cell apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome;|P98175 A0A0A0MR66 C4AM81 Q14136 Q5JRR2 Q9BTE4 Q9BTX0 Q9NTB1,RNA-binding protein 10 {ECO:0000305},G patch domain-containing protein 9;RNA-binding motif protein 10;RNA-binding protein S1-1 {ECO:0000250|UniProtKB:P70501};, PF01585;PF17780;PF00076;PF00641;, GO:0016607;GO:0005634;GO:0032991;GO:0042802;GO:0046872;GO:0035198;GO:0003723;GO:0070935;GO:0000398;GO:0008285;GO:0048025;GO:0000122;GO:0034393;GO:0000381;, C:nuclear speck; C:nucleus; C:protein-containing complex;, F:identical protein binding; F:metal ion binding; F:miRNA binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of smooth muscle cell apoptotic process; P:regulation of alternative mRNA splicing, via spliceosome;|Q9NX14 Q5JRR3 Q5JRR4 Q6IAB6 Q8WZ96 Q9BXX9,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial,Complex I-ESSS;NADH-ubiquinone oxidoreductase ESSS subunit;Neuronal protein 17.3;, PF10183;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, , P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|Q9NX14 Q5JRR3 Q5JRR4 Q6IAB6 Q8WZ96 Q9BXX9,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial,Complex I-ESSS;NADH-ubiquinone oxidoreductase ESSS subunit;Neuronal protein 17.3;, PF10183;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, , P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|Q9NX14 Q5JRR3 Q5JRR4 Q6IAB6 Q8WZ96 Q9BXX9,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial,Complex I-ESSS;NADH-ubiquinone oxidoreductase ESSS subunit;Neuronal protein 17.3;, PF10183;, GO:0016021;GO:0005743;GO:0005747;GO:0005739;GO:0006120;GO:0032981;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, , P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold163 indexed_genome mRNA 943969 958991 . - . ID=transcript_14977;Q15493 A4FTW1 A8K271 Q53FC9 Q5JRR5,Regucalcin,Gluconolactonase;Senescence marker protein 30;, PF08450;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0030234;GO:0004341;GO:0008270;GO:0007568;GO:0006874;GO:0001822;GO:0019853;GO:0097421;GO:0043066;GO:1903011;GO:1903611;GO:0051344;GO:2000279;GO:1903625;GO:0050680;GO:1901318;GO:0034260;GO:1903634;GO:0045019;GO:0032515;GO:0006469;GO:1902679;GO:0032781;GO:1901896;GO:1903629;GO:0045723;GO:0010907;GO:0043547;GO:0010922;GO:1903052;GO:1901671;GO:0010867;GO:0050848;GO:0007283;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:enzyme regulator activity; F:gluconolactonase activity; F:zinc ion binding;, P:aging; P:cellular calcium ion homeostasis; P:kidney development; P:L-ascorbic acid biosynthetic process; P:liver regeneration; P:negative regulation of apoptotic process; P:negative regulation of bone development; P:negative regulation of calcium-dependent ATPase activity; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:negative regulation of DNA biosynthetic process; P:negative regulation of DNA catabolic process; P:negative regulation of epithelial cell proliferation; P:negative regulation of flagellated sperm motility; P:negative regulation of GTPase activity; P:negative regulation of leucine-tRNA ligase activity; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein kinase activity; P:negative regulation of RNA biosynthetic process; P:positive regulation of ATPase activity; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of dUTP diphosphatase activity; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glucose metabolic process; P:positive regulation of GTPase activity; P:positive regulation of phosphatase activity; P:positive regulation of proteolysis involved in cellular protein catabolic process; P:positive regulation of superoxide dismutase activity; P:positive regulation of triglyceride biosynthetic process; P:regulation of calcium-mediated signaling; P:spermatogenesis;|Q15493 A4FTW1 A8K271 Q53FC9 Q5JRR5,Regucalcin,Gluconolactonase;Senescence marker protein 30;, PF08450;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0030234;GO:0004341;GO:0008270;GO:0007568;GO:0006874;GO:0001822;GO:0019853;GO:0097421;GO:0043066;GO:1903011;GO:1903611;GO:0051344;GO:2000279;GO:1903625;GO:0050680;GO:1901318;GO:0034260;GO:1903634;GO:0045019;GO:0032515;GO:0006469;GO:1902679;GO:0032781;GO:1901896;GO:1903629;GO:0045723;GO:0010907;GO:0043547;GO:0010922;GO:1903052;GO:1901671;GO:0010867;GO:0050848;GO:0007283;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:enzyme regulator activity; F:gluconolactonase activity; F:zinc ion binding;, P:aging; P:cellular calcium ion homeostasis; P:kidney development; P:L-ascorbic acid biosynthetic process; P:liver regeneration; P:negative regulation of apoptotic process; P:negative regulation of bone development; P:negative regulation of calcium-dependent ATPase activity; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:negative regulation of DNA biosynthetic process; P:negative regulation of DNA catabolic process; P:negative regulation of epithelial cell proliferation; P:negative regulation of flagellated sperm motility; P:negative regulation of GTPase activity; P:negative regulation of leucine-tRNA ligase activity; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein kinase activity; P:negative regulation of RNA biosynthetic process; P:positive regulation of ATPase activity; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of dUTP diphosphatase activity; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glucose metabolic process; P:positive regulation of GTPase activity; P:positive regulation of phosphatase activity; P:positive regulation of proteolysis involved in cellular protein catabolic process; P:positive regulation of superoxide dismutase activity; P:positive regulation of triglyceride biosynthetic process; P:regulation of calcium-mediated signaling; P:spermatogenesis;|Q15493 A4FTW1 A8K271 Q53FC9 Q5JRR5,Regucalcin,Gluconolactonase;Senescence marker protein 30;, PF08450;, GO:0005737;GO:0005829;GO:0005634;GO:0005509;GO:0030234;GO:0004341;GO:0008270;GO:0007568;GO:0006874;GO:0001822;GO:0019853;GO:0097421;GO:0043066;GO:1903011;GO:1903611;GO:0051344;GO:2000279;GO:1903625;GO:0050680;GO:1901318;GO:0034260;GO:1903634;GO:0045019;GO:0032515;GO:0006469;GO:1902679;GO:0032781;GO:1901896;GO:1903629;GO:0045723;GO:0010907;GO:0043547;GO:0010922;GO:1903052;GO:1901671;GO:0010867;GO:0050848;GO:0007283;, C:cytoplasm; C:cytosol; C:nucleus;, F:calcium ion binding; F:enzyme regulator activity; F:gluconolactonase activity; F:zinc ion binding;, P:aging; P:cellular calcium ion homeostasis; P:kidney development; P:L-ascorbic acid biosynthetic process; P:liver regeneration; P:negative regulation of apoptotic process; P:negative regulation of bone development; P:negative regulation of calcium-dependent ATPase activity; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; P:negative regulation of DNA biosynthetic process; P:negative regulation of DNA catabolic process; P:negative regulation of epithelial cell proliferation; P:negative regulation of flagellated sperm motility; P:negative regulation of GTPase activity; P:negative regulation of leucine-tRNA ligase activity; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein kinase activity; P:negative regulation of RNA biosynthetic process; P:positive regulation of ATPase activity; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; P:positive regulation of dUTP diphosphatase activity; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of glucose metabolic process; P:positive regulation of GTPase activity; P:positive regulation of phosphatase activity; P:positive regulation of proteolysis involved in cellular protein catabolic process; P:positive regulation of superoxide dismutase activity; P:positive regulation of triglyceride biosynthetic process; P:regulation of calcium-mediated signaling; P:spermatogenesis; scaffold163 indexed_genome mRNA 980762 1117984 . - . ID=transcript_14978;Q92613 Q6IE79,Protein Jade-3,Jade family PHD finger protein 3;PHD finger protein 16;, PF10513;, GO:0000123;GO:0046872;GO:0043966;GO:0043983;GO:0043981;GO:0043982;, C:histone acetyltransferase complex;, F:metal ion binding;, P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; scaffold163 indexed_genome mRNA 1146850 1200893 . - . ID=transcript_14979;O75695 Q86XJ7 Q9NU67,Protein XRP2,, PF07986;, GO:0005814;GO:0036064;GO:0005929;GO:0005737;GO:0031410;GO:0070062;GO:0005794;GO:0016604;GO:0005654;GO:1990075;GO:0005886;GO:0005525;GO:0005096;GO:0000287;GO:0051082;GO:0000902;GO:0060271;GO:0006892;GO:0006457;GO:0015031;GO:0007601;, C:centriole; C:ciliary basal body; C:cilium; C:cytoplasm; C:cytoplasmic vesicle; C:extracellular exosome; C:Golgi apparatus; C:nuclear body; C:nucleoplasm; C:periciliary membrane compartment; C:plasma membrane;, F:GTP binding; F:GTPase activator activity; F:magnesium ion binding; F:unfolded protein binding;, P:cell morphogenesis; P:cilium assembly; P:post-Golgi vesicle-mediated transport; P:protein folding; P:protein transport; P:visual perception; scaffold163 indexed_genome mRNA 1325102 1488089 . + . ID=transcript_14980;Q96T83 O75827 Q5JXP9,Sodium/hydrogen exchanger 7,Na(+)/H(+) exchanger 7;Solute carrier family 9 member 7;, PF00999;, GO:0000139;GO:0016021;GO:0043231;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0015386;GO:0015385;GO:0006811;GO:0071805;GO:1905526;GO:0051453;GO:0006885;GO:0098719;, C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network;, F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;, P:ion transport; P:potassium ion transmembrane transport; P:regulation of Golgi lumen acidification; P:regulation of intracellular pH; P:regulation of pH; P:sodium ion import across plasma membrane; scaffold163 indexed_genome mRNA 1488405 1515250 . - . ID=transcript_14981;Q9NS84 O75667,Carbohydrate sulfotransferase 7,Chondroitin 6-sulfotransferase 2;Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5;N-acetylglucosamine 6-O-sulfotransferase 4;, PF00685;, GO:0000139;GO:0016021;GO:0005802;GO:0008459;GO:0001517;GO:0030206;GO:0006044;GO:0005976;GO:0006790;, C:Golgi membrane; C:integral component of membrane; C:trans-Golgi network;, F:chondroitin 6-sulfotransferase activity; F:N-acetylglucosamine 6-O-sulfotransferase activity;, P:chondroitin sulfate biosynthetic process; P:N-acetylglucosamine metabolic process; P:polysaccharide metabolic process; P:sulfur compound metabolic process; scaffold164 indexed_genome mRNA 11138 37662 . + . ID=transcript_14982;Q9BXI3 Q3SYB9 Q5TG98 Q9BWT8,Cytosolic 5'-nucleotidase 1A,Cytosolic 5'-nucleotidase IA;, PF06189;, GO:0005829;GO:0008253;GO:0000287;GO:0000166;GO:0046085;GO:0046059;GO:0009116;GO:0006195;GO:0046135;, C:cytosol;, F:5'-nucleotidase activity; F:magnesium ion binding; F:nucleotide binding;, P:adenosine metabolic process; P:dAMP catabolic process; P:nucleoside metabolic process; P:purine nucleotide catabolic process; P:pyrimidine nucleoside catabolic process; scaffold164 indexed_genome mRNA 63625 71590 . + . ID=transcript_14983;Q9NQ87 Q5TG99,Hairy/enhancer-of-split related with YRPW motif-like protein,Class B basic helix-loop-helix protein 33;Hairy-related transcription factor 3;, PF07527;PF00010;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0050683;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0042803;GO:0000978;GO:0008134;GO:0009952;GO:0003180;GO:0003181;GO:0060317;GO:0003208;GO:0071773;GO:0003203;GO:0003198;GO:0032835;GO:0014031;GO:0060766;GO:0043433;GO:0045892;GO:0061314;GO:0007219;GO:0003151;GO:0045666;GO:0045944;GO:0007221;GO:0072014;GO:0003184;GO:0050767;GO:0006357;GO:0035914;GO:0060412;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:AF-1 domain binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:aortic valve morphogenesis; P:atrioventricular valve morphogenesis; P:cardiac epithelial to mesenchymal transition; P:cardiac ventricle morphogenesis; P:cellular response to BMP stimulus; P:endocardial cushion morphogenesis; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:glomerulus development; P:mesenchymal cell development; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription, DNA-templated; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:outflow tract morphogenesis; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of Notch receptor target; P:proximal tubule development; P:pulmonary valve morphogenesis; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; P:ventricular septum morphogenesis; scaffold164 indexed_genome mRNA 108545 122291 . + . ID=transcript_14984;Q13310 B1ANQ8 Q4VC03 Q6P0N3,Polyadenylate-binding protein 4,Activated-platelet protein 1;Inducible poly(A)-binding protein;, PF00658;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0007596;GO:0061515;GO:0043488;GO:0006401;GO:0006396;GO:0006412;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:blood coagulation; P:myeloid cell development; P:regulation of mRNA stability; P:RNA catabolic process; P:RNA processing; P:translation;|Q13310 B1ANQ8 Q4VC03 Q6P0N3,Polyadenylate-binding protein 4,Activated-platelet protein 1;Inducible poly(A)-binding protein;, PF00658;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0007596;GO:0061515;GO:0043488;GO:0006401;GO:0006396;GO:0006412;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:blood coagulation; P:myeloid cell development; P:regulation of mRNA stability; P:RNA catabolic process; P:RNA processing; P:translation;|Q13310 B1ANQ8 Q4VC03 Q6P0N3,Polyadenylate-binding protein 4,Activated-platelet protein 1;Inducible poly(A)-binding protein;, PF00658;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0007596;GO:0061515;GO:0043488;GO:0006401;GO:0006396;GO:0006412;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:blood coagulation; P:myeloid cell development; P:regulation of mRNA stability; P:RNA catabolic process; P:RNA processing; P:translation;|Q13310 B1ANQ8 Q4VC03 Q6P0N3,Polyadenylate-binding protein 4,Activated-platelet protein 1;Inducible poly(A)-binding protein;, PF00658;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0007596;GO:0061515;GO:0043488;GO:0006401;GO:0006396;GO:0006412;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:blood coagulation; P:myeloid cell development; P:regulation of mRNA stability; P:RNA catabolic process; P:RNA processing; P:translation;|Q13310 B1ANQ8 Q4VC03 Q6P0N3,Polyadenylate-binding protein 4,Activated-platelet protein 1;Inducible poly(A)-binding protein;, PF00658;PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005634;GO:1990904;GO:0003730;GO:0008143;GO:0008266;GO:0003723;GO:0007596;GO:0061515;GO:0043488;GO:0006401;GO:0006396;GO:0006412;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nucleus; C:ribonucleoprotein complex;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:poly(U) RNA binding; F:RNA binding;, P:blood coagulation; P:myeloid cell development; P:regulation of mRNA stability; P:RNA catabolic process; P:RNA processing; P:translation; scaffold164 indexed_genome mRNA 197271 410709 . - . ID=transcript_14985;Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|O94854 E9PMC2 Q6ZSB2,Uncharacterized protein KIAA0754|O94854 E9PMC2 Q6ZSB2,Uncharacterized protein KIAA0754|O94854 E9PMC2 Q6ZSB2,Uncharacterized protein KIAA0754|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing;|Q9UKP0 Q9ULG9,Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5,620 kDa actin-binding protein;Actin cross-linking family protein 7 {ECO:0000303|PubMed:20937854};Macrophin-1 {ECO:0000303|PubMed:10529403};Trabeculin-alpha;, PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;, GO:0015629;GO:0005737;GO:0005856;GO:0005794;GO:0016020;GO:0005874;GO:0005886;GO:0032587;GO:0003779;GO:0051015;GO:0016887;GO:0045296;GO:0005509;GO:0051011;GO:0003723;GO:0005198;GO:0043001;GO:0045104;GO:0045773;GO:0030177;GO:0030334;GO:0010632;GO:0051893;GO:0032886;GO:0150011;GO:0016055;GO:0042060;, C:actin cytoskeleton; C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:membrane; C:microtubule; C:plasma membrane; C:ruffle membrane;, F:actin binding; F:actin filament binding; F:ATPase activity; F:cadherin binding; F:calcium ion binding; F:microtubule minus-end binding; F:RNA binding; F:structural molecule activity;, P:Golgi to plasma membrane protein transport; P:intermediate filament cytoskeleton organization; P:positive regulation of axon extension; P:positive regulation of Wnt signaling pathway; P:regulation of cell migration; P:regulation of epithelial cell migration; P:regulation of focal adhesion assembly; P:regulation of microtubule-based process; P:regulation of neuron projection arborization; P:Wnt signaling pathway; P:wound healing; scaffold164 indexed_genome mRNA 582442 588103 . - . ID=transcript_14986;O43920,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5,Complex I-15 kDa;NADH-ubiquinone oxidoreductase 15 kDa subunit;, PF10200;, GO:0005743;GO:0005758;GO:0005747;GO:0005739;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold164 indexed_genome mRNA 597622 608535 . - . ID=transcript_14987;Q9H9L7 B4DZU6 Q0VDB3 Q53FK8,Akirin-1 {ECO:0000305},, , GO:0000785;GO:0031965;GO:0005654;GO:0005634;GO:0003712;GO:0014839;GO:1902725;GO:1902723;GO:0010592;GO:0010759;GO:0045663;GO:0045944;, C:chromatin; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity;, P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of macrophage chemotaxis; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II;|Q9H9L7 B4DZU6 Q0VDB3 Q53FK8,Akirin-1 {ECO:0000305},, , GO:0000785;GO:0031965;GO:0005654;GO:0005634;GO:0003712;GO:0014839;GO:1902725;GO:1902723;GO:0010592;GO:0010759;GO:0045663;GO:0045944;, C:chromatin; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity;, P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of macrophage chemotaxis; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II;|Q9H9L7 B4DZU6 Q0VDB3 Q53FK8,Akirin-1 {ECO:0000305},, , GO:0000785;GO:0031965;GO:0005654;GO:0005634;GO:0003712;GO:0014839;GO:1902725;GO:1902723;GO:0010592;GO:0010759;GO:0045663;GO:0045944;, C:chromatin; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity;, P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of macrophage chemotaxis; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II;|Q9H9L7 B4DZU6 Q0VDB3 Q53FK8,Akirin-1 {ECO:0000305},, , GO:0000785;GO:0031965;GO:0005654;GO:0005634;GO:0003712;GO:0014839;GO:1902725;GO:1902723;GO:0010592;GO:0010759;GO:0045663;GO:0045944;, C:chromatin; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity;, P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of macrophage chemotaxis; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; scaffold164 indexed_genome mRNA 671219 700998 . + . ID=transcript_14988;Q9NX52 B2RNT3 B9EH75 Q6P175 Q8NER8 Q96E02,Rhomboid-related protein 2,Rhomboid-like protein 2;, PF01694;, GO:0016021;GO:0005886;GO:0004252;, C:integral component of membrane; C:plasma membrane;, F:serine-type endopeptidase activity; scaffold164 indexed_genome mRNA 704427 705323 . + . ID=transcript_14989;P57773 B2R722 B3KVQ2 Q5TA63 Q96KG0,Gap junction alpha-9 protein,Connexin-58;Connexin-59;Gap junction alpha-10 protein;, PF00029;, GO:0005922;GO:0016021;GO:0005243;GO:0007267;, C:connexin complex; C:integral component of membrane;, F:gap junction channel activity;, P:cell-cell signaling; scaffold164 indexed_genome mRNA 705580 706085 . + . ID=transcript_14990;P57773 B2R722 B3KVQ2 Q5TA63 Q96KG0,Gap junction alpha-9 protein,Connexin-58;Connexin-59;Gap junction alpha-10 protein;, PF00029;, GO:0005922;GO:0016021;GO:0005243;GO:0007267;, C:connexin complex; C:integral component of membrane;, F:gap junction channel activity;, P:cell-cell signaling; scaffold164 indexed_genome mRNA 707879 717153 . + . ID=transcript_14991;Q99417 B2R4N0 Q5TA64 Q96HE2,c-Myc-binding protein {ECO:0000305},Associate of Myc 1;, , GO:0005737;GO:0005739;GO:0005654;GO:0005634;GO:0003713;GO:0006355;GO:0007283;, C:cytoplasm; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:transcription coactivator activity;, P:regulation of transcription, DNA-templated; P:spermatogenesis; scaffold164 indexed_genome mRNA 732932 744684 . + . ID=transcript_14992;Q9HB90 Q9H202 Q9H8Q8,Ras-related GTP-binding protein C,GTPase-interacting protein 2;TIB929;, PF04670;, GO:0005737;GO:0005829;GO:0034448;GO:1990131;GO:0043231;GO:0005764;GO:0005654;GO:0005634;GO:0019003;GO:0005525;GO:0003924;GO:0051020;GO:0000287;GO:0046982;GO:0006915;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:0009267;GO:0032008;GO:0010506;GO:0016241;GO:0032006;GO:1903432;GO:0043200;GO:0008380;GO:0007264;GO:0006351;, C:cytoplasm; C:cytosol; C:EGO complex; C:Gtr1-Gtr2 GTPase complex; C:intracellular membrane-bounded organelle; C:lysosome; C:nucleoplasm; C:nucleus;, F:GDP binding; F:GTP binding; F:GTPase activity; F:GTPase binding; F:magnesium ion binding; F:protein heterodimerization activity;, P:apoptotic process; P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to starvation; P:positive regulation of TOR signaling; P:regulation of autophagy; P:regulation of macroautophagy; P:regulation of TOR signaling; P:regulation of TORC1 signaling; P:response to amino acid; P:RNA splicing; P:small GTPase mediated signal transduction; P:transcription, DNA-templated;|Q9HB90 Q9H202 Q9H8Q8,Ras-related GTP-binding protein C,GTPase-interacting protein 2;TIB929;, PF04670;, GO:0005737;GO:0005829;GO:0034448;GO:1990131;GO:0043231;GO:0005764;GO:0005654;GO:0005634;GO:0019003;GO:0005525;GO:0003924;GO:0051020;GO:0000287;GO:0046982;GO:0006915;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:0009267;GO:0032008;GO:0010506;GO:0016241;GO:0032006;GO:1903432;GO:0043200;GO:0008380;GO:0007264;GO:0006351;, C:cytoplasm; C:cytosol; C:EGO complex; C:Gtr1-Gtr2 GTPase complex; C:intracellular membrane-bounded organelle; C:lysosome; C:nucleoplasm; C:nucleus;, F:GDP binding; F:GTP binding; F:GTPase activity; F:GTPase binding; F:magnesium ion binding; F:protein heterodimerization activity;, P:apoptotic process; P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to starvation; P:positive regulation of TOR signaling; P:regulation of autophagy; P:regulation of macroautophagy; P:regulation of TOR signaling; P:regulation of TORC1 signaling; P:response to amino acid; P:RNA splicing; P:small GTPase mediated signal transduction; P:transcription, DNA-templated;|Q9HB90 Q9H202 Q9H8Q8,Ras-related GTP-binding protein C,GTPase-interacting protein 2;TIB929;, PF04670;, GO:0005737;GO:0005829;GO:0034448;GO:1990131;GO:0043231;GO:0005764;GO:0005654;GO:0005634;GO:0019003;GO:0005525;GO:0003924;GO:0051020;GO:0000287;GO:0046982;GO:0006915;GO:0007050;GO:0034613;GO:0034198;GO:0071230;GO:0009267;GO:0032008;GO:0010506;GO:0016241;GO:0032006;GO:1903432;GO:0043200;GO:0008380;GO:0007264;GO:0006351;, C:cytoplasm; C:cytosol; C:EGO complex; C:Gtr1-Gtr2 GTPase complex; C:intracellular membrane-bounded organelle; C:lysosome; C:nucleoplasm; C:nucleus;, F:GDP binding; F:GTP binding; F:GTPase activity; F:GTPase binding; F:magnesium ion binding; F:protein heterodimerization activity;, P:apoptotic process; P:cell cycle arrest; P:cellular protein localization; P:cellular response to amino acid starvation; P:cellular response to amino acid stimulus; P:cellular response to starvation; P:positive regulation of TOR signaling; P:regulation of autophagy; P:regulation of macroautophagy; P:regulation of TOR signaling; P:regulation of TORC1 signaling; P:response to amino acid; P:RNA splicing; P:small GTPase mediated signal transduction; P:transcription, DNA-templated; scaffold164 indexed_genome mRNA 1531208 1542874 . - . ID=transcript_14993;Q9Y3A2 A8K785 B4DJC6 D3DPT7 Q5VT93 Q9BS98 Q9NS31,Probable U3 small nucleolar RNA-associated protein 11,UTP11-like protein;, PF03998;, GO:0005737;GO:0005615;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0007399;GO:0043065;GO:0006364;, C:cytoplasm; C:extracellular space; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:nervous system development; P:positive regulation of apoptotic process; P:rRNA processing;|Q9Y3A2 A8K785 B4DJC6 D3DPT7 Q5VT93 Q9BS98 Q9NS31,Probable U3 small nucleolar RNA-associated protein 11,UTP11-like protein;, PF03998;, GO:0005737;GO:0005615;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0007399;GO:0043065;GO:0006364;, C:cytoplasm; C:extracellular space; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:nervous system development; P:positive regulation of apoptotic process; P:rRNA processing;|Q9Y3A2 A8K785 B4DJC6 D3DPT7 Q5VT93 Q9BS98 Q9NS31,Probable U3 small nucleolar RNA-associated protein 11,UTP11-like protein;, PF03998;, GO:0005737;GO:0005615;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0007399;GO:0043065;GO:0006364;, C:cytoplasm; C:extracellular space; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:nervous system development; P:positive regulation of apoptotic process; P:rRNA processing;|Q9Y3A2 A8K785 B4DJC6 D3DPT7 Q5VT93 Q9BS98 Q9NS31,Probable U3 small nucleolar RNA-associated protein 11,UTP11-like protein;, PF03998;, GO:0005737;GO:0005615;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0007399;GO:0043065;GO:0006364;, C:cytoplasm; C:extracellular space; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:nervous system development; P:positive regulation of apoptotic process; P:rRNA processing;|Q9Y3A2 A8K785 B4DJC6 D3DPT7 Q5VT93 Q9BS98 Q9NS31,Probable U3 small nucleolar RNA-associated protein 11,UTP11-like protein;, PF03998;, GO:0005737;GO:0005615;GO:0005730;GO:0005654;GO:0032040;GO:0003723;GO:0007399;GO:0043065;GO:0006364;, C:cytoplasm; C:extracellular space; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:RNA binding;, P:nervous system development; P:positive regulation of apoptotic process; P:rRNA processing; scaffold164 indexed_genome mRNA 1554014 1556698 . + . ID=transcript_14994;Q13643 D3DPT6 Q6I9T0 Q9BVA2,Four and a half LIM domains protein 3,Skeletal muscle LIM-protein 2;, PF00412;, GO:0005925;GO:0005634;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0003712;GO:0030036;GO:0007517;, C:focal adhesion; C:nucleus; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:transcription coregulator activity;, P:actin cytoskeleton organization; P:muscle organ development;|Q13643 D3DPT6 Q6I9T0 Q9BVA2,Four and a half LIM domains protein 3,Skeletal muscle LIM-protein 2;, PF00412;, GO:0005925;GO:0005634;GO:0001725;GO:0030018;GO:0003779;GO:0046872;GO:0003712;GO:0030036;GO:0007517;, C:focal adhesion; C:nucleus; C:stress fiber; C:Z disc;, F:actin binding; F:metal ion binding; F:transcription coregulator activity;, P:actin cytoskeleton organization; P:muscle organ development; scaffold164 indexed_genome mRNA 1559733 1582189 . + . ID=transcript_14995;Q12874 D3DPT5 Q15460 Q5VT87,Splicing factor 3A subunit 3,SF3a60 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847};Spliceosome-associated protein 61;, PF11931;PF16837;PF12108;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0003723;GO:0008270;GO:0000389;GO:0006397;GO:0000398;GO:0000375;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:RNA binding; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; P:U2-type prespliceosome assembly;|Q12874 D3DPT5 Q15460 Q5VT87,Splicing factor 3A subunit 3,SF3a60 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847};Spliceosome-associated protein 61;, PF11931;PF16837;PF12108;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0003723;GO:0008270;GO:0000389;GO:0006397;GO:0000398;GO:0000375;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:RNA binding; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; P:U2-type prespliceosome assembly;|Q12874 D3DPT5 Q15460 Q5VT87,Splicing factor 3A subunit 3,SF3a60 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847};Spliceosome-associated protein 61;, PF11931;PF16837;PF12108;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0003723;GO:0008270;GO:0000389;GO:0006397;GO:0000398;GO:0000375;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:RNA binding; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; P:U2-type prespliceosome assembly;|Q12874 D3DPT5 Q15460 Q5VT87,Splicing factor 3A subunit 3,SF3a60 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847};Spliceosome-associated protein 61;, PF11931;PF16837;PF12108;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0003723;GO:0008270;GO:0000389;GO:0006397;GO:0000398;GO:0000375;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome;, F:RNA binding; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; P:U2-type prespliceosome assembly; scaffold165 indexed_genome mRNA 791697 793878 . - . ID=transcript_14996;Q7Z5A7 A6NII9 B0QZ13 B0QZ14 B0QZ15 O95902 Q5H9C4 Q6UWC9 Q8IXR8,Chemokine-like protein TAFA-5 {ECO:0000305},, PF12020;, GO:0005615;GO:0005125;GO:0007186;GO:1904706;, C:extracellular space;, F:cytokine activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of vascular associated smooth muscle cell proliferation; scaffold165 indexed_genome mRNA 1449081 1458624 . - . ID=transcript_14997;O95696 A6ZJA4,Bromodomain-containing protein 1 {ECO:0000303|PubMed:16387653},BR140-like protein {ECO:0000303|PubMed:10602503};Bromodomain and PHD finger-containing protein 2 {ECO:0000303|PubMed:16387653};, PF00439;PF10513;PF00855;, GO:0005694;GO:0030425;GO:0036409;GO:0070776;GO:0016607;GO:0005634;GO:0043204;GO:0042393;GO:0046872;GO:0043249;GO:0043966;GO:0044154;GO:0043972;GO:0045648;GO:0051602;GO:0035902;, C:chromosome; C:dendrite; C:histone H3-K14 acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nuclear speck; C:nucleus; C:perikaryon;, F:histone binding; F:metal ion binding;, P:erythrocyte maturation; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:positive regulation of erythrocyte differentiation; P:response to electrical stimulus; P:response to immobilization stress;|O95696 A6ZJA4,Bromodomain-containing protein 1 {ECO:0000303|PubMed:16387653},BR140-like protein {ECO:0000303|PubMed:10602503};Bromodomain and PHD finger-containing protein 2 {ECO:0000303|PubMed:16387653};, PF00439;PF10513;PF00855;, GO:0005694;GO:0030425;GO:0036409;GO:0070776;GO:0016607;GO:0005634;GO:0043204;GO:0042393;GO:0046872;GO:0043249;GO:0043966;GO:0044154;GO:0043972;GO:0045648;GO:0051602;GO:0035902;, C:chromosome; C:dendrite; C:histone H3-K14 acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nuclear speck; C:nucleus; C:perikaryon;, F:histone binding; F:metal ion binding;, P:erythrocyte maturation; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:positive regulation of erythrocyte differentiation; P:response to electrical stimulus; P:response to immobilization stress;|O95696 A6ZJA4,Bromodomain-containing protein 1 {ECO:0000303|PubMed:16387653},BR140-like protein {ECO:0000303|PubMed:10602503};Bromodomain and PHD finger-containing protein 2 {ECO:0000303|PubMed:16387653};, PF00439;PF10513;PF00855;, GO:0005694;GO:0030425;GO:0036409;GO:0070776;GO:0016607;GO:0005634;GO:0043204;GO:0042393;GO:0046872;GO:0043249;GO:0043966;GO:0044154;GO:0043972;GO:0045648;GO:0051602;GO:0035902;, C:chromosome; C:dendrite; C:histone H3-K14 acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nuclear speck; C:nucleus; C:perikaryon;, F:histone binding; F:metal ion binding;, P:erythrocyte maturation; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:positive regulation of erythrocyte differentiation; P:response to electrical stimulus; P:response to immobilization stress;|O95696 A6ZJA4,Bromodomain-containing protein 1 {ECO:0000303|PubMed:16387653},BR140-like protein {ECO:0000303|PubMed:10602503};Bromodomain and PHD finger-containing protein 2 {ECO:0000303|PubMed:16387653};, PF00439;PF10513;PF00855;, GO:0005694;GO:0030425;GO:0036409;GO:0070776;GO:0016607;GO:0005634;GO:0043204;GO:0042393;GO:0046872;GO:0043249;GO:0043966;GO:0044154;GO:0043972;GO:0045648;GO:0051602;GO:0035902;, C:chromosome; C:dendrite; C:histone H3-K14 acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nuclear speck; C:nucleus; C:perikaryon;, F:histone binding; F:metal ion binding;, P:erythrocyte maturation; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:positive regulation of erythrocyte differentiation; P:response to electrical stimulus; P:response to immobilization stress; scaffold165 indexed_genome mRNA 1458642 1478783 . - . ID=transcript_14998;O95696 A6ZJA4,Bromodomain-containing protein 1 {ECO:0000303|PubMed:16387653},BR140-like protein {ECO:0000303|PubMed:10602503};Bromodomain and PHD finger-containing protein 2 {ECO:0000303|PubMed:16387653};, PF00439;PF10513;PF00855;, GO:0005694;GO:0030425;GO:0036409;GO:0070776;GO:0016607;GO:0005634;GO:0043204;GO:0042393;GO:0046872;GO:0043249;GO:0043966;GO:0044154;GO:0043972;GO:0045648;GO:0051602;GO:0035902;, C:chromosome; C:dendrite; C:histone H3-K14 acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:nuclear speck; C:nucleus; C:perikaryon;, F:histone binding; F:metal ion binding;, P:erythrocyte maturation; P:histone H3 acetylation; P:histone H3-K14 acetylation; P:histone H3-K23 acetylation; P:positive regulation of erythrocyte differentiation; P:response to electrical stimulus; P:response to immobilization stress; scaffold165 indexed_genome mRNA 1535255 1540894 . - . ID=transcript_14999;O75132 B2RZH1 Q1ECU0 Q9UGG8,Zinc finger BED domain-containing protein 4,, PF05699;PF02892;, GO:0000785;GO:0005737;GO:0005654;GO:0005634;GO:0001917;GO:0000981;GO:0042802;GO:0046872;GO:0046983;GO:0003723;GO:0000976;GO:0045944;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:nucleus; C:photoreceptor inner segment;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:protein dimerization activity; F:RNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; scaffold165 indexed_genome mRNA 1550229 1565337 . - . ID=transcript_15000;Q9BV10 A6PWM1 Q4KMH4 Q8NG10 Q96AA4,Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase,Asparagine-linked glycosylation protein 12 homolog;Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase;Mannosyltransferase ALG12 homolog;Membrane protein SB87;, PF03901;, GO:0005783;GO:0005788;GO:0005789;GO:0016021;GO:0016020;GO:0000009;GO:0052917;GO:0000030;GO:0006488;GO:0006457;GO:0006487;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:alpha-1,6-mannosyltransferase activity; F:dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase; F:mannosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein folding; P:protein N-linked glycosylation;|Q9BV10 A6PWM1 Q4KMH4 Q8NG10 Q96AA4,Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase,Asparagine-linked glycosylation protein 12 homolog;Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase;Mannosyltransferase ALG12 homolog;Membrane protein SB87;, PF03901;, GO:0005783;GO:0005788;GO:0005789;GO:0016021;GO:0016020;GO:0000009;GO:0052917;GO:0000030;GO:0006488;GO:0006457;GO:0006487;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:alpha-1,6-mannosyltransferase activity; F:dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase; F:mannosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein folding; P:protein N-linked glycosylation;|Q9BV10 A6PWM1 Q4KMH4 Q8NG10 Q96AA4,Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase,Asparagine-linked glycosylation protein 12 homolog;Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase;Mannosyltransferase ALG12 homolog;Membrane protein SB87;, PF03901;, GO:0005783;GO:0005788;GO:0005789;GO:0016021;GO:0016020;GO:0000009;GO:0052917;GO:0000030;GO:0006488;GO:0006457;GO:0006487;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:alpha-1,6-mannosyltransferase activity; F:dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase; F:mannosyltransferase activity;, P:dolichol-linked oligosaccharide biosynthetic process; P:protein folding; P:protein N-linked glycosylation;|Q6UXH1 A5GZA2 A5GZA3 A5GZA4 A5GZA5 A5GZA6 Q4W0V0 Q86UC0 Q9BU47,Protein disulfide isomerase CRELD2 {ECO:0000305},Cysteine-rich with EGF-like domain protein 2 {ECO:0000305};, PF07645;, GO:0005783;GO:0005615;GO:0005794;GO:0005509;GO:0003756;, C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus;, F:calcium ion binding; F:protein disulfide isomerase activity;|Q6UXH1 A5GZA2 A5GZA3 A5GZA4 A5GZA5 A5GZA6 Q4W0V0 Q86UC0 Q9BU47,Protein disulfide isomerase CRELD2 {ECO:0000305},Cysteine-rich with EGF-like domain protein 2 {ECO:0000305};, PF07645;, GO:0005783;GO:0005615;GO:0005794;GO:0005509;GO:0003756;, C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus;, F:calcium ion binding; F:protein disulfide isomerase activity;|Q6UXH1 A5GZA2 A5GZA3 A5GZA4 A5GZA5 A5GZA6 Q4W0V0 Q86UC0 Q9BU47,Protein disulfide isomerase CRELD2 {ECO:0000305},Cysteine-rich with EGF-like domain protein 2 {ECO:0000305};, PF07645;, GO:0005783;GO:0005615;GO:0005794;GO:0005509;GO:0003756;, C:endoplasmic reticulum; C:extracellular space; C:Golgi apparatus;, F:calcium ion binding; F:protein disulfide isomerase activity; scaffold166 indexed_genome mRNA 289289 290916 . - . ID=transcript_15001;Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization; scaffold166 indexed_genome mRNA 786659 860144 . + . ID=transcript_15002;Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5,Epidermal growth factor receptor {ECO:0000305},Proto-oncogene c-ErbB-1;Receptor tyrosine-protein kinase erbB-1;, PF00757;PF14843;PF07714;PF01030;, GO:0016324;GO:0009925;GO:0016323;GO:0030054;GO:0009986;GO:0030669;GO:0005737;GO:0031901;GO:0005789;GO:0005768;GO:0010008;GO:0005615;GO:0005925;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0097489;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0043235;GO:0070435;GO:0045202;GO:0051015;GO:0005524;GO:0051117;GO:0045296;GO:0005516;GO:0003682;GO:0003690;GO:0019899;GO:0048408;GO:0005006;GO:0042802;GO:0005178;GO:0019900;GO:0004709;GO:0019901;GO:0019903;GO:0004713;GO:0004714;GO:0004888;GO:0031625;GO:0001618;GO:0043006;GO:0007202;GO:0048143;GO:0030154;GO:0007166;GO:0098609;GO:0071276;GO:0071549;GO:0035690;GO:0071364;GO:0071392;GO:0071260;GO:0034614;GO:0007623;GO:0016101;GO:0007173;GO:0038128;GO:0001942;GO:0042743;GO:0007611;GO:0097421;GO:0030324;GO:0010960;GO:0000165;GO:0061024;GO:0007494;GO:0007275;GO:0043066;GO:1905208;GO:0042059;GO:1901185;GO:0045930;GO:0045746;GO:0042177;GO:0048812;GO:0001503;GO:0042698;GO:0038083;GO:0018108;GO:0045780;GO:0090263;GO:0030307;GO:0030335;GO:0008284;GO:0045737;GO:0045739;GO:0045740;GO:0050679;GO:0070374;GO:1900087;GO:0050729;GO:0033674;GO:0043406;GO:1901224;GO:0010750;GO:0033138;GO:0042327;GO:1903800;GO:1902722;GO:0051897;GO:1900020;GO:1903078;GO:0001934;GO:0048661;GO:0032930;GO:0051968;GO:0045944;GO:0045893;GO:0045907;GO:0046777;GO:0051205;GO:2000145;GO:0070372;GO:0046328;GO:0050999;GO:0050730;GO:0014066;GO:0006357;GO:0051592;GO:0033590;GO:0033594;GO:0006970;GO:0070141;GO:0007165;GO:0043586;GO:0006412;GO:0007169;GO:0046718;GO:0019058;GO:0042060;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:early endosome membrane; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular space; C:focal adhesion; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:multivesicular body, internal vesicle lumen; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:Shc-EGFR complex; C:synapse;, F:actin filament binding; F:ATP binding; F:ATPase binding; F:cadherin binding; F:calmodulin binding; F:chromatin binding; F:double-stranded DNA binding; F:enzyme binding; F:epidermal growth factor binding; F:epidermal growth factor-activated receptor activity; F:identical protein binding; F:integrin binding; F:kinase binding; F:MAP kinase kinase kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane signaling receptor activity; F:ubiquitin protein ligase binding; F:virus receptor activity;, P:activation of phospholipase A2 activity by calcium-mediated signaling; P:activation of phospholipase C activity; P:astrocyte activation; P:cell differentiation; P:cell surface receptor signaling pathway; P:cell-cell adhesion; P:cellular response to cadmium ion; P:cellular response to dexamethasone stimulus; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:circadian rhythm; P:diterpenoid metabolic process; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:hair follicle development; P:hydrogen peroxide metabolic process; P:learning or memory; P:liver regeneration; P:lung development; P:magnesium ion homeostasis; P:MAPK cascade; P:membrane organization; P:midgut development; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of cardiocyte differentiation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of ERBB signaling pathway; P:negative regulation of mitotic cell cycle; P:negative regulation of Notch signaling pathway; P:negative regulation of protein catabolic process; P:neuron projection morphogenesis; P:ossification; P:ovulation cycle; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of bone resorption; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of epithelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of inflammatory response; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric oxide mediated signal transduction; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphorylation; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of prolactin secretion; P:positive regulation of protein kinase B signaling; P:positive regulation of protein kinase C activity; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of superoxide anion generation; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vasoconstriction; P:protein autophosphorylation; P:protein insertion into membrane; P:regulation of cell motility; P:regulation of ERK1 and ERK2 cascade; P:regulation of JNK cascade; P:regulation of nitric-oxide synthase activity; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of transcription by RNA polymerase II; P:response to calcium ion; P:response to cobalamin; P:response to hydroxyisoflavone; P:response to osmotic stress; P:response to UV-A; P:signal transduction; P:tongue development; P:translation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral entry into host cell; P:viral life cycle; P:wound healing;|Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5,Epidermal growth factor receptor {ECO:0000305},Proto-oncogene c-ErbB-1;Receptor tyrosine-protein kinase erbB-1;, PF00757;PF14843;PF07714;PF01030;, GO:0016324;GO:0009925;GO:0016323;GO:0030054;GO:0009986;GO:0030669;GO:0005737;GO:0031901;GO:0005789;GO:0005768;GO:0010008;GO:0005615;GO:0005925;GO:0000139;GO:0005887;GO:0016020;GO:0045121;GO:0097489;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:0032991;GO:0043235;GO:0070435;GO:0045202;GO:0051015;GO:0005524;GO:0051117;GO:0045296;GO:0005516;GO:0003682;GO:0003690;GO:0019899;GO:0048408;GO:0005006;GO:0042802;GO:0005178;GO:0019900;GO:0004709;GO:0019901;GO:0019903;GO:0004713;GO:0004714;GO:0004888;GO:0031625;GO:0001618;GO:0043006;GO:0007202;GO:0048143;GO:0030154;GO:0007166;GO:0098609;GO:0071276;GO:0071549;GO:0035690;GO:0071364;GO:0071392;GO:0071260;GO:0034614;GO:0007623;GO:0016101;GO:0007173;GO:0038128;GO:0001942;GO:0042743;GO:0007611;GO:0097421;GO:0030324;GO:0010960;GO:0000165;GO:0061024;GO:0007494;GO:0007275;GO:0043066;GO:1905208;GO:0042059;GO:1901185;GO:0045930;GO:0045746;GO:0042177;GO:0048812;GO:0001503;GO:0042698;GO:0038083;GO:0018108;GO:0045780;GO:0090263;GO:0030307;GO:0030335;GO:0008284;GO:0045737;GO:0045739;GO:0045740;GO:0050679;GO:0070374;GO:1900087;GO:0050729;GO:0033674;GO:0043406;GO:1901224;GO:0010750;GO:0033138;GO:0042327;GO:1903800;GO:1902722;GO:0051897;GO:1900020;GO:1903078;GO:0001934;GO:0048661;GO:0032930;GO:0051968;GO:0045944;GO:0045893;GO:0045907;GO:0046777;GO:0051205;GO:2000145;GO:0070372;GO:0046328;GO:0050999;GO:0050730;GO:0014066;GO:0006357;GO:0051592;GO:0033590;GO:0033594;GO:0006970;GO:0070141;GO:0007165;GO:0043586;GO:0006412;GO:0007169;GO:0046718;GO:0019058;GO:0042060;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cell junction; C:cell surface; C:clathrin-coated endocytic vesicle membrane; C:cytoplasm; C:early endosome membrane; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:extracellular space; C:focal adhesion; C:Golgi membrane; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:multivesicular body, internal vesicle lumen; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex; C:receptor complex; C:Shc-EGFR complex; C:synapse;, F:actin filament binding; F:ATP binding; F:ATPase binding; F:cadherin binding; F:calmodulin binding; F:chromatin binding; F:double-stranded DNA binding; F:enzyme binding; F:epidermal growth factor binding; F:epidermal growth factor-activated receptor activity; F:identical protein binding; F:integrin binding; F:kinase binding; F:MAP kinase kinase kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane signaling receptor activity; F:ubiquitin protein ligase binding; F:virus receptor activity;, P:activation of phospholipase A2 activity by calcium-mediated signaling; P:activation of phospholipase C activity; P:astrocyte activation; P:cell differentiation; P:cell surface receptor signaling pathway; P:cell-cell adhesion; P:cellular response to cadmium ion; P:cellular response to dexamethasone stimulus; P:cellular response to drug; P:cellular response to epidermal growth factor stimulus; P:cellular response to estradiol stimulus; P:cellular response to mechanical stimulus; P:cellular response to reactive oxygen species; P:circadian rhythm; P:diterpenoid metabolic process; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:hair follicle development; P:hydrogen peroxide metabolic process; P:learning or memory; P:liver regeneration; P:lung development; P:magnesium ion homeostasis; P:MAPK cascade; P:membrane organization; P:midgut development; P:multicellular organism development; P:negative regulation of apoptotic process; P:negative regulation of cardiocyte differentiation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of ERBB signaling pathway; P:negative regulation of mitotic cell cycle; P:negative regulation of Notch signaling pathway; P:negative regulation of protein catabolic process; P:neuron projection morphogenesis; P:ossification; P:ovulation cycle; P:peptidyl-tyrosine autophosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of bone resorption; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of DNA repair; P:positive regulation of DNA replication; P:positive regulation of epithelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of inflammatory response; P:positive regulation of kinase activity; P:positive regulation of MAP kinase activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of nitric oxide mediated signal transduction; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phosphorylation; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of prolactin secretion; P:positive regulation of protein kinase B signaling; P:positive regulation of protein kinase C activity; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of superoxide anion generation; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vasoconstriction; P:protein autophosphorylation; P:protein insertion into membrane; P:regulation of cell motility; P:regulation of ERK1 and ERK2 cascade; P:regulation of JNK cascade; P:regulation of nitric-oxide synthase activity; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of transcription by RNA polymerase II; P:response to calcium ion; P:response to cobalamin; P:response to hydroxyisoflavone; P:response to osmotic stress; P:response to UV-A; P:signal transduction; P:tongue development; P:translation; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:viral entry into host cell; P:viral life cycle; P:wound healing; scaffold166 indexed_genome mRNA 941289 1034267 . + . ID=transcript_15003;Q9NS86 B2R8D4 Q6NSL4 Q8TCQ3 Q9BSR1,LanC-like protein 2,Testis-specific adriamycin sensitivity protein;, PF05147;, GO:0030864;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005525;GO:0032266;GO:0070273;GO:0010314;GO:0005975;GO:0045892;GO:0009789;, C:cortical actin cytoskeleton; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:GTP binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:carbohydrate metabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of abscisic acid-activated signaling pathway;|Q9NS86 B2R8D4 Q6NSL4 Q8TCQ3 Q9BSR1,LanC-like protein 2,Testis-specific adriamycin sensitivity protein;, PF05147;, GO:0030864;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005525;GO:0032266;GO:0070273;GO:0010314;GO:0005975;GO:0045892;GO:0009789;, C:cortical actin cytoskeleton; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:GTP binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:carbohydrate metabolic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of abscisic acid-activated signaling pathway; scaffold166 indexed_genome mRNA 1058749 1208645 . - . ID=transcript_15004;Q96AW1 B0AZU1 B2RAT4 B3KS72 C9JWR3 Q6FIE3 Q8NBN8 Q96RE5 Q9H0W4,Vesicular, overexpressed in cancer, prosurvival protein 1,EGFR-coamplified and overexpressed protein;Glioblastoma-amplified secreted protein;Putative NF-kappa-B-activating protein 055N;, , GO:0030659;GO:0005768;GO:0031301;, C:cytoplasmic vesicle membrane; C:endosome; C:integral component of organelle membrane; scaffold166 indexed_genome mRNA 1284114 1291518 . + . ID=transcript_15005;Q9H2P9 A8JZY6 D3DT62 Q9P017 Q9P0I4 Q9Y319,Diphthine methyl ester synthase,Diphthamide biosynthesis methyltransferase;, PF00590;, GO:0005829;GO:0004164;GO:0032259;GO:0017183;, C:cytosol;, F:diphthine synthase activity;, P:methylation; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; scaffold166 indexed_genome mRNA 1319838 1336283 . + . ID=transcript_15006;P15259,Phosphoglycerate mutase 2,BPG-dependent PGAM 2;Muscle-specific phosphoglycerate mutase;Phosphoglycerate mutase isozyme M;, PF00300;, GO:0005829;GO:0070062;GO:0005634;GO:0046538;GO:0004082;GO:0016787;GO:0042802;GO:0004619;GO:0061621;GO:0006094;GO:0006096;GO:0007219;GO:0046689;GO:0007283;GO:0006941;, C:cytosol; C:extracellular exosome; C:nucleus;, F:2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity; F:bisphosphoglycerate mutase activity; F:hydrolase activity; F:identical protein binding; F:phosphoglycerate mutase activity;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:Notch signaling pathway; P:response to mercury ion; P:spermatogenesis; P:striated muscle contraction;|Q9HBN8 Q9NR72,Drebrin-like protein,Cervical SH3P7;Cervical mucin-associated protein;Drebrin-F;HPK1-interacting protein of 55 kDa;SH3 domain-containing protein 7;, PF00241;PF14604;, GO:0005938;GO:0030665;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0005769;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0030027;GO:0043204;GO:0005886;GO:0002102;GO:0014069;GO:0045211;GO:0001726;GO:0034774;GO:0030427;GO:1904724;GO:0003779;GO:0051015;GO:0045296;GO:0008047;GO:0008022;GO:0019904;GO:0007257;GO:0002250;GO:0048812;GO:0043312;GO:0071800;GO:0045773;GO:0061003;GO:0098974;GO:0016601;GO:0006898;GO:0030833;GO:0097178;GO:0007416;, C:cell cortex; C:clathrin-coated vesicle membrane; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:early endosome; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:lamellipodium; C:perikaryon; C:plasma membrane; C:podosome; C:postsynaptic density; C:postsynaptic membrane; C:ruffle; C:secretory granule lumen; C:site of polarized growth; C:tertiary granule lumen;, F:actin binding; F:actin filament binding; F:cadherin binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein domain specific binding;, P:activation of JUN kinase activity; P:adaptive immune response; P:neuron projection morphogenesis; P:neutrophil degranulation; P:podosome assembly; P:positive regulation of axon extension; P:positive regulation of dendritic spine morphogenesis; P:postsynaptic actin cytoskeleton organization; P:Rac protein signal transduction; P:receptor-mediated endocytosis; P:regulation of actin filament polymerization; P:ruffle assembly; P:synapse assembly;|Q9HBN8 Q9NR72,Drebrin-like protein,Cervical SH3P7;Cervical mucin-associated protein;Drebrin-F;HPK1-interacting protein of 55 kDa;SH3 domain-containing protein 7;, PF00241;PF14604;, GO:0005938;GO:0030665;GO:0030864;GO:0005737;GO:0005829;GO:0030425;GO:0005769;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0030027;GO:0043204;GO:0005886;GO:0002102;GO:0014069;GO:0045211;GO:0001726;GO:0034774;GO:0030427;GO:1904724;GO:0003779;GO:0051015;GO:0045296;GO:0008047;GO:0008022;GO:0019904;GO:0007257;GO:0002250;GO:0048812;GO:0043312;GO:0071800;GO:0045773;GO:0061003;GO:0098974;GO:0016601;GO:0006898;GO:0030833;GO:0097178;GO:0007416;, C:cell cortex; C:clathrin-coated vesicle membrane; C:cortical actin cytoskeleton; C:cytoplasm; C:cytosol; C:dendrite; C:early endosome; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:lamellipodium; C:perikaryon; C:plasma membrane; C:podosome; C:postsynaptic density; C:postsynaptic membrane; C:ruffle; C:secretory granule lumen; C:site of polarized growth; C:tertiary granule lumen;, F:actin binding; F:actin filament binding; F:cadherin binding; F:enzyme activator activity; F:protein C-terminus binding; F:protein domain specific binding;, P:activation of JUN kinase activity; P:adaptive immune response; P:neuron projection morphogenesis; P:neutrophil degranulation; P:podosome assembly; P:positive regulation of axon extension; P:positive regulation of dendritic spine morphogenesis; P:postsynaptic actin cytoskeleton organization; P:Rac protein signal transduction; P:receptor-mediated endocytosis; P:regulation of actin filament polymerization; P:ruffle assembly; P:synapse assembly; scaffold166 indexed_genome mRNA 1348239 1375654 . - . ID=transcript_15007;Q9Y2X8 A4D1V0,Ubiquitin-conjugating enzyme E2 D4,E2 ubiquitin-conjugating enzyme D4;HBUCE1;Ubiquitin carrier protein D4;Ubiquitin-protein ligase D4;, PF00179;, GO:0005634;GO:0000151;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0070979;GO:0044314;GO:0035519;GO:0070936;GO:0085020;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:protein K11-linked ubiquitination; P:protein K27-linked ubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9Y2X8 A4D1V0,Ubiquitin-conjugating enzyme E2 D4,E2 ubiquitin-conjugating enzyme D4;HBUCE1;Ubiquitin carrier protein D4;Ubiquitin-protein ligase D4;, PF00179;, GO:0005634;GO:0000151;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0070979;GO:0044314;GO:0035519;GO:0070936;GO:0085020;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:protein K11-linked ubiquitination; P:protein K27-linked ubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9Y2X8 A4D1V0,Ubiquitin-conjugating enzyme E2 D4,E2 ubiquitin-conjugating enzyme D4;HBUCE1;Ubiquitin carrier protein D4;Ubiquitin-protein ligase D4;, PF00179;, GO:0005634;GO:0000151;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0070979;GO:0044314;GO:0035519;GO:0070936;GO:0085020;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:protein K11-linked ubiquitination; P:protein K27-linked ubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P61077 A6NJ93 A6NJB1 A6NM99 P47986 Q6IB88 Q6NXS4 Q8N924,Ubiquitin-conjugating enzyme E2 D3,(E3-independent) E2 ubiquitin-conjugating enzyme D3;E2 ubiquitin-conjugating enzyme D3;Ubiquitin carrier protein D3;Ubiquitin-conjugating enzyme E2(17)KB 3;Ubiquitin-conjugating enzyme E2-17 kDa 3;Ubiquitin-protein ligase D3;, PF00179;, GO:0005829;GO:0010008;GO:0070062;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0061631;GO:0061630;GO:0004842;GO:0006915;GO:0006464;GO:0071276;GO:0071288;GO:0006281;GO:0002756;GO:0030514;GO:0000122;GO:1903955;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0008104;GO:0006513;GO:0000209;GO:0016567;GO:0035666;, C:cytosol; C:endosome membrane; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cellular protein modification process; P:cellular response to cadmium ion; P:cellular response to mercury ion; P:DNA repair; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of BMP signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein targeting to mitochondrion; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein localization; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:TRIF-dependent toll-like receptor signaling pathway;|Q9Y2X8 A4D1V0,Ubiquitin-conjugating enzyme E2 D4,E2 ubiquitin-conjugating enzyme D4;HBUCE1;Ubiquitin carrier protein D4;Ubiquitin-protein ligase D4;, PF00179;, GO:0005634;GO:0000151;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0070979;GO:0044314;GO:0035519;GO:0070936;GO:0085020;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:protein K11-linked ubiquitination; P:protein K27-linked ubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q9Y2X8 A4D1V0,Ubiquitin-conjugating enzyme E2 D4,E2 ubiquitin-conjugating enzyme D4;HBUCE1;Ubiquitin carrier protein D4;Ubiquitin-protein ligase D4;, PF00179;, GO:0005634;GO:0000151;GO:0005524;GO:0061631;GO:0031625;GO:0004842;GO:0070979;GO:0044314;GO:0035519;GO:0070936;GO:0085020;GO:0070534;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:protein K11-linked ubiquitination; P:protein K27-linked ubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold166 indexed_genome mRNA 1493610 1502544 . + . ID=transcript_15008;Q8TCY9 E9PFF6 Q658M4 Q68DH6 Q6MZZ5 Q8WV98 Q9NWR7 Q9P221,Up-regulator of cell proliferation,HBV X protein up-regulated gene 4 protein;HBxAg up-regulated gene 4 protein;, , GO:0005829;GO:0005634;GO:0005525;GO:0007049;, C:cytosol; C:nucleus;, F:GTP binding;, P:cell cycle;|Q8TCY9 E9PFF6 Q658M4 Q68DH6 Q6MZZ5 Q8WV98 Q9NWR7 Q9P221,Up-regulator of cell proliferation,HBV X protein up-regulated gene 4 protein;HBxAg up-regulated gene 4 protein;, , GO:0005829;GO:0005634;GO:0005525;GO:0007049;, C:cytosol; C:nucleus;, F:GTP binding;, P:cell cycle; scaffold166 indexed_genome mRNA 1507565 1521317 . + . ID=transcript_15009;Q96EL2 A4D1U9 P82668 Q96Q23 Q9P047,28S ribosomal protein S24, mitochondrial,Mitochondrial small ribosomal subunit protein uS3m {ECO:0000303|PubMed:25838379};bMRP-47;, PF14955;, GO:0005743;GO:0005763;GO:0003723;GO:0003735;GO:0032543;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold167 indexed_genome mRNA 23869 35035 . + . ID=transcript_15010;Q12824 O75784 O95474 Q17S11 Q38GA1 Q76N08 Q9UBH2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1,BRG1-associated factor 47;Integrase interactor 1 protein;SNF5 homolog;, PF04855;, GO:0035060;GO:0000785;GO:0001650;GO:0043231;GO:0071565;GO:0071564;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003677;GO:0002039;GO:0030957;GO:0003713;GO:0003712;GO:0043044;GO:0007049;GO:0006338;GO:0015074;GO:1900110;GO:1900113;GO:0007399;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:2000617;GO:0090240;GO:0045944;GO:1901838;GO:0006357;GO:0001188;GO:0039692;, C:brahma complex; C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:DNA binding; F:p53 binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:chromatin remodeling; P:DNA integration; P:negative regulation of histone H3-K9 dimethylation; P:negative regulation of histone H3-K9 trimethylation; P:nervous system development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly; P:single stranded viral RNA replication via double stranded DNA intermediate;|Q12824 O75784 O95474 Q17S11 Q38GA1 Q76N08 Q9UBH2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1,BRG1-associated factor 47;Integrase interactor 1 protein;SNF5 homolog;, PF04855;, GO:0035060;GO:0000785;GO:0001650;GO:0043231;GO:0071565;GO:0071564;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003677;GO:0002039;GO:0030957;GO:0003713;GO:0003712;GO:0043044;GO:0007049;GO:0006338;GO:0015074;GO:1900110;GO:1900113;GO:0007399;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:2000617;GO:0090240;GO:0045944;GO:1901838;GO:0006357;GO:0001188;GO:0039692;, C:brahma complex; C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:DNA binding; F:p53 binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:chromatin remodeling; P:DNA integration; P:negative regulation of histone H3-K9 dimethylation; P:negative regulation of histone H3-K9 trimethylation; P:nervous system development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly; P:single stranded viral RNA replication via double stranded DNA intermediate;|Q12824 O75784 O95474 Q17S11 Q38GA1 Q76N08 Q9UBH2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1,BRG1-associated factor 47;Integrase interactor 1 protein;SNF5 homolog;, PF04855;, GO:0035060;GO:0000785;GO:0001650;GO:0043231;GO:0071565;GO:0071564;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003677;GO:0002039;GO:0030957;GO:0003713;GO:0003712;GO:0043044;GO:0007049;GO:0006338;GO:0015074;GO:1900110;GO:1900113;GO:0007399;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:2000617;GO:0090240;GO:0045944;GO:1901838;GO:0006357;GO:0001188;GO:0039692;, C:brahma complex; C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:DNA binding; F:p53 binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:chromatin remodeling; P:DNA integration; P:negative regulation of histone H3-K9 dimethylation; P:negative regulation of histone H3-K9 trimethylation; P:nervous system development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly; P:single stranded viral RNA replication via double stranded DNA intermediate;|Q12824 O75784 O95474 Q17S11 Q38GA1 Q76N08 Q9UBH2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1,BRG1-associated factor 47;Integrase interactor 1 protein;SNF5 homolog;, PF04855;, GO:0035060;GO:0000785;GO:0001650;GO:0043231;GO:0071565;GO:0071564;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003677;GO:0002039;GO:0030957;GO:0003713;GO:0003712;GO:0043044;GO:0007049;GO:0006338;GO:0015074;GO:1900110;GO:1900113;GO:0007399;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:2000617;GO:0090240;GO:0045944;GO:1901838;GO:0006357;GO:0001188;GO:0039692;, C:brahma complex; C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:DNA binding; F:p53 binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:chromatin remodeling; P:DNA integration; P:negative regulation of histone H3-K9 dimethylation; P:negative regulation of histone H3-K9 trimethylation; P:nervous system development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly; P:single stranded viral RNA replication via double stranded DNA intermediate;|Q12824 O75784 O95474 Q17S11 Q38GA1 Q76N08 Q9UBH2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1,BRG1-associated factor 47;Integrase interactor 1 protein;SNF5 homolog;, PF04855;, GO:0035060;GO:0000785;GO:0001650;GO:0043231;GO:0071565;GO:0071564;GO:0000228;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0003677;GO:0002039;GO:0030957;GO:0003713;GO:0003712;GO:0043044;GO:0007049;GO:0006338;GO:0015074;GO:1900110;GO:1900113;GO:0007399;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:2000617;GO:0090240;GO:0045944;GO:1901838;GO:0006357;GO:0001188;GO:0039692;, C:brahma complex; C:chromatin; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nBAF complex; C:npBAF complex; C:nuclear chromosome; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;, F:DNA binding; F:p53 binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:ATP-dependent chromatin remodeling; P:cell cycle; P:chromatin remodeling; P:DNA integration; P:negative regulation of histone H3-K9 dimethylation; P:negative regulation of histone H3-K9 trimethylation; P:nervous system development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly; P:single stranded viral RNA replication via double stranded DNA intermediate; scaffold167 indexed_genome mRNA 36228 38568 . - . ID=transcript_15011;Q96Q80 F2Z3B6 Q6ICJ6 Q6PEX0 Q6ZUB5,Derlin-3 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 3;Der1-like protein 3 {ECO:0000303|PubMed:15215855};, PF04511;, GO:0000839;GO:0030176;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:0030968;GO:1904153;GO:0018279;GO:0030433;, C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein N-linked glycosylation via asparagine; P:ubiquitin-dependent ERAD pathway;|Q96Q80 F2Z3B6 Q6ICJ6 Q6PEX0 Q6ZUB5,Derlin-3 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 3;Der1-like protein 3 {ECO:0000303|PubMed:15215855};, PF04511;, GO:0000839;GO:0030176;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:0030968;GO:1904153;GO:0018279;GO:0030433;, C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein N-linked glycosylation via asparagine; P:ubiquitin-dependent ERAD pathway;|Q96Q80 F2Z3B6 Q6ICJ6 Q6PEX0 Q6ZUB5,Derlin-3 {ECO:0000303|PubMed:15215855},Degradation in endoplasmic reticulum protein 3;Der1-like protein 3 {ECO:0000303|PubMed:15215855};, PF04511;, GO:0000839;GO:0030176;GO:0051787;GO:0044877;GO:0005047;GO:1990381;GO:0030968;GO:1904153;GO:0018279;GO:0030433;, C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane;, F:misfolded protein binding; F:protein-containing complex binding; F:signal recognition particle binding; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein N-linked glycosylation via asparagine; P:ubiquitin-dependent ERAD pathway; scaffold167 indexed_genome mRNA 53977 71578 . + . ID=transcript_15012;Q9BYW1 E9PH55 Q542Y4 Q6ICJ5 Q8WXF9 Q8WYM4,Solute carrier family 2, facilitated glucose transporter member 11 {ECO:0000305},Glucose transporter type 11 {ECO:0000303|PubMed:11741323};, PF00083;, GO:0030054;GO:0016021;GO:0005654;GO:0005886;GO:0005355;GO:1904659;GO:0008645;, C:cell junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:glucose transmembrane transporter activity;, P:glucose transmembrane transport; P:hexose transmembrane transport;|Q9BYW1 E9PH55 Q542Y4 Q6ICJ5 Q8WXF9 Q8WYM4,Solute carrier family 2, facilitated glucose transporter member 11 {ECO:0000305},Glucose transporter type 11 {ECO:0000303|PubMed:11741323};, PF00083;, GO:0030054;GO:0016021;GO:0005654;GO:0005886;GO:0005355;GO:1904659;GO:0008645;, C:cell junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:glucose transmembrane transporter activity;, P:glucose transmembrane transport; P:hexose transmembrane transport;|Q9BYW1 E9PH55 Q542Y4 Q6ICJ5 Q8WXF9 Q8WYM4,Solute carrier family 2, facilitated glucose transporter member 11 {ECO:0000305},Glucose transporter type 11 {ECO:0000303|PubMed:11741323};, PF00083;, GO:0030054;GO:0016021;GO:0005654;GO:0005886;GO:0005355;GO:1904659;GO:0008645;, C:cell junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:glucose transmembrane transporter activity;, P:glucose transmembrane transport; P:hexose transmembrane transport;|Q9BYW1 E9PH55 Q542Y4 Q6ICJ5 Q8WXF9 Q8WYM4,Solute carrier family 2, facilitated glucose transporter member 11 {ECO:0000305},Glucose transporter type 11 {ECO:0000303|PubMed:11741323};, PF00083;, GO:0030054;GO:0016021;GO:0005654;GO:0005886;GO:0005355;GO:1904659;GO:0008645;, C:cell junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:glucose transmembrane transporter activity;, P:glucose transmembrane transport; P:hexose transmembrane transport;|Q9BYW1 E9PH55 Q542Y4 Q6ICJ5 Q8WXF9 Q8WYM4,Solute carrier family 2, facilitated glucose transporter member 11 {ECO:0000305},Glucose transporter type 11 {ECO:0000303|PubMed:11741323};, PF00083;, GO:0030054;GO:0016021;GO:0005654;GO:0005886;GO:0005355;GO:1904659;GO:0008645;, C:cell junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:glucose transmembrane transporter activity;, P:glucose transmembrane transport; P:hexose transmembrane transport; scaffold167 indexed_genome mRNA 103415 104236 . - . ID=transcript_15013;P30711 O00226 Q5TZY2 Q6IC69 Q969K8 Q96IY3,Glutathione S-transferase theta-1,GST class-theta-1;Glutathione transferase T1-1;, PF00043;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0004602;GO:0004364;GO:1901687;GO:0006749;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glutathione peroxidase activity; F:glutathione transferase activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; scaffold167 indexed_genome mRNA 105405 107308 . - . ID=transcript_15014;P0CG30 O60665 P30712 Q6IPV7 Q9HD76,Glutathione S-transferase theta-2B,GST class-theta-2;Glutathione S-transferase theta-2;, PF00043;PF02798;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0004364;GO:1901687;GO:0006749;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:glutathione transferase activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process; scaffold167 indexed_genome mRNA 108377 111507 . + . ID=transcript_15015;A0A1W2PR19,Glutathione S-transferase theta-4 {ECO:0000305},GST class-theta-4;Glutathione S-transferase theta pseudogene 1 {ECO:0000312|HGNC:HGNC:26930};, PF00043;PF13417;, GO:0005737;GO:0004364;GO:0006749;, C:cytoplasm;, F:glutathione transferase activity;, P:glutathione metabolic process; scaffold167 indexed_genome mRNA 113366 131207 . - . ID=transcript_15016;P30711 O00226 Q5TZY2 Q6IC69 Q969K8 Q96IY3,Glutathione S-transferase theta-1,GST class-theta-1;Glutathione transferase T1-1;, PF00043;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0004602;GO:0004364;GO:1901687;GO:0006749;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glutathione peroxidase activity; F:glutathione transferase activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process;|P30711 O00226 Q5TZY2 Q6IC69 Q969K8 Q96IY3,Glutathione S-transferase theta-1,GST class-theta-1;Glutathione transferase T1-1;, PF00043;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0004602;GO:0004364;GO:1901687;GO:0006749;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glutathione peroxidase activity; F:glutathione transferase activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process;|P30711 O00226 Q5TZY2 Q6IC69 Q969K8 Q96IY3,Glutathione S-transferase theta-1,GST class-theta-1;Glutathione transferase T1-1;, PF00043;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0004602;GO:0004364;GO:1901687;GO:0006749;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glutathione peroxidase activity; F:glutathione transferase activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process;|P30711 O00226 Q5TZY2 Q6IC69 Q969K8 Q96IY3,Glutathione S-transferase theta-1,GST class-theta-1;Glutathione transferase T1-1;, PF00043;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0004602;GO:0004364;GO:1901687;GO:0006749;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glutathione peroxidase activity; F:glutathione transferase activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process;|P30711 O00226 Q5TZY2 Q6IC69 Q969K8 Q96IY3,Glutathione S-transferase theta-1,GST class-theta-1;Glutathione transferase T1-1;, PF00043;PF13417;, GO:0005737;GO:0005829;GO:0070062;GO:0004602;GO:0004364;GO:1901687;GO:0006749;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glutathione peroxidase activity; F:glutathione transferase activity;, P:glutathione derivative biosynthetic process; P:glutathione metabolic process;|A6NHG4 B4DJJ7,D-dopachrome decarboxylase-like protein,D-dopachrome tautomerase-like protein;, PF01187;, GO:0005737;GO:0070062;GO:0016829;, C:cytoplasm; C:extracellular exosome;, F:lyase activity;|P30046 B7Z522 O00774 O60787 Q13534,D-dopachrome decarboxylase,D-dopachrome tautomerase;Phenylpyruvate tautomerase II;, PF01187;, GO:0005737;GO:0070062;GO:0005615;GO:0005126;GO:0033981;GO:0004167;GO:0050178;GO:0042438;GO:0010760;GO:0070374;GO:0050729;GO:0032760;, C:cytoplasm; C:extracellular exosome; C:extracellular space;, F:cytokine receptor binding; F:D-dopachrome decarboxylase activity; F:dopachrome isomerase activity; F:phenylpyruvate tautomerase activity;, P:melanin biosynthetic process; P:negative regulation of macrophage chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of inflammatory response; P:positive regulation of tumor necrosis factor production; scaffold167 indexed_genome mRNA 138664 204329 . + . ID=transcript_15017;Q9Y6J0 G5E9F3 Q6PHY0 Q9Y460,Calcineurin-binding protein cabin-1,Calcineurin inhibitor;, PF09047;, GO:0016235;GO:0005829;GO:0005654;GO:0005634;GO:0004864;GO:0007166;GO:0006336;, C:aggresome; C:cytosol; C:nucleoplasm; C:nucleus;, F:protein phosphatase inhibitor activity;, P:cell surface receptor signaling pathway; P:DNA replication-independent nucleosome assembly;|Q9Y6J0 G5E9F3 Q6PHY0 Q9Y460,Calcineurin-binding protein cabin-1,Calcineurin inhibitor;, PF09047;, GO:0016235;GO:0005829;GO:0005654;GO:0005634;GO:0004864;GO:0007166;GO:0006336;, C:aggresome; C:cytosol; C:nucleoplasm; C:nucleus;, F:protein phosphatase inhibitor activity;, P:cell surface receptor signaling pathway; P:DNA replication-independent nucleosome assembly;|Q9Y6J0 G5E9F3 Q6PHY0 Q9Y460,Calcineurin-binding protein cabin-1,Calcineurin inhibitor;, PF09047;, GO:0016235;GO:0005829;GO:0005654;GO:0005634;GO:0004864;GO:0007166;GO:0006336;, C:aggresome; C:cytosol; C:nucleoplasm; C:nucleus;, F:protein phosphatase inhibitor activity;, P:cell surface receptor signaling pathway; P:DNA replication-independent nucleosome assembly;|Q9Y6J0 G5E9F3 Q6PHY0 Q9Y460,Calcineurin-binding protein cabin-1,Calcineurin inhibitor;, PF09047;, GO:0016235;GO:0005829;GO:0005654;GO:0005634;GO:0004864;GO:0007166;GO:0006336;, C:aggresome; C:cytosol; C:nucleoplasm; C:nucleus;, F:protein phosphatase inhibitor activity;, P:cell surface receptor signaling pathway; P:DNA replication-independent nucleosome assembly;|Q9Y6J0 G5E9F3 Q6PHY0 Q9Y460,Calcineurin-binding protein cabin-1,Calcineurin inhibitor;, PF09047;, GO:0016235;GO:0005829;GO:0005654;GO:0005634;GO:0004864;GO:0007166;GO:0006336;, C:aggresome; C:cytosol; C:nucleoplasm; C:nucleus;, F:protein phosphatase inhibitor activity;, P:cell surface receptor signaling pathway; P:DNA replication-independent nucleosome assembly;|Q9Y6J0 G5E9F3 Q6PHY0 Q9Y460,Calcineurin-binding protein cabin-1,Calcineurin inhibitor;, PF09047;, GO:0016235;GO:0005829;GO:0005654;GO:0005634;GO:0004864;GO:0007166;GO:0006336;, C:aggresome; C:cytosol; C:nucleoplasm; C:nucleus;, F:protein phosphatase inhibitor activity;, P:cell surface receptor signaling pathway; P:DNA replication-independent nucleosome assembly; scaffold167 indexed_genome mRNA 217918 220648 . + . ID=transcript_15018;Q96NT3 B5MCB8 B5MCL7 Q96Q79 Q9BU32,Protein GUCD1,Guanylyl cyclase domain-containing protein 1;Protein LLN4;, PF09778; scaffold167 indexed_genome mRNA 221372 252451 . - . ID=transcript_15019;Q9UBR1 A3KMF8 Q9UIR3,Beta-ureidopropionase,BUP-1 {ECO:0000303|PubMed:10542323};Beta-alanine synthase;N-carbamoyl-beta-alanine amidohydrolase;, PF00795;, GO:0005829;GO:0070062;GO:0003837;GO:0016811;GO:0042803;GO:0033396;GO:0046079;GO:0051260;GO:0051289;GO:0046135;GO:0046050;, C:cytosol; C:extracellular exosome;, F:beta-ureidopropionase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:protein homodimerization activity;, P:beta-alanine biosynthetic process via 3-ureidopropionate; P:dUMP catabolic process; P:protein homooligomerization; P:protein homotetramerization; P:pyrimidine nucleoside catabolic process; P:UMP catabolic process;|Q9UBR1 A3KMF8 Q9UIR3,Beta-ureidopropionase,BUP-1 {ECO:0000303|PubMed:10542323};Beta-alanine synthase;N-carbamoyl-beta-alanine amidohydrolase;, PF00795;, GO:0005829;GO:0070062;GO:0003837;GO:0016811;GO:0042803;GO:0033396;GO:0046079;GO:0051260;GO:0051289;GO:0046135;GO:0046050;, C:cytosol; C:extracellular exosome;, F:beta-ureidopropionase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:protein homodimerization activity;, P:beta-alanine biosynthetic process via 3-ureidopropionate; P:dUMP catabolic process; P:protein homooligomerization; P:protein homotetramerization; P:pyrimidine nucleoside catabolic process; P:UMP catabolic process;|Q9UBR1 A3KMF8 Q9UIR3,Beta-ureidopropionase,BUP-1 {ECO:0000303|PubMed:10542323};Beta-alanine synthase;N-carbamoyl-beta-alanine amidohydrolase;, PF00795;, GO:0005829;GO:0070062;GO:0003837;GO:0016811;GO:0042803;GO:0033396;GO:0046079;GO:0051260;GO:0051289;GO:0046135;GO:0046050;, C:cytosol; C:extracellular exosome;, F:beta-ureidopropionase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:protein homodimerization activity;, P:beta-alanine biosynthetic process via 3-ureidopropionate; P:dUMP catabolic process; P:protein homooligomerization; P:protein homotetramerization; P:pyrimidine nucleoside catabolic process; P:UMP catabolic process;|Q9UBR1 A3KMF8 Q9UIR3,Beta-ureidopropionase,BUP-1 {ECO:0000303|PubMed:10542323};Beta-alanine synthase;N-carbamoyl-beta-alanine amidohydrolase;, PF00795;, GO:0005829;GO:0070062;GO:0003837;GO:0016811;GO:0042803;GO:0033396;GO:0046079;GO:0051260;GO:0051289;GO:0046135;GO:0046050;, C:cytosol; C:extracellular exosome;, F:beta-ureidopropionase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:protein homodimerization activity;, P:beta-alanine biosynthetic process via 3-ureidopropionate; P:dUMP catabolic process; P:protein homooligomerization; P:protein homotetramerization; P:pyrimidine nucleoside catabolic process; P:UMP catabolic process;|Q9UBR1 A3KMF8 Q9UIR3,Beta-ureidopropionase,BUP-1 {ECO:0000303|PubMed:10542323};Beta-alanine synthase;N-carbamoyl-beta-alanine amidohydrolase;, PF00795;, GO:0005829;GO:0070062;GO:0003837;GO:0016811;GO:0042803;GO:0033396;GO:0046079;GO:0051260;GO:0051289;GO:0046135;GO:0046050;, C:cytosol; C:extracellular exosome;, F:beta-ureidopropionase activity; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:protein homodimerization activity;, P:beta-alanine biosynthetic process via 3-ureidopropionate; P:dUMP catabolic process; P:protein homooligomerization; P:protein homotetramerization; P:pyrimidine nucleoside catabolic process; P:UMP catabolic process; scaffold167 indexed_genome mRNA 296736 304553 . - . ID=transcript_15020;P29274 B2R7E0,Adenosine receptor A2a,, PF00001;, GO:0030673;GO:0030425;GO:0012505;GO:0098978;GO:0005887;GO:0099055;GO:0099056;GO:0005882;GO:0016020;GO:0043025;GO:0005886;GO:0014069;GO:0048786;GO:0051393;GO:0019899;GO:0001609;GO:0042802;GO:0044877;GO:0031802;GO:0007189;GO:0007188;GO:0006915;GO:0048143;GO:0008015;GO:0007596;GO:0007267;GO:0006968;GO:0044267;GO:0007417;GO:0042755;GO:0060079;GO:0007186;GO:0006954;GO:0007626;GO:0051899;GO:0008285;GO:0043154;GO:0002862;GO:0040013;GO:0043524;GO:0006469;GO:0043116;GO:0048812;GO:0006909;GO:0014057;GO:0045938;GO:0014049;GO:1900273;GO:0050714;GO:0035815;GO:0051968;GO:0035810;GO:0060134;GO:0007205;GO:0051924;GO:0051881;GO:0014061;GO:2000300;GO:0006355;GO:0031000;GO:0042493;GO:0007600;GO:0007271;GO:0035249;GO:0042311;, C:axolemma; C:dendrite; C:endomembrane system; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:intermediate filament; C:membrane; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:presynaptic active zone;, F:alpha-actinin binding; F:enzyme binding; F:G protein-coupled adenosine receptor activity; F:identical protein binding; F:protein-containing complex binding; F:type 5 metabotropic glutamate receptor binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:apoptotic process; P:astrocyte activation; P:blood circulation; P:blood coagulation; P:cell-cell signaling; P:cellular defense response; P:cellular protein metabolic process; P:central nervous system development; P:eating behavior; P:excitatory postsynaptic potential; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:locomotory behavior; P:membrane depolarization; P:negative regulation of cell population proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of locomotion; P:negative regulation of neuron apoptotic process; P:negative regulation of protein kinase activity; P:negative regulation of vascular permeability; P:neuron projection morphogenesis; P:phagocytosis; P:positive regulation of acetylcholine secretion, neurotransmission; P:positive regulation of circadian sleep/wake cycle, sleep; P:positive regulation of glutamate secretion; P:positive regulation of long-term synaptic potentiation; P:positive regulation of protein secretion; P:positive regulation of renal sodium excretion; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of urine volume; P:prepulse inhibition; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:regulation of calcium ion transport; P:regulation of mitochondrial membrane potential; P:regulation of norepinephrine secretion; P:regulation of synaptic vesicle exocytosis; P:regulation of transcription, DNA-templated; P:response to caffeine; P:response to drug; P:sensory perception; P:synaptic transmission, cholinergic; P:synaptic transmission, glutamatergic; P:vasodilation; scaffold167 indexed_genome mRNA 323451 385158 . - . ID=transcript_15021;Q69YQ0 B7Z758 F5H1H6 O15081,Cytospin-A,Renal carcinoma antigen NY-REN-22;Sperm antigen with calponin homology and coiled-coil domains 1-like;, PF00307;, GO:0015629;GO:0005737;GO:0031941;GO:0005921;GO:0005815;GO:0005819;GO:0030036;GO:0007155;GO:0007049;GO:0051301;, C:actin cytoskeleton; C:cytoplasm; C:filamentous actin; C:gap junction; C:microtubule organizing center; C:spindle;, , P:actin cytoskeleton organization; P:cell adhesion; P:cell cycle; P:cell division;|Q69YQ0 B7Z758 F5H1H6 O15081,Cytospin-A,Renal carcinoma antigen NY-REN-22;Sperm antigen with calponin homology and coiled-coil domains 1-like;, PF00307;, GO:0015629;GO:0005737;GO:0031941;GO:0005921;GO:0005815;GO:0005819;GO:0030036;GO:0007155;GO:0007049;GO:0051301;, C:actin cytoskeleton; C:cytoplasm; C:filamentous actin; C:gap junction; C:microtubule organizing center; C:spindle;, , P:actin cytoskeleton organization; P:cell adhesion; P:cell cycle; P:cell division;|Q69YQ0 B7Z758 F5H1H6 O15081,Cytospin-A,Renal carcinoma antigen NY-REN-22;Sperm antigen with calponin homology and coiled-coil domains 1-like;, PF00307;, GO:0015629;GO:0005737;GO:0031941;GO:0005921;GO:0005815;GO:0005819;GO:0030036;GO:0007155;GO:0007049;GO:0051301;, C:actin cytoskeleton; C:cytoplasm; C:filamentous actin; C:gap junction; C:microtubule organizing center; C:spindle;, , P:actin cytoskeleton organization; P:cell adhesion; P:cell cycle; P:cell division;|Q69YQ0 B7Z758 F5H1H6 O15081,Cytospin-A,Renal carcinoma antigen NY-REN-22;Sperm antigen with calponin homology and coiled-coil domains 1-like;, PF00307;, GO:0015629;GO:0005737;GO:0031941;GO:0005921;GO:0005815;GO:0005819;GO:0030036;GO:0007155;GO:0007049;GO:0051301;, C:actin cytoskeleton; C:cytoplasm; C:filamentous actin; C:gap junction; C:microtubule organizing center; C:spindle;, , P:actin cytoskeleton organization; P:cell adhesion; P:cell cycle; P:cell division; scaffold167 indexed_genome mRNA 416629 478503 . - . ID=transcript_15022;P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction;|P11274 P78501 Q12842 Q4LE80 Q6NZI3,Breakpoint cluster region protein {ECO:0000305},Renal carcinoma antigen NY-REN-26;, PF09036;PF00168;PF00620;PF00621;, GO:0030424;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0016020;GO:0099092;GO:0032991;GO:0098685;GO:0005524;GO:0019899;GO:0005096;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0048041;GO:0030216;GO:0050804;GO:0048008;GO:0046777;GO:0006468;GO:0035023;GO:0051056;GO:0007165;GO:0007264;, C:axon; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:postsynaptic density, intracellular component; C:protein-containing complex; C:Schaffer collateral - CA1 synapse;, F:ATP binding; F:enzyme binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:focal adhesion assembly; P:keratinocyte differentiation; P:modulation of chemical synaptic transmission; P:platelet-derived growth factor receptor signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction; scaffold167 indexed_genome mRNA 589778 598872 . + . ID=transcript_15023;O95985 A0M8Q3 Q9BUP5,DNA topoisomerase 3-beta-1,DNA topoisomerase III beta-1;, PF01131;PF01751;, GO:0000793;GO:0005634;GO:0003677;GO:0003916;GO:0003917;GO:0003723;GO:0007059;GO:0006265;, C:condensed chromosome; C:nucleus;, F:DNA binding; F:DNA topoisomerase activity; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:RNA binding;, P:chromosome segregation; P:DNA topological change;|O95985 A0M8Q3 Q9BUP5,DNA topoisomerase 3-beta-1,DNA topoisomerase III beta-1;, PF01131;PF01751;, GO:0000793;GO:0005634;GO:0003677;GO:0003916;GO:0003917;GO:0003723;GO:0007059;GO:0006265;, C:condensed chromosome; C:nucleus;, F:DNA binding; F:DNA topoisomerase activity; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:RNA binding;, P:chromosome segregation; P:DNA topological change;|O95985 A0M8Q3 Q9BUP5,DNA topoisomerase 3-beta-1,DNA topoisomerase III beta-1;, PF01131;PF01751;, GO:0000793;GO:0005634;GO:0003677;GO:0003916;GO:0003917;GO:0003723;GO:0007059;GO:0006265;, C:condensed chromosome; C:nucleus;, F:DNA binding; F:DNA topoisomerase activity; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:RNA binding;, P:chromosome segregation; P:DNA topological change;|O95985 A0M8Q3 Q9BUP5,DNA topoisomerase 3-beta-1,DNA topoisomerase III beta-1;, PF01131;PF01751;, GO:0000793;GO:0005634;GO:0003677;GO:0003916;GO:0003917;GO:0003723;GO:0007059;GO:0006265;, C:condensed chromosome; C:nucleus;, F:DNA binding; F:DNA topoisomerase activity; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:RNA binding;, P:chromosome segregation; P:DNA topological change;|O95985 A0M8Q3 Q9BUP5,DNA topoisomerase 3-beta-1,DNA topoisomerase III beta-1;, PF01131;PF01751;, GO:0000793;GO:0005634;GO:0003677;GO:0003916;GO:0003917;GO:0003723;GO:0007059;GO:0006265;, C:condensed chromosome; C:nucleus;, F:DNA binding; F:DNA topoisomerase activity; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; F:RNA binding;, P:chromosome segregation; P:DNA topological change; scaffold167 indexed_genome mRNA 614372 630826 . + . ID=transcript_15024;P49593 A8K6G3 B7Z2C3 Q96PM2,Protein phosphatase 1F,Ca(2+)/calmodulin-dependent protein kinase phosphatase;Partner of PIX 2;Protein fem-2 homolog;, PF00481;, GO:0005829;GO:0005634;GO:0048471;GO:0032991;GO:0033192;GO:0004724;GO:0046872;GO:0106306;GO:0004722;GO:0106307;GO:0008138;GO:0035690;GO:0016576;GO:0097193;GO:2000048;GO:0033137;GO:0006469;GO:0044387;GO:0051224;GO:0045892;GO:0070262;GO:0035970;GO:0030335;GO:0010811;GO:0050921;GO:0043280;GO:0010634;GO:0051894;GO:0010628;GO:0045927;GO:0051496;GO:0006470;GO:1903827;, C:cytosol; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:calmodulin-dependent protein phosphatase activity; F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cellular response to drug; P:histone dephosphorylation; P:intrinsic apoptotic signaling pathway; P:negative regulation of cell-cell adhesion mediated by cadherin; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:negative regulation of protein transport; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of cell migration; P:positive regulation of cell-substrate adhesion; P:positive regulation of chemotaxis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of epithelial cell migration; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of growth; P:positive regulation of stress fiber assembly; P:protein dephosphorylation; P:regulation of cellular protein localization; scaffold167 indexed_genome mRNA 682777 703680 . + . ID=transcript_15025;P28482 A8CZ64,Mitogen-activated protein kinase 1,ERT1;Extracellular signal-regulated kinase 2;MAP kinase isoform p42;Mitogen-activated protein kinase 2;, PF00069;, GO:0030424;GO:0035578;GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0032839;GO:0005769;GO:0005788;GO:0005576;GO:1904813;GO:0005925;GO:0005794;GO:0005770;GO:0005815;GO:0005739;GO:0072686;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0032991;GO:0031143;GO:0005524;GO:0003690;GO:0042802;GO:0004707;GO:0004708;GO:0031435;GO:0019902;GO:0001784;GO:0106310;GO:0004674;GO:0106311;GO:0008353;GO:0008134;GO:0000187;GO:0000186;GO:0007568;GO:0006915;GO:0007411;GO:0050853;GO:0060020;GO:0061308;GO:0072584;GO:0007049;GO:0007166;GO:0034198;GO:0071276;GO:0006974;GO:1903351;GO:0097011;GO:0034614;GO:0071356;GO:0007268;GO:0006935;GO:0019858;GO:0046697;GO:0015966;GO:0038127;GO:0070371;GO:0060324;GO:0038095;GO:0038096;GO:0008543;GO:0035556;GO:0060716;GO:0007611;GO:0031663;GO:0060291;GO:0060425;GO:0033598;GO:0000165;GO:0033668;GO:0045596;GO:0043312;GO:0042473;GO:0018105;GO:0018107;GO:0030168;GO:0060045;GO:0010628;GO:0010759;GO:0120041;GO:0010800;GO:0042307;GO:0051973;GO:1904355;GO:0032212;GO:0045893;GO:0045727;GO:0006468;GO:0030641;GO:1900034;GO:0051493;GO:0051090;GO:2000641;GO:0010468;GO:0090170;GO:0030278;GO:0014066;GO:0031647;GO:0032872;GO:0070849;GO:0043627;GO:0043330;GO:0035094;GO:0009636;GO:0019233;GO:0007165;GO:0051403;GO:0050852;GO:0048538;GO:0030878;GO:0060440;GO:0016032;, C:axon; C:azurophil granule lumen; C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule organizing center; C:mitochondrion; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:pseudopodium;, F:ATP binding; F:double-stranded DNA binding; F:identical protein binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:phosphatase binding; F:phosphotyrosine residue binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription factor binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:aging; P:apoptotic process; P:axon guidance; P:B cell receptor signaling pathway; P:Bergmann glial cell differentiation; P:cardiac neural crest cell development involved in heart development; P:caveolin-mediated endocytosis; P:cell cycle; P:cell surface receptor signaling pathway; P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:cellular response to dopamine; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:chemical synaptic transmission; P:chemotaxis; P:cytosine metabolic process; P:decidualization; P:diadenosine tetraphosphate biosynthetic process; P:ERBB signaling pathway; P:ERK1 and ERK2 cascade; P:face development; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:intracellular signal transduction; P:labyrinthine layer blood vessel development; P:learning or memory; P:lipopolysaccharide-mediated signaling pathway; P:long-term synaptic potentiation; P:lung morphogenesis; P:mammary gland epithelial cell proliferation; P:MAPK cascade; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of cell differentiation; P:neutrophil degranulation; P:outer ear morphogenesis; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of gene expression; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:protein phosphorylation; P:regulation of cellular pH; P:regulation of cellular response to heat; P:regulation of cytoskeleton organization; P:regulation of DNA-binding transcription factor activity; P:regulation of early endosome to late endosome transport; P:regulation of gene expression; P:regulation of Golgi inheritance; P:regulation of ossification; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein stability; P:regulation of stress-activated MAPK cascade; P:response to epidermal growth factor; P:response to estrogen; P:response to exogenous dsRNA; P:response to nicotine; P:response to toxic substance; P:sensory perception of pain; P:signal transduction; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:thymus development; P:thyroid gland development; P:trachea formation; P:viral process;|P28482 A8CZ64,Mitogen-activated protein kinase 1,ERT1;Extracellular signal-regulated kinase 2;MAP kinase isoform p42;Mitogen-activated protein kinase 2;, PF00069;, GO:0030424;GO:0035578;GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0032839;GO:0005769;GO:0005788;GO:0005576;GO:1904813;GO:0005925;GO:0005794;GO:0005770;GO:0005815;GO:0005739;GO:0072686;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0032991;GO:0031143;GO:0005524;GO:0003690;GO:0042802;GO:0004707;GO:0004708;GO:0031435;GO:0019902;GO:0001784;GO:0106310;GO:0004674;GO:0106311;GO:0008353;GO:0008134;GO:0000187;GO:0000186;GO:0007568;GO:0006915;GO:0007411;GO:0050853;GO:0060020;GO:0061308;GO:0072584;GO:0007049;GO:0007166;GO:0034198;GO:0071276;GO:0006974;GO:1903351;GO:0097011;GO:0034614;GO:0071356;GO:0007268;GO:0006935;GO:0019858;GO:0046697;GO:0015966;GO:0038127;GO:0070371;GO:0060324;GO:0038095;GO:0038096;GO:0008543;GO:0035556;GO:0060716;GO:0007611;GO:0031663;GO:0060291;GO:0060425;GO:0033598;GO:0000165;GO:0033668;GO:0045596;GO:0043312;GO:0042473;GO:0018105;GO:0018107;GO:0030168;GO:0060045;GO:0010628;GO:0010759;GO:0120041;GO:0010800;GO:0042307;GO:0051973;GO:1904355;GO:0032212;GO:0045893;GO:0045727;GO:0006468;GO:0030641;GO:1900034;GO:0051493;GO:0051090;GO:2000641;GO:0010468;GO:0090170;GO:0030278;GO:0014066;GO:0031647;GO:0032872;GO:0070849;GO:0043627;GO:0043330;GO:0035094;GO:0009636;GO:0019233;GO:0007165;GO:0051403;GO:0050852;GO:0048538;GO:0030878;GO:0060440;GO:0016032;, C:axon; C:azurophil granule lumen; C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule organizing center; C:mitochondrion; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:pseudopodium;, F:ATP binding; F:double-stranded DNA binding; F:identical protein binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:phosphatase binding; F:phosphotyrosine residue binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription factor binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:aging; P:apoptotic process; P:axon guidance; P:B cell receptor signaling pathway; P:Bergmann glial cell differentiation; P:cardiac neural crest cell development involved in heart development; P:caveolin-mediated endocytosis; P:cell cycle; P:cell surface receptor signaling pathway; P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:cellular response to dopamine; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:chemical synaptic transmission; P:chemotaxis; P:cytosine metabolic process; P:decidualization; P:diadenosine tetraphosphate biosynthetic process; P:ERBB signaling pathway; P:ERK1 and ERK2 cascade; P:face development; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:intracellular signal transduction; P:labyrinthine layer blood vessel development; P:learning or memory; P:lipopolysaccharide-mediated signaling pathway; P:long-term synaptic potentiation; P:lung morphogenesis; P:mammary gland epithelial cell proliferation; P:MAPK cascade; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of cell differentiation; P:neutrophil degranulation; P:outer ear morphogenesis; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of gene expression; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:protein phosphorylation; P:regulation of cellular pH; P:regulation of cellular response to heat; P:regulation of cytoskeleton organization; P:regulation of DNA-binding transcription factor activity; P:regulation of early endosome to late endosome transport; P:regulation of gene expression; P:regulation of Golgi inheritance; P:regulation of ossification; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein stability; P:regulation of stress-activated MAPK cascade; P:response to epidermal growth factor; P:response to estrogen; P:response to exogenous dsRNA; P:response to nicotine; P:response to toxic substance; P:sensory perception of pain; P:signal transduction; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:thymus development; P:thyroid gland development; P:trachea formation; P:viral process;|P28482 A8CZ64,Mitogen-activated protein kinase 1,ERT1;Extracellular signal-regulated kinase 2;MAP kinase isoform p42;Mitogen-activated protein kinase 2;, PF00069;, GO:0030424;GO:0035578;GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0032839;GO:0005769;GO:0005788;GO:0005576;GO:1904813;GO:0005925;GO:0005794;GO:0005770;GO:0005815;GO:0005739;GO:0072686;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0032991;GO:0031143;GO:0005524;GO:0003690;GO:0042802;GO:0004707;GO:0004708;GO:0031435;GO:0019902;GO:0001784;GO:0106310;GO:0004674;GO:0106311;GO:0008353;GO:0008134;GO:0000187;GO:0000186;GO:0007568;GO:0006915;GO:0007411;GO:0050853;GO:0060020;GO:0061308;GO:0072584;GO:0007049;GO:0007166;GO:0034198;GO:0071276;GO:0006974;GO:1903351;GO:0097011;GO:0034614;GO:0071356;GO:0007268;GO:0006935;GO:0019858;GO:0046697;GO:0015966;GO:0038127;GO:0070371;GO:0060324;GO:0038095;GO:0038096;GO:0008543;GO:0035556;GO:0060716;GO:0007611;GO:0031663;GO:0060291;GO:0060425;GO:0033598;GO:0000165;GO:0033668;GO:0045596;GO:0043312;GO:0042473;GO:0018105;GO:0018107;GO:0030168;GO:0060045;GO:0010628;GO:0010759;GO:0120041;GO:0010800;GO:0042307;GO:0051973;GO:1904355;GO:0032212;GO:0045893;GO:0045727;GO:0006468;GO:0030641;GO:1900034;GO:0051493;GO:0051090;GO:2000641;GO:0010468;GO:0090170;GO:0030278;GO:0014066;GO:0031647;GO:0032872;GO:0070849;GO:0043627;GO:0043330;GO:0035094;GO:0009636;GO:0019233;GO:0007165;GO:0051403;GO:0050852;GO:0048538;GO:0030878;GO:0060440;GO:0016032;, C:axon; C:azurophil granule lumen; C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule organizing center; C:mitochondrion; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:pseudopodium;, F:ATP binding; F:double-stranded DNA binding; F:identical protein binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:phosphatase binding; F:phosphotyrosine residue binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription factor binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:aging; P:apoptotic process; P:axon guidance; P:B cell receptor signaling pathway; P:Bergmann glial cell differentiation; P:cardiac neural crest cell development involved in heart development; P:caveolin-mediated endocytosis; P:cell cycle; P:cell surface receptor signaling pathway; P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:cellular response to dopamine; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:chemical synaptic transmission; P:chemotaxis; P:cytosine metabolic process; P:decidualization; P:diadenosine tetraphosphate biosynthetic process; P:ERBB signaling pathway; P:ERK1 and ERK2 cascade; P:face development; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:intracellular signal transduction; P:labyrinthine layer blood vessel development; P:learning or memory; P:lipopolysaccharide-mediated signaling pathway; P:long-term synaptic potentiation; P:lung morphogenesis; P:mammary gland epithelial cell proliferation; P:MAPK cascade; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of cell differentiation; P:neutrophil degranulation; P:outer ear morphogenesis; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of gene expression; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:protein phosphorylation; P:regulation of cellular pH; P:regulation of cellular response to heat; P:regulation of cytoskeleton organization; P:regulation of DNA-binding transcription factor activity; P:regulation of early endosome to late endosome transport; P:regulation of gene expression; P:regulation of Golgi inheritance; P:regulation of ossification; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein stability; P:regulation of stress-activated MAPK cascade; P:response to epidermal growth factor; P:response to estrogen; P:response to exogenous dsRNA; P:response to nicotine; P:response to toxic substance; P:sensory perception of pain; P:signal transduction; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:thymus development; P:thyroid gland development; P:trachea formation; P:viral process;|P28482 A8CZ64,Mitogen-activated protein kinase 1,ERT1;Extracellular signal-regulated kinase 2;MAP kinase isoform p42;Mitogen-activated protein kinase 2;, PF00069;, GO:0030424;GO:0035578;GO:0005901;GO:0005737;GO:0005856;GO:0005829;GO:0032839;GO:0005769;GO:0005788;GO:0005576;GO:1904813;GO:0005925;GO:0005794;GO:0005770;GO:0005815;GO:0005739;GO:0072686;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0014069;GO:0032991;GO:0031143;GO:0005524;GO:0003690;GO:0042802;GO:0004707;GO:0004708;GO:0031435;GO:0019902;GO:0001784;GO:0106310;GO:0004674;GO:0106311;GO:0008353;GO:0008134;GO:0000187;GO:0000186;GO:0007568;GO:0006915;GO:0007411;GO:0050853;GO:0060020;GO:0061308;GO:0072584;GO:0007049;GO:0007166;GO:0034198;GO:0071276;GO:0006974;GO:1903351;GO:0097011;GO:0034614;GO:0071356;GO:0007268;GO:0006935;GO:0019858;GO:0046697;GO:0015966;GO:0038127;GO:0070371;GO:0060324;GO:0038095;GO:0038096;GO:0008543;GO:0035556;GO:0060716;GO:0007611;GO:0031663;GO:0060291;GO:0060425;GO:0033598;GO:0000165;GO:0033668;GO:0045596;GO:0043312;GO:0042473;GO:0018105;GO:0018107;GO:0030168;GO:0060045;GO:0010628;GO:0010759;GO:0120041;GO:0010800;GO:0042307;GO:0051973;GO:1904355;GO:0032212;GO:0045893;GO:0045727;GO:0006468;GO:0030641;GO:1900034;GO:0051493;GO:0051090;GO:2000641;GO:0010468;GO:0090170;GO:0030278;GO:0014066;GO:0031647;GO:0032872;GO:0070849;GO:0043627;GO:0043330;GO:0035094;GO:0009636;GO:0019233;GO:0007165;GO:0051403;GO:0050852;GO:0048538;GO:0030878;GO:0060440;GO:0016032;, C:axon; C:azurophil granule lumen; C:caveola; C:cytoplasm; C:cytoskeleton; C:cytosol; C:dendrite cytoplasm; C:early endosome; C:endoplasmic reticulum lumen; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:Golgi apparatus; C:late endosome; C:microtubule organizing center; C:mitochondrion; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:protein-containing complex; C:pseudopodium;, F:ATP binding; F:double-stranded DNA binding; F:identical protein binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:phosphatase binding; F:phosphotyrosine residue binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity; F:transcription factor binding;, P:activation of MAPK activity; P:activation of MAPKK activity; P:aging; P:apoptotic process; P:axon guidance; P:B cell receptor signaling pathway; P:Bergmann glial cell differentiation; P:cardiac neural crest cell development involved in heart development; P:caveolin-mediated endocytosis; P:cell cycle; P:cell surface receptor signaling pathway; P:cellular response to amino acid starvation; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:cellular response to dopamine; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:chemical synaptic transmission; P:chemotaxis; P:cytosine metabolic process; P:decidualization; P:diadenosine tetraphosphate biosynthetic process; P:ERBB signaling pathway; P:ERK1 and ERK2 cascade; P:face development; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:fibroblast growth factor receptor signaling pathway; P:intracellular signal transduction; P:labyrinthine layer blood vessel development; P:learning or memory; P:lipopolysaccharide-mediated signaling pathway; P:long-term synaptic potentiation; P:lung morphogenesis; P:mammary gland epithelial cell proliferation; P:MAPK cascade; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of cell differentiation; P:neutrophil degranulation; P:outer ear morphogenesis; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:platelet activation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of gene expression; P:positive regulation of macrophage chemotaxis; P:positive regulation of macrophage proliferation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:protein phosphorylation; P:regulation of cellular pH; P:regulation of cellular response to heat; P:regulation of cytoskeleton organization; P:regulation of DNA-binding transcription factor activity; P:regulation of early endosome to late endosome transport; P:regulation of gene expression; P:regulation of Golgi inheritance; P:regulation of ossification; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein stability; P:regulation of stress-activated MAPK cascade; P:response to epidermal growth factor; P:response to estrogen; P:response to exogenous dsRNA; P:response to nicotine; P:response to toxic substance; P:sensory perception of pain; P:signal transduction; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:thymus development; P:thyroid gland development; P:trachea formation; P:viral process; scaffold167 indexed_genome mRNA 725588 756662 . - . ID=transcript_15026;O60688 Q65ZA1 Q6GLI6,Protein yippee-like 1,, PF03226;, GO:0005634;GO:0046872;, C:nucleus;, F:metal ion binding;|O60688 Q65ZA1 Q6GLI6,Protein yippee-like 1,, PF03226;, GO:0005634;GO:0046872;, C:nucleus;, F:metal ion binding;|Q13356 Q13357 Q8TAH2 Q9BWR8,RING-type E3 ubiquitin-protein ligase PPIL2 {ECO:0000305},CYC4 {ECO:0000303|PubMed:11435423};Cyclophilin-60 {ECO:0000303|PubMed:8660300};Probable inactive peptidyl-prolyl cis-trans isomerase-like 2 {ECO:0000305|PubMed:20676357};Rotamase PPIL2 {ECO:0000305};, PF00160;, GO:0005737;GO:0005796;GO:0005654;GO:0005634;GO:0005886;GO:0061630;GO:0034450;GO:0050900;GO:0006457;GO:0072659;GO:0000413;GO:0000209;, C:cytoplasm; C:Golgi lumen; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity;, P:leukocyte migration; P:protein folding; P:protein localization to plasma membrane; P:protein peptidyl-prolyl isomerization; P:protein polyubiquitination;|Q13356 Q13357 Q8TAH2 Q9BWR8,RING-type E3 ubiquitin-protein ligase PPIL2 {ECO:0000305},CYC4 {ECO:0000303|PubMed:11435423};Cyclophilin-60 {ECO:0000303|PubMed:8660300};Probable inactive peptidyl-prolyl cis-trans isomerase-like 2 {ECO:0000305|PubMed:20676357};Rotamase PPIL2 {ECO:0000305};, PF00160;, GO:0005737;GO:0005796;GO:0005654;GO:0005634;GO:0005886;GO:0061630;GO:0034450;GO:0050900;GO:0006457;GO:0072659;GO:0000413;GO:0000209;, C:cytoplasm; C:Golgi lumen; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity;, P:leukocyte migration; P:protein folding; P:protein localization to plasma membrane; P:protein peptidyl-prolyl isomerization; P:protein polyubiquitination;|Q13356 Q13357 Q8TAH2 Q9BWR8,RING-type E3 ubiquitin-protein ligase PPIL2 {ECO:0000305},CYC4 {ECO:0000303|PubMed:11435423};Cyclophilin-60 {ECO:0000303|PubMed:8660300};Probable inactive peptidyl-prolyl cis-trans isomerase-like 2 {ECO:0000305|PubMed:20676357};Rotamase PPIL2 {ECO:0000305};, PF00160;, GO:0005737;GO:0005796;GO:0005654;GO:0005634;GO:0005886;GO:0061630;GO:0034450;GO:0050900;GO:0006457;GO:0072659;GO:0000413;GO:0000209;, C:cytoplasm; C:Golgi lumen; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ubiquitin protein ligase activity; F:ubiquitin-ubiquitin ligase activity;, P:leukocyte migration; P:protein folding; P:protein localization to plasma membrane; P:protein peptidyl-prolyl isomerization; P:protein polyubiquitination; scaffold167 indexed_genome mRNA 778720 782894 . - . ID=transcript_15027;Q8IYX3 B7Z7H5 Q8N9Y9,Coiled-coil domain-containing protein 116,, PF15774;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm;|Q8IYX3 B7Z7H5 Q8N9Y9,Coiled-coil domain-containing protein 116,, PF15774;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm; scaffold167 indexed_genome mRNA 789496 798733 . - . ID=transcript_15028;P68036 B2R4A7 B4DDG1 B4DSZ4 E7EWS7 P51966 P70653 Q9HAV1,Ubiquitin-conjugating enzyme E2 L3,E2 ubiquitin-conjugating enzyme L3;L-UBC;UbcH7;Ubiquitin carrier protein L3;Ubiquitin-conjugating enzyme E2-F1;Ubiquitin-protein ligase L3;, PF00179;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0005524;GO:0019899;GO:0003723;GO:0003713;GO:0061631;GO:0031625;GO:0097027;GO:0004842;GO:0044770;GO:0008283;GO:0006464;GO:0071385;GO:0071383;GO:1903955;GO:0031398;GO:0051443;GO:0070979;GO:0000209;GO:0016567;GO:0006355;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:enzyme binding; F:RNA binding; F:transcription coactivator activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity; F:ubiquitin-protein transferase activity;, P:cell cycle phase transition; P:cell population proliferation; P:cellular protein modification process; P:cellular response to glucocorticoid stimulus; P:cellular response to steroid hormone stimulus; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-protein transferase activity; P:protein K11-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process;|P68036 B2R4A7 B4DDG1 B4DSZ4 E7EWS7 P51966 P70653 Q9HAV1,Ubiquitin-conjugating enzyme E2 L3,E2 ubiquitin-conjugating enzyme L3;L-UBC;UbcH7;Ubiquitin carrier protein L3;Ubiquitin-conjugating enzyme E2-F1;Ubiquitin-protein ligase L3;, PF00179;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0005524;GO:0019899;GO:0003723;GO:0003713;GO:0061631;GO:0031625;GO:0097027;GO:0004842;GO:0044770;GO:0008283;GO:0006464;GO:0071385;GO:0071383;GO:1903955;GO:0031398;GO:0051443;GO:0070979;GO:0000209;GO:0016567;GO:0006355;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:enzyme binding; F:RNA binding; F:transcription coactivator activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity; F:ubiquitin-protein transferase activity;, P:cell cycle phase transition; P:cell population proliferation; P:cellular protein modification process; P:cellular response to glucocorticoid stimulus; P:cellular response to steroid hormone stimulus; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-protein transferase activity; P:protein K11-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process;|P68036 B2R4A7 B4DDG1 B4DSZ4 E7EWS7 P51966 P70653 Q9HAV1,Ubiquitin-conjugating enzyme E2 L3,E2 ubiquitin-conjugating enzyme L3;L-UBC;UbcH7;Ubiquitin carrier protein L3;Ubiquitin-conjugating enzyme E2-F1;Ubiquitin-protein ligase L3;, PF00179;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0000151;GO:0005524;GO:0019899;GO:0003723;GO:0003713;GO:0061631;GO:0031625;GO:0097027;GO:0004842;GO:0044770;GO:0008283;GO:0006464;GO:0071385;GO:0071383;GO:1903955;GO:0031398;GO:0051443;GO:0070979;GO:0000209;GO:0016567;GO:0006355;GO:0006511;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:ATP binding; F:enzyme binding; F:RNA binding; F:transcription coactivator activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activator activity; F:ubiquitin-protein transferase activity;, P:cell cycle phase transition; P:cell population proliferation; P:cellular protein modification process; P:cellular response to glucocorticoid stimulus; P:cellular response to steroid hormone stimulus; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of ubiquitin-protein transferase activity; P:protein K11-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of transcription, DNA-templated; P:ubiquitin-dependent protein catabolic process; scaffold167 indexed_genome mRNA 826060 826665 . - . ID=transcript_15029;Q9UFD9 Q8IYP7 Q9BY94 Q9UFQ5,RIMS-binding protein 3A,RIMS-binding protein 3.1;, PF07653;, GO:0005737;GO:0005856;GO:0005634;GO:0045202;GO:0030156;GO:0009566;GO:0007286;, C:cytoplasm; C:cytoskeleton; C:nucleus; C:synapse;, F:benzodiazepine receptor binding;, P:fertilization; P:spermatid development; scaffold167 indexed_genome mRNA 854367 857998 . - . ID=transcript_15030;Q96JB3 Q504T6 Q96KR3 Q9NSM9 Q9UPX9,Hypermethylated in cancer 2 protein,HIC1-related gene on chromosome 22 protein;Hic-3;Zinc finger and BTB domain-containing protein 30;, PF00651;PF00096;, GO:0005654;GO:0005634;GO:0003677;GO:0001227;GO:0046872;GO:0008022;GO:0000978;GO:0045892;GO:0006357;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:protein C-terminus binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold167 indexed_genome mRNA 867286 885039 . - . ID=transcript_15031;P42356 Q7Z625 Q9UPG2,Phosphatidylinositol 4-kinase alpha,Phosphatidylinositol 4-Kinase III alpha;, PF00454;PF00613;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030660;GO:0016020;GO:0005886;GO:0019034;GO:0004430;GO:0005524;GO:0045296;GO:0016301;GO:0052742;GO:0044803;GO:0006661;GO:0046854;GO:0048015;GO:0016310;GO:0007165;GO:0046786;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi-associated vesicle membrane; C:membrane; C:plasma membrane; C:viral replication complex;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding; F:cadherin binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:multi-organism membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:signal transduction; P:viral replication complex formation and maintenance; P:viral RNA genome replication;|P42356 Q7Z625 Q9UPG2,Phosphatidylinositol 4-kinase alpha,Phosphatidylinositol 4-Kinase III alpha;, PF00454;PF00613;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030660;GO:0016020;GO:0005886;GO:0019034;GO:0004430;GO:0005524;GO:0045296;GO:0016301;GO:0052742;GO:0044803;GO:0006661;GO:0046854;GO:0048015;GO:0016310;GO:0007165;GO:0046786;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi-associated vesicle membrane; C:membrane; C:plasma membrane; C:viral replication complex;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding; F:cadherin binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:multi-organism membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:signal transduction; P:viral replication complex formation and maintenance; P:viral RNA genome replication;|P42356 Q7Z625 Q9UPG2,Phosphatidylinositol 4-kinase alpha,Phosphatidylinositol 4-Kinase III alpha;, PF00454;PF00613;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030660;GO:0016020;GO:0005886;GO:0019034;GO:0004430;GO:0005524;GO:0045296;GO:0016301;GO:0052742;GO:0044803;GO:0006661;GO:0046854;GO:0048015;GO:0016310;GO:0007165;GO:0046786;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi-associated vesicle membrane; C:membrane; C:plasma membrane; C:viral replication complex;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding; F:cadherin binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:multi-organism membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:signal transduction; P:viral replication complex formation and maintenance; P:viral RNA genome replication;|P42356 Q7Z625 Q9UPG2,Phosphatidylinositol 4-kinase alpha,Phosphatidylinositol 4-Kinase III alpha;, PF00454;PF00613;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030660;GO:0016020;GO:0005886;GO:0019034;GO:0004430;GO:0005524;GO:0045296;GO:0016301;GO:0052742;GO:0044803;GO:0006661;GO:0046854;GO:0048015;GO:0016310;GO:0007165;GO:0046786;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi-associated vesicle membrane; C:membrane; C:plasma membrane; C:viral replication complex;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding; F:cadherin binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:multi-organism membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:signal transduction; P:viral replication complex formation and maintenance; P:viral RNA genome replication;|P42356 Q7Z625 Q9UPG2,Phosphatidylinositol 4-kinase alpha,Phosphatidylinositol 4-Kinase III alpha;, PF00454;PF00613;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030660;GO:0016020;GO:0005886;GO:0019034;GO:0004430;GO:0005524;GO:0045296;GO:0016301;GO:0052742;GO:0044803;GO:0006661;GO:0046854;GO:0048015;GO:0016310;GO:0007165;GO:0046786;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi-associated vesicle membrane; C:membrane; C:plasma membrane; C:viral replication complex;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding; F:cadherin binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:multi-organism membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:signal transduction; P:viral replication complex formation and maintenance; P:viral RNA genome replication; scaffold167 indexed_genome mRNA 887678 927496 . - . ID=transcript_15032;P42356 Q7Z625 Q9UPG2,Phosphatidylinositol 4-kinase alpha,Phosphatidylinositol 4-Kinase III alpha;, PF00454;PF00613;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030660;GO:0016020;GO:0005886;GO:0019034;GO:0004430;GO:0005524;GO:0045296;GO:0016301;GO:0052742;GO:0044803;GO:0006661;GO:0046854;GO:0048015;GO:0016310;GO:0007165;GO:0046786;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi-associated vesicle membrane; C:membrane; C:plasma membrane; C:viral replication complex;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding; F:cadherin binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:multi-organism membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:signal transduction; P:viral replication complex formation and maintenance; P:viral RNA genome replication;|P42356 Q7Z625 Q9UPG2,Phosphatidylinositol 4-kinase alpha,Phosphatidylinositol 4-Kinase III alpha;, PF00454;PF00613;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030660;GO:0016020;GO:0005886;GO:0019034;GO:0004430;GO:0005524;GO:0045296;GO:0016301;GO:0052742;GO:0044803;GO:0006661;GO:0046854;GO:0048015;GO:0016310;GO:0007165;GO:0046786;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi-associated vesicle membrane; C:membrane; C:plasma membrane; C:viral replication complex;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding; F:cadherin binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:multi-organism membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:signal transduction; P:viral replication complex formation and maintenance; P:viral RNA genome replication;|P42356 Q7Z625 Q9UPG2,Phosphatidylinositol 4-kinase alpha,Phosphatidylinositol 4-Kinase III alpha;, PF00454;PF00613;, GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030660;GO:0016020;GO:0005886;GO:0019034;GO:0004430;GO:0005524;GO:0045296;GO:0016301;GO:0052742;GO:0044803;GO:0006661;GO:0046854;GO:0048015;GO:0016310;GO:0007165;GO:0046786;GO:0039694;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:Golgi-associated vesicle membrane; C:membrane; C:plasma membrane; C:viral replication complex;, F:1-phosphatidylinositol 4-kinase activity; F:ATP binding; F:cadherin binding; F:kinase activity; F:phosphatidylinositol kinase activity;, P:multi-organism membrane organization; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:phosphorylation; P:signal transduction; P:viral replication complex formation and maintenance; P:viral RNA genome replication;|P05546 B2RAI1 D3DX34 Q6IBZ5,Heparin cofactor 2,Heparin cofactor II;Protease inhibitor leuserpin-2;Serpin D1;, PF00079;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0004866;GO:0008201;GO:0004867;GO:0007596;GO:0044267;GO:0006935;GO:0010951;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:endopeptidase inhibitor activity; F:heparin binding; F:serine-type endopeptidase inhibitor activity;, P:blood coagulation; P:cellular protein metabolic process; P:chemotaxis; P:negative regulation of endopeptidase activity; P:post-translational protein modification;|P05546 B2RAI1 D3DX34 Q6IBZ5,Heparin cofactor 2,Heparin cofactor II;Protease inhibitor leuserpin-2;Serpin D1;, PF00079;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0004866;GO:0008201;GO:0004867;GO:0007596;GO:0044267;GO:0006935;GO:0010951;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:endopeptidase inhibitor activity; F:heparin binding; F:serine-type endopeptidase inhibitor activity;, P:blood coagulation; P:cellular protein metabolic process; P:chemotaxis; P:negative regulation of endopeptidase activity; P:post-translational protein modification;|P05546 B2RAI1 D3DX34 Q6IBZ5,Heparin cofactor 2,Heparin cofactor II;Protease inhibitor leuserpin-2;Serpin D1;, PF00079;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0004866;GO:0008201;GO:0004867;GO:0007596;GO:0044267;GO:0006935;GO:0010951;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:endopeptidase inhibitor activity; F:heparin binding; F:serine-type endopeptidase inhibitor activity;, P:blood coagulation; P:cellular protein metabolic process; P:chemotaxis; P:negative regulation of endopeptidase activity; P:post-translational protein modification;|P05546 B2RAI1 D3DX34 Q6IBZ5,Heparin cofactor 2,Heparin cofactor II;Protease inhibitor leuserpin-2;Serpin D1;, PF00079;, GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0004866;GO:0008201;GO:0004867;GO:0007596;GO:0044267;GO:0006935;GO:0010951;GO:0043687;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:endopeptidase inhibitor activity; F:heparin binding; F:serine-type endopeptidase inhibitor activity;, P:blood coagulation; P:cellular protein metabolic process; P:chemotaxis; P:negative regulation of endopeptidase activity; P:post-translational protein modification; scaffold167 indexed_genome mRNA 948588 971070 . - . ID=transcript_15033;Q8N653 Q14776 Q20WK0,Leucine-zipper-like transcriptional regulator 1 {ECO:0000303|PubMed:7633402},, PF00651;PF01344;PF07646;, GO:0031463;GO:0012505;GO:0005794;GO:0055038;GO:0031267;GO:0046580;GO:0016567;, C:Cul3-RING ubiquitin ligase complex; C:endomembrane system; C:Golgi apparatus; C:recycling endosome membrane;, F:small GTPase binding;, P:negative regulation of Ras protein signal transduction; P:protein ubiquitination;|Q8N653 Q14776 Q20WK0,Leucine-zipper-like transcriptional regulator 1 {ECO:0000303|PubMed:7633402},, PF00651;PF01344;PF07646;, GO:0031463;GO:0012505;GO:0005794;GO:0055038;GO:0031267;GO:0046580;GO:0016567;, C:Cul3-RING ubiquitin ligase complex; C:endomembrane system; C:Golgi apparatus; C:recycling endosome membrane;, F:small GTPase binding;, P:negative regulation of Ras protein signal transduction; P:protein ubiquitination; scaffold167 indexed_genome mRNA 971264 976291 . + . ID=transcript_15034;Q6ZQY2,Leucine-rich repeat-containing protein 74B {ECO:0000312|HGNC:HGNC:34301},, PF13516; scaffold167 indexed_genome mRNA 976785 977969 . - . ID=transcript_15035;Q6ZQY2,Leucine-rich repeat-containing protein 74B {ECO:0000312|HGNC:HGNC:34301},, PF13516; scaffold167 indexed_genome mRNA 984678 993119 . + . ID=transcript_15036;O15547 F6V3D7 Q32MB6 Q58F04 Q6IC33 Q9UL50,P2X purinoceptor 6,ATP receptor;P2XM;Purinergic receptor;Purinergic receptor P2X-like 1;, , GO:0030054;GO:0005737;GO:0043197;GO:0098978;GO:0005639;GO:0005887;GO:0099060;GO:0043025;GO:0098688;GO:0005886;GO:0014069;GO:0043235;GO:0005524;GO:0015267;GO:0004931;GO:0044877;GO:0001614;GO:0004888;GO:0007596;GO:0006936;GO:0033198;GO:0007165;, C:cell junction; C:cytoplasm; C:dendritic spine; C:glutamatergic synapse; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic density; C:receptor complex;, F:ATP binding; F:channel activity; F:extracellularly ATP-gated cation channel activity; F:protein-containing complex binding; F:purinergic nucleotide receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:muscle contraction; P:response to ATP; P:signal transduction;|O15547 F6V3D7 Q32MB6 Q58F04 Q6IC33 Q9UL50,P2X purinoceptor 6,ATP receptor;P2XM;Purinergic receptor;Purinergic receptor P2X-like 1;, , GO:0030054;GO:0005737;GO:0043197;GO:0098978;GO:0005639;GO:0005887;GO:0099060;GO:0043025;GO:0098688;GO:0005886;GO:0014069;GO:0043235;GO:0005524;GO:0015267;GO:0004931;GO:0044877;GO:0001614;GO:0004888;GO:0007596;GO:0006936;GO:0033198;GO:0007165;, C:cell junction; C:cytoplasm; C:dendritic spine; C:glutamatergic synapse; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic density; C:receptor complex;, F:ATP binding; F:channel activity; F:extracellularly ATP-gated cation channel activity; F:protein-containing complex binding; F:purinergic nucleotide receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:muscle contraction; P:response to ATP; P:signal transduction;|O15547 F6V3D7 Q32MB6 Q58F04 Q6IC33 Q9UL50,P2X purinoceptor 6,ATP receptor;P2XM;Purinergic receptor;Purinergic receptor P2X-like 1;, , GO:0030054;GO:0005737;GO:0043197;GO:0098978;GO:0005639;GO:0005887;GO:0099060;GO:0043025;GO:0098688;GO:0005886;GO:0014069;GO:0043235;GO:0005524;GO:0015267;GO:0004931;GO:0044877;GO:0001614;GO:0004888;GO:0007596;GO:0006936;GO:0033198;GO:0007165;, C:cell junction; C:cytoplasm; C:dendritic spine; C:glutamatergic synapse; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic density; C:receptor complex;, F:ATP binding; F:channel activity; F:extracellularly ATP-gated cation channel activity; F:protein-containing complex binding; F:purinergic nucleotide receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:muscle contraction; P:response to ATP; P:signal transduction;|O15547 F6V3D7 Q32MB6 Q58F04 Q6IC33 Q9UL50,P2X purinoceptor 6,ATP receptor;P2XM;Purinergic receptor;Purinergic receptor P2X-like 1;, , GO:0030054;GO:0005737;GO:0043197;GO:0098978;GO:0005639;GO:0005887;GO:0099060;GO:0043025;GO:0098688;GO:0005886;GO:0014069;GO:0043235;GO:0005524;GO:0015267;GO:0004931;GO:0044877;GO:0001614;GO:0004888;GO:0007596;GO:0006936;GO:0033198;GO:0007165;, C:cell junction; C:cytoplasm; C:dendritic spine; C:glutamatergic synapse; C:integral component of nuclear inner membrane; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:plasma membrane; C:postsynaptic density; C:receptor complex;, F:ATP binding; F:channel activity; F:extracellularly ATP-gated cation channel activity; F:protein-containing complex binding; F:purinergic nucleotide receptor activity; F:transmembrane signaling receptor activity;, P:blood coagulation; P:muscle contraction; P:response to ATP; P:signal transduction; scaffold167 indexed_genome mRNA 995729 996963 . + . ID=transcript_15037;O43246 Q0P5U2 Q3KNQ6 Q4VC45 Q6IBY8 Q96H88,Cationic amino acid transporter 4,Solute carrier family 7 member 4;, PF13520;PF13906;, GO:0016021;GO:0005886;GO:0015171;GO:0015174;GO:0006865;, C:integral component of membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:basic amino acid transmembrane transporter activity;, P:amino acid transport; scaffold167 indexed_genome mRNA 1013907 1015126 . - . ID=transcript_15038;P0DPH7 A6NJQ0 Q13748 Q5W099 Q6PEY3 Q96F18,Tubulin alpha-3C chain,Alpha-tubulin 2;Alpha-tubulin 3C;Tubulin alpha-2 chain;, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0005634;GO:0005525;GO:0003924;GO:0005200;GO:0000226;GO:0000278;, C:cytoplasm; C:microtubule; C:nucleus;, F:GTP binding; F:GTPase activity; F:structural constituent of cytoskeleton;, P:microtubule cytoskeleton organization; P:mitotic cell cycle; scaffold167 indexed_genome mRNA 1019773 1023080 . - . ID=transcript_15039;Q6P582 Q3SWV8 Q8WVB2,Mitotic-spindle organizing protein 2A,Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2A;, PF12926;, GO:0005813;GO:0005829;GO:0008274;GO:0005654;GO:0005819;, C:centrosome; C:cytosol; C:gamma-tubulin ring complex; C:nucleoplasm; C:spindle; scaffold167 indexed_genome mRNA 1027570 1042877 . + . ID=transcript_15040;Q6FI76 Q6P1P7 Q6ZT43 Q9H0M2 Q9NW20 Q9NWL2 Q9P2C9,Sphingomyelin phosphodiesterase 4 {ECO:0000305},Neutral sphingomyelinase 3 {ECO:0000303|PubMed:18505924};Neutral sphingomyelinase III;, PF14724;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005635;GO:0005640;GO:0042383;GO:0005802;GO:0046872;GO:0004767;GO:0050290;GO:0071356;GO:0046513;GO:0007029;GO:0046475;GO:0006687;GO:0006685;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nuclear envelope; C:nuclear outer membrane; C:sarcolemma; C:trans-Golgi network;, F:metal ion binding; F:sphingomyelin phosphodiesterase activity; F:sphingomyelin phosphodiesterase D activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:endoplasmic reticulum organization; P:glycerophospholipid catabolic process; P:glycosphingolipid metabolic process; P:sphingomyelin catabolic process;|Q6FI76 Q6P1P7 Q6ZT43 Q9H0M2 Q9NW20 Q9NWL2 Q9P2C9,Sphingomyelin phosphodiesterase 4 {ECO:0000305},Neutral sphingomyelinase 3 {ECO:0000303|PubMed:18505924};Neutral sphingomyelinase III;, PF14724;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005635;GO:0005640;GO:0042383;GO:0005802;GO:0046872;GO:0004767;GO:0050290;GO:0071356;GO:0046513;GO:0007029;GO:0046475;GO:0006687;GO:0006685;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nuclear envelope; C:nuclear outer membrane; C:sarcolemma; C:trans-Golgi network;, F:metal ion binding; F:sphingomyelin phosphodiesterase activity; F:sphingomyelin phosphodiesterase D activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:endoplasmic reticulum organization; P:glycerophospholipid catabolic process; P:glycosphingolipid metabolic process; P:sphingomyelin catabolic process;|Q6FI76 Q6P1P7 Q6ZT43 Q9H0M2 Q9NW20 Q9NWL2 Q9P2C9,Sphingomyelin phosphodiesterase 4 {ECO:0000305},Neutral sphingomyelinase 3 {ECO:0000303|PubMed:18505924};Neutral sphingomyelinase III;, PF14724;, GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005635;GO:0005640;GO:0042383;GO:0005802;GO:0046872;GO:0004767;GO:0050290;GO:0071356;GO:0046513;GO:0007029;GO:0046475;GO:0006687;GO:0006685;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:nuclear envelope; C:nuclear outer membrane; C:sarcolemma; C:trans-Golgi network;, F:metal ion binding; F:sphingomyelin phosphodiesterase activity; F:sphingomyelin phosphodiesterase D activity;, P:cellular response to tumor necrosis factor; P:ceramide biosynthetic process; P:endoplasmic reticulum organization; P:glycerophospholipid catabolic process; P:glycosphingolipid metabolic process; P:sphingomyelin catabolic process; scaffold167 indexed_genome mRNA 1046072 1050400 . + . ID=transcript_15041;Q9BXR3 Q6KH04 Q9BXR4 Q9UKH5 Q9UP31 Q9WIK9 Q9WJR4,Endogenous retrovirus group K member 6 Pol protein,HERV-K(C7) Pol protein;HERV-K(HML-2.HOM) Pol protein;HERV-K108 Pol protein;HERV-K_7p22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold167 indexed_genome mRNA 1058408 1059481 . + . ID=transcript_15042;Q96RN5 D3DX31 D3DX32 O15413 Q6IC31 Q8NF16 Q96CT0 Q96IH7 Q9P1T3,Mediator of RNA polymerase II transcription subunit 15,Activator-recruited cofactor 105 kDa component;CTG repeat protein 7a;Mediator complex subunit 15;Positive cofactor 2 glutamine/Q-rich-associated protein;TPA-inducible gene 1 protein;Trinucleotide repeat-containing gene 7 protein;, PF09606;, GO:0005737;GO:0016592;GO:0016020;GO:0005654;GO:0003712;GO:0060260;, C:cytoplasm; C:mediator complex; C:membrane; C:nucleoplasm;, F:transcription coregulator activity;, P:regulation of transcription initiation from RNA polymerase II promoter; scaffold167 indexed_genome mRNA 1059598 1061573 . - . ID=transcript_15043;Q96RN5 D3DX31 D3DX32 O15413 Q6IC31 Q8NF16 Q96CT0 Q96IH7 Q9P1T3,Mediator of RNA polymerase II transcription subunit 15,Activator-recruited cofactor 105 kDa component;CTG repeat protein 7a;Mediator complex subunit 15;Positive cofactor 2 glutamine/Q-rich-associated protein;TPA-inducible gene 1 protein;Trinucleotide repeat-containing gene 7 protein;, PF09606;, GO:0005737;GO:0016592;GO:0016020;GO:0005654;GO:0003712;GO:0060260;, C:cytoplasm; C:mediator complex; C:membrane; C:nucleoplasm;, F:transcription coregulator activity;, P:regulation of transcription initiation from RNA polymerase II promoter;|Q96RN5 D3DX31 D3DX32 O15413 Q6IC31 Q8NF16 Q96CT0 Q96IH7 Q9P1T3,Mediator of RNA polymerase II transcription subunit 15,Activator-recruited cofactor 105 kDa component;CTG repeat protein 7a;Mediator complex subunit 15;Positive cofactor 2 glutamine/Q-rich-associated protein;TPA-inducible gene 1 protein;Trinucleotide repeat-containing gene 7 protein;, PF09606;, GO:0005737;GO:0016592;GO:0016020;GO:0005654;GO:0003712;GO:0060260;, C:cytoplasm; C:mediator complex; C:membrane; C:nucleoplasm;, F:transcription coregulator activity;, P:regulation of transcription initiation from RNA polymerase II promoter; scaffold167 indexed_genome mRNA 1066718 1100581 . - . ID=transcript_15044;Q96RN5 D3DX31 D3DX32 O15413 Q6IC31 Q8NF16 Q96CT0 Q96IH7 Q9P1T3,Mediator of RNA polymerase II transcription subunit 15,Activator-recruited cofactor 105 kDa component;CTG repeat protein 7a;Mediator complex subunit 15;Positive cofactor 2 glutamine/Q-rich-associated protein;TPA-inducible gene 1 protein;Trinucleotide repeat-containing gene 7 protein;, PF09606;, GO:0005737;GO:0016592;GO:0016020;GO:0005654;GO:0003712;GO:0060260;, C:cytoplasm; C:mediator complex; C:membrane; C:nucleoplasm;, F:transcription coregulator activity;, P:regulation of transcription initiation from RNA polymerase II promoter; scaffold167 indexed_genome mRNA 1114181 1130191 . + . ID=transcript_15045;Q53GT1 A8K3Q4 A8MTV3 B7Z2G1 D3DX30 Q96B68 Q96KC6,Kelch-like protein 22 {ECO:0000305},, PF07707;PF00651;PF01344;, GO:0005813;GO:0031463;GO:0005737;GO:0005829;GO:0045171;GO:0043231;GO:0005764;GO:0015630;GO:0072686;GO:0005634;GO:0005827;GO:0071889;GO:0051301;GO:0071233;GO:0000070;GO:0007094;GO:0010507;GO:0030307;GO:1904263;GO:0043687;GO:0043161;GO:0006513;, C:centrosome; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:lysosome; C:microtubule cytoskeleton; C:mitotic spindle; C:nucleus; C:polar microtubule;, F:14-3-3 protein binding;, P:cell division; P:cellular response to leucine; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:negative regulation of autophagy; P:positive regulation of cell growth; P:positive regulation of TORC1 signaling; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination;|Q53GT1 A8K3Q4 A8MTV3 B7Z2G1 D3DX30 Q96B68 Q96KC6,Kelch-like protein 22 {ECO:0000305},, PF07707;PF00651;PF01344;, GO:0005813;GO:0031463;GO:0005737;GO:0005829;GO:0045171;GO:0043231;GO:0005764;GO:0015630;GO:0072686;GO:0005634;GO:0005827;GO:0071889;GO:0051301;GO:0071233;GO:0000070;GO:0007094;GO:0010507;GO:0030307;GO:1904263;GO:0043687;GO:0043161;GO:0006513;, C:centrosome; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:lysosome; C:microtubule cytoskeleton; C:mitotic spindle; C:nucleus; C:polar microtubule;, F:14-3-3 protein binding;, P:cell division; P:cellular response to leucine; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:negative regulation of autophagy; P:positive regulation of cell growth; P:positive regulation of TORC1 signaling; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination;|Q53GT1 A8K3Q4 A8MTV3 B7Z2G1 D3DX30 Q96B68 Q96KC6,Kelch-like protein 22 {ECO:0000305},, PF07707;PF00651;PF01344;, GO:0005813;GO:0031463;GO:0005737;GO:0005829;GO:0045171;GO:0043231;GO:0005764;GO:0015630;GO:0072686;GO:0005634;GO:0005827;GO:0071889;GO:0051301;GO:0071233;GO:0000070;GO:0007094;GO:0010507;GO:0030307;GO:1904263;GO:0043687;GO:0043161;GO:0006513;, C:centrosome; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:lysosome; C:microtubule cytoskeleton; C:mitotic spindle; C:nucleus; C:polar microtubule;, F:14-3-3 protein binding;, P:cell division; P:cellular response to leucine; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:negative regulation of autophagy; P:positive regulation of cell growth; P:positive regulation of TORC1 signaling; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination;|Q53GT1 A8K3Q4 A8MTV3 B7Z2G1 D3DX30 Q96B68 Q96KC6,Kelch-like protein 22 {ECO:0000305},, PF07707;PF00651;PF01344;, GO:0005813;GO:0031463;GO:0005737;GO:0005829;GO:0045171;GO:0043231;GO:0005764;GO:0015630;GO:0072686;GO:0005634;GO:0005827;GO:0071889;GO:0051301;GO:0071233;GO:0000070;GO:0007094;GO:0010507;GO:0030307;GO:1904263;GO:0043687;GO:0043161;GO:0006513;, C:centrosome; C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:lysosome; C:microtubule cytoskeleton; C:mitotic spindle; C:nucleus; C:polar microtubule;, F:14-3-3 protein binding;, P:cell division; P:cellular response to leucine; P:mitotic sister chromatid segregation; P:mitotic spindle assembly checkpoint; P:negative regulation of autophagy; P:positive regulation of cell growth; P:positive regulation of TORC1 signaling; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; scaffold167 indexed_genome mRNA 1140114 1140762 . - . ID=transcript_15046;Q96GP6 E5RFB8 Q58A83 Q8IXF3 Q9BW74,Scavenger receptor class F member 2,SRECRP-1;Scavenger receptor expressed by endothelial cells 2 protein;, PF00053;, GO:0005925;GO:0016021;GO:0005044;GO:0007157;, C:focal adhesion; C:integral component of membrane;, F:scavenger receptor activity;, P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; scaffold167 indexed_genome mRNA 1165349 1168252 . - . ID=transcript_15047;Q16587 B5MCE3 B7Z5Y2 Q6IBV2 Q6PJP1 Q9UC04 Q9UF05 Q9UF06 Q9UF07,Zinc finger protein 74,Zinc finger protein 520;hZNF7;, PF01352;PF00096;, GO:0015629;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0003723;GO:0000978;GO:0007275;GO:0006357;GO:0006355;, C:actin cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold167 indexed_genome mRNA 1187111 1196173 . - . ID=transcript_15048;P98153 A6NIB5 A8K6K5 B5TY34 B7Z935,Integral membrane protein DGCR2/IDD,, PF00057;PF00059;, GO:0016021;GO:0016020;GO:0030246;GO:0009887;GO:0007155;GO:0050890;, C:integral component of membrane; C:membrane;, F:carbohydrate binding;, P:animal organ morphogenesis; P:cell adhesion; P:cognition;|P98153 A6NIB5 A8K6K5 B5TY34 B7Z935,Integral membrane protein DGCR2/IDD,, PF00057;PF00059;, GO:0016021;GO:0016020;GO:0030246;GO:0009887;GO:0007155;GO:0050890;, C:integral component of membrane; C:membrane;, F:carbohydrate binding;, P:animal organ morphogenesis; P:cell adhesion; P:cognition; scaffold167 indexed_genome mRNA 1229313 1242266 . - . ID=transcript_15049;Q96DF8 Q49AH7 Q9BTZ4,Splicing factor ESS-2 homolog {ECO:0000305},DiGeorge syndrome critical region 13;DiGeorge syndrome critical region 14;DiGeorge syndrome protein H;Protein ES2;, PF09751;, GO:0071013;GO:0005634;GO:0000398;GO:0007399;, C:catalytic step 2 spliceosome; C:nucleus;, , P:mRNA splicing, via spliceosome; P:nervous system development; scaffold167 indexed_genome mRNA 1256202 1258409 . - . ID=transcript_15050;P53007 A8K8E8 Q9BSK6,Tricarboxylate transport protein, mitochondrial,Citrate transport protein;Solute carrier family 25 member 1;Tricarboxylate carrier protein;, PF00153;, GO:0070062;GO:0016021;GO:0005743;GO:0005634;GO:0071913;GO:0015137;GO:0046949;GO:0006094;GO:0006843;, C:extracellular exosome; C:integral component of membrane; C:mitochondrial inner membrane; C:nucleus;, F:citrate secondary active transmembrane transporter activity; F:citrate transmembrane transporter activity;, P:fatty-acyl-CoA biosynthetic process; P:gluconeogenesis; P:mitochondrial citrate transmembrane transport;|P53007 A8K8E8 Q9BSK6,Tricarboxylate transport protein, mitochondrial,Citrate transport protein;Solute carrier family 25 member 1;Tricarboxylate carrier protein;, PF00153;, GO:0070062;GO:0016021;GO:0005743;GO:0005634;GO:0071913;GO:0015137;GO:0046949;GO:0006094;GO:0006843;, C:extracellular exosome; C:integral component of membrane; C:mitochondrial inner membrane; C:nucleus;, F:citrate secondary active transmembrane transporter activity; F:citrate transmembrane transporter activity;, P:fatty-acyl-CoA biosynthetic process; P:gluconeogenesis; P:mitochondrial citrate transmembrane transport; scaffold167 indexed_genome mRNA 1276365 1277602 . + . ID=transcript_15051;P53007 A8K8E8 Q9BSK6,Tricarboxylate transport protein, mitochondrial,Citrate transport protein;Solute carrier family 25 member 1;Tricarboxylate carrier protein;, PF00153;, GO:0070062;GO:0016021;GO:0005743;GO:0005634;GO:0071913;GO:0015137;GO:0046949;GO:0006094;GO:0006843;, C:extracellular exosome; C:integral component of membrane; C:mitochondrial inner membrane; C:nucleus;, F:citrate secondary active transmembrane transporter activity; F:citrate transmembrane transporter activity;, P:fatty-acyl-CoA biosynthetic process; P:gluconeogenesis; P:mitochondrial citrate transmembrane transport; scaffold167 indexed_genome mRNA 1287523 1288817 . - . ID=transcript_15052;P54198 Q05BU9 Q8IXN2,Protein HIRA,TUP1-like enhancer of split protein 1;, PF07569;PF00400;, GO:0000785;GO:0070062;GO:0000417;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0042393;GO:0001085;GO:0003714;GO:0009653;GO:0006336;GO:0006357;GO:0006351;, C:chromatin; C:extracellular exosome; C:HIR complex; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:histone binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:DNA replication-independent nucleosome assembly; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold167 indexed_genome mRNA 1290084 1296944 . - . ID=transcript_15053;P54198 Q05BU9 Q8IXN2,Protein HIRA,TUP1-like enhancer of split protein 1;, PF07569;PF00400;, GO:0000785;GO:0070062;GO:0000417;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0042393;GO:0001085;GO:0003714;GO:0009653;GO:0006336;GO:0006357;GO:0006351;, C:chromatin; C:extracellular exosome; C:HIR complex; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:histone binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:DNA replication-independent nucleosome assembly; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated;|P54198 Q05BU9 Q8IXN2,Protein HIRA,TUP1-like enhancer of split protein 1;, PF07569;PF00400;, GO:0000785;GO:0070062;GO:0000417;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0042393;GO:0001085;GO:0003714;GO:0009653;GO:0006336;GO:0006357;GO:0006351;, C:chromatin; C:extracellular exosome; C:HIR complex; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:histone binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:DNA replication-independent nucleosome assembly; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated;|P54198 Q05BU9 Q8IXN2,Protein HIRA,TUP1-like enhancer of split protein 1;, PF07569;PF00400;, GO:0000785;GO:0070062;GO:0000417;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0042393;GO:0001085;GO:0003714;GO:0009653;GO:0006336;GO:0006357;GO:0006351;, C:chromatin; C:extracellular exosome; C:HIR complex; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:histone binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:DNA replication-independent nucleosome assembly; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold167 indexed_genome mRNA 1298357 1299539 . + . ID=transcript_15054;P54198 Q05BU9 Q8IXN2,Protein HIRA,TUP1-like enhancer of split protein 1;, PF07569;PF00400;, GO:0000785;GO:0070062;GO:0000417;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0042393;GO:0001085;GO:0003714;GO:0009653;GO:0006336;GO:0006357;GO:0006351;, C:chromatin; C:extracellular exosome; C:HIR complex; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:histone binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:DNA replication-independent nucleosome assembly; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold167 indexed_genome mRNA 1300211 1301943 . - . ID=transcript_15055;P62906 B2R801 P52859 P53025 Q5TZT6 Q8J013,60S ribosomal protein L10a,CSA-19;Large ribosomal subunit protein uL1 {ECO:0000303|PubMed:24524803};Neural precursor cell expressed developmentally down-regulated protein 6;, PF00687;, GO:0005829;GO:0022625;GO:0070062;GO:0005925;GO:0016020;GO:0005634;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000470;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleus; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:maturation of LSU-rRNA; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold167 indexed_genome mRNA 1302052 1305702 . - . ID=transcript_15056;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold167 indexed_genome mRNA 1305733 1307513 . - . ID=transcript_15057;P54198 Q05BU9 Q8IXN2,Protein HIRA,TUP1-like enhancer of split protein 1;, PF07569;PF00400;, GO:0000785;GO:0070062;GO:0000417;GO:0005654;GO:0005634;GO:0016605;GO:0032991;GO:0042393;GO:0001085;GO:0003714;GO:0009653;GO:0006336;GO:0006357;GO:0006351;, C:chromatin; C:extracellular exosome; C:HIR complex; C:nucleoplasm; C:nucleus; C:PML body; C:protein-containing complex;, F:histone binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:anatomical structure morphogenesis; P:DNA replication-independent nucleosome assembly; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated; scaffold167 indexed_genome mRNA 1336437 1337372 . + . ID=transcript_15058;Q9NQ50 B3KVZ7 O95134,39S ribosomal protein L40, mitochondrial,Mitochondrial large ribosomal subunit protein mL40 {ECO:0000303|PubMed:25278503};Nuclear localization signal-containing protein deleted in velocardiofacial syndrome;Up-regulated in metastasis;, PF09812;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0005730;GO:0005634;GO:0003723;GO:0009653;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion; C:nucleolus; C:nucleus;, F:RNA binding;, P:anatomical structure morphogenesis; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold167 indexed_genome mRNA 1338040 1342357 . - . ID=transcript_15059;Q6P5X5 A8MTW6 D3DX18 F5H3A8 J3KNP9,UPF0545 protein C22orf39,, PF11326; scaffold167 indexed_genome mRNA 1343657 1358383 . - . ID=transcript_15060;Q92890 A8MW31 Q9Y5N0,Ubiquitin recognition factor in ER-associated degradation protein 1 {ECO:0000312|HGNC:HGNC:12520},Ubiquitin fusion degradation protein 1;, PF03152;, GO:0005829;GO:0005654;GO:0005634;GO:0036501;GO:0034098;GO:0051117;GO:0036435;GO:0031593;GO:0044877;GO:0005102;GO:0004843;GO:0071712;GO:0070987;GO:0039536;GO:0032480;GO:0016579;GO:0030970;GO:0001501;GO:0030433;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus; C:UFD1-NPL4 complex; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:ATPase binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding; F:protein-containing complex binding; F:signaling receptor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:ER-associated misfolded protein catabolic process; P:error-free translesion synthesis; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:protein deubiquitination; P:retrograde protein transport, ER to cytosol; P:skeletal system development; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q92890 A8MW31 Q9Y5N0,Ubiquitin recognition factor in ER-associated degradation protein 1 {ECO:0000312|HGNC:HGNC:12520},Ubiquitin fusion degradation protein 1;, PF03152;, GO:0005829;GO:0005654;GO:0005634;GO:0036501;GO:0034098;GO:0051117;GO:0036435;GO:0031593;GO:0044877;GO:0005102;GO:0004843;GO:0071712;GO:0070987;GO:0039536;GO:0032480;GO:0016579;GO:0030970;GO:0001501;GO:0030433;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus; C:UFD1-NPL4 complex; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:ATPase binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding; F:protein-containing complex binding; F:signaling receptor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:ER-associated misfolded protein catabolic process; P:error-free translesion synthesis; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:protein deubiquitination; P:retrograde protein transport, ER to cytosol; P:skeletal system development; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q92890 A8MW31 Q9Y5N0,Ubiquitin recognition factor in ER-associated degradation protein 1 {ECO:0000312|HGNC:HGNC:12520},Ubiquitin fusion degradation protein 1;, PF03152;, GO:0005829;GO:0005654;GO:0005634;GO:0036501;GO:0034098;GO:0051117;GO:0036435;GO:0031593;GO:0044877;GO:0005102;GO:0004843;GO:0071712;GO:0070987;GO:0039536;GO:0032480;GO:0016579;GO:0030970;GO:0001501;GO:0030433;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus; C:UFD1-NPL4 complex; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:ATPase binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding; F:protein-containing complex binding; F:signaling receptor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:ER-associated misfolded protein catabolic process; P:error-free translesion synthesis; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:protein deubiquitination; P:retrograde protein transport, ER to cytosol; P:skeletal system development; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q92890 A8MW31 Q9Y5N0,Ubiquitin recognition factor in ER-associated degradation protein 1 {ECO:0000312|HGNC:HGNC:12520},Ubiquitin fusion degradation protein 1;, PF03152;, GO:0005829;GO:0005654;GO:0005634;GO:0036501;GO:0034098;GO:0051117;GO:0036435;GO:0031593;GO:0044877;GO:0005102;GO:0004843;GO:0071712;GO:0070987;GO:0039536;GO:0032480;GO:0016579;GO:0030970;GO:0001501;GO:0030433;GO:0006511;, C:cytosol; C:nucleoplasm; C:nucleus; C:UFD1-NPL4 complex; C:VCP-NPL4-UFD1 AAA ATPase complex;, F:ATPase binding; F:K48-linked polyubiquitin modification-dependent protein binding; F:polyubiquitin modification-dependent protein binding; F:protein-containing complex binding; F:signaling receptor binding; F:thiol-dependent ubiquitin-specific protease activity;, P:ER-associated misfolded protein catabolic process; P:error-free translesion synthesis; P:negative regulation of RIG-I signaling pathway; P:negative regulation of type I interferon production; P:protein deubiquitination; P:retrograde protein transport, ER to cytosol; P:skeletal system development; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold167 indexed_genome mRNA 1358917 1371122 . + . ID=transcript_15061;O75419 B4DDB4 B4DDU3 E9PDH7 O60856 Q20WK8 Q6UW54 Q9UP68,Cell division control protein 45 homolog,PORC-PI-1;, PF02724;, GO:0005813;GO:0036064;GO:0005737;GO:0031261;GO:0005654;GO:0005634;GO:0003682;GO:0003688;GO:0003697;GO:0006260;GO:0000076;GO:0006270;GO:0000727;GO:1902977;GO:0031938;GO:0000083;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:DNA replication preinitiation complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA replication origin binding; F:single-stranded DNA binding;, P:DNA replication; P:DNA replication checkpoint; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:mitotic DNA replication preinitiation complex assembly; P:regulation of chromatin silencing at telomere; P:regulation of transcription involved in G1/S transition of mitotic cell cycle;|O75419 B4DDB4 B4DDU3 E9PDH7 O60856 Q20WK8 Q6UW54 Q9UP68,Cell division control protein 45 homolog,PORC-PI-1;, PF02724;, GO:0005813;GO:0036064;GO:0005737;GO:0031261;GO:0005654;GO:0005634;GO:0003682;GO:0003688;GO:0003697;GO:0006260;GO:0000076;GO:0006270;GO:0000727;GO:1902977;GO:0031938;GO:0000083;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:DNA replication preinitiation complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:DNA replication origin binding; F:single-stranded DNA binding;, P:DNA replication; P:DNA replication checkpoint; P:DNA replication initiation; P:double-strand break repair via break-induced replication; P:mitotic DNA replication preinitiation complex assembly; P:regulation of chromatin silencing at telomere; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; scaffold167 indexed_genome mRNA 1376069 1377614 . + . ID=transcript_15062;O00501 B3KS11 Q53XW2 Q8WUW3,Claudin-5,Transmembrane protein deleted in VCFS;, PF00822;, GO:0016327;GO:0005923;GO:0030054;GO:0005911;GO:0016021;GO:0005886;GO:0070160;GO:0042802;GO:0005198;GO:0070830;GO:0016338;GO:0007155;GO:0007043;GO:1990963;GO:0060325;GO:0007612;GO:0035633;GO:0016525;GO:0030336;GO:0010629;GO:0043116;GO:0003151;GO:1903348;GO:0008284;GO:1903142;GO:0010628;GO:0032092;GO:2000810;GO:0060021;GO:0120192;GO:0007179;, C:apicolateral plasma membrane; C:bicellular tight junction; C:cell junction; C:cell-cell junction; C:integral component of membrane; C:plasma membrane; C:tight junction;, F:identical protein binding; F:structural molecule activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:cell-cell junction assembly; P:establishment of blood-retinal barrier; P:face morphogenesis; P:learning; P:maintenance of blood-brain barrier; P:negative regulation of angiogenesis; P:negative regulation of cell migration; P:negative regulation of gene expression; P:negative regulation of vascular permeability; P:outflow tract morphogenesis; P:positive regulation of bicellular tight junction assembly; P:positive regulation of cell population proliferation; P:positive regulation of establishment of endothelial barrier; P:positive regulation of gene expression; P:positive regulation of protein binding; P:regulation of bicellular tight junction assembly; P:roof of mouth development; P:tight junction assembly; P:transforming growth factor beta receptor signaling pathway; scaffold167 indexed_genome mRNA 1476679 1483845 . - . ID=transcript_15063;Q9BYB4 Q9H2S2 Q9H4M4,Guanine nucleotide-binding protein subunit beta-like protein 1,DGCRK3;WD repeat-containing protein 14;WD40 repeat-containing protein deleted in VCFS;, PF00400;, GO:0009898;GO:0007186;GO:0035556;, C:cytoplasmic side of plasma membrane;, , P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction;|Q9BYB4 Q9H2S2 Q9H4M4,Guanine nucleotide-binding protein subunit beta-like protein 1,DGCRK3;WD repeat-containing protein 14;WD40 repeat-containing protein deleted in VCFS;, PF00400;, GO:0009898;GO:0007186;GO:0035556;, C:cytoplasmic side of plasma membrane;, , P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction;|Q9BYB4 Q9H2S2 Q9H4M4,Guanine nucleotide-binding protein subunit beta-like protein 1,DGCRK3;WD repeat-containing protein 14;WD40 repeat-containing protein deleted in VCFS;, PF00400;, GO:0009898;GO:0007186;GO:0035556;, C:cytoplasmic side of plasma membrane;, , P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction;|Q9BYB4 Q9H2S2 Q9H4M4,Guanine nucleotide-binding protein subunit beta-like protein 1,DGCRK3;WD repeat-containing protein 14;WD40 repeat-containing protein deleted in VCFS;, PF00400;, GO:0009898;GO:0007186;GO:0035556;, C:cytoplasmic side of plasma membrane;, , P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; scaffold168 indexed_genome mRNA 38894 39731 . + . ID=transcript_15064;Q6DN90 A0A087WWK8 O94863 Q96D85,IQ motif and SEC7 domain-containing protein 1 {ECO:0000305},ADP-ribosylation factors guanine nucleotide-exchange protein 100;ADP-ribosylation factors guanine nucleotide-exchange protein 2;Brefeldin-resistant Arf-GEF 2 protein {ECO:0000303|PubMed:16461286};, PF16453;PF01369;, GO:0043231;GO:0016020;GO:0005730;GO:0014069;GO:0008021;GO:0005085;GO:0008289;GO:0030036;GO:0060996;GO:0120183;GO:0043547;GO:0051549;GO:0032012;, C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:postsynaptic density; C:synaptic vesicle;, F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:actin cytoskeleton organization; P:dendritic spine development; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:regulation of ARF protein signal transduction; scaffold168 indexed_genome mRNA 43080 57406 . + . ID=transcript_15065;Q6DN90 A0A087WWK8 O94863 Q96D85,IQ motif and SEC7 domain-containing protein 1 {ECO:0000305},ADP-ribosylation factors guanine nucleotide-exchange protein 100;ADP-ribosylation factors guanine nucleotide-exchange protein 2;Brefeldin-resistant Arf-GEF 2 protein {ECO:0000303|PubMed:16461286};, PF16453;PF01369;, GO:0043231;GO:0016020;GO:0005730;GO:0014069;GO:0008021;GO:0005085;GO:0008289;GO:0030036;GO:0060996;GO:0120183;GO:0043547;GO:0051549;GO:0032012;, C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:postsynaptic density; C:synaptic vesicle;, F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:actin cytoskeleton organization; P:dendritic spine development; P:positive regulation of focal adhesion disassembly; P:positive regulation of GTPase activity; P:positive regulation of keratinocyte migration; P:regulation of ARF protein signal transduction; scaffold168 indexed_genome mRNA 112561 114380 . + . ID=transcript_15066;Q9H845 D3DNB8 Q8WXX3,Complex I assembly factor ACAD9, mitochondrial {ECO:0000303|PubMed:24158852},Acyl-CoA dehydrogenase family member 9 {ECO:0000303|PubMed:12359260};, PF00441;PF02770;PF02771;, GO:0030425;GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0000062;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0001676;GO:0051791;GO:0032981;, C:dendrite; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:long-chain fatty acid metabolic process; P:medium-chain fatty acid metabolic process; P:mitochondrial respiratory chain complex I assembly; scaffold168 indexed_genome mRNA 114754 118871 . - . ID=transcript_15067;Q9H845 D3DNB8 Q8WXX3,Complex I assembly factor ACAD9, mitochondrial {ECO:0000303|PubMed:24158852},Acyl-CoA dehydrogenase family member 9 {ECO:0000303|PubMed:12359260};, PF00441;PF02770;PF02771;, GO:0030425;GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0000062;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0001676;GO:0051791;GO:0032981;, C:dendrite; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:long-chain fatty acid metabolic process; P:medium-chain fatty acid metabolic process; P:mitochondrial respiratory chain complex I assembly; scaffold168 indexed_genome mRNA 119202 150756 . + . ID=transcript_15068;Q9H845 D3DNB8 Q8WXX3,Complex I assembly factor ACAD9, mitochondrial {ECO:0000303|PubMed:24158852},Acyl-CoA dehydrogenase family member 9 {ECO:0000303|PubMed:12359260};, PF00441;PF02770;PF02771;, GO:0030425;GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0000062;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0001676;GO:0051791;GO:0032981;, C:dendrite; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:long-chain fatty acid metabolic process; P:medium-chain fatty acid metabolic process; P:mitochondrial respiratory chain complex I assembly;|Q9H845 D3DNB8 Q8WXX3,Complex I assembly factor ACAD9, mitochondrial {ECO:0000303|PubMed:24158852},Acyl-CoA dehydrogenase family member 9 {ECO:0000303|PubMed:12359260};, PF00441;PF02770;PF02771;, GO:0030425;GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0000062;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0001676;GO:0051791;GO:0032981;, C:dendrite; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:long-chain fatty acid metabolic process; P:medium-chain fatty acid metabolic process; P:mitochondrial respiratory chain complex I assembly;|Q9H845 D3DNB8 Q8WXX3,Complex I assembly factor ACAD9, mitochondrial {ECO:0000303|PubMed:24158852},Acyl-CoA dehydrogenase family member 9 {ECO:0000303|PubMed:12359260};, PF00441;PF02770;PF02771;, GO:0030425;GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0000062;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0001676;GO:0051791;GO:0032981;, C:dendrite; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:long-chain fatty acid metabolic process; P:medium-chain fatty acid metabolic process; P:mitochondrial respiratory chain complex I assembly;|Q9H845 D3DNB8 Q8WXX3,Complex I assembly factor ACAD9, mitochondrial {ECO:0000303|PubMed:24158852},Acyl-CoA dehydrogenase family member 9 {ECO:0000303|PubMed:12359260};, PF00441;PF02770;PF02771;, GO:0030425;GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0000062;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0001676;GO:0051791;GO:0032981;, C:dendrite; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:long-chain fatty acid metabolic process; P:medium-chain fatty acid metabolic process; P:mitochondrial respiratory chain complex I assembly;|Q9H845 D3DNB8 Q8WXX3,Complex I assembly factor ACAD9, mitochondrial {ECO:0000303|PubMed:24158852},Acyl-CoA dehydrogenase family member 9 {ECO:0000303|PubMed:12359260};, PF00441;PF02770;PF02771;, GO:0030425;GO:0005743;GO:0031966;GO:0005739;GO:0005634;GO:0000062;GO:0050660;GO:0004466;GO:0070991;GO:0017099;GO:0001676;GO:0051791;GO:0032981;, C:dendrite; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrion; C:nucleus;, F:fatty-acyl-CoA binding; F:flavin adenine dinucleotide binding; F:long-chain-acyl-CoA dehydrogenase activity; F:medium-chain-acyl-CoA dehydrogenase activity; F:very-long-chain-acyl-CoA dehydrogenase activity;, P:long-chain fatty acid metabolic process; P:medium-chain fatty acid metabolic process; P:mitochondrial respiratory chain complex I assembly;|Q6ZUG5,Uncharacterized protein FLJ43738|Q6ZUG5,Uncharacterized protein FLJ43738 scaffold168 indexed_genome mRNA 151341 153795 . - . ID=transcript_15069;Q9ULG3 Q8IXY7 Q8N5T4,Uncharacterized protein CFAP92,Putative cilia and flagella associated protein 92 {ECO:0000312|HGNC:HGNC:29231};, PF15084; scaffold168 indexed_genome mRNA 184222 191010 . - . ID=transcript_15070;Q9HA90 A8MYE2,EF-hand and coiled-coil domain-containing protein 1,Coiled-coil domain-containing protein 48;, PF15799;, GO:0005829;GO:0005509;, C:cytosol;, F:calcium ion binding;|Q9HA90 A8MYE2,EF-hand and coiled-coil domain-containing protein 1,Coiled-coil domain-containing protein 48;, PF15799;, GO:0005829;GO:0005509;, C:cytosol;, F:calcium ion binding;|Q9HA90 A8MYE2,EF-hand and coiled-coil domain-containing protein 1,Coiled-coil domain-containing protein 48;, PF15799;, GO:0005829;GO:0005509;, C:cytosol;, F:calcium ion binding;|Q9HA90 A8MYE2,EF-hand and coiled-coil domain-containing protein 1,Coiled-coil domain-containing protein 48;, PF15799;, GO:0005829;GO:0005509;, C:cytosol;, F:calcium ion binding; scaffold168 indexed_genome mRNA 231246 246456 . - . ID=transcript_15071;Q9ULR0 Q96IL2 Q9BT05,Pre-mRNA-splicing factor ISY1 homolog,, PF06246;, GO:0071013;GO:0005654;GO:0005634;GO:0071014;GO:0071020;GO:0000974;GO:0071006;GO:0003723;GO:0000350;GO:0000389;GO:0000398;GO:0006283;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:post-spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 1 spliceosome;, F:RNA binding;, P:generation of catalytic spliceosome for second transesterification step; P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:transcription-coupled nucleotide-excision repair;|Q9ULR0 Q96IL2 Q9BT05,Pre-mRNA-splicing factor ISY1 homolog,, PF06246;, GO:0071013;GO:0005654;GO:0005634;GO:0071014;GO:0071020;GO:0000974;GO:0071006;GO:0003723;GO:0000350;GO:0000389;GO:0000398;GO:0006283;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:post-spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 1 spliceosome;, F:RNA binding;, P:generation of catalytic spliceosome for second transesterification step; P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:transcription-coupled nucleotide-excision repair;|Q9ULR0 Q96IL2 Q9BT05,Pre-mRNA-splicing factor ISY1 homolog,, PF06246;, GO:0071013;GO:0005654;GO:0005634;GO:0071014;GO:0071020;GO:0000974;GO:0071006;GO:0003723;GO:0000350;GO:0000389;GO:0000398;GO:0006283;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:post-spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 1 spliceosome;, F:RNA binding;, P:generation of catalytic spliceosome for second transesterification step; P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:transcription-coupled nucleotide-excision repair;|Q9ULR0 Q96IL2 Q9BT05,Pre-mRNA-splicing factor ISY1 homolog,, PF06246;, GO:0071013;GO:0005654;GO:0005634;GO:0071014;GO:0071020;GO:0000974;GO:0071006;GO:0003723;GO:0000350;GO:0000389;GO:0000398;GO:0006283;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:post-spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 1 spliceosome;, F:RNA binding;, P:generation of catalytic spliceosome for second transesterification step; P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:transcription-coupled nucleotide-excision repair;|Q9ULR0 Q96IL2 Q9BT05,Pre-mRNA-splicing factor ISY1 homolog,, PF06246;, GO:0071013;GO:0005654;GO:0005634;GO:0071014;GO:0071020;GO:0000974;GO:0071006;GO:0003723;GO:0000350;GO:0000389;GO:0000398;GO:0006283;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:post-spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 1 spliceosome;, F:RNA binding;, P:generation of catalytic spliceosome for second transesterification step; P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:transcription-coupled nucleotide-excision repair;|Q9ULR0 Q96IL2 Q9BT05,Pre-mRNA-splicing factor ISY1 homolog,, PF06246;, GO:0071013;GO:0005654;GO:0005634;GO:0071014;GO:0071020;GO:0000974;GO:0071006;GO:0003723;GO:0000350;GO:0000389;GO:0000398;GO:0006283;, C:catalytic step 2 spliceosome; C:nucleoplasm; C:nucleus; C:post-mRNA release spliceosomal complex; C:post-spliceosomal complex; C:Prp19 complex; C:U2-type catalytic step 1 spliceosome;, F:RNA binding;, P:generation of catalytic spliceosome for second transesterification step; P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:transcription-coupled nucleotide-excision repair; scaffold168 indexed_genome mRNA 253164 267101 . - . ID=transcript_15072;Q4JGY0 Q4JGY1 Q5QJR0 Q5U0E9 Q6PJI7 Q96NV3,Cellular nucleic acid-binding protein,Zinc finger protein 9;, PF00098;, GO:0005737;GO:0005829;GO:0005783;GO:0005634;GO:0051880;GO:0003729;GO:0003723;GO:0003697;GO:0003727;GO:0045182;GO:0008270;GO:0042632;GO:0071919;GO:0000122;GO:0008284;GO:2000767;GO:0045944;GO:0045893;GO:0006355;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleus;, F:G-quadruplex DNA binding; F:mRNA binding; F:RNA binding; F:single-stranded DNA binding; F:single-stranded RNA binding; F:translation regulator activity; F:zinc ion binding;, P:cholesterol homeostasis; P:G-quadruplex DNA formation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of cytoplasmic translation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated;|Q4JGY0 Q4JGY1 Q5QJR0 Q5U0E9 Q6PJI7 Q96NV3,Cellular nucleic acid-binding protein,Zinc finger protein 9;, PF00098;, GO:0005737;GO:0005829;GO:0005783;GO:0005634;GO:0051880;GO:0003729;GO:0003723;GO:0003697;GO:0003727;GO:0045182;GO:0008270;GO:0042632;GO:0071919;GO:0000122;GO:0008284;GO:2000767;GO:0045944;GO:0045893;GO:0006355;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleus;, F:G-quadruplex DNA binding; F:mRNA binding; F:RNA binding; F:single-stranded DNA binding; F:single-stranded RNA binding; F:translation regulator activity; F:zinc ion binding;, P:cholesterol homeostasis; P:G-quadruplex DNA formation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of cytoplasmic translation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold168 indexed_genome mRNA 324237 325705 . + . ID=transcript_15073;Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold168 indexed_genome mRNA 326561 338892 . - . ID=transcript_15074;Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9Y678 A8K6M8 B3KMF6 Q54AC4,Coatomer subunit gamma-1,Gamma-1-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0005794;GO:0000139;GO:0030133;GO:0005198;GO:0006888;GO:0051683;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:Golgi membrane; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:establishment of Golgi localization; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold168 indexed_genome mRNA 350886 351423 . + . ID=transcript_15075;Q96FZ2 A6NJR9 Q96G34 Q9NRP3,Abasic site processing protein HMCES {ECO:0000305},Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein {ECO:0000312|HGNC:HGNC:24446};Peptidase HMCES {ECO:0000305};SRAP domain-containing protein 1 {ECO:0000250|UniProtKB:Q8R1M0};, PF02586;, GO:0005657;GO:0008233;GO:0003697;GO:0006974;GO:0097681;GO:0045830;GO:0018142;, C:replication fork;, F:peptidase activity; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair via alternative nonhomologous end joining; P:positive regulation of isotype switching; P:protein-DNA covalent cross-linking; scaffold168 indexed_genome mRNA 352290 357403 . + . ID=transcript_15076;Q96FZ2 A6NJR9 Q96G34 Q9NRP3,Abasic site processing protein HMCES {ECO:0000305},Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein {ECO:0000312|HGNC:HGNC:24446};Peptidase HMCES {ECO:0000305};SRAP domain-containing protein 1 {ECO:0000250|UniProtKB:Q8R1M0};, PF02586;, GO:0005657;GO:0008233;GO:0003697;GO:0006974;GO:0097681;GO:0045830;GO:0018142;, C:replication fork;, F:peptidase activity; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair via alternative nonhomologous end joining; P:positive regulation of isotype switching; P:protein-DNA covalent cross-linking;|Q96FZ2 A6NJR9 Q96G34 Q9NRP3,Abasic site processing protein HMCES {ECO:0000305},Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein {ECO:0000312|HGNC:HGNC:24446};Peptidase HMCES {ECO:0000305};SRAP domain-containing protein 1 {ECO:0000250|UniProtKB:Q8R1M0};, PF02586;, GO:0005657;GO:0008233;GO:0003697;GO:0006974;GO:0097681;GO:0045830;GO:0018142;, C:replication fork;, F:peptidase activity; F:single-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair via alternative nonhomologous end joining; P:positive regulation of isotype switching; P:protein-DNA covalent cross-linking; scaffold168 indexed_genome mRNA 388836 398249 . - . ID=transcript_15077;P51149 A8K3V6 Q9NWJ0 Q9UPB0,Ras-related protein Rab-7a {ECO:0000305},, PF00071;, GO:0000421;GO:0005829;GO:0010008;GO:0070062;GO:0032419;GO:0005770;GO:0031902;GO:0005811;GO:0005765;GO:0005764;GO:0033162;GO:0045335;GO:0030670;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0003924;GO:1905394;GO:0019886;GO:0000045;GO:0045022;GO:0006897;GO:0008333;GO:0099638;GO:0007174;GO:0016042;GO:0061724;GO:1902586;GO:1903542;GO:1905366;GO:0043312;GO:0090383;GO:0090382;GO:0090385;GO:1903543;GO:0045732;GO:0048524;GO:0006622;GO:0022615;GO:0015031;GO:0042147;GO:0034054;GO:0019076;, C:autophagosome membrane; C:cytosol; C:endosome membrane; C:extracellular exosome; C:extrinsic component of lysosome membrane; C:late endosome; C:late endosome membrane; C:lipid droplet; C:lysosomal membrane; C:lysosome; C:melanosome membrane; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:retromer complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:autophagosome assembly; P:early endosome to late endosome transport; P:endocytosis; P:endosome to lysosome transport; P:endosome to plasma membrane protein transport; P:epidermal growth factor catabolic process; P:lipid catabolic process; P:lipophagy; P:multi-organism intercellular transport; P:negative regulation of exosomal secretion; P:negative regulation of intralumenal vesicle formation; P:neutrophil degranulation; P:phagosome acidification; P:phagosome maturation; P:phagosome-lysosome fusion; P:positive regulation of exosomal secretion; P:positive regulation of protein catabolic process; P:positive regulation of viral process; P:protein targeting to lysosome; P:protein to membrane docking; P:protein transport; P:retrograde transport, endosome to Golgi; P:suppression by symbiont of host defense-related programmed cell death; P:viral release from host cell;|P51149 A8K3V6 Q9NWJ0 Q9UPB0,Ras-related protein Rab-7a {ECO:0000305},, PF00071;, GO:0000421;GO:0005829;GO:0010008;GO:0070062;GO:0032419;GO:0005770;GO:0031902;GO:0005811;GO:0005765;GO:0005764;GO:0033162;GO:0045335;GO:0030670;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0003924;GO:1905394;GO:0019886;GO:0000045;GO:0045022;GO:0006897;GO:0008333;GO:0099638;GO:0007174;GO:0016042;GO:0061724;GO:1902586;GO:1903542;GO:1905366;GO:0043312;GO:0090383;GO:0090382;GO:0090385;GO:1903543;GO:0045732;GO:0048524;GO:0006622;GO:0022615;GO:0015031;GO:0042147;GO:0034054;GO:0019076;, C:autophagosome membrane; C:cytosol; C:endosome membrane; C:extracellular exosome; C:extrinsic component of lysosome membrane; C:late endosome; C:late endosome membrane; C:lipid droplet; C:lysosomal membrane; C:lysosome; C:melanosome membrane; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:retromer complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:autophagosome assembly; P:early endosome to late endosome transport; P:endocytosis; P:endosome to lysosome transport; P:endosome to plasma membrane protein transport; P:epidermal growth factor catabolic process; P:lipid catabolic process; P:lipophagy; P:multi-organism intercellular transport; P:negative regulation of exosomal secretion; P:negative regulation of intralumenal vesicle formation; P:neutrophil degranulation; P:phagosome acidification; P:phagosome maturation; P:phagosome-lysosome fusion; P:positive regulation of exosomal secretion; P:positive regulation of protein catabolic process; P:positive regulation of viral process; P:protein targeting to lysosome; P:protein to membrane docking; P:protein transport; P:retrograde transport, endosome to Golgi; P:suppression by symbiont of host defense-related programmed cell death; P:viral release from host cell;|P51149 A8K3V6 Q9NWJ0 Q9UPB0,Ras-related protein Rab-7a {ECO:0000305},, PF00071;, GO:0000421;GO:0005829;GO:0010008;GO:0070062;GO:0032419;GO:0005770;GO:0031902;GO:0005811;GO:0005765;GO:0005764;GO:0033162;GO:0045335;GO:0030670;GO:0005886;GO:0030667;GO:0019003;GO:0005525;GO:0003924;GO:1905394;GO:0019886;GO:0000045;GO:0045022;GO:0006897;GO:0008333;GO:0099638;GO:0007174;GO:0016042;GO:0061724;GO:1902586;GO:1903542;GO:1905366;GO:0043312;GO:0090383;GO:0090382;GO:0090385;GO:1903543;GO:0045732;GO:0048524;GO:0006622;GO:0022615;GO:0015031;GO:0042147;GO:0034054;GO:0019076;, C:autophagosome membrane; C:cytosol; C:endosome membrane; C:extracellular exosome; C:extrinsic component of lysosome membrane; C:late endosome; C:late endosome membrane; C:lipid droplet; C:lysosomal membrane; C:lysosome; C:melanosome membrane; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:retromer complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:autophagosome assembly; P:early endosome to late endosome transport; P:endocytosis; P:endosome to lysosome transport; P:endosome to plasma membrane protein transport; P:epidermal growth factor catabolic process; P:lipid catabolic process; P:lipophagy; P:multi-organism intercellular transport; P:negative regulation of exosomal secretion; P:negative regulation of intralumenal vesicle formation; P:neutrophil degranulation; P:phagosome acidification; P:phagosome maturation; P:phagosome-lysosome fusion; P:positive regulation of exosomal secretion; P:positive regulation of protein catabolic process; P:positive regulation of viral process; P:protein targeting to lysosome; P:protein to membrane docking; P:protein transport; P:retrograde transport, endosome to Golgi; P:suppression by symbiont of host defense-related programmed cell death; P:viral release from host cell; scaffold168 indexed_genome mRNA 469815 472141 . - . ID=transcript_15078;P04843 B2R5Z0 D3DNB6 Q68DT1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit;Ribophorin I;Ribophorin-1;, PF04597;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0042470;GO:0016020;GO:0008250;GO:0005791;GO:0003723;GO:0006464;GO:0006487;GO:0018279;GO:0019082;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:melanosome; C:membrane; C:oligosaccharyltransferase complex; C:rough endoplasmic reticulum;, F:RNA binding;, P:cellular protein modification process; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing; scaffold168 indexed_genome mRNA 474692 475263 . - . ID=transcript_15079;P04843 B2R5Z0 D3DNB6 Q68DT1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit;Ribophorin I;Ribophorin-1;, PF04597;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0042470;GO:0016020;GO:0008250;GO:0005791;GO:0003723;GO:0006464;GO:0006487;GO:0018279;GO:0019082;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:melanosome; C:membrane; C:oligosaccharyltransferase complex; C:rough endoplasmic reticulum;, F:RNA binding;, P:cellular protein modification process; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing; scaffold168 indexed_genome mRNA 475277 475932 . - . ID=transcript_15080;P04843 B2R5Z0 D3DNB6 Q68DT1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit;Ribophorin I;Ribophorin-1;, PF04597;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0042470;GO:0016020;GO:0008250;GO:0005791;GO:0003723;GO:0006464;GO:0006487;GO:0018279;GO:0019082;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:melanosome; C:membrane; C:oligosaccharyltransferase complex; C:rough endoplasmic reticulum;, F:RNA binding;, P:cellular protein modification process; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing; scaffold168 indexed_genome mRNA 476225 481289 . + . ID=transcript_15081;P04843 B2R5Z0 D3DNB6 Q68DT1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit;Ribophorin I;Ribophorin-1;, PF04597;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0042470;GO:0016020;GO:0008250;GO:0005791;GO:0003723;GO:0006464;GO:0006487;GO:0018279;GO:0019082;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:melanosome; C:membrane; C:oligosaccharyltransferase complex; C:rough endoplasmic reticulum;, F:RNA binding;, P:cellular protein modification process; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing;|P04843 B2R5Z0 D3DNB6 Q68DT1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit;Ribophorin I;Ribophorin-1;, PF04597;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0042470;GO:0016020;GO:0008250;GO:0005791;GO:0003723;GO:0006464;GO:0006487;GO:0018279;GO:0019082;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:melanosome; C:membrane; C:oligosaccharyltransferase complex; C:rough endoplasmic reticulum;, F:RNA binding;, P:cellular protein modification process; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing;|P04843 B2R5Z0 D3DNB6 Q68DT1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit;Ribophorin I;Ribophorin-1;, PF04597;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0042470;GO:0016020;GO:0008250;GO:0005791;GO:0003723;GO:0006464;GO:0006487;GO:0018279;GO:0019082;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:melanosome; C:membrane; C:oligosaccharyltransferase complex; C:rough endoplasmic reticulum;, F:RNA binding;, P:cellular protein modification process; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:viral protein processing; scaffold168 indexed_genome mRNA 544887 548977 . - . ID=transcript_15082;P23769 D3DNB3 Q53YE0 Q96BH0 Q96BH8 Q9BUJ6,Endothelial transcription factor GATA-2,GATA-binding protein 2;, PF00320;, GO:0005737;GO:0005654;GO:0005634;GO:0005667;GO:0070742;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0008270;GO:0007596;GO:0021533;GO:0045165;GO:0001709;GO:0048469;GO:0021954;GO:0090102;GO:0021902;GO:0060216;GO:0001892;GO:0035854;GO:0097154;GO:0048873;GO:0042472;GO:2000352;GO:0045599;GO:0070345;GO:0010629;GO:0045650;GO:2000178;GO:0045746;GO:0000122;GO:0001764;GO:0006909;GO:0021983;GO:0045766;GO:0043536;GO:1903589;GO:0090050;GO:0007204;GO:0045648;GO:0010628;GO:0043306;GO:0045654;GO:0045666;GO:0050766;GO:0060100;GO:1902895;GO:0045944;GO:2000977;GO:1902036;GO:0035065;GO:0010725;GO:0006357;GO:0033993;GO:0060872;GO:0035019;GO:0001655;GO:0061042;GO:0021514;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:C2H2 zinc finger domain binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:zinc ion binding;, P:blood coagulation; P:cell differentiation in hindbrain; P:cell fate commitment; P:cell fate determination; P:cell maturation; P:central nervous system neuron development; P:cochlea development; P:commitment of neuronal cell to specific neuron type in forebrain; P:definitive hemopoiesis; P:embryonic placenta development; P:eosinophil fate commitment; P:GABAergic neuron differentiation; P:homeostasis of number of cells within a tissue; P:inner ear morphogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of fat cell differentiation; P:negative regulation of fat cell proliferation; P:negative regulation of gene expression; P:negative regulation of macrophage differentiation; P:negative regulation of neural precursor cell proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neuron migration; P:phagocytosis; P:pituitary gland development; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of mast cell degranulation; P:positive regulation of megakaryocyte differentiation; P:positive regulation of neuron differentiation; P:positive regulation of phagocytosis; P:positive regulation of phagocytosis, engulfment; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of forebrain neuron differentiation; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone acetylation; P:regulation of primitive erythrocyte differentiation; P:regulation of transcription by RNA polymerase II; P:response to lipid; P:semicircular canal development; P:somatic stem cell population maintenance; P:urogenital system development; P:vascular wound healing; P:ventral spinal cord interneuron differentiation;|P23769 D3DNB3 Q53YE0 Q96BH0 Q96BH8 Q9BUJ6,Endothelial transcription factor GATA-2,GATA-binding protein 2;, PF00320;, GO:0005737;GO:0005654;GO:0005634;GO:0005667;GO:0070742;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0008270;GO:0007596;GO:0021533;GO:0045165;GO:0001709;GO:0048469;GO:0021954;GO:0090102;GO:0021902;GO:0060216;GO:0001892;GO:0035854;GO:0097154;GO:0048873;GO:0042472;GO:2000352;GO:0045599;GO:0070345;GO:0010629;GO:0045650;GO:2000178;GO:0045746;GO:0000122;GO:0001764;GO:0006909;GO:0021983;GO:0045766;GO:0043536;GO:1903589;GO:0090050;GO:0007204;GO:0045648;GO:0010628;GO:0043306;GO:0045654;GO:0045666;GO:0050766;GO:0060100;GO:1902895;GO:0045944;GO:2000977;GO:1902036;GO:0035065;GO:0010725;GO:0006357;GO:0033993;GO:0060872;GO:0035019;GO:0001655;GO:0061042;GO:0021514;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:C2H2 zinc finger domain binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:zinc ion binding;, P:blood coagulation; P:cell differentiation in hindbrain; P:cell fate commitment; P:cell fate determination; P:cell maturation; P:central nervous system neuron development; P:cochlea development; P:commitment of neuronal cell to specific neuron type in forebrain; P:definitive hemopoiesis; P:embryonic placenta development; P:eosinophil fate commitment; P:GABAergic neuron differentiation; P:homeostasis of number of cells within a tissue; P:inner ear morphogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of fat cell differentiation; P:negative regulation of fat cell proliferation; P:negative regulation of gene expression; P:negative regulation of macrophage differentiation; P:negative regulation of neural precursor cell proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neuron migration; P:phagocytosis; P:pituitary gland development; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of mast cell degranulation; P:positive regulation of megakaryocyte differentiation; P:positive regulation of neuron differentiation; P:positive regulation of phagocytosis; P:positive regulation of phagocytosis, engulfment; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of forebrain neuron differentiation; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone acetylation; P:regulation of primitive erythrocyte differentiation; P:regulation of transcription by RNA polymerase II; P:response to lipid; P:semicircular canal development; P:somatic stem cell population maintenance; P:urogenital system development; P:vascular wound healing; P:ventral spinal cord interneuron differentiation;|P23769 D3DNB3 Q53YE0 Q96BH0 Q96BH8 Q9BUJ6,Endothelial transcription factor GATA-2,GATA-binding protein 2;, PF00320;, GO:0005737;GO:0005654;GO:0005634;GO:0005667;GO:0070742;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0008270;GO:0007596;GO:0021533;GO:0045165;GO:0001709;GO:0048469;GO:0021954;GO:0090102;GO:0021902;GO:0060216;GO:0001892;GO:0035854;GO:0097154;GO:0048873;GO:0042472;GO:2000352;GO:0045599;GO:0070345;GO:0010629;GO:0045650;GO:2000178;GO:0045746;GO:0000122;GO:0001764;GO:0006909;GO:0021983;GO:0045766;GO:0043536;GO:1903589;GO:0090050;GO:0007204;GO:0045648;GO:0010628;GO:0043306;GO:0045654;GO:0045666;GO:0050766;GO:0060100;GO:1902895;GO:0045944;GO:2000977;GO:1902036;GO:0035065;GO:0010725;GO:0006357;GO:0033993;GO:0060872;GO:0035019;GO:0001655;GO:0061042;GO:0021514;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:C2H2 zinc finger domain binding; F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:zinc ion binding;, P:blood coagulation; P:cell differentiation in hindbrain; P:cell fate commitment; P:cell fate determination; P:cell maturation; P:central nervous system neuron development; P:cochlea development; P:commitment of neuronal cell to specific neuron type in forebrain; P:definitive hemopoiesis; P:embryonic placenta development; P:eosinophil fate commitment; P:GABAergic neuron differentiation; P:homeostasis of number of cells within a tissue; P:inner ear morphogenesis; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of fat cell differentiation; P:negative regulation of fat cell proliferation; P:negative regulation of gene expression; P:negative regulation of macrophage differentiation; P:negative regulation of neural precursor cell proliferation; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neuron migration; P:phagocytosis; P:pituitary gland development; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of erythrocyte differentiation; P:positive regulation of gene expression; P:positive regulation of mast cell degranulation; P:positive regulation of megakaryocyte differentiation; P:positive regulation of neuron differentiation; P:positive regulation of phagocytosis; P:positive regulation of phagocytosis, engulfment; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of forebrain neuron differentiation; P:regulation of hematopoietic stem cell differentiation; P:regulation of histone acetylation; P:regulation of primitive erythrocyte differentiation; P:regulation of transcription by RNA polymerase II; P:response to lipid; P:semicircular canal development; P:somatic stem cell population maintenance; P:urogenital system development; P:vascular wound healing; P:ventral spinal cord interneuron differentiation; scaffold168 indexed_genome mRNA 586150 651357 . - . ID=transcript_15083;P57772 Q96HZ6,Selenocysteine-specific elongation factor,Elongation factor sec;Eukaryotic elongation factor, selenocysteine-tRNA-specific;, PF00009;, GO:0005737;GO:0005634;GO:1990904;GO:0005525;GO:0003924;GO:0043021;GO:0035368;GO:0003746;GO:0000049;GO:0001514;GO:0006414;, C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:GTP binding; F:GTPase activity; F:ribonucleoprotein complex binding; F:selenocysteine insertion sequence binding; F:translation elongation factor activity; F:tRNA binding;, P:selenocysteine incorporation; P:translational elongation;|P57772 Q96HZ6,Selenocysteine-specific elongation factor,Elongation factor sec;Eukaryotic elongation factor, selenocysteine-tRNA-specific;, PF00009;, GO:0005737;GO:0005634;GO:1990904;GO:0005525;GO:0003924;GO:0043021;GO:0035368;GO:0003746;GO:0000049;GO:0001514;GO:0006414;, C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:GTP binding; F:GTPase activity; F:ribonucleoprotein complex binding; F:selenocysteine insertion sequence binding; F:translation elongation factor activity; F:tRNA binding;, P:selenocysteine incorporation; P:translational elongation; scaffold168 indexed_genome mRNA 712234 743065 . + . ID=transcript_15084;Q9Y265 B2R5S0 P82276 Q1KMR0 Q53HK5 Q53HL7 Q53Y27 Q9BSX9,RuvB-like 1,49 kDa TATA box-binding protein-interacting protein;54 kDa erythrocyte cytosolic protein;INO80 complex subunit H;Nuclear matrix protein 238;Pontin 52;TIP49a;TIP60-associated protein 54-alpha;, PF06068;PF17856;, GO:0005829;GO:0070062;GO:0031011;GO:0016020;GO:0005815;GO:0071339;GO:0035267;GO:0016363;GO:0005654;GO:0005634;GO:0097255;GO:1990904;GO:0000812;GO:0043139;GO:0043531;GO:0005524;GO:0016887;GO:0051117;GO:0045296;GO:0003678;GO:0017025;GO:0001094;GO:0003713;GO:1904837;GO:0000492;GO:0007049;GO:0051301;GO:0034080;GO:0006338;GO:0006310;GO:0006281;GO:0016573;GO:0043968;GO:0043967;GO:0090263;GO:1904874;GO:0016579;GO:0040008;GO:0006357;GO:0007283;, C:cytosol; C:extracellular exosome; C:Ino80 complex; C:membrane; C:microtubule organizing center; C:MLL1 complex; C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:R2TP complex; C:ribonucleoprotein complex; C:Swr1 complex;, F:5'-3' DNA helicase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:cadherin binding; F:DNA helicase activity; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:box C/D snoRNP assembly; P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomerase RNA localization to Cajal body; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9Y265 B2R5S0 P82276 Q1KMR0 Q53HK5 Q53HL7 Q53Y27 Q9BSX9,RuvB-like 1,49 kDa TATA box-binding protein-interacting protein;54 kDa erythrocyte cytosolic protein;INO80 complex subunit H;Nuclear matrix protein 238;Pontin 52;TIP49a;TIP60-associated protein 54-alpha;, PF06068;PF17856;, GO:0005829;GO:0070062;GO:0031011;GO:0016020;GO:0005815;GO:0071339;GO:0035267;GO:0016363;GO:0005654;GO:0005634;GO:0097255;GO:1990904;GO:0000812;GO:0043139;GO:0043531;GO:0005524;GO:0016887;GO:0051117;GO:0045296;GO:0003678;GO:0017025;GO:0001094;GO:0003713;GO:1904837;GO:0000492;GO:0007049;GO:0051301;GO:0034080;GO:0006338;GO:0006310;GO:0006281;GO:0016573;GO:0043968;GO:0043967;GO:0090263;GO:1904874;GO:0016579;GO:0040008;GO:0006357;GO:0007283;, C:cytosol; C:extracellular exosome; C:Ino80 complex; C:membrane; C:microtubule organizing center; C:MLL1 complex; C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:R2TP complex; C:ribonucleoprotein complex; C:Swr1 complex;, F:5'-3' DNA helicase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:cadherin binding; F:DNA helicase activity; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:box C/D snoRNP assembly; P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomerase RNA localization to Cajal body; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9Y265 B2R5S0 P82276 Q1KMR0 Q53HK5 Q53HL7 Q53Y27 Q9BSX9,RuvB-like 1,49 kDa TATA box-binding protein-interacting protein;54 kDa erythrocyte cytosolic protein;INO80 complex subunit H;Nuclear matrix protein 238;Pontin 52;TIP49a;TIP60-associated protein 54-alpha;, PF06068;PF17856;, GO:0005829;GO:0070062;GO:0031011;GO:0016020;GO:0005815;GO:0071339;GO:0035267;GO:0016363;GO:0005654;GO:0005634;GO:0097255;GO:1990904;GO:0000812;GO:0043139;GO:0043531;GO:0005524;GO:0016887;GO:0051117;GO:0045296;GO:0003678;GO:0017025;GO:0001094;GO:0003713;GO:1904837;GO:0000492;GO:0007049;GO:0051301;GO:0034080;GO:0006338;GO:0006310;GO:0006281;GO:0016573;GO:0043968;GO:0043967;GO:0090263;GO:1904874;GO:0016579;GO:0040008;GO:0006357;GO:0007283;, C:cytosol; C:extracellular exosome; C:Ino80 complex; C:membrane; C:microtubule organizing center; C:MLL1 complex; C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:R2TP complex; C:ribonucleoprotein complex; C:Swr1 complex;, F:5'-3' DNA helicase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:cadherin binding; F:DNA helicase activity; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:box C/D snoRNP assembly; P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomerase RNA localization to Cajal body; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9Y265 B2R5S0 P82276 Q1KMR0 Q53HK5 Q53HL7 Q53Y27 Q9BSX9,RuvB-like 1,49 kDa TATA box-binding protein-interacting protein;54 kDa erythrocyte cytosolic protein;INO80 complex subunit H;Nuclear matrix protein 238;Pontin 52;TIP49a;TIP60-associated protein 54-alpha;, PF06068;PF17856;, GO:0005829;GO:0070062;GO:0031011;GO:0016020;GO:0005815;GO:0071339;GO:0035267;GO:0016363;GO:0005654;GO:0005634;GO:0097255;GO:1990904;GO:0000812;GO:0043139;GO:0043531;GO:0005524;GO:0016887;GO:0051117;GO:0045296;GO:0003678;GO:0017025;GO:0001094;GO:0003713;GO:1904837;GO:0000492;GO:0007049;GO:0051301;GO:0034080;GO:0006338;GO:0006310;GO:0006281;GO:0016573;GO:0043968;GO:0043967;GO:0090263;GO:1904874;GO:0016579;GO:0040008;GO:0006357;GO:0007283;, C:cytosol; C:extracellular exosome; C:Ino80 complex; C:membrane; C:microtubule organizing center; C:MLL1 complex; C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:R2TP complex; C:ribonucleoprotein complex; C:Swr1 complex;, F:5'-3' DNA helicase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:cadherin binding; F:DNA helicase activity; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:box C/D snoRNP assembly; P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomerase RNA localization to Cajal body; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9Y265 B2R5S0 P82276 Q1KMR0 Q53HK5 Q53HL7 Q53Y27 Q9BSX9,RuvB-like 1,49 kDa TATA box-binding protein-interacting protein;54 kDa erythrocyte cytosolic protein;INO80 complex subunit H;Nuclear matrix protein 238;Pontin 52;TIP49a;TIP60-associated protein 54-alpha;, PF06068;PF17856;, GO:0005829;GO:0070062;GO:0031011;GO:0016020;GO:0005815;GO:0071339;GO:0035267;GO:0016363;GO:0005654;GO:0005634;GO:0097255;GO:1990904;GO:0000812;GO:0043139;GO:0043531;GO:0005524;GO:0016887;GO:0051117;GO:0045296;GO:0003678;GO:0017025;GO:0001094;GO:0003713;GO:1904837;GO:0000492;GO:0007049;GO:0051301;GO:0034080;GO:0006338;GO:0006310;GO:0006281;GO:0016573;GO:0043968;GO:0043967;GO:0090263;GO:1904874;GO:0016579;GO:0040008;GO:0006357;GO:0007283;, C:cytosol; C:extracellular exosome; C:Ino80 complex; C:membrane; C:microtubule organizing center; C:MLL1 complex; C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:R2TP complex; C:ribonucleoprotein complex; C:Swr1 complex;, F:5'-3' DNA helicase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:cadherin binding; F:DNA helicase activity; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:box C/D snoRNP assembly; P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomerase RNA localization to Cajal body; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9Y265 B2R5S0 P82276 Q1KMR0 Q53HK5 Q53HL7 Q53Y27 Q9BSX9,RuvB-like 1,49 kDa TATA box-binding protein-interacting protein;54 kDa erythrocyte cytosolic protein;INO80 complex subunit H;Nuclear matrix protein 238;Pontin 52;TIP49a;TIP60-associated protein 54-alpha;, PF06068;PF17856;, GO:0005829;GO:0070062;GO:0031011;GO:0016020;GO:0005815;GO:0071339;GO:0035267;GO:0016363;GO:0005654;GO:0005634;GO:0097255;GO:1990904;GO:0000812;GO:0043139;GO:0043531;GO:0005524;GO:0016887;GO:0051117;GO:0045296;GO:0003678;GO:0017025;GO:0001094;GO:0003713;GO:1904837;GO:0000492;GO:0007049;GO:0051301;GO:0034080;GO:0006338;GO:0006310;GO:0006281;GO:0016573;GO:0043968;GO:0043967;GO:0090263;GO:1904874;GO:0016579;GO:0040008;GO:0006357;GO:0007283;, C:cytosol; C:extracellular exosome; C:Ino80 complex; C:membrane; C:microtubule organizing center; C:MLL1 complex; C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:R2TP complex; C:ribonucleoprotein complex; C:Swr1 complex;, F:5'-3' DNA helicase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:cadherin binding; F:DNA helicase activity; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:box C/D snoRNP assembly; P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomerase RNA localization to Cajal body; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9Y265 B2R5S0 P82276 Q1KMR0 Q53HK5 Q53HL7 Q53Y27 Q9BSX9,RuvB-like 1,49 kDa TATA box-binding protein-interacting protein;54 kDa erythrocyte cytosolic protein;INO80 complex subunit H;Nuclear matrix protein 238;Pontin 52;TIP49a;TIP60-associated protein 54-alpha;, PF06068;PF17856;, GO:0005829;GO:0070062;GO:0031011;GO:0016020;GO:0005815;GO:0071339;GO:0035267;GO:0016363;GO:0005654;GO:0005634;GO:0097255;GO:1990904;GO:0000812;GO:0043139;GO:0043531;GO:0005524;GO:0016887;GO:0051117;GO:0045296;GO:0003678;GO:0017025;GO:0001094;GO:0003713;GO:1904837;GO:0000492;GO:0007049;GO:0051301;GO:0034080;GO:0006338;GO:0006310;GO:0006281;GO:0016573;GO:0043968;GO:0043967;GO:0090263;GO:1904874;GO:0016579;GO:0040008;GO:0006357;GO:0007283;, C:cytosol; C:extracellular exosome; C:Ino80 complex; C:membrane; C:microtubule organizing center; C:MLL1 complex; C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:R2TP complex; C:ribonucleoprotein complex; C:Swr1 complex;, F:5'-3' DNA helicase activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase binding; F:cadherin binding; F:DNA helicase activity; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:box C/D snoRNP assembly; P:cell cycle; P:cell division; P:CENP-A containing nucleosome assembly; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of telomerase RNA localization to Cajal body; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold168 indexed_genome mRNA 748626 761920 . - . ID=transcript_15085;P61619 P38378 P57726 Q5JPF8 Q8N0Z4 Q8N3U3 Q8NC71 Q9BU16 Q9Y2R3,Protein transport protein Sec61 subunit alpha isoform 1,, PF10559;PF00344;, GO:0005789;GO:0030176;GO:0016020;GO:0005784;GO:0005262;GO:0008320;GO:0043022;GO:0005048;GO:0006613;GO:0007029;GO:0006620;GO:0031204;GO:0039019;GO:0045047;GO:0006614;GO:0006616;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:Sec61 translocon complex;, F:calcium channel activity; F:protein transmembrane transporter activity; F:ribosome binding; F:signal sequence binding;, P:cotranslational protein targeting to membrane; P:endoplasmic reticulum organization; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:pronephric nephron development; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61619 P38378 P57726 Q5JPF8 Q8N0Z4 Q8N3U3 Q8NC71 Q9BU16 Q9Y2R3,Protein transport protein Sec61 subunit alpha isoform 1,, PF10559;PF00344;, GO:0005789;GO:0030176;GO:0016020;GO:0005784;GO:0005262;GO:0008320;GO:0043022;GO:0005048;GO:0006613;GO:0007029;GO:0006620;GO:0031204;GO:0039019;GO:0045047;GO:0006614;GO:0006616;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:Sec61 translocon complex;, F:calcium channel activity; F:protein transmembrane transporter activity; F:ribosome binding; F:signal sequence binding;, P:cotranslational protein targeting to membrane; P:endoplasmic reticulum organization; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:pronephric nephron development; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61619 P38378 P57726 Q5JPF8 Q8N0Z4 Q8N3U3 Q8NC71 Q9BU16 Q9Y2R3,Protein transport protein Sec61 subunit alpha isoform 1,, PF10559;PF00344;, GO:0005789;GO:0030176;GO:0016020;GO:0005784;GO:0005262;GO:0008320;GO:0043022;GO:0005048;GO:0006613;GO:0007029;GO:0006620;GO:0031204;GO:0039019;GO:0045047;GO:0006614;GO:0006616;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:Sec61 translocon complex;, F:calcium channel activity; F:protein transmembrane transporter activity; F:ribosome binding; F:signal sequence binding;, P:cotranslational protein targeting to membrane; P:endoplasmic reticulum organization; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:pronephric nephron development; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61619 P38378 P57726 Q5JPF8 Q8N0Z4 Q8N3U3 Q8NC71 Q9BU16 Q9Y2R3,Protein transport protein Sec61 subunit alpha isoform 1,, PF10559;PF00344;, GO:0005789;GO:0030176;GO:0016020;GO:0005784;GO:0005262;GO:0008320;GO:0043022;GO:0005048;GO:0006613;GO:0007029;GO:0006620;GO:0031204;GO:0039019;GO:0045047;GO:0006614;GO:0006616;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:Sec61 translocon complex;, F:calcium channel activity; F:protein transmembrane transporter activity; F:ribosome binding; F:signal sequence binding;, P:cotranslational protein targeting to membrane; P:endoplasmic reticulum organization; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:pronephric nephron development; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61619 P38378 P57726 Q5JPF8 Q8N0Z4 Q8N3U3 Q8NC71 Q9BU16 Q9Y2R3,Protein transport protein Sec61 subunit alpha isoform 1,, PF10559;PF00344;, GO:0005789;GO:0030176;GO:0016020;GO:0005784;GO:0005262;GO:0008320;GO:0043022;GO:0005048;GO:0006613;GO:0007029;GO:0006620;GO:0031204;GO:0039019;GO:0045047;GO:0006614;GO:0006616;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:Sec61 translocon complex;, F:calcium channel activity; F:protein transmembrane transporter activity; F:ribosome binding; F:signal sequence binding;, P:cotranslational protein targeting to membrane; P:endoplasmic reticulum organization; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:pronephric nephron development; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation;|P61619 P38378 P57726 Q5JPF8 Q8N0Z4 Q8N3U3 Q8NC71 Q9BU16 Q9Y2R3,Protein transport protein Sec61 subunit alpha isoform 1,, PF10559;PF00344;, GO:0005789;GO:0030176;GO:0016020;GO:0005784;GO:0005262;GO:0008320;GO:0043022;GO:0005048;GO:0006613;GO:0007029;GO:0006620;GO:0031204;GO:0039019;GO:0045047;GO:0006614;GO:0006616;, C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:membrane; C:Sec61 translocon complex;, F:calcium channel activity; F:protein transmembrane transporter activity; F:ribosome binding; F:signal sequence binding;, P:cotranslational protein targeting to membrane; P:endoplasmic reticulum organization; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:posttranslational protein targeting to membrane, translocation; P:pronephric nephron development; P:protein targeting to ER; P:SRP-dependent cotranslational protein targeting to membrane; P:SRP-dependent cotranslational protein targeting to membrane, translocation; scaffold168 indexed_genome mRNA 790223 838768 . - . ID=transcript_15086;Q3ZCT8 B5MCC6 Q6ZRK1,Kelch repeat and BTB domain-containing protein 12,Kelch domain-containing protein 6;, PF07707;PF00651;PF01344;|Q3ZCT8 B5MCC6 Q6ZRK1,Kelch repeat and BTB domain-containing protein 12,Kelch domain-containing protein 6;, PF07707;PF00651;PF01344;|Q3ZCT8 B5MCC6 Q6ZRK1,Kelch repeat and BTB domain-containing protein 12,Kelch domain-containing protein 6;, PF07707;PF00651;PF01344; scaffold168 indexed_genome mRNA 967967 1036328 . + . ID=transcript_15087;Q99685 B3KRC2 B7Z9D1 Q6IBG9 Q96AA5,Monoglyceride lipase {ECO:0000303|PubMed:11470505},HU-K5 {ECO:0000303|PubMed:9495531};Lysophospholipase homolog;Lysophospholipase-like;Monoacylglycerol lipase {ECO:0000303|PubMed:20079333};, PF12146;, GO:0005829;GO:0005789;GO:0019898;GO:0016020;GO:0005654;GO:0005886;GO:0047372;GO:0016298;GO:0004622;GO:0042803;GO:0036155;GO:0046464;GO:0019369;GO:0006633;GO:0006954;GO:0006629;GO:0052651;GO:2000124;GO:0050727;GO:0051930;GO:0009966;GO:0019433;, C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:acylglycerol lipase activity; F:lipase activity; F:lysophospholipase activity; F:protein homodimerization activity;, P:acylglycerol acyl-chain remodeling; P:acylglycerol catabolic process; P:arachidonic acid metabolic process; P:fatty acid biosynthetic process; P:inflammatory response; P:lipid metabolic process; P:monoacylglycerol catabolic process; P:regulation of endocannabinoid signaling pathway; P:regulation of inflammatory response; P:regulation of sensory perception of pain; P:regulation of signal transduction; P:triglyceride catabolic process; scaffold168 indexed_genome mRNA 1051238 1056423 . - . ID=transcript_15088;Q99685 B3KRC2 B7Z9D1 Q6IBG9 Q96AA5,Monoglyceride lipase {ECO:0000303|PubMed:11470505},HU-K5 {ECO:0000303|PubMed:9495531};Lysophospholipase homolog;Lysophospholipase-like;Monoacylglycerol lipase {ECO:0000303|PubMed:20079333};, PF12146;, GO:0005829;GO:0005789;GO:0019898;GO:0016020;GO:0005654;GO:0005886;GO:0047372;GO:0016298;GO:0004622;GO:0042803;GO:0036155;GO:0046464;GO:0019369;GO:0006633;GO:0006954;GO:0006629;GO:0052651;GO:2000124;GO:0050727;GO:0051930;GO:0009966;GO:0019433;, C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:acylglycerol lipase activity; F:lipase activity; F:lysophospholipase activity; F:protein homodimerization activity;, P:acylglycerol acyl-chain remodeling; P:acylglycerol catabolic process; P:arachidonic acid metabolic process; P:fatty acid biosynthetic process; P:inflammatory response; P:lipid metabolic process; P:monoacylglycerol catabolic process; P:regulation of endocannabinoid signaling pathway; P:regulation of inflammatory response; P:regulation of sensory perception of pain; P:regulation of signal transduction; P:triglyceride catabolic process;|Q99685 B3KRC2 B7Z9D1 Q6IBG9 Q96AA5,Monoglyceride lipase {ECO:0000303|PubMed:11470505},HU-K5 {ECO:0000303|PubMed:9495531};Lysophospholipase homolog;Lysophospholipase-like;Monoacylglycerol lipase {ECO:0000303|PubMed:20079333};, PF12146;, GO:0005829;GO:0005789;GO:0019898;GO:0016020;GO:0005654;GO:0005886;GO:0047372;GO:0016298;GO:0004622;GO:0042803;GO:0036155;GO:0046464;GO:0019369;GO:0006633;GO:0006954;GO:0006629;GO:0052651;GO:2000124;GO:0050727;GO:0051930;GO:0009966;GO:0019433;, C:cytosol; C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:acylglycerol lipase activity; F:lipase activity; F:lysophospholipase activity; F:protein homodimerization activity;, P:acylglycerol acyl-chain remodeling; P:acylglycerol catabolic process; P:arachidonic acid metabolic process; P:fatty acid biosynthetic process; P:inflammatory response; P:lipid metabolic process; P:monoacylglycerol catabolic process; P:regulation of endocannabinoid signaling pathway; P:regulation of inflammatory response; P:regulation of sensory perception of pain; P:regulation of signal transduction; P:triglyceride catabolic process; scaffold168 indexed_genome mRNA 1061029 1069168 . - . ID=transcript_15089;Q969K4 D3DNB0 Q6ZNU9 Q71MF1 Q96S62 Q96S63,Ankyrin repeat and BTB/POZ domain-containing protein 1,Elongation factor 1A-binding protein;, PF12796;PF00651;, GO:0005737;GO:0005829;GO:0005730;GO:0005886;GO:0000151;GO:0003746;, C:cytoplasm; C:cytosol; C:nucleolus; C:plasma membrane; C:ubiquitin ligase complex;, F:translation elongation factor activity;|Q969K4 D3DNB0 Q6ZNU9 Q71MF1 Q96S62 Q96S63,Ankyrin repeat and BTB/POZ domain-containing protein 1,Elongation factor 1A-binding protein;, PF12796;PF00651;, GO:0005737;GO:0005829;GO:0005730;GO:0005886;GO:0000151;GO:0003746;, C:cytoplasm; C:cytosol; C:nucleolus; C:plasma membrane; C:ubiquitin ligase complex;, F:translation elongation factor activity;|Q969K4 D3DNB0 Q6ZNU9 Q71MF1 Q96S62 Q96S63,Ankyrin repeat and BTB/POZ domain-containing protein 1,Elongation factor 1A-binding protein;, PF12796;PF00651;, GO:0005737;GO:0005829;GO:0005730;GO:0005886;GO:0000151;GO:0003746;, C:cytoplasm; C:cytosol; C:nucleolus; C:plasma membrane; C:ubiquitin ligase complex;, F:translation elongation factor activity;|Q9NZ53 Q6UVY4 Q8WUV6,Podocalyxin-like protein 2,Endoglycan;, PF06365;, GO:0005796;GO:0005887;GO:0005539;GO:0050901;, C:Golgi lumen; C:integral component of plasma membrane;, F:glycosaminoglycan binding;, P:leukocyte tethering or rolling;|Q9NZ53 Q6UVY4 Q8WUV6,Podocalyxin-like protein 2,Endoglycan;, PF06365;, GO:0005796;GO:0005887;GO:0005539;GO:0050901;, C:Golgi lumen; C:integral component of plasma membrane;, F:glycosaminoglycan binding;, P:leukocyte tethering or rolling; scaffold168 indexed_genome mRNA 1069675 1113207 . - . ID=transcript_15090;Q9NZ53 Q6UVY4 Q8WUV6,Podocalyxin-like protein 2,Endoglycan;, PF06365;, GO:0005796;GO:0005887;GO:0005539;GO:0050901;, C:Golgi lumen; C:integral component of plasma membrane;, F:glycosaminoglycan binding;, P:leukocyte tethering or rolling;|Q9NZ53 Q6UVY4 Q8WUV6,Podocalyxin-like protein 2,Endoglycan;, PF06365;, GO:0005796;GO:0005887;GO:0005539;GO:0050901;, C:Golgi lumen; C:integral component of plasma membrane;, F:glycosaminoglycan binding;, P:leukocyte tethering or rolling;|Q9NZ53 Q6UVY4 Q8WUV6,Podocalyxin-like protein 2,Endoglycan;, PF06365;, GO:0005796;GO:0005887;GO:0005539;GO:0050901;, C:Golgi lumen; C:integral component of plasma membrane;, F:glycosaminoglycan binding;, P:leukocyte tethering or rolling; scaffold168 indexed_genome mRNA 1127543 1142174 . - . ID=transcript_15091;P49736 Q14577 Q15023 Q8N2V1 Q969W7 Q96AE1 Q9BRM7,DNA replication licensing factor MCM2,Minichromosome maintenance protein 2 homolog;Nuclear protein BM28;, PF00493;PF12619;PF17855;PF14551;PF17207;, GO:0000785;GO:0000781;GO:0071162;GO:0005737;GO:0042555;GO:0005664;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003678;GO:0003688;GO:0019899;GO:0042393;GO:0046872;GO:0003697;GO:0006915;GO:0071353;GO:0090102;GO:0006260;GO:0006270;GO:0006268;GO:0000727;GO:1902975;GO:1905775;GO:0006334;GO:0036388;GO:0006267;, C:chromatin; C:chromosome, telomeric region; C:CMG complex; C:cytoplasm; C:MCM complex; C:nuclear origin of replication recognition complex; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:DNA replication origin binding; F:enzyme binding; F:histone binding; F:metal ion binding; F:single-stranded DNA binding;, P:apoptotic process; P:cellular response to interleukin-4; P:cochlea development; P:DNA replication; P:DNA replication initiation; P:DNA unwinding involved in DNA replication; P:double-strand break repair via break-induced replication; P:mitotic DNA replication initiation; P:negative regulation of DNA helicase activity; P:nucleosome assembly; P:pre-replicative complex assembly; P:pre-replicative complex assembly involved in nuclear cell cycle DNA replication; scaffold168 indexed_genome mRNA 1162101 1162763 . - . ID=transcript_15092;Q86W33 A8MVB8 D3DNA9 Q8WZ24 Q96AJ6 Q9P2R4,Transmembrane protein adipocyte-associated 1,Integral membrane protein GPR175;Transmembrane protein 227;, PF10160;, GO:0016021;GO:0004930;GO:0007568;GO:0040016;GO:0006629;GO:1901991;, C:integral component of membrane;, F:G protein-coupled receptor activity;, P:aging; P:embryonic cleavage; P:lipid metabolic process; P:negative regulation of mitotic cell cycle phase transition; scaffold169 indexed_genome mRNA 170573 173739 . - . ID=transcript_15093;Q6ZN57 A5PLN5 B7ZM23 Q9H6Z6,Zinc finger protein 2 homolog,Zinc finger protein 751;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold169 indexed_genome mRNA 182996 214688 . - . ID=transcript_15094;Q86XU0,Zinc finger protein 677,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8WV37 Q5JPG9 Q6P0Q4 Q8N1M5,Zinc finger protein 480,, PF01352;PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold169 indexed_genome mRNA 218187 227030 . - . ID=transcript_15095;Q9HCG1 Q14589 Q504Q8 Q96JC5 Q9BVY9 Q9H7N6,Zinc finger protein 160,Zinc finger protein HZF5;Zinc finger protein Kr18;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0030097;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:hemopoiesis; P:regulation of transcription by RNA polymerase II; scaffold169 indexed_genome mRNA 246414 266460 . - . ID=transcript_15096;Q9H7R5 A8K5T8,Zinc finger protein 665,Zinc finger protein 160-like;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q08AN1 B3KRV1 Q0P658 Q658V7,Zinc finger protein 616,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold169 indexed_genome mRNA 277126 291637 . + . ID=transcript_15097;Q7Z5H5 Q2M3E2 Q7Z5H6 Q7Z5H7 Q8TDU2,Vomeronasal type-1 receptor 4,G-protein coupled receptor GPCR27;V1r-like receptor 4;, PF03402;, GO:0016021;GO:0005886;GO:0016503;GO:0019236;, C:integral component of membrane; C:plasma membrane;, F:pheromone receptor activity;, P:response to pheromone; scaffold169 indexed_genome mRNA 293041 293966 . - . ID=transcript_15098;Q8NFZ6 A1L411 Q8TDU4,Vomeronasal type-1 receptor 2,G-protein coupled receptor GPCR25;V1r-like receptor 2;, PF03402;, GO:0016021;GO:0005886;GO:0016503;GO:0019236;, C:integral component of membrane; C:plasma membrane;, F:pheromone receptor activity;, P:response to pheromone; scaffold169 indexed_genome mRNA 311785 312469 . - . ID=transcript_15099;Q8NFZ6 A1L411 Q8TDU4,Vomeronasal type-1 receptor 2,G-protein coupled receptor GPCR25;V1r-like receptor 2;, PF03402;, GO:0016021;GO:0005886;GO:0016503;GO:0019236;, C:integral component of membrane; C:plasma membrane;, F:pheromone receptor activity;, P:response to pheromone; scaffold169 indexed_genome mRNA 363178 363929 . - . ID=transcript_15100;Q7Z5H5 Q2M3E2 Q7Z5H6 Q7Z5H7 Q8TDU2,Vomeronasal type-1 receptor 4,G-protein coupled receptor GPCR27;V1r-like receptor 4;, PF03402;, GO:0016021;GO:0005886;GO:0016503;GO:0019236;, C:integral component of membrane; C:plasma membrane;, F:pheromone receptor activity;, P:response to pheromone; scaffold169 indexed_genome mRNA 760331 783169 . - . ID=transcript_15101;P30153 Q13773 Q6ICQ3 Q96DH3,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,Medium tumor antigen-associated 61 kDa protein;PP2A subunit A isoform PR65-alpha;PP2A subunit A isoform R1-alpha;, PF02985;, GO:0000775;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0016328;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0000159;GO:0008287;GO:1990405;GO:0046982;GO:0019888;GO:0006915;GO:0006672;GO:0007059;GO:0097711;GO:0000086;GO:0000188;GO:0007084;GO:0030308;GO:0042532;GO:0000184;GO:0006470;GO:0065003;GO:0030155;GO:0045595;GO:0006275;GO:0010389;GO:0040008;GO:0006355;GO:0030111;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:lateral plasma membrane; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein antigen binding; F:protein heterodimerization activity; F:protein phosphatase regulator activity;, P:apoptotic process; P:ceramide metabolic process; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:inactivation of MAPK activity; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein dephosphorylation; P:protein-containing complex assembly; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of growth; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling;|P30153 Q13773 Q6ICQ3 Q96DH3,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,Medium tumor antigen-associated 61 kDa protein;PP2A subunit A isoform PR65-alpha;PP2A subunit A isoform R1-alpha;, PF02985;, GO:0000775;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0016328;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0000159;GO:0008287;GO:1990405;GO:0046982;GO:0019888;GO:0006915;GO:0006672;GO:0007059;GO:0097711;GO:0000086;GO:0000188;GO:0007084;GO:0030308;GO:0042532;GO:0000184;GO:0006470;GO:0065003;GO:0030155;GO:0045595;GO:0006275;GO:0010389;GO:0040008;GO:0006355;GO:0030111;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:lateral plasma membrane; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein antigen binding; F:protein heterodimerization activity; F:protein phosphatase regulator activity;, P:apoptotic process; P:ceramide metabolic process; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:inactivation of MAPK activity; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein dephosphorylation; P:protein-containing complex assembly; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of growth; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling;|P30153 Q13773 Q6ICQ3 Q96DH3,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,Medium tumor antigen-associated 61 kDa protein;PP2A subunit A isoform PR65-alpha;PP2A subunit A isoform R1-alpha;, PF02985;, GO:0000775;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0016328;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0000159;GO:0008287;GO:1990405;GO:0046982;GO:0019888;GO:0006915;GO:0006672;GO:0007059;GO:0097711;GO:0000086;GO:0000188;GO:0007084;GO:0030308;GO:0042532;GO:0000184;GO:0006470;GO:0065003;GO:0030155;GO:0045595;GO:0006275;GO:0010389;GO:0040008;GO:0006355;GO:0030111;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:lateral plasma membrane; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein antigen binding; F:protein heterodimerization activity; F:protein phosphatase regulator activity;, P:apoptotic process; P:ceramide metabolic process; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:inactivation of MAPK activity; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein dephosphorylation; P:protein-containing complex assembly; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of growth; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling;|P30153 Q13773 Q6ICQ3 Q96DH3,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,Medium tumor antigen-associated 61 kDa protein;PP2A subunit A isoform PR65-alpha;PP2A subunit A isoform R1-alpha;, PF02985;, GO:0000775;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0016328;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0000159;GO:0008287;GO:1990405;GO:0046982;GO:0019888;GO:0006915;GO:0006672;GO:0007059;GO:0097711;GO:0000086;GO:0000188;GO:0007084;GO:0030308;GO:0042532;GO:0000184;GO:0006470;GO:0065003;GO:0030155;GO:0045595;GO:0006275;GO:0010389;GO:0040008;GO:0006355;GO:0030111;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:lateral plasma membrane; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein antigen binding; F:protein heterodimerization activity; F:protein phosphatase regulator activity;, P:apoptotic process; P:ceramide metabolic process; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:inactivation of MAPK activity; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein dephosphorylation; P:protein-containing complex assembly; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of growth; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling;|P30153 Q13773 Q6ICQ3 Q96DH3,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,Medium tumor antigen-associated 61 kDa protein;PP2A subunit A isoform PR65-alpha;PP2A subunit A isoform R1-alpha;, PF02985;, GO:0000775;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0016328;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0000159;GO:0008287;GO:1990405;GO:0046982;GO:0019888;GO:0006915;GO:0006672;GO:0007059;GO:0097711;GO:0000086;GO:0000188;GO:0007084;GO:0030308;GO:0042532;GO:0000184;GO:0006470;GO:0065003;GO:0030155;GO:0045595;GO:0006275;GO:0010389;GO:0040008;GO:0006355;GO:0030111;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:lateral plasma membrane; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein antigen binding; F:protein heterodimerization activity; F:protein phosphatase regulator activity;, P:apoptotic process; P:ceramide metabolic process; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:inactivation of MAPK activity; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein dephosphorylation; P:protein-containing complex assembly; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of growth; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling;|P30153 Q13773 Q6ICQ3 Q96DH3,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,Medium tumor antigen-associated 61 kDa protein;PP2A subunit A isoform PR65-alpha;PP2A subunit A isoform R1-alpha;, PF02985;, GO:0000775;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0016328;GO:0016020;GO:0015630;GO:0005739;GO:0005634;GO:0000159;GO:0008287;GO:1990405;GO:0046982;GO:0019888;GO:0006915;GO:0006672;GO:0007059;GO:0097711;GO:0000086;GO:0000188;GO:0007084;GO:0030308;GO:0042532;GO:0000184;GO:0006470;GO:0065003;GO:0030155;GO:0045595;GO:0006275;GO:0010389;GO:0040008;GO:0006355;GO:0030111;GO:0010033;GO:0008380;GO:0019932;, C:chromosome, centromeric region; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:lateral plasma membrane; C:membrane; C:microtubule cytoskeleton; C:mitochondrion; C:nucleus; C:protein phosphatase type 2A complex; C:protein serine/threonine phosphatase complex;, F:protein antigen binding; F:protein heterodimerization activity; F:protein phosphatase regulator activity;, P:apoptotic process; P:ceramide metabolic process; P:chromosome segregation; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:inactivation of MAPK activity; P:mitotic nuclear envelope reassembly; P:negative regulation of cell growth; P:negative regulation of tyrosine phosphorylation of STAT protein; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:protein dephosphorylation; P:protein-containing complex assembly; P:regulation of cell adhesion; P:regulation of cell differentiation; P:regulation of DNA replication; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of growth; P:regulation of transcription, DNA-templated; P:regulation of Wnt signaling pathway; P:response to organic substance; P:RNA splicing; P:second-messenger-mediated signaling; scaffold169 indexed_genome mRNA 792266 793196 . - . ID=transcript_15102;Q7Z5H5 Q2M3E2 Q7Z5H6 Q7Z5H7 Q8TDU2,Vomeronasal type-1 receptor 4,G-protein coupled receptor GPCR27;V1r-like receptor 4;, PF03402;, GO:0016021;GO:0005886;GO:0016503;GO:0019236;, C:integral component of membrane; C:plasma membrane;, F:pheromone receptor activity;, P:response to pheromone; scaffold169 indexed_genome mRNA 876213 896708 . - . ID=transcript_15103;Q8N883 Q494T8 Q8TCF4 Q9BSN8,Zinc finger protein 614,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold169 indexed_genome mRNA 916591 928177 . - . ID=transcript_15104;Q6PF04 Q96SS9,Zinc finger protein 613,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold169 indexed_genome mRNA 933002 959509 . - . ID=transcript_15105;Q6PF04 Q96SS9,Zinc finger protein 613,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P61158 P32391 Q53QM2,Actin-related protein 3,Actin-like protein 3;, PF00022;, GO:0015629;GO:0005885;GO:0005903;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030027;GO:0016020;GO:0005634;GO:0035861;GO:0003779;GO:0005524;GO:0005200;GO:0070358;GO:0034314;GO:0008356;GO:0071346;GO:0060271;GO:0048013;GO:0007163;GO:0038096;GO:0016344;GO:0033206;GO:0061024;GO:0010592;GO:0045944;GO:0051653;, C:actin cytoskeleton; C:Arp2/3 protein complex; C:brush border; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:lamellipodium; C:membrane; C:nucleus; C:site of double-strand break;, F:actin binding; F:ATP binding; F:structural constituent of cytoskeleton;, P:actin polymerization-dependent cell motility; P:Arp2/3 complex-mediated actin nucleation; P:asymmetric cell division; P:cellular response to interferon-gamma; P:cilium assembly; P:ephrin receptor signaling pathway; P:establishment or maintenance of cell polarity; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:meiotic chromosome movement towards spindle pole; P:meiotic cytokinesis; P:membrane organization; P:positive regulation of lamellipodium assembly; P:positive regulation of transcription by RNA polymerase II; P:spindle localization; scaffold169 indexed_genome mRNA 959583 982049 . - . ID=transcript_15106;Q9BSK1 A8K0B4 A8K6Z7 C9JFB9,Zinc finger protein 577,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|P21506 B2RBS1 Q8TC91,Zinc finger protein 10,Zinc finger protein KOX1;, PF01352;PF00096;, GO:0005634;GO:0032991;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus; C:protein-containing complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P51523 B2RAK5 D3DXJ1 Q3ZCV9 Q5D057 Q86XU8 Q9NNX7 Q9UC17 Q9UC18,Zinc finger protein 84,Zinc finger protein HPF2;, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold169 indexed_genome mRNA 988427 992123 . - . ID=transcript_15107;Q9GZP7 B3KSV5 Q7Z5H8 Q7Z5H9,Vomeronasal type-1 receptor 1,G-protein coupled receptor GPCR24;V1r-like receptor 1;V3r-related gene protein;Vomeronasal olfactory receptor chromosome 19 subtype I member 1;, PF03402;, GO:0016021;GO:0005886;GO:0016503;GO:0019236;, C:integral component of membrane; C:plasma membrane;, F:pheromone receptor activity;, P:response to pheromone; scaffold169 indexed_genome mRNA 1016641 1028377 . + . ID=transcript_15108;Q92839 Q14470 Q9NS49,Hyaluronan synthase 1,Hyaluronate synthase 1;Hyaluronic acid synthase 1;, , GO:0005887;GO:0005886;GO:0050501;GO:0042802;GO:0007155;GO:0036120;GO:0085029;GO:0045226;GO:0006024;GO:0030213;GO:0010764;, C:integral component of plasma membrane; C:plasma membrane;, F:hyaluronan synthase activity; F:identical protein binding;, P:cell adhesion; P:cellular response to platelet-derived growth factor stimulus; P:extracellular matrix assembly; P:extracellular polysaccharide biosynthetic process; P:glycosaminoglycan biosynthetic process; P:hyaluronan biosynthetic process; P:negative regulation of fibroblast migration;|Q92839 Q14470 Q9NS49,Hyaluronan synthase 1,Hyaluronate synthase 1;Hyaluronic acid synthase 1;, , GO:0005887;GO:0005886;GO:0050501;GO:0042802;GO:0007155;GO:0036120;GO:0085029;GO:0045226;GO:0006024;GO:0030213;GO:0010764;, C:integral component of plasma membrane; C:plasma membrane;, F:hyaluronan synthase activity; F:identical protein binding;, P:cell adhesion; P:cellular response to platelet-derived growth factor stimulus; P:extracellular matrix assembly; P:extracellular polysaccharide biosynthetic process; P:glycosaminoglycan biosynthetic process; P:hyaluronan biosynthetic process; P:negative regulation of fibroblast migration; scaffold169 indexed_genome mRNA 1039048 1046104 . - . ID=transcript_15109;W5XKT8 C0H5Y6 Q6UWG3,Sperm acrosome membrane-associated protein 6 {ECO:0000303|PubMed:24275887},BACHELOR-like protein {ECO:0000312|EMBL:AHI16960.1};, , GO:0002080;GO:0016021;GO:0007342;, C:acrosomal membrane; C:integral component of membrane;, , P:fusion of sperm to egg plasma membrane involved in single fertilization; scaffold169 indexed_genome mRNA 1079013 1079620 . - . ID=transcript_15110;Q08ET2 Q6UXG0,Sialic acid-binding Ig-like lectin 14,, PF08205;PF13895;PF07686;, GO:0101003;GO:0016021;GO:0005886;GO:0070821;GO:0030246;GO:0033691;GO:0007155;GO:0045087;GO:0043312;, C:ficolin-1-rich granule membrane; C:integral component of membrane; C:plasma membrane; C:tertiary granule membrane;, F:carbohydrate binding; F:sialic acid binding;, P:cell adhesion; P:innate immune response; P:neutrophil degranulation; scaffold169 indexed_genome mRNA 1131896 1142430 . - . ID=transcript_15111;Q9Y473 A8K9H2,Zinc finger protein 175,Zinc finger protein OTK18;, PF01352;PF00096;, GO:0005829;GO:0045111;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:0051607;GO:0000122;GO:0045944;GO:0006357;, C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:defense response to virus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9Y473 A8K9H2,Zinc finger protein 175,Zinc finger protein OTK18;, PF01352;PF00096;, GO:0005829;GO:0045111;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0046872;GO:0000978;GO:0000977;GO:0051607;GO:0000122;GO:0045944;GO:0006357;, C:cytosol; C:intermediate filament cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:defense response to virus; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold169 indexed_genome mRNA 1210008 1211801 . + . ID=transcript_15112;Q96LC8,Sialic acid-binding Ig-like lectin 10,Siglec-like protein 2;, PF13895;PF07686;, GO:0005576;GO:0016021;GO:0005886;GO:0030246;GO:0019902;GO:0042169;GO:0033691;GO:0002250;GO:0007155;GO:0045087;GO:0106015;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:carbohydrate binding; F:phosphatase binding; F:SH2 domain binding; F:sialic acid binding;, P:adaptive immune response; P:cell adhesion; P:innate immune response; P:negative regulation of inflammatory response to wounding; scaffold169 indexed_genome mRNA 1231707 1233183 . + . ID=transcript_15113;Q16617,Protein NKG7,G-CSF-induced gene 1 protein;Granule membrane protein of 17 kDa;Natural killer cell protein 7;p15-TIA-1;, PF00822;, GO:0005887;GO:0005886;, C:integral component of plasma membrane; C:plasma membrane; scaffold169 indexed_genome mRNA 1236303 1236989 . - . ID=transcript_15114;Q8NHS1,Claudin domain-containing protein 2,, PF00822;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold169 indexed_genome mRNA 1237531 1238257 . - . ID=transcript_15115;P03905 Q6RL39 Q6RQN9 Q8HNR8,NADH-ubiquinone oxidoreductase chain 4,NADH dehydrogenase subunit 4;, PF01059;PF00361;, GO:0016021;GO:0005743;GO:0005747;GO:0008137;GO:0048039;GO:0009060;GO:0007568;GO:0021549;GO:0015990;GO:0001701;GO:0006120;GO:0032981;GO:0045471;GO:0001666;GO:0035094;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity; F:ubiquinone binding;, P:aerobic respiration; P:aging; P:cerebellum development; P:electron transport coupled proton transport; P:in utero embryonic development; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to ethanol; P:response to hypoxia; P:response to nicotine; scaffold169 indexed_genome mRNA 1242455 1261088 . - . ID=transcript_15116;P38117 A8K766 B3KNY2 Q6IBH7 Q71RF6 Q9Y3S7,Electron transfer flavoprotein subunit beta {ECO:0000305},, PF01012;, GO:0005759;GO:0005739;GO:0009055;GO:0033539;GO:0022904;, C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:respiratory electron transport chain;|P38117 A8K766 B3KNY2 Q6IBH7 Q71RF6 Q9Y3S7,Electron transfer flavoprotein subunit beta {ECO:0000305},, PF01012;, GO:0005759;GO:0005739;GO:0009055;GO:0033539;GO:0022904;, C:mitochondrial matrix; C:mitochondrion;, F:electron transfer activity;, P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:respiratory electron transport chain;|Q86VR7,V-set and immunoglobulin domain-containing protein 10-like,, PF13895;, GO:0016021;GO:0005654;, C:integral component of membrane; C:nucleoplasm;|Q86VR7,V-set and immunoglobulin domain-containing protein 10-like,, PF13895;, GO:0016021;GO:0005654;, C:integral component of membrane; C:nucleoplasm; scaffold169 indexed_genome mRNA 1262765 1268926 . - . ID=transcript_15117;A6NGN9,IgLON family member 5,, PF00047;, GO:0005576;, C:extracellular region;|A6NGN9,IgLON family member 5,, PF00047;, GO:0005576;, C:extracellular region; scaffold170 indexed_genome mRNA 123426 139513 . - . ID=transcript_15118;O43741 A8K9V5 B4DH06 Q5VXY0,5'-AMP-activated protein kinase subunit beta-2,, PF16561;PF04739;, GO:0005737;GO:0005829;GO:0005654;GO:0031588;GO:0005634;GO:0042802;GO:0019901;GO:0006853;GO:0007050;GO:0006633;GO:0016236;GO:0120162;GO:0006468;GO:0050790;GO:0042304;GO:0016241;GO:0080090;GO:1901796;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:identical protein binding; F:protein kinase binding;, P:carnitine shuttle; P:cell cycle arrest; P:fatty acid biosynthetic process; P:macroautophagy; P:positive regulation of cold-induced thermogenesis; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of fatty acid biosynthetic process; P:regulation of macroautophagy; P:regulation of primary metabolic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction;|O43741 A8K9V5 B4DH06 Q5VXY0,5'-AMP-activated protein kinase subunit beta-2,, PF16561;PF04739;, GO:0005737;GO:0005829;GO:0005654;GO:0031588;GO:0005634;GO:0042802;GO:0019901;GO:0006853;GO:0007050;GO:0006633;GO:0016236;GO:0120162;GO:0006468;GO:0050790;GO:0042304;GO:0016241;GO:0080090;GO:1901796;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:identical protein binding; F:protein kinase binding;, P:carnitine shuttle; P:cell cycle arrest; P:fatty acid biosynthetic process; P:macroautophagy; P:positive regulation of cold-induced thermogenesis; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of fatty acid biosynthetic process; P:regulation of macroautophagy; P:regulation of primary metabolic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction;|O43741 A8K9V5 B4DH06 Q5VXY0,5'-AMP-activated protein kinase subunit beta-2,, PF16561;PF04739;, GO:0005737;GO:0005829;GO:0005654;GO:0031588;GO:0005634;GO:0042802;GO:0019901;GO:0006853;GO:0007050;GO:0006633;GO:0016236;GO:0120162;GO:0006468;GO:0050790;GO:0042304;GO:0016241;GO:0080090;GO:1901796;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:identical protein binding; F:protein kinase binding;, P:carnitine shuttle; P:cell cycle arrest; P:fatty acid biosynthetic process; P:macroautophagy; P:positive regulation of cold-induced thermogenesis; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of fatty acid biosynthetic process; P:regulation of macroautophagy; P:regulation of primary metabolic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction;|O43741 A8K9V5 B4DH06 Q5VXY0,5'-AMP-activated protein kinase subunit beta-2,, PF16561;PF04739;, GO:0005737;GO:0005829;GO:0005654;GO:0031588;GO:0005634;GO:0042802;GO:0019901;GO:0006853;GO:0007050;GO:0006633;GO:0016236;GO:0120162;GO:0006468;GO:0050790;GO:0042304;GO:0016241;GO:0080090;GO:1901796;GO:0007165;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleotide-activated protein kinase complex; C:nucleus;, F:identical protein binding; F:protein kinase binding;, P:carnitine shuttle; P:cell cycle arrest; P:fatty acid biosynthetic process; P:macroautophagy; P:positive regulation of cold-induced thermogenesis; P:protein phosphorylation; P:regulation of catalytic activity; P:regulation of fatty acid biosynthetic process; P:regulation of macroautophagy; P:regulation of primary metabolic process; P:regulation of signal transduction by p53 class mediator; P:signal transduction; scaffold170 indexed_genome mRNA 163196 205338 . + . ID=transcript_15119;P49326 B2RBG1 C9JJD1 Q8IV22,Flavin-containing monooxygenase 5,Baeyer-Villiger monooxygenase 1 {ECO:0000303|PubMed:28783300};Dimethylaniline monooxygenase [N-oxide-forming] 5 {ECO:0000305};Dimethylaniline oxidase 5;NAPDH oxidase {ECO:0000303|PubMed:20947616};, PF00743;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0004031;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0106294;GO:0017144;GO:0070995;GO:0090181;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:aldehyde oxidase activity; F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:NADPH oxidase H202-forming activity;, P:drug metabolic process; P:NADPH oxidation; P:regulation of cholesterol metabolic process;|P49326 B2RBG1 C9JJD1 Q8IV22,Flavin-containing monooxygenase 5,Baeyer-Villiger monooxygenase 1 {ECO:0000303|PubMed:28783300};Dimethylaniline monooxygenase [N-oxide-forming] 5 {ECO:0000305};Dimethylaniline oxidase 5;NAPDH oxidase {ECO:0000303|PubMed:20947616};, PF00743;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0004031;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0106294;GO:0017144;GO:0070995;GO:0090181;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:aldehyde oxidase activity; F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:NADPH oxidase H202-forming activity;, P:drug metabolic process; P:NADPH oxidation; P:regulation of cholesterol metabolic process;|Q99518 Q5EBX4 Q86U73 Q9BRX1,Dimethylaniline monooxygenase [N-oxide-forming] 2,Dimethylaniline oxidase 2;FMO 1B1;Pulmonary flavin-containing monooxygenase 2;, PF00743;, GO:0005789;GO:0016021;GO:0016020;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0017144;GO:0006739;GO:0070995;GO:0006082;GO:0072592;GO:0009404;GO:0006805;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding;, P:drug metabolic process; P:NADP metabolic process; P:NADPH oxidation; P:organic acid metabolic process; P:oxygen metabolic process; P:toxin metabolic process; P:xenobiotic metabolic process;|P49326 B2RBG1 C9JJD1 Q8IV22,Flavin-containing monooxygenase 5,Baeyer-Villiger monooxygenase 1 {ECO:0000303|PubMed:28783300};Dimethylaniline monooxygenase [N-oxide-forming] 5 {ECO:0000305};Dimethylaniline oxidase 5;NAPDH oxidase {ECO:0000303|PubMed:20947616};, PF00743;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0004031;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0106294;GO:0017144;GO:0070995;GO:0090181;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:aldehyde oxidase activity; F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:NADPH oxidase H202-forming activity;, P:drug metabolic process; P:NADPH oxidation; P:regulation of cholesterol metabolic process;|P49326 B2RBG1 C9JJD1 Q8IV22,Flavin-containing monooxygenase 5,Baeyer-Villiger monooxygenase 1 {ECO:0000303|PubMed:28783300};Dimethylaniline monooxygenase [N-oxide-forming] 5 {ECO:0000305};Dimethylaniline oxidase 5;NAPDH oxidase {ECO:0000303|PubMed:20947616};, PF00743;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0004031;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0106294;GO:0017144;GO:0070995;GO:0090181;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:aldehyde oxidase activity; F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:NADPH oxidase H202-forming activity;, P:drug metabolic process; P:NADPH oxidation; P:regulation of cholesterol metabolic process;|P49326 B2RBG1 C9JJD1 Q8IV22,Flavin-containing monooxygenase 5,Baeyer-Villiger monooxygenase 1 {ECO:0000303|PubMed:28783300};Dimethylaniline monooxygenase [N-oxide-forming] 5 {ECO:0000305};Dimethylaniline oxidase 5;NAPDH oxidase {ECO:0000303|PubMed:20947616};, PF00743;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0004031;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0106294;GO:0017144;GO:0070995;GO:0090181;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:aldehyde oxidase activity; F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:NADPH oxidase H202-forming activity;, P:drug metabolic process; P:NADPH oxidation; P:regulation of cholesterol metabolic process;|P49326 B2RBG1 C9JJD1 Q8IV22,Flavin-containing monooxygenase 5,Baeyer-Villiger monooxygenase 1 {ECO:0000303|PubMed:28783300};Dimethylaniline monooxygenase [N-oxide-forming] 5 {ECO:0000305};Dimethylaniline oxidase 5;NAPDH oxidase {ECO:0000303|PubMed:20947616};, PF00743;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0004031;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0106294;GO:0017144;GO:0070995;GO:0090181;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:aldehyde oxidase activity; F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:NADPH oxidase H202-forming activity;, P:drug metabolic process; P:NADPH oxidation; P:regulation of cholesterol metabolic process;|P49326 B2RBG1 C9JJD1 Q8IV22,Flavin-containing monooxygenase 5,Baeyer-Villiger monooxygenase 1 {ECO:0000303|PubMed:28783300};Dimethylaniline monooxygenase [N-oxide-forming] 5 {ECO:0000305};Dimethylaniline oxidase 5;NAPDH oxidase {ECO:0000303|PubMed:20947616};, PF00743;, GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0004031;GO:0050660;GO:0004497;GO:0004499;GO:0050661;GO:0106294;GO:0017144;GO:0070995;GO:0090181;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:aldehyde oxidase activity; F:flavin adenine dinucleotide binding; F:monooxygenase activity; F:N,N-dimethylaniline monooxygenase activity; F:NADP binding; F:NADPH oxidase H202-forming activity;, P:drug metabolic process; P:NADPH oxidation; P:regulation of cholesterol metabolic process; scaffold170 indexed_genome mRNA 234024 259797 . + . ID=transcript_15120;Q96HF7 Q96SP3 Q9BVJ1 Q9NVV8,Chromodomain-helicase-DNA-binding protein 1-like {ECO:0000305},Amplified in liver cancer protein 1 {ECO:0000303|PubMed:18023026};, PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0003678;GO:0070615;GO:0000166;GO:0006974;GO:0006338;GO:0006281;GO:0070911;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:nucleotide binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; scaffold170 indexed_genome mRNA 259886 295335 . + . ID=transcript_15121;Q96HF7 Q96SP3 Q9BVJ1 Q9NVV8,Chromodomain-helicase-DNA-binding protein 1-like {ECO:0000305},Amplified in liver cancer protein 1 {ECO:0000303|PubMed:18023026};, PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0003678;GO:0070615;GO:0000166;GO:0006974;GO:0006338;GO:0006281;GO:0070911;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:nucleotide binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization;|Q96HF7 Q96SP3 Q9BVJ1 Q9NVV8,Chromodomain-helicase-DNA-binding protein 1-like {ECO:0000305},Amplified in liver cancer protein 1 {ECO:0000303|PubMed:18023026};, PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0003678;GO:0070615;GO:0000166;GO:0006974;GO:0006338;GO:0006281;GO:0070911;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:nucleotide binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization;|Q96HF7 Q96SP3 Q9BVJ1 Q9NVV8,Chromodomain-helicase-DNA-binding protein 1-like {ECO:0000305},Amplified in liver cancer protein 1 {ECO:0000303|PubMed:18023026};, PF00271;PF00176;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0016887;GO:0003678;GO:0070615;GO:0000166;GO:0006974;GO:0006338;GO:0006281;GO:0070911;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:DNA helicase activity; F:nucleosome-dependent ATPase activity; F:nucleotide binding;, P:cellular response to DNA damage stimulus; P:chromatin remodeling; P:DNA repair; P:global genome nucleotide-excision repair; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; scaffold170 indexed_genome mRNA 546868 648924 . + . ID=transcript_15122;O00512 Q5T489,B-cell CLL/lymphoma 9 protein,Protein legless homolog;, PF11502;, GO:1990907;GO:0005801;GO:0005654;GO:0008013;GO:0003713;GO:1904837;GO:0060070;GO:0014908;GO:0045944;GO:0035914;GO:0035019;, C:beta-catenin-TCF complex; C:cis-Golgi network; C:nucleoplasm;, F:beta-catenin binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:canonical Wnt signaling pathway; P:myotube differentiation involved in skeletal muscle regeneration; P:positive regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; P:somatic stem cell population maintenance;|O00512 Q5T489,B-cell CLL/lymphoma 9 protein,Protein legless homolog;, PF11502;, GO:1990907;GO:0005801;GO:0005654;GO:0008013;GO:0003713;GO:1904837;GO:0060070;GO:0014908;GO:0045944;GO:0035914;GO:0035019;, C:beta-catenin-TCF complex; C:cis-Golgi network; C:nucleoplasm;, F:beta-catenin binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:canonical Wnt signaling pathway; P:myotube differentiation involved in skeletal muscle regeneration; P:positive regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; P:somatic stem cell population maintenance;|O00512 Q5T489,B-cell CLL/lymphoma 9 protein,Protein legless homolog;, PF11502;, GO:1990907;GO:0005801;GO:0005654;GO:0008013;GO:0003713;GO:1904837;GO:0060070;GO:0014908;GO:0045944;GO:0035914;GO:0035019;, C:beta-catenin-TCF complex; C:cis-Golgi network; C:nucleoplasm;, F:beta-catenin binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:canonical Wnt signaling pathway; P:myotube differentiation involved in skeletal muscle regeneration; P:positive regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; P:somatic stem cell population maintenance;|O00512 Q5T489,B-cell CLL/lymphoma 9 protein,Protein legless homolog;, PF11502;, GO:1990907;GO:0005801;GO:0005654;GO:0008013;GO:0003713;GO:1904837;GO:0060070;GO:0014908;GO:0045944;GO:0035914;GO:0035019;, C:beta-catenin-TCF complex; C:cis-Golgi network; C:nucleoplasm;, F:beta-catenin binding; F:transcription coactivator activity;, P:beta-catenin-TCF complex assembly; P:canonical Wnt signaling pathway; P:myotube differentiation involved in skeletal muscle regeneration; P:positive regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; P:somatic stem cell population maintenance; scaffold170 indexed_genome mRNA 669861 690007 . - . ID=transcript_15123;Q9NPH0 Q59G61 Q5T490 Q6IAQ3 Q7LG81 Q9UIG6 X5D289,Lysophosphatidic acid phosphatase type 6,Acid phosphatase 6, lysophosphatidic;Acid phosphatase-like protein 1;PACPL1;, PF00328;, GO:0005737;GO:0005759;GO:0005739;GO:0003993;GO:0052642;GO:0016791;GO:0016311;GO:0002244;GO:2001311;GO:0006654;GO:0006644;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:acid phosphatase activity; F:lysophosphatidic acid phosphatase activity; F:phosphatase activity;, P:dephosphorylation; P:hematopoietic progenitor cell differentiation; P:lysobisphosphatidic acid metabolic process; P:phosphatidic acid biosynthetic process; P:phospholipid metabolic process;|Q9NPH0 Q59G61 Q5T490 Q6IAQ3 Q7LG81 Q9UIG6 X5D289,Lysophosphatidic acid phosphatase type 6,Acid phosphatase 6, lysophosphatidic;Acid phosphatase-like protein 1;PACPL1;, PF00328;, GO:0005737;GO:0005759;GO:0005739;GO:0003993;GO:0052642;GO:0016791;GO:0016311;GO:0002244;GO:2001311;GO:0006654;GO:0006644;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:acid phosphatase activity; F:lysophosphatidic acid phosphatase activity; F:phosphatase activity;, P:dephosphorylation; P:hematopoietic progenitor cell differentiation; P:lysobisphosphatidic acid metabolic process; P:phosphatidic acid biosynthetic process; P:phospholipid metabolic process;|Q9NPH0 Q59G61 Q5T490 Q6IAQ3 Q7LG81 Q9UIG6 X5D289,Lysophosphatidic acid phosphatase type 6,Acid phosphatase 6, lysophosphatidic;Acid phosphatase-like protein 1;PACPL1;, PF00328;, GO:0005737;GO:0005759;GO:0005739;GO:0003993;GO:0052642;GO:0016791;GO:0016311;GO:0002244;GO:2001311;GO:0006654;GO:0006644;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:acid phosphatase activity; F:lysophosphatidic acid phosphatase activity; F:phosphatase activity;, P:dephosphorylation; P:hematopoietic progenitor cell differentiation; P:lysobisphosphatidic acid metabolic process; P:phosphatidic acid biosynthetic process; P:phospholipid metabolic process; scaffold170 indexed_genome mRNA 759113 762557 . + . ID=transcript_15124;P36382 Q5T3B6 Q5U0N6,Gap junction alpha-5 protein,Connexin-40;, PF00029;PF16791;, GO:0042995;GO:0005922;GO:0005921;GO:0005887;GO:0014704;GO:0071253;GO:0097718;GO:0005243;GO:0086076;GO:0086077;GO:0086078;GO:0086075;GO:0086079;GO:0086020;GO:0055077;GO:0001525;GO:0048844;GO:0086044;GO:0003283;GO:0086053;GO:0086054;GO:0010643;GO:0086064;GO:0007267;GO:0003158;GO:0016264;GO:0003174;GO:0045776;GO:0003105;GO:0003151;GO:0010652;GO:0045907;GO:0006813;GO:0003193;GO:0086055;GO:0098910;GO:0060371;GO:0098904;GO:0098905;GO:0055117;GO:0010649;GO:0098906;GO:0060373;GO:0060307;GO:0086021;GO:1990029;GO:0003281;, C:cell projection; C:connexin complex; C:gap junction; C:integral component of plasma membrane; C:intercalated disc;, F:connexin binding; F:disordered domain specific binding; F:gap junction channel activity; F:gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling; F:gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling; F:gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling; F:gap junction channel activity involved in cardiac conduction electrical coupling; F:gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling; F:gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling; F:gap junction hemi-channel activity;, P:angiogenesis; P:artery morphogenesis; P:atrial cardiac muscle cell to AV node cell communication by electrical coupling; P:atrial septum development; P:AV node cell to bundle of His cell communication by electrical coupling; P:bundle of His cell to Purkinje myocyte communication by electrical coupling; P:cell communication by chemical coupling; P:cell communication by electrical coupling involved in cardiac conduction; P:cell-cell signaling; P:endothelium development; P:gap junction assembly; P:mitral valve development; P:negative regulation of blood pressure; P:negative regulation of glomerular filtration; P:outflow tract morphogenesis; P:positive regulation of cell communication by chemical coupling; P:positive regulation of vasoconstriction; P:potassium ion transport; P:pulmonary valve formation; P:Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling; P:regulation of atrial cardiac muscle cell action potential; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of AV node cell action potential; P:regulation of bundle of His cell action potential; P:regulation of cardiac muscle contraction; P:regulation of cell communication by electrical coupling; P:regulation of Purkinje myocyte action potential; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:SA node cell to atrial cardiac muscle cell communication by electrical coupling; P:vasomotion; P:ventricular septum development; scaffold170 indexed_genome mRNA 911855 963527 . + . ID=transcript_15125;Q659E2 Q6NVY5 Q9P0S4 Q9Y302,Golgi pH regulator A,Protein GPR89A;Putative MAPK-activating protein PM01;Putative NF-kappa-B-activating protein 90;, PF12430;PF12537;, GO:0032580;GO:0030660;GO:0016021;GO:0008308;GO:0051452;GO:0043123;GO:0015031;GO:0034765;GO:0030217;, C:Golgi cisterna membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane;, F:voltage-gated anion channel activity;, P:intracellular pH reduction; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein transport; P:regulation of ion transmembrane transport; P:T cell differentiation;|Q659E2 Q6NVY5 Q9P0S4 Q9Y302,Golgi pH regulator A,Protein GPR89A;Putative MAPK-activating protein PM01;Putative NF-kappa-B-activating protein 90;, PF12430;PF12537;, GO:0032580;GO:0030660;GO:0016021;GO:0008308;GO:0051452;GO:0043123;GO:0015031;GO:0034765;GO:0030217;, C:Golgi cisterna membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane;, F:voltage-gated anion channel activity;, P:intracellular pH reduction; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein transport; P:regulation of ion transmembrane transport; P:T cell differentiation;|Q659E2 Q6NVY5 Q9P0S4 Q9Y302,Golgi pH regulator A,Protein GPR89A;Putative MAPK-activating protein PM01;Putative NF-kappa-B-activating protein 90;, PF12430;PF12537;, GO:0032580;GO:0030660;GO:0016021;GO:0008308;GO:0051452;GO:0043123;GO:0015031;GO:0034765;GO:0030217;, C:Golgi cisterna membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane;, F:voltage-gated anion channel activity;, P:intracellular pH reduction; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein transport; P:regulation of ion transmembrane transport; P:T cell differentiation;|Q659E2 Q6NVY5 Q9P0S4 Q9Y302,Golgi pH regulator A,Protein GPR89A;Putative MAPK-activating protein PM01;Putative NF-kappa-B-activating protein 90;, PF12430;PF12537;, GO:0032580;GO:0030660;GO:0016021;GO:0008308;GO:0051452;GO:0043123;GO:0015031;GO:0034765;GO:0030217;, C:Golgi cisterna membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane;, F:voltage-gated anion channel activity;, P:intracellular pH reduction; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein transport; P:regulation of ion transmembrane transport; P:T cell differentiation;|Q659E2 Q6NVY5 Q9P0S4 Q9Y302,Golgi pH regulator A,Protein GPR89A;Putative MAPK-activating protein PM01;Putative NF-kappa-B-activating protein 90;, PF12430;PF12537;, GO:0032580;GO:0030660;GO:0016021;GO:0008308;GO:0051452;GO:0043123;GO:0015031;GO:0034765;GO:0030217;, C:Golgi cisterna membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane;, F:voltage-gated anion channel activity;, P:intracellular pH reduction; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein transport; P:regulation of ion transmembrane transport; P:T cell differentiation;|Q659E2 Q6NVY5 Q9P0S4 Q9Y302,Golgi pH regulator A,Protein GPR89A;Putative MAPK-activating protein PM01;Putative NF-kappa-B-activating protein 90;, PF12430;PF12537;, GO:0032580;GO:0030660;GO:0016021;GO:0008308;GO:0051452;GO:0043123;GO:0015031;GO:0034765;GO:0030217;, C:Golgi cisterna membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane;, F:voltage-gated anion channel activity;, P:intracellular pH reduction; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein transport; P:regulation of ion transmembrane transport; P:T cell differentiation;|Q659E2 Q6NVY5 Q9P0S4 Q9Y302,Golgi pH regulator A,Protein GPR89A;Putative MAPK-activating protein PM01;Putative NF-kappa-B-activating protein 90;, PF12430;PF12537;, GO:0032580;GO:0030660;GO:0016021;GO:0008308;GO:0051452;GO:0043123;GO:0015031;GO:0034765;GO:0030217;, C:Golgi cisterna membrane; C:Golgi-associated vesicle membrane; C:integral component of membrane;, F:voltage-gated anion channel activity;, P:intracellular pH reduction; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein transport; P:regulation of ion transmembrane transport; P:T cell differentiation; scaffold170 indexed_genome mRNA 967847 975783 . - . ID=transcript_15126;Q5T2W1 B4DPB9 E7EU02 O60450 Q5T5P6 Q9BQ41,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,CFTR-associated protein of 70 kDa;Na(+)/H(+) exchanger regulatory factor 3;Na/Pi cotransporter C-terminal-associated protein 1;PDZ domain-containing protein 1;Sodium-hydrogen exchanger regulatory factor 3;, PF00595;PF17820;, GO:0016324;GO:0005903;GO:0031526;GO:0070062;GO:0045121;GO:0031528;GO:0005886;GO:0030165;GO:0044877;GO:0043495;GO:0005124;GO:0015879;GO:1904064;GO:0032414;GO:1905477;GO:0090314;GO:0072659;GO:0044070;GO:1990961;, C:apical plasma membrane; C:brush border; C:brush border membrane; C:extracellular exosome; C:membrane raft; C:microvillus membrane; C:plasma membrane;, F:PDZ domain binding; F:protein-containing complex binding; F:protein-membrane adaptor activity; F:scavenger receptor binding;, P:carnitine transport; P:positive regulation of cation transmembrane transport; P:positive regulation of ion transmembrane transporter activity; P:positive regulation of protein localization to membrane; P:positive regulation of protein targeting to membrane; P:protein localization to plasma membrane; P:regulation of anion transport; P:xenobiotic detoxification by transmembrane export across the plasma membrane;|A8MUH7,Putative PDZ domain-containing protein PDZK1P1 {ECO:0000305},PDZ domain-containing 1 pseudogene 1 {ECO:0000312|HGNC:HGNC:31974};PDZ domain-containing 1 pseudogene 2 {ECO:0000312|HGNC:HGNC:31974};, PF00595;PF17820;, GO:0016324;GO:0043495;GO:0072659;, C:apical plasma membrane;, F:protein-membrane adaptor activity;, P:protein localization to plasma membrane; scaffold170 indexed_genome mRNA 1042125 1049032 . - . ID=transcript_15127;Q9Y4L5 A8K3Y4 Q5T2V9 Q7Z2J2,E3 ubiquitin-protein ligase RNF115 {ECO:0000305},RING finger protein 115 {ECO:0000312|HGNC:HGNC:18154};RING-type E3 ubiquitin transferase RNF115 {ECO:0000305};Rabring 7 {ECO:0000250|UniProtKB:Q9D0C1};Zinc finger protein 364 {ECO:0000303|Ref.1};, PF13639;, GO:0005829;GO:0046872;GO:0061630;GO:0004842;GO:0042059;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0043162;, C:cytosol;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9Y4L5 A8K3Y4 Q5T2V9 Q7Z2J2,E3 ubiquitin-protein ligase RNF115 {ECO:0000305},RING finger protein 115 {ECO:0000312|HGNC:HGNC:18154};RING-type E3 ubiquitin transferase RNF115 {ECO:0000305};Rabring 7 {ECO:0000250|UniProtKB:Q9D0C1};Zinc finger protein 364 {ECO:0000303|Ref.1};, PF13639;, GO:0005829;GO:0046872;GO:0061630;GO:0004842;GO:0042059;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0043162;, C:cytosol;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold170 indexed_genome mRNA 1067307 1117749 . - . ID=transcript_15128;Q9Y4L5 A8K3Y4 Q5T2V9 Q7Z2J2,E3 ubiquitin-protein ligase RNF115 {ECO:0000305},RING finger protein 115 {ECO:0000312|HGNC:HGNC:18154};RING-type E3 ubiquitin transferase RNF115 {ECO:0000305};Rabring 7 {ECO:0000250|UniProtKB:Q9D0C1};Zinc finger protein 364 {ECO:0000303|Ref.1};, PF13639;, GO:0005829;GO:0046872;GO:0061630;GO:0004842;GO:0042059;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0043162;, C:cytosol;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9Y4L5 A8K3Y4 Q5T2V9 Q7Z2J2,E3 ubiquitin-protein ligase RNF115 {ECO:0000305},RING finger protein 115 {ECO:0000312|HGNC:HGNC:18154};RING-type E3 ubiquitin transferase RNF115 {ECO:0000305};Rabring 7 {ECO:0000250|UniProtKB:Q9D0C1};Zinc finger protein 364 {ECO:0000303|Ref.1};, PF13639;, GO:0005829;GO:0046872;GO:0061630;GO:0004842;GO:0042059;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0043162;, C:cytosol;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9Y4L5 A8K3Y4 Q5T2V9 Q7Z2J2,E3 ubiquitin-protein ligase RNF115 {ECO:0000305},RING finger protein 115 {ECO:0000312|HGNC:HGNC:18154};RING-type E3 ubiquitin transferase RNF115 {ECO:0000305};Rabring 7 {ECO:0000250|UniProtKB:Q9D0C1};Zinc finger protein 364 {ECO:0000303|Ref.1};, PF13639;, GO:0005829;GO:0046872;GO:0061630;GO:0004842;GO:0042059;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0043162;, C:cytosol;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9Y4L5 A8K3Y4 Q5T2V9 Q7Z2J2,E3 ubiquitin-protein ligase RNF115 {ECO:0000305},RING finger protein 115 {ECO:0000312|HGNC:HGNC:18154};RING-type E3 ubiquitin transferase RNF115 {ECO:0000305};Rabring 7 {ECO:0000250|UniProtKB:Q9D0C1};Zinc finger protein 364 {ECO:0000303|Ref.1};, PF13639;, GO:0005829;GO:0046872;GO:0061630;GO:0004842;GO:0042059;GO:0051865;GO:0070936;GO:0070534;GO:0000209;GO:0043162;, C:cytosol;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9BUI4 O15317 Q9Y3R6,DNA-directed RNA polymerase III subunit RPC3,DNA-directed RNA polymerase III subunit C;RNA polymerase III 62 kDa subunit;, PF08221;PF05645;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003697;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription, DNA-templated;|Q9BUI4 O15317 Q9Y3R6,DNA-directed RNA polymerase III subunit RPC3,DNA-directed RNA polymerase III subunit C;RNA polymerase III 62 kDa subunit;, PF08221;PF05645;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003697;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription, DNA-templated;|Q9BUI4 O15317 Q9Y3R6,DNA-directed RNA polymerase III subunit RPC3,DNA-directed RNA polymerase III subunit C;RNA polymerase III 62 kDa subunit;, PF08221;PF05645;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003697;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription, DNA-templated; scaffold170 indexed_genome mRNA 1117862 1125344 . + . ID=transcript_15129;Q9BUI4 O15317 Q9Y3R6,DNA-directed RNA polymerase III subunit RPC3,DNA-directed RNA polymerase III subunit C;RNA polymerase III 62 kDa subunit;, PF08221;PF05645;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003697;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription, DNA-templated;|Q9BUI4 O15317 Q9Y3R6,DNA-directed RNA polymerase III subunit RPC3,DNA-directed RNA polymerase III subunit C;RNA polymerase III 62 kDa subunit;, PF08221;PF05645;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003697;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription, DNA-templated;|P0C025,Nucleoside diphosphate-linked moiety X motif 17,, PF00293;, GO:0005829;GO:0005777;GO:0046872;GO:0035529;GO:0019677;GO:0006734;GO:0006742;, C:cytosol; C:peroxisome;, F:metal ion binding; F:NADH pyrophosphatase activity;, P:NAD catabolic process; P:NADH metabolic process; P:NADP catabolic process;|Q9BUI4 O15317 Q9Y3R6,DNA-directed RNA polymerase III subunit RPC3,DNA-directed RNA polymerase III subunit C;RNA polymerase III 62 kDa subunit;, PF08221;PF05645;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003697;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription, DNA-templated;|Q9BUI4 O15317 Q9Y3R6,DNA-directed RNA polymerase III subunit RPC3,DNA-directed RNA polymerase III subunit C;RNA polymerase III 62 kDa subunit;, PF08221;PF05645;, GO:0005829;GO:0005654;GO:0005666;GO:0003899;GO:0003697;GO:0051607;GO:0045087;GO:0045089;GO:0032728;GO:0032481;GO:0006359;GO:0006351;, C:cytosol; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:single-stranded DNA binding;, P:defense response to virus; P:innate immune response; P:positive regulation of innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase III; P:transcription, DNA-templated;|P0C025,Nucleoside diphosphate-linked moiety X motif 17,, PF00293;, GO:0005829;GO:0005777;GO:0046872;GO:0035529;GO:0019677;GO:0006734;GO:0006742;, C:cytosol; C:peroxisome;, F:metal ion binding; F:NADH pyrophosphatase activity;, P:NAD catabolic process; P:NADH metabolic process; P:NADP catabolic process; scaffold170 indexed_genome mRNA 1125619 1135954 . - . ID=transcript_15130;Q9Y6X2 Q9UFI3,E3 SUMO-protein ligase PIAS3,E3 SUMO-protein transferase PIAS3 {ECO:0000305};Protein inhibitor of activated STAT protein 3;, PF14324;PF02891;, GO:0005737;GO:0030425;GO:0016607;GO:0005654;GO:0045202;GO:0019899;GO:0015459;GO:0008022;GO:0047485;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0008270;GO:0045671;GO:0033234;GO:0000122;GO:0010628;GO:0045838;GO:0033235;GO:0016925;GO:0006357;GO:0009725;GO:0071847;, C:cytoplasm; C:dendrite; C:nuclear speck; C:nucleoplasm; C:synapse;, F:enzyme binding; F:potassium channel regulator activity; F:protein C-terminus binding; F:protein N-terminus binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:zinc ion binding;, P:negative regulation of osteoclast differentiation; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of gene expression; P:positive regulation of membrane potential; P:positive regulation of protein sumoylation; P:protein sumoylation; P:regulation of transcription by RNA polymerase II; P:response to hormone; P:TNFSF11-mediated signaling pathway;|Q9Y6X2 Q9UFI3,E3 SUMO-protein ligase PIAS3,E3 SUMO-protein transferase PIAS3 {ECO:0000305};Protein inhibitor of activated STAT protein 3;, PF14324;PF02891;, GO:0005737;GO:0030425;GO:0016607;GO:0005654;GO:0045202;GO:0019899;GO:0015459;GO:0008022;GO:0047485;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0008270;GO:0045671;GO:0033234;GO:0000122;GO:0010628;GO:0045838;GO:0033235;GO:0016925;GO:0006357;GO:0009725;GO:0071847;, C:cytoplasm; C:dendrite; C:nuclear speck; C:nucleoplasm; C:synapse;, F:enzyme binding; F:potassium channel regulator activity; F:protein C-terminus binding; F:protein N-terminus binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:zinc ion binding;, P:negative regulation of osteoclast differentiation; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of gene expression; P:positive regulation of membrane potential; P:positive regulation of protein sumoylation; P:protein sumoylation; P:regulation of transcription by RNA polymerase II; P:response to hormone; P:TNFSF11-mediated signaling pathway;|Q9Y6X2 Q9UFI3,E3 SUMO-protein ligase PIAS3,E3 SUMO-protein transferase PIAS3 {ECO:0000305};Protein inhibitor of activated STAT protein 3;, PF14324;PF02891;, GO:0005737;GO:0030425;GO:0016607;GO:0005654;GO:0045202;GO:0019899;GO:0015459;GO:0008022;GO:0047485;GO:0001085;GO:0061665;GO:0019789;GO:0003712;GO:0008270;GO:0045671;GO:0033234;GO:0000122;GO:0010628;GO:0045838;GO:0033235;GO:0016925;GO:0006357;GO:0009725;GO:0071847;, C:cytoplasm; C:dendrite; C:nuclear speck; C:nucleoplasm; C:synapse;, F:enzyme binding; F:potassium channel regulator activity; F:protein C-terminus binding; F:protein N-terminus binding; F:RNA polymerase II transcription factor binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription coregulator activity; F:zinc ion binding;, P:negative regulation of osteoclast differentiation; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of gene expression; P:positive regulation of membrane potential; P:positive regulation of protein sumoylation; P:protein sumoylation; P:regulation of transcription by RNA polymerase II; P:response to hormone; P:TNFSF11-mediated signaling pathway; scaffold170 indexed_genome mRNA 1139472 1144880 . - . ID=transcript_15131;Q8N283 A6NEU0 B4DL62 Q3MJ10 Q96LS3,Ankyrin repeat domain-containing protein 35,, PF00023;PF12796; scaffold170 indexed_genome mRNA 1144916 1147901 . - . ID=transcript_15132;Q8N283 A6NEU0 B4DL62 Q3MJ10 Q96LS3,Ankyrin repeat domain-containing protein 35,, PF00023;PF12796; scaffold170 indexed_genome mRNA 1148124 1148855 . - . ID=transcript_15133;Q8N283 A6NEU0 B4DL62 Q3MJ10 Q96LS3,Ankyrin repeat domain-containing protein 35,, PF00023;PF12796; scaffold170 indexed_genome mRNA 1161278 1169439 . - . ID=transcript_15134;O75578 B2RAM4 B2RTV5 Q6UXJ6 Q9UHZ8,Integrin alpha-10,, PF01839;PF08441;PF00092;, GO:0034680;GO:0008305;GO:0005886;GO:0005518;GO:0098639;GO:0046872;GO:0007160;GO:0030198;GO:0007229;, C:integrin alpha10-beta1 complex; C:integrin complex; C:plasma membrane;, F:collagen binding; F:collagen binding involved in cell-matrix adhesion; F:metal ion binding;, P:cell-matrix adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway;|O75578 B2RAM4 B2RTV5 Q6UXJ6 Q9UHZ8,Integrin alpha-10,, PF01839;PF08441;PF00092;, GO:0034680;GO:0008305;GO:0005886;GO:0005518;GO:0098639;GO:0046872;GO:0007160;GO:0030198;GO:0007229;, C:integrin alpha10-beta1 complex; C:integrin complex; C:plasma membrane;, F:collagen binding; F:collagen binding involved in cell-matrix adhesion; F:metal ion binding;, P:cell-matrix adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway;|O75578 B2RAM4 B2RTV5 Q6UXJ6 Q9UHZ8,Integrin alpha-10,, PF01839;PF08441;PF00092;, GO:0034680;GO:0008305;GO:0005886;GO:0005518;GO:0098639;GO:0046872;GO:0007160;GO:0030198;GO:0007229;, C:integrin alpha10-beta1 complex; C:integrin complex; C:plasma membrane;, F:collagen binding; F:collagen binding involved in cell-matrix adhesion; F:metal ion binding;, P:cell-matrix adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; scaffold170 indexed_genome mRNA 1174535 1180780 . - . ID=transcript_15135;O96011 B3KN85 B4DXH9 Q96ET2,Peroxisomal membrane protein 11B,Peroxin-11B;Peroxisomal biogenesis factor 11B;Protein PEX11 homolog beta;, PF05648;, GO:0005829;GO:0005779;GO:0043231;GO:0016020;GO:0005739;GO:0005654;GO:0005778;GO:0005777;GO:0032991;GO:0042802;GO:0042803;GO:0016559;GO:0007031;GO:0045046;GO:0044375;GO:0007165;, C:cytosol; C:integral component of peroxisomal membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nucleoplasm; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:identical protein binding; F:protein homodimerization activity;, P:peroxisome fission; P:peroxisome organization; P:protein import into peroxisome membrane; P:regulation of peroxisome size; P:signal transduction;|O96011 B3KN85 B4DXH9 Q96ET2,Peroxisomal membrane protein 11B,Peroxin-11B;Peroxisomal biogenesis factor 11B;Protein PEX11 homolog beta;, PF05648;, GO:0005829;GO:0005779;GO:0043231;GO:0016020;GO:0005739;GO:0005654;GO:0005778;GO:0005777;GO:0032991;GO:0042802;GO:0042803;GO:0016559;GO:0007031;GO:0045046;GO:0044375;GO:0007165;, C:cytosol; C:integral component of peroxisomal membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion; C:nucleoplasm; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:identical protein binding; F:protein homodimerization activity;, P:peroxisome fission; P:peroxisome organization; P:protein import into peroxisome membrane; P:regulation of peroxisome size; P:signal transduction; scaffold170 indexed_genome mRNA 1181288 1189075 . + . ID=transcript_15136;Q96P88 E7EN27 Q8TCX8,Putative gonadotropin-releasing hormone II receptor,Type II GnRH receptor;, PF00001;, GO:0005887;GO:0005886;GO:0004930;GO:0004968;GO:0042277;GO:0007186;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:gonadotropin-releasing hormone receptor activity; F:peptide binding;, P:G protein-coupled receptor signaling pathway;|Q9Y5S9 B3KQI9 Q6FHD1 Q6IQ40 Q9GZX8 Q9NZI4,RNA-binding protein 8A,Binder of OVCA1-1;RNA-binding motif protein 8A;RNA-binding protein Y14 {ECO:0000303|PubMed:11030346};Ribonucleoprotein RBM8A;, PF00076;, GO:0071013;GO:0005737;GO:0005829;GO:0030425;GO:0035145;GO:0043025;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0003729;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0000381;GO:0006417;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:dendrite; C:exon-exon junction complex; C:neuronal cell body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of translation; P:RNA export from nucleus; P:RNA splicing;|Q9Y5S9 B3KQI9 Q6FHD1 Q6IQ40 Q9GZX8 Q9NZI4,RNA-binding protein 8A,Binder of OVCA1-1;RNA-binding motif protein 8A;RNA-binding protein Y14 {ECO:0000303|PubMed:11030346};Ribonucleoprotein RBM8A;, PF00076;, GO:0071013;GO:0005737;GO:0005829;GO:0030425;GO:0035145;GO:0043025;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0003729;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0000381;GO:0006417;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:dendrite; C:exon-exon junction complex; C:neuronal cell body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of translation; P:RNA export from nucleus; P:RNA splicing;|Q9Y5S9 B3KQI9 Q6FHD1 Q6IQ40 Q9GZX8 Q9NZI4,RNA-binding protein 8A,Binder of OVCA1-1;RNA-binding motif protein 8A;RNA-binding protein Y14 {ECO:0000303|PubMed:11030346};Ribonucleoprotein RBM8A;, PF00076;, GO:0071013;GO:0005737;GO:0005829;GO:0030425;GO:0035145;GO:0043025;GO:0016607;GO:0005654;GO:0005634;GO:0071006;GO:0003729;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0000381;GO:0006417;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:dendrite; C:exon-exon junction complex; C:neuronal cell body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome;, F:mRNA binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of translation; P:RNA export from nucleus; P:RNA splicing; scaffold170 indexed_genome mRNA 1193025 1211872 . + . ID=transcript_15137;Q8IVB5 Q6AI36,LIX1-like protein,, PF14954;, GO:0005737;GO:0097352;, C:cytoplasm;, , P:autophagosome maturation;|Q8IVB5 Q6AI36,LIX1-like protein,, PF14954;, GO:0005737;GO:0097352;, C:cytoplasm;, , P:autophagosome maturation;|Q8IVB5 Q6AI36,LIX1-like protein,, PF14954;, GO:0005737;GO:0097352;, C:cytoplasm;, , P:autophagosome maturation; scaffold170 indexed_genome mRNA 1213282 1216889 . - . ID=transcript_15138;Q69YU3 B3KSU3,Ankyrin repeat domain-containing protein 34A,, PF12796; scaffold170 indexed_genome mRNA 1218024 1231524 . + . ID=transcript_15139;Q9BT43 B1MVG5,DNA-directed RNA polymerase III subunit RPC7-like,DNA-directed RNA polymerase III subunit G-like;RNA polymerase III 32 kDa beta subunit;, PF11705;, GO:0005829;GO:0005654;GO:0005634;GO:0005666;GO:0032481;GO:0006383;, C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase III complex;, , P:positive regulation of type I interferon production; P:transcription by RNA polymerase III; scaffold170 indexed_genome mRNA 1240402 1244585 . + . ID=transcript_15140;Q9H3M7 B4E3D3 Q16226 Q6PML0 Q9BXG9,Thioredoxin-interacting protein,Thioredoxin-binding protein 2;Vitamin D3 up-regulated protein 1;, PF02752;PF00339;, GO:0005737;GO:0005829;GO:0005758;GO:0005634;GO:0004857;GO:0031625;GO:0007049;GO:0071228;GO:0030216;GO:0051782;GO:0000122;GO:0048008;GO:0043065;GO:0006606;GO:0015031;GO:0035590;GO:0042127;GO:0051592;GO:0042493;GO:0032355;GO:0009749;GO:0042542;GO:0009612;GO:0032570;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:nucleus;, F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:cell cycle; P:cellular response to tumor cell; P:keratinocyte differentiation; P:negative regulation of cell division; P:negative regulation of transcription by RNA polymerase II; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of apoptotic process; P:protein import into nucleus; P:protein transport; P:purinergic nucleotide receptor signaling pathway; P:regulation of cell population proliferation; P:response to calcium ion; P:response to drug; P:response to estradiol; P:response to glucose; P:response to hydrogen peroxide; P:response to mechanical stimulus; P:response to progesterone;|Q9H3M7 B4E3D3 Q16226 Q6PML0 Q9BXG9,Thioredoxin-interacting protein,Thioredoxin-binding protein 2;Vitamin D3 up-regulated protein 1;, PF02752;PF00339;, GO:0005737;GO:0005829;GO:0005758;GO:0005634;GO:0004857;GO:0031625;GO:0007049;GO:0071228;GO:0030216;GO:0051782;GO:0000122;GO:0048008;GO:0043065;GO:0006606;GO:0015031;GO:0035590;GO:0042127;GO:0051592;GO:0042493;GO:0032355;GO:0009749;GO:0042542;GO:0009612;GO:0032570;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:nucleus;, F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:cell cycle; P:cellular response to tumor cell; P:keratinocyte differentiation; P:negative regulation of cell division; P:negative regulation of transcription by RNA polymerase II; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of apoptotic process; P:protein import into nucleus; P:protein transport; P:purinergic nucleotide receptor signaling pathway; P:regulation of cell population proliferation; P:response to calcium ion; P:response to drug; P:response to estradiol; P:response to glucose; P:response to hydrogen peroxide; P:response to mechanical stimulus; P:response to progesterone;|Q9H3M7 B4E3D3 Q16226 Q6PML0 Q9BXG9,Thioredoxin-interacting protein,Thioredoxin-binding protein 2;Vitamin D3 up-regulated protein 1;, PF02752;PF00339;, GO:0005737;GO:0005829;GO:0005758;GO:0005634;GO:0004857;GO:0031625;GO:0007049;GO:0071228;GO:0030216;GO:0051782;GO:0000122;GO:0048008;GO:0043065;GO:0006606;GO:0015031;GO:0035590;GO:0042127;GO:0051592;GO:0042493;GO:0032355;GO:0009749;GO:0042542;GO:0009612;GO:0032570;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:nucleus;, F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:cell cycle; P:cellular response to tumor cell; P:keratinocyte differentiation; P:negative regulation of cell division; P:negative regulation of transcription by RNA polymerase II; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of apoptotic process; P:protein import into nucleus; P:protein transport; P:purinergic nucleotide receptor signaling pathway; P:regulation of cell population proliferation; P:response to calcium ion; P:response to drug; P:response to estradiol; P:response to glucose; P:response to hydrogen peroxide; P:response to mechanical stimulus; P:response to progesterone;|Q9H3M7 B4E3D3 Q16226 Q6PML0 Q9BXG9,Thioredoxin-interacting protein,Thioredoxin-binding protein 2;Vitamin D3 up-regulated protein 1;, PF02752;PF00339;, GO:0005737;GO:0005829;GO:0005758;GO:0005634;GO:0004857;GO:0031625;GO:0007049;GO:0071228;GO:0030216;GO:0051782;GO:0000122;GO:0048008;GO:0043065;GO:0006606;GO:0015031;GO:0035590;GO:0042127;GO:0051592;GO:0042493;GO:0032355;GO:0009749;GO:0042542;GO:0009612;GO:0032570;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:nucleus;, F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:cell cycle; P:cellular response to tumor cell; P:keratinocyte differentiation; P:negative regulation of cell division; P:negative regulation of transcription by RNA polymerase II; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of apoptotic process; P:protein import into nucleus; P:protein transport; P:purinergic nucleotide receptor signaling pathway; P:regulation of cell population proliferation; P:response to calcium ion; P:response to drug; P:response to estradiol; P:response to glucose; P:response to hydrogen peroxide; P:response to mechanical stimulus; P:response to progesterone;|Q9H3M7 B4E3D3 Q16226 Q6PML0 Q9BXG9,Thioredoxin-interacting protein,Thioredoxin-binding protein 2;Vitamin D3 up-regulated protein 1;, PF02752;PF00339;, GO:0005737;GO:0005829;GO:0005758;GO:0005634;GO:0004857;GO:0031625;GO:0007049;GO:0071228;GO:0030216;GO:0051782;GO:0000122;GO:0048008;GO:0043065;GO:0006606;GO:0015031;GO:0035590;GO:0042127;GO:0051592;GO:0042493;GO:0032355;GO:0009749;GO:0042542;GO:0009612;GO:0032570;, C:cytoplasm; C:cytosol; C:mitochondrial intermembrane space; C:nucleus;, F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:cell cycle; P:cellular response to tumor cell; P:keratinocyte differentiation; P:negative regulation of cell division; P:negative regulation of transcription by RNA polymerase II; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of apoptotic process; P:protein import into nucleus; P:protein transport; P:purinergic nucleotide receptor signaling pathway; P:regulation of cell population proliferation; P:response to calcium ion; P:response to drug; P:response to estradiol; P:response to glucose; P:response to hydrogen peroxide; P:response to mechanical stimulus; P:response to progesterone; scaffold170 indexed_genome mRNA 1259283 1263592 . - . ID=transcript_15141;Q6ZVN8 B1ALI7 Q2PQ63 Q6IMF6 Q8NAH2 Q8WVJ5,Hemojuvelin {ECO:0000305},Hemochromatosis type 2 protein;Hemojuvelin BMP coreceptor {ECO:0000305};RGM domain family member C;, PF06534;PF06535;, GO:0031225;GO:0070724;GO:0005615;GO:1990712;GO:0005886;GO:0098797;GO:0036122;GO:0015026;GO:0005102;GO:1990459;GO:0032924;GO:0030509;GO:0006879;GO:0071773;GO:0055072;GO:0000122;GO:0045944;GO:0016540;, C:anchored component of membrane; C:BMP receptor complex; C:extracellular space; C:HFE-transferrin receptor complex; C:plasma membrane; C:plasma membrane protein complex;, F:BMP binding; F:coreceptor activity; F:signaling receptor binding; F:transferrin receptor binding;, P:activin receptor signaling pathway; P:BMP signaling pathway; P:cellular iron ion homeostasis; P:cellular response to BMP stimulus; P:iron ion homeostasis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:protein autoprocessing; scaffold171 indexed_genome mRNA 22675 28854 . + . ID=transcript_15142;P78329 A0A024R7K3 A8K425 B4DV75 Q16677 Q6NWT4 Q6NWT6 Q9NNZ0 Q9UIU8,Cytochrome P450 4F2 {ECO:0000303|PubMed:20861217},20-hydroxyeicosatetraenoic acid synthase {ECO:0000303|PubMed:10660572};Arachidonic acid omega-hydroxylase {ECO:0000303|PubMed:10660572};CYPIVF2;Cytochrome P450-LTB-omega;Docosahexaenoic acid omega-hydroxylase;Leukotriene-B(4) 20-monooxygenase 1;Leukotriene-B(4) omega-hydroxylase 1 {ECO:0000305};Phylloquinone omega-hydroxylase CYP4F2 {ECO:0000305};, PF00067;, GO:0016324;GO:0005737;GO:0005789;GO:0043231;GO:0018685;GO:0052871;GO:0008392;GO:0008391;GO:0052869;GO:0070330;GO:0102207;GO:0020037;GO:0005506;GO:0050051;GO:0016709;GO:0052872;GO:0019369;GO:0007596;GO:0017144;GO:0019373;GO:0006690;GO:0036101;GO:0006691;GO:0001676;GO:0042361;GO:0032304;GO:0097267;GO:0042376;GO:0032305;GO:0003095;GO:0008217;GO:0003091;GO:0055078;GO:0000038;GO:0042360;GO:0042377;, C:apical plasma membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:alkane 1-monooxygenase activity; F:alpha-tocopherol omega-hydroxylase activity; F:arachidonic acid epoxygenase activity; F:arachidonic acid monooxygenase activity; F:arachidonic acid omega-hydroxylase activity; F:aromatase activity; F:docosanoate omega-hydroxylase activity; F:heme binding; F:iron ion binding; F:leukotriene-B4 20-monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:tocotrienol omega-hydroxylase activity;, P:arachidonic acid metabolic process; P:blood coagulation; P:drug metabolic process; P:epoxygenase P450 pathway; P:icosanoid metabolic process; P:leukotriene B4 catabolic process; P:leukotriene metabolic process; P:long-chain fatty acid metabolic process; P:menaquinone catabolic process; P:negative regulation of icosanoid secretion; P:omega-hydroxylase P450 pathway; P:phylloquinone catabolic process; P:positive regulation of icosanoid secretion; P:pressure natriuresis; P:regulation of blood pressure; P:renal water homeostasis; P:sodium ion homeostasis; P:very long-chain fatty acid metabolic process; P:vitamin E metabolic process; P:vitamin K catabolic process; scaffold171 indexed_genome mRNA 453120 467574 . + . ID=transcript_15143;Q9UCS4,Tropomyosin alpha-4 chain,TM30p1;Tropomyosin-4;, PF00261;, GO:0005884;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005862;GO:0001725;GO:0051015;GO:0005509;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0001649;, C:actin filament; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:muscle thin filament tropomyosin; C:stress fiber;, F:actin filament binding; F:calcium ion binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:osteoblast differentiation;|Q9UCS4,Tropomyosin alpha-4 chain,TM30p1;Tropomyosin-4;, PF00261;, GO:0005884;GO:0005856;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005862;GO:0001725;GO:0051015;GO:0005509;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0001649;, C:actin filament; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:muscle thin filament tropomyosin; C:stress fiber;, F:actin filament binding; F:calcium ion binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:osteoblast differentiation; scaffold171 indexed_genome mRNA 470423 491234 . + . ID=transcript_15144;P61006 B4DEK7 P24407 Q6FHV5,Ras-related protein Rab-8A,Oncogene c-mel;, PF00071;, GO:0005814;GO:0005813;GO:0005929;GO:0005829;GO:0043197;GO:0005768;GO:0070062;GO:0098978;GO:0000139;GO:0030496;GO:0043025;GO:0097730;GO:0045335;GO:0030670;GO:0005886;GO:0014069;GO:0055038;GO:0008021;GO:0032588;GO:0030140;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019901;GO:0031267;GO:0006914;GO:0007409;GO:0032869;GO:0060271;GO:0048210;GO:0098969;GO:0098887;GO:0043687;GO:0072659;GO:0009306;GO:0010506;GO:0017157;GO:0048169;GO:0051223;GO:0006904;GO:0099003;, C:centriole; C:centrosome; C:cilium; C:cytosol; C:dendritic spine; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:Golgi membrane; C:midbody; C:neuronal cell body; C:non-motile cilium; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane; C:synaptic vesicle; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding; F:protein kinase binding; F:small GTPase binding;, P:autophagy; P:axonogenesis; P:cellular response to insulin stimulus; P:cilium assembly; P:Golgi vesicle fusion to target membrane; P:neurotransmitter receptor transport to postsynaptic membrane; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:post-translational protein modification; P:protein localization to plasma membrane; P:protein secretion; P:regulation of autophagy; P:regulation of exocytosis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of protein transport; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport in synapse;|P61006 B4DEK7 P24407 Q6FHV5,Ras-related protein Rab-8A,Oncogene c-mel;, PF00071;, GO:0005814;GO:0005813;GO:0005929;GO:0005829;GO:0043197;GO:0005768;GO:0070062;GO:0098978;GO:0000139;GO:0030496;GO:0043025;GO:0097730;GO:0045335;GO:0030670;GO:0005886;GO:0014069;GO:0055038;GO:0008021;GO:0032588;GO:0030140;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019901;GO:0031267;GO:0006914;GO:0007409;GO:0032869;GO:0060271;GO:0048210;GO:0098969;GO:0098887;GO:0043687;GO:0072659;GO:0009306;GO:0010506;GO:0017157;GO:0048169;GO:0051223;GO:0006904;GO:0099003;, C:centriole; C:centrosome; C:cilium; C:cytosol; C:dendritic spine; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:Golgi membrane; C:midbody; C:neuronal cell body; C:non-motile cilium; C:phagocytic vesicle; C:phagocytic vesicle membrane; C:plasma membrane; C:postsynaptic density; C:recycling endosome membrane; C:synaptic vesicle; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding; F:protein kinase binding; F:small GTPase binding;, P:autophagy; P:axonogenesis; P:cellular response to insulin stimulus; P:cilium assembly; P:Golgi vesicle fusion to target membrane; P:neurotransmitter receptor transport to postsynaptic membrane; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:post-translational protein modification; P:protein localization to plasma membrane; P:protein secretion; P:regulation of autophagy; P:regulation of exocytosis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of protein transport; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport in synapse; scaffold171 indexed_genome mRNA 526789 532819 . + . ID=transcript_15145;Q9Y421 Q9BT02,Protein FAM32A,Ovarian tumor-associated gene 12;, PF08555;, GO:0005730;GO:0005654;GO:0003723;GO:0006915;GO:0007049;, C:nucleolus; C:nucleoplasm;, F:RNA binding;, P:apoptotic process; P:cell cycle; scaffold171 indexed_genome mRNA 542931 565361 . + . ID=transcript_15146;Q9BXS5 Q4TTY5,AP-1 complex subunit mu-1,AP-mu chain family member mu1A;Adaptor protein complex AP-1 subunit mu-1;Adaptor-related protein complex 1 subunit mu-1;Clathrin assembly protein complex 1 mu-1 medium chain 1;Clathrin coat assembly protein AP47;Clathrin coat-associated protein AP47;Golgi adaptor HA1/AP1 adaptin mu-1 subunit;Mu-adaptin 1;Mu1A-adaptin;, PF00928;, GO:0030131;GO:0030136;GO:0030665;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0035579;GO:0032588;GO:0035615;GO:0019886;GO:0035646;GO:0006886;GO:0032438;GO:0043312;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network membrane;, F:clathrin adaptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endosome to melanosome transport; P:intracellular protein transport; P:melanosome organization; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q9BXS5 Q4TTY5,AP-1 complex subunit mu-1,AP-mu chain family member mu1A;Adaptor protein complex AP-1 subunit mu-1;Adaptor-related protein complex 1 subunit mu-1;Clathrin assembly protein complex 1 mu-1 medium chain 1;Clathrin coat assembly protein AP47;Clathrin coat-associated protein AP47;Golgi adaptor HA1/AP1 adaptin mu-1 subunit;Mu-adaptin 1;Mu1A-adaptin;, PF00928;, GO:0030131;GO:0030136;GO:0030665;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0035579;GO:0032588;GO:0035615;GO:0019886;GO:0035646;GO:0006886;GO:0032438;GO:0043312;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network membrane;, F:clathrin adaptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endosome to melanosome transport; P:intracellular protein transport; P:melanosome organization; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q9BXS5 Q4TTY5,AP-1 complex subunit mu-1,AP-mu chain family member mu1A;Adaptor protein complex AP-1 subunit mu-1;Adaptor-related protein complex 1 subunit mu-1;Clathrin assembly protein complex 1 mu-1 medium chain 1;Clathrin coat assembly protein AP47;Clathrin coat-associated protein AP47;Golgi adaptor HA1/AP1 adaptin mu-1 subunit;Mu-adaptin 1;Mu1A-adaptin;, PF00928;, GO:0030131;GO:0030136;GO:0030665;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0035579;GO:0032588;GO:0035615;GO:0019886;GO:0035646;GO:0006886;GO:0032438;GO:0043312;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network membrane;, F:clathrin adaptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endosome to melanosome transport; P:intracellular protein transport; P:melanosome organization; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q9BXS5 Q4TTY5,AP-1 complex subunit mu-1,AP-mu chain family member mu1A;Adaptor protein complex AP-1 subunit mu-1;Adaptor-related protein complex 1 subunit mu-1;Clathrin assembly protein complex 1 mu-1 medium chain 1;Clathrin coat assembly protein AP47;Clathrin coat-associated protein AP47;Golgi adaptor HA1/AP1 adaptin mu-1 subunit;Mu-adaptin 1;Mu1A-adaptin;, PF00928;, GO:0030131;GO:0030136;GO:0030665;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0035579;GO:0032588;GO:0035615;GO:0019886;GO:0035646;GO:0006886;GO:0032438;GO:0043312;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network membrane;, F:clathrin adaptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endosome to melanosome transport; P:intracellular protein transport; P:melanosome organization; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport;|Q9BXS5 Q4TTY5,AP-1 complex subunit mu-1,AP-mu chain family member mu1A;Adaptor protein complex AP-1 subunit mu-1;Adaptor-related protein complex 1 subunit mu-1;Clathrin assembly protein complex 1 mu-1 medium chain 1;Clathrin coat assembly protein AP47;Clathrin coat-associated protein AP47;Golgi adaptor HA1/AP1 adaptin mu-1 subunit;Mu-adaptin 1;Mu1A-adaptin;, PF00928;, GO:0030131;GO:0030136;GO:0030665;GO:0031410;GO:0030659;GO:0005829;GO:0070062;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0005886;GO:0035579;GO:0032588;GO:0035615;GO:0019886;GO:0035646;GO:0006886;GO:0032438;GO:0043312;GO:0006892;GO:0050690;GO:0016192;, C:clathrin adaptor complex; C:clathrin-coated vesicle; C:clathrin-coated vesicle membrane; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:plasma membrane; C:specific granule membrane; C:trans-Golgi network membrane;, F:clathrin adaptor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:endosome to melanosome transport; P:intracellular protein transport; P:melanosome organization; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; P:regulation of defense response to virus by virus; P:vesicle-mediated transport; scaffold171 indexed_genome mRNA 697535 732104 . - . ID=transcript_15147;Q9UBC2 A2RRF3 A5PL29 B4DKA3,Epidermal growth factor receptor substrate 15-like 1,Eps15-related protein;, PF12763;, GO:0030132;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0045296;GO:0005509;GO:0006897;GO:0016197;GO:0061024;GO:0042059;, C:clathrin coat of coated pit; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway;|Q9UBC2 A2RRF3 A5PL29 B4DKA3,Epidermal growth factor receptor substrate 15-like 1,Eps15-related protein;, PF12763;, GO:0030132;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0045296;GO:0005509;GO:0006897;GO:0016197;GO:0061024;GO:0042059;, C:clathrin coat of coated pit; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; scaffold171 indexed_genome mRNA 734233 771982 . - . ID=transcript_15148;Q9UBC2 A2RRF3 A5PL29 B4DKA3,Epidermal growth factor receptor substrate 15-like 1,Eps15-related protein;, PF12763;, GO:0030132;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0045296;GO:0005509;GO:0006897;GO:0016197;GO:0061024;GO:0042059;, C:clathrin coat of coated pit; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway;|Q9UBC2 A2RRF3 A5PL29 B4DKA3,Epidermal growth factor receptor substrate 15-like 1,Eps15-related protein;, PF12763;, GO:0030132;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0045296;GO:0005509;GO:0006897;GO:0016197;GO:0061024;GO:0042059;, C:clathrin coat of coated pit; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway;|Q9UBC2 A2RRF3 A5PL29 B4DKA3,Epidermal growth factor receptor substrate 15-like 1,Eps15-related protein;, PF12763;, GO:0030132;GO:0005829;GO:0016020;GO:0005634;GO:0005886;GO:0045296;GO:0005509;GO:0006897;GO:0016197;GO:0061024;GO:0042059;, C:clathrin coat of coated pit; C:cytosol; C:membrane; C:nucleus; C:plasma membrane;, F:cadherin binding; F:calcium ion binding;, P:endocytosis; P:endosomal transport; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; scaffold171 indexed_genome mRNA 816962 817465 . - . ID=transcript_15149;Q96L12 D9N574 Q96LN3,Calreticulin-3,Calreticulin-2;Calsperin;, PF00262;, GO:0005788;GO:0005789;GO:0005635;GO:0030246;GO:0046872;GO:0044183;GO:0051082;GO:0030154;GO:0030968;GO:0006457;GO:0007283;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:nuclear envelope;, F:carbohydrate binding; F:metal ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:cell differentiation; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:spermatogenesis; scaffold171 indexed_genome mRNA 817800 818792 . + . ID=transcript_15150;Q96L12 D9N574 Q96LN3,Calreticulin-3,Calreticulin-2;Calsperin;, PF00262;, GO:0005788;GO:0005789;GO:0005635;GO:0030246;GO:0046872;GO:0044183;GO:0051082;GO:0030154;GO:0030968;GO:0006457;GO:0007283;, C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:nuclear envelope;, F:carbohydrate binding; F:metal ion binding; F:protein folding chaperone; F:unfolded protein binding;, P:cell differentiation; P:endoplasmic reticulum unfolded protein response; P:protein folding; P:spermatogenesis; scaffold171 indexed_genome mRNA 838640 878069 . + . ID=transcript_15151;Q9H6X5 Q8N6Y7,Uncharacterized protein C19orf44,, PF15391;|Q8IWX8 O00302 Q4G0Y5 Q8WU30 Q99492,Calcium homeostasis endoplasmic reticulum protein,ERPROT 213-21;SR-related CTD-associated factor 6;, PF04818;PF01585;PF01805;, GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0033017;GO:0044325;GO:0003723;GO:0006874;GO:0000398;GO:0008285;GO:0007399;GO:0070886;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:RNA binding;, P:cellular calcium ion homeostasis; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:nervous system development; P:positive regulation of calcineurin-NFAT signaling cascade; P:release of sequestered calcium ion into cytosol;|Q8IWX8 O00302 Q4G0Y5 Q8WU30 Q99492,Calcium homeostasis endoplasmic reticulum protein,ERPROT 213-21;SR-related CTD-associated factor 6;, PF04818;PF01585;PF01805;, GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0033017;GO:0044325;GO:0003723;GO:0006874;GO:0000398;GO:0008285;GO:0007399;GO:0070886;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:RNA binding;, P:cellular calcium ion homeostasis; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:nervous system development; P:positive regulation of calcineurin-NFAT signaling cascade; P:release of sequestered calcium ion into cytosol;|Q8IWX8 O00302 Q4G0Y5 Q8WU30 Q99492,Calcium homeostasis endoplasmic reticulum protein,ERPROT 213-21;SR-related CTD-associated factor 6;, PF04818;PF01585;PF01805;, GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0033017;GO:0044325;GO:0003723;GO:0006874;GO:0000398;GO:0008285;GO:0007399;GO:0070886;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:RNA binding;, P:cellular calcium ion homeostasis; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:nervous system development; P:positive regulation of calcineurin-NFAT signaling cascade; P:release of sequestered calcium ion into cytosol;|Q8IWX8 O00302 Q4G0Y5 Q8WU30 Q99492,Calcium homeostasis endoplasmic reticulum protein,ERPROT 213-21;SR-related CTD-associated factor 6;, PF04818;PF01585;PF01805;, GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0033017;GO:0044325;GO:0003723;GO:0006874;GO:0000398;GO:0008285;GO:0007399;GO:0070886;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:RNA binding;, P:cellular calcium ion homeostasis; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:nervous system development; P:positive regulation of calcineurin-NFAT signaling cascade; P:release of sequestered calcium ion into cytosol;|Q8IWX8 O00302 Q4G0Y5 Q8WU30 Q99492,Calcium homeostasis endoplasmic reticulum protein,ERPROT 213-21;SR-related CTD-associated factor 6;, PF04818;PF01585;PF01805;, GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0033017;GO:0044325;GO:0003723;GO:0006874;GO:0000398;GO:0008285;GO:0007399;GO:0070886;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:RNA binding;, P:cellular calcium ion homeostasis; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:nervous system development; P:positive regulation of calcineurin-NFAT signaling cascade; P:release of sequestered calcium ion into cytosol;|Q8IWX8 O00302 Q4G0Y5 Q8WU30 Q99492,Calcium homeostasis endoplasmic reticulum protein,ERPROT 213-21;SR-related CTD-associated factor 6;, PF04818;PF01585;PF01805;, GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0033017;GO:0044325;GO:0003723;GO:0006874;GO:0000398;GO:0008285;GO:0007399;GO:0070886;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:RNA binding;, P:cellular calcium ion homeostasis; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:nervous system development; P:positive regulation of calcineurin-NFAT signaling cascade; P:release of sequestered calcium ion into cytosol;|Q8IWX8 O00302 Q4G0Y5 Q8WU30 Q99492,Calcium homeostasis endoplasmic reticulum protein,ERPROT 213-21;SR-related CTD-associated factor 6;, PF04818;PF01585;PF01805;, GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0033017;GO:0044325;GO:0003723;GO:0006874;GO:0000398;GO:0008285;GO:0007399;GO:0070886;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:RNA binding;, P:cellular calcium ion homeostasis; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:nervous system development; P:positive regulation of calcineurin-NFAT signaling cascade; P:release of sequestered calcium ion into cytosol;|Q8IWX8 O00302 Q4G0Y5 Q8WU30 Q99492,Calcium homeostasis endoplasmic reticulum protein,ERPROT 213-21;SR-related CTD-associated factor 6;, PF04818;PF01585;PF01805;, GO:0005737;GO:0016020;GO:0005654;GO:0048471;GO:0033017;GO:0044325;GO:0003723;GO:0006874;GO:0000398;GO:0008285;GO:0007399;GO:0070886;GO:0051209;, C:cytoplasm; C:membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:sarcoplasmic reticulum membrane;, F:ion channel binding; F:RNA binding;, P:cellular calcium ion homeostasis; P:mRNA splicing, via spliceosome; P:negative regulation of cell population proliferation; P:nervous system development; P:positive regulation of calcineurin-NFAT signaling cascade; P:release of sequestered calcium ion into cytosol; scaffold171 indexed_genome mRNA 882663 901424 . - . ID=transcript_15152;Q96K37 Q8NBQ2 Q96JV7,Solute carrier family 35 member E1,, PF03151;, GO:0005794;GO:0016021;GO:0015297;, C:Golgi apparatus; C:integral component of membrane;, F:antiporter activity; scaffold171 indexed_genome mRNA 909318 951534 . - . ID=transcript_15153;O95402 A1A4S3 Q0VGB6,Mediator of RNA polymerase II transcription subunit 26,Activator-recruited cofactor 70 kDa component;Cofactor required for Sp1 transcriptional activation subunit 7;Mediator complex subunit 26;Transcriptional coactivator CRSP70;, PF08711;PF15693;PF15694;, GO:0070847;GO:0016592;GO:0005654;GO:0003713;GO:0003712;GO:0010628;GO:0006357;GO:0060260;GO:0006367;, C:core mediator complex; C:mediator complex; C:nucleoplasm;, F:transcription coactivator activity; F:transcription coregulator activity;, P:positive regulation of gene expression; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; scaffold171 indexed_genome mRNA 962071 980782 . - . ID=transcript_15154;Q9BQ49 A8MX44,Small integral membrane protein 7,, , GO:0016021;, C:integral component of membrane; scaffold171 indexed_genome mRNA 991993 1026553 . + . ID=transcript_15155;Q9H6F2 A8K9P9,Trimeric intracellular cation channel type A,Transmembrane protein 38A;, PF05197;, GO:0070062;GO:0016021;GO:0031965;GO:0033017;GO:0042802;GO:0005267;GO:0071313;GO:0007029;GO:0010881;GO:0014808;, C:extracellular exosome; C:integral component of membrane; C:nuclear membrane; C:sarcoplasmic reticulum membrane;, F:identical protein binding; F:potassium channel activity;, P:cellular response to caffeine; P:endoplasmic reticulum organization; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;|Q9H6F2 A8K9P9,Trimeric intracellular cation channel type A,Transmembrane protein 38A;, PF05197;, GO:0070062;GO:0016021;GO:0031965;GO:0033017;GO:0042802;GO:0005267;GO:0071313;GO:0007029;GO:0010881;GO:0014808;, C:extracellular exosome; C:integral component of membrane; C:nuclear membrane; C:sarcoplasmic reticulum membrane;, F:identical protein binding; F:potassium channel activity;, P:cellular response to caffeine; P:endoplasmic reticulum organization; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;|Q9H6F2 A8K9P9,Trimeric intracellular cation channel type A,Transmembrane protein 38A;, PF05197;, GO:0070062;GO:0016021;GO:0031965;GO:0033017;GO:0042802;GO:0005267;GO:0071313;GO:0007029;GO:0010881;GO:0014808;, C:extracellular exosome; C:integral component of membrane; C:nuclear membrane; C:sarcoplasmic reticulum membrane;, F:identical protein binding; F:potassium channel activity;, P:cellular response to caffeine; P:endoplasmic reticulum organization; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;|Q9H6F2 A8K9P9,Trimeric intracellular cation channel type A,Transmembrane protein 38A;, PF05197;, GO:0070062;GO:0016021;GO:0031965;GO:0033017;GO:0042802;GO:0005267;GO:0071313;GO:0007029;GO:0010881;GO:0014808;, C:extracellular exosome; C:integral component of membrane; C:nuclear membrane; C:sarcoplasmic reticulum membrane;, F:identical protein binding; F:potassium channel activity;, P:cellular response to caffeine; P:endoplasmic reticulum organization; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;|P05198,Eukaryotic translation initiation factor 2 subunit 1,Eukaryotic translation initiation factor 2 subunit alpha;, PF07541;PF00575;, GO:0010494;GO:0005829;GO:0033290;GO:0005850;GO:0005851;GO:0070062;GO:0097451;GO:0016020;GO:0043614;GO:0005634;GO:0005844;GO:0045202;GO:0044207;GO:0043022;GO:0003723;GO:0003743;GO:0007568;GO:0034198;GO:0034605;GO:0034599;GO:0034644;GO:1905098;GO:0032057;GO:0036499;GO:1901216;GO:2000676;GO:0046777;GO:0034976;GO:1990737;GO:0034063;GO:0006413;GO:0055085;, C:cytoplasmic stress granule; C:cytosol; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 2 complex; C:eukaryotic translation initiation factor 2B complex; C:extracellular exosome; C:glial limiting end-foot; C:membrane; C:multi-eIF complex; C:nucleus; C:polysome; C:synapse; C:translation initiation ternary complex;, F:ribosome binding; F:RNA binding; F:translation initiation factor activity;, P:aging; P:cellular response to amino acid starvation; P:cellular response to heat; P:cellular response to oxidative stress; P:cellular response to UV; P:negative regulation of guanyl-nucleotide exchange factor activity; P:negative regulation of translational initiation in response to stress; P:PERK-mediated unfolded protein response; P:positive regulation of neuron death; P:positive regulation of type B pancreatic cell apoptotic process; P:protein autophosphorylation; P:response to endoplasmic reticulum stress; P:response to manganese-induced endoplasmic reticulum stress; P:stress granule assembly; P:translational initiation; P:transmembrane transport; scaffold171 indexed_genome mRNA 1152462 1196925 . + . ID=transcript_15156;O75182 Q2NL91 Q68GC2 Q6P4B8 Q8TB34 Q9BSC8,Paired amphipathic helix protein Sin3b,Histone deacetylase complex subunit Sin3b;Transcriptional corepressor Sin3b;, PF02671;PF08295;PF16879;, GO:0030849;GO:0000785;GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0016580;GO:0000805;GO:0001741;GO:0000806;GO:0003682;GO:0003714;GO:0016575;GO:0000122;GO:0019216;, C:autosome; C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:X chromosome; C:XY body; C:Y chromosome;, F:chromatin binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process;|O75182 Q2NL91 Q68GC2 Q6P4B8 Q8TB34 Q9BSC8,Paired amphipathic helix protein Sin3b,Histone deacetylase complex subunit Sin3b;Transcriptional corepressor Sin3b;, PF02671;PF08295;PF16879;, GO:0030849;GO:0000785;GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0016580;GO:0000805;GO:0001741;GO:0000806;GO:0003682;GO:0003714;GO:0016575;GO:0000122;GO:0019216;, C:autosome; C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:X chromosome; C:XY body; C:Y chromosome;, F:chromatin binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process;|O75182 Q2NL91 Q68GC2 Q6P4B8 Q8TB34 Q9BSC8,Paired amphipathic helix protein Sin3b,Histone deacetylase complex subunit Sin3b;Transcriptional corepressor Sin3b;, PF02671;PF08295;PF16879;, GO:0030849;GO:0000785;GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0016580;GO:0000805;GO:0001741;GO:0000806;GO:0003682;GO:0003714;GO:0016575;GO:0000122;GO:0019216;, C:autosome; C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:X chromosome; C:XY body; C:Y chromosome;, F:chromatin binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process;|O75182 Q2NL91 Q68GC2 Q6P4B8 Q8TB34 Q9BSC8,Paired amphipathic helix protein Sin3b,Histone deacetylase complex subunit Sin3b;Transcriptional corepressor Sin3b;, PF02671;PF08295;PF16879;, GO:0030849;GO:0000785;GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0016580;GO:0000805;GO:0001741;GO:0000806;GO:0003682;GO:0003714;GO:0016575;GO:0000122;GO:0019216;, C:autosome; C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:X chromosome; C:XY body; C:Y chromosome;, F:chromatin binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process;|O75182 Q2NL91 Q68GC2 Q6P4B8 Q8TB34 Q9BSC8,Paired amphipathic helix protein Sin3b,Histone deacetylase complex subunit Sin3b;Transcriptional corepressor Sin3b;, PF02671;PF08295;PF16879;, GO:0030849;GO:0000785;GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0016580;GO:0000805;GO:0001741;GO:0000806;GO:0003682;GO:0003714;GO:0016575;GO:0000122;GO:0019216;, C:autosome; C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:X chromosome; C:XY body; C:Y chromosome;, F:chromatin binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process;|O75182 Q2NL91 Q68GC2 Q6P4B8 Q8TB34 Q9BSC8,Paired amphipathic helix protein Sin3b,Histone deacetylase complex subunit Sin3b;Transcriptional corepressor Sin3b;, PF02671;PF08295;PF16879;, GO:0030849;GO:0000785;GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0016580;GO:0000805;GO:0001741;GO:0000806;GO:0003682;GO:0003714;GO:0016575;GO:0000122;GO:0019216;, C:autosome; C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:X chromosome; C:XY body; C:Y chromosome;, F:chromatin binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process;|O75182 Q2NL91 Q68GC2 Q6P4B8 Q8TB34 Q9BSC8,Paired amphipathic helix protein Sin3b,Histone deacetylase complex subunit Sin3b;Transcriptional corepressor Sin3b;, PF02671;PF08295;PF16879;, GO:0030849;GO:0000785;GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0016580;GO:0000805;GO:0001741;GO:0000806;GO:0003682;GO:0003714;GO:0016575;GO:0000122;GO:0019216;, C:autosome; C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:X chromosome; C:XY body; C:Y chromosome;, F:chromatin binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process;|O75182 Q2NL91 Q68GC2 Q6P4B8 Q8TB34 Q9BSC8,Paired amphipathic helix protein Sin3b,Histone deacetylase complex subunit Sin3b;Transcriptional corepressor Sin3b;, PF02671;PF08295;PF16879;, GO:0030849;GO:0000785;GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0016580;GO:0000805;GO:0001741;GO:0000806;GO:0003682;GO:0003714;GO:0016575;GO:0000122;GO:0019216;, C:autosome; C:chromatin; C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus; C:Sin3 complex; C:X chromosome; C:XY body; C:Y chromosome;, F:chromatin binding; F:transcription corepressor activity;, P:histone deacetylation; P:negative regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process; scaffold171 indexed_genome mRNA 1202629 1254732 . - . ID=transcript_15157;Q8IZJ3 Q8NC09 Q9ULD7,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 {ECO:0000303|PubMed:15177561},, PF00207;PF07703;PF07677;PF07648;PF12248;PF01835;PF17791;PF17789;PF07678;, GO:0005615;GO:0005886;GO:0004867;GO:0001654;, C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase inhibitor activity;, P:eye development;|Q8IZJ3 Q8NC09 Q9ULD7,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 {ECO:0000303|PubMed:15177561},, PF00207;PF07703;PF07677;PF07648;PF12248;PF01835;PF17791;PF17789;PF07678;, GO:0005615;GO:0005886;GO:0004867;GO:0001654;, C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase inhibitor activity;, P:eye development; scaffold171 indexed_genome mRNA 1257883 1266650 . - . ID=transcript_15158;Q8IZJ3 Q8NC09 Q9ULD7,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 {ECO:0000303|PubMed:15177561},, PF00207;PF07703;PF07677;PF07648;PF12248;PF01835;PF17791;PF17789;PF07678;, GO:0005615;GO:0005886;GO:0004867;GO:0001654;, C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase inhibitor activity;, P:eye development; scaffold171 indexed_genome mRNA 1266758 1279786 . - . ID=transcript_15159;Q8IZJ3 Q8NC09 Q9ULD7,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 {ECO:0000303|PubMed:15177561},, PF00207;PF07703;PF07677;PF07648;PF12248;PF01835;PF17791;PF17789;PF07678;, GO:0005615;GO:0005886;GO:0004867;GO:0001654;, C:extracellular space; C:plasma membrane;, F:serine-type endopeptidase inhibitor activity;, P:eye development; scaffold171 indexed_genome mRNA 1363990 1373924 . - . ID=transcript_15160;Q9BT25 B4DJA7 C9JBZ4 Q49AC4 Q86WF0 Q96FX3,HAUS augmin-like complex subunit 8,HEC1/NDC80-interacting centrosome-associated protein 1;Sarcoma antigen NY-SAR-48;, , GO:0005813;GO:0005737;GO:0005829;GO:0070652;GO:1990498;GO:0005880;GO:0000922;GO:0008017;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytoplasm; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule; C:nuclear microtubule; C:spindle pole;, F:microtubule binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q9BT25 B4DJA7 C9JBZ4 Q49AC4 Q86WF0 Q96FX3,HAUS augmin-like complex subunit 8,HEC1/NDC80-interacting centrosome-associated protein 1;Sarcoma antigen NY-SAR-48;, , GO:0005813;GO:0005737;GO:0005829;GO:0070652;GO:1990498;GO:0005880;GO:0000922;GO:0008017;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytoplasm; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule; C:nuclear microtubule; C:spindle pole;, F:microtubule binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q9BT25 B4DJA7 C9JBZ4 Q49AC4 Q86WF0 Q96FX3,HAUS augmin-like complex subunit 8,HEC1/NDC80-interacting centrosome-associated protein 1;Sarcoma antigen NY-SAR-48;, , GO:0005813;GO:0005737;GO:0005829;GO:0070652;GO:1990498;GO:0005880;GO:0000922;GO:0008017;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytoplasm; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule; C:nuclear microtubule; C:spindle pole;, F:microtubule binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold171 indexed_genome mRNA 1373937 1388586 . - . ID=transcript_15161;Q9BT25 B4DJA7 C9JBZ4 Q49AC4 Q86WF0 Q96FX3,HAUS augmin-like complex subunit 8,HEC1/NDC80-interacting centrosome-associated protein 1;Sarcoma antigen NY-SAR-48;, , GO:0005813;GO:0005737;GO:0005829;GO:0070652;GO:1990498;GO:0005880;GO:0000922;GO:0008017;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytoplasm; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule; C:nuclear microtubule; C:spindle pole;, F:microtubule binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold172 indexed_genome mRNA 329798 339514 . + . ID=transcript_15162;Q9NYB0 B4DQN4 Q4W4Y2 Q8WYZ3 Q9NWR2,Telomeric repeat-binding factor 2-interacting protein 1,Dopamine receptor-interacting protein 5;Repressor/activator protein 1 homolog;, PF16589;PF08914;PF11626;, GO:0000781;GO:0005737;GO:0005829;GO:0016604;GO:0000228;GO:0000783;GO:0005654;GO:0005634;GO:0070187;GO:0098505;GO:0019902;GO:0042162;GO:0045007;GO:0048239;GO:0001933;GO:0032205;GO:1900051;GO:0043123;GO:0051092;GO:1901224;GO:0033138;GO:1901985;GO:0031848;GO:0070198;GO:0010569;GO:0032204;GO:0006355;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0010833;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:nuclear body; C:nuclear chromosome; C:nuclear telomere cap complex; C:nucleoplasm; C:nucleus; C:shelterin complex;, F:G-rich strand telomeric DNA binding; F:phosphatase binding; F:telomeric DNA binding;, P:depurination; P:negative regulation of DNA recombination at telomere; P:negative regulation of protein phosphorylation; P:negative regulation of telomere maintenance; P:positive regulation of histone exchange; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:protection from non-homologous end joining at telomere; P:protein localization to chromosome, telomeric region; P:regulation of double-strand break repair via homologous recombination; P:regulation of telomere maintenance; P:regulation of transcription, DNA-templated; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomere maintenance via telomere lengthening;|Q9NYB0 B4DQN4 Q4W4Y2 Q8WYZ3 Q9NWR2,Telomeric repeat-binding factor 2-interacting protein 1,Dopamine receptor-interacting protein 5;Repressor/activator protein 1 homolog;, PF16589;PF08914;PF11626;, GO:0000781;GO:0005737;GO:0005829;GO:0016604;GO:0000228;GO:0000783;GO:0005654;GO:0005634;GO:0070187;GO:0098505;GO:0019902;GO:0042162;GO:0045007;GO:0048239;GO:0001933;GO:0032205;GO:1900051;GO:0043123;GO:0051092;GO:1901224;GO:0033138;GO:1901985;GO:0031848;GO:0070198;GO:0010569;GO:0032204;GO:0006355;GO:0016233;GO:0000723;GO:0032201;GO:0007004;GO:0010833;, C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:nuclear body; C:nuclear chromosome; C:nuclear telomere cap complex; C:nucleoplasm; C:nucleus; C:shelterin complex;, F:G-rich strand telomeric DNA binding; F:phosphatase binding; F:telomeric DNA binding;, P:depurination; P:negative regulation of DNA recombination at telomere; P:negative regulation of protein phosphorylation; P:negative regulation of telomere maintenance; P:positive regulation of histone exchange; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein acetylation; P:protection from non-homologous end joining at telomere; P:protein localization to chromosome, telomeric region; P:regulation of double-strand break repair via homologous recombination; P:regulation of telomere maintenance; P:regulation of transcription, DNA-templated; P:telomere capping; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:telomere maintenance via telomerase; P:telomere maintenance via telomere lengthening; scaffold172 indexed_genome mRNA 339894 353362 . + . ID=transcript_15163;Q15046 A8MSK1 D3DUK4 O14946 Q96J25 Q9HB23,Lysine--tRNA ligase,Lysyl-tRNA synthetase;, PF00152;PF01336;, GO:0017101;GO:0005829;GO:0005615;GO:0005759;GO:0005739;GO:0005634;GO:0005886;GO:0016597;GO:0003877;GO:0005524;GO:0042802;GO:0004824;GO:0042803;GO:0000049;GO:0002276;GO:0015966;GO:0070371;GO:0006430;GO:0002863;GO:0043032;GO:0045893;GO:0010165;GO:0006418;GO:0008033;GO:0016032;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytosol; C:extracellular space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:plasma membrane;, F:amino acid binding; F:ATP adenylyltransferase activity; F:ATP binding; F:identical protein binding; F:lysine-tRNA ligase activity; F:protein homodimerization activity; F:tRNA binding;, P:basophil activation involved in immune response; P:diadenosine tetraphosphate biosynthetic process; P:ERK1 and ERK2 cascade; P:lysyl-tRNA aminoacylation; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of macrophage activation; P:positive regulation of transcription, DNA-templated; P:response to X-ray; P:tRNA aminoacylation for protein translation; P:tRNA processing; P:viral process;|Q15046 A8MSK1 D3DUK4 O14946 Q96J25 Q9HB23,Lysine--tRNA ligase,Lysyl-tRNA synthetase;, PF00152;PF01336;, GO:0017101;GO:0005829;GO:0005615;GO:0005759;GO:0005739;GO:0005634;GO:0005886;GO:0016597;GO:0003877;GO:0005524;GO:0042802;GO:0004824;GO:0042803;GO:0000049;GO:0002276;GO:0015966;GO:0070371;GO:0006430;GO:0002863;GO:0043032;GO:0045893;GO:0010165;GO:0006418;GO:0008033;GO:0016032;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytosol; C:extracellular space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:plasma membrane;, F:amino acid binding; F:ATP adenylyltransferase activity; F:ATP binding; F:identical protein binding; F:lysine-tRNA ligase activity; F:protein homodimerization activity; F:tRNA binding;, P:basophil activation involved in immune response; P:diadenosine tetraphosphate biosynthetic process; P:ERK1 and ERK2 cascade; P:lysyl-tRNA aminoacylation; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of macrophage activation; P:positive regulation of transcription, DNA-templated; P:response to X-ray; P:tRNA aminoacylation for protein translation; P:tRNA processing; P:viral process;|Q15046 A8MSK1 D3DUK4 O14946 Q96J25 Q9HB23,Lysine--tRNA ligase,Lysyl-tRNA synthetase;, PF00152;PF01336;, GO:0017101;GO:0005829;GO:0005615;GO:0005759;GO:0005739;GO:0005634;GO:0005886;GO:0016597;GO:0003877;GO:0005524;GO:0042802;GO:0004824;GO:0042803;GO:0000049;GO:0002276;GO:0015966;GO:0070371;GO:0006430;GO:0002863;GO:0043032;GO:0045893;GO:0010165;GO:0006418;GO:0008033;GO:0016032;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytosol; C:extracellular space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:plasma membrane;, F:amino acid binding; F:ATP adenylyltransferase activity; F:ATP binding; F:identical protein binding; F:lysine-tRNA ligase activity; F:protein homodimerization activity; F:tRNA binding;, P:basophil activation involved in immune response; P:diadenosine tetraphosphate biosynthetic process; P:ERK1 and ERK2 cascade; P:lysyl-tRNA aminoacylation; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of macrophage activation; P:positive regulation of transcription, DNA-templated; P:response to X-ray; P:tRNA aminoacylation for protein translation; P:tRNA processing; P:viral process;|Q15046 A8MSK1 D3DUK4 O14946 Q96J25 Q9HB23,Lysine--tRNA ligase,Lysyl-tRNA synthetase;, PF00152;PF01336;, GO:0017101;GO:0005829;GO:0005615;GO:0005759;GO:0005739;GO:0005634;GO:0005886;GO:0016597;GO:0003877;GO:0005524;GO:0042802;GO:0004824;GO:0042803;GO:0000049;GO:0002276;GO:0015966;GO:0070371;GO:0006430;GO:0002863;GO:0043032;GO:0045893;GO:0010165;GO:0006418;GO:0008033;GO:0016032;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytosol; C:extracellular space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:plasma membrane;, F:amino acid binding; F:ATP adenylyltransferase activity; F:ATP binding; F:identical protein binding; F:lysine-tRNA ligase activity; F:protein homodimerization activity; F:tRNA binding;, P:basophil activation involved in immune response; P:diadenosine tetraphosphate biosynthetic process; P:ERK1 and ERK2 cascade; P:lysyl-tRNA aminoacylation; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of macrophage activation; P:positive regulation of transcription, DNA-templated; P:response to X-ray; P:tRNA aminoacylation for protein translation; P:tRNA processing; P:viral process;|Q15046 A8MSK1 D3DUK4 O14946 Q96J25 Q9HB23,Lysine--tRNA ligase,Lysyl-tRNA synthetase;, PF00152;PF01336;, GO:0017101;GO:0005829;GO:0005615;GO:0005759;GO:0005739;GO:0005634;GO:0005886;GO:0016597;GO:0003877;GO:0005524;GO:0042802;GO:0004824;GO:0042803;GO:0000049;GO:0002276;GO:0015966;GO:0070371;GO:0006430;GO:0002863;GO:0043032;GO:0045893;GO:0010165;GO:0006418;GO:0008033;GO:0016032;, C:aminoacyl-tRNA synthetase multienzyme complex; C:cytosol; C:extracellular space; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:plasma membrane;, F:amino acid binding; F:ATP adenylyltransferase activity; F:ATP binding; F:identical protein binding; F:lysine-tRNA ligase activity; F:protein homodimerization activity; F:tRNA binding;, P:basophil activation involved in immune response; P:diadenosine tetraphosphate biosynthetic process; P:ERK1 and ERK2 cascade; P:lysyl-tRNA aminoacylation; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of macrophage activation; P:positive regulation of transcription, DNA-templated; P:response to X-ray; P:tRNA aminoacylation for protein translation; P:tRNA processing; P:viral process; scaffold172 indexed_genome mRNA 355158 368932 . + . ID=transcript_15164;Q9BUB4 Q9NVB7 Q9UNG3,tRNA-specific adenosine deaminase 1,tRNA-specific adenosine-37 deaminase;, PF02137;, GO:0046872;GO:0003723;GO:0008251;GO:0008033;, , F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:tRNA processing; scaffold172 indexed_genome mRNA 377900 381673 . + . ID=transcript_15165;Q9BUB4 Q9NVB7 Q9UNG3,tRNA-specific adenosine deaminase 1,tRNA-specific adenosine-37 deaminase;, PF02137;, GO:0046872;GO:0003723;GO:0008251;GO:0008033;, , F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:tRNA processing; scaffold172 indexed_genome mRNA 381695 384060 . + . ID=transcript_15166;Q9BUB4 Q9NVB7 Q9UNG3,tRNA-specific adenosine deaminase 1,tRNA-specific adenosine-37 deaminase;, PF02137;, GO:0046872;GO:0003723;GO:0008251;GO:0008033;, , F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity;, P:tRNA processing; scaffold172 indexed_genome mRNA 394726 404159 . - . ID=transcript_15167;P60520 O08765 Q6FG91 Q9DCP8 Q9UQF7,Gamma-aminobutyric acid receptor-associated protein-like 2,GABA(A) receptor-associated protein-like 2;Ganglioside expression factor 2;General protein transport factor p16;Golgi-associated ATPase enhancer of 16 kDa;MAP1 light chain 3-related protein;, PF02991;, GO:0005776;GO:0000421;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0051117;GO:0048487;GO:0050811;GO:0008017;GO:0000149;GO:0031625;GO:0000045;GO:0097352;GO:0006914;GO:0000422;GO:0006995;GO:0006891;GO:0016236;GO:1901799;GO:0032781;GO:0070972;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane;, F:ATPase binding; F:beta-tubulin binding; F:GABA receptor binding; F:microtubule binding; F:SNARE binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagosome maturation; P:autophagy; P:autophagy of mitochondrion; P:cellular response to nitrogen starvation; P:intra-Golgi vesicle-mediated transport; P:macroautophagy; P:negative regulation of proteasomal protein catabolic process; P:positive regulation of ATPase activity; P:protein localization to endoplasmic reticulum; P:protein transport;|P60520 O08765 Q6FG91 Q9DCP8 Q9UQF7,Gamma-aminobutyric acid receptor-associated protein-like 2,GABA(A) receptor-associated protein-like 2;Ganglioside expression factor 2;General protein transport factor p16;Golgi-associated ATPase enhancer of 16 kDa;MAP1 light chain 3-related protein;, PF02991;, GO:0005776;GO:0000421;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0051117;GO:0048487;GO:0050811;GO:0008017;GO:0000149;GO:0031625;GO:0000045;GO:0097352;GO:0006914;GO:0000422;GO:0006995;GO:0006891;GO:0016236;GO:1901799;GO:0032781;GO:0070972;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane;, F:ATPase binding; F:beta-tubulin binding; F:GABA receptor binding; F:microtubule binding; F:SNARE binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagosome maturation; P:autophagy; P:autophagy of mitochondrion; P:cellular response to nitrogen starvation; P:intra-Golgi vesicle-mediated transport; P:macroautophagy; P:negative regulation of proteasomal protein catabolic process; P:positive regulation of ATPase activity; P:protein localization to endoplasmic reticulum; P:protein transport;|P60520 O08765 Q6FG91 Q9DCP8 Q9UQF7,Gamma-aminobutyric acid receptor-associated protein-like 2,GABA(A) receptor-associated protein-like 2;Ganglioside expression factor 2;General protein transport factor p16;Golgi-associated ATPase enhancer of 16 kDa;MAP1 light chain 3-related protein;, PF02991;, GO:0005776;GO:0000421;GO:0005737;GO:0031410;GO:0005829;GO:0005789;GO:0005794;GO:0000139;GO:0051117;GO:0048487;GO:0050811;GO:0008017;GO:0000149;GO:0031625;GO:0000045;GO:0097352;GO:0006914;GO:0000422;GO:0006995;GO:0006891;GO:0016236;GO:1901799;GO:0032781;GO:0070972;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane;, F:ATPase binding; F:beta-tubulin binding; F:GABA receptor binding; F:microtubule binding; F:SNARE binding; F:ubiquitin protein ligase binding;, P:autophagosome assembly; P:autophagosome maturation; P:autophagy; P:autophagy of mitochondrion; P:cellular response to nitrogen starvation; P:intra-Golgi vesicle-mediated transport; P:macroautophagy; P:negative regulation of proteasomal protein catabolic process; P:positive regulation of ATPase activity; P:protein localization to endoplasmic reticulum; P:protein transport; scaffold172 indexed_genome mRNA 413205 434627 . + . ID=transcript_15168;Q9H6L2 A0JLU1 A6NDZ6 B3KU85 G5E9E3 Q6P450 Q6UWW5,Transmembrane protein 231,, PF10149;, GO:0060170;GO:0035869;GO:0016021;GO:0036038;GO:0043010;GO:0060271;GO:0042733;GO:0001701;GO:0060563;GO:0032880;GO:0007224;GO:0001944;, C:ciliary membrane; C:ciliary transition zone; C:integral component of membrane; C:MKS complex;, , P:camera-type eye development; P:cilium assembly; P:embryonic digit morphogenesis; P:in utero embryonic development; P:neuroepithelial cell differentiation; P:regulation of protein localization; P:smoothened signaling pathway; P:vasculature development;|Q9H6L2 A0JLU1 A6NDZ6 B3KU85 G5E9E3 Q6P450 Q6UWW5,Transmembrane protein 231,, PF10149;, GO:0060170;GO:0035869;GO:0016021;GO:0036038;GO:0043010;GO:0060271;GO:0042733;GO:0001701;GO:0060563;GO:0032880;GO:0007224;GO:0001944;, C:ciliary membrane; C:ciliary transition zone; C:integral component of membrane; C:MKS complex;, , P:camera-type eye development; P:cilium assembly; P:embryonic digit morphogenesis; P:in utero embryonic development; P:neuroepithelial cell differentiation; P:regulation of protein localization; P:smoothened signaling pathway; P:vasculature development;|Q9H6L2 A0JLU1 A6NDZ6 B3KU85 G5E9E3 Q6P450 Q6UWW5,Transmembrane protein 231,, PF10149;, GO:0060170;GO:0035869;GO:0016021;GO:0036038;GO:0043010;GO:0060271;GO:0042733;GO:0001701;GO:0060563;GO:0032880;GO:0007224;GO:0001944;, C:ciliary membrane; C:ciliary transition zone; C:integral component of membrane; C:MKS complex;, , P:camera-type eye development; P:cilium assembly; P:embryonic digit morphogenesis; P:in utero embryonic development; P:neuroepithelial cell differentiation; P:regulation of protein localization; P:smoothened signaling pathway; P:vasculature development;|Q9H6L2 A0JLU1 A6NDZ6 B3KU85 G5E9E3 Q6P450 Q6UWW5,Transmembrane protein 231,, PF10149;, GO:0060170;GO:0035869;GO:0016021;GO:0036038;GO:0043010;GO:0060271;GO:0042733;GO:0001701;GO:0060563;GO:0032880;GO:0007224;GO:0001944;, C:ciliary membrane; C:ciliary transition zone; C:integral component of membrane; C:MKS complex;, , P:camera-type eye development; P:cilium assembly; P:embryonic digit morphogenesis; P:in utero embryonic development; P:neuroepithelial cell differentiation; P:regulation of protein localization; P:smoothened signaling pathway; P:vasculature development; scaffold172 indexed_genome mRNA 442985 443585 . + . ID=transcript_15169;P41567 Q9UNQ9,Eukaryotic translation initiation factor 1,A121;Protein translation factor SUI1 homolog;Sui1iso1;, PF01253;, GO:0005737;GO:0016282;GO:0005634;GO:0043024;GO:0003723;GO:0008135;GO:0003743;GO:0006446;, C:cytoplasm; C:eukaryotic 43S preinitiation complex; C:nucleus;, F:ribosomal small subunit binding; F:RNA binding; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:regulation of translational initiation; scaffold172 indexed_genome mRNA 449932 458676 . + . ID=transcript_15170;Q9GZX3 D3DUK3,Carbohydrate sulfotransferase 6,Corneal N-acetylglucosamine-6-O-sulfotransferase;Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta;N-acetylglucosamine 6-O-sulfotransferase 5;, PF00685;, GO:0005794;GO:0000139;GO:0016021;GO:0005802;GO:0001517;GO:0005975;GO:0018146;GO:0006044;GO:0006790;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:trans-Golgi network;, F:N-acetylglucosamine 6-O-sulfotransferase activity;, P:carbohydrate metabolic process; P:keratan sulfate biosynthetic process; P:N-acetylglucosamine metabolic process; P:sulfur compound metabolic process; scaffold172 indexed_genome mRNA 460759 472744 . + . ID=transcript_15171;Q8WVE7 B2R4R3 B4DPS4 D3DUK2 Q7Z6F3,Transmembrane protein 170A,, PF10190;, GO:0005789;GO:0016021;GO:0005635;GO:0071786;GO:0006998;GO:0051292;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, , P:endoplasmic reticulum tubular network organization; P:nuclear envelope organization; P:nuclear pore complex assembly;|Q8WVE7 B2R4R3 B4DPS4 D3DUK2 Q7Z6F3,Transmembrane protein 170A,, PF10190;, GO:0005789;GO:0016021;GO:0005635;GO:0071786;GO:0006998;GO:0051292;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, , P:endoplasmic reticulum tubular network organization; P:nuclear envelope organization; P:nuclear pore complex assembly;|Q8WVE7 B2R4R3 B4DPS4 D3DUK2 Q7Z6F3,Transmembrane protein 170A,, PF10190;, GO:0005789;GO:0016021;GO:0005635;GO:0071786;GO:0006998;GO:0051292;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, , P:endoplasmic reticulum tubular network organization; P:nuclear envelope organization; P:nuclear pore complex assembly;|Q8WVE7 B2R4R3 B4DPS4 D3DUK2 Q7Z6F3,Transmembrane protein 170A,, PF10190;, GO:0005789;GO:0016021;GO:0005635;GO:0071786;GO:0006998;GO:0051292;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear envelope;, , P:endoplasmic reticulum tubular network organization; P:nuclear envelope organization; P:nuclear pore complex assembly; scaffold172 indexed_genome mRNA 480467 515512 . + . ID=transcript_15172;Q9UEE9 O00393 O00404 Q9UEF0 Q9UEF1 Q9UEF8,Craniofacial development protein 1,Bucentaur;, PF07572;, GO:0000777;GO:0007155;GO:0007275;GO:2000270;GO:0042127;GO:0008360;, C:condensed chromosome kinetochore;, , P:cell adhesion; P:multicellular organism development; P:negative regulation of fibroblast apoptotic process; P:regulation of cell population proliferation; P:regulation of cell shape;|Q9UEE9 O00393 O00404 Q9UEF0 Q9UEF1 Q9UEF8,Craniofacial development protein 1,Bucentaur;, PF07572;, GO:0000777;GO:0007155;GO:0007275;GO:2000270;GO:0042127;GO:0008360;, C:condensed chromosome kinetochore;, , P:cell adhesion; P:multicellular organism development; P:negative regulation of fibroblast apoptotic process; P:regulation of cell population proliferation; P:regulation of cell shape;|Q9UEE9 O00393 O00404 Q9UEF0 Q9UEF1 Q9UEF8,Craniofacial development protein 1,Bucentaur;, PF07572;, GO:0000777;GO:0007155;GO:0007275;GO:2000270;GO:0042127;GO:0008360;, C:condensed chromosome kinetochore;, , P:cell adhesion; P:multicellular organism development; P:negative regulation of fibroblast apoptotic process; P:regulation of cell population proliferation; P:regulation of cell shape; scaffold172 indexed_genome mRNA 524194 546211 . + . ID=transcript_15173;Q9UEE9 O00393 O00404 Q9UEF0 Q9UEF1 Q9UEF8,Craniofacial development protein 1,Bucentaur;, PF07572;, GO:0000777;GO:0007155;GO:0007275;GO:2000270;GO:0042127;GO:0008360;, C:condensed chromosome kinetochore;, , P:cell adhesion; P:multicellular organism development; P:negative regulation of fibroblast apoptotic process; P:regulation of cell population proliferation; P:regulation of cell shape;|Q9UEE9 O00393 O00404 Q9UEF0 Q9UEF1 Q9UEF8,Craniofacial development protein 1,Bucentaur;, PF07572;, GO:0000777;GO:0007155;GO:0007275;GO:2000270;GO:0042127;GO:0008360;, C:condensed chromosome kinetochore;, , P:cell adhesion; P:multicellular organism development; P:negative regulation of fibroblast apoptotic process; P:regulation of cell population proliferation; P:regulation of cell shape; scaffold172 indexed_genome mRNA 552625 664919 . + . ID=transcript_15174;Q9UEE9 O00393 O00404 Q9UEF0 Q9UEF1 Q9UEF8,Craniofacial development protein 1,Bucentaur;, PF07572;, GO:0000777;GO:0007155;GO:0007275;GO:2000270;GO:0042127;GO:0008360;, C:condensed chromosome kinetochore;, , P:cell adhesion; P:multicellular organism development; P:negative regulation of fibroblast apoptotic process; P:regulation of cell population proliferation; P:regulation of cell shape;|Q9UEE9 O00393 O00404 Q9UEF0 Q9UEF1 Q9UEF8,Craniofacial development protein 1,Bucentaur;, PF07572;, GO:0000777;GO:0007155;GO:0007275;GO:2000270;GO:0042127;GO:0008360;, C:condensed chromosome kinetochore;, , P:cell adhesion; P:multicellular organism development; P:negative regulation of fibroblast apoptotic process; P:regulation of cell population proliferation; P:regulation of cell shape; scaffold172 indexed_genome mRNA 712779 726905 . - . ID=transcript_15175;F5GXV6 F5H7Z0 F8WA69 Q6QEF7,Breast cancer anti-estrogen resistance protein 1,CRK-associated substrate;Cas scaffolding protein family member 1;p130cas;, PF12026;PF08824;PF00018;, GO:0015629;GO:0030424;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0001726;GO:0019901;GO:0017124;GO:0007015;GO:0090527;GO:0050851;GO:0050853;GO:0007155;GO:0060326;GO:0051301;GO:0016477;GO:0035729;GO:0086100;GO:0007173;GO:0007186;GO:0048012;GO:0008286;GO:0007229;GO:0048011;GO:0048008;GO:0030335;GO:0010595;GO:0042981;GO:0001558;GO:0050852;GO:0007169;GO:0048010;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:ruffle;, F:protein kinase binding; F:SH3 domain binding;, P:actin filament organization; P:actin filament reorganization; P:antigen receptor-mediated signaling pathway; P:B cell receptor signaling pathway; P:cell adhesion; P:cell chemotaxis; P:cell division; P:cell migration; P:cellular response to hepatocyte growth factor stimulus; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hepatocyte growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell migration; P:positive regulation of endothelial cell migration; P:regulation of apoptotic process; P:regulation of cell growth; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|F5GXV6 F5H7Z0 F8WA69 Q6QEF7,Breast cancer anti-estrogen resistance protein 1,CRK-associated substrate;Cas scaffolding protein family member 1;p130cas;, PF12026;PF08824;PF00018;, GO:0015629;GO:0030424;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0001726;GO:0019901;GO:0017124;GO:0007015;GO:0090527;GO:0050851;GO:0050853;GO:0007155;GO:0060326;GO:0051301;GO:0016477;GO:0035729;GO:0086100;GO:0007173;GO:0007186;GO:0048012;GO:0008286;GO:0007229;GO:0048011;GO:0048008;GO:0030335;GO:0010595;GO:0042981;GO:0001558;GO:0050852;GO:0007169;GO:0048010;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:ruffle;, F:protein kinase binding; F:SH3 domain binding;, P:actin filament organization; P:actin filament reorganization; P:antigen receptor-mediated signaling pathway; P:B cell receptor signaling pathway; P:cell adhesion; P:cell chemotaxis; P:cell division; P:cell migration; P:cellular response to hepatocyte growth factor stimulus; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hepatocyte growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell migration; P:positive regulation of endothelial cell migration; P:regulation of apoptotic process; P:regulation of cell growth; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|F5GXV6 F5H7Z0 F8WA69 Q6QEF7,Breast cancer anti-estrogen resistance protein 1,CRK-associated substrate;Cas scaffolding protein family member 1;p130cas;, PF12026;PF08824;PF00018;, GO:0015629;GO:0030424;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0001726;GO:0019901;GO:0017124;GO:0007015;GO:0090527;GO:0050851;GO:0050853;GO:0007155;GO:0060326;GO:0051301;GO:0016477;GO:0035729;GO:0086100;GO:0007173;GO:0007186;GO:0048012;GO:0008286;GO:0007229;GO:0048011;GO:0048008;GO:0030335;GO:0010595;GO:0042981;GO:0001558;GO:0050852;GO:0007169;GO:0048010;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:ruffle;, F:protein kinase binding; F:SH3 domain binding;, P:actin filament organization; P:actin filament reorganization; P:antigen receptor-mediated signaling pathway; P:B cell receptor signaling pathway; P:cell adhesion; P:cell chemotaxis; P:cell division; P:cell migration; P:cellular response to hepatocyte growth factor stimulus; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hepatocyte growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell migration; P:positive regulation of endothelial cell migration; P:regulation of apoptotic process; P:regulation of cell growth; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|F5GXV6 F5H7Z0 F8WA69 Q6QEF7,Breast cancer anti-estrogen resistance protein 1,CRK-associated substrate;Cas scaffolding protein family member 1;p130cas;, PF12026;PF08824;PF00018;, GO:0015629;GO:0030424;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0001726;GO:0019901;GO:0017124;GO:0007015;GO:0090527;GO:0050851;GO:0050853;GO:0007155;GO:0060326;GO:0051301;GO:0016477;GO:0035729;GO:0086100;GO:0007173;GO:0007186;GO:0048012;GO:0008286;GO:0007229;GO:0048011;GO:0048008;GO:0030335;GO:0010595;GO:0042981;GO:0001558;GO:0050852;GO:0007169;GO:0048010;, C:actin cytoskeleton; C:axon; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:ruffle;, F:protein kinase binding; F:SH3 domain binding;, P:actin filament organization; P:actin filament reorganization; P:antigen receptor-mediated signaling pathway; P:B cell receptor signaling pathway; P:cell adhesion; P:cell chemotaxis; P:cell division; P:cell migration; P:cellular response to hepatocyte growth factor stimulus; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hepatocyte growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell migration; P:positive regulation of endothelial cell migration; P:regulation of apoptotic process; P:regulation of cell growth; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold172 indexed_genome mRNA 791695 797053 . - . ID=transcript_15176;Q6P2D0 A8K5Q7 B4DKG9 Q8N188 Q8N9F9,Zinc finger protein 1 homolog,Zinc finger protein 475;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold172 indexed_genome mRNA 835913 847188 . - . ID=transcript_15177;Q86WU2 Q8IZK5,Probable D-lactate dehydrogenase, mitochondrial,, PF02913;PF01565;, GO:0005743;GO:0005739;GO:0004458;GO:0008720;GO:0071949;GO:0050660;GO:1903457;, C:mitochondrial inner membrane; C:mitochondrion;, F:D-lactate dehydrogenase (cytochrome) activity; F:D-lactate dehydrogenase activity; F:FAD binding; F:flavin adenine dinucleotide binding;, P:lactate catabolic process;|Q86WU2 Q8IZK5,Probable D-lactate dehydrogenase, mitochondrial,, PF02913;PF01565;, GO:0005743;GO:0005739;GO:0004458;GO:0008720;GO:0071949;GO:0050660;GO:1903457;, C:mitochondrial inner membrane; C:mitochondrion;, F:D-lactate dehydrogenase (cytochrome) activity; F:D-lactate dehydrogenase activity; F:FAD binding; F:flavin adenine dinucleotide binding;, P:lactate catabolic process;|Q86WU2 Q8IZK5,Probable D-lactate dehydrogenase, mitochondrial,, PF02913;PF01565;, GO:0005743;GO:0005739;GO:0004458;GO:0008720;GO:0071949;GO:0050660;GO:1903457;, C:mitochondrial inner membrane; C:mitochondrion;, F:D-lactate dehydrogenase (cytochrome) activity; F:D-lactate dehydrogenase activity; F:FAD binding; F:flavin adenine dinucleotide binding;, P:lactate catabolic process;|Q86WU2 Q8IZK5,Probable D-lactate dehydrogenase, mitochondrial,, PF02913;PF01565;, GO:0005743;GO:0005739;GO:0004458;GO:0008720;GO:0071949;GO:0050660;GO:1903457;, C:mitochondrial inner membrane; C:mitochondrion;, F:D-lactate dehydrogenase (cytochrome) activity; F:D-lactate dehydrogenase activity; F:FAD binding; F:flavin adenine dinucleotide binding;, P:lactate catabolic process;|Q86WU2 Q8IZK5,Probable D-lactate dehydrogenase, mitochondrial,, PF02913;PF01565;, GO:0005743;GO:0005739;GO:0004458;GO:0008720;GO:0071949;GO:0050660;GO:1903457;, C:mitochondrial inner membrane; C:mitochondrion;, F:D-lactate dehydrogenase (cytochrome) activity; F:D-lactate dehydrogenase activity; F:FAD binding; F:flavin adenine dinucleotide binding;, P:lactate catabolic process; scaffold172 indexed_genome mRNA 853123 855602 . - . ID=transcript_15178;Q8ND25 D3DUJ9 Q9H083,E3 ubiquitin-protein ligase ZNRF1,Nerve injury-induced gene 283 protein;RING-type E3 ubiquitin transferase ZNRF1;Zinc/RING finger protein 1;, PF13639;, GO:0005829;GO:0005768;GO:0005764;GO:0016020;GO:0030672;GO:0046872;GO:0061630;GO:0004842;GO:0043161;GO:0070936;GO:0000209;, C:cytosol; C:endosome; C:lysosome; C:membrane; C:synaptic vesicle membrane;, F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein polyubiquitination; scaffold172 indexed_genome mRNA 959634 1036958 . + . ID=transcript_15179;Q6PJI9 B3KRC3 Q71RE7 Q96PW5 Q9BSW6 Q9HA43,GATOR complex protein WDR59 {ECO:0000305},WD repeat-containing protein 59 {ECO:0000312|HGNC:HGNC:25706};, PF00400;, GO:0061700;GO:0005765;GO:0034198;GO:0032008;, C:GATOR2 complex; C:lysosomal membrane;, , P:cellular response to amino acid starvation; P:positive regulation of TOR signaling;|Q6PJI9 B3KRC3 Q71RE7 Q96PW5 Q9BSW6 Q9HA43,GATOR complex protein WDR59 {ECO:0000305},WD repeat-containing protein 59 {ECO:0000312|HGNC:HGNC:25706};, PF00400;, GO:0061700;GO:0005765;GO:0034198;GO:0032008;, C:GATOR2 complex; C:lysosomal membrane;, , P:cellular response to amino acid starvation; P:positive regulation of TOR signaling;|Q6PJI9 B3KRC3 Q71RE7 Q96PW5 Q9BSW6 Q9HA43,GATOR complex protein WDR59 {ECO:0000305},WD repeat-containing protein 59 {ECO:0000312|HGNC:HGNC:25706};, PF00400;, GO:0061700;GO:0005765;GO:0034198;GO:0032008;, C:GATOR2 complex; C:lysosomal membrane;, , P:cellular response to amino acid starvation; P:positive regulation of TOR signaling;|Q6PJI9 B3KRC3 Q71RE7 Q96PW5 Q9BSW6 Q9HA43,GATOR complex protein WDR59 {ECO:0000305},WD repeat-containing protein 59 {ECO:0000312|HGNC:HGNC:25706};, PF00400;, GO:0061700;GO:0005765;GO:0034198;GO:0032008;, C:GATOR2 complex; C:lysosomal membrane;, , P:cellular response to amino acid starvation; P:positive regulation of TOR signaling;|Q6PJI9 B3KRC3 Q71RE7 Q96PW5 Q9BSW6 Q9HA43,GATOR complex protein WDR59 {ECO:0000305},WD repeat-containing protein 59 {ECO:0000312|HGNC:HGNC:25706};, PF00400;, GO:0061700;GO:0005765;GO:0034198;GO:0032008;, C:GATOR2 complex; C:lysosomal membrane;, , P:cellular response to amino acid starvation; P:positive regulation of TOR signaling;|Q6PJI9 B3KRC3 Q71RE7 Q96PW5 Q9BSW6 Q9HA43,GATOR complex protein WDR59 {ECO:0000305},WD repeat-containing protein 59 {ECO:0000312|HGNC:HGNC:25706};, PF00400;, GO:0061700;GO:0005765;GO:0034198;GO:0032008;, C:GATOR2 complex; C:lysosomal membrane;, , P:cellular response to amino acid starvation; P:positive regulation of TOR signaling;|Q6PJI9 B3KRC3 Q71RE7 Q96PW5 Q9BSW6 Q9HA43,GATOR complex protein WDR59 {ECO:0000305},WD repeat-containing protein 59 {ECO:0000312|HGNC:HGNC:25706};, PF00400;, GO:0061700;GO:0005765;GO:0034198;GO:0032008;, C:GATOR2 complex; C:lysosomal membrane;, , P:cellular response to amino acid starvation; P:positive regulation of TOR signaling;|Q6PJI9 B3KRC3 Q71RE7 Q96PW5 Q9BSW6 Q9HA43,GATOR complex protein WDR59 {ECO:0000305},WD repeat-containing protein 59 {ECO:0000312|HGNC:HGNC:25706};, PF00400;, GO:0061700;GO:0005765;GO:0034198;GO:0032008;, C:GATOR2 complex; C:lysosomal membrane;, , P:cellular response to amino acid starvation; P:positive regulation of TOR signaling; scaffold172 indexed_genome mRNA 1100649 1156104 . + . ID=transcript_15180;Q7L5A8 B7Z8T6 O75213 Q96DK1 Q9H1A5,Fatty acid 2-hydroxylase {ECO:0000303|PubMed:15337768, ECO:0000303|PubMed:15863841, ECO:0000303|PubMed:17355976, ECO:0000303|PubMed:22517924},Fatty acid alpha-hydroxylase {ECO:0000303|PubMed:15863841};Fatty acid hydroxylase domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21197};, PF00173;PF04116;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0080132;GO:0020037;GO:0005506;GO:0032286;GO:0046513;GO:0061436;GO:0006633;GO:0006631;GO:0006682;GO:0006679;GO:0030258;GO:0032287;GO:0044857;GO:0042127;GO:0042634;GO:0001949;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:fatty acid alpha-hydroxylase activity; F:heme binding; F:iron ion binding;, P:central nervous system myelin maintenance; P:ceramide biosynthetic process; P:establishment of skin barrier; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:galactosylceramide biosynthetic process; P:glucosylceramide biosynthetic process; P:lipid modification; P:peripheral nervous system myelin maintenance; P:plasma membrane raft organization; P:regulation of cell population proliferation; P:regulation of hair cycle; P:sebaceous gland cell differentiation; P:sphingolipid biosynthetic process;|Q7L5A8 B7Z8T6 O75213 Q96DK1 Q9H1A5,Fatty acid 2-hydroxylase {ECO:0000303|PubMed:15337768, ECO:0000303|PubMed:15863841, ECO:0000303|PubMed:17355976, ECO:0000303|PubMed:22517924},Fatty acid alpha-hydroxylase {ECO:0000303|PubMed:15863841};Fatty acid hydroxylase domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21197};, PF00173;PF04116;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0080132;GO:0020037;GO:0005506;GO:0032286;GO:0046513;GO:0061436;GO:0006633;GO:0006631;GO:0006682;GO:0006679;GO:0030258;GO:0032287;GO:0044857;GO:0042127;GO:0042634;GO:0001949;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:fatty acid alpha-hydroxylase activity; F:heme binding; F:iron ion binding;, P:central nervous system myelin maintenance; P:ceramide biosynthetic process; P:establishment of skin barrier; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:galactosylceramide biosynthetic process; P:glucosylceramide biosynthetic process; P:lipid modification; P:peripheral nervous system myelin maintenance; P:plasma membrane raft organization; P:regulation of cell population proliferation; P:regulation of hair cycle; P:sebaceous gland cell differentiation; P:sphingolipid biosynthetic process;|Q7L5A8 B7Z8T6 O75213 Q96DK1 Q9H1A5,Fatty acid 2-hydroxylase {ECO:0000303|PubMed:15337768, ECO:0000303|PubMed:15863841, ECO:0000303|PubMed:17355976, ECO:0000303|PubMed:22517924},Fatty acid alpha-hydroxylase {ECO:0000303|PubMed:15863841};Fatty acid hydroxylase domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21197};, PF00173;PF04116;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0080132;GO:0020037;GO:0005506;GO:0032286;GO:0046513;GO:0061436;GO:0006633;GO:0006631;GO:0006682;GO:0006679;GO:0030258;GO:0032287;GO:0044857;GO:0042127;GO:0042634;GO:0001949;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:fatty acid alpha-hydroxylase activity; F:heme binding; F:iron ion binding;, P:central nervous system myelin maintenance; P:ceramide biosynthetic process; P:establishment of skin barrier; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:galactosylceramide biosynthetic process; P:glucosylceramide biosynthetic process; P:lipid modification; P:peripheral nervous system myelin maintenance; P:plasma membrane raft organization; P:regulation of cell population proliferation; P:regulation of hair cycle; P:sebaceous gland cell differentiation; P:sphingolipid biosynthetic process;|Q7L5A8 B7Z8T6 O75213 Q96DK1 Q9H1A5,Fatty acid 2-hydroxylase {ECO:0000303|PubMed:15337768, ECO:0000303|PubMed:15863841, ECO:0000303|PubMed:17355976, ECO:0000303|PubMed:22517924},Fatty acid alpha-hydroxylase {ECO:0000303|PubMed:15863841};Fatty acid hydroxylase domain-containing protein 1 {ECO:0000312|HGNC:HGNC:21197};, PF00173;PF04116;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0080132;GO:0020037;GO:0005506;GO:0032286;GO:0046513;GO:0061436;GO:0006633;GO:0006631;GO:0006682;GO:0006679;GO:0030258;GO:0032287;GO:0044857;GO:0042127;GO:0042634;GO:0001949;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:fatty acid alpha-hydroxylase activity; F:heme binding; F:iron ion binding;, P:central nervous system myelin maintenance; P:ceramide biosynthetic process; P:establishment of skin barrier; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:galactosylceramide biosynthetic process; P:glucosylceramide biosynthetic process; P:lipid modification; P:peripheral nervous system myelin maintenance; P:plasma membrane raft organization; P:regulation of cell population proliferation; P:regulation of hair cycle; P:sebaceous gland cell differentiation; P:sphingolipid biosynthetic process; scaffold172 indexed_genome mRNA 1165749 1177929 . + . ID=transcript_15181;Q8NB16 A6NCE4 Q8N6V0,Mixed lineage kinase domain-like protein {ECO:0000305},, PF07714;, GO:0030054;GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0042802;GO:0004706;GO:0004672;GO:0019901;GO:0044877;GO:0007257;GO:0007166;GO:0051607;GO:0097528;GO:0019054;GO:0070266;GO:0097527;GO:0070207;GO:0060544;, C:cell junction; C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein-containing complex binding;, P:activation of JUN kinase activity; P:cell surface receptor signaling pathway; P:defense response to virus; P:execution phase of necroptosis; P:modulation by virus of host cellular process; P:necroptotic process; P:necroptotic signaling pathway; P:protein homotrimerization; P:regulation of necroptotic process; scaffold172 indexed_genome mRNA 1177955 1185027 . + . ID=transcript_15182;Q8NB16 A6NCE4 Q8N6V0,Mixed lineage kinase domain-like protein {ECO:0000305},, PF07714;, GO:0030054;GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0042802;GO:0004706;GO:0004672;GO:0019901;GO:0044877;GO:0007257;GO:0007166;GO:0051607;GO:0097528;GO:0019054;GO:0070266;GO:0097527;GO:0070207;GO:0060544;, C:cell junction; C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:protein kinase activity; F:protein kinase binding; F:protein-containing complex binding;, P:activation of JUN kinase activity; P:cell surface receptor signaling pathway; P:defense response to virus; P:execution phase of necroptosis; P:modulation by virus of host cellular process; P:necroptotic process; P:necroptotic signaling pathway; P:protein homotrimerization; P:regulation of necroptotic process; scaffold172 indexed_genome mRNA 1198181 1198731 . + . ID=transcript_15183;Q6PCD5 A8K585 B2RE35 D3DUJ8 Q5XKR3 Q9H9Q3 Q9NVT4,E3 ubiquitin-protein ligase RFWD3 {ECO:0000305},RING finger and WD repeat domain-containing protein 3;RING finger protein 201;, PF13639;, GO:0005737;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0097371;GO:0046872;GO:0002039;GO:0061630;GO:0006974;GO:0031052;GO:0000724;GO:0036297;GO:0031571;GO:0016567;GO:2000001;GO:0031297;GO:0010212;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:MDM2/MDM4 family protein binding; F:metal ion binding; F:p53 binding; F:ubiquitin protein ligase activity;, P:cellular response to DNA damage stimulus; P:chromosome breakage; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:mitotic G1 DNA damage checkpoint; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:replication fork processing; P:response to ionizing radiation; scaffold172 indexed_genome mRNA 1205467 1229525 . + . ID=transcript_15184;Q6PCD5 A8K585 B2RE35 D3DUJ8 Q5XKR3 Q9H9Q3 Q9NVT4,E3 ubiquitin-protein ligase RFWD3 {ECO:0000305},RING finger and WD repeat domain-containing protein 3;RING finger protein 201;, PF13639;, GO:0005737;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0097371;GO:0046872;GO:0002039;GO:0061630;GO:0006974;GO:0031052;GO:0000724;GO:0036297;GO:0031571;GO:0016567;GO:2000001;GO:0031297;GO:0010212;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:MDM2/MDM4 family protein binding; F:metal ion binding; F:p53 binding; F:ubiquitin protein ligase activity;, P:cellular response to DNA damage stimulus; P:chromosome breakage; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:mitotic G1 DNA damage checkpoint; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:replication fork processing; P:response to ionizing radiation;|Q6PCD5 A8K585 B2RE35 D3DUJ8 Q5XKR3 Q9H9Q3 Q9NVT4,E3 ubiquitin-protein ligase RFWD3 {ECO:0000305},RING finger and WD repeat domain-containing protein 3;RING finger protein 201;, PF13639;, GO:0005737;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0097371;GO:0046872;GO:0002039;GO:0061630;GO:0006974;GO:0031052;GO:0000724;GO:0036297;GO:0031571;GO:0016567;GO:2000001;GO:0031297;GO:0010212;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:MDM2/MDM4 family protein binding; F:metal ion binding; F:p53 binding; F:ubiquitin protein ligase activity;, P:cellular response to DNA damage stimulus; P:chromosome breakage; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:mitotic G1 DNA damage checkpoint; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:replication fork processing; P:response to ionizing radiation;|Q6PCD5 A8K585 B2RE35 D3DUJ8 Q5XKR3 Q9H9Q3 Q9NVT4,E3 ubiquitin-protein ligase RFWD3 {ECO:0000305},RING finger and WD repeat domain-containing protein 3;RING finger protein 201;, PF13639;, GO:0005737;GO:0005654;GO:0005634;GO:0016605;GO:0090734;GO:0097371;GO:0046872;GO:0002039;GO:0061630;GO:0006974;GO:0031052;GO:0000724;GO:0036297;GO:0031571;GO:0016567;GO:2000001;GO:0031297;GO:0010212;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:PML body; C:site of DNA damage;, F:MDM2/MDM4 family protein binding; F:metal ion binding; F:p53 binding; F:ubiquitin protein ligase activity;, P:cellular response to DNA damage stimulus; P:chromosome breakage; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:mitotic G1 DNA damage checkpoint; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:replication fork processing; P:response to ionizing radiation; scaffold172 indexed_genome mRNA 1329447 1372321 . + . ID=transcript_15185;Q92896 B7Z8Y4 D3DUJ7 Q13221 Q6P9D1,Golgi apparatus protein 1,CFR-1;Cysteine-rich fibroblast growth factor receptor;E-selectin ligand 1;Golgi sialoglycoprotein MG-160;, PF00839;, GO:0005856;GO:0070062;GO:0031012;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0150051;GO:0017134;GO:0005102;GO:0060349;GO:0050900;GO:0010955;GO:0030512;GO:0032330;, C:cytoskeleton; C:extracellular exosome; C:extracellular matrix; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:postsynaptic Golgi apparatus;, F:fibroblast growth factor binding; F:signaling receptor binding;, P:bone morphogenesis; P:leukocyte migration; P:negative regulation of protein processing; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of chondrocyte differentiation;|Q92896 B7Z8Y4 D3DUJ7 Q13221 Q6P9D1,Golgi apparatus protein 1,CFR-1;Cysteine-rich fibroblast growth factor receptor;E-selectin ligand 1;Golgi sialoglycoprotein MG-160;, PF00839;, GO:0005856;GO:0070062;GO:0031012;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0150051;GO:0017134;GO:0005102;GO:0060349;GO:0050900;GO:0010955;GO:0030512;GO:0032330;, C:cytoskeleton; C:extracellular exosome; C:extracellular matrix; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:postsynaptic Golgi apparatus;, F:fibroblast growth factor binding; F:signaling receptor binding;, P:bone morphogenesis; P:leukocyte migration; P:negative regulation of protein processing; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of chondrocyte differentiation;|Q92896 B7Z8Y4 D3DUJ7 Q13221 Q6P9D1,Golgi apparatus protein 1,CFR-1;Cysteine-rich fibroblast growth factor receptor;E-selectin ligand 1;Golgi sialoglycoprotein MG-160;, PF00839;, GO:0005856;GO:0070062;GO:0031012;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0150051;GO:0017134;GO:0005102;GO:0060349;GO:0050900;GO:0010955;GO:0030512;GO:0032330;, C:cytoskeleton; C:extracellular exosome; C:extracellular matrix; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:postsynaptic Golgi apparatus;, F:fibroblast growth factor binding; F:signaling receptor binding;, P:bone morphogenesis; P:leukocyte migration; P:negative regulation of protein processing; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of chondrocyte differentiation; scaffold173 indexed_genome mRNA 6586 35506 . + . ID=transcript_15186;Q96JL7,Actin-binding LIM protein 2,Actin-binding LIM protein family member 2;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0051015;GO:0046872;GO:0030036;GO:0030032;GO:0006351;, C:actin cytoskeleton; C:cytoplasm;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:lamellipodium assembly; P:transcription, DNA-templated;|Q96JL7,Actin-binding LIM protein 2,Actin-binding LIM protein family member 2;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0051015;GO:0046872;GO:0030036;GO:0030032;GO:0006351;, C:actin cytoskeleton; C:cytoplasm;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:lamellipodium assembly; P:transcription, DNA-templated;|Q96JL7,Actin-binding LIM protein 2,Actin-binding LIM protein family member 2;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0051015;GO:0046872;GO:0030036;GO:0030032;GO:0006351;, C:actin cytoskeleton; C:cytoplasm;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:lamellipodium assembly; P:transcription, DNA-templated; scaffold173 indexed_genome mRNA 51713 56741 . + . ID=transcript_15187;Q96JL7,Actin-binding LIM protein 2,Actin-binding LIM protein family member 2;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0051015;GO:0046872;GO:0030036;GO:0030032;GO:0006351;, C:actin cytoskeleton; C:cytoplasm;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:lamellipodium assembly; P:transcription, DNA-templated; scaffold173 indexed_genome mRNA 60000 64113 . - . ID=transcript_15188;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold173 indexed_genome mRNA 67767 69876 . + . ID=transcript_15189;Q96JL7,Actin-binding LIM protein 2,Actin-binding LIM protein family member 2;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0051015;GO:0046872;GO:0030036;GO:0030032;GO:0006351;, C:actin cytoskeleton; C:cytoplasm;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:lamellipodium assembly; P:transcription, DNA-templated; scaffold173 indexed_genome mRNA 162983 204566 . + . ID=transcript_15190;Q8N556 A8K442 B4DMU2 E9PDT7 Q59EY5 Q9HBY1,Actin filament-associated protein 1,110 kDa actin filament-associated protein;, PF00169;, GO:0015629;GO:0005829;GO:0005925;GO:0003779;GO:0042169;GO:0017124;GO:0051493;GO:0009966;, C:actin cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:SH2 domain binding; F:SH3 domain binding;, P:regulation of cytoskeleton organization; P:regulation of signal transduction; scaffold173 indexed_genome mRNA 216630 232499 . + . ID=transcript_15191;Q8N556 A8K442 B4DMU2 E9PDT7 Q59EY5 Q9HBY1,Actin filament-associated protein 1,110 kDa actin filament-associated protein;, PF00169;, GO:0015629;GO:0005829;GO:0005925;GO:0003779;GO:0042169;GO:0017124;GO:0051493;GO:0009966;, C:actin cytoskeleton; C:cytosol; C:focal adhesion;, F:actin binding; F:SH2 domain binding; F:SH3 domain binding;, P:regulation of cytoskeleton organization; P:regulation of signal transduction; scaffold173 indexed_genome mRNA 244224 333805 . - . ID=transcript_15192;Q96PQ0 Q9P2L7,VPS10 domain-containing receptor SorCS2,, PF00801;PF15902;PF15901;, GO:0030659;GO:0043197;GO:0031901;GO:0016021;GO:0005887;GO:0016020;GO:0043204;GO:0098839;GO:0055038;GO:0008188;GO:0006886;GO:0060292;GO:0007218;, C:cytoplasmic vesicle membrane; C:dendritic spine; C:early endosome membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:perikaryon; C:postsynaptic density membrane; C:recycling endosome membrane;, F:neuropeptide receptor activity;, P:intracellular protein transport; P:long-term synaptic depression; P:neuropeptide signaling pathway; scaffold173 indexed_genome mRNA 524615 528672 . + . ID=transcript_15193;Q6NUJ1 A0A184 Q8N7T4,Proactivator polypeptide-like 1,, PF02199;PF05184;PF03489;, GO:0005829;GO:0005615;GO:0005764;GO:0007193;GO:0060742;GO:0060736;GO:0019216;GO:0006665;, C:cytosol; C:extracellular space; C:lysosome;, , P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:epithelial cell differentiation involved in prostate gland development; P:prostate gland growth; P:regulation of lipid metabolic process; P:sphingolipid metabolic process; scaffold173 indexed_genome mRNA 823364 840754 . + . ID=transcript_15194;Q9HAV7 B2R783 Q549M6,GrpE protein homolog 1, mitochondrial,HMGE;Mt-GrpE#1;, PF01025;, GO:0005759;GO:0005739;GO:0005654;GO:0001405;GO:0000774;GO:0051087;GO:0042802;GO:0042803;GO:0051082;GO:0006457;GO:0030150;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:PAM complex, Tim23 associated import motor;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:identical protein binding; F:protein homodimerization activity; F:unfolded protein binding;, P:protein folding; P:protein import into mitochondrial matrix;|Q9HAV7 B2R783 Q549M6,GrpE protein homolog 1, mitochondrial,HMGE;Mt-GrpE#1;, PF01025;, GO:0005759;GO:0005739;GO:0005654;GO:0001405;GO:0000774;GO:0051087;GO:0042802;GO:0042803;GO:0051082;GO:0006457;GO:0030150;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:PAM complex, Tim23 associated import motor;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:identical protein binding; F:protein homodimerization activity; F:unfolded protein binding;, P:protein folding; P:protein import into mitochondrial matrix;|Q9HAV7 B2R783 Q549M6,GrpE protein homolog 1, mitochondrial,HMGE;Mt-GrpE#1;, PF01025;, GO:0005759;GO:0005739;GO:0005654;GO:0001405;GO:0000774;GO:0051087;GO:0042802;GO:0042803;GO:0051082;GO:0006457;GO:0030150;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:PAM complex, Tim23 associated import motor;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:identical protein binding; F:protein homodimerization activity; F:unfolded protein binding;, P:protein folding; P:protein import into mitochondrial matrix;|Q9HAV7 B2R783 Q549M6,GrpE protein homolog 1, mitochondrial,HMGE;Mt-GrpE#1;, PF01025;, GO:0005759;GO:0005739;GO:0005654;GO:0001405;GO:0000774;GO:0051087;GO:0042802;GO:0042803;GO:0051082;GO:0006457;GO:0030150;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:PAM complex, Tim23 associated import motor;, F:adenyl-nucleotide exchange factor activity; F:chaperone binding; F:identical protein binding; F:protein homodimerization activity; F:unfolded protein binding;, P:protein folding; P:protein import into mitochondrial matrix; scaffold173 indexed_genome mRNA 858969 859895 . + . ID=transcript_15195;Q2M329 Q8N2I7,Coiled-coil domain-containing protein 96,, PF13870;, GO:0005930;GO:0036064;GO:0060271;, C:axoneme; C:ciliary basal body;, , P:cilium assembly; scaffold173 indexed_genome mRNA 859905 861774 . + . ID=transcript_15196;Q2M329 Q8N2I7,Coiled-coil domain-containing protein 96,, PF13870;, GO:0005930;GO:0036064;GO:0060271;, C:axoneme; C:ciliary basal body;, , P:cilium assembly; scaffold173 indexed_genome mRNA 865507 960450 . - . ID=transcript_15197;Q9P2M4 B9A6L5 D3DVT4 E9PAZ6 Q8IW15 Q8NDK3,TBC1 domain family member 14,, PF00566;, GO:0005776;GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0055037;GO:0005096;GO:0019901;GO:0090630;GO:0006914;GO:0006886;GO:0010507;GO:0071955;GO:2000785;, C:autophagosome; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:recycling endosome;, F:GTPase activator activity; F:protein kinase binding;, P:activation of GTPase activity; P:autophagy; P:intracellular protein transport; P:negative regulation of autophagy; P:recycling endosome to Golgi transport; P:regulation of autophagosome assembly;|Q9P2M4 B9A6L5 D3DVT4 E9PAZ6 Q8IW15 Q8NDK3,TBC1 domain family member 14,, PF00566;, GO:0005776;GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0055037;GO:0005096;GO:0019901;GO:0090630;GO:0006914;GO:0006886;GO:0010507;GO:0071955;GO:2000785;, C:autophagosome; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:recycling endosome;, F:GTPase activator activity; F:protein kinase binding;, P:activation of GTPase activity; P:autophagy; P:intracellular protein transport; P:negative regulation of autophagy; P:recycling endosome to Golgi transport; P:regulation of autophagosome assembly;|Q9P2M4 B9A6L5 D3DVT4 E9PAZ6 Q8IW15 Q8NDK3,TBC1 domain family member 14,, PF00566;, GO:0005776;GO:0005829;GO:0005794;GO:0043231;GO:0005654;GO:0055037;GO:0005096;GO:0019901;GO:0090630;GO:0006914;GO:0006886;GO:0010507;GO:0071955;GO:2000785;, C:autophagosome; C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:recycling endosome;, F:GTPase activator activity; F:protein kinase binding;, P:activation of GTPase activity; P:autophagy; P:intracellular protein transport; P:negative regulation of autophagy; P:recycling endosome to Golgi transport; P:regulation of autophagosome assembly;|O60347 Q5VYA6 Q8WX26 Q8WX59 Q9UG83,TBC1 domain family member 12,, PF00566;, GO:0005776;GO:0055037;GO:0005096;GO:0090630;GO:0006886;GO:2000785;, C:autophagosome; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of autophagosome assembly; scaffold173 indexed_genome mRNA 1006253 1055517 . + . ID=transcript_15198;Q92628 A7E2D2,Uncharacterized protein KIAA0232,, PF15376;, GO:0005524;, , F:ATP binding;|Q92628 A7E2D2,Uncharacterized protein KIAA0232,, PF15376;, GO:0005524;, , F:ATP binding;|Q92628 A7E2D2,Uncharacterized protein KIAA0232,, PF15376;, GO:0005524;, , F:ATP binding;|Q92628 A7E2D2,Uncharacterized protein KIAA0232,, PF15376;, GO:0005524;, , F:ATP binding; scaffold173 indexed_genome mRNA 1182045 1184411 . - . ID=transcript_15199;Q9Y605 B3KVT2 D3DVT3,MORF4 family-associated protein 1,Protein PGR1;Protein associated with MRG of 14 kDa;, PF15155;, GO:0005654;GO:0048471;, C:nucleoplasm; C:perinuclear region of cytoplasm; scaffold174 indexed_genome mRNA 445520 631030 . + . ID=transcript_15200;A0A0A6YYC5,T cell receptor alpha variable 14/delta variable 4 {ECO:0000303|Ref.2},, PF07686;, GO:0005615;GO:0042101;GO:0002250;GO:0006955;, C:extracellular space; C:T cell receptor complex;, , P:adaptive immune response; P:immune response; scaffold174 indexed_genome mRNA 631051 631564 . + . ID=transcript_15201;B7Z8K6,T cell receptor delta constant {ECO:0000303|Ref.4},, PF07654;, GO:0009897;GO:0042571;GO:0016021;GO:0042101;GO:0003823;GO:0034987;GO:0050853;GO:0006958;GO:0042742;GO:0045087;GO:0006911;GO:0006910;GO:0050871;, C:external side of plasma membrane; C:immunoglobulin complex, circulating; C:integral component of membrane; C:T cell receptor complex;, F:antigen binding; F:immunoglobulin receptor binding;, P:B cell receptor signaling pathway; P:complement activation, classical pathway; P:defense response to bacterium; P:innate immune response; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; scaffold174 indexed_genome mRNA 732549 756228 . - . ID=transcript_15202;P61803 D3DS25 O08552 O70364 P46966 P46968 Q6FGA3 Q96GB7,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1,Defender against cell death 1;, PF02109;, GO:0005789;GO:0016021;GO:0016020;GO:0008250;GO:0008047;GO:0006915;GO:0001824;GO:0043066;GO:0006486;GO:0006487;GO:0018279;GO:0031647;GO:0042493;GO:0007584;GO:0019082;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:oligosaccharyltransferase complex;, F:enzyme activator activity;, P:apoptotic process; P:blastocyst development; P:negative regulation of apoptotic process; P:protein glycosylation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:regulation of protein stability; P:response to drug; P:response to nutrient; P:viral protein processing; scaffold174 indexed_genome mRNA 768665 781108 . + . ID=transcript_15203;Q8TB40 B4DDH7 Q9H9E0,(Lyso)-N-acylphosphatidylethanolamine lipase {ECO:0000305},Alpha/beta hydrolase domain-containing protein 4 {ECO:0000305};Alpha/beta-hydrolase 4;, PF00561;, GO:0005789;GO:0005811;GO:0005739;GO:0052689;GO:0042171;GO:0004622;GO:0016042;GO:0055088;GO:0070292;GO:0006654;GO:0036152;, C:endoplasmic reticulum membrane; C:lipid droplet; C:mitochondrion;, F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity; F:lysophospholipase activity;, P:lipid catabolic process; P:lipid homeostasis; P:N-acylphosphatidylethanolamine metabolic process; P:phosphatidic acid biosynthetic process; P:phosphatidylethanolamine acyl-chain remodeling;|Q8TB40 B4DDH7 Q9H9E0,(Lyso)-N-acylphosphatidylethanolamine lipase {ECO:0000305},Alpha/beta hydrolase domain-containing protein 4 {ECO:0000305};Alpha/beta-hydrolase 4;, PF00561;, GO:0005789;GO:0005811;GO:0005739;GO:0052689;GO:0042171;GO:0004622;GO:0016042;GO:0055088;GO:0070292;GO:0006654;GO:0036152;, C:endoplasmic reticulum membrane; C:lipid droplet; C:mitochondrion;, F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity; F:lysophospholipase activity;, P:lipid catabolic process; P:lipid homeostasis; P:N-acylphosphatidylethanolamine metabolic process; P:phosphatidic acid biosynthetic process; P:phosphatidylethanolamine acyl-chain remodeling;|Q8TB40 B4DDH7 Q9H9E0,(Lyso)-N-acylphosphatidylethanolamine lipase {ECO:0000305},Alpha/beta hydrolase domain-containing protein 4 {ECO:0000305};Alpha/beta-hydrolase 4;, PF00561;, GO:0005789;GO:0005811;GO:0005739;GO:0052689;GO:0042171;GO:0004622;GO:0016042;GO:0055088;GO:0070292;GO:0006654;GO:0036152;, C:endoplasmic reticulum membrane; C:lipid droplet; C:mitochondrion;, F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity; F:lysophospholipase activity;, P:lipid catabolic process; P:lipid homeostasis; P:N-acylphosphatidylethanolamine metabolic process; P:phosphatidic acid biosynthetic process; P:phosphatidylethanolamine acyl-chain remodeling;|Q8TB40 B4DDH7 Q9H9E0,(Lyso)-N-acylphosphatidylethanolamine lipase {ECO:0000305},Alpha/beta hydrolase domain-containing protein 4 {ECO:0000305};Alpha/beta-hydrolase 4;, PF00561;, GO:0005789;GO:0005811;GO:0005739;GO:0052689;GO:0042171;GO:0004622;GO:0016042;GO:0055088;GO:0070292;GO:0006654;GO:0036152;, C:endoplasmic reticulum membrane; C:lipid droplet; C:mitochondrion;, F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity; F:lysophospholipase activity;, P:lipid catabolic process; P:lipid homeostasis; P:N-acylphosphatidylethanolamine metabolic process; P:phosphatidic acid biosynthetic process; P:phosphatidylethanolamine acyl-chain remodeling;|Q8TB40 B4DDH7 Q9H9E0,(Lyso)-N-acylphosphatidylethanolamine lipase {ECO:0000305},Alpha/beta hydrolase domain-containing protein 4 {ECO:0000305};Alpha/beta-hydrolase 4;, PF00561;, GO:0005789;GO:0005811;GO:0005739;GO:0052689;GO:0042171;GO:0004622;GO:0016042;GO:0055088;GO:0070292;GO:0006654;GO:0036152;, C:endoplasmic reticulum membrane; C:lipid droplet; C:mitochondrion;, F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity; F:lysophospholipase activity;, P:lipid catabolic process; P:lipid homeostasis; P:N-acylphosphatidylethanolamine metabolic process; P:phosphatidic acid biosynthetic process; P:phosphatidylethanolamine acyl-chain remodeling;|Q8TB40 B4DDH7 Q9H9E0,(Lyso)-N-acylphosphatidylethanolamine lipase {ECO:0000305},Alpha/beta hydrolase domain-containing protein 4 {ECO:0000305};Alpha/beta-hydrolase 4;, PF00561;, GO:0005789;GO:0005811;GO:0005739;GO:0052689;GO:0042171;GO:0004622;GO:0016042;GO:0055088;GO:0070292;GO:0006654;GO:0036152;, C:endoplasmic reticulum membrane; C:lipid droplet; C:mitochondrion;, F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity; F:lysophospholipase activity;, P:lipid catabolic process; P:lipid homeostasis; P:N-acylphosphatidylethanolamine metabolic process; P:phosphatidic acid biosynthetic process; P:phosphatidylethanolamine acyl-chain remodeling; scaffold174 indexed_genome mRNA 923112 972025 . + . ID=transcript_15204;Q9UM01 B2RAU0 D3DS26 O95984 Q53XC1 Q86U07 Q9P2V5,Y+L amino acid transporter 1,Monocyte amino acid permease 2;Solute carrier family 7 member 7;y(+)L-type amino acid transporter 1;, PF13520;, GO:0016323;GO:0005887;GO:0005886;GO:0015174;GO:0015179;GO:0006865;GO:1990822;GO:0050900;GO:0000821;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:basic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity;, P:amino acid transport; P:basic amino acid transmembrane transport; P:leukocyte migration; P:regulation of arginine metabolic process;|Q15070 B4DPA2,Mitochondrial inner membrane protein OXA1L,Hsa;OXA1Hs;Oxidase assembly 1-like protein;, PF02096;, GO:0031305;GO:0032592;GO:0005759;GO:0031966;GO:0005746;GO:0005739;GO:0032991;GO:0032977;GO:0097177;GO:0042803;GO:0009060;GO:0033617;GO:0033615;GO:0032981;GO:0070125;GO:0070126;GO:0032780;GO:0051354;GO:0051205;GO:0032979;GO:0051262;GO:0065003;, C:integral component of mitochondrial inner membrane; C:integral component of mitochondrial membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respirasome; C:mitochondrion; C:protein-containing complex;, F:membrane insertase activity; F:mitochondrial ribosome binding; F:protein homodimerization activity;, P:aerobic respiration; P:mitochondrial cytochrome c oxidase assembly; P:mitochondrial proton-transporting ATP synthase complex assembly; P:mitochondrial respiratory chain complex I assembly; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:negative regulation of ATPase activity; P:negative regulation of oxidoreductase activity; P:protein insertion into membrane; P:protein insertion into mitochondrial inner membrane from matrix; P:protein tetramerization; P:protein-containing complex assembly;|Q15070 B4DPA2,Mitochondrial inner membrane protein OXA1L,Hsa;OXA1Hs;Oxidase assembly 1-like protein;, PF02096;, GO:0031305;GO:0032592;GO:0005759;GO:0031966;GO:0005746;GO:0005739;GO:0032991;GO:0032977;GO:0097177;GO:0042803;GO:0009060;GO:0033617;GO:0033615;GO:0032981;GO:0070125;GO:0070126;GO:0032780;GO:0051354;GO:0051205;GO:0032979;GO:0051262;GO:0065003;, C:integral component of mitochondrial inner membrane; C:integral component of mitochondrial membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrial respirasome; C:mitochondrion; C:protein-containing complex;, F:membrane insertase activity; F:mitochondrial ribosome binding; F:protein homodimerization activity;, P:aerobic respiration; P:mitochondrial cytochrome c oxidase assembly; P:mitochondrial proton-transporting ATP synthase complex assembly; P:mitochondrial respiratory chain complex I assembly; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:negative regulation of ATPase activity; P:negative regulation of oxidoreductase activity; P:protein insertion into membrane; P:protein insertion into mitochondrial inner membrane from matrix; P:protein tetramerization; P:protein-containing complex assembly;|Q9UM01 B2RAU0 D3DS26 O95984 Q53XC1 Q86U07 Q9P2V5,Y+L amino acid transporter 1,Monocyte amino acid permease 2;Solute carrier family 7 member 7;y(+)L-type amino acid transporter 1;, PF13520;, GO:0016323;GO:0005887;GO:0005886;GO:0015174;GO:0015179;GO:0006865;GO:1990822;GO:0050900;GO:0000821;, C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;, F:basic amino acid transmembrane transporter activity; F:L-amino acid transmembrane transporter activity;, P:amino acid transport; P:basic amino acid transmembrane transport; P:leukocyte migration; P:regulation of arginine metabolic process; scaffold174 indexed_genome mRNA 977939 981765 . + . ID=transcript_15205;Q86TS9 A6NMQ8 A8MXK5 A8MYI6 G3XCN9 Q6NVH8,39S ribosomal protein L52, mitochondrial,Mitochondrial large ribosomal subunit protein mL52 {ECO:0000303|PubMed:25278503};, PF18699;, GO:0005743;GO:0005762;GO:0005739;GO:0005654;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q86TS9 A6NMQ8 A8MXK5 A8MYI6 G3XCN9 Q6NVH8,39S ribosomal protein L52, mitochondrial,Mitochondrial large ribosomal subunit protein mL52 {ECO:0000303|PubMed:25278503};, PF18699;, GO:0005743;GO:0005762;GO:0005739;GO:0005654;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q86TS9 A6NMQ8 A8MXK5 A8MYI6 G3XCN9 Q6NVH8,39S ribosomal protein L52, mitochondrial,Mitochondrial large ribosomal subunit protein mL52 {ECO:0000303|PubMed:25278503};, PF18699;, GO:0005743;GO:0005762;GO:0005739;GO:0005654;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion; C:nucleoplasm;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold174 indexed_genome mRNA 983800 993851 . + . ID=transcript_15206;P50281 A8K5L0 Q6GSF3 Q92678,Matrix metalloproteinase-14,MMP-X1;Membrane-type matrix metalloproteinase 1;Membrane-type-1 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0031410;GO:0005829;GO:0031012;GO:0005615;GO:0005925;GO:0005796;GO:0005887;GO:0045111;GO:0044354;GO:0042470;GO:0005634;GO:0005886;GO:0004175;GO:0005178;GO:0070006;GO:0004222;GO:0008270;GO:0001525;GO:0043615;GO:0048754;GO:0048870;GO:0035988;GO:0030574;GO:0097094;GO:0048701;GO:0001958;GO:0035987;GO:0001935;GO:0022617;GO:0030198;GO:0060322;GO:0030324;GO:0008584;GO:0051895;GO:0045746;GO:0001541;GO:0045579;GO:0030307;GO:0030335;GO:1905523;GO:0010831;GO:0010954;GO:0016485;GO:0006508;GO:1903076;GO:0043627;GO:0001666;GO:0009612;GO:1990834;GO:0014070;GO:0006979;GO:0001501;GO:0048771;GO:0031638;, C:cytoplasmic vesicle; C:cytosol; C:extracellular matrix; C:extracellular space; C:focal adhesion; C:Golgi lumen; C:integral component of plasma membrane; C:intermediate filament cytoskeleton; C:macropinosome; C:melanosome; C:nucleus; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:metalloaminopeptidase activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:angiogenesis; P:astrocyte cell migration; P:branching morphogenesis of an epithelial tube; P:cell motility; P:chondrocyte proliferation; P:collagen catabolic process; P:craniofacial suture morphogenesis; P:embryonic cranial skeleton morphogenesis; P:endochondral ossification; P:endodermal cell differentiation; P:endothelial cell proliferation; P:extracellular matrix disassembly; P:extracellular matrix organization; P:head development; P:lung development; P:male gonad development; P:negative regulation of focal adhesion assembly; P:negative regulation of Notch signaling pathway; P:ovarian follicle development; P:positive regulation of B cell differentiation; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of macrophage migration; P:positive regulation of myotube differentiation; P:positive regulation of protein processing; P:protein processing; P:proteolysis; P:regulation of protein localization to plasma membrane; P:response to estrogen; P:response to hypoxia; P:response to mechanical stimulus; P:response to odorant; P:response to organic cyclic compound; P:response to oxidative stress; P:skeletal system development; P:tissue remodeling; P:zymogen activation;|P50281 A8K5L0 Q6GSF3 Q92678,Matrix metalloproteinase-14,MMP-X1;Membrane-type matrix metalloproteinase 1;Membrane-type-1 matrix metalloproteinase;, PF11857;PF00045;PF00413;PF01471;, GO:0031410;GO:0005829;GO:0031012;GO:0005615;GO:0005925;GO:0005796;GO:0005887;GO:0045111;GO:0044354;GO:0042470;GO:0005634;GO:0005886;GO:0004175;GO:0005178;GO:0070006;GO:0004222;GO:0008270;GO:0001525;GO:0043615;GO:0048754;GO:0048870;GO:0035988;GO:0030574;GO:0097094;GO:0048701;GO:0001958;GO:0035987;GO:0001935;GO:0022617;GO:0030198;GO:0060322;GO:0030324;GO:0008584;GO:0051895;GO:0045746;GO:0001541;GO:0045579;GO:0030307;GO:0030335;GO:1905523;GO:0010831;GO:0010954;GO:0016485;GO:0006508;GO:1903076;GO:0043627;GO:0001666;GO:0009612;GO:1990834;GO:0014070;GO:0006979;GO:0001501;GO:0048771;GO:0031638;, C:cytoplasmic vesicle; C:cytosol; C:extracellular matrix; C:extracellular space; C:focal adhesion; C:Golgi lumen; C:integral component of plasma membrane; C:intermediate filament cytoskeleton; C:macropinosome; C:melanosome; C:nucleus; C:plasma membrane;, F:endopeptidase activity; F:integrin binding; F:metalloaminopeptidase activity; F:metalloendopeptidase activity; F:zinc ion binding;, P:angiogenesis; P:astrocyte cell migration; P:branching morphogenesis of an epithelial tube; P:cell motility; P:chondrocyte proliferation; P:collagen catabolic process; P:craniofacial suture morphogenesis; P:embryonic cranial skeleton morphogenesis; P:endochondral ossification; P:endodermal cell differentiation; P:endothelial cell proliferation; P:extracellular matrix disassembly; P:extracellular matrix organization; P:head development; P:lung development; P:male gonad development; P:negative regulation of focal adhesion assembly; P:negative regulation of Notch signaling pathway; P:ovarian follicle development; P:positive regulation of B cell differentiation; P:positive regulation of cell growth; P:positive regulation of cell migration; P:positive regulation of macrophage migration; P:positive regulation of myotube differentiation; P:positive regulation of protein processing; P:protein processing; P:proteolysis; P:regulation of protein localization to plasma membrane; P:response to estrogen; P:response to hypoxia; P:response to mechanical stimulus; P:response to odorant; P:response to organic cyclic compound; P:response to oxidative stress; P:skeletal system development; P:tissue remodeling; P:zymogen activation; scaffold174 indexed_genome mRNA 1008058 1013779 . + . ID=transcript_15207;Q7Z4F1 A8K4R5 D3DS31 O95882 Q14CK7 Q86T02 Q8NCZ4 Q9HC42 Q9UG33,Low-density lipoprotein receptor-related protein 10,, PF00431;PF00057;, GO:0005905;GO:0016021;GO:0016020;GO:0005041;GO:0048839;GO:0006629;GO:0006869;, C:clathrin-coated pit; C:integral component of membrane; C:membrane;, F:low-density lipoprotein particle receptor activity;, P:inner ear development; P:lipid metabolic process; P:lipid transport;|Q7Z4F1 A8K4R5 D3DS31 O95882 Q14CK7 Q86T02 Q8NCZ4 Q9HC42 Q9UG33,Low-density lipoprotein receptor-related protein 10,, PF00431;PF00057;, GO:0005905;GO:0016021;GO:0016020;GO:0005041;GO:0048839;GO:0006629;GO:0006869;, C:clathrin-coated pit; C:integral component of membrane; C:membrane;, F:low-density lipoprotein particle receptor activity;, P:inner ear development; P:lipid metabolic process; P:lipid transport; scaffold174 indexed_genome mRNA 1017225 1021593 . + . ID=transcript_15208;Q8IYK8 B7Z5P1 Q8N8R8,GTP-binding protein REM 2,Rad and Gem-like GTP-binding protein 2;, PF00071;, GO:0005886;GO:0005246;GO:0005525;GO:0003924;GO:0007165;, C:plasma membrane;, F:calcium channel regulator activity; F:GTP binding; F:GTPase activity;, P:signal transduction; scaffold174 indexed_genome mRNA 1029914 1037223 . - . ID=transcript_15209;Q86U06 D3DS32 Q8ND16 Q8TB88 Q8WY40 Q9BUJ1 Q9NVV7,Probable RNA-binding protein 23 {ECO:0000303|PubMed:31693891},CAPER beta {ECO:0000303|PubMed:15694343};RNA-binding motif protein 23;RNA-binding region-containing protein 4;Splicing factor SF2;, PF15519;PF00076;, GO:0016020;GO:0005634;GO:0003723;GO:0006397;GO:0045893;GO:0048024;GO:0008380;, C:membrane; C:nucleus;, F:RNA binding;, P:mRNA processing; P:positive regulation of transcription, DNA-templated; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing;|Q86U06 D3DS32 Q8ND16 Q8TB88 Q8WY40 Q9BUJ1 Q9NVV7,Probable RNA-binding protein 23 {ECO:0000303|PubMed:31693891},CAPER beta {ECO:0000303|PubMed:15694343};RNA-binding motif protein 23;RNA-binding region-containing protein 4;Splicing factor SF2;, PF15519;PF00076;, GO:0016020;GO:0005634;GO:0003723;GO:0006397;GO:0045893;GO:0048024;GO:0008380;, C:membrane; C:nucleus;, F:RNA binding;, P:mRNA processing; P:positive regulation of transcription, DNA-templated; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing;|Q86U06 D3DS32 Q8ND16 Q8TB88 Q8WY40 Q9BUJ1 Q9NVV7,Probable RNA-binding protein 23 {ECO:0000303|PubMed:31693891},CAPER beta {ECO:0000303|PubMed:15694343};RNA-binding motif protein 23;RNA-binding region-containing protein 4;Splicing factor SF2;, PF15519;PF00076;, GO:0016020;GO:0005634;GO:0003723;GO:0006397;GO:0045893;GO:0048024;GO:0008380;, C:membrane; C:nucleus;, F:RNA binding;, P:mRNA processing; P:positive regulation of transcription, DNA-templated; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing;|Q86U06 D3DS32 Q8ND16 Q8TB88 Q8WY40 Q9BUJ1 Q9NVV7,Probable RNA-binding protein 23 {ECO:0000303|PubMed:31693891},CAPER beta {ECO:0000303|PubMed:15694343};RNA-binding motif protein 23;RNA-binding region-containing protein 4;Splicing factor SF2;, PF15519;PF00076;, GO:0016020;GO:0005634;GO:0003723;GO:0006397;GO:0045893;GO:0048024;GO:0008380;, C:membrane; C:nucleus;, F:RNA binding;, P:mRNA processing; P:positive regulation of transcription, DNA-templated; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing;|Q86U06 D3DS32 Q8ND16 Q8TB88 Q8WY40 Q9BUJ1 Q9NVV7,Probable RNA-binding protein 23 {ECO:0000303|PubMed:31693891},CAPER beta {ECO:0000303|PubMed:15694343};RNA-binding motif protein 23;RNA-binding region-containing protein 4;Splicing factor SF2;, PF15519;PF00076;, GO:0016020;GO:0005634;GO:0003723;GO:0006397;GO:0045893;GO:0048024;GO:0008380;, C:membrane; C:nucleus;, F:RNA binding;, P:mRNA processing; P:positive regulation of transcription, DNA-templated; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing; scaffold174 indexed_genome mRNA 1041440 1049133 . - . ID=transcript_15210;Q9UKH1,Protein arginine N-methyltransferase 5,72 kDa ICln-binding protein;Histone-arginine N-methyltransferase PRMT5;Jak-binding protein 1;Shk1 kinase-binding protein 1 homolog;, PF05185;PF17286;PF17285;, GO:0000785;GO:0005737;GO:0005829;GO:0005794;GO:0035097;GO:0034709;GO:0005654;GO:0005634;GO:0070888;GO:0044020;GO:0008469;GO:0042802;GO:0008327;GO:0008168;GO:0002039;GO:0046982;GO:0016274;GO:0035243;GO:0043021;GO:0003714;GO:0032922;GO:0006353;GO:0042118;GO:0090161;GO:0034969;GO:0043985;GO:0097421;GO:0045596;GO:0018216;GO:0035246;GO:1904992;GO:0048714;GO:0044030;GO:0070372;GO:0007088;GO:1901796;GO:0006355;GO:0000387;, C:chromatin; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone methyltransferase complex; C:methylosome; C:nucleoplasm; C:nucleus;, F:E-box binding; F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:identical protein binding; F:methyl-CpG binding; F:methyltransferase activity; F:p53 binding; F:protein heterodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity; F:ribonucleoprotein complex binding; F:transcription corepressor activity;, P:circadian regulation of gene expression; P:DNA-templated transcription, termination; P:endothelial cell activation; P:Golgi ribbon formation; P:histone arginine methylation; P:histone H4-R3 methylation; P:liver regeneration; P:negative regulation of cell differentiation; P:peptidyl-arginine methylation; P:peptidyl-arginine N-methylation; P:positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:positive regulation of oligodendrocyte differentiation; P:regulation of DNA methylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of mitotic nuclear division; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:spliceosomal snRNP assembly;|Q9UKH1,Protein arginine N-methyltransferase 5,72 kDa ICln-binding protein;Histone-arginine N-methyltransferase PRMT5;Jak-binding protein 1;Shk1 kinase-binding protein 1 homolog;, PF05185;PF17286;PF17285;, GO:0000785;GO:0005737;GO:0005829;GO:0005794;GO:0035097;GO:0034709;GO:0005654;GO:0005634;GO:0070888;GO:0044020;GO:0008469;GO:0042802;GO:0008327;GO:0008168;GO:0002039;GO:0046982;GO:0016274;GO:0035243;GO:0043021;GO:0003714;GO:0032922;GO:0006353;GO:0042118;GO:0090161;GO:0034969;GO:0043985;GO:0097421;GO:0045596;GO:0018216;GO:0035246;GO:1904992;GO:0048714;GO:0044030;GO:0070372;GO:0007088;GO:1901796;GO:0006355;GO:0000387;, C:chromatin; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone methyltransferase complex; C:methylosome; C:nucleoplasm; C:nucleus;, F:E-box binding; F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:identical protein binding; F:methyl-CpG binding; F:methyltransferase activity; F:p53 binding; F:protein heterodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity; F:ribonucleoprotein complex binding; F:transcription corepressor activity;, P:circadian regulation of gene expression; P:DNA-templated transcription, termination; P:endothelial cell activation; P:Golgi ribbon formation; P:histone arginine methylation; P:histone H4-R3 methylation; P:liver regeneration; P:negative regulation of cell differentiation; P:peptidyl-arginine methylation; P:peptidyl-arginine N-methylation; P:positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:positive regulation of oligodendrocyte differentiation; P:regulation of DNA methylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of mitotic nuclear division; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:spliceosomal snRNP assembly;|Q9UKH1,Protein arginine N-methyltransferase 5,72 kDa ICln-binding protein;Histone-arginine N-methyltransferase PRMT5;Jak-binding protein 1;Shk1 kinase-binding protein 1 homolog;, PF05185;PF17286;PF17285;, GO:0000785;GO:0005737;GO:0005829;GO:0005794;GO:0035097;GO:0034709;GO:0005654;GO:0005634;GO:0070888;GO:0044020;GO:0008469;GO:0042802;GO:0008327;GO:0008168;GO:0002039;GO:0046982;GO:0016274;GO:0035243;GO:0043021;GO:0003714;GO:0032922;GO:0006353;GO:0042118;GO:0090161;GO:0034969;GO:0043985;GO:0097421;GO:0045596;GO:0018216;GO:0035246;GO:1904992;GO:0048714;GO:0044030;GO:0070372;GO:0007088;GO:1901796;GO:0006355;GO:0000387;, C:chromatin; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone methyltransferase complex; C:methylosome; C:nucleoplasm; C:nucleus;, F:E-box binding; F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:identical protein binding; F:methyl-CpG binding; F:methyltransferase activity; F:p53 binding; F:protein heterodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity; F:ribonucleoprotein complex binding; F:transcription corepressor activity;, P:circadian regulation of gene expression; P:DNA-templated transcription, termination; P:endothelial cell activation; P:Golgi ribbon formation; P:histone arginine methylation; P:histone H4-R3 methylation; P:liver regeneration; P:negative regulation of cell differentiation; P:peptidyl-arginine methylation; P:peptidyl-arginine N-methylation; P:positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:positive regulation of oligodendrocyte differentiation; P:regulation of DNA methylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of mitotic nuclear division; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:spliceosomal snRNP assembly;|Q9UKH1,Protein arginine N-methyltransferase 5,72 kDa ICln-binding protein;Histone-arginine N-methyltransferase PRMT5;Jak-binding protein 1;Shk1 kinase-binding protein 1 homolog;, PF05185;PF17286;PF17285;, GO:0000785;GO:0005737;GO:0005829;GO:0005794;GO:0035097;GO:0034709;GO:0005654;GO:0005634;GO:0070888;GO:0044020;GO:0008469;GO:0042802;GO:0008327;GO:0008168;GO:0002039;GO:0046982;GO:0016274;GO:0035243;GO:0043021;GO:0003714;GO:0032922;GO:0006353;GO:0042118;GO:0090161;GO:0034969;GO:0043985;GO:0097421;GO:0045596;GO:0018216;GO:0035246;GO:1904992;GO:0048714;GO:0044030;GO:0070372;GO:0007088;GO:1901796;GO:0006355;GO:0000387;, C:chromatin; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone methyltransferase complex; C:methylosome; C:nucleoplasm; C:nucleus;, F:E-box binding; F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:identical protein binding; F:methyl-CpG binding; F:methyltransferase activity; F:p53 binding; F:protein heterodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity; F:ribonucleoprotein complex binding; F:transcription corepressor activity;, P:circadian regulation of gene expression; P:DNA-templated transcription, termination; P:endothelial cell activation; P:Golgi ribbon formation; P:histone arginine methylation; P:histone H4-R3 methylation; P:liver regeneration; P:negative regulation of cell differentiation; P:peptidyl-arginine methylation; P:peptidyl-arginine N-methylation; P:positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:positive regulation of oligodendrocyte differentiation; P:regulation of DNA methylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of mitotic nuclear division; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:spliceosomal snRNP assembly;|Q9UKH1,Protein arginine N-methyltransferase 5,72 kDa ICln-binding protein;Histone-arginine N-methyltransferase PRMT5;Jak-binding protein 1;Shk1 kinase-binding protein 1 homolog;, PF05185;PF17286;PF17285;, GO:0000785;GO:0005737;GO:0005829;GO:0005794;GO:0035097;GO:0034709;GO:0005654;GO:0005634;GO:0070888;GO:0044020;GO:0008469;GO:0042802;GO:0008327;GO:0008168;GO:0002039;GO:0046982;GO:0016274;GO:0035243;GO:0043021;GO:0003714;GO:0032922;GO:0006353;GO:0042118;GO:0090161;GO:0034969;GO:0043985;GO:0097421;GO:0045596;GO:0018216;GO:0035246;GO:1904992;GO:0048714;GO:0044030;GO:0070372;GO:0007088;GO:1901796;GO:0006355;GO:0000387;, C:chromatin; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone methyltransferase complex; C:methylosome; C:nucleoplasm; C:nucleus;, F:E-box binding; F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:identical protein binding; F:methyl-CpG binding; F:methyltransferase activity; F:p53 binding; F:protein heterodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity; F:ribonucleoprotein complex binding; F:transcription corepressor activity;, P:circadian regulation of gene expression; P:DNA-templated transcription, termination; P:endothelial cell activation; P:Golgi ribbon formation; P:histone arginine methylation; P:histone H4-R3 methylation; P:liver regeneration; P:negative regulation of cell differentiation; P:peptidyl-arginine methylation; P:peptidyl-arginine N-methylation; P:positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:positive regulation of oligodendrocyte differentiation; P:regulation of DNA methylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of mitotic nuclear division; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:spliceosomal snRNP assembly;|Q9UKH1,Protein arginine N-methyltransferase 5,72 kDa ICln-binding protein;Histone-arginine N-methyltransferase PRMT5;Jak-binding protein 1;Shk1 kinase-binding protein 1 homolog;, PF05185;PF17286;PF17285;, GO:0000785;GO:0005737;GO:0005829;GO:0005794;GO:0035097;GO:0034709;GO:0005654;GO:0005634;GO:0070888;GO:0044020;GO:0008469;GO:0042802;GO:0008327;GO:0008168;GO:0002039;GO:0046982;GO:0016274;GO:0035243;GO:0043021;GO:0003714;GO:0032922;GO:0006353;GO:0042118;GO:0090161;GO:0034969;GO:0043985;GO:0097421;GO:0045596;GO:0018216;GO:0035246;GO:1904992;GO:0048714;GO:0044030;GO:0070372;GO:0007088;GO:1901796;GO:0006355;GO:0000387;, C:chromatin; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:histone methyltransferase complex; C:methylosome; C:nucleoplasm; C:nucleus;, F:E-box binding; F:histone methyltransferase activity (H4-R3 specific); F:histone-arginine N-methyltransferase activity; F:identical protein binding; F:methyl-CpG binding; F:methyltransferase activity; F:p53 binding; F:protein heterodimerization activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N symmetric methyltransferase activity; F:ribonucleoprotein complex binding; F:transcription corepressor activity;, P:circadian regulation of gene expression; P:DNA-templated transcription, termination; P:endothelial cell activation; P:Golgi ribbon formation; P:histone arginine methylation; P:histone H4-R3 methylation; P:liver regeneration; P:negative regulation of cell differentiation; P:peptidyl-arginine methylation; P:peptidyl-arginine N-methylation; P:positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:positive regulation of oligodendrocyte differentiation; P:regulation of DNA methylation; P:regulation of ERK1 and ERK2 cascade; P:regulation of mitotic nuclear division; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription, DNA-templated; P:spliceosomal snRNP assembly; scaffold174 indexed_genome mRNA 1071387 1074830 . - . ID=transcript_15211;Q9H6D7 B7WP17 D3DS34 Q86T15 Q86T16 Q86U43 Q9NX59,HAUS augmin-like complex subunit 4,, PF14735;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051011;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, F:microtubule minus-end binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q9H6D7 B7WP17 D3DS34 Q86T15 Q86T16 Q86U43 Q9NX59,HAUS augmin-like complex subunit 4,, PF14735;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051011;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, F:microtubule minus-end binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q9H6D7 B7WP17 D3DS34 Q86T15 Q86T16 Q86U43 Q9NX59,HAUS augmin-like complex subunit 4,, PF14735;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051011;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, F:microtubule minus-end binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold174 indexed_genome mRNA 1074980 1079266 . - . ID=transcript_15212;Q9H6D7 B7WP17 D3DS34 Q86T15 Q86T16 Q86U43 Q9NX59,HAUS augmin-like complex subunit 4,, PF14735;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051011;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, F:microtubule minus-end binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q9H6D7 B7WP17 D3DS34 Q86T15 Q86T16 Q86U43 Q9NX59,HAUS augmin-like complex subunit 4,, PF14735;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051011;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, F:microtubule minus-end binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q9H6D7 B7WP17 D3DS34 Q86T15 Q86T16 Q86U43 Q9NX59,HAUS augmin-like complex subunit 4,, PF14735;, GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051011;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, F:microtubule minus-end binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold174 indexed_genome mRNA 1095411 1101708 . - . ID=transcript_15213;Q96IF1 A8MX18 D3DS37,LIM domain-containing protein ajuba,, PF00412;, GO:0005912;GO:0005911;GO:0005829;GO:0005925;GO:0005794;GO:0030027;GO:0005815;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0005667;GO:0051015;GO:0045294;GO:0003682;GO:0046872;GO:0003714;GO:0016339;GO:0034613;GO:0007010;GO:0048041;GO:0000086;GO:0035195;GO:0046474;GO:0030032;GO:0035331;GO:0033673;GO:0000122;GO:0031328;GO:2000637;GO:0043123;GO:0043406;GO:0031334;GO:0030334;GO:1900037;GO:0043087;GO:0006355;GO:0001666;GO:0035313;, C:adherens junction; C:cell-cell junction; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane; C:transcription regulator complex;, F:actin filament binding; F:alpha-catenin binding; F:chromatin binding; F:metal ion binding; F:transcription corepressor activity;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular protein localization; P:cytoskeleton organization; P:focal adhesion assembly; P:G2/M transition of mitotic cell cycle; P:gene silencing by miRNA; P:glycerophospholipid biosynthetic process; P:lamellipodium assembly; P:negative regulation of hippo signaling; P:negative regulation of kinase activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cellular biosynthetic process; P:positive regulation of gene silencing by miRNA; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of protein-containing complex assembly; P:regulation of cell migration; P:regulation of cellular response to hypoxia; P:regulation of GTPase activity; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:wound healing, spreading of epidermal cells;|Q96IF1 A8MX18 D3DS37,LIM domain-containing protein ajuba,, PF00412;, GO:0005912;GO:0005911;GO:0005829;GO:0005925;GO:0005794;GO:0030027;GO:0005815;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0005667;GO:0051015;GO:0045294;GO:0003682;GO:0046872;GO:0003714;GO:0016339;GO:0034613;GO:0007010;GO:0048041;GO:0000086;GO:0035195;GO:0046474;GO:0030032;GO:0035331;GO:0033673;GO:0000122;GO:0031328;GO:2000637;GO:0043123;GO:0043406;GO:0031334;GO:0030334;GO:1900037;GO:0043087;GO:0006355;GO:0001666;GO:0035313;, C:adherens junction; C:cell-cell junction; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane; C:transcription regulator complex;, F:actin filament binding; F:alpha-catenin binding; F:chromatin binding; F:metal ion binding; F:transcription corepressor activity;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular protein localization; P:cytoskeleton organization; P:focal adhesion assembly; P:G2/M transition of mitotic cell cycle; P:gene silencing by miRNA; P:glycerophospholipid biosynthetic process; P:lamellipodium assembly; P:negative regulation of hippo signaling; P:negative regulation of kinase activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cellular biosynthetic process; P:positive regulation of gene silencing by miRNA; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of protein-containing complex assembly; P:regulation of cell migration; P:regulation of cellular response to hypoxia; P:regulation of GTPase activity; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:wound healing, spreading of epidermal cells;|Q96IF1 A8MX18 D3DS37,LIM domain-containing protein ajuba,, PF00412;, GO:0005912;GO:0005911;GO:0005829;GO:0005925;GO:0005794;GO:0030027;GO:0005815;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0005667;GO:0051015;GO:0045294;GO:0003682;GO:0046872;GO:0003714;GO:0016339;GO:0034613;GO:0007010;GO:0048041;GO:0000086;GO:0035195;GO:0046474;GO:0030032;GO:0035331;GO:0033673;GO:0000122;GO:0031328;GO:2000637;GO:0043123;GO:0043406;GO:0031334;GO:0030334;GO:1900037;GO:0043087;GO:0006355;GO:0001666;GO:0035313;, C:adherens junction; C:cell-cell junction; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane; C:transcription regulator complex;, F:actin filament binding; F:alpha-catenin binding; F:chromatin binding; F:metal ion binding; F:transcription corepressor activity;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular protein localization; P:cytoskeleton organization; P:focal adhesion assembly; P:G2/M transition of mitotic cell cycle; P:gene silencing by miRNA; P:glycerophospholipid biosynthetic process; P:lamellipodium assembly; P:negative regulation of hippo signaling; P:negative regulation of kinase activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cellular biosynthetic process; P:positive regulation of gene silencing by miRNA; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of protein-containing complex assembly; P:regulation of cell migration; P:regulation of cellular response to hypoxia; P:regulation of GTPase activity; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:wound healing, spreading of epidermal cells;|Q96IF1 A8MX18 D3DS37,LIM domain-containing protein ajuba,, PF00412;, GO:0005912;GO:0005911;GO:0005829;GO:0005925;GO:0005794;GO:0030027;GO:0005815;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0005667;GO:0051015;GO:0045294;GO:0003682;GO:0046872;GO:0003714;GO:0016339;GO:0034613;GO:0007010;GO:0048041;GO:0000086;GO:0035195;GO:0046474;GO:0030032;GO:0035331;GO:0033673;GO:0000122;GO:0031328;GO:2000637;GO:0043123;GO:0043406;GO:0031334;GO:0030334;GO:1900037;GO:0043087;GO:0006355;GO:0001666;GO:0035313;, C:adherens junction; C:cell-cell junction; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane; C:transcription regulator complex;, F:actin filament binding; F:alpha-catenin binding; F:chromatin binding; F:metal ion binding; F:transcription corepressor activity;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular protein localization; P:cytoskeleton organization; P:focal adhesion assembly; P:G2/M transition of mitotic cell cycle; P:gene silencing by miRNA; P:glycerophospholipid biosynthetic process; P:lamellipodium assembly; P:negative regulation of hippo signaling; P:negative regulation of kinase activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cellular biosynthetic process; P:positive regulation of gene silencing by miRNA; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of protein-containing complex assembly; P:regulation of cell migration; P:regulation of cellular response to hypoxia; P:regulation of GTPase activity; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:wound healing, spreading of epidermal cells;|Q96IF1 A8MX18 D3DS37,LIM domain-containing protein ajuba,, PF00412;, GO:0005912;GO:0005911;GO:0005829;GO:0005925;GO:0005794;GO:0030027;GO:0005815;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0005667;GO:0051015;GO:0045294;GO:0003682;GO:0046872;GO:0003714;GO:0016339;GO:0034613;GO:0007010;GO:0048041;GO:0000086;GO:0035195;GO:0046474;GO:0030032;GO:0035331;GO:0033673;GO:0000122;GO:0031328;GO:2000637;GO:0043123;GO:0043406;GO:0031334;GO:0030334;GO:1900037;GO:0043087;GO:0006355;GO:0001666;GO:0035313;, C:adherens junction; C:cell-cell junction; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane; C:transcription regulator complex;, F:actin filament binding; F:alpha-catenin binding; F:chromatin binding; F:metal ion binding; F:transcription corepressor activity;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular protein localization; P:cytoskeleton organization; P:focal adhesion assembly; P:G2/M transition of mitotic cell cycle; P:gene silencing by miRNA; P:glycerophospholipid biosynthetic process; P:lamellipodium assembly; P:negative regulation of hippo signaling; P:negative regulation of kinase activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cellular biosynthetic process; P:positive regulation of gene silencing by miRNA; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of protein-containing complex assembly; P:regulation of cell migration; P:regulation of cellular response to hypoxia; P:regulation of GTPase activity; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:wound healing, spreading of epidermal cells; scaffold174 indexed_genome mRNA 1108107 1109863 . - . ID=transcript_15214;Q96IF1 A8MX18 D3DS37,LIM domain-containing protein ajuba,, PF00412;, GO:0005912;GO:0005911;GO:0005829;GO:0005925;GO:0005794;GO:0030027;GO:0005815;GO:0005654;GO:0005634;GO:0000932;GO:0005886;GO:0005667;GO:0051015;GO:0045294;GO:0003682;GO:0046872;GO:0003714;GO:0016339;GO:0034613;GO:0007010;GO:0048041;GO:0000086;GO:0035195;GO:0046474;GO:0030032;GO:0035331;GO:0033673;GO:0000122;GO:0031328;GO:2000637;GO:0043123;GO:0043406;GO:0031334;GO:0030334;GO:1900037;GO:0043087;GO:0006355;GO:0001666;GO:0035313;, C:adherens junction; C:cell-cell junction; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:lamellipodium; C:microtubule organizing center; C:nucleoplasm; C:nucleus; C:P-body; C:plasma membrane; C:transcription regulator complex;, F:actin filament binding; F:alpha-catenin binding; F:chromatin binding; F:metal ion binding; F:transcription corepressor activity;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular protein localization; P:cytoskeleton organization; P:focal adhesion assembly; P:G2/M transition of mitotic cell cycle; P:gene silencing by miRNA; P:glycerophospholipid biosynthetic process; P:lamellipodium assembly; P:negative regulation of hippo signaling; P:negative regulation of kinase activity; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cellular biosynthetic process; P:positive regulation of gene silencing by miRNA; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of MAP kinase activity; P:positive regulation of protein-containing complex assembly; P:regulation of cell migration; P:regulation of cellular response to hypoxia; P:regulation of GTPase activity; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:wound healing, spreading of epidermal cells; scaffold174 indexed_genome mRNA 1113323 1122769 . - . ID=transcript_15215;Q9H972 B7WP03 D3DS38 D3DS39 Q86SE6 Q96CF7 Q9HA68,Uncharacterized protein C14orf93,, PF15394;, GO:0005576;GO:0003723;GO:0048856;GO:0030154;GO:0010628;, C:extracellular region;, F:RNA binding;, P:anatomical structure development; P:cell differentiation; P:positive regulation of gene expression;|Q9H972 B7WP03 D3DS38 D3DS39 Q86SE6 Q96CF7 Q9HA68,Uncharacterized protein C14orf93,, PF15394;, GO:0005576;GO:0003723;GO:0048856;GO:0030154;GO:0010628;, C:extracellular region;, F:RNA binding;, P:anatomical structure development; P:cell differentiation; P:positive regulation of gene expression; scaffold174 indexed_genome mRNA 1148965 1155197 . - . ID=transcript_15216;Q9TNN9,Proteasome subunit beta type-5,Macropain epsilon chain;Multicatalytic endopeptidase complex epsilon chain;Proteasome chain 6;Proteasome epsilon chain;Proteasome subunit MB1;Proteasome subunit X;, PF00227;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0004175;GO:0008233;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006508;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0006979;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:endopeptidase activity; F:peptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to oxidative stress; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9TNN9,Proteasome subunit beta type-5,Macropain epsilon chain;Multicatalytic endopeptidase complex epsilon chain;Proteasome chain 6;Proteasome epsilon chain;Proteasome subunit MB1;Proteasome subunit X;, PF00227;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0004175;GO:0008233;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006508;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0006979;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:endopeptidase activity; F:peptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to oxidative stress; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9TNN9,Proteasome subunit beta type-5,Macropain epsilon chain;Multicatalytic endopeptidase complex epsilon chain;Proteasome chain 6;Proteasome epsilon chain;Proteasome subunit MB1;Proteasome subunit X;, PF00227;, GO:0005813;GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0004175;GO:0008233;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006508;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0006979;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:centrosome; C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex;, F:endopeptidase activity; F:peptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to oxidative stress; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold174 indexed_genome mRNA 1168580 1176275 . - . ID=transcript_15217;Q86UP0 D3DS44 Q86UP1 Q9NT84,Cadherin-24,, PF00028;PF01049;, GO:0005912;GO:0016342;GO:0005911;GO:0016021;GO:0005886;GO:0045294;GO:0008013;GO:0045296;GO:0005509;GO:0070097;GO:0034332;GO:0016339;GO:0000902;GO:0098609;GO:0098742;GO:0007043;GO:0007156;GO:0007275;, C:adherens junction; C:catenin complex; C:cell-cell junction; C:integral component of membrane; C:plasma membrane;, F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:calcium ion binding; F:delta-catenin binding;, P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development; scaffold174 indexed_genome mRNA 1181614 1192205 . - . ID=transcript_15218;Q9UKV3 B2RTT4 D3DS45 O75158 Q9UG91 Q9UKV1 Q9UKV2,Apoptotic chromatin condensation inducer in the nucleus,, PF16294;PF02037;, GO:0061574;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016887;GO:0019899;GO:0003676;GO:0003723;GO:0030263;GO:0030218;GO:0006397;GO:0048025;GO:0043065;GO:0045657;GO:0008380;, C:ASAP complex; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATPase activity; F:enzyme binding; F:nucleic acid binding; F:RNA binding;, P:apoptotic chromosome condensation; P:erythrocyte differentiation; P:mRNA processing; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of monocyte differentiation; P:RNA splicing;|Q9UKV3 B2RTT4 D3DS45 O75158 Q9UG91 Q9UKV1 Q9UKV2,Apoptotic chromatin condensation inducer in the nucleus,, PF16294;PF02037;, GO:0061574;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016887;GO:0019899;GO:0003676;GO:0003723;GO:0030263;GO:0030218;GO:0006397;GO:0048025;GO:0043065;GO:0045657;GO:0008380;, C:ASAP complex; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATPase activity; F:enzyme binding; F:nucleic acid binding; F:RNA binding;, P:apoptotic chromosome condensation; P:erythrocyte differentiation; P:mRNA processing; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of monocyte differentiation; P:RNA splicing;|Q9UKV3 B2RTT4 D3DS45 O75158 Q9UG91 Q9UKV1 Q9UKV2,Apoptotic chromatin condensation inducer in the nucleus,, PF16294;PF02037;, GO:0061574;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016887;GO:0019899;GO:0003676;GO:0003723;GO:0030263;GO:0030218;GO:0006397;GO:0048025;GO:0043065;GO:0045657;GO:0008380;, C:ASAP complex; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATPase activity; F:enzyme binding; F:nucleic acid binding; F:RNA binding;, P:apoptotic chromosome condensation; P:erythrocyte differentiation; P:mRNA processing; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of monocyte differentiation; P:RNA splicing;|Q9UKV3 B2RTT4 D3DS45 O75158 Q9UG91 Q9UKV1 Q9UKV2,Apoptotic chromatin condensation inducer in the nucleus,, PF16294;PF02037;, GO:0061574;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016887;GO:0019899;GO:0003676;GO:0003723;GO:0030263;GO:0030218;GO:0006397;GO:0048025;GO:0043065;GO:0045657;GO:0008380;, C:ASAP complex; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATPase activity; F:enzyme binding; F:nucleic acid binding; F:RNA binding;, P:apoptotic chromosome condensation; P:erythrocyte differentiation; P:mRNA processing; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of monocyte differentiation; P:RNA splicing;|Q9UKV3 B2RTT4 D3DS45 O75158 Q9UG91 Q9UKV1 Q9UKV2,Apoptotic chromatin condensation inducer in the nucleus,, PF16294;PF02037;, GO:0061574;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016887;GO:0019899;GO:0003676;GO:0003723;GO:0030263;GO:0030218;GO:0006397;GO:0048025;GO:0043065;GO:0045657;GO:0008380;, C:ASAP complex; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATPase activity; F:enzyme binding; F:nucleic acid binding; F:RNA binding;, P:apoptotic chromosome condensation; P:erythrocyte differentiation; P:mRNA processing; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of monocyte differentiation; P:RNA splicing; scaffold174 indexed_genome mRNA 1205416 1219338 . + . ID=transcript_15219;Q9UKV3 B2RTT4 D3DS45 O75158 Q9UG91 Q9UKV1 Q9UKV2,Apoptotic chromatin condensation inducer in the nucleus,, PF16294;PF02037;, GO:0061574;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016887;GO:0019899;GO:0003676;GO:0003723;GO:0030263;GO:0030218;GO:0006397;GO:0048025;GO:0043065;GO:0045657;GO:0008380;, C:ASAP complex; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:ATPase activity; F:enzyme binding; F:nucleic acid binding; F:RNA binding;, P:apoptotic chromosome condensation; P:erythrocyte differentiation; P:mRNA processing; P:negative regulation of mRNA splicing, via spliceosome; P:positive regulation of apoptotic process; P:positive regulation of monocyte differentiation; P:RNA splicing; scaffold174 indexed_genome mRNA 1221111 1299025 . + . ID=transcript_15220;Q9NWQ9 Q6IAA7,Uncharacterized protein C14orf119,, PF14969;, GO:0005829;GO:0005739;, C:cytosol; C:mitochondrion;|Q15744 Q15745 Q8IYI2 Q99803,CCAAT/enhancer-binding protein epsilon,, PF07716;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0044877;GO:0000978;GO:1990837;GO:0071222;GO:0006952;GO:0042742;GO:0030851;GO:0030225;GO:0030099;GO:0006909;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to lipopolysaccharide; P:defense response; P:defense response to bacterium; P:granulocyte differentiation; P:macrophage differentiation; P:myeloid cell differentiation; P:phagocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q9UKQ8 Q9Y445,Large neutral amino acids transporter small subunit 2,L-type amino acid transporter 2;Solute carrier family 7 member 8;, PF13520;, GO:0016324;GO:0009925;GO:0016323;GO:0005737;GO:0005887;GO:0031528;GO:0005886;GO:0015171;GO:0015187;GO:0015180;GO:0015179;GO:0015190;GO:0015175;GO:0015101;GO:0042605;GO:0015349;GO:0019534;GO:0089718;GO:0006865;GO:0015816;GO:1904273;GO:1903801;GO:0098713;GO:0015820;GO:0050900;GO:0055065;GO:0015804;GO:0035524;GO:0009636;GO:0070327;GO:0150104;GO:0015827;GO:0015829;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:integral component of plasma membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:glycine transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:organic cation transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity; F:toxin transmembrane transporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:glycine transport; P:L-alanine import across plasma membrane; P:L-leucine import across plasma membrane; P:leucine import across plasma membrane; P:leucine transport; P:leukocyte migration; P:metal ion homeostasis; P:neutral amino acid transport; P:proline transmembrane transport; P:response to toxic substance; P:thyroid hormone transport; P:transport across blood-brain barrier; P:tryptophan transport; P:valine transport;|Q9UKQ8 Q9Y445,Large neutral amino acids transporter small subunit 2,L-type amino acid transporter 2;Solute carrier family 7 member 8;, PF13520;, GO:0016324;GO:0009925;GO:0016323;GO:0005737;GO:0005887;GO:0031528;GO:0005886;GO:0015171;GO:0015187;GO:0015180;GO:0015179;GO:0015190;GO:0015175;GO:0015101;GO:0042605;GO:0015349;GO:0019534;GO:0089718;GO:0006865;GO:0015816;GO:1904273;GO:1903801;GO:0098713;GO:0015820;GO:0050900;GO:0055065;GO:0015804;GO:0035524;GO:0009636;GO:0070327;GO:0150104;GO:0015827;GO:0015829;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:integral component of plasma membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:glycine transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:organic cation transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity; F:toxin transmembrane transporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:glycine transport; P:L-alanine import across plasma membrane; P:L-leucine import across plasma membrane; P:leucine import across plasma membrane; P:leucine transport; P:leukocyte migration; P:metal ion homeostasis; P:neutral amino acid transport; P:proline transmembrane transport; P:response to toxic substance; P:thyroid hormone transport; P:transport across blood-brain barrier; P:tryptophan transport; P:valine transport;|Q9UKQ8 Q9Y445,Large neutral amino acids transporter small subunit 2,L-type amino acid transporter 2;Solute carrier family 7 member 8;, PF13520;, GO:0016324;GO:0009925;GO:0016323;GO:0005737;GO:0005887;GO:0031528;GO:0005886;GO:0015171;GO:0015187;GO:0015180;GO:0015179;GO:0015190;GO:0015175;GO:0015101;GO:0042605;GO:0015349;GO:0019534;GO:0089718;GO:0006865;GO:0015816;GO:1904273;GO:1903801;GO:0098713;GO:0015820;GO:0050900;GO:0055065;GO:0015804;GO:0035524;GO:0009636;GO:0070327;GO:0150104;GO:0015827;GO:0015829;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:integral component of plasma membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:glycine transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:organic cation transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity; F:toxin transmembrane transporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:glycine transport; P:L-alanine import across plasma membrane; P:L-leucine import across plasma membrane; P:leucine import across plasma membrane; P:leucine transport; P:leukocyte migration; P:metal ion homeostasis; P:neutral amino acid transport; P:proline transmembrane transport; P:response to toxic substance; P:thyroid hormone transport; P:transport across blood-brain barrier; P:tryptophan transport; P:valine transport;|Q9UKQ8 Q9Y445,Large neutral amino acids transporter small subunit 2,L-type amino acid transporter 2;Solute carrier family 7 member 8;, PF13520;, GO:0016324;GO:0009925;GO:0016323;GO:0005737;GO:0005887;GO:0031528;GO:0005886;GO:0015171;GO:0015187;GO:0015180;GO:0015179;GO:0015190;GO:0015175;GO:0015101;GO:0042605;GO:0015349;GO:0019534;GO:0089718;GO:0006865;GO:0015816;GO:1904273;GO:1903801;GO:0098713;GO:0015820;GO:0050900;GO:0055065;GO:0015804;GO:0035524;GO:0009636;GO:0070327;GO:0150104;GO:0015827;GO:0015829;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:integral component of plasma membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:glycine transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:organic cation transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity; F:toxin transmembrane transporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:glycine transport; P:L-alanine import across plasma membrane; P:L-leucine import across plasma membrane; P:leucine import across plasma membrane; P:leucine transport; P:leukocyte migration; P:metal ion homeostasis; P:neutral amino acid transport; P:proline transmembrane transport; P:response to toxic substance; P:thyroid hormone transport; P:transport across blood-brain barrier; P:tryptophan transport; P:valine transport;|Q9UKQ8 Q9Y445,Large neutral amino acids transporter small subunit 2,L-type amino acid transporter 2;Solute carrier family 7 member 8;, PF13520;, GO:0016324;GO:0009925;GO:0016323;GO:0005737;GO:0005887;GO:0031528;GO:0005886;GO:0015171;GO:0015187;GO:0015180;GO:0015179;GO:0015190;GO:0015175;GO:0015101;GO:0042605;GO:0015349;GO:0019534;GO:0089718;GO:0006865;GO:0015816;GO:1904273;GO:1903801;GO:0098713;GO:0015820;GO:0050900;GO:0055065;GO:0015804;GO:0035524;GO:0009636;GO:0070327;GO:0150104;GO:0015827;GO:0015829;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:integral component of plasma membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:glycine transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:organic cation transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity; F:toxin transmembrane transporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:glycine transport; P:L-alanine import across plasma membrane; P:L-leucine import across plasma membrane; P:leucine import across plasma membrane; P:leucine transport; P:leukocyte migration; P:metal ion homeostasis; P:neutral amino acid transport; P:proline transmembrane transport; P:response to toxic substance; P:thyroid hormone transport; P:transport across blood-brain barrier; P:tryptophan transport; P:valine transport; scaffold174 indexed_genome mRNA 1308716 1330733 . + . ID=transcript_15221;A8MTL3,RING finger protein 212B,, , GO:0000795;GO:0046872;GO:0019789;GO:0007129;GO:0016925;GO:0007131;, C:synaptonemal complex;, F:metal ion binding; F:SUMO transferase activity;, P:homologous chromosome pairing at meiosis; P:protein sumoylation; P:reciprocal meiotic recombination; scaffold174 indexed_genome mRNA 1333188 1333982 . + . ID=transcript_15222;Q8N6V1 Q8NCJ7,Calcium-transporting ATPase type 2C member 1,ATP-dependent Ca(2+) pump PMR1;, PF00689;PF00690;, GO:0005783;GO:0005794;GO:0000139;GO:0016021;GO:0016020;GO:0005886;GO:0005802;GO:0005524;GO:0016887;GO:0005509;GO:0005388;GO:0030145;GO:0015410;GO:0046872;GO:0008553;GO:0031532;GO:0070588;GO:0006816;GO:0016339;GO:0006874;GO:0030026;GO:0008544;GO:0032468;GO:0032472;GO:0034220;GO:0006828;GO:0043123;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:manganese ion binding; F:manganese transmembrane transporter activity, phosphorylative mechanism; F:metal ion binding; F:proton-exporting ATPase activity, phosphorylative mechanism;, P:actin cytoskeleton reorganization; P:calcium ion transmembrane transport; P:calcium ion transport; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cellular calcium ion homeostasis; P:cellular manganese ion homeostasis; P:epidermis development; P:Golgi calcium ion homeostasis; P:Golgi calcium ion transport; P:ion transmembrane transport; P:manganese ion transport; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; scaffold174 indexed_genome mRNA 1337390 1338883 . + . ID=transcript_15223;A8MTL3,RING finger protein 212B,, , GO:0000795;GO:0046872;GO:0019789;GO:0007129;GO:0016925;GO:0007131;, C:synaptonemal complex;, F:metal ion binding; F:SUMO transferase activity;, P:homologous chromosome pairing at meiosis; P:protein sumoylation; P:reciprocal meiotic recombination; scaffold175 indexed_genome mRNA 3605 13254 . + . ID=transcript_15224;P22607 D3DVP9 D3DVQ0 Q14308 Q16294 Q16608 Q59FL9,Fibroblast growth factor receptor 3,, PF18123;PF07679;PF07714;, GO:0009986;GO:0005783;GO:0005576;GO:0005794;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0030133;GO:0005524;GO:0017134;GO:0005007;GO:0042802;GO:0004713;GO:0004714;GO:0070977;GO:0030282;GO:0060349;GO:0007267;GO:0002062;GO:0035988;GO:0003416;GO:0001958;GO:1902178;GO:0008543;GO:0000165;GO:0007275;GO:0048640;GO:0018108;GO:0008284;GO:0070374;GO:0033674;GO:0043410;GO:0043552;GO:0010518;GO:0051897;GO:0042531;GO:0046777;GO:0001501;GO:0007169;, C:cell surface; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex; C:transport vesicle;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:identical protein binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:bone maturation; P:bone mineralization; P:bone morphogenesis; P:cell-cell signaling; P:chondrocyte differentiation; P:chondrocyte proliferation; P:endochondral bone growth; P:endochondral ossification; P:fibroblast growth factor receptor apoptotic signaling pathway; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of developmental growth; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P22607 D3DVP9 D3DVQ0 Q14308 Q16294 Q16608 Q59FL9,Fibroblast growth factor receptor 3,, PF18123;PF07679;PF07714;, GO:0009986;GO:0005783;GO:0005576;GO:0005794;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0030133;GO:0005524;GO:0017134;GO:0005007;GO:0042802;GO:0004713;GO:0004714;GO:0070977;GO:0030282;GO:0060349;GO:0007267;GO:0002062;GO:0035988;GO:0003416;GO:0001958;GO:1902178;GO:0008543;GO:0000165;GO:0007275;GO:0048640;GO:0018108;GO:0008284;GO:0070374;GO:0033674;GO:0043410;GO:0043552;GO:0010518;GO:0051897;GO:0042531;GO:0046777;GO:0001501;GO:0007169;, C:cell surface; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex; C:transport vesicle;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:identical protein binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:bone maturation; P:bone mineralization; P:bone morphogenesis; P:cell-cell signaling; P:chondrocyte differentiation; P:chondrocyte proliferation; P:endochondral bone growth; P:endochondral ossification; P:fibroblast growth factor receptor apoptotic signaling pathway; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of developmental growth; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P22607 D3DVP9 D3DVQ0 Q14308 Q16294 Q16608 Q59FL9,Fibroblast growth factor receptor 3,, PF18123;PF07679;PF07714;, GO:0009986;GO:0005783;GO:0005576;GO:0005794;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0030133;GO:0005524;GO:0017134;GO:0005007;GO:0042802;GO:0004713;GO:0004714;GO:0070977;GO:0030282;GO:0060349;GO:0007267;GO:0002062;GO:0035988;GO:0003416;GO:0001958;GO:1902178;GO:0008543;GO:0000165;GO:0007275;GO:0048640;GO:0018108;GO:0008284;GO:0070374;GO:0033674;GO:0043410;GO:0043552;GO:0010518;GO:0051897;GO:0042531;GO:0046777;GO:0001501;GO:0007169;, C:cell surface; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex; C:transport vesicle;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:identical protein binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:bone maturation; P:bone mineralization; P:bone morphogenesis; P:cell-cell signaling; P:chondrocyte differentiation; P:chondrocyte proliferation; P:endochondral bone growth; P:endochondral ossification; P:fibroblast growth factor receptor apoptotic signaling pathway; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of developmental growth; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P22607 D3DVP9 D3DVQ0 Q14308 Q16294 Q16608 Q59FL9,Fibroblast growth factor receptor 3,, PF18123;PF07679;PF07714;, GO:0009986;GO:0005783;GO:0005576;GO:0005794;GO:0005887;GO:0005634;GO:0005886;GO:0043235;GO:0030133;GO:0005524;GO:0017134;GO:0005007;GO:0042802;GO:0004713;GO:0004714;GO:0070977;GO:0030282;GO:0060349;GO:0007267;GO:0002062;GO:0035988;GO:0003416;GO:0001958;GO:1902178;GO:0008543;GO:0000165;GO:0007275;GO:0048640;GO:0018108;GO:0008284;GO:0070374;GO:0033674;GO:0043410;GO:0043552;GO:0010518;GO:0051897;GO:0042531;GO:0046777;GO:0001501;GO:0007169;, C:cell surface; C:endoplasmic reticulum; C:extracellular region; C:Golgi apparatus; C:integral component of plasma membrane; C:nucleus; C:plasma membrane; C:receptor complex; C:transport vesicle;, F:ATP binding; F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:identical protein binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:bone maturation; P:bone mineralization; P:bone morphogenesis; P:cell-cell signaling; P:chondrocyte differentiation; P:chondrocyte proliferation; P:endochondral bone growth; P:endochondral ossification; P:fibroblast growth factor receptor apoptotic signaling pathway; P:fibroblast growth factor receptor signaling pathway; P:MAPK cascade; P:multicellular organism development; P:negative regulation of developmental growth; P:peptidyl-tyrosine phosphorylation; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phospholipase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold175 indexed_genome mRNA 16455 27741 . - . ID=transcript_15225;O95202 B4DED2 Q9UF65,Mitochondrial proton/calcium exchanger protein {ECO:0000305},Leucine zipper-EF-hand-containing transmembrane protein 1;, PF07766;, GO:0016021;GO:0005743;GO:0005739;GO:0005509;GO:0015369;GO:0043022;GO:0099093;GO:0006875;GO:0042407;GO:0051560;GO:0006851;GO:0051562;GO:0034214;GO:0051260;GO:1900069;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:calcium:proton antiporter activity; F:ribosome binding;, P:calcium export from the mitochondrion; P:cellular metal ion homeostasis; P:cristae formation; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of mitochondrial calcium ion concentration; P:protein hexamerization; P:protein homooligomerization; P:regulation of cellular hyperosmotic salinity response;|O95202 B4DED2 Q9UF65,Mitochondrial proton/calcium exchanger protein {ECO:0000305},Leucine zipper-EF-hand-containing transmembrane protein 1;, PF07766;, GO:0016021;GO:0005743;GO:0005739;GO:0005509;GO:0015369;GO:0043022;GO:0099093;GO:0006875;GO:0042407;GO:0051560;GO:0006851;GO:0051562;GO:0034214;GO:0051260;GO:1900069;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:calcium:proton antiporter activity; F:ribosome binding;, P:calcium export from the mitochondrion; P:cellular metal ion homeostasis; P:cristae formation; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of mitochondrial calcium ion concentration; P:protein hexamerization; P:protein homooligomerization; P:regulation of cellular hyperosmotic salinity response;|O95202 B4DED2 Q9UF65,Mitochondrial proton/calcium exchanger protein {ECO:0000305},Leucine zipper-EF-hand-containing transmembrane protein 1;, PF07766;, GO:0016021;GO:0005743;GO:0005739;GO:0005509;GO:0015369;GO:0043022;GO:0099093;GO:0006875;GO:0042407;GO:0051560;GO:0006851;GO:0051562;GO:0034214;GO:0051260;GO:1900069;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:calcium:proton antiporter activity; F:ribosome binding;, P:calcium export from the mitochondrion; P:cellular metal ion homeostasis; P:cristae formation; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of mitochondrial calcium ion concentration; P:protein hexamerization; P:protein homooligomerization; P:regulation of cellular hyperosmotic salinity response;|O95202 B4DED2 Q9UF65,Mitochondrial proton/calcium exchanger protein {ECO:0000305},Leucine zipper-EF-hand-containing transmembrane protein 1;, PF07766;, GO:0016021;GO:0005743;GO:0005739;GO:0005509;GO:0015369;GO:0043022;GO:0099093;GO:0006875;GO:0042407;GO:0051560;GO:0006851;GO:0051562;GO:0034214;GO:0051260;GO:1900069;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:calcium:proton antiporter activity; F:ribosome binding;, P:calcium export from the mitochondrion; P:cellular metal ion homeostasis; P:cristae formation; P:mitochondrial calcium ion homeostasis; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of mitochondrial calcium ion concentration; P:protein hexamerization; P:protein homooligomerization; P:regulation of cellular hyperosmotic salinity response; scaffold175 indexed_genome mRNA 89658 104368 . + . ID=transcript_15226;Q6IS00 Q86V01 Q9BZB4 Q9UI92 Q9UPR2,Histone-lysine N-methyltransferase NSD2,Multiple myeloma SET domain-containing protein {ECO:0000303|PubMed:9787135};Nuclear SET domain-containing protein 2;Protein trithorax-5;Wolf-Hirschhorn syndrome candidate 1 protein;, PF17907;PF17982;PF00505;PF00855;PF00856;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0046975;GO:0046872;GO:0043565;GO:0003289;GO:0003290;GO:0060348;GO:0006302;GO:0006303;GO:0034770;GO:0003149;GO:0000122;GO:0048298;GO:2001032;GO:0070201;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H3-K36 specific); F:metal ion binding; F:sequence-specific DNA binding;, P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:bone development; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H4-K20 methylation; P:membranous septum morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of isotype switching to IgA isotypes; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of establishment of protein localization; P:regulation of transcription, DNA-templated; scaffold175 indexed_genome mRNA 106149 134303 . + . ID=transcript_15227;Q6IS00 Q86V01 Q9BZB4 Q9UI92 Q9UPR2,Histone-lysine N-methyltransferase NSD2,Multiple myeloma SET domain-containing protein {ECO:0000303|PubMed:9787135};Nuclear SET domain-containing protein 2;Protein trithorax-5;Wolf-Hirschhorn syndrome candidate 1 protein;, PF17907;PF17982;PF00505;PF00855;PF00856;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0046975;GO:0046872;GO:0043565;GO:0003289;GO:0003290;GO:0060348;GO:0006302;GO:0006303;GO:0034770;GO:0003149;GO:0000122;GO:0048298;GO:2001032;GO:0070201;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H3-K36 specific); F:metal ion binding; F:sequence-specific DNA binding;, P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:bone development; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H4-K20 methylation; P:membranous septum morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of isotype switching to IgA isotypes; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of establishment of protein localization; P:regulation of transcription, DNA-templated;|Q6IS00 Q86V01 Q9BZB4 Q9UI92 Q9UPR2,Histone-lysine N-methyltransferase NSD2,Multiple myeloma SET domain-containing protein {ECO:0000303|PubMed:9787135};Nuclear SET domain-containing protein 2;Protein trithorax-5;Wolf-Hirschhorn syndrome candidate 1 protein;, PF17907;PF17982;PF00505;PF00855;PF00856;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0046975;GO:0046872;GO:0043565;GO:0003289;GO:0003290;GO:0060348;GO:0006302;GO:0006303;GO:0034770;GO:0003149;GO:0000122;GO:0048298;GO:2001032;GO:0070201;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H3-K36 specific); F:metal ion binding; F:sequence-specific DNA binding;, P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:bone development; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H4-K20 methylation; P:membranous septum morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of isotype switching to IgA isotypes; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of establishment of protein localization; P:regulation of transcription, DNA-templated;|Q6IS00 Q86V01 Q9BZB4 Q9UI92 Q9UPR2,Histone-lysine N-methyltransferase NSD2,Multiple myeloma SET domain-containing protein {ECO:0000303|PubMed:9787135};Nuclear SET domain-containing protein 2;Protein trithorax-5;Wolf-Hirschhorn syndrome candidate 1 protein;, PF17907;PF17982;PF00505;PF00855;PF00856;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0046975;GO:0046872;GO:0043565;GO:0003289;GO:0003290;GO:0060348;GO:0006302;GO:0006303;GO:0034770;GO:0003149;GO:0000122;GO:0048298;GO:2001032;GO:0070201;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H3-K36 specific); F:metal ion binding; F:sequence-specific DNA binding;, P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:bone development; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H4-K20 methylation; P:membranous septum morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of isotype switching to IgA isotypes; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of establishment of protein localization; P:regulation of transcription, DNA-templated;|Q6IS00 Q86V01 Q9BZB4 Q9UI92 Q9UPR2,Histone-lysine N-methyltransferase NSD2,Multiple myeloma SET domain-containing protein {ECO:0000303|PubMed:9787135};Nuclear SET domain-containing protein 2;Protein trithorax-5;Wolf-Hirschhorn syndrome candidate 1 protein;, PF17907;PF17982;PF00505;PF00855;PF00856;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0046975;GO:0046872;GO:0043565;GO:0003289;GO:0003290;GO:0060348;GO:0006302;GO:0006303;GO:0034770;GO:0003149;GO:0000122;GO:0048298;GO:2001032;GO:0070201;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H3-K36 specific); F:metal ion binding; F:sequence-specific DNA binding;, P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:bone development; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H4-K20 methylation; P:membranous septum morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of isotype switching to IgA isotypes; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of establishment of protein localization; P:regulation of transcription, DNA-templated;|Q6IS00 Q86V01 Q9BZB4 Q9UI92 Q9UPR2,Histone-lysine N-methyltransferase NSD2,Multiple myeloma SET domain-containing protein {ECO:0000303|PubMed:9787135};Nuclear SET domain-containing protein 2;Protein trithorax-5;Wolf-Hirschhorn syndrome candidate 1 protein;, PF17907;PF17982;PF00505;PF00855;PF00856;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0046975;GO:0046872;GO:0043565;GO:0003289;GO:0003290;GO:0060348;GO:0006302;GO:0006303;GO:0034770;GO:0003149;GO:0000122;GO:0048298;GO:2001032;GO:0070201;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H3-K36 specific); F:metal ion binding; F:sequence-specific DNA binding;, P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:bone development; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H4-K20 methylation; P:membranous septum morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of isotype switching to IgA isotypes; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of establishment of protein localization; P:regulation of transcription, DNA-templated;|Q6IS00 Q86V01 Q9BZB4 Q9UI92 Q9UPR2,Histone-lysine N-methyltransferase NSD2,Multiple myeloma SET domain-containing protein {ECO:0000303|PubMed:9787135};Nuclear SET domain-containing protein 2;Protein trithorax-5;Wolf-Hirschhorn syndrome candidate 1 protein;, PF17907;PF17982;PF00505;PF00855;PF00856;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0046975;GO:0046872;GO:0043565;GO:0003289;GO:0003290;GO:0060348;GO:0006302;GO:0006303;GO:0034770;GO:0003149;GO:0000122;GO:0048298;GO:2001032;GO:0070201;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H3-K36 specific); F:metal ion binding; F:sequence-specific DNA binding;, P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:bone development; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H4-K20 methylation; P:membranous septum morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of isotype switching to IgA isotypes; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of establishment of protein localization; P:regulation of transcription, DNA-templated;|Q6IS00 Q86V01 Q9BZB4 Q9UI92 Q9UPR2,Histone-lysine N-methyltransferase NSD2,Multiple myeloma SET domain-containing protein {ECO:0000303|PubMed:9787135};Nuclear SET domain-containing protein 2;Protein trithorax-5;Wolf-Hirschhorn syndrome candidate 1 protein;, PF17907;PF17982;PF00505;PF00855;PF00856;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0046975;GO:0046872;GO:0043565;GO:0003289;GO:0003290;GO:0060348;GO:0006302;GO:0006303;GO:0034770;GO:0003149;GO:0000122;GO:0048298;GO:2001032;GO:0070201;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H3-K36 specific); F:metal ion binding; F:sequence-specific DNA binding;, P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:bone development; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H4-K20 methylation; P:membranous septum morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of isotype switching to IgA isotypes; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of establishment of protein localization; P:regulation of transcription, DNA-templated;|Q6IS00 Q86V01 Q9BZB4 Q9UI92 Q9UPR2,Histone-lysine N-methyltransferase NSD2,Multiple myeloma SET domain-containing protein {ECO:0000303|PubMed:9787135};Nuclear SET domain-containing protein 2;Protein trithorax-5;Wolf-Hirschhorn syndrome candidate 1 protein;, PF17907;PF17982;PF00505;PF00855;PF00856;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0046975;GO:0046872;GO:0043565;GO:0003289;GO:0003290;GO:0060348;GO:0006302;GO:0006303;GO:0034770;GO:0003149;GO:0000122;GO:0048298;GO:2001032;GO:0070201;GO:0006355;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone methyltransferase activity (H3-K36 specific); F:metal ion binding; F:sequence-specific DNA binding;, P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:bone development; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone H4-K20 methylation; P:membranous septum morphogenesis; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of isotype switching to IgA isotypes; P:regulation of double-strand break repair via nonhomologous end joining; P:regulation of establishment of protein localization; P:regulation of transcription, DNA-templated; scaffold175 indexed_genome mRNA 140278 149009 . - . ID=transcript_15228;Q9H3P2 A2A2T1 O95392,Negative elongation factor A,Wolf-Hirschhorn syndrome candidate 2 protein;, , GO:0005829;GO:0032021;GO:0016604;GO:0005654;GO:0007275;GO:0034244;GO:0050434;GO:0006366;GO:0006368;, C:cytosol; C:NELF complex; C:nuclear body; C:nucleoplasm;, , P:multicellular organism development; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9H3P2 A2A2T1 O95392,Negative elongation factor A,Wolf-Hirschhorn syndrome candidate 2 protein;, , GO:0005829;GO:0032021;GO:0016604;GO:0005654;GO:0007275;GO:0034244;GO:0050434;GO:0006366;GO:0006368;, C:cytosol; C:NELF complex; C:nuclear body; C:nucleoplasm;, , P:multicellular organism development; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9H3P2 A2A2T1 O95392,Negative elongation factor A,Wolf-Hirschhorn syndrome candidate 2 protein;, , GO:0005829;GO:0032021;GO:0016604;GO:0005654;GO:0007275;GO:0034244;GO:0050434;GO:0006366;GO:0006368;, C:cytosol; C:NELF complex; C:nuclear body; C:nucleoplasm;, , P:multicellular organism development; P:negative regulation of transcription elongation from RNA polymerase II promoter; P:positive regulation of viral transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold175 indexed_genome mRNA 177253 178417 . + . ID=transcript_15229;Q5BLP8 B6ZDN0 B7ZBI7 B7ZBI8 X6RBU3,Neuropeptide-like protein C4orf48,, PF15161;, GO:0005576;, C:extracellular region; scaffold175 indexed_genome mRNA 185663 186805 . + . ID=transcript_15230;Q8N9F0,N-acetylaspartate synthetase,Camello-like protein 3;N-acetyltransferase 8-like protein;, PF00583;, GO:0005737;GO:0016021;GO:0005759;GO:0031966;GO:0005739;GO:0030867;GO:0017188;GO:0008080;GO:0009066;, C:cytoplasm; C:integral component of membrane; C:mitochondrial matrix; C:mitochondrial membrane; C:mitochondrion; C:rough endoplasmic reticulum membrane;, F:aspartate N-acetyltransferase activity; F:N-acetyltransferase activity;, P:aspartate family amino acid metabolic process; scaffold175 indexed_genome mRNA 193149 266902 . - . ID=transcript_15231;Q7Z5Q5 A2A336 B4E158 Q4TTW4 Q6ZNF4,DNA polymerase nu,, PF00476;PF18049;, GO:0005737;GO:0005654;GO:0005634;GO:0030332;GO:0003677;GO:0003887;GO:0006261;GO:0000724;GO:0036297;GO:0019985;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:DNA binding; F:DNA-directed DNA polymerase activity;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:translesion synthesis;|Q7Z5Q5 A2A336 B4E158 Q4TTW4 Q6ZNF4,DNA polymerase nu,, PF00476;PF18049;, GO:0005737;GO:0005654;GO:0005634;GO:0030332;GO:0003677;GO:0003887;GO:0006261;GO:0000724;GO:0036297;GO:0019985;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:DNA binding; F:DNA-directed DNA polymerase activity;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:translesion synthesis;|Q7Z5Q5 A2A336 B4E158 Q4TTW4 Q6ZNF4,DNA polymerase nu,, PF00476;PF18049;, GO:0005737;GO:0005654;GO:0005634;GO:0030332;GO:0003677;GO:0003887;GO:0006261;GO:0000724;GO:0036297;GO:0019985;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:DNA binding; F:DNA-directed DNA polymerase activity;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:translesion synthesis;|Q7Z5Q5 A2A336 B4E158 Q4TTW4 Q6ZNF4,DNA polymerase nu,, PF00476;PF18049;, GO:0005737;GO:0005654;GO:0005634;GO:0030332;GO:0003677;GO:0003887;GO:0006261;GO:0000724;GO:0036297;GO:0019985;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:DNA binding; F:DNA-directed DNA polymerase activity;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:translesion synthesis;|Q7Z5Q5 A2A336 B4E158 Q4TTW4 Q6ZNF4,DNA polymerase nu,, PF00476;PF18049;, GO:0005737;GO:0005654;GO:0005634;GO:0030332;GO:0003677;GO:0003887;GO:0006261;GO:0000724;GO:0036297;GO:0019985;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:DNA binding; F:DNA-directed DNA polymerase activity;, P:DNA-dependent DNA replication; P:double-strand break repair via homologous recombination; P:interstrand cross-link repair; P:translesion synthesis; scaffold175 indexed_genome mRNA 342238 359243 . - . ID=transcript_15232;Q68CZ6 B4DF64 O43606 Q8TAZ5 Q9BTJ9,HAUS augmin-like complex subunit 3,, PF14932;, GO:0005813;GO:0005829;GO:0070652;GO:0045171;GO:0015630;GO:0005739;GO:0072686;GO:1990498;GO:0005654;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:intercellular bridge; C:microtubule cytoskeleton; C:mitochondrion; C:mitotic spindle; C:mitotic spindle microtubule; C:nucleoplasm;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q68CZ6 B4DF64 O43606 Q8TAZ5 Q9BTJ9,HAUS augmin-like complex subunit 3,, PF14932;, GO:0005813;GO:0005829;GO:0070652;GO:0045171;GO:0015630;GO:0005739;GO:0072686;GO:1990498;GO:0005654;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:intercellular bridge; C:microtubule cytoskeleton; C:mitochondrion; C:mitotic spindle; C:mitotic spindle microtubule; C:nucleoplasm;, , P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold175 indexed_genome mRNA 363589 375186 . - . ID=transcript_15233;Q14582 A2A335 Q5TZX4,Max dimerization protein 4,Class C basic helix-loop-helix protein 12;Max-associated protein 4;Max-interacting transcriptional repressor MAD4;, PF00010;, GO:0000785;GO:0005654;GO:0000981;GO:0046983;GO:0000978;GO:0000122;GO:0006357;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14582 A2A335 Q5TZX4,Max dimerization protein 4,Class C basic helix-loop-helix protein 12;Max-associated protein 4;Max-interacting transcriptional repressor MAD4;, PF00010;, GO:0000785;GO:0005654;GO:0000981;GO:0046983;GO:0000978;GO:0000122;GO:0006357;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q14582 A2A335 Q5TZX4,Max dimerization protein 4,Class C basic helix-loop-helix protein 12;Max-associated protein 4;Max-interacting transcriptional repressor MAD4;, PF00010;, GO:0000785;GO:0005654;GO:0000981;GO:0046983;GO:0000978;GO:0000122;GO:0006357;, C:chromatin; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold175 indexed_genome mRNA 384320 425343 . - . ID=transcript_15234;E9PG77 Q7Z6J3,Lateral signaling target protein 2 homolog,Zinc finger FYVE domain-containing protein 28;, PF01363;, GO:0005829;GO:0031901;GO:0046872;GO:0032266;GO:0042059;GO:0007175;, C:cytosol; C:early endosome membrane;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity;|E9PG77 Q7Z6J3,Lateral signaling target protein 2 homolog,Zinc finger FYVE domain-containing protein 28;, PF01363;, GO:0005829;GO:0031901;GO:0046872;GO:0032266;GO:0042059;GO:0007175;, C:cytosol; C:early endosome membrane;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity;|E9PG77 Q7Z6J3,Lateral signaling target protein 2 homolog,Zinc finger FYVE domain-containing protein 28;, PF01363;, GO:0005829;GO:0031901;GO:0046872;GO:0032266;GO:0042059;GO:0007175;, C:cytosol; C:early endosome membrane;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity;|E9PG77 Q7Z6J3,Lateral signaling target protein 2 homolog,Zinc finger FYVE domain-containing protein 28;, PF01363;, GO:0005829;GO:0031901;GO:0046872;GO:0032266;GO:0042059;GO:0007175;, C:cytosol; C:early endosome membrane;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity;|E9PG77 Q7Z6J3,Lateral signaling target protein 2 homolog,Zinc finger FYVE domain-containing protein 28;, PF01363;, GO:0005829;GO:0031901;GO:0046872;GO:0032266;GO:0042059;GO:0007175;, C:cytosol; C:early endosome membrane;, F:metal ion binding; F:phosphatidylinositol-3-phosphate binding;, P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of epidermal growth factor-activated receptor activity; scaffold175 indexed_genome mRNA 488474 509229 . + . ID=transcript_15235;D6REC4,Cilia- and flagella-associated protein 99 {ECO:0000312|HGNC:HGNC:51180},, , GO:0031514;, C:motile cilium; scaffold175 indexed_genome mRNA 523565 556428 . + . ID=transcript_15236;P78317 B2R6D6 D6RF58 Q49AR8,E3 ubiquitin-protein ligase RNF4,RING finger protein 4;RING-type E3 ubiquitin transferase RNF4 {ECO:0000305};Small nuclear ring finger protein;, , GO:0005737;GO:1990752;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0042802;GO:0030374;GO:0031491;GO:0032184;GO:0008134;GO:0004842;GO:0008270;GO:0045944;GO:0045893;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0085020;GO:0070534;GO:0090234;GO:0090169;GO:0046685;, C:cytoplasm; C:microtubule end; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:identical protein binding; F:nuclear receptor coactivator activity; F:nucleosome binding; F:SUMO polymer binding; F:transcription factor binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:regulation of kinetochore assembly; P:regulation of spindle assembly; P:response to arsenic-containing substance;|P78317 B2R6D6 D6RF58 Q49AR8,E3 ubiquitin-protein ligase RNF4,RING finger protein 4;RING-type E3 ubiquitin transferase RNF4 {ECO:0000305};Small nuclear ring finger protein;, , GO:0005737;GO:1990752;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0042802;GO:0030374;GO:0031491;GO:0032184;GO:0008134;GO:0004842;GO:0008270;GO:0045944;GO:0045893;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0085020;GO:0070534;GO:0090234;GO:0090169;GO:0046685;, C:cytoplasm; C:microtubule end; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:identical protein binding; F:nuclear receptor coactivator activity; F:nucleosome binding; F:SUMO polymer binding; F:transcription factor binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:regulation of kinetochore assembly; P:regulation of spindle assembly; P:response to arsenic-containing substance; scaffold175 indexed_genome mRNA 556435 558597 . + . ID=transcript_15237;P78317 B2R6D6 D6RF58 Q49AR8,E3 ubiquitin-protein ligase RNF4,RING finger protein 4;RING-type E3 ubiquitin transferase RNF4 {ECO:0000305};Small nuclear ring finger protein;, , GO:0005737;GO:1990752;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0003677;GO:0042802;GO:0030374;GO:0031491;GO:0032184;GO:0008134;GO:0004842;GO:0008270;GO:0045944;GO:0045893;GO:0043161;GO:0051865;GO:0070979;GO:0070936;GO:0085020;GO:0070534;GO:0090234;GO:0090169;GO:0046685;, C:cytoplasm; C:microtubule end; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:DNA binding; F:identical protein binding; F:nuclear receptor coactivator activity; F:nucleosome binding; F:SUMO polymer binding; F:transcription factor binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:regulation of kinetochore assembly; P:regulation of spindle assembly; P:response to arsenic-containing substance; scaffold175 indexed_genome mRNA 596258 744075 . + . ID=transcript_15238;P78312 B7ZM85 B9EGR0 E9PFA1 O43607 P78311 P78313 Q9UEG8,Protein FAM193A,Protein IT14;, PF15914;|P78312 B7ZM85 B9EGR0 E9PFA1 O43607 P78311 P78313 Q9UEG8,Protein FAM193A,Protein IT14;, PF15914;|P78312 B7ZM85 B9EGR0 E9PFA1 O43607 P78311 P78313 Q9UEG8,Protein FAM193A,Protein IT14;, PF15914;|P78312 B7ZM85 B9EGR0 E9PFA1 O43607 P78311 P78313 Q9UEG8,Protein FAM193A,Protein IT14;, PF15914;|P78312 B7ZM85 B9EGR0 E9PFA1 O43607 P78311 P78313 Q9UEG8,Protein FAM193A,Protein IT14;, PF15914; scaffold175 indexed_genome mRNA 754461 755879 . - . ID=transcript_15239;Q8NFZ5 B1AKS4 B3KTY8 D3DVQ9 Q7L5L2 Q9BQR6 Q9H682,TNFAIP3-interacting protein 2,A20-binding inhibitor of NF-kappa-B activation 2;Fetal liver LKB1-interacting protein;, PF12180;, GO:0005829;GO:0005654;GO:0070530;GO:0046872;GO:0031593;GO:0019901;GO:0006915;GO:0023035;GO:0071222;GO:0006954;GO:0070498;GO:2000352;GO:0050871;GO:0043123;GO:0043032;GO:0045944;GO:0016579;GO:0050821;GO:0051403;GO:0034134;GO:0034138;GO:0034162;, C:cytosol; C:nucleoplasm;, F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein kinase binding;, P:apoptotic process; P:CD40 signaling pathway; P:cellular response to lipopolysaccharide; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:negative regulation of endothelial cell apoptotic process; P:positive regulation of B cell activation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macrophage activation; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein stabilization; P:stress-activated MAPK cascade; P:toll-like receptor 2 signaling pathway; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 9 signaling pathway; scaffold175 indexed_genome mRNA 756646 758892 . - . ID=transcript_15240;Q8NFZ5 B1AKS4 B3KTY8 D3DVQ9 Q7L5L2 Q9BQR6 Q9H682,TNFAIP3-interacting protein 2,A20-binding inhibitor of NF-kappa-B activation 2;Fetal liver LKB1-interacting protein;, PF12180;, GO:0005829;GO:0005654;GO:0070530;GO:0046872;GO:0031593;GO:0019901;GO:0006915;GO:0023035;GO:0071222;GO:0006954;GO:0070498;GO:2000352;GO:0050871;GO:0043123;GO:0043032;GO:0045944;GO:0016579;GO:0050821;GO:0051403;GO:0034134;GO:0034138;GO:0034162;, C:cytosol; C:nucleoplasm;, F:K63-linked polyubiquitin modification-dependent protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein kinase binding;, P:apoptotic process; P:CD40 signaling pathway; P:cellular response to lipopolysaccharide; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:negative regulation of endothelial cell apoptotic process; P:positive regulation of B cell activation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macrophage activation; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein stabilization; P:stress-activated MAPK cascade; P:toll-like receptor 2 signaling pathway; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 9 signaling pathway; scaffold175 indexed_genome mRNA 843472 858795 . + . ID=transcript_15241;P78314 A6NNC2 B2R5R6 B4DT04 D3DVR0 D6R919 O00500 O15373 P78315,SH3 domain-binding protein 2,, PF00169;PF00017;, GO:0001784;GO:0017124;GO:0007165;, , F:phosphotyrosine residue binding; F:SH3 domain binding;, P:signal transduction;|P78314 A6NNC2 B2R5R6 B4DT04 D3DVR0 D6R919 O00500 O15373 P78315,SH3 domain-binding protein 2,, PF00169;PF00017;, GO:0001784;GO:0017124;GO:0007165;, , F:phosphotyrosine residue binding; F:SH3 domain binding;, P:signal transduction; scaffold175 indexed_genome mRNA 871287 951963 . + . ID=transcript_15242;Q16156 Q86XM2 Q9UJB6,Alpha-adducin,Erythrocyte adducin subunit alpha;, PF00596;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0008290;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0003779;GO:0051015;GO:0045296;GO:0005516;GO:0046982;GO:0042803;GO:0003723;GO:0030507;GO:0005200;GO:0008134;GO:0030036;GO:0051017;GO:0051016;GO:0000902;GO:0006884;GO:0071277;GO:0030218;GO:0020027;GO:0048873;GO:0001701;GO:0036498;GO:0035264;GO:1903393;GO:1903142;GO:0032092;GO:0055085;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:cadherin binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:transcription factor binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:cell morphogenesis; P:cell volume homeostasis; P:cellular response to calcium ion; P:erythrocyte differentiation; P:hemoglobin metabolic process; P:homeostasis of number of cells within a tissue; P:in utero embryonic development; P:IRE1-mediated unfolded protein response; P:multicellular organism growth; P:positive regulation of adherens junction organization; P:positive regulation of establishment of endothelial barrier; P:positive regulation of protein binding; P:transmembrane transport;|Q16156 Q86XM2 Q9UJB6,Alpha-adducin,Erythrocyte adducin subunit alpha;, PF00596;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0008290;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0003779;GO:0051015;GO:0045296;GO:0005516;GO:0046982;GO:0042803;GO:0003723;GO:0030507;GO:0005200;GO:0008134;GO:0030036;GO:0051017;GO:0051016;GO:0000902;GO:0006884;GO:0071277;GO:0030218;GO:0020027;GO:0048873;GO:0001701;GO:0036498;GO:0035264;GO:1903393;GO:1903142;GO:0032092;GO:0055085;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:cadherin binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:transcription factor binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:cell morphogenesis; P:cell volume homeostasis; P:cellular response to calcium ion; P:erythrocyte differentiation; P:hemoglobin metabolic process; P:homeostasis of number of cells within a tissue; P:in utero embryonic development; P:IRE1-mediated unfolded protein response; P:multicellular organism growth; P:positive regulation of adherens junction organization; P:positive regulation of establishment of endothelial barrier; P:positive regulation of protein binding; P:transmembrane transport;|Q16156 Q86XM2 Q9UJB6,Alpha-adducin,Erythrocyte adducin subunit alpha;, PF00596;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0008290;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0003779;GO:0051015;GO:0045296;GO:0005516;GO:0046982;GO:0042803;GO:0003723;GO:0030507;GO:0005200;GO:0008134;GO:0030036;GO:0051017;GO:0051016;GO:0000902;GO:0006884;GO:0071277;GO:0030218;GO:0020027;GO:0048873;GO:0001701;GO:0036498;GO:0035264;GO:1903393;GO:1903142;GO:0032092;GO:0055085;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:cadherin binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:transcription factor binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:cell morphogenesis; P:cell volume homeostasis; P:cellular response to calcium ion; P:erythrocyte differentiation; P:hemoglobin metabolic process; P:homeostasis of number of cells within a tissue; P:in utero embryonic development; P:IRE1-mediated unfolded protein response; P:multicellular organism growth; P:positive regulation of adherens junction organization; P:positive regulation of establishment of endothelial barrier; P:positive regulation of protein binding; P:transmembrane transport;|Q16156 Q86XM2 Q9UJB6,Alpha-adducin,Erythrocyte adducin subunit alpha;, PF00596;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0008290;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0003779;GO:0051015;GO:0045296;GO:0005516;GO:0046982;GO:0042803;GO:0003723;GO:0030507;GO:0005200;GO:0008134;GO:0030036;GO:0051017;GO:0051016;GO:0000902;GO:0006884;GO:0071277;GO:0030218;GO:0020027;GO:0048873;GO:0001701;GO:0036498;GO:0035264;GO:1903393;GO:1903142;GO:0032092;GO:0055085;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:cadherin binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:transcription factor binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:cell morphogenesis; P:cell volume homeostasis; P:cellular response to calcium ion; P:erythrocyte differentiation; P:hemoglobin metabolic process; P:homeostasis of number of cells within a tissue; P:in utero embryonic development; P:IRE1-mediated unfolded protein response; P:multicellular organism growth; P:positive regulation of adherens junction organization; P:positive regulation of establishment of endothelial barrier; P:positive regulation of protein binding; P:transmembrane transport;|Q16156 Q86XM2 Q9UJB6,Alpha-adducin,Erythrocyte adducin subunit alpha;, PF00596;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0008290;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0003779;GO:0051015;GO:0045296;GO:0005516;GO:0046982;GO:0042803;GO:0003723;GO:0030507;GO:0005200;GO:0008134;GO:0030036;GO:0051017;GO:0051016;GO:0000902;GO:0006884;GO:0071277;GO:0030218;GO:0020027;GO:0048873;GO:0001701;GO:0036498;GO:0035264;GO:1903393;GO:1903142;GO:0032092;GO:0055085;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:cadherin binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:transcription factor binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:cell morphogenesis; P:cell volume homeostasis; P:cellular response to calcium ion; P:erythrocyte differentiation; P:hemoglobin metabolic process; P:homeostasis of number of cells within a tissue; P:in utero embryonic development; P:IRE1-mediated unfolded protein response; P:multicellular organism growth; P:positive regulation of adherens junction organization; P:positive regulation of establishment of endothelial barrier; P:positive regulation of protein binding; P:transmembrane transport;|Q16156 Q86XM2 Q9UJB6,Alpha-adducin,Erythrocyte adducin subunit alpha;, PF00596;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0008290;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0003779;GO:0051015;GO:0045296;GO:0005516;GO:0046982;GO:0042803;GO:0003723;GO:0030507;GO:0005200;GO:0008134;GO:0030036;GO:0051017;GO:0051016;GO:0000902;GO:0006884;GO:0071277;GO:0030218;GO:0020027;GO:0048873;GO:0001701;GO:0036498;GO:0035264;GO:1903393;GO:1903142;GO:0032092;GO:0055085;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:cadherin binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:transcription factor binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:cell morphogenesis; P:cell volume homeostasis; P:cellular response to calcium ion; P:erythrocyte differentiation; P:hemoglobin metabolic process; P:homeostasis of number of cells within a tissue; P:in utero embryonic development; P:IRE1-mediated unfolded protein response; P:multicellular organism growth; P:positive regulation of adherens junction organization; P:positive regulation of establishment of endothelial barrier; P:positive regulation of protein binding; P:transmembrane transport;|Q16156 Q86XM2 Q9UJB6,Alpha-adducin,Erythrocyte adducin subunit alpha;, PF00596;, GO:0005912;GO:0005737;GO:0005856;GO:0005829;GO:0008290;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0014069;GO:0003779;GO:0051015;GO:0045296;GO:0005516;GO:0046982;GO:0042803;GO:0003723;GO:0030507;GO:0005200;GO:0008134;GO:0030036;GO:0051017;GO:0051016;GO:0000902;GO:0006884;GO:0071277;GO:0030218;GO:0020027;GO:0048873;GO:0001701;GO:0036498;GO:0035264;GO:1903393;GO:1903142;GO:0032092;GO:0055085;, C:adherens junction; C:cytoplasm; C:cytoskeleton; C:cytosol; C:F-actin capping protein complex; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynaptic density;, F:actin binding; F:actin filament binding; F:cadherin binding; F:calmodulin binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:spectrin binding; F:structural constituent of cytoskeleton; F:transcription factor binding;, P:actin cytoskeleton organization; P:actin filament bundle assembly; P:barbed-end actin filament capping; P:cell morphogenesis; P:cell volume homeostasis; P:cellular response to calcium ion; P:erythrocyte differentiation; P:hemoglobin metabolic process; P:homeostasis of number of cells within a tissue; P:in utero embryonic development; P:IRE1-mediated unfolded protein response; P:multicellular organism growth; P:positive regulation of adherens junction organization; P:positive regulation of establishment of endothelial barrier; P:positive regulation of protein binding; P:transmembrane transport; scaffold175 indexed_genome mRNA 952097 954604 . - . ID=transcript_15243;Q14728 Q07706,Major facilitator superfamily domain-containing protein 10,Tetracycline transporter-like protein;, PF07690;, GO:0031526;GO:0030659;GO:0016021;GO:0005637;GO:0008514;GO:0008493;GO:0006915;GO:0043252;, C:brush border membrane; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:nuclear inner membrane;, F:organic anion transmembrane transporter activity; F:tetracycline transmembrane transporter activity;, P:apoptotic process; P:sodium-independent organic anion transport; scaffold175 indexed_genome mRNA 960039 961991 . + . ID=transcript_15244;Q14728 Q07706,Major facilitator superfamily domain-containing protein 10,Tetracycline transporter-like protein;, PF07690;, GO:0031526;GO:0030659;GO:0016021;GO:0005637;GO:0008514;GO:0008493;GO:0006915;GO:0043252;, C:brush border membrane; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:nuclear inner membrane;, F:organic anion transmembrane transporter activity; F:tetracycline transmembrane transporter activity;, P:apoptotic process; P:sodium-independent organic anion transport;|Q14728 Q07706,Major facilitator superfamily domain-containing protein 10,Tetracycline transporter-like protein;, PF07690;, GO:0031526;GO:0030659;GO:0016021;GO:0005637;GO:0008514;GO:0008493;GO:0006915;GO:0043252;, C:brush border membrane; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:nuclear inner membrane;, F:organic anion transmembrane transporter activity; F:tetracycline transmembrane transporter activity;, P:apoptotic process; P:sodium-independent organic anion transport;|Q14728 Q07706,Major facilitator superfamily domain-containing protein 10,Tetracycline transporter-like protein;, PF07690;, GO:0031526;GO:0030659;GO:0016021;GO:0005637;GO:0008514;GO:0008493;GO:0006915;GO:0043252;, C:brush border membrane; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:nuclear inner membrane;, F:organic anion transmembrane transporter activity; F:tetracycline transmembrane transporter activity;, P:apoptotic process; P:sodium-independent organic anion transport; scaffold175 indexed_genome mRNA 963317 978612 . - . ID=transcript_15245;P78316 D3DVR6 Q7LGI5 Q7Z6K0 Q8TBR6,Nucleolar protein 14,Nucleolar complex protein 14;, PF04147;, GO:0030686;GO:0016020;GO:0030692;GO:0005730;GO:0005654;GO:0032040;GO:0019899;GO:0003723;GO:0030515;GO:0000480;GO:0000447;GO:0000472;GO:0030490;GO:0000462;GO:0042274;GO:0006364;, C:90S preribosome; C:membrane; C:Noc4p-Nop14p complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:enzyme binding; F:RNA binding; F:snoRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit biogenesis; P:rRNA processing;|P78316 D3DVR6 Q7LGI5 Q7Z6K0 Q8TBR6,Nucleolar protein 14,Nucleolar complex protein 14;, PF04147;, GO:0030686;GO:0016020;GO:0030692;GO:0005730;GO:0005654;GO:0032040;GO:0019899;GO:0003723;GO:0030515;GO:0000480;GO:0000447;GO:0000472;GO:0030490;GO:0000462;GO:0042274;GO:0006364;, C:90S preribosome; C:membrane; C:Noc4p-Nop14p complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:enzyme binding; F:RNA binding; F:snoRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit biogenesis; P:rRNA processing;|P78316 D3DVR6 Q7LGI5 Q7Z6K0 Q8TBR6,Nucleolar protein 14,Nucleolar complex protein 14;, PF04147;, GO:0030686;GO:0016020;GO:0030692;GO:0005730;GO:0005654;GO:0032040;GO:0019899;GO:0003723;GO:0030515;GO:0000480;GO:0000447;GO:0000472;GO:0030490;GO:0000462;GO:0042274;GO:0006364;, C:90S preribosome; C:membrane; C:Noc4p-Nop14p complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:enzyme binding; F:RNA binding; F:snoRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit biogenesis; P:rRNA processing;|P78316 D3DVR6 Q7LGI5 Q7Z6K0 Q8TBR6,Nucleolar protein 14,Nucleolar complex protein 14;, PF04147;, GO:0030686;GO:0016020;GO:0030692;GO:0005730;GO:0005654;GO:0032040;GO:0019899;GO:0003723;GO:0030515;GO:0000480;GO:0000447;GO:0000472;GO:0030490;GO:0000462;GO:0042274;GO:0006364;, C:90S preribosome; C:membrane; C:Noc4p-Nop14p complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:enzyme binding; F:RNA binding; F:snoRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit biogenesis; P:rRNA processing;|P78316 D3DVR6 Q7LGI5 Q7Z6K0 Q8TBR6,Nucleolar protein 14,Nucleolar complex protein 14;, PF04147;, GO:0030686;GO:0016020;GO:0030692;GO:0005730;GO:0005654;GO:0032040;GO:0019899;GO:0003723;GO:0030515;GO:0000480;GO:0000447;GO:0000472;GO:0030490;GO:0000462;GO:0042274;GO:0006364;, C:90S preribosome; C:membrane; C:Noc4p-Nop14p complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:enzyme binding; F:RNA binding; F:snoRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit biogenesis; P:rRNA processing;|P78316 D3DVR6 Q7LGI5 Q7Z6K0 Q8TBR6,Nucleolar protein 14,Nucleolar complex protein 14;, PF04147;, GO:0030686;GO:0016020;GO:0030692;GO:0005730;GO:0005654;GO:0032040;GO:0019899;GO:0003723;GO:0030515;GO:0000480;GO:0000447;GO:0000472;GO:0030490;GO:0000462;GO:0042274;GO:0006364;, C:90S preribosome; C:membrane; C:Noc4p-Nop14p complex; C:nucleolus; C:nucleoplasm; C:small-subunit processome;, F:enzyme binding; F:RNA binding; F:snoRNA binding;, P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:ribosomal small subunit biogenesis; P:rRNA processing; scaffold175 indexed_genome mRNA 1013162 1018752 . + . ID=transcript_15246;Q15314 Q15315 Q15316 Q17RH6 Q53EQ8,G protein-coupled receptor kinase 4,G protein-coupled receptor kinase GRK4;ITI1;, PF00069;PF00615;, GO:0005938;GO:0005829;GO:0030425;GO:0043025;GO:0097381;GO:0005524;GO:0004703;GO:0050254;GO:0002031;GO:0031623;GO:0008277;GO:0022400;GO:0007165;, C:cell cortex; C:cytosol; C:dendrite; C:neuronal cell body; C:photoreceptor disc membrane;, F:ATP binding; F:G protein-coupled receptor kinase activity; F:rhodopsin kinase activity;, P:G protein-coupled receptor internalization; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of rhodopsin mediated signaling pathway; P:signal transduction;|Q15314 Q15315 Q15316 Q17RH6 Q53EQ8,G protein-coupled receptor kinase 4,G protein-coupled receptor kinase GRK4;ITI1;, PF00069;PF00615;, GO:0005938;GO:0005829;GO:0030425;GO:0043025;GO:0097381;GO:0005524;GO:0004703;GO:0050254;GO:0002031;GO:0031623;GO:0008277;GO:0022400;GO:0007165;, C:cell cortex; C:cytosol; C:dendrite; C:neuronal cell body; C:photoreceptor disc membrane;, F:ATP binding; F:G protein-coupled receptor kinase activity; F:rhodopsin kinase activity;, P:G protein-coupled receptor internalization; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of rhodopsin mediated signaling pathway; P:signal transduction;|Q15314 Q15315 Q15316 Q17RH6 Q53EQ8,G protein-coupled receptor kinase 4,G protein-coupled receptor kinase GRK4;ITI1;, PF00069;PF00615;, GO:0005938;GO:0005829;GO:0030425;GO:0043025;GO:0097381;GO:0005524;GO:0004703;GO:0050254;GO:0002031;GO:0031623;GO:0008277;GO:0022400;GO:0007165;, C:cell cortex; C:cytosol; C:dendrite; C:neuronal cell body; C:photoreceptor disc membrane;, F:ATP binding; F:G protein-coupled receptor kinase activity; F:rhodopsin kinase activity;, P:G protein-coupled receptor internalization; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of rhodopsin mediated signaling pathway; P:signal transduction; scaffold175 indexed_genome mRNA 1021240 1041774 . + . ID=transcript_15247;Q15314 Q15315 Q15316 Q17RH6 Q53EQ8,G protein-coupled receptor kinase 4,G protein-coupled receptor kinase GRK4;ITI1;, PF00069;PF00615;, GO:0005938;GO:0005829;GO:0030425;GO:0043025;GO:0097381;GO:0005524;GO:0004703;GO:0050254;GO:0002031;GO:0031623;GO:0008277;GO:0022400;GO:0007165;, C:cell cortex; C:cytosol; C:dendrite; C:neuronal cell body; C:photoreceptor disc membrane;, F:ATP binding; F:G protein-coupled receptor kinase activity; F:rhodopsin kinase activity;, P:G protein-coupled receptor internalization; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of rhodopsin mediated signaling pathway; P:signal transduction;|Q15314 Q15315 Q15316 Q17RH6 Q53EQ8,G protein-coupled receptor kinase 4,G protein-coupled receptor kinase GRK4;ITI1;, PF00069;PF00615;, GO:0005938;GO:0005829;GO:0030425;GO:0043025;GO:0097381;GO:0005524;GO:0004703;GO:0050254;GO:0002031;GO:0031623;GO:0008277;GO:0022400;GO:0007165;, C:cell cortex; C:cytosol; C:dendrite; C:neuronal cell body; C:photoreceptor disc membrane;, F:ATP binding; F:G protein-coupled receptor kinase activity; F:rhodopsin kinase activity;, P:G protein-coupled receptor internalization; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of rhodopsin mediated signaling pathway; P:signal transduction;|Q15314 Q15315 Q15316 Q17RH6 Q53EQ8,G protein-coupled receptor kinase 4,G protein-coupled receptor kinase GRK4;ITI1;, PF00069;PF00615;, GO:0005938;GO:0005829;GO:0030425;GO:0043025;GO:0097381;GO:0005524;GO:0004703;GO:0050254;GO:0002031;GO:0031623;GO:0008277;GO:0022400;GO:0007165;, C:cell cortex; C:cytosol; C:dendrite; C:neuronal cell body; C:photoreceptor disc membrane;, F:ATP binding; F:G protein-coupled receptor kinase activity; F:rhodopsin kinase activity;, P:G protein-coupled receptor internalization; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of rhodopsin mediated signaling pathway; P:signal transduction;|Q15314 Q15315 Q15316 Q17RH6 Q53EQ8,G protein-coupled receptor kinase 4,G protein-coupled receptor kinase GRK4;ITI1;, PF00069;PF00615;, GO:0005938;GO:0005829;GO:0030425;GO:0043025;GO:0097381;GO:0005524;GO:0004703;GO:0050254;GO:0002031;GO:0031623;GO:0008277;GO:0022400;GO:0007165;, C:cell cortex; C:cytosol; C:dendrite; C:neuronal cell body; C:photoreceptor disc membrane;, F:ATP binding; F:G protein-coupled receptor kinase activity; F:rhodopsin kinase activity;, P:G protein-coupled receptor internalization; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of rhodopsin mediated signaling pathway; P:signal transduction;|Q8N6M6 Q5T9B1 Q5T9B3 Q5T9B4 Q8WUL6 Q96M23 Q96SS1,Aminopeptidase O {ECO:0000305},, PF09127;PF01433;, GO:0005829;GO:0005730;GO:0070006;GO:0008270;GO:0002003;, C:cytosol; C:nucleolus;, F:metalloaminopeptidase activity; F:zinc ion binding;, P:angiotensin maturation;|Q15314 Q15315 Q15316 Q17RH6 Q53EQ8,G protein-coupled receptor kinase 4,G protein-coupled receptor kinase GRK4;ITI1;, PF00069;PF00615;, GO:0005938;GO:0005829;GO:0030425;GO:0043025;GO:0097381;GO:0005524;GO:0004703;GO:0050254;GO:0002031;GO:0031623;GO:0008277;GO:0022400;GO:0007165;, C:cell cortex; C:cytosol; C:dendrite; C:neuronal cell body; C:photoreceptor disc membrane;, F:ATP binding; F:G protein-coupled receptor kinase activity; F:rhodopsin kinase activity;, P:G protein-coupled receptor internalization; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of rhodopsin mediated signaling pathway; P:signal transduction;|Q15314 Q15315 Q15316 Q17RH6 Q53EQ8,G protein-coupled receptor kinase 4,G protein-coupled receptor kinase GRK4;ITI1;, PF00069;PF00615;, GO:0005938;GO:0005829;GO:0030425;GO:0043025;GO:0097381;GO:0005524;GO:0004703;GO:0050254;GO:0002031;GO:0031623;GO:0008277;GO:0022400;GO:0007165;, C:cell cortex; C:cytosol; C:dendrite; C:neuronal cell body; C:photoreceptor disc membrane;, F:ATP binding; F:G protein-coupled receptor kinase activity; F:rhodopsin kinase activity;, P:G protein-coupled receptor internalization; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway; P:regulation of rhodopsin mediated signaling pathway; P:signal transduction; scaffold175 indexed_genome mRNA 1071227 1172406 . + . ID=transcript_15248;P42858 Q9UQB7,Huntingtin,Huntington disease protein;, PF12372;, GO:0005776;GO:0030424;GO:0005814;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005783;GO:0005794;GO:0016234;GO:0005770;GO:0005654;GO:0005634;GO:0048471;GO:0099524;GO:0099523;GO:0032991;GO:0048487;GO:0034452;GO:0045505;GO:0031072;GO:0042802;GO:0044325;GO:0019900;GO:0002039;GO:0005522;GO:0006915;GO:0000132;GO:0007030;GO:0099111;GO:2001237;GO:1905337;GO:0043065;GO:1903599;GO:0045724;GO:0031587;GO:1904504;GO:0031648;GO:1905289;GO:2000479;GO:0043666;GO:0006890;GO:0047496;GO:0042297;, C:autophagosome; C:axon; C:centriole; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:inclusion body; C:late endosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:presynaptic cytosol; C:protein-containing complex;, F:beta-tubulin binding; F:dynactin binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:p53 binding; F:profilin binding;, P:apoptotic process; P:establishment of mitotic spindle orientation; P:Golgi organization; P:microtubule-based transport; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of aggrephagy; P:positive regulation of apoptotic process; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cilium assembly; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of lipophagy; P:protein destabilization; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of cAMP-dependent protein kinase activity; P:regulation of phosphoprotein phosphatase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle transport along microtubule; P:vocal learning;|P42858 Q9UQB7,Huntingtin,Huntington disease protein;, PF12372;, GO:0005776;GO:0030424;GO:0005814;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005783;GO:0005794;GO:0016234;GO:0005770;GO:0005654;GO:0005634;GO:0048471;GO:0099524;GO:0099523;GO:0032991;GO:0048487;GO:0034452;GO:0045505;GO:0031072;GO:0042802;GO:0044325;GO:0019900;GO:0002039;GO:0005522;GO:0006915;GO:0000132;GO:0007030;GO:0099111;GO:2001237;GO:1905337;GO:0043065;GO:1903599;GO:0045724;GO:0031587;GO:1904504;GO:0031648;GO:1905289;GO:2000479;GO:0043666;GO:0006890;GO:0047496;GO:0042297;, C:autophagosome; C:axon; C:centriole; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:inclusion body; C:late endosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:presynaptic cytosol; C:protein-containing complex;, F:beta-tubulin binding; F:dynactin binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:p53 binding; F:profilin binding;, P:apoptotic process; P:establishment of mitotic spindle orientation; P:Golgi organization; P:microtubule-based transport; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of aggrephagy; P:positive regulation of apoptotic process; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cilium assembly; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of lipophagy; P:protein destabilization; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of cAMP-dependent protein kinase activity; P:regulation of phosphoprotein phosphatase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle transport along microtubule; P:vocal learning;|P42858 Q9UQB7,Huntingtin,Huntington disease protein;, PF12372;, GO:0005776;GO:0030424;GO:0005814;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005783;GO:0005794;GO:0016234;GO:0005770;GO:0005654;GO:0005634;GO:0048471;GO:0099524;GO:0099523;GO:0032991;GO:0048487;GO:0034452;GO:0045505;GO:0031072;GO:0042802;GO:0044325;GO:0019900;GO:0002039;GO:0005522;GO:0006915;GO:0000132;GO:0007030;GO:0099111;GO:2001237;GO:1905337;GO:0043065;GO:1903599;GO:0045724;GO:0031587;GO:1904504;GO:0031648;GO:1905289;GO:2000479;GO:0043666;GO:0006890;GO:0047496;GO:0042297;, C:autophagosome; C:axon; C:centriole; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:inclusion body; C:late endosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:presynaptic cytosol; C:protein-containing complex;, F:beta-tubulin binding; F:dynactin binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:p53 binding; F:profilin binding;, P:apoptotic process; P:establishment of mitotic spindle orientation; P:Golgi organization; P:microtubule-based transport; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of aggrephagy; P:positive regulation of apoptotic process; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cilium assembly; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of lipophagy; P:protein destabilization; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of cAMP-dependent protein kinase activity; P:regulation of phosphoprotein phosphatase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle transport along microtubule; P:vocal learning;|P42858 Q9UQB7,Huntingtin,Huntington disease protein;, PF12372;, GO:0005776;GO:0030424;GO:0005814;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005783;GO:0005794;GO:0016234;GO:0005770;GO:0005654;GO:0005634;GO:0048471;GO:0099524;GO:0099523;GO:0032991;GO:0048487;GO:0034452;GO:0045505;GO:0031072;GO:0042802;GO:0044325;GO:0019900;GO:0002039;GO:0005522;GO:0006915;GO:0000132;GO:0007030;GO:0099111;GO:2001237;GO:1905337;GO:0043065;GO:1903599;GO:0045724;GO:0031587;GO:1904504;GO:0031648;GO:1905289;GO:2000479;GO:0043666;GO:0006890;GO:0047496;GO:0042297;, C:autophagosome; C:axon; C:centriole; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:inclusion body; C:late endosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:presynaptic cytosol; C:protein-containing complex;, F:beta-tubulin binding; F:dynactin binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:p53 binding; F:profilin binding;, P:apoptotic process; P:establishment of mitotic spindle orientation; P:Golgi organization; P:microtubule-based transport; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of aggrephagy; P:positive regulation of apoptotic process; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cilium assembly; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of lipophagy; P:protein destabilization; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of cAMP-dependent protein kinase activity; P:regulation of phosphoprotein phosphatase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle transport along microtubule; P:vocal learning;|P42858 Q9UQB7,Huntingtin,Huntington disease protein;, PF12372;, GO:0005776;GO:0030424;GO:0005814;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005783;GO:0005794;GO:0016234;GO:0005770;GO:0005654;GO:0005634;GO:0048471;GO:0099524;GO:0099523;GO:0032991;GO:0048487;GO:0034452;GO:0045505;GO:0031072;GO:0042802;GO:0044325;GO:0019900;GO:0002039;GO:0005522;GO:0006915;GO:0000132;GO:0007030;GO:0099111;GO:2001237;GO:1905337;GO:0043065;GO:1903599;GO:0045724;GO:0031587;GO:1904504;GO:0031648;GO:1905289;GO:2000479;GO:0043666;GO:0006890;GO:0047496;GO:0042297;, C:autophagosome; C:axon; C:centriole; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:inclusion body; C:late endosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:presynaptic cytosol; C:protein-containing complex;, F:beta-tubulin binding; F:dynactin binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:p53 binding; F:profilin binding;, P:apoptotic process; P:establishment of mitotic spindle orientation; P:Golgi organization; P:microtubule-based transport; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of aggrephagy; P:positive regulation of apoptotic process; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cilium assembly; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of lipophagy; P:protein destabilization; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of cAMP-dependent protein kinase activity; P:regulation of phosphoprotein phosphatase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle transport along microtubule; P:vocal learning;|P42858 Q9UQB7,Huntingtin,Huntington disease protein;, PF12372;, GO:0005776;GO:0030424;GO:0005814;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005783;GO:0005794;GO:0016234;GO:0005770;GO:0005654;GO:0005634;GO:0048471;GO:0099524;GO:0099523;GO:0032991;GO:0048487;GO:0034452;GO:0045505;GO:0031072;GO:0042802;GO:0044325;GO:0019900;GO:0002039;GO:0005522;GO:0006915;GO:0000132;GO:0007030;GO:0099111;GO:2001237;GO:1905337;GO:0043065;GO:1903599;GO:0045724;GO:0031587;GO:1904504;GO:0031648;GO:1905289;GO:2000479;GO:0043666;GO:0006890;GO:0047496;GO:0042297;, C:autophagosome; C:axon; C:centriole; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:inclusion body; C:late endosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:presynaptic cytosol; C:protein-containing complex;, F:beta-tubulin binding; F:dynactin binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:p53 binding; F:profilin binding;, P:apoptotic process; P:establishment of mitotic spindle orientation; P:Golgi organization; P:microtubule-based transport; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of aggrephagy; P:positive regulation of apoptotic process; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cilium assembly; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of lipophagy; P:protein destabilization; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of cAMP-dependent protein kinase activity; P:regulation of phosphoprotein phosphatase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle transport along microtubule; P:vocal learning;|P42858 Q9UQB7,Huntingtin,Huntington disease protein;, PF12372;, GO:0005776;GO:0030424;GO:0005814;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005783;GO:0005794;GO:0016234;GO:0005770;GO:0005654;GO:0005634;GO:0048471;GO:0099524;GO:0099523;GO:0032991;GO:0048487;GO:0034452;GO:0045505;GO:0031072;GO:0042802;GO:0044325;GO:0019900;GO:0002039;GO:0005522;GO:0006915;GO:0000132;GO:0007030;GO:0099111;GO:2001237;GO:1905337;GO:0043065;GO:1903599;GO:0045724;GO:0031587;GO:1904504;GO:0031648;GO:1905289;GO:2000479;GO:0043666;GO:0006890;GO:0047496;GO:0042297;, C:autophagosome; C:axon; C:centriole; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:inclusion body; C:late endosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:presynaptic cytosol; C:protein-containing complex;, F:beta-tubulin binding; F:dynactin binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:p53 binding; F:profilin binding;, P:apoptotic process; P:establishment of mitotic spindle orientation; P:Golgi organization; P:microtubule-based transport; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of aggrephagy; P:positive regulation of apoptotic process; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cilium assembly; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of lipophagy; P:protein destabilization; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of cAMP-dependent protein kinase activity; P:regulation of phosphoprotein phosphatase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle transport along microtubule; P:vocal learning;|P42858 Q9UQB7,Huntingtin,Huntington disease protein;, PF12372;, GO:0005776;GO:0030424;GO:0005814;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005783;GO:0005794;GO:0016234;GO:0005770;GO:0005654;GO:0005634;GO:0048471;GO:0099524;GO:0099523;GO:0032991;GO:0048487;GO:0034452;GO:0045505;GO:0031072;GO:0042802;GO:0044325;GO:0019900;GO:0002039;GO:0005522;GO:0006915;GO:0000132;GO:0007030;GO:0099111;GO:2001237;GO:1905337;GO:0043065;GO:1903599;GO:0045724;GO:0031587;GO:1904504;GO:0031648;GO:1905289;GO:2000479;GO:0043666;GO:0006890;GO:0047496;GO:0042297;, C:autophagosome; C:axon; C:centriole; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:inclusion body; C:late endosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:presynaptic cytosol; C:protein-containing complex;, F:beta-tubulin binding; F:dynactin binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:p53 binding; F:profilin binding;, P:apoptotic process; P:establishment of mitotic spindle orientation; P:Golgi organization; P:microtubule-based transport; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of aggrephagy; P:positive regulation of apoptotic process; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cilium assembly; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of lipophagy; P:protein destabilization; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of cAMP-dependent protein kinase activity; P:regulation of phosphoprotein phosphatase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle transport along microtubule; P:vocal learning; scaffold175 indexed_genome mRNA 1172419 1193092 . + . ID=transcript_15249;P42858 Q9UQB7,Huntingtin,Huntington disease protein;, PF12372;, GO:0005776;GO:0030424;GO:0005814;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0005769;GO:0005783;GO:0005794;GO:0016234;GO:0005770;GO:0005654;GO:0005634;GO:0048471;GO:0099524;GO:0099523;GO:0032991;GO:0048487;GO:0034452;GO:0045505;GO:0031072;GO:0042802;GO:0044325;GO:0019900;GO:0002039;GO:0005522;GO:0006915;GO:0000132;GO:0007030;GO:0099111;GO:2001237;GO:1905337;GO:0043065;GO:1903599;GO:0045724;GO:0031587;GO:1904504;GO:0031648;GO:1905289;GO:2000479;GO:0043666;GO:0006890;GO:0047496;GO:0042297;, C:autophagosome; C:axon; C:centriole; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:early endosome; C:endoplasmic reticulum; C:Golgi apparatus; C:inclusion body; C:late endosome; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:postsynaptic cytosol; C:presynaptic cytosol; C:protein-containing complex;, F:beta-tubulin binding; F:dynactin binding; F:dynein intermediate chain binding; F:heat shock protein binding; F:identical protein binding; F:ion channel binding; F:kinase binding; F:p53 binding; F:profilin binding;, P:apoptotic process; P:establishment of mitotic spindle orientation; P:Golgi organization; P:microtubule-based transport; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of aggrephagy; P:positive regulation of apoptotic process; P:positive regulation of autophagy of mitochondrion; P:positive regulation of cilium assembly; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of lipophagy; P:protein destabilization; P:regulation of CAMKK-AMPK signaling cascade; P:regulation of cAMP-dependent protein kinase activity; P:regulation of phosphoprotein phosphatase activity; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:vesicle transport along microtubule; P:vocal learning;|Q6ZTZ1 C9J6V0,Myb/SANT-like DNA-binding domain-containing protein 1,, , GO:0016604;GO:0045893;, C:nuclear body;, , P:positive regulation of transcription, DNA-templated; scaffold176 indexed_genome mRNA 335 8349 . - . ID=transcript_15250;Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; scaffold176 indexed_genome mRNA 10466 11806 . - . ID=transcript_15251;Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; scaffold176 indexed_genome mRNA 15010 18407 . - . ID=transcript_15252;Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; scaffold176 indexed_genome mRNA 24461 47916 . - . ID=transcript_15253;Q9H4M9 O14611 Q2M3Q4 Q9UNR3,EH domain-containing protein 1 {ECO:0000305},PAST homolog 1 {ECO:0000303|PubMed:9253601};Testilin {ECO:0000312|EMBL:AAD45866.1};, PF18150;PF00350;PF12763;PF16880;, GO:0020018;GO:0005769;GO:0031901;GO:0030139;GO:0010008;GO:0070062;GO:0043231;GO:0005811;GO:0016020;GO:0048471;GO:0005886;GO:0031095;GO:0055038;GO:0005524;GO:0045296;GO:0005509;GO:0005525;GO:0042802;GO:0031267;GO:0007596;GO:1990090;GO:0042632;GO:0060271;GO:0032456;GO:0006897;GO:0016197;GO:0006886;GO:0034383;GO:0031175;GO:0010886;GO:2001137;GO:1901741;GO:0051260;GO:0061512;GO:0072659;, C:ciliary pocket membrane; C:early endosome; C:early endosome membrane; C:endocytic vesicle; C:endosome membrane; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:platelet dense tubular network membrane; C:recycling endosome membrane;, F:ATP binding; F:cadherin binding; F:calcium ion binding; F:GTP binding; F:identical protein binding; F:small GTPase binding;, P:blood coagulation; P:cellular response to nerve growth factor stimulus; P:cholesterol homeostasis; P:cilium assembly; P:endocytic recycling; P:endocytosis; P:endosomal transport; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:neuron projection development; P:positive regulation of cholesterol storage; P:positive regulation of endocytic recycling; P:positive regulation of myoblast fusion; P:protein homooligomerization; P:protein localization to cilium; P:protein localization to plasma membrane; scaffold176 indexed_genome mRNA 72318 92601 . + . ID=transcript_15254;Q2TAZ0 O43154 Q14DM2 Q6ZTV2 Q7Z6K8 Q8IVY5 Q8TAI8 Q96HH7,Autophagy-related protein 2 homolog A,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0000407;GO:0034045;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy;|Q2TAZ0 O43154 Q14DM2 Q6ZTV2 Q7Z6K8 Q8IVY5 Q8TAI8 Q96HH7,Autophagy-related protein 2 homolog A,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0000407;GO:0034045;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy;|Q2TAZ0 O43154 Q14DM2 Q6ZTV2 Q7Z6K8 Q8IVY5 Q8TAI8 Q96HH7,Autophagy-related protein 2 homolog A,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0000407;GO:0034045;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy;|Q2TAZ0 O43154 Q14DM2 Q6ZTV2 Q7Z6K8 Q8IVY5 Q8TAI8 Q96HH7,Autophagy-related protein 2 homolog A,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0000407;GO:0034045;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy;|Q2TAZ0 O43154 Q14DM2 Q6ZTV2 Q7Z6K8 Q8IVY5 Q8TAI8 Q96HH7,Autophagy-related protein 2 homolog A,, PF09333;PF12624;, GO:0005789;GO:0019898;GO:0005811;GO:0000407;GO:0034045;GO:0032266;GO:0000045;GO:0000422;GO:0044805;GO:0034727;GO:0061709;, C:endoplasmic reticulum membrane; C:extrinsic component of membrane; C:lipid droplet; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol-3-phosphate binding;, P:autophagosome assembly; P:autophagy of mitochondrion; P:late nucleophagy; P:piecemeal microautophagy of the nucleus; P:reticulophagy; scaffold176 indexed_genome mRNA 102462 111678 . + . ID=transcript_15255;Q15173 Q13853,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform,PP2A B subunit isoform B'-beta;PP2A B subunit isoform B56-beta;PP2A B subunit isoform PR61-beta;PP2A B subunit isoform R5-beta;, PF01603;, GO:0005737;GO:0005829;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0071363;GO:0036498;GO:0070317;GO:0051898;GO:0071158;GO:0051091;GO:0010976;GO:0051388;GO:0031334;GO:0045944;GO:0006470;GO:0050730;GO:0014066;GO:0031952;GO:0010469;, C:cytoplasm; C:cytosol; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:cellular response to growth factor stimulus; P:IRE1-mediated unfolded protein response; P:negative regulation of G0 to G1 transition; P:negative regulation of protein kinase B signaling; P:positive regulation of cell cycle arrest; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signaling receptor activity;|Q15173 Q13853,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform,PP2A B subunit isoform B'-beta;PP2A B subunit isoform B56-beta;PP2A B subunit isoform PR61-beta;PP2A B subunit isoform R5-beta;, PF01603;, GO:0005737;GO:0005829;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0071363;GO:0036498;GO:0070317;GO:0051898;GO:0071158;GO:0051091;GO:0010976;GO:0051388;GO:0031334;GO:0045944;GO:0006470;GO:0050730;GO:0014066;GO:0031952;GO:0010469;, C:cytoplasm; C:cytosol; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:cellular response to growth factor stimulus; P:IRE1-mediated unfolded protein response; P:negative regulation of G0 to G1 transition; P:negative regulation of protein kinase B signaling; P:positive regulation of cell cycle arrest; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signaling receptor activity;|Q15173 Q13853,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform,PP2A B subunit isoform B'-beta;PP2A B subunit isoform B56-beta;PP2A B subunit isoform PR61-beta;PP2A B subunit isoform R5-beta;, PF01603;, GO:0005737;GO:0005829;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0071363;GO:0036498;GO:0070317;GO:0051898;GO:0071158;GO:0051091;GO:0010976;GO:0051388;GO:0031334;GO:0045944;GO:0006470;GO:0050730;GO:0014066;GO:0031952;GO:0010469;, C:cytoplasm; C:cytosol; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:cellular response to growth factor stimulus; P:IRE1-mediated unfolded protein response; P:negative regulation of G0 to G1 transition; P:negative regulation of protein kinase B signaling; P:positive regulation of cell cycle arrest; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signaling receptor activity;|Q15173 Q13853,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform,PP2A B subunit isoform B'-beta;PP2A B subunit isoform B56-beta;PP2A B subunit isoform PR61-beta;PP2A B subunit isoform R5-beta;, PF01603;, GO:0005737;GO:0005829;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0071363;GO:0036498;GO:0070317;GO:0051898;GO:0071158;GO:0051091;GO:0010976;GO:0051388;GO:0031334;GO:0045944;GO:0006470;GO:0050730;GO:0014066;GO:0031952;GO:0010469;, C:cytoplasm; C:cytosol; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:cellular response to growth factor stimulus; P:IRE1-mediated unfolded protein response; P:negative regulation of G0 to G1 transition; P:negative regulation of protein kinase B signaling; P:positive regulation of cell cycle arrest; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signaling receptor activity;|Q15173 Q13853,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform,PP2A B subunit isoform B'-beta;PP2A B subunit isoform B56-beta;PP2A B subunit isoform PR61-beta;PP2A B subunit isoform R5-beta;, PF01603;, GO:0005737;GO:0005829;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0071363;GO:0036498;GO:0070317;GO:0051898;GO:0071158;GO:0051091;GO:0010976;GO:0051388;GO:0031334;GO:0045944;GO:0006470;GO:0050730;GO:0014066;GO:0031952;GO:0010469;, C:cytoplasm; C:cytosol; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:cellular response to growth factor stimulus; P:IRE1-mediated unfolded protein response; P:negative regulation of G0 to G1 transition; P:negative regulation of protein kinase B signaling; P:positive regulation of cell cycle arrest; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signaling receptor activity;|Q15173 Q13853,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform,PP2A B subunit isoform B'-beta;PP2A B subunit isoform B56-beta;PP2A B subunit isoform PR61-beta;PP2A B subunit isoform R5-beta;, PF01603;, GO:0005737;GO:0005829;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0071363;GO:0036498;GO:0070317;GO:0051898;GO:0071158;GO:0051091;GO:0010976;GO:0051388;GO:0031334;GO:0045944;GO:0006470;GO:0050730;GO:0014066;GO:0031952;GO:0010469;, C:cytoplasm; C:cytosol; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:cellular response to growth factor stimulus; P:IRE1-mediated unfolded protein response; P:negative regulation of G0 to G1 transition; P:negative regulation of protein kinase B signaling; P:positive regulation of cell cycle arrest; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signaling receptor activity;|Q15173 Q13853,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform,PP2A B subunit isoform B'-beta;PP2A B subunit isoform B56-beta;PP2A B subunit isoform PR61-beta;PP2A B subunit isoform R5-beta;, PF01603;, GO:0005737;GO:0005829;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0071363;GO:0036498;GO:0070317;GO:0051898;GO:0071158;GO:0051091;GO:0010976;GO:0051388;GO:0031334;GO:0045944;GO:0006470;GO:0050730;GO:0014066;GO:0031952;GO:0010469;, C:cytoplasm; C:cytosol; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:cellular response to growth factor stimulus; P:IRE1-mediated unfolded protein response; P:negative regulation of G0 to G1 transition; P:negative regulation of protein kinase B signaling; P:positive regulation of cell cycle arrest; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signaling receptor activity;|Q15173 Q13853,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform,PP2A B subunit isoform B'-beta;PP2A B subunit isoform B56-beta;PP2A B subunit isoform PR61-beta;PP2A B subunit isoform R5-beta;, PF01603;, GO:0005737;GO:0005829;GO:0005634;GO:0000159;GO:0072542;GO:0019888;GO:0071363;GO:0036498;GO:0070317;GO:0051898;GO:0071158;GO:0051091;GO:0010976;GO:0051388;GO:0031334;GO:0045944;GO:0006470;GO:0050730;GO:0014066;GO:0031952;GO:0010469;, C:cytoplasm; C:cytosol; C:nucleus; C:protein phosphatase type 2A complex;, F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:cellular response to growth factor stimulus; P:IRE1-mediated unfolded protein response; P:negative regulation of G0 to G1 transition; P:negative regulation of protein kinase B signaling; P:positive regulation of cell cycle arrest; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of neuron projection development; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of transcription by RNA polymerase II; P:protein dephosphorylation; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein autophosphorylation; P:regulation of signaling receptor activity; scaffold176 indexed_genome mRNA 193113 195869 . + . ID=transcript_15256;P36404 G3V184 Q9BUK8,ADP-ribosylation factor-like protein 2,, PF00025;, GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0016328;GO:0015630;GO:0005758;GO:0005759;GO:0005730;GO:0005654;GO:0005634;GO:0019003;GO:0005525;GO:0003924;GO:0005095;GO:0070830;GO:0007098;GO:0051457;GO:0000165;GO:0034260;GO:0010811;GO:0031116;GO:0031113;GO:0007021;, C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:lateral plasma membrane; C:microtubule cytoskeleton; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:nucleolus; C:nucleoplasm; C:nucleus;, F:GDP binding; F:GTP binding; F:GTPase activity; F:GTPase inhibitor activity;, P:bicellular tight junction assembly; P:centrosome cycle; P:maintenance of protein location in nucleus; P:MAPK cascade; P:negative regulation of GTPase activity; P:positive regulation of cell-substrate adhesion; P:positive regulation of microtubule polymerization; P:regulation of microtubule polymerization; P:tubulin complex assembly; scaffold176 indexed_genome mRNA 200242 212282 . + . ID=transcript_15257;Q9NRS6 E5KQS6 Q9NRS5,Sorting nexin-15,, PF04212;PF00787;, GO:0030659;GO:0005829;GO:0005769;GO:0043231;GO:0016020;GO:0005730;GO:0005886;GO:0035091;GO:0006886;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:plasma membrane;, F:phosphatidylinositol binding;, P:intracellular protein transport;|Q9NRS6 E5KQS6 Q9NRS5,Sorting nexin-15,, PF04212;PF00787;, GO:0030659;GO:0005829;GO:0005769;GO:0043231;GO:0016020;GO:0005730;GO:0005886;GO:0035091;GO:0006886;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:plasma membrane;, F:phosphatidylinositol binding;, P:intracellular protein transport;|Q9NRS6 E5KQS6 Q9NRS5,Sorting nexin-15,, PF04212;PF00787;, GO:0030659;GO:0005829;GO:0005769;GO:0043231;GO:0016020;GO:0005730;GO:0005886;GO:0035091;GO:0006886;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:plasma membrane;, F:phosphatidylinositol binding;, P:intracellular protein transport;|Q9NRS6 E5KQS6 Q9NRS5,Sorting nexin-15,, PF04212;PF00787;, GO:0030659;GO:0005829;GO:0005769;GO:0043231;GO:0016020;GO:0005730;GO:0005886;GO:0035091;GO:0006886;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:plasma membrane;, F:phosphatidylinositol binding;, P:intracellular protein transport; scaffold176 indexed_genome mRNA 212598 215664 . + . ID=transcript_15258;A6NKF1 A8MX08 Q99773,SAC3 domain-containing protein 1,SAC3 homology domain-containing protein 1;, PF03399;, GO:0005813;GO:0005737;GO:0005634;GO:0005819;GO:0051301;GO:0051298;GO:0051225;, C:centrosome; C:cytoplasm; C:nucleus; C:spindle;, , P:cell division; P:centrosome duplication; P:spindle assembly; scaffold176 indexed_genome mRNA 254673 258728 . + . ID=transcript_15259;O95159 A8K7E9 O14616 Q9UID0,Zinc finger protein-like 1,Zinc finger protein MCG4;, , GO:0005794;GO:0016021;GO:0005634;GO:0003677;GO:0008270;GO:0006355;GO:0016192;, C:Golgi apparatus; C:integral component of membrane; C:nucleus;, F:DNA binding; F:zinc ion binding;, P:regulation of transcription, DNA-templated; P:vesicle-mediated transport; scaffold176 indexed_genome mRNA 262692 275307 . + . ID=transcript_15260;Q9UID3 Q6PJV5 Q7L8A6 Q8WZ35 Q96DF4 Q96GR3,Vacuolar protein sorting-associated protein 51 homolog,Another new gene 2 protein;Protein fat-free homolog;, , GO:0005829;GO:1990745;GO:0000938;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0005730;GO:0055037;GO:0032588;GO:0006914;GO:0048854;GO:0032456;GO:0007030;GO:0048193;GO:0006869;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:GARP complex; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:recycling endosome; C:trans-Golgi network membrane;, , P:autophagy; P:brain morphogenesis; P:endocytic recycling; P:Golgi organization; P:Golgi vesicle transport; P:lipid transport; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q9UID3 Q6PJV5 Q7L8A6 Q8WZ35 Q96DF4 Q96GR3,Vacuolar protein sorting-associated protein 51 homolog,Another new gene 2 protein;Protein fat-free homolog;, , GO:0005829;GO:1990745;GO:0000938;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0005730;GO:0055037;GO:0032588;GO:0006914;GO:0048854;GO:0032456;GO:0007030;GO:0048193;GO:0006869;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:GARP complex; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:recycling endosome; C:trans-Golgi network membrane;, , P:autophagy; P:brain morphogenesis; P:endocytic recycling; P:Golgi organization; P:Golgi vesicle transport; P:lipid transport; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q9UID3 Q6PJV5 Q7L8A6 Q8WZ35 Q96DF4 Q96GR3,Vacuolar protein sorting-associated protein 51 homolog,Another new gene 2 protein;Protein fat-free homolog;, , GO:0005829;GO:1990745;GO:0000938;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0005730;GO:0055037;GO:0032588;GO:0006914;GO:0048854;GO:0032456;GO:0007030;GO:0048193;GO:0006869;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:GARP complex; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:recycling endosome; C:trans-Golgi network membrane;, , P:autophagy; P:brain morphogenesis; P:endocytic recycling; P:Golgi organization; P:Golgi vesicle transport; P:lipid transport; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi;|Q9UID3 Q6PJV5 Q7L8A6 Q8WZ35 Q96DF4 Q96GR3,Vacuolar protein sorting-associated protein 51 homolog,Another new gene 2 protein;Protein fat-free homolog;, , GO:0005829;GO:1990745;GO:0000938;GO:0005794;GO:0016021;GO:0043231;GO:0016020;GO:0005730;GO:0055037;GO:0032588;GO:0006914;GO:0048854;GO:0032456;GO:0007030;GO:0048193;GO:0006869;GO:0007041;GO:0015031;GO:0042147;, C:cytosol; C:EARP complex; C:GARP complex; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:nucleolus; C:recycling endosome; C:trans-Golgi network membrane;, , P:autophagy; P:brain morphogenesis; P:endocytic recycling; P:Golgi organization; P:Golgi vesicle transport; P:lipid transport; P:lysosomal transport; P:protein transport; P:retrograde transport, endosome to Golgi; scaffold176 indexed_genome mRNA 275429 278669 . + . ID=transcript_15261;O76062 A8K4H0 O95982 Q8IY06 Q96E64 Q96GZ1,Delta(14)-sterol reductase TM7SF2,3-beta-hydroxysterol Delta (14)-reductase {ECO:0000303|PubMed:16784888};Another new gene 1 protein;C-14 sterol reductase;Putative sterol reductase SR-1;Sterol C14-reductase;Transmembrane 7 superfamily member 2;, PF01222;, GO:0005783;GO:0005789;GO:0030176;GO:0005887;GO:0043231;GO:0005637;GO:0043235;GO:0050613;GO:0050661;GO:0016627;GO:0006695;GO:0019216;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nuclear inner membrane; C:receptor complex;, F:delta14-sterol reductase activity; F:NADP binding; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:sterol biosynthetic process;|O76062 A8K4H0 O95982 Q8IY06 Q96E64 Q96GZ1,Delta(14)-sterol reductase TM7SF2,3-beta-hydroxysterol Delta (14)-reductase {ECO:0000303|PubMed:16784888};Another new gene 1 protein;C-14 sterol reductase;Putative sterol reductase SR-1;Sterol C14-reductase;Transmembrane 7 superfamily member 2;, PF01222;, GO:0005783;GO:0005789;GO:0030176;GO:0005887;GO:0043231;GO:0005637;GO:0043235;GO:0050613;GO:0050661;GO:0016627;GO:0006695;GO:0019216;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nuclear inner membrane; C:receptor complex;, F:delta14-sterol reductase activity; F:NADP binding; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:sterol biosynthetic process;|O76062 A8K4H0 O95982 Q8IY06 Q96E64 Q96GZ1,Delta(14)-sterol reductase TM7SF2,3-beta-hydroxysterol Delta (14)-reductase {ECO:0000303|PubMed:16784888};Another new gene 1 protein;C-14 sterol reductase;Putative sterol reductase SR-1;Sterol C14-reductase;Transmembrane 7 superfamily member 2;, PF01222;, GO:0005783;GO:0005789;GO:0030176;GO:0005887;GO:0043231;GO:0005637;GO:0043235;GO:0050613;GO:0050661;GO:0016627;GO:0006695;GO:0019216;GO:0016126;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:nuclear inner membrane; C:receptor complex;, F:delta14-sterol reductase activity; F:NADP binding; F:oxidoreductase activity, acting on the CH-CH group of donors;, P:cholesterol biosynthetic process; P:regulation of lipid metabolic process; P:sterol biosynthetic process; scaffold176 indexed_genome mRNA 280229 281502 . - . ID=transcript_15262;Q9UHR6 Q3SY14 Q8IUV0,Zinc finger HIT domain-containing protein 2,Protein FON;, PF04438;, GO:0046872;, , F:metal ion binding; scaffold176 indexed_genome mRNA 283907 285510 . - . ID=transcript_15263;P35544 Q9H5V4,Ubiquitin-like protein FUBI,, PF00240;, GO:0003723;, , F:RNA binding;|P35544 Q9H5V4,Ubiquitin-like protein FUBI,, PF00240;, GO:0003723;, , F:RNA binding; scaffold176 indexed_genome mRNA 285601 297549 . - . ID=transcript_15264;Q86TM6 Q8N3K3 Q8N6E8 Q96JL5 Q96PK3,E3 ubiquitin-protein ligase synoviolin,RING-type E3 ubiquitin transferase synoviolin {ECO:0000303|PubMed:12975321};Synovial apoptosis inhibitor 1;, PF13639;, GO:0005737;GO:0036513;GO:0005783;GO:0005789;GO:0044322;GO:0000836;GO:0000839;GO:0030176;GO:0016020;GO:0005654;GO:0005790;GO:0051117;GO:0051087;GO:0046872;GO:0061630;GO:1990381;GO:0051082;GO:1904380;GO:0036503;GO:0002327;GO:0036498;GO:1902236;GO:0070936;GO:0050821;GO:0016567;GO:0030970;GO:0030433;GO:0006511;, C:cytoplasm; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nucleoplasm; C:smooth endoplasmic reticulum;, F:ATPase binding; F:chaperone binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-specific protease binding; F:unfolded protein binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:immature B cell differentiation; P:IRE1-mediated unfolded protein response; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:protein K48-linked ubiquitination; P:protein stabilization; P:protein ubiquitination; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q86TM6 Q8N3K3 Q8N6E8 Q96JL5 Q96PK3,E3 ubiquitin-protein ligase synoviolin,RING-type E3 ubiquitin transferase synoviolin {ECO:0000303|PubMed:12975321};Synovial apoptosis inhibitor 1;, PF13639;, GO:0005737;GO:0036513;GO:0005783;GO:0005789;GO:0044322;GO:0000836;GO:0000839;GO:0030176;GO:0016020;GO:0005654;GO:0005790;GO:0051117;GO:0051087;GO:0046872;GO:0061630;GO:1990381;GO:0051082;GO:1904380;GO:0036503;GO:0002327;GO:0036498;GO:1902236;GO:0070936;GO:0050821;GO:0016567;GO:0030970;GO:0030433;GO:0006511;, C:cytoplasm; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nucleoplasm; C:smooth endoplasmic reticulum;, F:ATPase binding; F:chaperone binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-specific protease binding; F:unfolded protein binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:immature B cell differentiation; P:IRE1-mediated unfolded protein response; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:protein K48-linked ubiquitination; P:protein stabilization; P:protein ubiquitination; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|Q86TM6 Q8N3K3 Q8N6E8 Q96JL5 Q96PK3,E3 ubiquitin-protein ligase synoviolin,RING-type E3 ubiquitin transferase synoviolin {ECO:0000303|PubMed:12975321};Synovial apoptosis inhibitor 1;, PF13639;, GO:0005737;GO:0036513;GO:0005783;GO:0005789;GO:0044322;GO:0000836;GO:0000839;GO:0030176;GO:0016020;GO:0005654;GO:0005790;GO:0051117;GO:0051087;GO:0046872;GO:0061630;GO:1990381;GO:0051082;GO:1904380;GO:0036503;GO:0002327;GO:0036498;GO:1902236;GO:0070936;GO:0050821;GO:0016567;GO:0030970;GO:0030433;GO:0006511;, C:cytoplasm; C:Derlin-1 retrotranslocation complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:membrane; C:nucleoplasm; C:smooth endoplasmic reticulum;, F:ATPase binding; F:chaperone binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-specific protease binding; F:unfolded protein binding;, P:endoplasmic reticulum mannose trimming; P:ERAD pathway; P:immature B cell differentiation; P:IRE1-mediated unfolded protein response; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:protein K48-linked ubiquitination; P:protein stabilization; P:protein ubiquitination; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold176 indexed_genome mRNA 339165 341975 . + . ID=transcript_15265;Q5MJ68 B2RP32 B7ZMH7,Speedy protein C,Rapid inducer of G2/M progression in oocytes C;, PF11357;, GO:0005737;GO:0005634;GO:0019901;GO:0007049;, C:cytoplasm; C:nucleus;, F:protein kinase binding;, P:cell cycle; scaffold176 indexed_genome mRNA 354608 382167 . - . ID=transcript_15266;P07384 Q2TTR0 Q6DHV4,Calpain-1 catalytic subunit {ECO:0000305},Calcium-activated neutral proteinase 1 {ECO:0000303|PubMed:3017764};Calpain mu-type {ECO:0000303|PubMed:2400579};Calpain-1 large subunit {ECO:0000303|PubMed:3017764};Cell proliferation-inducing gene 30 protein {ECO:0000303|Ref.3};Micromolar-calpain {ECO:0000303|PubMed:3017764};, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005764;GO:0016020;GO:0005739;GO:0005886;GO:0005509;GO:0004198;GO:0008233;GO:0070268;GO:0022617;GO:0060056;GO:0043312;GO:0008284;GO:0006508;GO:0032801;GO:0050790;GO:0016241;GO:2000310;GO:0097264;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lysosome; C:membrane; C:mitochondrion; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:peptidase activity;, P:cornification; P:extracellular matrix disassembly; P:mammary gland involution; P:neutrophil degranulation; P:positive regulation of cell population proliferation; P:proteolysis; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of NMDA receptor activity; P:self proteolysis;|P07384 Q2TTR0 Q6DHV4,Calpain-1 catalytic subunit {ECO:0000305},Calcium-activated neutral proteinase 1 {ECO:0000303|PubMed:3017764};Calpain mu-type {ECO:0000303|PubMed:2400579};Calpain-1 large subunit {ECO:0000303|PubMed:3017764};Cell proliferation-inducing gene 30 protein {ECO:0000303|Ref.3};Micromolar-calpain {ECO:0000303|PubMed:3017764};, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005764;GO:0016020;GO:0005739;GO:0005886;GO:0005509;GO:0004198;GO:0008233;GO:0070268;GO:0022617;GO:0060056;GO:0043312;GO:0008284;GO:0006508;GO:0032801;GO:0050790;GO:0016241;GO:2000310;GO:0097264;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lysosome; C:membrane; C:mitochondrion; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:peptidase activity;, P:cornification; P:extracellular matrix disassembly; P:mammary gland involution; P:neutrophil degranulation; P:positive regulation of cell population proliferation; P:proteolysis; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of NMDA receptor activity; P:self proteolysis;|P07384 Q2TTR0 Q6DHV4,Calpain-1 catalytic subunit {ECO:0000305},Calcium-activated neutral proteinase 1 {ECO:0000303|PubMed:3017764};Calpain mu-type {ECO:0000303|PubMed:2400579};Calpain-1 large subunit {ECO:0000303|PubMed:3017764};Cell proliferation-inducing gene 30 protein {ECO:0000303|Ref.3};Micromolar-calpain {ECO:0000303|PubMed:3017764};, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005764;GO:0016020;GO:0005739;GO:0005886;GO:0005509;GO:0004198;GO:0008233;GO:0070268;GO:0022617;GO:0060056;GO:0043312;GO:0008284;GO:0006508;GO:0032801;GO:0050790;GO:0016241;GO:2000310;GO:0097264;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lysosome; C:membrane; C:mitochondrion; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:peptidase activity;, P:cornification; P:extracellular matrix disassembly; P:mammary gland involution; P:neutrophil degranulation; P:positive regulation of cell population proliferation; P:proteolysis; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of NMDA receptor activity; P:self proteolysis;|P07384 Q2TTR0 Q6DHV4,Calpain-1 catalytic subunit {ECO:0000305},Calcium-activated neutral proteinase 1 {ECO:0000303|PubMed:3017764};Calpain mu-type {ECO:0000303|PubMed:2400579};Calpain-1 large subunit {ECO:0000303|PubMed:3017764};Cell proliferation-inducing gene 30 protein {ECO:0000303|Ref.3};Micromolar-calpain {ECO:0000303|PubMed:3017764};, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005764;GO:0016020;GO:0005739;GO:0005886;GO:0005509;GO:0004198;GO:0008233;GO:0070268;GO:0022617;GO:0060056;GO:0043312;GO:0008284;GO:0006508;GO:0032801;GO:0050790;GO:0016241;GO:2000310;GO:0097264;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lysosome; C:membrane; C:mitochondrion; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:peptidase activity;, P:cornification; P:extracellular matrix disassembly; P:mammary gland involution; P:neutrophil degranulation; P:positive regulation of cell population proliferation; P:proteolysis; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of NMDA receptor activity; P:self proteolysis;|P07384 Q2TTR0 Q6DHV4,Calpain-1 catalytic subunit {ECO:0000305},Calcium-activated neutral proteinase 1 {ECO:0000303|PubMed:3017764};Calpain mu-type {ECO:0000303|PubMed:2400579};Calpain-1 large subunit {ECO:0000303|PubMed:3017764};Cell proliferation-inducing gene 30 protein {ECO:0000303|Ref.3};Micromolar-calpain {ECO:0000303|PubMed:3017764};, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005764;GO:0016020;GO:0005739;GO:0005886;GO:0005509;GO:0004198;GO:0008233;GO:0070268;GO:0022617;GO:0060056;GO:0043312;GO:0008284;GO:0006508;GO:0032801;GO:0050790;GO:0016241;GO:2000310;GO:0097264;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lysosome; C:membrane; C:mitochondrion; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:peptidase activity;, P:cornification; P:extracellular matrix disassembly; P:mammary gland involution; P:neutrophil degranulation; P:positive regulation of cell population proliferation; P:proteolysis; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of NMDA receptor activity; P:self proteolysis;|P07384 Q2TTR0 Q6DHV4,Calpain-1 catalytic subunit {ECO:0000305},Calcium-activated neutral proteinase 1 {ECO:0000303|PubMed:3017764};Calpain mu-type {ECO:0000303|PubMed:2400579};Calpain-1 large subunit {ECO:0000303|PubMed:3017764};Cell proliferation-inducing gene 30 protein {ECO:0000303|Ref.3};Micromolar-calpain {ECO:0000303|PubMed:3017764};, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005764;GO:0016020;GO:0005739;GO:0005886;GO:0005509;GO:0004198;GO:0008233;GO:0070268;GO:0022617;GO:0060056;GO:0043312;GO:0008284;GO:0006508;GO:0032801;GO:0050790;GO:0016241;GO:2000310;GO:0097264;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lysosome; C:membrane; C:mitochondrion; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:peptidase activity;, P:cornification; P:extracellular matrix disassembly; P:mammary gland involution; P:neutrophil degranulation; P:positive regulation of cell population proliferation; P:proteolysis; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of NMDA receptor activity; P:self proteolysis;|P07384 Q2TTR0 Q6DHV4,Calpain-1 catalytic subunit {ECO:0000305},Calcium-activated neutral proteinase 1 {ECO:0000303|PubMed:3017764};Calpain mu-type {ECO:0000303|PubMed:2400579};Calpain-1 large subunit {ECO:0000303|PubMed:3017764};Cell proliferation-inducing gene 30 protein {ECO:0000303|Ref.3};Micromolar-calpain {ECO:0000303|PubMed:3017764};, PF01067;PF13833;PF00648;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005925;GO:0005764;GO:0016020;GO:0005739;GO:0005886;GO:0005509;GO:0004198;GO:0008233;GO:0070268;GO:0022617;GO:0060056;GO:0043312;GO:0008284;GO:0006508;GO:0032801;GO:0050790;GO:0016241;GO:2000310;GO:0097264;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:focal adhesion; C:lysosome; C:membrane; C:mitochondrion; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity; F:peptidase activity;, P:cornification; P:extracellular matrix disassembly; P:mammary gland involution; P:neutrophil degranulation; P:positive regulation of cell population proliferation; P:proteolysis; P:receptor catabolic process; P:regulation of catalytic activity; P:regulation of macroautophagy; P:regulation of NMDA receptor activity; P:self proteolysis; scaffold176 indexed_genome mRNA 430971 457569 . + . ID=transcript_15267;Q14181 B4DNB4 Q9BPV3,DNA polymerase alpha subunit B,DNA polymerase alpha 70 kDa subunit;, PF04042;PF08418;, GO:0005658;GO:0005829;GO:0005654;GO:0003677;GO:0006260;GO:0006270;GO:0006269;GO:0032201;, C:alpha DNA polymerase:primase complex; C:cytosol; C:nucleoplasm;, F:DNA binding;, P:DNA replication; P:DNA replication initiation; P:DNA replication, synthesis of RNA primer; P:telomere maintenance via semi-conservative replication; scaffold176 indexed_genome mRNA 474461 480382 . + . ID=transcript_15268;O14613 B2RD85 Q9UNS0,Cdc42 effector protein 2,Binder of Rho GTPases 1;, PF14957;PF00786;, GO:0005737;GO:0005856;GO:0005829;GO:0012505;GO:0016020;GO:0015630;GO:0045335;GO:0005886;GO:0005096;GO:0001515;GO:0031267;GO:0030036;GO:0007015;GO:0071346;GO:0030838;GO:0031334;GO:0031274;GO:0008360;GO:0007266;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endomembrane system; C:membrane; C:microtubule cytoskeleton; C:phagocytic vesicle; C:plasma membrane;, F:GTPase activator activity; F:opioid peptide activity; F:small GTPase binding;, P:actin cytoskeleton organization; P:actin filament organization; P:cellular response to interferon-gamma; P:positive regulation of actin filament polymerization; P:positive regulation of protein-containing complex assembly; P:positive regulation of pseudopodium assembly; P:regulation of cell shape; P:Rho protein signal transduction; scaffold176 indexed_genome mRNA 488161 501726 . + . ID=transcript_15269;Q92785 A8K7C9 B4DT58,Zinc finger protein ubi-d4,Apoptosis response zinc finger protein;BRG1-associated factor 45D;D4, zinc and double PHD fingers family 2;Protein requiem;, PF00628;PF14051;, GO:0005813;GO:0000785;GO:0005829;GO:0043231;GO:0071565;GO:0005654;GO:0005634;GO:0062072;GO:0042393;GO:0070577;GO:0046872;GO:0003712;GO:0003714;GO:0006915;GO:0097190;GO:0006325;GO:1905454;GO:0000122;GO:0045892;GO:0007399;GO:0045944;, C:centrosome; C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nBAF complex; C:nucleoplasm; C:nucleus;, F:H3K9me3 modified histone binding; F:histone binding; F:lysine-acetylated histone binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity;, P:apoptotic process; P:apoptotic signaling pathway; P:chromatin organization; P:negative regulation of myeloid progenitor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II;|Q92785 A8K7C9 B4DT58,Zinc finger protein ubi-d4,Apoptosis response zinc finger protein;BRG1-associated factor 45D;D4, zinc and double PHD fingers family 2;Protein requiem;, PF00628;PF14051;, GO:0005813;GO:0000785;GO:0005829;GO:0043231;GO:0071565;GO:0005654;GO:0005634;GO:0062072;GO:0042393;GO:0070577;GO:0046872;GO:0003712;GO:0003714;GO:0006915;GO:0097190;GO:0006325;GO:1905454;GO:0000122;GO:0045892;GO:0007399;GO:0045944;, C:centrosome; C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nBAF complex; C:nucleoplasm; C:nucleus;, F:H3K9me3 modified histone binding; F:histone binding; F:lysine-acetylated histone binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity;, P:apoptotic process; P:apoptotic signaling pathway; P:chromatin organization; P:negative regulation of myeloid progenitor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II;|Q92785 A8K7C9 B4DT58,Zinc finger protein ubi-d4,Apoptosis response zinc finger protein;BRG1-associated factor 45D;D4, zinc and double PHD fingers family 2;Protein requiem;, PF00628;PF14051;, GO:0005813;GO:0000785;GO:0005829;GO:0043231;GO:0071565;GO:0005654;GO:0005634;GO:0062072;GO:0042393;GO:0070577;GO:0046872;GO:0003712;GO:0003714;GO:0006915;GO:0097190;GO:0006325;GO:1905454;GO:0000122;GO:0045892;GO:0007399;GO:0045944;, C:centrosome; C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nBAF complex; C:nucleoplasm; C:nucleus;, F:H3K9me3 modified histone binding; F:histone binding; F:lysine-acetylated histone binding; F:metal ion binding; F:transcription coregulator activity; F:transcription corepressor activity;, P:apoptotic process; P:apoptotic signaling pathway; P:chromatin organization; P:negative regulation of myeloid progenitor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:positive regulation of transcription by RNA polymerase II; scaffold176 indexed_genome mRNA 531353 550829 . + . ID=transcript_15270;Q9BZ67 B4E2P1 Q86V56 Q8NCB5,FERM domain-containing protein 8,Band4.1 inhibitor LRP interactor {ECO:0000303|PubMed:19572019};iRhom tail-associated protein {ECO:0000303|PubMed:29897333};, PF00373;, GO:0034451;GO:0005829;GO:0005654;GO:0005886;GO:0032760;, C:centriolar satellite; C:cytosol; C:nucleoplasm; C:plasma membrane;, , P:positive regulation of tumor necrosis factor production;|Q9BZ67 B4E2P1 Q86V56 Q8NCB5,FERM domain-containing protein 8,Band4.1 inhibitor LRP interactor {ECO:0000303|PubMed:19572019};iRhom tail-associated protein {ECO:0000303|PubMed:29897333};, PF00373;, GO:0034451;GO:0005829;GO:0005654;GO:0005886;GO:0032760;, C:centriolar satellite; C:cytosol; C:nucleoplasm; C:plasma membrane;, , P:positive regulation of tumor necrosis factor production;|Q9BZ67 B4E2P1 Q86V56 Q8NCB5,FERM domain-containing protein 8,Band4.1 inhibitor LRP interactor {ECO:0000303|PubMed:19572019};iRhom tail-associated protein {ECO:0000303|PubMed:29897333};, PF00373;, GO:0034451;GO:0005829;GO:0005654;GO:0005886;GO:0032760;, C:centriolar satellite; C:cytosol; C:nucleoplasm; C:plasma membrane;, , P:positive regulation of tumor necrosis factor production;|Q9BZ67 B4E2P1 Q86V56 Q8NCB5,FERM domain-containing protein 8,Band4.1 inhibitor LRP interactor {ECO:0000303|PubMed:19572019};iRhom tail-associated protein {ECO:0000303|PubMed:29897333};, PF00373;, GO:0034451;GO:0005829;GO:0005654;GO:0005886;GO:0032760;, C:centriolar satellite; C:cytosol; C:nucleoplasm; C:plasma membrane;, , P:positive regulation of tumor necrosis factor production; scaffold176 indexed_genome mRNA 643422 676884 . + . ID=transcript_15271;Q96KG9 A6NJF1 Q96G50 Q96KG8 Q96KH1 Q9HAW5 Q9HBL3 Q9NR53,N-terminal kinase-like protein,Coated vesicle-associated kinase of 90 kDa;SCY1-like protein 1;Telomerase regulation-associated protein;Telomerase transcriptional element-interacting factor;Teratoma-associated tyrosine kinase;, PF00069;, GO:0005801;GO:0030126;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0005815;GO:0005634;GO:0005524;GO:0045296;GO:0003677;GO:0004713;GO:0034613;GO:0006954;GO:0048666;GO:0006890;GO:0021522;, C:cis-Golgi network; C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane; C:microtubule organizing center; C:nucleus;, F:ATP binding; F:cadherin binding; F:DNA binding; F:protein tyrosine kinase activity;, P:cellular protein localization; P:inflammatory response; P:neuron development; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:spinal cord motor neuron differentiation;|Q96KG9 A6NJF1 Q96G50 Q96KG8 Q96KH1 Q9HAW5 Q9HBL3 Q9NR53,N-terminal kinase-like protein,Coated vesicle-associated kinase of 90 kDa;SCY1-like protein 1;Telomerase regulation-associated protein;Telomerase transcriptional element-interacting factor;Teratoma-associated tyrosine kinase;, PF00069;, GO:0005801;GO:0030126;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0005815;GO:0005634;GO:0005524;GO:0045296;GO:0003677;GO:0004713;GO:0034613;GO:0006954;GO:0048666;GO:0006890;GO:0021522;, C:cis-Golgi network; C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane; C:microtubule organizing center; C:nucleus;, F:ATP binding; F:cadherin binding; F:DNA binding; F:protein tyrosine kinase activity;, P:cellular protein localization; P:inflammatory response; P:neuron development; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:spinal cord motor neuron differentiation;|Q96KG9 A6NJF1 Q96G50 Q96KG8 Q96KH1 Q9HAW5 Q9HBL3 Q9NR53,N-terminal kinase-like protein,Coated vesicle-associated kinase of 90 kDa;SCY1-like protein 1;Telomerase regulation-associated protein;Telomerase transcriptional element-interacting factor;Teratoma-associated tyrosine kinase;, PF00069;, GO:0005801;GO:0030126;GO:0005737;GO:0005829;GO:0005793;GO:0005794;GO:0016020;GO:0005815;GO:0005634;GO:0005524;GO:0045296;GO:0003677;GO:0004713;GO:0034613;GO:0006954;GO:0048666;GO:0006890;GO:0021522;, C:cis-Golgi network; C:COPI vesicle coat; C:cytoplasm; C:cytosol; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:membrane; C:microtubule organizing center; C:nucleus;, F:ATP binding; F:cadherin binding; F:DNA binding; F:protein tyrosine kinase activity;, P:cellular protein localization; P:inflammatory response; P:neuron development; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:spinal cord motor neuron differentiation;|Q9NS15 O15107 Q96HB9 Q9H7K2 Q9UFN4,Latent-transforming growth factor beta-binding protein 3,, PF12662;PF07645;PF00683;, GO:0062023;GO:0070062;GO:0005576;GO:0005509;GO:0050431;GO:0060349;GO:0046849;GO:0048251;GO:0060430;GO:0030502;GO:0032331;GO:0045780;GO:2000741;GO:1902462;GO:0036363;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:calcium ion binding; F:transforming growth factor beta binding;, P:bone morphogenesis; P:bone remodeling; P:elastic fiber assembly; P:lung saccule development; P:negative regulation of bone mineralization; P:negative regulation of chondrocyte differentiation; P:positive regulation of bone resorption; P:positive regulation of mesenchymal stem cell differentiation; P:positive regulation of mesenchymal stem cell proliferation; P:transforming growth factor beta activation; P:transforming growth factor beta receptor signaling pathway;|Q9NS15 O15107 Q96HB9 Q9H7K2 Q9UFN4,Latent-transforming growth factor beta-binding protein 3,, PF12662;PF07645;PF00683;, GO:0062023;GO:0070062;GO:0005576;GO:0005509;GO:0050431;GO:0060349;GO:0046849;GO:0048251;GO:0060430;GO:0030502;GO:0032331;GO:0045780;GO:2000741;GO:1902462;GO:0036363;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:calcium ion binding; F:transforming growth factor beta binding;, P:bone morphogenesis; P:bone remodeling; P:elastic fiber assembly; P:lung saccule development; P:negative regulation of bone mineralization; P:negative regulation of chondrocyte differentiation; P:positive regulation of bone resorption; P:positive regulation of mesenchymal stem cell differentiation; P:positive regulation of mesenchymal stem cell proliferation; P:transforming growth factor beta activation; P:transforming growth factor beta receptor signaling pathway;|Q9NS15 O15107 Q96HB9 Q9H7K2 Q9UFN4,Latent-transforming growth factor beta-binding protein 3,, PF12662;PF07645;PF00683;, GO:0062023;GO:0070062;GO:0005576;GO:0005509;GO:0050431;GO:0060349;GO:0046849;GO:0048251;GO:0060430;GO:0030502;GO:0032331;GO:0045780;GO:2000741;GO:1902462;GO:0036363;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:calcium ion binding; F:transforming growth factor beta binding;, P:bone morphogenesis; P:bone remodeling; P:elastic fiber assembly; P:lung saccule development; P:negative regulation of bone mineralization; P:negative regulation of chondrocyte differentiation; P:positive regulation of bone resorption; P:positive regulation of mesenchymal stem cell differentiation; P:positive regulation of mesenchymal stem cell proliferation; P:transforming growth factor beta activation; P:transforming growth factor beta receptor signaling pathway;|Q9NS15 O15107 Q96HB9 Q9H7K2 Q9UFN4,Latent-transforming growth factor beta-binding protein 3,, PF12662;PF07645;PF00683;, GO:0062023;GO:0070062;GO:0005576;GO:0005509;GO:0050431;GO:0060349;GO:0046849;GO:0048251;GO:0060430;GO:0030502;GO:0032331;GO:0045780;GO:2000741;GO:1902462;GO:0036363;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:calcium ion binding; F:transforming growth factor beta binding;, P:bone morphogenesis; P:bone remodeling; P:elastic fiber assembly; P:lung saccule development; P:negative regulation of bone mineralization; P:negative regulation of chondrocyte differentiation; P:positive regulation of bone resorption; P:positive regulation of mesenchymal stem cell differentiation; P:positive regulation of mesenchymal stem cell proliferation; P:transforming growth factor beta activation; P:transforming growth factor beta receptor signaling pathway;|Q9NS15 O15107 Q96HB9 Q9H7K2 Q9UFN4,Latent-transforming growth factor beta-binding protein 3,, PF12662;PF07645;PF00683;, GO:0062023;GO:0070062;GO:0005576;GO:0005509;GO:0050431;GO:0060349;GO:0046849;GO:0048251;GO:0060430;GO:0030502;GO:0032331;GO:0045780;GO:2000741;GO:1902462;GO:0036363;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:calcium ion binding; F:transforming growth factor beta binding;, P:bone morphogenesis; P:bone remodeling; P:elastic fiber assembly; P:lung saccule development; P:negative regulation of bone mineralization; P:negative regulation of chondrocyte differentiation; P:positive regulation of bone resorption; P:positive regulation of mesenchymal stem cell differentiation; P:positive regulation of mesenchymal stem cell proliferation; P:transforming growth factor beta activation; P:transforming growth factor beta receptor signaling pathway;|Q9NS15 O15107 Q96HB9 Q9H7K2 Q9UFN4,Latent-transforming growth factor beta-binding protein 3,, PF12662;PF07645;PF00683;, GO:0062023;GO:0070062;GO:0005576;GO:0005509;GO:0050431;GO:0060349;GO:0046849;GO:0048251;GO:0060430;GO:0030502;GO:0032331;GO:0045780;GO:2000741;GO:1902462;GO:0036363;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region;, F:calcium ion binding; F:transforming growth factor beta binding;, P:bone morphogenesis; P:bone remodeling; P:elastic fiber assembly; P:lung saccule development; P:negative regulation of bone mineralization; P:negative regulation of chondrocyte differentiation; P:positive regulation of bone resorption; P:positive regulation of mesenchymal stem cell differentiation; P:positive regulation of mesenchymal stem cell proliferation; P:transforming growth factor beta activation; P:transforming growth factor beta receptor signaling pathway; scaffold176 indexed_genome mRNA 691261 694898 . + . ID=transcript_15272;O60232,Protein ZNRD2 {ECO:0000305},Autoantigen p27 {ECO:0000303|PubMed:9486406};Sjoegren syndrome/scleroderma autoantigen 1;Zinc ribbon domain-containing protein 2 {ECO:0000305};, PF06677;, GO:0051301;GO:0000278;, , , P:cell division; P:mitotic cell cycle; scaffold176 indexed_genome mRNA 703921 704637 . + . ID=transcript_15273;Q8N3D4 Q8TB89 Q9H7M7,EH domain-binding protein 1-like protein 1,, PF00307;PF12130;PF10358;, GO:0005768;GO:0031941;GO:0016020;GO:0005815;GO:0030036;, C:endosome; C:filamentous actin; C:membrane; C:microtubule organizing center;, , P:actin cytoskeleton organization; scaffold176 indexed_genome mRNA 713070 715863 . - . ID=transcript_15274;Q9Y2U2 Q3SYI2 Q9Y2U3 Q9Y2U4,Potassium channel subfamily K member 7,, PF07885;, GO:0005887;GO:0005886;GO:0005267;GO:0022841;GO:0005244;GO:0071805;GO:0006813;GO:0034765;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane;, F:potassium channel activity; F:potassium ion leak channel activity; F:voltage-gated ion channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:stabilization of membrane potential;|Q9Y2U2 Q3SYI2 Q9Y2U3 Q9Y2U4,Potassium channel subfamily K member 7,, PF07885;, GO:0005887;GO:0005886;GO:0005267;GO:0022841;GO:0005244;GO:0071805;GO:0006813;GO:0034765;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane;, F:potassium channel activity; F:potassium ion leak channel activity; F:voltage-gated ion channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:stabilization of membrane potential;|Q9Y2U2 Q3SYI2 Q9Y2U3 Q9Y2U4,Potassium channel subfamily K member 7,, PF07885;, GO:0005887;GO:0005886;GO:0005267;GO:0022841;GO:0005244;GO:0071805;GO:0006813;GO:0034765;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane;, F:potassium channel activity; F:potassium ion leak channel activity; F:voltage-gated ion channel activity;, P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:stabilization of membrane potential; scaffold176 indexed_genome mRNA 717267 727501 . - . ID=transcript_15275;Q16584 B4DS76 Q53H00 Q59F06 Q6P2G4,Mitogen-activated protein kinase kinase kinase 11,Mixed lineage kinase 3;Src-homology 3 domain-containing proline-rich kinase;, PF07714;PF14604;, GO:0005813;GO:0005737;GO:0016020;GO:0005874;GO:0005524;GO:0042802;GO:0004706;GO:0031434;GO:0031435;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000187;GO:0044843;GO:0008219;GO:0007254;GO:0007017;GO:0043065;GO:0046330;GO:0043507;GO:0043525;GO:0046777;GO:0006468;, C:centrosome; C:cytoplasm; C:membrane; C:microtubule;, F:ATP binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:cell cycle G1/S phase transition; P:cell death; P:JNK cascade; P:microtubule-based process; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of neuron apoptotic process; P:protein autophosphorylation; P:protein phosphorylation;|Q16584 B4DS76 Q53H00 Q59F06 Q6P2G4,Mitogen-activated protein kinase kinase kinase 11,Mixed lineage kinase 3;Src-homology 3 domain-containing proline-rich kinase;, PF07714;PF14604;, GO:0005813;GO:0005737;GO:0016020;GO:0005874;GO:0005524;GO:0042802;GO:0004706;GO:0031434;GO:0031435;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000187;GO:0044843;GO:0008219;GO:0007254;GO:0007017;GO:0043065;GO:0046330;GO:0043507;GO:0043525;GO:0046777;GO:0006468;, C:centrosome; C:cytoplasm; C:membrane; C:microtubule;, F:ATP binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:cell cycle G1/S phase transition; P:cell death; P:JNK cascade; P:microtubule-based process; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of neuron apoptotic process; P:protein autophosphorylation; P:protein phosphorylation; scaffold176 indexed_genome mRNA 732005 734247 . - . ID=transcript_15276;Q16584 B4DS76 Q53H00 Q59F06 Q6P2G4,Mitogen-activated protein kinase kinase kinase 11,Mixed lineage kinase 3;Src-homology 3 domain-containing proline-rich kinase;, PF07714;PF14604;, GO:0005813;GO:0005737;GO:0016020;GO:0005874;GO:0005524;GO:0042802;GO:0004706;GO:0031434;GO:0031435;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0000187;GO:0044843;GO:0008219;GO:0007254;GO:0007017;GO:0043065;GO:0046330;GO:0043507;GO:0043525;GO:0046777;GO:0006468;, C:centrosome; C:cytoplasm; C:membrane; C:microtubule;, F:ATP binding; F:identical protein binding; F:JUN kinase kinase kinase activity; F:mitogen-activated protein kinase kinase binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:cell cycle G1/S phase transition; P:cell death; P:JNK cascade; P:microtubule-based process; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of neuron apoptotic process; P:protein autophosphorylation; P:protein phosphorylation; scaffold176 indexed_genome mRNA 734399 754100 . + . ID=transcript_15277;Q9H6A9 Q6MZN8,Pecanex-like protein 3,Pecanex homolog protein 3 {ECO:0000312|HGNC:HGNC:18760};, PF05041;, GO:0016021;, C:integral component of membrane;|Q9H6A9 Q6MZN8,Pecanex-like protein 3,Pecanex homolog protein 3 {ECO:0000312|HGNC:HGNC:18760};, PF05041;, GO:0016021;, C:integral component of membrane; scaffold176 indexed_genome mRNA 769657 771450 . + . ID=transcript_15278;Q96FS4 O14518 O60484 O60618 Q2YD83,Signal-induced proliferation-associated protein 1,GTPase-activating protein Spa-1;p130 SPA-1;, PF00595;PF02145;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0048471;GO:0032991;GO:0030133;GO:0005096;GO:0008022;GO:0090630;GO:0002250;GO:0042631;GO:0007010;GO:0035556;GO:0007162;GO:0045786;GO:0030308;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:transport vesicle;, F:GTPase activator activity; F:protein C-terminus binding;, P:activation of GTPase activity; P:adaptive immune response; P:cellular response to water deprivation; P:cytoskeleton organization; P:intracellular signal transduction; P:negative regulation of cell adhesion; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q96FS4 O14518 O60484 O60618 Q2YD83,Signal-induced proliferation-associated protein 1,GTPase-activating protein Spa-1;p130 SPA-1;, PF00595;PF02145;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0048471;GO:0032991;GO:0030133;GO:0005096;GO:0008022;GO:0090630;GO:0002250;GO:0042631;GO:0007010;GO:0035556;GO:0007162;GO:0045786;GO:0030308;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:transport vesicle;, F:GTPase activator activity; F:protein C-terminus binding;, P:activation of GTPase activity; P:adaptive immune response; P:cellular response to water deprivation; P:cytoskeleton organization; P:intracellular signal transduction; P:negative regulation of cell adhesion; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold176 indexed_genome mRNA 775909 790260 . - . ID=transcript_15279;Q04206 Q6GTV1 Q6SLK1,Transcription factor p65,Nuclear factor NF-kappa-B p65 subunit;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3;, PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0098978;GO:0035525;GO:0005654;GO:0005634;GO:0005667;GO:0042805;GO:0033613;GO:0071532;GO:0003682;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0140297;GO:0001227;GO:0019899;GO:0042826;GO:0042802;GO:0051059;GO:0042277;GO:0042301;GO:0042803;GO:0019901;GO:0047485;GO:0044877;GO:0070491;GO:0000978;GO:0000979;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0031625;GO:0006117;GO:0007568;GO:0009887;GO:0006968;GO:1904385;GO:0035729;GO:0070301;GO:0071347;GO:0071354;GO:0071222;GO:0071223;GO:0071316;GO:0071224;GO:0071356;GO:0035924;GO:0006325;GO:0019221;GO:0051607;GO:0038095;GO:0001942;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0001889;GO:0031293;GO:0043066;GO:2001237;GO:0046627;GO:1901223;GO:1902894;GO:0042177;GO:0033234;GO:0000122;GO:0045892;GO:0038061;GO:0070431;GO:1902004;GO:0008284;GO:0043123;GO:0032735;GO:0032757;GO:1904996;GO:2000630;GO:0051092;GO:1901224;GO:1902895;GO:0014040;GO:0050862;GO:0045944;GO:1901522;GO:0045893;GO:0032481;GO:0099527;GO:0043620;GO:0050727;GO:1901222;GO:0006357;GO:0060260;GO:0006355;GO:0043200;GO:0051591;GO:0033590;GO:0034097;GO:0042493;GO:0032868;GO:0070555;GO:0043278;GO:0032495;GO:0035994;GO:0010033;GO:0032570;GO:0010224;GO:0002223;GO:0050852;GO:0006351;GO:0033209;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:NF-kappaB p50/p65 complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:actinin binding; F:activating transcription factor binding; F:ankyrin repeat binding; F:chromatin binding; F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:NF-kappaB binding; F:peptide binding; F:phosphate ion binding; F:protein homodimerization activity; F:protein kinase binding; F:protein N-terminus binding; F:protein-containing complex binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:acetaldehyde metabolic process; P:aging; P:animal organ morphogenesis; P:cellular defense response; P:cellular response to angiotensin; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to nicotine; P:cellular response to peptidoglycan; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:chromatin organization; P:cytokine-mediated signaling pathway; P:defense response to virus; P:Fc-epsilon receptor signaling pathway; P:hair follicle development; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:liver development; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein catabolic process; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of amyloid-beta formation; P:positive regulation of cell population proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-8 production; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of Schwann cell differentiation; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:postsynapse to nucleus signaling pathway; P:regulation of DNA-templated transcription in response to stress; P:regulation of inflammatory response; P:regulation of NIK/NF-kappaB signaling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:response to amino acid; P:response to cAMP; P:response to cobalamin; P:response to cytokine; P:response to drug; P:response to insulin; P:response to interleukin-1; P:response to morphine; P:response to muramyl dipeptide; P:response to muscle stretch; P:response to organic substance; P:response to progesterone; P:response to UV-B; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transcription, DNA-templated; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|Q04206 Q6GTV1 Q6SLK1,Transcription factor p65,Nuclear factor NF-kappa-B p65 subunit;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3;, PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0098978;GO:0035525;GO:0005654;GO:0005634;GO:0005667;GO:0042805;GO:0033613;GO:0071532;GO:0003682;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0140297;GO:0001227;GO:0019899;GO:0042826;GO:0042802;GO:0051059;GO:0042277;GO:0042301;GO:0042803;GO:0019901;GO:0047485;GO:0044877;GO:0070491;GO:0000978;GO:0000979;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0031625;GO:0006117;GO:0007568;GO:0009887;GO:0006968;GO:1904385;GO:0035729;GO:0070301;GO:0071347;GO:0071354;GO:0071222;GO:0071223;GO:0071316;GO:0071224;GO:0071356;GO:0035924;GO:0006325;GO:0019221;GO:0051607;GO:0038095;GO:0001942;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0001889;GO:0031293;GO:0043066;GO:2001237;GO:0046627;GO:1901223;GO:1902894;GO:0042177;GO:0033234;GO:0000122;GO:0045892;GO:0038061;GO:0070431;GO:1902004;GO:0008284;GO:0043123;GO:0032735;GO:0032757;GO:1904996;GO:2000630;GO:0051092;GO:1901224;GO:1902895;GO:0014040;GO:0050862;GO:0045944;GO:1901522;GO:0045893;GO:0032481;GO:0099527;GO:0043620;GO:0050727;GO:1901222;GO:0006357;GO:0060260;GO:0006355;GO:0043200;GO:0051591;GO:0033590;GO:0034097;GO:0042493;GO:0032868;GO:0070555;GO:0043278;GO:0032495;GO:0035994;GO:0010033;GO:0032570;GO:0010224;GO:0002223;GO:0050852;GO:0006351;GO:0033209;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:NF-kappaB p50/p65 complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:actinin binding; F:activating transcription factor binding; F:ankyrin repeat binding; F:chromatin binding; F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:NF-kappaB binding; F:peptide binding; F:phosphate ion binding; F:protein homodimerization activity; F:protein kinase binding; F:protein N-terminus binding; F:protein-containing complex binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:acetaldehyde metabolic process; P:aging; P:animal organ morphogenesis; P:cellular defense response; P:cellular response to angiotensin; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to nicotine; P:cellular response to peptidoglycan; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:chromatin organization; P:cytokine-mediated signaling pathway; P:defense response to virus; P:Fc-epsilon receptor signaling pathway; P:hair follicle development; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:liver development; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein catabolic process; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of amyloid-beta formation; P:positive regulation of cell population proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-8 production; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of Schwann cell differentiation; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:postsynapse to nucleus signaling pathway; P:regulation of DNA-templated transcription in response to stress; P:regulation of inflammatory response; P:regulation of NIK/NF-kappaB signaling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:response to amino acid; P:response to cAMP; P:response to cobalamin; P:response to cytokine; P:response to drug; P:response to insulin; P:response to interleukin-1; P:response to morphine; P:response to muramyl dipeptide; P:response to muscle stretch; P:response to organic substance; P:response to progesterone; P:response to UV-B; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transcription, DNA-templated; P:tumor necrosis factor-mediated signaling pathway; P:viral process;|Q04206 Q6GTV1 Q6SLK1,Transcription factor p65,Nuclear factor NF-kappa-B p65 subunit;Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3;, PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0098978;GO:0035525;GO:0005654;GO:0005634;GO:0005667;GO:0042805;GO:0033613;GO:0071532;GO:0003682;GO:0031490;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0140297;GO:0001227;GO:0019899;GO:0042826;GO:0042802;GO:0051059;GO:0042277;GO:0042301;GO:0042803;GO:0019901;GO:0047485;GO:0044877;GO:0070491;GO:0000978;GO:0000979;GO:0001225;GO:0000977;GO:0008134;GO:0000976;GO:0031625;GO:0006117;GO:0007568;GO:0009887;GO:0006968;GO:1904385;GO:0035729;GO:0070301;GO:0071347;GO:0071354;GO:0071222;GO:0071223;GO:0071316;GO:0071224;GO:0071356;GO:0035924;GO:0006325;GO:0019221;GO:0051607;GO:0038095;GO:0001942;GO:0007249;GO:0006954;GO:0045087;GO:0070498;GO:0001889;GO:0031293;GO:0043066;GO:2001237;GO:0046627;GO:1901223;GO:1902894;GO:0042177;GO:0033234;GO:0000122;GO:0045892;GO:0038061;GO:0070431;GO:1902004;GO:0008284;GO:0043123;GO:0032735;GO:0032757;GO:1904996;GO:2000630;GO:0051092;GO:1901224;GO:1902895;GO:0014040;GO:0050862;GO:0045944;GO:1901522;GO:0045893;GO:0032481;GO:0099527;GO:0043620;GO:0050727;GO:1901222;GO:0006357;GO:0060260;GO:0006355;GO:0043200;GO:0051591;GO:0033590;GO:0034097;GO:0042493;GO:0032868;GO:0070555;GO:0043278;GO:0032495;GO:0035994;GO:0010033;GO:0032570;GO:0010224;GO:0002223;GO:0050852;GO:0006351;GO:0033209;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:NF-kappaB p50/p65 complex; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:actinin binding; F:activating transcription factor binding; F:ankyrin repeat binding; F:chromatin binding; F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription factor binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:enzyme binding; F:histone deacetylase binding; F:identical protein binding; F:NF-kappaB binding; F:peptide binding; F:phosphate ion binding; F:protein homodimerization activity; F:protein kinase binding; F:protein N-terminus binding; F:protein-containing complex binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:acetaldehyde metabolic process; P:aging; P:animal organ morphogenesis; P:cellular defense response; P:cellular response to angiotensin; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interleukin-1; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to lipoteichoic acid; P:cellular response to nicotine; P:cellular response to peptidoglycan; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:chromatin organization; P:cytokine-mediated signaling pathway; P:defense response to virus; P:Fc-epsilon receptor signaling pathway; P:hair follicle development; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:liver development; P:membrane protein intracellular domain proteolysis; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein catabolic process; P:negative regulation of protein sumoylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:NIK/NF-kappaB signaling; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of amyloid-beta formation; P:positive regulation of cell population proliferation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-8 production; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of miRNA metabolic process; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of Schwann cell differentiation; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:postsynapse to nucleus signaling pathway; P:regulation of DNA-templated transcription in response to stress; P:regulation of inflammatory response; P:regulation of NIK/NF-kappaB signaling; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:regulation of transcription, DNA-templated; P:response to amino acid; P:response to cAMP; P:response to cobalamin; P:response to cytokine; P:response to drug; P:response to insulin; P:response to interleukin-1; P:response to morphine; P:response to muramyl dipeptide; P:response to muscle stretch; P:response to organic substance; P:response to progesterone; P:response to UV-B; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transcription, DNA-templated; P:tumor necrosis factor-mediated signaling pathway; P:viral process; scaffold176 indexed_genome mRNA 822210 830833 . + . ID=transcript_15280;Q92993 B4E3C7 C9JL99 O95624 Q13430 Q17RW5 Q561W3 Q6GSE8 Q9BWK7,Histone acetyltransferase KAT5,60 kDa Tat-interactive protein;Histone acetyltransferase HTATIP;Lysine acetyltransferase 5;cPLA(2)-interacting protein;, PF01853;PF11717;PF17772;, GO:0035267;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0032777;GO:0000812;GO:0005667;GO:0004402;GO:0042393;GO:0046872;GO:0061733;GO:0070491;GO:0003713;GO:0003712;GO:1904837;GO:0071392;GO:0006978;GO:0000729;GO:0006260;GO:0006302;GO:0006303;GO:0016573;GO:0032703;GO:0000122;GO:0045892;GO:0018394;GO:0010508;GO:1901985;GO:0045944;GO:0045893;GO:0043161;GO:0040008;GO:1901796;GO:0010212;GO:0016032;, C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Piccolo NuA4 histone acetyltransferase complex; C:Swr1 complex; C:transcription regulator complex;, F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:peptide-lysine-N-acetyltransferase activity; F:repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:cellular response to estradiol stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone acetylation; P:negative regulation of interleukin-2 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine acetylation; P:positive regulation of autophagy; P:positive regulation of protein acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of growth; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; P:viral process;|Q92993 B4E3C7 C9JL99 O95624 Q13430 Q17RW5 Q561W3 Q6GSE8 Q9BWK7,Histone acetyltransferase KAT5,60 kDa Tat-interactive protein;Histone acetyltransferase HTATIP;Lysine acetyltransferase 5;cPLA(2)-interacting protein;, PF01853;PF11717;PF17772;, GO:0035267;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0032777;GO:0000812;GO:0005667;GO:0004402;GO:0042393;GO:0046872;GO:0061733;GO:0070491;GO:0003713;GO:0003712;GO:1904837;GO:0071392;GO:0006978;GO:0000729;GO:0006260;GO:0006302;GO:0006303;GO:0016573;GO:0032703;GO:0000122;GO:0045892;GO:0018394;GO:0010508;GO:1901985;GO:0045944;GO:0045893;GO:0043161;GO:0040008;GO:1901796;GO:0010212;GO:0016032;, C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Piccolo NuA4 histone acetyltransferase complex; C:Swr1 complex; C:transcription regulator complex;, F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:peptide-lysine-N-acetyltransferase activity; F:repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:cellular response to estradiol stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone acetylation; P:negative regulation of interleukin-2 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine acetylation; P:positive regulation of autophagy; P:positive regulation of protein acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of growth; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; P:viral process;|Q92993 B4E3C7 C9JL99 O95624 Q13430 Q17RW5 Q561W3 Q6GSE8 Q9BWK7,Histone acetyltransferase KAT5,60 kDa Tat-interactive protein;Histone acetyltransferase HTATIP;Lysine acetyltransferase 5;cPLA(2)-interacting protein;, PF01853;PF11717;PF17772;, GO:0035267;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0032777;GO:0000812;GO:0005667;GO:0004402;GO:0042393;GO:0046872;GO:0061733;GO:0070491;GO:0003713;GO:0003712;GO:1904837;GO:0071392;GO:0006978;GO:0000729;GO:0006260;GO:0006302;GO:0006303;GO:0016573;GO:0032703;GO:0000122;GO:0045892;GO:0018394;GO:0010508;GO:1901985;GO:0045944;GO:0045893;GO:0043161;GO:0040008;GO:1901796;GO:0010212;GO:0016032;, C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Piccolo NuA4 histone acetyltransferase complex; C:Swr1 complex; C:transcription regulator complex;, F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:peptide-lysine-N-acetyltransferase activity; F:repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:cellular response to estradiol stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone acetylation; P:negative regulation of interleukin-2 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine acetylation; P:positive regulation of autophagy; P:positive regulation of protein acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of growth; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; P:viral process;|Q92993 B4E3C7 C9JL99 O95624 Q13430 Q17RW5 Q561W3 Q6GSE8 Q9BWK7,Histone acetyltransferase KAT5,60 kDa Tat-interactive protein;Histone acetyltransferase HTATIP;Lysine acetyltransferase 5;cPLA(2)-interacting protein;, PF01853;PF11717;PF17772;, GO:0035267;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0032777;GO:0000812;GO:0005667;GO:0004402;GO:0042393;GO:0046872;GO:0061733;GO:0070491;GO:0003713;GO:0003712;GO:1904837;GO:0071392;GO:0006978;GO:0000729;GO:0006260;GO:0006302;GO:0006303;GO:0016573;GO:0032703;GO:0000122;GO:0045892;GO:0018394;GO:0010508;GO:1901985;GO:0045944;GO:0045893;GO:0043161;GO:0040008;GO:1901796;GO:0010212;GO:0016032;, C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Piccolo NuA4 histone acetyltransferase complex; C:Swr1 complex; C:transcription regulator complex;, F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:peptide-lysine-N-acetyltransferase activity; F:repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:cellular response to estradiol stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone acetylation; P:negative regulation of interleukin-2 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine acetylation; P:positive regulation of autophagy; P:positive regulation of protein acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of growth; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; P:viral process;|Q92993 B4E3C7 C9JL99 O95624 Q13430 Q17RW5 Q561W3 Q6GSE8 Q9BWK7,Histone acetyltransferase KAT5,60 kDa Tat-interactive protein;Histone acetyltransferase HTATIP;Lysine acetyltransferase 5;cPLA(2)-interacting protein;, PF01853;PF11717;PF17772;, GO:0035267;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0032777;GO:0000812;GO:0005667;GO:0004402;GO:0042393;GO:0046872;GO:0061733;GO:0070491;GO:0003713;GO:0003712;GO:1904837;GO:0071392;GO:0006978;GO:0000729;GO:0006260;GO:0006302;GO:0006303;GO:0016573;GO:0032703;GO:0000122;GO:0045892;GO:0018394;GO:0010508;GO:1901985;GO:0045944;GO:0045893;GO:0043161;GO:0040008;GO:1901796;GO:0010212;GO:0016032;, C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Piccolo NuA4 histone acetyltransferase complex; C:Swr1 complex; C:transcription regulator complex;, F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:peptide-lysine-N-acetyltransferase activity; F:repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:cellular response to estradiol stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone acetylation; P:negative regulation of interleukin-2 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine acetylation; P:positive regulation of autophagy; P:positive regulation of protein acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of growth; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; P:viral process;|Q92993 B4E3C7 C9JL99 O95624 Q13430 Q17RW5 Q561W3 Q6GSE8 Q9BWK7,Histone acetyltransferase KAT5,60 kDa Tat-interactive protein;Histone acetyltransferase HTATIP;Lysine acetyltransferase 5;cPLA(2)-interacting protein;, PF01853;PF11717;PF17772;, GO:0035267;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0032777;GO:0000812;GO:0005667;GO:0004402;GO:0042393;GO:0046872;GO:0061733;GO:0070491;GO:0003713;GO:0003712;GO:1904837;GO:0071392;GO:0006978;GO:0000729;GO:0006260;GO:0006302;GO:0006303;GO:0016573;GO:0032703;GO:0000122;GO:0045892;GO:0018394;GO:0010508;GO:1901985;GO:0045944;GO:0045893;GO:0043161;GO:0040008;GO:1901796;GO:0010212;GO:0016032;, C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:Piccolo NuA4 histone acetyltransferase complex; C:Swr1 complex; C:transcription regulator complex;, F:histone acetyltransferase activity; F:histone binding; F:metal ion binding; F:peptide-lysine-N-acetyltransferase activity; F:repressing transcription factor binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:beta-catenin-TCF complex assembly; P:cellular response to estradiol stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA double-strand break processing; P:DNA replication; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:histone acetylation; P:negative regulation of interleukin-2 production; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine acetylation; P:positive regulation of autophagy; P:positive regulation of protein acetylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of growth; P:regulation of signal transduction by p53 class mediator; P:response to ionizing radiation; P:viral process; scaffold176 indexed_genome mRNA 841525 844599 . - . ID=transcript_15281;Q2VPB7 A1L0S6 H6WUK2 Q0D2Q2 Q8N3J7 Q8WYH6,AP-5 complex subunit beta-1,Adaptor-related protein complex 5 beta subunit;, , GO:0030119;GO:0005765;GO:0016197;GO:0015031;, C:AP-type membrane coat adaptor complex; C:lysosomal membrane;, , P:endosomal transport; P:protein transport; scaffold176 indexed_genome mRNA 900716 909745 . + . ID=transcript_15282;Q86XE0 Q8IW53 Q96NG4,Sorting nexin-32,Sorting nexin-6B;, PF00787;PF09325;, GO:0005829;GO:0005768;GO:0035091;GO:0015031;GO:0016241;GO:0042147;, C:cytosol; C:endosome;, F:phosphatidylinositol binding;, P:protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi;|Q86XE0 Q8IW53 Q96NG4,Sorting nexin-32,Sorting nexin-6B;, PF00787;PF09325;, GO:0005829;GO:0005768;GO:0035091;GO:0015031;GO:0016241;GO:0042147;, C:cytosol; C:endosome;, F:phosphatidylinositol binding;, P:protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi;|Q86XE0 Q8IW53 Q96NG4,Sorting nexin-32,Sorting nexin-6B;, PF00787;PF09325;, GO:0005829;GO:0005768;GO:0035091;GO:0015031;GO:0016241;GO:0042147;, C:cytosol; C:endosome;, F:phosphatidylinositol binding;, P:protein transport; P:regulation of macroautophagy; P:retrograde transport, endosome to Golgi; scaffold176 indexed_genome mRNA 916675 926946 . + . ID=transcript_15283;Q96NY9 Q9H7D9,Crossover junction endonuclease MUS81,, PF02732;, GO:0048476;GO:0005730;GO:0005654;GO:0005634;GO:0048257;GO:0003677;GO:0046872;GO:0000737;GO:0006281;GO:0000727;GO:0036297;GO:0031573;GO:0033687;GO:0000712;GO:0072429;, C:Holliday junction resolvase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-flap endonuclease activity; F:DNA binding; F:metal ion binding;, P:DNA catabolic process, endonucleolytic; P:DNA repair; P:double-strand break repair via break-induced replication; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:osteoblast proliferation; P:resolution of meiotic recombination intermediates; P:response to intra-S DNA damage checkpoint signaling;|Q96NY9 Q9H7D9,Crossover junction endonuclease MUS81,, PF02732;, GO:0048476;GO:0005730;GO:0005654;GO:0005634;GO:0048257;GO:0003677;GO:0046872;GO:0000737;GO:0006281;GO:0000727;GO:0036297;GO:0031573;GO:0033687;GO:0000712;GO:0072429;, C:Holliday junction resolvase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-flap endonuclease activity; F:DNA binding; F:metal ion binding;, P:DNA catabolic process, endonucleolytic; P:DNA repair; P:double-strand break repair via break-induced replication; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:osteoblast proliferation; P:resolution of meiotic recombination intermediates; P:response to intra-S DNA damage checkpoint signaling;|O95967 A8K7R4 B3KM31 B3KQT1 O75967,EGF-containing fibulin-like extracellular matrix protein 2 {ECO:0000305},Fibulin-4 {ECO:0000303|PubMed:10601734};Protein UPH1;, PF12662;PF07645;, GO:0005604;GO:0062023;GO:0071953;GO:0070062;GO:0031012;GO:0005576;GO:1903561;GO:0001527;GO:0005509;GO:0005201;GO:0008201;GO:0042803;GO:0035904;GO:0060414;GO:0048251;GO:1904706;GO:1904831;GO:1904028;GO:1905609;GO:1904026;GO:0097084;, C:basement membrane; C:collagen-containing extracellular matrix; C:elastic fiber; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular vesicle; C:microfibril;, F:calcium ion binding; F:extracellular matrix structural constituent; F:heparin binding; F:protein homodimerization activity;, P:aorta development; P:aorta smooth muscle tissue morphogenesis; P:elastic fiber assembly; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of aortic smooth muscle cell differentiation; P:positive regulation of collagen fibril organization; P:positive regulation of smooth muscle cell-matrix adhesion; P:regulation of collagen fibril organization; P:vascular associated smooth muscle cell development;|O95967 A8K7R4 B3KM31 B3KQT1 O75967,EGF-containing fibulin-like extracellular matrix protein 2 {ECO:0000305},Fibulin-4 {ECO:0000303|PubMed:10601734};Protein UPH1;, PF12662;PF07645;, GO:0005604;GO:0062023;GO:0071953;GO:0070062;GO:0031012;GO:0005576;GO:1903561;GO:0001527;GO:0005509;GO:0005201;GO:0008201;GO:0042803;GO:0035904;GO:0060414;GO:0048251;GO:1904706;GO:1904831;GO:1904028;GO:1905609;GO:1904026;GO:0097084;, C:basement membrane; C:collagen-containing extracellular matrix; C:elastic fiber; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular vesicle; C:microfibril;, F:calcium ion binding; F:extracellular matrix structural constituent; F:heparin binding; F:protein homodimerization activity;, P:aorta development; P:aorta smooth muscle tissue morphogenesis; P:elastic fiber assembly; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of aortic smooth muscle cell differentiation; P:positive regulation of collagen fibril organization; P:positive regulation of smooth muscle cell-matrix adhesion; P:regulation of collagen fibril organization; P:vascular associated smooth muscle cell development; scaffold176 indexed_genome mRNA 938937 942361 . + . ID=transcript_15284;P56202 Q86VT4,Cathepsin W,Lymphopain;, PF08246;PF00112;, GO:0005783;GO:0005576;GO:0005615;GO:0005764;GO:0016020;GO:0031089;GO:0004197;GO:0008234;GO:0006955;GO:0002576;GO:0051603;, C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:lysosome; C:membrane; C:platelet dense granule lumen;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:immune response; P:platelet degranulation; P:proteolysis involved in cellular protein catabolic process;|P56202 Q86VT4,Cathepsin W,Lymphopain;, PF08246;PF00112;, GO:0005783;GO:0005576;GO:0005615;GO:0005764;GO:0016020;GO:0031089;GO:0004197;GO:0008234;GO:0006955;GO:0002576;GO:0051603;, C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:lysosome; C:membrane; C:platelet dense granule lumen;, F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity;, P:immune response; P:platelet degranulation; P:proteolysis involved in cellular protein catabolic process; scaffold176 indexed_genome mRNA 942362 946783 . - . ID=transcript_15285;O43427 A8K0J7 Q27Q85 Q6IBQ3 Q9HD65,Acidic fibroblast growth factor intracellular-binding protein,FGF-1 intracellular-binding protein;, PF05427;, GO:0012505;GO:0016020;GO:0005739;GO:0016607;GO:0005634;GO:0017134;GO:0008543;GO:0070527;, C:endomembrane system; C:membrane; C:mitochondrion; C:nuclear speck; C:nucleus;, F:fibroblast growth factor binding;, P:fibroblast growth factor receptor signaling pathway; P:platelet aggregation;|O43427 A8K0J7 Q27Q85 Q6IBQ3 Q9HD65,Acidic fibroblast growth factor intracellular-binding protein,FGF-1 intracellular-binding protein;, PF05427;, GO:0012505;GO:0016020;GO:0005739;GO:0016607;GO:0005634;GO:0017134;GO:0008543;GO:0070527;, C:endomembrane system; C:membrane; C:mitochondrion; C:nuclear speck; C:nucleus;, F:fibroblast growth factor binding;, P:fibroblast growth factor receptor signaling pathway; P:platelet aggregation; scaffold176 indexed_genome mRNA 946791 949939 . - . ID=transcript_15286;Q15834 B2R598 Q96HA0,Coiled-coil domain-containing protein 85B,Hepatitis delta antigen-interacting protein A;, PF10226;, GO:0005912;GO:0005813;GO:0005737;GO:0005634;GO:0070097;GO:0030154;GO:0030308;GO:0045599;GO:0045892;GO:0016032;, C:adherens junction; C:centrosome; C:cytoplasm; C:nucleus;, F:delta-catenin binding;, P:cell differentiation; P:negative regulation of cell growth; P:negative regulation of fat cell differentiation; P:negative regulation of transcription, DNA-templated; P:viral process; scaffold176 indexed_genome mRNA 951209 954224 . + . ID=transcript_15287;P15407 B4DR11 Q6FG51,Fos-related antigen 1,, PF00170;, GO:0000785;GO:0005829;GO:0043005;GO:0005654;GO:0005634;GO:0042734;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0006968;GO:0031668;GO:0006935;GO:0007565;GO:0001701;GO:0007612;GO:0008285;GO:0060674;GO:0043065;GO:0045787;GO:0008284;GO:0051091;GO:2000144;GO:1902895;GO:0006357;GO:0051591;GO:0051412;GO:0034097;GO:0042493;GO:0009629;GO:0042542;GO:0009612;GO:0032570;GO:0009615;GO:0007296;, C:chromatin; C:cytosol; C:neuron projection; C:nucleoplasm; C:nucleus; C:presynaptic membrane;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular defense response; P:cellular response to extracellular stimulus; P:chemotaxis; P:female pregnancy; P:in utero embryonic development; P:learning; P:negative regulation of cell population proliferation; P:placenta blood vessel development; P:positive regulation of apoptotic process; P:positive regulation of cell cycle; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of DNA-templated transcription, initiation; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to cAMP; P:response to corticosterone; P:response to cytokine; P:response to drug; P:response to gravity; P:response to hydrogen peroxide; P:response to mechanical stimulus; P:response to progesterone; P:response to virus; P:vitellogenesis; scaffold176 indexed_genome mRNA 969342 971358 . + . ID=transcript_15288;Q9H3H3 J3KQG9 Q9BT13,UPF0696 protein C11orf68,Basophilic leukemia-expressed protein Bles03;Protein p5326;, PF08939;, GO:0003723;, , F:RNA binding; scaffold176 indexed_genome mRNA 981376 983620 . + . ID=transcript_15289;Q14919 Q13448,Dr1-associated corepressor,Dr1-associated protein 1;Negative cofactor 2-alpha;, PF00808;, GO:0017054;GO:0005634;GO:0090575;GO:0001046;GO:0042802;GO:0046982;GO:0016251;GO:0001091;GO:0017025;GO:0003713;GO:0003714;GO:0000122;GO:0045944;GO:0006355;GO:0006366;, C:negative cofactor 2 complex; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:core promoter sequence-specific DNA binding; F:identical protein binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II general transcription initiation factor binding; F:TBP-class protein binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II;|Q14919 Q13448,Dr1-associated corepressor,Dr1-associated protein 1;Negative cofactor 2-alpha;, PF00808;, GO:0017054;GO:0005634;GO:0090575;GO:0001046;GO:0042802;GO:0046982;GO:0016251;GO:0001091;GO:0017025;GO:0003713;GO:0003714;GO:0000122;GO:0045944;GO:0006355;GO:0006366;, C:negative cofactor 2 complex; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:core promoter sequence-specific DNA binding; F:identical protein binding; F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II general transcription initiation factor binding; F:TBP-class protein binding; F:transcription coactivator activity; F:transcription corepressor activity;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription by RNA polymerase II; scaffold176 indexed_genome mRNA 1003432 1012084 . + . ID=transcript_15290;Q3SY00 Q3SXZ9 Q3SY01 Q96M26,Testis-specific protein 10-interacting protein,Tsga10-interacting protein;, , GO:0032391;GO:0044782;, C:photoreceptor connecting cilium;, , P:cilium organization;|Q3SY00 Q3SXZ9 Q3SY01 Q96M26,Testis-specific protein 10-interacting protein,Tsga10-interacting protein;, , GO:0032391;GO:0044782;, C:photoreceptor connecting cilium;, , P:cilium organization; scaffold176 indexed_genome mRNA 1013148 1026590 . + . ID=transcript_15291;O43290 A6NDN1 Q53GB5,U4/U6.U5 tri-snRNP-associated protein 1,SNU66 homolog;Squamous cell carcinoma antigen recognized by T-cells 1;U4/U6.U5 tri-snRNP-associated 110 kDa protein;, PF03343;, GO:0015030;GO:0071013;GO:0005737;GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0071005;GO:0046540;GO:0003723;GO:0000481;GO:0045292;GO:0000398;GO:0045585;GO:0000387;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:RNA binding;, P:maturation of 5S rRNA; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:positive regulation of cytotoxic T cell differentiation; P:spliceosomal snRNP assembly;|O43290 A6NDN1 Q53GB5,U4/U6.U5 tri-snRNP-associated protein 1,SNU66 homolog;Squamous cell carcinoma antigen recognized by T-cells 1;U4/U6.U5 tri-snRNP-associated 110 kDa protein;, PF03343;, GO:0015030;GO:0071013;GO:0005737;GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0071005;GO:0046540;GO:0003723;GO:0000481;GO:0045292;GO:0000398;GO:0045585;GO:0000387;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:RNA binding;, P:maturation of 5S rRNA; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:positive regulation of cytotoxic T cell differentiation; P:spliceosomal snRNP assembly;|O43290 A6NDN1 Q53GB5,U4/U6.U5 tri-snRNP-associated protein 1,SNU66 homolog;Squamous cell carcinoma antigen recognized by T-cells 1;U4/U6.U5 tri-snRNP-associated 110 kDa protein;, PF03343;, GO:0015030;GO:0071013;GO:0005737;GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0071005;GO:0046540;GO:0003723;GO:0000481;GO:0045292;GO:0000398;GO:0045585;GO:0000387;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:RNA binding;, P:maturation of 5S rRNA; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:positive regulation of cytotoxic T cell differentiation; P:spliceosomal snRNP assembly;|O43290 A6NDN1 Q53GB5,U4/U6.U5 tri-snRNP-associated protein 1,SNU66 homolog;Squamous cell carcinoma antigen recognized by T-cells 1;U4/U6.U5 tri-snRNP-associated 110 kDa protein;, PF03343;, GO:0015030;GO:0071013;GO:0005737;GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0071005;GO:0046540;GO:0003723;GO:0000481;GO:0045292;GO:0000398;GO:0045585;GO:0000387;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:RNA binding;, P:maturation of 5S rRNA; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:positive regulation of cytotoxic T cell differentiation; P:spliceosomal snRNP assembly;|O43290 A6NDN1 Q53GB5,U4/U6.U5 tri-snRNP-associated protein 1,SNU66 homolog;Squamous cell carcinoma antigen recognized by T-cells 1;U4/U6.U5 tri-snRNP-associated 110 kDa protein;, PF03343;, GO:0015030;GO:0071013;GO:0005737;GO:0005829;GO:0005794;GO:0016607;GO:0005654;GO:0005634;GO:0071005;GO:0046540;GO:0003723;GO:0000481;GO:0045292;GO:0000398;GO:0045585;GO:0000387;, C:Cajal body; C:catalytic step 2 spliceosome; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex;, F:RNA binding;, P:maturation of 5S rRNA; P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome; P:positive regulation of cytotoxic T cell differentiation; P:spliceosomal snRNP assembly; scaffold176 indexed_genome mRNA 1039462 1044715 . - . ID=transcript_15292;Q8N9N8 B2R4N5 Q9BSC1,Probable RNA-binding protein EIF1AD,Eukaryotic translation initiation factor 1A domain-containing protein;Haponin;, PF01176;, GO:0045111;GO:0043231;GO:0005654;GO:0005634;GO:0003743;, C:intermediate filament cytoskeleton; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:translation initiation factor activity; scaffold176 indexed_genome mRNA 1045128 1046794 . + . ID=transcript_15293;O75531 O60558 Q6FGG7,Barrier-to-autointegration factor,Breakpoint cluster region protein 1;, PF02961;, GO:0000793;GO:0005737;GO:0005829;GO:0005635;GO:0005654;GO:0005634;GO:0003677;GO:0019899;GO:0042802;GO:0097726;GO:0008022;GO:0042803;GO:0047485;GO:0030261;GO:0007059;GO:0015074;GO:0075713;GO:0007084;GO:0045071;GO:0051169;GO:0009615;, C:condensed chromosome; C:cytoplasm; C:cytosol; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:DNA binding; F:enzyme binding; F:identical protein binding; F:LEM domain binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein N-terminus binding;, P:chromosome condensation; P:chromosome segregation; P:DNA integration; P:establishment of integrated proviral latency; P:mitotic nuclear envelope reassembly; P:negative regulation of viral genome replication; P:nuclear transport; P:response to virus;|O75531 O60558 Q6FGG7,Barrier-to-autointegration factor,Breakpoint cluster region protein 1;, PF02961;, GO:0000793;GO:0005737;GO:0005829;GO:0005635;GO:0005654;GO:0005634;GO:0003677;GO:0019899;GO:0042802;GO:0097726;GO:0008022;GO:0042803;GO:0047485;GO:0030261;GO:0007059;GO:0015074;GO:0075713;GO:0007084;GO:0045071;GO:0051169;GO:0009615;, C:condensed chromosome; C:cytoplasm; C:cytosol; C:nuclear envelope; C:nucleoplasm; C:nucleus;, F:DNA binding; F:enzyme binding; F:identical protein binding; F:LEM domain binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein N-terminus binding;, P:chromosome condensation; P:chromosome segregation; P:DNA integration; P:establishment of integrated proviral latency; P:mitotic nuclear envelope reassembly; P:negative regulation of viral genome replication; P:nuclear transport; P:response to virus; scaffold176 indexed_genome mRNA 1077615 1087931 . - . ID=transcript_15294;Q96A11 Q14D05,Galactose-3-O-sulfotransferase 3,Beta-galactose-3-O-sulfotransferase 3;Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3;, PF06990;, GO:0032580;GO:0016021;GO:0050656;GO:0030246;GO:0050694;GO:0001733;GO:0050698;GO:0008146;GO:0009247;GO:0005996;GO:0009311;GO:0030309;GO:0030166;GO:0006790;, C:Golgi cisterna membrane; C:integral component of membrane;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:carbohydrate binding; F:galactose 3-O-sulfotransferase activity; F:galactosylceramide sulfotransferase activity; F:proteoglycan sulfotransferase activity; F:sulfotransferase activity;, P:glycolipid biosynthetic process; P:monosaccharide metabolic process; P:oligosaccharide metabolic process; P:poly-N-acetyllactosamine metabolic process; P:proteoglycan biosynthetic process; P:sulfur compound metabolic process; scaffold176 indexed_genome mRNA 1090844 1105951 . + . ID=transcript_15295;Q13435 A8K485 B4DT19 Q7L4T5 Q7Z627 Q969K1 Q96CM6 Q9BWD2,Splicing factor 3B subunit 2,Pre-mRNA-splicing factor SF3b 145 kDa subunit;Spliceosome-associated protein 145;, PF04037;PF04046;PF02037;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0005681;GO:0005689;GO:0005686;GO:0071005;GO:0005684;GO:0003723;GO:0006397;GO:0000398;GO:0008380;GO:0016032;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:viral process;|Q13435 A8K485 B4DT19 Q7L4T5 Q7Z627 Q969K1 Q96CM6 Q9BWD2,Splicing factor 3B subunit 2,Pre-mRNA-splicing factor SF3b 145 kDa subunit;Spliceosome-associated protein 145;, PF04037;PF04046;PF02037;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0005681;GO:0005689;GO:0005686;GO:0071005;GO:0005684;GO:0003723;GO:0006397;GO:0000398;GO:0008380;GO:0016032;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:viral process;|Q13435 A8K485 B4DT19 Q7L4T5 Q7Z627 Q969K1 Q96CM6 Q9BWD2,Splicing factor 3B subunit 2,Pre-mRNA-splicing factor SF3b 145 kDa subunit;Spliceosome-associated protein 145;, PF04037;PF04046;PF02037;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0005681;GO:0005689;GO:0005686;GO:0071005;GO:0005684;GO:0003723;GO:0006397;GO:0000398;GO:0008380;GO:0016032;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:viral process;|Q13435 A8K485 B4DT19 Q7L4T5 Q7Z627 Q969K1 Q96CM6 Q9BWD2,Splicing factor 3B subunit 2,Pre-mRNA-splicing factor SF3b 145 kDa subunit;Spliceosome-associated protein 145;, PF04037;PF04046;PF02037;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0005681;GO:0005689;GO:0005686;GO:0071005;GO:0005684;GO:0003723;GO:0006397;GO:0000398;GO:0008380;GO:0016032;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:viral process;|Q13435 A8K485 B4DT19 Q7L4T5 Q7Z627 Q969K1 Q96CM6 Q9BWD2,Splicing factor 3B subunit 2,Pre-mRNA-splicing factor SF3b 145 kDa subunit;Spliceosome-associated protein 145;, PF04037;PF04046;PF02037;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0005681;GO:0005689;GO:0005686;GO:0071005;GO:0005684;GO:0003723;GO:0006397;GO:0000398;GO:0008380;GO:0016032;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:viral process;|Q13435 A8K485 B4DT19 Q7L4T5 Q7Z627 Q969K1 Q96CM6 Q9BWD2,Splicing factor 3B subunit 2,Pre-mRNA-splicing factor SF3b 145 kDa subunit;Spliceosome-associated protein 145;, PF04037;PF04046;PF02037;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0005681;GO:0005689;GO:0005686;GO:0071005;GO:0005684;GO:0003723;GO:0006397;GO:0000398;GO:0008380;GO:0016032;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:viral process;|Q13435 A8K485 B4DT19 Q7L4T5 Q7Z627 Q969K1 Q96CM6 Q9BWD2,Splicing factor 3B subunit 2,Pre-mRNA-splicing factor SF3b 145 kDa subunit;Spliceosome-associated protein 145;, PF04037;PF04046;PF02037;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0071011;GO:0005681;GO:0005689;GO:0005686;GO:0071005;GO:0005684;GO:0003723;GO:0006397;GO:0000398;GO:0008380;GO:0016032;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:precatalytic spliceosome; C:spliceosomal complex; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type spliceosomal complex;, F:RNA binding;, P:mRNA processing; P:mRNA splicing, via spliceosome; P:RNA splicing; P:viral process; scaffold176 indexed_genome mRNA 1229516 1258106 . + . ID=transcript_15296;Q6VY07 Q6PJY6 Q6PKB6 Q7Z590 Q7Z5W4 Q8N8K6 Q96MW0 Q9NW92 Q9ULP5,Phosphofurin acidic cluster sorting protein 1,, PF10254;, GO:0030137;GO:0005829;GO:0005794;GO:0044325;GO:0034067;GO:0072659;GO:0050690;, C:COPI-coated vesicle; C:cytosol; C:Golgi apparatus;, F:ion channel binding;, P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:regulation of defense response to virus by virus;|Q6VY07 Q6PJY6 Q6PKB6 Q7Z590 Q7Z5W4 Q8N8K6 Q96MW0 Q9NW92 Q9ULP5,Phosphofurin acidic cluster sorting protein 1,, PF10254;, GO:0030137;GO:0005829;GO:0005794;GO:0044325;GO:0034067;GO:0072659;GO:0050690;, C:COPI-coated vesicle; C:cytosol; C:Golgi apparatus;, F:ion channel binding;, P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:regulation of defense response to virus by virus;|Q6VY07 Q6PJY6 Q6PKB6 Q7Z590 Q7Z5W4 Q8N8K6 Q96MW0 Q9NW92 Q9ULP5,Phosphofurin acidic cluster sorting protein 1,, PF10254;, GO:0030137;GO:0005829;GO:0005794;GO:0044325;GO:0034067;GO:0072659;GO:0050690;, C:COPI-coated vesicle; C:cytosol; C:Golgi apparatus;, F:ion channel binding;, P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:regulation of defense response to virus by virus;|Q6VY07 Q6PJY6 Q6PKB6 Q7Z590 Q7Z5W4 Q8N8K6 Q96MW0 Q9NW92 Q9ULP5,Phosphofurin acidic cluster sorting protein 1,, PF10254;, GO:0030137;GO:0005829;GO:0005794;GO:0044325;GO:0034067;GO:0072659;GO:0050690;, C:COPI-coated vesicle; C:cytosol; C:Golgi apparatus;, F:ion channel binding;, P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:regulation of defense response to virus by virus;|Q6VY07 Q6PJY6 Q6PKB6 Q7Z590 Q7Z5W4 Q8N8K6 Q96MW0 Q9NW92 Q9ULP5,Phosphofurin acidic cluster sorting protein 1,, PF10254;, GO:0030137;GO:0005829;GO:0005794;GO:0044325;GO:0034067;GO:0072659;GO:0050690;, C:COPI-coated vesicle; C:cytosol; C:Golgi apparatus;, F:ion channel binding;, P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:regulation of defense response to virus by virus;|Q6VY07 Q6PJY6 Q6PKB6 Q7Z590 Q7Z5W4 Q8N8K6 Q96MW0 Q9NW92 Q9ULP5,Phosphofurin acidic cluster sorting protein 1,, PF10254;, GO:0030137;GO:0005829;GO:0005794;GO:0044325;GO:0034067;GO:0072659;GO:0050690;, C:COPI-coated vesicle; C:cytosol; C:Golgi apparatus;, F:ion channel binding;, P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:regulation of defense response to virus by virus; scaffold176 indexed_genome mRNA 1269591 1279897 . - . ID=transcript_15297;Q9H0B6 A8MXL7 B2RDY4 Q9H9C8 Q9HA20,Kinesin light chain 2,, , GO:0005829;GO:0005871;GO:0016938;GO:0016020;GO:0005874;GO:0005739;GO:0005654;GO:0005886;GO:0032991;GO:0045296;GO:0019894;GO:0019886;GO:0007018;GO:0006890;, C:cytosol; C:kinesin complex; C:kinesin I complex; C:membrane; C:microtubule; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:cadherin binding; F:kinesin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9H0B6 A8MXL7 B2RDY4 Q9H9C8 Q9HA20,Kinesin light chain 2,, , GO:0005829;GO:0005871;GO:0016938;GO:0016020;GO:0005874;GO:0005739;GO:0005654;GO:0005886;GO:0032991;GO:0045296;GO:0019894;GO:0019886;GO:0007018;GO:0006890;, C:cytosol; C:kinesin complex; C:kinesin I complex; C:membrane; C:microtubule; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:cadherin binding; F:kinesin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9H0B6 A8MXL7 B2RDY4 Q9H9C8 Q9HA20,Kinesin light chain 2,, , GO:0005829;GO:0005871;GO:0016938;GO:0016020;GO:0005874;GO:0005739;GO:0005654;GO:0005886;GO:0032991;GO:0045296;GO:0019894;GO:0019886;GO:0007018;GO:0006890;, C:cytosol; C:kinesin complex; C:kinesin I complex; C:membrane; C:microtubule; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:cadherin binding; F:kinesin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q9H0B6 A8MXL7 B2RDY4 Q9H9C8 Q9HA20,Kinesin light chain 2,, , GO:0005829;GO:0005871;GO:0016938;GO:0016020;GO:0005874;GO:0005739;GO:0005654;GO:0005886;GO:0032991;GO:0045296;GO:0019894;GO:0019886;GO:0007018;GO:0006890;, C:cytosol; C:kinesin complex; C:kinesin I complex; C:membrane; C:microtubule; C:mitochondrion; C:nucleoplasm; C:plasma membrane; C:protein-containing complex;, F:cadherin binding; F:kinesin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold176 indexed_genome mRNA 1280092 1287389 . + . ID=transcript_15298;Q9H0U4 A8K7S1,Ras-related protein Rab-1B,, PF00071;, GO:0005829;GO:0012505;GO:0005789;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0048471;GO:0034045;GO:0030133;GO:0005525;GO:0003924;GO:0000045;GO:0048208;GO:0006888;GO:0006886;GO:1903020;GO:0043687;GO:2000785;GO:0006890;GO:0019068;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:perinuclear region of cytoplasm; C:phagophore assembly site membrane; C:transport vesicle;, F:GTP binding; F:GTPase activity;, P:autophagosome assembly; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:positive regulation of glycoprotein metabolic process; P:post-translational protein modification; P:regulation of autophagosome assembly; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:virion assembly;|P62820 P11476 Q6FIE7 Q96N61 Q9Y3T2,Ras-related protein Rab-1A,YPT1-related protein;, PF00071;, GO:0005829;GO:0005769;GO:0012505;GO:0005783;GO:0070062;GO:0005794;GO:0000139;GO:0042470;GO:0030658;GO:0045296;GO:0005525;GO:0003924;GO:0000045;GO:0006914;GO:0016477;GO:0048208;GO:0090110;GO:0042742;GO:0006897;GO:0006888;GO:0007030;GO:0030252;GO:0006886;GO:0032402;GO:1903020;GO:0032757;GO:1904668;GO:0043687;GO:0006890;GO:0034446;GO:0047496;GO:0016192;GO:0019068;, C:cytosol; C:early endosome; C:endomembrane system; C:endoplasmic reticulum; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:melanosome; C:transport vesicle membrane;, F:cadherin binding; F:GTP binding; F:GTPase activity;, P:autophagosome assembly; P:autophagy; P:cell migration; P:COPII vesicle coating; P:COPII-coated vesicle cargo loading; P:defense response to bacterium; P:endocytosis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:growth hormone secretion; P:intracellular protein transport; P:melanosome transport; P:positive regulation of glycoprotein metabolic process; P:positive regulation of interleukin-8 production; P:positive regulation of ubiquitin protein ligase activity; P:post-translational protein modification; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:substrate adhesion-dependent cell spreading; P:vesicle transport along microtubule; P:vesicle-mediated transport; P:virion assembly;|Q9H0U4 A8K7S1,Ras-related protein Rab-1B,, PF00071;, GO:0005829;GO:0012505;GO:0005789;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0048471;GO:0034045;GO:0030133;GO:0005525;GO:0003924;GO:0000045;GO:0048208;GO:0006888;GO:0006886;GO:1903020;GO:0043687;GO:2000785;GO:0006890;GO:0019068;, C:cytosol; C:endomembrane system; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:perinuclear region of cytoplasm; C:phagophore assembly site membrane; C:transport vesicle;, F:GTP binding; F:GTPase activity;, P:autophagosome assembly; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular protein transport; P:positive regulation of glycoprotein metabolic process; P:post-translational protein modification; P:regulation of autophagosome assembly; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:virion assembly; scaffold177 indexed_genome mRNA 83874 139570 . + . ID=transcript_15299;Q86TV6 Q86U24 Q86VT3,Tetratricopeptide repeat protein 7B,Tetratricopeptide repeat protein 7-like-1;, PF13181;, GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q86TV6 Q86U24 Q86VT3,Tetratricopeptide repeat protein 7B,Tetratricopeptide repeat protein 7-like-1;, PF13181;, GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane;|Q86TV6 Q86U24 Q86VT3,Tetratricopeptide repeat protein 7B,Tetratricopeptide repeat protein 7-like-1;, PF13181;, GO:0005829;GO:0005886;GO:0046854;GO:0072659;, C:cytosol; C:plasma membrane;, , P:phosphatidylinositol phosphorylation; P:protein localization to plasma membrane; scaffold177 indexed_genome mRNA 299223 308139 . + . ID=transcript_15300;O75582 B7Z2Y5 O95316 Q96AF7,Ribosomal protein S6 kinase alpha-5,90 kDa ribosomal protein S6 kinase 5;Nuclear mitogen- and stress-activated protein kinase 1;RSK-like protein kinase;, PF00069;PF00433;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007173;GO:0043990;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0045892;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;GO:0002223;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:epidermal growth factor receptor signaling pathway; P:histone H2A-S1 phosphorylation; P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated; P:stimulatory C-type lectin receptor signaling pathway;|O75582 B7Z2Y5 O95316 Q96AF7,Ribosomal protein S6 kinase alpha-5,90 kDa ribosomal protein S6 kinase 5;Nuclear mitogen- and stress-activated protein kinase 1;RSK-like protein kinase;, PF00069;PF00433;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007173;GO:0043990;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0045892;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;GO:0002223;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:epidermal growth factor receptor signaling pathway; P:histone H2A-S1 phosphorylation; P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated; P:stimulatory C-type lectin receptor signaling pathway; scaffold177 indexed_genome mRNA 308800 403472 . + . ID=transcript_15301;O75582 B7Z2Y5 O95316 Q96AF7,Ribosomal protein S6 kinase alpha-5,90 kDa ribosomal protein S6 kinase 5;Nuclear mitogen- and stress-activated protein kinase 1;RSK-like protein kinase;, PF00069;PF00433;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007173;GO:0043990;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0045892;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;GO:0002223;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:epidermal growth factor receptor signaling pathway; P:histone H2A-S1 phosphorylation; P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated; P:stimulatory C-type lectin receptor signaling pathway;|O75582 B7Z2Y5 O95316 Q96AF7,Ribosomal protein S6 kinase alpha-5,90 kDa ribosomal protein S6 kinase 5;Nuclear mitogen- and stress-activated protein kinase 1;RSK-like protein kinase;, PF00069;PF00433;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007173;GO:0043990;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0045892;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;GO:0002223;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:epidermal growth factor receptor signaling pathway; P:histone H2A-S1 phosphorylation; P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated; P:stimulatory C-type lectin receptor signaling pathway;|O75582 B7Z2Y5 O95316 Q96AF7,Ribosomal protein S6 kinase alpha-5,90 kDa ribosomal protein S6 kinase 5;Nuclear mitogen- and stress-activated protein kinase 1;RSK-like protein kinase;, PF00069;PF00433;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007173;GO:0043990;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0045892;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;GO:0002223;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:epidermal growth factor receptor signaling pathway; P:histone H2A-S1 phosphorylation; P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated; P:stimulatory C-type lectin receptor signaling pathway;|O75582 B7Z2Y5 O95316 Q96AF7,Ribosomal protein S6 kinase alpha-5,90 kDa ribosomal protein S6 kinase 5;Nuclear mitogen- and stress-activated protein kinase 1;RSK-like protein kinase;, PF00069;PF00433;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007173;GO:0043990;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0045892;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;GO:0002223;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:epidermal growth factor receptor signaling pathway; P:histone H2A-S1 phosphorylation; P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated; P:stimulatory C-type lectin receptor signaling pathway;|O75582 B7Z2Y5 O95316 Q96AF7,Ribosomal protein S6 kinase alpha-5,90 kDa ribosomal protein S6 kinase 5;Nuclear mitogen- and stress-activated protein kinase 1;RSK-like protein kinase;, PF00069;PF00433;, GO:0005737;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007173;GO:0043990;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0045892;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;GO:0002223;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:epidermal growth factor receptor signaling pathway; P:histone H2A-S1 phosphorylation; P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated; P:stimulatory C-type lectin receptor signaling pathway; scaffold177 indexed_genome mRNA 578076 578591 . + . ID=transcript_15302;Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response; scaffold177 indexed_genome mRNA 582782 681827 . + . ID=transcript_15303;Q6P4E1 B4DPZ6 G5E934 Q6UY45 Q96EM1,Protein GOLM2 {ECO:0000305},Cancer susceptibility candidate gene 4 protein;Golgi membrane protein 2 {ECO:0000305};, , GO:0005794;GO:0016021;, C:Golgi apparatus; C:integral component of membrane; scaffold177 indexed_genome mRNA 695619 754348 . + . ID=transcript_15304;Q05D32 Q3ZTU1 Q6AI06 Q8IYI9 Q9NVT2 Q9NZX8 Q9P030,CTD small phosphatase-like protein 2,, PF03031;, GO:0005654;GO:0004721;GO:0008420;GO:0030514;GO:0046827;, C:nucleoplasm;, F:phosphoprotein phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:negative regulation of BMP signaling pathway; P:positive regulation of protein export from nucleus;|Q05D32 Q3ZTU1 Q6AI06 Q8IYI9 Q9NVT2 Q9NZX8 Q9P030,CTD small phosphatase-like protein 2,, PF03031;, GO:0005654;GO:0004721;GO:0008420;GO:0030514;GO:0046827;, C:nucleoplasm;, F:phosphoprotein phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:negative regulation of BMP signaling pathway; P:positive regulation of protein export from nucleus; scaffold177 indexed_genome mRNA 762688 769152 . + . ID=transcript_15305;Q05D32 Q3ZTU1 Q6AI06 Q8IYI9 Q9NVT2 Q9NZX8 Q9P030,CTD small phosphatase-like protein 2,, PF03031;, GO:0005654;GO:0004721;GO:0008420;GO:0030514;GO:0046827;, C:nucleoplasm;, F:phosphoprotein phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:negative regulation of BMP signaling pathway; P:positive regulation of protein export from nucleus;|Q05D32 Q3ZTU1 Q6AI06 Q8IYI9 Q9NVT2 Q9NZX8 Q9P030,CTD small phosphatase-like protein 2,, PF03031;, GO:0005654;GO:0004721;GO:0008420;GO:0030514;GO:0046827;, C:nucleoplasm;, F:phosphoprotein phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:negative regulation of BMP signaling pathway; P:positive regulation of protein export from nucleus;|Q05D32 Q3ZTU1 Q6AI06 Q8IYI9 Q9NVT2 Q9NZX8 Q9P030,CTD small phosphatase-like protein 2,, PF03031;, GO:0005654;GO:0004721;GO:0008420;GO:0030514;GO:0046827;, C:nucleoplasm;, F:phosphoprotein phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:negative regulation of BMP signaling pathway; P:positive regulation of protein export from nucleus;|Q05D32 Q3ZTU1 Q6AI06 Q8IYI9 Q9NVT2 Q9NZX8 Q9P030,CTD small phosphatase-like protein 2,, PF03031;, GO:0005654;GO:0004721;GO:0008420;GO:0030514;GO:0046827;, C:nucleoplasm;, F:phosphoprotein phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:negative regulation of BMP signaling pathway; P:positive regulation of protein export from nucleus; scaffold177 indexed_genome mRNA 794442 816236 . + . ID=transcript_15306;O75822 B4DUI3 F5H425 Q9BUD2 Q9H8Q2 Q9UI65,Eukaryotic translation initiation factor 3 subunit J {ECO:0000255|HAMAP-Rule:MF_03009},Eukaryotic translation initiation factor 3 subunit 1 {ECO:0000255|HAMAP-Rule:MF_03009};eIF-3-alpha {ECO:0000255|HAMAP-Rule:MF_03009};eIF3 p35 {ECO:0000255|HAMAP-Rule:MF_03009};, PF08597;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0042802;GO:0003743;GO:0001732;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex;, F:identical protein binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:translational initiation;|O75822 B4DUI3 F5H425 Q9BUD2 Q9H8Q2 Q9UI65,Eukaryotic translation initiation factor 3 subunit J {ECO:0000255|HAMAP-Rule:MF_03009},Eukaryotic translation initiation factor 3 subunit 1 {ECO:0000255|HAMAP-Rule:MF_03009};eIF-3-alpha {ECO:0000255|HAMAP-Rule:MF_03009};eIF3 p35 {ECO:0000255|HAMAP-Rule:MF_03009};, PF08597;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0042802;GO:0003743;GO:0001732;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex;, F:identical protein binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:translational initiation;|O75822 B4DUI3 F5H425 Q9BUD2 Q9H8Q2 Q9UI65,Eukaryotic translation initiation factor 3 subunit J {ECO:0000255|HAMAP-Rule:MF_03009},Eukaryotic translation initiation factor 3 subunit 1 {ECO:0000255|HAMAP-Rule:MF_03009};eIF-3-alpha {ECO:0000255|HAMAP-Rule:MF_03009};eIF3 p35 {ECO:0000255|HAMAP-Rule:MF_03009};, PF08597;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0042802;GO:0003743;GO:0001732;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex;, F:identical protein binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:translational initiation;|O75822 B4DUI3 F5H425 Q9BUD2 Q9H8Q2 Q9UI65,Eukaryotic translation initiation factor 3 subunit J {ECO:0000255|HAMAP-Rule:MF_03009},Eukaryotic translation initiation factor 3 subunit 1 {ECO:0000255|HAMAP-Rule:MF_03009};eIF-3-alpha {ECO:0000255|HAMAP-Rule:MF_03009};eIF3 p35 {ECO:0000255|HAMAP-Rule:MF_03009};, PF08597;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0042802;GO:0003743;GO:0001732;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex;, F:identical protein binding; F:translation initiation factor activity;, P:formation of cytoplasmic translation initiation complex; P:translational initiation;|Q8TBU9 Q9H734,Spatacsin,Colorectal carcinoma-associated protein;Spastic paraplegia 11 protein;, PF14649;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005765;GO:0005730;GO:0005886;GO:0045202;GO:0008088;GO:0048675;GO:0007268;GO:0090389;GO:0048489;GO:0090659;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:lysosomal membrane; C:nucleolus; C:plasma membrane; C:synapse;, , P:axo-dendritic transport; P:axon extension; P:chemical synaptic transmission; P:phagosome-lysosome fusion involved in apoptotic cell clearance; P:synaptic vesicle transport; P:walking behavior;|Q8TBU9 Q9H734,Spatacsin,Colorectal carcinoma-associated protein;Spastic paraplegia 11 protein;, PF14649;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005765;GO:0005730;GO:0005886;GO:0045202;GO:0008088;GO:0048675;GO:0007268;GO:0090389;GO:0048489;GO:0090659;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:lysosomal membrane; C:nucleolus; C:plasma membrane; C:synapse;, , P:axo-dendritic transport; P:axon extension; P:chemical synaptic transmission; P:phagosome-lysosome fusion involved in apoptotic cell clearance; P:synaptic vesicle transport; P:walking behavior;|Q8TBU9 Q9H734,Spatacsin,Colorectal carcinoma-associated protein;Spastic paraplegia 11 protein;, PF14649;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005765;GO:0005730;GO:0005886;GO:0045202;GO:0008088;GO:0048675;GO:0007268;GO:0090389;GO:0048489;GO:0090659;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:lysosomal membrane; C:nucleolus; C:plasma membrane; C:synapse;, , P:axo-dendritic transport; P:axon extension; P:chemical synaptic transmission; P:phagosome-lysosome fusion involved in apoptotic cell clearance; P:synaptic vesicle transport; P:walking behavior;|Q8TBU9 Q9H734,Spatacsin,Colorectal carcinoma-associated protein;Spastic paraplegia 11 protein;, PF14649;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005765;GO:0005730;GO:0005886;GO:0045202;GO:0008088;GO:0048675;GO:0007268;GO:0090389;GO:0048489;GO:0090659;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:lysosomal membrane; C:nucleolus; C:plasma membrane; C:synapse;, , P:axo-dendritic transport; P:axon extension; P:chemical synaptic transmission; P:phagosome-lysosome fusion involved in apoptotic cell clearance; P:synaptic vesicle transport; P:walking behavior;|Q8TBU9 Q9H734,Spatacsin,Colorectal carcinoma-associated protein;Spastic paraplegia 11 protein;, PF14649;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005765;GO:0005730;GO:0005886;GO:0045202;GO:0008088;GO:0048675;GO:0007268;GO:0090389;GO:0048489;GO:0090659;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:lysosomal membrane; C:nucleolus; C:plasma membrane; C:synapse;, , P:axo-dendritic transport; P:axon extension; P:chemical synaptic transmission; P:phagosome-lysosome fusion involved in apoptotic cell clearance; P:synaptic vesicle transport; P:walking behavior; scaffold177 indexed_genome mRNA 817028 845959 . - . ID=transcript_15307;Q8TBU9 Q9H734,Spatacsin,Colorectal carcinoma-associated protein;Spastic paraplegia 11 protein;, PF14649;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005765;GO:0005730;GO:0005886;GO:0045202;GO:0008088;GO:0048675;GO:0007268;GO:0090389;GO:0048489;GO:0090659;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:lysosomal membrane; C:nucleolus; C:plasma membrane; C:synapse;, , P:axo-dendritic transport; P:axon extension; P:chemical synaptic transmission; P:phagosome-lysosome fusion involved in apoptotic cell clearance; P:synaptic vesicle transport; P:walking behavior;|Q8TBU9 Q9H734,Spatacsin,Colorectal carcinoma-associated protein;Spastic paraplegia 11 protein;, PF14649;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005765;GO:0005730;GO:0005886;GO:0045202;GO:0008088;GO:0048675;GO:0007268;GO:0090389;GO:0048489;GO:0090659;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:lysosomal membrane; C:nucleolus; C:plasma membrane; C:synapse;, , P:axo-dendritic transport; P:axon extension; P:chemical synaptic transmission; P:phagosome-lysosome fusion involved in apoptotic cell clearance; P:synaptic vesicle transport; P:walking behavior;|Q8TBU9 Q9H734,Spatacsin,Colorectal carcinoma-associated protein;Spastic paraplegia 11 protein;, PF14649;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005765;GO:0005730;GO:0005886;GO:0045202;GO:0008088;GO:0048675;GO:0007268;GO:0090389;GO:0048489;GO:0090659;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:lysosomal membrane; C:nucleolus; C:plasma membrane; C:synapse;, , P:axo-dendritic transport; P:axon extension; P:chemical synaptic transmission; P:phagosome-lysosome fusion involved in apoptotic cell clearance; P:synaptic vesicle transport; P:walking behavior;|Q8TBU9 Q9H734,Spatacsin,Colorectal carcinoma-associated protein;Spastic paraplegia 11 protein;, PF14649;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005765;GO:0005730;GO:0005886;GO:0045202;GO:0008088;GO:0048675;GO:0007268;GO:0090389;GO:0048489;GO:0090659;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:lysosomal membrane; C:nucleolus; C:plasma membrane; C:synapse;, , P:axo-dendritic transport; P:axon extension; P:chemical synaptic transmission; P:phagosome-lysosome fusion involved in apoptotic cell clearance; P:synaptic vesicle transport; P:walking behavior; scaffold177 indexed_genome mRNA 845971 876468 . - . ID=transcript_15308;Q8TBU9 Q9H734,Spatacsin,Colorectal carcinoma-associated protein;Spastic paraplegia 11 protein;, PF14649;, GO:0030424;GO:0005737;GO:0031410;GO:0005829;GO:0030425;GO:0005765;GO:0005730;GO:0005886;GO:0045202;GO:0008088;GO:0048675;GO:0007268;GO:0090389;GO:0048489;GO:0090659;, C:axon; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:lysosomal membrane; C:nucleolus; C:plasma membrane; C:synapse;, , P:axo-dendritic transport; P:axon extension; P:chemical synaptic transmission; P:phagosome-lysosome fusion involved in apoptotic cell clearance; P:synaptic vesicle transport; P:walking behavior; scaffold177 indexed_genome mRNA 881339 891171 . - . ID=transcript_15309;C9JE40,Protein PAT1 homolog 2,PAT1-like protein 2;Protein PAT1 homolog a;, PF09770;, GO:0005737;GO:0005634;GO:0000932;GO:0003723;GO:0000290;GO:0010607;GO:0017148;GO:0033962;, C:cytoplasm; C:nucleus; C:P-body;, F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of cytoplasmic mRNA processing body assembly; P:negative regulation of translation; P:P-body assembly;|C9JE40,Protein PAT1 homolog 2,PAT1-like protein 2;Protein PAT1 homolog a;, PF09770;, GO:0005737;GO:0005634;GO:0000932;GO:0003723;GO:0000290;GO:0010607;GO:0017148;GO:0033962;, C:cytoplasm; C:nucleus; C:P-body;, F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of cytoplasmic mRNA processing body assembly; P:negative regulation of translation; P:P-body assembly;|C9JE40,Protein PAT1 homolog 2,PAT1-like protein 2;Protein PAT1 homolog a;, PF09770;, GO:0005737;GO:0005634;GO:0000932;GO:0003723;GO:0000290;GO:0010607;GO:0017148;GO:0033962;, C:cytoplasm; C:nucleus; C:P-body;, F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of cytoplasmic mRNA processing body assembly; P:negative regulation of translation; P:P-body assembly;|C9JE40,Protein PAT1 homolog 2,PAT1-like protein 2;Protein PAT1 homolog a;, PF09770;, GO:0005737;GO:0005634;GO:0000932;GO:0003723;GO:0000290;GO:0010607;GO:0017148;GO:0033962;, C:cytoplasm; C:nucleus; C:P-body;, F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of cytoplasmic mRNA processing body assembly; P:negative regulation of translation; P:P-body assembly;|C9JE40,Protein PAT1 homolog 2,PAT1-like protein 2;Protein PAT1 homolog a;, PF09770;, GO:0005737;GO:0005634;GO:0000932;GO:0003723;GO:0000290;GO:0010607;GO:0017148;GO:0033962;, C:cytoplasm; C:nucleus; C:P-body;, F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of cytoplasmic mRNA processing body assembly; P:negative regulation of translation; P:P-body assembly;|C9JE40,Protein PAT1 homolog 2,PAT1-like protein 2;Protein PAT1 homolog a;, PF09770;, GO:0005737;GO:0005634;GO:0000932;GO:0003723;GO:0000290;GO:0010607;GO:0017148;GO:0033962;, C:cytoplasm; C:nucleus; C:P-body;, F:RNA binding;, P:deadenylation-dependent decapping of nuclear-transcribed mRNA; P:negative regulation of cytoplasmic mRNA processing body assembly; P:negative regulation of translation; P:P-body assembly; scaffold177 indexed_genome mRNA 971642 1001403 . + . ID=transcript_15310;Q86WT6 A8MX03 Q309B0 Q4G1A5 Q6W897 Q8IYY3 Q8WY16 Q8WY17,E3 ubiquitin-protein ligase TRIM69,RFP-like domain-containing protein trimless;RING finger protein 36;RING-type E3 ubiquitin transferase TRIM69 {ECO:0000305};Tripartite motif-containing protein 69;, PF13765;PF00622;, GO:0005737;GO:0005829;GO:0016607;GO:0005634;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0006915;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleus;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:protein polyubiquitination; P:protein ubiquitination; scaffold177 indexed_genome mRNA 1002514 1005014 . + . ID=transcript_15311;Q86WT6 A8MX03 Q309B0 Q4G1A5 Q6W897 Q8IYY3 Q8WY16 Q8WY17,E3 ubiquitin-protein ligase TRIM69,RFP-like domain-containing protein trimless;RING finger protein 36;RING-type E3 ubiquitin transferase TRIM69 {ECO:0000305};Tripartite motif-containing protein 69;, PF13765;PF00622;, GO:0005737;GO:0005829;GO:0016607;GO:0005634;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0006915;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleus;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:protein polyubiquitination; P:protein ubiquitination; scaffold177 indexed_genome mRNA 1014216 1014768 . - . ID=transcript_15312;Q86WT6 A8MX03 Q309B0 Q4G1A5 Q6W897 Q8IYY3 Q8WY16 Q8WY17,E3 ubiquitin-protein ligase TRIM69,RFP-like domain-containing protein trimless;RING finger protein 36;RING-type E3 ubiquitin transferase TRIM69 {ECO:0000305};Tripartite motif-containing protein 69;, PF13765;PF00622;, GO:0005737;GO:0005829;GO:0016607;GO:0005634;GO:0042802;GO:0046872;GO:0061630;GO:0004842;GO:0006915;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleus;, F:identical protein binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:protein polyubiquitination; P:protein ubiquitination; scaffold177 indexed_genome mRNA 1145103 1145618 . + . ID=transcript_15313;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold177 indexed_genome mRNA 1150706 1158359 . + . ID=transcript_15314;Q9B2Z0 Q9B2Z4 Q9T6H6 Q9T9Y0 Q9TEH4,Cytochrome b,Complex III subunit 3;Complex III subunit III;Cytochrome b-c1 complex subunit 3;Ubiquinol-cytochrome-c reductase complex cytochrome b subunit;, PF00032;PF00033;, GO:0031305;GO:0005743;GO:0005750;GO:0005739;GO:0046872;GO:0044877;GO:0008121;GO:0031100;GO:0015990;GO:0042538;GO:0006122;GO:0046686;GO:0051592;GO:0033590;GO:0046688;GO:0042493;GO:0045471;GO:0033762;GO:0009408;GO:0055093;GO:0001666;GO:0046689;GO:0009636;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion;, F:metal ion binding; F:protein-containing complex binding; F:ubiquinol-cytochrome-c reductase activity;, P:animal organ regeneration; P:electron transport coupled proton transport; P:hyperosmotic salinity response; P:mitochondrial electron transport, ubiquinol to cytochrome c; P:response to cadmium ion; P:response to calcium ion; P:response to cobalamin; P:response to copper ion; P:response to drug; P:response to ethanol; P:response to glucagon; P:response to heat; P:response to hyperoxia; P:response to hypoxia; P:response to mercury ion; P:response to toxic substance;|P63136,Endogenous retrovirus group K member 25 Pol protein,HERV-K_11q22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold177 indexed_genome mRNA 1199679 1202804 . + . ID=transcript_15315;Q8NEQ6 B3KXI9,Steroid receptor-associated and regulated protein {ECO:0000312|HGNC:HGNC:28339},ER-related factor {ECO:0000303|PubMed:22341523};Steroid receptor-regulated protein {ECO:0000303|PubMed:28915724};, PF15547;, GO:0005737;GO:0005634;GO:0030331;GO:0033148;, C:cytoplasm; C:nucleus;, F:estrogen receptor binding;, P:positive regulation of intracellular estrogen receptor signaling pathway; scaffold177 indexed_genome mRNA 1211582 1222639 . - . ID=transcript_15316;Q9UBY9 B3KQ37 C9K0Y0 Q9NU17,Heat shock protein beta-7,Cardiovascular heat shock protein;, PF00011;, GO:0016235;GO:0015030;GO:0005737;GO:0005654;GO:0005634;GO:0008022;GO:0007507;GO:0008016;GO:0006986;, C:aggresome; C:Cajal body; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:protein C-terminus binding;, P:heart development; P:regulation of heart contraction; P:response to unfolded protein;|Q9UBY9 B3KQ37 C9K0Y0 Q9NU17,Heat shock protein beta-7,Cardiovascular heat shock protein;, PF00011;, GO:0016235;GO:0015030;GO:0005737;GO:0005654;GO:0005634;GO:0008022;GO:0007507;GO:0008016;GO:0006986;, C:aggresome; C:Cajal body; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:protein C-terminus binding;, P:heart development; P:regulation of heart contraction; P:response to unfolded protein;|Q9UBY9 B3KQ37 C9K0Y0 Q9NU17,Heat shock protein beta-7,Cardiovascular heat shock protein;, PF00011;, GO:0016235;GO:0015030;GO:0005737;GO:0005654;GO:0005634;GO:0008022;GO:0007507;GO:0008016;GO:0006986;, C:aggresome; C:Cajal body; C:cytoplasm; C:nucleoplasm; C:nucleus;, F:protein C-terminus binding;, P:heart development; P:regulation of heart contraction; P:response to unfolded protein; scaffold177 indexed_genome mRNA 1225334 1226463 . + . ID=transcript_15317;P51801 B3KUY3 Q5T5Q7 Q5T5Q8,Chloride channel protein ClC-Kb,ClC-K2;, PF00571;PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0046872;GO:0005247;GO:0006821;GO:0007588;GO:0034220;GO:0034765;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:metal ion binding; F:voltage-gated chloride channel activity;, P:chloride transport; P:excretion; P:ion transmembrane transport; P:regulation of ion transmembrane transport; scaffold177 indexed_genome mRNA 1228964 1233376 . + . ID=transcript_15318;P51800 B4DPD3 E7EPH6 Q5T5P8 Q5T5Q4 Q7Z6D1 Q86VT1,Chloride channel protein ClC-Ka,ClC-K1;, PF00571;PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0042802;GO:0046872;GO:0005247;GO:0006821;GO:0007588;GO:0034220;GO:0034765;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:identical protein binding; F:metal ion binding; F:voltage-gated chloride channel activity;, P:chloride transport; P:excretion; P:ion transmembrane transport; P:regulation of ion transmembrane transport;|P51800 B4DPD3 E7EPH6 Q5T5P8 Q5T5Q4 Q7Z6D1 Q86VT1,Chloride channel protein ClC-Ka,ClC-K1;, PF00571;PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0042802;GO:0046872;GO:0005247;GO:0006821;GO:0007588;GO:0034220;GO:0034765;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:identical protein binding; F:metal ion binding; F:voltage-gated chloride channel activity;, P:chloride transport; P:excretion; P:ion transmembrane transport; P:regulation of ion transmembrane transport; scaffold177 indexed_genome mRNA 1234378 1238346 . - . ID=transcript_15319;P51801 B3KUY3 Q5T5Q7 Q5T5Q8,Chloride channel protein ClC-Kb,ClC-K2;, PF00571;PF00654;, GO:0034707;GO:0005887;GO:0005886;GO:0046872;GO:0005247;GO:0006821;GO:0007588;GO:0034220;GO:0034765;, C:chloride channel complex; C:integral component of plasma membrane; C:plasma membrane;, F:metal ion binding; F:voltage-gated chloride channel activity;, P:chloride transport; P:excretion; P:ion transmembrane transport; P:regulation of ion transmembrane transport; scaffold177 indexed_genome mRNA 1240182 1240868 . + . ID=transcript_15320;P29317 B5A968 Q8N3Z2,Ephrin type-A receptor 2,Epithelial cell kinase;Tyrosine-protein kinase receptor ECK;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0009986;GO:0005925;GO:0005887;GO:0030027;GO:0031258;GO:0031256;GO:0043005;GO:0005886;GO:0043235;GO:0032587;GO:0070160;GO:0005524;GO:0045296;GO:0019838;GO:0004714;GO:0005005;GO:0001618;GO:0090630;GO:0048320;GO:0007411;GO:0002043;GO:0046849;GO:0060444;GO:0046058;GO:0007155;GO:0060326;GO:0016477;GO:0048870;GO:0050830;GO:0048013;GO:0006954;GO:0008630;GO:0030216;GO:0070309;GO:0033598;GO:0007275;GO:0016525;GO:0032682;GO:1901491;GO:0051898;GO:0021915;GO:0060035;GO:0014028;GO:0001649;GO:0030316;GO:1904238;GO:1903348;GO:0033674;GO:1903078;GO:0036342;GO:0043491;GO:0072659;GO:0045765;GO:0043535;GO:0033628;GO:0070372;GO:0010591;GO:0070848;GO:0001501;GO:0007169;GO:0001570;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:leading edge membrane; C:neuron projection; C:plasma membrane; C:receptor complex; C:ruffle membrane; C:tight junction;, F:ATP binding; F:cadherin binding; F:growth factor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity; F:virus receptor activity;, P:activation of GTPase activity; P:axial mesoderm formation; P:axon guidance; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:cAMP metabolic process; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell motility; P:defense response to Gram-positive bacterium; P:ephrin receptor signaling pathway; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:keratinocyte differentiation; P:lens fiber cell morphogenesis; P:mammary gland epithelial cell proliferation; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of chemokine production; P:negative regulation of lymphangiogenesis; P:negative regulation of protein kinase B signaling; P:neural tube development; P:notochord cell development; P:notochord formation; P:osteoblast differentiation; P:osteoclast differentiation; P:pericyte cell differentiation; P:positive regulation of bicellular tight junction assembly; P:positive regulation of kinase activity; P:positive regulation of protein localization to plasma membrane; P:post-anal tail morphogenesis; P:protein kinase B signaling; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of ERK1 and ERK2 cascade; P:regulation of lamellipodium assembly; P:response to growth factor; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis; scaffold178 indexed_genome mRNA 712713 719679 . - . ID=transcript_15321;Q9Y271 B2R954 D3DTE4 Q5JS94 Q8IV19,Cysteinyl leukotriene receptor 1,Cysteinyl leukotriene D4 receptor;G-protein coupled receptor HG55;HMTMF81;, PF00001;, GO:0005887;GO:0016020;GO:0005886;GO:0001631;GO:0008528;GO:0004974;GO:0006816;GO:0007166;GO:0006935;GO:0006952;GO:0007186;GO:0002437;GO:0002862;GO:0007218;GO:0007204;GO:0007585;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:cysteinyl leukotriene receptor activity; F:G protein-coupled peptide receptor activity; F:leukotriene receptor activity;, P:calcium ion transport; P:cell surface receptor signaling pathway; P:chemotaxis; P:defense response; P:G protein-coupled receptor signaling pathway; P:inflammatory response to antigenic stimulus; P:negative regulation of inflammatory response to antigenic stimulus; P:neuropeptide signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:respiratory gaseous exchange by respiratory system; scaffold178 indexed_genome mRNA 859387 871763 . + . ID=transcript_15322;Q9HBM6 B2RUZ9 Q9Y2S3,Transcription initiation factor TFIID subunit 9B,Neuronal cell death-related protein 7;Transcription initiation factor TFIID subunit 9-like;Transcription-associated factor TAFII31L;, PF02291;, GO:0005654;GO:0005669;GO:0033276;GO:0046982;GO:0016251;GO:0003714;GO:0043066;GO:1902166;GO:0000122;GO:0030307;GO:0016579;GO:0050821;GO:1901796;GO:0006366;GO:0006367;, C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription corepressor activity;, P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:protein deubiquitination; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q9HBM6 B2RUZ9 Q9Y2S3,Transcription initiation factor TFIID subunit 9B,Neuronal cell death-related protein 7;Transcription initiation factor TFIID subunit 9-like;Transcription-associated factor TAFII31L;, PF02291;, GO:0005654;GO:0005669;GO:0033276;GO:0046982;GO:0016251;GO:0003714;GO:0043066;GO:1902166;GO:0000122;GO:0030307;GO:0016579;GO:0050821;GO:1901796;GO:0006366;GO:0006367;, C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription corepressor activity;, P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:protein deubiquitination; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q9HBM6 B2RUZ9 Q9Y2S3,Transcription initiation factor TFIID subunit 9B,Neuronal cell death-related protein 7;Transcription initiation factor TFIID subunit 9-like;Transcription-associated factor TAFII31L;, PF02291;, GO:0005654;GO:0005669;GO:0033276;GO:0046982;GO:0016251;GO:0003714;GO:0043066;GO:1902166;GO:0000122;GO:0030307;GO:0016579;GO:0050821;GO:1901796;GO:0006366;GO:0006367;, C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription corepressor activity;, P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:protein deubiquitination; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter;|Q9HBM6 B2RUZ9 Q9Y2S3,Transcription initiation factor TFIID subunit 9B,Neuronal cell death-related protein 7;Transcription initiation factor TFIID subunit 9-like;Transcription-associated factor TAFII31L;, PF02291;, GO:0005654;GO:0005669;GO:0033276;GO:0046982;GO:0016251;GO:0003714;GO:0043066;GO:1902166;GO:0000122;GO:0030307;GO:0016579;GO:0050821;GO:1901796;GO:0006366;GO:0006367;, C:nucleoplasm; C:transcription factor TFIID complex; C:transcription factor TFTC complex;, F:protein heterodimerization activity; F:RNA polymerase II general transcription initiation factor activity; F:transcription corepressor activity;, P:negative regulation of apoptotic process; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell growth; P:protein deubiquitination; P:protein stabilization; P:regulation of signal transduction by p53 class mediator; P:transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold178 indexed_genome mRNA 873250 896916 . - . ID=transcript_15323;P00558 A8K4W6 B7Z7A9 Q5J7W1 Q6IBT6 Q8NI87,Phosphoglycerate kinase 1,Cell migration-inducing gene 10 protein;Primer recognition protein 2;, PF00162;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0045121;GO:0043531;GO:0005524;GO:0004618;GO:0047134;GO:0061621;GO:0071456;GO:0030855;GO:0006094;GO:0006096;GO:0044003;GO:0016525;GO:0016310;GO:0031639;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:membrane raft;, F:ADP binding; F:ATP binding; F:phosphoglycerate kinase activity; F:protein-disulfide reductase activity;, P:canonical glycolysis; P:cellular response to hypoxia; P:epithelial cell differentiation; P:gluconeogenesis; P:glycolytic process; P:modulation by symbiont of host process; P:negative regulation of angiogenesis; P:phosphorylation; P:plasminogen activation;|P00558 A8K4W6 B7Z7A9 Q5J7W1 Q6IBT6 Q8NI87,Phosphoglycerate kinase 1,Cell migration-inducing gene 10 protein;Primer recognition protein 2;, PF00162;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0045121;GO:0043531;GO:0005524;GO:0004618;GO:0047134;GO:0061621;GO:0071456;GO:0030855;GO:0006094;GO:0006096;GO:0044003;GO:0016525;GO:0016310;GO:0031639;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:membrane raft;, F:ADP binding; F:ATP binding; F:phosphoglycerate kinase activity; F:protein-disulfide reductase activity;, P:canonical glycolysis; P:cellular response to hypoxia; P:epithelial cell differentiation; P:gluconeogenesis; P:glycolytic process; P:modulation by symbiont of host process; P:negative regulation of angiogenesis; P:phosphorylation; P:plasminogen activation;|P00558 A8K4W6 B7Z7A9 Q5J7W1 Q6IBT6 Q8NI87,Phosphoglycerate kinase 1,Cell migration-inducing gene 10 protein;Primer recognition protein 2;, PF00162;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0045121;GO:0043531;GO:0005524;GO:0004618;GO:0047134;GO:0061621;GO:0071456;GO:0030855;GO:0006094;GO:0006096;GO:0044003;GO:0016525;GO:0016310;GO:0031639;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:membrane raft;, F:ADP binding; F:ATP binding; F:phosphoglycerate kinase activity; F:protein-disulfide reductase activity;, P:canonical glycolysis; P:cellular response to hypoxia; P:epithelial cell differentiation; P:gluconeogenesis; P:glycolytic process; P:modulation by symbiont of host process; P:negative regulation of angiogenesis; P:phosphorylation; P:plasminogen activation; scaffold178 indexed_genome mRNA 973741 1028464 . - . ID=transcript_15324;Q04656 B1AT72 O00227 O00745 Q9BYY8,Copper-transporting ATPase 1,Copper pump 1;Menkes disease-associated protein;, PF00403;, GO:0016324;GO:0030424;GO:0016323;GO:0031526;GO:0031252;GO:0005829;GO:0030425;GO:0031901;GO:0005783;GO:0005794;GO:0016021;GO:0005770;GO:0033162;GO:0016020;GO:0045121;GO:0005902;GO:0043005;GO:0043025;GO:0005634;GO:0043204;GO:0048471;GO:0030670;GO:0005886;GO:0030141;GO:0005802;GO:0032588;GO:0030140;GO:0005524;GO:0051087;GO:0005507;GO:0005375;GO:0032767;GO:1903136;GO:0043682;GO:0016532;GO:0019730;GO:0001568;GO:0001974;GO:0051216;GO:0006584;GO:0006878;GO:0071230;GO:0071236;GO:0071276;GO:0071279;GO:0071280;GO:0071456;GO:0071281;GO:0071284;GO:0036120;GO:0021954;GO:0021702;GO:0030199;GO:0060003;GO:0015677;GO:0006825;GO:0010273;GO:0042417;GO:0048251;GO:0051542;GO:0042414;GO:0030198;GO:0007565;GO:0031069;GO:0001701;GO:0034220;GO:0007595;GO:0001889;GO:0007626;GO:0048286;GO:0007005;GO:0034760;GO:0048812;GO:0042415;GO:0018205;GO:0043473;GO:0043085;GO:0045793;GO:0050679;GO:0010592;GO:0048023;GO:0032773;GO:0051353;GO:1903036;GO:1904754;GO:0021860;GO:1904959;GO:0010468;GO:0002082;GO:0019430;GO:0010041;GO:0010042;GO:0010043;GO:0042428;GO:0043588;GO:0042093;GO:0006568;, C:apical plasma membrane; C:axon; C:basolateral plasma membrane; C:brush border membrane; C:cell leading edge; C:cytosol; C:dendrite; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:late endosome; C:melanosome membrane; C:membrane; C:membrane raft; C:microvillus; C:neuron projection; C:neuronal cell body; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle;, F:ATP binding; F:chaperone binding; F:copper ion binding; F:copper ion transmembrane transporter activity; F:copper-dependent protein binding; F:cuprous ion binding; F:P-type divalent copper transporter activity; F:superoxide dismutase copper chaperone activity;, P:antimicrobial humoral response; P:blood vessel development; P:blood vessel remodeling; P:cartilage development; P:catecholamine metabolic process; P:cellular copper ion homeostasis; P:cellular response to amino acid stimulus; P:cellular response to antibiotic; P:cellular response to cadmium ion; P:cellular response to cobalt ion; P:cellular response to copper ion; P:cellular response to hypoxia; P:cellular response to iron ion; P:cellular response to lead ion; P:cellular response to platelet-derived growth factor stimulus; P:central nervous system neuron development; P:cerebellar Purkinje cell differentiation; P:collagen fibril organization; P:copper ion export; P:copper ion import; P:copper ion transport; P:detoxification of copper ion; P:dopamine metabolic process; P:elastic fiber assembly; P:elastin biosynthetic process; P:epinephrine metabolic process; P:extracellular matrix organization; P:female pregnancy; P:hair follicle morphogenesis; P:in utero embryonic development; P:ion transmembrane transport; P:lactation; P:liver development; P:locomotory behavior; P:lung alveolus development; P:mitochondrion organization; P:negative regulation of iron ion transmembrane transport; P:neuron projection morphogenesis; P:norepinephrine metabolic process; P:peptidyl-lysine modification; P:pigmentation; P:positive regulation of catalytic activity; P:positive regulation of cell size; P:positive regulation of epithelial cell proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of melanin biosynthetic process; P:positive regulation of monophenol monooxygenase activity; P:positive regulation of oxidoreductase activity; P:positive regulation of response to wounding; P:positive regulation of vascular associated smooth muscle cell migration; P:pyramidal neuron development; P:regulation of cytochrome-c oxidase activity; P:regulation of gene expression; P:regulation of oxidative phosphorylation; P:removal of superoxide radicals; P:response to iron(III) ion; P:response to manganese ion; P:response to zinc ion; P:serotonin metabolic process; P:skin development; P:T-helper cell differentiation; P:tryptophan metabolic process;|Q04656 B1AT72 O00227 O00745 Q9BYY8,Copper-transporting ATPase 1,Copper pump 1;Menkes disease-associated protein;, PF00403;, GO:0016324;GO:0030424;GO:0016323;GO:0031526;GO:0031252;GO:0005829;GO:0030425;GO:0031901;GO:0005783;GO:0005794;GO:0016021;GO:0005770;GO:0033162;GO:0016020;GO:0045121;GO:0005902;GO:0043005;GO:0043025;GO:0005634;GO:0043204;GO:0048471;GO:0030670;GO:0005886;GO:0030141;GO:0005802;GO:0032588;GO:0030140;GO:0005524;GO:0051087;GO:0005507;GO:0005375;GO:0032767;GO:1903136;GO:0043682;GO:0016532;GO:0019730;GO:0001568;GO:0001974;GO:0051216;GO:0006584;GO:0006878;GO:0071230;GO:0071236;GO:0071276;GO:0071279;GO:0071280;GO:0071456;GO:0071281;GO:0071284;GO:0036120;GO:0021954;GO:0021702;GO:0030199;GO:0060003;GO:0015677;GO:0006825;GO:0010273;GO:0042417;GO:0048251;GO:0051542;GO:0042414;GO:0030198;GO:0007565;GO:0031069;GO:0001701;GO:0034220;GO:0007595;GO:0001889;GO:0007626;GO:0048286;GO:0007005;GO:0034760;GO:0048812;GO:0042415;GO:0018205;GO:0043473;GO:0043085;GO:0045793;GO:0050679;GO:0010592;GO:0048023;GO:0032773;GO:0051353;GO:1903036;GO:1904754;GO:0021860;GO:1904959;GO:0010468;GO:0002082;GO:0019430;GO:0010041;GO:0010042;GO:0010043;GO:0042428;GO:0043588;GO:0042093;GO:0006568;, C:apical plasma membrane; C:axon; C:basolateral plasma membrane; C:brush border membrane; C:cell leading edge; C:cytosol; C:dendrite; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:late endosome; C:melanosome membrane; C:membrane; C:membrane raft; C:microvillus; C:neuron projection; C:neuronal cell body; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle;, F:ATP binding; F:chaperone binding; F:copper ion binding; F:copper ion transmembrane transporter activity; F:copper-dependent protein binding; F:cuprous ion binding; F:P-type divalent copper transporter activity; F:superoxide dismutase copper chaperone activity;, P:antimicrobial humoral response; P:blood vessel development; P:blood vessel remodeling; P:cartilage development; P:catecholamine metabolic process; P:cellular copper ion homeostasis; P:cellular response to amino acid stimulus; P:cellular response to antibiotic; P:cellular response to cadmium ion; P:cellular response to cobalt ion; P:cellular response to copper ion; P:cellular response to hypoxia; P:cellular response to iron ion; P:cellular response to lead ion; P:cellular response to platelet-derived growth factor stimulus; P:central nervous system neuron development; P:cerebellar Purkinje cell differentiation; P:collagen fibril organization; P:copper ion export; P:copper ion import; P:copper ion transport; P:detoxification of copper ion; P:dopamine metabolic process; P:elastic fiber assembly; P:elastin biosynthetic process; P:epinephrine metabolic process; P:extracellular matrix organization; P:female pregnancy; P:hair follicle morphogenesis; P:in utero embryonic development; P:ion transmembrane transport; P:lactation; P:liver development; P:locomotory behavior; P:lung alveolus development; P:mitochondrion organization; P:negative regulation of iron ion transmembrane transport; P:neuron projection morphogenesis; P:norepinephrine metabolic process; P:peptidyl-lysine modification; P:pigmentation; P:positive regulation of catalytic activity; P:positive regulation of cell size; P:positive regulation of epithelial cell proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of melanin biosynthetic process; P:positive regulation of monophenol monooxygenase activity; P:positive regulation of oxidoreductase activity; P:positive regulation of response to wounding; P:positive regulation of vascular associated smooth muscle cell migration; P:pyramidal neuron development; P:regulation of cytochrome-c oxidase activity; P:regulation of gene expression; P:regulation of oxidative phosphorylation; P:removal of superoxide radicals; P:response to iron(III) ion; P:response to manganese ion; P:response to zinc ion; P:serotonin metabolic process; P:skin development; P:T-helper cell differentiation; P:tryptophan metabolic process;|Q04656 B1AT72 O00227 O00745 Q9BYY8,Copper-transporting ATPase 1,Copper pump 1;Menkes disease-associated protein;, PF00403;, GO:0016324;GO:0030424;GO:0016323;GO:0031526;GO:0031252;GO:0005829;GO:0030425;GO:0031901;GO:0005783;GO:0005794;GO:0016021;GO:0005770;GO:0033162;GO:0016020;GO:0045121;GO:0005902;GO:0043005;GO:0043025;GO:0005634;GO:0043204;GO:0048471;GO:0030670;GO:0005886;GO:0030141;GO:0005802;GO:0032588;GO:0030140;GO:0005524;GO:0051087;GO:0005507;GO:0005375;GO:0032767;GO:1903136;GO:0043682;GO:0016532;GO:0019730;GO:0001568;GO:0001974;GO:0051216;GO:0006584;GO:0006878;GO:0071230;GO:0071236;GO:0071276;GO:0071279;GO:0071280;GO:0071456;GO:0071281;GO:0071284;GO:0036120;GO:0021954;GO:0021702;GO:0030199;GO:0060003;GO:0015677;GO:0006825;GO:0010273;GO:0042417;GO:0048251;GO:0051542;GO:0042414;GO:0030198;GO:0007565;GO:0031069;GO:0001701;GO:0034220;GO:0007595;GO:0001889;GO:0007626;GO:0048286;GO:0007005;GO:0034760;GO:0048812;GO:0042415;GO:0018205;GO:0043473;GO:0043085;GO:0045793;GO:0050679;GO:0010592;GO:0048023;GO:0032773;GO:0051353;GO:1903036;GO:1904754;GO:0021860;GO:1904959;GO:0010468;GO:0002082;GO:0019430;GO:0010041;GO:0010042;GO:0010043;GO:0042428;GO:0043588;GO:0042093;GO:0006568;, C:apical plasma membrane; C:axon; C:basolateral plasma membrane; C:brush border membrane; C:cell leading edge; C:cytosol; C:dendrite; C:early endosome membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:late endosome; C:melanosome membrane; C:membrane; C:membrane raft; C:microvillus; C:neuron projection; C:neuronal cell body; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:phagocytic vesicle membrane; C:plasma membrane; C:secretory granule; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle;, F:ATP binding; F:chaperone binding; F:copper ion binding; F:copper ion transmembrane transporter activity; F:copper-dependent protein binding; F:cuprous ion binding; F:P-type divalent copper transporter activity; F:superoxide dismutase copper chaperone activity;, P:antimicrobial humoral response; P:blood vessel development; P:blood vessel remodeling; P:cartilage development; P:catecholamine metabolic process; P:cellular copper ion homeostasis; P:cellular response to amino acid stimulus; P:cellular response to antibiotic; P:cellular response to cadmium ion; P:cellular response to cobalt ion; P:cellular response to copper ion; P:cellular response to hypoxia; P:cellular response to iron ion; P:cellular response to lead ion; P:cellular response to platelet-derived growth factor stimulus; P:central nervous system neuron development; P:cerebellar Purkinje cell differentiation; P:collagen fibril organization; P:copper ion export; P:copper ion import; P:copper ion transport; P:detoxification of copper ion; P:dopamine metabolic process; P:elastic fiber assembly; P:elastin biosynthetic process; P:epinephrine metabolic process; P:extracellular matrix organization; P:female pregnancy; P:hair follicle morphogenesis; P:in utero embryonic development; P:ion transmembrane transport; P:lactation; P:liver development; P:locomotory behavior; P:lung alveolus development; P:mitochondrion organization; P:negative regulation of iron ion transmembrane transport; P:neuron projection morphogenesis; P:norepinephrine metabolic process; P:peptidyl-lysine modification; P:pigmentation; P:positive regulation of catalytic activity; P:positive regulation of cell size; P:positive regulation of epithelial cell proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of melanin biosynthetic process; P:positive regulation of monophenol monooxygenase activity; P:positive regulation of oxidoreductase activity; P:positive regulation of response to wounding; P:positive regulation of vascular associated smooth muscle cell migration; P:pyramidal neuron development; P:regulation of cytochrome-c oxidase activity; P:regulation of gene expression; P:regulation of oxidative phosphorylation; P:removal of superoxide radicals; P:response to iron(III) ion; P:response to manganese ion; P:response to zinc ion; P:serotonin metabolic process; P:skin development; P:T-helper cell differentiation; P:tryptophan metabolic process; scaffold178 indexed_genome mRNA 1137244 1139510 . - . ID=transcript_15325;P24311 B2R4M3 Q6ICR1,Cytochrome c oxidase subunit 7B, mitochondrial,Cytochrome c oxidase polypeptide VIIb;, PF05392;, GO:0016021;GO:0005743;GO:0005746;GO:0045277;GO:0004129;GO:0007417;GO:0006123;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respirasome; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity;, P:central nervous system development; P:mitochondrial electron transport, cytochrome c to oxygen; scaffold178 indexed_genome mRNA 1149898 1197123 . + . ID=transcript_15326;Q9H0U3 B2RAR4 D3DTE3 Q53G00 Q6P577 Q8NBN6,Magnesium transporter protein 1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1;Implantation-associated protein;, PF04756;, GO:0035577;GO:0005783;GO:0005887;GO:0016020;GO:0008250;GO:0005886;GO:0015095;GO:0050890;GO:0015693;GO:0043312;GO:0006487;GO:0018279;GO:0055085;GO:0019082;, C:azurophil granule membrane; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:oligosaccharyltransferase complex; C:plasma membrane;, F:magnesium ion transmembrane transporter activity;, P:cognition; P:magnesium ion transport; P:neutrophil degranulation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:transmembrane transport; P:viral protein processing;|Q9H0U3 B2RAR4 D3DTE3 Q53G00 Q6P577 Q8NBN6,Magnesium transporter protein 1,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1;Implantation-associated protein;, PF04756;, GO:0035577;GO:0005783;GO:0005887;GO:0016020;GO:0008250;GO:0005886;GO:0015095;GO:0050890;GO:0015693;GO:0043312;GO:0006487;GO:0018279;GO:0055085;GO:0019082;, C:azurophil granule membrane; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:oligosaccharyltransferase complex; C:plasma membrane;, F:magnesium ion transmembrane transporter activity;, P:cognition; P:magnesium ion transport; P:neutrophil degranulation; P:protein N-linked glycosylation; P:protein N-linked glycosylation via asparagine; P:transmembrane transport; P:viral protein processing; scaffold179 indexed_genome mRNA 19151 45820 . + . ID=transcript_15327;Q8TD17 A8K384 B4E377 Q8TD18 Q9P2K7 Q9UDV8,Zinc finger protein 398,Zinc finger DNA-binding protein p52/p71;, PF12417;PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0045893;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold179 indexed_genome mRNA 52606 69829 . + . ID=transcript_15328;Q9UDV7 B4DRI5 O43691 Q6DKK0,Zinc finger protein 282,HTLV-I U5RE-binding protein 1;, PF12417;PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0000977;GO:1990837;GO:0008270;GO:0000122;GO:0045892;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9UDV7 B4DRI5 O43691 Q6DKK0,Zinc finger protein 282,HTLV-I U5RE-binding protein 1;, PF12417;PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0000977;GO:1990837;GO:0008270;GO:0000122;GO:0045892;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold179 indexed_genome mRNA 69981 72335 . - . ID=transcript_15329;Q9UDV7 B4DRI5 O43691 Q6DKK0,Zinc finger protein 282,HTLV-I U5RE-binding protein 1;, PF12417;PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0000977;GO:1990837;GO:0008270;GO:0000122;GO:0045892;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold179 indexed_genome mRNA 88672 104035 . + . ID=transcript_15330;Q9UDV6 B2RCF4 Q13396 Q8N664,Zinc finger protein 212,Zinc finger protein C2H2-150;, PF12417;PF01352;PF00096;, GO:0005654;GO:0003700;GO:0042802;GO:0000978;GO:0008270;GO:0006357;GO:0006355;, C:nucleoplasm;, F:DNA-binding transcription factor activity; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9UDV6 B2RCF4 Q13396 Q8N664,Zinc finger protein 212,Zinc finger protein C2H2-150;, PF12417;PF01352;PF00096;, GO:0005654;GO:0003700;GO:0042802;GO:0000978;GO:0008270;GO:0006357;GO:0006355;, C:nucleoplasm;, F:DNA-binding transcription factor activity; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;|Q9UDV6 B2RCF4 Q13396 Q8N664,Zinc finger protein 212,Zinc finger protein C2H2-150;, PF12417;PF01352;PF00096;, GO:0005654;GO:0003700;GO:0042802;GO:0000978;GO:0008270;GO:0006357;GO:0006355;, C:nucleoplasm;, F:DNA-binding transcription factor activity; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold179 indexed_genome mRNA 119007 128820 . + . ID=transcript_15331;Q6ZMS7 C9J9J2,Protein ZNF783,, PF12417;PF01352;, GO:0005634;GO:0003700;GO:0042802;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold179 indexed_genome mRNA 197354 218120 . - . ID=transcript_15332;Q9ULD5 Q8N2R2 Q8N659,Zinc finger protein 777,, PF12417;PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9ULD5 Q8N2R2 Q8N659,Zinc finger protein 777,, PF12417;PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold179 indexed_genome mRNA 243270 248299 . - . ID=transcript_15333;Q6NUN9 A8K6Z9 Q6ZRF9,Zinc finger protein 746,Parkin-interacting substrate;, PF12417;PF01352;PF00096;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0000976;GO:0031625;GO:0000122;GO:0045892;GO:1901216;GO:0045944;GO:0006357;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of neuron death; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q6NUN9 A8K6Z9 Q6ZRF9,Zinc finger protein 746,Parkin-interacting substrate;, PF12417;PF01352;PF00096;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0000976;GO:0031625;GO:0000122;GO:0045892;GO:1901216;GO:0045944;GO:0006357;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of neuron death; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold179 indexed_genome mRNA 342609 348725 . - . ID=transcript_15334;A5PL33 A7E2F5 E7ENE9 Q8N4X0 Q96JG5,Protein KRBA1,, PF15287; scaffold179 indexed_genome mRNA 356030 358209 . - . ID=transcript_15335;Q08050 O43258 O43259 O43260 Q4ZGG7 Q9BRL2,Forkhead box protein M1,Forkhead-related protein FKHL16;Hepatocyte nuclear factor 3 forkhead homolog 11;M-phase phosphoprotein 2;MPM-2 reactive phosphoprotein 2;Transcription factor Trident;Winged-helix factor from INS-1 cells;, PF00250;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0019901;GO:0000977;GO:0006978;GO:0006281;GO:0000086;GO:0090344;GO:0032873;GO:0000122;GO:0045892;GO:0008284;GO:2000781;GO:0045944;GO:0045893;GO:0051726;GO:0071156;GO:0001558;GO:0042127;GO:0046578;GO:2000377;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA repair; P:G2/M transition of mitotic cell cycle; P:negative regulation of cell aging; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell population proliferation; P:positive regulation of double-strand break repair; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cell cycle; P:regulation of cell cycle arrest; P:regulation of cell growth; P:regulation of cell population proliferation; P:regulation of Ras protein signal transduction; P:regulation of reactive oxygen species metabolic process; P:regulation of transcription by RNA polymerase II; scaffold179 indexed_genome mRNA 372841 374362 . + . ID=transcript_15336;Q7Z7K2,Zinc finger protein 467,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold179 indexed_genome mRNA 375128 378368 . - . ID=transcript_15337;Q7Z7K2,Zinc finger protein 467,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q7Z7K2,Zinc finger protein 467,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold179 indexed_genome mRNA 379709 423743 . + . ID=transcript_15338;A2VEC9 A0A096LNW2 Q76B61,SCO-spondin {ECO:0000305},SCO-spondin pseudogene {ECO:0000312|HGNC:HGNC:21998};, PF08742;PF00754;PF00057;PF01826;PF00090;PF00094;, GO:0031012;GO:0005615;GO:0030414;GO:0007155;GO:0030154;GO:0007399;, C:extracellular matrix; C:extracellular space;, F:peptidase inhibitor activity;, P:cell adhesion; P:cell differentiation; P:nervous system development;|A2VEC9 A0A096LNW2 Q76B61,SCO-spondin {ECO:0000305},SCO-spondin pseudogene {ECO:0000312|HGNC:HGNC:21998};, PF08742;PF00754;PF00057;PF01826;PF00090;PF00094;, GO:0031012;GO:0005615;GO:0030414;GO:0007155;GO:0030154;GO:0007399;, C:extracellular matrix; C:extracellular space;, F:peptidase inhibitor activity;, P:cell adhesion; P:cell differentiation; P:nervous system development;|A2VEC9 A0A096LNW2 Q76B61,SCO-spondin {ECO:0000305},SCO-spondin pseudogene {ECO:0000312|HGNC:HGNC:21998};, PF08742;PF00754;PF00057;PF01826;PF00090;PF00094;, GO:0031012;GO:0005615;GO:0030414;GO:0007155;GO:0030154;GO:0007399;, C:extracellular matrix; C:extracellular space;, F:peptidase inhibitor activity;, P:cell adhesion; P:cell differentiation; P:nervous system development;|A2VEC9 A0A096LNW2 Q76B61,SCO-spondin {ECO:0000305},SCO-spondin pseudogene {ECO:0000312|HGNC:HGNC:21998};, PF08742;PF00754;PF00057;PF01826;PF00090;PF00094;, GO:0031012;GO:0005615;GO:0030414;GO:0007155;GO:0030154;GO:0007399;, C:extracellular matrix; C:extracellular space;, F:peptidase inhibitor activity;, P:cell adhesion; P:cell differentiation; P:nervous system development; scaffold179 indexed_genome mRNA 435924 469203 . + . ID=transcript_15339;O60290 A0AUL8,Zinc finger protein 862,, PF05699;PF14291;PF01352;, GO:0005634;GO:0046872;GO:0046983;GO:0006355;, C:nucleus;, F:metal ion binding; F:protein dimerization activity;, P:regulation of transcription, DNA-templated; scaffold179 indexed_genome mRNA 469262 474517 . + . ID=transcript_15340;Q8NHE4 A2T863 A2T8L7 B5MDP5 J3KQW7 Q6MZW1 Q75L47 Q7Z4R7 Q8N7I8,V-type proton ATPase subunit e 2,Lysosomal 9 kDa H(+)-transporting ATPase V0 subunit e2;Vacuolar proton pump subunit e 2;, PF05493;, GO:0010008;GO:0016021;GO:0005765;GO:0030670;GO:0033179;GO:0042625;GO:0016787;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0055085;GO:0007035;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:phagocytic vesicle membrane; C:proton-transporting V-type ATPase, V0 domain;, F:ATPase-coupled ion transmembrane transporter activity; F:hydrolase activity; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:transmembrane transport; P:vacuolar acidification;|Q8NHE4 A2T863 A2T8L7 B5MDP5 J3KQW7 Q6MZW1 Q75L47 Q7Z4R7 Q8N7I8,V-type proton ATPase subunit e 2,Lysosomal 9 kDa H(+)-transporting ATPase V0 subunit e2;Vacuolar proton pump subunit e 2;, PF05493;, GO:0010008;GO:0016021;GO:0005765;GO:0030670;GO:0033179;GO:0042625;GO:0016787;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0055085;GO:0007035;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:phagocytic vesicle membrane; C:proton-transporting V-type ATPase, V0 domain;, F:ATPase-coupled ion transmembrane transporter activity; F:hydrolase activity; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:transmembrane transport; P:vacuolar acidification;|Q8NHE4 A2T863 A2T8L7 B5MDP5 J3KQW7 Q6MZW1 Q75L47 Q7Z4R7 Q8N7I8,V-type proton ATPase subunit e 2,Lysosomal 9 kDa H(+)-transporting ATPase V0 subunit e2;Vacuolar proton pump subunit e 2;, PF05493;, GO:0010008;GO:0016021;GO:0005765;GO:0030670;GO:0033179;GO:0042625;GO:0016787;GO:0046961;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;GO:0055085;GO:0007035;, C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:phagocytic vesicle membrane; C:proton-transporting V-type ATPase, V0 domain;, F:ATPase-coupled ion transmembrane transporter activity; F:hydrolase activity; F:proton-transporting ATPase activity, rotational mechanism;, P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; P:transmembrane transport; P:vacuolar acidification; scaffold179 indexed_genome mRNA 493639 502427 . + . ID=transcript_15341;Q9BV99 B3KUW0 D3DWY8,Leucine-rich repeat-containing protein 61,, PF13855;, GO:0005737;GO:0005829;, C:cytoplasm; C:cytosol;|Q96FA7,ZBED6 C-terminal-like protein scaffold179 indexed_genome mRNA 502832 504521 . - . ID=transcript_15342;Q99969 Q7LE02,Retinoic acid receptor responder protein 2,Chemerin;RAR-responsive protein TIG2;Tazarotene-induced gene 2 protein;, , GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0031089;GO:0005102;GO:0019732;GO:0061760;GO:0030154;GO:0006935;GO:0050829;GO:0050830;GO:0048566;GO:0006954;GO:0045087;GO:0008286;GO:0002576;GO:0050921;GO:0045600;GO:0010759;GO:0001934;GO:0003084;GO:0050994;GO:0014823;GO:0061771;GO:0001523;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:platelet dense granule lumen;, F:signaling receptor binding;, P:antifungal humoral response; P:antifungal innate immune response; P:cell differentiation; P:chemotaxis; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:embryonic digestive tract development; P:inflammatory response; P:innate immune response; P:insulin receptor signaling pathway; P:platelet degranulation; P:positive regulation of chemotaxis; P:positive regulation of fat cell differentiation; P:positive regulation of macrophage chemotaxis; P:positive regulation of protein phosphorylation; P:positive regulation of systemic arterial blood pressure; P:regulation of lipid catabolic process; P:response to activity; P:response to caloric restriction; P:retinoid metabolic process; scaffold179 indexed_genome mRNA 510354 511077 . + . ID=transcript_15343;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold179 indexed_genome mRNA 525712 527538 . - . ID=transcript_15344;Q9BWE0 C9J3L7 D3DWZ1 Q7LE03 Q9BUZ6 Q9NZH2 Q9UMP5,Replication initiator 1,60 kDa origin-specific DNA-binding protein;60 kDa replication initiation region protein;ATT-binding protein;DHFR oribeta-binding protein RIP60;Zinc finger protein 464;, PF00096;, GO:0005694;GO:0005664;GO:0005654;GO:0043035;GO:0003677;GO:0046872;GO:0003723;GO:0006260;GO:0006357;, C:chromosome; C:nuclear origin of replication recognition complex; C:nucleoplasm;, F:chromatin insulator sequence binding; F:DNA binding; F:metal ion binding; F:RNA binding;, P:DNA replication; P:regulation of transcription by RNA polymerase II; scaffold179 indexed_genome mRNA 541701 552610 . + . ID=transcript_15345;Q96BV0 Q8IY24,Zinc finger protein 775,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold179 indexed_genome mRNA 560565 565582 . + . ID=transcript_15346;O14709 B2RAH8 Q86VG0,Zinc finger protein 197,Zinc finger protein with KRAB and SCAN domains 9;ZnF20;pVHL-associated KRAB domain-containing protein;, PF01352;PF02023;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold179 indexed_genome mRNA 585887 610025 . + . ID=transcript_15347;Q8ND71 A0A090N8H2,GTPase IMAP family member 8,Immune-associated nucleotide-binding protein 9;Protein IanT;, PF04548;, GO:0005829;GO:0005783;GO:0005794;GO:0005739;GO:0005525;GO:0070232;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:mitochondrion;, F:GTP binding;, P:regulation of T cell apoptotic process; scaffold179 indexed_genome mRNA 709356 713928 . - . ID=transcript_15348;Q8NHV1,GTPase IMAP family member 7,Immunity-associated nucleotide 7 protein;, PF04548;, GO:0005829;GO:0005783;GO:0005794;GO:0043231;GO:0005811;GO:0005525;GO:0003924;GO:0042802;GO:0042803;GO:0046039;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lipid droplet;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:protein homodimerization activity;, P:GTP metabolic process; scaffold179 indexed_genome mRNA 768957 774447 . - . ID=transcript_15349;Q9NUV9,GTPase IMAP family member 4,Immunity-associated nucleotide 1 protein;Immunity-associated protein 4;, PF04548;, GO:0005829;GO:0005525;, C:cytosol;, F:GTP binding; scaffold179 indexed_genome mRNA 916903 923259 . - . ID=transcript_15350;Q6P9H5 C9J7B6 D3DWZ4 Q5ZPR6 Q9H612,GTPase IMAP family member 6,Immunity-associated nucleotide 2 protein;Immunity-associated nucleotide 6 protein;, PF04548;, GO:0005829;GO:0005525;, C:cytosol;, F:GTP binding;|Q6P9H5 C9J7B6 D3DWZ4 Q5ZPR6 Q9H612,GTPase IMAP family member 6,Immunity-associated nucleotide 2 protein;Immunity-associated nucleotide 6 protein;, PF04548;, GO:0005829;GO:0005525;, C:cytosol;, F:GTP binding; scaffold179 indexed_genome mRNA 948697 950259 . + . ID=transcript_15351;Q8NHV1,GTPase IMAP family member 7,Immunity-associated nucleotide 7 protein;, PF04548;, GO:0005829;GO:0005783;GO:0005794;GO:0043231;GO:0005811;GO:0005525;GO:0003924;GO:0042802;GO:0042803;GO:0046039;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lipid droplet;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:protein homodimerization activity;, P:GTP metabolic process; scaffold179 indexed_genome mRNA 984863 987864 . + . ID=transcript_15352;Q8WWP7 B2RCI3 Q8NAZ0,GTPase IMAP family member 1,Immunity-associated protein 1;, PF04548;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005525;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:GTP binding;|Q8WWP7 B2RCI3 Q8NAZ0,GTPase IMAP family member 1,Immunity-associated protein 1;, PF04548;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0005525;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:GTP binding; scaffold179 indexed_genome mRNA 1000593 1001546 . + . ID=transcript_15353;Q96F15 D3DWZ5 Q6IA75 Q96NE4 Q9NUK9,GTPase IMAP family member 5,Immune-associated nucleotide-binding protein 5;Immunity-associated nucleotide 4-like 1 protein;Immunity-associated nucleotide 5 protein;Immunity-associated protein 3;, PF04548;, GO:0016021;GO:0005765;GO:0032585;GO:0005525;, C:integral component of membrane; C:lysosomal membrane; C:multivesicular body membrane;, F:GTP binding; scaffold179 indexed_genome mRNA 1004656 1011850 . + . ID=transcript_15354;Q96F15 D3DWZ5 Q6IA75 Q96NE4 Q9NUK9,GTPase IMAP family member 5,Immune-associated nucleotide-binding protein 5;Immunity-associated nucleotide 4-like 1 protein;Immunity-associated nucleotide 5 protein;Immunity-associated protein 3;, PF04548;, GO:0016021;GO:0005765;GO:0032585;GO:0005525;, C:integral component of membrane; C:lysosomal membrane; C:multivesicular body membrane;, F:GTP binding;|Q96F15 D3DWZ5 Q6IA75 Q96NE4 Q9NUK9,GTPase IMAP family member 5,Immune-associated nucleotide-binding protein 5;Immunity-associated nucleotide 4-like 1 protein;Immunity-associated nucleotide 5 protein;Immunity-associated protein 3;, PF04548;, GO:0016021;GO:0005765;GO:0032585;GO:0005525;, C:integral component of membrane; C:lysosomal membrane; C:multivesicular body membrane;, F:GTP binding; scaffold179 indexed_genome mRNA 1059210 1068363 . - . ID=transcript_15355;Q3YBM2 B2RDK2 D3DWZ7 E9PAV4 Q5BJI2 Q9BT42 Q9Y609,Transmembrane protein 176B,Protein LR8;, PF04103;, GO:0016021;GO:0031965;GO:0009887;GO:0030154;GO:2001199;, C:integral component of membrane; C:nuclear membrane;, , P:animal organ morphogenesis; P:cell differentiation; P:negative regulation of dendritic cell differentiation;|Q3YBM2 B2RDK2 D3DWZ7 E9PAV4 Q5BJI2 Q9BT42 Q9Y609,Transmembrane protein 176B,Protein LR8;, PF04103;, GO:0016021;GO:0031965;GO:0009887;GO:0030154;GO:2001199;, C:integral component of membrane; C:nuclear membrane;, , P:animal organ morphogenesis; P:cell differentiation; P:negative regulation of dendritic cell differentiation;|Q3YBM2 B2RDK2 D3DWZ7 E9PAV4 Q5BJI2 Q9BT42 Q9Y609,Transmembrane protein 176B,Protein LR8;, PF04103;, GO:0016021;GO:0031965;GO:0009887;GO:0030154;GO:2001199;, C:integral component of membrane; C:nuclear membrane;, , P:animal organ morphogenesis; P:cell differentiation; P:negative regulation of dendritic cell differentiation;|Q3YBM2 B2RDK2 D3DWZ7 E9PAV4 Q5BJI2 Q9BT42 Q9Y609,Transmembrane protein 176B,Protein LR8;, PF04103;, GO:0016021;GO:0031965;GO:0009887;GO:0030154;GO:2001199;, C:integral component of membrane; C:nuclear membrane;, , P:animal organ morphogenesis; P:cell differentiation; P:negative regulation of dendritic cell differentiation; scaffold179 indexed_genome mRNA 1068830 1073330 . + . ID=transcript_15356;Q96HP8 D3DX00 Q9NYC7,Transmembrane protein 176A,Hepatocellular carcinoma-associated antigen 112;, PF04103;, GO:0016021;GO:2001199;, C:integral component of membrane;, , P:negative regulation of dendritic cell differentiation; scaffold179 indexed_genome mRNA 1111623 1126966 . + . ID=transcript_15357;P19801 C9J690 Q16683 Q16684 Q56II4 Q6GU42,Amiloride-sensitive amine oxidase [copper-containing],Amiloride-binding protein 1;Amine oxidase copper domain-containing protein 1;Histaminase;Kidney amine oxidase;, PF01179;PF02727;PF02728;, GO:0005923;GO:0070062;GO:0005576;GO:0005615;GO:0005777;GO:0005886;GO:0035580;GO:0005509;GO:0005507;GO:0052597;GO:0008201;GO:0052598;GO:0052599;GO:0008131;GO:0052600;GO:0042803;GO:0044877;GO:0048038;GO:0008270;GO:0009308;GO:0097185;GO:0071280;GO:0035874;GO:0071504;GO:0071420;GO:0043312;GO:0009445;GO:0046677;GO:0006805;, C:bicellular tight junction; C:extracellular exosome; C:extracellular region; C:extracellular space; C:peroxisome; C:plasma membrane; C:specific granule lumen;, F:calcium ion binding; F:copper ion binding; F:diamine oxidase activity; F:heparin binding; F:histamine oxidase activity; F:methylputrescine oxidase activity; F:primary amine oxidase activity; F:propane-1,3-diamine oxidase activity; F:protein homodimerization activity; F:protein-containing complex binding; F:quinone binding; F:zinc ion binding;, P:amine metabolic process; P:cellular response to azide; P:cellular response to copper ion; P:cellular response to copper ion starvation; P:cellular response to heparin; P:cellular response to histamine; P:neutrophil degranulation; P:putrescine metabolic process; P:response to antibiotic; P:xenobiotic metabolic process; scaffold179 indexed_genome mRNA 1187082 1196890 . - . ID=transcript_15358;Q9H3P0,Potassium voltage-gated channel subfamily H member 2,Eag homolog;Ether-a-go-go-related gene potassium channel 1;Voltage-gated potassium channel subunit Kv11.1;, PF00027;PF00520;PF13426;, GO:0009986;GO:0005887;GO:1902937;GO:0048471;GO:0005886;GO:0008076;GO:0055131;GO:0005251;GO:0042802;GO:0005242;GO:0042803;GO:0097110;GO:0000976;GO:0031625;GO:0005249;GO:0086008;GO:1902282;GO:0061337;GO:0060048;GO:0035690;GO:0086010;GO:0086009;GO:0086011;GO:0086013;GO:0098915;GO:1903765;GO:1901380;GO:1901381;GO:0045893;GO:0097623;GO:0055075;GO:1990573;GO:0071805;GO:0086091;GO:0003064;GO:0042391;GO:0060306;GO:1901379;GO:0060307;GO:0086005;, C:cell surface; C:integral component of plasma membrane; C:inward rectifier potassium channel complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:voltage-gated potassium channel complex;, F:C3HC4-type RING finger domain binding; F:delayed rectifier potassium channel activity; F:identical protein binding; F:inward rectifier potassium channel activity; F:protein homodimerization activity; F:scaffold protein binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding; F:voltage-gated potassium channel activity; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:cardiac conduction; P:cardiac muscle contraction; P:cellular response to drug; P:membrane depolarization during action potential; P:membrane repolarization; P:membrane repolarization during action potential; P:membrane repolarization during cardiac muscle cell action potential; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:negative regulation of potassium ion export across plasma membrane; P:negative regulation of potassium ion transmembrane transport; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of transcription, DNA-templated; P:potassium ion export across plasma membrane; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of heart rate by cardiac conduction; P:regulation of heart rate by hormone; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:ventricular cardiac muscle cell action potential;|Q9H3P0,Potassium voltage-gated channel subfamily H member 2,Eag homolog;Ether-a-go-go-related gene potassium channel 1;Voltage-gated potassium channel subunit Kv11.1;, PF00027;PF00520;PF13426;, GO:0009986;GO:0005887;GO:1902937;GO:0048471;GO:0005886;GO:0008076;GO:0055131;GO:0005251;GO:0042802;GO:0005242;GO:0042803;GO:0097110;GO:0000976;GO:0031625;GO:0005249;GO:0086008;GO:1902282;GO:0061337;GO:0060048;GO:0035690;GO:0086010;GO:0086009;GO:0086011;GO:0086013;GO:0098915;GO:1903765;GO:1901380;GO:1901381;GO:0045893;GO:0097623;GO:0055075;GO:1990573;GO:0071805;GO:0086091;GO:0003064;GO:0042391;GO:0060306;GO:1901379;GO:0060307;GO:0086005;, C:cell surface; C:integral component of plasma membrane; C:inward rectifier potassium channel complex; C:perinuclear region of cytoplasm; C:plasma membrane; C:voltage-gated potassium channel complex;, F:C3HC4-type RING finger domain binding; F:delayed rectifier potassium channel activity; F:identical protein binding; F:inward rectifier potassium channel activity; F:protein homodimerization activity; F:scaffold protein binding; F:transcription regulatory region sequence-specific DNA binding; F:ubiquitin protein ligase binding; F:voltage-gated potassium channel activity; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:cardiac conduction; P:cardiac muscle contraction; P:cellular response to drug; P:membrane depolarization during action potential; P:membrane repolarization; P:membrane repolarization during action potential; P:membrane repolarization during cardiac muscle cell action potential; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:negative regulation of potassium ion export across plasma membrane; P:negative regulation of potassium ion transmembrane transport; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of transcription, DNA-templated; P:potassium ion export across plasma membrane; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of heart rate by cardiac conduction; P:regulation of heart rate by hormone; P:regulation of membrane potential; P:regulation of membrane repolarization; P:regulation of potassium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:ventricular cardiac muscle cell action potential; scaffold180 indexed_genome mRNA 1086866 1088671 . - . ID=transcript_15359;Q8TBP6 A8K483 D6W5P6 Q53GB1 Q9UHR1,Solute carrier family 25 member 40,Mitochondrial carrier family protein;, PF00153;, GO:0016021;GO:0005743;GO:0055085;, C:integral component of membrane; C:mitochondrial inner membrane;, , P:transmembrane transport; scaffold181 indexed_genome mRNA 168587 174096 . - . ID=transcript_15360;Q8N6Y1 A8K1K9 B1AQU2 Q8NDN4 Q9NRT9,Protocadherin-20,Protocadherin-13;, PF00028;, GO:0005887;GO:0005509;GO:0003723;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding; F:RNA binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q8N6Y1 A8K1K9 B1AQU2 Q8NDN4 Q9NRT9,Protocadherin-20,Protocadherin-13;, PF00028;, GO:0005887;GO:0005509;GO:0003723;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding; F:RNA binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold182 indexed_genome mRNA 504205 507277 . + . ID=transcript_15361;Q9NR97 B3Y654 D1CS70 D1CS76 Q495P4 Q6UXL6 Q9NYG9,Toll-like receptor 8,, PF13855;PF01582;, GO:0036020;GO:0005789;GO:0010008;GO:0009897;GO:0000139;GO:0016021;GO:0005886;GO:0003677;GO:0003725;GO:0008144;GO:0042802;GO:0038187;GO:0003723;GO:0038023;GO:0003727;GO:0004888;GO:0071260;GO:0051607;GO:0007249;GO:0006955;GO:0016064;GO:0006954;GO:0045087;GO:0001774;GO:0002755;GO:0032695;GO:0045089;GO:0032727;GO:0032728;GO:0032729;GO:0032731;GO:0032755;GO:0032757;GO:0001932;GO:0009615;GO:0034158;GO:0002224;, C:endolysosome membrane; C:endoplasmic reticulum membrane; C:endosome membrane; C:external side of plasma membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane;, F:DNA binding; F:double-stranded RNA binding; F:drug binding; F:identical protein binding; F:pattern recognition receptor activity; F:RNA binding; F:signaling receptor activity; F:single-stranded RNA binding; F:transmembrane signaling receptor activity;, P:cellular response to mechanical stimulus; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:immune response; P:immunoglobulin mediated immune response; P:inflammatory response; P:innate immune response; P:microglial cell activation; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of interleukin-12 production; P:positive regulation of innate immune response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:regulation of protein phosphorylation; P:response to virus; P:toll-like receptor 8 signaling pathway; P:toll-like receptor signaling pathway; scaffold182 indexed_genome mRNA 547208 550124 . - . ID=transcript_15362;Q9NYK1 D1CS69 Q9NR98,Toll-like receptor 7,, PF13306;PF13855;PF01582;, GO:0005737;GO:0032009;GO:0036020;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0000139;GO:0016021;GO:0005764;GO:0005886;GO:0043235;GO:0003725;GO:0008144;GO:0038187;GO:0003727;GO:0035197;GO:0004888;GO:0071260;GO:0051607;GO:0007249;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0001774;GO:0032722;GO:0050729;GO:0032727;GO:0032728;GO:0032729;GO:0032755;GO:0032757;GO:1901224;GO:0001932;GO:0034154;GO:0034162;GO:0002224;, C:cytoplasm; C:early phagosome; C:endolysosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:Golgi membrane; C:integral component of membrane; C:lysosome; C:plasma membrane; C:receptor complex;, F:double-stranded RNA binding; F:drug binding; F:pattern recognition receptor activity; F:single-stranded RNA binding; F:siRNA binding; F:transmembrane signaling receptor activity;, P:cellular response to mechanical stimulus; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:microglial cell activation; P:positive regulation of chemokine production; P:positive regulation of inflammatory response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of protein phosphorylation; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9NYK1 D1CS69 Q9NR98,Toll-like receptor 7,, PF13306;PF13855;PF01582;, GO:0005737;GO:0032009;GO:0036020;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0000139;GO:0016021;GO:0005764;GO:0005886;GO:0043235;GO:0003725;GO:0008144;GO:0038187;GO:0003727;GO:0035197;GO:0004888;GO:0071260;GO:0051607;GO:0007249;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0001774;GO:0032722;GO:0050729;GO:0032727;GO:0032728;GO:0032729;GO:0032755;GO:0032757;GO:1901224;GO:0001932;GO:0034154;GO:0034162;GO:0002224;, C:cytoplasm; C:early phagosome; C:endolysosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:Golgi membrane; C:integral component of membrane; C:lysosome; C:plasma membrane; C:receptor complex;, F:double-stranded RNA binding; F:drug binding; F:pattern recognition receptor activity; F:single-stranded RNA binding; F:siRNA binding; F:transmembrane signaling receptor activity;, P:cellular response to mechanical stimulus; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:microglial cell activation; P:positive regulation of chemokine production; P:positive regulation of inflammatory response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of protein phosphorylation; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; scaffold182 indexed_genome mRNA 550148 550848 . + . ID=transcript_15363;Q9NYK1 D1CS69 Q9NR98,Toll-like receptor 7,, PF13306;PF13855;PF01582;, GO:0005737;GO:0032009;GO:0036020;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0000139;GO:0016021;GO:0005764;GO:0005886;GO:0043235;GO:0003725;GO:0008144;GO:0038187;GO:0003727;GO:0035197;GO:0004888;GO:0071260;GO:0051607;GO:0007249;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0001774;GO:0032722;GO:0050729;GO:0032727;GO:0032728;GO:0032729;GO:0032755;GO:0032757;GO:1901224;GO:0001932;GO:0034154;GO:0034162;GO:0002224;, C:cytoplasm; C:early phagosome; C:endolysosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:Golgi membrane; C:integral component of membrane; C:lysosome; C:plasma membrane; C:receptor complex;, F:double-stranded RNA binding; F:drug binding; F:pattern recognition receptor activity; F:single-stranded RNA binding; F:siRNA binding; F:transmembrane signaling receptor activity;, P:cellular response to mechanical stimulus; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:microglial cell activation; P:positive regulation of chemokine production; P:positive regulation of inflammatory response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of protein phosphorylation; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; scaffold182 indexed_genome mRNA 550869 564029 . - . ID=transcript_15364;Q9NYK1 D1CS69 Q9NR98,Toll-like receptor 7,, PF13306;PF13855;PF01582;, GO:0005737;GO:0032009;GO:0036020;GO:0005783;GO:0005789;GO:0005768;GO:0010008;GO:0000139;GO:0016021;GO:0005764;GO:0005886;GO:0043235;GO:0003725;GO:0008144;GO:0038187;GO:0003727;GO:0035197;GO:0004888;GO:0071260;GO:0051607;GO:0007249;GO:0007252;GO:0006955;GO:0006954;GO:0045087;GO:0001774;GO:0032722;GO:0050729;GO:0032727;GO:0032728;GO:0032729;GO:0032755;GO:0032757;GO:1901224;GO:0001932;GO:0034154;GO:0034162;GO:0002224;, C:cytoplasm; C:early phagosome; C:endolysosome membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:endosome membrane; C:Golgi membrane; C:integral component of membrane; C:lysosome; C:plasma membrane; C:receptor complex;, F:double-stranded RNA binding; F:drug binding; F:pattern recognition receptor activity; F:single-stranded RNA binding; F:siRNA binding; F:transmembrane signaling receptor activity;, P:cellular response to mechanical stimulus; P:defense response to virus; P:I-kappaB kinase/NF-kappaB signaling; P:I-kappaB phosphorylation; P:immune response; P:inflammatory response; P:innate immune response; P:microglial cell activation; P:positive regulation of chemokine production; P:positive regulation of inflammatory response; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of protein phosphorylation; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; scaffold182 indexed_genome mRNA 582154 606147 . - . ID=transcript_15365;P11908 Q0VDH9 Q0VDI0 Q15245 Q2TAK7,Ribose-phosphate pyrophosphokinase 2,PPRibP;Phosphoribosyl pyrophosphate synthase II;, PF14572;PF13793;, GO:0005737;GO:0002189;GO:0043531;GO:0016208;GO:0005524;GO:0030246;GO:0019003;GO:0042802;GO:0016301;GO:0000287;GO:0042803;GO:0004749;GO:0006015;GO:0006167;GO:0031100;GO:0006139;GO:0009116;GO:0006164;, C:cytoplasm; C:ribose phosphate diphosphokinase complex;, F:ADP binding; F:AMP binding; F:ATP binding; F:carbohydrate binding; F:GDP binding; F:identical protein binding; F:kinase activity; F:magnesium ion binding; F:protein homodimerization activity; F:ribose phosphate diphosphokinase activity;, P:5-phosphoribose 1-diphosphate biosynthetic process; P:AMP biosynthetic process; P:animal organ regeneration; P:nucleobase-containing compound metabolic process; P:nucleoside metabolic process; P:purine nucleotide biosynthetic process; scaffold182 indexed_genome mRNA 652577 656142 . - . ID=transcript_15366;Q14CM0 A8K0X9 O15032,FERM and PDZ domain-containing protein 4,PDZ domain-containing protein 10;PSD-95-interacting regulator of spine morphogenesis;, PF00373;PF00595;, GO:0005856;GO:0043197;GO:0032991;GO:0005546;GO:0051835;, C:cytoskeleton; C:dendritic spine; C:protein-containing complex;, F:phosphatidylinositol-4,5-bisphosphate binding;, P:positive regulation of synapse structural plasticity; scaffold182 indexed_genome mRNA 656797 657798 . - . ID=transcript_15367;Q14CM0 A8K0X9 O15032,FERM and PDZ domain-containing protein 4,PDZ domain-containing protein 10;PSD-95-interacting regulator of spine morphogenesis;, PF00373;PF00595;, GO:0005856;GO:0043197;GO:0032991;GO:0005546;GO:0051835;, C:cytoskeleton; C:dendritic spine; C:protein-containing complex;, F:phosphatidylinositol-4,5-bisphosphate binding;, P:positive regulation of synapse structural plasticity; scaffold182 indexed_genome mRNA 657815 674292 . - . ID=transcript_15368;Q14CM0 A8K0X9 O15032,FERM and PDZ domain-containing protein 4,PDZ domain-containing protein 10;PSD-95-interacting regulator of spine morphogenesis;, PF00373;PF00595;, GO:0005856;GO:0043197;GO:0032991;GO:0005546;GO:0051835;, C:cytoskeleton; C:dendritic spine; C:protein-containing complex;, F:phosphatidylinositol-4,5-bisphosphate binding;, P:positive regulation of synapse structural plasticity; scaffold183 indexed_genome mRNA 1 12360 . + . ID=transcript_15369;P54259 Q99495 Q99621 Q9UEK7,Atrophin-1,Dentatorubral-pallidoluysian atrophy protein;, PF03154;, GO:0030054;GO:0005737;GO:0016363;GO:0005654;GO:0005634;GO:0048471;GO:0019904;GO:0001085;GO:0003714;GO:0007417;GO:0000122;GO:0051402;, C:cell junction; C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:protein domain specific binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:central nervous system development; P:negative regulation of transcription by RNA polymerase II; P:neuron apoptotic process;|P54259 Q99495 Q99621 Q9UEK7,Atrophin-1,Dentatorubral-pallidoluysian atrophy protein;, PF03154;, GO:0030054;GO:0005737;GO:0016363;GO:0005654;GO:0005634;GO:0048471;GO:0019904;GO:0001085;GO:0003714;GO:0007417;GO:0000122;GO:0051402;, C:cell junction; C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:protein domain specific binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:central nervous system development; P:negative regulation of transcription by RNA polymerase II; P:neuron apoptotic process;|P54259 Q99495 Q99621 Q9UEK7,Atrophin-1,Dentatorubral-pallidoluysian atrophy protein;, PF03154;, GO:0030054;GO:0005737;GO:0016363;GO:0005654;GO:0005634;GO:0048471;GO:0019904;GO:0001085;GO:0003714;GO:0007417;GO:0000122;GO:0051402;, C:cell junction; C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:protein domain specific binding; F:RNA polymerase II transcription factor binding; F:transcription corepressor activity;, P:central nervous system development; P:negative regulation of transcription by RNA polymerase II; P:neuron apoptotic process; scaffold183 indexed_genome mRNA 13486 14014 . - . ID=transcript_15370;Q99622 B2R4Q6,Protein C10,, PF14974;, GO:0005737;GO:0016607;GO:0048593;GO:0050890;GO:0021540;GO:0009791;GO:0036343;GO:0014819;GO:0021678;, C:cytoplasm; C:nuclear speck;, , P:camera-type eye morphogenesis; P:cognition; P:corpus callosum morphogenesis; P:post-embryonic development; P:psychomotor behavior; P:regulation of skeletal muscle contraction; P:third ventricle development; scaffold183 indexed_genome mRNA 14392 15033 . + . ID=transcript_15371;Q99622 B2R4Q6,Protein C10,, PF14974;, GO:0005737;GO:0016607;GO:0048593;GO:0050890;GO:0021540;GO:0009791;GO:0036343;GO:0014819;GO:0021678;, C:cytoplasm; C:nuclear speck;, , P:camera-type eye morphogenesis; P:cognition; P:corpus callosum morphogenesis; P:post-embryonic development; P:psychomotor behavior; P:regulation of skeletal muscle contraction; P:third ventricle development; scaffold183 indexed_genome mRNA 21643 31021 . + . ID=transcript_15372;P29350 A8K306 G3V0F8 Q969V8 Q9UK67,Tyrosine-protein phosphatase non-receptor type 6,Hematopoietic cell protein-tyrosine phosphatase;Protein-tyrosine phosphatase 1C;Protein-tyrosine phosphatase SHP-1;SH-PTP1;, PF00017;PF00102;, GO:0042105;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0035580;GO:1904724;GO:0050839;GO:0140031;GO:0001784;GO:0019901;GO:0004725;GO:0042169;GO:0017124;GO:0005001;GO:0033277;GO:0050853;GO:0030154;GO:0071345;GO:0019221;GO:1905867;GO:0007186;GO:0002244;GO:0035556;GO:0050900;GO:0035855;GO:0042267;GO:0008285;GO:0002924;GO:0032715;GO:0043407;GO:0050732;GO:0042130;GO:0050860;GO:0032720;GO:0043312;GO:0035335;GO:0018108;GO:0030168;GO:0070527;GO:0030220;GO:0033630;GO:0008284;GO:0014068;GO:0006470;GO:0042981;GO:0045577;GO:0070372;GO:2000045;GO:0051279;GO:0060338;GO:0031295;, C:alpha-beta T cell receptor complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:specific granule lumen; C:tertiary granule lumen;, F:cell adhesion molecule binding; F:phosphorylation-dependent protein binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:SH2 domain binding; F:SH3 domain binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:abortive mitotic cell cycle; P:B cell receptor signaling pathway; P:cell differentiation; P:cellular response to cytokine stimulus; P:cytokine-mediated signaling pathway; P:epididymis development; P:G protein-coupled receptor signaling pathway; P:hematopoietic progenitor cell differentiation; P:intracellular signal transduction; P:leukocyte migration; P:megakaryocyte development; P:natural killer cell mediated cytotoxicity; P:negative regulation of cell population proliferation; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; P:negative regulation of interleukin-6 production; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of T cell proliferation; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:neutrophil degranulation; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:platelet aggregation; P:platelet formation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell population proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein dephosphorylation; P:regulation of apoptotic process; P:regulation of B cell differentiation; P:regulation of ERK1 and ERK2 cascade; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of type I interferon-mediated signaling pathway; P:T cell costimulation;|P29350 A8K306 G3V0F8 Q969V8 Q9UK67,Tyrosine-protein phosphatase non-receptor type 6,Hematopoietic cell protein-tyrosine phosphatase;Protein-tyrosine phosphatase 1C;Protein-tyrosine phosphatase SHP-1;SH-PTP1;, PF00017;PF00102;, GO:0042105;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0035580;GO:1904724;GO:0050839;GO:0140031;GO:0001784;GO:0019901;GO:0004725;GO:0042169;GO:0017124;GO:0005001;GO:0033277;GO:0050853;GO:0030154;GO:0071345;GO:0019221;GO:1905867;GO:0007186;GO:0002244;GO:0035556;GO:0050900;GO:0035855;GO:0042267;GO:0008285;GO:0002924;GO:0032715;GO:0043407;GO:0050732;GO:0042130;GO:0050860;GO:0032720;GO:0043312;GO:0035335;GO:0018108;GO:0030168;GO:0070527;GO:0030220;GO:0033630;GO:0008284;GO:0014068;GO:0006470;GO:0042981;GO:0045577;GO:0070372;GO:2000045;GO:0051279;GO:0060338;GO:0031295;, C:alpha-beta T cell receptor complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:specific granule lumen; C:tertiary granule lumen;, F:cell adhesion molecule binding; F:phosphorylation-dependent protein binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:SH2 domain binding; F:SH3 domain binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:abortive mitotic cell cycle; P:B cell receptor signaling pathway; P:cell differentiation; P:cellular response to cytokine stimulus; P:cytokine-mediated signaling pathway; P:epididymis development; P:G protein-coupled receptor signaling pathway; P:hematopoietic progenitor cell differentiation; P:intracellular signal transduction; P:leukocyte migration; P:megakaryocyte development; P:natural killer cell mediated cytotoxicity; P:negative regulation of cell population proliferation; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; P:negative regulation of interleukin-6 production; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of T cell proliferation; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:neutrophil degranulation; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:platelet aggregation; P:platelet formation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell population proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein dephosphorylation; P:regulation of apoptotic process; P:regulation of B cell differentiation; P:regulation of ERK1 and ERK2 cascade; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of type I interferon-mediated signaling pathway; P:T cell costimulation;|P29350 A8K306 G3V0F8 Q969V8 Q9UK67,Tyrosine-protein phosphatase non-receptor type 6,Hematopoietic cell protein-tyrosine phosphatase;Protein-tyrosine phosphatase 1C;Protein-tyrosine phosphatase SHP-1;SH-PTP1;, PF00017;PF00102;, GO:0042105;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0035580;GO:1904724;GO:0050839;GO:0140031;GO:0001784;GO:0019901;GO:0004725;GO:0042169;GO:0017124;GO:0005001;GO:0033277;GO:0050853;GO:0030154;GO:0071345;GO:0019221;GO:1905867;GO:0007186;GO:0002244;GO:0035556;GO:0050900;GO:0035855;GO:0042267;GO:0008285;GO:0002924;GO:0032715;GO:0043407;GO:0050732;GO:0042130;GO:0050860;GO:0032720;GO:0043312;GO:0035335;GO:0018108;GO:0030168;GO:0070527;GO:0030220;GO:0033630;GO:0008284;GO:0014068;GO:0006470;GO:0042981;GO:0045577;GO:0070372;GO:2000045;GO:0051279;GO:0060338;GO:0031295;, C:alpha-beta T cell receptor complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:specific granule lumen; C:tertiary granule lumen;, F:cell adhesion molecule binding; F:phosphorylation-dependent protein binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:SH2 domain binding; F:SH3 domain binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:abortive mitotic cell cycle; P:B cell receptor signaling pathway; P:cell differentiation; P:cellular response to cytokine stimulus; P:cytokine-mediated signaling pathway; P:epididymis development; P:G protein-coupled receptor signaling pathway; P:hematopoietic progenitor cell differentiation; P:intracellular signal transduction; P:leukocyte migration; P:megakaryocyte development; P:natural killer cell mediated cytotoxicity; P:negative regulation of cell population proliferation; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; P:negative regulation of interleukin-6 production; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of T cell proliferation; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:neutrophil degranulation; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:platelet aggregation; P:platelet formation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell population proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein dephosphorylation; P:regulation of apoptotic process; P:regulation of B cell differentiation; P:regulation of ERK1 and ERK2 cascade; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of type I interferon-mediated signaling pathway; P:T cell costimulation;|P29350 A8K306 G3V0F8 Q969V8 Q9UK67,Tyrosine-protein phosphatase non-receptor type 6,Hematopoietic cell protein-tyrosine phosphatase;Protein-tyrosine phosphatase 1C;Protein-tyrosine phosphatase SHP-1;SH-PTP1;, PF00017;PF00102;, GO:0042105;GO:0005911;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0035580;GO:1904724;GO:0050839;GO:0140031;GO:0001784;GO:0019901;GO:0004725;GO:0042169;GO:0017124;GO:0005001;GO:0033277;GO:0050853;GO:0030154;GO:0071345;GO:0019221;GO:1905867;GO:0007186;GO:0002244;GO:0035556;GO:0050900;GO:0035855;GO:0042267;GO:0008285;GO:0002924;GO:0032715;GO:0043407;GO:0050732;GO:0042130;GO:0050860;GO:0032720;GO:0043312;GO:0035335;GO:0018108;GO:0030168;GO:0070527;GO:0030220;GO:0033630;GO:0008284;GO:0014068;GO:0006470;GO:0042981;GO:0045577;GO:0070372;GO:2000045;GO:0051279;GO:0060338;GO:0031295;, C:alpha-beta T cell receptor complex; C:cell-cell junction; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:specific granule lumen; C:tertiary granule lumen;, F:cell adhesion molecule binding; F:phosphorylation-dependent protein binding; F:phosphotyrosine residue binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:SH2 domain binding; F:SH3 domain binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:abortive mitotic cell cycle; P:B cell receptor signaling pathway; P:cell differentiation; P:cellular response to cytokine stimulus; P:cytokine-mediated signaling pathway; P:epididymis development; P:G protein-coupled receptor signaling pathway; P:hematopoietic progenitor cell differentiation; P:intracellular signal transduction; P:leukocyte migration; P:megakaryocyte development; P:natural killer cell mediated cytotoxicity; P:negative regulation of cell population proliferation; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; P:negative regulation of interleukin-6 production; P:negative regulation of MAP kinase activity; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of T cell proliferation; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of tumor necrosis factor production; P:neutrophil degranulation; P:peptidyl-tyrosine dephosphorylation; P:peptidyl-tyrosine phosphorylation; P:platelet activation; P:platelet aggregation; P:platelet formation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell population proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:protein dephosphorylation; P:regulation of apoptotic process; P:regulation of B cell differentiation; P:regulation of ERK1 and ERK2 cascade; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of release of sequestered calcium ion into cytosol; P:regulation of type I interferon-mediated signaling pathway; P:T cell costimulation; scaffold183 indexed_genome mRNA 36154 40371 . - . ID=transcript_15373;Q99623 B4DP75 Q2YDA4 Q7KYU3 Q92978,Prohibitin-2,B-cell receptor-associated protein BAP37;D-prohibitin;Repressor of estrogen receptor activity;, PF01145;, GO:0030424;GO:0071944;GO:0009986;GO:0005737;GO:0098982;GO:0098978;GO:0005743;GO:0005741;GO:0035632;GO:0005739;GO:0016363;GO:0005634;GO:0005886;GO:0014069;GO:0048786;GO:0032991;GO:0033218;GO:0030331;GO:0042802;GO:0008022;GO:0046982;GO:0042803;GO:0047485;GO:0046625;GO:0007202;GO:1990051;GO:0140374;GO:0042113;GO:0023035;GO:0016477;GO:0071456;GO:0071300;GO:0039520;GO:0060749;GO:0060744;GO:0006851;GO:0007005;GO:0000423;GO:0043066;GO:0043433;GO:0033147;GO:0033600;GO:0045892;GO:1902808;GO:0051091;GO:0070374;GO:0031536;GO:0002639;GO:1901224;GO:0006606;GO:0050821;GO:0060762;GO:1900208;GO:1904959;GO:0009611;GO:0039529;GO:0007062;, C:axon; C:cell periphery; C:cell surface; C:cytoplasm; C:GABA-ergic synapse; C:glutamatergic synapse; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrial prohibitin complex; C:mitochondrion; C:nuclear matrix; C:nucleus; C:plasma membrane; C:postsynaptic density; C:presynaptic active zone; C:protein-containing complex;, F:amide binding; F:estrogen receptor binding; F:identical protein binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein N-terminus binding; F:sphingolipid binding;, P:activation of phospholipase C activity; P:activation of protein kinase C activity; P:antiviral innate immune response; P:B cell activation; P:CD40 signaling pathway; P:cell migration; P:cellular response to hypoxia; P:cellular response to retinoic acid; P:induction by virus of host autophagy; P:mammary gland alveolus development; P:mammary gland branching involved in thelarche; P:mitochondrial calcium ion transmembrane transport; P:mitochondrion organization; P:mitophagy; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of mammary gland epithelial cell proliferation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exit from mitosis; P:positive regulation of immunoglobulin production; P:positive regulation of NIK/NF-kappaB signaling; P:protein import into nucleus; P:protein stabilization; P:regulation of branching involved in mammary gland duct morphogenesis; P:regulation of cardiolipin metabolic process; P:regulation of cytochrome-c oxidase activity; P:response to wounding; P:RIG-I signaling pathway; P:sister chromatid cohesion;|Q99623 B4DP75 Q2YDA4 Q7KYU3 Q92978,Prohibitin-2,B-cell receptor-associated protein BAP37;D-prohibitin;Repressor of estrogen receptor activity;, PF01145;, GO:0030424;GO:0071944;GO:0009986;GO:0005737;GO:0098982;GO:0098978;GO:0005743;GO:0005741;GO:0035632;GO:0005739;GO:0016363;GO:0005634;GO:0005886;GO:0014069;GO:0048786;GO:0032991;GO:0033218;GO:0030331;GO:0042802;GO:0008022;GO:0046982;GO:0042803;GO:0047485;GO:0046625;GO:0007202;GO:1990051;GO:0140374;GO:0042113;GO:0023035;GO:0016477;GO:0071456;GO:0071300;GO:0039520;GO:0060749;GO:0060744;GO:0006851;GO:0007005;GO:0000423;GO:0043066;GO:0043433;GO:0033147;GO:0033600;GO:0045892;GO:1902808;GO:0051091;GO:0070374;GO:0031536;GO:0002639;GO:1901224;GO:0006606;GO:0050821;GO:0060762;GO:1900208;GO:1904959;GO:0009611;GO:0039529;GO:0007062;, C:axon; C:cell periphery; C:cell surface; C:cytoplasm; C:GABA-ergic synapse; C:glutamatergic synapse; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrial prohibitin complex; C:mitochondrion; C:nuclear matrix; C:nucleus; C:plasma membrane; C:postsynaptic density; C:presynaptic active zone; C:protein-containing complex;, F:amide binding; F:estrogen receptor binding; F:identical protein binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein N-terminus binding; F:sphingolipid binding;, P:activation of phospholipase C activity; P:activation of protein kinase C activity; P:antiviral innate immune response; P:B cell activation; P:CD40 signaling pathway; P:cell migration; P:cellular response to hypoxia; P:cellular response to retinoic acid; P:induction by virus of host autophagy; P:mammary gland alveolus development; P:mammary gland branching involved in thelarche; P:mitochondrial calcium ion transmembrane transport; P:mitochondrion organization; P:mitophagy; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of mammary gland epithelial cell proliferation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exit from mitosis; P:positive regulation of immunoglobulin production; P:positive regulation of NIK/NF-kappaB signaling; P:protein import into nucleus; P:protein stabilization; P:regulation of branching involved in mammary gland duct morphogenesis; P:regulation of cardiolipin metabolic process; P:regulation of cytochrome-c oxidase activity; P:response to wounding; P:RIG-I signaling pathway; P:sister chromatid cohesion;|Q99623 B4DP75 Q2YDA4 Q7KYU3 Q92978,Prohibitin-2,B-cell receptor-associated protein BAP37;D-prohibitin;Repressor of estrogen receptor activity;, PF01145;, GO:0030424;GO:0071944;GO:0009986;GO:0005737;GO:0098982;GO:0098978;GO:0005743;GO:0005741;GO:0035632;GO:0005739;GO:0016363;GO:0005634;GO:0005886;GO:0014069;GO:0048786;GO:0032991;GO:0033218;GO:0030331;GO:0042802;GO:0008022;GO:0046982;GO:0042803;GO:0047485;GO:0046625;GO:0007202;GO:1990051;GO:0140374;GO:0042113;GO:0023035;GO:0016477;GO:0071456;GO:0071300;GO:0039520;GO:0060749;GO:0060744;GO:0006851;GO:0007005;GO:0000423;GO:0043066;GO:0043433;GO:0033147;GO:0033600;GO:0045892;GO:1902808;GO:0051091;GO:0070374;GO:0031536;GO:0002639;GO:1901224;GO:0006606;GO:0050821;GO:0060762;GO:1900208;GO:1904959;GO:0009611;GO:0039529;GO:0007062;, C:axon; C:cell periphery; C:cell surface; C:cytoplasm; C:GABA-ergic synapse; C:glutamatergic synapse; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:mitochondrial prohibitin complex; C:mitochondrion; C:nuclear matrix; C:nucleus; C:plasma membrane; C:postsynaptic density; C:presynaptic active zone; C:protein-containing complex;, F:amide binding; F:estrogen receptor binding; F:identical protein binding; F:protein C-terminus binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein N-terminus binding; F:sphingolipid binding;, P:activation of phospholipase C activity; P:activation of protein kinase C activity; P:antiviral innate immune response; P:B cell activation; P:CD40 signaling pathway; P:cell migration; P:cellular response to hypoxia; P:cellular response to retinoic acid; P:induction by virus of host autophagy; P:mammary gland alveolus development; P:mammary gland branching involved in thelarche; P:mitochondrial calcium ion transmembrane transport; P:mitochondrion organization; P:mitophagy; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of mammary gland epithelial cell proliferation; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exit from mitosis; P:positive regulation of immunoglobulin production; P:positive regulation of NIK/NF-kappaB signaling; P:protein import into nucleus; P:protein stabilization; P:regulation of branching involved in mammary gland duct morphogenesis; P:regulation of cardiolipin metabolic process; P:regulation of cytochrome-c oxidase activity; P:response to wounding; P:RIG-I signaling pathway; P:sister chromatid cohesion; scaffold183 indexed_genome mRNA 40694 79998 . + . ID=transcript_15374;Q92979 O00675 O00726,Ribosomal RNA small subunit methyltransferase NEP1 {ECO:0000305|PubMed:20047967},18S rRNA (pseudouridine(1248)-N1)-methyltransferase {ECO:0000303|PubMed:20047967};18S rRNA Psi1248 methyltransferase {ECO:0000303|PubMed:20047967};Nucleolar protein EMG1 homolog {ECO:0000250|UniProtKB:Q06287};Protein C2f {ECO:0000303|PubMed:9074930};Ribosome biogenesis protein NEP1 {ECO:0000303|PubMed:20047967};, PF03587;, GO:0005694;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0032040;GO:0042802;GO:0003723;GO:0070037;GO:0019843;GO:0001824;GO:0017126;GO:0042274;GO:0070475;GO:0006364;, C:chromosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:small-subunit processome;, F:identical protein binding; F:RNA binding; F:rRNA (pseudouridine) methyltransferase activity; F:rRNA binding;, P:blastocyst development; P:nucleologenesis; P:ribosomal small subunit biogenesis; P:rRNA base methylation; P:rRNA processing;|Q92979 O00675 O00726,Ribosomal RNA small subunit methyltransferase NEP1 {ECO:0000305|PubMed:20047967},18S rRNA (pseudouridine(1248)-N1)-methyltransferase {ECO:0000303|PubMed:20047967};18S rRNA Psi1248 methyltransferase {ECO:0000303|PubMed:20047967};Nucleolar protein EMG1 homolog {ECO:0000250|UniProtKB:Q06287};Protein C2f {ECO:0000303|PubMed:9074930};Ribosome biogenesis protein NEP1 {ECO:0000303|PubMed:20047967};, PF03587;, GO:0005694;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0032040;GO:0042802;GO:0003723;GO:0070037;GO:0019843;GO:0001824;GO:0017126;GO:0042274;GO:0070475;GO:0006364;, C:chromosome; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus; C:small-subunit processome;, F:identical protein binding; F:RNA binding; F:rRNA (pseudouridine) methyltransferase activity; F:rRNA binding;, P:blastocyst development; P:nucleologenesis; P:ribosomal small subunit biogenesis; P:rRNA base methylation; P:rRNA processing;|Q6P1A2 B2RDH0 B7Z3N3 Q7KZS1 Q92980 Q9BW40,Lysophospholipid acyltransferase 5,1-acylglycerophosphocholine O-acyltransferase;1-acylglycerophosphoethanolamine O-acyltransferase;1-acylglycerophosphoserine O-acyltransferase;Lysophosphatidylcholine acyltransferase;Lysophosphatidylcholine acyltransferase 3;Lysophosphatidylserine acyltransferase;Membrane-bound O-acyltransferase domain-containing protein 5;, PF03062;, GO:0005789;GO:0016021;GO:0016020;GO:0047184;GO:0106262;GO:0106263;GO:0071617;GO:0016746;GO:0034378;GO:0090158;GO:0036335;GO:0030258;GO:0050728;GO:1903573;GO:0036151;GO:0006656;GO:0036152;GO:0036150;GO:0045797;GO:1901310;GO:1905885;GO:0045540;GO:0034379;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; F:1-acylglycerophosphoserine O-acyltransferase activity; F:lysophospholipid acyltransferase activity; F:transferase activity, transferring acyl groups;, P:chylomicron assembly; P:endoplasmic reticulum membrane organization; P:intestinal stem cell homeostasis; P:lipid modification; P:negative regulation of inflammatory response; P:negative regulation of response to endoplasmic reticulum stress; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine acyl-chain remodeling; P:phosphatidylserine acyl-chain remodeling; P:positive regulation of intestinal cholesterol absorption; P:positive regulation of sterol regulatory element binding protein cleavage; P:positive regulation of triglyceride transport; P:regulation of cholesterol biosynthetic process; P:very-low-density lipoprotein particle assembly; scaffold183 indexed_genome mRNA 108769 119772 . + . ID=transcript_15375;Q9UCV4 Q9UCV5 Q9UM14,Complement C1s subcomponent,C1 esterase;Complement component 1 subcomponent s;, PF00431;PF00084;PF00089;, GO:0072562;GO:0005576;GO:0005615;GO:0005509;GO:0042802;GO:0004252;GO:0006956;GO:0006958;GO:0045087;GO:0030449;, C:blood microparticle; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:identical protein binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:innate immune response; P:regulation of complement activation;|Q9UCV4 Q9UCV5 Q9UM14,Complement C1s subcomponent,C1 esterase;Complement component 1 subcomponent s;, PF00431;PF00084;PF00089;, GO:0072562;GO:0005576;GO:0005615;GO:0005509;GO:0042802;GO:0004252;GO:0006956;GO:0006958;GO:0045087;GO:0030449;, C:blood microparticle; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:identical protein binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:innate immune response; P:regulation of complement activation;|Q9UCV4 Q9UCV5 Q9UM14,Complement C1s subcomponent,C1 esterase;Complement component 1 subcomponent s;, PF00431;PF00084;PF00089;, GO:0072562;GO:0005576;GO:0005615;GO:0005509;GO:0042802;GO:0004252;GO:0006956;GO:0006958;GO:0045087;GO:0030449;, C:blood microparticle; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:identical protein binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:innate immune response; P:regulation of complement activation;|Q9UCV4 Q9UCV5 Q9UM14,Complement C1s subcomponent,C1 esterase;Complement component 1 subcomponent s;, PF00431;PF00084;PF00089;, GO:0072562;GO:0005576;GO:0005615;GO:0005509;GO:0042802;GO:0004252;GO:0006956;GO:0006958;GO:0045087;GO:0030449;, C:blood microparticle; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:identical protein binding; F:serine-type endopeptidase activity;, P:complement activation; P:complement activation, classical pathway; P:innate immune response; P:regulation of complement activation; scaffold183 indexed_genome mRNA 138710 149840 . - . ID=transcript_15376;P00736 A6NJQ8 Q68D77 Q8J012,Complement C1r subcomponent,Complement component 1 subcomponent r;, PF00431;PF00084;PF00089;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0042802;GO:0004252;GO:0008236;GO:0006956;GO:0006958;GO:0006955;GO:0045087;GO:0030449;GO:0031638;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:identical protein binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:complement activation; P:complement activation, classical pathway; P:immune response; P:innate immune response; P:regulation of complement activation; P:zymogen activation;|P00736 A6NJQ8 Q68D77 Q8J012,Complement C1r subcomponent,Complement component 1 subcomponent r;, PF00431;PF00084;PF00089;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0042802;GO:0004252;GO:0008236;GO:0006956;GO:0006958;GO:0006955;GO:0045087;GO:0030449;GO:0031638;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:identical protein binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:complement activation; P:complement activation, classical pathway; P:immune response; P:innate immune response; P:regulation of complement activation; P:zymogen activation;|P00736 A6NJQ8 Q68D77 Q8J012,Complement C1r subcomponent,Complement component 1 subcomponent r;, PF00431;PF00084;PF00089;, GO:0072562;GO:0070062;GO:0005576;GO:0005615;GO:0005509;GO:0042802;GO:0004252;GO:0008236;GO:0006956;GO:0006958;GO:0006955;GO:0045087;GO:0030449;GO:0031638;, C:blood microparticle; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:identical protein binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:complement activation; P:complement activation, classical pathway; P:immune response; P:innate immune response; P:regulation of complement activation; P:zymogen activation; scaffold183 indexed_genome mRNA 177756 186606 . - . ID=transcript_15377;Q9NZP8 Q53GX9,Complement C1r subcomponent-like protein,C1r-like serine protease analog protein;, PF00431;PF00089;, GO:0072562;GO:0070062;GO:0005615;GO:0004252;GO:0006958;GO:0045087;GO:0031638;, C:blood microparticle; C:extracellular exosome; C:extracellular space;, F:serine-type endopeptidase activity;, P:complement activation, classical pathway; P:innate immune response; P:zymogen activation; scaffold183 indexed_genome mRNA 201953 238490 . - . ID=transcript_15378;P82980 Q53FB1,Retinol-binding protein 5,Cellular retinol-binding protein III;HRBPiso;, PF00061;, GO:0005737;GO:0070062;GO:0016918;GO:0005501;GO:0019841;, C:cytoplasm; C:extracellular exosome;, F:retinal binding; F:retinoid binding; F:retinol binding;|P82980 Q53FB1,Retinol-binding protein 5,Cellular retinol-binding protein III;HRBPiso;, PF00061;, GO:0005737;GO:0070062;GO:0016918;GO:0005501;GO:0019841;, C:cytoplasm; C:extracellular exosome;, F:retinal binding; F:retinoid binding; F:retinol binding;|P82980 Q53FB1,Retinol-binding protein 5,Cellular retinol-binding protein III;HRBPiso;, PF00061;, GO:0005737;GO:0070062;GO:0016918;GO:0005501;GO:0019841;, C:cytoplasm; C:extracellular exosome;, F:retinal binding; F:retinoid binding; F:retinol binding;|P82980 Q53FB1,Retinol-binding protein 5,Cellular retinol-binding protein III;HRBPiso;, PF00061;, GO:0005737;GO:0070062;GO:0016918;GO:0005501;GO:0019841;, C:cytoplasm; C:extracellular exosome;, F:retinal binding; F:retinoid binding; F:retinol binding;|Q9BQT9 D3DUT6 O94831 Q2T9J5 Q5UE57,Calsyntenin-3,Alcadein-beta;, PF00028;, GO:0009986;GO:0030425;GO:0005789;GO:0098982;GO:0098978;GO:0000139;GO:0099061;GO:0045211;GO:0032991;GO:0005509;GO:0007156;GO:1902474;GO:0051965;GO:0050806;GO:0001558;GO:1905606;GO:0007416;GO:0051932;GO:0035249;, C:cell surface; C:dendrite; C:endoplasmic reticulum membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi membrane; C:integral component of postsynaptic density membrane; C:postsynaptic membrane; C:protein-containing complex;, F:calcium ion binding;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of protein localization to synapse; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission; P:regulation of cell growth; P:regulation of presynapse assembly; P:synapse assembly; P:synaptic transmission, GABAergic; P:synaptic transmission, glutamatergic;|Q9BQT9 D3DUT6 O94831 Q2T9J5 Q5UE57,Calsyntenin-3,Alcadein-beta;, PF00028;, GO:0009986;GO:0030425;GO:0005789;GO:0098982;GO:0098978;GO:0000139;GO:0099061;GO:0045211;GO:0032991;GO:0005509;GO:0007156;GO:1902474;GO:0051965;GO:0050806;GO:0001558;GO:1905606;GO:0007416;GO:0051932;GO:0035249;, C:cell surface; C:dendrite; C:endoplasmic reticulum membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi membrane; C:integral component of postsynaptic density membrane; C:postsynaptic membrane; C:protein-containing complex;, F:calcium ion binding;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of protein localization to synapse; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission; P:regulation of cell growth; P:regulation of presynapse assembly; P:synapse assembly; P:synaptic transmission, GABAergic; P:synaptic transmission, glutamatergic;|Q9BQT9 D3DUT6 O94831 Q2T9J5 Q5UE57,Calsyntenin-3,Alcadein-beta;, PF00028;, GO:0009986;GO:0030425;GO:0005789;GO:0098982;GO:0098978;GO:0000139;GO:0099061;GO:0045211;GO:0032991;GO:0005509;GO:0007156;GO:1902474;GO:0051965;GO:0050806;GO:0001558;GO:1905606;GO:0007416;GO:0051932;GO:0035249;, C:cell surface; C:dendrite; C:endoplasmic reticulum membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi membrane; C:integral component of postsynaptic density membrane; C:postsynaptic membrane; C:protein-containing complex;, F:calcium ion binding;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of protein localization to synapse; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission; P:regulation of cell growth; P:regulation of presynapse assembly; P:synapse assembly; P:synaptic transmission, GABAergic; P:synaptic transmission, glutamatergic;|Q9BQT9 D3DUT6 O94831 Q2T9J5 Q5UE57,Calsyntenin-3,Alcadein-beta;, PF00028;, GO:0009986;GO:0030425;GO:0005789;GO:0098982;GO:0098978;GO:0000139;GO:0099061;GO:0045211;GO:0032991;GO:0005509;GO:0007156;GO:1902474;GO:0051965;GO:0050806;GO:0001558;GO:1905606;GO:0007416;GO:0051932;GO:0035249;, C:cell surface; C:dendrite; C:endoplasmic reticulum membrane; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi membrane; C:integral component of postsynaptic density membrane; C:postsynaptic membrane; C:protein-containing complex;, F:calcium ion binding;, P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of protein localization to synapse; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission; P:regulation of cell growth; P:regulation of presynapse assembly; P:synapse assembly; P:synaptic transmission, GABAergic; P:synaptic transmission, glutamatergic; scaffold183 indexed_genome mRNA 265920 281817 . + . ID=transcript_15379;P50542 A8K891 B4DZ45 B7ZAD5 D3DUT8 Q15115 Q15266 Q96FN7,Peroxisomal targeting signal 1 receptor,PTS1-BP;Peroxin-5;Peroxisomal C-terminal targeting signal import receptor;Peroxisome receptor 1;, PF13181;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0032991;GO:0019899;GO:0005052;GO:0033328;GO:0000268;GO:0008022;GO:0047485;GO:0140311;GO:0031267;GO:0031333;GO:0000425;GO:0016558;GO:0016560;GO:0016561;GO:0045046;GO:0008104;GO:0006625;GO:0051262;GO:0016567;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:enzyme binding; F:peroxisome matrix targeting signal-1 binding; F:peroxisome membrane targeting sequence binding; F:peroxisome targeting sequence binding; F:protein C-terminus binding; F:protein N-terminus binding; F:protein sequestering activity; F:small GTPase binding;, P:negative regulation of protein-containing complex assembly; P:pexophagy; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome matrix, translocation; P:protein import into peroxisome membrane; P:protein localization; P:protein targeting to peroxisome; P:protein tetramerization; P:protein ubiquitination;|P50542 A8K891 B4DZ45 B7ZAD5 D3DUT8 Q15115 Q15266 Q96FN7,Peroxisomal targeting signal 1 receptor,PTS1-BP;Peroxin-5;Peroxisomal C-terminal targeting signal import receptor;Peroxisome receptor 1;, PF13181;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0032991;GO:0019899;GO:0005052;GO:0033328;GO:0000268;GO:0008022;GO:0047485;GO:0140311;GO:0031267;GO:0031333;GO:0000425;GO:0016558;GO:0016560;GO:0016561;GO:0045046;GO:0008104;GO:0006625;GO:0051262;GO:0016567;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:enzyme binding; F:peroxisome matrix targeting signal-1 binding; F:peroxisome membrane targeting sequence binding; F:peroxisome targeting sequence binding; F:protein C-terminus binding; F:protein N-terminus binding; F:protein sequestering activity; F:small GTPase binding;, P:negative regulation of protein-containing complex assembly; P:pexophagy; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome matrix, translocation; P:protein import into peroxisome membrane; P:protein localization; P:protein targeting to peroxisome; P:protein tetramerization; P:protein ubiquitination;|P50542 A8K891 B4DZ45 B7ZAD5 D3DUT8 Q15115 Q15266 Q96FN7,Peroxisomal targeting signal 1 receptor,PTS1-BP;Peroxin-5;Peroxisomal C-terminal targeting signal import receptor;Peroxisome receptor 1;, PF13181;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0032991;GO:0019899;GO:0005052;GO:0033328;GO:0000268;GO:0008022;GO:0047485;GO:0140311;GO:0031267;GO:0031333;GO:0000425;GO:0016558;GO:0016560;GO:0016561;GO:0045046;GO:0008104;GO:0006625;GO:0051262;GO:0016567;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:enzyme binding; F:peroxisome matrix targeting signal-1 binding; F:peroxisome membrane targeting sequence binding; F:peroxisome targeting sequence binding; F:protein C-terminus binding; F:protein N-terminus binding; F:protein sequestering activity; F:small GTPase binding;, P:negative regulation of protein-containing complex assembly; P:pexophagy; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome matrix, translocation; P:protein import into peroxisome membrane; P:protein localization; P:protein targeting to peroxisome; P:protein tetramerization; P:protein ubiquitination;|P50542 A8K891 B4DZ45 B7ZAD5 D3DUT8 Q15115 Q15266 Q96FN7,Peroxisomal targeting signal 1 receptor,PTS1-BP;Peroxin-5;Peroxisomal C-terminal targeting signal import receptor;Peroxisome receptor 1;, PF13181;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0032991;GO:0019899;GO:0005052;GO:0033328;GO:0000268;GO:0008022;GO:0047485;GO:0140311;GO:0031267;GO:0031333;GO:0000425;GO:0016558;GO:0016560;GO:0016561;GO:0045046;GO:0008104;GO:0006625;GO:0051262;GO:0016567;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:enzyme binding; F:peroxisome matrix targeting signal-1 binding; F:peroxisome membrane targeting sequence binding; F:peroxisome targeting sequence binding; F:protein C-terminus binding; F:protein N-terminus binding; F:protein sequestering activity; F:small GTPase binding;, P:negative regulation of protein-containing complex assembly; P:pexophagy; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome matrix, translocation; P:protein import into peroxisome membrane; P:protein localization; P:protein targeting to peroxisome; P:protein tetramerization; P:protein ubiquitination;|P50542 A8K891 B4DZ45 B7ZAD5 D3DUT8 Q15115 Q15266 Q96FN7,Peroxisomal targeting signal 1 receptor,PTS1-BP;Peroxin-5;Peroxisomal C-terminal targeting signal import receptor;Peroxisome receptor 1;, PF13181;, GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005782;GO:0005778;GO:0005777;GO:0032991;GO:0019899;GO:0005052;GO:0033328;GO:0000268;GO:0008022;GO:0047485;GO:0140311;GO:0031267;GO:0031333;GO:0000425;GO:0016558;GO:0016560;GO:0016561;GO:0045046;GO:0008104;GO:0006625;GO:0051262;GO:0016567;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane; C:peroxisomal matrix; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:enzyme binding; F:peroxisome matrix targeting signal-1 binding; F:peroxisome membrane targeting sequence binding; F:peroxisome targeting sequence binding; F:protein C-terminus binding; F:protein N-terminus binding; F:protein sequestering activity; F:small GTPase binding;, P:negative regulation of protein-containing complex assembly; P:pexophagy; P:protein import into peroxisome matrix; P:protein import into peroxisome matrix, docking; P:protein import into peroxisome matrix, translocation; P:protein import into peroxisome membrane; P:protein localization; P:protein targeting to peroxisome; P:protein tetramerization; P:protein ubiquitination; scaffold183 indexed_genome mRNA 962251 963941 . - . ID=transcript_15380;Q86VB7 C9JIG2 Q07898 Q07899 Q07900 Q07901 Q2VLH7,Scavenger receptor cysteine-rich type 1 protein M130,Hemoglobin scavenger receptor;, PF00530;, GO:0005829;GO:0030666;GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0005044;GO:0006953;GO:0002862;GO:0006898;, C:cytosol; C:endocytic vesicle membrane; C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane;, F:scavenger receptor activity;, P:acute-phase response; P:negative regulation of inflammatory response to antigenic stimulus; P:receptor-mediated endocytosis; scaffold184 indexed_genome mRNA 52875 161279 . + . ID=transcript_15381;Q7L576 A8K6D9 Q14467 Q5IED0 Q6ZSX1 Q9BSD9 Q9BVC7,Cytoplasmic FMR1-interacting protein 1,Specifically Rac1-associated protein 1;p140sra-1;, PF07159;PF05994;, GO:0044295;GO:0090724;GO:0005829;GO:0044294;GO:0043197;GO:0060076;GO:0070062;GO:0005576;GO:0032433;GO:0005925;GO:0030027;GO:0005845;GO:0043005;GO:0043025;GO:0048471;GO:0090725;GO:0001726;GO:0031209;GO:0034774;GO:0035580;GO:0045202;GO:0043195;GO:1904724;GO:0051015;GO:0000340;GO:0031267;GO:0045182;GO:0048675;GO:0007411;GO:0000902;GO:0030031;GO:0032869;GO:0050890;GO:0097484;GO:0038096;GO:0030032;GO:0099563;GO:1903422;GO:0043312;GO:2000601;GO:0045773;GO:1900006;GO:0010592;GO:0051388;GO:1900029;GO:0016601;GO:0008360;GO:1905274;GO:0031641;GO:0006417;GO:0099578;GO:0051602;GO:0031529;GO:0048010;, C:axonal growth cone; C:central region of growth cone; C:cytosol; C:dendritic growth cone; C:dendritic spine; C:excitatory synapse; C:extracellular exosome; C:extracellular region; C:filopodium tip; C:focal adhesion; C:lamellipodium; C:mRNA cap binding complex; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:peripheral region of growth cone; C:ruffle; C:SCAR complex; C:secretory granule lumen; C:specific granule lumen; C:synapse; C:terminal bouton; C:tertiary granule lumen;, F:actin filament binding; F:RNA 7-methylguanosine cap binding; F:small GTPase binding; F:translation regulator activity;, P:axon extension; P:axon guidance; P:cell morphogenesis; P:cell projection assembly; P:cellular response to insulin stimulus; P:cognition; P:dendrite extension; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium assembly; P:modification of synaptic structure; P:negative regulation of synaptic vesicle recycling; P:neutrophil degranulation; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of axon extension; P:positive regulation of dendrite development; P:positive regulation of lamellipodium assembly; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of ruffle assembly; P:Rac protein signal transduction; P:regulation of cell shape; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of myelination; P:regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:response to electrical stimulus; P:ruffle organization; P:vascular endothelial growth factor receptor signaling pathway;|Q7L576 A8K6D9 Q14467 Q5IED0 Q6ZSX1 Q9BSD9 Q9BVC7,Cytoplasmic FMR1-interacting protein 1,Specifically Rac1-associated protein 1;p140sra-1;, PF07159;PF05994;, GO:0044295;GO:0090724;GO:0005829;GO:0044294;GO:0043197;GO:0060076;GO:0070062;GO:0005576;GO:0032433;GO:0005925;GO:0030027;GO:0005845;GO:0043005;GO:0043025;GO:0048471;GO:0090725;GO:0001726;GO:0031209;GO:0034774;GO:0035580;GO:0045202;GO:0043195;GO:1904724;GO:0051015;GO:0000340;GO:0031267;GO:0045182;GO:0048675;GO:0007411;GO:0000902;GO:0030031;GO:0032869;GO:0050890;GO:0097484;GO:0038096;GO:0030032;GO:0099563;GO:1903422;GO:0043312;GO:2000601;GO:0045773;GO:1900006;GO:0010592;GO:0051388;GO:1900029;GO:0016601;GO:0008360;GO:1905274;GO:0031641;GO:0006417;GO:0099578;GO:0051602;GO:0031529;GO:0048010;, C:axonal growth cone; C:central region of growth cone; C:cytosol; C:dendritic growth cone; C:dendritic spine; C:excitatory synapse; C:extracellular exosome; C:extracellular region; C:filopodium tip; C:focal adhesion; C:lamellipodium; C:mRNA cap binding complex; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:peripheral region of growth cone; C:ruffle; C:SCAR complex; C:secretory granule lumen; C:specific granule lumen; C:synapse; C:terminal bouton; C:tertiary granule lumen;, F:actin filament binding; F:RNA 7-methylguanosine cap binding; F:small GTPase binding; F:translation regulator activity;, P:axon extension; P:axon guidance; P:cell morphogenesis; P:cell projection assembly; P:cellular response to insulin stimulus; P:cognition; P:dendrite extension; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium assembly; P:modification of synaptic structure; P:negative regulation of synaptic vesicle recycling; P:neutrophil degranulation; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of axon extension; P:positive regulation of dendrite development; P:positive regulation of lamellipodium assembly; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of ruffle assembly; P:Rac protein signal transduction; P:regulation of cell shape; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of myelination; P:regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:response to electrical stimulus; P:ruffle organization; P:vascular endothelial growth factor receptor signaling pathway;|Q7L576 A8K6D9 Q14467 Q5IED0 Q6ZSX1 Q9BSD9 Q9BVC7,Cytoplasmic FMR1-interacting protein 1,Specifically Rac1-associated protein 1;p140sra-1;, PF07159;PF05994;, GO:0044295;GO:0090724;GO:0005829;GO:0044294;GO:0043197;GO:0060076;GO:0070062;GO:0005576;GO:0032433;GO:0005925;GO:0030027;GO:0005845;GO:0043005;GO:0043025;GO:0048471;GO:0090725;GO:0001726;GO:0031209;GO:0034774;GO:0035580;GO:0045202;GO:0043195;GO:1904724;GO:0051015;GO:0000340;GO:0031267;GO:0045182;GO:0048675;GO:0007411;GO:0000902;GO:0030031;GO:0032869;GO:0050890;GO:0097484;GO:0038096;GO:0030032;GO:0099563;GO:1903422;GO:0043312;GO:2000601;GO:0045773;GO:1900006;GO:0010592;GO:0051388;GO:1900029;GO:0016601;GO:0008360;GO:1905274;GO:0031641;GO:0006417;GO:0099578;GO:0051602;GO:0031529;GO:0048010;, C:axonal growth cone; C:central region of growth cone; C:cytosol; C:dendritic growth cone; C:dendritic spine; C:excitatory synapse; C:extracellular exosome; C:extracellular region; C:filopodium tip; C:focal adhesion; C:lamellipodium; C:mRNA cap binding complex; C:neuron projection; C:neuronal cell body; C:perinuclear region of cytoplasm; C:peripheral region of growth cone; C:ruffle; C:SCAR complex; C:secretory granule lumen; C:specific granule lumen; C:synapse; C:terminal bouton; C:tertiary granule lumen;, F:actin filament binding; F:RNA 7-methylguanosine cap binding; F:small GTPase binding; F:translation regulator activity;, P:axon extension; P:axon guidance; P:cell morphogenesis; P:cell projection assembly; P:cellular response to insulin stimulus; P:cognition; P:dendrite extension; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium assembly; P:modification of synaptic structure; P:negative regulation of synaptic vesicle recycling; P:neutrophil degranulation; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of axon extension; P:positive regulation of dendrite development; P:positive regulation of lamellipodium assembly; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:positive regulation of ruffle assembly; P:Rac protein signal transduction; P:regulation of cell shape; P:regulation of modification of postsynaptic actin cytoskeleton; P:regulation of myelination; P:regulation of translation; P:regulation of translation at postsynapse, modulating synaptic transmission; P:response to electrical stimulus; P:ruffle organization; P:vascular endothelial growth factor receptor signaling pathway; scaffold184 indexed_genome mRNA 163233 165752 . - . ID=transcript_15382;Q8N8Q9 F8W7Y8 Q96F03 Q9BVS2,Magnesium transporter NIPA2,Non-imprinted in Prader-Willi/Angelman syndrome region protein 2;, PF05653;, GO:0005769;GO:0016021;GO:0016020;GO:0005886;GO:0015095;GO:0015693;, C:early endosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport;|Q8N8Q9 F8W7Y8 Q96F03 Q9BVS2,Magnesium transporter NIPA2,Non-imprinted in Prader-Willi/Angelman syndrome region protein 2;, PF05653;, GO:0005769;GO:0016021;GO:0016020;GO:0005886;GO:0015095;GO:0015693;, C:early endosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport; scaffold184 indexed_genome mRNA 170444 173190 . + . ID=transcript_15383;Q8N8Q9 F8W7Y8 Q96F03 Q9BVS2,Magnesium transporter NIPA2,Non-imprinted in Prader-Willi/Angelman syndrome region protein 2;, PF05653;, GO:0005769;GO:0016021;GO:0016020;GO:0005886;GO:0015095;GO:0015693;, C:early endosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport; scaffold184 indexed_genome mRNA 190363 236146 . + . ID=transcript_15384;Q7RTP0 B2RA76 Q5HYA9 Q7KZB0 Q86XW4,Magnesium transporter NIPA1,Non-imprinted in Prader-Willi/Angelman syndrome region protein 1;Spastic paraplegia 6 protein;, PF05653;, GO:0005769;GO:0016021;GO:0016020;GO:0005886;GO:0015095;GO:0015693;GO:0055085;, C:early endosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport; P:transmembrane transport;|Q7RTP0 B2RA76 Q5HYA9 Q7KZB0 Q86XW4,Magnesium transporter NIPA1,Non-imprinted in Prader-Willi/Angelman syndrome region protein 1;Spastic paraplegia 6 protein;, PF05653;, GO:0005769;GO:0016021;GO:0016020;GO:0005886;GO:0015095;GO:0015693;GO:0055085;, C:early endosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:magnesium ion transmembrane transporter activity;, P:magnesium ion transport; P:transmembrane transport; scaffold184 indexed_genome mRNA 288901 514128 . + . ID=transcript_15385;Q86YY8 Q86YY9 Q86YZ0 Q86YZ1,E3 ubiquitin-protein ligase HERC2,HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;, PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;, GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;, C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination;|Q86YY8 Q86YY9 Q86YZ0 Q86YZ1,E3 ubiquitin-protein ligase HERC2,HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;, PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;, GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;, C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination;|Q86YY8 Q86YY9 Q86YZ0 Q86YZ1,E3 ubiquitin-protein ligase HERC2,HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;, PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;, GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;, C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination;|Q86YY8 Q86YY9 Q86YZ0 Q86YZ1,E3 ubiquitin-protein ligase HERC2,HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;, PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;, GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;, C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination;|Q86YY8 Q86YY9 Q86YZ0 Q86YZ1,E3 ubiquitin-protein ligase HERC2,HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;, PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;, GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;, C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination;|Q86YY8 Q86YY9 Q86YZ0 Q86YZ1,E3 ubiquitin-protein ligase HERC2,HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;, PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;, GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;, C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q86YY8 Q86YY9 Q86YZ0 Q86YZ1,E3 ubiquitin-protein ligase HERC2,HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;, PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;, GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;, C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination;|Q86YY8 Q86YY9 Q86YZ0 Q86YZ1,E3 ubiquitin-protein ligase HERC2,HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;, PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;, GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;, C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination;|Q86YY8 Q86YY9 Q86YZ0 Q86YZ1,E3 ubiquitin-protein ligase HERC2,HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;, PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;, GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;, C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination;|Q86YY8 Q86YY9 Q86YZ0 Q86YZ1,E3 ubiquitin-protein ligase HERC2,HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;, PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;, GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;, C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination; scaffold184 indexed_genome mRNA 585753 654748 . + . ID=transcript_15386;Q04671 Q15211 Q15212 Q96EN1 Q9UMI5,P protein,Melanocyte-specific transporter protein;Pink-eyed dilution protein homolog;, PF03600;, GO:0005737;GO:0005789;GO:0010008;GO:0016021;GO:0005765;GO:0033162;GO:0005302;GO:0005215;GO:0008283;GO:0006726;GO:0042438;GO:0030318;GO:0007286;, C:cytoplasm; C:endoplasmic reticulum membrane; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:melanosome membrane;, F:L-tyrosine transmembrane transporter activity; F:transporter activity;, P:cell population proliferation; P:eye pigment biosynthetic process; P:melanin biosynthetic process; P:melanocyte differentiation; P:spermatid development;|Q04671 Q15211 Q15212 Q96EN1 Q9UMI5,P protein,Melanocyte-specific transporter protein;Pink-eyed dilution protein homolog;, PF03600;, GO:0005737;GO:0005789;GO:0010008;GO:0016021;GO:0005765;GO:0033162;GO:0005302;GO:0005215;GO:0008283;GO:0006726;GO:0042438;GO:0030318;GO:0007286;, C:cytoplasm; C:endoplasmic reticulum membrane; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:melanosome membrane;, F:L-tyrosine transmembrane transporter activity; F:transporter activity;, P:cell population proliferation; P:eye pigment biosynthetic process; P:melanin biosynthetic process; P:melanocyte differentiation; P:spermatid development; scaffold184 indexed_genome mRNA 666416 667410 . - . ID=transcript_15387;Q04671 Q15211 Q15212 Q96EN1 Q9UMI5,P protein,Melanocyte-specific transporter protein;Pink-eyed dilution protein homolog;, PF03600;, GO:0005737;GO:0005789;GO:0010008;GO:0016021;GO:0005765;GO:0033162;GO:0005302;GO:0005215;GO:0008283;GO:0006726;GO:0042438;GO:0030318;GO:0007286;, C:cytoplasm; C:endoplasmic reticulum membrane; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:melanosome membrane;, F:L-tyrosine transmembrane transporter activity; F:transporter activity;, P:cell population proliferation; P:eye pigment biosynthetic process; P:melanin biosynthetic process; P:melanocyte differentiation; P:spermatid development; scaffold184 indexed_genome mRNA 702664 831554 . + . ID=transcript_15388;Q04671 Q15211 Q15212 Q96EN1 Q9UMI5,P protein,Melanocyte-specific transporter protein;Pink-eyed dilution protein homolog;, PF03600;, GO:0005737;GO:0005789;GO:0010008;GO:0016021;GO:0005765;GO:0033162;GO:0005302;GO:0005215;GO:0008283;GO:0006726;GO:0042438;GO:0030318;GO:0007286;, C:cytoplasm; C:endoplasmic reticulum membrane; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane; C:melanosome membrane;, F:L-tyrosine transmembrane transporter activity; F:transporter activity;, P:cell population proliferation; P:eye pigment biosynthetic process; P:melanin biosynthetic process; P:melanocyte differentiation; P:spermatid development; scaffold185 indexed_genome mRNA 1009 5649 . + . ID=transcript_15389;O00257 B1PJR7 Q6TPI8 Q96C04,E3 SUMO-protein ligase CBX4,Chromobox protein homolog 4;Polycomb 2 homolog;, PF17218;PF00385;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0019899;GO:0035064;GO:0051219;GO:0003727;GO:0032183;GO:0061665;GO:0019789;GO:0003714;GO:0000976;GO:0006325;GO:0043066;GO:0000122;GO:0045892;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:enzyme binding; F:methylated histone binding; F:phosphoprotein binding; F:single-stranded RNA binding; F:SUMO binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated;|O00257 B1PJR7 Q6TPI8 Q96C04,E3 SUMO-protein ligase CBX4,Chromobox protein homolog 4;Polycomb 2 homolog;, PF17218;PF00385;, GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0003682;GO:0019899;GO:0035064;GO:0051219;GO:0003727;GO:0032183;GO:0061665;GO:0019789;GO:0003714;GO:0000976;GO:0006325;GO:0043066;GO:0000122;GO:0045892;, C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:chromatin binding; F:enzyme binding; F:methylated histone binding; F:phosphoprotein binding; F:single-stranded RNA binding; F:SUMO binding; F:SUMO ligase activity; F:SUMO transferase activity; F:transcription corepressor activity; F:transcription regulatory region sequence-specific DNA binding;, P:chromatin organization; P:negative regulation of apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; scaffold185 indexed_genome mRNA 46805 49667 . + . ID=transcript_15390;Q9HC52 Q96H39 Q9NR07,Chromobox protein homolog 8,Polycomb 3 homolog;Rectachrome 1;, PF17218;PF00385;, GO:0000785;GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0035064;GO:0003727;GO:0097027;GO:0070301;GO:0016574;GO:0000122;GO:0008284;GO:0032967;GO:0045739;, C:chromatin; C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:methylated histone binding; F:single-stranded RNA binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to hydrogen peroxide; P:histone ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA repair;|Q9HC52 Q96H39 Q9NR07,Chromobox protein homolog 8,Polycomb 3 homolog;Rectachrome 1;, PF17218;PF00385;, GO:0000785;GO:0000792;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0035064;GO:0003727;GO:0097027;GO:0070301;GO:0016574;GO:0000122;GO:0008284;GO:0032967;GO:0045739;, C:chromatin; C:heterochromatin; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex;, F:methylated histone binding; F:single-stranded RNA binding; F:ubiquitin-protein transferase activator activity;, P:cellular response to hydrogen peroxide; P:histone ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of DNA repair; scaffold185 indexed_genome mRNA 595502 618793 . + . ID=transcript_15391;A6NFN3 B4DEG6 B4DF29,RNA binding protein fox-1 homolog 3,Fox-1 homolog C;Neuronal nuclei antigen;, PF12414;PF00076;, GO:0005737;GO:0005634;GO:0003729;GO:0006397;GO:0007399;GO:0000381;GO:0008380;, C:cytoplasm; C:nucleus;, F:mRNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;|A6NFN3 B4DEG6 B4DF29,RNA binding protein fox-1 homolog 3,Fox-1 homolog C;Neuronal nuclei antigen;, PF12414;PF00076;, GO:0005737;GO:0005634;GO:0003729;GO:0006397;GO:0007399;GO:0000381;GO:0008380;, C:cytoplasm; C:nucleus;, F:mRNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;|A6NFN3 B4DEG6 B4DF29,RNA binding protein fox-1 homolog 3,Fox-1 homolog C;Neuronal nuclei antigen;, PF12414;PF00076;, GO:0005737;GO:0005634;GO:0003729;GO:0006397;GO:0007399;GO:0000381;GO:0008380;, C:cytoplasm; C:nucleus;, F:mRNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;|A6NFN3 B4DEG6 B4DF29,RNA binding protein fox-1 homolog 3,Fox-1 homolog C;Neuronal nuclei antigen;, PF12414;PF00076;, GO:0005737;GO:0005634;GO:0003729;GO:0006397;GO:0007399;GO:0000381;GO:0008380;, C:cytoplasm; C:nucleus;, F:mRNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;|A6NFN3 B4DEG6 B4DF29,RNA binding protein fox-1 homolog 3,Fox-1 homolog C;Neuronal nuclei antigen;, PF12414;PF00076;, GO:0005737;GO:0005634;GO:0003729;GO:0006397;GO:0007399;GO:0000381;GO:0008380;, C:cytoplasm; C:nucleus;, F:mRNA binding;, P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing; scaffold185 indexed_genome mRNA 621174 630110 . - . ID=transcript_15392;Q8NFI3 Q659F0 Q8TB86 Q9H6U4,Cytosolic endo-beta-N-acetylglucosaminidase,, PF03644;, GO:0005829;GO:0004553;GO:0033925;GO:0006517;GO:0006457;, C:cytosol;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity;, P:protein deglycosylation; P:protein folding;|Q8NFI3 Q659F0 Q8TB86 Q9H6U4,Cytosolic endo-beta-N-acetylglucosaminidase,, PF03644;, GO:0005829;GO:0004553;GO:0033925;GO:0006517;GO:0006457;, C:cytosol;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity;, P:protein deglycosylation; P:protein folding;|Q8NFI3 Q659F0 Q8TB86 Q9H6U4,Cytosolic endo-beta-N-acetylglucosaminidase,, PF03644;, GO:0005829;GO:0004553;GO:0033925;GO:0006517;GO:0006457;, C:cytosol;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity;, P:protein deglycosylation; P:protein folding;|Q8NFI3 Q659F0 Q8TB86 Q9H6U4,Cytosolic endo-beta-N-acetylglucosaminidase,, PF03644;, GO:0005829;GO:0004553;GO:0033925;GO:0006517;GO:0006457;, C:cytosol;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity;, P:protein deglycosylation; P:protein folding; scaffold185 indexed_genome mRNA 683422 689148 . + . ID=transcript_15393;Q8WVQ1 B4DJ54 Q7Z2J7 Q8NG05 Q8NHP0 Q9BSD5,Soluble calcium-activated nucleotidase 1,Apyrase homolog;Putative MAPK-activating protein PM09;Putative NF-kappa-B-activating protein 107;, , GO:0005789;GO:0070062;GO:0005576;GO:1904813;GO:0005794;GO:0032580;GO:0016021;GO:0016020;GO:0005886;GO:0035580;GO:1904724;GO:0043262;GO:0005509;GO:0004382;GO:0042803;GO:0045134;GO:0043312;GO:0043123;GO:0030166;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:specific granule lumen; C:tertiary granule lumen;, F:adenosine-diphosphatase activity; F:calcium ion binding; F:guanosine-diphosphatase activity; F:protein homodimerization activity; F:uridine-diphosphatase activity;, P:neutrophil degranulation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:proteoglycan biosynthetic process;|Q8WVQ1 B4DJ54 Q7Z2J7 Q8NG05 Q8NHP0 Q9BSD5,Soluble calcium-activated nucleotidase 1,Apyrase homolog;Putative MAPK-activating protein PM09;Putative NF-kappa-B-activating protein 107;, , GO:0005789;GO:0070062;GO:0005576;GO:1904813;GO:0005794;GO:0032580;GO:0016021;GO:0016020;GO:0005886;GO:0035580;GO:1904724;GO:0043262;GO:0005509;GO:0004382;GO:0042803;GO:0045134;GO:0043312;GO:0043123;GO:0030166;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi apparatus; C:Golgi cisterna membrane; C:integral component of membrane; C:membrane; C:plasma membrane; C:specific granule lumen; C:tertiary granule lumen;, F:adenosine-diphosphatase activity; F:calcium ion binding; F:guanosine-diphosphatase activity; F:protein homodimerization activity; F:uridine-diphosphatase activity;, P:neutrophil degranulation; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:proteoglycan biosynthetic process; scaffold185 indexed_genome mRNA 698335 708721 . + . ID=transcript_15394;Q08380 Q7M4S0 Q9UCH8 Q9UCH9 Q9UCI0,Galectin-3-binding protein,Basement membrane autoantigen p105;Lectin galactoside-binding soluble 3-binding protein;Mac-2-binding protein;Tumor-associated antigen 90K;, PF07707;PF00530;, GO:0072562;GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0031089;GO:0005044;GO:0007155;GO:0006968;GO:0002576;GO:0007165;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:platelet dense granule lumen;, F:scavenger receptor activity;, P:cell adhesion; P:cellular defense response; P:platelet degranulation; P:signal transduction; scaffold185 indexed_genome mRNA 746764 798535 . + . ID=transcript_15395;P16035 Q16121 Q93006 Q9UDF7,Metalloproteinase inhibitor 2,CSC-21K;Tissue inhibitor of metalloproteinases 2;, PF00965;, GO:0009986;GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:1904813;GO:0030426;GO:0043025;GO:0035580;GO:1904724;GO:0005178;GO:0008191;GO:0030414;GO:0002020;GO:0008270;GO:0007568;GO:0007417;GO:0022617;GO:0008285;GO:0010951;GO:0051045;GO:1905049;GO:0045930;GO:0046580;GO:0043312;GO:0045762;GO:0043410;GO:0045666;GO:0032487;GO:0034097;GO:0042493;GO:0009725;GO:0010033;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:growth cone; C:neuronal cell body; C:specific granule lumen; C:tertiary granule lumen;, F:integrin binding; F:metalloendopeptidase inhibitor activity; F:peptidase inhibitor activity; F:protease binding; F:zinc ion binding;, P:aging; P:central nervous system development; P:extracellular matrix disassembly; P:negative regulation of cell population proliferation; P:negative regulation of endopeptidase activity; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of metallopeptidase activity; P:negative regulation of mitotic cell cycle; P:negative regulation of Ras protein signal transduction; P:neutrophil degranulation; P:positive regulation of adenylate cyclase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:regulation of Rap protein signal transduction; P:response to cytokine; P:response to drug; P:response to hormone; P:response to organic substance;|P16035 Q16121 Q93006 Q9UDF7,Metalloproteinase inhibitor 2,CSC-21K;Tissue inhibitor of metalloproteinases 2;, PF00965;, GO:0009986;GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:1904813;GO:0030426;GO:0043025;GO:0035580;GO:1904724;GO:0005178;GO:0008191;GO:0030414;GO:0002020;GO:0008270;GO:0007568;GO:0007417;GO:0022617;GO:0008285;GO:0010951;GO:0051045;GO:1905049;GO:0045930;GO:0046580;GO:0043312;GO:0045762;GO:0043410;GO:0045666;GO:0032487;GO:0034097;GO:0042493;GO:0009725;GO:0010033;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:growth cone; C:neuronal cell body; C:specific granule lumen; C:tertiary granule lumen;, F:integrin binding; F:metalloendopeptidase inhibitor activity; F:peptidase inhibitor activity; F:protease binding; F:zinc ion binding;, P:aging; P:central nervous system development; P:extracellular matrix disassembly; P:negative regulation of cell population proliferation; P:negative regulation of endopeptidase activity; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of metallopeptidase activity; P:negative regulation of mitotic cell cycle; P:negative regulation of Ras protein signal transduction; P:neutrophil degranulation; P:positive regulation of adenylate cyclase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:regulation of Rap protein signal transduction; P:response to cytokine; P:response to drug; P:response to hormone; P:response to organic substance;|P16035 Q16121 Q93006 Q9UDF7,Metalloproteinase inhibitor 2,CSC-21K;Tissue inhibitor of metalloproteinases 2;, PF00965;, GO:0009986;GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:1904813;GO:0030426;GO:0043025;GO:0035580;GO:1904724;GO:0005178;GO:0008191;GO:0030414;GO:0002020;GO:0008270;GO:0007568;GO:0007417;GO:0022617;GO:0008285;GO:0010951;GO:0051045;GO:1905049;GO:0045930;GO:0046580;GO:0043312;GO:0045762;GO:0043410;GO:0045666;GO:0032487;GO:0034097;GO:0042493;GO:0009725;GO:0010033;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:growth cone; C:neuronal cell body; C:specific granule lumen; C:tertiary granule lumen;, F:integrin binding; F:metalloendopeptidase inhibitor activity; F:peptidase inhibitor activity; F:protease binding; F:zinc ion binding;, P:aging; P:central nervous system development; P:extracellular matrix disassembly; P:negative regulation of cell population proliferation; P:negative regulation of endopeptidase activity; P:negative regulation of membrane protein ectodomain proteolysis; P:negative regulation of metallopeptidase activity; P:negative regulation of mitotic cell cycle; P:negative regulation of Ras protein signal transduction; P:neutrophil degranulation; P:positive regulation of adenylate cyclase activity; P:positive regulation of MAPK cascade; P:positive regulation of neuron differentiation; P:regulation of Rap protein signal transduction; P:response to cytokine; P:response to drug; P:response to hormone; P:response to organic substance; scaffold185 indexed_genome mRNA 806859 845292 . + . ID=transcript_15396;Q9P275 Q05C98 Q05DD0 Q6IQ38 Q8NDM8 Q9NVC8,Ubiquitin carboxyl-terminal hydrolase 36 {ECO:0000305},Deubiquitinating enzyme 36;Ubiquitin thioesterase 36;Ubiquitin-specific-processing protease 36;, PF00443;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0004197;GO:0003723;GO:0004843;GO:0016578;GO:0016242;GO:0007000;GO:1903955;GO:0016579;GO:0050821;GO:0042981;GO:1903146;GO:0031647;GO:2000232;GO:0006511;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:histone deubiquitination; P:negative regulation of macroautophagy; P:nucleolus organization; P:positive regulation of protein targeting to mitochondrion; P:protein deubiquitination; P:protein stabilization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein stability; P:regulation of rRNA processing; P:ubiquitin-dependent protein catabolic process;|Q9P275 Q05C98 Q05DD0 Q6IQ38 Q8NDM8 Q9NVC8,Ubiquitin carboxyl-terminal hydrolase 36 {ECO:0000305},Deubiquitinating enzyme 36;Ubiquitin thioesterase 36;Ubiquitin-specific-processing protease 36;, PF00443;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0004197;GO:0003723;GO:0004843;GO:0016578;GO:0016242;GO:0007000;GO:1903955;GO:0016579;GO:0050821;GO:0042981;GO:1903146;GO:0031647;GO:2000232;GO:0006511;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:histone deubiquitination; P:negative regulation of macroautophagy; P:nucleolus organization; P:positive regulation of protein targeting to mitochondrion; P:protein deubiquitination; P:protein stabilization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein stability; P:regulation of rRNA processing; P:ubiquitin-dependent protein catabolic process;|Q9P275 Q05C98 Q05DD0 Q6IQ38 Q8NDM8 Q9NVC8,Ubiquitin carboxyl-terminal hydrolase 36 {ECO:0000305},Deubiquitinating enzyme 36;Ubiquitin thioesterase 36;Ubiquitin-specific-processing protease 36;, PF00443;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0004197;GO:0003723;GO:0004843;GO:0016578;GO:0016242;GO:0007000;GO:1903955;GO:0016579;GO:0050821;GO:0042981;GO:1903146;GO:0031647;GO:2000232;GO:0006511;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:histone deubiquitination; P:negative regulation of macroautophagy; P:nucleolus organization; P:positive regulation of protein targeting to mitochondrion; P:protein deubiquitination; P:protein stabilization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein stability; P:regulation of rRNA processing; P:ubiquitin-dependent protein catabolic process;|Q9P275 Q05C98 Q05DD0 Q6IQ38 Q8NDM8 Q9NVC8,Ubiquitin carboxyl-terminal hydrolase 36 {ECO:0000305},Deubiquitinating enzyme 36;Ubiquitin thioesterase 36;Ubiquitin-specific-processing protease 36;, PF00443;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0004197;GO:0003723;GO:0004843;GO:0016578;GO:0016242;GO:0007000;GO:1903955;GO:0016579;GO:0050821;GO:0042981;GO:1903146;GO:0031647;GO:2000232;GO:0006511;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:histone deubiquitination; P:negative regulation of macroautophagy; P:nucleolus organization; P:positive regulation of protein targeting to mitochondrion; P:protein deubiquitination; P:protein stabilization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein stability; P:regulation of rRNA processing; P:ubiquitin-dependent protein catabolic process;|Q9P275 Q05C98 Q05DD0 Q6IQ38 Q8NDM8 Q9NVC8,Ubiquitin carboxyl-terminal hydrolase 36 {ECO:0000305},Deubiquitinating enzyme 36;Ubiquitin thioesterase 36;Ubiquitin-specific-processing protease 36;, PF00443;, GO:0005737;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0004197;GO:0003723;GO:0004843;GO:0016578;GO:0016242;GO:0007000;GO:1903955;GO:0016579;GO:0050821;GO:0042981;GO:1903146;GO:0031647;GO:2000232;GO:0006511;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cysteine-type endopeptidase activity; F:RNA binding; F:thiol-dependent ubiquitin-specific protease activity;, P:histone deubiquitination; P:negative regulation of macroautophagy; P:nucleolus organization; P:positive regulation of protein targeting to mitochondrion; P:protein deubiquitination; P:protein stabilization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein stability; P:regulation of rRNA processing; P:ubiquitin-dependent protein catabolic process; scaffold185 indexed_genome mRNA 902576 930025 . + . ID=transcript_15397;Q15438 A6NFW7 B7Z1T4 Q9P123 Q9P124,Cytohesin-1,PH, SEC7 and coiled-coil domain-containing protein 1;SEC7 homolog B2-1;, PF00169;PF01369;, GO:0005912;GO:0005923;GO:0005737;GO:0005829;GO:0031234;GO:0000139;GO:0005886;GO:0005085;GO:0008289;GO:0090162;GO:0032012;GO:0030155;GO:0016192;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:Golgi membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:establishment of epithelial cell polarity; P:regulation of ARF protein signal transduction; P:regulation of cell adhesion; P:vesicle-mediated transport;|Q15438 A6NFW7 B7Z1T4 Q9P123 Q9P124,Cytohesin-1,PH, SEC7 and coiled-coil domain-containing protein 1;SEC7 homolog B2-1;, PF00169;PF01369;, GO:0005912;GO:0005923;GO:0005737;GO:0005829;GO:0031234;GO:0000139;GO:0005886;GO:0005085;GO:0008289;GO:0090162;GO:0032012;GO:0030155;GO:0016192;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:Golgi membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:establishment of epithelial cell polarity; P:regulation of ARF protein signal transduction; P:regulation of cell adhesion; P:vesicle-mediated transport; scaffold185 indexed_genome mRNA 1014851 1015683 . - . ID=transcript_15398;Q9UFH2 O00431 O15206 Q2M2Y1 Q6ZRQ2 Q8N7Q7,Dynein heavy chain 17, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 17;Axonemal dynein heavy chain-like protein 1;Ciliary dynein heavy chain 17;Ciliary dynein heavy chain-like protein 1;Dynein light chain 2, axonemal;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:microtubule-based movement; P:outer dynein arm assembly; scaffold185 indexed_genome mRNA 1015748 1016386 . + . ID=transcript_15399;Q9UFH2 O00431 O15206 Q2M2Y1 Q6ZRQ2 Q8N7Q7,Dynein heavy chain 17, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 17;Axonemal dynein heavy chain-like protein 1;Ciliary dynein heavy chain 17;Ciliary dynein heavy chain-like protein 1;Dynein light chain 2, axonemal;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:microtubule-based movement; P:outer dynein arm assembly; scaffold185 indexed_genome mRNA 1018692 1019675 . + . ID=transcript_15400;Q9UFH2 O00431 O15206 Q2M2Y1 Q6ZRQ2 Q8N7Q7,Dynein heavy chain 17, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 17;Axonemal dynein heavy chain-like protein 1;Ciliary dynein heavy chain 17;Ciliary dynein heavy chain-like protein 1;Dynein light chain 2, axonemal;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:microtubule-based movement; P:outer dynein arm assembly; scaffold185 indexed_genome mRNA 1034940 1036088 . + . ID=transcript_15401;Q9UFH2 O00431 O15206 Q2M2Y1 Q6ZRQ2 Q8N7Q7,Dynein heavy chain 17, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 17;Axonemal dynein heavy chain-like protein 1;Ciliary dynein heavy chain 17;Ciliary dynein heavy chain-like protein 1;Dynein light chain 2, axonemal;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:microtubule-based movement; P:outer dynein arm assembly; scaffold185 indexed_genome mRNA 1052047 1052855 . - . ID=transcript_15402;Q9UFH2 O00431 O15206 Q2M2Y1 Q6ZRQ2 Q8N7Q7,Dynein heavy chain 17, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 17;Axonemal dynein heavy chain-like protein 1;Ciliary dynein heavy chain 17;Ciliary dynein heavy chain-like protein 1;Dynein light chain 2, axonemal;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:microtubule-based movement; P:outer dynein arm assembly; scaffold185 indexed_genome mRNA 1053360 1054080 . + . ID=transcript_15403;Q9UFH2 O00431 O15206 Q2M2Y1 Q6ZRQ2 Q8N7Q7,Dynein heavy chain 17, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 17;Axonemal dynein heavy chain-like protein 1;Ciliary dynein heavy chain 17;Ciliary dynein heavy chain-like protein 1;Dynein light chain 2, axonemal;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:microtubule-based movement; P:outer dynein arm assembly; scaffold185 indexed_genome mRNA 1054111 1059802 . + . ID=transcript_15404;Q9UFH2 O00431 O15206 Q2M2Y1 Q6ZRQ2 Q8N7Q7,Dynein heavy chain 17, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 17;Axonemal dynein heavy chain-like protein 1;Ciliary dynein heavy chain 17;Ciliary dynein heavy chain-like protein 1;Dynein light chain 2, axonemal;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:microtubule-based movement; P:outer dynein arm assembly; scaffold185 indexed_genome mRNA 1062473 1066136 . + . ID=transcript_15405;Q9UFH2 O00431 O15206 Q2M2Y1 Q6ZRQ2 Q8N7Q7,Dynein heavy chain 17, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 17;Axonemal dynein heavy chain-like protein 1;Ciliary dynein heavy chain 17;Ciliary dynein heavy chain-like protein 1;Dynein light chain 2, axonemal;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:microtubule-based movement; P:outer dynein arm assembly; scaffold185 indexed_genome mRNA 1067260 1077253 . + . ID=transcript_15406;Q9UFH2 O00431 O15206 Q2M2Y1 Q6ZRQ2 Q8N7Q7,Dynein heavy chain 17, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 17;Axonemal dynein heavy chain-like protein 1;Ciliary dynein heavy chain 17;Ciliary dynein heavy chain-like protein 1;Dynein light chain 2, axonemal;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:microtubule-based movement; P:outer dynein arm assembly;|Q9UFH2 O00431 O15206 Q2M2Y1 Q6ZRQ2 Q8N7Q7,Dynein heavy chain 17, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 17;Axonemal dynein heavy chain-like protein 1;Ciliary dynein heavy chain 17;Ciliary dynein heavy chain-like protein 1;Dynein light chain 2, axonemal;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0005858;GO:0005930;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0036126;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0003777;GO:0003341;GO:0060285;GO:0007018;GO:0036158;, C:axonemal dynein complex; C:axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm; C:sperm flagellum;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding; F:microtubule motor activity;, P:cilium movement; P:cilium-dependent cell motility; P:microtubule-based movement; P:outer dynein arm assembly;|Q32NB8 B7ZA32 Q8IYK9 Q8TA85 Q96A75 Q9H7G9 Q9NPW7,CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial,Phosphatidylglycerophosphate synthase 1;, , GO:0005783;GO:0005743;GO:0005739;GO:0005524;GO:0005509;GO:0008444;GO:0032049;GO:0046339;GO:0006655;, C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:calcium ion binding; F:CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity;, P:cardiolipin biosynthetic process; P:diacylglycerol metabolic process; P:phosphatidylglycerol biosynthetic process; scaffold185 indexed_genome mRNA 1079595 1088821 . + . ID=transcript_15407;Q32NB8 B7ZA32 Q8IYK9 Q8TA85 Q96A75 Q9H7G9 Q9NPW7,CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial,Phosphatidylglycerophosphate synthase 1;, , GO:0005783;GO:0005743;GO:0005739;GO:0005524;GO:0005509;GO:0008444;GO:0032049;GO:0046339;GO:0006655;, C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:calcium ion binding; F:CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity;, P:cardiolipin biosynthetic process; P:diacylglycerol metabolic process; P:phosphatidylglycerol biosynthetic process;|Q32NB8 B7ZA32 Q8IYK9 Q8TA85 Q96A75 Q9H7G9 Q9NPW7,CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial,Phosphatidylglycerophosphate synthase 1;, , GO:0005783;GO:0005743;GO:0005739;GO:0005524;GO:0005509;GO:0008444;GO:0032049;GO:0046339;GO:0006655;, C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:calcium ion binding; F:CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity;, P:cardiolipin biosynthetic process; P:diacylglycerol metabolic process; P:phosphatidylglycerol biosynthetic process; scaffold185 indexed_genome mRNA 1088927 1106283 . - . ID=transcript_15408;Q32NB8 B7ZA32 Q8IYK9 Q8TA85 Q96A75 Q9H7G9 Q9NPW7,CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial,Phosphatidylglycerophosphate synthase 1;, , GO:0005783;GO:0005743;GO:0005739;GO:0005524;GO:0005509;GO:0008444;GO:0032049;GO:0046339;GO:0006655;, C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion;, F:ATP binding; F:calcium ion binding; F:CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity;, P:cardiolipin biosynthetic process; P:diacylglycerol metabolic process; P:phosphatidylglycerol biosynthetic process; scaffold186 indexed_genome mRNA 575022 576384 . + . ID=transcript_15409;Q8TCT0 A0JNT4 A8K611 Q6NX59 Q9BYB3 Q9UGE5,Ceramide kinase,Acylsphingosine kinase;Lipid kinase 4;, PF00781;, GO:0005737;GO:0016021;GO:0005886;GO:0005524;GO:0001729;GO:0102773;GO:0001727;GO:0000287;GO:0003951;GO:0006672;GO:0006687;GO:0016310;GO:0006665;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:ceramide kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:magnesium ion binding; F:NAD+ kinase activity;, P:ceramide metabolic process; P:glycosphingolipid metabolic process; P:phosphorylation; P:sphingolipid metabolic process; scaffold186 indexed_genome mRNA 576451 589043 . + . ID=transcript_15410;Q8TCT0 A0JNT4 A8K611 Q6NX59 Q9BYB3 Q9UGE5,Ceramide kinase,Acylsphingosine kinase;Lipid kinase 4;, PF00781;, GO:0005737;GO:0016021;GO:0005886;GO:0005524;GO:0001729;GO:0102773;GO:0001727;GO:0000287;GO:0003951;GO:0006672;GO:0006687;GO:0016310;GO:0006665;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:ceramide kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:magnesium ion binding; F:NAD+ kinase activity;, P:ceramide metabolic process; P:glycosphingolipid metabolic process; P:phosphorylation; P:sphingolipid metabolic process;|Q8TCT0 A0JNT4 A8K611 Q6NX59 Q9BYB3 Q9UGE5,Ceramide kinase,Acylsphingosine kinase;Lipid kinase 4;, PF00781;, GO:0005737;GO:0016021;GO:0005886;GO:0005524;GO:0001729;GO:0102773;GO:0001727;GO:0000287;GO:0003951;GO:0006672;GO:0006687;GO:0016310;GO:0006665;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:ceramide kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:magnesium ion binding; F:NAD+ kinase activity;, P:ceramide metabolic process; P:glycosphingolipid metabolic process; P:phosphorylation; P:sphingolipid metabolic process;|Q8TCT0 A0JNT4 A8K611 Q6NX59 Q9BYB3 Q9UGE5,Ceramide kinase,Acylsphingosine kinase;Lipid kinase 4;, PF00781;, GO:0005737;GO:0016021;GO:0005886;GO:0005524;GO:0001729;GO:0102773;GO:0001727;GO:0000287;GO:0003951;GO:0006672;GO:0006687;GO:0016310;GO:0006665;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:ceramide kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:magnesium ion binding; F:NAD+ kinase activity;, P:ceramide metabolic process; P:glycosphingolipid metabolic process; P:phosphorylation; P:sphingolipid metabolic process; scaffold186 indexed_genome mRNA 589154 592829 . + . ID=transcript_15411;Q8TCT0 A0JNT4 A8K611 Q6NX59 Q9BYB3 Q9UGE5,Ceramide kinase,Acylsphingosine kinase;Lipid kinase 4;, PF00781;, GO:0005737;GO:0016021;GO:0005886;GO:0005524;GO:0001729;GO:0102773;GO:0001727;GO:0000287;GO:0003951;GO:0006672;GO:0006687;GO:0016310;GO:0006665;, C:cytoplasm; C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:ceramide kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:magnesium ion binding; F:NAD+ kinase activity;, P:ceramide metabolic process; P:glycosphingolipid metabolic process; P:phosphorylation; P:sphingolipid metabolic process; scaffold186 indexed_genome mRNA 602377 603641 . - . ID=transcript_15412;Q6IC98 A9IN51 A9IN57 Q68EN0 Q9UGE6 Q9Y4B9,GRAM domain-containing protein 4 {ECO:0000305},Death-inducing protein;, PF02893;, GO:0005789;GO:0016021;GO:0031966;GO:0005739;GO:0006915;GO:0034164;GO:0043280;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;, , P:apoptotic process; P:negative regulation of toll-like receptor 9 signaling pathway; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; scaffold186 indexed_genome mRNA 624755 625337 . - . ID=transcript_15413;Q6IC98 A9IN51 A9IN57 Q68EN0 Q9UGE6 Q9Y4B9,GRAM domain-containing protein 4 {ECO:0000305},Death-inducing protein;, PF02893;, GO:0005789;GO:0016021;GO:0031966;GO:0005739;GO:0006915;GO:0034164;GO:0043280;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial membrane; C:mitochondrion;, , P:apoptotic process; P:negative regulation of toll-like receptor 9 signaling pathway; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; scaffold186 indexed_genome mRNA 777974 822371 . + . ID=transcript_15414;Q9NYQ6 O95722 Q5TH47 Q9BWQ5 Q9Y506 Q9Y526,Cadherin EGF LAG seven-pass G-type receptor 1,Cadherin family member 9;Flamingo homolog 2;, PF00002;PF00028;PF00008;PF16489;PF01825;PF02793;PF00053;PF02210;, GO:0016021;GO:0005654;GO:0005886;GO:0005509;GO:0004930;GO:0045176;GO:0098609;GO:0007417;GO:0048105;GO:0001736;GO:0042249;GO:0007156;GO:0060490;GO:0001843;GO:0001764;GO:0060488;GO:0060489;GO:0090251;GO:0032956;GO:0007266;GO:0060071;, C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:apical protein localization; P:cell-cell adhesion; P:central nervous system development; P:establishment of body hair planar orientation; P:establishment of planar polarity; P:establishment of planar polarity of embryonic epithelium; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:lateral sprouting involved in lung morphogenesis; P:neural tube closure; P:neuron migration; P:orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis; P:planar dichotomous subdivision of terminal units involved in lung branching morphogenesis; P:protein localization involved in establishment of planar polarity; P:regulation of actin cytoskeleton organization; P:Rho protein signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; scaffold186 indexed_genome mRNA 826833 841171 . + . ID=transcript_15415;Q9NYQ6 O95722 Q5TH47 Q9BWQ5 Q9Y506 Q9Y526,Cadherin EGF LAG seven-pass G-type receptor 1,Cadherin family member 9;Flamingo homolog 2;, PF00002;PF00028;PF00008;PF16489;PF01825;PF02793;PF00053;PF02210;, GO:0016021;GO:0005654;GO:0005886;GO:0005509;GO:0004930;GO:0045176;GO:0098609;GO:0007417;GO:0048105;GO:0001736;GO:0042249;GO:0007156;GO:0060490;GO:0001843;GO:0001764;GO:0060488;GO:0060489;GO:0090251;GO:0032956;GO:0007266;GO:0060071;, C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:apical protein localization; P:cell-cell adhesion; P:central nervous system development; P:establishment of body hair planar orientation; P:establishment of planar polarity; P:establishment of planar polarity of embryonic epithelium; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:lateral sprouting involved in lung morphogenesis; P:neural tube closure; P:neuron migration; P:orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis; P:planar dichotomous subdivision of terminal units involved in lung branching morphogenesis; P:protein localization involved in establishment of planar polarity; P:regulation of actin cytoskeleton organization; P:Rho protein signal transduction; P:Wnt signaling pathway, planar cell polarity pathway;|Q9NYQ6 O95722 Q5TH47 Q9BWQ5 Q9Y506 Q9Y526,Cadherin EGF LAG seven-pass G-type receptor 1,Cadherin family member 9;Flamingo homolog 2;, PF00002;PF00028;PF00008;PF16489;PF01825;PF02793;PF00053;PF02210;, GO:0016021;GO:0005654;GO:0005886;GO:0005509;GO:0004930;GO:0045176;GO:0098609;GO:0007417;GO:0048105;GO:0001736;GO:0042249;GO:0007156;GO:0060490;GO:0001843;GO:0001764;GO:0060488;GO:0060489;GO:0090251;GO:0032956;GO:0007266;GO:0060071;, C:integral component of membrane; C:nucleoplasm; C:plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:apical protein localization; P:cell-cell adhesion; P:central nervous system development; P:establishment of body hair planar orientation; P:establishment of planar polarity; P:establishment of planar polarity of embryonic epithelium; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:lateral sprouting involved in lung morphogenesis; P:neural tube closure; P:neuron migration; P:orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis; P:planar dichotomous subdivision of terminal units involved in lung branching morphogenesis; P:protein localization involved in establishment of planar polarity; P:regulation of actin cytoskeleton organization; P:Rho protein signal transduction; P:Wnt signaling pathway, planar cell polarity pathway; scaffold186 indexed_genome mRNA 853540 863664 . - . ID=transcript_15416;O75648 A8K3U7 Q05C99 Q5W9C8 Q66K31 Q6ICC3 Q9NWC1,Mitochondrial tRNA-specific 2-thiouridylase 1,MTO2 homolog;, , GO:0005739;GO:0005524;GO:0000049;GO:0061708;GO:0002143;, C:mitochondrion;, F:ATP binding; F:tRNA binding; F:tRNA-5-taurinomethyluridine 2-sulfurtransferase;, P:tRNA wobble position uridine thiolation;|O75648 A8K3U7 Q05C99 Q5W9C8 Q66K31 Q6ICC3 Q9NWC1,Mitochondrial tRNA-specific 2-thiouridylase 1,MTO2 homolog;, , GO:0005739;GO:0005524;GO:0000049;GO:0061708;GO:0002143;, C:mitochondrion;, F:ATP binding; F:tRNA binding; F:tRNA-5-taurinomethyluridine 2-sulfurtransferase;, P:tRNA wobble position uridine thiolation;|O75648 A8K3U7 Q05C99 Q5W9C8 Q66K31 Q6ICC3 Q9NWC1,Mitochondrial tRNA-specific 2-thiouridylase 1,MTO2 homolog;, , GO:0005739;GO:0005524;GO:0000049;GO:0061708;GO:0002143;, C:mitochondrion;, F:ATP binding; F:tRNA binding; F:tRNA-5-taurinomethyluridine 2-sulfurtransferase;, P:tRNA wobble position uridine thiolation;|O75648 A8K3U7 Q05C99 Q5W9C8 Q66K31 Q6ICC3 Q9NWC1,Mitochondrial tRNA-specific 2-thiouridylase 1,MTO2 homolog;, , GO:0005739;GO:0005524;GO:0000049;GO:0061708;GO:0002143;, C:mitochondrion;, F:ATP binding; F:tRNA binding; F:tRNA-5-taurinomethyluridine 2-sulfurtransferase;, P:tRNA wobble position uridine thiolation;|O75648 A8K3U7 Q05C99 Q5W9C8 Q66K31 Q6ICC3 Q9NWC1,Mitochondrial tRNA-specific 2-thiouridylase 1,MTO2 homolog;, , GO:0005739;GO:0005524;GO:0000049;GO:0061708;GO:0002143;, C:mitochondrion;, F:ATP binding; F:tRNA binding; F:tRNA-5-taurinomethyluridine 2-sulfurtransferase;, P:tRNA wobble position uridine thiolation;|O75648 A8K3U7 Q05C99 Q5W9C8 Q66K31 Q6ICC3 Q9NWC1,Mitochondrial tRNA-specific 2-thiouridylase 1,MTO2 homolog;, , GO:0005739;GO:0005524;GO:0000049;GO:0061708;GO:0002143;, C:mitochondrion;, F:ATP binding; F:tRNA binding; F:tRNA-5-taurinomethyluridine 2-sulfurtransferase;, P:tRNA wobble position uridine thiolation;|O75648 A8K3U7 Q05C99 Q5W9C8 Q66K31 Q6ICC3 Q9NWC1,Mitochondrial tRNA-specific 2-thiouridylase 1,MTO2 homolog;, , GO:0005739;GO:0005524;GO:0000049;GO:0061708;GO:0002143;, C:mitochondrion;, F:ATP binding; F:tRNA binding; F:tRNA-5-taurinomethyluridine 2-sulfurtransferase;, P:tRNA wobble position uridine thiolation; scaffold186 indexed_genome mRNA 873776 878784 . - . ID=transcript_15417;Q9NYZ3 B0QYM3 Q20WK2 Q53GX5 Q5R3I6 Q6DHX4 Q9BRE0 Q9UGZ9 Q9Y557,G2 and S phase-expressed protein 1,Protein B99 homolog;, PF15259;, GO:0005881;GO:0005829;GO:0016020;GO:0015630;GO:0005654;GO:0008017;GO:0006977;GO:0007017;GO:0030335;GO:0046827;GO:1900182;GO:0050821;GO:1902749;, C:cytoplasmic microtubule; C:cytosol; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm;, F:microtubule binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:microtubule-based process; P:positive regulation of cell migration; P:positive regulation of protein export from nucleus; P:positive regulation of protein localization to nucleus; P:protein stabilization; P:regulation of cell cycle G2/M phase transition;|Q9NYZ3 B0QYM3 Q20WK2 Q53GX5 Q5R3I6 Q6DHX4 Q9BRE0 Q9UGZ9 Q9Y557,G2 and S phase-expressed protein 1,Protein B99 homolog;, PF15259;, GO:0005881;GO:0005829;GO:0016020;GO:0015630;GO:0005654;GO:0008017;GO:0006977;GO:0007017;GO:0030335;GO:0046827;GO:1900182;GO:0050821;GO:1902749;, C:cytoplasmic microtubule; C:cytosol; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm;, F:microtubule binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:microtubule-based process; P:positive regulation of cell migration; P:positive regulation of protein export from nucleus; P:positive regulation of protein localization to nucleus; P:protein stabilization; P:regulation of cell cycle G2/M phase transition; scaffold186 indexed_genome mRNA 878802 882706 . + . ID=transcript_15418;Q9NYZ3 B0QYM3 Q20WK2 Q53GX5 Q5R3I6 Q6DHX4 Q9BRE0 Q9UGZ9 Q9Y557,G2 and S phase-expressed protein 1,Protein B99 homolog;, PF15259;, GO:0005881;GO:0005829;GO:0016020;GO:0015630;GO:0005654;GO:0008017;GO:0006977;GO:0007017;GO:0030335;GO:0046827;GO:1900182;GO:0050821;GO:1902749;, C:cytoplasmic microtubule; C:cytosol; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm;, F:microtubule binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:microtubule-based process; P:positive regulation of cell migration; P:positive regulation of protein export from nucleus; P:positive regulation of protein localization to nucleus; P:protein stabilization; P:regulation of cell cycle G2/M phase transition; scaffold186 indexed_genome mRNA 883530 894741 . - . ID=transcript_15419;Q9NYZ3 B0QYM3 Q20WK2 Q53GX5 Q5R3I6 Q6DHX4 Q9BRE0 Q9UGZ9 Q9Y557,G2 and S phase-expressed protein 1,Protein B99 homolog;, PF15259;, GO:0005881;GO:0005829;GO:0016020;GO:0015630;GO:0005654;GO:0008017;GO:0006977;GO:0007017;GO:0030335;GO:0046827;GO:1900182;GO:0050821;GO:1902749;, C:cytoplasmic microtubule; C:cytosol; C:membrane; C:microtubule cytoskeleton; C:nucleoplasm;, F:microtubule binding;, P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:microtubule-based process; P:positive regulation of cell migration; P:positive regulation of protein export from nucleus; P:positive regulation of protein localization to nucleus; P:protein stabilization; P:regulation of cell cycle G2/M phase transition; scaffold186 indexed_genome mRNA 895005 922907 . + . ID=transcript_15420;Q5R3I4 Q8WV27 Q9NWP8,Tetratricopeptide repeat protein 38,, , GO:0070062;, C:extracellular exosome;|Q5R3I4 Q8WV27 Q9NWP8,Tetratricopeptide repeat protein 38,, , GO:0070062;, C:extracellular exosome;|Q5R3I4 Q8WV27 Q9NWP8,Tetratricopeptide repeat protein 38,, , GO:0070062;, C:extracellular exosome;|Q5R3I4 Q8WV27 Q9NWP8,Tetratricopeptide repeat protein 38,, , GO:0070062;, C:extracellular exosome;|Q5R3I4 Q8WV27 Q9NWP8,Tetratricopeptide repeat protein 38,, , GO:0070062;, C:extracellular exosome; scaffold186 indexed_genome mRNA 938852 946823 . + . ID=transcript_15421;Q6NVV7 A6NCA1 A9IU12 A9IU16 Q3ZCR8,Cysteine-rich DPF motif domain-containing protein 1,, PF10170;|Q6NVV7 A6NCA1 A9IU12 A9IU16 Q3ZCR8,Cysteine-rich DPF motif domain-containing protein 1,, PF10170; scaffold186 indexed_genome mRNA 952416 974652 . - . ID=transcript_15422;Q07869 B0G0X3 Q16241 Q6I9S0 Q92486 Q92689 Q9Y3N1,Peroxisome proliferator-activated receptor alpha,Nuclear receptor subfamily 1 group C member 1;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0008144;GO:0008289;GO:0097371;GO:0051525;GO:0004879;GO:0019902;GO:0019904;GO:0044877;GO:0000978;GO:0001103;GO:0043565;GO:0003707;GO:0001223;GO:0008134;GO:0031624;GO:0008270;GO:0035095;GO:0030154;GO:0009267;GO:0032922;GO:0070166;GO:0008544;GO:0006631;GO:0007507;GO:0009755;GO:0010876;GO:0042157;GO:0032099;GO:0045776;GO:0061052;GO:0010887;GO:1900016;GO:0045820;GO:1903944;GO:0050728;GO:1903038;GO:0010745;GO:1901215;GO:1902894;GO:0032091;GO:0051898;GO:1903427;GO:0010891;GO:2000272;GO:0000122;GO:0030512;GO:2001171;GO:0032000;GO:0045923;GO:0046321;GO:0045722;GO:0046889;GO:0045944;GO:0045893;GO:0045070;GO:0010565;GO:0042752;GO:0019217;GO:2000191;GO:0019216;GO:0045471;GO:0001666;GO:0032868;GO:0033993;GO:0006367;GO:0042060;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:drug binding; F:lipid binding; F:MDM2/MDM4 family protein binding; F:NFAT protein binding; F:nuclear receptor activity; F:phosphatase binding; F:protein domain specific binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:steroid hormone receptor activity; F:transcription coactivator binding; F:transcription factor binding; F:ubiquitin conjugating enzyme binding; F:zinc ion binding;, P:behavioral response to nicotine; P:cell differentiation; P:cellular response to starvation; P:circadian regulation of gene expression; P:enamel mineralization; P:epidermis development; P:fatty acid metabolic process; P:heart development; P:hormone-mediated signaling pathway; P:lipid localization; P:lipoprotein metabolic process; P:negative regulation of appetite; P:negative regulation of blood pressure; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of cholesterol storage; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of glycolytic process; P:negative regulation of hepatocyte apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of neuron death; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein binding; P:negative regulation of protein kinase B signaling; P:negative regulation of reactive oxygen species biosynthetic process; P:negative regulation of sequestering of triglyceride; P:negative regulation of signaling receptor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of ATP biosynthetic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of fatty acid metabolic process; P:positive regulation of fatty acid oxidation; P:positive regulation of gluconeogenesis; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral genome replication; P:regulation of cellular ketone metabolic process; P:regulation of circadian rhythm; P:regulation of fatty acid metabolic process; P:regulation of fatty acid transport; P:regulation of lipid metabolic process; P:response to ethanol; P:response to hypoxia; P:response to insulin; P:response to lipid; P:transcription initiation from RNA polymerase II promoter; P:wound healing;|Q07869 B0G0X3 Q16241 Q6I9S0 Q92486 Q92689 Q9Y3N1,Peroxisome proliferator-activated receptor alpha,Nuclear receptor subfamily 1 group C member 1;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0001227;GO:0008144;GO:0008289;GO:0097371;GO:0051525;GO:0004879;GO:0019902;GO:0019904;GO:0044877;GO:0000978;GO:0001103;GO:0043565;GO:0003707;GO:0001223;GO:0008134;GO:0031624;GO:0008270;GO:0035095;GO:0030154;GO:0009267;GO:0032922;GO:0070166;GO:0008544;GO:0006631;GO:0007507;GO:0009755;GO:0010876;GO:0042157;GO:0032099;GO:0045776;GO:0061052;GO:0010887;GO:1900016;GO:0045820;GO:1903944;GO:0050728;GO:1903038;GO:0010745;GO:1901215;GO:1902894;GO:0032091;GO:0051898;GO:1903427;GO:0010891;GO:2000272;GO:0000122;GO:0030512;GO:2001171;GO:0032000;GO:0045923;GO:0046321;GO:0045722;GO:0046889;GO:0045944;GO:0045893;GO:0045070;GO:0010565;GO:0042752;GO:0019217;GO:2000191;GO:0019216;GO:0045471;GO:0001666;GO:0032868;GO:0033993;GO:0006367;GO:0042060;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:drug binding; F:lipid binding; F:MDM2/MDM4 family protein binding; F:NFAT protein binding; F:nuclear receptor activity; F:phosphatase binding; F:protein domain specific binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific DNA binding; F:steroid hormone receptor activity; F:transcription coactivator binding; F:transcription factor binding; F:ubiquitin conjugating enzyme binding; F:zinc ion binding;, P:behavioral response to nicotine; P:cell differentiation; P:cellular response to starvation; P:circadian regulation of gene expression; P:enamel mineralization; P:epidermis development; P:fatty acid metabolic process; P:heart development; P:hormone-mediated signaling pathway; P:lipid localization; P:lipoprotein metabolic process; P:negative regulation of appetite; P:negative regulation of blood pressure; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of cholesterol storage; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of glycolytic process; P:negative regulation of hepatocyte apoptotic process; P:negative regulation of inflammatory response; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of neuron death; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of protein binding; P:negative regulation of protein kinase B signaling; P:negative regulation of reactive oxygen species biosynthetic process; P:negative regulation of sequestering of triglyceride; P:negative regulation of signaling receptor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of ATP biosynthetic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of fatty acid metabolic process; P:positive regulation of fatty acid oxidation; P:positive regulation of gluconeogenesis; P:positive regulation of lipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral genome replication; P:regulation of cellular ketone metabolic process; P:regulation of circadian rhythm; P:regulation of fatty acid metabolic process; P:regulation of fatty acid transport; P:regulation of lipid metabolic process; P:response to ethanol; P:response to hypoxia; P:response to insulin; P:response to lipid; P:transcription initiation from RNA polymerase II promoter; P:wound healing; scaffold187 indexed_genome mRNA 19419 20287 . - . ID=transcript_15423;Q9UPS8 A6NH29 Q2TAZ3 Q6ZR14 Q9H1Q1 Q9NSK9 Q9NTD5 Q9NW69,Ankyrin repeat domain-containing protein 26 {ECO:0000305},, PF00023;PF12796;PF14915;PF12001;, GO:0005813;GO:0045599;, C:centrosome;, , P:negative regulation of fat cell differentiation; scaffold187 indexed_genome mRNA 60082 103666 . + . ID=transcript_15424;Q9BUP0 B2RD83 E9PFH3 Q9BTF8 Q9H8I2 Q9HBQ0,EF-hand domain-containing protein D1,EF-hand domain-containing protein 1;Swiprosin-2;, PF13499;, GO:0005743;GO:0005739;GO:0005509;GO:0061891;GO:0031175;GO:1900069;, C:mitochondrial inner membrane; C:mitochondrion;, F:calcium ion binding; F:calcium ion sensor activity;, P:neuron projection development; P:regulation of cellular hyperosmotic salinity response; scaffold187 indexed_genome mRNA 117000 243448 . + . ID=transcript_15425;Q6Y7W6 A6H8W4 B9EG55 E9PBB0 O75137 Q7Z2Z8 Q7Z3I2 Q96HU4 Q9NV82,GRB10-interacting GYF protein 2 {ECO:0000303|PubMed:12771153},PERQ amino acid-rich with GYF domain-containing protein 2;Trinucleotide repeat-containing gene 15 protein {ECO:0000303|PubMed:18358451};, PF02213;, GO:0010494;GO:0005829;GO:0005783;GO:0005768;GO:0005794;GO:0016020;GO:0043204;GO:0032991;GO:1990635;GO:0045296;GO:0070064;GO:0003723;GO:0048009;GO:0061157;GO:0017148;GO:0016441;, C:cytoplasmic stress granule; C:cytosol; C:endoplasmic reticulum; C:endosome; C:Golgi apparatus; C:membrane; C:perikaryon; C:protein-containing complex; C:proximal dendrite;, F:cadherin binding; F:proline-rich region binding; F:RNA binding;, P:insulin-like growth factor receptor signaling pathway; P:mRNA destabilization; P:negative regulation of translation; P:posttranscriptional gene silencing;|Q6Y7W6 A6H8W4 B9EG55 E9PBB0 O75137 Q7Z2Z8 Q7Z3I2 Q96HU4 Q9NV82,GRB10-interacting GYF protein 2 {ECO:0000303|PubMed:12771153},PERQ amino acid-rich with GYF domain-containing protein 2;Trinucleotide repeat-containing gene 15 protein {ECO:0000303|PubMed:18358451};, PF02213;, GO:0010494;GO:0005829;GO:0005783;GO:0005768;GO:0005794;GO:0016020;GO:0043204;GO:0032991;GO:1990635;GO:0045296;GO:0070064;GO:0003723;GO:0048009;GO:0061157;GO:0017148;GO:0016441;, C:cytoplasmic stress granule; C:cytosol; C:endoplasmic reticulum; C:endosome; C:Golgi apparatus; C:membrane; C:perikaryon; C:protein-containing complex; C:proximal dendrite;, F:cadherin binding; F:proline-rich region binding; F:RNA binding;, P:insulin-like growth factor receptor signaling pathway; P:mRNA destabilization; P:negative regulation of translation; P:posttranscriptional gene silencing;|Q6Y7W6 A6H8W4 B9EG55 E9PBB0 O75137 Q7Z2Z8 Q7Z3I2 Q96HU4 Q9NV82,GRB10-interacting GYF protein 2 {ECO:0000303|PubMed:12771153},PERQ amino acid-rich with GYF domain-containing protein 2;Trinucleotide repeat-containing gene 15 protein {ECO:0000303|PubMed:18358451};, PF02213;, GO:0010494;GO:0005829;GO:0005783;GO:0005768;GO:0005794;GO:0016020;GO:0043204;GO:0032991;GO:1990635;GO:0045296;GO:0070064;GO:0003723;GO:0048009;GO:0061157;GO:0017148;GO:0016441;, C:cytoplasmic stress granule; C:cytosol; C:endoplasmic reticulum; C:endosome; C:Golgi apparatus; C:membrane; C:perikaryon; C:protein-containing complex; C:proximal dendrite;, F:cadherin binding; F:proline-rich region binding; F:RNA binding;, P:insulin-like growth factor receptor signaling pathway; P:mRNA destabilization; P:negative regulation of translation; P:posttranscriptional gene silencing;|Q6Y7W6 A6H8W4 B9EG55 E9PBB0 O75137 Q7Z2Z8 Q7Z3I2 Q96HU4 Q9NV82,GRB10-interacting GYF protein 2 {ECO:0000303|PubMed:12771153},PERQ amino acid-rich with GYF domain-containing protein 2;Trinucleotide repeat-containing gene 15 protein {ECO:0000303|PubMed:18358451};, PF02213;, GO:0010494;GO:0005829;GO:0005783;GO:0005768;GO:0005794;GO:0016020;GO:0043204;GO:0032991;GO:1990635;GO:0045296;GO:0070064;GO:0003723;GO:0048009;GO:0061157;GO:0017148;GO:0016441;, C:cytoplasmic stress granule; C:cytosol; C:endoplasmic reticulum; C:endosome; C:Golgi apparatus; C:membrane; C:perikaryon; C:protein-containing complex; C:proximal dendrite;, F:cadherin binding; F:proline-rich region binding; F:RNA binding;, P:insulin-like growth factor receptor signaling pathway; P:mRNA destabilization; P:negative regulation of translation; P:posttranscriptional gene silencing; scaffold187 indexed_genome mRNA 266977 276221 . - . ID=transcript_15426;Q8N5V2 B4DMB8 B9A045 E9PC42 Q53QQ4 Q53ST7 Q6GMQ5 Q9NQD6,Ephexin-1,Eph-interacting exchange protein;Neuronal guanine nucleotide exchange factor;, PF00169;PF00621;PF00018;, GO:0005829;GO:0030426;GO:0016020;GO:0005085;GO:0090630;GO:0030154;GO:0048013;GO:0007186;GO:0061002;GO:0007399;GO:0043065;GO:0043087;GO:0051056;, C:cytosol; C:growth cone; C:membrane;, F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell differentiation; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of dendritic spine morphogenesis; P:nervous system development; P:positive regulation of apoptotic process; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction;|Q8N5V2 B4DMB8 B9A045 E9PC42 Q53QQ4 Q53ST7 Q6GMQ5 Q9NQD6,Ephexin-1,Eph-interacting exchange protein;Neuronal guanine nucleotide exchange factor;, PF00169;PF00621;PF00018;, GO:0005829;GO:0030426;GO:0016020;GO:0005085;GO:0090630;GO:0030154;GO:0048013;GO:0007186;GO:0061002;GO:0007399;GO:0043065;GO:0043087;GO:0051056;, C:cytosol; C:growth cone; C:membrane;, F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell differentiation; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of dendritic spine morphogenesis; P:nervous system development; P:positive regulation of apoptotic process; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold187 indexed_genome mRNA 310953 386557 . - . ID=transcript_15427;Q8N5V2 B4DMB8 B9A045 E9PC42 Q53QQ4 Q53ST7 Q6GMQ5 Q9NQD6,Ephexin-1,Eph-interacting exchange protein;Neuronal guanine nucleotide exchange factor;, PF00169;PF00621;PF00018;, GO:0005829;GO:0030426;GO:0016020;GO:0005085;GO:0090630;GO:0030154;GO:0048013;GO:0007186;GO:0061002;GO:0007399;GO:0043065;GO:0043087;GO:0051056;, C:cytosol; C:growth cone; C:membrane;, F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell differentiation; P:ephrin receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of dendritic spine morphogenesis; P:nervous system development; P:positive regulation of apoptotic process; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; scaffold187 indexed_genome mRNA 517644 599918 . + . ID=transcript_15428;Q92835 O00145 Q13544 Q13545 Q6P5A4 Q92656 Q9UE80,Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1,Inositol polyphosphate-5-phosphatase D;Inositol polyphosphate-5-phosphatase of 145 kDa {ECO:0000303|PubMed:8874179};Phosphatidylinositol 4,5-bisphosphate 5-phosphatase;SH2 domain-containing inositol 5'-phosphatase 1 {ECO:0000303|PubMed:9108392};p150Ship;, PF03372;PF00017;, GO:0005856;GO:0005829;GO:0045121;GO:0005886;GO:0052659;GO:0052658;GO:0004445;GO:0034485;GO:0004439;GO:0017124;GO:0006915;GO:0019221;GO:0008340;GO:0016064;GO:0043647;GO:0035556;GO:0050900;GO:0030889;GO:0045779;GO:0050777;GO:0032715;GO:0045656;GO:0045659;GO:0045671;GO:0009968;GO:0006796;GO:0006661;GO:0046856;GO:0043065;GO:0045579;GO:0045648;GO:0007165;GO:0050852;, C:cytoskeleton; C:cytosol; C:membrane raft; C:plasma membrane;, F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:SH3 domain binding;, P:apoptotic process; P:cytokine-mediated signaling pathway; P:determination of adult lifespan; P:immunoglobulin mediated immune response; P:inositol phosphate metabolic process; P:intracellular signal transduction; P:leukocyte migration; P:negative regulation of B cell proliferation; P:negative regulation of bone resorption; P:negative regulation of immune response; P:negative regulation of interleukin-6 production; P:negative regulation of monocyte differentiation; P:negative regulation of neutrophil differentiation; P:negative regulation of osteoclast differentiation; P:negative regulation of signal transduction; P:phosphate-containing compound metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of B cell differentiation; P:positive regulation of erythrocyte differentiation; P:signal transduction; P:T cell receptor signaling pathway;|Q92835 O00145 Q13544 Q13545 Q6P5A4 Q92656 Q9UE80,Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1,Inositol polyphosphate-5-phosphatase D;Inositol polyphosphate-5-phosphatase of 145 kDa {ECO:0000303|PubMed:8874179};Phosphatidylinositol 4,5-bisphosphate 5-phosphatase;SH2 domain-containing inositol 5'-phosphatase 1 {ECO:0000303|PubMed:9108392};p150Ship;, PF03372;PF00017;, GO:0005856;GO:0005829;GO:0045121;GO:0005886;GO:0052659;GO:0052658;GO:0004445;GO:0034485;GO:0004439;GO:0017124;GO:0006915;GO:0019221;GO:0008340;GO:0016064;GO:0043647;GO:0035556;GO:0050900;GO:0030889;GO:0045779;GO:0050777;GO:0032715;GO:0045656;GO:0045659;GO:0045671;GO:0009968;GO:0006796;GO:0006661;GO:0046856;GO:0043065;GO:0045579;GO:0045648;GO:0007165;GO:0050852;, C:cytoskeleton; C:cytosol; C:membrane raft; C:plasma membrane;, F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:SH3 domain binding;, P:apoptotic process; P:cytokine-mediated signaling pathway; P:determination of adult lifespan; P:immunoglobulin mediated immune response; P:inositol phosphate metabolic process; P:intracellular signal transduction; P:leukocyte migration; P:negative regulation of B cell proliferation; P:negative regulation of bone resorption; P:negative regulation of immune response; P:negative regulation of interleukin-6 production; P:negative regulation of monocyte differentiation; P:negative regulation of neutrophil differentiation; P:negative regulation of osteoclast differentiation; P:negative regulation of signal transduction; P:phosphate-containing compound metabolic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:positive regulation of apoptotic process; P:positive regulation of B cell differentiation; P:positive regulation of erythrocyte differentiation; P:signal transduction; P:T cell receptor signaling pathway; scaffold187 indexed_genome mRNA 631104 695204 . + . ID=transcript_15429;Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport;|Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport;|Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport;|Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport;|Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport;|Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport;|Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport;|Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport;|P10523 A0FDN6 Q53SV3 Q99858,S-arrestin,48 kDa protein;Retinal S-antigen {ECO:0000303|PubMed:3164688};Rod photoreceptor arrestin;, PF02752;PF00339;, GO:0005829;GO:0016020;GO:0001917;GO:0001750;GO:0001664;GO:0002046;GO:0051219;GO:0004864;GO:0007166;GO:0002031;GO:0022400;GO:0016056;, C:cytosol; C:membrane; C:photoreceptor inner segment; C:photoreceptor outer segment;, F:G protein-coupled receptor binding; F:opsin binding; F:phosphoprotein binding; F:protein phosphatase inhibitor activity;, P:cell surface receptor signaling pathway; P:G protein-coupled receptor internalization; P:regulation of rhodopsin mediated signaling pathway; P:rhodopsin mediated signaling pathway;|Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport;|Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport;|Q9H619,Autophagy-related protein 16-1,APG16-like 1;, PF08614;PF00400;, GO:0005776;GO:0000421;GO:0005930;GO:0005829;GO:0034045;GO:0120095;GO:0051020;GO:0042802;GO:0000045;GO:0016236;GO:0039689;GO:0018215;GO:0015031;, C:autophagosome; C:autophagosome membrane; C:axoneme; C:cytosol; C:phagophore assembly site membrane; C:vacuole-isolation membrane contact site;, F:GTPase binding; F:identical protein binding;, P:autophagosome assembly; P:macroautophagy; P:negative stranded viral RNA replication; P:protein phosphopantetheinylation; P:protein transport; scaffold187 indexed_genome mRNA 699865 704873 . + . ID=transcript_15430;P10523 A0FDN6 Q53SV3 Q99858,S-arrestin,48 kDa protein;Retinal S-antigen {ECO:0000303|PubMed:3164688};Rod photoreceptor arrestin;, PF02752;PF00339;, GO:0005829;GO:0016020;GO:0001917;GO:0001750;GO:0001664;GO:0002046;GO:0051219;GO:0004864;GO:0007166;GO:0002031;GO:0022400;GO:0016056;, C:cytosol; C:membrane; C:photoreceptor inner segment; C:photoreceptor outer segment;, F:G protein-coupled receptor binding; F:opsin binding; F:phosphoprotein binding; F:protein phosphatase inhibitor activity;, P:cell surface receptor signaling pathway; P:G protein-coupled receptor internalization; P:regulation of rhodopsin mediated signaling pathway; P:rhodopsin mediated signaling pathway; scaffold187 indexed_genome mRNA 706996 715285 . + . ID=transcript_15431;P10523 A0FDN6 Q53SV3 Q99858,S-arrestin,48 kDa protein;Retinal S-antigen {ECO:0000303|PubMed:3164688};Rod photoreceptor arrestin;, PF02752;PF00339;, GO:0005829;GO:0016020;GO:0001917;GO:0001750;GO:0001664;GO:0002046;GO:0051219;GO:0004864;GO:0007166;GO:0002031;GO:0022400;GO:0016056;, C:cytosol; C:membrane; C:photoreceptor inner segment; C:photoreceptor outer segment;, F:G protein-coupled receptor binding; F:opsin binding; F:phosphoprotein binding; F:protein phosphatase inhibitor activity;, P:cell surface receptor signaling pathway; P:G protein-coupled receptor internalization; P:regulation of rhodopsin mediated signaling pathway; P:rhodopsin mediated signaling pathway; scaffold187 indexed_genome mRNA 762476 836255 . + . ID=transcript_15432;Q16760 Q14158 Q6PK55 Q8NG53,Diacylglycerol kinase delta {ECO:0000305},130 kDa diacylglycerol kinase;Diglyceride kinase delta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0019992;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0046982;GO:0042803;GO:0046339;GO:0006897;GO:0007173;GO:0035556;GO:0046834;GO:0007275;GO:0090038;GO:0006654;GO:0030168;GO:2000370;GO:0045742;GO:0007205;GO:0015031;GO:0010033;GO:0019932;GO:0007165;, C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:diacylglycerol binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:diacylglycerol metabolic process; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:lipid phosphorylation; P:multicellular organism development; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein transport; P:response to organic substance; P:second-messenger-mediated signaling; P:signal transduction;|Q16760 Q14158 Q6PK55 Q8NG53,Diacylglycerol kinase delta {ECO:0000305},130 kDa diacylglycerol kinase;Diglyceride kinase delta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0019992;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0046982;GO:0042803;GO:0046339;GO:0006897;GO:0007173;GO:0035556;GO:0046834;GO:0007275;GO:0090038;GO:0006654;GO:0030168;GO:2000370;GO:0045742;GO:0007205;GO:0015031;GO:0010033;GO:0019932;GO:0007165;, C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:diacylglycerol binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:diacylglycerol metabolic process; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:lipid phosphorylation; P:multicellular organism development; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein transport; P:response to organic substance; P:second-messenger-mediated signaling; P:signal transduction;|Q16760 Q14158 Q6PK55 Q8NG53,Diacylglycerol kinase delta {ECO:0000305},130 kDa diacylglycerol kinase;Diglyceride kinase delta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0019992;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0046982;GO:0042803;GO:0046339;GO:0006897;GO:0007173;GO:0035556;GO:0046834;GO:0007275;GO:0090038;GO:0006654;GO:0030168;GO:2000370;GO:0045742;GO:0007205;GO:0015031;GO:0010033;GO:0019932;GO:0007165;, C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:diacylglycerol binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:diacylglycerol metabolic process; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:lipid phosphorylation; P:multicellular organism development; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein transport; P:response to organic substance; P:second-messenger-mediated signaling; P:signal transduction;|Q16760 Q14158 Q6PK55 Q8NG53,Diacylglycerol kinase delta {ECO:0000305},130 kDa diacylglycerol kinase;Diglyceride kinase delta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0019992;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0046982;GO:0042803;GO:0046339;GO:0006897;GO:0007173;GO:0035556;GO:0046834;GO:0007275;GO:0090038;GO:0006654;GO:0030168;GO:2000370;GO:0045742;GO:0007205;GO:0015031;GO:0010033;GO:0019932;GO:0007165;, C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:diacylglycerol binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:diacylglycerol metabolic process; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:lipid phosphorylation; P:multicellular organism development; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein transport; P:response to organic substance; P:second-messenger-mediated signaling; P:signal transduction;|Q16760 Q14158 Q6PK55 Q8NG53,Diacylglycerol kinase delta {ECO:0000305},130 kDa diacylglycerol kinase;Diglyceride kinase delta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0019992;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0046982;GO:0042803;GO:0046339;GO:0006897;GO:0007173;GO:0035556;GO:0046834;GO:0007275;GO:0090038;GO:0006654;GO:0030168;GO:2000370;GO:0045742;GO:0007205;GO:0015031;GO:0010033;GO:0019932;GO:0007165;, C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:diacylglycerol binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:diacylglycerol metabolic process; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:lipid phosphorylation; P:multicellular organism development; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein transport; P:response to organic substance; P:second-messenger-mediated signaling; P:signal transduction;|Q16760 Q14158 Q6PK55 Q8NG53,Diacylglycerol kinase delta {ECO:0000305},130 kDa diacylglycerol kinase;Diglyceride kinase delta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0019992;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0046982;GO:0042803;GO:0046339;GO:0006897;GO:0007173;GO:0035556;GO:0046834;GO:0007275;GO:0090038;GO:0006654;GO:0030168;GO:2000370;GO:0045742;GO:0007205;GO:0015031;GO:0010033;GO:0019932;GO:0007165;, C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:diacylglycerol binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:diacylglycerol metabolic process; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:lipid phosphorylation; P:multicellular organism development; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein transport; P:response to organic substance; P:second-messenger-mediated signaling; P:signal transduction;|Q16760 Q14158 Q6PK55 Q8NG53,Diacylglycerol kinase delta {ECO:0000305},130 kDa diacylglycerol kinase;Diglyceride kinase delta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0019992;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0046982;GO:0042803;GO:0046339;GO:0006897;GO:0007173;GO:0035556;GO:0046834;GO:0007275;GO:0090038;GO:0006654;GO:0030168;GO:2000370;GO:0045742;GO:0007205;GO:0015031;GO:0010033;GO:0019932;GO:0007165;, C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:diacylglycerol binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:diacylglycerol metabolic process; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:lipid phosphorylation; P:multicellular organism development; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein transport; P:response to organic substance; P:second-messenger-mediated signaling; P:signal transduction;|Q16760 Q14158 Q6PK55 Q8NG53,Diacylglycerol kinase delta {ECO:0000305},130 kDa diacylglycerol kinase;Diglyceride kinase delta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0019992;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0046982;GO:0042803;GO:0046339;GO:0006897;GO:0007173;GO:0035556;GO:0046834;GO:0007275;GO:0090038;GO:0006654;GO:0030168;GO:2000370;GO:0045742;GO:0007205;GO:0015031;GO:0010033;GO:0019932;GO:0007165;, C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:diacylglycerol binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:diacylglycerol metabolic process; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:lipid phosphorylation; P:multicellular organism development; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein transport; P:response to organic substance; P:second-messenger-mediated signaling; P:signal transduction;|Q16760 Q14158 Q6PK55 Q8NG53,Diacylglycerol kinase delta {ECO:0000305},130 kDa diacylglycerol kinase;Diglyceride kinase delta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0019992;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0046982;GO:0042803;GO:0046339;GO:0006897;GO:0007173;GO:0035556;GO:0046834;GO:0007275;GO:0090038;GO:0006654;GO:0030168;GO:2000370;GO:0045742;GO:0007205;GO:0015031;GO:0010033;GO:0019932;GO:0007165;, C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:diacylglycerol binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:diacylglycerol metabolic process; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:lipid phosphorylation; P:multicellular organism development; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein transport; P:response to organic substance; P:second-messenger-mediated signaling; P:signal transduction;|Q16760 Q14158 Q6PK55 Q8NG53,Diacylglycerol kinase delta {ECO:0000305},130 kDa diacylglycerol kinase;Diglyceride kinase delta;, PF00130;PF00609;PF00781;PF00169;PF07647;, GO:0005905;GO:0005737;GO:0031410;GO:0005829;GO:0005634;GO:0005886;GO:0005524;GO:0019992;GO:0004143;GO:0042802;GO:0019900;GO:0046872;GO:0003951;GO:0046982;GO:0042803;GO:0046339;GO:0006897;GO:0007173;GO:0035556;GO:0046834;GO:0007275;GO:0090038;GO:0006654;GO:0030168;GO:2000370;GO:0045742;GO:0007205;GO:0015031;GO:0010033;GO:0019932;GO:0007165;, C:clathrin-coated pit; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:nucleus; C:plasma membrane;, F:ATP binding; F:diacylglycerol binding; F:diacylglycerol kinase activity; F:identical protein binding; F:kinase binding; F:metal ion binding; F:NAD+ kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:diacylglycerol metabolic process; P:endocytosis; P:epidermal growth factor receptor signaling pathway; P:intracellular signal transduction; P:lipid phosphorylation; P:multicellular organism development; P:negative regulation of protein kinase C signaling; P:phosphatidic acid biosynthetic process; P:platelet activation; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein kinase C-activating G protein-coupled receptor signaling pathway; P:protein transport; P:response to organic substance; P:second-messenger-mediated signaling; P:signal transduction; scaffold187 indexed_genome mRNA 846109 922373 . - . ID=transcript_15433;Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process;|Q9NVE5 Q6NX38 Q70EL0,Ubiquitin carboxyl-terminal hydrolase 40,Deubiquitinating enzyme 40;Ubiquitin thioesterase 40;Ubiquitin-specific-processing protease 40;, PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0016579;GO:0031647;GO:0006511;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination; P:regulation of protein stability; P:ubiquitin-dependent protein catabolic process; scaffold187 indexed_genome mRNA 938423 1058720 . + . ID=transcript_15434;Q9HAW8 O00474 Q6NT91 Q7Z6H8,UDP-glucuronosyltransferase 1A10 {ECO:0000303|PubMed:15472229},UDP-glucuronosyltransferase 1-10;UDP-glucuronosyltransferase 1-J;, PF00201;, GO:0005783;GO:0005789;GO:0016021;GO:0019899;GO:0015020;GO:0046982;GO:0042803;GO:0005080;GO:0052695;GO:0051552;GO:0052696;GO:2001030;GO:0045922;GO:1904224;GO:0052697;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:enzyme binding; F:glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase C binding;, P:cellular glucuronidation; P:flavone metabolic process; P:flavonoid glucuronidation; P:negative regulation of cellular glucuronidation; P:negative regulation of fatty acid metabolic process; P:negative regulation of glucuronosyltransferase activity; P:xenobiotic glucuronidation;|P19224 A6NKK6 B8K289 Q96TE7,UDP-glucuronosyltransferase 1-6,Phenol-metabolizing UDP-glucuronosyltransferase;UDP-glucuronosyltransferase 1-F;UDP-glucuronosyltransferase 1A6;, PF00201;, GO:0005783;GO:0005789;GO:0016021;GO:0019899;GO:0015020;GO:0046982;GO:0042803;GO:0052695;GO:0052696;GO:2001030;GO:0045922;GO:1904224;GO:0052697;GO:0006805;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:enzyme binding; F:glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity;, P:cellular glucuronidation; P:flavonoid glucuronidation; P:negative regulation of cellular glucuronidation; P:negative regulation of fatty acid metabolic process; P:negative regulation of glucuronosyltransferase activity; P:xenobiotic glucuronidation; P:xenobiotic metabolic process;|P35503 B8K287,UDP-glucuronosyltransferase 1A3 {ECO:0000303|PubMed:15472229, ECO:0000303|PubMed:18719240},UDP-glucuronosyltransferase 1-3;UDP-glucuronosyltransferase 1-C;UDP-glucuronosyltransferase 1A isoform 3;, PF00201;, GO:0005783;GO:0005789;GO:0016021;GO:0019899;GO:0015020;GO:0046982;GO:0042803;GO:0001972;GO:0032782;GO:0052695;GO:0008210;GO:0052696;GO:0030522;GO:2001030;GO:0045922;GO:1904224;GO:0042573;GO:0070640;GO:0052697;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:enzyme binding; F:glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:retinoic acid binding;, P:bile acid secretion; P:cellular glucuronidation; P:estrogen metabolic process; P:flavonoid glucuronidation; P:intracellular receptor signaling pathway; P:negative regulation of cellular glucuronidation; P:negative regulation of fatty acid metabolic process; P:negative regulation of glucuronosyltransferase activity; P:retinoic acid metabolic process; P:vitamin D3 metabolic process; P:xenobiotic glucuronidation;|P35503 B8K287,UDP-glucuronosyltransferase 1A3 {ECO:0000303|PubMed:15472229, ECO:0000303|PubMed:18719240},UDP-glucuronosyltransferase 1-3;UDP-glucuronosyltransferase 1-C;UDP-glucuronosyltransferase 1A isoform 3;, PF00201;, GO:0005783;GO:0005789;GO:0016021;GO:0019899;GO:0015020;GO:0046982;GO:0042803;GO:0001972;GO:0032782;GO:0052695;GO:0008210;GO:0052696;GO:0030522;GO:2001030;GO:0045922;GO:1904224;GO:0042573;GO:0070640;GO:0052697;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:enzyme binding; F:glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:retinoic acid binding;, P:bile acid secretion; P:cellular glucuronidation; P:estrogen metabolic process; P:flavonoid glucuronidation; P:intracellular receptor signaling pathway; P:negative regulation of cellular glucuronidation; P:negative regulation of fatty acid metabolic process; P:negative regulation of glucuronosyltransferase activity; P:retinoic acid metabolic process; P:vitamin D3 metabolic process; P:xenobiotic glucuronidation;|P22309 A6NJC3 B8K286,UDP-glucuronosyltransferase 1A1 {ECO:0000303|PubMed:15472229, ECO:0000303|PubMed:18719240},Bilirubin-specific UDPGT isozyme 1;UDP-glucuronosyltransferase 1-1;UDP-glucuronosyltransferase 1A isoform 1;, PF00201;, GO:0070069;GO:0005783;GO:0034663;GO:0005789;GO:0005887;GO:0048471;GO:0019899;GO:0004857;GO:0015020;GO:0046982;GO:0042803;GO:0001972;GO:0005496;GO:0006953;GO:0031100;GO:0006789;GO:0070980;GO:0052695;GO:0071392;GO:0071361;GO:0071385;GO:0017144;GO:0008210;GO:0051552;GO:0052696;GO:0042167;GO:0046483;GO:0001889;GO:2001030;GO:0045922;GO:1904224;GO:0045939;GO:0042493;GO:0032496;GO:0007584;GO:0042594;GO:0042573;GO:0008202;GO:0052697;, C:cytochrome complex; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm;, F:enzyme binding; F:enzyme inhibitor activity; F:glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:retinoic acid binding; F:steroid binding;, P:acute-phase response; P:animal organ regeneration; P:bilirubin conjugation; P:biphenyl catabolic process; P:cellular glucuronidation; P:cellular response to estradiol stimulus; P:cellular response to ethanol; P:cellular response to glucocorticoid stimulus; P:drug metabolic process; P:estrogen metabolic process; P:flavone metabolic process; P:flavonoid glucuronidation; P:heme catabolic process; P:heterocycle metabolic process; P:liver development; P:negative regulation of cellular glucuronidation; P:negative regulation of fatty acid metabolic process; P:negative regulation of glucuronosyltransferase activity; P:negative regulation of steroid metabolic process; P:response to drug; P:response to lipopolysaccharide; P:response to nutrient; P:response to starvation; P:retinoic acid metabolic process; P:steroid metabolic process; P:xenobiotic glucuronidation;|P22309 A6NJC3 B8K286,UDP-glucuronosyltransferase 1A1 {ECO:0000303|PubMed:15472229, ECO:0000303|PubMed:18719240},Bilirubin-specific UDPGT isozyme 1;UDP-glucuronosyltransferase 1-1;UDP-glucuronosyltransferase 1A isoform 1;, PF00201;, GO:0070069;GO:0005783;GO:0034663;GO:0005789;GO:0005887;GO:0048471;GO:0019899;GO:0004857;GO:0015020;GO:0046982;GO:0042803;GO:0001972;GO:0005496;GO:0006953;GO:0031100;GO:0006789;GO:0070980;GO:0052695;GO:0071392;GO:0071361;GO:0071385;GO:0017144;GO:0008210;GO:0051552;GO:0052696;GO:0042167;GO:0046483;GO:0001889;GO:2001030;GO:0045922;GO:1904224;GO:0045939;GO:0042493;GO:0032496;GO:0007584;GO:0042594;GO:0042573;GO:0008202;GO:0052697;, C:cytochrome complex; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm;, F:enzyme binding; F:enzyme inhibitor activity; F:glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:retinoic acid binding; F:steroid binding;, P:acute-phase response; P:animal organ regeneration; P:bilirubin conjugation; P:biphenyl catabolic process; P:cellular glucuronidation; P:cellular response to estradiol stimulus; P:cellular response to ethanol; P:cellular response to glucocorticoid stimulus; P:drug metabolic process; P:estrogen metabolic process; P:flavone metabolic process; P:flavonoid glucuronidation; P:heme catabolic process; P:heterocycle metabolic process; P:liver development; P:negative regulation of cellular glucuronidation; P:negative regulation of fatty acid metabolic process; P:negative regulation of glucuronosyltransferase activity; P:negative regulation of steroid metabolic process; P:response to drug; P:response to lipopolysaccharide; P:response to nutrient; P:response to starvation; P:retinoic acid metabolic process; P:steroid metabolic process; P:xenobiotic glucuronidation;|P22309 A6NJC3 B8K286,UDP-glucuronosyltransferase 1A1 {ECO:0000303|PubMed:15472229, ECO:0000303|PubMed:18719240},Bilirubin-specific UDPGT isozyme 1;UDP-glucuronosyltransferase 1-1;UDP-glucuronosyltransferase 1A isoform 1;, PF00201;, GO:0070069;GO:0005783;GO:0034663;GO:0005789;GO:0005887;GO:0048471;GO:0019899;GO:0004857;GO:0015020;GO:0046982;GO:0042803;GO:0001972;GO:0005496;GO:0006953;GO:0031100;GO:0006789;GO:0070980;GO:0052695;GO:0071392;GO:0071361;GO:0071385;GO:0017144;GO:0008210;GO:0051552;GO:0052696;GO:0042167;GO:0046483;GO:0001889;GO:2001030;GO:0045922;GO:1904224;GO:0045939;GO:0042493;GO:0032496;GO:0007584;GO:0042594;GO:0042573;GO:0008202;GO:0052697;, C:cytochrome complex; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm;, F:enzyme binding; F:enzyme inhibitor activity; F:glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:retinoic acid binding; F:steroid binding;, P:acute-phase response; P:animal organ regeneration; P:bilirubin conjugation; P:biphenyl catabolic process; P:cellular glucuronidation; P:cellular response to estradiol stimulus; P:cellular response to ethanol; P:cellular response to glucocorticoid stimulus; P:drug metabolic process; P:estrogen metabolic process; P:flavone metabolic process; P:flavonoid glucuronidation; P:heme catabolic process; P:heterocycle metabolic process; P:liver development; P:negative regulation of cellular glucuronidation; P:negative regulation of fatty acid metabolic process; P:negative regulation of glucuronosyltransferase activity; P:negative regulation of steroid metabolic process; P:response to drug; P:response to lipopolysaccharide; P:response to nutrient; P:response to starvation; P:retinoic acid metabolic process; P:steroid metabolic process; P:xenobiotic glucuronidation; scaffold187 indexed_genome mRNA 1059379 1061538 . - . ID=transcript_15435;P22309 A6NJC3 B8K286,UDP-glucuronosyltransferase 1A1 {ECO:0000303|PubMed:15472229, ECO:0000303|PubMed:18719240},Bilirubin-specific UDPGT isozyme 1;UDP-glucuronosyltransferase 1-1;UDP-glucuronosyltransferase 1A isoform 1;, PF00201;, GO:0070069;GO:0005783;GO:0034663;GO:0005789;GO:0005887;GO:0048471;GO:0019899;GO:0004857;GO:0015020;GO:0046982;GO:0042803;GO:0001972;GO:0005496;GO:0006953;GO:0031100;GO:0006789;GO:0070980;GO:0052695;GO:0071392;GO:0071361;GO:0071385;GO:0017144;GO:0008210;GO:0051552;GO:0052696;GO:0042167;GO:0046483;GO:0001889;GO:2001030;GO:0045922;GO:1904224;GO:0045939;GO:0042493;GO:0032496;GO:0007584;GO:0042594;GO:0042573;GO:0008202;GO:0052697;, C:cytochrome complex; C:endoplasmic reticulum; C:endoplasmic reticulum chaperone complex; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm;, F:enzyme binding; F:enzyme inhibitor activity; F:glucuronosyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:retinoic acid binding; F:steroid binding;, P:acute-phase response; P:animal organ regeneration; P:bilirubin conjugation; P:biphenyl catabolic process; P:cellular glucuronidation; P:cellular response to estradiol stimulus; P:cellular response to ethanol; P:cellular response to glucocorticoid stimulus; P:drug metabolic process; P:estrogen metabolic process; P:flavone metabolic process; P:flavonoid glucuronidation; P:heme catabolic process; P:heterocycle metabolic process; P:liver development; P:negative regulation of cellular glucuronidation; P:negative regulation of fatty acid metabolic process; P:negative regulation of glucuronosyltransferase activity; P:negative regulation of steroid metabolic process; P:response to drug; P:response to lipopolysaccharide; P:response to nutrient; P:response to starvation; P:retinoic acid metabolic process; P:steroid metabolic process; P:xenobiotic glucuronidation; scaffold188 indexed_genome mRNA 147981 152003 . - . ID=transcript_15436;P0DMW3 A0A0G2JPJ8,Small integral membrane protein 10-like protein 1 {ECO:0000305},, PF15118; scaffold188 indexed_genome mRNA 421506 424875 . + . ID=transcript_15437;P16989 B2RBW6 Q14121 Q969N6 Q96B76,Y-box-binding protein 3,Cold shock domain-containing protein A;DNA-binding protein A;Single-strand DNA-binding protein NF-GMB;, PF00313;, GO:0005923;GO:0005737;GO:0005829;GO:0005634;GO:0048471;GO:0003730;GO:0003676;GO:1905538;GO:0003723;GO:0000977;GO:0031267;GO:0070935;GO:0071474;GO:0071356;GO:0009566;GO:0001701;GO:0008584;GO:1902219;GO:0060546;GO:0048642;GO:0000122;GO:2000767;GO:0046622;GO:0010468;GO:0007283;, C:bicellular tight junction; C:cytoplasm; C:cytosol; C:nucleus; C:perinuclear region of cytoplasm;, F:mRNA 3'-UTR binding; F:nucleic acid binding; F:polysome binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:small GTPase binding;, P:3'-UTR-mediated mRNA stabilization; P:cellular hyperosmotic response; P:cellular response to tumor necrosis factor; P:fertilization; P:in utero embryonic development; P:male gonad development; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:negative regulation of necroptotic process; P:negative regulation of skeletal muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cytoplasmic translation; P:positive regulation of organ growth; P:regulation of gene expression; P:spermatogenesis; scaffold188 indexed_genome mRNA 512325 516964 . + . ID=transcript_15438;Q96A72,Protein mago nashi homolog 2,, PF02792;, GO:0071013;GO:0035145;GO:0043025;GO:0005654;GO:0005634;GO:0071006;GO:0071005;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:exon-exon junction complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:RNA export from nucleus; P:RNA splicing;|Q96A72,Protein mago nashi homolog 2,, PF02792;, GO:0071013;GO:0035145;GO:0043025;GO:0005654;GO:0005634;GO:0071006;GO:0071005;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:exon-exon junction complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:RNA export from nucleus; P:RNA splicing;|Q96A72,Protein mago nashi homolog 2,, PF02792;, GO:0071013;GO:0035145;GO:0043025;GO:0005654;GO:0005634;GO:0071006;GO:0071005;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:exon-exon junction complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:RNA export from nucleus; P:RNA splicing; scaffold188 indexed_genome mRNA 977249 982121 . + . ID=transcript_15439;P26715,NKG2-A/NKG2-B type II integral membrane protein,CD159 antigen-like family member A;NK cell receptor A;NKG2-A/B-activating NK receptor;, PF00059;, GO:0005887;GO:0005886;GO:0043235;GO:0030246;GO:0062082;GO:0023024;GO:0004888;GO:0002250;GO:0002305;GO:0007166;GO:0045087;GO:0002769;GO:0045953;GO:0001915;GO:0050776;, C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:carbohydrate binding; F:HLA-E specific inhibitory MHC class Ib receptor activity; F:MHC class I protein complex binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:CD8-positive, gamma-delta intraepithelial T cell differentiation; P:cell surface receptor signaling pathway; P:innate immune response; P:natural killer cell inhibitory signaling pathway; P:negative regulation of natural killer cell mediated cytotoxicity; P:negative regulation of T cell mediated cytotoxicity; P:regulation of immune response; scaffold188 indexed_genome mRNA 1034742 1041447 . + . ID=transcript_15440;P26718 A8K7K5 A8K7P4 Q9NR41,NKG2-D type II integral membrane protein,Killer cell lectin-like receptor subfamily K member 1;NK cell receptor D;NKG2-D-activating NK receptor;, PF00059;, GO:0009986;GO:0009897;GO:0016021;GO:0005887;GO:0005886;GO:0030246;GO:0038023;GO:0002250;GO:0030154;GO:0030101;GO:0042267;GO:0034260;GO:2000502;GO:0045954;GO:0050776;GO:0007165;GO:0031295;, C:cell surface; C:external side of plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:carbohydrate binding; F:signaling receptor activity;, P:adaptive immune response; P:cell differentiation; P:natural killer cell activation; P:natural killer cell mediated cytotoxicity; P:negative regulation of GTPase activity; P:negative regulation of natural killer cell chemotaxis; P:positive regulation of natural killer cell mediated cytotoxicity; P:regulation of immune response; P:signal transduction; P:T cell costimulation; scaffold189 indexed_genome mRNA 8076 15771 . + . ID=transcript_15441;Q9NSY0 B4DF59 Q2HIX8 Q597G7 Q8NCX8 Q8WYS5,Nuclear receptor-binding protein 2,Transformation-related gene 16 protein;, PF00069;, GO:0005737;GO:0012505;GO:0005524;GO:0004674;GO:0006888;GO:0035556;GO:0016242;GO:0043524;GO:0030182;GO:0006468;, C:cytoplasm; C:endomembrane system;, F:ATP binding; F:protein serine/threonine kinase activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular signal transduction; P:negative regulation of macroautophagy; P:negative regulation of neuron apoptotic process; P:neuron differentiation; P:protein phosphorylation;|Q9NSY0 B4DF59 Q2HIX8 Q597G7 Q8NCX8 Q8WYS5,Nuclear receptor-binding protein 2,Transformation-related gene 16 protein;, PF00069;, GO:0005737;GO:0012505;GO:0005524;GO:0004674;GO:0006888;GO:0035556;GO:0016242;GO:0043524;GO:0030182;GO:0006468;, C:cytoplasm; C:endomembrane system;, F:ATP binding; F:protein serine/threonine kinase activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intracellular signal transduction; P:negative regulation of macroautophagy; P:negative regulation of neuron apoptotic process; P:neuron differentiation; P:protein phosphorylation; scaffold189 indexed_genome mRNA 21699 26521 . + . ID=transcript_15442;Q9UHX1 A8K8K8 Q969E7 Q96D94 Q96H63 Q99628 Q9NZA0 Q9UJY7,Poly(U)-binding-splicing factor PUF60,60 kDa poly(U)-binding-splicing factor;FUSE-binding protein-interacting repressor;Ro-binding protein 1;Siah-binding protein 1;, PF00076;, GO:0030054;GO:0005654;GO:0045296;GO:0003677;GO:0042802;GO:0003723;GO:0000380;GO:0006915;GO:0006376;GO:0000398;GO:0000381;, C:cell junction; C:nucleoplasm;, F:cadherin binding; F:DNA binding; F:identical protein binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:apoptotic process; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome;|Q9UHX1 A8K8K8 Q969E7 Q96D94 Q96H63 Q99628 Q9NZA0 Q9UJY7,Poly(U)-binding-splicing factor PUF60,60 kDa poly(U)-binding-splicing factor;FUSE-binding protein-interacting repressor;Ro-binding protein 1;Siah-binding protein 1;, PF00076;, GO:0030054;GO:0005654;GO:0045296;GO:0003677;GO:0042802;GO:0003723;GO:0000380;GO:0006915;GO:0006376;GO:0000398;GO:0000381;, C:cell junction; C:nucleoplasm;, F:cadherin binding; F:DNA binding; F:identical protein binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:apoptotic process; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; scaffold189 indexed_genome mRNA 28043 30068 . + . ID=transcript_15443;Q9UHX1 A8K8K8 Q969E7 Q96D94 Q96H63 Q99628 Q9NZA0 Q9UJY7,Poly(U)-binding-splicing factor PUF60,60 kDa poly(U)-binding-splicing factor;FUSE-binding protein-interacting repressor;Ro-binding protein 1;Siah-binding protein 1;, PF00076;, GO:0030054;GO:0005654;GO:0045296;GO:0003677;GO:0042802;GO:0003723;GO:0000380;GO:0006915;GO:0006376;GO:0000398;GO:0000381;, C:cell junction; C:nucleoplasm;, F:cadherin binding; F:DNA binding; F:identical protein binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:apoptotic process; P:mRNA splice site selection; P:mRNA splicing, via spliceosome; P:regulation of alternative mRNA splicing, via spliceosome; scaffold189 indexed_genome mRNA 31094 52390 . - . ID=transcript_15444;Q14160 Q6P496 Q7Z5D1 Q8WWV8 Q96C69 Q96GG1,Protein scribble homolog,Protein LAP4;, PF13855;PF00595;, GO:0005912;GO:0016323;GO:0030054;GO:0005911;GO:0070062;GO:0001772;GO:0030027;GO:0005654;GO:0005886;GO:0014069;GO:0098793;GO:0034750;GO:0045296;GO:0090630;GO:0060561;GO:0016477;GO:0008283;GO:0098609;GO:0035089;GO:0001768;GO:0045197;GO:0060603;GO:0030683;GO:0046007;GO:0045930;GO:0001843;GO:0098968;GO:0098887;GO:0030859;GO:0050918;GO:0043065;GO:0032729;GO:0001921;GO:0071896;GO:0043113;GO:0097120;GO:0039563;GO:0039564;, C:adherens junction; C:basolateral plasma membrane; C:cell junction; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:lamellipodium; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:presynapse; C:Scrib-APC-beta-catenin complex;, F:cadherin binding;, P:activation of GTPase activity; P:apoptotic process involved in morphogenesis; P:cell migration; P:cell population proliferation; P:cell-cell adhesion; P:establishment of apical/basal cell polarity; P:establishment of T cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:mammary gland duct morphogenesis; P:mitigation of host immune response by virus; P:negative regulation of activated T cell proliferation; P:negative regulation of mitotic cell cycle; P:neural tube closure; P:neurotransmitter receptor transport postsynaptic membrane to endosome; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:polarized epithelial cell differentiation; P:positive chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of interferon-gamma production; P:positive regulation of receptor recycling; P:protein localization to adherens junction; P:receptor clustering; P:receptor localization to synapse; P:suppression by virus of host STAT1 activity; P:suppression by virus of host STAT2 activity;|Q14160 Q6P496 Q7Z5D1 Q8WWV8 Q96C69 Q96GG1,Protein scribble homolog,Protein LAP4;, PF13855;PF00595;, GO:0005912;GO:0016323;GO:0030054;GO:0005911;GO:0070062;GO:0001772;GO:0030027;GO:0005654;GO:0005886;GO:0014069;GO:0098793;GO:0034750;GO:0045296;GO:0090630;GO:0060561;GO:0016477;GO:0008283;GO:0098609;GO:0035089;GO:0001768;GO:0045197;GO:0060603;GO:0030683;GO:0046007;GO:0045930;GO:0001843;GO:0098968;GO:0098887;GO:0030859;GO:0050918;GO:0043065;GO:0032729;GO:0001921;GO:0071896;GO:0043113;GO:0097120;GO:0039563;GO:0039564;, C:adherens junction; C:basolateral plasma membrane; C:cell junction; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:lamellipodium; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:presynapse; C:Scrib-APC-beta-catenin complex;, F:cadherin binding;, P:activation of GTPase activity; P:apoptotic process involved in morphogenesis; P:cell migration; P:cell population proliferation; P:cell-cell adhesion; P:establishment of apical/basal cell polarity; P:establishment of T cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:mammary gland duct morphogenesis; P:mitigation of host immune response by virus; P:negative regulation of activated T cell proliferation; P:negative regulation of mitotic cell cycle; P:neural tube closure; P:neurotransmitter receptor transport postsynaptic membrane to endosome; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:polarized epithelial cell differentiation; P:positive chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of interferon-gamma production; P:positive regulation of receptor recycling; P:protein localization to adherens junction; P:receptor clustering; P:receptor localization to synapse; P:suppression by virus of host STAT1 activity; P:suppression by virus of host STAT2 activity;|Q14160 Q6P496 Q7Z5D1 Q8WWV8 Q96C69 Q96GG1,Protein scribble homolog,Protein LAP4;, PF13855;PF00595;, GO:0005912;GO:0016323;GO:0030054;GO:0005911;GO:0070062;GO:0001772;GO:0030027;GO:0005654;GO:0005886;GO:0014069;GO:0098793;GO:0034750;GO:0045296;GO:0090630;GO:0060561;GO:0016477;GO:0008283;GO:0098609;GO:0035089;GO:0001768;GO:0045197;GO:0060603;GO:0030683;GO:0046007;GO:0045930;GO:0001843;GO:0098968;GO:0098887;GO:0030859;GO:0050918;GO:0043065;GO:0032729;GO:0001921;GO:0071896;GO:0043113;GO:0097120;GO:0039563;GO:0039564;, C:adherens junction; C:basolateral plasma membrane; C:cell junction; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:lamellipodium; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:presynapse; C:Scrib-APC-beta-catenin complex;, F:cadherin binding;, P:activation of GTPase activity; P:apoptotic process involved in morphogenesis; P:cell migration; P:cell population proliferation; P:cell-cell adhesion; P:establishment of apical/basal cell polarity; P:establishment of T cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:mammary gland duct morphogenesis; P:mitigation of host immune response by virus; P:negative regulation of activated T cell proliferation; P:negative regulation of mitotic cell cycle; P:neural tube closure; P:neurotransmitter receptor transport postsynaptic membrane to endosome; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:polarized epithelial cell differentiation; P:positive chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of interferon-gamma production; P:positive regulation of receptor recycling; P:protein localization to adherens junction; P:receptor clustering; P:receptor localization to synapse; P:suppression by virus of host STAT1 activity; P:suppression by virus of host STAT2 activity;|Q14160 Q6P496 Q7Z5D1 Q8WWV8 Q96C69 Q96GG1,Protein scribble homolog,Protein LAP4;, PF13855;PF00595;, GO:0005912;GO:0016323;GO:0030054;GO:0005911;GO:0070062;GO:0001772;GO:0030027;GO:0005654;GO:0005886;GO:0014069;GO:0098793;GO:0034750;GO:0045296;GO:0090630;GO:0060561;GO:0016477;GO:0008283;GO:0098609;GO:0035089;GO:0001768;GO:0045197;GO:0060603;GO:0030683;GO:0046007;GO:0045930;GO:0001843;GO:0098968;GO:0098887;GO:0030859;GO:0050918;GO:0043065;GO:0032729;GO:0001921;GO:0071896;GO:0043113;GO:0097120;GO:0039563;GO:0039564;, C:adherens junction; C:basolateral plasma membrane; C:cell junction; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:lamellipodium; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:presynapse; C:Scrib-APC-beta-catenin complex;, F:cadherin binding;, P:activation of GTPase activity; P:apoptotic process involved in morphogenesis; P:cell migration; P:cell population proliferation; P:cell-cell adhesion; P:establishment of apical/basal cell polarity; P:establishment of T cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:mammary gland duct morphogenesis; P:mitigation of host immune response by virus; P:negative regulation of activated T cell proliferation; P:negative regulation of mitotic cell cycle; P:neural tube closure; P:neurotransmitter receptor transport postsynaptic membrane to endosome; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:polarized epithelial cell differentiation; P:positive chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of interferon-gamma production; P:positive regulation of receptor recycling; P:protein localization to adherens junction; P:receptor clustering; P:receptor localization to synapse; P:suppression by virus of host STAT1 activity; P:suppression by virus of host STAT2 activity;|Q14160 Q6P496 Q7Z5D1 Q8WWV8 Q96C69 Q96GG1,Protein scribble homolog,Protein LAP4;, PF13855;PF00595;, GO:0005912;GO:0016323;GO:0030054;GO:0005911;GO:0070062;GO:0001772;GO:0030027;GO:0005654;GO:0005886;GO:0014069;GO:0098793;GO:0034750;GO:0045296;GO:0090630;GO:0060561;GO:0016477;GO:0008283;GO:0098609;GO:0035089;GO:0001768;GO:0045197;GO:0060603;GO:0030683;GO:0046007;GO:0045930;GO:0001843;GO:0098968;GO:0098887;GO:0030859;GO:0050918;GO:0043065;GO:0032729;GO:0001921;GO:0071896;GO:0043113;GO:0097120;GO:0039563;GO:0039564;, C:adherens junction; C:basolateral plasma membrane; C:cell junction; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:lamellipodium; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:presynapse; C:Scrib-APC-beta-catenin complex;, F:cadherin binding;, P:activation of GTPase activity; P:apoptotic process involved in morphogenesis; P:cell migration; P:cell population proliferation; P:cell-cell adhesion; P:establishment of apical/basal cell polarity; P:establishment of T cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:mammary gland duct morphogenesis; P:mitigation of host immune response by virus; P:negative regulation of activated T cell proliferation; P:negative regulation of mitotic cell cycle; P:neural tube closure; P:neurotransmitter receptor transport postsynaptic membrane to endosome; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:polarized epithelial cell differentiation; P:positive chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of interferon-gamma production; P:positive regulation of receptor recycling; P:protein localization to adherens junction; P:receptor clustering; P:receptor localization to synapse; P:suppression by virus of host STAT1 activity; P:suppression by virus of host STAT2 activity;|Q14160 Q6P496 Q7Z5D1 Q8WWV8 Q96C69 Q96GG1,Protein scribble homolog,Protein LAP4;, PF13855;PF00595;, GO:0005912;GO:0016323;GO:0030054;GO:0005911;GO:0070062;GO:0001772;GO:0030027;GO:0005654;GO:0005886;GO:0014069;GO:0098793;GO:0034750;GO:0045296;GO:0090630;GO:0060561;GO:0016477;GO:0008283;GO:0098609;GO:0035089;GO:0001768;GO:0045197;GO:0060603;GO:0030683;GO:0046007;GO:0045930;GO:0001843;GO:0098968;GO:0098887;GO:0030859;GO:0050918;GO:0043065;GO:0032729;GO:0001921;GO:0071896;GO:0043113;GO:0097120;GO:0039563;GO:0039564;, C:adherens junction; C:basolateral plasma membrane; C:cell junction; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:lamellipodium; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:presynapse; C:Scrib-APC-beta-catenin complex;, F:cadherin binding;, P:activation of GTPase activity; P:apoptotic process involved in morphogenesis; P:cell migration; P:cell population proliferation; P:cell-cell adhesion; P:establishment of apical/basal cell polarity; P:establishment of T cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:mammary gland duct morphogenesis; P:mitigation of host immune response by virus; P:negative regulation of activated T cell proliferation; P:negative regulation of mitotic cell cycle; P:neural tube closure; P:neurotransmitter receptor transport postsynaptic membrane to endosome; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:polarized epithelial cell differentiation; P:positive chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of interferon-gamma production; P:positive regulation of receptor recycling; P:protein localization to adherens junction; P:receptor clustering; P:receptor localization to synapse; P:suppression by virus of host STAT1 activity; P:suppression by virus of host STAT2 activity;|Q14160 Q6P496 Q7Z5D1 Q8WWV8 Q96C69 Q96GG1,Protein scribble homolog,Protein LAP4;, PF13855;PF00595;, GO:0005912;GO:0016323;GO:0030054;GO:0005911;GO:0070062;GO:0001772;GO:0030027;GO:0005654;GO:0005886;GO:0014069;GO:0098793;GO:0034750;GO:0045296;GO:0090630;GO:0060561;GO:0016477;GO:0008283;GO:0098609;GO:0035089;GO:0001768;GO:0045197;GO:0060603;GO:0030683;GO:0046007;GO:0045930;GO:0001843;GO:0098968;GO:0098887;GO:0030859;GO:0050918;GO:0043065;GO:0032729;GO:0001921;GO:0071896;GO:0043113;GO:0097120;GO:0039563;GO:0039564;, C:adherens junction; C:basolateral plasma membrane; C:cell junction; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:lamellipodium; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:presynapse; C:Scrib-APC-beta-catenin complex;, F:cadherin binding;, P:activation of GTPase activity; P:apoptotic process involved in morphogenesis; P:cell migration; P:cell population proliferation; P:cell-cell adhesion; P:establishment of apical/basal cell polarity; P:establishment of T cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:mammary gland duct morphogenesis; P:mitigation of host immune response by virus; P:negative regulation of activated T cell proliferation; P:negative regulation of mitotic cell cycle; P:neural tube closure; P:neurotransmitter receptor transport postsynaptic membrane to endosome; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:polarized epithelial cell differentiation; P:positive chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of interferon-gamma production; P:positive regulation of receptor recycling; P:protein localization to adherens junction; P:receptor clustering; P:receptor localization to synapse; P:suppression by virus of host STAT1 activity; P:suppression by virus of host STAT2 activity;|Q14160 Q6P496 Q7Z5D1 Q8WWV8 Q96C69 Q96GG1,Protein scribble homolog,Protein LAP4;, PF13855;PF00595;, GO:0005912;GO:0016323;GO:0030054;GO:0005911;GO:0070062;GO:0001772;GO:0030027;GO:0005654;GO:0005886;GO:0014069;GO:0098793;GO:0034750;GO:0045296;GO:0090630;GO:0060561;GO:0016477;GO:0008283;GO:0098609;GO:0035089;GO:0001768;GO:0045197;GO:0060603;GO:0030683;GO:0046007;GO:0045930;GO:0001843;GO:0098968;GO:0098887;GO:0030859;GO:0050918;GO:0043065;GO:0032729;GO:0001921;GO:0071896;GO:0043113;GO:0097120;GO:0039563;GO:0039564;, C:adherens junction; C:basolateral plasma membrane; C:cell junction; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:lamellipodium; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:presynapse; C:Scrib-APC-beta-catenin complex;, F:cadherin binding;, P:activation of GTPase activity; P:apoptotic process involved in morphogenesis; P:cell migration; P:cell population proliferation; P:cell-cell adhesion; P:establishment of apical/basal cell polarity; P:establishment of T cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:mammary gland duct morphogenesis; P:mitigation of host immune response by virus; P:negative regulation of activated T cell proliferation; P:negative regulation of mitotic cell cycle; P:neural tube closure; P:neurotransmitter receptor transport postsynaptic membrane to endosome; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:polarized epithelial cell differentiation; P:positive chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of interferon-gamma production; P:positive regulation of receptor recycling; P:protein localization to adherens junction; P:receptor clustering; P:receptor localization to synapse; P:suppression by virus of host STAT1 activity; P:suppression by virus of host STAT2 activity;|Q14160 Q6P496 Q7Z5D1 Q8WWV8 Q96C69 Q96GG1,Protein scribble homolog,Protein LAP4;, PF13855;PF00595;, GO:0005912;GO:0016323;GO:0030054;GO:0005911;GO:0070062;GO:0001772;GO:0030027;GO:0005654;GO:0005886;GO:0014069;GO:0098793;GO:0034750;GO:0045296;GO:0090630;GO:0060561;GO:0016477;GO:0008283;GO:0098609;GO:0035089;GO:0001768;GO:0045197;GO:0060603;GO:0030683;GO:0046007;GO:0045930;GO:0001843;GO:0098968;GO:0098887;GO:0030859;GO:0050918;GO:0043065;GO:0032729;GO:0001921;GO:0071896;GO:0043113;GO:0097120;GO:0039563;GO:0039564;, C:adherens junction; C:basolateral plasma membrane; C:cell junction; C:cell-cell junction; C:extracellular exosome; C:immunological synapse; C:lamellipodium; C:nucleoplasm; C:plasma membrane; C:postsynaptic density; C:presynapse; C:Scrib-APC-beta-catenin complex;, F:cadherin binding;, P:activation of GTPase activity; P:apoptotic process involved in morphogenesis; P:cell migration; P:cell population proliferation; P:cell-cell adhesion; P:establishment of apical/basal cell polarity; P:establishment of T cell polarity; P:establishment or maintenance of epithelial cell apical/basal polarity; P:mammary gland duct morphogenesis; P:mitigation of host immune response by virus; P:negative regulation of activated T cell proliferation; P:negative regulation of mitotic cell cycle; P:neural tube closure; P:neurotransmitter receptor transport postsynaptic membrane to endosome; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:polarized epithelial cell differentiation; P:positive chemotaxis; P:positive regulation of apoptotic process; P:positive regulation of interferon-gamma production; P:positive regulation of receptor recycling; P:protein localization to adherens junction; P:receptor clustering; P:receptor localization to synapse; P:suppression by virus of host STAT1 activity; P:suppression by virus of host STAT2 activity;|A8MXQ7 A0A1B0GTG1,IQ motif and ankyrin repeat domain-containing protein 1 {ECO:0000305},, , GO:0005737;GO:0005634;GO:2000812;, C:cytoplasm; C:nucleus;, , P:regulation of barbed-end actin filament capping;|A8MXQ7 A0A1B0GTG1,IQ motif and ankyrin repeat domain-containing protein 1 {ECO:0000305},, , GO:0005737;GO:0005634;GO:2000812;, C:cytoplasm; C:nucleus;, , P:regulation of barbed-end actin filament capping; scaffold189 indexed_genome mRNA 57056 58387 . - . ID=transcript_15445;A8MXQ7 A0A1B0GTG1,IQ motif and ankyrin repeat domain-containing protein 1 {ECO:0000305},, , GO:0005737;GO:0005634;GO:2000812;, C:cytoplasm; C:nucleus;, , P:regulation of barbed-end actin filament capping; scaffold189 indexed_genome mRNA 77317 82992 . - . ID=transcript_15446;Q6ZRV2 A0JLS2 Q8N4W0,Protein FAM83H {ECO:0000305},, PF07894;, GO:0005737;GO:0005856;GO:1990254;GO:0019901;GO:0031214;GO:0045104;GO:0030335;GO:0044380;GO:0007165;, C:cytoplasm; C:cytoskeleton;, F:keratin filament binding; F:protein kinase binding;, P:biomineral tissue development; P:intermediate filament cytoskeleton organization; P:positive regulation of cell migration; P:protein localization to cytoskeleton; P:signal transduction; scaffold189 indexed_genome mRNA 84871 87130 . - . ID=transcript_15447;Q8TD08 Q2TCF9 Q8N362,Mitogen-activated protein kinase 15 {ECO:0000305},Extracellular signal-regulated kinase 7;Extracellular signal-regulated kinase 8;, PF00069;, GO:0005776;GO:0005923;GO:0005911;GO:0005814;GO:0036064;GO:0005737;GO:0031410;GO:0005576;GO:0005794;GO:0072687;GO:0005634;GO:0005524;GO:0003682;GO:0016301;GO:0004707;GO:0004672;GO:0106310;GO:0106311;GO:0017124;GO:0006974;GO:0090494;GO:0007029;GO:0035556;GO:0030336;GO:0008284;GO:1905188;GO:1905832;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:1904491;GO:0010506;GO:1902017;GO:0003400;GO:0010468;, C:autophagosome; C:bicellular tight junction; C:cell-cell junction; C:centriole; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:extracellular region; C:Golgi apparatus; C:meiotic spindle; C:nucleus;, F:ATP binding; F:chromatin binding; F:kinase activity; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:SH3 domain binding;, P:cellular response to DNA damage stimulus; P:dopamine uptake; P:endoplasmic reticulum organization; P:intracellular signal transduction; P:negative regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of metaphase/anaphase transition of meiosis I; P:positive regulation of spindle assembly; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to ciliary transition zone; P:regulation of autophagy; P:regulation of cilium assembly; P:regulation of COPII vesicle coating; P:regulation of gene expression; scaffold189 indexed_genome mRNA 87458 88127 . - . ID=transcript_15448;Q8TD08 Q2TCF9 Q8N362,Mitogen-activated protein kinase 15 {ECO:0000305},Extracellular signal-regulated kinase 7;Extracellular signal-regulated kinase 8;, PF00069;, GO:0005776;GO:0005923;GO:0005911;GO:0005814;GO:0036064;GO:0005737;GO:0031410;GO:0005576;GO:0005794;GO:0072687;GO:0005634;GO:0005524;GO:0003682;GO:0016301;GO:0004707;GO:0004672;GO:0106310;GO:0106311;GO:0017124;GO:0006974;GO:0090494;GO:0007029;GO:0035556;GO:0030336;GO:0008284;GO:1905188;GO:1905832;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:1904491;GO:0010506;GO:1902017;GO:0003400;GO:0010468;, C:autophagosome; C:bicellular tight junction; C:cell-cell junction; C:centriole; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:extracellular region; C:Golgi apparatus; C:meiotic spindle; C:nucleus;, F:ATP binding; F:chromatin binding; F:kinase activity; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:SH3 domain binding;, P:cellular response to DNA damage stimulus; P:dopamine uptake; P:endoplasmic reticulum organization; P:intracellular signal transduction; P:negative regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of metaphase/anaphase transition of meiosis I; P:positive regulation of spindle assembly; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to ciliary transition zone; P:regulation of autophagy; P:regulation of cilium assembly; P:regulation of COPII vesicle coating; P:regulation of gene expression; scaffold189 indexed_genome mRNA 88136 90648 . - . ID=transcript_15449;Q8TD08 Q2TCF9 Q8N362,Mitogen-activated protein kinase 15 {ECO:0000305},Extracellular signal-regulated kinase 7;Extracellular signal-regulated kinase 8;, PF00069;, GO:0005776;GO:0005923;GO:0005911;GO:0005814;GO:0036064;GO:0005737;GO:0031410;GO:0005576;GO:0005794;GO:0072687;GO:0005634;GO:0005524;GO:0003682;GO:0016301;GO:0004707;GO:0004672;GO:0106310;GO:0106311;GO:0017124;GO:0006974;GO:0090494;GO:0007029;GO:0035556;GO:0030336;GO:0008284;GO:1905188;GO:1905832;GO:0051973;GO:1904355;GO:0032212;GO:0046777;GO:1904491;GO:0010506;GO:1902017;GO:0003400;GO:0010468;, C:autophagosome; C:bicellular tight junction; C:cell-cell junction; C:centriole; C:ciliary basal body; C:cytoplasm; C:cytoplasmic vesicle; C:extracellular region; C:Golgi apparatus; C:meiotic spindle; C:nucleus;, F:ATP binding; F:chromatin binding; F:kinase activity; F:MAP kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:SH3 domain binding;, P:cellular response to DNA damage stimulus; P:dopamine uptake; P:endoplasmic reticulum organization; P:intracellular signal transduction; P:negative regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of metaphase/anaphase transition of meiosis I; P:positive regulation of spindle assembly; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:protein autophosphorylation; P:protein localization to ciliary transition zone; P:regulation of autophagy; P:regulation of cilium assembly; P:regulation of COPII vesicle coating; P:regulation of gene expression; scaffold189 indexed_genome mRNA 115311 126362 . - . ID=transcript_15450;O75123 A4FU80 B4DGP3 E7ENV5,Zinc finger protein 623,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold189 indexed_genome mRNA 132504 138615 . + . ID=transcript_15451;O75820 O75802 Q5T7D7 Q5T7D8 Q5T7D9 Q9UBL4 Q9UPE9 Q9UPF0 Q9UPF1,Zinc finger protein 189,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold189 indexed_genome mRNA 139868 152875 . + . ID=transcript_15452;Q13630 B2R8Y7 D3DWK5 Q567Q9 Q9UDG7,GDP-L-fucose synthase {ECO:0000305},GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase;Protein FX;Red cell NADP(H)-binding protein;Short-chain dehydrogenase/reductase family 4E member 1;, PF01370;, GO:0005829;GO:0070062;GO:0009055;GO:0042356;GO:0050577;GO:0047918;GO:0042802;GO:0042351;GO:0019673;GO:0007159;GO:0010595;GO:1904906;, C:cytosol; C:extracellular exosome;, F:electron transfer activity; F:GDP-4-dehydro-D-rhamnose reductase activity; F:GDP-L-fucose synthase activity; F:GDP-mannose 3,5-epimerase activity; F:identical protein binding;, P:'de novo' GDP-L-fucose biosynthetic process; P:GDP-mannose metabolic process; P:leukocyte cell-cell adhesion; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell-matrix adhesion via fibronectin;|Q13630 B2R8Y7 D3DWK5 Q567Q9 Q9UDG7,GDP-L-fucose synthase {ECO:0000305},GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase;Protein FX;Red cell NADP(H)-binding protein;Short-chain dehydrogenase/reductase family 4E member 1;, PF01370;, GO:0005829;GO:0070062;GO:0009055;GO:0042356;GO:0050577;GO:0047918;GO:0042802;GO:0042351;GO:0019673;GO:0007159;GO:0010595;GO:1904906;, C:cytosol; C:extracellular exosome;, F:electron transfer activity; F:GDP-4-dehydro-D-rhamnose reductase activity; F:GDP-L-fucose synthase activity; F:GDP-mannose 3,5-epimerase activity; F:identical protein binding;, P:'de novo' GDP-L-fucose biosynthetic process; P:GDP-mannose metabolic process; P:leukocyte cell-cell adhesion; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell-matrix adhesion via fibronectin;|Q13630 B2R8Y7 D3DWK5 Q567Q9 Q9UDG7,GDP-L-fucose synthase {ECO:0000305},GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase;Protein FX;Red cell NADP(H)-binding protein;Short-chain dehydrogenase/reductase family 4E member 1;, PF01370;, GO:0005829;GO:0070062;GO:0009055;GO:0042356;GO:0050577;GO:0047918;GO:0042802;GO:0042351;GO:0019673;GO:0007159;GO:0010595;GO:1904906;, C:cytosol; C:extracellular exosome;, F:electron transfer activity; F:GDP-4-dehydro-D-rhamnose reductase activity; F:GDP-L-fucose synthase activity; F:GDP-mannose 3,5-epimerase activity; F:identical protein binding;, P:'de novo' GDP-L-fucose biosynthetic process; P:GDP-mannose metabolic process; P:leukocyte cell-cell adhesion; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell-matrix adhesion via fibronectin;|Q13630 B2R8Y7 D3DWK5 Q567Q9 Q9UDG7,GDP-L-fucose synthase {ECO:0000305},GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase;Protein FX;Red cell NADP(H)-binding protein;Short-chain dehydrogenase/reductase family 4E member 1;, PF01370;, GO:0005829;GO:0070062;GO:0009055;GO:0042356;GO:0050577;GO:0047918;GO:0042802;GO:0042351;GO:0019673;GO:0007159;GO:0010595;GO:1904906;, C:cytosol; C:extracellular exosome;, F:electron transfer activity; F:GDP-4-dehydro-D-rhamnose reductase activity; F:GDP-L-fucose synthase activity; F:GDP-mannose 3,5-epimerase activity; F:identical protein binding;, P:'de novo' GDP-L-fucose biosynthetic process; P:GDP-mannose metabolic process; P:leukocyte cell-cell adhesion; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell-matrix adhesion via fibronectin;|Q13630 B2R8Y7 D3DWK5 Q567Q9 Q9UDG7,GDP-L-fucose synthase {ECO:0000305},GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase;Protein FX;Red cell NADP(H)-binding protein;Short-chain dehydrogenase/reductase family 4E member 1;, PF01370;, GO:0005829;GO:0070062;GO:0009055;GO:0042356;GO:0050577;GO:0047918;GO:0042802;GO:0042351;GO:0019673;GO:0007159;GO:0010595;GO:1904906;, C:cytosol; C:extracellular exosome;, F:electron transfer activity; F:GDP-4-dehydro-D-rhamnose reductase activity; F:GDP-L-fucose synthase activity; F:GDP-mannose 3,5-epimerase activity; F:identical protein binding;, P:'de novo' GDP-L-fucose biosynthetic process; P:GDP-mannose metabolic process; P:leukocyte cell-cell adhesion; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell-matrix adhesion via fibronectin;|Q96QD5 G5E941 Q8N602 Q8NCU9 Q9UGK5,DEP domain-containing protein 7,Protein TR2/D15;, PF00610;, GO:0005829;GO:0035556;GO:0051056;, C:cytosol;, , P:intracellular signal transduction; P:regulation of small GTPase mediated signal transduction;|Q53H96 B3KMB5 B4DVT6 H0Y6C3 Q8N3N9 Q96HX4 Q9H896,Pyrroline-5-carboxylate reductase 3 {ECO:0000312|HGNC:HGNC:25846},Pyrroline-5-carboxylate reductase-like protein;, PF03807;PF14748;, GO:0005829;GO:0045171;GO:0072686;GO:0004735;GO:0009064;GO:0055129;, C:cytosol; C:intercellular bridge; C:mitotic spindle;, F:pyrroline-5-carboxylate reductase activity;, P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process;|Q53H96 B3KMB5 B4DVT6 H0Y6C3 Q8N3N9 Q96HX4 Q9H896,Pyrroline-5-carboxylate reductase 3 {ECO:0000312|HGNC:HGNC:25846},Pyrroline-5-carboxylate reductase-like protein;, PF03807;PF14748;, GO:0005829;GO:0045171;GO:0072686;GO:0004735;GO:0009064;GO:0055129;, C:cytosol; C:intercellular bridge; C:mitotic spindle;, F:pyrroline-5-carboxylate reductase activity;, P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process;|Q53H96 B3KMB5 B4DVT6 H0Y6C3 Q8N3N9 Q96HX4 Q9H896,Pyrroline-5-carboxylate reductase 3 {ECO:0000312|HGNC:HGNC:25846},Pyrroline-5-carboxylate reductase-like protein;, PF03807;PF14748;, GO:0005829;GO:0045171;GO:0072686;GO:0004735;GO:0009064;GO:0055129;, C:cytosol; C:intercellular bridge; C:mitotic spindle;, F:pyrroline-5-carboxylate reductase activity;, P:glutamine family amino acid metabolic process; P:L-proline biosynthetic process; scaffold189 indexed_genome mRNA 160903 168289 . - . ID=transcript_15453;P29692 B4DDU4 D3DWK3 E9PBQ9 Q4VBZ6 Q969J1 Q96I38,Elongation factor 1-delta,Antigen NY-CO-4;, PF10587;PF00736;, GO:0005737;GO:0005829;GO:0005853;GO:0001650;GO:0005654;GO:0005634;GO:0033613;GO:0045296;GO:0003677;GO:0005085;GO:0031072;GO:0003746;GO:0008135;GO:0071479;GO:0009299;GO:0043123;GO:0010941;GO:0006414;, C:cytoplasm; C:cytosol; C:eukaryotic translation elongation factor 1 complex; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:cadherin binding; F:DNA binding; F:guanyl-nucleotide exchange factor activity; F:heat shock protein binding; F:translation elongation factor activity; F:translation factor activity, RNA binding;, P:cellular response to ionizing radiation; P:mRNA transcription; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of cell death; P:translational elongation;|P29692 B4DDU4 D3DWK3 E9PBQ9 Q4VBZ6 Q969J1 Q96I38,Elongation factor 1-delta,Antigen NY-CO-4;, PF10587;PF00736;, GO:0005737;GO:0005829;GO:0005853;GO:0001650;GO:0005654;GO:0005634;GO:0033613;GO:0045296;GO:0003677;GO:0005085;GO:0031072;GO:0003746;GO:0008135;GO:0071479;GO:0009299;GO:0043123;GO:0010941;GO:0006414;, C:cytoplasm; C:cytosol; C:eukaryotic translation elongation factor 1 complex; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:cadherin binding; F:DNA binding; F:guanyl-nucleotide exchange factor activity; F:heat shock protein binding; F:translation elongation factor activity; F:translation factor activity, RNA binding;, P:cellular response to ionizing radiation; P:mRNA transcription; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of cell death; P:translational elongation; scaffold189 indexed_genome mRNA 168301 169523 . + . ID=transcript_15454;P29692 B4DDU4 D3DWK3 E9PBQ9 Q4VBZ6 Q969J1 Q96I38,Elongation factor 1-delta,Antigen NY-CO-4;, PF10587;PF00736;, GO:0005737;GO:0005829;GO:0005853;GO:0001650;GO:0005654;GO:0005634;GO:0033613;GO:0045296;GO:0003677;GO:0005085;GO:0031072;GO:0003746;GO:0008135;GO:0071479;GO:0009299;GO:0043123;GO:0010941;GO:0006414;, C:cytoplasm; C:cytosol; C:eukaryotic translation elongation factor 1 complex; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:activating transcription factor binding; F:cadherin binding; F:DNA binding; F:guanyl-nucleotide exchange factor activity; F:heat shock protein binding; F:translation elongation factor activity; F:translation factor activity, RNA binding;, P:cellular response to ionizing radiation; P:mRNA transcription; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of cell death; P:translational elongation; scaffold189 indexed_genome mRNA 171490 182012 . + . ID=transcript_15455;A6NGR9 A8MWB1,Maestro heat-like repeat-containing protein family member 6|Q6XQN6 A7BFI3 Q6PJL1 Q6XQN4 Q6XQN5 Q8N5E8 Q9BRG0,Nicotinate phosphoribosyltransferase,FHA-HIT-interacting protein;Nicotinate phosphoribosyltransferase domain-containing protein 1;, PF17956;PF17767;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0046872;GO:0004516;GO:0004514;GO:0034356;GO:0034355;GO:0043312;GO:0006979;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region;, F:metal ion binding; F:nicotinate phosphoribosyltransferase activity; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity;, P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:NAD salvage; P:neutrophil degranulation; P:response to oxidative stress; scaffold189 indexed_genome mRNA 184990 189711 . - . ID=transcript_15456;P57764 A8K702 D3DWJ9 Q96Q98,Gasdermin-D {ECO:0000303|PubMed:26375259},Gasdermin domain-containing protein 1 {ECO:0000303|PubMed:15289881};, PF04598;PF17708;, GO:0005829;GO:0005576;GO:0005615;GO:1904813;GO:0016021;GO:0072559;GO:0005654;GO:0005886;GO:0035580;GO:1904724;GO:1901612;GO:0070300;GO:0005546;GO:0070273;GO:0001786;GO:0022829;GO:0042742;GO:0050829;GO:0050830;GO:0006954;GO:0045087;GO:0043312;GO:0046931;GO:0035915;GO:0032731;GO:0051260;GO:0070269;, C:cytosol; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:integral component of membrane; C:NLRP3 inflammasome complex; C:nucleoplasm; C:plasma membrane; C:specific granule lumen; C:tertiary granule lumen;, F:cardiolipin binding; F:phosphatidic acid binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:wide pore channel activity;, P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:inflammatory response; P:innate immune response; P:neutrophil degranulation; P:pore complex assembly; P:pore formation in membrane of other organism; P:positive regulation of interleukin-1 beta production; P:protein homooligomerization; P:pyroptosis; scaffold189 indexed_genome mRNA 197778 247968 . + . ID=transcript_15457;Q8IXZ2 Q14163 Q8N4E2 Q9BUS4,Zinc finger CCCH domain-containing protein 3,Smad-interacting CPSF-like factor {ECO:0000250|UniProtKB:Q8CHP0};, PF00642;, GO:0005847;GO:0005634;GO:0003677;GO:0046872;GO:0070412;GO:0031124;GO:0051028;GO:0032927;GO:1900363;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleus;, F:DNA binding; F:metal ion binding; F:R-SMAD binding;, P:mRNA 3'-end processing; P:mRNA transport; P:positive regulation of activin receptor signaling pathway; P:regulation of mRNA polyadenylation; scaffold189 indexed_genome mRNA 254984 259612 . - . ID=transcript_15458;Q8IXZ2 Q14163 Q8N4E2 Q9BUS4,Zinc finger CCCH domain-containing protein 3,Smad-interacting CPSF-like factor {ECO:0000250|UniProtKB:Q8CHP0};, PF00642;, GO:0005847;GO:0005634;GO:0003677;GO:0046872;GO:0070412;GO:0031124;GO:0051028;GO:0032927;GO:1900363;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleus;, F:DNA binding; F:metal ion binding; F:R-SMAD binding;, P:mRNA 3'-end processing; P:mRNA transport; P:positive regulation of activin receptor signaling pathway; P:regulation of mRNA polyadenylation;|Q8IXZ2 Q14163 Q8N4E2 Q9BUS4,Zinc finger CCCH domain-containing protein 3,Smad-interacting CPSF-like factor {ECO:0000250|UniProtKB:Q8CHP0};, PF00642;, GO:0005847;GO:0005634;GO:0003677;GO:0046872;GO:0070412;GO:0031124;GO:0051028;GO:0032927;GO:1900363;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleus;, F:DNA binding; F:metal ion binding; F:R-SMAD binding;, P:mRNA 3'-end processing; P:mRNA transport; P:positive regulation of activin receptor signaling pathway; P:regulation of mRNA polyadenylation;|Q8IXZ2 Q14163 Q8N4E2 Q9BUS4,Zinc finger CCCH domain-containing protein 3,Smad-interacting CPSF-like factor {ECO:0000250|UniProtKB:Q8CHP0};, PF00642;, GO:0005847;GO:0005634;GO:0003677;GO:0046872;GO:0070412;GO:0031124;GO:0051028;GO:0032927;GO:1900363;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleus;, F:DNA binding; F:metal ion binding; F:R-SMAD binding;, P:mRNA 3'-end processing; P:mRNA transport; P:positive regulation of activin receptor signaling pathway; P:regulation of mRNA polyadenylation;|Q8IXZ2 Q14163 Q8N4E2 Q9BUS4,Zinc finger CCCH domain-containing protein 3,Smad-interacting CPSF-like factor {ECO:0000250|UniProtKB:Q8CHP0};, PF00642;, GO:0005847;GO:0005634;GO:0003677;GO:0046872;GO:0070412;GO:0031124;GO:0051028;GO:0032927;GO:1900363;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleus;, F:DNA binding; F:metal ion binding; F:R-SMAD binding;, P:mRNA 3'-end processing; P:mRNA transport; P:positive regulation of activin receptor signaling pathway; P:regulation of mRNA polyadenylation; scaffold189 indexed_genome mRNA 313172 322301 . - . ID=transcript_15459;Q8TCX5 Q8TAV1 Q96PV9,Rhophilin-1 {ECO:0000305},GTP-Rho-binding protein 1;, PF03097;PF02185;PF00595;, GO:0005829;GO:0007165;, C:cytosol;, , P:signal transduction;|Q8TCX5 Q8TAV1 Q96PV9,Rhophilin-1 {ECO:0000305},GTP-Rho-binding protein 1;, PF03097;PF02185;PF00595;, GO:0005829;GO:0007165;, C:cytosol;, , P:signal transduction; scaffold189 indexed_genome mRNA 342874 345701 . + . ID=transcript_15460;Q9H7X3 A0AVE2,Zinc finger protein 696,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold189 indexed_genome mRNA 357301 383740 . + . ID=transcript_15461;P10075 Q96CK9,Zinc finger protein GLI4,Krueppel-related zinc finger protein 4;Protein HKR4;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated;|Q8IV16 Q6P3T2 Q86W15,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,High density lipoprotein-binding protein 1;, PF00021;, GO:0031362;GO:0031225;GO:0016324;GO:0016323;GO:0009897;GO:0005576;GO:0005886;GO:0035478;GO:0035473;GO:0008289;GO:0071813;GO:0140318;GO:0042632;GO:0034371;GO:0006886;GO:0090321;GO:0051006;GO:0017038;GO:0034394;GO:0050821;GO:0051004;GO:0071503;GO:0001523;GO:0045056;GO:0070328;, C:anchored component of external side of plasma membrane; C:anchored component of membrane; C:apical plasma membrane; C:basolateral plasma membrane; C:external side of plasma membrane; C:extracellular region; C:plasma membrane;, F:chylomicron binding; F:lipase binding; F:lipid binding; F:lipoprotein particle binding; F:protein transporter activity;, P:cholesterol homeostasis; P:chylomicron remodeling; P:intracellular protein transport; P:positive regulation of chylomicron remnant clearance; P:positive regulation of lipoprotein lipase activity; P:protein import; P:protein localization to cell surface; P:protein stabilization; P:regulation of lipoprotein lipase activity; P:response to heparin; P:retinoid metabolic process; P:transcytosis; P:triglyceride homeostasis;|Q8N8Y5 D3DWJ5,Zinc finger protein 41 homolog,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0030154;GO:0007275;GO:0006357;GO:0007283;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:multicellular organism development; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold189 indexed_genome mRNA 397004 398129 . + . ID=transcript_15462;Q59H93 Q75RX9 Q75RY0 Q86UR3 Q8IZC9 Q96J69,Sodium channel protein type 5 subunit alpha,Sodium channel protein cardiac muscle subunit alpha;Sodium channel protein type V subunit alpha;Voltage-gated sodium channel subunit alpha Nav1.5;hH1 {ECO:0000303|PubMed:1309946};, PF00520;PF06512;PF11933;, GO:0005901;GO:0009986;GO:0005783;GO:0016021;GO:0014704;GO:0016328;GO:0005730;GO:0005654;GO:0048471;GO:0005886;GO:0042383;GO:0030315;GO:0001518;GO:0030018;GO:0030506;GO:0005516;GO:0019899;GO:0017134;GO:0044325;GO:0050998;GO:0019904;GO:0019901;GO:0097110;GO:0031625;GO:0005244;GO:0005248;GO:0086060;GO:0086061;GO:0086006;GO:0086062;GO:0086063;GO:0086014;GO:0086016;GO:0086067;GO:0003360;GO:0086043;GO:0061337;GO:0086002;GO:0060048;GO:0003231;GO:0071277;GO:0021549;GO:0051899;GO:0086010;GO:0098912;GO:0086045;GO:0086048;GO:0086012;GO:0086047;GO:0086046;GO:0019228;GO:0042475;GO:0045760;GO:0050679;GO:0010765;GO:0060371;GO:0060372;GO:0086004;GO:0002027;GO:0086091;GO:1902305;GO:0060373;GO:0060307;GO:0014894;GO:0086015;GO:0035725;GO:0006814;GO:0021537;GO:0086005;, C:caveola; C:cell surface; C:endoplasmic reticulum; C:integral component of membrane; C:intercalated disc; C:lateral plasma membrane; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:T-tubule; C:voltage-gated sodium channel complex; C:Z disc;, F:ankyrin binding; F:calmodulin binding; F:enzyme binding; F:fibroblast growth factor binding; F:ion channel binding; F:nitric-oxide synthase binding; F:protein domain specific binding; F:protein kinase binding; F:scaffold protein binding; F:ubiquitin protein ligase binding; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity; F:voltage-gated sodium channel activity involved in AV node cell action potential; F:voltage-gated sodium channel activity involved in bundle of His cell action potential; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; F:voltage-gated sodium channel activity involved in Purkinje myocyte action potential; F:voltage-gated sodium channel activity involved in SA node cell action potential;, P:atrial cardiac muscle cell action potential; P:AV node cell action potential; P:AV node cell to bundle of His cell communication; P:brainstem development; P:bundle of His cell action potential; P:cardiac conduction; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:cardiac ventricle development; P:cellular response to calcium ion; P:cerebellum development; P:membrane depolarization; P:membrane depolarization during action potential; P:membrane depolarization during atrial cardiac muscle cell action potential; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during bundle of His cell action potential; P:membrane depolarization during cardiac muscle cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:membrane depolarization during SA node cell action potential; P:neuronal action potential; P:odontogenesis of dentin-containing tooth; P:positive regulation of action potential; P:positive regulation of epithelial cell proliferation; P:positive regulation of sodium ion transport; P:regulation of atrial cardiac muscle cell membrane depolarization; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of cardiac muscle cell contraction; P:regulation of heart rate; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transport; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:response to denervation involved in regulation of muscle adaptation; P:SA node cell action potential; P:sodium ion transmembrane transport; P:sodium ion transport; P:telencephalon development; P:ventricular cardiac muscle cell action potential; scaffold189 indexed_genome mRNA 423227 426626 . - . ID=transcript_15463;H3BQJ8,Lymphocyte antigen 6L {ECO:0000305},Lymphocyte antigen 6 complex locus protein L {ECO:0000312|HGNC:HGNC:52284};, PF00021;, GO:0031225;GO:0005886;, C:anchored component of membrane; C:plasma membrane; scaffold189 indexed_genome mRNA 433942 434538 . - . ID=transcript_15464;P10266 P87890 Q14273,Endogenous retrovirus group K member 10 Pol protein,HERV-K10 Pol protein;HERV-K107 Pol protein;HERV-K_5q33.3 provirus ancestral Pol protein;, PF13804;PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold189 indexed_genome mRNA 435553 436197 . + . ID=transcript_15465;Q9BXR3 Q6KH04 Q9BXR4 Q9UKH5 Q9UP31 Q9WIK9 Q9WJR4,Endogenous retrovirus group K member 6 Pol protein,HERV-K(C7) Pol protein;HERV-K(HML-2.HOM) Pol protein;HERV-K108 Pol protein;HERV-K_7p22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold189 indexed_genome mRNA 436824 439687 . - . ID=transcript_15466;P61570,Endogenous retrovirus group K member 25 Env polyprotein,Envelope polyprotein;HERV-K_11q22.1 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity; scaffold189 indexed_genome mRNA 458736 459274 . - . ID=transcript_15467;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold189 indexed_genome mRNA 470374 472785 . - . ID=transcript_15468;Q16553 B2R4X5 D3DWJ2 Q0VDE5,Lymphocyte antigen 6E {ECO:0000305},Retinoic acid-induced gene E protein;Stem cell antigen 2;Thymic shared antigen 1;, PF00021;, GO:0031225;GO:0005576;GO:0005886;GO:0030550;GO:0007166;GO:0046597;, C:anchored component of membrane; C:extracellular region; C:plasma membrane;, F:acetylcholine receptor inhibitor activity;, P:cell surface receptor signaling pathway; P:negative regulation of viral entry into host cell; scaffold189 indexed_genome mRNA 675522 684042 . + . ID=transcript_15469;P0DP58 A0A140VJN6 D3DWI7 G3XAC2 Q86SR0 Q9BZG9,Ly-6/neurotoxin-like protein 1 {ECO:0000305},Endogenous prototoxin LYNX1 {ECO:0000303|PubMed:21252236};Testicular tissue protein Li 112 {ECO:0000312|EMBL:AEE61023.1};, PF00087;, GO:0031225;GO:0030425;GO:0005783;GO:0005886;GO:0045202;GO:0033130;GO:0030550;GO:0030548;GO:0008200;GO:0099601;GO:0007271;, C:anchored component of membrane; C:dendrite; C:endoplasmic reticulum; C:plasma membrane; C:synapse;, F:acetylcholine receptor binding; F:acetylcholine receptor inhibitor activity; F:acetylcholine receptor regulator activity; F:ion channel inhibitor activity;, P:regulation of neurotransmitter receptor activity; P:synaptic transmission, cholinergic;|P0DP58 A0A140VJN6 D3DWI7 G3XAC2 Q86SR0 Q9BZG9,Ly-6/neurotoxin-like protein 1 {ECO:0000305},Endogenous prototoxin LYNX1 {ECO:0000303|PubMed:21252236};Testicular tissue protein Li 112 {ECO:0000312|EMBL:AEE61023.1};, PF00087;, GO:0031225;GO:0030425;GO:0005783;GO:0005886;GO:0045202;GO:0033130;GO:0030550;GO:0030548;GO:0008200;GO:0099601;GO:0007271;, C:anchored component of membrane; C:dendrite; C:endoplasmic reticulum; C:plasma membrane; C:synapse;, F:acetylcholine receptor binding; F:acetylcholine receptor inhibitor activity; F:acetylcholine receptor regulator activity; F:ion channel inhibitor activity;, P:regulation of neurotransmitter receptor activity; P:synaptic transmission, cholinergic; scaffold189 indexed_genome mRNA 691691 696537 . - . ID=transcript_15470;Q6UXB3 A8K2R6 Q0VD64 Q0VF31,Ly6/PLAUR domain-containing protein 2,, PF00087;, GO:0031225;GO:0005576;GO:0005886;, C:anchored component of membrane; C:extracellular region; C:plasma membrane; scaffold189 indexed_genome mRNA 777318 797317 . + . ID=transcript_15471;O14514,Adhesion G protein-coupled receptor B1 {ECO:0000312|HGNC:HGNC:943},Brain-specific angiogenesis inhibitor 1 {ECO:0000303|PubMed:9393972};, PF00002;PF19188;PF16489;PF01825;PF02793;PF00090;, GO:0005911;GO:0030425;GO:0043197;GO:0005615;GO:0005925;GO:0016021;GO:0005887;GO:0048471;GO:0001891;GO:0005886;GO:0014069;GO:0004930;GO:0001530;GO:0030165;GO:0001786;GO:0007189;GO:0043277;GO:0007409;GO:0007155;GO:0007166;GO:0050829;GO:0043652;GO:0007186;GO:0045087;GO:0007517;GO:0016525;GO:0008285;GO:0010596;GO:0042177;GO:0031397;GO:0007422;GO:0006910;GO:1901741;GO:1903428;GO:0051965;GO:0048167;GO:0007165;, C:cell-cell junction; C:dendrite; C:dendritic spine; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:phagocytic cup; C:plasma membrane; C:postsynaptic density;, F:G protein-coupled receptor activity; F:lipopolysaccharide binding; F:PDZ domain binding; F:phosphatidylserine binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:apoptotic cell clearance; P:axonogenesis; P:cell adhesion; P:cell surface receptor signaling pathway; P:defense response to Gram-negative bacterium; P:engulfment of apoptotic cell; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:muscle organ development; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of protein catabolic process; P:negative regulation of protein ubiquitination; P:peripheral nervous system development; P:phagocytosis, recognition; P:positive regulation of myoblast fusion; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of synapse assembly; P:regulation of synaptic plasticity; P:signal transduction;|O14514,Adhesion G protein-coupled receptor B1 {ECO:0000312|HGNC:HGNC:943},Brain-specific angiogenesis inhibitor 1 {ECO:0000303|PubMed:9393972};, PF00002;PF19188;PF16489;PF01825;PF02793;PF00090;, GO:0005911;GO:0030425;GO:0043197;GO:0005615;GO:0005925;GO:0016021;GO:0005887;GO:0048471;GO:0001891;GO:0005886;GO:0014069;GO:0004930;GO:0001530;GO:0030165;GO:0001786;GO:0007189;GO:0043277;GO:0007409;GO:0007155;GO:0007166;GO:0050829;GO:0043652;GO:0007186;GO:0045087;GO:0007517;GO:0016525;GO:0008285;GO:0010596;GO:0042177;GO:0031397;GO:0007422;GO:0006910;GO:1901741;GO:1903428;GO:0051965;GO:0048167;GO:0007165;, C:cell-cell junction; C:dendrite; C:dendritic spine; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:phagocytic cup; C:plasma membrane; C:postsynaptic density;, F:G protein-coupled receptor activity; F:lipopolysaccharide binding; F:PDZ domain binding; F:phosphatidylserine binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:apoptotic cell clearance; P:axonogenesis; P:cell adhesion; P:cell surface receptor signaling pathway; P:defense response to Gram-negative bacterium; P:engulfment of apoptotic cell; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:muscle organ development; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of protein catabolic process; P:negative regulation of protein ubiquitination; P:peripheral nervous system development; P:phagocytosis, recognition; P:positive regulation of myoblast fusion; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of synapse assembly; P:regulation of synaptic plasticity; P:signal transduction;|O60242 B7Z1K0 O60297 Q2NKN6 Q5VY37 Q9BX54,Adhesion G protein-coupled receptor B3 {ECO:0000303|PubMed:25713288},Brain-specific angiogenesis inhibitor 3;, PF00002;PF19188;PF16489;PF01825;PF02793;PF00090;, GO:0016021;GO:0005887;GO:0005886;GO:0098794;GO:0043083;GO:0004930;GO:0005096;GO:0007189;GO:0007166;GO:0007186;GO:0099558;GO:0061743;GO:0007520;GO:0016525;GO:0016322;GO:0051965;GO:0048814;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:postsynapse; C:synaptic cleft;, F:G protein-coupled receptor activity; F:GTPase activator activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:maintenance of synapse structure; P:motor learning; P:myoblast fusion; P:negative regulation of angiogenesis; P:neuron remodeling; P:positive regulation of synapse assembly; P:regulation of dendrite morphogenesis; scaffold189 indexed_genome mRNA 815513 835410 . - . ID=transcript_15472;O14514,Adhesion G protein-coupled receptor B1 {ECO:0000312|HGNC:HGNC:943},Brain-specific angiogenesis inhibitor 1 {ECO:0000303|PubMed:9393972};, PF00002;PF19188;PF16489;PF01825;PF02793;PF00090;, GO:0005911;GO:0030425;GO:0043197;GO:0005615;GO:0005925;GO:0016021;GO:0005887;GO:0048471;GO:0001891;GO:0005886;GO:0014069;GO:0004930;GO:0001530;GO:0030165;GO:0001786;GO:0007189;GO:0043277;GO:0007409;GO:0007155;GO:0007166;GO:0050829;GO:0043652;GO:0007186;GO:0045087;GO:0007517;GO:0016525;GO:0008285;GO:0010596;GO:0042177;GO:0031397;GO:0007422;GO:0006910;GO:1901741;GO:1903428;GO:0051965;GO:0048167;GO:0007165;, C:cell-cell junction; C:dendrite; C:dendritic spine; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:phagocytic cup; C:plasma membrane; C:postsynaptic density;, F:G protein-coupled receptor activity; F:lipopolysaccharide binding; F:PDZ domain binding; F:phosphatidylserine binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:apoptotic cell clearance; P:axonogenesis; P:cell adhesion; P:cell surface receptor signaling pathway; P:defense response to Gram-negative bacterium; P:engulfment of apoptotic cell; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:muscle organ development; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of protein catabolic process; P:negative regulation of protein ubiquitination; P:peripheral nervous system development; P:phagocytosis, recognition; P:positive regulation of myoblast fusion; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of synapse assembly; P:regulation of synaptic plasticity; P:signal transduction; scaffold189 indexed_genome mRNA 928237 933662 . + . ID=transcript_15473;Q96NA8 B7ZLB0 Q14D03,t-SNARE domain-containing protein 1,, PF13873;PF05739;PF14523;, GO:0012505;GO:0016021;GO:0031201;GO:0005484;GO:0000149;GO:0006886;GO:0048278;GO:0006906;, C:endomembrane system; C:integral component of membrane; C:SNARE complex;, F:SNAP receptor activity; F:SNARE binding;, P:intracellular protein transport; P:vesicle docking; P:vesicle fusion; scaffold189 indexed_genome mRNA 939057 951334 . - . ID=transcript_15474;Q96NA8 B7ZLB0 Q14D03,t-SNARE domain-containing protein 1,, PF13873;PF05739;PF14523;, GO:0012505;GO:0016021;GO:0031201;GO:0005484;GO:0000149;GO:0006886;GO:0048278;GO:0006906;, C:endomembrane system; C:integral component of membrane; C:SNARE complex;, F:SNAP receptor activity; F:SNARE binding;, P:intracellular protein transport; P:vesicle docking; P:vesicle fusion; scaffold190 indexed_genome mRNA 384 2900 . - . ID=transcript_15475;Q10586 A2I2P4,D site-binding protein,Albumin D box-binding protein;Albumin D-element-binding protein;Tax-responsive enhancer element-binding protein 302;, PF07716;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0000977;GO:1990837;GO:0007623;GO:0001889;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:circadian rhythm; P:liver development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold190 indexed_genome mRNA 3393 11466 . + . ID=transcript_15476;Q9NRA0 A0T4C8 B4DU87 Q9BRN1 Q9H0Q2 Q9NWU7,Sphingosine kinase 2 {ECO:0000305},, PF00781;, GO:0005737;GO:0005829;GO:0005783;GO:0043231;GO:0005765;GO:0016020;GO:0005743;GO:0005739;GO:0005654;GO:0000786;GO:0005634;GO:0005524;GO:0017050;GO:0001727;GO:0003951;GO:0031493;GO:0031267;GO:0008481;GO:0038036;GO:1904628;GO:0043977;GO:0043980;GO:0030308;GO:1901726;GO:0031064;GO:0016310;GO:0043065;GO:0090280;GO:2000304;GO:0002720;GO:0045815;GO:2000617;GO:0032736;GO:0032755;GO:0033008;GO:0043306;GO:0090037;GO:0032760;GO:2001169;GO:1904959;GO:0043122;GO:1903426;GO:0006669;GO:0030148;GO:0006665;GO:0046512;GO:0006670;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleosome; C:nucleus;, F:ATP binding; F:D-erythro-sphingosine kinase activity; F:lipid kinase activity; F:NAD+ kinase activity; F:nucleosomal histone binding; F:small GTPase binding; F:sphinganine kinase activity; F:sphingosine-1-phosphate receptor activity;, P:cellular response to phorbol 13-acetate 12-myristate; P:histone H2A-K5 acetylation; P:histone H2B-K12 acetylation; P:negative regulation of cell growth; P:negative regulation of histone deacetylase activity; P:negative regulation of histone deacetylation; P:phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of calcium ion import; P:positive regulation of ceramide biosynthetic process; P:positive regulation of cytokine production involved in immune response; P:positive regulation of gene expression, epigenetic; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-6 production; P:positive regulation of mast cell activation involved in immune response; P:positive regulation of mast cell degranulation; P:positive regulation of protein kinase C signaling; P:positive regulation of tumor necrosis factor production; P:regulation of ATP biosynthetic process; P:regulation of cytochrome-c oxidase activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of reactive oxygen species biosynthetic process; P:sphinganine-1-phosphate biosynthetic process; P:sphingolipid biosynthetic process; P:sphingolipid metabolic process; P:sphingosine biosynthetic process; P:sphingosine metabolic process;|Q9NRA0 A0T4C8 B4DU87 Q9BRN1 Q9H0Q2 Q9NWU7,Sphingosine kinase 2 {ECO:0000305},, PF00781;, GO:0005737;GO:0005829;GO:0005783;GO:0043231;GO:0005765;GO:0016020;GO:0005743;GO:0005739;GO:0005654;GO:0000786;GO:0005634;GO:0005524;GO:0017050;GO:0001727;GO:0003951;GO:0031493;GO:0031267;GO:0008481;GO:0038036;GO:1904628;GO:0043977;GO:0043980;GO:0030308;GO:1901726;GO:0031064;GO:0016310;GO:0043065;GO:0090280;GO:2000304;GO:0002720;GO:0045815;GO:2000617;GO:0032736;GO:0032755;GO:0033008;GO:0043306;GO:0090037;GO:0032760;GO:2001169;GO:1904959;GO:0043122;GO:1903426;GO:0006669;GO:0030148;GO:0006665;GO:0046512;GO:0006670;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:nucleosome; C:nucleus;, F:ATP binding; F:D-erythro-sphingosine kinase activity; F:lipid kinase activity; F:NAD+ kinase activity; F:nucleosomal histone binding; F:small GTPase binding; F:sphinganine kinase activity; F:sphingosine-1-phosphate receptor activity;, P:cellular response to phorbol 13-acetate 12-myristate; P:histone H2A-K5 acetylation; P:histone H2B-K12 acetylation; P:negative regulation of cell growth; P:negative regulation of histone deacetylase activity; P:negative regulation of histone deacetylation; P:phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of calcium ion import; P:positive regulation of ceramide biosynthetic process; P:positive regulation of cytokine production involved in immune response; P:positive regulation of gene expression, epigenetic; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-6 production; P:positive regulation of mast cell activation involved in immune response; P:positive regulation of mast cell degranulation; P:positive regulation of protein kinase C signaling; P:positive regulation of tumor necrosis factor production; P:regulation of ATP biosynthetic process; P:regulation of cytochrome-c oxidase activity; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of reactive oxygen species biosynthetic process; P:sphinganine-1-phosphate biosynthetic process; P:sphingolipid biosynthetic process; P:sphingolipid metabolic process; P:sphingosine biosynthetic process; P:sphingosine metabolic process; scaffold190 indexed_genome mRNA 12667 15394 . - . ID=transcript_15477;Q07020 F8VWC5 Q8WTZ6,60S ribosomal protein L18,Large ribosomal subunit protein eL18 {ECO:0000303|PubMed:24524803};, PF17135;, GO:0005829;GO:0022625;GO:0005783;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:0042788;GO:0005791;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:polysomal ribosome; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q07020 F8VWC5 Q8WTZ6,60S ribosomal protein L18,Large ribosomal subunit protein eL18 {ECO:0000303|PubMed:24524803};, PF17135;, GO:0005829;GO:0022625;GO:0005783;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:0042788;GO:0005791;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:polysomal ribosome; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q07020 F8VWC5 Q8WTZ6,60S ribosomal protein L18,Large ribosomal subunit protein eL18 {ECO:0000303|PubMed:24524803};, PF17135;, GO:0005829;GO:0022625;GO:0005783;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:0042788;GO:0005791;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:polysomal ribosome; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q07020 F8VWC5 Q8WTZ6,60S ribosomal protein L18,Large ribosomal subunit protein eL18 {ECO:0000303|PubMed:24524803};, PF17135;, GO:0005829;GO:0022625;GO:0005783;GO:0005925;GO:0016020;GO:0005730;GO:0005634;GO:0042788;GO:0005791;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:endoplasmic reticulum; C:focal adhesion; C:membrane; C:nucleolus; C:nucleus; C:polysomal ribosome; C:rough endoplasmic reticulum;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold190 indexed_genome mRNA 99996 108673 . + . ID=transcript_15478;Q96Q04 Q4G0U1,Serine/threonine-protein kinase LMTK3,Lemur tyrosine kinase 3;, PF07714;, GO:0030424;GO:0030425;GO:0000139;GO:0016021;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0010923;GO:0006468;, C:axon; C:dendrite; C:Golgi membrane; C:integral component of membrane;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:negative regulation of phosphatase activity; P:protein phosphorylation; scaffold190 indexed_genome mRNA 108798 120070 . + . ID=transcript_15479;Q96Q04 Q4G0U1,Serine/threonine-protein kinase LMTK3,Lemur tyrosine kinase 3;, PF07714;, GO:0030424;GO:0030425;GO:0000139;GO:0016021;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0010923;GO:0006468;, C:axon; C:dendrite; C:Golgi membrane; C:integral component of membrane;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:negative regulation of phosphatase activity; P:protein phosphorylation; scaffold190 indexed_genome mRNA 124102 133353 . - . ID=transcript_15480;Q99418 A8K8P0 Q8IXY9 Q92958,Cytohesin-2,ARF exchange factor;ARF nucleotide-binding site opener;PH, SEC7 and coiled-coil domain-containing protein 2;, PF00169;PF01369;, GO:0005912;GO:0005923;GO:0005737;GO:0005829;GO:0000139;GO:0030426;GO:0016020;GO:0005886;GO:0005085;GO:0070679;GO:0008289;GO:0030036;GO:0006897;GO:0032012;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytosol; C:Golgi membrane; C:growth cone; C:membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:inositol 1,4,5 trisphosphate binding; F:lipid binding;, P:actin cytoskeleton organization; P:endocytosis; P:regulation of ARF protein signal transduction;|Q99418 A8K8P0 Q8IXY9 Q92958,Cytohesin-2,ARF exchange factor;ARF nucleotide-binding site opener;PH, SEC7 and coiled-coil domain-containing protein 2;, PF00169;PF01369;, GO:0005912;GO:0005923;GO:0005737;GO:0005829;GO:0000139;GO:0030426;GO:0016020;GO:0005886;GO:0005085;GO:0070679;GO:0008289;GO:0030036;GO:0006897;GO:0032012;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytosol; C:Golgi membrane; C:growth cone; C:membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:inositol 1,4,5 trisphosphate binding; F:lipid binding;, P:actin cytoskeleton organization; P:endocytosis; P:regulation of ARF protein signal transduction; scaffold190 indexed_genome mRNA 145404 151717 . - . ID=transcript_15481;Q9BQ67 A0MNN5 Q8TF59,Glutamate-rich WD repeat-containing protein 1,, PF12265;PF00400;, GO:0005694;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003688;GO:0042393;GO:0003723;GO:0006260;GO:0006334;GO:0006337;, C:chromosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:DNA replication origin binding; F:histone binding; F:RNA binding;, P:DNA replication; P:nucleosome assembly; P:nucleosome disassembly; scaffold190 indexed_genome mRNA 174713 179931 . - . ID=transcript_15482;O15399,Glutamate receptor ionotropic, NMDA 2D,EB11;Glutamate [NMDA] receptor subunit epsilon-4;N-methyl D-aspartate receptor subtype 2D;, PF01094;PF00060;PF10613;, GO:0005789;GO:0005887;GO:0017146;GO:0005886;GO:0098839;GO:0022849;GO:0004970;GO:0015276;GO:0004972;GO:0038023;GO:0008344;GO:0007420;GO:0097553;GO:0098976;GO:0060079;GO:0060291;GO:0051930;GO:0048167;GO:0001964;, C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density membrane;, F:glutamate-gated calcium ion channel activity; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:NMDA glutamate receptor activity; F:signaling receptor activity;, P:adult locomotory behavior; P:brain development; P:calcium ion transmembrane import into cytosol; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:long-term synaptic potentiation; P:regulation of sensory perception of pain; P:regulation of synaptic plasticity; P:startle response; scaffold190 indexed_genome mRNA 190078 197978 . + . ID=transcript_15483;P24390 B2R6N4 Q54A39 Q8NBW7,ER lumen protein-retaining receptor 1,KDEL endoplasmic reticulum protein retention receptor 1;Putative MAPK-activating protein PM23;, PF00810;, GO:0005801;GO:0030663;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0000139;GO:0016021;GO:0030133;GO:0046923;GO:0005046;GO:0006888;GO:0006621;GO:0015031;GO:0006890;, C:cis-Golgi network; C:COPI-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:ER retention sequence binding; F:KDEL sequence binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein retention in ER lumen; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P24390 B2R6N4 Q54A39 Q8NBW7,ER lumen protein-retaining receptor 1,KDEL endoplasmic reticulum protein retention receptor 1;Putative MAPK-activating protein PM23;, PF00810;, GO:0005801;GO:0030663;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0000139;GO:0016021;GO:0030133;GO:0046923;GO:0005046;GO:0006888;GO:0006621;GO:0015031;GO:0006890;, C:cis-Golgi network; C:COPI-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:ER retention sequence binding; F:KDEL sequence binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein retention in ER lumen; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|P24390 B2R6N4 Q54A39 Q8NBW7,ER lumen protein-retaining receptor 1,KDEL endoplasmic reticulum protein retention receptor 1;Putative MAPK-activating protein PM23;, PF00810;, GO:0005801;GO:0030663;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0000139;GO:0016021;GO:0030133;GO:0046923;GO:0005046;GO:0006888;GO:0006621;GO:0015031;GO:0006890;, C:cis-Golgi network; C:COPI-coated vesicle membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:integral component of membrane; C:transport vesicle;, F:ER retention sequence binding; F:KDEL sequence binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein retention in ER lumen; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold190 indexed_genome mRNA 211403 226519 . + . ID=transcript_15484;Q96AN5 A8K656 Q6UXY4 Q9NV49,Transmembrane protein 143,, PF12576;, GO:0016021;GO:0005739;, C:integral component of membrane; C:mitochondrion; scaffold190 indexed_genome mRNA 226537 236604 . + . ID=transcript_15485;Q96AN5 A8K656 Q6UXY4 Q9NV49,Transmembrane protein 143,, PF12576;, GO:0016021;GO:0005739;, C:integral component of membrane; C:mitochondrion;|P54852 Q6FH01,Epithelial membrane protein 3,Hematopoietic neural membrane protein 1;Protein YMP;, PF00822;, GO:0016021;GO:0005886;GO:0032060;GO:0008219;, C:integral component of membrane; C:plasma membrane;, , P:bleb assembly; P:cell death;|P54852 Q6FH01,Epithelial membrane protein 3,Hematopoietic neural membrane protein 1;Protein YMP;, PF00822;, GO:0016021;GO:0005886;GO:0032060;GO:0008219;, C:integral component of membrane; C:plasma membrane;, , P:bleb assembly; P:cell death; scaffold190 indexed_genome mRNA 240167 259703 . + . ID=transcript_15486;Q96M63 Q6ZRL4 Q96M06 Q9UFG8,Outer dynein arm-docking complex subunit 1,Coiled-coil domain-containing protein 114;, , GO:0005930;GO:0005929;GO:0036157;GO:0003341;GO:0036158;, C:axoneme; C:cilium; C:outer dynein arm;, , P:cilium movement; P:outer dynein arm assembly;|Q96M63 Q6ZRL4 Q96M06 Q9UFG8,Outer dynein arm-docking complex subunit 1,Coiled-coil domain-containing protein 114;, , GO:0005930;GO:0005929;GO:0036157;GO:0003341;GO:0036158;, C:axoneme; C:cilium; C:outer dynein arm;, , P:cilium movement; P:outer dynein arm assembly; scaffold190 indexed_genome mRNA 261597 263867 . + . ID=transcript_15487;Q96M63 Q6ZRL4 Q96M06 Q9UFG8,Outer dynein arm-docking complex subunit 1,Coiled-coil domain-containing protein 114;, , GO:0005930;GO:0005929;GO:0036157;GO:0003341;GO:0036158;, C:axoneme; C:cilium; C:outer dynein arm;, , P:cilium movement; P:outer dynein arm assembly; scaffold190 indexed_genome mRNA 341405 345764 . - . ID=transcript_15488;Q6ZN57 A5PLN5 B7ZM23 Q9H6Z6,Zinc finger protein 2 homolog,Zinc finger protein 751;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold190 indexed_genome mRNA 359325 379525 . - . ID=transcript_15489;Q86XI8 A0A087WWL5,Uncharacterized protein ZSWIM9,, PF17738; scaffold190 indexed_genome mRNA 382171 406059 . + . ID=transcript_15490;P18858 B2RAI8 B4DTU4 Q2TB12 Q32P23,DNA ligase 1,DNA ligase I;Polydeoxyribonucleotide synthase [ATP] 1;, PF04679;PF01068;PF04675;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0046872;GO:0009653;GO:0006284;GO:0006287;GO:0051301;GO:0071897;GO:0006266;GO:0006310;GO:0006281;GO:0006273;GO:0006298;GO:0006297;GO:1903461;GO:0006283;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:metal ion binding;, P:anatomical structure morphogenesis; P:base-excision repair; P:base-excision repair, gap-filling; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:DNA recombination; P:DNA repair; P:lagging strand elongation; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:Okazaki fragment processing involved in mitotic DNA replication; P:transcription-coupled nucleotide-excision repair;|P18858 B2RAI8 B4DTU4 Q2TB12 Q32P23,DNA ligase 1,DNA ligase I;Polydeoxyribonucleotide synthase [ATP] 1;, PF04679;PF01068;PF04675;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0046872;GO:0009653;GO:0006284;GO:0006287;GO:0051301;GO:0071897;GO:0006266;GO:0006310;GO:0006281;GO:0006273;GO:0006298;GO:0006297;GO:1903461;GO:0006283;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:metal ion binding;, P:anatomical structure morphogenesis; P:base-excision repair; P:base-excision repair, gap-filling; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:DNA recombination; P:DNA repair; P:lagging strand elongation; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:Okazaki fragment processing involved in mitotic DNA replication; P:transcription-coupled nucleotide-excision repair;|P18858 B2RAI8 B4DTU4 Q2TB12 Q32P23,DNA ligase 1,DNA ligase I;Polydeoxyribonucleotide synthase [ATP] 1;, PF04679;PF01068;PF04675;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0046872;GO:0009653;GO:0006284;GO:0006287;GO:0051301;GO:0071897;GO:0006266;GO:0006310;GO:0006281;GO:0006273;GO:0006298;GO:0006297;GO:1903461;GO:0006283;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:metal ion binding;, P:anatomical structure morphogenesis; P:base-excision repair; P:base-excision repair, gap-filling; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:DNA recombination; P:DNA repair; P:lagging strand elongation; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:Okazaki fragment processing involved in mitotic DNA replication; P:transcription-coupled nucleotide-excision repair;|P18858 B2RAI8 B4DTU4 Q2TB12 Q32P23,DNA ligase 1,DNA ligase I;Polydeoxyribonucleotide synthase [ATP] 1;, PF04679;PF01068;PF04675;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0046872;GO:0009653;GO:0006284;GO:0006287;GO:0051301;GO:0071897;GO:0006266;GO:0006310;GO:0006281;GO:0006273;GO:0006298;GO:0006297;GO:1903461;GO:0006283;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:metal ion binding;, P:anatomical structure morphogenesis; P:base-excision repair; P:base-excision repair, gap-filling; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:DNA recombination; P:DNA repair; P:lagging strand elongation; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:Okazaki fragment processing involved in mitotic DNA replication; P:transcription-coupled nucleotide-excision repair;|P18858 B2RAI8 B4DTU4 Q2TB12 Q32P23,DNA ligase 1,DNA ligase I;Polydeoxyribonucleotide synthase [ATP] 1;, PF04679;PF01068;PF04675;, GO:0005737;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0003677;GO:0003910;GO:0003909;GO:0046872;GO:0009653;GO:0006284;GO:0006287;GO:0051301;GO:0071897;GO:0006266;GO:0006310;GO:0006281;GO:0006273;GO:0006298;GO:0006297;GO:1903461;GO:0006283;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:DNA binding; F:DNA ligase (ATP) activity; F:DNA ligase activity; F:metal ion binding;, P:anatomical structure morphogenesis; P:base-excision repair; P:base-excision repair, gap-filling; P:cell division; P:DNA biosynthetic process; P:DNA ligation; P:DNA recombination; P:DNA repair; P:lagging strand elongation; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:Okazaki fragment processing involved in mitotic DNA replication; P:transcription-coupled nucleotide-excision repair; scaffold190 indexed_genome mRNA 445618 453871 . + . ID=transcript_15491;Q075Z2 A6NIZ5,Binder of sperm protein homolog 1,Bovine seminal plasma protein homolog 1;Bovine seminal plasma protein-like 1;, PF00040;, GO:0009986;GO:0005576;GO:0008201;GO:0007338;GO:0048240;, C:cell surface; C:extracellular region;, F:heparin binding;, P:single fertilization; P:sperm capacitation; scaffold190 indexed_genome mRNA 495649 510236 . + . ID=transcript_15492;Q06520,Sulfotransferase 2A1,Bile salt sulfotransferase;Dehydroepiandrosterone sulfotransferase {ECO:0000303|PubMed:7678732};Hydroxysteroid Sulfotransferase;ST2;SULT2A3 {ECO:0000303|PubMed:10854859};, PF00685;, GO:0005737;GO:0005829;GO:0050656;GO:0004027;GO:0047704;GO:0050294;GO:0008146;GO:0050427;GO:0030573;GO:0008203;GO:0006068;GO:0016042;GO:0019222;GO:0008202;GO:0051923;GO:0042403;GO:0006805;, C:cytoplasm; C:cytosol;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:alcohol sulfotransferase activity; F:bile-salt sulfotransferase activity; F:steroid sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:bile acid catabolic process; P:cholesterol metabolic process; P:ethanol catabolic process; P:lipid catabolic process; P:regulation of metabolic process; P:steroid metabolic process; P:sulfation; P:thyroid hormone metabolic process; P:xenobiotic metabolic process; scaffold190 indexed_genome mRNA 515336 526766 . + . ID=transcript_15493;Q06520,Sulfotransferase 2A1,Bile salt sulfotransferase;Dehydroepiandrosterone sulfotransferase {ECO:0000303|PubMed:7678732};Hydroxysteroid Sulfotransferase;ST2;SULT2A3 {ECO:0000303|PubMed:10854859};, PF00685;, GO:0005737;GO:0005829;GO:0050656;GO:0004027;GO:0047704;GO:0050294;GO:0008146;GO:0050427;GO:0030573;GO:0008203;GO:0006068;GO:0016042;GO:0019222;GO:0008202;GO:0051923;GO:0042403;GO:0006805;, C:cytoplasm; C:cytosol;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:alcohol sulfotransferase activity; F:bile-salt sulfotransferase activity; F:steroid sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:bile acid catabolic process; P:cholesterol metabolic process; P:ethanol catabolic process; P:lipid catabolic process; P:regulation of metabolic process; P:steroid metabolic process; P:sulfation; P:thyroid hormone metabolic process; P:xenobiotic metabolic process;|Q06520,Sulfotransferase 2A1,Bile salt sulfotransferase;Dehydroepiandrosterone sulfotransferase {ECO:0000303|PubMed:7678732};Hydroxysteroid Sulfotransferase;ST2;SULT2A3 {ECO:0000303|PubMed:10854859};, PF00685;, GO:0005737;GO:0005829;GO:0050656;GO:0004027;GO:0047704;GO:0050294;GO:0008146;GO:0050427;GO:0030573;GO:0008203;GO:0006068;GO:0016042;GO:0019222;GO:0008202;GO:0051923;GO:0042403;GO:0006805;, C:cytoplasm; C:cytosol;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:alcohol sulfotransferase activity; F:bile-salt sulfotransferase activity; F:steroid sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:bile acid catabolic process; P:cholesterol metabolic process; P:ethanol catabolic process; P:lipid catabolic process; P:regulation of metabolic process; P:steroid metabolic process; P:sulfation; P:thyroid hormone metabolic process; P:xenobiotic metabolic process;|Q06520,Sulfotransferase 2A1,Bile salt sulfotransferase;Dehydroepiandrosterone sulfotransferase {ECO:0000303|PubMed:7678732};Hydroxysteroid Sulfotransferase;ST2;SULT2A3 {ECO:0000303|PubMed:10854859};, PF00685;, GO:0005737;GO:0005829;GO:0050656;GO:0004027;GO:0047704;GO:0050294;GO:0008146;GO:0050427;GO:0030573;GO:0008203;GO:0006068;GO:0016042;GO:0019222;GO:0008202;GO:0051923;GO:0042403;GO:0006805;, C:cytoplasm; C:cytosol;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:alcohol sulfotransferase activity; F:bile-salt sulfotransferase activity; F:steroid sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:bile acid catabolic process; P:cholesterol metabolic process; P:ethanol catabolic process; P:lipid catabolic process; P:regulation of metabolic process; P:steroid metabolic process; P:sulfation; P:thyroid hormone metabolic process; P:xenobiotic metabolic process; scaffold190 indexed_genome mRNA 551118 569813 . + . ID=transcript_15494;Q06520,Sulfotransferase 2A1,Bile salt sulfotransferase;Dehydroepiandrosterone sulfotransferase {ECO:0000303|PubMed:7678732};Hydroxysteroid Sulfotransferase;ST2;SULT2A3 {ECO:0000303|PubMed:10854859};, PF00685;, GO:0005737;GO:0005829;GO:0050656;GO:0004027;GO:0047704;GO:0050294;GO:0008146;GO:0050427;GO:0030573;GO:0008203;GO:0006068;GO:0016042;GO:0019222;GO:0008202;GO:0051923;GO:0042403;GO:0006805;, C:cytoplasm; C:cytosol;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:alcohol sulfotransferase activity; F:bile-salt sulfotransferase activity; F:steroid sulfotransferase activity; F:sulfotransferase activity;, P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; P:bile acid catabolic process; P:cholesterol metabolic process; P:ethanol catabolic process; P:lipid catabolic process; P:regulation of metabolic process; P:steroid metabolic process; P:sulfation; P:thyroid hormone metabolic process; P:xenobiotic metabolic process; scaffold190 indexed_genome mRNA 623203 627133 . + . ID=transcript_15495;P63302 A8MRR7 O15532 O19096 Q86TI9 Q96KM5,Selenoprotein W {ECO:0000303|PubMed:27645994, ECO:0000303|PubMed:9256076},, PF10262;, GO:0005829;GO:0016209;GO:0010269;, C:cytosol;, F:antioxidant activity;, P:response to selenium ion; scaffold190 indexed_genome mRNA 649387 651725 . + . ID=transcript_15496;Q9NZM5 Q9BTC6 Q9HAX6 Q9NPP1 Q9NPR4 Q9UFI2,Ribosome biogenesis protein NOP53 {ECO:0000305},Glioma tumor suppressor candidate region gene 2 protein {ECO:0000312|HGNC:HGNC:4333};Protein interacting with carboxyl terminus 1 {ECO:0000303|PubMed:15355975};p60 {ECO:0000303|PubMed:10196275};, PF07767;, GO:0005829;GO:0001650;GO:0043231;GO:0005730;GO:0005654;GO:0008097;GO:0042802;GO:0002039;GO:0003723;GO:0006974;GO:0071456;GO:0006281;GO:0007095;GO:0014067;GO:0032435;GO:0051898;GO:0031333;GO:1901797;GO:0000122;GO:1901837;GO:0032436;GO:1903006;GO:1902570;GO:1990173;GO:0050821;GO:1903715;GO:0042981;GO:0051726;GO:0001932;GO:0039535;GO:1901796;GO:0000027;GO:0006364;GO:0016032;, C:cytosol; C:fibrillar center; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm;, F:5S rRNA binding; F:identical protein binding; F:p53 binding; F:RNA binding;, P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:DNA repair; P:mitotic G2 DNA damage checkpoint; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of protein kinase B signaling; P:negative regulation of protein-containing complex assembly; P:negative regulation of signal transduction by p53 class mediator; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein K63-linked deubiquitination; P:protein localization to nucleolus; P:protein localization to nucleoplasm; P:protein stabilization; P:regulation of aerobic respiration; P:regulation of apoptotic process; P:regulation of cell cycle; P:regulation of protein phosphorylation; P:regulation of RIG-I signaling pathway; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:rRNA processing; P:viral process; scaffold190 indexed_genome mRNA 653613 677145 . - . ID=transcript_15497;Q9NZN4 B2RDH9 B4DNU6 Q96CB6,EH domain-containing protein 2 {ECO:0000305},PAST homolog 2 {ECO:0000305};, PF18150;PF00350;PF12763;PF16880;, GO:0005901;GO:0005829;GO:0005769;GO:0030139;GO:0010008;GO:0070062;GO:0019898;GO:0045171;GO:0043231;GO:0015630;GO:0005634;GO:0048471;GO:0005886;GO:0055038;GO:0005524;GO:0005509;GO:0005525;GO:0016787;GO:0042802;GO:0003676;GO:0019904;GO:0007596;GO:0060271;GO:0030866;GO:0032456;GO:0006897;GO:0016197;GO:0097320;GO:2001137;GO:1901741;GO:0072659;, C:caveola; C:cytosol; C:early endosome; C:endocytic vesicle; C:endosome membrane; C:extracellular exosome; C:extrinsic component of membrane; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:microtubule cytoskeleton; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome membrane;, F:ATP binding; F:calcium ion binding; F:GTP binding; F:hydrolase activity; F:identical protein binding; F:nucleic acid binding; F:protein domain specific binding;, P:blood coagulation; P:cilium assembly; P:cortical actin cytoskeleton organization; P:endocytic recycling; P:endocytosis; P:endosomal transport; P:plasma membrane tubulation; P:positive regulation of endocytic recycling; P:positive regulation of myoblast fusion; P:protein localization to plasma membrane;|Q9NZN4 B2RDH9 B4DNU6 Q96CB6,EH domain-containing protein 2 {ECO:0000305},PAST homolog 2 {ECO:0000305};, PF18150;PF00350;PF12763;PF16880;, GO:0005901;GO:0005829;GO:0005769;GO:0030139;GO:0010008;GO:0070062;GO:0019898;GO:0045171;GO:0043231;GO:0015630;GO:0005634;GO:0048471;GO:0005886;GO:0055038;GO:0005524;GO:0005509;GO:0005525;GO:0016787;GO:0042802;GO:0003676;GO:0019904;GO:0007596;GO:0060271;GO:0030866;GO:0032456;GO:0006897;GO:0016197;GO:0097320;GO:2001137;GO:1901741;GO:0072659;, C:caveola; C:cytosol; C:early endosome; C:endocytic vesicle; C:endosome membrane; C:extracellular exosome; C:extrinsic component of membrane; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:microtubule cytoskeleton; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome membrane;, F:ATP binding; F:calcium ion binding; F:GTP binding; F:hydrolase activity; F:identical protein binding; F:nucleic acid binding; F:protein domain specific binding;, P:blood coagulation; P:cilium assembly; P:cortical actin cytoskeleton organization; P:endocytic recycling; P:endocytosis; P:endosomal transport; P:plasma membrane tubulation; P:positive regulation of endocytic recycling; P:positive regulation of myoblast fusion; P:protein localization to plasma membrane;|Q9NZN4 B2RDH9 B4DNU6 Q96CB6,EH domain-containing protein 2 {ECO:0000305},PAST homolog 2 {ECO:0000305};, PF18150;PF00350;PF12763;PF16880;, GO:0005901;GO:0005829;GO:0005769;GO:0030139;GO:0010008;GO:0070062;GO:0019898;GO:0045171;GO:0043231;GO:0015630;GO:0005634;GO:0048471;GO:0005886;GO:0055038;GO:0005524;GO:0005509;GO:0005525;GO:0016787;GO:0042802;GO:0003676;GO:0019904;GO:0007596;GO:0060271;GO:0030866;GO:0032456;GO:0006897;GO:0016197;GO:0097320;GO:2001137;GO:1901741;GO:0072659;, C:caveola; C:cytosol; C:early endosome; C:endocytic vesicle; C:endosome membrane; C:extracellular exosome; C:extrinsic component of membrane; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:microtubule cytoskeleton; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome membrane;, F:ATP binding; F:calcium ion binding; F:GTP binding; F:hydrolase activity; F:identical protein binding; F:nucleic acid binding; F:protein domain specific binding;, P:blood coagulation; P:cilium assembly; P:cortical actin cytoskeleton organization; P:endocytic recycling; P:endocytosis; P:endosomal transport; P:plasma membrane tubulation; P:positive regulation of endocytic recycling; P:positive regulation of myoblast fusion; P:protein localization to plasma membrane; scaffold190 indexed_genome mRNA 689995 691551 . - . ID=transcript_15498;Q9NZM4 A8MW01,BRD4-interacting chromatin-remodeling complex-associated protein {ECO:0000305},Glioma tumor suppressor candidate region gene 1 protein {ECO:0000312|HGNC:HGNC:4332};, PF15249;, GO:0005634;GO:0016514;GO:0140537;GO:0045893;, C:nucleus; C:SWI/SNF complex;, F:transcription regulator activator activity;, P:positive regulation of transcription, DNA-templated; scaffold190 indexed_genome mRNA 692818 759689 . - . ID=transcript_15499;Q9NZM4 A8MW01,BRD4-interacting chromatin-remodeling complex-associated protein {ECO:0000305},Glioma tumor suppressor candidate region gene 1 protein {ECO:0000312|HGNC:HGNC:4332};, PF15249;, GO:0005634;GO:0016514;GO:0140537;GO:0045893;, C:nucleus; C:SWI/SNF complex;, F:transcription regulator activator activity;, P:positive regulation of transcription, DNA-templated; scaffold190 indexed_genome mRNA 800434 801050 . + . ID=transcript_15500;Q9H0D2 Q8NDK8,Zinc finger protein 541,, PF01448;PF00096;, GO:0000118;GO:0005634;GO:0005667;GO:0046872;GO:0003714;GO:0030154;GO:0016575;GO:0007275;GO:0045892;GO:0006357;GO:0007283;, C:histone deacetylase complex; C:nucleus; C:transcription regulator complex;, F:metal ion binding; F:transcription corepressor activity;, P:cell differentiation; P:histone deacetylation; P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold190 indexed_genome mRNA 807433 811739 . - . ID=transcript_15501;Q9H0D2 Q8NDK8,Zinc finger protein 541,, PF01448;PF00096;, GO:0000118;GO:0005634;GO:0005667;GO:0046872;GO:0003714;GO:0030154;GO:0016575;GO:0007275;GO:0045892;GO:0006357;GO:0007283;, C:histone deacetylase complex; C:nucleus; C:transcription regulator complex;, F:metal ion binding; F:transcription corepressor activity;, P:cell differentiation; P:histone deacetylation; P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:spermatogenesis;|Q9H0D2 Q8NDK8,Zinc finger protein 541,, PF01448;PF00096;, GO:0000118;GO:0005634;GO:0005667;GO:0046872;GO:0003714;GO:0030154;GO:0016575;GO:0007275;GO:0045892;GO:0006357;GO:0007283;, C:histone deacetylase complex; C:nucleus; C:transcription regulator complex;, F:metal ion binding; F:transcription corepressor activity;, P:cell differentiation; P:histone deacetylation; P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:spermatogenesis; scaffold190 indexed_genome mRNA 815081 820359 . - . ID=transcript_15502;P62314 B5BTZ1 P13641,Small nuclear ribonucleoprotein Sm D1,Sm-D autoantigen;snRNP core protein D1;, PF01423;, GO:0071013;GO:0000243;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0034715;GO:0071011;GO:0030532;GO:0034719;GO:0097526;GO:0005685;GO:0005689;GO:0005686;GO:0071007;GO:0071005;GO:0005687;GO:0046540;GO:0005682;GO:0003723;GO:1990446;GO:0051170;GO:0000398;GO:0008380;GO:0000245;GO:0000387;, C:catalytic step 2 spliceosome; C:commitment complex; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:precatalytic spliceosome; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal tri-snRNP complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, F:RNA binding; F:U1 snRNP binding;, P:import into nucleus; P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly; scaffold190 indexed_genome mRNA 820711 846905 . + . ID=transcript_15503;P54920 A8K879 Q96IK3 Q9BVJ3,Alpha-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein alpha;, , GO:0005829;GO:0070062;GO:0098978;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0031201;GO:0070044;GO:0005774;GO:0044877;GO:0000149;GO:0005483;GO:0019905;GO:0045176;GO:0007420;GO:0048208;GO:0006888;GO:0006891;GO:0006886;GO:0061025;GO:0030182;GO:0032781;GO:0006892;GO:0010807;GO:0006890;GO:0035494;GO:0035249;GO:0016082;, C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse; C:SNARE complex; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; C:vacuolar membrane;, F:protein-containing complex binding; F:SNARE binding; F:soluble NSF attachment protein activity; F:syntaxin binding;, P:apical protein localization; P:brain development; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane fusion; P:neuron differentiation; P:positive regulation of ATPase activity; P:post-Golgi vesicle-mediated transport; P:regulation of synaptic vesicle priming; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:SNARE complex disassembly; P:synaptic transmission, glutamatergic; P:synaptic vesicle priming;|P54920 A8K879 Q96IK3 Q9BVJ3,Alpha-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein alpha;, , GO:0005829;GO:0070062;GO:0098978;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0031201;GO:0070044;GO:0005774;GO:0044877;GO:0000149;GO:0005483;GO:0019905;GO:0045176;GO:0007420;GO:0048208;GO:0006888;GO:0006891;GO:0006886;GO:0061025;GO:0030182;GO:0032781;GO:0006892;GO:0010807;GO:0006890;GO:0035494;GO:0035249;GO:0016082;, C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse; C:SNARE complex; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; C:vacuolar membrane;, F:protein-containing complex binding; F:SNARE binding; F:soluble NSF attachment protein activity; F:syntaxin binding;, P:apical protein localization; P:brain development; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane fusion; P:neuron differentiation; P:positive regulation of ATPase activity; P:post-Golgi vesicle-mediated transport; P:regulation of synaptic vesicle priming; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:SNARE complex disassembly; P:synaptic transmission, glutamatergic; P:synaptic vesicle priming;|P54920 A8K879 Q96IK3 Q9BVJ3,Alpha-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein alpha;, , GO:0005829;GO:0070062;GO:0098978;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0031201;GO:0070044;GO:0005774;GO:0044877;GO:0000149;GO:0005483;GO:0019905;GO:0045176;GO:0007420;GO:0048208;GO:0006888;GO:0006891;GO:0006886;GO:0061025;GO:0030182;GO:0032781;GO:0006892;GO:0010807;GO:0006890;GO:0035494;GO:0035249;GO:0016082;, C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse; C:SNARE complex; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; C:vacuolar membrane;, F:protein-containing complex binding; F:SNARE binding; F:soluble NSF attachment protein activity; F:syntaxin binding;, P:apical protein localization; P:brain development; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane fusion; P:neuron differentiation; P:positive regulation of ATPase activity; P:post-Golgi vesicle-mediated transport; P:regulation of synaptic vesicle priming; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:SNARE complex disassembly; P:synaptic transmission, glutamatergic; P:synaptic vesicle priming;|P54920 A8K879 Q96IK3 Q9BVJ3,Alpha-soluble NSF attachment protein,N-ethylmaleimide-sensitive factor attachment protein alpha;, , GO:0005829;GO:0070062;GO:0098978;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0031201;GO:0070044;GO:0005774;GO:0044877;GO:0000149;GO:0005483;GO:0019905;GO:0045176;GO:0007420;GO:0048208;GO:0006888;GO:0006891;GO:0006886;GO:0061025;GO:0030182;GO:0032781;GO:0006892;GO:0010807;GO:0006890;GO:0035494;GO:0035249;GO:0016082;, C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse; C:SNARE complex; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; C:vacuolar membrane;, F:protein-containing complex binding; F:SNARE binding; F:soluble NSF attachment protein activity; F:syntaxin binding;, P:apical protein localization; P:brain development; P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane fusion; P:neuron differentiation; P:positive regulation of ATPase activity; P:post-Golgi vesicle-mediated transport; P:regulation of synaptic vesicle priming; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:SNARE complex disassembly; P:synaptic transmission, glutamatergic; P:synaptic vesicle priming; scaffold190 indexed_genome mRNA 850419 865438 . + . ID=transcript_15504;Q9Y664 B3KN86 B4DQ76 Q96GT1,KICSTOR complex protein kaptin {ECO:0000305|PubMed:10099934},Actin-associated protein 2E4 {ECO:0000303|PubMed:10099934};, , GO:0140007;GO:0030027;GO:0005765;GO:0098871;GO:0032420;GO:0051015;GO:0007015;GO:0034198;GO:0042149;GO:1904262;GO:0061462;, C:KICSTOR complex; C:lamellipodium; C:lysosomal membrane; C:postsynaptic actin cytoskeleton; C:stereocilium;, F:actin filament binding;, P:actin filament organization; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:negative regulation of TORC1 signaling; P:protein localization to lysosome;|Q9Y664 B3KN86 B4DQ76 Q96GT1,KICSTOR complex protein kaptin {ECO:0000305|PubMed:10099934},Actin-associated protein 2E4 {ECO:0000303|PubMed:10099934};, , GO:0140007;GO:0030027;GO:0005765;GO:0098871;GO:0032420;GO:0051015;GO:0007015;GO:0034198;GO:0042149;GO:1904262;GO:0061462;, C:KICSTOR complex; C:lamellipodium; C:lysosomal membrane; C:postsynaptic actin cytoskeleton; C:stereocilium;, F:actin filament binding;, P:actin filament organization; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:negative regulation of TORC1 signaling; P:protein localization to lysosome;|Q9Y664 B3KN86 B4DQ76 Q96GT1,KICSTOR complex protein kaptin {ECO:0000305|PubMed:10099934},Actin-associated protein 2E4 {ECO:0000303|PubMed:10099934};, , GO:0140007;GO:0030027;GO:0005765;GO:0098871;GO:0032420;GO:0051015;GO:0007015;GO:0034198;GO:0042149;GO:1904262;GO:0061462;, C:KICSTOR complex; C:lamellipodium; C:lysosomal membrane; C:postsynaptic actin cytoskeleton; C:stereocilium;, F:actin filament binding;, P:actin filament organization; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:negative regulation of TORC1 signaling; P:protein localization to lysosome;|Q9Y664 B3KN86 B4DQ76 Q96GT1,KICSTOR complex protein kaptin {ECO:0000305|PubMed:10099934},Actin-associated protein 2E4 {ECO:0000303|PubMed:10099934};, , GO:0140007;GO:0030027;GO:0005765;GO:0098871;GO:0032420;GO:0051015;GO:0007015;GO:0034198;GO:0042149;GO:1904262;GO:0061462;, C:KICSTOR complex; C:lamellipodium; C:lysosomal membrane; C:postsynaptic actin cytoskeleton; C:stereocilium;, F:actin filament binding;, P:actin filament organization; P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:negative regulation of TORC1 signaling; P:protein localization to lysosome; scaffold190 indexed_genome mRNA 866818 871984 . - . ID=transcript_15505;Q9UPR5 B4DYQ9,Sodium/calcium exchanger 2,Na(+)/Ca(2+)-exchange protein 2;Solute carrier family 8 member 2;, PF03160;PF01699;PF16494;, GO:0030424;GO:0043679;GO:0016323;GO:0030425;GO:0043197;GO:0005887;GO:0016020;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0014069;GO:0098793;GO:0042383;GO:0045202;GO:0015085;GO:1905060;GO:0005432;GO:0005516;GO:0015491;GO:0046872;GO:0015081;GO:1990034;GO:0098703;GO:0070588;GO:0007154;GO:0006874;GO:0050890;GO:0006811;GO:0007612;GO:0007611;GO:0060291;GO:0007613;GO:0030001;GO:0098815;GO:0070050;GO:0071902;GO:0099608;GO:0106056;GO:1903779;GO:0051480;GO:0010468;GO:0048172;GO:0002931;GO:0035725;GO:0050808;GO:0150104;, C:axon; C:axon terminus; C:basolateral plasma membrane; C:dendrite; C:dendritic spine; C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:presynapse; C:sarcolemma; C:synapse;, F:calcium ion transmembrane transporter activity; F:calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium:sodium antiporter activity; F:calmodulin binding; F:cation:cation antiporter activity; F:metal ion binding; F:sodium ion transmembrane transporter activity;, P:calcium ion export across plasma membrane; P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:cell communication; P:cellular calcium ion homeostasis; P:cognition; P:ion transport; P:learning; P:learning or memory; P:long-term synaptic potentiation; P:memory; P:metal ion transport; P:modulation of excitatory postsynaptic potential; P:neuron cellular homeostasis; P:positive regulation of protein serine/threonine kinase activity; P:regulation of action potential firing pattern; P:regulation of calcineurin-mediated signaling; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:regulation of gene expression; P:regulation of short-term neuronal synaptic plasticity; P:response to ischemia; P:sodium ion transmembrane transport; P:synapse organization; P:transport across blood-brain barrier; scaffold190 indexed_genome mRNA 890940 901291 . + . ID=transcript_15506;Q9UPR5 B4DYQ9,Sodium/calcium exchanger 2,Na(+)/Ca(2+)-exchange protein 2;Solute carrier family 8 member 2;, PF03160;PF01699;PF16494;, GO:0030424;GO:0043679;GO:0016323;GO:0030425;GO:0043197;GO:0005887;GO:0016020;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0014069;GO:0098793;GO:0042383;GO:0045202;GO:0015085;GO:1905060;GO:0005432;GO:0005516;GO:0015491;GO:0046872;GO:0015081;GO:1990034;GO:0098703;GO:0070588;GO:0007154;GO:0006874;GO:0050890;GO:0006811;GO:0007612;GO:0007611;GO:0060291;GO:0007613;GO:0030001;GO:0098815;GO:0070050;GO:0071902;GO:0099608;GO:0106056;GO:1903779;GO:0051480;GO:0010468;GO:0048172;GO:0002931;GO:0035725;GO:0050808;GO:0150104;, C:axon; C:axon terminus; C:basolateral plasma membrane; C:dendrite; C:dendritic spine; C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:presynapse; C:sarcolemma; C:synapse;, F:calcium ion transmembrane transporter activity; F:calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium:sodium antiporter activity; F:calmodulin binding; F:cation:cation antiporter activity; F:metal ion binding; F:sodium ion transmembrane transporter activity;, P:calcium ion export across plasma membrane; P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:cell communication; P:cellular calcium ion homeostasis; P:cognition; P:ion transport; P:learning; P:learning or memory; P:long-term synaptic potentiation; P:memory; P:metal ion transport; P:modulation of excitatory postsynaptic potential; P:neuron cellular homeostasis; P:positive regulation of protein serine/threonine kinase activity; P:regulation of action potential firing pattern; P:regulation of calcineurin-mediated signaling; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:regulation of gene expression; P:regulation of short-term neuronal synaptic plasticity; P:response to ischemia; P:sodium ion transmembrane transport; P:synapse organization; P:transport across blood-brain barrier;|Q9UPR5 B4DYQ9,Sodium/calcium exchanger 2,Na(+)/Ca(2+)-exchange protein 2;Solute carrier family 8 member 2;, PF03160;PF01699;PF16494;, GO:0030424;GO:0043679;GO:0016323;GO:0030425;GO:0043197;GO:0005887;GO:0016020;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0014069;GO:0098793;GO:0042383;GO:0045202;GO:0015085;GO:1905060;GO:0005432;GO:0005516;GO:0015491;GO:0046872;GO:0015081;GO:1990034;GO:0098703;GO:0070588;GO:0007154;GO:0006874;GO:0050890;GO:0006811;GO:0007612;GO:0007611;GO:0060291;GO:0007613;GO:0030001;GO:0098815;GO:0070050;GO:0071902;GO:0099608;GO:0106056;GO:1903779;GO:0051480;GO:0010468;GO:0048172;GO:0002931;GO:0035725;GO:0050808;GO:0150104;, C:axon; C:axon terminus; C:basolateral plasma membrane; C:dendrite; C:dendritic spine; C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:presynapse; C:sarcolemma; C:synapse;, F:calcium ion transmembrane transporter activity; F:calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium:sodium antiporter activity; F:calmodulin binding; F:cation:cation antiporter activity; F:metal ion binding; F:sodium ion transmembrane transporter activity;, P:calcium ion export across plasma membrane; P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:cell communication; P:cellular calcium ion homeostasis; P:cognition; P:ion transport; P:learning; P:learning or memory; P:long-term synaptic potentiation; P:memory; P:metal ion transport; P:modulation of excitatory postsynaptic potential; P:neuron cellular homeostasis; P:positive regulation of protein serine/threonine kinase activity; P:regulation of action potential firing pattern; P:regulation of calcineurin-mediated signaling; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:regulation of gene expression; P:regulation of short-term neuronal synaptic plasticity; P:response to ischemia; P:sodium ion transmembrane transport; P:synapse organization; P:transport across blood-brain barrier;|Q9UPR5 B4DYQ9,Sodium/calcium exchanger 2,Na(+)/Ca(2+)-exchange protein 2;Solute carrier family 8 member 2;, PF03160;PF01699;PF16494;, GO:0030424;GO:0043679;GO:0016323;GO:0030425;GO:0043197;GO:0005887;GO:0016020;GO:0043025;GO:0043204;GO:0005886;GO:0098794;GO:0014069;GO:0098793;GO:0042383;GO:0045202;GO:0015085;GO:1905060;GO:0005432;GO:0005516;GO:0015491;GO:0046872;GO:0015081;GO:1990034;GO:0098703;GO:0070588;GO:0007154;GO:0006874;GO:0050890;GO:0006811;GO:0007612;GO:0007611;GO:0060291;GO:0007613;GO:0030001;GO:0098815;GO:0070050;GO:0071902;GO:0099608;GO:0106056;GO:1903779;GO:0051480;GO:0010468;GO:0048172;GO:0002931;GO:0035725;GO:0050808;GO:0150104;, C:axon; C:axon terminus; C:basolateral plasma membrane; C:dendrite; C:dendritic spine; C:integral component of plasma membrane; C:membrane; C:neuronal cell body; C:perikaryon; C:plasma membrane; C:postsynapse; C:postsynaptic density; C:presynapse; C:sarcolemma; C:synapse;, F:calcium ion transmembrane transporter activity; F:calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration; F:calcium:sodium antiporter activity; F:calmodulin binding; F:cation:cation antiporter activity; F:metal ion binding; F:sodium ion transmembrane transporter activity;, P:calcium ion export across plasma membrane; P:calcium ion import across plasma membrane; P:calcium ion transmembrane transport; P:cell communication; P:cellular calcium ion homeostasis; P:cognition; P:ion transport; P:learning; P:learning or memory; P:long-term synaptic potentiation; P:memory; P:metal ion transport; P:modulation of excitatory postsynaptic potential; P:neuron cellular homeostasis; P:positive regulation of protein serine/threonine kinase activity; P:regulation of action potential firing pattern; P:regulation of calcineurin-mediated signaling; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; P:regulation of gene expression; P:regulation of short-term neuronal synaptic plasticity; P:response to ischemia; P:sodium ion transmembrane transport; P:synapse organization; P:transport across blood-brain barrier; scaffold190 indexed_genome mRNA 922146 931783 . + . ID=transcript_15507;Q99687 A8K1N5 Q6NT73 Q8TC66 Q9NPW2,Homeobox protein Meis3,Meis1-related protein 2;, PF05920;PF16493;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0009887;GO:0007420;GO:0009880;GO:0001654;GO:0008284;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ morphogenesis; P:brain development; P:embryonic pattern specification; P:eye development; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q99687 A8K1N5 Q6NT73 Q8TC66 Q9NPW2,Homeobox protein Meis3,Meis1-related protein 2;, PF05920;PF16493;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0009887;GO:0007420;GO:0009880;GO:0001654;GO:0008284;GO:0045944;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ morphogenesis; P:brain development; P:embryonic pattern specification; P:eye development; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|A8K0S8,Putative homeobox protein Meis3-like 2,, PF05920;PF16493;, GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:0009887;GO:0007420;GO:0009880;GO:0001654;GO:0008284;GO:0045944;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:animal organ morphogenesis; P:brain development; P:embryonic pattern specification; P:eye development; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold190 indexed_genome mRNA 945918 949208 . - . ID=transcript_15508;Q14147 B4DMY8,Probable ATP-dependent RNA helicase DHX34,DEAH box protein 34;, PF04408;PF00271;PF07717;, GO:0016020;GO:0005524;GO:0003723;GO:0003724;GO:2000623;GO:0000956;GO:0000184;, C:membrane;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; scaffold190 indexed_genome mRNA 949944 954297 . - . ID=transcript_15509;Q14147 B4DMY8,Probable ATP-dependent RNA helicase DHX34,DEAH box protein 34;, PF04408;PF00271;PF07717;, GO:0016020;GO:0005524;GO:0003723;GO:0003724;GO:2000623;GO:0000956;GO:0000184;, C:membrane;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; scaffold190 indexed_genome mRNA 966435 972108 . - . ID=transcript_15510;Q14147 B4DMY8,Probable ATP-dependent RNA helicase DHX34,DEAH box protein 34;, PF04408;PF00271;PF07717;, GO:0016020;GO:0005524;GO:0003723;GO:0003724;GO:2000623;GO:0000956;GO:0000184;, C:membrane;, F:ATP binding; F:RNA binding; F:RNA helicase activity;, P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; scaffold190 indexed_genome mRNA 974400 979677 . - . ID=transcript_15511;Q9P296 B2RA09,C5a anaphylatoxin chemotactic receptor 2,Complement component 5a receptor 2;G-protein coupled receptor 77;, PF00001;, GO:0045177;GO:0009925;GO:0016021;GO:0005886;GO:0004878;GO:0004875;GO:0004930;GO:0006935;GO:0002430;GO:0007186;GO:0006954;GO:0032715;GO:0090024;GO:0032720;GO:0007200;GO:0007204;GO:0050679;GO:0070374;GO:0030449;GO:0032677;, C:apical part of cell; C:basal plasma membrane; C:integral component of membrane; C:plasma membrane;, F:complement component C5a receptor activity; F:complement receptor activity; F:G protein-coupled receptor activity;, P:chemotaxis; P:complement receptor mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of interleukin-6 production; P:negative regulation of neutrophil chemotaxis; P:negative regulation of tumor necrosis factor production; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of epithelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:regulation of complement activation; P:regulation of interleukin-8 production; scaffold190 indexed_genome mRNA 988499 1001954 . - . ID=transcript_15512;P21730,C5a anaphylatoxin chemotactic receptor 1,C5a anaphylatoxin chemotactic receptor;, PF00001;, GO:0045177;GO:0016323;GO:0009986;GO:0005887;GO:0005886;GO:0030667;GO:0001856;GO:0004878;GO:0004875;GO:0004930;GO:0000187;GO:0007202;GO:0097242;GO:0031100;GO:0006915;GO:0048143;GO:0021534;GO:0006968;GO:0006935;GO:0050890;GO:0038178;GO:0002430;GO:0050830;GO:0007186;GO:0006955;GO:0006954;GO:0001774;GO:0042789;GO:0043524;GO:0030593;GO:0043312;GO:0007200;GO:0045766;GO:0007204;GO:0050679;GO:0070374;GO:0010759;GO:0090023;GO:0010575;GO:0099172;GO:0030449;GO:1902947;GO:0032496;GO:0032494;GO:0007606;GO:0007165;, C:apical part of cell; C:basolateral plasma membrane; C:cell surface; C:integral component of plasma membrane; C:plasma membrane; C:secretory granule membrane;, F:complement component C5a binding; F:complement component C5a receptor activity; F:complement receptor activity; F:G protein-coupled receptor activity;, P:activation of MAPK activity; P:activation of phospholipase C activity; P:amyloid-beta clearance; P:animal organ regeneration; P:apoptotic process; P:astrocyte activation; P:cell proliferation in hindbrain; P:cellular defense response; P:chemotaxis; P:cognition; P:complement component C5a signaling pathway; P:complement receptor mediated signaling pathway; P:defense response to Gram-positive bacterium; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:microglial cell activation; P:mRNA transcription by RNA polymerase II; P:negative regulation of neuron apoptotic process; P:neutrophil chemotaxis; P:neutrophil degranulation; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of epithelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of macrophage chemotaxis; P:positive regulation of neutrophil chemotaxis; P:positive regulation of vascular endothelial growth factor production; P:presynapse organization; P:regulation of complement activation; P:regulation of tau-protein kinase activity; P:response to lipopolysaccharide; P:response to peptidoglycan; P:sensory perception of chemical stimulus; P:signal transduction; scaffold190 indexed_genome mRNA 1059238 1060233 . - . ID=transcript_15513;Q9BXH1 B9EGI3 O00171 Q96PG9,Bcl-2-binding component 3, isoforms 1/2,JFY-1;p53 up-regulated modulator of apoptosis;, PF15826;, GO:0005829;GO:0005783;GO:0005741;GO:0005739;GO:0006919;GO:0097190;GO:0006974;GO:0071456;GO:0008340;GO:0097194;GO:0070059;GO:0032471;GO:0045926;GO:2001056;GO:1902237;GO:2001244;GO:1903896;GO:0043525;GO:0032464;GO:1900740;GO:0031334;GO:0090200;GO:0070245;GO:0001844;GO:0042981;GO:0001836;GO:0051209;GO:0034976;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial outer membrane; C:mitochondrion;, , P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic signaling pathway; P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:determination of adult lifespan; P:execution phase of apoptosis; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of growth; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of neuron apoptotic process; P:positive regulation of protein homooligomerization; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of thymocyte apoptotic process; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:release of cytochrome c from mitochondria; P:release of sequestered calcium ion into cytosol; P:response to endoplasmic reticulum stress; scaffold191 indexed_genome mRNA 360841 370360 . + . ID=transcript_15514;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold191 indexed_genome mRNA 376051 376695 . - . ID=transcript_15515;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold191 indexed_genome mRNA 382103 383948 . + . ID=transcript_15516;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold191 indexed_genome mRNA 401506 402137 . - . ID=transcript_15517;Q9Y696 Q9UFW9 Q9UQJ6,Chloride intracellular channel protein 4,Intracellular chloride ion channel protein p64H1;, , GO:0015629;GO:0045177;GO:0009986;GO:0005911;GO:0005813;GO:0034707;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0005902;GO:0030496;GO:0005739;GO:0016363;GO:0005634;GO:0048471;GO:0005886;GO:0005254;GO:0005244;GO:0001525;GO:0048754;GO:0030154;GO:0071277;GO:0006821;GO:0001886;GO:0035088;GO:0009566;GO:0030216;GO:0035264;GO:0030336;GO:0051493;GO:0034765;GO:0061299;GO:0007035;, C:actin cytoskeleton; C:apical part of cell; C:cell surface; C:cell-cell junction; C:centrosome; C:chloride channel complex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:microvillus; C:midbody; C:mitochondrion; C:nuclear matrix; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:chloride channel activity; F:voltage-gated ion channel activity;, P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:cell differentiation; P:cellular response to calcium ion; P:chloride transport; P:endothelial cell morphogenesis; P:establishment or maintenance of apical/basal cell polarity; P:fertilization; P:keratinocyte differentiation; P:multicellular organism growth; P:negative regulation of cell migration; P:regulation of cytoskeleton organization; P:regulation of ion transmembrane transport; P:retina vasculature morphogenesis in camera-type eye; P:vacuolar acidification; scaffold191 indexed_genome mRNA 406760 409817 . + . ID=transcript_15518;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold191 indexed_genome mRNA 574569 577074 . - . ID=transcript_15519;Q9BYG4 A8QM57,Partitioning defective 6 homolog gamma,PAR6D;, PF00564;PF00595;, GO:0016324;GO:0005923;GO:0005938;GO:0005829;GO:0005634;GO:0005886;GO:0032991;GO:0005080;GO:0070830;GO:0051301;GO:0007098;GO:0007163;GO:0060341;, C:apical plasma membrane; C:bicellular tight junction; C:cell cortex; C:cytosol; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:protein kinase C binding;, P:bicellular tight junction assembly; P:cell division; P:centrosome cycle; P:establishment or maintenance of cell polarity; P:regulation of cellular localization; scaffold191 indexed_genome mRNA 593963 616750 . - . ID=transcript_15520;Q6IQ32 A8K951 O94943 Q9H9P3,Activity-dependent neuroprotector homeobox protein 2,Zinc finger protein 508;, , GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0034599;GO:0071300;GO:0060548;GO:0030182;GO:0030307;GO:0010468;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;, P:cellular response to oxidative stress; P:cellular response to retinoic acid; P:negative regulation of cell death; P:neuron differentiation; P:positive regulation of cell growth; P:regulation of gene expression; scaffold191 indexed_genome mRNA 640517 649826 . - . ID=transcript_15521;Q8N0V3 Q6PF07 Q8WZ65 Q9H776,Putative ribosome-binding factor A, mitochondrial,, PF02033;, GO:0005739;GO:0006364;, C:mitochondrion;, , P:rRNA processing; scaffold191 indexed_genome mRNA 650074 655360 . + . ID=transcript_15522;Q8N0V3 Q6PF07 Q8WZ65 Q9H776,Putative ribosome-binding factor A, mitochondrial,, PF02033;, GO:0005739;GO:0006364;, C:mitochondrion;, , P:rRNA processing;|Q8N0V3 Q6PF07 Q8WZ65 Q9H776,Putative ribosome-binding factor A, mitochondrial,, PF02033;, GO:0005739;GO:0006364;, C:mitochondrion;, , P:rRNA processing; scaffold191 indexed_genome mRNA 656109 660448 . - . ID=transcript_15523;Q9UBQ7 Q5T945 Q9H3E9 Q9H636 Q9UKX1,Glyoxylate reductase/hydroxypyruvate reductase,, PF00389;PF02826;, GO:1902494;GO:0005737;GO:0005829;GO:0070062;GO:0005782;GO:0008465;GO:0030267;GO:0016618;GO:0051287;GO:0070402;GO:0042803;GO:0019752;GO:0007588;GO:0046487;, C:catalytic complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal matrix;, F:glycerate dehydrogenase activity; F:glyoxylate reductase (NADP+) activity; F:hydroxypyruvate reductase activity; F:NAD binding; F:NADPH binding; F:protein homodimerization activity;, P:carboxylic acid metabolic process; P:excretion; P:glyoxylate metabolic process;|Q9UBQ7 Q5T945 Q9H3E9 Q9H636 Q9UKX1,Glyoxylate reductase/hydroxypyruvate reductase,, PF00389;PF02826;, GO:1902494;GO:0005737;GO:0005829;GO:0070062;GO:0005782;GO:0008465;GO:0030267;GO:0016618;GO:0051287;GO:0070402;GO:0042803;GO:0019752;GO:0007588;GO:0046487;, C:catalytic complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:peroxisomal matrix;, F:glycerate dehydrogenase activity; F:glyoxylate reductase (NADP+) activity; F:hydroxypyruvate reductase activity; F:NAD binding; F:NADPH binding; F:protein homodimerization activity;, P:carboxylic acid metabolic process; P:excretion; P:glyoxylate metabolic process; scaffold191 indexed_genome mRNA 664022 691786 . + . ID=transcript_15524;P83876 B2RC18 O14834,Thioredoxin-like protein 4A,DIM1 protein homolog {ECO:0000303|PubMed:11054566, ECO:0000303|Ref.1};Spliceosomal U5 snRNP-specific 15 kDa protein {ECO:0000303|PubMed:10610776};Thioredoxin-like U5 snRNP protein U5-15kD;, PF02966;, GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0046540;GO:0005682;GO:0007049;GO:0051301;GO:0000398;GO:0000375;GO:0000245;, C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, , P:cell cycle; P:cell division; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly;|P83876 B2RC18 O14834,Thioredoxin-like protein 4A,DIM1 protein homolog {ECO:0000303|PubMed:11054566, ECO:0000303|Ref.1};Spliceosomal U5 snRNP-specific 15 kDa protein {ECO:0000303|PubMed:10610776};Thioredoxin-like U5 snRNP protein U5-15kD;, PF02966;, GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0046540;GO:0005682;GO:0007049;GO:0051301;GO:0000398;GO:0000375;GO:0000245;, C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, , P:cell cycle; P:cell division; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly;|P83876 B2RC18 O14834,Thioredoxin-like protein 4A,DIM1 protein homolog {ECO:0000303|PubMed:11054566, ECO:0000303|Ref.1};Spliceosomal U5 snRNP-specific 15 kDa protein {ECO:0000303|PubMed:10610776};Thioredoxin-like U5 snRNP protein U5-15kD;, PF02966;, GO:0005829;GO:0031965;GO:0005654;GO:0005634;GO:0005681;GO:0071005;GO:0046540;GO:0005682;GO:0007049;GO:0051301;GO:0000398;GO:0000375;GO:0000245;, C:cytosol; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type precatalytic spliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP;, , P:cell cycle; P:cell division; P:mRNA splicing, via spliceosome; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; scaffold191 indexed_genome mRNA 692846 700133 . - . ID=transcript_15525;C9JCN9 B2RXG9,Heat shock factor-binding protein 1-like protein 1,, PF06825;, GO:0005829;GO:0005634;GO:0003714;GO:0070370;, C:cytosol; C:nucleus;, F:transcription corepressor activity;, P:cellular heat acclimation; scaffold191 indexed_genome mRNA 739091 752823 . + . ID=transcript_15526;Q8N2U9 B7Z7D9 G5E989 Q9H6D0,Solute carrier family 66 member 2 {ECO:0000305},PQ-loop repeat-containing protein 1;, PF04193;, GO:0005829;GO:0005768;GO:0016021;GO:0005802;GO:0045332;GO:0042147;, C:cytosol; C:endosome; C:integral component of membrane; C:trans-Golgi network;, , P:phospholipid translocation; P:retrograde transport, endosome to Golgi;|Q8N2U9 B7Z7D9 G5E989 Q9H6D0,Solute carrier family 66 member 2 {ECO:0000305},PQ-loop repeat-containing protein 1;, PF04193;, GO:0005829;GO:0005768;GO:0016021;GO:0005802;GO:0045332;GO:0042147;, C:cytosol; C:endosome; C:integral component of membrane; C:trans-Golgi network;, , P:phospholipid translocation; P:retrograde transport, endosome to Golgi; scaffold191 indexed_genome mRNA 831870 855079 . - . ID=transcript_15527;Q9Y5B0 A8MY97 Q7Z644 Q96BZ1 Q9Y6F5,RNA polymerase II subunit A C-terminal domain phosphatase,TFIIF-associating CTD phosphatase;, PF09309;PF03031;, GO:0005813;GO:0005737;GO:0043231;GO:0030496;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0051233;GO:0000922;GO:0106306;GO:0106307;GO:0008420;GO:0030957;GO:0001096;GO:0051301;GO:0070940;GO:0010458;GO:0061052;GO:0043923;GO:0050434;GO:0006470;GO:0006366;GO:0006368;, C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:midbody; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle midzone; C:spindle pole;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity; F:Tat protein binding; F:TFIIF-class transcription factor complex binding;, P:cell division; P:dephosphorylation of RNA polymerase II C-terminal domain; P:exit from mitosis; P:negative regulation of cell growth involved in cardiac muscle cell development; P:positive regulation by host of viral transcription; P:positive regulation of viral transcription; P:protein dephosphorylation; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9Y5B0 A8MY97 Q7Z644 Q96BZ1 Q9Y6F5,RNA polymerase II subunit A C-terminal domain phosphatase,TFIIF-associating CTD phosphatase;, PF09309;PF03031;, GO:0005813;GO:0005737;GO:0043231;GO:0030496;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0051233;GO:0000922;GO:0106306;GO:0106307;GO:0008420;GO:0030957;GO:0001096;GO:0051301;GO:0070940;GO:0010458;GO:0061052;GO:0043923;GO:0050434;GO:0006470;GO:0006366;GO:0006368;, C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:midbody; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle midzone; C:spindle pole;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity; F:Tat protein binding; F:TFIIF-class transcription factor complex binding;, P:cell division; P:dephosphorylation of RNA polymerase II C-terminal domain; P:exit from mitosis; P:negative regulation of cell growth involved in cardiac muscle cell development; P:positive regulation by host of viral transcription; P:positive regulation of viral transcription; P:protein dephosphorylation; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9Y5B0 A8MY97 Q7Z644 Q96BZ1 Q9Y6F5,RNA polymerase II subunit A C-terminal domain phosphatase,TFIIF-associating CTD phosphatase;, PF09309;PF03031;, GO:0005813;GO:0005737;GO:0043231;GO:0030496;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0051233;GO:0000922;GO:0106306;GO:0106307;GO:0008420;GO:0030957;GO:0001096;GO:0051301;GO:0070940;GO:0010458;GO:0061052;GO:0043923;GO:0050434;GO:0006470;GO:0006366;GO:0006368;, C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:midbody; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle midzone; C:spindle pole;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity; F:Tat protein binding; F:TFIIF-class transcription factor complex binding;, P:cell division; P:dephosphorylation of RNA polymerase II C-terminal domain; P:exit from mitosis; P:negative regulation of cell growth involved in cardiac muscle cell development; P:positive regulation by host of viral transcription; P:positive regulation of viral transcription; P:protein dephosphorylation; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9Y5B0 A8MY97 Q7Z644 Q96BZ1 Q9Y6F5,RNA polymerase II subunit A C-terminal domain phosphatase,TFIIF-associating CTD phosphatase;, PF09309;PF03031;, GO:0005813;GO:0005737;GO:0043231;GO:0030496;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0051233;GO:0000922;GO:0106306;GO:0106307;GO:0008420;GO:0030957;GO:0001096;GO:0051301;GO:0070940;GO:0010458;GO:0061052;GO:0043923;GO:0050434;GO:0006470;GO:0006366;GO:0006368;, C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:midbody; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle midzone; C:spindle pole;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity; F:Tat protein binding; F:TFIIF-class transcription factor complex binding;, P:cell division; P:dephosphorylation of RNA polymerase II C-terminal domain; P:exit from mitosis; P:negative regulation of cell growth involved in cardiac muscle cell development; P:positive regulation by host of viral transcription; P:positive regulation of viral transcription; P:protein dephosphorylation; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|Q9Y5B0 A8MY97 Q7Z644 Q96BZ1 Q9Y6F5,RNA polymerase II subunit A C-terminal domain phosphatase,TFIIF-associating CTD phosphatase;, PF09309;PF03031;, GO:0005813;GO:0005737;GO:0043231;GO:0030496;GO:0005654;GO:0005634;GO:0032991;GO:0005819;GO:0051233;GO:0000922;GO:0106306;GO:0106307;GO:0008420;GO:0030957;GO:0001096;GO:0051301;GO:0070940;GO:0010458;GO:0061052;GO:0043923;GO:0050434;GO:0006470;GO:0006366;GO:0006368;, C:centrosome; C:cytoplasm; C:intracellular membrane-bounded organelle; C:midbody; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle; C:spindle midzone; C:spindle pole;, F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity; F:Tat protein binding; F:TFIIF-class transcription factor complex binding;, P:cell division; P:dephosphorylation of RNA polymerase II C-terminal domain; P:exit from mitosis; P:negative regulation of cell growth involved in cardiac muscle cell development; P:positive regulation by host of viral transcription; P:positive regulation of viral transcription; P:protein dephosphorylation; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold191 indexed_genome mRNA 925707 1003904 . - . ID=transcript_15528;Q15793 Q2M1S3,Nuclear factor of activated T-cells, cytoplasmic 1,NFAT transcription complex cytosolic component;, PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0005528;GO:0048273;GO:0000978;GO:0001225;GO:0001085;GO:1990837;GO:0008134;GO:0003180;GO:0033173;GO:0038095;GO:0035556;GO:1905064;GO:0030178;GO:0045944;GO:0045893;GO:0003184;GO:0006357;GO:0007223;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:FK506 binding; F:mitogen-activated protein kinase p38 binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription factor binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:aortic valve morphogenesis; P:calcineurin-NFAT signaling cascade; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of vascular associated smooth muscle cell differentiation; P:negative regulation of Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:pulmonary valve morphogenesis; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway, calcium modulating pathway;|Q15793 Q2M1S3,Nuclear factor of activated T-cells, cytoplasmic 1,NFAT transcription complex cytosolic component;, PF16179;PF00554;, GO:0000785;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0001228;GO:0003700;GO:0000981;GO:0005528;GO:0048273;GO:0000978;GO:0001225;GO:0001085;GO:1990837;GO:0008134;GO:0003180;GO:0033173;GO:0038095;GO:0035556;GO:1905064;GO:0030178;GO:0045944;GO:0045893;GO:0003184;GO:0006357;GO:0007223;, C:chromatin; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:FK506 binding; F:mitogen-activated protein kinase p38 binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription coactivator binding; F:RNA polymerase II transcription factor binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:aortic valve morphogenesis; P:calcineurin-NFAT signaling cascade; P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of vascular associated smooth muscle cell differentiation; P:negative regulation of Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:pulmonary valve morphogenesis; P:regulation of transcription by RNA polymerase II; P:Wnt signaling pathway, calcium modulating pathway; scaffold192 indexed_genome mRNA 5660 15047 . - . ID=transcript_15529;Q96RK0 Q7LGI1 Q9UEG5 Q9Y6T1,Protein capicua homolog,, PF00505;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0000981;GO:0000977;GO:0007420;GO:0007612;GO:0007613;GO:0045892;GO:0006357;GO:0035176;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:brain development; P:learning; P:memory; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:social behavior;|Q96RK0 Q7LGI1 Q9UEG5 Q9Y6T1,Protein capicua homolog,, PF00505;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0000981;GO:0000977;GO:0007420;GO:0007612;GO:0007613;GO:0045892;GO:0006357;GO:0035176;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:brain development; P:learning; P:memory; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:social behavior;|Q96RK0 Q7LGI1 Q9UEG5 Q9Y6T1,Protein capicua homolog,, PF00505;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0000981;GO:0000977;GO:0007420;GO:0007612;GO:0007613;GO:0045892;GO:0006357;GO:0035176;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:brain development; P:learning; P:memory; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:social behavior; scaffold192 indexed_genome mRNA 15774 18452 . - . ID=transcript_15530;Q15102 Q53X88,Platelet-activating factor acetylhydrolase IB subunit alpha1 {ECO:0000305},PAF acetylhydrolase 29 kDa subunit;PAF-AH subunit gamma;, PF13472;, GO:0008247;GO:0005737;GO:0005829;GO:0016020;GO:0003847;GO:0042802;GO:0047179;GO:0046982;GO:0042803;GO:0044877;GO:0007420;GO:0016042;GO:0006629;GO:0007399;GO:0007283;, C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:cytoplasm; C:cytosol; C:membrane;, F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:identical protein binding; F:platelet-activating factor acetyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding;, P:brain development; P:lipid catabolic process; P:lipid metabolic process; P:nervous system development; P:spermatogenesis; scaffold192 indexed_genome mRNA 20968 23070 . + . ID=transcript_15531;A6NJB7 A8K663 B3KW48 Q6P584,Proline-rich protein 19,, PF15455; scaffold192 indexed_genome mRNA 34701 41450 . + . ID=transcript_15532;Q8NBT3,Transmembrane protein 145,, PF10192;, GO:0016021;GO:0007186;GO:0019236;, C:integral component of membrane;, , P:G protein-coupled receptor signaling pathway; P:response to pheromone;|Q8NBT3,Transmembrane protein 145,, PF10192;, GO:0016021;GO:0007186;GO:0019236;, C:integral component of membrane;, , P:G protein-coupled receptor signaling pathway; P:response to pheromone;|Q8NBT3,Transmembrane protein 145,, PF10192;, GO:0016021;GO:0007186;GO:0019236;, C:integral component of membrane;, , P:G protein-coupled receptor signaling pathway; P:response to pheromone;|Q8NBT3,Transmembrane protein 145,, PF10192;, GO:0016021;GO:0007186;GO:0019236;, C:integral component of membrane;, , P:G protein-coupled receptor signaling pathway; P:response to pheromone; scaffold192 indexed_genome mRNA 41861 82988 . + . ID=transcript_15533;Q7Z7M0 A8KAY0 O75097,Multiple epidermal growth factor-like domains protein 8,Epidermal growth factor-like protein 4;, PF00431;PF12947;PF07645;PF00053;PF01437;, GO:0070062;GO:0016021;GO:0005634;GO:0005509;GO:0009887;GO:0030509;GO:0042074;GO:0060976;GO:0097094;GO:0071907;GO:0061371;GO:0060971;GO:0003143;GO:0030326;GO:0048704;GO:0055113;GO:0097155;GO:0060972;GO:0035108;GO:0045879;GO:0048842;GO:0010468;GO:0009888;, C:extracellular exosome; C:integral component of membrane; C:nucleus;, F:calcium ion binding;, P:animal organ morphogenesis; P:BMP signaling pathway; P:cell migration involved in gastrulation; P:coronary vasculature development; P:craniofacial suture morphogenesis; P:determination of digestive tract left/right asymmetry; P:determination of heart left/right asymmetry; P:embryonic heart tube left/right pattern formation; P:embryonic heart tube morphogenesis; P:embryonic limb morphogenesis; P:embryonic skeletal system morphogenesis; P:epiboly involved in gastrulation with mouth forming second; P:fasciculation of sensory neuron axon; P:left/right pattern formation; P:limb morphogenesis; P:negative regulation of smoothened signaling pathway; P:positive regulation of axon extension involved in axon guidance; P:regulation of gene expression; P:tissue development;|Q7Z7M0 A8KAY0 O75097,Multiple epidermal growth factor-like domains protein 8,Epidermal growth factor-like protein 4;, PF00431;PF12947;PF07645;PF00053;PF01437;, GO:0070062;GO:0016021;GO:0005634;GO:0005509;GO:0009887;GO:0030509;GO:0042074;GO:0060976;GO:0097094;GO:0071907;GO:0061371;GO:0060971;GO:0003143;GO:0030326;GO:0048704;GO:0055113;GO:0097155;GO:0060972;GO:0035108;GO:0045879;GO:0048842;GO:0010468;GO:0009888;, C:extracellular exosome; C:integral component of membrane; C:nucleus;, F:calcium ion binding;, P:animal organ morphogenesis; P:BMP signaling pathway; P:cell migration involved in gastrulation; P:coronary vasculature development; P:craniofacial suture morphogenesis; P:determination of digestive tract left/right asymmetry; P:determination of heart left/right asymmetry; P:embryonic heart tube left/right pattern formation; P:embryonic heart tube morphogenesis; P:embryonic limb morphogenesis; P:embryonic skeletal system morphogenesis; P:epiboly involved in gastrulation with mouth forming second; P:fasciculation of sensory neuron axon; P:left/right pattern formation; P:limb morphogenesis; P:negative regulation of smoothened signaling pathway; P:positive regulation of axon extension involved in axon guidance; P:regulation of gene expression; P:tissue development;|Q7Z7M0 A8KAY0 O75097,Multiple epidermal growth factor-like domains protein 8,Epidermal growth factor-like protein 4;, PF00431;PF12947;PF07645;PF00053;PF01437;, GO:0070062;GO:0016021;GO:0005634;GO:0005509;GO:0009887;GO:0030509;GO:0042074;GO:0060976;GO:0097094;GO:0071907;GO:0061371;GO:0060971;GO:0003143;GO:0030326;GO:0048704;GO:0055113;GO:0097155;GO:0060972;GO:0035108;GO:0045879;GO:0048842;GO:0010468;GO:0009888;, C:extracellular exosome; C:integral component of membrane; C:nucleus;, F:calcium ion binding;, P:animal organ morphogenesis; P:BMP signaling pathway; P:cell migration involved in gastrulation; P:coronary vasculature development; P:craniofacial suture morphogenesis; P:determination of digestive tract left/right asymmetry; P:determination of heart left/right asymmetry; P:embryonic heart tube left/right pattern formation; P:embryonic heart tube morphogenesis; P:embryonic limb morphogenesis; P:embryonic skeletal system morphogenesis; P:epiboly involved in gastrulation with mouth forming second; P:fasciculation of sensory neuron axon; P:left/right pattern formation; P:limb morphogenesis; P:negative regulation of smoothened signaling pathway; P:positive regulation of axon extension involved in axon guidance; P:regulation of gene expression; P:tissue development;|Q7Z7M0 A8KAY0 O75097,Multiple epidermal growth factor-like domains protein 8,Epidermal growth factor-like protein 4;, PF00431;PF12947;PF07645;PF00053;PF01437;, GO:0070062;GO:0016021;GO:0005634;GO:0005509;GO:0009887;GO:0030509;GO:0042074;GO:0060976;GO:0097094;GO:0071907;GO:0061371;GO:0060971;GO:0003143;GO:0030326;GO:0048704;GO:0055113;GO:0097155;GO:0060972;GO:0035108;GO:0045879;GO:0048842;GO:0010468;GO:0009888;, C:extracellular exosome; C:integral component of membrane; C:nucleus;, F:calcium ion binding;, P:animal organ morphogenesis; P:BMP signaling pathway; P:cell migration involved in gastrulation; P:coronary vasculature development; P:craniofacial suture morphogenesis; P:determination of digestive tract left/right asymmetry; P:determination of heart left/right asymmetry; P:embryonic heart tube left/right pattern formation; P:embryonic heart tube morphogenesis; P:embryonic limb morphogenesis; P:embryonic skeletal system morphogenesis; P:epiboly involved in gastrulation with mouth forming second; P:fasciculation of sensory neuron axon; P:left/right pattern formation; P:limb morphogenesis; P:negative regulation of smoothened signaling pathway; P:positive regulation of axon extension involved in axon guidance; P:regulation of gene expression; P:tissue development;|Q7Z7M0 A8KAY0 O75097,Multiple epidermal growth factor-like domains protein 8,Epidermal growth factor-like protein 4;, PF00431;PF12947;PF07645;PF00053;PF01437;, GO:0070062;GO:0016021;GO:0005634;GO:0005509;GO:0009887;GO:0030509;GO:0042074;GO:0060976;GO:0097094;GO:0071907;GO:0061371;GO:0060971;GO:0003143;GO:0030326;GO:0048704;GO:0055113;GO:0097155;GO:0060972;GO:0035108;GO:0045879;GO:0048842;GO:0010468;GO:0009888;, C:extracellular exosome; C:integral component of membrane; C:nucleus;, F:calcium ion binding;, P:animal organ morphogenesis; P:BMP signaling pathway; P:cell migration involved in gastrulation; P:coronary vasculature development; P:craniofacial suture morphogenesis; P:determination of digestive tract left/right asymmetry; P:determination of heart left/right asymmetry; P:embryonic heart tube left/right pattern formation; P:embryonic heart tube morphogenesis; P:embryonic limb morphogenesis; P:embryonic skeletal system morphogenesis; P:epiboly involved in gastrulation with mouth forming second; P:fasciculation of sensory neuron axon; P:left/right pattern formation; P:limb morphogenesis; P:negative regulation of smoothened signaling pathway; P:positive regulation of axon extension involved in axon guidance; P:regulation of gene expression; P:tissue development;|Q7Z7M0 A8KAY0 O75097,Multiple epidermal growth factor-like domains protein 8,Epidermal growth factor-like protein 4;, PF00431;PF12947;PF07645;PF00053;PF01437;, GO:0070062;GO:0016021;GO:0005634;GO:0005509;GO:0009887;GO:0030509;GO:0042074;GO:0060976;GO:0097094;GO:0071907;GO:0061371;GO:0060971;GO:0003143;GO:0030326;GO:0048704;GO:0055113;GO:0097155;GO:0060972;GO:0035108;GO:0045879;GO:0048842;GO:0010468;GO:0009888;, C:extracellular exosome; C:integral component of membrane; C:nucleus;, F:calcium ion binding;, P:animal organ morphogenesis; P:BMP signaling pathway; P:cell migration involved in gastrulation; P:coronary vasculature development; P:craniofacial suture morphogenesis; P:determination of digestive tract left/right asymmetry; P:determination of heart left/right asymmetry; P:embryonic heart tube left/right pattern formation; P:embryonic heart tube morphogenesis; P:embryonic limb morphogenesis; P:embryonic skeletal system morphogenesis; P:epiboly involved in gastrulation with mouth forming second; P:fasciculation of sensory neuron axon; P:left/right pattern formation; P:limb morphogenesis; P:negative regulation of smoothened signaling pathway; P:positive regulation of axon extension involved in axon guidance; P:regulation of gene expression; P:tissue development; scaffold192 indexed_genome mRNA 97602 115039 . + . ID=transcript_15534;Q05469 Q3LRT2 Q6NSL7,Hormone-sensitive lipase,Monoacylglycerol lipase LIPE;Retinyl ester hydrolase {ECO:0000303|PubMed:15955102};, PF07859;PF06350;, GO:0005901;GO:0005829;GO:0005811;GO:0016020;GO:0102259;GO:0102258;GO:0047372;GO:0047376;GO:0033878;GO:0050253;GO:0004771;GO:0004806;GO:0008203;GO:0046340;GO:0046485;GO:0016042;GO:0006468;GO:0019433;, C:caveola; C:cytosol; C:lipid droplet; C:membrane;, F:1,2-diacylglycerol acylhydrolase activity; F:1,3-diacylglycerol acylhydrolase activity; F:acylglycerol lipase activity; F:all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity; F:hormone-sensitive lipase activity; F:retinyl-palmitate esterase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:cholesterol metabolic process; P:diacylglycerol catabolic process; P:ether lipid metabolic process; P:lipid catabolic process; P:protein phosphorylation; P:triglyceride catabolic process;|Q05469 Q3LRT2 Q6NSL7,Hormone-sensitive lipase,Monoacylglycerol lipase LIPE;Retinyl ester hydrolase {ECO:0000303|PubMed:15955102};, PF07859;PF06350;, GO:0005901;GO:0005829;GO:0005811;GO:0016020;GO:0102259;GO:0102258;GO:0047372;GO:0047376;GO:0033878;GO:0050253;GO:0004771;GO:0004806;GO:0008203;GO:0046340;GO:0046485;GO:0016042;GO:0006468;GO:0019433;, C:caveola; C:cytosol; C:lipid droplet; C:membrane;, F:1,2-diacylglycerol acylhydrolase activity; F:1,3-diacylglycerol acylhydrolase activity; F:acylglycerol lipase activity; F:all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity; F:hormone-sensitive lipase activity; F:retinyl-palmitate esterase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:cholesterol metabolic process; P:diacylglycerol catabolic process; P:ether lipid metabolic process; P:lipid catabolic process; P:protein phosphorylation; P:triglyceride catabolic process;|Q05469 Q3LRT2 Q6NSL7,Hormone-sensitive lipase,Monoacylglycerol lipase LIPE;Retinyl ester hydrolase {ECO:0000303|PubMed:15955102};, PF07859;PF06350;, GO:0005901;GO:0005829;GO:0005811;GO:0016020;GO:0102259;GO:0102258;GO:0047372;GO:0047376;GO:0033878;GO:0050253;GO:0004771;GO:0004806;GO:0008203;GO:0046340;GO:0046485;GO:0016042;GO:0006468;GO:0019433;, C:caveola; C:cytosol; C:lipid droplet; C:membrane;, F:1,2-diacylglycerol acylhydrolase activity; F:1,3-diacylglycerol acylhydrolase activity; F:acylglycerol lipase activity; F:all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity; F:hormone-sensitive lipase activity; F:retinyl-palmitate esterase activity; F:sterol esterase activity; F:triglyceride lipase activity;, P:cholesterol metabolic process; P:diacylglycerol catabolic process; P:ether lipid metabolic process; P:lipid catabolic process; P:protein phosphorylation; P:triglyceride catabolic process; scaffold192 indexed_genome mRNA 163018 180730 . - . ID=transcript_15535;P40199 Q13774 Q14920 Q53XP7,Carcinoembryonic antigen-related cell adhesion molecule 6,Non-specific crossreacting antigen;Normal cross-reacting antigen;, PF13895;PF07686;, GO:0031225;GO:0016324;GO:0035577;GO:0009986;GO:0005615;GO:0005886;GO:0042802;GO:0046982;GO:0006915;GO:0007157;GO:0007156;GO:0050900;GO:2000811;GO:0043312;GO:0030335;GO:0008284;GO:1904906;GO:0034116;GO:0007165;, C:anchored component of membrane; C:apical plasma membrane; C:azurophil granule membrane; C:cell surface; C:extracellular space; C:plasma membrane;, F:identical protein binding; F:protein heterodimerization activity;, P:apoptotic process; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte migration; P:negative regulation of anoikis; P:neutrophil degranulation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell-matrix adhesion via fibronectin; P:positive regulation of heterotypic cell-cell adhesion; P:signal transduction; scaffold192 indexed_genome mRNA 266399 273348 . + . ID=transcript_15536;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|Q68D85 Q7Z3M6,Natural cytotoxicity triggering receptor 3 ligand 1,B7 homolog 6;, PF07654;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response; scaffold192 indexed_genome mRNA 326528 330085 . + . ID=transcript_15537;Q9NW81 B4DDC0 B4DMZ4 B4DP55 B4DXE8 F5H4W7 K7EMF6 Q96D43,Distal membrane-arm assembly complex protein 2 {ECO:0000305},ATP synthase subunit s-like protein {ECO:0000305};, , GO:0005739;GO:0019005;GO:0032981;GO:0031146;, C:mitochondrion; C:SCF ubiquitin ligase complex;, , P:mitochondrial respiratory chain complex I assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9NW81 B4DDC0 B4DMZ4 B4DP55 B4DXE8 F5H4W7 K7EMF6 Q96D43,Distal membrane-arm assembly complex protein 2 {ECO:0000305},ATP synthase subunit s-like protein {ECO:0000305};, , GO:0005739;GO:0019005;GO:0032981;GO:0031146;, C:mitochondrion; C:SCF ubiquitin ligase complex;, , P:mitochondrial respiratory chain complex I assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9NW81 B4DDC0 B4DMZ4 B4DP55 B4DXE8 F5H4W7 K7EMF6 Q96D43,Distal membrane-arm assembly complex protein 2 {ECO:0000305},ATP synthase subunit s-like protein {ECO:0000305};, , GO:0005739;GO:0019005;GO:0032981;GO:0031146;, C:mitochondrion; C:SCF ubiquitin ligase complex;, , P:mitochondrial respiratory chain complex I assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9NW81 B4DDC0 B4DMZ4 B4DP55 B4DXE8 F5H4W7 K7EMF6 Q96D43,Distal membrane-arm assembly complex protein 2 {ECO:0000305},ATP synthase subunit s-like protein {ECO:0000305};, , GO:0005739;GO:0019005;GO:0032981;GO:0031146;, C:mitochondrion; C:SCF ubiquitin ligase complex;, , P:mitochondrial respiratory chain complex I assembly; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold192 indexed_genome mRNA 334698 356020 . - . ID=transcript_15538;Q7Z7M8,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8,, PF01762;, GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0008376;GO:0008375;GO:0008532;GO:0016262;GO:0016266;GO:0030311;GO:0006486;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; F:protein N-acetylglucosaminyltransferase activity;, P:O-glycan processing; P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation;|P12694 B4DP47 E7EW46 Q16034 Q16472,2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial,Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain;, PF00676;, GO:0005947;GO:0005759;GO:0005739;GO:0003863;GO:0003826;GO:0016831;GO:0046872;GO:0009083;, C:mitochondrial alpha-ketoglutarate dehydrogenase complex; C:mitochondrial matrix; C:mitochondrion;, F:3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; F:alpha-ketoacid dehydrogenase activity; F:carboxy-lyase activity; F:metal ion binding;, P:branched-chain amino acid catabolic process; scaffold192 indexed_genome mRNA 356211 365428 . + . ID=transcript_15539;Q9NQT4 Q32Q81 Q8NG16 Q96I89,Exosome complex component RRP46,Chronic myelogenous leukemia tumor antigen 28;Exosome component 5;Ribosomal RNA-processing protein 46;p12B;, PF01138;PF03725;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0035327;GO:0000175;GO:0003723;GO:0051607;GO:0045006;GO:0043928;GO:0071028;GO:0034427;GO:0071051;GO:0043488;GO:0016075;GO:0006364;GO:0034475;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:transcriptionally active chromatin;, F:3'-5'-exoribonuclease activity; F:RNA binding;, P:defense response to virus; P:DNA deamination; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear mRNA surveillance; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyadenylation-dependent snoRNA 3'-end processing; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U4 snRNA 3'-end processing;|Q9NQT4 Q32Q81 Q8NG16 Q96I89,Exosome complex component RRP46,Chronic myelogenous leukemia tumor antigen 28;Exosome component 5;Ribosomal RNA-processing protein 46;p12B;, PF01138;PF03725;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0035327;GO:0000175;GO:0003723;GO:0051607;GO:0045006;GO:0043928;GO:0071028;GO:0034427;GO:0071051;GO:0043488;GO:0016075;GO:0006364;GO:0034475;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:transcriptionally active chromatin;, F:3'-5'-exoribonuclease activity; F:RNA binding;, P:defense response to virus; P:DNA deamination; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear mRNA surveillance; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyadenylation-dependent snoRNA 3'-end processing; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U4 snRNA 3'-end processing;|Q9NQT4 Q32Q81 Q8NG16 Q96I89,Exosome complex component RRP46,Chronic myelogenous leukemia tumor antigen 28;Exosome component 5;Ribosomal RNA-processing protein 46;p12B;, PF01138;PF03725;, GO:0005737;GO:0000177;GO:0005829;GO:0000178;GO:0000176;GO:0005730;GO:0005654;GO:0035327;GO:0000175;GO:0003723;GO:0051607;GO:0045006;GO:0043928;GO:0071028;GO:0034427;GO:0071051;GO:0043488;GO:0016075;GO:0006364;GO:0034475;, C:cytoplasm; C:cytoplasmic exosome (RNase complex); C:cytosol; C:exosome (RNase complex); C:nuclear exosome (RNase complex); C:nucleolus; C:nucleoplasm; C:transcriptionally active chromatin;, F:3'-5'-exoribonuclease activity; F:RNA binding;, P:defense response to virus; P:DNA deamination; P:exonucleolytic catabolism of deadenylated mRNA; P:nuclear mRNA surveillance; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; P:polyadenylation-dependent snoRNA 3'-end processing; P:regulation of mRNA stability; P:rRNA catabolic process; P:rRNA processing; P:U4 snRNA 3'-end processing; scaffold192 indexed_genome mRNA 380592 387881 . + . ID=transcript_15540;Q9BPU9,B9 domain-containing protein 2,MKS1-related protein 2;, PF07162;, GO:0005813;GO:0036064;GO:0005829;GO:0016020;GO:0036038;GO:0005634;GO:0043015;GO:0097711;GO:0060271;GO:0007052;, C:centrosome; C:ciliary basal body; C:cytosol; C:membrane; C:MKS complex; C:nucleus;, F:gamma-tubulin binding;, P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:mitotic spindle organization; scaffold192 indexed_genome mRNA 388438 397503 . + . ID=transcript_15541;P01137 A8K792 Q9UCG4,Transforming growth factor beta-1 proprotein,, PF00019;PF00688;, GO:0072562;GO:0009986;GO:0062023;GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0005634;GO:0005886;GO:0031093;GO:0003823;GO:0005125;GO:0019899;GO:0008083;GO:0042802;GO:0034713;GO:0005114;GO:0034714;GO:0003180;GO:0006754;GO:0030509;GO:0007050;GO:0016477;GO:0045216;GO:0071407;GO:0071560;GO:0002062;GO:0007182;GO:0002248;GO:0019221;GO:1990402;GO:0007173;GO:0001837;GO:0085029;GO:0097191;GO:0007507;GO:0003179;GO:0002244;GO:0030214;GO:0006954;GO:0050900;GO:0031663;GO:0048535;GO:0010742;GO:0000165;GO:0031293;GO:0070168;GO:0043537;GO:0045786;GO:0045596;GO:0030308;GO:0008285;GO:0022408;GO:0045918;GO:0050680;GO:0010716;GO:0045599;GO:0010629;GO:0060965;GO:1900126;GO:0010936;GO:0045930;GO:0045662;GO:1902894;GO:1903799;GO:1903077;GO:0001933;GO:0048642;GO:0045892;GO:0030512;GO:0001843;GO:0021915;GO:0043932;GO:0060389;GO:0006796;GO:0002576;GO:0043536;GO:0030501;GO:0090263;GO:2000727;GO:0051781;GO:0030335;GO:0008284;GO:0032270;GO:0050921;GO:0032967;GO:0010718;GO:0070374;GO:1901203;GO:0010763;GO:0010628;GO:0032740;GO:0048298;GO:0043406;GO:0014008;GO:1901666;GO:0010862;GO:0033138;GO:0010800;GO:0050731;GO:0043552;GO:1902895;GO:1903800;GO:0035307;GO:0042307;GO:0051897;GO:1900182;GO:0001934;GO:0050714;GO:0031334;GO:0060391;GO:0032930;GO:0045944;GO:2000679;GO:0045893;GO:0010575;GO:0043117;GO:0006611;GO:0043491;GO:0006468;GO:0032801;GO:0051098;GO:0060312;GO:0030334;GO:0042127;GO:0051101;GO:0042306;GO:0060390;GO:0016202;GO:0017015;GO:0070723;GO:0032355;GO:0032570;GO:0009611;GO:0007435;GO:0007183;GO:0060395;GO:0007179;GO:1905313;GO:0001570;GO:0055010;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:nucleus; C:plasma membrane; C:platelet alpha granule lumen;, F:antigen binding; F:cytokine activity; F:enzyme binding; F:growth factor activity; F:identical protein binding; F:type I transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding; F:type III transforming growth factor beta receptor binding;, P:aortic valve morphogenesis; P:ATP biosynthetic process; P:BMP signaling pathway; P:cell cycle arrest; P:cell migration; P:cell-cell junction organization; P:cellular response to organic cyclic compound; P:cellular response to transforming growth factor beta stimulus; P:chondrocyte differentiation; P:common-partner SMAD protein phosphorylation; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:embryonic liver development; P:epidermal growth factor receptor signaling pathway; P:epithelial to mesenchymal transition; P:extracellular matrix assembly; P:extrinsic apoptotic signaling pathway; P:heart development; P:heart valve morphogenesis; P:hematopoietic progenitor cell differentiation; P:hyaluronan catabolic process; P:inflammatory response; P:leukocyte migration; P:lipopolysaccharide-mediated signaling pathway; P:lymph node development; P:macrophage derived foam cell differentiation; P:MAPK cascade; P:membrane protein intracellular domain proteolysis; P:negative regulation of biomineral tissue development; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell cycle; P:negative regulation of cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of cytolysis; P:negative regulation of epithelial cell proliferation; P:negative regulation of extracellular matrix disassembly; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of gene silencing by miRNA; P:negative regulation of hyaluronan biosynthetic process; P:negative regulation of macrophage cytokine production; P:negative regulation of mitotic cell cycle; P:negative regulation of myoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of protein localization to plasma membrane; P:negative regulation of protein phosphorylation; P:negative regulation of skeletal muscle tissue development; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neural tube closure; P:neural tube development; P:ossification involved in bone remodeling; P:pathway-restricted SMAD protein phosphorylation; P:phosphate-containing compound metabolic process; P:platelet degranulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of bone mineralization; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein metabolic process; P:positive regulation of chemotaxis; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extracellular matrix assembly; P:positive regulation of fibroblast migration; P:positive regulation of gene expression; P:positive regulation of interleukin-17 production; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of MAP kinase activity; P:positive regulation of microglia differentiation; P:positive regulation of NAD+ ADP-ribosyltransferase activity; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein dephosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein secretion; P:positive regulation of protein-containing complex assembly; P:positive regulation of SMAD protein signal transduction; P:positive regulation of superoxide anion generation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular permeability; P:protein export from nucleus; P:protein kinase B signaling; P:protein phosphorylation; P:receptor catabolic process; P:regulation of binding; P:regulation of blood vessel remodeling; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA binding; P:regulation of protein import into nucleus; P:regulation of SMAD protein signal transduction; P:regulation of striated muscle tissue development; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to cholesterol; P:response to estradiol; P:response to progesterone; P:response to wounding; P:salivary gland morphogenesis; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway involved in heart development; P:vasculogenesis; P:ventricular cardiac muscle tissue morphogenesis;|P01137 A8K792 Q9UCG4,Transforming growth factor beta-1 proprotein,, PF00019;PF00688;, GO:0072562;GO:0009986;GO:0062023;GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0005634;GO:0005886;GO:0031093;GO:0003823;GO:0005125;GO:0019899;GO:0008083;GO:0042802;GO:0034713;GO:0005114;GO:0034714;GO:0003180;GO:0006754;GO:0030509;GO:0007050;GO:0016477;GO:0045216;GO:0071407;GO:0071560;GO:0002062;GO:0007182;GO:0002248;GO:0019221;GO:1990402;GO:0007173;GO:0001837;GO:0085029;GO:0097191;GO:0007507;GO:0003179;GO:0002244;GO:0030214;GO:0006954;GO:0050900;GO:0031663;GO:0048535;GO:0010742;GO:0000165;GO:0031293;GO:0070168;GO:0043537;GO:0045786;GO:0045596;GO:0030308;GO:0008285;GO:0022408;GO:0045918;GO:0050680;GO:0010716;GO:0045599;GO:0010629;GO:0060965;GO:1900126;GO:0010936;GO:0045930;GO:0045662;GO:1902894;GO:1903799;GO:1903077;GO:0001933;GO:0048642;GO:0045892;GO:0030512;GO:0001843;GO:0021915;GO:0043932;GO:0060389;GO:0006796;GO:0002576;GO:0043536;GO:0030501;GO:0090263;GO:2000727;GO:0051781;GO:0030335;GO:0008284;GO:0032270;GO:0050921;GO:0032967;GO:0010718;GO:0070374;GO:1901203;GO:0010763;GO:0010628;GO:0032740;GO:0048298;GO:0043406;GO:0014008;GO:1901666;GO:0010862;GO:0033138;GO:0010800;GO:0050731;GO:0043552;GO:1902895;GO:1903800;GO:0035307;GO:0042307;GO:0051897;GO:1900182;GO:0001934;GO:0050714;GO:0031334;GO:0060391;GO:0032930;GO:0045944;GO:2000679;GO:0045893;GO:0010575;GO:0043117;GO:0006611;GO:0043491;GO:0006468;GO:0032801;GO:0051098;GO:0060312;GO:0030334;GO:0042127;GO:0051101;GO:0042306;GO:0060390;GO:0016202;GO:0017015;GO:0070723;GO:0032355;GO:0032570;GO:0009611;GO:0007435;GO:0007183;GO:0060395;GO:0007179;GO:1905313;GO:0001570;GO:0055010;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:nucleus; C:plasma membrane; C:platelet alpha granule lumen;, F:antigen binding; F:cytokine activity; F:enzyme binding; F:growth factor activity; F:identical protein binding; F:type I transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding; F:type III transforming growth factor beta receptor binding;, P:aortic valve morphogenesis; P:ATP biosynthetic process; P:BMP signaling pathway; P:cell cycle arrest; P:cell migration; P:cell-cell junction organization; P:cellular response to organic cyclic compound; P:cellular response to transforming growth factor beta stimulus; P:chondrocyte differentiation; P:common-partner SMAD protein phosphorylation; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:embryonic liver development; P:epidermal growth factor receptor signaling pathway; P:epithelial to mesenchymal transition; P:extracellular matrix assembly; P:extrinsic apoptotic signaling pathway; P:heart development; P:heart valve morphogenesis; P:hematopoietic progenitor cell differentiation; P:hyaluronan catabolic process; P:inflammatory response; P:leukocyte migration; P:lipopolysaccharide-mediated signaling pathway; P:lymph node development; P:macrophage derived foam cell differentiation; P:MAPK cascade; P:membrane protein intracellular domain proteolysis; P:negative regulation of biomineral tissue development; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell cycle; P:negative regulation of cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of cytolysis; P:negative regulation of epithelial cell proliferation; P:negative regulation of extracellular matrix disassembly; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of gene silencing by miRNA; P:negative regulation of hyaluronan biosynthetic process; P:negative regulation of macrophage cytokine production; P:negative regulation of mitotic cell cycle; P:negative regulation of myoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of protein localization to plasma membrane; P:negative regulation of protein phosphorylation; P:negative regulation of skeletal muscle tissue development; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neural tube closure; P:neural tube development; P:ossification involved in bone remodeling; P:pathway-restricted SMAD protein phosphorylation; P:phosphate-containing compound metabolic process; P:platelet degranulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of bone mineralization; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein metabolic process; P:positive regulation of chemotaxis; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extracellular matrix assembly; P:positive regulation of fibroblast migration; P:positive regulation of gene expression; P:positive regulation of interleukin-17 production; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of MAP kinase activity; P:positive regulation of microglia differentiation; P:positive regulation of NAD+ ADP-ribosyltransferase activity; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein dephosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein secretion; P:positive regulation of protein-containing complex assembly; P:positive regulation of SMAD protein signal transduction; P:positive regulation of superoxide anion generation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular permeability; P:protein export from nucleus; P:protein kinase B signaling; P:protein phosphorylation; P:receptor catabolic process; P:regulation of binding; P:regulation of blood vessel remodeling; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA binding; P:regulation of protein import into nucleus; P:regulation of SMAD protein signal transduction; P:regulation of striated muscle tissue development; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to cholesterol; P:response to estradiol; P:response to progesterone; P:response to wounding; P:salivary gland morphogenesis; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway involved in heart development; P:vasculogenesis; P:ventricular cardiac muscle tissue morphogenesis; scaffold192 indexed_genome mRNA 398819 407827 . + . ID=transcript_15542;P01137 A8K792 Q9UCG4,Transforming growth factor beta-1 proprotein,, PF00019;PF00688;, GO:0072562;GO:0009986;GO:0062023;GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0005634;GO:0005886;GO:0031093;GO:0003823;GO:0005125;GO:0019899;GO:0008083;GO:0042802;GO:0034713;GO:0005114;GO:0034714;GO:0003180;GO:0006754;GO:0030509;GO:0007050;GO:0016477;GO:0045216;GO:0071407;GO:0071560;GO:0002062;GO:0007182;GO:0002248;GO:0019221;GO:1990402;GO:0007173;GO:0001837;GO:0085029;GO:0097191;GO:0007507;GO:0003179;GO:0002244;GO:0030214;GO:0006954;GO:0050900;GO:0031663;GO:0048535;GO:0010742;GO:0000165;GO:0031293;GO:0070168;GO:0043537;GO:0045786;GO:0045596;GO:0030308;GO:0008285;GO:0022408;GO:0045918;GO:0050680;GO:0010716;GO:0045599;GO:0010629;GO:0060965;GO:1900126;GO:0010936;GO:0045930;GO:0045662;GO:1902894;GO:1903799;GO:1903077;GO:0001933;GO:0048642;GO:0045892;GO:0030512;GO:0001843;GO:0021915;GO:0043932;GO:0060389;GO:0006796;GO:0002576;GO:0043536;GO:0030501;GO:0090263;GO:2000727;GO:0051781;GO:0030335;GO:0008284;GO:0032270;GO:0050921;GO:0032967;GO:0010718;GO:0070374;GO:1901203;GO:0010763;GO:0010628;GO:0032740;GO:0048298;GO:0043406;GO:0014008;GO:1901666;GO:0010862;GO:0033138;GO:0010800;GO:0050731;GO:0043552;GO:1902895;GO:1903800;GO:0035307;GO:0042307;GO:0051897;GO:1900182;GO:0001934;GO:0050714;GO:0031334;GO:0060391;GO:0032930;GO:0045944;GO:2000679;GO:0045893;GO:0010575;GO:0043117;GO:0006611;GO:0043491;GO:0006468;GO:0032801;GO:0051098;GO:0060312;GO:0030334;GO:0042127;GO:0051101;GO:0042306;GO:0060390;GO:0016202;GO:0017015;GO:0070723;GO:0032355;GO:0032570;GO:0009611;GO:0007435;GO:0007183;GO:0060395;GO:0007179;GO:1905313;GO:0001570;GO:0055010;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:nucleus; C:plasma membrane; C:platelet alpha granule lumen;, F:antigen binding; F:cytokine activity; F:enzyme binding; F:growth factor activity; F:identical protein binding; F:type I transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding; F:type III transforming growth factor beta receptor binding;, P:aortic valve morphogenesis; P:ATP biosynthetic process; P:BMP signaling pathway; P:cell cycle arrest; P:cell migration; P:cell-cell junction organization; P:cellular response to organic cyclic compound; P:cellular response to transforming growth factor beta stimulus; P:chondrocyte differentiation; P:common-partner SMAD protein phosphorylation; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:embryonic liver development; P:epidermal growth factor receptor signaling pathway; P:epithelial to mesenchymal transition; P:extracellular matrix assembly; P:extrinsic apoptotic signaling pathway; P:heart development; P:heart valve morphogenesis; P:hematopoietic progenitor cell differentiation; P:hyaluronan catabolic process; P:inflammatory response; P:leukocyte migration; P:lipopolysaccharide-mediated signaling pathway; P:lymph node development; P:macrophage derived foam cell differentiation; P:MAPK cascade; P:membrane protein intracellular domain proteolysis; P:negative regulation of biomineral tissue development; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell cycle; P:negative regulation of cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of cytolysis; P:negative regulation of epithelial cell proliferation; P:negative regulation of extracellular matrix disassembly; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of gene silencing by miRNA; P:negative regulation of hyaluronan biosynthetic process; P:negative regulation of macrophage cytokine production; P:negative regulation of mitotic cell cycle; P:negative regulation of myoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of protein localization to plasma membrane; P:negative regulation of protein phosphorylation; P:negative regulation of skeletal muscle tissue development; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neural tube closure; P:neural tube development; P:ossification involved in bone remodeling; P:pathway-restricted SMAD protein phosphorylation; P:phosphate-containing compound metabolic process; P:platelet degranulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of bone mineralization; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein metabolic process; P:positive regulation of chemotaxis; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extracellular matrix assembly; P:positive regulation of fibroblast migration; P:positive regulation of gene expression; P:positive regulation of interleukin-17 production; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of MAP kinase activity; P:positive regulation of microglia differentiation; P:positive regulation of NAD+ ADP-ribosyltransferase activity; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein dephosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein secretion; P:positive regulation of protein-containing complex assembly; P:positive regulation of SMAD protein signal transduction; P:positive regulation of superoxide anion generation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular permeability; P:protein export from nucleus; P:protein kinase B signaling; P:protein phosphorylation; P:receptor catabolic process; P:regulation of binding; P:regulation of blood vessel remodeling; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA binding; P:regulation of protein import into nucleus; P:regulation of SMAD protein signal transduction; P:regulation of striated muscle tissue development; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to cholesterol; P:response to estradiol; P:response to progesterone; P:response to wounding; P:salivary gland morphogenesis; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway involved in heart development; P:vasculogenesis; P:ventricular cardiac muscle tissue morphogenesis;|P01137 A8K792 Q9UCG4,Transforming growth factor beta-1 proprotein,, PF00019;PF00688;, GO:0072562;GO:0009986;GO:0062023;GO:0005737;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0005634;GO:0005886;GO:0031093;GO:0003823;GO:0005125;GO:0019899;GO:0008083;GO:0042802;GO:0034713;GO:0005114;GO:0034714;GO:0003180;GO:0006754;GO:0030509;GO:0007050;GO:0016477;GO:0045216;GO:0071407;GO:0071560;GO:0002062;GO:0007182;GO:0002248;GO:0019221;GO:1990402;GO:0007173;GO:0001837;GO:0085029;GO:0097191;GO:0007507;GO:0003179;GO:0002244;GO:0030214;GO:0006954;GO:0050900;GO:0031663;GO:0048535;GO:0010742;GO:0000165;GO:0031293;GO:0070168;GO:0043537;GO:0045786;GO:0045596;GO:0030308;GO:0008285;GO:0022408;GO:0045918;GO:0050680;GO:0010716;GO:0045599;GO:0010629;GO:0060965;GO:1900126;GO:0010936;GO:0045930;GO:0045662;GO:1902894;GO:1903799;GO:1903077;GO:0001933;GO:0048642;GO:0045892;GO:0030512;GO:0001843;GO:0021915;GO:0043932;GO:0060389;GO:0006796;GO:0002576;GO:0043536;GO:0030501;GO:0090263;GO:2000727;GO:0051781;GO:0030335;GO:0008284;GO:0032270;GO:0050921;GO:0032967;GO:0010718;GO:0070374;GO:1901203;GO:0010763;GO:0010628;GO:0032740;GO:0048298;GO:0043406;GO:0014008;GO:1901666;GO:0010862;GO:0033138;GO:0010800;GO:0050731;GO:0043552;GO:1902895;GO:1903800;GO:0035307;GO:0042307;GO:0051897;GO:1900182;GO:0001934;GO:0050714;GO:0031334;GO:0060391;GO:0032930;GO:0045944;GO:2000679;GO:0045893;GO:0010575;GO:0043117;GO:0006611;GO:0043491;GO:0006468;GO:0032801;GO:0051098;GO:0060312;GO:0030334;GO:0042127;GO:0051101;GO:0042306;GO:0060390;GO:0016202;GO:0017015;GO:0070723;GO:0032355;GO:0032570;GO:0009611;GO:0007435;GO:0007183;GO:0060395;GO:0007179;GO:1905313;GO:0001570;GO:0055010;, C:blood microparticle; C:cell surface; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:nucleus; C:plasma membrane; C:platelet alpha granule lumen;, F:antigen binding; F:cytokine activity; F:enzyme binding; F:growth factor activity; F:identical protein binding; F:type I transforming growth factor beta receptor binding; F:type II transforming growth factor beta receptor binding; F:type III transforming growth factor beta receptor binding;, P:aortic valve morphogenesis; P:ATP biosynthetic process; P:BMP signaling pathway; P:cell cycle arrest; P:cell migration; P:cell-cell junction organization; P:cellular response to organic cyclic compound; P:cellular response to transforming growth factor beta stimulus; P:chondrocyte differentiation; P:common-partner SMAD protein phosphorylation; P:connective tissue replacement involved in inflammatory response wound healing; P:cytokine-mediated signaling pathway; P:embryonic liver development; P:epidermal growth factor receptor signaling pathway; P:epithelial to mesenchymal transition; P:extracellular matrix assembly; P:extrinsic apoptotic signaling pathway; P:heart development; P:heart valve morphogenesis; P:hematopoietic progenitor cell differentiation; P:hyaluronan catabolic process; P:inflammatory response; P:leukocyte migration; P:lipopolysaccharide-mediated signaling pathway; P:lymph node development; P:macrophage derived foam cell differentiation; P:MAPK cascade; P:membrane protein intracellular domain proteolysis; P:negative regulation of biomineral tissue development; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of cell cycle; P:negative regulation of cell differentiation; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cell-cell adhesion; P:negative regulation of cytolysis; P:negative regulation of epithelial cell proliferation; P:negative regulation of extracellular matrix disassembly; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of gene silencing by miRNA; P:negative regulation of hyaluronan biosynthetic process; P:negative regulation of macrophage cytokine production; P:negative regulation of mitotic cell cycle; P:negative regulation of myoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of protein localization to plasma membrane; P:negative regulation of protein phosphorylation; P:negative regulation of skeletal muscle tissue development; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:neural tube closure; P:neural tube development; P:ossification involved in bone remodeling; P:pathway-restricted SMAD protein phosphorylation; P:phosphate-containing compound metabolic process; P:platelet degranulation; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of bone mineralization; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein metabolic process; P:positive regulation of chemotaxis; P:positive regulation of collagen biosynthetic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extracellular matrix assembly; P:positive regulation of fibroblast migration; P:positive regulation of gene expression; P:positive regulation of interleukin-17 production; P:positive regulation of isotype switching to IgA isotypes; P:positive regulation of MAP kinase activity; P:positive regulation of microglia differentiation; P:positive regulation of NAD+ ADP-ribosyltransferase activity; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of protein dephosphorylation; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of protein localization to nucleus; P:positive regulation of protein phosphorylation; P:positive regulation of protein secretion; P:positive regulation of protein-containing complex assembly; P:positive regulation of SMAD protein signal transduction; P:positive regulation of superoxide anion generation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of transcription, DNA-templated; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of vascular permeability; P:protein export from nucleus; P:protein kinase B signaling; P:protein phosphorylation; P:receptor catabolic process; P:regulation of binding; P:regulation of blood vessel remodeling; P:regulation of cell migration; P:regulation of cell population proliferation; P:regulation of DNA binding; P:regulation of protein import into nucleus; P:regulation of SMAD protein signal transduction; P:regulation of striated muscle tissue development; P:regulation of transforming growth factor beta receptor signaling pathway; P:response to cholesterol; P:response to estradiol; P:response to progesterone; P:response to wounding; P:salivary gland morphogenesis; P:SMAD protein complex assembly; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway involved in heart development; P:vasculogenesis; P:ventricular cardiac muscle tissue morphogenesis; scaffold192 indexed_genome mRNA 415965 427917 . - . ID=transcript_15543;Q96F63 Q658N6 Q96IF3,Coiled-coil domain-containing protein 97,, PF09747;|Q96F63 Q658N6 Q96IF3,Coiled-coil domain-containing protein 97,, PF09747;|Q96F63 Q658N6 Q96IF3,Coiled-coil domain-containing protein 97,, PF09747; scaffold192 indexed_genome mRNA 428170 429795 . + . ID=transcript_15544;Q5SRP9 Q5STC1 Q5STX1 Q5STX3 Q96SA6 Q9BCN4,Large proline-rich protein BAG6 {ECO:0000305},BAG family molecular chaperone regulator 6;BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};Protein G3;Protein Scythe {ECO:0000303|PubMed:17403783};, PF12057;PF00240;, GO:0071818;GO:0005737;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005654;GO:0005634;GO:0042802;GO:0051787;GO:0031593;GO:0070628;GO:0043022;GO:0005102;GO:0031625;GO:1990381;GO:0006915;GO:0007420;GO:0030154;GO:0006325;GO:0061857;GO:0071712;GO:0002429;GO:0018393;GO:0042771;GO:0070059;GO:0001822;GO:0030324;GO:1904378;GO:0030101;GO:0032435;GO:0045861;GO:1904294;GO:0010498;GO:1904379;GO:0050821;GO:0045995;GO:0007283;GO:0007130;GO:0071816;GO:0030433;GO:0006511;, C:BAT3 complex; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleoplasm; C:nucleus;, F:identical protein binding; F:misfolded protein binding; F:polyubiquitin modification-dependent protein binding; F:proteasome binding; F:ribosome binding; F:signaling receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-specific protease binding;, P:apoptotic process; P:brain development; P:cell differentiation; P:chromatin organization; P:endoplasmic reticulum stress-induced pre-emptive quality control; P:ER-associated misfolded protein catabolic process; P:immune response-activating cell surface receptor signaling pathway; P:internal peptidyl-lysine acetylation; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:lung development; P:maintenance of unfolded protein involved in ERAD pathway; P:natural killer cell activation; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; P:negative regulation of proteolysis; P:positive regulation of ERAD pathway; P:proteasomal protein catabolic process; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; P:protein stabilization; P:regulation of embryonic development; P:spermatogenesis; P:synaptonemal complex assembly; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold192 indexed_genome mRNA 429865 436921 . - . ID=transcript_15545;Q9BUJ2 B3KMW7 O76022 Q6ZSZ0 Q7L8P4 Q8N6Z4 Q96G37 Q9HAL3 Q9UG75,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Adenovirus early region 1B-associated protein 5;E1B-55 kDa-associated protein 5;, PF02037;PF00622;, GO:0005654;GO:0005634;GO:0019899;GO:0003723;GO:0000398;GO:0009615;GO:0006396;, C:nucleoplasm; C:nucleus;, F:enzyme binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:response to virus; P:RNA processing;|Q9BUJ2 B3KMW7 O76022 Q6ZSZ0 Q7L8P4 Q8N6Z4 Q96G37 Q9HAL3 Q9UG75,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Adenovirus early region 1B-associated protein 5;E1B-55 kDa-associated protein 5;, PF02037;PF00622;, GO:0005654;GO:0005634;GO:0019899;GO:0003723;GO:0000398;GO:0009615;GO:0006396;, C:nucleoplasm; C:nucleus;, F:enzyme binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:response to virus; P:RNA processing; scaffold192 indexed_genome mRNA 440595 460403 . - . ID=transcript_15546;Q9BUJ2 B3KMW7 O76022 Q6ZSZ0 Q7L8P4 Q8N6Z4 Q96G37 Q9HAL3 Q9UG75,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Adenovirus early region 1B-associated protein 5;E1B-55 kDa-associated protein 5;, PF02037;PF00622;, GO:0005654;GO:0005634;GO:0019899;GO:0003723;GO:0000398;GO:0009615;GO:0006396;, C:nucleoplasm; C:nucleus;, F:enzyme binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:response to virus; P:RNA processing; scaffold192 indexed_genome mRNA 460523 461881 . - . ID=transcript_15547;Q9BUJ2 B3KMW7 O76022 Q6ZSZ0 Q7L8P4 Q8N6Z4 Q96G37 Q9HAL3 Q9UG75,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Adenovirus early region 1B-associated protein 5;E1B-55 kDa-associated protein 5;, PF02037;PF00622;, GO:0005654;GO:0005634;GO:0019899;GO:0003723;GO:0000398;GO:0009615;GO:0006396;, C:nucleoplasm; C:nucleus;, F:enzyme binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:response to virus; P:RNA processing; scaffold192 indexed_genome mRNA 464313 499167 . - . ID=transcript_15548;P30530 Q8N5L2 Q9UD27,Tyrosine-protein kinase receptor UFO,AXL oncogene;, PF00041;PF07714;, GO:0015629;GO:0009986;GO:0070062;GO:0005615;GO:0044228;GO:0005887;GO:0043231;GO:0005886;GO:0043235;GO:0005524;GO:0032036;GO:0043548;GO:0001786;GO:0004713;GO:0004714;GO:0001618;GO:0031100;GO:0001974;GO:0048469;GO:0016477;GO:0031668;GO:0070301;GO:0035457;GO:0071222;GO:0097028;GO:0034101;GO:0021885;GO:0006954;GO:0045087;GO:0007275;GO:0001779;GO:0043066;GO:2000669;GO:0032689;GO:0051250;GO:0043524;GO:0032720;GO:0007399;GO:0001764;GO:0097350;GO:0042698;GO:0006909;GO:0030168;GO:0001961;GO:0033674;GO:0032825;GO:0048549;GO:0051897;GO:1903902;GO:0043491;GO:0032940;GO:0007165;GO:0007283;GO:0034446;GO:0007169;GO:0060068;GO:0048010;GO:0046718;, C:actin cytoskeleton; C:cell surface; C:extracellular exosome; C:extracellular space; C:host cell surface; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:receptor complex;, F:ATP binding; F:myosin heavy chain binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylserine binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:virus receptor activity;, P:animal organ regeneration; P:blood vessel remodeling; P:cell maturation; P:cell migration; P:cellular response to extracellular stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interferon-alpha; P:cellular response to lipopolysaccharide; P:dendritic cell differentiation; P:erythrocyte homeostasis; P:forebrain cell migration; P:inflammatory response; P:innate immune response; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of interferon-gamma production; P:negative regulation of lymphocyte activation; P:negative regulation of neuron apoptotic process; P:negative regulation of tumor necrosis factor production; P:nervous system development; P:neuron migration; P:neutrophil clearance; P:ovulation cycle; P:phagocytosis; P:platelet activation; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of kinase activity; P:positive regulation of natural killer cell differentiation; P:positive regulation of pinocytosis; P:positive regulation of protein kinase B signaling; P:positive regulation of viral life cycle; P:protein kinase B signaling; P:secretion by cell; P:signal transduction; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development; P:vascular endothelial growth factor receptor signaling pathway; P:viral entry into host cell;|P30530 Q8N5L2 Q9UD27,Tyrosine-protein kinase receptor UFO,AXL oncogene;, PF00041;PF07714;, GO:0015629;GO:0009986;GO:0070062;GO:0005615;GO:0044228;GO:0005887;GO:0043231;GO:0005886;GO:0043235;GO:0005524;GO:0032036;GO:0043548;GO:0001786;GO:0004713;GO:0004714;GO:0001618;GO:0031100;GO:0001974;GO:0048469;GO:0016477;GO:0031668;GO:0070301;GO:0035457;GO:0071222;GO:0097028;GO:0034101;GO:0021885;GO:0006954;GO:0045087;GO:0007275;GO:0001779;GO:0043066;GO:2000669;GO:0032689;GO:0051250;GO:0043524;GO:0032720;GO:0007399;GO:0001764;GO:0097350;GO:0042698;GO:0006909;GO:0030168;GO:0001961;GO:0033674;GO:0032825;GO:0048549;GO:0051897;GO:1903902;GO:0043491;GO:0032940;GO:0007165;GO:0007283;GO:0034446;GO:0007169;GO:0060068;GO:0048010;GO:0046718;, C:actin cytoskeleton; C:cell surface; C:extracellular exosome; C:extracellular space; C:host cell surface; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:receptor complex;, F:ATP binding; F:myosin heavy chain binding; F:phosphatidylinositol 3-kinase binding; F:phosphatidylserine binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:virus receptor activity;, P:animal organ regeneration; P:blood vessel remodeling; P:cell maturation; P:cell migration; P:cellular response to extracellular stimulus; P:cellular response to hydrogen peroxide; P:cellular response to interferon-alpha; P:cellular response to lipopolysaccharide; P:dendritic cell differentiation; P:erythrocyte homeostasis; P:forebrain cell migration; P:inflammatory response; P:innate immune response; P:multicellular organism development; P:natural killer cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of interferon-gamma production; P:negative regulation of lymphocyte activation; P:negative regulation of neuron apoptotic process; P:negative regulation of tumor necrosis factor production; P:nervous system development; P:neuron migration; P:neutrophil clearance; P:ovulation cycle; P:phagocytosis; P:platelet activation; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of kinase activity; P:positive regulation of natural killer cell differentiation; P:positive regulation of pinocytosis; P:positive regulation of protein kinase B signaling; P:positive regulation of viral life cycle; P:protein kinase B signaling; P:secretion by cell; P:signal transduction; P:spermatogenesis; P:substrate adhesion-dependent cell spreading; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vagina development; P:vascular endothelial growth factor receptor signaling pathway; P:viral entry into host cell; scaffold192 indexed_genome mRNA 508313 522974 . - . ID=transcript_15549;Q96SQ9 Q9BZ66,Cytochrome P450 2S1 {ECO:0000303|PubMed:11181079},CYPIIS1;Hydroperoxy icosatetraenoate dehydratase;Thromboxane-A synthase;, PF00067;, GO:0005737;GO:0005783;GO:0005789;GO:0043231;GO:0036134;GO:0008392;GO:0020037;GO:0016836;GO:0106256;GO:0005506;GO:0004497;GO:0016712;GO:0008395;GO:0004796;GO:0019373;GO:0042738;GO:0006690;GO:0006082;GO:0006693;GO:0042573;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:12-hydroxyheptadecatrienoic acid synthase activity; F:arachidonic acid epoxygenase activity; F:heme binding; F:hydro-lyase activity; F:hydroperoxy icosatetraenoate dehydratase activity; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity; F:thromboxane-A synthase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:icosanoid metabolic process; P:organic acid metabolic process; P:prostaglandin metabolic process; P:retinoic acid metabolic process; P:xenobiotic metabolic process; scaffold192 indexed_genome mRNA 602835 607104 . + . ID=transcript_15550;P20813 B4DWP3 Q2V565 Q9UK46,Cytochrome P450 2B6,1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};CYPIIB6;Cytochrome P450 IIB1 {ECO:0000303|PubMed:2573390};, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0062188;GO:0062189;GO:0062187;GO:0008392;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0008395;GO:0008390;GO:0062184;GO:0042180;GO:0017144;GO:0019373;GO:0042738;GO:0006082;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:arachidonic acid epoxygenase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity; F:testosterone 16-alpha-hydroxylase activity; F:testosterone 16-beta-hydroxylase activity;, P:cellular ketone metabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process; scaffold192 indexed_genome mRNA 629721 631035 . + . ID=transcript_15551;P20813 B4DWP3 Q2V565 Q9UK46,Cytochrome P450 2B6,1,4-cineole 2-exo-monooxygenase {ECO:0000303|PubMed:11695850};CYPIIB6;Cytochrome P450 IIB1 {ECO:0000303|PubMed:2573390};, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0062188;GO:0062189;GO:0062187;GO:0008392;GO:0101021;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0008395;GO:0008390;GO:0062184;GO:0042180;GO:0017144;GO:0019373;GO:0042738;GO:0006082;GO:0008202;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:anandamide 11,12 epoxidase activity; F:anandamide 14,15 epoxidase activity; F:anandamide 8,9 epoxidase activity; F:arachidonic acid epoxygenase activity; F:estrogen 2-hydroxylase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity; F:testosterone 16-alpha-hydroxylase activity; F:testosterone 16-beta-hydroxylase activity;, P:cellular ketone metabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:steroid metabolic process; P:xenobiotic metabolic process; scaffold192 indexed_genome mRNA 773558 774737 . - . ID=transcript_15552;Q16696 Q53YR8 Q6R569 Q6R570 Q9H2X2,Cytochrome P450 2A13,CYPIIA13;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0016712;GO:0008395;GO:0046222;GO:0009804;GO:0019373;GO:0042738;GO:0006082;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:steroid hydroxylase activity;, P:aflatoxin metabolic process; P:coumarin metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:organic acid metabolic process; P:xenobiotic metabolic process; scaffold192 indexed_genome mRNA 843738 844943 . + . ID=transcript_15553;P24903 A7KAU6 A7KAU7 A7KAU8 A7KAU9 A7KAV0 Q32MN5 Q8WWJ2,Cytochrome P450 2F1,CYPIIF1;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008395;GO:0019373;GO:0042738;GO:0018931;GO:0006082;GO:0018979;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:naphthalene metabolic process; P:organic acid metabolic process; P:trichloroethylene metabolic process; P:xenobiotic metabolic process; scaffold192 indexed_genome mRNA 847313 855179 . + . ID=transcript_15554;P24903 A7KAU6 A7KAU7 A7KAU8 A7KAU9 A7KAV0 Q32MN5 Q8WWJ2,Cytochrome P450 2F1,CYPIIF1;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008395;GO:0019373;GO:0042738;GO:0018931;GO:0006082;GO:0018979;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:naphthalene metabolic process; P:organic acid metabolic process; P:trichloroethylene metabolic process; P:xenobiotic metabolic process;|P24903 A7KAU6 A7KAU7 A7KAU8 A7KAU9 A7KAV0 Q32MN5 Q8WWJ2,Cytochrome P450 2F1,CYPIIF1;, PF00067;, GO:0005737;GO:0005789;GO:0043231;GO:0008392;GO:0070330;GO:0020037;GO:0005506;GO:0004497;GO:0016712;GO:0019825;GO:0008395;GO:0019373;GO:0042738;GO:0018931;GO:0006082;GO:0018979;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:arachidonic acid epoxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:naphthalene metabolic process; P:organic acid metabolic process; P:trichloroethylene metabolic process; P:xenobiotic metabolic process; scaffold192 indexed_genome mRNA 857045 869132 . - . ID=transcript_15555;Q96KS0 A8K5S0 Q8WWY4 Q9BV14,Prolyl hydroxylase EGLN2 {ECO:0000305},Egl nine homolog 2 {ECO:0000305};Estrogen-induced tag 6 {ECO:0000303|PubMed:11850811};HPH-3;Hypoxia-inducible factor prolyl hydroxylase 1;Prolyl hydroxylase domain-containing protein 1 {ECO:0000303|PubMed:11595184};, PF13640;, GO:0005737;GO:0005654;GO:0005634;GO:0016706;GO:0008198;GO:0031418;GO:0019826;GO:0031545;GO:0031543;GO:0045454;GO:0071456;GO:0030520;GO:0018401;GO:0045732;GO:0001558;GO:0043523;GO:0061418;GO:0001666;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:ferrous iron binding; F:L-ascorbic acid binding; F:oxygen sensor activity; F:peptidyl-proline 4-dioxygenase activity; F:peptidyl-proline dioxygenase activity;, P:cell redox homeostasis; P:cellular response to hypoxia; P:intracellular estrogen receptor signaling pathway; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:positive regulation of protein catabolic process; P:regulation of cell growth; P:regulation of neuron apoptotic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to hypoxia;|Q96KS0 A8K5S0 Q8WWY4 Q9BV14,Prolyl hydroxylase EGLN2 {ECO:0000305},Egl nine homolog 2 {ECO:0000305};Estrogen-induced tag 6 {ECO:0000303|PubMed:11850811};HPH-3;Hypoxia-inducible factor prolyl hydroxylase 1;Prolyl hydroxylase domain-containing protein 1 {ECO:0000303|PubMed:11595184};, PF13640;, GO:0005737;GO:0005654;GO:0005634;GO:0016706;GO:0008198;GO:0031418;GO:0019826;GO:0031545;GO:0031543;GO:0045454;GO:0071456;GO:0030520;GO:0018401;GO:0045732;GO:0001558;GO:0043523;GO:0061418;GO:0001666;, C:cytoplasm; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:ferrous iron binding; F:L-ascorbic acid binding; F:oxygen sensor activity; F:peptidyl-proline 4-dioxygenase activity; F:peptidyl-proline dioxygenase activity;, P:cell redox homeostasis; P:cellular response to hypoxia; P:intracellular estrogen receptor signaling pathway; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:positive regulation of protein catabolic process; P:regulation of cell growth; P:regulation of neuron apoptotic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to hypoxia; scaffold192 indexed_genome mRNA 870660 879512 . - . ID=transcript_15556;P61018 P22750 Q7Z514 Q9HBR6,Ras-related protein Rab-4B,, PF00071;, GO:0005768;GO:0032593;GO:0048471;GO:0005886;GO:0055037;GO:0030667;GO:0005525;GO:0003924;GO:0046323;GO:0043312;GO:0015031;GO:0032482;GO:0030100;, C:endosome; C:insulin-responsive compartment; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule membrane;, F:GTP binding; F:GTPase activity;, P:glucose import; P:neutrophil degranulation; P:protein transport; P:Rab protein signal transduction; P:regulation of endocytosis;|P61018 P22750 Q7Z514 Q9HBR6,Ras-related protein Rab-4B,, PF00071;, GO:0005768;GO:0032593;GO:0048471;GO:0005886;GO:0055037;GO:0030667;GO:0005525;GO:0003924;GO:0046323;GO:0043312;GO:0015031;GO:0032482;GO:0030100;, C:endosome; C:insulin-responsive compartment; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule membrane;, F:GTP binding; F:GTPase activity;, P:glucose import; P:neutrophil degranulation; P:protein transport; P:Rab protein signal transduction; P:regulation of endocytosis;|P61018 P22750 Q7Z514 Q9HBR6,Ras-related protein Rab-4B,, PF00071;, GO:0005768;GO:0032593;GO:0048471;GO:0005886;GO:0055037;GO:0030667;GO:0005525;GO:0003924;GO:0046323;GO:0043312;GO:0015031;GO:0032482;GO:0030100;, C:endosome; C:insulin-responsive compartment; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule membrane;, F:GTP binding; F:GTPase activity;, P:glucose import; P:neutrophil degranulation; P:protein transport; P:Rab protein signal transduction; P:regulation of endocytosis;|P61018 P22750 Q7Z514 Q9HBR6,Ras-related protein Rab-4B,, PF00071;, GO:0005768;GO:0032593;GO:0048471;GO:0005886;GO:0055037;GO:0030667;GO:0005525;GO:0003924;GO:0046323;GO:0043312;GO:0015031;GO:0032482;GO:0030100;, C:endosome; C:insulin-responsive compartment; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome; C:secretory granule membrane;, F:GTP binding; F:GTPase activity;, P:glucose import; P:neutrophil degranulation; P:protein transport; P:Rab protein signal transduction; P:regulation of endocytosis; scaffold192 indexed_genome mRNA 880117 894470 . - . ID=transcript_15557;P09012,U1 small nuclear ribonucleoprotein A,, PF00076;, GO:0005654;GO:0005681;GO:0005685;GO:0042802;GO:0003723;GO:0030619;GO:1990446;GO:0000398;GO:1900363;, C:nucleoplasm; C:spliceosomal complex; C:U1 snRNP;, F:identical protein binding; F:RNA binding; F:U1 snRNA binding; F:U1 snRNP binding;, P:mRNA splicing, via spliceosome; P:regulation of mRNA polyadenylation;|P09012,U1 small nuclear ribonucleoprotein A,, PF00076;, GO:0005654;GO:0005681;GO:0005685;GO:0042802;GO:0003723;GO:0030619;GO:1990446;GO:0000398;GO:1900363;, C:nucleoplasm; C:spliceosomal complex; C:U1 snRNP;, F:identical protein binding; F:RNA binding; F:U1 snRNA binding; F:U1 snRNP binding;, P:mRNA splicing, via spliceosome; P:regulation of mRNA polyadenylation;|P09012,U1 small nuclear ribonucleoprotein A,, PF00076;, GO:0005654;GO:0005681;GO:0005685;GO:0042802;GO:0003723;GO:0030619;GO:1990446;GO:0000398;GO:1900363;, C:nucleoplasm; C:spliceosomal complex; C:U1 snRNP;, F:identical protein binding; F:RNA binding; F:U1 snRNA binding; F:U1 snRNP binding;, P:mRNA splicing, via spliceosome; P:regulation of mRNA polyadenylation; scaffold192 indexed_genome mRNA 894910 902383 . + . ID=transcript_15558;Q5BKX5 A8MSZ5 B4DNU7,UPF0692 protein C19orf54|Q5BKX5 A8MSZ5 B4DNU7,UPF0692 protein C19orf54 scaffold192 indexed_genome mRNA 902410 920120 . - . ID=transcript_15559;Q96DU7 Q9UE25 Q9Y475,Inositol-trisphosphate 3-kinase C,Inositol 1,4,5-trisphosphate 3-kinase C;, PF03770;, GO:0005737;GO:0005829;GO:0016607;GO:0005634;GO:0005524;GO:0005516;GO:0000828;GO:0008440;GO:0016301;GO:0032958;GO:0043647;GO:0046854;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleus;, F:ATP binding; F:calmodulin binding; F:inositol hexakisphosphate kinase activity; F:inositol-1,4,5-trisphosphate 3-kinase activity; F:kinase activity;, P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:phosphatidylinositol phosphorylation;|Q96DU7 Q9UE25 Q9Y475,Inositol-trisphosphate 3-kinase C,Inositol 1,4,5-trisphosphate 3-kinase C;, PF03770;, GO:0005737;GO:0005829;GO:0016607;GO:0005634;GO:0005524;GO:0005516;GO:0000828;GO:0008440;GO:0016301;GO:0032958;GO:0043647;GO:0046854;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleus;, F:ATP binding; F:calmodulin binding; F:inositol hexakisphosphate kinase activity; F:inositol-1,4,5-trisphosphate 3-kinase activity; F:kinase activity;, P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:phosphatidylinositol phosphorylation;|Q96DU7 Q9UE25 Q9Y475,Inositol-trisphosphate 3-kinase C,Inositol 1,4,5-trisphosphate 3-kinase C;, PF03770;, GO:0005737;GO:0005829;GO:0016607;GO:0005634;GO:0005524;GO:0005516;GO:0000828;GO:0008440;GO:0016301;GO:0032958;GO:0043647;GO:0046854;, C:cytoplasm; C:cytosol; C:nuclear speck; C:nucleus;, F:ATP binding; F:calmodulin binding; F:inositol hexakisphosphate kinase activity; F:inositol-1,4,5-trisphosphate 3-kinase activity; F:kinase activity;, P:inositol phosphate biosynthetic process; P:inositol phosphate metabolic process; P:phosphatidylinositol phosphorylation; scaffold192 indexed_genome mRNA 928681 946380 . + . ID=transcript_15560;Q96D53 Q8TAJ1 Q9HA52,Atypical kinase COQ8B, mitochondrial {ECO:0000305},AarF domain-containing protein kinase 4 {ECO:0000312|HGNC:HGNC:19041};Coenzyme Q protein 8B {ECO:0000305};, PF03109;, GO:0005829;GO:0031314;GO:0016021;GO:0005739;GO:0005886;GO:0005524;GO:0016887;GO:0016301;GO:0008289;GO:0021692;GO:0006468;GO:0006744;, C:cytosol; C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:mitochondrion; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:kinase activity; F:lipid binding;, P:cerebellar Purkinje cell layer morphogenesis; P:protein phosphorylation; P:ubiquinone biosynthetic process;|Q96D53 Q8TAJ1 Q9HA52,Atypical kinase COQ8B, mitochondrial {ECO:0000305},AarF domain-containing protein kinase 4 {ECO:0000312|HGNC:HGNC:19041};Coenzyme Q protein 8B {ECO:0000305};, PF03109;, GO:0005829;GO:0031314;GO:0016021;GO:0005739;GO:0005886;GO:0005524;GO:0016887;GO:0016301;GO:0008289;GO:0021692;GO:0006468;GO:0006744;, C:cytosol; C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:mitochondrion; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:kinase activity; F:lipid binding;, P:cerebellar Purkinje cell layer morphogenesis; P:protein phosphorylation; P:ubiquinone biosynthetic process; scaffold192 indexed_genome mRNA 947133 953326 . + . ID=transcript_15561;Q9Y6R0 Q7Z4J9,Numb-like protein,Numb-related protein;, PF06311;PF00640;, GO:0005737;GO:0034332;GO:0007409;GO:0019221;GO:0021670;GO:0007399;GO:0021849;GO:0050769;GO:0019538;, C:cytoplasm;, , P:adherens junction organization; P:axonogenesis; P:cytokine-mediated signaling pathway; P:lateral ventricle development; P:nervous system development; P:neuroblast division in subventricular zone; P:positive regulation of neurogenesis; P:protein metabolic process;|Q9Y6R0 Q7Z4J9,Numb-like protein,Numb-related protein;, PF06311;PF00640;, GO:0005737;GO:0034332;GO:0007409;GO:0019221;GO:0021670;GO:0007399;GO:0021849;GO:0050769;GO:0019538;, C:cytoplasm;, , P:adherens junction organization; P:axonogenesis; P:cytokine-mediated signaling pathway; P:lateral ventricle development; P:nervous system development; P:neuroblast division in subventricular zone; P:positive regulation of neurogenesis; P:protein metabolic process; scaffold192 indexed_genome mRNA 955136 971203 . + . ID=transcript_15562;Q9Y6R0 Q7Z4J9,Numb-like protein,Numb-related protein;, PF06311;PF00640;, GO:0005737;GO:0034332;GO:0007409;GO:0019221;GO:0021670;GO:0007399;GO:0021849;GO:0050769;GO:0019538;, C:cytoplasm;, , P:adherens junction organization; P:axonogenesis; P:cytokine-mediated signaling pathway; P:lateral ventricle development; P:nervous system development; P:neuroblast division in subventricular zone; P:positive regulation of neurogenesis; P:protein metabolic process;|Q9Y6R0 Q7Z4J9,Numb-like protein,Numb-related protein;, PF06311;PF00640;, GO:0005737;GO:0034332;GO:0007409;GO:0019221;GO:0021670;GO:0007399;GO:0021849;GO:0050769;GO:0019538;, C:cytoplasm;, , P:adherens junction organization; P:axonogenesis; P:cytokine-mediated signaling pathway; P:lateral ventricle development; P:nervous system development; P:neuroblast division in subventricular zone; P:positive regulation of neurogenesis; P:protein metabolic process;|Q9Y6R0 Q7Z4J9,Numb-like protein,Numb-related protein;, PF06311;PF00640;, GO:0005737;GO:0034332;GO:0007409;GO:0019221;GO:0021670;GO:0007399;GO:0021849;GO:0050769;GO:0019538;, C:cytoplasm;, , P:adherens junction organization; P:axonogenesis; P:cytokine-mediated signaling pathway; P:lateral ventricle development; P:nervous system development; P:neuroblast division in subventricular zone; P:positive regulation of neurogenesis; P:protein metabolic process; scaffold192 indexed_genome mRNA 992686 994482 . - . ID=transcript_15563;Q8N2S1 O00508 O75412 O75413,Latent-transforming growth factor beta-binding protein 4,, PF07645;PF12661;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0001527;GO:0005509;GO:0005539;GO:0005178;GO:0050431;GO:0005024;GO:0048251;GO:0030252;GO:0007275;GO:0006457;GO:0045595;GO:0001558;GO:0030162;GO:0017015;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:microfibril;, F:calcium ion binding; F:glycosaminoglycan binding; F:integrin binding; F:transforming growth factor beta binding; F:transforming growth factor beta-activated receptor activity;, P:elastic fiber assembly; P:growth hormone secretion; P:multicellular organism development; P:protein folding; P:regulation of cell differentiation; P:regulation of cell growth; P:regulation of proteolysis; P:regulation of transforming growth factor beta receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway;|Q8N2S1 O00508 O75412 O75413,Latent-transforming growth factor beta-binding protein 4,, PF07645;PF12661;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0001527;GO:0005509;GO:0005539;GO:0005178;GO:0050431;GO:0005024;GO:0048251;GO:0030252;GO:0007275;GO:0006457;GO:0045595;GO:0001558;GO:0030162;GO:0017015;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:microfibril;, F:calcium ion binding; F:glycosaminoglycan binding; F:integrin binding; F:transforming growth factor beta binding; F:transforming growth factor beta-activated receptor activity;, P:elastic fiber assembly; P:growth hormone secretion; P:multicellular organism development; P:protein folding; P:regulation of cell differentiation; P:regulation of cell growth; P:regulation of proteolysis; P:regulation of transforming growth factor beta receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway; scaffold192 indexed_genome mRNA 995686 996799 . - . ID=transcript_15564;Q8N2S1 O00508 O75412 O75413,Latent-transforming growth factor beta-binding protein 4,, PF07645;PF12661;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0001527;GO:0005509;GO:0005539;GO:0005178;GO:0050431;GO:0005024;GO:0048251;GO:0030252;GO:0007275;GO:0006457;GO:0045595;GO:0001558;GO:0030162;GO:0017015;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:microfibril;, F:calcium ion binding; F:glycosaminoglycan binding; F:integrin binding; F:transforming growth factor beta binding; F:transforming growth factor beta-activated receptor activity;, P:elastic fiber assembly; P:growth hormone secretion; P:multicellular organism development; P:protein folding; P:regulation of cell differentiation; P:regulation of cell growth; P:regulation of proteolysis; P:regulation of transforming growth factor beta receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway; scaffold192 indexed_genome mRNA 1005013 1005516 . - . ID=transcript_15565;Q8N2S1 O00508 O75412 O75413,Latent-transforming growth factor beta-binding protein 4,, PF07645;PF12661;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005615;GO:0001527;GO:0005509;GO:0005539;GO:0005178;GO:0050431;GO:0005024;GO:0048251;GO:0030252;GO:0007275;GO:0006457;GO:0045595;GO:0001558;GO:0030162;GO:0017015;GO:0007179;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular space; C:microfibril;, F:calcium ion binding; F:glycosaminoglycan binding; F:integrin binding; F:transforming growth factor beta binding; F:transforming growth factor beta-activated receptor activity;, P:elastic fiber assembly; P:growth hormone secretion; P:multicellular organism development; P:protein folding; P:regulation of cell differentiation; P:regulation of cell growth; P:regulation of proteolysis; P:regulation of transforming growth factor beta receptor signaling pathway; P:transforming growth factor beta receptor signaling pathway; scaffold193 indexed_genome mRNA 2320 4383 . - . ID=transcript_15566;Q86VF5 Q496A6 Q496A7 Q496A8 Q9UDW7,2-acylglycerol O-acyltransferase 3 {ECO:0000305},Acyl-CoA:monoacylglycerol acyltransferase 3 {ECO:0000303|PubMed:27184406};Diacylglycerol O-acyltransferase candidate 7;Diacylglycerol acyltransferase 2-like protein 7;Monoacylglycerol O-acyltransferase 3;, PF03982;, GO:0005789;GO:0016021;GO:1990578;GO:0003846;GO:0004144;GO:0008374;GO:0006071;GO:0006629;GO:0006640;GO:0019432;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:perinuclear endoplasmic reticulum membrane;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:O-acyltransferase activity;, P:glycerol metabolic process; P:lipid metabolic process; P:monoacylglycerol biosynthetic process; P:triglyceride biosynthetic process; scaffold193 indexed_genome mRNA 8053 8608 . + . ID=transcript_15567;Q96PD7 A6ND76 Q5U810 Q68CL3 Q68DJ0 Q8NDB7 Q96BS0 Q9BYE5,Diacylglycerol O-acyltransferase 2 {ECO:0000305},Acyl-CoA retinol O-fatty-acyltransferase;Diglyceride acyltransferase 2;, PF03982;, GO:0005829;GO:0005783;GO:0005789;GO:0030176;GO:0016021;GO:0043231;GO:0005811;GO:0005739;GO:1990578;GO:0048471;GO:0003846;GO:0004144;GO:0008374;GO:0042803;GO:0050252;GO:0036155;GO:0038183;GO:0071400;GO:0035356;GO:0042632;GO:0006651;GO:0046339;GO:0060613;GO:0055089;GO:0006071;GO:0006629;GO:0019915;GO:0035336;GO:0034383;GO:0006640;GO:0046322;GO:0045722;GO:0010867;GO:0090181;GO:0050746;GO:0097006;GO:0019432;, C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion; C:perinuclear endoplasmic reticulum membrane; C:perinuclear region of cytoplasm;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:O-acyltransferase activity; F:protein homodimerization activity; F:retinol O-fatty-acyltransferase activity;, P:acylglycerol acyl-chain remodeling; P:bile acid signaling pathway; P:cellular response to oleic acid; P:cellular triglyceride homeostasis; P:cholesterol homeostasis; P:diacylglycerol biosynthetic process; P:diacylglycerol metabolic process; P:fat pad development; P:fatty acid homeostasis; P:glycerol metabolic process; P:lipid metabolic process; P:lipid storage; P:long-chain fatty-acyl-CoA metabolic process; P:low-density lipoprotein particle clearance; P:monoacylglycerol biosynthetic process; P:negative regulation of fatty acid oxidation; P:positive regulation of gluconeogenesis; P:positive regulation of triglyceride biosynthetic process; P:regulation of cholesterol metabolic process; P:regulation of lipoprotein metabolic process; P:regulation of plasma lipoprotein particle levels; P:triglyceride biosynthetic process; scaffold193 indexed_genome mRNA 11530 19119 . - . ID=transcript_15568;O60568 B2R6W6 Q540C3,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3,, PF03171;, GO:0062023;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005615;GO:0005794;GO:0005791;GO:0005802;GO:0005506;GO:0031418;GO:0050211;GO:0033823;GO:0008475;GO:0070831;GO:0032870;GO:0030199;GO:0032963;GO:0001886;GO:0048730;GO:0046947;GO:0001701;GO:0060425;GO:0021915;GO:0017185;GO:0008104;GO:0006493;GO:0042311;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen galactosyltransferase activity; F:procollagen glucosyltransferase activity; F:procollagen-lysine 5-dioxygenase activity;, P:basement membrane assembly; P:cellular response to hormone stimulus; P:collagen fibril organization; P:collagen metabolic process; P:endothelial cell morphogenesis; P:epidermis morphogenesis; P:hydroxylysine biosynthetic process; P:in utero embryonic development; P:lung morphogenesis; P:neural tube development; P:peptidyl-lysine hydroxylation; P:protein localization; P:protein O-linked glycosylation; P:vasodilation;|O60568 B2R6W6 Q540C3,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3,, PF03171;, GO:0062023;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005615;GO:0005794;GO:0005791;GO:0005802;GO:0005506;GO:0031418;GO:0050211;GO:0033823;GO:0008475;GO:0070831;GO:0032870;GO:0030199;GO:0032963;GO:0001886;GO:0048730;GO:0046947;GO:0001701;GO:0060425;GO:0021915;GO:0017185;GO:0008104;GO:0006493;GO:0042311;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen galactosyltransferase activity; F:procollagen glucosyltransferase activity; F:procollagen-lysine 5-dioxygenase activity;, P:basement membrane assembly; P:cellular response to hormone stimulus; P:collagen fibril organization; P:collagen metabolic process; P:endothelial cell morphogenesis; P:epidermis morphogenesis; P:hydroxylysine biosynthetic process; P:in utero embryonic development; P:lung morphogenesis; P:neural tube development; P:peptidyl-lysine hydroxylation; P:protein localization; P:protein O-linked glycosylation; P:vasodilation;|O60568 B2R6W6 Q540C3,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3,, PF03171;, GO:0062023;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005615;GO:0005794;GO:0005791;GO:0005802;GO:0005506;GO:0031418;GO:0050211;GO:0033823;GO:0008475;GO:0070831;GO:0032870;GO:0030199;GO:0032963;GO:0001886;GO:0048730;GO:0046947;GO:0001701;GO:0060425;GO:0021915;GO:0017185;GO:0008104;GO:0006493;GO:0042311;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen galactosyltransferase activity; F:procollagen glucosyltransferase activity; F:procollagen-lysine 5-dioxygenase activity;, P:basement membrane assembly; P:cellular response to hormone stimulus; P:collagen fibril organization; P:collagen metabolic process; P:endothelial cell morphogenesis; P:epidermis morphogenesis; P:hydroxylysine biosynthetic process; P:in utero embryonic development; P:lung morphogenesis; P:neural tube development; P:peptidyl-lysine hydroxylation; P:protein localization; P:protein O-linked glycosylation; P:vasodilation;|O60568 B2R6W6 Q540C3,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3,, PF03171;, GO:0062023;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005615;GO:0005794;GO:0005791;GO:0005802;GO:0005506;GO:0031418;GO:0050211;GO:0033823;GO:0008475;GO:0070831;GO:0032870;GO:0030199;GO:0032963;GO:0001886;GO:0048730;GO:0046947;GO:0001701;GO:0060425;GO:0021915;GO:0017185;GO:0008104;GO:0006493;GO:0042311;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen galactosyltransferase activity; F:procollagen glucosyltransferase activity; F:procollagen-lysine 5-dioxygenase activity;, P:basement membrane assembly; P:cellular response to hormone stimulus; P:collagen fibril organization; P:collagen metabolic process; P:endothelial cell morphogenesis; P:epidermis morphogenesis; P:hydroxylysine biosynthetic process; P:in utero embryonic development; P:lung morphogenesis; P:neural tube development; P:peptidyl-lysine hydroxylation; P:protein localization; P:protein O-linked glycosylation; P:vasodilation;|O60568 B2R6W6 Q540C3,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3,, PF03171;, GO:0062023;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005615;GO:0005794;GO:0005791;GO:0005802;GO:0005506;GO:0031418;GO:0050211;GO:0033823;GO:0008475;GO:0070831;GO:0032870;GO:0030199;GO:0032963;GO:0001886;GO:0048730;GO:0046947;GO:0001701;GO:0060425;GO:0021915;GO:0017185;GO:0008104;GO:0006493;GO:0042311;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular space; C:Golgi apparatus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen galactosyltransferase activity; F:procollagen glucosyltransferase activity; F:procollagen-lysine 5-dioxygenase activity;, P:basement membrane assembly; P:cellular response to hormone stimulus; P:collagen fibril organization; P:collagen metabolic process; P:endothelial cell morphogenesis; P:epidermis morphogenesis; P:hydroxylysine biosynthetic process; P:in utero embryonic development; P:lung morphogenesis; P:neural tube development; P:peptidyl-lysine hydroxylation; P:protein localization; P:protein O-linked glycosylation; P:vasodilation; scaffold193 indexed_genome mRNA 19959 26438 . + . ID=transcript_15569;O43257 Q6IB12,Zinc finger HIT domain-containing protein 1,Cyclin-G1-binding protein 1;Zinc finger protein subfamily 4A member 1;p18 Hamlet;, PF04438;, GO:0005654;GO:0005634;GO:0000812;GO:0046872;GO:0031491;GO:0043486;, C:nucleoplasm; C:nucleus; C:Swr1 complex;, F:metal ion binding; F:nucleosome binding;, P:histone exchange; scaffold193 indexed_genome mRNA 31066 37135 . - . ID=transcript_15570;P56746 B3KPB5,Claudin-15,, PF00822;, GO:0005923;GO:0016021;GO:0016328;GO:0005886;GO:0042802;GO:0005198;GO:0070830;GO:0016338;GO:0007155;GO:0006811;, C:bicellular tight junction; C:integral component of membrane; C:lateral plasma membrane; C:plasma membrane;, F:identical protein binding; F:structural molecule activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:ion transport;|Q9NYC9 A2VCQ8 O15064 O95494 Q9NQ28,Dynein heavy chain 9, axonemal {ECO:0000305},Axonemal beta dynein heavy chain 9;Ciliary dynein heavy chain 9;, PF12774;PF12780;PF12781;PF17857;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;, GO:0097729;GO:0005930;GO:0120135;GO:0030286;GO:0005874;GO:0031514;GO:0036157;GO:0005524;GO:0008569;GO:0045505;GO:0051959;GO:0030030;GO:0003341;GO:0007018;, C:9+2 motile cilium; C:axoneme; C:distal portion of axoneme; C:dynein complex; C:microtubule; C:motile cilium; C:outer dynein arm;, F:ATP binding; F:ATP-dependent microtubule motor activity, minus-end-directed; F:dynein intermediate chain binding; F:dynein light intermediate chain binding;, P:cell projection organization; P:cilium movement; P:microtubule-based movement; scaffold193 indexed_genome mRNA 37932 42124 . - . ID=transcript_15571;Q9Y3D6 Q9BTP3,Mitochondrial fission 1 protein,FIS1 homolog;Tetratricopeptide repeat protein 11;, PF14853;PF14852;, GO:0005829;GO:0005783;GO:0031307;GO:0005779;GO:0016020;GO:0005739;GO:0005778;GO:0005777;GO:0032991;GO:0042802;GO:0000422;GO:0035584;GO:0000266;GO:0043653;GO:0008053;GO:0070584;GO:1903579;GO:0032471;GO:2000192;GO:0016559;GO:0043280;GO:0007204;GO:2001244;GO:0051561;GO:0090141;GO:0090314;GO:0045046;GO:0006626;GO:0010821;GO:0001836;, C:cytosol; C:endoplasmic reticulum; C:integral component of mitochondrial outer membrane; C:integral component of peroxisomal membrane; C:membrane; C:mitochondrion; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:identical protein binding;, P:autophagy of mitochondrion; P:calcium-mediated signaling using intracellular calcium source; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:negative regulation of ATP metabolic process; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of fatty acid transport; P:peroxisome fission; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial fission; P:positive regulation of protein targeting to membrane; P:protein import into peroxisome membrane; P:protein targeting to mitochondrion; P:regulation of mitochondrion organization; P:release of cytochrome c from mitochondria;|Q9Y3D6 Q9BTP3,Mitochondrial fission 1 protein,FIS1 homolog;Tetratricopeptide repeat protein 11;, PF14853;PF14852;, GO:0005829;GO:0005783;GO:0031307;GO:0005779;GO:0016020;GO:0005739;GO:0005778;GO:0005777;GO:0032991;GO:0042802;GO:0000422;GO:0035584;GO:0000266;GO:0043653;GO:0008053;GO:0070584;GO:1903579;GO:0032471;GO:2000192;GO:0016559;GO:0043280;GO:0007204;GO:2001244;GO:0051561;GO:0090141;GO:0090314;GO:0045046;GO:0006626;GO:0010821;GO:0001836;, C:cytosol; C:endoplasmic reticulum; C:integral component of mitochondrial outer membrane; C:integral component of peroxisomal membrane; C:membrane; C:mitochondrion; C:peroxisomal membrane; C:peroxisome; C:protein-containing complex;, F:identical protein binding;, P:autophagy of mitochondrion; P:calcium-mediated signaling using intracellular calcium source; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:negative regulation of ATP metabolic process; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of fatty acid transport; P:peroxisome fission; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of mitochondrial fission; P:positive regulation of protein targeting to membrane; P:protein import into peroxisome membrane; P:protein targeting to mitochondrion; P:regulation of mitochondrion organization; P:release of cytochrome c from mitochondria; scaffold193 indexed_genome mRNA 80234 84952 . - . ID=transcript_15572;Q9H7X7 Q49AG1 Q69YV5 Q9BSW4,Intraflagellar transport protein 22 homolog,Rab-like protein 5;, , GO:0005813;GO:0097542;GO:0005929;GO:0012505;GO:0030992;GO:0005525;GO:0003924;GO:0006886;GO:0035735;, C:centrosome; C:ciliary tip; C:cilium; C:endomembrane system; C:intraciliary transport particle B;, F:GTP binding; F:GTPase activity;, P:intracellular protein transport; P:intraciliary transport involved in cilium assembly; scaffold193 indexed_genome mRNA 642801 801387 . + . ID=transcript_15573;Q13948 B3KWH3 B3KWH8 B4DZZ2 G3V1Z6 J3KPQ6 Q53GU9 Q8TBS3,Protein CASP,, PF08172;, GO:0005794;GO:0000139;GO:0030173;GO:0005654;GO:0006891;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:nucleoplasm;, , P:intra-Golgi vesicle-mediated transport;|Q13948 B3KWH3 B3KWH8 B4DZZ2 G3V1Z6 J3KPQ6 Q53GU9 Q8TBS3,Protein CASP,, PF08172;, GO:0005794;GO:0000139;GO:0030173;GO:0005654;GO:0006891;, C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:nucleoplasm;, , P:intra-Golgi vesicle-mediated transport; scaffold193 indexed_genome mRNA 834747 835256 . + . ID=transcript_15574;O14492 A0A0A0MTI2 A6ND74,SH2B adapter protein 2,Adapter protein with pleckstrin homology and Src homology 2 domains;SH2 and PH domain-containing adapter protein APS;, PF00169;PF08916;PF00017;, GO:0005737;GO:0005829;GO:0005886;GO:0042169;GO:0035591;GO:0005068;GO:0050851;GO:0050853;GO:0007596;GO:0008286;GO:0035556;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:SH2 domain binding; F:signaling adaptor activity; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:antigen receptor-mediated signaling pathway; P:B cell receptor signaling pathway; P:blood coagulation; P:insulin receptor signaling pathway; P:intracellular signal transduction; scaffold193 indexed_genome mRNA 858429 888607 . + . ID=transcript_15575;Q9H875 B4DGM2 Q8NDM6 Q96CF8,PRKR-interacting protein 1,, PF06658;, GO:0070062;GO:0005730;GO:0005681;GO:0003725;GO:0019901;GO:0004860;GO:0006397;GO:0042326;GO:0006469;GO:0003014;GO:0008380;, C:extracellular exosome; C:nucleolus; C:spliceosomal complex;, F:double-stranded RNA binding; F:protein kinase binding; F:protein kinase inhibitor activity;, P:mRNA processing; P:negative regulation of phosphorylation; P:negative regulation of protein kinase activity; P:renal system process; P:RNA splicing;|P62308 D6W5G6 Q15357 Q6IB86,Small nuclear ribonucleoprotein G,Sm protein G;, PF01423;, GO:0071013;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0043186;GO:0071011;GO:1990904;GO:0030532;GO:0034719;GO:0005681;GO:0097526;GO:0005685;GO:0005689;GO:0005686;GO:0071007;GO:0071005;GO:0071004;GO:0005687;GO:0046540;GO:0005682;GO:0005683;GO:0003723;GO:0008334;GO:0051170;GO:0000398;GO:0008380;GO:0000245;GO:0000387;GO:0006369;, C:catalytic step 2 spliceosome; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus; C:P granule; C:precatalytic spliceosome; C:ribonucleoprotein complex; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal complex; C:spliceosomal tri-snRNP complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:U7 snRNP;, F:RNA binding;, P:histone mRNA metabolic process; P:import into nucleus; P:mRNA splicing, via spliceosome; P:RNA splicing; P:spliceosomal complex assembly; P:spliceosomal snRNP assembly; P:termination of RNA polymerase II transcription; scaffold193 indexed_genome mRNA 926618 937364 . + . ID=transcript_15576;Q9UFC0 A8K4K2 B2R9G2 Q8N0T9 Q8WV43 Q96GJ2,Leucine-rich repeat and WD repeat-containing protein 1,Centromere protein 33;Origin recognition complex-associated protein;, PF12799;, GO:0000781;GO:0000777;GO:0005737;GO:0043231;GO:0000776;GO:0005815;GO:0005664;GO:0005730;GO:0005654;GO:0005634;GO:0005721;GO:0003682;GO:0008327;GO:0035064;GO:0006325;GO:0006270;GO:0071169;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:cytoplasm; C:intracellular membrane-bounded organelle; C:kinetochore; C:microtubule organizing center; C:nuclear origin of replication recognition complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:chromatin binding; F:methyl-CpG binding; F:methylated histone binding;, P:chromatin organization; P:DNA replication initiation; P:establishment of protein localization to chromatin;|Q9UFC0 A8K4K2 B2R9G2 Q8N0T9 Q8WV43 Q96GJ2,Leucine-rich repeat and WD repeat-containing protein 1,Centromere protein 33;Origin recognition complex-associated protein;, PF12799;, GO:0000781;GO:0000777;GO:0005737;GO:0043231;GO:0000776;GO:0005815;GO:0005664;GO:0005730;GO:0005654;GO:0005634;GO:0005721;GO:0003682;GO:0008327;GO:0035064;GO:0006325;GO:0006270;GO:0071169;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:cytoplasm; C:intracellular membrane-bounded organelle; C:kinetochore; C:microtubule organizing center; C:nuclear origin of replication recognition complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:chromatin binding; F:methyl-CpG binding; F:methylated histone binding;, P:chromatin organization; P:DNA replication initiation; P:establishment of protein localization to chromatin;|P52435 A5D6V8 O43375,DNA-directed RNA polymerase II subunit RPB11-a,DNA-directed RNA polymerase II subunit J-1;RNA polymerase II 13.3 kDa subunit;, PF13656;, GO:0005654;GO:0005634;GO:0005665;GO:0003677;GO:0003899;GO:0030275;GO:0046983;GO:0001055;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:LRR domain binding; F:protein dimerization activity; F:RNA polymerase II activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair;|P52435 A5D6V8 O43375,DNA-directed RNA polymerase II subunit RPB11-a,DNA-directed RNA polymerase II subunit J-1;RNA polymerase II 13.3 kDa subunit;, PF13656;, GO:0005654;GO:0005634;GO:0005665;GO:0003677;GO:0003899;GO:0030275;GO:0046983;GO:0001055;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0050434;GO:0060964;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;, C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:LRR domain binding; F:protein dimerization activity; F:RNA polymerase II activity;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; scaffold193 indexed_genome mRNA 941184 944428 . - . ID=transcript_15577;O43374 O60286 Q14CQ4 Q86UW3 Q96QU0,Ras GTPase-activating protein 4,Calcium-promoted Ras inactivator;Ras p21 protein activator 4;RasGAP-activating-like protein 2;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0005886;GO:0005096;GO:0046872;GO:0005543;GO:0071277;GO:0000165;GO:0034260;GO:0046580;, C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:cellular response to calcium ion; P:MAPK cascade; P:negative regulation of GTPase activity; P:negative regulation of Ras protein signal transduction; scaffold193 indexed_genome mRNA 945259 949218 . - . ID=transcript_15578;O43374 O60286 Q14CQ4 Q86UW3 Q96QU0,Ras GTPase-activating protein 4,Calcium-promoted Ras inactivator;Ras p21 protein activator 4;RasGAP-activating-like protein 2;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0005886;GO:0005096;GO:0046872;GO:0005543;GO:0071277;GO:0000165;GO:0034260;GO:0046580;, C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:cellular response to calcium ion; P:MAPK cascade; P:negative regulation of GTPase activity; P:negative regulation of Ras protein signal transduction;|O43374 O60286 Q14CQ4 Q86UW3 Q96QU0,Ras GTPase-activating protein 4,Calcium-promoted Ras inactivator;Ras p21 protein activator 4;RasGAP-activating-like protein 2;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0005886;GO:0005096;GO:0046872;GO:0005543;GO:0071277;GO:0000165;GO:0034260;GO:0046580;, C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:cellular response to calcium ion; P:MAPK cascade; P:negative regulation of GTPase activity; P:negative regulation of Ras protein signal transduction; scaffold193 indexed_genome mRNA 950313 963449 . - . ID=transcript_15579;C9J798,Ras GTPase-activating protein 4B,, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0005886;GO:0005096;GO:0046872;GO:0005543;GO:0071277;GO:0035556;GO:0046580;, C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:cellular response to calcium ion; P:intracellular signal transduction; P:negative regulation of Ras protein signal transduction;|C9J798,Ras GTPase-activating protein 4B,, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0005886;GO:0005096;GO:0046872;GO:0005543;GO:0071277;GO:0035556;GO:0046580;, C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:cellular response to calcium ion; P:intracellular signal transduction; P:negative regulation of Ras protein signal transduction;|O43374 O60286 Q14CQ4 Q86UW3 Q96QU0,Ras GTPase-activating protein 4,Calcium-promoted Ras inactivator;Ras p21 protein activator 4;RasGAP-activating-like protein 2;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0005886;GO:0005096;GO:0046872;GO:0005543;GO:0071277;GO:0000165;GO:0034260;GO:0046580;, C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:cellular response to calcium ion; P:MAPK cascade; P:negative regulation of GTPase activity; P:negative regulation of Ras protein signal transduction;|O43374 O60286 Q14CQ4 Q86UW3 Q96QU0,Ras GTPase-activating protein 4,Calcium-promoted Ras inactivator;Ras p21 protein activator 4;RasGAP-activating-like protein 2;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0005886;GO:0005096;GO:0046872;GO:0005543;GO:0071277;GO:0000165;GO:0034260;GO:0046580;, C:cytosol; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding; F:phospholipid binding;, P:cellular response to calcium ion; P:MAPK cascade; P:negative regulation of GTPase activity; P:negative regulation of Ras protein signal transduction; scaffold194 indexed_genome mRNA 78955 83555 . + . ID=transcript_15580;Q8TE69 A0A0A0MTB5 A8K784 B7Z6H6 B7ZL96 D6RA72 E7ENU3 Q2M3E9,Protein EOLA1 {ECO:0000305},Endothelial-overexpressed lipopolysaccharide-associated factor 1 {ECO:0000303|PubMed:15541360};Endothelium and lymphocyte associated ASCH domain 1 {ECO:0000312|HGNC:HGNC:28089};, , GO:0010468;GO:0032675;, , , P:regulation of gene expression; P:regulation of interleukin-6 production;|A0A1B0GWH4,Heat shock transcription factor, X-linked member 3,, PF00447;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold194 indexed_genome mRNA 107180 173422 . - . ID=transcript_15581;E9PFR6 F5GXF7 F5GZL4 F8W8V7 H0Y4M8 O00345 Q8N1R8 Q9NSD2,Zinc finger protein 185,LIM domain protein ZNF185;P1-A;, , GO:0015629;GO:0005737;GO:0005925;GO:0051015;GO:0008270;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:actin filament binding; F:zinc ion binding;|E9PFR6 F5GXF7 F5GZL4 F8W8V7 H0Y4M8 O00345 Q8N1R8 Q9NSD2,Zinc finger protein 185,LIM domain protein ZNF185;P1-A;, , GO:0015629;GO:0005737;GO:0005925;GO:0051015;GO:0008270;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:actin filament binding; F:zinc ion binding;|E9PFR6 F5GXF7 F5GZL4 F8W8V7 H0Y4M8 O00345 Q8N1R8 Q9NSD2,Zinc finger protein 185,LIM domain protein ZNF185;P1-A;, , GO:0015629;GO:0005737;GO:0005925;GO:0051015;GO:0008270;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:actin filament binding; F:zinc ion binding;|E9PFR6 F5GXF7 F5GZL4 F8W8V7 H0Y4M8 O00345 Q8N1R8 Q9NSD2,Zinc finger protein 185,LIM domain protein ZNF185;P1-A;, , GO:0015629;GO:0005737;GO:0005925;GO:0051015;GO:0008270;, C:actin cytoskeleton; C:cytoplasm; C:focal adhesion;, F:actin filament binding; F:zinc ion binding; scaffold194 indexed_genome mRNA 200502 236265 . - . ID=transcript_15582;Q15738 D3DWT6 O00344,Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating,Protein H105e3;, PF01073;, GO:0005783;GO:0005789;GO:0016021;GO:0005811;GO:0003854;GO:0102175;GO:0103066;GO:0103067;GO:0000252;GO:0016616;GO:0047012;GO:0006695;GO:0008203;GO:0001942;GO:0060716;GO:0007224;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet;, F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; F:3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity; F:4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity; F:4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity; F:C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity;, P:cholesterol biosynthetic process; P:cholesterol metabolic process; P:hair follicle development; P:labyrinthine layer blood vessel development; P:smoothened signaling pathway; scaffold194 indexed_genome mRNA 237433 240615 . + . ID=transcript_15583;P41208 B2R4T4 Q53XW1,Centrin-2,Caltractin isoform 1;, PF13499;, GO:0097729;GO:0045177;GO:0005814;GO:0005813;GO:0036064;GO:0005829;GO:0044615;GO:0005654;GO:0032391;GO:0070390;GO:0071942;GO:0005509;GO:0031683;GO:0032795;GO:0008017;GO:0051301;GO:0007099;GO:0097711;GO:0000086;GO:0070911;GO:0000278;GO:0051028;GO:0006289;GO:0000715;GO:0000717;GO:0006294;GO:0015031;GO:0032465;GO:0010389;GO:0007283;, C:9+2 motile cilium; C:apical part of cell; C:centriole; C:centrosome; C:ciliary basal body; C:cytosol; C:nuclear pore nuclear basket; C:nucleoplasm; C:photoreceptor connecting cilium; C:transcription export complex 2; C:XPC complex;, F:calcium ion binding; F:G-protein beta/gamma-subunit complex binding; F:heterotrimeric G-protein binding; F:microtubule binding;, P:cell division; P:centriole replication; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:mitotic cell cycle; P:mRNA transport; P:nucleotide-excision repair; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, preincision complex assembly; P:protein transport; P:regulation of cytokinesis; P:regulation of G2/M transition of mitotic cell cycle; P:spermatogenesis; scaffold194 indexed_genome mRNA 652350 738724 . + . ID=transcript_15584;P34903 Q8TAF9,Gamma-aminobutyric acid receptor subunit alpha-3,GABA(A) receptor subunit alpha-3;, PF02931;PF02932;, GO:0034707;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0099060;GO:0043005;GO:0005886;GO:0098794;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold194 indexed_genome mRNA 775374 776317 . - . ID=transcript_15585;P34903 Q8TAF9,Gamma-aminobutyric acid receptor subunit alpha-3,GABA(A) receptor subunit alpha-3;, PF02931;PF02932;, GO:0034707;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0099060;GO:0043005;GO:0005886;GO:0098794;GO:0045202;GO:0008503;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:synapse;, F:benzodiazepine receptor activity; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold194 indexed_genome mRNA 924044 929035 . + . ID=transcript_15586;P78334 E7ET93 O15345 O15346 Q6PCD2 Q99520,Gamma-aminobutyric acid receptor subunit epsilon,GABA(A) receptor subunit epsilon;, PF02931;PF02932;, GO:0034707;GO:0032590;GO:1902711;GO:0005887;GO:0043005;GO:0098794;GO:0045211;GO:0045202;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:2001226;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;, C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:postsynapse; C:postsynaptic membrane; C:synapse;, F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:negative regulation of chloride transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic; scaffold196 indexed_genome mRNA 102411 150140 . + . ID=transcript_15587;Q8NGA7,Adhesion G protein-coupled receptor E1 {ECO:0000303|PubMed:25713288},EGF-like module receptor 1;EGF-like module-containing mucin-like hormone receptor-like 1;EMR1 hormone receptor;, PF00002;PF12662;PF07645;PF01825;, GO:0005887;GO:0005509;GO:0004930;GO:0002250;GO:0007189;GO:0007155;GO:0007166;GO:0007186;, C:integral component of plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:adaptive immune response; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway;|Q8NGA7,Adhesion G protein-coupled receptor E1 {ECO:0000303|PubMed:25713288},EGF-like module receptor 1;EGF-like module-containing mucin-like hormone receptor-like 1;EMR1 hormone receptor;, PF00002;PF12662;PF07645;PF01825;, GO:0005887;GO:0005509;GO:0004930;GO:0002250;GO:0007189;GO:0007155;GO:0007166;GO:0007186;, C:integral component of plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:adaptive immune response; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold196 indexed_genome mRNA 224824 242639 . + . ID=transcript_15588;Q8NGA7,Adhesion G protein-coupled receptor E1 {ECO:0000303|PubMed:25713288},EGF-like module receptor 1;EGF-like module-containing mucin-like hormone receptor-like 1;EMR1 hormone receptor;, PF00002;PF12662;PF07645;PF01825;, GO:0005887;GO:0005509;GO:0004930;GO:0002250;GO:0007189;GO:0007155;GO:0007166;GO:0007186;, C:integral component of plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:adaptive immune response; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell adhesion; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold196 indexed_genome mRNA 247464 258990 . + . ID=transcript_15589;Q86SQ3 Q86SP1,Putative adhesion G protein-coupled receptor E4P,EGF-like module receptor 4;EGF-like module-containing mucin-like hormone receptor-like 4;G-protein coupled receptor 127;G-protein coupled receptor PGR16;, PF00002;PF07645;PF01825;, GO:0005576;GO:0016021;GO:0005887;GO:0005509;GO:0004930;GO:0007189;GO:0007166;GO:0007186;, C:extracellular region; C:integral component of membrane; C:integral component of plasma membrane;, F:calcium ion binding; F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; scaffold196 indexed_genome mRNA 459471 476097 . + . ID=transcript_15590;Q9H324 M0QZE4,A disintegrin and metalloproteinase with thrombospondin motifs 10,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0001527;GO:0046872;GO:0004222;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:microfibril;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q9H324 M0QZE4,A disintegrin and metalloproteinase with thrombospondin motifs 10,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0001527;GO:0046872;GO:0004222;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:microfibril;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q9H324 M0QZE4,A disintegrin and metalloproteinase with thrombospondin motifs 10,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0001527;GO:0046872;GO:0004222;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:microfibril;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q9H324 M0QZE4,A disintegrin and metalloproteinase with thrombospondin motifs 10,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0001527;GO:0046872;GO:0004222;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:microfibril;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q9H324 M0QZE4,A disintegrin and metalloproteinase with thrombospondin motifs 10,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0001527;GO:0046872;GO:0004222;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:microfibril;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q9H324 M0QZE4,A disintegrin and metalloproteinase with thrombospondin motifs 10,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0001527;GO:0046872;GO:0004222;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:microfibril;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q9H324 M0QZE4,A disintegrin and metalloproteinase with thrombospondin motifs 10,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0001527;GO:0046872;GO:0004222;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:microfibril;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold196 indexed_genome mRNA 476416 479489 . + . ID=transcript_15591;Q9H324 M0QZE4,A disintegrin and metalloproteinase with thrombospondin motifs 10,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0001527;GO:0046872;GO:0004222;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:microfibril;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization;|Q9H324 M0QZE4,A disintegrin and metalloproteinase with thrombospondin motifs 10,, PF17771;PF05986;PF01562;PF08686;PF01421;PF00090;, GO:0062023;GO:0031012;GO:0005576;GO:0001527;GO:0046872;GO:0004222;GO:0030198;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:microfibril;, F:metal ion binding; F:metalloendopeptidase activity;, P:extracellular matrix organization; scaffold196 indexed_genome mRNA 481219 520389 . + . ID=transcript_15592;O00160 Q8WWN7,Unconventional myosin-If,Myosin-Ie;, PF00063;PF06017;PF00018;, GO:0015629;GO:0005737;GO:0005829;GO:0005902;GO:0005886;GO:0016461;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:microvillus; C:plasma membrane; C:unconventional myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:vesicle transport along actin filament;|O00160 Q8WWN7,Unconventional myosin-If,Myosin-Ie;, PF00063;PF06017;PF00018;, GO:0015629;GO:0005737;GO:0005829;GO:0005902;GO:0005886;GO:0016461;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:microvillus; C:plasma membrane; C:unconventional myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:vesicle transport along actin filament;|O00160 Q8WWN7,Unconventional myosin-If,Myosin-Ie;, PF00063;PF06017;PF00018;, GO:0015629;GO:0005737;GO:0005829;GO:0005902;GO:0005886;GO:0016461;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:microvillus; C:plasma membrane; C:unconventional myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:vesicle transport along actin filament;|O00160 Q8WWN7,Unconventional myosin-If,Myosin-Ie;, PF00063;PF06017;PF00018;, GO:0015629;GO:0005737;GO:0005829;GO:0005902;GO:0005886;GO:0016461;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0005524;GO:0005516;GO:0000146;GO:0007015;GO:0030050;, C:actin cytoskeleton; C:cytoplasm; C:cytosol; C:microvillus; C:plasma membrane; C:unconventional myosin complex; C:vesicle;, F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:actin filament organization; P:vesicle transport along actin filament; scaffold196 indexed_genome mRNA 526977 529514 . - . ID=transcript_15593;Q96IQ9 A8MY94,Zinc finger protein 414,, PF15909;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;|Q96IQ9 A8MY94,Zinc finger protein 414,, PF15909;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;|Q96IQ9 A8MY94,Zinc finger protein 414,, PF15909;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;|Q96IQ9 A8MY94,Zinc finger protein 414,, PF15909;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; scaffold196 indexed_genome mRNA 529618 530365 . + . ID=transcript_15594;Q96IQ9 A8MY94,Zinc finger protein 414,, PF15909;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; scaffold196 indexed_genome mRNA 539969 540770 . + . ID=transcript_15595;Q96QH2 Q8N6W7,PML-RARA-regulated adapter molecule 1,, PF14603;, GO:0005886;GO:0032991;GO:0008289;GO:0019901;GO:0007229;GO:0072659;GO:0043313;GO:0050852;, C:plasma membrane; C:protein-containing complex;, F:lipid binding; F:protein kinase binding;, P:integrin-mediated signaling pathway; P:protein localization to plasma membrane; P:regulation of neutrophil degranulation; P:T cell receptor signaling pathway; scaffold196 indexed_genome mRNA 543706 545938 . + . ID=transcript_15596;Q96QH2 Q8N6W7,PML-RARA-regulated adapter molecule 1,, PF14603;, GO:0005886;GO:0032991;GO:0008289;GO:0019901;GO:0007229;GO:0072659;GO:0043313;GO:0050852;, C:plasma membrane; C:protein-containing complex;, F:lipid binding; F:protein kinase binding;, P:integrin-mediated signaling pathway; P:protein localization to plasma membrane; P:regulation of neutrophil degranulation; P:T cell receptor signaling pathway; scaffold196 indexed_genome mRNA 547300 586266 . - . ID=transcript_15597;P52272 Q15584 Q8WZ44 Q96H56 Q9BWL9 Q9Y492,Heterogeneous nuclear ribonucleoprotein M,, PF11532;PF00076;, GO:0071013;GO:0062023;GO:0005737;GO:0070062;GO:0016020;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0042382;GO:0071014;GO:1990904;GO:0005681;GO:0003729;GO:0019904;GO:0003723;GO:0000380;GO:0008543;GO:0000398;GO:2000815;GO:0016070;, C:catalytic step 2 spliceosome; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:paraspeckles; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex; C:spliceosomal complex;, F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of mRNA stability involved in response to oxidative stress; P:RNA metabolic process;|P52272 Q15584 Q8WZ44 Q96H56 Q9BWL9 Q9Y492,Heterogeneous nuclear ribonucleoprotein M,, PF11532;PF00076;, GO:0071013;GO:0062023;GO:0005737;GO:0070062;GO:0016020;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0042382;GO:0071014;GO:1990904;GO:0005681;GO:0003729;GO:0019904;GO:0003723;GO:0000380;GO:0008543;GO:0000398;GO:2000815;GO:0016070;, C:catalytic step 2 spliceosome; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:paraspeckles; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex; C:spliceosomal complex;, F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of mRNA stability involved in response to oxidative stress; P:RNA metabolic process;|P52272 Q15584 Q8WZ44 Q96H56 Q9BWL9 Q9Y492,Heterogeneous nuclear ribonucleoprotein M,, PF11532;PF00076;, GO:0071013;GO:0062023;GO:0005737;GO:0070062;GO:0016020;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0042382;GO:0071014;GO:1990904;GO:0005681;GO:0003729;GO:0019904;GO:0003723;GO:0000380;GO:0008543;GO:0000398;GO:2000815;GO:0016070;, C:catalytic step 2 spliceosome; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:paraspeckles; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex; C:spliceosomal complex;, F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of mRNA stability involved in response to oxidative stress; P:RNA metabolic process;|P52272 Q15584 Q8WZ44 Q96H56 Q9BWL9 Q9Y492,Heterogeneous nuclear ribonucleoprotein M,, PF11532;PF00076;, GO:0071013;GO:0062023;GO:0005737;GO:0070062;GO:0016020;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0042382;GO:0071014;GO:1990904;GO:0005681;GO:0003729;GO:0019904;GO:0003723;GO:0000380;GO:0008543;GO:0000398;GO:2000815;GO:0016070;, C:catalytic step 2 spliceosome; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:paraspeckles; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex; C:spliceosomal complex;, F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of mRNA stability involved in response to oxidative stress; P:RNA metabolic process;|P52272 Q15584 Q8WZ44 Q96H56 Q9BWL9 Q9Y492,Heterogeneous nuclear ribonucleoprotein M,, PF11532;PF00076;, GO:0071013;GO:0062023;GO:0005737;GO:0070062;GO:0016020;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0042382;GO:0071014;GO:1990904;GO:0005681;GO:0003729;GO:0019904;GO:0003723;GO:0000380;GO:0008543;GO:0000398;GO:2000815;GO:0016070;, C:catalytic step 2 spliceosome; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:paraspeckles; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex; C:spliceosomal complex;, F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of mRNA stability involved in response to oxidative stress; P:RNA metabolic process;|P52272 Q15584 Q8WZ44 Q96H56 Q9BWL9 Q9Y492,Heterogeneous nuclear ribonucleoprotein M,, PF11532;PF00076;, GO:0071013;GO:0062023;GO:0005737;GO:0070062;GO:0016020;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0042382;GO:0071014;GO:1990904;GO:0005681;GO:0003729;GO:0019904;GO:0003723;GO:0000380;GO:0008543;GO:0000398;GO:2000815;GO:0016070;, C:catalytic step 2 spliceosome; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:paraspeckles; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex; C:spliceosomal complex;, F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of mRNA stability involved in response to oxidative stress; P:RNA metabolic process;|P52272 Q15584 Q8WZ44 Q96H56 Q9BWL9 Q9Y492,Heterogeneous nuclear ribonucleoprotein M,, PF11532;PF00076;, GO:0071013;GO:0062023;GO:0005737;GO:0070062;GO:0016020;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0042382;GO:0071014;GO:1990904;GO:0005681;GO:0003729;GO:0019904;GO:0003723;GO:0000380;GO:0008543;GO:0000398;GO:2000815;GO:0016070;, C:catalytic step 2 spliceosome; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:paraspeckles; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex; C:spliceosomal complex;, F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of mRNA stability involved in response to oxidative stress; P:RNA metabolic process;|P52272 Q15584 Q8WZ44 Q96H56 Q9BWL9 Q9Y492,Heterogeneous nuclear ribonucleoprotein M,, PF11532;PF00076;, GO:0071013;GO:0062023;GO:0005737;GO:0070062;GO:0016020;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0042382;GO:0071014;GO:1990904;GO:0005681;GO:0003729;GO:0019904;GO:0003723;GO:0000380;GO:0008543;GO:0000398;GO:2000815;GO:0016070;, C:catalytic step 2 spliceosome; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:paraspeckles; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex; C:spliceosomal complex;, F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of mRNA stability involved in response to oxidative stress; P:RNA metabolic process;|P52272 Q15584 Q8WZ44 Q96H56 Q9BWL9 Q9Y492,Heterogeneous nuclear ribonucleoprotein M,, PF11532;PF00076;, GO:0071013;GO:0062023;GO:0005737;GO:0070062;GO:0016020;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0042382;GO:0071014;GO:1990904;GO:0005681;GO:0003729;GO:0019904;GO:0003723;GO:0000380;GO:0008543;GO:0000398;GO:2000815;GO:0016070;, C:catalytic step 2 spliceosome; C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular exosome; C:membrane; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:paraspeckles; C:post-mRNA release spliceosomal complex; C:ribonucleoprotein complex; C:spliceosomal complex;, F:mRNA binding; F:protein domain specific binding; F:RNA binding;, P:alternative mRNA splicing, via spliceosome; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:regulation of mRNA stability involved in response to oxidative stress; P:RNA metabolic process; scaffold196 indexed_genome mRNA 589884 605936 . - . ID=transcript_15598;Q9P0N8 A6NP10 Q5H785 Q8N5A3 Q96B78,E3 ubiquitin-protein ligase MARCHF2,Membrane-associated RING finger protein 2;Membrane-associated RING-CH protein II;RING finger protein 172;RING-type E3 ubiquitin transferase MARCHF2 {ECO:0000305};, PF12906;, GO:0031410;GO:0005829;GO:0005783;GO:0005789;GO:0010008;GO:0016021;GO:0005765;GO:0061630;GO:0004842;GO:0008270;GO:0006897;GO:0016567;, C:cytoplasmic vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome membrane; C:integral component of membrane; C:lysosomal membrane;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:endocytosis; P:protein ubiquitination; scaffold196 indexed_genome mRNA 615099 619656 . - . ID=transcript_15599;P62491 B2R4B6 B4DT13 P24410 Q5TZN9 Q9JLX1,Ras-related protein Rab-11A,YL8;, PF00071;, GO:0030424;GO:0034451;GO:0005813;GO:0032154;GO:0031410;GO:0030659;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0005794;GO:0043231;GO:0005771;GO:0048471;GO:0045335;GO:0098837;GO:0032991;GO:0055037;GO:0055038;GO:0098685;GO:0000922;GO:0005802;GO:0030133;GO:0031982;GO:0005525;GO:0003924;GO:0008017;GO:0031489;GO:0019905;GO:0150093;GO:0030953;GO:0097711;GO:0060271;GO:0090150;GO:0072594;GO:0051650;GO:0006887;GO:1990182;GO:0032402;GO:0007080;GO:0090307;GO:0036258;GO:0031175;GO:0098887;GO:0048227;GO:0045773;GO:0010634;GO:0010971;GO:1903078;GO:0043687;GO:0034394;GO:0072659;GO:0032465;GO:0048169;GO:0010796;GO:0051223;GO:0060627;GO:0003091;GO:0016192;GO:0099003;, C:axon; C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:multivesicular body; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:postsynaptic recycling endosome; C:protein-containing complex; C:recycling endosome; C:recycling endosome membrane; C:Schaffer collateral - CA1 synapse; C:spindle pole; C:trans-Golgi network; C:transport vesicle; C:vesicle;, F:GTP binding; F:GTPase activity; F:microtubule binding; F:myosin V binding; F:syntaxin binding;, P:amyloid-beta clearance by transcytosis; P:astral microtubule organization; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of protein localization to membrane; P:establishment of protein localization to organelle; P:establishment of vesicle localization; P:exocytosis; P:exosomal secretion; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle assembly; P:multivesicular body assembly; P:neuron projection development; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:plasma membrane to endosome transport; P:positive regulation of axon extension; P:positive regulation of epithelial cell migration; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of protein localization to plasma membrane; P:post-translational protein modification; P:protein localization to cell surface; P:protein localization to plasma membrane; P:regulation of cytokinesis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of multivesicular body size; P:regulation of protein transport; P:regulation of vesicle-mediated transport; P:renal water homeostasis; P:vesicle-mediated transport; P:vesicle-mediated transport in synapse;|P62491 B2R4B6 B4DT13 P24410 Q5TZN9 Q9JLX1,Ras-related protein Rab-11A,YL8;, PF00071;, GO:0030424;GO:0034451;GO:0005813;GO:0032154;GO:0031410;GO:0030659;GO:0005829;GO:0005768;GO:0070062;GO:0098978;GO:0005794;GO:0043231;GO:0005771;GO:0048471;GO:0045335;GO:0098837;GO:0032991;GO:0055037;GO:0055038;GO:0098685;GO:0000922;GO:0005802;GO:0030133;GO:0031982;GO:0005525;GO:0003924;GO:0008017;GO:0031489;GO:0019905;GO:0150093;GO:0030953;GO:0097711;GO:0060271;GO:0090150;GO:0072594;GO:0051650;GO:0006887;GO:1990182;GO:0032402;GO:0007080;GO:0090307;GO:0036258;GO:0031175;GO:0098887;GO:0048227;GO:0045773;GO:0010634;GO:0010971;GO:1903078;GO:0043687;GO:0034394;GO:0072659;GO:0032465;GO:0048169;GO:0010796;GO:0051223;GO:0060627;GO:0003091;GO:0016192;GO:0099003;, C:axon; C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:endosome; C:extracellular exosome; C:glutamatergic synapse; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:multivesicular body; C:perinuclear region of cytoplasm; C:phagocytic vesicle; C:postsynaptic recycling endosome; C:protein-containing complex; C:recycling endosome; C:recycling endosome membrane; C:Schaffer collateral - CA1 synapse; C:spindle pole; C:trans-Golgi network; C:transport vesicle; C:vesicle;, F:GTP binding; F:GTPase activity; F:microtubule binding; F:myosin V binding; F:syntaxin binding;, P:amyloid-beta clearance by transcytosis; P:astral microtubule organization; P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:establishment of protein localization to membrane; P:establishment of protein localization to organelle; P:establishment of vesicle localization; P:exocytosis; P:exosomal secretion; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle assembly; P:multivesicular body assembly; P:neuron projection development; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:plasma membrane to endosome transport; P:positive regulation of axon extension; P:positive regulation of epithelial cell migration; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of protein localization to plasma membrane; P:post-translational protein modification; P:protein localization to cell surface; P:protein localization to plasma membrane; P:regulation of cytokinesis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of multivesicular body size; P:regulation of protein transport; P:regulation of vesicle-mediated transport; P:renal water homeostasis; P:vesicle-mediated transport; P:vesicle-mediated transport in synapse; scaffold196 indexed_genome mRNA 630228 638148 . - . ID=transcript_15600;Q9NZU4 Q9Y5B3,Angiopoietin-related protein 4,Angiopoietin-like protein 4;Hepatic fibrinogen/angiopoietin-related protein {ECO:0000303|PubMed:10698685};, PF00147;, GO:0072562;GO:0062023;GO:0005576;GO:0005615;GO:0004857;GO:0042802;GO:0005102;GO:0001525;GO:0006629;GO:0043066;GO:2000352;GO:0051005;GO:0045766;GO:0043335;GO:0019222;GO:0001666;GO:0070328;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:enzyme inhibitor activity; F:identical protein binding; F:signaling receptor binding;, P:angiogenesis; P:lipid metabolic process; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of lipoprotein lipase activity; P:positive regulation of angiogenesis; P:protein unfolding; P:regulation of metabolic process; P:response to hypoxia; P:triglyceride homeostasis;|Q9NZU4 Q9Y5B3,Angiopoietin-related protein 4,Angiopoietin-like protein 4;Hepatic fibrinogen/angiopoietin-related protein {ECO:0000303|PubMed:10698685};, PF00147;, GO:0072562;GO:0062023;GO:0005576;GO:0005615;GO:0004857;GO:0042802;GO:0005102;GO:0001525;GO:0006629;GO:0043066;GO:2000352;GO:0051005;GO:0045766;GO:0043335;GO:0019222;GO:0001666;GO:0070328;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:enzyme inhibitor activity; F:identical protein binding; F:signaling receptor binding;, P:angiogenesis; P:lipid metabolic process; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of lipoprotein lipase activity; P:positive regulation of angiogenesis; P:protein unfolding; P:regulation of metabolic process; P:response to hypoxia; P:triglyceride homeostasis;|Q9NZU4 Q9Y5B3,Angiopoietin-related protein 4,Angiopoietin-like protein 4;Hepatic fibrinogen/angiopoietin-related protein {ECO:0000303|PubMed:10698685};, PF00147;, GO:0072562;GO:0062023;GO:0005576;GO:0005615;GO:0004857;GO:0042802;GO:0005102;GO:0001525;GO:0006629;GO:0043066;GO:2000352;GO:0051005;GO:0045766;GO:0043335;GO:0019222;GO:0001666;GO:0070328;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:enzyme inhibitor activity; F:identical protein binding; F:signaling receptor binding;, P:angiogenesis; P:lipid metabolic process; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of lipoprotein lipase activity; P:positive regulation of angiogenesis; P:protein unfolding; P:regulation of metabolic process; P:response to hypoxia; P:triglyceride homeostasis;|Q9NZU4 Q9Y5B3,Angiopoietin-related protein 4,Angiopoietin-like protein 4;Hepatic fibrinogen/angiopoietin-related protein {ECO:0000303|PubMed:10698685};, PF00147;, GO:0072562;GO:0062023;GO:0005576;GO:0005615;GO:0004857;GO:0042802;GO:0005102;GO:0001525;GO:0006629;GO:0043066;GO:2000352;GO:0051005;GO:0045766;GO:0043335;GO:0019222;GO:0001666;GO:0070328;, C:blood microparticle; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;, F:enzyme inhibitor activity; F:identical protein binding; F:signaling receptor binding;, P:angiogenesis; P:lipid metabolic process; P:negative regulation of apoptotic process; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of lipoprotein lipase activity; P:positive regulation of angiogenesis; P:protein unfolding; P:regulation of metabolic process; P:response to hypoxia; P:triglyceride homeostasis; scaffold196 indexed_genome mRNA 661963 677020 . + . ID=transcript_15601;Q6NY19 Q6NZI1 Q6ZQR3 Q8IUV2,KN motif and ankyrin repeat domain-containing protein 3,Ankyrin repeat domain-containing protein 47;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0030837;, C:cytoplasm; C:cytoskeleton;, , P:negative regulation of actin filament polymerization;|Q6NY19 Q6NZI1 Q6ZQR3 Q8IUV2,KN motif and ankyrin repeat domain-containing protein 3,Ankyrin repeat domain-containing protein 47;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0030837;, C:cytoplasm; C:cytoskeleton;, , P:negative regulation of actin filament polymerization;|Q6NY19 Q6NZI1 Q6ZQR3 Q8IUV2,KN motif and ankyrin repeat domain-containing protein 3,Ankyrin repeat domain-containing protein 47;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0030837;, C:cytoplasm; C:cytoskeleton;, , P:negative regulation of actin filament polymerization;|Q6NY19 Q6NZI1 Q6ZQR3 Q8IUV2,KN motif and ankyrin repeat domain-containing protein 3,Ankyrin repeat domain-containing protein 47;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0030837;, C:cytoplasm; C:cytoskeleton;, , P:negative regulation of actin filament polymerization;|Q6NY19 Q6NZI1 Q6ZQR3 Q8IUV2,KN motif and ankyrin repeat domain-containing protein 3,Ankyrin repeat domain-containing protein 47;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0030837;, C:cytoplasm; C:cytoskeleton;, , P:negative regulation of actin filament polymerization;|Q6NY19 Q6NZI1 Q6ZQR3 Q8IUV2,KN motif and ankyrin repeat domain-containing protein 3,Ankyrin repeat domain-containing protein 47;, PF12796;PF12075;, GO:0005737;GO:0005856;GO:0030837;, C:cytoplasm; C:cytoskeleton;, , P:negative regulation of actin filament polymerization; scaffold196 indexed_genome mRNA 679111 685195 . + . ID=transcript_15602;O95182,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7,Complex I-B14.5a;NADH-ubiquinone oxidoreductase subunit B14.5a;, PF07347;, GO:0005743;GO:0005747;GO:0005761;GO:0005739;GO:0008137;GO:0003735;GO:0006120;GO:0032981;GO:0032543;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrial ribosome; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity; F:structural constituent of ribosome;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:mitochondrial translation;|O95182,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7,Complex I-B14.5a;NADH-ubiquinone oxidoreductase subunit B14.5a;, PF07347;, GO:0005743;GO:0005747;GO:0005761;GO:0005739;GO:0008137;GO:0003735;GO:0006120;GO:0032981;GO:0032543;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrial ribosome; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity; F:structural constituent of ribosome;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:mitochondrial translation;|O95182,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7,Complex I-B14.5a;NADH-ubiquinone oxidoreductase subunit B14.5a;, PF07347;, GO:0005743;GO:0005747;GO:0005761;GO:0005739;GO:0008137;GO:0003735;GO:0006120;GO:0032981;GO:0032543;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrial ribosome; C:mitochondrion;, F:NADH dehydrogenase (ubiquinone) activity; F:structural constituent of ribosome;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:mitochondrial translation; scaffold196 indexed_genome mRNA 687215 693269 . + . ID=transcript_15603;Q9NPF0 B2RDS5 D6W668 F5H6D3 Q53HF7,CD320 antigen,8D6 antigen {ECO:0000303|PubMed:10727470};FDC-signaling molecule 8D6 {ECO:0000303|PubMed:10727470, ECO:0000303|PubMed:11418631};Transcobalamin receptor {ECO:0000303|PubMed:18779389};, PF00057;, GO:0005783;GO:0010008;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0031419;GO:0008083;GO:0031296;GO:0009235;GO:0015889;GO:0030890;, C:endoplasmic reticulum; C:endosome membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:cobalamin binding; F:growth factor activity;, P:B cell costimulation; P:cobalamin metabolic process; P:cobalamin transport; P:positive regulation of B cell proliferation;|Q9NPF0 B2RDS5 D6W668 F5H6D3 Q53HF7,CD320 antigen,8D6 antigen {ECO:0000303|PubMed:10727470};FDC-signaling molecule 8D6 {ECO:0000303|PubMed:10727470, ECO:0000303|PubMed:11418631};Transcobalamin receptor {ECO:0000303|PubMed:18779389};, PF00057;, GO:0005783;GO:0010008;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0031419;GO:0008083;GO:0031296;GO:0009235;GO:0015889;GO:0030890;, C:endoplasmic reticulum; C:endosome membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:cobalamin binding; F:growth factor activity;, P:B cell costimulation; P:cobalamin metabolic process; P:cobalamin transport; P:positive regulation of B cell proliferation;|Q9NPF0 B2RDS5 D6W668 F5H6D3 Q53HF7,CD320 antigen,8D6 antigen {ECO:0000303|PubMed:10727470};FDC-signaling molecule 8D6 {ECO:0000303|PubMed:10727470, ECO:0000303|PubMed:11418631};Transcobalamin receptor {ECO:0000303|PubMed:18779389};, PF00057;, GO:0005783;GO:0010008;GO:0005887;GO:0016020;GO:0005886;GO:0005509;GO:0031419;GO:0008083;GO:0031296;GO:0009235;GO:0015889;GO:0030890;, C:endoplasmic reticulum; C:endosome membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:calcium ion binding; F:cobalamin binding; F:growth factor activity;, P:B cell costimulation; P:cobalamin metabolic process; P:cobalamin transport; P:positive regulation of B cell proliferation; scaffold196 indexed_genome mRNA 708008 752777 . + . ID=transcript_15604;Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|P35556 B4DU01 Q59ES6,Fibrillin-2,, PF12662;PF07645;PF18193;PF12661;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0001527;GO:0005509;GO:0030023;GO:0005201;GO:0009653;GO:0060346;GO:0043010;GO:0048048;GO:0030326;GO:0030198;GO:0030501;GO:0045669;GO:0035583;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:microfibril;, F:calcium ion binding; F:extracellular matrix constituent conferring elasticity; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis; P:bone trabecula formation; P:camera-type eye development; P:embryonic eye morphogenesis; P:embryonic limb morphogenesis; P:extracellular matrix organization; P:positive regulation of bone mineralization; P:positive regulation of osteoblast differentiation; P:sequestering of TGFbeta in extracellular matrix;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis; scaffold196 indexed_genome mRNA 753572 777994 . + . ID=transcript_15605;Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis;|Q75N90 Q75N91 Q75N92 Q75N93 Q86SJ5 Q96JP8,Fibrillin-3,, PF12662;PF07645;PF18193;PF00683;, GO:0062023;GO:0031012;GO:0005576;GO:0005509;GO:0005201;GO:0009653;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region;, F:calcium ion binding; F:extracellular matrix structural constituent;, P:anatomical structure morphogenesis; scaffold196 indexed_genome mRNA 778001 779491 . - . ID=transcript_15606;O15444 A1L4J4 A6NI52 A8K9E7 B5MCA5 Q96KJ7,C-C motif chemokine 25,Chemokine TECK;Small-inducible cytokine A25;Thymus-expressed chemokine;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0031735;GO:0008009;GO:0042379;GO:0005179;GO:0061844;GO:0060326;GO:0007166;GO:0071346;GO:0071347;GO:0071356;GO:0070098;GO:0006935;GO:0007186;GO:0006955;GO:0006954;GO:0031640;GO:0048247;GO:0002548;GO:1903237;GO:0030593;GO:0001954;GO:0070374;GO:0043547;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:CCR10 chemokine receptor binding; F:chemokine activity; F:chemokine receptor binding; F:hormone activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell chemotaxis; P:cell surface receptor signaling pathway; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:immune response; P:inflammatory response; P:killing of cells of other organism; P:lymphocyte chemotaxis; P:monocyte chemotaxis; P:negative regulation of leukocyte tethering or rolling; P:neutrophil chemotaxis; P:positive regulation of cell-matrix adhesion; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; scaffold196 indexed_genome mRNA 820832 846994 . + . ID=transcript_15607;Q15717 B4DVB8 Q53XN6 Q9BTT1,ELAV-like protein 1,Hu-antigen R;, PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005783;GO:0098978;GO:0016020;GO:0005654;GO:0005634;GO:0098794;GO:1990904;GO:0003725;GO:0035198;GO:0035925;GO:0003730;GO:0003729;GO:0042803;GO:0019901;GO:0003723;GO:0070935;GO:0000398;GO:0048255;GO:0060965;GO:0045727;GO:0016441;GO:0051260;GO:0006606;GO:0043488;GO:2000036;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:endoplasmic reticulum; C:glutamatergic synapse; C:membrane; C:nucleoplasm; C:nucleus; C:postsynapse; C:ribonucleoprotein complex;, F:double-stranded RNA binding; F:miRNA binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:protein homodimerization activity; F:protein kinase binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:negative regulation of gene silencing by miRNA; P:positive regulation of translation; P:posttranscriptional gene silencing; P:protein homooligomerization; P:protein import into nucleus; P:regulation of mRNA stability; P:regulation of stem cell population maintenance;|Q15717 B4DVB8 Q53XN6 Q9BTT1,ELAV-like protein 1,Hu-antigen R;, PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005783;GO:0098978;GO:0016020;GO:0005654;GO:0005634;GO:0098794;GO:1990904;GO:0003725;GO:0035198;GO:0035925;GO:0003730;GO:0003729;GO:0042803;GO:0019901;GO:0003723;GO:0070935;GO:0000398;GO:0048255;GO:0060965;GO:0045727;GO:0016441;GO:0051260;GO:0006606;GO:0043488;GO:2000036;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:endoplasmic reticulum; C:glutamatergic synapse; C:membrane; C:nucleoplasm; C:nucleus; C:postsynapse; C:ribonucleoprotein complex;, F:double-stranded RNA binding; F:miRNA binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:protein homodimerization activity; F:protein kinase binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:negative regulation of gene silencing by miRNA; P:positive regulation of translation; P:posttranscriptional gene silencing; P:protein homooligomerization; P:protein import into nucleus; P:regulation of mRNA stability; P:regulation of stem cell population maintenance;|Q15717 B4DVB8 Q53XN6 Q9BTT1,ELAV-like protein 1,Hu-antigen R;, PF00076;, GO:0005737;GO:0010494;GO:0005829;GO:0005783;GO:0098978;GO:0016020;GO:0005654;GO:0005634;GO:0098794;GO:1990904;GO:0003725;GO:0035198;GO:0035925;GO:0003730;GO:0003729;GO:0042803;GO:0019901;GO:0003723;GO:0070935;GO:0000398;GO:0048255;GO:0060965;GO:0045727;GO:0016441;GO:0051260;GO:0006606;GO:0043488;GO:2000036;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:endoplasmic reticulum; C:glutamatergic synapse; C:membrane; C:nucleoplasm; C:nucleus; C:postsynapse; C:ribonucleoprotein complex;, F:double-stranded RNA binding; F:miRNA binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:protein homodimerization activity; F:protein kinase binding; F:RNA binding;, P:3'-UTR-mediated mRNA stabilization; P:mRNA splicing, via spliceosome; P:mRNA stabilization; P:negative regulation of gene silencing by miRNA; P:positive regulation of translation; P:posttranscriptional gene silencing; P:protein homooligomerization; P:protein import into nucleus; P:regulation of mRNA stability; P:regulation of stem cell population maintenance; scaffold196 indexed_genome mRNA 866659 875827 . + . ID=transcript_15608;O43615 A8K0R9 D6W664 Q8N193,Mitochondrial import inner membrane translocase subunit TIM44,, PF04280;, GO:0001650;GO:0005743;GO:0005759;GO:0005739;GO:0005524;GO:0051087;GO:0030150;GO:0006626;, C:fibrillar center; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:chaperone binding;, P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion;|O43615 A8K0R9 D6W664 Q8N193,Mitochondrial import inner membrane translocase subunit TIM44,, PF04280;, GO:0001650;GO:0005743;GO:0005759;GO:0005739;GO:0005524;GO:0051087;GO:0030150;GO:0006626;, C:fibrillar center; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:chaperone binding;, P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion;|O43615 A8K0R9 D6W664 Q8N193,Mitochondrial import inner membrane translocase subunit TIM44,, PF04280;, GO:0001650;GO:0005743;GO:0005759;GO:0005739;GO:0005524;GO:0051087;GO:0030150;GO:0006626;, C:fibrillar center; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:chaperone binding;, P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion;|O43615 A8K0R9 D6W664 Q8N193,Mitochondrial import inner membrane translocase subunit TIM44,, PF04280;, GO:0001650;GO:0005743;GO:0005759;GO:0005739;GO:0005524;GO:0051087;GO:0030150;GO:0006626;, C:fibrillar center; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:chaperone binding;, P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion;|O43615 A8K0R9 D6W664 Q8N193,Mitochondrial import inner membrane translocase subunit TIM44,, PF04280;, GO:0001650;GO:0005743;GO:0005759;GO:0005739;GO:0005524;GO:0051087;GO:0030150;GO:0006626;, C:fibrillar center; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:chaperone binding;, P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; scaffold196 indexed_genome mRNA 879201 906203 . - . ID=transcript_15609;Q13487 B2RBZ6 D6W663 Q13486,snRNA-activating protein complex subunit 2,Proximal sequence element-binding transcription factor subunit delta;Small nuclear RNA-activating complex polypeptide 2;snRNA-activating protein complex 45 kDa subunit;, PF11035;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0016251;GO:0009301;GO:0042795;GO:0006366;GO:0006383;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:RNA polymerase II general transcription initiation factor activity;, P:snRNA transcription; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription by RNA polymerase III;|O14733 B2R9S5 D6W659 O14648 O14816 O60452 O60453 Q1PG43 Q8IY10,Dual specificity mitogen-activated protein kinase kinase 7,JNK-activating kinase 2;MAPK/ERK kinase 7;Stress-activated protein kinase kinase 4;c-Jun N-terminal kinase kinase 2;, PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0019899;GO:0008545;GO:0000287;GO:0004708;GO:0019901;GO:0019903;GO:0106310;GO:0106311;GO:0004714;GO:0007257;GO:0000187;GO:0006915;GO:0038095;GO:0007254;GO:0070374;GO:0051973;GO:1904355;GO:0032212;GO:0045893;GO:0009408;GO:0006970;GO:0034612;GO:0009411;GO:0007165;GO:0051403;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:enzyme binding; F:JUN kinase kinase activity; F:magnesium ion binding; F:MAP kinase kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:apoptotic process; P:Fc-epsilon receptor signaling pathway; P:JNK cascade; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription, DNA-templated; P:response to heat; P:response to osmotic stress; P:response to tumor necrosis factor; P:response to UV; P:signal transduction; P:stress-activated MAPK cascade;|O14733 B2R9S5 D6W659 O14648 O14816 O60452 O60453 Q1PG43 Q8IY10,Dual specificity mitogen-activated protein kinase kinase 7,JNK-activating kinase 2;MAPK/ERK kinase 7;Stress-activated protein kinase kinase 4;c-Jun N-terminal kinase kinase 2;, PF00069;, GO:0005737;GO:0005829;GO:0005634;GO:0005524;GO:0019899;GO:0008545;GO:0000287;GO:0004708;GO:0019901;GO:0019903;GO:0106310;GO:0106311;GO:0004714;GO:0007257;GO:0000187;GO:0006915;GO:0038095;GO:0007254;GO:0070374;GO:0051973;GO:1904355;GO:0032212;GO:0045893;GO:0009408;GO:0006970;GO:0034612;GO:0009411;GO:0007165;GO:0051403;, C:cytoplasm; C:cytosol; C:nucleus;, F:ATP binding; F:enzyme binding; F:JUN kinase kinase activity; F:magnesium ion binding; F:MAP kinase kinase activity; F:protein kinase binding; F:protein phosphatase binding; F:protein serine kinase activity; F:protein threonine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:apoptotic process; P:Fc-epsilon receptor signaling pathway; P:JNK cascade; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of transcription, DNA-templated; P:response to heat; P:response to osmotic stress; P:response to tumor necrosis factor; P:response to UV; P:signal transduction; P:stress-activated MAPK cascade; scaffold196 indexed_genome mRNA 907726 909278 . - . ID=transcript_15610;Q6NSJ5 B3KR78 Q2YDY3 Q7L236 Q8N3B0 Q9H5H8,Volume-regulated anion channel subunit LRRC8E {ECO:0000305},Leucine-rich repeat-containing protein 8E {ECO:0000303|PubMed:22532330};, PF13855;PF12534;, GO:0005737;GO:0030176;GO:1905103;GO:0005887;GO:0034702;GO:0005886;GO:0005225;GO:0098656;GO:0015810;GO:0006884;GO:0071470;GO:0140361;GO:0055085;, C:cytoplasm; C:integral component of endoplasmic reticulum membrane; C:integral component of lysosomal membrane; C:integral component of plasma membrane; C:ion channel complex; C:plasma membrane;, F:volume-sensitive anion channel activity;, P:anion transmembrane transport; P:aspartate transmembrane transport; P:cell volume homeostasis; P:cellular response to osmotic stress; P:cyclic-GMP-AMP transmembrane import across plasma membrane; P:transmembrane transport; scaffold196 indexed_genome mRNA 909335 912798 . + . ID=transcript_15611;Q6NSJ5 B3KR78 Q2YDY3 Q7L236 Q8N3B0 Q9H5H8,Volume-regulated anion channel subunit LRRC8E {ECO:0000305},Leucine-rich repeat-containing protein 8E {ECO:0000303|PubMed:22532330};, PF13855;PF12534;, GO:0005737;GO:0030176;GO:1905103;GO:0005887;GO:0034702;GO:0005886;GO:0005225;GO:0098656;GO:0015810;GO:0006884;GO:0071470;GO:0140361;GO:0055085;, C:cytoplasm; C:integral component of endoplasmic reticulum membrane; C:integral component of lysosomal membrane; C:integral component of plasma membrane; C:ion channel complex; C:plasma membrane;, F:volume-sensitive anion channel activity;, P:anion transmembrane transport; P:aspartate transmembrane transport; P:cell volume homeostasis; P:cellular response to osmotic stress; P:cyclic-GMP-AMP transmembrane import across plasma membrane; P:transmembrane transport;|Q6NSJ5 B3KR78 Q2YDY3 Q7L236 Q8N3B0 Q9H5H8,Volume-regulated anion channel subunit LRRC8E {ECO:0000305},Leucine-rich repeat-containing protein 8E {ECO:0000303|PubMed:22532330};, PF13855;PF12534;, GO:0005737;GO:0030176;GO:1905103;GO:0005887;GO:0034702;GO:0005886;GO:0005225;GO:0098656;GO:0015810;GO:0006884;GO:0071470;GO:0140361;GO:0055085;, C:cytoplasm; C:integral component of endoplasmic reticulum membrane; C:integral component of lysosomal membrane; C:integral component of plasma membrane; C:ion channel complex; C:plasma membrane;, F:volume-sensitive anion channel activity;, P:anion transmembrane transport; P:aspartate transmembrane transport; P:cell volume homeostasis; P:cellular response to osmotic stress; P:cyclic-GMP-AMP transmembrane import across plasma membrane; P:transmembrane transport; scaffold196 indexed_genome mRNA 929574 946366 . - . ID=transcript_15612;Q96CN4 B9A6I9,EVI5-like protein,Ecotropic viral integration site 5-like protein;, PF00566;, GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:1902018;GO:0043547;, , F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:negative regulation of cilium assembly; P:positive regulation of GTPase activity;|Q96CN4 B9A6I9,EVI5-like protein,Ecotropic viral integration site 5-like protein;, PF00566;, GO:0005096;GO:0031267;GO:0090630;GO:0006886;GO:1902018;GO:0043547;, , F:GTPase activator activity; F:small GTPase binding;, P:activation of GTPase activity; P:intracellular protein transport; P:negative regulation of cilium assembly; P:positive regulation of GTPase activity; scaffold197 indexed_genome mRNA 167 8760 . - . ID=transcript_15613;Q99638 B2RCZ8 Q6FI29 Q96C41,Cell cycle checkpoint control protein RAD9A,DNA repair exonuclease rad9 homolog A;, PF04139;, GO:0030896;GO:0005654;GO:0005634;GO:0008408;GO:0019899;GO:0008853;GO:0042826;GO:0019901;GO:0017124;GO:0006974;GO:0071479;GO:0000077;GO:0006281;GO:0006260;GO:0000076;GO:0031573;GO:1901796;, C:checkpoint clamp complex; C:nucleoplasm; C:nucleus;, F:3'-5' exonuclease activity; F:enzyme binding; F:exodeoxyribonuclease III activity; F:histone deacetylase binding; F:protein kinase binding; F:SH3 domain binding;, P:cellular response to DNA damage stimulus; P:cellular response to ionizing radiation; P:DNA damage checkpoint; P:DNA repair; P:DNA replication; P:DNA replication checkpoint; P:intra-S DNA damage checkpoint; P:regulation of signal transduction by p53 class mediator;|P62136 A6NNR3 B2R908 P08129 P20653 P22802 Q07161,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit,, PF00149;PF16891;, GO:0005912;GO:0005737;GO:0005829;GO:0043197;GO:0070062;GO:0098978;GO:0042587;GO:0005730;GO:0005654;GO:0005634;GO:0043204;GO:0005886;GO:0098793;GO:0000164;GO:0072357;GO:0098641;GO:0046872;GO:0016791;GO:0004721;GO:0008157;GO:0106306;GO:0004722;GO:0106307;GO:0043021;GO:1904886;GO:0048754;GO:0007049;GO:0051301;GO:0032922;GO:0016311;GO:0043153;GO:0005977;GO:0030324;GO:0032091;GO:0070262;GO:0035970;GO:2001241;GO:0006470;GO:0060828;GO:0042752;GO:0005979;GO:0005981;GO:0036496;GO:0010288;GO:0016032;, C:adherens junction; C:cytoplasm; C:cytosol; C:dendritic spine; C:extracellular exosome; C:glutamatergic synapse; C:glycogen granule; C:nucleolus; C:nucleoplasm; C:nucleus; C:perikaryon; C:plasma membrane; C:presynapse; C:protein phosphatase type 1 complex; C:PTW/PP1 phosphatase complex;, F:cadherin binding involved in cell-cell adhesion; F:metal ion binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein phosphatase 1 binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:ribonucleoprotein complex binding;, P:beta-catenin destruction complex disassembly; P:branching morphogenesis of an epithelial tube; P:cell cycle; P:cell division; P:circadian regulation of gene expression; P:dephosphorylation; P:entrainment of circadian clock by photoperiod; P:glycogen metabolic process; P:lung development; P:negative regulation of protein binding; P:peptidyl-serine dephosphorylation; P:peptidyl-threonine dephosphorylation; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein dephosphorylation; P:regulation of canonical Wnt signaling pathway; P:regulation of circadian rhythm; P:regulation of glycogen biosynthetic process; P:regulation of glycogen catabolic process; P:regulation of translational initiation by eIF2 alpha dephosphorylation; P:response to lead ion; P:viral process; scaffold197 indexed_genome mRNA 35785 40158 . + . ID=transcript_15614;Q9UBD9 B4DNT4 Q6NZA4,Cardiotrophin-like cytokine factor 1,B-cell-stimulating factor 3;Novel neurotrophin-1;, PF06875;, GO:0097059;GO:0097058;GO:0005576;GO:0005127;GO:0005125;GO:0008083;GO:0005102;GO:0030183;GO:0007166;GO:0019221;GO:0043524;GO:0048711;GO:0030890;GO:0008284;GO:0002639;GO:0048295;GO:0042531;GO:0007259;, C:CNTFR-CLCF1 complex; C:CRLF-CLCF1 complex; C:extracellular region;, F:ciliary neurotrophic factor receptor binding; F:cytokine activity; F:growth factor activity; F:signaling receptor binding;, P:B cell differentiation; P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:negative regulation of neuron apoptotic process; P:positive regulation of astrocyte differentiation; P:positive regulation of B cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of immunoglobulin production; P:positive regulation of isotype switching to IgE isotypes; P:positive regulation of tyrosine phosphorylation of STAT protein; P:receptor signaling pathway via JAK-STAT;|Q9UBD9 B4DNT4 Q6NZA4,Cardiotrophin-like cytokine factor 1,B-cell-stimulating factor 3;Novel neurotrophin-1;, PF06875;, GO:0097059;GO:0097058;GO:0005576;GO:0005127;GO:0005125;GO:0008083;GO:0005102;GO:0030183;GO:0007166;GO:0019221;GO:0043524;GO:0048711;GO:0030890;GO:0008284;GO:0002639;GO:0048295;GO:0042531;GO:0007259;, C:CNTFR-CLCF1 complex; C:CRLF-CLCF1 complex; C:extracellular region;, F:ciliary neurotrophic factor receptor binding; F:cytokine activity; F:growth factor activity; F:signaling receptor binding;, P:B cell differentiation; P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:negative regulation of neuron apoptotic process; P:positive regulation of astrocyte differentiation; P:positive regulation of B cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of immunoglobulin production; P:positive regulation of isotype switching to IgE isotypes; P:positive regulation of tyrosine phosphorylation of STAT protein; P:receptor signaling pathway via JAK-STAT;|Q9UBD9 B4DNT4 Q6NZA4,Cardiotrophin-like cytokine factor 1,B-cell-stimulating factor 3;Novel neurotrophin-1;, PF06875;, GO:0097059;GO:0097058;GO:0005576;GO:0005127;GO:0005125;GO:0008083;GO:0005102;GO:0030183;GO:0007166;GO:0019221;GO:0043524;GO:0048711;GO:0030890;GO:0008284;GO:0002639;GO:0048295;GO:0042531;GO:0007259;, C:CNTFR-CLCF1 complex; C:CRLF-CLCF1 complex; C:extracellular region;, F:ciliary neurotrophic factor receptor binding; F:cytokine activity; F:growth factor activity; F:signaling receptor binding;, P:B cell differentiation; P:cell surface receptor signaling pathway; P:cytokine-mediated signaling pathway; P:negative regulation of neuron apoptotic process; P:positive regulation of astrocyte differentiation; P:positive regulation of B cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of immunoglobulin production; P:positive regulation of isotype switching to IgE isotypes; P:positive regulation of tyrosine phosphorylation of STAT protein; P:receptor signaling pathway via JAK-STAT; scaffold197 indexed_genome mRNA 48421 50223 . + . ID=transcript_15615;Q9HCU8 F5H506,DNA polymerase delta subunit 4,DNA polymerase delta subunit p12;, PF04081;, GO:0043625;GO:0005654;GO:0006287;GO:0042769;GO:0000731;GO:0006261;GO:0006298;GO:0006297;GO:0033683;GO:0006296;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:delta DNA polymerase complex; C:nucleoplasm;, , P:base-excision repair, gap-filling; P:DNA damage response, detection of DNA damage; P:DNA synthesis involved in DNA repair; P:DNA-dependent DNA replication; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold197 indexed_genome mRNA 72664 80642 . - . ID=transcript_15616;Q8TE77 Q6PK42 Q76I75 Q8N9L8 Q8WYL0 Q9NV45 Q9NWZ7,Protein phosphatase Slingshot homolog 3,SSH-like protein 3;, PF08766;, GO:0005737;GO:0005856;GO:0005634;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0030837;, C:cytoplasm; C:cytoskeleton; C:nucleus;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization;|Q8TE77 Q6PK42 Q76I75 Q8N9L8 Q8WYL0 Q9NV45 Q9NWZ7,Protein phosphatase Slingshot homolog 3,SSH-like protein 3;, PF08766;, GO:0005737;GO:0005856;GO:0005634;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0030837;, C:cytoplasm; C:cytoskeleton; C:nucleus;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization;|Q8TE77 Q6PK42 Q76I75 Q8N9L8 Q8WYL0 Q9NV45 Q9NWZ7,Protein phosphatase Slingshot homolog 3,SSH-like protein 3;, PF08766;, GO:0005737;GO:0005856;GO:0005634;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0030837;, C:cytoplasm; C:cytoskeleton; C:nucleus;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization;|Q8TE77 Q6PK42 Q76I75 Q8N9L8 Q8WYL0 Q9NV45 Q9NWZ7,Protein phosphatase Slingshot homolog 3,SSH-like protein 3;, PF08766;, GO:0005737;GO:0005856;GO:0005634;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0030837;, C:cytoplasm; C:cytoskeleton; C:nucleus;, F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:actin cytoskeleton organization; P:negative regulation of actin filament polymerization; scaffold197 indexed_genome mRNA 81588 91788 . - . ID=transcript_15617;Q6ZTN6 D6RCN6 Q0VAK0 Q0VGC3 Q6ZVD0 Q86SU1,Ankyrin repeat domain-containing protein 13D,, PF11904;, GO:0005737;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:0002091;, C:cytoplasm; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of receptor internalization;|Q6ZTN6 D6RCN6 Q0VAK0 Q0VGC3 Q6ZVD0 Q86SU1,Ankyrin repeat domain-containing protein 13D,, PF11904;, GO:0005737;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:0002091;, C:cytoplasm; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of receptor internalization;|Q6ZTN6 D6RCN6 Q0VAK0 Q0VGC3 Q6ZVD0 Q86SU1,Ankyrin repeat domain-containing protein 13D,, PF11904;, GO:0005737;GO:0005770;GO:0048471;GO:0005886;GO:0140036;GO:0002091;, C:cytoplasm; C:late endosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:ubiquitin-dependent protein binding;, P:negative regulation of receptor internalization; scaffold197 indexed_genome mRNA 104777 116357 . - . ID=transcript_15618;P25098 B0ZBE1 Q13837 Q6GTT3,Beta-adrenergic receptor kinase 1,G-protein coupled receptor kinase 2 {ECO:0000312|HGNC:HGNC:289};, PF00169;PF00069;PF00615;, GO:0005929;GO:0005737;GO:0005829;GO:0016020;GO:0005886;GO:0045202;GO:0031694;GO:0005524;GO:0047696;GO:0031755;GO:0004703;GO:0004672;GO:0060048;GO:0002029;GO:0007213;GO:0007186;GO:0007507;GO:1901081;GO:0045988;GO:0003108;GO:0018105;GO:0018107;GO:0033605;GO:0031623;GO:0007217;GO:0046718;GO:0019079;, C:cilium; C:cytoplasm; C:cytosol; C:membrane; C:plasma membrane; C:synapse;, F:alpha-2A adrenergic receptor binding; F:ATP binding; F:beta-adrenergic receptor kinase activity; F:Edg-2 lysophosphatidic acid receptor binding; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:cardiac muscle contraction; P:desensitization of G protein-coupled receptor signaling pathway; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heart development; P:negative regulation of relaxation of smooth muscle; P:negative regulation of striated muscle contraction; P:negative regulation of the force of heart contraction by chemical signal; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of catecholamine secretion; P:receptor internalization; P:tachykinin receptor signaling pathway; P:viral entry into host cell; P:viral genome replication;|P25098 B0ZBE1 Q13837 Q6GTT3,Beta-adrenergic receptor kinase 1,G-protein coupled receptor kinase 2 {ECO:0000312|HGNC:HGNC:289};, PF00169;PF00069;PF00615;, GO:0005929;GO:0005737;GO:0005829;GO:0016020;GO:0005886;GO:0045202;GO:0031694;GO:0005524;GO:0047696;GO:0031755;GO:0004703;GO:0004672;GO:0060048;GO:0002029;GO:0007213;GO:0007186;GO:0007507;GO:1901081;GO:0045988;GO:0003108;GO:0018105;GO:0018107;GO:0033605;GO:0031623;GO:0007217;GO:0046718;GO:0019079;, C:cilium; C:cytoplasm; C:cytosol; C:membrane; C:plasma membrane; C:synapse;, F:alpha-2A adrenergic receptor binding; F:ATP binding; F:beta-adrenergic receptor kinase activity; F:Edg-2 lysophosphatidic acid receptor binding; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:cardiac muscle contraction; P:desensitization of G protein-coupled receptor signaling pathway; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heart development; P:negative regulation of relaxation of smooth muscle; P:negative regulation of striated muscle contraction; P:negative regulation of the force of heart contraction by chemical signal; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of catecholamine secretion; P:receptor internalization; P:tachykinin receptor signaling pathway; P:viral entry into host cell; P:viral genome replication;|P25098 B0ZBE1 Q13837 Q6GTT3,Beta-adrenergic receptor kinase 1,G-protein coupled receptor kinase 2 {ECO:0000312|HGNC:HGNC:289};, PF00169;PF00069;PF00615;, GO:0005929;GO:0005737;GO:0005829;GO:0016020;GO:0005886;GO:0045202;GO:0031694;GO:0005524;GO:0047696;GO:0031755;GO:0004703;GO:0004672;GO:0060048;GO:0002029;GO:0007213;GO:0007186;GO:0007507;GO:1901081;GO:0045988;GO:0003108;GO:0018105;GO:0018107;GO:0033605;GO:0031623;GO:0007217;GO:0046718;GO:0019079;, C:cilium; C:cytoplasm; C:cytosol; C:membrane; C:plasma membrane; C:synapse;, F:alpha-2A adrenergic receptor binding; F:ATP binding; F:beta-adrenergic receptor kinase activity; F:Edg-2 lysophosphatidic acid receptor binding; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:cardiac muscle contraction; P:desensitization of G protein-coupled receptor signaling pathway; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heart development; P:negative regulation of relaxation of smooth muscle; P:negative regulation of striated muscle contraction; P:negative regulation of the force of heart contraction by chemical signal; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of catecholamine secretion; P:receptor internalization; P:tachykinin receptor signaling pathway; P:viral entry into host cell; P:viral genome replication;|P25098 B0ZBE1 Q13837 Q6GTT3,Beta-adrenergic receptor kinase 1,G-protein coupled receptor kinase 2 {ECO:0000312|HGNC:HGNC:289};, PF00169;PF00069;PF00615;, GO:0005929;GO:0005737;GO:0005829;GO:0016020;GO:0005886;GO:0045202;GO:0031694;GO:0005524;GO:0047696;GO:0031755;GO:0004703;GO:0004672;GO:0060048;GO:0002029;GO:0007213;GO:0007186;GO:0007507;GO:1901081;GO:0045988;GO:0003108;GO:0018105;GO:0018107;GO:0033605;GO:0031623;GO:0007217;GO:0046718;GO:0019079;, C:cilium; C:cytoplasm; C:cytosol; C:membrane; C:plasma membrane; C:synapse;, F:alpha-2A adrenergic receptor binding; F:ATP binding; F:beta-adrenergic receptor kinase activity; F:Edg-2 lysophosphatidic acid receptor binding; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:cardiac muscle contraction; P:desensitization of G protein-coupled receptor signaling pathway; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heart development; P:negative regulation of relaxation of smooth muscle; P:negative regulation of striated muscle contraction; P:negative regulation of the force of heart contraction by chemical signal; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of catecholamine secretion; P:receptor internalization; P:tachykinin receptor signaling pathway; P:viral entry into host cell; P:viral genome replication;|P25098 B0ZBE1 Q13837 Q6GTT3,Beta-adrenergic receptor kinase 1,G-protein coupled receptor kinase 2 {ECO:0000312|HGNC:HGNC:289};, PF00169;PF00069;PF00615;, GO:0005929;GO:0005737;GO:0005829;GO:0016020;GO:0005886;GO:0045202;GO:0031694;GO:0005524;GO:0047696;GO:0031755;GO:0004703;GO:0004672;GO:0060048;GO:0002029;GO:0007213;GO:0007186;GO:0007507;GO:1901081;GO:0045988;GO:0003108;GO:0018105;GO:0018107;GO:0033605;GO:0031623;GO:0007217;GO:0046718;GO:0019079;, C:cilium; C:cytoplasm; C:cytosol; C:membrane; C:plasma membrane; C:synapse;, F:alpha-2A adrenergic receptor binding; F:ATP binding; F:beta-adrenergic receptor kinase activity; F:Edg-2 lysophosphatidic acid receptor binding; F:G protein-coupled receptor kinase activity; F:protein kinase activity;, P:cardiac muscle contraction; P:desensitization of G protein-coupled receptor signaling pathway; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heart development; P:negative regulation of relaxation of smooth muscle; P:negative regulation of striated muscle contraction; P:negative regulation of the force of heart contraction by chemical signal; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of catecholamine secretion; P:receptor internalization; P:tachykinin receptor signaling pathway; P:viral entry into host cell; P:viral genome replication; scaffold197 indexed_genome mRNA 133555 174629 . - . ID=transcript_15619;Q9UK66,Lysine-specific demethylase 2A,CXXC-type zinc finger protein 8;F-box and leucine-rich repeat protein 11;F-box protein FBL7;F-box protein Lilina;F-box/LRR-repeat protein 11;JmjC domain-containing histone demethylation protein 1A;[Histone-H3]-lysine-36 demethylase 1A;, PF00646;PF17811;PF16866;PF02008;, GO:0005654;GO:0032452;GO:0051864;GO:0003712;GO:0045322;GO:0008270;GO:0032922;GO:0006303;GO:0070544;GO:0010944;GO:0006482;GO:0042752;GO:0006357;, C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:circadian regulation of gene expression; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 demethylation; P:negative regulation of transcription by competitive promoter binding; P:protein demethylation; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II;|Q9UK66,Lysine-specific demethylase 2A,CXXC-type zinc finger protein 8;F-box and leucine-rich repeat protein 11;F-box protein FBL7;F-box protein Lilina;F-box/LRR-repeat protein 11;JmjC domain-containing histone demethylation protein 1A;[Histone-H3]-lysine-36 demethylase 1A;, PF00646;PF17811;PF16866;PF02008;, GO:0005654;GO:0032452;GO:0051864;GO:0003712;GO:0045322;GO:0008270;GO:0032922;GO:0006303;GO:0070544;GO:0010944;GO:0006482;GO:0042752;GO:0006357;, C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:circadian regulation of gene expression; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 demethylation; P:negative regulation of transcription by competitive promoter binding; P:protein demethylation; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II;|Q9UK66,Lysine-specific demethylase 2A,CXXC-type zinc finger protein 8;F-box and leucine-rich repeat protein 11;F-box protein FBL7;F-box protein Lilina;F-box/LRR-repeat protein 11;JmjC domain-containing histone demethylation protein 1A;[Histone-H3]-lysine-36 demethylase 1A;, PF00646;PF17811;PF16866;PF02008;, GO:0005654;GO:0032452;GO:0051864;GO:0003712;GO:0045322;GO:0008270;GO:0032922;GO:0006303;GO:0070544;GO:0010944;GO:0006482;GO:0042752;GO:0006357;, C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:circadian regulation of gene expression; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 demethylation; P:negative regulation of transcription by competitive promoter binding; P:protein demethylation; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II;|Q9UK66,Lysine-specific demethylase 2A,CXXC-type zinc finger protein 8;F-box and leucine-rich repeat protein 11;F-box protein FBL7;F-box protein Lilina;F-box/LRR-repeat protein 11;JmjC domain-containing histone demethylation protein 1A;[Histone-H3]-lysine-36 demethylase 1A;, PF00646;PF17811;PF16866;PF02008;, GO:0005654;GO:0032452;GO:0051864;GO:0003712;GO:0045322;GO:0008270;GO:0032922;GO:0006303;GO:0070544;GO:0010944;GO:0006482;GO:0042752;GO:0006357;, C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:circadian regulation of gene expression; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 demethylation; P:negative regulation of transcription by competitive promoter binding; P:protein demethylation; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II;|Q9UK66,Lysine-specific demethylase 2A,CXXC-type zinc finger protein 8;F-box and leucine-rich repeat protein 11;F-box protein FBL7;F-box protein Lilina;F-box/LRR-repeat protein 11;JmjC domain-containing histone demethylation protein 1A;[Histone-H3]-lysine-36 demethylase 1A;, PF00646;PF17811;PF16866;PF02008;, GO:0005654;GO:0032452;GO:0051864;GO:0003712;GO:0045322;GO:0008270;GO:0032922;GO:0006303;GO:0070544;GO:0010944;GO:0006482;GO:0042752;GO:0006357;, C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:circadian regulation of gene expression; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 demethylation; P:negative regulation of transcription by competitive promoter binding; P:protein demethylation; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II;|Q9UK66,Lysine-specific demethylase 2A,CXXC-type zinc finger protein 8;F-box and leucine-rich repeat protein 11;F-box protein FBL7;F-box protein Lilina;F-box/LRR-repeat protein 11;JmjC domain-containing histone demethylation protein 1A;[Histone-H3]-lysine-36 demethylase 1A;, PF00646;PF17811;PF16866;PF02008;, GO:0005654;GO:0032452;GO:0051864;GO:0003712;GO:0045322;GO:0008270;GO:0032922;GO:0006303;GO:0070544;GO:0010944;GO:0006482;GO:0042752;GO:0006357;, C:nucleoplasm;, F:histone demethylase activity; F:histone demethylase activity (H3-K36 specific); F:transcription coregulator activity; F:unmethylated CpG binding; F:zinc ion binding;, P:circadian regulation of gene expression; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 demethylation; P:negative regulation of transcription by competitive promoter binding; P:protein demethylation; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II; scaffold197 indexed_genome mRNA 264600 274785 . - . ID=transcript_15620;Q8IV01,Synaptotagmin-12 {ECO:0000250|UniProtKB:Q920N7},Synaptotagmin XII {ECO:0000250|UniProtKB:Q920N7};, PF00168;, GO:0070382;GO:0098686;GO:0016021;GO:0005886;GO:0030672;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0000149;GO:0019905;GO:0017156;GO:0071277;GO:0060291;GO:0017158;GO:0014059;GO:0046928;GO:0048792;GO:0016192;, C:exocytic vesicle; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:plasma membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:long-term synaptic potentiation; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of neurotransmitter secretion; P:spontaneous exocytosis of neurotransmitter; P:vesicle-mediated transport;|Q8IV01,Synaptotagmin-12 {ECO:0000250|UniProtKB:Q920N7},Synaptotagmin XII {ECO:0000250|UniProtKB:Q920N7};, PF00168;, GO:0070382;GO:0098686;GO:0016021;GO:0005886;GO:0030672;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0000149;GO:0019905;GO:0017156;GO:0071277;GO:0060291;GO:0017158;GO:0014059;GO:0046928;GO:0048792;GO:0016192;, C:exocytic vesicle; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:plasma membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:long-term synaptic potentiation; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of neurotransmitter secretion; P:spontaneous exocytosis of neurotransmitter; P:vesicle-mediated transport;|Q8IV01,Synaptotagmin-12 {ECO:0000250|UniProtKB:Q920N7},Synaptotagmin XII {ECO:0000250|UniProtKB:Q920N7};, PF00168;, GO:0070382;GO:0098686;GO:0016021;GO:0005886;GO:0030672;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0000149;GO:0019905;GO:0017156;GO:0071277;GO:0060291;GO:0017158;GO:0014059;GO:0046928;GO:0048792;GO:0016192;, C:exocytic vesicle; C:hippocampal mossy fiber to CA3 synapse; C:integral component of membrane; C:plasma membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:long-term synaptic potentiation; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:regulation of neurotransmitter secretion; P:spontaneous exocytosis of neurotransmitter; P:vesicle-mediated transport; scaffold197 indexed_genome mRNA 314270 316030 . - . ID=transcript_15621;A6NJI1,Uncharacterized protein C11orf86,, PF15464; scaffold197 indexed_genome mRNA 338818 424977 . + . ID=transcript_15622;P11498 B4DN00 Q16705,Pyruvate carboxylase, mitochondrial,Pyruvic carboxylase;, PF02785;PF00289;PF00364;PF02786;PF00682;PF02436;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0004736;GO:0006768;GO:0006094;GO:0006629;GO:0010629;GO:0044794;GO:0044791;GO:0006090;GO:0019074;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding; F:pyruvate carboxylase activity;, P:biotin metabolic process; P:gluconeogenesis; P:lipid metabolic process; P:negative regulation of gene expression; P:positive regulation by host of viral process; P:positive regulation by host of viral release from host cell; P:pyruvate metabolic process; P:viral RNA genome packaging;|P11498 B4DN00 Q16705,Pyruvate carboxylase, mitochondrial,Pyruvic carboxylase;, PF02785;PF00289;PF00364;PF02786;PF00682;PF02436;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0004736;GO:0006768;GO:0006094;GO:0006629;GO:0010629;GO:0044794;GO:0044791;GO:0006090;GO:0019074;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding; F:pyruvate carboxylase activity;, P:biotin metabolic process; P:gluconeogenesis; P:lipid metabolic process; P:negative regulation of gene expression; P:positive regulation by host of viral process; P:positive regulation by host of viral release from host cell; P:pyruvate metabolic process; P:viral RNA genome packaging; scaffold197 indexed_genome mRNA 437382 442057 . - . ID=transcript_15623;P11498 B4DN00 Q16705,Pyruvate carboxylase, mitochondrial,Pyruvic carboxylase;, PF02785;PF00289;PF00364;PF02786;PF00682;PF02436;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0004736;GO:0006768;GO:0006094;GO:0006629;GO:0010629;GO:0044794;GO:0044791;GO:0006090;GO:0019074;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding; F:pyruvate carboxylase activity;, P:biotin metabolic process; P:gluconeogenesis; P:lipid metabolic process; P:negative regulation of gene expression; P:positive regulation by host of viral process; P:positive regulation by host of viral release from host cell; P:pyruvate metabolic process; P:viral RNA genome packaging;|P11498 B4DN00 Q16705,Pyruvate carboxylase, mitochondrial,Pyruvic carboxylase;, PF02785;PF00289;PF00364;PF02786;PF00682;PF02436;, GO:0005737;GO:0005829;GO:0005759;GO:0005739;GO:0005524;GO:0009374;GO:0042802;GO:0046872;GO:0004736;GO:0006768;GO:0006094;GO:0006629;GO:0010629;GO:0044794;GO:0044791;GO:0006090;GO:0019074;, C:cytoplasm; C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:biotin binding; F:identical protein binding; F:metal ion binding; F:pyruvate carboxylase activity;, P:biotin metabolic process; P:gluconeogenesis; P:lipid metabolic process; P:negative regulation of gene expression; P:positive regulation by host of viral process; P:positive regulation by host of viral release from host cell; P:pyruvate metabolic process; P:viral RNA genome packaging; scaffold197 indexed_genome mRNA 443894 466074 . - . ID=transcript_15624;Q9Y256 Q52LZ9,CAAX prenyl protease 2,Farnesylated proteins-converting enzyme 2;Prenyl protein-specific endoprotease 2;RCE1 homolog;, PF02517;, GO:0005829;GO:0005789;GO:0030176;GO:0005887;GO:0016020;GO:0004197;GO:0004175;GO:0008238;GO:0004222;GO:0071586;GO:0000165;GO:0016579;GO:0018342;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:cysteine-type endopeptidase activity; F:endopeptidase activity; F:exopeptidase activity; F:metalloendopeptidase activity;, P:CAAX-box protein processing; P:MAPK cascade; P:protein deubiquitination; P:protein prenylation;|Q9Y256 Q52LZ9,CAAX prenyl protease 2,Farnesylated proteins-converting enzyme 2;Prenyl protein-specific endoprotease 2;RCE1 homolog;, PF02517;, GO:0005829;GO:0005789;GO:0030176;GO:0005887;GO:0016020;GO:0004197;GO:0004175;GO:0008238;GO:0004222;GO:0071586;GO:0000165;GO:0016579;GO:0018342;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:cysteine-type endopeptidase activity; F:endopeptidase activity; F:exopeptidase activity; F:metalloendopeptidase activity;, P:CAAX-box protein processing; P:MAPK cascade; P:protein deubiquitination; P:protein prenylation;|Q9Y256 Q52LZ9,CAAX prenyl protease 2,Farnesylated proteins-converting enzyme 2;Prenyl protein-specific endoprotease 2;RCE1 homolog;, PF02517;, GO:0005829;GO:0005789;GO:0030176;GO:0005887;GO:0016020;GO:0004197;GO:0004175;GO:0008238;GO:0004222;GO:0071586;GO:0000165;GO:0016579;GO:0018342;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:membrane;, F:cysteine-type endopeptidase activity; F:endopeptidase activity; F:exopeptidase activity; F:metalloendopeptidase activity;, P:CAAX-box protein processing; P:MAPK cascade; P:protein deubiquitination; P:protein prenylation;|Q8N6T0 Q9H677,Type 2 DNA topoisomerase 6 subunit B-like {ECO:0000250|UniProtKB:J3QMY9},Type 2 DNA topoisomerase VI subunit B-like {ECO:0000250|UniProtKB:J3QMY9};, PF15091;, GO:0005694;GO:0042138;GO:0007131;, C:chromosome;, , P:meiotic DNA double-strand break formation; P:reciprocal meiotic recombination; scaffold197 indexed_genome mRNA 472434 475315 . - . ID=transcript_15625;Q8N6T0 Q9H677,Type 2 DNA topoisomerase 6 subunit B-like {ECO:0000250|UniProtKB:J3QMY9},Type 2 DNA topoisomerase VI subunit B-like {ECO:0000250|UniProtKB:J3QMY9};, PF15091;, GO:0005694;GO:0042138;GO:0007131;, C:chromosome;, , P:meiotic DNA double-strand break formation; P:reciprocal meiotic recombination;|Q8N6T0 Q9H677,Type 2 DNA topoisomerase 6 subunit B-like {ECO:0000250|UniProtKB:J3QMY9},Type 2 DNA topoisomerase VI subunit B-like {ECO:0000250|UniProtKB:J3QMY9};, PF15091;, GO:0005694;GO:0042138;GO:0007131;, C:chromosome;, , P:meiotic DNA double-strand break formation; P:reciprocal meiotic recombination; scaffold197 indexed_genome mRNA 475349 519014 . - . ID=transcript_15626;Q8N6T0 Q9H677,Type 2 DNA topoisomerase 6 subunit B-like {ECO:0000250|UniProtKB:J3QMY9},Type 2 DNA topoisomerase VI subunit B-like {ECO:0000250|UniProtKB:J3QMY9};, PF15091;, GO:0005694;GO:0042138;GO:0007131;, C:chromosome;, , P:meiotic DNA double-strand break formation; P:reciprocal meiotic recombination; scaffold197 indexed_genome mRNA 562438 593686 . + . ID=transcript_15627;O15020 O14872 O14873,Spectrin beta chain, non-erythrocytic 2,Beta-III spectrin;Spinocerebellar ataxia 5 protein;, PF00307;PF15410;PF00435;, GO:0016324;GO:0005829;GO:0005615;GO:0098978;GO:0043025;GO:0098688;GO:0099189;GO:0098793;GO:0008091;GO:0003779;GO:0045296;GO:0005543;GO:0005200;GO:0098918;GO:0051693;GO:0030534;GO:0019886;GO:0007411;GO:0021692;GO:0006888;GO:0000165;GO:0035264;GO:0099173;GO:0007416;GO:0016192;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:glutamatergic synapse; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:postsynaptic spectrin-associated cytoskeleton; C:presynapse; C:spectrin;, F:actin binding; F:cadherin binding; F:phospholipid binding; F:structural constituent of cytoskeleton; F:structural constituent of synapse;, P:actin filament capping; P:adult behavior; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:cerebellar Purkinje cell layer morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:multicellular organism growth; P:postsynapse organization; P:synapse assembly; P:vesicle-mediated transport;|O15020 O14872 O14873,Spectrin beta chain, non-erythrocytic 2,Beta-III spectrin;Spinocerebellar ataxia 5 protein;, PF00307;PF15410;PF00435;, GO:0016324;GO:0005829;GO:0005615;GO:0098978;GO:0043025;GO:0098688;GO:0099189;GO:0098793;GO:0008091;GO:0003779;GO:0045296;GO:0005543;GO:0005200;GO:0098918;GO:0051693;GO:0030534;GO:0019886;GO:0007411;GO:0021692;GO:0006888;GO:0000165;GO:0035264;GO:0099173;GO:0007416;GO:0016192;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:glutamatergic synapse; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:postsynaptic spectrin-associated cytoskeleton; C:presynapse; C:spectrin;, F:actin binding; F:cadherin binding; F:phospholipid binding; F:structural constituent of cytoskeleton; F:structural constituent of synapse;, P:actin filament capping; P:adult behavior; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:cerebellar Purkinje cell layer morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:multicellular organism growth; P:postsynapse organization; P:synapse assembly; P:vesicle-mediated transport;|O15020 O14872 O14873,Spectrin beta chain, non-erythrocytic 2,Beta-III spectrin;Spinocerebellar ataxia 5 protein;, PF00307;PF15410;PF00435;, GO:0016324;GO:0005829;GO:0005615;GO:0098978;GO:0043025;GO:0098688;GO:0099189;GO:0098793;GO:0008091;GO:0003779;GO:0045296;GO:0005543;GO:0005200;GO:0098918;GO:0051693;GO:0030534;GO:0019886;GO:0007411;GO:0021692;GO:0006888;GO:0000165;GO:0035264;GO:0099173;GO:0007416;GO:0016192;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:glutamatergic synapse; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:postsynaptic spectrin-associated cytoskeleton; C:presynapse; C:spectrin;, F:actin binding; F:cadherin binding; F:phospholipid binding; F:structural constituent of cytoskeleton; F:structural constituent of synapse;, P:actin filament capping; P:adult behavior; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:cerebellar Purkinje cell layer morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:multicellular organism growth; P:postsynapse organization; P:synapse assembly; P:vesicle-mediated transport;|O15020 O14872 O14873,Spectrin beta chain, non-erythrocytic 2,Beta-III spectrin;Spinocerebellar ataxia 5 protein;, PF00307;PF15410;PF00435;, GO:0016324;GO:0005829;GO:0005615;GO:0098978;GO:0043025;GO:0098688;GO:0099189;GO:0098793;GO:0008091;GO:0003779;GO:0045296;GO:0005543;GO:0005200;GO:0098918;GO:0051693;GO:0030534;GO:0019886;GO:0007411;GO:0021692;GO:0006888;GO:0000165;GO:0035264;GO:0099173;GO:0007416;GO:0016192;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:glutamatergic synapse; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:postsynaptic spectrin-associated cytoskeleton; C:presynapse; C:spectrin;, F:actin binding; F:cadherin binding; F:phospholipid binding; F:structural constituent of cytoskeleton; F:structural constituent of synapse;, P:actin filament capping; P:adult behavior; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:cerebellar Purkinje cell layer morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:multicellular organism growth; P:postsynapse organization; P:synapse assembly; P:vesicle-mediated transport;|O15020 O14872 O14873,Spectrin beta chain, non-erythrocytic 2,Beta-III spectrin;Spinocerebellar ataxia 5 protein;, PF00307;PF15410;PF00435;, GO:0016324;GO:0005829;GO:0005615;GO:0098978;GO:0043025;GO:0098688;GO:0099189;GO:0098793;GO:0008091;GO:0003779;GO:0045296;GO:0005543;GO:0005200;GO:0098918;GO:0051693;GO:0030534;GO:0019886;GO:0007411;GO:0021692;GO:0006888;GO:0000165;GO:0035264;GO:0099173;GO:0007416;GO:0016192;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:glutamatergic synapse; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:postsynaptic spectrin-associated cytoskeleton; C:presynapse; C:spectrin;, F:actin binding; F:cadherin binding; F:phospholipid binding; F:structural constituent of cytoskeleton; F:structural constituent of synapse;, P:actin filament capping; P:adult behavior; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:cerebellar Purkinje cell layer morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:multicellular organism growth; P:postsynapse organization; P:synapse assembly; P:vesicle-mediated transport;|O15020 O14872 O14873,Spectrin beta chain, non-erythrocytic 2,Beta-III spectrin;Spinocerebellar ataxia 5 protein;, PF00307;PF15410;PF00435;, GO:0016324;GO:0005829;GO:0005615;GO:0098978;GO:0043025;GO:0098688;GO:0099189;GO:0098793;GO:0008091;GO:0003779;GO:0045296;GO:0005543;GO:0005200;GO:0098918;GO:0051693;GO:0030534;GO:0019886;GO:0007411;GO:0021692;GO:0006888;GO:0000165;GO:0035264;GO:0099173;GO:0007416;GO:0016192;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:glutamatergic synapse; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:postsynaptic spectrin-associated cytoskeleton; C:presynapse; C:spectrin;, F:actin binding; F:cadherin binding; F:phospholipid binding; F:structural constituent of cytoskeleton; F:structural constituent of synapse;, P:actin filament capping; P:adult behavior; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:cerebellar Purkinje cell layer morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:multicellular organism growth; P:postsynapse organization; P:synapse assembly; P:vesicle-mediated transport;|O15020 O14872 O14873,Spectrin beta chain, non-erythrocytic 2,Beta-III spectrin;Spinocerebellar ataxia 5 protein;, PF00307;PF15410;PF00435;, GO:0016324;GO:0005829;GO:0005615;GO:0098978;GO:0043025;GO:0098688;GO:0099189;GO:0098793;GO:0008091;GO:0003779;GO:0045296;GO:0005543;GO:0005200;GO:0098918;GO:0051693;GO:0030534;GO:0019886;GO:0007411;GO:0021692;GO:0006888;GO:0000165;GO:0035264;GO:0099173;GO:0007416;GO:0016192;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:glutamatergic synapse; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:postsynaptic spectrin-associated cytoskeleton; C:presynapse; C:spectrin;, F:actin binding; F:cadherin binding; F:phospholipid binding; F:structural constituent of cytoskeleton; F:structural constituent of synapse;, P:actin filament capping; P:adult behavior; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:cerebellar Purkinje cell layer morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:multicellular organism growth; P:postsynapse organization; P:synapse assembly; P:vesicle-mediated transport;|O15020 O14872 O14873,Spectrin beta chain, non-erythrocytic 2,Beta-III spectrin;Spinocerebellar ataxia 5 protein;, PF00307;PF15410;PF00435;, GO:0016324;GO:0005829;GO:0005615;GO:0098978;GO:0043025;GO:0098688;GO:0099189;GO:0098793;GO:0008091;GO:0003779;GO:0045296;GO:0005543;GO:0005200;GO:0098918;GO:0051693;GO:0030534;GO:0019886;GO:0007411;GO:0021692;GO:0006888;GO:0000165;GO:0035264;GO:0099173;GO:0007416;GO:0016192;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:glutamatergic synapse; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:postsynaptic spectrin-associated cytoskeleton; C:presynapse; C:spectrin;, F:actin binding; F:cadherin binding; F:phospholipid binding; F:structural constituent of cytoskeleton; F:structural constituent of synapse;, P:actin filament capping; P:adult behavior; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:cerebellar Purkinje cell layer morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:multicellular organism growth; P:postsynapse organization; P:synapse assembly; P:vesicle-mediated transport;|O15020 O14872 O14873,Spectrin beta chain, non-erythrocytic 2,Beta-III spectrin;Spinocerebellar ataxia 5 protein;, PF00307;PF15410;PF00435;, GO:0016324;GO:0005829;GO:0005615;GO:0098978;GO:0043025;GO:0098688;GO:0099189;GO:0098793;GO:0008091;GO:0003779;GO:0045296;GO:0005543;GO:0005200;GO:0098918;GO:0051693;GO:0030534;GO:0019886;GO:0007411;GO:0021692;GO:0006888;GO:0000165;GO:0035264;GO:0099173;GO:0007416;GO:0016192;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:glutamatergic synapse; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:postsynaptic spectrin-associated cytoskeleton; C:presynapse; C:spectrin;, F:actin binding; F:cadherin binding; F:phospholipid binding; F:structural constituent of cytoskeleton; F:structural constituent of synapse;, P:actin filament capping; P:adult behavior; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:cerebellar Purkinje cell layer morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:multicellular organism growth; P:postsynapse organization; P:synapse assembly; P:vesicle-mediated transport;|O15020 O14872 O14873,Spectrin beta chain, non-erythrocytic 2,Beta-III spectrin;Spinocerebellar ataxia 5 protein;, PF00307;PF15410;PF00435;, GO:0016324;GO:0005829;GO:0005615;GO:0098978;GO:0043025;GO:0098688;GO:0099189;GO:0098793;GO:0008091;GO:0003779;GO:0045296;GO:0005543;GO:0005200;GO:0098918;GO:0051693;GO:0030534;GO:0019886;GO:0007411;GO:0021692;GO:0006888;GO:0000165;GO:0035264;GO:0099173;GO:0007416;GO:0016192;, C:apical plasma membrane; C:cytosol; C:extracellular space; C:glutamatergic synapse; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:postsynaptic spectrin-associated cytoskeleton; C:presynapse; C:spectrin;, F:actin binding; F:cadherin binding; F:phospholipid binding; F:structural constituent of cytoskeleton; F:structural constituent of synapse;, P:actin filament capping; P:adult behavior; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:cerebellar Purkinje cell layer morphogenesis; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:MAPK cascade; P:multicellular organism growth; P:postsynapse organization; P:synapse assembly; P:vesicle-mediated transport; scaffold197 indexed_genome mRNA 600175 612318 . - . ID=transcript_15628;Q9BWF3 B3KUN0 B4E1U0 E7EQS3 O02916 Q4VC48 Q6P1P2 Q8WU85,RNA-binding protein 4,Lark homolog;RNA-binding motif protein 4;RNA-binding motif protein 4a;, PF00076;PF00098;, GO:0005737;GO:0010494;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0030332;GO:0035198;GO:0003730;GO:0003729;GO:0097157;GO:0097158;GO:0003723;GO:0008270;GO:0002190;GO:0030154;GO:0097167;GO:0043153;GO:0002192;GO:0035278;GO:0000398;GO:0017148;GO:0032055;GO:0045947;GO:0051149;GO:0000381;GO:0046822;GO:0046685;GO:0006396;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA intronic binding; F:pre-mRNA intronic pyrimidine-rich binding; F:RNA binding; F:zinc ion binding;, P:cap-independent translational initiation; P:cell differentiation; P:circadian regulation of translation; P:entrainment of circadian clock by photoperiod; P:IRES-dependent translational initiation of linear mRNA; P:miRNA mediated inhibition of translation; P:mRNA splicing, via spliceosome; P:negative regulation of translation; P:negative regulation of translation in response to stress; P:negative regulation of translational initiation; P:positive regulation of muscle cell differentiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of nucleocytoplasmic transport; P:response to arsenic-containing substance; P:RNA processing;|Q9BQ04 B3KT83,RNA-binding protein 4B,RNA-binding motif protein 30;RNA-binding motif protein 4B;RNA-binding protein 30;, PF00076;PF00098;, GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0032991;GO:0003729;GO:0003723;GO:0008270;GO:0032922;GO:0007623;GO:0043153;GO:0000398;GO:0006417;, C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:protein-containing complex;, F:mRNA binding; F:RNA binding; F:zinc ion binding;, P:circadian regulation of gene expression; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:mRNA splicing, via spliceosome; P:regulation of translation; scaffold197 indexed_genome mRNA 624303 648597 . - . ID=transcript_15629;Q9BWF3 B3KUN0 B4E1U0 E7EQS3 O02916 Q4VC48 Q6P1P2 Q8WU85,RNA-binding protein 4,Lark homolog;RNA-binding motif protein 4;RNA-binding motif protein 4a;, PF00076;PF00098;, GO:0005737;GO:0010494;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0030332;GO:0035198;GO:0003730;GO:0003729;GO:0097157;GO:0097158;GO:0003723;GO:0008270;GO:0002190;GO:0030154;GO:0097167;GO:0043153;GO:0002192;GO:0035278;GO:0000398;GO:0017148;GO:0032055;GO:0045947;GO:0051149;GO:0000381;GO:0046822;GO:0046685;GO:0006396;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA intronic binding; F:pre-mRNA intronic pyrimidine-rich binding; F:RNA binding; F:zinc ion binding;, P:cap-independent translational initiation; P:cell differentiation; P:circadian regulation of translation; P:entrainment of circadian clock by photoperiod; P:IRES-dependent translational initiation of linear mRNA; P:miRNA mediated inhibition of translation; P:mRNA splicing, via spliceosome; P:negative regulation of translation; P:negative regulation of translation in response to stress; P:negative regulation of translational initiation; P:positive regulation of muscle cell differentiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of nucleocytoplasmic transport; P:response to arsenic-containing substance; P:RNA processing;|Q9BWF3 B3KUN0 B4E1U0 E7EQS3 O02916 Q4VC48 Q6P1P2 Q8WU85,RNA-binding protein 4,Lark homolog;RNA-binding motif protein 4;RNA-binding motif protein 4a;, PF00076;PF00098;, GO:0005737;GO:0010494;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0030332;GO:0035198;GO:0003730;GO:0003729;GO:0097157;GO:0097158;GO:0003723;GO:0008270;GO:0002190;GO:0030154;GO:0097167;GO:0043153;GO:0002192;GO:0035278;GO:0000398;GO:0017148;GO:0032055;GO:0045947;GO:0051149;GO:0000381;GO:0046822;GO:0046685;GO:0006396;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA intronic binding; F:pre-mRNA intronic pyrimidine-rich binding; F:RNA binding; F:zinc ion binding;, P:cap-independent translational initiation; P:cell differentiation; P:circadian regulation of translation; P:entrainment of circadian clock by photoperiod; P:IRES-dependent translational initiation of linear mRNA; P:miRNA mediated inhibition of translation; P:mRNA splicing, via spliceosome; P:negative regulation of translation; P:negative regulation of translation in response to stress; P:negative regulation of translational initiation; P:positive regulation of muscle cell differentiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of nucleocytoplasmic transport; P:response to arsenic-containing substance; P:RNA processing;|Q9BWF3 B3KUN0 B4E1U0 E7EQS3 O02916 Q4VC48 Q6P1P2 Q8WU85,RNA-binding protein 4,Lark homolog;RNA-binding motif protein 4;RNA-binding motif protein 4a;, PF00076;PF00098;, GO:0005737;GO:0010494;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0030332;GO:0035198;GO:0003730;GO:0003729;GO:0097157;GO:0097158;GO:0003723;GO:0008270;GO:0002190;GO:0030154;GO:0097167;GO:0043153;GO:0002192;GO:0035278;GO:0000398;GO:0017148;GO:0032055;GO:0045947;GO:0051149;GO:0000381;GO:0046822;GO:0046685;GO:0006396;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cyclin binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA intronic binding; F:pre-mRNA intronic pyrimidine-rich binding; F:RNA binding; F:zinc ion binding;, P:cap-independent translational initiation; P:cell differentiation; P:circadian regulation of translation; P:entrainment of circadian clock by photoperiod; P:IRES-dependent translational initiation of linear mRNA; P:miRNA mediated inhibition of translation; P:mRNA splicing, via spliceosome; P:negative regulation of translation; P:negative regulation of translation in response to stress; P:negative regulation of translational initiation; P:positive regulation of muscle cell differentiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of nucleocytoplasmic transport; P:response to arsenic-containing substance; P:RNA processing;|Q96PK6 B0LM41 B3KMN4 D6RGD8 O75932 Q2PYN1 Q53GV1 Q68DQ9 Q96PK5,RNA-binding protein 14,Paraspeckle protein 2;RNA-binding motif protein 14;RRM-containing coactivator activator/modulator;Synaptotagmin-interacting protein;, PF00076;, GO:0005737;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005667;GO:0003729;GO:0030374;GO:0003723;GO:0002218;GO:0098534;GO:0016575;GO:0045087;GO:0000398;GO:0046600;GO:0045944;GO:0009725;GO:0060395;, C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:transcription regulator complex;, F:mRNA binding; F:nuclear receptor coactivator activity; F:RNA binding;, P:activation of innate immune response; P:centriole assembly; P:histone deacetylation; P:innate immune response; P:mRNA splicing, via spliceosome; P:negative regulation of centriole replication; P:positive regulation of transcription by RNA polymerase II; P:response to hormone; P:SMAD protein signal transduction;|Q96PK6 B0LM41 B3KMN4 D6RGD8 O75932 Q2PYN1 Q53GV1 Q68DQ9 Q96PK5,RNA-binding protein 14,Paraspeckle protein 2;RNA-binding motif protein 14;RRM-containing coactivator activator/modulator;Synaptotagmin-interacting protein;, PF00076;, GO:0005737;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005667;GO:0003729;GO:0030374;GO:0003723;GO:0002218;GO:0098534;GO:0016575;GO:0045087;GO:0000398;GO:0046600;GO:0045944;GO:0009725;GO:0060395;, C:cytoplasm; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:transcription regulator complex;, F:mRNA binding; F:nuclear receptor coactivator activity; F:RNA binding;, P:activation of innate immune response; P:centriole assembly; P:histone deacetylation; P:innate immune response; P:mRNA splicing, via spliceosome; P:negative regulation of centriole replication; P:positive regulation of transcription by RNA polymerase II; P:response to hormone; P:SMAD protein signal transduction; scaffold197 indexed_genome mRNA 658073 671550 . - . ID=transcript_15630;O14618 Q2M366 Q8NEV0,Copper chaperone for superoxide dismutase,Superoxide dismutase copper chaperone;, PF00403;PF00080;, GO:0005737;GO:0005829;GO:0005634;GO:0045296;GO:0005507;GO:0034599;GO:0051353;GO:0015680;GO:0019430;GO:0006801;, C:cytoplasm; C:cytosol; C:nucleus;, F:cadherin binding; F:copper ion binding;, P:cellular response to oxidative stress; P:positive regulation of oxidoreductase activity; P:protein maturation by copper ion transfer; P:removal of superoxide radicals; P:superoxide metabolic process;|O14618 Q2M366 Q8NEV0,Copper chaperone for superoxide dismutase,Superoxide dismutase copper chaperone;, PF00403;PF00080;, GO:0005737;GO:0005829;GO:0005634;GO:0045296;GO:0005507;GO:0034599;GO:0051353;GO:0015680;GO:0019430;GO:0006801;, C:cytoplasm; C:cytosol; C:nucleus;, F:cadherin binding; F:copper ion binding;, P:cellular response to oxidative stress; P:positive regulation of oxidoreductase activity; P:protein maturation by copper ion transfer; P:removal of superoxide radicals; P:superoxide metabolic process;|O14618 Q2M366 Q8NEV0,Copper chaperone for superoxide dismutase,Superoxide dismutase copper chaperone;, PF00403;PF00080;, GO:0005737;GO:0005829;GO:0005634;GO:0045296;GO:0005507;GO:0034599;GO:0051353;GO:0015680;GO:0019430;GO:0006801;, C:cytoplasm; C:cytosol; C:nucleus;, F:cadherin binding; F:copper ion binding;, P:cellular response to oxidative stress; P:positive regulation of oxidoreductase activity; P:protein maturation by copper ion transfer; P:removal of superoxide radicals; P:superoxide metabolic process;|O14618 Q2M366 Q8NEV0,Copper chaperone for superoxide dismutase,Superoxide dismutase copper chaperone;, PF00403;PF00080;, GO:0005737;GO:0005829;GO:0005634;GO:0045296;GO:0005507;GO:0034599;GO:0051353;GO:0015680;GO:0019430;GO:0006801;, C:cytoplasm; C:cytosol; C:nucleus;, F:cadherin binding; F:copper ion binding;, P:cellular response to oxidative stress; P:positive regulation of oxidoreductase activity; P:protein maturation by copper ion transfer; P:removal of superoxide radicals; P:superoxide metabolic process;|P23434 Q9H1E9,Glycine cleavage system H protein, mitochondrial {ECO:0000303|PubMed:1671321},Lipoic acid-containing protein;, PF01597;, GO:0005737;GO:0005960;GO:0005759;GO:0005739;GO:0004047;GO:0006546;GO:0019464;GO:0009249;, C:cytoplasm; C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion;, F:aminomethyltransferase activity;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein lipoylation; scaffold197 indexed_genome mRNA 673915 674640 . + . ID=transcript_15631;Q9NVE4 Q8NE76,Coiled-coil domain-containing protein 87,, , GO:0030154;GO:2000344;GO:1905516;GO:0007338;GO:0007283;, , , P:cell differentiation; P:positive regulation of acrosome reaction; P:positive regulation of fertilization; P:single fertilization; P:spermatogenesis; scaffold197 indexed_genome mRNA 692741 697919 . + . ID=transcript_15632;Q9UBX1 B2R964 O95240 Q9NSU4 Q9UKQ5,Cathepsin F,, PF08246;PF00112;, GO:0062023;GO:0070062;GO:0005615;GO:1903561;GO:0043202;GO:0005764;GO:0004197;GO:0019886;GO:0006508;GO:0051603;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space; C:extracellular vesicle; C:lysosomal lumen; C:lysosome;, F:cysteine-type endopeptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:proteolysis; P:proteolysis involved in cellular protein catabolic process;|Q9UBX1 B2R964 O95240 Q9NSU4 Q9UKQ5,Cathepsin F,, PF08246;PF00112;, GO:0062023;GO:0070062;GO:0005615;GO:1903561;GO:0043202;GO:0005764;GO:0004197;GO:0019886;GO:0006508;GO:0051603;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space; C:extracellular vesicle; C:lysosomal lumen; C:lysosome;, F:cysteine-type endopeptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:proteolysis; P:proteolysis involved in cellular protein catabolic process;|Q9UBX1 B2R964 O95240 Q9NSU4 Q9UKQ5,Cathepsin F,, PF08246;PF00112;, GO:0062023;GO:0070062;GO:0005615;GO:1903561;GO:0043202;GO:0005764;GO:0004197;GO:0019886;GO:0006508;GO:0051603;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space; C:extracellular vesicle; C:lysosomal lumen; C:lysosome;, F:cysteine-type endopeptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; scaffold197 indexed_genome mRNA 698056 709908 . - . ID=transcript_15633;Q08043 A6NP77 Q4KKV2,Alpha-actinin-3,Alpha-actinin skeletal muscle isoform 3;F-actin cross-linking protein;, PF00307;PF08726;PF00435;, GO:0005884;GO:0005829;GO:0070062;GO:0005925;GO:0031143;GO:0003779;GO:0005509;GO:0042802;GO:0005178;GO:0044325;GO:0008307;GO:0048041;GO:0030049;GO:0070885;GO:0120163;GO:0045820;GO:0090324;GO:1904025;GO:0048633;GO:1903715;GO:0042981;GO:0014728;GO:0014894;GO:0014732;GO:0014883;, C:actin filament; C:cytosol; C:extracellular exosome; C:focal adhesion; C:pseudopodium;, F:actin binding; F:calcium ion binding; F:identical protein binding; F:integrin binding; F:ion channel binding; F:structural constituent of muscle;, P:focal adhesion assembly; P:muscle filament sliding; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cold-induced thermogenesis; P:negative regulation of glycolytic process; P:negative regulation of oxidative phosphorylation; P:positive regulation of glucose catabolic process to lactate via pyruvate; P:positive regulation of skeletal muscle tissue growth; P:regulation of aerobic respiration; P:regulation of apoptotic process; P:regulation of the force of skeletal muscle contraction; P:response to denervation involved in regulation of muscle adaptation; P:skeletal muscle atrophy; P:transition between fast and slow fiber;|Q08043 A6NP77 Q4KKV2,Alpha-actinin-3,Alpha-actinin skeletal muscle isoform 3;F-actin cross-linking protein;, PF00307;PF08726;PF00435;, GO:0005884;GO:0005829;GO:0070062;GO:0005925;GO:0031143;GO:0003779;GO:0005509;GO:0042802;GO:0005178;GO:0044325;GO:0008307;GO:0048041;GO:0030049;GO:0070885;GO:0120163;GO:0045820;GO:0090324;GO:1904025;GO:0048633;GO:1903715;GO:0042981;GO:0014728;GO:0014894;GO:0014732;GO:0014883;, C:actin filament; C:cytosol; C:extracellular exosome; C:focal adhesion; C:pseudopodium;, F:actin binding; F:calcium ion binding; F:identical protein binding; F:integrin binding; F:ion channel binding; F:structural constituent of muscle;, P:focal adhesion assembly; P:muscle filament sliding; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cold-induced thermogenesis; P:negative regulation of glycolytic process; P:negative regulation of oxidative phosphorylation; P:positive regulation of glucose catabolic process to lactate via pyruvate; P:positive regulation of skeletal muscle tissue growth; P:regulation of aerobic respiration; P:regulation of apoptotic process; P:regulation of the force of skeletal muscle contraction; P:response to denervation involved in regulation of muscle adaptation; P:skeletal muscle atrophy; P:transition between fast and slow fiber;|Q08043 A6NP77 Q4KKV2,Alpha-actinin-3,Alpha-actinin skeletal muscle isoform 3;F-actin cross-linking protein;, PF00307;PF08726;PF00435;, GO:0005884;GO:0005829;GO:0070062;GO:0005925;GO:0031143;GO:0003779;GO:0005509;GO:0042802;GO:0005178;GO:0044325;GO:0008307;GO:0048041;GO:0030049;GO:0070885;GO:0120163;GO:0045820;GO:0090324;GO:1904025;GO:0048633;GO:1903715;GO:0042981;GO:0014728;GO:0014894;GO:0014732;GO:0014883;, C:actin filament; C:cytosol; C:extracellular exosome; C:focal adhesion; C:pseudopodium;, F:actin binding; F:calcium ion binding; F:identical protein binding; F:integrin binding; F:ion channel binding; F:structural constituent of muscle;, P:focal adhesion assembly; P:muscle filament sliding; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cold-induced thermogenesis; P:negative regulation of glycolytic process; P:negative regulation of oxidative phosphorylation; P:positive regulation of glucose catabolic process to lactate via pyruvate; P:positive regulation of skeletal muscle tissue growth; P:regulation of aerobic respiration; P:regulation of apoptotic process; P:regulation of the force of skeletal muscle contraction; P:response to denervation involved in regulation of muscle adaptation; P:skeletal muscle atrophy; P:transition between fast and slow fiber;|Q08043 A6NP77 Q4KKV2,Alpha-actinin-3,Alpha-actinin skeletal muscle isoform 3;F-actin cross-linking protein;, PF00307;PF08726;PF00435;, GO:0005884;GO:0005829;GO:0070062;GO:0005925;GO:0031143;GO:0003779;GO:0005509;GO:0042802;GO:0005178;GO:0044325;GO:0008307;GO:0048041;GO:0030049;GO:0070885;GO:0120163;GO:0045820;GO:0090324;GO:1904025;GO:0048633;GO:1903715;GO:0042981;GO:0014728;GO:0014894;GO:0014732;GO:0014883;, C:actin filament; C:cytosol; C:extracellular exosome; C:focal adhesion; C:pseudopodium;, F:actin binding; F:calcium ion binding; F:identical protein binding; F:integrin binding; F:ion channel binding; F:structural constituent of muscle;, P:focal adhesion assembly; P:muscle filament sliding; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cold-induced thermogenesis; P:negative regulation of glycolytic process; P:negative regulation of oxidative phosphorylation; P:positive regulation of glucose catabolic process to lactate via pyruvate; P:positive regulation of skeletal muscle tissue growth; P:regulation of aerobic respiration; P:regulation of apoptotic process; P:regulation of the force of skeletal muscle contraction; P:response to denervation involved in regulation of muscle adaptation; P:skeletal muscle atrophy; P:transition between fast and slow fiber;|Q08043 A6NP77 Q4KKV2,Alpha-actinin-3,Alpha-actinin skeletal muscle isoform 3;F-actin cross-linking protein;, PF00307;PF08726;PF00435;, GO:0005884;GO:0005829;GO:0070062;GO:0005925;GO:0031143;GO:0003779;GO:0005509;GO:0042802;GO:0005178;GO:0044325;GO:0008307;GO:0048041;GO:0030049;GO:0070885;GO:0120163;GO:0045820;GO:0090324;GO:1904025;GO:0048633;GO:1903715;GO:0042981;GO:0014728;GO:0014894;GO:0014732;GO:0014883;, C:actin filament; C:cytosol; C:extracellular exosome; C:focal adhesion; C:pseudopodium;, F:actin binding; F:calcium ion binding; F:identical protein binding; F:integrin binding; F:ion channel binding; F:structural constituent of muscle;, P:focal adhesion assembly; P:muscle filament sliding; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of cold-induced thermogenesis; P:negative regulation of glycolytic process; P:negative regulation of oxidative phosphorylation; P:positive regulation of glucose catabolic process to lactate via pyruvate; P:positive regulation of skeletal muscle tissue growth; P:regulation of aerobic respiration; P:regulation of apoptotic process; P:regulation of the force of skeletal muscle contraction; P:response to denervation involved in regulation of muscle adaptation; P:skeletal muscle atrophy; P:transition between fast and slow fiber; scaffold197 indexed_genome mRNA 710621 739415 . + . ID=transcript_15634;Q8NFJ9 Q32MM9 Q32MN0 Q96SN4,Bardet-Biedl syndrome 1 protein,BBS2-like protein 2;, PF14779;, GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0005113;GO:0001103;GO:0005119;GO:0060271;GO:0043001;GO:1905515;GO:0045494;GO:0061512;GO:0050896;GO:0007608;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol;, F:patched binding; F:RNA polymerase II repressing transcription factor binding; F:smoothened binding;, P:cilium assembly; P:Golgi to plasma membrane protein transport; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:protein localization to cilium; P:response to stimulus; P:sensory perception of smell; P:visual perception;|Q6UX98 Q6PEW7 Q9BSJ0,Probable palmitoyltransferase ZDHHC24 {ECO:0000305},Zinc finger DHHC domain-containing protein 24 {ECO:0000312|HGNC:HGNC:27387};, PF01529;, GO:0005783;GO:0005794;GO:0016021;GO:0019706;GO:0018230;GO:0006612;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane;, F:protein-cysteine S-palmitoyltransferase activity;, P:peptidyl-L-cysteine S-palmitoylation; P:protein targeting to membrane;|Q8NFJ9 Q32MM9 Q32MN0 Q96SN4,Bardet-Biedl syndrome 1 protein,BBS2-like protein 2;, PF14779;, GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0005113;GO:0001103;GO:0005119;GO:0060271;GO:0043001;GO:1905515;GO:0045494;GO:0061512;GO:0050896;GO:0007608;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol;, F:patched binding; F:RNA polymerase II repressing transcription factor binding; F:smoothened binding;, P:cilium assembly; P:Golgi to plasma membrane protein transport; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:protein localization to cilium; P:response to stimulus; P:sensory perception of smell; P:visual perception;|Q8NFJ9 Q32MM9 Q32MN0 Q96SN4,Bardet-Biedl syndrome 1 protein,BBS2-like protein 2;, PF14779;, GO:0005930;GO:0034464;GO:0005813;GO:0036064;GO:0060170;GO:0005829;GO:0005113;GO:0001103;GO:0005119;GO:0060271;GO:0043001;GO:1905515;GO:0045494;GO:0061512;GO:0050896;GO:0007608;GO:0007601;, C:axoneme; C:BBSome; C:centrosome; C:ciliary basal body; C:ciliary membrane; C:cytosol;, F:patched binding; F:RNA polymerase II repressing transcription factor binding; F:smoothened binding;, P:cilium assembly; P:Golgi to plasma membrane protein transport; P:non-motile cilium assembly; P:photoreceptor cell maintenance; P:protein localization to cilium; P:response to stimulus; P:sensory perception of smell; P:visual perception; scaffold197 indexed_genome mRNA 740904 763795 . - . ID=transcript_15635;Q9NY33 B2RDB5 B4DLX4 F5H8L6 O95748 Q969H2 Q9BV67 Q9HAL6,Dipeptidyl peptidase 3,Dipeptidyl aminopeptidase III;Dipeptidyl arylamidase III;Dipeptidyl peptidase III;Enkephalinase B;, PF03571;, GO:0005737;GO:0005829;GO:0070062;GO:0008239;GO:0070006;GO:0008270;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:dipeptidyl-peptidase activity; F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9NY33 B2RDB5 B4DLX4 F5H8L6 O95748 Q969H2 Q9BV67 Q9HAL6,Dipeptidyl peptidase 3,Dipeptidyl aminopeptidase III;Dipeptidyl arylamidase III;Dipeptidyl peptidase III;Enkephalinase B;, PF03571;, GO:0005737;GO:0005829;GO:0070062;GO:0008239;GO:0070006;GO:0008270;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:dipeptidyl-peptidase activity; F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9NY33 B2RDB5 B4DLX4 F5H8L6 O95748 Q969H2 Q9BV67 Q9HAL6,Dipeptidyl peptidase 3,Dipeptidyl aminopeptidase III;Dipeptidyl arylamidase III;Dipeptidyl peptidase III;Enkephalinase B;, PF03571;, GO:0005737;GO:0005829;GO:0070062;GO:0008239;GO:0070006;GO:0008270;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:dipeptidyl-peptidase activity; F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9NY33 B2RDB5 B4DLX4 F5H8L6 O95748 Q969H2 Q9BV67 Q9HAL6,Dipeptidyl peptidase 3,Dipeptidyl aminopeptidase III;Dipeptidyl arylamidase III;Dipeptidyl peptidase III;Enkephalinase B;, PF03571;, GO:0005737;GO:0005829;GO:0070062;GO:0008239;GO:0070006;GO:0008270;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:dipeptidyl-peptidase activity; F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9NY33 B2RDB5 B4DLX4 F5H8L6 O95748 Q969H2 Q9BV67 Q9HAL6,Dipeptidyl peptidase 3,Dipeptidyl aminopeptidase III;Dipeptidyl arylamidase III;Dipeptidyl peptidase III;Enkephalinase B;, PF03571;, GO:0005737;GO:0005829;GO:0070062;GO:0008239;GO:0070006;GO:0008270;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:dipeptidyl-peptidase activity; F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9NY33 B2RDB5 B4DLX4 F5H8L6 O95748 Q969H2 Q9BV67 Q9HAL6,Dipeptidyl peptidase 3,Dipeptidyl aminopeptidase III;Dipeptidyl arylamidase III;Dipeptidyl peptidase III;Enkephalinase B;, PF03571;, GO:0005737;GO:0005829;GO:0070062;GO:0008239;GO:0070006;GO:0008270;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:dipeptidyl-peptidase activity; F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis; scaffold197 indexed_genome mRNA 769398 771075 . - . ID=transcript_15636;Q9NY33 B2RDB5 B4DLX4 F5H8L6 O95748 Q969H2 Q9BV67 Q9HAL6,Dipeptidyl peptidase 3,Dipeptidyl aminopeptidase III;Dipeptidyl arylamidase III;Dipeptidyl peptidase III;Enkephalinase B;, PF03571;, GO:0005737;GO:0005829;GO:0070062;GO:0008239;GO:0070006;GO:0008270;GO:0006508;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:dipeptidyl-peptidase activity; F:metalloaminopeptidase activity; F:zinc ion binding;, P:proteolysis; scaffold197 indexed_genome mRNA 774860 785300 . - . ID=transcript_15637;Q8N2H9 Q8N3E1 Q8N9Q6 Q8TAW7 Q8TED5,E3 ubiquitin-protein ligase pellino homolog 3,RING-type E3 ubiquitin transferase pellino homolog 3 {ECO:0000305};, PF04710;, GO:0005829;GO:0061630;GO:0070498;GO:2001237;GO:0010804;GO:0070534;GO:0000209;GO:0008592;GO:0008063;, C:cytosol;, F:ubiquitin protein ligase activity;, P:interleukin-1-mediated signaling pathway; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of Toll signaling pathway; P:Toll signaling pathway; scaffold197 indexed_genome mRNA 804791 809198 . + . ID=transcript_15638;Q9Y3B7 A6NLT0 A8K219 Q32P46 Q96Q73,39S ribosomal protein L11, mitochondrial,Mitochondrial large ribosomal subunit protein uL11m {ECO:0000303|PubMed:25278503};, PF00298;PF03946;, GO:0015934;GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0070180;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:large ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:large ribosomal subunit rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9Y3B7 A6NLT0 A8K219 Q32P46 Q96Q73,39S ribosomal protein L11, mitochondrial,Mitochondrial large ribosomal subunit protein uL11m {ECO:0000303|PubMed:25278503};, PF00298;PF03946;, GO:0015934;GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0070180;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:large ribosomal subunit; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:large ribosomal subunit rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold197 indexed_genome mRNA 822438 827391 . - . ID=transcript_15639;Q8IUM7 B7ZL81 Q8N8S5 Q8N9Q9,Neuronal PAS domain-containing protein 4 {ECO:0000305},Class E basic helix-loop-helix protein 79 {ECO:0000305};HLH-PAS transcription factor NXF {ECO:0000303|PubMed:14701734};PAS domain-containing protein 10 {ECO:0000305};, PF08447;, GO:0000785;GO:0005634;GO:0098794;GO:0005667;GO:0001228;GO:0000981;GO:0046982;GO:0044877;GO:0000978;GO:0000977;GO:0030154;GO:0071386;GO:0060079;GO:0060080;GO:1904862;GO:0007612;GO:0007616;GO:0045944;GO:0048167;GO:0032228;GO:0006357;GO:0007614;GO:0035176;, C:chromatin; C:nucleus; C:postsynapse; C:transcription regulator complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:cell differentiation; P:cellular response to corticosterone stimulus; P:excitatory postsynaptic potential; P:inhibitory postsynaptic potential; P:inhibitory synapse assembly; P:learning; P:long-term memory; P:positive regulation of transcription by RNA polymerase II; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, GABAergic; P:regulation of transcription by RNA polymerase II; P:short-term memory; P:social behavior; scaffold197 indexed_genome mRNA 868343 876548 . - . ID=transcript_15640;Q14542 B3KPY7 O43530 Q52M84 Q96R00 Q9UPE0,Equilibrative nucleoside transporter 2,36 kDa nucleolar protein HNP36;Delayed-early response protein 12;Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter;Hydrophobic nucleolar protein, 36 kDa;Nucleoside transporter, ei-type;Solute carrier family 29 member 2;, PF01733;, GO:0016323;GO:0016021;GO:0005887;GO:0031965;GO:0005730;GO:0005886;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0015853;GO:0032238;GO:0015854;GO:0035344;GO:0098810;GO:0006836;GO:0001504;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0035364;GO:0150104;GO:0015862;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenine transport; P:adenosine transport; P:guanine transport; P:hypoxanthine transport; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:thymine transport; P:transport across blood-brain barrier; P:uridine transport;|Q14542 B3KPY7 O43530 Q52M84 Q96R00 Q9UPE0,Equilibrative nucleoside transporter 2,36 kDa nucleolar protein HNP36;Delayed-early response protein 12;Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter;Hydrophobic nucleolar protein, 36 kDa;Nucleoside transporter, ei-type;Solute carrier family 29 member 2;, PF01733;, GO:0016323;GO:0016021;GO:0005887;GO:0031965;GO:0005730;GO:0005886;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0015853;GO:0032238;GO:0015854;GO:0035344;GO:0098810;GO:0006836;GO:0001504;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0035364;GO:0150104;GO:0015862;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenine transport; P:adenosine transport; P:guanine transport; P:hypoxanthine transport; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:thymine transport; P:transport across blood-brain barrier; P:uridine transport;|Q14542 B3KPY7 O43530 Q52M84 Q96R00 Q9UPE0,Equilibrative nucleoside transporter 2,36 kDa nucleolar protein HNP36;Delayed-early response protein 12;Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter;Hydrophobic nucleolar protein, 36 kDa;Nucleoside transporter, ei-type;Solute carrier family 29 member 2;, PF01733;, GO:0016323;GO:0016021;GO:0005887;GO:0031965;GO:0005730;GO:0005886;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0015853;GO:0032238;GO:0015854;GO:0035344;GO:0098810;GO:0006836;GO:0001504;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0035364;GO:0150104;GO:0015862;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenine transport; P:adenosine transport; P:guanine transport; P:hypoxanthine transport; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:thymine transport; P:transport across blood-brain barrier; P:uridine transport;|Q14542 B3KPY7 O43530 Q52M84 Q96R00 Q9UPE0,Equilibrative nucleoside transporter 2,36 kDa nucleolar protein HNP36;Delayed-early response protein 12;Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter;Hydrophobic nucleolar protein, 36 kDa;Nucleoside transporter, ei-type;Solute carrier family 29 member 2;, PF01733;, GO:0016323;GO:0016021;GO:0005887;GO:0031965;GO:0005730;GO:0005886;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0015853;GO:0032238;GO:0015854;GO:0035344;GO:0098810;GO:0006836;GO:0001504;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0035364;GO:0150104;GO:0015862;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenine transport; P:adenosine transport; P:guanine transport; P:hypoxanthine transport; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:thymine transport; P:transport across blood-brain barrier; P:uridine transport;|Q14542 B3KPY7 O43530 Q52M84 Q96R00 Q9UPE0,Equilibrative nucleoside transporter 2,36 kDa nucleolar protein HNP36;Delayed-early response protein 12;Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter;Hydrophobic nucleolar protein, 36 kDa;Nucleoside transporter, ei-type;Solute carrier family 29 member 2;, PF01733;, GO:0016323;GO:0016021;GO:0005887;GO:0031965;GO:0005730;GO:0005886;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0015853;GO:0032238;GO:0015854;GO:0035344;GO:0098810;GO:0006836;GO:0001504;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0035364;GO:0150104;GO:0015862;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenine transport; P:adenosine transport; P:guanine transport; P:hypoxanthine transport; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:thymine transport; P:transport across blood-brain barrier; P:uridine transport;|Q14542 B3KPY7 O43530 Q52M84 Q96R00 Q9UPE0,Equilibrative nucleoside transporter 2,36 kDa nucleolar protein HNP36;Delayed-early response protein 12;Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter;Hydrophobic nucleolar protein, 36 kDa;Nucleoside transporter, ei-type;Solute carrier family 29 member 2;, PF01733;, GO:0016323;GO:0016021;GO:0005887;GO:0031965;GO:0005730;GO:0005886;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0015853;GO:0032238;GO:0015854;GO:0035344;GO:0098810;GO:0006836;GO:0001504;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0035364;GO:0150104;GO:0015862;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenine transport; P:adenosine transport; P:guanine transport; P:hypoxanthine transport; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:thymine transport; P:transport across blood-brain barrier; P:uridine transport;|Q14542 B3KPY7 O43530 Q52M84 Q96R00 Q9UPE0,Equilibrative nucleoside transporter 2,36 kDa nucleolar protein HNP36;Delayed-early response protein 12;Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter;Hydrophobic nucleolar protein, 36 kDa;Nucleoside transporter, ei-type;Solute carrier family 29 member 2;, PF01733;, GO:0016323;GO:0016021;GO:0005887;GO:0031965;GO:0005730;GO:0005886;GO:0098793;GO:0005326;GO:0005337;GO:0015211;GO:0015213;GO:0015853;GO:0032238;GO:0015854;GO:0035344;GO:0098810;GO:0006836;GO:0001504;GO:1901642;GO:0015858;GO:0015860;GO:0072531;GO:0035364;GO:0150104;GO:0015862;, C:basolateral plasma membrane; C:integral component of membrane; C:integral component of plasma membrane; C:nuclear membrane; C:nucleolus; C:plasma membrane; C:presynapse;, F:neurotransmitter transmembrane transporter activity; F:nucleoside transmembrane transporter activity; F:purine nucleoside transmembrane transporter activity; F:uridine transmembrane transporter activity;, P:adenine transport; P:adenosine transport; P:guanine transport; P:hypoxanthine transport; P:neurotransmitter reuptake; P:neurotransmitter transport; P:neurotransmitter uptake; P:nucleoside transmembrane transport; P:nucleoside transport; P:purine nucleoside transmembrane transport; P:pyrimidine-containing compound transmembrane transport; P:thymine transport; P:transport across blood-brain barrier; P:uridine transport; scaffold197 indexed_genome mRNA 885542 895185 . + . ID=transcript_15641;O43505 Q4TTN0,Beta-1,4-glucuronyltransferase 1 {ECO:0000303|PubMed:25279697, ECO:0000303|PubMed:25279699, ECO:0000312|HGNC:HGNC:15685},I-beta-1,3-N-acetylglucosaminyltransferase;N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase;Poly-N-acetyllactosamine extension enzyme;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1;, , GO:0070062;GO:0005794;GO:0000139;GO:0030173;GO:0015020;GO:0046872;GO:0018146;GO:0006493;GO:0035269;, C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane;, F:glucuronosyltransferase activity; F:metal ion binding;, P:keratan sulfate biosynthetic process; P:protein O-linked glycosylation; P:protein O-linked mannosylation;|Q9HCU9 Q6IAI2,Breast cancer metastasis-suppressor 1,, PF08598;, GO:0005737;GO:0005654;GO:0005634;GO:0070822;GO:0042826;GO:0051059;GO:0006915;GO:0016575;GO:0032088;GO:0000122;GO:0045892;GO:2000210;GO:0090312;GO:0042981;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:Sin3-type complex;, F:histone deacetylase binding; F:NF-kappaB binding;, P:apoptotic process; P:histone deacetylation; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of anoikis; P:positive regulation of protein deacetylation; P:regulation of apoptotic process;|Q9HCU9 Q6IAI2,Breast cancer metastasis-suppressor 1,, PF08598;, GO:0005737;GO:0005654;GO:0005634;GO:0070822;GO:0042826;GO:0051059;GO:0006915;GO:0016575;GO:0032088;GO:0000122;GO:0045892;GO:2000210;GO:0090312;GO:0042981;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:Sin3-type complex;, F:histone deacetylase binding; F:NF-kappaB binding;, P:apoptotic process; P:histone deacetylation; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of anoikis; P:positive regulation of protein deacetylation; P:regulation of apoptotic process; scaffold197 indexed_genome mRNA 895997 897566 . + . ID=transcript_15642;Q13671 O15010 Q00427 Q96CC8,Ras and Rab interactor 1,Ras inhibitor JC99;Ras interaction/interference protein 1;, PF00788;PF02204;, GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0005096;GO:0006897;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:GTPase activator activity;, P:endocytosis; P:signal transduction; scaffold197 indexed_genome mRNA 897601 900700 . - . ID=transcript_15643;Q13671 O15010 Q00427 Q96CC8,Ras and Rab interactor 1,Ras inhibitor JC99;Ras interaction/interference protein 1;, PF00788;PF02204;, GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0005096;GO:0006897;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:GTPase activator activity;, P:endocytosis; P:signal transduction;|Q13671 O15010 Q00427 Q96CC8,Ras and Rab interactor 1,Ras inhibitor JC99;Ras interaction/interference protein 1;, PF00788;PF02204;, GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0005096;GO:0006897;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:GTPase activator activity;, P:endocytosis; P:signal transduction; scaffold197 indexed_genome mRNA 900702 902703 . + . ID=transcript_15644;Q13671 O15010 Q00427 Q96CC8,Ras and Rab interactor 1,Ras inhibitor JC99;Ras interaction/interference protein 1;, PF00788;PF02204;, GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0005096;GO:0006897;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;, F:GTPase activator activity;, P:endocytosis; P:signal transduction; scaffold197 indexed_genome mRNA 917380 919758 . + . ID=transcript_15645;Q9HCU0 Q2M2V5 Q3SX55 Q96KB6,Endosialin,Tumor endothelial marker 1;, PF00059;, GO:0005737;GO:0009897;GO:0070062;GO:0031012;GO:0016021;GO:0005509;GO:0030246;GO:0050840;GO:1990430;GO:0060033;GO:0016477;GO:0048535;GO:0008284;GO:2000353;, C:cytoplasm; C:external side of plasma membrane; C:extracellular exosome; C:extracellular matrix; C:integral component of membrane;, F:calcium ion binding; F:carbohydrate binding; F:extracellular matrix binding; F:extracellular matrix protein binding;, P:anatomical structure regression; P:cell migration; P:lymph node development; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process;|Q9HCU0 Q2M2V5 Q3SX55 Q96KB6,Endosialin,Tumor endothelial marker 1;, PF00059;, GO:0005737;GO:0009897;GO:0070062;GO:0031012;GO:0016021;GO:0005509;GO:0030246;GO:0050840;GO:1990430;GO:0060033;GO:0016477;GO:0048535;GO:0008284;GO:2000353;, C:cytoplasm; C:external side of plasma membrane; C:extracellular exosome; C:extracellular matrix; C:integral component of membrane;, F:calcium ion binding; F:carbohydrate binding; F:extracellular matrix binding; F:extracellular matrix protein binding;, P:anatomical structure regression; P:cell migration; P:lymph node development; P:positive regulation of cell population proliferation; P:positive regulation of endothelial cell apoptotic process; scaffold197 indexed_genome mRNA 938143 941979 . - . ID=transcript_15646;Q8N4L1 Q8ND14,Transmembrane protein 151A,, PF14857;, GO:0016021;, C:integral component of membrane; scaffold198 indexed_genome mRNA 85 629 . - . ID=transcript_15647;P43487 Q53EY3,Ran-specific GTPase-activating protein,Ran-binding protein 1;, PF00638;, GO:0005813;GO:0005737;GO:0005829;GO:0005635;GO:0005643;GO:0005634;GO:0045296;GO:0005092;GO:0005096;GO:0031267;GO:0046907;GO:0046604;GO:0007165;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear envelope; C:nuclear pore; C:nucleus;, F:cadherin binding; F:GDP-dissociation inhibitor activity; F:GTPase activator activity; F:small GTPase binding;, P:intracellular transport; P:positive regulation of mitotic centrosome separation; P:signal transduction; P:viral process; scaffold198 indexed_genome mRNA 2144 3805 . - . ID=transcript_15648;P43487 Q53EY3,Ran-specific GTPase-activating protein,Ran-binding protein 1;, PF00638;, GO:0005813;GO:0005737;GO:0005829;GO:0005635;GO:0005643;GO:0005634;GO:0045296;GO:0005092;GO:0005096;GO:0031267;GO:0046907;GO:0046604;GO:0007165;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:nuclear envelope; C:nuclear pore; C:nucleus;, F:cadherin binding; F:GDP-dissociation inhibitor activity; F:GTPase activator activity; F:small GTPase binding;, P:intracellular transport; P:positive regulation of mitotic centrosome separation; P:signal transduction; P:viral process; scaffold198 indexed_genome mRNA 6225 15473 . + . ID=transcript_15649;Q9ULC8 Q2TGE9 Q6ICL1 Q6ZNF5 Q7Z6L9,Palmitoyltransferase ZDHHC8 {ECO:0000305},Zinc finger DHHC domain-containing protein 8 {ECO:0000312|HGNC:HGNC:18474};Zinc finger protein 378;, PF01529;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0031966;GO:0016409;GO:0019706;GO:0034380;GO:0007626;GO:0018230;GO:0010875;GO:1903078;GO:0018345;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:mitochondrial membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:high-density lipoprotein particle assembly; P:locomotory behavior; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of cholesterol efflux; P:positive regulation of protein localization to plasma membrane; P:protein palmitoylation;|Q9ULC8 Q2TGE9 Q6ICL1 Q6ZNF5 Q7Z6L9,Palmitoyltransferase ZDHHC8 {ECO:0000305},Zinc finger DHHC domain-containing protein 8 {ECO:0000312|HGNC:HGNC:18474};Zinc finger protein 378;, PF01529;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0031966;GO:0016409;GO:0019706;GO:0034380;GO:0007626;GO:0018230;GO:0010875;GO:1903078;GO:0018345;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:mitochondrial membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:high-density lipoprotein particle assembly; P:locomotory behavior; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of cholesterol efflux; P:positive regulation of protein localization to plasma membrane; P:protein palmitoylation;|Q9ULC8 Q2TGE9 Q6ICL1 Q6ZNF5 Q7Z6L9,Palmitoyltransferase ZDHHC8 {ECO:0000305},Zinc finger DHHC domain-containing protein 8 {ECO:0000312|HGNC:HGNC:18474};Zinc finger protein 378;, PF01529;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0031966;GO:0016409;GO:0019706;GO:0034380;GO:0007626;GO:0018230;GO:0010875;GO:1903078;GO:0018345;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:mitochondrial membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:high-density lipoprotein particle assembly; P:locomotory behavior; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of cholesterol efflux; P:positive regulation of protein localization to plasma membrane; P:protein palmitoylation;|Q9ULC8 Q2TGE9 Q6ICL1 Q6ZNF5 Q7Z6L9,Palmitoyltransferase ZDHHC8 {ECO:0000305},Zinc finger DHHC domain-containing protein 8 {ECO:0000312|HGNC:HGNC:18474};Zinc finger protein 378;, PF01529;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0031966;GO:0016409;GO:0019706;GO:0034380;GO:0007626;GO:0018230;GO:0010875;GO:1903078;GO:0018345;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:mitochondrial membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:high-density lipoprotein particle assembly; P:locomotory behavior; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of cholesterol efflux; P:positive regulation of protein localization to plasma membrane; P:protein palmitoylation;|Q9ULC8 Q2TGE9 Q6ICL1 Q6ZNF5 Q7Z6L9,Palmitoyltransferase ZDHHC8 {ECO:0000305},Zinc finger DHHC domain-containing protein 8 {ECO:0000312|HGNC:HGNC:18474};Zinc finger protein 378;, PF01529;, GO:0005829;GO:0005794;GO:0000139;GO:0016021;GO:0031966;GO:0016409;GO:0019706;GO:0034380;GO:0007626;GO:0018230;GO:0010875;GO:1903078;GO:0018345;, C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:mitochondrial membrane;, F:palmitoyltransferase activity; F:protein-cysteine S-palmitoyltransferase activity;, P:high-density lipoprotein particle assembly; P:locomotory behavior; P:peptidyl-L-cysteine S-palmitoylation; P:positive regulation of cholesterol efflux; P:positive regulation of protein localization to plasma membrane; P:protein palmitoylation; scaffold198 indexed_genome mRNA 73200 77240 . - . ID=transcript_15650;Q9BZR6 D3DX28,Reticulon-4 receptor,Nogo receptor;Nogo-66 receptor;, PF13855;, GO:0031362;GO:0044295;GO:0009986;GO:0043198;GO:0005783;GO:0070062;GO:0005887;GO:0045121;GO:0043005;GO:0043025;GO:0043204;GO:0005886;GO:0035374;GO:1905573;GO:1905576;GO:0008201;GO:0038131;GO:0038023;GO:0007166;GO:0022038;GO:0030517;GO:0048681;GO:0050771;GO:0010977;GO:0023041;GO:0043547;GO:0035025;, C:anchored component of external side of plasma membrane; C:axonal growth cone; C:cell surface; C:dendritic shaft; C:endoplasmic reticulum; C:extracellular exosome; C:integral component of plasma membrane; C:membrane raft; C:neuron projection; C:neuronal cell body; C:perikaryon; C:plasma membrane;, F:chondroitin sulfate binding; F:ganglioside GM1 binding; F:ganglioside GT1b binding; F:heparin binding; F:neuregulin receptor activity; F:signaling receptor activity;, P:cell surface receptor signaling pathway; P:corpus callosum development; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of axonogenesis; P:negative regulation of neuron projection development; P:neuronal signal transduction; P:positive regulation of GTPase activity; P:positive regulation of Rho protein signal transduction; scaffold198 indexed_genome mRNA 115636 135788 . + . ID=transcript_15651;O43272 A6NF53 O14680 Q0P507 Q147W8 Q504W1 Q59FI8 Q6NV86 Q9UF13,Proline dehydrogenase 1, mitochondrial {ECO:0000305},Proline oxidase;Proline oxidase 2;p53-induced gene 6 protein;, PF01619;, GO:0043231;GO:0005743;GO:0005759;GO:0005739;GO:0005654;GO:0071949;GO:0004657;GO:0019470;GO:0008631;GO:0010942;GO:0006562;GO:0010133;GO:0006560;, C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:FAD binding; F:proline dehydrogenase activity;, P:4-hydroxyproline catabolic process; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:positive regulation of cell death; P:proline catabolic process; P:proline catabolic process to glutamate; P:proline metabolic process;|O43272 A6NF53 O14680 Q0P507 Q147W8 Q504W1 Q59FI8 Q6NV86 Q9UF13,Proline dehydrogenase 1, mitochondrial {ECO:0000305},Proline oxidase;Proline oxidase 2;p53-induced gene 6 protein;, PF01619;, GO:0043231;GO:0005743;GO:0005759;GO:0005739;GO:0005654;GO:0071949;GO:0004657;GO:0019470;GO:0008631;GO:0010942;GO:0006562;GO:0010133;GO:0006560;, C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:FAD binding; F:proline dehydrogenase activity;, P:4-hydroxyproline catabolic process; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:positive regulation of cell death; P:proline catabolic process; P:proline catabolic process to glutamate; P:proline metabolic process;|O43272 A6NF53 O14680 Q0P507 Q147W8 Q504W1 Q59FI8 Q6NV86 Q9UF13,Proline dehydrogenase 1, mitochondrial {ECO:0000305},Proline oxidase;Proline oxidase 2;p53-induced gene 6 protein;, PF01619;, GO:0043231;GO:0005743;GO:0005759;GO:0005739;GO:0005654;GO:0071949;GO:0004657;GO:0019470;GO:0008631;GO:0010942;GO:0006562;GO:0010133;GO:0006560;, C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:FAD binding; F:proline dehydrogenase activity;, P:4-hydroxyproline catabolic process; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:positive regulation of cell death; P:proline catabolic process; P:proline catabolic process to glutamate; P:proline metabolic process;|O43272 A6NF53 O14680 Q0P507 Q147W8 Q504W1 Q59FI8 Q6NV86 Q9UF13,Proline dehydrogenase 1, mitochondrial {ECO:0000305},Proline oxidase;Proline oxidase 2;p53-induced gene 6 protein;, PF01619;, GO:0043231;GO:0005743;GO:0005759;GO:0005739;GO:0005654;GO:0071949;GO:0004657;GO:0019470;GO:0008631;GO:0010942;GO:0006562;GO:0010133;GO:0006560;, C:intracellular membrane-bounded organelle; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:FAD binding; F:proline dehydrogenase activity;, P:4-hydroxyproline catabolic process; P:intrinsic apoptotic signaling pathway in response to oxidative stress; P:positive regulation of cell death; P:proline catabolic process; P:proline catabolic process to glutamate; P:proline metabolic process;|Q14129 B2RCH5 D3DX15 G5E9J8 Q9BY28,Protein DGCR6,DiGeorge syndrome critical region 6;, PF07324;, GO:0031012;GO:0005634;GO:0009887;GO:0007155;, C:extracellular matrix; C:nucleus;, , P:animal organ morphogenesis; P:cell adhesion;|Q14129 B2RCH5 D3DX15 G5E9J8 Q9BY28,Protein DGCR6,DiGeorge syndrome critical region 6;, PF07324;, GO:0031012;GO:0005634;GO:0009887;GO:0007155;, C:extracellular matrix; C:nucleus;, , P:animal organ morphogenesis; P:cell adhesion; scaffold198 indexed_genome mRNA 280126 306069 . + . ID=transcript_15652;Q9NRW4 B4DK56 Q59GW2 Q5VWR2 Q96AR1,Dual specificity protein phosphatase 22,JNK-stimulatory phosphatase-1;Low molecular weight dual specificity phosphatase 2;Mitogen-activated protein kinase phosphatase x;, , GO:0005737;GO:0005829;GO:0031941;GO:0061851;GO:0005634;GO:0005886;GO:0004726;GO:0106306;GO:0106307;GO:1990782;GO:0004725;GO:0008138;GO:0071364;GO:0030336;GO:0051895;GO:1903996;GO:0000122;GO:0035335;GO:0046330;GO:0042127;GO:0007179;, C:cytoplasm; C:cytosol; C:filamentous actin; C:leading edge of lamellipodium; C:nucleus; C:plasma membrane;, F:non-membrane spanning protein tyrosine phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cellular response to epidermal growth factor stimulus; P:negative regulation of cell migration; P:negative regulation of focal adhesion assembly; P:negative regulation of non-membrane spanning protein tyrosine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of JNK cascade; P:regulation of cell population proliferation; P:transforming growth factor beta receptor signaling pathway;|Q9NRW4 B4DK56 Q59GW2 Q5VWR2 Q96AR1,Dual specificity protein phosphatase 22,JNK-stimulatory phosphatase-1;Low molecular weight dual specificity phosphatase 2;Mitogen-activated protein kinase phosphatase x;, , GO:0005737;GO:0005829;GO:0031941;GO:0061851;GO:0005634;GO:0005886;GO:0004726;GO:0106306;GO:0106307;GO:1990782;GO:0004725;GO:0008138;GO:0071364;GO:0030336;GO:0051895;GO:1903996;GO:0000122;GO:0035335;GO:0046330;GO:0042127;GO:0007179;, C:cytoplasm; C:cytosol; C:filamentous actin; C:leading edge of lamellipodium; C:nucleus; C:plasma membrane;, F:non-membrane spanning protein tyrosine phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cellular response to epidermal growth factor stimulus; P:negative regulation of cell migration; P:negative regulation of focal adhesion assembly; P:negative regulation of non-membrane spanning protein tyrosine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of JNK cascade; P:regulation of cell population proliferation; P:transforming growth factor beta receptor signaling pathway; scaffold198 indexed_genome mRNA 309707 325700 . - . ID=transcript_15653;Q9NRW4 B4DK56 Q59GW2 Q5VWR2 Q96AR1,Dual specificity protein phosphatase 22,JNK-stimulatory phosphatase-1;Low molecular weight dual specificity phosphatase 2;Mitogen-activated protein kinase phosphatase x;, , GO:0005737;GO:0005829;GO:0031941;GO:0061851;GO:0005634;GO:0005886;GO:0004726;GO:0106306;GO:0106307;GO:1990782;GO:0004725;GO:0008138;GO:0071364;GO:0030336;GO:0051895;GO:1903996;GO:0000122;GO:0035335;GO:0046330;GO:0042127;GO:0007179;, C:cytoplasm; C:cytosol; C:filamentous actin; C:leading edge of lamellipodium; C:nucleus; C:plasma membrane;, F:non-membrane spanning protein tyrosine phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cellular response to epidermal growth factor stimulus; P:negative regulation of cell migration; P:negative regulation of focal adhesion assembly; P:negative regulation of non-membrane spanning protein tyrosine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of JNK cascade; P:regulation of cell population proliferation; P:transforming growth factor beta receptor signaling pathway;|Q9NRW4 B4DK56 Q59GW2 Q5VWR2 Q96AR1,Dual specificity protein phosphatase 22,JNK-stimulatory phosphatase-1;Low molecular weight dual specificity phosphatase 2;Mitogen-activated protein kinase phosphatase x;, , GO:0005737;GO:0005829;GO:0031941;GO:0061851;GO:0005634;GO:0005886;GO:0004726;GO:0106306;GO:0106307;GO:1990782;GO:0004725;GO:0008138;GO:0071364;GO:0030336;GO:0051895;GO:1903996;GO:0000122;GO:0035335;GO:0046330;GO:0042127;GO:0007179;, C:cytoplasm; C:cytosol; C:filamentous actin; C:leading edge of lamellipodium; C:nucleus; C:plasma membrane;, F:non-membrane spanning protein tyrosine phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:cellular response to epidermal growth factor stimulus; P:negative regulation of cell migration; P:negative regulation of focal adhesion assembly; P:negative regulation of non-membrane spanning protein tyrosine kinase activity; P:negative regulation of transcription by RNA polymerase II; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of JNK cascade; P:regulation of cell population proliferation; P:transforming growth factor beta receptor signaling pathway; scaffold198 indexed_genome mRNA 348899 366368 . + . ID=transcript_15654;Q15306 Q5VUI7 Q99660,Interferon regulatory factor 4,Lymphocyte-specific interferon regulatory factor;Multiple myeloma oncogene 1;NF-EM5;, PF00605;PF10401;, GO:0000785;GO:0005829;GO:0016020;GO:0005654;GO:0000786;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0003713;GO:0008134;GO:0019221;GO:0042832;GO:0043966;GO:0043967;GO:0002376;GO:0060333;GO:0043011;GO:0034122;GO:0120162;GO:0043388;GO:0032733;GO:0032736;GO:0032743;GO:0032753;GO:0045944;GO:0045893;GO:0045622;GO:0006357;GO:0042110;GO:0072540;GO:0060337;, C:chromatin; C:cytosol; C:membrane; C:nucleoplasm; C:nucleosome; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription coactivator activity; F:transcription factor binding;, P:cytokine-mediated signaling pathway; P:defense response to protozoan; P:histone H3 acetylation; P:histone H4 acetylation; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:myeloid dendritic cell differentiation; P:negative regulation of toll-like receptor signaling pathway; P:positive regulation of cold-induced thermogenesis; P:positive regulation of DNA binding; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-13 production; P:positive regulation of interleukin-2 production; P:positive regulation of interleukin-4 production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of T-helper cell differentiation; P:regulation of transcription by RNA polymerase II; P:T cell activation; P:T-helper 17 cell lineage commitment; P:type I interferon signaling pathway; scaffold198 indexed_genome mRNA 399840 498419 . - . ID=transcript_15655;Q96KP1 B2RBE6 Q5JPC8 Q96AN6 Q9NUZ8 Q9UJM7,Exocyst complex component 2,Exocyst complex component Sec5;, PF15469;PF01833;, GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0005886;GO:0019901;GO:0047485;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:2000535;, C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:plasma membrane;, F:protein kinase binding; F:protein N-terminus binding; F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:regulation of entry of bacterium into host cell;|Q96KP1 B2RBE6 Q5JPC8 Q96AN6 Q9NUZ8 Q9UJM7,Exocyst complex component 2,Exocyst complex component Sec5;, PF15469;PF01833;, GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0005886;GO:0019901;GO:0047485;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:2000535;, C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:plasma membrane;, F:protein kinase binding; F:protein N-terminus binding; F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:regulation of entry of bacterium into host cell;|Q96KP1 B2RBE6 Q5JPC8 Q96AN6 Q9NUZ8 Q9UJM7,Exocyst complex component 2,Exocyst complex component Sec5;, PF15469;PF01833;, GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0005886;GO:0019901;GO:0047485;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:2000535;, C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:plasma membrane;, F:protein kinase binding; F:protein N-terminus binding; F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:regulation of entry of bacterium into host cell;|Q96KP1 B2RBE6 Q5JPC8 Q96AN6 Q9NUZ8 Q9UJM7,Exocyst complex component 2,Exocyst complex component Sec5;, PF15469;PF01833;, GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0005886;GO:0019901;GO:0047485;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:2000535;, C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:plasma membrane;, F:protein kinase binding; F:protein N-terminus binding; F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:regulation of entry of bacterium into host cell;|Q96KP1 B2RBE6 Q5JPC8 Q96AN6 Q9NUZ8 Q9UJM7,Exocyst complex component 2,Exocyst complex component Sec5;, PF15469;PF01833;, GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0005886;GO:0019901;GO:0047485;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:2000535;, C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:plasma membrane;, F:protein kinase binding; F:protein N-terminus binding; F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:regulation of entry of bacterium into host cell;|Q96KP1 B2RBE6 Q5JPC8 Q96AN6 Q9NUZ8 Q9UJM7,Exocyst complex component 2,Exocyst complex component Sec5;, PF15469;PF01833;, GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0005886;GO:0019901;GO:0047485;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:2000535;, C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:plasma membrane;, F:protein kinase binding; F:protein N-terminus binding; F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:regulation of entry of bacterium into host cell;|Q96KP1 B2RBE6 Q5JPC8 Q96AN6 Q9NUZ8 Q9UJM7,Exocyst complex component 2,Exocyst complex component Sec5;, PF15469;PF01833;, GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0005886;GO:0019901;GO:0047485;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:2000535;, C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:plasma membrane;, F:protein kinase binding; F:protein N-terminus binding; F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:regulation of entry of bacterium into host cell;|Q96KP1 B2RBE6 Q5JPC8 Q96AN6 Q9NUZ8 Q9UJM7,Exocyst complex component 2,Exocyst complex component Sec5;, PF15469;PF01833;, GO:0005829;GO:0000145;GO:0090543;GO:0016020;GO:0005886;GO:0019901;GO:0047485;GO:0031267;GO:0060271;GO:0006887;GO:0006893;GO:0015031;GO:2000535;, C:cytosol; C:exocyst; C:Flemming body; C:membrane; C:plasma membrane;, F:protein kinase binding; F:protein N-terminus binding; F:small GTPase binding;, P:cilium assembly; P:exocytosis; P:Golgi to plasma membrane transport; P:protein transport; P:regulation of entry of bacterium into host cell; scaffold199 indexed_genome mRNA 475876 592584 . + . ID=transcript_15656;Q9UL68 A7E2C7 B2RP54 Q6IQ17 Q9UPP6,Myelin transcription factor 1-like protein {ECO:0000303|Ref.1},, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0007399;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:regulation of transcription by RNA polymerase II;|Q9UL68 A7E2C7 B2RP54 Q6IQ17 Q9UPP6,Myelin transcription factor 1-like protein {ECO:0000303|Ref.1},, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0007399;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:regulation of transcription by RNA polymerase II; scaffold199 indexed_genome mRNA 651649 688386 . + . ID=transcript_15657;Q92626 A8QM65 D6W4Y0 Q4KMG2,Peroxidasin homolog,Melanoma-associated antigen MG50;Vascular peroxidase 1;p53-responsive gene 2 protein;, PF03098;PF07679;PF13855;PF00093;, GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0019806;GO:0005201;GO:0020037;GO:0005152;GO:0046872;GO:0004601;GO:0070831;GO:0030199;GO:0030198;GO:0042744;GO:0006955;GO:0006979;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:bromide peroxidase activity; F:extracellular matrix structural constituent; F:heme binding; F:interleukin-1 receptor antagonist activity; F:metal ion binding; F:peroxidase activity;, P:basement membrane assembly; P:collagen fibril organization; P:extracellular matrix organization; P:hydrogen peroxide catabolic process; P:immune response; P:response to oxidative stress;|Q92626 A8QM65 D6W4Y0 Q4KMG2,Peroxidasin homolog,Melanoma-associated antigen MG50;Vascular peroxidase 1;p53-responsive gene 2 protein;, PF03098;PF07679;PF13855;PF00093;, GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0019806;GO:0005201;GO:0020037;GO:0005152;GO:0046872;GO:0004601;GO:0070831;GO:0030199;GO:0030198;GO:0042744;GO:0006955;GO:0006979;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:bromide peroxidase activity; F:extracellular matrix structural constituent; F:heme binding; F:interleukin-1 receptor antagonist activity; F:metal ion binding; F:peroxidase activity;, P:basement membrane assembly; P:collagen fibril organization; P:extracellular matrix organization; P:hydrogen peroxide catabolic process; P:immune response; P:response to oxidative stress;|Q92626 A8QM65 D6W4Y0 Q4KMG2,Peroxidasin homolog,Melanoma-associated antigen MG50;Vascular peroxidase 1;p53-responsive gene 2 protein;, PF03098;PF07679;PF13855;PF00093;, GO:0062023;GO:0005783;GO:0070062;GO:0005576;GO:0005615;GO:0019806;GO:0005201;GO:0020037;GO:0005152;GO:0046872;GO:0004601;GO:0070831;GO:0030199;GO:0030198;GO:0042744;GO:0006955;GO:0006979;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular exosome; C:extracellular region; C:extracellular space;, F:bromide peroxidase activity; F:extracellular matrix structural constituent; F:heme binding; F:interleukin-1 receptor antagonist activity; F:metal ion binding; F:peroxidase activity;, P:basement membrane assembly; P:collagen fibril organization; P:extracellular matrix organization; P:hydrogen peroxide catabolic process; P:immune response; P:response to oxidative stress; scaffold199 indexed_genome mRNA 752608 794456 . - . ID=transcript_15658;Q9NY99 Q05AH5,Gamma-2-syntrophin,Syntrophin-5;, PF00595;, GO:0005737;GO:0005856;GO:0016010;GO:0005654;GO:0005886;GO:0042383;GO:0016013;GO:0003779;GO:0097109;GO:0030165;GO:0005198;GO:0007417;, C:cytoplasm; C:cytoskeleton; C:dystrophin-associated glycoprotein complex; C:nucleoplasm; C:plasma membrane; C:sarcolemma; C:syntrophin complex;, F:actin binding; F:neuroligin family protein binding; F:PDZ domain binding; F:structural molecule activity;, P:central nervous system development; scaffold200 indexed_genome mRNA 15322 47593 . - . ID=transcript_15659;Q9BYP7 B1AKG2 Q5JRC1 Q6JP76 Q8TCX6 Q9HCK6,Serine/threonine-protein kinase WNK3 {ECO:0000305},Protein kinase lysine-deficient 3 {ECO:0000312|HGNC:HGNC:14543};Protein kinase with no lysine 3 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005912;GO:0005923;GO:0005737;GO:0005829;GO:0005524;GO:0019869;GO:0019870;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006884;GO:0035556;GO:0050801;GO:0035633;GO:0043066;GO:0010766;GO:0007231;GO:0018107;GO:0051928;GO:0032414;GO:0010800;GO:1903288;GO:1903078;GO:2000651;GO:0010765;GO:0046777;GO:0072659;GO:0006468;GO:0090279;GO:1904062;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytosol;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell volume homeostasis; P:intracellular signal transduction; P:ion homeostasis; P:maintenance of blood-brain barrier; P:negative regulation of apoptotic process; P:negative regulation of sodium ion transport; P:osmosensory signaling pathway; P:peptidyl-threonine phosphorylation; P:positive regulation of calcium ion transport; P:positive regulation of ion transmembrane transporter activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of protein localization to plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of calcium ion import; P:regulation of cation transmembrane transport; scaffold200 indexed_genome mRNA 48347 58059 . - . ID=transcript_15660;Q9BYP7 B1AKG2 Q5JRC1 Q6JP76 Q8TCX6 Q9HCK6,Serine/threonine-protein kinase WNK3 {ECO:0000305},Protein kinase lysine-deficient 3 {ECO:0000312|HGNC:HGNC:14543};Protein kinase with no lysine 3 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005912;GO:0005923;GO:0005737;GO:0005829;GO:0005524;GO:0019869;GO:0019870;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006884;GO:0035556;GO:0050801;GO:0035633;GO:0043066;GO:0010766;GO:0007231;GO:0018107;GO:0051928;GO:0032414;GO:0010800;GO:1903288;GO:1903078;GO:2000651;GO:0010765;GO:0046777;GO:0072659;GO:0006468;GO:0090279;GO:1904062;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytosol;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell volume homeostasis; P:intracellular signal transduction; P:ion homeostasis; P:maintenance of blood-brain barrier; P:negative regulation of apoptotic process; P:negative regulation of sodium ion transport; P:osmosensory signaling pathway; P:peptidyl-threonine phosphorylation; P:positive regulation of calcium ion transport; P:positive regulation of ion transmembrane transporter activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of protein localization to plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of calcium ion import; P:regulation of cation transmembrane transport; scaffold200 indexed_genome mRNA 61541 131998 . - . ID=transcript_15661;Q9BYP7 B1AKG2 Q5JRC1 Q6JP76 Q8TCX6 Q9HCK6,Serine/threonine-protein kinase WNK3 {ECO:0000305},Protein kinase lysine-deficient 3 {ECO:0000312|HGNC:HGNC:14543};Protein kinase with no lysine 3 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005912;GO:0005923;GO:0005737;GO:0005829;GO:0005524;GO:0019869;GO:0019870;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006884;GO:0035556;GO:0050801;GO:0035633;GO:0043066;GO:0010766;GO:0007231;GO:0018107;GO:0051928;GO:0032414;GO:0010800;GO:1903288;GO:1903078;GO:2000651;GO:0010765;GO:0046777;GO:0072659;GO:0006468;GO:0090279;GO:1904062;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytosol;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell volume homeostasis; P:intracellular signal transduction; P:ion homeostasis; P:maintenance of blood-brain barrier; P:negative regulation of apoptotic process; P:negative regulation of sodium ion transport; P:osmosensory signaling pathway; P:peptidyl-threonine phosphorylation; P:positive regulation of calcium ion transport; P:positive regulation of ion transmembrane transporter activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of protein localization to plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of calcium ion import; P:regulation of cation transmembrane transport;|Q9BYP7 B1AKG2 Q5JRC1 Q6JP76 Q8TCX6 Q9HCK6,Serine/threonine-protein kinase WNK3 {ECO:0000305},Protein kinase lysine-deficient 3 {ECO:0000312|HGNC:HGNC:14543};Protein kinase with no lysine 3 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005912;GO:0005923;GO:0005737;GO:0005829;GO:0005524;GO:0019869;GO:0019870;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006884;GO:0035556;GO:0050801;GO:0035633;GO:0043066;GO:0010766;GO:0007231;GO:0018107;GO:0051928;GO:0032414;GO:0010800;GO:1903288;GO:1903078;GO:2000651;GO:0010765;GO:0046777;GO:0072659;GO:0006468;GO:0090279;GO:1904062;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytosol;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell volume homeostasis; P:intracellular signal transduction; P:ion homeostasis; P:maintenance of blood-brain barrier; P:negative regulation of apoptotic process; P:negative regulation of sodium ion transport; P:osmosensory signaling pathway; P:peptidyl-threonine phosphorylation; P:positive regulation of calcium ion transport; P:positive regulation of ion transmembrane transporter activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of protein localization to plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of calcium ion import; P:regulation of cation transmembrane transport; scaffold200 indexed_genome mRNA 132025 159141 . - . ID=transcript_15662;Q9BYP7 B1AKG2 Q5JRC1 Q6JP76 Q8TCX6 Q9HCK6,Serine/threonine-protein kinase WNK3 {ECO:0000305},Protein kinase lysine-deficient 3 {ECO:0000312|HGNC:HGNC:14543};Protein kinase with no lysine 3 {ECO:0000303|PubMed:11571656};, PF12202;PF00069;, GO:0005912;GO:0005923;GO:0005737;GO:0005829;GO:0005524;GO:0019869;GO:0019870;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0006884;GO:0035556;GO:0050801;GO:0035633;GO:0043066;GO:0010766;GO:0007231;GO:0018107;GO:0051928;GO:0032414;GO:0010800;GO:1903288;GO:1903078;GO:2000651;GO:0010765;GO:0046777;GO:0072659;GO:0006468;GO:0090279;GO:1904062;, C:adherens junction; C:bicellular tight junction; C:cytoplasm; C:cytosol;, F:ATP binding; F:chloride channel inhibitor activity; F:potassium channel inhibitor activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell volume homeostasis; P:intracellular signal transduction; P:ion homeostasis; P:maintenance of blood-brain barrier; P:negative regulation of apoptotic process; P:negative regulation of sodium ion transport; P:osmosensory signaling pathway; P:peptidyl-threonine phosphorylation; P:positive regulation of calcium ion transport; P:positive regulation of ion transmembrane transporter activity; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of potassium ion import across plasma membrane; P:positive regulation of protein localization to plasma membrane; P:positive regulation of sodium ion transmembrane transporter activity; P:positive regulation of sodium ion transport; P:protein autophosphorylation; P:protein localization to plasma membrane; P:protein phosphorylation; P:regulation of calcium ion import; P:regulation of cation transmembrane transport; scaffold200 indexed_genome mRNA 259554 272254 . + . ID=transcript_15663;Q969E8,Pre-rRNA-processing protein TSR2 homolog,, PF10273;, GO:0000462;, , , P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);|P98174 Q5H999 Q8N4D9,FYVE, RhoGEF and PH domain-containing protein 1,Faciogenital dysplasia 1 protein;Rho/Rac guanine nucleotide exchange factor FGD1;Zinc finger FYVE domain-containing protein 3;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0009887;GO:0007010;GO:0046847;GO:0007186;GO:0007275;GO:0043065;GO:0008360;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:animal organ morphogenesis; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold200 indexed_genome mRNA 272313 278617 . - . ID=transcript_15664;P98174 Q5H999 Q8N4D9,FYVE, RhoGEF and PH domain-containing protein 1,Faciogenital dysplasia 1 protein;Rho/Rac guanine nucleotide exchange factor FGD1;Zinc finger FYVE domain-containing protein 3;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0009887;GO:0007010;GO:0046847;GO:0007186;GO:0007275;GO:0043065;GO:0008360;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:animal organ morphogenesis; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold200 indexed_genome mRNA 278625 304605 . - . ID=transcript_15665;P98174 Q5H999 Q8N4D9,FYVE, RhoGEF and PH domain-containing protein 1,Faciogenital dysplasia 1 protein;Rho/Rac guanine nucleotide exchange factor FGD1;Zinc finger FYVE domain-containing protein 3;, PF01363;PF00169;PF00621;, GO:0005737;GO:0005856;GO:0005829;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0009887;GO:0007010;GO:0046847;GO:0007186;GO:0007275;GO:0043065;GO:0008360;GO:0043087;GO:0051056;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:Golgi apparatus; C:lamellipodium; C:ruffle;, F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:animal organ morphogenesis; P:cytoskeleton organization; P:filopodium assembly; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:positive regulation of apoptotic process; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold200 indexed_genome mRNA 330541 360309 . + . ID=transcript_15666;Q9NVN8,Guanine nucleotide-binding protein-like 3-like protein,, PF01926;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005697;GO:0005525;GO:0003723;GO:0032091;GO:0033234;GO:0031397;GO:0032211;GO:1904816;GO:0031334;GO:0031647;GO:0042254;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm; C:telomerase holoenzyme complex;, F:GTP binding; F:RNA binding;, P:negative regulation of protein binding; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of protein localization to chromosome, telomeric region; P:positive regulation of protein-containing complex assembly; P:regulation of protein stability; P:ribosome biogenesis;|Q9NVN8,Guanine nucleotide-binding protein-like 3-like protein,, PF01926;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005697;GO:0005525;GO:0003723;GO:0032091;GO:0033234;GO:0031397;GO:0032211;GO:1904816;GO:0031334;GO:0031647;GO:0042254;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm; C:telomerase holoenzyme complex;, F:GTP binding; F:RNA binding;, P:negative regulation of protein binding; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of protein localization to chromosome, telomeric region; P:positive regulation of protein-containing complex assembly; P:regulation of protein stability; P:ribosome biogenesis;|Q9NVN8,Guanine nucleotide-binding protein-like 3-like protein,, PF01926;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005697;GO:0005525;GO:0003723;GO:0032091;GO:0033234;GO:0031397;GO:0032211;GO:1904816;GO:0031334;GO:0031647;GO:0042254;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm; C:telomerase holoenzyme complex;, F:GTP binding; F:RNA binding;, P:negative regulation of protein binding; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of protein localization to chromosome, telomeric region; P:positive regulation of protein-containing complex assembly; P:regulation of protein stability; P:ribosome biogenesis;|Q9NVN8,Guanine nucleotide-binding protein-like 3-like protein,, PF01926;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005697;GO:0005525;GO:0003723;GO:0032091;GO:0033234;GO:0031397;GO:0032211;GO:1904816;GO:0031334;GO:0031647;GO:0042254;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm; C:telomerase holoenzyme complex;, F:GTP binding; F:RNA binding;, P:negative regulation of protein binding; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of protein localization to chromosome, telomeric region; P:positive regulation of protein-containing complex assembly; P:regulation of protein stability; P:ribosome biogenesis;|Q9NVN8,Guanine nucleotide-binding protein-like 3-like protein,, PF01926;, GO:0005829;GO:0016020;GO:0005730;GO:0005654;GO:0005697;GO:0005525;GO:0003723;GO:0032091;GO:0033234;GO:0031397;GO:0032211;GO:1904816;GO:0031334;GO:0031647;GO:0042254;, C:cytosol; C:membrane; C:nucleolus; C:nucleoplasm; C:telomerase holoenzyme complex;, F:GTP binding; F:RNA binding;, P:negative regulation of protein binding; P:negative regulation of protein sumoylation; P:negative regulation of protein ubiquitination; P:negative regulation of telomere maintenance via telomerase; P:positive regulation of protein localization to chromosome, telomeric region; P:positive regulation of protein-containing complex assembly; P:regulation of protein stability; P:ribosome biogenesis; scaffold200 indexed_genome mRNA 577912 586509 . - . ID=transcript_15667;Q9UNF1 A6NMX0 O76058 Q5BJF3 Q8NAL6 Q9H218 Q9P0U9 Q9UM52,Melanoma-associated antigen D2,11B6;Breast cancer-associated gene 1 protein;Hepatocellular carcinoma-associated protein JCL-1;MAGE-D2 antigen;, PF01454;, GO:0005829;GO:0005576;GO:0016020;GO:0005730;GO:0005654;GO:0031093;GO:0007565;GO:0002576;GO:0070294;, C:cytosol; C:extracellular region; C:membrane; C:nucleolus; C:nucleoplasm; C:platelet alpha granule lumen;, , P:female pregnancy; P:platelet degranulation; P:renal sodium ion absorption;|Q9UNF1 A6NMX0 O76058 Q5BJF3 Q8NAL6 Q9H218 Q9P0U9 Q9UM52,Melanoma-associated antigen D2,11B6;Breast cancer-associated gene 1 protein;Hepatocellular carcinoma-associated protein JCL-1;MAGE-D2 antigen;, PF01454;, GO:0005829;GO:0005576;GO:0016020;GO:0005730;GO:0005654;GO:0031093;GO:0007565;GO:0002576;GO:0070294;, C:cytosol; C:extracellular region; C:membrane; C:nucleolus; C:nucleoplasm; C:platelet alpha granule lumen;, , P:female pregnancy; P:platelet degranulation; P:renal sodium ion absorption; scaffold200 indexed_genome mRNA 593658 673482 . - . ID=transcript_15668;P16118 B2RA88 B4DUN5 Q5JXS5 Q99951,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1,6PF-2-K/Fru-2,6-P2ase liver isozyme;, PF01591;PF00300;, GO:0043540;GO:0005829;GO:0003873;GO:0005524;GO:0004331;GO:0070095;GO:0042802;GO:0019900;GO:0031100;GO:0006003;GO:0006000;GO:0006094;GO:0006096;GO:0045820;GO:0033133;GO:0045821;GO:0051591;GO:0033762;GO:0051384;GO:0032868;GO:0042594;, C:6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex; C:cytosol;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding;, P:animal organ regeneration; P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:negative regulation of glycolytic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:response to cAMP; P:response to glucagon; P:response to glucocorticoid; P:response to insulin; P:response to starvation;|P16118 B2RA88 B4DUN5 Q5JXS5 Q99951,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1,6PF-2-K/Fru-2,6-P2ase liver isozyme;, PF01591;PF00300;, GO:0043540;GO:0005829;GO:0003873;GO:0005524;GO:0004331;GO:0070095;GO:0042802;GO:0019900;GO:0031100;GO:0006003;GO:0006000;GO:0006094;GO:0006096;GO:0045820;GO:0033133;GO:0045821;GO:0051591;GO:0033762;GO:0051384;GO:0032868;GO:0042594;, C:6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex; C:cytosol;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding;, P:animal organ regeneration; P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:negative regulation of glycolytic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:response to cAMP; P:response to glucagon; P:response to glucocorticoid; P:response to insulin; P:response to starvation;|P16118 B2RA88 B4DUN5 Q5JXS5 Q99951,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1,6PF-2-K/Fru-2,6-P2ase liver isozyme;, PF01591;PF00300;, GO:0043540;GO:0005829;GO:0003873;GO:0005524;GO:0004331;GO:0070095;GO:0042802;GO:0019900;GO:0031100;GO:0006003;GO:0006000;GO:0006094;GO:0006096;GO:0045820;GO:0033133;GO:0045821;GO:0051591;GO:0033762;GO:0051384;GO:0032868;GO:0042594;, C:6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex; C:cytosol;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding;, P:animal organ regeneration; P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:negative regulation of glycolytic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:response to cAMP; P:response to glucagon; P:response to glucocorticoid; P:response to insulin; P:response to starvation;|P16118 B2RA88 B4DUN5 Q5JXS5 Q99951,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1,6PF-2-K/Fru-2,6-P2ase liver isozyme;, PF01591;PF00300;, GO:0043540;GO:0005829;GO:0003873;GO:0005524;GO:0004331;GO:0070095;GO:0042802;GO:0019900;GO:0031100;GO:0006003;GO:0006000;GO:0006094;GO:0006096;GO:0045820;GO:0033133;GO:0045821;GO:0051591;GO:0033762;GO:0051384;GO:0032868;GO:0042594;, C:6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex; C:cytosol;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding;, P:animal organ regeneration; P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:negative regulation of glycolytic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:response to cAMP; P:response to glucagon; P:response to glucocorticoid; P:response to insulin; P:response to starvation;|P16118 B2RA88 B4DUN5 Q5JXS5 Q99951,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1,6PF-2-K/Fru-2,6-P2ase liver isozyme;, PF01591;PF00300;, GO:0043540;GO:0005829;GO:0003873;GO:0005524;GO:0004331;GO:0070095;GO:0042802;GO:0019900;GO:0031100;GO:0006003;GO:0006000;GO:0006094;GO:0006096;GO:0045820;GO:0033133;GO:0045821;GO:0051591;GO:0033762;GO:0051384;GO:0032868;GO:0042594;, C:6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex; C:cytosol;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding;, P:animal organ regeneration; P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:negative regulation of glycolytic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:response to cAMP; P:response to glucagon; P:response to glucocorticoid; P:response to insulin; P:response to starvation; scaffold200 indexed_genome mRNA 674425 750104 . - . ID=transcript_15669;P16118 B2RA88 B4DUN5 Q5JXS5 Q99951,6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1,6PF-2-K/Fru-2,6-P2ase liver isozyme;, PF01591;PF00300;, GO:0043540;GO:0005829;GO:0003873;GO:0005524;GO:0004331;GO:0070095;GO:0042802;GO:0019900;GO:0031100;GO:0006003;GO:0006000;GO:0006094;GO:0006096;GO:0045820;GO:0033133;GO:0045821;GO:0051591;GO:0033762;GO:0051384;GO:0032868;GO:0042594;, C:6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex; C:cytosol;, F:6-phosphofructo-2-kinase activity; F:ATP binding; F:fructose-2,6-bisphosphate 2-phosphatase activity; F:fructose-6-phosphate binding; F:identical protein binding; F:kinase binding;, P:animal organ regeneration; P:fructose 2,6-bisphosphate metabolic process; P:fructose metabolic process; P:gluconeogenesis; P:glycolytic process; P:negative regulation of glycolytic process; P:positive regulation of glucokinase activity; P:positive regulation of glycolytic process; P:response to cAMP; P:response to glucagon; P:response to glucocorticoid; P:response to insulin; P:response to starvation; scaffold200 indexed_genome mRNA 754925 762579 . + . ID=transcript_15670;Q9UBZ4 Q9Y5X7,DNA-(apurinic or apyrimidinic site) endonuclease 2,AP endonuclease XTH2;APEX nuclease 2;APEX nuclease-like 2;Apurinic-apyrimidinic endonuclease 2;, PF03372;PF06839;, GO:0001650;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0003906;GO:0008311;GO:0004519;GO:0004528;GO:0008270;GO:0006284;GO:0007049;GO:0006310;, C:fibrillar center; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA 3'-5' exodeoxyribonuclease activity; F:endonuclease activity; F:phosphodiesterase I activity; F:zinc ion binding;, P:base-excision repair; P:cell cycle; P:DNA recombination;|Q9UBZ4 Q9Y5X7,DNA-(apurinic or apyrimidinic site) endonuclease 2,AP endonuclease XTH2;APEX nuclease 2;APEX nuclease-like 2;Apurinic-apyrimidinic endonuclease 2;, PF03372;PF06839;, GO:0001650;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0003906;GO:0008311;GO:0004519;GO:0004528;GO:0008270;GO:0006284;GO:0007049;GO:0006310;, C:fibrillar center; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA 3'-5' exodeoxyribonuclease activity; F:endonuclease activity; F:phosphodiesterase I activity; F:zinc ion binding;, P:base-excision repair; P:cell cycle; P:DNA recombination;|Q9UBZ4 Q9Y5X7,DNA-(apurinic or apyrimidinic site) endonuclease 2,AP endonuclease XTH2;APEX nuclease 2;APEX nuclease-like 2;Apurinic-apyrimidinic endonuclease 2;, PF03372;PF06839;, GO:0001650;GO:0043231;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0003906;GO:0008311;GO:0004519;GO:0004528;GO:0008270;GO:0006284;GO:0007049;GO:0006310;, C:fibrillar center; C:intracellular membrane-bounded organelle; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA 3'-5' exodeoxyribonuclease activity; F:endonuclease activity; F:phosphodiesterase I activity; F:zinc ion binding;, P:base-excision repair; P:cell cycle; P:DNA recombination; scaffold200 indexed_genome mRNA 768239 779858 . - . ID=transcript_15671;P22557 A8K3F0 A8K6C4 Q13735 Q5JZF5 Q8N6H3,5-aminolevulinate synthase, erythroid-specific, mitochondrial,5-aminolevulinic acid synthase 2;Delta-ALA synthase 2;Delta-aminolevulinate synthase 2;, PF00155;PF09029;, GO:0005743;GO:0005759;GO:0005739;GO:0003870;GO:0030170;GO:0006879;GO:0048821;GO:0030218;GO:0006783;GO:0042541;GO:0032364;GO:0006782;GO:0001666;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:5-aminolevulinate synthase activity; F:pyridoxal phosphate binding;, P:cellular iron ion homeostasis; P:erythrocyte development; P:erythrocyte differentiation; P:heme biosynthetic process; P:hemoglobin biosynthetic process; P:oxygen homeostasis; P:protoporphyrinogen IX biosynthetic process; P:response to hypoxia; scaffold200 indexed_genome mRNA 780416 790622 . - . ID=transcript_15672;P22557 A8K3F0 A8K6C4 Q13735 Q5JZF5 Q8N6H3,5-aminolevulinate synthase, erythroid-specific, mitochondrial,5-aminolevulinic acid synthase 2;Delta-ALA synthase 2;Delta-aminolevulinate synthase 2;, PF00155;PF09029;, GO:0005743;GO:0005759;GO:0005739;GO:0003870;GO:0030170;GO:0006879;GO:0048821;GO:0030218;GO:0006783;GO:0042541;GO:0032364;GO:0006782;GO:0001666;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;, F:5-aminolevulinate synthase activity; F:pyridoxal phosphate binding;, P:cellular iron ion homeostasis; P:erythrocyte development; P:erythrocyte differentiation; P:heme biosynthetic process; P:hemoglobin biosynthetic process; P:oxygen homeostasis; P:protoporphyrinogen IX biosynthetic process; P:response to hypoxia; scaffold201 indexed_genome mRNA 141713 167608 . + . ID=transcript_15673;P06858 B2R5T9 Q16282 Q16283 Q96FC4,Lipoprotein lipase,Phospholipase A1;, PF00151;PF01477;, GO:0009986;GO:0042627;GO:0005576;GO:0005615;GO:0005886;GO:0034361;GO:0052740;GO:0034185;GO:0005509;GO:0043395;GO:0008201;GO:0016298;GO:0004465;GO:0071813;GO:0052739;GO:0008970;GO:0004620;GO:0042803;GO:0043495;GO:0005102;GO:0017129;GO:0004806;GO:0071398;GO:0031670;GO:0042632;GO:0034371;GO:0006633;GO:0006631;GO:0016042;GO:0055096;GO:1900077;GO:0006644;GO:2000343;GO:0032722;GO:0010886;GO:0045600;GO:0050729;GO:0032731;GO:0032755;GO:0010884;GO:0010744;GO:0010890;GO:0032760;GO:0051004;GO:0009617;GO:0009409;GO:0042493;GO:0009749;GO:0001523;GO:0019432;GO:0019433;GO:0070328;GO:0006641;GO:0034372;, C:cell surface; C:chylomicron; C:extracellular region; C:extracellular space; C:plasma membrane; C:very-low-density lipoprotein particle;, F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; F:apolipoprotein binding; F:calcium ion binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:lipase activity; F:lipoprotein lipase activity; F:lipoprotein particle binding; F:phosphatidylserine 1-acylhydrolase activity; F:phospholipase A1 activity; F:phospholipase activity; F:protein homodimerization activity; F:protein-membrane adaptor activity; F:signaling receptor binding; F:triglyceride binding; F:triglyceride lipase activity;, P:cellular response to fatty acid; P:cellular response to nutrient; P:cholesterol homeostasis; P:chylomicron remodeling; P:fatty acid biosynthetic process; P:fatty acid metabolic process; P:lipid catabolic process; P:low-density lipoprotein particle mediated signaling; P:negative regulation of cellular response to insulin stimulus; P:phospholipid metabolic process; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; P:positive regulation of chemokine production; P:positive regulation of cholesterol storage; P:positive regulation of fat cell differentiation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of lipid storage; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of sequestering of triglyceride; P:positive regulation of tumor necrosis factor production; P:regulation of lipoprotein lipase activity; P:response to bacterium; P:response to cold; P:response to drug; P:response to glucose; P:retinoid metabolic process; P:triglyceride biosynthetic process; P:triglyceride catabolic process; P:triglyceride homeostasis; P:triglyceride metabolic process; P:very-low-density lipoprotein particle remodeling; scaffold201 indexed_genome mRNA 410282 435539 . + . ID=transcript_15674;P21281 B2R5Z3 D3DSQ5 Q14544 Q15859 Q96IR0,V-type proton ATPase subunit B, brain isoform,Endomembrane proton pump 58 kDa subunit;HO57;Vacuolar proton pump subunit B 2;, PF00006;PF02874;, GO:0016324;GO:0005829;GO:0012505;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0005902;GO:0005886;GO:0033180;GO:0001726;GO:0005524;GO:0016787;GO:0015078;GO:0046961;GO:0046034;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:microvillus; C:plasma membrane; C:proton-transporting V-type ATPase, V1 domain; C:ruffle;, F:ATP binding; F:hydrolase activity; F:proton transmembrane transporter activity; F:proton-transporting ATPase activity, rotational mechanism;, P:ATP metabolic process; P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P21281 B2R5Z3 D3DSQ5 Q14544 Q15859 Q96IR0,V-type proton ATPase subunit B, brain isoform,Endomembrane proton pump 58 kDa subunit;HO57;Vacuolar proton pump subunit B 2;, PF00006;PF02874;, GO:0016324;GO:0005829;GO:0012505;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0005902;GO:0005886;GO:0033180;GO:0001726;GO:0005524;GO:0016787;GO:0015078;GO:0046961;GO:0046034;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:microvillus; C:plasma membrane; C:proton-transporting V-type ATPase, V1 domain; C:ruffle;, F:ATP binding; F:hydrolase activity; F:proton transmembrane transporter activity; F:proton-transporting ATPase activity, rotational mechanism;, P:ATP metabolic process; P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P21281 B2R5Z3 D3DSQ5 Q14544 Q15859 Q96IR0,V-type proton ATPase subunit B, brain isoform,Endomembrane proton pump 58 kDa subunit;HO57;Vacuolar proton pump subunit B 2;, PF00006;PF02874;, GO:0016324;GO:0005829;GO:0012505;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0005902;GO:0005886;GO:0033180;GO:0001726;GO:0005524;GO:0016787;GO:0015078;GO:0046961;GO:0046034;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:microvillus; C:plasma membrane; C:proton-transporting V-type ATPase, V1 domain; C:ruffle;, F:ATP binding; F:hydrolase activity; F:proton transmembrane transporter activity; F:proton-transporting ATPase activity, rotational mechanism;, P:ATP metabolic process; P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P21281 B2R5Z3 D3DSQ5 Q14544 Q15859 Q96IR0,V-type proton ATPase subunit B, brain isoform,Endomembrane proton pump 58 kDa subunit;HO57;Vacuolar proton pump subunit B 2;, PF00006;PF02874;, GO:0016324;GO:0005829;GO:0012505;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0005902;GO:0005886;GO:0033180;GO:0001726;GO:0005524;GO:0016787;GO:0015078;GO:0046961;GO:0046034;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:microvillus; C:plasma membrane; C:proton-transporting V-type ATPase, V1 domain; C:ruffle;, F:ATP binding; F:hydrolase activity; F:proton transmembrane transporter activity; F:proton-transporting ATPase activity, rotational mechanism;, P:ATP metabolic process; P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P21281 B2R5Z3 D3DSQ5 Q14544 Q15859 Q96IR0,V-type proton ATPase subunit B, brain isoform,Endomembrane proton pump 58 kDa subunit;HO57;Vacuolar proton pump subunit B 2;, PF00006;PF02874;, GO:0016324;GO:0005829;GO:0012505;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0005902;GO:0005886;GO:0033180;GO:0001726;GO:0005524;GO:0016787;GO:0015078;GO:0046961;GO:0046034;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:microvillus; C:plasma membrane; C:proton-transporting V-type ATPase, V1 domain; C:ruffle;, F:ATP binding; F:hydrolase activity; F:proton transmembrane transporter activity; F:proton-transporting ATPase activity, rotational mechanism;, P:ATP metabolic process; P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P21281 B2R5Z3 D3DSQ5 Q14544 Q15859 Q96IR0,V-type proton ATPase subunit B, brain isoform,Endomembrane proton pump 58 kDa subunit;HO57;Vacuolar proton pump subunit B 2;, PF00006;PF02874;, GO:0016324;GO:0005829;GO:0012505;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0005902;GO:0005886;GO:0033180;GO:0001726;GO:0005524;GO:0016787;GO:0015078;GO:0046961;GO:0046034;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:microvillus; C:plasma membrane; C:proton-transporting V-type ATPase, V1 domain; C:ruffle;, F:ATP binding; F:hydrolase activity; F:proton transmembrane transporter activity; F:proton-transporting ATPase activity, rotational mechanism;, P:ATP metabolic process; P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport;|P21281 B2R5Z3 D3DSQ5 Q14544 Q15859 Q96IR0,V-type proton ATPase subunit B, brain isoform,Endomembrane proton pump 58 kDa subunit;HO57;Vacuolar proton pump subunit B 2;, PF00006;PF02874;, GO:0016324;GO:0005829;GO:0012505;GO:0070062;GO:0016021;GO:0043231;GO:0005765;GO:0042470;GO:0005902;GO:0005886;GO:0033180;GO:0001726;GO:0005524;GO:0016787;GO:0015078;GO:0046961;GO:0046034;GO:0034198;GO:0008286;GO:0034220;GO:0090383;GO:1902600;GO:0016241;GO:0033572;, C:apical plasma membrane; C:cytosol; C:endomembrane system; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:melanosome; C:microvillus; C:plasma membrane; C:proton-transporting V-type ATPase, V1 domain; C:ruffle;, F:ATP binding; F:hydrolase activity; F:proton transmembrane transporter activity; F:proton-transporting ATPase activity, rotational mechanism;, P:ATP metabolic process; P:cellular response to amino acid starvation; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:phagosome acidification; P:proton transmembrane transport; P:regulation of macroautophagy; P:transferrin transport; scaffold201 indexed_genome mRNA 479482 485763 . - . ID=transcript_15675;Q9Y250 D3DSQ6 Q9Y5V7 Q9Y5V8 Q9Y5V9 Q9Y5W0 Q9Y5W1 Q9Y5W2,Leucine zipper putative tumor suppressor 1,F37/esophageal cancer-related gene-coding leucine-zipper motif;Fez1;, , GO:0016324;GO:0044297;GO:0005737;GO:0043198;GO:0043197;GO:0014069;GO:0045211;GO:0008017;GO:0044772;GO:0016242;GO:0048814;GO:0048167;, C:apical plasma membrane; C:cell body; C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:postsynaptic density; C:postsynaptic membrane;, F:microtubule binding;, P:mitotic cell cycle phase transition; P:negative regulation of macroautophagy; P:regulation of dendrite morphogenesis; P:regulation of synaptic plasticity;|Q9Y250 D3DSQ6 Q9Y5V7 Q9Y5V8 Q9Y5V9 Q9Y5W0 Q9Y5W1 Q9Y5W2,Leucine zipper putative tumor suppressor 1,F37/esophageal cancer-related gene-coding leucine-zipper motif;Fez1;, , GO:0016324;GO:0044297;GO:0005737;GO:0043198;GO:0043197;GO:0014069;GO:0045211;GO:0008017;GO:0044772;GO:0016242;GO:0048814;GO:0048167;, C:apical plasma membrane; C:cell body; C:cytoplasm; C:dendritic shaft; C:dendritic spine; C:postsynaptic density; C:postsynaptic membrane;, F:microtubule binding;, P:mitotic cell cycle phase transition; P:negative regulation of macroautophagy; P:regulation of dendrite morphogenesis; P:regulation of synaptic plasticity; scaffold202 indexed_genome mRNA 217366 218238 . + . ID=transcript_15676;P56524 E9PGB9 F5GX36 Q86YH7 Q9UND6,Histone deacetylase 4,, PF12203;PF00850;, GO:0031672;GO:0042641;GO:0005737;GO:0005829;GO:0000118;GO:0031594;GO:0016607;GO:0005654;GO:0005634;GO:0017053;GO:0030018;GO:0033613;GO:0004407;GO:0042826;GO:0042802;GO:0032041;GO:0030955;GO:1990841;GO:0033558;GO:0019901;GO:0070491;GO:0000978;GO:0001085;GO:0019789;GO:0003714;GO:0008134;GO:0008270;GO:0042113;GO:0030183;GO:0014898;GO:0071260;GO:0071374;GO:0071356;GO:0006338;GO:0016575;GO:0070932;GO:0070933;GO:0006954;GO:0008285;GO:0043433;GO:0045820;GO:0010832;GO:0045668;GO:1902894;GO:0000122;GO:0045892;GO:0007399;GO:0002076;GO:0034983;GO:0008284;GO:0051091;GO:0010592;GO:1902437;GO:0043525;GO:0033235;GO:1903428;GO:0014911;GO:0048661;GO:0045944;GO:0045893;GO:0006476;GO:0010882;GO:0040029;GO:0043393;GO:0048742;GO:0014894;GO:0042493;GO:0070555;GO:0001501;, C:A band; C:actomyosin; C:cytoplasm; C:cytosol; C:histone deacetylase complex; C:neuromuscular junction; C:nuclear speck; C:nucleoplasm; C:nucleus; C:transcription repressor complex; C:Z disc;, F:activating transcription factor binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:potassium ion binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:protein kinase binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:SUMO transferase activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:B cell activation; P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cellular response to mechanical stimulus; P:cellular response to parathyroid hormone stimulus; P:cellular response to tumor necrosis factor; P:chromatin remodeling; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:inflammatory response; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of glycolytic process; P:negative regulation of myotube differentiation; P:negative regulation of osteoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:osteoblast development; P:peptidyl-lysine deacetylation; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of lamellipodium assembly; P:positive regulation of male mating behavior; P:positive regulation of neuron apoptotic process; P:positive regulation of protein sumoylation; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deacetylation; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of gene expression, epigenetic; P:regulation of protein binding; P:regulation of skeletal muscle fiber development; P:response to denervation involved in regulation of muscle adaptation; P:response to drug; P:response to interleukin-1; P:skeletal system development; scaffold202 indexed_genome mRNA 239554 241817 . + . ID=transcript_15677;P56524 E9PGB9 F5GX36 Q86YH7 Q9UND6,Histone deacetylase 4,, PF12203;PF00850;, GO:0031672;GO:0042641;GO:0005737;GO:0005829;GO:0000118;GO:0031594;GO:0016607;GO:0005654;GO:0005634;GO:0017053;GO:0030018;GO:0033613;GO:0004407;GO:0042826;GO:0042802;GO:0032041;GO:0030955;GO:1990841;GO:0033558;GO:0019901;GO:0070491;GO:0000978;GO:0001085;GO:0019789;GO:0003714;GO:0008134;GO:0008270;GO:0042113;GO:0030183;GO:0014898;GO:0071260;GO:0071374;GO:0071356;GO:0006338;GO:0016575;GO:0070932;GO:0070933;GO:0006954;GO:0008285;GO:0043433;GO:0045820;GO:0010832;GO:0045668;GO:1902894;GO:0000122;GO:0045892;GO:0007399;GO:0002076;GO:0034983;GO:0008284;GO:0051091;GO:0010592;GO:1902437;GO:0043525;GO:0033235;GO:1903428;GO:0014911;GO:0048661;GO:0045944;GO:0045893;GO:0006476;GO:0010882;GO:0040029;GO:0043393;GO:0048742;GO:0014894;GO:0042493;GO:0070555;GO:0001501;, C:A band; C:actomyosin; C:cytoplasm; C:cytosol; C:histone deacetylase complex; C:neuromuscular junction; C:nuclear speck; C:nucleoplasm; C:nucleus; C:transcription repressor complex; C:Z disc;, F:activating transcription factor binding; F:histone deacetylase activity; F:histone deacetylase binding; F:identical protein binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:potassium ion binding; F:promoter-specific chromatin binding; F:protein deacetylase activity; F:protein kinase binding; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:SUMO transferase activity; F:transcription corepressor activity; F:transcription factor binding; F:zinc ion binding;, P:B cell activation; P:B cell differentiation; P:cardiac muscle hypertrophy in response to stress; P:cellular response to mechanical stimulus; P:cellular response to parathyroid hormone stimulus; P:cellular response to tumor necrosis factor; P:chromatin remodeling; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:inflammatory response; P:negative regulation of cell population proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of glycolytic process; P:negative regulation of myotube differentiation; P:negative regulation of osteoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:osteoblast development; P:peptidyl-lysine deacetylation; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of lamellipodium assembly; P:positive regulation of male mating behavior; P:positive regulation of neuron apoptotic process; P:positive regulation of protein sumoylation; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of smooth muscle cell migration; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deacetylation; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of gene expression, epigenetic; P:regulation of protein binding; P:regulation of skeletal muscle fiber development; P:response to denervation involved in regulation of muscle adaptation; P:response to drug; P:response to interleukin-1; P:skeletal system development; scaffold202 indexed_genome mRNA 653245 654934 . + . ID=transcript_15678;P51523 B2RAK5 D3DXJ1 Q3ZCV9 Q5D057 Q86XU8 Q9NNX7 Q9UC17 Q9UC18,Zinc finger protein 84,Zinc finger protein HPF2;, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold202 indexed_genome mRNA 661915 680852 . - . ID=transcript_15679;Q9Y576 A6NL50 Q4ZG29 Q9ULS4,Ankyrin repeat and SOCS box protein 1,, PF12796;PF07525;, GO:0005829;GO:0000151;GO:0035556;GO:0030539;GO:0001818;GO:0043687;GO:0016567;, C:cytosol; C:ubiquitin ligase complex;, , P:intracellular signal transduction; P:male genitalia development; P:negative regulation of cytokine production; P:post-translational protein modification; P:protein ubiquitination;|Q9Y576 A6NL50 Q4ZG29 Q9ULS4,Ankyrin repeat and SOCS box protein 1,, PF12796;PF07525;, GO:0005829;GO:0000151;GO:0035556;GO:0030539;GO:0001818;GO:0043687;GO:0016567;, C:cytosol; C:ubiquitin ligase complex;, , P:intracellular signal transduction; P:male genitalia development; P:negative regulation of cytokine production; P:post-translational protein modification; P:protein ubiquitination; scaffold202 indexed_genome mRNA 704031 705748 . - . ID=transcript_15680;Q8TDR0 Q6PCT1 Q7L8N9 Q9NRD6 Q9Y4Q1,TRAF3-interacting protein 1,Interleukin-13 receptor alpha 1-binding protein 1;Intraflagellar transport protein 54 homolog;Microtubule-interacting protein associated with TRAF3;, PF10243;PF17749;, GO:0005930;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0035869;GO:0005929;GO:0030992;GO:0008017;GO:0060271;GO:0042073;GO:0035735;GO:0001822;GO:0001738;GO:0050687;GO:0001933;GO:0031333;GO:0032480;GO:0070507;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:ciliary transition zone; C:cilium; C:intraciliary transport particle B;, F:microtubule binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:morphogenesis of a polarized epithelium; P:negative regulation of defense response to virus; P:negative regulation of protein phosphorylation; P:negative regulation of protein-containing complex assembly; P:negative regulation of type I interferon production; P:regulation of microtubule cytoskeleton organization;|Q8TDR0 Q6PCT1 Q7L8N9 Q9NRD6 Q9Y4Q1,TRAF3-interacting protein 1,Interleukin-13 receptor alpha 1-binding protein 1;Intraflagellar transport protein 54 homolog;Microtubule-interacting protein associated with TRAF3;, PF10243;PF17749;, GO:0005930;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0035869;GO:0005929;GO:0030992;GO:0008017;GO:0060271;GO:0042073;GO:0035735;GO:0001822;GO:0001738;GO:0050687;GO:0001933;GO:0031333;GO:0032480;GO:0070507;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:ciliary transition zone; C:cilium; C:intraciliary transport particle B;, F:microtubule binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:morphogenesis of a polarized epithelium; P:negative regulation of defense response to virus; P:negative regulation of protein phosphorylation; P:negative regulation of protein-containing complex assembly; P:negative regulation of type I interferon production; P:regulation of microtubule cytoskeleton organization; scaffold202 indexed_genome mRNA 738208 761734 . - . ID=transcript_15681;Q8TDR0 Q6PCT1 Q7L8N9 Q9NRD6 Q9Y4Q1,TRAF3-interacting protein 1,Interleukin-13 receptor alpha 1-binding protein 1;Intraflagellar transport protein 54 homolog;Microtubule-interacting protein associated with TRAF3;, PF10243;PF17749;, GO:0005930;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0035869;GO:0005929;GO:0030992;GO:0008017;GO:0060271;GO:0042073;GO:0035735;GO:0001822;GO:0001738;GO:0050687;GO:0001933;GO:0031333;GO:0032480;GO:0070507;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:ciliary transition zone; C:cilium; C:intraciliary transport particle B;, F:microtubule binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:morphogenesis of a polarized epithelium; P:negative regulation of defense response to virus; P:negative regulation of protein phosphorylation; P:negative regulation of protein-containing complex assembly; P:negative regulation of type I interferon production; P:regulation of microtubule cytoskeleton organization; scaffold202 indexed_genome mRNA 814830 844581 . + . ID=transcript_15682;O15055 A2I2P7 Q4ZG49 Q6DT41 Q9UQ45,Period circadian protein homolog 2,Circadian clock protein PERIOD 2;, PF08447;PF12114;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0003713;GO:0001222;GO:0000976;GO:0032922;GO:0097167;GO:0007623;GO:0043153;GO:0006631;GO:0006094;GO:0005978;GO:0070932;GO:0019249;GO:0042754;GO:0070345;GO:0031397;GO:0000122;GO:2000678;GO:0045892;GO:0120162;GO:0051726;GO:0042752;GO:0051946;GO:0050796;GO:0050767;GO:0019229;GO:0002931;GO:0050872;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:transcription coactivator activity; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian regulation of translation; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:fatty acid metabolic process; P:gluconeogenesis; P:glycogen biosynthetic process; P:histone H3 deacetylation; P:lactate biosynthetic process; P:negative regulation of circadian rhythm; P:negative regulation of fat cell proliferation; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:positive regulation of cold-induced thermogenesis; P:regulation of cell cycle; P:regulation of circadian rhythm; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of vasoconstriction; P:response to ischemia; P:white fat cell differentiation;|O15055 A2I2P7 Q4ZG49 Q6DT41 Q9UQ45,Period circadian protein homolog 2,Circadian clock protein PERIOD 2;, PF08447;PF12114;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0003713;GO:0001222;GO:0000976;GO:0032922;GO:0097167;GO:0007623;GO:0043153;GO:0006631;GO:0006094;GO:0005978;GO:0070932;GO:0019249;GO:0042754;GO:0070345;GO:0031397;GO:0000122;GO:2000678;GO:0045892;GO:0120162;GO:0051726;GO:0042752;GO:0051946;GO:0050796;GO:0050767;GO:0019229;GO:0002931;GO:0050872;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:transcription coactivator activity; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian regulation of translation; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:fatty acid metabolic process; P:gluconeogenesis; P:glycogen biosynthetic process; P:histone H3 deacetylation; P:lactate biosynthetic process; P:negative regulation of circadian rhythm; P:negative regulation of fat cell proliferation; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:positive regulation of cold-induced thermogenesis; P:regulation of cell cycle; P:regulation of circadian rhythm; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of vasoconstriction; P:response to ischemia; P:white fat cell differentiation;|O15055 A2I2P7 Q4ZG49 Q6DT41 Q9UQ45,Period circadian protein homolog 2,Circadian clock protein PERIOD 2;, PF08447;PF12114;, GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0003713;GO:0001222;GO:0000976;GO:0032922;GO:0097167;GO:0007623;GO:0043153;GO:0006631;GO:0006094;GO:0005978;GO:0070932;GO:0019249;GO:0042754;GO:0070345;GO:0031397;GO:0000122;GO:2000678;GO:0045892;GO:0120162;GO:0051726;GO:0042752;GO:0051946;GO:0050796;GO:0050767;GO:0019229;GO:0002931;GO:0050872;, C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;, F:transcription coactivator activity; F:transcription corepressor binding; F:transcription regulatory region sequence-specific DNA binding;, P:circadian regulation of gene expression; P:circadian regulation of translation; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:fatty acid metabolic process; P:gluconeogenesis; P:glycogen biosynthetic process; P:histone H3 deacetylation; P:lactate biosynthetic process; P:negative regulation of circadian rhythm; P:negative regulation of fat cell proliferation; P:negative regulation of protein ubiquitination; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:positive regulation of cold-induced thermogenesis; P:regulation of cell cycle; P:regulation of circadian rhythm; P:regulation of glutamate uptake involved in transmission of nerve impulse; P:regulation of insulin secretion; P:regulation of neurogenesis; P:regulation of vasoconstriction; P:response to ischemia; P:white fat cell differentiation; scaffold202 indexed_genome mRNA 860110 861480 . + . ID=transcript_15683;Q96HZ4 A8KAP6 B8ZZA9 Q53SN9 Q8N2J2 Q96T93 Q9P2S3,Transcription cofactor HES-6,C-HAIRY1;Class B basic helix-loop-helix protein 41;Hairy and enhancer of split 6;, PF07527;PF00010;, GO:0000785;GO:0005634;GO:0005667;GO:0003700;GO:0000981;GO:0001227;GO:0046983;GO:0000978;GO:0061629;GO:1990837;GO:0008134;GO:0009952;GO:0043433;GO:0050767;GO:0006357;GO:0006355;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:anterior/posterior pattern specification; P:negative regulation of DNA-binding transcription factor activity; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold202 indexed_genome mRNA 894180 911620 . + . ID=transcript_15684;Q9H0C8 B3KM39,Integrin-linked kinase-associated serine/threonine phosphatase 2C,, PF00481;, GO:0005829;GO:0005654;GO:0005634;GO:0004724;GO:0046872;GO:0106306;GO:0106307;GO:0006470;, C:cytosol; C:nucleoplasm; C:nucleus;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation;|Q9H0C8 B3KM39,Integrin-linked kinase-associated serine/threonine phosphatase 2C,, PF00481;, GO:0005829;GO:0005654;GO:0005634;GO:0004724;GO:0046872;GO:0106306;GO:0106307;GO:0006470;, C:cytosol; C:nucleoplasm; C:nucleus;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation;|Q9H0C8 B3KM39,Integrin-linked kinase-associated serine/threonine phosphatase 2C,, PF00481;, GO:0005829;GO:0005654;GO:0005634;GO:0004724;GO:0046872;GO:0106306;GO:0106307;GO:0006470;, C:cytosol; C:nucleoplasm; C:nucleus;, F:magnesium-dependent protein serine/threonine phosphatase activity; F:metal ion binding; F:protein serine phosphatase activity; F:protein threonine phosphatase activity;, P:protein dephosphorylation; scaffold203 indexed_genome mRNA 30754 292538 . - . ID=transcript_15685;Q6ZU35 Q9NTE2 Q9NTP8 Q9ULK9,Capping protein inhibiting regulator of actin dynamics {ECO:0000312|HGNC:HGNC:29219},Cancer-related regulator of actin dynamics {ECO:0000303|PubMed:30361697};, PF15262;, GO:0005829;GO:0010669;GO:0030277;GO:2000813;GO:0030838;, C:cytosol;, , P:epithelial structure maintenance; P:maintenance of gastrointestinal epithelium; P:negative regulation of barbed-end actin filament capping; P:positive regulation of actin filament polymerization;|Q6ZU35 Q9NTE2 Q9NTP8 Q9ULK9,Capping protein inhibiting regulator of actin dynamics {ECO:0000312|HGNC:HGNC:29219},Cancer-related regulator of actin dynamics {ECO:0000303|PubMed:30361697};, PF15262;, GO:0005829;GO:0010669;GO:0030277;GO:2000813;GO:0030838;, C:cytosol;, , P:epithelial structure maintenance; P:maintenance of gastrointestinal epithelium; P:negative regulation of barbed-end actin filament capping; P:positive regulation of actin filament polymerization; scaffold203 indexed_genome mRNA 295293 298701 . + . ID=transcript_15686;Q6ZU35 Q9NTE2 Q9NTP8 Q9ULK9,Capping protein inhibiting regulator of actin dynamics {ECO:0000312|HGNC:HGNC:29219},Cancer-related regulator of actin dynamics {ECO:0000303|PubMed:30361697};, PF15262;, GO:0005829;GO:0010669;GO:0030277;GO:2000813;GO:0030838;, C:cytosol;, , P:epithelial structure maintenance; P:maintenance of gastrointestinal epithelium; P:negative regulation of barbed-end actin filament capping; P:positive regulation of actin filament polymerization; scaffold203 indexed_genome mRNA 298708 316314 . + . ID=transcript_15687;Q6ZU35 Q9NTE2 Q9NTP8 Q9ULK9,Capping protein inhibiting regulator of actin dynamics {ECO:0000312|HGNC:HGNC:29219},Cancer-related regulator of actin dynamics {ECO:0000303|PubMed:30361697};, PF15262;, GO:0005829;GO:0010669;GO:0030277;GO:2000813;GO:0030838;, C:cytosol;, , P:epithelial structure maintenance; P:maintenance of gastrointestinal epithelium; P:negative regulation of barbed-end actin filament capping; P:positive regulation of actin filament polymerization; scaffold203 indexed_genome mRNA 324911 326803 . + . ID=transcript_15688;Q9P064,Beta-alanine-activating enzyme {ECO:0000250|UniProtKB:Q80WC9},Acyl-CoA synthetase family member 4;Protein NRPS998;, PF00501;PF00550;PF13360;PF13570;, GO:0016878;GO:0005524;GO:0043041;GO:0019482;GO:0006631;, , F:acid-thiol ligase activity; F:ATP binding;, P:amino acid activation for nonribosomal peptide biosynthetic process; P:beta-alanine metabolic process; P:fatty acid metabolic process; scaffold203 indexed_genome mRNA 327313 336658 . - . ID=transcript_15689;Q9P064,Beta-alanine-activating enzyme {ECO:0000250|UniProtKB:Q80WC9},Acyl-CoA synthetase family member 4;Protein NRPS998;, PF00501;PF00550;PF13360;PF13570;, GO:0016878;GO:0005524;GO:0043041;GO:0019482;GO:0006631;, , F:acid-thiol ligase activity; F:ATP binding;, P:amino acid activation for nonribosomal peptide biosynthetic process; P:beta-alanine metabolic process; P:fatty acid metabolic process;|Q9P064,Beta-alanine-activating enzyme {ECO:0000250|UniProtKB:Q80WC9},Acyl-CoA synthetase family member 4;Protein NRPS998;, PF00501;PF00550;PF13360;PF13570;, GO:0016878;GO:0005524;GO:0043041;GO:0019482;GO:0006631;, , F:acid-thiol ligase activity; F:ATP binding;, P:amino acid activation for nonribosomal peptide biosynthetic process; P:beta-alanine metabolic process; P:fatty acid metabolic process; scaffold203 indexed_genome mRNA 337160 337715 . + . ID=transcript_15690;Q9P064,Beta-alanine-activating enzyme {ECO:0000250|UniProtKB:Q80WC9},Acyl-CoA synthetase family member 4;Protein NRPS998;, PF00501;PF00550;PF13360;PF13570;, GO:0016878;GO:0005524;GO:0043041;GO:0019482;GO:0006631;, , F:acid-thiol ligase activity; F:ATP binding;, P:amino acid activation for nonribosomal peptide biosynthetic process; P:beta-alanine metabolic process; P:fatty acid metabolic process; scaffold203 indexed_genome mRNA 337815 354089 . - . ID=transcript_15691;Q9P064,Beta-alanine-activating enzyme {ECO:0000250|UniProtKB:Q80WC9},Acyl-CoA synthetase family member 4;Protein NRPS998;, PF00501;PF00550;PF13360;PF13570;, GO:0016878;GO:0005524;GO:0043041;GO:0019482;GO:0006631;, , F:acid-thiol ligase activity; F:ATP binding;, P:amino acid activation for nonribosomal peptide biosynthetic process; P:beta-alanine metabolic process; P:fatty acid metabolic process; scaffold203 indexed_genome mRNA 362075 419024 . - . ID=transcript_15692;Q06203,Amidophosphoribosyltransferase,Glutamine phosphoribosylpyrophosphate amidotransferase;, , GO:0005829;GO:0051539;GO:0004044;GO:0042802;GO:0046872;GO:0006189;GO:0031100;GO:0035690;GO:0032869;GO:0000082;GO:0006543;GO:0001822;GO:0007595;GO:0060135;GO:0009116;GO:0009113;GO:0006164;GO:0009168;, C:cytosol;, F:4 iron, 4 sulfur cluster binding; F:amidophosphoribosyltransferase activity; F:identical protein binding; F:metal ion binding;, P:'de novo' IMP biosynthetic process; P:animal organ regeneration; P:cellular response to drug; P:cellular response to insulin stimulus; P:G1/S transition of mitotic cell cycle; P:glutamine catabolic process; P:kidney development; P:lactation; P:maternal process involved in female pregnancy; P:nucleoside metabolic process; P:purine nucleobase biosynthetic process; P:purine nucleotide biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process;|P22234 E9PDH9 Q68CQ5,Multifunctional protein ADE2,, PF00731;PF01259;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043727;GO:0005524;GO:0045296;GO:0042802;GO:0004638;GO:0004639;GO:0006189;GO:0009113;GO:0009168;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:5-amino-4-imidazole carboxylate lyase activity; F:ATP binding; F:cadherin binding; F:identical protein binding; F:phosphoribosylaminoimidazole carboxylase activity; F:phosphoribosylaminoimidazolesuccinocarboxamide synthase activity;, P:'de novo' IMP biosynthetic process; P:purine nucleobase biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process;|P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P22234 E9PDH9 Q68CQ5,Multifunctional protein ADE2,, PF00731;PF01259;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043727;GO:0005524;GO:0045296;GO:0042802;GO:0004638;GO:0004639;GO:0006189;GO:0009113;GO:0009168;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:5-amino-4-imidazole carboxylate lyase activity; F:ATP binding; F:cadherin binding; F:identical protein binding; F:phosphoribosylaminoimidazole carboxylase activity; F:phosphoribosylaminoimidazolesuccinocarboxamide synthase activity;, P:'de novo' IMP biosynthetic process; P:purine nucleobase biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process;|P22234 E9PDH9 Q68CQ5,Multifunctional protein ADE2,, PF00731;PF01259;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0043727;GO:0005524;GO:0045296;GO:0042802;GO:0004638;GO:0004639;GO:0006189;GO:0009113;GO:0009168;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane;, F:5-amino-4-imidazole carboxylate lyase activity; F:ATP binding; F:cadherin binding; F:identical protein binding; F:phosphoribosylaminoimidazole carboxylase activity; F:phosphoribosylaminoimidazolesuccinocarboxamide synthase activity;, P:'de novo' IMP biosynthetic process; P:purine nucleobase biosynthetic process; P:purine ribonucleoside monophosphate biosynthetic process; scaffold203 indexed_genome mRNA 444478 447626 . + . ID=transcript_15693;O76094 G5E9Z8 Q7Z3C0,Signal recognition particle subunit SRP72,Signal recognition particle 72 kDa protein;, PF08492;PF17004;PF13181;, GO:0005829;GO:0005783;GO:0048500;GO:0005786;GO:0008312;GO:0003723;GO:0005047;GO:0030911;GO:0006614;, C:cytosol; C:endoplasmic reticulum; C:signal recognition particle; C:signal recognition particle, endoplasmic reticulum targeting;, F:7S RNA binding; F:RNA binding; F:signal recognition particle binding; F:TPR domain binding;, P:SRP-dependent cotranslational protein targeting to membrane; scaffold203 indexed_genome mRNA 449005 463100 . + . ID=transcript_15694;Q6T311,ADP-ribosylation factor-like protein 9,, PF00025;, GO:0005525;, , F:GTP binding; scaffold203 indexed_genome mRNA 550310 586964 . + . ID=transcript_15695;Q9BPY8 A8K0Z2 E9PB55 G3V294 Q8N0V6 Q96CI1,Homeodomain-only protein,Lung cancer-associated Y protein;Not expressed in choriocarcinoma protein 1;Odd homeobox protein 1;, PF00046;, GO:0000785;GO:0005737;GO:0005634;GO:0003677;GO:0051131;GO:0045596;GO:0006357;GO:0001829;, C:chromatin; C:cytoplasm; C:nucleus;, F:DNA binding;, P:chaperone-mediated protein complex assembly; P:negative regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; P:trophectodermal cell differentiation;|Q9BPY8 A8K0Z2 E9PB55 G3V294 Q8N0V6 Q96CI1,Homeodomain-only protein,Lung cancer-associated Y protein;Not expressed in choriocarcinoma protein 1;Odd homeobox protein 1;, PF00046;, GO:0000785;GO:0005737;GO:0005634;GO:0003677;GO:0051131;GO:0045596;GO:0006357;GO:0001829;, C:chromatin; C:cytoplasm; C:nucleus;, F:DNA binding;, P:chaperone-mediated protein complex assembly; P:negative regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; P:trophectodermal cell differentiation;|Q9BPY8 A8K0Z2 E9PB55 G3V294 Q8N0V6 Q96CI1,Homeodomain-only protein,Lung cancer-associated Y protein;Not expressed in choriocarcinoma protein 1;Odd homeobox protein 1;, PF00046;, GO:0000785;GO:0005737;GO:0005634;GO:0003677;GO:0051131;GO:0045596;GO:0006357;GO:0001829;, C:chromatin; C:cytoplasm; C:nucleus;, F:DNA binding;, P:chaperone-mediated protein complex assembly; P:negative regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; P:trophectodermal cell differentiation; scaffold203 indexed_genome mRNA 675075 681926 . - . ID=transcript_15696;P20155 Q6FGH2,Serine protease inhibitor Kazal-type 2,Acrosin-trypsin inhibitor;Epididymis tissue protein Li 172;HUSI-II;, PF00050;, GO:0001669;GO:0005576;GO:0004866;GO:0004867;GO:0001675;GO:1900004;GO:0007286;, C:acrosomal vesicle; C:extracellular region;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:acrosome assembly; P:negative regulation of serine-type endopeptidase activity; P:spermatid development; scaffold203 indexed_genome mRNA 771900 787982 . + . ID=transcript_15697;Q13127 A2RUE0 B9EGJ0 Q12956 Q12957 Q13134 Q59ER1 Q8IWI3,RE1-silencing transcription factor,Neural-restrictive silencer factor;X2 box repressor;, , GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0017053;GO:0003682;GO:0003700;GO:0001227;GO:0042802;GO:0046872;GO:0000978;GO:0008134;GO:0000976;GO:0060088;GO:0060379;GO:0035690;GO:0071257;GO:0071385;GO:0050910;GO:0070933;GO:0099563;GO:0043922;GO:0032348;GO:2000798;GO:0045955;GO:0008285;GO:2000065;GO:2000706;GO:0010629;GO:0046676;GO:2000740;GO:0050768;GO:0045665;GO:1903204;GO:0000122;GO:2000678;GO:0045892;GO:0050885;GO:0097150;GO:0043065;GO:0043280;GO:0010628;GO:0045666;GO:1903223;GO:1902459;GO:0045944;GO:0045893;GO:0000381;GO:0010468;GO:0045667;GO:1903203;GO:0006355;GO:0001666;GO:0002931;GO:0035019;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:chromatin binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:auditory receptor cell stereocilium organization; P:cardiac muscle cell myoblast differentiation; P:cellular response to drug; P:cellular response to electrical stimulus; P:cellular response to glucocorticoid stimulus; P:detection of mechanical stimulus involved in sensory perception of sound; P:histone H4 deacetylation; P:modification of synaptic structure; P:negative regulation by host of viral transcription; P:negative regulation of aldosterone biosynthetic process; P:negative regulation of amniotic stem cell differentiation; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of cell population proliferation; P:negative regulation of cortisol biosynthetic process; P:negative regulation of dense core granule biogenesis; P:negative regulation of gene expression; P:negative regulation of insulin secretion; P:negative regulation of mesenchymal stem cell differentiation; P:negative regulation of neurogenesis; P:negative regulation of neuron differentiation; P:negative regulation of oxidative stress-induced neuron death; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription, DNA-templated; P:neuromuscular process controlling balance; P:neuronal stem cell population maintenance; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:positive regulation of oxidative stress-induced neuron death; P:positive regulation of stem cell population maintenance; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of osteoblast differentiation; P:regulation of oxidative stress-induced neuron death; P:regulation of transcription, DNA-templated; P:response to hypoxia; P:response to ischemia; P:somatic stem cell population maintenance; scaffold203 indexed_genome mRNA 798488 801727 . + . ID=transcript_15698;Q8NC60 Q8N7L6 Q9BSQ9,Nitric oxide-associated protein 1,, PF01926;, GO:0005743;GO:0005739;GO:0005525;GO:0003723;GO:0006915;GO:0032543;GO:0010941;GO:0043457;, C:mitochondrial inner membrane; C:mitochondrion;, F:GTP binding; F:RNA binding;, P:apoptotic process; P:mitochondrial translation; P:regulation of cell death; P:regulation of cellular respiration; scaffold203 indexed_genome mRNA 802198 802750 . - . ID=transcript_15699;Q8NC60 Q8N7L6 Q9BSQ9,Nitric oxide-associated protein 1,, PF01926;, GO:0005743;GO:0005739;GO:0005525;GO:0003723;GO:0006915;GO:0032543;GO:0010941;GO:0043457;, C:mitochondrial inner membrane; C:mitochondrion;, F:GTP binding; F:RNA binding;, P:apoptotic process; P:mitochondrial translation; P:regulation of cell death; P:regulation of cellular respiration; scaffold203 indexed_genome mRNA 837509 856218 . - . ID=transcript_15700;P20155 Q6FGH2,Serine protease inhibitor Kazal-type 2,Acrosin-trypsin inhibitor;Epididymis tissue protein Li 172;HUSI-II;, PF00050;, GO:0001669;GO:0005576;GO:0004866;GO:0004867;GO:0001675;GO:1900004;GO:0007286;, C:acrosomal vesicle; C:extracellular region;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:acrosome assembly; P:negative regulation of serine-type endopeptidase activity; P:spermatid development;|P20155 Q6FGH2,Serine protease inhibitor Kazal-type 2,Acrosin-trypsin inhibitor;Epididymis tissue protein Li 172;HUSI-II;, PF00050;, GO:0001669;GO:0005576;GO:0004866;GO:0004867;GO:0001675;GO:1900004;GO:0007286;, C:acrosomal vesicle; C:extracellular region;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:acrosome assembly; P:negative regulation of serine-type endopeptidase activity; P:spermatid development;|P20155 Q6FGH2,Serine protease inhibitor Kazal-type 2,Acrosin-trypsin inhibitor;Epididymis tissue protein Li 172;HUSI-II;, PF00050;, GO:0001669;GO:0005576;GO:0004866;GO:0004867;GO:0001675;GO:1900004;GO:0007286;, C:acrosomal vesicle; C:extracellular region;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity;, P:acrosome assembly; P:negative regulation of serine-type endopeptidase activity; P:spermatid development; scaffold204 indexed_genome mRNA 116191 135561 . - . ID=transcript_15701;Q99784 Q53XZ8 Q6IMJ4 Q6IMJ5 Q8N8R0 Q969S7 Q99452,Noelin,Neuronal olfactomedin-related ER localized protein;Olfactomedin-1;, PF12308;PF02191;, GO:0030424;GO:0044295;GO:0005783;GO:0005615;GO:0043025;GO:0043204;GO:0045202;GO:0003190;GO:0060317;GO:0010629;GO:0007399;GO:0023041;GO:0043065;GO:0010718;GO:0010628;GO:0030516;, C:axon; C:axonal growth cone; C:endoplasmic reticulum; C:extracellular space; C:neuronal cell body; C:perikaryon; C:synapse;, , P:atrioventricular valve formation; P:cardiac epithelial to mesenchymal transition; P:negative regulation of gene expression; P:nervous system development; P:neuronal signal transduction; P:positive regulation of apoptotic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:regulation of axon extension;|Q99784 Q53XZ8 Q6IMJ4 Q6IMJ5 Q8N8R0 Q969S7 Q99452,Noelin,Neuronal olfactomedin-related ER localized protein;Olfactomedin-1;, PF12308;PF02191;, GO:0030424;GO:0044295;GO:0005783;GO:0005615;GO:0043025;GO:0043204;GO:0045202;GO:0003190;GO:0060317;GO:0010629;GO:0007399;GO:0023041;GO:0043065;GO:0010718;GO:0010628;GO:0030516;, C:axon; C:axonal growth cone; C:endoplasmic reticulum; C:extracellular space; C:neuronal cell body; C:perikaryon; C:synapse;, , P:atrioventricular valve formation; P:cardiac epithelial to mesenchymal transition; P:negative regulation of gene expression; P:nervous system development; P:neuronal signal transduction; P:positive regulation of apoptotic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:regulation of axon extension;|Q99784 Q53XZ8 Q6IMJ4 Q6IMJ5 Q8N8R0 Q969S7 Q99452,Noelin,Neuronal olfactomedin-related ER localized protein;Olfactomedin-1;, PF12308;PF02191;, GO:0030424;GO:0044295;GO:0005783;GO:0005615;GO:0043025;GO:0043204;GO:0045202;GO:0003190;GO:0060317;GO:0010629;GO:0007399;GO:0023041;GO:0043065;GO:0010718;GO:0010628;GO:0030516;, C:axon; C:axonal growth cone; C:endoplasmic reticulum; C:extracellular space; C:neuronal cell body; C:perikaryon; C:synapse;, , P:atrioventricular valve formation; P:cardiac epithelial to mesenchymal transition; P:negative regulation of gene expression; P:nervous system development; P:neuronal signal transduction; P:positive regulation of apoptotic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:regulation of axon extension;|Q99784 Q53XZ8 Q6IMJ4 Q6IMJ5 Q8N8R0 Q969S7 Q99452,Noelin,Neuronal olfactomedin-related ER localized protein;Olfactomedin-1;, PF12308;PF02191;, GO:0030424;GO:0044295;GO:0005783;GO:0005615;GO:0043025;GO:0043204;GO:0045202;GO:0003190;GO:0060317;GO:0010629;GO:0007399;GO:0023041;GO:0043065;GO:0010718;GO:0010628;GO:0030516;, C:axon; C:axonal growth cone; C:endoplasmic reticulum; C:extracellular space; C:neuronal cell body; C:perikaryon; C:synapse;, , P:atrioventricular valve formation; P:cardiac epithelial to mesenchymal transition; P:negative regulation of gene expression; P:nervous system development; P:neuronal signal transduction; P:positive regulation of apoptotic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of gene expression; P:regulation of axon extension; scaffold204 indexed_genome mRNA 293424 406690 . - . ID=transcript_15702;P20908 A0A087WXW9 Q15094 Q5SUX4,Collagen alpha-1(V) chain,, PF01410;PF01391;, GO:0005604;GO:0005588;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0008201;GO:0005178;GO:0046872;GO:0048407;GO:0043394;GO:0001568;GO:0007155;GO:0016477;GO:0032964;GO:0030199;GO:0030198;GO:0048592;GO:0003007;GO:0045112;GO:1903225;GO:0051128;GO:0043588;GO:0097435;GO:0035989;GO:0035313;, C:basement membrane; C:collagen type V trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:heparin binding; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor binding; F:proteoglycan binding;, P:blood vessel development; P:cell adhesion; P:cell migration; P:collagen biosynthetic process; P:collagen fibril organization; P:extracellular matrix organization; P:eye morphogenesis; P:heart morphogenesis; P:integrin biosynthetic process; P:negative regulation of endodermal cell differentiation; P:regulation of cellular component organization; P:skin development; P:supramolecular fiber organization; P:tendon development; P:wound healing, spreading of epidermal cells;|P20908 A0A087WXW9 Q15094 Q5SUX4,Collagen alpha-1(V) chain,, PF01410;PF01391;, GO:0005604;GO:0005588;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0008201;GO:0005178;GO:0046872;GO:0048407;GO:0043394;GO:0001568;GO:0007155;GO:0016477;GO:0032964;GO:0030199;GO:0030198;GO:0048592;GO:0003007;GO:0045112;GO:1903225;GO:0051128;GO:0043588;GO:0097435;GO:0035989;GO:0035313;, C:basement membrane; C:collagen type V trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:heparin binding; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor binding; F:proteoglycan binding;, P:blood vessel development; P:cell adhesion; P:cell migration; P:collagen biosynthetic process; P:collagen fibril organization; P:extracellular matrix organization; P:eye morphogenesis; P:heart morphogenesis; P:integrin biosynthetic process; P:negative regulation of endodermal cell differentiation; P:regulation of cellular component organization; P:skin development; P:supramolecular fiber organization; P:tendon development; P:wound healing, spreading of epidermal cells;|P20908 A0A087WXW9 Q15094 Q5SUX4,Collagen alpha-1(V) chain,, PF01410;PF01391;, GO:0005604;GO:0005588;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030020;GO:0008201;GO:0005178;GO:0046872;GO:0048407;GO:0043394;GO:0001568;GO:0007155;GO:0016477;GO:0032964;GO:0030199;GO:0030198;GO:0048592;GO:0003007;GO:0045112;GO:1903225;GO:0051128;GO:0043588;GO:0097435;GO:0035989;GO:0035313;, C:basement membrane; C:collagen type V trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring tensile strength; F:heparin binding; F:integrin binding; F:metal ion binding; F:platelet-derived growth factor binding; F:proteoglycan binding;, P:blood vessel development; P:cell adhesion; P:cell migration; P:collagen biosynthetic process; P:collagen fibril organization; P:extracellular matrix organization; P:eye morphogenesis; P:heart morphogenesis; P:integrin biosynthetic process; P:negative regulation of endodermal cell differentiation; P:regulation of cellular component organization; P:skin development; P:supramolecular fiber organization; P:tendon development; P:wound healing, spreading of epidermal cells; scaffold204 indexed_genome mRNA 595098 632377 . - . ID=transcript_15703;P19793 B3KY83 Q2NL52 Q2V504,Retinoic acid receptor RXR-alpha,Nuclear receptor subfamily 2 group B member 1;Retinoid X receptor alpha;, PF00104;PF11825;PF00105;, GO:0000785;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043235;GO:0090575;GO:0050692;GO:0003700;GO:0000981;GO:0003690;GO:0019899;GO:0042802;GO:0050693;GO:0004879;GO:0016922;GO:0042277;GO:0001972;GO:0044323;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0003707;GO:0000976;GO:0042809;GO:0008270;GO:0048856;GO:0015721;GO:0030154;GO:0008203;GO:0030851;GO:0030522;GO:0019048;GO:0000122;GO:0035357;GO:0045944;GO:0045893;GO:0019216;GO:0006357;GO:0032526;GO:0048384;GO:0006367;, C:chromatin; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding domain binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:enzyme binding; F:identical protein binding; F:LBD domain binding; F:nuclear receptor activity; F:nuclear receptor binding; F:peptide binding; F:retinoic acid binding; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription regulatory region sequence-specific DNA binding; F:vitamin D receptor binding; F:zinc ion binding;, P:anatomical structure development; P:bile acid and bile salt transport; P:cell differentiation; P:cholesterol metabolic process; P:granulocyte differentiation; P:intracellular receptor signaling pathway; P:modulation by virus of host process; P:negative regulation of transcription by RNA polymerase II; P:peroxisome proliferator activated receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter;|P48443 A6NIP1 Q6IBU7,Retinoic acid receptor RXR-gamma,Nuclear receptor subfamily 2 group B member 3;Retinoid X receptor gamma;, PF00104;PF11825;PF00105;, GO:0000785;GO:0005737;GO:0005654;GO:0090575;GO:0000981;GO:0004879;GO:0044323;GO:0000978;GO:1990837;GO:0003707;GO:0008270;GO:0048856;GO:0030154;GO:0045944;GO:0006357;GO:0032526;GO:0048384;GO:0006367;, C:chromatin; C:cytoplasm; C:nucleoplasm; C:RNA polymerase II transcription regulator complex;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter;|P19793 B3KY83 Q2NL52 Q2V504,Retinoic acid receptor RXR-alpha,Nuclear receptor subfamily 2 group B member 1;Retinoid X receptor alpha;, PF00104;PF11825;PF00105;, GO:0000785;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043235;GO:0090575;GO:0050692;GO:0003700;GO:0000981;GO:0003690;GO:0019899;GO:0042802;GO:0050693;GO:0004879;GO:0016922;GO:0042277;GO:0001972;GO:0044323;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0003707;GO:0000976;GO:0042809;GO:0008270;GO:0048856;GO:0015721;GO:0030154;GO:0008203;GO:0030851;GO:0030522;GO:0019048;GO:0000122;GO:0035357;GO:0045944;GO:0045893;GO:0019216;GO:0006357;GO:0032526;GO:0048384;GO:0006367;, C:chromatin; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding domain binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:enzyme binding; F:identical protein binding; F:LBD domain binding; F:nuclear receptor activity; F:nuclear receptor binding; F:peptide binding; F:retinoic acid binding; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription regulatory region sequence-specific DNA binding; F:vitamin D receptor binding; F:zinc ion binding;, P:anatomical structure development; P:bile acid and bile salt transport; P:cell differentiation; P:cholesterol metabolic process; P:granulocyte differentiation; P:intracellular receptor signaling pathway; P:modulation by virus of host process; P:negative regulation of transcription by RNA polymerase II; P:peroxisome proliferator activated receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter;|P19793 B3KY83 Q2NL52 Q2V504,Retinoic acid receptor RXR-alpha,Nuclear receptor subfamily 2 group B member 1;Retinoid X receptor alpha;, PF00104;PF11825;PF00105;, GO:0000785;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0043235;GO:0090575;GO:0050692;GO:0003700;GO:0000981;GO:0003690;GO:0019899;GO:0042802;GO:0050693;GO:0004879;GO:0016922;GO:0042277;GO:0001972;GO:0044323;GO:0000978;GO:0000977;GO:0043565;GO:1990837;GO:0003707;GO:0000976;GO:0042809;GO:0008270;GO:0048856;GO:0015721;GO:0030154;GO:0008203;GO:0030851;GO:0030522;GO:0019048;GO:0000122;GO:0035357;GO:0045944;GO:0045893;GO:0019216;GO:0006357;GO:0032526;GO:0048384;GO:0006367;, C:chromatin; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:receptor complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding domain binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:enzyme binding; F:identical protein binding; F:LBD domain binding; F:nuclear receptor activity; F:nuclear receptor binding; F:peptide binding; F:retinoic acid binding; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription regulatory region sequence-specific DNA binding; F:vitamin D receptor binding; F:zinc ion binding;, P:anatomical structure development; P:bile acid and bile salt transport; P:cell differentiation; P:cholesterol metabolic process; P:granulocyte differentiation; P:intracellular receptor signaling pathway; P:modulation by virus of host process; P:negative regulation of transcription by RNA polymerase II; P:peroxisome proliferator activated receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:response to retinoic acid; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; scaffold204 indexed_genome mRNA 841328 848373 . - . ID=transcript_15704;P61964 Q91VA5 Q9NWX7 Q9UGP9,WD repeat-containing protein 5,BMP2-induced 3-kb gene protein;, PF00400;, GO:0005671;GO:0000123;GO:0035097;GO:0071339;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0042393;GO:0035064;GO:0043966;GO:0051568;GO:0043984;GO:0043981;GO:0043982;GO:0051572;GO:0031175;GO:0045722;GO:0051571;GO:0043687;GO:0045652;GO:0001501;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:histone acetyltransferase complex; C:histone methyltransferase complex; C:MLL1 complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:histone binding; F:methylated histone binding;, P:histone H3 acetylation; P:histone H3-K4 methylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of histone H3-K4 methylation; P:neuron projection development; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K4 methylation; P:post-translational protein modification; P:regulation of megakaryocyte differentiation; P:skeletal system development;|P61964 Q91VA5 Q9NWX7 Q9UGP9,WD repeat-containing protein 5,BMP2-induced 3-kb gene protein;, PF00400;, GO:0005671;GO:0000123;GO:0035097;GO:0071339;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0042393;GO:0035064;GO:0043966;GO:0051568;GO:0043984;GO:0043981;GO:0043982;GO:0051572;GO:0031175;GO:0045722;GO:0051571;GO:0043687;GO:0045652;GO:0001501;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:histone acetyltransferase complex; C:histone methyltransferase complex; C:MLL1 complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:histone binding; F:methylated histone binding;, P:histone H3 acetylation; P:histone H3-K4 methylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of histone H3-K4 methylation; P:neuron projection development; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K4 methylation; P:post-translational protein modification; P:regulation of megakaryocyte differentiation; P:skeletal system development;|P61964 Q91VA5 Q9NWX7 Q9UGP9,WD repeat-containing protein 5,BMP2-induced 3-kb gene protein;, PF00400;, GO:0005671;GO:0000123;GO:0035097;GO:0071339;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0042393;GO:0035064;GO:0043966;GO:0051568;GO:0043984;GO:0043981;GO:0043982;GO:0051572;GO:0031175;GO:0045722;GO:0051571;GO:0043687;GO:0045652;GO:0001501;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:histone acetyltransferase complex; C:histone methyltransferase complex; C:MLL1 complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:histone binding; F:methylated histone binding;, P:histone H3 acetylation; P:histone H3-K4 methylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of histone H3-K4 methylation; P:neuron projection development; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K4 methylation; P:post-translational protein modification; P:regulation of megakaryocyte differentiation; P:skeletal system development; scaffold204 indexed_genome mRNA 848401 856684 . - . ID=transcript_15705;P61964 Q91VA5 Q9NWX7 Q9UGP9,WD repeat-containing protein 5,BMP2-induced 3-kb gene protein;, PF00400;, GO:0005671;GO:0000123;GO:0035097;GO:0071339;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0042393;GO:0035064;GO:0043966;GO:0051568;GO:0043984;GO:0043981;GO:0043982;GO:0051572;GO:0031175;GO:0045722;GO:0051571;GO:0043687;GO:0045652;GO:0001501;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:histone acetyltransferase complex; C:histone methyltransferase complex; C:MLL1 complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:histone binding; F:methylated histone binding;, P:histone H3 acetylation; P:histone H3-K4 methylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of histone H3-K4 methylation; P:neuron projection development; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K4 methylation; P:post-translational protein modification; P:regulation of megakaryocyte differentiation; P:skeletal system development;|P61964 Q91VA5 Q9NWX7 Q9UGP9,WD repeat-containing protein 5,BMP2-induced 3-kb gene protein;, PF00400;, GO:0005671;GO:0000123;GO:0035097;GO:0071339;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0042393;GO:0035064;GO:0043966;GO:0051568;GO:0043984;GO:0043981;GO:0043982;GO:0051572;GO:0031175;GO:0045722;GO:0051571;GO:0043687;GO:0045652;GO:0001501;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:histone acetyltransferase complex; C:histone methyltransferase complex; C:MLL1 complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:histone binding; F:methylated histone binding;, P:histone H3 acetylation; P:histone H3-K4 methylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of histone H3-K4 methylation; P:neuron projection development; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K4 methylation; P:post-translational protein modification; P:regulation of megakaryocyte differentiation; P:skeletal system development;|P61964 Q91VA5 Q9NWX7 Q9UGP9,WD repeat-containing protein 5,BMP2-induced 3-kb gene protein;, PF00400;, GO:0005671;GO:0000123;GO:0035097;GO:0071339;GO:0044666;GO:0005654;GO:0005634;GO:0048188;GO:0042393;GO:0035064;GO:0043966;GO:0051568;GO:0043984;GO:0043981;GO:0043982;GO:0051572;GO:0031175;GO:0045722;GO:0051571;GO:0043687;GO:0045652;GO:0001501;, C:Ada2/Gcn5/Ada3 transcription activator complex; C:histone acetyltransferase complex; C:histone methyltransferase complex; C:MLL1 complex; C:MLL3/4 complex; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:histone binding; F:methylated histone binding;, P:histone H3 acetylation; P:histone H3-K4 methylation; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of histone H3-K4 methylation; P:neuron projection development; P:positive regulation of gluconeogenesis; P:positive regulation of histone H3-K4 methylation; P:post-translational protein modification; P:regulation of megakaryocyte differentiation; P:skeletal system development; scaffold205 indexed_genome mRNA 1 2883 . + . ID=transcript_15706;Q7Z429 B3KXM7 O43836 Q8IVW7,Protein lifeguard 1,Glutamate [NMDA] receptor-associated protein 1;NMDA receptor glutamate-binding subunit;Putative MAPK-activating protein PM02;Transmembrane BAX inhibitor motif-containing protein 3;, PF01027;, GO:0005783;GO:0005794;GO:0016021;GO:0044325;GO:0032469;GO:1902236;, C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane;, F:ion channel binding;, P:endoplasmic reticulum calcium ion homeostasis; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; scaffold205 indexed_genome mRNA 42235 44800 . + . ID=transcript_15707;Q76KD6 B4DWW9 Q5U5I8 Q7Z6L7,Speriolin,Spermatogenesis and centriole-associated protein 1;Spermatogenesis-associated protein 15;Spermatogenic cell-specific Cdc20-binding protein;, PF15059;PF15058;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm; scaffold205 indexed_genome mRNA 44915 47087 . + . ID=transcript_15708;Q76KD6 B4DWW9 Q5U5I8 Q7Z6L7,Speriolin,Spermatogenesis and centriole-associated protein 1;Spermatogenesis-associated protein 15;Spermatogenic cell-specific Cdc20-binding protein;, PF15059;PF15058;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm; scaffold205 indexed_genome mRNA 48152 54528 . - . ID=transcript_15709;Q76KD6 B4DWW9 Q5U5I8 Q7Z6L7,Speriolin,Spermatogenesis and centriole-associated protein 1;Spermatogenesis-associated protein 15;Spermatogenic cell-specific Cdc20-binding protein;, PF15059;PF15058;, GO:0005813;GO:0005737;, C:centrosome; C:cytoplasm; scaffold205 indexed_genome mRNA 58279 60688 . - . ID=transcript_15710;O14841 A5PKY8 Q75W65 Q9Y4Q0,5-oxoprolinase,5-oxo-L-prolinase;Pyroglutamase;, PF05378;PF01968;PF02538;, GO:0005829;GO:0017168;GO:0005524;GO:0042802;GO:0006750;GO:0006749;, C:cytosol;, F:5-oxoprolinase (ATP-hydrolyzing) activity; F:ATP binding; F:identical protein binding;, P:glutathione biosynthetic process; P:glutathione metabolic process;|O14841 A5PKY8 Q75W65 Q9Y4Q0,5-oxoprolinase,5-oxo-L-prolinase;Pyroglutamase;, PF05378;PF01968;PF02538;, GO:0005829;GO:0017168;GO:0005524;GO:0042802;GO:0006750;GO:0006749;, C:cytosol;, F:5-oxoprolinase (ATP-hydrolyzing) activity; F:ATP binding; F:identical protein binding;, P:glutathione biosynthetic process; P:glutathione metabolic process;|O14841 A5PKY8 Q75W65 Q9Y4Q0,5-oxoprolinase,5-oxo-L-prolinase;Pyroglutamase;, PF05378;PF01968;PF02538;, GO:0005829;GO:0017168;GO:0005524;GO:0042802;GO:0006750;GO:0006749;, C:cytosol;, F:5-oxoprolinase (ATP-hydrolyzing) activity; F:ATP binding; F:identical protein binding;, P:glutathione biosynthetic process; P:glutathione metabolic process;|O14841 A5PKY8 Q75W65 Q9Y4Q0,5-oxoprolinase,5-oxo-L-prolinase;Pyroglutamase;, PF05378;PF01968;PF02538;, GO:0005829;GO:0017168;GO:0005524;GO:0042802;GO:0006750;GO:0006749;, C:cytosol;, F:5-oxoprolinase (ATP-hydrolyzing) activity; F:ATP binding; F:identical protein binding;, P:glutathione biosynthetic process; P:glutathione metabolic process; scaffold205 indexed_genome mRNA 67019 85460 . - . ID=transcript_15711;O43292 Q9NSS0 Q9UQ31,Glycosylphosphatidylinositol anchor attachment 1 protein,GAA1 protein homolog;, PF04114;, GO:0005813;GO:0005829;GO:0005783;GO:0005789;GO:0042765;GO:0016020;GO:0005739;GO:0015631;GO:0016255;GO:0006621;GO:0065003;GO:0006508;, C:centrosome; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane; C:mitochondrion;, F:tubulin binding;, P:attachment of GPI anchor to protein; P:protein retention in ER lumen; P:protein-containing complex assembly; P:proteolysis;|O43292 Q9NSS0 Q9UQ31,Glycosylphosphatidylinositol anchor attachment 1 protein,GAA1 protein homolog;, PF04114;, GO:0005813;GO:0005829;GO:0005783;GO:0005789;GO:0042765;GO:0016020;GO:0005739;GO:0015631;GO:0016255;GO:0006621;GO:0065003;GO:0006508;, C:centrosome; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane; C:mitochondrion;, F:tubulin binding;, P:attachment of GPI anchor to protein; P:protein retention in ER lumen; P:protein-containing complex assembly; P:proteolysis;|O43292 Q9NSS0 Q9UQ31,Glycosylphosphatidylinositol anchor attachment 1 protein,GAA1 protein homolog;, PF04114;, GO:0005813;GO:0005829;GO:0005783;GO:0005789;GO:0042765;GO:0016020;GO:0005739;GO:0015631;GO:0016255;GO:0006621;GO:0065003;GO:0006508;, C:centrosome; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:GPI-anchor transamidase complex; C:membrane; C:mitochondrion;, F:tubulin binding;, P:attachment of GPI anchor to protein; P:protein retention in ER lumen; P:protein-containing complex assembly; P:proteolysis; scaffold205 indexed_genome mRNA 88277 95495 . + . ID=transcript_15712;P08574 Q5U062 Q6FHS7,Cytochrome c1, heme protein, mitochondrial,Complex III subunit 4;Complex III subunit IV;Cytochrome b-c1 complex subunit 4;Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit;, PF02167;, GO:0016021;GO:0016020;GO:0005743;GO:0005750;GO:0005739;GO:0005634;GO:0020037;GO:0046872;GO:0008121;GO:0006122;GO:0033762;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion; C:nucleus;, F:heme binding; F:metal ion binding; F:ubiquinol-cytochrome-c reductase activity;, P:mitochondrial electron transport, ubiquinol to cytochrome c; P:response to glucagon;|P08574 Q5U062 Q6FHS7,Cytochrome c1, heme protein, mitochondrial,Complex III subunit 4;Complex III subunit IV;Cytochrome b-c1 complex subunit 4;Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit;, PF02167;, GO:0016021;GO:0016020;GO:0005743;GO:0005750;GO:0005739;GO:0005634;GO:0020037;GO:0046872;GO:0008121;GO:0006122;GO:0033762;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion; C:nucleus;, F:heme binding; F:metal ion binding; F:ubiquinol-cytochrome-c reductase activity;, P:mitochondrial electron transport, ubiquinol to cytochrome c; P:response to glucagon;|P08574 Q5U062 Q6FHS7,Cytochrome c1, heme protein, mitochondrial,Complex III subunit 4;Complex III subunit IV;Cytochrome b-c1 complex subunit 4;Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit;, PF02167;, GO:0016021;GO:0016020;GO:0005743;GO:0005750;GO:0005739;GO:0005634;GO:0020037;GO:0046872;GO:0008121;GO:0006122;GO:0033762;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex III; C:mitochondrion; C:nucleus;, F:heme binding; F:metal ion binding; F:ubiquinol-cytochrome-c reductase activity;, P:mitochondrial electron transport, ubiquinol to cytochrome c; P:response to glucagon;|Q9H0F6 A6NEG3 C0L3L2 D3DWL3 Q8IXF5 Q8IXF6 Q8N2E7 Q8TB25 Q9BUE4,Sharpin {ECO:0000303|PubMed:20179993},Shank-associated RH domain-interacting protein;Shank-interacting protein-like 1;, PF16764;, GO:0005829;GO:0030425;GO:0071797;GO:0014069;GO:0000151;GO:0042802;GO:0046872;GO:0031593;GO:0044877;GO:0043130;GO:0004842;GO:0030262;GO:0007420;GO:0007249;GO:0031424;GO:0007005;GO:0050728;GO:0043123;GO:0043161;GO:0097039;GO:2000348;GO:0010803;, C:cytosol; C:dendrite; C:LUBAC complex; C:postsynaptic density; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein-containing complex binding; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:apoptotic nuclear changes; P:brain development; P:I-kappaB kinase/NF-kappaB signaling; P:keratinization; P:mitochondrion organization; P:negative regulation of inflammatory response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein linear polyubiquitination; P:regulation of CD40 signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q9H0F6 A6NEG3 C0L3L2 D3DWL3 Q8IXF5 Q8IXF6 Q8N2E7 Q8TB25 Q9BUE4,Sharpin {ECO:0000303|PubMed:20179993},Shank-associated RH domain-interacting protein;Shank-interacting protein-like 1;, PF16764;, GO:0005829;GO:0030425;GO:0071797;GO:0014069;GO:0000151;GO:0042802;GO:0046872;GO:0031593;GO:0044877;GO:0043130;GO:0004842;GO:0030262;GO:0007420;GO:0007249;GO:0031424;GO:0007005;GO:0050728;GO:0043123;GO:0043161;GO:0097039;GO:2000348;GO:0010803;, C:cytosol; C:dendrite; C:LUBAC complex; C:postsynaptic density; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein-containing complex binding; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:apoptotic nuclear changes; P:brain development; P:I-kappaB kinase/NF-kappaB signaling; P:keratinization; P:mitochondrion organization; P:negative regulation of inflammatory response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein linear polyubiquitination; P:regulation of CD40 signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q9H0F6 A6NEG3 C0L3L2 D3DWL3 Q8IXF5 Q8IXF6 Q8N2E7 Q8TB25 Q9BUE4,Sharpin {ECO:0000303|PubMed:20179993},Shank-associated RH domain-interacting protein;Shank-interacting protein-like 1;, PF16764;, GO:0005829;GO:0030425;GO:0071797;GO:0014069;GO:0000151;GO:0042802;GO:0046872;GO:0031593;GO:0044877;GO:0043130;GO:0004842;GO:0030262;GO:0007420;GO:0007249;GO:0031424;GO:0007005;GO:0050728;GO:0043123;GO:0043161;GO:0097039;GO:2000348;GO:0010803;, C:cytosol; C:dendrite; C:LUBAC complex; C:postsynaptic density; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein-containing complex binding; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:apoptotic nuclear changes; P:brain development; P:I-kappaB kinase/NF-kappaB signaling; P:keratinization; P:mitochondrion organization; P:negative regulation of inflammatory response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein linear polyubiquitination; P:regulation of CD40 signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q9H0F6 A6NEG3 C0L3L2 D3DWL3 Q8IXF5 Q8IXF6 Q8N2E7 Q8TB25 Q9BUE4,Sharpin {ECO:0000303|PubMed:20179993},Shank-associated RH domain-interacting protein;Shank-interacting protein-like 1;, PF16764;, GO:0005829;GO:0030425;GO:0071797;GO:0014069;GO:0000151;GO:0042802;GO:0046872;GO:0031593;GO:0044877;GO:0043130;GO:0004842;GO:0030262;GO:0007420;GO:0007249;GO:0031424;GO:0007005;GO:0050728;GO:0043123;GO:0043161;GO:0097039;GO:2000348;GO:0010803;, C:cytosol; C:dendrite; C:LUBAC complex; C:postsynaptic density; C:ubiquitin ligase complex;, F:identical protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein-containing complex binding; F:ubiquitin binding; F:ubiquitin-protein transferase activity;, P:apoptotic nuclear changes; P:brain development; P:I-kappaB kinase/NF-kappaB signaling; P:keratinization; P:mitochondrion organization; P:negative regulation of inflammatory response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein linear polyubiquitination; P:regulation of CD40 signaling pathway; P:regulation of tumor necrosis factor-mediated signaling pathway; scaffold205 indexed_genome mRNA 96589 110952 . + . ID=transcript_15713;A6NE52 Q96JF2,WD repeat-containing protein 97 {ECO:0000312|HGNC:HGNC:26959},, PF00400;|Q9H063 D3DWL4,Repressor of RNA polymerase III transcription MAF1 homolog,, PF09174;, GO:0005737;GO:0005829;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0000994;GO:0001002;GO:0001003;GO:0001006;GO:0016479;GO:0016480;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA polymerase III core binding; F:RNA polymerase III type 1 promoter sequence-specific DNA binding; F:RNA polymerase III type 2 promoter sequence-specific DNA binding; F:RNA polymerase III type 3 promoter sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase I; P:negative regulation of transcription by RNA polymerase III; scaffold205 indexed_genome mRNA 113675 119161 . + . ID=transcript_15714;Q9BTY7 P0CB43,Protein HGH1 homolog,, PF04063;PF04064;|Q96PF2 Q8IY55,Testis-specific serine/threonine-protein kinase 2,DiGeorge syndrome protein G;Serine/threonine-protein kinase 22B;, PF00069;, GO:0001669;GO:0005814;GO:0005737;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0044877;GO:0035556;GO:0007275;GO:0018105;GO:0046777;GO:0006468;GO:0007286;, C:acrosomal vesicle; C:centriole; C:cytoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:protein-containing complex binding;, P:intracellular signal transduction; P:multicellular organism development; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:spermatid development; scaffold205 indexed_genome mRNA 138554 177769 . + . ID=transcript_15715;Q96JJ4,Maestro heat-like repeat-containing protein family member 1,HEAT repeat-containing protein 7A;, PF02985;|Q96JJ4,Maestro heat-like repeat-containing protein family member 1,HEAT repeat-containing protein 7A;, PF02985;|Q96JJ4,Maestro heat-like repeat-containing protein family member 1,HEAT repeat-containing protein 7A;, PF02985;|Q96JJ4,Maestro heat-like repeat-containing protein family member 1,HEAT repeat-containing protein 7A;, PF02985;|Q96JJ4,Maestro heat-like repeat-containing protein family member 1,HEAT repeat-containing protein 7A;, PF02985;|Q96JJ4,Maestro heat-like repeat-containing protein family member 1,HEAT repeat-containing protein 7A;, PF02985;|Q96JJ4,Maestro heat-like repeat-containing protein family member 1,HEAT repeat-containing protein 7A;, PF02985;|Q96JJ4,Maestro heat-like repeat-containing protein family member 1,HEAT repeat-containing protein 7A;, PF02985;|Q96JJ4,Maestro heat-like repeat-containing protein family member 1,HEAT repeat-containing protein 7A;, PF02985;|Q14137 Q969Z6 Q96IS8 Q96Q25 Q9BSA7 Q9BVM0,Ribosome biogenesis protein BOP1 {ECO:0000255|HAMAP-Rule:MF_03027},Block of proliferation 1 protein {ECO:0000255|HAMAP-Rule:MF_03027};, PF08145;PF00400;, GO:0005694;GO:0005730;GO:0005654;GO:0070545;GO:0030687;GO:1990904;GO:0043021;GO:0003723;GO:0008283;GO:0000448;GO:0000463;GO:0051726;GO:1901796;GO:0000027;GO:0042254;GO:0006364;, C:chromosome; C:nucleolus; C:nucleoplasm; C:PeBoW complex; C:preribosome, large subunit precursor; C:ribonucleoprotein complex;, F:ribonucleoprotein complex binding; F:RNA binding;, P:cell population proliferation; P:cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of cell cycle; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosome biogenesis; P:rRNA processing;|Q14137 Q969Z6 Q96IS8 Q96Q25 Q9BSA7 Q9BVM0,Ribosome biogenesis protein BOP1 {ECO:0000255|HAMAP-Rule:MF_03027},Block of proliferation 1 protein {ECO:0000255|HAMAP-Rule:MF_03027};, PF08145;PF00400;, GO:0005694;GO:0005730;GO:0005654;GO:0070545;GO:0030687;GO:1990904;GO:0043021;GO:0003723;GO:0008283;GO:0000448;GO:0000463;GO:0051726;GO:1901796;GO:0000027;GO:0042254;GO:0006364;, C:chromosome; C:nucleolus; C:nucleoplasm; C:PeBoW complex; C:preribosome, large subunit precursor; C:ribonucleoprotein complex;, F:ribonucleoprotein complex binding; F:RNA binding;, P:cell population proliferation; P:cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of cell cycle; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosome biogenesis; P:rRNA processing;|Q14137 Q969Z6 Q96IS8 Q96Q25 Q9BSA7 Q9BVM0,Ribosome biogenesis protein BOP1 {ECO:0000255|HAMAP-Rule:MF_03027},Block of proliferation 1 protein {ECO:0000255|HAMAP-Rule:MF_03027};, PF08145;PF00400;, GO:0005694;GO:0005730;GO:0005654;GO:0070545;GO:0030687;GO:1990904;GO:0043021;GO:0003723;GO:0008283;GO:0000448;GO:0000463;GO:0051726;GO:1901796;GO:0000027;GO:0042254;GO:0006364;, C:chromosome; C:nucleolus; C:nucleoplasm; C:PeBoW complex; C:preribosome, large subunit precursor; C:ribonucleoprotein complex;, F:ribonucleoprotein complex binding; F:RNA binding;, P:cell population proliferation; P:cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:regulation of cell cycle; P:regulation of signal transduction by p53 class mediator; P:ribosomal large subunit assembly; P:ribosome biogenesis; P:rRNA processing; scaffold205 indexed_genome mRNA 178534 181279 . + . ID=transcript_15716;Q7RTU7,Basic helix-loop-helix transcription factor scleraxis,Class A basic helix-loop-helix protein 41;Class A basic helix-loop-helix protein 48;, PF00010;, GO:0000785;GO:0005634;GO:0005667;GO:0043425;GO:0003677;GO:0001228;GO:0000981;GO:0070888;GO:0046983;GO:0000977;GO:0043565;GO:0030509;GO:0030154;GO:0071260;GO:0071560;GO:0002062;GO:0030199;GO:0035993;GO:0032502;GO:0048706;GO:0001958;GO:0060325;GO:0003188;GO:0003179;GO:0001707;GO:0043066;GO:0045892;GO:0061036;GO:0008284;GO:0032967;GO:2000543;GO:0010628;GO:0045944;GO:0045893;GO:0061035;GO:0006357;GO:0061056;GO:0060008;GO:0035914;GO:0035990;GO:0035989;GO:0035992;GO:0001894;GO:0006351;, C:chromatin; C:nucleus; C:transcription regulator complex;, F:bHLH transcription factor binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:protein dimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:BMP signaling pathway; P:cell differentiation; P:cellular response to mechanical stimulus; P:cellular response to transforming growth factor beta stimulus; P:chondrocyte differentiation; P:collagen fibril organization; P:deltoid tuberosity development; P:developmental process; P:embryonic skeletal system development; P:endochondral ossification; P:face morphogenesis; P:heart valve formation; P:heart valve morphogenesis; P:mesoderm formation; P:negative regulation of apoptotic process; P:negative regulation of transcription, DNA-templated; P:positive regulation of cartilage development; P:positive regulation of cell population proliferation; P:positive regulation of collagen biosynthetic process; P:positive regulation of gastrulation; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of cartilage development; P:regulation of transcription by RNA polymerase II; P:sclerotome development; P:Sertoli cell differentiation; P:skeletal muscle cell differentiation; P:tendon cell differentiation; P:tendon development; P:tendon formation; P:tissue homeostasis; P:transcription, DNA-templated; scaffold205 indexed_genome mRNA 192123 226590 . - . ID=transcript_15717;Q00613 A8K4L0 A8MW26 Q53XT4,Heat shock factor protein 1 {ECO:0000305},Heat shock transcription factor 1 {ECO:0000312|HGNC:HGNC:5224};, PF00447;PF06546;, GO:0005813;GO:0101031;GO:0000785;GO:0000777;GO:0005737;GO:0005829;GO:0000791;GO:0000792;GO:0000776;GO:0097431;GO:0097165;GO:0005654;GO:0005634;GO:0048471;GO:0016605;GO:1990904;GO:0031490;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0031072;GO:0051879;GO:0042802;GO:1990841;GO:0046982;GO:0019901;GO:0043621;GO:0000978;GO:0001162;GO:0043565;GO:1990837;GO:0098847;GO:0097677;GO:0000976;GO:0061770;GO:0034622;GO:1904385;GO:0071276;GO:0071280;GO:0072738;GO:0071392;GO:0071480;GO:0034605;GO:0070301;GO:1904845;GO:0071222;GO:1904843;GO:0035865;GO:1903936;GO:0034620;GO:0006952;GO:0006281;GO:0000165;GO:0006397;GO:0009299;GO:0051028;GO:0010667;GO:2001033;GO:0090084;GO:1901215;GO:0031333;GO:0000122;GO:1902512;GO:0008284;GO:0120162;GO:0043280;GO:0051091;GO:0090261;GO:0045651;GO:1904528;GO:0045931;GO:1900365;GO:0045944;GO:0061408;GO:0042531;GO:1900034;GO:0006357;GO:0014823;GO:1990910;GO:0007584;GO:1990911;GO:0033574;GO:0016032;, C:centrosome; C:chaperone complex; C:chromatin; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:euchromatin; C:heterochromatin; C:kinetochore; C:mitotic spindle pole; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:PML body; C:ribonucleoprotein complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:heat shock protein binding; F:Hsp90 protein binding; F:identical protein binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:sequence-specific single stranded DNA binding; F:STAT family protein binding; F:transcription regulatory region sequence-specific DNA binding; F:translation elongation factor binding;, P:cellular protein-containing complex assembly; P:cellular response to angiotensin; P:cellular response to cadmium ion; P:cellular response to copper ion; P:cellular response to diamide; P:cellular response to estradiol stimulus; P:cellular response to gamma radiation; P:cellular response to heat; P:cellular response to hydrogen peroxide; P:cellular response to L-glutamine; P:cellular response to lipopolysaccharide; P:cellular response to nitroglycerin; P:cellular response to potassium ion; P:cellular response to sodium arsenite; P:cellular response to unfolded protein; P:defense response; P:DNA repair; P:MAPK cascade; P:mRNA processing; P:mRNA transcription; P:mRNA transport; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of inclusion body assembly; P:negative regulation of neuron death; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of inclusion body assembly; P:positive regulation of macrophage differentiation; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of mRNA polyadenylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to heat stress; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of cellular response to heat; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to hypobaric hypoxia; P:response to nutrient; P:response to psychosocial stress; P:response to testosterone; P:viral process;|Q00613 A8K4L0 A8MW26 Q53XT4,Heat shock factor protein 1 {ECO:0000305},Heat shock transcription factor 1 {ECO:0000312|HGNC:HGNC:5224};, PF00447;PF06546;, GO:0005813;GO:0101031;GO:0000785;GO:0000777;GO:0005737;GO:0005829;GO:0000791;GO:0000792;GO:0000776;GO:0097431;GO:0097165;GO:0005654;GO:0005634;GO:0048471;GO:0016605;GO:1990904;GO:0031490;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0031072;GO:0051879;GO:0042802;GO:1990841;GO:0046982;GO:0019901;GO:0043621;GO:0000978;GO:0001162;GO:0043565;GO:1990837;GO:0098847;GO:0097677;GO:0000976;GO:0061770;GO:0034622;GO:1904385;GO:0071276;GO:0071280;GO:0072738;GO:0071392;GO:0071480;GO:0034605;GO:0070301;GO:1904845;GO:0071222;GO:1904843;GO:0035865;GO:1903936;GO:0034620;GO:0006952;GO:0006281;GO:0000165;GO:0006397;GO:0009299;GO:0051028;GO:0010667;GO:2001033;GO:0090084;GO:1901215;GO:0031333;GO:0000122;GO:1902512;GO:0008284;GO:0120162;GO:0043280;GO:0051091;GO:0090261;GO:0045651;GO:1904528;GO:0045931;GO:1900365;GO:0045944;GO:0061408;GO:0042531;GO:1900034;GO:0006357;GO:0014823;GO:1990910;GO:0007584;GO:1990911;GO:0033574;GO:0016032;, C:centrosome; C:chaperone complex; C:chromatin; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:euchromatin; C:heterochromatin; C:kinetochore; C:mitotic spindle pole; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:PML body; C:ribonucleoprotein complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:heat shock protein binding; F:Hsp90 protein binding; F:identical protein binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:sequence-specific single stranded DNA binding; F:STAT family protein binding; F:transcription regulatory region sequence-specific DNA binding; F:translation elongation factor binding;, P:cellular protein-containing complex assembly; P:cellular response to angiotensin; P:cellular response to cadmium ion; P:cellular response to copper ion; P:cellular response to diamide; P:cellular response to estradiol stimulus; P:cellular response to gamma radiation; P:cellular response to heat; P:cellular response to hydrogen peroxide; P:cellular response to L-glutamine; P:cellular response to lipopolysaccharide; P:cellular response to nitroglycerin; P:cellular response to potassium ion; P:cellular response to sodium arsenite; P:cellular response to unfolded protein; P:defense response; P:DNA repair; P:MAPK cascade; P:mRNA processing; P:mRNA transcription; P:mRNA transport; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of inclusion body assembly; P:negative regulation of neuron death; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of inclusion body assembly; P:positive regulation of macrophage differentiation; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of mRNA polyadenylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to heat stress; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of cellular response to heat; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to hypobaric hypoxia; P:response to nutrient; P:response to psychosocial stress; P:response to testosterone; P:viral process;|Q00613 A8K4L0 A8MW26 Q53XT4,Heat shock factor protein 1 {ECO:0000305},Heat shock transcription factor 1 {ECO:0000312|HGNC:HGNC:5224};, PF00447;PF06546;, GO:0005813;GO:0101031;GO:0000785;GO:0000777;GO:0005737;GO:0005829;GO:0000791;GO:0000792;GO:0000776;GO:0097431;GO:0097165;GO:0005654;GO:0005634;GO:0048471;GO:0016605;GO:1990904;GO:0031490;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0031072;GO:0051879;GO:0042802;GO:1990841;GO:0046982;GO:0019901;GO:0043621;GO:0000978;GO:0001162;GO:0043565;GO:1990837;GO:0098847;GO:0097677;GO:0000976;GO:0061770;GO:0034622;GO:1904385;GO:0071276;GO:0071280;GO:0072738;GO:0071392;GO:0071480;GO:0034605;GO:0070301;GO:1904845;GO:0071222;GO:1904843;GO:0035865;GO:1903936;GO:0034620;GO:0006952;GO:0006281;GO:0000165;GO:0006397;GO:0009299;GO:0051028;GO:0010667;GO:2001033;GO:0090084;GO:1901215;GO:0031333;GO:0000122;GO:1902512;GO:0008284;GO:0120162;GO:0043280;GO:0051091;GO:0090261;GO:0045651;GO:1904528;GO:0045931;GO:1900365;GO:0045944;GO:0061408;GO:0042531;GO:1900034;GO:0006357;GO:0014823;GO:1990910;GO:0007584;GO:1990911;GO:0033574;GO:0016032;, C:centrosome; C:chaperone complex; C:chromatin; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:euchromatin; C:heterochromatin; C:kinetochore; C:mitotic spindle pole; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:PML body; C:ribonucleoprotein complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:heat shock protein binding; F:Hsp90 protein binding; F:identical protein binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:sequence-specific single stranded DNA binding; F:STAT family protein binding; F:transcription regulatory region sequence-specific DNA binding; F:translation elongation factor binding;, P:cellular protein-containing complex assembly; P:cellular response to angiotensin; P:cellular response to cadmium ion; P:cellular response to copper ion; P:cellular response to diamide; P:cellular response to estradiol stimulus; P:cellular response to gamma radiation; P:cellular response to heat; P:cellular response to hydrogen peroxide; P:cellular response to L-glutamine; P:cellular response to lipopolysaccharide; P:cellular response to nitroglycerin; P:cellular response to potassium ion; P:cellular response to sodium arsenite; P:cellular response to unfolded protein; P:defense response; P:DNA repair; P:MAPK cascade; P:mRNA processing; P:mRNA transcription; P:mRNA transport; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of inclusion body assembly; P:negative regulation of neuron death; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of inclusion body assembly; P:positive regulation of macrophage differentiation; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of mRNA polyadenylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to heat stress; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of cellular response to heat; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to hypobaric hypoxia; P:response to nutrient; P:response to psychosocial stress; P:response to testosterone; P:viral process;|Q00613 A8K4L0 A8MW26 Q53XT4,Heat shock factor protein 1 {ECO:0000305},Heat shock transcription factor 1 {ECO:0000312|HGNC:HGNC:5224};, PF00447;PF06546;, GO:0005813;GO:0101031;GO:0000785;GO:0000777;GO:0005737;GO:0005829;GO:0000791;GO:0000792;GO:0000776;GO:0097431;GO:0097165;GO:0005654;GO:0005634;GO:0048471;GO:0016605;GO:1990904;GO:0031490;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0031072;GO:0051879;GO:0042802;GO:1990841;GO:0046982;GO:0019901;GO:0043621;GO:0000978;GO:0001162;GO:0043565;GO:1990837;GO:0098847;GO:0097677;GO:0000976;GO:0061770;GO:0034622;GO:1904385;GO:0071276;GO:0071280;GO:0072738;GO:0071392;GO:0071480;GO:0034605;GO:0070301;GO:1904845;GO:0071222;GO:1904843;GO:0035865;GO:1903936;GO:0034620;GO:0006952;GO:0006281;GO:0000165;GO:0006397;GO:0009299;GO:0051028;GO:0010667;GO:2001033;GO:0090084;GO:1901215;GO:0031333;GO:0000122;GO:1902512;GO:0008284;GO:0120162;GO:0043280;GO:0051091;GO:0090261;GO:0045651;GO:1904528;GO:0045931;GO:1900365;GO:0045944;GO:0061408;GO:0042531;GO:1900034;GO:0006357;GO:0014823;GO:1990910;GO:0007584;GO:1990911;GO:0033574;GO:0016032;, C:centrosome; C:chaperone complex; C:chromatin; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:euchromatin; C:heterochromatin; C:kinetochore; C:mitotic spindle pole; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:PML body; C:ribonucleoprotein complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:heat shock protein binding; F:Hsp90 protein binding; F:identical protein binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:sequence-specific single stranded DNA binding; F:STAT family protein binding; F:transcription regulatory region sequence-specific DNA binding; F:translation elongation factor binding;, P:cellular protein-containing complex assembly; P:cellular response to angiotensin; P:cellular response to cadmium ion; P:cellular response to copper ion; P:cellular response to diamide; P:cellular response to estradiol stimulus; P:cellular response to gamma radiation; P:cellular response to heat; P:cellular response to hydrogen peroxide; P:cellular response to L-glutamine; P:cellular response to lipopolysaccharide; P:cellular response to nitroglycerin; P:cellular response to potassium ion; P:cellular response to sodium arsenite; P:cellular response to unfolded protein; P:defense response; P:DNA repair; P:MAPK cascade; P:mRNA processing; P:mRNA transcription; P:mRNA transport; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of inclusion body assembly; P:negative regulation of neuron death; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of inclusion body assembly; P:positive regulation of macrophage differentiation; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of mRNA polyadenylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to heat stress; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of cellular response to heat; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to hypobaric hypoxia; P:response to nutrient; P:response to psychosocial stress; P:response to testosterone; P:viral process;|Q00613 A8K4L0 A8MW26 Q53XT4,Heat shock factor protein 1 {ECO:0000305},Heat shock transcription factor 1 {ECO:0000312|HGNC:HGNC:5224};, PF00447;PF06546;, GO:0005813;GO:0101031;GO:0000785;GO:0000777;GO:0005737;GO:0005829;GO:0000791;GO:0000792;GO:0000776;GO:0097431;GO:0097165;GO:0005654;GO:0005634;GO:0048471;GO:0016605;GO:1990904;GO:0031490;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0031072;GO:0051879;GO:0042802;GO:1990841;GO:0046982;GO:0019901;GO:0043621;GO:0000978;GO:0001162;GO:0043565;GO:1990837;GO:0098847;GO:0097677;GO:0000976;GO:0061770;GO:0034622;GO:1904385;GO:0071276;GO:0071280;GO:0072738;GO:0071392;GO:0071480;GO:0034605;GO:0070301;GO:1904845;GO:0071222;GO:1904843;GO:0035865;GO:1903936;GO:0034620;GO:0006952;GO:0006281;GO:0000165;GO:0006397;GO:0009299;GO:0051028;GO:0010667;GO:2001033;GO:0090084;GO:1901215;GO:0031333;GO:0000122;GO:1902512;GO:0008284;GO:0120162;GO:0043280;GO:0051091;GO:0090261;GO:0045651;GO:1904528;GO:0045931;GO:1900365;GO:0045944;GO:0061408;GO:0042531;GO:1900034;GO:0006357;GO:0014823;GO:1990910;GO:0007584;GO:1990911;GO:0033574;GO:0016032;, C:centrosome; C:chaperone complex; C:chromatin; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:euchromatin; C:heterochromatin; C:kinetochore; C:mitotic spindle pole; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:PML body; C:ribonucleoprotein complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:heat shock protein binding; F:Hsp90 protein binding; F:identical protein binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:sequence-specific single stranded DNA binding; F:STAT family protein binding; F:transcription regulatory region sequence-specific DNA binding; F:translation elongation factor binding;, P:cellular protein-containing complex assembly; P:cellular response to angiotensin; P:cellular response to cadmium ion; P:cellular response to copper ion; P:cellular response to diamide; P:cellular response to estradiol stimulus; P:cellular response to gamma radiation; P:cellular response to heat; P:cellular response to hydrogen peroxide; P:cellular response to L-glutamine; P:cellular response to lipopolysaccharide; P:cellular response to nitroglycerin; P:cellular response to potassium ion; P:cellular response to sodium arsenite; P:cellular response to unfolded protein; P:defense response; P:DNA repair; P:MAPK cascade; P:mRNA processing; P:mRNA transcription; P:mRNA transport; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of inclusion body assembly; P:negative regulation of neuron death; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of inclusion body assembly; P:positive regulation of macrophage differentiation; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of mRNA polyadenylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to heat stress; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of cellular response to heat; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to hypobaric hypoxia; P:response to nutrient; P:response to psychosocial stress; P:response to testosterone; P:viral process;|Q00613 A8K4L0 A8MW26 Q53XT4,Heat shock factor protein 1 {ECO:0000305},Heat shock transcription factor 1 {ECO:0000312|HGNC:HGNC:5224};, PF00447;PF06546;, GO:0005813;GO:0101031;GO:0000785;GO:0000777;GO:0005737;GO:0005829;GO:0000791;GO:0000792;GO:0000776;GO:0097431;GO:0097165;GO:0005654;GO:0005634;GO:0048471;GO:0016605;GO:1990904;GO:0031490;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0031072;GO:0051879;GO:0042802;GO:1990841;GO:0046982;GO:0019901;GO:0043621;GO:0000978;GO:0001162;GO:0043565;GO:1990837;GO:0098847;GO:0097677;GO:0000976;GO:0061770;GO:0034622;GO:1904385;GO:0071276;GO:0071280;GO:0072738;GO:0071392;GO:0071480;GO:0034605;GO:0070301;GO:1904845;GO:0071222;GO:1904843;GO:0035865;GO:1903936;GO:0034620;GO:0006952;GO:0006281;GO:0000165;GO:0006397;GO:0009299;GO:0051028;GO:0010667;GO:2001033;GO:0090084;GO:1901215;GO:0031333;GO:0000122;GO:1902512;GO:0008284;GO:0120162;GO:0043280;GO:0051091;GO:0090261;GO:0045651;GO:1904528;GO:0045931;GO:1900365;GO:0045944;GO:0061408;GO:0042531;GO:1900034;GO:0006357;GO:0014823;GO:1990910;GO:0007584;GO:1990911;GO:0033574;GO:0016032;, C:centrosome; C:chaperone complex; C:chromatin; C:condensed chromosome kinetochore; C:cytoplasm; C:cytosol; C:euchromatin; C:heterochromatin; C:kinetochore; C:mitotic spindle pole; C:nuclear stress granule; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:PML body; C:ribonucleoprotein complex;, F:chromatin DNA binding; F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:heat shock protein binding; F:Hsp90 protein binding; F:identical protein binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase binding; F:protein self-association; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:sequence-specific single stranded DNA binding; F:STAT family protein binding; F:transcription regulatory region sequence-specific DNA binding; F:translation elongation factor binding;, P:cellular protein-containing complex assembly; P:cellular response to angiotensin; P:cellular response to cadmium ion; P:cellular response to copper ion; P:cellular response to diamide; P:cellular response to estradiol stimulus; P:cellular response to gamma radiation; P:cellular response to heat; P:cellular response to hydrogen peroxide; P:cellular response to L-glutamine; P:cellular response to lipopolysaccharide; P:cellular response to nitroglycerin; P:cellular response to potassium ion; P:cellular response to sodium arsenite; P:cellular response to unfolded protein; P:defense response; P:DNA repair; P:MAPK cascade; P:mRNA processing; P:mRNA transcription; P:mRNA transport; P:negative regulation of cardiac muscle cell apoptotic process; P:negative regulation of double-strand break repair via nonhomologous end joining; P:negative regulation of inclusion body assembly; P:negative regulation of neuron death; P:negative regulation of protein-containing complex assembly; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of inclusion body assembly; P:positive regulation of macrophage differentiation; P:positive regulation of microtubule binding; P:positive regulation of mitotic cell cycle; P:positive regulation of mRNA polyadenylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to heat stress; P:positive regulation of tyrosine phosphorylation of STAT protein; P:regulation of cellular response to heat; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to hypobaric hypoxia; P:response to nutrient; P:response to psychosocial stress; P:response to testosterone; P:viral process;|O75907 B2RWQ2 D3DWL6 Q96BB8,Diacylglycerol O-acyltransferase 1 {ECO:0000305},ACAT-related gene product 1;Acyl-CoA retinol O-fatty-acyltransferase {ECO:0000303|PubMed:16214399};Diglyceride acyltransferase;, PF03062;, GO:0005789;GO:0016021;GO:0005886;GO:0035579;GO:0003846;GO:0004144;GO:0042802;GO:0008374;GO:0050252;GO:0016746;GO:0036155;GO:0046339;GO:0055089;GO:0019915;GO:0035336;GO:0006640;GO:0043312;GO:0019432;GO:0006641;GO:0034379;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:specific granule membrane;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:identical protein binding; F:O-acyltransferase activity; F:retinol O-fatty-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acylglycerol acyl-chain remodeling; P:diacylglycerol metabolic process; P:fatty acid homeostasis; P:lipid storage; P:long-chain fatty-acyl-CoA metabolic process; P:monoacylglycerol biosynthetic process; P:neutrophil degranulation; P:triglyceride biosynthetic process; P:triglyceride metabolic process; P:very-low-density lipoprotein particle assembly;|O75907 B2RWQ2 D3DWL6 Q96BB8,Diacylglycerol O-acyltransferase 1 {ECO:0000305},ACAT-related gene product 1;Acyl-CoA retinol O-fatty-acyltransferase {ECO:0000303|PubMed:16214399};Diglyceride acyltransferase;, PF03062;, GO:0005789;GO:0016021;GO:0005886;GO:0035579;GO:0003846;GO:0004144;GO:0042802;GO:0008374;GO:0050252;GO:0016746;GO:0036155;GO:0046339;GO:0055089;GO:0019915;GO:0035336;GO:0006640;GO:0043312;GO:0019432;GO:0006641;GO:0034379;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:specific granule membrane;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:identical protein binding; F:O-acyltransferase activity; F:retinol O-fatty-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acylglycerol acyl-chain remodeling; P:diacylglycerol metabolic process; P:fatty acid homeostasis; P:lipid storage; P:long-chain fatty-acyl-CoA metabolic process; P:monoacylglycerol biosynthetic process; P:neutrophil degranulation; P:triglyceride biosynthetic process; P:triglyceride metabolic process; P:very-low-density lipoprotein particle assembly;|O75907 B2RWQ2 D3DWL6 Q96BB8,Diacylglycerol O-acyltransferase 1 {ECO:0000305},ACAT-related gene product 1;Acyl-CoA retinol O-fatty-acyltransferase {ECO:0000303|PubMed:16214399};Diglyceride acyltransferase;, PF03062;, GO:0005789;GO:0016021;GO:0005886;GO:0035579;GO:0003846;GO:0004144;GO:0042802;GO:0008374;GO:0050252;GO:0016746;GO:0036155;GO:0046339;GO:0055089;GO:0019915;GO:0035336;GO:0006640;GO:0043312;GO:0019432;GO:0006641;GO:0034379;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:specific granule membrane;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:identical protein binding; F:O-acyltransferase activity; F:retinol O-fatty-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acylglycerol acyl-chain remodeling; P:diacylglycerol metabolic process; P:fatty acid homeostasis; P:lipid storage; P:long-chain fatty-acyl-CoA metabolic process; P:monoacylglycerol biosynthetic process; P:neutrophil degranulation; P:triglyceride biosynthetic process; P:triglyceride metabolic process; P:very-low-density lipoprotein particle assembly;|O75907 B2RWQ2 D3DWL6 Q96BB8,Diacylglycerol O-acyltransferase 1 {ECO:0000305},ACAT-related gene product 1;Acyl-CoA retinol O-fatty-acyltransferase {ECO:0000303|PubMed:16214399};Diglyceride acyltransferase;, PF03062;, GO:0005789;GO:0016021;GO:0005886;GO:0035579;GO:0003846;GO:0004144;GO:0042802;GO:0008374;GO:0050252;GO:0016746;GO:0036155;GO:0046339;GO:0055089;GO:0019915;GO:0035336;GO:0006640;GO:0043312;GO:0019432;GO:0006641;GO:0034379;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:specific granule membrane;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:identical protein binding; F:O-acyltransferase activity; F:retinol O-fatty-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acylglycerol acyl-chain remodeling; P:diacylglycerol metabolic process; P:fatty acid homeostasis; P:lipid storage; P:long-chain fatty-acyl-CoA metabolic process; P:monoacylglycerol biosynthetic process; P:neutrophil degranulation; P:triglyceride biosynthetic process; P:triglyceride metabolic process; P:very-low-density lipoprotein particle assembly;|O75907 B2RWQ2 D3DWL6 Q96BB8,Diacylglycerol O-acyltransferase 1 {ECO:0000305},ACAT-related gene product 1;Acyl-CoA retinol O-fatty-acyltransferase {ECO:0000303|PubMed:16214399};Diglyceride acyltransferase;, PF03062;, GO:0005789;GO:0016021;GO:0005886;GO:0035579;GO:0003846;GO:0004144;GO:0042802;GO:0008374;GO:0050252;GO:0016746;GO:0036155;GO:0046339;GO:0055089;GO:0019915;GO:0035336;GO:0006640;GO:0043312;GO:0019432;GO:0006641;GO:0034379;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:specific granule membrane;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:identical protein binding; F:O-acyltransferase activity; F:retinol O-fatty-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acylglycerol acyl-chain remodeling; P:diacylglycerol metabolic process; P:fatty acid homeostasis; P:lipid storage; P:long-chain fatty-acyl-CoA metabolic process; P:monoacylglycerol biosynthetic process; P:neutrophil degranulation; P:triglyceride biosynthetic process; P:triglyceride metabolic process; P:very-low-density lipoprotein particle assembly;|O75907 B2RWQ2 D3DWL6 Q96BB8,Diacylglycerol O-acyltransferase 1 {ECO:0000305},ACAT-related gene product 1;Acyl-CoA retinol O-fatty-acyltransferase {ECO:0000303|PubMed:16214399};Diglyceride acyltransferase;, PF03062;, GO:0005789;GO:0016021;GO:0005886;GO:0035579;GO:0003846;GO:0004144;GO:0042802;GO:0008374;GO:0050252;GO:0016746;GO:0036155;GO:0046339;GO:0055089;GO:0019915;GO:0035336;GO:0006640;GO:0043312;GO:0019432;GO:0006641;GO:0034379;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:specific granule membrane;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:identical protein binding; F:O-acyltransferase activity; F:retinol O-fatty-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acylglycerol acyl-chain remodeling; P:diacylglycerol metabolic process; P:fatty acid homeostasis; P:lipid storage; P:long-chain fatty-acyl-CoA metabolic process; P:monoacylglycerol biosynthetic process; P:neutrophil degranulation; P:triglyceride biosynthetic process; P:triglyceride metabolic process; P:very-low-density lipoprotein particle assembly;|O75907 B2RWQ2 D3DWL6 Q96BB8,Diacylglycerol O-acyltransferase 1 {ECO:0000305},ACAT-related gene product 1;Acyl-CoA retinol O-fatty-acyltransferase {ECO:0000303|PubMed:16214399};Diglyceride acyltransferase;, PF03062;, GO:0005789;GO:0016021;GO:0005886;GO:0035579;GO:0003846;GO:0004144;GO:0042802;GO:0008374;GO:0050252;GO:0016746;GO:0036155;GO:0046339;GO:0055089;GO:0019915;GO:0035336;GO:0006640;GO:0043312;GO:0019432;GO:0006641;GO:0034379;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; C:specific granule membrane;, F:2-acylglycerol O-acyltransferase activity; F:diacylglycerol O-acyltransferase activity; F:identical protein binding; F:O-acyltransferase activity; F:retinol O-fatty-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acylglycerol acyl-chain remodeling; P:diacylglycerol metabolic process; P:fatty acid homeostasis; P:lipid storage; P:long-chain fatty-acyl-CoA metabolic process; P:monoacylglycerol biosynthetic process; P:neutrophil degranulation; P:triglyceride biosynthetic process; P:triglyceride metabolic process; P:very-low-density lipoprotein particle assembly; scaffold205 indexed_genome mRNA 240817 242132 . + . ID=transcript_15718;Q2WGJ8,Transmembrane protein 249,, PF15158;, GO:0016021;, C:integral component of membrane; scaffold205 indexed_genome mRNA 243681 249321 . - . ID=transcript_15719;Q8N531 Q53G43 Q9H5W9 Q9UKC7,F-box/LRR-repeat protein 6,F-box and leucine-rich repeat protein 6;F-box protein FBL6;FBL6A;, PF12937;PF13516;, GO:0005829;GO:0005634;GO:0019005;GO:0004842;GO:0043153;GO:0000086;GO:0006508;GO:0051726;GO:0031146;, C:cytosol; C:nucleus; C:SCF ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:entrainment of circadian clock by photoperiod; P:G2/M transition of mitotic cell cycle; P:proteolysis; P:regulation of cell cycle; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q9NWF4 B5MEV1 B5MEV2 Q6P9E0 Q86UT0,Solute carrier family 52, riboflavin transporter, member 1,Porcine endogenous retrovirus A receptor 2 {ECO:0000303|PubMed:12740431};Protein GPR172B;Riboflavin transporter 1;, PF06237;, GO:0005887;GO:0005886;GO:0032217;GO:0001618;GO:0006771;GO:0032218;, C:integral component of plasma membrane; C:plasma membrane;, F:riboflavin transmembrane transporter activity; F:virus receptor activity;, P:riboflavin metabolic process; P:riboflavin transport;|Q9HAB3 A8K6B6 D3DWL8 G1UCY1 Q86UT1,Solute carrier family 52, riboflavin transporter, member 2,Porcine endogenous retrovirus A receptor 1 {ECO:0000303|PubMed:12740431};Protein GPR172A;Riboflavin transporter 3;, PF06237;, GO:0005887;GO:0005886;GO:0062124;GO:0032217;GO:0001618;GO:0006771;GO:0032218;, C:integral component of plasma membrane; C:plasma membrane;, F:4-hydroxybutyrate receptor activity; F:riboflavin transmembrane transporter activity; F:virus receptor activity;, P:riboflavin metabolic process; P:riboflavin transport;|Q9HAB3 A8K6B6 D3DWL8 G1UCY1 Q86UT1,Solute carrier family 52, riboflavin transporter, member 2,Porcine endogenous retrovirus A receptor 1 {ECO:0000303|PubMed:12740431};Protein GPR172A;Riboflavin transporter 3;, PF06237;, GO:0005887;GO:0005886;GO:0062124;GO:0032217;GO:0001618;GO:0006771;GO:0032218;, C:integral component of plasma membrane; C:plasma membrane;, F:4-hydroxybutyrate receptor activity; F:riboflavin transmembrane transporter activity; F:virus receptor activity;, P:riboflavin metabolic process; P:riboflavin transport; scaffold205 indexed_genome mRNA 259334 270525 . + . ID=transcript_15720;Q3MIX3 B3KS46 Q5U4P1 Q6P2S4 Q8N5V3,Uncharacterized aarF domain-containing protein kinase 5,, PF03109;, GO:0016021;GO:0004674;, C:integral component of membrane;, F:protein serine/threonine kinase activity;|Q3MIX3 B3KS46 Q5U4P1 Q6P2S4 Q8N5V3,Uncharacterized aarF domain-containing protein kinase 5,, PF03109;, GO:0016021;GO:0004674;, C:integral component of membrane;, F:protein serine/threonine kinase activity;|Q3MIX3 B3KS46 Q5U4P1 Q6P2S4 Q8N5V3,Uncharacterized aarF domain-containing protein kinase 5,, PF03109;, GO:0016021;GO:0004674;, C:integral component of membrane;, F:protein serine/threonine kinase activity;|Q3MIX3 B3KS46 Q5U4P1 Q6P2S4 Q8N5V3,Uncharacterized aarF domain-containing protein kinase 5,, PF03109;, GO:0016021;GO:0004674;, C:integral component of membrane;, F:protein serine/threonine kinase activity;|Q3MIX3 B3KS46 Q5U4P1 Q6P2S4 Q8N5V3,Uncharacterized aarF domain-containing protein kinase 5,, PF03109;, GO:0016021;GO:0004674;, C:integral component of membrane;, F:protein serine/threonine kinase activity;|Q3MIX3 B3KS46 Q5U4P1 Q6P2S4 Q8N5V3,Uncharacterized aarF domain-containing protein kinase 5,, PF03109;, GO:0016021;GO:0004674;, C:integral component of membrane;, F:protein serine/threonine kinase activity; scaffold205 indexed_genome mRNA 270618 286255 . - . ID=transcript_15721;Q10570 Q96AF0,Cleavage and polyadenylation specificity factor subunit 1,Cleavage and polyadenylation specificity factor 160 kDa subunit;, PF03178;PF10433;, GO:0005847;GO:0005654;GO:0005634;GO:0019899;GO:0035925;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0098789;GO:0006369;GO:0006388;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:mRNA 3'-UTR AU-rich region binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q10570 Q96AF0,Cleavage and polyadenylation specificity factor subunit 1,Cleavage and polyadenylation specificity factor 160 kDa subunit;, PF03178;PF10433;, GO:0005847;GO:0005654;GO:0005634;GO:0019899;GO:0035925;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0098789;GO:0006369;GO:0006388;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:mRNA 3'-UTR AU-rich region binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q10570 Q96AF0,Cleavage and polyadenylation specificity factor subunit 1,Cleavage and polyadenylation specificity factor 160 kDa subunit;, PF03178;PF10433;, GO:0005847;GO:0005654;GO:0005634;GO:0019899;GO:0035925;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0098789;GO:0006369;GO:0006388;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:mRNA 3'-UTR AU-rich region binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q10570 Q96AF0,Cleavage and polyadenylation specificity factor subunit 1,Cleavage and polyadenylation specificity factor 160 kDa subunit;, PF03178;PF10433;, GO:0005847;GO:0005654;GO:0005634;GO:0019899;GO:0035925;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0098789;GO:0006369;GO:0006388;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:mRNA 3'-UTR AU-rich region binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; P:tRNA splicing, via endonucleolytic cleavage and ligation;|Q10570 Q96AF0,Cleavage and polyadenylation specificity factor subunit 1,Cleavage and polyadenylation specificity factor 160 kDa subunit;, PF03178;PF10433;, GO:0005847;GO:0005654;GO:0005634;GO:0019899;GO:0035925;GO:0031124;GO:0006406;GO:0006378;GO:0000398;GO:0098789;GO:0006369;GO:0006388;, C:mRNA cleavage and polyadenylation specificity factor complex; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:mRNA 3'-UTR AU-rich region binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA polyadenylation; P:mRNA splicing, via spliceosome; P:pre-mRNA cleavage required for polyadenylation; P:termination of RNA polymerase II transcription; P:tRNA splicing, via endonucleolytic cleavage and ligation; scaffold205 indexed_genome mRNA 289322 294391 . - . ID=transcript_15722;Q6P5W5 Q7L5S5 Q9H6T8 Q9NXC4,Zinc transporter ZIP4,Solute carrier family 39 member 4;Zrt- and Irt-like protein 4;, PF02535;PF18292;, GO:0016324;GO:0031410;GO:0005887;GO:0005886;GO:0055038;GO:0005385;GO:0034224;GO:0006882;GO:0071578;GO:0071577;, C:apical plasma membrane; C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane; C:recycling endosome membrane;, F:zinc ion transmembrane transporter activity;, P:cellular response to zinc ion starvation; P:cellular zinc ion homeostasis; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport;|Q6P5W5 Q7L5S5 Q9H6T8 Q9NXC4,Zinc transporter ZIP4,Solute carrier family 39 member 4;Zrt- and Irt-like protein 4;, PF02535;PF18292;, GO:0016324;GO:0031410;GO:0005887;GO:0005886;GO:0055038;GO:0005385;GO:0034224;GO:0006882;GO:0071578;GO:0071577;, C:apical plasma membrane; C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane; C:recycling endosome membrane;, F:zinc ion transmembrane transporter activity;, P:cellular response to zinc ion starvation; P:cellular zinc ion homeostasis; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport;|Q6P5W5 Q7L5S5 Q9H6T8 Q9NXC4,Zinc transporter ZIP4,Solute carrier family 39 member 4;Zrt- and Irt-like protein 4;, PF02535;PF18292;, GO:0016324;GO:0031410;GO:0005887;GO:0005886;GO:0055038;GO:0005385;GO:0034224;GO:0006882;GO:0071578;GO:0071577;, C:apical plasma membrane; C:cytoplasmic vesicle; C:integral component of plasma membrane; C:plasma membrane; C:recycling endosome membrane;, F:zinc ion transmembrane transporter activity;, P:cellular response to zinc ion starvation; P:cellular zinc ion homeostasis; P:zinc ion import across plasma membrane; P:zinc ion transmembrane transport; scaffold205 indexed_genome mRNA 303412 307677 . - . ID=transcript_15723;Q9UK41 Q86VK0,Vacuolar protein sorting-associated protein 28 homolog,ESCRT-I complex subunit VPS28;, PF03997;, GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0000813;GO:0070062;GO:0043657;GO:0031902;GO:0005886;GO:0044877;GO:0043130;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:0031397;GO:0045732;GO:2000397;GO:0043328;GO:0043162;GO:0039702;GO:0019058;, C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:host cell; C:late endosome membrane; C:plasma membrane;, F:protein-containing complex binding; F:ubiquitin binding;, P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:negative regulation of protein ubiquitination; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin-dependent endocytosis; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle;|Q9UK41 Q86VK0,Vacuolar protein sorting-associated protein 28 homolog,ESCRT-I complex subunit VPS28;, PF03997;, GO:0005737;GO:0005829;GO:0005769;GO:0005768;GO:0010008;GO:0000813;GO:0070062;GO:0043657;GO:0031902;GO:0005886;GO:0044877;GO:0043130;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:0031397;GO:0045732;GO:2000397;GO:0043328;GO:0043162;GO:0039702;GO:0019058;, C:cytoplasm; C:cytosol; C:early endosome; C:endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:host cell; C:late endosome membrane; C:plasma membrane;, F:protein-containing complex binding; F:ubiquitin binding;, P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:negative regulation of protein ubiquitination; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin-dependent endocytosis; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle; scaffold205 indexed_genome mRNA 308827 319932 . - . ID=transcript_15724;Q96HA7 B5MDP0 C9JKB1 C9JNV8 Q13006 Q9UGJ2,Tonsoku-like protein,Inhibitor of kappa B-related protein;NF-kappa-B inhibitor-like protein 2;Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2;, PF12796;PF13516;PF13181;, GO:0005737;GO:0016604;GO:0043596;GO:0005654;GO:0042393;GO:0000724;GO:0031297;, C:cytoplasm; C:nuclear body; C:nuclear replication fork; C:nucleoplasm;, F:histone binding;, P:double-strand break repair via homologous recombination; P:replication fork processing;|Q96HA7 B5MDP0 C9JKB1 C9JNV8 Q13006 Q9UGJ2,Tonsoku-like protein,Inhibitor of kappa B-related protein;NF-kappa-B inhibitor-like protein 2;Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2;, PF12796;PF13516;PF13181;, GO:0005737;GO:0016604;GO:0043596;GO:0005654;GO:0042393;GO:0000724;GO:0031297;, C:cytoplasm; C:nuclear body; C:nuclear replication fork; C:nucleoplasm;, F:histone binding;, P:double-strand break repair via homologous recombination; P:replication fork processing; scaffold205 indexed_genome mRNA 321413 333705 . - . ID=transcript_15725;Q6ZMK1 B3KSX0 D3DWM3 Q9BSF6 Q9BSU6,Cysteine and histidine-rich protein 1,, , GO:0005654;GO:0048471;GO:0008270;, C:nucleoplasm; C:perinuclear region of cytoplasm;, F:zinc ion binding;|Q6ZMK1 B3KSX0 D3DWM3 Q9BSF6 Q9BSU6,Cysteine and histidine-rich protein 1,, , GO:0005654;GO:0048471;GO:0008270;, C:nucleoplasm; C:perinuclear region of cytoplasm;, F:zinc ion binding; scaffold205 indexed_genome mRNA 334934 337014 . + . ID=transcript_15726;Q6ZMK1 B3KSX0 D3DWM3 Q9BSF6 Q9BSU6,Cysteine and histidine-rich protein 1,, , GO:0005654;GO:0048471;GO:0008270;, C:nucleoplasm; C:perinuclear region of cytoplasm;, F:zinc ion binding; scaffold205 indexed_genome mRNA 338074 338746 . + . ID=transcript_15727;Q96AC6 E9PHB2 Q96NN6,Kinesin-like protein KIFC2,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0005815;GO:0072686;GO:0005634;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;GO:0090307;, C:cytoplasm; C:kinesin complex; C:microtubule; C:microtubule organizing center; C:mitotic spindle; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:mitotic spindle assembly; scaffold205 indexed_genome mRNA 339063 345676 . + . ID=transcript_15728;Q96AC6 E9PHB2 Q96NN6,Kinesin-like protein KIFC2,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0005815;GO:0072686;GO:0005634;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;GO:0090307;, C:cytoplasm; C:kinesin complex; C:microtubule; C:microtubule organizing center; C:mitotic spindle; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:mitotic spindle assembly;|Q96AC6 E9PHB2 Q96NN6,Kinesin-like protein KIFC2,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0005815;GO:0072686;GO:0005634;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;GO:0090307;, C:cytoplasm; C:kinesin complex; C:microtubule; C:microtubule organizing center; C:mitotic spindle; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:mitotic spindle assembly;|Q96AC6 E9PHB2 Q96NN6,Kinesin-like protein KIFC2,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0005815;GO:0072686;GO:0005634;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;GO:0090307;, C:cytoplasm; C:kinesin complex; C:microtubule; C:microtubule organizing center; C:mitotic spindle; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; P:mitotic spindle assembly;|O75593 D3DWM4,Forkhead box protein H1,Forkhead activin signal transducer 1;Forkhead activin signal transducer 2;, PF00250;, GO:0032444;GO:0000785;GO:0005654;GO:0005634;GO:0005667;GO:0050681;GO:0043425;GO:0000987;GO:0070410;GO:0001228;GO:0003700;GO:0000981;GO:0019904;GO:0070412;GO:0043565;GO:0046332;GO:0000976;GO:0035909;GO:0048318;GO:0003215;GO:0071345;GO:0035054;GO:0001947;GO:0060766;GO:0043433;GO:0033147;GO:0000122;GO:1900164;GO:0003151;GO:0045944;GO:0045893;GO:0003139;GO:0007179;GO:0003222;, C:activin responsive factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:androgen receptor binding; F:bHLH transcription factor binding; F:cis-regulatory region sequence-specific DNA binding; F:co-SMAD binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:R-SMAD binding; F:sequence-specific DNA binding; F:SMAD binding; F:transcription regulatory region sequence-specific DNA binding;, P:aorta morphogenesis; P:axial mesoderm development; P:cardiac right ventricle morphogenesis; P:cellular response to cytokine stimulus; P:embryonic heart tube anterior/posterior pattern specification; P:heart looping; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry; P:outflow tract morphogenesis; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:secondary heart field specification; P:transforming growth factor beta receptor signaling pathway; P:ventricular trabecula myocardium morphogenesis; scaffold205 indexed_genome mRNA 361605 376561 . + . ID=transcript_15729;Q96I34 D3DWM5,Protein phosphatase 1 regulatory subunit 16A,Myosin phosphatase-targeting subunit 3;, PF12796;, GO:0005886;GO:0017020;GO:0008157;GO:0019888;GO:0035304;, C:plasma membrane;, F:myosin phosphatase regulator activity; F:protein phosphatase 1 binding; F:protein phosphatase regulator activity;, P:regulation of protein dephosphorylation;|Q96I34 D3DWM5,Protein phosphatase 1 regulatory subunit 16A,Myosin phosphatase-targeting subunit 3;, PF12796;, GO:0005886;GO:0017020;GO:0008157;GO:0019888;GO:0035304;, C:plasma membrane;, F:myosin phosphatase regulator activity; F:protein phosphatase 1 binding; F:protein phosphatase regulator activity;, P:regulation of protein dephosphorylation; scaffold205 indexed_genome mRNA 376882 381566 . + . ID=transcript_15730;P24298 B0YJ18 D3DWM7 P78398 Q93076,Alanine aminotransferase 1,Glutamate pyruvate transaminase 1;Glutamic--alanine transaminase 1;Glutamic--pyruvic transaminase 1;, PF00155;, GO:0005829;GO:0070062;GO:0004021;GO:0030170;GO:0009058;GO:0032869;GO:0042853;GO:0045722;GO:0009078;GO:0042594;, C:cytosol; C:extracellular exosome;, F:L-alanine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding;, P:biosynthetic process; P:cellular response to insulin stimulus; P:L-alanine catabolic process; P:positive regulation of gluconeogenesis; P:pyruvate family amino acid metabolic process; P:response to starvation; scaffold205 indexed_genome mRNA 384347 386133 . - . ID=transcript_15731;O94761 A0A087WZ30 Q3Y424 Q96DW2 Q96F55,ATP-dependent DNA helicase Q4,DNA helicase, RecQ-like type 4;RTS;RecQ protein-like 4;, PF00270;PF11719;PF00271;, GO:0005694;GO:0000781;GO:0005737;GO:0016020;GO:0005634;GO:0043138;GO:0036310;GO:0005524;GO:0000405;GO:0009378;GO:0004386;GO:0032357;GO:0061821;GO:0032508;GO:0006310;GO:0006281;GO:0006260;GO:0000733;GO:0006268;GO:0000724;GO:0007275;GO:0000723;GO:0061820;, C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:membrane; C:nucleus;, F:3'-5' DNA helicase activity; F:annealing helicase activity; F:ATP binding; F:bubble DNA binding; F:four-way junction helicase activity; F:helicase activity; F:oxidized purine DNA binding; F:telomeric D-loop binding;, P:DNA duplex unwinding; P:DNA recombination; P:DNA repair; P:DNA replication; P:DNA strand renaturation; P:DNA unwinding involved in DNA replication; P:double-strand break repair via homologous recombination; P:multicellular organism development; P:telomere maintenance; P:telomeric D-loop disassembly; scaffold205 indexed_genome mRNA 389797 394254 . + . ID=transcript_15732;Q15048 A8K0A8 D3DWM8,Leucine-rich repeat-containing protein 14 {ECO:0000305},, PF13516;, GO:0005737;GO:0019900;GO:0032088;GO:0034122;, C:cytoplasm;, F:kinase binding;, P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of toll-like receptor signaling pathway;|Q50LG9,Leucine-rich repeat-containing protein 24,, PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0051965;, C:extracellular matrix; C:extracellular space; C:integral component of membrane;, , P:positive regulation of synapse assembly; scaffold205 indexed_genome mRNA 399146 400739 . - . ID=transcript_15733;Q6P1X6 Q6GMR2 Q6P2Q7,UPF0598 protein C8orf82,, PF14956; scaffold205 indexed_genome mRNA 401367 441083 . - . ID=transcript_15734;Q9C0H5 B4E1I1,Rho GTPase-activating protein 39,, PF00784;PF00620;, GO:0005737;GO:0005856;GO:0005829;GO:0098978;GO:0005634;GO:0005096;GO:0099173;GO:0051056;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:nucleus;, F:GTPase activator activity;, P:postsynapse organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9C0H5 B4E1I1,Rho GTPase-activating protein 39,, PF00784;PF00620;, GO:0005737;GO:0005856;GO:0005829;GO:0098978;GO:0005634;GO:0005096;GO:0099173;GO:0051056;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:nucleus;, F:GTPase activator activity;, P:postsynapse organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q9C0H5 B4E1I1,Rho GTPase-activating protein 39,, PF00784;PF00620;, GO:0005737;GO:0005856;GO:0005829;GO:0098978;GO:0005634;GO:0005096;GO:0099173;GO:0051056;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:nucleus;, F:GTPase activator activity;, P:postsynapse organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;|Q13765 A8MTN7 B2R4P8 F8VU71 Q3KQV4 Q53A18 Q53G46,Nascent polypeptide-associated complex subunit alpha,Alpha-NAC;, PF19026;PF01849;, GO:0005737;GO:0070062;GO:0005854;GO:0005634;GO:0003677;GO:0003713;GO:0003231;GO:0061384;GO:0010664;GO:1901227;GO:2000138;GO:0048633;GO:1901228;GO:0015031;GO:0048742;GO:0043403;GO:0006412;GO:0042060;, C:cytoplasm; C:extracellular exosome; C:nascent polypeptide-associated complex; C:nucleus;, F:DNA binding; F:transcription coactivator activity;, P:cardiac ventricle development; P:heart trabecula morphogenesis; P:negative regulation of striated muscle cell apoptotic process; P:negative regulation of transcription from RNA polymerase II promoter involved in heart development; P:positive regulation of cell proliferation involved in heart morphogenesis; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; P:protein transport; P:regulation of skeletal muscle fiber development; P:skeletal muscle tissue regeneration; P:translation; P:wound healing;|Q9C0H5 B4E1I1,Rho GTPase-activating protein 39,, PF00784;PF00620;, GO:0005737;GO:0005856;GO:0005829;GO:0098978;GO:0005634;GO:0005096;GO:0099173;GO:0051056;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:nucleus;, F:GTPase activator activity;, P:postsynapse organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold205 indexed_genome mRNA 469226 475267 . + . ID=transcript_15735;Q9GZQ3 D3DWN7 Q9NVN6 Q9UHX5,COMM domain-containing protein 5,Hypertension-related calcium-regulated gene protein;, PF07258;, GO:0005829;GO:0005654;GO:0005634;, C:cytosol; C:nucleoplasm; C:nucleus; scaffold205 indexed_genome mRNA 476649 485207 . - . ID=transcript_15736;P17097 B4DT08 D3DWN6 P17015 Q8N8Y4,Zinc finger protein 7,Zinc finger protein HF.16;Zinc finger protein KOX4;, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:0007275;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II;|P17097 B4DT08 D3DWN6 P17015 Q8N8Y4,Zinc finger protein 7,Zinc finger protein HF.16;Zinc finger protein KOX4;, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:0007275;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; scaffold205 indexed_genome mRNA 498651 501261 . + . ID=transcript_15737;P62917 A8K094 D3DWN2 P25120 Q567Q7 Q969V7 Q9BWQ9,60S ribosomal protein L8,Large ribosomal subunit protein uL2 {ECO:0000303|PubMed:24524803};, PF00181;PF03947;, GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0042788;GO:0098794;GO:0014069;GO:1990932;GO:0003723;GO:0003735;GO:1990090;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:polysomal ribosome; C:postsynapse; C:postsynaptic density;, F:5.8S rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cellular response to nerve growth factor stimulus; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62917 A8K094 D3DWN2 P25120 Q567Q7 Q969V7 Q9BWQ9,60S ribosomal protein L8,Large ribosomal subunit protein uL2 {ECO:0000303|PubMed:24524803};, PF00181;PF03947;, GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0042788;GO:0098794;GO:0014069;GO:1990932;GO:0003723;GO:0003735;GO:1990090;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:polysomal ribosome; C:postsynapse; C:postsynaptic density;, F:5.8S rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cellular response to nerve growth factor stimulus; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62917 A8K094 D3DWN2 P25120 Q567Q7 Q969V7 Q9BWQ9,60S ribosomal protein L8,Large ribosomal subunit protein uL2 {ECO:0000303|PubMed:24524803};, PF00181;PF03947;, GO:0005829;GO:0022625;GO:0005925;GO:0016020;GO:0042788;GO:0098794;GO:0014069;GO:1990932;GO:0003723;GO:0003735;GO:1990090;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:membrane; C:polysomal ribosome; C:postsynapse; C:postsynaptic density;, F:5.8S rRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cellular response to nerve growth factor stimulus; P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold205 indexed_genome mRNA 509410 513355 . - . ID=transcript_15738;Q9WJR5 O15312,Endogenous retrovirus group K member 19 Pol protein,HERV-K(C19) Pol protein;HERV-K_19q11 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold205 indexed_genome mRNA 516237 518110 . + . ID=transcript_15739;Q8IZ26 D3DWN1 Q9BSZ0,Zinc finger protein 34,Zinc finger protein KOX32;, PF01352;PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8IZ26 D3DWN1 Q9BSZ0,Zinc finger protein 34,Zinc finger protein KOX32;, PF01352;PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold205 indexed_genome mRNA 520083 523187 . + . ID=transcript_15740;Q8IZ26 D3DWN1 Q9BSZ0,Zinc finger protein 34,Zinc finger protein KOX32;, PF01352;PF00096;, GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold205 indexed_genome mRNA 523737 527664 . - . ID=transcript_15741;Q9H7E9 A6NGC0 Q96BT8,UPF0488 protein C8orf33,, PF15393;|Q9H7E9 A6NGC0 Q96BT8,UPF0488 protein C8orf33,, PF15393;|Q9H7E9 A6NGC0 Q96BT8,UPF0488 protein C8orf33,, PF15393; scaffold205 indexed_genome mRNA 566483 581350 . + . ID=transcript_15742;P17020 B3KXM4 D3DWP2 Q45SH7 Q96FG0 Q9NRA4,Zinc finger protein 16,Zinc finger protein KOX9;, PF00096;, GO:0005730;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0007049;GO:0051301;GO:0072707;GO:0043066;GO:1901989;GO:0051781;GO:0008284;GO:0045648;GO:0033674;GO:0045654;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle; P:cell division; P:cellular response to sodium dodecyl sulfate; P:negative regulation of apoptotic process; P:positive regulation of cell cycle phase transition; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of erythrocyte differentiation; P:positive regulation of kinase activity; P:positive regulation of megakaryocyte differentiation; P:regulation of transcription by RNA polymerase II;|P17020 B3KXM4 D3DWP2 Q45SH7 Q96FG0 Q9NRA4,Zinc finger protein 16,Zinc finger protein KOX9;, PF00096;, GO:0005730;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0007049;GO:0051301;GO:0072707;GO:0043066;GO:1901989;GO:0051781;GO:0008284;GO:0045648;GO:0033674;GO:0045654;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:cell cycle; P:cell division; P:cellular response to sodium dodecyl sulfate; P:negative regulation of apoptotic process; P:positive regulation of cell cycle phase transition; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of erythrocyte differentiation; P:positive regulation of kinase activity; P:positive regulation of megakaryocyte differentiation; P:regulation of transcription by RNA polymerase II; scaffold205 indexed_genome mRNA 587611 598762 . + . ID=transcript_15743;P15622 D3DWP1 Q59HE9 Q8N942 Q96AH9,Zinc finger protein 250,Zinc finger protein 647;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|P15622 D3DWP1 Q59HE9 Q8N942 Q96AH9,Zinc finger protein 250,Zinc finger protein 647;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0042802;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold205 indexed_genome mRNA 648701 651713 . - . ID=transcript_15744;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold205 indexed_genome mRNA 655934 657995 . + . ID=transcript_15745;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold205 indexed_genome mRNA 660806 662106 . - . ID=transcript_15746;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold205 indexed_genome mRNA 664470 669365 . - . ID=transcript_15747;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold205 indexed_genome mRNA 670995 672921 . - . ID=transcript_15748;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold205 indexed_genome mRNA 675715 685987 . - . ID=transcript_15749;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold206 indexed_genome mRNA 96039 109816 . + . ID=transcript_15750;Q9UKX7 B1AHA4 B2RB15 O75644 Q8N6V5 Q9NPM9 Q9NPR6 Q9P1K5,Nuclear pore complex protein Nup50,50 kDa nucleoporin;Nuclear pore-associated protein 60 kDa-like;Nucleoporin Nup50;, PF08911;PF00638;, GO:0043657;GO:0031965;GO:0005643;GO:0005654;GO:0075733;GO:0006406;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:host cell; C:nuclear membrane; C:nuclear pore; C:nucleoplasm;, , P:intracellular transport of virus; P:mRNA export from nucleus; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold206 indexed_genome mRNA 116455 129979 . - . ID=transcript_15751;Q6ICG6 B0QY17 B0QY19 B3KT48 Q6ZVE5 Q7Z6K9 Q8IZ76 Q9Y2E2,Uncharacterized protein KIAA0930,, PF09741; scaffold206 indexed_genome mRNA 220685 237381 . + . ID=transcript_15752;Q9NWS6 B3KWG4 B4DY02 Q5TII5 Q96CY3,Protein FAM118A,, PF13289;, GO:0016021;GO:0042802;, C:integral component of membrane;, F:identical protein binding;|Q9NWS6 B3KWG4 B4DY02 Q5TII5 Q96CY3,Protein FAM118A,, PF13289;, GO:0016021;GO:0042802;, C:integral component of membrane;, F:identical protein binding;|Q9NWS6 B3KWG4 B4DY02 Q5TII5 Q96CY3,Protein FAM118A,, PF13289;, GO:0016021;GO:0042802;, C:integral component of membrane;, F:identical protein binding; scaffold206 indexed_genome mRNA 237383 239171 . - . ID=transcript_15753;Q9NWS6 B3KWG4 B4DY02 Q5TII5 Q96CY3,Protein FAM118A,, PF13289;, GO:0016021;GO:0042802;, C:integral component of membrane;, F:identical protein binding; scaffold206 indexed_genome mRNA 323353 334323 . + . ID=transcript_15754;Q9H4K1 A0A087X0F7 Q6ICD0 Q9Y413,RIB43A-like with coiled-coils protein 2 {ECO:0000305},, PF05914;, GO:0005634;, C:nucleus; scaffold206 indexed_genome mRNA 401498 469483 . + . ID=transcript_15755;Q9UC21 Q9UGR4 Q9UH41,Fibulin-1,, PF12662;PF07645;, GO:0062023;GO:0071953;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005509;GO:0005201;GO:0070051;GO:0001968;GO:0042802;GO:0005178;GO:0016504;GO:0008022;GO:0044877;GO:0072378;GO:0030198;GO:0007162;GO:2000146;GO:0070373;GO:0001933;GO:2000647;GO:1900025;GO:1904188;GO:0071635;GO:0048146;GO:0010628;GO:1904237;GO:0016032;, C:collagen-containing extracellular matrix; C:elastic fiber; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:extracellular matrix structural constituent; F:fibrinogen binding; F:fibronectin binding; F:identical protein binding; F:integrin binding; F:peptidase activator activity; F:protein C-terminus binding; F:protein-containing complex binding;, P:blood coagulation, fibrin clot formation; P:extracellular matrix organization; P:negative regulation of cell adhesion; P:negative regulation of cell motility; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of protein phosphorylation; P:negative regulation of stem cell proliferation; P:negative regulation of substrate adhesion-dependent cell spreading; P:negative regulation of transformation of host cell by virus; P:negative regulation of transforming growth factor beta production; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of substrate-dependent cell migration, cell attachment to substrate; P:viral process;|P98095 B7Z9C5 Q8IUI0 Q8IUI1,Fibulin-2,, PF01821;PF12662;PF07645;, GO:0062023;GO:0031012;GO:0005576;GO:1903561;GO:0005509;GO:0050840;GO:0030023;GO:0005201;GO:0030198;GO:0010811;, C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:extracellular vesicle;, F:calcium ion binding; F:extracellular matrix binding; F:extracellular matrix constituent conferring elasticity; F:extracellular matrix structural constituent;, P:extracellular matrix organization; P:positive regulation of cell-substrate adhesion; scaffold206 indexed_genome mRNA 537687 538779 . - . ID=transcript_15756;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold206 indexed_genome mRNA 556219 677934 . + . ID=transcript_15757;Q9UBB4 A6NLC4 B4DG05 O14998 O15009 Q6I9X4,Ataxin-10,Brain protein E46 homolog;Spinocerebellar ataxia type 10 protein;, PF09759;, GO:0005737;GO:0005829;GO:0030425;GO:0005615;GO:0016020;GO:0043025;GO:0048471;GO:0005886;GO:0019899;GO:0042802;GO:0060271;GO:0007399;GO:0031175;, C:cytoplasm; C:cytosol; C:dendrite; C:extracellular space; C:membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane;, F:enzyme binding; F:identical protein binding;, P:cilium assembly; P:nervous system development; P:neuron projection development; scaffold207 indexed_genome mRNA 547940 626672 . - . ID=transcript_15758;P08842 B2RA47,Steryl-sulfatase,Arylsulfatase C;Estrone sulfatase {ECO:0000303|PubMed:12657638};Steroid sulfatase;Steryl-sulfate sulfohydrolase;, PF00884;, GO:0005783;GO:0005788;GO:0005789;GO:0005768;GO:0005794;GO:0016021;GO:0043231;GO:0005764;GO:0016020;GO:0005886;GO:0004065;GO:0046872;GO:0004773;GO:0008484;GO:0008544;GO:0007565;GO:0006687;GO:0006706;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosome; C:membrane; C:plasma membrane;, F:arylsulfatase activity; F:metal ion binding; F:steryl-sulfatase activity; F:sulfuric ester hydrolase activity;, P:epidermis development; P:female pregnancy; P:glycosphingolipid metabolic process; P:steroid catabolic process; scaffold208 indexed_genome mRNA 115529 119841 . - . ID=transcript_15759;Q9UHG2 Q4VC04,ProSAAS,Proprotein convertase subtilisin/kexin type 1 inhibitor;pro-SAAS;, PF07259;, GO:0005615;GO:0030141;GO:0005802;GO:0004866;GO:0004867;GO:0005102;GO:0007218;GO:0016486;GO:0009409;GO:0002021;, C:extracellular space; C:secretory granule; C:trans-Golgi network;, F:endopeptidase inhibitor activity; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding;, P:neuropeptide signaling pathway; P:peptide hormone processing; P:response to cold; P:response to dietary excess; scaffold208 indexed_genome mRNA 121501 126015 . + . ID=transcript_15760;Q7Z444,GTPase ERas,Embryonic stem cell-expressed Ras;, PF00071;, GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0007265;, C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:Ras protein signal transduction; scaffold208 indexed_genome mRNA 126016 144375 . - . ID=transcript_15761;Q9UBN7 O94975 Q6NT75 Q7L3E5 Q96CY0,Histone deacetylase 6,Tubulin-lysine deacetylase HDAC6 {ECO:0000305};, PF00850;PF02148;, GO:0016235;GO:0030424;GO:0005901;GO:0031252;GO:0005737;GO:0005829;GO:0030425;GO:0000118;GO:0016234;GO:0005874;GO:0005875;GO:0005771;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0003779;GO:0043014;GO:0008013;GO:0048487;GO:0070840;GO:0019899;GO:0004407;GO:0042826;GO:0051879;GO:0008017;GO:0051787;GO:0032041;GO:0031593;GO:0033558;GO:0000978;GO:0001226;GO:0048156;GO:0042903;GO:0043130;GO:0031625;GO:0008270;GO:0035973;GO:0070842;GO:0070301;GO:0071218;GO:0035967;GO:0060271;GO:0048668;GO:0060997;GO:0016575;GO:0070846;GO:0006886;GO:0032418;GO:0051646;GO:0010727;GO:0007026;GO:0051354;GO:0031333;GO:0043242;GO:0045861;GO:0045892;GO:0061734;GO:0034983;GO:0070845;GO:0010634;GO:1901300;GO:0033138;GO:2000273;GO:0006476;GO:0031648;GO:0000209;GO:0006515;GO:0032984;GO:0060765;GO:0010506;GO:1903146;GO:0070201;GO:0045598;GO:0040029;GO:0016241;GO:0060632;GO:0031647;GO:0070848;GO:0051788;GO:0090042;GO:0043162;, C:aggresome; C:axon; C:caveola; C:cell leading edge; C:cytoplasm; C:cytosol; C:dendrite; C:histone deacetylase complex; C:inclusion body; C:microtubule; C:microtubule associated complex; C:multivesicular body; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm;, F:actin binding; F:alpha-tubulin binding; F:beta-catenin binding; F:beta-tubulin binding; F:dynein complex binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:Hsp90 protein binding; F:microtubule binding; F:misfolded protein binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:polyubiquitin modification-dependent protein binding; F:protein deacetylase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:tau protein binding; F:tubulin deacetylase activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:aggrephagy; P:aggresome assembly; P:cellular response to hydrogen peroxide; P:cellular response to misfolded protein; P:cellular response to topologically incorrect protein; P:cilium assembly; P:collateral sprouting; P:dendritic spine morphogenesis; P:histone deacetylation; P:Hsp90 deacetylation; P:intracellular protein transport; P:lysosome localization; P:mitochondrion localization; P:negative regulation of hydrogen peroxide metabolic process; P:negative regulation of microtubule depolymerization; P:negative regulation of oxidoreductase activity; P:negative regulation of protein-containing complex assembly; P:negative regulation of protein-containing complex disassembly; P:negative regulation of proteolysis; P:negative regulation of transcription, DNA-templated; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:peptidyl-lysine deacetylation; P:polyubiquitinated misfolded protein transport; P:positive regulation of epithelial cell migration; P:positive regulation of hydrogen peroxide-mediated programmed cell death; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of signaling receptor activity; P:protein deacetylation; P:protein destabilization; P:protein polyubiquitination; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein-containing complex disassembly; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of autophagy of mitochondrion; P:regulation of establishment of protein localization; P:regulation of fat cell differentiation; P:regulation of gene expression, epigenetic; P:regulation of macroautophagy; P:regulation of microtubule-based movement; P:regulation of protein stability; P:response to growth factor; P:response to misfolded protein; P:tubulin deacetylation; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;|Q9UBN7 O94975 Q6NT75 Q7L3E5 Q96CY0,Histone deacetylase 6,Tubulin-lysine deacetylase HDAC6 {ECO:0000305};, PF00850;PF02148;, GO:0016235;GO:0030424;GO:0005901;GO:0031252;GO:0005737;GO:0005829;GO:0030425;GO:0000118;GO:0016234;GO:0005874;GO:0005875;GO:0005771;GO:0005654;GO:0005634;GO:0043204;GO:0048471;GO:0003779;GO:0043014;GO:0008013;GO:0048487;GO:0070840;GO:0019899;GO:0004407;GO:0042826;GO:0051879;GO:0008017;GO:0051787;GO:0032041;GO:0031593;GO:0033558;GO:0000978;GO:0001226;GO:0048156;GO:0042903;GO:0043130;GO:0031625;GO:0008270;GO:0035973;GO:0070842;GO:0070301;GO:0071218;GO:0035967;GO:0060271;GO:0048668;GO:0060997;GO:0016575;GO:0070846;GO:0006886;GO:0032418;GO:0051646;GO:0010727;GO:0007026;GO:0051354;GO:0031333;GO:0043242;GO:0045861;GO:0045892;GO:0061734;GO:0034983;GO:0070845;GO:0010634;GO:1901300;GO:0033138;GO:2000273;GO:0006476;GO:0031648;GO:0000209;GO:0006515;GO:0032984;GO:0060765;GO:0010506;GO:1903146;GO:0070201;GO:0045598;GO:0040029;GO:0016241;GO:0060632;GO:0031647;GO:0070848;GO:0051788;GO:0090042;GO:0043162;, C:aggresome; C:axon; C:caveola; C:cell leading edge; C:cytoplasm; C:cytosol; C:dendrite; C:histone deacetylase complex; C:inclusion body; C:microtubule; C:microtubule associated complex; C:multivesicular body; C:nucleoplasm; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm;, F:actin binding; F:alpha-tubulin binding; F:beta-catenin binding; F:beta-tubulin binding; F:dynein complex binding; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:Hsp90 protein binding; F:microtubule binding; F:misfolded protein binding; F:NAD-dependent histone deacetylase activity (H3-K14 specific); F:polyubiquitin modification-dependent protein binding; F:protein deacetylase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription corepressor binding; F:tau protein binding; F:tubulin deacetylase activity; F:ubiquitin binding; F:ubiquitin protein ligase binding; F:zinc ion binding;, P:aggrephagy; P:aggresome assembly; P:cellular response to hydrogen peroxide; P:cellular response to misfolded protein; P:cellular response to topologically incorrect protein; P:cilium assembly; P:collateral sprouting; P:dendritic spine morphogenesis; P:histone deacetylation; P:Hsp90 deacetylation; P:intracellular protein transport; P:lysosome localization; P:mitochondrion localization; P:negative regulation of hydrogen peroxide metabolic process; P:negative regulation of microtubule depolymerization; P:negative regulation of oxidoreductase activity; P:negative regulation of protein-containing complex assembly; P:negative regulation of protein-containing complex disassembly; P:negative regulation of proteolysis; P:negative regulation of transcription, DNA-templated; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; P:peptidyl-lysine deacetylation; P:polyubiquitinated misfolded protein transport; P:positive regulation of epithelial cell migration; P:positive regulation of hydrogen peroxide-mediated programmed cell death; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of signaling receptor activity; P:protein deacetylation; P:protein destabilization; P:protein polyubiquitination; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein-containing complex disassembly; P:regulation of androgen receptor signaling pathway; P:regulation of autophagy; P:regulation of autophagy of mitochondrion; P:regulation of establishment of protein localization; P:regulation of fat cell differentiation; P:regulation of gene expression, epigenetic; P:regulation of macroautophagy; P:regulation of microtubule-based movement; P:regulation of protein stability; P:response to growth factor; P:response to misfolded protein; P:tubulin deacetylation; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold208 indexed_genome mRNA 233349 235406 . + . ID=transcript_15762;O43463 B2R6E8 B4DST0 Q53G60 Q6FHK6,Histone-lysine N-methyltransferase SUV39H1,Histone H3-K9 methyltransferase 1;Lysine N-methyltransferase 1A;Position-effect variegation 3-9 homolog;Suppressor of variegation 3-9 homolog 1;, PF00385;PF05033;PF00856;, GO:0005677;GO:0000775;GO:0000794;GO:0000792;GO:0005652;GO:0005654;GO:0005634;GO:0033553;GO:0003682;GO:0042054;GO:0046974;GO:0018024;GO:0047485;GO:0008757;GO:0000976;GO:0008270;GO:0007049;GO:0030154;GO:0006974;GO:0071456;GO:0006325;GO:0036123;GO:0036124;GO:0034968;GO:0042754;GO:0000122;GO:0045892;GO:0000183;GO:0048511;GO:0006364;GO:0016032;, C:chromatin silencing complex; C:chromosome, centromeric region; C:condensed nuclear chromosome; C:heterochromatin; C:nuclear lamina; C:nucleoplasm; C:nucleus; C:rDNA heterochromatin;, F:chromatin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:protein N-terminus binding; F:S-adenosylmethionine-dependent methyltransferase activity; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell cycle; P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:chromatin organization; P:histone H3-K9 dimethylation; P:histone H3-K9 trimethylation; P:histone lysine methylation; P:negative regulation of circadian rhythm; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:rDNA heterochromatin assembly; P:rhythmic process; P:rRNA processing; P:viral process; scaffold208 indexed_genome mRNA 235451 247234 . - . ID=transcript_15763;O43463 B2R6E8 B4DST0 Q53G60 Q6FHK6,Histone-lysine N-methyltransferase SUV39H1,Histone H3-K9 methyltransferase 1;Lysine N-methyltransferase 1A;Position-effect variegation 3-9 homolog;Suppressor of variegation 3-9 homolog 1;, PF00385;PF05033;PF00856;, GO:0005677;GO:0000775;GO:0000794;GO:0000792;GO:0005652;GO:0005654;GO:0005634;GO:0033553;GO:0003682;GO:0042054;GO:0046974;GO:0018024;GO:0047485;GO:0008757;GO:0000976;GO:0008270;GO:0007049;GO:0030154;GO:0006974;GO:0071456;GO:0006325;GO:0036123;GO:0036124;GO:0034968;GO:0042754;GO:0000122;GO:0045892;GO:0000183;GO:0048511;GO:0006364;GO:0016032;, C:chromatin silencing complex; C:chromosome, centromeric region; C:condensed nuclear chromosome; C:heterochromatin; C:nuclear lamina; C:nucleoplasm; C:nucleus; C:rDNA heterochromatin;, F:chromatin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:protein N-terminus binding; F:S-adenosylmethionine-dependent methyltransferase activity; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell cycle; P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:chromatin organization; P:histone H3-K9 dimethylation; P:histone H3-K9 trimethylation; P:histone lysine methylation; P:negative regulation of circadian rhythm; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:rDNA heterochromatin assembly; P:rhythmic process; P:rRNA processing; P:viral process;|O43463 B2R6E8 B4DST0 Q53G60 Q6FHK6,Histone-lysine N-methyltransferase SUV39H1,Histone H3-K9 methyltransferase 1;Lysine N-methyltransferase 1A;Position-effect variegation 3-9 homolog;Suppressor of variegation 3-9 homolog 1;, PF00385;PF05033;PF00856;, GO:0005677;GO:0000775;GO:0000794;GO:0000792;GO:0005652;GO:0005654;GO:0005634;GO:0033553;GO:0003682;GO:0042054;GO:0046974;GO:0018024;GO:0047485;GO:0008757;GO:0000976;GO:0008270;GO:0007049;GO:0030154;GO:0006974;GO:0071456;GO:0006325;GO:0036123;GO:0036124;GO:0034968;GO:0042754;GO:0000122;GO:0045892;GO:0000183;GO:0048511;GO:0006364;GO:0016032;, C:chromatin silencing complex; C:chromosome, centromeric region; C:condensed nuclear chromosome; C:heterochromatin; C:nuclear lamina; C:nucleoplasm; C:nucleus; C:rDNA heterochromatin;, F:chromatin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:protein N-terminus binding; F:S-adenosylmethionine-dependent methyltransferase activity; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell cycle; P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:chromatin organization; P:histone H3-K9 dimethylation; P:histone H3-K9 trimethylation; P:histone lysine methylation; P:negative regulation of circadian rhythm; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:rDNA heterochromatin assembly; P:rhythmic process; P:rRNA processing; P:viral process;|O43463 B2R6E8 B4DST0 Q53G60 Q6FHK6,Histone-lysine N-methyltransferase SUV39H1,Histone H3-K9 methyltransferase 1;Lysine N-methyltransferase 1A;Position-effect variegation 3-9 homolog;Suppressor of variegation 3-9 homolog 1;, PF00385;PF05033;PF00856;, GO:0005677;GO:0000775;GO:0000794;GO:0000792;GO:0005652;GO:0005654;GO:0005634;GO:0033553;GO:0003682;GO:0042054;GO:0046974;GO:0018024;GO:0047485;GO:0008757;GO:0000976;GO:0008270;GO:0007049;GO:0030154;GO:0006974;GO:0071456;GO:0006325;GO:0036123;GO:0036124;GO:0034968;GO:0042754;GO:0000122;GO:0045892;GO:0000183;GO:0048511;GO:0006364;GO:0016032;, C:chromatin silencing complex; C:chromosome, centromeric region; C:condensed nuclear chromosome; C:heterochromatin; C:nuclear lamina; C:nucleoplasm; C:nucleus; C:rDNA heterochromatin;, F:chromatin binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:protein N-terminus binding; F:S-adenosylmethionine-dependent methyltransferase activity; F:transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell cycle; P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to hypoxia; P:chromatin organization; P:histone H3-K9 dimethylation; P:histone H3-K9 trimethylation; P:histone lysine methylation; P:negative regulation of circadian rhythm; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:rDNA heterochromatin assembly; P:rhythmic process; P:rRNA processing; P:viral process; scaffold208 indexed_genome mRNA 251753 259070 . - . ID=transcript_15764;P42768 Q9BU11 Q9UNJ9,Wiskott-Aldrich syndrome protein,, PF00786;PF00568;PF02205;, GO:0015629;GO:0005884;GO:0005911;GO:0005829;GO:0070062;GO:0005634;GO:0045335;GO:0005886;GO:0035861;GO:0012506;GO:0003779;GO:0030695;GO:0042802;GO:0043274;GO:0019901;GO:0017124;GO:0031267;GO:0030041;GO:0030048;GO:0008154;GO:0007596;GO:0032488;GO:0071346;GO:0006952;GO:0016197;GO:0008544;GO:0038096;GO:0006955;GO:2000146;GO:0051497;GO:2000601;GO:1905168;GO:0045944;GO:0065003;GO:0008064;GO:0010591;GO:0051492;GO:0002625;GO:0042110;GO:0050852;, C:actin cytoskeleton; C:actin filament; C:cell-cell junction; C:cytosol; C:extracellular exosome; C:nucleus; C:phagocytic vesicle; C:plasma membrane; C:site of double-strand break; C:vesicle membrane;, F:actin binding; F:GTPase regulator activity; F:identical protein binding; F:phospholipase binding; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:actin filament polymerization; P:actin filament-based movement; P:actin polymerization or depolymerization; P:blood coagulation; P:Cdc42 protein signal transduction; P:cellular response to interferon-gamma; P:defense response; P:endosomal transport; P:epidermis development; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:immune response; P:negative regulation of cell motility; P:negative regulation of stress fiber assembly; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of actin polymerization or depolymerization; P:regulation of lamellipodium assembly; P:regulation of stress fiber assembly; P:regulation of T cell antigen processing and presentation; P:T cell activation; P:T cell receptor signaling pathway;|P42768 Q9BU11 Q9UNJ9,Wiskott-Aldrich syndrome protein,, PF00786;PF00568;PF02205;, GO:0015629;GO:0005884;GO:0005911;GO:0005829;GO:0070062;GO:0005634;GO:0045335;GO:0005886;GO:0035861;GO:0012506;GO:0003779;GO:0030695;GO:0042802;GO:0043274;GO:0019901;GO:0017124;GO:0031267;GO:0030041;GO:0030048;GO:0008154;GO:0007596;GO:0032488;GO:0071346;GO:0006952;GO:0016197;GO:0008544;GO:0038096;GO:0006955;GO:2000146;GO:0051497;GO:2000601;GO:1905168;GO:0045944;GO:0065003;GO:0008064;GO:0010591;GO:0051492;GO:0002625;GO:0042110;GO:0050852;, C:actin cytoskeleton; C:actin filament; C:cell-cell junction; C:cytosol; C:extracellular exosome; C:nucleus; C:phagocytic vesicle; C:plasma membrane; C:site of double-strand break; C:vesicle membrane;, F:actin binding; F:GTPase regulator activity; F:identical protein binding; F:phospholipase binding; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:actin filament polymerization; P:actin filament-based movement; P:actin polymerization or depolymerization; P:blood coagulation; P:Cdc42 protein signal transduction; P:cellular response to interferon-gamma; P:defense response; P:endosomal transport; P:epidermis development; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:immune response; P:negative regulation of cell motility; P:negative regulation of stress fiber assembly; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of actin polymerization or depolymerization; P:regulation of lamellipodium assembly; P:regulation of stress fiber assembly; P:regulation of T cell antigen processing and presentation; P:T cell activation; P:T cell receptor signaling pathway;|P42768 Q9BU11 Q9UNJ9,Wiskott-Aldrich syndrome protein,, PF00786;PF00568;PF02205;, GO:0015629;GO:0005884;GO:0005911;GO:0005829;GO:0070062;GO:0005634;GO:0045335;GO:0005886;GO:0035861;GO:0012506;GO:0003779;GO:0030695;GO:0042802;GO:0043274;GO:0019901;GO:0017124;GO:0031267;GO:0030041;GO:0030048;GO:0008154;GO:0007596;GO:0032488;GO:0071346;GO:0006952;GO:0016197;GO:0008544;GO:0038096;GO:0006955;GO:2000146;GO:0051497;GO:2000601;GO:1905168;GO:0045944;GO:0065003;GO:0008064;GO:0010591;GO:0051492;GO:0002625;GO:0042110;GO:0050852;, C:actin cytoskeleton; C:actin filament; C:cell-cell junction; C:cytosol; C:extracellular exosome; C:nucleus; C:phagocytic vesicle; C:plasma membrane; C:site of double-strand break; C:vesicle membrane;, F:actin binding; F:GTPase regulator activity; F:identical protein binding; F:phospholipase binding; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:actin filament polymerization; P:actin filament-based movement; P:actin polymerization or depolymerization; P:blood coagulation; P:Cdc42 protein signal transduction; P:cellular response to interferon-gamma; P:defense response; P:endosomal transport; P:epidermis development; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:immune response; P:negative regulation of cell motility; P:negative regulation of stress fiber assembly; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of actin polymerization or depolymerization; P:regulation of lamellipodium assembly; P:regulation of stress fiber assembly; P:regulation of T cell antigen processing and presentation; P:T cell activation; P:T cell receptor signaling pathway;|P42768 Q9BU11 Q9UNJ9,Wiskott-Aldrich syndrome protein,, PF00786;PF00568;PF02205;, GO:0015629;GO:0005884;GO:0005911;GO:0005829;GO:0070062;GO:0005634;GO:0045335;GO:0005886;GO:0035861;GO:0012506;GO:0003779;GO:0030695;GO:0042802;GO:0043274;GO:0019901;GO:0017124;GO:0031267;GO:0030041;GO:0030048;GO:0008154;GO:0007596;GO:0032488;GO:0071346;GO:0006952;GO:0016197;GO:0008544;GO:0038096;GO:0006955;GO:2000146;GO:0051497;GO:2000601;GO:1905168;GO:0045944;GO:0065003;GO:0008064;GO:0010591;GO:0051492;GO:0002625;GO:0042110;GO:0050852;, C:actin cytoskeleton; C:actin filament; C:cell-cell junction; C:cytosol; C:extracellular exosome; C:nucleus; C:phagocytic vesicle; C:plasma membrane; C:site of double-strand break; C:vesicle membrane;, F:actin binding; F:GTPase regulator activity; F:identical protein binding; F:phospholipase binding; F:protein kinase binding; F:SH3 domain binding; F:small GTPase binding;, P:actin filament polymerization; P:actin filament-based movement; P:actin polymerization or depolymerization; P:blood coagulation; P:Cdc42 protein signal transduction; P:cellular response to interferon-gamma; P:defense response; P:endosomal transport; P:epidermis development; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:immune response; P:negative regulation of cell motility; P:negative regulation of stress fiber assembly; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of double-strand break repair via homologous recombination; P:positive regulation of transcription by RNA polymerase II; P:protein-containing complex assembly; P:regulation of actin polymerization or depolymerization; P:regulation of lamellipodium assembly; P:regulation of stress fiber assembly; P:regulation of T cell antigen processing and presentation; P:T cell activation; P:T cell receptor signaling pathway; scaffold208 indexed_genome mRNA 300828 327128 . - . ID=transcript_15765;Q9H1Z4 Q06DW8 Q06DX0 Q06DX1 Q9BUL7 Q9NWW4,WD repeat-containing protein 13,, PF00400;, GO:0034451;GO:0005654;GO:0005886;GO:1990841;GO:1904691;, C:centriolar satellite; C:nucleoplasm; C:plasma membrane;, F:promoter-specific chromatin binding;, P:negative regulation of type B pancreatic cell proliferation;|Q9H1Z4 Q06DW8 Q06DX0 Q06DX1 Q9BUL7 Q9NWW4,WD repeat-containing protein 13,, PF00400;, GO:0034451;GO:0005654;GO:0005886;GO:1990841;GO:1904691;, C:centriolar satellite; C:nucleoplasm; C:plasma membrane;, F:promoter-specific chromatin binding;, P:negative regulation of type B pancreatic cell proliferation;|Q9H1Z4 Q06DW8 Q06DX0 Q06DX1 Q9BUL7 Q9NWW4,WD repeat-containing protein 13,, PF00400;, GO:0034451;GO:0005654;GO:0005886;GO:1990841;GO:1904691;, C:centriolar satellite; C:nucleoplasm; C:plasma membrane;, F:promoter-specific chromatin binding;, P:negative regulation of type B pancreatic cell proliferation;|Q9H1Z4 Q06DW8 Q06DX0 Q06DX1 Q9BUL7 Q9NWW4,WD repeat-containing protein 13,, PF00400;, GO:0034451;GO:0005654;GO:0005886;GO:1990841;GO:1904691;, C:centriolar satellite; C:nucleoplasm; C:plasma membrane;, F:promoter-specific chromatin binding;, P:negative regulation of type B pancreatic cell proliferation; scaffold208 indexed_genome mRNA 338946 342375 . - . ID=transcript_15766;P98179,RNA-binding protein 3,RNA-binding motif protein 3;RNPL;, PF00076;, GO:0005737;GO:0030425;GO:0005654;GO:0005634;GO:0005681;GO:0043023;GO:0003723;GO:0048026;GO:0045727;GO:0006417;GO:0006396;, C:cytoplasm; C:dendrite; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:ribosomal large subunit binding; F:RNA binding;, P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of translation; P:regulation of translation; P:RNA processing;|P98179,RNA-binding protein 3,RNA-binding motif protein 3;RNPL;, PF00076;, GO:0005737;GO:0030425;GO:0005654;GO:0005634;GO:0005681;GO:0043023;GO:0003723;GO:0048026;GO:0045727;GO:0006417;GO:0006396;, C:cytoplasm; C:dendrite; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:ribosomal large subunit binding; F:RNA binding;, P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of translation; P:regulation of translation; P:RNA processing;|P98179,RNA-binding protein 3,RNA-binding motif protein 3;RNPL;, PF00076;, GO:0005737;GO:0030425;GO:0005654;GO:0005634;GO:0005681;GO:0043023;GO:0003723;GO:0048026;GO:0045727;GO:0006417;GO:0006396;, C:cytoplasm; C:dendrite; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:ribosomal large subunit binding; F:RNA binding;, P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of translation; P:regulation of translation; P:RNA processing;|P98179,RNA-binding protein 3,RNA-binding motif protein 3;RNPL;, PF00076;, GO:0005737;GO:0030425;GO:0005654;GO:0005634;GO:0005681;GO:0043023;GO:0003723;GO:0048026;GO:0045727;GO:0006417;GO:0006396;, C:cytoplasm; C:dendrite; C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:ribosomal large subunit binding; F:RNA binding;, P:positive regulation of mRNA splicing, via spliceosome; P:positive regulation of translation; P:regulation of translation; P:RNA processing; scaffold208 indexed_genome mRNA 351895 364983 . - . ID=transcript_15767;Q3MII6 Q08AN9 Q3MII4 Q8TAR9,TBC1 domain family member 25,, PF00566;, GO:0005776;GO:0031410;GO:0005096;GO:0090630;GO:0006914;GO:0006886;GO:1901096;, C:autophagosome; C:cytoplasmic vesicle;, F:GTPase activator activity;, P:activation of GTPase activity; P:autophagy; P:intracellular protein transport; P:regulation of autophagosome maturation; scaffold208 indexed_genome mRNA 367158 371931 . + . ID=transcript_15768;Q15125 Q6FGL3 Q6IBI9,3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase {ECO:0000305},Cholestenol Delta-isomerase;Delta(8)-Delta(7) sterol isomerase;Emopamil-binding protein;, , GO:0031410;GO:0005783;GO:0005789;GO:0005887;GO:0005635;GO:0000247;GO:0047750;GO:0042802;GO:0004769;GO:0004888;GO:0042910;GO:0006695;GO:0033489;GO:0033490;GO:0008203;GO:0001501;GO:0016126;, C:cytoplasmic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope;, F:C-8 sterol isomerase activity; F:cholestenol delta-isomerase activity; F:identical protein binding; F:steroid delta-isomerase activity; F:transmembrane signaling receptor activity; F:xenobiotic transmembrane transporter activity;, P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:cholesterol metabolic process; P:skeletal system development; P:sterol biosynthetic process;|Q15125 Q6FGL3 Q6IBI9,3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase {ECO:0000305},Cholestenol Delta-isomerase;Delta(8)-Delta(7) sterol isomerase;Emopamil-binding protein;, , GO:0031410;GO:0005783;GO:0005789;GO:0005887;GO:0005635;GO:0000247;GO:0047750;GO:0042802;GO:0004769;GO:0004888;GO:0042910;GO:0006695;GO:0033489;GO:0033490;GO:0008203;GO:0001501;GO:0016126;, C:cytoplasmic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope;, F:C-8 sterol isomerase activity; F:cholestenol delta-isomerase activity; F:identical protein binding; F:steroid delta-isomerase activity; F:transmembrane signaling receptor activity; F:xenobiotic transmembrane transporter activity;, P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:cholesterol metabolic process; P:skeletal system development; P:sterol biosynthetic process;|Q15125 Q6FGL3 Q6IBI9,3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase {ECO:0000305},Cholestenol Delta-isomerase;Delta(8)-Delta(7) sterol isomerase;Emopamil-binding protein;, , GO:0031410;GO:0005783;GO:0005789;GO:0005887;GO:0005635;GO:0000247;GO:0047750;GO:0042802;GO:0004769;GO:0004888;GO:0042910;GO:0006695;GO:0033489;GO:0033490;GO:0008203;GO:0001501;GO:0016126;, C:cytoplasmic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope;, F:C-8 sterol isomerase activity; F:cholestenol delta-isomerase activity; F:identical protein binding; F:steroid delta-isomerase activity; F:transmembrane signaling receptor activity; F:xenobiotic transmembrane transporter activity;, P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:cholesterol metabolic process; P:skeletal system development; P:sterol biosynthetic process;|Q15125 Q6FGL3 Q6IBI9,3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase {ECO:0000305},Cholestenol Delta-isomerase;Delta(8)-Delta(7) sterol isomerase;Emopamil-binding protein;, , GO:0031410;GO:0005783;GO:0005789;GO:0005887;GO:0005635;GO:0000247;GO:0047750;GO:0042802;GO:0004769;GO:0004888;GO:0042910;GO:0006695;GO:0033489;GO:0033490;GO:0008203;GO:0001501;GO:0016126;, C:cytoplasmic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:nuclear envelope;, F:C-8 sterol isomerase activity; F:cholestenol delta-isomerase activity; F:identical protein binding; F:steroid delta-isomerase activity; F:transmembrane signaling receptor activity; F:xenobiotic transmembrane transporter activity;, P:cholesterol biosynthetic process; P:cholesterol biosynthetic process via desmosterol; P:cholesterol biosynthetic process via lathosterol; P:cholesterol metabolic process; P:skeletal system development; P:sterol biosynthetic process; scaffold208 indexed_genome mRNA 372586 382169 . - . ID=transcript_15769;Q9H237 B2RBN8 B7ZAR3 Q14829 Q9H234 Q9H235 Q9H236 Q9UJU7,Protein-serine O-palmitoleoyltransferase porcupine {ECO:0000250|UniProtKB:Q9JJJ7},Protein MG61 {ECO:0000303|PubMed:12034504};, PF03062;, GO:0032281;GO:0005783;GO:0005789;GO:0098978;GO:0030176;GO:0016020;GO:1990698;GO:0016746;GO:0017147;GO:0060070;GO:0009100;GO:0030258;GO:0006497;GO:0045234;GO:0018345;GO:0099072;GO:0061355;GO:0016055;, C:AMPA glutamate receptor complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:palmitoleoyltransferase activity; F:transferase activity, transferring acyl groups; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:glycoprotein metabolic process; P:lipid modification; P:protein lipidation; P:protein palmitoleylation; P:protein palmitoylation; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt protein secretion; P:Wnt signaling pathway;|Q9H237 B2RBN8 B7ZAR3 Q14829 Q9H234 Q9H235 Q9H236 Q9UJU7,Protein-serine O-palmitoleoyltransferase porcupine {ECO:0000250|UniProtKB:Q9JJJ7},Protein MG61 {ECO:0000303|PubMed:12034504};, PF03062;, GO:0032281;GO:0005783;GO:0005789;GO:0098978;GO:0030176;GO:0016020;GO:1990698;GO:0016746;GO:0017147;GO:0060070;GO:0009100;GO:0030258;GO:0006497;GO:0045234;GO:0018345;GO:0099072;GO:0061355;GO:0016055;, C:AMPA glutamate receptor complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:palmitoleoyltransferase activity; F:transferase activity, transferring acyl groups; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:glycoprotein metabolic process; P:lipid modification; P:protein lipidation; P:protein palmitoleylation; P:protein palmitoylation; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt protein secretion; P:Wnt signaling pathway;|Q9H237 B2RBN8 B7ZAR3 Q14829 Q9H234 Q9H235 Q9H236 Q9UJU7,Protein-serine O-palmitoleoyltransferase porcupine {ECO:0000250|UniProtKB:Q9JJJ7},Protein MG61 {ECO:0000303|PubMed:12034504};, PF03062;, GO:0032281;GO:0005783;GO:0005789;GO:0098978;GO:0030176;GO:0016020;GO:1990698;GO:0016746;GO:0017147;GO:0060070;GO:0009100;GO:0030258;GO:0006497;GO:0045234;GO:0018345;GO:0099072;GO:0061355;GO:0016055;, C:AMPA glutamate receptor complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:palmitoleoyltransferase activity; F:transferase activity, transferring acyl groups; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:glycoprotein metabolic process; P:lipid modification; P:protein lipidation; P:protein palmitoleylation; P:protein palmitoylation; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt protein secretion; P:Wnt signaling pathway;|Q9H237 B2RBN8 B7ZAR3 Q14829 Q9H234 Q9H235 Q9H236 Q9UJU7,Protein-serine O-palmitoleoyltransferase porcupine {ECO:0000250|UniProtKB:Q9JJJ7},Protein MG61 {ECO:0000303|PubMed:12034504};, PF03062;, GO:0032281;GO:0005783;GO:0005789;GO:0098978;GO:0030176;GO:0016020;GO:1990698;GO:0016746;GO:0017147;GO:0060070;GO:0009100;GO:0030258;GO:0006497;GO:0045234;GO:0018345;GO:0099072;GO:0061355;GO:0016055;, C:AMPA glutamate receptor complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:palmitoleoyltransferase activity; F:transferase activity, transferring acyl groups; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:glycoprotein metabolic process; P:lipid modification; P:protein lipidation; P:protein palmitoleylation; P:protein palmitoylation; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt protein secretion; P:Wnt signaling pathway;|Q9H237 B2RBN8 B7ZAR3 Q14829 Q9H234 Q9H235 Q9H236 Q9UJU7,Protein-serine O-palmitoleoyltransferase porcupine {ECO:0000250|UniProtKB:Q9JJJ7},Protein MG61 {ECO:0000303|PubMed:12034504};, PF03062;, GO:0032281;GO:0005783;GO:0005789;GO:0098978;GO:0030176;GO:0016020;GO:1990698;GO:0016746;GO:0017147;GO:0060070;GO:0009100;GO:0030258;GO:0006497;GO:0045234;GO:0018345;GO:0099072;GO:0061355;GO:0016055;, C:AMPA glutamate receptor complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:palmitoleoyltransferase activity; F:transferase activity, transferring acyl groups; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:glycoprotein metabolic process; P:lipid modification; P:protein lipidation; P:protein palmitoleylation; P:protein palmitoylation; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt protein secretion; P:Wnt signaling pathway;|Q9H237 B2RBN8 B7ZAR3 Q14829 Q9H234 Q9H235 Q9H236 Q9UJU7,Protein-serine O-palmitoleoyltransferase porcupine {ECO:0000250|UniProtKB:Q9JJJ7},Protein MG61 {ECO:0000303|PubMed:12034504};, PF03062;, GO:0032281;GO:0005783;GO:0005789;GO:0098978;GO:0030176;GO:0016020;GO:1990698;GO:0016746;GO:0017147;GO:0060070;GO:0009100;GO:0030258;GO:0006497;GO:0045234;GO:0018345;GO:0099072;GO:0061355;GO:0016055;, C:AMPA glutamate receptor complex; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:membrane;, F:palmitoleoyltransferase activity; F:transferase activity, transferring acyl groups; F:Wnt-protein binding;, P:canonical Wnt signaling pathway; P:glycoprotein metabolic process; P:lipid modification; P:protein lipidation; P:protein palmitoleylation; P:protein palmitoylation; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:Wnt protein secretion; P:Wnt signaling pathway; scaffold208 indexed_genome mRNA 421937 425635 . - . ID=transcript_15770;Q9UET6 B2RCJ0 O75670,Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03162},2'-O-ribose RNA methyltransferase TRM7 homolog {ECO:0000255|HAMAP-Rule:MF_03162};Protein ftsJ homolog 1 {ECO:0000255|HAMAP-Rule:MF_03162};, PF01728;, GO:0005737;GO:0005829;GO:0008173;GO:0052666;GO:0009020;GO:0008175;GO:0002181;GO:0001510;GO:0030488;GO:0006400;GO:0002128;, C:cytoplasm; C:cytosol;, F:RNA methyltransferase activity; F:tRNA (cytosine-2'-O-)-methyltransferase activity; F:tRNA (guanosine-2'-O-)-methyltransferase activity; F:tRNA methyltransferase activity;, P:cytoplasmic translation; P:RNA methylation; P:tRNA methylation; P:tRNA modification; P:tRNA nucleoside ribose methylation;|Q9UET6 B2RCJ0 O75670,Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03162},2'-O-ribose RNA methyltransferase TRM7 homolog {ECO:0000255|HAMAP-Rule:MF_03162};Protein ftsJ homolog 1 {ECO:0000255|HAMAP-Rule:MF_03162};, PF01728;, GO:0005737;GO:0005829;GO:0008173;GO:0052666;GO:0009020;GO:0008175;GO:0002181;GO:0001510;GO:0030488;GO:0006400;GO:0002128;, C:cytoplasm; C:cytosol;, F:RNA methyltransferase activity; F:tRNA (cytosine-2'-O-)-methyltransferase activity; F:tRNA (guanosine-2'-O-)-methyltransferase activity; F:tRNA methyltransferase activity;, P:cytoplasmic translation; P:RNA methylation; P:tRNA methylation; P:tRNA modification; P:tRNA nucleoside ribose methylation;|Q9UET6 B2RCJ0 O75670,Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03162},2'-O-ribose RNA methyltransferase TRM7 homolog {ECO:0000255|HAMAP-Rule:MF_03162};Protein ftsJ homolog 1 {ECO:0000255|HAMAP-Rule:MF_03162};, PF01728;, GO:0005737;GO:0005829;GO:0008173;GO:0052666;GO:0009020;GO:0008175;GO:0002181;GO:0001510;GO:0030488;GO:0006400;GO:0002128;, C:cytoplasm; C:cytosol;, F:RNA methyltransferase activity; F:tRNA (cytosine-2'-O-)-methyltransferase activity; F:tRNA (guanosine-2'-O-)-methyltransferase activity; F:tRNA methyltransferase activity;, P:cytoplasmic translation; P:RNA methylation; P:tRNA methylation; P:tRNA modification; P:tRNA nucleoside ribose methylation; scaffold208 indexed_genome mRNA 576055 592932 . + . ID=transcript_15771;P17025 A2IDD7 Q3KP67 Q96QH7,Zinc finger protein 182,Zinc finger protein 21;Zinc finger protein KOX14;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold208 indexed_genome mRNA 667183 752777 . - . ID=transcript_15772;P51508 Q6RX22 Q96QH6,Zinc finger protein 81,HFZ20;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold209 indexed_genome mRNA 1087 10088 . + . ID=transcript_15773;Q9H7P9 B8ZZK6 C9J0Y4 Q6DHV6 Q96BU2 Q96D18 Q9H699,Pleckstrin homology domain-containing family G member 2,, PF00169;PF00621;, GO:0005829;GO:0005085;GO:0007186;GO:0043065;GO:0030833;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin filament polymerization; P:regulation of small GTPase mediated signal transduction;|Q9H7P9 B8ZZK6 C9J0Y4 Q6DHV6 Q96BU2 Q96D18 Q9H699,Pleckstrin homology domain-containing family G member 2,, PF00169;PF00621;, GO:0005829;GO:0005085;GO:0007186;GO:0043065;GO:0030833;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin filament polymerization; P:regulation of small GTPase mediated signal transduction;|Q9H7P9 B8ZZK6 C9J0Y4 Q6DHV6 Q96BU2 Q96D18 Q9H699,Pleckstrin homology domain-containing family G member 2,, PF00169;PF00621;, GO:0005829;GO:0005085;GO:0007186;GO:0043065;GO:0030833;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin filament polymerization; P:regulation of small GTPase mediated signal transduction;|Q9H7P9 B8ZZK6 C9J0Y4 Q6DHV6 Q96BU2 Q96D18 Q9H699,Pleckstrin homology domain-containing family G member 2,, PF00169;PF00621;, GO:0005829;GO:0005085;GO:0007186;GO:0043065;GO:0030833;GO:0051056;, C:cytosol;, F:guanyl-nucleotide exchange factor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of actin filament polymerization; P:regulation of small GTPase mediated signal transduction; scaffold209 indexed_genome mRNA 14526 17117 . - . ID=transcript_15774;P62249 B2RDD5 P17008,40S ribosomal protein S16,Small ribosomal subunit protein uS9 {ECO:0000303|PubMed:24524803};, PF00380;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0015935;GO:0003723;GO:0003735;GO:0000462;GO:0000184;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold209 indexed_genome mRNA 17155 17976 . - . ID=transcript_15775;P62249 B2RDD5 P17008,40S ribosomal protein S16,Small ribosomal subunit protein uS9 {ECO:0000303|PubMed:24524803};, PF00380;, GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005654;GO:0015935;GO:0003723;GO:0003735;GO:0000462;GO:0000184;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleoplasm; C:small ribosomal subunit;, F:RNA binding; F:structural constituent of ribosome;, P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold209 indexed_genome mRNA 30699 36722 . + . ID=transcript_15776;O00267 O43279 Q59G52 Q99639,Transcription elongation factor SPT5,DRB sensitivity-inducing factor 160 kDa subunit;DRB sensitivity-inducing factor large subunit;Tat-cotransactivator 1 protein;, PF00467;PF03439;PF11942;, GO:0032044;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0003729;GO:0046982;GO:0003723;GO:0006370;GO:0032785;GO:1900364;GO:0000122;GO:0032786;GO:0016239;GO:0045944;GO:0050434;GO:0006357;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:mRNA binding; F:protein heterodimerization activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of mRNA polyadenylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of macroautophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold209 indexed_genome mRNA 36746 51668 . - . ID=transcript_15777;O00267 O43279 Q59G52 Q99639,Transcription elongation factor SPT5,DRB sensitivity-inducing factor 160 kDa subunit;DRB sensitivity-inducing factor large subunit;Tat-cotransactivator 1 protein;, PF00467;PF03439;PF11942;, GO:0032044;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0003729;GO:0046982;GO:0003723;GO:0006370;GO:0032785;GO:1900364;GO:0000122;GO:0032786;GO:0016239;GO:0045944;GO:0050434;GO:0006357;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:mRNA binding; F:protein heterodimerization activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of mRNA polyadenylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of macroautophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O00267 O43279 Q59G52 Q99639,Transcription elongation factor SPT5,DRB sensitivity-inducing factor 160 kDa subunit;DRB sensitivity-inducing factor large subunit;Tat-cotransactivator 1 protein;, PF00467;PF03439;PF11942;, GO:0032044;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0003729;GO:0046982;GO:0003723;GO:0006370;GO:0032785;GO:1900364;GO:0000122;GO:0032786;GO:0016239;GO:0045944;GO:0050434;GO:0006357;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:mRNA binding; F:protein heterodimerization activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of mRNA polyadenylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of macroautophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O00267 O43279 Q59G52 Q99639,Transcription elongation factor SPT5,DRB sensitivity-inducing factor 160 kDa subunit;DRB sensitivity-inducing factor large subunit;Tat-cotransactivator 1 protein;, PF00467;PF03439;PF11942;, GO:0032044;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0003729;GO:0046982;GO:0003723;GO:0006370;GO:0032785;GO:1900364;GO:0000122;GO:0032786;GO:0016239;GO:0045944;GO:0050434;GO:0006357;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:mRNA binding; F:protein heterodimerization activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of mRNA polyadenylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of macroautophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O00267 O43279 Q59G52 Q99639,Transcription elongation factor SPT5,DRB sensitivity-inducing factor 160 kDa subunit;DRB sensitivity-inducing factor large subunit;Tat-cotransactivator 1 protein;, PF00467;PF03439;PF11942;, GO:0032044;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0003729;GO:0046982;GO:0003723;GO:0006370;GO:0032785;GO:1900364;GO:0000122;GO:0032786;GO:0016239;GO:0045944;GO:0050434;GO:0006357;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:mRNA binding; F:protein heterodimerization activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of mRNA polyadenylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of macroautophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O00267 O43279 Q59G52 Q99639,Transcription elongation factor SPT5,DRB sensitivity-inducing factor 160 kDa subunit;DRB sensitivity-inducing factor large subunit;Tat-cotransactivator 1 protein;, PF00467;PF03439;PF11942;, GO:0032044;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0003729;GO:0046982;GO:0003723;GO:0006370;GO:0032785;GO:1900364;GO:0000122;GO:0032786;GO:0016239;GO:0045944;GO:0050434;GO:0006357;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:mRNA binding; F:protein heterodimerization activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of mRNA polyadenylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of macroautophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O00267 O43279 Q59G52 Q99639,Transcription elongation factor SPT5,DRB sensitivity-inducing factor 160 kDa subunit;DRB sensitivity-inducing factor large subunit;Tat-cotransactivator 1 protein;, PF00467;PF03439;PF11942;, GO:0032044;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0003729;GO:0046982;GO:0003723;GO:0006370;GO:0032785;GO:1900364;GO:0000122;GO:0032786;GO:0016239;GO:0045944;GO:0050434;GO:0006357;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:mRNA binding; F:protein heterodimerization activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of mRNA polyadenylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of macroautophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O00267 O43279 Q59G52 Q99639,Transcription elongation factor SPT5,DRB sensitivity-inducing factor 160 kDa subunit;DRB sensitivity-inducing factor large subunit;Tat-cotransactivator 1 protein;, PF00467;PF03439;PF11942;, GO:0032044;GO:0005654;GO:0005634;GO:0003682;GO:0019899;GO:0003729;GO:0046982;GO:0003723;GO:0006370;GO:0032785;GO:1900364;GO:0000122;GO:0032786;GO:0016239;GO:0045944;GO:0050434;GO:0006357;GO:0006366;GO:0006368;, C:DSIF complex; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:enzyme binding; F:mRNA binding; F:protein heterodimerization activity; F:RNA binding;, P:7-methylguanosine mRNA capping; P:negative regulation of DNA-templated transcription, elongation; P:negative regulation of mRNA polyadenylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of macroautophagy; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of viral transcription; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold209 indexed_genome mRNA 53452 61290 . + . ID=transcript_15778;Q3ZCQ8 Q330K1 Q6QA00 Q96FJ5 Q96GY2 Q9H370,Mitochondrial import inner membrane translocase subunit TIM50,, PF03031;, GO:0016021;GO:0005743;GO:0005739;GO:0016607;GO:0005654;GO:0005744;GO:0005134;GO:0004721;GO:0004722;GO:0004725;GO:0043021;GO:0003723;GO:0007006;GO:0006470;GO:0030150;GO:0001836;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:TIM23 mitochondrial import inner membrane translocase complex;, F:interleukin-2 receptor binding; F:phosphoprotein phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:ribonucleoprotein complex binding; F:RNA binding;, P:mitochondrial membrane organization; P:protein dephosphorylation; P:protein import into mitochondrial matrix; P:release of cytochrome c from mitochondria;|Q3ZCQ8 Q330K1 Q6QA00 Q96FJ5 Q96GY2 Q9H370,Mitochondrial import inner membrane translocase subunit TIM50,, PF03031;, GO:0016021;GO:0005743;GO:0005739;GO:0016607;GO:0005654;GO:0005744;GO:0005134;GO:0004721;GO:0004722;GO:0004725;GO:0043021;GO:0003723;GO:0007006;GO:0006470;GO:0030150;GO:0001836;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:TIM23 mitochondrial import inner membrane translocase complex;, F:interleukin-2 receptor binding; F:phosphoprotein phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:ribonucleoprotein complex binding; F:RNA binding;, P:mitochondrial membrane organization; P:protein dephosphorylation; P:protein import into mitochondrial matrix; P:release of cytochrome c from mitochondria;|Q3ZCQ8 Q330K1 Q6QA00 Q96FJ5 Q96GY2 Q9H370,Mitochondrial import inner membrane translocase subunit TIM50,, PF03031;, GO:0016021;GO:0005743;GO:0005739;GO:0016607;GO:0005654;GO:0005744;GO:0005134;GO:0004721;GO:0004722;GO:0004725;GO:0043021;GO:0003723;GO:0007006;GO:0006470;GO:0030150;GO:0001836;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:TIM23 mitochondrial import inner membrane translocase complex;, F:interleukin-2 receptor binding; F:phosphoprotein phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:ribonucleoprotein complex binding; F:RNA binding;, P:mitochondrial membrane organization; P:protein dephosphorylation; P:protein import into mitochondrial matrix; P:release of cytochrome c from mitochondria;|Q3ZCQ8 Q330K1 Q6QA00 Q96FJ5 Q96GY2 Q9H370,Mitochondrial import inner membrane translocase subunit TIM50,, PF03031;, GO:0016021;GO:0005743;GO:0005739;GO:0016607;GO:0005654;GO:0005744;GO:0005134;GO:0004721;GO:0004722;GO:0004725;GO:0043021;GO:0003723;GO:0007006;GO:0006470;GO:0030150;GO:0001836;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nuclear speck; C:nucleoplasm; C:TIM23 mitochondrial import inner membrane translocase complex;, F:interleukin-2 receptor binding; F:phosphoprotein phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:ribonucleoprotein complex binding; F:RNA binding;, P:mitochondrial membrane organization; P:protein dephosphorylation; P:protein import into mitochondrial matrix; P:release of cytochrome c from mitochondria; scaffold209 indexed_genome mRNA 65509 68611 . + . ID=transcript_15779;Q9NYJ7 E9PFG2 Q8NBS4,Delta-like protein 3,Drosophila Delta homolog 3;, PF00008;PF12661;, GO:0016021;GO:0005509;GO:0005112;GO:0007386;GO:0050768;GO:0007219;GO:0048339;GO:0001501;GO:0001756;, C:integral component of membrane;, F:calcium ion binding; F:Notch binding;, P:compartment pattern specification; P:negative regulation of neurogenesis; P:Notch signaling pathway; P:paraxial mesoderm development; P:skeletal system development; P:somitogenesis; scaffold209 indexed_genome mRNA 68763 69864 . - . ID=transcript_15780;Q9NYJ7 E9PFG2 Q8NBS4,Delta-like protein 3,Drosophila Delta homolog 3;, PF00008;PF12661;, GO:0016021;GO:0005509;GO:0005112;GO:0007386;GO:0050768;GO:0007219;GO:0048339;GO:0001501;GO:0001756;, C:integral component of membrane;, F:calcium ion binding; F:Notch binding;, P:compartment pattern specification; P:negative regulation of neurogenesis; P:Notch signaling pathway; P:paraxial mesoderm development; P:skeletal system development; P:somitogenesis; scaffold209 indexed_genome mRNA 95907 104355 . - . ID=transcript_15781;Q8N6I1 A7YQ71 Q6X7T0 Q6ZR61,EP300-interacting inhibitor of differentiation 2,CREBBP/EP300 inhibitor 2;EID-1-like inhibitor of differentiation 2;, , GO:0005654;GO:0005634;GO:0046332;GO:0003714;GO:0030154;GO:0007517;GO:0000122;GO:0045892;GO:0030512;GO:0042127;GO:0017015;GO:0007183;GO:0007181;, C:nucleoplasm; C:nucleus;, F:SMAD binding; F:transcription corepressor activity;, P:cell differentiation; P:muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cell population proliferation; P:regulation of transforming growth factor beta receptor signaling pathway; P:SMAD protein complex assembly; P:transforming growth factor beta receptor complex assembly; scaffold209 indexed_genome mRNA 185551 186216 . + . ID=transcript_15782;A8MZ59 A0A1W2PQ33,Paired-like homeodomain transcription factor LEUTX,Leucine-twenty homeobox;Paired-like homeobox transcription factor LEUTX {ECO:0000303|PubMed:27578796};, PF00046;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold209 indexed_genome mRNA 218705 237532 . - . ID=transcript_15783;Q9Y463 O75258 O75788 O75789,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Minibrain-related kinase;Mirk protein kinase;, PF00069;, GO:0005694;GO:0005654;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0003713;GO:0004714;GO:0060612;GO:0007520;GO:0018105;GO:0018107;GO:0045893;GO:0046777;GO:0006468;, C:chromosome; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity; F:transcription coactivator activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adipose tissue development; P:myoblast fusion; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; scaffold209 indexed_genome mRNA 252560 258687 . - . ID=transcript_15784;P22087 B5BUE8 O75259 Q6IAT5 Q9UPI6,rRNA 2'-O-methyltransferase fibrillarin,34 kDa nucleolar scleroderma antigen;Histone-glutamine methyltransferase;U6 snRNA 2'-O-methyltransferase fibrillarin {ECO:0000305};, PF01269;, GO:0031428;GO:0015030;GO:0005694;GO:0001651;GO:0070062;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032040;GO:0051117;GO:1990259;GO:0003723;GO:0008649;GO:0001094;GO:0000494;GO:1990258;GO:0001649;GO:0031167;GO:0006364;GO:0048254;, C:box C/D RNP complex; C:Cajal body; C:chromosome; C:dense fibrillar component; C:extracellular exosome; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:small-subunit processome;, F:ATPase binding; F:histone-glutamine methyltransferase activity; F:RNA binding; F:rRNA methyltransferase activity; F:TFIID-class transcription factor complex binding;, P:box C/D RNA 3'-end processing; P:histone glutamine methylation; P:osteoblast differentiation; P:rRNA methylation; P:rRNA processing; P:snoRNA localization;|P22087 B5BUE8 O75259 Q6IAT5 Q9UPI6,rRNA 2'-O-methyltransferase fibrillarin,34 kDa nucleolar scleroderma antigen;Histone-glutamine methyltransferase;U6 snRNA 2'-O-methyltransferase fibrillarin {ECO:0000305};, PF01269;, GO:0031428;GO:0015030;GO:0005694;GO:0001651;GO:0070062;GO:0001650;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032040;GO:0051117;GO:1990259;GO:0003723;GO:0008649;GO:0001094;GO:0000494;GO:1990258;GO:0001649;GO:0031167;GO:0006364;GO:0048254;, C:box C/D RNP complex; C:Cajal body; C:chromosome; C:dense fibrillar component; C:extracellular exosome; C:fibrillar center; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:small-subunit processome;, F:ATPase binding; F:histone-glutamine methyltransferase activity; F:RNA binding; F:rRNA methyltransferase activity; F:TFIID-class transcription factor complex binding;, P:box C/D RNA 3'-end processing; P:histone glutamine methylation; P:osteoblast differentiation; P:rRNA methylation; P:rRNA processing; P:snoRNA localization; scaffold209 indexed_genome mRNA 270602 286287 . - . ID=transcript_15785;Q9Y6R7 O95784,IgGFc-binding protein,Fcgamma-binding protein antigen;, PF08742;PF17517;PF01826;PF12714;PF00094;, GO:0070062;GO:0031012;GO:0005615;, C:extracellular exosome; C:extracellular matrix; C:extracellular space; scaffold209 indexed_genome mRNA 286331 311470 . - . ID=transcript_15786;Q9Y6R7 O95784,IgGFc-binding protein,Fcgamma-binding protein antigen;, PF08742;PF17517;PF01826;PF12714;PF00094;, GO:0070062;GO:0031012;GO:0005615;, C:extracellular exosome; C:extracellular matrix; C:extracellular space; scaffold209 indexed_genome mRNA 337617 339063 . + . ID=transcript_15787;P43686 Q96FV5 Q9UBM3 Q9UEX3,26S proteasome regulatory subunit 6B,26S proteasome AAA-ATPase subunit RPT3;MB67-interacting protein;MIP224;Proteasome 26S subunit ATPase 4;Tat-binding protein 7;, PF00004;PF17862;PF16450;, GO:0005829;GO:0031597;GO:0016234;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0008540;GO:0045202;GO:0005524;GO:0016887;GO:0036402;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0045899;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006508;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytosol; C:cytosolic proteasome complex; C:inclusion body; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle, base subcomplex; C:synapse;, F:ATP binding; F:ATPase activity; F:proteasome-activating ATPase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:proteolysis; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold209 indexed_genome mRNA 489797 492874 . + . ID=transcript_15788;Q02779 Q12761 Q14871,Mitogen-activated protein kinase kinase kinase 10,Mixed lineage kinase 2;Protein kinase MST;, PF07714;PF14604;, GO:0005737;GO:0005524;GO:0043425;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003714;GO:0007257;GO:0006915;GO:0007254;GO:0043433;GO:0045892;GO:0018105;GO:0018107;GO:0043065;GO:0046330;GO:0043507;GO:0046777;GO:0007165;GO:0007224;, C:cytoplasm;, F:ATP binding; F:bHLH transcription factor binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transcription corepressor activity;, P:activation of JUN kinase activity; P:apoptotic process; P:JNK cascade; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:protein autophosphorylation; P:signal transduction; P:smoothened signaling pathway; scaffold209 indexed_genome mRNA 493118 498228 . + . ID=transcript_15789;Q02779 Q12761 Q14871,Mitogen-activated protein kinase kinase kinase 10,Mixed lineage kinase 2;Protein kinase MST;, PF07714;PF14604;, GO:0005737;GO:0005524;GO:0043425;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003714;GO:0007257;GO:0006915;GO:0007254;GO:0043433;GO:0045892;GO:0018105;GO:0018107;GO:0043065;GO:0046330;GO:0043507;GO:0046777;GO:0007165;GO:0007224;, C:cytoplasm;, F:ATP binding; F:bHLH transcription factor binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transcription corepressor activity;, P:activation of JUN kinase activity; P:apoptotic process; P:JNK cascade; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:protein autophosphorylation; P:signal transduction; P:smoothened signaling pathway;|Q02779 Q12761 Q14871,Mitogen-activated protein kinase kinase kinase 10,Mixed lineage kinase 2;Protein kinase MST;, PF07714;PF14604;, GO:0005737;GO:0005524;GO:0043425;GO:0004706;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0003714;GO:0007257;GO:0006915;GO:0007254;GO:0043433;GO:0045892;GO:0018105;GO:0018107;GO:0043065;GO:0046330;GO:0043507;GO:0046777;GO:0007165;GO:0007224;, C:cytoplasm;, F:ATP binding; F:bHLH transcription factor binding; F:JUN kinase kinase kinase activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:transcription corepressor activity;, P:activation of JUN kinase activity; P:apoptotic process; P:JNK cascade; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of transcription, DNA-templated; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:protein autophosphorylation; P:signal transduction; P:smoothened signaling pathway; scaffold209 indexed_genome mRNA 505776 507074 . - . ID=transcript_15790;Q8N6N2 A8K0I5 Q96NP9,Tetratricopeptide repeat protein 9B,, PF07719;|Q8N6N2 A8K0I5 Q96NP9,Tetratricopeptide repeat protein 9B,, PF07719; scaffold209 indexed_genome mRNA 519082 547871 . - . ID=transcript_15791;P31751 B2RBD8 Q05BV0 Q0VAN0 Q0VAN1 Q68GC0,RAC-beta serine/threonine-protein kinase,Protein kinase Akt-2;Protein kinase B beta;RAC-PK-beta;, PF00169;PF00069;PF00433;, GO:0005938;GO:0005829;GO:0005769;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032587;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0008643;GO:0006464;GO:0071486;GO:0032869;GO:0045444;GO:0006006;GO:0005978;GO:0008286;GO:0065002;GO:0035556;GO:0060644;GO:0043066;GO:0010748;GO:0018105;GO:0032287;GO:0030335;GO:2000147;GO:0008284;GO:0032000;GO:0046326;GO:0010907;GO:0045725;GO:0010918;GO:0051897;GO:0001934;GO:0090314;GO:0031340;GO:0072659;GO:0071156;GO:0030334;GO:0006417;GO:0097473;GO:0007165;, C:cell cortex; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle membrane;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:carbohydrate transport; P:cellular protein modification process; P:cellular response to high light intensity; P:cellular response to insulin stimulus; P:fat cell differentiation; P:glucose metabolic process; P:glycogen biosynthetic process; P:insulin receptor signaling pathway; P:intracellular protein transmembrane transport; P:intracellular signal transduction; P:mammary gland epithelial cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of long-chain fatty acid import across plasma membrane; P:peptidyl-serine phosphorylation; P:peripheral nervous system myelin maintenance; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane; P:regulation of cell cycle arrest; P:regulation of cell migration; P:regulation of translation; P:retinal rod cell apoptotic process; P:signal transduction;|P31751 B2RBD8 Q05BV0 Q0VAN0 Q0VAN1 Q68GC0,RAC-beta serine/threonine-protein kinase,Protein kinase Akt-2;Protein kinase B beta;RAC-PK-beta;, PF00169;PF00069;PF00433;, GO:0005938;GO:0005829;GO:0005769;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032587;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0008643;GO:0006464;GO:0071486;GO:0032869;GO:0045444;GO:0006006;GO:0005978;GO:0008286;GO:0065002;GO:0035556;GO:0060644;GO:0043066;GO:0010748;GO:0018105;GO:0032287;GO:0030335;GO:2000147;GO:0008284;GO:0032000;GO:0046326;GO:0010907;GO:0045725;GO:0010918;GO:0051897;GO:0001934;GO:0090314;GO:0031340;GO:0072659;GO:0071156;GO:0030334;GO:0006417;GO:0097473;GO:0007165;, C:cell cortex; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle membrane;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:carbohydrate transport; P:cellular protein modification process; P:cellular response to high light intensity; P:cellular response to insulin stimulus; P:fat cell differentiation; P:glucose metabolic process; P:glycogen biosynthetic process; P:insulin receptor signaling pathway; P:intracellular protein transmembrane transport; P:intracellular signal transduction; P:mammary gland epithelial cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of long-chain fatty acid import across plasma membrane; P:peptidyl-serine phosphorylation; P:peripheral nervous system myelin maintenance; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane; P:regulation of cell cycle arrest; P:regulation of cell migration; P:regulation of translation; P:retinal rod cell apoptotic process; P:signal transduction;|P31751 B2RBD8 Q05BV0 Q0VAN0 Q0VAN1 Q68GC0,RAC-beta serine/threonine-protein kinase,Protein kinase Akt-2;Protein kinase B beta;RAC-PK-beta;, PF00169;PF00069;PF00433;, GO:0005938;GO:0005829;GO:0005769;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032587;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0008643;GO:0006464;GO:0071486;GO:0032869;GO:0045444;GO:0006006;GO:0005978;GO:0008286;GO:0065002;GO:0035556;GO:0060644;GO:0043066;GO:0010748;GO:0018105;GO:0032287;GO:0030335;GO:2000147;GO:0008284;GO:0032000;GO:0046326;GO:0010907;GO:0045725;GO:0010918;GO:0051897;GO:0001934;GO:0090314;GO:0031340;GO:0072659;GO:0071156;GO:0030334;GO:0006417;GO:0097473;GO:0007165;, C:cell cortex; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle membrane;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:carbohydrate transport; P:cellular protein modification process; P:cellular response to high light intensity; P:cellular response to insulin stimulus; P:fat cell differentiation; P:glucose metabolic process; P:glycogen biosynthetic process; P:insulin receptor signaling pathway; P:intracellular protein transmembrane transport; P:intracellular signal transduction; P:mammary gland epithelial cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of long-chain fatty acid import across plasma membrane; P:peptidyl-serine phosphorylation; P:peripheral nervous system myelin maintenance; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane; P:regulation of cell cycle arrest; P:regulation of cell migration; P:regulation of translation; P:retinal rod cell apoptotic process; P:signal transduction;|P31751 B2RBD8 Q05BV0 Q0VAN0 Q0VAN1 Q68GC0,RAC-beta serine/threonine-protein kinase,Protein kinase Akt-2;Protein kinase B beta;RAC-PK-beta;, PF00169;PF00069;PF00433;, GO:0005938;GO:0005829;GO:0005769;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032587;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0008643;GO:0006464;GO:0071486;GO:0032869;GO:0045444;GO:0006006;GO:0005978;GO:0008286;GO:0065002;GO:0035556;GO:0060644;GO:0043066;GO:0010748;GO:0018105;GO:0032287;GO:0030335;GO:2000147;GO:0008284;GO:0032000;GO:0046326;GO:0010907;GO:0045725;GO:0010918;GO:0051897;GO:0001934;GO:0090314;GO:0031340;GO:0072659;GO:0071156;GO:0030334;GO:0006417;GO:0097473;GO:0007165;, C:cell cortex; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle membrane;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:carbohydrate transport; P:cellular protein modification process; P:cellular response to high light intensity; P:cellular response to insulin stimulus; P:fat cell differentiation; P:glucose metabolic process; P:glycogen biosynthetic process; P:insulin receptor signaling pathway; P:intracellular protein transmembrane transport; P:intracellular signal transduction; P:mammary gland epithelial cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of long-chain fatty acid import across plasma membrane; P:peptidyl-serine phosphorylation; P:peripheral nervous system myelin maintenance; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane; P:regulation of cell cycle arrest; P:regulation of cell migration; P:regulation of translation; P:retinal rod cell apoptotic process; P:signal transduction;|P31751 B2RBD8 Q05BV0 Q0VAN0 Q0VAN1 Q68GC0,RAC-beta serine/threonine-protein kinase,Protein kinase Akt-2;Protein kinase B beta;RAC-PK-beta;, PF00169;PF00069;PF00433;, GO:0005938;GO:0005829;GO:0005769;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032587;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0008643;GO:0006464;GO:0071486;GO:0032869;GO:0045444;GO:0006006;GO:0005978;GO:0008286;GO:0065002;GO:0035556;GO:0060644;GO:0043066;GO:0010748;GO:0018105;GO:0032287;GO:0030335;GO:2000147;GO:0008284;GO:0032000;GO:0046326;GO:0010907;GO:0045725;GO:0010918;GO:0051897;GO:0001934;GO:0090314;GO:0031340;GO:0072659;GO:0071156;GO:0030334;GO:0006417;GO:0097473;GO:0007165;, C:cell cortex; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle membrane;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:carbohydrate transport; P:cellular protein modification process; P:cellular response to high light intensity; P:cellular response to insulin stimulus; P:fat cell differentiation; P:glucose metabolic process; P:glycogen biosynthetic process; P:insulin receptor signaling pathway; P:intracellular protein transmembrane transport; P:intracellular signal transduction; P:mammary gland epithelial cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of long-chain fatty acid import across plasma membrane; P:peptidyl-serine phosphorylation; P:peripheral nervous system myelin maintenance; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane; P:regulation of cell cycle arrest; P:regulation of cell migration; P:regulation of translation; P:retinal rod cell apoptotic process; P:signal transduction;|Q9Y243 Q0VAA6 Q5VTI1 Q5VTI2 Q96QV3 Q9UFP5,RAC-gamma serine/threonine-protein kinase,Protein kinase Akt-3;Protein kinase B gamma;RAC-PK-gamma;STK-2;, PF00169;PF00069;PF00433;, GO:0005737;GO:0016020;GO:0005634;GO:0005524;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0048854;GO:0048873;GO:0035556;GO:0000002;GO:2000773;GO:0018105;GO:0045766;GO:1905653;GO:0043536;GO:0090050;GO:0045793;GO:0001938;GO:0032008;GO:1905564;GO:0006468;GO:0007165;, C:cytoplasm; C:membrane; C:nucleus;, F:ATP binding; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:brain morphogenesis; P:homeostasis of number of cells within a tissue; P:intracellular signal transduction; P:mitochondrial genome maintenance; P:negative regulation of cellular senescence; P:peptidyl-serine phosphorylation; P:positive regulation of angiogenesis; P:positive regulation of artery morphogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of cell size; P:positive regulation of endothelial cell proliferation; P:positive regulation of TOR signaling; P:positive regulation of vascular endothelial cell proliferation; P:protein phosphorylation; P:signal transduction;|P31751 B2RBD8 Q05BV0 Q0VAN0 Q0VAN1 Q68GC0,RAC-beta serine/threonine-protein kinase,Protein kinase Akt-2;Protein kinase B beta;RAC-PK-beta;, PF00169;PF00069;PF00433;, GO:0005938;GO:0005829;GO:0005769;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032587;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0008643;GO:0006464;GO:0071486;GO:0032869;GO:0045444;GO:0006006;GO:0005978;GO:0008286;GO:0065002;GO:0035556;GO:0060644;GO:0043066;GO:0010748;GO:0018105;GO:0032287;GO:0030335;GO:2000147;GO:0008284;GO:0032000;GO:0046326;GO:0010907;GO:0045725;GO:0010918;GO:0051897;GO:0001934;GO:0090314;GO:0031340;GO:0072659;GO:0071156;GO:0030334;GO:0006417;GO:0097473;GO:0007165;, C:cell cortex; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle membrane;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:carbohydrate transport; P:cellular protein modification process; P:cellular response to high light intensity; P:cellular response to insulin stimulus; P:fat cell differentiation; P:glucose metabolic process; P:glycogen biosynthetic process; P:insulin receptor signaling pathway; P:intracellular protein transmembrane transport; P:intracellular signal transduction; P:mammary gland epithelial cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of long-chain fatty acid import across plasma membrane; P:peptidyl-serine phosphorylation; P:peripheral nervous system myelin maintenance; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane; P:regulation of cell cycle arrest; P:regulation of cell migration; P:regulation of translation; P:retinal rod cell apoptotic process; P:signal transduction;|P31751 B2RBD8 Q05BV0 Q0VAN0 Q0VAN1 Q68GC0,RAC-beta serine/threonine-protein kinase,Protein kinase Akt-2;Protein kinase B beta;RAC-PK-beta;, PF00169;PF00069;PF00433;, GO:0005938;GO:0005829;GO:0005769;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0032587;GO:0005524;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0090630;GO:0008643;GO:0006464;GO:0071486;GO:0032869;GO:0045444;GO:0006006;GO:0005978;GO:0008286;GO:0065002;GO:0035556;GO:0060644;GO:0043066;GO:0010748;GO:0018105;GO:0032287;GO:0030335;GO:2000147;GO:0008284;GO:0032000;GO:0046326;GO:0010907;GO:0045725;GO:0010918;GO:0051897;GO:0001934;GO:0090314;GO:0031340;GO:0072659;GO:0071156;GO:0030334;GO:0006417;GO:0097473;GO:0007165;, C:cell cortex; C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:ruffle membrane;, F:ATP binding; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of GTPase activity; P:carbohydrate transport; P:cellular protein modification process; P:cellular response to high light intensity; P:cellular response to insulin stimulus; P:fat cell differentiation; P:glucose metabolic process; P:glycogen biosynthetic process; P:insulin receptor signaling pathway; P:intracellular protein transmembrane transport; P:intracellular signal transduction; P:mammary gland epithelial cell differentiation; P:negative regulation of apoptotic process; P:negative regulation of long-chain fatty acid import across plasma membrane; P:peptidyl-serine phosphorylation; P:peripheral nervous system myelin maintenance; P:positive regulation of cell migration; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of vesicle fusion; P:protein localization to plasma membrane; P:regulation of cell cycle arrest; P:regulation of cell migration; P:regulation of translation; P:retinal rod cell apoptotic process; P:signal transduction; scaffold209 indexed_genome mRNA 588799 604801 . - . ID=transcript_15792;Q8N9M1 Q8IZ33 Q8N0V9,Uncharacterized protein C19orf47,, PF17740;, GO:0005654;GO:0005634;, C:nucleoplasm; C:nucleus; scaffold209 indexed_genome mRNA 617512 639461 . + . ID=transcript_15793;Q8IV08 Q92853 Q9BW87,5'-3' exonuclease PLD3 {ECO:0000305},Choline phosphatase 3;HindIII K4L homolog;Hu-K4 {ECO:0000303|PubMed:15794758};Phosphatidylcholine-hydrolyzing phospholipase D3;Phospholipase D3;, PF00614;PF13918;, GO:0031901;GO:0005789;GO:0070062;GO:0000139;GO:0016021;GO:0031902;GO:0043202;GO:0005765;GO:0004630;GO:0045145;GO:0002376;GO:0006954;GO:0014902;GO:1900015;, C:early endosome membrane; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi membrane; C:integral component of membrane; C:late endosome membrane; C:lysosomal lumen; C:lysosomal membrane;, F:phospholipase D activity; F:single-stranded DNA 5'-3' exodeoxyribonuclease activity;, P:immune system process; P:inflammatory response; P:myotube differentiation; P:regulation of cytokine production involved in inflammatory response;|Q8IV08 Q92853 Q9BW87,5'-3' exonuclease PLD3 {ECO:0000305},Choline phosphatase 3;HindIII K4L homolog;Hu-K4 {ECO:0000303|PubMed:15794758};Phosphatidylcholine-hydrolyzing phospholipase D3;Phospholipase D3;, PF00614;PF13918;, GO:0031901;GO:0005789;GO:0070062;GO:0000139;GO:0016021;GO:0031902;GO:0043202;GO:0005765;GO:0004630;GO:0045145;GO:0002376;GO:0006954;GO:0014902;GO:1900015;, C:early endosome membrane; C:endoplasmic reticulum membrane; C:extracellular exosome; C:Golgi membrane; C:integral component of membrane; C:late endosome membrane; C:lysosomal lumen; C:lysosomal membrane;, F:phospholipase D activity; F:single-stranded DNA 5'-3' exodeoxyribonuclease activity;, P:immune system process; P:inflammatory response; P:myotube differentiation; P:regulation of cytokine production involved in inflammatory response; scaffold209 indexed_genome mRNA 663919 664978 . + . ID=transcript_15794;Q9UHV2 Q9BUE7,SERTA domain-containing protein 1,CDK4-binding protein p34SEI1;Transcriptional regulator interacting with the PHD-bromodomain 1;, PF06031;, GO:0005737;GO:0005634;GO:0048096;GO:0008284;GO:0045944;GO:0000079;, C:cytoplasm; C:nucleus;, , P:chromatin-mediated maintenance of transcription; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; scaffold209 indexed_genome mRNA 673766 677068 . - . ID=transcript_15795;Q9UJW9 B3KQB3 Q96CQ2,SERTA domain-containing protein 3,Replication protein-binding trans-activator;, PF06031;, GO:0005634;GO:0030308;GO:0045893;GO:0006355;, C:nucleus;, , P:negative regulation of cell growth; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold209 indexed_genome mRNA 679629 694868 . - . ID=transcript_15796;P30043 A6NKD8 B2R5C6 P32078 P53005 Q32LZ2,Flavin reductase (NADPH),Biliverdin reductase B;Biliverdin-IX beta-reductase;Green heme-binding protein;NADPH-dependent diaphorase;NADPH-flavin reductase;, PF13460;, GO:0005829;GO:0070062;GO:0043231;GO:0005654;GO:0005886;GO:0106276;GO:0004074;GO:0106277;GO:0042602;GO:0042167;, C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:biliberdin reductase NAD+ activity; F:biliverdin reductase (NAD(P)+) activity; F:biliverdin reductase (NADP+) activity; F:riboflavin reductase (NADPH) activity;, P:heme catabolic process;|P30043 A6NKD8 B2R5C6 P32078 P53005 Q32LZ2,Flavin reductase (NADPH),Biliverdin reductase B;Biliverdin-IX beta-reductase;Green heme-binding protein;NADPH-dependent diaphorase;NADPH-flavin reductase;, PF13460;, GO:0005829;GO:0070062;GO:0043231;GO:0005654;GO:0005886;GO:0106276;GO:0004074;GO:0106277;GO:0042602;GO:0042167;, C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:plasma membrane;, F:biliberdin reductase NAD+ activity; F:biliverdin reductase (NAD(P)+) activity; F:biliverdin reductase (NADP+) activity; F:riboflavin reductase (NADPH) activity;, P:heme catabolic process; scaffold209 indexed_genome mRNA 695973 714548 . + . ID=transcript_15797;Q9H254 E9PGQ5 Q9H1K7 Q9H1K8 Q9H1K9 Q9H253 Q9H3G8 Q9HCD0,Spectrin beta chain, non-erythrocytic 4,Beta-IV spectrin;Spectrin, non-erythroid beta chain 3;, PF00307;PF15410;PF00435;, GO:0005884;GO:0043203;GO:0043194;GO:0070852;GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0016020;GO:0043025;GO:0033268;GO:0016363;GO:0033270;GO:0005886;GO:0016605;GO:0008091;GO:0003779;GO:0030506;GO:0106006;GO:0019902;GO:0005543;GO:0030507;GO:0005200;GO:0051693;GO:0007628;GO:0007411;GO:0007409;GO:0061337;GO:0021952;GO:0045162;GO:0006888;GO:0009566;GO:0000165;GO:0010459;GO:0040018;GO:0072659;GO:0033135;GO:0002028;GO:0007605;GO:0019226;GO:0016192;, C:actin filament; C:axon hillock; C:axon initial segment; C:cell body fiber; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:membrane; C:neuronal cell body; C:node of Ranvier; C:nuclear matrix; C:paranode region of axon; C:plasma membrane; C:PML body; C:spectrin;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein-membrane anchor activity; F:phosphatase binding; F:phospholipid binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:adult walking behavior; P:axon guidance; P:axonogenesis; P:cardiac conduction; P:central nervous system projection neuron axonogenesis; P:clustering of voltage-gated sodium channels; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fertilization; P:MAPK cascade; P:negative regulation of heart rate; P:positive regulation of multicellular organism growth; P:protein localization to plasma membrane; P:regulation of peptidyl-serine phosphorylation; P:regulation of sodium ion transport; P:sensory perception of sound; P:transmission of nerve impulse; P:vesicle-mediated transport;|Q9H254 E9PGQ5 Q9H1K7 Q9H1K8 Q9H1K9 Q9H253 Q9H3G8 Q9HCD0,Spectrin beta chain, non-erythrocytic 4,Beta-IV spectrin;Spectrin, non-erythroid beta chain 3;, PF00307;PF15410;PF00435;, GO:0005884;GO:0043203;GO:0043194;GO:0070852;GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0016020;GO:0043025;GO:0033268;GO:0016363;GO:0033270;GO:0005886;GO:0016605;GO:0008091;GO:0003779;GO:0030506;GO:0106006;GO:0019902;GO:0005543;GO:0030507;GO:0005200;GO:0051693;GO:0007628;GO:0007411;GO:0007409;GO:0061337;GO:0021952;GO:0045162;GO:0006888;GO:0009566;GO:0000165;GO:0010459;GO:0040018;GO:0072659;GO:0033135;GO:0002028;GO:0007605;GO:0019226;GO:0016192;, C:actin filament; C:axon hillock; C:axon initial segment; C:cell body fiber; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:membrane; C:neuronal cell body; C:node of Ranvier; C:nuclear matrix; C:paranode region of axon; C:plasma membrane; C:PML body; C:spectrin;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein-membrane anchor activity; F:phosphatase binding; F:phospholipid binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:adult walking behavior; P:axon guidance; P:axonogenesis; P:cardiac conduction; P:central nervous system projection neuron axonogenesis; P:clustering of voltage-gated sodium channels; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fertilization; P:MAPK cascade; P:negative regulation of heart rate; P:positive regulation of multicellular organism growth; P:protein localization to plasma membrane; P:regulation of peptidyl-serine phosphorylation; P:regulation of sodium ion transport; P:sensory perception of sound; P:transmission of nerve impulse; P:vesicle-mediated transport; scaffold209 indexed_genome mRNA 739213 770913 . - . ID=transcript_15798;Q9H254 E9PGQ5 Q9H1K7 Q9H1K8 Q9H1K9 Q9H253 Q9H3G8 Q9HCD0,Spectrin beta chain, non-erythrocytic 4,Beta-IV spectrin;Spectrin, non-erythroid beta chain 3;, PF00307;PF15410;PF00435;, GO:0005884;GO:0043203;GO:0043194;GO:0070852;GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0016020;GO:0043025;GO:0033268;GO:0016363;GO:0033270;GO:0005886;GO:0016605;GO:0008091;GO:0003779;GO:0030506;GO:0106006;GO:0019902;GO:0005543;GO:0030507;GO:0005200;GO:0051693;GO:0007628;GO:0007411;GO:0007409;GO:0061337;GO:0021952;GO:0045162;GO:0006888;GO:0009566;GO:0000165;GO:0010459;GO:0040018;GO:0072659;GO:0033135;GO:0002028;GO:0007605;GO:0019226;GO:0016192;, C:actin filament; C:axon hillock; C:axon initial segment; C:cell body fiber; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:membrane; C:neuronal cell body; C:node of Ranvier; C:nuclear matrix; C:paranode region of axon; C:plasma membrane; C:PML body; C:spectrin;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein-membrane anchor activity; F:phosphatase binding; F:phospholipid binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:adult walking behavior; P:axon guidance; P:axonogenesis; P:cardiac conduction; P:central nervous system projection neuron axonogenesis; P:clustering of voltage-gated sodium channels; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fertilization; P:MAPK cascade; P:negative regulation of heart rate; P:positive regulation of multicellular organism growth; P:protein localization to plasma membrane; P:regulation of peptidyl-serine phosphorylation; P:regulation of sodium ion transport; P:sensory perception of sound; P:transmission of nerve impulse; P:vesicle-mediated transport;|Q9H254 E9PGQ5 Q9H1K7 Q9H1K8 Q9H1K9 Q9H253 Q9H3G8 Q9HCD0,Spectrin beta chain, non-erythrocytic 4,Beta-IV spectrin;Spectrin, non-erythroid beta chain 3;, PF00307;PF15410;PF00435;, GO:0005884;GO:0043203;GO:0043194;GO:0070852;GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0016020;GO:0043025;GO:0033268;GO:0016363;GO:0033270;GO:0005886;GO:0016605;GO:0008091;GO:0003779;GO:0030506;GO:0106006;GO:0019902;GO:0005543;GO:0030507;GO:0005200;GO:0051693;GO:0007628;GO:0007411;GO:0007409;GO:0061337;GO:0021952;GO:0045162;GO:0006888;GO:0009566;GO:0000165;GO:0010459;GO:0040018;GO:0072659;GO:0033135;GO:0002028;GO:0007605;GO:0019226;GO:0016192;, C:actin filament; C:axon hillock; C:axon initial segment; C:cell body fiber; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:membrane; C:neuronal cell body; C:node of Ranvier; C:nuclear matrix; C:paranode region of axon; C:plasma membrane; C:PML body; C:spectrin;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein-membrane anchor activity; F:phosphatase binding; F:phospholipid binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:adult walking behavior; P:axon guidance; P:axonogenesis; P:cardiac conduction; P:central nervous system projection neuron axonogenesis; P:clustering of voltage-gated sodium channels; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fertilization; P:MAPK cascade; P:negative regulation of heart rate; P:positive regulation of multicellular organism growth; P:protein localization to plasma membrane; P:regulation of peptidyl-serine phosphorylation; P:regulation of sodium ion transport; P:sensory perception of sound; P:transmission of nerve impulse; P:vesicle-mediated transport;|Q9H254 E9PGQ5 Q9H1K7 Q9H1K8 Q9H1K9 Q9H253 Q9H3G8 Q9HCD0,Spectrin beta chain, non-erythrocytic 4,Beta-IV spectrin;Spectrin, non-erythroid beta chain 3;, PF00307;PF15410;PF00435;, GO:0005884;GO:0043203;GO:0043194;GO:0070852;GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0016020;GO:0043025;GO:0033268;GO:0016363;GO:0033270;GO:0005886;GO:0016605;GO:0008091;GO:0003779;GO:0030506;GO:0106006;GO:0019902;GO:0005543;GO:0030507;GO:0005200;GO:0051693;GO:0007628;GO:0007411;GO:0007409;GO:0061337;GO:0021952;GO:0045162;GO:0006888;GO:0009566;GO:0000165;GO:0010459;GO:0040018;GO:0072659;GO:0033135;GO:0002028;GO:0007605;GO:0019226;GO:0016192;, C:actin filament; C:axon hillock; C:axon initial segment; C:cell body fiber; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:membrane; C:neuronal cell body; C:node of Ranvier; C:nuclear matrix; C:paranode region of axon; C:plasma membrane; C:PML body; C:spectrin;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein-membrane anchor activity; F:phosphatase binding; F:phospholipid binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:adult walking behavior; P:axon guidance; P:axonogenesis; P:cardiac conduction; P:central nervous system projection neuron axonogenesis; P:clustering of voltage-gated sodium channels; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fertilization; P:MAPK cascade; P:negative regulation of heart rate; P:positive regulation of multicellular organism growth; P:protein localization to plasma membrane; P:regulation of peptidyl-serine phosphorylation; P:regulation of sodium ion transport; P:sensory perception of sound; P:transmission of nerve impulse; P:vesicle-mediated transport;|Q9H254 E9PGQ5 Q9H1K7 Q9H1K8 Q9H1K9 Q9H253 Q9H3G8 Q9HCD0,Spectrin beta chain, non-erythrocytic 4,Beta-IV spectrin;Spectrin, non-erythroid beta chain 3;, PF00307;PF15410;PF00435;, GO:0005884;GO:0043203;GO:0043194;GO:0070852;GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0016020;GO:0043025;GO:0033268;GO:0016363;GO:0033270;GO:0005886;GO:0016605;GO:0008091;GO:0003779;GO:0030506;GO:0106006;GO:0019902;GO:0005543;GO:0030507;GO:0005200;GO:0051693;GO:0007628;GO:0007411;GO:0007409;GO:0061337;GO:0021952;GO:0045162;GO:0006888;GO:0009566;GO:0000165;GO:0010459;GO:0040018;GO:0072659;GO:0033135;GO:0002028;GO:0007605;GO:0019226;GO:0016192;, C:actin filament; C:axon hillock; C:axon initial segment; C:cell body fiber; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:membrane; C:neuronal cell body; C:node of Ranvier; C:nuclear matrix; C:paranode region of axon; C:plasma membrane; C:PML body; C:spectrin;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein-membrane anchor activity; F:phosphatase binding; F:phospholipid binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:adult walking behavior; P:axon guidance; P:axonogenesis; P:cardiac conduction; P:central nervous system projection neuron axonogenesis; P:clustering of voltage-gated sodium channels; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fertilization; P:MAPK cascade; P:negative regulation of heart rate; P:positive regulation of multicellular organism growth; P:protein localization to plasma membrane; P:regulation of peptidyl-serine phosphorylation; P:regulation of sodium ion transport; P:sensory perception of sound; P:transmission of nerve impulse; P:vesicle-mediated transport;|Q9H254 E9PGQ5 Q9H1K7 Q9H1K8 Q9H1K9 Q9H253 Q9H3G8 Q9HCD0,Spectrin beta chain, non-erythrocytic 4,Beta-IV spectrin;Spectrin, non-erythroid beta chain 3;, PF00307;PF15410;PF00435;, GO:0005884;GO:0043203;GO:0043194;GO:0070852;GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0016020;GO:0043025;GO:0033268;GO:0016363;GO:0033270;GO:0005886;GO:0016605;GO:0008091;GO:0003779;GO:0030506;GO:0106006;GO:0019902;GO:0005543;GO:0030507;GO:0005200;GO:0051693;GO:0007628;GO:0007411;GO:0007409;GO:0061337;GO:0021952;GO:0045162;GO:0006888;GO:0009566;GO:0000165;GO:0010459;GO:0040018;GO:0072659;GO:0033135;GO:0002028;GO:0007605;GO:0019226;GO:0016192;, C:actin filament; C:axon hillock; C:axon initial segment; C:cell body fiber; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:membrane; C:neuronal cell body; C:node of Ranvier; C:nuclear matrix; C:paranode region of axon; C:plasma membrane; C:PML body; C:spectrin;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein-membrane anchor activity; F:phosphatase binding; F:phospholipid binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:adult walking behavior; P:axon guidance; P:axonogenesis; P:cardiac conduction; P:central nervous system projection neuron axonogenesis; P:clustering of voltage-gated sodium channels; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fertilization; P:MAPK cascade; P:negative regulation of heart rate; P:positive regulation of multicellular organism growth; P:protein localization to plasma membrane; P:regulation of peptidyl-serine phosphorylation; P:regulation of sodium ion transport; P:sensory perception of sound; P:transmission of nerve impulse; P:vesicle-mediated transport; scaffold209 indexed_genome mRNA 772255 772902 . + . ID=transcript_15799;Q9H254 E9PGQ5 Q9H1K7 Q9H1K8 Q9H1K9 Q9H253 Q9H3G8 Q9HCD0,Spectrin beta chain, non-erythrocytic 4,Beta-IV spectrin;Spectrin, non-erythroid beta chain 3;, PF00307;PF15410;PF00435;, GO:0005884;GO:0043203;GO:0043194;GO:0070852;GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0016020;GO:0043025;GO:0033268;GO:0016363;GO:0033270;GO:0005886;GO:0016605;GO:0008091;GO:0003779;GO:0030506;GO:0106006;GO:0019902;GO:0005543;GO:0030507;GO:0005200;GO:0051693;GO:0007628;GO:0007411;GO:0007409;GO:0061337;GO:0021952;GO:0045162;GO:0006888;GO:0009566;GO:0000165;GO:0010459;GO:0040018;GO:0072659;GO:0033135;GO:0002028;GO:0007605;GO:0019226;GO:0016192;, C:actin filament; C:axon hillock; C:axon initial segment; C:cell body fiber; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:membrane; C:neuronal cell body; C:node of Ranvier; C:nuclear matrix; C:paranode region of axon; C:plasma membrane; C:PML body; C:spectrin;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein-membrane anchor activity; F:phosphatase binding; F:phospholipid binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:adult walking behavior; P:axon guidance; P:axonogenesis; P:cardiac conduction; P:central nervous system projection neuron axonogenesis; P:clustering of voltage-gated sodium channels; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fertilization; P:MAPK cascade; P:negative regulation of heart rate; P:positive regulation of multicellular organism growth; P:protein localization to plasma membrane; P:regulation of peptidyl-serine phosphorylation; P:regulation of sodium ion transport; P:sensory perception of sound; P:transmission of nerve impulse; P:vesicle-mediated transport; scaffold209 indexed_genome mRNA 773353 787718 . + . ID=transcript_15800;Q8TBC3 Q8N2I6 Q8WY93 Q96IB8,SH3KBP1-binding protein 1,SETA-binding protein 1 {ECO:0000303|PubMed:16733801};, PF02214;, GO:0005764;GO:0042802;GO:0045742;GO:0051260;, C:lysosome;, F:identical protein binding;, P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein homooligomerization;|Q8TBC3 Q8N2I6 Q8WY93 Q96IB8,SH3KBP1-binding protein 1,SETA-binding protein 1 {ECO:0000303|PubMed:16733801};, PF02214;, GO:0005764;GO:0042802;GO:0045742;GO:0051260;, C:lysosome;, F:identical protein binding;, P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein homooligomerization;|Q8TBC3 Q8N2I6 Q8WY93 Q96IB8,SH3KBP1-binding protein 1,SETA-binding protein 1 {ECO:0000303|PubMed:16733801};, PF02214;, GO:0005764;GO:0042802;GO:0045742;GO:0051260;, C:lysosome;, F:identical protein binding;, P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein homooligomerization;|Q8TBC3 Q8N2I6 Q8WY93 Q96IB8,SH3KBP1-binding protein 1,SETA-binding protein 1 {ECO:0000303|PubMed:16733801};, PF02214;, GO:0005764;GO:0042802;GO:0045742;GO:0051260;, C:lysosome;, F:identical protein binding;, P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein homooligomerization;|Q8TBC3 Q8N2I6 Q8WY93 Q96IB8,SH3KBP1-binding protein 1,SETA-binding protein 1 {ECO:0000303|PubMed:16733801};, PF02214;, GO:0005764;GO:0042802;GO:0045742;GO:0051260;, C:lysosome;, F:identical protein binding;, P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein homooligomerization;|Q8TBC3 Q8N2I6 Q8WY93 Q96IB8,SH3KBP1-binding protein 1,SETA-binding protein 1 {ECO:0000303|PubMed:16733801};, PF02214;, GO:0005764;GO:0042802;GO:0045742;GO:0051260;, C:lysosome;, F:identical protein binding;, P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein homooligomerization;|Q8TBC3 Q8N2I6 Q8WY93 Q96IB8,SH3KBP1-binding protein 1,SETA-binding protein 1 {ECO:0000303|PubMed:16733801};, PF02214;, GO:0005764;GO:0042802;GO:0045742;GO:0051260;, C:lysosome;, F:identical protein binding;, P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein homooligomerization;|Q8TBC3 Q8N2I6 Q8WY93 Q96IB8,SH3KBP1-binding protein 1,SETA-binding protein 1 {ECO:0000303|PubMed:16733801};, PF02214;, GO:0005764;GO:0042802;GO:0045742;GO:0051260;, C:lysosome;, F:identical protein binding;, P:positive regulation of epidermal growth factor receptor signaling pathway; P:protein homooligomerization; scaffold209 indexed_genome mRNA 798372 800004 . + . ID=transcript_15801;Q15057 A8K2V4 Q8N5Z8 Q9UQR3,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2,Centaurin-beta-2;, PF12796;PF01412;PF00169;, GO:0010008;GO:0016020;GO:0001726;GO:0005096;GO:0046872;GO:0030029;GO:1990090;GO:0032456;, C:endosome membrane; C:membrane; C:ruffle;, F:GTPase activator activity; F:metal ion binding;, P:actin filament-based process; P:cellular response to nerve growth factor stimulus; P:endocytic recycling; scaffold210 indexed_genome mRNA 78 622 . - . ID=transcript_15802;O00459 Q5EAT5 Q9UPH9,Phosphatidylinositol 3-kinase regulatory subunit beta,Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta;, PF16454;PF00620;PF00017;, GO:0005829;GO:0005634;GO:0005942;GO:0046935;GO:0001784;GO:0046982;GO:0019903;GO:0030971;GO:0001678;GO:0032869;GO:0038095;GO:0038096;GO:0008286;GO:0050900;GO:0000165;GO:0043409;GO:0014065;GO:0006661;GO:0046854;GO:0048015;GO:0042307;GO:0051897;GO:0045944;GO:0015031;GO:0010506;GO:0043551;GO:0051056;GO:0034976;GO:0050852;GO:0048010;, C:cytosol; C:nucleus; C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase regulator activity; F:phosphotyrosine residue binding; F:protein heterodimerization activity; F:protein phosphatase binding; F:receptor tyrosine kinase binding;, P:cellular glucose homeostasis; P:cellular response to insulin stimulus; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:insulin receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:negative regulation of MAPK cascade; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:protein transport; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase activity; P:regulation of small GTPase mediated signal transduction; P:response to endoplasmic reticulum stress; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold210 indexed_genome mRNA 649 11774 . - . ID=transcript_15803;O00459 Q5EAT5 Q9UPH9,Phosphatidylinositol 3-kinase regulatory subunit beta,Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta;, PF16454;PF00620;PF00017;, GO:0005829;GO:0005634;GO:0005942;GO:0046935;GO:0001784;GO:0046982;GO:0019903;GO:0030971;GO:0001678;GO:0032869;GO:0038095;GO:0038096;GO:0008286;GO:0050900;GO:0000165;GO:0043409;GO:0014065;GO:0006661;GO:0046854;GO:0048015;GO:0042307;GO:0051897;GO:0045944;GO:0015031;GO:0010506;GO:0043551;GO:0051056;GO:0034976;GO:0050852;GO:0048010;, C:cytosol; C:nucleus; C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase regulator activity; F:phosphotyrosine residue binding; F:protein heterodimerization activity; F:protein phosphatase binding; F:receptor tyrosine kinase binding;, P:cellular glucose homeostasis; P:cellular response to insulin stimulus; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:insulin receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:negative regulation of MAPK cascade; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:protein transport; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase activity; P:regulation of small GTPase mediated signal transduction; P:response to endoplasmic reticulum stress; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|O00459 Q5EAT5 Q9UPH9,Phosphatidylinositol 3-kinase regulatory subunit beta,Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta;, PF16454;PF00620;PF00017;, GO:0005829;GO:0005634;GO:0005942;GO:0046935;GO:0001784;GO:0046982;GO:0019903;GO:0030971;GO:0001678;GO:0032869;GO:0038095;GO:0038096;GO:0008286;GO:0050900;GO:0000165;GO:0043409;GO:0014065;GO:0006661;GO:0046854;GO:0048015;GO:0042307;GO:0051897;GO:0045944;GO:0015031;GO:0010506;GO:0043551;GO:0051056;GO:0034976;GO:0050852;GO:0048010;, C:cytosol; C:nucleus; C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase regulator activity; F:phosphotyrosine residue binding; F:protein heterodimerization activity; F:protein phosphatase binding; F:receptor tyrosine kinase binding;, P:cellular glucose homeostasis; P:cellular response to insulin stimulus; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:insulin receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:negative regulation of MAPK cascade; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:protein transport; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase activity; P:regulation of small GTPase mediated signal transduction; P:response to endoplasmic reticulum stress; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold210 indexed_genome mRNA 12780 30587 . - . ID=transcript_15804;O60307 Q7LDZ8 Q9UPI0,Microtubule-associated serine/threonine-protein kinase 3,, PF08926;PF17820;PF00069;, GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;, , F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; scaffold210 indexed_genome mRNA 30609 44950 . - . ID=transcript_15805;O60307 Q7LDZ8 Q9UPI0,Microtubule-associated serine/threonine-protein kinase 3,, PF08926;PF17820;PF00069;, GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;, , F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation;|O60307 Q7LDZ8 Q9UPI0,Microtubule-associated serine/threonine-protein kinase 3,, PF08926;PF17820;PF00069;, GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;, , F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation;|O60307 Q7LDZ8 Q9UPI0,Microtubule-associated serine/threonine-protein kinase 3,, PF08926;PF17820;PF00069;, GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;, , F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation;|O60307 Q7LDZ8 Q9UPI0,Microtubule-associated serine/threonine-protein kinase 3,, PF08926;PF17820;PF00069;, GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;, , F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation;|O60307 Q7LDZ8 Q9UPI0,Microtubule-associated serine/threonine-protein kinase 3,, PF08926;PF17820;PF00069;, GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0007010;GO:0035556;GO:0018105;, , F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; scaffold210 indexed_genome mRNA 77130 78779 . + . ID=transcript_15806;P42701 A8K308 B2RPF1 B7ZKK3 Q8N6Q7,Interleukin-12 receptor subunit beta-1,IL-12 receptor beta component;, PF00041;, GO:0009897;GO:0042022;GO:0072536;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0071346;GO:0019221;GO:0035722;GO:0038155;GO:0042104;GO:0002230;GO:0032729;GO:0043382;GO:0001916;GO:0002827;GO:2000330;GO:2000318;GO:0007165;, C:external side of plasma membrane; C:interleukin-12 receptor complex; C:interleukin-23 receptor complex; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity;, P:cellular response to interferon-gamma; P:cytokine-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:interleukin-23-mediated signaling pathway; P:positive regulation of activated T cell proliferation; P:positive regulation of defense response to virus by host; P:positive regulation of interferon-gamma production; P:positive regulation of memory T cell differentiation; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of T-helper 1 type immune response; P:positive regulation of T-helper 17 cell lineage commitment; P:positive regulation of T-helper 17 type immune response; P:signal transduction; scaffold210 indexed_genome mRNA 113049 118134 . - . ID=transcript_15807;Q8TBH0 B2RBG9 O95895 Q6ZRV9 Q8WYG6,Arrestin domain-containing protein 2,, PF02752;PF00339;, GO:0005737;GO:0031410;GO:0005886;GO:0015031;, C:cytoplasm; C:cytoplasmic vesicle; C:plasma membrane;, , P:protein transport;|Q8TBH0 B2RBG9 O95895 Q6ZRV9 Q8WYG6,Arrestin domain-containing protein 2,, PF02752;PF00339;, GO:0005737;GO:0031410;GO:0005886;GO:0015031;, C:cytoplasm; C:cytoplasmic vesicle; C:plasma membrane;, , P:protein transport;|Q8TBH0 B2RBG9 O95895 Q6ZRV9 Q8WYG6,Arrestin domain-containing protein 2,, PF02752;PF00339;, GO:0005737;GO:0031410;GO:0005886;GO:0015031;, C:cytoplasm; C:cytoplasmic vesicle; C:plasma membrane;, , P:protein transport;|Q8TBH0 B2RBG9 O95895 Q6ZRV9 Q8WYG6,Arrestin domain-containing protein 2,, PF02752;PF00339;, GO:0005737;GO:0031410;GO:0005886;GO:0015031;, C:cytoplasm; C:cytoplasmic vesicle; C:plasma membrane;, , P:protein transport; scaffold210 indexed_genome mRNA 131735 159893 . - . ID=transcript_15808;Q92952 Q5KR10 Q6DJU4,Small conductance calcium-activated potassium channel protein 1,KCa2.1;, PF02888;PF07885;PF03530;, GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0008076;GO:0015269;GO:0005516;GO:0044877;GO:0016286;GO:0007268;GO:0006811;GO:1901381;GO:0071805;GO:0006813;, C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:calcium-activated potassium channel activity; F:calmodulin binding; F:protein-containing complex binding; F:small conductance calcium-activated potassium channel activity;, P:chemical synaptic transmission; P:ion transport; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport;|Q92952 Q5KR10 Q6DJU4,Small conductance calcium-activated potassium channel protein 1,KCa2.1;, PF02888;PF07885;PF03530;, GO:0043005;GO:0043025;GO:0005886;GO:0045202;GO:0008076;GO:0015269;GO:0005516;GO:0044877;GO:0016286;GO:0007268;GO:0006811;GO:1901381;GO:0071805;GO:0006813;, C:neuron projection; C:neuronal cell body; C:plasma membrane; C:synapse; C:voltage-gated potassium channel complex;, F:calcium-activated potassium channel activity; F:calmodulin binding; F:protein-containing complex binding; F:small conductance calcium-activated potassium channel activity;, P:chemical synaptic transmission; P:ion transport; P:positive regulation of potassium ion transmembrane transport; P:potassium ion transmembrane transport; P:potassium ion transport; scaffold210 indexed_genome mRNA 178793 189701 . - . ID=transcript_15809;Q96CT7,Coiled-coil domain-containing protein 124,, PF06244;, GO:0005829;GO:0005815;GO:0030496;GO:0005886;GO:0003723;GO:0007049;GO:0051301;, C:cytosol; C:microtubule organizing center; C:midbody; C:plasma membrane;, F:RNA binding;, P:cell cycle; P:cell division; scaffold210 indexed_genome mRNA 233413 236779 . - . ID=transcript_15810;Q02543,60S ribosomal protein L18a,Large ribosomal subunit protein eL20 {ECO:0000303|PubMed:24524803};, PF01775;, GO:0005829;GO:0022625;GO:0016020;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:membrane; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|Q02543,60S ribosomal protein L18a,Large ribosomal subunit protein eL20 {ECO:0000303|PubMed:24524803};, PF01775;, GO:0005829;GO:0022625;GO:0016020;GO:0042788;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:membrane; C:polysomal ribosome;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold210 indexed_genome mRNA 259469 276419 . + . ID=transcript_15811;P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2,Tyrosine-protein kinase JAK3 {ECO:0000305},Janus kinase 3;Leukocyte janus kinase;, PF18379;PF18377;PF17887;PF07714;, GO:0005856;GO:0005829;GO:0005768;GO:0005886;GO:0005524;GO:0004715;GO:0019903;GO:0004713;GO:0004714;GO:0002250;GO:0030183;GO:0019221;GO:0007167;GO:0030218;GO:0060397;GO:0045087;GO:0035723;GO:0038110;GO:0038114;GO:0035771;GO:0038111;GO:0038113;GO:0035556;GO:0000165;GO:0002731;GO:0045221;GO:0032693;GO:0032695;GO:0050868;GO:0045626;GO:0070244;GO:0018108;GO:0042102;GO:0006468;GO:0042981;GO:0046425;GO:0070232;GO:0070672;GO:0070669;GO:0070670;GO:0071104;GO:0043029;GO:0007260;, C:cytoskeleton; C:cytosol; C:endosome; C:plasma membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell differentiation; P:cytokine-mediated signaling pathway; P:enzyme linked receptor protein signaling pathway; P:erythrocyte differentiation; P:growth hormone receptor signaling pathway via JAK-STAT; P:innate immune response; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-4-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of dendritic cell cytokine production; P:negative regulation of FasL production; P:negative regulation of interleukin-10 production; P:negative regulation of interleukin-12 production; P:negative regulation of T cell activation; P:negative regulation of T-helper 1 cell differentiation; P:negative regulation of thymocyte apoptotic process; P:peptidyl-tyrosine phosphorylation; P:positive regulation of T cell proliferation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of T cell apoptotic process; P:response to interleukin-15; P:response to interleukin-2; P:response to interleukin-4; P:response to interleukin-9; P:T cell homeostasis; P:tyrosine phosphorylation of STAT protein;|P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2,Tyrosine-protein kinase JAK3 {ECO:0000305},Janus kinase 3;Leukocyte janus kinase;, PF18379;PF18377;PF17887;PF07714;, GO:0005856;GO:0005829;GO:0005768;GO:0005886;GO:0005524;GO:0004715;GO:0019903;GO:0004713;GO:0004714;GO:0002250;GO:0030183;GO:0019221;GO:0007167;GO:0030218;GO:0060397;GO:0045087;GO:0035723;GO:0038110;GO:0038114;GO:0035771;GO:0038111;GO:0038113;GO:0035556;GO:0000165;GO:0002731;GO:0045221;GO:0032693;GO:0032695;GO:0050868;GO:0045626;GO:0070244;GO:0018108;GO:0042102;GO:0006468;GO:0042981;GO:0046425;GO:0070232;GO:0070672;GO:0070669;GO:0070670;GO:0071104;GO:0043029;GO:0007260;, C:cytoskeleton; C:cytosol; C:endosome; C:plasma membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell differentiation; P:cytokine-mediated signaling pathway; P:enzyme linked receptor protein signaling pathway; P:erythrocyte differentiation; P:growth hormone receptor signaling pathway via JAK-STAT; P:innate immune response; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-4-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of dendritic cell cytokine production; P:negative regulation of FasL production; P:negative regulation of interleukin-10 production; P:negative regulation of interleukin-12 production; P:negative regulation of T cell activation; P:negative regulation of T-helper 1 cell differentiation; P:negative regulation of thymocyte apoptotic process; P:peptidyl-tyrosine phosphorylation; P:positive regulation of T cell proliferation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of T cell apoptotic process; P:response to interleukin-15; P:response to interleukin-2; P:response to interleukin-4; P:response to interleukin-9; P:T cell homeostasis; P:tyrosine phosphorylation of STAT protein;|P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2,Tyrosine-protein kinase JAK3 {ECO:0000305},Janus kinase 3;Leukocyte janus kinase;, PF18379;PF18377;PF17887;PF07714;, GO:0005856;GO:0005829;GO:0005768;GO:0005886;GO:0005524;GO:0004715;GO:0019903;GO:0004713;GO:0004714;GO:0002250;GO:0030183;GO:0019221;GO:0007167;GO:0030218;GO:0060397;GO:0045087;GO:0035723;GO:0038110;GO:0038114;GO:0035771;GO:0038111;GO:0038113;GO:0035556;GO:0000165;GO:0002731;GO:0045221;GO:0032693;GO:0032695;GO:0050868;GO:0045626;GO:0070244;GO:0018108;GO:0042102;GO:0006468;GO:0042981;GO:0046425;GO:0070232;GO:0070672;GO:0070669;GO:0070670;GO:0071104;GO:0043029;GO:0007260;, C:cytoskeleton; C:cytosol; C:endosome; C:plasma membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell differentiation; P:cytokine-mediated signaling pathway; P:enzyme linked receptor protein signaling pathway; P:erythrocyte differentiation; P:growth hormone receptor signaling pathway via JAK-STAT; P:innate immune response; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-4-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of dendritic cell cytokine production; P:negative regulation of FasL production; P:negative regulation of interleukin-10 production; P:negative regulation of interleukin-12 production; P:negative regulation of T cell activation; P:negative regulation of T-helper 1 cell differentiation; P:negative regulation of thymocyte apoptotic process; P:peptidyl-tyrosine phosphorylation; P:positive regulation of T cell proliferation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of T cell apoptotic process; P:response to interleukin-15; P:response to interleukin-2; P:response to interleukin-4; P:response to interleukin-9; P:T cell homeostasis; P:tyrosine phosphorylation of STAT protein;|P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2,Tyrosine-protein kinase JAK3 {ECO:0000305},Janus kinase 3;Leukocyte janus kinase;, PF18379;PF18377;PF17887;PF07714;, GO:0005856;GO:0005829;GO:0005768;GO:0005886;GO:0005524;GO:0004715;GO:0019903;GO:0004713;GO:0004714;GO:0002250;GO:0030183;GO:0019221;GO:0007167;GO:0030218;GO:0060397;GO:0045087;GO:0035723;GO:0038110;GO:0038114;GO:0035771;GO:0038111;GO:0038113;GO:0035556;GO:0000165;GO:0002731;GO:0045221;GO:0032693;GO:0032695;GO:0050868;GO:0045626;GO:0070244;GO:0018108;GO:0042102;GO:0006468;GO:0042981;GO:0046425;GO:0070232;GO:0070672;GO:0070669;GO:0070670;GO:0071104;GO:0043029;GO:0007260;, C:cytoskeleton; C:cytosol; C:endosome; C:plasma membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein phosphatase binding; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:adaptive immune response; P:B cell differentiation; P:cytokine-mediated signaling pathway; P:enzyme linked receptor protein signaling pathway; P:erythrocyte differentiation; P:growth hormone receptor signaling pathway via JAK-STAT; P:innate immune response; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:interleukin-21-mediated signaling pathway; P:interleukin-4-mediated signaling pathway; P:interleukin-7-mediated signaling pathway; P:interleukin-9-mediated signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:negative regulation of dendritic cell cytokine production; P:negative regulation of FasL production; P:negative regulation of interleukin-10 production; P:negative regulation of interleukin-12 production; P:negative regulation of T cell activation; P:negative regulation of T-helper 1 cell differentiation; P:negative regulation of thymocyte apoptotic process; P:peptidyl-tyrosine phosphorylation; P:positive regulation of T cell proliferation; P:protein phosphorylation; P:regulation of apoptotic process; P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of T cell apoptotic process; P:response to interleukin-15; P:response to interleukin-2; P:response to interleukin-4; P:response to interleukin-9; P:T cell homeostasis; P:tyrosine phosphorylation of STAT protein; scaffold210 indexed_genome mRNA 309292 310382 . + . ID=transcript_15812;Q9Y2A9 B2RAS4 Q6NWU9 Q6NXU9 Q8WWR6 Q9C0J2,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3,Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase;Beta-1,3-galactosyltransferase 8;Beta-3-Gx-T8;Core 1 extending beta-1,3-N-acetylglucosaminyltransferase {ECO:0000303|PubMed:11439191};Core1-beta3GlcNAcT {ECO:0000303|PubMed:11439191};Transmembrane protein 3;UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3;UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8;, PF01762;, GO:0005794;GO:0000139;GO:0005887;GO:0008376;GO:0008375;GO:0047223;GO:0008457;GO:0008532;GO:0018146;GO:0016266;GO:0030311;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity; F:beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity;, P:keratan sulfate biosynthetic process; P:O-glycan processing; P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation; scaffold210 indexed_genome mRNA 310394 315308 . - . ID=transcript_15813;Q9Y2A9 B2RAS4 Q6NWU9 Q6NXU9 Q8WWR6 Q9C0J2,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3,Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase;Beta-1,3-galactosyltransferase 8;Beta-3-Gx-T8;Core 1 extending beta-1,3-N-acetylglucosaminyltransferase {ECO:0000303|PubMed:11439191};Core1-beta3GlcNAcT {ECO:0000303|PubMed:11439191};Transmembrane protein 3;UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3;UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8;, PF01762;, GO:0005794;GO:0000139;GO:0005887;GO:0008376;GO:0008375;GO:0047223;GO:0008457;GO:0008532;GO:0018146;GO:0016266;GO:0030311;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane;, F:acetylgalactosaminyltransferase activity; F:acetylglucosaminyltransferase activity; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity; F:beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity;, P:keratan sulfate biosynthetic process; P:O-glycan processing; P:poly-N-acetyllactosamine biosynthetic process; P:protein glycosylation; scaffold210 indexed_genome mRNA 333886 363019 . + . ID=transcript_15814;O14526 A6NHE6 A8K5U5 B4E120 Q05C93 Q8IW22,F-BAR domain only protein 1,, PF00611;PF10291;, GO:0005905;GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0005886;GO:0035612;GO:0048268;GO:0072583;GO:0061024;, C:clathrin-coated pit; C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:AP-2 adaptor complex binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane organization;|O14526 A6NHE6 A8K5U5 B4E120 Q05C93 Q8IW22,F-BAR domain only protein 1,, PF00611;PF10291;, GO:0005905;GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0005886;GO:0035612;GO:0048268;GO:0072583;GO:0061024;, C:clathrin-coated pit; C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:AP-2 adaptor complex binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane organization;|O14526 A6NHE6 A8K5U5 B4E120 Q05C93 Q8IW22,F-BAR domain only protein 1,, PF00611;PF10291;, GO:0005905;GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0005886;GO:0035612;GO:0048268;GO:0072583;GO:0061024;, C:clathrin-coated pit; C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:AP-2 adaptor complex binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane organization;|O14526 A6NHE6 A8K5U5 B4E120 Q05C93 Q8IW22,F-BAR domain only protein 1,, PF00611;PF10291;, GO:0005905;GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0005886;GO:0035612;GO:0048268;GO:0072583;GO:0061024;, C:clathrin-coated pit; C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:AP-2 adaptor complex binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane organization;|O14526 A6NHE6 A8K5U5 B4E120 Q05C93 Q8IW22,F-BAR domain only protein 1,, PF00611;PF10291;, GO:0005905;GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0005886;GO:0035612;GO:0048268;GO:0072583;GO:0061024;, C:clathrin-coated pit; C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:AP-2 adaptor complex binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane organization;|O14526 A6NHE6 A8K5U5 B4E120 Q05C93 Q8IW22,F-BAR domain only protein 1,, PF00611;PF10291;, GO:0005905;GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0005886;GO:0035612;GO:0048268;GO:0072583;GO:0061024;, C:clathrin-coated pit; C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:plasma membrane;, F:AP-2 adaptor complex binding;, P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:membrane organization; scaffold210 indexed_genome mRNA 371093 408440 . - . ID=transcript_15815;Q96SP8 Q9BRC6 Q9H928 Q9NVK7,Microtubule-associated protein 1S,BPY2-interacting protein 1;Microtubule-associated protein 8;Variable charge Y chromosome 2-interacting protein 1;, , GO:0030054;GO:0042995;GO:0005829;GO:0030425;GO:0005874;GO:0005875;GO:0043025;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005819;GO:0045202;GO:0003779;GO:0051015;GO:0048487;GO:0003677;GO:0008017;GO:0015631;GO:0006915;GO:0006914;GO:0007409;GO:0007420;GO:0016358;GO:0006259;GO:0001578;GO:0000226;GO:0047497;GO:0007399;GO:0048812;GO:0010848;GO:0031114;, C:cell junction; C:cell projection; C:cytosol; C:dendrite; C:microtubule; C:microtubule associated complex; C:neuronal cell body; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:spindle; C:synapse;, F:actin binding; F:actin filament binding; F:beta-tubulin binding; F:DNA binding; F:microtubule binding; F:tubulin binding;, P:apoptotic process; P:autophagy; P:axonogenesis; P:brain development; P:dendrite development; P:DNA metabolic process; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:mitochondrion transport along microtubule; P:nervous system development; P:neuron projection morphogenesis; P:regulation of chromatin disassembly; P:regulation of microtubule depolymerization; scaffold210 indexed_genome mRNA 440165 486783 . + . ID=transcript_15816;Q9UPW8 E5RHY9,Protein unc-13 homolog A {ECO:0000305},Munc13-1;, PF00130;PF00168;PF06292;PF10540;, GO:0031594;GO:0043005;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0005543;GO:0017075;GO:0030154;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0007269;GO:1903861;GO:0099525;GO:0051966;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:phospholipid binding; F:syntaxin-1 binding;, P:cell differentiation; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter secretion; P:positive regulation of dendrite extension; P:presynaptic dense core vesicle exocytosis; P:regulation of synaptic transmission, glutamatergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|Q9UPW8 E5RHY9,Protein unc-13 homolog A {ECO:0000305},Munc13-1;, PF00130;PF00168;PF06292;PF10540;, GO:0031594;GO:0043005;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0005543;GO:0017075;GO:0030154;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0007269;GO:1903861;GO:0099525;GO:0051966;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:phospholipid binding; F:syntaxin-1 binding;, P:cell differentiation; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter secretion; P:positive regulation of dendrite extension; P:presynaptic dense core vesicle exocytosis; P:regulation of synaptic transmission, glutamatergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|Q9UPW8 E5RHY9,Protein unc-13 homolog A {ECO:0000305},Munc13-1;, PF00130;PF00168;PF06292;PF10540;, GO:0031594;GO:0043005;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0005543;GO:0017075;GO:0030154;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0007269;GO:1903861;GO:0099525;GO:0051966;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:phospholipid binding; F:syntaxin-1 binding;, P:cell differentiation; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter secretion; P:positive regulation of dendrite extension; P:presynaptic dense core vesicle exocytosis; P:regulation of synaptic transmission, glutamatergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming; scaffold210 indexed_genome mRNA 490256 499621 . + . ID=transcript_15817;Q9UPW8 E5RHY9,Protein unc-13 homolog A {ECO:0000305},Munc13-1;, PF00130;PF00168;PF06292;PF10540;, GO:0031594;GO:0043005;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0005543;GO:0017075;GO:0030154;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0007269;GO:1903861;GO:0099525;GO:0051966;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:phospholipid binding; F:syntaxin-1 binding;, P:cell differentiation; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter secretion; P:positive regulation of dendrite extension; P:presynaptic dense core vesicle exocytosis; P:regulation of synaptic transmission, glutamatergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming;|Q9UPW8 E5RHY9,Protein unc-13 homolog A {ECO:0000305},Munc13-1;, PF00130;PF00168;PF06292;PF10540;, GO:0031594;GO:0043005;GO:0005886;GO:0048786;GO:0098831;GO:0042734;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0005543;GO:0017075;GO:0030154;GO:0061789;GO:0035556;GO:0007528;GO:0099011;GO:0007269;GO:1903861;GO:0099525;GO:0051966;GO:0035249;GO:0016081;GO:0016188;GO:0016082;, C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;, F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:phospholipid binding; F:syntaxin-1 binding;, P:cell differentiation; P:dense core granule priming; P:intracellular signal transduction; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter secretion; P:positive regulation of dendrite extension; P:presynaptic dense core vesicle exocytosis; P:regulation of synaptic transmission, glutamatergic; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle maturation; P:synaptic vesicle priming; scaffold210 indexed_genome mRNA 516475 523656 . - . ID=transcript_15818;Q8NBJ5 Q8NC64,Procollagen galactosyltransferase 1,Collagen beta(1-O)galactosyltransferase 1;Glycosyltransferase 25 family member 1;Hydroxylysine galactosyltransferase 1;, PF01755;, GO:0005788;GO:0016020;GO:0050211;GO:0030199;GO:1904028;, C:endoplasmic reticulum lumen; C:membrane;, F:procollagen galactosyltransferase activity;, P:collagen fibril organization; P:positive regulation of collagen fibril organization;|Q8NBJ5 Q8NC64,Procollagen galactosyltransferase 1,Collagen beta(1-O)galactosyltransferase 1;Glycosyltransferase 25 family member 1;Hydroxylysine galactosyltransferase 1;, PF01755;, GO:0005788;GO:0016020;GO:0050211;GO:0030199;GO:1904028;, C:endoplasmic reticulum lumen; C:membrane;, F:procollagen galactosyltransferase activity;, P:collagen fibril organization; P:positive regulation of collagen fibril organization; scaffold210 indexed_genome mRNA 523724 530866 . - . ID=transcript_15819;Q8NBJ5 Q8NC64,Procollagen galactosyltransferase 1,Collagen beta(1-O)galactosyltransferase 1;Glycosyltransferase 25 family member 1;Hydroxylysine galactosyltransferase 1;, PF01755;, GO:0005788;GO:0016020;GO:0050211;GO:0030199;GO:1904028;, C:endoplasmic reticulum lumen; C:membrane;, F:procollagen galactosyltransferase activity;, P:collagen fibril organization; P:positive regulation of collagen fibril organization;|Q8NBJ5 Q8NC64,Procollagen galactosyltransferase 1,Collagen beta(1-O)galactosyltransferase 1;Glycosyltransferase 25 family member 1;Hydroxylysine galactosyltransferase 1;, PF01755;, GO:0005788;GO:0016020;GO:0050211;GO:0030199;GO:1904028;, C:endoplasmic reticulum lumen; C:membrane;, F:procollagen galactosyltransferase activity;, P:collagen fibril organization; P:positive regulation of collagen fibril organization; scaffold210 indexed_genome mRNA 535829 536373 . - . ID=transcript_15820;Q8NBJ5 Q8NC64,Procollagen galactosyltransferase 1,Collagen beta(1-O)galactosyltransferase 1;Glycosyltransferase 25 family member 1;Hydroxylysine galactosyltransferase 1;, PF01755;, GO:0005788;GO:0016020;GO:0050211;GO:0030199;GO:1904028;, C:endoplasmic reticulum lumen; C:membrane;, F:procollagen galactosyltransferase activity;, P:collagen fibril organization; P:positive regulation of collagen fibril organization; scaffold210 indexed_genome mRNA 537950 538572 . - . ID=transcript_15821;Q8NBJ5 Q8NC64,Procollagen galactosyltransferase 1,Collagen beta(1-O)galactosyltransferase 1;Glycosyltransferase 25 family member 1;Hydroxylysine galactosyltransferase 1;, PF01755;, GO:0005788;GO:0016020;GO:0050211;GO:0030199;GO:1904028;, C:endoplasmic reticulum lumen; C:membrane;, F:procollagen galactosyltransferase activity;, P:collagen fibril organization; P:positive regulation of collagen fibril organization; scaffold210 indexed_genome mRNA 545529 551053 . - . ID=transcript_15822;Q86XR2 B4DNU3 B4DVN7 Q7Z6H6 Q86XR3 Q86XR4 Q8TEQ3,Protein Niban 3 {ECO:0000305},B-cell novel protein 1 {ECO:0000303|PubMed:12886250};Niban-like protein 2 {ECO:0000305};Protein FAM129C; scaffold210 indexed_genome mRNA 552505 554765 . - . ID=transcript_15823;Q86XR2 B4DNU3 B4DVN7 Q7Z6H6 Q86XR3 Q86XR4 Q8TEQ3,Protein Niban 3 {ECO:0000305},B-cell novel protein 1 {ECO:0000303|PubMed:12886250};Niban-like protein 2 {ECO:0000305};Protein FAM129C; scaffold210 indexed_genome mRNA 567093 575603 . + . ID=transcript_15824;O95336,6-phosphogluconolactonase,, PF01182;, GO:0005737;GO:0005829;GO:0070062;GO:0017057;GO:0005975;GO:0006098;GO:0009051;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:6-phosphogluconolactonase activity;, P:carbohydrate metabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch;|O95336,6-phosphogluconolactonase,, PF01182;, GO:0005737;GO:0005829;GO:0070062;GO:0017057;GO:0005975;GO:0006098;GO:0009051;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:6-phosphogluconolactonase activity;, P:carbohydrate metabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch;|O95336,6-phosphogluconolactonase,, PF01182;, GO:0005737;GO:0005829;GO:0070062;GO:0017057;GO:0005975;GO:0006098;GO:0009051;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:6-phosphogluconolactonase activity;, P:carbohydrate metabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch;|O95336,6-phosphogluconolactonase,, PF01182;, GO:0005737;GO:0005829;GO:0070062;GO:0017057;GO:0005975;GO:0006098;GO:0009051;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:6-phosphogluconolactonase activity;, P:carbohydrate metabolic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch; scaffold210 indexed_genome mRNA 581002 615010 . - . ID=transcript_15825;Q6PCB7 A6NIH2 B7Z662,Long-chain fatty acid transport protein 1 {ECO:0000305},Solute carrier family 27 member 1 {ECO:0000312|HGNC:HGNC:10995};, PF00501;PF13193;, GO:0009925;GO:0005783;GO:0005887;GO:0016020;GO:0005886;GO:0047676;GO:0015225;GO:0015562;GO:0015245;GO:0005324;GO:0004467;GO:0000166;GO:1901480;GO:0090434;GO:0031957;GO:0033211;GO:1905135;GO:0015878;GO:0032049;GO:0140115;GO:0044381;GO:1990379;GO:0015911;GO:0044539;GO:0015909;GO:0001579;GO:0071072;GO:0006654;GO:0006656;GO:0006646;GO:0006655;GO:0006661;GO:0006659;GO:0031652;GO:0071902;GO:0010867;GO:0019222;GO:0009409;GO:0032868;GO:0150104;, C:basal plasma membrane; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:fatty acid transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:nucleotide binding; F:oleate transmembrane transporter activity; F:oleoyl-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:biotin import across plasma membrane; P:biotin transport; P:cardiolipin biosynthetic process; P:export across plasma membrane; P:glucose import in response to insulin stimulus; P:lipid transport across blood-brain barrier; P:long-chain fatty acid import across plasma membrane; P:long-chain fatty acid import into cell; P:long-chain fatty acid transport; P:medium-chain fatty acid transport; P:negative regulation of phospholipid biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:phosphatidylglycerol biosynthetic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylserine biosynthetic process; P:positive regulation of heat generation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of triglyceride biosynthetic process; P:regulation of metabolic process; P:response to cold; P:response to insulin; P:transport across blood-brain barrier;|Q6PCB7 A6NIH2 B7Z662,Long-chain fatty acid transport protein 1 {ECO:0000305},Solute carrier family 27 member 1 {ECO:0000312|HGNC:HGNC:10995};, PF00501;PF13193;, GO:0009925;GO:0005783;GO:0005887;GO:0016020;GO:0005886;GO:0047676;GO:0015225;GO:0015562;GO:0015245;GO:0005324;GO:0004467;GO:0000166;GO:1901480;GO:0090434;GO:0031957;GO:0033211;GO:1905135;GO:0015878;GO:0032049;GO:0140115;GO:0044381;GO:1990379;GO:0015911;GO:0044539;GO:0015909;GO:0001579;GO:0071072;GO:0006654;GO:0006656;GO:0006646;GO:0006655;GO:0006661;GO:0006659;GO:0031652;GO:0071902;GO:0010867;GO:0019222;GO:0009409;GO:0032868;GO:0150104;, C:basal plasma membrane; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:fatty acid transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:nucleotide binding; F:oleate transmembrane transporter activity; F:oleoyl-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:biotin import across plasma membrane; P:biotin transport; P:cardiolipin biosynthetic process; P:export across plasma membrane; P:glucose import in response to insulin stimulus; P:lipid transport across blood-brain barrier; P:long-chain fatty acid import across plasma membrane; P:long-chain fatty acid import into cell; P:long-chain fatty acid transport; P:medium-chain fatty acid transport; P:negative regulation of phospholipid biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:phosphatidylglycerol biosynthetic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylserine biosynthetic process; P:positive regulation of heat generation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of triglyceride biosynthetic process; P:regulation of metabolic process; P:response to cold; P:response to insulin; P:transport across blood-brain barrier;|Q6PCB7 A6NIH2 B7Z662,Long-chain fatty acid transport protein 1 {ECO:0000305},Solute carrier family 27 member 1 {ECO:0000312|HGNC:HGNC:10995};, PF00501;PF13193;, GO:0009925;GO:0005783;GO:0005887;GO:0016020;GO:0005886;GO:0047676;GO:0015225;GO:0015562;GO:0015245;GO:0005324;GO:0004467;GO:0000166;GO:1901480;GO:0090434;GO:0031957;GO:0033211;GO:1905135;GO:0015878;GO:0032049;GO:0140115;GO:0044381;GO:1990379;GO:0015911;GO:0044539;GO:0015909;GO:0001579;GO:0071072;GO:0006654;GO:0006656;GO:0006646;GO:0006655;GO:0006661;GO:0006659;GO:0031652;GO:0071902;GO:0010867;GO:0019222;GO:0009409;GO:0032868;GO:0150104;, C:basal plasma membrane; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:fatty acid transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:nucleotide binding; F:oleate transmembrane transporter activity; F:oleoyl-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:biotin import across plasma membrane; P:biotin transport; P:cardiolipin biosynthetic process; P:export across plasma membrane; P:glucose import in response to insulin stimulus; P:lipid transport across blood-brain barrier; P:long-chain fatty acid import across plasma membrane; P:long-chain fatty acid import into cell; P:long-chain fatty acid transport; P:medium-chain fatty acid transport; P:negative regulation of phospholipid biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:phosphatidylglycerol biosynthetic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylserine biosynthetic process; P:positive regulation of heat generation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of triglyceride biosynthetic process; P:regulation of metabolic process; P:response to cold; P:response to insulin; P:transport across blood-brain barrier;|Q6PCB7 A6NIH2 B7Z662,Long-chain fatty acid transport protein 1 {ECO:0000305},Solute carrier family 27 member 1 {ECO:0000312|HGNC:HGNC:10995};, PF00501;PF13193;, GO:0009925;GO:0005783;GO:0005887;GO:0016020;GO:0005886;GO:0047676;GO:0015225;GO:0015562;GO:0015245;GO:0005324;GO:0004467;GO:0000166;GO:1901480;GO:0090434;GO:0031957;GO:0033211;GO:1905135;GO:0015878;GO:0032049;GO:0140115;GO:0044381;GO:1990379;GO:0015911;GO:0044539;GO:0015909;GO:0001579;GO:0071072;GO:0006654;GO:0006656;GO:0006646;GO:0006655;GO:0006661;GO:0006659;GO:0031652;GO:0071902;GO:0010867;GO:0019222;GO:0009409;GO:0032868;GO:0150104;, C:basal plasma membrane; C:endoplasmic reticulum; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:arachidonate-CoA ligase activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:fatty acid transmembrane transporter activity; F:long-chain fatty acid transporter activity; F:long-chain fatty acid-CoA ligase activity; F:nucleotide binding; F:oleate transmembrane transporter activity; F:oleoyl-CoA ligase activity; F:very long-chain fatty acid-CoA ligase activity;, P:adiponectin-activated signaling pathway; P:biotin import across plasma membrane; P:biotin transport; P:cardiolipin biosynthetic process; P:export across plasma membrane; P:glucose import in response to insulin stimulus; P:lipid transport across blood-brain barrier; P:long-chain fatty acid import across plasma membrane; P:long-chain fatty acid import into cell; P:long-chain fatty acid transport; P:medium-chain fatty acid transport; P:negative regulation of phospholipid biosynthetic process; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; P:phosphatidylglycerol biosynthetic process; P:phosphatidylinositol biosynthetic process; P:phosphatidylserine biosynthetic process; P:positive regulation of heat generation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of triglyceride biosynthetic process; P:regulation of metabolic process; P:response to cold; P:response to insulin; P:transport across blood-brain barrier; scaffold210 indexed_genome mRNA 661890 665850 . - . ID=transcript_15826;Q96EY5 Q96I18,Multivesicular body subunit 12A,CIN85/CD2AP family-binding protein;ESCRT-I complex subunit MVB12A;Protein FAM125A;, PF10240;, GO:0005813;GO:0005829;GO:0010008;GO:0000813;GO:0070062;GO:0005794;GO:0043657;GO:0031902;GO:0005654;GO:0031982;GO:0008289;GO:0017124;GO:0043130;GO:0016197;GO:0032510;GO:0075733;GO:0016236;GO:0036258;GO:0015031;GO:0032801;GO:0042058;GO:0043162;GO:0046755;GO:0039702;GO:0019058;GO:0019075;, C:centrosome; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:Golgi apparatus; C:host cell; C:late endosome membrane; C:nucleoplasm; C:vesicle;, F:lipid binding; F:SH3 domain binding; F:ubiquitin binding;, P:endosomal transport; P:endosome to lysosome transport via multivesicular body sorting pathway; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein transport; P:receptor catabolic process; P:regulation of epidermal growth factor receptor signaling pathway; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle; P:virus maturation;|Q96EY5 Q96I18,Multivesicular body subunit 12A,CIN85/CD2AP family-binding protein;ESCRT-I complex subunit MVB12A;Protein FAM125A;, PF10240;, GO:0005813;GO:0005829;GO:0010008;GO:0000813;GO:0070062;GO:0005794;GO:0043657;GO:0031902;GO:0005654;GO:0031982;GO:0008289;GO:0017124;GO:0043130;GO:0016197;GO:0032510;GO:0075733;GO:0016236;GO:0036258;GO:0015031;GO:0032801;GO:0042058;GO:0043162;GO:0046755;GO:0039702;GO:0019058;GO:0019075;, C:centrosome; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:Golgi apparatus; C:host cell; C:late endosome membrane; C:nucleoplasm; C:vesicle;, F:lipid binding; F:SH3 domain binding; F:ubiquitin binding;, P:endosomal transport; P:endosome to lysosome transport via multivesicular body sorting pathway; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein transport; P:receptor catabolic process; P:regulation of epidermal growth factor receptor signaling pathway; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle; P:virus maturation;|Q96EY5 Q96I18,Multivesicular body subunit 12A,CIN85/CD2AP family-binding protein;ESCRT-I complex subunit MVB12A;Protein FAM125A;, PF10240;, GO:0005813;GO:0005829;GO:0010008;GO:0000813;GO:0070062;GO:0005794;GO:0043657;GO:0031902;GO:0005654;GO:0031982;GO:0008289;GO:0017124;GO:0043130;GO:0016197;GO:0032510;GO:0075733;GO:0016236;GO:0036258;GO:0015031;GO:0032801;GO:0042058;GO:0043162;GO:0046755;GO:0039702;GO:0019058;GO:0019075;, C:centrosome; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:Golgi apparatus; C:host cell; C:late endosome membrane; C:nucleoplasm; C:vesicle;, F:lipid binding; F:SH3 domain binding; F:ubiquitin binding;, P:endosomal transport; P:endosome to lysosome transport via multivesicular body sorting pathway; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein transport; P:receptor catabolic process; P:regulation of epidermal growth factor receptor signaling pathway; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle; P:virus maturation;|Q96EY5 Q96I18,Multivesicular body subunit 12A,CIN85/CD2AP family-binding protein;ESCRT-I complex subunit MVB12A;Protein FAM125A;, PF10240;, GO:0005813;GO:0005829;GO:0010008;GO:0000813;GO:0070062;GO:0005794;GO:0043657;GO:0031902;GO:0005654;GO:0031982;GO:0008289;GO:0017124;GO:0043130;GO:0016197;GO:0032510;GO:0075733;GO:0016236;GO:0036258;GO:0015031;GO:0032801;GO:0042058;GO:0043162;GO:0046755;GO:0039702;GO:0019058;GO:0019075;, C:centrosome; C:cytosol; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:Golgi apparatus; C:host cell; C:late endosome membrane; C:nucleoplasm; C:vesicle;, F:lipid binding; F:SH3 domain binding; F:ubiquitin binding;, P:endosomal transport; P:endosome to lysosome transport via multivesicular body sorting pathway; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:protein transport; P:receptor catabolic process; P:regulation of epidermal growth factor receptor signaling pathway; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding; P:viral budding via host ESCRT complex; P:viral life cycle; P:virus maturation; scaffold210 indexed_genome mRNA 750042 759644 . + . ID=transcript_15827;Q9BX97 Q86VP0 Q8N8Y0 Q8ND68 Q8TER8 Q9BZD5,Plasmalemma vesicle-associated protein,Fenestrated endothelial-linked structure protein;Plasmalemma vesicle protein 1;, PF06637;, GO:0005901;GO:0009986;GO:0070062;GO:0016021;GO:0048471;GO:0042802;GO:0032502;GO:0000165;GO:0002693;GO:0033209;, C:caveola; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:identical protein binding;, P:developmental process; P:MAPK cascade; P:positive regulation of cellular extravasation; P:tumor necrosis factor-mediated signaling pathway; scaffold210 indexed_genome mRNA 765301 769275 . - . ID=transcript_15828;Q9BX61,tRNA modification GTPase GTPBP3, mitochondrial,GTP-binding protein 3;Mitochondrial GTP-binding protein 1;, PF01926;PF12631;PF10396;, GO:0005737;GO:0005739;GO:0005634;GO:0005525;GO:0003924;GO:0030488;GO:0002098;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:GTP binding; F:GTPase activity;, P:tRNA methylation; P:tRNA wobble uridine modification;|Q9BX61,tRNA modification GTPase GTPBP3, mitochondrial,GTP-binding protein 3;Mitochondrial GTP-binding protein 1;, PF01926;PF12631;PF10396;, GO:0005737;GO:0005739;GO:0005634;GO:0005525;GO:0003924;GO:0030488;GO:0002098;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:GTP binding; F:GTPase activity;, P:tRNA methylation; P:tRNA wobble uridine modification;|Q9BX61,tRNA modification GTPase GTPBP3, mitochondrial,GTP-binding protein 3;Mitochondrial GTP-binding protein 1;, PF01926;PF12631;PF10396;, GO:0005737;GO:0005739;GO:0005634;GO:0005525;GO:0003924;GO:0030488;GO:0002098;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:GTP binding; F:GTPase activity;, P:tRNA methylation; P:tRNA wobble uridine modification; scaffold210 indexed_genome mRNA 775191 780551 . + . ID=transcript_15829;Q9HCE9 A6NIJ0,Anoctamin-8,Transmembrane protein 16H;, PF04547;, GO:0005788;GO:0016021;GO:0005886;GO:0005229;GO:0044267;GO:0006821;GO:0034220;GO:0043687;GO:0055085;, C:endoplasmic reticulum lumen; C:integral component of membrane; C:plasma membrane;, F:intracellular calcium activated chloride channel activity;, P:cellular protein metabolic process; P:chloride transport; P:ion transmembrane transport; P:post-translational protein modification; P:transmembrane transport;|Q9HCE9 A6NIJ0,Anoctamin-8,Transmembrane protein 16H;, PF04547;, GO:0005788;GO:0016021;GO:0005886;GO:0005229;GO:0044267;GO:0006821;GO:0034220;GO:0043687;GO:0055085;, C:endoplasmic reticulum lumen; C:integral component of membrane; C:plasma membrane;, F:intracellular calcium activated chloride channel activity;, P:cellular protein metabolic process; P:chloride transport; P:ion transmembrane transport; P:post-translational protein modification; P:transmembrane transport;|Q9HCE9 A6NIJ0,Anoctamin-8,Transmembrane protein 16H;, PF04547;, GO:0005788;GO:0016021;GO:0005886;GO:0005229;GO:0044267;GO:0006821;GO:0034220;GO:0043687;GO:0055085;, C:endoplasmic reticulum lumen; C:integral component of membrane; C:plasma membrane;, F:intracellular calcium activated chloride channel activity;, P:cellular protein metabolic process; P:chloride transport; P:ion transmembrane transport; P:post-translational protein modification; P:transmembrane transport; scaffold210 indexed_genome mRNA 780563 794132 . - . ID=transcript_15830;Q9HCE9 A6NIJ0,Anoctamin-8,Transmembrane protein 16H;, PF04547;, GO:0005788;GO:0016021;GO:0005886;GO:0005229;GO:0044267;GO:0006821;GO:0034220;GO:0043687;GO:0055085;, C:endoplasmic reticulum lumen; C:integral component of membrane; C:plasma membrane;, F:intracellular calcium activated chloride channel activity;, P:cellular protein metabolic process; P:chloride transport; P:ion transmembrane transport; P:post-translational protein modification; P:transmembrane transport;|Q9HCE9 A6NIJ0,Anoctamin-8,Transmembrane protein 16H;, PF04547;, GO:0005788;GO:0016021;GO:0005886;GO:0005229;GO:0044267;GO:0006821;GO:0034220;GO:0043687;GO:0055085;, C:endoplasmic reticulum lumen; C:integral component of membrane; C:plasma membrane;, F:intracellular calcium activated chloride channel activity;, P:cellular protein metabolic process; P:chloride transport; P:ion transmembrane transport; P:post-translational protein modification; P:transmembrane transport;|Q9BW61,DET1- and DDB1-associated protein 1 {ECO:0000303|PubMed:17452440},Placenta cross-immune reaction antigen 1 {ECO:0000303|Ref.2};, PF10172;, GO:0080008;GO:0005654;GO:0032436;GO:0043687;GO:0000209;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein polyubiquitination; scaffold211 indexed_genome mRNA 82942 83452 . - . ID=transcript_15831;Q8WZA9 B2RNP3,Immunity-related GTPase family Q protein,, , GO:0005525;, , F:GTP binding; scaffold211 indexed_genome mRNA 84435 90918 . - . ID=transcript_15832;Q8WZA9 B2RNP3,Immunity-related GTPase family Q protein,, , GO:0005525;, , F:GTP binding;|Q9H609 Q9BU03,Zinc finger protein 576,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0043565;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 95551 104324 . - . ID=transcript_15833;Q96B54 O95054 Q6X3Y3,Zinc finger protein 428,Enzyme-like protein PIT13;, , GO:0046872;, , F:metal ion binding; scaffold211 indexed_genome mRNA 107190 112728 . - . ID=transcript_15834;Q8NFZ8 B2R7L5 Q9Y4A4,Cell adhesion molecule 4,Immunoglobulin superfamily member 4C;Nectin-like protein 4;TSLC1-like protein 2;, PF08205;PF07686;, GO:0031252;GO:0044291;GO:0016021;GO:0019903;GO:0030971;GO:0043183;GO:0043184;GO:0007155;GO:0010801;GO:0050732;GO:0001933;GO:0030948;GO:1900747;GO:2000145;GO:0042127;GO:0001932;GO:0035020;GO:0061041;, C:cell leading edge; C:cell-cell contact zone; C:integral component of membrane;, F:protein phosphatase binding; F:receptor tyrosine kinase binding; F:vascular endothelial growth factor receptor 1 binding; F:vascular endothelial growth factor receptor 2 binding;, P:cell adhesion; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:regulation of cell motility; P:regulation of cell population proliferation; P:regulation of protein phosphorylation; P:regulation of Rac protein signal transduction; P:regulation of wound healing;|Q8NFZ8 B2R7L5 Q9Y4A4,Cell adhesion molecule 4,Immunoglobulin superfamily member 4C;Nectin-like protein 4;TSLC1-like protein 2;, PF08205;PF07686;, GO:0031252;GO:0044291;GO:0016021;GO:0019903;GO:0030971;GO:0043183;GO:0043184;GO:0007155;GO:0010801;GO:0050732;GO:0001933;GO:0030948;GO:1900747;GO:2000145;GO:0042127;GO:0001932;GO:0035020;GO:0061041;, C:cell leading edge; C:cell-cell contact zone; C:integral component of membrane;, F:protein phosphatase binding; F:receptor tyrosine kinase binding; F:vascular endothelial growth factor receptor 1 binding; F:vascular endothelial growth factor receptor 2 binding;, P:cell adhesion; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of protein phosphorylation; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:regulation of cell motility; P:regulation of cell population proliferation; P:regulation of protein phosphorylation; P:regulation of Rac protein signal transduction; P:regulation of wound healing; scaffold211 indexed_genome mRNA 130553 144269 . - . ID=transcript_15835;Q9UEA6 Q9UM92 Q9UMV0,Urokinase plasminogen activator surface receptor,Monocyte activation antigen Mo3;, PF00021;, GO:0031225;GO:0042995;GO:0009986;GO:0005788;GO:0005789;GO:0005576;GO:0019898;GO:0005925;GO:0016021;GO:0005887;GO:0005886;GO:0035579;GO:0019899;GO:0019904;GO:0038023;GO:0005102;GO:0030377;GO:0007596;GO:0006935;GO:0042730;GO:0043066;GO:2001268;GO:2001243;GO:0043312;GO:0043388;GO:0045742;GO:0034112;GO:0001934;GO:0090200;GO:0030162;GO:0007165;, C:anchored component of membrane; C:cell projection; C:cell surface; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular region; C:extrinsic component of membrane; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane; C:specific granule membrane;, F:enzyme binding; F:protein domain specific binding; F:signaling receptor activity; F:signaling receptor binding; F:urokinase plasminogen activator receptor activity;, P:blood coagulation; P:chemotaxis; P:fibrinolysis; P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of intrinsic apoptotic signaling pathway; P:neutrophil degranulation; P:positive regulation of DNA binding; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of homotypic cell-cell adhesion; P:positive regulation of protein phosphorylation; P:positive regulation of release of cytochrome c from mitochondria; P:regulation of proteolysis; P:signal transduction; scaffold211 indexed_genome mRNA 185721 187737 . + . ID=transcript_15836;Q6NXR0 Q05BR8,Interferon-inducible GTPase 5,Immunity-related GTPase cinema 1;, PF05049;, GO:0005789;GO:0005525;GO:0003924;GO:0035458;GO:0006952;, C:endoplasmic reticulum membrane;, F:GTP binding; F:GTPase activity;, P:cellular response to interferon-beta; P:defense response; scaffold211 indexed_genome mRNA 194882 216667 . - . ID=transcript_15837;Q9H0W8 O60429 Q9H9A9,Protein SMG9 {ECO:0000305},Protein SMG-9 {ECO:0000303|PubMed:19417104};, PF10220;, GO:0005829;GO:0042802;GO:0007420;GO:0001654;GO:0007507;GO:0001701;GO:0000184;, C:cytosol;, F:identical protein binding;, P:brain development; P:eye development; P:heart development; P:in utero embryonic development; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;|Q9H0W8 O60429 Q9H9A9,Protein SMG9 {ECO:0000305},Protein SMG-9 {ECO:0000303|PubMed:19417104};, PF10220;, GO:0005829;GO:0042802;GO:0007420;GO:0001654;GO:0007507;GO:0001701;GO:0000184;, C:cytosol;, F:identical protein binding;, P:brain development; P:eye development; P:heart development; P:in utero embryonic development; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; scaffold211 indexed_genome mRNA 297362 298144 . - . ID=transcript_15838;Q96SK3 F5H141 Q6ZMN2 Q6ZMN4 Q96C40,Zinc finger protein 607,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 304161 306856 . - . ID=transcript_15839;Q8N7M2 B4DGZ5 B7WP04 Q6RFR9 Q86WM6,Zinc finger protein 283,Zinc finger protein HZF19;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 307391 315967 . + . ID=transcript_15840;Q494X3 A4FU30 K7ELF2,Zinc finger protein 404,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 317441 330326 . - . ID=transcript_15841;Q494X3 A4FU30 K7ELF2,Zinc finger protein 404,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 335358 348888 . + . ID=transcript_15842;Q9NZL3 A6NFW9 P17033 Q86V10 Q8IZC8 Q9UID9 Q9Y2P6,Zinc finger protein 224,Bone marrow zinc finger 2;Zinc finger protein 233;Zinc finger protein 255;Zinc finger protein 27;Zinc finger protein KOX22;, PF01352;PF00096;, GO:0031965;GO:0005654;GO:0005634;GO:0017053;GO:0001228;GO:0001227;GO:0046872;GO:0000978;GO:0043565;GO:0000122;GO:0045892;GO:0006357;, C:nuclear membrane; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q9UK11 Q15736 Q8TBJ3 Q9HCA9,Zinc finger protein 223,, PF01352;PF00096;, GO:0005634;GO:0003677;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 350951 354274 . + . ID=transcript_15843;Q02386 P17016 P78472 Q9P1U9,Zinc finger protein 45,BRC1744;Zinc finger protein 13;Zinc finger protein KOX5;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0007275;GO:0006357;GO:0060260;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|Q02386 P17016 P78472 Q9P1U9,Zinc finger protein 45,BRC1744;Zinc finger protein 13;Zinc finger protein KOX5;, PF01352;PF00096;, GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0007275;GO:0006357;GO:0060260;, C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:multicellular organism development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; scaffold211 indexed_genome mRNA 379771 389108 . + . ID=transcript_15844;Q9NYT6 Q8WWE6 Q96TE6 Q9NS44,Zinc finger protein 226,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9NYT6 Q8WWE6 Q96TE6 Q9NS44,Zinc finger protein 226,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9NYT6 Q8WWE6 Q96TE6 Q9NS44,Zinc finger protein 226,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 389296 389982 . + . ID=transcript_15845;Q9NYT6 Q8WWE6 Q96TE6 Q9NS44,Zinc finger protein 226,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 392456 393867 . + . ID=transcript_15846;Q9NYT6 Q8WWE6 Q96TE6 Q9NS44,Zinc finger protein 226,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 398919 418164 . + . ID=transcript_15847;Q86WZ6 B3KRU7 B7Z5P9,Zinc finger protein 227,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 422146 426056 . + . ID=transcript_15848;A6NK53 B2RN78 B2RN79 Q86WL8,Zinc finger protein 233,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 461871 476015 . - . ID=transcript_15849;Q14590 B4DTQ7 O14898 O14899 Q17RR8,Zinc finger protein 235,Zinc finger protein 270;Zinc finger protein 93 homolog;Zinc finger protein HZF6;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q14590 B4DTQ7 O14898 O14899 Q17RR8,Zinc finger protein 235,Zinc finger protein 270;Zinc finger protein 93 homolog;Zinc finger protein HZF6;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 498617 524096 . - . ID=transcript_15850;Q9UJU3 A4FU53 Q9HCA7,Zinc finger protein 112,Zinc finger protein 228;, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9UJU3 A4FU53 Q9HCA7,Zinc finger protein 112,Zinc finger protein 228;, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9UJU3 A4FU53 Q9HCA7,Zinc finger protein 112,Zinc finger protein 228;, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 557448 575598 . - . ID=transcript_15851;Q9UJW8 B2RCN6 B3KV56 K7EQX9 Q58F03 Q9P1U2,Zinc finger protein 180,HHZ168;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold211 indexed_genome mRNA 656438 660517 . + . ID=transcript_15852;Q14002 A8K848 O15148 O15149 Q0VAC1 Q13983 Q9UPJ2,Carcinoembryonic antigen-related cell adhesion molecule 7,Carcinoembryonic antigen CGM2;, PF07686;, GO:0031225;GO:0016324;GO:0005576;GO:0005886;, C:anchored component of membrane; C:apical plasma membrane; C:extracellular region; C:plasma membrane; scaffold211 indexed_genome mRNA 677597 699567 . + . ID=transcript_15853;P15151 B4DTS9 P15152 Q15267 Q15268 Q96BJ1,Poliovirus receptor,Nectin-like protein 5;, PF08205;PF07686;, GO:0005912;GO:0009986;GO:0005737;GO:0005615;GO:0005925;GO:0016021;GO:0005886;GO:0050839;GO:0038023;GO:0001618;GO:0034332;GO:0007157;GO:0007156;GO:0045954;GO:0002860;GO:0050776;GO:0042271;GO:0060370;, C:adherens junction; C:cell surface; C:cytoplasm; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:plasma membrane;, F:cell adhesion molecule binding; F:signaling receptor activity; F:virus receptor activity;, P:adherens junction organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:positive regulation of natural killer cell mediated cytotoxicity; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:regulation of immune response; P:susceptibility to natural killer cell mediated cytotoxicity; P:susceptibility to T cell mediated cytotoxicity; scaffold211 indexed_genome mRNA 743558 749218 . + . ID=transcript_15854;Q2WEN9 A7LI12,Carcinoembryonic antigen-related cell adhesion molecule 16 {ECO:0000305},Carcinoembryonic antigen-like 2;, PF13895;PF07686;, GO:0005615;GO:0032426;GO:0042802;GO:0007605;, C:extracellular space; C:stereocilium tip;, F:identical protein binding;, P:sensory perception of sound;|Q2WEN9 A7LI12,Carcinoembryonic antigen-related cell adhesion molecule 16 {ECO:0000305},Carcinoembryonic antigen-like 2;, PF13895;PF07686;, GO:0005615;GO:0032426;GO:0042802;GO:0007605;, C:extracellular space; C:stereocilium tip;, F:identical protein binding;, P:sensory perception of sound;|Q2WEN9 A7LI12,Carcinoembryonic antigen-related cell adhesion molecule 16 {ECO:0000305},Carcinoembryonic antigen-like 2;, PF13895;PF07686;, GO:0005615;GO:0032426;GO:0042802;GO:0007605;, C:extracellular space; C:stereocilium tip;, F:identical protein binding;, P:sensory perception of sound; scaffold212 indexed_genome mRNA 73291 86469 . - . ID=transcript_15855;Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; scaffold212 indexed_genome mRNA 86483 227706 . - . ID=transcript_15856;Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9P0A9,E3 ubiquitin-protein ligase HUWE1,ARF-binding protein 1;HECT, UBA and WWE domain-containing protein 1;HECT-type E3 ubiquitin transferase HUWE1;Homologous to E6AP carboxyl terminus homologous protein 9;Large structure of UREB1;Mcl-1 ubiquitin ligase E3;Upstream regulatory element-binding protein 1;, PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0000139;GO:0016020;GO:0005654;GO:0005634;GO:0034774;GO:0003677;GO:0003723;GO:0061630;GO:0004842;GO:0006284;GO:0030154;GO:0032922;GO:0007030;GO:0016574;GO:0061025;GO:0010637;GO:0043312;GO:0098779;GO:0045732;GO:1903955;GO:0031398;GO:0043161;GO:0006513;GO:0000209;GO:0016567;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:Golgi membrane; C:membrane; C:nucleoplasm; C:nucleus; C:secretory granule lumen;, F:DNA binding; F:RNA binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:base-excision repair; P:cell differentiation; P:circadian regulation of gene expression; P:Golgi organization; P:histone ubiquitination; P:membrane fusion; P:negative regulation of mitochondrial fusion; P:neutrophil degranulation; P:positive regulation of mitophagy in response to mitochondrial depolarization; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; scaffold212 indexed_genome mRNA 465953 520746 . - . ID=transcript_15857;Q7Z6D4 Q9HAH2,Histone lysine demethylase PHF8,PHD finger protein 8;[histone H3]-dimethyl-L-lysine(36) demethylase PHF8 {ECO:0000305};[histone H3]-dimethyl-L-lysine(9) demethylase PHF8 {ECO:0000305};, PF17811;PF02373;PF00628;, GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016706;GO:0003682;GO:0032452;GO:0071558;GO:0051864;GO:0032454;GO:0035575;GO:0005506;GO:0035064;GO:0003712;GO:0008270;GO:0007420;GO:0000082;GO:0071557;GO:0070544;GO:0033169;GO:0035574;GO:0007076;GO:0061188;GO:0045943;GO:0045893;GO:0006482;GO:0006357;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:chromatin binding; F:histone demethylase activity; F:histone demethylase activity (H3-K27 specific); F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:histone demethylase activity (H4-K20 specific); F:iron ion binding; F:methylated histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:brain development; P:G1/S transition of mitotic cell cycle; P:histone H3-K27 demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:histone H4-K20 demethylation; P:mitotic chromosome condensation; P:negative regulation of ribosomal DNA heterochromatin assembly; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:regulation of transcription by RNA polymerase II;|Q7Z6D4 Q9HAH2,Histone lysine demethylase PHF8,PHD finger protein 8;[histone H3]-dimethyl-L-lysine(36) demethylase PHF8 {ECO:0000305};[histone H3]-dimethyl-L-lysine(9) demethylase PHF8 {ECO:0000305};, PF17811;PF02373;PF00628;, GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016706;GO:0003682;GO:0032452;GO:0071558;GO:0051864;GO:0032454;GO:0035575;GO:0005506;GO:0035064;GO:0003712;GO:0008270;GO:0007420;GO:0000082;GO:0071557;GO:0070544;GO:0033169;GO:0035574;GO:0007076;GO:0061188;GO:0045943;GO:0045893;GO:0006482;GO:0006357;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:chromatin binding; F:histone demethylase activity; F:histone demethylase activity (H3-K27 specific); F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:histone demethylase activity (H4-K20 specific); F:iron ion binding; F:methylated histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:brain development; P:G1/S transition of mitotic cell cycle; P:histone H3-K27 demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:histone H4-K20 demethylation; P:mitotic chromosome condensation; P:negative regulation of ribosomal DNA heterochromatin assembly; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:regulation of transcription by RNA polymerase II;|Q7Z6D4 Q9HAH2,Histone lysine demethylase PHF8,PHD finger protein 8;[histone H3]-dimethyl-L-lysine(36) demethylase PHF8 {ECO:0000305};[histone H3]-dimethyl-L-lysine(9) demethylase PHF8 {ECO:0000305};, PF17811;PF02373;PF00628;, GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016706;GO:0003682;GO:0032452;GO:0071558;GO:0051864;GO:0032454;GO:0035575;GO:0005506;GO:0035064;GO:0003712;GO:0008270;GO:0007420;GO:0000082;GO:0071557;GO:0070544;GO:0033169;GO:0035574;GO:0007076;GO:0061188;GO:0045943;GO:0045893;GO:0006482;GO:0006357;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:chromatin binding; F:histone demethylase activity; F:histone demethylase activity (H3-K27 specific); F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:histone demethylase activity (H4-K20 specific); F:iron ion binding; F:methylated histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:brain development; P:G1/S transition of mitotic cell cycle; P:histone H3-K27 demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:histone H4-K20 demethylation; P:mitotic chromosome condensation; P:negative regulation of ribosomal DNA heterochromatin assembly; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:regulation of transcription by RNA polymerase II;|Q7Z6D4 Q9HAH2,Histone lysine demethylase PHF8,PHD finger protein 8;[histone H3]-dimethyl-L-lysine(36) demethylase PHF8 {ECO:0000305};[histone H3]-dimethyl-L-lysine(9) demethylase PHF8 {ECO:0000305};, PF17811;PF02373;PF00628;, GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016706;GO:0003682;GO:0032452;GO:0071558;GO:0051864;GO:0032454;GO:0035575;GO:0005506;GO:0035064;GO:0003712;GO:0008270;GO:0007420;GO:0000082;GO:0071557;GO:0070544;GO:0033169;GO:0035574;GO:0007076;GO:0061188;GO:0045943;GO:0045893;GO:0006482;GO:0006357;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:chromatin binding; F:histone demethylase activity; F:histone demethylase activity (H3-K27 specific); F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:histone demethylase activity (H4-K20 specific); F:iron ion binding; F:methylated histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:brain development; P:G1/S transition of mitotic cell cycle; P:histone H3-K27 demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:histone H4-K20 demethylation; P:mitotic chromosome condensation; P:negative regulation of ribosomal DNA heterochromatin assembly; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:regulation of transcription by RNA polymerase II;|Q7Z6D4 Q9HAH2,Histone lysine demethylase PHF8,PHD finger protein 8;[histone H3]-dimethyl-L-lysine(36) demethylase PHF8 {ECO:0000305};[histone H3]-dimethyl-L-lysine(9) demethylase PHF8 {ECO:0000305};, PF17811;PF02373;PF00628;, GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016706;GO:0003682;GO:0032452;GO:0071558;GO:0051864;GO:0032454;GO:0035575;GO:0005506;GO:0035064;GO:0003712;GO:0008270;GO:0007420;GO:0000082;GO:0071557;GO:0070544;GO:0033169;GO:0035574;GO:0007076;GO:0061188;GO:0045943;GO:0045893;GO:0006482;GO:0006357;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:chromatin binding; F:histone demethylase activity; F:histone demethylase activity (H3-K27 specific); F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:histone demethylase activity (H4-K20 specific); F:iron ion binding; F:methylated histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:brain development; P:G1/S transition of mitotic cell cycle; P:histone H3-K27 demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:histone H4-K20 demethylation; P:mitotic chromosome condensation; P:negative regulation of ribosomal DNA heterochromatin assembly; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:regulation of transcription by RNA polymerase II; scaffold212 indexed_genome mRNA 521167 567104 . - . ID=transcript_15858;Q7Z6D4 Q9HAH2,Histone lysine demethylase PHF8,PHD finger protein 8;[histone H3]-dimethyl-L-lysine(36) demethylase PHF8 {ECO:0000305};[histone H3]-dimethyl-L-lysine(9) demethylase PHF8 {ECO:0000305};, PF17811;PF02373;PF00628;, GO:0031965;GO:0005730;GO:0005654;GO:0005634;GO:0016706;GO:0003682;GO:0032452;GO:0071558;GO:0051864;GO:0032454;GO:0035575;GO:0005506;GO:0035064;GO:0003712;GO:0008270;GO:0007420;GO:0000082;GO:0071557;GO:0070544;GO:0033169;GO:0035574;GO:0007076;GO:0061188;GO:0045943;GO:0045893;GO:0006482;GO:0006357;, C:nuclear membrane; C:nucleolus; C:nucleoplasm; C:nucleus;, F:2-oxoglutarate-dependent dioxygenase activity; F:chromatin binding; F:histone demethylase activity; F:histone demethylase activity (H3-K27 specific); F:histone demethylase activity (H3-K36 specific); F:histone demethylase activity (H3-K9 specific); F:histone demethylase activity (H4-K20 specific); F:iron ion binding; F:methylated histone binding; F:transcription coregulator activity; F:zinc ion binding;, P:brain development; P:G1/S transition of mitotic cell cycle; P:histone H3-K27 demethylation; P:histone H3-K36 demethylation; P:histone H3-K9 demethylation; P:histone H4-K20 demethylation; P:mitotic chromosome condensation; P:negative regulation of ribosomal DNA heterochromatin assembly; P:positive regulation of transcription by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:protein demethylation; P:regulation of transcription by RNA polymerase II; scaffold212 indexed_genome mRNA 586890 587471 . + . ID=transcript_15859;Q86SX6 Q0X088 Q3YML0 Q86WY3 Q8IZ54,Glutaredoxin-related protein 5, mitochondrial,Monothiol glutaredoxin-5;, PF00462;, GO:0030425;GO:0005759;GO:0005739;GO:0043025;GO:0005634;GO:0051537;GO:0046872;GO:0015035;GO:0044571;GO:0030097;GO:0016226;GO:0106034;GO:0106035;, C:dendrite; C:mitochondrial matrix; C:mitochondrion; C:neuronal cell body; C:nucleus;, F:2 iron, 2 sulfur cluster binding; F:metal ion binding; F:protein disulfide oxidoreductase activity;, P:[2Fe-2S] cluster assembly; P:hemopoiesis; P:iron-sulfur cluster assembly; P:protein maturation by [2Fe-2S] cluster transfer; P:protein maturation by [4Fe-4S] cluster transfer; scaffold212 indexed_genome mRNA 605589 706458 . - . ID=transcript_15860;Q9NX05 B2RMT7,Constitutive coactivator of PPAR-gamma-like protein 2,Protein FAM120C;Tumor antigen BJ-HCC-21;, , GO:0005634;GO:0003723;, C:nucleus;, F:RNA binding; scaffold213 indexed_genome mRNA 37179 38585 . - . ID=transcript_15861;P18887 Q6IBS4 Q9HCB1,DNA repair protein XRCC1,X-ray repair cross-complementing protein 1;, PF00533;PF16589;PF01834;, GO:0000785;GO:0000781;GO:0070522;GO:0005730;GO:0005654;GO:0005634;GO:1990599;GO:0019899;GO:0032356;GO:0006284;GO:0006288;GO:0006287;GO:0021587;GO:0000724;GO:0006303;GO:0021766;GO:1905765;GO:0010836;GO:0006297;GO:1904877;GO:1903518;GO:1990414;GO:0042493;GO:0033194;GO:0001666;GO:0010033;GO:0000012;GO:0061819;GO:0006283;GO:0050882;, C:chromatin; C:chromosome, telomeric region; C:ERCC4-ERCC1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3' overhang single-stranded DNA endodeoxyribonuclease activity; F:enzyme binding; F:oxidized DNA binding;, P:base-excision repair; P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cerebellum morphogenesis; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:hippocampus development; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of protein ADP-ribosylation; P:nucleotide-excision repair, DNA gap filling; P:positive regulation of DNA ligase activity; P:positive regulation of single strand break repair; P:replication-born double-strand break repair via sister chromatid exchange; P:response to drug; P:response to hydroperoxide; P:response to hypoxia; P:response to organic substance; P:single strand break repair; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:voluntary musculoskeletal movement;|P18887 Q6IBS4 Q9HCB1,DNA repair protein XRCC1,X-ray repair cross-complementing protein 1;, PF00533;PF16589;PF01834;, GO:0000785;GO:0000781;GO:0070522;GO:0005730;GO:0005654;GO:0005634;GO:1990599;GO:0019899;GO:0032356;GO:0006284;GO:0006288;GO:0006287;GO:0021587;GO:0000724;GO:0006303;GO:0021766;GO:1905765;GO:0010836;GO:0006297;GO:1904877;GO:1903518;GO:1990414;GO:0042493;GO:0033194;GO:0001666;GO:0010033;GO:0000012;GO:0061819;GO:0006283;GO:0050882;, C:chromatin; C:chromosome, telomeric region; C:ERCC4-ERCC1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3' overhang single-stranded DNA endodeoxyribonuclease activity; F:enzyme binding; F:oxidized DNA binding;, P:base-excision repair; P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cerebellum morphogenesis; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:hippocampus development; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of protein ADP-ribosylation; P:nucleotide-excision repair, DNA gap filling; P:positive regulation of DNA ligase activity; P:positive regulation of single strand break repair; P:replication-born double-strand break repair via sister chromatid exchange; P:response to drug; P:response to hydroperoxide; P:response to hypoxia; P:response to organic substance; P:single strand break repair; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:voluntary musculoskeletal movement; scaffold213 indexed_genome mRNA 39112 44161 . + . ID=transcript_15862;P18887 Q6IBS4 Q9HCB1,DNA repair protein XRCC1,X-ray repair cross-complementing protein 1;, PF00533;PF16589;PF01834;, GO:0000785;GO:0000781;GO:0070522;GO:0005730;GO:0005654;GO:0005634;GO:1990599;GO:0019899;GO:0032356;GO:0006284;GO:0006288;GO:0006287;GO:0021587;GO:0000724;GO:0006303;GO:0021766;GO:1905765;GO:0010836;GO:0006297;GO:1904877;GO:1903518;GO:1990414;GO:0042493;GO:0033194;GO:0001666;GO:0010033;GO:0000012;GO:0061819;GO:0006283;GO:0050882;, C:chromatin; C:chromosome, telomeric region; C:ERCC4-ERCC1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3' overhang single-stranded DNA endodeoxyribonuclease activity; F:enzyme binding; F:oxidized DNA binding;, P:base-excision repair; P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cerebellum morphogenesis; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:hippocampus development; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of protein ADP-ribosylation; P:nucleotide-excision repair, DNA gap filling; P:positive regulation of DNA ligase activity; P:positive regulation of single strand break repair; P:replication-born double-strand break repair via sister chromatid exchange; P:response to drug; P:response to hydroperoxide; P:response to hypoxia; P:response to organic substance; P:single strand break repair; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:voluntary musculoskeletal movement;|P18887 Q6IBS4 Q9HCB1,DNA repair protein XRCC1,X-ray repair cross-complementing protein 1;, PF00533;PF16589;PF01834;, GO:0000785;GO:0000781;GO:0070522;GO:0005730;GO:0005654;GO:0005634;GO:1990599;GO:0019899;GO:0032356;GO:0006284;GO:0006288;GO:0006287;GO:0021587;GO:0000724;GO:0006303;GO:0021766;GO:1905765;GO:0010836;GO:0006297;GO:1904877;GO:1903518;GO:1990414;GO:0042493;GO:0033194;GO:0001666;GO:0010033;GO:0000012;GO:0061819;GO:0006283;GO:0050882;, C:chromatin; C:chromosome, telomeric region; C:ERCC4-ERCC1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3' overhang single-stranded DNA endodeoxyribonuclease activity; F:enzyme binding; F:oxidized DNA binding;, P:base-excision repair; P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cerebellum morphogenesis; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:hippocampus development; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of protein ADP-ribosylation; P:nucleotide-excision repair, DNA gap filling; P:positive regulation of DNA ligase activity; P:positive regulation of single strand break repair; P:replication-born double-strand break repair via sister chromatid exchange; P:response to drug; P:response to hydroperoxide; P:response to hypoxia; P:response to organic substance; P:single strand break repair; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:voluntary musculoskeletal movement;|P18887 Q6IBS4 Q9HCB1,DNA repair protein XRCC1,X-ray repair cross-complementing protein 1;, PF00533;PF16589;PF01834;, GO:0000785;GO:0000781;GO:0070522;GO:0005730;GO:0005654;GO:0005634;GO:1990599;GO:0019899;GO:0032356;GO:0006284;GO:0006288;GO:0006287;GO:0021587;GO:0000724;GO:0006303;GO:0021766;GO:1905765;GO:0010836;GO:0006297;GO:1904877;GO:1903518;GO:1990414;GO:0042493;GO:0033194;GO:0001666;GO:0010033;GO:0000012;GO:0061819;GO:0006283;GO:0050882;, C:chromatin; C:chromosome, telomeric region; C:ERCC4-ERCC1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3' overhang single-stranded DNA endodeoxyribonuclease activity; F:enzyme binding; F:oxidized DNA binding;, P:base-excision repair; P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cerebellum morphogenesis; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:hippocampus development; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of protein ADP-ribosylation; P:nucleotide-excision repair, DNA gap filling; P:positive regulation of DNA ligase activity; P:positive regulation of single strand break repair; P:replication-born double-strand break repair via sister chromatid exchange; P:response to drug; P:response to hydroperoxide; P:response to hypoxia; P:response to organic substance; P:single strand break repair; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:voluntary musculoskeletal movement;|P18887 Q6IBS4 Q9HCB1,DNA repair protein XRCC1,X-ray repair cross-complementing protein 1;, PF00533;PF16589;PF01834;, GO:0000785;GO:0000781;GO:0070522;GO:0005730;GO:0005654;GO:0005634;GO:1990599;GO:0019899;GO:0032356;GO:0006284;GO:0006288;GO:0006287;GO:0021587;GO:0000724;GO:0006303;GO:0021766;GO:1905765;GO:0010836;GO:0006297;GO:1904877;GO:1903518;GO:1990414;GO:0042493;GO:0033194;GO:0001666;GO:0010033;GO:0000012;GO:0061819;GO:0006283;GO:0050882;, C:chromatin; C:chromosome, telomeric region; C:ERCC4-ERCC1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3' overhang single-stranded DNA endodeoxyribonuclease activity; F:enzyme binding; F:oxidized DNA binding;, P:base-excision repair; P:base-excision repair, DNA ligation; P:base-excision repair, gap-filling; P:cerebellum morphogenesis; P:double-strand break repair via homologous recombination; P:double-strand break repair via nonhomologous end joining; P:hippocampus development; P:negative regulation of protection from non-homologous end joining at telomere; P:negative regulation of protein ADP-ribosylation; P:nucleotide-excision repair, DNA gap filling; P:positive regulation of DNA ligase activity; P:positive regulation of single strand break repair; P:replication-born double-strand break repair via sister chromatid exchange; P:response to drug; P:response to hydroperoxide; P:response to hypoxia; P:response to organic substance; P:single strand break repair; P:telomeric DNA-containing double minutes formation; P:transcription-coupled nucleotide-excision repair; P:voluntary musculoskeletal movement; scaffold213 indexed_genome mRNA 50789 53464 . - . ID=transcript_15863;Q86XF7 B4DX54,Zinc finger protein 575,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold213 indexed_genome mRNA 59691 76355 . + . ID=transcript_15864;O95571 Q96HR0 Q9H001,Persulfide dioxygenase ETHE1, mitochondrial,Ethylmalonic encephalopathy protein 1;Hepatoma subtracted clone one protein;Sulfur dioxygenase ETHE1;, PF00753;, GO:0005737;GO:0005759;GO:0005739;GO:0005654;GO:0016788;GO:0042802;GO:0005506;GO:0050313;GO:0006749;GO:0070813;GO:0070221;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:hydrolase activity, acting on ester bonds; F:identical protein binding; F:iron ion binding; F:sulfur dioxygenase activity;, P:glutathione metabolic process; P:hydrogen sulfide metabolic process; P:sulfide oxidation, using sulfide:quinone oxidoreductase;|O95571 Q96HR0 Q9H001,Persulfide dioxygenase ETHE1, mitochondrial,Ethylmalonic encephalopathy protein 1;Hepatoma subtracted clone one protein;Sulfur dioxygenase ETHE1;, PF00753;, GO:0005737;GO:0005759;GO:0005739;GO:0005654;GO:0016788;GO:0042802;GO:0005506;GO:0050313;GO:0006749;GO:0070813;GO:0070221;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm;, F:hydrolase activity, acting on ester bonds; F:identical protein binding; F:iron ion binding; F:sulfur dioxygenase activity;, P:glutathione metabolic process; P:hydrogen sulfide metabolic process; P:sulfide oxidation, using sulfide:quinone oxidoreductase; scaffold213 indexed_genome mRNA 78163 103176 . - . ID=transcript_15865;Q6NSJ2 Q8N7Z4,Pleckstrin homology-like domain family B member 3,, PF00169;, GO:0019899;, , F:enzyme binding; scaffold213 indexed_genome mRNA 282552 292981 . + . ID=transcript_15866;Q6UXB2 A8KAC0,C-X-C motif chemokine 17,Dendritic cell and monocyte chemokine-like protein;VEGF coregulated chemokine 1;, PF15211;, GO:0005615;GO:0000187;GO:0001525;GO:0030154;GO:0048246;GO:0050728;GO:0010759;GO:0090026;GO:0010575;, C:extracellular space;, , P:activation of MAPK activity; P:angiogenesis; P:cell differentiation; P:macrophage chemotaxis; P:negative regulation of inflammatory response; P:positive regulation of macrophage chemotaxis; P:positive regulation of monocyte chemotaxis; P:positive regulation of vascular endothelial growth factor production; scaffold213 indexed_genome mRNA 334369 336947 . + . ID=transcript_15867;Q13860 Q15600 Q15601 Q16170 Q5UB49 Q7KYP5 Q96CA7 Q9UQV9,Carcinoembryonic antigen-related cell adhesion molecule 1 {ECO:0000303|Ref.8},Biliary glycoprotein 1 {ECO:0000303|PubMed:7628460};, PF00047;PF13895;PF07686;, GO:0005912;GO:0016324;GO:0009925;GO:0030054;GO:0009986;GO:0005911;GO:0070062;GO:0016021;GO:0005887;GO:0016328;GO:0016020;GO:0031528;GO:0005886;GO:0035579;GO:0070821;GO:0030658;GO:0003779;GO:0015125;GO:0005516;GO:0031005;GO:0042802;GO:0019900;GO:0046983;GO:0042803;GO:0019903;GO:1990782;GO:0001525;GO:0015721;GO:0001568;GO:0007155;GO:0016477;GO:0098742;GO:0032869;GO:0035726;GO:0038158;GO:0007156;GO:1901143;GO:0038016;GO:0007229;GO:0050900;GO:0043318;GO:0045717;GO:0030853;GO:2000346;GO:0032692;GO:0051055;GO:0002859;GO:0090331;GO:0006469;GO:0001915;GO:0050860;GO:0043116;GO:0043312;GO:2001214;GO:0060312;GO:0001558;GO:0030334;GO:0045601;GO:0010594;GO:0042058;GO:0070372;GO:1903385;GO:0014066;GO:1903670;GO:0044319;, C:adherens junction; C:apical plasma membrane; C:basal plasma membrane; C:cell junction; C:cell surface; C:cell-cell junction; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:lateral plasma membrane; C:membrane; C:microvillus membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane; C:transport vesicle membrane;, F:actin binding; F:bile acid transmembrane transporter activity; F:calmodulin binding; F:filamin binding; F:identical protein binding; F:kinase binding; F:protein dimerization activity; F:protein homodimerization activity; F:protein phosphatase binding; F:protein tyrosine kinase binding;, P:angiogenesis; P:bile acid and bile salt transport; P:blood vessel development; P:cell adhesion; P:cell migration; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cellular response to insulin stimulus; P:common myeloid progenitor cell proliferation; P:granulocyte colony-stimulating factor signaling pathway; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:insulin catabolic process; P:insulin receptor internalization; P:integrin-mediated signaling pathway; P:leukocyte migration; P:negative regulation of cytotoxic T cell degranulation; P:negative regulation of fatty acid biosynthetic process; P:negative regulation of granulocyte differentiation; P:negative regulation of hepatocyte proliferation; P:negative regulation of interleukin-1 production; P:negative regulation of lipid biosynthetic process; P:negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; P:negative regulation of platelet aggregation; P:negative regulation of protein kinase activity; P:negative regulation of T cell mediated cytotoxicity; P:negative regulation of T cell receptor signaling pathway; P:negative regulation of vascular permeability; P:neutrophil degranulation; P:positive regulation of vasculogenesis; P:regulation of blood vessel remodeling; P:regulation of cell growth; P:regulation of cell migration; P:regulation of endothelial cell differentiation; P:regulation of endothelial cell migration; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of ERK1 and ERK2 cascade; P:regulation of homophilic cell adhesion; P:regulation of phosphatidylinositol 3-kinase signaling; P:regulation of sprouting angiogenesis; P:wound healing, spreading of cells; scaffold213 indexed_genome mRNA 390094 397699 . + . ID=transcript_15868;P39019,40S ribosomal protein S19,Small ribosomal subunit protein eS19 {ECO:0000303|PubMed:24524803};, PF01090;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0014069;GO:0005840;GO:0017134;GO:0042802;GO:0019901;GO:0003723;GO:0003735;GO:0061844;GO:0050829;GO:0030218;GO:0031640;GO:0030490;GO:0000462;GO:0002548;GO:0060266;GO:0000184;GO:0007000;GO:0051272;GO:0060265;GO:0009991;GO:0000028;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:postsynaptic density; C:ribosome;, F:fibroblast growth factor binding; F:identical protein binding; F:protein kinase binding; F:RNA binding; F:structural constituent of ribosome;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:defense response to Gram-negative bacterium; P:erythrocyte differentiation; P:killing of cells of other organism; P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:monocyte chemotaxis; P:negative regulation of respiratory burst involved in inflammatory response; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nucleolus organization; P:positive regulation of cellular component movement; P:positive regulation of respiratory burst involved in inflammatory response; P:response to extracellular stimulus; P:ribosomal small subunit assembly; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P39019,40S ribosomal protein S19,Small ribosomal subunit protein eS19 {ECO:0000303|PubMed:24524803};, PF01090;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0014069;GO:0005840;GO:0017134;GO:0042802;GO:0019901;GO:0003723;GO:0003735;GO:0061844;GO:0050829;GO:0030218;GO:0031640;GO:0030490;GO:0000462;GO:0002548;GO:0060266;GO:0000184;GO:0007000;GO:0051272;GO:0060265;GO:0009991;GO:0000028;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:postsynaptic density; C:ribosome;, F:fibroblast growth factor binding; F:identical protein binding; F:protein kinase binding; F:RNA binding; F:structural constituent of ribosome;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:defense response to Gram-negative bacterium; P:erythrocyte differentiation; P:killing of cells of other organism; P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:monocyte chemotaxis; P:negative regulation of respiratory burst involved in inflammatory response; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nucleolus organization; P:positive regulation of cellular component movement; P:positive regulation of respiratory burst involved in inflammatory response; P:response to extracellular stimulus; P:ribosomal small subunit assembly; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P39019,40S ribosomal protein S19,Small ribosomal subunit protein eS19 {ECO:0000303|PubMed:24524803};, PF01090;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0014069;GO:0005840;GO:0017134;GO:0042802;GO:0019901;GO:0003723;GO:0003735;GO:0061844;GO:0050829;GO:0030218;GO:0031640;GO:0030490;GO:0000462;GO:0002548;GO:0060266;GO:0000184;GO:0007000;GO:0051272;GO:0060265;GO:0009991;GO:0000028;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:postsynaptic density; C:ribosome;, F:fibroblast growth factor binding; F:identical protein binding; F:protein kinase binding; F:RNA binding; F:structural constituent of ribosome;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:defense response to Gram-negative bacterium; P:erythrocyte differentiation; P:killing of cells of other organism; P:maturation of SSU-rRNA; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:monocyte chemotaxis; P:negative regulation of respiratory burst involved in inflammatory response; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:nucleolus organization; P:positive regulation of cellular component movement; P:positive regulation of respiratory burst involved in inflammatory response; P:response to extracellular stimulus; P:ribosomal small subunit assembly; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold213 indexed_genome mRNA 404436 408130 . + . ID=transcript_15869;P11912 A0N775 Q53FB8,B-cell antigen receptor complex-associated protein alpha chain,Ig-alpha;MB-1 membrane glycoprotein;Membrane-bound immunoglobulin-associated protein;Surface IgM-associated protein;, PF00047;PF02189;, GO:0019815;GO:0009897;GO:0016021;GO:0045121;GO:0005771;GO:0005886;GO:0042802;GO:0004888;GO:0002250;GO:0042113;GO:0030183;GO:0042100;GO:0050853;, C:B cell receptor complex; C:external side of plasma membrane; C:integral component of membrane; C:membrane raft; C:multivesicular body; C:plasma membrane;, F:identical protein binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:B cell activation; P:B cell differentiation; P:B cell proliferation; P:B cell receptor signaling pathway; scaffold213 indexed_genome mRNA 409374 429431 . + . ID=transcript_15870;Q92888 O00513 Q6NX52 Q8N4J4 Q96BF4 Q96F17 Q9BSB1,Rho guanine nucleotide exchange factor 1,115 kDa guanine nucleotide exchange factor;Sub1.5;, PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0005886;GO:0001664;GO:0005096;GO:0005085;GO:0003723;GO:0007186;GO:0043065;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q92888 O00513 Q6NX52 Q8N4J4 Q96BF4 Q96F17 Q9BSB1,Rho guanine nucleotide exchange factor 1,115 kDa guanine nucleotide exchange factor;Sub1.5;, PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0005886;GO:0001664;GO:0005096;GO:0005085;GO:0003723;GO:0007186;GO:0043065;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q92888 O00513 Q6NX52 Q8N4J4 Q96BF4 Q96F17 Q9BSB1,Rho guanine nucleotide exchange factor 1,115 kDa guanine nucleotide exchange factor;Sub1.5;, PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0005886;GO:0001664;GO:0005096;GO:0005085;GO:0003723;GO:0007186;GO:0043065;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|Q92888 O00513 Q6NX52 Q8N4J4 Q96BF4 Q96F17 Q9BSB1,Rho guanine nucleotide exchange factor 1,115 kDa guanine nucleotide exchange factor;Sub1.5;, PF17838;PF09128;PF00621;, GO:0005737;GO:0005829;GO:0005886;GO:0001664;GO:0005096;GO:0005085;GO:0003723;GO:0007186;GO:0043065;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:plasma membrane;, F:G protein-coupled receptor binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:RNA binding;, P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold213 indexed_genome mRNA 477975 481104 . - . ID=transcript_15871;Q9UI14 Q7Z4Y2 Q9Y3R1,Prenylated Rab acceptor protein 1,PRA1 family protein 1;, PF03208;, GO:0005794;GO:0016021;GO:0016020;GO:0005886;GO:0008021;GO:0042802;GO:0070064;GO:0008022;, C:Golgi apparatus; C:integral component of membrane; C:membrane; C:plasma membrane; C:synaptic vesicle;, F:identical protein binding; F:proline-rich region binding; F:protein C-terminus binding; scaffold213 indexed_genome mRNA 484837 501593 . - . ID=transcript_15872;P13637 B7Z2T0 B7Z401 F5H6J6 Q16732 Q16735 Q969K5,Sodium/potassium-transporting ATPase subunit alpha-3,Na(+)/K(+) ATPase alpha(III) subunit;Sodium pump subunit alpha-3;, PF00689;PF00690;, GO:0030424;GO:0005783;GO:1903561;GO:0005794;GO:0016021;GO:0016020;GO:0098984;GO:0043025;GO:0032809;GO:0031090;GO:0001917;GO:0060342;GO:0005886;GO:0005890;GO:0045202;GO:0001540;GO:0005524;GO:0051087;GO:0099520;GO:0046872;GO:0005391;GO:0008556;GO:1990239;GO:0086064;GO:0030007;GO:1904646;GO:0071383;GO:0006883;GO:0034220;GO:1990535;GO:1990573;GO:1902600;GO:1903779;GO:0060075;GO:1903416;GO:0036376;, C:axon; C:endoplasmic reticulum; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:neuron to neuron synapse; C:neuronal cell body; C:neuronal cell body membrane; C:organelle membrane; C:photoreceptor inner segment; C:photoreceptor inner segment membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:synapse;, F:amyloid-beta binding; F:ATP binding; F:chaperone binding; F:ion antiporter activity involved in regulation of presynaptic membrane potential; F:metal ion binding; F:P-type sodium:potassium-exchanging ATPase activity; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:steroid hormone binding;, P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to amyloid-beta; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:neuron projection maintenance; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of cardiac conduction; P:regulation of resting membrane potential; P:response to glycoside; P:sodium ion export across plasma membrane;|P13637 B7Z2T0 B7Z401 F5H6J6 Q16732 Q16735 Q969K5,Sodium/potassium-transporting ATPase subunit alpha-3,Na(+)/K(+) ATPase alpha(III) subunit;Sodium pump subunit alpha-3;, PF00689;PF00690;, GO:0030424;GO:0005783;GO:1903561;GO:0005794;GO:0016021;GO:0016020;GO:0098984;GO:0043025;GO:0032809;GO:0031090;GO:0001917;GO:0060342;GO:0005886;GO:0005890;GO:0045202;GO:0001540;GO:0005524;GO:0051087;GO:0099520;GO:0046872;GO:0005391;GO:0008556;GO:1990239;GO:0086064;GO:0030007;GO:1904646;GO:0071383;GO:0006883;GO:0034220;GO:1990535;GO:1990573;GO:1902600;GO:1903779;GO:0060075;GO:1903416;GO:0036376;, C:axon; C:endoplasmic reticulum; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:neuron to neuron synapse; C:neuronal cell body; C:neuronal cell body membrane; C:organelle membrane; C:photoreceptor inner segment; C:photoreceptor inner segment membrane; C:plasma membrane; C:sodium:potassium-exchanging ATPase complex; C:synapse;, F:amyloid-beta binding; F:ATP binding; F:chaperone binding; F:ion antiporter activity involved in regulation of presynaptic membrane potential; F:metal ion binding; F:P-type sodium:potassium-exchanging ATPase activity; F:potassium transmembrane transporter activity, phosphorylative mechanism; F:steroid hormone binding;, P:cell communication by electrical coupling involved in cardiac conduction; P:cellular potassium ion homeostasis; P:cellular response to amyloid-beta; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:ion transmembrane transport; P:neuron projection maintenance; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of cardiac conduction; P:regulation of resting membrane potential; P:response to glycoside; P:sodium ion export across plasma membrane; scaffold213 indexed_genome mRNA 509148 510680 . - . ID=transcript_15873;Q16478 Q8WWG8,Glutamate receptor ionotropic, kainate 5,Excitatory amino acid receptor 2;Glutamate receptor KA-2;, PF01094;PF00060;PF10613;, GO:0030425;GO:0005783;GO:0098978;GO:0098686;GO:0099061;GO:0099056;GO:0032983;GO:0005654;GO:0043204;GO:0005886;GO:0045211;GO:0043195;GO:0008066;GO:0042802;GO:0015277;GO:0015276;GO:0030165;GO:0017124;GO:0038023;GO:1904315;GO:0071333;GO:0051649;GO:0060079;GO:0050804;GO:0043525;GO:0006621;GO:0043113;GO:0031630;GO:0035249;, C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:kainate selective glutamate receptor complex; C:nucleoplasm; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:terminal bouton;, F:glutamate receptor activity; F:identical protein binding; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:PDZ domain binding; F:SH3 domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to glucose stimulus; P:establishment of localization in cell; P:excitatory postsynaptic potential; P:modulation of chemical synaptic transmission; P:positive regulation of neuron apoptotic process; P:protein retention in ER lumen; P:receptor clustering; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic transmission, glutamatergic; scaffold213 indexed_genome mRNA 514792 558252 . - . ID=transcript_15874;Q16478 Q8WWG8,Glutamate receptor ionotropic, kainate 5,Excitatory amino acid receptor 2;Glutamate receptor KA-2;, PF01094;PF00060;PF10613;, GO:0030425;GO:0005783;GO:0098978;GO:0098686;GO:0099061;GO:0099056;GO:0032983;GO:0005654;GO:0043204;GO:0005886;GO:0045211;GO:0043195;GO:0008066;GO:0042802;GO:0015277;GO:0015276;GO:0030165;GO:0017124;GO:0038023;GO:1904315;GO:0071333;GO:0051649;GO:0060079;GO:0050804;GO:0043525;GO:0006621;GO:0043113;GO:0031630;GO:0035249;, C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:kainate selective glutamate receptor complex; C:nucleoplasm; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:terminal bouton;, F:glutamate receptor activity; F:identical protein binding; F:kainate selective glutamate receptor activity; F:ligand-gated ion channel activity; F:PDZ domain binding; F:SH3 domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:cellular response to glucose stimulus; P:establishment of localization in cell; P:excitatory postsynaptic potential; P:modulation of chemical synaptic transmission; P:positive regulation of neuron apoptotic process; P:protein retention in ER lumen; P:receptor clustering; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic transmission, glutamatergic; scaffold213 indexed_genome mRNA 576554 582132 . + . ID=transcript_15875;Q6ZN55 Q6IPE0 Q6ZN10 Q7L5Z5 Q8NCE3 Q9H6N0,Zinc finger protein 574,, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold213 indexed_genome mRNA 590689 708990 . + . ID=transcript_15876;P09086 Q16648 Q7M4M8 Q9BRS4,POU domain, class 2, transcription factor 2 {ECO:0000305},Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2;Octamer-binding protein 2;Octamer-binding transcription factor 2;, PF00046;PF00157;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0098586;GO:0006959;GO:0032755;GO:0045944;GO:0006357;GO:0042795;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to virus; P:humoral immune response; P:positive regulation of interleukin-6 production; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II;|P09086 Q16648 Q7M4M8 Q9BRS4,POU domain, class 2, transcription factor 2 {ECO:0000305},Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2;Octamer-binding protein 2;Octamer-binding transcription factor 2;, PF00046;PF00157;, GO:0000785;GO:0005737;GO:0043231;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0043565;GO:1990837;GO:0000976;GO:0098586;GO:0006959;GO:0032755;GO:0045944;GO:0006357;GO:0042795;, C:chromatin; C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cellular response to virus; P:humoral immune response; P:positive regulation of interleukin-6 production; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II;|Q8WXF8 Q8NBR2 Q8NES1 Q8TAA8 Q96D35,DNA-binding death effector domain-containing protein 2,DED-containing protein FLAME-3;FADD-like anti-apoptotic molecule 3;, PF01335;, GO:0005730;GO:0005654;GO:0003677;GO:0030159;GO:0030262;GO:0019725;GO:0008625;GO:0035556;GO:0045892;GO:2001238;GO:0006396;GO:0016075;, C:nucleolus; C:nucleoplasm;, F:DNA binding; F:signaling receptor complex adaptor activity;, P:apoptotic nuclear changes; P:cellular homeostasis; P:extrinsic apoptotic signaling pathway via death domain receptors; P:intracellular signal transduction; P:negative regulation of transcription, DNA-templated; P:positive regulation of extrinsic apoptotic signaling pathway; P:RNA processing; P:rRNA catabolic process;|Q8WXF8 Q8NBR2 Q8NES1 Q8TAA8 Q96D35,DNA-binding death effector domain-containing protein 2,DED-containing protein FLAME-3;FADD-like anti-apoptotic molecule 3;, PF01335;, GO:0005730;GO:0005654;GO:0003677;GO:0030159;GO:0030262;GO:0019725;GO:0008625;GO:0035556;GO:0045892;GO:2001238;GO:0006396;GO:0016075;, C:nucleolus; C:nucleoplasm;, F:DNA binding; F:signaling receptor complex adaptor activity;, P:apoptotic nuclear changes; P:cellular homeostasis; P:extrinsic apoptotic signaling pathway via death domain receptors; P:intracellular signal transduction; P:negative regulation of transcription, DNA-templated; P:positive regulation of extrinsic apoptotic signaling pathway; P:RNA processing; P:rRNA catabolic process;|Q8WXF8 Q8NBR2 Q8NES1 Q8TAA8 Q96D35,DNA-binding death effector domain-containing protein 2,DED-containing protein FLAME-3;FADD-like anti-apoptotic molecule 3;, PF01335;, GO:0005730;GO:0005654;GO:0003677;GO:0030159;GO:0030262;GO:0019725;GO:0008625;GO:0035556;GO:0045892;GO:2001238;GO:0006396;GO:0016075;, C:nucleolus; C:nucleoplasm;, F:DNA binding; F:signaling receptor complex adaptor activity;, P:apoptotic nuclear changes; P:cellular homeostasis; P:extrinsic apoptotic signaling pathway via death domain receptors; P:intracellular signal transduction; P:negative regulation of transcription, DNA-templated; P:positive regulation of extrinsic apoptotic signaling pathway; P:RNA processing; P:rRNA catabolic process;|Q8WXF8 Q8NBR2 Q8NES1 Q8TAA8 Q96D35,DNA-binding death effector domain-containing protein 2,DED-containing protein FLAME-3;FADD-like anti-apoptotic molecule 3;, PF01335;, GO:0005730;GO:0005654;GO:0003677;GO:0030159;GO:0030262;GO:0019725;GO:0008625;GO:0035556;GO:0045892;GO:2001238;GO:0006396;GO:0016075;, C:nucleolus; C:nucleoplasm;, F:DNA binding; F:signaling receptor complex adaptor activity;, P:apoptotic nuclear changes; P:cellular homeostasis; P:extrinsic apoptotic signaling pathway via death domain receptors; P:intracellular signal transduction; P:negative regulation of transcription, DNA-templated; P:positive regulation of extrinsic apoptotic signaling pathway; P:RNA processing; P:rRNA catabolic process; scaffold213 indexed_genome mRNA 710823 715854 . + . ID=transcript_15877;Q8TF50 B3KV29 Q69YI2 Q96E24,Zinc finger protein 526,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold213 indexed_genome mRNA 717932 726899 . + . ID=transcript_15878;P49840 O14959,Glycogen synthase kinase-3 alpha,Serine/threonine-protein kinase GSK3A;, PF00069;, GO:0097440;GO:0030424;GO:0030877;GO:0005737;GO:0005829;GO:0005874;GO:0005739;GO:0043025;GO:0005634;GO:0098794;GO:1990635;GO:0005524;GO:0034236;GO:0106310;GO:0004674;GO:0106311;GO:0005102;GO:0048156;GO:0050321;GO:0007568;GO:0003214;GO:0016477;GO:0032869;GO:0036016;GO:0071285;GO:0007212;GO:0060079;GO:0097191;GO:0097192;GO:0005977;GO:0044027;GO:0008286;GO:0036498;GO:0090090;GO:0061052;GO:2000171;GO:0046325;GO:2000466;GO:0045719;GO:1904227;GO:0046627;GO:0032007;GO:2000077;GO:0010905;GO:0007399;GO:0018105;GO:0018107;GO:0071879;GO:0106071;GO:1902004;GO:0010508;GO:0010628;GO:2000467;GO:0045823;GO:1901030;GO:0043525;GO:0033138;GO:0010800;GO:0032436;GO:0045732;GO:1903955;GO:0031398;GO:0045944;GO:0043161;GO:0006468;GO:1903146;GO:0006349;GO:0010975;GO:0003073;GO:0007165;GO:0016055;, C:apical dendrite; C:axon; C:beta-catenin destruction complex; C:cytoplasm; C:cytosol; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleus; C:postsynapse; C:proximal dendrite;, F:ATP binding; F:protein kinase A catalytic subunit binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor binding; F:tau protein binding; F:tau-protein kinase activity;, P:aging; P:cardiac left ventricle morphogenesis; P:cell migration; P:cellular response to insulin stimulus; P:cellular response to interleukin-3; P:cellular response to lithium ion; P:dopamine receptor signaling pathway; P:excitatory postsynaptic potential; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glycogen metabolic process; P:hypermethylation of CpG island; P:insulin receptor signaling pathway; P:IRE1-mediated unfolded protein response; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of dendrite development; P:negative regulation of glucose import; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of glycogen synthase activity, transferring glucose-1-phosphate; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of type B pancreatic cell development; P:negative regulation of UDP-glucose catabolic process; P:nervous system development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; P:positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:positive regulation of amyloid-beta formation; P:positive regulation of autophagy; P:positive regulation of gene expression; P:positive regulation of glycogen (starch) synthase activity; P:positive regulation of heart contraction; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein phosphorylation; P:regulation of autophagy of mitochondrion; P:regulation of gene expression by genetic imprinting; P:regulation of neuron projection development; P:regulation of systemic arterial blood pressure; P:signal transduction; P:Wnt signaling pathway;|P49841 D3DN89 Q9BWH3 Q9UL47,Glycogen synthase kinase-3 beta,Serine/threonine-protein kinase GSK3B;, PF00069;, GO:0030424;GO:0030877;GO:0005813;GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0098794;GO:1990909;GO:0005524;GO:0008013;GO:0034452;GO:0016301;GO:0051059;GO:0002039;GO:0002020;GO:0034236;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0001085;GO:0048156;GO:0050321;GO:0031625;GO:1904885;GO:1904886;GO:1904646;GO:0036016;GO:0007623;GO:0007212;GO:0001837;GO:0006983;GO:0030010;GO:0060079;GO:0097191;GO:0097192;GO:0005977;GO:0021766;GO:0008286;GO:0035556;GO:0030011;GO:0043066;GO:0070885;GO:0090090;GO:1904339;GO:1902042;GO:2000466;GO:0045719;GO:1901215;GO:0032515;GO:1901984;GO:0032091;GO:1900181;GO:0031333;GO:2000077;GO:0031175;GO:0106027;GO:0018105;GO:0018107;GO:0010508;GO:0001954;GO:0010628;GO:0043547;GO:1901030;GO:0010822;GO:1901216;GO:0032436;GO:0032092;GO:0045732;GO:0046827;GO:1904781;GO:0031334;GO:0046777;GO:0006468;GO:0030516;GO:0050770;GO:1900034;GO:0042752;GO:0048814;GO:1900271;GO:0150101;GO:0070507;GO:0032886;GO:0010975;GO:2000300;GO:0007165;GO:0071109;GO:0019082;GO:0016055;, C:axon; C:beta-catenin destruction complex; C:centrosome; C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynapse; C:Wnt signalosome;, F:ATP binding; F:beta-catenin binding; F:dynactin binding; F:kinase activity; F:NF-kappaB binding; F:p53 binding; F:protease binding; F:protein kinase A catalytic subunit binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II transcription factor binding; F:tau protein binding; F:tau-protein kinase activity; F:ubiquitin protein ligase binding;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cellular response to amyloid-beta; P:cellular response to interleukin-3; P:circadian rhythm; P:dopamine receptor signaling pathway; P:epithelial to mesenchymal transition; P:ER overload response; P:establishment of cell polarity; P:excitatory postsynaptic potential; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glycogen metabolic process; P:hippocampus development; P:insulin receptor signaling pathway; P:intracellular signal transduction; P:maintenance of cell polarity; P:negative regulation of apoptotic process; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of dopaminergic neuron differentiation; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of neuron death; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein acetylation; P:negative regulation of protein binding; P:negative regulation of protein localization to nucleus; P:negative regulation of protein-containing complex assembly; P:negative regulation of type B pancreatic cell development; P:neuron projection development; P:neuron projection organization; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell-matrix adhesion; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of mitochondrion organization; P:positive regulation of neuron death; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:positive regulation of protein export from nucleus; P:positive regulation of protein localization to centrosome; P:positive regulation of protein-containing complex assembly; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axon extension; P:regulation of axonogenesis; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of dendrite morphogenesis; P:regulation of long-term synaptic potentiation; P:regulation of microtubule anchoring at centrosome; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule-based process; P:regulation of neuron projection development; P:regulation of synaptic vesicle exocytosis; P:signal transduction; P:superior temporal gyrus development; P:viral protein processing; P:Wnt signaling pathway;|P49840 O14959,Glycogen synthase kinase-3 alpha,Serine/threonine-protein kinase GSK3A;, PF00069;, GO:0097440;GO:0030424;GO:0030877;GO:0005737;GO:0005829;GO:0005874;GO:0005739;GO:0043025;GO:0005634;GO:0098794;GO:1990635;GO:0005524;GO:0034236;GO:0106310;GO:0004674;GO:0106311;GO:0005102;GO:0048156;GO:0050321;GO:0007568;GO:0003214;GO:0016477;GO:0032869;GO:0036016;GO:0071285;GO:0007212;GO:0060079;GO:0097191;GO:0097192;GO:0005977;GO:0044027;GO:0008286;GO:0036498;GO:0090090;GO:0061052;GO:2000171;GO:0046325;GO:2000466;GO:0045719;GO:1904227;GO:0046627;GO:0032007;GO:2000077;GO:0010905;GO:0007399;GO:0018105;GO:0018107;GO:0071879;GO:0106071;GO:1902004;GO:0010508;GO:0010628;GO:2000467;GO:0045823;GO:1901030;GO:0043525;GO:0033138;GO:0010800;GO:0032436;GO:0045732;GO:1903955;GO:0031398;GO:0045944;GO:0043161;GO:0006468;GO:1903146;GO:0006349;GO:0010975;GO:0003073;GO:0007165;GO:0016055;, C:apical dendrite; C:axon; C:beta-catenin destruction complex; C:cytoplasm; C:cytosol; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleus; C:postsynapse; C:proximal dendrite;, F:ATP binding; F:protein kinase A catalytic subunit binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor binding; F:tau protein binding; F:tau-protein kinase activity;, P:aging; P:cardiac left ventricle morphogenesis; P:cell migration; P:cellular response to insulin stimulus; P:cellular response to interleukin-3; P:cellular response to lithium ion; P:dopamine receptor signaling pathway; P:excitatory postsynaptic potential; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glycogen metabolic process; P:hypermethylation of CpG island; P:insulin receptor signaling pathway; P:IRE1-mediated unfolded protein response; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of dendrite development; P:negative regulation of glucose import; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of glycogen synthase activity, transferring glucose-1-phosphate; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of type B pancreatic cell development; P:negative regulation of UDP-glucose catabolic process; P:nervous system development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; P:positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:positive regulation of amyloid-beta formation; P:positive regulation of autophagy; P:positive regulation of gene expression; P:positive regulation of glycogen (starch) synthase activity; P:positive regulation of heart contraction; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein phosphorylation; P:regulation of autophagy of mitochondrion; P:regulation of gene expression by genetic imprinting; P:regulation of neuron projection development; P:regulation of systemic arterial blood pressure; P:signal transduction; P:Wnt signaling pathway;|P49841 D3DN89 Q9BWH3 Q9UL47,Glycogen synthase kinase-3 beta,Serine/threonine-protein kinase GSK3B;, PF00069;, GO:0030424;GO:0030877;GO:0005813;GO:0005737;GO:0005829;GO:0030425;GO:0098978;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0098794;GO:1990909;GO:0005524;GO:0008013;GO:0034452;GO:0016301;GO:0051059;GO:0002039;GO:0002020;GO:0034236;GO:0004672;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0001085;GO:0048156;GO:0050321;GO:0031625;GO:1904885;GO:1904886;GO:1904646;GO:0036016;GO:0007623;GO:0007212;GO:0001837;GO:0006983;GO:0030010;GO:0060079;GO:0097191;GO:0097192;GO:0005977;GO:0021766;GO:0008286;GO:0035556;GO:0030011;GO:0043066;GO:0070885;GO:0090090;GO:1904339;GO:1902042;GO:2000466;GO:0045719;GO:1901215;GO:0032515;GO:1901984;GO:0032091;GO:1900181;GO:0031333;GO:2000077;GO:0031175;GO:0106027;GO:0018105;GO:0018107;GO:0010508;GO:0001954;GO:0010628;GO:0043547;GO:1901030;GO:0010822;GO:1901216;GO:0032436;GO:0032092;GO:0045732;GO:0046827;GO:1904781;GO:0031334;GO:0046777;GO:0006468;GO:0030516;GO:0050770;GO:1900034;GO:0042752;GO:0048814;GO:1900271;GO:0150101;GO:0070507;GO:0032886;GO:0010975;GO:2000300;GO:0007165;GO:0071109;GO:0019082;GO:0016055;, C:axon; C:beta-catenin destruction complex; C:centrosome; C:cytoplasm; C:cytosol; C:dendrite; C:glutamatergic synapse; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynapse; C:Wnt signalosome;, F:ATP binding; F:beta-catenin binding; F:dynactin binding; F:kinase activity; F:NF-kappaB binding; F:p53 binding; F:protease binding; F:protein kinase A catalytic subunit binding; F:protein kinase activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II transcription factor binding; F:tau protein binding; F:tau-protein kinase activity; F:ubiquitin protein ligase binding;, P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cellular response to amyloid-beta; P:cellular response to interleukin-3; P:circadian rhythm; P:dopamine receptor signaling pathway; P:epithelial to mesenchymal transition; P:ER overload response; P:establishment of cell polarity; P:excitatory postsynaptic potential; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glycogen metabolic process; P:hippocampus development; P:insulin receptor signaling pathway; P:intracellular signal transduction; P:maintenance of cell polarity; P:negative regulation of apoptotic process; P:negative regulation of calcineurin-NFAT signaling cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of dopaminergic neuron differentiation; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of neuron death; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein acetylation; P:negative regulation of protein binding; P:negative regulation of protein localization to nucleus; P:negative regulation of protein-containing complex assembly; P:negative regulation of type B pancreatic cell development; P:neuron projection development; P:neuron projection organization; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of autophagy; P:positive regulation of cell-matrix adhesion; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of mitochondrion organization; P:positive regulation of neuron death; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:positive regulation of protein catabolic process; P:positive regulation of protein export from nucleus; P:positive regulation of protein localization to centrosome; P:positive regulation of protein-containing complex assembly; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of axon extension; P:regulation of axonogenesis; P:regulation of cellular response to heat; P:regulation of circadian rhythm; P:regulation of dendrite morphogenesis; P:regulation of long-term synaptic potentiation; P:regulation of microtubule anchoring at centrosome; P:regulation of microtubule cytoskeleton organization; P:regulation of microtubule-based process; P:regulation of neuron projection development; P:regulation of synaptic vesicle exocytosis; P:signal transduction; P:superior temporal gyrus development; P:viral protein processing; P:Wnt signaling pathway;|P49840 O14959,Glycogen synthase kinase-3 alpha,Serine/threonine-protein kinase GSK3A;, PF00069;, GO:0097440;GO:0030424;GO:0030877;GO:0005737;GO:0005829;GO:0005874;GO:0005739;GO:0043025;GO:0005634;GO:0098794;GO:1990635;GO:0005524;GO:0034236;GO:0106310;GO:0004674;GO:0106311;GO:0005102;GO:0048156;GO:0050321;GO:0007568;GO:0003214;GO:0016477;GO:0032869;GO:0036016;GO:0071285;GO:0007212;GO:0060079;GO:0097191;GO:0097192;GO:0005977;GO:0044027;GO:0008286;GO:0036498;GO:0090090;GO:0061052;GO:2000171;GO:0046325;GO:2000466;GO:0045719;GO:1904227;GO:0046627;GO:0032007;GO:2000077;GO:0010905;GO:0007399;GO:0018105;GO:0018107;GO:0071879;GO:0106071;GO:1902004;GO:0010508;GO:0010628;GO:2000467;GO:0045823;GO:1901030;GO:0043525;GO:0033138;GO:0010800;GO:0032436;GO:0045732;GO:1903955;GO:0031398;GO:0045944;GO:0043161;GO:0006468;GO:1903146;GO:0006349;GO:0010975;GO:0003073;GO:0007165;GO:0016055;, C:apical dendrite; C:axon; C:beta-catenin destruction complex; C:cytoplasm; C:cytosol; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleus; C:postsynapse; C:proximal dendrite;, F:ATP binding; F:protein kinase A catalytic subunit binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor binding; F:tau protein binding; F:tau-protein kinase activity;, P:aging; P:cardiac left ventricle morphogenesis; P:cell migration; P:cellular response to insulin stimulus; P:cellular response to interleukin-3; P:cellular response to lithium ion; P:dopamine receptor signaling pathway; P:excitatory postsynaptic potential; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glycogen metabolic process; P:hypermethylation of CpG island; P:insulin receptor signaling pathway; P:IRE1-mediated unfolded protein response; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of dendrite development; P:negative regulation of glucose import; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of glycogen synthase activity, transferring glucose-1-phosphate; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of type B pancreatic cell development; P:negative regulation of UDP-glucose catabolic process; P:nervous system development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; P:positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:positive regulation of amyloid-beta formation; P:positive regulation of autophagy; P:positive regulation of gene expression; P:positive regulation of glycogen (starch) synthase activity; P:positive regulation of heart contraction; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein phosphorylation; P:regulation of autophagy of mitochondrion; P:regulation of gene expression by genetic imprinting; P:regulation of neuron projection development; P:regulation of systemic arterial blood pressure; P:signal transduction; P:Wnt signaling pathway;|P49840 O14959,Glycogen synthase kinase-3 alpha,Serine/threonine-protein kinase GSK3A;, PF00069;, GO:0097440;GO:0030424;GO:0030877;GO:0005737;GO:0005829;GO:0005874;GO:0005739;GO:0043025;GO:0005634;GO:0098794;GO:1990635;GO:0005524;GO:0034236;GO:0106310;GO:0004674;GO:0106311;GO:0005102;GO:0048156;GO:0050321;GO:0007568;GO:0003214;GO:0016477;GO:0032869;GO:0036016;GO:0071285;GO:0007212;GO:0060079;GO:0097191;GO:0097192;GO:0005977;GO:0044027;GO:0008286;GO:0036498;GO:0090090;GO:0061052;GO:2000171;GO:0046325;GO:2000466;GO:0045719;GO:1904227;GO:0046627;GO:0032007;GO:2000077;GO:0010905;GO:0007399;GO:0018105;GO:0018107;GO:0071879;GO:0106071;GO:1902004;GO:0010508;GO:0010628;GO:2000467;GO:0045823;GO:1901030;GO:0043525;GO:0033138;GO:0010800;GO:0032436;GO:0045732;GO:1903955;GO:0031398;GO:0045944;GO:0043161;GO:0006468;GO:1903146;GO:0006349;GO:0010975;GO:0003073;GO:0007165;GO:0016055;, C:apical dendrite; C:axon; C:beta-catenin destruction complex; C:cytoplasm; C:cytosol; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleus; C:postsynapse; C:proximal dendrite;, F:ATP binding; F:protein kinase A catalytic subunit binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor binding; F:tau protein binding; F:tau-protein kinase activity;, P:aging; P:cardiac left ventricle morphogenesis; P:cell migration; P:cellular response to insulin stimulus; P:cellular response to interleukin-3; P:cellular response to lithium ion; P:dopamine receptor signaling pathway; P:excitatory postsynaptic potential; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glycogen metabolic process; P:hypermethylation of CpG island; P:insulin receptor signaling pathway; P:IRE1-mediated unfolded protein response; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of dendrite development; P:negative regulation of glucose import; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of glycogen synthase activity, transferring glucose-1-phosphate; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of type B pancreatic cell development; P:negative regulation of UDP-glucose catabolic process; P:nervous system development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; P:positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:positive regulation of amyloid-beta formation; P:positive regulation of autophagy; P:positive regulation of gene expression; P:positive regulation of glycogen (starch) synthase activity; P:positive regulation of heart contraction; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein phosphorylation; P:regulation of autophagy of mitochondrion; P:regulation of gene expression by genetic imprinting; P:regulation of neuron projection development; P:regulation of systemic arterial blood pressure; P:signal transduction; P:Wnt signaling pathway;|P49840 O14959,Glycogen synthase kinase-3 alpha,Serine/threonine-protein kinase GSK3A;, PF00069;, GO:0097440;GO:0030424;GO:0030877;GO:0005737;GO:0005829;GO:0005874;GO:0005739;GO:0043025;GO:0005634;GO:0098794;GO:1990635;GO:0005524;GO:0034236;GO:0106310;GO:0004674;GO:0106311;GO:0005102;GO:0048156;GO:0050321;GO:0007568;GO:0003214;GO:0016477;GO:0032869;GO:0036016;GO:0071285;GO:0007212;GO:0060079;GO:0097191;GO:0097192;GO:0005977;GO:0044027;GO:0008286;GO:0036498;GO:0090090;GO:0061052;GO:2000171;GO:0046325;GO:2000466;GO:0045719;GO:1904227;GO:0046627;GO:0032007;GO:2000077;GO:0010905;GO:0007399;GO:0018105;GO:0018107;GO:0071879;GO:0106071;GO:1902004;GO:0010508;GO:0010628;GO:2000467;GO:0045823;GO:1901030;GO:0043525;GO:0033138;GO:0010800;GO:0032436;GO:0045732;GO:1903955;GO:0031398;GO:0045944;GO:0043161;GO:0006468;GO:1903146;GO:0006349;GO:0010975;GO:0003073;GO:0007165;GO:0016055;, C:apical dendrite; C:axon; C:beta-catenin destruction complex; C:cytoplasm; C:cytosol; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleus; C:postsynapse; C:proximal dendrite;, F:ATP binding; F:protein kinase A catalytic subunit binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:signaling receptor binding; F:tau protein binding; F:tau-protein kinase activity;, P:aging; P:cardiac left ventricle morphogenesis; P:cell migration; P:cellular response to insulin stimulus; P:cellular response to interleukin-3; P:cellular response to lithium ion; P:dopamine receptor signaling pathway; P:excitatory postsynaptic potential; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:glycogen metabolic process; P:hypermethylation of CpG island; P:insulin receptor signaling pathway; P:IRE1-mediated unfolded protein response; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of dendrite development; P:negative regulation of glucose import; P:negative regulation of glycogen (starch) synthase activity; P:negative regulation of glycogen biosynthetic process; P:negative regulation of glycogen synthase activity, transferring glucose-1-phosphate; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of TOR signaling; P:negative regulation of type B pancreatic cell development; P:negative regulation of UDP-glucose catabolic process; P:nervous system development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; P:positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:positive regulation of amyloid-beta formation; P:positive regulation of autophagy; P:positive regulation of gene expression; P:positive regulation of glycogen (starch) synthase activity; P:positive regulation of heart contraction; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein catabolic process; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein phosphorylation; P:regulation of autophagy of mitochondrion; P:regulation of gene expression by genetic imprinting; P:regulation of neuron projection development; P:regulation of systemic arterial blood pressure; P:signal transduction; P:Wnt signaling pathway; scaffold213 indexed_genome mRNA 733752 734273 . - . ID=transcript_15879;P50548 B2RAP1 B7Z4R0 Q59G38 Q9UPI7,ETS domain-containing transcription factor ERF,Ets2 repressor factor;PE-2;, PF00178;, GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0043565;GO:0030154;GO:0000122;GO:0006357;, C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:sequence-specific DNA binding;, P:cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold214 indexed_genome mRNA 152188 160370 . - . ID=transcript_15880;Q9H156 A8K117 Q2KHN3 Q5JXB1 Q8NBC7 Q96JH3,SLIT and NTRK-like protein 2,, PF13855;, GO:0098982;GO:0098978;GO:0099055;GO:0005886;GO:0007409;GO:0051965;GO:1905606;GO:0050807;GO:0099560;, C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of postsynaptic membrane; C:plasma membrane;, , P:axonogenesis; P:positive regulation of synapse assembly; P:regulation of presynapse assembly; P:regulation of synapse organization; P:synaptic membrane adhesion; scaffold215 indexed_genome mRNA 9178 12026 . + . ID=transcript_15881;P07101 B7ZL70 B7ZL73 Q0PWM2 Q0PWM3 Q15585 Q15588 Q15589 Q2M3B4,Tyrosine 3-monooxygenase,Tyrosine 3-hydroxylase;, PF00351;PF12549;, GO:0030424;GO:0005737;GO:0009898;GO:0031410;GO:0005829;GO:0030425;GO:0033162;GO:0005739;GO:0043005;GO:0005634;GO:0043204;GO:0048471;GO:0005790;GO:0008021;GO:0043195;GO:0016597;GO:0035240;GO:0019899;GO:0008199;GO:0008198;GO:0042802;GO:0019825;GO:0019904;GO:0034617;GO:0004511;GO:0015842;GO:0009653;GO:0009887;GO:0042423;GO:0071312;GO:0035690;GO:0071333;GO:0071363;GO:0071287;GO:0071316;GO:0021987;GO:0042745;GO:0042416;GO:0006585;GO:0042755;GO:0048596;GO:0042418;GO:0042462;GO:0006631;GO:0016137;GO:0007507;GO:0003007;GO:1990384;GO:0033076;GO:0007612;GO:0007626;GO:0007617;GO:0007613;GO:0010259;GO:0042136;GO:0042421;GO:0018963;GO:0052314;GO:0043473;GO:0008016;GO:0014823;GO:0001975;GO:0051412;GO:0051602;GO:0032355;GO:0045471;GO:0045472;GO:0009635;GO:0001666;GO:0035902;GO:0035900;GO:0009416;GO:0032496;GO:0031667;GO:0043434;GO:0046684;GO:0009651;GO:0009414;GO:0010043;GO:0007605;GO:0035176;GO:0006665;GO:0001963;GO:0042214;GO:0007601;, C:axon; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoplasmic vesicle; C:cytosol; C:dendrite; C:melanosome membrane; C:mitochondrion; C:neuron projection; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:smooth endoplasmic reticulum; C:synaptic vesicle; C:terminal bouton;, F:amino acid binding; F:dopamine binding; F:enzyme binding; F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:oxygen binding; F:protein domain specific binding; F:tetrahydrobiopterin binding; F:tyrosine 3-monooxygenase activity;, P:aminergic neurotransmitter loading into synaptic vesicle; P:anatomical structure morphogenesis; P:animal organ morphogenesis; P:catecholamine biosynthetic process; P:cellular response to alkaloid; P:cellular response to drug; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:cellular response to manganese ion; P:cellular response to nicotine; P:cerebral cortex development; P:circadian sleep/wake cycle; P:dopamine biosynthetic process; P:dopamine biosynthetic process from tyrosine; P:eating behavior; P:embryonic camera-type eye morphogenesis; P:epinephrine biosynthetic process; P:eye photoreceptor cell development; P:fatty acid metabolic process; P:glycoside metabolic process; P:heart development; P:heart morphogenesis; P:hyaloid vascular plexus regression; P:isoquinoline alkaloid metabolic process; P:learning; P:locomotory behavior; P:mating behavior; P:memory; P:multicellular organism aging; P:neurotransmitter biosynthetic process; P:norepinephrine biosynthetic process; P:phthalate metabolic process; P:phytoalexin metabolic process; P:pigmentation; P:regulation of heart contraction; P:response to activity; P:response to amphetamine; P:response to corticosterone; P:response to electrical stimulus; P:response to estradiol; P:response to ethanol; P:response to ether; P:response to herbicide; P:response to hypoxia; P:response to immobilization stress; P:response to isolation stress; P:response to light stimulus; P:response to lipopolysaccharide; P:response to nutrient levels; P:response to peptide hormone; P:response to pyrethroid; P:response to salt stress; P:response to water deprivation; P:response to zinc ion; P:sensory perception of sound; P:social behavior; P:sphingolipid metabolic process; P:synaptic transmission, dopaminergic; P:terpene metabolic process; P:visual perception; scaffold215 indexed_genome mRNA 136953 144647 . + . ID=transcript_15882;Q96QS1 Q96KX4 Q9HC50 Q9HC51 Q9Y5U1,Tetraspanin-32,Protein Phemx;, PF00335;, GO:0009986;GO:0005887;GO:0070442;GO:0007267;GO:0007010;GO:0042832;GO:0007229;GO:0008285;GO:0030886;GO:0070527;GO:0072659;GO:0051604;GO:0050688;, C:cell surface; C:integral component of plasma membrane; C:integrin alphaIIb-beta3 complex;, , P:cell-cell signaling; P:cytoskeleton organization; P:defense response to protozoan; P:integrin-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of myeloid dendritic cell activation; P:platelet aggregation; P:protein localization to plasma membrane; P:protein maturation; P:regulation of defense response to virus; scaffold215 indexed_genome mRNA 145621 148099 . + . ID=transcript_15883;Q96QS1 Q96KX4 Q9HC50 Q9HC51 Q9Y5U1,Tetraspanin-32,Protein Phemx;, PF00335;, GO:0009986;GO:0005887;GO:0070442;GO:0007267;GO:0007010;GO:0042832;GO:0007229;GO:0008285;GO:0030886;GO:0070527;GO:0072659;GO:0051604;GO:0050688;, C:cell surface; C:integral component of plasma membrane; C:integrin alphaIIb-beta3 complex;, , P:cell-cell signaling; P:cytoskeleton organization; P:defense response to protozoan; P:integrin-mediated signaling pathway; P:negative regulation of cell population proliferation; P:negative regulation of myeloid dendritic cell activation; P:platelet aggregation; P:protein localization to plasma membrane; P:protein maturation; P:regulation of defense response to virus; scaffold215 indexed_genome mRNA 177163 178696 . - . ID=transcript_15884;P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold215 indexed_genome mRNA 206795 216107 . - . ID=transcript_15885;P60033 P18582 Q5U0J6,CD81 antigen,26 kDa cell surface protein TAPA-1 {ECO:0000303|PubMed:1695320};Target of the antiproliferative antibody 1 {ECO:0000303|PubMed:1695320};Tetraspanin-28;, PF00335;, GO:0009925;GO:0016323;GO:0070062;GO:0005925;GO:0001772;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0097197;GO:0031982;GO:0015485;GO:0005178;GO:0042289;GO:0023026;GO:1990459;GO:0001618;GO:0000187;GO:0035783;GO:0071404;GO:0002455;GO:0001771;GO:0034238;GO:0014905;GO:0072675;GO:0043128;GO:1905676;GO:0030890;GO:0050861;GO:2000563;GO:0008284;GO:0002863;GO:0050731;GO:1904352;GO:0070863;GO:1903911;GO:2001190;GO:0050862;GO:2000553;GO:0045944;GO:0008104;GO:0061462;GO:0072659;GO:0031623;GO:0046813;GO:0030449;GO:0050776;GO:1905521;GO:0031647;GO:0046718;, C:basal plasma membrane; C:basolateral plasma membrane; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:tetraspanin-enriched microdomain; C:vesicle;, F:cholesterol binding; F:integrin binding; F:MHC class II protein binding; F:MHC class II protein complex binding; F:transferrin receptor binding; F:virus receptor activity;, P:activation of MAPK activity; P:CD4-positive, alpha-beta T cell costimulation; P:cellular response to low-density lipoprotein particle stimulus; P:humoral immune response mediated by circulating immunoglobulin; P:immunological synapse formation; P:macrophage fusion; P:myoblast fusion involved in skeletal muscle regeneration; P:osteoclast fusion; P:positive regulation of 1-phosphatidylinositol 4-kinase activity; P:positive regulation of adaptive immune memory response; P:positive regulation of B cell proliferation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein catabolic process in the vacuole; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of receptor clustering; P:positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of transcription by RNA polymerase II; P:protein localization; P:protein localization to lysosome; P:protein localization to plasma membrane; P:receptor internalization; P:receptor-mediated virion attachment to host cell; P:regulation of complement activation; P:regulation of immune response; P:regulation of macrophage migration; P:regulation of protein stability; P:viral entry into host cell;|P60033 P18582 Q5U0J6,CD81 antigen,26 kDa cell surface protein TAPA-1 {ECO:0000303|PubMed:1695320};Target of the antiproliferative antibody 1 {ECO:0000303|PubMed:1695320};Tetraspanin-28;, PF00335;, GO:0009925;GO:0016323;GO:0070062;GO:0005925;GO:0001772;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0097197;GO:0031982;GO:0015485;GO:0005178;GO:0042289;GO:0023026;GO:1990459;GO:0001618;GO:0000187;GO:0035783;GO:0071404;GO:0002455;GO:0001771;GO:0034238;GO:0014905;GO:0072675;GO:0043128;GO:1905676;GO:0030890;GO:0050861;GO:2000563;GO:0008284;GO:0002863;GO:0050731;GO:1904352;GO:0070863;GO:1903911;GO:2001190;GO:0050862;GO:2000553;GO:0045944;GO:0008104;GO:0061462;GO:0072659;GO:0031623;GO:0046813;GO:0030449;GO:0050776;GO:1905521;GO:0031647;GO:0046718;, C:basal plasma membrane; C:basolateral plasma membrane; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:tetraspanin-enriched microdomain; C:vesicle;, F:cholesterol binding; F:integrin binding; F:MHC class II protein binding; F:MHC class II protein complex binding; F:transferrin receptor binding; F:virus receptor activity;, P:activation of MAPK activity; P:CD4-positive, alpha-beta T cell costimulation; P:cellular response to low-density lipoprotein particle stimulus; P:humoral immune response mediated by circulating immunoglobulin; P:immunological synapse formation; P:macrophage fusion; P:myoblast fusion involved in skeletal muscle regeneration; P:osteoclast fusion; P:positive regulation of 1-phosphatidylinositol 4-kinase activity; P:positive regulation of adaptive immune memory response; P:positive regulation of B cell proliferation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein catabolic process in the vacuole; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of receptor clustering; P:positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of transcription by RNA polymerase II; P:protein localization; P:protein localization to lysosome; P:protein localization to plasma membrane; P:receptor internalization; P:receptor-mediated virion attachment to host cell; P:regulation of complement activation; P:regulation of immune response; P:regulation of macrophage migration; P:regulation of protein stability; P:viral entry into host cell;|P60033 P18582 Q5U0J6,CD81 antigen,26 kDa cell surface protein TAPA-1 {ECO:0000303|PubMed:1695320};Target of the antiproliferative antibody 1 {ECO:0000303|PubMed:1695320};Tetraspanin-28;, PF00335;, GO:0009925;GO:0016323;GO:0070062;GO:0005925;GO:0001772;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0097197;GO:0031982;GO:0015485;GO:0005178;GO:0042289;GO:0023026;GO:1990459;GO:0001618;GO:0000187;GO:0035783;GO:0071404;GO:0002455;GO:0001771;GO:0034238;GO:0014905;GO:0072675;GO:0043128;GO:1905676;GO:0030890;GO:0050861;GO:2000563;GO:0008284;GO:0002863;GO:0050731;GO:1904352;GO:0070863;GO:1903911;GO:2001190;GO:0050862;GO:2000553;GO:0045944;GO:0008104;GO:0061462;GO:0072659;GO:0031623;GO:0046813;GO:0030449;GO:0050776;GO:1905521;GO:0031647;GO:0046718;, C:basal plasma membrane; C:basolateral plasma membrane; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:tetraspanin-enriched microdomain; C:vesicle;, F:cholesterol binding; F:integrin binding; F:MHC class II protein binding; F:MHC class II protein complex binding; F:transferrin receptor binding; F:virus receptor activity;, P:activation of MAPK activity; P:CD4-positive, alpha-beta T cell costimulation; P:cellular response to low-density lipoprotein particle stimulus; P:humoral immune response mediated by circulating immunoglobulin; P:immunological synapse formation; P:macrophage fusion; P:myoblast fusion involved in skeletal muscle regeneration; P:osteoclast fusion; P:positive regulation of 1-phosphatidylinositol 4-kinase activity; P:positive regulation of adaptive immune memory response; P:positive regulation of B cell proliferation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein catabolic process in the vacuole; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of receptor clustering; P:positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of transcription by RNA polymerase II; P:protein localization; P:protein localization to lysosome; P:protein localization to plasma membrane; P:receptor internalization; P:receptor-mediated virion attachment to host cell; P:regulation of complement activation; P:regulation of immune response; P:regulation of macrophage migration; P:regulation of protein stability; P:viral entry into host cell;|P60033 P18582 Q5U0J6,CD81 antigen,26 kDa cell surface protein TAPA-1 {ECO:0000303|PubMed:1695320};Target of the antiproliferative antibody 1 {ECO:0000303|PubMed:1695320};Tetraspanin-28;, PF00335;, GO:0009925;GO:0016323;GO:0070062;GO:0005925;GO:0001772;GO:0016021;GO:0005887;GO:0016020;GO:0005886;GO:0097197;GO:0031982;GO:0015485;GO:0005178;GO:0042289;GO:0023026;GO:1990459;GO:0001618;GO:0000187;GO:0035783;GO:0071404;GO:0002455;GO:0001771;GO:0034238;GO:0014905;GO:0072675;GO:0043128;GO:1905676;GO:0030890;GO:0050861;GO:2000563;GO:0008284;GO:0002863;GO:0050731;GO:1904352;GO:0070863;GO:1903911;GO:2001190;GO:0050862;GO:2000553;GO:0045944;GO:0008104;GO:0061462;GO:0072659;GO:0031623;GO:0046813;GO:0030449;GO:0050776;GO:1905521;GO:0031647;GO:0046718;, C:basal plasma membrane; C:basolateral plasma membrane; C:extracellular exosome; C:focal adhesion; C:immunological synapse; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:tetraspanin-enriched microdomain; C:vesicle;, F:cholesterol binding; F:integrin binding; F:MHC class II protein binding; F:MHC class II protein complex binding; F:transferrin receptor binding; F:virus receptor activity;, P:activation of MAPK activity; P:CD4-positive, alpha-beta T cell costimulation; P:cellular response to low-density lipoprotein particle stimulus; P:humoral immune response mediated by circulating immunoglobulin; P:immunological synapse formation; P:macrophage fusion; P:myoblast fusion involved in skeletal muscle regeneration; P:osteoclast fusion; P:positive regulation of 1-phosphatidylinositol 4-kinase activity; P:positive regulation of adaptive immune memory response; P:positive regulation of B cell proliferation; P:positive regulation of B cell receptor signaling pathway; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; P:positive regulation of cell population proliferation; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein catabolic process in the vacuole; P:positive regulation of protein exit from endoplasmic reticulum; P:positive regulation of receptor clustering; P:positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:positive regulation of T cell receptor signaling pathway; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of transcription by RNA polymerase II; P:protein localization; P:protein localization to lysosome; P:protein localization to plasma membrane; P:receptor internalization; P:receptor-mediated virion attachment to host cell; P:regulation of complement activation; P:regulation of immune response; P:regulation of macrophage migration; P:regulation of protein stability; P:viral entry into host cell; scaffold215 indexed_genome mRNA 228801 230740 . + . ID=transcript_15886;Q9Y5U2 C9JS66 Q86VL2 Q9BRS6,Protein TSSC4,Tumor-suppressing STF cDNA 4 protein;Tumor-suppressing subchromosomal transferable fragment candidate gene 4 protein;, PF15264; scaffold215 indexed_genome mRNA 231861 234470 . + . ID=transcript_15887;Q9NZQ8 A6NHS0 Q52LU2 Q9NY34,Transient receptor potential cation channel subfamily M member 5,Long transient receptor potential channel 5;MLSN1- and TRP-related gene 1 protein;, PF00520;PF18139;, GO:0016021;GO:0005887;GO:0005886;GO:0005227;GO:0005261;GO:0005216;GO:0099604;GO:0005244;GO:0070588;GO:0098655;GO:0030001;GO:0034765;GO:0050909;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:cation channel activity; F:ion channel activity; F:ligand-gated calcium channel activity; F:voltage-gated ion channel activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:metal ion transport; P:regulation of ion transmembrane transport; P:sensory perception of taste;|Q9NZQ8 A6NHS0 Q52LU2 Q9NY34,Transient receptor potential cation channel subfamily M member 5,Long transient receptor potential channel 5;MLSN1- and TRP-related gene 1 protein;, PF00520;PF18139;, GO:0016021;GO:0005887;GO:0005886;GO:0005227;GO:0005261;GO:0005216;GO:0099604;GO:0005244;GO:0070588;GO:0098655;GO:0030001;GO:0034765;GO:0050909;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:cation channel activity; F:ion channel activity; F:ligand-gated calcium channel activity; F:voltage-gated ion channel activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:metal ion transport; P:regulation of ion transmembrane transport; P:sensory perception of taste; scaffold215 indexed_genome mRNA 241515 242394 . - . ID=transcript_15888;Q9NZQ8 A6NHS0 Q52LU2 Q9NY34,Transient receptor potential cation channel subfamily M member 5,Long transient receptor potential channel 5;MLSN1- and TRP-related gene 1 protein;, PF00520;PF18139;, GO:0016021;GO:0005887;GO:0005886;GO:0005227;GO:0005261;GO:0005216;GO:0099604;GO:0005244;GO:0070588;GO:0098655;GO:0030001;GO:0034765;GO:0050909;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:cation channel activity; F:ion channel activity; F:ligand-gated calcium channel activity; F:voltage-gated ion channel activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:metal ion transport; P:regulation of ion transmembrane transport; P:sensory perception of taste; scaffold215 indexed_genome mRNA 242786 244823 . - . ID=transcript_15889;Q9NZQ8 A6NHS0 Q52LU2 Q9NY34,Transient receptor potential cation channel subfamily M member 5,Long transient receptor potential channel 5;MLSN1- and TRP-related gene 1 protein;, PF00520;PF18139;, GO:0016021;GO:0005887;GO:0005886;GO:0005227;GO:0005261;GO:0005216;GO:0099604;GO:0005244;GO:0070588;GO:0098655;GO:0030001;GO:0034765;GO:0050909;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:calcium activated cation channel activity; F:cation channel activity; F:ion channel activity; F:ligand-gated calcium channel activity; F:voltage-gated ion channel activity;, P:calcium ion transmembrane transport; P:cation transmembrane transport; P:metal ion transport; P:regulation of ion transmembrane transport; P:sensory perception of taste; scaffold215 indexed_genome mRNA 378668 664543 . + . ID=transcript_15890;P51787 O00347 O60607 O94787 Q14D14 Q7Z6G9 Q92960 Q9UMN8 Q9UMN9,Potassium voltage-gated channel subfamily KQT member 1 {ECO:0000305},IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1 {ECO:0000305|PubMed:9312006};KQT-like 1 {ECO:0000305};Voltage-gated potassium channel subunit Kv7.1 {ECO:0000305|PubMed:20533308};, PF00520;PF03520;, GO:0016323;GO:0005737;GO:0030659;GO:0005769;GO:0005783;GO:0016021;GO:0034702;GO:0005770;GO:0005764;GO:0045121;GO:0005886;GO:0008076;GO:0005516;GO:0005251;GO:0044325;GO:0015271;GO:0005546;GO:0034236;GO:0034237;GO:0008157;GO:0097110;GO:0005249;GO:0086089;GO:0086008;GO:1902282;GO:0086014;GO:0061337;GO:0060048;GO:0071320;GO:0035690;GO:0071872;GO:0072359;GO:0016458;GO:0048839;GO:0050892;GO:0086011;GO:0098914;GO:0086013;GO:0098915;GO:1902260;GO:1903817;GO:0060452;GO:0010460;GO:1901381;GO:0097623;GO:0071805;GO:0060372;GO:0060453;GO:0006349;GO:0008016;GO:0086091;GO:0060306;GO:0060307;GO:0070293;GO:0007605;GO:0086005;, C:basolateral plasma membrane; C:cytoplasm; C:cytoplasmic vesicle membrane; C:early endosome; C:endoplasmic reticulum; C:integral component of membrane; C:ion channel complex; C:late endosome; C:lysosome; C:membrane raft; C:plasma membrane; C:voltage-gated potassium channel complex;, F:calmodulin binding; F:delayed rectifier potassium channel activity; F:ion channel binding; F:outward rectifier potassium channel activity; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein kinase A catalytic subunit binding; F:protein kinase A regulatory subunit binding; F:protein phosphatase 1 binding; F:scaffold protein binding; F:voltage-gated potassium channel activity; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization;, P:atrial cardiac muscle cell action potential; P:cardiac conduction; P:cardiac muscle contraction; P:cellular response to cAMP; P:cellular response to drug; P:cellular response to epinephrine stimulus; P:circulatory system development; P:gene silencing; P:inner ear development; P:intestinal absorption; P:membrane repolarization during action potential; P:membrane repolarization during atrial cardiac muscle cell action potential; P:membrane repolarization during cardiac muscle cell action potential; P:membrane repolarization during ventricular cardiac muscle cell action potential; P:negative regulation of delayed rectifier potassium channel activity; P:negative regulation of voltage-gated potassium channel activity; P:positive regulation of cardiac muscle contraction; P:positive regulation of heart rate; P:positive regulation of potassium ion transmembrane transport; P:potassium ion export across plasma membrane; P:potassium ion transmembrane transport; P:regulation of atrial cardiac muscle cell membrane repolarization; P:regulation of gastric acid secretion; P:regulation of gene expression by genetic imprinting; P:regulation of heart contraction; P:regulation of heart rate by cardiac conduction; P:regulation of membrane repolarization; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:renal absorption; P:sensory perception of sound; P:ventricular cardiac muscle cell action potential; scaffold216 indexed_genome mRNA 1 1116 . + . ID=transcript_15891;Q96B36 A8MTQ1 B2RE93 J3KPM3 Q96BI4 Q96IK7 Q96NG2 Q9BWR5,Proline-rich AKT1 substrate 1,40 kDa proline-rich AKT substrate;, PF15798;, GO:0005737;GO:0005829;GO:0005654;GO:0032991;GO:0045792;GO:0006469;GO:0032007;GO:0048011;GO:0042981;GO:1900034;GO:0043523;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:protein-containing complex;, , P:negative regulation of cell size; P:negative regulation of protein kinase activity; P:negative regulation of TOR signaling; P:neurotrophin TRK receptor signaling pathway; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of neuron apoptotic process; scaffold216 indexed_genome mRNA 1897 2784 . + . ID=transcript_15892;Q96B36 A8MTQ1 B2RE93 J3KPM3 Q96BI4 Q96IK7 Q96NG2 Q9BWR5,Proline-rich AKT1 substrate 1,40 kDa proline-rich AKT substrate;, PF15798;, GO:0005737;GO:0005829;GO:0005654;GO:0032991;GO:0045792;GO:0006469;GO:0032007;GO:0048011;GO:0042981;GO:1900034;GO:0043523;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:protein-containing complex;, , P:negative regulation of cell size; P:negative regulation of protein kinase activity; P:negative regulation of TOR signaling; P:neurotrophin TRK receptor signaling pathway; P:regulation of apoptotic process; P:regulation of cellular response to heat; P:regulation of neuron apoptotic process; scaffold216 indexed_genome mRNA 4416 17504 . + . ID=transcript_15893;Q96T60 Q9BUL2 Q9P1V2 Q9UKU8 Q9UNF8 Q9UNI0,Bifunctional polynucleotide phosphatase/kinase,DNA 5'-kinase/3'-phosphatase;Polynucleotide kinase-3'-phosphatase;, PF17913;PF08645;, GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0046404;GO:0003684;GO:0003690;GO:0004519;GO:0046403;GO:0017076;GO:0006287;GO:0016311;GO:0042769;GO:0006281;GO:0006261;GO:0010836;GO:0046939;GO:0000718;GO:2001034;GO:0051973;GO:1904355;GO:0032212;GO:0006979;GO:0009314;, C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; F:damaged DNA binding; F:double-stranded DNA binding; F:endonuclease activity; F:polynucleotide 3'-phosphatase activity; F:purine nucleotide binding;, P:base-excision repair, gap-filling; P:dephosphorylation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:DNA-dependent DNA replication; P:negative regulation of protein ADP-ribosylation; P:nucleotide phosphorylation; P:nucleotide-excision repair, DNA damage removal; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to oxidative stress; P:response to radiation;|Q96T60 Q9BUL2 Q9P1V2 Q9UKU8 Q9UNF8 Q9UNI0,Bifunctional polynucleotide phosphatase/kinase,DNA 5'-kinase/3'-phosphatase;Polynucleotide kinase-3'-phosphatase;, PF17913;PF08645;, GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0046404;GO:0003684;GO:0003690;GO:0004519;GO:0046403;GO:0017076;GO:0006287;GO:0016311;GO:0042769;GO:0006281;GO:0006261;GO:0010836;GO:0046939;GO:0000718;GO:2001034;GO:0051973;GO:1904355;GO:0032212;GO:0006979;GO:0009314;, C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; F:damaged DNA binding; F:double-stranded DNA binding; F:endonuclease activity; F:polynucleotide 3'-phosphatase activity; F:purine nucleotide binding;, P:base-excision repair, gap-filling; P:dephosphorylation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:DNA-dependent DNA replication; P:negative regulation of protein ADP-ribosylation; P:nucleotide phosphorylation; P:nucleotide-excision repair, DNA damage removal; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to oxidative stress; P:response to radiation;|Q96T60 Q9BUL2 Q9P1V2 Q9UKU8 Q9UNF8 Q9UNI0,Bifunctional polynucleotide phosphatase/kinase,DNA 5'-kinase/3'-phosphatase;Polynucleotide kinase-3'-phosphatase;, PF17913;PF08645;, GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0046404;GO:0003684;GO:0003690;GO:0004519;GO:0046403;GO:0017076;GO:0006287;GO:0016311;GO:0042769;GO:0006281;GO:0006261;GO:0010836;GO:0046939;GO:0000718;GO:2001034;GO:0051973;GO:1904355;GO:0032212;GO:0006979;GO:0009314;, C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; F:damaged DNA binding; F:double-stranded DNA binding; F:endonuclease activity; F:polynucleotide 3'-phosphatase activity; F:purine nucleotide binding;, P:base-excision repair, gap-filling; P:dephosphorylation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:DNA-dependent DNA replication; P:negative regulation of protein ADP-ribosylation; P:nucleotide phosphorylation; P:nucleotide-excision repair, DNA damage removal; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to oxidative stress; P:response to radiation;|Q96T60 Q9BUL2 Q9P1V2 Q9UKU8 Q9UNF8 Q9UNI0,Bifunctional polynucleotide phosphatase/kinase,DNA 5'-kinase/3'-phosphatase;Polynucleotide kinase-3'-phosphatase;, PF17913;PF08645;, GO:0016020;GO:0005739;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0046404;GO:0003684;GO:0003690;GO:0004519;GO:0046403;GO:0017076;GO:0006287;GO:0016311;GO:0042769;GO:0006281;GO:0006261;GO:0010836;GO:0046939;GO:0000718;GO:2001034;GO:0051973;GO:1904355;GO:0032212;GO:0006979;GO:0009314;, C:membrane; C:mitochondrion; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; F:damaged DNA binding; F:double-stranded DNA binding; F:endonuclease activity; F:polynucleotide 3'-phosphatase activity; F:purine nucleotide binding;, P:base-excision repair, gap-filling; P:dephosphorylation; P:DNA damage response, detection of DNA damage; P:DNA repair; P:DNA-dependent DNA replication; P:negative regulation of protein ADP-ribosylation; P:nucleotide phosphorylation; P:nucleotide-excision repair, DNA damage removal; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to oxidative stress; P:response to radiation;|Q86YD1 Q6UXX7 Q96BU3 Q9HBN4 Q9NYL1,Prostate tumor-overexpressed gene 1 protein,Activator interaction domain-containing protein 2;, PF11232;, GO:0005654;GO:0048471;GO:0005886;GO:0005667;GO:0045944;, C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:transcription regulator complex;, , P:positive regulation of transcription by RNA polymerase II;|Q86YD1 Q6UXX7 Q96BU3 Q9HBN4 Q9NYL1,Prostate tumor-overexpressed gene 1 protein,Activator interaction domain-containing protein 2;, PF11232;, GO:0005654;GO:0048471;GO:0005886;GO:0005667;GO:0045944;, C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:transcription regulator complex;, , P:positive regulation of transcription by RNA polymerase II;|Q86YD1 Q6UXX7 Q96BU3 Q9HBN4 Q9NYL1,Prostate tumor-overexpressed gene 1 protein,Activator interaction domain-containing protein 2;, PF11232;, GO:0005654;GO:0048471;GO:0005886;GO:0005667;GO:0045944;, C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:transcription regulator complex;, , P:positive regulation of transcription by RNA polymerase II;|Q86YD1 Q6UXX7 Q96BU3 Q9HBN4 Q9NYL1,Prostate tumor-overexpressed gene 1 protein,Activator interaction domain-containing protein 2;, PF11232;, GO:0005654;GO:0048471;GO:0005886;GO:0005667;GO:0045944;, C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:transcription regulator complex;, , P:positive regulation of transcription by RNA polymerase II;|Q86YD1 Q6UXX7 Q96BU3 Q9HBN4 Q9NYL1,Prostate tumor-overexpressed gene 1 protein,Activator interaction domain-containing protein 2;, PF11232;, GO:0005654;GO:0048471;GO:0005886;GO:0005667;GO:0045944;, C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane; C:transcription regulator complex;, , P:positive regulation of transcription by RNA polymerase II; scaffold216 indexed_genome mRNA 35164 38075 . + . ID=transcript_15894;Q6EKJ0 B2RNE9 Q69GU6 Q8N979 Q9H739,General transcription factor II-I repeat domain-containing protein 2B,Transcription factor GTF2IRD2-beta;, PF02946;PF18658;, GO:0005654;GO:0005634;GO:0003677;GO:0000981;, C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; scaffold216 indexed_genome mRNA 38123 51530 . - . ID=transcript_15895;Q9HB34,Mediator of RNA polymerase II transcription subunit 25,Activator interaction domain-containing protein 1;Activator-recruited cofactor 92 kDa component;Mediator complex subunit 25;p78;, PF11232;PF11244;PF11235;PF11265;, GO:0016592;GO:0005654;GO:0005667;GO:0042974;GO:0046965;GO:0001223;GO:0008134;GO:0048147;GO:0000122;GO:0071158;GO:0035563;GO:2001178;GO:0045944;GO:0060260;, C:mediator complex; C:nucleoplasm; C:transcription regulator complex;, F:retinoic acid receptor binding; F:retinoid X receptor binding; F:transcription coactivator binding; F:transcription factor binding;, P:negative regulation of fibroblast proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell cycle arrest; P:positive regulation of chromatin binding; P:positive regulation of mediator complex assembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|Q9HB34,Mediator of RNA polymerase II transcription subunit 25,Activator interaction domain-containing protein 1;Activator-recruited cofactor 92 kDa component;Mediator complex subunit 25;p78;, PF11232;PF11244;PF11235;PF11265;, GO:0016592;GO:0005654;GO:0005667;GO:0042974;GO:0046965;GO:0001223;GO:0008134;GO:0048147;GO:0000122;GO:0071158;GO:0035563;GO:2001178;GO:0045944;GO:0060260;, C:mediator complex; C:nucleoplasm; C:transcription regulator complex;, F:retinoic acid receptor binding; F:retinoid X receptor binding; F:transcription coactivator binding; F:transcription factor binding;, P:negative regulation of fibroblast proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell cycle arrest; P:positive regulation of chromatin binding; P:positive regulation of mediator complex assembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|Q9HB34,Mediator of RNA polymerase II transcription subunit 25,Activator interaction domain-containing protein 1;Activator-recruited cofactor 92 kDa component;Mediator complex subunit 25;p78;, PF11232;PF11244;PF11235;PF11265;, GO:0016592;GO:0005654;GO:0005667;GO:0042974;GO:0046965;GO:0001223;GO:0008134;GO:0048147;GO:0000122;GO:0071158;GO:0035563;GO:2001178;GO:0045944;GO:0060260;, C:mediator complex; C:nucleoplasm; C:transcription regulator complex;, F:retinoic acid receptor binding; F:retinoid X receptor binding; F:transcription coactivator binding; F:transcription factor binding;, P:negative regulation of fibroblast proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell cycle arrest; P:positive regulation of chromatin binding; P:positive regulation of mediator complex assembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;|Q9HB34,Mediator of RNA polymerase II transcription subunit 25,Activator interaction domain-containing protein 1;Activator-recruited cofactor 92 kDa component;Mediator complex subunit 25;p78;, PF11232;PF11244;PF11235;PF11265;, GO:0016592;GO:0005654;GO:0005667;GO:0042974;GO:0046965;GO:0001223;GO:0008134;GO:0048147;GO:0000122;GO:0071158;GO:0035563;GO:2001178;GO:0045944;GO:0060260;, C:mediator complex; C:nucleoplasm; C:transcription regulator complex;, F:retinoic acid receptor binding; F:retinoid X receptor binding; F:transcription coactivator binding; F:transcription factor binding;, P:negative regulation of fibroblast proliferation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell cycle arrest; P:positive regulation of chromatin binding; P:positive regulation of mediator complex assembly; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; scaffold216 indexed_genome mRNA 64114 77055 . + . ID=transcript_15896;O95782 Q96CI7 Q96PP6 Q96PP7 Q9H070,AP-2 complex subunit alpha-1,100 kDa coated vesicle protein A;Adaptor protein complex AP-2 subunit alpha-1;Adaptor-related protein complex 2 subunit alpha-1;Alpha-adaptin A;Alpha1-adaptin;Clathrin assembly protein complex 2 alpha-A large chain;Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0016324;GO:0016323;GO:0030130;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0032433;GO:0016020;GO:0005886;GO:0140312;GO:0035615;GO:0050750;GO:0008022;GO:0019901;GO:0044877;GO:0019886;GO:0072583;GO:0006897;GO:0048013;GO:0006895;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:1900126;GO:0010976;GO:0048260;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:apical plasma membrane; C:basolateral plasma membrane; C:clathrin coat of trans-Golgi network vesicle; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:filopodium tip; C:membrane; C:plasma membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding; F:protein kinase binding; F:protein-containing complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:endocytosis; P:ephrin receptor signaling pathway; P:Golgi to endosome transport; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of hyaluronan biosynthetic process; P:positive regulation of neuron projection development; P:positive regulation of receptor-mediated endocytosis; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O95782 Q96CI7 Q96PP6 Q96PP7 Q9H070,AP-2 complex subunit alpha-1,100 kDa coated vesicle protein A;Adaptor protein complex AP-2 subunit alpha-1;Adaptor-related protein complex 2 subunit alpha-1;Alpha-adaptin A;Alpha1-adaptin;Clathrin assembly protein complex 2 alpha-A large chain;Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0016324;GO:0016323;GO:0030130;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0032433;GO:0016020;GO:0005886;GO:0140312;GO:0035615;GO:0050750;GO:0008022;GO:0019901;GO:0044877;GO:0019886;GO:0072583;GO:0006897;GO:0048013;GO:0006895;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:1900126;GO:0010976;GO:0048260;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:apical plasma membrane; C:basolateral plasma membrane; C:clathrin coat of trans-Golgi network vesicle; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:filopodium tip; C:membrane; C:plasma membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding; F:protein kinase binding; F:protein-containing complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:endocytosis; P:ephrin receptor signaling pathway; P:Golgi to endosome transport; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of hyaluronan biosynthetic process; P:positive regulation of neuron projection development; P:positive regulation of receptor-mediated endocytosis; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O95782 Q96CI7 Q96PP6 Q96PP7 Q9H070,AP-2 complex subunit alpha-1,100 kDa coated vesicle protein A;Adaptor protein complex AP-2 subunit alpha-1;Adaptor-related protein complex 2 subunit alpha-1;Alpha-adaptin A;Alpha1-adaptin;Clathrin assembly protein complex 2 alpha-A large chain;Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0016324;GO:0016323;GO:0030130;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0032433;GO:0016020;GO:0005886;GO:0140312;GO:0035615;GO:0050750;GO:0008022;GO:0019901;GO:0044877;GO:0019886;GO:0072583;GO:0006897;GO:0048013;GO:0006895;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:1900126;GO:0010976;GO:0048260;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:apical plasma membrane; C:basolateral plasma membrane; C:clathrin coat of trans-Golgi network vesicle; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:filopodium tip; C:membrane; C:plasma membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding; F:protein kinase binding; F:protein-containing complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:endocytosis; P:ephrin receptor signaling pathway; P:Golgi to endosome transport; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of hyaluronan biosynthetic process; P:positive regulation of neuron projection development; P:positive regulation of receptor-mediated endocytosis; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O95782 Q96CI7 Q96PP6 Q96PP7 Q9H070,AP-2 complex subunit alpha-1,100 kDa coated vesicle protein A;Adaptor protein complex AP-2 subunit alpha-1;Adaptor-related protein complex 2 subunit alpha-1;Alpha-adaptin A;Alpha1-adaptin;Clathrin assembly protein complex 2 alpha-A large chain;Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0016324;GO:0016323;GO:0030130;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0032433;GO:0016020;GO:0005886;GO:0140312;GO:0035615;GO:0050750;GO:0008022;GO:0019901;GO:0044877;GO:0019886;GO:0072583;GO:0006897;GO:0048013;GO:0006895;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:1900126;GO:0010976;GO:0048260;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:apical plasma membrane; C:basolateral plasma membrane; C:clathrin coat of trans-Golgi network vesicle; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:filopodium tip; C:membrane; C:plasma membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding; F:protein kinase binding; F:protein-containing complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:endocytosis; P:ephrin receptor signaling pathway; P:Golgi to endosome transport; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of hyaluronan biosynthetic process; P:positive regulation of neuron projection development; P:positive regulation of receptor-mediated endocytosis; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway; scaffold216 indexed_genome mRNA 77807 83936 . - . ID=transcript_15897;O95782 Q96CI7 Q96PP6 Q96PP7 Q9H070,AP-2 complex subunit alpha-1,100 kDa coated vesicle protein A;Adaptor protein complex AP-2 subunit alpha-1;Adaptor-related protein complex 2 subunit alpha-1;Alpha-adaptin A;Alpha1-adaptin;Clathrin assembly protein complex 2 alpha-A large chain;Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0016324;GO:0016323;GO:0030130;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0032433;GO:0016020;GO:0005886;GO:0140312;GO:0035615;GO:0050750;GO:0008022;GO:0019901;GO:0044877;GO:0019886;GO:0072583;GO:0006897;GO:0048013;GO:0006895;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:1900126;GO:0010976;GO:0048260;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:apical plasma membrane; C:basolateral plasma membrane; C:clathrin coat of trans-Golgi network vesicle; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:filopodium tip; C:membrane; C:plasma membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding; F:protein kinase binding; F:protein-containing complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:endocytosis; P:ephrin receptor signaling pathway; P:Golgi to endosome transport; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of hyaluronan biosynthetic process; P:positive regulation of neuron projection development; P:positive regulation of receptor-mediated endocytosis; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O95782 Q96CI7 Q96PP6 Q96PP7 Q9H070,AP-2 complex subunit alpha-1,100 kDa coated vesicle protein A;Adaptor protein complex AP-2 subunit alpha-1;Adaptor-related protein complex 2 subunit alpha-1;Alpha-adaptin A;Alpha1-adaptin;Clathrin assembly protein complex 2 alpha-A large chain;Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0016324;GO:0016323;GO:0030130;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0032433;GO:0016020;GO:0005886;GO:0140312;GO:0035615;GO:0050750;GO:0008022;GO:0019901;GO:0044877;GO:0019886;GO:0072583;GO:0006897;GO:0048013;GO:0006895;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:1900126;GO:0010976;GO:0048260;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:apical plasma membrane; C:basolateral plasma membrane; C:clathrin coat of trans-Golgi network vesicle; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:filopodium tip; C:membrane; C:plasma membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:low-density lipoprotein particle receptor binding; F:protein C-terminus binding; F:protein kinase binding; F:protein-containing complex binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:endocytosis; P:ephrin receptor signaling pathway; P:Golgi to endosome transport; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of hyaluronan biosynthetic process; P:positive regulation of neuron projection development; P:positive regulation of receptor-mediated endocytosis; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway; scaffold216 indexed_genome mRNA 120918 121558 . + . ID=transcript_15898;P02792 B2R4B9 Q6IBT7 Q7Z2W1 Q86WI9 Q8WU07 Q96AU9 Q96CU0 Q9BTZ8,Ferritin light chain,, PF00210;, GO:0044754;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0008043;GO:0016020;GO:0008199;GO:0008198;GO:0042802;GO:0005506;GO:0006879;GO:0006880;GO:0055072;GO:0006826;GO:0043312;GO:0006892;, C:autolysosome; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular ferritin complex; C:membrane;, F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:iron ion binding;, P:cellular iron ion homeostasis; P:intracellular sequestering of iron ion; P:iron ion homeostasis; P:iron ion transport; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; scaffold216 indexed_genome mRNA 121792 133118 . - . ID=transcript_15899;Q8TCG5 A8K0Z8 Q5K6N5 Q8N6Q9 Q8NDS6 Q8TE84,Carnitine O-palmitoyltransferase 1, brain isoform,CPT IC;Carnitine O-palmitoyltransferase I, brain isoform;Carnitine palmitoyltransferase 1C;, PF00755;PF16484;, GO:0032281;GO:0030424;GO:0030425;GO:0005783;GO:0098978;GO:0030176;GO:0005741;GO:0005739;GO:0098794;GO:0004095;GO:0009437;GO:0006635;GO:0006631;GO:0099072;, C:AMPA glutamate receptor complex; C:axon; C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrion; C:postsynapse;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:regulation of postsynaptic membrane neurotransmitter receptor levels;|Q8TCG5 A8K0Z8 Q5K6N5 Q8N6Q9 Q8NDS6 Q8TE84,Carnitine O-palmitoyltransferase 1, brain isoform,CPT IC;Carnitine O-palmitoyltransferase I, brain isoform;Carnitine palmitoyltransferase 1C;, PF00755;PF16484;, GO:0032281;GO:0030424;GO:0030425;GO:0005783;GO:0098978;GO:0030176;GO:0005741;GO:0005739;GO:0098794;GO:0004095;GO:0009437;GO:0006635;GO:0006631;GO:0099072;, C:AMPA glutamate receptor complex; C:axon; C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrion; C:postsynapse;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:regulation of postsynaptic membrane neurotransmitter receptor levels;|Q8TCG5 A8K0Z8 Q5K6N5 Q8N6Q9 Q8NDS6 Q8TE84,Carnitine O-palmitoyltransferase 1, brain isoform,CPT IC;Carnitine O-palmitoyltransferase I, brain isoform;Carnitine palmitoyltransferase 1C;, PF00755;PF16484;, GO:0032281;GO:0030424;GO:0030425;GO:0005783;GO:0098978;GO:0030176;GO:0005741;GO:0005739;GO:0098794;GO:0004095;GO:0009437;GO:0006635;GO:0006631;GO:0099072;, C:AMPA glutamate receptor complex; C:axon; C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrion; C:postsynapse;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:regulation of postsynaptic membrane neurotransmitter receptor levels;|Q8TCG5 A8K0Z8 Q5K6N5 Q8N6Q9 Q8NDS6 Q8TE84,Carnitine O-palmitoyltransferase 1, brain isoform,CPT IC;Carnitine O-palmitoyltransferase I, brain isoform;Carnitine palmitoyltransferase 1C;, PF00755;PF16484;, GO:0032281;GO:0030424;GO:0030425;GO:0005783;GO:0098978;GO:0030176;GO:0005741;GO:0005739;GO:0098794;GO:0004095;GO:0009437;GO:0006635;GO:0006631;GO:0099072;, C:AMPA glutamate receptor complex; C:axon; C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrion; C:postsynapse;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:regulation of postsynaptic membrane neurotransmitter receptor levels;|Q8TCG5 A8K0Z8 Q5K6N5 Q8N6Q9 Q8NDS6 Q8TE84,Carnitine O-palmitoyltransferase 1, brain isoform,CPT IC;Carnitine O-palmitoyltransferase I, brain isoform;Carnitine palmitoyltransferase 1C;, PF00755;PF16484;, GO:0032281;GO:0030424;GO:0030425;GO:0005783;GO:0098978;GO:0030176;GO:0005741;GO:0005739;GO:0098794;GO:0004095;GO:0009437;GO:0006635;GO:0006631;GO:0099072;, C:AMPA glutamate receptor complex; C:axon; C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrion; C:postsynapse;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:regulation of postsynaptic membrane neurotransmitter receptor levels;|Q8TCG5 A8K0Z8 Q5K6N5 Q8N6Q9 Q8NDS6 Q8TE84,Carnitine O-palmitoyltransferase 1, brain isoform,CPT IC;Carnitine O-palmitoyltransferase I, brain isoform;Carnitine palmitoyltransferase 1C;, PF00755;PF16484;, GO:0032281;GO:0030424;GO:0030425;GO:0005783;GO:0098978;GO:0030176;GO:0005741;GO:0005739;GO:0098794;GO:0004095;GO:0009437;GO:0006635;GO:0006631;GO:0099072;, C:AMPA glutamate receptor complex; C:axon; C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrion; C:postsynapse;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:regulation of postsynaptic membrane neurotransmitter receptor levels; scaffold216 indexed_genome mRNA 133307 136186 . + . ID=transcript_15900;Q8TCG5 A8K0Z8 Q5K6N5 Q8N6Q9 Q8NDS6 Q8TE84,Carnitine O-palmitoyltransferase 1, brain isoform,CPT IC;Carnitine O-palmitoyltransferase I, brain isoform;Carnitine palmitoyltransferase 1C;, PF00755;PF16484;, GO:0032281;GO:0030424;GO:0030425;GO:0005783;GO:0098978;GO:0030176;GO:0005741;GO:0005739;GO:0098794;GO:0004095;GO:0009437;GO:0006635;GO:0006631;GO:0099072;, C:AMPA glutamate receptor complex; C:axon; C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrion; C:postsynapse;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:regulation of postsynaptic membrane neurotransmitter receptor levels;|Q8TCG5 A8K0Z8 Q5K6N5 Q8N6Q9 Q8NDS6 Q8TE84,Carnitine O-palmitoyltransferase 1, brain isoform,CPT IC;Carnitine O-palmitoyltransferase I, brain isoform;Carnitine palmitoyltransferase 1C;, PF00755;PF16484;, GO:0032281;GO:0030424;GO:0030425;GO:0005783;GO:0098978;GO:0030176;GO:0005741;GO:0005739;GO:0098794;GO:0004095;GO:0009437;GO:0006635;GO:0006631;GO:0099072;, C:AMPA glutamate receptor complex; C:axon; C:dendrite; C:endoplasmic reticulum; C:glutamatergic synapse; C:integral component of endoplasmic reticulum membrane; C:mitochondrial outer membrane; C:mitochondrion; C:postsynapse;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:regulation of postsynaptic membrane neurotransmitter receptor levels; scaffold216 indexed_genome mRNA 142048 143659 . - . ID=transcript_15901;C9JUS6,Putative adrenomedullin-5-like protein,, , GO:0005576;, C:extracellular region; scaffold216 indexed_genome mRNA 144281 154139 . - . ID=transcript_15902;Q99872 Q99874 Q9NZ04 Q9NZ05 Q9NZ06,Protein arginine N-methyltransferase 1 {ECO:0000305},Histone-arginine N-methyltransferase PRMT1;Interferon receptor 1-bound protein 4;, PF13649;, GO:0005737;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0019899;GO:0042054;GO:0044020;GO:0042802;GO:0008327;GO:0008168;GO:0048273;GO:0008170;GO:0008276;GO:0016274;GO:0035242;GO:0035241;GO:0003723;GO:1904047;GO:0007166;GO:0006977;GO:0043985;GO:0016571;GO:0001701;GO:0045653;GO:0031175;GO:0018216;GO:0008284;GO:0045648;GO:0046985;GO:1900745;GO:0051260;GO:0006479;GO:0045652;, C:cytoplasm; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H4-R3 specific); F:identical protein binding; F:methyl-CpG binding; F:methyltransferase activity; F:mitogen-activated protein kinase p38 binding; F:N-methyltransferase activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:RNA binding; F:S-adenosyl-L-methionine binding;, P:cell surface receptor signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H4-R3 methylation; P:histone methylation; P:in utero embryonic development; P:negative regulation of megakaryocyte differentiation; P:neuron projection development; P:peptidyl-arginine methylation; P:positive regulation of cell population proliferation; P:positive regulation of erythrocyte differentiation; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of p38MAPK cascade; P:protein homooligomerization; P:protein methylation; P:regulation of megakaryocyte differentiation;|Q99872 Q99874 Q9NZ04 Q9NZ05 Q9NZ06,Protein arginine N-methyltransferase 1 {ECO:0000305},Histone-arginine N-methyltransferase PRMT1;Interferon receptor 1-bound protein 4;, PF13649;, GO:0005737;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0019899;GO:0042054;GO:0044020;GO:0042802;GO:0008327;GO:0008168;GO:0048273;GO:0008170;GO:0008276;GO:0016274;GO:0035242;GO:0035241;GO:0003723;GO:1904047;GO:0007166;GO:0006977;GO:0043985;GO:0016571;GO:0001701;GO:0045653;GO:0031175;GO:0018216;GO:0008284;GO:0045648;GO:0046985;GO:1900745;GO:0051260;GO:0006479;GO:0045652;, C:cytoplasm; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H4-R3 specific); F:identical protein binding; F:methyl-CpG binding; F:methyltransferase activity; F:mitogen-activated protein kinase p38 binding; F:N-methyltransferase activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:RNA binding; F:S-adenosyl-L-methionine binding;, P:cell surface receptor signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H4-R3 methylation; P:histone methylation; P:in utero embryonic development; P:negative regulation of megakaryocyte differentiation; P:neuron projection development; P:peptidyl-arginine methylation; P:positive regulation of cell population proliferation; P:positive regulation of erythrocyte differentiation; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of p38MAPK cascade; P:protein homooligomerization; P:protein methylation; P:regulation of megakaryocyte differentiation;|Q99872 Q99874 Q9NZ04 Q9NZ05 Q9NZ06,Protein arginine N-methyltransferase 1 {ECO:0000305},Histone-arginine N-methyltransferase PRMT1;Interferon receptor 1-bound protein 4;, PF13649;, GO:0005737;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0019899;GO:0042054;GO:0044020;GO:0042802;GO:0008327;GO:0008168;GO:0048273;GO:0008170;GO:0008276;GO:0016274;GO:0035242;GO:0035241;GO:0003723;GO:1904047;GO:0007166;GO:0006977;GO:0043985;GO:0016571;GO:0001701;GO:0045653;GO:0031175;GO:0018216;GO:0008284;GO:0045648;GO:0046985;GO:1900745;GO:0051260;GO:0006479;GO:0045652;, C:cytoplasm; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H4-R3 specific); F:identical protein binding; F:methyl-CpG binding; F:methyltransferase activity; F:mitogen-activated protein kinase p38 binding; F:N-methyltransferase activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:RNA binding; F:S-adenosyl-L-methionine binding;, P:cell surface receptor signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H4-R3 methylation; P:histone methylation; P:in utero embryonic development; P:negative regulation of megakaryocyte differentiation; P:neuron projection development; P:peptidyl-arginine methylation; P:positive regulation of cell population proliferation; P:positive regulation of erythrocyte differentiation; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of p38MAPK cascade; P:protein homooligomerization; P:protein methylation; P:regulation of megakaryocyte differentiation;|Q99872 Q99874 Q9NZ04 Q9NZ05 Q9NZ06,Protein arginine N-methyltransferase 1 {ECO:0000305},Histone-arginine N-methyltransferase PRMT1;Interferon receptor 1-bound protein 4;, PF13649;, GO:0005737;GO:0005829;GO:0034709;GO:0005654;GO:0005634;GO:0019899;GO:0042054;GO:0044020;GO:0042802;GO:0008327;GO:0008168;GO:0048273;GO:0008170;GO:0008276;GO:0016274;GO:0035242;GO:0035241;GO:0003723;GO:1904047;GO:0007166;GO:0006977;GO:0043985;GO:0016571;GO:0001701;GO:0045653;GO:0031175;GO:0018216;GO:0008284;GO:0045648;GO:0046985;GO:1900745;GO:0051260;GO:0006479;GO:0045652;, C:cytoplasm; C:cytosol; C:methylosome; C:nucleoplasm; C:nucleus;, F:enzyme binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H4-R3 specific); F:identical protein binding; F:methyl-CpG binding; F:methyltransferase activity; F:mitogen-activated protein kinase p38 binding; F:N-methyltransferase activity; F:protein methyltransferase activity; F:protein-arginine N-methyltransferase activity; F:protein-arginine omega-N asymmetric methyltransferase activity; F:protein-arginine omega-N monomethyltransferase activity; F:RNA binding; F:S-adenosyl-L-methionine binding;, P:cell surface receptor signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:histone H4-R3 methylation; P:histone methylation; P:in utero embryonic development; P:negative regulation of megakaryocyte differentiation; P:neuron projection development; P:peptidyl-arginine methylation; P:positive regulation of cell population proliferation; P:positive regulation of erythrocyte differentiation; P:positive regulation of hemoglobin biosynthetic process; P:positive regulation of p38MAPK cascade; P:protein homooligomerization; P:protein methylation; P:regulation of megakaryocyte differentiation; scaffold216 indexed_genome mRNA 158434 161678 . - . ID=transcript_15903;Q9HB09 Q3SY11 Q3SY13 Q96I96 Q9HB08,Bcl-2-like protein 12,Bcl-2-related proline-rich protein;, , GO:0016020;GO:0005634;GO:0002039;GO:0006915;GO:1990001;GO:2000773;GO:1902166;GO:0045944;GO:2001236;, C:membrane; C:nucleus;, F:p53 binding;, P:apoptotic process; P:inhibition of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of cellular senescence; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:positive regulation of transcription by RNA polymerase II; P:regulation of extrinsic apoptotic signaling pathway; scaffold216 indexed_genome mRNA 165234 171399 . + . ID=transcript_15904;Q14653 A8K7L2 B2RAZ3 Q5FBY1 Q5FBY2 Q5FBY4 Q7Z5G6,Interferon regulatory factor 3 {ECO:0000303|PubMed:9566918, ECO:0000303|PubMed:9803267},, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0001227;GO:0042802;GO:0019904;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0006915;GO:0006974;GO:0071360;GO:0098586;GO:0051607;GO:0002376;GO:0060333;GO:0031663;GO:0071888;GO:0039530;GO:0032480;GO:0043123;GO:0032727;GO:0032728;GO:0045944;GO:0032481;GO:0060340;GO:0097300;GO:0042981;GO:0050727;GO:0006357;GO:0032479;GO:0035666;GO:0060337;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein domain specific binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to exogenous dsRNA; P:cellular response to virus; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:macrophage apoptotic process; P:MDA-5 signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:programmed necrotic cell death; P:regulation of apoptotic process; P:regulation of inflammatory response; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production; P:TRIF-dependent toll-like receptor signaling pathway; P:type I interferon signaling pathway; P:viral process;|Q14653 A8K7L2 B2RAZ3 Q5FBY1 Q5FBY2 Q5FBY4 Q7Z5G6,Interferon regulatory factor 3 {ECO:0000303|PubMed:9566918, ECO:0000303|PubMed:9803267},, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0001227;GO:0042802;GO:0019904;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0006915;GO:0006974;GO:0071360;GO:0098586;GO:0051607;GO:0002376;GO:0060333;GO:0031663;GO:0071888;GO:0039530;GO:0032480;GO:0043123;GO:0032727;GO:0032728;GO:0045944;GO:0032481;GO:0060340;GO:0097300;GO:0042981;GO:0050727;GO:0006357;GO:0032479;GO:0035666;GO:0060337;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein domain specific binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to exogenous dsRNA; P:cellular response to virus; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:macrophage apoptotic process; P:MDA-5 signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:programmed necrotic cell death; P:regulation of apoptotic process; P:regulation of inflammatory response; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production; P:TRIF-dependent toll-like receptor signaling pathway; P:type I interferon signaling pathway; P:viral process;|Q14653 A8K7L2 B2RAZ3 Q5FBY1 Q5FBY2 Q5FBY4 Q7Z5G6,Interferon regulatory factor 3 {ECO:0000303|PubMed:9566918, ECO:0000303|PubMed:9803267},, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0001227;GO:0042802;GO:0019904;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0006915;GO:0006974;GO:0071360;GO:0098586;GO:0051607;GO:0002376;GO:0060333;GO:0031663;GO:0071888;GO:0039530;GO:0032480;GO:0043123;GO:0032727;GO:0032728;GO:0045944;GO:0032481;GO:0060340;GO:0097300;GO:0042981;GO:0050727;GO:0006357;GO:0032479;GO:0035666;GO:0060337;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein domain specific binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to exogenous dsRNA; P:cellular response to virus; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:macrophage apoptotic process; P:MDA-5 signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:programmed necrotic cell death; P:regulation of apoptotic process; P:regulation of inflammatory response; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production; P:TRIF-dependent toll-like receptor signaling pathway; P:type I interferon signaling pathway; P:viral process;|Q14653 A8K7L2 B2RAZ3 Q5FBY1 Q5FBY2 Q5FBY4 Q7Z5G6,Interferon regulatory factor 3 {ECO:0000303|PubMed:9566918, ECO:0000303|PubMed:9803267},, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0001227;GO:0042802;GO:0019904;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0006915;GO:0006974;GO:0071360;GO:0098586;GO:0051607;GO:0002376;GO:0060333;GO:0031663;GO:0071888;GO:0039530;GO:0032480;GO:0043123;GO:0032727;GO:0032728;GO:0045944;GO:0032481;GO:0060340;GO:0097300;GO:0042981;GO:0050727;GO:0006357;GO:0032479;GO:0035666;GO:0060337;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein domain specific binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to exogenous dsRNA; P:cellular response to virus; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:macrophage apoptotic process; P:MDA-5 signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:programmed necrotic cell death; P:regulation of apoptotic process; P:regulation of inflammatory response; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production; P:TRIF-dependent toll-like receptor signaling pathway; P:type I interferon signaling pathway; P:viral process;|Q14653 A8K7L2 B2RAZ3 Q5FBY1 Q5FBY2 Q5FBY4 Q7Z5G6,Interferon regulatory factor 3 {ECO:0000303|PubMed:9566918, ECO:0000303|PubMed:9803267},, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0001227;GO:0042802;GO:0019904;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0006915;GO:0006974;GO:0071360;GO:0098586;GO:0051607;GO:0002376;GO:0060333;GO:0031663;GO:0071888;GO:0039530;GO:0032480;GO:0043123;GO:0032727;GO:0032728;GO:0045944;GO:0032481;GO:0060340;GO:0097300;GO:0042981;GO:0050727;GO:0006357;GO:0032479;GO:0035666;GO:0060337;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein domain specific binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to exogenous dsRNA; P:cellular response to virus; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:macrophage apoptotic process; P:MDA-5 signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:programmed necrotic cell death; P:regulation of apoptotic process; P:regulation of inflammatory response; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production; P:TRIF-dependent toll-like receptor signaling pathway; P:type I interferon signaling pathway; P:viral process;|Q14653 A8K7L2 B2RAZ3 Q5FBY1 Q5FBY2 Q5FBY4 Q7Z5G6,Interferon regulatory factor 3 {ECO:0000303|PubMed:9566918, ECO:0000303|PubMed:9803267},, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0001227;GO:0042802;GO:0019904;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0006915;GO:0006974;GO:0071360;GO:0098586;GO:0051607;GO:0002376;GO:0060333;GO:0031663;GO:0071888;GO:0039530;GO:0032480;GO:0043123;GO:0032727;GO:0032728;GO:0045944;GO:0032481;GO:0060340;GO:0097300;GO:0042981;GO:0050727;GO:0006357;GO:0032479;GO:0035666;GO:0060337;GO:0016032;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:protein domain specific binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:apoptotic process; P:cellular response to DNA damage stimulus; P:cellular response to exogenous dsRNA; P:cellular response to virus; P:defense response to virus; P:immune system process; P:interferon-gamma-mediated signaling pathway; P:lipopolysaccharide-mediated signaling pathway; P:macrophage apoptotic process; P:MDA-5 signaling pathway; P:negative regulation of type I interferon production; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:programmed necrotic cell death; P:regulation of apoptotic process; P:regulation of inflammatory response; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production; P:TRIF-dependent toll-like receptor signaling pathway; P:type I interferon signaling pathway; P:viral process; scaffold216 indexed_genome mRNA 171923 183688 . - . ID=transcript_15905;Q9H7N4 Q7Z5V7 Q8WVA1 Q9NR59,Splicing factor, arginine/serine-rich 19,SR-related C-terminal domain-associated factor 1;SR-related-CTD-associated factor;Serine arginine-rich pre-mRNA splicing factor SR-A1;, , GO:0005634;GO:0019904;GO:0003723;GO:0099122;GO:0006397;GO:0008380;GO:0006366;, C:nucleus;, F:protein domain specific binding; F:RNA binding; F:RNA polymerase II C-terminal domain binding;, P:mRNA processing; P:RNA splicing; P:transcription by RNA polymerase II;|Q9H7N4 Q7Z5V7 Q8WVA1 Q9NR59,Splicing factor, arginine/serine-rich 19,SR-related C-terminal domain-associated factor 1;SR-related-CTD-associated factor;Serine arginine-rich pre-mRNA splicing factor SR-A1;, , GO:0005634;GO:0019904;GO:0003723;GO:0099122;GO:0006397;GO:0008380;GO:0006366;, C:nucleus;, F:protein domain specific binding; F:RNA binding; F:RNA polymerase II C-terminal domain binding;, P:mRNA processing; P:RNA splicing; P:transcription by RNA polymerase II;|Q9H7N4 Q7Z5V7 Q8WVA1 Q9NR59,Splicing factor, arginine/serine-rich 19,SR-related C-terminal domain-associated factor 1;SR-related-CTD-associated factor;Serine arginine-rich pre-mRNA splicing factor SR-A1;, , GO:0005634;GO:0019904;GO:0003723;GO:0099122;GO:0006397;GO:0008380;GO:0006366;, C:nucleus;, F:protein domain specific binding; F:RNA binding; F:RNA polymerase II C-terminal domain binding;, P:mRNA processing; P:RNA splicing; P:transcription by RNA polymerase II; scaffold216 indexed_genome mRNA 187113 190799 . + . ID=transcript_15906;P10301 Q6FH12,Ras-related protein R-Ras,p23;, PF00071;, GO:0070062;GO:0005925;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0044877;GO:0060325;GO:0002521;GO:0030336;GO:0045766;GO:0010595;GO:1904906;GO:2001214;GO:0007265;GO:0070372;GO:0051896;, C:extracellular exosome; C:focal adhesion; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:protein-containing complex binding;, P:face morphogenesis; P:leukocyte differentiation; P:negative regulation of cell migration; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell-matrix adhesion via fibronectin; P:positive regulation of vasculogenesis; P:Ras protein signal transduction; P:regulation of ERK1 and ERK2 cascade; P:regulation of protein kinase B signaling;|P10301 Q6FH12,Ras-related protein R-Ras,p23;, PF00071;, GO:0070062;GO:0005925;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0044877;GO:0060325;GO:0002521;GO:0030336;GO:0045766;GO:0010595;GO:1904906;GO:2001214;GO:0007265;GO:0070372;GO:0051896;, C:extracellular exosome; C:focal adhesion; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:protein-containing complex binding;, P:face morphogenesis; P:leukocyte differentiation; P:negative regulation of cell migration; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell-matrix adhesion via fibronectin; P:positive regulation of vasculogenesis; P:Ras protein signal transduction; P:regulation of ERK1 and ERK2 cascade; P:regulation of protein kinase B signaling;|P10301 Q6FH12,Ras-related protein R-Ras,p23;, PF00071;, GO:0070062;GO:0005925;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0044877;GO:0060325;GO:0002521;GO:0030336;GO:0045766;GO:0010595;GO:1904906;GO:2001214;GO:0007265;GO:0070372;GO:0051896;, C:extracellular exosome; C:focal adhesion; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:protein-containing complex binding;, P:face morphogenesis; P:leukocyte differentiation; P:negative regulation of cell migration; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell-matrix adhesion via fibronectin; P:positive regulation of vasculogenesis; P:Ras protein signal transduction; P:regulation of ERK1 and ERK2 cascade; P:regulation of protein kinase B signaling; scaffold216 indexed_genome mRNA 194821 215420 . - . ID=transcript_15907;Q9ULL5 E9PB06 Q8N4J6,Proline-rich protein 12,, PF13926;, GO:0043005;GO:0005634;GO:0014069;, C:neuron projection; C:nucleus; C:postsynaptic density; scaffold216 indexed_genome mRNA 215821 225736 . - . ID=transcript_15908;Q9ULL5 E9PB06 Q8N4J6,Proline-rich protein 12,, PF13926;, GO:0043005;GO:0005634;GO:0014069;, C:neuron projection; C:nucleus; C:postsynaptic density; scaffold216 indexed_genome mRNA 225962 227818 . - . ID=transcript_15909;O14669 Q6IBF8,Transmembrane gamma-carboxyglutamic acid protein 2,Proline-rich gamma-carboxyglutamic acid protein 2;, PF00594;, GO:0005615;GO:0005887;GO:0005886;GO:0005509;, C:extracellular space; C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; scaffold216 indexed_genome mRNA 232469 241808 . + . ID=transcript_15910;Q9Y314 Q96FD2,Nitric oxide synthase-interacting protein,E3 ubiquitin-protein ligase NOSIP;RING-type E3 ubiquitin transferase NOSIP {ECO:0000305};eNOS-interacting protein;, PF15906;, GO:0005737;GO:0005829;GO:0000139;GO:0005654;GO:0005634;GO:0003723;GO:0061630;GO:0007275;GO:0043086;GO:0051001;GO:0050999;, C:cytoplasm; C:cytosol; C:Golgi membrane; C:nucleoplasm; C:nucleus;, F:RNA binding; F:ubiquitin protein ligase activity;, P:multicellular organism development; P:negative regulation of catalytic activity; P:negative regulation of nitric-oxide synthase activity; P:regulation of nitric-oxide synthase activity;|Q9Y314 Q96FD2,Nitric oxide synthase-interacting protein,E3 ubiquitin-protein ligase NOSIP;RING-type E3 ubiquitin transferase NOSIP {ECO:0000305};eNOS-interacting protein;, PF15906;, GO:0005737;GO:0005829;GO:0000139;GO:0005654;GO:0005634;GO:0003723;GO:0061630;GO:0007275;GO:0043086;GO:0051001;GO:0050999;, C:cytoplasm; C:cytosol; C:Golgi membrane; C:nucleoplasm; C:nucleus;, F:RNA binding; F:ubiquitin protein ligase activity;, P:multicellular organism development; P:negative regulation of catalytic activity; P:negative regulation of nitric-oxide synthase activity; P:regulation of nitric-oxide synthase activity;|Q9Y314 Q96FD2,Nitric oxide synthase-interacting protein,E3 ubiquitin-protein ligase NOSIP;RING-type E3 ubiquitin transferase NOSIP {ECO:0000305};eNOS-interacting protein;, PF15906;, GO:0005737;GO:0005829;GO:0000139;GO:0005654;GO:0005634;GO:0003723;GO:0061630;GO:0007275;GO:0043086;GO:0051001;GO:0050999;, C:cytoplasm; C:cytosol; C:Golgi membrane; C:nucleoplasm; C:nucleus;, F:RNA binding; F:ubiquitin protein ligase activity;, P:multicellular organism development; P:negative regulation of catalytic activity; P:negative regulation of nitric-oxide synthase activity; P:regulation of nitric-oxide synthase activity; scaffold216 indexed_genome mRNA 242233 243539 . - . ID=transcript_15911;Q9Y314 Q96FD2,Nitric oxide synthase-interacting protein,E3 ubiquitin-protein ligase NOSIP;RING-type E3 ubiquitin transferase NOSIP {ECO:0000305};eNOS-interacting protein;, PF15906;, GO:0005737;GO:0005829;GO:0000139;GO:0005654;GO:0005634;GO:0003723;GO:0061630;GO:0007275;GO:0043086;GO:0051001;GO:0050999;, C:cytoplasm; C:cytosol; C:Golgi membrane; C:nucleoplasm; C:nucleus;, F:RNA binding; F:ubiquitin protein ligase activity;, P:multicellular organism development; P:negative regulation of catalytic activity; P:negative regulation of nitric-oxide synthase activity; P:regulation of nitric-oxide synthase activity;|Q9Y314 Q96FD2,Nitric oxide synthase-interacting protein,E3 ubiquitin-protein ligase NOSIP;RING-type E3 ubiquitin transferase NOSIP {ECO:0000305};eNOS-interacting protein;, PF15906;, GO:0005737;GO:0005829;GO:0000139;GO:0005654;GO:0005634;GO:0003723;GO:0061630;GO:0007275;GO:0043086;GO:0051001;GO:0050999;, C:cytoplasm; C:cytosol; C:Golgi membrane; C:nucleoplasm; C:nucleus;, F:RNA binding; F:ubiquitin protein ligase activity;, P:multicellular organism development; P:negative regulation of catalytic activity; P:negative regulation of nitric-oxide synthase activity; P:regulation of nitric-oxide synthase activity; scaffold216 indexed_genome mRNA 252590 272400 . - . ID=transcript_15912;Q96D15 Q9HBZ8,Reticulocalbin-3 {ECO:0000305},EF-hand calcium-binding protein RLP49;, PF13202;, GO:0005783;GO:0005788;GO:0043231;GO:0005509;GO:0032964;GO:0036503;GO:0060428;GO:0055091;GO:0010952;GO:0009306;GO:0015031;GO:0051896;GO:0043129;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:intracellular membrane-bounded organelle;, F:calcium ion binding;, P:collagen biosynthetic process; P:ERAD pathway; P:lung epithelium development; P:phospholipid homeostasis; P:positive regulation of peptidase activity; P:protein secretion; P:protein transport; P:regulation of protein kinase B signaling; P:surfactant homeostasis; scaffold216 indexed_genome mRNA 281528 283806 . - . ID=transcript_15913;P62280 B2R4F5 P04643 Q498Y6 Q6IRY0,40S ribosomal protein S11,Small ribosomal subunit protein uS17 {ECO:0000303|PubMed:24524803};, PF00366;PF16205;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005840;GO:0003723;GO:0019843;GO:0003735;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:ribosome;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P62280 B2R4F5 P04643 Q498Y6 Q6IRY0,40S ribosomal protein S11,Small ribosomal subunit protein uS17 {ECO:0000303|PubMed:24524803};, PF00366;PF16205;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005840;GO:0003723;GO:0019843;GO:0003735;GO:0000184;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:ribosome;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold216 indexed_genome mRNA 289035 296043 . - . ID=transcript_15914;P40429 A8K505,60S ribosomal protein L13a,23 kDa highly basic protein;Large ribosomal subunit protein uL13 {ECO:0000303|PubMed:24524803};, PF00572;, GO:0005737;GO:0005829;GO:0022625;GO:0005925;GO:0097452;GO:0015934;GO:0016020;GO:0005730;GO:0005634;GO:1990904;GO:0005840;GO:0003729;GO:0003723;GO:0003735;GO:0071346;GO:1901194;GO:0017148;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic large ribosomal subunit; C:focal adhesion; C:GAIT complex; C:large ribosomal subunit; C:membrane; C:nucleolus; C:nucleus; C:ribonucleoprotein complex; C:ribosome;, F:mRNA binding; F:RNA binding; F:structural constituent of ribosome;, P:cellular response to interferon-gamma; P:negative regulation of formation of translation preinitiation complex; P:negative regulation of translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold216 indexed_genome mRNA 297278 308492 . - . ID=transcript_15915;P49771 A0AVC2 B9EGH2 Q05C96,Fms-related tyrosine kinase 3 ligand,SL cytokine;, PF02947;, GO:0009986;GO:0005829;GO:0005576;GO:0005615;GO:0016021;GO:0016020;GO:0005886;GO:0005125;GO:0030971;GO:0005102;GO:0019221;GO:0035162;GO:0000165;GO:0008284;GO:0032819;GO:0051897;GO:0007165;, C:cell surface; C:cytosol; C:extracellular region; C:extracellular space; C:integral component of membrane; C:membrane; C:plasma membrane;, F:cytokine activity; F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:cytokine-mediated signaling pathway; P:embryonic hemopoiesis; P:MAPK cascade; P:positive regulation of cell population proliferation; P:positive regulation of natural killer cell proliferation; P:positive regulation of protein kinase B signaling; P:signal transduction; scaffold216 indexed_genome mRNA 314424 328937 . - . ID=transcript_15916;Q8IZ83 B4DLQ1 C9JBH6 Q86YF0 Q8IYL4 Q8TEI8,Aldehyde dehydrogenase family 16 member A1,, PF00171;, GO:0016020;GO:0016620;, C:membrane;, F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor;|Q8IZ83 B4DLQ1 C9JBH6 Q86YF0 Q8IYL4 Q8TEI8,Aldehyde dehydrogenase family 16 member A1,, PF00171;, GO:0016020;GO:0016620;, C:membrane;, F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; scaffold216 indexed_genome mRNA 329883 335122 . + . ID=transcript_15917;Q9NWS0 B4DGN7 B4E2X7 Q9BVL0,PIH1 domain-containing protein 1,Nucleolar protein 17 homolog;, PF08190;PF18201;, GO:0005737;GO:0005730;GO:0005634;GO:0070761;GO:0097255;GO:1990904;GO:0051117;GO:0042393;GO:0051219;GO:0019901;GO:0001164;GO:0000492;GO:0006338;GO:0030855;GO:0071169;GO:2001268;GO:1900110;GO:1900113;GO:2000619;GO:1902661;GO:2000617;GO:0090240;GO:0071902;GO:0031334;GO:1904263;GO:1901838;GO:0051569;GO:0006364;GO:0048254;, C:cytoplasm; C:nucleolus; C:nucleus; C:pre-snoRNP complex; C:R2TP complex; C:ribonucleoprotein complex;, F:ATPase binding; F:histone binding; F:phosphoprotein binding; F:protein kinase binding; F:RNA polymerase I core promoter sequence-specific DNA binding;, P:box C/D snoRNP assembly; P:chromatin remodeling; P:epithelial cell differentiation; P:establishment of protein localization to chromatin; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of histone H3-K9 dimethylation; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of histone H4-K16 acetylation; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of TORC1 signaling; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:regulation of histone H3-K4 methylation; P:rRNA processing; P:snoRNA localization;|Q9NWS0 B4DGN7 B4E2X7 Q9BVL0,PIH1 domain-containing protein 1,Nucleolar protein 17 homolog;, PF08190;PF18201;, GO:0005737;GO:0005730;GO:0005634;GO:0070761;GO:0097255;GO:1990904;GO:0051117;GO:0042393;GO:0051219;GO:0019901;GO:0001164;GO:0000492;GO:0006338;GO:0030855;GO:0071169;GO:2001268;GO:1900110;GO:1900113;GO:2000619;GO:1902661;GO:2000617;GO:0090240;GO:0071902;GO:0031334;GO:1904263;GO:1901838;GO:0051569;GO:0006364;GO:0048254;, C:cytoplasm; C:nucleolus; C:nucleus; C:pre-snoRNP complex; C:R2TP complex; C:ribonucleoprotein complex;, F:ATPase binding; F:histone binding; F:phosphoprotein binding; F:protein kinase binding; F:RNA polymerase I core promoter sequence-specific DNA binding;, P:box C/D snoRNP assembly; P:chromatin remodeling; P:epithelial cell differentiation; P:establishment of protein localization to chromatin; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of histone H3-K9 dimethylation; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of histone H4-K16 acetylation; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of TORC1 signaling; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:regulation of histone H3-K4 methylation; P:rRNA processing; P:snoRNA localization;|Q9NWS0 B4DGN7 B4E2X7 Q9BVL0,PIH1 domain-containing protein 1,Nucleolar protein 17 homolog;, PF08190;PF18201;, GO:0005737;GO:0005730;GO:0005634;GO:0070761;GO:0097255;GO:1990904;GO:0051117;GO:0042393;GO:0051219;GO:0019901;GO:0001164;GO:0000492;GO:0006338;GO:0030855;GO:0071169;GO:2001268;GO:1900110;GO:1900113;GO:2000619;GO:1902661;GO:2000617;GO:0090240;GO:0071902;GO:0031334;GO:1904263;GO:1901838;GO:0051569;GO:0006364;GO:0048254;, C:cytoplasm; C:nucleolus; C:nucleus; C:pre-snoRNP complex; C:R2TP complex; C:ribonucleoprotein complex;, F:ATPase binding; F:histone binding; F:phosphoprotein binding; F:protein kinase binding; F:RNA polymerase I core promoter sequence-specific DNA binding;, P:box C/D snoRNP assembly; P:chromatin remodeling; P:epithelial cell differentiation; P:establishment of protein localization to chromatin; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of histone H3-K9 dimethylation; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of histone H4-K16 acetylation; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of TORC1 signaling; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:regulation of histone H3-K4 methylation; P:rRNA processing; P:snoRNA localization;|Q9NWS0 B4DGN7 B4E2X7 Q9BVL0,PIH1 domain-containing protein 1,Nucleolar protein 17 homolog;, PF08190;PF18201;, GO:0005737;GO:0005730;GO:0005634;GO:0070761;GO:0097255;GO:1990904;GO:0051117;GO:0042393;GO:0051219;GO:0019901;GO:0001164;GO:0000492;GO:0006338;GO:0030855;GO:0071169;GO:2001268;GO:1900110;GO:1900113;GO:2000619;GO:1902661;GO:2000617;GO:0090240;GO:0071902;GO:0031334;GO:1904263;GO:1901838;GO:0051569;GO:0006364;GO:0048254;, C:cytoplasm; C:nucleolus; C:nucleus; C:pre-snoRNP complex; C:R2TP complex; C:ribonucleoprotein complex;, F:ATPase binding; F:histone binding; F:phosphoprotein binding; F:protein kinase binding; F:RNA polymerase I core promoter sequence-specific DNA binding;, P:box C/D snoRNP assembly; P:chromatin remodeling; P:epithelial cell differentiation; P:establishment of protein localization to chromatin; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of histone H3-K9 dimethylation; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of histone H4-K16 acetylation; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of TORC1 signaling; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:regulation of histone H3-K4 methylation; P:rRNA processing; P:snoRNA localization;|Q9NWS0 B4DGN7 B4E2X7 Q9BVL0,PIH1 domain-containing protein 1,Nucleolar protein 17 homolog;, PF08190;PF18201;, GO:0005737;GO:0005730;GO:0005634;GO:0070761;GO:0097255;GO:1990904;GO:0051117;GO:0042393;GO:0051219;GO:0019901;GO:0001164;GO:0000492;GO:0006338;GO:0030855;GO:0071169;GO:2001268;GO:1900110;GO:1900113;GO:2000619;GO:1902661;GO:2000617;GO:0090240;GO:0071902;GO:0031334;GO:1904263;GO:1901838;GO:0051569;GO:0006364;GO:0048254;, C:cytoplasm; C:nucleolus; C:nucleus; C:pre-snoRNP complex; C:R2TP complex; C:ribonucleoprotein complex;, F:ATPase binding; F:histone binding; F:phosphoprotein binding; F:protein kinase binding; F:RNA polymerase I core promoter sequence-specific DNA binding;, P:box C/D snoRNP assembly; P:chromatin remodeling; P:epithelial cell differentiation; P:establishment of protein localization to chromatin; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:negative regulation of histone H3-K9 dimethylation; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of histone H4-K16 acetylation; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of histone H3-K9 acetylation; P:positive regulation of histone H4 acetylation; P:positive regulation of protein serine/threonine kinase activity; P:positive regulation of protein-containing complex assembly; P:positive regulation of TORC1 signaling; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:regulation of histone H3-K4 methylation; P:rRNA processing; P:snoRNA localization; scaffold216 indexed_genome mRNA 338028 343569 . + . ID=transcript_15918;Q9P2U7 B4DFR9 B4DG46 Q6PCD0,Vesicular glutamate transporter 1,Brain-specific Na(+)-dependent inorganic phosphate cotransporter;Solute carrier family 17 member 7;, PF07690;, GO:0060203;GO:0060076;GO:0016021;GO:0030285;GO:0043229;GO:0043005;GO:0005886;GO:0048786;GO:0030672;GO:0005313;GO:0005326;GO:0015319;GO:0005436;GO:0022857;GO:0006820;GO:0007420;GO:0006811;GO:0003407;GO:0098700;GO:0006836;GO:0006817;GO:0050803;GO:1900242;GO:0035249;, C:clathrin-sculpted glutamate transport vesicle membrane; C:excitatory synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular organelle; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:sodium:inorganic phosphate symporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:brain development; P:ion transport; P:neural retina development; P:neurotransmitter loading into synaptic vesicle; P:neurotransmitter transport; P:phosphate ion transport; P:regulation of synapse structure or activity; P:regulation of synaptic vesicle endocytosis; P:synaptic transmission, glutamatergic;|Q9P2U7 B4DFR9 B4DG46 Q6PCD0,Vesicular glutamate transporter 1,Brain-specific Na(+)-dependent inorganic phosphate cotransporter;Solute carrier family 17 member 7;, PF07690;, GO:0060203;GO:0060076;GO:0016021;GO:0030285;GO:0043229;GO:0043005;GO:0005886;GO:0048786;GO:0030672;GO:0005313;GO:0005326;GO:0015319;GO:0005436;GO:0022857;GO:0006820;GO:0007420;GO:0006811;GO:0003407;GO:0098700;GO:0006836;GO:0006817;GO:0050803;GO:1900242;GO:0035249;, C:clathrin-sculpted glutamate transport vesicle membrane; C:excitatory synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular organelle; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:sodium:inorganic phosphate symporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:brain development; P:ion transport; P:neural retina development; P:neurotransmitter loading into synaptic vesicle; P:neurotransmitter transport; P:phosphate ion transport; P:regulation of synapse structure or activity; P:regulation of synaptic vesicle endocytosis; P:synaptic transmission, glutamatergic; scaffold216 indexed_genome mRNA 343573 349402 . + . ID=transcript_15919;Q9P2U7 B4DFR9 B4DG46 Q6PCD0,Vesicular glutamate transporter 1,Brain-specific Na(+)-dependent inorganic phosphate cotransporter;Solute carrier family 17 member 7;, PF07690;, GO:0060203;GO:0060076;GO:0016021;GO:0030285;GO:0043229;GO:0043005;GO:0005886;GO:0048786;GO:0030672;GO:0005313;GO:0005326;GO:0015319;GO:0005436;GO:0022857;GO:0006820;GO:0007420;GO:0006811;GO:0003407;GO:0098700;GO:0006836;GO:0006817;GO:0050803;GO:1900242;GO:0035249;, C:clathrin-sculpted glutamate transport vesicle membrane; C:excitatory synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular organelle; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:sodium:inorganic phosphate symporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:brain development; P:ion transport; P:neural retina development; P:neurotransmitter loading into synaptic vesicle; P:neurotransmitter transport; P:phosphate ion transport; P:regulation of synapse structure or activity; P:regulation of synaptic vesicle endocytosis; P:synaptic transmission, glutamatergic;|Q9P2U7 B4DFR9 B4DG46 Q6PCD0,Vesicular glutamate transporter 1,Brain-specific Na(+)-dependent inorganic phosphate cotransporter;Solute carrier family 17 member 7;, PF07690;, GO:0060203;GO:0060076;GO:0016021;GO:0030285;GO:0043229;GO:0043005;GO:0005886;GO:0048786;GO:0030672;GO:0005313;GO:0005326;GO:0015319;GO:0005436;GO:0022857;GO:0006820;GO:0007420;GO:0006811;GO:0003407;GO:0098700;GO:0006836;GO:0006817;GO:0050803;GO:1900242;GO:0035249;, C:clathrin-sculpted glutamate transport vesicle membrane; C:excitatory synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular organelle; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:sodium:inorganic phosphate symporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:brain development; P:ion transport; P:neural retina development; P:neurotransmitter loading into synaptic vesicle; P:neurotransmitter transport; P:phosphate ion transport; P:regulation of synapse structure or activity; P:regulation of synaptic vesicle endocytosis; P:synaptic transmission, glutamatergic;|Q9P2U7 B4DFR9 B4DG46 Q6PCD0,Vesicular glutamate transporter 1,Brain-specific Na(+)-dependent inorganic phosphate cotransporter;Solute carrier family 17 member 7;, PF07690;, GO:0060203;GO:0060076;GO:0016021;GO:0030285;GO:0043229;GO:0043005;GO:0005886;GO:0048786;GO:0030672;GO:0005313;GO:0005326;GO:0015319;GO:0005436;GO:0022857;GO:0006820;GO:0007420;GO:0006811;GO:0003407;GO:0098700;GO:0006836;GO:0006817;GO:0050803;GO:1900242;GO:0035249;, C:clathrin-sculpted glutamate transport vesicle membrane; C:excitatory synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular organelle; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:sodium:inorganic phosphate symporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:brain development; P:ion transport; P:neural retina development; P:neurotransmitter loading into synaptic vesicle; P:neurotransmitter transport; P:phosphate ion transport; P:regulation of synapse structure or activity; P:regulation of synaptic vesicle endocytosis; P:synaptic transmission, glutamatergic;|Q9P2U7 B4DFR9 B4DG46 Q6PCD0,Vesicular glutamate transporter 1,Brain-specific Na(+)-dependent inorganic phosphate cotransporter;Solute carrier family 17 member 7;, PF07690;, GO:0060203;GO:0060076;GO:0016021;GO:0030285;GO:0043229;GO:0043005;GO:0005886;GO:0048786;GO:0030672;GO:0005313;GO:0005326;GO:0015319;GO:0005436;GO:0022857;GO:0006820;GO:0007420;GO:0006811;GO:0003407;GO:0098700;GO:0006836;GO:0006817;GO:0050803;GO:1900242;GO:0035249;, C:clathrin-sculpted glutamate transport vesicle membrane; C:excitatory synapse; C:integral component of membrane; C:integral component of synaptic vesicle membrane; C:intracellular organelle; C:neuron projection; C:plasma membrane; C:presynaptic active zone; C:synaptic vesicle membrane;, F:L-glutamate transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:sodium:inorganic phosphate symporter activity; F:sodium:phosphate symporter activity; F:transmembrane transporter activity;, P:anion transport; P:brain development; P:ion transport; P:neural retina development; P:neurotransmitter loading into synaptic vesicle; P:neurotransmitter transport; P:phosphate ion transport; P:regulation of synapse structure or activity; P:regulation of synaptic vesicle endocytosis; P:synaptic transmission, glutamatergic; scaffold216 indexed_genome mRNA 354936 356719 . + . ID=transcript_15920;Q96A98 Q96DJ4,Tuberoinfundibular peptide of 39 residues,Parathyroid hormone 2;, PF14980;, GO:0005576;GO:0007186;GO:0002862;GO:0007218;, C:extracellular region;, , P:G protein-coupled receptor signaling pathway; P:negative regulation of inflammatory response to antigenic stimulus; P:neuropeptide signaling pathway; scaffold216 indexed_genome mRNA 356742 382408 . - . ID=transcript_15921;Q8N6L0 Q96MC3,Protein KASH5 {ECO:0000305},Coiled-coil domain-containing protein 155;KASH domain-containing protein 5;, PF14658;PF14662;, GO:0000781;GO:0016021;GO:0000800;GO:0034993;GO:0090619;GO:0005640;GO:0070840;GO:0042802;GO:0007015;GO:0090220;GO:0000724;GO:0007129;GO:0090172;GO:0048477;GO:0007283;GO:0051225;GO:0051653;GO:0034397;, C:chromosome, telomeric region; C:integral component of membrane; C:lateral element; C:meiotic nuclear membrane microtubule tethering complex; C:meiotic spindle pole; C:nuclear outer membrane;, F:dynein complex binding; F:identical protein binding;, P:actin filament organization; P:chromosome localization to nuclear envelope involved in homologous chromosome segregation; P:double-strand break repair via homologous recombination; P:homologous chromosome pairing at meiosis; P:microtubule cytoskeleton organization involved in homologous chromosome segregation; P:oogenesis; P:spermatogenesis; P:spindle assembly; P:spindle localization; P:telomere localization;|Q8N6L0 Q96MC3,Protein KASH5 {ECO:0000305},Coiled-coil domain-containing protein 155;KASH domain-containing protein 5;, PF14658;PF14662;, GO:0000781;GO:0016021;GO:0000800;GO:0034993;GO:0090619;GO:0005640;GO:0070840;GO:0042802;GO:0007015;GO:0090220;GO:0000724;GO:0007129;GO:0090172;GO:0048477;GO:0007283;GO:0051225;GO:0051653;GO:0034397;, C:chromosome, telomeric region; C:integral component of membrane; C:lateral element; C:meiotic nuclear membrane microtubule tethering complex; C:meiotic spindle pole; C:nuclear outer membrane;, F:dynein complex binding; F:identical protein binding;, P:actin filament organization; P:chromosome localization to nuclear envelope involved in homologous chromosome segregation; P:double-strand break repair via homologous recombination; P:homologous chromosome pairing at meiosis; P:microtubule cytoskeleton organization involved in homologous chromosome segregation; P:oogenesis; P:spermatogenesis; P:spindle assembly; P:spindle localization; P:telomere localization;|Q8N6L0 Q96MC3,Protein KASH5 {ECO:0000305},Coiled-coil domain-containing protein 155;KASH domain-containing protein 5;, PF14658;PF14662;, GO:0000781;GO:0016021;GO:0000800;GO:0034993;GO:0090619;GO:0005640;GO:0070840;GO:0042802;GO:0007015;GO:0090220;GO:0000724;GO:0007129;GO:0090172;GO:0048477;GO:0007283;GO:0051225;GO:0051653;GO:0034397;, C:chromosome, telomeric region; C:integral component of membrane; C:lateral element; C:meiotic nuclear membrane microtubule tethering complex; C:meiotic spindle pole; C:nuclear outer membrane;, F:dynein complex binding; F:identical protein binding;, P:actin filament organization; P:chromosome localization to nuclear envelope involved in homologous chromosome segregation; P:double-strand break repair via homologous recombination; P:homologous chromosome pairing at meiosis; P:microtubule cytoskeleton organization involved in homologous chromosome segregation; P:oogenesis; P:spermatogenesis; P:spindle assembly; P:spindle localization; P:telomere localization;|Q8N6L0 Q96MC3,Protein KASH5 {ECO:0000305},Coiled-coil domain-containing protein 155;KASH domain-containing protein 5;, PF14658;PF14662;, GO:0000781;GO:0016021;GO:0000800;GO:0034993;GO:0090619;GO:0005640;GO:0070840;GO:0042802;GO:0007015;GO:0090220;GO:0000724;GO:0007129;GO:0090172;GO:0048477;GO:0007283;GO:0051225;GO:0051653;GO:0034397;, C:chromosome, telomeric region; C:integral component of membrane; C:lateral element; C:meiotic nuclear membrane microtubule tethering complex; C:meiotic spindle pole; C:nuclear outer membrane;, F:dynein complex binding; F:identical protein binding;, P:actin filament organization; P:chromosome localization to nuclear envelope involved in homologous chromosome segregation; P:double-strand break repair via homologous recombination; P:homologous chromosome pairing at meiosis; P:microtubule cytoskeleton organization involved in homologous chromosome segregation; P:oogenesis; P:spermatogenesis; P:spindle assembly; P:spindle localization; P:telomere localization;|Q8N6L0 Q96MC3,Protein KASH5 {ECO:0000305},Coiled-coil domain-containing protein 155;KASH domain-containing protein 5;, PF14658;PF14662;, GO:0000781;GO:0016021;GO:0000800;GO:0034993;GO:0090619;GO:0005640;GO:0070840;GO:0042802;GO:0007015;GO:0090220;GO:0000724;GO:0007129;GO:0090172;GO:0048477;GO:0007283;GO:0051225;GO:0051653;GO:0034397;, C:chromosome, telomeric region; C:integral component of membrane; C:lateral element; C:meiotic nuclear membrane microtubule tethering complex; C:meiotic spindle pole; C:nuclear outer membrane;, F:dynein complex binding; F:identical protein binding;, P:actin filament organization; P:chromosome localization to nuclear envelope involved in homologous chromosome segregation; P:double-strand break repair via homologous recombination; P:homologous chromosome pairing at meiosis; P:microtubule cytoskeleton organization involved in homologous chromosome segregation; P:oogenesis; P:spermatogenesis; P:spindle assembly; P:spindle localization; P:telomere localization;|Q8N6L0 Q96MC3,Protein KASH5 {ECO:0000305},Coiled-coil domain-containing protein 155;KASH domain-containing protein 5;, PF14658;PF14662;, GO:0000781;GO:0016021;GO:0000800;GO:0034993;GO:0090619;GO:0005640;GO:0070840;GO:0042802;GO:0007015;GO:0090220;GO:0000724;GO:0007129;GO:0090172;GO:0048477;GO:0007283;GO:0051225;GO:0051653;GO:0034397;, C:chromosome, telomeric region; C:integral component of membrane; C:lateral element; C:meiotic nuclear membrane microtubule tethering complex; C:meiotic spindle pole; C:nuclear outer membrane;, F:dynein complex binding; F:identical protein binding;, P:actin filament organization; P:chromosome localization to nuclear envelope involved in homologous chromosome segregation; P:double-strand break repair via homologous recombination; P:homologous chromosome pairing at meiosis; P:microtubule cytoskeleton organization involved in homologous chromosome segregation; P:oogenesis; P:spermatogenesis; P:spindle assembly; P:spindle localization; P:telomere localization;|Q8N6L0 Q96MC3,Protein KASH5 {ECO:0000305},Coiled-coil domain-containing protein 155;KASH domain-containing protein 5;, PF14658;PF14662;, GO:0000781;GO:0016021;GO:0000800;GO:0034993;GO:0090619;GO:0005640;GO:0070840;GO:0042802;GO:0007015;GO:0090220;GO:0000724;GO:0007129;GO:0090172;GO:0048477;GO:0007283;GO:0051225;GO:0051653;GO:0034397;, C:chromosome, telomeric region; C:integral component of membrane; C:lateral element; C:meiotic nuclear membrane microtubule tethering complex; C:meiotic spindle pole; C:nuclear outer membrane;, F:dynein complex binding; F:identical protein binding;, P:actin filament organization; P:chromosome localization to nuclear envelope involved in homologous chromosome segregation; P:double-strand break repair via homologous recombination; P:homologous chromosome pairing at meiosis; P:microtubule cytoskeleton organization involved in homologous chromosome segregation; P:oogenesis; P:spermatogenesis; P:spindle assembly; P:spindle localization; P:telomere localization; scaffold216 indexed_genome mRNA 396403 409865 . + . ID=transcript_15922;Q15562 B4DTJ6 M0R1T9 Q8NA25 Q96IG3,Transcriptional enhancer factor TEF-4,TEA domain family member 2;, PF01285;PF17725;, GO:0000785;GO:0005829;GO:0043231;GO:0005654;GO:0005634;GO:0140552;GO:0005667;GO:0097718;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0001223;GO:0071300;GO:0003143;GO:0048568;GO:0035329;GO:0048368;GO:0060548;GO:0001843;GO:0030903;GO:0048339;GO:0045944;GO:0045893;GO:0065003;GO:2000736;GO:0006357;GO:0006355;GO:0006367;GO:0001570;, C:chromatin; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:TEAD-YAP complex; C:transcription regulator complex;, F:disordered domain specific binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription coactivator binding;, P:cellular response to retinoic acid; P:embryonic heart tube morphogenesis; P:embryonic organ development; P:hippo signaling; P:lateral mesoderm development; P:negative regulation of cell death; P:neural tube closure; P:notochord development; P:paraxial mesoderm development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein-containing complex assembly; P:regulation of stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter; P:vasculogenesis; scaffold216 indexed_genome mRNA 409867 415015 . - . ID=transcript_15923;P11049 B4DVC1 Q3KPF9,Leukocyte antigen CD37,Tetraspanin-26;, PF00335;, GO:0070062;GO:0001772;GO:0005887;GO:0016020;, C:extracellular exosome; C:immunological synapse; C:integral component of plasma membrane; C:membrane;|P11049 B4DVC1 Q3KPF9,Leukocyte antigen CD37,Tetraspanin-26;, PF00335;, GO:0070062;GO:0001772;GO:0005887;GO:0016020;, C:extracellular exosome; C:immunological synapse; C:integral component of plasma membrane; C:membrane; scaffold216 indexed_genome mRNA 522126 525942 . - . ID=transcript_15924;Q8TD43 A2RU25 Q7Z5D9 Q96L84 Q9NXV1,Transient receptor potential cation channel subfamily M member 4,Calcium-activated non-selective cation channel 1;Long transient receptor potential channel 4;Melastatin-4;, PF00520;PF18139;, GO:0005829;GO:0005783;GO:0005794;GO:0005887;GO:0043025;GO:0005654;GO:0005886;GO:0034706;GO:0089717;GO:0044214;GO:0005524;GO:0005227;GO:0005509;GO:0005516;GO:0005261;GO:0042802;GO:0099604;GO:0002250;GO:0070588;GO:0019722;GO:0098655;GO:0071318;GO:0002407;GO:0098662;GO:0086045;GO:0086048;GO:0086047;GO:0030001;GO:0030502;GO:0045668;GO:1904179;GO:1903949;GO:0090263;GO:0008284;GO:0007204;GO:0045600;GO:0010460;GO:0035774;GO:1904199;GO:0045907;GO:0051289;GO:0016925;GO:0086091;GO:0002724;GO:0098911;GO:0098719;GO:0042310;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of plasma membrane; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:sodium channel complex; C:spanning component of membrane; C:spanning component of plasma membrane;, F:ATP binding; F:calcium activated cation channel activity; F:calcium ion binding; F:calmodulin binding; F:cation channel activity; F:identical protein binding; F:ligand-gated calcium channel activity;, P:adaptive immune response; P:calcium ion transmembrane transport; P:calcium-mediated signaling; P:cation transmembrane transport; P:cellular response to ATP; P:dendritic cell chemotaxis; P:inorganic cation transmembrane transport; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during bundle of His cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:metal ion transport; P:negative regulation of bone mineralization; P:negative regulation of osteoblast differentiation; P:positive regulation of adipose tissue development; P:positive regulation of atrial cardiac muscle cell action potential; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of fat cell differentiation; P:positive regulation of heart rate; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization; P:positive regulation of vasoconstriction; P:protein homotetramerization; P:protein sumoylation; P:regulation of heart rate by cardiac conduction; P:regulation of T cell cytokine production; P:regulation of ventricular cardiac muscle cell action potential; P:sodium ion import across plasma membrane; P:vasoconstriction;|Q8TD43 A2RU25 Q7Z5D9 Q96L84 Q9NXV1,Transient receptor potential cation channel subfamily M member 4,Calcium-activated non-selective cation channel 1;Long transient receptor potential channel 4;Melastatin-4;, PF00520;PF18139;, GO:0005829;GO:0005783;GO:0005794;GO:0005887;GO:0043025;GO:0005654;GO:0005886;GO:0034706;GO:0089717;GO:0044214;GO:0005524;GO:0005227;GO:0005509;GO:0005516;GO:0005261;GO:0042802;GO:0099604;GO:0002250;GO:0070588;GO:0019722;GO:0098655;GO:0071318;GO:0002407;GO:0098662;GO:0086045;GO:0086048;GO:0086047;GO:0030001;GO:0030502;GO:0045668;GO:1904179;GO:1903949;GO:0090263;GO:0008284;GO:0007204;GO:0045600;GO:0010460;GO:0035774;GO:1904199;GO:0045907;GO:0051289;GO:0016925;GO:0086091;GO:0002724;GO:0098911;GO:0098719;GO:0042310;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of plasma membrane; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:sodium channel complex; C:spanning component of membrane; C:spanning component of plasma membrane;, F:ATP binding; F:calcium activated cation channel activity; F:calcium ion binding; F:calmodulin binding; F:cation channel activity; F:identical protein binding; F:ligand-gated calcium channel activity;, P:adaptive immune response; P:calcium ion transmembrane transport; P:calcium-mediated signaling; P:cation transmembrane transport; P:cellular response to ATP; P:dendritic cell chemotaxis; P:inorganic cation transmembrane transport; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during bundle of His cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:metal ion transport; P:negative regulation of bone mineralization; P:negative regulation of osteoblast differentiation; P:positive regulation of adipose tissue development; P:positive regulation of atrial cardiac muscle cell action potential; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of fat cell differentiation; P:positive regulation of heart rate; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization; P:positive regulation of vasoconstriction; P:protein homotetramerization; P:protein sumoylation; P:regulation of heart rate by cardiac conduction; P:regulation of T cell cytokine production; P:regulation of ventricular cardiac muscle cell action potential; P:sodium ion import across plasma membrane; P:vasoconstriction; scaffold216 indexed_genome mRNA 526428 564657 . - . ID=transcript_15925;Q8TD43 A2RU25 Q7Z5D9 Q96L84 Q9NXV1,Transient receptor potential cation channel subfamily M member 4,Calcium-activated non-selective cation channel 1;Long transient receptor potential channel 4;Melastatin-4;, PF00520;PF18139;, GO:0005829;GO:0005783;GO:0005794;GO:0005887;GO:0043025;GO:0005654;GO:0005886;GO:0034706;GO:0089717;GO:0044214;GO:0005524;GO:0005227;GO:0005509;GO:0005516;GO:0005261;GO:0042802;GO:0099604;GO:0002250;GO:0070588;GO:0019722;GO:0098655;GO:0071318;GO:0002407;GO:0098662;GO:0086045;GO:0086048;GO:0086047;GO:0030001;GO:0030502;GO:0045668;GO:1904179;GO:1903949;GO:0090263;GO:0008284;GO:0007204;GO:0045600;GO:0010460;GO:0035774;GO:1904199;GO:0045907;GO:0051289;GO:0016925;GO:0086091;GO:0002724;GO:0098911;GO:0098719;GO:0042310;, C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of plasma membrane; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:sodium channel complex; C:spanning component of membrane; C:spanning component of plasma membrane;, F:ATP binding; F:calcium activated cation channel activity; F:calcium ion binding; F:calmodulin binding; F:cation channel activity; F:identical protein binding; F:ligand-gated calcium channel activity;, P:adaptive immune response; P:calcium ion transmembrane transport; P:calcium-mediated signaling; P:cation transmembrane transport; P:cellular response to ATP; P:dendritic cell chemotaxis; P:inorganic cation transmembrane transport; P:membrane depolarization during AV node cell action potential; P:membrane depolarization during bundle of His cell action potential; P:membrane depolarization during Purkinje myocyte cell action potential; P:metal ion transport; P:negative regulation of bone mineralization; P:negative regulation of osteoblast differentiation; P:positive regulation of adipose tissue development; P:positive regulation of atrial cardiac muscle cell action potential; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of fat cell differentiation; P:positive regulation of heart rate; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization; P:positive regulation of vasoconstriction; P:protein homotetramerization; P:protein sumoylation; P:regulation of heart rate by cardiac conduction; P:regulation of T cell cytokine production; P:regulation of ventricular cardiac muscle cell action potential; P:sodium ion import across plasma membrane; P:vasoconstriction; scaffold216 indexed_genome mRNA 566375 592158 . - . ID=transcript_15926;O75145 A8K142 Q3MJA0 Q9H8B5 Q9UEW4,Liprin-alpha-3,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3;, PF00536;PF07647;, GO:0001669;GO:0005829;GO:0098875;GO:0098978;GO:0048786;GO:0098831;GO:0007269;GO:0006836;GO:0048172;GO:0050808;GO:0016081;, C:acrosomal vesicle; C:cytosol; C:epididymosome; C:glutamatergic synapse; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component;, , P:neurotransmitter secretion; P:neurotransmitter transport; P:regulation of short-term neuronal synaptic plasticity; P:synapse organization; P:synaptic vesicle docking;|O75145 A8K142 Q3MJA0 Q9H8B5 Q9UEW4,Liprin-alpha-3,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3;, PF00536;PF07647;, GO:0001669;GO:0005829;GO:0098875;GO:0098978;GO:0048786;GO:0098831;GO:0007269;GO:0006836;GO:0048172;GO:0050808;GO:0016081;, C:acrosomal vesicle; C:cytosol; C:epididymosome; C:glutamatergic synapse; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component;, , P:neurotransmitter secretion; P:neurotransmitter transport; P:regulation of short-term neuronal synaptic plasticity; P:synapse organization; P:synaptic vesicle docking;|O75145 A8K142 Q3MJA0 Q9H8B5 Q9UEW4,Liprin-alpha-3,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3;, PF00536;PF07647;, GO:0001669;GO:0005829;GO:0098875;GO:0098978;GO:0048786;GO:0098831;GO:0007269;GO:0006836;GO:0048172;GO:0050808;GO:0016081;, C:acrosomal vesicle; C:cytosol; C:epididymosome; C:glutamatergic synapse; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component;, , P:neurotransmitter secretion; P:neurotransmitter transport; P:regulation of short-term neuronal synaptic plasticity; P:synapse organization; P:synaptic vesicle docking;|O75145 A8K142 Q3MJA0 Q9H8B5 Q9UEW4,Liprin-alpha-3,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3;, PF00536;PF07647;, GO:0001669;GO:0005829;GO:0098875;GO:0098978;GO:0048786;GO:0098831;GO:0007269;GO:0006836;GO:0048172;GO:0050808;GO:0016081;, C:acrosomal vesicle; C:cytosol; C:epididymosome; C:glutamatergic synapse; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component;, , P:neurotransmitter secretion; P:neurotransmitter transport; P:regulation of short-term neuronal synaptic plasticity; P:synapse organization; P:synaptic vesicle docking;|O75145 A8K142 Q3MJA0 Q9H8B5 Q9UEW4,Liprin-alpha-3,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3;, PF00536;PF07647;, GO:0001669;GO:0005829;GO:0098875;GO:0098978;GO:0048786;GO:0098831;GO:0007269;GO:0006836;GO:0048172;GO:0050808;GO:0016081;, C:acrosomal vesicle; C:cytosol; C:epididymosome; C:glutamatergic synapse; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component;, , P:neurotransmitter secretion; P:neurotransmitter transport; P:regulation of short-term neuronal synaptic plasticity; P:synapse organization; P:synaptic vesicle docking;|O75145 A8K142 Q3MJA0 Q9H8B5 Q9UEW4,Liprin-alpha-3,Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3;, PF00536;PF07647;, GO:0001669;GO:0005829;GO:0098875;GO:0098978;GO:0048786;GO:0098831;GO:0007269;GO:0006836;GO:0048172;GO:0050808;GO:0016081;, C:acrosomal vesicle; C:cytosol; C:epididymosome; C:glutamatergic synapse; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component;, , P:neurotransmitter secretion; P:neurotransmitter transport; P:regulation of short-term neuronal synaptic plasticity; P:synapse organization; P:synaptic vesicle docking; scaffold216 indexed_genome mRNA 593200 596614 . - . ID=transcript_15927;Q9HAP6,Protein lin-7 homolog B,Mammalian lin-seven protein 2;Vertebrate lin-7 homolog 2;, PF02828;PF00595;, GO:0016323;GO:0005923;GO:0005911;GO:0097025;GO:0005886;GO:0098839;GO:0098793;GO:0045202;GO:0097016;GO:0030165;GO:0019904;GO:0006887;GO:0045199;GO:0007269;GO:0006836;GO:1903361;GO:0015031;, C:basolateral plasma membrane; C:bicellular tight junction; C:cell-cell junction; C:MPP7-DLG1-LIN7 complex; C:plasma membrane; C:postsynaptic density membrane; C:presynapse; C:synapse;, F:L27 domain binding; F:PDZ domain binding; F:protein domain specific binding;, P:exocytosis; P:maintenance of epithelial cell apical/basal polarity; P:neurotransmitter secretion; P:neurotransmitter transport; P:protein localization to basolateral plasma membrane; P:protein transport;|Q9HAP6,Protein lin-7 homolog B,Mammalian lin-seven protein 2;Vertebrate lin-7 homolog 2;, PF02828;PF00595;, GO:0016323;GO:0005923;GO:0005911;GO:0097025;GO:0005886;GO:0098839;GO:0098793;GO:0045202;GO:0097016;GO:0030165;GO:0019904;GO:0006887;GO:0045199;GO:0007269;GO:0006836;GO:1903361;GO:0015031;, C:basolateral plasma membrane; C:bicellular tight junction; C:cell-cell junction; C:MPP7-DLG1-LIN7 complex; C:plasma membrane; C:postsynaptic density membrane; C:presynapse; C:synapse;, F:L27 domain binding; F:PDZ domain binding; F:protein domain specific binding;, P:exocytosis; P:maintenance of epithelial cell apical/basal polarity; P:neurotransmitter secretion; P:neurotransmitter transport; P:protein localization to basolateral plasma membrane; P:protein transport; scaffold216 indexed_genome mRNA 611224 620069 . - . ID=transcript_15928;Q9UE45 Q9UE46 Q9UE47 Q9UE48 Q9UFQ6,U1 small nuclear ribonucleoprotein 70 kDa,, PF00076;PF12220;, GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005685;GO:0071004;GO:0003729;GO:0003723;GO:0017069;GO:0030619;GO:0000398;GO:1904715;GO:0061084;GO:0048026;GO:0043462;GO:0043484;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U1 snRNP; C:U2-type prespliceosome;, F:mRNA binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of chaperone-mediated autophagy; P:negative regulation of protein refolding; P:positive regulation of mRNA splicing, via spliceosome; P:regulation of ATPase activity; P:regulation of RNA splicing;|Q9UE45 Q9UE46 Q9UE47 Q9UE48 Q9UFQ6,U1 small nuclear ribonucleoprotein 70 kDa,, PF00076;PF12220;, GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005685;GO:0071004;GO:0003729;GO:0003723;GO:0017069;GO:0030619;GO:0000398;GO:1904715;GO:0061084;GO:0048026;GO:0043462;GO:0043484;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U1 snRNP; C:U2-type prespliceosome;, F:mRNA binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of chaperone-mediated autophagy; P:negative regulation of protein refolding; P:positive regulation of mRNA splicing, via spliceosome; P:regulation of ATPase activity; P:regulation of RNA splicing; scaffold216 indexed_genome mRNA 647684 648698 . - . ID=transcript_15929;P34130 Q6FH56,Neurotrophin-4,Neurotrophin-5;Neutrophic factor 4;, PF00243;, GO:0030424;GO:0030425;GO:0005576;GO:0005615;GO:0008021;GO:0008083;GO:0005163;GO:0007202;GO:0008344;GO:0008544;GO:0007402;GO:0060384;GO:0007616;GO:0042490;GO:0007613;GO:0050804;GO:0043524;GO:0021675;GO:0038180;GO:0048812;GO:0048011;GO:0007422;GO:0033138;GO:0045664;GO:0008052;GO:0061193;GO:0007169;, C:axon; C:dendrite; C:extracellular region; C:extracellular space; C:synaptic vesicle;, F:growth factor activity; F:nerve growth factor receptor binding;, P:activation of phospholipase C activity; P:adult locomotory behavior; P:epidermis development; P:ganglion mother cell fate determination; P:innervation; P:long-term memory; P:mechanoreceptor differentiation; P:memory; P:modulation of chemical synaptic transmission; P:negative regulation of neuron apoptotic process; P:nerve development; P:nerve growth factor signaling pathway; P:neuron projection morphogenesis; P:neurotrophin TRK receptor signaling pathway; P:peripheral nervous system development; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of neuron differentiation; P:sensory organ boundary specification; P:taste bud development; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold216 indexed_genome mRNA 653880 654641 . + . ID=transcript_15930;P01229 Q9UDI0,Lutropin subunit beta,Luteinizing hormone subunit beta;, PF00007;, GO:0005737;GO:0005576;GO:0005615;GO:0005796;GO:0005179;GO:0005102;GO:0007267;GO:0007186;GO:0009755;GO:0008584;GO:0002862;GO:0016486;GO:0006701;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space; C:Golgi lumen;, F:hormone activity; F:signaling receptor binding;, P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:hormone-mediated signaling pathway; P:male gonad development; P:negative regulation of inflammatory response to antigenic stimulus; P:peptide hormone processing; P:progesterone biosynthetic process; P:signal transduction; scaffold216 indexed_genome mRNA 656819 658331 . - . ID=transcript_15931;Q9Y230 B3KQ59 E7ETE5 Q6FIB9 Q6PK27 Q9Y361,RuvB-like 2,48 kDa TATA box-binding protein-interacting protein;51 kDa erythrocyte cytosolic protein;INO80 complex subunit J;Repressing pontin 52;TIP49b;TIP60-associated protein 54-beta;, PF06068;PF17856;, GO:0005813;GO:0005737;GO:0005829;GO:0000791;GO:0070062;GO:0031011;GO:0016020;GO:0071339;GO:0035267;GO:0016363;GO:0005654;GO:0005634;GO:0097255;GO:1990904;GO:0000812;GO:0043139;GO:0043531;GO:0005524;GO:0051117;GO:0008013;GO:0031490;GO:0003678;GO:0042802;GO:0042803;GO:0000978;GO:0000979;GO:0017025;GO:0001094;GO:0003714;GO:0051082;GO:0000492;GO:0071392;GO:0034644;GO:0006338;GO:0006310;GO:0006281;GO:0071169;GO:0016573;GO:0043968;GO:0043967;GO:0090090;GO:0071899;GO:0035066;GO:1904874;GO:0045944;GO:0006457;GO:0040008;GO:0006357;GO:0071733;, C:centrosome; C:cytoplasm; C:cytosol; C:euchromatin; C:extracellular exosome; C:Ino80 complex; C:membrane; C:MLL1 complex; C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:R2TP complex; C:ribonucleoprotein complex; C:Swr1 complex;, F:5'-3' DNA helicase activity; F:ADP binding; F:ATP binding; F:ATPase binding; F:beta-catenin binding; F:chromatin DNA binding; F:DNA helicase activity; F:identical protein binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription corepressor activity; F:unfolded protein binding;, P:box C/D snoRNP assembly; P:cellular response to estradiol stimulus; P:cellular response to UV; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:establishment of protein localization to chromatin; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of estrogen receptor binding; P:positive regulation of histone acetylation; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of transcription by RNA polymerase II; P:protein folding; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:transcriptional activation by promoter-enhancer looping; scaffold217 indexed_genome mRNA 31905 43550 . - . ID=transcript_15932;Q9UBF2 A6NH74 Q2NLA0 Q54AC3 Q8WVW8,Coatomer subunit gamma-2,Gamma-2-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0000139;GO:0030426;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:growth cone; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold217 indexed_genome mRNA 44469 59903 . + . ID=transcript_15933;Q5EB52 B2R6S1 O14973 O15007 Q6AI49 Q92571,Mesoderm-specific transcript homolog protein,Paternally-expressed gene 1 protein;, PF00561;, GO:0005783;GO:0005789;GO:0070062;GO:0016021;GO:0016787;GO:0007498;GO:0010883;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane;, F:hydrolase activity;, P:mesoderm development; P:regulation of lipid storage;|Q9UBF2 A6NH74 Q2NLA0 Q54AC3 Q8WVW8,Coatomer subunit gamma-2,Gamma-2-coat protein;, PF01602;PF16381;PF08752;, GO:0030126;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0000139;GO:0030426;GO:0030133;GO:0005198;GO:0006888;GO:0006891;GO:0006886;GO:0072384;GO:0009306;GO:0006890;, C:COPI vesicle coat; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi membrane; C:growth cone; C:transport vesicle;, F:structural molecule activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:organelle transport along microtubule; P:protein secretion; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold217 indexed_genome mRNA 119619 146658 . + . ID=transcript_15934;Q9BYV8 A4D1M0 B4DQ35 F5H0V6 Q7Z496 Q86TM1 Q8NFU8 Q9H6A3 Q9NPV3,Centrosomal protein of 41 kDa,Testis-specific gene A14 protein;, PF00581;, GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0016020;GO:0097711;GO:0060271;GO:0000086;GO:0018095;GO:0015031;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:membrane;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:protein polyglutamylation; P:protein transport; P:regulation of G2/M transition of mitotic cell cycle; scaffold217 indexed_genome mRNA 148632 168267 . + . ID=transcript_15935;Q9BYV8 A4D1M0 B4DQ35 F5H0V6 Q7Z496 Q86TM1 Q8NFU8 Q9H6A3 Q9NPV3,Centrosomal protein of 41 kDa,Testis-specific gene A14 protein;, PF00581;, GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0016020;GO:0097711;GO:0060271;GO:0000086;GO:0018095;GO:0015031;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:membrane;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:protein polyglutamylation; P:protein transport; P:regulation of G2/M transition of mitotic cell cycle;|Q9BYV8 A4D1M0 B4DQ35 F5H0V6 Q7Z496 Q86TM1 Q8NFU8 Q9H6A3 Q9NPV3,Centrosomal protein of 41 kDa,Testis-specific gene A14 protein;, PF00581;, GO:0005814;GO:0005813;GO:0036064;GO:0005929;GO:0005829;GO:0016020;GO:0097711;GO:0060271;GO:0000086;GO:0018095;GO:0015031;GO:0010389;, C:centriole; C:centrosome; C:ciliary basal body; C:cilium; C:cytosol; C:membrane;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; P:G2/M transition of mitotic cell cycle; P:protein polyglutamylation; P:protein transport; P:regulation of G2/M transition of mitotic cell cycle; scaffold217 indexed_genome mRNA 241042 249859 . - . ID=transcript_15936;Q9UI42 B7Z576 Q86UY9,Carboxypeptidase A4,Carboxypeptidase A3;, PF00246;PF02244;, GO:0005615;GO:0004181;GO:0008270;GO:0016573;GO:0006508;, C:extracellular space;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:histone acetylation; P:proteolysis; scaffold217 indexed_genome mRNA 329209 357749 . + . ID=transcript_15937;Q96SK2 A4D1L1 Q49A50 Q6PF00 Q8NCH3 Q96SL6,Transmembrane protein 209,, PF09786;, GO:0016021;, C:integral component of membrane;|Q96SK2 A4D1L1 Q49A50 Q6PF00 Q8NCH3 Q96SL6,Transmembrane protein 209,, PF09786;, GO:0016021;, C:integral component of membrane;|Q96SK2 A4D1L1 Q49A50 Q6PF00 Q8NCH3 Q96SL6,Transmembrane protein 209,, PF09786;, GO:0016021;, C:integral component of membrane; scaffold217 indexed_genome mRNA 368933 431207 . - . ID=transcript_15938;Q6PID8 Q86Y99 Q92554,Kelch domain-containing protein 10,, PF01344;, GO:0005737;GO:0005654;GO:0032874;, C:cytoplasm; C:nucleoplasm;, , P:positive regulation of stress-activated MAPK cascade;|Q6PID8 Q86Y99 Q92554,Kelch domain-containing protein 10,, PF01344;, GO:0005737;GO:0005654;GO:0032874;, C:cytoplasm; C:nucleoplasm;, , P:positive regulation of stress-activated MAPK cascade;|Q6PID8 Q86Y99 Q92554,Kelch domain-containing protein 10,, PF01344;, GO:0005737;GO:0005654;GO:0032874;, C:cytoplasm; C:nucleoplasm;, , P:positive regulation of stress-activated MAPK cascade;|Q6PID8 Q86Y99 Q92554,Kelch domain-containing protein 10,, PF01344;, GO:0005737;GO:0005654;GO:0032874;, C:cytoplasm; C:nucleoplasm;, , P:positive regulation of stress-activated MAPK cascade;|Q6PID8 Q86Y99 Q92554,Kelch domain-containing protein 10,, PF01344;, GO:0005737;GO:0005654;GO:0032874;, C:cytoplasm; C:nucleoplasm;, , P:positive regulation of stress-activated MAPK cascade;|Q6PID8 Q86Y99 Q92554,Kelch domain-containing protein 10,, PF01344;, GO:0005737;GO:0005654;GO:0032874;, C:cytoplasm; C:nucleoplasm;, , P:positive regulation of stress-activated MAPK cascade; scaffold217 indexed_genome mRNA 462987 485788 . + . ID=transcript_15939;Q86WB0 A6NH66 Q75MF3 Q75MF4 Q8N330 Q96F75 Q9HA34 Q9NVX4 Q9P0R0,Nuclear-interacting partner of ALK,Nuclear-interacting partner of anaplastic lymphoma kinase;Zinc finger C3HC-type protein 1;, PF08600;PF07967;, GO:0031965;GO:0005654;GO:0005634;GO:0019901;GO:0008270;GO:0007049;GO:0051301;GO:2001240;GO:0016567;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:protein kinase binding; F:zinc ion binding;, P:cell cycle; P:cell division; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein ubiquitination;|Q86WB0 A6NH66 Q75MF3 Q75MF4 Q8N330 Q96F75 Q9HA34 Q9NVX4 Q9P0R0,Nuclear-interacting partner of ALK,Nuclear-interacting partner of anaplastic lymphoma kinase;Zinc finger C3HC-type protein 1;, PF08600;PF07967;, GO:0031965;GO:0005654;GO:0005634;GO:0019901;GO:0008270;GO:0007049;GO:0051301;GO:2001240;GO:0016567;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:protein kinase binding; F:zinc ion binding;, P:cell cycle; P:cell division; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein ubiquitination;|Q86WB0 A6NH66 Q75MF3 Q75MF4 Q8N330 Q96F75 Q9HA34 Q9NVX4 Q9P0R0,Nuclear-interacting partner of ALK,Nuclear-interacting partner of anaplastic lymphoma kinase;Zinc finger C3HC-type protein 1;, PF08600;PF07967;, GO:0031965;GO:0005654;GO:0005634;GO:0019901;GO:0008270;GO:0007049;GO:0051301;GO:2001240;GO:0016567;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:protein kinase binding; F:zinc ion binding;, P:cell cycle; P:cell division; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein ubiquitination;|Q86WB0 A6NH66 Q75MF3 Q75MF4 Q8N330 Q96F75 Q9HA34 Q9NVX4 Q9P0R0,Nuclear-interacting partner of ALK,Nuclear-interacting partner of anaplastic lymphoma kinase;Zinc finger C3HC-type protein 1;, PF08600;PF07967;, GO:0031965;GO:0005654;GO:0005634;GO:0019901;GO:0008270;GO:0007049;GO:0051301;GO:2001240;GO:0016567;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:protein kinase binding; F:zinc ion binding;, P:cell cycle; P:cell division; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein ubiquitination;|Q86WB0 A6NH66 Q75MF3 Q75MF4 Q8N330 Q96F75 Q9HA34 Q9NVX4 Q9P0R0,Nuclear-interacting partner of ALK,Nuclear-interacting partner of anaplastic lymphoma kinase;Zinc finger C3HC-type protein 1;, PF08600;PF07967;, GO:0031965;GO:0005654;GO:0005634;GO:0019901;GO:0008270;GO:0007049;GO:0051301;GO:2001240;GO:0016567;, C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:protein kinase binding; F:zinc ion binding;, P:cell cycle; P:cell division; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:protein ubiquitination; scaffold217 indexed_genome mRNA 625352 652783 . + . ID=transcript_15940;P62256 A4D1L6 C9JY93 P37286 Q7Z6F4,Ubiquitin-conjugating enzyme E2 H,(E3-independent) E2 ubiquitin-conjugating enzyme H;E2 ubiquitin-conjugating enzyme H;UbcH2;Ubiquitin carrier protein H;Ubiquitin-conjugating enzyme E2-20K;Ubiquitin-protein ligase H;, PF00179;, GO:0005829;GO:0005634;GO:0005524;GO:0061631;GO:0004842;GO:0043161;GO:0070979;GO:0070936;GO:0000209;GO:0016567;GO:0006511;, C:cytosol; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P62256 A4D1L6 C9JY93 P37286 Q7Z6F4,Ubiquitin-conjugating enzyme E2 H,(E3-independent) E2 ubiquitin-conjugating enzyme H;E2 ubiquitin-conjugating enzyme H;UbcH2;Ubiquitin carrier protein H;Ubiquitin-conjugating enzyme E2-20K;Ubiquitin-protein ligase H;, PF00179;, GO:0005829;GO:0005634;GO:0005524;GO:0061631;GO:0004842;GO:0043161;GO:0070979;GO:0070936;GO:0000209;GO:0016567;GO:0006511;, C:cytosol; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P62256 A4D1L6 C9JY93 P37286 Q7Z6F4,Ubiquitin-conjugating enzyme E2 H,(E3-independent) E2 ubiquitin-conjugating enzyme H;E2 ubiquitin-conjugating enzyme H;UbcH2;Ubiquitin carrier protein H;Ubiquitin-conjugating enzyme E2-20K;Ubiquitin-protein ligase H;, PF00179;, GO:0005829;GO:0005634;GO:0005524;GO:0061631;GO:0004842;GO:0043161;GO:0070979;GO:0070936;GO:0000209;GO:0016567;GO:0006511;, C:cytosol; C:nucleus;, F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K11-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold218 indexed_genome mRNA 4836 16679 . - . ID=transcript_15941;Q9Y5P8 Q6P4G9 Q7RTT1 Q96H01,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta,PP2A subunit B isoform PR48;Protein phosphatase 2A 48 kDa regulatory subunit;, PF17958;PF13499;, GO:0005829;GO:0005654;GO:0005634;GO:0000159;GO:0005509;GO:0019888;GO:0007050;GO:0006470;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:calcium ion binding; F:protein phosphatase regulator activity;, P:cell cycle arrest; P:protein dephosphorylation; scaffold218 indexed_genome mRNA 35961 50527 . - . ID=transcript_15942;Q9Y5P8 Q6P4G9 Q7RTT1 Q96H01,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta,PP2A subunit B isoform PR48;Protein phosphatase 2A 48 kDa regulatory subunit;, PF17958;PF13499;, GO:0005829;GO:0005654;GO:0005634;GO:0000159;GO:0005509;GO:0019888;GO:0007050;GO:0006470;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein phosphatase type 2A complex;, F:calcium ion binding; F:protein phosphatase regulator activity;, P:cell cycle arrest; P:protein dephosphorylation; scaffold218 indexed_genome mRNA 504115 600282 . + . ID=transcript_15943;Q14431 Q16564,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CDw116;, PF18611;PF09240;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0038023;GO:0044267;GO:0019221;GO:0000165;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:signaling receptor activity;, P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:MAPK cascade;|Q14431 Q16564,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CDw116;, PF18611;PF09240;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0038023;GO:0044267;GO:0019221;GO:0000165;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:signaling receptor activity;, P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:MAPK cascade;|Q14431 Q16564,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CDw116;, PF18611;PF09240;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0038023;GO:0044267;GO:0019221;GO:0000165;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:signaling receptor activity;, P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:MAPK cascade;|Q14431 Q16564,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CDw116;, PF18611;PF09240;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0038023;GO:0044267;GO:0019221;GO:0000165;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:signaling receptor activity;, P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:MAPK cascade;|Q14431 Q16564,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CDw116;, PF18611;PF09240;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0038023;GO:0044267;GO:0019221;GO:0000165;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:signaling receptor activity;, P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:MAPK cascade; scaffold218 indexed_genome mRNA 632923 636396 . + . ID=transcript_15944;P12236 Q96C49,ADP/ATP translocase 3 {ECO:0000305},ADP,ATP carrier protein 3 {ECO:0000303|PubMed:31341297};ADP,ATP carrier protein, isoform T2 {ECO:0000303|PubMed:2541251};Adenine nucleotide translocator 3 {ECO:0000303|PubMed:8486369};Solute carrier family 25 member 6 {ECO:0000305};, PF00153;, GO:0016021;GO:0016020;GO:0005743;GO:0005739;GO:0005634;GO:0005744;GO:0005471;GO:0006915;GO:0140021;GO:1990544;GO:0006626;GO:0016032;, C:integral component of membrane; C:membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus; C:TIM23 mitochondrial import inner membrane translocase complex;, F:ATP:ADP antiporter activity;, F:ATP:ADP antiporter activity; P:apoptotic process; P:mitochondrial ADP transmembrane transport; P:mitochondrial ATP transmembrane transport; P:protein targeting to mitochondrion; P:viral process; scaffold219 indexed_genome mRNA 143383 193988 . - . ID=transcript_15945;Q96KR4 B3LDG9 B3LDH0 C9J796 F8WB28 Q96KR5,Leishmanolysin-like peptidase {ECO:0000305},Invadolysin {ECO:0000303|PubMed:19706689};, PF01457;, GO:0005737;GO:0005829;GO:0005925;GO:0005811;GO:0016020;GO:0046872;GO:0004222;GO:0008233;GO:0007155;GO:0007049;GO:0051301;, C:cytoplasm; C:cytosol; C:focal adhesion; C:lipid droplet; C:membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:peptidase activity;, P:cell adhesion; P:cell cycle; P:cell division; scaffold219 indexed_genome mRNA 207391 210595 . - . ID=transcript_15946;P18077 Q08ES9 Q9BVN7,60S ribosomal protein L35a,Cell growth-inhibiting gene 33 protein;Large ribosomal subunit protein eL33 {ECO:0000303|PubMed:24524803};, PF01247;, GO:0005829;GO:0022625;GO:0070062;GO:0016020;GO:0003723;GO:0003735;GO:0000049;GO:0002181;GO:0000184;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:membrane;, F:RNA binding; F:structural constituent of ribosome; F:tRNA binding;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P18077 Q08ES9 Q9BVN7,60S ribosomal protein L35a,Cell growth-inhibiting gene 33 protein;Large ribosomal subunit protein eL33 {ECO:0000303|PubMed:24524803};, PF01247;, GO:0005829;GO:0022625;GO:0070062;GO:0016020;GO:0003723;GO:0003735;GO:0000049;GO:0002181;GO:0000184;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:membrane;, F:RNA binding; F:structural constituent of ribosome; F:tRNA binding;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P18077 Q08ES9 Q9BVN7,60S ribosomal protein L35a,Cell growth-inhibiting gene 33 protein;Large ribosomal subunit protein eL33 {ECO:0000303|PubMed:24524803};, PF01247;, GO:0005829;GO:0022625;GO:0070062;GO:0016020;GO:0003723;GO:0003735;GO:0000049;GO:0002181;GO:0000184;GO:0042273;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:extracellular exosome; C:membrane;, F:RNA binding; F:structural constituent of ribosome; F:tRNA binding;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:ribosomal large subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold219 indexed_genome mRNA 216879 253697 . + . ID=transcript_15947;Q9H095 Q9BST2 Q9HAG8,Dynein regulatory complex protein 9 {ECO:0000250|UniProtKB:A8HQ54},IQ domain-containing protein G;, PF00612;, GO:0005737;GO:0005829;GO:0070062;GO:0002177;GO:0031514;GO:0036126;GO:0005516;GO:0030544;GO:0044782;GO:0007288;GO:0007286;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:manchette; C:motile cilium; C:sperm flagellum;, F:calmodulin binding; F:Hsp70 protein binding;, P:cilium organization; P:sperm axoneme assembly; P:spermatid development; scaffold219 indexed_genome mRNA 253872 355015 . - . ID=transcript_15948;Q96II8 B4E0T7 Q96FP9 Q9NT52,DISP complex protein LRCH3 {ECO:0000305|PubMed:29467281},Leucine-rich repeat and calponin homology domain-containing protein 3 {ECO:0000312|HGNC:HGNC:28637};, PF00307;PF13855;, GO:0005737;GO:0005829;GO:0032185;, C:cytoplasm; C:cytosol;, , P:septin cytoskeleton organization;|Q96II8 B4E0T7 Q96FP9 Q9NT52,DISP complex protein LRCH3 {ECO:0000305|PubMed:29467281},Leucine-rich repeat and calponin homology domain-containing protein 3 {ECO:0000312|HGNC:HGNC:28637};, PF00307;PF13855;, GO:0005737;GO:0005829;GO:0032185;, C:cytoplasm; C:cytosol;, , P:septin cytoskeleton organization; scaffold219 indexed_genome mRNA 359013 401450 . - . ID=transcript_15949;C9JTH3 C9JY50 Q96SL9 Q9BQI8,UAP56-interacting factor,Forty-two-three domain-containing protein 1;, , GO:0016607;GO:0005654;GO:0003729;GO:0003723;GO:0006406;, C:nuclear speck; C:nucleoplasm;, F:mRNA binding; F:RNA binding;, P:mRNA export from nucleus;|C9JTH3 C9JY50 Q96SL9 Q9BQI8,UAP56-interacting factor,Forty-two-three domain-containing protein 1;, , GO:0016607;GO:0005654;GO:0003729;GO:0003723;GO:0006406;, C:nuclear speck; C:nucleoplasm;, F:mRNA binding; F:RNA binding;, P:mRNA export from nucleus;|C9JTH3 C9JY50 Q96SL9 Q9BQI8,UAP56-interacting factor,Forty-two-three domain-containing protein 1;, , GO:0016607;GO:0005654;GO:0003729;GO:0003723;GO:0006406;, C:nuclear speck; C:nucleoplasm;, F:mRNA binding; F:RNA binding;, P:mRNA export from nucleus;|C9JTH3 C9JY50 Q96SL9 Q9BQI8,UAP56-interacting factor,Forty-two-three domain-containing protein 1;, , GO:0016607;GO:0005654;GO:0003729;GO:0003723;GO:0006406;, C:nuclear speck; C:nucleoplasm;, F:mRNA binding; F:RNA binding;, P:mRNA export from nucleus;|C9JTH3 C9JY50 Q96SL9 Q9BQI8,UAP56-interacting factor,Forty-two-three domain-containing protein 1;, , GO:0016607;GO:0005654;GO:0003729;GO:0003723;GO:0006406;, C:nuclear speck; C:nucleoplasm;, F:mRNA binding; F:RNA binding;, P:mRNA export from nucleus; scaffold219 indexed_genome mRNA 425671 458608 . + . ID=transcript_15950;Q92622 Q96CK5,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein {ECO:0000312|HGNC:HGNC:28991},Beclin-1 associated RUN domain containing protein;, PF02759;PF13901;, GO:0005829;GO:0005769;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:1901981;GO:0006914;GO:0006897;GO:0002376;GO:0071985;GO:1901097;GO:0010507;GO:0045806;GO:0043553;GO:0006909;, C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm;, F:phosphatidylinositol phosphate binding;, P:autophagy; P:endocytosis; P:immune system process; P:multivesicular body sorting pathway; P:negative regulation of autophagosome maturation; P:negative regulation of autophagy; P:negative regulation of endocytosis; P:negative regulation of phosphatidylinositol 3-kinase activity; P:phagocytosis;|Q92622 Q96CK5,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein {ECO:0000312|HGNC:HGNC:28991},Beclin-1 associated RUN domain containing protein;, PF02759;PF13901;, GO:0005829;GO:0005769;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:1901981;GO:0006914;GO:0006897;GO:0002376;GO:0071985;GO:1901097;GO:0010507;GO:0045806;GO:0043553;GO:0006909;, C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm;, F:phosphatidylinositol phosphate binding;, P:autophagy; P:endocytosis; P:immune system process; P:multivesicular body sorting pathway; P:negative regulation of autophagosome maturation; P:negative regulation of autophagy; P:negative regulation of endocytosis; P:negative regulation of phosphatidylinositol 3-kinase activity; P:phagocytosis;|Q92622 Q96CK5,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein {ECO:0000312|HGNC:HGNC:28991},Beclin-1 associated RUN domain containing protein;, PF02759;PF13901;, GO:0005829;GO:0005769;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:1901981;GO:0006914;GO:0006897;GO:0002376;GO:0071985;GO:1901097;GO:0010507;GO:0045806;GO:0043553;GO:0006909;, C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm;, F:phosphatidylinositol phosphate binding;, P:autophagy; P:endocytosis; P:immune system process; P:multivesicular body sorting pathway; P:negative regulation of autophagosome maturation; P:negative regulation of autophagy; P:negative regulation of endocytosis; P:negative regulation of phosphatidylinositol 3-kinase activity; P:phagocytosis;|P14625 Q96A97,Endoplasmin,94 kDa glucose-regulated protein;Heat shock protein 90 kDa beta member 1;Tumor rejection antigen 1;gp96 homolog;, PF02518;PF00183;, GO:0062023;GO:0005829;GO:0071682;GO:0005783;GO:0005788;GO:0005789;GO:0070062;GO:0005576;GO:0005925;GO:0042470;GO:0016020;GO:0030496;GO:0005634;GO:0048471;GO:0032991;GO:0033018;GO:0005524;GO:0016887;GO:0005509;GO:0050750;GO:0019903;GO:0003723;GO:0051082;GO:0031247;GO:0036500;GO:0044267;GO:0071318;GO:0019221;GO:0043066;GO:0043687;GO:0006457;GO:0034975;GO:0015031;GO:0006898;GO:0043666;GO:0034976;GO:0001666;GO:0030970;GO:0051208;GO:0002224;GO:0030433;, C:collagen-containing extracellular matrix; C:cytosol; C:endocytic vesicle lumen; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:melanosome; C:membrane; C:midbody; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:sarcoplasmic reticulum lumen;, F:ATP binding; F:ATPase activity; F:calcium ion binding; F:low-density lipoprotein particle receptor binding; F:protein phosphatase binding; F:RNA binding; F:unfolded protein binding;, P:actin rod assembly; P:ATF6-mediated unfolded protein response; P:cellular protein metabolic process; P:cellular response to ATP; P:cytokine-mediated signaling pathway; P:negative regulation of apoptotic process; P:post-translational protein modification; P:protein folding; P:protein folding in endoplasmic reticulum; P:protein transport; P:receptor-mediated endocytosis; P:regulation of phosphoprotein phosphatase activity; P:response to endoplasmic reticulum stress; P:response to hypoxia; P:retrograde protein transport, ER to cytosol; P:sequestering of calcium ion; P:toll-like receptor signaling pathway; P:ubiquitin-dependent ERAD pathway;|Q92622 Q96CK5,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein {ECO:0000312|HGNC:HGNC:28991},Beclin-1 associated RUN domain containing protein;, PF02759;PF13901;, GO:0005829;GO:0005769;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:1901981;GO:0006914;GO:0006897;GO:0002376;GO:0071985;GO:1901097;GO:0010507;GO:0045806;GO:0043553;GO:0006909;, C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm;, F:phosphatidylinositol phosphate binding;, P:autophagy; P:endocytosis; P:immune system process; P:multivesicular body sorting pathway; P:negative regulation of autophagosome maturation; P:negative regulation of autophagy; P:negative regulation of endocytosis; P:negative regulation of phosphatidylinositol 3-kinase activity; P:phagocytosis;|Q92622 Q96CK5,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein {ECO:0000312|HGNC:HGNC:28991},Beclin-1 associated RUN domain containing protein;, PF02759;PF13901;, GO:0005829;GO:0005769;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:1901981;GO:0006914;GO:0006897;GO:0002376;GO:0071985;GO:1901097;GO:0010507;GO:0045806;GO:0043553;GO:0006909;, C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm;, F:phosphatidylinositol phosphate binding;, P:autophagy; P:endocytosis; P:immune system process; P:multivesicular body sorting pathway; P:negative regulation of autophagosome maturation; P:negative regulation of autophagy; P:negative regulation of endocytosis; P:negative regulation of phosphatidylinositol 3-kinase activity; P:phagocytosis; scaffold219 indexed_genome mRNA 459782 460645 . - . ID=transcript_15951;Q92622 Q96CK5,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein {ECO:0000312|HGNC:HGNC:28991},Beclin-1 associated RUN domain containing protein;, PF02759;PF13901;, GO:0005829;GO:0005769;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:1901981;GO:0006914;GO:0006897;GO:0002376;GO:0071985;GO:1901097;GO:0010507;GO:0045806;GO:0043553;GO:0006909;, C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm;, F:phosphatidylinositol phosphate binding;, P:autophagy; P:endocytosis; P:immune system process; P:multivesicular body sorting pathway; P:negative regulation of autophagosome maturation; P:negative regulation of autophagy; P:negative regulation of endocytosis; P:negative regulation of phosphatidylinositol 3-kinase activity; P:phagocytosis; scaffold219 indexed_genome mRNA 495379 507604 . + . ID=transcript_15952;Q8N307 Q6UX97 Q76I83 Q76I85 Q86ST8 Q8NBY6 Q96KA1 Q9P2I8,Mucin-20,, , GO:0016324;GO:0009925;GO:0005576;GO:0005796;GO:0031528;GO:0005886;GO:0042802;GO:0000187;GO:0048012;GO:0016266;GO:0002223;, C:apical plasma membrane; C:basal plasma membrane; C:extracellular region; C:Golgi lumen; C:microvillus membrane; C:plasma membrane;, F:identical protein binding;, P:activation of MAPK activity; P:hepatocyte growth factor receptor signaling pathway; P:O-glycan processing; P:stimulatory C-type lectin receptor signaling pathway; scaffold219 indexed_genome mRNA 519540 523339 . + . ID=transcript_15953;Q9NY78 Q9NY79 Q9NY80 Q9NY81,Mucin-4,Ascites sialoglycoprotein;Pancreatic adenocarcinoma mucin;Testis mucin;Tracheobronchial mucin;, PF06119;PF00094;, GO:0070062;GO:0031012;GO:0005615;GO:0005796;GO:0005887;GO:0016020;GO:0005886;GO:0031982;GO:0005176;GO:0030197;GO:0007160;GO:0030277;GO:0016266;GO:0010469;GO:0002223;, C:extracellular exosome; C:extracellular matrix; C:extracellular space; C:Golgi lumen; C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:vesicle;, F:ErbB-2 class receptor binding; F:extracellular matrix constituent, lubricant activity;, P:cell-matrix adhesion; P:maintenance of gastrointestinal epithelium; P:O-glycan processing; P:regulation of signaling receptor activity; P:stimulatory C-type lectin receptor signaling pathway; scaffold220 indexed_genome mRNA 47003 73113 . + . ID=transcript_15954;Q8IYL2 Q8NA95,Probable tRNA (uracil-O(2)-)-methyltransferase,Methyltransferase-like protein 19;, PF07757;, GO:0005737;GO:0046872;GO:0016300;GO:0030488;, C:cytoplasm;, F:metal ion binding; F:tRNA (uracil) methyltransferase activity;, P:tRNA methylation;|Q8IYL2 Q8NA95,Probable tRNA (uracil-O(2)-)-methyltransferase,Methyltransferase-like protein 19;, PF07757;, GO:0005737;GO:0046872;GO:0016300;GO:0030488;, C:cytoplasm;, F:metal ion binding; F:tRNA (uracil) methyltransferase activity;, P:tRNA methylation;|Q8IYL2 Q8NA95,Probable tRNA (uracil-O(2)-)-methyltransferase,Methyltransferase-like protein 19;, PF07757;, GO:0005737;GO:0046872;GO:0016300;GO:0030488;, C:cytoplasm;, F:metal ion binding; F:tRNA (uracil) methyltransferase activity;, P:tRNA methylation;|Q8IYL2 Q8NA95,Probable tRNA (uracil-O(2)-)-methyltransferase,Methyltransferase-like protein 19;, PF07757;, GO:0005737;GO:0046872;GO:0016300;GO:0030488;, C:cytoplasm;, F:metal ion binding; F:tRNA (uracil) methyltransferase activity;, P:tRNA methylation;|Q8IYL2 Q8NA95,Probable tRNA (uracil-O(2)-)-methyltransferase,Methyltransferase-like protein 19;, PF07757;, GO:0005737;GO:0046872;GO:0016300;GO:0030488;, C:cytoplasm;, F:metal ion binding; F:tRNA (uracil) methyltransferase activity;, P:tRNA methylation; scaffold220 indexed_genome mRNA 84141 135397 . + . ID=transcript_15955;O15254 Q96AJ8,Peroxisomal acyl-coenzyme A oxidase 3,Branched-chain acyl-CoA oxidase;Pristanoyl-CoA oxidase {ECO:0000250|UniProtKB:Q63448};, PF01756;PF02770;, GO:0005829;GO:0016020;GO:0005782;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016402;GO:0033540;GO:0055088;GO:0008104;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:pristanoyl-CoA oxidase activity;, P:fatty acid beta-oxidation using acyl-CoA oxidase; P:lipid homeostasis; P:protein localization;|O15254 Q96AJ8,Peroxisomal acyl-coenzyme A oxidase 3,Branched-chain acyl-CoA oxidase;Pristanoyl-CoA oxidase {ECO:0000250|UniProtKB:Q63448};, PF01756;PF02770;, GO:0005829;GO:0016020;GO:0005782;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016402;GO:0033540;GO:0055088;GO:0008104;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:pristanoyl-CoA oxidase activity;, P:fatty acid beta-oxidation using acyl-CoA oxidase; P:lipid homeostasis; P:protein localization;|O15254 Q96AJ8,Peroxisomal acyl-coenzyme A oxidase 3,Branched-chain acyl-CoA oxidase;Pristanoyl-CoA oxidase {ECO:0000250|UniProtKB:Q63448};, PF01756;PF02770;, GO:0005829;GO:0016020;GO:0005782;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016402;GO:0033540;GO:0055088;GO:0008104;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:pristanoyl-CoA oxidase activity;, P:fatty acid beta-oxidation using acyl-CoA oxidase; P:lipid homeostasis; P:protein localization;|O15254 Q96AJ8,Peroxisomal acyl-coenzyme A oxidase 3,Branched-chain acyl-CoA oxidase;Pristanoyl-CoA oxidase {ECO:0000250|UniProtKB:Q63448};, PF01756;PF02770;, GO:0005829;GO:0016020;GO:0005782;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016402;GO:0033540;GO:0055088;GO:0008104;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:pristanoyl-CoA oxidase activity;, P:fatty acid beta-oxidation using acyl-CoA oxidase; P:lipid homeostasis; P:protein localization;|O15254 Q96AJ8,Peroxisomal acyl-coenzyme A oxidase 3,Branched-chain acyl-CoA oxidase;Pristanoyl-CoA oxidase {ECO:0000250|UniProtKB:Q63448};, PF01756;PF02770;, GO:0005829;GO:0016020;GO:0005782;GO:0005777;GO:0003997;GO:0071949;GO:0005504;GO:0050660;GO:0016402;GO:0033540;GO:0055088;GO:0008104;, C:cytosol; C:membrane; C:peroxisomal matrix; C:peroxisome;, F:acyl-CoA oxidase activity; F:FAD binding; F:fatty acid binding; F:flavin adenine dinucleotide binding; F:pristanoyl-CoA oxidase activity;, P:fatty acid beta-oxidation using acyl-CoA oxidase; P:lipid homeostasis; P:protein localization; scaffold220 indexed_genome mRNA 170806 199339 . - . ID=transcript_15956;P83110 Q7Z7A2,Serine protease HTRA3,High-temperature requirement factor A3;Pregnancy-related serine protease;, PF00219;PF07648;PF17820;, GO:0005576;GO:0004175;GO:0042802;GO:0005520;GO:0004252;GO:0008236;GO:0030514;GO:0030512;GO:0006508;, C:extracellular region;, F:endopeptidase activity; F:identical protein binding; F:insulin-like growth factor binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:proteolysis;|P83110 Q7Z7A2,Serine protease HTRA3,High-temperature requirement factor A3;Pregnancy-related serine protease;, PF00219;PF07648;PF17820;, GO:0005576;GO:0004175;GO:0042802;GO:0005520;GO:0004252;GO:0008236;GO:0030514;GO:0030512;GO:0006508;, C:extracellular region;, F:endopeptidase activity; F:identical protein binding; F:insulin-like growth factor binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:proteolysis; scaffold220 indexed_genome mRNA 240255 242740 . + . ID=transcript_15957;Q8TE82 Q4W5G5,SH3 domain and tetratricopeptide repeat-containing protein 1 scaffold220 indexed_genome mRNA 246882 256704 . - . ID=transcript_15958;Q8TE82 Q4W5G5,SH3 domain and tetratricopeptide repeat-containing protein 1|Q8TE82 Q4W5G5,SH3 domain and tetratricopeptide repeat-containing protein 1 scaffold220 indexed_genome mRNA 256725 273977 . - . ID=transcript_15959;Q8TE82 Q4W5G5,SH3 domain and tetratricopeptide repeat-containing protein 1 scaffold220 indexed_genome mRNA 383549 510952 . - . ID=transcript_15960;Q8NBN4 Q96SJ4,Heparan-sulfate 6-O-sulfotransferase 2 {ECO:0000305},, PF03567;, GO:0000139;GO:0016021;GO:0017095;GO:0006024;GO:0015015;, C:Golgi membrane; C:integral component of membrane;, F:heparan sulfate 6-O-sulfotransferase activity;, P:glycosaminoglycan biosynthetic process; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; scaffold222 indexed_genome mRNA 554 10569 . + . ID=transcript_15961;O15260 B7Z6A4 O60923 Q5T8U6 Q9UNZ0 Q9UNZ1,Surfeit locus protein 4,, PF02077;, GO:0035577;GO:0005829;GO:0005789;GO:0005793;GO:0033116;GO:0000139;GO:0016021;GO:0005886;GO:0030133;GO:0007030;GO:0043312;GO:0010638;GO:0006890;, C:azurophil granule membrane; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:transport vesicle;, , P:Golgi organization; P:neutrophil degranulation; P:positive regulation of organelle organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O15260 B7Z6A4 O60923 Q5T8U6 Q9UNZ0 Q9UNZ1,Surfeit locus protein 4,, PF02077;, GO:0035577;GO:0005829;GO:0005789;GO:0005793;GO:0033116;GO:0000139;GO:0016021;GO:0005886;GO:0030133;GO:0007030;GO:0043312;GO:0010638;GO:0006890;, C:azurophil granule membrane; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:transport vesicle;, , P:Golgi organization; P:neutrophil degranulation; P:positive regulation of organelle organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|O15260 B7Z6A4 O60923 Q5T8U6 Q9UNZ0 Q9UNZ1,Surfeit locus protein 4,, PF02077;, GO:0035577;GO:0005829;GO:0005789;GO:0005793;GO:0033116;GO:0000139;GO:0016021;GO:0005886;GO:0030133;GO:0007030;GO:0043312;GO:0010638;GO:0006890;, C:azurophil granule membrane; C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi membrane; C:integral component of membrane; C:plasma membrane; C:transport vesicle;, , P:Golgi organization; P:neutrophil degranulation; P:positive regulation of organelle organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold222 indexed_genome mRNA 18525 36777 . + . ID=transcript_15962;Q8NE28 Q5T8U8 Q6ZMP6 Q6ZMQ5,Serine/threonine kinase-like domain-containing protein STKLD1,Serine/threonine kinase-like domain-containing protein 1;Sugen kinase 071;, PF00069;, GO:0005524;GO:0004674;, , F:ATP binding; F:protein serine/threonine kinase activity; scaffold222 indexed_genome mRNA 37740 42721 . + . ID=transcript_15963;Q8NE28 Q5T8U8 Q6ZMP6 Q6ZMQ5,Serine/threonine kinase-like domain-containing protein STKLD1,Serine/threonine kinase-like domain-containing protein 1;Sugen kinase 071;, PF00069;, GO:0005524;GO:0004674;, , F:ATP binding; F:protein serine/threonine kinase activity; scaffold222 indexed_genome mRNA 46021 56311 . - . ID=transcript_15964;Q9GZR2 B2RAT2 Q5T8S4 Q5T8S5 Q5T8S6 Q9GZW3,RNA exonuclease 4,Exonuclease XPMC2;Prevents mitotic catastrophe 2 protein homolog;, PF00929;, GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0008408;GO:0003690;GO:0004519;GO:0004527;GO:0003723;GO:0003697;GO:0000737;GO:0000738;GO:0000726;GO:0006355;GO:0006364;, C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-5' exonuclease activity; F:double-stranded DNA binding; F:endonuclease activity; F:exonuclease activity; F:RNA binding; F:single-stranded DNA binding;, P:DNA catabolic process, endonucleolytic; P:DNA catabolic process, exonucleolytic; P:non-recombinational repair; P:regulation of transcription, DNA-templated; P:rRNA processing; scaffold222 indexed_genome mRNA 72222 104012 . + . ID=transcript_15965;Q76LX8 Q6UY16 Q710F6 Q711T8 Q96L37 Q9H0G3 Q9UGQ1,A disintegrin and metalloproteinase with thrombospondin motifs 13,von Willebrand factor-cleaving protease;, PF17771;PF01421;PF00090;, GO:0009986;GO:0005788;GO:0031012;GO:0005615;GO:0005509;GO:0005178;GO:0004222;GO:0008237;GO:0008270;GO:0007160;GO:0071346;GO:0071353;GO:0071222;GO:0071356;GO:0030198;GO:0009100;GO:0007229;GO:0043171;GO:0030168;GO:0016485;GO:0006508;GO:0014075;GO:0035864;GO:0009636;, C:cell surface; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular space;, F:calcium ion binding; F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:cell-matrix adhesion; P:cellular response to interferon-gamma; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:extracellular matrix organization; P:glycoprotein metabolic process; P:integrin-mediated signaling pathway; P:peptide catabolic process; P:platelet activation; P:protein processing; P:proteolysis; P:response to amine; P:response to potassium ion; P:response to toxic substance;|Q76LX8 Q6UY16 Q710F6 Q711T8 Q96L37 Q9H0G3 Q9UGQ1,A disintegrin and metalloproteinase with thrombospondin motifs 13,von Willebrand factor-cleaving protease;, PF17771;PF01421;PF00090;, GO:0009986;GO:0005788;GO:0031012;GO:0005615;GO:0005509;GO:0005178;GO:0004222;GO:0008237;GO:0008270;GO:0007160;GO:0071346;GO:0071353;GO:0071222;GO:0071356;GO:0030198;GO:0009100;GO:0007229;GO:0043171;GO:0030168;GO:0016485;GO:0006508;GO:0014075;GO:0035864;GO:0009636;, C:cell surface; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular space;, F:calcium ion binding; F:integrin binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding;, P:cell-matrix adhesion; P:cellular response to interferon-gamma; P:cellular response to interleukin-4; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:extracellular matrix organization; P:glycoprotein metabolic process; P:integrin-mediated signaling pathway; P:peptide catabolic process; P:platelet activation; P:protein processing; P:proteolysis; P:response to amine; P:response to potassium ion; P:response to toxic substance; scaffold222 indexed_genome mRNA 113005 126058 . + . ID=transcript_15966;Q9UGQ2 B7Z3T8 B7Z5E1 F5GXX4 Q5SXD4 Q8NBM6,Calcium channel flower homolog,Calcium channel flower domain-containing protein 1;, PF10233;, GO:0016021;GO:0016192;, C:integral component of membrane;, , P:vesicle-mediated transport;|Q9UGQ2 B7Z3T8 B7Z5E1 F5GXX4 Q5SXD4 Q8NBM6,Calcium channel flower homolog,Calcium channel flower domain-containing protein 1;, PF10233;, GO:0016021;GO:0016192;, C:integral component of membrane;, , P:vesicle-mediated transport;|Q9UGQ3 A6NNU6 Q5SXD7 Q8NCC2,Solute carrier family 2, facilitated glucose transporter member 6 {ECO:0000305},Glucose transporter type 6 {ECO:0000303|PubMed:30431159};, PF00083;, GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0033300;GO:0005353;GO:0005355;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0006110;, C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:regulation of glycolytic process;|Q9UGQ3 A6NNU6 Q5SXD7 Q8NCC2,Solute carrier family 2, facilitated glucose transporter member 6 {ECO:0000305},Glucose transporter type 6 {ECO:0000303|PubMed:30431159};, PF00083;, GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0033300;GO:0005353;GO:0005355;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0006110;, C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:regulation of glycolytic process;|Q9UGQ3 A6NNU6 Q5SXD7 Q8NCC2,Solute carrier family 2, facilitated glucose transporter member 6 {ECO:0000305},Glucose transporter type 6 {ECO:0000303|PubMed:30431159};, PF00083;, GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0033300;GO:0005353;GO:0005355;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0006110;, C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:regulation of glycolytic process;|Q9UGQ3 A6NNU6 Q5SXD7 Q8NCC2,Solute carrier family 2, facilitated glucose transporter member 6 {ECO:0000305},Glucose transporter type 6 {ECO:0000303|PubMed:30431159};, PF00083;, GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0033300;GO:0005353;GO:0005355;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0006110;, C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:regulation of glycolytic process;|Q9UGQ3 A6NNU6 Q5SXD7 Q8NCC2,Solute carrier family 2, facilitated glucose transporter member 6 {ECO:0000305},Glucose transporter type 6 {ECO:0000303|PubMed:30431159};, PF00083;, GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0033300;GO:0005353;GO:0005355;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0006110;, C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:regulation of glycolytic process;|Q9UGQ3 A6NNU6 Q5SXD7 Q8NCC2,Solute carrier family 2, facilitated glucose transporter member 6 {ECO:0000305},Glucose transporter type 6 {ECO:0000303|PubMed:30431159};, PF00083;, GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0033300;GO:0005353;GO:0005355;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0006110;, C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:regulation of glycolytic process;|Q9UGQ3 A6NNU6 Q5SXD7 Q8NCC2,Solute carrier family 2, facilitated glucose transporter member 6 {ECO:0000305},Glucose transporter type 6 {ECO:0000303|PubMed:30431159};, PF00083;, GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0033300;GO:0005353;GO:0005355;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0006110;, C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:regulation of glycolytic process;|Q9UGQ3 A6NNU6 Q5SXD7 Q8NCC2,Solute carrier family 2, facilitated glucose transporter member 6 {ECO:0000305},Glucose transporter type 6 {ECO:0000303|PubMed:30431159};, PF00083;, GO:0016021;GO:0005765;GO:0016020;GO:0005886;GO:0033300;GO:0005353;GO:0005355;GO:0070837;GO:0015755;GO:1904659;GO:0008645;GO:0006110;, C:integral component of membrane; C:lysosomal membrane; C:membrane; C:plasma membrane;, F:dehydroascorbic acid transmembrane transporter activity; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:dehydroascorbic acid transport; P:fructose transmembrane transport; P:glucose transmembrane transport; P:hexose transmembrane transport; P:regulation of glycolytic process; scaffold222 indexed_genome mRNA 182917 207472 . + . ID=transcript_15967;Q86TH1 B1B0D5 O60345,ADAMTS-like protein 2,, PF05986;PF08686;PF00090;, GO:0031012;GO:0005576;GO:0004222;GO:0030198;GO:0030512;, C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity;, P:extracellular matrix organization; P:negative regulation of transforming growth factor beta receptor signaling pathway;|Q86TH1 B1B0D5 O60345,ADAMTS-like protein 2,, PF05986;PF08686;PF00090;, GO:0031012;GO:0005576;GO:0004222;GO:0030198;GO:0030512;, C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity;, P:extracellular matrix organization; P:negative regulation of transforming growth factor beta receptor signaling pathway;|Q86TH1 B1B0D5 O60345,ADAMTS-like protein 2,, PF05986;PF08686;PF00090;, GO:0031012;GO:0005576;GO:0004222;GO:0030198;GO:0030512;, C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity;, P:extracellular matrix organization; P:negative regulation of transforming growth factor beta receptor signaling pathway; scaffold222 indexed_genome mRNA 208587 221871 . + . ID=transcript_15968;Q86TH1 B1B0D5 O60345,ADAMTS-like protein 2,, PF05986;PF08686;PF00090;, GO:0031012;GO:0005576;GO:0004222;GO:0030198;GO:0030512;, C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity;, P:extracellular matrix organization; P:negative regulation of transforming growth factor beta receptor signaling pathway;|Q86TH1 B1B0D5 O60345,ADAMTS-like protein 2,, PF05986;PF08686;PF00090;, GO:0031012;GO:0005576;GO:0004222;GO:0030198;GO:0030512;, C:extracellular matrix; C:extracellular region;, F:metalloendopeptidase activity;, P:extracellular matrix organization; P:negative regulation of transforming growth factor beta receptor signaling pathway; scaffold222 indexed_genome mRNA 223763 252390 . - . ID=transcript_15969;P0C2L3 B2RUZ5,Protein FAM163B,, PF15069;, GO:0016021;, C:integral component of membrane; scaffold222 indexed_genome mRNA 279708 281609 . + . ID=transcript_15970;P09172 Q5T381 Q96AG2,Dopamine beta-hydroxylase,Dopamine beta-monooxygenase;, PF03712;PF01082;PF03351;, GO:0034451;GO:0034466;GO:0042584;GO:0005737;GO:0005783;GO:0005576;GO:0005615;GO:0016021;GO:0043231;GO:0016020;GO:0034774;GO:0030667;GO:0045202;GO:0030658;GO:0003824;GO:0005507;GO:0004500;GO:0031418;GO:0048149;GO:0001974;GO:0042423;GO:0007268;GO:0042420;GO:0042596;GO:0042593;GO:0042309;GO:0002443;GO:0050900;GO:0007626;GO:0042711;GO:0007613;GO:0042421;GO:0006589;GO:0120162;GO:0045907;GO:0042127;GO:2001236;GO:0001975;GO:0048265;GO:0008542;, C:centriolar satellite; C:chromaffin granule lumen; C:chromaffin granule membrane; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:secretory granule lumen; C:secretory granule membrane; C:synapse; C:transport vesicle membrane;, F:catalytic activity; F:copper ion binding; F:dopamine beta-monooxygenase activity; F:L-ascorbic acid binding;, P:behavioral response to ethanol; P:blood vessel remodeling; P:catecholamine biosynthetic process; P:chemical synaptic transmission; P:dopamine catabolic process; P:fear response; P:glucose homeostasis; P:homoiothermy; P:leukocyte mediated immunity; P:leukocyte migration; P:locomotory behavior; P:maternal behavior; P:memory; P:norepinephrine biosynthetic process; P:octopamine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of vasoconstriction; P:regulation of cell population proliferation; P:regulation of extrinsic apoptotic signaling pathway; P:response to amphetamine; P:response to pain; P:visual learning;|P09172 Q5T381 Q96AG2,Dopamine beta-hydroxylase,Dopamine beta-monooxygenase;, PF03712;PF01082;PF03351;, GO:0034451;GO:0034466;GO:0042584;GO:0005737;GO:0005783;GO:0005576;GO:0005615;GO:0016021;GO:0043231;GO:0016020;GO:0034774;GO:0030667;GO:0045202;GO:0030658;GO:0003824;GO:0005507;GO:0004500;GO:0031418;GO:0048149;GO:0001974;GO:0042423;GO:0007268;GO:0042420;GO:0042596;GO:0042593;GO:0042309;GO:0002443;GO:0050900;GO:0007626;GO:0042711;GO:0007613;GO:0042421;GO:0006589;GO:0120162;GO:0045907;GO:0042127;GO:2001236;GO:0001975;GO:0048265;GO:0008542;, C:centriolar satellite; C:chromaffin granule lumen; C:chromaffin granule membrane; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:secretory granule lumen; C:secretory granule membrane; C:synapse; C:transport vesicle membrane;, F:catalytic activity; F:copper ion binding; F:dopamine beta-monooxygenase activity; F:L-ascorbic acid binding;, P:behavioral response to ethanol; P:blood vessel remodeling; P:catecholamine biosynthetic process; P:chemical synaptic transmission; P:dopamine catabolic process; P:fear response; P:glucose homeostasis; P:homoiothermy; P:leukocyte mediated immunity; P:leukocyte migration; P:locomotory behavior; P:maternal behavior; P:memory; P:norepinephrine biosynthetic process; P:octopamine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of vasoconstriction; P:regulation of cell population proliferation; P:regulation of extrinsic apoptotic signaling pathway; P:response to amphetamine; P:response to pain; P:visual learning; scaffold222 indexed_genome mRNA 283196 284045 . - . ID=transcript_15971;P09172 Q5T381 Q96AG2,Dopamine beta-hydroxylase,Dopamine beta-monooxygenase;, PF03712;PF01082;PF03351;, GO:0034451;GO:0034466;GO:0042584;GO:0005737;GO:0005783;GO:0005576;GO:0005615;GO:0016021;GO:0043231;GO:0016020;GO:0034774;GO:0030667;GO:0045202;GO:0030658;GO:0003824;GO:0005507;GO:0004500;GO:0031418;GO:0048149;GO:0001974;GO:0042423;GO:0007268;GO:0042420;GO:0042596;GO:0042593;GO:0042309;GO:0002443;GO:0050900;GO:0007626;GO:0042711;GO:0007613;GO:0042421;GO:0006589;GO:0120162;GO:0045907;GO:0042127;GO:2001236;GO:0001975;GO:0048265;GO:0008542;, C:centriolar satellite; C:chromaffin granule lumen; C:chromaffin granule membrane; C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:secretory granule lumen; C:secretory granule membrane; C:synapse; C:transport vesicle membrane;, F:catalytic activity; F:copper ion binding; F:dopamine beta-monooxygenase activity; F:L-ascorbic acid binding;, P:behavioral response to ethanol; P:blood vessel remodeling; P:catecholamine biosynthetic process; P:chemical synaptic transmission; P:dopamine catabolic process; P:fear response; P:glucose homeostasis; P:homoiothermy; P:leukocyte mediated immunity; P:leukocyte migration; P:locomotory behavior; P:maternal behavior; P:memory; P:norepinephrine biosynthetic process; P:octopamine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of vasoconstriction; P:regulation of cell population proliferation; P:regulation of extrinsic apoptotic signaling pathway; P:response to amphetamine; P:response to pain; P:visual learning; scaffold222 indexed_genome mRNA 293956 333121 . - . ID=transcript_15972;Q9UL12 B2RMR5 B4DPI2 B7ZLT6 Q5SYV0 Q9Y280 Q9Y2Y3,Sarcosine dehydrogenase, mitochondrial,BPR-2;, PF01266;PF16350;PF01571;PF08669;, GO:0005737;GO:0005759;GO:0005739;GO:0016491;GO:0008480;GO:0042426;GO:1901053;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:oxidoreductase activity; F:sarcosine dehydrogenase activity;, P:choline catabolic process; P:sarcosine catabolic process; scaffold222 indexed_genome mRNA 333128 351951 . - . ID=transcript_15973;Q9UL12 B2RMR5 B4DPI2 B7ZLT6 Q5SYV0 Q9Y280 Q9Y2Y3,Sarcosine dehydrogenase, mitochondrial,BPR-2;, PF01266;PF16350;PF01571;PF08669;, GO:0005737;GO:0005759;GO:0005739;GO:0016491;GO:0008480;GO:0042426;GO:1901053;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrion;, F:oxidoreductase activity; F:sarcosine dehydrogenase activity;, P:choline catabolic process; P:sarcosine catabolic process; scaffold222 indexed_genome mRNA 362506 377299 . - . ID=transcript_15974;Q6Q317,Guanine nucleotide exchange factor VAV2,, PF00130;PF11971;PF00169;PF00621;PF00017;PF07653;, GO:0005829;GO:0005886;GO:0005154;GO:0005085;GO:0046872;GO:0001784;GO:0001525;GO:0016477;GO:0048013;GO:0038095;GO:0038096;GO:0007186;GO:0030032;GO:0030168;GO:0043065;GO:0043552;GO:0008361;GO:0043087;GO:0051056;GO:0007165;GO:0007264;GO:0048010;, C:cytosol; C:plasma membrane;, F:epidermal growth factor receptor binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphotyrosine residue binding;, P:angiogenesis; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:lamellipodium assembly; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction; P:vascular endothelial growth factor receptor signaling pathway; scaffold222 indexed_genome mRNA 377671 401404 . - . ID=transcript_15975;Q6Q317,Guanine nucleotide exchange factor VAV2,, PF00130;PF11971;PF00169;PF00621;PF00017;PF07653;, GO:0005829;GO:0005886;GO:0005154;GO:0005085;GO:0046872;GO:0001784;GO:0001525;GO:0016477;GO:0048013;GO:0038095;GO:0038096;GO:0007186;GO:0030032;GO:0030168;GO:0043065;GO:0043552;GO:0008361;GO:0043087;GO:0051056;GO:0007165;GO:0007264;GO:0048010;, C:cytosol; C:plasma membrane;, F:epidermal growth factor receptor binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphotyrosine residue binding;, P:angiogenesis; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:lamellipodium assembly; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction; P:vascular endothelial growth factor receptor signaling pathway;|Q6Q317,Guanine nucleotide exchange factor VAV2,, PF00130;PF11971;PF00169;PF00621;PF00017;PF07653;, GO:0005829;GO:0005886;GO:0005154;GO:0005085;GO:0046872;GO:0001784;GO:0001525;GO:0016477;GO:0048013;GO:0038095;GO:0038096;GO:0007186;GO:0030032;GO:0030168;GO:0043065;GO:0043552;GO:0008361;GO:0043087;GO:0051056;GO:0007165;GO:0007264;GO:0048010;, C:cytosol; C:plasma membrane;, F:epidermal growth factor receptor binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphotyrosine residue binding;, P:angiogenesis; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:lamellipodium assembly; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction; P:vascular endothelial growth factor receptor signaling pathway;|Q6Q317,Guanine nucleotide exchange factor VAV2,, PF00130;PF11971;PF00169;PF00621;PF00017;PF07653;, GO:0005829;GO:0005886;GO:0005154;GO:0005085;GO:0046872;GO:0001784;GO:0001525;GO:0016477;GO:0048013;GO:0038095;GO:0038096;GO:0007186;GO:0030032;GO:0030168;GO:0043065;GO:0043552;GO:0008361;GO:0043087;GO:0051056;GO:0007165;GO:0007264;GO:0048010;, C:cytosol; C:plasma membrane;, F:epidermal growth factor receptor binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphotyrosine residue binding;, P:angiogenesis; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:lamellipodium assembly; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction; P:vascular endothelial growth factor receptor signaling pathway;|Q6Q317,Guanine nucleotide exchange factor VAV2,, PF00130;PF11971;PF00169;PF00621;PF00017;PF07653;, GO:0005829;GO:0005886;GO:0005154;GO:0005085;GO:0046872;GO:0001784;GO:0001525;GO:0016477;GO:0048013;GO:0038095;GO:0038096;GO:0007186;GO:0030032;GO:0030168;GO:0043065;GO:0043552;GO:0008361;GO:0043087;GO:0051056;GO:0007165;GO:0007264;GO:0048010;, C:cytosol; C:plasma membrane;, F:epidermal growth factor receptor binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphotyrosine residue binding;, P:angiogenesis; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:lamellipodium assembly; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction; P:vascular endothelial growth factor receptor signaling pathway;|Q6Q317,Guanine nucleotide exchange factor VAV2,, PF00130;PF11971;PF00169;PF00621;PF00017;PF07653;, GO:0005829;GO:0005886;GO:0005154;GO:0005085;GO:0046872;GO:0001784;GO:0001525;GO:0016477;GO:0048013;GO:0038095;GO:0038096;GO:0007186;GO:0030032;GO:0030168;GO:0043065;GO:0043552;GO:0008361;GO:0043087;GO:0051056;GO:0007165;GO:0007264;GO:0048010;, C:cytosol; C:plasma membrane;, F:epidermal growth factor receptor binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphotyrosine residue binding;, P:angiogenesis; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:lamellipodium assembly; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction; P:vascular endothelial growth factor receptor signaling pathway;|Q6Q317,Guanine nucleotide exchange factor VAV2,, PF00130;PF11971;PF00169;PF00621;PF00017;PF07653;, GO:0005829;GO:0005886;GO:0005154;GO:0005085;GO:0046872;GO:0001784;GO:0001525;GO:0016477;GO:0048013;GO:0038095;GO:0038096;GO:0007186;GO:0030032;GO:0030168;GO:0043065;GO:0043552;GO:0008361;GO:0043087;GO:0051056;GO:0007165;GO:0007264;GO:0048010;, C:cytosol; C:plasma membrane;, F:epidermal growth factor receptor binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphotyrosine residue binding;, P:angiogenesis; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:lamellipodium assembly; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction; P:vascular endothelial growth factor receptor signaling pathway;|Q6Q317,Guanine nucleotide exchange factor VAV2,, PF00130;PF11971;PF00169;PF00621;PF00017;PF07653;, GO:0005829;GO:0005886;GO:0005154;GO:0005085;GO:0046872;GO:0001784;GO:0001525;GO:0016477;GO:0048013;GO:0038095;GO:0038096;GO:0007186;GO:0030032;GO:0030168;GO:0043065;GO:0043552;GO:0008361;GO:0043087;GO:0051056;GO:0007165;GO:0007264;GO:0048010;, C:cytosol; C:plasma membrane;, F:epidermal growth factor receptor binding; F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:phosphotyrosine residue binding;, P:angiogenesis; P:cell migration; P:ephrin receptor signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:G protein-coupled receptor signaling pathway; P:lamellipodium assembly; P:platelet activation; P:positive regulation of apoptotic process; P:positive regulation of phosphatidylinositol 3-kinase activity; P:regulation of cell size; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:small GTPase mediated signal transduction; P:vascular endothelial growth factor receptor signaling pathway; scaffold222 indexed_genome mRNA 536616 562774 . + . ID=transcript_15976;A0A1B0GUI7,Putative uncharacterized protein BRD3OS {ECO:0000305},BRD3 opposite strand protein {ECO:0000305};Long intergenic non-protein coding RNA 94 {ECO:0000312|HGNC:HGNC:24742};Non-protein coding RNA 94 {ECO:0000312|HGNC:HGNC:24742}; scaffold222 indexed_genome mRNA 565515 585366 . - . ID=transcript_15977;Q15059 B1APD9 Q4G5Y3 Q5T1R7 Q8N5M3 Q92645,Bromodomain-containing protein 3,RING3-like protein;, PF17035;PF00439;, GO:0005634;GO:0003682;GO:0070577;GO:0006325;GO:0006357;, C:nucleus;, F:chromatin binding; F:lysine-acetylated histone binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II;|Q15059 B1APD9 Q4G5Y3 Q5T1R7 Q8N5M3 Q92645,Bromodomain-containing protein 3,RING3-like protein;, PF17035;PF00439;, GO:0005634;GO:0003682;GO:0070577;GO:0006325;GO:0006357;, C:nucleus;, F:chromatin binding; F:lysine-acetylated histone binding;, P:chromatin organization; P:regulation of transcription by RNA polymerase II; scaffold223 indexed_genome mRNA 11691 33724 . + . ID=transcript_15978;P14209 A6NIW1 O00518 Q6ICV7,CD99 antigen,12E7;E2 antigen;Protein MIC2;T-cell surface glycoprotein E2;, PF12301;, GO:0005737;GO:0005925;GO:0005887;GO:0005886;GO:0034109;GO:2000391;GO:0050776;GO:0072683;, C:cytoplasm; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane;, , P:homotypic cell-cell adhesion; P:positive regulation of neutrophil extravasation; P:regulation of immune response; P:T cell extravasation; scaffold223 indexed_genome mRNA 151876 249185 . + . ID=transcript_15979;Q8N5I4 Q6UWC7 Q8WUS4 Q96GR8 Q9NTF6,Dehydrogenase/reductase SDR family member on chromosome X,DHRSXY;Short chain dehydrogenase/reductase family 46C member 1;Short chain dehydrogenase/reductase family 7C member 6;, PF00106;, GO:0005576;GO:0016491;GO:0010508;, C:extracellular region;, F:oxidoreductase activity;, P:positive regulation of autophagy; scaffold223 indexed_genome mRNA 477480 489491 . - . ID=transcript_15980;Q02040 Q02832 Q2TB98 Q5JQ74 Q5JQ76 Q8N6U9,A-kinase anchor protein 17A,721P;B-lymphocyte antigen;Protein XE7;Protein kinase A-anchoring protein 17A;Splicing factor, arginine/serine-rich 17A;, , GO:0005829;GO:0016607;GO:0005634;GO:0005681;GO:0051018;GO:0003723;GO:0042113;GO:0006397;GO:0043484;GO:0006355;GO:0008380;GO:0007165;, C:cytosol; C:nuclear speck; C:nucleus; C:spliceosomal complex;, F:protein kinase A binding; F:RNA binding;, P:B cell activation; P:mRNA processing; P:regulation of RNA splicing; P:regulation of transcription, DNA-templated; P:RNA splicing; P:signal transduction;|Q02040 Q02832 Q2TB98 Q5JQ74 Q5JQ76 Q8N6U9,A-kinase anchor protein 17A,721P;B-lymphocyte antigen;Protein XE7;Protein kinase A-anchoring protein 17A;Splicing factor, arginine/serine-rich 17A;, , GO:0005829;GO:0016607;GO:0005634;GO:0005681;GO:0051018;GO:0003723;GO:0042113;GO:0006397;GO:0043484;GO:0006355;GO:0008380;GO:0007165;, C:cytosol; C:nuclear speck; C:nucleus; C:spliceosomal complex;, F:protein kinase A binding; F:RNA binding;, P:B cell activation; P:mRNA processing; P:regulation of RNA splicing; P:regulation of transcription, DNA-templated; P:RNA splicing; P:signal transduction; scaffold224 indexed_genome mRNA 56283 82160 . - . ID=transcript_15981;Q9NRB3 A4D1Z9 Q502W3 Q9NXY7,Carbohydrate sulfotransferase 12,Chondroitin 4-O-sulfotransferase 2;Chondroitin 4-sulfotransferase 2;Sulfotransferase Hlo;, PF03567;, GO:0000139;GO:0030173;GO:0016020;GO:0050656;GO:0047756;GO:0008146;GO:0016051;GO:0030206;GO:0030208;GO:0030166;, C:Golgi membrane; C:integral component of Golgi membrane; C:membrane;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:chondroitin 4-sulfotransferase activity; F:sulfotransferase activity;, P:carbohydrate biosynthetic process; P:chondroitin sulfate biosynthetic process; P:dermatan sulfate biosynthetic process; P:proteoglycan biosynthetic process; scaffold224 indexed_genome mRNA 101644 107708 . - . ID=transcript_15982;Q2TAC6 A6NLG2 B7ZKR1 Q52M87 Q8N1X8 Q8TAB6,Kinesin-like protein KIF19,, PF00225;, GO:0005930;GO:0005929;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0060404;GO:0007018;GO:0070462;, C:axoneme; C:cilium; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:axonemal microtubule depolymerization; P:microtubule-based movement; P:plus-end specific microtubule depolymerization; scaffold224 indexed_genome mRNA 108510 113874 . - . ID=transcript_15983;Q2TAC6 A6NLG2 B7ZKR1 Q52M87 Q8N1X8 Q8TAB6,Kinesin-like protein KIF19,, PF00225;, GO:0005930;GO:0005929;GO:0005871;GO:0005874;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0060404;GO:0007018;GO:0070462;, C:axoneme; C:cilium; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:axonemal microtubule depolymerization; P:microtubule-based movement; P:plus-end specific microtubule depolymerization; scaffold224 indexed_genome mRNA 124478 132093 . - . ID=transcript_15984;P55884 A4D208 Q2NL77 Q9UMF9,Eukaryotic translation initiation factor 3 subunit B {ECO:0000255|HAMAP-Rule:MF_03001},Eukaryotic translation initiation factor 3 subunit 9 {ECO:0000255|HAMAP-Rule:MF_03001};Prt1 homolog;eIF-3-eta {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p110 {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p116;, PF08662;PF00076;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0045202;GO:0060090;GO:0003723;GO:0003743;GO:0031369;GO:0001732;GO:0075522;GO:0006446;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome; C:synapse;, F:molecular adaptor activity; F:RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:regulation of translational initiation; P:translational initiation; P:viral translational termination-reinitiation;|P55884 A4D208 Q2NL77 Q9UMF9,Eukaryotic translation initiation factor 3 subunit B {ECO:0000255|HAMAP-Rule:MF_03001},Eukaryotic translation initiation factor 3 subunit 9 {ECO:0000255|HAMAP-Rule:MF_03001};Prt1 homolog;eIF-3-eta {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p110 {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p116;, PF08662;PF00076;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0045202;GO:0060090;GO:0003723;GO:0003743;GO:0031369;GO:0001732;GO:0075522;GO:0006446;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome; C:synapse;, F:molecular adaptor activity; F:RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:regulation of translational initiation; P:translational initiation; P:viral translational termination-reinitiation;|P55884 A4D208 Q2NL77 Q9UMF9,Eukaryotic translation initiation factor 3 subunit B {ECO:0000255|HAMAP-Rule:MF_03001},Eukaryotic translation initiation factor 3 subunit 9 {ECO:0000255|HAMAP-Rule:MF_03001};Prt1 homolog;eIF-3-eta {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p110 {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p116;, PF08662;PF00076;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0045202;GO:0060090;GO:0003723;GO:0003743;GO:0031369;GO:0001732;GO:0075522;GO:0006446;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome; C:synapse;, F:molecular adaptor activity; F:RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:regulation of translational initiation; P:translational initiation; P:viral translational termination-reinitiation; scaffold224 indexed_genome mRNA 133345 134982 . + . ID=transcript_15985;P55884 A4D208 Q2NL77 Q9UMF9,Eukaryotic translation initiation factor 3 subunit B {ECO:0000255|HAMAP-Rule:MF_03001},Eukaryotic translation initiation factor 3 subunit 9 {ECO:0000255|HAMAP-Rule:MF_03001};Prt1 homolog;eIF-3-eta {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p110 {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p116;, PF08662;PF00076;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0045202;GO:0060090;GO:0003723;GO:0003743;GO:0031369;GO:0001732;GO:0075522;GO:0006446;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome; C:synapse;, F:molecular adaptor activity; F:RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:regulation of translational initiation; P:translational initiation; P:viral translational termination-reinitiation; scaffold224 indexed_genome mRNA 137798 139530 . - . ID=transcript_15986;P55884 A4D208 Q2NL77 Q9UMF9,Eukaryotic translation initiation factor 3 subunit B {ECO:0000255|HAMAP-Rule:MF_03001},Eukaryotic translation initiation factor 3 subunit 9 {ECO:0000255|HAMAP-Rule:MF_03001};Prt1 homolog;eIF-3-eta {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p110 {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p116;, PF08662;PF00076;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0045202;GO:0060090;GO:0003723;GO:0003743;GO:0031369;GO:0001732;GO:0075522;GO:0006446;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome; C:synapse;, F:molecular adaptor activity; F:RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:regulation of translational initiation; P:translational initiation; P:viral translational termination-reinitiation;|P55884 A4D208 Q2NL77 Q9UMF9,Eukaryotic translation initiation factor 3 subunit B {ECO:0000255|HAMAP-Rule:MF_03001},Eukaryotic translation initiation factor 3 subunit 9 {ECO:0000255|HAMAP-Rule:MF_03001};Prt1 homolog;eIF-3-eta {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p110 {ECO:0000255|HAMAP-Rule:MF_03001};eIF3 p116;, PF08662;PF00076;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0070062;GO:0045202;GO:0060090;GO:0003723;GO:0003743;GO:0031369;GO:0001732;GO:0075522;GO:0006446;GO:0006413;GO:0075525;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:extracellular exosome; C:synapse;, F:molecular adaptor activity; F:RNA binding; F:translation initiation factor activity; F:translation initiation factor binding;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:regulation of translational initiation; P:translational initiation; P:viral translational termination-reinitiation; scaffold224 indexed_genome mRNA 206273 225350 . + . ID=transcript_15987;Q9Y5X2 A4D207 Q96I67,Sorting nexin-8,, PF00787;, GO:0005829;GO:0031901;GO:0043231;GO:0042802;GO:0035091;GO:0034498;GO:0006886;, C:cytosol; C:early endosome membrane; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:phosphatidylinositol binding;, P:early endosome to Golgi transport; P:intracellular protein transport;|Q9Y5X2 A4D207 Q96I67,Sorting nexin-8,, PF00787;, GO:0005829;GO:0031901;GO:0043231;GO:0042802;GO:0035091;GO:0034498;GO:0006886;, C:cytosol; C:early endosome membrane; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:phosphatidylinositol binding;, P:early endosome to Golgi transport; P:intracellular protein transport;|Q9Y5X2 A4D207 Q96I67,Sorting nexin-8,, PF00787;, GO:0005829;GO:0031901;GO:0043231;GO:0042802;GO:0035091;GO:0034498;GO:0006886;, C:cytosol; C:early endosome membrane; C:intracellular membrane-bounded organelle;, F:identical protein binding; F:phosphatidylinositol binding;, P:early endosome to Golgi transport; P:intracellular protein transport;|P36639 A4D205 Q6LES7 Q6P0Y6 Q7Z7N6 Q8IV95 Q9UBM0 Q9UBM9,7,8-dihydro-8-oxoguanine triphosphatase,2-hydroxy-dATP diphosphatase;8-oxo-dGTPase;Nucleoside diphosphate-linked moiety X motif 1;, PF00293;, GO:0001669;GO:0005737;GO:0005829;GO:0005615;GO:0005759;GO:0005739;GO:0031965;GO:0005634;GO:0005886;GO:0044714;GO:0035539;GO:0008413;GO:0047693;GO:0008828;GO:0046872;GO:0030515;GO:0007568;GO:0042262;GO:0006281;GO:0008584;GO:0034656;GO:0046686;GO:0006979;, C:acrosomal vesicle; C:cytoplasm; C:cytosol; C:extracellular space; C:mitochondrial matrix; C:mitochondrion; C:nuclear membrane; C:nucleus; C:plasma membrane;, F:2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity; F:8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity; F:8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity; F:ATP diphosphatase activity; F:dATP pyrophosphohydrolase activity; F:metal ion binding; F:snoRNA binding;, P:aging; P:DNA protection; P:DNA repair; P:male gonad development; P:nucleobase-containing small molecule catabolic process; P:response to cadmium ion; P:response to oxidative stress; scaffold224 indexed_genome mRNA 228355 232497 . + . ID=transcript_15988;Q9UI43 Q24JR8,rRNA methyltransferase 2, mitochondrial {ECO:0000303|PubMed:24036117},16S rRNA (uridine(1369)-2'-O)-methyltransferase {ECO:0000303|PubMed:25074936};16S rRNA [Um1369] 2'-O-methyltransferase {ECO:0000303|PubMed:25074936};Protein ftsJ homolog 2 {ECO:0000303|PubMed:11827451};, PF01728;, GO:0005759;GO:0005739;GO:0005730;GO:0008173;GO:0008650;GO:0001510;GO:0000451;GO:0031167;GO:0006364;, C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:RNA methyltransferase activity; F:rRNA (uridine-2'-O-)-methyltransferase activity;, P:RNA methylation; P:rRNA 2'-O-methylation; P:rRNA methylation; P:rRNA processing; scaffold224 indexed_genome mRNA 234160 488166 . + . ID=transcript_15989;Q9Y6D9 B3KR41 Q13312 Q75MI0 Q86UM4 Q9UNH0,Mitotic spindle assembly checkpoint protein MAD1,Mitotic arrest deficient 1-like protein 1;Mitotic checkpoint MAD1 protein homolog;Tax-binding protein 181;, PF05557;, GO:0005813;GO:0000777;GO:0005829;GO:0000776;GO:0072686;GO:0044615;GO:0005819;GO:0000922;GO:0042802;GO:0043515;GO:0051315;GO:0051301;GO:0007094;GO:0007052;GO:0042130;GO:0090235;GO:0048538;, C:centrosome; C:condensed chromosome kinetochore; C:cytosol; C:kinetochore; C:mitotic spindle; C:nuclear pore nuclear basket; C:spindle; C:spindle pole;, F:identical protein binding; F:kinetochore binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:mitotic spindle assembly checkpoint; P:mitotic spindle organization; P:negative regulation of T cell proliferation; P:regulation of metaphase plate congression; P:thymus development; scaffold224 indexed_genome mRNA 523230 523988 . + . ID=transcript_15990;P0C7U0 H3BS57,Protein ELFN1,Extracellular leucine-rich repeat and fibronectin type-III domain-containing protein 1;Protein phosphatase 1 regulatory subunit 28;, PF13855;, GO:0030425;GO:0060076;GO:0031012;GO:0005615;GO:0016021;GO:0004864;GO:0010923;GO:0050808;, C:dendrite; C:excitatory synapse; C:extracellular matrix; C:extracellular space; C:integral component of membrane;, F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity; P:synapse organization; scaffold225 indexed_genome mRNA 6269 18194 . + . ID=transcript_15991;P30533 D3DVR9 Q2M310 Q53HQ3 Q53HS6,Alpha-2-macroglobulin receptor-associated protein {ECO:0000305},Low density lipoprotein receptor-related protein-associated protein 1;, PF06401;PF06400;, GO:0009986;GO:0005801;GO:0012505;GO:0005783;GO:0005793;GO:0005768;GO:0031904;GO:0005576;GO:0005794;GO:0005796;GO:0005886;GO:0048237;GO:0001540;GO:0008201;GO:0035473;GO:0050750;GO:0048019;GO:0048018;GO:0005102;GO:0070326;GO:0150093;GO:1900116;GO:1900222;GO:0060548;GO:0032091;GO:0002091;GO:0010916;GO:1900223;GO:0048259;GO:0007165;, C:cell surface; C:cis-Golgi network; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome; C:endosome lumen; C:extracellular region; C:Golgi apparatus; C:Golgi lumen; C:plasma membrane; C:rough endoplasmic reticulum lumen;, F:amyloid-beta binding; F:heparin binding; F:lipase binding; F:low-density lipoprotein particle receptor binding; F:receptor antagonist activity; F:receptor ligand activity; F:signaling receptor binding; F:very-low-density lipoprotein particle receptor binding;, P:amyloid-beta clearance by transcytosis; P:extracellular negative regulation of signal transduction; P:negative regulation of amyloid-beta clearance; P:negative regulation of cell death; P:negative regulation of protein binding; P:negative regulation of receptor internalization; P:negative regulation of very-low-density lipoprotein particle clearance; P:positive regulation of amyloid-beta clearance; P:regulation of receptor-mediated endocytosis; P:signal transduction;|P30533 D3DVR9 Q2M310 Q53HQ3 Q53HS6,Alpha-2-macroglobulin receptor-associated protein {ECO:0000305},Low density lipoprotein receptor-related protein-associated protein 1;, PF06401;PF06400;, GO:0009986;GO:0005801;GO:0012505;GO:0005783;GO:0005793;GO:0005768;GO:0031904;GO:0005576;GO:0005794;GO:0005796;GO:0005886;GO:0048237;GO:0001540;GO:0008201;GO:0035473;GO:0050750;GO:0048019;GO:0048018;GO:0005102;GO:0070326;GO:0150093;GO:1900116;GO:1900222;GO:0060548;GO:0032091;GO:0002091;GO:0010916;GO:1900223;GO:0048259;GO:0007165;, C:cell surface; C:cis-Golgi network; C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:endosome; C:endosome lumen; C:extracellular region; C:Golgi apparatus; C:Golgi lumen; C:plasma membrane; C:rough endoplasmic reticulum lumen;, F:amyloid-beta binding; F:heparin binding; F:lipase binding; F:low-density lipoprotein particle receptor binding; F:receptor antagonist activity; F:receptor ligand activity; F:signaling receptor binding; F:very-low-density lipoprotein particle receptor binding;, P:amyloid-beta clearance by transcytosis; P:extracellular negative regulation of signal transduction; P:negative regulation of amyloid-beta clearance; P:negative regulation of cell death; P:negative regulation of protein binding; P:negative regulation of receptor internalization; P:negative regulation of very-low-density lipoprotein particle clearance; P:positive regulation of amyloid-beta clearance; P:regulation of receptor-mediated endocytosis; P:signal transduction; scaffold225 indexed_genome mRNA 548456 562601 . - . ID=transcript_15992;Q66K79 O00520 Q96MX2,Carboxypeptidase Z,, PF01392;PF00246;, GO:0005615;GO:0004181;GO:0008270;GO:0006518;GO:0016485;GO:0006508;GO:0016055;, C:extracellular space;, F:metallocarboxypeptidase activity; F:zinc ion binding;, P:peptide metabolic process; P:protein processing; P:proteolysis; P:Wnt signaling pathway; scaffold226 indexed_genome mRNA 3536 11753 . + . ID=transcript_15993;O96009 Q8WWD9,Napsin-A,Aspartyl protease 4;Napsin-1;TA01/TA02;, PF00026;, GO:0097208;GO:0070062;GO:0005615;GO:0005764;GO:0097486;GO:0004190;GO:0004175;GO:0008233;GO:0044267;GO:0033619;GO:0006508;GO:0043129;, C:alveolar lamellar body; C:extracellular exosome; C:extracellular space; C:lysosome; C:multivesicular body lumen;, F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:peptidase activity;, P:cellular protein metabolic process; P:membrane protein proteolysis; P:proteolysis; P:surfactant homeostasis;|O96009 Q8WWD9,Napsin-A,Aspartyl protease 4;Napsin-1;TA01/TA02;, PF00026;, GO:0097208;GO:0070062;GO:0005615;GO:0005764;GO:0097486;GO:0004190;GO:0004175;GO:0008233;GO:0044267;GO:0033619;GO:0006508;GO:0043129;, C:alveolar lamellar body; C:extracellular exosome; C:extracellular space; C:lysosome; C:multivesicular body lumen;, F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:peptidase activity;, P:cellular protein metabolic process; P:membrane protein proteolysis; P:proteolysis; P:surfactant homeostasis;|O96009 Q8WWD9,Napsin-A,Aspartyl protease 4;Napsin-1;TA01/TA02;, PF00026;, GO:0097208;GO:0070062;GO:0005615;GO:0005764;GO:0097486;GO:0004190;GO:0004175;GO:0008233;GO:0044267;GO:0033619;GO:0006508;GO:0043129;, C:alveolar lamellar body; C:extracellular exosome; C:extracellular space; C:lysosome; C:multivesicular body lumen;, F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:peptidase activity;, P:cellular protein metabolic process; P:membrane protein proteolysis; P:proteolysis; P:surfactant homeostasis;|O96009 Q8WWD9,Napsin-A,Aspartyl protease 4;Napsin-1;TA01/TA02;, PF00026;, GO:0097208;GO:0070062;GO:0005615;GO:0005764;GO:0097486;GO:0004190;GO:0004175;GO:0008233;GO:0044267;GO:0033619;GO:0006508;GO:0043129;, C:alveolar lamellar body; C:extracellular exosome; C:extracellular space; C:lysosome; C:multivesicular body lumen;, F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:peptidase activity;, P:cellular protein metabolic process; P:membrane protein proteolysis; P:proteolysis; P:surfactant homeostasis;|O96009 Q8WWD9,Napsin-A,Aspartyl protease 4;Napsin-1;TA01/TA02;, PF00026;, GO:0097208;GO:0070062;GO:0005615;GO:0005764;GO:0097486;GO:0004190;GO:0004175;GO:0008233;GO:0044267;GO:0033619;GO:0006508;GO:0043129;, C:alveolar lamellar body; C:extracellular exosome; C:extracellular space; C:lysosome; C:multivesicular body lumen;, F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:peptidase activity;, P:cellular protein metabolic process; P:membrane protein proteolysis; P:proteolysis; P:surfactant homeostasis;|O96009 Q8WWD9,Napsin-A,Aspartyl protease 4;Napsin-1;TA01/TA02;, PF00026;, GO:0097208;GO:0070062;GO:0005615;GO:0005764;GO:0097486;GO:0004190;GO:0004175;GO:0008233;GO:0044267;GO:0033619;GO:0006508;GO:0043129;, C:alveolar lamellar body; C:extracellular exosome; C:extracellular space; C:lysosome; C:multivesicular body lumen;, F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:peptidase activity;, P:cellular protein metabolic process; P:membrane protein proteolysis; P:proteolysis; P:surfactant homeostasis;|O96009 Q8WWD9,Napsin-A,Aspartyl protease 4;Napsin-1;TA01/TA02;, PF00026;, GO:0097208;GO:0070062;GO:0005615;GO:0005764;GO:0097486;GO:0004190;GO:0004175;GO:0008233;GO:0044267;GO:0033619;GO:0006508;GO:0043129;, C:alveolar lamellar body; C:extracellular exosome; C:extracellular space; C:lysosome; C:multivesicular body lumen;, F:aspartic-type endopeptidase activity; F:endopeptidase activity; F:peptidase activity;, P:cellular protein metabolic process; P:membrane protein proteolysis; P:proteolysis; P:surfactant homeostasis; scaffold226 indexed_genome mRNA 27538 30326 . + . ID=transcript_15994;Q9UQB9 O60681 O75442 Q6AZY8 Q6DLZ0 Q9UPK5,Aurora kinase C,Aurora 3;Aurora/IPL1-related kinase 3;Aurora/IPL1/Eg2 protein 2;Serine/threonine-protein kinase 13;Serine/threonine-protein kinase aurora-C;, PF00069;, GO:0032133;GO:0000775;GO:0000793;GO:0005737;GO:0030496;GO:0005634;GO:0005819;GO:0005876;GO:0051233;GO:0031616;GO:0005524;GO:0035174;GO:0004672;GO:0106310;GO:0004712;GO:0106311;GO:0008608;GO:0051301;GO:0016570;GO:0051321;GO:0051256;GO:0007052;GO:0048599;GO:0032467;GO:0006468;GO:0032465;GO:0007283;, C:chromosome passenger complex; C:chromosome, centromeric region; C:condensed chromosome; C:cytoplasm; C:midbody; C:nucleus; C:spindle; C:spindle microtubule; C:spindle midzone; C:spindle pole centrosome;, F:ATP binding; F:histone serine kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:attachment of spindle microtubules to kinetochore; P:cell division; P:histone modification; P:meiotic cell cycle; P:mitotic spindle midzone assembly; P:mitotic spindle organization; P:oocyte development; P:positive regulation of cytokinesis; P:protein phosphorylation; P:regulation of cytokinesis; P:spermatogenesis; scaffold226 indexed_genome mRNA 32540 38203 . + . ID=transcript_15995;P55055 A8K490 B4DNM6 E7EWA6 Q12970 Q5I0Y1,Oxysterols receptor LXR-beta,Liver X receptor beta;Nuclear receptor NER;Nuclear receptor subfamily 1 group H member 2;Ubiquitously-expressed nuclear receptor;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0034191;GO:0051117;GO:0003677;GO:0001228;GO:0000981;GO:0004879;GO:0046965;GO:0000978;GO:0008270;GO:0030154;GO:0042632;GO:0030522;GO:0010887;GO:0120163;GO:0060336;GO:0032369;GO:0010745;GO:0048550;GO:0045861;GO:1903573;GO:0000122;GO:0045892;GO:0036151;GO:0032270;GO:0010875;GO:0032376;GO:0045723;GO:0090108;GO:0010884;GO:0051006;GO:0090187;GO:0090340;GO:0045944;GO:0045893;GO:0010867;GO:0031667;GO:0048384;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:apolipoprotein A-I receptor binding; F:ATPase binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:cholesterol homeostasis; P:intracellular receptor signaling pathway; P:negative regulation of cholesterol storage; P:negative regulation of cold-induced thermogenesis; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of pinocytosis; P:negative regulation of proteolysis; P:negative regulation of response to endoplasmic reticulum stress; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:phosphatidylcholine acyl-chain remodeling; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol transport; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of high-density lipoprotein particle assembly; P:positive regulation of lipid storage; P:positive regulation of lipoprotein lipase activity; P:positive regulation of pancreatic juice secretion; P:positive regulation of secretion of lysosomal enzymes; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of triglyceride biosynthetic process; P:response to nutrient levels; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter;|P55055 A8K490 B4DNM6 E7EWA6 Q12970 Q5I0Y1,Oxysterols receptor LXR-beta,Liver X receptor beta;Nuclear receptor NER;Nuclear receptor subfamily 1 group H member 2;Ubiquitously-expressed nuclear receptor;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0034191;GO:0051117;GO:0003677;GO:0001228;GO:0000981;GO:0004879;GO:0046965;GO:0000978;GO:0008270;GO:0030154;GO:0042632;GO:0030522;GO:0010887;GO:0120163;GO:0060336;GO:0032369;GO:0010745;GO:0048550;GO:0045861;GO:1903573;GO:0000122;GO:0045892;GO:0036151;GO:0032270;GO:0010875;GO:0032376;GO:0045723;GO:0090108;GO:0010884;GO:0051006;GO:0090187;GO:0090340;GO:0045944;GO:0045893;GO:0010867;GO:0031667;GO:0048384;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:apolipoprotein A-I receptor binding; F:ATPase binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:cholesterol homeostasis; P:intracellular receptor signaling pathway; P:negative regulation of cholesterol storage; P:negative regulation of cold-induced thermogenesis; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of pinocytosis; P:negative regulation of proteolysis; P:negative regulation of response to endoplasmic reticulum stress; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:phosphatidylcholine acyl-chain remodeling; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol transport; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of high-density lipoprotein particle assembly; P:positive regulation of lipid storage; P:positive regulation of lipoprotein lipase activity; P:positive regulation of pancreatic juice secretion; P:positive regulation of secretion of lysosomal enzymes; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of triglyceride biosynthetic process; P:response to nutrient levels; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter;|P55055 A8K490 B4DNM6 E7EWA6 Q12970 Q5I0Y1,Oxysterols receptor LXR-beta,Liver X receptor beta;Nuclear receptor NER;Nuclear receptor subfamily 1 group H member 2;Ubiquitously-expressed nuclear receptor;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0034191;GO:0051117;GO:0003677;GO:0001228;GO:0000981;GO:0004879;GO:0046965;GO:0000978;GO:0008270;GO:0030154;GO:0042632;GO:0030522;GO:0010887;GO:0120163;GO:0060336;GO:0032369;GO:0010745;GO:0048550;GO:0045861;GO:1903573;GO:0000122;GO:0045892;GO:0036151;GO:0032270;GO:0010875;GO:0032376;GO:0045723;GO:0090108;GO:0010884;GO:0051006;GO:0090187;GO:0090340;GO:0045944;GO:0045893;GO:0010867;GO:0031667;GO:0048384;GO:0006367;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:apolipoprotein A-I receptor binding; F:ATPase binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoid X receptor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:cell differentiation; P:cholesterol homeostasis; P:intracellular receptor signaling pathway; P:negative regulation of cholesterol storage; P:negative regulation of cold-induced thermogenesis; P:negative regulation of interferon-gamma-mediated signaling pathway; P:negative regulation of lipid transport; P:negative regulation of macrophage derived foam cell differentiation; P:negative regulation of pinocytosis; P:negative regulation of proteolysis; P:negative regulation of response to endoplasmic reticulum stress; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:phosphatidylcholine acyl-chain remodeling; P:positive regulation of cellular protein metabolic process; P:positive regulation of cholesterol efflux; P:positive regulation of cholesterol transport; P:positive regulation of fatty acid biosynthetic process; P:positive regulation of high-density lipoprotein particle assembly; P:positive regulation of lipid storage; P:positive regulation of lipoprotein lipase activity; P:positive regulation of pancreatic juice secretion; P:positive regulation of secretion of lysosomal enzymes; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of triglyceride biosynthetic process; P:response to nutrient levels; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter; scaffold226 indexed_genome mRNA 52505 61279 . + . ID=transcript_15996;P28340 Q8NER3 Q96H98,DNA polymerase delta catalytic subunit {ECO:0000305},3'-5' exodeoxyribonuclease {ECO:0000305};DNA polymerase subunit delta p125;, PF00136;PF03104;PF14260;, GO:0016235;GO:0005829;GO:0043625;GO:0016020;GO:0005654;GO:0000109;GO:0005634;GO:0008296;GO:0051539;GO:0003682;GO:0003684;GO:0003677;GO:0003887;GO:0046872;GO:0000166;GO:0006287;GO:0034644;GO:0071897;GO:0042769;GO:0006281;GO:0006260;GO:0045004;GO:0000731;GO:0006261;GO:0070987;GO:0055089;GO:0006298;GO:0006297;GO:0033683;GO:0006296;GO:0009411;GO:0000723;GO:0032201;GO:0006283;GO:0019985;, C:aggresome; C:cytosol; C:delta DNA polymerase complex; C:membrane; C:nucleoplasm; C:nucleotide-excision repair complex; C:nucleus;, F:3'-5'-exodeoxyribonuclease activity; F:4 iron, 4 sulfur cluster binding; F:chromatin binding; F:damaged DNA binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:nucleotide binding;, P:base-excision repair, gap-filling; P:cellular response to UV; P:DNA biosynthetic process; P:DNA damage response, detection of DNA damage; P:DNA repair; P:DNA replication; P:DNA replication proofreading; P:DNA synthesis involved in DNA repair; P:DNA-dependent DNA replication; P:error-free translesion synthesis; P:fatty acid homeostasis; P:mismatch repair; P:nucleotide-excision repair, DNA gap filling; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:response to UV; P:telomere maintenance; P:telomere maintenance via semi-conservative replication; P:transcription-coupled nucleotide-excision repair; P:translesion synthesis; scaffold226 indexed_genome mRNA 62639 71067 . + . ID=transcript_15997;Q01892 A8K9C9 B4DUG6 Q15359,Transcription factor Spi-B,, PF00178;, GO:0000785;GO:0005737;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0030154;GO:0045944;GO:0006357;, C:chromatin; C:cytoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold226 indexed_genome mRNA 72468 148038 . + . ID=transcript_15998;Q14324 A1L4G9,Myosin-binding protein C, fast-type,C-protein, skeletal muscle fast isoform;, PF00041;PF07679;PF18362;, GO:0005829;GO:0032982;GO:0003779;GO:0008307;GO:0007155;GO:0030049;, C:cytosol; C:myosin filament;, F:actin binding; F:structural constituent of muscle;, P:cell adhesion; P:muscle filament sliding;|Q14324 A1L4G9,Myosin-binding protein C, fast-type,C-protein, skeletal muscle fast isoform;, PF00041;PF07679;PF18362;, GO:0005829;GO:0032982;GO:0003779;GO:0008307;GO:0007155;GO:0030049;, C:cytosol; C:myosin filament;, F:actin binding; F:structural constituent of muscle;, P:cell adhesion; P:muscle filament sliding;|Q14324 A1L4G9,Myosin-binding protein C, fast-type,C-protein, skeletal muscle fast isoform;, PF00041;PF07679;PF18362;, GO:0005829;GO:0032982;GO:0003779;GO:0008307;GO:0007155;GO:0030049;, C:cytosol; C:myosin filament;, F:actin binding; F:structural constituent of muscle;, P:cell adhesion; P:muscle filament sliding;|Q14324 A1L4G9,Myosin-binding protein C, fast-type,C-protein, skeletal muscle fast isoform;, PF00041;PF07679;PF18362;, GO:0005829;GO:0032982;GO:0003779;GO:0008307;GO:0007155;GO:0030049;, C:cytosol; C:myosin filament;, F:actin binding; F:structural constituent of muscle;, P:cell adhesion; P:muscle filament sliding;|Q14324 A1L4G9,Myosin-binding protein C, fast-type,C-protein, skeletal muscle fast isoform;, PF00041;PF07679;PF18362;, GO:0005829;GO:0032982;GO:0003779;GO:0008307;GO:0007155;GO:0030049;, C:cytosol; C:myosin filament;, F:actin binding; F:structural constituent of muscle;, P:cell adhesion; P:muscle filament sliding;|Q6IPT2 Q96EJ5 Q9BSM9,Protein FAM71E1,, PF12480;|Q14324 A1L4G9,Myosin-binding protein C, fast-type,C-protein, skeletal muscle fast isoform;, PF00041;PF07679;PF18362;, GO:0005829;GO:0032982;GO:0003779;GO:0008307;GO:0007155;GO:0030049;, C:cytosol; C:myosin filament;, F:actin binding; F:structural constituent of muscle;, P:cell adhesion; P:muscle filament sliding;|Q6IPT2 Q96EJ5 Q9BSM9,Protein FAM71E1,, PF12480;|Q5UCC4 Q5UCC6 Q69YT5 Q6UWP3 Q86YL4 Q8N541,ER membrane protein complex subunit 10,Hematopoietic signal peptide-containing membrane domain-containing protein 1;, , GO:0072546;GO:0005576;GO:0030176;GO:0016021;GO:0001525;GO:0045766;GO:0010595;GO:0001938;GO:1900745;GO:0045050;GO:0071816;, C:EMC complex; C:extracellular region; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:angiogenesis; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of p38MAPK cascade; P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q5UCC4 Q5UCC6 Q69YT5 Q6UWP3 Q86YL4 Q8N541,ER membrane protein complex subunit 10,Hematopoietic signal peptide-containing membrane domain-containing protein 1;, , GO:0072546;GO:0005576;GO:0030176;GO:0016021;GO:0001525;GO:0045766;GO:0010595;GO:0001938;GO:1900745;GO:0045050;GO:0071816;, C:EMC complex; C:extracellular region; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:angiogenesis; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of p38MAPK cascade; P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q5UCC4 Q5UCC6 Q69YT5 Q6UWP3 Q86YL4 Q8N541,ER membrane protein complex subunit 10,Hematopoietic signal peptide-containing membrane domain-containing protein 1;, , GO:0072546;GO:0005576;GO:0030176;GO:0016021;GO:0001525;GO:0045766;GO:0010595;GO:0001938;GO:1900745;GO:0045050;GO:0071816;, C:EMC complex; C:extracellular region; C:integral component of endoplasmic reticulum membrane; C:integral component of membrane;, , P:angiogenesis; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of p38MAPK cascade; P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;|Q8TAC2 M0QX25,Josephin-2,Josephin domain-containing protein 2;, PF02099;, GO:0005829;GO:0004843;GO:0016579;, C:cytosol;, F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|Q8TAC2 M0QX25,Josephin-2,Josephin domain-containing protein 2;, PF02099;, GO:0005829;GO:0004843;GO:0016579;, C:cytosol;, F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|Q8TAC2 M0QX25,Josephin-2,Josephin domain-containing protein 2;, PF02099;, GO:0005829;GO:0004843;GO:0016579;, C:cytosol;, F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|A6ND91 Q6NZ37,Putative L-aspartate dehydrogenase,Aspartate dehydrogenase domain-containing protein;, PF01958;PF03447;, GO:0033735;GO:0050661;GO:0009435;, , F:aspartate dehydrogenase activity; F:NADP binding;, P:NAD biosynthetic process;|Q8TAC2 M0QX25,Josephin-2,Josephin domain-containing protein 2;, PF02099;, GO:0005829;GO:0004843;GO:0016579;, C:cytosol;, F:thiol-dependent ubiquitin-specific protease activity;, P:protein deubiquitination;|A6ND91 Q6NZ37,Putative L-aspartate dehydrogenase,Aspartate dehydrogenase domain-containing protein;, PF01958;PF03447;, GO:0033735;GO:0050661;GO:0009435;, , F:aspartate dehydrogenase activity; F:NADP binding;, P:NAD biosynthetic process;|Q9NT99 Q3ZCQ4 Q58F20,Leucine-rich repeat-containing protein 4B,Netrin-G3 ligand;, PF07679;PF13855;, GO:0044300;GO:0098978;GO:0099061;GO:0005886;GO:0042734;GO:0005102;GO:0051965;GO:0099151;GO:1905606;GO:0099560;, C:cerebellar mossy fiber; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:plasma membrane; C:presynaptic membrane;, F:signaling receptor binding;, P:positive regulation of synapse assembly; P:regulation of postsynaptic density assembly; P:regulation of presynapse assembly; P:synaptic membrane adhesion; scaffold226 indexed_genome mRNA 209555 224299 . - . ID=transcript_15999;Q9BQG1 Q8N5Z1 Q8N640,Synaptotagmin-3,Synaptotagmin III;, PF00168;, GO:0005768;GO:0070382;GO:0016021;GO:0005886;GO:0030658;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0000149;GO:0019905;GO:0017156;GO:0030154;GO:0071277;GO:1903861;GO:0017158;GO:0014059;GO:0016192;, C:endosome; C:exocytic vesicle; C:integral component of membrane; C:plasma membrane; C:transport vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:vesicle-mediated transport;|Q9BQG1 Q8N5Z1 Q8N640,Synaptotagmin-3,Synaptotagmin III;, PF00168;, GO:0005768;GO:0070382;GO:0016021;GO:0005886;GO:0030658;GO:0005509;GO:0005544;GO:0030276;GO:0001786;GO:0000149;GO:0019905;GO:0017156;GO:0030154;GO:0071277;GO:1903861;GO:0017158;GO:0014059;GO:0016192;, C:endosome; C:exocytic vesicle; C:integral component of membrane; C:plasma membrane; C:transport vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:positive regulation of dendrite extension; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:vesicle-mediated transport; scaffold226 indexed_genome mRNA 241410 242942 . - . ID=transcript_16000;C9J6K1,Putative uncharacterized protein C19orf81,, PF15876; scaffold226 indexed_genome mRNA 246576 247906 . + . ID=transcript_16001;Q9Y566 A8MXP5 B7WNY6 Q9NYW9,SH3 and multiple ankyrin repeat domains protein 1,Somatostatin receptor-interacting protein;, PF12796;PF17820;PF00536;PF07653;, GO:0005829;GO:0030425;GO:0043197;GO:0060076;GO:0016020;GO:0043005;GO:0005886;GO:0014069;GO:0045211;GO:0071532;GO:0042802;GO:0035255;GO:0008022;GO:0044877;GO:0097110;GO:0017124;GO:0031877;GO:0030160;GO:0030534;GO:0008306;GO:0048854;GO:0060997;GO:0050894;GO:0007616;GO:0060291;GO:0032232;GO:0050885;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:0035418;GO:0065003;GO:2000311;GO:0035176;GO:0060074;GO:0051124;GO:0071625;, C:cytosol; C:dendrite; C:dendritic spine; C:excitatory synapse; C:membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:ankyrin repeat binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein-containing complex binding; F:scaffold protein binding; F:SH3 domain binding; F:somatostatin receptor binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:associative learning; P:brain morphogenesis; P:dendritic spine morphogenesis; P:determination of affect; P:long-term memory; P:long-term synaptic potentiation; P:negative regulation of actin filament bundle assembly; P:neuromuscular process controlling balance; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:protein localization to synapse; P:protein-containing complex assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse maturation; P:synaptic growth at neuromuscular junction; P:vocalization behavior; scaffold226 indexed_genome mRNA 250828 255866 . + . ID=transcript_16002;Q9Y566 A8MXP5 B7WNY6 Q9NYW9,SH3 and multiple ankyrin repeat domains protein 1,Somatostatin receptor-interacting protein;, PF12796;PF17820;PF00536;PF07653;, GO:0005829;GO:0030425;GO:0043197;GO:0060076;GO:0016020;GO:0043005;GO:0005886;GO:0014069;GO:0045211;GO:0071532;GO:0042802;GO:0035255;GO:0008022;GO:0044877;GO:0097110;GO:0017124;GO:0031877;GO:0030160;GO:0030534;GO:0008306;GO:0048854;GO:0060997;GO:0050894;GO:0007616;GO:0060291;GO:0032232;GO:0050885;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:0035418;GO:0065003;GO:2000311;GO:0035176;GO:0060074;GO:0051124;GO:0071625;, C:cytosol; C:dendrite; C:dendritic spine; C:excitatory synapse; C:membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:ankyrin repeat binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein-containing complex binding; F:scaffold protein binding; F:SH3 domain binding; F:somatostatin receptor binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:associative learning; P:brain morphogenesis; P:dendritic spine morphogenesis; P:determination of affect; P:long-term memory; P:long-term synaptic potentiation; P:negative regulation of actin filament bundle assembly; P:neuromuscular process controlling balance; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:protein localization to synapse; P:protein-containing complex assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse maturation; P:synaptic growth at neuromuscular junction; P:vocalization behavior; scaffold226 indexed_genome mRNA 260456 290964 . - . ID=transcript_16003;Q9Y566 A8MXP5 B7WNY6 Q9NYW9,SH3 and multiple ankyrin repeat domains protein 1,Somatostatin receptor-interacting protein;, PF12796;PF17820;PF00536;PF07653;, GO:0005829;GO:0030425;GO:0043197;GO:0060076;GO:0016020;GO:0043005;GO:0005886;GO:0014069;GO:0045211;GO:0071532;GO:0042802;GO:0035255;GO:0008022;GO:0044877;GO:0097110;GO:0017124;GO:0031877;GO:0030160;GO:0030534;GO:0008306;GO:0048854;GO:0060997;GO:0050894;GO:0007616;GO:0060291;GO:0032232;GO:0050885;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:0035418;GO:0065003;GO:2000311;GO:0035176;GO:0060074;GO:0051124;GO:0071625;, C:cytosol; C:dendrite; C:dendritic spine; C:excitatory synapse; C:membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:ankyrin repeat binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein-containing complex binding; F:scaffold protein binding; F:SH3 domain binding; F:somatostatin receptor binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:associative learning; P:brain morphogenesis; P:dendritic spine morphogenesis; P:determination of affect; P:long-term memory; P:long-term synaptic potentiation; P:negative regulation of actin filament bundle assembly; P:neuromuscular process controlling balance; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:protein localization to synapse; P:protein-containing complex assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse maturation; P:synaptic growth at neuromuscular junction; P:vocalization behavior;|Q9Y566 A8MXP5 B7WNY6 Q9NYW9,SH3 and multiple ankyrin repeat domains protein 1,Somatostatin receptor-interacting protein;, PF12796;PF17820;PF00536;PF07653;, GO:0005829;GO:0030425;GO:0043197;GO:0060076;GO:0016020;GO:0043005;GO:0005886;GO:0014069;GO:0045211;GO:0071532;GO:0042802;GO:0035255;GO:0008022;GO:0044877;GO:0097110;GO:0017124;GO:0031877;GO:0030160;GO:0030534;GO:0008306;GO:0048854;GO:0060997;GO:0050894;GO:0007616;GO:0060291;GO:0032232;GO:0050885;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:0035418;GO:0065003;GO:2000311;GO:0035176;GO:0060074;GO:0051124;GO:0071625;, C:cytosol; C:dendrite; C:dendritic spine; C:excitatory synapse; C:membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:ankyrin repeat binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein-containing complex binding; F:scaffold protein binding; F:SH3 domain binding; F:somatostatin receptor binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:associative learning; P:brain morphogenesis; P:dendritic spine morphogenesis; P:determination of affect; P:long-term memory; P:long-term synaptic potentiation; P:negative regulation of actin filament bundle assembly; P:neuromuscular process controlling balance; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:protein localization to synapse; P:protein-containing complex assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse maturation; P:synaptic growth at neuromuscular junction; P:vocalization behavior;|Q9Y566 A8MXP5 B7WNY6 Q9NYW9,SH3 and multiple ankyrin repeat domains protein 1,Somatostatin receptor-interacting protein;, PF12796;PF17820;PF00536;PF07653;, GO:0005829;GO:0030425;GO:0043197;GO:0060076;GO:0016020;GO:0043005;GO:0005886;GO:0014069;GO:0045211;GO:0071532;GO:0042802;GO:0035255;GO:0008022;GO:0044877;GO:0097110;GO:0017124;GO:0031877;GO:0030160;GO:0030534;GO:0008306;GO:0048854;GO:0060997;GO:0050894;GO:0007616;GO:0060291;GO:0032232;GO:0050885;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:0035418;GO:0065003;GO:2000311;GO:0035176;GO:0060074;GO:0051124;GO:0071625;, C:cytosol; C:dendrite; C:dendritic spine; C:excitatory synapse; C:membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:ankyrin repeat binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein-containing complex binding; F:scaffold protein binding; F:SH3 domain binding; F:somatostatin receptor binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:associative learning; P:brain morphogenesis; P:dendritic spine morphogenesis; P:determination of affect; P:long-term memory; P:long-term synaptic potentiation; P:negative regulation of actin filament bundle assembly; P:neuromuscular process controlling balance; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:protein localization to synapse; P:protein-containing complex assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse maturation; P:synaptic growth at neuromuscular junction; P:vocalization behavior;|Q9Y566 A8MXP5 B7WNY6 Q9NYW9,SH3 and multiple ankyrin repeat domains protein 1,Somatostatin receptor-interacting protein;, PF12796;PF17820;PF00536;PF07653;, GO:0005829;GO:0030425;GO:0043197;GO:0060076;GO:0016020;GO:0043005;GO:0005886;GO:0014069;GO:0045211;GO:0071532;GO:0042802;GO:0035255;GO:0008022;GO:0044877;GO:0097110;GO:0017124;GO:0031877;GO:0030160;GO:0030534;GO:0008306;GO:0048854;GO:0060997;GO:0050894;GO:0007616;GO:0060291;GO:0032232;GO:0050885;GO:0060999;GO:2000463;GO:0051968;GO:0097107;GO:0035418;GO:0065003;GO:2000311;GO:0035176;GO:0060074;GO:0051124;GO:0071625;, C:cytosol; C:dendrite; C:dendritic spine; C:excitatory synapse; C:membrane; C:neuron projection; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane;, F:ankyrin repeat binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein-containing complex binding; F:scaffold protein binding; F:SH3 domain binding; F:somatostatin receptor binding; F:synaptic receptor adaptor activity;, P:adult behavior; P:associative learning; P:brain morphogenesis; P:dendritic spine morphogenesis; P:determination of affect; P:long-term memory; P:long-term synaptic potentiation; P:negative regulation of actin filament bundle assembly; P:neuromuscular process controlling balance; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:protein localization to synapse; P:protein-containing complex assembly; P:regulation of AMPA receptor activity; P:social behavior; P:synapse maturation; P:synaptic growth at neuromuscular junction; P:vocalization behavior; scaffold226 indexed_genome mRNA 297400 299255 . + . ID=transcript_16004;Q9Y240 B2RAD4,C-type lectin domain family 11 member A,C-type lectin superfamily member 3;Lymphocyte secreted C-type lectin;Osteolectin {ECO:0000303|PubMed:27976999};Stem cell growth factor;p47;, PF00059;, GO:0005737;GO:0005576;GO:0005615;GO:0030246;GO:0008083;GO:0001503;GO:0008284;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:carbohydrate binding; F:growth factor activity;, P:ossification; P:positive regulation of cell population proliferation; scaffold226 indexed_genome mRNA 353352 354181 . + . ID=transcript_16005;Q9BZG2 C0H3P7 Q9BZG3 Q9BZG4,Testicular acid phosphatase {ECO:0000305},Acid phosphatase 4 {ECO:0000312|HGNC:HGNC:14376};, PF00328;, GO:0016021;GO:0005764;GO:0045211;GO:0003993;GO:0016791;GO:0004725;GO:0030971;GO:0016311;GO:0007040;GO:0120154;GO:0010977;GO:0010955;GO:0042476;GO:1990264;GO:0048168;, C:integral component of membrane; C:lysosome; C:postsynaptic membrane;, F:acid phosphatase activity; F:phosphatase activity; F:protein tyrosine phosphatase activity; F:receptor tyrosine kinase binding;, P:dephosphorylation; P:lysosome organization; P:negative regulation of ERBB4 signaling pathway; P:negative regulation of neuron projection development; P:negative regulation of protein processing; P:odontogenesis; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:regulation of neuronal synaptic plasticity; scaffold226 indexed_genome mRNA 376604 378476 . - . ID=transcript_16006;P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1,Kallikrein-1,Kidney/pancreas/salivary gland kallikrein;Tissue kallikrein;, PF00089;, GO:0070062;GO:0005634;GO:0030141;GO:0004252;GO:0003073;GO:0031638;, C:extracellular exosome; C:nucleus; C:secretory granule;, F:serine-type endopeptidase activity;, P:regulation of systemic arterial blood pressure; P:zymogen activation; scaffold226 indexed_genome mRNA 441273 449754 . - . ID=transcript_16007;Q92876 A6NJA1 A8MW09 Q6H301,Kallikrein-6,Neurosin;Protease M;SP59;Serine protease 18;Serine protease 9;Zyme;, PF00089;, GO:0005737;GO:0005783;GO:0005576;GO:0005615;GO:0005739;GO:0005730;GO:0030141;GO:0004252;GO:0042982;GO:0007417;GO:0030574;GO:0042445;GO:0042552;GO:0045745;GO:0016540;GO:0045595;GO:0010975;GO:0009611;GO:0042246;, C:cytoplasm; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:mitochondrion; C:nucleolus; C:secretory granule;, F:serine-type endopeptidase activity;, P:amyloid precursor protein metabolic process; P:central nervous system development; P:collagen catabolic process; P:hormone metabolic process; P:myelination; P:positive regulation of G protein-coupled receptor signaling pathway; P:protein autoprocessing; P:regulation of cell differentiation; P:regulation of neuron projection development; P:response to wounding; P:tissue regeneration; scaffold226 indexed_genome mRNA 472321 473470 . - . ID=transcript_16008;O60259 Q5V9X1 Q5V9X2 Q8IW69 Q9HCB3 Q9NR68 Q9NR69 Q9UIL9 Q9UQ47,Kallikrein-8,Neuropsin;Ovasin;Serine protease 19;Serine protease TADG-14;Tumor-associated differentially expressed gene 14 protein;, PF00089;, GO:0005737;GO:0005576;GO:0005615;GO:0030141;GO:0097180;GO:0004252;GO:0008219;GO:0043616;GO:0007613;GO:0048681;GO:0031642;GO:0048812;GO:0050807;GO:0009611;GO:0050808;, C:cytoplasm; C:extracellular region; C:extracellular space; C:secretory granule; C:serine protease inhibitor complex;, F:serine-type endopeptidase activity;, P:cell death; P:keratinocyte proliferation; P:memory; P:negative regulation of axon regeneration; P:negative regulation of myelination; P:neuron projection morphogenesis; P:regulation of synapse organization; P:response to wounding; P:synapse organization; scaffold226 indexed_genome mRNA 485310 490222 . - . ID=transcript_16009;O43240 A6NC12 Q53YL3 Q99920 Q9GZW9,Kallikrein-10,Normal epithelial cell-specific 1;Protease serine-like 1;, PF00089;, GO:0005576;GO:0030141;GO:0004252;GO:0008236;GO:0007049;, C:extracellular region; C:secretory granule;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:cell cycle; scaffold226 indexed_genome mRNA 514885 516123 . - . ID=transcript_16010;Q9UKR3 A7UNK6 Q86VI8 Q9Y433,Kallikrein-13,Kallikrein-like protein 4;, PF00089;, GO:0005737;GO:0005576;GO:0005615;GO:0030141;GO:0016787;GO:0004252;GO:0070268;GO:0016485;GO:0006508;, C:cytoplasm; C:extracellular region; C:extracellular space; C:secretory granule;, F:hydrolase activity; F:serine-type endopeptidase activity;, P:cornification; P:protein processing; P:proteolysis; scaffold227 indexed_genome mRNA 10467 24281 . - . ID=transcript_16011;Q9BTX4 Q9NPP2,Nicalin,Nicastrin-like protein;, PF04389;, GO:0005789;GO:0016021;GO:0016020;GO:0032991;GO:0050821;GO:0061635;GO:0043254;GO:0009966;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:protein-containing complex;, , P:protein stabilization; P:regulation of protein complex stability; P:regulation of protein-containing complex assembly; P:regulation of signal transduction;|Q9BTX4 Q9NPP2,Nicalin,Nicastrin-like protein;, PF04389;, GO:0005789;GO:0016021;GO:0016020;GO:0032991;GO:0050821;GO:0061635;GO:0043254;GO:0009966;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:protein-containing complex;, , P:protein stabilization; P:regulation of protein complex stability; P:regulation of protein-containing complex assembly; P:regulation of signal transduction;|Q9BTX4 Q9NPP2,Nicalin,Nicastrin-like protein;, PF04389;, GO:0005789;GO:0016021;GO:0016020;GO:0032991;GO:0050821;GO:0061635;GO:0043254;GO:0009966;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:protein-containing complex;, , P:protein stabilization; P:regulation of protein complex stability; P:regulation of protein-containing complex assembly; P:regulation of signal transduction;|Q9BTX4 Q9NPP2,Nicalin,Nicastrin-like protein;, PF04389;, GO:0005789;GO:0016021;GO:0016020;GO:0032991;GO:0050821;GO:0061635;GO:0043254;GO:0009966;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:protein-containing complex;, , P:protein stabilization; P:regulation of protein complex stability; P:regulation of protein-containing complex assembly; P:regulation of signal transduction; scaffold227 indexed_genome mRNA 30736 31550 . + . ID=transcript_16012;O95977 D6W612,Sphingosine 1-phosphate receptor 4,Endothelial differentiation G-protein coupled receptor 6;Sphingosine 1-phosphate receptor Edg-6;, PF00001;, GO:0005737;GO:0005887;GO:0005739;GO:0005886;GO:0004930;GO:0008289;GO:0038036;GO:0007202;GO:0007189;GO:0007186;GO:0006955;GO:0007204;GO:0019222;, C:cytoplasm; C:integral component of plasma membrane; C:mitochondrion; C:plasma membrane;, F:G protein-coupled receptor activity; F:lipid binding; F:sphingosine-1-phosphate receptor activity;, P:activation of phospholipase C activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:immune response; P:positive regulation of cytosolic calcium ion concentration; P:regulation of metabolic process; scaffold227 indexed_genome mRNA 31551 32209 . - . ID=transcript_16013;O95977 D6W612,Sphingosine 1-phosphate receptor 4,Endothelial differentiation G-protein coupled receptor 6;Sphingosine 1-phosphate receptor Edg-6;, PF00001;, GO:0005737;GO:0005887;GO:0005739;GO:0005886;GO:0004930;GO:0008289;GO:0038036;GO:0007202;GO:0007189;GO:0007186;GO:0006955;GO:0007204;GO:0019222;, C:cytoplasm; C:integral component of plasma membrane; C:mitochondrion; C:plasma membrane;, F:G protein-coupled receptor activity; F:lipid binding; F:sphingosine-1-phosphate receptor activity;, P:activation of phospholipase C activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:immune response; P:positive regulation of cytosolic calcium ion concentration; P:regulation of metabolic process; scaffold227 indexed_genome mRNA 43994 63416 . - . ID=transcript_16014;P30679 E9KL40 E9KL47 O75247 Q53XK2,Guanine nucleotide-binding protein subunit alpha-15,Epididymis tissue protein Li 17E;Guanine nucleotide-binding protein subunit alpha-16;, PF00503;, GO:0005834;GO:0005886;GO:0045202;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007202;GO:0007188;GO:0007186;GO:0060158;GO:0007207;GO:0030168;GO:0051482;, C:heterotrimeric G-protein complex; C:plasma membrane; C:synapse;, F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;, P:action potential; P:activation of phospholipase C activity; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:phospholipase C-activating dopamine receptor signaling pathway; P:phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;|P30679 E9KL40 E9KL47 O75247 Q53XK2,Guanine nucleotide-binding protein subunit alpha-15,Epididymis tissue protein Li 17E;Guanine nucleotide-binding protein subunit alpha-16;, PF00503;, GO:0005834;GO:0005886;GO:0045202;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007202;GO:0007188;GO:0007186;GO:0060158;GO:0007207;GO:0030168;GO:0051482;, C:heterotrimeric G-protein complex; C:plasma membrane; C:synapse;, F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;, P:action potential; P:activation of phospholipase C activity; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:phospholipase C-activating dopamine receptor signaling pathway; P:phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway; P:platelet activation; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; scaffold227 indexed_genome mRNA 73920 77215 . + . ID=transcript_16015;P29992 O15109 Q14350 Q6IB00,Guanine nucleotide-binding protein subunit alpha-11,Guanine nucleotide-binding protein G(y) subunit alpha;, PF00503;, GO:0005737;GO:0070062;GO:0005834;GO:0005765;GO:0001750;GO:0005886;GO:0045202;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007188;GO:0071467;GO:0048066;GO:0009649;GO:0007213;GO:0007186;GO:0007507;GO:0060158;GO:0007603;GO:0030168;GO:0045634;GO:0007165;GO:0001501;, C:cytoplasm; C:extracellular exosome; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:photoreceptor outer segment; C:plasma membrane; C:synapse;, F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;, P:action potential; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cellular response to pH; P:developmental pigmentation; P:entrainment of circadian clock; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heart development; P:phospholipase C-activating dopamine receptor signaling pathway; P:phototransduction, visible light; P:platelet activation; P:regulation of melanocyte differentiation; P:signal transduction; P:skeletal system development;|P50148 O15108 Q13462 Q6NT27 Q92471 Q9BZB9,Guanine nucleotide-binding protein G(q) subunit alpha,Guanine nucleotide-binding protein alpha-q;, PF00503;, GO:0005737;GO:0070062;GO:0005794;GO:0005834;GO:0005765;GO:0031965;GO:0001750;GO:0005886;GO:0045202;GO:0001664;GO:0031683;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007202;GO:0007189;GO:0007188;GO:0007596;GO:0009649;GO:0007213;GO:0007186;GO:0007215;GO:0006469;GO:0007603;GO:0030168;GO:0050821;GO:0060828;, C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:nuclear membrane; C:photoreceptor outer segment; C:plasma membrane; C:synapse;, F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;, P:action potential; P:activation of phospholipase C activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:blood coagulation; P:entrainment of circadian clock; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glutamate receptor signaling pathway; P:negative regulation of protein kinase activity; P:phototransduction, visible light; P:platelet activation; P:protein stabilization; P:regulation of canonical Wnt signaling pathway; scaffold227 indexed_genome mRNA 79555 81666 . - . ID=transcript_16016;P29992 O15109 Q14350 Q6IB00,Guanine nucleotide-binding protein subunit alpha-11,Guanine nucleotide-binding protein G(y) subunit alpha;, PF00503;, GO:0005737;GO:0070062;GO:0005834;GO:0005765;GO:0001750;GO:0005886;GO:0045202;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007188;GO:0071467;GO:0048066;GO:0009649;GO:0007213;GO:0007186;GO:0007507;GO:0060158;GO:0007603;GO:0030168;GO:0045634;GO:0007165;GO:0001501;, C:cytoplasm; C:extracellular exosome; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:photoreceptor outer segment; C:plasma membrane; C:synapse;, F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;, P:action potential; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cellular response to pH; P:developmental pigmentation; P:entrainment of circadian clock; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heart development; P:phospholipase C-activating dopamine receptor signaling pathway; P:phototransduction, visible light; P:platelet activation; P:regulation of melanocyte differentiation; P:signal transduction; P:skeletal system development;|P29992 O15109 Q14350 Q6IB00,Guanine nucleotide-binding protein subunit alpha-11,Guanine nucleotide-binding protein G(y) subunit alpha;, PF00503;, GO:0005737;GO:0070062;GO:0005834;GO:0005765;GO:0001750;GO:0005886;GO:0045202;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007188;GO:0071467;GO:0048066;GO:0009649;GO:0007213;GO:0007186;GO:0007507;GO:0060158;GO:0007603;GO:0030168;GO:0045634;GO:0007165;GO:0001501;, C:cytoplasm; C:extracellular exosome; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:photoreceptor outer segment; C:plasma membrane; C:synapse;, F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;, P:action potential; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cellular response to pH; P:developmental pigmentation; P:entrainment of circadian clock; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:heart development; P:phospholipase C-activating dopamine receptor signaling pathway; P:phototransduction, visible light; P:platelet activation; P:regulation of melanocyte differentiation; P:signal transduction; P:skeletal system development; scaffold227 indexed_genome mRNA 122317 128318 . + . ID=transcript_16017;Q08117 B2RBL0 Q12808 Q14CJ1 Q96TG9 Q9UDY9,TLE family member 5 {ECO:0000305},Amino-terminal enhancer of split;Gp130-associated protein GAM;Grg-5;Groucho-related protein 5;Protein ESP1;Protein GRG;TLE family member 5, transcriptional modulator {ECO:0000305};, PF03920;, GO:0005634;GO:0005667;GO:0042802;GO:0070491;GO:0003714;GO:0009887;GO:0031668;GO:0007275;GO:0090090;GO:0010629;GO:0032091;GO:0060761;GO:0000122;GO:0045892;GO:2000210;GO:0040008;GO:0070555;GO:0001501;GO:0016055;, C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:cellular response to extracellular stimulus; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:negative regulation of protein binding; P:negative regulation of response to cytokine stimulus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of anoikis; P:regulation of growth; P:response to interleukin-1; P:skeletal system development; P:Wnt signaling pathway;|Q08117 B2RBL0 Q12808 Q14CJ1 Q96TG9 Q9UDY9,TLE family member 5 {ECO:0000305},Amino-terminal enhancer of split;Gp130-associated protein GAM;Grg-5;Groucho-related protein 5;Protein ESP1;Protein GRG;TLE family member 5, transcriptional modulator {ECO:0000305};, PF03920;, GO:0005634;GO:0005667;GO:0042802;GO:0070491;GO:0003714;GO:0009887;GO:0031668;GO:0007275;GO:0090090;GO:0010629;GO:0032091;GO:0060761;GO:0000122;GO:0045892;GO:2000210;GO:0040008;GO:0070555;GO:0001501;GO:0016055;, C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:cellular response to extracellular stimulus; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:negative regulation of protein binding; P:negative regulation of response to cytokine stimulus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of anoikis; P:regulation of growth; P:response to interleukin-1; P:skeletal system development; P:Wnt signaling pathway; scaffold227 indexed_genome mRNA 128402 129265 . - . ID=transcript_16018;Q08117 B2RBL0 Q12808 Q14CJ1 Q96TG9 Q9UDY9,TLE family member 5 {ECO:0000305},Amino-terminal enhancer of split;Gp130-associated protein GAM;Grg-5;Groucho-related protein 5;Protein ESP1;Protein GRG;TLE family member 5, transcriptional modulator {ECO:0000305};, PF03920;, GO:0005634;GO:0005667;GO:0042802;GO:0070491;GO:0003714;GO:0009887;GO:0031668;GO:0007275;GO:0090090;GO:0010629;GO:0032091;GO:0060761;GO:0000122;GO:0045892;GO:2000210;GO:0040008;GO:0070555;GO:0001501;GO:0016055;, C:nucleus; C:transcription regulator complex;, F:identical protein binding; F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:cellular response to extracellular stimulus; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of gene expression; P:negative regulation of protein binding; P:negative regulation of response to cytokine stimulus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of anoikis; P:regulation of growth; P:response to interleukin-1; P:skeletal system development; P:Wnt signaling pathway; scaffold227 indexed_genome mRNA 147709 167434 . + . ID=transcript_16019;Q04725 B4DE03 E9PEV7 F8WCH2 Q8WVY0 Q9Y6S0,Transducin-like enhancer protein 2,Enhancer of split groucho-like protein 2;, PF03920;PF00400;, GO:0005615;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0009887;GO:1904837;GO:0090090;GO:0045892;GO:0007165;GO:0016055;, C:extracellular space; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;|Q04725 B4DE03 E9PEV7 F8WCH2 Q8WVY0 Q9Y6S0,Transducin-like enhancer protein 2,Enhancer of split groucho-like protein 2;, PF03920;PF00400;, GO:0005615;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0009887;GO:1904837;GO:0090090;GO:0045892;GO:0007165;GO:0016055;, C:extracellular space; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;|Q04725 B4DE03 E9PEV7 F8WCH2 Q8WVY0 Q9Y6S0,Transducin-like enhancer protein 2,Enhancer of split groucho-like protein 2;, PF03920;PF00400;, GO:0005615;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0009887;GO:1904837;GO:0090090;GO:0045892;GO:0007165;GO:0016055;, C:extracellular space; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;|Q04725 B4DE03 E9PEV7 F8WCH2 Q8WVY0 Q9Y6S0,Transducin-like enhancer protein 2,Enhancer of split groucho-like protein 2;, PF03920;PF00400;, GO:0005615;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0009887;GO:1904837;GO:0090090;GO:0045892;GO:0007165;GO:0016055;, C:extracellular space; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;|Q04725 B4DE03 E9PEV7 F8WCH2 Q8WVY0 Q9Y6S0,Transducin-like enhancer protein 2,Enhancer of split groucho-like protein 2;, PF03920;PF00400;, GO:0005615;GO:0005925;GO:0016604;GO:0005654;GO:0005634;GO:0005667;GO:0070491;GO:0003714;GO:0009887;GO:1904837;GO:0090090;GO:0045892;GO:0007165;GO:0016055;, C:extracellular space; C:focal adhesion; C:nuclear body; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:animal organ morphogenesis; P:beta-catenin-TCF complex assembly; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway; scaffold227 indexed_genome mRNA 169188 170596 . - . ID=transcript_16020;Q9H808 J3KMZ1,Transducin-like enhancer protein 6,, , GO:0005938;GO:0005737;GO:0005634;GO:0032991;GO:0106333;GO:0005667;GO:0070491;GO:0003714;GO:0007015;GO:0060136;GO:0051643;GO:0051293;GO:0051646;GO:0090090;GO:0000122;GO:0040019;GO:0051302;, C:cell cortex; C:cytoplasm; C:nucleus; C:protein-containing complex; C:subcortical maternal complex; C:transcription regulator complex;, F:repressing transcription factor binding; F:transcription corepressor activity;, P:actin filament organization; P:embryonic process involved in female pregnancy; P:endoplasmic reticulum localization; P:establishment of spindle localization; P:mitochondrion localization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of embryonic development; P:regulation of cell division; scaffold227 indexed_genome mRNA 198119 200818 . - . ID=transcript_16021;Q15935 Q86XJ3 Q9NPP0,Zinc finger protein 77,ZNFpT1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q15935 Q86XJ3 Q9NPP0,Zinc finger protein 77,ZNFpT1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold227 indexed_genome mRNA 218870 227454 . - . ID=transcript_16022;Q15935 Q86XJ3 Q9NPP0,Zinc finger protein 77,ZNFpT1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q15935 Q86XJ3 Q9NPP0,Zinc finger protein 77,ZNFpT1;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold227 indexed_genome mRNA 232850 237280 . - . ID=transcript_16023;Q8NEP9 A8KA89 K7EQM2 Q8NA46 Q96MP1,Zinc finger protein 555,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|Q8NEP9 A8KA89 K7EQM2 Q8NA46 Q96MP1,Zinc finger protein 555,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold227 indexed_genome mRNA 237284 237815 . + . ID=transcript_16024;Q68EA5 Q8N6R9,Zinc finger protein 57,Zinc finger protein 424;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold227 indexed_genome mRNA 253203 261293 . - . ID=transcript_16025;Q86TJ5 Q8NAT3 Q9BWN3,Zinc finger protein 554,, PF01352;PF00096;, GO:0005730;GO:0005654;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleolus; C:nucleoplasm;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold227 indexed_genome mRNA 264302 283835 . - . ID=transcript_16026;P52888 B3KSE2 Q9UCB3,Thimet oligopeptidase,Endopeptidase 24.15;MP78;, PF01432;, GO:0005829;GO:0005758;GO:0046872;GO:0004222;GO:0042277;GO:0006518;GO:0000209;GO:0006508;, C:cytosol; C:mitochondrial intermembrane space;, F:metal ion binding; F:metalloendopeptidase activity; F:peptide binding;, P:peptide metabolic process; P:protein polyubiquitination; P:proteolysis;|P52888 B3KSE2 Q9UCB3,Thimet oligopeptidase,Endopeptidase 24.15;MP78;, PF01432;, GO:0005829;GO:0005758;GO:0046872;GO:0004222;GO:0042277;GO:0006518;GO:0000209;GO:0006508;, C:cytosol; C:mitochondrial intermembrane space;, F:metal ion binding; F:metalloendopeptidase activity; F:peptide binding;, P:peptide metabolic process; P:protein polyubiquitination; P:proteolysis;|P52888 B3KSE2 Q9UCB3,Thimet oligopeptidase,Endopeptidase 24.15;MP78;, PF01432;, GO:0005829;GO:0005758;GO:0046872;GO:0004222;GO:0042277;GO:0006518;GO:0000209;GO:0006508;, C:cytosol; C:mitochondrial intermembrane space;, F:metal ion binding; F:metalloendopeptidase activity; F:peptide binding;, P:peptide metabolic process; P:protein polyubiquitination; P:proteolysis;|P52888 B3KSE2 Q9UCB3,Thimet oligopeptidase,Endopeptidase 24.15;MP78;, PF01432;, GO:0005829;GO:0005758;GO:0046872;GO:0004222;GO:0042277;GO:0006518;GO:0000209;GO:0006508;, C:cytosol; C:mitochondrial intermembrane space;, F:metal ion binding; F:metalloendopeptidase activity; F:peptide binding;, P:peptide metabolic process; P:protein polyubiquitination; P:proteolysis; scaffold227 indexed_genome mRNA 291033 300148 . + . ID=transcript_16027;O43765 D6W610 Q6FIA9 Q9BTZ9,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,Alpha-SGT;Vpu-binding protein;, PF16546;PF00515;PF13181;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0072380;GO:1904288;GO:0042802;GO:0060090;GO:0043621;GO:1903070;GO:2000059;GO:1903646;GO:1903071;GO:0006620;GO:0045048;GO:0071816;GO:0030433;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:TRC complex;, F:BAT3 complex binding; F:identical protein binding; F:molecular adaptor activity; F:protein self-association;, P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of chaperone-mediated protein folding; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:protein insertion into ER membrane; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:viral process;|O43765 D6W610 Q6FIA9 Q9BTZ9,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,Alpha-SGT;Vpu-binding protein;, PF16546;PF00515;PF13181;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0072380;GO:1904288;GO:0042802;GO:0060090;GO:0043621;GO:1903070;GO:2000059;GO:1903646;GO:1903071;GO:0006620;GO:0045048;GO:0071816;GO:0030433;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:TRC complex;, F:BAT3 complex binding; F:identical protein binding; F:molecular adaptor activity; F:protein self-association;, P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of chaperone-mediated protein folding; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:protein insertion into ER membrane; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:viral process;|O43765 D6W610 Q6FIA9 Q9BTZ9,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,Alpha-SGT;Vpu-binding protein;, PF16546;PF00515;PF13181;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0072380;GO:1904288;GO:0042802;GO:0060090;GO:0043621;GO:1903070;GO:2000059;GO:1903646;GO:1903071;GO:0006620;GO:0045048;GO:0071816;GO:0030433;GO:0016032;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:TRC complex;, F:BAT3 complex binding; F:identical protein binding; F:molecular adaptor activity; F:protein self-association;, P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of chaperone-mediated protein folding; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:posttranslational protein targeting to endoplasmic reticulum membrane; P:protein insertion into ER membrane; P:tail-anchored membrane protein insertion into ER membrane; P:ubiquitin-dependent ERAD pathway; P:viral process; scaffold227 indexed_genome mRNA 311078 320490 . - . ID=transcript_16028;Q9BRY0 B3KMJ3 Q8WUG1,Zinc transporter ZIP3,Solute carrier family 39 member 3;Zrt- and Irt-like protein 3;, PF02535;, GO:0016021;GO:0016020;GO:0005886;GO:0005385;GO:0071577;, C:integral component of membrane; C:membrane; C:plasma membrane;, F:zinc ion transmembrane transporter activity;, P:zinc ion transmembrane transport; scaffold227 indexed_genome mRNA 331876 335506 . + . ID=transcript_16029;O95057,GTP-binding protein Di-Ras1,Distinct subgroup of the Ras family member 1;Ras-related inhibitor of cell growth;Small GTP-binding tumor suppressor 1;, PF00071;, GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0007165;, C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:signal transduction; scaffold227 indexed_genome mRNA 467859 474820 . + . ID=transcript_16030;O60262 B2R496,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7,, PF00631;, GO:0070062;GO:0031680;GO:0005834;GO:0005886;GO:0031681;GO:0007186;GO:0008277;, C:extracellular exosome; C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:plasma membrane;, F:G-protein beta-subunit binding;, P:G protein-coupled receptor signaling pathway; P:regulation of G protein-coupled receptor signaling pathway; scaffold227 indexed_genome mRNA 492647 494561 . - . ID=transcript_16031;O75293 A8KAM2 O75960 Q17R46,Growth arrest and DNA damage-inducible protein GADD45 beta,Myeloid differentiation primary response protein MyD118;Negative growth regulatory protein MyD118;, PF01248;, GO:0005737;GO:0005634;GO:0000185;GO:0006915;GO:0030154;GO:0007275;GO:0043065;GO:0046330;GO:1900745;GO:0051726;, C:cytoplasm; C:nucleus;, , P:activation of MAPKKK activity; P:apoptotic process; P:cell differentiation; P:multicellular organism development; P:positive regulation of apoptotic process; P:positive regulation of JNK cascade; P:positive regulation of p38MAPK cascade; P:regulation of cell cycle; scaffold227 indexed_genome mRNA 508498 544605 . + . ID=transcript_16032;Q03252 O75292 Q14734 Q96DF6,Lamin-B2,, PF00038;PF00932;, GO:0005882;GO:0005637;GO:0031965;GO:0042802;, C:intermediate filament; C:nuclear inner membrane; C:nuclear membrane;, F:identical protein binding;|Q7Z410 Q6ZND6 Q7Z411,Transmembrane protease serine 9,Polyserase-I;Polyserine protease 1;, PF00057;PF00089;, GO:0005887;GO:0004252;, C:integral component of plasma membrane;, F:serine-type endopeptidase activity;|Q9Y5L4 P62206 Q9UHL8 Q9WTL1,Mitochondrial import inner membrane translocase subunit Tim13,, PF02953;, GO:0001650;GO:0005743;GO:0042719;GO:0005739;GO:0008270;GO:0072321;GO:0045039;GO:0006626;GO:0007605;, C:fibrillar center; C:mitochondrial inner membrane; C:mitochondrial intermembrane space protein transporter complex; C:mitochondrion;, F:zinc ion binding;, P:chaperone-mediated protein transport; P:protein insertion into mitochondrial inner membrane; P:protein targeting to mitochondrion; P:sensory perception of sound; scaffold229 indexed_genome mRNA 490718 495601 . - . ID=transcript_16033;P60484 B2R904 F2YHV0 O00633 O02679 Q6ICT7,Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN,Mutated in multiple advanced cancers 1;Phosphatase and tensin homolog;, PF10409;, GO:0016324;GO:0042995;GO:0005737;GO:0009898;GO:0005829;GO:0043197;GO:0005576;GO:0005739;GO:0035749;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0099524;GO:0045211;GO:0043220;GO:0010997;GO:0019899;GO:0042802;GO:0051717;GO:0035255;GO:0008289;GO:0030165;GO:0016314;GO:0051800;GO:0004438;GO:0004721;GO:0005161;GO:0106306;GO:0004722;GO:0106307;GO:1990782;GO:0004725;GO:1990381;GO:0030534;GO:0007568;GO:0001525;GO:0006915;GO:0048854;GO:0060070;GO:0048738;GO:0016477;GO:0048870;GO:0071257;GO:0071361;GO:0071456;GO:0032869;GO:1990314;GO:0044320;GO:1990090;GO:0007417;GO:0032286;GO:0021955;GO:0060997;GO:0021542;GO:0016311;GO:0043542;GO:0048853;GO:0007507;GO:0046855;GO:0043647;GO:0007611;GO:0045475;GO:0007626;GO:0060292;GO:0060291;GO:0060179;GO:0042711;GO:0007613;GO:0033555;GO:0043066;GO:0048681;GO:0050771;GO:0060044;GO:0090344;GO:1902807;GO:0030336;GO:0008285;GO:0045792;GO:0045736;GO:0061002;GO:0050680;GO:0010719;GO:0070373;GO:0090394;GO:0051895;GO:2000134;GO:0051548;GO:0031642;GO:0010977;GO:0046621;GO:0033137;GO:0050765;GO:0014067;GO:1901017;GO:0051898;GO:0001933;GO:0090071;GO:2000272;GO:2000808;GO:1904706;GO:1903690;GO:0007270;GO:0014065;GO:0006661;GO:0046856;GO:0048008;GO:0010666;GO:0008284;GO:0051091;GO:0070374;GO:2000463;GO:0010628;GO:0045666;GO:1903984;GO:1904668;GO:2000060;GO:0097107;GO:0060134;GO:0097105;GO:0060736;GO:0006470;GO:0016579;GO:0043491;GO:0050821;GO:0002902;GO:0032535;GO:0033032;GO:0010975;GO:0051896;GO:0031647;GO:0032228;GO:0060260;GO:0014823;GO:0046685;GO:0033198;GO:0042493;GO:0032355;GO:0009749;GO:0007584;GO:0010043;GO:0060024;GO:0035176;GO:0007416;GO:0060074;, C:apical plasma membrane; C:cell projection; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:dendritic spine; C:extracellular region; C:mitochondrion; C:myelin sheath adaxonal region; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:postsynaptic cytosol; C:postsynaptic membrane; C:Schmidt-Lanterman incisure;, F:anaphase-promoting complex binding; F:enzyme binding; F:identical protein binding; F:inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity; F:ionotropic glutamate receptor binding; F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphoprotein phosphatase activity; F:platelet-derived growth factor receptor binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine kinase binding; F:protein tyrosine phosphatase activity; F:ubiquitin-specific protease binding;, P:adult behavior; P:aging; P:angiogenesis; P:apoptotic process; P:brain morphogenesis; P:canonical Wnt signaling pathway; P:cardiac muscle tissue development; P:cell migration; P:cell motility; P:cellular response to electrical stimulus; P:cellular response to ethanol; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to insulin-like growth factor stimulus; P:cellular response to leptin stimulus; P:cellular response to nerve growth factor stimulus; P:central nervous system development; P:central nervous system myelin maintenance; P:central nervous system neuron axonogenesis; P:dendritic spine morphogenesis; P:dentate gyrus development; P:dephosphorylation; P:endothelial cell migration; P:forebrain morphogenesis; P:heart development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning or memory; P:locomotor rhythm; P:locomotory behavior; P:long-term synaptic depression; P:long-term synaptic potentiation; P:male mating behavior; P:maternal behavior; P:memory; P:multicellular organismal response to stress; P:negative regulation of apoptotic process; P:negative regulation of axon regeneration; P:negative regulation of axonogenesis; P:negative regulation of cardiac muscle cell proliferation; P:negative regulation of cell aging; P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of cell size; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of excitatory postsynaptic potential; P:negative regulation of focal adhesion assembly; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of keratinocyte migration; P:negative regulation of myelination; P:negative regulation of neuron projection development; P:negative regulation of organ growth; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of phagocytosis; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein kinase B signaling; P:negative regulation of protein phosphorylation; P:negative regulation of ribosome biogenesis; P:negative regulation of signaling receptor activity; P:negative regulation of synaptic vesicle clustering; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of wound healing, spreading of epidermal cells; P:neuron-neuron synaptic transmission; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cardiac muscle cell apoptotic process; P:positive regulation of cell population proliferation; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of gene expression; P:positive regulation of neuron differentiation; P:positive regulation of TRAIL-activated apoptotic signaling pathway; P:positive regulation of ubiquitin protein ligase activity; P:positive regulation of ubiquitin-dependent protein catabolic process; P:postsynaptic density assembly; P:prepulse inhibition; P:presynaptic membrane assembly; P:prostate gland growth; P:protein dephosphorylation; P:protein deubiquitination; P:protein kinase B signaling; P:protein stabilization; P:regulation of B cell apoptotic process; P:regulation of cellular component size; P:regulation of myeloid cell apoptotic process; P:regulation of neuron projection development; P:regulation of protein kinase B signaling; P:regulation of protein stability; P:regulation of synaptic transmission, GABAergic; P:regulation of transcription initiation from RNA polymerase II promoter; P:response to activity; P:response to arsenic-containing substance; P:response to ATP; P:response to drug; P:response to estradiol; P:response to glucose; P:response to nutrient; P:response to zinc ion; P:rhythmic synaptic transmission; P:social behavior; P:synapse assembly; P:synapse maturation;|A0A1B0GWH4,Heat shock transcription factor, X-linked member 3,, PF00447;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold230 indexed_genome mRNA 53669 61137 . - . ID=transcript_16034;Q1W6H9,Protein FAM110C,, PF14160;PF14161;, GO:0005938;GO:0005874;GO:0005815;GO:0005634;GO:0000922;GO:0043014;GO:0030335;GO:0051897;GO:0060491;, C:cell cortex; C:microtubule; C:microtubule organizing center; C:nucleus; C:spindle pole;, F:alpha-tubulin binding;, P:positive regulation of cell migration; P:positive regulation of protein kinase B signaling; P:regulation of cell projection assembly; scaffold230 indexed_genome mRNA 153902 180427 . - . ID=transcript_16035;Q96HL8 A8K8E7 B7WNJ4 B7WPL6 Q8NEL2 Q9H5X4 Q9Y3V5,SH3 domain-containing YSC84-like protein 1,, PF00018;PF04366;, GO:0032587;GO:0019902;GO:0035091;GO:0006661;GO:1900027;, C:ruffle membrane;, F:phosphatase binding; F:phosphatidylinositol binding;, P:phosphatidylinositol biosynthetic process; P:regulation of ruffle assembly;|Q96HL8 A8K8E7 B7WNJ4 B7WPL6 Q8NEL2 Q9H5X4 Q9Y3V5,SH3 domain-containing YSC84-like protein 1,, PF00018;PF04366;, GO:0032587;GO:0019902;GO:0035091;GO:0006661;GO:1900027;, C:ruffle membrane;, F:phosphatase binding; F:phosphatidylinositol binding;, P:phosphatidylinositol biosynthetic process; P:regulation of ruffle assembly; scaffold230 indexed_genome mRNA 217466 232927 . + . ID=transcript_16036;P24666 A8K1L9 B5MCC7 P24667 Q16035 Q16036 Q16725 Q3KQX8 Q53RU0,Low molecular weight phosphotyrosine protein phosphatase,Adipocyte acid phosphatase;Low molecular weight cytosolic acid phosphatase;Red cell acid phosphatase 1;, PF01451;, GO:0005737;GO:0009898;GO:0070062;GO:0003993;GO:0004726;GO:0004725;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:extracellular exosome;, F:acid phosphatase activity; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;|P24666 A8K1L9 B5MCC7 P24667 Q16035 Q16036 Q16725 Q3KQX8 Q53RU0,Low molecular weight phosphotyrosine protein phosphatase,Adipocyte acid phosphatase;Low molecular weight cytosolic acid phosphatase;Red cell acid phosphatase 1;, PF01451;, GO:0005737;GO:0009898;GO:0070062;GO:0003993;GO:0004726;GO:0004725;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:extracellular exosome;, F:acid phosphatase activity; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;|P24666 A8K1L9 B5MCC7 P24667 Q16035 Q16036 Q16725 Q3KQX8 Q53RU0,Low molecular weight phosphotyrosine protein phosphatase,Adipocyte acid phosphatase;Low molecular weight cytosolic acid phosphatase;Red cell acid phosphatase 1;, PF01451;, GO:0005737;GO:0009898;GO:0070062;GO:0003993;GO:0004726;GO:0004725;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:extracellular exosome;, F:acid phosphatase activity; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;|P24666 A8K1L9 B5MCC7 P24667 Q16035 Q16036 Q16725 Q3KQX8 Q53RU0,Low molecular weight phosphotyrosine protein phosphatase,Adipocyte acid phosphatase;Low molecular weight cytosolic acid phosphatase;Red cell acid phosphatase 1;, PF01451;, GO:0005737;GO:0009898;GO:0070062;GO:0003993;GO:0004726;GO:0004725;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:extracellular exosome;, F:acid phosphatase activity; F:non-membrane spanning protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity; scaffold230 indexed_genome mRNA 474676 479027 . - . ID=transcript_16037;Q96B42 D6W4X9 Q8N5H2 Q9NTH3,Transmembrane protein 18,, PF14770;, GO:0005737;GO:0016021;GO:0031965;GO:0003677;GO:0016477;, C:cytoplasm; C:integral component of membrane; C:nuclear membrane;, F:DNA binding;, P:cell migration;|Q96B42 D6W4X9 Q8N5H2 Q9NTH3,Transmembrane protein 18,, PF14770;, GO:0005737;GO:0016021;GO:0031965;GO:0003677;GO:0016477;, C:cytoplasm; C:integral component of membrane; C:nuclear membrane;, F:DNA binding;, P:cell migration;|Q96B42 D6W4X9 Q8N5H2 Q9NTH3,Transmembrane protein 18,, PF14770;, GO:0005737;GO:0016021;GO:0031965;GO:0003677;GO:0016477;, C:cytoplasm; C:integral component of membrane; C:nuclear membrane;, F:DNA binding;, P:cell migration; scaffold231 indexed_genome mRNA 1 1591 . + . ID=transcript_16038;Q16619 A8MVX4 Q5U5Y7,Cardiotrophin-1,, , GO:0005576;GO:0005615;GO:0005125;GO:0005146;GO:0007166;GO:0007267;GO:0019221;GO:0048861;GO:0007517;GO:0048666;GO:0030182;GO:0008284;GO:0042531;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:leukemia inhibitory factor receptor binding;, P:cell surface receptor signaling pathway; P:cell-cell signaling; P:cytokine-mediated signaling pathway; P:leukemia inhibitory factor signaling pathway; P:muscle organ development; P:neuron development; P:neuron differentiation; P:positive regulation of cell population proliferation; P:positive regulation of tyrosine phosphorylation of STAT protein; scaffold231 indexed_genome mRNA 69522 78369 . + . ID=transcript_16039;Q9UEG4 Q15938,Zinc finger protein 629,Zinc finger protein 65;, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold231 indexed_genome mRNA 81557 94123 . - . ID=transcript_16040;O75150 A0A024QZG0 Q6AHZ6 Q6N005 Q7L3T6 Q8N615 Q96T18 Q9BSV9 Q9HC82,E3 ubiquitin-protein ligase BRE1B,95 kDa retinoblastoma-associated protein;RING finger protein 40;RING-type E3 ubiquitin transferase BRE1B {ECO:0000305};, , GO:0043679;GO:0005829;GO:0019898;GO:0033503;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0000151;GO:0046872;GO:0003730;GO:0042803;GO:0044877;GO:0017075;GO:0031624;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:1900364;GO:2001168;GO:1901800;GO:1902916;GO:0016567;GO:0043434;GO:0006511;, C:axon terminus; C:cytosol; C:extrinsic component of membrane; C:HULC complex; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:mRNA 3'-UTR binding; F:protein homodimerization activity; F:protein-containing complex binding; F:syntaxin-1 binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein polyubiquitination; P:protein ubiquitination; P:response to peptide hormone; P:ubiquitin-dependent protein catabolic process;|O75150 A0A024QZG0 Q6AHZ6 Q6N005 Q7L3T6 Q8N615 Q96T18 Q9BSV9 Q9HC82,E3 ubiquitin-protein ligase BRE1B,95 kDa retinoblastoma-associated protein;RING finger protein 40;RING-type E3 ubiquitin transferase BRE1B {ECO:0000305};, , GO:0043679;GO:0005829;GO:0019898;GO:0033503;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0000151;GO:0046872;GO:0003730;GO:0042803;GO:0044877;GO:0017075;GO:0031624;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:1900364;GO:2001168;GO:1901800;GO:1902916;GO:0016567;GO:0043434;GO:0006511;, C:axon terminus; C:cytosol; C:extrinsic component of membrane; C:HULC complex; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:mRNA 3'-UTR binding; F:protein homodimerization activity; F:protein-containing complex binding; F:syntaxin-1 binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein polyubiquitination; P:protein ubiquitination; P:response to peptide hormone; P:ubiquitin-dependent protein catabolic process;|O75150 A0A024QZG0 Q6AHZ6 Q6N005 Q7L3T6 Q8N615 Q96T18 Q9BSV9 Q9HC82,E3 ubiquitin-protein ligase BRE1B,95 kDa retinoblastoma-associated protein;RING finger protein 40;RING-type E3 ubiquitin transferase BRE1B {ECO:0000305};, , GO:0043679;GO:0005829;GO:0019898;GO:0033503;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0000151;GO:0046872;GO:0003730;GO:0042803;GO:0044877;GO:0017075;GO:0031624;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:1900364;GO:2001168;GO:1901800;GO:1902916;GO:0016567;GO:0043434;GO:0006511;, C:axon terminus; C:cytosol; C:extrinsic component of membrane; C:HULC complex; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:mRNA 3'-UTR binding; F:protein homodimerization activity; F:protein-containing complex binding; F:syntaxin-1 binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein polyubiquitination; P:protein ubiquitination; P:response to peptide hormone; P:ubiquitin-dependent protein catabolic process;|O75150 A0A024QZG0 Q6AHZ6 Q6N005 Q7L3T6 Q8N615 Q96T18 Q9BSV9 Q9HC82,E3 ubiquitin-protein ligase BRE1B,95 kDa retinoblastoma-associated protein;RING finger protein 40;RING-type E3 ubiquitin transferase BRE1B {ECO:0000305};, , GO:0043679;GO:0005829;GO:0019898;GO:0033503;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0000151;GO:0046872;GO:0003730;GO:0042803;GO:0044877;GO:0017075;GO:0031624;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:1900364;GO:2001168;GO:1901800;GO:1902916;GO:0016567;GO:0043434;GO:0006511;, C:axon terminus; C:cytosol; C:extrinsic component of membrane; C:HULC complex; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:mRNA 3'-UTR binding; F:protein homodimerization activity; F:protein-containing complex binding; F:syntaxin-1 binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein polyubiquitination; P:protein ubiquitination; P:response to peptide hormone; P:ubiquitin-dependent protein catabolic process;|O75150 A0A024QZG0 Q6AHZ6 Q6N005 Q7L3T6 Q8N615 Q96T18 Q9BSV9 Q9HC82,E3 ubiquitin-protein ligase BRE1B,95 kDa retinoblastoma-associated protein;RING finger protein 40;RING-type E3 ubiquitin transferase BRE1B {ECO:0000305};, , GO:0043679;GO:0005829;GO:0019898;GO:0033503;GO:0016020;GO:0043005;GO:0005654;GO:0005634;GO:0000151;GO:0046872;GO:0003730;GO:0042803;GO:0044877;GO:0017075;GO:0031624;GO:0031625;GO:0004842;GO:0033523;GO:0010390;GO:1900364;GO:2001168;GO:1901800;GO:1902916;GO:0016567;GO:0043434;GO:0006511;, C:axon terminus; C:cytosol; C:extrinsic component of membrane; C:HULC complex; C:membrane; C:neuron projection; C:nucleoplasm; C:nucleus; C:ubiquitin ligase complex;, F:metal ion binding; F:mRNA 3'-UTR binding; F:protein homodimerization activity; F:protein-containing complex binding; F:syntaxin-1 binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:histone H2B ubiquitination; P:histone monoubiquitination; P:negative regulation of mRNA polyadenylation; P:positive regulation of histone H2B ubiquitination; P:positive regulation of proteasomal protein catabolic process; P:positive regulation of protein polyubiquitination; P:protein ubiquitination; P:response to peptide hormone; P:ubiquitin-dependent protein catabolic process; scaffold231 indexed_genome mRNA 94535 96461 . + . ID=transcript_16041;A1A4V9 A1A4V8 F5GX13 Q569G2,Coiled-coil domain-containing protein 189,, PF14769; scaffold231 indexed_genome mRNA 96842 98460 . + . ID=transcript_16042;A1A4V9 A1A4V8 F5GX13 Q569G2,Coiled-coil domain-containing protein 189,, PF14769; scaffold231 indexed_genome mRNA 98504 103790 . - . ID=transcript_16043;P15735 A8K0C7 B4DEB7 E9PEU3 P11800,Phosphorylase b kinase gamma catalytic chain, liver/testis isoform,PSK-C3;Phosphorylase kinase subunit gamma-2;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0004689;GO:0004674;GO:0050321;GO:0006091;GO:0005978;GO:0005980;GO:0005977;GO:0045819;GO:0006468;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:phosphorylase kinase activity; F:protein serine/threonine kinase activity; F:tau-protein kinase activity;, P:generation of precursor metabolites and energy; P:glycogen biosynthetic process; P:glycogen catabolic process; P:glycogen metabolic process; P:positive regulation of glycogen catabolic process; P:protein phosphorylation;|P15735 A8K0C7 B4DEB7 E9PEU3 P11800,Phosphorylase b kinase gamma catalytic chain, liver/testis isoform,PSK-C3;Phosphorylase kinase subunit gamma-2;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0004689;GO:0004674;GO:0050321;GO:0006091;GO:0005978;GO:0005980;GO:0005977;GO:0045819;GO:0006468;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:phosphorylase kinase activity; F:protein serine/threonine kinase activity; F:tau-protein kinase activity;, P:generation of precursor metabolites and energy; P:glycogen biosynthetic process; P:glycogen catabolic process; P:glycogen metabolic process; P:positive regulation of glycogen catabolic process; P:protein phosphorylation;|P15735 A8K0C7 B4DEB7 E9PEU3 P11800,Phosphorylase b kinase gamma catalytic chain, liver/testis isoform,PSK-C3;Phosphorylase kinase subunit gamma-2;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0004689;GO:0004674;GO:0050321;GO:0006091;GO:0005978;GO:0005980;GO:0005977;GO:0045819;GO:0006468;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:phosphorylase kinase activity; F:protein serine/threonine kinase activity; F:tau-protein kinase activity;, P:generation of precursor metabolites and energy; P:glycogen biosynthetic process; P:glycogen catabolic process; P:glycogen metabolic process; P:positive regulation of glycogen catabolic process; P:protein phosphorylation;|P15735 A8K0C7 B4DEB7 E9PEU3 P11800,Phosphorylase b kinase gamma catalytic chain, liver/testis isoform,PSK-C3;Phosphorylase kinase subunit gamma-2;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0004689;GO:0004674;GO:0050321;GO:0006091;GO:0005978;GO:0005980;GO:0005977;GO:0045819;GO:0006468;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:phosphorylase kinase activity; F:protein serine/threonine kinase activity; F:tau-protein kinase activity;, P:generation of precursor metabolites and energy; P:glycogen biosynthetic process; P:glycogen catabolic process; P:glycogen metabolic process; P:positive regulation of glycogen catabolic process; P:protein phosphorylation;|P15735 A8K0C7 B4DEB7 E9PEU3 P11800,Phosphorylase b kinase gamma catalytic chain, liver/testis isoform,PSK-C3;Phosphorylase kinase subunit gamma-2;, PF00069;, GO:0005829;GO:0005964;GO:0005524;GO:0005516;GO:0004689;GO:0004674;GO:0050321;GO:0006091;GO:0005978;GO:0005980;GO:0005977;GO:0045819;GO:0006468;, C:cytosol; C:phosphorylase kinase complex;, F:ATP binding; F:calmodulin binding; F:phosphorylase kinase activity; F:protein serine/threonine kinase activity; F:tau-protein kinase activity;, P:generation of precursor metabolites and energy; P:glycogen biosynthetic process; P:glycogen catabolic process; P:glycogen metabolic process; P:positive regulation of glycogen catabolic process; P:protein phosphorylation; scaffold231 indexed_genome mRNA 112048 116547 . - . ID=transcript_16044;A0A087WTH1,Transmembrane protein 265 {ECO:0000312|HGNC:HGNC:51241},, PF04505;, GO:0016021;, C:integral component of membrane; scaffold231 indexed_genome mRNA 116588 147295 . - . ID=transcript_16045;Q6ZRS2 B0JZA6 O15026 Q7Z744 Q9Y5L9,Helicase SRCAP,Domino homolog 2;Snf2-related CBP activator;, PF00271;PF07529;PF00176;, GO:0005794;GO:0016604;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0000812;GO:0005524;GO:0016887;GO:0003677;GO:0004386;GO:0004402;GO:0042393;GO:0070615;GO:0003713;GO:0043044;GO:0016458;GO:0043486;GO:0006357;GO:0016032;, C:Golgi apparatus; C:nuclear body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:Swr1 complex;, F:ATP binding; F:ATPase activity; F:DNA binding; F:helicase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleosome-dependent ATPase activity; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:gene silencing; P:histone exchange; P:regulation of transcription by RNA polymerase II; P:viral process;|Q6ZRS2 B0JZA6 O15026 Q7Z744 Q9Y5L9,Helicase SRCAP,Domino homolog 2;Snf2-related CBP activator;, PF00271;PF07529;PF00176;, GO:0005794;GO:0016604;GO:0005654;GO:0005634;GO:0048471;GO:0032991;GO:0000812;GO:0005524;GO:0016887;GO:0003677;GO:0004386;GO:0004402;GO:0042393;GO:0070615;GO:0003713;GO:0043044;GO:0016458;GO:0043486;GO:0006357;GO:0016032;, C:Golgi apparatus; C:nuclear body; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:Swr1 complex;, F:ATP binding; F:ATPase activity; F:DNA binding; F:helicase activity; F:histone acetyltransferase activity; F:histone binding; F:nucleosome-dependent ATPase activity; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:gene silencing; P:histone exchange; P:regulation of transcription by RNA polymerase II; P:viral process; scaffold231 indexed_genome mRNA 183472 186113 . - . ID=transcript_16046;Q9HAH7 B4DP86 Q96CI9 Q9H9X4,Probable fibrosin-1,, PF15336;|Q9HAH7 B4DP86 Q96CI9 Q9H9X4,Probable fibrosin-1,, PF15336; scaffold231 indexed_genome mRNA 186117 195842 . - . ID=transcript_16047;Q9HAH7 B4DP86 Q96CI9 Q9H9X4,Probable fibrosin-1,, PF15336;|Q9HAH7 B4DP86 Q96CI9 Q9H9X4,Probable fibrosin-1,, PF15336;|Q9HAH7 B4DP86 Q96CI9 Q9H9X4,Probable fibrosin-1,, PF15336;|Q9HCM7 Q86XQ1,Fibrosin-1-like protein,AUTS2-like protein;HBV X-transactivated gene 9 protein;HBV XAg-transactivated protein 9;, PF15336;, GO:0003723;, , F:RNA binding; scaffold231 indexed_genome mRNA 197298 200859 . - . ID=transcript_16048;Q9BWN1 Q8WTX2,Proline-rich protein 14,, PF15386;, GO:0005694;GO:0005652;GO:0005654;GO:0007517;, C:chromosome; C:nuclear lamina; C:nucleoplasm;, , P:muscle organ development;|Q9BWN1 Q8WTX2,Proline-rich protein 14,, PF15386;, GO:0005694;GO:0005652;GO:0005654;GO:0007517;, C:chromosome; C:nuclear lamina; C:nucleoplasm;, , P:muscle organ development;|Q9BWN1 Q8WTX2,Proline-rich protein 14,, PF15386;, GO:0005694;GO:0005652;GO:0005654;GO:0007517;, C:chromosome; C:nuclear lamina; C:nucleoplasm;, , P:muscle organ development;|Q9BWN1 Q8WTX2,Proline-rich protein 14,, PF15386;, GO:0005694;GO:0005652;GO:0005654;GO:0007517;, C:chromosome; C:nuclear lamina; C:nucleoplasm;, , P:muscle organ development;|Q9BWN1 Q8WTX2,Proline-rich protein 14,, PF15386;, GO:0005694;GO:0005652;GO:0005654;GO:0007517;, C:chromosome; C:nuclear lamina; C:nucleoplasm;, , P:muscle organ development; scaffold231 indexed_genome mRNA 201039 201989 . + . ID=transcript_16049;Q9BWN1 Q8WTX2,Proline-rich protein 14,, PF15386;, GO:0005694;GO:0005652;GO:0005654;GO:0007517;, C:chromosome; C:nuclear lamina; C:nucleoplasm;, , P:muscle organ development; scaffold231 indexed_genome mRNA 220736 227339 . + . ID=transcript_16050;Q96CS4 Q658J5,Zinc finger protein 689,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;GO:0035914;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:skeletal muscle cell differentiation; scaffold231 indexed_genome mRNA 244359 247414 . + . ID=transcript_16051;P0C7X2 A8MV39 B3KV51 O75701 Q8IW91 Q8WV14 Q96MN0,Zinc finger protein 688,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;|P0C7X2 A8MV39 B3KV51 O75701 Q8IW91 Q8WV14 Q96MN0,Zinc finger protein 688,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold231 indexed_genome mRNA 260014 263889 . + . ID=transcript_16052;Q96H86 A8MZF4 B3KSN2 H9KV99 Q9BWS1,Zinc finger protein 764,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold231 indexed_genome mRNA 268631 271642 . + . ID=transcript_16053;Q9H5H4 Q569L7 Q96CX4,Zinc finger protein 768,, PF05001;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0003723;GO:0000977;GO:0006357;GO:0006366;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold231 indexed_genome mRNA 277908 321498 . - . ID=transcript_16054;P20701 O43746 Q45H73 Q96HB1 Q9UBC8,Integrin alpha-L,CD11 antigen-like family member A;Leukocyte adhesion glycoprotein LFA-1 alpha chain;Leukocyte function-associated molecule 1 alpha chain;, PF01839;PF00357;PF08441;PF00092;, GO:0009986;GO:0070062;GO:0034687;GO:0008305;GO:0016020;GO:0005886;GO:0035579;GO:0050839;GO:0030369;GO:0046872;GO:0044877;GO:0007155;GO:0098609;GO:0007160;GO:0030198;GO:0007157;GO:0006954;GO:0007229;GO:0007159;GO:0050900;GO:0035683;GO:0043312;GO:0006909;GO:0043113;GO:0050776;GO:0007165;GO:0002291;GO:0016032;, C:cell surface; C:extracellular exosome; C:integrin alphaL-beta2 complex; C:integrin complex; C:membrane; C:plasma membrane; C:specific granule membrane;, F:cell adhesion molecule binding; F:ICAM-3 receptor activity; F:metal ion binding; F:protein-containing complex binding;, P:cell adhesion; P:cell-cell adhesion; P:cell-matrix adhesion; P:extracellular matrix organization; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:inflammatory response; P:integrin-mediated signaling pathway; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:memory T cell extravasation; P:neutrophil degranulation; P:phagocytosis; P:receptor clustering; P:regulation of immune response; P:signal transduction; P:T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; P:viral process;|Q9UL46 Q15129,Proteasome activator complex subunit 2,11S regulator complex subunit beta;Activator of multicatalytic protease subunit 2;Proteasome activator 28 subunit beta;, PF02251;PF02252;, GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0008537;GO:0000502;GO:0061133;GO:0042802;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0035722;GO:0000165;GO:0090090;GO:0010972;GO:0038061;GO:0090263;GO:0010950;GO:0043687;GO:0036388;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:2000045;GO:1902036;GO:1901990;GO:0043488;GO:0061136;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:proteasome activator complex; C:proteasome complex;, F:endopeptidase activator activity; F:identical protein binding;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:interleukin-12-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endopeptidase activity; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of G1/S transition of mitotic cell cycle; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of proteasomal protein catabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:Wnt signaling pathway, planar cell polarity pathway; scaffold231 indexed_genome mRNA 358090 360331 . + . ID=transcript_16055;Q99611 Q9BUQ2,Selenide, water dikinase 2,Selenium donor protein 2;Selenophosphate synthase 2;, PF00586;PF02769;, GO:0005737;GO:0005829;GO:0005524;GO:0046872;GO:0004756;GO:0001887;GO:0016260;GO:0016259;, C:cytoplasm; C:cytosol;, F:ATP binding; F:metal ion binding; F:selenide, water dikinase activity;, P:selenium compound metabolic process; P:selenocysteine biosynthetic process; P:selenocysteine metabolic process; scaffold231 indexed_genome mRNA 375803 379197 . + . ID=transcript_16056;Q9H773,dCTP pyrophosphatase 1 {ECO:0000305},Deoxycytidine-triphosphatase 1;RS21C6 {ECO:0000312|EMBL:AAK48422.1};XTP3-transactivated gene A protein {ECO:0000312|EMBL:AAR26724.1};, PF12643;, GO:0005829;GO:0005739;GO:0005634;GO:0047840;GO:0042802;GO:0000287;GO:0047429;GO:0032556;GO:0006253;GO:0042262;GO:0009143;, C:cytosol; C:mitochondrion; C:nucleus;, F:dCTP diphosphatase activity; F:identical protein binding; F:magnesium ion binding; F:nucleoside-triphosphate diphosphatase activity; F:pyrimidine deoxyribonucleotide binding;, P:dCTP catabolic process; P:DNA protection; P:nucleoside triphosphate catabolic process; scaffold231 indexed_genome mRNA 382591 390247 . - . ID=transcript_16057;Q7L3S4 Q8TAQ7 Q9NYI6,Zinc finger protein 771,Mesenchymal stem cell protein DSC43;, PF00096;, GO:0005730;GO:0005654;GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold231 indexed_genome mRNA 395108 396508 . - . ID=transcript_16058;Q96MX3 Q15920 Q4G0R3 Q69YP3 Q96IL9,Zinc finger protein 48,Zinc finger protein 553;, PF00096;, GO:0005634;GO:0001228;GO:0042802;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:identical protein binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold231 indexed_genome mRNA 409393 412982 . + . ID=transcript_16059;Q8WYJ6 B4DVE6 Q658T1 Q8NEZ1 Q96EL4 Q9H285,Septin-1,LARP;Peanut-like protein 3;Serologically defined breast cancer antigen NY-BR-24;, PF00735;, GO:0032153;GO:0015630;GO:0005815;GO:0030496;GO:0031105;GO:0005940;GO:0008021;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0061640;GO:0017157;, C:cell division site; C:microtubule cytoskeleton; C:microtubule organizing center; C:midbody; C:septin complex; C:septin ring; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:regulation of exocytosis;|Q8WYJ6 B4DVE6 Q658T1 Q8NEZ1 Q96EL4 Q9H285,Septin-1,LARP;Peanut-like protein 3;Serologically defined breast cancer antigen NY-BR-24;, PF00735;, GO:0032153;GO:0015630;GO:0005815;GO:0030496;GO:0031105;GO:0005940;GO:0008021;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0034613;GO:0061640;GO:0017157;, C:cell division site; C:microtubule cytoskeleton; C:microtubule organizing center; C:midbody; C:septin complex; C:septin ring; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity;, P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:regulation of exocytosis; scaffold231 indexed_genome mRNA 413017 415681 . - . ID=transcript_16060;Q96A32 B2RA83 Q14843 Q6IB41,Myosin regulatory light chain 2, skeletal muscle isoform,Fast skeletal myosin light chain 2;MLC2B;, PF13405;, GO:0005829;GO:0005765;GO:0005859;GO:0005509;GO:0008307;GO:0006936;GO:0007519;, C:cytosol; C:lysosomal membrane; C:muscle myosin complex;, F:calcium ion binding; F:structural constituent of muscle;, P:muscle contraction; P:skeletal muscle tissue development;|Q96A32 B2RA83 Q14843 Q6IB41,Myosin regulatory light chain 2, skeletal muscle isoform,Fast skeletal myosin light chain 2;MLC2B;, PF13405;, GO:0005829;GO:0005765;GO:0005859;GO:0005509;GO:0008307;GO:0006936;GO:0007519;, C:cytosol; C:lysosomal membrane; C:muscle myosin complex;, F:calcium ion binding; F:structural constituent of muscle;, P:muscle contraction; P:skeletal muscle tissue development; scaffold231 indexed_genome mRNA 420308 436448 . + . ID=transcript_16061;Q4KMP7 B9A6L0 Q6IN54 Q6P530 Q71RG7 Q86VC5 Q9H8Z2 Q9NUN6 Q9UFP2,TBC1 domain family member 10B,Rab27A-GAP-beta;, PF00566;, GO:0005829;GO:0005886;GO:0005096;GO:0090630;GO:0006886;GO:0043087;GO:0042147;, C:cytosol; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of GTPase activity; P:retrograde transport, endosome to Golgi;|Q4KMP7 B9A6L0 Q6IN54 Q6P530 Q71RG7 Q86VC5 Q9H8Z2 Q9NUN6 Q9UFP2,TBC1 domain family member 10B,Rab27A-GAP-beta;, PF00566;, GO:0005829;GO:0005886;GO:0005096;GO:0090630;GO:0006886;GO:0043087;GO:0042147;, C:cytosol; C:plasma membrane;, F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; P:regulation of GTPase activity; P:retrograde transport, endosome to Golgi;|O95400 B2RDX2 Q9ULP2,CD2 antigen cytoplasmic tail-binding protein 2,U5 snRNP 52K protein;, PF02213;, GO:0005737;GO:0005829;GO:0001650;GO:0016607;GO:0005654;GO:0005634;GO:0005682;GO:0043021;GO:0000398;GO:0010923;GO:0000244;, C:cytoplasm; C:cytosol; C:fibrillar center; C:nuclear speck; C:nucleoplasm; C:nucleus; C:U5 snRNP;, F:ribonucleoprotein complex binding;, P:mRNA splicing, via spliceosome; P:negative regulation of phosphatase activity; P:spliceosomal tri-snRNP complex assembly; scaffold231 indexed_genome mRNA 460869 464202 . + . ID=transcript_16062;P16150 A8K9B1,Leukosialin,GPL115 {ECO:0000303|PubMed:3711098};Galactoglycoprotein;Leukocyte sialoglycoprotein;Sialophorin;, , GO:0009986;GO:0009897;GO:0070062;GO:0005615;GO:0005887;GO:0016020;GO:0005902;GO:0005886;GO:0016605;GO:0001931;GO:0031072;GO:0030544;GO:0004888;GO:0007166;GO:0006968;GO:0006935;GO:0042742;GO:0007163;GO:0006955;GO:0050900;GO:0050901;GO:0007162;GO:0042130;GO:2000406;GO:0032760;GO:0050776;GO:2000404;GO:0007165;GO:0002296;, C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:integral component of plasma membrane; C:membrane; C:microvillus; C:plasma membrane; C:PML body; C:uropod;, F:heat shock protein binding; F:Hsp70 protein binding; F:transmembrane signaling receptor activity;, P:cell surface receptor signaling pathway; P:cellular defense response; P:chemotaxis; P:defense response to bacterium; P:establishment or maintenance of cell polarity; P:immune response; P:leukocyte migration; P:leukocyte tethering or rolling; P:negative regulation of cell adhesion; P:negative regulation of T cell proliferation; P:positive regulation of T cell migration; P:positive regulation of tumor necrosis factor production; P:regulation of immune response; P:regulation of T cell migration; P:signal transduction; P:T-helper 1 cell lineage commitment; scaffold231 indexed_genome mRNA 468012 481052 . + . ID=transcript_16063;Q15274 Q53XW7 Q96G22 Q9BSG6,Nicotinate-nucleotide pyrophosphorylase [carboxylating],Quinolinate phosphoribosyltransferase [decarboxylating];, PF01729;PF02749;, GO:1902494;GO:0005737;GO:0005829;GO:0070062;GO:0042802;GO:0004514;GO:0009435;GO:0019674;GO:0034213;, C:catalytic complex; C:cytoplasm; C:cytosol; C:extracellular exosome;, F:identical protein binding; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity;, P:NAD biosynthetic process; P:NAD metabolic process; P:quinolinate catabolic process; scaffold231 indexed_genome mRNA 492968 494920 . - . ID=transcript_16064;Q6UWD8 A6NJR6 Q8NAB0,Transmembrane protein C16orf54,, PF15755;, GO:0016021;, C:integral component of membrane; scaffold231 indexed_genome mRNA 527390 529859 . - . ID=transcript_16065;Q14807 B2R5M0 B7Z265 O60845 O94814 Q53F58 Q9BT46,Kinesin-like protein KIF22,Kinesin-like DNA-binding protein;Kinesin-like protein 4;, PF00225;, GO:0000785;GO:0005829;GO:0005871;GO:0000776;GO:0005874;GO:0072686;GO:0016607;GO:0005634;GO:0005524;GO:1990939;GO:0016887;GO:0003677;GO:0008017;GO:0003777;GO:0019886;GO:0006281;GO:0051310;GO:0007018;GO:0000278;GO:0007080;GO:0006890;GO:0007062;, C:chromatin; C:cytosol; C:kinesin complex; C:kinetochore; C:microtubule; C:mitotic spindle; C:nuclear speck; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:DNA binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:DNA repair; P:metaphase plate congression; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:sister chromatid cohesion; scaffold231 indexed_genome mRNA 530555 533645 . + . ID=transcript_16066;Q14807 B2R5M0 B7Z265 O60845 O94814 Q53F58 Q9BT46,Kinesin-like protein KIF22,Kinesin-like DNA-binding protein;Kinesin-like protein 4;, PF00225;, GO:0000785;GO:0005829;GO:0005871;GO:0000776;GO:0005874;GO:0072686;GO:0016607;GO:0005634;GO:0005524;GO:1990939;GO:0016887;GO:0003677;GO:0008017;GO:0003777;GO:0019886;GO:0006281;GO:0051310;GO:0007018;GO:0000278;GO:0007080;GO:0006890;GO:0007062;, C:chromatin; C:cytosol; C:kinesin complex; C:kinetochore; C:microtubule; C:mitotic spindle; C:nuclear speck; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:DNA binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:DNA repair; P:metaphase plate congression; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:sister chromatid cohesion; scaffold231 indexed_genome mRNA 534663 535411 . + . ID=transcript_16067;Q14807 B2R5M0 B7Z265 O60845 O94814 Q53F58 Q9BT46,Kinesin-like protein KIF22,Kinesin-like DNA-binding protein;Kinesin-like protein 4;, PF00225;, GO:0000785;GO:0005829;GO:0005871;GO:0000776;GO:0005874;GO:0072686;GO:0016607;GO:0005634;GO:0005524;GO:1990939;GO:0016887;GO:0003677;GO:0008017;GO:0003777;GO:0019886;GO:0006281;GO:0051310;GO:0007018;GO:0000278;GO:0007080;GO:0006890;GO:0007062;, C:chromatin; C:cytosol; C:kinesin complex; C:kinetochore; C:microtubule; C:mitotic spindle; C:nuclear speck; C:nucleus;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:DNA binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:DNA repair; P:metaphase plate congression; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic metaphase plate congression; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:sister chromatid cohesion; scaffold232 indexed_genome mRNA 50236 52434 . + . ID=transcript_16068;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold232 indexed_genome mRNA 72242 75459 . - . ID=transcript_16069;Q9Y2Y1 Q1W6H4 Q96S35,DNA-directed RNA polymerase III subunit RPC10,DNA-directed RNA polymerase III subunit K;RNA polymerase III 12.5 kDa subunit;RNA polymerase III subunit C11;, PF02150;PF01096;, GO:0005829;GO:0005730;GO:0005654;GO:0005666;GO:0003899;GO:0003676;GO:0008270;GO:0051607;GO:0045087;GO:0032481;GO:0006386;GO:0006383;GO:0042779;, C:cytosol; C:nucleolus; C:nucleoplasm; C:RNA polymerase III complex;, F:DNA-directed 5'-3' RNA polymerase activity; F:nucleic acid binding; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:positive regulation of type I interferon production; P:termination of RNA polymerase III transcription; P:transcription by RNA polymerase III; P:tRNA 3'-trailer cleavage; scaffold232 indexed_genome mRNA 79615 86627 . - . ID=transcript_16070;Q96CC6 Q04842 Q1W6H2 Q4TT59 Q96S34 Q9H6E1,Inactive rhomboid protein 1,Epidermal growth factor receptor-related protein;Rhomboid 5 homolog 1;Rhomboid family member 1;p100hRho;, PF01694;PF12595;, GO:0005789;GO:0000139;GO:0016021;GO:0019838;GO:0016477;GO:0008283;GO:0050709;GO:0015031;GO:0006508;GO:0042058;GO:0061136;GO:0050708;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:growth factor binding;, P:cell migration; P:cell population proliferation; P:negative regulation of protein secretion; P:protein transport; P:proteolysis; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of proteasomal protein catabolic process; P:regulation of protein secretion;|Q96CC6 Q04842 Q1W6H2 Q4TT59 Q96S34 Q9H6E1,Inactive rhomboid protein 1,Epidermal growth factor receptor-related protein;Rhomboid 5 homolog 1;Rhomboid family member 1;p100hRho;, PF01694;PF12595;, GO:0005789;GO:0000139;GO:0016021;GO:0019838;GO:0016477;GO:0008283;GO:0050709;GO:0015031;GO:0006508;GO:0042058;GO:0061136;GO:0050708;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:growth factor binding;, P:cell migration; P:cell population proliferation; P:negative regulation of protein secretion; P:protein transport; P:proteolysis; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of proteasomal protein catabolic process; P:regulation of protein secretion;|Q96CC6 Q04842 Q1W6H2 Q4TT59 Q96S34 Q9H6E1,Inactive rhomboid protein 1,Epidermal growth factor receptor-related protein;Rhomboid 5 homolog 1;Rhomboid family member 1;p100hRho;, PF01694;PF12595;, GO:0005789;GO:0000139;GO:0016021;GO:0019838;GO:0016477;GO:0008283;GO:0050709;GO:0015031;GO:0006508;GO:0042058;GO:0061136;GO:0050708;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:growth factor binding;, P:cell migration; P:cell population proliferation; P:negative regulation of protein secretion; P:protein transport; P:proteolysis; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of proteasomal protein catabolic process; P:regulation of protein secretion;|Q96CC6 Q04842 Q1W6H2 Q4TT59 Q96S34 Q9H6E1,Inactive rhomboid protein 1,Epidermal growth factor receptor-related protein;Rhomboid 5 homolog 1;Rhomboid family member 1;p100hRho;, PF01694;PF12595;, GO:0005789;GO:0000139;GO:0016021;GO:0019838;GO:0016477;GO:0008283;GO:0050709;GO:0015031;GO:0006508;GO:0042058;GO:0061136;GO:0050708;, C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:growth factor binding;, P:cell migration; P:cell population proliferation; P:negative regulation of protein secretion; P:protein transport; P:proteolysis; P:regulation of epidermal growth factor receptor signaling pathway; P:regulation of proteasomal protein catabolic process; P:regulation of protein secretion; scaffold232 indexed_genome mRNA 103627 143236 . + . ID=transcript_16071;P29372 G5E9E2 Q13770 Q15275 Q15961 Q5J9I4 Q96BZ6 Q96S33 Q9NNX5,DNA-3-methyladenine glycosylase,3-alkyladenine DNA glycosylase;3-methyladenine DNA glycosidase;ADPG;N-methylpurine-DNA glycosylase;, PF02245;, GO:0005829;GO:0042645;GO:0005654;GO:0003905;GO:0003684;GO:0008725;GO:0052822;GO:0052821;GO:0043916;GO:0006284;GO:0006287;GO:0045007;GO:0006307;, C:cytosol; C:mitochondrial nucleoid; C:nucleoplasm;, F:alkylbase DNA N-glycosylase activity; F:damaged DNA binding; F:DNA-3-methyladenine glycosylase activity; F:DNA-3-methylguanine glycosylase activity; F:DNA-7-methyladenine glycosylase activity; F:DNA-7-methylguanine glycosylase activity;, P:base-excision repair; P:base-excision repair, gap-filling; P:depurination; P:DNA dealkylation involved in DNA repair;|P29372 G5E9E2 Q13770 Q15275 Q15961 Q5J9I4 Q96BZ6 Q96S33 Q9NNX5,DNA-3-methyladenine glycosylase,3-alkyladenine DNA glycosylase;3-methyladenine DNA glycosidase;ADPG;N-methylpurine-DNA glycosylase;, PF02245;, GO:0005829;GO:0042645;GO:0005654;GO:0003905;GO:0003684;GO:0008725;GO:0052822;GO:0052821;GO:0043916;GO:0006284;GO:0006287;GO:0045007;GO:0006307;, C:cytosol; C:mitochondrial nucleoid; C:nucleoplasm;, F:alkylbase DNA N-glycosylase activity; F:damaged DNA binding; F:DNA-3-methyladenine glycosylase activity; F:DNA-3-methylguanine glycosylase activity; F:DNA-7-methyladenine glycosylase activity; F:DNA-7-methylguanine glycosylase activity;, P:base-excision repair; P:base-excision repair, gap-filling; P:depurination; P:DNA dealkylation involved in DNA repair;|Q12980 D3DU40 Q1W6H0 Q4TT56 Q92469,GATOR complex protein NPRL3 {ECO:0000305},-14 gene protein {ECO:0000303|PubMed:8575760};Alpha-globin regulatory element-containing gene protein {ECO:0000303|PubMed:8575760};Nitrogen permease regulator 3-like protein {ECO:0000312|HGNC:HGNC:14124};Protein CGTHBA;, PF03666;, GO:1990130;GO:0005765;GO:0005096;GO:0035909;GO:0048738;GO:0034198;GO:0032007;GO:2000785;GO:0060021;GO:0038202;GO:0003281;, C:GATOR1 complex; C:lysosomal membrane;, F:GTPase activator activity;, P:aorta morphogenesis; P:cardiac muscle tissue development; P:cellular response to amino acid starvation; P:negative regulation of TOR signaling; P:regulation of autophagosome assembly; P:roof of mouth development; P:TORC1 signaling; P:ventricular septum development;|Q12980 D3DU40 Q1W6H0 Q4TT56 Q92469,GATOR complex protein NPRL3 {ECO:0000305},-14 gene protein {ECO:0000303|PubMed:8575760};Alpha-globin regulatory element-containing gene protein {ECO:0000303|PubMed:8575760};Nitrogen permease regulator 3-like protein {ECO:0000312|HGNC:HGNC:14124};Protein CGTHBA;, PF03666;, GO:1990130;GO:0005765;GO:0005096;GO:0035909;GO:0048738;GO:0034198;GO:0032007;GO:2000785;GO:0060021;GO:0038202;GO:0003281;, C:GATOR1 complex; C:lysosomal membrane;, F:GTPase activator activity;, P:aorta morphogenesis; P:cardiac muscle tissue development; P:cellular response to amino acid starvation; P:negative regulation of TOR signaling; P:regulation of autophagosome assembly; P:roof of mouth development; P:TORC1 signaling; P:ventricular septum development;|Q12980 D3DU40 Q1W6H0 Q4TT56 Q92469,GATOR complex protein NPRL3 {ECO:0000305},-14 gene protein {ECO:0000303|PubMed:8575760};Alpha-globin regulatory element-containing gene protein {ECO:0000303|PubMed:8575760};Nitrogen permease regulator 3-like protein {ECO:0000312|HGNC:HGNC:14124};Protein CGTHBA;, PF03666;, GO:1990130;GO:0005765;GO:0005096;GO:0035909;GO:0048738;GO:0034198;GO:0032007;GO:2000785;GO:0060021;GO:0038202;GO:0003281;, C:GATOR1 complex; C:lysosomal membrane;, F:GTPase activator activity;, P:aorta morphogenesis; P:cardiac muscle tissue development; P:cellular response to amino acid starvation; P:negative regulation of TOR signaling; P:regulation of autophagosome assembly; P:roof of mouth development; P:TORC1 signaling; P:ventricular septum development; scaffold232 indexed_genome mRNA 175634 176486 . + . ID=transcript_16072;P69905 P01922 Q1HDT5 Q3MIF5 Q53F97 Q96KF1 Q9NYR7 Q9UCM0,Hemoglobin subunit alpha,Alpha-globin;Hemoglobin alpha chain;, PF00042;, GO:0072562;GO:0005829;GO:0022627;GO:0071682;GO:0070062;GO:0005576;GO:0005615;GO:0031838;GO:0005833;GO:0016020;GO:0020037;GO:0005506;GO:0043177;GO:0019825;GO:0005344;GO:0015701;GO:0098869;GO:0042744;GO:0015671;GO:0010942;GO:0006898;GO:0042542;, C:blood microparticle; C:cytosol; C:cytosolic small ribosomal subunit; C:endocytic vesicle lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:haptoglobin-hemoglobin complex; C:hemoglobin complex; C:membrane;, F:heme binding; F:iron ion binding; F:organic acid binding; F:oxygen binding; F:oxygen carrier activity;, P:bicarbonate transport; P:cellular oxidant detoxification; P:hydrogen peroxide catabolic process; P:oxygen transport; P:positive regulation of cell death; P:receptor-mediated endocytosis; P:response to hydrogen peroxide; scaffold232 indexed_genome mRNA 178585 181161 . + . ID=transcript_16073;P09105 Q13723 Q1W6G5,Hemoglobin subunit theta-1,Hemoglobin theta-1 chain;Theta-1-globin;, PF00042;, GO:0031838;GO:0005833;GO:0020037;GO:0005506;GO:0043177;GO:0019825;GO:0005344;GO:0098869;GO:0042744;GO:0015671;, C:haptoglobin-hemoglobin complex; C:hemoglobin complex;, F:heme binding; F:iron ion binding; F:organic acid binding; F:oxygen binding; F:oxygen carrier activity;, P:cellular oxidant detoxification; P:hydrogen peroxide catabolic process; P:oxygen transport; scaffold232 indexed_genome mRNA 184683 203699 . - . ID=transcript_16074;Q9NQ29 B8ZZ13 Q96S32 Q9NPH4,Putative RNA-binding protein Luc7-like 1,Putative SR protein LUC7B1;SR+89;, PF03194;, GO:0005685;GO:0071004;GO:0042802;GO:0003729;GO:0006376;, C:U1 snRNP; C:U2-type prespliceosome;, F:identical protein binding; F:mRNA binding;, P:mRNA splice site selection; scaffold232 indexed_genome mRNA 203748 213298 . - . ID=transcript_16075;Q9NQ29 B8ZZ13 Q96S32 Q9NPH4,Putative RNA-binding protein Luc7-like 1,Putative SR protein LUC7B1;SR+89;, PF03194;, GO:0005685;GO:0071004;GO:0042802;GO:0003729;GO:0006376;, C:U1 snRNP; C:U2-type prespliceosome;, F:identical protein binding; F:mRNA binding;, P:mRNA splice site selection; scaffold232 indexed_genome mRNA 230204 236278 . + . ID=transcript_16076;Q9H0X4 D3DU45 Q7L416 Q96FR1 Q96MC7 Q96S30,Protein FAM234A,Protein ITFG3;, , GO:0009986;GO:0070062;GO:0016021;, C:cell surface; C:extracellular exosome; C:integral component of membrane;|Q9H0X4 D3DU45 Q7L416 Q96FR1 Q96MC7 Q96S30,Protein FAM234A,Protein ITFG3;, , GO:0009986;GO:0070062;GO:0016021;, C:cell surface; C:extracellular exosome; C:integral component of membrane; scaffold232 indexed_genome mRNA 236589 239572 . + . ID=transcript_16077;Q9H0X4 D3DU45 Q7L416 Q96FR1 Q96MC7 Q96S30,Protein FAM234A,Protein ITFG3;, , GO:0009986;GO:0070062;GO:0016021;, C:cell surface; C:extracellular exosome; C:integral component of membrane;|Q9H0X4 D3DU45 Q7L416 Q96FR1 Q96MC7 Q96S30,Protein FAM234A,Protein ITFG3;, , GO:0009986;GO:0070062;GO:0016021;, C:cell surface; C:extracellular exosome; C:integral component of membrane; scaffold232 indexed_genome mRNA 240485 247194 . - . ID=transcript_16078;O94810 O75883 Q4TT71 Q4TT72,Regulator of G-protein signaling 11,, PF00610;PF00631;PF00615;PF18148;, GO:0005886;GO:0032991;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0008277;, C:plasma membrane; C:protein-containing complex;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway;|O94810 O75883 Q4TT71 Q4TT72,Regulator of G-protein signaling 11,, PF00610;PF00631;PF00615;PF18148;, GO:0005886;GO:0032991;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0008277;, C:plasma membrane; C:protein-containing complex;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway;|O94810 O75883 Q4TT71 Q4TT72,Regulator of G-protein signaling 11,, PF00610;PF00631;PF00615;PF18148;, GO:0005886;GO:0032991;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0008277;, C:plasma membrane; C:protein-containing complex;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway;|O94810 O75883 Q4TT71 Q4TT72,Regulator of G-protein signaling 11,, PF00610;PF00631;PF00615;PF18148;, GO:0005886;GO:0032991;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0008277;, C:plasma membrane; C:protein-containing complex;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway;|O94810 O75883 Q4TT71 Q4TT72,Regulator of G-protein signaling 11,, PF00610;PF00631;PF00615;PF18148;, GO:0005886;GO:0032991;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0008277;, C:plasma membrane; C:protein-containing complex;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway;|O94810 O75883 Q4TT71 Q4TT72,Regulator of G-protein signaling 11,, PF00610;PF00631;PF00615;PF18148;, GO:0005886;GO:0032991;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0008277;, C:plasma membrane; C:protein-containing complex;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway;|O94810 O75883 Q4TT71 Q4TT72,Regulator of G-protein signaling 11,, PF00610;PF00631;PF00615;PF18148;, GO:0005886;GO:0032991;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0008277;, C:plasma membrane; C:protein-containing complex;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway; scaffold232 indexed_genome mRNA 247374 247979 . - . ID=transcript_16079;O94810 O75883 Q4TT71 Q4TT72,Regulator of G-protein signaling 11,, PF00610;PF00631;PF00615;PF18148;, GO:0005886;GO:0032991;GO:0031681;GO:0005096;GO:0007186;GO:0035556;GO:0009968;GO:0008277;, C:plasma membrane; C:protein-containing complex;, F:G-protein beta-subunit binding; F:GTPase activator activity;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway; scaffold232 indexed_genome mRNA 250391 255870 . + . ID=transcript_16080;Q99819 Q4TT69 Q96S29,Rho GDP-dissociation inhibitor 3,Rho-GDI gamma;, PF02115;, GO:0031410;GO:0005829;GO:0016020;GO:0005886;GO:0005096;GO:0005094;GO:0001835;GO:0007162;GO:0032880;GO:0051056;GO:0007266;, C:cytoplasmic vesicle; C:cytosol; C:membrane; C:plasma membrane;, F:GTPase activator activity; F:Rho GDP-dissociation inhibitor activity;, P:blastocyst hatching; P:negative regulation of cell adhesion; P:regulation of protein localization; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold232 indexed_genome mRNA 256172 296441 . - . ID=transcript_16081;O15169 Q4TT26 Q4TT27 Q86YA7 Q8WVW6 Q96S28,Axin-1,Axis inhibition protein 1;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0071944;GO:0005737;GO:0031410;GO:0005829;GO:0016328;GO:0005634;GO:0048471;GO:0070016;GO:0008013;GO:0019899;GO:0070411;GO:0042802;GO:0060090;GO:0042803;GO:0019901;GO:0035591;GO:0030159;GO:0046332;GO:0031625;GO:0032147;GO:0006915;GO:1904885;GO:1904886;GO:0034622;GO:0007275;GO:0090090;GO:0090263;GO:0046330;GO:0033138;GO:0010800;GO:0045732;GO:0001934;GO:0031398;GO:0045893;GO:2000060;GO:0051443;GO:0033146;GO:0030111;GO:0016055;, C:beta-catenin destruction complex; C:cell periphery; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lateral plasma membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:armadillo repeat domain binding; F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:identical protein binding; F:molecular adaptor activity; F:protein homodimerization activity; F:protein kinase binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity; F:SMAD binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase activity; P:apoptotic process; P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cellular protein-containing complex assembly; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of Wnt signaling pathway; P:Wnt signaling pathway;|O15169 Q4TT26 Q4TT27 Q86YA7 Q8WVW6 Q96S28,Axin-1,Axis inhibition protein 1;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0071944;GO:0005737;GO:0031410;GO:0005829;GO:0016328;GO:0005634;GO:0048471;GO:0070016;GO:0008013;GO:0019899;GO:0070411;GO:0042802;GO:0060090;GO:0042803;GO:0019901;GO:0035591;GO:0030159;GO:0046332;GO:0031625;GO:0032147;GO:0006915;GO:1904885;GO:1904886;GO:0034622;GO:0007275;GO:0090090;GO:0090263;GO:0046330;GO:0033138;GO:0010800;GO:0045732;GO:0001934;GO:0031398;GO:0045893;GO:2000060;GO:0051443;GO:0033146;GO:0030111;GO:0016055;, C:beta-catenin destruction complex; C:cell periphery; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lateral plasma membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:armadillo repeat domain binding; F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:identical protein binding; F:molecular adaptor activity; F:protein homodimerization activity; F:protein kinase binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity; F:SMAD binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase activity; P:apoptotic process; P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cellular protein-containing complex assembly; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of Wnt signaling pathway; P:Wnt signaling pathway;|O15169 Q4TT26 Q4TT27 Q86YA7 Q8WVW6 Q96S28,Axin-1,Axis inhibition protein 1;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0071944;GO:0005737;GO:0031410;GO:0005829;GO:0016328;GO:0005634;GO:0048471;GO:0070016;GO:0008013;GO:0019899;GO:0070411;GO:0042802;GO:0060090;GO:0042803;GO:0019901;GO:0035591;GO:0030159;GO:0046332;GO:0031625;GO:0032147;GO:0006915;GO:1904885;GO:1904886;GO:0034622;GO:0007275;GO:0090090;GO:0090263;GO:0046330;GO:0033138;GO:0010800;GO:0045732;GO:0001934;GO:0031398;GO:0045893;GO:2000060;GO:0051443;GO:0033146;GO:0030111;GO:0016055;, C:beta-catenin destruction complex; C:cell periphery; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lateral plasma membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:armadillo repeat domain binding; F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:identical protein binding; F:molecular adaptor activity; F:protein homodimerization activity; F:protein kinase binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity; F:SMAD binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase activity; P:apoptotic process; P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cellular protein-containing complex assembly; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of Wnt signaling pathway; P:Wnt signaling pathway;|O15169 Q4TT26 Q4TT27 Q86YA7 Q8WVW6 Q96S28,Axin-1,Axis inhibition protein 1;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0071944;GO:0005737;GO:0031410;GO:0005829;GO:0016328;GO:0005634;GO:0048471;GO:0070016;GO:0008013;GO:0019899;GO:0070411;GO:0042802;GO:0060090;GO:0042803;GO:0019901;GO:0035591;GO:0030159;GO:0046332;GO:0031625;GO:0032147;GO:0006915;GO:1904885;GO:1904886;GO:0034622;GO:0007275;GO:0090090;GO:0090263;GO:0046330;GO:0033138;GO:0010800;GO:0045732;GO:0001934;GO:0031398;GO:0045893;GO:2000060;GO:0051443;GO:0033146;GO:0030111;GO:0016055;, C:beta-catenin destruction complex; C:cell periphery; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lateral plasma membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:armadillo repeat domain binding; F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:identical protein binding; F:molecular adaptor activity; F:protein homodimerization activity; F:protein kinase binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity; F:SMAD binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase activity; P:apoptotic process; P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cellular protein-containing complex assembly; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of Wnt signaling pathway; P:Wnt signaling pathway;|O15169 Q4TT26 Q4TT27 Q86YA7 Q8WVW6 Q96S28,Axin-1,Axis inhibition protein 1;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0071944;GO:0005737;GO:0031410;GO:0005829;GO:0016328;GO:0005634;GO:0048471;GO:0070016;GO:0008013;GO:0019899;GO:0070411;GO:0042802;GO:0060090;GO:0042803;GO:0019901;GO:0035591;GO:0030159;GO:0046332;GO:0031625;GO:0032147;GO:0006915;GO:1904885;GO:1904886;GO:0034622;GO:0007275;GO:0090090;GO:0090263;GO:0046330;GO:0033138;GO:0010800;GO:0045732;GO:0001934;GO:0031398;GO:0045893;GO:2000060;GO:0051443;GO:0033146;GO:0030111;GO:0016055;, C:beta-catenin destruction complex; C:cell periphery; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lateral plasma membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:armadillo repeat domain binding; F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:identical protein binding; F:molecular adaptor activity; F:protein homodimerization activity; F:protein kinase binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity; F:SMAD binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase activity; P:apoptotic process; P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cellular protein-containing complex assembly; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of Wnt signaling pathway; P:Wnt signaling pathway;|O15169 Q4TT26 Q4TT27 Q86YA7 Q8WVW6 Q96S28,Axin-1,Axis inhibition protein 1;, PF16646;PF08833;PF00778;PF00615;, GO:0030877;GO:0071944;GO:0005737;GO:0031410;GO:0005829;GO:0016328;GO:0005634;GO:0048471;GO:0070016;GO:0008013;GO:0019899;GO:0070411;GO:0042802;GO:0060090;GO:0042803;GO:0019901;GO:0035591;GO:0030159;GO:0046332;GO:0031625;GO:0032147;GO:0006915;GO:1904885;GO:1904886;GO:0034622;GO:0007275;GO:0090090;GO:0090263;GO:0046330;GO:0033138;GO:0010800;GO:0045732;GO:0001934;GO:0031398;GO:0045893;GO:2000060;GO:0051443;GO:0033146;GO:0030111;GO:0016055;, C:beta-catenin destruction complex; C:cell periphery; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:lateral plasma membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:armadillo repeat domain binding; F:beta-catenin binding; F:enzyme binding; F:I-SMAD binding; F:identical protein binding; F:molecular adaptor activity; F:protein homodimerization activity; F:protein kinase binding; F:signaling adaptor activity; F:signaling receptor complex adaptor activity; F:SMAD binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase activity; P:apoptotic process; P:beta-catenin destruction complex assembly; P:beta-catenin destruction complex disassembly; P:cellular protein-containing complex assembly; P:multicellular organism development; P:negative regulation of canonical Wnt signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of JNK cascade; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of protein ubiquitination; P:positive regulation of transcription, DNA-templated; P:positive regulation of ubiquitin-dependent protein catabolic process; P:positive regulation of ubiquitin-protein transferase activity; P:regulation of intracellular estrogen receptor signaling pathway; P:regulation of Wnt signaling pathway; P:Wnt signaling pathway; scaffold232 indexed_genome mRNA 304289 317144 . - . ID=transcript_16082;Q13084 B2RCM4 D3DU46 Q4TT39 Q96S26 Q9BQD8 Q9BR04,39S ribosomal protein L28, mitochondrial,Melanoma antigen p15;Melanoma-associated antigen recognized by T-lymphocytes;Mitochondrial large ribosomal subunit protein bL28m {ECO:0000303|PubMed:25278503};, PF00830;, GO:0005829;GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003723;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q9HCN3 D3DU49 Q4TT35 Q8WU24 Q96S25 Q9BR03 Q9BT97 Q9H7B9,Post-GPI attachment to proteins factor 6 {ECO:0000303|PubMed:27881714},GPI processing phospholipase A2 {ECO:0000303|PubMed:27881714};Protein M83;Transmembrane protein 6;Transmembrane protein 8;Transmembrane protein 8A;, PF12036;, GO:0070062;GO:0005887;GO:0005765;GO:0005886;GO:0004623;GO:0102567;GO:0102568;, C:extracellular exosome; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane;, F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);|Q9HCN3 D3DU49 Q4TT35 Q8WU24 Q96S25 Q9BR03 Q9BT97 Q9H7B9,Post-GPI attachment to proteins factor 6 {ECO:0000303|PubMed:27881714},GPI processing phospholipase A2 {ECO:0000303|PubMed:27881714};Protein M83;Transmembrane protein 6;Transmembrane protein 8;Transmembrane protein 8A;, PF12036;, GO:0070062;GO:0005887;GO:0005765;GO:0005886;GO:0004623;GO:0102567;GO:0102568;, C:extracellular exosome; C:integral component of plasma membrane; C:lysosomal membrane; C:plasma membrane;, F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); scaffold232 indexed_genome mRNA 343357 346788 . + . ID=transcript_16083;O00746 A2IDD0 Q5U0M9,Nucleoside diphosphate kinase, mitochondrial {ECO:0000305},Nucleoside diphosphate kinase D;nm23-H4;, PF00334;, GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005524;GO:1901612;GO:0046872;GO:0004550;GO:0006241;GO:0006183;GO:0006869;GO:0015949;GO:0009116;GO:0006228;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:cardiolipin binding; F:metal ion binding; F:nucleoside diphosphate kinase activity;, P:CTP biosynthetic process; P:GTP biosynthetic process; P:lipid transport; P:nucleobase-containing small molecule interconversion; P:nucleoside metabolic process; P:UTP biosynthetic process;|O00746 A2IDD0 Q5U0M9,Nucleoside diphosphate kinase, mitochondrial {ECO:0000305},Nucleoside diphosphate kinase D;nm23-H4;, PF00334;, GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005524;GO:1901612;GO:0046872;GO:0004550;GO:0006241;GO:0006183;GO:0006869;GO:0015949;GO:0009116;GO:0006228;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:cardiolipin binding; F:metal ion binding; F:nucleoside diphosphate kinase activity;, P:CTP biosynthetic process; P:GTP biosynthetic process; P:lipid transport; P:nucleobase-containing small molecule interconversion; P:nucleoside metabolic process; P:UTP biosynthetic process;|O00746 A2IDD0 Q5U0M9,Nucleoside diphosphate kinase, mitochondrial {ECO:0000305},Nucleoside diphosphate kinase D;nm23-H4;, PF00334;, GO:0005743;GO:0005758;GO:0005759;GO:0005739;GO:0005524;GO:1901612;GO:0046872;GO:0004550;GO:0006241;GO:0006183;GO:0006869;GO:0015949;GO:0009116;GO:0006228;, C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:cardiolipin binding; F:metal ion binding; F:nucleoside diphosphate kinase activity;, P:CTP biosynthetic process; P:GTP biosynthetic process; P:lipid transport; P:nucleobase-containing small molecule interconversion; P:nucleoside metabolic process; P:UTP biosynthetic process; scaffold232 indexed_genome mRNA 347596 354706 . - . ID=transcript_16084;Q9NUI1 Q6ZRS7 Q96ET0,Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing],2,4-dienoyl-CoA reductase 2;Short chain dehydrogenase/reductase family 17C member 1;, , GO:0005829;GO:0005778;GO:0008670;GO:0019166;GO:0033540;GO:0008104;GO:0006636;, C:cytosol; C:peroxisomal membrane;, F:2,4-dienoyl-CoA reductase (NADPH) activity; F:trans-2-enoyl-CoA reductase (NADPH) activity;, P:fatty acid beta-oxidation using acyl-CoA oxidase; P:protein localization; P:unsaturated fatty acid biosynthetic process;|Q9NUI1 Q6ZRS7 Q96ET0,Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing],2,4-dienoyl-CoA reductase 2;Short chain dehydrogenase/reductase family 17C member 1;, , GO:0005829;GO:0005778;GO:0008670;GO:0019166;GO:0033540;GO:0008104;GO:0006636;, C:cytosol; C:peroxisomal membrane;, F:2,4-dienoyl-CoA reductase (NADPH) activity; F:trans-2-enoyl-CoA reductase (NADPH) activity;, P:fatty acid beta-oxidation using acyl-CoA oxidase; P:protein localization; P:unsaturated fatty acid biosynthetic process; scaffold232 indexed_genome mRNA 364282 407237 . + . ID=transcript_16085;Q9H1G0 Q9NUI0,Rab11 family-interacting protein 3,Arfophilin-1;EF hands-containing Rab-interacting protein;MU-MB-17.148;, PF09457;, GO:0034451;GO:0005813;GO:0032154;GO:0005829;GO:0030139;GO:0005768;GO:0045171;GO:0043231;GO:0030496;GO:0005739;GO:0005654;GO:0055037;GO:0055038;GO:0005509;GO:0051959;GO:0042803;GO:0031267;GO:0007049;GO:0051301;GO:0060271;GO:0032456;GO:0070164;GO:0061512;GO:0032465;GO:0016192;, C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytosol; C:endocytic vesicle; C:endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:midbody; C:mitochondrion; C:nucleoplasm; C:recycling endosome; C:recycling endosome membrane;, F:calcium ion binding; F:dynein light intermediate chain binding; F:protein homodimerization activity; F:small GTPase binding;, P:cell cycle; P:cell division; P:cilium assembly; P:endocytic recycling; P:negative regulation of adiponectin secretion; P:protein localization to cilium; P:regulation of cytokinesis; P:vesicle-mediated transport;|Q9H1G0 Q9NUI0,Rab11 family-interacting protein 3,Arfophilin-1;EF hands-containing Rab-interacting protein;MU-MB-17.148;, PF09457;, GO:0034451;GO:0005813;GO:0032154;GO:0005829;GO:0030139;GO:0005768;GO:0045171;GO:0043231;GO:0030496;GO:0005739;GO:0005654;GO:0055037;GO:0055038;GO:0005509;GO:0051959;GO:0042803;GO:0031267;GO:0007049;GO:0051301;GO:0060271;GO:0032456;GO:0070164;GO:0061512;GO:0032465;GO:0016192;, C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytosol; C:endocytic vesicle; C:endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:midbody; C:mitochondrion; C:nucleoplasm; C:recycling endosome; C:recycling endosome membrane;, F:calcium ion binding; F:dynein light intermediate chain binding; F:protein homodimerization activity; F:small GTPase binding;, P:cell cycle; P:cell division; P:cilium assembly; P:endocytic recycling; P:negative regulation of adiponectin secretion; P:protein localization to cilium; P:regulation of cytokinesis; P:vesicle-mediated transport;|Q9H1G0 Q9NUI0,Rab11 family-interacting protein 3,Arfophilin-1;EF hands-containing Rab-interacting protein;MU-MB-17.148;, PF09457;, GO:0034451;GO:0005813;GO:0032154;GO:0005829;GO:0030139;GO:0005768;GO:0045171;GO:0043231;GO:0030496;GO:0005739;GO:0005654;GO:0055037;GO:0055038;GO:0005509;GO:0051959;GO:0042803;GO:0031267;GO:0007049;GO:0051301;GO:0060271;GO:0032456;GO:0070164;GO:0061512;GO:0032465;GO:0016192;, C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytosol; C:endocytic vesicle; C:endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:midbody; C:mitochondrion; C:nucleoplasm; C:recycling endosome; C:recycling endosome membrane;, F:calcium ion binding; F:dynein light intermediate chain binding; F:protein homodimerization activity; F:small GTPase binding;, P:cell cycle; P:cell division; P:cilium assembly; P:endocytic recycling; P:negative regulation of adiponectin secretion; P:protein localization to cilium; P:regulation of cytokinesis; P:vesicle-mediated transport;|Q9H1G0 Q9NUI0,Rab11 family-interacting protein 3,Arfophilin-1;EF hands-containing Rab-interacting protein;MU-MB-17.148;, PF09457;, GO:0034451;GO:0005813;GO:0032154;GO:0005829;GO:0030139;GO:0005768;GO:0045171;GO:0043231;GO:0030496;GO:0005739;GO:0005654;GO:0055037;GO:0055038;GO:0005509;GO:0051959;GO:0042803;GO:0031267;GO:0007049;GO:0051301;GO:0060271;GO:0032456;GO:0070164;GO:0061512;GO:0032465;GO:0016192;, C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytosol; C:endocytic vesicle; C:endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:midbody; C:mitochondrion; C:nucleoplasm; C:recycling endosome; C:recycling endosome membrane;, F:calcium ion binding; F:dynein light intermediate chain binding; F:protein homodimerization activity; F:small GTPase binding;, P:cell cycle; P:cell division; P:cilium assembly; P:endocytic recycling; P:negative regulation of adiponectin secretion; P:protein localization to cilium; P:regulation of cytokinesis; P:vesicle-mediated transport;|Q9H1G0 Q9NUI0,Rab11 family-interacting protein 3,Arfophilin-1;EF hands-containing Rab-interacting protein;MU-MB-17.148;, PF09457;, GO:0034451;GO:0005813;GO:0032154;GO:0005829;GO:0030139;GO:0005768;GO:0045171;GO:0043231;GO:0030496;GO:0005739;GO:0005654;GO:0055037;GO:0055038;GO:0005509;GO:0051959;GO:0042803;GO:0031267;GO:0007049;GO:0051301;GO:0060271;GO:0032456;GO:0070164;GO:0061512;GO:0032465;GO:0016192;, C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytosol; C:endocytic vesicle; C:endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:midbody; C:mitochondrion; C:nucleoplasm; C:recycling endosome; C:recycling endosome membrane;, F:calcium ion binding; F:dynein light intermediate chain binding; F:protein homodimerization activity; F:small GTPase binding;, P:cell cycle; P:cell division; P:cilium assembly; P:endocytic recycling; P:negative regulation of adiponectin secretion; P:protein localization to cilium; P:regulation of cytokinesis; P:vesicle-mediated transport;|Q9H1G0 Q9NUI0,Rab11 family-interacting protein 3,Arfophilin-1;EF hands-containing Rab-interacting protein;MU-MB-17.148;, PF09457;, GO:0034451;GO:0005813;GO:0032154;GO:0005829;GO:0030139;GO:0005768;GO:0045171;GO:0043231;GO:0030496;GO:0005739;GO:0005654;GO:0055037;GO:0055038;GO:0005509;GO:0051959;GO:0042803;GO:0031267;GO:0007049;GO:0051301;GO:0060271;GO:0032456;GO:0070164;GO:0061512;GO:0032465;GO:0016192;, C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytosol; C:endocytic vesicle; C:endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:midbody; C:mitochondrion; C:nucleoplasm; C:recycling endosome; C:recycling endosome membrane;, F:calcium ion binding; F:dynein light intermediate chain binding; F:protein homodimerization activity; F:small GTPase binding;, P:cell cycle; P:cell division; P:cilium assembly; P:endocytic recycling; P:negative regulation of adiponectin secretion; P:protein localization to cilium; P:regulation of cytokinesis; P:vesicle-mediated transport; scaffold232 indexed_genome mRNA 408179 414101 . + . ID=transcript_16086;Q9H1G0 Q9NUI0,Rab11 family-interacting protein 3,Arfophilin-1;EF hands-containing Rab-interacting protein;MU-MB-17.148;, PF09457;, GO:0034451;GO:0005813;GO:0032154;GO:0005829;GO:0030139;GO:0005768;GO:0045171;GO:0043231;GO:0030496;GO:0005739;GO:0005654;GO:0055037;GO:0055038;GO:0005509;GO:0051959;GO:0042803;GO:0031267;GO:0007049;GO:0051301;GO:0060271;GO:0032456;GO:0070164;GO:0061512;GO:0032465;GO:0016192;, C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytosol; C:endocytic vesicle; C:endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:midbody; C:mitochondrion; C:nucleoplasm; C:recycling endosome; C:recycling endosome membrane;, F:calcium ion binding; F:dynein light intermediate chain binding; F:protein homodimerization activity; F:small GTPase binding;, P:cell cycle; P:cell division; P:cilium assembly; P:endocytic recycling; P:negative regulation of adiponectin secretion; P:protein localization to cilium; P:regulation of cytokinesis; P:vesicle-mediated transport;|Q9H1G0 Q9NUI0,Rab11 family-interacting protein 3,Arfophilin-1;EF hands-containing Rab-interacting protein;MU-MB-17.148;, PF09457;, GO:0034451;GO:0005813;GO:0032154;GO:0005829;GO:0030139;GO:0005768;GO:0045171;GO:0043231;GO:0030496;GO:0005739;GO:0005654;GO:0055037;GO:0055038;GO:0005509;GO:0051959;GO:0042803;GO:0031267;GO:0007049;GO:0051301;GO:0060271;GO:0032456;GO:0070164;GO:0061512;GO:0032465;GO:0016192;, C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytosol; C:endocytic vesicle; C:endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:midbody; C:mitochondrion; C:nucleoplasm; C:recycling endosome; C:recycling endosome membrane;, F:calcium ion binding; F:dynein light intermediate chain binding; F:protein homodimerization activity; F:small GTPase binding;, P:cell cycle; P:cell division; P:cilium assembly; P:endocytic recycling; P:negative regulation of adiponectin secretion; P:protein localization to cilium; P:regulation of cytokinesis; P:vesicle-mediated transport; scaffold232 indexed_genome mRNA 415117 421835 . - . ID=transcript_16087;Q9H1G0 Q9NUI0,Rab11 family-interacting protein 3,Arfophilin-1;EF hands-containing Rab-interacting protein;MU-MB-17.148;, PF09457;, GO:0034451;GO:0005813;GO:0032154;GO:0005829;GO:0030139;GO:0005768;GO:0045171;GO:0043231;GO:0030496;GO:0005739;GO:0005654;GO:0055037;GO:0055038;GO:0005509;GO:0051959;GO:0042803;GO:0031267;GO:0007049;GO:0051301;GO:0060271;GO:0032456;GO:0070164;GO:0061512;GO:0032465;GO:0016192;, C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytosol; C:endocytic vesicle; C:endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:midbody; C:mitochondrion; C:nucleoplasm; C:recycling endosome; C:recycling endosome membrane;, F:calcium ion binding; F:dynein light intermediate chain binding; F:protein homodimerization activity; F:small GTPase binding;, P:cell cycle; P:cell division; P:cilium assembly; P:endocytic recycling; P:negative regulation of adiponectin secretion; P:protein localization to cilium; P:regulation of cytokinesis; P:vesicle-mediated transport;|Q9H1G0 Q9NUI0,Rab11 family-interacting protein 3,Arfophilin-1;EF hands-containing Rab-interacting protein;MU-MB-17.148;, PF09457;, GO:0034451;GO:0005813;GO:0032154;GO:0005829;GO:0030139;GO:0005768;GO:0045171;GO:0043231;GO:0030496;GO:0005739;GO:0005654;GO:0055037;GO:0055038;GO:0005509;GO:0051959;GO:0042803;GO:0031267;GO:0007049;GO:0051301;GO:0060271;GO:0032456;GO:0070164;GO:0061512;GO:0032465;GO:0016192;, C:centriolar satellite; C:centrosome; C:cleavage furrow; C:cytosol; C:endocytic vesicle; C:endosome; C:intercellular bridge; C:intracellular membrane-bounded organelle; C:midbody; C:mitochondrion; C:nucleoplasm; C:recycling endosome; C:recycling endosome membrane;, F:calcium ion binding; F:dynein light intermediate chain binding; F:protein homodimerization activity; F:small GTPase binding;, P:cell cycle; P:cell division; P:cilium assembly; P:endocytic recycling; P:negative regulation of adiponectin secretion; P:protein localization to cilium; P:regulation of cytokinesis; P:vesicle-mediated transport; scaffold232 indexed_genome mRNA 427687 442509 . - . ID=transcript_16088;O75808 B1B1M4 Q2KHS2 Q8WTY9 Q9BUW0,Calpain-15,Small optic lobes homolog;, PF00648;PF00641;, GO:0005737;GO:0004198;GO:0046872;GO:0006508;, C:cytoplasm;, F:calcium-dependent cysteine-type endopeptidase activity; F:metal ion binding;, P:proteolysis;|O75808 B1B1M4 Q2KHS2 Q8WTY9 Q9BUW0,Calpain-15,Small optic lobes homolog;, PF00648;PF00641;, GO:0005737;GO:0004198;GO:0046872;GO:0006508;, C:cytoplasm;, F:calcium-dependent cysteine-type endopeptidase activity; F:metal ion binding;, P:proteolysis;|O75808 B1B1M4 Q2KHS2 Q8WTY9 Q9BUW0,Calpain-15,Small optic lobes homolog;, PF00648;PF00641;, GO:0005737;GO:0004198;GO:0046872;GO:0006508;, C:cytoplasm;, F:calcium-dependent cysteine-type endopeptidase activity; F:metal ion binding;, P:proteolysis;|O75808 B1B1M4 Q2KHS2 Q8WTY9 Q9BUW0,Calpain-15,Small optic lobes homolog;, PF00648;PF00641;, GO:0005737;GO:0004198;GO:0046872;GO:0006508;, C:cytoplasm;, F:calcium-dependent cysteine-type endopeptidase activity; F:metal ion binding;, P:proteolysis;|O75808 B1B1M4 Q2KHS2 Q8WTY9 Q9BUW0,Calpain-15,Small optic lobes homolog;, PF00648;PF00641;, GO:0005737;GO:0004198;GO:0046872;GO:0006508;, C:cytoplasm;, F:calcium-dependent cysteine-type endopeptidase activity; F:metal ion binding;, P:proteolysis; scaffold232 indexed_genome mRNA 454442 455197 . + . ID=transcript_16089;P0CG20 B8ZZ27 Q8N233 Q96AX3 Q96S23,Proline-rich protein 35,Uncharacterized protein RJD1;, PF15269; scaffold232 indexed_genome mRNA 459259 472076 . + . ID=transcript_16090;Q9BRB3 A2IDE1 D3DU52 O14927 Q96G00 Q96S22 Q9UJH4,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q {ECO:0000305},N-acetylglucosamyl transferase component GPI1;Phosphatidylinositol-glycan biosynthesis class Q protein;, PF05024;, GO:0005789;GO:0000506;GO:0016021;GO:0017176;GO:0005975;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:carbohydrate metabolic process; P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9BRB3 A2IDE1 D3DU52 O14927 Q96G00 Q96S22 Q9UJH4,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q {ECO:0000305},N-acetylglucosamyl transferase component GPI1;Phosphatidylinositol-glycan biosynthesis class Q protein;, PF05024;, GO:0005789;GO:0000506;GO:0016021;GO:0017176;GO:0005975;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:carbohydrate metabolic process; P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9BRB3 A2IDE1 D3DU52 O14927 Q96G00 Q96S22 Q9UJH4,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q {ECO:0000305},N-acetylglucosamyl transferase component GPI1;Phosphatidylinositol-glycan biosynthesis class Q protein;, PF05024;, GO:0005789;GO:0000506;GO:0016021;GO:0017176;GO:0005975;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:carbohydrate metabolic process; P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane;|Q9BRB3 A2IDE1 D3DU52 O14927 Q96G00 Q96S22 Q9UJH4,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q {ECO:0000305},N-acetylglucosamyl transferase component GPI1;Phosphatidylinositol-glycan biosynthesis class Q protein;, PF05024;, GO:0005789;GO:0000506;GO:0016021;GO:0017176;GO:0005975;GO:0006506;GO:0016254;, C:endoplasmic reticulum membrane; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; C:integral component of membrane;, F:phosphatidylinositol N-acetylglucosaminyltransferase activity;, P:carbohydrate metabolic process; P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold232 indexed_genome mRNA 506048 513071 . + . ID=transcript_16091;Q96S21 A2IDE2 D3DU54 O60795 Q4TT41 Q5PXE8 Q6PIU5,Ras-related protein Rab-40C,Rar-like protein;Ras-like protein family member 8C;SOCS box-containing protein RAR3;, PF00071;PF07525;, GO:0005768;GO:0048471;GO:0005886;GO:0008021;GO:0019003;GO:0005525;GO:0003924;GO:0035556;GO:0072659;GO:0016567;, C:endosome; C:perinuclear region of cytoplasm; C:plasma membrane; C:synaptic vesicle;, F:GDP binding; F:GTP binding; F:GTPase activity;, P:intracellular signal transduction; P:protein localization to plasma membrane; P:protein ubiquitination; scaffold232 indexed_genome mRNA 515681 516918 . - . ID=transcript_16092;Q96NZ8 Q7LDW0 Q8NBQ1 Q96S20,WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1,Growth and differentiation factor-associated serum protein 2;WAP, follistatin, immunoglobulin, Kunitz and NTR domain-containing protein;, PF00014;PF00095;, GO:0005576;GO:0008191;GO:0048019;GO:0004867;GO:0050431;GO:0048747;GO:0043392;GO:0032091;GO:0030512;GO:0060021;GO:0001501;, C:extracellular region;, F:metalloendopeptidase inhibitor activity; F:receptor antagonist activity; F:serine-type endopeptidase inhibitor activity; F:transforming growth factor beta binding;, P:muscle fiber development; P:negative regulation of DNA binding; P:negative regulation of protein binding; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:roof of mouth development; P:skeletal system development; scaffold232 indexed_genome mRNA 517282 522841 . + . ID=transcript_16093;Q96IW1 Q96MD6,Methyltransferase-like 26 {ECO:0000312|HGNC:HGNC:14141},, PF06080;|Q96IW1 Q96MD6,Methyltransferase-like 26 {ECO:0000312|HGNC:HGNC:14141},, PF06080; scaffold233 indexed_genome mRNA 27664 34872 . - . ID=transcript_16094;Q86TM9 Q86YX9 Q9BXP7,Acetylcholinesterase,, PF08674;PF00135;, GO:0031225;GO:0005604;GO:0009986;GO:0005576;GO:0005615;GO:0005794;GO:0016020;GO:0031594;GO:0005634;GO:0048471;GO:0005886;GO:0045202;GO:0043083;GO:0042166;GO:0003990;GO:0001540;GO:0052689;GO:0004104;GO:0005518;GO:0016787;GO:0043236;GO:0042803;GO:0043621;GO:0017171;GO:0006581;GO:0001507;GO:0095500;GO:0042982;GO:0007155;GO:0032223;GO:0007399;GO:0042136;GO:0002076;GO:0006656;GO:0120162;GO:0050714;GO:0031623;GO:0001919;GO:0060041;GO:0007416;, C:anchored component of membrane; C:basement membrane; C:cell surface; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:membrane; C:neuromuscular junction; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse; C:synaptic cleft;, F:acetylcholine binding; F:acetylcholinesterase activity; F:amyloid-beta binding; F:carboxylic ester hydrolase activity; F:cholinesterase activity; F:collagen binding; F:hydrolase activity; F:laminin binding; F:protein homodimerization activity; F:protein self-association; F:serine hydrolase activity;, P:acetylcholine catabolic process; P:acetylcholine catabolic process in synaptic cleft; P:acetylcholine receptor signaling pathway; P:amyloid precursor protein metabolic process; P:cell adhesion; P:negative regulation of synaptic transmission, cholinergic; P:nervous system development; P:neurotransmitter biosynthetic process; P:osteoblast development; P:phosphatidylcholine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein secretion; P:receptor internalization; P:regulation of receptor recycling; P:retina development in camera-type eye; P:synapse assembly;|Q86TM9 Q86YX9 Q9BXP7,Acetylcholinesterase,, PF08674;PF00135;, GO:0031225;GO:0005604;GO:0009986;GO:0005576;GO:0005615;GO:0005794;GO:0016020;GO:0031594;GO:0005634;GO:0048471;GO:0005886;GO:0045202;GO:0043083;GO:0042166;GO:0003990;GO:0001540;GO:0052689;GO:0004104;GO:0005518;GO:0016787;GO:0043236;GO:0042803;GO:0043621;GO:0017171;GO:0006581;GO:0001507;GO:0095500;GO:0042982;GO:0007155;GO:0032223;GO:0007399;GO:0042136;GO:0002076;GO:0006656;GO:0120162;GO:0050714;GO:0031623;GO:0001919;GO:0060041;GO:0007416;, C:anchored component of membrane; C:basement membrane; C:cell surface; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:membrane; C:neuromuscular junction; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse; C:synaptic cleft;, F:acetylcholine binding; F:acetylcholinesterase activity; F:amyloid-beta binding; F:carboxylic ester hydrolase activity; F:cholinesterase activity; F:collagen binding; F:hydrolase activity; F:laminin binding; F:protein homodimerization activity; F:protein self-association; F:serine hydrolase activity;, P:acetylcholine catabolic process; P:acetylcholine catabolic process in synaptic cleft; P:acetylcholine receptor signaling pathway; P:amyloid precursor protein metabolic process; P:cell adhesion; P:negative regulation of synaptic transmission, cholinergic; P:nervous system development; P:neurotransmitter biosynthetic process; P:osteoblast development; P:phosphatidylcholine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein secretion; P:receptor internalization; P:regulation of receptor recycling; P:retina development in camera-type eye; P:synapse assembly;|Q86TM9 Q86YX9 Q9BXP7,Acetylcholinesterase,, PF08674;PF00135;, GO:0031225;GO:0005604;GO:0009986;GO:0005576;GO:0005615;GO:0005794;GO:0016020;GO:0031594;GO:0005634;GO:0048471;GO:0005886;GO:0045202;GO:0043083;GO:0042166;GO:0003990;GO:0001540;GO:0052689;GO:0004104;GO:0005518;GO:0016787;GO:0043236;GO:0042803;GO:0043621;GO:0017171;GO:0006581;GO:0001507;GO:0095500;GO:0042982;GO:0007155;GO:0032223;GO:0007399;GO:0042136;GO:0002076;GO:0006656;GO:0120162;GO:0050714;GO:0031623;GO:0001919;GO:0060041;GO:0007416;, C:anchored component of membrane; C:basement membrane; C:cell surface; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:membrane; C:neuromuscular junction; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:synapse; C:synaptic cleft;, F:acetylcholine binding; F:acetylcholinesterase activity; F:amyloid-beta binding; F:carboxylic ester hydrolase activity; F:cholinesterase activity; F:collagen binding; F:hydrolase activity; F:laminin binding; F:protein homodimerization activity; F:protein self-association; F:serine hydrolase activity;, P:acetylcholine catabolic process; P:acetylcholine catabolic process in synaptic cleft; P:acetylcholine receptor signaling pathway; P:amyloid precursor protein metabolic process; P:cell adhesion; P:negative regulation of synaptic transmission, cholinergic; P:nervous system development; P:neurotransmitter biosynthetic process; P:osteoblast development; P:phosphatidylcholine biosynthetic process; P:positive regulation of cold-induced thermogenesis; P:positive regulation of protein secretion; P:receptor internalization; P:regulation of receptor recycling; P:retina development in camera-type eye; P:synapse assembly; scaffold233 indexed_genome mRNA 34899 41506 . - . ID=transcript_16095;Q8TDQ5 Q9BWP6 Q9BXP4 Q9Y4S4,Serrate RNA effector molecule homolog,Arsenite-resistance protein 2;, PF04959;PF12066;, GO:0005737;GO:0016604;GO:0005654;GO:0032991;GO:0003677;GO:0003723;GO:0000398;GO:0097150;GO:0050769;GO:0031053;GO:0006355;GO:0046685;GO:0042795;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:protein-containing complex;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:neuronal stem cell population maintenance; P:positive regulation of neurogenesis; P:primary miRNA processing; P:regulation of transcription, DNA-templated; P:response to arsenic-containing substance; P:snRNA transcription by RNA polymerase II;|Q8TDQ5 Q9BWP6 Q9BXP4 Q9Y4S4,Serrate RNA effector molecule homolog,Arsenite-resistance protein 2;, PF04959;PF12066;, GO:0005737;GO:0016604;GO:0005654;GO:0032991;GO:0003677;GO:0003723;GO:0000398;GO:0097150;GO:0050769;GO:0031053;GO:0006355;GO:0046685;GO:0042795;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:protein-containing complex;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:neuronal stem cell population maintenance; P:positive regulation of neurogenesis; P:primary miRNA processing; P:regulation of transcription, DNA-templated; P:response to arsenic-containing substance; P:snRNA transcription by RNA polymerase II;|Q8TDQ5 Q9BWP6 Q9BXP4 Q9Y4S4,Serrate RNA effector molecule homolog,Arsenite-resistance protein 2;, PF04959;PF12066;, GO:0005737;GO:0016604;GO:0005654;GO:0032991;GO:0003677;GO:0003723;GO:0000398;GO:0097150;GO:0050769;GO:0031053;GO:0006355;GO:0046685;GO:0042795;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:protein-containing complex;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:neuronal stem cell population maintenance; P:positive regulation of neurogenesis; P:primary miRNA processing; P:regulation of transcription, DNA-templated; P:response to arsenic-containing substance; P:snRNA transcription by RNA polymerase II;|Q8TDQ5 Q9BWP6 Q9BXP4 Q9Y4S4,Serrate RNA effector molecule homolog,Arsenite-resistance protein 2;, PF04959;PF12066;, GO:0005737;GO:0016604;GO:0005654;GO:0032991;GO:0003677;GO:0003723;GO:0000398;GO:0097150;GO:0050769;GO:0031053;GO:0006355;GO:0046685;GO:0042795;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:protein-containing complex;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:neuronal stem cell population maintenance; P:positive regulation of neurogenesis; P:primary miRNA processing; P:regulation of transcription, DNA-templated; P:response to arsenic-containing substance; P:snRNA transcription by RNA polymerase II;|Q8TDQ5 Q9BWP6 Q9BXP4 Q9Y4S4,Serrate RNA effector molecule homolog,Arsenite-resistance protein 2;, PF04959;PF12066;, GO:0005737;GO:0016604;GO:0005654;GO:0032991;GO:0003677;GO:0003723;GO:0000398;GO:0097150;GO:0050769;GO:0031053;GO:0006355;GO:0046685;GO:0042795;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:protein-containing complex;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:neuronal stem cell population maintenance; P:positive regulation of neurogenesis; P:primary miRNA processing; P:regulation of transcription, DNA-templated; P:response to arsenic-containing substance; P:snRNA transcription by RNA polymerase II; scaffold233 indexed_genome mRNA 41942 48512 . - . ID=transcript_16096;Q8TDQ5 Q9BWP6 Q9BXP4 Q9Y4S4,Serrate RNA effector molecule homolog,Arsenite-resistance protein 2;, PF04959;PF12066;, GO:0005737;GO:0016604;GO:0005654;GO:0032991;GO:0003677;GO:0003723;GO:0000398;GO:0097150;GO:0050769;GO:0031053;GO:0006355;GO:0046685;GO:0042795;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:protein-containing complex;, F:DNA binding; F:RNA binding;, P:mRNA splicing, via spliceosome; P:neuronal stem cell population maintenance; P:positive regulation of neurogenesis; P:primary miRNA processing; P:regulation of transcription, DNA-templated; P:response to arsenic-containing substance; P:snRNA transcription by RNA polymerase II; scaffold233 indexed_genome mRNA 48824 53220 . + . ID=transcript_16097;Q9UNT4,Thyroid receptor-interacting protein 6,Opa-interacting protein 1;Zyxin-related protein 1;, PF00412;, GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0001725;GO:0005149;GO:0019900;GO:0046872;GO:0003723;GO:0046966;GO:0043009;GO:0048041;GO:0030335;GO:1901224;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane; C:stress fiber;, F:interleukin-1 receptor binding; F:kinase binding; F:metal ion binding; F:RNA binding; F:thyroid hormone receptor binding;, P:chordate embryonic development; P:focal adhesion assembly; P:positive regulation of cell migration; P:positive regulation of NIK/NF-kappaB signaling; P:signal transduction;|Q9UNT4,Thyroid receptor-interacting protein 6,Opa-interacting protein 1;Zyxin-related protein 1;, PF00412;, GO:0005737;GO:0005856;GO:0005829;GO:0005925;GO:0005634;GO:0005886;GO:0001725;GO:0005149;GO:0019900;GO:0046872;GO:0003723;GO:0046966;GO:0043009;GO:0048041;GO:0030335;GO:1901224;GO:0007165;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:focal adhesion; C:nucleus; C:plasma membrane; C:stress fiber;, F:interleukin-1 receptor binding; F:kinase binding; F:metal ion binding; F:RNA binding; F:thyroid hormone receptor binding;, P:chordate embryonic development; P:focal adhesion assembly; P:positive regulation of cell migration; P:positive regulation of NIK/NF-kappaB signaling; P:signal transduction; scaffold233 indexed_genome mRNA 53570 63160 . - . ID=transcript_16098;Q9BXP2 B7Z740 D6W5X0 D6W5X2 F5H8C2 Q9BWL2 Q9BXP1 Q9BYI0 Q9NQR5,Solute carrier family 12 member 9,Cation-chloride cotransporter 6;Cation-chloride cotransporter-interacting protein 1;Potassium-chloride transporter 9;WO3.3;, PF00324;PF03522;, GO:0070062;GO:0016021;GO:0005886;GO:0015377;GO:0015379;GO:0006884;GO:0055064;GO:1902476;GO:0055075;GO:1990573;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:cation:chloride symporter activity; F:potassium:chloride symporter activity;, P:cell volume homeostasis; P:chloride ion homeostasis; P:chloride transmembrane transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|Q9BXP2 B7Z740 D6W5X0 D6W5X2 F5H8C2 Q9BWL2 Q9BXP1 Q9BYI0 Q9NQR5,Solute carrier family 12 member 9,Cation-chloride cotransporter 6;Cation-chloride cotransporter-interacting protein 1;Potassium-chloride transporter 9;WO3.3;, PF00324;PF03522;, GO:0070062;GO:0016021;GO:0005886;GO:0015377;GO:0015379;GO:0006884;GO:0055064;GO:1902476;GO:0055075;GO:1990573;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:cation:chloride symporter activity; F:potassium:chloride symporter activity;, P:cell volume homeostasis; P:chloride ion homeostasis; P:chloride transmembrane transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|Q9BXP2 B7Z740 D6W5X0 D6W5X2 F5H8C2 Q9BWL2 Q9BXP1 Q9BYI0 Q9NQR5,Solute carrier family 12 member 9,Cation-chloride cotransporter 6;Cation-chloride cotransporter-interacting protein 1;Potassium-chloride transporter 9;WO3.3;, PF00324;PF03522;, GO:0070062;GO:0016021;GO:0005886;GO:0015377;GO:0015379;GO:0006884;GO:0055064;GO:1902476;GO:0055075;GO:1990573;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:cation:chloride symporter activity; F:potassium:chloride symporter activity;, P:cell volume homeostasis; P:chloride ion homeostasis; P:chloride transmembrane transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane;|Q9BXP2 B7Z740 D6W5X0 D6W5X2 F5H8C2 Q9BWL2 Q9BXP1 Q9BYI0 Q9NQR5,Solute carrier family 12 member 9,Cation-chloride cotransporter 6;Cation-chloride cotransporter-interacting protein 1;Potassium-chloride transporter 9;WO3.3;, PF00324;PF03522;, GO:0070062;GO:0016021;GO:0005886;GO:0015377;GO:0015379;GO:0006884;GO:0055064;GO:1902476;GO:0055075;GO:1990573;, C:extracellular exosome; C:integral component of membrane; C:plasma membrane;, F:cation:chloride symporter activity; F:potassium:chloride symporter activity;, P:cell volume homeostasis; P:chloride ion homeostasis; P:chloride transmembrane transport; P:potassium ion homeostasis; P:potassium ion import across plasma membrane; scaffold233 indexed_genome mRNA 74667 99390 . + . ID=transcript_16099;P54760 B5A970 B5A971 B5A972 Q7Z635 Q9BTA5 Q9BXP0,Ephrin type-B receptor 4,Hepatoma transmembrane kinase;Tyrosine-protein kinase TYRO11;, PF14575;PF01404;PF07699;PF00041;PF07714;PF00536;, GO:0005829;GO:0070062;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0005003;GO:0004714;GO:0005005;GO:0001525;GO:0007411;GO:0007155;GO:0002042;GO:0048013;GO:0003007;GO:0007275;GO:0033674;GO:0046777;GO:0007169;, C:cytosol; C:extracellular exosome; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ephrin receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:angiogenesis; P:axon guidance; P:cell adhesion; P:cell migration involved in sprouting angiogenesis; P:ephrin receptor signaling pathway; P:heart morphogenesis; P:multicellular organism development; P:positive regulation of kinase activity; P:protein autophosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P54760 B5A970 B5A971 B5A972 Q7Z635 Q9BTA5 Q9BXP0,Ephrin type-B receptor 4,Hepatoma transmembrane kinase;Tyrosine-protein kinase TYRO11;, PF14575;PF01404;PF07699;PF00041;PF07714;PF00536;, GO:0005829;GO:0070062;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0005003;GO:0004714;GO:0005005;GO:0001525;GO:0007411;GO:0007155;GO:0002042;GO:0048013;GO:0003007;GO:0007275;GO:0033674;GO:0046777;GO:0007169;, C:cytosol; C:extracellular exosome; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ephrin receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:angiogenesis; P:axon guidance; P:cell adhesion; P:cell migration involved in sprouting angiogenesis; P:ephrin receptor signaling pathway; P:heart morphogenesis; P:multicellular organism development; P:positive regulation of kinase activity; P:protein autophosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|P54760 B5A970 B5A971 B5A972 Q7Z635 Q9BTA5 Q9BXP0,Ephrin type-B receptor 4,Hepatoma transmembrane kinase;Tyrosine-protein kinase TYRO11;, PF14575;PF01404;PF07699;PF00041;PF07714;PF00536;, GO:0005829;GO:0070062;GO:0005576;GO:0005887;GO:0043005;GO:0005886;GO:0043235;GO:0005524;GO:0005003;GO:0004714;GO:0005005;GO:0001525;GO:0007411;GO:0007155;GO:0002042;GO:0048013;GO:0003007;GO:0007275;GO:0033674;GO:0046777;GO:0007169;, C:cytosol; C:extracellular exosome; C:extracellular region; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:receptor complex;, F:ATP binding; F:ephrin receptor activity; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;, P:angiogenesis; P:axon guidance; P:cell adhesion; P:cell migration involved in sprouting angiogenesis; P:ephrin receptor signaling pathway; P:heart morphogenesis; P:multicellular organism development; P:positive regulation of kinase activity; P:protein autophosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway;|Q96L89 Q96L90 Q9BXN9 Q9BZ83 Q9BZ84 Q9BZ85 Q9BZ86 Q9BZ87 Q9BZ88,Zonadhesin,, PF08742;PF00629;PF01826;PF12714;PF00094;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0007339;GO:0098609;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:binding of sperm to zona pellucida; P:cell-cell adhesion; scaffold233 indexed_genome mRNA 99816 113587 . - . ID=transcript_16100;Q96L89 Q96L90 Q9BXN9 Q9BZ83 Q9BZ84 Q9BZ85 Q9BZ86 Q9BZ87 Q9BZ88,Zonadhesin,, PF08742;PF00629;PF01826;PF12714;PF00094;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0007339;GO:0098609;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:binding of sperm to zona pellucida; P:cell-cell adhesion;|Q96L89 Q96L90 Q9BXN9 Q9BZ83 Q9BZ84 Q9BZ85 Q9BZ86 Q9BZ87 Q9BZ88,Zonadhesin,, PF08742;PF00629;PF01826;PF12714;PF00094;, GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0007339;GO:0098609;, C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:binding of sperm to zona pellucida; P:cell-cell adhesion; scaffold233 indexed_genome mRNA 146674 148141 . - . ID=transcript_16101;O75817 A4D2E0 Q9BV74,Ribonuclease P protein subunit p20,Ribonucleases P/MRP protein subunit POP7 homolog;, PF12328;, GO:0005737;GO:0043231;GO:0030681;GO:0005730;GO:0005654;GO:0005634;GO:0000172;GO:0004526;GO:0033204;GO:0003723;GO:0090502;GO:0006364;GO:0001682;GO:0008033;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:multimeric ribonuclease P complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonuclease MRP complex;, F:ribonuclease P activity; F:ribonuclease P RNA binding; F:RNA binding;, P:RNA phosphodiester bond hydrolysis, endonucleolytic; P:rRNA processing; P:tRNA 5'-leader removal; P:tRNA processing; scaffold233 indexed_genome mRNA 166222 173660 . + . ID=transcript_16102;O75420 Q6Y7W7 Q8WZ38,GRB10-interacting GYF protein 1,PERQ amino acid-rich with GYF domain-containing protein 1;, PF02213;, GO:0032991;, C:protein-containing complex;|O75420 Q6Y7W7 Q8WZ38,GRB10-interacting GYF protein 1,PERQ amino acid-rich with GYF domain-containing protein 1;, PF02213;, GO:0032991;, C:protein-containing complex;|O75420 Q6Y7W7 Q8WZ38,GRB10-interacting GYF protein 1,PERQ amino acid-rich with GYF domain-containing protein 1;, PF02213;, GO:0032991;, C:protein-containing complex; scaffold233 indexed_genome mRNA 173661 178625 . + . ID=transcript_16103;O75420 Q6Y7W7 Q8WZ38,GRB10-interacting GYF protein 1,PERQ amino acid-rich with GYF domain-containing protein 1;, PF02213;, GO:0032991;, C:protein-containing complex;|O75420 Q6Y7W7 Q8WZ38,GRB10-interacting GYF protein 1,PERQ amino acid-rich with GYF domain-containing protein 1;, PF02213;, GO:0032991;, C:protein-containing complex;|O75420 Q6Y7W7 Q8WZ38,GRB10-interacting GYF protein 1,PERQ amino acid-rich with GYF domain-containing protein 1;, PF02213;, GO:0032991;, C:protein-containing complex;|O75420 Q6Y7W7 Q8WZ38,GRB10-interacting GYF protein 1,PERQ amino acid-rich with GYF domain-containing protein 1;, PF02213;, GO:0032991;, C:protein-containing complex;|O75420 Q6Y7W7 Q8WZ38,GRB10-interacting GYF protein 1,PERQ amino acid-rich with GYF domain-containing protein 1;, PF02213;, GO:0032991;, C:protein-containing complex; scaffold233 indexed_genome mRNA 180777 186140 . - . ID=transcript_16104;P62879 B3KPU1 P11016 P54312,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2,G protein subunit beta-2;Transducin beta chain 2;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0005925;GO:0005834;GO:0005765;GO:0016020;GO:0048471;GO:0031982;GO:0005246;GO:0031682;GO:0003924;GO:0051020;GO:0044877;GO:0007186;GO:0006457;, C:cell body; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:perinuclear region of cytoplasm; C:vesicle;, F:calcium channel regulator activity; F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:protein-containing complex binding;, P:G protein-coupled receptor signaling pathway; P:protein folding;|P62879 B3KPU1 P11016 P54312,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2,G protein subunit beta-2;Transducin beta chain 2;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0070062;GO:0005615;GO:0005925;GO:0005834;GO:0005765;GO:0016020;GO:0048471;GO:0031982;GO:0005246;GO:0031682;GO:0003924;GO:0051020;GO:0044877;GO:0007186;GO:0006457;, C:cell body; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:membrane; C:perinuclear region of cytoplasm; C:vesicle;, F:calcium channel regulator activity; F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:protein-containing complex binding;, P:G protein-coupled receptor signaling pathway; P:protein folding; scaffold233 indexed_genome mRNA 193710 203711 . + . ID=transcript_16105;O94805 A4D2D0 O75421,Actin-like protein 6B {ECO:0000305},53 kDa BRG1-associated factor B;Actin-related protein Baf53b;ArpNalpha;BRG1-associated factor 53B;, PF00022;, GO:0071565;GO:0035267;GO:0005634;GO:0016514;GO:0003682;GO:0005200;GO:0003713;GO:0043044;GO:0006325;GO:0006338;GO:0016358;GO:0043967;GO:0007399;GO:0042551;GO:0006357;GO:0021510;, C:nBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:structural constituent of cytoskeleton; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin organization; P:chromatin remodeling; P:dendrite development; P:histone H4 acetylation; P:nervous system development; P:neuron maturation; P:regulation of transcription by RNA polymerase II; P:spinal cord development;|O94805 A4D2D0 O75421,Actin-like protein 6B {ECO:0000305},53 kDa BRG1-associated factor B;Actin-related protein Baf53b;ArpNalpha;BRG1-associated factor 53B;, PF00022;, GO:0071565;GO:0035267;GO:0005634;GO:0016514;GO:0003682;GO:0005200;GO:0003713;GO:0043044;GO:0006325;GO:0006338;GO:0016358;GO:0043967;GO:0007399;GO:0042551;GO:0006357;GO:0021510;, C:nBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:structural constituent of cytoskeleton; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin organization; P:chromatin remodeling; P:dendrite development; P:histone H4 acetylation; P:nervous system development; P:neuron maturation; P:regulation of transcription by RNA polymerase II; P:spinal cord development;|O94805 A4D2D0 O75421,Actin-like protein 6B {ECO:0000305},53 kDa BRG1-associated factor B;Actin-related protein Baf53b;ArpNalpha;BRG1-associated factor 53B;, PF00022;, GO:0071565;GO:0035267;GO:0005634;GO:0016514;GO:0003682;GO:0005200;GO:0003713;GO:0043044;GO:0006325;GO:0006338;GO:0016358;GO:0043967;GO:0007399;GO:0042551;GO:0006357;GO:0021510;, C:nBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:structural constituent of cytoskeleton; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin organization; P:chromatin remodeling; P:dendrite development; P:histone H4 acetylation; P:nervous system development; P:neuron maturation; P:regulation of transcription by RNA polymerase II; P:spinal cord development;|O94805 A4D2D0 O75421,Actin-like protein 6B {ECO:0000305},53 kDa BRG1-associated factor B;Actin-related protein Baf53b;ArpNalpha;BRG1-associated factor 53B;, PF00022;, GO:0071565;GO:0035267;GO:0005634;GO:0016514;GO:0003682;GO:0005200;GO:0003713;GO:0043044;GO:0006325;GO:0006338;GO:0016358;GO:0043967;GO:0007399;GO:0042551;GO:0006357;GO:0021510;, C:nBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:structural constituent of cytoskeleton; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin organization; P:chromatin remodeling; P:dendrite development; P:histone H4 acetylation; P:nervous system development; P:neuron maturation; P:regulation of transcription by RNA polymerase II; P:spinal cord development;|O94805 A4D2D0 O75421,Actin-like protein 6B {ECO:0000305},53 kDa BRG1-associated factor B;Actin-related protein Baf53b;ArpNalpha;BRG1-associated factor 53B;, PF00022;, GO:0071565;GO:0035267;GO:0005634;GO:0016514;GO:0003682;GO:0005200;GO:0003713;GO:0043044;GO:0006325;GO:0006338;GO:0016358;GO:0043967;GO:0007399;GO:0042551;GO:0006357;GO:0021510;, C:nBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:structural constituent of cytoskeleton; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin organization; P:chromatin remodeling; P:dendrite development; P:histone H4 acetylation; P:nervous system development; P:neuron maturation; P:regulation of transcription by RNA polymerase II; P:spinal cord development;|O96019 B3KMN1 D3DNR9 Q8TAE5 Q9BVS8 Q9H0W6,Actin-like protein 6A,53 kDa BRG1-associated factor A;Actin-related protein Baf53a;ArpNbeta;BRG1-associated factor 53A;INO80 complex subunit K;, PF00022;, GO:0000785;GO:0031011;GO:0071564;GO:0035267;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0016514;GO:0003682;GO:0003713;GO:0043044;GO:0001825;GO:0006338;GO:0006310;GO:0006281;GO:0043968;GO:0043967;GO:0007399;GO:0003407;GO:0016579;GO:0040008;GO:0006357;GO:0007165;GO:0021510;, C:chromatin; C:Ino80 complex; C:npBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:blastocyst formation; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone H2A acetylation; P:histone H4 acetylation; P:nervous system development; P:neural retina development; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:spinal cord development;|O94805 A4D2D0 O75421,Actin-like protein 6B {ECO:0000305},53 kDa BRG1-associated factor B;Actin-related protein Baf53b;ArpNalpha;BRG1-associated factor 53B;, PF00022;, GO:0071565;GO:0035267;GO:0005634;GO:0016514;GO:0003682;GO:0005200;GO:0003713;GO:0043044;GO:0006325;GO:0006338;GO:0016358;GO:0043967;GO:0007399;GO:0042551;GO:0006357;GO:0021510;, C:nBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleus; C:SWI/SNF complex;, F:chromatin binding; F:structural constituent of cytoskeleton; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:chromatin organization; P:chromatin remodeling; P:dendrite development; P:histone H4 acetylation; P:nervous system development; P:neuron maturation; P:regulation of transcription by RNA polymerase II; P:spinal cord development;|O96019 B3KMN1 D3DNR9 Q8TAE5 Q9BVS8 Q9H0W6,Actin-like protein 6A,53 kDa BRG1-associated factor A;Actin-related protein Baf53a;ArpNbeta;BRG1-associated factor 53A;INO80 complex subunit K;, PF00022;, GO:0000785;GO:0031011;GO:0071564;GO:0035267;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0016514;GO:0003682;GO:0003713;GO:0043044;GO:0001825;GO:0006338;GO:0006310;GO:0006281;GO:0043968;GO:0043967;GO:0007399;GO:0003407;GO:0016579;GO:0040008;GO:0006357;GO:0007165;GO:0021510;, C:chromatin; C:Ino80 complex; C:npBAF complex; C:NuA4 histone acetyltransferase complex; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex; C:SWI/SNF complex;, F:chromatin binding; F:transcription coactivator activity;, P:ATP-dependent chromatin remodeling; P:blastocyst formation; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:histone H2A acetylation; P:histone H4 acetylation; P:nervous system development; P:neural retina development; P:protein deubiquitination; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:spinal cord development; scaffold233 indexed_genome mRNA 205586 217405 . + . ID=transcript_16106;Q9UP52 A6NGM7 O75422 Q1HE13 Q9HA99 Q9NX67,Transferrin receptor protein 2,, PF02225;PF04389;, GO:0031410;GO:0009897;GO:1990712;GO:0005887;GO:0005886;GO:0039706;GO:0004998;GO:0006953;GO:0006879;GO:0071281;GO:0140298;GO:0055072;GO:0006826;GO:0045807;GO:0090277;GO:1903319;GO:0045944;GO:0006898;GO:0010039;GO:0033572;, C:cytoplasmic vesicle; C:external side of plasma membrane; C:HFE-transferrin receptor complex; C:integral component of plasma membrane; C:plasma membrane;, F:co-receptor binding; F:transferrin receptor activity;, P:acute-phase response; P:cellular iron ion homeostasis; P:cellular response to iron ion; P:endocytic iron import into cell; P:iron ion homeostasis; P:iron ion transport; P:positive regulation of endocytosis; P:positive regulation of peptide hormone secretion; P:positive regulation of protein maturation; P:positive regulation of transcription by RNA polymerase II; P:receptor-mediated endocytosis; P:response to iron ion; P:transferrin transport; scaffold233 indexed_genome mRNA 219121 224098 . - . ID=transcript_16107;O75425 A4D2D1 A6NG17 C9JE89 D6W5W1 O75423 O75424,Motile sperm domain-containing protein 3,, PF00635;, GO:0005789;GO:0016021;GO:0005886;GO:0033149;GO:0090158;GO:0061817;GO:0007507;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:FFAT motif binding;, P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum-plasma membrane tethering; P:heart development;|O75425 A4D2D1 A6NG17 C9JE89 D6W5W1 O75423 O75424,Motile sperm domain-containing protein 3,, PF00635;, GO:0005789;GO:0016021;GO:0005886;GO:0033149;GO:0090158;GO:0061817;GO:0007507;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:FFAT motif binding;, P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum-plasma membrane tethering; P:heart development;|O75425 A4D2D1 A6NG17 C9JE89 D6W5W1 O75423 O75424,Motile sperm domain-containing protein 3,, PF00635;, GO:0005789;GO:0016021;GO:0005886;GO:0033149;GO:0090158;GO:0061817;GO:0007507;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;, F:FFAT motif binding;, P:endoplasmic reticulum membrane organization; P:endoplasmic reticulum-plasma membrane tethering; P:heart development; scaffold233 indexed_genome mRNA 225058 233763 . - . ID=transcript_16108;Q15113 B2R9E1 O14550,Procollagen C-endopeptidase enhancer 1,Procollagen COOH-terminal proteinase enhancer 1;Type 1 procollagen C-proteinase enhancer protein;Type I procollagen COOH-terminal proteinase enhancer;, PF00431;PF01759;, GO:0070062;GO:0005576;GO:0005615;GO:0005518;GO:0008201;GO:0016504;GO:0007275;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:collagen binding; F:heparin binding; F:peptidase activator activity;, P:multicellular organism development;|Q15113 B2R9E1 O14550,Procollagen C-endopeptidase enhancer 1,Procollagen COOH-terminal proteinase enhancer 1;Type 1 procollagen C-proteinase enhancer protein;Type I procollagen COOH-terminal proteinase enhancer;, PF00431;PF01759;, GO:0070062;GO:0005576;GO:0005615;GO:0005518;GO:0008201;GO:0016504;GO:0007275;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:collagen binding; F:heparin binding; F:peptidase activator activity;, P:multicellular organism development;|Q15113 B2R9E1 O14550,Procollagen C-endopeptidase enhancer 1,Procollagen COOH-terminal proteinase enhancer 1;Type 1 procollagen C-proteinase enhancer protein;Type I procollagen COOH-terminal proteinase enhancer;, PF00431;PF01759;, GO:0070062;GO:0005576;GO:0005615;GO:0005518;GO:0008201;GO:0016504;GO:0007275;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:collagen binding; F:heparin binding; F:peptidase activator activity;, P:multicellular organism development;|Q15113 B2R9E1 O14550,Procollagen C-endopeptidase enhancer 1,Procollagen COOH-terminal proteinase enhancer 1;Type 1 procollagen C-proteinase enhancer protein;Type I procollagen COOH-terminal proteinase enhancer;, PF00431;PF01759;, GO:0070062;GO:0005576;GO:0005615;GO:0005518;GO:0008201;GO:0016504;GO:0007275;, C:extracellular exosome; C:extracellular region; C:extracellular space;, F:collagen binding; F:heparin binding; F:peptidase activator activity;, P:multicellular organism development; scaffold233 indexed_genome mRNA 235036 255414 . - . ID=transcript_16109;O75426 A4D2D4 B4DX91 B4DY42 Q9H0G1,F-box only protein 24,, PF12937;PF00415;, GO:0000151;GO:0004842;GO:0016567;, C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:protein ubiquitination;|O75426 A4D2D4 B4DX91 B4DY42 Q9H0G1,F-box only protein 24,, PF12937;PF00415;, GO:0000151;GO:0004842;GO:0016567;, C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:protein ubiquitination;|O75426 A4D2D4 B4DX91 B4DY42 Q9H0G1,F-box only protein 24,, PF12937;PF00415;, GO:0000151;GO:0004842;GO:0016567;, C:ubiquitin ligase complex;, F:ubiquitin-protein transferase activity;, P:protein ubiquitination;|O75427 A4D2D5 Q8WV85 Q96ID0,Leucine-rich repeat and calponin homology domain-containing protein 4,Leucine-rich repeat neuronal protein 4;, PF00307;PF13855;, GO:0016605;GO:0007399;, C:PML body;, , P:nervous system development;|O75427 A4D2D5 Q8WV85 Q96ID0,Leucine-rich repeat and calponin homology domain-containing protein 4,Leucine-rich repeat neuronal protein 4;, PF00307;PF13855;, GO:0016605;GO:0007399;, C:PML body;, , P:nervous system development;|O75427 A4D2D5 Q8WV85 Q96ID0,Leucine-rich repeat and calponin homology domain-containing protein 4,Leucine-rich repeat neuronal protein 4;, PF00307;PF13855;, GO:0016605;GO:0007399;, C:PML body;, , P:nervous system development;|O75427 A4D2D5 Q8WV85 Q96ID0,Leucine-rich repeat and calponin homology domain-containing protein 4,Leucine-rich repeat neuronal protein 4;, PF00307;PF13855;, GO:0016605;GO:0007399;, C:PML body;, , P:nervous system development;|O75427 A4D2D5 Q8WV85 Q96ID0,Leucine-rich repeat and calponin homology domain-containing protein 4,Leucine-rich repeat neuronal protein 4;, PF00307;PF13855;, GO:0016605;GO:0007399;, C:PML body;, , P:nervous system development; scaffold233 indexed_genome mRNA 255858 258423 . - . ID=transcript_16110;P35568,Insulin receptor substrate 1,, PF02174;PF00169;, GO:0005901;GO:0005737;GO:0005829;GO:0005899;GO:0043231;GO:0005654;GO:0005634;GO:0005886;GO:0005158;GO:0005159;GO:0043548;GO:0001784;GO:0005080;GO:0042169;GO:0030159;GO:0005068;GO:0071398;GO:0032869;GO:0042593;GO:0008286;GO:0048009;GO:0038111;GO:0000165;GO:0046627;GO:0046676;GO:0014065;GO:0048015;GO:0008284;GO:0032000;GO:0046326;GO:0010907;GO:0045725;GO:0046628;GO:0043552;GO:0051897;GO:0032868;GO:0043434;GO:0007165;, C:caveola; C:cytoplasm; C:cytosol; C:insulin receptor complex; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:insulin receptor binding; F:insulin-like growth factor receptor binding; F:phosphatidylinositol 3-kinase binding; F:phosphotyrosine residue binding; F:protein kinase C binding; F:SH2 domain binding; F:signaling receptor complex adaptor activity; F:transmembrane receptor protein tyrosine kinase adaptor activity;, P:cellular response to fatty acid; P:cellular response to insulin stimulus; P:glucose homeostasis; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:interleukin-7-mediated signaling pathway; P:MAPK cascade; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of insulin secretion; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol-mediated signaling; P:positive regulation of cell population proliferation; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of protein kinase B signaling; P:response to insulin; P:response to peptide hormone; P:signal transduction; scaffold233 indexed_genome mRNA 262417 283265 . - . ID=transcript_16111;O95081 O75429 Q96AB9 Q96GL4,Arf-GAP domain and FG repeat-containing protein 2,HIV-1 Rev-binding protein-like protein;Rev/Rex activation domain-binding protein related;, PF01412;, GO:0016020;GO:0005096;GO:0046872;, C:membrane;, F:GTPase activator activity; F:metal ion binding;|O95081 O75429 Q96AB9 Q96GL4,Arf-GAP domain and FG repeat-containing protein 2,HIV-1 Rev-binding protein-like protein;Rev/Rex activation domain-binding protein related;, PF01412;, GO:0016020;GO:0005096;GO:0046872;, C:membrane;, F:GTPase activator activity; F:metal ion binding;|O95081 O75429 Q96AB9 Q96GL4,Arf-GAP domain and FG repeat-containing protein 2,HIV-1 Rev-binding protein-like protein;Rev/Rex activation domain-binding protein related;, PF01412;, GO:0016020;GO:0005096;GO:0046872;, C:membrane;, F:GTPase activator activity; F:metal ion binding;|O95081 O75429 Q96AB9 Q96GL4,Arf-GAP domain and FG repeat-containing protein 2,HIV-1 Rev-binding protein-like protein;Rev/Rex activation domain-binding protein related;, PF01412;, GO:0016020;GO:0005096;GO:0046872;, C:membrane;, F:GTPase activator activity; F:metal ion binding; scaffold233 indexed_genome mRNA 335109 339019 . - . ID=transcript_16112;Q6ZVC0 Q6U9Y3 Q8N1V0,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1,, PF15452;PF15439;, GO:0048812;GO:0014065;, , , P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling;|Q6ZVC0 Q6U9Y3 Q8N1V0,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1,, PF15452;PF15439;, GO:0048812;GO:0014065;, , , P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling;|Q6ZVC0 Q6U9Y3 Q8N1V0,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1,, PF15452;PF15439;, GO:0048812;GO:0014065;, , , P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling;|Q6ZVC0 Q6U9Y3 Q8N1V0,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1,, PF15452;PF15439;, GO:0048812;GO:0014065;, , , P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling; scaffold233 indexed_genome mRNA 339020 343707 . - . ID=transcript_16113;Q6ZVC0 Q6U9Y3 Q8N1V0,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1,, PF15452;PF15439;, GO:0048812;GO:0014065;, , , P:neuron projection morphogenesis; P:phosphatidylinositol 3-kinase signaling; scaffold233 indexed_genome mRNA 345667 350638 . + . ID=transcript_16114;Q9Y3Q8 A4D2C3 A8MWR6 D6W5V9,TSC22 domain family protein 4,TSC22-related-inducible leucine zipper protein 2;Tsc-22-like protein THG-1;, PF01166;, GO:0005634;GO:0045892;GO:0006357;GO:0006970;, C:nucleus;, , P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress; scaffold233 indexed_genome mRNA 351418 356879 . - . ID=transcript_16115;Q9Y3Q8 A4D2C3 A8MWR6 D6W5V9,TSC22 domain family protein 4,TSC22-related-inducible leucine zipper protein 2;Tsc-22-like protein THG-1;, PF01166;, GO:0005634;GO:0045892;GO:0006357;GO:0006970;, C:nucleus;, , P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress; scaffold233 indexed_genome mRNA 357301 360862 . + . ID=transcript_16116;Q8IZ16,Uncharacterized protein C7orf61,, PF15775;, GO:0005634;, C:nucleus;|Q8IZ16,Uncharacterized protein C7orf61,, PF15775;, GO:0005634;, C:nucleus; scaffold233 indexed_genome mRNA 380161 381373 . + . ID=transcript_16117;Q8TAP8 A4D2C5,Protein phosphatase 1 regulatory subunit 35,, PF15503;, GO:0019902;GO:0004864;GO:0010923;, , F:phosphatase binding; F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity; scaffold233 indexed_genome mRNA 383140 384044 . + . ID=transcript_16118;Q7L2J0 B3KP86 D6W5V7 Q9NPD4,7SK snRNA methylphosphate capping enzyme {ECO:0000303|PubMed:30559425},Bicoid-interacting protein 3 homolog {ECO:0000303|PubMed:17643375};, PF06859;PF13847;, GO:0120259;GO:0005634;GO:1990904;GO:0097322;GO:0008171;GO:1990276;GO:0003723;GO:0008173;GO:0008757;GO:0017069;GO:0035562;GO:0000122;GO:1900087;GO:1904871;GO:1905382;GO:0001510;GO:0016073;GO:0040031;, C:7SK snRNP; C:nucleus; C:ribonucleoprotein complex;, F:7SK snRNA binding; F:O-methyltransferase activity; F:RNA 5'-methyltransferase activity; F:RNA binding; F:RNA methyltransferase activity; F:S-adenosylmethionine-dependent methyltransferase activity; F:snRNA binding;, P:negative regulation of chromatin binding; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein localization to Cajal body; P:positive regulation of snRNA transcription by RNA polymerase II; P:RNA methylation; P:snRNA metabolic process; P:snRNA modification; scaffold233 indexed_genome mRNA 387944 411243 . + . ID=transcript_16119;Q9H0M4 A8MVF5 B4DUQ2 Q8NA98 Q9BUD0 Q9NWF7,Zinc finger CW-type PWWP domain protein 1,, PF00855;PF07496;, GO:0005694;GO:0005634;GO:0008327;GO:0035064;GO:0008270;GO:0030154;GO:0007129;GO:0007127;GO:0045911;GO:2000781;GO:0007283;, C:chromosome; C:nucleus;, F:methyl-CpG binding; F:methylated histone binding; F:zinc ion binding;, P:cell differentiation; P:homologous chromosome pairing at meiosis; P:meiosis I; P:positive regulation of DNA recombination; P:positive regulation of double-strand break repair; P:spermatogenesis; scaffold233 indexed_genome mRNA 458512 459688 . - . ID=transcript_16120;Q6DKI7 D6W5U9 Q9BVK3,Transmembrane protein PVRIG,CD112 receptor;Poliovirus receptor-related immunoglobulin domain-containing protein;, , GO:0016021;GO:0005886;GO:0019902;GO:0038023;GO:0050860;, C:integral component of membrane; C:plasma membrane;, F:phosphatase binding; F:signaling receptor activity;, P:negative regulation of T cell receptor signaling pathway; scaffold233 indexed_genome mRNA 469259 494292 . - . ID=transcript_16121;Q9UJ98 A6H8Z1 B4DZ10 D6W5U8 H7BYK9 Q8NDP3,Cohesin subunit SA-3,SCC3 homolog 3;Stromal antigen 3;Stromalin-3;, PF08514;, GO:0000785;GO:0000775;GO:0008278;GO:0005615;GO:0030893;GO:0005730;GO:0005654;GO:0005634;GO:0000795;GO:0003682;GO:0007062;GO:0007130;, C:chromatin; C:chromosome, centromeric region; C:cohesin complex; C:extracellular space; C:meiotic cohesin complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:sister chromatid cohesion; P:synaptonemal complex assembly;|Q9UJ98 A6H8Z1 B4DZ10 D6W5U8 H7BYK9 Q8NDP3,Cohesin subunit SA-3,SCC3 homolog 3;Stromal antigen 3;Stromalin-3;, PF08514;, GO:0000785;GO:0000775;GO:0008278;GO:0005615;GO:0030893;GO:0005730;GO:0005654;GO:0005634;GO:0000795;GO:0003682;GO:0007062;GO:0007130;, C:chromatin; C:chromosome, centromeric region; C:cohesin complex; C:extracellular space; C:meiotic cohesin complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:sister chromatid cohesion; P:synaptonemal complex assembly; scaffold233 indexed_genome mRNA 494977 498521 . - . ID=transcript_16122;Q9UJ98 A6H8Z1 B4DZ10 D6W5U8 H7BYK9 Q8NDP3,Cohesin subunit SA-3,SCC3 homolog 3;Stromal antigen 3;Stromalin-3;, PF08514;, GO:0000785;GO:0000775;GO:0008278;GO:0005615;GO:0030893;GO:0005730;GO:0005654;GO:0005634;GO:0000795;GO:0003682;GO:0007062;GO:0007130;, C:chromatin; C:chromosome, centromeric region; C:cohesin complex; C:extracellular space; C:meiotic cohesin complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:synaptonemal complex;, F:chromatin binding;, P:sister chromatid cohesion; P:synaptonemal complex assembly; scaffold233 indexed_genome mRNA 500896 503316 . + . ID=transcript_16123;Q8N158 A4D2A7,Glypican-2,, PF01153;, GO:0046658;GO:0009986;GO:0062023;GO:0005783;GO:0005576;GO:0005615;GO:0005796;GO:0043202;GO:0005886;GO:0045202;GO:0016477;GO:0006024;GO:0006027;GO:0030182;GO:0010976;GO:1905475;GO:0009966;GO:0001523;GO:0007224;, C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:Golgi lumen; C:lysosomal lumen; C:plasma membrane; C:synapse;, , P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:neuron differentiation; P:positive regulation of neuron projection development; P:regulation of protein localization to membrane; P:regulation of signal transduction; P:retinoid metabolic process; P:smoothened signaling pathway; scaffold233 indexed_genome mRNA 508043 509433 . + . ID=transcript_16124;Q8N158 A4D2A7,Glypican-2,, PF01153;, GO:0046658;GO:0009986;GO:0062023;GO:0005783;GO:0005576;GO:0005615;GO:0005796;GO:0043202;GO:0005886;GO:0045202;GO:0016477;GO:0006024;GO:0006027;GO:0030182;GO:0010976;GO:1905475;GO:0009966;GO:0001523;GO:0007224;, C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:endoplasmic reticulum; C:extracellular region; C:extracellular space; C:Golgi lumen; C:lysosomal lumen; C:plasma membrane; C:synapse;, , P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:neuron differentiation; P:positive regulation of neuron projection development; P:regulation of protein localization to membrane; P:regulation of signal transduction; P:retinoid metabolic process; P:smoothened signaling pathway; scaffold233 indexed_genome mRNA 510493 512782 . + . ID=transcript_16125;Q96RP7 A4D2A8 B4DWL8 D6W5U5 Q8N3P7 Q8WZ17 Q96E33 Q9HA78,Galactose-3-O-sulfotransferase 4,Beta-galactose-3-O-sulfotransferase 4;Gal-beta-1,3-GalNAc 3'-sulfotransferase;, PF06990;, GO:0070062;GO:0032580;GO:0016021;GO:0016020;GO:0050656;GO:0050694;GO:0001733;GO:0050698;GO:0008146;GO:0007267;GO:0009247;GO:0009101;GO:0009100;GO:0009311;GO:0030166;GO:0006790;, C:extracellular exosome; C:Golgi cisterna membrane; C:integral component of membrane; C:membrane;, F:3'-phosphoadenosine 5'-phosphosulfate binding; F:galactose 3-O-sulfotransferase activity; F:galactosylceramide sulfotransferase activity; F:proteoglycan sulfotransferase activity; F:sulfotransferase activity;, P:cell-cell signaling; P:glycolipid biosynthetic process; P:glycoprotein biosynthetic process; P:glycoprotein metabolic process; P:oligosaccharide metabolic process; P:proteoglycan biosynthetic process; P:sulfur compound metabolic process; scaffold234 indexed_genome mRNA 55286 81307 . + . ID=transcript_16126;Q13042 A2A365 Q5T8C8 Q7Z651 Q96AE6 Q9Y564,Cell division cycle protein 16 homolog,Anaphase-promoting complex subunit 6;CDC16 homolog;Cyclosome subunit 6;, , GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q13042 A2A365 Q5T8C8 Q7Z651 Q96AE6 Q9Y564,Cell division cycle protein 16 homolog,Anaphase-promoting complex subunit 6;CDC16 homolog;Cyclosome subunit 6;, , GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q13042 A2A365 Q5T8C8 Q7Z651 Q96AE6 Q9Y564,Cell division cycle protein 16 homolog,Anaphase-promoting complex subunit 6;CDC16 homolog;Cyclosome subunit 6;, , GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q13042 A2A365 Q5T8C8 Q7Z651 Q96AE6 Q9Y564,Cell division cycle protein 16 homolog,Anaphase-promoting complex subunit 6;CDC16 homolog;Cyclosome subunit 6;, , GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q13042 A2A365 Q5T8C8 Q7Z651 Q96AE6 Q9Y564,Cell division cycle protein 16 homolog,Anaphase-promoting complex subunit 6;CDC16 homolog;Cyclosome subunit 6;, , GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q13042 A2A365 Q5T8C8 Q7Z651 Q96AE6 Q9Y564,Cell division cycle protein 16 homolog,Anaphase-promoting complex subunit 6;CDC16 homolog;Cyclosome subunit 6;, , GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q13042 A2A365 Q5T8C8 Q7Z651 Q96AE6 Q9Y564,Cell division cycle protein 16 homolog,Anaphase-promoting complex subunit 6;CDC16 homolog;Cyclosome subunit 6;, , GO:0005680;GO:0005813;GO:0005737;GO:0005829;GO:0072686;GO:0005654;GO:0031145;GO:0051301;GO:0007091;GO:0045842;GO:0070979;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:centrosome; C:cytoplasm; C:cytosol; C:mitotic spindle; C:nucleoplasm;, , P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:metaphase/anaphase transition of mitotic cell cycle; P:positive regulation of mitotic metaphase/anaphase transition; P:protein K11-linked ubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold234 indexed_genome mRNA 87193 110207 . + . ID=transcript_16127;Q9H1J1 A2A366 Q5T8C3 Q5T8C9 Q7Z6N3 Q86YK1 Q9BZI8,Regulator of nonsense transcripts 3A,Nonsense mRNA reducing factor 3A;Up-frameshift suppressor 3 homolog A;, PF03467;, GO:0005737;GO:0005829;GO:0035145;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0003723;GO:0017056;GO:0042162;GO:0051028;GO:0000184;GO:0045727;, C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA binding; F:structural constituent of nuclear pore; F:telomeric DNA binding;, P:mRNA transport; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation;|Q9H1J1 A2A366 Q5T8C3 Q5T8C9 Q7Z6N3 Q86YK1 Q9BZI8,Regulator of nonsense transcripts 3A,Nonsense mRNA reducing factor 3A;Up-frameshift suppressor 3 homolog A;, PF03467;, GO:0005737;GO:0005829;GO:0035145;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0003723;GO:0017056;GO:0042162;GO:0051028;GO:0000184;GO:0045727;, C:cytoplasm; C:cytosol; C:exon-exon junction complex; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:RNA binding; F:structural constituent of nuclear pore; F:telomeric DNA binding;, P:mRNA transport; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of translation; scaffold234 indexed_genome mRNA 122910 129826 . + . ID=transcript_16128;Q96JM3 B3KU06 Q6P181 Q8NC88 Q9BST0,Chromosome alignment-maintaining phosphoprotein 1,Zinc finger protein 828;, , GO:0000793;GO:0000777;GO:0005737;GO:0090543;GO:0016604;GO:0005654;GO:0005634;GO:0005819;GO:0046872;GO:0051315;GO:0034501;GO:0035372;GO:0031134;, C:condensed chromosome; C:condensed chromosome kinetochore; C:cytoplasm; C:Flemming body; C:nuclear body; C:nucleoplasm; C:nucleus; C:spindle;, F:metal ion binding;, P:attachment of mitotic spindle microtubules to kinetochore; P:protein localization to kinetochore; P:protein localization to microtubule; P:sister chromatid biorientation; scaffold235 indexed_genome mRNA 72 3040 . + . ID=transcript_16129;P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold235 indexed_genome mRNA 3062 9868 . - . ID=transcript_16130;Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis;|Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis; scaffold235 indexed_genome mRNA 10431 38321 . + . ID=transcript_16131;Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis;|Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis;|Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis;|Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis;|Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis;|Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis;|Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis;|Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis;|Q96CZ7 Q9HA14 Q9UH98,SUN domain-containing protein 1,Protein unc-84 homolog A;Sad1/unc-84 protein-like 1;, PF18580;PF09387;PF07738;, GO:0005639;GO:0043231;GO:0034993;GO:0005635;GO:0031965;GO:0140444;GO:0043495;GO:0030154;GO:0051321;GO:0006998;GO:0090292;GO:0007283;, C:integral component of nuclear inner membrane; C:intracellular membrane-bounded organelle; C:meiotic nuclear membrane microtubule tethering complex; C:nuclear envelope; C:nuclear membrane;, F:cytoskeleton-nuclear membrane anchor activity; F:protein-membrane adaptor activity;, P:cell differentiation; P:meiotic cell cycle; P:nuclear envelope organization; P:nuclear matrix anchoring at nuclear membrane; P:spermatogenesis; scaffold235 indexed_genome mRNA 73735 95571 . - . ID=transcript_16132;Q86Y56 Q69YL1 Q96FI9 Q9NX75,Dynein assembly factor 5, axonemal {ECO:0000303|PubMed:25232951, ECO:0000312|HGNC:HGNC:26013},HEAT repeat-containing protein 2 {ECO:0000305};, , GO:0005737;GO:0045505;GO:0003341;GO:0036159;GO:0036158;, C:cytoplasm;, F:dynein intermediate chain binding;, P:cilium movement; P:inner dynein arm assembly; P:outer dynein arm assembly;|Q86Y56 Q69YL1 Q96FI9 Q9NX75,Dynein assembly factor 5, axonemal {ECO:0000303|PubMed:25232951, ECO:0000312|HGNC:HGNC:26013},HEAT repeat-containing protein 2 {ECO:0000305};, , GO:0005737;GO:0045505;GO:0003341;GO:0036159;GO:0036158;, C:cytoplasm;, F:dynein intermediate chain binding;, P:cilium movement; P:inner dynein arm assembly; P:outer dynein arm assembly;|Q86Y56 Q69YL1 Q96FI9 Q9NX75,Dynein assembly factor 5, axonemal {ECO:0000303|PubMed:25232951, ECO:0000312|HGNC:HGNC:26013},HEAT repeat-containing protein 2 {ECO:0000305};, , GO:0005737;GO:0045505;GO:0003341;GO:0036159;GO:0036158;, C:cytoplasm;, F:dynein intermediate chain binding;, P:cilium movement; P:inner dynein arm assembly; P:outer dynein arm assembly;|Q86Y56 Q69YL1 Q96FI9 Q9NX75,Dynein assembly factor 5, axonemal {ECO:0000303|PubMed:25232951, ECO:0000312|HGNC:HGNC:26013},HEAT repeat-containing protein 2 {ECO:0000305};, , GO:0005737;GO:0045505;GO:0003341;GO:0036159;GO:0036158;, C:cytoplasm;, F:dynein intermediate chain binding;, P:cilium movement; P:inner dynein arm assembly; P:outer dynein arm assembly;|Q86Y56 Q69YL1 Q96FI9 Q9NX75,Dynein assembly factor 5, axonemal {ECO:0000303|PubMed:25232951, ECO:0000312|HGNC:HGNC:26013},HEAT repeat-containing protein 2 {ECO:0000305};, , GO:0005737;GO:0045505;GO:0003341;GO:0036159;GO:0036158;, C:cytoplasm;, F:dynein intermediate chain binding;, P:cilium movement; P:inner dynein arm assembly; P:outer dynein arm assembly;|Q86Y56 Q69YL1 Q96FI9 Q9NX75,Dynein assembly factor 5, axonemal {ECO:0000303|PubMed:25232951, ECO:0000312|HGNC:HGNC:26013},HEAT repeat-containing protein 2 {ECO:0000305};, , GO:0005737;GO:0045505;GO:0003341;GO:0036159;GO:0036158;, C:cytoplasm;, F:dynein intermediate chain binding;, P:cilium movement; P:inner dynein arm assembly; P:outer dynein arm assembly; scaffold235 indexed_genome mRNA 169202 169904 . + . ID=transcript_16133;P31321 Q8N422,cAMP-dependent protein kinase type I-beta regulatory subunit,, PF00027;PF02197;, GO:0005952;GO:0097546;GO:0005829;GO:0098978;GO:0098686;GO:0005771;GO:0005886;GO:0098685;GO:0030552;GO:0004862;GO:0008603;GO:0034236;GO:0034199;GO:0007596;GO:0071377;GO:0007268;GO:0007611;GO:0050804;GO:2000480;GO:0002862;GO:0006468;GO:0043949;GO:0010738;GO:0098693;GO:0003091;, C:cAMP-dependent protein kinase complex; C:ciliary base; C:cytosol; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:multivesicular body; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cAMP binding; F:cAMP-dependent protein kinase inhibitor activity; F:cAMP-dependent protein kinase regulator activity; F:protein kinase A catalytic subunit binding;, P:activation of protein kinase A activity; P:blood coagulation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:learning or memory; P:modulation of chemical synaptic transmission; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of inflammatory response to antigenic stimulus; P:protein phosphorylation; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:regulation of synaptic vesicle cycle; P:renal water homeostasis; scaffold235 indexed_genome mRNA 177845 182298 . - . ID=transcript_16134;P31321 Q8N422,cAMP-dependent protein kinase type I-beta regulatory subunit,, PF00027;PF02197;, GO:0005952;GO:0097546;GO:0005829;GO:0098978;GO:0098686;GO:0005771;GO:0005886;GO:0098685;GO:0030552;GO:0004862;GO:0008603;GO:0034236;GO:0034199;GO:0007596;GO:0071377;GO:0007268;GO:0007611;GO:0050804;GO:2000480;GO:0002862;GO:0006468;GO:0043949;GO:0010738;GO:0098693;GO:0003091;, C:cAMP-dependent protein kinase complex; C:ciliary base; C:cytosol; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:multivesicular body; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cAMP binding; F:cAMP-dependent protein kinase inhibitor activity; F:cAMP-dependent protein kinase regulator activity; F:protein kinase A catalytic subunit binding;, P:activation of protein kinase A activity; P:blood coagulation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:learning or memory; P:modulation of chemical synaptic transmission; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of inflammatory response to antigenic stimulus; P:protein phosphorylation; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:regulation of synaptic vesicle cycle; P:renal water homeostasis;|P31321 Q8N422,cAMP-dependent protein kinase type I-beta regulatory subunit,, PF00027;PF02197;, GO:0005952;GO:0097546;GO:0005829;GO:0098978;GO:0098686;GO:0005771;GO:0005886;GO:0098685;GO:0030552;GO:0004862;GO:0008603;GO:0034236;GO:0034199;GO:0007596;GO:0071377;GO:0007268;GO:0007611;GO:0050804;GO:2000480;GO:0002862;GO:0006468;GO:0043949;GO:0010738;GO:0098693;GO:0003091;, C:cAMP-dependent protein kinase complex; C:ciliary base; C:cytosol; C:glutamatergic synapse; C:hippocampal mossy fiber to CA3 synapse; C:multivesicular body; C:plasma membrane; C:Schaffer collateral - CA1 synapse;, F:cAMP binding; F:cAMP-dependent protein kinase inhibitor activity; F:cAMP-dependent protein kinase regulator activity; F:protein kinase A catalytic subunit binding;, P:activation of protein kinase A activity; P:blood coagulation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:learning or memory; P:modulation of chemical synaptic transmission; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of inflammatory response to antigenic stimulus; P:protein phosphorylation; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:regulation of synaptic vesicle cycle; P:renal water homeostasis; scaffold235 indexed_genome mRNA 212997 221233 . + . ID=transcript_16135;P04085 B5BU73,Platelet-derived growth factor subunit A,PDGF-1;Platelet-derived growth factor A chain;Platelet-derived growth factor alpha polypeptide;, PF00341;PF04692;, GO:0009986;GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0000139;GO:0005902;GO:0031093;GO:0005518;GO:0008083;GO:0070851;GO:0042802;GO:0048407;GO:0005161;GO:0046982;GO:0042803;GO:0030036;GO:0001525;GO:0009887;GO:0001775;GO:0030031;GO:0007267;GO:1990401;GO:0030198;GO:0001942;GO:0048286;GO:0000165;GO:0050919;GO:0010512;GO:0010544;GO:0002576;GO:0048008;GO:0051781;GO:0030335;GO:0008284;GO:0070374;GO:0048146;GO:0043406;GO:0043410;GO:0002053;GO:0035793;GO:0014068;GO:0031954;GO:0051897;GO:0032956;GO:0060683;GO:0050730;GO:0014910;GO:0009611;GO:0043588;GO:0042060;, C:cell surface; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen; C:Golgi membrane; C:microvillus; C:platelet alpha granule lumen;, F:collagen binding; F:growth factor activity; F:growth factor receptor binding; F:identical protein binding; F:platelet-derived growth factor binding; F:platelet-derived growth factor receptor binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:actin cytoskeleton organization; P:angiogenesis; P:animal organ morphogenesis; P:cell activation; P:cell projection assembly; P:cell-cell signaling; P:embryonic lung development; P:extracellular matrix organization; P:hair follicle development; P:lung alveolus development; P:MAPK cascade; P:negative chemotaxis; P:negative regulation of phosphatidylinositol biosynthetic process; P:negative regulation of platelet activation; P:platelet degranulation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:regulation of actin cytoskeleton organization; P:regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of smooth muscle cell migration; P:response to wounding; P:skin development; P:wound healing;|P04085 B5BU73,Platelet-derived growth factor subunit A,PDGF-1;Platelet-derived growth factor A chain;Platelet-derived growth factor alpha polypeptide;, PF00341;PF04692;, GO:0009986;GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0000139;GO:0005902;GO:0031093;GO:0005518;GO:0008083;GO:0070851;GO:0042802;GO:0048407;GO:0005161;GO:0046982;GO:0042803;GO:0030036;GO:0001525;GO:0009887;GO:0001775;GO:0030031;GO:0007267;GO:1990401;GO:0030198;GO:0001942;GO:0048286;GO:0000165;GO:0050919;GO:0010512;GO:0010544;GO:0002576;GO:0048008;GO:0051781;GO:0030335;GO:0008284;GO:0070374;GO:0048146;GO:0043406;GO:0043410;GO:0002053;GO:0035793;GO:0014068;GO:0031954;GO:0051897;GO:0032956;GO:0060683;GO:0050730;GO:0014910;GO:0009611;GO:0043588;GO:0042060;, C:cell surface; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen; C:Golgi membrane; C:microvillus; C:platelet alpha granule lumen;, F:collagen binding; F:growth factor activity; F:growth factor receptor binding; F:identical protein binding; F:platelet-derived growth factor binding; F:platelet-derived growth factor receptor binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:actin cytoskeleton organization; P:angiogenesis; P:animal organ morphogenesis; P:cell activation; P:cell projection assembly; P:cell-cell signaling; P:embryonic lung development; P:extracellular matrix organization; P:hair follicle development; P:lung alveolus development; P:MAPK cascade; P:negative chemotaxis; P:negative regulation of phosphatidylinositol biosynthetic process; P:negative regulation of platelet activation; P:platelet degranulation; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell division; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein autophosphorylation; P:positive regulation of protein kinase B signaling; P:regulation of actin cytoskeleton organization; P:regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling; P:regulation of peptidyl-tyrosine phosphorylation; P:regulation of smooth muscle cell migration; P:response to wounding; P:skin development; P:wound healing; scaffold235 indexed_genome mRNA 337277 341379 . - . ID=transcript_16136;Q8IXL6 A4D2Q5 L8B5W8 Q5I0W9 Q7Z4I0 Q9NPT2,Extracellular serine/threonine protein kinase FAM20C {ECO:0000305},Dentin matrix protein 4 {ECO:0000250|UniProtKB:Q5MJS3};Golgi casein kinase {ECO:0000303|PubMed:22582013};Golgi-enriched fraction casein kinase {ECO:0000303|PubMed:22582013};, PF06702;, GO:0005788;GO:0070062;GO:0005615;GO:0005794;GO:0005524;GO:0030145;GO:0016773;GO:0106310;GO:0004674;GO:0106311;GO:0046034;GO:0031214;GO:0044267;GO:0070166;GO:0071895;GO:0043687;GO:0006468;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:Golgi apparatus;, F:ATP binding; F:manganese ion binding; F:phosphotransferase activity, alcohol group as acceptor; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:ATP metabolic process; P:biomineral tissue development; P:cellular protein metabolic process; P:enamel mineralization; P:odontoblast differentiation; P:post-translational protein modification; P:protein phosphorylation;|Q8IXL6 A4D2Q5 L8B5W8 Q5I0W9 Q7Z4I0 Q9NPT2,Extracellular serine/threonine protein kinase FAM20C {ECO:0000305},Dentin matrix protein 4 {ECO:0000250|UniProtKB:Q5MJS3};Golgi casein kinase {ECO:0000303|PubMed:22582013};Golgi-enriched fraction casein kinase {ECO:0000303|PubMed:22582013};, PF06702;, GO:0005788;GO:0070062;GO:0005615;GO:0005794;GO:0005524;GO:0030145;GO:0016773;GO:0106310;GO:0004674;GO:0106311;GO:0046034;GO:0031214;GO:0044267;GO:0070166;GO:0071895;GO:0043687;GO:0006468;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:Golgi apparatus;, F:ATP binding; F:manganese ion binding; F:phosphotransferase activity, alcohol group as acceptor; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:ATP metabolic process; P:biomineral tissue development; P:cellular protein metabolic process; P:enamel mineralization; P:odontoblast differentiation; P:post-translational protein modification; P:protein phosphorylation;|Q8IXL6 A4D2Q5 L8B5W8 Q5I0W9 Q7Z4I0 Q9NPT2,Extracellular serine/threonine protein kinase FAM20C {ECO:0000305},Dentin matrix protein 4 {ECO:0000250|UniProtKB:Q5MJS3};Golgi casein kinase {ECO:0000303|PubMed:22582013};Golgi-enriched fraction casein kinase {ECO:0000303|PubMed:22582013};, PF06702;, GO:0005788;GO:0070062;GO:0005615;GO:0005794;GO:0005524;GO:0030145;GO:0016773;GO:0106310;GO:0004674;GO:0106311;GO:0046034;GO:0031214;GO:0044267;GO:0070166;GO:0071895;GO:0043687;GO:0006468;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:Golgi apparatus;, F:ATP binding; F:manganese ion binding; F:phosphotransferase activity, alcohol group as acceptor; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:ATP metabolic process; P:biomineral tissue development; P:cellular protein metabolic process; P:enamel mineralization; P:odontoblast differentiation; P:post-translational protein modification; P:protein phosphorylation;|Q8IXL6 A4D2Q5 L8B5W8 Q5I0W9 Q7Z4I0 Q9NPT2,Extracellular serine/threonine protein kinase FAM20C {ECO:0000305},Dentin matrix protein 4 {ECO:0000250|UniProtKB:Q5MJS3};Golgi casein kinase {ECO:0000303|PubMed:22582013};Golgi-enriched fraction casein kinase {ECO:0000303|PubMed:22582013};, PF06702;, GO:0005788;GO:0070062;GO:0005615;GO:0005794;GO:0005524;GO:0030145;GO:0016773;GO:0106310;GO:0004674;GO:0106311;GO:0046034;GO:0031214;GO:0044267;GO:0070166;GO:0071895;GO:0043687;GO:0006468;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:Golgi apparatus;, F:ATP binding; F:manganese ion binding; F:phosphotransferase activity, alcohol group as acceptor; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:ATP metabolic process; P:biomineral tissue development; P:cellular protein metabolic process; P:enamel mineralization; P:odontoblast differentiation; P:post-translational protein modification; P:protein phosphorylation; scaffold236 indexed_genome mRNA 45321 76355 . + . ID=transcript_16137;Q14644 A6NL15 F8W6X8 Q8IUY2,Ras GTPase-activating protein 3,GAP1(IP4BP);Ins P4-binding protein;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0031235;GO:0015278;GO:0005096;GO:0046872;GO:0000165;GO:0046580;GO:0007165;, C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane;, F:calcium-release channel activity; F:GTPase activator activity; F:metal ion binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:signal transduction;|Q14644 A6NL15 F8W6X8 Q8IUY2,Ras GTPase-activating protein 3,GAP1(IP4BP);Ins P4-binding protein;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0031235;GO:0015278;GO:0005096;GO:0046872;GO:0000165;GO:0046580;GO:0007165;, C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane;, F:calcium-release channel activity; F:GTPase activator activity; F:metal ion binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:signal transduction;|Q14644 A6NL15 F8W6X8 Q8IUY2,Ras GTPase-activating protein 3,GAP1(IP4BP);Ins P4-binding protein;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0031235;GO:0015278;GO:0005096;GO:0046872;GO:0000165;GO:0046580;GO:0007165;, C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane;, F:calcium-release channel activity; F:GTPase activator activity; F:metal ion binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:signal transduction;|Q14644 A6NL15 F8W6X8 Q8IUY2,Ras GTPase-activating protein 3,GAP1(IP4BP);Ins P4-binding protein;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0031235;GO:0015278;GO:0005096;GO:0046872;GO:0000165;GO:0046580;GO:0007165;, C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane;, F:calcium-release channel activity; F:GTPase activator activity; F:metal ion binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:signal transduction;|Q14644 A6NL15 F8W6X8 Q8IUY2,Ras GTPase-activating protein 3,GAP1(IP4BP);Ins P4-binding protein;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0031235;GO:0015278;GO:0005096;GO:0046872;GO:0000165;GO:0046580;GO:0007165;, C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane;, F:calcium-release channel activity; F:GTPase activator activity; F:metal ion binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:signal transduction;|Q14644 A6NL15 F8W6X8 Q8IUY2,Ras GTPase-activating protein 3,GAP1(IP4BP);Ins P4-binding protein;, PF00779;PF00168;PF00169;PF00616;, GO:0005829;GO:0031235;GO:0015278;GO:0005096;GO:0046872;GO:0000165;GO:0046580;GO:0007165;, C:cytosol; C:intrinsic component of the cytoplasmic side of the plasma membrane;, F:calcium-release channel activity; F:GTPase activator activity; F:metal ion binding;, P:MAPK cascade; P:negative regulation of Ras protein signal transduction; P:signal transduction; scaffold236 indexed_genome mRNA 166873 184816 . + . ID=transcript_16138;Q14393 B3KRQ7 B3KVL4 E9PBL7 Q6IMN1 Q7Z7N3,Growth arrest-specific protein 6 {ECO:0000305},AXL receptor tyrosine kinase ligand;, PF12662;PF07645;PF00594;PF12661;PF00054;PF02210;, GO:0005737;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0031093;GO:0005509;GO:0043027;GO:0001786;GO:0030296;GO:0030674;GO:0048018;GO:0030971;GO:0005102;GO:0032148;GO:0031100;GO:0043277;GO:0035754;GO:0007596;GO:0070588;GO:0031589;GO:0044267;GO:0035690;GO:0071333;GO:0071363;GO:0035457;GO:0009267;GO:0071307;GO:0097028;GO:0006888;GO:0007167;GO:0085029;GO:0019064;GO:0097241;GO:0050900;GO:0043066;GO:0070168;GO:0043154;GO:2000669;GO:0043433;GO:2000352;GO:2000270;GO:0032689;GO:0032692;GO:0032715;GO:1900142;GO:2000533;GO:0045892;GO:0032720;GO:0010804;GO:0001764;GO:0018105;GO:0006909;GO:0002576;GO:0001961;GO:2000510;GO:0070374;GO:0048146;GO:0010628;GO:0003104;GO:0032825;GO:0033138;GO:0050766;GO:0046827;GO:0045860;GO:0051897;GO:0001934;GO:0061098;GO:0032008;GO:0043687;GO:0043491;GO:0072659;GO:0006468;GO:0046813;GO:0040008;GO:0007165;GO:0046718;GO:0019079;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:platelet alpha granule lumen;, F:calcium ion binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:phosphatidylserine binding; F:protein tyrosine kinase activator activity; F:protein-macromolecule adaptor activity; F:receptor ligand activity; F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:activation of protein kinase B activity; P:animal organ regeneration; P:apoptotic cell clearance; P:B cell chemotaxis; P:blood coagulation; P:calcium ion transmembrane transport; P:cell-substrate adhesion; P:cellular protein metabolic process; P:cellular response to drug; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:cellular response to interferon-alpha; P:cellular response to starvation; P:cellular response to vitamin K; P:dendritic cell differentiation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:enzyme linked receptor protein signaling pathway; P:extracellular matrix assembly; P:fusion of virus membrane with host plasma membrane; P:hematopoietic stem cell migration to bone marrow; P:leukocyte migration; P:negative regulation of apoptotic process; P:negative regulation of biomineral tissue development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of fibroblast apoptotic process; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 production; P:negative regulation of interleukin-6 production; P:negative regulation of oligodendrocyte apoptotic process; P:negative regulation of renal albumin absorption; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:neuron migration; P:peptidyl-serine phosphorylation; P:phagocytosis; P:platelet degranulation; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of glomerular filtration; P:positive regulation of natural killer cell differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phagocytosis; P:positive regulation of protein export from nucleus; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of TOR signaling; P:post-translational protein modification; P:protein kinase B signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:receptor-mediated virion attachment to host cell; P:regulation of growth; P:signal transduction; P:viral entry into host cell; P:viral genome replication;|Q14393 B3KRQ7 B3KVL4 E9PBL7 Q6IMN1 Q7Z7N3,Growth arrest-specific protein 6 {ECO:0000305},AXL receptor tyrosine kinase ligand;, PF12662;PF07645;PF00594;PF12661;PF00054;PF02210;, GO:0005737;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0031093;GO:0005509;GO:0043027;GO:0001786;GO:0030296;GO:0030674;GO:0048018;GO:0030971;GO:0005102;GO:0032148;GO:0031100;GO:0043277;GO:0035754;GO:0007596;GO:0070588;GO:0031589;GO:0044267;GO:0035690;GO:0071333;GO:0071363;GO:0035457;GO:0009267;GO:0071307;GO:0097028;GO:0006888;GO:0007167;GO:0085029;GO:0019064;GO:0097241;GO:0050900;GO:0043066;GO:0070168;GO:0043154;GO:2000669;GO:0043433;GO:2000352;GO:2000270;GO:0032689;GO:0032692;GO:0032715;GO:1900142;GO:2000533;GO:0045892;GO:0032720;GO:0010804;GO:0001764;GO:0018105;GO:0006909;GO:0002576;GO:0001961;GO:2000510;GO:0070374;GO:0048146;GO:0010628;GO:0003104;GO:0032825;GO:0033138;GO:0050766;GO:0046827;GO:0045860;GO:0051897;GO:0001934;GO:0061098;GO:0032008;GO:0043687;GO:0043491;GO:0072659;GO:0006468;GO:0046813;GO:0040008;GO:0007165;GO:0046718;GO:0019079;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:platelet alpha granule lumen;, F:calcium ion binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:phosphatidylserine binding; F:protein tyrosine kinase activator activity; F:protein-macromolecule adaptor activity; F:receptor ligand activity; F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:activation of protein kinase B activity; P:animal organ regeneration; P:apoptotic cell clearance; P:B cell chemotaxis; P:blood coagulation; P:calcium ion transmembrane transport; P:cell-substrate adhesion; P:cellular protein metabolic process; P:cellular response to drug; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:cellular response to interferon-alpha; P:cellular response to starvation; P:cellular response to vitamin K; P:dendritic cell differentiation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:enzyme linked receptor protein signaling pathway; P:extracellular matrix assembly; P:fusion of virus membrane with host plasma membrane; P:hematopoietic stem cell migration to bone marrow; P:leukocyte migration; P:negative regulation of apoptotic process; P:negative regulation of biomineral tissue development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of fibroblast apoptotic process; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 production; P:negative regulation of interleukin-6 production; P:negative regulation of oligodendrocyte apoptotic process; P:negative regulation of renal albumin absorption; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:neuron migration; P:peptidyl-serine phosphorylation; P:phagocytosis; P:platelet degranulation; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of glomerular filtration; P:positive regulation of natural killer cell differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phagocytosis; P:positive regulation of protein export from nucleus; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of TOR signaling; P:post-translational protein modification; P:protein kinase B signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:receptor-mediated virion attachment to host cell; P:regulation of growth; P:signal transduction; P:viral entry into host cell; P:viral genome replication;|Q14393 B3KRQ7 B3KVL4 E9PBL7 Q6IMN1 Q7Z7N3,Growth arrest-specific protein 6 {ECO:0000305},AXL receptor tyrosine kinase ligand;, PF12662;PF07645;PF00594;PF12661;PF00054;PF02210;, GO:0005737;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0031093;GO:0005509;GO:0043027;GO:0001786;GO:0030296;GO:0030674;GO:0048018;GO:0030971;GO:0005102;GO:0032148;GO:0031100;GO:0043277;GO:0035754;GO:0007596;GO:0070588;GO:0031589;GO:0044267;GO:0035690;GO:0071333;GO:0071363;GO:0035457;GO:0009267;GO:0071307;GO:0097028;GO:0006888;GO:0007167;GO:0085029;GO:0019064;GO:0097241;GO:0050900;GO:0043066;GO:0070168;GO:0043154;GO:2000669;GO:0043433;GO:2000352;GO:2000270;GO:0032689;GO:0032692;GO:0032715;GO:1900142;GO:2000533;GO:0045892;GO:0032720;GO:0010804;GO:0001764;GO:0018105;GO:0006909;GO:0002576;GO:0001961;GO:2000510;GO:0070374;GO:0048146;GO:0010628;GO:0003104;GO:0032825;GO:0033138;GO:0050766;GO:0046827;GO:0045860;GO:0051897;GO:0001934;GO:0061098;GO:0032008;GO:0043687;GO:0043491;GO:0072659;GO:0006468;GO:0046813;GO:0040008;GO:0007165;GO:0046718;GO:0019079;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:platelet alpha granule lumen;, F:calcium ion binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:phosphatidylserine binding; F:protein tyrosine kinase activator activity; F:protein-macromolecule adaptor activity; F:receptor ligand activity; F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:activation of protein kinase B activity; P:animal organ regeneration; P:apoptotic cell clearance; P:B cell chemotaxis; P:blood coagulation; P:calcium ion transmembrane transport; P:cell-substrate adhesion; P:cellular protein metabolic process; P:cellular response to drug; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:cellular response to interferon-alpha; P:cellular response to starvation; P:cellular response to vitamin K; P:dendritic cell differentiation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:enzyme linked receptor protein signaling pathway; P:extracellular matrix assembly; P:fusion of virus membrane with host plasma membrane; P:hematopoietic stem cell migration to bone marrow; P:leukocyte migration; P:negative regulation of apoptotic process; P:negative regulation of biomineral tissue development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of fibroblast apoptotic process; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 production; P:negative regulation of interleukin-6 production; P:negative regulation of oligodendrocyte apoptotic process; P:negative regulation of renal albumin absorption; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:neuron migration; P:peptidyl-serine phosphorylation; P:phagocytosis; P:platelet degranulation; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of glomerular filtration; P:positive regulation of natural killer cell differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phagocytosis; P:positive regulation of protein export from nucleus; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of TOR signaling; P:post-translational protein modification; P:protein kinase B signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:receptor-mediated virion attachment to host cell; P:regulation of growth; P:signal transduction; P:viral entry into host cell; P:viral genome replication;|Q14393 B3KRQ7 B3KVL4 E9PBL7 Q6IMN1 Q7Z7N3,Growth arrest-specific protein 6 {ECO:0000305},AXL receptor tyrosine kinase ligand;, PF12662;PF07645;PF00594;PF12661;PF00054;PF02210;, GO:0005737;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0031093;GO:0005509;GO:0043027;GO:0001786;GO:0030296;GO:0030674;GO:0048018;GO:0030971;GO:0005102;GO:0032148;GO:0031100;GO:0043277;GO:0035754;GO:0007596;GO:0070588;GO:0031589;GO:0044267;GO:0035690;GO:0071333;GO:0071363;GO:0035457;GO:0009267;GO:0071307;GO:0097028;GO:0006888;GO:0007167;GO:0085029;GO:0019064;GO:0097241;GO:0050900;GO:0043066;GO:0070168;GO:0043154;GO:2000669;GO:0043433;GO:2000352;GO:2000270;GO:0032689;GO:0032692;GO:0032715;GO:1900142;GO:2000533;GO:0045892;GO:0032720;GO:0010804;GO:0001764;GO:0018105;GO:0006909;GO:0002576;GO:0001961;GO:2000510;GO:0070374;GO:0048146;GO:0010628;GO:0003104;GO:0032825;GO:0033138;GO:0050766;GO:0046827;GO:0045860;GO:0051897;GO:0001934;GO:0061098;GO:0032008;GO:0043687;GO:0043491;GO:0072659;GO:0006468;GO:0046813;GO:0040008;GO:0007165;GO:0046718;GO:0019079;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:platelet alpha granule lumen;, F:calcium ion binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:phosphatidylserine binding; F:protein tyrosine kinase activator activity; F:protein-macromolecule adaptor activity; F:receptor ligand activity; F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:activation of protein kinase B activity; P:animal organ regeneration; P:apoptotic cell clearance; P:B cell chemotaxis; P:blood coagulation; P:calcium ion transmembrane transport; P:cell-substrate adhesion; P:cellular protein metabolic process; P:cellular response to drug; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:cellular response to interferon-alpha; P:cellular response to starvation; P:cellular response to vitamin K; P:dendritic cell differentiation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:enzyme linked receptor protein signaling pathway; P:extracellular matrix assembly; P:fusion of virus membrane with host plasma membrane; P:hematopoietic stem cell migration to bone marrow; P:leukocyte migration; P:negative regulation of apoptotic process; P:negative regulation of biomineral tissue development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of fibroblast apoptotic process; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 production; P:negative regulation of interleukin-6 production; P:negative regulation of oligodendrocyte apoptotic process; P:negative regulation of renal albumin absorption; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:neuron migration; P:peptidyl-serine phosphorylation; P:phagocytosis; P:platelet degranulation; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of glomerular filtration; P:positive regulation of natural killer cell differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phagocytosis; P:positive regulation of protein export from nucleus; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of TOR signaling; P:post-translational protein modification; P:protein kinase B signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:receptor-mediated virion attachment to host cell; P:regulation of growth; P:signal transduction; P:viral entry into host cell; P:viral genome replication;|Q14393 B3KRQ7 B3KVL4 E9PBL7 Q6IMN1 Q7Z7N3,Growth arrest-specific protein 6 {ECO:0000305},AXL receptor tyrosine kinase ligand;, PF12662;PF07645;PF00594;PF12661;PF00054;PF02210;, GO:0005737;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0031093;GO:0005509;GO:0043027;GO:0001786;GO:0030296;GO:0030674;GO:0048018;GO:0030971;GO:0005102;GO:0032148;GO:0031100;GO:0043277;GO:0035754;GO:0007596;GO:0070588;GO:0031589;GO:0044267;GO:0035690;GO:0071333;GO:0071363;GO:0035457;GO:0009267;GO:0071307;GO:0097028;GO:0006888;GO:0007167;GO:0085029;GO:0019064;GO:0097241;GO:0050900;GO:0043066;GO:0070168;GO:0043154;GO:2000669;GO:0043433;GO:2000352;GO:2000270;GO:0032689;GO:0032692;GO:0032715;GO:1900142;GO:2000533;GO:0045892;GO:0032720;GO:0010804;GO:0001764;GO:0018105;GO:0006909;GO:0002576;GO:0001961;GO:2000510;GO:0070374;GO:0048146;GO:0010628;GO:0003104;GO:0032825;GO:0033138;GO:0050766;GO:0046827;GO:0045860;GO:0051897;GO:0001934;GO:0061098;GO:0032008;GO:0043687;GO:0043491;GO:0072659;GO:0006468;GO:0046813;GO:0040008;GO:0007165;GO:0046718;GO:0019079;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:platelet alpha granule lumen;, F:calcium ion binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:phosphatidylserine binding; F:protein tyrosine kinase activator activity; F:protein-macromolecule adaptor activity; F:receptor ligand activity; F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:activation of protein kinase B activity; P:animal organ regeneration; P:apoptotic cell clearance; P:B cell chemotaxis; P:blood coagulation; P:calcium ion transmembrane transport; P:cell-substrate adhesion; P:cellular protein metabolic process; P:cellular response to drug; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:cellular response to interferon-alpha; P:cellular response to starvation; P:cellular response to vitamin K; P:dendritic cell differentiation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:enzyme linked receptor protein signaling pathway; P:extracellular matrix assembly; P:fusion of virus membrane with host plasma membrane; P:hematopoietic stem cell migration to bone marrow; P:leukocyte migration; P:negative regulation of apoptotic process; P:negative regulation of biomineral tissue development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of fibroblast apoptotic process; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 production; P:negative regulation of interleukin-6 production; P:negative regulation of oligodendrocyte apoptotic process; P:negative regulation of renal albumin absorption; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:neuron migration; P:peptidyl-serine phosphorylation; P:phagocytosis; P:platelet degranulation; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of glomerular filtration; P:positive regulation of natural killer cell differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phagocytosis; P:positive regulation of protein export from nucleus; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of TOR signaling; P:post-translational protein modification; P:protein kinase B signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:receptor-mediated virion attachment to host cell; P:regulation of growth; P:signal transduction; P:viral entry into host cell; P:viral genome replication;|Q14393 B3KRQ7 B3KVL4 E9PBL7 Q6IMN1 Q7Z7N3,Growth arrest-specific protein 6 {ECO:0000305},AXL receptor tyrosine kinase ligand;, PF12662;PF07645;PF00594;PF12661;PF00054;PF02210;, GO:0005737;GO:0005788;GO:0070062;GO:0005576;GO:0005615;GO:0005796;GO:0031093;GO:0005509;GO:0043027;GO:0001786;GO:0030296;GO:0030674;GO:0048018;GO:0030971;GO:0005102;GO:0032148;GO:0031100;GO:0043277;GO:0035754;GO:0007596;GO:0070588;GO:0031589;GO:0044267;GO:0035690;GO:0071333;GO:0071363;GO:0035457;GO:0009267;GO:0071307;GO:0097028;GO:0006888;GO:0007167;GO:0085029;GO:0019064;GO:0097241;GO:0050900;GO:0043066;GO:0070168;GO:0043154;GO:2000669;GO:0043433;GO:2000352;GO:2000270;GO:0032689;GO:0032692;GO:0032715;GO:1900142;GO:2000533;GO:0045892;GO:0032720;GO:0010804;GO:0001764;GO:0018105;GO:0006909;GO:0002576;GO:0001961;GO:2000510;GO:0070374;GO:0048146;GO:0010628;GO:0003104;GO:0032825;GO:0033138;GO:0050766;GO:0046827;GO:0045860;GO:0051897;GO:0001934;GO:0061098;GO:0032008;GO:0043687;GO:0043491;GO:0072659;GO:0006468;GO:0046813;GO:0040008;GO:0007165;GO:0046718;GO:0019079;, C:cytoplasm; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi lumen; C:platelet alpha granule lumen;, F:calcium ion binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:phosphatidylserine binding; F:protein tyrosine kinase activator activity; F:protein-macromolecule adaptor activity; F:receptor ligand activity; F:receptor tyrosine kinase binding; F:signaling receptor binding;, P:activation of protein kinase B activity; P:animal organ regeneration; P:apoptotic cell clearance; P:B cell chemotaxis; P:blood coagulation; P:calcium ion transmembrane transport; P:cell-substrate adhesion; P:cellular protein metabolic process; P:cellular response to drug; P:cellular response to glucose stimulus; P:cellular response to growth factor stimulus; P:cellular response to interferon-alpha; P:cellular response to starvation; P:cellular response to vitamin K; P:dendritic cell differentiation; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:enzyme linked receptor protein signaling pathway; P:extracellular matrix assembly; P:fusion of virus membrane with host plasma membrane; P:hematopoietic stem cell migration to bone marrow; P:leukocyte migration; P:negative regulation of apoptotic process; P:negative regulation of biomineral tissue development; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of dendritic cell apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of fibroblast apoptotic process; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 production; P:negative regulation of interleukin-6 production; P:negative regulation of oligodendrocyte apoptotic process; P:negative regulation of renal albumin absorption; P:negative regulation of transcription, DNA-templated; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:neuron migration; P:peptidyl-serine phosphorylation; P:phagocytosis; P:platelet degranulation; P:positive regulation of cytokine-mediated signaling pathway; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of fibroblast proliferation; P:positive regulation of gene expression; P:positive regulation of glomerular filtration; P:positive regulation of natural killer cell differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of phagocytosis; P:positive regulation of protein export from nucleus; P:positive regulation of protein kinase activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of protein tyrosine kinase activity; P:positive regulation of TOR signaling; P:post-translational protein modification; P:protein kinase B signaling; P:protein localization to plasma membrane; P:protein phosphorylation; P:receptor-mediated virion attachment to host cell; P:regulation of growth; P:signal transduction; P:viral entry into host cell; P:viral genome replication; scaffold236 indexed_genome mRNA 264433 265310 . - . ID=transcript_16139;Q8NDY3 Q5JUG2 Q96GD1,[Protein ADP-ribosylarginine] hydrolase-like protein 1,ADP-ribosylhydrolase 2;, PF03747;, GO:0003875;GO:0000287;GO:0051725;, , F:ADP-ribosylarginine hydrolase activity; F:magnesium ion binding;, P:protein de-ADP-ribosylation; scaffold236 indexed_genome mRNA 265690 270691 . + . ID=transcript_16140;Q8NDY3 Q5JUG2 Q96GD1,[Protein ADP-ribosylarginine] hydrolase-like protein 1,ADP-ribosylhydrolase 2;, PF03747;, GO:0003875;GO:0000287;GO:0051725;, , F:ADP-ribosylarginine hydrolase activity; F:magnesium ion binding;, P:protein de-ADP-ribosylation; scaffold236 indexed_genome mRNA 300151 323494 . + . ID=transcript_16141;Q5TC63 B9A6K2 Q2M232 Q5TC64 Q66K26 Q6P659 Q8N528 Q9H695,Growth hormone-regulated TBC protein 1,TBC1 domain family member 6;, PF00566;, GO:0005096;GO:0090630;GO:0006886;, , F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport;|Q5TC63 B9A6K2 Q2M232 Q5TC64 Q66K26 Q6P659 Q8N528 Q9H695,Growth hormone-regulated TBC protein 1,TBC1 domain family member 6;, PF00566;, GO:0005096;GO:0090630;GO:0006886;, , F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport;|Q5TC63 B9A6K2 Q2M232 Q5TC64 Q66K26 Q6P659 Q8N528 Q9H695,Growth hormone-regulated TBC protein 1,TBC1 domain family member 6;, PF00566;, GO:0005096;GO:0090630;GO:0006886;, , F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport;|P11279 B4DWL3 Q8WU33 Q96I40 Q9BRD2 Q9NP13,Lysosome-associated membrane glycoprotein 1,CD107 antigen-like family member A;, PF01299;, GO:0097208;GO:0044754;GO:0000421;GO:0035577;GO:0044194;GO:0005737;GO:0005829;GO:0030425;GO:0010008;GO:0009897;GO:0070062;GO:0101003;GO:0005887;GO:0030285;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0042470;GO:0016020;GO:0005771;GO:0043025;GO:0048471;GO:0061474;GO:0005886;GO:0042383;GO:0019899;GO:0019904;GO:0001618;GO:0048102;GO:0072594;GO:0090160;GO:0140507;GO:0043312;GO:0043323;GO:0045954;GO:0050821;GO:1902513;, C:alveolar lamellar body; C:autolysosome; C:autophagosome membrane; C:azurophil granule membrane; C:cytolytic granule; C:cytoplasm; C:cytosol; C:dendrite; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane; C:multivesicular body; C:neuronal cell body; C:perinuclear region of cytoplasm; C:phagolysosome membrane; C:plasma membrane; C:sarcolemma;, F:enzyme binding; F:protein domain specific binding; F:virus receptor activity;, P:autophagic cell death; P:establishment of protein localization to organelle; P:Golgi to lysosome transport; P:granzyme-mediated programmed cell death signaling pathway; P:neutrophil degranulation; P:positive regulation of natural killer cell degranulation; P:positive regulation of natural killer cell mediated cytotoxicity; P:protein stabilization; P:regulation of organelle transport along microtubule;|P11279 B4DWL3 Q8WU33 Q96I40 Q9BRD2 Q9NP13,Lysosome-associated membrane glycoprotein 1,CD107 antigen-like family member A;, PF01299;, GO:0097208;GO:0044754;GO:0000421;GO:0035577;GO:0044194;GO:0005737;GO:0005829;GO:0030425;GO:0010008;GO:0009897;GO:0070062;GO:0101003;GO:0005887;GO:0030285;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0042470;GO:0016020;GO:0005771;GO:0043025;GO:0048471;GO:0061474;GO:0005886;GO:0042383;GO:0019899;GO:0019904;GO:0001618;GO:0048102;GO:0072594;GO:0090160;GO:0140507;GO:0043312;GO:0043323;GO:0045954;GO:0050821;GO:1902513;, C:alveolar lamellar body; C:autolysosome; C:autophagosome membrane; C:azurophil granule membrane; C:cytolytic granule; C:cytoplasm; C:cytosol; C:dendrite; C:endosome membrane; C:external side of plasma membrane; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:integral component of synaptic vesicle membrane; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane; C:multivesicular body; C:neuronal cell body; C:perinuclear region of cytoplasm; C:phagolysosome membrane; C:plasma membrane; C:sarcolemma;, F:enzyme binding; F:protein domain specific binding; F:virus receptor activity;, P:autophagic cell death; P:establishment of protein localization to organelle; P:Golgi to lysosome transport; P:granzyme-mediated programmed cell death signaling pathway; P:neutrophil degranulation; P:positive regulation of natural killer cell degranulation; P:positive regulation of natural killer cell mediated cytotoxicity; P:protein stabilization; P:regulation of organelle transport along microtubule; scaffold236 indexed_genome mRNA 341885 367671 . - . ID=transcript_16142;Q13619 A2A2W2 O75834 Q589T6 Q5TC62 Q6UP08 Q9UP17,Cullin-4A,, PF00888;PF10557;, GO:0080008;GO:0031464;GO:0031461;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0030097;GO:0001701;GO:0097193;GO:0030853;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0008284;GO:1900087;GO:0043687;GO:0043161;GO:0016567;GO:2000001;GO:2000819;GO:0051246;GO:0048511;GO:0042254;GO:0031146;GO:0035019;GO:0006283;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:hemopoiesis; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway; P:negative regulation of granulocyte differentiation; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of cell population proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of nucleotide-excision repair; P:regulation of protein metabolic process; P:rhythmic process; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:somatic stem cell population maintenance; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q13619 A2A2W2 O75834 Q589T6 Q5TC62 Q6UP08 Q9UP17,Cullin-4A,, PF00888;PF10557;, GO:0080008;GO:0031464;GO:0031461;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0030097;GO:0001701;GO:0097193;GO:0030853;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0008284;GO:1900087;GO:0043687;GO:0043161;GO:0016567;GO:2000001;GO:2000819;GO:0051246;GO:0048511;GO:0042254;GO:0031146;GO:0035019;GO:0006283;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:hemopoiesis; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway; P:negative regulation of granulocyte differentiation; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of cell population proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of nucleotide-excision repair; P:regulation of protein metabolic process; P:rhythmic process; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:somatic stem cell population maintenance; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q13619 A2A2W2 O75834 Q589T6 Q5TC62 Q6UP08 Q9UP17,Cullin-4A,, PF00888;PF10557;, GO:0080008;GO:0031464;GO:0031461;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0030097;GO:0001701;GO:0097193;GO:0030853;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0008284;GO:1900087;GO:0043687;GO:0043161;GO:0016567;GO:2000001;GO:2000819;GO:0051246;GO:0048511;GO:0042254;GO:0031146;GO:0035019;GO:0006283;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:hemopoiesis; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway; P:negative regulation of granulocyte differentiation; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of cell population proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of nucleotide-excision repair; P:regulation of protein metabolic process; P:rhythmic process; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:somatic stem cell population maintenance; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q13619 A2A2W2 O75834 Q589T6 Q5TC62 Q6UP08 Q9UP17,Cullin-4A,, PF00888;PF10557;, GO:0080008;GO:0031464;GO:0031461;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0030097;GO:0001701;GO:0097193;GO:0030853;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0008284;GO:1900087;GO:0043687;GO:0043161;GO:0016567;GO:2000001;GO:2000819;GO:0051246;GO:0048511;GO:0042254;GO:0031146;GO:0035019;GO:0006283;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:hemopoiesis; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway; P:negative regulation of granulocyte differentiation; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of cell population proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of nucleotide-excision repair; P:regulation of protein metabolic process; P:rhythmic process; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:somatic stem cell population maintenance; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q13619 A2A2W2 O75834 Q589T6 Q5TC62 Q6UP08 Q9UP17,Cullin-4A,, PF00888;PF10557;, GO:0080008;GO:0031464;GO:0031461;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0030097;GO:0001701;GO:0097193;GO:0030853;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0008284;GO:1900087;GO:0043687;GO:0043161;GO:0016567;GO:2000001;GO:2000819;GO:0051246;GO:0048511;GO:0042254;GO:0031146;GO:0035019;GO:0006283;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:hemopoiesis; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway; P:negative regulation of granulocyte differentiation; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of cell population proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of nucleotide-excision repair; P:regulation of protein metabolic process; P:rhythmic process; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:somatic stem cell population maintenance; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q13619 A2A2W2 O75834 Q589T6 Q5TC62 Q6UP08 Q9UP17,Cullin-4A,, PF00888;PF10557;, GO:0080008;GO:0031464;GO:0031461;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0030097;GO:0001701;GO:0097193;GO:0030853;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0008284;GO:1900087;GO:0043687;GO:0043161;GO:0016567;GO:2000001;GO:2000819;GO:0051246;GO:0048511;GO:0042254;GO:0031146;GO:0035019;GO:0006283;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:hemopoiesis; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway; P:negative regulation of granulocyte differentiation; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of cell population proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of nucleotide-excision repair; P:regulation of protein metabolic process; P:rhythmic process; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:somatic stem cell population maintenance; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q13619 A2A2W2 O75834 Q589T6 Q5TC62 Q6UP08 Q9UP17,Cullin-4A,, PF00888;PF10557;, GO:0080008;GO:0031464;GO:0031461;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0030097;GO:0001701;GO:0097193;GO:0030853;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0008284;GO:1900087;GO:0043687;GO:0043161;GO:0016567;GO:2000001;GO:2000819;GO:0051246;GO:0048511;GO:0042254;GO:0031146;GO:0035019;GO:0006283;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:hemopoiesis; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway; P:negative regulation of granulocyte differentiation; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of cell population proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of nucleotide-excision repair; P:regulation of protein metabolic process; P:rhythmic process; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:somatic stem cell population maintenance; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q13619 A2A2W2 O75834 Q589T6 Q5TC62 Q6UP08 Q9UP17,Cullin-4A,, PF00888;PF10557;, GO:0080008;GO:0031464;GO:0031461;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0030097;GO:0001701;GO:0097193;GO:0030853;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0008284;GO:1900087;GO:0043687;GO:0043161;GO:0016567;GO:2000001;GO:2000819;GO:0051246;GO:0048511;GO:0042254;GO:0031146;GO:0035019;GO:0006283;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:hemopoiesis; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway; P:negative regulation of granulocyte differentiation; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of cell population proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of nucleotide-excision repair; P:regulation of protein metabolic process; P:rhythmic process; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:somatic stem cell population maintenance; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q13619 A2A2W2 O75834 Q589T6 Q5TC62 Q6UP08 Q9UP17,Cullin-4A,, PF00888;PF10557;, GO:0080008;GO:0031464;GO:0031461;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0030097;GO:0001701;GO:0097193;GO:0030853;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0008284;GO:1900087;GO:0043687;GO:0043161;GO:0016567;GO:2000001;GO:2000819;GO:0051246;GO:0048511;GO:0042254;GO:0031146;GO:0035019;GO:0006283;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:hemopoiesis; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway; P:negative regulation of granulocyte differentiation; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of cell population proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of nucleotide-excision repair; P:regulation of protein metabolic process; P:rhythmic process; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:somatic stem cell population maintenance; P:transcription-coupled nucleotide-excision repair; P:viral process;|Q13619 A2A2W2 O75834 Q589T6 Q5TC62 Q6UP08 Q9UP17,Cullin-4A,, PF00888;PF10557;, GO:0080008;GO:0031464;GO:0031461;GO:0005654;GO:0019005;GO:0031625;GO:0004842;GO:0006974;GO:0042769;GO:0000082;GO:0070911;GO:0030097;GO:0001701;GO:0097193;GO:0030853;GO:0000715;GO:0000717;GO:0033683;GO:0006295;GO:0006296;GO:0006294;GO:0006293;GO:0008284;GO:1900087;GO:0043687;GO:0043161;GO:0016567;GO:2000001;GO:2000819;GO:0051246;GO:0048511;GO:0042254;GO:0031146;GO:0035019;GO:0006283;GO:0016032;, C:Cul4-RING E3 ubiquitin ligase complex; C:Cul4A-RING E3 ubiquitin ligase complex; C:cullin-RING ubiquitin ligase complex; C:nucleoplasm; C:SCF ubiquitin ligase complex;, F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:G1/S transition of mitotic cell cycle; P:global genome nucleotide-excision repair; P:hemopoiesis; P:in utero embryonic development; P:intrinsic apoptotic signaling pathway; P:negative regulation of granulocyte differentiation; P:nucleotide-excision repair, DNA damage recognition; P:nucleotide-excision repair, DNA duplex unwinding; P:nucleotide-excision repair, DNA incision; P:nucleotide-excision repair, DNA incision, 3'-to lesion; P:nucleotide-excision repair, DNA incision, 5'-to lesion; P:nucleotide-excision repair, preincision complex assembly; P:nucleotide-excision repair, preincision complex stabilization; P:positive regulation of cell population proliferation; P:positive regulation of G1/S transition of mitotic cell cycle; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ubiquitination; P:regulation of DNA damage checkpoint; P:regulation of nucleotide-excision repair; P:regulation of protein metabolic process; P:rhythmic process; P:ribosome biogenesis; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:somatic stem cell population maintenance; P:transcription-coupled nucleotide-excision repair; P:viral process; scaffold236 indexed_genome mRNA 377598 382416 . + . ID=transcript_16143;Q9NW44 Q9NWH3,PCI domain-containing protein 2,CSN12-like protein;, PF01399;, GO:0005737;GO:0044615;GO:0005634;GO:0070390;GO:0003690;GO:0003723;GO:0043066;GO:2000117;GO:0071033;GO:0016973;GO:0045579;GO:0090267;GO:0045893;GO:0000973;GO:0043488;GO:0048536;GO:0006368;, C:cytoplasm; C:nuclear pore nuclear basket; C:nucleus; C:transcription export complex 2;, F:double-stranded DNA binding; F:RNA binding;, P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity; P:nuclear retention of pre-mRNA at the site of transcription; P:poly(A)+ mRNA export from nucleus; P:positive regulation of B cell differentiation; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:positive regulation of transcription, DNA-templated; P:posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery; P:regulation of mRNA stability; P:spleen development; P:transcription elongation from RNA polymerase II promoter; scaffold236 indexed_genome mRNA 383115 388807 . + . ID=transcript_16144;Q9NW44 Q9NWH3,PCI domain-containing protein 2,CSN12-like protein;, PF01399;, GO:0005737;GO:0044615;GO:0005634;GO:0070390;GO:0003690;GO:0003723;GO:0043066;GO:2000117;GO:0071033;GO:0016973;GO:0045579;GO:0090267;GO:0045893;GO:0000973;GO:0043488;GO:0048536;GO:0006368;, C:cytoplasm; C:nuclear pore nuclear basket; C:nucleus; C:transcription export complex 2;, F:double-stranded DNA binding; F:RNA binding;, P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity; P:nuclear retention of pre-mRNA at the site of transcription; P:poly(A)+ mRNA export from nucleus; P:positive regulation of B cell differentiation; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:positive regulation of transcription, DNA-templated; P:posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery; P:regulation of mRNA stability; P:spleen development; P:transcription elongation from RNA polymerase II promoter;|Q9NW44 Q9NWH3,PCI domain-containing protein 2,CSN12-like protein;, PF01399;, GO:0005737;GO:0044615;GO:0005634;GO:0070390;GO:0003690;GO:0003723;GO:0043066;GO:2000117;GO:0071033;GO:0016973;GO:0045579;GO:0090267;GO:0045893;GO:0000973;GO:0043488;GO:0048536;GO:0006368;, C:cytoplasm; C:nuclear pore nuclear basket; C:nucleus; C:transcription export complex 2;, F:double-stranded DNA binding; F:RNA binding;, P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity; P:nuclear retention of pre-mRNA at the site of transcription; P:poly(A)+ mRNA export from nucleus; P:positive regulation of B cell differentiation; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:positive regulation of transcription, DNA-templated; P:posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery; P:regulation of mRNA stability; P:spleen development; P:transcription elongation from RNA polymerase II promoter;|Q9NW44 Q9NWH3,PCI domain-containing protein 2,CSN12-like protein;, PF01399;, GO:0005737;GO:0044615;GO:0005634;GO:0070390;GO:0003690;GO:0003723;GO:0043066;GO:2000117;GO:0071033;GO:0016973;GO:0045579;GO:0090267;GO:0045893;GO:0000973;GO:0043488;GO:0048536;GO:0006368;, C:cytoplasm; C:nuclear pore nuclear basket; C:nucleus; C:transcription export complex 2;, F:double-stranded DNA binding; F:RNA binding;, P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity; P:nuclear retention of pre-mRNA at the site of transcription; P:poly(A)+ mRNA export from nucleus; P:positive regulation of B cell differentiation; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:positive regulation of transcription, DNA-templated; P:posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery; P:regulation of mRNA stability; P:spleen development; P:transcription elongation from RNA polymerase II promoter;|Q9NW44 Q9NWH3,PCI domain-containing protein 2,CSN12-like protein;, PF01399;, GO:0005737;GO:0044615;GO:0005634;GO:0070390;GO:0003690;GO:0003723;GO:0043066;GO:2000117;GO:0071033;GO:0016973;GO:0045579;GO:0090267;GO:0045893;GO:0000973;GO:0043488;GO:0048536;GO:0006368;, C:cytoplasm; C:nuclear pore nuclear basket; C:nucleus; C:transcription export complex 2;, F:double-stranded DNA binding; F:RNA binding;, P:negative regulation of apoptotic process; P:negative regulation of cysteine-type endopeptidase activity; P:nuclear retention of pre-mRNA at the site of transcription; P:poly(A)+ mRNA export from nucleus; P:positive regulation of B cell differentiation; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; P:positive regulation of transcription, DNA-templated; P:posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery; P:regulation of mRNA stability; P:spleen development; P:transcription elongation from RNA polymerase II promoter; scaffold236 indexed_genome mRNA 397011 420403 . - . ID=transcript_16145;P22891 A6NMB4 Q15213 Q5JVF5 Q5JVF6,Vitamin K-dependent protein Z,, PF00008;PF00594;PF00089;, GO:0005788;GO:0070062;GO:0005615;GO:0005796;GO:0005509;GO:0004252;GO:0007596;GO:0006888;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:Golgi lumen;, F:calcium ion binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|P22891 A6NMB4 Q15213 Q5JVF5 Q5JVF6,Vitamin K-dependent protein Z,, PF00008;PF00594;PF00089;, GO:0005788;GO:0070062;GO:0005615;GO:0005796;GO:0005509;GO:0004252;GO:0007596;GO:0006888;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:Golgi lumen;, F:calcium ion binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|P22891 A6NMB4 Q15213 Q5JVF5 Q5JVF6,Vitamin K-dependent protein Z,, PF00008;PF00594;PF00089;, GO:0005788;GO:0070062;GO:0005615;GO:0005796;GO:0005509;GO:0004252;GO:0007596;GO:0006888;, C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular space; C:Golgi lumen;, F:calcium ion binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:endoplasmic reticulum to Golgi vesicle-mediated transport;|P00742 Q14340,Coagulation factor X,Stuart factor;Stuart-Prower factor;, PF00008;PF00594;PF00089;, GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0031233;GO:0005886;GO:0005509;GO:0005543;GO:0004252;GO:0007596;GO:0007598;GO:0006888;GO:2000264;GO:0030335;GO:0051897;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen; C:intrinsic component of external side of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:phospholipid binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:blood coagulation, extrinsic pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of blood coagulation, extrinsic pathway; P:positive regulation of cell migration; P:positive regulation of protein kinase B signaling;|P00742 Q14340,Coagulation factor X,Stuart factor;Stuart-Prower factor;, PF00008;PF00594;PF00089;, GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0031233;GO:0005886;GO:0005509;GO:0005543;GO:0004252;GO:0007596;GO:0007598;GO:0006888;GO:2000264;GO:0030335;GO:0051897;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen; C:intrinsic component of external side of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:phospholipid binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:blood coagulation, extrinsic pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of blood coagulation, extrinsic pathway; P:positive regulation of cell migration; P:positive regulation of protein kinase B signaling;|P00742 Q14340,Coagulation factor X,Stuart factor;Stuart-Prower factor;, PF00008;PF00594;PF00089;, GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0031233;GO:0005886;GO:0005509;GO:0005543;GO:0004252;GO:0007596;GO:0007598;GO:0006888;GO:2000264;GO:0030335;GO:0051897;, C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen; C:intrinsic component of external side of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:phospholipid binding; F:serine-type endopeptidase activity;, P:blood coagulation; P:blood coagulation, extrinsic pathway; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of blood coagulation, extrinsic pathway; P:positive regulation of cell migration; P:positive regulation of protein kinase B signaling; scaffold236 indexed_genome mRNA 422674 428213 . - . ID=transcript_16146;P08709 B0YJC8 Q14339 Q5JVF1 Q5JVF2 Q9UD52 Q9UD53 Q9UD54,Coagulation factor VII,Proconvertin;Serum prothrombin conversion accelerator;, PF00008;PF00594;PF00089;, GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:1905286;GO:0031982;GO:0005509;GO:0004252;GO:0008236;GO:0005102;GO:0031100;GO:0007596;GO:0007598;GO:0007623;GO:0006888;GO:2000264;GO:0030194;GO:0030335;GO:0002690;GO:0010641;GO:0050927;GO:0051897;GO:0016485;GO:1904612;GO:0061476;GO:1905217;GO:0010037;GO:0070723;GO:0032355;GO:0043627;GO:0033595;GO:0060416;GO:0001666;GO:1904400;GO:1905225;GO:0097068;GO:0032571;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane; C:serine-type peptidase complex; C:vesicle;, F:calcium ion binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding;, P:animal organ regeneration; P:blood coagulation; P:blood coagulation, extrinsic pathway; P:circadian rhythm; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of blood coagulation, extrinsic pathway; P:positive regulation of blood coagulation; P:positive regulation of cell migration; P:positive regulation of leukocyte chemotaxis; P:positive regulation of platelet-derived growth factor receptor signaling pathway; P:positive regulation of positive chemotaxis; P:positive regulation of protein kinase B signaling; P:protein processing; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:response to anticoagulant; P:response to astaxanthin; P:response to carbon dioxide; P:response to cholesterol; P:response to estradiol; P:response to estrogen; P:response to genistein; P:response to growth hormone; P:response to hypoxia; P:response to Thyroid stimulating hormone; P:response to thyrotropin-releasing hormone; P:response to thyroxine; P:response to vitamin K;|P08709 B0YJC8 Q14339 Q5JVF1 Q5JVF2 Q9UD52 Q9UD53 Q9UD54,Coagulation factor VII,Proconvertin;Serum prothrombin conversion accelerator;, PF00008;PF00594;PF00089;, GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:1905286;GO:0031982;GO:0005509;GO:0004252;GO:0008236;GO:0005102;GO:0031100;GO:0007596;GO:0007598;GO:0007623;GO:0006888;GO:2000264;GO:0030194;GO:0030335;GO:0002690;GO:0010641;GO:0050927;GO:0051897;GO:0016485;GO:1904612;GO:0061476;GO:1905217;GO:0010037;GO:0070723;GO:0032355;GO:0043627;GO:0033595;GO:0060416;GO:0001666;GO:1904400;GO:1905225;GO:0097068;GO:0032571;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane; C:serine-type peptidase complex; C:vesicle;, F:calcium ion binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding;, P:animal organ regeneration; P:blood coagulation; P:blood coagulation, extrinsic pathway; P:circadian rhythm; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of blood coagulation, extrinsic pathway; P:positive regulation of blood coagulation; P:positive regulation of cell migration; P:positive regulation of leukocyte chemotaxis; P:positive regulation of platelet-derived growth factor receptor signaling pathway; P:positive regulation of positive chemotaxis; P:positive regulation of protein kinase B signaling; P:protein processing; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:response to anticoagulant; P:response to astaxanthin; P:response to carbon dioxide; P:response to cholesterol; P:response to estradiol; P:response to estrogen; P:response to genistein; P:response to growth hormone; P:response to hypoxia; P:response to Thyroid stimulating hormone; P:response to thyrotropin-releasing hormone; P:response to thyroxine; P:response to vitamin K;|P08709 B0YJC8 Q14339 Q5JVF1 Q5JVF2 Q9UD52 Q9UD53 Q9UD54,Coagulation factor VII,Proconvertin;Serum prothrombin conversion accelerator;, PF00008;PF00594;PF00089;, GO:0062023;GO:0005788;GO:0005576;GO:0005615;GO:0005796;GO:0005886;GO:1905286;GO:0031982;GO:0005509;GO:0004252;GO:0008236;GO:0005102;GO:0031100;GO:0007596;GO:0007598;GO:0007623;GO:0006888;GO:2000264;GO:0030194;GO:0030335;GO:0002690;GO:0010641;GO:0050927;GO:0051897;GO:0016485;GO:1904612;GO:0061476;GO:1905217;GO:0010037;GO:0070723;GO:0032355;GO:0043627;GO:0033595;GO:0060416;GO:0001666;GO:1904400;GO:1905225;GO:0097068;GO:0032571;, C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi lumen; C:plasma membrane; C:serine-type peptidase complex; C:vesicle;, F:calcium ion binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity; F:signaling receptor binding;, P:animal organ regeneration; P:blood coagulation; P:blood coagulation, extrinsic pathway; P:circadian rhythm; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of blood coagulation, extrinsic pathway; P:positive regulation of blood coagulation; P:positive regulation of cell migration; P:positive regulation of leukocyte chemotaxis; P:positive regulation of platelet-derived growth factor receptor signaling pathway; P:positive regulation of positive chemotaxis; P:positive regulation of protein kinase B signaling; P:protein processing; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:response to anticoagulant; P:response to astaxanthin; P:response to carbon dioxide; P:response to cholesterol; P:response to estradiol; P:response to estrogen; P:response to genistein; P:response to growth hormone; P:response to hypoxia; P:response to Thyroid stimulating hormone; P:response to thyrotropin-releasing hormone; P:response to thyroxine; P:response to vitamin K; scaffold236 indexed_genome mRNA 432326 434672 . - . ID=transcript_16147;Q5VXT1 Q6ZWD4 Q765G8 Q765G9 Q8N679,Guanine nucleotide exchange factor DBS,DBL's big sister;MCF2-transforming sequence-like protein;, PF13716;PF00169;PF00621;PF07653;PF00435;, GO:0005737;GO:0005829;GO:0012505;GO:0005615;GO:0031234;GO:0005886;GO:0005085;GO:0035091;GO:0007186;GO:0035556;GO:0043065;GO:0035025;GO:0051056;, C:cytoplasm; C:cytosol; C:endomembrane system; C:extracellular space; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol binding;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; scaffold236 indexed_genome mRNA 440085 459225 . - . ID=transcript_16148;Q5VXT1 Q6ZWD4 Q765G8 Q765G9 Q8N679,Guanine nucleotide exchange factor DBS,DBL's big sister;MCF2-transforming sequence-like protein;, PF13716;PF00169;PF00621;PF07653;PF00435;, GO:0005737;GO:0005829;GO:0012505;GO:0005615;GO:0031234;GO:0005886;GO:0005085;GO:0035091;GO:0007186;GO:0035556;GO:0043065;GO:0035025;GO:0051056;, C:cytoplasm; C:cytosol; C:endomembrane system; C:extracellular space; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol binding;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q5VXT1 Q6ZWD4 Q765G8 Q765G9 Q8N679,Guanine nucleotide exchange factor DBS,DBL's big sister;MCF2-transforming sequence-like protein;, PF13716;PF00169;PF00621;PF07653;PF00435;, GO:0005737;GO:0005829;GO:0012505;GO:0005615;GO:0031234;GO:0005886;GO:0005085;GO:0035091;GO:0007186;GO:0035556;GO:0043065;GO:0035025;GO:0051056;, C:cytoplasm; C:cytosol; C:endomembrane system; C:extracellular space; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol binding;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q5VXT1 Q6ZWD4 Q765G8 Q765G9 Q8N679,Guanine nucleotide exchange factor DBS,DBL's big sister;MCF2-transforming sequence-like protein;, PF13716;PF00169;PF00621;PF07653;PF00435;, GO:0005737;GO:0005829;GO:0012505;GO:0005615;GO:0031234;GO:0005886;GO:0005085;GO:0035091;GO:0007186;GO:0035556;GO:0043065;GO:0035025;GO:0051056;, C:cytoplasm; C:cytosol; C:endomembrane system; C:extracellular space; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol binding;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q5VXT1 Q6ZWD4 Q765G8 Q765G9 Q8N679,Guanine nucleotide exchange factor DBS,DBL's big sister;MCF2-transforming sequence-like protein;, PF13716;PF00169;PF00621;PF07653;PF00435;, GO:0005737;GO:0005829;GO:0012505;GO:0005615;GO:0031234;GO:0005886;GO:0005085;GO:0035091;GO:0007186;GO:0035556;GO:0043065;GO:0035025;GO:0051056;, C:cytoplasm; C:cytosol; C:endomembrane system; C:extracellular space; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol binding;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; scaffold236 indexed_genome mRNA 464406 465314 . - . ID=transcript_16149;Q5VXT1 Q6ZWD4 Q765G8 Q765G9 Q8N679,Guanine nucleotide exchange factor DBS,DBL's big sister;MCF2-transforming sequence-like protein;, PF13716;PF00169;PF00621;PF07653;PF00435;, GO:0005737;GO:0005829;GO:0012505;GO:0005615;GO:0031234;GO:0005886;GO:0005085;GO:0035091;GO:0007186;GO:0035556;GO:0043065;GO:0035025;GO:0051056;, C:cytoplasm; C:cytosol; C:endomembrane system; C:extracellular space; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol binding;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; scaffold236 indexed_genome mRNA 477682 479372 . - . ID=transcript_16150;Q5VXT1 Q6ZWD4 Q765G8 Q765G9 Q8N679,Guanine nucleotide exchange factor DBS,DBL's big sister;MCF2-transforming sequence-like protein;, PF13716;PF00169;PF00621;PF07653;PF00435;, GO:0005737;GO:0005829;GO:0012505;GO:0005615;GO:0031234;GO:0005886;GO:0005085;GO:0035091;GO:0007186;GO:0035556;GO:0043065;GO:0035025;GO:0051056;, C:cytoplasm; C:cytosol; C:endomembrane system; C:extracellular space; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol binding;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction;|Q5VXT1 Q6ZWD4 Q765G8 Q765G9 Q8N679,Guanine nucleotide exchange factor DBS,DBL's big sister;MCF2-transforming sequence-like protein;, PF13716;PF00169;PF00621;PF07653;PF00435;, GO:0005737;GO:0005829;GO:0012505;GO:0005615;GO:0031234;GO:0005886;GO:0005085;GO:0035091;GO:0007186;GO:0035556;GO:0043065;GO:0035025;GO:0051056;, C:cytoplasm; C:cytosol; C:endomembrane system; C:extracellular space; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:guanyl-nucleotide exchange factor activity; F:phosphatidylinositol binding;, P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:positive regulation of apoptotic process; P:positive regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; scaffold237 indexed_genome mRNA 1 3262 . + . ID=transcript_16151;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold237 indexed_genome mRNA 151725 159884 . + . ID=transcript_16152;Q8IZE5 Q8IZE6 Q8IZE7 Q8IZP3 Q8IZP4,Adhesion G-protein coupled receptor G2 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 64;Human epididymis-specific protein 6;, PF00002;PF01825;, GO:0016324;GO:0009986;GO:0005829;GO:0070062;GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0007189;GO:0007166;GO:0007186;GO:0007283;, C:apical plasma membrane; C:cell surface; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:spermatogenesis; scaffold237 indexed_genome mRNA 161523 182999 . + . ID=transcript_16153;Q8IZE5 Q8IZE6 Q8IZE7 Q8IZP3 Q8IZP4,Adhesion G-protein coupled receptor G2 {ECO:0000303|PubMed:25713288},G-protein coupled receptor 64;Human epididymis-specific protein 6;, PF00002;PF01825;, GO:0016324;GO:0009986;GO:0005829;GO:0070062;GO:0016021;GO:0005887;GO:0005886;GO:0004930;GO:0007189;GO:0007166;GO:0007186;GO:0007283;, C:apical plasma membrane; C:cell surface; C:cytosol; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:spermatogenesis; scaffold237 indexed_genome mRNA 188917 281853 . + . ID=transcript_16154;P46019 A8K1T1 Q6LAJ5 Q7Z6W0 Q96CR3 Q9UDA1,Phosphorylase b kinase regulatory subunit alpha, liver isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0005975;GO:0006464;GO:0006091;GO:0005980;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:generation of precursor metabolites and energy; P:glycogen catabolic process;|P46019 A8K1T1 Q6LAJ5 Q7Z6W0 Q96CR3 Q9UDA1,Phosphorylase b kinase regulatory subunit alpha, liver isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0005975;GO:0006464;GO:0006091;GO:0005980;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:generation of precursor metabolites and energy; P:glycogen catabolic process;|P46019 A8K1T1 Q6LAJ5 Q7Z6W0 Q96CR3 Q9UDA1,Phosphorylase b kinase regulatory subunit alpha, liver isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0005975;GO:0006464;GO:0006091;GO:0005980;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:generation of precursor metabolites and energy; P:glycogen catabolic process;|P46019 A8K1T1 Q6LAJ5 Q7Z6W0 Q96CR3 Q9UDA1,Phosphorylase b kinase regulatory subunit alpha, liver isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0005975;GO:0006464;GO:0006091;GO:0005980;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:generation of precursor metabolites and energy; P:glycogen catabolic process;|P46019 A8K1T1 Q6LAJ5 Q7Z6W0 Q96CR3 Q9UDA1,Phosphorylase b kinase regulatory subunit alpha, liver isoform,, PF00723;, GO:0005829;GO:0005964;GO:0005886;GO:0005516;GO:0004689;GO:0005975;GO:0006464;GO:0006091;GO:0005980;, C:cytosol; C:phosphorylase kinase complex; C:plasma membrane;, F:calmodulin binding; F:phosphorylase kinase activity;, P:carbohydrate metabolic process; P:cellular protein modification process; P:generation of precursor metabolites and energy; P:glycogen catabolic process; scaffold237 indexed_genome mRNA 326233 476823 . - . ID=transcript_16155;O14829 A6NHP4 A8K348 O15253 Q9NU21 Q9UJH0,Serine/threonine-protein phosphatase with EF-hands 1,Protein phosphatase with EF calcium-binding domain;Serine/threonine-protein phosphatase 7;, PF13499;PF00612;PF00149;PF08321;, GO:0005829;GO:0005634;GO:0005509;GO:0005506;GO:0030145;GO:0106306;GO:0004722;GO:0106307;GO:0050906;GO:0006470;GO:0022400;, C:cytosol; C:nucleus;, F:calcium ion binding; F:iron ion binding; F:manganese ion binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:detection of stimulus involved in sensory perception; P:protein dephosphorylation; P:regulation of rhodopsin mediated signaling pathway; scaffold238 indexed_genome mRNA 23887 26343 . + . ID=transcript_16156;P48029 B2KY47 B4DIA3 E9PFC0 Q13032 Q66I36,Sodium- and chloride-dependent creatine transporter 1,Solute carrier family 6 member 8;, PF00209;, GO:0016021;GO:0005887;GO:0005886;GO:0005308;GO:0005309;GO:0006600;GO:0015881;GO:0006936;GO:0006836;GO:0071705;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:creatine transmembrane transporter activity; F:creatine:sodium symporter activity;, P:creatine metabolic process; P:creatine transmembrane transport; P:muscle contraction; P:neurotransmitter transport; P:nitrogen compound transport; P:sodium ion transmembrane transport; scaffold238 indexed_genome mRNA 26433 31917 . + . ID=transcript_16157;P48029 B2KY47 B4DIA3 E9PFC0 Q13032 Q66I36,Sodium- and chloride-dependent creatine transporter 1,Solute carrier family 6 member 8;, PF00209;, GO:0016021;GO:0005887;GO:0005886;GO:0005308;GO:0005309;GO:0006600;GO:0015881;GO:0006936;GO:0006836;GO:0071705;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:creatine transmembrane transporter activity; F:creatine:sodium symporter activity;, P:creatine metabolic process; P:creatine transmembrane transport; P:muscle contraction; P:neurotransmitter transport; P:nitrogen compound transport; P:sodium ion transmembrane transport;|P48029 B2KY47 B4DIA3 E9PFC0 Q13032 Q66I36,Sodium- and chloride-dependent creatine transporter 1,Solute carrier family 6 member 8;, PF00209;, GO:0016021;GO:0005887;GO:0005886;GO:0005308;GO:0005309;GO:0006600;GO:0015881;GO:0006936;GO:0006836;GO:0071705;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:creatine transmembrane transporter activity; F:creatine:sodium symporter activity;, P:creatine metabolic process; P:creatine transmembrane transport; P:muscle contraction; P:neurotransmitter transport; P:nitrogen compound transport; P:sodium ion transmembrane transport;|P48029 B2KY47 B4DIA3 E9PFC0 Q13032 Q66I36,Sodium- and chloride-dependent creatine transporter 1,Solute carrier family 6 member 8;, PF00209;, GO:0016021;GO:0005887;GO:0005886;GO:0005308;GO:0005309;GO:0006600;GO:0015881;GO:0006936;GO:0006836;GO:0071705;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:creatine transmembrane transporter activity; F:creatine:sodium symporter activity;, P:creatine metabolic process; P:creatine transmembrane transport; P:muscle contraction; P:neurotransmitter transport; P:nitrogen compound transport; P:sodium ion transmembrane transport;|P48029 B2KY47 B4DIA3 E9PFC0 Q13032 Q66I36,Sodium- and chloride-dependent creatine transporter 1,Solute carrier family 6 member 8;, PF00209;, GO:0016021;GO:0005887;GO:0005886;GO:0005308;GO:0005309;GO:0006600;GO:0015881;GO:0006936;GO:0006836;GO:0071705;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:creatine transmembrane transporter activity; F:creatine:sodium symporter activity;, P:creatine metabolic process; P:creatine transmembrane transport; P:muscle contraction; P:neurotransmitter transport; P:nitrogen compound transport; P:sodium ion transmembrane transport;|P48029 B2KY47 B4DIA3 E9PFC0 Q13032 Q66I36,Sodium- and chloride-dependent creatine transporter 1,Solute carrier family 6 member 8;, PF00209;, GO:0016021;GO:0005887;GO:0005886;GO:0005308;GO:0005309;GO:0006600;GO:0015881;GO:0006936;GO:0006836;GO:0071705;GO:0035725;, C:integral component of membrane; C:integral component of plasma membrane; C:plasma membrane;, F:creatine transmembrane transporter activity; F:creatine:sodium symporter activity;, P:creatine metabolic process; P:creatine transmembrane transport; P:muscle contraction; P:neurotransmitter transport; P:nitrogen compound transport; P:sodium ion transmembrane transport; scaffold238 indexed_genome mRNA 38457 40100 . + . ID=transcript_16158;P51572 B3KQ79 D3DWV5 Q13836 Q96CF0,B-cell receptor-associated protein 31,6C6-AG tumor-associated antigen;Protein CDM;p28;, PF05529;PF18035;, GO:0030136;GO:0005829;GO:0005783;GO:0005789;GO:0033116;GO:0032580;GO:0071556;GO:0005887;GO:0005811;GO:0016020;GO:0044233;GO:0005739;GO:0097038;GO:0042288;GO:0044877;GO:0002474;GO:0006915;GO:0035584;GO:0006888;GO:0032471;GO:0043280;GO:0007204;GO:1903071;GO:2001244;GO:0051561;GO:1904154;GO:0070973;GO:0006626;GO:0034976;GO:0007283;GO:0016032;, C:clathrin-coated vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi cisterna membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:integral component of plasma membrane; C:lipid droplet; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane; C:mitochondrion; C:perinuclear endoplasmic reticulum;, F:MHC class I protein binding; F:protein-containing complex binding;, P:antigen processing and presentation of peptide antigen via MHC class I; P:apoptotic process; P:calcium-mediated signaling using intracellular calcium source; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of mitochondrial calcium ion concentration; P:positive regulation of retrograde protein transport, ER to cytosol; P:protein localization to endoplasmic reticulum exit site; P:protein targeting to mitochondrion; P:response to endoplasmic reticulum stress; P:spermatogenesis; P:viral process; scaffold238 indexed_genome mRNA 63543 79709 . + . ID=transcript_16159;P33897 Q6GTZ2,ATP-binding cassette sub-family D member 1 {ECO:0000305},Adrenoleukodystrophy protein {ECO:0000303|PubMed:10777694};, PF06472;PF00005;, GO:0005737;GO:0005829;GO:0005789;GO:0005779;GO:0005765;GO:0016020;GO:0031966;GO:0048471;GO:0005778;GO:0005777;GO:0015607;GO:0043531;GO:0005524;GO:0016887;GO:0042626;GO:0019899;GO:0042802;GO:0005324;GO:0042803;GO:0036109;GO:0006635;GO:0033540;GO:0030497;GO:0055089;GO:0043651;GO:0006869;GO:0042758;GO:0015910;GO:0043217;GO:1900016;GO:1903427;GO:1990535;GO:0015919;GO:0007031;GO:0032000;GO:2001280;GO:0045046;GO:1900407;GO:0031998;GO:0051900;GO:0002082;GO:0055092;GO:0042760;GO:0036113;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of peroxisomal membrane; C:lysosomal membrane; C:membrane; C:mitochondrial membrane; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:peroxisome;, F:ABC-type fatty-acyl-CoA transporter activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:enzyme binding; F:identical protein binding; F:long-chain fatty acid transporter activity; F:protein homodimerization activity;, P:alpha-linolenic acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid elongation; P:fatty acid homeostasis; P:linoleic acid metabolic process; P:lipid transport; P:long-chain fatty acid catabolic process; P:long-chain fatty acid import into peroxisome; P:myelin maintenance; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of reactive oxygen species biosynthetic process; P:neuron projection maintenance; P:peroxisomal membrane transport; P:peroxisome organization; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of unsaturated fatty acid biosynthetic process; P:protein import into peroxisome membrane; P:regulation of cellular response to oxidative stress; P:regulation of fatty acid beta-oxidation; P:regulation of mitochondrial depolarization; P:regulation of oxidative phosphorylation; P:sterol homeostasis; P:very long-chain fatty acid catabolic process; P:very long-chain fatty-acyl-CoA catabolic process;|P33897 Q6GTZ2,ATP-binding cassette sub-family D member 1 {ECO:0000305},Adrenoleukodystrophy protein {ECO:0000303|PubMed:10777694};, PF06472;PF00005;, GO:0005737;GO:0005829;GO:0005789;GO:0005779;GO:0005765;GO:0016020;GO:0031966;GO:0048471;GO:0005778;GO:0005777;GO:0015607;GO:0043531;GO:0005524;GO:0016887;GO:0042626;GO:0019899;GO:0042802;GO:0005324;GO:0042803;GO:0036109;GO:0006635;GO:0033540;GO:0030497;GO:0055089;GO:0043651;GO:0006869;GO:0042758;GO:0015910;GO:0043217;GO:1900016;GO:1903427;GO:1990535;GO:0015919;GO:0007031;GO:0032000;GO:2001280;GO:0045046;GO:1900407;GO:0031998;GO:0051900;GO:0002082;GO:0055092;GO:0042760;GO:0036113;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of peroxisomal membrane; C:lysosomal membrane; C:membrane; C:mitochondrial membrane; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:peroxisome;, F:ABC-type fatty-acyl-CoA transporter activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:enzyme binding; F:identical protein binding; F:long-chain fatty acid transporter activity; F:protein homodimerization activity;, P:alpha-linolenic acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid elongation; P:fatty acid homeostasis; P:linoleic acid metabolic process; P:lipid transport; P:long-chain fatty acid catabolic process; P:long-chain fatty acid import into peroxisome; P:myelin maintenance; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of reactive oxygen species biosynthetic process; P:neuron projection maintenance; P:peroxisomal membrane transport; P:peroxisome organization; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of unsaturated fatty acid biosynthetic process; P:protein import into peroxisome membrane; P:regulation of cellular response to oxidative stress; P:regulation of fatty acid beta-oxidation; P:regulation of mitochondrial depolarization; P:regulation of oxidative phosphorylation; P:sterol homeostasis; P:very long-chain fatty acid catabolic process; P:very long-chain fatty-acyl-CoA catabolic process;|P33897 Q6GTZ2,ATP-binding cassette sub-family D member 1 {ECO:0000305},Adrenoleukodystrophy protein {ECO:0000303|PubMed:10777694};, PF06472;PF00005;, GO:0005737;GO:0005829;GO:0005789;GO:0005779;GO:0005765;GO:0016020;GO:0031966;GO:0048471;GO:0005778;GO:0005777;GO:0015607;GO:0043531;GO:0005524;GO:0016887;GO:0042626;GO:0019899;GO:0042802;GO:0005324;GO:0042803;GO:0036109;GO:0006635;GO:0033540;GO:0030497;GO:0055089;GO:0043651;GO:0006869;GO:0042758;GO:0015910;GO:0043217;GO:1900016;GO:1903427;GO:1990535;GO:0015919;GO:0007031;GO:0032000;GO:2001280;GO:0045046;GO:1900407;GO:0031998;GO:0051900;GO:0002082;GO:0055092;GO:0042760;GO:0036113;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of peroxisomal membrane; C:lysosomal membrane; C:membrane; C:mitochondrial membrane; C:perinuclear region of cytoplasm; C:peroxisomal membrane; C:peroxisome;, F:ABC-type fatty-acyl-CoA transporter activity; F:ADP binding; F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:enzyme binding; F:identical protein binding; F:long-chain fatty acid transporter activity; F:protein homodimerization activity;, P:alpha-linolenic acid metabolic process; P:fatty acid beta-oxidation; P:fatty acid beta-oxidation using acyl-CoA oxidase; P:fatty acid elongation; P:fatty acid homeostasis; P:linoleic acid metabolic process; P:lipid transport; P:long-chain fatty acid catabolic process; P:long-chain fatty acid import into peroxisome; P:myelin maintenance; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of reactive oxygen species biosynthetic process; P:neuron projection maintenance; P:peroxisomal membrane transport; P:peroxisome organization; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of unsaturated fatty acid biosynthetic process; P:protein import into peroxisome membrane; P:regulation of cellular response to oxidative stress; P:regulation of fatty acid beta-oxidation; P:regulation of mitochondrial depolarization; P:regulation of oxidative phosphorylation; P:sterol homeostasis; P:very long-chain fatty acid catabolic process; P:very long-chain fatty-acyl-CoA catabolic process; scaffold238 indexed_genome mRNA 89199 110542 . + . ID=transcript_16160;Q9ULL4 B7Z3E6 F5H773 Q9HDA4,Plexin-B3,, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0009986;GO:0005887;GO:0005886;GO:0002116;GO:0098632;GO:0019904;GO:0051022;GO:0017154;GO:0060326;GO:0007156;GO:0007162;GO:0030336;GO:0034260;GO:0010593;GO:0050918;GO:0050772;GO:0001938;GO:0010976;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;, C:cell surface; C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:cell-cell adhesion mediator activity; F:protein domain specific binding; F:Rho GDP-dissociation inhibitor binding; F:semaphorin receptor activity;, P:cell chemotaxis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:negative regulation of cell migration; P:negative regulation of GTPase activity; P:negative regulation of lamellipodium assembly; P:positive chemotaxis; P:positive regulation of axonogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of neuron projection development; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|Q9ULL4 B7Z3E6 F5H773 Q9HDA4,Plexin-B3,, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0009986;GO:0005887;GO:0005886;GO:0002116;GO:0098632;GO:0019904;GO:0051022;GO:0017154;GO:0060326;GO:0007156;GO:0007162;GO:0030336;GO:0034260;GO:0010593;GO:0050918;GO:0050772;GO:0001938;GO:0010976;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;, C:cell surface; C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:cell-cell adhesion mediator activity; F:protein domain specific binding; F:Rho GDP-dissociation inhibitor binding; F:semaphorin receptor activity;, P:cell chemotaxis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:negative regulation of cell migration; P:negative regulation of GTPase activity; P:negative regulation of lamellipodium assembly; P:positive chemotaxis; P:positive regulation of axonogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of neuron projection development; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|Q9ULL4 B7Z3E6 F5H773 Q9HDA4,Plexin-B3,, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0009986;GO:0005887;GO:0005886;GO:0002116;GO:0098632;GO:0019904;GO:0051022;GO:0017154;GO:0060326;GO:0007156;GO:0007162;GO:0030336;GO:0034260;GO:0010593;GO:0050918;GO:0050772;GO:0001938;GO:0010976;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;, C:cell surface; C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:cell-cell adhesion mediator activity; F:protein domain specific binding; F:Rho GDP-dissociation inhibitor binding; F:semaphorin receptor activity;, P:cell chemotaxis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:negative regulation of cell migration; P:negative regulation of GTPase activity; P:negative regulation of lamellipodium assembly; P:positive chemotaxis; P:positive regulation of axonogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of neuron projection development; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|Q9ULL4 B7Z3E6 F5H773 Q9HDA4,Plexin-B3,, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0009986;GO:0005887;GO:0005886;GO:0002116;GO:0098632;GO:0019904;GO:0051022;GO:0017154;GO:0060326;GO:0007156;GO:0007162;GO:0030336;GO:0034260;GO:0010593;GO:0050918;GO:0050772;GO:0001938;GO:0010976;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;, C:cell surface; C:integral component of plasma membrane; C:plasma membrane; C:semaphorin receptor complex;, F:cell-cell adhesion mediator activity; F:protein domain specific binding; F:Rho GDP-dissociation inhibitor binding; F:semaphorin receptor activity;, P:cell chemotaxis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:negative regulation of cell migration; P:negative regulation of GTPase activity; P:negative regulation of lamellipodium assembly; P:positive chemotaxis; P:positive regulation of axonogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of neuron projection development; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|Q9UPE1 Q13583 Q4F970 Q562F5 Q9UM62,SRSF protein kinase 3,Muscle-specific serine kinase 1;Serine/arginine-rich protein-specific kinase 3;Serine/threonine-protein kinase 23;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0030154;GO:0035556;GO:0007517;GO:0060537;GO:0010468;GO:0050684;GO:0000245;, C:cytoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:intracellular signal transduction; P:muscle organ development; P:muscle tissue development; P:regulation of gene expression; P:regulation of mRNA processing; P:spliceosomal complex assembly;|Q9UPE1 Q13583 Q4F970 Q562F5 Q9UM62,SRSF protein kinase 3,Muscle-specific serine kinase 1;Serine/arginine-rich protein-specific kinase 3;Serine/threonine-protein kinase 23;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0030154;GO:0035556;GO:0007517;GO:0060537;GO:0010468;GO:0050684;GO:0000245;, C:cytoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:intracellular signal transduction; P:muscle organ development; P:muscle tissue development; P:regulation of gene expression; P:regulation of mRNA processing; P:spliceosomal complex assembly;|Q9UPE1 Q13583 Q4F970 Q562F5 Q9UM62,SRSF protein kinase 3,Muscle-specific serine kinase 1;Serine/arginine-rich protein-specific kinase 3;Serine/threonine-protein kinase 23;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0030154;GO:0035556;GO:0007517;GO:0060537;GO:0010468;GO:0050684;GO:0000245;, C:cytoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:intracellular signal transduction; P:muscle organ development; P:muscle tissue development; P:regulation of gene expression; P:regulation of mRNA processing; P:spliceosomal complex assembly;|Q9UPE1 Q13583 Q4F970 Q562F5 Q9UM62,SRSF protein kinase 3,Muscle-specific serine kinase 1;Serine/arginine-rich protein-specific kinase 3;Serine/threonine-protein kinase 23;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0030154;GO:0035556;GO:0007517;GO:0060537;GO:0010468;GO:0050684;GO:0000245;, C:cytoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:intracellular signal transduction; P:muscle organ development; P:muscle tissue development; P:regulation of gene expression; P:regulation of mRNA processing; P:spliceosomal complex assembly;|Q9UPE1 Q13583 Q4F970 Q562F5 Q9UM62,SRSF protein kinase 3,Muscle-specific serine kinase 1;Serine/arginine-rich protein-specific kinase 3;Serine/threonine-protein kinase 23;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0030154;GO:0035556;GO:0007517;GO:0060537;GO:0010468;GO:0050684;GO:0000245;, C:cytoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:cell differentiation; P:intracellular signal transduction; P:muscle organ development; P:muscle tissue development; P:regulation of gene expression; P:regulation of mRNA processing; P:spliceosomal complex assembly; scaffold238 indexed_genome mRNA 110640 123556 . - . ID=transcript_16161;P51553 E9PDD5 Q9BUU5,Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial,Isocitric dehydrogenase subunit gamma;NAD(+)-specific ICDH subunit gamma;, PF00180;, GO:0005759;GO:0005739;GO:0005730;GO:0005524;GO:0004449;GO:0000287;GO:0051287;GO:0005975;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:ATP binding; F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:carbohydrate metabolic process; P:isocitrate metabolic process; P:tricarboxylic acid cycle;|P51553 E9PDD5 Q9BUU5,Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial,Isocitric dehydrogenase subunit gamma;NAD(+)-specific ICDH subunit gamma;, PF00180;, GO:0005759;GO:0005739;GO:0005730;GO:0005524;GO:0004449;GO:0000287;GO:0051287;GO:0005975;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:ATP binding; F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:carbohydrate metabolic process; P:isocitrate metabolic process; P:tricarboxylic acid cycle;|P51553 E9PDD5 Q9BUU5,Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial,Isocitric dehydrogenase subunit gamma;NAD(+)-specific ICDH subunit gamma;, PF00180;, GO:0005759;GO:0005739;GO:0005730;GO:0005524;GO:0004449;GO:0000287;GO:0051287;GO:0005975;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:ATP binding; F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:carbohydrate metabolic process; P:isocitrate metabolic process; P:tricarboxylic acid cycle;|P51553 E9PDD5 Q9BUU5,Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial,Isocitric dehydrogenase subunit gamma;NAD(+)-specific ICDH subunit gamma;, PF00180;, GO:0005759;GO:0005739;GO:0005730;GO:0005524;GO:0004449;GO:0000287;GO:0051287;GO:0005975;GO:0006102;GO:0006099;, C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:ATP binding; F:isocitrate dehydrogenase (NAD+) activity; F:magnesium ion binding; F:NAD binding;, P:carbohydrate metabolic process; P:isocitrate metabolic process; P:tricarboxylic acid cycle; scaffold238 indexed_genome mRNA 126448 130127 . - . ID=transcript_16162;Q76G19 B3KXB1 B7ZKY3 Q8NB75 Q9BUH9 Q9P284,PDZ domain-containing protein 4,PDZ domain-containing RING finger protein 4-like protein;, PF00595;, GO:0005938;, C:cell cortex; scaffold238 indexed_genome mRNA 183462 206630 . - . ID=transcript_16163;P32004 A0AV65 A4ZYW4 B2RMU7 G3XAF4 Q8TA87,Neural cell adhesion molecule L1,, PF13882;PF00041;PF07679;, GO:0030424;GO:0044295;GO:0009986;GO:0062023;GO:0030425;GO:0005925;GO:0016021;GO:0043025;GO:0005886;GO:0008046;GO:0019904;GO:0061564;GO:0007411;GO:0007155;GO:0016477;GO:0007160;GO:0006935;GO:0007156;GO:0050900;GO:0007399;GO:0031175;GO:0045773;GO:0050808;, C:axon; C:axonal growth cone; C:cell surface; C:collagen-containing extracellular matrix; C:dendrite; C:focal adhesion; C:integral component of membrane; C:neuronal cell body; C:plasma membrane;, F:axon guidance receptor activity; F:protein domain specific binding;, P:axon development; P:axon guidance; P:cell adhesion; P:cell migration; P:cell-matrix adhesion; P:chemotaxis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte migration; P:nervous system development; P:neuron projection development; P:positive regulation of axon extension; P:synapse organization;|P32004 A0AV65 A4ZYW4 B2RMU7 G3XAF4 Q8TA87,Neural cell adhesion molecule L1,, PF13882;PF00041;PF07679;, GO:0030424;GO:0044295;GO:0009986;GO:0062023;GO:0030425;GO:0005925;GO:0016021;GO:0043025;GO:0005886;GO:0008046;GO:0019904;GO:0061564;GO:0007411;GO:0007155;GO:0016477;GO:0007160;GO:0006935;GO:0007156;GO:0050900;GO:0007399;GO:0031175;GO:0045773;GO:0050808;, C:axon; C:axonal growth cone; C:cell surface; C:collagen-containing extracellular matrix; C:dendrite; C:focal adhesion; C:integral component of membrane; C:neuronal cell body; C:plasma membrane;, F:axon guidance receptor activity; F:protein domain specific binding;, P:axon development; P:axon guidance; P:cell adhesion; P:cell migration; P:cell-matrix adhesion; P:chemotaxis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte migration; P:nervous system development; P:neuron projection development; P:positive regulation of axon extension; P:synapse organization;|P32004 A0AV65 A4ZYW4 B2RMU7 G3XAF4 Q8TA87,Neural cell adhesion molecule L1,, PF13882;PF00041;PF07679;, GO:0030424;GO:0044295;GO:0009986;GO:0062023;GO:0030425;GO:0005925;GO:0016021;GO:0043025;GO:0005886;GO:0008046;GO:0019904;GO:0061564;GO:0007411;GO:0007155;GO:0016477;GO:0007160;GO:0006935;GO:0007156;GO:0050900;GO:0007399;GO:0031175;GO:0045773;GO:0050808;, C:axon; C:axonal growth cone; C:cell surface; C:collagen-containing extracellular matrix; C:dendrite; C:focal adhesion; C:integral component of membrane; C:neuronal cell body; C:plasma membrane;, F:axon guidance receptor activity; F:protein domain specific binding;, P:axon development; P:axon guidance; P:cell adhesion; P:cell migration; P:cell-matrix adhesion; P:chemotaxis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte migration; P:nervous system development; P:neuron projection development; P:positive regulation of axon extension; P:synapse organization;|P32004 A0AV65 A4ZYW4 B2RMU7 G3XAF4 Q8TA87,Neural cell adhesion molecule L1,, PF13882;PF00041;PF07679;, GO:0030424;GO:0044295;GO:0009986;GO:0062023;GO:0030425;GO:0005925;GO:0016021;GO:0043025;GO:0005886;GO:0008046;GO:0019904;GO:0061564;GO:0007411;GO:0007155;GO:0016477;GO:0007160;GO:0006935;GO:0007156;GO:0050900;GO:0007399;GO:0031175;GO:0045773;GO:0050808;, C:axon; C:axonal growth cone; C:cell surface; C:collagen-containing extracellular matrix; C:dendrite; C:focal adhesion; C:integral component of membrane; C:neuronal cell body; C:plasma membrane;, F:axon guidance receptor activity; F:protein domain specific binding;, P:axon development; P:axon guidance; P:cell adhesion; P:cell migration; P:cell-matrix adhesion; P:chemotaxis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:leukocyte migration; P:nervous system development; P:neuron projection development; P:positive regulation of axon extension; P:synapse organization; scaffold238 indexed_genome mRNA 228826 243296 . + . ID=transcript_16164;P30518 C5HF20 O43192 Q3MJD3 Q9UCV9,Vasopressin V2 receptor,AVPR V2;Antidiuretic hormone receptor;Renal-type arginine vasopressin receptor;, PF00001;, GO:0030669;GO:0030139;GO:0005783;GO:0005768;GO:0005794;GO:0016021;GO:0005887;GO:0048471;GO:0005886;GO:0004930;GO:0042277;GO:0005000;GO:0007190;GO:0007188;GO:0007588;GO:0007186;GO:0007599;GO:0061024;GO:0008285;GO:0002862;GO:0010628;GO:0045907;GO:0001992;GO:0003091;, C:clathrin-coated endocytic vesicle membrane; C:endocytic vesicle; C:endoplasmic reticulum; C:endosome; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:G protein-coupled receptor activity; F:peptide binding; F:vasopressin receptor activity;, P:activation of adenylate cyclase activity; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:excretion; P:G protein-coupled receptor signaling pathway; P:hemostasis; P:membrane organization; P:negative regulation of cell population proliferation; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of gene expression; P:positive regulation of vasoconstriction; P:regulation of systemic arterial blood pressure by vasopressin; P:renal water homeostasis;|P98171 Q14144 Q86UY3,Rho GTPase-activating protein 4 {ECO:0000305},Rho-GAP hematopoietic protein C1;Rho-type GTPase-activating protein 4;p115;, PF00611;PF00620;PF14604;, GO:0005737;GO:0005829;GO:0005794;GO:0030426;GO:0005874;GO:0005096;GO:0042802;GO:0007010;GO:0030517;GO:0030336;GO:0010764;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:growth cone; C:microtubule;, F:GTPase activator activity; F:identical protein binding;, P:cytoskeleton organization; P:negative regulation of axon extension; P:negative regulation of cell migration; P:negative regulation of fibroblast migration; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|P98171 Q14144 Q86UY3,Rho GTPase-activating protein 4 {ECO:0000305},Rho-GAP hematopoietic protein C1;Rho-type GTPase-activating protein 4;p115;, PF00611;PF00620;PF14604;, GO:0005737;GO:0005829;GO:0005794;GO:0030426;GO:0005874;GO:0005096;GO:0042802;GO:0007010;GO:0030517;GO:0030336;GO:0010764;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:growth cone; C:microtubule;, F:GTPase activator activity; F:identical protein binding;, P:cytoskeleton organization; P:negative regulation of axon extension; P:negative regulation of cell migration; P:negative regulation of fibroblast migration; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|P98171 Q14144 Q86UY3,Rho GTPase-activating protein 4 {ECO:0000305},Rho-GAP hematopoietic protein C1;Rho-type GTPase-activating protein 4;p115;, PF00611;PF00620;PF14604;, GO:0005737;GO:0005829;GO:0005794;GO:0030426;GO:0005874;GO:0005096;GO:0042802;GO:0007010;GO:0030517;GO:0030336;GO:0010764;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:growth cone; C:microtubule;, F:GTPase activator activity; F:identical protein binding;, P:cytoskeleton organization; P:negative regulation of axon extension; P:negative regulation of cell migration; P:negative regulation of fibroblast migration; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|P98171 Q14144 Q86UY3,Rho GTPase-activating protein 4 {ECO:0000305},Rho-GAP hematopoietic protein C1;Rho-type GTPase-activating protein 4;p115;, PF00611;PF00620;PF14604;, GO:0005737;GO:0005829;GO:0005794;GO:0030426;GO:0005874;GO:0005096;GO:0042802;GO:0007010;GO:0030517;GO:0030336;GO:0010764;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:growth cone; C:microtubule;, F:GTPase activator activity; F:identical protein binding;, P:cytoskeleton organization; P:negative regulation of axon extension; P:negative regulation of cell migration; P:negative regulation of fibroblast migration; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|P98171 Q14144 Q86UY3,Rho GTPase-activating protein 4 {ECO:0000305},Rho-GAP hematopoietic protein C1;Rho-type GTPase-activating protein 4;p115;, PF00611;PF00620;PF14604;, GO:0005737;GO:0005829;GO:0005794;GO:0030426;GO:0005874;GO:0005096;GO:0042802;GO:0007010;GO:0030517;GO:0030336;GO:0010764;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:growth cone; C:microtubule;, F:GTPase activator activity; F:identical protein binding;, P:cytoskeleton organization; P:negative regulation of axon extension; P:negative regulation of cell migration; P:negative regulation of fibroblast migration; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction;|P98171 Q14144 Q86UY3,Rho GTPase-activating protein 4 {ECO:0000305},Rho-GAP hematopoietic protein C1;Rho-type GTPase-activating protein 4;p115;, PF00611;PF00620;PF14604;, GO:0005737;GO:0005829;GO:0005794;GO:0030426;GO:0005874;GO:0005096;GO:0042802;GO:0007010;GO:0030517;GO:0030336;GO:0010764;GO:0051056;GO:0007266;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:growth cone; C:microtubule;, F:GTPase activator activity; F:identical protein binding;, P:cytoskeleton organization; P:negative regulation of axon extension; P:negative regulation of cell migration; P:negative regulation of fibroblast migration; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold238 indexed_genome mRNA 250483 255505 . - . ID=transcript_16165;P41227 A6NM98,N-alpha-acetyltransferase 10,N-terminal acetyltransferase complex ARD1 subunit homolog A;NatA catalytic subunit Naa10;, PF00583;, GO:0005737;GO:0005829;GO:0016020;GO:0031415;GO:0005730;GO:0005634;GO:0008080;GO:0004596;GO:1990190;GO:1990189;GO:0006323;GO:0006475;GO:0018002;GO:0017198;GO:0006474;GO:2000719;GO:0006473;, C:cytoplasm; C:cytosol; C:membrane; C:NatA complex; C:nucleolus; C:nucleus;, F:N-acetyltransferase activity; F:peptide alpha-N-acetyltransferase activity; F:peptide-glutamate-N-acetyltransferase activity; F:peptide-serine-N-acetyltransferase activity;, P:DNA packaging; P:internal protein amino acid acetylation; P:N-terminal peptidyl-glutamic acid acetylation; P:N-terminal peptidyl-serine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric; P:protein acetylation;|P41227 A6NM98,N-alpha-acetyltransferase 10,N-terminal acetyltransferase complex ARD1 subunit homolog A;NatA catalytic subunit Naa10;, PF00583;, GO:0005737;GO:0005829;GO:0016020;GO:0031415;GO:0005730;GO:0005634;GO:0008080;GO:0004596;GO:1990190;GO:1990189;GO:0006323;GO:0006475;GO:0018002;GO:0017198;GO:0006474;GO:2000719;GO:0006473;, C:cytoplasm; C:cytosol; C:membrane; C:NatA complex; C:nucleolus; C:nucleus;, F:N-acetyltransferase activity; F:peptide alpha-N-acetyltransferase activity; F:peptide-glutamate-N-acetyltransferase activity; F:peptide-serine-N-acetyltransferase activity;, P:DNA packaging; P:internal protein amino acid acetylation; P:N-terminal peptidyl-glutamic acid acetylation; P:N-terminal peptidyl-serine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric; P:protein acetylation;|P41227 A6NM98,N-alpha-acetyltransferase 10,N-terminal acetyltransferase complex ARD1 subunit homolog A;NatA catalytic subunit Naa10;, PF00583;, GO:0005737;GO:0005829;GO:0016020;GO:0031415;GO:0005730;GO:0005634;GO:0008080;GO:0004596;GO:1990190;GO:1990189;GO:0006323;GO:0006475;GO:0018002;GO:0017198;GO:0006474;GO:2000719;GO:0006473;, C:cytoplasm; C:cytosol; C:membrane; C:NatA complex; C:nucleolus; C:nucleus;, F:N-acetyltransferase activity; F:peptide alpha-N-acetyltransferase activity; F:peptide-glutamate-N-acetyltransferase activity; F:peptide-serine-N-acetyltransferase activity;, P:DNA packaging; P:internal protein amino acid acetylation; P:N-terminal peptidyl-glutamic acid acetylation; P:N-terminal peptidyl-serine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric; P:protein acetylation;|P41227 A6NM98,N-alpha-acetyltransferase 10,N-terminal acetyltransferase complex ARD1 subunit homolog A;NatA catalytic subunit Naa10;, PF00583;, GO:0005737;GO:0005829;GO:0016020;GO:0031415;GO:0005730;GO:0005634;GO:0008080;GO:0004596;GO:1990190;GO:1990189;GO:0006323;GO:0006475;GO:0018002;GO:0017198;GO:0006474;GO:2000719;GO:0006473;, C:cytoplasm; C:cytosol; C:membrane; C:NatA complex; C:nucleolus; C:nucleus;, F:N-acetyltransferase activity; F:peptide alpha-N-acetyltransferase activity; F:peptide-glutamate-N-acetyltransferase activity; F:peptide-serine-N-acetyltransferase activity;, P:DNA packaging; P:internal protein amino acid acetylation; P:N-terminal peptidyl-glutamic acid acetylation; P:N-terminal peptidyl-serine acetylation; P:N-terminal protein amino acid acetylation; P:negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric; P:protein acetylation; scaffold238 indexed_genome mRNA 255977 263089 . - . ID=transcript_16166;P51606 B4DNZ3 Q96BI6,N-acylglucosamine 2-epimerase,GlcNAc 2-epimerase;N-acetyl-D-glucosamine 2-epimerase;Renin-binding protein;, , GO:0005829;GO:0070062;GO:0005524;GO:0004866;GO:0042802;GO:0050121;GO:0030414;GO:0005975;GO:0006044;GO:0006051;GO:0019262;GO:0008217;GO:0006048;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:endopeptidase inhibitor activity; F:identical protein binding; F:N-acylglucosamine 2-epimerase activity; F:peptidase inhibitor activity;, P:carbohydrate metabolic process; P:N-acetylglucosamine metabolic process; P:N-acetylmannosamine metabolic process; P:N-acetylneuraminate catabolic process; P:regulation of blood pressure; P:UDP-N-acetylglucosamine biosynthetic process;|P51606 B4DNZ3 Q96BI6,N-acylglucosamine 2-epimerase,GlcNAc 2-epimerase;N-acetyl-D-glucosamine 2-epimerase;Renin-binding protein;, , GO:0005829;GO:0070062;GO:0005524;GO:0004866;GO:0042802;GO:0050121;GO:0030414;GO:0005975;GO:0006044;GO:0006051;GO:0019262;GO:0008217;GO:0006048;, C:cytosol; C:extracellular exosome;, F:ATP binding; F:endopeptidase inhibitor activity; F:identical protein binding; F:N-acylglucosamine 2-epimerase activity; F:peptidase inhibitor activity;, P:carbohydrate metabolic process; P:N-acetylglucosamine metabolic process; P:N-acetylmannosamine metabolic process; P:N-acetylneuraminate catabolic process; P:regulation of blood pressure; P:UDP-N-acetylglucosamine biosynthetic process; scaffold238 indexed_genome mRNA 267759 288639 . + . ID=transcript_16167;P51610 Q6P4G5,Host cell factor 1,C1 factor;CFF;VCAF;VP16 accessory protein;, PF01344;, GO:0005737;GO:0000123;GO:0035097;GO:0016020;GO:0071339;GO:0043025;GO:0005654;GO:0005634;GO:0032991;GO:0048188;GO:0033613;GO:0045296;GO:0003682;GO:0042802;GO:0030674;GO:0003713;GO:0007049;GO:0006338;GO:0043984;GO:0043981;GO:0043982;GO:0007005;GO:0000122;GO:0045787;GO:0010628;GO:0045944;GO:0045893;GO:0016579;GO:0050821;GO:0043254;GO:0006355;GO:0019046;, C:cytoplasm; C:histone acetyltransferase complex; C:histone methyltransferase complex; C:membrane; C:MLL1 complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:Set1C/COMPASS complex;, F:activating transcription factor binding; F:cadherin binding; F:chromatin binding; F:identical protein binding; F:protein-macromolecule adaptor activity; F:transcription coactivator activity;, P:cell cycle; P:chromatin remodeling; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:mitochondrion organization; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:protein stabilization; P:regulation of protein-containing complex assembly; P:regulation of transcription, DNA-templated; P:release from viral latency;|P51610 Q6P4G5,Host cell factor 1,C1 factor;CFF;VCAF;VP16 accessory protein;, PF01344;, GO:0005737;GO:0000123;GO:0035097;GO:0016020;GO:0071339;GO:0043025;GO:0005654;GO:0005634;GO:0032991;GO:0048188;GO:0033613;GO:0045296;GO:0003682;GO:0042802;GO:0030674;GO:0003713;GO:0007049;GO:0006338;GO:0043984;GO:0043981;GO:0043982;GO:0007005;GO:0000122;GO:0045787;GO:0010628;GO:0045944;GO:0045893;GO:0016579;GO:0050821;GO:0043254;GO:0006355;GO:0019046;, C:cytoplasm; C:histone acetyltransferase complex; C:histone methyltransferase complex; C:membrane; C:MLL1 complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:Set1C/COMPASS complex;, F:activating transcription factor binding; F:cadherin binding; F:chromatin binding; F:identical protein binding; F:protein-macromolecule adaptor activity; F:transcription coactivator activity;, P:cell cycle; P:chromatin remodeling; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:mitochondrion organization; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:protein stabilization; P:regulation of protein-containing complex assembly; P:regulation of transcription, DNA-templated; P:release from viral latency;|P51610 Q6P4G5,Host cell factor 1,C1 factor;CFF;VCAF;VP16 accessory protein;, PF01344;, GO:0005737;GO:0000123;GO:0035097;GO:0016020;GO:0071339;GO:0043025;GO:0005654;GO:0005634;GO:0032991;GO:0048188;GO:0033613;GO:0045296;GO:0003682;GO:0042802;GO:0030674;GO:0003713;GO:0007049;GO:0006338;GO:0043984;GO:0043981;GO:0043982;GO:0007005;GO:0000122;GO:0045787;GO:0010628;GO:0045944;GO:0045893;GO:0016579;GO:0050821;GO:0043254;GO:0006355;GO:0019046;, C:cytoplasm; C:histone acetyltransferase complex; C:histone methyltransferase complex; C:membrane; C:MLL1 complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:Set1C/COMPASS complex;, F:activating transcription factor binding; F:cadherin binding; F:chromatin binding; F:identical protein binding; F:protein-macromolecule adaptor activity; F:transcription coactivator activity;, P:cell cycle; P:chromatin remodeling; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:mitochondrion organization; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:protein stabilization; P:regulation of protein-containing complex assembly; P:regulation of transcription, DNA-templated; P:release from viral latency;|P51610 Q6P4G5,Host cell factor 1,C1 factor;CFF;VCAF;VP16 accessory protein;, PF01344;, GO:0005737;GO:0000123;GO:0035097;GO:0016020;GO:0071339;GO:0043025;GO:0005654;GO:0005634;GO:0032991;GO:0048188;GO:0033613;GO:0045296;GO:0003682;GO:0042802;GO:0030674;GO:0003713;GO:0007049;GO:0006338;GO:0043984;GO:0043981;GO:0043982;GO:0007005;GO:0000122;GO:0045787;GO:0010628;GO:0045944;GO:0045893;GO:0016579;GO:0050821;GO:0043254;GO:0006355;GO:0019046;, C:cytoplasm; C:histone acetyltransferase complex; C:histone methyltransferase complex; C:membrane; C:MLL1 complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:Set1C/COMPASS complex;, F:activating transcription factor binding; F:cadherin binding; F:chromatin binding; F:identical protein binding; F:protein-macromolecule adaptor activity; F:transcription coactivator activity;, P:cell cycle; P:chromatin remodeling; P:histone H4-K16 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:mitochondrion organization; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell cycle; P:positive regulation of gene expression; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein deubiquitination; P:protein stabilization; P:regulation of protein-containing complex assembly; P:regulation of transcription, DNA-templated; P:release from viral latency; scaffold238 indexed_genome mRNA 289575 294429 . + . ID=transcript_16168;Q14656 B2RC47 Q6IAV7,Transmembrane protein 187,Protein ITBA1;, PF15100;, GO:0016021;GO:0030133;, C:integral component of membrane; C:transport vesicle; scaffold238 indexed_genome mRNA 316131 323661 . - . ID=transcript_16169;P51617 D3DWW3 D3DWW4 Q7Z5V4 Q96C06 Q96RL2,Interleukin-1 receptor-associated kinase 1,, PF00531;PF00069;, GO:0005737;GO:0005829;GO:0010008;GO:0005811;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005524;GO:0031072;GO:0042802;GO:0016301;GO:0004704;GO:0046982;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000187;GO:0007250;GO:0007568;GO:0034605;GO:0071456;GO:0071222;GO:0019221;GO:0045087;GO:0070498;GO:0035556;GO:0007254;GO:0031663;GO:0002755;GO:0043066;GO:0032088;GO:0070423;GO:0043123;GO:1904996;GO:0043406;GO:0051092;GO:1901224;GO:0048661;GO:0032481;GO:0046777;GO:0006468;GO:0001959;GO:0070555;GO:0032496;GO:0034134;GO:0034142;GO:0034162;GO:0002224;GO:0060337;GO:0016032;, C:cytoplasm; C:cytosol; C:endosome membrane; C:lipid droplet; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:ATP binding; F:heat shock protein binding; F:identical protein binding; F:kinase activity; F:NF-kappaB-inducing kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:activation of NF-kappaB-inducing kinase activity; P:aging; P:cellular response to heat; P:cellular response to hypoxia; P:cellular response to lipopolysaccharide; P:cytokine-mediated signaling pathway; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:lipopolysaccharide-mediated signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of MAP kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of type I interferon production; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cytokine-mediated signaling pathway; P:response to interleukin-1; P:response to lipopolysaccharide; P:toll-like receptor 2 signaling pathway; P:toll-like receptor 4 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; P:type I interferon signaling pathway; P:viral process;|P51617 D3DWW3 D3DWW4 Q7Z5V4 Q96C06 Q96RL2,Interleukin-1 receptor-associated kinase 1,, PF00531;PF00069;, GO:0005737;GO:0005829;GO:0010008;GO:0005811;GO:0005654;GO:0005634;GO:0005886;GO:0032991;GO:0005524;GO:0031072;GO:0042802;GO:0016301;GO:0004704;GO:0046982;GO:0042803;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0000187;GO:0007250;GO:0007568;GO:0034605;GO:0071456;GO:0071222;GO:0019221;GO:0045087;GO:0070498;GO:0035556;GO:0007254;GO:0031663;GO:0002755;GO:0043066;GO:0032088;GO:0070423;GO:0043123;GO:1904996;GO:0043406;GO:0051092;GO:1901224;GO:0048661;GO:0032481;GO:0046777;GO:0006468;GO:0001959;GO:0070555;GO:0032496;GO:0034134;GO:0034142;GO:0034162;GO:0002224;GO:0060337;GO:0016032;, C:cytoplasm; C:cytosol; C:endosome membrane; C:lipid droplet; C:nucleoplasm; C:nucleus; C:plasma membrane; C:protein-containing complex;, F:ATP binding; F:heat shock protein binding; F:identical protein binding; F:kinase activity; F:NF-kappaB-inducing kinase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:activation of NF-kappaB-inducing kinase activity; P:aging; P:cellular response to heat; P:cellular response to hypoxia; P:cellular response to lipopolysaccharide; P:cytokine-mediated signaling pathway; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:lipopolysaccharide-mediated signaling pathway; P:MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of apoptotic process; P:negative regulation of NF-kappaB transcription factor activity; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of MAP kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of type I interferon production; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cytokine-mediated signaling pathway; P:response to interleukin-1; P:response to lipopolysaccharide; P:toll-like receptor 2 signaling pathway; P:toll-like receptor 4 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; P:type I interferon signaling pathway; P:viral process; scaffold238 indexed_genome mRNA 334857 386278 . + . ID=transcript_16170;P51608 O15233 Q6QHH9 Q7Z384,Methyl-CpG-binding protein 2,, PF01429;, GO:0005813;GO:0005829;GO:0005615;GO:0000792;GO:0005654;GO:0005634;GO:0098794;GO:0003682;GO:0003677;GO:0003700;GO:0010385;GO:0008327;GO:0003729;GO:1990841;GO:0019904;GO:0047485;GO:0003723;GO:0035197;GO:0003714;GO:0008134;GO:0008344;GO:0001662;GO:0032048;GO:0006576;GO:0021549;GO:0006342;GO:0016358;GO:0060079;GO:0008211;GO:0006541;GO:0016573;GO:0016571;GO:0006020;GO:0007616;GO:0060291;GO:0007052;GO:0016525;GO:0043537;GO:0010629;GO:0043524;GO:0051151;GO:0000122;GO:2000820;GO:0045892;GO:0001976;GO:0042551;GO:0046470;GO:0008284;GO:1905643;GO:0010971;GO:1900114;GO:0090063;GO:0045944;GO:0009791;GO:0019230;GO:0008104;GO:0006349;GO:0002087;GO:0060260;GO:0007585;GO:0001666;GO:0051707;GO:0019233;GO:0035176;GO:0001964;GO:0007416;GO:0021591;GO:0008542;, C:centrosome; C:cytosol; C:extracellular space; C:heterochromatin; C:nucleoplasm; C:nucleus; C:postsynapse;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:double-stranded methylated DNA binding; F:methyl-CpG binding; F:mRNA binding; F:promoter-specific chromatin binding; F:protein domain specific binding; F:protein N-terminus binding; F:RNA binding; F:siRNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:adult locomotory behavior; P:behavioral fear response; P:cardiolipin metabolic process; P:cellular biogenic amine metabolic process; P:cerebellum development; P:chromatin silencing; P:dendrite development; P:excitatory postsynaptic potential; P:glucocorticoid metabolic process; P:glutamine metabolic process; P:histone acetylation; P:histone methylation; P:inositol metabolic process; P:long-term memory; P:long-term synaptic potentiation; P:mitotic spindle organization; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of smooth muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; P:negative regulation of transcription, DNA-templated; P:nervous system process involved in regulation of systemic arterial blood pressure; P:neuron maturation; P:phosphatidylcholine metabolic process; P:positive regulation of cell population proliferation; P:positive regulation of DNA methylation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of histone H3-K9 trimethylation; P:positive regulation of microtubule nucleation; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:proprioception; P:protein localization; P:regulation of gene expression by genetic imprinting; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription initiation from RNA polymerase II promoter; P:respiratory gaseous exchange by respiratory system; P:response to hypoxia; P:response to other organism; P:sensory perception of pain; P:social behavior; P:startle response; P:synapse assembly; P:ventricular system development; P:visual learning;|P51608 O15233 Q6QHH9 Q7Z384,Methyl-CpG-binding protein 2,, PF01429;, GO:0005813;GO:0005829;GO:0005615;GO:0000792;GO:0005654;GO:0005634;GO:0098794;GO:0003682;GO:0003677;GO:0003700;GO:0010385;GO:0008327;GO:0003729;GO:1990841;GO:0019904;GO:0047485;GO:0003723;GO:0035197;GO:0003714;GO:0008134;GO:0008344;GO:0001662;GO:0032048;GO:0006576;GO:0021549;GO:0006342;GO:0016358;GO:0060079;GO:0008211;GO:0006541;GO:0016573;GO:0016571;GO:0006020;GO:0007616;GO:0060291;GO:0007052;GO:0016525;GO:0043537;GO:0010629;GO:0043524;GO:0051151;GO:0000122;GO:2000820;GO:0045892;GO:0001976;GO:0042551;GO:0046470;GO:0008284;GO:1905643;GO:0010971;GO:1900114;GO:0090063;GO:0045944;GO:0009791;GO:0019230;GO:0008104;GO:0006349;GO:0002087;GO:0060260;GO:0007585;GO:0001666;GO:0051707;GO:0019233;GO:0035176;GO:0001964;GO:0007416;GO:0021591;GO:0008542;, C:centrosome; C:cytosol; C:extracellular space; C:heterochromatin; C:nucleoplasm; C:nucleus; C:postsynapse;, F:chromatin binding; F:DNA binding; F:DNA-binding transcription factor activity; F:double-stranded methylated DNA binding; F:methyl-CpG binding; F:mRNA binding; F:promoter-specific chromatin binding; F:protein domain specific binding; F:protein N-terminus binding; F:RNA binding; F:siRNA binding; F:transcription corepressor activity; F:transcription factor binding;, P:adult locomotory behavior; P:behavioral fear response; P:cardiolipin metabolic process; P:cellular biogenic amine metabolic process; P:cerebellum development; P:chromatin silencing; P:dendrite development; P:excitatory postsynaptic potential; P:glucocorticoid metabolic process; P:glutamine metabolic process; P:histone acetylation; P:histone methylation; P:inositol metabolic process; P:long-term memory; P:long-term synaptic potentiation; P:mitotic spindle organization; P:negative regulation of angiogenesis; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of smooth muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; P:negative regulation of transcription, DNA-templated; P:nervous system process involved in regulation of systemic arterial blood pressure; P:neuron maturation; P:phosphatidylcholine metabolic process; P:positive regulation of cell population proliferation; P:positive regulation of DNA methylation; P:positive regulation of G2/M transition of mitotic cell cycle; P:positive regulation of histone H3-K9 trimethylation; P:positive regulation of microtubule nucleation; P:positive regulation of transcription by RNA polymerase II; P:post-embryonic development; P:proprioception; P:protein localization; P:regulation of gene expression by genetic imprinting; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription initiation from RNA polymerase II promoter; P:respiratory gaseous exchange by respiratory system; P:response to hypoxia; P:response to other organism; P:sensory perception of pain; P:social behavior; P:startle response; P:synapse assembly; P:ventricular system development; P:visual learning; scaffold239 indexed_genome mRNA 632 6786 . + . ID=transcript_16171;Q9H4A4 Q9BVM9 Q9H1D4 Q9NPT7,Aminopeptidase B,Arginine aminopeptidase;Arginyl aminopeptidase;, PF09127;PF01433;, GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004177;GO:0004301;GO:0070006;GO:0008235;GO:0008270;GO:0006508;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:aminopeptidase activity; F:epoxide hydrolase activity; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9H4A4 Q9BVM9 Q9H1D4 Q9NPT7,Aminopeptidase B,Arginine aminopeptidase;Arginyl aminopeptidase;, PF09127;PF01433;, GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004177;GO:0004301;GO:0070006;GO:0008235;GO:0008270;GO:0006508;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:aminopeptidase activity; F:epoxide hydrolase activity; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:zinc ion binding;, P:proteolysis;|Q9H4A4 Q9BVM9 Q9H1D4 Q9NPT7,Aminopeptidase B,Arginine aminopeptidase;Arginyl aminopeptidase;, PF09127;PF01433;, GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004177;GO:0004301;GO:0070006;GO:0008235;GO:0008270;GO:0006508;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:aminopeptidase activity; F:epoxide hydrolase activity; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:zinc ion binding;, P:proteolysis; scaffold239 indexed_genome mRNA 7240 8602 . - . ID=transcript_16172;Q9H4A4 Q9BVM9 Q9H1D4 Q9NPT7,Aminopeptidase B,Arginine aminopeptidase;Arginyl aminopeptidase;, PF09127;PF01433;, GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004177;GO:0004301;GO:0070006;GO:0008235;GO:0008270;GO:0006508;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:aminopeptidase activity; F:epoxide hydrolase activity; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:zinc ion binding;, P:proteolysis; scaffold239 indexed_genome mRNA 8928 9992 . + . ID=transcript_16173;Q9H4A4 Q9BVM9 Q9H1D4 Q9NPT7,Aminopeptidase B,Arginine aminopeptidase;Arginyl aminopeptidase;, PF09127;PF01433;, GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0004177;GO:0004301;GO:0070006;GO:0008235;GO:0008270;GO:0006508;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane;, F:aminopeptidase activity; F:epoxide hydrolase activity; F:metalloaminopeptidase activity; F:metalloexopeptidase activity; F:zinc ion binding;, P:proteolysis; scaffold239 indexed_genome mRNA 21963 29550 . - . ID=transcript_16174;Q99595 B2RDM5 Q9BWF5,Mitochondrial import inner membrane translocase subunit Tim17-A,Inner membrane preprotein translocase Tim17a;, , GO:0031305;GO:0005743;GO:0005739;GO:0005654;GO:0005744;GO:0008320;GO:0010954;GO:0030150;GO:0006626;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:TIM23 mitochondrial import inner membrane translocase complex;, F:protein transmembrane transporter activity;, P:positive regulation of protein processing; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion;|Q99595 B2RDM5 Q9BWF5,Mitochondrial import inner membrane translocase subunit Tim17-A,Inner membrane preprotein translocase Tim17a;, , GO:0031305;GO:0005743;GO:0005739;GO:0005654;GO:0005744;GO:0008320;GO:0010954;GO:0030150;GO:0006626;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:TIM23 mitochondrial import inner membrane translocase complex;, F:protein transmembrane transporter activity;, P:positive regulation of protein processing; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion;|Q99595 B2RDM5 Q9BWF5,Mitochondrial import inner membrane translocase subunit Tim17-A,Inner membrane preprotein translocase Tim17a;, , GO:0031305;GO:0005743;GO:0005739;GO:0005654;GO:0005744;GO:0008320;GO:0010954;GO:0030150;GO:0006626;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:TIM23 mitochondrial import inner membrane translocase complex;, F:protein transmembrane transporter activity;, P:positive regulation of protein processing; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion;|Q99595 B2RDM5 Q9BWF5,Mitochondrial import inner membrane translocase subunit Tim17-A,Inner membrane preprotein translocase Tim17a;, , GO:0031305;GO:0005743;GO:0005739;GO:0005654;GO:0005744;GO:0008320;GO:0010954;GO:0030150;GO:0006626;, C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleoplasm; C:TIM23 mitochondrial import inner membrane translocase complex;, F:protein transmembrane transporter activity;, P:positive regulation of protein processing; P:protein import into mitochondrial matrix; P:protein targeting to mitochondrion; scaffold239 indexed_genome mRNA 84100 100753 . - . ID=transcript_16175;Q96P70 B1ASV5 Q8N1Y1 Q8N3I2 Q8NCG9 Q96SU6 Q9NW01 Q9P0A8 Q9ULM8,Importin-9,Ran-binding protein 9;, PF03810;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0042393;GO:0061608;GO:0031267;GO:0006606;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope;, F:histone binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus;|Q96P70 B1ASV5 Q8N1Y1 Q8N3I2 Q8NCG9 Q96SU6 Q9NW01 Q9P0A8 Q9ULM8,Importin-9,Ran-binding protein 9;, PF03810;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0042393;GO:0061608;GO:0031267;GO:0006606;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope;, F:histone binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus;|Q96P70 B1ASV5 Q8N1Y1 Q8N3I2 Q8NCG9 Q96SU6 Q9NW01 Q9P0A8 Q9ULM8,Importin-9,Ran-binding protein 9;, PF03810;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0042393;GO:0061608;GO:0031267;GO:0006606;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope;, F:histone binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus;|Q96P70 B1ASV5 Q8N1Y1 Q8N3I2 Q8NCG9 Q96SU6 Q9NW01 Q9P0A8 Q9ULM8,Importin-9,Ran-binding protein 9;, PF03810;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0042393;GO:0061608;GO:0031267;GO:0006606;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope;, F:histone binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus;|Q96P70 B1ASV5 Q8N1Y1 Q8N3I2 Q8NCG9 Q96SU6 Q9NW01 Q9P0A8 Q9ULM8,Importin-9,Ran-binding protein 9;, PF03810;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0042393;GO:0061608;GO:0031267;GO:0006606;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope;, F:histone binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus;|Q96P70 B1ASV5 Q8N1Y1 Q8N3I2 Q8NCG9 Q96SU6 Q9NW01 Q9P0A8 Q9ULM8,Importin-9,Ran-binding protein 9;, PF03810;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0042393;GO:0061608;GO:0031267;GO:0006606;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope;, F:histone binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus; scaffold239 indexed_genome mRNA 102383 116680 . - . ID=transcript_16176;Q96P70 B1ASV5 Q8N1Y1 Q8N3I2 Q8NCG9 Q96SU6 Q9NW01 Q9P0A8 Q9ULM8,Importin-9,Ran-binding protein 9;, PF03810;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0042393;GO:0061608;GO:0031267;GO:0006606;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope;, F:histone binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus;|Q96P70 B1ASV5 Q8N1Y1 Q8N3I2 Q8NCG9 Q96SU6 Q9NW01 Q9P0A8 Q9ULM8,Importin-9,Ran-binding protein 9;, PF03810;, GO:0005737;GO:0005829;GO:0016020;GO:0005635;GO:0042393;GO:0061608;GO:0031267;GO:0006606;, C:cytoplasm; C:cytosol; C:membrane; C:nuclear envelope;, F:histone binding; F:nuclear import signal receptor activity; F:small GTPase binding;, P:protein import into nucleus; scaffold239 indexed_genome mRNA 127212 282792 . - . ID=transcript_16177;Q9H7V9 Q9H9S9 Q9H9T5 Q9UGI1 Q9ULK7 Q9ULR9,Neuron navigator 1,Pore membrane and/or filament-interacting-like protein 3;Steerin-1;Unc-53 homolog 1;, , GO:0043194;GO:0005737;GO:0005874;GO:0015630;GO:0001578;GO:0007399;GO:0001764;, C:axon initial segment; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton;, , P:microtubule bundle formation; P:nervous system development; P:neuron migration;|Q9H7V9 Q9H9S9 Q9H9T5 Q9UGI1 Q9ULK7 Q9ULR9,Neuron navigator 1,Pore membrane and/or filament-interacting-like protein 3;Steerin-1;Unc-53 homolog 1;, , GO:0043194;GO:0005737;GO:0005874;GO:0015630;GO:0001578;GO:0007399;GO:0001764;, C:axon initial segment; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton;, , P:microtubule bundle formation; P:nervous system development; P:neuron migration;|Q9H7V9 Q9H9S9 Q9H9T5 Q9UGI1 Q9ULK7 Q9ULR9,Neuron navigator 1,Pore membrane and/or filament-interacting-like protein 3;Steerin-1;Unc-53 homolog 1;, , GO:0043194;GO:0005737;GO:0005874;GO:0015630;GO:0001578;GO:0007399;GO:0001764;, C:axon initial segment; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton;, , P:microtubule bundle formation; P:nervous system development; P:neuron migration;|Q9H7V9 Q9H9S9 Q9H9T5 Q9UGI1 Q9ULK7 Q9ULR9,Neuron navigator 1,Pore membrane and/or filament-interacting-like protein 3;Steerin-1;Unc-53 homolog 1;, , GO:0043194;GO:0005737;GO:0005874;GO:0015630;GO:0001578;GO:0007399;GO:0001764;, C:axon initial segment; C:cytoplasm; C:microtubule; C:microtubule cytoskeleton;, , P:microtubule bundle formation; P:nervous system development; P:neuron migration; scaffold239 indexed_genome mRNA 366821 388519 . + . ID=transcript_16178;P21291 A8K268 Q5U0J2,Cysteine and glycine-rich protein 1,Cysteine-rich protein 1;Epididymis luminal protein 141;, PF00412;, GO:0005737;GO:0070062;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0003723;GO:0008307;GO:0008270;GO:0030036;GO:0060537;GO:0070527;GO:0045214;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:RNA binding; F:structural constituent of muscle; F:zinc ion binding;, P:actin cytoskeleton organization; P:muscle tissue development; P:platelet aggregation; P:sarcomere organization;|P21291 A8K268 Q5U0J2,Cysteine and glycine-rich protein 1,Cysteine-rich protein 1;Epididymis luminal protein 141;, PF00412;, GO:0005737;GO:0070062;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0003723;GO:0008307;GO:0008270;GO:0030036;GO:0060537;GO:0070527;GO:0045214;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:RNA binding; F:structural constituent of muscle; F:zinc ion binding;, P:actin cytoskeleton organization; P:muscle tissue development; P:platelet aggregation; P:sarcomere organization;|P21291 A8K268 Q5U0J2,Cysteine and glycine-rich protein 1,Cysteine-rich protein 1;Epididymis luminal protein 141;, PF00412;, GO:0005737;GO:0070062;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0003723;GO:0008307;GO:0008270;GO:0030036;GO:0060537;GO:0070527;GO:0045214;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:RNA binding; F:structural constituent of muscle; F:zinc ion binding;, P:actin cytoskeleton organization; P:muscle tissue development; P:platelet aggregation; P:sarcomere organization;|P21291 A8K268 Q5U0J2,Cysteine and glycine-rich protein 1,Cysteine-rich protein 1;Epididymis luminal protein 141;, PF00412;, GO:0005737;GO:0070062;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0003723;GO:0008307;GO:0008270;GO:0030036;GO:0060537;GO:0070527;GO:0045214;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:RNA binding; F:structural constituent of muscle; F:zinc ion binding;, P:actin cytoskeleton organization; P:muscle tissue development; P:platelet aggregation; P:sarcomere organization;|P21291 A8K268 Q5U0J2,Cysteine and glycine-rich protein 1,Cysteine-rich protein 1;Epididymis luminal protein 141;, PF00412;, GO:0005737;GO:0070062;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0003723;GO:0008307;GO:0008270;GO:0030036;GO:0060537;GO:0070527;GO:0045214;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:RNA binding; F:structural constituent of muscle; F:zinc ion binding;, P:actin cytoskeleton organization; P:muscle tissue development; P:platelet aggregation; P:sarcomere organization;|P21291 A8K268 Q5U0J2,Cysteine and glycine-rich protein 1,Cysteine-rich protein 1;Epididymis luminal protein 141;, PF00412;, GO:0005737;GO:0070062;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0003723;GO:0008307;GO:0008270;GO:0030036;GO:0060537;GO:0070527;GO:0045214;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:RNA binding; F:structural constituent of muscle; F:zinc ion binding;, P:actin cytoskeleton organization; P:muscle tissue development; P:platelet aggregation; P:sarcomere organization;|P21291 A8K268 Q5U0J2,Cysteine and glycine-rich protein 1,Cysteine-rich protein 1;Epididymis luminal protein 141;, PF00412;, GO:0005737;GO:0070062;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0003723;GO:0008307;GO:0008270;GO:0030036;GO:0060537;GO:0070527;GO:0045214;, C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:RNA binding; F:structural constituent of muscle; F:zinc ion binding;, P:actin cytoskeleton organization; P:muscle tissue development; P:platelet aggregation; P:sarcomere organization;|Q16527 Q93030,Cysteine and glycine-rich protein 2,Cysteine-rich protein 2;LIM domain only protein 5;Smooth muscle cell LIM protein;, PF00412;, GO:0005737;GO:0005925;GO:0005634;GO:0030018;GO:0042805;GO:0046872;GO:0008307;GO:0030036;GO:0030154;GO:0007275;GO:0060537;GO:0045214;, C:cytoplasm; C:focal adhesion; C:nucleus; C:Z disc;, F:actinin binding; F:metal ion binding; F:structural constituent of muscle;, P:actin cytoskeleton organization; P:cell differentiation; P:multicellular organism development; P:muscle tissue development; P:sarcomere organization; scaffold239 indexed_genome mRNA 403455 409282 . + . ID=transcript_16179;Q9Y5J5 B2R5A4 Q53HD6 Q8NBW9,Pleckstrin homology-like domain family A member 3,TDAG51/Ipl homolog 1;, , GO:0005737;GO:0005886;GO:0005547;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0010314;GO:0009653;GO:0042771;GO:0051898;GO:0043065;, C:cytoplasm; C:plasma membrane;, F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylinositol-5-phosphate binding;, P:anatomical structure morphogenesis; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of protein kinase B signaling; P:positive regulation of apoptotic process; scaffold239 indexed_genome mRNA 427304 430796 . + . ID=transcript_16180;P19237 A6NEH3 A8MSJ0 Q659A5 Q6FGS7 Q6FGW1 Q6ICU2 Q86T57 Q96DT9,Troponin I, slow skeletal muscle,Troponin I, slow-twitch isoform;, PF00992;, GO:0005829;GO:0005861;GO:0003779;GO:0046872;GO:0060048;GO:0006936;GO:0030049;GO:0006942;GO:0003009;, C:cytosol; C:troponin complex;, F:actin binding; F:metal ion binding;, P:cardiac muscle contraction; P:muscle contraction; P:muscle filament sliding; P:regulation of striated muscle contraction; P:skeletal muscle contraction; scaffold239 indexed_genome mRNA 430930 433210 . + . ID=transcript_16181;P19237 A6NEH3 A8MSJ0 Q659A5 Q6FGS7 Q6FGW1 Q6ICU2 Q86T57 Q96DT9,Troponin I, slow skeletal muscle,Troponin I, slow-twitch isoform;, PF00992;, GO:0005829;GO:0005861;GO:0003779;GO:0046872;GO:0060048;GO:0006936;GO:0030049;GO:0006942;GO:0003009;, C:cytosol; C:troponin complex;, F:actin binding; F:metal ion binding;, P:cardiac muscle contraction; P:muscle contraction; P:muscle filament sliding; P:regulation of striated muscle contraction; P:skeletal muscle contraction;|P19237 A6NEH3 A8MSJ0 Q659A5 Q6FGS7 Q6FGW1 Q6ICU2 Q86T57 Q96DT9,Troponin I, slow skeletal muscle,Troponin I, slow-twitch isoform;, PF00992;, GO:0005829;GO:0005861;GO:0003779;GO:0046872;GO:0060048;GO:0006936;GO:0030049;GO:0006942;GO:0003009;, C:cytosol; C:troponin complex;, F:actin binding; F:metal ion binding;, P:cardiac muscle contraction; P:muscle contraction; P:muscle filament sliding; P:regulation of striated muscle contraction; P:skeletal muscle contraction; scaffold239 indexed_genome mRNA 451473 452140 . + . ID=transcript_16182;O00515 O95614 Q96GD8,Ladinin-1,Linear IgA disease antigen;, , GO:0015629;GO:0005604;GO:0070062;GO:0045296;GO:0005198;, C:actin cytoskeleton; C:basement membrane; C:extracellular exosome;, F:cadherin binding; F:structural molecule activity; scaffold240 indexed_genome mRNA 59208 75516 . - . ID=transcript_16183;Q9UBK7 B7ZBD6 Q9NU37,Rab-like protein 2A,, PF00071;, GO:0012505;GO:0005525;GO:0003924;GO:0006886;, C:endomembrane system;, F:GTP binding; F:GTPase activity;, P:intracellular protein transport;|Q9UNT1 Q5TZT8 Q96C33,Rab-like protein 2B,, PF00071;, GO:0005814;GO:0036064;GO:0005737;GO:0012505;GO:0000242;GO:0005525;GO:0003924;GO:0060271;GO:0006886;GO:0042073;, C:centriole; C:ciliary basal body; C:cytoplasm; C:endomembrane system; C:pericentriolar material;, F:GTP binding; F:GTPase activity;, P:cilium assembly; P:intracellular protein transport; P:intraciliary transport;|Q9UNT1 Q5TZT8 Q96C33,Rab-like protein 2B,, PF00071;, GO:0005814;GO:0036064;GO:0005737;GO:0012505;GO:0000242;GO:0005525;GO:0003924;GO:0060271;GO:0006886;GO:0042073;, C:centriole; C:ciliary basal body; C:cytoplasm; C:endomembrane system; C:pericentriolar material;, F:GTP binding; F:GTPase activity;, P:cilium assembly; P:intracellular protein transport; P:intraciliary transport; scaffold240 indexed_genome mRNA 119946 170313 . + . ID=transcript_16184;Q9BYB0 D7UT47 Q8TET3,SH3 and multiple ankyrin repeat domains protein 3,Proline-rich synapse-associated protein 2;, PF12796;PF17820;PF00536;PF07653;, GO:0060170;GO:0005829;GO:0043197;GO:0031234;GO:0043005;GO:0044309;GO:0014069;GO:0003779;GO:0035255;GO:0008022;GO:0043621;GO:0097110;GO:0017124;GO:0030160;GO:0008270;GO:0030534;GO:0097113;GO:0007411;GO:0048854;GO:0060997;GO:0097117;GO:0007612;GO:0060291;GO:0000165;GO:0007613;GO:0032232;GO:0045794;GO:0097114;GO:2000969;GO:0060999;GO:2000463;GO:1900451;GO:0048170;GO:1900273;GO:0051835;GO:0051968;GO:0097107;GO:2000311;GO:0061001;GO:1900452;GO:1900271;GO:0035176;GO:0021773;GO:0007416;GO:0051124;GO:0042297;GO:0071625;, C:ciliary membrane; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:neuron projection; C:neuron spine; C:postsynaptic density;, F:actin binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein self-association; F:scaffold protein binding; F:SH3 domain binding; F:synaptic receptor adaptor activity; F:zinc ion binding;, P:adult behavior; P:AMPA glutamate receptor clustering; P:axon guidance; P:brain morphogenesis; P:dendritic spine morphogenesis; P:guanylate kinase-associated protein clustering; P:learning; P:long-term synaptic potentiation; P:MAPK cascade; P:memory; P:negative regulation of actin filament bundle assembly; P:negative regulation of cell volume; P:NMDA glutamate receptor clustering; P:positive regulation of AMPA receptor activity; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of glutamate receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of synapse structural plasticity; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:regulation of AMPA receptor activity; P:regulation of dendritic spine morphogenesis; P:regulation of long-term synaptic depression; P:regulation of long-term synaptic potentiation; P:social behavior; P:striatal medium spiny neuron differentiation; P:synapse assembly; P:synaptic growth at neuromuscular junction; P:vocal learning; P:vocalization behavior;|Q9BYB0 D7UT47 Q8TET3,SH3 and multiple ankyrin repeat domains protein 3,Proline-rich synapse-associated protein 2;, PF12796;PF17820;PF00536;PF07653;, GO:0060170;GO:0005829;GO:0043197;GO:0031234;GO:0043005;GO:0044309;GO:0014069;GO:0003779;GO:0035255;GO:0008022;GO:0043621;GO:0097110;GO:0017124;GO:0030160;GO:0008270;GO:0030534;GO:0097113;GO:0007411;GO:0048854;GO:0060997;GO:0097117;GO:0007612;GO:0060291;GO:0000165;GO:0007613;GO:0032232;GO:0045794;GO:0097114;GO:2000969;GO:0060999;GO:2000463;GO:1900451;GO:0048170;GO:1900273;GO:0051835;GO:0051968;GO:0097107;GO:2000311;GO:0061001;GO:1900452;GO:1900271;GO:0035176;GO:0021773;GO:0007416;GO:0051124;GO:0042297;GO:0071625;, C:ciliary membrane; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:neuron projection; C:neuron spine; C:postsynaptic density;, F:actin binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein self-association; F:scaffold protein binding; F:SH3 domain binding; F:synaptic receptor adaptor activity; F:zinc ion binding;, P:adult behavior; P:AMPA glutamate receptor clustering; P:axon guidance; P:brain morphogenesis; P:dendritic spine morphogenesis; P:guanylate kinase-associated protein clustering; P:learning; P:long-term synaptic potentiation; P:MAPK cascade; P:memory; P:negative regulation of actin filament bundle assembly; P:negative regulation of cell volume; P:NMDA glutamate receptor clustering; P:positive regulation of AMPA receptor activity; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of glutamate receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of synapse structural plasticity; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:regulation of AMPA receptor activity; P:regulation of dendritic spine morphogenesis; P:regulation of long-term synaptic depression; P:regulation of long-term synaptic potentiation; P:social behavior; P:striatal medium spiny neuron differentiation; P:synapse assembly; P:synaptic growth at neuromuscular junction; P:vocal learning; P:vocalization behavior;|Q9BYB0 D7UT47 Q8TET3,SH3 and multiple ankyrin repeat domains protein 3,Proline-rich synapse-associated protein 2;, PF12796;PF17820;PF00536;PF07653;, GO:0060170;GO:0005829;GO:0043197;GO:0031234;GO:0043005;GO:0044309;GO:0014069;GO:0003779;GO:0035255;GO:0008022;GO:0043621;GO:0097110;GO:0017124;GO:0030160;GO:0008270;GO:0030534;GO:0097113;GO:0007411;GO:0048854;GO:0060997;GO:0097117;GO:0007612;GO:0060291;GO:0000165;GO:0007613;GO:0032232;GO:0045794;GO:0097114;GO:2000969;GO:0060999;GO:2000463;GO:1900451;GO:0048170;GO:1900273;GO:0051835;GO:0051968;GO:0097107;GO:2000311;GO:0061001;GO:1900452;GO:1900271;GO:0035176;GO:0021773;GO:0007416;GO:0051124;GO:0042297;GO:0071625;, C:ciliary membrane; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:neuron projection; C:neuron spine; C:postsynaptic density;, F:actin binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein self-association; F:scaffold protein binding; F:SH3 domain binding; F:synaptic receptor adaptor activity; F:zinc ion binding;, P:adult behavior; P:AMPA glutamate receptor clustering; P:axon guidance; P:brain morphogenesis; P:dendritic spine morphogenesis; P:guanylate kinase-associated protein clustering; P:learning; P:long-term synaptic potentiation; P:MAPK cascade; P:memory; P:negative regulation of actin filament bundle assembly; P:negative regulation of cell volume; P:NMDA glutamate receptor clustering; P:positive regulation of AMPA receptor activity; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of glutamate receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of synapse structural plasticity; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:regulation of AMPA receptor activity; P:regulation of dendritic spine morphogenesis; P:regulation of long-term synaptic depression; P:regulation of long-term synaptic potentiation; P:social behavior; P:striatal medium spiny neuron differentiation; P:synapse assembly; P:synaptic growth at neuromuscular junction; P:vocal learning; P:vocalization behavior;|Q9BYB0 D7UT47 Q8TET3,SH3 and multiple ankyrin repeat domains protein 3,Proline-rich synapse-associated protein 2;, PF12796;PF17820;PF00536;PF07653;, GO:0060170;GO:0005829;GO:0043197;GO:0031234;GO:0043005;GO:0044309;GO:0014069;GO:0003779;GO:0035255;GO:0008022;GO:0043621;GO:0097110;GO:0017124;GO:0030160;GO:0008270;GO:0030534;GO:0097113;GO:0007411;GO:0048854;GO:0060997;GO:0097117;GO:0007612;GO:0060291;GO:0000165;GO:0007613;GO:0032232;GO:0045794;GO:0097114;GO:2000969;GO:0060999;GO:2000463;GO:1900451;GO:0048170;GO:1900273;GO:0051835;GO:0051968;GO:0097107;GO:2000311;GO:0061001;GO:1900452;GO:1900271;GO:0035176;GO:0021773;GO:0007416;GO:0051124;GO:0042297;GO:0071625;, C:ciliary membrane; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:neuron projection; C:neuron spine; C:postsynaptic density;, F:actin binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein self-association; F:scaffold protein binding; F:SH3 domain binding; F:synaptic receptor adaptor activity; F:zinc ion binding;, P:adult behavior; P:AMPA glutamate receptor clustering; P:axon guidance; P:brain morphogenesis; P:dendritic spine morphogenesis; P:guanylate kinase-associated protein clustering; P:learning; P:long-term synaptic potentiation; P:MAPK cascade; P:memory; P:negative regulation of actin filament bundle assembly; P:negative regulation of cell volume; P:NMDA glutamate receptor clustering; P:positive regulation of AMPA receptor activity; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of glutamate receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of synapse structural plasticity; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:regulation of AMPA receptor activity; P:regulation of dendritic spine morphogenesis; P:regulation of long-term synaptic depression; P:regulation of long-term synaptic potentiation; P:social behavior; P:striatal medium spiny neuron differentiation; P:synapse assembly; P:synaptic growth at neuromuscular junction; P:vocal learning; P:vocalization behavior;|Q9BYB0 D7UT47 Q8TET3,SH3 and multiple ankyrin repeat domains protein 3,Proline-rich synapse-associated protein 2;, PF12796;PF17820;PF00536;PF07653;, GO:0060170;GO:0005829;GO:0043197;GO:0031234;GO:0043005;GO:0044309;GO:0014069;GO:0003779;GO:0035255;GO:0008022;GO:0043621;GO:0097110;GO:0017124;GO:0030160;GO:0008270;GO:0030534;GO:0097113;GO:0007411;GO:0048854;GO:0060997;GO:0097117;GO:0007612;GO:0060291;GO:0000165;GO:0007613;GO:0032232;GO:0045794;GO:0097114;GO:2000969;GO:0060999;GO:2000463;GO:1900451;GO:0048170;GO:1900273;GO:0051835;GO:0051968;GO:0097107;GO:2000311;GO:0061001;GO:1900452;GO:1900271;GO:0035176;GO:0021773;GO:0007416;GO:0051124;GO:0042297;GO:0071625;, C:ciliary membrane; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:neuron projection; C:neuron spine; C:postsynaptic density;, F:actin binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein self-association; F:scaffold protein binding; F:SH3 domain binding; F:synaptic receptor adaptor activity; F:zinc ion binding;, P:adult behavior; P:AMPA glutamate receptor clustering; P:axon guidance; P:brain morphogenesis; P:dendritic spine morphogenesis; P:guanylate kinase-associated protein clustering; P:learning; P:long-term synaptic potentiation; P:MAPK cascade; P:memory; P:negative regulation of actin filament bundle assembly; P:negative regulation of cell volume; P:NMDA glutamate receptor clustering; P:positive regulation of AMPA receptor activity; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of glutamate receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of synapse structural plasticity; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:regulation of AMPA receptor activity; P:regulation of dendritic spine morphogenesis; P:regulation of long-term synaptic depression; P:regulation of long-term synaptic potentiation; P:social behavior; P:striatal medium spiny neuron differentiation; P:synapse assembly; P:synaptic growth at neuromuscular junction; P:vocal learning; P:vocalization behavior;|Q9BYB0 D7UT47 Q8TET3,SH3 and multiple ankyrin repeat domains protein 3,Proline-rich synapse-associated protein 2;, PF12796;PF17820;PF00536;PF07653;, GO:0060170;GO:0005829;GO:0043197;GO:0031234;GO:0043005;GO:0044309;GO:0014069;GO:0003779;GO:0035255;GO:0008022;GO:0043621;GO:0097110;GO:0017124;GO:0030160;GO:0008270;GO:0030534;GO:0097113;GO:0007411;GO:0048854;GO:0060997;GO:0097117;GO:0007612;GO:0060291;GO:0000165;GO:0007613;GO:0032232;GO:0045794;GO:0097114;GO:2000969;GO:0060999;GO:2000463;GO:1900451;GO:0048170;GO:1900273;GO:0051835;GO:0051968;GO:0097107;GO:2000311;GO:0061001;GO:1900452;GO:1900271;GO:0035176;GO:0021773;GO:0007416;GO:0051124;GO:0042297;GO:0071625;, C:ciliary membrane; C:cytosol; C:dendritic spine; C:extrinsic component of cytoplasmic side of plasma membrane; C:neuron projection; C:neuron spine; C:postsynaptic density;, F:actin binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein self-association; F:scaffold protein binding; F:SH3 domain binding; F:synaptic receptor adaptor activity; F:zinc ion binding;, P:adult behavior; P:AMPA glutamate receptor clustering; P:axon guidance; P:brain morphogenesis; P:dendritic spine morphogenesis; P:guanylate kinase-associated protein clustering; P:learning; P:long-term synaptic potentiation; P:MAPK cascade; P:memory; P:negative regulation of actin filament bundle assembly; P:negative regulation of cell volume; P:NMDA glutamate receptor clustering; P:positive regulation of AMPA receptor activity; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of glutamate receptor signaling pathway; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of synapse structural plasticity; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic density assembly; P:regulation of AMPA receptor activity; P:regulation of dendritic spine morphogenesis; P:regulation of long-term synaptic depression; P:regulation of long-term synaptic potentiation; P:social behavior; P:striatal medium spiny neuron differentiation; P:synapse assembly; P:synaptic growth at neuromuscular junction; P:vocal learning; P:vocalization behavior; scaffold240 indexed_genome mRNA 197519 202021 . + . ID=transcript_16185;P15289 B2RCA6 B7XD04 F8WCC8 Q6ICI5 Q96CJ0,Arylsulfatase A,Cerebroside-sulfatase;, PF00884;, GO:0035578;GO:0005788;GO:0070062;GO:0005576;GO:0043202;GO:0005764;GO:0004065;GO:0005509;GO:0004098;GO:0008484;GO:0006687;GO:0043312;, C:azurophil granule lumen; C:endoplasmic reticulum lumen; C:extracellular exosome; C:extracellular region; C:lysosomal lumen; C:lysosome;, F:arylsulfatase activity; F:calcium ion binding; F:cerebroside-sulfatase activity; F:sulfuric ester hydrolase activity;, P:glycosphingolipid metabolic process; P:neutrophil degranulation; scaffold240 indexed_genome mRNA 212091 222462 . - . ID=transcript_16186;Q13387 Q96G62 Q99771 Q9NZ59 Q9UKQ4,C-Jun-amino-terminal kinase-interacting protein 2,Islet-brain-2;JNK MAP kinase scaffold protein 2;Mitogen-activated protein kinase 8-interacting protein 2;, PF00640;PF14604;, GO:0005737;GO:0043025;GO:0014069;GO:0032991;GO:0001540;GO:0019894;GO:0005078;GO:0030295;GO:0019901;GO:0044877;GO:0005198;GO:0001662;GO:0048813;GO:0060079;GO:0007254;GO:0000165;GO:0007617;GO:2001234;GO:0046958;GO:0032874;GO:2000311;GO:0046328;GO:2000310;GO:0010469;GO:0051966;GO:0007172;GO:0035176;, C:cytoplasm; C:neuronal cell body; C:postsynaptic density; C:protein-containing complex;, F:amyloid-beta binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:protein kinase activator activity; F:protein kinase binding; F:protein-containing complex binding; F:structural molecule activity;, P:behavioral fear response; P:dendrite morphogenesis; P:excitatory postsynaptic potential; P:JNK cascade; P:MAPK cascade; P:mating behavior; P:negative regulation of apoptotic signaling pathway; P:nonassociative learning; P:positive regulation of stress-activated MAPK cascade; P:regulation of AMPA receptor activity; P:regulation of JNK cascade; P:regulation of NMDA receptor activity; P:regulation of signaling receptor activity; P:regulation of synaptic transmission, glutamatergic; P:signal complex assembly; P:social behavior;|Q13387 Q96G62 Q99771 Q9NZ59 Q9UKQ4,C-Jun-amino-terminal kinase-interacting protein 2,Islet-brain-2;JNK MAP kinase scaffold protein 2;Mitogen-activated protein kinase 8-interacting protein 2;, PF00640;PF14604;, GO:0005737;GO:0043025;GO:0014069;GO:0032991;GO:0001540;GO:0019894;GO:0005078;GO:0030295;GO:0019901;GO:0044877;GO:0005198;GO:0001662;GO:0048813;GO:0060079;GO:0007254;GO:0000165;GO:0007617;GO:2001234;GO:0046958;GO:0032874;GO:2000311;GO:0046328;GO:2000310;GO:0010469;GO:0051966;GO:0007172;GO:0035176;, C:cytoplasm; C:neuronal cell body; C:postsynaptic density; C:protein-containing complex;, F:amyloid-beta binding; F:kinesin binding; F:MAP-kinase scaffold activity; F:protein kinase activator activity; F:protein kinase binding; F:protein-containing complex binding; F:structural molecule activity;, P:behavioral fear response; P:dendrite morphogenesis; P:excitatory postsynaptic potential; P:JNK cascade; P:MAPK cascade; P:mating behavior; P:negative regulation of apoptotic signaling pathway; P:nonassociative learning; P:positive regulation of stress-activated MAPK cascade; P:regulation of AMPA receptor activity; P:regulation of JNK cascade; P:regulation of NMDA receptor activity; P:regulation of signaling receptor activity; P:regulation of synaptic transmission, glutamatergic; P:signal complex assembly; P:social behavior; scaffold240 indexed_genome mRNA 239941 241317 . + . ID=transcript_16187;Q9Y259 A0PJM6 Q13388,Choline/ethanolamine kinase,Choline kinase beta;Choline kinase-like protein;Ethanolamine kinase;Ethanolamine kinase beta;choline/ethanolamine kinase beta;, , GO:0005829;GO:0005524;GO:0004103;GO:0004305;GO:0006656;GO:0006646;, C:cytosol;, F:ATP binding; F:choline kinase activity; F:ethanolamine kinase activity;, P:phosphatidylcholine biosynthetic process; P:phosphatidylethanolamine biosynthetic process; scaffold240 indexed_genome mRNA 242580 243564 . + . ID=transcript_16188;Q92523 B7Z4U4 B7Z5T8 E9PCP2 Q13389 Q99655 Q9BY90,Carnitine O-palmitoyltransferase 1, muscle isoform,Carnitine O-palmitoyltransferase I, muscle isoform;Carnitine palmitoyltransferase 1B;Carnitine palmitoyltransferase I-like protein;, PF00755;PF16484;, GO:0016021;GO:0005741;GO:0005739;GO:0004095;GO:0009437;GO:0006853;GO:0006635;GO:0006631;GO:0015909;GO:0009637;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:carnitine shuttle; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:long-chain fatty acid transport; P:response to blue light; scaffold240 indexed_genome mRNA 244262 245561 . + . ID=transcript_16189;Q92523 B7Z4U4 B7Z5T8 E9PCP2 Q13389 Q99655 Q9BY90,Carnitine O-palmitoyltransferase 1, muscle isoform,Carnitine O-palmitoyltransferase I, muscle isoform;Carnitine palmitoyltransferase 1B;Carnitine palmitoyltransferase I-like protein;, PF00755;PF16484;, GO:0016021;GO:0005741;GO:0005739;GO:0004095;GO:0009437;GO:0006853;GO:0006635;GO:0006631;GO:0015909;GO:0009637;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:carnitine shuttle; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:long-chain fatty acid transport; P:response to blue light; scaffold240 indexed_genome mRNA 247288 247837 . + . ID=transcript_16190;Q92523 B7Z4U4 B7Z5T8 E9PCP2 Q13389 Q99655 Q9BY90,Carnitine O-palmitoyltransferase 1, muscle isoform,Carnitine O-palmitoyltransferase I, muscle isoform;Carnitine palmitoyltransferase 1B;Carnitine palmitoyltransferase I-like protein;, PF00755;PF16484;, GO:0016021;GO:0005741;GO:0005739;GO:0004095;GO:0009437;GO:0006853;GO:0006635;GO:0006631;GO:0015909;GO:0009637;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:carnitine shuttle; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:long-chain fatty acid transport; P:response to blue light; scaffold240 indexed_genome mRNA 248274 249780 . - . ID=transcript_16191;Q92523 B7Z4U4 B7Z5T8 E9PCP2 Q13389 Q99655 Q9BY90,Carnitine O-palmitoyltransferase 1, muscle isoform,Carnitine O-palmitoyltransferase I, muscle isoform;Carnitine palmitoyltransferase 1B;Carnitine palmitoyltransferase I-like protein;, PF00755;PF16484;, GO:0016021;GO:0005741;GO:0005739;GO:0004095;GO:0009437;GO:0006853;GO:0006635;GO:0006631;GO:0015909;GO:0009637;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:carnitine shuttle; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:long-chain fatty acid transport; P:response to blue light;|Q92523 B7Z4U4 B7Z5T8 E9PCP2 Q13389 Q99655 Q9BY90,Carnitine O-palmitoyltransferase 1, muscle isoform,Carnitine O-palmitoyltransferase I, muscle isoform;Carnitine palmitoyltransferase 1B;Carnitine palmitoyltransferase I-like protein;, PF00755;PF16484;, GO:0016021;GO:0005741;GO:0005739;GO:0004095;GO:0009437;GO:0006853;GO:0006635;GO:0006631;GO:0015909;GO:0009637;, C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:carnitine O-palmitoyltransferase activity;, P:carnitine metabolic process; P:carnitine shuttle; P:fatty acid beta-oxidation; P:fatty acid metabolic process; P:long-chain fatty acid transport; P:response to blue light; scaffold240 indexed_genome mRNA 255046 281991 . + . ID=transcript_16192;A1L190,Synaptonemal complex central element protein 3,Testis highly expressed gene 2 protein;, PF15191;, GO:0000801;GO:0005694;GO:0005634;GO:0051301;GO:0043065;GO:0007131;GO:0007283;GO:0007130;, C:central element; C:chromosome; C:nucleus;, , P:cell division; P:positive regulation of apoptotic process; P:reciprocal meiotic recombination; P:spermatogenesis; P:synaptonemal complex assembly; scaffold240 indexed_genome mRNA 283407 284757 . - . ID=transcript_16193;Q96G42,Kelch domain-containing protein 7B,, PF01344; scaffold240 indexed_genome mRNA 303795 311024 . + . ID=transcript_16194;A8MYP8 A0PK18,Outer dense fiber protein 3B,Outer dense fiber protein 3-like protein 3;, PF07004;, GO:0005856;, C:cytoskeleton;|A8MYP8 A0PK18,Outer dense fiber protein 3B,Outer dense fiber protein 3-like protein 3;, PF07004;, GO:0005856;, C:cytoskeleton;|A8MYP8 A0PK18,Outer dense fiber protein 3B,Outer dense fiber protein 3-like protein 3;, PF07004;, GO:0005856;, C:cytoskeleton;|A8MYP8 A0PK18,Outer dense fiber protein 3B,Outer dense fiber protein 3-like protein 3;, PF07004;, GO:0005856;, C:cytoskeleton; scaffold240 indexed_genome mRNA 311112 325661 . + . ID=transcript_16195;O43819 Q3T1B5 Q9UK87,Protein SCO2 homolog, mitochondrial,, PF02630;, GO:0031305;GO:0005759;GO:0005739;GO:0030016;GO:0016531;GO:0005507;GO:0015035;GO:0006878;GO:0001654;GO:0001701;GO:0033617;GO:0003012;GO:0022904;GO:0014823;, C:integral component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:myofibril;, F:copper chaperone activity; F:copper ion binding; F:protein disulfide oxidoreductase activity;, P:cellular copper ion homeostasis; P:eye development; P:in utero embryonic development; P:mitochondrial cytochrome c oxidase assembly; P:muscle system process; P:respiratory electron transport chain; P:response to activity;|O43819 Q3T1B5 Q9UK87,Protein SCO2 homolog, mitochondrial,, PF02630;, GO:0031305;GO:0005759;GO:0005739;GO:0030016;GO:0016531;GO:0005507;GO:0015035;GO:0006878;GO:0001654;GO:0001701;GO:0033617;GO:0003012;GO:0022904;GO:0014823;, C:integral component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:myofibril;, F:copper chaperone activity; F:copper ion binding; F:protein disulfide oxidoreductase activity;, P:cellular copper ion homeostasis; P:eye development; P:in utero embryonic development; P:mitochondrial cytochrome c oxidase assembly; P:muscle system process; P:respiratory electron transport chain; P:response to activity;|O43819 Q3T1B5 Q9UK87,Protein SCO2 homolog, mitochondrial,, PF02630;, GO:0031305;GO:0005759;GO:0005739;GO:0030016;GO:0016531;GO:0005507;GO:0015035;GO:0006878;GO:0001654;GO:0001701;GO:0033617;GO:0003012;GO:0022904;GO:0014823;, C:integral component of mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion; C:myofibril;, F:copper chaperone activity; F:copper ion binding; F:protein disulfide oxidoreductase activity;, P:cellular copper ion homeostasis; P:eye development; P:in utero embryonic development; P:mitochondrial cytochrome c oxidase assembly; P:muscle system process; P:respiratory electron transport chain; P:response to activity;|Q6IBW4 B7WPH1 O43788 Q13391 Q96C14 Q96GJ0 Q9BQ71 Q9BUT3 Q9BVD1,Condensin-2 complex subunit H2,Chromosome-associated protein H2;Kleisin-beta;Non-SMC condensin II complex subunit H2;, PF16858;PF16869;PF06278;, GO:0030054;GO:0000793;GO:0000796;GO:0045171;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0051309;GO:0010032;GO:0007076;GO:0051306;GO:0033077;, C:cell junction; C:condensed chromosome; C:condensin complex; C:intercellular bridge; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:female meiosis chromosome separation; P:meiotic chromosome condensation; P:mitotic chromosome condensation; P:mitotic sister chromatid separation; P:T cell differentiation in thymus;|Q6IBW4 B7WPH1 O43788 Q13391 Q96C14 Q96GJ0 Q9BQ71 Q9BUT3 Q9BVD1,Condensin-2 complex subunit H2,Chromosome-associated protein H2;Kleisin-beta;Non-SMC condensin II complex subunit H2;, PF16858;PF16869;PF06278;, GO:0030054;GO:0000793;GO:0000796;GO:0045171;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0051309;GO:0010032;GO:0007076;GO:0051306;GO:0033077;, C:cell junction; C:condensed chromosome; C:condensin complex; C:intercellular bridge; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:female meiosis chromosome separation; P:meiotic chromosome condensation; P:mitotic chromosome condensation; P:mitotic sister chromatid separation; P:T cell differentiation in thymus;|Q6IBW4 B7WPH1 O43788 Q13391 Q96C14 Q96GJ0 Q9BQ71 Q9BUT3 Q9BVD1,Condensin-2 complex subunit H2,Chromosome-associated protein H2;Kleisin-beta;Non-SMC condensin II complex subunit H2;, PF16858;PF16869;PF06278;, GO:0030054;GO:0000793;GO:0000796;GO:0045171;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0051309;GO:0010032;GO:0007076;GO:0051306;GO:0033077;, C:cell junction; C:condensed chromosome; C:condensin complex; C:intercellular bridge; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:female meiosis chromosome separation; P:meiotic chromosome condensation; P:mitotic chromosome condensation; P:mitotic sister chromatid separation; P:T cell differentiation in thymus;|Q6IBW4 B7WPH1 O43788 Q13391 Q96C14 Q96GJ0 Q9BQ71 Q9BUT3 Q9BVD1,Condensin-2 complex subunit H2,Chromosome-associated protein H2;Kleisin-beta;Non-SMC condensin II complex subunit H2;, PF16858;PF16869;PF06278;, GO:0030054;GO:0000793;GO:0000796;GO:0045171;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0051309;GO:0010032;GO:0007076;GO:0051306;GO:0033077;, C:cell junction; C:condensed chromosome; C:condensin complex; C:intercellular bridge; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:female meiosis chromosome separation; P:meiotic chromosome condensation; P:mitotic chromosome condensation; P:mitotic sister chromatid separation; P:T cell differentiation in thymus;|Q6IBW4 B7WPH1 O43788 Q13391 Q96C14 Q96GJ0 Q9BQ71 Q9BUT3 Q9BVD1,Condensin-2 complex subunit H2,Chromosome-associated protein H2;Kleisin-beta;Non-SMC condensin II complex subunit H2;, PF16858;PF16869;PF06278;, GO:0030054;GO:0000793;GO:0000796;GO:0045171;GO:0016020;GO:0005654;GO:0005634;GO:0003682;GO:0051309;GO:0010032;GO:0007076;GO:0051306;GO:0033077;, C:cell junction; C:condensed chromosome; C:condensin complex; C:intercellular bridge; C:membrane; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:female meiosis chromosome separation; P:meiotic chromosome condensation; P:mitotic chromosome condensation; P:mitotic sister chromatid separation; P:T cell differentiation in thymus; scaffold240 indexed_genome mRNA 330840 335500 . + . ID=transcript_16196;Q9BU23 A6NEZ0 Q13392 Q6ZNR2 Q8WU74 Q96C62,Lipase maturation factor 2,Transmembrane protein 112B;Transmembrane protein 153;, PF06762;, GO:0005789;GO:0016021;GO:0016020;GO:0051604;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:protein maturation;|Q9BU23 A6NEZ0 Q13392 Q6ZNR2 Q8WU74 Q96C62,Lipase maturation factor 2,Transmembrane protein 112B;Transmembrane protein 153;, PF06762;, GO:0005789;GO:0016021;GO:0016020;GO:0051604;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, , P:protein maturation; scaffold240 indexed_genome mRNA 343603 347813 . - . ID=transcript_16197;Q7Z4H4 Q3LFQ0,Protein ADM2,Intermedin;, PF00214;, GO:0005576;GO:0005179;GO:0044877;GO:0007189;GO:0001525;GO:0007586;GO:0007631;GO:0007186;GO:0045776;GO:0002862;GO:0045766;GO:0010628;GO:0006468;, C:extracellular region;, F:hormone activity; F:protein-containing complex binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:angiogenesis; P:digestion; P:feeding behavior; P:G protein-coupled receptor signaling pathway; P:negative regulation of blood pressure; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of angiogenesis; P:positive regulation of gene expression; P:protein phosphorylation; scaffold240 indexed_genome mRNA 358302 380138 . + . ID=transcript_16198;O95248 A0A024R4Z9 A6PVG9 G5E933 O60228 Q5JXD8 Q5PPM2 Q96GR9 Q9UGB8,Myotubularin-related protein 5,Inactive phosphatidylinositol 3-phosphatase 5 {ECO:0000305};SET-binding factor 1;, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0005737;GO:0005829;GO:0005789;GO:0016021;GO:0016604;GO:0048471;GO:0005085;GO:0019208;GO:0008138;GO:0006661;GO:0006470;GO:0043087;GO:0007283;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear body; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of GTPase activity; P:spermatogenesis;|O95248 A0A024R4Z9 A6PVG9 G5E933 O60228 Q5JXD8 Q5PPM2 Q96GR9 Q9UGB8,Myotubularin-related protein 5,Inactive phosphatidylinositol 3-phosphatase 5 {ECO:0000305};SET-binding factor 1;, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0005737;GO:0005829;GO:0005789;GO:0016021;GO:0016604;GO:0048471;GO:0005085;GO:0019208;GO:0008138;GO:0006661;GO:0006470;GO:0043087;GO:0007283;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear body; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of GTPase activity; P:spermatogenesis;|O95248 A0A024R4Z9 A6PVG9 G5E933 O60228 Q5JXD8 Q5PPM2 Q96GR9 Q9UGB8,Myotubularin-related protein 5,Inactive phosphatidylinositol 3-phosphatase 5 {ECO:0000305};SET-binding factor 1;, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0005737;GO:0005829;GO:0005789;GO:0016021;GO:0016604;GO:0048471;GO:0005085;GO:0019208;GO:0008138;GO:0006661;GO:0006470;GO:0043087;GO:0007283;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear body; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of GTPase activity; P:spermatogenesis;|O95248 A0A024R4Z9 A6PVG9 G5E933 O60228 Q5JXD8 Q5PPM2 Q96GR9 Q9UGB8,Myotubularin-related protein 5,Inactive phosphatidylinositol 3-phosphatase 5 {ECO:0000305};SET-binding factor 1;, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0005737;GO:0005829;GO:0005789;GO:0016021;GO:0016604;GO:0048471;GO:0005085;GO:0019208;GO:0008138;GO:0006661;GO:0006470;GO:0043087;GO:0007283;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear body; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of GTPase activity; P:spermatogenesis;|O95248 A0A024R4Z9 A6PVG9 G5E933 O60228 Q5JXD8 Q5PPM2 Q96GR9 Q9UGB8,Myotubularin-related protein 5,Inactive phosphatidylinositol 3-phosphatase 5 {ECO:0000305};SET-binding factor 1;, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0005737;GO:0005829;GO:0005789;GO:0016021;GO:0016604;GO:0048471;GO:0005085;GO:0019208;GO:0008138;GO:0006661;GO:0006470;GO:0043087;GO:0007283;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear body; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of GTPase activity; P:spermatogenesis;|O95248 A0A024R4Z9 A6PVG9 G5E933 O60228 Q5JXD8 Q5PPM2 Q96GR9 Q9UGB8,Myotubularin-related protein 5,Inactive phosphatidylinositol 3-phosphatase 5 {ECO:0000305};SET-binding factor 1;, PF02141;PF02893;PF06602;PF00169;PF12335;PF03456;, GO:0005737;GO:0005829;GO:0005789;GO:0016021;GO:0016604;GO:0048471;GO:0005085;GO:0019208;GO:0008138;GO:0006661;GO:0006470;GO:0043087;GO:0007283;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nuclear body; C:perinuclear region of cytoplasm;, F:guanyl-nucleotide exchange factor activity; F:phosphatase regulator activity; F:protein tyrosine/serine/threonine phosphatase activity;, P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of GTPase activity; P:spermatogenesis; scaffold240 indexed_genome mRNA 380325 384715 . + . ID=transcript_16199;O75170 A6PVG3 B7Z7T3 Q5U5P3 Q7Z2L2 Q7Z5G5 Q7Z731 Q9UGB9,Serine/threonine-protein phosphatase 6 regulatory subunit 2,SAPS domain family member 2;, PF04499;, GO:0005829;GO:0043231;GO:0005634;GO:0019903;GO:0019888;GO:0043666;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:regulation of phosphoprotein phosphatase activity; scaffold240 indexed_genome mRNA 385172 390083 . + . ID=transcript_16200;O75170 A6PVG3 B7Z7T3 Q5U5P3 Q7Z2L2 Q7Z5G5 Q7Z731 Q9UGB9,Serine/threonine-protein phosphatase 6 regulatory subunit 2,SAPS domain family member 2;, PF04499;, GO:0005829;GO:0043231;GO:0005634;GO:0019903;GO:0019888;GO:0043666;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:regulation of phosphoprotein phosphatase activity; scaffold240 indexed_genome mRNA 392692 403039 . - . ID=transcript_16201;Q5JT82 Q86VQ7 Q8N805,Krueppel-like factor 17,Zinc finger protein 393;, PF00096;, GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0000976;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II;|O75170 A6PVG3 B7Z7T3 Q5U5P3 Q7Z2L2 Q7Z5G5 Q7Z731 Q9UGB9,Serine/threonine-protein phosphatase 6 regulatory subunit 2,SAPS domain family member 2;, PF04499;, GO:0005829;GO:0043231;GO:0005634;GO:0019903;GO:0019888;GO:0043666;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:regulation of phosphoprotein phosphatase activity;|O75170 A6PVG3 B7Z7T3 Q5U5P3 Q7Z2L2 Q7Z5G5 Q7Z731 Q9UGB9,Serine/threonine-protein phosphatase 6 regulatory subunit 2,SAPS domain family member 2;, PF04499;, GO:0005829;GO:0043231;GO:0005634;GO:0019903;GO:0019888;GO:0043666;, C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity;, P:regulation of phosphoprotein phosphatase activity; scaffold241 indexed_genome mRNA 98 14420 . + . ID=transcript_16202;Q7LDG7 A6NDC7 O00538 Q9UL65,RAS guanyl-releasing protein 2,Calcium and DAG-regulated guanine nucleotide exchange factor I;Cdc25-like protein;F25B3.3 kinase-like protein;, PF00130;PF13499;PF00617;PF00618;, GO:0005829;GO:0043005;GO:0005886;GO:0032587;GO:0045202;GO:0005509;GO:0019992;GO:0005085;GO:0008289;GO:0002250;GO:0071277;GO:0043547;GO:0007265;GO:0001558;GO:0007165;, C:cytosol; C:neuron projection; C:plasma membrane; C:ruffle membrane; C:synapse;, F:calcium ion binding; F:diacylglycerol binding; F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:adaptive immune response; P:cellular response to calcium ion; P:positive regulation of GTPase activity; P:Ras protein signal transduction; P:regulation of cell growth; P:signal transduction;|Q7LDG7 A6NDC7 O00538 Q9UL65,RAS guanyl-releasing protein 2,Calcium and DAG-regulated guanine nucleotide exchange factor I;Cdc25-like protein;F25B3.3 kinase-like protein;, PF00130;PF13499;PF00617;PF00618;, GO:0005829;GO:0043005;GO:0005886;GO:0032587;GO:0045202;GO:0005509;GO:0019992;GO:0005085;GO:0008289;GO:0002250;GO:0071277;GO:0043547;GO:0007265;GO:0001558;GO:0007165;, C:cytosol; C:neuron projection; C:plasma membrane; C:ruffle membrane; C:synapse;, F:calcium ion binding; F:diacylglycerol binding; F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:adaptive immune response; P:cellular response to calcium ion; P:positive regulation of GTPase activity; P:Ras protein signal transduction; P:regulation of cell growth; P:signal transduction;|Q7LDG7 A6NDC7 O00538 Q9UL65,RAS guanyl-releasing protein 2,Calcium and DAG-regulated guanine nucleotide exchange factor I;Cdc25-like protein;F25B3.3 kinase-like protein;, PF00130;PF13499;PF00617;PF00618;, GO:0005829;GO:0043005;GO:0005886;GO:0032587;GO:0045202;GO:0005509;GO:0019992;GO:0005085;GO:0008289;GO:0002250;GO:0071277;GO:0043547;GO:0007265;GO:0001558;GO:0007165;, C:cytosol; C:neuron projection; C:plasma membrane; C:ruffle membrane; C:synapse;, F:calcium ion binding; F:diacylglycerol binding; F:guanyl-nucleotide exchange factor activity; F:lipid binding;, P:adaptive immune response; P:cellular response to calcium ion; P:positive regulation of GTPase activity; P:Ras protein signal transduction; P:regulation of cell growth; P:signal transduction; scaffold241 indexed_genome mRNA 17994 129713 . + . ID=transcript_16203;Q9P2S2 A7E2C1 Q9Y2D6,Neurexin-2,Neurexin II-alpha;Neurexin-2-alpha;, PF02210;, GO:0016021;GO:0005886;GO:0098793;GO:0032991;GO:0005246;GO:0050839;GO:0046872;GO:0097109;GO:0004888;GO:0030534;GO:0007268;GO:0097116;GO:0097118;GO:0007158;GO:0007269;GO:0097119;GO:0097104;GO:0007165;GO:0035176;GO:0007416;GO:0042297;GO:0071625;, C:integral component of membrane; C:plasma membrane; C:presynapse; C:protein-containing complex;, F:calcium channel regulator activity; F:cell adhesion molecule binding; F:metal ion binding; F:neuroligin family protein binding; F:transmembrane signaling receptor activity;, P:adult behavior; P:chemical synaptic transmission; P:gephyrin clustering involved in postsynaptic density assembly; P:neuroligin clustering involved in postsynaptic membrane assembly; P:neuron cell-cell adhesion; P:neurotransmitter secretion; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:signal transduction; P:social behavior; P:synapse assembly; P:vocal learning; P:vocalization behavior;|P58401,Neurexin-2-beta,Neurexin II-beta;, PF02210;PF01034;, GO:0016021;GO:0005886;GO:0050839;GO:0097109;GO:0004888;GO:0007158;GO:0007165;, C:integral component of membrane; C:plasma membrane;, F:cell adhesion molecule binding; F:neuroligin family protein binding; F:transmembrane signaling receptor activity;, P:neuron cell-cell adhesion; P:signal transduction;|Q9UIE3 Q9ULA5 Q9Y486,Neurexin-3,Neurexin III-alpha;Neurexin-3-alpha;, PF00008;PF02210;PF01034;, GO:0005887;GO:0005886;GO:0050839;GO:0046872;GO:0097109;GO:0038023;GO:0030534;GO:0007411;GO:0007612;GO:0007158;GO:0035176;GO:0071625;, C:integral component of plasma membrane; C:plasma membrane;, F:cell adhesion molecule binding; F:metal ion binding; F:neuroligin family protein binding; F:signaling receptor activity;, P:adult behavior; P:axon guidance; P:learning; P:neuron cell-cell adhesion; P:social behavior; P:vocalization behavior;|Q9P2S2 A7E2C1 Q9Y2D6,Neurexin-2,Neurexin II-alpha;Neurexin-2-alpha;, PF02210;, GO:0016021;GO:0005886;GO:0098793;GO:0032991;GO:0005246;GO:0050839;GO:0046872;GO:0097109;GO:0004888;GO:0030534;GO:0007268;GO:0097116;GO:0097118;GO:0007158;GO:0007269;GO:0097119;GO:0097104;GO:0007165;GO:0035176;GO:0007416;GO:0042297;GO:0071625;, C:integral component of membrane; C:plasma membrane; C:presynapse; C:protein-containing complex;, F:calcium channel regulator activity; F:cell adhesion molecule binding; F:metal ion binding; F:neuroligin family protein binding; F:transmembrane signaling receptor activity;, P:adult behavior; P:chemical synaptic transmission; P:gephyrin clustering involved in postsynaptic density assembly; P:neuroligin clustering involved in postsynaptic membrane assembly; P:neuron cell-cell adhesion; P:neurotransmitter secretion; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:signal transduction; P:social behavior; P:synapse assembly; P:vocal learning; P:vocalization behavior;|Q9P2S2 A7E2C1 Q9Y2D6,Neurexin-2,Neurexin II-alpha;Neurexin-2-alpha;, PF02210;, GO:0016021;GO:0005886;GO:0098793;GO:0032991;GO:0005246;GO:0050839;GO:0046872;GO:0097109;GO:0004888;GO:0030534;GO:0007268;GO:0097116;GO:0097118;GO:0007158;GO:0007269;GO:0097119;GO:0097104;GO:0007165;GO:0035176;GO:0007416;GO:0042297;GO:0071625;, C:integral component of membrane; C:plasma membrane; C:presynapse; C:protein-containing complex;, F:calcium channel regulator activity; F:cell adhesion molecule binding; F:metal ion binding; F:neuroligin family protein binding; F:transmembrane signaling receptor activity;, P:adult behavior; P:chemical synaptic transmission; P:gephyrin clustering involved in postsynaptic density assembly; P:neuroligin clustering involved in postsynaptic membrane assembly; P:neuron cell-cell adhesion; P:neurotransmitter secretion; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:signal transduction; P:social behavior; P:synapse assembly; P:vocal learning; P:vocalization behavior; scaffold241 indexed_genome mRNA 129736 131923 . + . ID=transcript_16204;P58401,Neurexin-2-beta,Neurexin II-beta;, PF02210;PF01034;, GO:0016021;GO:0005886;GO:0050839;GO:0097109;GO:0004888;GO:0007158;GO:0007165;, C:integral component of membrane; C:plasma membrane;, F:cell adhesion molecule binding; F:neuroligin family protein binding; F:transmembrane signaling receptor activity;, P:neuron cell-cell adhesion; P:signal transduction; scaffold241 indexed_genome mRNA 326513 339631 . - . ID=transcript_16205;O75676 A8K7Z8 O75585 Q53ES8,Ribosomal protein S6 kinase alpha-4,90 kDa ribosomal protein S6 kinase 4;Nuclear mitogen- and stress-activated protein kinase 2;Ribosomal protein kinase B;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated;|O75676 A8K7Z8 O75585 Q53ES8,Ribosomal protein S6 kinase alpha-4,90 kDa ribosomal protein S6 kinase 4;Nuclear mitogen- and stress-activated protein kinase 2;Ribosomal protein kinase B;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated;|O75676 A8K7Z8 O75585 Q53ES8,Ribosomal protein S6 kinase alpha-4,90 kDa ribosomal protein S6 kinase 4;Nuclear mitogen- and stress-activated protein kinase 2;Ribosomal protein kinase B;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated;|O75676 A8K7Z8 O75585 Q53ES8,Ribosomal protein S6 kinase alpha-4,90 kDa ribosomal protein S6 kinase 4;Nuclear mitogen- and stress-activated protein kinase 2;Ribosomal protein kinase B;, PF00069;PF00433;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0004711;GO:0043987;GO:0043988;GO:0016572;GO:0006954;GO:0070498;GO:0035556;GO:0001818;GO:0018105;GO:0032793;GO:0035066;GO:0033129;GO:0051092;GO:0045944;GO:0006468;GO:0006355;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribosomal protein S6 kinase activity;, P:histone H3-S10 phosphorylation; P:histone H3-S28 phosphorylation; P:histone phosphorylation; P:inflammatory response; P:interleukin-1-mediated signaling pathway; P:intracellular signal transduction; P:negative regulation of cytokine production; P:peptidyl-serine phosphorylation; P:positive regulation of CREB transcription factor activity; P:positive regulation of histone acetylation; P:positive regulation of histone phosphorylation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:regulation of transcription, DNA-templated; scaffold241 indexed_genome mRNA 342394 345292 . + . ID=transcript_16206;A6NC98 A5D8Y5 B5MDM2 Q05BL2 Q6RUV3 Q8N1Q6 Q8NF44 Q9H0H1,Coiled-coil domain-containing protein 88B,Brain leucine zipper domain-containing protein;Gipie {ECO:0000303|PubMed:21289099};Hook-related protein 3 {ECO:0000303|PubMed:25762780};, PF19047;, GO:0005813;GO:0005737;GO:0005783;GO:0005794;GO:0016020;GO:0051959;GO:0008017;GO:0031122;GO:0030705;GO:0042832;GO:0001819;GO:0050870;GO:0042102;, C:centrosome; C:cytoplasm; C:endoplasmic reticulum; C:Golgi apparatus; C:membrane;, F:dynein light intermediate chain binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:defense response to protozoan; P:positive regulation of cytokine production; P:positive regulation of T cell activation; P:positive regulation of T cell proliferation; scaffold241 indexed_genome mRNA 345313 357082 . - . ID=transcript_16207;A6NC98 A5D8Y5 B5MDM2 Q05BL2 Q6RUV3 Q8N1Q6 Q8NF44 Q9H0H1,Coiled-coil domain-containing protein 88B,Brain leucine zipper domain-containing protein;Gipie {ECO:0000303|PubMed:21289099};Hook-related protein 3 {ECO:0000303|PubMed:25762780};, PF19047;, GO:0005813;GO:0005737;GO:0005783;GO:0005794;GO:0016020;GO:0051959;GO:0008017;GO:0031122;GO:0030705;GO:0042832;GO:0001819;GO:0050870;GO:0042102;, C:centrosome; C:cytoplasm; C:endoplasmic reticulum; C:Golgi apparatus; C:membrane;, F:dynein light intermediate chain binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:cytoskeleton-dependent intracellular transport; P:defense response to protozoan; P:positive regulation of cytokine production; P:positive regulation of T cell activation; P:positive regulation of T cell proliferation; scaffold241 indexed_genome mRNA 371250 374568 . - . ID=transcript_16208;Q9UKX4,Peroxiredoxin-5, mitochondrial,Alu corepressor 1;Antioxidant enzyme B166;Liver tissue 2D-page spot 71B;PLP;Peroxiredoxin V;Peroxisomal antioxidant enzyme;TPx type VI;Thioredoxin peroxidase PMP20;Thioredoxin-dependent peroxiredoxin 5 {ECO:0000305};, PF08534;, GO:0005737;GO:0031410;GO:0005829;GO:0070062;GO:0005615;GO:0043231;GO:0005759;GO:0005739;GO:0005634;GO:0048471;GO:0005782;GO:0005777;GO:0016209;GO:0043027;GO:0004601;GO:0051920;GO:0072541;GO:0001016;GO:0005102;GO:0008379;GO:0045454;GO:0034599;GO:0034614;GO:0042744;GO:0006954;GO:0070995;GO:0043066;GO:0051354;GO:0016480;GO:0032967;GO:2001057;GO:0060785;GO:0006979;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:extracellular space; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:peroxisomal matrix; C:peroxisome;, F:antioxidant activity; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:peroxidase activity; F:peroxiredoxin activity; F:peroxynitrite reductase activity; F:RNA polymerase III transcription regulatory region sequence-specific DNA binding; F:signaling receptor binding; F:thioredoxin peroxidase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:cellular response to reactive oxygen species; P:hydrogen peroxide catabolic process; P:inflammatory response; P:NADPH oxidation; P:negative regulation of apoptotic process; P:negative regulation of oxidoreductase activity; P:negative regulation of transcription by RNA polymerase III; P:positive regulation of collagen biosynthetic process; P:reactive nitrogen species metabolic process; P:regulation of apoptosis involved in tissue homeostasis; P:response to oxidative stress;|Q9UKX4,Peroxiredoxin-5, mitochondrial,Alu corepressor 1;Antioxidant enzyme B166;Liver tissue 2D-page spot 71B;PLP;Peroxiredoxin V;Peroxisomal antioxidant enzyme;TPx type VI;Thioredoxin peroxidase PMP20;Thioredoxin-dependent peroxiredoxin 5 {ECO:0000305};, PF08534;, GO:0005737;GO:0031410;GO:0005829;GO:0070062;GO:0005615;GO:0043231;GO:0005759;GO:0005739;GO:0005634;GO:0048471;GO:0005782;GO:0005777;GO:0016209;GO:0043027;GO:0004601;GO:0051920;GO:0072541;GO:0001016;GO:0005102;GO:0008379;GO:0045454;GO:0034599;GO:0034614;GO:0042744;GO:0006954;GO:0070995;GO:0043066;GO:0051354;GO:0016480;GO:0032967;GO:2001057;GO:0060785;GO:0006979;, C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:extracellular exosome; C:extracellular space; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm; C:peroxisomal matrix; C:peroxisome;, F:antioxidant activity; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; F:peroxidase activity; F:peroxiredoxin activity; F:peroxynitrite reductase activity; F:RNA polymerase III transcription regulatory region sequence-specific DNA binding; F:signaling receptor binding; F:thioredoxin peroxidase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:cellular response to reactive oxygen species; P:hydrogen peroxide catabolic process; P:inflammatory response; P:NADPH oxidation; P:negative regulation of apoptotic process; P:negative regulation of oxidoreductase activity; P:negative regulation of transcription by RNA polymerase III; P:positive regulation of collagen biosynthetic process; P:reactive nitrogen species metabolic process; P:regulation of apoptosis involved in tissue homeostasis; P:response to oxidative stress; scaffold241 indexed_genome mRNA 374622 382282 . - . ID=transcript_16209;Q6P274 Q6PK28 Q6TS38 Q9R1F3 Q9UNJ4,Estrogen-related receptor gamma,ERR gamma-2;Estrogen receptor-related protein 3;Nuclear receptor subfamily 3 group B member 3;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0050682;GO:0001228;GO:0000981;GO:0042802;GO:0004879;GO:0000978;GO:1990837;GO:0005496;GO:0003707;GO:0008270;GO:0120162;GO:0045893;GO:0006357;GO:0006355;GO:0048384;GO:0006367;, C:chromatin; C:nucleoplasm;, F:AF-2 domain binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:positive regulation of cold-induced thermogenesis; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:retinoic acid receptor signaling pathway; P:transcription initiation from RNA polymerase II promoter;|P11474 Q14514,Steroid hormone receptor ERR1,Estrogen receptor-like 1;Estrogen-related receptor alpha;Nuclear receptor subfamily 3 group B member 1;, PF00104;PF00105;, GO:0000785;GO:0005737;GO:0001650;GO:0045171;GO:0015630;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0004879;GO:0019904;GO:0000978;GO:0043565;GO:1990837;GO:0005496;GO:0003707;GO:0008270;GO:0007005;GO:0045944;GO:0006357;GO:0006355;GO:0006367;, C:chromatin; C:cytoplasm; C:fibrillar center; C:intercellular bridge; C:microtubule cytoskeleton; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:protein domain specific binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:steroid binding; F:steroid hormone receptor activity; F:zinc ion binding;, P:mitochondrion organization; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:transcription initiation from RNA polymerase II promoter; scaffold241 indexed_genome mRNA 384296 393848 . + . ID=transcript_16210;Q9NYG8 B5TJL1 Q96T94,Potassium channel subfamily K member 4,TWIK-related arachidonic acid-stimulated potassium channel protein {ECO:0000303|PubMed:23341632};Two pore potassium channel KT4.1;, PF07885;, GO:0005887;GO:0005886;GO:0034705;GO:0042802;GO:0098782;GO:0005267;GO:0022841;GO:0097604;GO:0005244;GO:0071469;GO:0071398;GO:0071260;GO:0071502;GO:0050976;GO:0007613;GO:0071805;GO:0006813;GO:0034765;GO:0019233;GO:0050951;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane; C:potassium channel complex;, F:identical protein binding; F:mechanosensitived potassium channel activity; F:potassium channel activity; F:potassium ion leak channel activity; F:temperature-gated cation channel activity; F:voltage-gated ion channel activity;, P:cellular response to alkaline pH; P:cellular response to fatty acid; P:cellular response to mechanical stimulus; P:cellular response to temperature stimulus; P:detection of mechanical stimulus involved in sensory perception of touch; P:memory; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:sensory perception of pain; P:sensory perception of temperature stimulus; P:stabilization of membrane potential;|Q9NYG8 B5TJL1 Q96T94,Potassium channel subfamily K member 4,TWIK-related arachidonic acid-stimulated potassium channel protein {ECO:0000303|PubMed:23341632};Two pore potassium channel KT4.1;, PF07885;, GO:0005887;GO:0005886;GO:0034705;GO:0042802;GO:0098782;GO:0005267;GO:0022841;GO:0097604;GO:0005244;GO:0071469;GO:0071398;GO:0071260;GO:0071502;GO:0050976;GO:0007613;GO:0071805;GO:0006813;GO:0034765;GO:0019233;GO:0050951;GO:0030322;, C:integral component of plasma membrane; C:plasma membrane; C:potassium channel complex;, F:identical protein binding; F:mechanosensitived potassium channel activity; F:potassium channel activity; F:potassium ion leak channel activity; F:temperature-gated cation channel activity; F:voltage-gated ion channel activity;, P:cellular response to alkaline pH; P:cellular response to fatty acid; P:cellular response to mechanical stimulus; P:cellular response to temperature stimulus; P:detection of mechanical stimulus involved in sensory perception of touch; P:memory; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:sensory perception of pain; P:sensory perception of temperature stimulus; P:stabilization of membrane potential; scaffold241 indexed_genome mRNA 397060 401699 . - . ID=transcript_16211;Q96N19 B4DTG7 B7Z7M1 Q4G0Y9 Q8N4K6,Integral membrane protein GPR137,Transmembrane 7 superfamily member 1-like 1 protein;, , GO:0016021;GO:0005765;GO:0006914;GO:0045779;GO:0045671;GO:1904263;GO:0010506;, C:integral component of membrane; C:lysosomal membrane;, , P:autophagy; P:negative regulation of bone resorption; P:negative regulation of osteoclast differentiation; P:positive regulation of TORC1 signaling; P:regulation of autophagy;|Q96N19 B4DTG7 B7Z7M1 Q4G0Y9 Q8N4K6,Integral membrane protein GPR137,Transmembrane 7 superfamily member 1-like 1 protein;, , GO:0016021;GO:0005765;GO:0006914;GO:0045779;GO:0045671;GO:1904263;GO:0010506;, C:integral component of membrane; C:lysosomal membrane;, , P:autophagy; P:negative regulation of bone resorption; P:negative regulation of osteoclast differentiation; P:positive regulation of TORC1 signaling; P:regulation of autophagy;|Q96N19 B4DTG7 B7Z7M1 Q4G0Y9 Q8N4K6,Integral membrane protein GPR137,Transmembrane 7 superfamily member 1-like 1 protein;, , GO:0016021;GO:0005765;GO:0006914;GO:0045779;GO:0045671;GO:1904263;GO:0010506;, C:integral component of membrane; C:lysosomal membrane;, , P:autophagy; P:negative regulation of bone resorption; P:negative regulation of osteoclast differentiation; P:positive regulation of TORC1 signaling; P:regulation of autophagy; scaffold241 indexed_genome mRNA 401763 413279 . + . ID=transcript_16212;Q92934 O14803 Q6FH21,Bcl2-associated agonist of cell death,Bcl-2-binding component 6;Bcl-2-like protein 8;Bcl-xL/Bcl-2-associated death promoter;Bcl2 antagonist of cell death;, PF10514;, GO:0005829;GO:0005741;GO:0005739;GO:0071889;GO:0008656;GO:0008289;GO:0005543;GO:0043422;GO:0019901;GO:0030346;GO:0019903;GO:0097202;GO:0006919;GO:0046031;GO:0006915;GO:0046034;GO:0071247;GO:0071456;GO:0071396;GO:0071260;GO:0071316;GO:0021987;GO:0019221;GO:0097191;GO:0097192;GO:0008625;GO:0006007;GO:0042593;GO:0097193;GO:0008630;GO:0046931;GO:0043065;GO:0060139;GO:0010508;GO:0045579;GO:0043280;GO:0050679;GO:0033133;GO:1904710;GO:0032024;GO:0035774;GO:2001244;GO:1902220;GO:0010918;GO:1901216;GO:1900740;GO:0045862;GO:0090200;GO:0045582;GO:2000078;GO:0001844;GO:0046902;GO:0001836;GO:0043200;GO:1901423;GO:0051592;GO:0042493;GO:0032355;GO:0045471;GO:0051384;GO:0009749;GO:0042542;GO:0034201;GO:0032570;GO:0033574;GO:0007283;GO:0019050;GO:0044342;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:14-3-3 protein binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:lipid binding; F:phospholipid binding; F:protein kinase B binding; F:protein kinase binding; F:protein phosphatase 2B binding; F:protein phosphatase binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:ADP metabolic process; P:apoptotic process; P:ATP metabolic process; P:cellular response to chromate; P:cellular response to hypoxia; P:cellular response to lipid; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cerebral cortex development; P:cytokine-mediated signaling pathway; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:glucose catabolic process; P:glucose homeostasis; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:pore complex assembly; P:positive regulation of apoptotic process; P:positive regulation of apoptotic process by virus; P:positive regulation of autophagy; P:positive regulation of B cell differentiation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of epithelial cell proliferation; P:positive regulation of glucokinase activity; P:positive regulation of granulosa cell apoptotic process; P:positive regulation of insulin secretion; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:positive regulation of mitochondrial membrane potential; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of proteolysis; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of T cell differentiation; P:positive regulation of type B pancreatic cell development; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of mitochondrial membrane permeability; P:release of cytochrome c from mitochondria; P:response to amino acid; P:response to benzene; P:response to calcium ion; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to glucocorticoid; P:response to glucose; P:response to hydrogen peroxide; P:response to oleic acid; P:response to progesterone; P:response to testosterone; P:spermatogenesis; P:suppression by virus of host apoptotic process; P:type B pancreatic cell proliferation;|Q92934 O14803 Q6FH21,Bcl2-associated agonist of cell death,Bcl-2-binding component 6;Bcl-2-like protein 8;Bcl-xL/Bcl-2-associated death promoter;Bcl2 antagonist of cell death;, PF10514;, GO:0005829;GO:0005741;GO:0005739;GO:0071889;GO:0008656;GO:0008289;GO:0005543;GO:0043422;GO:0019901;GO:0030346;GO:0019903;GO:0097202;GO:0006919;GO:0046031;GO:0006915;GO:0046034;GO:0071247;GO:0071456;GO:0071396;GO:0071260;GO:0071316;GO:0021987;GO:0019221;GO:0097191;GO:0097192;GO:0008625;GO:0006007;GO:0042593;GO:0097193;GO:0008630;GO:0046931;GO:0043065;GO:0060139;GO:0010508;GO:0045579;GO:0043280;GO:0050679;GO:0033133;GO:1904710;GO:0032024;GO:0035774;GO:2001244;GO:1902220;GO:0010918;GO:1901216;GO:1900740;GO:0045862;GO:0090200;GO:0045582;GO:2000078;GO:0001844;GO:0046902;GO:0001836;GO:0043200;GO:1901423;GO:0051592;GO:0042493;GO:0032355;GO:0045471;GO:0051384;GO:0009749;GO:0042542;GO:0034201;GO:0032570;GO:0033574;GO:0007283;GO:0019050;GO:0044342;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:14-3-3 protein binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:lipid binding; F:phospholipid binding; F:protein kinase B binding; F:protein kinase binding; F:protein phosphatase 2B binding; F:protein phosphatase binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:ADP metabolic process; P:apoptotic process; P:ATP metabolic process; P:cellular response to chromate; P:cellular response to hypoxia; P:cellular response to lipid; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cerebral cortex development; P:cytokine-mediated signaling pathway; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:glucose catabolic process; P:glucose homeostasis; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:pore complex assembly; P:positive regulation of apoptotic process; P:positive regulation of apoptotic process by virus; P:positive regulation of autophagy; P:positive regulation of B cell differentiation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of epithelial cell proliferation; P:positive regulation of glucokinase activity; P:positive regulation of granulosa cell apoptotic process; P:positive regulation of insulin secretion; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:positive regulation of mitochondrial membrane potential; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of proteolysis; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of T cell differentiation; P:positive regulation of type B pancreatic cell development; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of mitochondrial membrane permeability; P:release of cytochrome c from mitochondria; P:response to amino acid; P:response to benzene; P:response to calcium ion; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to glucocorticoid; P:response to glucose; P:response to hydrogen peroxide; P:response to oleic acid; P:response to progesterone; P:response to testosterone; P:spermatogenesis; P:suppression by virus of host apoptotic process; P:type B pancreatic cell proliferation;|Q92934 O14803 Q6FH21,Bcl2-associated agonist of cell death,Bcl-2-binding component 6;Bcl-2-like protein 8;Bcl-xL/Bcl-2-associated death promoter;Bcl2 antagonist of cell death;, PF10514;, GO:0005829;GO:0005741;GO:0005739;GO:0071889;GO:0008656;GO:0008289;GO:0005543;GO:0043422;GO:0019901;GO:0030346;GO:0019903;GO:0097202;GO:0006919;GO:0046031;GO:0006915;GO:0046034;GO:0071247;GO:0071456;GO:0071396;GO:0071260;GO:0071316;GO:0021987;GO:0019221;GO:0097191;GO:0097192;GO:0008625;GO:0006007;GO:0042593;GO:0097193;GO:0008630;GO:0046931;GO:0043065;GO:0060139;GO:0010508;GO:0045579;GO:0043280;GO:0050679;GO:0033133;GO:1904710;GO:0032024;GO:0035774;GO:2001244;GO:1902220;GO:0010918;GO:1901216;GO:1900740;GO:0045862;GO:0090200;GO:0045582;GO:2000078;GO:0001844;GO:0046902;GO:0001836;GO:0043200;GO:1901423;GO:0051592;GO:0042493;GO:0032355;GO:0045471;GO:0051384;GO:0009749;GO:0042542;GO:0034201;GO:0032570;GO:0033574;GO:0007283;GO:0019050;GO:0044342;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:14-3-3 protein binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:lipid binding; F:phospholipid binding; F:protein kinase B binding; F:protein kinase binding; F:protein phosphatase 2B binding; F:protein phosphatase binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:ADP metabolic process; P:apoptotic process; P:ATP metabolic process; P:cellular response to chromate; P:cellular response to hypoxia; P:cellular response to lipid; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cerebral cortex development; P:cytokine-mediated signaling pathway; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:glucose catabolic process; P:glucose homeostasis; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:pore complex assembly; P:positive regulation of apoptotic process; P:positive regulation of apoptotic process by virus; P:positive regulation of autophagy; P:positive regulation of B cell differentiation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of epithelial cell proliferation; P:positive regulation of glucokinase activity; P:positive regulation of granulosa cell apoptotic process; P:positive regulation of insulin secretion; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:positive regulation of mitochondrial membrane potential; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of proteolysis; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of T cell differentiation; P:positive regulation of type B pancreatic cell development; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of mitochondrial membrane permeability; P:release of cytochrome c from mitochondria; P:response to amino acid; P:response to benzene; P:response to calcium ion; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to glucocorticoid; P:response to glucose; P:response to hydrogen peroxide; P:response to oleic acid; P:response to progesterone; P:response to testosterone; P:spermatogenesis; P:suppression by virus of host apoptotic process; P:type B pancreatic cell proliferation;|Q92934 O14803 Q6FH21,Bcl2-associated agonist of cell death,Bcl-2-binding component 6;Bcl-2-like protein 8;Bcl-xL/Bcl-2-associated death promoter;Bcl2 antagonist of cell death;, PF10514;, GO:0005829;GO:0005741;GO:0005739;GO:0071889;GO:0008656;GO:0008289;GO:0005543;GO:0043422;GO:0019901;GO:0030346;GO:0019903;GO:0097202;GO:0006919;GO:0046031;GO:0006915;GO:0046034;GO:0071247;GO:0071456;GO:0071396;GO:0071260;GO:0071316;GO:0021987;GO:0019221;GO:0097191;GO:0097192;GO:0008625;GO:0006007;GO:0042593;GO:0097193;GO:0008630;GO:0046931;GO:0043065;GO:0060139;GO:0010508;GO:0045579;GO:0043280;GO:0050679;GO:0033133;GO:1904710;GO:0032024;GO:0035774;GO:2001244;GO:1902220;GO:0010918;GO:1901216;GO:1900740;GO:0045862;GO:0090200;GO:0045582;GO:2000078;GO:0001844;GO:0046902;GO:0001836;GO:0043200;GO:1901423;GO:0051592;GO:0042493;GO:0032355;GO:0045471;GO:0051384;GO:0009749;GO:0042542;GO:0034201;GO:0032570;GO:0033574;GO:0007283;GO:0019050;GO:0044342;, C:cytosol; C:mitochondrial outer membrane; C:mitochondrion;, F:14-3-3 protein binding; F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:lipid binding; F:phospholipid binding; F:protein kinase B binding; F:protein kinase binding; F:protein phosphatase 2B binding; F:protein phosphatase binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:ADP metabolic process; P:apoptotic process; P:ATP metabolic process; P:cellular response to chromate; P:cellular response to hypoxia; P:cellular response to lipid; P:cellular response to mechanical stimulus; P:cellular response to nicotine; P:cerebral cortex development; P:cytokine-mediated signaling pathway; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:glucose catabolic process; P:glucose homeostasis; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:pore complex assembly; P:positive regulation of apoptotic process; P:positive regulation of apoptotic process by virus; P:positive regulation of autophagy; P:positive regulation of B cell differentiation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of epithelial cell proliferation; P:positive regulation of glucokinase activity; P:positive regulation of granulosa cell apoptotic process; P:positive regulation of insulin secretion; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; P:positive regulation of mitochondrial membrane potential; P:positive regulation of neuron death; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of proteolysis; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of T cell differentiation; P:positive regulation of type B pancreatic cell development; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of mitochondrial membrane permeability; P:release of cytochrome c from mitochondria; P:response to amino acid; P:response to benzene; P:response to calcium ion; P:response to drug; P:response to estradiol; P:response to ethanol; P:response to glucocorticoid; P:response to glucose; P:response to hydrogen peroxide; P:response to oleic acid; P:response to progesterone; P:response to testosterone; P:spermatogenesis; P:suppression by virus of host apoptotic process; P:type B pancreatic cell proliferation; scaffold241 indexed_genome mRNA 415996 428246 . - . ID=transcript_16213;Q01970 A5PKZ6 G5E960 Q8N1A4,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 {ECO:0000305},Phosphoinositide phospholipase C-beta-3;Phospholipase C-beta-3;, PF00168;PF09279;PF17787;PF00388;PF00387;PF08703;, GO:0005829;GO:0016020;GO:0005634;GO:0099524;GO:0032991;GO:0045296;GO:0005509;GO:0005516;GO:0004435;GO:0004629;GO:0007186;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0003073;GO:0007223;, C:cytosol; C:membrane; C:nucleus; C:postsynaptic cytosol; C:protein-containing complex;, F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:regulation of systemic arterial blood pressure; P:Wnt signaling pathway, calcium modulating pathway;|Q01970 A5PKZ6 G5E960 Q8N1A4,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 {ECO:0000305},Phosphoinositide phospholipase C-beta-3;Phospholipase C-beta-3;, PF00168;PF09279;PF17787;PF00388;PF00387;PF08703;, GO:0005829;GO:0016020;GO:0005634;GO:0099524;GO:0032991;GO:0045296;GO:0005509;GO:0005516;GO:0004435;GO:0004629;GO:0007186;GO:0043647;GO:0016042;GO:0046488;GO:0048015;GO:0003073;GO:0007223;, C:cytosol; C:membrane; C:nucleus; C:postsynaptic cytosol; C:protein-containing complex;, F:cadherin binding; F:calcium ion binding; F:calmodulin binding; F:phosphatidylinositol phospholipase C activity; F:phospholipase C activity;, P:G protein-coupled receptor signaling pathway; P:inositol phosphate metabolic process; P:lipid catabolic process; P:phosphatidylinositol metabolic process; P:phosphatidylinositol-mediated signaling; P:regulation of systemic arterial blood pressure; P:Wnt signaling pathway, calcium modulating pathway; scaffold242 indexed_genome mRNA 4873 12671 . - . ID=transcript_16214;Q0D2K2 Q6ZUS1,Kelch-like protein 30,, PF07707;PF00651;PF01344; scaffold242 indexed_genome mRNA 12690 16935 . + . ID=transcript_16215;Q0D2K2 Q6ZUS1,Kelch-like protein 30,, PF07707;PF00651;PF01344; scaffold242 indexed_genome mRNA 48622 96529 . - . ID=transcript_16216;Q969M7 A8K1Z8 B4DDT9 B4DFI1 B4DMK3 B4DZU2 B8ZZG2 C9J212 H9KVB9,NEDD8-conjugating enzyme UBE2F,NEDD8 carrier protein UBE2F;NEDD8 protein ligase UBE2F;NEDD8-conjugating enzyme 2;RING-type E3 NEDD8 transferase UBE2F;Ubiquitin-conjugating enzyme E2 F;, PF00179;, GO:0005829;GO:0005634;GO:0005524;GO:0061654;GO:0019788;GO:0043687;GO:0045116;, C:cytosol; C:nucleus;, F:ATP binding; F:NEDD8 conjugating enzyme activity; F:NEDD8 transferase activity;, P:post-translational protein modification; P:protein neddylation;|Q969M7 A8K1Z8 B4DDT9 B4DFI1 B4DMK3 B4DZU2 B8ZZG2 C9J212 H9KVB9,NEDD8-conjugating enzyme UBE2F,NEDD8 carrier protein UBE2F;NEDD8 protein ligase UBE2F;NEDD8-conjugating enzyme 2;RING-type E3 NEDD8 transferase UBE2F;Ubiquitin-conjugating enzyme E2 F;, PF00179;, GO:0005829;GO:0005634;GO:0005524;GO:0061654;GO:0019788;GO:0043687;GO:0045116;, C:cytosol; C:nucleus;, F:ATP binding; F:NEDD8 conjugating enzyme activity; F:NEDD8 transferase activity;, P:post-translational protein modification; P:protein neddylation; scaffold242 indexed_genome mRNA 128870 159737 . + . ID=transcript_16217;O60894 Q6FGS5,Receptor activity-modifying protein 1,Calcitonin-receptor-like receptor activity-modifying protein 1;, PF04901;, GO:0150056;GO:0009986;GO:1990406;GO:0005615;GO:0005887;GO:0005886;GO:0043235;GO:0097643;GO:1990407;GO:0001635;GO:0015026;GO:0007189;GO:0097647;GO:0001525;GO:1990408;GO:0006816;GO:0032870;GO:0007186;GO:0006886;GO:0002862;GO:0032092;GO:0060050;GO:0072659;GO:0015031;GO:0031623;GO:0008277;, C:amylin receptor complex 1; C:cell surface; C:CGRP receptor complex; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:amylin receptor activity; F:calcitonin gene-related peptide binding; F:calcitonin gene-related peptide receptor activity; F:coreceptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:amylin receptor signaling pathway; P:angiogenesis; P:calcitonin gene-related peptide receptor signaling pathway; P:calcium ion transport; P:cellular response to hormone stimulus; P:G protein-coupled receptor signaling pathway; P:intracellular protein transport; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of protein binding; P:positive regulation of protein glycosylation; P:protein localization to plasma membrane; P:protein transport; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway;|O60894 Q6FGS5,Receptor activity-modifying protein 1,Calcitonin-receptor-like receptor activity-modifying protein 1;, PF04901;, GO:0150056;GO:0009986;GO:1990406;GO:0005615;GO:0005887;GO:0005886;GO:0043235;GO:0097643;GO:1990407;GO:0001635;GO:0015026;GO:0007189;GO:0097647;GO:0001525;GO:1990408;GO:0006816;GO:0032870;GO:0007186;GO:0006886;GO:0002862;GO:0032092;GO:0060050;GO:0072659;GO:0015031;GO:0031623;GO:0008277;, C:amylin receptor complex 1; C:cell surface; C:CGRP receptor complex; C:extracellular space; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:amylin receptor activity; F:calcitonin gene-related peptide binding; F:calcitonin gene-related peptide receptor activity; F:coreceptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:amylin receptor signaling pathway; P:angiogenesis; P:calcitonin gene-related peptide receptor signaling pathway; P:calcium ion transport; P:cellular response to hormone stimulus; P:G protein-coupled receptor signaling pathway; P:intracellular protein transport; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of protein binding; P:positive regulation of protein glycosylation; P:protein localization to plasma membrane; P:protein transport; P:receptor internalization; P:regulation of G protein-coupled receptor signaling pathway; scaffold242 indexed_genome mRNA 211388 250414 . - . ID=transcript_16218;Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway;|Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway;|Q9Y608 A8K649 A8MXR0 B4DY63 Q68CV3 Q9NXH5,Leucine-rich repeat flightless-interacting protein 2,, PF09738;, GO:0030275;GO:0006355;GO:0016055;, , F:LRR domain binding;, P:regulation of transcription, DNA-templated; P:Wnt signaling pathway;|Q32MZ4 E9PGZ2 O75766 O75799 Q32MZ5 Q53T49 Q6PKG2 Q9Y607,Leucine-rich repeat flightless-interacting protein 1,GC-binding factor 2;TAR RNA-interacting protein;, PF09738;, GO:0005737;GO:0005856;GO:0005829;GO:0005634;GO:0005886;GO:0045296;GO:0003677;GO:0000981;GO:0001227;GO:0003725;GO:0042803;GO:0000978;GO:0000122;GO:0051092;GO:0032481;GO:0006357;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleus; C:plasma membrane;, F:cadherin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:double-stranded RNA binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II;|Q32MZ4 E9PGZ2 O75766 O75799 Q32MZ5 Q53T49 Q6PKG2 Q9Y607,Leucine-rich repeat flightless-interacting protein 1,GC-binding factor 2;TAR RNA-interacting protein;, PF09738;, GO:0005737;GO:0005856;GO:0005829;GO:0005634;GO:0005886;GO:0045296;GO:0003677;GO:0000981;GO:0001227;GO:0003725;GO:0042803;GO:0000978;GO:0000122;GO:0051092;GO:0032481;GO:0006357;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleus; C:plasma membrane;, F:cadherin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:double-stranded RNA binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II;|Q32MZ4 E9PGZ2 O75766 O75799 Q32MZ5 Q53T49 Q6PKG2 Q9Y607,Leucine-rich repeat flightless-interacting protein 1,GC-binding factor 2;TAR RNA-interacting protein;, PF09738;, GO:0005737;GO:0005856;GO:0005829;GO:0005634;GO:0005886;GO:0045296;GO:0003677;GO:0000981;GO:0001227;GO:0003725;GO:0042803;GO:0000978;GO:0000122;GO:0051092;GO:0032481;GO:0006357;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleus; C:plasma membrane;, F:cadherin binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:double-stranded RNA binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of type I interferon production; P:regulation of transcription by RNA polymerase II; scaffold245 indexed_genome mRNA 49961 54966 . - . ID=transcript_16219;Q9NS66 B1B0A5,Probable G-protein coupled receptor 173,Super conserved receptor expressed in brain 3;, PF00001;, GO:0016021;GO:0005886;GO:0004930;GO:0004968;GO:0007165;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity; F:gonadotropin-releasing hormone receptor activity;, P:signal transduction; scaffold245 indexed_genome mRNA 58557 65737 . + . ID=transcript_16220;Q9H2G4 O94799 Q96DG7 Q9BZW6,Testis-specific Y-encoded-like protein 2,Cell division autoantigen 1;Cutaneous T-cell lymphoma-associated antigen se20-4;Differentially-expressed nucleolar TGF-beta1 target protein;Nuclear protein of 79 kDa;, PF00956;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0000182;GO:0007049;GO:0036498;GO:0045786;GO:0030308;GO:0008156;GO:0006334;GO:0045859;GO:0009966;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:rDNA binding;, P:cell cycle; P:IRE1-mediated unfolded protein response; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of DNA replication; P:nucleosome assembly; P:regulation of protein kinase activity; P:regulation of signal transduction;|Q9H2G4 O94799 Q96DG7 Q9BZW6,Testis-specific Y-encoded-like protein 2,Cell division autoantigen 1;Cutaneous T-cell lymphoma-associated antigen se20-4;Differentially-expressed nucleolar TGF-beta1 target protein;Nuclear protein of 79 kDa;, PF00956;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0000182;GO:0007049;GO:0036498;GO:0045786;GO:0030308;GO:0008156;GO:0006334;GO:0045859;GO:0009966;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:rDNA binding;, P:cell cycle; P:IRE1-mediated unfolded protein response; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of DNA replication; P:nucleosome assembly; P:regulation of protein kinase activity; P:regulation of signal transduction;|Q9H2G4 O94799 Q96DG7 Q9BZW6,Testis-specific Y-encoded-like protein 2,Cell division autoantigen 1;Cutaneous T-cell lymphoma-associated antigen se20-4;Differentially-expressed nucleolar TGF-beta1 target protein;Nuclear protein of 79 kDa;, PF00956;, GO:0000785;GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0003682;GO:0042393;GO:0000182;GO:0007049;GO:0036498;GO:0045786;GO:0030308;GO:0008156;GO:0006334;GO:0045859;GO:0009966;, C:chromatin; C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:rDNA binding;, P:cell cycle; P:IRE1-mediated unfolded protein response; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of DNA replication; P:nucleosome assembly; P:regulation of protein kinase activity; P:regulation of signal transduction;|Q8N831 Q6NUJ3,Testis-specific Y-encoded-like protein 6,, PF00956;, GO:0000785;GO:0005634;GO:0003682;GO:0042393;GO:0006334;, C:chromatin; C:nucleus;, F:chromatin binding; F:histone binding;, P:nucleosome assembly; scaffold245 indexed_genome mRNA 106843 109965 . + . ID=transcript_16221;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold245 indexed_genome mRNA 150906 172219 . - . ID=transcript_16222;P41229 B0QZ44 B4E3I2 F5H3T1 Q5JUX3 Q5JUX4 Q5JUX5 Q7Z5S5,Lysine-specific demethylase 5C,Histone demethylase JARID1C;Jumonji/ARID domain-containing protein 1C {ECO:0000303|PubMed:19636912};Protein SmcX {ECO:0000303|PubMed:19636912};Protein Xe169;[histone H3]-trimethyl-L-lysine(4) demethylase 5C {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0032452;GO:0032453;GO:0034647;GO:0008270;GO:0006338;GO:0034720;GO:0045892;GO:0009636;GO:0048511;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K4 demethylation; P:negative regulation of transcription, DNA-templated; P:response to toxic substance; P:rhythmic process;|P41229 B0QZ44 B4E3I2 F5H3T1 Q5JUX3 Q5JUX4 Q5JUX5 Q7Z5S5,Lysine-specific demethylase 5C,Histone demethylase JARID1C;Jumonji/ARID domain-containing protein 1C {ECO:0000303|PubMed:19636912};Protein SmcX {ECO:0000303|PubMed:19636912};Protein Xe169;[histone H3]-trimethyl-L-lysine(4) demethylase 5C {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0032452;GO:0032453;GO:0034647;GO:0008270;GO:0006338;GO:0034720;GO:0045892;GO:0009636;GO:0048511;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K4 demethylation; P:negative regulation of transcription, DNA-templated; P:response to toxic substance; P:rhythmic process;|P41229 B0QZ44 B4E3I2 F5H3T1 Q5JUX3 Q5JUX4 Q5JUX5 Q7Z5S5,Lysine-specific demethylase 5C,Histone demethylase JARID1C;Jumonji/ARID domain-containing protein 1C {ECO:0000303|PubMed:19636912};Protein SmcX {ECO:0000303|PubMed:19636912};Protein Xe169;[histone H3]-trimethyl-L-lysine(4) demethylase 5C {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0032452;GO:0032453;GO:0034647;GO:0008270;GO:0006338;GO:0034720;GO:0045892;GO:0009636;GO:0048511;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K4 demethylation; P:negative regulation of transcription, DNA-templated; P:response to toxic substance; P:rhythmic process;|P41229 B0QZ44 B4E3I2 F5H3T1 Q5JUX3 Q5JUX4 Q5JUX5 Q7Z5S5,Lysine-specific demethylase 5C,Histone demethylase JARID1C;Jumonji/ARID domain-containing protein 1C {ECO:0000303|PubMed:19636912};Protein SmcX {ECO:0000303|PubMed:19636912};Protein Xe169;[histone H3]-trimethyl-L-lysine(4) demethylase 5C {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0032452;GO:0032453;GO:0034647;GO:0008270;GO:0006338;GO:0034720;GO:0045892;GO:0009636;GO:0048511;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K4 demethylation; P:negative regulation of transcription, DNA-templated; P:response to toxic substance; P:rhythmic process; scaffold245 indexed_genome mRNA 172328 183160 . - . ID=transcript_16223;P41229 B0QZ44 B4E3I2 F5H3T1 Q5JUX3 Q5JUX4 Q5JUX5 Q7Z5S5,Lysine-specific demethylase 5C,Histone demethylase JARID1C;Jumonji/ARID domain-containing protein 1C {ECO:0000303|PubMed:19636912};Protein SmcX {ECO:0000303|PubMed:19636912};Protein Xe169;[histone H3]-trimethyl-L-lysine(4) demethylase 5C {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0032452;GO:0032453;GO:0034647;GO:0008270;GO:0006338;GO:0034720;GO:0045892;GO:0009636;GO:0048511;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K4 demethylation; P:negative regulation of transcription, DNA-templated; P:response to toxic substance; P:rhythmic process;|P41229 B0QZ44 B4E3I2 F5H3T1 Q5JUX3 Q5JUX4 Q5JUX5 Q7Z5S5,Lysine-specific demethylase 5C,Histone demethylase JARID1C;Jumonji/ARID domain-containing protein 1C {ECO:0000303|PubMed:19636912};Protein SmcX {ECO:0000303|PubMed:19636912};Protein Xe169;[histone H3]-trimethyl-L-lysine(4) demethylase 5C {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0032452;GO:0032453;GO:0034647;GO:0008270;GO:0006338;GO:0034720;GO:0045892;GO:0009636;GO:0048511;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K4 demethylation; P:negative regulation of transcription, DNA-templated; P:response to toxic substance; P:rhythmic process;|P41229 B0QZ44 B4E3I2 F5H3T1 Q5JUX3 Q5JUX4 Q5JUX5 Q7Z5S5,Lysine-specific demethylase 5C,Histone demethylase JARID1C;Jumonji/ARID domain-containing protein 1C {ECO:0000303|PubMed:19636912};Protein SmcX {ECO:0000303|PubMed:19636912};Protein Xe169;[histone H3]-trimethyl-L-lysine(4) demethylase 5C {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0005829;GO:0035097;GO:0005654;GO:0005634;GO:0051213;GO:0003677;GO:0032452;GO:0032453;GO:0034647;GO:0008270;GO:0006338;GO:0034720;GO:0045892;GO:0009636;GO:0048511;, C:cytosol; C:histone methyltransferase complex; C:nucleoplasm; C:nucleus;, F:dioxygenase activity; F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:zinc ion binding;, P:chromatin remodeling; P:histone H3-K4 demethylation; P:negative regulation of transcription, DNA-templated; P:response to toxic substance; P:rhythmic process;|Q9BY66 A2RU19 A6H8V7 B7ZLX1 Q92509 Q92809 Q9HCU1,Lysine-specific demethylase 5D,Histocompatibility Y antigen;Histone demethylase JARID1D;Jumonji/ARID domain-containing protein 1D;Protein SmcY;[histone H3]-trimethyl-L-lysine(4) demethylase 5D {ECO:0000305};, PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;, GO:0001650;GO:0035097;GO:0005654;GO:0050681;GO:0051213;GO:0003677;GO:0032452;GO:0032453;GO:0034647;GO:0046872;GO:0006338;GO:0034720;GO:0060765;, C:fibrillar center; C:histone methyltransferase complex; C:nucleoplasm;, F:androgen receptor binding; F:dioxygenase activity; F:DNA binding; F:histone demethylase activity; F:histone demethylase activity (H3-K4 specific); F:histone demethylase activity (H3-trimethyl-K4 specific); F:metal ion binding;, P:chromatin remodeling; P:histone H3-K4 demethylation; P:regulation of androgen receptor signaling pathway; scaffold245 indexed_genome mRNA 192794 193561 . + . ID=transcript_16224;Q5JU85 A0A1W2PQN3 B3KT97 C7SDG1 O60275 Q5JUX1,IQ motif and SEC7 domain-containing protein 2,, PF16453;PF01369;, GO:0005737;GO:0098685;GO:0005085;GO:0030036;GO:0050804;GO:0032012;GO:0098696;, C:cytoplasm; C:Schaffer collateral - CA1 synapse;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:modulation of chemical synaptic transmission; P:regulation of ARF protein signal transduction; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; scaffold245 indexed_genome mRNA 193597 195912 . + . ID=transcript_16225;Q5JU85 A0A1W2PQN3 B3KT97 C7SDG1 O60275 Q5JUX1,IQ motif and SEC7 domain-containing protein 2,, PF16453;PF01369;, GO:0005737;GO:0098685;GO:0005085;GO:0030036;GO:0050804;GO:0032012;GO:0098696;, C:cytoplasm; C:Schaffer collateral - CA1 synapse;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:modulation of chemical synaptic transmission; P:regulation of ARF protein signal transduction; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane;|Q5JU85 A0A1W2PQN3 B3KT97 C7SDG1 O60275 Q5JUX1,IQ motif and SEC7 domain-containing protein 2,, PF16453;PF01369;, GO:0005737;GO:0098685;GO:0005085;GO:0030036;GO:0050804;GO:0032012;GO:0098696;, C:cytoplasm; C:Schaffer collateral - CA1 synapse;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:modulation of chemical synaptic transmission; P:regulation of ARF protein signal transduction; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; scaffold245 indexed_genome mRNA 195927 204034 . - . ID=transcript_16226;Q5JU85 A0A1W2PQN3 B3KT97 C7SDG1 O60275 Q5JUX1,IQ motif and SEC7 domain-containing protein 2,, PF16453;PF01369;, GO:0005737;GO:0098685;GO:0005085;GO:0030036;GO:0050804;GO:0032012;GO:0098696;, C:cytoplasm; C:Schaffer collateral - CA1 synapse;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:modulation of chemical synaptic transmission; P:regulation of ARF protein signal transduction; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane;|Q5JU85 A0A1W2PQN3 B3KT97 C7SDG1 O60275 Q5JUX1,IQ motif and SEC7 domain-containing protein 2,, PF16453;PF01369;, GO:0005737;GO:0098685;GO:0005085;GO:0030036;GO:0050804;GO:0032012;GO:0098696;, C:cytoplasm; C:Schaffer collateral - CA1 synapse;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:modulation of chemical synaptic transmission; P:regulation of ARF protein signal transduction; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane;|Q5JU85 A0A1W2PQN3 B3KT97 C7SDG1 O60275 Q5JUX1,IQ motif and SEC7 domain-containing protein 2,, PF16453;PF01369;, GO:0005737;GO:0098685;GO:0005085;GO:0030036;GO:0050804;GO:0032012;GO:0098696;, C:cytoplasm; C:Schaffer collateral - CA1 synapse;, F:guanyl-nucleotide exchange factor activity;, P:actin cytoskeleton organization; P:modulation of chemical synaptic transmission; P:regulation of ARF protein signal transduction; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; scaffold245 indexed_genome mRNA 330207 366012 . - . ID=transcript_16227;Q14683 O14995 Q16351 Q2M228,Structural maintenance of chromosomes protein 1A,Sb1.8;, PF06470;PF02463;, GO:0005694;GO:0000775;GO:0008278;GO:0000777;GO:0000794;GO:0005829;GO:0000776;GO:0030893;GO:0097431;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0036033;GO:0046982;GO:0003723;GO:0051301;GO:0006281;GO:0051321;GO:0007064;GO:0000070;GO:0090307;GO:0072423;GO:0009314;GO:0007062;GO:0019827;, C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:condensed chromosome kinetochore; C:condensed nuclear chromosome; C:cytosol; C:kinetochore; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:mediator complex binding; F:protein heterodimerization activity; F:RNA binding;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic sister chromatid cohesion; P:mitotic sister chromatid segregation; P:mitotic spindle assembly; P:response to DNA damage checkpoint signaling; P:response to radiation; P:sister chromatid cohesion; P:stem cell population maintenance;|Q14683 O14995 Q16351 Q2M228,Structural maintenance of chromosomes protein 1A,Sb1.8;, PF06470;PF02463;, GO:0005694;GO:0000775;GO:0008278;GO:0000777;GO:0000794;GO:0005829;GO:0000776;GO:0030893;GO:0097431;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0036033;GO:0046982;GO:0003723;GO:0051301;GO:0006281;GO:0051321;GO:0007064;GO:0000070;GO:0090307;GO:0072423;GO:0009314;GO:0007062;GO:0019827;, C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:condensed chromosome kinetochore; C:condensed nuclear chromosome; C:cytosol; C:kinetochore; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:mediator complex binding; F:protein heterodimerization activity; F:RNA binding;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic sister chromatid cohesion; P:mitotic sister chromatid segregation; P:mitotic spindle assembly; P:response to DNA damage checkpoint signaling; P:response to radiation; P:sister chromatid cohesion; P:stem cell population maintenance;|Q14683 O14995 Q16351 Q2M228,Structural maintenance of chromosomes protein 1A,Sb1.8;, PF06470;PF02463;, GO:0005694;GO:0000775;GO:0008278;GO:0000777;GO:0000794;GO:0005829;GO:0000776;GO:0030893;GO:0097431;GO:0016363;GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0036033;GO:0046982;GO:0003723;GO:0051301;GO:0006281;GO:0051321;GO:0007064;GO:0000070;GO:0090307;GO:0072423;GO:0009314;GO:0007062;GO:0019827;, C:chromosome; C:chromosome, centromeric region; C:cohesin complex; C:condensed chromosome kinetochore; C:condensed nuclear chromosome; C:cytosol; C:kinetochore; C:meiotic cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nucleoplasm; C:nucleus;, F:ATP binding; F:ATPase activity; F:chromatin binding; F:mediator complex binding; F:protein heterodimerization activity; F:RNA binding;, P:cell division; P:DNA repair; P:meiotic cell cycle; P:mitotic sister chromatid cohesion; P:mitotic sister chromatid segregation; P:mitotic spindle assembly; P:response to DNA damage checkpoint signaling; P:response to radiation; P:sister chromatid cohesion; P:stem cell population maintenance; scaffold245 indexed_genome mRNA 366136 379386 . + . ID=transcript_16228;Q8N443 B4E297 E9PDU2 Q5H931 Q96A80,RIB43A-like with coiled-coils protein 1,, PF05914;|Q8N443 B4E297 E9PDU2 Q5H931 Q96A80,RIB43A-like with coiled-coils protein 1,, PF05914;|Q8N443 B4E297 E9PDU2 Q5H931 Q96A80,RIB43A-like with coiled-coils protein 1,, PF05914; scaffold245 indexed_genome mRNA 379569 381953 . - . ID=transcript_16229;Q99714 Q5H927 Q6IBS9 Q8TCV9 Q96HD5,3-hydroxyacyl-CoA dehydrogenase type-2,17-beta-estradiol 17-dehydrogenase;2-methyl-3-hydroxybutyryl-CoA dehydrogenase {ECO:0000303|PubMed:16148061};3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+));3-hydroxy-2-methylbutyryl-CoA dehydrogenase;3-hydroxyacyl-CoA dehydrogenase type II;3alpha(or 20beta)-hydroxysteroid dehydrogenase;7-alpha-hydroxysteroid dehydrogenase;Endoplasmic reticulum-associated amyloid beta-peptide-binding protein;Mitochondrial ribonuclease P protein 2;Short chain dehydrogenase/reductase family 5C member 1;Short-chain type dehydrogenase/reductase XH98G2;Type II HADH;, PF00106;, GO:0005737;GO:0005759;GO:0042645;GO:0030678;GO:0005739;GO:0005886;GO:0044594;GO:0047015;GO:0003857;GO:0047044;GO:0106281;GO:0008709;GO:0106282;GO:0003723;GO:0047035;GO:0030283;GO:0000049;GO:0106283;GO:0008209;GO:0006699;GO:0009083;GO:0062173;GO:0008207;GO:0008210;GO:0006635;GO:0006550;GO:0006629;GO:1990180;GO:0097745;GO:0070901;GO:0007005;GO:0051289;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrial ribonuclease P complex; C:mitochondrion; C:plasma membrane;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity; F:3-hydroxyacyl-CoA dehydrogenase activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity; F:cholate 7-alpha-dehydrogenase activity; F:isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity; F:RNA binding; F:testosterone dehydrogenase (NAD+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:tRNA binding; F:ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity;, P:androgen metabolic process; P:bile acid biosynthetic process; P:branched-chain amino acid catabolic process; P:brexanolone metabolic process; P:C21-steroid hormone metabolic process; P:estrogen metabolic process; P:fatty acid beta-oxidation; P:isoleucine catabolic process; P:lipid metabolic process; P:mitochondrial tRNA 3'-end processing; P:mitochondrial tRNA 5'-end processing; P:mitochondrial tRNA methylation; P:mitochondrion organization; P:protein homotetramerization;|Q99714 Q5H927 Q6IBS9 Q8TCV9 Q96HD5,3-hydroxyacyl-CoA dehydrogenase type-2,17-beta-estradiol 17-dehydrogenase;2-methyl-3-hydroxybutyryl-CoA dehydrogenase {ECO:0000303|PubMed:16148061};3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+));3-hydroxy-2-methylbutyryl-CoA dehydrogenase;3-hydroxyacyl-CoA dehydrogenase type II;3alpha(or 20beta)-hydroxysteroid dehydrogenase;7-alpha-hydroxysteroid dehydrogenase;Endoplasmic reticulum-associated amyloid beta-peptide-binding protein;Mitochondrial ribonuclease P protein 2;Short chain dehydrogenase/reductase family 5C member 1;Short-chain type dehydrogenase/reductase XH98G2;Type II HADH;, PF00106;, GO:0005737;GO:0005759;GO:0042645;GO:0030678;GO:0005739;GO:0005886;GO:0044594;GO:0047015;GO:0003857;GO:0047044;GO:0106281;GO:0008709;GO:0106282;GO:0003723;GO:0047035;GO:0030283;GO:0000049;GO:0106283;GO:0008209;GO:0006699;GO:0009083;GO:0062173;GO:0008207;GO:0008210;GO:0006635;GO:0006550;GO:0006629;GO:1990180;GO:0097745;GO:0070901;GO:0007005;GO:0051289;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrial ribonuclease P complex; C:mitochondrion; C:plasma membrane;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity; F:3-hydroxyacyl-CoA dehydrogenase activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity; F:cholate 7-alpha-dehydrogenase activity; F:isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity; F:RNA binding; F:testosterone dehydrogenase (NAD+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:tRNA binding; F:ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity;, P:androgen metabolic process; P:bile acid biosynthetic process; P:branched-chain amino acid catabolic process; P:brexanolone metabolic process; P:C21-steroid hormone metabolic process; P:estrogen metabolic process; P:fatty acid beta-oxidation; P:isoleucine catabolic process; P:lipid metabolic process; P:mitochondrial tRNA 3'-end processing; P:mitochondrial tRNA 5'-end processing; P:mitochondrial tRNA methylation; P:mitochondrion organization; P:protein homotetramerization;|Q99714 Q5H927 Q6IBS9 Q8TCV9 Q96HD5,3-hydroxyacyl-CoA dehydrogenase type-2,17-beta-estradiol 17-dehydrogenase;2-methyl-3-hydroxybutyryl-CoA dehydrogenase {ECO:0000303|PubMed:16148061};3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+));3-hydroxy-2-methylbutyryl-CoA dehydrogenase;3-hydroxyacyl-CoA dehydrogenase type II;3alpha(or 20beta)-hydroxysteroid dehydrogenase;7-alpha-hydroxysteroid dehydrogenase;Endoplasmic reticulum-associated amyloid beta-peptide-binding protein;Mitochondrial ribonuclease P protein 2;Short chain dehydrogenase/reductase family 5C member 1;Short-chain type dehydrogenase/reductase XH98G2;Type II HADH;, PF00106;, GO:0005737;GO:0005759;GO:0042645;GO:0030678;GO:0005739;GO:0005886;GO:0044594;GO:0047015;GO:0003857;GO:0047044;GO:0106281;GO:0008709;GO:0106282;GO:0003723;GO:0047035;GO:0030283;GO:0000049;GO:0106283;GO:0008209;GO:0006699;GO:0009083;GO:0062173;GO:0008207;GO:0008210;GO:0006635;GO:0006550;GO:0006629;GO:1990180;GO:0097745;GO:0070901;GO:0007005;GO:0051289;, C:cytoplasm; C:mitochondrial matrix; C:mitochondrial nucleoid; C:mitochondrial ribonuclease P complex; C:mitochondrion; C:plasma membrane;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity; F:3-hydroxyacyl-CoA dehydrogenase activity; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; F:chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity; F:cholate 7-alpha-dehydrogenase activity; F:isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity; F:RNA binding; F:testosterone dehydrogenase (NAD+) activity; F:testosterone dehydrogenase [NAD(P)] activity; F:tRNA binding; F:ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity;, P:androgen metabolic process; P:bile acid biosynthetic process; P:branched-chain amino acid catabolic process; P:brexanolone metabolic process; P:C21-steroid hormone metabolic process; P:estrogen metabolic process; P:fatty acid beta-oxidation; P:isoleucine catabolic process; P:lipid metabolic process; P:mitochondrial tRNA 3'-end processing; P:mitochondrial tRNA 5'-end processing; P:mitochondrial tRNA methylation; P:mitochondrion organization; P:protein homotetramerization; scaffold246 indexed_genome mRNA 26224 31887 . - . ID=transcript_16230;Q9NYM9 B3KMY0,BET1-like protein,Golgi SNARE with a size of 15 kDa;Vesicle transport protein GOS15;, , GO:0005829;GO:0005768;GO:0005794;GO:0000139;GO:0000138;GO:0030173;GO:0016020;GO:0031201;GO:0005484;GO:0006888;GO:0015031;GO:2000156;GO:0042147;, C:cytosol; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:Golgi trans cisterna; C:integral component of Golgi membrane; C:membrane; C:SNARE complex;, F:SNAP receptor activity;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; P:regulation of retrograde vesicle-mediated transport, Golgi to ER; P:retrograde transport, endosome to Golgi; scaffold246 indexed_genome mRNA 37143 42940 . + . ID=transcript_16231;Q9NPQ8 Q0P508 Q2T9J1 Q7Z352 Q96EZ1 Q96SZ2 Q9H064 Q9H5H3 Q9H9E7,Synembryn-A,Protein Ric-8A;, PF10165;, GO:0005737;GO:0005886;GO:0001965;GO:0005096;GO:0005085;GO:0007193;GO:0071711;GO:0042074;GO:0070586;GO:0007186;GO:0001701;GO:0001944;GO:0008542;, C:cytoplasm; C:plasma membrane;, F:G-protein alpha-subunit binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:basement membrane organization; P:cell migration involved in gastrulation; P:cell-cell adhesion involved in gastrulation; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:vasculature development; P:visual learning;|Q9NPQ8 Q0P508 Q2T9J1 Q7Z352 Q96EZ1 Q96SZ2 Q9H064 Q9H5H3 Q9H9E7,Synembryn-A,Protein Ric-8A;, PF10165;, GO:0005737;GO:0005886;GO:0001965;GO:0005096;GO:0005085;GO:0007193;GO:0071711;GO:0042074;GO:0070586;GO:0007186;GO:0001701;GO:0001944;GO:0008542;, C:cytoplasm; C:plasma membrane;, F:G-protein alpha-subunit binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:basement membrane organization; P:cell migration involved in gastrulation; P:cell-cell adhesion involved in gastrulation; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:vasculature development; P:visual learning;|Q9NPQ8 Q0P508 Q2T9J1 Q7Z352 Q96EZ1 Q96SZ2 Q9H064 Q9H5H3 Q9H9E7,Synembryn-A,Protein Ric-8A;, PF10165;, GO:0005737;GO:0005886;GO:0001965;GO:0005096;GO:0005085;GO:0007193;GO:0071711;GO:0042074;GO:0070586;GO:0007186;GO:0001701;GO:0001944;GO:0008542;, C:cytoplasm; C:plasma membrane;, F:G-protein alpha-subunit binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:basement membrane organization; P:cell migration involved in gastrulation; P:cell-cell adhesion involved in gastrulation; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:vasculature development; P:visual learning;|Q9NPQ8 Q0P508 Q2T9J1 Q7Z352 Q96EZ1 Q96SZ2 Q9H064 Q9H5H3 Q9H9E7,Synembryn-A,Protein Ric-8A;, PF10165;, GO:0005737;GO:0005886;GO:0001965;GO:0005096;GO:0005085;GO:0007193;GO:0071711;GO:0042074;GO:0070586;GO:0007186;GO:0001701;GO:0001944;GO:0008542;, C:cytoplasm; C:plasma membrane;, F:G-protein alpha-subunit binding; F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:basement membrane organization; P:cell migration involved in gastrulation; P:cell-cell adhesion involved in gastrulation; P:G protein-coupled receptor signaling pathway; P:in utero embryonic development; P:vasculature development; P:visual learning; scaffold246 indexed_genome mRNA 45267 48521 . - . ID=transcript_16232;Q9NTG7 B7Z5U6 Q9Y6E8,NAD-dependent protein deacetylase sirtuin-3, mitochondrial,Regulatory protein SIR2 homolog 3;SIR2-like protein 3;, PF02146;, GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0019899;GO:0003950;GO:0070403;GO:0017136;GO:0034979;GO:0043565;GO:0008270;GO:0009060;GO:0007568;GO:0007005;GO:0070373;GO:2000378;GO:0034983;GO:1902553;GO:2000304;GO:0032024;GO:1901671;GO:0006471;GO:0006476;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent protein deacetylase activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:aerobic respiration; P:aging; P:mitochondrion organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of reactive oxygen species metabolic process; P:peptidyl-lysine deacetylation; P:positive regulation of catalase activity; P:positive regulation of ceramide biosynthetic process; P:positive regulation of insulin secretion; P:positive regulation of superoxide dismutase activity; P:protein ADP-ribosylation; P:protein deacetylation; scaffold246 indexed_genome mRNA 48606 69371 . - . ID=transcript_16233;Q9NTG7 B7Z5U6 Q9Y6E8,NAD-dependent protein deacetylase sirtuin-3, mitochondrial,Regulatory protein SIR2 homolog 3;SIR2-like protein 3;, PF02146;, GO:0005759;GO:0005739;GO:0005654;GO:0005634;GO:0032991;GO:0019899;GO:0003950;GO:0070403;GO:0017136;GO:0034979;GO:0043565;GO:0008270;GO:0009060;GO:0007568;GO:0007005;GO:0070373;GO:2000378;GO:0034983;GO:1902553;GO:2000304;GO:0032024;GO:1901671;GO:0006471;GO:0006476;, C:mitochondrial matrix; C:mitochondrion; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:enzyme binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent protein deacetylase activity; F:sequence-specific DNA binding; F:zinc ion binding;, P:aerobic respiration; P:aging; P:mitochondrion organization; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of reactive oxygen species metabolic process; P:peptidyl-lysine deacetylation; P:positive regulation of catalase activity; P:positive regulation of ceramide biosynthetic process; P:positive regulation of insulin secretion; P:positive regulation of superoxide dismutase activity; P:protein ADP-ribosylation; P:protein deacetylation; scaffold246 indexed_genome mRNA 70032 80822 . + . ID=transcript_16234;Q9UNM6 B3KT15 O75831 Q53XU2 Q9UNV3,26S proteasome non-ATPase regulatory subunit 13,26S proteasome regulatory subunit RPN9;26S proteasome regulatory subunit S11;26S proteasome regulatory subunit p40.5;, PF01399;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0007127;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:meiosis I; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9UNM6 B3KT15 O75831 Q53XU2 Q9UNV3,26S proteasome non-ATPase regulatory subunit 13,26S proteasome regulatory subunit RPN9;26S proteasome regulatory subunit S11;26S proteasome regulatory subunit p40.5;, PF01399;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0007127;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:meiosis I; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9UNM6 B3KT15 O75831 Q53XU2 Q9UNV3,26S proteasome non-ATPase regulatory subunit 13,26S proteasome regulatory subunit RPN9;26S proteasome regulatory subunit S11;26S proteasome regulatory subunit p40.5;, PF01399;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0007127;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:meiosis I; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9UNM6 B3KT15 O75831 Q53XU2 Q9UNV3,26S proteasome non-ATPase regulatory subunit 13,26S proteasome regulatory subunit RPN9;26S proteasome regulatory subunit S11;26S proteasome regulatory subunit p40.5;, PF01399;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0007127;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:meiosis I; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9UNM6 B3KT15 O75831 Q53XU2 Q9UNV3,26S proteasome non-ATPase regulatory subunit 13,26S proteasome regulatory subunit RPN9;26S proteasome regulatory subunit S11;26S proteasome regulatory subunit p40.5;, PF01399;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0007127;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:meiosis I; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway;|Q9UNM6 B3KT15 O75831 Q53XU2 Q9UNV3,26S proteasome non-ATPase regulatory subunit 13,26S proteasome regulatory subunit RPN9;26S proteasome regulatory subunit S11;26S proteasome regulatory subunit p40.5;, PF01399;, GO:0005829;GO:0005576;GO:1904813;GO:0016020;GO:0005654;GO:0005634;GO:0022624;GO:0000502;GO:0005838;GO:0008541;GO:0034774;GO:0005198;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0007127;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0043248;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0006511;GO:0060071;, C:cytosol; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nucleoplasm; C:nucleus; C:proteasome accessory complex; C:proteasome complex; C:proteasome regulatory particle; C:proteasome regulatory particle, lid subcomplex; C:secretory granule lumen;, F:structural molecule activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:meiosis I; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasome assembly; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold246 indexed_genome mRNA 80891 82728 . - . ID=transcript_16235;P10176 P15955,Cytochrome c oxidase subunit 8A, mitochondrial,Cytochrome c oxidase polypeptide VIII-liver/heart;Cytochrome c oxidase subunit 8-2;, PF02285;, GO:0016021;GO:0005743;GO:0005739;GO:0045277;GO:0004129;GO:0006091;GO:0006123;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:respiratory chain complex IV;, F:cytochrome-c oxidase activity;, P:generation of precursor metabolites and energy; P:mitochondrial electron transport, cytochrome c to oxygen; scaffold246 indexed_genome mRNA 107051 107659 . - . ID=transcript_16236;Q32M88 Q658X8 Q8TEG9 Q9H635,Protein-glucosylgalactosylhydroxylysine glucosidase {ECO:0000303|PubMed:26682924},Acid trehalase-like protein 1 {ECO:0000312|HGNC:HGNC:26210};, PF03632;, GO:0005829;GO:0004553;GO:0047402;GO:0005975;, C:cytosol;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:protein-glucosylgalactosylhydroxylysine glucosidase activity;, P:carbohydrate metabolic process; scaffold246 indexed_genome mRNA 107878 113045 . + . ID=transcript_16237;Q32M88 Q658X8 Q8TEG9 Q9H635,Protein-glucosylgalactosylhydroxylysine glucosidase {ECO:0000303|PubMed:26682924},Acid trehalase-like protein 1 {ECO:0000312|HGNC:HGNC:26210};, PF03632;, GO:0005829;GO:0004553;GO:0047402;GO:0005975;, C:cytosol;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:protein-glucosylgalactosylhydroxylysine glucosidase activity;, P:carbohydrate metabolic process;|Q32M88 Q658X8 Q8TEG9 Q9H635,Protein-glucosylgalactosylhydroxylysine glucosidase {ECO:0000303|PubMed:26682924},Acid trehalase-like protein 1 {ECO:0000312|HGNC:HGNC:26210};, PF03632;, GO:0005829;GO:0004553;GO:0047402;GO:0005975;, C:cytosol;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:protein-glucosylgalactosylhydroxylysine glucosidase activity;, P:carbohydrate metabolic process;|Q32M88 Q658X8 Q8TEG9 Q9H635,Protein-glucosylgalactosylhydroxylysine glucosidase {ECO:0000303|PubMed:26682924},Acid trehalase-like protein 1 {ECO:0000312|HGNC:HGNC:26210};, PF03632;, GO:0005829;GO:0004553;GO:0047402;GO:0005975;, C:cytosol;, F:hydrolase activity, hydrolyzing O-glycosyl compounds; F:protein-glucosylgalactosylhydroxylysine glucosidase activity;, P:carbohydrate metabolic process; scaffold246 indexed_genome mRNA 114230 118206 . - . ID=transcript_16238;A6NNB3,Interferon-induced transmembrane protein 5,Bone-restricted interferon-induced transmembrane protein-like protein;Dispanin subfamily A member 1;, PF04505;, GO:0005887;GO:0005886;GO:0030282;GO:0060349;GO:0001701;GO:0030500;, C:integral component of plasma membrane; C:plasma membrane;, , P:bone mineralization; P:bone morphogenesis; P:in utero embryonic development; P:regulation of bone mineralization;|A6NNB3,Interferon-induced transmembrane protein 5,Bone-restricted interferon-induced transmembrane protein-like protein;Dispanin subfamily A member 1;, PF04505;, GO:0005887;GO:0005886;GO:0030282;GO:0060349;GO:0001701;GO:0030500;, C:integral component of plasma membrane; C:plasma membrane;, , P:bone mineralization; P:bone morphogenesis; P:in utero embryonic development; P:regulation of bone mineralization; scaffold246 indexed_genome mRNA 122371 123094 . - . ID=transcript_16239;P13164 Q15322 Q53XZ0,Interferon-induced transmembrane protein 1,Dispanin subfamily A member 2a;Interferon-induced protein 17;Interferon-inducible protein 9-27;Leu-13 antigen;, PF04505;, GO:0016021;GO:0016020;GO:0005886;GO:0032991;GO:0007166;GO:0051607;GO:0030336;GO:0008285;GO:0046597;GO:0045071;GO:0001503;GO:0045669;GO:0050776;GO:0035455;GO:0035456;GO:0034341;GO:0009615;GO:0060337;, C:integral component of membrane; C:membrane; C:plasma membrane; C:protein-containing complex;, , P:cell surface receptor signaling pathway; P:defense response to virus; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of viral entry into host cell; P:negative regulation of viral genome replication; P:ossification; P:positive regulation of osteoblast differentiation; P:regulation of immune response; P:response to interferon-alpha; P:response to interferon-beta; P:response to interferon-gamma; P:response to virus; P:type I interferon signaling pathway; scaffold246 indexed_genome mRNA 126237 127054 . + . ID=transcript_16240;Q01628 Q53Y76 Q96HK8 Q96J15,Interferon-induced transmembrane protein 3,Dispanin subfamily A member 2b;Interferon-inducible protein 1-8U;, PF04505;, GO:0016021;GO:0031902;GO:0005765;GO:0048471;GO:0005886;GO:0032991;GO:0051607;GO:0006955;GO:0046597;GO:0045071;GO:0032897;GO:0035455;GO:0035456;GO:0034341;GO:0009615;GO:0060337;, C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, , P:defense response to virus; P:immune response; P:negative regulation of viral entry into host cell; P:negative regulation of viral genome replication; P:negative regulation of viral transcription; P:response to interferon-alpha; P:response to interferon-beta; P:response to interferon-gamma; P:response to virus; P:type I interferon signaling pathway; scaffold246 indexed_genome mRNA 150681 151990 . - . ID=transcript_16241;P13164 Q15322 Q53XZ0,Interferon-induced transmembrane protein 1,Dispanin subfamily A member 2a;Interferon-induced protein 17;Interferon-inducible protein 9-27;Leu-13 antigen;, PF04505;, GO:0016021;GO:0016020;GO:0005886;GO:0032991;GO:0007166;GO:0051607;GO:0030336;GO:0008285;GO:0046597;GO:0045071;GO:0001503;GO:0045669;GO:0050776;GO:0035455;GO:0035456;GO:0034341;GO:0009615;GO:0060337;, C:integral component of membrane; C:membrane; C:plasma membrane; C:protein-containing complex;, , P:cell surface receptor signaling pathway; P:defense response to virus; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of viral entry into host cell; P:negative regulation of viral genome replication; P:ossification; P:positive regulation of osteoblast differentiation; P:regulation of immune response; P:response to interferon-alpha; P:response to interferon-beta; P:response to interferon-gamma; P:response to virus; P:type I interferon signaling pathway;|P13164 Q15322 Q53XZ0,Interferon-induced transmembrane protein 1,Dispanin subfamily A member 2a;Interferon-induced protein 17;Interferon-inducible protein 9-27;Leu-13 antigen;, PF04505;, GO:0016021;GO:0016020;GO:0005886;GO:0032991;GO:0007166;GO:0051607;GO:0030336;GO:0008285;GO:0046597;GO:0045071;GO:0001503;GO:0045669;GO:0050776;GO:0035455;GO:0035456;GO:0034341;GO:0009615;GO:0060337;, C:integral component of membrane; C:membrane; C:plasma membrane; C:protein-containing complex;, , P:cell surface receptor signaling pathway; P:defense response to virus; P:negative regulation of cell migration; P:negative regulation of cell population proliferation; P:negative regulation of viral entry into host cell; P:negative regulation of viral genome replication; P:ossification; P:positive regulation of osteoblast differentiation; P:regulation of immune response; P:response to interferon-alpha; P:response to interferon-beta; P:response to interferon-gamma; P:response to virus; P:type I interferon signaling pathway; scaffold246 indexed_genome mRNA 154756 155869 . - . ID=transcript_16242;Q01629 Q6FH82 Q96DA8,Interferon-induced transmembrane protein 2,Dispanin subfamily A member 2c;Interferon-inducible protein 1-8D;, PF04505;, GO:0016021;GO:0005886;GO:0032991;GO:0051607;GO:0006955;GO:0046597;GO:0045071;GO:0035455;GO:0035456;GO:0034341;GO:0009615;GO:0060337;, C:integral component of membrane; C:plasma membrane; C:protein-containing complex;, , P:defense response to virus; P:immune response; P:negative regulation of viral entry into host cell; P:negative regulation of viral genome replication; P:response to interferon-alpha; P:response to interferon-beta; P:response to interferon-gamma; P:response to virus; P:type I interferon signaling pathway; scaffold246 indexed_genome mRNA 208376 217111 . - . ID=transcript_16243;Q76KP1 Q96LV2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1,Beta-1,4-N-acetylgalactosaminyltransferase IV;, PF05679;, GO:0032580;GO:0016021;GO:0008376;GO:0033842;, C:Golgi cisterna membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity;|Q76KP1 Q96LV2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1,Beta-1,4-N-acetylgalactosaminyltransferase IV;, PF05679;, GO:0032580;GO:0016021;GO:0008376;GO:0033842;, C:Golgi cisterna membrane; C:integral component of membrane;, F:acetylgalactosaminyltransferase activity; F:N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity; scaffold246 indexed_genome mRNA 230584 238928 . + . ID=transcript_16244;Q9Y446 F8J390 Q53EX8,Plakophilin-3,, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0030057;GO:1990124;GO:0005654;GO:0005634;GO:0005886;GO:0045294;GO:0045296;GO:0098641;GO:0050839;GO:0019899;GO:0098609;GO:0007043;GO:0070268;GO:0002159;GO:0031424;GO:1902373;GO:0010628;GO:0072659;GO:0006417;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:desmosome; C:messenger ribonucleoprotein complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:alpha-catenin binding; F:cadherin binding; F:cadherin binding involved in cell-cell adhesion; F:cell adhesion molecule binding; F:enzyme binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cornification; P:desmosome assembly; P:keratinization; P:negative regulation of mRNA catabolic process; P:positive regulation of gene expression; P:protein localization to plasma membrane; P:regulation of translation;|Q9Y446 F8J390 Q53EX8,Plakophilin-3,, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0030057;GO:1990124;GO:0005654;GO:0005634;GO:0005886;GO:0045294;GO:0045296;GO:0098641;GO:0050839;GO:0019899;GO:0098609;GO:0007043;GO:0070268;GO:0002159;GO:0031424;GO:1902373;GO:0010628;GO:0072659;GO:0006417;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:desmosome; C:messenger ribonucleoprotein complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:alpha-catenin binding; F:cadherin binding; F:cadherin binding involved in cell-cell adhesion; F:cell adhesion molecule binding; F:enzyme binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cornification; P:desmosome assembly; P:keratinization; P:negative regulation of mRNA catabolic process; P:positive regulation of gene expression; P:protein localization to plasma membrane; P:regulation of translation;|Q9Y446 F8J390 Q53EX8,Plakophilin-3,, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0030057;GO:1990124;GO:0005654;GO:0005634;GO:0005886;GO:0045294;GO:0045296;GO:0098641;GO:0050839;GO:0019899;GO:0098609;GO:0007043;GO:0070268;GO:0002159;GO:0031424;GO:1902373;GO:0010628;GO:0072659;GO:0006417;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:desmosome; C:messenger ribonucleoprotein complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:alpha-catenin binding; F:cadherin binding; F:cadherin binding involved in cell-cell adhesion; F:cell adhesion molecule binding; F:enzyme binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cornification; P:desmosome assembly; P:keratinization; P:negative regulation of mRNA catabolic process; P:positive regulation of gene expression; P:protein localization to plasma membrane; P:regulation of translation;|Q9Y446 F8J390 Q53EX8,Plakophilin-3,, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0030057;GO:1990124;GO:0005654;GO:0005634;GO:0005886;GO:0045294;GO:0045296;GO:0098641;GO:0050839;GO:0019899;GO:0098609;GO:0007043;GO:0070268;GO:0002159;GO:0031424;GO:1902373;GO:0010628;GO:0072659;GO:0006417;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:desmosome; C:messenger ribonucleoprotein complex; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:alpha-catenin binding; F:cadherin binding; F:cadherin binding involved in cell-cell adhesion; F:cell adhesion molecule binding; F:enzyme binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cornification; P:desmosome assembly; P:keratinization; P:negative regulation of mRNA catabolic process; P:positive regulation of gene expression; P:protein localization to plasma membrane; P:regulation of translation; scaffold246 indexed_genome mRNA 240513 245667 . - . ID=transcript_16245;Q6IA17 Q3KQY2 Q6UXI3 Q9H733,Single Ig IL-1-related receptor,Single Ig IL-1R-related molecule;Single immunoglobulin domain-containing IL1R-related protein;Toll/interleukin-1 receptor 8;, PF01582;, GO:0016021;GO:0016020;GO:0005886;GO:0006953;GO:0071345;GO:0032682;GO:0001960;GO:0043433;GO:0031665;GO:0007165;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:acute-phase response; P:cellular response to cytokine stimulus; P:negative regulation of chemokine production; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:signal transduction;|Q6IA17 Q3KQY2 Q6UXI3 Q9H733,Single Ig IL-1-related receptor,Single Ig IL-1R-related molecule;Single immunoglobulin domain-containing IL1R-related protein;Toll/interleukin-1 receptor 8;, PF01582;, GO:0016021;GO:0016020;GO:0005886;GO:0006953;GO:0071345;GO:0032682;GO:0001960;GO:0043433;GO:0031665;GO:0007165;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:acute-phase response; P:cellular response to cytokine stimulus; P:negative regulation of chemokine production; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:signal transduction;|Q6IA17 Q3KQY2 Q6UXI3 Q9H733,Single Ig IL-1-related receptor,Single Ig IL-1R-related molecule;Single immunoglobulin domain-containing IL1R-related protein;Toll/interleukin-1 receptor 8;, PF01582;, GO:0016021;GO:0016020;GO:0005886;GO:0006953;GO:0071345;GO:0032682;GO:0001960;GO:0043433;GO:0031665;GO:0007165;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:acute-phase response; P:cellular response to cytokine stimulus; P:negative regulation of chemokine production; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:signal transduction;|Q6IA17 Q3KQY2 Q6UXI3 Q9H733,Single Ig IL-1-related receptor,Single Ig IL-1R-related molecule;Single immunoglobulin domain-containing IL1R-related protein;Toll/interleukin-1 receptor 8;, PF01582;, GO:0016021;GO:0016020;GO:0005886;GO:0006953;GO:0071345;GO:0032682;GO:0001960;GO:0043433;GO:0031665;GO:0007165;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:acute-phase response; P:cellular response to cytokine stimulus; P:negative regulation of chemokine production; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:signal transduction;|Q6IA17 Q3KQY2 Q6UXI3 Q9H733,Single Ig IL-1-related receptor,Single Ig IL-1R-related molecule;Single immunoglobulin domain-containing IL1R-related protein;Toll/interleukin-1 receptor 8;, PF01582;, GO:0016021;GO:0016020;GO:0005886;GO:0006953;GO:0071345;GO:0032682;GO:0001960;GO:0043433;GO:0031665;GO:0007165;, C:integral component of membrane; C:membrane; C:plasma membrane;, , P:acute-phase response; P:cellular response to cytokine stimulus; P:negative regulation of chemokine production; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:signal transduction; scaffold246 indexed_genome mRNA 263377 265841 . - . ID=transcript_16246;A1A5B4 B3KUC4 B4E134 Q8TEN4,Anoctamin-9,Transmembrane protein 16J;Tumor protein p53-inducible protein 5;p53-induced gene 5 protein;, PF04547;, GO:0016021;GO:0005886;GO:0005254;GO:0005229;GO:0017128;GO:0061591;GO:0061590;GO:0061589;GO:1902476;GO:0006821;GO:0034220;GO:1902939;GO:0055085;, C:integral component of membrane; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:phospholipid scramblase activity;, P:calcium activated galactosylceramide scrambling; P:calcium activated phosphatidylcholine scrambling; P:calcium activated phosphatidylserine scrambling; P:chloride transmembrane transport; P:chloride transport; P:ion transmembrane transport; P:negative regulation of intracellular calcium activated chloride channel activity; P:transmembrane transport; scaffold246 indexed_genome mRNA 288584 327582 . + . ID=transcript_16247;Q9BVG9,Phosphatidylserine synthase 2,Serine-exchange enzyme II;, PF03034;, GO:0005789;GO:0016021;GO:0016020;GO:0003882;GO:0106245;GO:0006659;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:CDP-diacylglycerol-serine O-phosphatidyltransferase activity; F:L-serine-phosphatidylethanolamine phosphatidyltransferase activity;, P:phosphatidylserine biosynthetic process;|Q9BVG9,Phosphatidylserine synthase 2,Serine-exchange enzyme II;, PF03034;, GO:0005789;GO:0016021;GO:0016020;GO:0003882;GO:0106245;GO:0006659;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:CDP-diacylglycerol-serine O-phosphatidyltransferase activity; F:L-serine-phosphatidylethanolamine phosphatidyltransferase activity;, P:phosphatidylserine biosynthetic process;|Q9BVG9,Phosphatidylserine synthase 2,Serine-exchange enzyme II;, PF03034;, GO:0005789;GO:0016021;GO:0016020;GO:0003882;GO:0106245;GO:0006659;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:CDP-diacylglycerol-serine O-phosphatidyltransferase activity; F:L-serine-phosphatidylethanolamine phosphatidyltransferase activity;, P:phosphatidylserine biosynthetic process;|P13489 Q8IZK8 Q96FD7 Q9BQ80 Q9UDK6,Ribonuclease inhibitor,Placental ribonuclease inhibitor;Ribonuclease/angiogenin inhibitor 1;, PF13516;PF18779;, GO:0032311;GO:0005829;GO:0070062;GO:0005654;GO:0008428;GO:0006402;GO:0045765;, C:angiogenin-PRI complex; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:ribonuclease inhibitor activity;, P:mRNA catabolic process; P:regulation of angiogenesis;|P13489 Q8IZK8 Q96FD7 Q9BQ80 Q9UDK6,Ribonuclease inhibitor,Placental ribonuclease inhibitor;Ribonuclease/angiogenin inhibitor 1;, PF13516;PF18779;, GO:0032311;GO:0005829;GO:0070062;GO:0005654;GO:0008428;GO:0006402;GO:0045765;, C:angiogenin-PRI complex; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:ribonuclease inhibitor activity;, P:mRNA catabolic process; P:regulation of angiogenesis;|P13489 Q8IZK8 Q96FD7 Q9BQ80 Q9UDK6,Ribonuclease inhibitor,Placental ribonuclease inhibitor;Ribonuclease/angiogenin inhibitor 1;, PF13516;PF18779;, GO:0032311;GO:0005829;GO:0070062;GO:0005654;GO:0008428;GO:0006402;GO:0045765;, C:angiogenin-PRI complex; C:cytosol; C:extracellular exosome; C:nucleoplasm;, F:ribonuclease inhibitor activity;, P:mRNA catabolic process; P:regulation of angiogenesis; scaffold246 indexed_genome mRNA 356088 358506 . - . ID=transcript_16248;P01112 B5BUA0 Q14080 Q6FHV9 Q9BR65 Q9UCE2,GTPase HRas,H-Ras-1;Ha-Ras;Transforming protein p21;c-H-ras;p21ras;, PF00071;, GO:0005737;GO:0005829;GO:0005789;GO:0098978;GO:0005794;GO:0000139;GO:0005654;GO:0048471;GO:0005886;GO:0019003;GO:0005525;GO:0003924;GO:0008022;GO:0044877;GO:0009887;GO:0007050;GO:0007166;GO:0071480;GO:0090398;GO:0006935;GO:0042832;GO:0006897;GO:0048013;GO:0097193;GO:0001889;GO:0000165;GO:0008285;GO:0010629;GO:0034260;GO:0043524;GO:2000251;GO:0030335;GO:0008284;GO:0045740;GO:0050679;GO:0070374;GO:0043547;GO:0032729;GO:0046330;GO:0043406;GO:0043410;GO:2000630;GO:0010863;GO:0001934;GO:0090314;GO:0046579;GO:1900029;GO:0045944;GO:0090303;GO:0007265;GO:0048169;GO:0098696;GO:0035900;GO:0007165;GO:0002223;GO:0050852;GO:0042088;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:nucleoplasm; C:perinuclear region of cytoplasm; C:plasma membrane;, F:GDP binding; F:GTP binding; F:GTPase activity; F:protein C-terminus binding; F:protein-containing complex binding;, P:animal organ morphogenesis; P:cell cycle arrest; P:cell surface receptor signaling pathway; P:cellular response to gamma radiation; P:cellular senescence; P:chemotaxis; P:defense response to protozoan; P:endocytosis; P:ephrin receptor signaling pathway; P:intrinsic apoptotic signaling pathway; P:liver development; P:MAPK cascade; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of GTPase activity; P:negative regulation of neuron apoptotic process; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of DNA replication; P:positive regulation of epithelial cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of GTPase activity; P:positive regulation of interferon-gamma production; P:positive regulation of JNK cascade; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of miRNA metabolic process; P:positive regulation of phospholipase C activity; P:positive regulation of protein phosphorylation; P:positive regulation of protein targeting to membrane; P:positive regulation of Ras protein signal transduction; P:positive regulation of ruffle assembly; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of wound healing; P:Ras protein signal transduction; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; P:response to isolation stress; P:signal transduction; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:T-helper 1 type immune response; scaffold246 indexed_genome mRNA 370136 384970 . + . ID=transcript_16249;Q8IYG6 Q8N3Q4,Leucine-rich repeat-containing protein 56,, , GO:0005929;GO:0030030;, C:cilium;, , P:cell projection organization; scaffold248 indexed_genome mRNA 260039 287651 . - . ID=transcript_16250;Q2YD98 A8K9E6 B2RU11 Q8WTX4 Q9P1Z8,UV-stimulated scaffold protein A,, PF09740;, GO:0005694;GO:0005654;GO:0000993;GO:0016567;GO:0009411;GO:0006283;, C:chromosome; C:nucleoplasm;, F:RNA polymerase II complex binding;, P:protein ubiquitination; P:response to UV; P:transcription-coupled nucleotide-excision repair;|Q2YD98 A8K9E6 B2RU11 Q8WTX4 Q9P1Z8,UV-stimulated scaffold protein A,, PF09740;, GO:0005694;GO:0005654;GO:0000993;GO:0016567;GO:0009411;GO:0006283;, C:chromosome; C:nucleoplasm;, F:RNA polymerase II complex binding;, P:protein ubiquitination; P:response to UV; P:transcription-coupled nucleotide-excision repair;|Q2YD98 A8K9E6 B2RU11 Q8WTX4 Q9P1Z8,UV-stimulated scaffold protein A,, PF09740;, GO:0005694;GO:0005654;GO:0000993;GO:0016567;GO:0009411;GO:0006283;, C:chromosome; C:nucleoplasm;, F:RNA polymerase II complex binding;, P:protein ubiquitination; P:response to UV; P:transcription-coupled nucleotide-excision repair; scaffold248 indexed_genome mRNA 364741 368415 . - . ID=transcript_16251;Q8N441 B2RAU9 Q6PJN1 Q9BXN7 Q9H4D7,Fibroblast growth factor receptor-like 1,FGF homologous factor receptor;FGFR-like protein;Fibroblast growth factor receptor 5;, PF07679;, GO:0044291;GO:0005794;GO:0016021;GO:0005886;GO:0030133;GO:0017134;GO:0005007;GO:0008201;GO:0042802;GO:0098742;GO:0008543;, C:cell-cell contact zone; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:transport vesicle;, F:fibroblast growth factor binding; F:fibroblast growth factor-activated receptor activity; F:heparin binding; F:identical protein binding;, P:cell-cell adhesion via plasma-membrane adhesion molecules; P:fibroblast growth factor receptor signaling pathway; scaffold249 indexed_genome mRNA 7412 22312 . - . ID=transcript_16252;Q9UIW2,Plexin-A1,Semaphorin receptor NOV;, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005829;GO:0070062;GO:0005887;GO:0005654;GO:0005886;GO:0002116;GO:0017154;GO:0038023;GO:0060666;GO:0007275;GO:0007162;GO:1990138;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:0014910;GO:1902287;, C:cytosol; C:extracellular exosome; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:signaling receptor activity;, P:dichotomous subdivision of terminal units involved in salivary gland branching; P:multicellular organism development; P:negative regulation of cell adhesion; P:neuron projection extension; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of smooth muscle cell migration; P:semaphorin-plexin signaling pathway involved in axon guidance; scaffold249 indexed_genome mRNA 35165 144156 . - . ID=transcript_16253;Q9BRQ6 D6R9U0 D6RIB4 H8Y0Y7,MICOS complex subunit MIC25,Coiled-coil-helix cristae morphology protein 1;Coiled-coil-helix-coiled-coil-helix domain-containing protein 6;, , GO:0005829;GO:0140275;GO:0061617;GO:0005743;GO:0005739;GO:0001401;GO:0006974;GO:0042407;GO:0007007;, C:cytosol; C:MIB complex; C:MICOS complex; C:mitochondrial inner membrane; C:mitochondrion; C:SAM complex;, , P:cellular response to DNA damage stimulus; P:cristae formation; P:inner mitochondrial membrane organization; scaffold249 indexed_genome mRNA 175427 203262 . + . ID=transcript_16254;Q86VQ6 Q6PIS8 Q9NNW6 Q9P101,Thioredoxin reductase 3,Thioredoxin and glutathione reductase;Thioredoxin reductase TR2;, PF00462;PF07992;PF02852;, GO:0005737;GO:0005829;GO:0005783;GO:0005739;GO:0005654;GO:0050660;GO:0015035;GO:0004791;GO:0030154;GO:0045454;GO:0007275;GO:0007283;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:mitochondrion; C:nucleoplasm;, F:flavin adenine dinucleotide binding; F:protein disulfide oxidoreductase activity; F:thioredoxin-disulfide reductase activity;, P:cell differentiation; P:cell redox homeostasis; P:multicellular organism development; P:spermatogenesis;|Q86VQ6 Q6PIS8 Q9NNW6 Q9P101,Thioredoxin reductase 3,Thioredoxin and glutathione reductase;Thioredoxin reductase TR2;, PF00462;PF07992;PF02852;, GO:0005737;GO:0005829;GO:0005783;GO:0005739;GO:0005654;GO:0050660;GO:0015035;GO:0004791;GO:0030154;GO:0045454;GO:0007275;GO:0007283;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:mitochondrion; C:nucleoplasm;, F:flavin adenine dinucleotide binding; F:protein disulfide oxidoreductase activity; F:thioredoxin-disulfide reductase activity;, P:cell differentiation; P:cell redox homeostasis; P:multicellular organism development; P:spermatogenesis;|Q86VQ6 Q6PIS8 Q9NNW6 Q9P101,Thioredoxin reductase 3,Thioredoxin and glutathione reductase;Thioredoxin reductase TR2;, PF00462;PF07992;PF02852;, GO:0005737;GO:0005829;GO:0005783;GO:0005739;GO:0005654;GO:0050660;GO:0015035;GO:0004791;GO:0030154;GO:0045454;GO:0007275;GO:0007283;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:mitochondrion; C:nucleoplasm;, F:flavin adenine dinucleotide binding; F:protein disulfide oxidoreductase activity; F:thioredoxin-disulfide reductase activity;, P:cell differentiation; P:cell redox homeostasis; P:multicellular organism development; P:spermatogenesis;|Q86VQ6 Q6PIS8 Q9NNW6 Q9P101,Thioredoxin reductase 3,Thioredoxin and glutathione reductase;Thioredoxin reductase TR2;, PF00462;PF07992;PF02852;, GO:0005737;GO:0005829;GO:0005783;GO:0005739;GO:0005654;GO:0050660;GO:0015035;GO:0004791;GO:0030154;GO:0045454;GO:0007275;GO:0007283;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:mitochondrion; C:nucleoplasm;, F:flavin adenine dinucleotide binding; F:protein disulfide oxidoreductase activity; F:thioredoxin-disulfide reductase activity;, P:cell differentiation; P:cell redox homeostasis; P:multicellular organism development; P:spermatogenesis; scaffold249 indexed_genome mRNA 205545 209447 . + . ID=transcript_16255;Q8N5N4 B3KUS9,Uncharacterized protein C3orf22|Q8N5N4 B3KUS9,Uncharacterized protein C3orf22 scaffold249 indexed_genome mRNA 210790 214228 . - . ID=transcript_16256;Q8NET6 Q3SYA3 Q3SYA5,Carbohydrate sulfotransferase 13,Chondroitin 4-O-sulfotransferase 3;Chondroitin 4-sulfotransferase 3;, PF03567;, GO:0000139;GO:0016021;GO:0047756;GO:0001537;GO:0008146;GO:0016051;GO:0030206;GO:0030166;, C:Golgi membrane; C:integral component of membrane;, F:chondroitin 4-sulfotransferase activity; F:N-acetylgalactosamine 4-O-sulfotransferase activity; F:sulfotransferase activity;, P:carbohydrate biosynthetic process; P:chondroitin sulfate biosynthetic process; P:proteoglycan biosynthetic process; scaffold249 indexed_genome mRNA 225594 227586 . + . ID=transcript_16257;Q96N76 E9PE13 Q14C64 Q68CJ7,Urocanate hydratase,Imidazolonepropionate hydrolase;, PF01175;PF17392;PF17391;, GO:0005829;GO:0016153;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:urocanate hydratase activity;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate; scaffold249 indexed_genome mRNA 227892 228676 . + . ID=transcript_16258;Q96N76 E9PE13 Q14C64 Q68CJ7,Urocanate hydratase,Imidazolonepropionate hydrolase;, PF01175;PF17392;PF17391;, GO:0005829;GO:0016153;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:urocanate hydratase activity;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate; scaffold249 indexed_genome mRNA 232192 236269 . + . ID=transcript_16259;Q96N76 E9PE13 Q14C64 Q68CJ7,Urocanate hydratase,Imidazolonepropionate hydrolase;, PF01175;PF17392;PF17391;, GO:0005829;GO:0016153;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:urocanate hydratase activity;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate; scaffold249 indexed_genome mRNA 237197 244084 . + . ID=transcript_16260;Q96N76 E9PE13 Q14C64 Q68CJ7,Urocanate hydratase,Imidazolonepropionate hydrolase;, PF01175;PF17392;PF17391;, GO:0005829;GO:0016153;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:urocanate hydratase activity;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate;|Q96N76 E9PE13 Q14C64 Q68CJ7,Urocanate hydratase,Imidazolonepropionate hydrolase;, PF01175;PF17392;PF17391;, GO:0005829;GO:0016153;GO:0006548;GO:0019556;GO:0019557;, C:cytosol;, F:urocanate hydratase activity;, P:histidine catabolic process; P:histidine catabolic process to glutamate and formamide; P:histidine catabolic process to glutamate and formate; scaffold249 indexed_genome mRNA 259085 278603 . + . ID=transcript_16261;Q2QGD7 C5J0H9 Q6DKI8 Q7L3L1 Q8NAU2,Zinc finger protein ZXDC,ZXD-like zinc finger protein;, PF00096;, GO:0005634;GO:0070742;GO:0030275;GO:0046872;GO:0003713;GO:0003712;GO:0045893;GO:0006357;, C:nucleus;, F:C2H2 zinc finger domain binding; F:LRR domain binding; F:metal ion binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q2QGD7 C5J0H9 Q6DKI8 Q7L3L1 Q8NAU2,Zinc finger protein ZXDC,ZXD-like zinc finger protein;, PF00096;, GO:0005634;GO:0070742;GO:0030275;GO:0046872;GO:0003713;GO:0003712;GO:0045893;GO:0006357;, C:nucleus;, F:C2H2 zinc finger domain binding; F:LRR domain binding; F:metal ion binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q2QGD7 C5J0H9 Q6DKI8 Q7L3L1 Q8NAU2,Zinc finger protein ZXDC,ZXD-like zinc finger protein;, PF00096;, GO:0005634;GO:0070742;GO:0030275;GO:0046872;GO:0003713;GO:0003712;GO:0045893;GO:0006357;, C:nucleus;, F:C2H2 zinc finger domain binding; F:LRR domain binding; F:metal ion binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;|Q2QGD7 C5J0H9 Q6DKI8 Q7L3L1 Q8NAU2,Zinc finger protein ZXDC,ZXD-like zinc finger protein;, PF00096;, GO:0005634;GO:0070742;GO:0030275;GO:0046872;GO:0003713;GO:0003712;GO:0045893;GO:0006357;, C:nucleus;, F:C2H2 zinc finger domain binding; F:LRR domain binding; F:metal ion binding; F:transcription coactivator activity; F:transcription coregulator activity;, P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; scaffold249 indexed_genome mRNA 279722 287912 . - . ID=transcript_16262;Q9HAB1 Q9NX30,Solute carrier family 41 member 3,, PF01769;, GO:0016021;GO:0005886;GO:0008324;, C:integral component of membrane; C:plasma membrane;, F:cation transmembrane transporter activity;|Q9HAB1 Q9NX30,Solute carrier family 41 member 3,, PF01769;, GO:0016021;GO:0005886;GO:0008324;, C:integral component of membrane; C:plasma membrane;, F:cation transmembrane transporter activity;|Q9HAB1 Q9NX30,Solute carrier family 41 member 3,, PF01769;, GO:0016021;GO:0005886;GO:0008324;, C:integral component of membrane; C:plasma membrane;, F:cation transmembrane transporter activity; scaffold249 indexed_genome mRNA 313796 315104 . - . ID=transcript_16263;O75891 B4DG36 E9PBX3 Q68CS1 Q8TBP8,Cytosolic 10-formyltetrahydrofolate dehydrogenase,Aldehyde dehydrogenase family 1 member L1;, PF00171;PF02911;PF00551;PF00550;, GO:0005829;GO:0070062;GO:0004029;GO:0003824;GO:0016155;GO:0016742;GO:0009258;GO:0009058;GO:0046655;GO:0006730;, C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:catalytic activity; F:formyltetrahydrofolate dehydrogenase activity; F:hydroxymethyl-, formyl- and related transferase activity;, P:10-formyltetrahydrofolate catabolic process; P:biosynthetic process; P:folic acid metabolic process; P:one-carbon metabolic process; scaffold249 indexed_genome mRNA 316559 336958 . - . ID=transcript_16264;O75891 B4DG36 E9PBX3 Q68CS1 Q8TBP8,Cytosolic 10-formyltetrahydrofolate dehydrogenase,Aldehyde dehydrogenase family 1 member L1;, PF00171;PF02911;PF00551;PF00550;, GO:0005829;GO:0070062;GO:0004029;GO:0003824;GO:0016155;GO:0016742;GO:0009258;GO:0009058;GO:0046655;GO:0006730;, C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:catalytic activity; F:formyltetrahydrofolate dehydrogenase activity; F:hydroxymethyl-, formyl- and related transferase activity;, P:10-formyltetrahydrofolate catabolic process; P:biosynthetic process; P:folic acid metabolic process; P:one-carbon metabolic process;|O75891 B4DG36 E9PBX3 Q68CS1 Q8TBP8,Cytosolic 10-formyltetrahydrofolate dehydrogenase,Aldehyde dehydrogenase family 1 member L1;, PF00171;PF02911;PF00551;PF00550;, GO:0005829;GO:0070062;GO:0004029;GO:0003824;GO:0016155;GO:0016742;GO:0009258;GO:0009058;GO:0046655;GO:0006730;, C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:catalytic activity; F:formyltetrahydrofolate dehydrogenase activity; F:hydroxymethyl-, formyl- and related transferase activity;, P:10-formyltetrahydrofolate catabolic process; P:biosynthetic process; P:folic acid metabolic process; P:one-carbon metabolic process;|O75891 B4DG36 E9PBX3 Q68CS1 Q8TBP8,Cytosolic 10-formyltetrahydrofolate dehydrogenase,Aldehyde dehydrogenase family 1 member L1;, PF00171;PF02911;PF00551;PF00550;, GO:0005829;GO:0070062;GO:0004029;GO:0003824;GO:0016155;GO:0016742;GO:0009258;GO:0009058;GO:0046655;GO:0006730;, C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:catalytic activity; F:formyltetrahydrofolate dehydrogenase activity; F:hydroxymethyl-, formyl- and related transferase activity;, P:10-formyltetrahydrofolate catabolic process; P:biosynthetic process; P:folic acid metabolic process; P:one-carbon metabolic process; scaffold249 indexed_genome mRNA 362818 363619 . + . ID=transcript_16265;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold251 indexed_genome mRNA 3505 4052 . - . ID=transcript_16266;Q14469 Q6FHB2,Transcription factor HES-1,Class B basic helix-loop-helix protein 39;Hairy and enhancer of split 1;Hairy homolog;Hairy-like protein;, PF07527;PF00010;, GO:0005737;GO:0005654;GO:0005634;GO:0032991;GO:0051087;GO:0003677;GO:0000981;GO:0001227;GO:0070888;GO:0042826;GO:0043398;GO:0071820;GO:0042803;GO:0000978;GO:0001085;GO:0043565;GO:1990837;GO:0008134;GO:0021984;GO:0009952;GO:0048844;GO:0035910;GO:0061309;GO:0007155;GO:0048469;GO:0016477;GO:0048667;GO:0090102;GO:0072049;GO:0061009;GO:0003143;GO:0090162;GO:0021861;GO:0072012;GO:0021575;GO:0060122;GO:0060716;GO:0046331;GO:0001889;GO:0030324;GO:0072282;GO:0030901;GO:0021555;GO:1905934;GO:0043433;GO:2000978;GO:0060253;GO:0045608;GO:0045665;GO:0048715;GO:2000227;GO:2000974;GO:2000737;GO:0061106;GO:0000122;GO:0045892;GO:0007399;GO:0097150;GO:0007219;GO:0021557;GO:0003151;GO:0031016;GO:0061626;GO:0048711;GO:0030513;GO:0008284;GO:0043388;GO:0045977;GO:0045747;GO:0046427;GO:0042102;GO:0045944;GO:0045893;GO:0042531;GO:0065003;GO:0050678;GO:0045598;GO:0050767;GO:0046425;GO:0003266;GO:0060164;GO:0006357;GO:0072141;GO:0072050;GO:0007224;GO:0035019;GO:0021537;GO:0048538;GO:0021558;GO:0060675;GO:0097084;GO:0003281;GO:0060412;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chaperone binding; F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:E-box binding; F:histone deacetylase binding; F:HLH domain binding; F:N-box binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription factor binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:adenohypophysis development; P:anterior/posterior pattern specification; P:artery morphogenesis; P:ascending aorta morphogenesis; P:cardiac neural crest cell development involved in outflow tract morphogenesis; P:cell adhesion; P:cell maturation; P:cell migration; P:cell morphogenesis involved in neuron differentiation; P:cochlea development; P:comma-shaped body morphogenesis; P:common bile duct development; P:embryonic heart tube morphogenesis; P:establishment of epithelial cell polarity; P:forebrain radial glial cell differentiation; P:glomerulus vasculature development; P:hindbrain morphogenesis; P:inner ear receptor cell stereocilium organization; P:labyrinthine layer blood vessel development; P:lateral inhibition; P:liver development; P:lung development; P:metanephric nephron tubule morphogenesis; P:midbrain development; P:midbrain-hindbrain boundary morphogenesis; P:negative regulation of cell fate determination; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of forebrain neuron differentiation; P:negative regulation of glial cell proliferation; P:negative regulation of inner ear auditory receptor cell differentiation; P:negative regulation of neuron differentiation; P:negative regulation of oligodendrocyte differentiation; P:negative regulation of pancreatic A cell differentiation; P:negative regulation of pro-B cell differentiation; P:negative regulation of stem cell differentiation; P:negative regulation of stomach neuroendocrine cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neuronal stem cell population maintenance; P:Notch signaling pathway; P:oculomotor nerve development; P:outflow tract morphogenesis; P:pancreas development; P:pharyngeal arch artery morphogenesis; P:positive regulation of astrocyte differentiation; P:positive regulation of BMP signaling pathway; P:positive regulation of cell population proliferation; P:positive regulation of DNA binding; P:positive regulation of mitotic cell cycle, embryonic; P:positive regulation of Notch signaling pathway; P:positive regulation of receptor signaling pathway via JAK-STAT; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein-containing complex assembly; P:regulation of epithelial cell proliferation; P:regulation of fat cell differentiation; P:regulation of neurogenesis; P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of secondary heart field cardioblast proliferation; P:regulation of timing of neuron differentiation; P:regulation of transcription by RNA polymerase II; P:renal interstitial fibroblast development; P:S-shaped body morphogenesis; P:smoothened signaling pathway; P:somatic stem cell population maintenance; P:telencephalon development; P:thymus development; P:trochlear nerve development; P:ureteric bud morphogenesis; P:vascular associated smooth muscle cell development; P:ventricular septum development; P:ventricular septum morphogenesis; scaffold251 indexed_genome mRNA 68290 72086 . + . ID=transcript_16267;P60842 B2R6L8 D3DTP9 J3QLC4 P04765 Q5U018 Q61516,Eukaryotic initiation factor 4A-I,ATP-dependent RNA helicase eIF4A-1;, PF00270;PF00271;, GO:0005737;GO:0005829;GO:0016281;GO:0070062;GO:0016020;GO:0005524;GO:0003725;GO:0004386;GO:0003729;GO:0003723;GO:0000339;GO:0003724;GO:0008135;GO:0003743;GO:0002183;GO:0006413;GO:0016032;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:extracellular exosome; C:membrane;, F:ATP binding; F:double-stranded RNA binding; F:helicase activity; F:mRNA binding; F:RNA binding; F:RNA cap binding; F:RNA helicase activity; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:cytoplasmic translational initiation; P:translational initiation; P:viral process;|Q14240 D3DNU9 Q53XJ6 Q96B90 Q96EA8,Eukaryotic initiation factor 4A-II,ATP-dependent RNA helicase eIF4A-2;, PF00270;PF00271;, GO:0005829;GO:0016281;GO:0048471;GO:0005524;GO:0016887;GO:0004386;GO:0003723;GO:0003724;GO:0003743;GO:1990830;GO:0002183;GO:1900260;GO:0006446;GO:0006413;GO:0016032;, C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:helicase activity; F:RNA binding; F:RNA helicase activity; F:translation initiation factor activity;, P:cellular response to leukemia inhibitory factor; P:cytoplasmic translational initiation; P:negative regulation of RNA-directed 5'-3' RNA polymerase activity; P:regulation of translational initiation; P:translational initiation; P:viral process;|P60842 B2R6L8 D3DTP9 J3QLC4 P04765 Q5U018 Q61516,Eukaryotic initiation factor 4A-I,ATP-dependent RNA helicase eIF4A-1;, PF00270;PF00271;, GO:0005737;GO:0005829;GO:0016281;GO:0070062;GO:0016020;GO:0005524;GO:0003725;GO:0004386;GO:0003729;GO:0003723;GO:0000339;GO:0003724;GO:0008135;GO:0003743;GO:0002183;GO:0006413;GO:0016032;, C:cytoplasm; C:cytosol; C:eukaryotic translation initiation factor 4F complex; C:extracellular exosome; C:membrane;, F:ATP binding; F:double-stranded RNA binding; F:helicase activity; F:mRNA binding; F:RNA binding; F:RNA cap binding; F:RNA helicase activity; F:translation factor activity, RNA binding; F:translation initiation factor activity;, P:cytoplasmic translational initiation; P:translational initiation; P:viral process; scaffold251 indexed_genome mRNA 74103 78512 . - . ID=transcript_16268;Q9H4L4 Q66K15 Q86VS7 Q96PS4 Q9Y3W9,Sentrin-specific protease 3,SUMO-1-specific protease 3;Sentrin/SUMO-specific protease SENP3;, PF02902;, GO:0005737;GO:0071339;GO:0005730;GO:0005654;GO:0005634;GO:0008234;GO:0016926;GO:0006364;, C:cytoplasm; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity;, P:protein desumoylation; P:rRNA processing;|Q9H4L4 Q66K15 Q86VS7 Q96PS4 Q9Y3W9,Sentrin-specific protease 3,SUMO-1-specific protease 3;Sentrin/SUMO-specific protease SENP3;, PF02902;, GO:0005737;GO:0071339;GO:0005730;GO:0005654;GO:0005634;GO:0008234;GO:0016926;GO:0006364;, C:cytoplasm; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity;, P:protein desumoylation; P:rRNA processing;|Q9H4L4 Q66K15 Q86VS7 Q96PS4 Q9Y3W9,Sentrin-specific protease 3,SUMO-1-specific protease 3;Sentrin/SUMO-specific protease SENP3;, PF02902;, GO:0005737;GO:0071339;GO:0005730;GO:0005654;GO:0005634;GO:0008234;GO:0016926;GO:0006364;, C:cytoplasm; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity;, P:protein desumoylation; P:rRNA processing; scaffold251 indexed_genome mRNA 78585 83141 . + . ID=transcript_16269;Q9H4L4 Q66K15 Q86VS7 Q96PS4 Q9Y3W9,Sentrin-specific protease 3,SUMO-1-specific protease 3;Sentrin/SUMO-specific protease SENP3;, PF02902;, GO:0005737;GO:0071339;GO:0005730;GO:0005654;GO:0005634;GO:0008234;GO:0016926;GO:0006364;, C:cytoplasm; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity;, P:protein desumoylation; P:rRNA processing;|Q9H4L4 Q66K15 Q86VS7 Q96PS4 Q9Y3W9,Sentrin-specific protease 3,SUMO-1-specific protease 3;Sentrin/SUMO-specific protease SENP3;, PF02902;, GO:0005737;GO:0071339;GO:0005730;GO:0005654;GO:0005634;GO:0008234;GO:0016926;GO:0006364;, C:cytoplasm; C:MLL1 complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:cysteine-type peptidase activity;, P:protein desumoylation; P:rRNA processing; scaffold251 indexed_genome mRNA 83662 87031 . - . ID=transcript_16270;O75888 A8MYD5 B4DVT2 Q541E1 Q5U0G8 Q96HV6 Q9P1M8 Q9P1M9,Tumor necrosis factor ligand superfamily member 13,A proliferation-inducing ligand;TNF- and APOL-related leukocyte expressed ligand 2;TNF-related death ligand 1;, PF00229;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005654;GO:0005125;GO:0048018;GO:0005102;GO:0005164;GO:0006955;GO:0008284;GO:0048298;GO:0043488;GO:0007165;GO:0033209;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:nucleoplasm;, F:cytokine activity; F:receptor ligand activity; F:signaling receptor binding; F:tumor necrosis factor receptor binding;, P:immune response; P:positive regulation of cell population proliferation; P:positive regulation of isotype switching to IgA isotypes; P:regulation of mRNA stability; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway;|O75888 A8MYD5 B4DVT2 Q541E1 Q5U0G8 Q96HV6 Q9P1M8 Q9P1M9,Tumor necrosis factor ligand superfamily member 13,A proliferation-inducing ligand;TNF- and APOL-related leukocyte expressed ligand 2;TNF-related death ligand 1;, PF00229;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0016020;GO:0005654;GO:0005125;GO:0048018;GO:0005102;GO:0005164;GO:0006955;GO:0008284;GO:0048298;GO:0043488;GO:0007165;GO:0033209;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:membrane; C:nucleoplasm;, F:cytokine activity; F:receptor ligand activity; F:signaling receptor binding; F:tumor necrosis factor receptor binding;, P:immune response; P:positive regulation of cell population proliferation; P:positive regulation of isotype switching to IgA isotypes; P:regulation of mRNA stability; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; scaffold251 indexed_genome mRNA 87407 95806 . - . ID=transcript_16271;O43508 Q8IZK7 Q8WUZ7,Tumor necrosis factor ligand superfamily member 12,APO3 ligand;TNF-related weak inducer of apoptosis;, PF00229;, GO:0005576;GO:0005615;GO:0005887;GO:0048471;GO:0005886;GO:0005125;GO:0048018;GO:0005102;GO:0005164;GO:0001525;GO:0006915;GO:0097190;GO:0030154;GO:0043542;GO:0097191;GO:0006955;GO:0045766;GO:0001938;GO:2001238;GO:0045732;GO:0007165;GO:0033209;, C:extracellular region; C:extracellular space; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;, F:cytokine activity; F:receptor ligand activity; F:signaling receptor binding; F:tumor necrosis factor receptor binding;, P:angiogenesis; P:apoptotic process; P:apoptotic signaling pathway; P:cell differentiation; P:endothelial cell migration; P:extrinsic apoptotic signaling pathway; P:immune response; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of protein catabolic process; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; scaffold251 indexed_genome mRNA 97635 98447 . + . ID=transcript_16272;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold251 indexed_genome mRNA 134639 154974 . - . ID=transcript_16273;P24928 A6NN93 B9EH88 Q6NX41,DNA-directed RNA polymerase II subunit RPB1 {ECO:0000305},DNA-directed RNA polymerase II subunit A;DNA-directed RNA polymerase III largest subunit;RNA-directed RNA polymerase II subunit RPB1;, PF04997;PF00623;PF04983;PF05000;PF04998;PF04992;PF04990;PF05001;, GO:0005694;GO:0005737;GO:0005654;GO:0005634;GO:0005665;GO:0003677;GO:0003899;GO:0019900;GO:0046872;GO:1990841;GO:0008022;GO:0003723;GO:0003968;GO:0031625;GO:0006370;GO:0006353;GO:0008543;GO:0000398;GO:0048239;GO:0033120;GO:0050434;GO:0060964;GO:0006355;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;GO:0016032;, C:chromosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:kinase binding; F:metal ion binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:RNA binding; F:RNA-directed 5'-3' RNA polymerase activity; F:ubiquitin protein ligase binding;, P:7-methylguanosine mRNA capping; P:DNA-templated transcription, termination; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of RNA splicing; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:regulation of transcription, DNA-templated; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; P:viral process;|P24928 A6NN93 B9EH88 Q6NX41,DNA-directed RNA polymerase II subunit RPB1 {ECO:0000305},DNA-directed RNA polymerase II subunit A;DNA-directed RNA polymerase III largest subunit;RNA-directed RNA polymerase II subunit RPB1;, PF04997;PF00623;PF04983;PF05000;PF04998;PF04992;PF04990;PF05001;, GO:0005694;GO:0005737;GO:0005654;GO:0005634;GO:0005665;GO:0003677;GO:0003899;GO:0019900;GO:0046872;GO:1990841;GO:0008022;GO:0003723;GO:0003968;GO:0031625;GO:0006370;GO:0006353;GO:0008543;GO:0000398;GO:0048239;GO:0033120;GO:0050434;GO:0060964;GO:0006355;GO:0016070;GO:0042795;GO:0006366;GO:0006368;GO:0006367;GO:0006351;GO:0006283;GO:0016032;, C:chromosome; C:cytoplasm; C:nucleoplasm; C:nucleus; C:RNA polymerase II, core complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:kinase binding; F:metal ion binding; F:promoter-specific chromatin binding; F:protein C-terminus binding; F:RNA binding; F:RNA-directed 5'-3' RNA polymerase activity; F:ubiquitin protein ligase binding;, P:7-methylguanosine mRNA capping; P:DNA-templated transcription, termination; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of RNA splicing; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:regulation of transcription, DNA-templated; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; P:viral process; scaffold251 indexed_genome mRNA 167860 174735 . + . ID=transcript_16274;Q9P1Z0 B3KVL6 Q7Z697 Q86XJ4 Q8N4V8,Zinc finger and BTB domain-containing protein 4,KAISO-like zinc finger protein 1;, PF00651;, GO:0005694;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0008327;GO:0010428;GO:0042803;GO:0019901;GO:0000978;GO:0000977;GO:0043565;GO:0006974;GO:0000122;GO:0045892;GO:0006355;, C:chromosome; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:methyl-CpG binding; F:methyl-CpNpG binding; F:protein homodimerization activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;, P:cellular response to DNA damage stimulus; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold251 indexed_genome mRNA 175299 183317 . - . ID=transcript_16275;P11230 B7Z5H1 Q8IZ46 Q96FB8,Acetylcholine receptor subunit beta,, PF02931;PF02932;, GO:0005892;GO:0005887;GO:0099060;GO:0031594;GO:0043005;GO:0045202;GO:0042166;GO:0022848;GO:0015267;GO:0015276;GO:0030594;GO:0004888;GO:1904315;GO:0035095;GO:0006812;GO:0007268;GO:0034220;GO:0006936;GO:0048747;GO:0050877;GO:0007274;GO:0001941;GO:0042391;GO:0007165;GO:0003009;GO:0007271;, C:acetylcholine-gated channel complex; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:neuromuscular junction; C:neuron projection; C:synapse;, F:acetylcholine binding; F:acetylcholine-gated cation-selective channel activity; F:channel activity; F:ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmembrane signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;, P:behavioral response to nicotine; P:cation transport; P:chemical synaptic transmission; P:ion transmembrane transport; P:muscle contraction; P:muscle fiber development; P:nervous system process; P:neuromuscular synaptic transmission; P:postsynaptic membrane organization; P:regulation of membrane potential; P:signal transduction; P:skeletal muscle contraction; P:synaptic transmission, cholinergic; scaffold251 indexed_genome mRNA 184679 187098 . - . ID=transcript_16276;Q92914 Q2YDX8,Fibroblast growth factor 11,Fibroblast growth factor homologous factor 3;, PF00167;, GO:0005737;GO:0005576;GO:0005634;GO:0008083;GO:0017080;GO:0007267;GO:0007399;GO:1905150;GO:0007165;, C:cytoplasm; C:extracellular region; C:nucleus;, F:growth factor activity; F:sodium channel regulator activity;, P:cell-cell signaling; P:nervous system development; P:regulation of voltage-gated sodium channel activity; P:signal transduction; scaffold251 indexed_genome mRNA 187213 187943 . - . ID=transcript_16277;Q92914 Q2YDX8,Fibroblast growth factor 11,Fibroblast growth factor homologous factor 3;, PF00167;, GO:0005737;GO:0005576;GO:0005634;GO:0008083;GO:0017080;GO:0007267;GO:0007399;GO:1905150;GO:0007165;, C:cytoplasm; C:extracellular region; C:nucleus;, F:growth factor activity; F:sodium channel regulator activity;, P:cell-cell signaling; P:nervous system development; P:regulation of voltage-gated sodium channel activity; P:signal transduction; scaffold251 indexed_genome mRNA 189535 191107 . + . ID=transcript_16278;Q92914 Q2YDX8,Fibroblast growth factor 11,Fibroblast growth factor homologous factor 3;, PF00167;, GO:0005737;GO:0005576;GO:0005634;GO:0008083;GO:0017080;GO:0007267;GO:0007399;GO:1905150;GO:0007165;, C:cytoplasm; C:extracellular region; C:nucleus;, F:growth factor activity; F:sodium channel regulator activity;, P:cell-cell signaling; P:nervous system development; P:regulation of voltage-gated sodium channel activity; P:signal transduction; scaffold251 indexed_genome mRNA 192041 192847 . + . ID=transcript_16279;Q8N9M5 D3DTP8,Transmembrane protein 102,Common beta-chain associated protein;, PF03281;, GO:0009986;GO:0016021;GO:0005739;GO:0005886;GO:0032991;GO:0006915;GO:0045785;GO:0010820;GO:2000406;GO:0042981;GO:1901028;GO:0050730;GO:0034097;GO:0007165;, C:cell surface; C:integral component of membrane; C:mitochondrion; C:plasma membrane; C:protein-containing complex;, , P:apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of T cell chemotaxis; P:positive regulation of T cell migration; P:regulation of apoptotic process; P:regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:regulation of peptidyl-tyrosine phosphorylation; P:response to cytokine; P:signal transduction; scaffold251 indexed_genome mRNA 193310 193936 . - . ID=transcript_16280;Q8N9M5 D3DTP8,Transmembrane protein 102,Common beta-chain associated protein;, PF03281;, GO:0009986;GO:0016021;GO:0005739;GO:0005886;GO:0032991;GO:0006915;GO:0045785;GO:0010820;GO:2000406;GO:0042981;GO:1901028;GO:0050730;GO:0034097;GO:0007165;, C:cell surface; C:integral component of membrane; C:mitochondrion; C:plasma membrane; C:protein-containing complex;, , P:apoptotic process; P:positive regulation of cell adhesion; P:positive regulation of T cell chemotaxis; P:positive regulation of T cell migration; P:regulation of apoptotic process; P:regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:regulation of peptidyl-tyrosine phosphorylation; P:response to cytokine; P:signal transduction; scaffold251 indexed_genome mRNA 204665 205634 . - . ID=transcript_16281;Q8N4L4,Spermatid maturation protein 1,, PF15670;, GO:0005737;GO:0016021;GO:0030317;GO:0007291;, C:cytoplasm; C:integral component of membrane;, , P:flagellated sperm motility; P:sperm individualization; scaffold251 indexed_genome mRNA 214072 215071 . + . ID=transcript_16282;Q8NFZ4 Q9P2I1,Neuroligin-2,, PF00135;, GO:0042995;GO:0009986;GO:0098691;GO:0098690;GO:0060077;GO:0005887;GO:0099055;GO:0099060;GO:0016020;GO:0005886;GO:0045211;GO:0042734;GO:0089717;GO:0098983;GO:0045202;GO:0050839;GO:0042802;GO:0042043;GO:0038023;GO:0098609;GO:0045217;GO:0007268;GO:0097116;GO:1904862;GO:0035641;GO:0050804;GO:0050885;GO:0007158;GO:2000463;GO:0097151;GO:0032024;GO:1902474;GO:0051965;GO:0032230;GO:0051968;GO:2000809;GO:0097119;GO:0097104;GO:0099054;GO:0097105;GO:0035418;GO:2000311;GO:0002087;GO:0019233;GO:0007416;GO:0050808;GO:0048488;GO:0072553;, C:cell projection; C:cell surface; C:dopaminergic synapse; C:glycinergic synapse; C:inhibitory synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of postsynaptic specialization membrane; C:membrane; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:spanning component of membrane; C:symmetric, GABA-ergic, inhibitory synapse; C:synapse;, F:cell adhesion molecule binding; F:identical protein binding; F:neurexin family protein binding; F:signaling receptor activity;, P:cell-cell adhesion; P:cell-cell junction maintenance; P:chemical synaptic transmission; P:gephyrin clustering involved in postsynaptic density assembly; P:inhibitory synapse assembly; P:locomotory exploration behavior; P:modulation of chemical synaptic transmission; P:neuromuscular process controlling balance; P:neuron cell-cell adhesion; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of insulin secretion; P:positive regulation of protein localization to synapse; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission, GABAergic; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of synaptic vesicle clustering; P:postsynaptic density protein 95 clustering; P:postsynaptic membrane assembly; P:presynapse assembly; P:presynaptic membrane assembly; P:protein localization to synapse; P:regulation of AMPA receptor activity; P:regulation of respiratory gaseous exchange by nervous system process; P:sensory perception of pain; P:synapse assembly; P:synapse organization; P:synaptic vesicle endocytosis; P:terminal button organization; scaffold251 indexed_genome mRNA 236380 237691 . + . ID=transcript_16283;Q8N2U0,Transmembrane protein 256,, PF04241;, GO:0070062;GO:0016021;, C:extracellular exosome; C:integral component of membrane; scaffold251 indexed_genome mRNA 237737 252664 . - . ID=transcript_16284;Q9NRY6 A8K252 Q567U0 Q8NBW6 Q96F13,Phospholipid scramblase 3,Ca(2+)-dependent phospholipid scramblase 3;, PF03803;, GO:0005829;GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0005886;GO:0005509;GO:0048306;GO:0032791;GO:0000287;GO:0045340;GO:0017128;GO:0043621;GO:0017124;GO:0006915;GO:0032049;GO:0071222;GO:0042632;GO:0042593;GO:0017121;GO:0042981;GO:0090199;, C:cytosol; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent protein binding; F:lead ion binding; F:magnesium ion binding; F:mercury ion binding; F:phospholipid scramblase activity; F:protein self-association; F:SH3 domain binding;, P:apoptotic process; P:cardiolipin biosynthetic process; P:cellular response to lipopolysaccharide; P:cholesterol homeostasis; P:glucose homeostasis; P:plasma membrane phospholipid scrambling; P:regulation of apoptotic process; P:regulation of release of cytochrome c from mitochondria;|Q13470 O95364 Q8IYI4,Non-receptor tyrosine-protein kinase TNK1,CD38 negative kinase 1;, PF07714;, GO:0005737;GO:0031234;GO:0016020;GO:0005524;GO:0004715;GO:0004713;GO:0005102;GO:0004714;GO:0030154;GO:0045087;GO:0046777;GO:0006468;GO:0007169;, C:cytoplasm; C:extrinsic component of cytoplasmic side of plasma membrane; C:membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:innate immune response; P:protein autophosphorylation; P:protein phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold251 indexed_genome mRNA 252738 256488 . - . ID=transcript_16285;Q13470 O95364 Q8IYI4,Non-receptor tyrosine-protein kinase TNK1,CD38 negative kinase 1;, PF07714;, GO:0005737;GO:0031234;GO:0016020;GO:0005524;GO:0004715;GO:0004713;GO:0005102;GO:0004714;GO:0030154;GO:0045087;GO:0046777;GO:0006468;GO:0007169;, C:cytoplasm; C:extrinsic component of cytoplasmic side of plasma membrane; C:membrane;, F:ATP binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein tyrosine kinase activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity;, P:cell differentiation; P:innate immune response; P:protein autophosphorylation; P:protein phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold251 indexed_genome mRNA 267898 269315 . + . ID=transcript_16286;Q693B1 B3KPE0,BTB/POZ domain-containing protein KCTD11,KCASH1 protein {ECO:0000303|PubMed:21472142};Potassium channel tetramerization domain-containing protein 11;RING-type E3 ubiquitin transferase subunit KCTD11 {ECO:0000303|PubMed:20081843};, PF02214;, GO:0042802;GO:0016740;GO:0007049;GO:0007275;GO:0045666;GO:0051260;GO:0016567;GO:0040008;, , F:identical protein binding; F:transferase activity;, P:cell cycle; P:multicellular organism development; P:positive regulation of neuron differentiation; P:protein homooligomerization; P:protein ubiquitination; P:regulation of growth; scaffold251 indexed_genome mRNA 270045 282843 . - . ID=transcript_16287;Q15027 Q53XN9,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1,Centaurin-beta-1;, PF12796;PF01412;PF00169;, GO:0016020;GO:0055038;GO:0005096;GO:0046872;GO:0015031;, C:membrane; C:recycling endosome membrane;, F:GTPase activator activity; F:metal ion binding;, P:protein transport;|Q15027 Q53XN9,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1,Centaurin-beta-1;, PF12796;PF01412;PF00169;, GO:0016020;GO:0055038;GO:0005096;GO:0046872;GO:0015031;, C:membrane; C:recycling endosome membrane;, F:GTPase activator activity; F:metal ion binding;, P:protein transport;|Q15027 Q53XN9,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1,Centaurin-beta-1;, PF12796;PF01412;PF00169;, GO:0016020;GO:0055038;GO:0005096;GO:0046872;GO:0015031;, C:membrane; C:recycling endosome membrane;, F:GTPase activator activity; F:metal ion binding;, P:protein transport;|Q15027 Q53XN9,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1,Centaurin-beta-1;, PF12796;PF01412;PF00169;, GO:0016020;GO:0055038;GO:0005096;GO:0046872;GO:0015031;, C:membrane; C:recycling endosome membrane;, F:GTPase activator activity; F:metal ion binding;, P:protein transport;|Q15027 Q53XN9,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1,Centaurin-beta-1;, PF12796;PF01412;PF00169;, GO:0016020;GO:0055038;GO:0005096;GO:0046872;GO:0015031;, C:membrane; C:recycling endosome membrane;, F:GTPase activator activity; F:metal ion binding;, P:protein transport;|Q15027 Q53XN9,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1,Centaurin-beta-1;, PF12796;PF01412;PF00169;, GO:0016020;GO:0055038;GO:0005096;GO:0046872;GO:0015031;, C:membrane; C:recycling endosome membrane;, F:GTPase activator activity; F:metal ion binding;, P:protein transport;|Q15027 Q53XN9,Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1,Centaurin-beta-1;, PF12796;PF01412;PF00169;, GO:0016020;GO:0055038;GO:0005096;GO:0046872;GO:0015031;, C:membrane; C:recycling endosome membrane;, F:GTPase activator activity; F:metal ion binding;, P:protein transport; scaffold251 indexed_genome mRNA 283006 286167 . - . ID=transcript_16288;P41236,Protein phosphatase inhibitor 2,, PF04979;, GO:0004864;GO:0004865;GO:0006091;GO:0005977;GO:0043666;GO:0009966;, , F:protein phosphatase inhibitor activity; F:protein serine/threonine phosphatase inhibitor activity;, P:generation of precursor metabolites and energy; P:glycogen metabolic process; P:regulation of phosphoprotein phosphatase activity; P:regulation of signal transduction; scaffold251 indexed_genome mRNA 288743 298477 . + . ID=transcript_16289;Q96JN8 Q6GPI8 Q96IU9 Q9H0B0,Neuralized-like protein 4,, PF07177;, GO:0005814;GO:0005737;GO:0061630;, C:centriole; C:cytoplasm;, F:ubiquitin protein ligase activity;|Q96JN8 Q6GPI8 Q96IU9 Q9H0B0,Neuralized-like protein 4,, PF07177;, GO:0005814;GO:0005737;GO:0061630;, C:centriole; C:cytoplasm;, F:ubiquitin protein ligase activity;|Q96JN8 Q6GPI8 Q96IU9 Q9H0B0,Neuralized-like protein 4,, PF07177;, GO:0005814;GO:0005737;GO:0061630;, C:centriole; C:cytoplasm;, F:ubiquitin protein ligase activity; scaffold251 indexed_genome mRNA 298725 301845 . + . ID=transcript_16290;Q13227 B4DXA1 Q6FHM8,G protein pathway suppressor 2 {ECO:0000303|PubMed:19917673, ECO:0000303|PubMed:8943324},, PF15991;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0017053;GO:0030332;GO:0005095;GO:0003713;GO:0003714;GO:0030183;GO:0000188;GO:0030522;GO:0007254;GO:0050859;GO:0045599;GO:0050728;GO:0046329;GO:1900045;GO:0034122;GO:0000122;GO:0010804;GO:0010875;GO:0035360;GO:0045944;GO:0045598;GO:0019216;GO:0098780;GO:0016032;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:cyclin binding; F:GTPase inhibitor activity; F:transcription coactivator activity; F:transcription corepressor activity;, P:B cell differentiation; P:inactivation of MAPK activity; P:intracellular receptor signaling pathway; P:JNK cascade; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of fat cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of JNK cascade; P:negative regulation of protein K63-linked ubiquitination; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of cholesterol efflux; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of fat cell differentiation; P:regulation of lipid metabolic process; P:response to mitochondrial depolarisation; P:viral process;|Q13227 B4DXA1 Q6FHM8,G protein pathway suppressor 2 {ECO:0000303|PubMed:19917673, ECO:0000303|PubMed:8943324},, PF15991;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0017053;GO:0030332;GO:0005095;GO:0003713;GO:0003714;GO:0030183;GO:0000188;GO:0030522;GO:0007254;GO:0050859;GO:0045599;GO:0050728;GO:0046329;GO:1900045;GO:0034122;GO:0000122;GO:0010804;GO:0010875;GO:0035360;GO:0045944;GO:0045598;GO:0019216;GO:0098780;GO:0016032;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:cyclin binding; F:GTPase inhibitor activity; F:transcription coactivator activity; F:transcription corepressor activity;, P:B cell differentiation; P:inactivation of MAPK activity; P:intracellular receptor signaling pathway; P:JNK cascade; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of fat cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of JNK cascade; P:negative regulation of protein K63-linked ubiquitination; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of cholesterol efflux; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of fat cell differentiation; P:regulation of lipid metabolic process; P:response to mitochondrial depolarisation; P:viral process;|Q13227 B4DXA1 Q6FHM8,G protein pathway suppressor 2 {ECO:0000303|PubMed:19917673, ECO:0000303|PubMed:8943324},, PF15991;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0017053;GO:0030332;GO:0005095;GO:0003713;GO:0003714;GO:0030183;GO:0000188;GO:0030522;GO:0007254;GO:0050859;GO:0045599;GO:0050728;GO:0046329;GO:1900045;GO:0034122;GO:0000122;GO:0010804;GO:0010875;GO:0035360;GO:0045944;GO:0045598;GO:0019216;GO:0098780;GO:0016032;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:cyclin binding; F:GTPase inhibitor activity; F:transcription coactivator activity; F:transcription corepressor activity;, P:B cell differentiation; P:inactivation of MAPK activity; P:intracellular receptor signaling pathway; P:JNK cascade; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of fat cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of JNK cascade; P:negative regulation of protein K63-linked ubiquitination; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of cholesterol efflux; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of fat cell differentiation; P:regulation of lipid metabolic process; P:response to mitochondrial depolarisation; P:viral process;|Q13227 B4DXA1 Q6FHM8,G protein pathway suppressor 2 {ECO:0000303|PubMed:19917673, ECO:0000303|PubMed:8943324},, PF15991;, GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0017053;GO:0030332;GO:0005095;GO:0003713;GO:0003714;GO:0030183;GO:0000188;GO:0030522;GO:0007254;GO:0050859;GO:0045599;GO:0050728;GO:0046329;GO:1900045;GO:0034122;GO:0000122;GO:0010804;GO:0010875;GO:0035360;GO:0045944;GO:0045598;GO:0019216;GO:0098780;GO:0016032;, C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:cyclin binding; F:GTPase inhibitor activity; F:transcription coactivator activity; F:transcription corepressor activity;, P:B cell differentiation; P:inactivation of MAPK activity; P:intracellular receptor signaling pathway; P:JNK cascade; P:negative regulation of B cell receptor signaling pathway; P:negative regulation of fat cell differentiation; P:negative regulation of inflammatory response; P:negative regulation of JNK cascade; P:negative regulation of protein K63-linked ubiquitination; P:negative regulation of toll-like receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:positive regulation of cholesterol efflux; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of fat cell differentiation; P:regulation of lipid metabolic process; P:response to mitochondrial depolarisation; P:viral process; scaffold251 indexed_genome mRNA 302005 302515 . + . ID=transcript_16291;P63241 A8K9A0 D3DTP2 P10159 Q16182 Q7L7L3 Q7Z4L1 Q9D0G2,Eukaryotic translation initiation factor 5A-1,Eukaryotic initiation factor 5A isoform 1;Rev-binding factor;eIF-4D;, PF01287;, GO:0005642;GO:0005737;GO:0005829;GO:0005789;GO:0016020;GO:0005643;GO:0005634;GO:0047485;GO:0043022;GO:0003723;GO:0003746;GO:0017070;GO:0006915;GO:0006406;GO:0006913;GO:0008284;GO:0045901;GO:0045905;GO:0006611;, C:annulate lamellae; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:membrane; C:nuclear pore; C:nucleus;, F:protein N-terminus binding; F:ribosome binding; F:RNA binding; F:translation elongation factor activity; F:U6 snRNA binding;, P:apoptotic process; P:mRNA export from nucleus; P:nucleocytoplasmic transport; P:positive regulation of cell population proliferation; P:positive regulation of translational elongation; P:positive regulation of translational termination; P:protein export from nucleus; scaffold251 indexed_genome mRNA 302791 305480 . + . ID=transcript_16292;P63241 A8K9A0 D3DTP2 P10159 Q16182 Q7L7L3 Q7Z4L1 Q9D0G2,Eukaryotic translation initiation factor 5A-1,Eukaryotic initiation factor 5A isoform 1;Rev-binding factor;eIF-4D;, PF01287;, GO:0005642;GO:0005737;GO:0005829;GO:0005789;GO:0016020;GO:0005643;GO:0005634;GO:0047485;GO:0043022;GO:0003723;GO:0003746;GO:0017070;GO:0006915;GO:0006406;GO:0006913;GO:0008284;GO:0045901;GO:0045905;GO:0006611;, C:annulate lamellae; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:membrane; C:nuclear pore; C:nucleus;, F:protein N-terminus binding; F:ribosome binding; F:RNA binding; F:translation elongation factor activity; F:U6 snRNA binding;, P:apoptotic process; P:mRNA export from nucleus; P:nucleocytoplasmic transport; P:positive regulation of cell population proliferation; P:positive regulation of translational elongation; P:positive regulation of translational termination; P:protein export from nucleus;|P63241 A8K9A0 D3DTP2 P10159 Q16182 Q7L7L3 Q7Z4L1 Q9D0G2,Eukaryotic translation initiation factor 5A-1,Eukaryotic initiation factor 5A isoform 1;Rev-binding factor;eIF-4D;, PF01287;, GO:0005642;GO:0005737;GO:0005829;GO:0005789;GO:0016020;GO:0005643;GO:0005634;GO:0047485;GO:0043022;GO:0003723;GO:0003746;GO:0017070;GO:0006915;GO:0006406;GO:0006913;GO:0008284;GO:0045901;GO:0045905;GO:0006611;, C:annulate lamellae; C:cytoplasm; C:cytosol; C:endoplasmic reticulum membrane; C:membrane; C:nuclear pore; C:nucleus;, F:protein N-terminus binding; F:ribosome binding; F:RNA binding; F:translation elongation factor activity; F:U6 snRNA binding;, P:apoptotic process; P:mRNA export from nucleus; P:nucleocytoplasmic transport; P:positive regulation of cell population proliferation; P:positive regulation of translational elongation; P:positive regulation of translational termination; P:protein export from nucleus; scaffold251 indexed_genome mRNA 334288 341563 . + . ID=transcript_16293;Q9Y2T7 D3DTP1 Q8N4P0,Y-box-binding protein 2,Contrin;DNA-binding protein C;Germ cell-specific Y-box-binding protein;MSY2 homolog;, PF00313;, GO:0005737;GO:0005634;GO:0003677;GO:0003676;GO:0003723;GO:0048599;GO:0120162;GO:0010468;GO:0007283;GO:0006366;GO:0009386;, C:cytoplasm; C:nucleus;, F:DNA binding; F:nucleic acid binding; F:RNA binding;, P:oocyte development; P:positive regulation of cold-induced thermogenesis; P:regulation of gene expression; P:spermatogenesis; P:transcription by RNA polymerase II; P:translational attenuation;|P14672 Q05BQ3 Q14CX2,Solute carrier family 2, facilitated glucose transporter member 4 {ECO:0000305},Glucose transporter type 4, insulin-responsive {ECO:0000303|PubMed:1397719};, PF00083;, GO:0005905;GO:0030136;GO:0030659;GO:0005829;GO:0012505;GO:0009897;GO:0070062;GO:0032593;GO:0005887;GO:0016020;GO:0045121;GO:0005771;GO:0048471;GO:0005886;GO:0098793;GO:0042383;GO:0016529;GO:0030315;GO:0005802;GO:0030140;GO:0012506;GO:0055056;GO:0005355;GO:0010021;GO:0050873;GO:0005975;GO:0071456;GO:0032869;GO:0071470;GO:0071356;GO:0042593;GO:0046323;GO:0044381;GO:1904659;GO:0007611;GO:0007616;GO:0031550;GO:0098694;GO:0045471;GO:0007614;GO:0150104;, C:clathrin-coated pit; C:clathrin-coated vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:endomembrane system; C:external side of plasma membrane; C:extracellular exosome; C:insulin-responsive compartment; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:multivesicular body; C:perinuclear region of cytoplasm; C:plasma membrane; C:presynapse; C:sarcolemma; C:sarcoplasmic reticulum; C:T-tubule; C:trans-Golgi network; C:trans-Golgi network transport vesicle; C:vesicle membrane;, F:D-glucose transmembrane transporter activity; F:glucose transmembrane transporter activity;, P:amylopectin biosynthetic process; P:brown fat cell differentiation; P:carbohydrate metabolic process; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to osmotic stress; P:cellular response to tumor necrosis factor; P:glucose homeostasis; P:glucose import; P:glucose import in response to insulin stimulus; P:glucose transmembrane transport; P:learning or memory; P:long-term memory; P:positive regulation of brain-derived neurotrophic factor receptor signaling pathway; P:regulation of synaptic vesicle budding from presynaptic endocytic zone membrane; P:response to ethanol; P:short-term memory; P:transport across blood-brain barrier; scaffold251 indexed_genome mRNA 353211 355447 . + . ID=transcript_16294;O95471 B2R9X7 D3DTP0 Q6IPN3 Q7Z4Y7 Q9BVN0,Claudin-7,, PF00822;, GO:0016327;GO:0016323;GO:0005923;GO:0016021;GO:0016328;GO:0005886;GO:0050839;GO:0042802;GO:0019904;GO:0005198;GO:0070830;GO:0016338;GO:0007155;GO:0043066;GO:0007162;GO:0031333;GO:2000147;GO:0008284;GO:0045471;, C:apicolateral plasma membrane; C:basolateral plasma membrane; C:bicellular tight junction; C:integral component of membrane; C:lateral plasma membrane; C:plasma membrane;, F:cell adhesion molecule binding; F:identical protein binding; F:protein domain specific binding; F:structural molecule activity;, P:bicellular tight junction assembly; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; P:cell adhesion; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of protein-containing complex assembly; P:positive regulation of cell motility; P:positive regulation of cell population proliferation; P:response to ethanol; scaffold251 indexed_genome mRNA 355869 361707 . - . ID=transcript_16295;Q8TE02 A8K1M5 D3DTN9 Q659B6 Q7Z2T4 Q8TDR9 Q9BUB2 Q9Y2Q4,Elongator complex protein 5 {ECO:0000303|PubMed:22854966},Dermal papilla-derived protein 6 {ECO:0000303|PubMed:16850183};S-phase 2 protein;, PF10483;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0005634;GO:0030335;GO:0006400;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:nucleus;, , P:positive regulation of cell migration; P:tRNA modification; P:tRNA wobble uridine modification;|Q8TE02 A8K1M5 D3DTN9 Q659B6 Q7Z2T4 Q8TDR9 Q9BUB2 Q9Y2Q4,Elongator complex protein 5 {ECO:0000303|PubMed:22854966},Dermal papilla-derived protein 6 {ECO:0000303|PubMed:16850183};S-phase 2 protein;, PF10483;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0005634;GO:0030335;GO:0006400;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:nucleus;, , P:positive regulation of cell migration; P:tRNA modification; P:tRNA wobble uridine modification;|Q8TE02 A8K1M5 D3DTN9 Q659B6 Q7Z2T4 Q8TDR9 Q9BUB2 Q9Y2Q4,Elongator complex protein 5 {ECO:0000303|PubMed:22854966},Dermal papilla-derived protein 6 {ECO:0000303|PubMed:16850183};S-phase 2 protein;, PF10483;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0005634;GO:0030335;GO:0006400;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:nucleus;, , P:positive regulation of cell migration; P:tRNA modification; P:tRNA wobble uridine modification;|Q8TE02 A8K1M5 D3DTN9 Q659B6 Q7Z2T4 Q8TDR9 Q9BUB2 Q9Y2Q4,Elongator complex protein 5 {ECO:0000303|PubMed:22854966},Dermal papilla-derived protein 6 {ECO:0000303|PubMed:16850183};S-phase 2 protein;, PF10483;, GO:0005737;GO:0005829;GO:0033588;GO:0005654;GO:0005634;GO:0030335;GO:0006400;GO:0002098;, C:cytoplasm; C:cytosol; C:elongator holoenzyme complex; C:nucleoplasm; C:nucleus;, , P:positive regulation of cell migration; P:tRNA modification; P:tRNA wobble uridine modification; scaffold251 indexed_genome mRNA 366018 367839 . - . ID=transcript_16296;O95476 D3DTN7 Q96GQ9,CTD nuclear envelope phosphatase 1,Serine/threonine-protein phosphatase dullard;, PF03031;, GO:0005737;GO:0005789;GO:0016021;GO:0005811;GO:0071595;GO:0005635;GO:0031965;GO:0004721;GO:0106306;GO:0004722;GO:0106307;GO:0007276;GO:0007498;GO:0007077;GO:0006998;GO:0090263;GO:0010867;GO:0006470;GO:0034504;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:Nem1-Spo7 phosphatase complex; C:nuclear envelope; C:nuclear membrane;, F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:gamete generation; P:mesoderm development; P:mitotic nuclear envelope disassembly; P:nuclear envelope organization; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of triglyceride biosynthetic process; P:protein dephosphorylation; P:protein localization to nucleus;|O95476 D3DTN7 Q96GQ9,CTD nuclear envelope phosphatase 1,Serine/threonine-protein phosphatase dullard;, PF03031;, GO:0005737;GO:0005789;GO:0016021;GO:0005811;GO:0071595;GO:0005635;GO:0031965;GO:0004721;GO:0106306;GO:0004722;GO:0106307;GO:0007276;GO:0007498;GO:0007077;GO:0006998;GO:0090263;GO:0010867;GO:0006470;GO:0034504;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:Nem1-Spo7 phosphatase complex; C:nuclear envelope; C:nuclear membrane;, F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;, P:gamete generation; P:mesoderm development; P:mitotic nuclear envelope disassembly; P:nuclear envelope organization; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of triglyceride biosynthetic process; P:protein dephosphorylation; P:protein localization to nucleus; scaffold252 indexed_genome mRNA 5090 41995 . + . ID=transcript_16297;Q7L5D6 A4D2Q1 B3KNC7 Q9UFC9 Q9Y309,Golgi to ER traffic protein 4 homolog {ECO:0000305},Conserved edge-expressed protein;Transmembrane domain recognition complex 35 kDa subunit;, PF04190;, GO:0071818;GO:0005694;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0051087;GO:0051220;GO:1904378;GO:0045048;GO:0071816;, C:BAT3 complex; C:chromosome; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm;, F:chaperone binding;, P:cytoplasmic sequestering of protein; P:maintenance of unfolded protein involved in ERAD pathway; P:protein insertion into ER membrane; P:tail-anchored membrane protein insertion into ER membrane;|Q7L5D6 A4D2Q1 B3KNC7 Q9UFC9 Q9Y309,Golgi to ER traffic protein 4 homolog {ECO:0000305},Conserved edge-expressed protein;Transmembrane domain recognition complex 35 kDa subunit;, PF04190;, GO:0071818;GO:0005694;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0051087;GO:0051220;GO:1904378;GO:0045048;GO:0071816;, C:BAT3 complex; C:chromosome; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm;, F:chaperone binding;, P:cytoplasmic sequestering of protein; P:maintenance of unfolded protein involved in ERAD pathway; P:protein insertion into ER membrane; P:tail-anchored membrane protein insertion into ER membrane;|Q7L5D6 A4D2Q1 B3KNC7 Q9UFC9 Q9Y309,Golgi to ER traffic protein 4 homolog {ECO:0000305},Conserved edge-expressed protein;Transmembrane domain recognition complex 35 kDa subunit;, PF04190;, GO:0071818;GO:0005694;GO:0005737;GO:0005829;GO:0005730;GO:0005654;GO:0051087;GO:0051220;GO:1904378;GO:0045048;GO:0071816;, C:BAT3 complex; C:chromosome; C:cytoplasm; C:cytosol; C:nucleolus; C:nucleoplasm;, F:chaperone binding;, P:cytoplasmic sequestering of protein; P:maintenance of unfolded protein involved in ERAD pathway; P:protein insertion into ER membrane; P:tail-anchored membrane protein insertion into ER membrane;|O75689 A4D2Q2 B3KRZ4 B4DVA6 F6XZ68 H7C2Q4,Arf-GAP with dual PH domain-containing protein 1,Centaurin-alpha-1;Putative MAPK-activating protein PM25;, PF01412;PF00169;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005096;GO:0043533;GO:0046872;GO:1902936;GO:0005547;GO:0007166;GO:0043087;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:metal ion binding; F:phosphatidylinositol bisphosphate binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:cell surface receptor signaling pathway; P:regulation of GTPase activity;|O75689 A4D2Q2 B3KRZ4 B4DVA6 F6XZ68 H7C2Q4,Arf-GAP with dual PH domain-containing protein 1,Centaurin-alpha-1;Putative MAPK-activating protein PM25;, PF01412;PF00169;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005096;GO:0043533;GO:0046872;GO:1902936;GO:0005547;GO:0007166;GO:0043087;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:metal ion binding; F:phosphatidylinositol bisphosphate binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:cell surface receptor signaling pathway; P:regulation of GTPase activity;|O75689 A4D2Q2 B3KRZ4 B4DVA6 F6XZ68 H7C2Q4,Arf-GAP with dual PH domain-containing protein 1,Centaurin-alpha-1;Putative MAPK-activating protein PM25;, PF01412;PF00169;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005096;GO:0043533;GO:0046872;GO:1902936;GO:0005547;GO:0007166;GO:0043087;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:metal ion binding; F:phosphatidylinositol bisphosphate binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:cell surface receptor signaling pathway; P:regulation of GTPase activity;|O75689 A4D2Q2 B3KRZ4 B4DVA6 F6XZ68 H7C2Q4,Arf-GAP with dual PH domain-containing protein 1,Centaurin-alpha-1;Putative MAPK-activating protein PM25;, PF01412;PF00169;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005096;GO:0043533;GO:0046872;GO:1902936;GO:0005547;GO:0007166;GO:0043087;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:metal ion binding; F:phosphatidylinositol bisphosphate binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:cell surface receptor signaling pathway; P:regulation of GTPase activity;|O75689 A4D2Q2 B3KRZ4 B4DVA6 F6XZ68 H7C2Q4,Arf-GAP with dual PH domain-containing protein 1,Centaurin-alpha-1;Putative MAPK-activating protein PM25;, PF01412;PF00169;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005096;GO:0043533;GO:0046872;GO:1902936;GO:0005547;GO:0007166;GO:0043087;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:metal ion binding; F:phosphatidylinositol bisphosphate binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:cell surface receptor signaling pathway; P:regulation of GTPase activity;|O75689 A4D2Q2 B3KRZ4 B4DVA6 F6XZ68 H7C2Q4,Arf-GAP with dual PH domain-containing protein 1,Centaurin-alpha-1;Putative MAPK-activating protein PM25;, PF01412;PF00169;, GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005096;GO:0043533;GO:0046872;GO:1902936;GO:0005547;GO:0007166;GO:0043087;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:GTPase activator activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:metal ion binding; F:phosphatidylinositol bisphosphate binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;, P:cell surface receptor signaling pathway; P:regulation of GTPase activity; scaffold252 indexed_genome mRNA 64414 67370 . + . ID=transcript_16298;Q49B96 A4FTX0,Cytochrome c oxidase assembly protein COX19,, PF06747;, GO:0005829;GO:0005758;GO:0005739;GO:0006878;GO:0033617;, C:cytosol; C:mitochondrial intermembrane space; C:mitochondrion;, , P:cellular copper ion homeostasis; P:mitochondrial cytochrome c oxidase assembly; scaffold252 indexed_genome mRNA 68189 70034 . - . ID=transcript_16299;Q49B96 A4FTX0,Cytochrome c oxidase assembly protein COX19,, PF06747;, GO:0005829;GO:0005758;GO:0005739;GO:0006878;GO:0033617;, C:cytosol; C:mitochondrial intermembrane space; C:mitochondrion;, , P:cellular copper ion homeostasis; P:mitochondrial cytochrome c oxidase assembly; scaffold252 indexed_genome mRNA 78882 81203 . - . ID=transcript_16300;Q9BRJ6,Uncharacterized protein C7orf50,, PF10180;, GO:0003723;, , F:RNA binding;|Q9BRJ6,Uncharacterized protein C7orf50,, PF10180;, GO:0003723;, , F:RNA binding; scaffold252 indexed_genome mRNA 81398 83353 . - . ID=transcript_16301;Q9BRJ6,Uncharacterized protein C7orf50,, PF10180;, GO:0003723;, , F:RNA binding; scaffold252 indexed_genome mRNA 107609 112503 . + . ID=transcript_16302;Q96CH1 Q86SP5,Probable G-protein coupled receptor 146,G-protein coupled receptor PGR8;, PF00001;, GO:0016021;GO:0005886;GO:0004930;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity; scaffold252 indexed_genome mRNA 120845 122563 . + . ID=transcript_16303;Q99527 A8K6C5 B5BUJ1 O00143 O43494 Q13631 Q6FHL1 Q96F42 Q99981,G-protein coupled estrogen receptor 1 {ECO:0000305},Chemoattractant receptor-like 2;Flow-induced endothelial G-protein coupled receptor 1;G protein-coupled estrogen receptor 1;G-protein coupled receptor 30 {ECO:0000303|PubMed:17379646, ECO:0000303|PubMed:18566127};GPCR-Br;IL8-related receptor DRY12;Lymphocyte-derived G-protein coupled receptor;Membrane estrogen receptor;, PF00001;, GO:0030424;GO:0043679;GO:0005737;GO:0030659;GO:0005829;GO:0030425;GO:0043198;GO:0044327;GO:0032591;GO:0005769;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0005887;GO:0043231;GO:0045095;GO:0031966;GO:0005635;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0048786;GO:0042734;GO:0055037;GO:0005802;GO:0003682;GO:0030284;GO:0004930;GO:0005496;GO:1990239;GO:0003707;GO:0007189;GO:0030263;GO:0007049;GO:0071392;GO:0071333;GO:0071389;GO:0071375;GO:0071356;GO:0007186;GO:0006954;GO:0045087;GO:0030518;GO:0071157;GO:0010948;GO:0008285;GO:0070373;GO:0045599;GO:0010629;GO:0050728;GO:0002695;GO:0051055;GO:0051898;GO:1904706;GO:0019228;GO:0030264;GO:0043065;GO:2000724;GO:0030335;GO:0008284;GO:0043280;GO:0007204;GO:2000353;GO:0045742;GO:0070374;GO:2001238;GO:0045745;GO:0010628;GO:0032962;GO:0032024;GO:0043410;GO:0050769;GO:0001956;GO:0014068;GO:1903078;GO:0001934;GO:0090200;GO:0051281;GO:0045944;GO:0070474;GO:0051480;GO:0043401;GO:0042311;, C:axon; C:axon terminus; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:dendrite; C:dendritic shaft; C:dendritic spine head; C:dendritic spine membrane; C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:keratin filament; C:mitochondrial membrane; C:nuclear envelope; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:presynaptic active zone; C:presynaptic membrane; C:recycling endosome; C:trans-Golgi network;, F:chromatin binding; F:estrogen receptor activity; F:G protein-coupled receptor activity; F:steroid binding; F:steroid hormone binding; F:steroid hormone receptor activity;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:apoptotic chromosome condensation; P:cell cycle; P:cellular response to estradiol stimulus; P:cellular response to glucose stimulus; P:cellular response to mineralocorticoid stimulus; P:cellular response to peptide hormone stimulus; P:cellular response to tumor necrosis factor; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:innate immune response; P:intracellular steroid hormone receptor signaling pathway; P:negative regulation of cell cycle arrest; P:negative regulation of cell cycle process; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:negative regulation of inflammatory response; P:negative regulation of leukocyte activation; P:negative regulation of lipid biosynthetic process; P:negative regulation of protein kinase B signaling; P:negative regulation of vascular associated smooth muscle cell proliferation; P:neuronal action potential; P:nuclear fragmentation involved in apoptotic nuclear change; P:positive regulation of apoptotic process; P:positive regulation of cardiac vascular smooth muscle cell differentiation; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of endothelial cell apoptotic process; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of G protein-coupled receptor signaling pathway; P:positive regulation of gene expression; P:positive regulation of inositol trisphosphate biosynthetic process; P:positive regulation of insulin secretion; P:positive regulation of MAPK cascade; P:positive regulation of neurogenesis; P:positive regulation of neurotransmitter secretion; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of uterine smooth muscle contraction; P:regulation of cytosolic calcium ion concentration; P:steroid hormone mediated signaling pathway; P:vasodilation; scaffold252 indexed_genome mRNA 148809 156339 . - . ID=transcript_16304;Q8N6M9 A4D220,AN1-type zinc finger protein 2A,, PF01428;, GO:0005737;GO:0005634;GO:0008270;, C:cytoplasm; C:nucleus;, F:zinc ion binding;|Q8N6M9 A4D220,AN1-type zinc finger protein 2A,, PF01428;, GO:0005737;GO:0005634;GO:0008270;, C:cytoplasm; C:nucleus;, F:zinc ion binding; scaffold252 indexed_genome mRNA 211238 211862 . - . ID=transcript_16305;A6NJT0 A4D221,Homeobox protein unc-4 homolog,Homeobox protein Uncx4.1;, PF00046;, GO:0000785;GO:0005634;GO:0000981;GO:1990837;GO:0001502;GO:0035726;GO:0021516;GO:0021889;GO:0007389;GO:0045595;GO:0010468;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific double-stranded DNA binding;, P:cartilage condensation; P:common myeloid progenitor cell proliferation; P:dorsal spinal cord development; P:olfactory bulb interneuron differentiation; P:pattern specification process; P:regulation of cell differentiation; P:regulation of gene expression; scaffold252 indexed_genome mRNA 344601 355602 . - . ID=transcript_16306;Q8IY33 D3YTD2 Q7RTP4 Q7Z655 Q8TEQ4 Q9H5F9,MICAL-like protein 2,Junctional Rab13-binding protein;Molecule interacting with CasL-like 2;, PF00307;PF12130;PF00412;, GO:0005923;GO:0005911;GO:0005829;GO:0043005;GO:0005886;GO:0055037;GO:0001725;GO:0051015;GO:0042805;GO:0031005;GO:0046872;GO:0031267;GO:0031532;GO:0030041;GO:0070830;GO:0032456;GO:0031175;GO:1903955;GO:0034446;, C:bicellular tight junction; C:cell-cell junction; C:cytosol; C:neuron projection; C:plasma membrane; C:recycling endosome; C:stress fiber;, F:actin filament binding; F:actinin binding; F:filamin binding; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton reorganization; P:actin filament polymerization; P:bicellular tight junction assembly; P:endocytic recycling; P:neuron projection development; P:positive regulation of protein targeting to mitochondrion; P:substrate adhesion-dependent cell spreading;|Q8IY33 D3YTD2 Q7RTP4 Q7Z655 Q8TEQ4 Q9H5F9,MICAL-like protein 2,Junctional Rab13-binding protein;Molecule interacting with CasL-like 2;, PF00307;PF12130;PF00412;, GO:0005923;GO:0005911;GO:0005829;GO:0043005;GO:0005886;GO:0055037;GO:0001725;GO:0051015;GO:0042805;GO:0031005;GO:0046872;GO:0031267;GO:0031532;GO:0030041;GO:0070830;GO:0032456;GO:0031175;GO:1903955;GO:0034446;, C:bicellular tight junction; C:cell-cell junction; C:cytosol; C:neuron projection; C:plasma membrane; C:recycling endosome; C:stress fiber;, F:actin filament binding; F:actinin binding; F:filamin binding; F:metal ion binding; F:small GTPase binding;, P:actin cytoskeleton reorganization; P:actin filament polymerization; P:bicellular tight junction assembly; P:endocytic recycling; P:neuron projection development; P:positive regulation of protein targeting to mitochondrion; P:substrate adhesion-dependent cell spreading; scaffold253 indexed_genome mRNA 1020 5395 . - . ID=transcript_16307;Q0D2I5 Q24JT6 Q7L5J9 Q7Z5X4 Q9BQ46,Non-homologous end joining factor IFFO1 {ECO:0000303|PubMed:31548606},Intermediate filament family orphan 1 {ECO:0000303|PubMed:31548606};Tumor antigen HOM-TES-103 {ECO:0000303|PubMed:12032826};, , GO:0005882;GO:0005637;GO:0016363;GO:0005654;GO:0035861;GO:1990683;GO:0006303;GO:1990166;, C:intermediate filament; C:nuclear inner membrane; C:nuclear matrix; C:nucleoplasm; C:site of double-strand break;, , P:DNA double-strand break attachment to nuclear envelope; P:double-strand break repair via nonhomologous end joining; P:protein localization to site of double-strand break;|Q0D2I5 Q24JT6 Q7L5J9 Q7Z5X4 Q9BQ46,Non-homologous end joining factor IFFO1 {ECO:0000303|PubMed:31548606},Intermediate filament family orphan 1 {ECO:0000303|PubMed:31548606};Tumor antigen HOM-TES-103 {ECO:0000303|PubMed:12032826};, , GO:0005882;GO:0005637;GO:0016363;GO:0005654;GO:0035861;GO:1990683;GO:0006303;GO:1990166;, C:intermediate filament; C:nuclear inner membrane; C:nuclear matrix; C:nucleoplasm; C:site of double-strand break;, , P:DNA double-strand break attachment to nuclear envelope; P:double-strand break repair via nonhomologous end joining; P:protein localization to site of double-strand break; scaffold253 indexed_genome mRNA 9572 48479 . - . ID=transcript_16308;P46087 A1A4Z3 B3KPD6 Q05BA7 Q0P5S5 Q3KQS4 Q58F30,Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase,Nucleolar protein 1;Nucleolar protein 2 homolog;Proliferating-cell nucleolar antigen p120;Proliferation-associated nucleolar protein p120;, PF01189;PF17125;PF08062;, GO:0005730;GO:0005654;GO:0003723;GO:0009383;GO:0000470;GO:0008284;GO:1901796;GO:0006357;GO:0000027;GO:0001510;GO:0070475;, C:nucleolus; C:nucleoplasm;, F:RNA binding; F:rRNA (cytosine-C5-)-methyltransferase activity;, P:maturation of LSU-rRNA; P:positive regulation of cell population proliferation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:ribosomal large subunit assembly; P:RNA methylation; P:rRNA base methylation;|P46087 A1A4Z3 B3KPD6 Q05BA7 Q0P5S5 Q3KQS4 Q58F30,Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase,Nucleolar protein 1;Nucleolar protein 2 homolog;Proliferating-cell nucleolar antigen p120;Proliferation-associated nucleolar protein p120;, PF01189;PF17125;PF08062;, GO:0005730;GO:0005654;GO:0003723;GO:0009383;GO:0000470;GO:0008284;GO:1901796;GO:0006357;GO:0000027;GO:0001510;GO:0070475;, C:nucleolus; C:nucleoplasm;, F:RNA binding; F:rRNA (cytosine-C5-)-methyltransferase activity;, P:maturation of LSU-rRNA; P:positive regulation of cell population proliferation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:ribosomal large subunit assembly; P:RNA methylation; P:rRNA base methylation;|P46087 A1A4Z3 B3KPD6 Q05BA7 Q0P5S5 Q3KQS4 Q58F30,Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase,Nucleolar protein 1;Nucleolar protein 2 homolog;Proliferating-cell nucleolar antigen p120;Proliferation-associated nucleolar protein p120;, PF01189;PF17125;PF08062;, GO:0005730;GO:0005654;GO:0003723;GO:0009383;GO:0000470;GO:0008284;GO:1901796;GO:0006357;GO:0000027;GO:0001510;GO:0070475;, C:nucleolus; C:nucleoplasm;, F:RNA binding; F:rRNA (cytosine-C5-)-methyltransferase activity;, P:maturation of LSU-rRNA; P:positive regulation of cell population proliferation; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; P:ribosomal large subunit assembly; P:RNA methylation; P:rRNA base methylation;|Q14839 Q8IXZ5,Chromodomain-helicase-DNA-binding protein 4,ATP-dependent helicase CHD4;Mi-2 autoantigen 218 kDa protein;Mi2-beta;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005813;GO:0000785;GO:0005737;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0090575;GO:0005524;GO:0003677;GO:0003678;GO:0042826;GO:0070615;GO:0001103;GO:0008134;GO:0008270;GO:0043044;GO:1901796;GO:0006357;, C:centrosome; C:chromatin; C:cytoplasm; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:RNA polymerase II transcription regulator complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:histone deacetylase binding; F:nucleosome-dependent ATPase activity; F:RNA polymerase II repressing transcription factor binding; F:transcription factor binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q14839 Q8IXZ5,Chromodomain-helicase-DNA-binding protein 4,ATP-dependent helicase CHD4;Mi-2 autoantigen 218 kDa protein;Mi2-beta;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005813;GO:0000785;GO:0005737;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0090575;GO:0005524;GO:0003677;GO:0003678;GO:0042826;GO:0070615;GO:0001103;GO:0008134;GO:0008270;GO:0043044;GO:1901796;GO:0006357;, C:centrosome; C:chromatin; C:cytoplasm; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:RNA polymerase II transcription regulator complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:histone deacetylase binding; F:nucleosome-dependent ATPase activity; F:RNA polymerase II repressing transcription factor binding; F:transcription factor binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q14839 Q8IXZ5,Chromodomain-helicase-DNA-binding protein 4,ATP-dependent helicase CHD4;Mi-2 autoantigen 218 kDa protein;Mi2-beta;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005813;GO:0000785;GO:0005737;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0090575;GO:0005524;GO:0003677;GO:0003678;GO:0042826;GO:0070615;GO:0001103;GO:0008134;GO:0008270;GO:0043044;GO:1901796;GO:0006357;, C:centrosome; C:chromatin; C:cytoplasm; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:RNA polymerase II transcription regulator complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:histone deacetylase binding; F:nucleosome-dependent ATPase activity; F:RNA polymerase II repressing transcription factor binding; F:transcription factor binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q14839 Q8IXZ5,Chromodomain-helicase-DNA-binding protein 4,ATP-dependent helicase CHD4;Mi-2 autoantigen 218 kDa protein;Mi2-beta;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005813;GO:0000785;GO:0005737;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0090575;GO:0005524;GO:0003677;GO:0003678;GO:0042826;GO:0070615;GO:0001103;GO:0008134;GO:0008270;GO:0043044;GO:1901796;GO:0006357;, C:centrosome; C:chromatin; C:cytoplasm; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:RNA polymerase II transcription regulator complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:histone deacetylase binding; F:nucleosome-dependent ATPase activity; F:RNA polymerase II repressing transcription factor binding; F:transcription factor binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q14839 Q8IXZ5,Chromodomain-helicase-DNA-binding protein 4,ATP-dependent helicase CHD4;Mi-2 autoantigen 218 kDa protein;Mi2-beta;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005813;GO:0000785;GO:0005737;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0090575;GO:0005524;GO:0003677;GO:0003678;GO:0042826;GO:0070615;GO:0001103;GO:0008134;GO:0008270;GO:0043044;GO:1901796;GO:0006357;, C:centrosome; C:chromatin; C:cytoplasm; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:RNA polymerase II transcription regulator complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:histone deacetylase binding; F:nucleosome-dependent ATPase activity; F:RNA polymerase II repressing transcription factor binding; F:transcription factor binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II;|Q14839 Q8IXZ5,Chromodomain-helicase-DNA-binding protein 4,ATP-dependent helicase CHD4;Mi-2 autoantigen 218 kDa protein;Mi2-beta;, PF08074;PF08073;PF00385;PF06461;PF06465;PF00271;PF00628;PF00176;, GO:0005813;GO:0000785;GO:0005737;GO:0016020;GO:0005654;GO:0016581;GO:0032991;GO:0090575;GO:0005524;GO:0003677;GO:0003678;GO:0042826;GO:0070615;GO:0001103;GO:0008134;GO:0008270;GO:0043044;GO:1901796;GO:0006357;, C:centrosome; C:chromatin; C:cytoplasm; C:membrane; C:nucleoplasm; C:NuRD complex; C:protein-containing complex; C:RNA polymerase II transcription regulator complex;, F:ATP binding; F:DNA binding; F:DNA helicase activity; F:histone deacetylase binding; F:nucleosome-dependent ATPase activity; F:RNA polymerase II repressing transcription factor binding; F:transcription factor binding; F:zinc ion binding;, P:ATP-dependent chromatin remodeling; P:regulation of signal transduction by p53 class mediator; P:regulation of transcription by RNA polymerase II; scaffold253 indexed_genome mRNA 58360 70728 . - . ID=transcript_16309;Q9H1C0,Lysophosphatidic acid receptor 5,G-protein coupled receptor 92;G-protein coupled receptor 93;, PF00001;, GO:0016021;GO:0005886;GO:0004930;GO:0048266;GO:0007186;GO:0032793;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:behavioral response to pain; P:G protein-coupled receptor signaling pathway; P:positive regulation of CREB transcription factor activity; scaffold253 indexed_genome mRNA 81342 88881 . - . ID=transcript_16310;Q9UNL4 A4KYM4 A4KYM6 D3DUR8 Q0EF62 Q0EF63 Q4VBQ6 Q96E15 Q9H3J0,Inhibitor of growth protein 4,p29ING4;, PF12998;, GO:0005829;GO:0000123;GO:0045111;GO:0070776;GO:0005654;GO:0005634;GO:0046872;GO:0035064;GO:0003713;GO:0006915;GO:0007050;GO:0006978;GO:0006260;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0008285;GO:0045926;GO:0045892;GO:0043065;GO:0006473;, C:cytosol; C:histone acetyltransferase complex; C:intermediate filament cytoskeleton; C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:methylated histone binding; F:transcription coactivator activity;, P:apoptotic process; P:cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA replication; P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of cell population proliferation; P:negative regulation of growth; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:protein acetylation;|Q9UNL4 A4KYM4 A4KYM6 D3DUR8 Q0EF62 Q0EF63 Q4VBQ6 Q96E15 Q9H3J0,Inhibitor of growth protein 4,p29ING4;, PF12998;, GO:0005829;GO:0000123;GO:0045111;GO:0070776;GO:0005654;GO:0005634;GO:0046872;GO:0035064;GO:0003713;GO:0006915;GO:0007050;GO:0006978;GO:0006260;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0008285;GO:0045926;GO:0045892;GO:0043065;GO:0006473;, C:cytosol; C:histone acetyltransferase complex; C:intermediate filament cytoskeleton; C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:methylated histone binding; F:transcription coactivator activity;, P:apoptotic process; P:cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA replication; P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of cell population proliferation; P:negative regulation of growth; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:protein acetylation;|Q9UNL4 A4KYM4 A4KYM6 D3DUR8 Q0EF62 Q0EF63 Q4VBQ6 Q96E15 Q9H3J0,Inhibitor of growth protein 4,p29ING4;, PF12998;, GO:0005829;GO:0000123;GO:0045111;GO:0070776;GO:0005654;GO:0005634;GO:0046872;GO:0035064;GO:0003713;GO:0006915;GO:0007050;GO:0006978;GO:0006260;GO:0043966;GO:0043983;GO:0043981;GO:0043982;GO:0008285;GO:0045926;GO:0045892;GO:0043065;GO:0006473;, C:cytosol; C:histone acetyltransferase complex; C:intermediate filament cytoskeleton; C:MOZ/MORF histone acetyltransferase complex; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:methylated histone binding; F:transcription coactivator activity;, P:apoptotic process; P:cell cycle arrest; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:DNA replication; P:histone H3 acetylation; P:histone H4-K12 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:negative regulation of cell population proliferation; P:negative regulation of growth; P:negative regulation of transcription, DNA-templated; P:positive regulation of apoptotic process; P:protein acetylation; scaffold253 indexed_genome mRNA 91055 110237 . - . ID=transcript_16311;Q8TF68 O15407 Q7Z722 Q8N938,Zinc finger protein 384,CAG repeat protein 1;CAS-interacting zinc finger protein;Nuclear matrix transcription factor 4;Trinucleotide repeat-containing gene 1 protein;, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8TF68 O15407 Q7Z722 Q8N938,Zinc finger protein 384,CAG repeat protein 1;CAS-interacting zinc finger protein;Nuclear matrix transcription factor 4;Trinucleotide repeat-containing gene 1 protein;, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|Q8TF68 O15407 Q7Z722 Q8N938,Zinc finger protein 384,CAG repeat protein 1;CAS-interacting zinc finger protein;Nuclear matrix transcription factor 4;Trinucleotide repeat-containing gene 1 protein;, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold253 indexed_genome mRNA 115939 120793 . - . ID=transcript_16312;Q8IYJ0 A8K0T3 B3KPF7 B3KRI6 Q6UX35,PILR alpha-associated neural protein,PILR-associating neural protein;Paired immunoglobin-like type 2 receptor-associating neural protein;, PF15298;, GO:0016323;GO:0016021;GO:0016020;GO:0005886;GO:0050776;, C:basolateral plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:regulation of immune response;|Q8IYJ0 A8K0T3 B3KPF7 B3KRI6 Q6UX35,PILR alpha-associated neural protein,PILR-associating neural protein;Paired immunoglobin-like type 2 receptor-associating neural protein;, PF15298;, GO:0016323;GO:0016021;GO:0016020;GO:0005886;GO:0050776;, C:basolateral plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:regulation of immune response;|Q8IYJ0 A8K0T3 B3KPF7 B3KRI6 Q6UX35,PILR alpha-associated neural protein,PILR-associating neural protein;Paired immunoglobin-like type 2 receptor-associating neural protein;, PF15298;, GO:0016323;GO:0016021;GO:0016020;GO:0005886;GO:0050776;, C:basolateral plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, , P:regulation of immune response; scaffold253 indexed_genome mRNA 146133 152250 . + . ID=transcript_16313;Q9UBW8 A8K9A6 Q9NVX3 Q9UJW4,COP9 signalosome complex subunit 7a,Dermal papilla-derived protein 10;JAB1-containing signalosome subunit 7a;, PF18392;PF01399;, GO:0008180;GO:0005829;GO:0005654;GO:0010387;GO:0000715;GO:0043687;GO:0000338;GO:0006283;GO:0016032;, C:COP9 signalosome; C:cytosol; C:nucleoplasm;, , P:COP9 signalosome assembly; P:nucleotide-excision repair, DNA damage recognition; P:post-translational protein modification; P:protein deneddylation; P:transcription-coupled nucleotide-excision repair; P:viral process; scaffold253 indexed_genome mRNA 169755 170601 . - . ID=transcript_16314;Q15773,Myeloid leukemia factor 2,Myelodysplasia-myeloid leukemia factor 2;, PF10248;, GO:0005737;GO:0016020;GO:0005634;GO:0006355;, C:cytoplasm; C:membrane; C:nucleus;, , P:regulation of transcription, DNA-templated; scaffold253 indexed_genome mRNA 171610 172665 . - . ID=transcript_16315;Q15773,Myeloid leukemia factor 2,Myelodysplasia-myeloid leukemia factor 2;, PF10248;, GO:0005737;GO:0016020;GO:0005634;GO:0006355;, C:cytoplasm; C:membrane; C:nucleus;, , P:regulation of transcription, DNA-templated; scaffold253 indexed_genome mRNA 189879 191838 . + . ID=transcript_16316;P20962,Parathymosin,, PF03247;, GO:0005634;GO:0006260;GO:0002376;, C:nucleus;, , P:DNA replication; P:immune system process; scaffold253 indexed_genome mRNA 193316 199908 . + . ID=transcript_16317;P18627 A8K7T9 Q7Z643,Lymphocyte activation gene 3 protein {ECO:0000303|PubMed:1692078},, , GO:0009897;GO:0005576;GO:0016021;GO:0005886;GO:0003823;GO:0042289;GO:0004888;GO:0002250;GO:0019886;GO:0007166;GO:0032703;GO:0045590;GO:0002270;GO:0045954;GO:0050776;, C:external side of plasma membrane; C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:antigen binding; F:MHC class II protein binding; F:transmembrane signaling receptor activity;, P:adaptive immune response; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell surface receptor signaling pathway; P:negative regulation of interleukin-2 production; P:negative regulation of regulatory T cell differentiation; P:plasmacytoid dendritic cell activation; P:positive regulation of natural killer cell mediated cytotoxicity; P:regulation of immune response; scaffold253 indexed_genome mRNA 210296 229485 . + . ID=transcript_16318;P01730 B2R737 D3DUS5 Q4ZGK2 Q5U066 Q9UDE5,T-cell surface glycoprotein CD4,T-cell surface antigen T4/Leu-3;, PF05790;PF09191;PF00047;PF12104;, GO:0030669;GO:0005769;GO:0005788;GO:0005789;GO:0009897;GO:0005887;GO:0045121;GO:0005886;GO:0042101;GO:0015026;GO:0019899;GO:0005201;GO:0042802;GO:0019865;GO:0042011;GO:0042012;GO:0042289;GO:0023026;GO:0042803;GO:0019901;GO:1990782;GO:0038023;GO:0004888;GO:0001618;GO:0008270;GO:0002250;GO:0007155;GO:0007166;GO:0097011;GO:0019221;GO:0050829;GO:0044409;GO:0007167;GO:0019064;GO:0035397;GO:0006955;GO:0006948;GO:0035723;GO:0030225;GO:0032507;GO:0061024;GO:0010524;GO:0050850;GO:0070374;GO:0043123;GO:0032743;GO:0033674;GO:0043410;GO:0045657;GO:0050731;GO:0045860;GO:0001934;GO:0042102;GO:0045893;GO:0046598;GO:0051924;GO:0050690;GO:0050863;GO:0032355;GO:0033280;GO:0007165;GO:0042110;GO:0030217;GO:0050852;GO:0045058;GO:0007169;, C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane; C:T cell receptor complex;, F:coreceptor activity; F:enzyme binding; F:extracellular matrix structural constituent; F:identical protein binding; F:immunoglobulin binding; F:interleukin-16 binding; F:interleukin-16 receptor activity; F:MHC class II protein binding; F:MHC class II protein complex binding; F:protein homodimerization activity; F:protein kinase binding; F:protein tyrosine kinase binding; F:signaling receptor activity; F:transmembrane signaling receptor activity; F:virus receptor activity; F:zinc ion binding;, P:adaptive immune response; P:cell adhesion; P:cell surface receptor signaling pathway; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cytokine-mediated signaling pathway; P:defense response to Gram-negative bacterium; P:entry into host; P:enzyme linked receptor protein signaling pathway; P:fusion of virus membrane with host plasma membrane; P:helper T cell enhancement of adaptive immune response; P:immune response; P:induction by virus of host cell-cell fusion; P:interleukin-15-mediated signaling pathway; P:macrophage differentiation; P:maintenance of protein location in cell; P:membrane organization; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of calcium-mediated signaling; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-2 production; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of monocyte differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein phosphorylation; P:positive regulation of T cell proliferation; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral entry into host cell; P:regulation of calcium ion transport; P:regulation of defense response to virus by virus; P:regulation of T cell activation; P:response to estradiol; P:response to vitamin D; P:signal transduction; P:T cell activation; P:T cell differentiation; P:T cell receptor signaling pathway; P:T cell selection; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold253 indexed_genome mRNA 229494 234294 . + . ID=transcript_16319;P01730 B2R737 D3DUS5 Q4ZGK2 Q5U066 Q9UDE5,T-cell surface glycoprotein CD4,T-cell surface antigen T4/Leu-3;, PF05790;PF09191;PF00047;PF12104;, GO:0030669;GO:0005769;GO:0005788;GO:0005789;GO:0009897;GO:0005887;GO:0045121;GO:0005886;GO:0042101;GO:0015026;GO:0019899;GO:0005201;GO:0042802;GO:0019865;GO:0042011;GO:0042012;GO:0042289;GO:0023026;GO:0042803;GO:0019901;GO:1990782;GO:0038023;GO:0004888;GO:0001618;GO:0008270;GO:0002250;GO:0007155;GO:0007166;GO:0097011;GO:0019221;GO:0050829;GO:0044409;GO:0007167;GO:0019064;GO:0035397;GO:0006955;GO:0006948;GO:0035723;GO:0030225;GO:0032507;GO:0061024;GO:0010524;GO:0050850;GO:0070374;GO:0043123;GO:0032743;GO:0033674;GO:0043410;GO:0045657;GO:0050731;GO:0045860;GO:0001934;GO:0042102;GO:0045893;GO:0046598;GO:0051924;GO:0050690;GO:0050863;GO:0032355;GO:0033280;GO:0007165;GO:0042110;GO:0030217;GO:0050852;GO:0045058;GO:0007169;, C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:external side of plasma membrane; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane; C:T cell receptor complex;, F:coreceptor activity; F:enzyme binding; F:extracellular matrix structural constituent; F:identical protein binding; F:immunoglobulin binding; F:interleukin-16 binding; F:interleukin-16 receptor activity; F:MHC class II protein binding; F:MHC class II protein complex binding; F:protein homodimerization activity; F:protein kinase binding; F:protein tyrosine kinase binding; F:signaling receptor activity; F:transmembrane signaling receptor activity; F:virus receptor activity; F:zinc ion binding;, P:adaptive immune response; P:cell adhesion; P:cell surface receptor signaling pathway; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cytokine-mediated signaling pathway; P:defense response to Gram-negative bacterium; P:entry into host; P:enzyme linked receptor protein signaling pathway; P:fusion of virus membrane with host plasma membrane; P:helper T cell enhancement of adaptive immune response; P:immune response; P:induction by virus of host cell-cell fusion; P:interleukin-15-mediated signaling pathway; P:macrophage differentiation; P:maintenance of protein location in cell; P:membrane organization; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of calcium-mediated signaling; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-2 production; P:positive regulation of kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of monocyte differentiation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein phosphorylation; P:positive regulation of T cell proliferation; P:positive regulation of transcription, DNA-templated; P:positive regulation of viral entry into host cell; P:regulation of calcium ion transport; P:regulation of defense response to virus by virus; P:regulation of T cell activation; P:response to estradiol; P:response to vitamin D; P:signal transduction; P:T cell activation; P:T cell differentiation; P:T cell receptor signaling pathway; P:T cell selection; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold253 indexed_genome mRNA 236297 238095 . + . ID=transcript_16320;Q16538 Q16664 Q59EH5 Q66K56,Probable G-protein coupled receptor 162,Gene-rich cluster gene A protein;, PF00001;, GO:0016021;GO:0005886;GO:0004930;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity; scaffold253 indexed_genome mRNA 238139 241224 . + . ID=transcript_16321;Q16538 Q16664 Q59EH5 Q66K56,Probable G-protein coupled receptor 162,Gene-rich cluster gene A protein;, PF00001;, GO:0016021;GO:0005886;GO:0004930;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity; scaffold253 indexed_genome mRNA 242019 255548 . + . ID=transcript_16322;Q8IVL6 Q13512 Q15740 Q66K32 Q6NX61 Q7L2T1,Prolyl 3-hydroxylase 3 {ECO:0000312|HGNC:HGNC:19318},Leprecan-like protein 2 {ECO:0000303|PubMed:15063763};Protein B {ECO:0000303|PubMed:8723724};, PF13640;, GO:1902494;GO:0005783;GO:0005506;GO:0031418;GO:0019797;GO:0032964;GO:0032963;GO:0008285;GO:0017185;, C:catalytic complex; C:endoplasmic reticulum;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:collagen biosynthetic process; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:peptidyl-lysine hydroxylation;|Q8IVL6 Q13512 Q15740 Q66K32 Q6NX61 Q7L2T1,Prolyl 3-hydroxylase 3 {ECO:0000312|HGNC:HGNC:19318},Leprecan-like protein 2 {ECO:0000303|PubMed:15063763};Protein B {ECO:0000303|PubMed:8723724};, PF13640;, GO:1902494;GO:0005783;GO:0005506;GO:0031418;GO:0019797;GO:0032964;GO:0032963;GO:0008285;GO:0017185;, C:catalytic complex; C:endoplasmic reticulum;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:collagen biosynthetic process; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:peptidyl-lysine hydroxylation;|Q8IVL6 Q13512 Q15740 Q66K32 Q6NX61 Q7L2T1,Prolyl 3-hydroxylase 3 {ECO:0000312|HGNC:HGNC:19318},Leprecan-like protein 2 {ECO:0000303|PubMed:15063763};Protein B {ECO:0000303|PubMed:8723724};, PF13640;, GO:1902494;GO:0005783;GO:0005506;GO:0031418;GO:0019797;GO:0032964;GO:0032963;GO:0008285;GO:0017185;, C:catalytic complex; C:endoplasmic reticulum;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:collagen biosynthetic process; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:peptidyl-lysine hydroxylation;|Q8IVL6 Q13512 Q15740 Q66K32 Q6NX61 Q7L2T1,Prolyl 3-hydroxylase 3 {ECO:0000312|HGNC:HGNC:19318},Leprecan-like protein 2 {ECO:0000303|PubMed:15063763};Protein B {ECO:0000303|PubMed:8723724};, PF13640;, GO:1902494;GO:0005783;GO:0005506;GO:0031418;GO:0019797;GO:0032964;GO:0032963;GO:0008285;GO:0017185;, C:catalytic complex; C:endoplasmic reticulum;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:collagen biosynthetic process; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:peptidyl-lysine hydroxylation;|Q8IVL6 Q13512 Q15740 Q66K32 Q6NX61 Q7L2T1,Prolyl 3-hydroxylase 3 {ECO:0000312|HGNC:HGNC:19318},Leprecan-like protein 2 {ECO:0000303|PubMed:15063763};Protein B {ECO:0000303|PubMed:8723724};, PF13640;, GO:1902494;GO:0005783;GO:0005506;GO:0031418;GO:0019797;GO:0032964;GO:0032963;GO:0008285;GO:0017185;, C:catalytic complex; C:endoplasmic reticulum;, F:iron ion binding; F:L-ascorbic acid binding; F:procollagen-proline 3-dioxygenase activity;, P:collagen biosynthetic process; P:collagen metabolic process; P:negative regulation of cell population proliferation; P:peptidyl-lysine hydroxylation; scaffold253 indexed_genome mRNA 256506 257223 . + . ID=transcript_16323;P16520 Q96B71 Q9BQC0,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3,Transducin beta chain 3;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005834;GO:0031682;GO:0003924;GO:0051020;GO:0030507;GO:0006884;GO:0007186;GO:0006457;GO:0008217;GO:0090181;GO:0045598;GO:0010468;GO:0010906;GO:0032350;GO:1903725;GO:0090207;, C:cell body; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:heterotrimeric G-protein complex;, F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:spectrin binding;, P:cell volume homeostasis; P:G protein-coupled receptor signaling pathway; P:protein folding; P:regulation of blood pressure; P:regulation of cholesterol metabolic process; P:regulation of fat cell differentiation; P:regulation of gene expression; P:regulation of glucose metabolic process; P:regulation of hormone metabolic process; P:regulation of phospholipid metabolic process; P:regulation of triglyceride metabolic process; scaffold253 indexed_genome mRNA 257256 260049 . + . ID=transcript_16324;P16520 Q96B71 Q9BQC0,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3,Transducin beta chain 3;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005834;GO:0031682;GO:0003924;GO:0051020;GO:0030507;GO:0006884;GO:0007186;GO:0006457;GO:0008217;GO:0090181;GO:0045598;GO:0010468;GO:0010906;GO:0032350;GO:1903725;GO:0090207;, C:cell body; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:heterotrimeric G-protein complex;, F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:spectrin binding;, P:cell volume homeostasis; P:G protein-coupled receptor signaling pathway; P:protein folding; P:regulation of blood pressure; P:regulation of cholesterol metabolic process; P:regulation of fat cell differentiation; P:regulation of gene expression; P:regulation of glucose metabolic process; P:regulation of hormone metabolic process; P:regulation of phospholipid metabolic process; P:regulation of triglyceride metabolic process; scaffold253 indexed_genome mRNA 261385 262747 . + . ID=transcript_16325;P16520 Q96B71 Q9BQC0,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3,Transducin beta chain 3;, PF00400;, GO:0044297;GO:0005737;GO:0005829;GO:0030425;GO:0070062;GO:0005834;GO:0031682;GO:0003924;GO:0051020;GO:0030507;GO:0006884;GO:0007186;GO:0006457;GO:0008217;GO:0090181;GO:0045598;GO:0010468;GO:0010906;GO:0032350;GO:1903725;GO:0090207;, C:cell body; C:cytoplasm; C:cytosol; C:dendrite; C:extracellular exosome; C:heterotrimeric G-protein complex;, F:G-protein gamma-subunit binding; F:GTPase activity; F:GTPase binding; F:spectrin binding;, P:cell volume homeostasis; P:G protein-coupled receptor signaling pathway; P:protein folding; P:regulation of blood pressure; P:regulation of cholesterol metabolic process; P:regulation of fat cell differentiation; P:regulation of gene expression; P:regulation of glucose metabolic process; P:regulation of hormone metabolic process; P:regulation of phospholipid metabolic process; P:regulation of triglyceride metabolic process; scaffold253 indexed_genome mRNA 265530 266801 . - . ID=transcript_16326;Q99618 A8K5V6 D3DUS6,Cell division cycle-associated protein 3,Gene-rich cluster protein C8;Trigger of mitotic entry protein 1;, , GO:0005912;GO:0005829;GO:0007049;GO:0051301;GO:0016567;, C:adherens junction; C:cytosol;, , P:cell cycle; P:cell division; P:protein ubiquitination; scaffold253 indexed_genome mRNA 267639 290483 . + . ID=transcript_16327;P45974 D3DUS7 D3DUS8 Q96J22,Ubiquitin carboxyl-terminal hydrolase 5,Deubiquitinating enzyme 5;Isopeptidase T;Ubiquitin thioesterase 5;Ubiquitin-specific-processing protease 5;, PF00627;PF00443;PF02148;PF17807;, GO:0005829;GO:0005764;GO:0005634;GO:0004197;GO:0004843;GO:0043130;GO:0008270;GO:0032436;GO:0016579;GO:0071108;GO:0016567;GO:0006511;, C:cytosol; C:lysosome; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:zinc ion binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P45974 D3DUS7 D3DUS8 Q96J22,Ubiquitin carboxyl-terminal hydrolase 5,Deubiquitinating enzyme 5;Isopeptidase T;Ubiquitin thioesterase 5;Ubiquitin-specific-processing protease 5;, PF00627;PF00443;PF02148;PF17807;, GO:0005829;GO:0005764;GO:0005634;GO:0004197;GO:0004843;GO:0043130;GO:0008270;GO:0032436;GO:0016579;GO:0071108;GO:0016567;GO:0006511;, C:cytosol; C:lysosome; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:zinc ion binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P45974 D3DUS7 D3DUS8 Q96J22,Ubiquitin carboxyl-terminal hydrolase 5,Deubiquitinating enzyme 5;Isopeptidase T;Ubiquitin thioesterase 5;Ubiquitin-specific-processing protease 5;, PF00627;PF00443;PF02148;PF17807;, GO:0005829;GO:0005764;GO:0005634;GO:0004197;GO:0004843;GO:0043130;GO:0008270;GO:0032436;GO:0016579;GO:0071108;GO:0016567;GO:0006511;, C:cytosol; C:lysosome; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:zinc ion binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P45974 D3DUS7 D3DUS8 Q96J22,Ubiquitin carboxyl-terminal hydrolase 5,Deubiquitinating enzyme 5;Isopeptidase T;Ubiquitin thioesterase 5;Ubiquitin-specific-processing protease 5;, PF00627;PF00443;PF02148;PF17807;, GO:0005829;GO:0005764;GO:0005634;GO:0004197;GO:0004843;GO:0043130;GO:0008270;GO:0032436;GO:0016579;GO:0071108;GO:0016567;GO:0006511;, C:cytosol; C:lysosome; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:zinc ion binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P45974 D3DUS7 D3DUS8 Q96J22,Ubiquitin carboxyl-terminal hydrolase 5,Deubiquitinating enzyme 5;Isopeptidase T;Ubiquitin thioesterase 5;Ubiquitin-specific-processing protease 5;, PF00627;PF00443;PF02148;PF17807;, GO:0005829;GO:0005764;GO:0005634;GO:0004197;GO:0004843;GO:0043130;GO:0008270;GO:0032436;GO:0016579;GO:0071108;GO:0016567;GO:0006511;, C:cytosol; C:lysosome; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:zinc ion binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|P45974 D3DUS7 D3DUS8 Q96J22,Ubiquitin carboxyl-terminal hydrolase 5,Deubiquitinating enzyme 5;Isopeptidase T;Ubiquitin thioesterase 5;Ubiquitin-specific-processing protease 5;, PF00627;PF00443;PF02148;PF17807;, GO:0005829;GO:0005764;GO:0005634;GO:0004197;GO:0004843;GO:0043130;GO:0008270;GO:0032436;GO:0016579;GO:0071108;GO:0016567;GO:0006511;, C:cytosol; C:lysosome; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitin binding; F:zinc ion binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold253 indexed_genome mRNA 303176 312411 . + . ID=transcript_16328;P60174 B7Z5D8 D3DUS9 P00938 Q6FHP9 Q6IS07 Q8WWD0 Q96AG5,Triosephosphate isomerase {ECO:0000305|PubMed:18562316},Methylglyoxal synthase {ECO:0000250|UniProtKB:P00939};Triose-phosphate isomerase;, PF00121;, GO:0005829;GO:0070062;GO:0005615;GO:0005634;GO:0008929;GO:0042803;GO:0004807;GO:0031625;GO:0061621;GO:0006094;GO:0046166;GO:0019563;GO:0006096;GO:0019242;GO:0007275;, C:cytosol; C:extracellular exosome; C:extracellular space; C:nucleus;, F:methylglyoxal synthase activity; F:protein homodimerization activity; F:triose-phosphate isomerase activity; F:ubiquitin protein ligase binding;, P:canonical glycolysis; P:gluconeogenesis; P:glyceraldehyde-3-phosphate biosynthetic process; P:glycerol catabolic process; P:glycolytic process; P:methylglyoxal biosynthetic process; P:multicellular organism development;|P60174 B7Z5D8 D3DUS9 P00938 Q6FHP9 Q6IS07 Q8WWD0 Q96AG5,Triosephosphate isomerase {ECO:0000305|PubMed:18562316},Methylglyoxal synthase {ECO:0000250|UniProtKB:P00939};Triose-phosphate isomerase;, PF00121;, GO:0005829;GO:0070062;GO:0005615;GO:0005634;GO:0008929;GO:0042803;GO:0004807;GO:0031625;GO:0061621;GO:0006094;GO:0046166;GO:0019563;GO:0006096;GO:0019242;GO:0007275;, C:cytosol; C:extracellular exosome; C:extracellular space; C:nucleus;, F:methylglyoxal synthase activity; F:protein homodimerization activity; F:triose-phosphate isomerase activity; F:ubiquitin protein ligase binding;, P:canonical glycolysis; P:gluconeogenesis; P:glyceraldehyde-3-phosphate biosynthetic process; P:glycerol catabolic process; P:glycolytic process; P:methylglyoxal biosynthetic process; P:multicellular organism development; scaffold253 indexed_genome mRNA 332727 353291 . + . ID=transcript_16329;Q53EV4 A8K8C6 D3DUT1 Q8N6K6 Q92977 Q99620,Leucine-rich repeat-containing protein 23,Leucine-rich protein B7;, , GO:0005737;GO:0005829;, C:cytoplasm; C:cytosol;|P09104 B7Z2X9 Q96J33,Gamma-enolase,2-phospho-D-glycerate hydro-lyase;Enolase 2;Neural enolase;Neuron-specific enolase;, PF00113;PF03952;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0043204;GO:0000015;GO:0001917;GO:0005886;GO:0000287;GO:0004634;GO:0061621;GO:0006094;GO:0006096;GO:0032889;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:perikaryon; C:phosphopyruvate hydratase complex; C:photoreceptor inner segment; C:plasma membrane;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:regulation of vacuole fusion, non-autophagic;|P09104 B7Z2X9 Q96J33,Gamma-enolase,2-phospho-D-glycerate hydro-lyase;Enolase 2;Neural enolase;Neuron-specific enolase;, PF00113;PF03952;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0043204;GO:0000015;GO:0001917;GO:0005886;GO:0000287;GO:0004634;GO:0061621;GO:0006094;GO:0006096;GO:0032889;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:perikaryon; C:phosphopyruvate hydratase complex; C:photoreceptor inner segment; C:plasma membrane;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:regulation of vacuole fusion, non-autophagic;|P09104 B7Z2X9 Q96J33,Gamma-enolase,2-phospho-D-glycerate hydro-lyase;Enolase 2;Neural enolase;Neuron-specific enolase;, PF00113;PF03952;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0043204;GO:0000015;GO:0001917;GO:0005886;GO:0000287;GO:0004634;GO:0061621;GO:0006094;GO:0006096;GO:0032889;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:perikaryon; C:phosphopyruvate hydratase complex; C:photoreceptor inner segment; C:plasma membrane;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:regulation of vacuole fusion, non-autophagic;|P09104 B7Z2X9 Q96J33,Gamma-enolase,2-phospho-D-glycerate hydro-lyase;Enolase 2;Neural enolase;Neuron-specific enolase;, PF00113;PF03952;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0043204;GO:0000015;GO:0001917;GO:0005886;GO:0000287;GO:0004634;GO:0061621;GO:0006094;GO:0006096;GO:0032889;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:perikaryon; C:phosphopyruvate hydratase complex; C:photoreceptor inner segment; C:plasma membrane;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:regulation of vacuole fusion, non-autophagic;|P09104 B7Z2X9 Q96J33,Gamma-enolase,2-phospho-D-glycerate hydro-lyase;Enolase 2;Neural enolase;Neuron-specific enolase;, PF00113;PF03952;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0043204;GO:0000015;GO:0001917;GO:0005886;GO:0000287;GO:0004634;GO:0061621;GO:0006094;GO:0006096;GO:0032889;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:perikaryon; C:phosphopyruvate hydratase complex; C:photoreceptor inner segment; C:plasma membrane;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:regulation of vacuole fusion, non-autophagic;|P09104 B7Z2X9 Q96J33,Gamma-enolase,2-phospho-D-glycerate hydro-lyase;Enolase 2;Neural enolase;Neuron-specific enolase;, PF00113;PF03952;, GO:0005829;GO:0070062;GO:0005615;GO:0016020;GO:0043204;GO:0000015;GO:0001917;GO:0005886;GO:0000287;GO:0004634;GO:0061621;GO:0006094;GO:0006096;GO:0032889;, C:cytosol; C:extracellular exosome; C:extracellular space; C:membrane; C:perikaryon; C:phosphopyruvate hydratase complex; C:photoreceptor inner segment; C:plasma membrane;, F:magnesium ion binding; F:phosphopyruvate hydratase activity;, P:canonical glycolysis; P:gluconeogenesis; P:glycolytic process; P:regulation of vacuole fusion, non-autophagic; scaffold254 indexed_genome mRNA 108910 156846 . + . ID=transcript_16330;O96013 B4DGG6 Q8N4E1 Q8NCH5 Q8NDE3 Q9BU33 Q9ULS8,Serine/threonine-protein kinase PAK 4,p21-activated kinase 4;, PF00786;PF00069;, GO:0005912;GO:0005737;GO:0005925;GO:0005794;GO:0005524;GO:0098641;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0007049;GO:0016477;GO:0071407;GO:0007010;GO:0060996;GO:2000352;GO:0045766;GO:0001558;GO:0007165;GO:0031098;, C:adherens junction; C:cytoplasm; C:focal adhesion; C:Golgi apparatus;, F:ATP binding; F:cadherin binding involved in cell-cell adhesion; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cell cycle; P:cell migration; P:cellular response to organic cyclic compound; P:cytoskeleton organization; P:dendritic spine development; P:negative regulation of endothelial cell apoptotic process; P:positive regulation of angiogenesis; P:regulation of cell growth; P:signal transduction; P:stress-activated protein kinase signaling cascade;|O96013 B4DGG6 Q8N4E1 Q8NCH5 Q8NDE3 Q9BU33 Q9ULS8,Serine/threonine-protein kinase PAK 4,p21-activated kinase 4;, PF00786;PF00069;, GO:0005912;GO:0005737;GO:0005925;GO:0005794;GO:0005524;GO:0098641;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0006915;GO:0007049;GO:0016477;GO:0071407;GO:0007010;GO:0060996;GO:2000352;GO:0045766;GO:0001558;GO:0007165;GO:0031098;, C:adherens junction; C:cytoplasm; C:focal adhesion; C:Golgi apparatus;, F:ATP binding; F:cadherin binding involved in cell-cell adhesion; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase activity; P:apoptotic process; P:cell cycle; P:cell migration; P:cellular response to organic cyclic compound; P:cytoskeleton organization; P:dendritic spine development; P:negative regulation of endothelial cell apoptotic process; P:positive regulation of angiogenesis; P:regulation of cell growth; P:signal transduction; P:stress-activated protein kinase signaling cascade; scaffold254 indexed_genome mRNA 270334 275698 . - . ID=transcript_16331;Q9P244 Q8TBS9,Leucine-rich repeat and fibronectin type III domain-containing protein 1,Synaptic adhesion-like molecule 2;, PF00041;PF07679;PF13855;, GO:0009986;GO:0099061;GO:0005886;GO:0099151;, C:cell surface; C:integral component of postsynaptic density membrane; C:plasma membrane;, , P:regulation of postsynaptic density assembly; scaffold254 indexed_genome mRNA 312133 334810 . + . ID=transcript_16332;Q5PRF9 A5Z0M6 Q6P194,Protein Smaug homolog 2,Sterile alpha motif domain-containing protein 4B;, PF00536;, GO:0005829;GO:0005634;GO:0000932;GO:0003729;GO:0003723;GO:0030371;GO:0017148;GO:0000289;GO:0043488;, C:cytosol; C:nucleus; C:P-body;, F:mRNA binding; F:RNA binding; F:translation repressor activity;, P:negative regulation of translation; P:nuclear-transcribed mRNA poly(A) tail shortening; P:regulation of mRNA stability; scaffold254 indexed_genome mRNA 334845 343499 . - . ID=transcript_16333;Q8N7H5 M0QX35 O75239 Q9H166 Q9NUU9,RNA polymerase II-associated factor 1 homolog,Pancreatic differentiation protein 2;, PF03985;, GO:0016593;GO:0030054;GO:0005737;GO:0016020;GO:0005654;GO:0035327;GO:0003682;GO:0000993;GO:0071222;GO:0001711;GO:0033523;GO:0010390;GO:0006378;GO:0045638;GO:0000122;GO:0016584;GO:1902808;GO:0031062;GO:0031442;GO:0034504;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:cell junction; C:cytoplasm; C:membrane; C:nucleoplasm; C:transcriptionally active chromatin;, F:chromatin binding; F:RNA polymerase II complex binding;, P:cellular response to lipopolysaccharide; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone monoubiquitination; P:mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:nucleosome positioning; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of histone methylation; P:positive regulation of mRNA 3'-end processing; P:protein localization to nucleus; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q8N7H5 M0QX35 O75239 Q9H166 Q9NUU9,RNA polymerase II-associated factor 1 homolog,Pancreatic differentiation protein 2;, PF03985;, GO:0016593;GO:0030054;GO:0005737;GO:0016020;GO:0005654;GO:0035327;GO:0003682;GO:0000993;GO:0071222;GO:0001711;GO:0033523;GO:0010390;GO:0006378;GO:0045638;GO:0000122;GO:0016584;GO:1902808;GO:0031062;GO:0031442;GO:0034504;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:cell junction; C:cytoplasm; C:membrane; C:nucleoplasm; C:transcriptionally active chromatin;, F:chromatin binding; F:RNA polymerase II complex binding;, P:cellular response to lipopolysaccharide; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone monoubiquitination; P:mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:nucleosome positioning; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of histone methylation; P:positive regulation of mRNA 3'-end processing; P:protein localization to nucleus; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway;|Q8N7H5 M0QX35 O75239 Q9H166 Q9NUU9,RNA polymerase II-associated factor 1 homolog,Pancreatic differentiation protein 2;, PF03985;, GO:0016593;GO:0030054;GO:0005737;GO:0016020;GO:0005654;GO:0035327;GO:0003682;GO:0000993;GO:0071222;GO:0001711;GO:0033523;GO:0010390;GO:0006378;GO:0045638;GO:0000122;GO:0016584;GO:1902808;GO:0031062;GO:0031442;GO:0034504;GO:0016567;GO:0019827;GO:0006366;GO:0006368;GO:0016055;, C:Cdc73/Paf1 complex; C:cell junction; C:cytoplasm; C:membrane; C:nucleoplasm; C:transcriptionally active chromatin;, F:chromatin binding; F:RNA polymerase II complex binding;, P:cellular response to lipopolysaccharide; P:endodermal cell fate commitment; P:histone H2B ubiquitination; P:histone monoubiquitination; P:mRNA polyadenylation; P:negative regulation of myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:nucleosome positioning; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of histone methylation; P:positive regulation of mRNA 3'-end processing; P:protein localization to nucleus; P:protein ubiquitination; P:stem cell population maintenance; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:Wnt signaling pathway; scaffold256 indexed_genome mRNA 150969 155453 . - . ID=transcript_16334;O00548 B2RAK7 B5M0B3 Q9NU41 Q9UJV2,Delta-like protein 1 {ECO:0000305},Drosophila Delta homolog 1;, PF01414;PF00008;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0031410;GO:0005576;GO:0005887;GO:0045121;GO:0005886;GO:0005509;GO:0005112;GO:0097110;GO:0030957;GO:0014002;GO:0030154;GO:0001709;GO:0021688;GO:0021693;GO:0072583;GO:0007386;GO:0007368;GO:0097102;GO:0097009;GO:0001947;GO:0030097;GO:0048839;GO:0046331;GO:0070986;GO:0072070;GO:0002315;GO:2000726;GO:0045596;GO:0008285;GO:0045605;GO:0030857;GO:0034351;GO:0045608;GO:0032693;GO:0045638;GO:0045662;GO:0045665;GO:0045746;GO:0072006;GO:0048665;GO:0097150;GO:0007219;GO:0060853;GO:0035265;GO:0008284;GO:0045807;GO:0045747;GO:0048633;GO:1903672;GO:0045944;GO:0072014;GO:0009954;GO:0008217;GO:0030155;GO:0051302;GO:0040008;GO:0050767;GO:0048631;GO:0014807;GO:1900746;GO:0060041;GO:0060042;GO:0048630;GO:0098773;GO:0001757;GO:0001756;GO:0021510;GO:0003323;, C:adherens junction; C:apical plasma membrane; C:cytoplasmic vesicle; C:extracellular region; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane;, F:calcium ion binding; F:Notch binding; F:scaffold protein binding; F:Tat protein binding;, P:astrocyte development; P:cell differentiation; P:cell fate determination; P:cerebellar molecular layer formation; P:cerebellar Purkinje cell layer structural organization; P:clathrin-dependent endocytosis; P:compartment pattern specification; P:determination of left/right symmetry; P:endothelial tip cell fate specification; P:energy homeostasis; P:heart looping; P:hemopoiesis; P:inner ear development; P:lateral inhibition; P:left/right axis specification; P:loop of Henle development; P:marginal zone B cell differentiation; P:negative regulation of cardiac muscle cell differentiation; P:negative regulation of cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of epidermal cell differentiation; P:negative regulation of epithelial cell differentiation; P:negative regulation of glial cell apoptotic process; P:negative regulation of inner ear auditory receptor cell differentiation; P:negative regulation of interleukin-10 production; P:negative regulation of myeloid cell differentiation; P:negative regulation of myoblast differentiation; P:negative regulation of neuron differentiation; P:negative regulation of Notch signaling pathway; P:nephron development; P:neuron fate specification; P:neuronal stem cell population maintenance; P:Notch signaling pathway; P:Notch signaling pathway involved in arterial endothelial cell fate commitment; P:organ growth; P:positive regulation of cell population proliferation; P:positive regulation of endocytosis; P:positive regulation of Notch signaling pathway; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:proximal tubule development; P:proximal/distal pattern formation; P:regulation of blood pressure; P:regulation of cell adhesion; P:regulation of cell division; P:regulation of growth; P:regulation of neurogenesis; P:regulation of skeletal muscle tissue growth; P:regulation of somitogenesis; P:regulation of vascular endothelial growth factor signaling pathway; P:retina development in camera-type eye; P:retina morphogenesis in camera-type eye; P:skeletal muscle tissue growth; P:skin epidermis development; P:somite specification; P:somitogenesis; P:spinal cord development; P:type B pancreatic cell development;|O00548 B2RAK7 B5M0B3 Q9NU41 Q9UJV2,Delta-like protein 1 {ECO:0000305},Drosophila Delta homolog 1;, PF01414;PF00008;PF12661;PF07657;, GO:0005912;GO:0016324;GO:0031410;GO:0005576;GO:0005887;GO:0045121;GO:0005886;GO:0005509;GO:0005112;GO:0097110;GO:0030957;GO:0014002;GO:0030154;GO:0001709;GO:0021688;GO:0021693;GO:0072583;GO:0007386;GO:0007368;GO:0097102;GO:0097009;GO:0001947;GO:0030097;GO:0048839;GO:0046331;GO:0070986;GO:0072070;GO:0002315;GO:2000726;GO:0045596;GO:0008285;GO:0045605;GO:0030857;GO:0034351;GO:0045608;GO:0032693;GO:0045638;GO:0045662;GO:0045665;GO:0045746;GO:0072006;GO:0048665;GO:0097150;GO:0007219;GO:0060853;GO:0035265;GO:0008284;GO:0045807;GO:0045747;GO:0048633;GO:1903672;GO:0045944;GO:0072014;GO:0009954;GO:0008217;GO:0030155;GO:0051302;GO:0040008;GO:0050767;GO:0048631;GO:0014807;GO:1900746;GO:0060041;GO:0060042;GO:0048630;GO:0098773;GO:0001757;GO:0001756;GO:0021510;GO:0003323;, C:adherens junction; C:apical plasma membrane; C:cytoplasmic vesicle; C:extracellular region; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane;, F:calcium ion binding; F:Notch binding; F:scaffold protein binding; F:Tat protein binding;, P:astrocyte development; P:cell differentiation; P:cell fate determination; P:cerebellar molecular layer formation; P:cerebellar Purkinje cell layer structural organization; P:clathrin-dependent endocytosis; P:compartment pattern specification; P:determination of left/right symmetry; P:endothelial tip cell fate specification; P:energy homeostasis; P:heart looping; P:hemopoiesis; P:inner ear development; P:lateral inhibition; P:left/right axis specification; P:loop of Henle development; P:marginal zone B cell differentiation; P:negative regulation of cardiac muscle cell differentiation; P:negative regulation of cell differentiation; P:negative regulation of cell population proliferation; P:negative regulation of epidermal cell differentiation; P:negative regulation of epithelial cell differentiation; P:negative regulation of glial cell apoptotic process; P:negative regulation of inner ear auditory receptor cell differentiation; P:negative regulation of interleukin-10 production; P:negative regulation of myeloid cell differentiation; P:negative regulation of myoblast differentiation; P:negative regulation of neuron differentiation; P:negative regulation of Notch signaling pathway; P:nephron development; P:neuron fate specification; P:neuronal stem cell population maintenance; P:Notch signaling pathway; P:Notch signaling pathway involved in arterial endothelial cell fate commitment; P:organ growth; P:positive regulation of cell population proliferation; P:positive regulation of endocytosis; P:positive regulation of Notch signaling pathway; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of sprouting angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:proximal tubule development; P:proximal/distal pattern formation; P:regulation of blood pressure; P:regulation of cell adhesion; P:regulation of cell division; P:regulation of growth; P:regulation of neurogenesis; P:regulation of skeletal muscle tissue growth; P:regulation of somitogenesis; P:regulation of vascular endothelial growth factor signaling pathway; P:retina development in camera-type eye; P:retina morphogenesis in camera-type eye; P:skeletal muscle tissue growth; P:skin epidermis development; P:somite specification; P:somitogenesis; P:spinal cord development; P:type B pancreatic cell development; scaffold256 indexed_genome mRNA 179361 185838 . + . ID=transcript_16335;Q96EK7 B4DL34 Q86V68 Q96JI9,Constitutive coactivator of peroxisome proliferator-activated receptor gamma,PPARG constitutive coactivator 1;Protein FAM120B;, , GO:0005634;GO:0045444;GO:0035357;, C:nucleus;, , P:fat cell differentiation; P:peroxisome proliferator activated receptor signaling pathway; scaffold256 indexed_genome mRNA 199619 230731 . - . ID=transcript_16336;Q96EK7 B4DL34 Q86V68 Q96JI9,Constitutive coactivator of peroxisome proliferator-activated receptor gamma,PPARG constitutive coactivator 1;Protein FAM120B;, , GO:0005634;GO:0045444;GO:0035357;, C:nucleus;, , P:fat cell differentiation; P:peroxisome proliferator activated receptor signaling pathway;|Q96EK7 B4DL34 Q86V68 Q96JI9,Constitutive coactivator of peroxisome proliferator-activated receptor gamma,PPARG constitutive coactivator 1;Protein FAM120B;, , GO:0005634;GO:0045444;GO:0035357;, C:nucleus;, , P:fat cell differentiation; P:peroxisome proliferator activated receptor signaling pathway;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold256 indexed_genome mRNA 279258 297936 . - . ID=transcript_16337;P20618 B5BU76 Q9BWA8,Proteasome subunit beta type-1,Macropain subunit C5;Multicatalytic endopeptidase complex subunit C5;Proteasome component C5;Proteasome gamma chain;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0034774;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:secretory granule lumen;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P20618 B5BU76 Q9BWA8,Proteasome subunit beta type-1,Macropain subunit C5;Multicatalytic endopeptidase complex subunit C5;Proteasome component C5;Proteasome gamma chain;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0034774;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:secretory granule lumen;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P20618 B5BU76 Q9BWA8,Proteasome subunit beta type-1,Macropain subunit C5;Multicatalytic endopeptidase complex subunit C5;Proteasome component C5;Proteasome gamma chain;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0034774;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:secretory granule lumen;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway;|P20618 B5BU76 Q9BWA8,Proteasome subunit beta type-1,Macropain subunit C5;Multicatalytic endopeptidase complex subunit C5;Proteasome component C5;Proteasome gamma chain;, PF00227;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0005654;GO:0005634;GO:0000502;GO:0005839;GO:0019774;GO:0034774;GO:0004175;GO:0004298;GO:0031145;GO:0002479;GO:0038095;GO:0070498;GO:0000165;GO:0090090;GO:0010972;GO:0043312;GO:0038061;GO:0090263;GO:0043687;GO:0036388;GO:0010499;GO:0043161;GO:0016579;GO:0000209;GO:0006521;GO:1902036;GO:1901990;GO:0043488;GO:0061418;GO:0031146;GO:0002223;GO:0050852;GO:0055085;GO:0033209;GO:0016032;GO:0060071;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:nucleoplasm; C:nucleus; C:proteasome complex; C:proteasome core complex; C:proteasome core complex, beta-subunit complex; C:secretory granule lumen;, F:endopeptidase activity; F:threonine-type endopeptidase activity;, P:anaphase-promoting complex-dependent catabolic process; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:Fc-epsilon receptor signaling pathway; P:interleukin-1-mediated signaling pathway; P:MAPK cascade; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of G2/M transition of mitotic cell cycle; P:neutrophil degranulation; P:NIK/NF-kappaB signaling; P:positive regulation of canonical Wnt signaling pathway; P:post-translational protein modification; P:pre-replicative complex assembly; P:proteasomal ubiquitin-independent protein catabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein deubiquitination; P:protein polyubiquitination; P:regulation of cellular amino acid metabolic process; P:regulation of hematopoietic stem cell differentiation; P:regulation of mitotic cell cycle phase transition; P:regulation of mRNA stability; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:stimulatory C-type lectin receptor signaling pathway; P:T cell receptor signaling pathway; P:transmembrane transport; P:tumor necrosis factor-mediated signaling pathway; P:viral process; P:Wnt signaling pathway, planar cell polarity pathway; scaffold256 indexed_genome mRNA 302617 314354 . + . ID=transcript_16338;P20226 B4E3B3 F5H869 Q16845 Q6IBM6 Q9UC02,TATA-box-binding protein,TATA sequence-binding protein;TATA-binding factor {ECO:0000303|PubMed:2194289, ECO:0000303|PubMed:2374612};TATA-box factor;Transcription initiation factor TFIID TBP subunit;, PF00352;, GO:0000785;GO:0005737;GO:0000791;GO:0001939;GO:0001940;GO:0005654;GO:0005634;GO:0032991;GO:0005672;GO:0005669;GO:0097550;GO:0017162;GO:0001046;GO:0019899;GO:0140223;GO:0070491;GO:0000978;GO:0000979;GO:0016251;GO:0001091;GO:0001103;GO:0000995;GO:0001093;GO:0008134;GO:0000976;GO:0006352;GO:0045815;GO:0045893;GO:1901796;GO:0051123;GO:0042795;GO:0007283;GO:0006363;GO:0006366;GO:0006383;GO:0006361;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:euchromatin; C:female pronucleus; C:male pronucleus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription factor TFIIA complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:aryl hydrocarbon receptor binding; F:core promoter sequence-specific DNA binding; F:enzyme binding; F:general transcription initiation factor activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II general transcription initiation factor binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase III general transcription initiation factor activity; F:TFIIB-class transcription factor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:DNA-templated transcription, initiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:spermatogenesis; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:viral process;|P20226 B4E3B3 F5H869 Q16845 Q6IBM6 Q9UC02,TATA-box-binding protein,TATA sequence-binding protein;TATA-binding factor {ECO:0000303|PubMed:2194289, ECO:0000303|PubMed:2374612};TATA-box factor;Transcription initiation factor TFIID TBP subunit;, PF00352;, GO:0000785;GO:0005737;GO:0000791;GO:0001939;GO:0001940;GO:0005654;GO:0005634;GO:0032991;GO:0005672;GO:0005669;GO:0097550;GO:0017162;GO:0001046;GO:0019899;GO:0140223;GO:0070491;GO:0000978;GO:0000979;GO:0016251;GO:0001091;GO:0001103;GO:0000995;GO:0001093;GO:0008134;GO:0000976;GO:0006352;GO:0045815;GO:0045893;GO:1901796;GO:0051123;GO:0042795;GO:0007283;GO:0006363;GO:0006366;GO:0006383;GO:0006361;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:euchromatin; C:female pronucleus; C:male pronucleus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription factor TFIIA complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:aryl hydrocarbon receptor binding; F:core promoter sequence-specific DNA binding; F:enzyme binding; F:general transcription initiation factor activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II general transcription initiation factor binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase III general transcription initiation factor activity; F:TFIIB-class transcription factor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:DNA-templated transcription, initiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:spermatogenesis; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:viral process;|P20226 B4E3B3 F5H869 Q16845 Q6IBM6 Q9UC02,TATA-box-binding protein,TATA sequence-binding protein;TATA-binding factor {ECO:0000303|PubMed:2194289, ECO:0000303|PubMed:2374612};TATA-box factor;Transcription initiation factor TFIID TBP subunit;, PF00352;, GO:0000785;GO:0005737;GO:0000791;GO:0001939;GO:0001940;GO:0005654;GO:0005634;GO:0032991;GO:0005672;GO:0005669;GO:0097550;GO:0017162;GO:0001046;GO:0019899;GO:0140223;GO:0070491;GO:0000978;GO:0000979;GO:0016251;GO:0001091;GO:0001103;GO:0000995;GO:0001093;GO:0008134;GO:0000976;GO:0006352;GO:0045815;GO:0045893;GO:1901796;GO:0051123;GO:0042795;GO:0007283;GO:0006363;GO:0006366;GO:0006383;GO:0006361;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:euchromatin; C:female pronucleus; C:male pronucleus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription factor TFIIA complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:aryl hydrocarbon receptor binding; F:core promoter sequence-specific DNA binding; F:enzyme binding; F:general transcription initiation factor activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II general transcription initiation factor binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase III general transcription initiation factor activity; F:TFIIB-class transcription factor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:DNA-templated transcription, initiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:spermatogenesis; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:viral process;|P20226 B4E3B3 F5H869 Q16845 Q6IBM6 Q9UC02,TATA-box-binding protein,TATA sequence-binding protein;TATA-binding factor {ECO:0000303|PubMed:2194289, ECO:0000303|PubMed:2374612};TATA-box factor;Transcription initiation factor TFIID TBP subunit;, PF00352;, GO:0000785;GO:0005737;GO:0000791;GO:0001939;GO:0001940;GO:0005654;GO:0005634;GO:0032991;GO:0005672;GO:0005669;GO:0097550;GO:0017162;GO:0001046;GO:0019899;GO:0140223;GO:0070491;GO:0000978;GO:0000979;GO:0016251;GO:0001091;GO:0001103;GO:0000995;GO:0001093;GO:0008134;GO:0000976;GO:0006352;GO:0045815;GO:0045893;GO:1901796;GO:0051123;GO:0042795;GO:0007283;GO:0006363;GO:0006366;GO:0006383;GO:0006361;GO:0006367;GO:0016032;, C:chromatin; C:cytoplasm; C:euchromatin; C:female pronucleus; C:male pronucleus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription factor TFIIA complex; C:transcription factor TFIID complex; C:transcription preinitiation complex;, F:aryl hydrocarbon receptor binding; F:core promoter sequence-specific DNA binding; F:enzyme binding; F:general transcription initiation factor activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II general transcription initiation factor binding; F:RNA polymerase II repressing transcription factor binding; F:RNA polymerase III general transcription initiation factor activity; F:TFIIB-class transcription factor binding; F:transcription factor binding; F:transcription regulatory region sequence-specific DNA binding;, P:DNA-templated transcription, initiation; P:positive regulation of gene expression, epigenetic; P:positive regulation of transcription, DNA-templated; P:regulation of signal transduction by p53 class mediator; P:RNA polymerase II preinitiation complex assembly; P:snRNA transcription by RNA polymerase II; P:spermatogenesis; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:viral process; scaffold256 indexed_genome mRNA 316091 325346 . - . ID=transcript_16339;Q16342 E9PCU7 F5GYS7 Q58HM9 Q58HN0 Q9UH12,Programmed cell death protein 2,Zinc finger MYND domain-containing protein 7;Zinc finger protein Rp-8;, PF04194;PF01753;, GO:0005737;GO:0070062;GO:0005634;GO:0003677;GO:0019899;GO:0046872;GO:0006919;GO:0006915;GO:0043065;GO:1902035;GO:1901532;, C:cytoplasm; C:extracellular exosome; C:nucleus;, F:DNA binding; F:enzyme binding; F:metal ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of hematopoietic stem cell proliferation; P:regulation of hematopoietic progenitor cell differentiation;|Q16342 E9PCU7 F5GYS7 Q58HM9 Q58HN0 Q9UH12,Programmed cell death protein 2,Zinc finger MYND domain-containing protein 7;Zinc finger protein Rp-8;, PF04194;PF01753;, GO:0005737;GO:0070062;GO:0005634;GO:0003677;GO:0019899;GO:0046872;GO:0006919;GO:0006915;GO:0043065;GO:1902035;GO:1901532;, C:cytoplasm; C:extracellular exosome; C:nucleus;, F:DNA binding; F:enzyme binding; F:metal ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of hematopoietic stem cell proliferation; P:regulation of hematopoietic progenitor cell differentiation;|Q16342 E9PCU7 F5GYS7 Q58HM9 Q58HN0 Q9UH12,Programmed cell death protein 2,Zinc finger MYND domain-containing protein 7;Zinc finger protein Rp-8;, PF04194;PF01753;, GO:0005737;GO:0070062;GO:0005634;GO:0003677;GO:0019899;GO:0046872;GO:0006919;GO:0006915;GO:0043065;GO:1902035;GO:1901532;, C:cytoplasm; C:extracellular exosome; C:nucleus;, F:DNA binding; F:enzyme binding; F:metal ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of hematopoietic stem cell proliferation; P:regulation of hematopoietic progenitor cell differentiation; scaffold257 indexed_genome mRNA 1502 5201 . + . ID=transcript_16340;Q4VY36 Q4VY37 Q4VY38 Q9GZP2 Q9GZU4 Q9GZZ4,Polyglutamine-binding protein 1 {ECO:0000303|PubMed:10332029, ECO:0000303|PubMed:11163963},38 kDa nuclear protein containing a WW domain {ECO:0000303|PubMed:10198427};Polyglutamine tract-binding protein 1 {ECO:0000303|PubMed:10332029};, , GO:0005737;GO:0010494;GO:0071598;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0043021;GO:0003713;GO:0002218;GO:0000380;GO:0071360;GO:0051607;GO:0045087;GO:0000398;GO:0031175;GO:0002230;GO:0032481;GO:0048814;GO:0043484;GO:0006355;, C:cytoplasm; C:cytoplasmic stress granule; C:neuronal ribonucleoprotein granule; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:ribonucleoprotein complex binding; F:transcription coactivator activity;, P:activation of innate immune response; P:alternative mRNA splicing, via spliceosome; P:cellular response to exogenous dsRNA; P:defense response to virus; P:innate immune response; P:mRNA splicing, via spliceosome; P:neuron projection development; P:positive regulation of defense response to virus by host; P:positive regulation of type I interferon production; P:regulation of dendrite morphogenesis; P:regulation of RNA splicing; P:regulation of transcription, DNA-templated;|Q4VY36 Q4VY37 Q4VY38 Q9GZP2 Q9GZU4 Q9GZZ4,Polyglutamine-binding protein 1 {ECO:0000303|PubMed:10332029, ECO:0000303|PubMed:11163963},38 kDa nuclear protein containing a WW domain {ECO:0000303|PubMed:10198427};Polyglutamine tract-binding protein 1 {ECO:0000303|PubMed:10332029};, , GO:0005737;GO:0010494;GO:0071598;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0043021;GO:0003713;GO:0002218;GO:0000380;GO:0071360;GO:0051607;GO:0045087;GO:0000398;GO:0031175;GO:0002230;GO:0032481;GO:0048814;GO:0043484;GO:0006355;, C:cytoplasm; C:cytoplasmic stress granule; C:neuronal ribonucleoprotein granule; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:ribonucleoprotein complex binding; F:transcription coactivator activity;, P:activation of innate immune response; P:alternative mRNA splicing, via spliceosome; P:cellular response to exogenous dsRNA; P:defense response to virus; P:innate immune response; P:mRNA splicing, via spliceosome; P:neuron projection development; P:positive regulation of defense response to virus by host; P:positive regulation of type I interferon production; P:regulation of dendrite morphogenesis; P:regulation of RNA splicing; P:regulation of transcription, DNA-templated;|Q4VY36 Q4VY37 Q4VY38 Q9GZP2 Q9GZU4 Q9GZZ4,Polyglutamine-binding protein 1 {ECO:0000303|PubMed:10332029, ECO:0000303|PubMed:11163963},38 kDa nuclear protein containing a WW domain {ECO:0000303|PubMed:10198427};Polyglutamine tract-binding protein 1 {ECO:0000303|PubMed:10332029};, , GO:0005737;GO:0010494;GO:0071598;GO:0016604;GO:0016607;GO:0005654;GO:0005634;GO:0003677;GO:0003690;GO:0043021;GO:0003713;GO:0002218;GO:0000380;GO:0071360;GO:0051607;GO:0045087;GO:0000398;GO:0031175;GO:0002230;GO:0032481;GO:0048814;GO:0043484;GO:0006355;, C:cytoplasm; C:cytoplasmic stress granule; C:neuronal ribonucleoprotein granule; C:nuclear body; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA binding; F:double-stranded DNA binding; F:ribonucleoprotein complex binding; F:transcription coactivator activity;, P:activation of innate immune response; P:alternative mRNA splicing, via spliceosome; P:cellular response to exogenous dsRNA; P:defense response to virus; P:innate immune response; P:mRNA splicing, via spliceosome; P:neuron projection development; P:positive regulation of defense response to virus by host; P:positive regulation of type I interferon production; P:regulation of dendrite morphogenesis; P:regulation of RNA splicing; P:regulation of transcription, DNA-templated; scaffold257 indexed_genome mRNA 5599 8657 . - . ID=transcript_16341;P78381 A8K2L9 A8K9V1 B4DE11 B4DPT2 E7EW45 Q8IV21 Q92553,UDP-galactose translocator,Solute carrier family 35 member A2;UDP-galactose transporter;, PF04142;, GO:0005783;GO:0005794;GO:0000139;GO:0030173;GO:0005654;GO:0005459;GO:0008643;GO:0006012;GO:0072334;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:nucleoplasm;, F:UDP-galactose transmembrane transporter activity;, P:carbohydrate transport; P:galactose metabolic process; P:UDP-galactose transmembrane transport;|P78381 A8K2L9 A8K9V1 B4DE11 B4DPT2 E7EW45 Q8IV21 Q92553,UDP-galactose translocator,Solute carrier family 35 member A2;UDP-galactose transporter;, PF04142;, GO:0005783;GO:0005794;GO:0000139;GO:0030173;GO:0005654;GO:0005459;GO:0008643;GO:0006012;GO:0072334;, C:endoplasmic reticulum; C:Golgi apparatus; C:Golgi membrane; C:integral component of Golgi membrane; C:nucleoplasm;, F:UDP-galactose transmembrane transporter activity;, P:carbohydrate transport; P:galactose metabolic process; P:UDP-galactose transmembrane transport; scaffold257 indexed_genome mRNA 14486 20448 . + . ID=transcript_16342;Q9P1W9 A8K4G6 Q99739,Serine/threonine-protein kinase pim-2,Pim-2h;, PF00069;, GO:0005737;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0000082;GO:0043066;GO:0008285;GO:0010508;GO:0043123;GO:0045893;GO:0046777;GO:0006468;GO:0050821;GO:0007346;GO:0009615;, C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:G1/S transition of mitotic cell cycle; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of autophagy; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of mitotic cell cycle; P:response to virus;|Q9P1W9 A8K4G6 Q99739,Serine/threonine-protein kinase pim-2,Pim-2h;, PF00069;, GO:0005737;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0000082;GO:0043066;GO:0008285;GO:0010508;GO:0043123;GO:0045893;GO:0046777;GO:0006468;GO:0050821;GO:0007346;GO:0009615;, C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:G1/S transition of mitotic cell cycle; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of autophagy; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of mitotic cell cycle; P:response to virus;|Q9P1W9 A8K4G6 Q99739,Serine/threonine-protein kinase pim-2,Pim-2h;, PF00069;, GO:0005737;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0000082;GO:0043066;GO:0008285;GO:0010508;GO:0043123;GO:0045893;GO:0046777;GO:0006468;GO:0050821;GO:0007346;GO:0009615;, C:cytoplasm;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:G1/S transition of mitotic cell cycle; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of autophagy; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of transcription, DNA-templated; P:protein autophosphorylation; P:protein phosphorylation; P:protein stabilization; P:regulation of mitotic cell cycle; P:response to virus; scaffold257 indexed_genome mRNA 23035 49448 . - . ID=transcript_16343;Q96G74 B4DGG7 G5E9D7 Q4KMN9 Q8N6T5 Q9H650 Q9H9U0 Q9NT65,OTU domain-containing protein 5,Deubiquitinating enzyme A;, PF02338;, GO:0005829;GO:0008234;GO:1990380;GO:0061578;GO:0004843;GO:0101005;GO:0032480;GO:0016579;GO:0071108;GO:0070536;GO:0032496;, C:cytosol;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:negative regulation of type I interferon production; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:response to lipopolysaccharide;|Q96G74 B4DGG7 G5E9D7 Q4KMN9 Q8N6T5 Q9H650 Q9H9U0 Q9NT65,OTU domain-containing protein 5,Deubiquitinating enzyme A;, PF02338;, GO:0005829;GO:0008234;GO:1990380;GO:0061578;GO:0004843;GO:0101005;GO:0032480;GO:0016579;GO:0071108;GO:0070536;GO:0032496;, C:cytosol;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:negative regulation of type I interferon production; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:response to lipopolysaccharide;|Q96G74 B4DGG7 G5E9D7 Q4KMN9 Q8N6T5 Q9H650 Q9H9U0 Q9NT65,OTU domain-containing protein 5,Deubiquitinating enzyme A;, PF02338;, GO:0005829;GO:0008234;GO:1990380;GO:0061578;GO:0004843;GO:0101005;GO:0032480;GO:0016579;GO:0071108;GO:0070536;GO:0032496;, C:cytosol;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:negative regulation of type I interferon production; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:response to lipopolysaccharide;|Q96G74 B4DGG7 G5E9D7 Q4KMN9 Q8N6T5 Q9H650 Q9H9U0 Q9NT65,OTU domain-containing protein 5,Deubiquitinating enzyme A;, PF02338;, GO:0005829;GO:0008234;GO:1990380;GO:0061578;GO:0004843;GO:0101005;GO:0032480;GO:0016579;GO:0071108;GO:0070536;GO:0032496;, C:cytosol;, F:cysteine-type peptidase activity; F:Lys48-specific deubiquitinase activity; F:Lys63-specific deubiquitinase activity; F:thiol-dependent ubiquitin-specific protease activity; F:ubiquitinyl hydrolase activity;, P:negative regulation of type I interferon production; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:protein K63-linked deubiquitination; P:response to lipopolysaccharide; scaffold257 indexed_genome mRNA 52988 58206 . - . ID=transcript_16344;Q9NSA2 A6NEF1 B2RCG0 O75671,Potassium voltage-gated channel subfamily D member 1,Voltage-gated potassium channel subunit Kv4.1;, PF02214;PF11879;PF00520;PF11601;, GO:0043197;GO:0016021;GO:0043025;GO:0005886;GO:0014069;GO:0045211;GO:0008076;GO:0005250;GO:0046872;GO:0005249;GO:0061337;GO:0071805;GO:0051260;GO:0034765;, C:dendritic spine; C:integral component of membrane; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:voltage-gated potassium channel complex;, F:A-type (transient outward) potassium channel activity; F:metal ion binding; F:voltage-gated potassium channel activity;, P:cardiac conduction; P:potassium ion transmembrane transport; P:protein homooligomerization; P:regulation of ion transmembrane transport; scaffold257 indexed_genome mRNA 58451 59011 . + . ID=transcript_16345;Q9NSA2 A6NEF1 B2RCG0 O75671,Potassium voltage-gated channel subfamily D member 1,Voltage-gated potassium channel subunit Kv4.1;, PF02214;PF11879;PF00520;PF11601;, GO:0043197;GO:0016021;GO:0043025;GO:0005886;GO:0014069;GO:0045211;GO:0008076;GO:0005250;GO:0046872;GO:0005249;GO:0061337;GO:0071805;GO:0051260;GO:0034765;, C:dendritic spine; C:integral component of membrane; C:neuronal cell body; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:voltage-gated potassium channel complex;, F:A-type (transient outward) potassium channel activity; F:metal ion binding; F:voltage-gated potassium channel activity;, P:cardiac conduction; P:potassium ion transmembrane transport; P:protein homooligomerization; P:regulation of ion transmembrane transport; scaffold257 indexed_genome mRNA 62510 83306 . - . ID=transcript_16346;Q9ULQ3,GRIP1-associated protein 1 {ECO:0000305},, , GO:0030424;GO:0072562;GO:0005829;GO:0030425;GO:0098998;GO:0098978;GO:0043231;GO:0005654;GO:0098837;GO:0055038;GO:0042802;GO:0098887;GO:1905244;GO:0099152;GO:0099158;, C:axon; C:blood microparticle; C:cytosol; C:dendrite; C:extrinsic component of postsynaptic early endosome membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:identical protein binding;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of modification of synaptic structure; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of recycling endosome localization within postsynapse;|Q9ULQ3,GRIP1-associated protein 1 {ECO:0000305},, , GO:0030424;GO:0072562;GO:0005829;GO:0030425;GO:0098998;GO:0098978;GO:0043231;GO:0005654;GO:0098837;GO:0055038;GO:0042802;GO:0098887;GO:1905244;GO:0099152;GO:0099158;, C:axon; C:blood microparticle; C:cytosol; C:dendrite; C:extrinsic component of postsynaptic early endosome membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:identical protein binding;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of modification of synaptic structure; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of recycling endosome localization within postsynapse;|Q9ULQ3,GRIP1-associated protein 1 {ECO:0000305},, , GO:0030424;GO:0072562;GO:0005829;GO:0030425;GO:0098998;GO:0098978;GO:0043231;GO:0005654;GO:0098837;GO:0055038;GO:0042802;GO:0098887;GO:1905244;GO:0099152;GO:0099158;, C:axon; C:blood microparticle; C:cytosol; C:dendrite; C:extrinsic component of postsynaptic early endosome membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:identical protein binding;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of modification of synaptic structure; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of recycling endosome localization within postsynapse;|Q9ULQ3,GRIP1-associated protein 1 {ECO:0000305},, , GO:0030424;GO:0072562;GO:0005829;GO:0030425;GO:0098998;GO:0098978;GO:0043231;GO:0005654;GO:0098837;GO:0055038;GO:0042802;GO:0098887;GO:1905244;GO:0099152;GO:0099158;, C:axon; C:blood microparticle; C:cytosol; C:dendrite; C:extrinsic component of postsynaptic early endosome membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:identical protein binding;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of modification of synaptic structure; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of recycling endosome localization within postsynapse;|Q9ULQ3,GRIP1-associated protein 1 {ECO:0000305},, , GO:0030424;GO:0072562;GO:0005829;GO:0030425;GO:0098998;GO:0098978;GO:0043231;GO:0005654;GO:0098837;GO:0055038;GO:0042802;GO:0098887;GO:1905244;GO:0099152;GO:0099158;, C:axon; C:blood microparticle; C:cytosol; C:dendrite; C:extrinsic component of postsynaptic early endosome membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:identical protein binding;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of modification of synaptic structure; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of recycling endosome localization within postsynapse;|Q9ULQ3,GRIP1-associated protein 1 {ECO:0000305},, , GO:0030424;GO:0072562;GO:0005829;GO:0030425;GO:0098998;GO:0098978;GO:0043231;GO:0005654;GO:0098837;GO:0055038;GO:0042802;GO:0098887;GO:1905244;GO:0099152;GO:0099158;, C:axon; C:blood microparticle; C:cytosol; C:dendrite; C:extrinsic component of postsynaptic early endosome membrane; C:glutamatergic synapse; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:postsynaptic recycling endosome; C:recycling endosome membrane;, F:identical protein binding;, P:neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of modification of synaptic structure; P:regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane; P:regulation of recycling endosome localization within postsynapse; scaffold257 indexed_genome mRNA 91145 101485 . - . ID=transcript_16347;P19532 A8MZL6 Q5JU74 Q92757 Q92758 Q99964,Transcription factor E3 {ECO:0000303|PubMed:9393982},Class E basic helix-loop-helix protein 33;, PF11851;PF00010;PF15951;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0046983;GO:0000978;GO:1990837;GO:0000976;GO:0002250;GO:0006959;GO:0120163;GO:0090336;GO:0045785;GO:0045944;GO:0045893;GO:0045670;GO:0006357;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:adaptive immune response; P:humoral immune response; P:negative regulation of cold-induced thermogenesis; P:positive regulation of brown fat cell differentiation; P:positive regulation of cell adhesion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of osteoclast differentiation; P:regulation of transcription by RNA polymerase II;|P19532 A8MZL6 Q5JU74 Q92757 Q92758 Q99964,Transcription factor E3 {ECO:0000303|PubMed:9393982},Class E basic helix-loop-helix protein 33;, PF11851;PF00010;PF15951;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0046983;GO:0000978;GO:1990837;GO:0000976;GO:0002250;GO:0006959;GO:0120163;GO:0090336;GO:0045785;GO:0045944;GO:0045893;GO:0045670;GO:0006357;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:adaptive immune response; P:humoral immune response; P:negative regulation of cold-induced thermogenesis; P:positive regulation of brown fat cell differentiation; P:positive regulation of cell adhesion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of osteoclast differentiation; P:regulation of transcription by RNA polymerase II;|P19532 A8MZL6 Q5JU74 Q92757 Q92758 Q99964,Transcription factor E3 {ECO:0000303|PubMed:9393982},Class E basic helix-loop-helix protein 33;, PF11851;PF00010;PF15951;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0046983;GO:0000978;GO:1990837;GO:0000976;GO:0002250;GO:0006959;GO:0120163;GO:0090336;GO:0045785;GO:0045944;GO:0045893;GO:0045670;GO:0006357;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:adaptive immune response; P:humoral immune response; P:negative regulation of cold-induced thermogenesis; P:positive regulation of brown fat cell differentiation; P:positive regulation of cell adhesion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of osteoclast differentiation; P:regulation of transcription by RNA polymerase II;|P19532 A8MZL6 Q5JU74 Q92757 Q92758 Q99964,Transcription factor E3 {ECO:0000303|PubMed:9393982},Class E basic helix-loop-helix protein 33;, PF11851;PF00010;PF15951;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0046983;GO:0000978;GO:1990837;GO:0000976;GO:0002250;GO:0006959;GO:0120163;GO:0090336;GO:0045785;GO:0045944;GO:0045893;GO:0045670;GO:0006357;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:adaptive immune response; P:humoral immune response; P:negative regulation of cold-induced thermogenesis; P:positive regulation of brown fat cell differentiation; P:positive regulation of cell adhesion; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of osteoclast differentiation; P:regulation of transcription by RNA polymerase II; scaffold257 indexed_genome mRNA 115121 131626 . + . ID=transcript_16348;Q96HB5 A8K5Q5 B4DF24 B4DFC1 B4DTU2 F5GZU4,Coiled-coil domain-containing protein 120,, PF11819;, GO:0120103;GO:0005814;GO:0005768;GO:0030426;GO:0034454;GO:0007275;GO:0008104;, C:centriolar subdistal appendage; C:centriole; C:endosome; C:growth cone;, , P:microtubule anchoring at centrosome; P:multicellular organism development; P:protein localization;|Q96HB5 A8K5Q5 B4DF24 B4DFC1 B4DTU2 F5GZU4,Coiled-coil domain-containing protein 120,, PF11819;, GO:0120103;GO:0005814;GO:0005768;GO:0030426;GO:0034454;GO:0007275;GO:0008104;, C:centriolar subdistal appendage; C:centriole; C:endosome; C:growth cone;, , P:microtubule anchoring at centrosome; P:multicellular organism development; P:protein localization;|Q96HB5 A8K5Q5 B4DF24 B4DFC1 B4DTU2 F5GZU4,Coiled-coil domain-containing protein 120,, PF11819;, GO:0120103;GO:0005814;GO:0005768;GO:0030426;GO:0034454;GO:0007275;GO:0008104;, C:centriolar subdistal appendage; C:centriole; C:endosome; C:growth cone;, , P:microtubule anchoring at centrosome; P:multicellular organism development; P:protein localization;|Q96HB5 A8K5Q5 B4DF24 B4DFC1 B4DTU2 F5GZU4,Coiled-coil domain-containing protein 120,, PF11819;, GO:0120103;GO:0005814;GO:0005768;GO:0030426;GO:0034454;GO:0007275;GO:0008104;, C:centriolar subdistal appendage; C:centriole; C:endosome; C:growth cone;, , P:microtubule anchoring at centrosome; P:multicellular organism development; P:protein localization; scaffold257 indexed_genome mRNA 131928 135133 . - . ID=transcript_16349;O60831 B2RD20,PRA1 family protein 2,, PF03208;, GO:0010008;GO:0016021;GO:0016020;GO:0015813;GO:0015031;, C:endosome membrane; C:integral component of membrane; C:membrane;, , P:L-glutamate transmembrane transport; P:protein transport;|O60831 B2RD20,PRA1 family protein 2,, PF03208;, GO:0010008;GO:0016021;GO:0016020;GO:0015813;GO:0015031;, C:endosome membrane; C:integral component of membrane; C:membrane;, , P:L-glutamate transmembrane transport; P:protein transport; scaffold257 indexed_genome mRNA 135252 140000 . - . ID=transcript_16350;Q9Y484 A6NGH5 B7WPI2 Q5MNZ5 Q6IBS7 Q6NT94 Q96H03,WD repeat domain phosphoinositide-interacting protein 4,WD repeat-containing protein 45;, PF00400;, GO:0005829;GO:0019898;GO:0000407;GO:0034045;GO:1901981;GO:0080025;GO:0032266;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0044804;GO:0009267;GO:0006497;GO:0034497;, C:cytosol; C:extrinsic component of membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:protein lipidation; P:protein localization to phagophore assembly site;|Q9Y484 A6NGH5 B7WPI2 Q5MNZ5 Q6IBS7 Q6NT94 Q96H03,WD repeat domain phosphoinositide-interacting protein 4,WD repeat-containing protein 45;, PF00400;, GO:0005829;GO:0019898;GO:0000407;GO:0034045;GO:1901981;GO:0080025;GO:0032266;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0044804;GO:0009267;GO:0006497;GO:0034497;, C:cytosol; C:extrinsic component of membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:protein lipidation; P:protein localization to phagophore assembly site;|Q9Y484 A6NGH5 B7WPI2 Q5MNZ5 Q6IBS7 Q6NT94 Q96H03,WD repeat domain phosphoinositide-interacting protein 4,WD repeat-containing protein 45;, PF00400;, GO:0005829;GO:0019898;GO:0000407;GO:0034045;GO:1901981;GO:0080025;GO:0032266;GO:0019901;GO:0000045;GO:0006914;GO:0000422;GO:0044804;GO:0009267;GO:0006497;GO:0034497;, C:cytosol; C:extrinsic component of membrane; C:phagophore assembly site; C:phagophore assembly site membrane;, F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:protein kinase binding;, P:autophagosome assembly; P:autophagy; P:autophagy of mitochondrion; P:autophagy of nucleus; P:cellular response to starvation; P:protein lipidation; P:protein localization to phagophore assembly site; scaffold257 indexed_genome mRNA 155334 165343 . - . ID=transcript_16351;Q92917 Q59EK5 Q9BQA8,G-patch domain and KOW motifs-containing protein,G-patch domain-containing protein 5;Protein MOS2 homolog;Protein T54;, PF12656;PF00467;, GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome;|Q92917 Q59EK5 Q9BQA8,G-patch domain and KOW motifs-containing protein,G-patch domain-containing protein 5;Protein MOS2 homolog;Protein T54;, PF12656;PF00467;, GO:0005654;GO:0005634;GO:0005681;GO:0003723;GO:0000398;, C:nucleoplasm; C:nucleus; C:spliceosomal complex;, F:RNA binding;, P:mRNA splicing, via spliceosome; scaffold257 indexed_genome mRNA 192693 195260 . + . ID=transcript_16352;Q9H6Y5 A0A075B7A2 A6XND4 A8MSX9 B7WP26 Q14C81,PDZ domain-containing protein MAGIX,, PF00595;|Q9H6Y5 A0A075B7A2 A6XND4 A8MSX9 B7WP26 Q14C81,PDZ domain-containing protein MAGIX,, PF00595;|Q9H6Y5 A0A075B7A2 A6XND4 A8MSX9 B7WP26 Q14C81,PDZ domain-containing protein MAGIX,, PF00595; scaffold257 indexed_genome mRNA 198287 201482 . + . ID=transcript_16353;Q04941 A6NDT7 Q32MM8,Proteolipid protein 2,Differentiation-dependent protein A4;Intestinal membrane A4 protein;, PF01284;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0019956;GO:0015075;GO:0006935;GO:0019221;GO:0006811;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:chemokine binding; F:ion transmembrane transporter activity;, P:chemotaxis; P:cytokine-mediated signaling pathway; P:ion transport;|Q04941 A6NDT7 Q32MM8,Proteolipid protein 2,Differentiation-dependent protein A4;Intestinal membrane A4 protein;, PF01284;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0019956;GO:0015075;GO:0006935;GO:0019221;GO:0006811;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:chemokine binding; F:ion transmembrane transporter activity;, P:chemotaxis; P:cytokine-mediated signaling pathway; P:ion transport; scaffold257 indexed_genome mRNA 201533 210791 . - . ID=transcript_16354;O43900 B7Z8F2 O76007 Q53XR5,Prickle planar cell polarity protein 3 {ECO:0000312|HGNC:HGNC:6645},LIM domain only protein 6;Prickle-like protein 3;Triple LIM domain protein 6;, PF00412;PF06297;, GO:0005737;GO:0005886;GO:0008270;GO:0030030;GO:0007275;, C:cytoplasm; C:plasma membrane;, F:zinc ion binding;, P:cell projection organization; P:multicellular organism development;|O43900 B7Z8F2 O76007 Q53XR5,Prickle planar cell polarity protein 3 {ECO:0000312|HGNC:HGNC:6645},LIM domain only protein 6;Prickle-like protein 3;Triple LIM domain protein 6;, PF00412;PF06297;, GO:0005737;GO:0005886;GO:0008270;GO:0030030;GO:0007275;, C:cytoplasm; C:plasma membrane;, F:zinc ion binding;, P:cell projection organization; P:multicellular organism development;|O43900 B7Z8F2 O76007 Q53XR5,Prickle planar cell polarity protein 3 {ECO:0000312|HGNC:HGNC:6645},LIM domain only protein 6;Prickle-like protein 3;Triple LIM domain protein 6;, PF00412;PF06297;, GO:0005737;GO:0005886;GO:0008270;GO:0030030;GO:0007275;, C:cytoplasm; C:plasma membrane;, F:zinc ion binding;, P:cell projection organization; P:multicellular organism development;|O43900 B7Z8F2 O76007 Q53XR5,Prickle planar cell polarity protein 3 {ECO:0000312|HGNC:HGNC:6645},LIM domain only protein 6;Prickle-like protein 3;Triple LIM domain protein 6;, PF00412;PF06297;, GO:0005737;GO:0005886;GO:0008270;GO:0030030;GO:0007275;, C:cytoplasm; C:plasma membrane;, F:zinc ion binding;, P:cell projection organization; P:multicellular organism development;|O43900 B7Z8F2 O76007 Q53XR5,Prickle planar cell polarity protein 3 {ECO:0000312|HGNC:HGNC:6645},LIM domain only protein 6;Prickle-like protein 3;Triple LIM domain protein 6;, PF00412;PF06297;, GO:0005737;GO:0005886;GO:0008270;GO:0030030;GO:0007275;, C:cytoplasm; C:plasma membrane;, F:zinc ion binding;, P:cell projection organization; P:multicellular organism development; scaffold257 indexed_genome mRNA 212325 224187 . - . ID=transcript_16355;P08247 B2R7L6 B7Z359 Q6P2F7,Synaptophysin,Major synaptic vesicle protein p38;, PF01284;, GO:0060076;GO:0030285;GO:0031594;GO:0043005;GO:0048471;GO:0048786;GO:0042734;GO:0098685;GO:0008021;GO:0030672;GO:0043195;GO:0015485;GO:0042802;GO:0043621;GO:0042169;GO:0017075;GO:0071310;GO:0006897;GO:0048169;GO:0048168;GO:2000474;GO:0048172;GO:2000300;GO:0048488;GO:0016188;GO:0048499;, C:excitatory synapse; C:integral component of synaptic vesicle membrane; C:neuromuscular junction; C:neuron projection; C:perinuclear region of cytoplasm; C:presynaptic active zone; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane; C:terminal bouton;, F:cholesterol binding; F:identical protein binding; F:protein self-association; F:SH2 domain binding; F:syntaxin-1 binding;, P:cellular response to organic substance; P:endocytosis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuronal synaptic plasticity; P:regulation of opioid receptor signaling pathway; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:synaptic vesicle endocytosis; P:synaptic vesicle maturation; P:synaptic vesicle membrane organization;|P08247 B2R7L6 B7Z359 Q6P2F7,Synaptophysin,Major synaptic vesicle protein p38;, PF01284;, GO:0060076;GO:0030285;GO:0031594;GO:0043005;GO:0048471;GO:0048786;GO:0042734;GO:0098685;GO:0008021;GO:0030672;GO:0043195;GO:0015485;GO:0042802;GO:0043621;GO:0042169;GO:0017075;GO:0071310;GO:0006897;GO:0048169;GO:0048168;GO:2000474;GO:0048172;GO:2000300;GO:0048488;GO:0016188;GO:0048499;, C:excitatory synapse; C:integral component of synaptic vesicle membrane; C:neuromuscular junction; C:neuron projection; C:perinuclear region of cytoplasm; C:presynaptic active zone; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane; C:terminal bouton;, F:cholesterol binding; F:identical protein binding; F:protein self-association; F:SH2 domain binding; F:syntaxin-1 binding;, P:cellular response to organic substance; P:endocytosis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuronal synaptic plasticity; P:regulation of opioid receptor signaling pathway; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:synaptic vesicle endocytosis; P:synaptic vesicle maturation; P:synaptic vesicle membrane organization;|P08247 B2R7L6 B7Z359 Q6P2F7,Synaptophysin,Major synaptic vesicle protein p38;, PF01284;, GO:0060076;GO:0030285;GO:0031594;GO:0043005;GO:0048471;GO:0048786;GO:0042734;GO:0098685;GO:0008021;GO:0030672;GO:0043195;GO:0015485;GO:0042802;GO:0043621;GO:0042169;GO:0017075;GO:0071310;GO:0006897;GO:0048169;GO:0048168;GO:2000474;GO:0048172;GO:2000300;GO:0048488;GO:0016188;GO:0048499;, C:excitatory synapse; C:integral component of synaptic vesicle membrane; C:neuromuscular junction; C:neuron projection; C:perinuclear region of cytoplasm; C:presynaptic active zone; C:presynaptic membrane; C:Schaffer collateral - CA1 synapse; C:synaptic vesicle; C:synaptic vesicle membrane; C:terminal bouton;, F:cholesterol binding; F:identical protein binding; F:protein self-association; F:SH2 domain binding; F:syntaxin-1 binding;, P:cellular response to organic substance; P:endocytosis; P:regulation of long-term neuronal synaptic plasticity; P:regulation of neuronal synaptic plasticity; P:regulation of opioid receptor signaling pathway; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic vesicle exocytosis; P:synaptic vesicle endocytosis; P:synaptic vesicle maturation; P:synaptic vesicle membrane organization; scaffold257 indexed_genome mRNA 257243 274674 . + . ID=transcript_16356;O60826 A8K7G1,Coiled-coil domain-containing protein 22,, PF05667;, GO:0005829;GO:0005768;GO:0005654;GO:0097602;GO:0006878;GO:0007253;GO:0032456;GO:0006893;GO:0043124;GO:0043123;GO:2000060;GO:0043687;GO:0015031;GO:0016567;GO:1990126;, C:cytosol; C:endosome; C:nucleoplasm;, F:cullin family protein binding;, P:cellular copper ion homeostasis; P:cytoplasmic sequestering of NF-kappaB; P:endocytic recycling; P:Golgi to plasma membrane transport; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein transport; P:protein ubiquitination; P:retrograde transport, endosome to plasma membrane;|O60826 A8K7G1,Coiled-coil domain-containing protein 22,, PF05667;, GO:0005829;GO:0005768;GO:0005654;GO:0097602;GO:0006878;GO:0007253;GO:0032456;GO:0006893;GO:0043124;GO:0043123;GO:2000060;GO:0043687;GO:0015031;GO:0016567;GO:1990126;, C:cytosol; C:endosome; C:nucleoplasm;, F:cullin family protein binding;, P:cellular copper ion homeostasis; P:cytoplasmic sequestering of NF-kappaB; P:endocytic recycling; P:Golgi to plasma membrane transport; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein transport; P:protein ubiquitination; P:retrograde transport, endosome to plasma membrane;|O60826 A8K7G1,Coiled-coil domain-containing protein 22,, PF05667;, GO:0005829;GO:0005768;GO:0005654;GO:0097602;GO:0006878;GO:0007253;GO:0032456;GO:0006893;GO:0043124;GO:0043123;GO:2000060;GO:0043687;GO:0015031;GO:0016567;GO:1990126;, C:cytosol; C:endosome; C:nucleoplasm;, F:cullin family protein binding;, P:cellular copper ion homeostasis; P:cytoplasmic sequestering of NF-kappaB; P:endocytic recycling; P:Golgi to plasma membrane transport; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein transport; P:protein ubiquitination; P:retrograde transport, endosome to plasma membrane;|O60826 A8K7G1,Coiled-coil domain-containing protein 22,, PF05667;, GO:0005829;GO:0005768;GO:0005654;GO:0097602;GO:0006878;GO:0007253;GO:0032456;GO:0006893;GO:0043124;GO:0043123;GO:2000060;GO:0043687;GO:0015031;GO:0016567;GO:1990126;, C:cytosol; C:endosome; C:nucleoplasm;, F:cullin family protein binding;, P:cellular copper ion homeostasis; P:cytoplasmic sequestering of NF-kappaB; P:endocytic recycling; P:Golgi to plasma membrane transport; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein transport; P:protein ubiquitination; P:retrograde transport, endosome to plasma membrane; scaffold257 indexed_genome mRNA 295812 296918 . - . ID=transcript_16357;Q6ZSY5 A2VDJ8 B3KPW2 E9PCM3,Protein phosphatase 1 regulatory subunit 3F,, PF03370;, GO:0016021;GO:0016020;GO:0000164;GO:2001069;GO:0008157;GO:0019903;GO:2000465;GO:0005979;, C:integral component of membrane; C:membrane; C:protein phosphatase type 1 complex;, F:glycogen binding; F:protein phosphatase 1 binding; F:protein phosphatase binding;, P:regulation of glycogen (starch) synthase activity; P:regulation of glycogen biosynthetic process; scaffold257 indexed_genome mRNA 299624 310945 . + . ID=transcript_16358;Q6ZSY5 A2VDJ8 B3KPW2 E9PCM3,Protein phosphatase 1 regulatory subunit 3F,, PF03370;, GO:0016021;GO:0016020;GO:0000164;GO:2001069;GO:0008157;GO:0019903;GO:2000465;GO:0005979;, C:integral component of membrane; C:membrane; C:protein phosphatase type 1 complex;, F:glycogen binding; F:protein phosphatase 1 binding; F:protein phosphatase binding;, P:regulation of glycogen (starch) synthase activity; P:regulation of glycogen biosynthetic process;|Q6ZSY5 A2VDJ8 B3KPW2 E9PCM3,Protein phosphatase 1 regulatory subunit 3F,, PF03370;, GO:0016021;GO:0016020;GO:0000164;GO:2001069;GO:0008157;GO:0019903;GO:2000465;GO:0005979;, C:integral component of membrane; C:membrane; C:protein phosphatase type 1 complex;, F:glycogen binding; F:protein phosphatase 1 binding; F:protein phosphatase binding;, P:regulation of glycogen (starch) synthase activity; P:regulation of glycogen biosynthetic process; scaffold258 indexed_genome mRNA 24667 32417 . + . ID=transcript_16359;Q9NSD4 A6NE92,Zinc finger protein 275,, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold258 indexed_genome mRNA 101516 107284 . + . ID=transcript_16360;Q9BQ50 Q45F08 Q9UN77,Three prime repair exonuclease 2,3'-5' exonuclease TREX2;, , GO:0005737;GO:0005634;GO:0008296;GO:0008853;GO:0000287;GO:0003676;GO:0042803;GO:0000738;GO:0006259;GO:0006281;, C:cytoplasm; C:nucleus;, F:3'-5'-exodeoxyribonuclease activity; F:exodeoxyribonuclease III activity; F:magnesium ion binding; F:nucleic acid binding; F:protein homodimerization activity;, P:DNA catabolic process, exonucleolytic; P:DNA metabolic process; P:DNA repair; scaffold258 indexed_genome mRNA 107363 129441 . - . ID=transcript_16361;Q99871 B4DUH6 D3DWT9 Q96HS8 Q9NP54 Q9UFH9,HAUS augmin-like complex subunit 7,26S proteasome-associated UCH37-interacting protein 1;UCHL5-interacting protein;X-linked protein STS1769;, , GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051011;GO:0031996;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, F:microtubule minus-end binding; F:thioesterase binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;|Q99871 B4DUH6 D3DWT9 Q96HS8 Q9NP54 Q9UFH9,HAUS augmin-like complex subunit 7,26S proteasome-associated UCH37-interacting protein 1;UCHL5-interacting protein;X-linked protein STS1769;, , GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051011;GO:0031996;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;, C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;, F:microtubule minus-end binding; F:thioesterase binding;, P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly; scaffold258 indexed_genome mRNA 149753 163608 . + . ID=transcript_16362;P21810 D3DWU3 P13247,Biglycan,Bone/cartilage proteoglycan I;PG-S1;, PF13855;PF01462;, GO:0009986;GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0005796;GO:0043202;GO:0042383;GO:0030133;GO:0050840;GO:0005201;GO:0030021;GO:0005539;GO:0061975;GO:0001974;GO:0060348;GO:0030206;GO:0030207;GO:0030208;GO:0030198;GO:0019800;, C:cell surface; C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:lysosomal lumen; C:sarcolemma; C:transport vesicle;, F:extracellular matrix binding; F:extracellular matrix structural constituent; F:extracellular matrix structural constituent conferring compression resistance; F:glycosaminoglycan binding;, P:articular cartilage development; P:blood vessel remodeling; P:bone development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate catabolic process; P:dermatan sulfate biosynthetic process; P:extracellular matrix organization; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; scaffold258 indexed_genome mRNA 186964 227513 . + . ID=transcript_16363;Q16720 B7WNR8 B7WNY5 Q12995 Q16858,Plasma membrane calcium-transporting ATPase 3,Plasma membrane calcium ATPase isoform 3;Plasma membrane calcium pump isoform 3;, PF12424;PF00689;PF00690;, GO:1903561;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098793;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:1990034;GO:0006874;GO:0034220;GO:1903779;GO:0051480;, C:extracellular vesicle; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration;|Q16720 B7WNR8 B7WNY5 Q12995 Q16858,Plasma membrane calcium-transporting ATPase 3,Plasma membrane calcium ATPase isoform 3;Plasma membrane calcium pump isoform 3;, PF12424;PF00689;PF00690;, GO:1903561;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098793;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:1990034;GO:0006874;GO:0034220;GO:1903779;GO:0051480;, C:extracellular vesicle; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration;|Q16720 B7WNR8 B7WNY5 Q12995 Q16858,Plasma membrane calcium-transporting ATPase 3,Plasma membrane calcium ATPase isoform 3;Plasma membrane calcium pump isoform 3;, PF12424;PF00689;PF00690;, GO:1903561;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098793;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:1990034;GO:0006874;GO:0034220;GO:1903779;GO:0051480;, C:extracellular vesicle; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration;|Q16720 B7WNR8 B7WNY5 Q12995 Q16858,Plasma membrane calcium-transporting ATPase 3,Plasma membrane calcium ATPase isoform 3;Plasma membrane calcium pump isoform 3;, PF12424;PF00689;PF00690;, GO:1903561;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098793;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:1990034;GO:0006874;GO:0034220;GO:1903779;GO:0051480;, C:extracellular vesicle; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration;|Q16720 B7WNR8 B7WNY5 Q12995 Q16858,Plasma membrane calcium-transporting ATPase 3,Plasma membrane calcium ATPase isoform 3;Plasma membrane calcium pump isoform 3;, PF12424;PF00689;PF00690;, GO:1903561;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098793;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:1990034;GO:0006874;GO:0034220;GO:1903779;GO:0051480;, C:extracellular vesicle; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration;|Q16720 B7WNR8 B7WNY5 Q12995 Q16858,Plasma membrane calcium-transporting ATPase 3,Plasma membrane calcium ATPase isoform 3;Plasma membrane calcium pump isoform 3;, PF12424;PF00689;PF00690;, GO:1903561;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098793;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:1990034;GO:0006874;GO:0034220;GO:1903779;GO:0051480;, C:extracellular vesicle; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration;|Q16720 B7WNR8 B7WNY5 Q12995 Q16858,Plasma membrane calcium-transporting ATPase 3,Plasma membrane calcium ATPase isoform 3;Plasma membrane calcium pump isoform 3;, PF12424;PF00689;PF00690;, GO:1903561;GO:0098982;GO:0098978;GO:0005887;GO:0043231;GO:0005886;GO:0098793;GO:0005524;GO:0019829;GO:0015085;GO:0005388;GO:1905056;GO:0005516;GO:0046872;GO:0030165;GO:1990034;GO:0006874;GO:0034220;GO:1903779;GO:0051480;, C:extracellular vesicle; C:GABA-ergic synapse; C:glutamatergic synapse; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:presynapse;, F:ATP binding; F:ATPase-coupled cation transmembrane transporter activity; F:calcium ion transmembrane transporter activity; F:calcium transmembrane transporter activity, phosphorylative mechanism; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; F:calmodulin binding; F:metal ion binding; F:PDZ domain binding;, P:calcium ion export across plasma membrane; P:cellular calcium ion homeostasis; P:ion transmembrane transport; P:regulation of cardiac conduction; P:regulation of cytosolic calcium ion concentration; scaffold258 indexed_genome mRNA 234329 243529 . + . ID=transcript_16364;Q8N1B3 Q2I380 Q330J9 Q96IU5 Q9BUU1,Cyclin-Q,CDK10-activating cyclin;Cyclin-M;Cyclin-related protein FAM58A;, PF00134;, GO:0005634;GO:0016538;GO:0006357;, C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II;|Q8N1B3 Q2I380 Q330J9 Q96IU5 Q9BUU1,Cyclin-Q,CDK10-activating cyclin;Cyclin-M;Cyclin-related protein FAM58A;, PF00134;, GO:0005634;GO:0016538;GO:0006357;, C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II;|Q8N1B3 Q2I380 Q330J9 Q96IU5 Q9BUU1,Cyclin-Q,CDK10-activating cyclin;Cyclin-M;Cyclin-related protein FAM58A;, PF00134;, GO:0005634;GO:0016538;GO:0006357;, C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II;|Q8N1B3 Q2I380 Q330J9 Q96IU5 Q9BUU1,Cyclin-Q,CDK10-activating cyclin;Cyclin-M;Cyclin-related protein FAM58A;, PF00134;, GO:0005634;GO:0016538;GO:0006357;, C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II;|Q8N1B3 Q2I380 Q330J9 Q96IU5 Q9BUU1,Cyclin-Q,CDK10-activating cyclin;Cyclin-M;Cyclin-related protein FAM58A;, PF00134;, GO:0005634;GO:0016538;GO:0006357;, C:nucleus;, F:cyclin-dependent protein serine/threonine kinase regulator activity;, P:regulation of transcription by RNA polymerase II; scaffold258 indexed_genome mRNA 297472 300646 . + . ID=transcript_16365;Q99956 D3DWU5,Dual specificity protein phosphatase 9,Mitogen-activated protein kinase phosphatase 4;, PF00581;, GO:0005737;GO:0005829;GO:0005634;GO:0017017;GO:0051019;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0000187;GO:0000188;GO:0007254;GO:0000165;GO:0070373;GO:0035970;GO:0035335;GO:0043065;GO:0006470;GO:0060420;, C:cytoplasm; C:cytosol; C:nucleus;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:activation of MAPK activity; P:inactivation of MAPK activity; P:JNK cascade; P:MAPK cascade; P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of apoptotic process; P:protein dephosphorylation; P:regulation of heart growth; scaffold258 indexed_genome mRNA 319926 321969 . - . ID=transcript_16366;Q6P2M8 B4DJR8 B4E1A6 B7WPG0 D3DWU7 Q8N4R0,Calcium/calmodulin-dependent protein kinase type 1B,CaM kinase I beta;Pregnancy up-regulated non-ubiquitously-expressed CaM kinase;, PF00069;, GO:0005737;GO:0005634;GO:0005524;GO:0005516;GO:0004683;GO:0106310;GO:0106311;GO:0018105;, C:cytoplasm; C:nucleus;, F:ATP binding; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:peptidyl-serine phosphorylation; scaffold259 indexed_genome mRNA 143064 148844 . + . ID=transcript_16367;Q96EI5 Q8WY12 Q9H2H1 Q9H775,Transcription elongation factor A protein-like 4,Transcription elongation factor S-II protein-like 4;, PF04538;, GO:0005634;GO:0050699;, C:nucleus;, F:WW domain binding; scaffold259 indexed_genome mRNA 149933 150997 . - . ID=transcript_16368;Q5T7N2 Q8NDA1 Q9NUV8 Q9NV78,LINE-1 type transposase domain-containing protein 1,ES cell-associated protein 11;, PF17490;PF02994;, GO:0043231;GO:1990904;GO:0003727;GO:0032197;, C:intracellular membrane-bounded organelle; C:ribonucleoprotein complex;, F:single-stranded RNA binding;, P:transposition, RNA-mediated; scaffold259 indexed_genome mRNA 154753 156437 . + . ID=transcript_16369;Q969E4 D3DXA4,Transcription elongation factor A protein-like 3,Transcription elongation factor S-II protein-like 3;, PF04538;, GO:0005634;GO:0050699;, C:nucleus;, F:WW domain binding; scaffold259 indexed_genome mRNA 221812 232645 . - . ID=transcript_16370;Q15014 B3KP92 D3DXA5 Q567V0 Q8J026,Mortality factor 4-like protein 2,MORF-related gene X protein;Protein MSL3-2;Transcription factor-like protein MRGX;, PF05712;, GO:0000123;GO:0035267;GO:0005730;GO:0005654;GO:0005886;GO:0006342;GO:0006281;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0051155;GO:0045944;GO:0040008;, C:histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm; C:plasma membrane;, , P:chromatin silencing; P:DNA repair; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of striated muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth;|Q15014 B3KP92 D3DXA5 Q567V0 Q8J026,Mortality factor 4-like protein 2,MORF-related gene X protein;Protein MSL3-2;Transcription factor-like protein MRGX;, PF05712;, GO:0000123;GO:0035267;GO:0005730;GO:0005654;GO:0005886;GO:0006342;GO:0006281;GO:0016573;GO:0016575;GO:0043968;GO:0043967;GO:0051155;GO:0045944;GO:0040008;, C:histone acetyltransferase complex; C:NuA4 histone acetyltransferase complex; C:nucleolus; C:nucleoplasm; C:plasma membrane;, , P:chromatin silencing; P:DNA repair; P:histone acetylation; P:histone deacetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:positive regulation of striated muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of growth; scaffold260 indexed_genome mRNA 10201 11670 . + . ID=transcript_16371;A6NMD0 A6NEU7,Interferon-induced transmembrane protein 10,Dispanin subfamily A member 3;, PF04505;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane;|A6NMD0 A6NEU7,Interferon-induced transmembrane protein 10,Dispanin subfamily A member 3;, PF04505;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold260 indexed_genome mRNA 73227 74321 . + . ID=transcript_16372;A6NMD0 A6NEU7,Interferon-induced transmembrane protein 10,Dispanin subfamily A member 3;, PF04505;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold260 indexed_genome mRNA 154543 155473 . + . ID=transcript_16373;P61604 O95421 Q04984 Q53X54 Q9UDH0,10 kDa heat shock protein, mitochondrial,10 kDa chaperonin;Chaperonin 10;Early-pregnancy factor;, PF00166;, GO:0070062;GO:0016020;GO:0005759;GO:0005739;GO:0005524;GO:0016887;GO:0051087;GO:0046872;GO:0003723;GO:0051082;GO:0006919;GO:0051085;GO:0001649;GO:0006457;GO:0006986;, C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:chaperone binding; F:metal ion binding; F:RNA binding; F:unfolded protein binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:chaperone cofactor-dependent protein refolding; P:osteoblast differentiation; P:protein folding; P:response to unfolded protein; scaffold260 indexed_genome mRNA 216502 222821 . + . ID=transcript_16374;Q13202 Q86SS8,Dual specificity protein phosphatase 8,Dual specificity protein phosphatase hVH-5;, PF00581;, GO:0005737;GO:0005829;GO:0005634;GO:0017017;GO:0051019;GO:0016791;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0016311;GO:0000188;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleus;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:dephosphorylation; P:inactivation of MAPK activity; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation;|Q13202 Q86SS8,Dual specificity protein phosphatase 8,Dual specificity protein phosphatase hVH-5;, PF00581;, GO:0005737;GO:0005829;GO:0005634;GO:0017017;GO:0051019;GO:0016791;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0016311;GO:0000188;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleus;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:dephosphorylation; P:inactivation of MAPK activity; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation;|Q13202 Q86SS8,Dual specificity protein phosphatase 8,Dual specificity protein phosphatase hVH-5;, PF00581;, GO:0005737;GO:0005829;GO:0005634;GO:0017017;GO:0051019;GO:0016791;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008330;GO:0016311;GO:0000188;GO:0035970;GO:0035335;GO:0006470;, C:cytoplasm; C:cytosol; C:nucleus;, F:MAP kinase tyrosine/serine/threonine phosphatase activity; F:mitogen-activated protein kinase binding; F:phosphatase activity; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/threonine phosphatase activity;, P:dephosphorylation; P:inactivation of MAPK activity; P:peptidyl-threonine dephosphorylation; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; scaffold260 indexed_genome mRNA 304731 308324 . - . ID=transcript_16375;Q8IWQ3 B3KVE9 E9PLM7 O60843 O95099 Q5J5B4 Q6ZMQ4 Q8TB60,Serine/threonine-protein kinase BRSK2,Brain-selective kinase 2;Brain-specific serine/threonine-protein kinase 2;Serine/threonine-protein kinase 29;Serine/threonine-protein kinase SAD-A;, PF00069;, GO:0005813;GO:0005737;GO:0150034;GO:0005783;GO:0005634;GO:0048471;GO:0005524;GO:0051117;GO:0060590;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0031532;GO:0007409;GO:0051301;GO:0042149;GO:0036503;GO:0030010;GO:0006887;GO:0000086;GO:0035556;GO:0070059;GO:0090176;GO:0030182;GO:0018105;GO:0006468;GO:0043462;GO:0050770;GO:0061178;GO:0010975;GO:1904152;GO:2000807;, C:centrosome; C:cytoplasm; C:distal axon; C:endoplasmic reticulum; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase binding; F:ATPase regulator activity; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton reorganization; P:axonogenesis; P:cell division; P:cellular response to glucose starvation; P:ERAD pathway; P:establishment of cell polarity; P:exocytosis; P:G2/M transition of mitotic cell cycle; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:microtubule cytoskeleton organization involved in establishment of planar polarity; P:neuron differentiation; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of ATPase activity; P:regulation of axonogenesis; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of neuron projection development; P:regulation of retrograde protein transport, ER to cytosol; P:regulation of synaptic vesicle clustering; scaffold260 indexed_genome mRNA 310597 312567 . - . ID=transcript_16376;Q8IWQ3 B3KVE9 E9PLM7 O60843 O95099 Q5J5B4 Q6ZMQ4 Q8TB60,Serine/threonine-protein kinase BRSK2,Brain-selective kinase 2;Brain-specific serine/threonine-protein kinase 2;Serine/threonine-protein kinase 29;Serine/threonine-protein kinase SAD-A;, PF00069;, GO:0005813;GO:0005737;GO:0150034;GO:0005783;GO:0005634;GO:0048471;GO:0005524;GO:0051117;GO:0060590;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0031532;GO:0007409;GO:0051301;GO:0042149;GO:0036503;GO:0030010;GO:0006887;GO:0000086;GO:0035556;GO:0070059;GO:0090176;GO:0030182;GO:0018105;GO:0006468;GO:0043462;GO:0050770;GO:0061178;GO:0010975;GO:1904152;GO:2000807;, C:centrosome; C:cytoplasm; C:distal axon; C:endoplasmic reticulum; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase binding; F:ATPase regulator activity; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton reorganization; P:axonogenesis; P:cell division; P:cellular response to glucose starvation; P:ERAD pathway; P:establishment of cell polarity; P:exocytosis; P:G2/M transition of mitotic cell cycle; P:intracellular signal transduction; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:microtubule cytoskeleton organization involved in establishment of planar polarity; P:neuron differentiation; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of ATPase activity; P:regulation of axonogenesis; P:regulation of insulin secretion involved in cellular response to glucose stimulus; P:regulation of neuron projection development; P:regulation of retrograde protein transport, ER to cytosol; P:regulation of synaptic vesicle clustering; scaffold261 indexed_genome mRNA 50458 197626 . - . ID=transcript_16377;Q96ID5 Q8NBR8,Immunoglobulin superfamily member 21 {ECO:0000305},, PF07686;, GO:0005912;GO:0031362;GO:0060077;GO:0045211;GO:0042734;GO:0007157;GO:0007156;GO:0060074;, C:adherens junction; C:anchored component of external side of plasma membrane; C:inhibitory synapse; C:postsynaptic membrane; C:presynaptic membrane;, , P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse maturation;|Q96ID5 Q8NBR8,Immunoglobulin superfamily member 21 {ECO:0000305},, PF07686;, GO:0005912;GO:0031362;GO:0060077;GO:0045211;GO:0042734;GO:0007157;GO:0007156;GO:0060074;, C:adherens junction; C:anchored component of external side of plasma membrane; C:inhibitory synapse; C:postsynaptic membrane; C:presynaptic membrane;, , P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse maturation;|Q96ID5 Q8NBR8,Immunoglobulin superfamily member 21 {ECO:0000305},, PF07686;, GO:0005912;GO:0031362;GO:0060077;GO:0045211;GO:0042734;GO:0007157;GO:0007156;GO:0060074;, C:adherens junction; C:anchored component of external side of plasma membrane; C:inhibitory synapse; C:postsynaptic membrane; C:presynaptic membrane;, , P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse maturation; scaffold262 indexed_genome mRNA 107 35274 . - . ID=transcript_16378;P16435 Q16455 Q197M5 Q8N181 Q9H3M8 Q9UDT3,NADPH--cytochrome P450 reductase {ECO:0000255|HAMAP-Rule:MF_03212},, PF00667;PF00258;PF00175;, GO:0005829;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0050660;GO:0010181;GO:0050661;GO:0003958;GO:0016491;GO:0016709;GO:0090346;GO:0022900;GO:0032770;GO:0009725;GO:0006805;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:flavin adenine dinucleotide binding; F:FMN binding; F:NADP binding; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:cellular organofluorine metabolic process; P:electron transport chain; P:positive regulation of monooxygenase activity; P:response to hormone; P:xenobiotic metabolic process;|Q9BXJ8 Q86TE9 Q8N6P1,Ion channel TACAN {ECO:0000303|PubMed:32084332},Transmembrane protein 120A {ECO:0000303|PubMed:26024229};Transmembrane protein induced by tumor necrosis factor alpha {ECO:0000303|Ref.1};, PF07851;, GO:0016021;GO:0016020;GO:0005637;GO:0005886;GO:0005216;GO:0050966;GO:0045444;GO:0034220;GO:0051291;GO:0051260;, C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:plasma membrane;, F:ion channel activity;, P:detection of mechanical stimulus involved in sensory perception of pain; P:fat cell differentiation; P:ion transmembrane transport; P:protein heterooligomerization; P:protein homooligomerization;|Q9BXJ8 Q86TE9 Q8N6P1,Ion channel TACAN {ECO:0000303|PubMed:32084332},Transmembrane protein 120A {ECO:0000303|PubMed:26024229};Transmembrane protein induced by tumor necrosis factor alpha {ECO:0000303|Ref.1};, PF07851;, GO:0016021;GO:0016020;GO:0005637;GO:0005886;GO:0005216;GO:0050966;GO:0045444;GO:0034220;GO:0051291;GO:0051260;, C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:plasma membrane;, F:ion channel activity;, P:detection of mechanical stimulus involved in sensory perception of pain; P:fat cell differentiation; P:ion transmembrane transport; P:protein heterooligomerization; P:protein homooligomerization;|Q9BXJ8 Q86TE9 Q8N6P1,Ion channel TACAN {ECO:0000303|PubMed:32084332},Transmembrane protein 120A {ECO:0000303|PubMed:26024229};Transmembrane protein induced by tumor necrosis factor alpha {ECO:0000303|Ref.1};, PF07851;, GO:0016021;GO:0016020;GO:0005637;GO:0005886;GO:0005216;GO:0050966;GO:0045444;GO:0034220;GO:0051291;GO:0051260;, C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:plasma membrane;, F:ion channel activity;, P:detection of mechanical stimulus involved in sensory perception of pain; P:fat cell differentiation; P:ion transmembrane transport; P:protein heterooligomerization; P:protein homooligomerization;|Q9BXJ8 Q86TE9 Q8N6P1,Ion channel TACAN {ECO:0000303|PubMed:32084332},Transmembrane protein 120A {ECO:0000303|PubMed:26024229};Transmembrane protein induced by tumor necrosis factor alpha {ECO:0000303|Ref.1};, PF07851;, GO:0016021;GO:0016020;GO:0005637;GO:0005886;GO:0005216;GO:0050966;GO:0045444;GO:0034220;GO:0051291;GO:0051260;, C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:plasma membrane;, F:ion channel activity;, P:detection of mechanical stimulus involved in sensory perception of pain; P:fat cell differentiation; P:ion transmembrane transport; P:protein heterooligomerization; P:protein homooligomerization;|Q9BXJ8 Q86TE9 Q8N6P1,Ion channel TACAN {ECO:0000303|PubMed:32084332},Transmembrane protein 120A {ECO:0000303|PubMed:26024229};Transmembrane protein induced by tumor necrosis factor alpha {ECO:0000303|Ref.1};, PF07851;, GO:0016021;GO:0016020;GO:0005637;GO:0005886;GO:0005216;GO:0050966;GO:0045444;GO:0034220;GO:0051291;GO:0051260;, C:integral component of membrane; C:membrane; C:nuclear inner membrane; C:plasma membrane;, F:ion channel activity;, P:detection of mechanical stimulus involved in sensory perception of pain; P:fat cell differentiation; P:ion transmembrane transport; P:protein heterooligomerization; P:protein homooligomerization;|Q9Y6J8 Q9UBP1 Q9UK06 Q9UK07 Q9UKG2 Q9UKG3,Serine/threonine/tyrosine-interacting-like protein 1,Dual specificity phosphatase inhibitor MK-STYX;Dual specificity protein phosphatase 24;Inactive dual specificity protein phosphatase MK-STYX {ECO:0000305};Map kinase phosphatase-like protein MK-STYX;, PF00581;, GO:0005759;GO:0005739;GO:0019903;GO:0004864;GO:0008138;GO:0001691;GO:0035556;GO:0032515;GO:0062030;GO:2001244;GO:0010976;GO:2001242;, C:mitochondrial matrix; C:mitochondrion;, F:protein phosphatase binding; F:protein phosphatase inhibitor activity; F:protein tyrosine/serine/threonine phosphatase activity; F:pseudophosphatase activity;, P:intracellular signal transduction; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of stress granule assembly; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of neuron projection development; P:regulation of intrinsic apoptotic signaling pathway;|Q9Y6J8 Q9UBP1 Q9UK06 Q9UK07 Q9UKG2 Q9UKG3,Serine/threonine/tyrosine-interacting-like protein 1,Dual specificity phosphatase inhibitor MK-STYX;Dual specificity protein phosphatase 24;Inactive dual specificity protein phosphatase MK-STYX {ECO:0000305};Map kinase phosphatase-like protein MK-STYX;, PF00581;, GO:0005759;GO:0005739;GO:0019903;GO:0004864;GO:0008138;GO:0001691;GO:0035556;GO:0032515;GO:0062030;GO:2001244;GO:0010976;GO:2001242;, C:mitochondrial matrix; C:mitochondrion;, F:protein phosphatase binding; F:protein phosphatase inhibitor activity; F:protein tyrosine/serine/threonine phosphatase activity; F:pseudophosphatase activity;, P:intracellular signal transduction; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of stress granule assembly; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of neuron projection development; P:regulation of intrinsic apoptotic signaling pathway; scaffold262 indexed_genome mRNA 35437 48672 . + . ID=transcript_16379;P40926 A8K414 B2RE78 B4DE44 E9PDB2 O43682,Malate dehydrogenase, mitochondrial,, PF02866;PF00056;, GO:0005737;GO:0070062;GO:0016020;GO:0005759;GO:0005739;GO:0005634;GO:0030060;GO:0046554;GO:0043621;GO:0003723;GO:0009060;GO:0006094;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, C:cytoplasm; C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:L-malate dehydrogenase activity; F:malate dehydrogenase (NADP+) activity; F:protein self-association; F:RNA binding;, P:aerobic respiration; P:gluconeogenesis; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle;|P40926 A8K414 B2RE78 B4DE44 E9PDB2 O43682,Malate dehydrogenase, mitochondrial,, PF02866;PF00056;, GO:0005737;GO:0070062;GO:0016020;GO:0005759;GO:0005739;GO:0005634;GO:0030060;GO:0046554;GO:0043621;GO:0003723;GO:0009060;GO:0006094;GO:0006108;GO:0006734;GO:0006107;GO:0006099;, C:cytoplasm; C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrion; C:nucleus;, F:L-malate dehydrogenase activity; F:malate dehydrogenase (NADP+) activity; F:protein self-association; F:RNA binding;, P:aerobic respiration; P:gluconeogenesis; P:malate metabolic process; P:NADH metabolic process; P:oxaloacetate metabolic process; P:tricarboxylic acid cycle; scaffold262 indexed_genome mRNA 65263 100167 . - . ID=transcript_16380;A6NNA2 A6ND75,Serine/arginine repetitive matrix protein 3,, PF08312;PF15230;, GO:0003729;, , F:mRNA binding; scaffold262 indexed_genome mRNA 126393 128050 . - . ID=transcript_16381;P04792 B2R4N8 Q6FI47 Q96C20 Q96EI7 Q9UC31 Q9UC34 Q9UC35 Q9UC36,Heat shock protein beta-1,28 kDa heat shock protein;Estrogen-regulated 24 kDa protein;Heat shock 27 kDa protein;Stress-responsive protein 27;, PF00011;, GO:1904115;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005615;GO:0005925;GO:0005634;GO:0000502;GO:0005819;GO:0042802;GO:0044183;GO:0042803;GO:0019901;GO:0005080;GO:0008426;GO:0003723;GO:0061629;GO:0043130;GO:0099641;GO:0035924;GO:0061077;GO:0035556;GO:0043066;GO:1902176;GO:0006469;GO:0070527;GO:0045766;GO:0043536;GO:2001028;GO:0038033;GO:0032731;GO:0032760;GO:0010506;GO:0043122;GO:0043488;GO:0001932;GO:0006446;GO:0006986;GO:0009615;GO:0001895;GO:0016032;, C:axon cytoplasm; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:nucleus; C:proteasome complex; C:spindle;, F:identical protein binding; F:protein folding chaperone; F:protein homodimerization activity; F:protein kinase binding; F:protein kinase C binding; F:protein kinase C inhibitor activity; F:RNA binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:ubiquitin binding;, P:anterograde axonal protein transport; P:cellular response to vascular endothelial growth factor stimulus; P:chaperone-mediated protein folding; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein kinase activity; P:platelet aggregation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of interleukin-1 beta production; P:positive regulation of tumor necrosis factor production; P:regulation of autophagy; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mRNA stability; P:regulation of protein phosphorylation; P:regulation of translational initiation; P:response to unfolded protein; P:response to virus; P:retina homeostasis; P:viral process;|P04792 B2R4N8 Q6FI47 Q96C20 Q96EI7 Q9UC31 Q9UC34 Q9UC35 Q9UC36,Heat shock protein beta-1,28 kDa heat shock protein;Estrogen-regulated 24 kDa protein;Heat shock 27 kDa protein;Stress-responsive protein 27;, PF00011;, GO:1904115;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005615;GO:0005925;GO:0005634;GO:0000502;GO:0005819;GO:0042802;GO:0044183;GO:0042803;GO:0019901;GO:0005080;GO:0008426;GO:0003723;GO:0061629;GO:0043130;GO:0099641;GO:0035924;GO:0061077;GO:0035556;GO:0043066;GO:1902176;GO:0006469;GO:0070527;GO:0045766;GO:0043536;GO:2001028;GO:0038033;GO:0032731;GO:0032760;GO:0010506;GO:0043122;GO:0043488;GO:0001932;GO:0006446;GO:0006986;GO:0009615;GO:0001895;GO:0016032;, C:axon cytoplasm; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:nucleus; C:proteasome complex; C:spindle;, F:identical protein binding; F:protein folding chaperone; F:protein homodimerization activity; F:protein kinase binding; F:protein kinase C binding; F:protein kinase C inhibitor activity; F:RNA binding; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:ubiquitin binding;, P:anterograde axonal protein transport; P:cellular response to vascular endothelial growth factor stimulus; P:chaperone-mediated protein folding; P:intracellular signal transduction; P:negative regulation of apoptotic process; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein kinase activity; P:platelet aggregation; P:positive regulation of angiogenesis; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of endothelial cell chemotaxis; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; P:positive regulation of interleukin-1 beta production; P:positive regulation of tumor necrosis factor production; P:regulation of autophagy; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of mRNA stability; P:regulation of protein phosphorylation; P:regulation of translational initiation; P:response to unfolded protein; P:response to virus; P:retina homeostasis; P:viral process; scaffold262 indexed_genome mRNA 152379 176080 . + . ID=transcript_16382;P61981 O70457 P35214 Q6FH52 Q9UDP2 Q9UN99,14-3-3 protein gamma,Protein kinase C inhibitor protein 1;, PF00244;, GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0005739;GO:0098793;GO:0042802;GO:0005159;GO:0019904;GO:0005080;GO:0008426;GO:0030971;GO:0003723;GO:0032869;GO:0097711;GO:0000086;GO:0006469;GO:1900740;GO:0006605;GO:0010389;GO:0045664;GO:0009966;GO:0048167;, C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:mitochondrion; C:presynapse;, F:identical protein binding; F:insulin-like growth factor receptor binding; F:protein domain specific binding; F:protein kinase C binding; F:protein kinase C inhibitor activity; F:receptor tyrosine kinase binding; F:RNA binding;, P:cellular response to insulin stimulus; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:negative regulation of protein kinase activity; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:protein targeting; P:regulation of G2/M transition of mitotic cell cycle; P:regulation of neuron differentiation; P:regulation of signal transduction; P:regulation of synaptic plasticity; scaffold262 indexed_genome mRNA 202454 222127 . - . ID=transcript_16383;Q8WTU2 Q2HIZ5 Q6ZMG3 Q96BF5,Scavenger receptor cysteine-rich domain-containing group B protein {ECO:0000303|PubMed:12466895, ECO:0000312|HGNC:HGNC:14461},Four scavenger receptor cysteine-rich domains-containing protein {ECO:0000312|HGNC:HGNC:14461};S4D-SRCRB {ECO:0000303|PubMed:12466895};, PF00530;, GO:0005576;GO:0016020;GO:0005044;, C:extracellular region; C:membrane;, F:scavenger receptor activity;|Q8WTU2 Q2HIZ5 Q6ZMG3 Q96BF5,Scavenger receptor cysteine-rich domain-containing group B protein {ECO:0000303|PubMed:12466895, ECO:0000312|HGNC:HGNC:14461},Four scavenger receptor cysteine-rich domains-containing protein {ECO:0000312|HGNC:HGNC:14461};S4D-SRCRB {ECO:0000303|PubMed:12466895};, PF00530;, GO:0005576;GO:0016020;GO:0005044;, C:extracellular region; C:membrane;, F:scavenger receptor activity; scaffold262 indexed_genome mRNA 256009 289566 . + . ID=transcript_16384;Q86UW9 Q4ZH49 Q6XM87 Q6XM88 Q96H69 Q9H890 Q9P200,Probable E3 ubiquitin-protein ligase DTX2,Protein deltex-2;RING finger protein 58;RING-type E3 ubiquitin transferase DTX2 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005737;GO:0031965;GO:0005654;GO:0061630;GO:0008270;GO:0007219;GO:0016567;, C:cytoplasm; C:nuclear membrane; C:nucleoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:Notch signaling pathway; P:protein ubiquitination;|Q86UW9 Q4ZH49 Q6XM87 Q6XM88 Q96H69 Q9H890 Q9P200,Probable E3 ubiquitin-protein ligase DTX2,Protein deltex-2;RING finger protein 58;RING-type E3 ubiquitin transferase DTX2 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005737;GO:0031965;GO:0005654;GO:0061630;GO:0008270;GO:0007219;GO:0016567;, C:cytoplasm; C:nuclear membrane; C:nucleoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:Notch signaling pathway; P:protein ubiquitination;|Q86UW9 Q4ZH49 Q6XM87 Q6XM88 Q96H69 Q9H890 Q9P200,Probable E3 ubiquitin-protein ligase DTX2,Protein deltex-2;RING finger protein 58;RING-type E3 ubiquitin transferase DTX2 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005737;GO:0031965;GO:0005654;GO:0061630;GO:0008270;GO:0007219;GO:0016567;, C:cytoplasm; C:nuclear membrane; C:nucleoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:Notch signaling pathway; P:protein ubiquitination;|Q86UW9 Q4ZH49 Q6XM87 Q6XM88 Q96H69 Q9H890 Q9P200,Probable E3 ubiquitin-protein ligase DTX2,Protein deltex-2;RING finger protein 58;RING-type E3 ubiquitin transferase DTX2 {ECO:0000305};, PF18102;PF02825;PF00097;, GO:0005737;GO:0031965;GO:0005654;GO:0061630;GO:0008270;GO:0007219;GO:0016567;, C:cytoplasm; C:nuclear membrane; C:nucleoplasm;, F:ubiquitin protein ligase activity; F:zinc ion binding;, P:Notch signaling pathway; P:protein ubiquitination; scaffold262 indexed_genome mRNA 292425 298927 . + . ID=transcript_16385;Q9BT76 A6NHH5 A8K231 A8MZA8 B3KPU5 Q75MM5 Q86W06,Uroplakin-3b,Uroplakin IIIb;p35;, , GO:0016021;GO:0005886;GO:0010629;, C:integral component of membrane; C:plasma membrane;, , P:negative regulation of gene expression;|Q9BT76 A6NHH5 A8K231 A8MZA8 B3KPU5 Q75MM5 Q86W06,Uroplakin-3b,Uroplakin IIIb;p35;, , GO:0016021;GO:0005886;GO:0010629;, C:integral component of membrane; C:plasma membrane;, , P:negative regulation of gene expression; scaffold264 indexed_genome mRNA 47296 58301 . - . ID=transcript_16386;Q8TCT7 D6W609 O60365 Q567S3 Q8IUH9 Q9BUY6 Q9H3M4 Q9NPN2 Q9P1Z6,Signal peptide peptidase-like 2B {ECO:0000303|PubMed:15385547, ECO:0000312|HGNC:HGNC:30627},Intramembrane protease 4 {ECO:0000303|PubMed:12139484};Presenilin homologous protein 4;Presenilin-like protein 1;, PF02225;PF04258;, GO:0015629;GO:0005813;GO:0010008;GO:0000139;GO:0030660;GO:0071458;GO:0071556;GO:0005765;GO:0016020;GO:0005654;GO:0005886;GO:0042500;GO:0042803;GO:0006509;GO:0031293;GO:0033619;GO:0050776;GO:0010803;, C:actin cytoskeleton; C:centrosome; C:endosome membrane; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:lysosomal membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:membrane protein proteolysis; P:regulation of immune response; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8TCT7 D6W609 O60365 Q567S3 Q8IUH9 Q9BUY6 Q9H3M4 Q9NPN2 Q9P1Z6,Signal peptide peptidase-like 2B {ECO:0000303|PubMed:15385547, ECO:0000312|HGNC:HGNC:30627},Intramembrane protease 4 {ECO:0000303|PubMed:12139484};Presenilin homologous protein 4;Presenilin-like protein 1;, PF02225;PF04258;, GO:0015629;GO:0005813;GO:0010008;GO:0000139;GO:0030660;GO:0071458;GO:0071556;GO:0005765;GO:0016020;GO:0005654;GO:0005886;GO:0042500;GO:0042803;GO:0006509;GO:0031293;GO:0033619;GO:0050776;GO:0010803;, C:actin cytoskeleton; C:centrosome; C:endosome membrane; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:lysosomal membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:membrane protein proteolysis; P:regulation of immune response; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8TCT7 D6W609 O60365 Q567S3 Q8IUH9 Q9BUY6 Q9H3M4 Q9NPN2 Q9P1Z6,Signal peptide peptidase-like 2B {ECO:0000303|PubMed:15385547, ECO:0000312|HGNC:HGNC:30627},Intramembrane protease 4 {ECO:0000303|PubMed:12139484};Presenilin homologous protein 4;Presenilin-like protein 1;, PF02225;PF04258;, GO:0015629;GO:0005813;GO:0010008;GO:0000139;GO:0030660;GO:0071458;GO:0071556;GO:0005765;GO:0016020;GO:0005654;GO:0005886;GO:0042500;GO:0042803;GO:0006509;GO:0031293;GO:0033619;GO:0050776;GO:0010803;, C:actin cytoskeleton; C:centrosome; C:endosome membrane; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:lysosomal membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:membrane protein proteolysis; P:regulation of immune response; P:regulation of tumor necrosis factor-mediated signaling pathway;|Q8TCT7 D6W609 O60365 Q567S3 Q8IUH9 Q9BUY6 Q9H3M4 Q9NPN2 Q9P1Z6,Signal peptide peptidase-like 2B {ECO:0000303|PubMed:15385547, ECO:0000312|HGNC:HGNC:30627},Intramembrane protease 4 {ECO:0000303|PubMed:12139484};Presenilin homologous protein 4;Presenilin-like protein 1;, PF02225;PF04258;, GO:0015629;GO:0005813;GO:0010008;GO:0000139;GO:0030660;GO:0071458;GO:0071556;GO:0005765;GO:0016020;GO:0005654;GO:0005886;GO:0042500;GO:0042803;GO:0006509;GO:0031293;GO:0033619;GO:0050776;GO:0010803;, C:actin cytoskeleton; C:centrosome; C:endosome membrane; C:Golgi membrane; C:Golgi-associated vesicle membrane; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; C:integral component of lumenal side of endoplasmic reticulum membrane; C:lysosomal membrane; C:membrane; C:nucleoplasm; C:plasma membrane;, F:aspartic endopeptidase activity, intramembrane cleaving; F:protein homodimerization activity;, P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:membrane protein proteolysis; P:regulation of immune response; P:regulation of tumor necrosis factor-mediated signaling pathway; scaffold264 indexed_genome mRNA 67350 71653 . - . ID=transcript_16387;Q9UK45,U6 snRNA-associated Sm-like protein LSm7,, PF01423;, GO:0071013;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:1990904;GO:0097526;GO:0005689;GO:0071005;GO:0071004;GO:0046540;GO:0005688;GO:0017070;GO:0043928;GO:0000398;, C:catalytic step 2 spliceosome; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal tri-snRNP complex; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:U6 snRNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA splicing, via spliceosome;|Q9UK45,U6 snRNA-associated Sm-like protein LSm7,, PF01423;, GO:0071013;GO:0005829;GO:1990726;GO:0120115;GO:0005654;GO:0005634;GO:1990904;GO:0097526;GO:0005689;GO:0071005;GO:0071004;GO:0046540;GO:0005688;GO:0017070;GO:0043928;GO:0000398;, C:catalytic step 2 spliceosome; C:cytosol; C:Lsm1-7-Pat1 complex; C:Lsm2-8 complex; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:spliceosomal tri-snRNP complex; C:U12-type spliceosomal complex; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome; C:U4/U6 x U5 tri-snRNP complex; C:U6 snRNP;, F:U6 snRNA binding;, P:exonucleolytic catabolism of deadenylated mRNA; P:mRNA splicing, via spliceosome; scaffold264 indexed_genome mRNA 104626 108602 . + . ID=transcript_16388;Q6ZS72,Protein PEAK3 {ECO:0000305},, , GO:0015629;GO:0005925;GO:0004672;GO:0043621;GO:0006468;GO:0032956;GO:0008360;, C:actin cytoskeleton; C:focal adhesion;, F:protein kinase activity; F:protein self-association;, P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; scaffold264 indexed_genome mRNA 110646 114034 . + . ID=transcript_16389;P54368 O43382 Q14989 Q92595 Q9UPL9,Ornithine decarboxylase antizyme 1,, PF02100;, GO:0005737;GO:0005829;GO:0005634;GO:0008073;GO:1902268;GO:0006596;GO:0090316;GO:0045732;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase inhibitor activity;, P:negative regulation of polyamine transmembrane transport; P:polyamine biosynthetic process; P:positive regulation of intracellular protein transport; P:positive regulation of protein catabolic process; P:regulation of cellular amino acid metabolic process;|P54368 O43382 Q14989 Q92595 Q9UPL9,Ornithine decarboxylase antizyme 1,, PF02100;, GO:0005737;GO:0005829;GO:0005634;GO:0008073;GO:1902268;GO:0006596;GO:0090316;GO:0045732;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase inhibitor activity;, P:negative regulation of polyamine transmembrane transport; P:polyamine biosynthetic process; P:positive regulation of intracellular protein transport; P:positive regulation of protein catabolic process; P:regulation of cellular amino acid metabolic process;|P54368 O43382 Q14989 Q92595 Q9UPL9,Ornithine decarboxylase antizyme 1,, PF02100;, GO:0005737;GO:0005829;GO:0005634;GO:0008073;GO:1902268;GO:0006596;GO:0090316;GO:0045732;GO:0006521;, C:cytoplasm; C:cytosol; C:nucleus;, F:ornithine decarboxylase inhibitor activity;, P:negative regulation of polyamine transmembrane transport; P:polyamine biosynthetic process; P:positive regulation of intracellular protein transport; P:positive regulation of protein catabolic process; P:regulation of cellular amino acid metabolic process; scaffold264 indexed_genome mRNA 156348 307921 . + . ID=transcript_16390;Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6,MAP kinase-interacting serine/threonine-protein kinase 2,MAP kinase signal-integrating kinase 2;, PF00069;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0007166;GO:0071243;GO:0097192;GO:0030097;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell surface receptor signaling pathway; P:cellular response to arsenic-containing substance; P:extrinsic apoptotic signaling pathway in absence of ligand; P:hemopoiesis; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q8TEK3 O60379 Q96JL1,Histone-lysine N-methyltransferase, H3 lysine-79 specific {ECO:0000305},DOT1-like protein;Histone H3-K79 methyltransferase;Lysine N-methyltransferase 4;, PF08123;, GO:0000781;GO:0043231;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042054;GO:0031151;GO:0018024;GO:0008134;GO:0006348;GO:0000077;GO:0006281;GO:0010467;GO:0034729;GO:0008284;GO:0045944;GO:0046425;GO:2000677;GO:0032200;, C:chromosome, telomeric region; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K79 specific); F:histone-lysine N-methyltransferase activity; F:transcription factor binding;, P:chromatin silencing at telomere; P:DNA damage checkpoint; P:DNA repair; P:gene expression; P:histone H3-K79 methylation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription regulatory region DNA binding; P:telomere organization;|Q8TEK3 O60379 Q96JL1,Histone-lysine N-methyltransferase, H3 lysine-79 specific {ECO:0000305},DOT1-like protein;Histone H3-K79 methyltransferase;Lysine N-methyltransferase 4;, PF08123;, GO:0000781;GO:0043231;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042054;GO:0031151;GO:0018024;GO:0008134;GO:0006348;GO:0000077;GO:0006281;GO:0010467;GO:0034729;GO:0008284;GO:0045944;GO:0046425;GO:2000677;GO:0032200;, C:chromosome, telomeric region; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K79 specific); F:histone-lysine N-methyltransferase activity; F:transcription factor binding;, P:chromatin silencing at telomere; P:DNA damage checkpoint; P:DNA repair; P:gene expression; P:histone H3-K79 methylation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription regulatory region DNA binding; P:telomere organization;|Q8TEK3 O60379 Q96JL1,Histone-lysine N-methyltransferase, H3 lysine-79 specific {ECO:0000305},DOT1-like protein;Histone H3-K79 methyltransferase;Lysine N-methyltransferase 4;, PF08123;, GO:0000781;GO:0043231;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042054;GO:0031151;GO:0018024;GO:0008134;GO:0006348;GO:0000077;GO:0006281;GO:0010467;GO:0034729;GO:0008284;GO:0045944;GO:0046425;GO:2000677;GO:0032200;, C:chromosome, telomeric region; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K79 specific); F:histone-lysine N-methyltransferase activity; F:transcription factor binding;, P:chromatin silencing at telomere; P:DNA damage checkpoint; P:DNA repair; P:gene expression; P:histone H3-K79 methylation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription regulatory region DNA binding; P:telomere organization;|Q8TEK3 O60379 Q96JL1,Histone-lysine N-methyltransferase, H3 lysine-79 specific {ECO:0000305},DOT1-like protein;Histone H3-K79 methyltransferase;Lysine N-methyltransferase 4;, PF08123;, GO:0000781;GO:0043231;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042054;GO:0031151;GO:0018024;GO:0008134;GO:0006348;GO:0000077;GO:0006281;GO:0010467;GO:0034729;GO:0008284;GO:0045944;GO:0046425;GO:2000677;GO:0032200;, C:chromosome, telomeric region; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K79 specific); F:histone-lysine N-methyltransferase activity; F:transcription factor binding;, P:chromatin silencing at telomere; P:DNA damage checkpoint; P:DNA repair; P:gene expression; P:histone H3-K79 methylation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription regulatory region DNA binding; P:telomere organization;|Q8TEK3 O60379 Q96JL1,Histone-lysine N-methyltransferase, H3 lysine-79 specific {ECO:0000305},DOT1-like protein;Histone H3-K79 methyltransferase;Lysine N-methyltransferase 4;, PF08123;, GO:0000781;GO:0043231;GO:0005654;GO:0005634;GO:0032991;GO:0003677;GO:0042054;GO:0031151;GO:0018024;GO:0008134;GO:0006348;GO:0000077;GO:0006281;GO:0010467;GO:0034729;GO:0008284;GO:0045944;GO:0046425;GO:2000677;GO:0032200;, C:chromosome, telomeric region; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:DNA binding; F:histone methyltransferase activity; F:histone methyltransferase activity (H3-K79 specific); F:histone-lysine N-methyltransferase activity; F:transcription factor binding;, P:chromatin silencing at telomere; P:DNA damage checkpoint; P:DNA repair; P:gene expression; P:histone H3-K79 methylation; P:positive regulation of cell population proliferation; P:positive regulation of transcription by RNA polymerase II; P:regulation of receptor signaling pathway via JAK-STAT; P:regulation of transcription regulatory region DNA binding; P:telomere organization;|Q9NW61 B3KUQ9 D6W604,Pleckstrin homology domain-containing family J member 1,Guanine nucleotide-releasing protein x;, PF00169;, GO:0005829;GO:0005769;GO:0055037;GO:0005802;GO:0007032;GO:0001881;GO:0042147;, C:cytosol; C:early endosome; C:recycling endosome; C:trans-Golgi network;, , P:endosome organization; P:receptor recycling; P:retrograde transport, endosome to Golgi;|Q15428 B2RBU1 D6W605 O75245,Splicing factor 3A subunit 2,SF3a66 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847};Spliceosome-associated protein 62;, PF16835;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0071004;GO:0003723;GO:0008270;GO:0000389;GO:0006397;GO:0000398;GO:0010976;GO:0000245;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome;, F:RNA binding; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:positive regulation of neuron projection development; P:spliceosomal complex assembly; P:U2-type prespliceosome assembly;|Q15428 B2RBU1 D6W605 O75245,Splicing factor 3A subunit 2,SF3a66 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847};Spliceosome-associated protein 62;, PF16835;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0071004;GO:0003723;GO:0008270;GO:0000389;GO:0006397;GO:0000398;GO:0010976;GO:0000245;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome;, F:RNA binding; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:positive regulation of neuron projection development; P:spliceosomal complex assembly; P:U2-type prespliceosome assembly;|Q15428 B2RBU1 D6W605 O75245,Splicing factor 3A subunit 2,SF3a66 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847};Spliceosome-associated protein 62;, PF16835;, GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0071004;GO:0003723;GO:0008270;GO:0000389;GO:0006397;GO:0000398;GO:0010976;GO:0000245;GO:1903241;, C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome;, F:RNA binding; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:positive regulation of neuron projection development; P:spliceosomal complex assembly; P:U2-type prespliceosome assembly;|Q96MG2,Junctional sarcoplasmic reticulum protein 1,Junctional-face membrane protein of 45 kDa homolog;, PF15312;, GO:0016529;GO:0033017;GO:0060314;GO:0003009;, C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, , P:regulation of ryanodine-sensitive calcium-release channel activity; P:skeletal muscle contraction;|Q96MG2,Junctional sarcoplasmic reticulum protein 1,Junctional-face membrane protein of 45 kDa homolog;, PF15312;, GO:0016529;GO:0033017;GO:0060314;GO:0003009;, C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, , P:regulation of ryanodine-sensitive calcium-release channel activity; P:skeletal muscle contraction;|Q96MG2,Junctional sarcoplasmic reticulum protein 1,Junctional-face membrane protein of 45 kDa homolog;, PF15312;, GO:0016529;GO:0033017;GO:0060314;GO:0003009;, C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane;, , P:regulation of ryanodine-sensitive calcium-release channel activity; P:skeletal muscle contraction;|O14617 O00202 O75262 Q59HF5 Q96G11 Q9H3C6,AP-3 complex subunit delta-1,AP-3 complex subunit delta;Adaptor-related protein complex 3 subunit delta-1;Delta-adaptin;, PF01602;PF06375;, GO:0030123;GO:1904115;GO:0010008;GO:0098978;GO:0005794;GO:0000139;GO:0005765;GO:0016020;GO:0098794;GO:0098830;GO:0043195;GO:0008089;GO:0048490;GO:0048007;GO:0035646;GO:0006896;GO:0006886;GO:0032438;GO:0098943;GO:0051138;GO:0045944;GO:0072657;GO:0006623;GO:0061088;GO:0016182;GO:0048499;, C:AP-3 adaptor complex; C:axon cytoplasm; C:endosome membrane; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:membrane; C:postsynapse; C:presynaptic endosome; C:terminal bouton;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:endosome to melanosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of NK T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to membrane; P:protein targeting to vacuole; P:regulation of sequestering of zinc ion; P:synaptic vesicle budding from endosome; P:synaptic vesicle membrane organization;|O14617 O00202 O75262 Q59HF5 Q96G11 Q9H3C6,AP-3 complex subunit delta-1,AP-3 complex subunit delta;Adaptor-related protein complex 3 subunit delta-1;Delta-adaptin;, PF01602;PF06375;, GO:0030123;GO:1904115;GO:0010008;GO:0098978;GO:0005794;GO:0000139;GO:0005765;GO:0016020;GO:0098794;GO:0098830;GO:0043195;GO:0008089;GO:0048490;GO:0048007;GO:0035646;GO:0006896;GO:0006886;GO:0032438;GO:0098943;GO:0051138;GO:0045944;GO:0072657;GO:0006623;GO:0061088;GO:0016182;GO:0048499;, C:AP-3 adaptor complex; C:axon cytoplasm; C:endosome membrane; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:membrane; C:postsynapse; C:presynaptic endosome; C:terminal bouton;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:endosome to melanosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of NK T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to membrane; P:protein targeting to vacuole; P:regulation of sequestering of zinc ion; P:synaptic vesicle budding from endosome; P:synaptic vesicle membrane organization;|O14617 O00202 O75262 Q59HF5 Q96G11 Q9H3C6,AP-3 complex subunit delta-1,AP-3 complex subunit delta;Adaptor-related protein complex 3 subunit delta-1;Delta-adaptin;, PF01602;PF06375;, GO:0030123;GO:1904115;GO:0010008;GO:0098978;GO:0005794;GO:0000139;GO:0005765;GO:0016020;GO:0098794;GO:0098830;GO:0043195;GO:0008089;GO:0048490;GO:0048007;GO:0035646;GO:0006896;GO:0006886;GO:0032438;GO:0098943;GO:0051138;GO:0045944;GO:0072657;GO:0006623;GO:0061088;GO:0016182;GO:0048499;, C:AP-3 adaptor complex; C:axon cytoplasm; C:endosome membrane; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:membrane; C:postsynapse; C:presynaptic endosome; C:terminal bouton;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:endosome to melanosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of NK T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to membrane; P:protein targeting to vacuole; P:regulation of sequestering of zinc ion; P:synaptic vesicle budding from endosome; P:synaptic vesicle membrane organization;|O14617 O00202 O75262 Q59HF5 Q96G11 Q9H3C6,AP-3 complex subunit delta-1,AP-3 complex subunit delta;Adaptor-related protein complex 3 subunit delta-1;Delta-adaptin;, PF01602;PF06375;, GO:0030123;GO:1904115;GO:0010008;GO:0098978;GO:0005794;GO:0000139;GO:0005765;GO:0016020;GO:0098794;GO:0098830;GO:0043195;GO:0008089;GO:0048490;GO:0048007;GO:0035646;GO:0006896;GO:0006886;GO:0032438;GO:0098943;GO:0051138;GO:0045944;GO:0072657;GO:0006623;GO:0061088;GO:0016182;GO:0048499;, C:AP-3 adaptor complex; C:axon cytoplasm; C:endosome membrane; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:membrane; C:postsynapse; C:presynaptic endosome; C:terminal bouton;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:endosome to melanosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of NK T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to membrane; P:protein targeting to vacuole; P:regulation of sequestering of zinc ion; P:synaptic vesicle budding from endosome; P:synaptic vesicle membrane organization;|O14617 O00202 O75262 Q59HF5 Q96G11 Q9H3C6,AP-3 complex subunit delta-1,AP-3 complex subunit delta;Adaptor-related protein complex 3 subunit delta-1;Delta-adaptin;, PF01602;PF06375;, GO:0030123;GO:1904115;GO:0010008;GO:0098978;GO:0005794;GO:0000139;GO:0005765;GO:0016020;GO:0098794;GO:0098830;GO:0043195;GO:0008089;GO:0048490;GO:0048007;GO:0035646;GO:0006896;GO:0006886;GO:0032438;GO:0098943;GO:0051138;GO:0045944;GO:0072657;GO:0006623;GO:0061088;GO:0016182;GO:0048499;, C:AP-3 adaptor complex; C:axon cytoplasm; C:endosome membrane; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:membrane; C:postsynapse; C:presynaptic endosome; C:terminal bouton;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:endosome to melanosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of NK T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to membrane; P:protein targeting to vacuole; P:regulation of sequestering of zinc ion; P:synaptic vesicle budding from endosome; P:synaptic vesicle membrane organization;|O14617 O00202 O75262 Q59HF5 Q96G11 Q9H3C6,AP-3 complex subunit delta-1,AP-3 complex subunit delta;Adaptor-related protein complex 3 subunit delta-1;Delta-adaptin;, PF01602;PF06375;, GO:0030123;GO:1904115;GO:0010008;GO:0098978;GO:0005794;GO:0000139;GO:0005765;GO:0016020;GO:0098794;GO:0098830;GO:0043195;GO:0008089;GO:0048490;GO:0048007;GO:0035646;GO:0006896;GO:0006886;GO:0032438;GO:0098943;GO:0051138;GO:0045944;GO:0072657;GO:0006623;GO:0061088;GO:0016182;GO:0048499;, C:AP-3 adaptor complex; C:axon cytoplasm; C:endosome membrane; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:membrane; C:postsynapse; C:presynaptic endosome; C:terminal bouton;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:endosome to melanosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of NK T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to membrane; P:protein targeting to vacuole; P:regulation of sequestering of zinc ion; P:synaptic vesicle budding from endosome; P:synaptic vesicle membrane organization;|O14617 O00202 O75262 Q59HF5 Q96G11 Q9H3C6,AP-3 complex subunit delta-1,AP-3 complex subunit delta;Adaptor-related protein complex 3 subunit delta-1;Delta-adaptin;, PF01602;PF06375;, GO:0030123;GO:1904115;GO:0010008;GO:0098978;GO:0005794;GO:0000139;GO:0005765;GO:0016020;GO:0098794;GO:0098830;GO:0043195;GO:0008089;GO:0048490;GO:0048007;GO:0035646;GO:0006896;GO:0006886;GO:0032438;GO:0098943;GO:0051138;GO:0045944;GO:0072657;GO:0006623;GO:0061088;GO:0016182;GO:0048499;, C:AP-3 adaptor complex; C:axon cytoplasm; C:endosome membrane; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:membrane; C:postsynapse; C:presynaptic endosome; C:terminal bouton;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:endosome to melanosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of NK T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to membrane; P:protein targeting to vacuole; P:regulation of sequestering of zinc ion; P:synaptic vesicle budding from endosome; P:synaptic vesicle membrane organization;|O14617 O00202 O75262 Q59HF5 Q96G11 Q9H3C6,AP-3 complex subunit delta-1,AP-3 complex subunit delta;Adaptor-related protein complex 3 subunit delta-1;Delta-adaptin;, PF01602;PF06375;, GO:0030123;GO:1904115;GO:0010008;GO:0098978;GO:0005794;GO:0000139;GO:0005765;GO:0016020;GO:0098794;GO:0098830;GO:0043195;GO:0008089;GO:0048490;GO:0048007;GO:0035646;GO:0006896;GO:0006886;GO:0032438;GO:0098943;GO:0051138;GO:0045944;GO:0072657;GO:0006623;GO:0061088;GO:0016182;GO:0048499;, C:AP-3 adaptor complex; C:axon cytoplasm; C:endosome membrane; C:glutamatergic synapse; C:Golgi apparatus; C:Golgi membrane; C:lysosomal membrane; C:membrane; C:postsynapse; C:presynaptic endosome; C:terminal bouton;, , P:anterograde axonal transport; P:anterograde synaptic vesicle transport; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; P:endosome to melanosome transport; P:Golgi to vacuole transport; P:intracellular protein transport; P:melanosome organization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of NK T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:protein localization to membrane; P:protein targeting to vacuole; P:regulation of sequestering of zinc ion; P:synaptic vesicle budding from endosome; P:synaptic vesicle membrane organization;|Q1ZYL8 A7RA93 A7RA94 Q6UXA2 Q96FT6 Q96L02,Izumo sperm-egg fusion protein 4,Sperm 22 kDa protein c113;, PF15005;, GO:0005576;GO:0005634;, C:extracellular region; C:nucleus;|Q96BX8 B3KTF1 O75249 Q8TF69,MOB kinase activator 3A,MOB-LAK;Mob1 homolog 2A;Mps one binder kinase activator-like 2A;, PF03637;, GO:0046872;, , F:metal ion binding;|Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6,MAP kinase-interacting serine/threonine-protein kinase 2,MAP kinase signal-integrating kinase 2;, PF00069;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0007166;GO:0071243;GO:0097192;GO:0030097;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell surface receptor signaling pathway; P:cellular response to arsenic-containing substance; P:extrinsic apoptotic signaling pathway in absence of ligand; P:hemopoiesis; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation;|Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6,MAP kinase-interacting serine/threonine-protein kinase 2,MAP kinase signal-integrating kinase 2;, PF00069;, GO:0005737;GO:0016604;GO:0005654;GO:0005634;GO:0016605;GO:0005524;GO:0009931;GO:0005516;GO:0004683;GO:0046872;GO:0106310;GO:0004674;GO:0106311;GO:0007166;GO:0071243;GO:0097192;GO:0030097;GO:0035556;GO:0018105;GO:0046777;GO:0006468;GO:0006417;, C:cytoplasm; C:nuclear body; C:nucleoplasm; C:nucleus; C:PML body;, F:ATP binding; F:calcium-dependent protein serine/threonine kinase activity; F:calmodulin binding; F:calmodulin-dependent protein kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell surface receptor signaling pathway; P:cellular response to arsenic-containing substance; P:extrinsic apoptotic signaling pathway in absence of ligand; P:hemopoiesis; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of translation; scaffold265 indexed_genome mRNA 9976 17164 . + . ID=transcript_16391;Q9BZL4 B4DME2 Q59FK8 Q6ZPD1 Q7L8F7 Q96HW1 Q9H5H5 Q9NT00,Protein phosphatase 1 regulatory subunit 12C,Protein phosphatase 1 myosin-binding subunit of 85 kDa;, PF12796;PF15898;, GO:0005737;GO:0005856;GO:0004857;GO:0019208;GO:0019901;GO:0007165;, C:cytoplasm; C:cytoskeleton;, F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:signal transduction;|Q9BZL4 B4DME2 Q59FK8 Q6ZPD1 Q7L8F7 Q96HW1 Q9H5H5 Q9NT00,Protein phosphatase 1 regulatory subunit 12C,Protein phosphatase 1 myosin-binding subunit of 85 kDa;, PF12796;PF15898;, GO:0005737;GO:0005856;GO:0004857;GO:0019208;GO:0019901;GO:0007165;, C:cytoplasm; C:cytoskeleton;, F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:signal transduction;|Q9BZL4 B4DME2 Q59FK8 Q6ZPD1 Q7L8F7 Q96HW1 Q9H5H5 Q9NT00,Protein phosphatase 1 regulatory subunit 12C,Protein phosphatase 1 myosin-binding subunit of 85 kDa;, PF12796;PF15898;, GO:0005737;GO:0005856;GO:0004857;GO:0019208;GO:0019901;GO:0007165;, C:cytoplasm; C:cytoskeleton;, F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:signal transduction; scaffold265 indexed_genome mRNA 19095 31160 . - . ID=transcript_16392;Q8TE68 Q71RE2 Q8NC10 Q96BB7 Q9BSQ2 Q9GZQ2 Q9NXH0,Epidermal growth factor receptor kinase substrate 8-like protein 1,Epidermal growth factor receptor pathway substrate 8-related protein 1;, PF08416;PF18016;PF00018;, GO:0005829;GO:0070062;GO:0005886;GO:0032991;GO:0032587;GO:0003779;GO:0045296;GO:0042608;GO:1900029;GO:0050790;GO:0035023;GO:0007266;, C:cytosol; C:extracellular exosome; C:plasma membrane; C:protein-containing complex; C:ruffle membrane;, F:actin binding; F:cadherin binding; F:T cell receptor binding;, P:positive regulation of ruffle assembly; P:regulation of catalytic activity; P:regulation of Rho protein signal transduction; P:Rho protein signal transduction;|Q8TE68 Q71RE2 Q8NC10 Q96BB7 Q9BSQ2 Q9GZQ2 Q9NXH0,Epidermal growth factor receptor kinase substrate 8-like protein 1,Epidermal growth factor receptor pathway substrate 8-related protein 1;, PF08416;PF18016;PF00018;, GO:0005829;GO:0070062;GO:0005886;GO:0032991;GO:0032587;GO:0003779;GO:0045296;GO:0042608;GO:1900029;GO:0050790;GO:0035023;GO:0007266;, C:cytosol; C:extracellular exosome; C:plasma membrane; C:protein-containing complex; C:ruffle membrane;, F:actin binding; F:cadherin binding; F:T cell receptor binding;, P:positive regulation of ruffle assembly; P:regulation of catalytic activity; P:regulation of Rho protein signal transduction; P:Rho protein signal transduction;|Q8TE68 Q71RE2 Q8NC10 Q96BB7 Q9BSQ2 Q9GZQ2 Q9NXH0,Epidermal growth factor receptor kinase substrate 8-like protein 1,Epidermal growth factor receptor pathway substrate 8-related protein 1;, PF08416;PF18016;PF00018;, GO:0005829;GO:0070062;GO:0005886;GO:0032991;GO:0032587;GO:0003779;GO:0045296;GO:0042608;GO:1900029;GO:0050790;GO:0035023;GO:0007266;, C:cytosol; C:extracellular exosome; C:plasma membrane; C:protein-containing complex; C:ruffle membrane;, F:actin binding; F:cadherin binding; F:T cell receptor binding;, P:positive regulation of ruffle assembly; P:regulation of catalytic activity; P:regulation of Rho protein signal transduction; P:Rho protein signal transduction; scaffold265 indexed_genome mRNA 43658 57449 . + . ID=transcript_16393;Q8NBN7 Q6UX79 Q96G88,Retinol dehydrogenase 13 {ECO:0000305},Short chain dehydrogenase/reductase family 7C member 3;, PF00106;, GO:0005743;GO:0052650;GO:0042462;GO:0009644;GO:0010842;GO:0042574;, C:mitochondrial inner membrane;, F:NADP-retinol dehydrogenase activity;, P:eye photoreceptor cell development; P:response to high light intensity; P:retina layer formation; P:retinal metabolic process;|Q8NBN7 Q6UX79 Q96G88,Retinol dehydrogenase 13 {ECO:0000305},Short chain dehydrogenase/reductase family 7C member 3;, PF00106;, GO:0005743;GO:0052650;GO:0042462;GO:0009644;GO:0010842;GO:0042574;, C:mitochondrial inner membrane;, F:NADP-retinol dehydrogenase activity;, P:eye photoreceptor cell development; P:response to high light intensity; P:retina layer formation; P:retinal metabolic process; scaffold265 indexed_genome mRNA 200534 207427 . - . ID=transcript_16394;Q53X39 Q92587 Q92588 Q92590 Q92592 Q92593 Q9UEK0,Immunoglobulin alpha Fc receptor,, , GO:0005576;GO:0101003;GO:0005887;GO:0005886;GO:0035579;GO:0070821;GO:0019862;GO:0019766;GO:0097011;GO:0035457;GO:0071346;GO:0071354;GO:0071222;GO:0071356;GO:0038093;GO:0006955;GO:0042119;GO:0043312;GO:0002446;GO:0033031;GO:1903209;, C:extracellular region; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:plasma membrane; C:specific granule membrane; C:tertiary granule membrane;, F:IgA binding; F:IgA receptor activity;, P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to interferon-alpha; P:cellular response to interferon-gamma; P:cellular response to interleukin-6; P:cellular response to lipopolysaccharide; P:cellular response to tumor necrosis factor; P:Fc receptor signaling pathway; P:immune response; P:neutrophil activation; P:neutrophil degranulation; P:neutrophil mediated immunity; P:positive regulation of neutrophil apoptotic process; P:positive regulation of oxidative stress-induced cell death; scaffold265 indexed_genome mRNA 231303 232658 . - . ID=transcript_16395;P43630 Q13238 Q14947 Q14948 Q92684 Q95366 Q95367 Q95368,Killer cell immunoglobulin-like receptor 3DL2,CD158 antigen-like family member K;MHC class I NK cell receptor;Natural killer-associated transcript 4;p70 natural killer cell receptor clone CL-5;, PF00047;, GO:0005887;GO:0005886;GO:0023029;GO:0006968;GO:1901215;GO:0050776;, C:integral component of plasma membrane; C:plasma membrane;, F:MHC class Ib protein binding;, P:cellular defense response; P:negative regulation of neuron death; P:regulation of immune response; scaffold266 indexed_genome mRNA 163501 164223 . + . ID=transcript_16396;Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport; scaffold266 indexed_genome mRNA 168403 171325 . + . ID=transcript_16397;Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport; scaffold266 indexed_genome mRNA 199540 201138 . - . ID=transcript_16398;Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport; scaffold266 indexed_genome mRNA 205703 248689 . - . ID=transcript_16399;Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport; scaffold266 indexed_genome mRNA 249556 258995 . + . ID=transcript_16400;O95427 Q7L8F8 Q8TC01 Q9NT05,GPI ethanolamine phosphate transferase 1,MCD4 homolog;Phosphatidylinositol-glycan biosynthesis class N protein;, PF01663;PF04987;, GO:0005829;GO:0005789;GO:0016021;GO:0016020;GO:0005886;GO:0051377;GO:0006506;GO:0016254;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:plasma membrane;, F:mannose-ethanolamine phosphotransferase activity;, P:GPI anchor biosynthetic process; P:preassembly of GPI anchor in ER membrane; scaffold267 indexed_genome mRNA 53773 57507 . - . ID=transcript_16401;P57073 Q9NZW2,Transcription factor SOX-8,, PF00505;PF12444;, GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0003677;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0060612;GO:0060018;GO:0045165;GO:0048469;GO:0048484;GO:0045444;GO:0001701;GO:0008584;GO:0072289;GO:0061138;GO:0002009;GO:0043066;GO:0045662;GO:0046533;GO:0000122;GO:0045892;GO:0014032;GO:0001755;GO:0048709;GO:0001649;GO:0007422;GO:0090190;GO:0014015;GO:0090184;GO:0033690;GO:0045944;GO:0045893;GO:0010817;GO:0006357;GO:0072034;GO:0060041;GO:0060221;GO:0060009;GO:0007165;GO:0035914;GO:0007283;GO:0072197;, C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:adipose tissue development; P:astrocyte fate commitment; P:cell fate commitment; P:cell maturation; P:enteric nervous system development; P:fat cell differentiation; P:in utero embryonic development; P:male gonad development; P:metanephric nephron tubule formation; P:morphogenesis of a branching epithelium; P:morphogenesis of an epithelium; P:negative regulation of apoptotic process; P:negative regulation of myoblast differentiation; P:negative regulation of photoreceptor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural crest cell development; P:neural crest cell migration; P:oligodendrocyte differentiation; P:osteoblast differentiation; P:peripheral nervous system development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of gliogenesis; P:positive regulation of kidney development; P:positive regulation of osteoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of hormone levels; P:regulation of transcription by RNA polymerase II; P:renal vesicle induction; P:retina development in camera-type eye; P:retinal rod cell differentiation; P:Sertoli cell development; P:signal transduction; P:skeletal muscle cell differentiation; P:spermatogenesis; P:ureter morphogenesis;|P57073 Q9NZW2,Transcription factor SOX-8,, PF00505;PF12444;, GO:0000785;GO:0005737;GO:0005634;GO:0005667;GO:0003677;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0060612;GO:0060018;GO:0045165;GO:0048469;GO:0048484;GO:0045444;GO:0001701;GO:0008584;GO:0072289;GO:0061138;GO:0002009;GO:0043066;GO:0045662;GO:0046533;GO:0000122;GO:0045892;GO:0014032;GO:0001755;GO:0048709;GO:0001649;GO:0007422;GO:0090190;GO:0014015;GO:0090184;GO:0033690;GO:0045944;GO:0045893;GO:0010817;GO:0006357;GO:0072034;GO:0060041;GO:0060221;GO:0060009;GO:0007165;GO:0035914;GO:0007283;GO:0072197;, C:chromatin; C:cytoplasm; C:nucleus; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:adipose tissue development; P:astrocyte fate commitment; P:cell fate commitment; P:cell maturation; P:enteric nervous system development; P:fat cell differentiation; P:in utero embryonic development; P:male gonad development; P:metanephric nephron tubule formation; P:morphogenesis of a branching epithelium; P:morphogenesis of an epithelium; P:negative regulation of apoptotic process; P:negative regulation of myoblast differentiation; P:negative regulation of photoreceptor cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural crest cell development; P:neural crest cell migration; P:oligodendrocyte differentiation; P:osteoblast differentiation; P:peripheral nervous system development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of gliogenesis; P:positive regulation of kidney development; P:positive regulation of osteoblast proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of hormone levels; P:regulation of transcription by RNA polymerase II; P:renal vesicle induction; P:retina development in camera-type eye; P:retinal rod cell differentiation; P:Sertoli cell development; P:signal transduction; P:skeletal muscle cell differentiation; P:spermatogenesis; P:ureter morphogenesis; scaffold267 indexed_genome mRNA 109171 113930 . - . ID=transcript_16402;Q96S06 B3KS80 Q68CJ3 Q96FJ4 Q9H6G4 Q9H9K7,Lipase maturation factor 1,Transmembrane protein 112;, PF06762;, GO:0005789;GO:0016021;GO:0051604;GO:0051004;GO:0006641;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:protein maturation; P:regulation of lipoprotein lipase activity; P:triglyceride metabolic process; scaffold267 indexed_genome mRNA 117978 119557 . - . ID=transcript_16403;Q96S06 B3KS80 Q68CJ3 Q96FJ4 Q9H6G4 Q9H9K7,Lipase maturation factor 1,Transmembrane protein 112;, PF06762;, GO:0005789;GO:0016021;GO:0051604;GO:0051004;GO:0006641;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:protein maturation; P:regulation of lipoprotein lipase activity; P:triglyceride metabolic process; scaffold267 indexed_genome mRNA 130485 131538 . + . ID=transcript_16404;Q96S06 B3KS80 Q68CJ3 Q96FJ4 Q9H6G4 Q9H9K7,Lipase maturation factor 1,Transmembrane protein 112;, PF06762;, GO:0005789;GO:0016021;GO:0051604;GO:0051004;GO:0006641;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:protein maturation; P:regulation of lipoprotein lipase activity; P:triglyceride metabolic process; scaffold267 indexed_genome mRNA 181039 183474 . + . ID=transcript_16405;Q9P2W3 B2R5C8 Q52LX0 Q9UJJ3,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13,, PF00631;, GO:0030425;GO:0005834;GO:0005886;GO:0031681;GO:0007200;GO:0050909;, C:dendrite; C:heterotrimeric G-protein complex; C:plasma membrane;, F:G-protein beta-subunit binding;, P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:sensory perception of taste; scaffold267 indexed_genome mRNA 191516 193856 . + . ID=transcript_16406;Q9UJJ7 D3DU66,RNA pseudouridylate synthase domain-containing protein 1,Ribosomal large subunit pseudouridine synthase C-like protein;, PF00849;, GO:0009982;GO:0003723;GO:0000455;, , F:pseudouridine synthase activity; F:RNA binding;, P:enzyme-directed rRNA pseudouridine synthesis; scaffold267 indexed_genome mRNA 206778 210458 . - . ID=transcript_16407;Q9UK57,Mesothelin,CAK1 antigen;Pre-pro-megakaryocyte-potentiating factor;, PF06060;, GO:0031225;GO:0009986;GO:0005788;GO:0005576;GO:0005615;GO:0005794;GO:0016020;GO:0005886;GO:0007155;GO:0007160;GO:0044267;GO:0031016;GO:0043687;, C:anchored component of membrane; C:cell surface; C:endoplasmic reticulum lumen; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:membrane; C:plasma membrane;, , P:cell adhesion; P:cell-matrix adhesion; P:cellular protein metabolic process; P:pancreas development; P:post-translational protein modification; scaffold267 indexed_genome mRNA 223531 264193 . + . ID=transcript_16408;Q9H6Q4 A1L385 B3KTJ3 Q53GC6 Q96S10 Q9H6J8,Cytosolic iron-sulfur assembly component 3 {ECO:0000305},Cytosolic Fe-S cluster assembly factor NARFL;Iron-only hydrogenase-like protein 1 {ECO:0000303|PubMed:16956324};Nuclear prelamin A recognition factor-like protein;Protein related to Narf;, PF02906;PF02256;, GO:0097361;GO:0051539;GO:0046872;GO:0002244;GO:0016226;GO:0032364;GO:0010468;GO:0001666;, C:CIA complex;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding;, P:hematopoietic progenitor cell differentiation; P:iron-sulfur cluster assembly; P:oxygen homeostasis; P:regulation of gene expression; P:response to hypoxia;|Q9H6Q4 A1L385 B3KTJ3 Q53GC6 Q96S10 Q9H6J8,Cytosolic iron-sulfur assembly component 3 {ECO:0000305},Cytosolic Fe-S cluster assembly factor NARFL;Iron-only hydrogenase-like protein 1 {ECO:0000303|PubMed:16956324};Nuclear prelamin A recognition factor-like protein;Protein related to Narf;, PF02906;PF02256;, GO:0097361;GO:0051539;GO:0046872;GO:0002244;GO:0016226;GO:0032364;GO:0010468;GO:0001666;, C:CIA complex;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding;, P:hematopoietic progenitor cell differentiation; P:iron-sulfur cluster assembly; P:oxygen homeostasis; P:regulation of gene expression; P:response to hypoxia;|Q9H6Q4 A1L385 B3KTJ3 Q53GC6 Q96S10 Q9H6J8,Cytosolic iron-sulfur assembly component 3 {ECO:0000305},Cytosolic Fe-S cluster assembly factor NARFL;Iron-only hydrogenase-like protein 1 {ECO:0000303|PubMed:16956324};Nuclear prelamin A recognition factor-like protein;Protein related to Narf;, PF02906;PF02256;, GO:0097361;GO:0051539;GO:0046872;GO:0002244;GO:0016226;GO:0032364;GO:0010468;GO:0001666;, C:CIA complex;, F:4 iron, 4 sulfur cluster binding; F:metal ion binding;, P:hematopoietic progenitor cell differentiation; P:iron-sulfur cluster assembly; P:oxygen homeostasis; P:regulation of gene expression; P:response to hypoxia;|Q6PII5 A6NCC4 D3DU64 Q59FX8 Q96BZ3 Q96NR5 Q96S11 Q9BT45,Hydroxyacylglutathione hydrolase-like protein,, PF00753;, GO:0016787;GO:0046872;, , F:hydrolase activity; F:metal ion binding;|Q96S12,Coiled-coil domain-containing protein 78,hsCCDC78;, PF14739;, GO:0005814;GO:0098536;GO:0048471;GO:0042383;GO:0016529;GO:0030030;GO:0098535;GO:0003009;, C:centriole; C:deuterosome; C:perinuclear region of cytoplasm; C:sarcolemma; C:sarcoplasmic reticulum;, , P:cell projection organization; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:skeletal muscle contraction;|Q8N461 B3KR59 D3DU60 Q2MHR2 Q96S14 Q9UJI0,F-box/LRR-repeat protein 16,F-box and leucine-rich repeat protein 16;, PF13516;, GO:0005829;GO:0019005;GO:0043687;GO:0000209;GO:0031146;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;|Q96S12,Coiled-coil domain-containing protein 78,hsCCDC78;, PF14739;, GO:0005814;GO:0098536;GO:0048471;GO:0042383;GO:0016529;GO:0030030;GO:0098535;GO:0003009;, C:centriole; C:deuterosome; C:perinuclear region of cytoplasm; C:sarcolemma; C:sarcoplasmic reticulum;, , P:cell projection organization; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:skeletal muscle contraction;|Q96S12,Coiled-coil domain-containing protein 78,hsCCDC78;, PF14739;, GO:0005814;GO:0098536;GO:0048471;GO:0042383;GO:0016529;GO:0030030;GO:0098535;GO:0003009;, C:centriole; C:deuterosome; C:perinuclear region of cytoplasm; C:sarcolemma; C:sarcoplasmic reticulum;, , P:cell projection organization; P:de novo centriole assembly involved in multi-ciliated epithelial cell differentiation; P:skeletal muscle contraction;|Q9UJH8 Q9UJH9,Meteorin,, , GO:0005615;GO:0005179;GO:0010001;GO:0050772;, C:extracellular space;, F:hormone activity;, P:glial cell differentiation; P:positive regulation of axonogenesis; scaffold267 indexed_genome mRNA 264408 270452 . + . ID=transcript_16409;Q96S15 A2IDB8 D3DU59 Q96GC7 Q9H0B7,GATOR complex protein WDR24 {ECO:0000305},WD repeat-containing protein 24 {ECO:0000312|HGNC:HGNC:20852};, PF00400;, GO:0005829;GO:0061700;GO:0043231;GO:0005765;GO:0006914;GO:0034198;GO:0032008;GO:0010506;, C:cytosol; C:GATOR2 complex; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, , P:autophagy; P:cellular response to amino acid starvation; P:positive regulation of TOR signaling; P:regulation of autophagy;|Q96S15 A2IDB8 D3DU59 Q96GC7 Q9H0B7,GATOR complex protein WDR24 {ECO:0000305},WD repeat-containing protein 24 {ECO:0000312|HGNC:HGNC:20852};, PF00400;, GO:0005829;GO:0061700;GO:0043231;GO:0005765;GO:0006914;GO:0034198;GO:0032008;GO:0010506;, C:cytosol; C:GATOR2 complex; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, , P:autophagy; P:cellular response to amino acid starvation; P:positive regulation of TOR signaling; P:regulation of autophagy;|Q96S15 A2IDB8 D3DU59 Q96GC7 Q9H0B7,GATOR complex protein WDR24 {ECO:0000305},WD repeat-containing protein 24 {ECO:0000312|HGNC:HGNC:20852};, PF00400;, GO:0005829;GO:0061700;GO:0043231;GO:0005765;GO:0006914;GO:0034198;GO:0032008;GO:0010506;, C:cytosol; C:GATOR2 complex; C:intracellular membrane-bounded organelle; C:lysosomal membrane;, , P:autophagy; P:cellular response to amino acid starvation; P:positive regulation of TOR signaling; P:regulation of autophagy; scaffold267 indexed_genome mRNA 270527 276454 . + . ID=transcript_16410;Q96S16 B2RNS7 D3DU58 Q4PKE3 Q4VBY1 Q6GMW5 Q71RB8,JmjC domain-containing protein 8 {ECO:0000305},Jumonji domain-containing protein 8;, PF13621;, GO:0005737;GO:0005783;GO:0005788;GO:0005634;GO:0043123;GO:1903672;GO:0006110;GO:1903302;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:nucleus;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of sprouting angiogenesis; P:regulation of glycolytic process; P:regulation of pyruvate kinase activity;|Q96S16 B2RNS7 D3DU58 Q4PKE3 Q4VBY1 Q6GMW5 Q71RB8,JmjC domain-containing protein 8 {ECO:0000305},Jumonji domain-containing protein 8;, PF13621;, GO:0005737;GO:0005783;GO:0005788;GO:0005634;GO:0043123;GO:1903672;GO:0006110;GO:1903302;, C:cytoplasm; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:nucleus;, , P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of sprouting angiogenesis; P:regulation of glycolytic process; P:regulation of pyruvate kinase activity;|Q9UNE7 A2IDB9 O60526 Q969U2 Q9HBT1,E3 ubiquitin-protein ligase CHIP {ECO:0000305},Antigen NY-CO-7 {ECO:0000303|PubMed:9610721};CLL-associated antigen KW-8 {ECO:0000303|PubMed:12200376};Carboxy terminus of Hsp70-interacting protein {ECO:0000303|PubMed:10330192};RING-type E3 ubiquitin transferase CHIP {ECO:0000305};STIP1 homology and U box-containing protein 1 {ECO:0000312|HGNC:HGNC:11427};, PF18391;PF04564;, GO:0101031;GO:0005737;GO:0005829;GO:0005783;GO:0042405;GO:0005654;GO:0005634;GO:0031371;GO:0000151;GO:0030018;GO:0051087;GO:0019899;GO:0001664;GO:0031072;GO:0030544;GO:0051879;GO:0019900;GO:0051787;GO:0042803;GO:0030674;GO:0046332;GO:0048156;GO:0030911;GO:0061630;GO:0031625;GO:0004842;GO:0034450;GO:0034605;GO:0071456;GO:0071218;GO:0061684;GO:0006281;GO:0030968;GO:0038128;GO:0032091;GO:0030512;GO:0090035;GO:0032436;GO:0031398;GO:0045862;GO:0051443;GO:0043161;GO:0051865;GO:0070534;GO:0051604;GO:0000209;GO:0006515;GO:0016567;GO:0031943;GO:0060544;GO:0031647;GO:0002931;GO:0030433;GO:0006511;GO:0030579;, C:chaperone complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear inclusion body; C:nucleoplasm; C:nucleus; C:ubiquitin conjugating enzyme complex; C:ubiquitin ligase complex; C:Z disc;, F:chaperone binding; F:enzyme binding; F:G protein-coupled receptor binding; F:heat shock protein binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:kinase binding; F:misfolded protein binding; F:protein homodimerization activity; F:protein-macromolecule adaptor activity; F:SMAD binding; F:tau protein binding; F:TPR domain binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:ubiquitin-ubiquitin ligase activity;, P:cellular response to heat; P:cellular response to hypoxia; P:cellular response to misfolded protein; P:chaperone-mediated autophagy; P:DNA repair; P:endoplasmic reticulum unfolded protein response; P:ERBB2 signaling pathway; P:negative regulation of protein binding; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of chaperone-mediated protein complex assembly; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:positive regulation of proteolysis; P:positive regulation of ubiquitin-protein transferase activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K63-linked ubiquitination; P:protein maturation; P:protein polyubiquitination; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein ubiquitination; P:regulation of glucocorticoid metabolic process; P:regulation of necroptotic process; P:regulation of protein stability; P:response to ischemia; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process;|Q9UNE7 A2IDB9 O60526 Q969U2 Q9HBT1,E3 ubiquitin-protein ligase CHIP {ECO:0000305},Antigen NY-CO-7 {ECO:0000303|PubMed:9610721};CLL-associated antigen KW-8 {ECO:0000303|PubMed:12200376};Carboxy terminus of Hsp70-interacting protein {ECO:0000303|PubMed:10330192};RING-type E3 ubiquitin transferase CHIP {ECO:0000305};STIP1 homology and U box-containing protein 1 {ECO:0000312|HGNC:HGNC:11427};, PF18391;PF04564;, GO:0101031;GO:0005737;GO:0005829;GO:0005783;GO:0042405;GO:0005654;GO:0005634;GO:0031371;GO:0000151;GO:0030018;GO:0051087;GO:0019899;GO:0001664;GO:0031072;GO:0030544;GO:0051879;GO:0019900;GO:0051787;GO:0042803;GO:0030674;GO:0046332;GO:0048156;GO:0030911;GO:0061630;GO:0031625;GO:0004842;GO:0034450;GO:0034605;GO:0071456;GO:0071218;GO:0061684;GO:0006281;GO:0030968;GO:0038128;GO:0032091;GO:0030512;GO:0090035;GO:0032436;GO:0031398;GO:0045862;GO:0051443;GO:0043161;GO:0051865;GO:0070534;GO:0051604;GO:0000209;GO:0006515;GO:0016567;GO:0031943;GO:0060544;GO:0031647;GO:0002931;GO:0030433;GO:0006511;GO:0030579;, C:chaperone complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear inclusion body; C:nucleoplasm; C:nucleus; C:ubiquitin conjugating enzyme complex; C:ubiquitin ligase complex; C:Z disc;, F:chaperone binding; F:enzyme binding; F:G protein-coupled receptor binding; F:heat shock protein binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:kinase binding; F:misfolded protein binding; F:protein homodimerization activity; F:protein-macromolecule adaptor activity; F:SMAD binding; F:tau protein binding; F:TPR domain binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:ubiquitin-ubiquitin ligase activity;, P:cellular response to heat; P:cellular response to hypoxia; P:cellular response to misfolded protein; P:chaperone-mediated autophagy; P:DNA repair; P:endoplasmic reticulum unfolded protein response; P:ERBB2 signaling pathway; P:negative regulation of protein binding; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of chaperone-mediated protein complex assembly; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:positive regulation of proteolysis; P:positive regulation of ubiquitin-protein transferase activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K63-linked ubiquitination; P:protein maturation; P:protein polyubiquitination; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein ubiquitination; P:regulation of glucocorticoid metabolic process; P:regulation of necroptotic process; P:regulation of protein stability; P:response to ischemia; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process;|Q9UNE7 A2IDB9 O60526 Q969U2 Q9HBT1,E3 ubiquitin-protein ligase CHIP {ECO:0000305},Antigen NY-CO-7 {ECO:0000303|PubMed:9610721};CLL-associated antigen KW-8 {ECO:0000303|PubMed:12200376};Carboxy terminus of Hsp70-interacting protein {ECO:0000303|PubMed:10330192};RING-type E3 ubiquitin transferase CHIP {ECO:0000305};STIP1 homology and U box-containing protein 1 {ECO:0000312|HGNC:HGNC:11427};, PF18391;PF04564;, GO:0101031;GO:0005737;GO:0005829;GO:0005783;GO:0042405;GO:0005654;GO:0005634;GO:0031371;GO:0000151;GO:0030018;GO:0051087;GO:0019899;GO:0001664;GO:0031072;GO:0030544;GO:0051879;GO:0019900;GO:0051787;GO:0042803;GO:0030674;GO:0046332;GO:0048156;GO:0030911;GO:0061630;GO:0031625;GO:0004842;GO:0034450;GO:0034605;GO:0071456;GO:0071218;GO:0061684;GO:0006281;GO:0030968;GO:0038128;GO:0032091;GO:0030512;GO:0090035;GO:0032436;GO:0031398;GO:0045862;GO:0051443;GO:0043161;GO:0051865;GO:0070534;GO:0051604;GO:0000209;GO:0006515;GO:0016567;GO:0031943;GO:0060544;GO:0031647;GO:0002931;GO:0030433;GO:0006511;GO:0030579;, C:chaperone complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nuclear inclusion body; C:nucleoplasm; C:nucleus; C:ubiquitin conjugating enzyme complex; C:ubiquitin ligase complex; C:Z disc;, F:chaperone binding; F:enzyme binding; F:G protein-coupled receptor binding; F:heat shock protein binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:kinase binding; F:misfolded protein binding; F:protein homodimerization activity; F:protein-macromolecule adaptor activity; F:SMAD binding; F:tau protein binding; F:TPR domain binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:ubiquitin-ubiquitin ligase activity;, P:cellular response to heat; P:cellular response to hypoxia; P:cellular response to misfolded protein; P:chaperone-mediated autophagy; P:DNA repair; P:endoplasmic reticulum unfolded protein response; P:ERBB2 signaling pathway; P:negative regulation of protein binding; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of chaperone-mediated protein complex assembly; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:positive regulation of proteolysis; P:positive regulation of ubiquitin-protein transferase activity; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein autoubiquitination; P:protein K63-linked ubiquitination; P:protein maturation; P:protein polyubiquitination; P:protein quality control for misfolded or incompletely synthesized proteins; P:protein ubiquitination; P:regulation of glucocorticoid metabolic process; P:regulation of necroptotic process; P:regulation of protein stability; P:response to ischemia; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent SMAD protein catabolic process; scaffold267 indexed_genome mRNA 276465 300209 . - . ID=transcript_16411;O75783 A2IDC0 A2IDC1 Q0VAX4 Q9NQ85,Rhomboid-related protein 1,Rhomboid-like protein 1;, PF01694;, GO:0005887;GO:0016020;GO:0004252;GO:0007165;, C:integral component of plasma membrane; C:membrane;, F:serine-type endopeptidase activity;, P:signal transduction;|O75783 A2IDC0 A2IDC1 Q0VAX4 Q9NQ85,Rhomboid-related protein 1,Rhomboid-like protein 1;, PF01694;, GO:0005887;GO:0016020;GO:0004252;GO:0007165;, C:integral component of plasma membrane; C:membrane;, F:serine-type endopeptidase activity;, P:signal transduction;|Q8IXI1 A2IDC2 Q8NF53 Q96C13 Q96S17 Q9BT60 Q9H7M8,Mitochondrial Rho GTPase 2,Ras homolog gene family member T2;, PF08355;PF08356;PF00071;, GO:0005829;GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0005509;GO:0005525;GO:0003924;GO:0019725;GO:0097345;GO:0007005;GO:0047497;GO:0010821;GO:0051056;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:cellular homeostasis; P:mitochondrial outer membrane permeabilization; P:mitochondrion organization; P:mitochondrion transport along microtubule; P:regulation of mitochondrion organization; P:regulation of small GTPase mediated signal transduction;|Q8IXI1 A2IDC2 Q8NF53 Q96C13 Q96S17 Q9BT60 Q9H7M8,Mitochondrial Rho GTPase 2,Ras homolog gene family member T2;, PF08355;PF08356;PF00071;, GO:0005829;GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0005509;GO:0005525;GO:0003924;GO:0019725;GO:0097345;GO:0007005;GO:0047497;GO:0010821;GO:0051056;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:cellular homeostasis; P:mitochondrial outer membrane permeabilization; P:mitochondrion organization; P:mitochondrion transport along microtubule; P:regulation of mitochondrion organization; P:regulation of small GTPase mediated signal transduction;|Q8IXI1 A2IDC2 Q8NF53 Q96C13 Q96S17 Q9BT60 Q9H7M8,Mitochondrial Rho GTPase 2,Ras homolog gene family member T2;, PF08355;PF08356;PF00071;, GO:0005829;GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0005509;GO:0005525;GO:0003924;GO:0019725;GO:0097345;GO:0007005;GO:0047497;GO:0010821;GO:0051056;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:cellular homeostasis; P:mitochondrial outer membrane permeabilization; P:mitochondrion organization; P:mitochondrion transport along microtubule; P:regulation of mitochondrion organization; P:regulation of small GTPase mediated signal transduction;|Q8IXI1 A2IDC2 Q8NF53 Q96C13 Q96S17 Q9BT60 Q9H7M8,Mitochondrial Rho GTPase 2,Ras homolog gene family member T2;, PF08355;PF08356;PF00071;, GO:0005829;GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0005509;GO:0005525;GO:0003924;GO:0019725;GO:0097345;GO:0007005;GO:0047497;GO:0010821;GO:0051056;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:cellular homeostasis; P:mitochondrial outer membrane permeabilization; P:mitochondrion organization; P:mitochondrion transport along microtubule; P:regulation of mitochondrion organization; P:regulation of small GTPase mediated signal transduction;|Q8IXI1 A2IDC2 Q8NF53 Q96C13 Q96S17 Q9BT60 Q9H7M8,Mitochondrial Rho GTPase 2,Ras homolog gene family member T2;, PF08355;PF08356;PF00071;, GO:0005829;GO:0031307;GO:0016020;GO:0005741;GO:0005739;GO:0005509;GO:0005525;GO:0003924;GO:0019725;GO:0097345;GO:0007005;GO:0047497;GO:0010821;GO:0051056;, C:cytosol; C:integral component of mitochondrial outer membrane; C:membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:calcium ion binding; F:GTP binding; F:GTPase activity;, P:cellular homeostasis; P:mitochondrial outer membrane permeabilization; P:mitochondrion organization; P:mitochondrion transport along microtubule; P:regulation of mitochondrion organization; P:regulation of small GTPase mediated signal transduction;|Q96PW4 Q96S18,WD repeat-containing protein 90,, PF05018;PF00400;, GO:0005814;GO:0005737;GO:0060271;, C:centriole; C:cytoplasm;, , P:cilium assembly;|Q96PW4 Q96S18,WD repeat-containing protein 90,, PF05018;PF00400;, GO:0005814;GO:0005737;GO:0060271;, C:centriole; C:cytoplasm;, , P:cilium assembly; scaffold267 indexed_genome mRNA 301276 302511 . - . ID=transcript_16412;Q9BUT9 Q969E9 Q96KV8,MAPK regulated corepressor interacting protein 2,Protein FAM195A;, PF14799;, GO:0005737;GO:0010494;GO:0005634;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleus; scaffold267 indexed_genome mRNA 302544 305821 . - . ID=transcript_16413;Q9BUT9 Q969E9 Q96KV8,MAPK regulated corepressor interacting protein 2,Protein FAM195A;, PF14799;, GO:0005737;GO:0010494;GO:0005634;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleus; scaffold269 indexed_genome mRNA 4436 13810 . - . ID=transcript_16414;Q9HA65 B4DT12 B9A6L8 F5H1W7,TBC1 domain family member 17,, PF12068;PF00566;, GO:0005776;GO:0005829;GO:0055037;GO:0005096;GO:0090630;GO:0006914;GO:0006886;GO:0042147;, C:autophagosome; C:cytosol; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:autophagy; P:intracellular protein transport; P:retrograde transport, endosome to Golgi;|Q9HA65 B4DT12 B9A6L8 F5H1W7,TBC1 domain family member 17,, PF12068;PF00566;, GO:0005776;GO:0005829;GO:0055037;GO:0005096;GO:0090630;GO:0006914;GO:0006886;GO:0042147;, C:autophagosome; C:cytosol; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:autophagy; P:intracellular protein transport; P:retrograde transport, endosome to Golgi;|Q9HA65 B4DT12 B9A6L8 F5H1W7,TBC1 domain family member 17,, PF12068;PF00566;, GO:0005776;GO:0005829;GO:0055037;GO:0005096;GO:0090630;GO:0006914;GO:0006886;GO:0042147;, C:autophagosome; C:cytosol; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:autophagy; P:intracellular protein transport; P:retrograde transport, endosome to Golgi;|Q9HA65 B4DT12 B9A6L8 F5H1W7,TBC1 domain family member 17,, PF12068;PF00566;, GO:0005776;GO:0005829;GO:0055037;GO:0005096;GO:0090630;GO:0006914;GO:0006886;GO:0042147;, C:autophagosome; C:cytosol; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:autophagy; P:intracellular protein transport; P:retrograde transport, endosome to Golgi;|Q9HA65 B4DT12 B9A6L8 F5H1W7,TBC1 domain family member 17,, PF12068;PF00566;, GO:0005776;GO:0005829;GO:0055037;GO:0005096;GO:0090630;GO:0006914;GO:0006886;GO:0042147;, C:autophagosome; C:cytosol; C:recycling endosome;, F:GTPase activator activity;, P:activation of GTPase activity; P:autophagy; P:intracellular protein transport; P:retrograde transport, endosome to Golgi; scaffold269 indexed_genome mRNA 14098 15116 . - . ID=transcript_16415;Q96RQ9 Q1WMJ3 Q4GZN1 Q4GZN2 Q6P2Q3 Q8TEM5 Q96RQ8,L-amino-acid oxidase {ECO:0000305},Interleukin-4-induced protein 1 {ECO:0000303|PubMed:16029492};Protein Fig-1 {ECO:0000303|PubMed:12031486};, PF01593;, GO:0001669;GO:0005576;GO:0001772;GO:0005764;GO:0097225;GO:0001716;GO:0106329;GO:0016491;GO:0046592;GO:0002250;GO:0009063;GO:0006559;GO:0006558;GO:0050868;GO:0002841;GO:0042130;GO:0045591;GO:0045944;GO:0002819;GO:0045577;GO:0006569;GO:0019440;GO:0006572;, C:acrosomal vesicle; C:extracellular region; C:immunological synapse; C:lysosome; C:sperm midpiece;, F:L-amino-acid oxidase activity; F:L-phenylalaine oxidase activity; F:oxidoreductase activity; F:polyamine oxidase activity;, P:adaptive immune response; P:cellular amino acid catabolic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:negative regulation of T cell activation; P:negative regulation of T cell mediated immune response to tumor cell; P:negative regulation of T cell proliferation; P:positive regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of adaptive immune response; P:regulation of B cell differentiation; P:tryptophan catabolic process; P:tryptophan catabolic process to indole-3-acetate; P:tyrosine catabolic process; scaffold269 indexed_genome mRNA 15459 18667 . - . ID=transcript_16416;Q96RQ9 Q1WMJ3 Q4GZN1 Q4GZN2 Q6P2Q3 Q8TEM5 Q96RQ8,L-amino-acid oxidase {ECO:0000305},Interleukin-4-induced protein 1 {ECO:0000303|PubMed:16029492};Protein Fig-1 {ECO:0000303|PubMed:12031486};, PF01593;, GO:0001669;GO:0005576;GO:0001772;GO:0005764;GO:0097225;GO:0001716;GO:0106329;GO:0016491;GO:0046592;GO:0002250;GO:0009063;GO:0006559;GO:0006558;GO:0050868;GO:0002841;GO:0042130;GO:0045591;GO:0045944;GO:0002819;GO:0045577;GO:0006569;GO:0019440;GO:0006572;, C:acrosomal vesicle; C:extracellular region; C:immunological synapse; C:lysosome; C:sperm midpiece;, F:L-amino-acid oxidase activity; F:L-phenylalaine oxidase activity; F:oxidoreductase activity; F:polyamine oxidase activity;, P:adaptive immune response; P:cellular amino acid catabolic process; P:L-phenylalanine catabolic process; P:L-phenylalanine metabolic process; P:negative regulation of T cell activation; P:negative regulation of T cell mediated immune response to tumor cell; P:negative regulation of T cell proliferation; P:positive regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of adaptive immune response; P:regulation of B cell differentiation; P:tryptophan catabolic process; P:tryptophan catabolic process to indole-3-acetate; P:tyrosine catabolic process; scaffold269 indexed_genome mRNA 25595 28646 . - . ID=transcript_16417;P37198 B3KWU5 Q503A4 Q6GTM2 Q96C43 Q9NSL1,Nuclear pore glycoprotein p62,62 kDa nucleoporin;Nucleoporin Nup62;, PF05064;, GO:0005642;GO:0005813;GO:0005737;GO:0090543;GO:0043657;GO:0072686;GO:0005635;GO:0031965;GO:0005643;GO:0044613;GO:0005654;GO:1990904;GO:0000922;GO:0003682;GO:0030544;GO:0051879;GO:0019894;GO:0005543;GO:0044877;GO:0051425;GO:0042169;GO:0030159;GO:0017056;GO:0043130;GO:0007569;GO:0008219;GO:0007166;GO:0098534;GO:0007098;GO:0075733;GO:0007100;GO:0007080;GO:0006406;GO:0043066;GO:0008285;GO:0042059;GO:0043407;GO:0043069;GO:0046580;GO:0046601;GO:0045742;GO:0043123;GO:1903438;GO:0045840;GO:1904781;GO:0045893;GO:0006606;GO:0016925;GO:1900034;GO:0060964;GO:0006110;GO:0060236;GO:0042306;GO:0046578;GO:0009966;GO:0006405;GO:0007283;GO:0006409;GO:0019058;GO:0016032;GO:0019083;, C:annulate lamellae; C:centrosome; C:cytoplasm; C:Flemming body; C:host cell; C:mitotic spindle; C:nuclear envelope; C:nuclear membrane; C:nuclear pore; C:nuclear pore central transport channel; C:nucleoplasm; C:ribonucleoprotein complex; C:spindle pole;, F:chromatin binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:kinesin binding; F:phospholipid binding; F:protein-containing complex binding; F:PTB domain binding; F:SH2 domain binding; F:signaling receptor complex adaptor activity; F:structural constituent of nuclear pore; F:ubiquitin binding;, P:cell aging; P:cell death; P:cell surface receptor signaling pathway; P:centriole assembly; P:centrosome cycle; P:intracellular transport of virus; P:mitotic centrosome separation; P:mitotic metaphase plate congression; P:mRNA export from nucleus; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of MAP kinase activity; P:negative regulation of programmed cell death; P:negative regulation of Ras protein signal transduction; P:positive regulation of centriole replication; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of mitotic cytokinetic process; P:positive regulation of mitotic nuclear division; P:positive regulation of protein localization to centrosome; P:positive regulation of transcription, DNA-templated; P:protein import into nucleus; P:protein sumoylation; P:regulation of cellular response to heat; P:regulation of gene silencing by miRNA; P:regulation of glycolytic process; P:regulation of mitotic spindle organization; P:regulation of protein import into nucleus; P:regulation of Ras protein signal transduction; P:regulation of signal transduction; P:RNA export from nucleus; P:spermatogenesis; P:tRNA export from nucleus; P:viral life cycle; P:viral process; P:viral transcription; scaffold269 indexed_genome mRNA 47536 52307 . + . ID=transcript_16418;Q9Y2D1 B3KND3 Q9BSA1 Q9UNQ3,Cyclic AMP-dependent transcription factor ATF-5,Activating transcription factor 5;Transcription factor ATFx;, PF00170;, GO:0005813;GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0003682;GO:0001228;GO:0003700;GO:0000981;GO:0019900;GO:0000977;GO:0043565;GO:0000976;GO:0015631;GO:0021930;GO:0007623;GO:0045444;GO:0035264;GO:0043066;GO:1902750;GO:0008285;GO:0045892;GO:0021891;GO:0045944;GO:0045893;GO:0009791;GO:0046605;GO:0006357;GO:0006355;, C:centrosome; C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;, F:chromatin binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:kinase binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding; F:tubulin binding;, P:cerebellar granule cell precursor proliferation; P:circadian rhythm; P:fat cell differentiation; P:multicellular organism growth; P:negative regulation of apoptotic process; P:negative regulation of cell cycle G2/M phase transition; P:negative regulation of cell population proliferation; P:negative regulation of transcription, DNA-templated; P:olfactory bulb interneuron development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:post-embryonic development; P:regulation of centrosome cycle; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold269 indexed_genome mRNA 60362 116544 . + . ID=transcript_16419;Q08ET2 Q6UXG0,Sialic acid-binding Ig-like lectin 14,, PF08205;PF13895;PF07686;, GO:0101003;GO:0016021;GO:0005886;GO:0070821;GO:0030246;GO:0033691;GO:0007155;GO:0045087;GO:0043312;, C:ficolin-1-rich granule membrane; C:integral component of membrane; C:plasma membrane; C:tertiary granule membrane;, F:carbohydrate binding; F:sialic acid binding;, P:cell adhesion; P:innate immune response; P:neutrophil degranulation;|Q9Y336 Q6GTU4 Q9BYI9,Sialic acid-binding Ig-like lectin 9,CDw329;Protein FOAP-9;, PF07686;, GO:0005887;GO:0005886;GO:0030667;GO:0030246;GO:0033691;GO:0007155;GO:0007166;GO:0043312;GO:0050776;, C:integral component of plasma membrane; C:plasma membrane; C:secretory granule membrane;, F:carbohydrate binding; F:sialic acid binding;, P:cell adhesion; P:cell surface receptor signaling pathway; P:neutrophil degranulation; P:regulation of immune response;|Q96RL6,Sialic acid-binding Ig-like lectin 11,, PF07679;PF07686;, GO:0016021;GO:0005886;GO:0030246;GO:0019902;GO:0033691;GO:0007155;, C:integral component of membrane; C:plasma membrane;, F:carbohydrate binding; F:phosphatase binding; F:sialic acid binding;, P:cell adhesion;|Q96LC8,Sialic acid-binding Ig-like lectin 10,Siglec-like protein 2;, PF13895;PF07686;, GO:0005576;GO:0016021;GO:0005886;GO:0030246;GO:0019902;GO:0042169;GO:0033691;GO:0002250;GO:0007155;GO:0045087;GO:0106015;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:carbohydrate binding; F:phosphatase binding; F:SH2 domain binding; F:sialic acid binding;, P:adaptive immune response; P:cell adhesion; P:innate immune response; P:negative regulation of inflammatory response to wounding;|Q96RL6,Sialic acid-binding Ig-like lectin 11,, PF07679;PF07686;, GO:0016021;GO:0005886;GO:0030246;GO:0019902;GO:0033691;GO:0007155;, C:integral component of membrane; C:plasma membrane;, F:carbohydrate binding; F:phosphatase binding; F:sialic acid binding;, P:cell adhesion;|Q8IV63 A6NEG5 A8KA53 Q502Y2 Q9P2V8,Inactive serine/threonine-protein kinase VRK3,Serine/threonine-protein pseudokinase VRK3;Vaccinia-related kinase 3;, PF00069;PF13240;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0019903;GO:0004674;GO:0070373;GO:0018105;GO:0032516;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein phosphatase binding; F:protein serine/threonine kinase activity;, P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-serine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity;|Q8IV63 A6NEG5 A8KA53 Q502Y2 Q9P2V8,Inactive serine/threonine-protein kinase VRK3,Serine/threonine-protein pseudokinase VRK3;Vaccinia-related kinase 3;, PF00069;PF13240;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0019903;GO:0004674;GO:0070373;GO:0018105;GO:0032516;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein phosphatase binding; F:protein serine/threonine kinase activity;, P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-serine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity;|Q8IV63 A6NEG5 A8KA53 Q502Y2 Q9P2V8,Inactive serine/threonine-protein kinase VRK3,Serine/threonine-protein pseudokinase VRK3;Vaccinia-related kinase 3;, PF00069;PF13240;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0019903;GO:0004674;GO:0070373;GO:0018105;GO:0032516;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein phosphatase binding; F:protein serine/threonine kinase activity;, P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-serine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity;|Q8IV63 A6NEG5 A8KA53 Q502Y2 Q9P2V8,Inactive serine/threonine-protein kinase VRK3,Serine/threonine-protein pseudokinase VRK3;Vaccinia-related kinase 3;, PF00069;PF13240;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0019903;GO:0004674;GO:0070373;GO:0018105;GO:0032516;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein phosphatase binding; F:protein serine/threonine kinase activity;, P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-serine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity;|Q8IV63 A6NEG5 A8KA53 Q502Y2 Q9P2V8,Inactive serine/threonine-protein kinase VRK3,Serine/threonine-protein pseudokinase VRK3;Vaccinia-related kinase 3;, PF00069;PF13240;, GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0019903;GO:0004674;GO:0070373;GO:0018105;GO:0032516;, C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:protein phosphatase binding; F:protein serine/threonine kinase activity;, P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-serine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity;|Q8WTR7 A8K8T7 Q9ULS9 Q9Y4Q7,Zinc finger protein 473,Zinc finger protein 100 homolog;, PF01352;PF00096;, GO:0015030;GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0008334;GO:0006398;GO:0006357;GO:0006369;, C:Cajal body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:regulation of transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; scaffold269 indexed_genome mRNA 116610 121106 . + . ID=transcript_16420;Q8WTR7 A8K8T7 Q9ULS9 Q9Y4Q7,Zinc finger protein 473,Zinc finger protein 100 homolog;, PF01352;PF00096;, GO:0015030;GO:0005654;GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0008334;GO:0006398;GO:0006357;GO:0006369;, C:Cajal body; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:regulation of transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; scaffold269 indexed_genome mRNA 134803 149781 . - . ID=transcript_16421;Q99676 B2R715 O60792 Q8TBA9,Zinc finger protein 184,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0000978;GO:0008270;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:regulation of transcription by RNA polymerase II; scaffold269 indexed_genome mRNA 160373 161066 . - . ID=transcript_16422;Q6UXV1 Q5GRG3 Q5GRG4 Q6ZNM5 Q8NHR8,Izumo sperm-egg fusion protein 2,, PF15005;, GO:0016021;, C:integral component of membrane; scaffold269 indexed_genome mRNA 207400 288113 . + . ID=transcript_16423;Q9BW35 Q9H882,Myosin-14,Myosin heavy chain 14;Myosin heavy chain, non-muscle IIc;Non-muscle myosin heavy chain IIc;, PF00063;PF01576;, GO:0042641;GO:0005903;GO:0005829;GO:0070062;GO:0030426;GO:0016020;GO:0016460;GO:0097513;GO:0001725;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0030048;GO:0031032;GO:0070584;GO:0019228;GO:0008360;GO:0007605;GO:0003009;GO:0007519;GO:0071625;, C:actomyosin; C:brush border; C:cytosol; C:extracellular exosome; C:growth cone; C:membrane; C:myosin II complex; C:myosin II filament; C:stress fiber;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:actin filament-based movement; P:actomyosin structure organization; P:mitochondrion morphogenesis; P:neuronal action potential; P:regulation of cell shape; P:sensory perception of sound; P:skeletal muscle contraction; P:skeletal muscle tissue development; P:vocalization behavior;|Q9BW35 Q9H882,Myosin-14,Myosin heavy chain 14;Myosin heavy chain, non-muscle IIc;Non-muscle myosin heavy chain IIc;, PF00063;PF01576;, GO:0042641;GO:0005903;GO:0005829;GO:0070062;GO:0030426;GO:0016020;GO:0016460;GO:0097513;GO:0001725;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0030048;GO:0031032;GO:0070584;GO:0019228;GO:0008360;GO:0007605;GO:0003009;GO:0007519;GO:0071625;, C:actomyosin; C:brush border; C:cytosol; C:extracellular exosome; C:growth cone; C:membrane; C:myosin II complex; C:myosin II filament; C:stress fiber;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:actin filament-based movement; P:actomyosin structure organization; P:mitochondrion morphogenesis; P:neuronal action potential; P:regulation of cell shape; P:sensory perception of sound; P:skeletal muscle contraction; P:skeletal muscle tissue development; P:vocalization behavior;|Q9BW35 Q9H882,Myosin-14,Myosin heavy chain 14;Myosin heavy chain, non-muscle IIc;Non-muscle myosin heavy chain IIc;, PF00063;PF01576;, GO:0042641;GO:0005903;GO:0005829;GO:0070062;GO:0030426;GO:0016020;GO:0016460;GO:0097513;GO:0001725;GO:0051015;GO:0030898;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0030048;GO:0031032;GO:0070584;GO:0019228;GO:0008360;GO:0007605;GO:0003009;GO:0007519;GO:0071625;, C:actomyosin; C:brush border; C:cytosol; C:extracellular exosome; C:growth cone; C:membrane; C:myosin II complex; C:myosin II filament; C:stress fiber;, F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:actin filament-based movement; P:actomyosin structure organization; P:mitochondrion morphogenesis; P:neuronal action potential; P:regulation of cell shape; P:sensory perception of sound; P:skeletal muscle contraction; P:skeletal muscle tissue development; P:vocalization behavior; scaffold269 indexed_genome mRNA 296213 297394 . - . ID=transcript_16424;Q14003,Potassium voltage-gated channel subfamily C member 3,KSHIIID;Voltage-gated potassium channel subunit Kv3.3;, PF02214;PF00520;PF11404;, GO:0030424;GO:0005938;GO:0005856;GO:0032590;GO:0032591;GO:0016021;GO:0032809;GO:0043204;GO:0005886;GO:0045211;GO:0042734;GO:0008076;GO:0005251;GO:0005249;GO:0071805;GO:0051260;GO:0051262;GO:0034765;, C:axon; C:cell cortex; C:cytoskeleton; C:dendrite membrane; C:dendritic spine membrane; C:integral component of membrane; C:neuronal cell body membrane; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:presynaptic membrane; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:protein homooligomerization; P:protein tetramerization; P:regulation of ion transmembrane transport; scaffold270 indexed_genome mRNA 196491 203648 . + . ID=transcript_16425;Q9UC06,Zinc finger protein 70,Zinc finger protein N27C7-1;, PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold270 indexed_genome mRNA 240211 240756 . - . ID=transcript_16426;P0DOY3 A0A075B6L0 A0M8Q4 P0CG05 P0CG06 P80423,Immunoglobulin lambda constant 3 {ECO:0000303|PubMed:11872955, ECO:0000303|Ref.9},Ig lambda chain C region DOT {ECO:0000305|PubMed:7737190};Ig lambda chain C region NEWM {ECO:0000305|PubMed:4814727};Ig lambda-3 chain C regions {ECO:0000305};, PF07654;, GO:0072562;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0042571;GO:0005886;GO:0003823;GO:0034987;GO:0050853;GO:0006956;GO:0006958;GO:0042742;GO:0038095;GO:0038096;GO:0045087;GO:0050900;GO:0002862;GO:0008228;GO:0018149;GO:0006911;GO:0006910;GO:0050871;GO:0006898;GO:0030449;GO:0050776;, C:blood microparticle; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:immunoglobulin complex, circulating; C:plasma membrane;, F:antigen binding; F:immunoglobulin receptor binding;, P:B cell receptor signaling pathway; P:complement activation; P:complement activation, classical pathway; P:defense response to bacterium; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:innate immune response; P:leukocyte migration; P:negative regulation of inflammatory response to antigenic stimulus; P:opsonization; P:peptide cross-linking; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; P:receptor-mediated endocytosis; P:regulation of complement activation; P:regulation of immune response; scaffold270 indexed_genome mRNA 366649 375711 . + . ID=transcript_16427;Q86YH2,Zinc finger protein 280B,5'OY11.1;Suppressor of hairy wing homolog 2;Zinc finger protein 279;Zinc finger protein 632;, PF13836;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription, DNA-templated; scaffold271 indexed_genome mRNA 18280 25273 . + . ID=transcript_16428;Q8NEG7 A6X8I5,Protein DENND6B,DENN domain-containing protein 6B;, PF09794;, GO:0005829;GO:0055037;GO:0005085;, C:cytosol; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;|Q8NEG7 A6X8I5,Protein DENND6B,DENN domain-containing protein 6B;, PF09794;, GO:0005829;GO:0055037;GO:0005085;, C:cytosol; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;|Q8NEG7 A6X8I5,Protein DENND6B,DENN domain-containing protein 6B;, PF09794;, GO:0005829;GO:0055037;GO:0005085;, C:cytosol; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity;|Q8NEG7 A6X8I5,Protein DENND6B,DENN domain-containing protein 6B;, PF09794;, GO:0005829;GO:0055037;GO:0005085;, C:cytosol; C:recycling endosome;, F:guanyl-nucleotide exchange factor activity; scaffold271 indexed_genome mRNA 41799 56160 . + . ID=transcript_16429;O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance;|O15031 A6QRH0 Q7KZU3 Q9BSU7,Plexin-B2,MM1;, PF08337;PF01437;PF01403;PF01833;PF17960;, GO:0009986;GO:0070062;GO:0005887;GO:0002116;GO:0017154;GO:0007420;GO:1904861;GO:0007156;GO:0007162;GO:0001843;GO:0007405;GO:0050772;GO:0010976;GO:0045727;GO:0030334;GO:0008360;GO:0043087;GO:2001222;GO:0001932;GO:0071526;GO:1902287;, C:cell surface; C:extracellular exosome; C:integral component of plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity;, P:brain development; P:excitatory synapse assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of cell adhesion; P:neural tube closure; P:neuroblast proliferation; P:positive regulation of axonogenesis; P:positive regulation of neuron projection development; P:positive regulation of translation; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of neuron migration; P:regulation of protein phosphorylation; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; scaffold271 indexed_genome mRNA 57832 66705 . + . ID=transcript_16430;Q15759 A8K730 B0LPG1 B7Z630 E7ETQ1 L7RT27 O00284 O15472 Q2XNF2,Mitogen-activated protein kinase 11,Mitogen-activated protein kinase p38 beta;Stress-activated protein kinase 2b;p38-2;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0000187;GO:0060348;GO:0071347;GO:0098586;GO:0035556;GO:0060044;GO:0001649;GO:0010628;GO:0032735;GO:0051149;GO:0007265;GO:0051090;GO:0010468;GO:1901796;GO:0051403;GO:0048010;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:bone development; P:cellular response to interleukin-1; P:cellular response to virus; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell proliferation; P:osteoblast differentiation; P:positive regulation of gene expression; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:Ras protein signal transduction; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of signal transduction by p53 class mediator; P:stress-activated MAPK cascade; P:vascular endothelial growth factor receptor signaling pathway;|Q15759 A8K730 B0LPG1 B7Z630 E7ETQ1 L7RT27 O00284 O15472 Q2XNF2,Mitogen-activated protein kinase 11,Mitogen-activated protein kinase p38 beta;Stress-activated protein kinase 2b;p38-2;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0000187;GO:0060348;GO:0071347;GO:0098586;GO:0035556;GO:0060044;GO:0001649;GO:0010628;GO:0032735;GO:0051149;GO:0007265;GO:0051090;GO:0010468;GO:1901796;GO:0051403;GO:0048010;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:bone development; P:cellular response to interleukin-1; P:cellular response to virus; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell proliferation; P:osteoblast differentiation; P:positive regulation of gene expression; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:Ras protein signal transduction; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of signal transduction by p53 class mediator; P:stress-activated MAPK cascade; P:vascular endothelial growth factor receptor signaling pathway;|Q15759 A8K730 B0LPG1 B7Z630 E7ETQ1 L7RT27 O00284 O15472 Q2XNF2,Mitogen-activated protein kinase 11,Mitogen-activated protein kinase p38 beta;Stress-activated protein kinase 2b;p38-2;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0000187;GO:0060348;GO:0071347;GO:0098586;GO:0035556;GO:0060044;GO:0001649;GO:0010628;GO:0032735;GO:0051149;GO:0007265;GO:0051090;GO:0010468;GO:1901796;GO:0051403;GO:0048010;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:bone development; P:cellular response to interleukin-1; P:cellular response to virus; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell proliferation; P:osteoblast differentiation; P:positive regulation of gene expression; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:Ras protein signal transduction; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of signal transduction by p53 class mediator; P:stress-activated MAPK cascade; P:vascular endothelial growth factor receptor signaling pathway;|Q15759 A8K730 B0LPG1 B7Z630 E7ETQ1 L7RT27 O00284 O15472 Q2XNF2,Mitogen-activated protein kinase 11,Mitogen-activated protein kinase p38 beta;Stress-activated protein kinase 2b;p38-2;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0000187;GO:0060348;GO:0071347;GO:0098586;GO:0035556;GO:0060044;GO:0001649;GO:0010628;GO:0032735;GO:0051149;GO:0007265;GO:0051090;GO:0010468;GO:1901796;GO:0051403;GO:0048010;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:bone development; P:cellular response to interleukin-1; P:cellular response to virus; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell proliferation; P:osteoblast differentiation; P:positive regulation of gene expression; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:Ras protein signal transduction; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of signal transduction by p53 class mediator; P:stress-activated MAPK cascade; P:vascular endothelial growth factor receptor signaling pathway;|Q15759 A8K730 B0LPG1 B7Z630 E7ETQ1 L7RT27 O00284 O15472 Q2XNF2,Mitogen-activated protein kinase 11,Mitogen-activated protein kinase p38 beta;Stress-activated protein kinase 2b;p38-2;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0000187;GO:0060348;GO:0071347;GO:0098586;GO:0035556;GO:0060044;GO:0001649;GO:0010628;GO:0032735;GO:0051149;GO:0007265;GO:0051090;GO:0010468;GO:1901796;GO:0051403;GO:0048010;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:bone development; P:cellular response to interleukin-1; P:cellular response to virus; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell proliferation; P:osteoblast differentiation; P:positive regulation of gene expression; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:Ras protein signal transduction; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of signal transduction by p53 class mediator; P:stress-activated MAPK cascade; P:vascular endothelial growth factor receptor signaling pathway;|Q15759 A8K730 B0LPG1 B7Z630 E7ETQ1 L7RT27 O00284 O15472 Q2XNF2,Mitogen-activated protein kinase 11,Mitogen-activated protein kinase p38 beta;Stress-activated protein kinase 2b;p38-2;, PF00069;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0004707;GO:0106310;GO:0106311;GO:0000187;GO:0060348;GO:0071347;GO:0098586;GO:0035556;GO:0060044;GO:0001649;GO:0010628;GO:0032735;GO:0051149;GO:0007265;GO:0051090;GO:0010468;GO:1901796;GO:0051403;GO:0048010;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;, F:ATP binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; P:bone development; P:cellular response to interleukin-1; P:cellular response to virus; P:intracellular signal transduction; P:negative regulation of cardiac muscle cell proliferation; P:osteoblast differentiation; P:positive regulation of gene expression; P:positive regulation of interleukin-12 production; P:positive regulation of muscle cell differentiation; P:Ras protein signal transduction; P:regulation of DNA-binding transcription factor activity; P:regulation of gene expression; P:regulation of signal transduction by p53 class mediator; P:stress-activated MAPK cascade; P:vascular endothelial growth factor receptor signaling pathway; scaffold271 indexed_genome mRNA 70935 72884 . - . ID=transcript_16431;P53778 Q14260 Q6IC53 Q99588 Q99672,Mitogen-activated protein kinase 12,Extracellular signal-regulated kinase 6;Mitogen-activated protein kinase p38 gamma;Stress-activated protein kinase 3;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0007050;GO:0006975;GO:0035556;GO:0000165;GO:0007517;GO:0045445;GO:0018105;GO:0051149;GO:0010952;GO:0010468;GO:0007165;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle arrest; P:DNA damage induced protein phosphorylation; P:intracellular signal transduction; P:MAPK cascade; P:muscle organ development; P:myoblast differentiation; P:peptidyl-serine phosphorylation; P:positive regulation of muscle cell differentiation; P:positive regulation of peptidase activity; P:regulation of gene expression; P:signal transduction;|P53778 Q14260 Q6IC53 Q99588 Q99672,Mitogen-activated protein kinase 12,Extracellular signal-regulated kinase 6;Mitogen-activated protein kinase p38 gamma;Stress-activated protein kinase 3;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0007050;GO:0006975;GO:0035556;GO:0000165;GO:0007517;GO:0045445;GO:0018105;GO:0051149;GO:0010952;GO:0010468;GO:0007165;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle arrest; P:DNA damage induced protein phosphorylation; P:intracellular signal transduction; P:MAPK cascade; P:muscle organ development; P:myoblast differentiation; P:peptidyl-serine phosphorylation; P:positive regulation of muscle cell differentiation; P:positive regulation of peptidase activity; P:regulation of gene expression; P:signal transduction; scaffold271 indexed_genome mRNA 73342 75894 . - . ID=transcript_16432;P53778 Q14260 Q6IC53 Q99588 Q99672,Mitogen-activated protein kinase 12,Extracellular signal-regulated kinase 6;Mitogen-activated protein kinase p38 gamma;Stress-activated protein kinase 3;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0007050;GO:0006975;GO:0035556;GO:0000165;GO:0007517;GO:0045445;GO:0018105;GO:0051149;GO:0010952;GO:0010468;GO:0007165;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle arrest; P:DNA damage induced protein phosphorylation; P:intracellular signal transduction; P:MAPK cascade; P:muscle organ development; P:myoblast differentiation; P:peptidyl-serine phosphorylation; P:positive regulation of muscle cell differentiation; P:positive regulation of peptidase activity; P:regulation of gene expression; P:signal transduction;|P53778 Q14260 Q6IC53 Q99588 Q99672,Mitogen-activated protein kinase 12,Extracellular signal-regulated kinase 6;Mitogen-activated protein kinase p38 gamma;Stress-activated protein kinase 3;, PF00069;, GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0007050;GO:0006975;GO:0035556;GO:0000165;GO:0007517;GO:0045445;GO:0018105;GO:0051149;GO:0010952;GO:0010468;GO:0007165;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:cell cycle arrest; P:DNA damage induced protein phosphorylation; P:intracellular signal transduction; P:MAPK cascade; P:muscle organ development; P:myoblast differentiation; P:peptidyl-serine phosphorylation; P:positive regulation of muscle cell differentiation; P:positive regulation of peptidase activity; P:regulation of gene expression; P:signal transduction; scaffold271 indexed_genome mRNA 77662 83714 . + . ID=transcript_16433;Q969S8 Q08AP4 Q6STF9 Q96P77 Q96P78 Q9H028 Q9UGX1 Q9UGX2,Polyamine deacetylase HDAC10,Histone deacetylase 10;, PF00850;, GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0047609;GO:0047611;GO:0019213;GO:0019899;GO:0004407;GO:0042826;GO:0033558;GO:0008270;GO:0006325;GO:0006281;GO:0016575;GO:0035825;GO:0016236;GO:0000122;GO:0045892;GO:0014003;GO:0034983;GO:0106047;GO:0032425;GO:0006476;GO:0006355;GO:0106048;GO:0006367;, C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:acetylputrescine deacetylase activity; F:acetylspermidine deacetylase activity; F:deacetylase activity; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:protein deacetylase activity; F:zinc ion binding;, P:chromatin organization; P:DNA repair; P:histone deacetylation; P:homologous recombination; P:macroautophagy; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:oligodendrocyte development; P:peptidyl-lysine deacetylation; P:polyamine deacetylation; P:positive regulation of mismatch repair; P:protein deacetylation; P:regulation of transcription, DNA-templated; P:spermidine deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q969S8 Q08AP4 Q6STF9 Q96P77 Q96P78 Q9H028 Q9UGX1 Q9UGX2,Polyamine deacetylase HDAC10,Histone deacetylase 10;, PF00850;, GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0047609;GO:0047611;GO:0019213;GO:0019899;GO:0004407;GO:0042826;GO:0033558;GO:0008270;GO:0006325;GO:0006281;GO:0016575;GO:0035825;GO:0016236;GO:0000122;GO:0045892;GO:0014003;GO:0034983;GO:0106047;GO:0032425;GO:0006476;GO:0006355;GO:0106048;GO:0006367;, C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:acetylputrescine deacetylase activity; F:acetylspermidine deacetylase activity; F:deacetylase activity; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:protein deacetylase activity; F:zinc ion binding;, P:chromatin organization; P:DNA repair; P:histone deacetylation; P:homologous recombination; P:macroautophagy; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:oligodendrocyte development; P:peptidyl-lysine deacetylation; P:polyamine deacetylation; P:positive regulation of mismatch repair; P:protein deacetylation; P:regulation of transcription, DNA-templated; P:spermidine deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q969S8 Q08AP4 Q6STF9 Q96P77 Q96P78 Q9H028 Q9UGX1 Q9UGX2,Polyamine deacetylase HDAC10,Histone deacetylase 10;, PF00850;, GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0047609;GO:0047611;GO:0019213;GO:0019899;GO:0004407;GO:0042826;GO:0033558;GO:0008270;GO:0006325;GO:0006281;GO:0016575;GO:0035825;GO:0016236;GO:0000122;GO:0045892;GO:0014003;GO:0034983;GO:0106047;GO:0032425;GO:0006476;GO:0006355;GO:0106048;GO:0006367;, C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:acetylputrescine deacetylase activity; F:acetylspermidine deacetylase activity; F:deacetylase activity; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:protein deacetylase activity; F:zinc ion binding;, P:chromatin organization; P:DNA repair; P:histone deacetylation; P:homologous recombination; P:macroautophagy; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:oligodendrocyte development; P:peptidyl-lysine deacetylation; P:polyamine deacetylation; P:positive regulation of mismatch repair; P:protein deacetylation; P:regulation of transcription, DNA-templated; P:spermidine deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q969S8 Q08AP4 Q6STF9 Q96P77 Q96P78 Q9H028 Q9UGX1 Q9UGX2,Polyamine deacetylase HDAC10,Histone deacetylase 10;, PF00850;, GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0047609;GO:0047611;GO:0019213;GO:0019899;GO:0004407;GO:0042826;GO:0033558;GO:0008270;GO:0006325;GO:0006281;GO:0016575;GO:0035825;GO:0016236;GO:0000122;GO:0045892;GO:0014003;GO:0034983;GO:0106047;GO:0032425;GO:0006476;GO:0006355;GO:0106048;GO:0006367;, C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:acetylputrescine deacetylase activity; F:acetylspermidine deacetylase activity; F:deacetylase activity; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:protein deacetylase activity; F:zinc ion binding;, P:chromatin organization; P:DNA repair; P:histone deacetylation; P:homologous recombination; P:macroautophagy; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:oligodendrocyte development; P:peptidyl-lysine deacetylation; P:polyamine deacetylation; P:positive regulation of mismatch repair; P:protein deacetylation; P:regulation of transcription, DNA-templated; P:spermidine deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q969S8 Q08AP4 Q6STF9 Q96P77 Q96P78 Q9H028 Q9UGX1 Q9UGX2,Polyamine deacetylase HDAC10,Histone deacetylase 10;, PF00850;, GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0047609;GO:0047611;GO:0019213;GO:0019899;GO:0004407;GO:0042826;GO:0033558;GO:0008270;GO:0006325;GO:0006281;GO:0016575;GO:0035825;GO:0016236;GO:0000122;GO:0045892;GO:0014003;GO:0034983;GO:0106047;GO:0032425;GO:0006476;GO:0006355;GO:0106048;GO:0006367;, C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:acetylputrescine deacetylase activity; F:acetylspermidine deacetylase activity; F:deacetylase activity; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:protein deacetylase activity; F:zinc ion binding;, P:chromatin organization; P:DNA repair; P:histone deacetylation; P:homologous recombination; P:macroautophagy; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:oligodendrocyte development; P:peptidyl-lysine deacetylation; P:polyamine deacetylation; P:positive regulation of mismatch repair; P:protein deacetylation; P:regulation of transcription, DNA-templated; P:spermidine deacetylation; P:transcription initiation from RNA polymerase II promoter;|Q969S8 Q08AP4 Q6STF9 Q96P77 Q96P78 Q9H028 Q9UGX1 Q9UGX2,Polyamine deacetylase HDAC10,Histone deacetylase 10;, PF00850;, GO:0005737;GO:0000118;GO:0005654;GO:0005634;GO:0047609;GO:0047611;GO:0019213;GO:0019899;GO:0004407;GO:0042826;GO:0033558;GO:0008270;GO:0006325;GO:0006281;GO:0016575;GO:0035825;GO:0016236;GO:0000122;GO:0045892;GO:0014003;GO:0034983;GO:0106047;GO:0032425;GO:0006476;GO:0006355;GO:0106048;GO:0006367;, C:cytoplasm; C:histone deacetylase complex; C:nucleoplasm; C:nucleus;, F:acetylputrescine deacetylase activity; F:acetylspermidine deacetylase activity; F:deacetylase activity; F:enzyme binding; F:histone deacetylase activity; F:histone deacetylase binding; F:protein deacetylase activity; F:zinc ion binding;, P:chromatin organization; P:DNA repair; P:histone deacetylation; P:homologous recombination; P:macroautophagy; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:oligodendrocyte development; P:peptidyl-lysine deacetylation; P:polyamine deacetylation; P:positive regulation of mismatch repair; P:protein deacetylation; P:regulation of transcription, DNA-templated; P:spermidine deacetylation; P:transcription initiation from RNA polymerase II promoter; scaffold271 indexed_genome mRNA 88251 91553 . + . ID=transcript_16434;O75962 D3DTD1 Q13458 Q59EQ7 Q6PJC9 Q6ZN05 Q8IWK8,Triple functional domain protein,PTPRF-interacting protein;, PF00650;PF07679;PF00169;PF00069;PF00621;PF00018;PF00435;, GO:0042995;GO:0005829;GO:0005524;GO:0005085;GO:0106310;GO:0004674;GO:0106311;GO:0007411;GO:0007417;GO:0007186;GO:0045599;GO:0048812;GO:0043065;GO:0051056;GO:0007185;, C:cell projection; C:cytosol;, F:ATP binding; F:guanyl-nucleotide exchange factor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:axon guidance; P:central nervous system development; P:G protein-coupled receptor signaling pathway; P:negative regulation of fat cell differentiation; P:neuron projection morphogenesis; P:positive regulation of apoptotic process; P:regulation of small GTPase mediated signal transduction; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; scaffold271 indexed_genome mRNA 94200 101173 . + . ID=transcript_16435;Q96RD6 B7Z684 Q96RD5 Q9UGX8,Pannexin-2,, PF00876;, GO:0005737;GO:0005921;GO:0016021;GO:0005886;GO:0005198;GO:0022829;GO:0006812;GO:0007267;GO:0032732;GO:0002931;, C:cytoplasm; C:gap junction; C:integral component of membrane; C:plasma membrane;, F:structural molecule activity; F:wide pore channel activity;, P:cation transport; P:cell-cell signaling; P:positive regulation of interleukin-1 production; P:response to ischemia; scaffold271 indexed_genome mRNA 111529 164937 . - . ID=transcript_16436;Q9UFB3 Q9UGX9,RNA helicase Mov10l1 {ECO:0000305},Moloney leukemia virus 10-like protein 1 {ECO:0000312|HGNC:HGNC:7201};, PF13086;PF13087;, GO:0005829;GO:0043186;GO:0071546;GO:0005524;GO:0000287;GO:0003723;GO:0003724;GO:0043046;GO:0007281;GO:0007141;GO:0007275;GO:0034587;GO:0035194;GO:0007283;, C:cytosol; C:P granule; C:pi-body;, F:ATP binding; F:magnesium ion binding; F:RNA binding; F:RNA helicase activity;, P:DNA methylation involved in gamete generation; P:germ cell development; P:male meiosis I; P:multicellular organism development; P:piRNA metabolic process; P:post-transcriptional gene silencing by RNA; P:spermatogenesis;|Q9UFB3 Q9UGX9,RNA helicase Mov10l1 {ECO:0000305},Moloney leukemia virus 10-like protein 1 {ECO:0000312|HGNC:HGNC:7201};, PF13086;PF13087;, GO:0005829;GO:0043186;GO:0071546;GO:0005524;GO:0000287;GO:0003723;GO:0003724;GO:0043046;GO:0007281;GO:0007141;GO:0007275;GO:0034587;GO:0035194;GO:0007283;, C:cytosol; C:P granule; C:pi-body;, F:ATP binding; F:magnesium ion binding; F:RNA binding; F:RNA helicase activity;, P:DNA methylation involved in gamete generation; P:germ cell development; P:male meiosis I; P:multicellular organism development; P:piRNA metabolic process; P:post-transcriptional gene silencing by RNA; P:spermatogenesis;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing;|Q9UFB3 Q9UGX9,RNA helicase Mov10l1 {ECO:0000305},Moloney leukemia virus 10-like protein 1 {ECO:0000312|HGNC:HGNC:7201};, PF13086;PF13087;, GO:0005829;GO:0043186;GO:0071546;GO:0005524;GO:0000287;GO:0003723;GO:0003724;GO:0043046;GO:0007281;GO:0007141;GO:0007275;GO:0034587;GO:0035194;GO:0007283;, C:cytosol; C:P granule; C:pi-body;, F:ATP binding; F:magnesium ion binding; F:RNA binding; F:RNA helicase activity;, P:DNA methylation involved in gamete generation; P:germ cell development; P:male meiosis I; P:multicellular organism development; P:piRNA metabolic process; P:post-transcriptional gene silencing by RNA; P:spermatogenesis; scaffold271 indexed_genome mRNA 169743 174820 . + . ID=transcript_16437;Q15049 B3KW61 B7Z659 Q5JZ83 Q8TAG4 Q96RP5 Q9UGY8,Membrane protein MLC1,, , GO:0016323;GO:0005901;GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0016021;GO:0005764;GO:0045121;GO:0048471;GO:0005886;GO:0055037;GO:0042802;GO:0044877;GO:0072584;GO:0071397;GO:0032388;GO:0015031;GO:0047484;GO:0016192;, C:basolateral plasma membrane; C:caveola; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:integral component of membrane; C:lysosome; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:protein-containing complex binding;, P:caveolin-mediated endocytosis; P:cellular response to cholesterol; P:positive regulation of intracellular transport; P:protein transport; P:regulation of response to osmotic stress; P:vesicle-mediated transport;|Q15049 B3KW61 B7Z659 Q5JZ83 Q8TAG4 Q96RP5 Q9UGY8,Membrane protein MLC1,, , GO:0016323;GO:0005901;GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0016021;GO:0005764;GO:0045121;GO:0048471;GO:0005886;GO:0055037;GO:0042802;GO:0044877;GO:0072584;GO:0071397;GO:0032388;GO:0015031;GO:0047484;GO:0016192;, C:basolateral plasma membrane; C:caveola; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:integral component of membrane; C:lysosome; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:protein-containing complex binding;, P:caveolin-mediated endocytosis; P:cellular response to cholesterol; P:positive regulation of intracellular transport; P:protein transport; P:regulation of response to osmotic stress; P:vesicle-mediated transport;|Q15049 B3KW61 B7Z659 Q5JZ83 Q8TAG4 Q96RP5 Q9UGY8,Membrane protein MLC1,, , GO:0016323;GO:0005901;GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0016021;GO:0005764;GO:0045121;GO:0048471;GO:0005886;GO:0055037;GO:0042802;GO:0044877;GO:0072584;GO:0071397;GO:0032388;GO:0015031;GO:0047484;GO:0016192;, C:basolateral plasma membrane; C:caveola; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:integral component of membrane; C:lysosome; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:protein-containing complex binding;, P:caveolin-mediated endocytosis; P:cellular response to cholesterol; P:positive regulation of intracellular transport; P:protein transport; P:regulation of response to osmotic stress; P:vesicle-mediated transport; scaffold271 indexed_genome mRNA 178530 190289 . - . ID=transcript_16438;Q15049 B3KW61 B7Z659 Q5JZ83 Q8TAG4 Q96RP5 Q9UGY8,Membrane protein MLC1,, , GO:0016323;GO:0005901;GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0016021;GO:0005764;GO:0045121;GO:0048471;GO:0005886;GO:0055037;GO:0042802;GO:0044877;GO:0072584;GO:0071397;GO:0032388;GO:0015031;GO:0047484;GO:0016192;, C:basolateral plasma membrane; C:caveola; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:integral component of membrane; C:lysosome; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:protein-containing complex binding;, P:caveolin-mediated endocytosis; P:cellular response to cholesterol; P:positive regulation of intracellular transport; P:protein transport; P:regulation of response to osmotic stress; P:vesicle-mediated transport;|Q15049 B3KW61 B7Z659 Q5JZ83 Q8TAG4 Q96RP5 Q9UGY8,Membrane protein MLC1,, , GO:0016323;GO:0005901;GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0016021;GO:0005764;GO:0045121;GO:0048471;GO:0005886;GO:0055037;GO:0042802;GO:0044877;GO:0072584;GO:0071397;GO:0032388;GO:0015031;GO:0047484;GO:0016192;, C:basolateral plasma membrane; C:caveola; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:integral component of membrane; C:lysosome; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:protein-containing complex binding;, P:caveolin-mediated endocytosis; P:cellular response to cholesterol; P:positive regulation of intracellular transport; P:protein transport; P:regulation of response to osmotic stress; P:vesicle-mediated transport;|Q15049 B3KW61 B7Z659 Q5JZ83 Q8TAG4 Q96RP5 Q9UGY8,Membrane protein MLC1,, , GO:0016323;GO:0005901;GO:0005737;GO:0031410;GO:0005829;GO:0005769;GO:0005783;GO:0005768;GO:0016021;GO:0005764;GO:0045121;GO:0048471;GO:0005886;GO:0055037;GO:0042802;GO:0044877;GO:0072584;GO:0071397;GO:0032388;GO:0015031;GO:0047484;GO:0016192;, C:basolateral plasma membrane; C:caveola; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:early endosome; C:endoplasmic reticulum; C:endosome; C:integral component of membrane; C:lysosome; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane; C:recycling endosome;, F:identical protein binding; F:protein-containing complex binding;, P:caveolin-mediated endocytosis; P:cellular response to cholesterol; P:positive regulation of intracellular transport; P:protein transport; P:regulation of response to osmotic stress; P:vesicle-mediated transport; scaffold271 indexed_genome mRNA 191820 219877 . + . ID=transcript_16439;A6PVC2 B5MDV0,Protein monoglycylase TTLL8,Tubulin--tyrosine ligase-like protein 8;, PF03133;, GO:0005930;GO:0005929;GO:0005829;GO:0005874;GO:0015630;GO:0005524;GO:0070735;GO:0070736;GO:0018094;, C:axoneme; C:cilium; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:protein-glycine ligase activity; F:protein-glycine ligase activity, initiating;, P:protein polyglycylation;|A6PVC2 B5MDV0,Protein monoglycylase TTLL8,Tubulin--tyrosine ligase-like protein 8;, PF03133;, GO:0005930;GO:0005929;GO:0005829;GO:0005874;GO:0015630;GO:0005524;GO:0070735;GO:0070736;GO:0018094;, C:axoneme; C:cilium; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:protein-glycine ligase activity; F:protein-glycine ligase activity, initiating;, P:protein polyglycylation;|A6PVC2 B5MDV0,Protein monoglycylase TTLL8,Tubulin--tyrosine ligase-like protein 8;, PF03133;, GO:0005930;GO:0005929;GO:0005829;GO:0005874;GO:0015630;GO:0005524;GO:0070735;GO:0070736;GO:0018094;, C:axoneme; C:cilium; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:protein-glycine ligase activity; F:protein-glycine ligase activity, initiating;, P:protein polyglycylation; scaffold271 indexed_genome mRNA 220278 255834 . + . ID=transcript_16440;A6PVC2 B5MDV0,Protein monoglycylase TTLL8,Tubulin--tyrosine ligase-like protein 8;, PF03133;, GO:0005930;GO:0005929;GO:0005829;GO:0005874;GO:0015630;GO:0005524;GO:0070735;GO:0070736;GO:0018094;, C:axoneme; C:cilium; C:cytosol; C:microtubule; C:microtubule cytoskeleton;, F:ATP binding; F:protein-glycine ligase activity; F:protein-glycine ligase activity, initiating;, P:protein polyglycylation; scaffold274 indexed_genome mRNA 92915 98076 . + . ID=transcript_16441;Q96PV6 A0A087WTE7 B0VJY9 Q8IZ27 Q8NCX6,Leukocyte receptor cluster member 8,, PF03399;, GO:0005634;, C:nucleus;|Q96PV6 A0A087WTE7 B0VJY9 Q8IZ27 Q8NCX6,Leukocyte receptor cluster member 8,, PF03399;, GO:0005634;, C:nucleus; scaffold274 indexed_genome mRNA 99798 101588 . + . ID=transcript_16442;Q6NZY7 B0VJZ2 Q8TB51,Cdc42 effector protein 5,Binder of Rho GTPases 3;, PF14957;PF00786;, GO:0005737;GO:0005856;GO:0005829;GO:0012505;GO:0016020;GO:0005886;GO:0031267;GO:0007254;GO:0030838;GO:0031274;GO:0008360;GO:0007266;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:endomembrane system; C:membrane; C:plasma membrane;, F:small GTPase binding;, P:JNK cascade; P:positive regulation of actin filament polymerization; P:positive regulation of pseudopodium assembly; P:regulation of cell shape; P:Rho protein signal transduction; scaffold274 indexed_genome mRNA 232667 245581 . + . ID=transcript_16443;Q8N149 O75020,Leukocyte immunoglobulin-like receptor subfamily A member 2,CD85 antigen-like family member H;Immunoglobulin-like transcript 1;Leukocyte immunoglobulin-like receptor 7 {ECO:0000303|PubMed:12529506};, PF00047;PF13895;, GO:0005576;GO:0005887;GO:0003823;GO:0001791;GO:0038023;GO:0006952;GO:0045087;GO:0002220;GO:0031665;GO:0034144;GO:0002283;GO:0051928;GO:0050867;GO:0071657;GO:0032725;GO:0032731;GO:0032755;GO:0032757;GO:0032760;GO:0007165;, C:extracellular region; C:integral component of plasma membrane;, F:antigen binding; F:IgM binding; F:signaling receptor activity;, P:defense response; P:innate immune response; P:innate immune response activating cell surface receptor signaling pathway; P:negative regulation of lipopolysaccharide-mediated signaling pathway; P:negative regulation of toll-like receptor 4 signaling pathway; P:neutrophil activation involved in immune response; P:positive regulation of calcium ion transport; P:positive regulation of cell activation; P:positive regulation of granulocyte colony-stimulating factor production; P:positive regulation of granulocyte macrophage colony-stimulating factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:signal transduction;|P46781 A9C4C1 Q4QRK7 Q9BVZ0,40S ribosomal protein S9,Small ribosomal subunit protein uS4 {ECO:0000303|PubMed:24524803};, PF00163;PF01479;, GO:0005737;GO:0005829;GO:0022627;GO:0070062;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0005840;GO:0015935;GO:0045202;GO:0003723;GO:0019843;GO:0003735;GO:0045182;GO:0000184;GO:0008284;GO:0045903;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytoplasm; C:cytosol; C:cytosolic small ribosomal subunit; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex; C:ribosome; C:small ribosomal subunit; C:synapse;, F:RNA binding; F:rRNA binding; F:structural constituent of ribosome; F:translation regulator activity;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of cell population proliferation; P:positive regulation of translational fidelity; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold274 indexed_genome mRNA 248713 251328 . - . ID=transcript_16444;Q9BSV6 A6NNB1 B0V3J1 Q9BVT1 Q9H6H5,tRNA-splicing endonuclease subunit Sen34,Leukocyte receptor cluster member 5;tRNA-intron endonuclease Sen34;, PF01974;, GO:0005730;GO:0005654;GO:0000214;GO:0016829;GO:0003676;GO:0000213;GO:0006397;GO:0006388;GO:0000379;, C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;, F:lyase activity; F:nucleic acid binding; F:tRNA-intron endonuclease activity;, P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage;|Q9BSV6 A6NNB1 B0V3J1 Q9BVT1 Q9H6H5,tRNA-splicing endonuclease subunit Sen34,Leukocyte receptor cluster member 5;tRNA-intron endonuclease Sen34;, PF01974;, GO:0005730;GO:0005654;GO:0000214;GO:0016829;GO:0003676;GO:0000213;GO:0006397;GO:0006388;GO:0000379;, C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;, F:lyase activity; F:nucleic acid binding; F:tRNA-intron endonuclease activity;, P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage; scaffold274 indexed_genome mRNA 253106 266850 . + . ID=transcript_16445;Q96N66 A9C4B6 B0V3I5 B4DQ87 Q05DF0 Q7L5N2 Q99908 Q9BPV2 Q9BRE9,Lysophospholipid acyltransferase 7 {ECO:0000305},1-acylglycerophosphatidylinositol O-acyltransferase {ECO:0000305};Bladder and breast carcinoma-overexpressed gene 1 protein;Leukocyte receptor cluster member 4;Lysophosphatidylinositol acyltransferase {ECO:0000303|PubMed:18094042, ECO:0000303|PubMed:18772128};Membrane-bound O-acyltransferase domain-containing protein 7 {ECO:0000303|PubMed:18094042};, PF03062;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0044233;GO:0071617;GO:0008374;GO:0016746;GO:0021819;GO:0030258;GO:0036151;GO:0036149;GO:0006661;GO:0090207;GO:0021591;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane;, F:lysophospholipid acyltransferase activity; F:O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:layer formation in cerebral cortex; P:lipid modification; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phosphatidylinositol biosynthetic process; P:regulation of triglyceride metabolic process; P:ventricular system development;|Q96N66 A9C4B6 B0V3I5 B4DQ87 Q05DF0 Q7L5N2 Q99908 Q9BPV2 Q9BRE9,Lysophospholipid acyltransferase 7 {ECO:0000305},1-acylglycerophosphatidylinositol O-acyltransferase {ECO:0000305};Bladder and breast carcinoma-overexpressed gene 1 protein;Leukocyte receptor cluster member 4;Lysophosphatidylinositol acyltransferase {ECO:0000303|PubMed:18094042, ECO:0000303|PubMed:18772128};Membrane-bound O-acyltransferase domain-containing protein 7 {ECO:0000303|PubMed:18094042};, PF03062;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0044233;GO:0071617;GO:0008374;GO:0016746;GO:0021819;GO:0030258;GO:0036151;GO:0036149;GO:0006661;GO:0090207;GO:0021591;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane;, F:lysophospholipid acyltransferase activity; F:O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:layer formation in cerebral cortex; P:lipid modification; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phosphatidylinositol biosynthetic process; P:regulation of triglyceride metabolic process; P:ventricular system development;|Q96N66 A9C4B6 B0V3I5 B4DQ87 Q05DF0 Q7L5N2 Q99908 Q9BPV2 Q9BRE9,Lysophospholipid acyltransferase 7 {ECO:0000305},1-acylglycerophosphatidylinositol O-acyltransferase {ECO:0000305};Bladder and breast carcinoma-overexpressed gene 1 protein;Leukocyte receptor cluster member 4;Lysophosphatidylinositol acyltransferase {ECO:0000303|PubMed:18094042, ECO:0000303|PubMed:18772128};Membrane-bound O-acyltransferase domain-containing protein 7 {ECO:0000303|PubMed:18094042};, PF03062;, GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0044233;GO:0071617;GO:0008374;GO:0016746;GO:0021819;GO:0030258;GO:0036151;GO:0036149;GO:0006661;GO:0090207;GO:0021591;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:mitochondria-associated endoplasmic reticulum membrane;, F:lysophospholipid acyltransferase activity; F:O-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:layer formation in cerebral cortex; P:lipid modification; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylinositol acyl-chain remodeling; P:phosphatidylinositol biosynthetic process; P:regulation of triglyceride metabolic process; P:ventricular system development; scaffold274 indexed_genome mRNA 267186 274842 . + . ID=transcript_16446;Q7Z404 Q7Z5M3 Q8N5E4 Q8TBS7,Transmembrane channel-like protein 4,, PF07810;, GO:0070062;GO:0005887;GO:0008381;, C:extracellular exosome; C:integral component of plasma membrane;, F:mechanosensitive ion channel activity; scaffold274 indexed_genome mRNA 279476 281259 . - . ID=transcript_16447;O75175 Q9NZN7 Q9UF76,CCR4-NOT transcription complex subunit 3 {ECO:0000305},CCR4-associated factor 3;Leukocyte receptor cluster member 2;, PF04153;PF04065;, GO:0030014;GO:0030015;GO:0005829;GO:0005634;GO:0000932;GO:0006977;GO:0031047;GO:0000289;GO:0120162;GO:2000036;GO:0006355;GO:0006417;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:nucleus; C:P-body;, , P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cold-induced thermogenesis; P:regulation of stem cell population maintenance; P:regulation of transcription, DNA-templated; P:regulation of translation; P:trophectodermal cell differentiation; scaffold274 indexed_genome mRNA 281491 282389 . - . ID=transcript_16448;O75175 Q9NZN7 Q9UF76,CCR4-NOT transcription complex subunit 3 {ECO:0000305},CCR4-associated factor 3;Leukocyte receptor cluster member 2;, PF04153;PF04065;, GO:0030014;GO:0030015;GO:0005829;GO:0005634;GO:0000932;GO:0006977;GO:0031047;GO:0000289;GO:0120162;GO:2000036;GO:0006355;GO:0006417;GO:0001829;, C:CCR4-NOT complex; C:CCR4-NOT core complex; C:cytosol; C:nucleus; C:P-body;, , P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:gene silencing by RNA; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of cold-induced thermogenesis; P:regulation of stem cell population maintenance; P:regulation of transcription, DNA-templated; P:regulation of translation; P:trophectodermal cell differentiation; scaffold276 indexed_genome mRNA 224056 229844 . + . ID=transcript_16449;Q7Z570 A7E253 Q6ZN26,Zinc finger protein 804A,, PF12171;, GO:0005737;GO:1901588;GO:0043198;GO:0043197;GO:0030426;GO:0043025;GO:0005634;GO:0005886;GO:0098794;GO:0098793;GO:0046872;GO:1902952;GO:0010628;GO:0010976;GO:0010975;, C:cytoplasm; C:dendritic microtubule; C:dendritic shaft; C:dendritic spine; C:growth cone; C:neuronal cell body; C:nucleus; C:plasma membrane; C:postsynapse; C:presynapse;, F:metal ion binding;, P:positive regulation of dendritic spine maintenance; P:positive regulation of gene expression; P:positive regulation of neuron projection development; P:regulation of neuron projection development; scaffold281 indexed_genome mRNA 32712 45197 . + . ID=transcript_16450;Q9UJX6 Q5VSG1 Q96DG5 Q96GG4 Q9P2E1,Anaphase-promoting complex subunit 2,Cyclosome subunit 2;, PF08672;PF00888;, GO:0005680;GO:0005829;GO:0005654;GO:0031625;GO:0031145;GO:0007049;GO:0051301;GO:0010629;GO:0045773;GO:0050775;GO:0090129;GO:0031915;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:negative regulation of gene expression; P:positive regulation of axon extension; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse maturation; P:positive regulation of synaptic plasticity; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX6 Q5VSG1 Q96DG5 Q96GG4 Q9P2E1,Anaphase-promoting complex subunit 2,Cyclosome subunit 2;, PF08672;PF00888;, GO:0005680;GO:0005829;GO:0005654;GO:0031625;GO:0031145;GO:0007049;GO:0051301;GO:0010629;GO:0045773;GO:0050775;GO:0090129;GO:0031915;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:negative regulation of gene expression; P:positive regulation of axon extension; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse maturation; P:positive regulation of synaptic plasticity; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX6 Q5VSG1 Q96DG5 Q96GG4 Q9P2E1,Anaphase-promoting complex subunit 2,Cyclosome subunit 2;, PF08672;PF00888;, GO:0005680;GO:0005829;GO:0005654;GO:0031625;GO:0031145;GO:0007049;GO:0051301;GO:0010629;GO:0045773;GO:0050775;GO:0090129;GO:0031915;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:negative regulation of gene expression; P:positive regulation of axon extension; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse maturation; P:positive regulation of synaptic plasticity; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX6 Q5VSG1 Q96DG5 Q96GG4 Q9P2E1,Anaphase-promoting complex subunit 2,Cyclosome subunit 2;, PF08672;PF00888;, GO:0005680;GO:0005829;GO:0005654;GO:0031625;GO:0031145;GO:0007049;GO:0051301;GO:0010629;GO:0045773;GO:0050775;GO:0090129;GO:0031915;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:negative regulation of gene expression; P:positive regulation of axon extension; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse maturation; P:positive regulation of synaptic plasticity; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX6 Q5VSG1 Q96DG5 Q96GG4 Q9P2E1,Anaphase-promoting complex subunit 2,Cyclosome subunit 2;, PF08672;PF00888;, GO:0005680;GO:0005829;GO:0005654;GO:0031625;GO:0031145;GO:0007049;GO:0051301;GO:0010629;GO:0045773;GO:0050775;GO:0090129;GO:0031915;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:negative regulation of gene expression; P:positive regulation of axon extension; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse maturation; P:positive regulation of synaptic plasticity; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX6 Q5VSG1 Q96DG5 Q96GG4 Q9P2E1,Anaphase-promoting complex subunit 2,Cyclosome subunit 2;, PF08672;PF00888;, GO:0005680;GO:0005829;GO:0005654;GO:0031625;GO:0031145;GO:0007049;GO:0051301;GO:0010629;GO:0045773;GO:0050775;GO:0090129;GO:0031915;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:negative regulation of gene expression; P:positive regulation of axon extension; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse maturation; P:positive regulation of synaptic plasticity; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process;|Q9UJX6 Q5VSG1 Q96DG5 Q96GG4 Q9P2E1,Anaphase-promoting complex subunit 2,Cyclosome subunit 2;, PF08672;PF00888;, GO:0005680;GO:0005829;GO:0005654;GO:0031625;GO:0031145;GO:0007049;GO:0051301;GO:0010629;GO:0045773;GO:0050775;GO:0090129;GO:0031915;GO:0070979;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm;, F:ubiquitin protein ligase binding;, P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:negative regulation of gene expression; P:positive regulation of axon extension; P:positive regulation of dendrite morphogenesis; P:positive regulation of synapse maturation; P:positive regulation of synaptic plasticity; P:protein K11-linked ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold281 indexed_genome mRNA 48587 62886 . - . ID=transcript_16451;Q5VSF5 Q5VSF6 Q5VSF7 Q5VSF8 Q9UPF8 Q9UPF9,Glutamate receptor ionotropic, NMDA 1,Glutamate [NMDA] receptor subunit zeta-1;N-methyl-D-aspartate receptor subunit NR1;, PF01094;PF10562;PF00060;PF10613;, GO:0009986;GO:0005737;GO:0030425;GO:0043197;GO:0005789;GO:0060076;GO:0005887;GO:0043005;GO:0017146;GO:0005886;GO:0014069;GO:0045211;GO:0045202;GO:0043083;GO:0097060;GO:0008021;GO:0043195;GO:0001540;GO:0005509;GO:0005516;GO:0016595;GO:0022849;GO:0016594;GO:0015276;GO:0042165;GO:0004972;GO:0044877;GO:0038023;GO:0007420;GO:0055074;GO:0097553;GO:0006812;GO:0007268;GO:0048013;GO:0098976;GO:0060079;GO:0035235;GO:0000165;GO:0010524;GO:2001056;GO:2000463;GO:1903428;GO:0045944;GO:0018964;GO:0051290;GO:0042391;GO:2000310;GO:0048167;GO:0045471;GO:1905429;GO:0008542;, C:cell surface; C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum membrane; C:excitatory synapse; C:integral component of plasma membrane; C:neuron projection; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:synapse; C:synaptic cleft; C:synaptic membrane; C:synaptic vesicle; C:terminal bouton;, F:amyloid-beta binding; F:calcium ion binding; F:calmodulin binding; F:glutamate binding; F:glutamate-gated calcium ion channel activity; F:glycine binding; F:ligand-gated ion channel activity; F:neurotransmitter binding; F:NMDA glutamate receptor activity; F:protein-containing complex binding; F:signaling receptor activity;, P:brain development; P:calcium ion homeostasis; P:calcium ion transmembrane import into cytosol; P:cation transport; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:ionotropic glutamate receptor signaling pathway; P:MAPK cascade; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:propylene metabolic process; P:protein heterotetramerization; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to ethanol; P:response to glycine; P:visual learning;|Q5VSF5 Q5VSF6 Q5VSF7 Q5VSF8 Q9UPF8 Q9UPF9,Glutamate receptor ionotropic, NMDA 1,Glutamate [NMDA] receptor subunit zeta-1;N-methyl-D-aspartate receptor subunit NR1;, PF01094;PF10562;PF00060;PF10613;, GO:0009986;GO:0005737;GO:0030425;GO:0043197;GO:0005789;GO:0060076;GO:0005887;GO:0043005;GO:0017146;GO:0005886;GO:0014069;GO:0045211;GO:0045202;GO:0043083;GO:0097060;GO:0008021;GO:0043195;GO:0001540;GO:0005509;GO:0005516;GO:0016595;GO:0022849;GO:0016594;GO:0015276;GO:0042165;GO:0004972;GO:0044877;GO:0038023;GO:0007420;GO:0055074;GO:0097553;GO:0006812;GO:0007268;GO:0048013;GO:0098976;GO:0060079;GO:0035235;GO:0000165;GO:0010524;GO:2001056;GO:2000463;GO:1903428;GO:0045944;GO:0018964;GO:0051290;GO:0042391;GO:2000310;GO:0048167;GO:0045471;GO:1905429;GO:0008542;, C:cell surface; C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum membrane; C:excitatory synapse; C:integral component of plasma membrane; C:neuron projection; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:synapse; C:synaptic cleft; C:synaptic membrane; C:synaptic vesicle; C:terminal bouton;, F:amyloid-beta binding; F:calcium ion binding; F:calmodulin binding; F:glutamate binding; F:glutamate-gated calcium ion channel activity; F:glycine binding; F:ligand-gated ion channel activity; F:neurotransmitter binding; F:NMDA glutamate receptor activity; F:protein-containing complex binding; F:signaling receptor activity;, P:brain development; P:calcium ion homeostasis; P:calcium ion transmembrane import into cytosol; P:cation transport; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:ionotropic glutamate receptor signaling pathway; P:MAPK cascade; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:propylene metabolic process; P:protein heterotetramerization; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to ethanol; P:response to glycine; P:visual learning;|Q5VSF5 Q5VSF6 Q5VSF7 Q5VSF8 Q9UPF8 Q9UPF9,Glutamate receptor ionotropic, NMDA 1,Glutamate [NMDA] receptor subunit zeta-1;N-methyl-D-aspartate receptor subunit NR1;, PF01094;PF10562;PF00060;PF10613;, GO:0009986;GO:0005737;GO:0030425;GO:0043197;GO:0005789;GO:0060076;GO:0005887;GO:0043005;GO:0017146;GO:0005886;GO:0014069;GO:0045211;GO:0045202;GO:0043083;GO:0097060;GO:0008021;GO:0043195;GO:0001540;GO:0005509;GO:0005516;GO:0016595;GO:0022849;GO:0016594;GO:0015276;GO:0042165;GO:0004972;GO:0044877;GO:0038023;GO:0007420;GO:0055074;GO:0097553;GO:0006812;GO:0007268;GO:0048013;GO:0098976;GO:0060079;GO:0035235;GO:0000165;GO:0010524;GO:2001056;GO:2000463;GO:1903428;GO:0045944;GO:0018964;GO:0051290;GO:0042391;GO:2000310;GO:0048167;GO:0045471;GO:1905429;GO:0008542;, C:cell surface; C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum membrane; C:excitatory synapse; C:integral component of plasma membrane; C:neuron projection; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:synapse; C:synaptic cleft; C:synaptic membrane; C:synaptic vesicle; C:terminal bouton;, F:amyloid-beta binding; F:calcium ion binding; F:calmodulin binding; F:glutamate binding; F:glutamate-gated calcium ion channel activity; F:glycine binding; F:ligand-gated ion channel activity; F:neurotransmitter binding; F:NMDA glutamate receptor activity; F:protein-containing complex binding; F:signaling receptor activity;, P:brain development; P:calcium ion homeostasis; P:calcium ion transmembrane import into cytosol; P:cation transport; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:ionotropic glutamate receptor signaling pathway; P:MAPK cascade; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:propylene metabolic process; P:protein heterotetramerization; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to ethanol; P:response to glycine; P:visual learning;|Q5VSF5 Q5VSF6 Q5VSF7 Q5VSF8 Q9UPF8 Q9UPF9,Glutamate receptor ionotropic, NMDA 1,Glutamate [NMDA] receptor subunit zeta-1;N-methyl-D-aspartate receptor subunit NR1;, PF01094;PF10562;PF00060;PF10613;, GO:0009986;GO:0005737;GO:0030425;GO:0043197;GO:0005789;GO:0060076;GO:0005887;GO:0043005;GO:0017146;GO:0005886;GO:0014069;GO:0045211;GO:0045202;GO:0043083;GO:0097060;GO:0008021;GO:0043195;GO:0001540;GO:0005509;GO:0005516;GO:0016595;GO:0022849;GO:0016594;GO:0015276;GO:0042165;GO:0004972;GO:0044877;GO:0038023;GO:0007420;GO:0055074;GO:0097553;GO:0006812;GO:0007268;GO:0048013;GO:0098976;GO:0060079;GO:0035235;GO:0000165;GO:0010524;GO:2001056;GO:2000463;GO:1903428;GO:0045944;GO:0018964;GO:0051290;GO:0042391;GO:2000310;GO:0048167;GO:0045471;GO:1905429;GO:0008542;, C:cell surface; C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum membrane; C:excitatory synapse; C:integral component of plasma membrane; C:neuron projection; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:synapse; C:synaptic cleft; C:synaptic membrane; C:synaptic vesicle; C:terminal bouton;, F:amyloid-beta binding; F:calcium ion binding; F:calmodulin binding; F:glutamate binding; F:glutamate-gated calcium ion channel activity; F:glycine binding; F:ligand-gated ion channel activity; F:neurotransmitter binding; F:NMDA glutamate receptor activity; F:protein-containing complex binding; F:signaling receptor activity;, P:brain development; P:calcium ion homeostasis; P:calcium ion transmembrane import into cytosol; P:cation transport; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:ionotropic glutamate receptor signaling pathway; P:MAPK cascade; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:propylene metabolic process; P:protein heterotetramerization; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to ethanol; P:response to glycine; P:visual learning;|Q5VSF5 Q5VSF6 Q5VSF7 Q5VSF8 Q9UPF8 Q9UPF9,Glutamate receptor ionotropic, NMDA 1,Glutamate [NMDA] receptor subunit zeta-1;N-methyl-D-aspartate receptor subunit NR1;, PF01094;PF10562;PF00060;PF10613;, GO:0009986;GO:0005737;GO:0030425;GO:0043197;GO:0005789;GO:0060076;GO:0005887;GO:0043005;GO:0017146;GO:0005886;GO:0014069;GO:0045211;GO:0045202;GO:0043083;GO:0097060;GO:0008021;GO:0043195;GO:0001540;GO:0005509;GO:0005516;GO:0016595;GO:0022849;GO:0016594;GO:0015276;GO:0042165;GO:0004972;GO:0044877;GO:0038023;GO:0007420;GO:0055074;GO:0097553;GO:0006812;GO:0007268;GO:0048013;GO:0098976;GO:0060079;GO:0035235;GO:0000165;GO:0010524;GO:2001056;GO:2000463;GO:1903428;GO:0045944;GO:0018964;GO:0051290;GO:0042391;GO:2000310;GO:0048167;GO:0045471;GO:1905429;GO:0008542;, C:cell surface; C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum membrane; C:excitatory synapse; C:integral component of plasma membrane; C:neuron projection; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:synapse; C:synaptic cleft; C:synaptic membrane; C:synaptic vesicle; C:terminal bouton;, F:amyloid-beta binding; F:calcium ion binding; F:calmodulin binding; F:glutamate binding; F:glutamate-gated calcium ion channel activity; F:glycine binding; F:ligand-gated ion channel activity; F:neurotransmitter binding; F:NMDA glutamate receptor activity; F:protein-containing complex binding; F:signaling receptor activity;, P:brain development; P:calcium ion homeostasis; P:calcium ion transmembrane import into cytosol; P:cation transport; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:ionotropic glutamate receptor signaling pathway; P:MAPK cascade; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:propylene metabolic process; P:protein heterotetramerization; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to ethanol; P:response to glycine; P:visual learning;|Q5VSF5 Q5VSF6 Q5VSF7 Q5VSF8 Q9UPF8 Q9UPF9,Glutamate receptor ionotropic, NMDA 1,Glutamate [NMDA] receptor subunit zeta-1;N-methyl-D-aspartate receptor subunit NR1;, PF01094;PF10562;PF00060;PF10613;, GO:0009986;GO:0005737;GO:0030425;GO:0043197;GO:0005789;GO:0060076;GO:0005887;GO:0043005;GO:0017146;GO:0005886;GO:0014069;GO:0045211;GO:0045202;GO:0043083;GO:0097060;GO:0008021;GO:0043195;GO:0001540;GO:0005509;GO:0005516;GO:0016595;GO:0022849;GO:0016594;GO:0015276;GO:0042165;GO:0004972;GO:0044877;GO:0038023;GO:0007420;GO:0055074;GO:0097553;GO:0006812;GO:0007268;GO:0048013;GO:0098976;GO:0060079;GO:0035235;GO:0000165;GO:0010524;GO:2001056;GO:2000463;GO:1903428;GO:0045944;GO:0018964;GO:0051290;GO:0042391;GO:2000310;GO:0048167;GO:0045471;GO:1905429;GO:0008542;, C:cell surface; C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum membrane; C:excitatory synapse; C:integral component of plasma membrane; C:neuron projection; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:synapse; C:synaptic cleft; C:synaptic membrane; C:synaptic vesicle; C:terminal bouton;, F:amyloid-beta binding; F:calcium ion binding; F:calmodulin binding; F:glutamate binding; F:glutamate-gated calcium ion channel activity; F:glycine binding; F:ligand-gated ion channel activity; F:neurotransmitter binding; F:NMDA glutamate receptor activity; F:protein-containing complex binding; F:signaling receptor activity;, P:brain development; P:calcium ion homeostasis; P:calcium ion transmembrane import into cytosol; P:cation transport; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:ionotropic glutamate receptor signaling pathway; P:MAPK cascade; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:propylene metabolic process; P:protein heterotetramerization; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to ethanol; P:response to glycine; P:visual learning; scaffold281 indexed_genome mRNA 62928 64539 . + . ID=transcript_16452;Q5VSF5 Q5VSF6 Q5VSF7 Q5VSF8 Q9UPF8 Q9UPF9,Glutamate receptor ionotropic, NMDA 1,Glutamate [NMDA] receptor subunit zeta-1;N-methyl-D-aspartate receptor subunit NR1;, PF01094;PF10562;PF00060;PF10613;, GO:0009986;GO:0005737;GO:0030425;GO:0043197;GO:0005789;GO:0060076;GO:0005887;GO:0043005;GO:0017146;GO:0005886;GO:0014069;GO:0045211;GO:0045202;GO:0043083;GO:0097060;GO:0008021;GO:0043195;GO:0001540;GO:0005509;GO:0005516;GO:0016595;GO:0022849;GO:0016594;GO:0015276;GO:0042165;GO:0004972;GO:0044877;GO:0038023;GO:0007420;GO:0055074;GO:0097553;GO:0006812;GO:0007268;GO:0048013;GO:0098976;GO:0060079;GO:0035235;GO:0000165;GO:0010524;GO:2001056;GO:2000463;GO:1903428;GO:0045944;GO:0018964;GO:0051290;GO:0042391;GO:2000310;GO:0048167;GO:0045471;GO:1905429;GO:0008542;, C:cell surface; C:cytoplasm; C:dendrite; C:dendritic spine; C:endoplasmic reticulum membrane; C:excitatory synapse; C:integral component of plasma membrane; C:neuron projection; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:synapse; C:synaptic cleft; C:synaptic membrane; C:synaptic vesicle; C:terminal bouton;, F:amyloid-beta binding; F:calcium ion binding; F:calmodulin binding; F:glutamate binding; F:glutamate-gated calcium ion channel activity; F:glycine binding; F:ligand-gated ion channel activity; F:neurotransmitter binding; F:NMDA glutamate receptor activity; F:protein-containing complex binding; F:signaling receptor activity;, P:brain development; P:calcium ion homeostasis; P:calcium ion transmembrane import into cytosol; P:cation transport; P:chemical synaptic transmission; P:ephrin receptor signaling pathway; P:excitatory chemical synaptic transmission; P:excitatory postsynaptic potential; P:ionotropic glutamate receptor signaling pathway; P:MAPK cascade; P:positive regulation of calcium ion transport into cytosol; P:positive regulation of cysteine-type endopeptidase activity; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:propylene metabolic process; P:protein heterotetramerization; P:regulation of membrane potential; P:regulation of NMDA receptor activity; P:regulation of synaptic plasticity; P:response to ethanol; P:response to glycine; P:visual learning; scaffold281 indexed_genome mRNA 71025 72248 . - . ID=transcript_16453;P56378 B2R588 G3V5Q3 Q86TT7,ATP synthase subunit ATP5MJ, mitochondrial {ECO:0000305},6.8 kDa mitochondrial proteolipid protein {ECO:0000303|PubMed:24330338};ATP synthase membrane subunit 6.8PL {ECO:0000312|HGNC:HGNC:1188};, PF08039;, GO:0016021;GO:0005753;, C:integral component of membrane; C:mitochondrial proton-transporting ATP synthase complex; scaffold281 indexed_genome mRNA 98945 101371 . + . ID=transcript_16454;Q9UHL4 A8K7U7 Q5VSF1 Q969X4,Dipeptidyl peptidase 2,Dipeptidyl aminopeptidase II;Dipeptidyl peptidase 7;Dipeptidyl peptidase II;Quiescent cell proline dipeptidase;, PF05577;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005794;GO:0043231;GO:0031982;GO:0004177;GO:0008239;GO:0008236;GO:0043312;GO:0006508;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:vesicle;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:neutrophil degranulation; P:proteolysis;|Q9UHL4 A8K7U7 Q5VSF1 Q969X4,Dipeptidyl peptidase 2,Dipeptidyl aminopeptidase II;Dipeptidyl peptidase 7;Dipeptidyl peptidase II;Quiescent cell proline dipeptidase;, PF05577;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005794;GO:0043231;GO:0031982;GO:0004177;GO:0008239;GO:0008236;GO:0043312;GO:0006508;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:vesicle;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:neutrophil degranulation; P:proteolysis;|Q9UHL4 A8K7U7 Q5VSF1 Q969X4,Dipeptidyl peptidase 2,Dipeptidyl aminopeptidase II;Dipeptidyl peptidase 7;Dipeptidyl peptidase II;Quiescent cell proline dipeptidase;, PF05577;, GO:0035578;GO:0005829;GO:0070062;GO:0005576;GO:0005794;GO:0043231;GO:0031982;GO:0004177;GO:0008239;GO:0008236;GO:0043312;GO:0006508;, C:azurophil granule lumen; C:cytosol; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:vesicle;, F:aminopeptidase activity; F:dipeptidyl-peptidase activity; F:serine-type peptidase activity;, P:neutrophil degranulation; P:proteolysis; scaffold281 indexed_genome mRNA 108177 109151 . + . ID=transcript_16455;Q9UKM7 Q5VSG3 Q9BRS9 Q9Y5K7,Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase,ER alpha-1,2-mannosidase;ER mannosidase 1;Man9GlcNAc2-specific-processing alpha-mannosidase;Mannosidase alpha class 1B member 1;, PF01532;, GO:0031410;GO:0005783;GO:0005789;GO:0044322;GO:1903561;GO:0005794;GO:0016021;GO:0016020;GO:0005509;GO:0004571;GO:1904380;GO:1904382;GO:0006491;GO:0009311;GO:0036508;GO:0006486;GO:0036511;GO:0036512;GO:0036509;GO:0036510;GO:0030433;GO:0019082;, C:cytoplasmic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:endoplasmic reticulum mannose trimming; P:mannose trimming involved in glycoprotein ERAD pathway; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein alpha-1,2-demannosylation; P:protein glycosylation; P:trimming of first mannose on A branch; P:trimming of second mannose on A branch; P:trimming of terminal mannose on B branch; P:trimming of terminal mannose on C branch; P:ubiquitin-dependent ERAD pathway; P:viral protein processing; scaffold281 indexed_genome mRNA 121946 128025 . - . ID=transcript_16456;Q3KQV9 A2AMJ8 Q5SPZ2 Q69YQ3 Q6ZR38,UDP-N-acetylhexosamine pyrophosphorylase-like protein 1,, PF01704;, GO:0003977;GO:0006048;, , F:UDP-N-acetylglucosamine diphosphorylase activity;, P:UDP-N-acetylglucosamine biosynthetic process;|Q3KQV9 A2AMJ8 Q5SPZ2 Q69YQ3 Q6ZR38,UDP-N-acetylhexosamine pyrophosphorylase-like protein 1,, PF01704;, GO:0003977;GO:0006048;, , F:UDP-N-acetylglucosamine diphosphorylase activity;, P:UDP-N-acetylglucosamine biosynthetic process; scaffold281 indexed_genome mRNA 149517 152332 . + . ID=transcript_16457;Q9Y5L3 O15464 Q5SPY6 Q5SPY7,Ectonucleoside triphosphate diphosphohydrolase 2,CD39 antigen-like 1;Ecto-ATP diphosphohydrolase 2;, PF01150;, GO:0005604;GO:0005789;GO:0070062;GO:0016021;GO:0016020;GO:0005886;GO:0005524;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0007186;GO:0034656;GO:0009134;GO:0030168;GO:0009181;, C:basement membrane; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:ATP binding; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:G protein-coupled receptor signaling pathway; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:platelet activation; P:purine ribonucleoside diphosphate catabolic process;|Q9Y5L3 O15464 Q5SPY6 Q5SPY7,Ectonucleoside triphosphate diphosphohydrolase 2,CD39 antigen-like 1;Ecto-ATP diphosphohydrolase 2;, PF01150;, GO:0005604;GO:0005789;GO:0070062;GO:0016021;GO:0016020;GO:0005886;GO:0005524;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0007186;GO:0034656;GO:0009134;GO:0030168;GO:0009181;, C:basement membrane; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:ATP binding; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:G protein-coupled receptor signaling pathway; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:platelet activation; P:purine ribonucleoside diphosphate catabolic process; scaffold281 indexed_genome mRNA 152604 155906 . + . ID=transcript_16458;Q9Y5L3 O15464 Q5SPY6 Q5SPY7,Ectonucleoside triphosphate diphosphohydrolase 2,CD39 antigen-like 1;Ecto-ATP diphosphohydrolase 2;, PF01150;, GO:0005604;GO:0005789;GO:0070062;GO:0016021;GO:0016020;GO:0005886;GO:0005524;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0007186;GO:0034656;GO:0009134;GO:0030168;GO:0009181;, C:basement membrane; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:ATP binding; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:G protein-coupled receptor signaling pathway; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:platelet activation; P:purine ribonucleoside diphosphate catabolic process;|Q9Y5L3 O15464 Q5SPY6 Q5SPY7,Ectonucleoside triphosphate diphosphohydrolase 2,CD39 antigen-like 1;Ecto-ATP diphosphohydrolase 2;, PF01150;, GO:0005604;GO:0005789;GO:0070062;GO:0016021;GO:0016020;GO:0005886;GO:0005524;GO:0004382;GO:0017110;GO:0017111;GO:0045134;GO:0007186;GO:0034656;GO:0009134;GO:0030168;GO:0009181;, C:basement membrane; C:endoplasmic reticulum membrane; C:extracellular exosome; C:integral component of membrane; C:membrane; C:plasma membrane;, F:ATP binding; F:guanosine-diphosphatase activity; F:nucleoside-diphosphatase activity; F:nucleoside-triphosphatase activity; F:uridine-diphosphatase activity;, P:G protein-coupled receptor signaling pathway; P:nucleobase-containing small molecule catabolic process; P:nucleoside diphosphate catabolic process; P:platelet activation; P:purine ribonucleoside diphosphate catabolic process; scaffold281 indexed_genome mRNA 160174 163663 . + . ID=transcript_16459;Q9NQX5 Q5SPY8 Q9BTD6 Q9BXT3 Q9NQS2 Q9Y434,Neural proliferation differentiation and control protein 1,, PF06809;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response;|Q9NQX5 Q5SPY8 Q9BTD6 Q9BXT3 Q9NQS2 Q9Y434,Neural proliferation differentiation and control protein 1,, PF06809;, GO:0016021;GO:0005886;GO:0050776;, C:integral component of membrane; C:plasma membrane;, , P:regulation of immune response; scaffold281 indexed_genome mRNA 167272 167964 . + . ID=transcript_16460;Q11130 B2R7U7 Q6DK54,Alpha-(1,3)-fucosyltransferase 7 {ECO:0000305},Fucosyltransferase 7;Fucosyltransferase VII {ECO:0000303|PubMed:8207002};Galactoside 3-L-fucosyltransferase;Selectin ligand synthase;, PF17039;PF00852;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0005802;GO:0017083;GO:0046920;GO:0008417;GO:0002361;GO:0006672;GO:0007566;GO:0036065;GO:0006954;GO:0042355;GO:0002522;GO:0002523;GO:0097021;GO:0009312;GO:0045785;GO:0022409;GO:1904996;GO:1903238;GO:0006486;GO:0060353;GO:0022407;GO:0046626;GO:1903037;GO:1903236;GO:2000389;GO:0001807;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network;, F:4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity; F:alpha-(1->3)-fucosyltransferase activity; F:fucosyltransferase activity;, P:CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; P:ceramide metabolic process; P:embryo implantation; P:fucosylation; P:inflammatory response; P:L-fucose catabolic process; P:leukocyte migration involved in immune response; P:leukocyte migration involved in inflammatory response; P:lymphocyte migration into lymphoid organs; P:oligosaccharide biosynthetic process; P:positive regulation of cell adhesion; P:positive regulation of cell-cell adhesion; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of leukocyte tethering or rolling; P:protein glycosylation; P:regulation of cell adhesion molecule production; P:regulation of cell-cell adhesion; P:regulation of insulin receptor signaling pathway; P:regulation of leukocyte cell-cell adhesion; P:regulation of leukocyte tethering or rolling; P:regulation of neutrophil extravasation; P:regulation of type IV hypersensitivity; scaffold281 indexed_genome mRNA 168209 169081 . + . ID=transcript_16461;Q11130 B2R7U7 Q6DK54,Alpha-(1,3)-fucosyltransferase 7 {ECO:0000305},Fucosyltransferase 7;Fucosyltransferase VII {ECO:0000303|PubMed:8207002};Galactoside 3-L-fucosyltransferase;Selectin ligand synthase;, PF17039;PF00852;, GO:0005794;GO:0032580;GO:0000139;GO:0016021;GO:0016020;GO:0005802;GO:0017083;GO:0046920;GO:0008417;GO:0002361;GO:0006672;GO:0007566;GO:0036065;GO:0006954;GO:0042355;GO:0002522;GO:0002523;GO:0097021;GO:0009312;GO:0045785;GO:0022409;GO:1904996;GO:1903238;GO:0006486;GO:0060353;GO:0022407;GO:0046626;GO:1903037;GO:1903236;GO:2000389;GO:0001807;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of membrane; C:membrane; C:trans-Golgi network;, F:4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity; F:alpha-(1->3)-fucosyltransferase activity; F:fucosyltransferase activity;, P:CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; P:ceramide metabolic process; P:embryo implantation; P:fucosylation; P:inflammatory response; P:L-fucose catabolic process; P:leukocyte migration involved in immune response; P:leukocyte migration involved in inflammatory response; P:lymphocyte migration into lymphoid organs; P:oligosaccharide biosynthetic process; P:positive regulation of cell adhesion; P:positive regulation of cell-cell adhesion; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of leukocyte tethering or rolling; P:protein glycosylation; P:regulation of cell adhesion molecule production; P:regulation of cell-cell adhesion; P:regulation of insulin receptor signaling pathway; P:regulation of leukocyte cell-cell adhesion; P:regulation of leukocyte tethering or rolling; P:regulation of neutrophil extravasation; P:regulation of type IV hypersensitivity; scaffold281 indexed_genome mRNA 173255 190385 . + . ID=transcript_16462;Q9BZC7 A6NED5 Q5SPY5 Q5W9G5 Q76MW7 Q9HC28,ATP-binding cassette sub-family A member 2 {ECO:0000305},ATP-binding cassette transporter 2;, PF00005;, GO:0043190;GO:0031410;GO:0005768;GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0005764;GO:0016020;GO:0005815;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0099038;GO:0061135;GO:0005319;GO:0000166;GO:0090156;GO:0032289;GO:0099040;GO:0042632;GO:0001573;GO:0006687;GO:0006629;GO:0006869;GO:0007626;GO:0090370;GO:0150110;GO:0032384;GO:1905598;GO:0071072;GO:1905601;GO:0090155;GO:0042986;GO:1902993;GO:1902004;GO:0032805;GO:0010872;GO:0032383;GO:1901873;GO:0060049;GO:1904375;GO:2000008;GO:0006357;GO:0070723;GO:0042493;GO:0048545;GO:0006684;GO:0046512;GO:0055085;GO:0150104;, C:ATP-binding cassette (ABC) transporter complex; C:cytoplasmic vesicle; C:endosome; C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:membrane; C:microtubule organizing center; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:ceramide floppase activity; F:endopeptidase regulator activity; F:lipid transporter activity; F:nucleotide binding;, P:cellular sphingolipid homeostasis; P:central nervous system myelin formation; P:ceramide translocation; P:cholesterol homeostasis; P:ganglioside metabolic process; P:glycosphingolipid metabolic process; P:lipid metabolic process; P:lipid transport; P:locomotory behavior; P:negative regulation of cholesterol efflux; P:negative regulation of cholesterol esterification; P:negative regulation of intracellular cholesterol transport; P:negative regulation of low-density lipoprotein receptor activity; P:negative regulation of phospholipid biosynthetic process; P:negative regulation of receptor-mediated endocytosis involved in cholesterol transport; P:negative regulation of sphingolipid biosynthetic process; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of amyloid precursor protein catabolic process; P:positive regulation of amyloid-beta formation; P:positive regulation of low-density lipoprotein particle receptor catabolic process; P:regulation of cholesterol esterification; P:regulation of intracellular cholesterol transport; P:regulation of post-translational protein modification; P:regulation of protein glycosylation; P:regulation of protein localization to cell periphery; P:regulation of protein localization to cell surface; P:regulation of transcription by RNA polymerase II; P:response to cholesterol; P:response to drug; P:response to steroid hormone; P:sphingomyelin metabolic process; P:sphingosine biosynthetic process; P:transmembrane transport; P:transport across blood-brain barrier;|Q9BZC7 A6NED5 Q5SPY5 Q5W9G5 Q76MW7 Q9HC28,ATP-binding cassette sub-family A member 2 {ECO:0000305},ATP-binding cassette transporter 2;, PF00005;, GO:0043190;GO:0031410;GO:0005768;GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0005764;GO:0016020;GO:0005815;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0099038;GO:0061135;GO:0005319;GO:0000166;GO:0090156;GO:0032289;GO:0099040;GO:0042632;GO:0001573;GO:0006687;GO:0006629;GO:0006869;GO:0007626;GO:0090370;GO:0150110;GO:0032384;GO:1905598;GO:0071072;GO:1905601;GO:0090155;GO:0042986;GO:1902993;GO:1902004;GO:0032805;GO:0010872;GO:0032383;GO:1901873;GO:0060049;GO:1904375;GO:2000008;GO:0006357;GO:0070723;GO:0042493;GO:0048545;GO:0006684;GO:0046512;GO:0055085;GO:0150104;, C:ATP-binding cassette (ABC) transporter complex; C:cytoplasmic vesicle; C:endosome; C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:membrane; C:microtubule organizing center; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:ceramide floppase activity; F:endopeptidase regulator activity; F:lipid transporter activity; F:nucleotide binding;, P:cellular sphingolipid homeostasis; P:central nervous system myelin formation; P:ceramide translocation; P:cholesterol homeostasis; P:ganglioside metabolic process; P:glycosphingolipid metabolic process; P:lipid metabolic process; P:lipid transport; P:locomotory behavior; P:negative regulation of cholesterol efflux; P:negative regulation of cholesterol esterification; P:negative regulation of intracellular cholesterol transport; P:negative regulation of low-density lipoprotein receptor activity; P:negative regulation of phospholipid biosynthetic process; P:negative regulation of receptor-mediated endocytosis involved in cholesterol transport; P:negative regulation of sphingolipid biosynthetic process; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of amyloid precursor protein catabolic process; P:positive regulation of amyloid-beta formation; P:positive regulation of low-density lipoprotein particle receptor catabolic process; P:regulation of cholesterol esterification; P:regulation of intracellular cholesterol transport; P:regulation of post-translational protein modification; P:regulation of protein glycosylation; P:regulation of protein localization to cell periphery; P:regulation of protein localization to cell surface; P:regulation of transcription by RNA polymerase II; P:response to cholesterol; P:response to drug; P:response to steroid hormone; P:sphingomyelin metabolic process; P:sphingosine biosynthetic process; P:transmembrane transport; P:transport across blood-brain barrier;|Q9BZC7 A6NED5 Q5SPY5 Q5W9G5 Q76MW7 Q9HC28,ATP-binding cassette sub-family A member 2 {ECO:0000305},ATP-binding cassette transporter 2;, PF00005;, GO:0043190;GO:0031410;GO:0005768;GO:0010008;GO:0016021;GO:0043231;GO:0005765;GO:0005764;GO:0016020;GO:0005815;GO:0005886;GO:0005524;GO:0016887;GO:0042626;GO:0099038;GO:0061135;GO:0005319;GO:0000166;GO:0090156;GO:0032289;GO:0099040;GO:0042632;GO:0001573;GO:0006687;GO:0006629;GO:0006869;GO:0007626;GO:0090370;GO:0150110;GO:0032384;GO:1905598;GO:0071072;GO:1905601;GO:0090155;GO:0042986;GO:1902993;GO:1902004;GO:0032805;GO:0010872;GO:0032383;GO:1901873;GO:0060049;GO:1904375;GO:2000008;GO:0006357;GO:0070723;GO:0042493;GO:0048545;GO:0006684;GO:0046512;GO:0055085;GO:0150104;, C:ATP-binding cassette (ABC) transporter complex; C:cytoplasmic vesicle; C:endosome; C:endosome membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:lysosome; C:membrane; C:microtubule organizing center; C:plasma membrane;, F:ATP binding; F:ATPase activity; F:ATPase-coupled transmembrane transporter activity; F:ceramide floppase activity; F:endopeptidase regulator activity; F:lipid transporter activity; F:nucleotide binding;, P:cellular sphingolipid homeostasis; P:central nervous system myelin formation; P:ceramide translocation; P:cholesterol homeostasis; P:ganglioside metabolic process; P:glycosphingolipid metabolic process; P:lipid metabolic process; P:lipid transport; P:locomotory behavior; P:negative regulation of cholesterol efflux; P:negative regulation of cholesterol esterification; P:negative regulation of intracellular cholesterol transport; P:negative regulation of low-density lipoprotein receptor activity; P:negative regulation of phospholipid biosynthetic process; P:negative regulation of receptor-mediated endocytosis involved in cholesterol transport; P:negative regulation of sphingolipid biosynthetic process; P:positive regulation of amyloid precursor protein biosynthetic process; P:positive regulation of amyloid precursor protein catabolic process; P:positive regulation of amyloid-beta formation; P:positive regulation of low-density lipoprotein particle receptor catabolic process; P:regulation of cholesterol esterification; P:regulation of intracellular cholesterol transport; P:regulation of post-translational protein modification; P:regulation of protein glycosylation; P:regulation of protein localization to cell periphery; P:regulation of protein localization to cell surface; P:regulation of transcription by RNA polymerase II; P:response to cholesterol; P:response to drug; P:response to steroid hormone; P:sphingomyelin metabolic process; P:sphingosine biosynthetic process; P:transmembrane transport; P:transport across blood-brain barrier; scaffold281 indexed_genome mRNA 190386 196556 . - . ID=transcript_16463;O95833 Q5SPZ7,Chloride intracellular channel protein 3,, PF13417;, GO:0034707;GO:0005737;GO:0070062;GO:0016604;GO:0005634;GO:0005254;GO:0005244;GO:0006821;GO:0006749;GO:0034765;GO:0007165;, C:chloride channel complex; C:cytoplasm; C:extracellular exosome; C:nuclear body; C:nucleus;, F:chloride channel activity; F:voltage-gated ion channel activity;, P:chloride transport; P:glutathione metabolic process; P:regulation of ion transmembrane transport; P:signal transduction;|O95833 Q5SPZ7,Chloride intracellular channel protein 3,, PF13417;, GO:0034707;GO:0005737;GO:0070062;GO:0016604;GO:0005634;GO:0005254;GO:0005244;GO:0006821;GO:0006749;GO:0034765;GO:0007165;, C:chloride channel complex; C:cytoplasm; C:extracellular exosome; C:nuclear body; C:nucleus;, F:chloride channel activity; F:voltage-gated ion channel activity;, P:chloride transport; P:glutathione metabolic process; P:regulation of ion transmembrane transport; P:signal transduction;|Q9BUH6 Q8IY19,Protein PAXX {ECO:0000305},Paralog of XRCC4 and XLF {ECO:0000303|PubMed:25574025};XRCC4-like small protein {ECO:0000303|PubMed:25941166};, PF15384;, GO:0070419;GO:0005654;GO:0005634;GO:0035861;GO:0042802;GO:0060090;GO:0042803;GO:0006974;GO:0006303;, C:nonhomologous end joining complex; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:identical protein binding; F:molecular adaptor activity; F:protein homodimerization activity;, P:cellular response to DNA damage stimulus; P:double-strand break repair via nonhomologous end joining;|Q9BUH6 Q8IY19,Protein PAXX {ECO:0000305},Paralog of XRCC4 and XLF {ECO:0000303|PubMed:25574025};XRCC4-like small protein {ECO:0000303|PubMed:25941166};, PF15384;, GO:0070419;GO:0005654;GO:0005634;GO:0035861;GO:0042802;GO:0060090;GO:0042803;GO:0006974;GO:0006303;, C:nonhomologous end joining complex; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:identical protein binding; F:molecular adaptor activity; F:protein homodimerization activity;, P:cellular response to DNA damage stimulus; P:double-strand break repair via nonhomologous end joining; scaffold281 indexed_genome mRNA 205540 212245 . - . ID=transcript_16464;Q6ZST4,Lipocalin-like 1 protein,, PF00061;, GO:0036094;, , F:small molecule binding;|P41222 B2R727 Q5SQ10 Q7M4P3 Q9UC22 Q9UCC9 Q9UCD9,Prostaglandin-H2 D-isomerase,Beta-trace protein;Cerebrin-28;Glutathione-independent PGD synthase;Lipocalin-type prostaglandin-D synthase;Prostaglandin-D2 synthase;, PF00061;, GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0031965;GO:0048471;GO:0005791;GO:0005504;GO:0004667;GO:0005501;GO:0036094;GO:0019371;GO:0043303;GO:0001516;GO:0045187;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:nuclear membrane; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum;, F:fatty acid binding; F:prostaglandin-D synthase activity; F:retinoid binding; F:small molecule binding;, P:cyclooxygenase pathway; P:mast cell degranulation; P:prostaglandin biosynthetic process; P:regulation of circadian sleep/wake cycle, sleep;|P41222 B2R727 Q5SQ10 Q7M4P3 Q9UC22 Q9UCC9 Q9UCD9,Prostaglandin-H2 D-isomerase,Beta-trace protein;Cerebrin-28;Glutathione-independent PGD synthase;Lipocalin-type prostaglandin-D synthase;Prostaglandin-D2 synthase;, PF00061;, GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0031965;GO:0048471;GO:0005791;GO:0005504;GO:0004667;GO:0005501;GO:0036094;GO:0019371;GO:0043303;GO:0001516;GO:0045187;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:nuclear membrane; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum;, F:fatty acid binding; F:prostaglandin-D synthase activity; F:retinoid binding; F:small molecule binding;, P:cyclooxygenase pathway; P:mast cell degranulation; P:prostaglandin biosynthetic process; P:regulation of circadian sleep/wake cycle, sleep;|P41222 B2R727 Q5SQ10 Q7M4P3 Q9UC22 Q9UCC9 Q9UCD9,Prostaglandin-H2 D-isomerase,Beta-trace protein;Cerebrin-28;Glutathione-independent PGD synthase;Lipocalin-type prostaglandin-D synthase;Prostaglandin-D2 synthase;, PF00061;, GO:0005789;GO:0070062;GO:0005576;GO:0005615;GO:0005794;GO:0031965;GO:0048471;GO:0005791;GO:0005504;GO:0004667;GO:0005501;GO:0036094;GO:0019371;GO:0043303;GO:0001516;GO:0045187;, C:endoplasmic reticulum membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:Golgi apparatus; C:nuclear membrane; C:perinuclear region of cytoplasm; C:rough endoplasmic reticulum;, F:fatty acid binding; F:prostaglandin-D synthase activity; F:retinoid binding; F:small molecule binding;, P:cyclooxygenase pathway; P:mast cell degranulation; P:prostaglandin biosynthetic process; P:regulation of circadian sleep/wake cycle, sleep; scaffold281 indexed_genome mRNA 253866 265076 . - . ID=transcript_16465;Q12933 A8K107 B4DPJ7 Q7Z337 Q96NT2,TNF receptor-associated factor 2,E3 ubiquitin-protein ligase TRAF2;RING-type E3 ubiquitin transferase TRAF2 {ECO:0000305};Tumor necrosis factor type 2 receptor-associated protein 3;, PF16673;PF00097;PF02176;, GO:0035631;GO:0005938;GO:0009898;GO:0005829;GO:1990604;GO:0045121;GO:0005654;GO:0097057;GO:0002947;GO:0000151;GO:0012506;GO:0005174;GO:0019899;GO:0042802;GO:0031435;GO:0019901;GO:0019903;GO:0044877;GO:0030674;GO:0046625;GO:0031996;GO:0043120;GO:0005164;GO:0031625;GO:0004842;GO:0008270;GO:0006919;GO:0007250;GO:0034622;GO:0071732;GO:0071550;GO:0007249;GO:0070059;GO:1902042;GO:0034351;GO:1901215;GO:0051091;GO:2001238;GO:0043123;GO:1903721;GO:0032743;GO:0046330;GO:0043507;GO:0051092;GO:0002726;GO:1903265;GO:0097300;GO:0051865;GO:0030163;GO:0016579;GO:0070534;GO:0065003;GO:0042981;GO:1902041;GO:0043122;GO:0002637;GO:0043254;GO:0010803;GO:0034976;GO:0007165;GO:0033209;, C:CD40 receptor complex; C:cell cortex; C:cytoplasmic side of plasma membrane; C:cytosol; C:IRE1-TRAF2-ASK1 complex; C:membrane raft; C:nucleoplasm; C:TRAF2-GSTP1 complex; C:tumor necrosis factor receptor superfamily complex; C:ubiquitin ligase complex; C:vesicle membrane;, F:CD40 receptor binding; F:enzyme binding; F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:sphingolipid binding; F:thioesterase binding; F:tumor necrosis factor binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of NF-kappaB-inducing kinase activity; P:cellular protein-containing complex assembly; P:cellular response to nitric oxide; P:death-inducing signaling complex assembly; P:I-kappaB kinase/NF-kappaB signaling; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of glial cell apoptotic process; P:negative regulation of neuron death; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of interleukin-2 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T cell cytokine production; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:programmed necrotic cell death; P:protein autoubiquitination; P:protein catabolic process; P:protein deubiquitination; P:protein K63-linked ubiquitination; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of immunoglobulin production; P:regulation of protein-containing complex assembly; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to endoplasmic reticulum stress; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway;|Q12933 A8K107 B4DPJ7 Q7Z337 Q96NT2,TNF receptor-associated factor 2,E3 ubiquitin-protein ligase TRAF2;RING-type E3 ubiquitin transferase TRAF2 {ECO:0000305};Tumor necrosis factor type 2 receptor-associated protein 3;, PF16673;PF00097;PF02176;, GO:0035631;GO:0005938;GO:0009898;GO:0005829;GO:1990604;GO:0045121;GO:0005654;GO:0097057;GO:0002947;GO:0000151;GO:0012506;GO:0005174;GO:0019899;GO:0042802;GO:0031435;GO:0019901;GO:0019903;GO:0044877;GO:0030674;GO:0046625;GO:0031996;GO:0043120;GO:0005164;GO:0031625;GO:0004842;GO:0008270;GO:0006919;GO:0007250;GO:0034622;GO:0071732;GO:0071550;GO:0007249;GO:0070059;GO:1902042;GO:0034351;GO:1901215;GO:0051091;GO:2001238;GO:0043123;GO:1903721;GO:0032743;GO:0046330;GO:0043507;GO:0051092;GO:0002726;GO:1903265;GO:0097300;GO:0051865;GO:0030163;GO:0016579;GO:0070534;GO:0065003;GO:0042981;GO:1902041;GO:0043122;GO:0002637;GO:0043254;GO:0010803;GO:0034976;GO:0007165;GO:0033209;, C:CD40 receptor complex; C:cell cortex; C:cytoplasmic side of plasma membrane; C:cytosol; C:IRE1-TRAF2-ASK1 complex; C:membrane raft; C:nucleoplasm; C:TRAF2-GSTP1 complex; C:tumor necrosis factor receptor superfamily complex; C:ubiquitin ligase complex; C:vesicle membrane;, F:CD40 receptor binding; F:enzyme binding; F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:sphingolipid binding; F:thioesterase binding; F:tumor necrosis factor binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of NF-kappaB-inducing kinase activity; P:cellular protein-containing complex assembly; P:cellular response to nitric oxide; P:death-inducing signaling complex assembly; P:I-kappaB kinase/NF-kappaB signaling; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of glial cell apoptotic process; P:negative regulation of neuron death; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of interleukin-2 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T cell cytokine production; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:programmed necrotic cell death; P:protein autoubiquitination; P:protein catabolic process; P:protein deubiquitination; P:protein K63-linked ubiquitination; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of immunoglobulin production; P:regulation of protein-containing complex assembly; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to endoplasmic reticulum stress; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; scaffold285 indexed_genome mRNA 135360 144891 . - . ID=transcript_16466;Q9H0E2 B3KXC6 Q9H9E6 Q9UJ69,Toll-interacting protein,, PF00168;PF02845;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0016604;GO:0048471;GO:0032991;GO:0035580;GO:0005150;GO:0019900;GO:0032183;GO:0035325;GO:0043130;GO:0031624;GO:0031625;GO:0006914;GO:0030855;GO:0006954;GO:0045087;GO:0070498;GO:0045321;GO:0043312;GO:0016310;GO:0033235;GO:0036010;GO:0007165;GO:0006511;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nuclear body; C:perinuclear region of cytoplasm; C:protein-containing complex; C:specific granule lumen;, F:interleukin-1, type I receptor binding; F:kinase binding; F:SUMO binding; F:Toll-like receptor binding; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding;, P:autophagy; P:epithelial cell differentiation; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:leukocyte activation; P:neutrophil degranulation; P:phosphorylation; P:positive regulation of protein sumoylation; P:protein localization to endosome; P:signal transduction; P:ubiquitin-dependent protein catabolic process;|Q9H0E2 B3KXC6 Q9H9E6 Q9UJ69,Toll-interacting protein,, PF00168;PF02845;, GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0016604;GO:0048471;GO:0032991;GO:0035580;GO:0005150;GO:0019900;GO:0032183;GO:0035325;GO:0043130;GO:0031624;GO:0031625;GO:0006914;GO:0030855;GO:0006954;GO:0045087;GO:0070498;GO:0045321;GO:0043312;GO:0016310;GO:0033235;GO:0036010;GO:0007165;GO:0006511;, C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:nuclear body; C:perinuclear region of cytoplasm; C:protein-containing complex; C:specific granule lumen;, F:interleukin-1, type I receptor binding; F:kinase binding; F:SUMO binding; F:Toll-like receptor binding; F:ubiquitin binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin protein ligase binding;, P:autophagy; P:epithelial cell differentiation; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:leukocyte activation; P:neutrophil degranulation; P:phosphorylation; P:positive regulation of protein sumoylation; P:protein localization to endosome; P:signal transduction; P:ubiquitin-dependent protein catabolic process; scaffold286 indexed_genome mRNA 37249 79364 . - . ID=transcript_16467;P05181 Q5VZD5 Q6NWT9 Q9UK47,Cytochrome P450 2E1 {ECO:0000303|PubMed:8031147},4-nitrophenol 2-hydroxylase;CYPIIE1;Cytochrome P450-J;, PF00067;, GO:0005737;GO:0005789;GO:0000139;GO:0043231;GO:0031227;GO:0005743;GO:0018601;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0030544;GO:0051879;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0016712;GO:0019825;GO:0008395;GO:0018960;GO:0018910;GO:0018885;GO:0017144;GO:0019373;GO:0042738;GO:0042197;GO:0046483;GO:0002933;GO:0042759;GO:0016098;GO:0006082;GO:0009617;GO:0045471;GO:0010243;GO:0010193;GO:0008202;GO:0006641;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of endoplasmic reticulum membrane; C:mitochondrial inner membrane;, F:4-nitrophenol 2-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:4-nitrophenol metabolic process; P:benzene metabolic process; P:carbon tetrachloride metabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:halogenated hydrocarbon metabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:organic acid metabolic process; P:response to bacterium; P:response to ethanol; P:response to organonitrogen compound; P:response to ozone; P:steroid metabolic process; P:triglyceride metabolic process; P:xenobiotic metabolic process;|Q8N0S2 B2RC80 Q9BWU3 Q9BWU4,Synaptonemal complex central element protein 1,Cancer/testis antigen 76;, PF15233;, GO:0000801;GO:0005694;GO:0005829;GO:0043231;GO:0005654;GO:0000795;GO:0051301;GO:0007130;, C:central element; C:chromosome; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:synaptonemal complex;, , P:cell division; P:synaptonemal complex assembly;|Q8N0S2 B2RC80 Q9BWU3 Q9BWU4,Synaptonemal complex central element protein 1,Cancer/testis antigen 76;, PF15233;, GO:0000801;GO:0005694;GO:0005829;GO:0043231;GO:0005654;GO:0000795;GO:0051301;GO:0007130;, C:central element; C:chromosome; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:synaptonemal complex;, , P:cell division; P:synaptonemal complex assembly;|P05181 Q5VZD5 Q6NWT9 Q9UK47,Cytochrome P450 2E1 {ECO:0000303|PubMed:8031147},4-nitrophenol 2-hydroxylase;CYPIIE1;Cytochrome P450-J;, PF00067;, GO:0005737;GO:0005789;GO:0000139;GO:0043231;GO:0031227;GO:0005743;GO:0018601;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0030544;GO:0051879;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0016712;GO:0019825;GO:0008395;GO:0018960;GO:0018910;GO:0018885;GO:0017144;GO:0019373;GO:0042738;GO:0042197;GO:0046483;GO:0002933;GO:0042759;GO:0016098;GO:0006082;GO:0009617;GO:0045471;GO:0010243;GO:0010193;GO:0008202;GO:0006641;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of endoplasmic reticulum membrane; C:mitochondrial inner membrane;, F:4-nitrophenol 2-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:4-nitrophenol metabolic process; P:benzene metabolic process; P:carbon tetrachloride metabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:halogenated hydrocarbon metabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:organic acid metabolic process; P:response to bacterium; P:response to ethanol; P:response to organonitrogen compound; P:response to ozone; P:steroid metabolic process; P:triglyceride metabolic process; P:xenobiotic metabolic process;|P05181 Q5VZD5 Q6NWT9 Q9UK47,Cytochrome P450 2E1 {ECO:0000303|PubMed:8031147},4-nitrophenol 2-hydroxylase;CYPIIE1;Cytochrome P450-J;, PF00067;, GO:0005737;GO:0005789;GO:0000139;GO:0043231;GO:0031227;GO:0005743;GO:0018601;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0030544;GO:0051879;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0016712;GO:0019825;GO:0008395;GO:0018960;GO:0018910;GO:0018885;GO:0017144;GO:0019373;GO:0042738;GO:0042197;GO:0046483;GO:0002933;GO:0042759;GO:0016098;GO:0006082;GO:0009617;GO:0045471;GO:0010243;GO:0010193;GO:0008202;GO:0006641;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of endoplasmic reticulum membrane; C:mitochondrial inner membrane;, F:4-nitrophenol 2-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:4-nitrophenol metabolic process; P:benzene metabolic process; P:carbon tetrachloride metabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:halogenated hydrocarbon metabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:organic acid metabolic process; P:response to bacterium; P:response to ethanol; P:response to organonitrogen compound; P:response to ozone; P:steroid metabolic process; P:triglyceride metabolic process; P:xenobiotic metabolic process;|P05181 Q5VZD5 Q6NWT9 Q9UK47,Cytochrome P450 2E1 {ECO:0000303|PubMed:8031147},4-nitrophenol 2-hydroxylase;CYPIIE1;Cytochrome P450-J;, PF00067;, GO:0005737;GO:0005789;GO:0000139;GO:0043231;GO:0031227;GO:0005743;GO:0018601;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0030544;GO:0051879;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0016712;GO:0019825;GO:0008395;GO:0018960;GO:0018910;GO:0018885;GO:0017144;GO:0019373;GO:0042738;GO:0042197;GO:0046483;GO:0002933;GO:0042759;GO:0016098;GO:0006082;GO:0009617;GO:0045471;GO:0010243;GO:0010193;GO:0008202;GO:0006641;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of endoplasmic reticulum membrane; C:mitochondrial inner membrane;, F:4-nitrophenol 2-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:4-nitrophenol metabolic process; P:benzene metabolic process; P:carbon tetrachloride metabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:halogenated hydrocarbon metabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:organic acid metabolic process; P:response to bacterium; P:response to ethanol; P:response to organonitrogen compound; P:response to ozone; P:steroid metabolic process; P:triglyceride metabolic process; P:xenobiotic metabolic process;|P05181 Q5VZD5 Q6NWT9 Q9UK47,Cytochrome P450 2E1 {ECO:0000303|PubMed:8031147},4-nitrophenol 2-hydroxylase;CYPIIE1;Cytochrome P450-J;, PF00067;, GO:0005737;GO:0005789;GO:0000139;GO:0043231;GO:0031227;GO:0005743;GO:0018601;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0030544;GO:0051879;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0016712;GO:0019825;GO:0008395;GO:0018960;GO:0018910;GO:0018885;GO:0017144;GO:0019373;GO:0042738;GO:0042197;GO:0046483;GO:0002933;GO:0042759;GO:0016098;GO:0006082;GO:0009617;GO:0045471;GO:0010243;GO:0010193;GO:0008202;GO:0006641;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of endoplasmic reticulum membrane; C:mitochondrial inner membrane;, F:4-nitrophenol 2-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:4-nitrophenol metabolic process; P:benzene metabolic process; P:carbon tetrachloride metabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:halogenated hydrocarbon metabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:organic acid metabolic process; P:response to bacterium; P:response to ethanol; P:response to organonitrogen compound; P:response to ozone; P:steroid metabolic process; P:triglyceride metabolic process; P:xenobiotic metabolic process;|P05181 Q5VZD5 Q6NWT9 Q9UK47,Cytochrome P450 2E1 {ECO:0000303|PubMed:8031147},4-nitrophenol 2-hydroxylase;CYPIIE1;Cytochrome P450-J;, PF00067;, GO:0005737;GO:0005789;GO:0000139;GO:0043231;GO:0031227;GO:0005743;GO:0018601;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0030544;GO:0051879;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0016712;GO:0019825;GO:0008395;GO:0018960;GO:0018910;GO:0018885;GO:0017144;GO:0019373;GO:0042738;GO:0042197;GO:0046483;GO:0002933;GO:0042759;GO:0016098;GO:0006082;GO:0009617;GO:0045471;GO:0010243;GO:0010193;GO:0008202;GO:0006641;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of endoplasmic reticulum membrane; C:mitochondrial inner membrane;, F:4-nitrophenol 2-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:4-nitrophenol metabolic process; P:benzene metabolic process; P:carbon tetrachloride metabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:halogenated hydrocarbon metabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:organic acid metabolic process; P:response to bacterium; P:response to ethanol; P:response to organonitrogen compound; P:response to ozone; P:steroid metabolic process; P:triglyceride metabolic process; P:xenobiotic metabolic process;|P05181 Q5VZD5 Q6NWT9 Q9UK47,Cytochrome P450 2E1 {ECO:0000303|PubMed:8031147},4-nitrophenol 2-hydroxylase;CYPIIE1;Cytochrome P450-J;, PF00067;, GO:0005737;GO:0005789;GO:0000139;GO:0043231;GO:0031227;GO:0005743;GO:0018601;GO:0008392;GO:0070330;GO:0019899;GO:0020037;GO:0030544;GO:0051879;GO:0005506;GO:0004497;GO:0016491;GO:0016709;GO:0016712;GO:0019825;GO:0008395;GO:0018960;GO:0018910;GO:0018885;GO:0017144;GO:0019373;GO:0042738;GO:0042197;GO:0046483;GO:0002933;GO:0042759;GO:0016098;GO:0006082;GO:0009617;GO:0045471;GO:0010243;GO:0010193;GO:0008202;GO:0006641;GO:0006805;, C:cytoplasm; C:endoplasmic reticulum membrane; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:intrinsic component of endoplasmic reticulum membrane; C:mitochondrial inner membrane;, F:4-nitrophenol 2-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:aromatase activity; F:enzyme binding; F:heme binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:oxygen binding; F:steroid hydroxylase activity;, P:4-nitrophenol metabolic process; P:benzene metabolic process; P:carbon tetrachloride metabolic process; P:drug metabolic process; P:epoxygenase P450 pathway; P:exogenous drug catabolic process; P:halogenated hydrocarbon metabolic process; P:heterocycle metabolic process; P:lipid hydroxylation; P:long-chain fatty acid biosynthetic process; P:monoterpenoid metabolic process; P:organic acid metabolic process; P:response to bacterium; P:response to ethanol; P:response to organonitrogen compound; P:response to ozone; P:steroid metabolic process; P:triglyceride metabolic process; P:xenobiotic metabolic process; scaffold290 indexed_genome mRNA 45408 46792 . - . ID=transcript_16468;O75380,NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial,Complex I-13kD-A;NADH-ubiquinone oxidoreductase 13 kDa-A subunit;, PF10276;, GO:0005743;GO:0005747;GO:0009055;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:electron transfer activity; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold290 indexed_genome mRNA 49065 50517 . - . ID=transcript_16469;O75380,NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial,Complex I-13kD-A;NADH-ubiquinone oxidoreductase 13 kDa-A subunit;, PF10276;, GO:0005743;GO:0005747;GO:0009055;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:electron transfer activity; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold293 indexed_genome mRNA 80112 89331 . - . ID=transcript_16470;Q9NXB0 B7WNX4 F5H885 Q284T0 Q96G13,Meckel syndrome type 1 protein,, PF07162;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0036038;GO:0097711;GO:0060271;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly;|Q9NXB0 B7WNX4 F5H885 Q284T0 Q96G13,Meckel syndrome type 1 protein,, PF07162;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0036038;GO:0097711;GO:0060271;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly;|Q9NXB0 B7WNX4 F5H885 Q284T0 Q96G13,Meckel syndrome type 1 protein,, PF07162;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0036038;GO:0097711;GO:0060271;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly;|Q9NXB0 B7WNX4 F5H885 Q284T0 Q96G13,Meckel syndrome type 1 protein,, PF07162;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0036038;GO:0097711;GO:0060271;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly;|Q9NXB0 B7WNX4 F5H885 Q284T0 Q96G13,Meckel syndrome type 1 protein,, PF07162;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0036038;GO:0097711;GO:0060271;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly;|Q9NXB0 B7WNX4 F5H885 Q284T0 Q96G13,Meckel syndrome type 1 protein,, PF07162;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0036038;GO:0097711;GO:0060271;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly;|Q9NXB0 B7WNX4 F5H885 Q284T0 Q96G13,Meckel syndrome type 1 protein,, PF07162;, GO:0005813;GO:0036064;GO:0005737;GO:0005829;GO:0036038;GO:0097711;GO:0060271;, C:centrosome; C:ciliary basal body; C:cytoplasm; C:cytosol; C:MKS complex;, , P:ciliary basal body-plasma membrane docking; P:cilium assembly; scaffold293 indexed_genome mRNA 204335 206217 . + . ID=transcript_16471;O95153 O75111 Q8N5W3,Peripheral-type benzodiazepine receptor-associated protein 1,Peripheral benzodiazepine receptor-interacting protein;RIMS-binding protein 1;TSPO-associated protein 1 {ECO:0000312|HGNC:HGNC:16831};, PF07653;PF14604;, GO:0044305;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0030156;GO:0099626;GO:0006700;GO:0006836;, C:calyx of Held; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion;, F:benzodiazepine receptor binding; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:C21-steroid hormone biosynthetic process; P:neurotransmitter transport; scaffold293 indexed_genome mRNA 207296 222934 . - . ID=transcript_16472;O95153 O75111 Q8N5W3,Peripheral-type benzodiazepine receptor-associated protein 1,Peripheral benzodiazepine receptor-interacting protein;RIMS-binding protein 1;TSPO-associated protein 1 {ECO:0000312|HGNC:HGNC:16831};, PF07653;PF14604;, GO:0044305;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0030156;GO:0099626;GO:0006700;GO:0006836;, C:calyx of Held; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion;, F:benzodiazepine receptor binding; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:C21-steroid hormone biosynthetic process; P:neurotransmitter transport;|O95153 O75111 Q8N5W3,Peripheral-type benzodiazepine receptor-associated protein 1,Peripheral benzodiazepine receptor-interacting protein;RIMS-binding protein 1;TSPO-associated protein 1 {ECO:0000312|HGNC:HGNC:16831};, PF07653;PF14604;, GO:0044305;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0030156;GO:0099626;GO:0006700;GO:0006836;, C:calyx of Held; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion;, F:benzodiazepine receptor binding; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:C21-steroid hormone biosynthetic process; P:neurotransmitter transport;|O95153 O75111 Q8N5W3,Peripheral-type benzodiazepine receptor-associated protein 1,Peripheral benzodiazepine receptor-interacting protein;RIMS-binding protein 1;TSPO-associated protein 1 {ECO:0000312|HGNC:HGNC:16831};, PF07653;PF14604;, GO:0044305;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0030156;GO:0099626;GO:0006700;GO:0006836;, C:calyx of Held; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion;, F:benzodiazepine receptor binding; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:C21-steroid hormone biosynthetic process; P:neurotransmitter transport;|O95153 O75111 Q8N5W3,Peripheral-type benzodiazepine receptor-associated protein 1,Peripheral benzodiazepine receptor-interacting protein;RIMS-binding protein 1;TSPO-associated protein 1 {ECO:0000312|HGNC:HGNC:16831};, PF07653;PF14604;, GO:0044305;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0030156;GO:0099626;GO:0006700;GO:0006836;, C:calyx of Held; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion;, F:benzodiazepine receptor binding; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:C21-steroid hormone biosynthetic process; P:neurotransmitter transport;|O95153 O75111 Q8N5W3,Peripheral-type benzodiazepine receptor-associated protein 1,Peripheral benzodiazepine receptor-interacting protein;RIMS-binding protein 1;TSPO-associated protein 1 {ECO:0000312|HGNC:HGNC:16831};, PF07653;PF14604;, GO:0044305;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0030156;GO:0099626;GO:0006700;GO:0006836;, C:calyx of Held; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion;, F:benzodiazepine receptor binding; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:C21-steroid hormone biosynthetic process; P:neurotransmitter transport;|O95153 O75111 Q8N5W3,Peripheral-type benzodiazepine receptor-associated protein 1,Peripheral benzodiazepine receptor-interacting protein;RIMS-binding protein 1;TSPO-associated protein 1 {ECO:0000312|HGNC:HGNC:16831};, PF07653;PF14604;, GO:0044305;GO:0005737;GO:0005829;GO:0098978;GO:0005739;GO:0030156;GO:0099626;GO:0006700;GO:0006836;, C:calyx of Held; C:cytoplasm; C:cytosol; C:glutamatergic synapse; C:mitochondrion;, F:benzodiazepine receptor binding; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels;, P:C21-steroid hormone biosynthetic process; P:neurotransmitter transport; scaffold295 indexed_genome mRNA 455 7295 . + . ID=transcript_16473;O75493 O60596 Q6FHI1 Q9UEC4,Carbonic anhydrase-related protein 11,CA-RP XI;Carbonic anhydrase-related protein 2;, PF00194;, GO:0016323;GO:0005576;GO:0016836;GO:0008270;GO:0006730;, C:basolateral plasma membrane; C:extracellular region;, F:hydro-lyase activity; F:zinc ion binding;, P:one-carbon metabolic process;|O75493 O60596 Q6FHI1 Q9UEC4,Carbonic anhydrase-related protein 11,CA-RP XI;Carbonic anhydrase-related protein 2;, PF00194;, GO:0016323;GO:0005576;GO:0016836;GO:0008270;GO:0006730;, C:basolateral plasma membrane; C:extracellular region;, F:hydro-lyase activity; F:zinc ion binding;, P:one-carbon metabolic process;|O75493 O60596 Q6FHI1 Q9UEC4,Carbonic anhydrase-related protein 11,CA-RP XI;Carbonic anhydrase-related protein 2;, PF00194;, GO:0016323;GO:0005576;GO:0016836;GO:0008270;GO:0006730;, C:basolateral plasma membrane; C:extracellular region;, F:hydro-lyase activity; F:zinc ion binding;, P:one-carbon metabolic process;|O75493 O60596 Q6FHI1 Q9UEC4,Carbonic anhydrase-related protein 11,CA-RP XI;Carbonic anhydrase-related protein 2;, PF00194;, GO:0016323;GO:0005576;GO:0016836;GO:0008270;GO:0006730;, C:basolateral plasma membrane; C:extracellular region;, F:hydro-lyase activity; F:zinc ion binding;, P:one-carbon metabolic process; scaffold295 indexed_genome mRNA 46012 51801 . - . ID=transcript_16474;Q6ZN01 B7ZKX4 Q3KQU9 Q8N9Y3,MEF2-activating motif and SAP domain-containing transcriptional regulator,MEF2-activating SAP transcriptional regulatory protein;, PF02037;, GO:0005634;GO:0003712;GO:0010831;GO:0045944;GO:0006357;, C:nucleus;, F:transcription coregulator activity;, P:positive regulation of myotube differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold295 indexed_genome mRNA 52735 55039 . - . ID=transcript_16475;Q5U651 Q6U676,Ras-interacting protein 1,, PF01843;PF00788;, GO:0005911;GO:0005795;GO:0048471;GO:0032991;GO:0051020;GO:0042803;GO:0001525;GO:0048754;GO:0010507;GO:1905709;GO:0035024;GO:2000299;GO:0033625;GO:0043087;GO:0007165;GO:0001570;, C:cell-cell junction; C:Golgi stack; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:GTPase binding; F:protein homodimerization activity;, P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:negative regulation of autophagy; P:negative regulation of membrane permeability; P:negative regulation of Rho protein signal transduction; P:negative regulation of Rho-dependent protein serine/threonine kinase activity; P:positive regulation of integrin activation; P:regulation of GTPase activity; P:signal transduction; P:vasculogenesis;|Q5U651 Q6U676,Ras-interacting protein 1,, PF01843;PF00788;, GO:0005911;GO:0005795;GO:0048471;GO:0032991;GO:0051020;GO:0042803;GO:0001525;GO:0048754;GO:0010507;GO:1905709;GO:0035024;GO:2000299;GO:0033625;GO:0043087;GO:0007165;GO:0001570;, C:cell-cell junction; C:Golgi stack; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:GTPase binding; F:protein homodimerization activity;, P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:negative regulation of autophagy; P:negative regulation of membrane permeability; P:negative regulation of Rho protein signal transduction; P:negative regulation of Rho-dependent protein serine/threonine kinase activity; P:positive regulation of integrin activation; P:regulation of GTPase activity; P:signal transduction; P:vasculogenesis;|Q5U651 Q6U676,Ras-interacting protein 1,, PF01843;PF00788;, GO:0005911;GO:0005795;GO:0048471;GO:0032991;GO:0051020;GO:0042803;GO:0001525;GO:0048754;GO:0010507;GO:1905709;GO:0035024;GO:2000299;GO:0033625;GO:0043087;GO:0007165;GO:0001570;, C:cell-cell junction; C:Golgi stack; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:GTPase binding; F:protein homodimerization activity;, P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:negative regulation of autophagy; P:negative regulation of membrane permeability; P:negative regulation of Rho protein signal transduction; P:negative regulation of Rho-dependent protein serine/threonine kinase activity; P:positive regulation of integrin activation; P:regulation of GTPase activity; P:signal transduction; P:vasculogenesis; scaffold295 indexed_genome mRNA 55341 62835 . + . ID=transcript_16476;Q5U651 Q6U676,Ras-interacting protein 1,, PF01843;PF00788;, GO:0005911;GO:0005795;GO:0048471;GO:0032991;GO:0051020;GO:0042803;GO:0001525;GO:0048754;GO:0010507;GO:1905709;GO:0035024;GO:2000299;GO:0033625;GO:0043087;GO:0007165;GO:0001570;, C:cell-cell junction; C:Golgi stack; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:GTPase binding; F:protein homodimerization activity;, P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:negative regulation of autophagy; P:negative regulation of membrane permeability; P:negative regulation of Rho protein signal transduction; P:negative regulation of Rho-dependent protein serine/threonine kinase activity; P:positive regulation of integrin activation; P:regulation of GTPase activity; P:signal transduction; P:vasculogenesis;|Q5U651 Q6U676,Ras-interacting protein 1,, PF01843;PF00788;, GO:0005911;GO:0005795;GO:0048471;GO:0032991;GO:0051020;GO:0042803;GO:0001525;GO:0048754;GO:0010507;GO:1905709;GO:0035024;GO:2000299;GO:0033625;GO:0043087;GO:0007165;GO:0001570;, C:cell-cell junction; C:Golgi stack; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:GTPase binding; F:protein homodimerization activity;, P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:negative regulation of autophagy; P:negative regulation of membrane permeability; P:negative regulation of Rho protein signal transduction; P:negative regulation of Rho-dependent protein serine/threonine kinase activity; P:positive regulation of integrin activation; P:regulation of GTPase activity; P:signal transduction; P:vasculogenesis; scaffold295 indexed_genome mRNA 71438 72047 . - . ID=transcript_16477;Q8IYV9 Q6Q8P6 Q6Q8P7,Izumo sperm-egg fusion protein 1 {ECO:0000305},Oocyte binding/fusion factor {ECO:0000303|PubMed:15759005};Sperm-specific protein izumo {ECO:0000303|PubMed:15759005};, PF15005;PF16706;, GO:0002080;GO:0016021;GO:0005886;GO:0042802;GO:0086080;GO:0042803;GO:0005102;GO:0007155;GO:0007342;GO:0034113;GO:0007338;GO:0035036;, C:acrosomal membrane; C:integral component of membrane; C:plasma membrane;, F:identical protein binding; F:protein binding involved in heterotypic cell-cell adhesion; F:protein homodimerization activity; F:signaling receptor binding;, P:cell adhesion; P:fusion of sperm to egg plasma membrane involved in single fertilization; P:heterotypic cell-cell adhesion; P:single fertilization; P:sperm-egg recognition; scaffold295 indexed_genome mRNA 75685 77345 . + . ID=transcript_16478;P19526 O14505 O14506 O14507,Galactoside alpha-(1,2)-fucosyltransferase 1 {ECO:0000305},Alpha(1,2)FT 1;Blood group H alpha 2-fucosyltransferase;Fucosyltransferase 1;GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1;Type 1 galactoside alpha-(1,2)-fucosyltransferase FUT1 {ECO:0000250|UniProtKB:O09160};Type 2 galactoside alpha-(1,2)-fucosyltransferase FUT1 {ECO:0000305};, PF01531;, GO:0005794;GO:0032580;GO:0000139;GO:0005887;GO:0016020;GO:0031127;GO:0008417;GO:0008107;GO:0005975;GO:0036065;GO:0042355;GO:0021772;GO:0009312;GO:0001954;GO:0010595;GO:1904906;GO:1903672;GO:0006486;GO:0030155;GO:0001936;, C:Golgi apparatus; C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of plasma membrane; C:membrane;, F:alpha-(1,2)-fucosyltransferase activity; F:fucosyltransferase activity; F:galactoside 2-alpha-L-fucosyltransferase activity;, P:carbohydrate metabolic process; P:fucosylation; P:L-fucose catabolic process; P:olfactory bulb development; P:oligosaccharide biosynthetic process; P:positive regulation of cell-matrix adhesion; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell-matrix adhesion via fibronectin; P:positive regulation of sprouting angiogenesis; P:protein glycosylation; P:regulation of cell adhesion; P:regulation of endothelial cell proliferation; scaffold295 indexed_genome mRNA 80995 82700 . - . ID=transcript_16479;Q9NSA1 Q8N683,Fibroblast growth factor 21,, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0009887;GO:0030154;GO:0007267;GO:0035690;GO:0071377;GO:0071333;GO:0071404;GO:0030968;GO:0072577;GO:0008543;GO:2000352;GO:1901215;GO:0008284;GO:0120162;GO:0070374;GO:0010628;GO:0046326;GO:1905599;GO:0090080;GO:0001934;GO:0010898;GO:0030334;GO:0010988;GO:0014823;GO:1904640;GO:0031667;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:cellular response to drug; P:cellular response to glucagon stimulus; P:cellular response to glucose stimulus; P:cellular response to low-density lipoprotein particle stimulus; P:endoplasmic reticulum unfolded protein response; P:endothelial cell apoptotic process; P:fibroblast growth factor receptor signaling pathway; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of neuron death; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; P:positive regulation of protein phosphorylation; P:positive regulation of triglyceride catabolic process; P:regulation of cell migration; P:regulation of low-density lipoprotein particle clearance; P:response to activity; P:response to methionine; P:response to nutrient levels; P:signal transduction;|Q9NSA1 Q8N683,Fibroblast growth factor 21,, PF00167;, GO:0005737;GO:0005576;GO:0005615;GO:0005104;GO:0008083;GO:0009887;GO:0030154;GO:0007267;GO:0035690;GO:0071377;GO:0071333;GO:0071404;GO:0030968;GO:0072577;GO:0008543;GO:2000352;GO:1901215;GO:0008284;GO:0120162;GO:0070374;GO:0010628;GO:0046326;GO:1905599;GO:0090080;GO:0001934;GO:0010898;GO:0030334;GO:0010988;GO:0014823;GO:1904640;GO:0031667;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space;, F:fibroblast growth factor receptor binding; F:growth factor activity;, P:animal organ morphogenesis; P:cell differentiation; P:cell-cell signaling; P:cellular response to drug; P:cellular response to glucagon stimulus; P:cellular response to glucose stimulus; P:cellular response to low-density lipoprotein particle stimulus; P:endoplasmic reticulum unfolded protein response; P:endothelial cell apoptotic process; P:fibroblast growth factor receptor signaling pathway; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of neuron death; P:positive regulation of cell population proliferation; P:positive regulation of cold-induced thermogenesis; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of low-density lipoprotein receptor activity; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; P:positive regulation of protein phosphorylation; P:positive regulation of triglyceride catabolic process; P:regulation of cell migration; P:regulation of low-density lipoprotein particle clearance; P:response to activity; P:response to methionine; P:response to nutrient levels; P:signal transduction; scaffold295 indexed_genome mRNA 106007 127109 . - . ID=transcript_16480;O15382 B2RB87 O00269 Q96KG1 Q9BTB6 Q9BUU6,Branched-chain-amino-acid aminotransferase, mitochondrial,Placental protein 18;, PF01063;, GO:0005759;GO:0005739;GO:0004084;GO:0052656;GO:0052654;GO:0050048;GO:0052655;GO:0009082;GO:0009083;GO:0009098;GO:0009099;, C:mitochondrial matrix; C:mitochondrion;, F:branched-chain-amino-acid transaminase activity; F:L-isoleucine transaminase activity; F:L-leucine transaminase activity; F:L-leucine:2-oxoglutarate aminotransferase activity; F:L-valine transaminase activity;, P:branched-chain amino acid biosynthetic process; P:branched-chain amino acid catabolic process; P:leucine biosynthetic process; P:valine biosynthetic process;|O15382 B2RB87 O00269 Q96KG1 Q9BTB6 Q9BUU6,Branched-chain-amino-acid aminotransferase, mitochondrial,Placental protein 18;, PF01063;, GO:0005759;GO:0005739;GO:0004084;GO:0052656;GO:0052654;GO:0050048;GO:0052655;GO:0009082;GO:0009083;GO:0009098;GO:0009099;, C:mitochondrial matrix; C:mitochondrion;, F:branched-chain-amino-acid transaminase activity; F:L-isoleucine transaminase activity; F:L-leucine transaminase activity; F:L-leucine:2-oxoglutarate aminotransferase activity; F:L-valine transaminase activity;, P:branched-chain amino acid biosynthetic process; P:branched-chain amino acid catabolic process; P:leucine biosynthetic process; P:valine biosynthetic process;|O15382 B2RB87 O00269 Q96KG1 Q9BTB6 Q9BUU6,Branched-chain-amino-acid aminotransferase, mitochondrial,Placental protein 18;, PF01063;, GO:0005759;GO:0005739;GO:0004084;GO:0052656;GO:0052654;GO:0050048;GO:0052655;GO:0009082;GO:0009083;GO:0009098;GO:0009099;, C:mitochondrial matrix; C:mitochondrion;, F:branched-chain-amino-acid transaminase activity; F:L-isoleucine transaminase activity; F:L-leucine transaminase activity; F:L-leucine:2-oxoglutarate aminotransferase activity; F:L-valine transaminase activity;, P:branched-chain amino acid biosynthetic process; P:branched-chain amino acid catabolic process; P:leucine biosynthetic process; P:valine biosynthetic process;|Q9BPX1 Q9UKU3,17-beta-hydroxysteroid dehydrogenase 14 {ECO:0000305},17-beta-hydroxysteroid dehydrogenase DHRS10;Dehydrogenase/reductase SDR family member 10;Retinal short-chain dehydrogenase/reductase retSDR3;Short chain dehydrogenase/reductase family 47C member 1;, , GO:0005829;GO:0044594;GO:0004303;GO:0042802;GO:0047045;GO:0006703;GO:0006706;, C:cytosol;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:estradiol 17-beta-dehydrogenase activity; F:identical protein binding; F:testosterone 17-beta-dehydrogenase (NADP+) activity;, P:estrogen biosynthetic process; P:steroid catabolic process; scaffold296 indexed_genome mRNA 6889 27832 . - . ID=transcript_16481;O14798 O14755 Q08AS6 Q6FH98 Q6UXM5,Tumor necrosis factor receptor superfamily member 10C,Antagonist decoy receptor for TRAIL/Apo-2L;Decoy TRAIL receptor without death domain;Decoy receptor 1;Lymphocyte inhibitor of TRAIL;TNF-related apoptosis-inducing ligand receptor 3;TRAIL receptor without an intracellular domain;, PF00020;, GO:0031225;GO:0009986;GO:0005886;GO:0045569;GO:0004888;GO:0043065;GO:0042981;GO:0036462;, C:anchored component of membrane; C:cell surface; C:plasma membrane;, F:TRAIL binding; F:transmembrane signaling receptor activity;, P:positive regulation of apoptotic process; P:regulation of apoptotic process; P:TRAIL-activated apoptotic signaling pathway; scaffold296 indexed_genome mRNA 31838 90302 . + . ID=transcript_16482;P49589 Q53XI8 Q5HYE4 Q9HD24 Q9HD25,Cysteine--tRNA ligase, cytoplasmic,Cysteinyl-tRNA synthetase;, PF01406;, GO:0005737;GO:0005829;GO:0005524;GO:0004817;GO:0042802;GO:0046872;GO:0042803;GO:0000049;GO:0006423;GO:0006418;, C:cytoplasm; C:cytosol;, F:ATP binding; F:cysteine-tRNA ligase activity; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:tRNA binding;, P:cysteinyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P49589 Q53XI8 Q5HYE4 Q9HD24 Q9HD25,Cysteine--tRNA ligase, cytoplasmic,Cysteinyl-tRNA synthetase;, PF01406;, GO:0005737;GO:0005829;GO:0005524;GO:0004817;GO:0042802;GO:0046872;GO:0042803;GO:0000049;GO:0006423;GO:0006418;, C:cytoplasm; C:cytosol;, F:ATP binding; F:cysteine-tRNA ligase activity; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:tRNA binding;, P:cysteinyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation;|P49589 Q53XI8 Q5HYE4 Q9HD24 Q9HD25,Cysteine--tRNA ligase, cytoplasmic,Cysteinyl-tRNA synthetase;, PF01406;, GO:0005737;GO:0005829;GO:0005524;GO:0004817;GO:0042802;GO:0046872;GO:0042803;GO:0000049;GO:0006423;GO:0006418;, C:cytoplasm; C:cytosol;, F:ATP binding; F:cysteine-tRNA ligase activity; F:identical protein binding; F:metal ion binding; F:protein homodimerization activity; F:tRNA binding;, P:cysteinyl-tRNA aminoacylation; P:tRNA aminoacylation for protein translation; scaffold296 indexed_genome mRNA 111263 111944 . + . ID=transcript_16483;Q9UQF0 B2RPD4 O95244 O95245 Q8NHY7 Q9NRZ2 Q9NZG3,Syncytin-1,Endogenous retrovirus group W member 1;Env-W;Envelope polyprotein gPr73;Enverin;HERV-7q Envelope protein;HERV-W envelope protein;HERV-W_7q21.2 provirus ancestral Env polyprotein;Syncytin;, PF00429;, GO:0016021;GO:0005886;GO:0009653;GO:0007520;GO:0006949;GO:0000768;, C:integral component of membrane; C:plasma membrane;, , P:anatomical structure morphogenesis; P:myoblast fusion; P:syncytium formation; P:syncytium formation by plasma membrane fusion; scaffold296 indexed_genome mRNA 114266 143907 . + . ID=transcript_16484;Q99733 B2R6J4 F5HFY4,Nucleosome assembly protein 1-like 4,Nucleosome assembly protein 2 {ECO:0000303|PubMed:8923002};, PF00956;, GO:0000785;GO:0005737;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0003723;GO:0051082;GO:0006334;, C:chromatin; C:cytoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:RNA binding; F:unfolded protein binding;, P:nucleosome assembly;|Q99733 B2R6J4 F5HFY4,Nucleosome assembly protein 1-like 4,Nucleosome assembly protein 2 {ECO:0000303|PubMed:8923002};, PF00956;, GO:0000785;GO:0005737;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0003723;GO:0051082;GO:0006334;, C:chromatin; C:cytoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:RNA binding; F:unfolded protein binding;, P:nucleosome assembly;|Q99733 B2R6J4 F5HFY4,Nucleosome assembly protein 1-like 4,Nucleosome assembly protein 2 {ECO:0000303|PubMed:8923002};, PF00956;, GO:0000785;GO:0005737;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0003723;GO:0051082;GO:0006334;, C:chromatin; C:cytoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:RNA binding; F:unfolded protein binding;, P:nucleosome assembly;|Q99733 B2R6J4 F5HFY4,Nucleosome assembly protein 1-like 4,Nucleosome assembly protein 2 {ECO:0000303|PubMed:8923002};, PF00956;, GO:0000785;GO:0005737;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0003723;GO:0051082;GO:0006334;, C:chromatin; C:cytoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:RNA binding; F:unfolded protein binding;, P:nucleosome assembly;|Q99733 B2R6J4 F5HFY4,Nucleosome assembly protein 1-like 4,Nucleosome assembly protein 2 {ECO:0000303|PubMed:8923002};, PF00956;, GO:0000785;GO:0005737;GO:0005634;GO:0003682;GO:0042393;GO:0031491;GO:0003723;GO:0051082;GO:0006334;, C:chromatin; C:cytoplasm; C:nucleus;, F:chromatin binding; F:histone binding; F:nucleosome binding; F:RNA binding; F:unfolded protein binding;, P:nucleosome assembly; scaffold296 indexed_genome mRNA 160969 178035 . - . ID=transcript_16485;Q96BI1 O14906 O43562 O60485 O60680 Q7LDS5 Q7LGF7,Solute carrier family 22 member 18,Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene A protein;Efflux transporter-like protein;Imprinted multi-membrane-spanning polyspecific transporter-related protein 1;Organic cation transporter-like protein 2;Solute carrier family 22 member 1-like;Tumor-suppressing STF cDNA 5 protein;Tumor-suppressing subchromosomal transferable fragment candidate gene 5 protein;p45-Beckwith-Wiedemann region 1 A;, PF07690;, GO:0016324;GO:0005737;GO:0016021;GO:0016020;GO:0005635;GO:0005886;GO:0015293;GO:0022857;GO:0031625;GO:0007588;GO:0015695;GO:1990961;GO:0042908;, C:apical plasma membrane; C:cytoplasm; C:integral component of membrane; C:membrane; C:nuclear envelope; C:plasma membrane;, F:symporter activity; F:transmembrane transporter activity; F:ubiquitin protein ligase binding;, P:excretion; P:organic cation transport; P:xenobiotic detoxification by transmembrane export across the plasma membrane; P:xenobiotic transport; scaffold298 indexed_genome mRNA 1 17458 . + . ID=transcript_16486;P21333 E9KL45 Q5HY53 Q5HY55 Q8NF52,Filamin-A,Actin-binding protein 280;Alpha-filamin;Endothelial actin-binding protein;Filamin-1;Non-muscle filamin;, PF00307;PF00630;, GO:0015629;GO:0005884;GO:0032432;GO:0097440;GO:0044295;GO:0005903;GO:0005911;GO:0030863;GO:0005737;GO:0005829;GO:0043198;GO:0070062;GO:0005576;GO:0005925;GO:0098978;GO:0016020;GO:0031523;GO:0005730;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0098794;GO:0005802;GO:0030018;GO:0051015;GO:0045296;GO:0034988;GO:0001664;GO:0051020;GO:0044325;GO:0019900;GO:0031852;GO:0015459;GO:0042803;GO:0005080;GO:0003723;GO:0046332;GO:0031267;GO:0008134;GO:0051764;GO:0031532;GO:0007195;GO:0001525;GO:0001974;GO:0034329;GO:0045216;GO:0021987;GO:0060271;GO:0051220;GO:0051607;GO:0045022;GO:0001837;GO:0045184;GO:0097368;GO:0021943;GO:0003007;GO:0090307;GO:0042789;GO:0043066;GO:0043433;GO:0010977;GO:0042177;GO:0016479;GO:0030168;GO:0070527;GO:0002576;GO:0032233;GO:0048680;GO:0043123;GO:2001046;GO:2000179;GO:2001224;GO:1901381;GO:0042307;GO:1900026;GO:1902396;GO:0034394;GO:0072659;GO:0050821;GO:0043113;GO:0030334;GO:1905000;GO:1905031;GO:0071526;GO:0050808;GO:0090042;GO:0044319;, C:actin cytoskeleton; C:actin filament; C:actin filament bundle; C:apical dendrite; C:axonal growth cone; C:brush border; C:cell-cell junction; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic shaft; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:glutamatergic synapse; C:membrane; C:Myb complex; C:nucleolus; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:trans-Golgi network; C:Z disc;, F:actin filament binding; F:cadherin binding; F:Fc-gamma receptor I complex binding; F:G protein-coupled receptor binding; F:GTPase binding; F:ion channel binding; F:kinase binding; F:mu-type opioid receptor binding; F:potassium channel regulator activity; F:protein homodimerization activity; F:protein kinase C binding; F:RNA binding; F:SMAD binding; F:small GTPase binding; F:transcription factor binding;, P:actin crosslink formation; P:actin cytoskeleton reorganization; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:angiogenesis; P:blood vessel remodeling; P:cell junction assembly; P:cell-cell junction organization; P:cerebral cortex development; P:cilium assembly; P:cytoplasmic sequestering of protein; P:defense response to virus; P:early endosome to late endosome transport; P:epithelial to mesenchymal transition; P:establishment of protein localization; P:establishment of Sertoli cell barrier; P:formation of radial glial scaffolds; P:heart morphogenesis; P:mitotic spindle assembly; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron projection development; P:negative regulation of protein catabolic process; P:negative regulation of transcription by RNA polymerase I; P:platelet activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of actin filament bundle assembly; P:positive regulation of axon regeneration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron migration; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of protein import into nucleus; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to bicellular tight junction; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein stabilization; P:receptor clustering; P:regulation of cell migration; P:regulation of membrane repolarization during atrial cardiac muscle cell action potential; P:regulation of membrane repolarization during cardiac muscle cell action potential; P:semaphorin-plexin signaling pathway; P:synapse organization; P:tubulin deacetylation; P:wound healing, spreading of cells;|P21333 E9KL45 Q5HY53 Q5HY55 Q8NF52,Filamin-A,Actin-binding protein 280;Alpha-filamin;Endothelial actin-binding protein;Filamin-1;Non-muscle filamin;, PF00307;PF00630;, GO:0015629;GO:0005884;GO:0032432;GO:0097440;GO:0044295;GO:0005903;GO:0005911;GO:0030863;GO:0005737;GO:0005829;GO:0043198;GO:0070062;GO:0005576;GO:0005925;GO:0098978;GO:0016020;GO:0031523;GO:0005730;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0098794;GO:0005802;GO:0030018;GO:0051015;GO:0045296;GO:0034988;GO:0001664;GO:0051020;GO:0044325;GO:0019900;GO:0031852;GO:0015459;GO:0042803;GO:0005080;GO:0003723;GO:0046332;GO:0031267;GO:0008134;GO:0051764;GO:0031532;GO:0007195;GO:0001525;GO:0001974;GO:0034329;GO:0045216;GO:0021987;GO:0060271;GO:0051220;GO:0051607;GO:0045022;GO:0001837;GO:0045184;GO:0097368;GO:0021943;GO:0003007;GO:0090307;GO:0042789;GO:0043066;GO:0043433;GO:0010977;GO:0042177;GO:0016479;GO:0030168;GO:0070527;GO:0002576;GO:0032233;GO:0048680;GO:0043123;GO:2001046;GO:2000179;GO:2001224;GO:1901381;GO:0042307;GO:1900026;GO:1902396;GO:0034394;GO:0072659;GO:0050821;GO:0043113;GO:0030334;GO:1905000;GO:1905031;GO:0071526;GO:0050808;GO:0090042;GO:0044319;, C:actin cytoskeleton; C:actin filament; C:actin filament bundle; C:apical dendrite; C:axonal growth cone; C:brush border; C:cell-cell junction; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic shaft; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:glutamatergic synapse; C:membrane; C:Myb complex; C:nucleolus; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:trans-Golgi network; C:Z disc;, F:actin filament binding; F:cadherin binding; F:Fc-gamma receptor I complex binding; F:G protein-coupled receptor binding; F:GTPase binding; F:ion channel binding; F:kinase binding; F:mu-type opioid receptor binding; F:potassium channel regulator activity; F:protein homodimerization activity; F:protein kinase C binding; F:RNA binding; F:SMAD binding; F:small GTPase binding; F:transcription factor binding;, P:actin crosslink formation; P:actin cytoskeleton reorganization; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:angiogenesis; P:blood vessel remodeling; P:cell junction assembly; P:cell-cell junction organization; P:cerebral cortex development; P:cilium assembly; P:cytoplasmic sequestering of protein; P:defense response to virus; P:early endosome to late endosome transport; P:epithelial to mesenchymal transition; P:establishment of protein localization; P:establishment of Sertoli cell barrier; P:formation of radial glial scaffolds; P:heart morphogenesis; P:mitotic spindle assembly; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron projection development; P:negative regulation of protein catabolic process; P:negative regulation of transcription by RNA polymerase I; P:platelet activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of actin filament bundle assembly; P:positive regulation of axon regeneration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron migration; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of protein import into nucleus; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to bicellular tight junction; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein stabilization; P:receptor clustering; P:regulation of cell migration; P:regulation of membrane repolarization during atrial cardiac muscle cell action potential; P:regulation of membrane repolarization during cardiac muscle cell action potential; P:semaphorin-plexin signaling pathway; P:synapse organization; P:tubulin deacetylation; P:wound healing, spreading of cells;|P21333 E9KL45 Q5HY53 Q5HY55 Q8NF52,Filamin-A,Actin-binding protein 280;Alpha-filamin;Endothelial actin-binding protein;Filamin-1;Non-muscle filamin;, PF00307;PF00630;, GO:0015629;GO:0005884;GO:0032432;GO:0097440;GO:0044295;GO:0005903;GO:0005911;GO:0030863;GO:0005737;GO:0005829;GO:0043198;GO:0070062;GO:0005576;GO:0005925;GO:0098978;GO:0016020;GO:0031523;GO:0005730;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0098794;GO:0005802;GO:0030018;GO:0051015;GO:0045296;GO:0034988;GO:0001664;GO:0051020;GO:0044325;GO:0019900;GO:0031852;GO:0015459;GO:0042803;GO:0005080;GO:0003723;GO:0046332;GO:0031267;GO:0008134;GO:0051764;GO:0031532;GO:0007195;GO:0001525;GO:0001974;GO:0034329;GO:0045216;GO:0021987;GO:0060271;GO:0051220;GO:0051607;GO:0045022;GO:0001837;GO:0045184;GO:0097368;GO:0021943;GO:0003007;GO:0090307;GO:0042789;GO:0043066;GO:0043433;GO:0010977;GO:0042177;GO:0016479;GO:0030168;GO:0070527;GO:0002576;GO:0032233;GO:0048680;GO:0043123;GO:2001046;GO:2000179;GO:2001224;GO:1901381;GO:0042307;GO:1900026;GO:1902396;GO:0034394;GO:0072659;GO:0050821;GO:0043113;GO:0030334;GO:1905000;GO:1905031;GO:0071526;GO:0050808;GO:0090042;GO:0044319;, C:actin cytoskeleton; C:actin filament; C:actin filament bundle; C:apical dendrite; C:axonal growth cone; C:brush border; C:cell-cell junction; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic shaft; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:glutamatergic synapse; C:membrane; C:Myb complex; C:nucleolus; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:trans-Golgi network; C:Z disc;, F:actin filament binding; F:cadherin binding; F:Fc-gamma receptor I complex binding; F:G protein-coupled receptor binding; F:GTPase binding; F:ion channel binding; F:kinase binding; F:mu-type opioid receptor binding; F:potassium channel regulator activity; F:protein homodimerization activity; F:protein kinase C binding; F:RNA binding; F:SMAD binding; F:small GTPase binding; F:transcription factor binding;, P:actin crosslink formation; P:actin cytoskeleton reorganization; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:angiogenesis; P:blood vessel remodeling; P:cell junction assembly; P:cell-cell junction organization; P:cerebral cortex development; P:cilium assembly; P:cytoplasmic sequestering of protein; P:defense response to virus; P:early endosome to late endosome transport; P:epithelial to mesenchymal transition; P:establishment of protein localization; P:establishment of Sertoli cell barrier; P:formation of radial glial scaffolds; P:heart morphogenesis; P:mitotic spindle assembly; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron projection development; P:negative regulation of protein catabolic process; P:negative regulation of transcription by RNA polymerase I; P:platelet activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of actin filament bundle assembly; P:positive regulation of axon regeneration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron migration; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of protein import into nucleus; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to bicellular tight junction; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein stabilization; P:receptor clustering; P:regulation of cell migration; P:regulation of membrane repolarization during atrial cardiac muscle cell action potential; P:regulation of membrane repolarization during cardiac muscle cell action potential; P:semaphorin-plexin signaling pathway; P:synapse organization; P:tubulin deacetylation; P:wound healing, spreading of cells; scaffold298 indexed_genome mRNA 17479 25232 . + . ID=transcript_16487;P21333 E9KL45 Q5HY53 Q5HY55 Q8NF52,Filamin-A,Actin-binding protein 280;Alpha-filamin;Endothelial actin-binding protein;Filamin-1;Non-muscle filamin;, PF00307;PF00630;, GO:0015629;GO:0005884;GO:0032432;GO:0097440;GO:0044295;GO:0005903;GO:0005911;GO:0030863;GO:0005737;GO:0005829;GO:0043198;GO:0070062;GO:0005576;GO:0005925;GO:0098978;GO:0016020;GO:0031523;GO:0005730;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0098794;GO:0005802;GO:0030018;GO:0051015;GO:0045296;GO:0034988;GO:0001664;GO:0051020;GO:0044325;GO:0019900;GO:0031852;GO:0015459;GO:0042803;GO:0005080;GO:0003723;GO:0046332;GO:0031267;GO:0008134;GO:0051764;GO:0031532;GO:0007195;GO:0001525;GO:0001974;GO:0034329;GO:0045216;GO:0021987;GO:0060271;GO:0051220;GO:0051607;GO:0045022;GO:0001837;GO:0045184;GO:0097368;GO:0021943;GO:0003007;GO:0090307;GO:0042789;GO:0043066;GO:0043433;GO:0010977;GO:0042177;GO:0016479;GO:0030168;GO:0070527;GO:0002576;GO:0032233;GO:0048680;GO:0043123;GO:2001046;GO:2000179;GO:2001224;GO:1901381;GO:0042307;GO:1900026;GO:1902396;GO:0034394;GO:0072659;GO:0050821;GO:0043113;GO:0030334;GO:1905000;GO:1905031;GO:0071526;GO:0050808;GO:0090042;GO:0044319;, C:actin cytoskeleton; C:actin filament; C:actin filament bundle; C:apical dendrite; C:axonal growth cone; C:brush border; C:cell-cell junction; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic shaft; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:glutamatergic synapse; C:membrane; C:Myb complex; C:nucleolus; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:trans-Golgi network; C:Z disc;, F:actin filament binding; F:cadherin binding; F:Fc-gamma receptor I complex binding; F:G protein-coupled receptor binding; F:GTPase binding; F:ion channel binding; F:kinase binding; F:mu-type opioid receptor binding; F:potassium channel regulator activity; F:protein homodimerization activity; F:protein kinase C binding; F:RNA binding; F:SMAD binding; F:small GTPase binding; F:transcription factor binding;, P:actin crosslink formation; P:actin cytoskeleton reorganization; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:angiogenesis; P:blood vessel remodeling; P:cell junction assembly; P:cell-cell junction organization; P:cerebral cortex development; P:cilium assembly; P:cytoplasmic sequestering of protein; P:defense response to virus; P:early endosome to late endosome transport; P:epithelial to mesenchymal transition; P:establishment of protein localization; P:establishment of Sertoli cell barrier; P:formation of radial glial scaffolds; P:heart morphogenesis; P:mitotic spindle assembly; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron projection development; P:negative regulation of protein catabolic process; P:negative regulation of transcription by RNA polymerase I; P:platelet activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of actin filament bundle assembly; P:positive regulation of axon regeneration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron migration; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of protein import into nucleus; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to bicellular tight junction; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein stabilization; P:receptor clustering; P:regulation of cell migration; P:regulation of membrane repolarization during atrial cardiac muscle cell action potential; P:regulation of membrane repolarization during cardiac muscle cell action potential; P:semaphorin-plexin signaling pathway; P:synapse organization; P:tubulin deacetylation; P:wound healing, spreading of cells;|P21333 E9KL45 Q5HY53 Q5HY55 Q8NF52,Filamin-A,Actin-binding protein 280;Alpha-filamin;Endothelial actin-binding protein;Filamin-1;Non-muscle filamin;, PF00307;PF00630;, GO:0015629;GO:0005884;GO:0032432;GO:0097440;GO:0044295;GO:0005903;GO:0005911;GO:0030863;GO:0005737;GO:0005829;GO:0043198;GO:0070062;GO:0005576;GO:0005925;GO:0098978;GO:0016020;GO:0031523;GO:0005730;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0098794;GO:0005802;GO:0030018;GO:0051015;GO:0045296;GO:0034988;GO:0001664;GO:0051020;GO:0044325;GO:0019900;GO:0031852;GO:0015459;GO:0042803;GO:0005080;GO:0003723;GO:0046332;GO:0031267;GO:0008134;GO:0051764;GO:0031532;GO:0007195;GO:0001525;GO:0001974;GO:0034329;GO:0045216;GO:0021987;GO:0060271;GO:0051220;GO:0051607;GO:0045022;GO:0001837;GO:0045184;GO:0097368;GO:0021943;GO:0003007;GO:0090307;GO:0042789;GO:0043066;GO:0043433;GO:0010977;GO:0042177;GO:0016479;GO:0030168;GO:0070527;GO:0002576;GO:0032233;GO:0048680;GO:0043123;GO:2001046;GO:2000179;GO:2001224;GO:1901381;GO:0042307;GO:1900026;GO:1902396;GO:0034394;GO:0072659;GO:0050821;GO:0043113;GO:0030334;GO:1905000;GO:1905031;GO:0071526;GO:0050808;GO:0090042;GO:0044319;, C:actin cytoskeleton; C:actin filament; C:actin filament bundle; C:apical dendrite; C:axonal growth cone; C:brush border; C:cell-cell junction; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic shaft; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:glutamatergic synapse; C:membrane; C:Myb complex; C:nucleolus; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:trans-Golgi network; C:Z disc;, F:actin filament binding; F:cadherin binding; F:Fc-gamma receptor I complex binding; F:G protein-coupled receptor binding; F:GTPase binding; F:ion channel binding; F:kinase binding; F:mu-type opioid receptor binding; F:potassium channel regulator activity; F:protein homodimerization activity; F:protein kinase C binding; F:RNA binding; F:SMAD binding; F:small GTPase binding; F:transcription factor binding;, P:actin crosslink formation; P:actin cytoskeleton reorganization; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:angiogenesis; P:blood vessel remodeling; P:cell junction assembly; P:cell-cell junction organization; P:cerebral cortex development; P:cilium assembly; P:cytoplasmic sequestering of protein; P:defense response to virus; P:early endosome to late endosome transport; P:epithelial to mesenchymal transition; P:establishment of protein localization; P:establishment of Sertoli cell barrier; P:formation of radial glial scaffolds; P:heart morphogenesis; P:mitotic spindle assembly; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron projection development; P:negative regulation of protein catabolic process; P:negative regulation of transcription by RNA polymerase I; P:platelet activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of actin filament bundle assembly; P:positive regulation of axon regeneration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron migration; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of protein import into nucleus; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to bicellular tight junction; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein stabilization; P:receptor clustering; P:regulation of cell migration; P:regulation of membrane repolarization during atrial cardiac muscle cell action potential; P:regulation of membrane repolarization during cardiac muscle cell action potential; P:semaphorin-plexin signaling pathway; P:synapse organization; P:tubulin deacetylation; P:wound healing, spreading of cells;|P21333 E9KL45 Q5HY53 Q5HY55 Q8NF52,Filamin-A,Actin-binding protein 280;Alpha-filamin;Endothelial actin-binding protein;Filamin-1;Non-muscle filamin;, PF00307;PF00630;, GO:0015629;GO:0005884;GO:0032432;GO:0097440;GO:0044295;GO:0005903;GO:0005911;GO:0030863;GO:0005737;GO:0005829;GO:0043198;GO:0070062;GO:0005576;GO:0005925;GO:0098978;GO:0016020;GO:0031523;GO:0005730;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0098794;GO:0005802;GO:0030018;GO:0051015;GO:0045296;GO:0034988;GO:0001664;GO:0051020;GO:0044325;GO:0019900;GO:0031852;GO:0015459;GO:0042803;GO:0005080;GO:0003723;GO:0046332;GO:0031267;GO:0008134;GO:0051764;GO:0031532;GO:0007195;GO:0001525;GO:0001974;GO:0034329;GO:0045216;GO:0021987;GO:0060271;GO:0051220;GO:0051607;GO:0045022;GO:0001837;GO:0045184;GO:0097368;GO:0021943;GO:0003007;GO:0090307;GO:0042789;GO:0043066;GO:0043433;GO:0010977;GO:0042177;GO:0016479;GO:0030168;GO:0070527;GO:0002576;GO:0032233;GO:0048680;GO:0043123;GO:2001046;GO:2000179;GO:2001224;GO:1901381;GO:0042307;GO:1900026;GO:1902396;GO:0034394;GO:0072659;GO:0050821;GO:0043113;GO:0030334;GO:1905000;GO:1905031;GO:0071526;GO:0050808;GO:0090042;GO:0044319;, C:actin cytoskeleton; C:actin filament; C:actin filament bundle; C:apical dendrite; C:axonal growth cone; C:brush border; C:cell-cell junction; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic shaft; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:glutamatergic synapse; C:membrane; C:Myb complex; C:nucleolus; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:trans-Golgi network; C:Z disc;, F:actin filament binding; F:cadherin binding; F:Fc-gamma receptor I complex binding; F:G protein-coupled receptor binding; F:GTPase binding; F:ion channel binding; F:kinase binding; F:mu-type opioid receptor binding; F:potassium channel regulator activity; F:protein homodimerization activity; F:protein kinase C binding; F:RNA binding; F:SMAD binding; F:small GTPase binding; F:transcription factor binding;, P:actin crosslink formation; P:actin cytoskeleton reorganization; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:angiogenesis; P:blood vessel remodeling; P:cell junction assembly; P:cell-cell junction organization; P:cerebral cortex development; P:cilium assembly; P:cytoplasmic sequestering of protein; P:defense response to virus; P:early endosome to late endosome transport; P:epithelial to mesenchymal transition; P:establishment of protein localization; P:establishment of Sertoli cell barrier; P:formation of radial glial scaffolds; P:heart morphogenesis; P:mitotic spindle assembly; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron projection development; P:negative regulation of protein catabolic process; P:negative regulation of transcription by RNA polymerase I; P:platelet activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of actin filament bundle assembly; P:positive regulation of axon regeneration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron migration; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of protein import into nucleus; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to bicellular tight junction; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein stabilization; P:receptor clustering; P:regulation of cell migration; P:regulation of membrane repolarization during atrial cardiac muscle cell action potential; P:regulation of membrane repolarization during cardiac muscle cell action potential; P:semaphorin-plexin signaling pathway; P:synapse organization; P:tubulin deacetylation; P:wound healing, spreading of cells;|P21333 E9KL45 Q5HY53 Q5HY55 Q8NF52,Filamin-A,Actin-binding protein 280;Alpha-filamin;Endothelial actin-binding protein;Filamin-1;Non-muscle filamin;, PF00307;PF00630;, GO:0015629;GO:0005884;GO:0032432;GO:0097440;GO:0044295;GO:0005903;GO:0005911;GO:0030863;GO:0005737;GO:0005829;GO:0043198;GO:0070062;GO:0005576;GO:0005925;GO:0098978;GO:0016020;GO:0031523;GO:0005730;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0098794;GO:0005802;GO:0030018;GO:0051015;GO:0045296;GO:0034988;GO:0001664;GO:0051020;GO:0044325;GO:0019900;GO:0031852;GO:0015459;GO:0042803;GO:0005080;GO:0003723;GO:0046332;GO:0031267;GO:0008134;GO:0051764;GO:0031532;GO:0007195;GO:0001525;GO:0001974;GO:0034329;GO:0045216;GO:0021987;GO:0060271;GO:0051220;GO:0051607;GO:0045022;GO:0001837;GO:0045184;GO:0097368;GO:0021943;GO:0003007;GO:0090307;GO:0042789;GO:0043066;GO:0043433;GO:0010977;GO:0042177;GO:0016479;GO:0030168;GO:0070527;GO:0002576;GO:0032233;GO:0048680;GO:0043123;GO:2001046;GO:2000179;GO:2001224;GO:1901381;GO:0042307;GO:1900026;GO:1902396;GO:0034394;GO:0072659;GO:0050821;GO:0043113;GO:0030334;GO:1905000;GO:1905031;GO:0071526;GO:0050808;GO:0090042;GO:0044319;, C:actin cytoskeleton; C:actin filament; C:actin filament bundle; C:apical dendrite; C:axonal growth cone; C:brush border; C:cell-cell junction; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic shaft; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:glutamatergic synapse; C:membrane; C:Myb complex; C:nucleolus; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:trans-Golgi network; C:Z disc;, F:actin filament binding; F:cadherin binding; F:Fc-gamma receptor I complex binding; F:G protein-coupled receptor binding; F:GTPase binding; F:ion channel binding; F:kinase binding; F:mu-type opioid receptor binding; F:potassium channel regulator activity; F:protein homodimerization activity; F:protein kinase C binding; F:RNA binding; F:SMAD binding; F:small GTPase binding; F:transcription factor binding;, P:actin crosslink formation; P:actin cytoskeleton reorganization; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:angiogenesis; P:blood vessel remodeling; P:cell junction assembly; P:cell-cell junction organization; P:cerebral cortex development; P:cilium assembly; P:cytoplasmic sequestering of protein; P:defense response to virus; P:early endosome to late endosome transport; P:epithelial to mesenchymal transition; P:establishment of protein localization; P:establishment of Sertoli cell barrier; P:formation of radial glial scaffolds; P:heart morphogenesis; P:mitotic spindle assembly; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron projection development; P:negative regulation of protein catabolic process; P:negative regulation of transcription by RNA polymerase I; P:platelet activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of actin filament bundle assembly; P:positive regulation of axon regeneration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron migration; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of protein import into nucleus; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to bicellular tight junction; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein stabilization; P:receptor clustering; P:regulation of cell migration; P:regulation of membrane repolarization during atrial cardiac muscle cell action potential; P:regulation of membrane repolarization during cardiac muscle cell action potential; P:semaphorin-plexin signaling pathway; P:synapse organization; P:tubulin deacetylation; P:wound healing, spreading of cells;|P21333 E9KL45 Q5HY53 Q5HY55 Q8NF52,Filamin-A,Actin-binding protein 280;Alpha-filamin;Endothelial actin-binding protein;Filamin-1;Non-muscle filamin;, PF00307;PF00630;, GO:0015629;GO:0005884;GO:0032432;GO:0097440;GO:0044295;GO:0005903;GO:0005911;GO:0030863;GO:0005737;GO:0005829;GO:0043198;GO:0070062;GO:0005576;GO:0005925;GO:0098978;GO:0016020;GO:0031523;GO:0005730;GO:0005634;GO:0043204;GO:0048471;GO:0005886;GO:0098794;GO:0005802;GO:0030018;GO:0051015;GO:0045296;GO:0034988;GO:0001664;GO:0051020;GO:0044325;GO:0019900;GO:0031852;GO:0015459;GO:0042803;GO:0005080;GO:0003723;GO:0046332;GO:0031267;GO:0008134;GO:0051764;GO:0031532;GO:0007195;GO:0001525;GO:0001974;GO:0034329;GO:0045216;GO:0021987;GO:0060271;GO:0051220;GO:0051607;GO:0045022;GO:0001837;GO:0045184;GO:0097368;GO:0021943;GO:0003007;GO:0090307;GO:0042789;GO:0043066;GO:0043433;GO:0010977;GO:0042177;GO:0016479;GO:0030168;GO:0070527;GO:0002576;GO:0032233;GO:0048680;GO:0043123;GO:2001046;GO:2000179;GO:2001224;GO:1901381;GO:0042307;GO:1900026;GO:1902396;GO:0034394;GO:0072659;GO:0050821;GO:0043113;GO:0030334;GO:1905000;GO:1905031;GO:0071526;GO:0050808;GO:0090042;GO:0044319;, C:actin cytoskeleton; C:actin filament; C:actin filament bundle; C:apical dendrite; C:axonal growth cone; C:brush border; C:cell-cell junction; C:cortical cytoskeleton; C:cytoplasm; C:cytosol; C:dendritic shaft; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:glutamatergic synapse; C:membrane; C:Myb complex; C:nucleolus; C:nucleus; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynapse; C:trans-Golgi network; C:Z disc;, F:actin filament binding; F:cadherin binding; F:Fc-gamma receptor I complex binding; F:G protein-coupled receptor binding; F:GTPase binding; F:ion channel binding; F:kinase binding; F:mu-type opioid receptor binding; F:potassium channel regulator activity; F:protein homodimerization activity; F:protein kinase C binding; F:RNA binding; F:SMAD binding; F:small GTPase binding; F:transcription factor binding;, P:actin crosslink formation; P:actin cytoskeleton reorganization; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; P:angiogenesis; P:blood vessel remodeling; P:cell junction assembly; P:cell-cell junction organization; P:cerebral cortex development; P:cilium assembly; P:cytoplasmic sequestering of protein; P:defense response to virus; P:early endosome to late endosome transport; P:epithelial to mesenchymal transition; P:establishment of protein localization; P:establishment of Sertoli cell barrier; P:formation of radial glial scaffolds; P:heart morphogenesis; P:mitotic spindle assembly; P:mRNA transcription by RNA polymerase II; P:negative regulation of apoptotic process; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of neuron projection development; P:negative regulation of protein catabolic process; P:negative regulation of transcription by RNA polymerase I; P:platelet activation; P:platelet aggregation; P:platelet degranulation; P:positive regulation of actin filament bundle assembly; P:positive regulation of axon regeneration; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of neural precursor cell proliferation; P:positive regulation of neuron migration; P:positive regulation of potassium ion transmembrane transport; P:positive regulation of protein import into nucleus; P:positive regulation of substrate adhesion-dependent cell spreading; P:protein localization to bicellular tight junction; P:protein localization to cell surface; P:protein localization to plasma membrane; P:protein stabilization; P:receptor clustering; P:regulation of cell migration; P:regulation of membrane repolarization during atrial cardiac muscle cell action potential; P:regulation of membrane repolarization during cardiac muscle cell action potential; P:semaphorin-plexin signaling pathway; P:synapse organization; P:tubulin deacetylation; P:wound healing, spreading of cells; scaffold298 indexed_genome mRNA 47853 51529 . - . ID=transcript_16488;P49184 D3DWW7 Q5HY41,Deoxyribonuclease-1-like 1,DNase X;Deoxyribonuclease I-like 1;Muscle-specific DNase I-like;XIB;, PF03372;, GO:0005783;GO:0005576;GO:0005634;GO:0035580;GO:0004536;GO:0004530;GO:0003677;GO:0006308;GO:0000737;GO:0006259;GO:0043312;, C:endoplasmic reticulum; C:extracellular region; C:nucleus; C:specific granule lumen;, F:deoxyribonuclease activity; F:deoxyribonuclease I activity; F:DNA binding;, P:DNA catabolic process; P:DNA catabolic process, endonucleolytic; P:DNA metabolic process; P:neutrophil degranulation;|P49184 D3DWW7 Q5HY41,Deoxyribonuclease-1-like 1,DNase X;Deoxyribonuclease I-like 1;Muscle-specific DNase I-like;XIB;, PF03372;, GO:0005783;GO:0005576;GO:0005634;GO:0035580;GO:0004536;GO:0004530;GO:0003677;GO:0006308;GO:0000737;GO:0006259;GO:0043312;, C:endoplasmic reticulum; C:extracellular region; C:nucleus; C:specific granule lumen;, F:deoxyribonuclease activity; F:deoxyribonuclease I activity; F:DNA binding;, P:DNA catabolic process; P:DNA catabolic process, endonucleolytic; P:DNA metabolic process; P:neutrophil degranulation; scaffold298 indexed_genome mRNA 59179 60564 . + . ID=transcript_16489;Q86XQ8 Q86XQ9 Q86XR0,Tafazzin,Protein G4.5;, PF01553;, GO:0016021;GO:0005743;GO:0031966;GO:0005741;GO:0005739;GO:0047184;GO:0008374;GO:0060048;GO:0048738;GO:0035965;GO:0032049;GO:0032048;GO:0042407;GO:0007507;GO:0030097;GO:0007007;GO:0042775;GO:0032981;GO:0006936;GO:0007519;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:O-acyltransferase activity;, P:cardiac muscle contraction; P:cardiac muscle tissue development; P:cardiolipin acyl-chain remodeling; P:cardiolipin biosynthetic process; P:cardiolipin metabolic process; P:cristae formation; P:heart development; P:hemopoiesis; P:inner mitochondrial membrane organization; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial respiratory chain complex I assembly; P:muscle contraction; P:skeletal muscle tissue development; scaffold298 indexed_genome mRNA 60825 67492 . + . ID=transcript_16490;Q86XQ8 Q86XQ9 Q86XR0,Tafazzin,Protein G4.5;, PF01553;, GO:0016021;GO:0005743;GO:0031966;GO:0005741;GO:0005739;GO:0047184;GO:0008374;GO:0060048;GO:0048738;GO:0035965;GO:0032049;GO:0032048;GO:0042407;GO:0007507;GO:0030097;GO:0007007;GO:0042775;GO:0032981;GO:0006936;GO:0007519;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:O-acyltransferase activity;, P:cardiac muscle contraction; P:cardiac muscle tissue development; P:cardiolipin acyl-chain remodeling; P:cardiolipin biosynthetic process; P:cardiolipin metabolic process; P:cristae formation; P:heart development; P:hemopoiesis; P:inner mitochondrial membrane organization; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial respiratory chain complex I assembly; P:muscle contraction; P:skeletal muscle tissue development;|Q86XQ8 Q86XQ9 Q86XR0,Tafazzin,Protein G4.5;, PF01553;, GO:0016021;GO:0005743;GO:0031966;GO:0005741;GO:0005739;GO:0047184;GO:0008374;GO:0060048;GO:0048738;GO:0035965;GO:0032049;GO:0032048;GO:0042407;GO:0007507;GO:0030097;GO:0007007;GO:0042775;GO:0032981;GO:0006936;GO:0007519;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion;, F:1-acylglycerophosphocholine O-acyltransferase activity; F:O-acyltransferase activity;, P:cardiac muscle contraction; P:cardiac muscle tissue development; P:cardiolipin acyl-chain remodeling; P:cardiolipin biosynthetic process; P:cardiolipin metabolic process; P:cristae formation; P:heart development; P:hemopoiesis; P:inner mitochondrial membrane organization; P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial respiratory chain complex I assembly; P:muscle contraction; P:skeletal muscle tissue development; scaffold298 indexed_genome mRNA 79759 87733 . + . ID=transcript_16491;Q15904 A6ZKI4 Q8NBT4 Q9H0C7,V-type proton ATPase subunit S1,Protein XAP-3;V-ATPase Ac45 subunit;V-ATPase S1 accessory protein;Vacuolar proton pump subunit S1;, PF05827;, GO:0005789;GO:0033116;GO:0010008;GO:0070062;GO:0016021;GO:0033181;GO:0016469;GO:0033180;GO:0005524;GO:0031267;GO:0006879;GO:0036295;GO:0051656;GO:0008286;GO:0034220;GO:0045851;GO:0045780;GO:0070374;GO:0045921;GO:0045669;GO:2001206;GO:1902600;GO:0030641;GO:0033572;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:endosome membrane; C:extracellular exosome; C:integral component of membrane; C:plasma membrane proton-transporting V-type ATPase complex; C:proton-transporting two-sector ATPase complex; C:proton-transporting V-type ATPase, V1 domain;, F:ATP binding; F:small GTPase binding;, P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:establishment of organelle localization; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:pH reduction; P:positive regulation of bone resorption; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoclast development; P:proton transmembrane transport; P:regulation of cellular pH; P:transferrin transport;|Q15904 A6ZKI4 Q8NBT4 Q9H0C7,V-type proton ATPase subunit S1,Protein XAP-3;V-ATPase Ac45 subunit;V-ATPase S1 accessory protein;Vacuolar proton pump subunit S1;, PF05827;, GO:0005789;GO:0033116;GO:0010008;GO:0070062;GO:0016021;GO:0033181;GO:0016469;GO:0033180;GO:0005524;GO:0031267;GO:0006879;GO:0036295;GO:0051656;GO:0008286;GO:0034220;GO:0045851;GO:0045780;GO:0070374;GO:0045921;GO:0045669;GO:2001206;GO:1902600;GO:0030641;GO:0033572;, C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:endosome membrane; C:extracellular exosome; C:integral component of membrane; C:plasma membrane proton-transporting V-type ATPase complex; C:proton-transporting two-sector ATPase complex; C:proton-transporting V-type ATPase, V1 domain;, F:ATP binding; F:small GTPase binding;, P:cellular iron ion homeostasis; P:cellular response to increased oxygen levels; P:establishment of organelle localization; P:insulin receptor signaling pathway; P:ion transmembrane transport; P:pH reduction; P:positive regulation of bone resorption; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of exocytosis; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoclast development; P:proton transmembrane transport; P:regulation of cellular pH; P:transferrin transport; scaffold298 indexed_genome mRNA 93022 94359 . - . ID=transcript_16492;P31150 P50394 Q6FG50 Q7Z2G6 Q7Z2G9 Q7Z2H5 Q7Z2I6,Rab GDP dissociation inhibitor alpha,Guanosine diphosphate dissociation inhibitor 1;Oligophrenin-2;Protein XAP-4;, PF00996;, GO:0030424;GO:0005737;GO:0005829;GO:0005794;GO:0030496;GO:0043209;GO:0043025;GO:0032991;GO:0005092;GO:0005096;GO:0005093;GO:0031267;GO:0050771;GO:0090315;GO:0045773;GO:0015031;GO:0032482;GO:0051592;GO:0007165;GO:0016192;, C:axon; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:midbody; C:myelin sheath; C:neuronal cell body; C:protein-containing complex;, F:GDP-dissociation inhibitor activity; F:GTPase activator activity; F:Rab GDP-dissociation inhibitor activity; F:small GTPase binding;, P:negative regulation of axonogenesis; P:negative regulation of protein targeting to membrane; P:positive regulation of axon extension; P:protein transport; P:Rab protein signal transduction; P:response to calcium ion; P:signal transduction; P:vesicle-mediated transport; scaffold298 indexed_genome mRNA 94918 98832 . + . ID=transcript_16493;P31150 P50394 Q6FG50 Q7Z2G6 Q7Z2G9 Q7Z2H5 Q7Z2I6,Rab GDP dissociation inhibitor alpha,Guanosine diphosphate dissociation inhibitor 1;Oligophrenin-2;Protein XAP-4;, PF00996;, GO:0030424;GO:0005737;GO:0005829;GO:0005794;GO:0030496;GO:0043209;GO:0043025;GO:0032991;GO:0005092;GO:0005096;GO:0005093;GO:0031267;GO:0050771;GO:0090315;GO:0045773;GO:0015031;GO:0032482;GO:0051592;GO:0007165;GO:0016192;, C:axon; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:midbody; C:myelin sheath; C:neuronal cell body; C:protein-containing complex;, F:GDP-dissociation inhibitor activity; F:GTPase activator activity; F:Rab GDP-dissociation inhibitor activity; F:small GTPase binding;, P:negative regulation of axonogenesis; P:negative regulation of protein targeting to membrane; P:positive regulation of axon extension; P:protein transport; P:Rab protein signal transduction; P:response to calcium ion; P:signal transduction; P:vesicle-mediated transport;|P31150 P50394 Q6FG50 Q7Z2G6 Q7Z2G9 Q7Z2H5 Q7Z2I6,Rab GDP dissociation inhibitor alpha,Guanosine diphosphate dissociation inhibitor 1;Oligophrenin-2;Protein XAP-4;, PF00996;, GO:0030424;GO:0005737;GO:0005829;GO:0005794;GO:0030496;GO:0043209;GO:0043025;GO:0032991;GO:0005092;GO:0005096;GO:0005093;GO:0031267;GO:0050771;GO:0090315;GO:0045773;GO:0015031;GO:0032482;GO:0051592;GO:0007165;GO:0016192;, C:axon; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:midbody; C:myelin sheath; C:neuronal cell body; C:protein-containing complex;, F:GDP-dissociation inhibitor activity; F:GTPase activator activity; F:Rab GDP-dissociation inhibitor activity; F:small GTPase binding;, P:negative regulation of axonogenesis; P:negative regulation of protein targeting to membrane; P:positive regulation of axon extension; P:protein transport; P:Rab protein signal transduction; P:response to calcium ion; P:signal transduction; P:vesicle-mediated transport;|P31150 P50394 Q6FG50 Q7Z2G6 Q7Z2G9 Q7Z2H5 Q7Z2I6,Rab GDP dissociation inhibitor alpha,Guanosine diphosphate dissociation inhibitor 1;Oligophrenin-2;Protein XAP-4;, PF00996;, GO:0030424;GO:0005737;GO:0005829;GO:0005794;GO:0030496;GO:0043209;GO:0043025;GO:0032991;GO:0005092;GO:0005096;GO:0005093;GO:0031267;GO:0050771;GO:0090315;GO:0045773;GO:0015031;GO:0032482;GO:0051592;GO:0007165;GO:0016192;, C:axon; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:midbody; C:myelin sheath; C:neuronal cell body; C:protein-containing complex;, F:GDP-dissociation inhibitor activity; F:GTPase activator activity; F:Rab GDP-dissociation inhibitor activity; F:small GTPase binding;, P:negative regulation of axonogenesis; P:negative regulation of protein targeting to membrane; P:positive regulation of axon extension; P:protein transport; P:Rab protein signal transduction; P:response to calcium ion; P:signal transduction; P:vesicle-mediated transport;|P31150 P50394 Q6FG50 Q7Z2G6 Q7Z2G9 Q7Z2H5 Q7Z2I6,Rab GDP dissociation inhibitor alpha,Guanosine diphosphate dissociation inhibitor 1;Oligophrenin-2;Protein XAP-4;, PF00996;, GO:0030424;GO:0005737;GO:0005829;GO:0005794;GO:0030496;GO:0043209;GO:0043025;GO:0032991;GO:0005092;GO:0005096;GO:0005093;GO:0031267;GO:0050771;GO:0090315;GO:0045773;GO:0015031;GO:0032482;GO:0051592;GO:0007165;GO:0016192;, C:axon; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:midbody; C:myelin sheath; C:neuronal cell body; C:protein-containing complex;, F:GDP-dissociation inhibitor activity; F:GTPase activator activity; F:Rab GDP-dissociation inhibitor activity; F:small GTPase binding;, P:negative regulation of axonogenesis; P:negative regulation of protein targeting to membrane; P:positive regulation of axon extension; P:protein transport; P:Rab protein signal transduction; P:response to calcium ion; P:signal transduction; P:vesicle-mediated transport; scaffold298 indexed_genome mRNA 101496 103035 . + . ID=transcript_16494;Q14320 A8KAQ4 B2R997 Q5HY37 Q6PJH5,Protein FAM50A,Protein HXC-26;Protein XAP-5;, PF04921;, GO:0005654;GO:0005634;GO:0003723;GO:0006325;GO:0007283;, C:nucleoplasm; C:nucleus;, F:RNA binding;, P:chromatin organization; P:spermatogenesis; scaffold298 indexed_genome mRNA 103145 105381 . + . ID=transcript_16495;Q14320 A8KAQ4 B2R997 Q5HY37 Q6PJH5,Protein FAM50A,Protein HXC-26;Protein XAP-5;, PF04921;, GO:0005654;GO:0005634;GO:0003723;GO:0006325;GO:0007283;, C:nucleoplasm; C:nucleus;, F:RNA binding;, P:chromatin organization; P:spermatogenesis;|Q14320 A8KAQ4 B2R997 Q5HY37 Q6PJH5,Protein FAM50A,Protein HXC-26;Protein XAP-5;, PF04921;, GO:0005654;GO:0005634;GO:0003723;GO:0006325;GO:0007283;, C:nucleoplasm; C:nucleus;, F:RNA binding;, P:chromatin organization; P:spermatogenesis; scaffold298 indexed_genome mRNA 115082 129532 . + . ID=transcript_16496;P51805 Q5HY36,Plexin-A3,Plexin-4;Semaphorin receptor SEX;, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005887;GO:0016020;GO:0005886;GO:0002116;GO:0017154;GO:0004888;GO:0021785;GO:0021612;GO:0021766;GO:0007275;GO:0050919;GO:0048843;GO:0007162;GO:1990138;GO:0050772;GO:0051495;GO:0021860;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0021637;, C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:transmembrane signaling receptor activity;, P:branchiomotor neuron axon guidance; P:facial nerve structural organization; P:hippocampus development; P:multicellular organism development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of cell adhesion; P:neuron projection extension; P:positive regulation of axonogenesis; P:positive regulation of cytoskeleton organization; P:pyramidal neuron development; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:trigeminal nerve structural organization;|P51805 Q5HY36,Plexin-A3,Plexin-4;Semaphorin receptor SEX;, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005887;GO:0016020;GO:0005886;GO:0002116;GO:0017154;GO:0004888;GO:0021785;GO:0021612;GO:0021766;GO:0007275;GO:0050919;GO:0048843;GO:0007162;GO:1990138;GO:0050772;GO:0051495;GO:0021860;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0021637;, C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:transmembrane signaling receptor activity;, P:branchiomotor neuron axon guidance; P:facial nerve structural organization; P:hippocampus development; P:multicellular organism development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of cell adhesion; P:neuron projection extension; P:positive regulation of axonogenesis; P:positive regulation of cytoskeleton organization; P:pyramidal neuron development; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:trigeminal nerve structural organization;|P51805 Q5HY36,Plexin-A3,Plexin-4;Semaphorin receptor SEX;, PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;, GO:0005887;GO:0016020;GO:0005886;GO:0002116;GO:0017154;GO:0004888;GO:0021785;GO:0021612;GO:0021766;GO:0007275;GO:0050919;GO:0048843;GO:0007162;GO:1990138;GO:0050772;GO:0051495;GO:0021860;GO:0030334;GO:0008360;GO:0043087;GO:0071526;GO:1902287;GO:0021637;, C:integral component of plasma membrane; C:membrane; C:plasma membrane; C:semaphorin receptor complex;, F:semaphorin receptor activity; F:transmembrane signaling receptor activity;, P:branchiomotor neuron axon guidance; P:facial nerve structural organization; P:hippocampus development; P:multicellular organism development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of cell adhesion; P:neuron projection extension; P:positive regulation of axonogenesis; P:positive regulation of cytoskeleton organization; P:pyramidal neuron development; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:semaphorin-plexin signaling pathway; P:semaphorin-plexin signaling pathway involved in axon guidance; P:trigeminal nerve structural organization; scaffold298 indexed_genome mRNA 130369 131928 . - . ID=transcript_16497;Q14657 Q5HY39 Q8IZ78,EKC/KEOPS complex subunit LAGE3 {ECO:0000305},L antigen family member 3 {ECO:0000303|PubMed:12384295};Protein ESO-3 {ECO:0000303|PubMed:12384295};Protein ITBA2 {ECO:0000303|PubMed:8786131};, PF09341;, GO:0005737;GO:0000408;GO:0016604;GO:0005654;GO:0005634;GO:0045944;GO:0008033;GO:0070525;, C:cytoplasm; C:EKC/KEOPS complex; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:positive regulation of transcription by RNA polymerase II; P:tRNA processing; P:tRNA threonylcarbamoyladenosine metabolic process; scaffold298 indexed_genome mRNA 139540 146530 . - . ID=transcript_16498;P09131 Q5HY79 Q9BSL2,P3 protein,Solute carrier family 10 member 3;, PF01758;, GO:0016021;GO:0008508;GO:0015721;, C:integral component of membrane;, F:bile acid:sodium symporter activity;, P:bile acid and bile salt transport; scaffold298 indexed_genome mRNA 151006 159226 . - . ID=transcript_16499;P98173 A6QRH6 B2RBI7 B4DFI8 D3DWX4 Q5HY76 Q96H51,Protein FAM3A,Cytokine-like protein 2-19;, PF15711;, GO:0005615;GO:0019732;GO:0061844;GO:1905035;GO:0045721;GO:0046890;, C:extracellular space;, , P:antifungal humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:negative regulation of antifungal innate immune response; P:negative regulation of gluconeogenesis; P:regulation of lipid biosynthetic process;|P98173 A6QRH6 B2RBI7 B4DFI8 D3DWX4 Q5HY76 Q96H51,Protein FAM3A,Cytokine-like protein 2-19;, PF15711;, GO:0005615;GO:0019732;GO:0061844;GO:1905035;GO:0045721;GO:0046890;, C:extracellular space;, , P:antifungal humoral response; P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:negative regulation of antifungal innate immune response; P:negative regulation of gluconeogenesis; P:regulation of lipid biosynthetic process; scaffold298 indexed_genome mRNA 165770 201201 . - . ID=transcript_16500;P11413 D3DWX9 Q16000 Q16765 Q8IU70 Q8IU88 Q8IUA6 Q96PQ2,Glucose-6-phosphate 1-dehydrogenase,, PF02781;PF00479;, GO:0034451;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005536;GO:0004345;GO:0042802;GO:0050661;GO:0042803;GO:0034599;GO:0006695;GO:0043249;GO:0051156;GO:0006006;GO:0006749;GO:0006629;GO:0006739;GO:0006740;GO:0061052;GO:0010734;GO:2000378;GO:0019322;GO:0006098;GO:0009051;GO:1904879;GO:0043523;GO:0045471;GO:0032094;GO:0010041;GO:0014070;GO:0046390;GO:0021762;, C:centriolar satellite; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus;, F:glucose binding; F:glucose-6-phosphate dehydrogenase activity; F:identical protein binding; F:NADP binding; F:protein homodimerization activity;, P:cellular response to oxidative stress; P:cholesterol biosynthetic process; P:erythrocyte maturation; P:glucose 6-phosphate metabolic process; P:glucose metabolic process; P:glutathione metabolic process; P:lipid metabolic process; P:NADP metabolic process; P:NADPH regeneration; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of protein glutathionylation; P:negative regulation of reactive oxygen species metabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of neuron apoptotic process; P:response to ethanol; P:response to food; P:response to iron(III) ion; P:response to organic cyclic compound; P:ribose phosphate biosynthetic process; P:substantia nigra development;|P11413 D3DWX9 Q16000 Q16765 Q8IU70 Q8IU88 Q8IUA6 Q96PQ2,Glucose-6-phosphate 1-dehydrogenase,, PF02781;PF00479;, GO:0034451;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005536;GO:0004345;GO:0042802;GO:0050661;GO:0042803;GO:0034599;GO:0006695;GO:0043249;GO:0051156;GO:0006006;GO:0006749;GO:0006629;GO:0006739;GO:0006740;GO:0061052;GO:0010734;GO:2000378;GO:0019322;GO:0006098;GO:0009051;GO:1904879;GO:0043523;GO:0045471;GO:0032094;GO:0010041;GO:0014070;GO:0046390;GO:0021762;, C:centriolar satellite; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus;, F:glucose binding; F:glucose-6-phosphate dehydrogenase activity; F:identical protein binding; F:NADP binding; F:protein homodimerization activity;, P:cellular response to oxidative stress; P:cholesterol biosynthetic process; P:erythrocyte maturation; P:glucose 6-phosphate metabolic process; P:glucose metabolic process; P:glutathione metabolic process; P:lipid metabolic process; P:NADP metabolic process; P:NADPH regeneration; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of protein glutathionylation; P:negative regulation of reactive oxygen species metabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of neuron apoptotic process; P:response to ethanol; P:response to food; P:response to iron(III) ion; P:response to organic cyclic compound; P:ribose phosphate biosynthetic process; P:substantia nigra development;|P11413 D3DWX9 Q16000 Q16765 Q8IU70 Q8IU88 Q8IUA6 Q96PQ2,Glucose-6-phosphate 1-dehydrogenase,, PF02781;PF00479;, GO:0034451;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005536;GO:0004345;GO:0042802;GO:0050661;GO:0042803;GO:0034599;GO:0006695;GO:0043249;GO:0051156;GO:0006006;GO:0006749;GO:0006629;GO:0006739;GO:0006740;GO:0061052;GO:0010734;GO:2000378;GO:0019322;GO:0006098;GO:0009051;GO:1904879;GO:0043523;GO:0045471;GO:0032094;GO:0010041;GO:0014070;GO:0046390;GO:0021762;, C:centriolar satellite; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus;, F:glucose binding; F:glucose-6-phosphate dehydrogenase activity; F:identical protein binding; F:NADP binding; F:protein homodimerization activity;, P:cellular response to oxidative stress; P:cholesterol biosynthetic process; P:erythrocyte maturation; P:glucose 6-phosphate metabolic process; P:glucose metabolic process; P:glutathione metabolic process; P:lipid metabolic process; P:NADP metabolic process; P:NADPH regeneration; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of protein glutathionylation; P:negative regulation of reactive oxygen species metabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of neuron apoptotic process; P:response to ethanol; P:response to food; P:response to iron(III) ion; P:response to organic cyclic compound; P:ribose phosphate biosynthetic process; P:substantia nigra development;|P11413 D3DWX9 Q16000 Q16765 Q8IU70 Q8IU88 Q8IUA6 Q96PQ2,Glucose-6-phosphate 1-dehydrogenase,, PF02781;PF00479;, GO:0034451;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005536;GO:0004345;GO:0042802;GO:0050661;GO:0042803;GO:0034599;GO:0006695;GO:0043249;GO:0051156;GO:0006006;GO:0006749;GO:0006629;GO:0006739;GO:0006740;GO:0061052;GO:0010734;GO:2000378;GO:0019322;GO:0006098;GO:0009051;GO:1904879;GO:0043523;GO:0045471;GO:0032094;GO:0010041;GO:0014070;GO:0046390;GO:0021762;, C:centriolar satellite; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus;, F:glucose binding; F:glucose-6-phosphate dehydrogenase activity; F:identical protein binding; F:NADP binding; F:protein homodimerization activity;, P:cellular response to oxidative stress; P:cholesterol biosynthetic process; P:erythrocyte maturation; P:glucose 6-phosphate metabolic process; P:glucose metabolic process; P:glutathione metabolic process; P:lipid metabolic process; P:NADP metabolic process; P:NADPH regeneration; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of protein glutathionylation; P:negative regulation of reactive oxygen species metabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of neuron apoptotic process; P:response to ethanol; P:response to food; P:response to iron(III) ion; P:response to organic cyclic compound; P:ribose phosphate biosynthetic process; P:substantia nigra development;|P11413 D3DWX9 Q16000 Q16765 Q8IU70 Q8IU88 Q8IUA6 Q96PQ2,Glucose-6-phosphate 1-dehydrogenase,, PF02781;PF00479;, GO:0034451;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005536;GO:0004345;GO:0042802;GO:0050661;GO:0042803;GO:0034599;GO:0006695;GO:0043249;GO:0051156;GO:0006006;GO:0006749;GO:0006629;GO:0006739;GO:0006740;GO:0061052;GO:0010734;GO:2000378;GO:0019322;GO:0006098;GO:0009051;GO:1904879;GO:0043523;GO:0045471;GO:0032094;GO:0010041;GO:0014070;GO:0046390;GO:0021762;, C:centriolar satellite; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus;, F:glucose binding; F:glucose-6-phosphate dehydrogenase activity; F:identical protein binding; F:NADP binding; F:protein homodimerization activity;, P:cellular response to oxidative stress; P:cholesterol biosynthetic process; P:erythrocyte maturation; P:glucose 6-phosphate metabolic process; P:glucose metabolic process; P:glutathione metabolic process; P:lipid metabolic process; P:NADP metabolic process; P:NADPH regeneration; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of protein glutathionylation; P:negative regulation of reactive oxygen species metabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of neuron apoptotic process; P:response to ethanol; P:response to food; P:response to iron(III) ion; P:response to organic cyclic compound; P:ribose phosphate biosynthetic process; P:substantia nigra development;|P11413 D3DWX9 Q16000 Q16765 Q8IU70 Q8IU88 Q8IUA6 Q96PQ2,Glucose-6-phosphate 1-dehydrogenase,, PF02781;PF00479;, GO:0034451;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005536;GO:0004345;GO:0042802;GO:0050661;GO:0042803;GO:0034599;GO:0006695;GO:0043249;GO:0051156;GO:0006006;GO:0006749;GO:0006629;GO:0006739;GO:0006740;GO:0061052;GO:0010734;GO:2000378;GO:0019322;GO:0006098;GO:0009051;GO:1904879;GO:0043523;GO:0045471;GO:0032094;GO:0010041;GO:0014070;GO:0046390;GO:0021762;, C:centriolar satellite; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus;, F:glucose binding; F:glucose-6-phosphate dehydrogenase activity; F:identical protein binding; F:NADP binding; F:protein homodimerization activity;, P:cellular response to oxidative stress; P:cholesterol biosynthetic process; P:erythrocyte maturation; P:glucose 6-phosphate metabolic process; P:glucose metabolic process; P:glutathione metabolic process; P:lipid metabolic process; P:NADP metabolic process; P:NADPH regeneration; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of protein glutathionylation; P:negative regulation of reactive oxygen species metabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of neuron apoptotic process; P:response to ethanol; P:response to food; P:response to iron(III) ion; P:response to organic cyclic compound; P:ribose phosphate biosynthetic process; P:substantia nigra development;|Q9Y6K9 Q7LBY6 Q7Z7F1,NF-kappa-B essential modulator,FIP-3;IkB kinase-associated protein 1;Inhibitor of nuclear factor kappa-B kinase subunit gamma;NF-kappa-B essential modifier;, PF16516;PF11577;, GO:0005737;GO:0005829;GO:0008385;GO:0072686;GO:0005654;GO:0005634;GO:0032991;GO:0000922;GO:0000151;GO:0042802;GO:0070530;GO:1990450;GO:0046872;GO:0042975;GO:0019904;GO:0046982;GO:0042803;GO:0044877;GO:1990459;GO:0031625;GO:0000187;GO:0043276;GO:0002479;GO:0006915;GO:0006974;GO:0051650;GO:0038095;GO:0007249;GO:0006955;GO:0006954;GO:0045087;GO:0070498;GO:0007254;GO:0002756;GO:1901215;GO:0070423;GO:0043123;GO:0016239;GO:0051092;GO:0045944;GO:0016579;GO:0065003;GO:0043122;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:IkappaB kinase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle pole; C:ubiquitin ligase complex;, F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:linear polyubiquitin binding; F:metal ion binding; F:peroxisome proliferator activated receptor binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding; F:transferrin receptor binding; F:ubiquitin protein ligase binding;, P:activation of MAPK activity; P:anoikis; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic process; P:cellular response to DNA damage stimulus; P:establishment of vesicle localization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of neuron death; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein-containing complex assembly; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|P11413 D3DWX9 Q16000 Q16765 Q8IU70 Q8IU88 Q8IUA6 Q96PQ2,Glucose-6-phosphate 1-dehydrogenase,, PF02781;PF00479;, GO:0034451;GO:0005737;GO:0009898;GO:0005829;GO:0070062;GO:0043231;GO:0016020;GO:0005634;GO:0005536;GO:0004345;GO:0042802;GO:0050661;GO:0042803;GO:0034599;GO:0006695;GO:0043249;GO:0051156;GO:0006006;GO:0006749;GO:0006629;GO:0006739;GO:0006740;GO:0061052;GO:0010734;GO:2000378;GO:0019322;GO:0006098;GO:0009051;GO:1904879;GO:0043523;GO:0045471;GO:0032094;GO:0010041;GO:0014070;GO:0046390;GO:0021762;, C:centriolar satellite; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:extracellular exosome; C:intracellular membrane-bounded organelle; C:membrane; C:nucleus;, F:glucose binding; F:glucose-6-phosphate dehydrogenase activity; F:identical protein binding; F:NADP binding; F:protein homodimerization activity;, P:cellular response to oxidative stress; P:cholesterol biosynthetic process; P:erythrocyte maturation; P:glucose 6-phosphate metabolic process; P:glucose metabolic process; P:glutathione metabolic process; P:lipid metabolic process; P:NADP metabolic process; P:NADPH regeneration; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of protein glutathionylation; P:negative regulation of reactive oxygen species metabolic process; P:pentose biosynthetic process; P:pentose-phosphate shunt; P:pentose-phosphate shunt, oxidative branch; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:regulation of neuron apoptotic process; P:response to ethanol; P:response to food; P:response to iron(III) ion; P:response to organic cyclic compound; P:ribose phosphate biosynthetic process; P:substantia nigra development;|Q9Y6K9 Q7LBY6 Q7Z7F1,NF-kappa-B essential modulator,FIP-3;IkB kinase-associated protein 1;Inhibitor of nuclear factor kappa-B kinase subunit gamma;NF-kappa-B essential modifier;, PF16516;PF11577;, GO:0005737;GO:0005829;GO:0008385;GO:0072686;GO:0005654;GO:0005634;GO:0032991;GO:0000922;GO:0000151;GO:0042802;GO:0070530;GO:1990450;GO:0046872;GO:0042975;GO:0019904;GO:0046982;GO:0042803;GO:0044877;GO:1990459;GO:0031625;GO:0000187;GO:0043276;GO:0002479;GO:0006915;GO:0006974;GO:0051650;GO:0038095;GO:0007249;GO:0006955;GO:0006954;GO:0045087;GO:0070498;GO:0007254;GO:0002756;GO:1901215;GO:0070423;GO:0043123;GO:0016239;GO:0051092;GO:0045944;GO:0016579;GO:0065003;GO:0043122;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:IkappaB kinase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle pole; C:ubiquitin ligase complex;, F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:linear polyubiquitin binding; F:metal ion binding; F:peroxisome proliferator activated receptor binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding; F:transferrin receptor binding; F:ubiquitin protein ligase binding;, P:activation of MAPK activity; P:anoikis; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic process; P:cellular response to DNA damage stimulus; P:establishment of vesicle localization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of neuron death; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein-containing complex assembly; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process;|Q9Y6K9 Q7LBY6 Q7Z7F1,NF-kappa-B essential modulator,FIP-3;IkB kinase-associated protein 1;Inhibitor of nuclear factor kappa-B kinase subunit gamma;NF-kappa-B essential modifier;, PF16516;PF11577;, GO:0005737;GO:0005829;GO:0008385;GO:0072686;GO:0005654;GO:0005634;GO:0032991;GO:0000922;GO:0000151;GO:0042802;GO:0070530;GO:1990450;GO:0046872;GO:0042975;GO:0019904;GO:0046982;GO:0042803;GO:0044877;GO:1990459;GO:0031625;GO:0000187;GO:0043276;GO:0002479;GO:0006915;GO:0006974;GO:0051650;GO:0038095;GO:0007249;GO:0006955;GO:0006954;GO:0045087;GO:0070498;GO:0007254;GO:0002756;GO:1901215;GO:0070423;GO:0043123;GO:0016239;GO:0051092;GO:0045944;GO:0016579;GO:0065003;GO:0043122;GO:0010803;GO:0009615;GO:0002223;GO:0051403;GO:0050852;GO:0035666;GO:0016032;, C:cytoplasm; C:cytosol; C:IkappaB kinase complex; C:mitotic spindle; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:spindle pole; C:ubiquitin ligase complex;, F:identical protein binding; F:K63-linked polyubiquitin modification-dependent protein binding; F:linear polyubiquitin binding; F:metal ion binding; F:peroxisome proliferator activated receptor binding; F:protein domain specific binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding; F:transferrin receptor binding; F:ubiquitin protein ligase binding;, P:activation of MAPK activity; P:anoikis; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; P:apoptotic process; P:cellular response to DNA damage stimulus; P:establishment of vesicle localization; P:Fc-epsilon receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:immune response; P:inflammatory response; P:innate immune response; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:MyD88-independent toll-like receptor signaling pathway; P:negative regulation of neuron death; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of macroautophagy; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:protein deubiquitination; P:protein-containing complex assembly; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to virus; P:stimulatory C-type lectin receptor signaling pathway; P:stress-activated MAPK cascade; P:T cell receptor signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process; scaffold299 indexed_genome mRNA 1 2753 . + . ID=transcript_16501;A6NL88,Protein shisa-7 {ECO:0000305},Cystine-knot AMPAR modulating protein of 59 kDa {ECO:0000250|UniProtKB:Q8C3Q5};GABA(A) receptor auxiliary subunit Shisa7;Protein shisa-6-like;, PF13908;, GO:0032281;GO:0098985;GO:0032591;GO:0014069;GO:0098839;GO:0045211;GO:0050811;GO:0035255;GO:0097112;GO:0007214;GO:0007613;GO:1900273;GO:1904717;GO:2000311;GO:0106040;GO:0048172;, C:AMPA glutamate receptor complex; C:asymmetric, glutamatergic, excitatory synapse; C:dendritic spine membrane; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic membrane;, F:GABA receptor binding; F:ionotropic glutamate receptor binding;, P:gamma-aminobutyric acid receptor clustering; P:gamma-aminobutyric acid signaling pathway; P:memory; P:positive regulation of long-term synaptic potentiation; P:regulation of AMPA glutamate receptor clustering; P:regulation of AMPA receptor activity; P:regulation of GABA-A receptor activity; P:regulation of short-term neuronal synaptic plasticity;|A6NL88,Protein shisa-7 {ECO:0000305},Cystine-knot AMPAR modulating protein of 59 kDa {ECO:0000250|UniProtKB:Q8C3Q5};GABA(A) receptor auxiliary subunit Shisa7;Protein shisa-6-like;, PF13908;, GO:0032281;GO:0098985;GO:0032591;GO:0014069;GO:0098839;GO:0045211;GO:0050811;GO:0035255;GO:0097112;GO:0007214;GO:0007613;GO:1900273;GO:1904717;GO:2000311;GO:0106040;GO:0048172;, C:AMPA glutamate receptor complex; C:asymmetric, glutamatergic, excitatory synapse; C:dendritic spine membrane; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic membrane;, F:GABA receptor binding; F:ionotropic glutamate receptor binding;, P:gamma-aminobutyric acid receptor clustering; P:gamma-aminobutyric acid signaling pathway; P:memory; P:positive regulation of long-term synaptic potentiation; P:regulation of AMPA glutamate receptor clustering; P:regulation of AMPA receptor activity; P:regulation of GABA-A receptor activity; P:regulation of short-term neuronal synaptic plasticity; scaffold299 indexed_genome mRNA 4099 9758 . - . ID=transcript_16502;A6NL88,Protein shisa-7 {ECO:0000305},Cystine-knot AMPAR modulating protein of 59 kDa {ECO:0000250|UniProtKB:Q8C3Q5};GABA(A) receptor auxiliary subunit Shisa7;Protein shisa-6-like;, PF13908;, GO:0032281;GO:0098985;GO:0032591;GO:0014069;GO:0098839;GO:0045211;GO:0050811;GO:0035255;GO:0097112;GO:0007214;GO:0007613;GO:1900273;GO:1904717;GO:2000311;GO:0106040;GO:0048172;, C:AMPA glutamate receptor complex; C:asymmetric, glutamatergic, excitatory synapse; C:dendritic spine membrane; C:postsynaptic density; C:postsynaptic density membrane; C:postsynaptic membrane;, F:GABA receptor binding; F:ionotropic glutamate receptor binding;, P:gamma-aminobutyric acid receptor clustering; P:gamma-aminobutyric acid signaling pathway; P:memory; P:positive regulation of long-term synaptic potentiation; P:regulation of AMPA glutamate receptor clustering; P:regulation of AMPA receptor activity; P:regulation of GABA-A receptor activity; P:regulation of short-term neuronal synaptic plasticity; scaffold299 indexed_genome mRNA 27079 27582 . - . ID=transcript_16503;Q16763 Q9BTC1,Ubiquitin-conjugating enzyme E2 S,E2 ubiquitin-conjugating enzyme S;E2-EPF;Ubiquitin carrier protein S;Ubiquitin-conjugating enzyme E2-24 kDa;Ubiquitin-conjugating enzyme E2-EPF5;Ubiquitin-protein ligase S;, PF00179;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0010997;GO:0005524;GO:0061631;GO:0004842;GO:0031145;GO:0051301;GO:0006464;GO:0010458;GO:0010994;GO:1904668;GO:0070979;GO:0044314;GO:0035519;GO:0085020;GO:0070534;GO:0000209;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus;, F:anaphase-promoting complex binding; F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:cellular protein modification process; P:exit from mitosis; P:free ubiquitin chain polymerization; P:positive regulation of ubiquitin protein ligase activity; P:protein K11-linked ubiquitination; P:protein K27-linked ubiquitination; P:protein K29-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold299 indexed_genome mRNA 28641 29543 . + . ID=transcript_16504;Q16763 Q9BTC1,Ubiquitin-conjugating enzyme E2 S,E2 ubiquitin-conjugating enzyme S;E2-EPF;Ubiquitin carrier protein S;Ubiquitin-conjugating enzyme E2-24 kDa;Ubiquitin-conjugating enzyme E2-EPF5;Ubiquitin-protein ligase S;, PF00179;, GO:0005680;GO:0005829;GO:0005654;GO:0005634;GO:0010997;GO:0005524;GO:0061631;GO:0004842;GO:0031145;GO:0051301;GO:0006464;GO:0010458;GO:0010994;GO:1904668;GO:0070979;GO:0044314;GO:0035519;GO:0085020;GO:0070534;GO:0000209;GO:0016567;GO:0007096;GO:1901990;GO:0006511;, C:anaphase-promoting complex; C:cytosol; C:nucleoplasm; C:nucleus;, F:anaphase-promoting complex binding; F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:anaphase-promoting complex-dependent catabolic process; P:cell division; P:cellular protein modification process; P:exit from mitosis; P:free ubiquitin chain polymerization; P:positive regulation of ubiquitin protein ligase activity; P:protein K11-linked ubiquitination; P:protein K27-linked ubiquitination; P:protein K29-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of exit from mitosis; P:regulation of mitotic cell cycle phase transition; P:ubiquitin-dependent protein catabolic process; scaffold299 indexed_genome mRNA 36251 38658 . - . ID=transcript_16505;P46779 B2R4A6 B4DEP9 C9JB50 E9PB24 G5E9L2 Q6IAY0 Q96FX1 Q9BWQ0,60S ribosomal protein L28,Large ribosomal subunit protein eL28 {ECO:0000303|PubMed:24524803};, PF01778;, GO:0044297;GO:0036464;GO:0005829;GO:0022625;GO:0030425;GO:0070062;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cell body; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:dendrite; C:extracellular exosome; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription;|P46779 B2R4A6 B4DEP9 C9JB50 E9PB24 G5E9L2 Q6IAY0 Q96FX1 Q9BWQ0,60S ribosomal protein L28,Large ribosomal subunit protein eL28 {ECO:0000303|PubMed:24524803};, PF01778;, GO:0044297;GO:0036464;GO:0005829;GO:0022625;GO:0030425;GO:0070062;GO:0016020;GO:0003723;GO:0003735;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cell body; C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:cytosolic large ribosomal subunit; C:dendrite; C:extracellular exosome; C:membrane;, F:RNA binding; F:structural constituent of ribosome;, P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold299 indexed_genome mRNA 82137 85011 . - . ID=transcript_16506;Q86Y97 Q8WZ10 Q9BRZ6,Histone-lysine N-methyltransferase KMT5C {ECO:0000305},Lysine N-methyltransferase 5C;Lysine-specific methyltransferase 5C {ECO:0000312|HGNC:HGNC:28405};Suppressor of variegation 4-20 homolog 2;[histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B {ECO:0000305};[histone H4]-lysine20 N-methyltransferase KMT5B {ECO:0000305};, PF00856;, GO:0000779;GO:0000792;GO:0005654;GO:0005634;GO:0005721;GO:0003682;GO:0042393;GO:0042799;GO:0046872;GO:1904047;GO:0006281;GO:0034772;GO:0034773;GO:2001034;GO:0045830;, C:condensed chromosome, centromeric region; C:heterochromatin; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:histone methyltransferase activity (H4-K20 specific); F:metal ion binding; F:S-adenosyl-L-methionine binding;, P:DNA repair; P:histone H4-K20 dimethylation; P:histone H4-K20 trimethylation; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching;|Q86Y97 Q8WZ10 Q9BRZ6,Histone-lysine N-methyltransferase KMT5C {ECO:0000305},Lysine N-methyltransferase 5C;Lysine-specific methyltransferase 5C {ECO:0000312|HGNC:HGNC:28405};Suppressor of variegation 4-20 homolog 2;[histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B {ECO:0000305};[histone H4]-lysine20 N-methyltransferase KMT5B {ECO:0000305};, PF00856;, GO:0000779;GO:0000792;GO:0005654;GO:0005634;GO:0005721;GO:0003682;GO:0042393;GO:0042799;GO:0046872;GO:1904047;GO:0006281;GO:0034772;GO:0034773;GO:2001034;GO:0045830;, C:condensed chromosome, centromeric region; C:heterochromatin; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:histone methyltransferase activity (H4-K20 specific); F:metal ion binding; F:S-adenosyl-L-methionine binding;, P:DNA repair; P:histone H4-K20 dimethylation; P:histone H4-K20 trimethylation; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching;|Q86Y97 Q8WZ10 Q9BRZ6,Histone-lysine N-methyltransferase KMT5C {ECO:0000305},Lysine N-methyltransferase 5C;Lysine-specific methyltransferase 5C {ECO:0000312|HGNC:HGNC:28405};Suppressor of variegation 4-20 homolog 2;[histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B {ECO:0000305};[histone H4]-lysine20 N-methyltransferase KMT5B {ECO:0000305};, PF00856;, GO:0000779;GO:0000792;GO:0005654;GO:0005634;GO:0005721;GO:0003682;GO:0042393;GO:0042799;GO:0046872;GO:1904047;GO:0006281;GO:0034772;GO:0034773;GO:2001034;GO:0045830;, C:condensed chromosome, centromeric region; C:heterochromatin; C:nucleoplasm; C:nucleus; C:pericentric heterochromatin;, F:chromatin binding; F:histone binding; F:histone methyltransferase activity (H4-K20 specific); F:metal ion binding; F:S-adenosyl-L-methionine binding;, P:DNA repair; P:histone H4-K20 dimethylation; P:histone H4-K20 trimethylation; P:positive regulation of double-strand break repair via nonhomologous end joining; P:positive regulation of isotype switching; scaffold299 indexed_genome mRNA 105278 133244 . - . ID=transcript_16507;A6NC51 B7ZW71,Modulator of macroautophagy TMEM150B {ECO:0000305},Protein DRAM-3 {ECO:0000303|PubMed:25929859};Transmembrane protein 150B {ECO:0000312|HGNC:HGNC:34415};Transmembrane protein 224 {ECO:0000312|HGNC:HGNC:34415};, PF10277;, GO:0000421;GO:0010008;GO:0005887;GO:0005764;GO:0006914;GO:0010506;, C:autophagosome membrane; C:endosome membrane; C:integral component of plasma membrane; C:lysosome;, , P:autophagy; P:regulation of autophagy;|A6NC51 B7ZW71,Modulator of macroautophagy TMEM150B {ECO:0000305},Protein DRAM-3 {ECO:0000303|PubMed:25929859};Transmembrane protein 150B {ECO:0000312|HGNC:HGNC:34415};Transmembrane protein 224 {ECO:0000312|HGNC:HGNC:34415};, PF10277;, GO:0000421;GO:0010008;GO:0005887;GO:0005764;GO:0006914;GO:0010506;, C:autophagosome membrane; C:endosome membrane; C:integral component of plasma membrane; C:lysosome;, , P:autophagy; P:regulation of autophagy;|Q8TDC3 F1DG44 Q5J5B5 Q8NDD0 Q8NDR4 Q8TDC2 Q96AV4 Q96JL4,Serine/threonine-protein kinase BRSK1,Brain-selective kinase 1;Brain-specific serine/threonine-protein kinase 1;Serine/threonine-protein kinase SAD-B;Synapses of Amphids Defective homolog 1;, PF00069;, GO:0030054;GO:0005813;GO:0005737;GO:0150034;GO:0005654;GO:0005634;GO:0048786;GO:0008021;GO:0005524;GO:0043015;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0008306;GO:0007409;GO:0006974;GO:0042149;GO:0051298;GO:0030010;GO:0000086;GO:0035556;GO:0090176;GO:0007095;GO:0030182;GO:0007269;GO:0018105;GO:0006468;GO:0050770;GO:0010975;GO:0048167;GO:2000807;GO:0009411;GO:0099504;, C:cell junction; C:centrosome; C:cytoplasm; C:distal axon; C:nucleoplasm; C:nucleus; C:presynaptic active zone; C:synaptic vesicle;, F:ATP binding; F:gamma-tubulin binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:associative learning; P:axonogenesis; P:cellular response to DNA damage stimulus; P:cellular response to glucose starvation; P:centrosome duplication; P:establishment of cell polarity; P:G2/M transition of mitotic cell cycle; P:intracellular signal transduction; P:microtubule cytoskeleton organization involved in establishment of planar polarity; P:mitotic G2 DNA damage checkpoint; P:neuron differentiation; P:neurotransmitter secretion; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of neuron projection development; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle clustering; P:response to UV; P:synaptic vesicle cycle;|Q8TDC3 F1DG44 Q5J5B5 Q8NDD0 Q8NDR4 Q8TDC2 Q96AV4 Q96JL4,Serine/threonine-protein kinase BRSK1,Brain-selective kinase 1;Brain-specific serine/threonine-protein kinase 1;Serine/threonine-protein kinase SAD-B;Synapses of Amphids Defective homolog 1;, PF00069;, GO:0030054;GO:0005813;GO:0005737;GO:0150034;GO:0005654;GO:0005634;GO:0048786;GO:0008021;GO:0005524;GO:0043015;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0008306;GO:0007409;GO:0006974;GO:0042149;GO:0051298;GO:0030010;GO:0000086;GO:0035556;GO:0090176;GO:0007095;GO:0030182;GO:0007269;GO:0018105;GO:0006468;GO:0050770;GO:0010975;GO:0048167;GO:2000807;GO:0009411;GO:0099504;, C:cell junction; C:centrosome; C:cytoplasm; C:distal axon; C:nucleoplasm; C:nucleus; C:presynaptic active zone; C:synaptic vesicle;, F:ATP binding; F:gamma-tubulin binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:associative learning; P:axonogenesis; P:cellular response to DNA damage stimulus; P:cellular response to glucose starvation; P:centrosome duplication; P:establishment of cell polarity; P:G2/M transition of mitotic cell cycle; P:intracellular signal transduction; P:microtubule cytoskeleton organization involved in establishment of planar polarity; P:mitotic G2 DNA damage checkpoint; P:neuron differentiation; P:neurotransmitter secretion; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of neuron projection development; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle clustering; P:response to UV; P:synaptic vesicle cycle;|Q8TDC3 F1DG44 Q5J5B5 Q8NDD0 Q8NDR4 Q8TDC2 Q96AV4 Q96JL4,Serine/threonine-protein kinase BRSK1,Brain-selective kinase 1;Brain-specific serine/threonine-protein kinase 1;Serine/threonine-protein kinase SAD-B;Synapses of Amphids Defective homolog 1;, PF00069;, GO:0030054;GO:0005813;GO:0005737;GO:0150034;GO:0005654;GO:0005634;GO:0048786;GO:0008021;GO:0005524;GO:0043015;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0008306;GO:0007409;GO:0006974;GO:0042149;GO:0051298;GO:0030010;GO:0000086;GO:0035556;GO:0090176;GO:0007095;GO:0030182;GO:0007269;GO:0018105;GO:0006468;GO:0050770;GO:0010975;GO:0048167;GO:2000807;GO:0009411;GO:0099504;, C:cell junction; C:centrosome; C:cytoplasm; C:distal axon; C:nucleoplasm; C:nucleus; C:presynaptic active zone; C:synaptic vesicle;, F:ATP binding; F:gamma-tubulin binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:associative learning; P:axonogenesis; P:cellular response to DNA damage stimulus; P:cellular response to glucose starvation; P:centrosome duplication; P:establishment of cell polarity; P:G2/M transition of mitotic cell cycle; P:intracellular signal transduction; P:microtubule cytoskeleton organization involved in establishment of planar polarity; P:mitotic G2 DNA damage checkpoint; P:neuron differentiation; P:neurotransmitter secretion; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of neuron projection development; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle clustering; P:response to UV; P:synaptic vesicle cycle;|Q8TDC3 F1DG44 Q5J5B5 Q8NDD0 Q8NDR4 Q8TDC2 Q96AV4 Q96JL4,Serine/threonine-protein kinase BRSK1,Brain-selective kinase 1;Brain-specific serine/threonine-protein kinase 1;Serine/threonine-protein kinase SAD-B;Synapses of Amphids Defective homolog 1;, PF00069;, GO:0030054;GO:0005813;GO:0005737;GO:0150034;GO:0005654;GO:0005634;GO:0048786;GO:0008021;GO:0005524;GO:0043015;GO:0000287;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0008306;GO:0007409;GO:0006974;GO:0042149;GO:0051298;GO:0030010;GO:0000086;GO:0035556;GO:0090176;GO:0007095;GO:0030182;GO:0007269;GO:0018105;GO:0006468;GO:0050770;GO:0010975;GO:0048167;GO:2000807;GO:0009411;GO:0099504;, C:cell junction; C:centrosome; C:cytoplasm; C:distal axon; C:nucleoplasm; C:nucleus; C:presynaptic active zone; C:synaptic vesicle;, F:ATP binding; F:gamma-tubulin binding; F:magnesium ion binding; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:associative learning; P:axonogenesis; P:cellular response to DNA damage stimulus; P:cellular response to glucose starvation; P:centrosome duplication; P:establishment of cell polarity; P:G2/M transition of mitotic cell cycle; P:intracellular signal transduction; P:microtubule cytoskeleton organization involved in establishment of planar polarity; P:mitotic G2 DNA damage checkpoint; P:neuron differentiation; P:neurotransmitter secretion; P:peptidyl-serine phosphorylation; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of neuron projection development; P:regulation of synaptic plasticity; P:regulation of synaptic vesicle clustering; P:response to UV; P:synaptic vesicle cycle; scaffold299 indexed_genome mRNA 137650 149192 . + . ID=transcript_16508;Q9NZL4 B3KQP0 B4DG11 O95351 Q6ZNU5,Hsp70-binding protein 1 {ECO:0000305},Heat shock protein-binding protein 1;Hsp70-binding protein 2;Hsp70-interacting protein 1;Hsp70-interacting protein 2;, PF08609;, GO:0005783;GO:0000774;GO:0004857;GO:0031625;GO:0032436;GO:0031398;GO:0006457;, C:endoplasmic reticulum;, F:adenyl-nucleotide exchange factor activity; F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein folding;|Q9NZL4 B3KQP0 B4DG11 O95351 Q6ZNU5,Hsp70-binding protein 1 {ECO:0000305},Heat shock protein-binding protein 1;Hsp70-binding protein 2;Hsp70-interacting protein 1;Hsp70-interacting protein 2;, PF08609;, GO:0005783;GO:0000774;GO:0004857;GO:0031625;GO:0032436;GO:0031398;GO:0006457;, C:endoplasmic reticulum;, F:adenyl-nucleotide exchange factor activity; F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein folding;|Q9NZL4 B3KQP0 B4DG11 O95351 Q6ZNU5,Hsp70-binding protein 1 {ECO:0000305},Heat shock protein-binding protein 1;Hsp70-binding protein 2;Hsp70-interacting protein 1;Hsp70-interacting protein 2;, PF08609;, GO:0005783;GO:0000774;GO:0004857;GO:0031625;GO:0032436;GO:0031398;GO:0006457;, C:endoplasmic reticulum;, F:adenyl-nucleotide exchange factor activity; F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein folding;|Q9NZL4 B3KQP0 B4DG11 O95351 Q6ZNU5,Hsp70-binding protein 1 {ECO:0000305},Heat shock protein-binding protein 1;Hsp70-binding protein 2;Hsp70-interacting protein 1;Hsp70-interacting protein 2;, PF08609;, GO:0005783;GO:0000774;GO:0004857;GO:0031625;GO:0032436;GO:0031398;GO:0006457;, C:endoplasmic reticulum;, F:adenyl-nucleotide exchange factor activity; F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein folding;|Q9NZL4 B3KQP0 B4DG11 O95351 Q6ZNU5,Hsp70-binding protein 1 {ECO:0000305},Heat shock protein-binding protein 1;Hsp70-binding protein 2;Hsp70-interacting protein 1;Hsp70-interacting protein 2;, PF08609;, GO:0005783;GO:0000774;GO:0004857;GO:0031625;GO:0032436;GO:0031398;GO:0006457;, C:endoplasmic reticulum;, F:adenyl-nucleotide exchange factor activity; F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein folding;|Q9NZL4 B3KQP0 B4DG11 O95351 Q6ZNU5,Hsp70-binding protein 1 {ECO:0000305},Heat shock protein-binding protein 1;Hsp70-binding protein 2;Hsp70-interacting protein 1;Hsp70-interacting protein 2;, PF08609;, GO:0005783;GO:0000774;GO:0004857;GO:0031625;GO:0032436;GO:0031398;GO:0006457;, C:endoplasmic reticulum;, F:adenyl-nucleotide exchange factor activity; F:enzyme inhibitor activity; F:ubiquitin protein ligase binding;, P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein folding; scaffold299 indexed_genome mRNA 197391 202664 . + . ID=transcript_16509;O00445 B3KWJ8 B7Z300 Q86X72,Synaptotagmin-5,Synaptotagmin V;, PF00168;, GO:0030424;GO:0031045;GO:0070382;GO:0099066;GO:0043025;GO:0048471;GO:0005886;GO:1990769;GO:0055038;GO:0030672;GO:0005509;GO:0005544;GO:0030276;GO:0005546;GO:0001786;GO:0046982;GO:0000149;GO:0019905;GO:0048791;GO:0017156;GO:0071277;GO:0007268;GO:0017158;GO:0014059;GO:0048488;GO:0016192;, C:axon; C:dense core granule; C:exocytic vesicle; C:integral component of neuronal dense core vesicle membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:proximal neuron projection; C:recycling endosome membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:protein heterodimerization activity; F:SNARE binding; F:syntaxin binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:chemical synaptic transmission; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:synaptic vesicle endocytosis; P:vesicle-mediated transport;|O00445 B3KWJ8 B7Z300 Q86X72,Synaptotagmin-5,Synaptotagmin V;, PF00168;, GO:0030424;GO:0031045;GO:0070382;GO:0099066;GO:0043025;GO:0048471;GO:0005886;GO:1990769;GO:0055038;GO:0030672;GO:0005509;GO:0005544;GO:0030276;GO:0005546;GO:0001786;GO:0046982;GO:0000149;GO:0019905;GO:0048791;GO:0017156;GO:0071277;GO:0007268;GO:0017158;GO:0014059;GO:0048488;GO:0016192;, C:axon; C:dense core granule; C:exocytic vesicle; C:integral component of neuronal dense core vesicle membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:proximal neuron projection; C:recycling endosome membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:protein heterodimerization activity; F:SNARE binding; F:syntaxin binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:chemical synaptic transmission; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:synaptic vesicle endocytosis; P:vesicle-mediated transport; scaffold299 indexed_genome mRNA 204784 210714 . + . ID=transcript_16510;Q8N9W5 A8MUY0 E3W9A1 E9PAX5 Q6P4F6 Q8N9W0 Q96AR2,Dynein assembly factor 3, axonemal,, PF14737;PF14740;, GO:0005737;GO:0070286;GO:0044458;, C:cytoplasm;, , P:axonemal dynein complex assembly; P:motile cilium assembly;|Q8N9W5 A8MUY0 E3W9A1 E9PAX5 Q6P4F6 Q8N9W0 Q96AR2,Dynein assembly factor 3, axonemal,, PF14737;PF14740;, GO:0005737;GO:0070286;GO:0044458;, C:cytoplasm;, , P:axonemal dynein complex assembly; P:motile cilium assembly; scaffold299 indexed_genome mRNA 211637 216481 . + . ID=transcript_16511;P19429,Troponin I, cardiac muscle,Cardiac troponin I;, PF00992;PF11636;, GO:0097512;GO:1990584;GO:0005829;GO:0030017;GO:0005861;GO:0003779;GO:0051015;GO:0019855;GO:0048306;GO:0046872;GO:0019904;GO:0019901;GO:0030172;GO:0031014;GO:0060048;GO:0006874;GO:0060047;GO:0007507;GO:0006936;GO:0030049;GO:0032780;GO:0010882;GO:0001980;GO:0003009;GO:0001570;GO:0055010;, C:cardiac myofibril; C:cardiac Troponin complex; C:cytosol; C:sarcomere; C:troponin complex;, F:actin binding; F:actin filament binding; F:calcium channel inhibitor activity; F:calcium-dependent protein binding; F:metal ion binding; F:protein domain specific binding; F:protein kinase binding; F:troponin C binding; F:troponin T binding;, P:cardiac muscle contraction; P:cellular calcium ion homeostasis; P:heart contraction; P:heart development; P:muscle contraction; P:muscle filament sliding; P:negative regulation of ATPase activity; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of systemic arterial blood pressure by ischemic conditions; P:skeletal muscle contraction; P:vasculogenesis; P:ventricular cardiac muscle tissue morphogenesis;|P19429,Troponin I, cardiac muscle,Cardiac troponin I;, PF00992;PF11636;, GO:0097512;GO:1990584;GO:0005829;GO:0030017;GO:0005861;GO:0003779;GO:0051015;GO:0019855;GO:0048306;GO:0046872;GO:0019904;GO:0019901;GO:0030172;GO:0031014;GO:0060048;GO:0006874;GO:0060047;GO:0007507;GO:0006936;GO:0030049;GO:0032780;GO:0010882;GO:0001980;GO:0003009;GO:0001570;GO:0055010;, C:cardiac myofibril; C:cardiac Troponin complex; C:cytosol; C:sarcomere; C:troponin complex;, F:actin binding; F:actin filament binding; F:calcium channel inhibitor activity; F:calcium-dependent protein binding; F:metal ion binding; F:protein domain specific binding; F:protein kinase binding; F:troponin C binding; F:troponin T binding;, P:cardiac muscle contraction; P:cellular calcium ion homeostasis; P:heart contraction; P:heart development; P:muscle contraction; P:muscle filament sliding; P:negative regulation of ATPase activity; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of systemic arterial blood pressure by ischemic conditions; P:skeletal muscle contraction; P:vasculogenesis; P:ventricular cardiac muscle tissue morphogenesis;|P19429,Troponin I, cardiac muscle,Cardiac troponin I;, PF00992;PF11636;, GO:0097512;GO:1990584;GO:0005829;GO:0030017;GO:0005861;GO:0003779;GO:0051015;GO:0019855;GO:0048306;GO:0046872;GO:0019904;GO:0019901;GO:0030172;GO:0031014;GO:0060048;GO:0006874;GO:0060047;GO:0007507;GO:0006936;GO:0030049;GO:0032780;GO:0010882;GO:0001980;GO:0003009;GO:0001570;GO:0055010;, C:cardiac myofibril; C:cardiac Troponin complex; C:cytosol; C:sarcomere; C:troponin complex;, F:actin binding; F:actin filament binding; F:calcium channel inhibitor activity; F:calcium-dependent protein binding; F:metal ion binding; F:protein domain specific binding; F:protein kinase binding; F:troponin C binding; F:troponin T binding;, P:cardiac muscle contraction; P:cellular calcium ion homeostasis; P:heart contraction; P:heart development; P:muscle contraction; P:muscle filament sliding; P:negative regulation of ATPase activity; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of systemic arterial blood pressure by ischemic conditions; P:skeletal muscle contraction; P:vasculogenesis; P:ventricular cardiac muscle tissue morphogenesis; scaffold300 indexed_genome mRNA 189502 203536 . + . ID=transcript_16512;Q02224 A6NKY9 A8K2U7 Q4LE75,Centromere-associated protein E,Centromere protein E;Kinesin-7 {ECO:0000303|PubMed:25908662};Kinesin-related protein CENPE;, PF00225;, GO:0005694;GO:0000775;GO:0000777;GO:0000779;GO:0005829;GO:0000776;GO:0005828;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0043515;GO:0008017;GO:0003777;GO:0019886;GO:0051315;GO:0051301;GO:0007059;GO:0051382;GO:0099607;GO:0051310;GO:0099606;GO:0007018;GO:0000278;GO:0007079;GO:0007080;GO:0007052;GO:0007275;GO:0045860;GO:0030071;GO:0006890;, C:chromosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:condensed chromosome, centromeric region; C:cytosol; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:kinetochore binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore assembly; P:lateral attachment of mitotic spindle microtubules to kinetochore; P:metaphase plate congression; P:microtubule plus-end directed mitotic chromosome migration; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:multicellular organism development; P:positive regulation of protein kinase activity; P:regulation of mitotic metaphase/anaphase transition; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;|Q02224 A6NKY9 A8K2U7 Q4LE75,Centromere-associated protein E,Centromere protein E;Kinesin-7 {ECO:0000303|PubMed:25908662};Kinesin-related protein CENPE;, PF00225;, GO:0005694;GO:0000775;GO:0000777;GO:0000779;GO:0005829;GO:0000776;GO:0005828;GO:0016020;GO:0005874;GO:0015630;GO:0030496;GO:1990023;GO:0005654;GO:0005634;GO:0051233;GO:0005524;GO:0008574;GO:0043515;GO:0008017;GO:0003777;GO:0019886;GO:0051315;GO:0051301;GO:0007059;GO:0051382;GO:0099607;GO:0051310;GO:0099606;GO:0007018;GO:0000278;GO:0007079;GO:0007080;GO:0007052;GO:0007275;GO:0045860;GO:0030071;GO:0006890;, C:chromosome; C:chromosome, centromeric region; C:condensed chromosome kinetochore; C:condensed chromosome, centromeric region; C:cytosol; C:kinetochore; C:kinetochore microtubule; C:membrane; C:microtubule; C:microtubule cytoskeleton; C:midbody; C:mitotic spindle midzone; C:nucleoplasm; C:nucleus; C:spindle midzone;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:kinetochore binding; F:microtubule binding; F:microtubule motor activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:attachment of mitotic spindle microtubules to kinetochore; P:cell division; P:chromosome segregation; P:kinetochore assembly; P:lateral attachment of mitotic spindle microtubules to kinetochore; P:metaphase plate congression; P:microtubule plus-end directed mitotic chromosome migration; P:microtubule-based movement; P:mitotic cell cycle; P:mitotic chromosome movement towards spindle pole; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:multicellular organism development; P:positive regulation of protein kinase activity; P:regulation of mitotic metaphase/anaphase transition; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold301 indexed_genome mRNA 73 4201 . + . ID=transcript_16513;Q15526 Q5T8T3 Q5T8T4,Surfeit locus protein 1,, PF02104;, GO:0016021;GO:0005746;GO:0004129;GO:0009060;GO:0033617;GO:0006119;GO:0008535;, C:integral component of membrane; C:mitochondrial respirasome;, F:cytochrome-c oxidase activity;, P:aerobic respiration; P:mitochondrial cytochrome c oxidase assembly; P:oxidative phosphorylation; P:respiratory chain complex IV assembly;|Q15526 Q5T8T3 Q5T8T4,Surfeit locus protein 1,, PF02104;, GO:0016021;GO:0005746;GO:0004129;GO:0009060;GO:0033617;GO:0006119;GO:0008535;, C:integral component of membrane; C:mitochondrial respirasome;, F:cytochrome-c oxidase activity;, P:aerobic respiration; P:mitochondrial cytochrome c oxidase assembly; P:oxidative phosphorylation; P:respiratory chain complex IV assembly;|Q15526 Q5T8T3 Q5T8T4,Surfeit locus protein 1,, PF02104;, GO:0016021;GO:0005746;GO:0004129;GO:0009060;GO:0033617;GO:0006119;GO:0008535;, C:integral component of membrane; C:mitochondrial respirasome;, F:cytochrome-c oxidase activity;, P:aerobic respiration; P:mitochondrial cytochrome c oxidase assembly; P:oxidative phosphorylation; P:respiratory chain complex IV assembly; scaffold301 indexed_genome mRNA 69388 71443 . - . ID=transcript_16514;Q9NPH6 Q5VSP6 Q9NY51 Q9NY52,Odorant-binding protein 2b,Odorant-binding protein IIb;, PF00061;, GO:0005615;GO:0005549;GO:0036094;GO:0007635;GO:0007608;, C:extracellular space;, F:odorant binding; F:small molecule binding;, P:chemosensory behavior; P:sensory perception of smell; scaffold301 indexed_genome mRNA 113947 118051 . + . ID=transcript_16515;Q6UWW0,Lipocalin-15,, PF00061;, GO:0005576;GO:0036094;, C:extracellular region;, F:small molecule binding; scaffold301 indexed_genome mRNA 196165 201588 . - . ID=transcript_16516;O75683 Q5T8U1 Q9BRK9 Q9BTZ5 Q9UK24,Surfeit locus protein 6,, PF04935;, GO:0005694;GO:0001652;GO:0005730;GO:0005654;GO:0003677;GO:0003723;GO:0042273;GO:0042274;, C:chromosome; C:granular component; C:nucleolus; C:nucleoplasm;, F:DNA binding; F:RNA binding;, P:ribosomal large subunit biogenesis; P:ribosomal small subunit biogenesis; scaffold301 indexed_genome mRNA 202575 208501 . - . ID=transcript_16517;Q15528 B3KW83 B3KWX4 O76072 Q5T8U0,Mediator of RNA polymerase II transcription subunit 22,Mediator complex subunit 22;Surfeit locus protein 5;, PF06179;, GO:0005737;GO:0016592;GO:0003712;GO:0006357;, C:cytoplasm; C:mediator complex;, F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II;|Q15528 B3KW83 B3KWX4 O76072 Q5T8U0,Mediator of RNA polymerase II transcription subunit 22,Mediator complex subunit 22;Surfeit locus protein 5;, PF06179;, GO:0005737;GO:0016592;GO:0003712;GO:0006357;, C:cytoplasm; C:mediator complex;, F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II;|Q15528 B3KW83 B3KWX4 O76072 Q5T8U0,Mediator of RNA polymerase II transcription subunit 22,Mediator complex subunit 22;Surfeit locus protein 5;, PF06179;, GO:0005737;GO:0016592;GO:0003712;GO:0006357;, C:cytoplasm; C:mediator complex;, F:transcription coregulator activity;, P:regulation of transcription by RNA polymerase II; scaffold302 indexed_genome mRNA 88299 90741 . + . ID=transcript_16518;Q9BRZ2 Q6PJS5 Q86VT6 Q8N2H8 Q8NAC0 Q9H031,E3 ubiquitin-protein ligase TRIM56,RING finger protein 109;RING-type E3 ubiquitin transferase TRIM56 {ECO:0000305};Tripartite motif-containing protein 56;, PF00643;PF13445;, GO:0000785;GO:0005737;GO:0005829;GO:0005654;GO:0003723;GO:0004842;GO:0008270;GO:0051607;GO:0045087;GO:0032728;GO:0045893;GO:0070534;GO:0032479;GO:0034340;, C:chromatin; C:cytoplasm; C:cytosol; C:nucleoplasm;, F:RNA binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:defense response to virus; P:innate immune response; P:positive regulation of interferon-beta production; P:positive regulation of transcription, DNA-templated; P:protein K63-linked ubiquitination; P:regulation of type I interferon production; P:response to type I interferon; scaffold302 indexed_genome mRNA 118288 124764 . + . ID=transcript_16519;P05121 B7Z4S0 F8WD53,Plasminogen activator inhibitor 1,Endothelial plasminogen activator inhibitor;Serpin E1;, PF00079;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0031093;GO:0002020;GO:0004867;GO:0005102;GO:0001525;GO:0071222;GO:0007623;GO:0050829;GO:0097187;GO:0030198;GO:0042730;GO:0030195;GO:0033629;GO:0030336;GO:0010951;GO:2000352;GO:1902042;GO:0051918;GO:0010757;GO:0014912;GO:2000098;GO:0061044;GO:0061045;GO:0002576;GO:0045766;GO:0030194;GO:0050729;GO:0032757;GO:0035491;GO:0090026;GO:1901331;GO:0048260;GO:0045944;GO:0010469;GO:0090399;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:platelet alpha granule lumen;, F:protease binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding;, P:angiogenesis; P:cellular response to lipopolysaccharide; P:circadian rhythm; P:defense response to Gram-negative bacterium; P:dentinogenesis; P:extracellular matrix organization; P:fibrinolysis; P:negative regulation of blood coagulation; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell migration; P:negative regulation of endopeptidase activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of fibrinolysis; P:negative regulation of plasminogen activation; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell-matrix adhesion; P:negative regulation of vascular wound healing; P:negative regulation of wound healing; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-8 production; P:positive regulation of leukotriene production involved in inflammatory response; P:positive regulation of monocyte chemotaxis; P:positive regulation of odontoblast differentiation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of signaling receptor activity; P:replicative senescence;|P05121 B7Z4S0 F8WD53,Plasminogen activator inhibitor 1,Endothelial plasminogen activator inhibitor;Serpin E1;, PF00079;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0031093;GO:0002020;GO:0004867;GO:0005102;GO:0001525;GO:0071222;GO:0007623;GO:0050829;GO:0097187;GO:0030198;GO:0042730;GO:0030195;GO:0033629;GO:0030336;GO:0010951;GO:2000352;GO:1902042;GO:0051918;GO:0010757;GO:0014912;GO:2000098;GO:0061044;GO:0061045;GO:0002576;GO:0045766;GO:0030194;GO:0050729;GO:0032757;GO:0035491;GO:0090026;GO:1901331;GO:0048260;GO:0045944;GO:0010469;GO:0090399;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:platelet alpha granule lumen;, F:protease binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding;, P:angiogenesis; P:cellular response to lipopolysaccharide; P:circadian rhythm; P:defense response to Gram-negative bacterium; P:dentinogenesis; P:extracellular matrix organization; P:fibrinolysis; P:negative regulation of blood coagulation; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell migration; P:negative regulation of endopeptidase activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of fibrinolysis; P:negative regulation of plasminogen activation; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell-matrix adhesion; P:negative regulation of vascular wound healing; P:negative regulation of wound healing; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-8 production; P:positive regulation of leukotriene production involved in inflammatory response; P:positive regulation of monocyte chemotaxis; P:positive regulation of odontoblast differentiation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of signaling receptor activity; P:replicative senescence;|P05121 B7Z4S0 F8WD53,Plasminogen activator inhibitor 1,Endothelial plasminogen activator inhibitor;Serpin E1;, PF00079;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0031093;GO:0002020;GO:0004867;GO:0005102;GO:0001525;GO:0071222;GO:0007623;GO:0050829;GO:0097187;GO:0030198;GO:0042730;GO:0030195;GO:0033629;GO:0030336;GO:0010951;GO:2000352;GO:1902042;GO:0051918;GO:0010757;GO:0014912;GO:2000098;GO:0061044;GO:0061045;GO:0002576;GO:0045766;GO:0030194;GO:0050729;GO:0032757;GO:0035491;GO:0090026;GO:1901331;GO:0048260;GO:0045944;GO:0010469;GO:0090399;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:platelet alpha granule lumen;, F:protease binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding;, P:angiogenesis; P:cellular response to lipopolysaccharide; P:circadian rhythm; P:defense response to Gram-negative bacterium; P:dentinogenesis; P:extracellular matrix organization; P:fibrinolysis; P:negative regulation of blood coagulation; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell migration; P:negative regulation of endopeptidase activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of fibrinolysis; P:negative regulation of plasminogen activation; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell-matrix adhesion; P:negative regulation of vascular wound healing; P:negative regulation of wound healing; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-8 production; P:positive regulation of leukotriene production involved in inflammatory response; P:positive regulation of monocyte chemotaxis; P:positive regulation of odontoblast differentiation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of signaling receptor activity; P:replicative senescence;|P05121 B7Z4S0 F8WD53,Plasminogen activator inhibitor 1,Endothelial plasminogen activator inhibitor;Serpin E1;, PF00079;, GO:0062023;GO:0070062;GO:0005576;GO:0005615;GO:0005886;GO:0031093;GO:0002020;GO:0004867;GO:0005102;GO:0001525;GO:0071222;GO:0007623;GO:0050829;GO:0097187;GO:0030198;GO:0042730;GO:0030195;GO:0033629;GO:0030336;GO:0010951;GO:2000352;GO:1902042;GO:0051918;GO:0010757;GO:0014912;GO:2000098;GO:0061044;GO:0061045;GO:0002576;GO:0045766;GO:0030194;GO:0050729;GO:0032757;GO:0035491;GO:0090026;GO:1901331;GO:0048260;GO:0045944;GO:0010469;GO:0090399;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular region; C:extracellular space; C:plasma membrane; C:platelet alpha granule lumen;, F:protease binding; F:serine-type endopeptidase inhibitor activity; F:signaling receptor binding;, P:angiogenesis; P:cellular response to lipopolysaccharide; P:circadian rhythm; P:defense response to Gram-negative bacterium; P:dentinogenesis; P:extracellular matrix organization; P:fibrinolysis; P:negative regulation of blood coagulation; P:negative regulation of cell adhesion mediated by integrin; P:negative regulation of cell migration; P:negative regulation of endopeptidase activity; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of fibrinolysis; P:negative regulation of plasminogen activation; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell-matrix adhesion; P:negative regulation of vascular wound healing; P:negative regulation of wound healing; P:platelet degranulation; P:positive regulation of angiogenesis; P:positive regulation of blood coagulation; P:positive regulation of inflammatory response; P:positive regulation of interleukin-8 production; P:positive regulation of leukotriene production involved in inflammatory response; P:positive regulation of monocyte chemotaxis; P:positive regulation of odontoblast differentiation; P:positive regulation of receptor-mediated endocytosis; P:positive regulation of transcription by RNA polymerase II; P:regulation of signaling receptor activity; P:replicative senescence; scaffold302 indexed_genome mRNA 139024 141374 . + . ID=transcript_16520;P61966 B2R5D8 P82267 Q00382 Q53YA7 Q9BTN4 Q9UDW9,AP-1 complex subunit sigma-1A,Adaptor protein complex AP-1 subunit sigma-1A;Adaptor-related protein complex 1 subunit sigma-1A;Clathrin assembly protein complex 1 sigma-1A small chain;Clathrin coat assembly protein AP19;Golgi adaptor HA1/AP1 adaptin sigma-1A subunit;HA1 19 kDa subunit;Sigma 1a subunit of AP-1 clathrin;Sigma-adaptin 1A;Sigma1A-adaptin;, PF01217;, GO:0030121;GO:0005905;GO:0030659;GO:0005829;GO:0005794;GO:0000139;GO:0043231;GO:0005765;GO:0016020;GO:0032588;GO:0019886;GO:0006886;GO:0006892;GO:0006898;GO:0050690;GO:0009615;GO:0016192;, C:AP-1 adaptor complex; C:clathrin-coated pit; C:cytoplasmic vesicle membrane; C:cytosol; C:Golgi apparatus; C:Golgi membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:trans-Golgi network membrane;, , P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:intracellular protein transport; P:post-Golgi vesicle-mediated transport; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:response to virus; P:vesicle-mediated transport; scaffold302 indexed_genome mRNA 148218 150161 . - . ID=transcript_16521;O15240 Q9UDW8,Neurosecretory protein VGF,, , GO:0031410;GO:0005788;GO:0005615;GO:0005794;GO:0043231;GO:0030133;GO:0008083;GO:0005179;GO:0005184;GO:0033500;GO:0044267;GO:0042742;GO:0006091;GO:0042593;GO:0030073;GO:0001541;GO:0043687;GO:0048167;GO:0051591;GO:0009409;GO:0002021;GO:0032868;GO:0019953;, C:cytoplasmic vesicle; C:endoplasmic reticulum lumen; C:extracellular space; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:transport vesicle;, F:growth factor activity; F:hormone activity; F:neuropeptide hormone activity;, P:carbohydrate homeostasis; P:cellular protein metabolic process; P:defense response to bacterium; P:generation of precursor metabolites and energy; P:glucose homeostasis; P:insulin secretion; P:ovarian follicle development; P:post-translational protein modification; P:regulation of synaptic plasticity; P:response to cAMP; P:response to cold; P:response to dietary excess; P:response to insulin; P:sexual reproduction; scaffold303 indexed_genome mRNA 414 2639 . - . ID=transcript_16522;P56270 A8QJL9 C6G496 G5E927 H3BQD6 Q15703 Q8NFN7 Q99443,Myc-associated zinc finger protein,Pur-1;Purine-binding transcription factor;Serum amyloid A-activating factor-1;Transcription factor Zif87;ZF87;Zinc finger protein 801;, PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0003723;GO:0000978;GO:2001234;GO:0000122;GO:0030335;GO:0008284;GO:0010628;GO:0014068;GO:0051897;GO:0045893;GO:0006357;GO:0006369;GO:0006367;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; P:transcription initiation from RNA polymerase II promoter;|P56270 A8QJL9 C6G496 G5E927 H3BQD6 Q15703 Q8NFN7 Q99443,Myc-associated zinc finger protein,Pur-1;Purine-binding transcription factor;Serum amyloid A-activating factor-1;Transcription factor Zif87;ZF87;Zinc finger protein 801;, PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0003723;GO:0000978;GO:2001234;GO:0000122;GO:0030335;GO:0008284;GO:0010628;GO:0014068;GO:0051897;GO:0045893;GO:0006357;GO:0006369;GO:0006367;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; P:transcription initiation from RNA polymerase II promoter;|P56270 A8QJL9 C6G496 G5E927 H3BQD6 Q15703 Q8NFN7 Q99443,Myc-associated zinc finger protein,Pur-1;Purine-binding transcription factor;Serum amyloid A-activating factor-1;Transcription factor Zif87;ZF87;Zinc finger protein 801;, PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0003723;GO:0000978;GO:2001234;GO:0000122;GO:0030335;GO:0008284;GO:0010628;GO:0014068;GO:0051897;GO:0045893;GO:0006357;GO:0006369;GO:0006367;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:termination of RNA polymerase II transcription; P:transcription initiation from RNA polymerase II promoter; scaffold303 indexed_genome mRNA 4785 12260 . - . ID=transcript_16523;Q7Z6L0 A8K8M8 Q8N2N8 Q8NAQ7 Q8ND36 Q96FA8,Proline-rich transmembrane protein 2,Dispanin subfamily B member 3;, PF04505;, GO:0043679;GO:0043197;GO:0016021;GO:0016020;GO:0005886;GO:0098839;GO:0098793;GO:0042734;GO:0008021;GO:0030672;GO:0031982;GO:0017075;GO:1905513;GO:0035544;GO:0050884;GO:0031629;, C:axon terminus; C:dendritic spine; C:integral component of membrane; C:membrane; C:plasma membrane; C:postsynaptic density membrane; C:presynapse; C:presynaptic membrane; C:synaptic vesicle; C:synaptic vesicle membrane; C:vesicle;, F:syntaxin-1 binding;, P:negative regulation of short-term synaptic potentiation; P:negative regulation of SNARE complex assembly; P:neuromuscular process controlling posture; P:synaptic vesicle fusion to presynaptic active zone membrane;|Q7Z6L0 A8K8M8 Q8N2N8 Q8NAQ7 Q8ND36 Q96FA8,Proline-rich transmembrane protein 2,Dispanin subfamily B member 3;, PF04505;, GO:0043679;GO:0043197;GO:0016021;GO:0016020;GO:0005886;GO:0098839;GO:0098793;GO:0042734;GO:0008021;GO:0030672;GO:0031982;GO:0017075;GO:1905513;GO:0035544;GO:0050884;GO:0031629;, C:axon terminus; C:dendritic spine; C:integral component of membrane; C:membrane; C:plasma membrane; C:postsynaptic density membrane; C:presynapse; C:presynaptic membrane; C:synaptic vesicle; C:synaptic vesicle membrane; C:vesicle;, F:syntaxin-1 binding;, P:negative regulation of short-term synaptic potentiation; P:negative regulation of SNARE complex assembly; P:neuromuscular process controlling posture; P:synaptic vesicle fusion to presynaptic active zone membrane;|Q9BTK6 A2ICR6,PAXIP1-associated glutamate-rich protein 1,Glutamate-rich coactivator interacting with SRC1 {ECO:0000303|PubMed:19039327};PAXIP1-associated protein 1;PTIP-associated protein 1;, PF15364;, GO:0035097;GO:0044666;GO:0005634;GO:0030331;GO:0006310;GO:0006281;GO:0051568;GO:1902808;GO:0033148;GO:0045944;, C:histone methyltransferase complex; C:MLL3/4 complex; C:nucleus;, F:estrogen receptor binding;, P:DNA recombination; P:DNA repair; P:histone H3-K4 methylation; P:positive regulation of cell cycle G1/S phase transition; P:positive regulation of intracellular estrogen receptor signaling pathway; P:positive regulation of transcription by RNA polymerase II; scaffold303 indexed_genome mRNA 12816 32930 . - . ID=transcript_16524;Q14764 Q96BG4 Q9BPW6 Q9BQT1 Q9UBD1,Major vault protein,Lung resistance-related protein;, PF11978;PF01505;PF17794;PF17795;PF17796;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005643;GO:0005634;GO:0048471;GO:0034774;GO:0042802;GO:0019901;GO:0019903;GO:0038127;GO:0051028;GO:0042059;GO:0031953;GO:0061099;GO:0043312;GO:0015031;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear pore; C:nucleus; C:perinuclear region of cytoplasm; C:secretory granule lumen;, F:identical protein binding; F:protein kinase binding; F:protein phosphatase binding;, P:ERBB signaling pathway; P:mRNA transport; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of protein autophosphorylation; P:negative regulation of protein tyrosine kinase activity; P:neutrophil degranulation; P:protein transport;|Q14764 Q96BG4 Q9BPW6 Q9BQT1 Q9UBD1,Major vault protein,Lung resistance-related protein;, PF11978;PF01505;PF17794;PF17795;PF17796;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005643;GO:0005634;GO:0048471;GO:0034774;GO:0042802;GO:0019901;GO:0019903;GO:0038127;GO:0051028;GO:0042059;GO:0031953;GO:0061099;GO:0043312;GO:0015031;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear pore; C:nucleus; C:perinuclear region of cytoplasm; C:secretory granule lumen;, F:identical protein binding; F:protein kinase binding; F:protein phosphatase binding;, P:ERBB signaling pathway; P:mRNA transport; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of protein autophosphorylation; P:negative regulation of protein tyrosine kinase activity; P:neutrophil degranulation; P:protein transport;|Q14764 Q96BG4 Q9BPW6 Q9BQT1 Q9UBD1,Major vault protein,Lung resistance-related protein;, PF11978;PF01505;PF17794;PF17795;PF17796;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005643;GO:0005634;GO:0048471;GO:0034774;GO:0042802;GO:0019901;GO:0019903;GO:0038127;GO:0051028;GO:0042059;GO:0031953;GO:0061099;GO:0043312;GO:0015031;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear pore; C:nucleus; C:perinuclear region of cytoplasm; C:secretory granule lumen;, F:identical protein binding; F:protein kinase binding; F:protein phosphatase binding;, P:ERBB signaling pathway; P:mRNA transport; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of protein autophosphorylation; P:negative regulation of protein tyrosine kinase activity; P:neutrophil degranulation; P:protein transport;|Q14764 Q96BG4 Q9BPW6 Q9BQT1 Q9UBD1,Major vault protein,Lung resistance-related protein;, PF11978;PF01505;PF17794;PF17795;PF17796;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005643;GO:0005634;GO:0048471;GO:0034774;GO:0042802;GO:0019901;GO:0019903;GO:0038127;GO:0051028;GO:0042059;GO:0031953;GO:0061099;GO:0043312;GO:0015031;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear pore; C:nucleus; C:perinuclear region of cytoplasm; C:secretory granule lumen;, F:identical protein binding; F:protein kinase binding; F:protein phosphatase binding;, P:ERBB signaling pathway; P:mRNA transport; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of protein autophosphorylation; P:negative regulation of protein tyrosine kinase activity; P:neutrophil degranulation; P:protein transport;|Q14764 Q96BG4 Q9BPW6 Q9BQT1 Q9UBD1,Major vault protein,Lung resistance-related protein;, PF11978;PF01505;PF17794;PF17795;PF17796;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005643;GO:0005634;GO:0048471;GO:0034774;GO:0042802;GO:0019901;GO:0019903;GO:0038127;GO:0051028;GO:0042059;GO:0031953;GO:0061099;GO:0043312;GO:0015031;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear pore; C:nucleus; C:perinuclear region of cytoplasm; C:secretory granule lumen;, F:identical protein binding; F:protein kinase binding; F:protein phosphatase binding;, P:ERBB signaling pathway; P:mRNA transport; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of protein autophosphorylation; P:negative regulation of protein tyrosine kinase activity; P:neutrophil degranulation; P:protein transport;|Q14764 Q96BG4 Q9BPW6 Q9BQT1 Q9UBD1,Major vault protein,Lung resistance-related protein;, PF11978;PF01505;PF17794;PF17795;PF17796;, GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:1904813;GO:0016020;GO:0005643;GO:0005634;GO:0048471;GO:0034774;GO:0042802;GO:0019901;GO:0019903;GO:0038127;GO:0051028;GO:0042059;GO:0031953;GO:0061099;GO:0043312;GO:0015031;, C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:ficolin-1-rich granule lumen; C:membrane; C:nuclear pore; C:nucleus; C:perinuclear region of cytoplasm; C:secretory granule lumen;, F:identical protein binding; F:protein kinase binding; F:protein phosphatase binding;, P:ERBB signaling pathway; P:mRNA transport; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of protein autophosphorylation; P:negative regulation of protein tyrosine kinase activity; P:neutrophil degranulation; P:protein transport; scaffold303 indexed_genome mRNA 42861 54680 . - . ID=transcript_16525;O14735 B4DUV0 H3BTV1 Q6FGU1 Q6ZN70,CDP-diacylglycerol--inositol 3-phosphatidyltransferase {ECO:0000305},Phosphatidylinositol synthase;, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0016020;GO:0005886;GO:0003881;GO:0006661;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:plasma membrane;, F:CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity;, P:phosphatidylinositol biosynthetic process;|O14735 B4DUV0 H3BTV1 Q6FGU1 Q6ZN70,CDP-diacylglycerol--inositol 3-phosphatidyltransferase {ECO:0000305},Phosphatidylinositol synthase;, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0016020;GO:0005886;GO:0003881;GO:0006661;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:plasma membrane;, F:CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity;, P:phosphatidylinositol biosynthetic process;|O14735 B4DUV0 H3BTV1 Q6FGU1 Q6ZN70,CDP-diacylglycerol--inositol 3-phosphatidyltransferase {ECO:0000305},Phosphatidylinositol synthase;, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0016020;GO:0005886;GO:0003881;GO:0006661;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:plasma membrane;, F:CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity;, P:phosphatidylinositol biosynthetic process;|O14735 B4DUV0 H3BTV1 Q6FGU1 Q6ZN70,CDP-diacylglycerol--inositol 3-phosphatidyltransferase {ECO:0000305},Phosphatidylinositol synthase;, PF01066;, GO:0005789;GO:0005794;GO:0016021;GO:0016020;GO:0005886;GO:0003881;GO:0006661;, C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:plasma membrane;, F:CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity;, P:phosphatidylinositol biosynthetic process;|P0DO92,Putative protein T-ENOL {ECO:0000305},CDIP transferase opposite strand, pseudogene {ECO:0000312|HGNC:HGNC:48609};CDIPT antisense RNA 1 {ECO:0000312|HGNC:HGNC:48609};|Q6UXD5 B7Z1N0 F5H293 H7BXQ6 Q9BW82 Q9UJ45 Q9UJ46 Q9UJ47,Seizure 6-like protein 2,, PF00431;PF00084;, GO:0005789;GO:0016021;GO:0005886;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;|Q6UXD5 B7Z1N0 F5H293 H7BXQ6 Q9BW82 Q9UJ45 Q9UJ46 Q9UJ47,Seizure 6-like protein 2,, PF00431;PF00084;, GO:0005789;GO:0016021;GO:0005886;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; scaffold303 indexed_genome mRNA 55366 73593 . - . ID=transcript_16526;Q6UXD5 B7Z1N0 F5H293 H7BXQ6 Q9BW82 Q9UJ45 Q9UJ46 Q9UJ47,Seizure 6-like protein 2,, PF00431;PF00084;, GO:0005789;GO:0016021;GO:0005886;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;|Q6UXD5 B7Z1N0 F5H293 H7BXQ6 Q9BW82 Q9UJ45 Q9UJ46 Q9UJ47,Seizure 6-like protein 2,, PF00431;PF00084;, GO:0005789;GO:0016021;GO:0005886;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;|Q6UXD5 B7Z1N0 F5H293 H7BXQ6 Q9BW82 Q9UJ45 Q9UJ46 Q9UJ47,Seizure 6-like protein 2,, PF00431;PF00084;, GO:0005789;GO:0016021;GO:0005886;, C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane; scaffold303 indexed_genome mRNA 73895 79421 . + . ID=transcript_16527;Q5U4P2 A0AVE3 B7ZLZ3 Q8IW63 Q8N316 Q96H00,Aspartate beta-hydroxylase domain-containing protein 1,, PF05118;, GO:0016021;GO:0051213;GO:0018193;, C:integral component of membrane;, F:dioxygenase activity;, P:peptidyl-amino acid modification;|Q5U4P2 A0AVE3 B7ZLZ3 Q8IW63 Q8N316 Q96H00,Aspartate beta-hydroxylase domain-containing protein 1,, PF05118;, GO:0016021;GO:0051213;GO:0018193;, C:integral component of membrane;, F:dioxygenase activity;, P:peptidyl-amino acid modification; scaffold303 indexed_genome mRNA 80073 91564 . + . ID=transcript_16528;Q8WZ19 A8K0R5 Q96P93 Q96SA1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1 {ECO:0000303|PubMed:19782033},BTB/POZ domain-containing protein KCTD13 {ECO:0000305};Polymerase delta-interacting protein 1 {ECO:0000303|PubMed:11593007};TNFAIP1-like protein;, PF02214;, GO:0031463;GO:0016604;GO:0005654;GO:0042802;GO:0019904;GO:0031267;GO:0016477;GO:0035024;GO:0045740;GO:0050806;GO:0043161;GO:0051260;GO:0016567;GO:0043149;, C:Cul3-RING ubiquitin ligase complex; C:nuclear body; C:nucleoplasm;, F:identical protein binding; F:protein domain specific binding; F:small GTPase binding;, P:cell migration; P:negative regulation of Rho protein signal transduction; P:positive regulation of DNA replication; P:positive regulation of synaptic transmission; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; P:stress fiber assembly;|Q8WZ19 A8K0R5 Q96P93 Q96SA1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1 {ECO:0000303|PubMed:19782033},BTB/POZ domain-containing protein KCTD13 {ECO:0000305};Polymerase delta-interacting protein 1 {ECO:0000303|PubMed:11593007};TNFAIP1-like protein;, PF02214;, GO:0031463;GO:0016604;GO:0005654;GO:0042802;GO:0019904;GO:0031267;GO:0016477;GO:0035024;GO:0045740;GO:0050806;GO:0043161;GO:0051260;GO:0016567;GO:0043149;, C:Cul3-RING ubiquitin ligase complex; C:nuclear body; C:nucleoplasm;, F:identical protein binding; F:protein domain specific binding; F:small GTPase binding;, P:cell migration; P:negative regulation of Rho protein signal transduction; P:positive regulation of DNA replication; P:positive regulation of synaptic transmission; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; P:stress fiber assembly;|Q8WZ19 A8K0R5 Q96P93 Q96SA1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1 {ECO:0000303|PubMed:19782033},BTB/POZ domain-containing protein KCTD13 {ECO:0000305};Polymerase delta-interacting protein 1 {ECO:0000303|PubMed:11593007};TNFAIP1-like protein;, PF02214;, GO:0031463;GO:0016604;GO:0005654;GO:0042802;GO:0019904;GO:0031267;GO:0016477;GO:0035024;GO:0045740;GO:0050806;GO:0043161;GO:0051260;GO:0016567;GO:0043149;, C:Cul3-RING ubiquitin ligase complex; C:nuclear body; C:nucleoplasm;, F:identical protein binding; F:protein domain specific binding; F:small GTPase binding;, P:cell migration; P:negative regulation of Rho protein signal transduction; P:positive regulation of DNA replication; P:positive regulation of synaptic transmission; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; P:stress fiber assembly;|Q8WZ19 A8K0R5 Q96P93 Q96SA1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1 {ECO:0000303|PubMed:19782033},BTB/POZ domain-containing protein KCTD13 {ECO:0000305};Polymerase delta-interacting protein 1 {ECO:0000303|PubMed:11593007};TNFAIP1-like protein;, PF02214;, GO:0031463;GO:0016604;GO:0005654;GO:0042802;GO:0019904;GO:0031267;GO:0016477;GO:0035024;GO:0045740;GO:0050806;GO:0043161;GO:0051260;GO:0016567;GO:0043149;, C:Cul3-RING ubiquitin ligase complex; C:nuclear body; C:nucleoplasm;, F:identical protein binding; F:protein domain specific binding; F:small GTPase binding;, P:cell migration; P:negative regulation of Rho protein signal transduction; P:positive regulation of DNA replication; P:positive regulation of synaptic transmission; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; P:stress fiber assembly;|Q8WZ19 A8K0R5 Q96P93 Q96SA1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1 {ECO:0000303|PubMed:19782033},BTB/POZ domain-containing protein KCTD13 {ECO:0000305};Polymerase delta-interacting protein 1 {ECO:0000303|PubMed:11593007};TNFAIP1-like protein;, PF02214;, GO:0031463;GO:0016604;GO:0005654;GO:0042802;GO:0019904;GO:0031267;GO:0016477;GO:0035024;GO:0045740;GO:0050806;GO:0043161;GO:0051260;GO:0016567;GO:0043149;, C:Cul3-RING ubiquitin ligase complex; C:nuclear body; C:nucleoplasm;, F:identical protein binding; F:protein domain specific binding; F:small GTPase binding;, P:cell migration; P:negative regulation of Rho protein signal transduction; P:positive regulation of DNA replication; P:positive regulation of synaptic transmission; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein homooligomerization; P:protein ubiquitination; P:stress fiber assembly; scaffold303 indexed_genome mRNA 119643 133747 . + . ID=transcript_16529;Q86XT9 D5FK14 Q8WVV8,Insulin-like growth factor-binding protein 3 receptor,Transmembrane protein 219;, PF14940;, GO:0016021;GO:0005886;GO:0006915;GO:0042981;, C:integral component of membrane; C:plasma membrane;, , P:apoptotic process; P:regulation of apoptotic process;|Q86XT9 D5FK14 Q8WVV8,Insulin-like growth factor-binding protein 3 receptor,Transmembrane protein 219;, PF14940;, GO:0016021;GO:0005886;GO:0006915;GO:0042981;, C:integral component of membrane; C:plasma membrane;, , P:apoptotic process; P:regulation of apoptotic process;|Q86XT9 D5FK14 Q8WVV8,Insulin-like growth factor-binding protein 3 receptor,Transmembrane protein 219;, PF14940;, GO:0016021;GO:0005886;GO:0006915;GO:0042981;, C:integral component of membrane; C:plasma membrane;, , P:apoptotic process; P:regulation of apoptotic process; scaffold303 indexed_genome mRNA 134643 148483 . + . ID=transcript_16530;Q9UL54 A5PKY1 A7MCZ2 B2RN35 B7ZM88 O94957 Q6UW73 Q7LC09 Q9NSW2,Serine/threonine-protein kinase TAO2,Kinase from chicken homolog C;Prostate-derived sterile 20-like kinase 1;Thousand and one amino acid protein kinase 2;, PF00069;, GO:0015629;GO:0030424;GO:0044295;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0044294;GO:0016021;GO:0043005;GO:0005730;GO:0005654;GO:0043235;GO:0005524;GO:0004709;GO:0031434;GO:0038191;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0030036;GO:0007257;GO:0000187;GO:0000186;GO:0032147;GO:0006915;GO:0007409;GO:0150020;GO:0150019;GO:0016477;GO:0006974;GO:0048041;GO:0000165;GO:0007095;GO:0048812;GO:0046330;GO:0031954;GO:0032874;GO:0046777;GO:0006612;GO:0032956;GO:0001558;GO:0008360;GO:0051403;GO:0031098;, C:actin cytoskeleton; C:axon; C:axonal growth cone; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic growth cone; C:integral component of membrane; C:neuron projection; C:nucleolus; C:nucleoplasm; C:receptor complex;, F:ATP binding; F:MAP kinase kinase kinase activity; F:mitogen-activated protein kinase kinase binding; F:neuropilin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton organization; P:activation of JUN kinase activity; P:activation of MAPK activity; P:activation of MAPKK activity; P:activation of protein kinase activity; P:apoptotic process; P:axonogenesis; P:basal dendrite arborization; P:basal dendrite morphogenesis; P:cell migration; P:cellular response to DNA damage stimulus; P:focal adhesion assembly; P:MAPK cascade; P:mitotic G2 DNA damage checkpoint; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of protein autophosphorylation; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein targeting to membrane; P:regulation of actin cytoskeleton organization; P:regulation of cell growth; P:regulation of cell shape; P:stress-activated MAPK cascade; P:stress-activated protein kinase signaling cascade;|Q9UL54 A5PKY1 A7MCZ2 B2RN35 B7ZM88 O94957 Q6UW73 Q7LC09 Q9NSW2,Serine/threonine-protein kinase TAO2,Kinase from chicken homolog C;Prostate-derived sterile 20-like kinase 1;Thousand and one amino acid protein kinase 2;, PF00069;, GO:0015629;GO:0030424;GO:0044295;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0044294;GO:0016021;GO:0043005;GO:0005730;GO:0005654;GO:0043235;GO:0005524;GO:0004709;GO:0031434;GO:0038191;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0030036;GO:0007257;GO:0000187;GO:0000186;GO:0032147;GO:0006915;GO:0007409;GO:0150020;GO:0150019;GO:0016477;GO:0006974;GO:0048041;GO:0000165;GO:0007095;GO:0048812;GO:0046330;GO:0031954;GO:0032874;GO:0046777;GO:0006612;GO:0032956;GO:0001558;GO:0008360;GO:0051403;GO:0031098;, C:actin cytoskeleton; C:axon; C:axonal growth cone; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic growth cone; C:integral component of membrane; C:neuron projection; C:nucleolus; C:nucleoplasm; C:receptor complex;, F:ATP binding; F:MAP kinase kinase kinase activity; F:mitogen-activated protein kinase kinase binding; F:neuropilin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton organization; P:activation of JUN kinase activity; P:activation of MAPK activity; P:activation of MAPKK activity; P:activation of protein kinase activity; P:apoptotic process; P:axonogenesis; P:basal dendrite arborization; P:basal dendrite morphogenesis; P:cell migration; P:cellular response to DNA damage stimulus; P:focal adhesion assembly; P:MAPK cascade; P:mitotic G2 DNA damage checkpoint; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of protein autophosphorylation; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein targeting to membrane; P:regulation of actin cytoskeleton organization; P:regulation of cell growth; P:regulation of cell shape; P:stress-activated MAPK cascade; P:stress-activated protein kinase signaling cascade;|Q9UL54 A5PKY1 A7MCZ2 B2RN35 B7ZM88 O94957 Q6UW73 Q7LC09 Q9NSW2,Serine/threonine-protein kinase TAO2,Kinase from chicken homolog C;Prostate-derived sterile 20-like kinase 1;Thousand and one amino acid protein kinase 2;, PF00069;, GO:0015629;GO:0030424;GO:0044295;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0044294;GO:0016021;GO:0043005;GO:0005730;GO:0005654;GO:0043235;GO:0005524;GO:0004709;GO:0031434;GO:0038191;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0030036;GO:0007257;GO:0000187;GO:0000186;GO:0032147;GO:0006915;GO:0007409;GO:0150020;GO:0150019;GO:0016477;GO:0006974;GO:0048041;GO:0000165;GO:0007095;GO:0048812;GO:0046330;GO:0031954;GO:0032874;GO:0046777;GO:0006612;GO:0032956;GO:0001558;GO:0008360;GO:0051403;GO:0031098;, C:actin cytoskeleton; C:axon; C:axonal growth cone; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic growth cone; C:integral component of membrane; C:neuron projection; C:nucleolus; C:nucleoplasm; C:receptor complex;, F:ATP binding; F:MAP kinase kinase kinase activity; F:mitogen-activated protein kinase kinase binding; F:neuropilin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton organization; P:activation of JUN kinase activity; P:activation of MAPK activity; P:activation of MAPKK activity; P:activation of protein kinase activity; P:apoptotic process; P:axonogenesis; P:basal dendrite arborization; P:basal dendrite morphogenesis; P:cell migration; P:cellular response to DNA damage stimulus; P:focal adhesion assembly; P:MAPK cascade; P:mitotic G2 DNA damage checkpoint; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of protein autophosphorylation; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein targeting to membrane; P:regulation of actin cytoskeleton organization; P:regulation of cell growth; P:regulation of cell shape; P:stress-activated MAPK cascade; P:stress-activated protein kinase signaling cascade;|Q9UL54 A5PKY1 A7MCZ2 B2RN35 B7ZM88 O94957 Q6UW73 Q7LC09 Q9NSW2,Serine/threonine-protein kinase TAO2,Kinase from chicken homolog C;Prostate-derived sterile 20-like kinase 1;Thousand and one amino acid protein kinase 2;, PF00069;, GO:0015629;GO:0030424;GO:0044295;GO:0005737;GO:0031410;GO:0030659;GO:0005829;GO:0044294;GO:0016021;GO:0043005;GO:0005730;GO:0005654;GO:0043235;GO:0005524;GO:0004709;GO:0031434;GO:0038191;GO:0106310;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0030036;GO:0007257;GO:0000187;GO:0000186;GO:0032147;GO:0006915;GO:0007409;GO:0150020;GO:0150019;GO:0016477;GO:0006974;GO:0048041;GO:0000165;GO:0007095;GO:0048812;GO:0046330;GO:0031954;GO:0032874;GO:0046777;GO:0006612;GO:0032956;GO:0001558;GO:0008360;GO:0051403;GO:0031098;, C:actin cytoskeleton; C:axon; C:axonal growth cone; C:cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:cytosol; C:dendritic growth cone; C:integral component of membrane; C:neuron projection; C:nucleolus; C:nucleoplasm; C:receptor complex;, F:ATP binding; F:MAP kinase kinase kinase activity; F:mitogen-activated protein kinase kinase binding; F:neuropilin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity;, P:actin cytoskeleton organization; P:activation of JUN kinase activity; P:activation of MAPK activity; P:activation of MAPKK activity; P:activation of protein kinase activity; P:apoptotic process; P:axonogenesis; P:basal dendrite arborization; P:basal dendrite morphogenesis; P:cell migration; P:cellular response to DNA damage stimulus; P:focal adhesion assembly; P:MAPK cascade; P:mitotic G2 DNA damage checkpoint; P:neuron projection morphogenesis; P:positive regulation of JNK cascade; P:positive regulation of protein autophosphorylation; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein targeting to membrane; P:regulation of actin cytoskeleton organization; P:regulation of cell growth; P:regulation of cell shape; P:stress-activated MAPK cascade; P:stress-activated protein kinase signaling cascade; scaffold303 indexed_genome mRNA 148562 152305 . + . ID=transcript_16531;Q7L7X3 A2RUT8 B7ZLV6 Q96L75 Q9H2K7 Q9H7S5 Q9P2I6,Serine/threonine-protein kinase TAO1,Kinase from chicken homolog B;MARK Kinase;Prostate-derived sterile 20-like kinase 2;Thousand and one amino acid protein kinase 1;, PF00069;, GO:0005737;GO:0005829;GO:0070062;GO:0015630;GO:0048471;GO:0043014;GO:0005524;GO:0048487;GO:0016301;GO:0004672;GO:0106310;GO:0043539;GO:0004674;GO:0106311;GO:0048156;GO:0050321;GO:0016740;GO:0007257;GO:0000187;GO:0032147;GO:0006974;GO:0006281;GO:0097194;GO:0000165;GO:0000226;GO:0007095;GO:0007052;GO:0007026;GO:0070050;GO:0048812;GO:0016310;GO:0046330;GO:1901985;GO:0032874;GO:0046777;GO:0006468;GO:0032956;GO:0051493;GO:0070507;GO:0031098;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule cytoskeleton; C:perinuclear region of cytoplasm;, F:alpha-tubulin binding; F:ATP binding; F:beta-tubulin binding; F:kinase activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activator activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:tau protein binding; F:tau-protein kinase activity; F:transferase activity;, P:activation of JUN kinase activity; P:activation of MAPK activity; P:activation of protein kinase activity; P:cellular response to DNA damage stimulus; P:DNA repair; P:execution phase of apoptosis; P:MAPK cascade; P:microtubule cytoskeleton organization; P:mitotic G2 DNA damage checkpoint; P:mitotic spindle organization; P:negative regulation of microtubule depolymerization; P:neuron cellular homeostasis; P:neuron projection morphogenesis; P:phosphorylation; P:positive regulation of JNK cascade; P:positive regulation of protein acetylation; P:positive regulation of stress-activated MAPK cascade; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of actin cytoskeleton organization; P:regulation of cytoskeleton organization; P:regulation of microtubule cytoskeleton organization; P:stress-activated protein kinase signaling cascade; scaffold303 indexed_genome mRNA 153056 170088 . + . ID=transcript_16532;Q9BW71 H3BSR3 O75707 O75708,HIRA-interacting protein 3,, PF09649;, GO:0005730;GO:0005654;GO:0005634;GO:0006333;, C:nucleolus; C:nucleoplasm; C:nucleus;, , P:chromatin assembly or disassembly;|Q9BW71 H3BSR3 O75707 O75708,HIRA-interacting protein 3,, PF09649;, GO:0005730;GO:0005654;GO:0005634;GO:0006333;, C:nucleolus; C:nucleoplasm; C:nucleus;, , P:chromatin assembly or disassembly;|Q9BW71 H3BSR3 O75707 O75708,HIRA-interacting protein 3,, PF09649;, GO:0005730;GO:0005654;GO:0005634;GO:0006333;, C:nucleolus; C:nucleoplasm; C:nucleus;, , P:chromatin assembly or disassembly;|Q9BW71 H3BSR3 O75707 O75708,HIRA-interacting protein 3,, PF09649;, GO:0005730;GO:0005654;GO:0005634;GO:0006333;, C:nucleolus; C:nucleoplasm; C:nucleus;, , P:chromatin assembly or disassembly;|Q8NBZ0 Q6Y2K3,INO80 complex subunit E,Coiled-coil domain-containing protein 95;, , GO:0031011;GO:0005730;GO:0005654;GO:0006338;GO:0006310;GO:0006281;GO:0016579;, C:Ino80 complex; C:nucleolus; C:nucleoplasm;, , P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:protein deubiquitination;|Q14183 B4DEJ2 H3BNH6 Q6P4G4 Q7Z5G0 Q8IVX0,Double C2-like domain-containing protein alpha,, PF00168;, GO:0030054;GO:0098850;GO:0005764;GO:0043005;GO:0005730;GO:0005654;GO:0005509;GO:0005544;GO:0007268;GO:0007399;GO:0017158;GO:0061669;GO:0016079;, C:cell junction; C:extrinsic component of synaptic vesicle membrane; C:lysosome; C:neuron projection; C:nucleolus; C:nucleoplasm;, F:calcium ion binding; F:calcium-dependent phospholipid binding;, P:chemical synaptic transmission; P:nervous system development; P:regulation of calcium ion-dependent exocytosis; P:spontaneous neurotransmitter secretion; P:synaptic vesicle exocytosis; scaffold303 indexed_genome mRNA 176690 177292 . + . ID=transcript_16533;Q96LL3 Q494R8,Fertilization-influencing membrane protein {ECO:0000303|PubMed:32295885},, PF17672;, GO:0016021;GO:0005886;GO:0009566;GO:0007342;, C:integral component of membrane; C:plasma membrane;, , P:fertilization; P:fusion of sperm to egg plasma membrane involved in single fertilization; scaffold303 indexed_genome mRNA 177435 184817 . - . ID=transcript_16534;Q71RH2 Q9H0J1,Ceramide synthase {ECO:0000250|UniProtKB:Q7TNV1},Protein FAM57B;TLC domain-containing protein 3B {ECO:0000305};, PF03798;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0050291;GO:0046513;GO:0055088;GO:0045599;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:lipid homeostasis; P:negative regulation of fat cell differentiation;|Q71RH2 Q9H0J1,Ceramide synthase {ECO:0000250|UniProtKB:Q7TNV1},Protein FAM57B;TLC domain-containing protein 3B {ECO:0000305};, PF03798;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0050291;GO:0046513;GO:0055088;GO:0045599;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:lipid homeostasis; P:negative regulation of fat cell differentiation;|Q71RH2 Q9H0J1,Ceramide synthase {ECO:0000250|UniProtKB:Q7TNV1},Protein FAM57B;TLC domain-containing protein 3B {ECO:0000305};, PF03798;, GO:0005783;GO:0005789;GO:0000139;GO:0016021;GO:0050291;GO:0046513;GO:0055088;GO:0045599;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi membrane; C:integral component of membrane;, F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:lipid homeostasis; P:negative regulation of fat cell differentiation; scaffold304 indexed_genome mRNA 1 193393 . + . ID=transcript_16535;Q12929 A6NMC3 A8K6W2 A8KA66 B4DX66 Q8N6J0,Epidermal growth factor receptor kinase substrate 8,, PF08416;PF18016;PF00018;, GO:0005938;GO:0070062;GO:0030426;GO:0005886;GO:0032587;GO:0032420;GO:0045202;GO:0031982;GO:0003779;GO:0035591;GO:0031267;GO:0051764;GO:0051017;GO:0070358;GO:0051016;GO:0036336;GO:0010458;GO:1900029;GO:0016601;GO:0030832;GO:0008360;GO:0035023;GO:0007266;, C:cell cortex; C:extracellular exosome; C:growth cone; C:plasma membrane; C:ruffle membrane; C:stereocilium; C:synapse; C:vesicle;, F:actin binding; F:signaling adaptor activity; F:small GTPase binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:actin polymerization-dependent cell motility; P:barbed-end actin filament capping; P:dendritic cell migration; P:exit from mitosis; P:positive regulation of ruffle assembly; P:Rac protein signal transduction; P:regulation of actin filament length; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:Rho protein signal transduction; scaffold304 indexed_genome mRNA 193571 196223 . - . ID=transcript_16536;Q12929 A6NMC3 A8K6W2 A8KA66 B4DX66 Q8N6J0,Epidermal growth factor receptor kinase substrate 8,, PF08416;PF18016;PF00018;, GO:0005938;GO:0070062;GO:0030426;GO:0005886;GO:0032587;GO:0032420;GO:0045202;GO:0031982;GO:0003779;GO:0035591;GO:0031267;GO:0051764;GO:0051017;GO:0070358;GO:0051016;GO:0036336;GO:0010458;GO:1900029;GO:0016601;GO:0030832;GO:0008360;GO:0035023;GO:0007266;, C:cell cortex; C:extracellular exosome; C:growth cone; C:plasma membrane; C:ruffle membrane; C:stereocilium; C:synapse; C:vesicle;, F:actin binding; F:signaling adaptor activity; F:small GTPase binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:actin polymerization-dependent cell motility; P:barbed-end actin filament capping; P:dendritic cell migration; P:exit from mitosis; P:positive regulation of ruffle assembly; P:Rac protein signal transduction; P:regulation of actin filament length; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:Rho protein signal transduction; scaffold305 indexed_genome mRNA 1 193378 . + . ID=transcript_16537;Q12929 A6NMC3 A8K6W2 A8KA66 B4DX66 Q8N6J0,Epidermal growth factor receptor kinase substrate 8,, PF08416;PF18016;PF00018;, GO:0005938;GO:0070062;GO:0030426;GO:0005886;GO:0032587;GO:0032420;GO:0045202;GO:0031982;GO:0003779;GO:0035591;GO:0031267;GO:0051764;GO:0051017;GO:0070358;GO:0051016;GO:0036336;GO:0010458;GO:1900029;GO:0016601;GO:0030832;GO:0008360;GO:0035023;GO:0007266;, C:cell cortex; C:extracellular exosome; C:growth cone; C:plasma membrane; C:ruffle membrane; C:stereocilium; C:synapse; C:vesicle;, F:actin binding; F:signaling adaptor activity; F:small GTPase binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:actin polymerization-dependent cell motility; P:barbed-end actin filament capping; P:dendritic cell migration; P:exit from mitosis; P:positive regulation of ruffle assembly; P:Rac protein signal transduction; P:regulation of actin filament length; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:Rho protein signal transduction; scaffold305 indexed_genome mRNA 193556 196208 . - . ID=transcript_16538;Q12929 A6NMC3 A8K6W2 A8KA66 B4DX66 Q8N6J0,Epidermal growth factor receptor kinase substrate 8,, PF08416;PF18016;PF00018;, GO:0005938;GO:0070062;GO:0030426;GO:0005886;GO:0032587;GO:0032420;GO:0045202;GO:0031982;GO:0003779;GO:0035591;GO:0031267;GO:0051764;GO:0051017;GO:0070358;GO:0051016;GO:0036336;GO:0010458;GO:1900029;GO:0016601;GO:0030832;GO:0008360;GO:0035023;GO:0007266;, C:cell cortex; C:extracellular exosome; C:growth cone; C:plasma membrane; C:ruffle membrane; C:stereocilium; C:synapse; C:vesicle;, F:actin binding; F:signaling adaptor activity; F:small GTPase binding;, P:actin crosslink formation; P:actin filament bundle assembly; P:actin polymerization-dependent cell motility; P:barbed-end actin filament capping; P:dendritic cell migration; P:exit from mitosis; P:positive regulation of ruffle assembly; P:Rac protein signal transduction; P:regulation of actin filament length; P:regulation of cell shape; P:regulation of Rho protein signal transduction; P:Rho protein signal transduction; scaffold306 indexed_genome mRNA 85543 94110 . + . ID=transcript_16539;Q9BX46 E9PAY4 Q6QDA4 Q8N9D3 Q96NI3,RNA-binding protein 24 {ECO:0000305},RNA-binding motif protein 24 {ECO:0000303|PubMed:20977548};RNA-binding region-containing protein 6;, PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0035925;GO:0003730;GO:1990715;GO:0097157;GO:1990825;GO:0061158;GO:0030154;GO:0006974;GO:0003197;GO:0061157;GO:0006397;GO:0048255;GO:2000766;GO:1905870;GO:0045663;GO:0010831;GO:1902811;GO:2000738;GO:0000381;GO:0043488;GO:0010830;GO:0008380;, C:cytosol; C:nucleoplasm; C:nucleus;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA CDS binding; F:pre-mRNA intronic binding; F:sequence-specific mRNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cell differentiation; P:cellular response to DNA damage stimulus; P:endocardial cushion development; P:mRNA destabilization; P:mRNA processing; P:mRNA stabilization; P:negative regulation of cytoplasmic translation; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:positive regulation of myoblast differentiation; P:positive regulation of myotube differentiation; P:positive regulation of skeletal muscle fiber differentiation; P:positive regulation of stem cell differentiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA stability; P:regulation of myotube differentiation; P:RNA splicing;|Q9BX46 E9PAY4 Q6QDA4 Q8N9D3 Q96NI3,RNA-binding protein 24 {ECO:0000305},RNA-binding motif protein 24 {ECO:0000303|PubMed:20977548};RNA-binding region-containing protein 6;, PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0035925;GO:0003730;GO:1990715;GO:0097157;GO:1990825;GO:0061158;GO:0030154;GO:0006974;GO:0003197;GO:0061157;GO:0006397;GO:0048255;GO:2000766;GO:1905870;GO:0045663;GO:0010831;GO:1902811;GO:2000738;GO:0000381;GO:0043488;GO:0010830;GO:0008380;, C:cytosol; C:nucleoplasm; C:nucleus;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA CDS binding; F:pre-mRNA intronic binding; F:sequence-specific mRNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cell differentiation; P:cellular response to DNA damage stimulus; P:endocardial cushion development; P:mRNA destabilization; P:mRNA processing; P:mRNA stabilization; P:negative regulation of cytoplasmic translation; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:positive regulation of myoblast differentiation; P:positive regulation of myotube differentiation; P:positive regulation of skeletal muscle fiber differentiation; P:positive regulation of stem cell differentiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA stability; P:regulation of myotube differentiation; P:RNA splicing;|Q9BX46 E9PAY4 Q6QDA4 Q8N9D3 Q96NI3,RNA-binding protein 24 {ECO:0000305},RNA-binding motif protein 24 {ECO:0000303|PubMed:20977548};RNA-binding region-containing protein 6;, PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0035925;GO:0003730;GO:1990715;GO:0097157;GO:1990825;GO:0061158;GO:0030154;GO:0006974;GO:0003197;GO:0061157;GO:0006397;GO:0048255;GO:2000766;GO:1905870;GO:0045663;GO:0010831;GO:1902811;GO:2000738;GO:0000381;GO:0043488;GO:0010830;GO:0008380;, C:cytosol; C:nucleoplasm; C:nucleus;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA CDS binding; F:pre-mRNA intronic binding; F:sequence-specific mRNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cell differentiation; P:cellular response to DNA damage stimulus; P:endocardial cushion development; P:mRNA destabilization; P:mRNA processing; P:mRNA stabilization; P:negative regulation of cytoplasmic translation; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:positive regulation of myoblast differentiation; P:positive regulation of myotube differentiation; P:positive regulation of skeletal muscle fiber differentiation; P:positive regulation of stem cell differentiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA stability; P:regulation of myotube differentiation; P:RNA splicing;|Q9BX46 E9PAY4 Q6QDA4 Q8N9D3 Q96NI3,RNA-binding protein 24 {ECO:0000305},RNA-binding motif protein 24 {ECO:0000303|PubMed:20977548};RNA-binding region-containing protein 6;, PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0035925;GO:0003730;GO:1990715;GO:0097157;GO:1990825;GO:0061158;GO:0030154;GO:0006974;GO:0003197;GO:0061157;GO:0006397;GO:0048255;GO:2000766;GO:1905870;GO:0045663;GO:0010831;GO:1902811;GO:2000738;GO:0000381;GO:0043488;GO:0010830;GO:0008380;, C:cytosol; C:nucleoplasm; C:nucleus;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA CDS binding; F:pre-mRNA intronic binding; F:sequence-specific mRNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cell differentiation; P:cellular response to DNA damage stimulus; P:endocardial cushion development; P:mRNA destabilization; P:mRNA processing; P:mRNA stabilization; P:negative regulation of cytoplasmic translation; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:positive regulation of myoblast differentiation; P:positive regulation of myotube differentiation; P:positive regulation of skeletal muscle fiber differentiation; P:positive regulation of stem cell differentiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA stability; P:regulation of myotube differentiation; P:RNA splicing; scaffold306 indexed_genome mRNA 99190 100584 . + . ID=transcript_16540;Q9BX46 E9PAY4 Q6QDA4 Q8N9D3 Q96NI3,RNA-binding protein 24 {ECO:0000305},RNA-binding motif protein 24 {ECO:0000303|PubMed:20977548};RNA-binding region-containing protein 6;, PF00076;, GO:0005829;GO:0005654;GO:0005634;GO:0035925;GO:0003730;GO:1990715;GO:0097157;GO:1990825;GO:0061158;GO:0030154;GO:0006974;GO:0003197;GO:0061157;GO:0006397;GO:0048255;GO:2000766;GO:1905870;GO:0045663;GO:0010831;GO:1902811;GO:2000738;GO:0000381;GO:0043488;GO:0010830;GO:0008380;, C:cytosol; C:nucleoplasm; C:nucleus;, F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding; F:mRNA CDS binding; F:pre-mRNA intronic binding; F:sequence-specific mRNA binding;, P:3'-UTR-mediated mRNA destabilization; P:cell differentiation; P:cellular response to DNA damage stimulus; P:endocardial cushion development; P:mRNA destabilization; P:mRNA processing; P:mRNA stabilization; P:negative regulation of cytoplasmic translation; P:positive regulation of 3'-UTR-mediated mRNA stabilization; P:positive regulation of myoblast differentiation; P:positive regulation of myotube differentiation; P:positive regulation of skeletal muscle fiber differentiation; P:positive regulation of stem cell differentiation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of mRNA stability; P:regulation of myotube differentiation; P:RNA splicing; scaffold307 indexed_genome mRNA 176799 187547 . - . ID=transcript_16541;Q9Y6I3 Q86ST3 Q9HA18,Epsin-1,EH domain-binding mitotic phosphoprotein;EPS-15-interacting protein 1;, PF01417;, GO:0030125;GO:0005905;GO:0005829;GO:0005768;GO:0043231;GO:0005634;GO:0005886;GO:0030276;GO:0005543;GO:0006897;GO:0061024;GO:0042059;GO:1903671;, C:clathrin vesicle coat; C:clathrin-coated pit; C:cytosol; C:endosome; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:clathrin binding; F:phospholipid binding;, P:endocytosis; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of sprouting angiogenesis;|Q9Y6I3 Q86ST3 Q9HA18,Epsin-1,EH domain-binding mitotic phosphoprotein;EPS-15-interacting protein 1;, PF01417;, GO:0030125;GO:0005905;GO:0005829;GO:0005768;GO:0043231;GO:0005634;GO:0005886;GO:0030276;GO:0005543;GO:0006897;GO:0061024;GO:0042059;GO:1903671;, C:clathrin vesicle coat; C:clathrin-coated pit; C:cytosol; C:endosome; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:clathrin binding; F:phospholipid binding;, P:endocytosis; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of sprouting angiogenesis;|Q9Y6I3 Q86ST3 Q9HA18,Epsin-1,EH domain-binding mitotic phosphoprotein;EPS-15-interacting protein 1;, PF01417;, GO:0030125;GO:0005905;GO:0005829;GO:0005768;GO:0043231;GO:0005634;GO:0005886;GO:0030276;GO:0005543;GO:0006897;GO:0061024;GO:0042059;GO:1903671;, C:clathrin vesicle coat; C:clathrin-coated pit; C:cytosol; C:endosome; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;, F:clathrin binding; F:phospholipid binding;, P:endocytosis; P:membrane organization; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of sprouting angiogenesis; scaffold307 indexed_genome mRNA 188420 196645 . - . ID=transcript_16542;P26368 Q96HC5,Splicing factor U2AF 65 kDa subunit,U2 auxiliary factor 65 kDa subunit;U2 snRNP auxiliary factor large subunit;, PF00076;, GO:0000243;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071004;GO:0089701;GO:0070742;GO:0019899;GO:0008187;GO:0030628;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0031397;GO:0033120;GO:0006405;, C:commitment complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type prespliceosome; C:U2AF complex;, F:C2H2 zinc finger domain binding; F:enzyme binding; F:poly-pyrimidine tract binding; F:pre-mRNA 3'-splice site binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of protein ubiquitination; P:positive regulation of RNA splicing; P:RNA export from nucleus;|P26368 Q96HC5,Splicing factor U2AF 65 kDa subunit,U2 auxiliary factor 65 kDa subunit;U2 snRNP auxiliary factor large subunit;, PF00076;, GO:0000243;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071004;GO:0089701;GO:0070742;GO:0019899;GO:0008187;GO:0030628;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0031397;GO:0033120;GO:0006405;, C:commitment complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type prespliceosome; C:U2AF complex;, F:C2H2 zinc finger domain binding; F:enzyme binding; F:poly-pyrimidine tract binding; F:pre-mRNA 3'-splice site binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of protein ubiquitination; P:positive regulation of RNA splicing; P:RNA export from nucleus;|P26368 Q96HC5,Splicing factor U2AF 65 kDa subunit,U2 auxiliary factor 65 kDa subunit;U2 snRNP auxiliary factor large subunit;, PF00076;, GO:0000243;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071004;GO:0089701;GO:0070742;GO:0019899;GO:0008187;GO:0030628;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0031397;GO:0033120;GO:0006405;, C:commitment complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type prespliceosome; C:U2AF complex;, F:C2H2 zinc finger domain binding; F:enzyme binding; F:poly-pyrimidine tract binding; F:pre-mRNA 3'-splice site binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of protein ubiquitination; P:positive regulation of RNA splicing; P:RNA export from nucleus;|P26368 Q96HC5,Splicing factor U2AF 65 kDa subunit,U2 auxiliary factor 65 kDa subunit;U2 snRNP auxiliary factor large subunit;, PF00076;, GO:0000243;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071004;GO:0089701;GO:0070742;GO:0019899;GO:0008187;GO:0030628;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0031397;GO:0033120;GO:0006405;, C:commitment complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type prespliceosome; C:U2AF complex;, F:C2H2 zinc finger domain binding; F:enzyme binding; F:poly-pyrimidine tract binding; F:pre-mRNA 3'-splice site binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of protein ubiquitination; P:positive regulation of RNA splicing; P:RNA export from nucleus;|P26368 Q96HC5,Splicing factor U2AF 65 kDa subunit,U2 auxiliary factor 65 kDa subunit;U2 snRNP auxiliary factor large subunit;, PF00076;, GO:0000243;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071004;GO:0089701;GO:0070742;GO:0019899;GO:0008187;GO:0030628;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0031397;GO:0033120;GO:0006405;, C:commitment complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type prespliceosome; C:U2AF complex;, F:C2H2 zinc finger domain binding; F:enzyme binding; F:poly-pyrimidine tract binding; F:pre-mRNA 3'-splice site binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of protein ubiquitination; P:positive regulation of RNA splicing; P:RNA export from nucleus;|P26368 Q96HC5,Splicing factor U2AF 65 kDa subunit,U2 auxiliary factor 65 kDa subunit;U2 snRNP auxiliary factor large subunit;, PF00076;, GO:0000243;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0071004;GO:0089701;GO:0070742;GO:0019899;GO:0008187;GO:0030628;GO:0003723;GO:0031124;GO:0006406;GO:0006397;GO:0000398;GO:0048025;GO:0031397;GO:0033120;GO:0006405;, C:commitment complex; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2-type prespliceosome; C:U2AF complex;, F:C2H2 zinc finger domain binding; F:enzyme binding; F:poly-pyrimidine tract binding; F:pre-mRNA 3'-splice site binding; F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA processing; P:mRNA splicing, via spliceosome; P:negative regulation of mRNA splicing, via spliceosome; P:negative regulation of protein ubiquitination; P:positive regulation of RNA splicing; P:RNA export from nucleus; scaffold308 indexed_genome mRNA 388 42538 . - . ID=transcript_16543;Q9BPX1 Q9UKU3,17-beta-hydroxysteroid dehydrogenase 14 {ECO:0000305},17-beta-hydroxysteroid dehydrogenase DHRS10;Dehydrogenase/reductase SDR family member 10;Retinal short-chain dehydrogenase/reductase retSDR3;Short chain dehydrogenase/reductase family 47C member 1;, , GO:0005829;GO:0044594;GO:0004303;GO:0042802;GO:0047045;GO:0006703;GO:0006706;, C:cytosol;, F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; F:estradiol 17-beta-dehydrogenase activity; F:identical protein binding; F:testosterone 17-beta-dehydrogenase (NADP+) activity;, P:estrogen biosynthetic process; P:steroid catabolic process;|Q9H4M7 Q8N4M8 Q8N658,Pleckstrin homology domain-containing family A member 4,Phosphoinositol 3-phosphate-binding protein 1;, PF00169;, GO:0005737;GO:0031234;GO:0005886;GO:0042802;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0006661;GO:0090263;GO:2000096;, C:cytoplasm; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:identical protein binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:phosphatidylinositol biosynthetic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway;|Q9H4M7 Q8N4M8 Q8N658,Pleckstrin homology domain-containing family A member 4,Phosphoinositol 3-phosphate-binding protein 1;, PF00169;, GO:0005737;GO:0031234;GO:0005886;GO:0042802;GO:0043325;GO:0080025;GO:0032266;GO:0005546;GO:0006661;GO:0090263;GO:2000096;, C:cytoplasm; C:extrinsic component of cytoplasmic side of plasma membrane; C:plasma membrane;, F:identical protein binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:phosphatidylinositol-3,5-bisphosphate binding; F:phosphatidylinositol-3-phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding;, P:phosphatidylinositol biosynthetic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; scaffold308 indexed_genome mRNA 44420 47912 . + . ID=transcript_16544;O75807 B4DKQ3 Q6IA96 Q9NVU6,Protein phosphatase 1 regulatory subunit 15A,Growth arrest and DNA damage-inducible protein GADD34;Myeloid differentiation primary response protein MyD116 homolog;, PF10488;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016020;GO:0005741;GO:0005739;GO:0000164;GO:0019901;GO:0008157;GO:0072542;GO:0019888;GO:0006915;GO:0007050;GO:0006974;GO:0070059;GO:1903898;GO:0032515;GO:0035308;GO:1903917;GO:1902310;GO:0032516;GO:0032058;GO:0070972;GO:0036496;GO:0034976;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:protein phosphatase type 1 complex;, F:protein kinase binding; F:protein phosphatase 1 binding; F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:apoptotic process; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation; P:positive regulation of peptidyl-serine dephosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of translational initiation in response to stress; P:protein localization to endoplasmic reticulum; P:regulation of translational initiation by eIF2 alpha dephosphorylation; P:response to endoplasmic reticulum stress;|O75807 B4DKQ3 Q6IA96 Q9NVU6,Protein phosphatase 1 regulatory subunit 15A,Growth arrest and DNA damage-inducible protein GADD34;Myeloid differentiation primary response protein MyD116 homolog;, PF10488;, GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016020;GO:0005741;GO:0005739;GO:0000164;GO:0019901;GO:0008157;GO:0072542;GO:0019888;GO:0006915;GO:0007050;GO:0006974;GO:0070059;GO:1903898;GO:0032515;GO:0035308;GO:1903917;GO:1902310;GO:0032516;GO:0032058;GO:0070972;GO:0036496;GO:0034976;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:membrane; C:mitochondrial outer membrane; C:mitochondrion; C:protein phosphatase type 1 complex;, F:protein kinase binding; F:protein phosphatase 1 binding; F:protein phosphatase activator activity; F:protein phosphatase regulator activity;, P:apoptotic process; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of phosphoprotein phosphatase activity; P:negative regulation of protein dephosphorylation; P:positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation; P:positive regulation of peptidyl-serine dephosphorylation; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of translational initiation in response to stress; P:protein localization to endoplasmic reticulum; P:regulation of translational initiation by eIF2 alpha dephosphorylation; P:response to endoplasmic reticulum stress; scaffold308 indexed_genome mRNA 49013 51950 . - . ID=transcript_16545;O00295 Q8TC50,Tubby-related protein 2,Cancer/testis antigen 65;Tubby-like protein 2;, PF01167;PF16322;, GO:0005929;GO:0005737;GO:0005576;GO:0044877;GO:0061512;GO:0007601;, C:cilium; C:cytoplasm; C:extracellular region;, F:protein-containing complex binding;, P:protein localization to cilium; P:visual perception;|O00295 Q8TC50,Tubby-related protein 2,Cancer/testis antigen 65;Tubby-like protein 2;, PF01167;PF16322;, GO:0005929;GO:0005737;GO:0005576;GO:0044877;GO:0061512;GO:0007601;, C:cilium; C:cytoplasm; C:extracellular region;, F:protein-containing complex binding;, P:protein localization to cilium; P:visual perception; scaffold308 indexed_genome mRNA 52007 107241 . + . ID=transcript_16546;Q9UCZ7 Q9UQD6,Apoptosis regulator BAX,Bcl-2-like protein 4;, PF00452;, GO:0097145;GO:0097144;GO:0097136;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0070062;GO:0016020;GO:0005741;GO:0005757;GO:0005739;GO:0005635;GO:0005634;GO:0046930;GO:0051434;GO:0015267;GO:0051087;GO:0030544;GO:0042802;GO:0008289;GO:0046982;GO:0042803;GO:0006919;GO:0008635;GO:0097296;GO:0008637;GO:0006915;GO:1902262;GO:1902263;GO:0097190;GO:0001783;GO:0001782;GO:0002358;GO:0002352;GO:1990117;GO:0001974;GO:0034620;GO:0034644;GO:0098586;GO:0021987;GO:0045136;GO:0006977;GO:0035234;GO:0032469;GO:0010248;GO:0097191;GO:0097192;GO:0008625;GO:0009566;GO:0007281;GO:0006687;GO:0048873;GO:0021854;GO:0097193;GO:0072332;GO:0008630;GO:0070059;GO:0001822;GO:0043653;GO:0008053;GO:0070584;GO:0002262;GO:2001234;GO:0032471;GO:0048147;GO:0010917;GO:0043524;GO:0033137;GO:0032091;GO:0051402;GO:0001764;GO:0042475;GO:0001541;GO:1902512;GO:0043065;GO:0060058;GO:0002904;GO:0048087;GO:1900103;GO:2001244;GO:1903896;GO:1901030;GO:0043525;GO:0031334;GO:0090200;GO:0051281;GO:0048597;GO:0001844;GO:0042981;GO:0033599;GO:1902445;GO:0051881;GO:0006808;GO:0060260;GO:0001836;GO:0032976;GO:0048678;GO:0010332;GO:0009651;GO:0009636;GO:0060041;GO:0046666;GO:0060011;GO:0048515;GO:0001777;GO:0070242;GO:0060068;GO:0016032;, C:BAK complex; C:BAX complex; C:Bcl-2 family protein complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nuclear envelope; C:nucleus; C:pore complex;, F:BH3 domain binding; F:channel activity; F:chaperone binding; F:Hsp70 protein binding; F:identical protein binding; F:lipid binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:apoptotic mitochondrial changes; P:apoptotic process; P:apoptotic process involved in blood vessel morphogenesis; P:apoptotic process involved in embryonic digit morphogenesis; P:apoptotic signaling pathway; P:B cell apoptotic process; P:B cell homeostasis; P:B cell homeostatic proliferation; P:B cell negative selection; P:B cell receptor apoptotic signaling pathway; P:blood vessel remodeling; P:cellular response to unfolded protein; P:cellular response to UV; P:cellular response to virus; P:cerebral cortex development; P:development of secondary sexual characteristics; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:ectopic germ cell programmed cell death; P:endoplasmic reticulum calcium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:fertilization; P:germ cell development; P:glycosphingolipid metabolic process; P:homeostasis of number of cells within a tissue; P:hypothalamus development; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:myeloid cell homeostasis; P:negative regulation of apoptotic signaling pathway; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of fibroblast proliferation; P:negative regulation of mitochondrial membrane potential; P:negative regulation of neuron apoptotic process; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein binding; P:neuron apoptotic process; P:neuron migration; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of apoptotic process; P:positive regulation of apoptotic process involved in mammary gland involution; P:positive regulation of B cell apoptotic process; P:positive regulation of developmental pigmentation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of release of sequestered calcium ion into cytosol; P:post-embryonic camera-type eye morphogenesis; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of mammary gland epithelial cell proliferation; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; P:regulation of mitochondrial membrane potential; P:regulation of nitrogen utilization; P:regulation of transcription initiation from RNA polymerase II promoter; P:release of cytochrome c from mitochondria; P:release of matrix enzymes from mitochondria; P:response to axon injury; P:response to gamma radiation; P:response to salt stress; P:response to toxic substance; P:retina development in camera-type eye; P:retinal cell programmed cell death; P:Sertoli cell proliferation; P:spermatid differentiation; P:T cell homeostatic proliferation; P:thymocyte apoptotic process; P:vagina development; P:viral process;|Q02818 B2RD64 Q15838 Q7Z4J7 Q9BUR1,Nucleobindin-1,CALNUC;, PF13499;, GO:0005801;GO:0005769;GO:0005788;GO:0005793;GO:0070062;GO:0005615;GO:0090498;GO:0032580;GO:0005798;GO:0098547;GO:0016020;GO:0005634;GO:0005791;GO:0005802;GO:0005509;GO:0003677;GO:0001965;GO:0005085;GO:0044267;GO:0043687;GO:1903533;GO:0072718;GO:0007264;, C:cis-Golgi network; C:early endosome; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular space; C:extrinsic component of Golgi membrane; C:Golgi cisterna membrane; C:Golgi-associated vesicle; C:lumenal side of Golgi membrane; C:membrane; C:nucleus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:calcium ion binding; F:DNA binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity;, P:cellular protein metabolic process; P:post-translational protein modification; P:regulation of protein targeting; P:response to cisplatin; P:small GTPase mediated signal transduction;|Q02818 B2RD64 Q15838 Q7Z4J7 Q9BUR1,Nucleobindin-1,CALNUC;, PF13499;, GO:0005801;GO:0005769;GO:0005788;GO:0005793;GO:0070062;GO:0005615;GO:0090498;GO:0032580;GO:0005798;GO:0098547;GO:0016020;GO:0005634;GO:0005791;GO:0005802;GO:0005509;GO:0003677;GO:0001965;GO:0005085;GO:0044267;GO:0043687;GO:1903533;GO:0072718;GO:0007264;, C:cis-Golgi network; C:early endosome; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular space; C:extrinsic component of Golgi membrane; C:Golgi cisterna membrane; C:Golgi-associated vesicle; C:lumenal side of Golgi membrane; C:membrane; C:nucleus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:calcium ion binding; F:DNA binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity;, P:cellular protein metabolic process; P:post-translational protein modification; P:regulation of protein targeting; P:response to cisplatin; P:small GTPase mediated signal transduction;|Q02818 B2RD64 Q15838 Q7Z4J7 Q9BUR1,Nucleobindin-1,CALNUC;, PF13499;, GO:0005801;GO:0005769;GO:0005788;GO:0005793;GO:0070062;GO:0005615;GO:0090498;GO:0032580;GO:0005798;GO:0098547;GO:0016020;GO:0005634;GO:0005791;GO:0005802;GO:0005509;GO:0003677;GO:0001965;GO:0005085;GO:0044267;GO:0043687;GO:1903533;GO:0072718;GO:0007264;, C:cis-Golgi network; C:early endosome; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular space; C:extrinsic component of Golgi membrane; C:Golgi cisterna membrane; C:Golgi-associated vesicle; C:lumenal side of Golgi membrane; C:membrane; C:nucleus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:calcium ion binding; F:DNA binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity;, P:cellular protein metabolic process; P:post-translational protein modification; P:regulation of protein targeting; P:response to cisplatin; P:small GTPase mediated signal transduction;|Q02818 B2RD64 Q15838 Q7Z4J7 Q9BUR1,Nucleobindin-1,CALNUC;, PF13499;, GO:0005801;GO:0005769;GO:0005788;GO:0005793;GO:0070062;GO:0005615;GO:0090498;GO:0032580;GO:0005798;GO:0098547;GO:0016020;GO:0005634;GO:0005791;GO:0005802;GO:0005509;GO:0003677;GO:0001965;GO:0005085;GO:0044267;GO:0043687;GO:1903533;GO:0072718;GO:0007264;, C:cis-Golgi network; C:early endosome; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular space; C:extrinsic component of Golgi membrane; C:Golgi cisterna membrane; C:Golgi-associated vesicle; C:lumenal side of Golgi membrane; C:membrane; C:nucleus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:calcium ion binding; F:DNA binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity;, P:cellular protein metabolic process; P:post-translational protein modification; P:regulation of protein targeting; P:response to cisplatin; P:small GTPase mediated signal transduction;|Q02818 B2RD64 Q15838 Q7Z4J7 Q9BUR1,Nucleobindin-1,CALNUC;, PF13499;, GO:0005801;GO:0005769;GO:0005788;GO:0005793;GO:0070062;GO:0005615;GO:0090498;GO:0032580;GO:0005798;GO:0098547;GO:0016020;GO:0005634;GO:0005791;GO:0005802;GO:0005509;GO:0003677;GO:0001965;GO:0005085;GO:0044267;GO:0043687;GO:1903533;GO:0072718;GO:0007264;, C:cis-Golgi network; C:early endosome; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular space; C:extrinsic component of Golgi membrane; C:Golgi cisterna membrane; C:Golgi-associated vesicle; C:lumenal side of Golgi membrane; C:membrane; C:nucleus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:calcium ion binding; F:DNA binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity;, P:cellular protein metabolic process; P:post-translational protein modification; P:regulation of protein targeting; P:response to cisplatin; P:small GTPase mediated signal transduction;|Q02818 B2RD64 Q15838 Q7Z4J7 Q9BUR1,Nucleobindin-1,CALNUC;, PF13499;, GO:0005801;GO:0005769;GO:0005788;GO:0005793;GO:0070062;GO:0005615;GO:0090498;GO:0032580;GO:0005798;GO:0098547;GO:0016020;GO:0005634;GO:0005791;GO:0005802;GO:0005509;GO:0003677;GO:0001965;GO:0005085;GO:0044267;GO:0043687;GO:1903533;GO:0072718;GO:0007264;, C:cis-Golgi network; C:early endosome; C:endoplasmic reticulum lumen; C:endoplasmic reticulum-Golgi intermediate compartment; C:extracellular exosome; C:extracellular space; C:extrinsic component of Golgi membrane; C:Golgi cisterna membrane; C:Golgi-associated vesicle; C:lumenal side of Golgi membrane; C:membrane; C:nucleus; C:rough endoplasmic reticulum; C:trans-Golgi network;, F:calcium ion binding; F:DNA binding; F:G-protein alpha-subunit binding; F:guanyl-nucleotide exchange factor activity;, P:cellular protein metabolic process; P:post-translational protein modification; P:regulation of protein targeting; P:response to cisplatin; P:small GTPase mediated signal transduction;|Q9UQ10,Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase,D-xylose 1-dehydrogenase;D-xylose-NADP dehydrogenase;Dimeric dihydrodiol dehydrogenase;Hum2DD;, PF01408;PF02894;, GO:0047837;GO:0009055;GO:0008746;GO:0047115;GO:0005975;GO:0042843;, , F:D-xylose 1-dehydrogenase (NADP+) activity; F:electron transfer activity; F:NAD(P)+ transhydrogenase activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:carbohydrate metabolic process; P:D-xylose catabolic process;|Q9UQ10,Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase,D-xylose 1-dehydrogenase;D-xylose-NADP dehydrogenase;Dimeric dihydrodiol dehydrogenase;Hum2DD;, PF01408;PF02894;, GO:0047837;GO:0009055;GO:0008746;GO:0047115;GO:0005975;GO:0042843;, , F:D-xylose 1-dehydrogenase (NADP+) activity; F:electron transfer activity; F:NAD(P)+ transhydrogenase activity; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;, P:carbohydrate metabolic process; P:D-xylose catabolic process;|Q9UCZ7 Q9UQD6,Apoptosis regulator BAX,Bcl-2-like protein 4;, PF00452;, GO:0097145;GO:0097144;GO:0097136;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0070062;GO:0016020;GO:0005741;GO:0005757;GO:0005739;GO:0005635;GO:0005634;GO:0046930;GO:0051434;GO:0015267;GO:0051087;GO:0030544;GO:0042802;GO:0008289;GO:0046982;GO:0042803;GO:0006919;GO:0008635;GO:0097296;GO:0008637;GO:0006915;GO:1902262;GO:1902263;GO:0097190;GO:0001783;GO:0001782;GO:0002358;GO:0002352;GO:1990117;GO:0001974;GO:0034620;GO:0034644;GO:0098586;GO:0021987;GO:0045136;GO:0006977;GO:0035234;GO:0032469;GO:0010248;GO:0097191;GO:0097192;GO:0008625;GO:0009566;GO:0007281;GO:0006687;GO:0048873;GO:0021854;GO:0097193;GO:0072332;GO:0008630;GO:0070059;GO:0001822;GO:0043653;GO:0008053;GO:0070584;GO:0002262;GO:2001234;GO:0032471;GO:0048147;GO:0010917;GO:0043524;GO:0033137;GO:0032091;GO:0051402;GO:0001764;GO:0042475;GO:0001541;GO:1902512;GO:0043065;GO:0060058;GO:0002904;GO:0048087;GO:1900103;GO:2001244;GO:1903896;GO:1901030;GO:0043525;GO:0031334;GO:0090200;GO:0051281;GO:0048597;GO:0001844;GO:0042981;GO:0033599;GO:1902445;GO:0051881;GO:0006808;GO:0060260;GO:0001836;GO:0032976;GO:0048678;GO:0010332;GO:0009651;GO:0009636;GO:0060041;GO:0046666;GO:0060011;GO:0048515;GO:0001777;GO:0070242;GO:0060068;GO:0016032;, C:BAK complex; C:BAX complex; C:Bcl-2 family protein complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nuclear envelope; C:nucleus; C:pore complex;, F:BH3 domain binding; F:channel activity; F:chaperone binding; F:Hsp70 protein binding; F:identical protein binding; F:lipid binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:apoptotic mitochondrial changes; P:apoptotic process; P:apoptotic process involved in blood vessel morphogenesis; P:apoptotic process involved in embryonic digit morphogenesis; P:apoptotic signaling pathway; P:B cell apoptotic process; P:B cell homeostasis; P:B cell homeostatic proliferation; P:B cell negative selection; P:B cell receptor apoptotic signaling pathway; P:blood vessel remodeling; P:cellular response to unfolded protein; P:cellular response to UV; P:cellular response to virus; P:cerebral cortex development; P:development of secondary sexual characteristics; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:ectopic germ cell programmed cell death; P:endoplasmic reticulum calcium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:fertilization; P:germ cell development; P:glycosphingolipid metabolic process; P:homeostasis of number of cells within a tissue; P:hypothalamus development; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:myeloid cell homeostasis; P:negative regulation of apoptotic signaling pathway; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of fibroblast proliferation; P:negative regulation of mitochondrial membrane potential; P:negative regulation of neuron apoptotic process; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein binding; P:neuron apoptotic process; P:neuron migration; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of apoptotic process; P:positive regulation of apoptotic process involved in mammary gland involution; P:positive regulation of B cell apoptotic process; P:positive regulation of developmental pigmentation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of release of sequestered calcium ion into cytosol; P:post-embryonic camera-type eye morphogenesis; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of mammary gland epithelial cell proliferation; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; P:regulation of mitochondrial membrane potential; P:regulation of nitrogen utilization; P:regulation of transcription initiation from RNA polymerase II promoter; P:release of cytochrome c from mitochondria; P:release of matrix enzymes from mitochondria; P:response to axon injury; P:response to gamma radiation; P:response to salt stress; P:response to toxic substance; P:retina development in camera-type eye; P:retinal cell programmed cell death; P:Sertoli cell proliferation; P:spermatid differentiation; P:T cell homeostatic proliferation; P:thymocyte apoptotic process; P:vagina development; P:viral process;|Q9UCZ7 Q9UQD6,Apoptosis regulator BAX,Bcl-2-like protein 4;, PF00452;, GO:0097145;GO:0097144;GO:0097136;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0070062;GO:0016020;GO:0005741;GO:0005757;GO:0005739;GO:0005635;GO:0005634;GO:0046930;GO:0051434;GO:0015267;GO:0051087;GO:0030544;GO:0042802;GO:0008289;GO:0046982;GO:0042803;GO:0006919;GO:0008635;GO:0097296;GO:0008637;GO:0006915;GO:1902262;GO:1902263;GO:0097190;GO:0001783;GO:0001782;GO:0002358;GO:0002352;GO:1990117;GO:0001974;GO:0034620;GO:0034644;GO:0098586;GO:0021987;GO:0045136;GO:0006977;GO:0035234;GO:0032469;GO:0010248;GO:0097191;GO:0097192;GO:0008625;GO:0009566;GO:0007281;GO:0006687;GO:0048873;GO:0021854;GO:0097193;GO:0072332;GO:0008630;GO:0070059;GO:0001822;GO:0043653;GO:0008053;GO:0070584;GO:0002262;GO:2001234;GO:0032471;GO:0048147;GO:0010917;GO:0043524;GO:0033137;GO:0032091;GO:0051402;GO:0001764;GO:0042475;GO:0001541;GO:1902512;GO:0043065;GO:0060058;GO:0002904;GO:0048087;GO:1900103;GO:2001244;GO:1903896;GO:1901030;GO:0043525;GO:0031334;GO:0090200;GO:0051281;GO:0048597;GO:0001844;GO:0042981;GO:0033599;GO:1902445;GO:0051881;GO:0006808;GO:0060260;GO:0001836;GO:0032976;GO:0048678;GO:0010332;GO:0009651;GO:0009636;GO:0060041;GO:0046666;GO:0060011;GO:0048515;GO:0001777;GO:0070242;GO:0060068;GO:0016032;, C:BAK complex; C:BAX complex; C:Bcl-2 family protein complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nuclear envelope; C:nucleus; C:pore complex;, F:BH3 domain binding; F:channel activity; F:chaperone binding; F:Hsp70 protein binding; F:identical protein binding; F:lipid binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:apoptotic mitochondrial changes; P:apoptotic process; P:apoptotic process involved in blood vessel morphogenesis; P:apoptotic process involved in embryonic digit morphogenesis; P:apoptotic signaling pathway; P:B cell apoptotic process; P:B cell homeostasis; P:B cell homeostatic proliferation; P:B cell negative selection; P:B cell receptor apoptotic signaling pathway; P:blood vessel remodeling; P:cellular response to unfolded protein; P:cellular response to UV; P:cellular response to virus; P:cerebral cortex development; P:development of secondary sexual characteristics; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:ectopic germ cell programmed cell death; P:endoplasmic reticulum calcium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:fertilization; P:germ cell development; P:glycosphingolipid metabolic process; P:homeostasis of number of cells within a tissue; P:hypothalamus development; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:myeloid cell homeostasis; P:negative regulation of apoptotic signaling pathway; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of fibroblast proliferation; P:negative regulation of mitochondrial membrane potential; P:negative regulation of neuron apoptotic process; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein binding; P:neuron apoptotic process; P:neuron migration; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of apoptotic process; P:positive regulation of apoptotic process involved in mammary gland involution; P:positive regulation of B cell apoptotic process; P:positive regulation of developmental pigmentation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of release of sequestered calcium ion into cytosol; P:post-embryonic camera-type eye morphogenesis; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of mammary gland epithelial cell proliferation; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; P:regulation of mitochondrial membrane potential; P:regulation of nitrogen utilization; P:regulation of transcription initiation from RNA polymerase II promoter; P:release of cytochrome c from mitochondria; P:release of matrix enzymes from mitochondria; P:response to axon injury; P:response to gamma radiation; P:response to salt stress; P:response to toxic substance; P:retina development in camera-type eye; P:retinal cell programmed cell death; P:Sertoli cell proliferation; P:spermatid differentiation; P:T cell homeostatic proliferation; P:thymocyte apoptotic process; P:vagina development; P:viral process;|Q9UCZ7 Q9UQD6,Apoptosis regulator BAX,Bcl-2-like protein 4;, PF00452;, GO:0097145;GO:0097144;GO:0097136;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0070062;GO:0016020;GO:0005741;GO:0005757;GO:0005739;GO:0005635;GO:0005634;GO:0046930;GO:0051434;GO:0015267;GO:0051087;GO:0030544;GO:0042802;GO:0008289;GO:0046982;GO:0042803;GO:0006919;GO:0008635;GO:0097296;GO:0008637;GO:0006915;GO:1902262;GO:1902263;GO:0097190;GO:0001783;GO:0001782;GO:0002358;GO:0002352;GO:1990117;GO:0001974;GO:0034620;GO:0034644;GO:0098586;GO:0021987;GO:0045136;GO:0006977;GO:0035234;GO:0032469;GO:0010248;GO:0097191;GO:0097192;GO:0008625;GO:0009566;GO:0007281;GO:0006687;GO:0048873;GO:0021854;GO:0097193;GO:0072332;GO:0008630;GO:0070059;GO:0001822;GO:0043653;GO:0008053;GO:0070584;GO:0002262;GO:2001234;GO:0032471;GO:0048147;GO:0010917;GO:0043524;GO:0033137;GO:0032091;GO:0051402;GO:0001764;GO:0042475;GO:0001541;GO:1902512;GO:0043065;GO:0060058;GO:0002904;GO:0048087;GO:1900103;GO:2001244;GO:1903896;GO:1901030;GO:0043525;GO:0031334;GO:0090200;GO:0051281;GO:0048597;GO:0001844;GO:0042981;GO:0033599;GO:1902445;GO:0051881;GO:0006808;GO:0060260;GO:0001836;GO:0032976;GO:0048678;GO:0010332;GO:0009651;GO:0009636;GO:0060041;GO:0046666;GO:0060011;GO:0048515;GO:0001777;GO:0070242;GO:0060068;GO:0016032;, C:BAK complex; C:BAX complex; C:Bcl-2 family protein complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nuclear envelope; C:nucleus; C:pore complex;, F:BH3 domain binding; F:channel activity; F:chaperone binding; F:Hsp70 protein binding; F:identical protein binding; F:lipid binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:apoptotic mitochondrial changes; P:apoptotic process; P:apoptotic process involved in blood vessel morphogenesis; P:apoptotic process involved in embryonic digit morphogenesis; P:apoptotic signaling pathway; P:B cell apoptotic process; P:B cell homeostasis; P:B cell homeostatic proliferation; P:B cell negative selection; P:B cell receptor apoptotic signaling pathway; P:blood vessel remodeling; P:cellular response to unfolded protein; P:cellular response to UV; P:cellular response to virus; P:cerebral cortex development; P:development of secondary sexual characteristics; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:ectopic germ cell programmed cell death; P:endoplasmic reticulum calcium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:fertilization; P:germ cell development; P:glycosphingolipid metabolic process; P:homeostasis of number of cells within a tissue; P:hypothalamus development; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:myeloid cell homeostasis; P:negative regulation of apoptotic signaling pathway; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of fibroblast proliferation; P:negative regulation of mitochondrial membrane potential; P:negative regulation of neuron apoptotic process; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein binding; P:neuron apoptotic process; P:neuron migration; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of apoptotic process; P:positive regulation of apoptotic process involved in mammary gland involution; P:positive regulation of B cell apoptotic process; P:positive regulation of developmental pigmentation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of release of sequestered calcium ion into cytosol; P:post-embryonic camera-type eye morphogenesis; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of mammary gland epithelial cell proliferation; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; P:regulation of mitochondrial membrane potential; P:regulation of nitrogen utilization; P:regulation of transcription initiation from RNA polymerase II promoter; P:release of cytochrome c from mitochondria; P:release of matrix enzymes from mitochondria; P:response to axon injury; P:response to gamma radiation; P:response to salt stress; P:response to toxic substance; P:retina development in camera-type eye; P:retinal cell programmed cell death; P:Sertoli cell proliferation; P:spermatid differentiation; P:T cell homeostatic proliferation; P:thymocyte apoptotic process; P:vagina development; P:viral process;|Q9UCZ7 Q9UQD6,Apoptosis regulator BAX,Bcl-2-like protein 4;, PF00452;, GO:0097145;GO:0097144;GO:0097136;GO:0005737;GO:0005829;GO:0005783;GO:0005789;GO:0070062;GO:0016020;GO:0005741;GO:0005757;GO:0005739;GO:0005635;GO:0005634;GO:0046930;GO:0051434;GO:0015267;GO:0051087;GO:0030544;GO:0042802;GO:0008289;GO:0046982;GO:0042803;GO:0006919;GO:0008635;GO:0097296;GO:0008637;GO:0006915;GO:1902262;GO:1902263;GO:0097190;GO:0001783;GO:0001782;GO:0002358;GO:0002352;GO:1990117;GO:0001974;GO:0034620;GO:0034644;GO:0098586;GO:0021987;GO:0045136;GO:0006977;GO:0035234;GO:0032469;GO:0010248;GO:0097191;GO:0097192;GO:0008625;GO:0009566;GO:0007281;GO:0006687;GO:0048873;GO:0021854;GO:0097193;GO:0072332;GO:0008630;GO:0070059;GO:0001822;GO:0043653;GO:0008053;GO:0070584;GO:0002262;GO:2001234;GO:0032471;GO:0048147;GO:0010917;GO:0043524;GO:0033137;GO:0032091;GO:0051402;GO:0001764;GO:0042475;GO:0001541;GO:1902512;GO:0043065;GO:0060058;GO:0002904;GO:0048087;GO:1900103;GO:2001244;GO:1903896;GO:1901030;GO:0043525;GO:0031334;GO:0090200;GO:0051281;GO:0048597;GO:0001844;GO:0042981;GO:0033599;GO:1902445;GO:0051881;GO:0006808;GO:0060260;GO:0001836;GO:0032976;GO:0048678;GO:0010332;GO:0009651;GO:0009636;GO:0060041;GO:0046666;GO:0060011;GO:0048515;GO:0001777;GO:0070242;GO:0060068;GO:0016032;, C:BAK complex; C:BAX complex; C:Bcl-2 family protein complex; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:extracellular exosome; C:membrane; C:mitochondrial outer membrane; C:mitochondrial permeability transition pore complex; C:mitochondrion; C:nuclear envelope; C:nucleus; C:pore complex;, F:BH3 domain binding; F:channel activity; F:chaperone binding; F:Hsp70 protein binding; F:identical protein binding; F:lipid binding; F:protein heterodimerization activity; F:protein homodimerization activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; P:apoptotic mitochondrial changes; P:apoptotic process; P:apoptotic process involved in blood vessel morphogenesis; P:apoptotic process involved in embryonic digit morphogenesis; P:apoptotic signaling pathway; P:B cell apoptotic process; P:B cell homeostasis; P:B cell homeostatic proliferation; P:B cell negative selection; P:B cell receptor apoptotic signaling pathway; P:blood vessel remodeling; P:cellular response to unfolded protein; P:cellular response to UV; P:cellular response to virus; P:cerebral cortex development; P:development of secondary sexual characteristics; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:ectopic germ cell programmed cell death; P:endoplasmic reticulum calcium ion homeostasis; P:establishment or maintenance of transmembrane electrochemical gradient; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:fertilization; P:germ cell development; P:glycosphingolipid metabolic process; P:homeostasis of number of cells within a tissue; P:hypothalamus development; P:intrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:kidney development; P:mitochondrial fragmentation involved in apoptotic process; P:mitochondrial fusion; P:mitochondrion morphogenesis; P:myeloid cell homeostasis; P:negative regulation of apoptotic signaling pathway; P:negative regulation of endoplasmic reticulum calcium ion concentration; P:negative regulation of fibroblast proliferation; P:negative regulation of mitochondrial membrane potential; P:negative regulation of neuron apoptotic process; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of protein binding; P:neuron apoptotic process; P:neuron migration; P:odontogenesis of dentin-containing tooth; P:ovarian follicle development; P:positive regulation of apoptotic DNA fragmentation; P:positive regulation of apoptotic process; P:positive regulation of apoptotic process involved in mammary gland involution; P:positive regulation of B cell apoptotic process; P:positive regulation of developmental pigmentation; P:positive regulation of endoplasmic reticulum unfolded protein response; P:positive regulation of intrinsic apoptotic signaling pathway; P:positive regulation of IRE1-mediated unfolded protein response; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; P:positive regulation of neuron apoptotic process; P:positive regulation of protein-containing complex assembly; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of release of sequestered calcium ion into cytosol; P:post-embryonic camera-type eye morphogenesis; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:regulation of apoptotic process; P:regulation of mammary gland epithelial cell proliferation; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; P:regulation of mitochondrial membrane potential; P:regulation of nitrogen utilization; P:regulation of transcription initiation from RNA polymerase II promoter; P:release of cytochrome c from mitochondria; P:release of matrix enzymes from mitochondria; P:response to axon injury; P:response to gamma radiation; P:response to salt stress; P:response to toxic substance; P:retina development in camera-type eye; P:retinal cell programmed cell death; P:Sertoli cell proliferation; P:spermatid differentiation; P:T cell homeostatic proliferation; P:thymocyte apoptotic process; P:vagina development; P:viral process; scaffold308 indexed_genome mRNA 108375 111735 . + . ID=transcript_16547;P02792 B2R4B9 Q6IBT7 Q7Z2W1 Q86WI9 Q8WU07 Q96AU9 Q96CU0 Q9BTZ8,Ferritin light chain,, PF00210;, GO:0044754;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0008043;GO:0016020;GO:0008199;GO:0008198;GO:0042802;GO:0005506;GO:0006879;GO:0006880;GO:0055072;GO:0006826;GO:0043312;GO:0006892;, C:autolysosome; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular ferritin complex; C:membrane;, F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:iron ion binding;, P:cellular iron ion homeostasis; P:intracellular sequestering of iron ion; P:iron ion homeostasis; P:iron ion transport; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport;|P02792 B2R4B9 Q6IBT7 Q7Z2W1 Q86WI9 Q8WU07 Q96AU9 Q96CU0 Q9BTZ8,Ferritin light chain,, PF00210;, GO:0044754;GO:0035578;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0008043;GO:0016020;GO:0008199;GO:0008198;GO:0042802;GO:0005506;GO:0006879;GO:0006880;GO:0055072;GO:0006826;GO:0043312;GO:0006892;, C:autolysosome; C:azurophil granule lumen; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:intracellular ferritin complex; C:membrane;, F:ferric iron binding; F:ferrous iron binding; F:identical protein binding; F:iron ion binding;, P:cellular iron ion homeostasis; P:intracellular sequestering of iron ion; P:iron ion homeostasis; P:iron ion transport; P:neutrophil degranulation; P:post-Golgi vesicle-mediated transport; scaffold308 indexed_genome mRNA 112477 129106 . - . ID=transcript_16548;P13807 Q9BTT9,Glycogen [starch] synthase, muscle,, PF05693;, GO:0005737;GO:0005829;GO:0016234;GO:0016020;GO:0005536;GO:0004373;GO:0061547;GO:0019901;GO:0005978;GO:0007507;, C:cytoplasm; C:cytosol; C:inclusion body; C:membrane;, F:glucose binding; F:glycogen (starch) synthase activity; F:glycogen synthase activity, transferring glucose-1-phosphate; F:protein kinase binding;, P:glycogen biosynthetic process; P:heart development;|P13807 Q9BTT9,Glycogen [starch] synthase, muscle,, PF05693;, GO:0005737;GO:0005829;GO:0016234;GO:0016020;GO:0005536;GO:0004373;GO:0061547;GO:0019901;GO:0005978;GO:0007507;, C:cytoplasm; C:cytosol; C:inclusion body; C:membrane;, F:glucose binding; F:glycogen (starch) synthase activity; F:glycogen synthase activity, transferring glucose-1-phosphate; F:protein kinase binding;, P:glycogen biosynthetic process; P:heart development;|P13807 Q9BTT9,Glycogen [starch] synthase, muscle,, PF05693;, GO:0005737;GO:0005829;GO:0016234;GO:0016020;GO:0005536;GO:0004373;GO:0061547;GO:0019901;GO:0005978;GO:0007507;, C:cytoplasm; C:cytosol; C:inclusion body; C:membrane;, F:glucose binding; F:glycogen (starch) synthase activity; F:glycogen synthase activity, transferring glucose-1-phosphate; F:protein kinase binding;, P:glycogen biosynthetic process; P:heart development;|P13807 Q9BTT9,Glycogen [starch] synthase, muscle,, PF05693;, GO:0005737;GO:0005829;GO:0016234;GO:0016020;GO:0005536;GO:0004373;GO:0061547;GO:0019901;GO:0005978;GO:0007507;, C:cytoplasm; C:cytosol; C:inclusion body; C:membrane;, F:glucose binding; F:glycogen (starch) synthase activity; F:glycogen synthase activity, transferring glucose-1-phosphate; F:protein kinase binding;, P:glycogen biosynthetic process; P:heart development;|P13807 Q9BTT9,Glycogen [starch] synthase, muscle,, PF05693;, GO:0005737;GO:0005829;GO:0016234;GO:0016020;GO:0005536;GO:0004373;GO:0061547;GO:0019901;GO:0005978;GO:0007507;, C:cytoplasm; C:cytosol; C:inclusion body; C:membrane;, F:glucose binding; F:glycogen (starch) synthase activity; F:glycogen synthase activity, transferring glucose-1-phosphate; F:protein kinase binding;, P:glycogen biosynthetic process; P:heart development;|P13807 Q9BTT9,Glycogen [starch] synthase, muscle,, PF05693;, GO:0005737;GO:0005829;GO:0016234;GO:0016020;GO:0005536;GO:0004373;GO:0061547;GO:0019901;GO:0005978;GO:0007507;, C:cytoplasm; C:cytosol; C:inclusion body; C:membrane;, F:glucose binding; F:glycogen (starch) synthase activity; F:glycogen synthase activity, transferring glucose-1-phosphate; F:protein kinase binding;, P:glycogen biosynthetic process; P:heart development;|P13807 Q9BTT9,Glycogen [starch] synthase, muscle,, PF05693;, GO:0005737;GO:0005829;GO:0016234;GO:0016020;GO:0005536;GO:0004373;GO:0061547;GO:0019901;GO:0005978;GO:0007507;, C:cytoplasm; C:cytosol; C:inclusion body; C:membrane;, F:glucose binding; F:glycogen (starch) synthase activity; F:glycogen synthase activity, transferring glucose-1-phosphate; F:protein kinase binding;, P:glycogen biosynthetic process; P:heart development;|P13807 Q9BTT9,Glycogen [starch] synthase, muscle,, PF05693;, GO:0005737;GO:0005829;GO:0016234;GO:0016020;GO:0005536;GO:0004373;GO:0061547;GO:0019901;GO:0005978;GO:0007507;, C:cytoplasm; C:cytosol; C:inclusion body; C:membrane;, F:glucose binding; F:glycogen (starch) synthase activity; F:glycogen synthase activity, transferring glucose-1-phosphate; F:protein kinase binding;, P:glycogen biosynthetic process; P:heart development;|P13807 Q9BTT9,Glycogen [starch] synthase, muscle,, PF05693;, GO:0005737;GO:0005829;GO:0016234;GO:0016020;GO:0005536;GO:0004373;GO:0061547;GO:0019901;GO:0005978;GO:0007507;, C:cytoplasm; C:cytosol; C:inclusion body; C:membrane;, F:glucose binding; F:glycogen (starch) synthase activity; F:glycogen synthase activity, transferring glucose-1-phosphate; F:protein kinase binding;, P:glycogen biosynthetic process; P:heart development; scaffold308 indexed_genome mRNA 129281 138788 . + . ID=transcript_16549;Q9Y230 B3KQ59 E7ETE5 Q6FIB9 Q6PK27 Q9Y361,RuvB-like 2,48 kDa TATA box-binding protein-interacting protein;51 kDa erythrocyte cytosolic protein;INO80 complex subunit J;Repressing pontin 52;TIP49b;TIP60-associated protein 54-beta;, PF06068;PF17856;, GO:0005813;GO:0005737;GO:0005829;GO:0000791;GO:0070062;GO:0031011;GO:0016020;GO:0071339;GO:0035267;GO:0016363;GO:0005654;GO:0005634;GO:0097255;GO:1990904;GO:0000812;GO:0043139;GO:0043531;GO:0005524;GO:0051117;GO:0008013;GO:0031490;GO:0003678;GO:0042802;GO:0042803;GO:0000978;GO:0000979;GO:0017025;GO:0001094;GO:0003714;GO:0051082;GO:0000492;GO:0071392;GO:0034644;GO:0006338;GO:0006310;GO:0006281;GO:0071169;GO:0016573;GO:0043968;GO:0043967;GO:0090090;GO:0071899;GO:0035066;GO:1904874;GO:0045944;GO:0006457;GO:0040008;GO:0006357;GO:0071733;, C:centrosome; C:cytoplasm; C:cytosol; C:euchromatin; C:extracellular exosome; C:Ino80 complex; C:membrane; C:MLL1 complex; C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:R2TP complex; C:ribonucleoprotein complex; C:Swr1 complex;, F:5'-3' DNA helicase activity; F:ADP binding; F:ATP binding; F:ATPase binding; F:beta-catenin binding; F:chromatin DNA binding; F:DNA helicase activity; F:identical protein binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription corepressor activity; F:unfolded protein binding;, P:box C/D snoRNP assembly; P:cellular response to estradiol stimulus; P:cellular response to UV; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:establishment of protein localization to chromatin; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of estrogen receptor binding; P:positive regulation of histone acetylation; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of transcription by RNA polymerase II; P:protein folding; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:transcriptional activation by promoter-enhancer looping; scaffold308 indexed_genome mRNA 156029 158586 . - . ID=transcript_16550;Q96RP8 A1KYX7 Q9BYS4,Potassium voltage-gated channel subfamily A member 7,Voltage-gated potassium channel subunit Kv1.7;, PF02214;PF00520;, GO:0016021;GO:0005886;GO:0008076;GO:0005251;GO:0005249;GO:0071805;GO:0051260;GO:0034765;, C:integral component of membrane; C:plasma membrane; C:voltage-gated potassium channel complex;, F:delayed rectifier potassium channel activity; F:voltage-gated potassium channel activity;, P:potassium ion transmembrane transport; P:protein homooligomerization; P:regulation of ion transmembrane transport; scaffold309 indexed_genome mRNA 4937 20737 . + . ID=transcript_16551;Q12977 Q12978 Q17RG9 Q6FH29 Q6N056 Q86TH6,Troponin T, fast skeletal muscle,Beta-TnTF;Fast skeletal muscle troponin T;, PF00992;, GO:0005829;GO:0005861;GO:0048306;GO:0005523;GO:0030172;GO:0031013;GO:0006936;GO:0030049;GO:1903612;GO:0043462;GO:0006942;GO:0045214;GO:0003009;, C:cytosol; C:troponin complex;, F:calcium-dependent protein binding; F:tropomyosin binding; F:troponin C binding; F:troponin I binding;, P:muscle contraction; P:muscle filament sliding; P:positive regulation of calcium-dependent ATPase activity; P:regulation of ATPase activity; P:regulation of striated muscle contraction; P:sarcomere organization; P:skeletal muscle contraction;|Q12977 Q12978 Q17RG9 Q6FH29 Q6N056 Q86TH6,Troponin T, fast skeletal muscle,Beta-TnTF;Fast skeletal muscle troponin T;, PF00992;, GO:0005829;GO:0005861;GO:0048306;GO:0005523;GO:0030172;GO:0031013;GO:0006936;GO:0030049;GO:1903612;GO:0043462;GO:0006942;GO:0045214;GO:0003009;, C:cytosol; C:troponin complex;, F:calcium-dependent protein binding; F:tropomyosin binding; F:troponin C binding; F:troponin I binding;, P:muscle contraction; P:muscle filament sliding; P:positive regulation of calcium-dependent ATPase activity; P:regulation of ATPase activity; P:regulation of striated muscle contraction; P:sarcomere organization; P:skeletal muscle contraction; scaffold309 indexed_genome mRNA 49913 57299 . - . ID=transcript_16552;Q16540 A8MT29 Q96Q71,39S ribosomal protein L23, mitochondrial,L23 mitochondrial-related protein;Mitochondrial large ribosomal subunit protein uL23m {ECO:0000303|PubMed:25278503};Ribosomal protein L23-like;, PF00276;, GO:0001650;GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:fibrillar center; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q16540 A8MT29 Q96Q71,39S ribosomal protein L23, mitochondrial,L23 mitochondrial-related protein;Mitochondrial large ribosomal subunit protein uL23m {ECO:0000303|PubMed:25278503};Ribosomal protein L23-like;, PF00276;, GO:0001650;GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:fibrillar center; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation;|Q16540 A8MT29 Q96Q71,39S ribosomal protein L23, mitochondrial,L23 mitochondrial-related protein;Mitochondrial large ribosomal subunit protein uL23m {ECO:0000303|PubMed:25278503};Ribosomal protein L23-like;, PF00276;, GO:0001650;GO:0005743;GO:0005762;GO:0005739;GO:0003723;GO:0003735;GO:0032543;GO:0070125;GO:0070126;GO:0006412;, C:fibrillar center; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, F:RNA binding; F:structural constituent of ribosome;, P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold309 indexed_genome mRNA 190034 191535 . + . ID=transcript_16553;Q9UC69,Insulin-like growth factor II,Somatomedin-A;T3M-11-derived growth factor;, PF08365;PF00049;, GO:0005576;GO:0005615;GO:0031093;GO:0008083;GO:0005179;GO:0005158;GO:0005159;GO:0005178;GO:0043539;GO:0048018;GO:0009887;GO:0044267;GO:0001892;GO:0060669;GO:0031017;GO:0006006;GO:0001701;GO:0008286;GO:0038028;GO:0007275;GO:0051148;GO:0000122;GO:0001649;GO:0002576;GO:0042104;GO:0043085;GO:0051781;GO:0008284;GO:2000467;GO:0045725;GO:0046628;GO:0043410;GO:0045840;GO:0040018;GO:0046622;GO:0050731;GO:0051897;GO:0001934;GO:0048633;GO:0045944;GO:1905564;GO:0006349;GO:0031056;GO:0051147;GO:0006355;GO:0001501;GO:0060720;GO:0051146;, C:extracellular region; C:extracellular space; C:platelet alpha granule lumen;, F:growth factor activity; F:hormone activity; F:insulin receptor binding; F:insulin-like growth factor receptor binding; F:integrin binding; F:protein serine/threonine kinase activator activity; F:receptor ligand activity;, P:animal organ morphogenesis; P:cellular protein metabolic process; P:embryonic placenta development; P:embryonic placenta morphogenesis; P:exocrine pancreas development; P:glucose metabolic process; P:in utero embryonic development; P:insulin receptor signaling pathway; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; P:multicellular organism development; P:negative regulation of muscle cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:osteoblast differentiation; P:platelet degranulation; P:positive regulation of activated T cell proliferation; P:positive regulation of catalytic activity; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of glycogen (starch) synthase activity; P:positive regulation of glycogen biosynthetic process; P:positive regulation of insulin receptor signaling pathway; P:positive regulation of MAPK cascade; P:positive regulation of mitotic nuclear division; P:positive regulation of multicellular organism growth; P:positive regulation of organ growth; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase B signaling; P:positive regulation of protein phosphorylation; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of vascular endothelial cell proliferation; P:regulation of gene expression by genetic imprinting; P:regulation of histone modification; P:regulation of muscle cell differentiation; P:regulation of transcription, DNA-templated; P:skeletal system development; P:spongiotrophoblast cell proliferation; P:striated muscle cell differentiation; scaffold311 indexed_genome mRNA 8311 20533 . + . ID=transcript_16554;Q9BT17 Q5VWX8 Q6PIY9 Q8IYJ4 Q8NC48 Q9BVU8,Mitochondrial ribosome-associated GTPase 1,GTP-binding protein 7;Mitochondrial GTPase 1;, PF01926;, GO:0005743;GO:0005759;GO:0005761;GO:0005739;GO:0005525;GO:0003924;GO:0070129;GO:0044065;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial ribosome; C:mitochondrion;, F:GTP binding; F:GTPase activity;, P:regulation of mitochondrial translation; P:regulation of respiratory system process;|Q9BT17 Q5VWX8 Q6PIY9 Q8IYJ4 Q8NC48 Q9BVU8,Mitochondrial ribosome-associated GTPase 1,GTP-binding protein 7;Mitochondrial GTPase 1;, PF01926;, GO:0005743;GO:0005759;GO:0005761;GO:0005739;GO:0005525;GO:0003924;GO:0070129;GO:0044065;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial ribosome; C:mitochondrion;, F:GTP binding; F:GTPase activity;, P:regulation of mitochondrial translation; P:regulation of respiratory system process;|Q6QHG2 Q6QHG3 Q6QHG4 Q6QHG5 Q6QHG6 Q86WP9 Q8N555 Q8NCX3,Peroxisomal N(1)-acetyl-spermine/spermidine oxidase,Polyamine oxidase;, PF01593;, GO:0005829;GO:0005782;GO:0052899;GO:0052904;GO:0052903;GO:0016491;GO:0046592;GO:0052902;GO:0052901;GO:0006596;GO:0006598;GO:1901307;GO:0008104;GO:0009446;GO:0009447;GO:0046203;GO:0046208;GO:0006805;, C:cytosol; C:peroxisomal matrix;, F:N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:oxidoreductase activity; F:polyamine oxidase activity; F:spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity; F:spermine:oxygen oxidoreductase (spermidine-forming) activity;, P:polyamine biosynthetic process; P:polyamine catabolic process; P:positive regulation of spermidine biosynthetic process; P:protein localization; P:putrescine biosynthetic process; P:putrescine catabolic process; P:spermidine catabolic process; P:spermine catabolic process; P:xenobiotic metabolic process; scaffold311 indexed_genome mRNA 20762 23437 . - . ID=transcript_16555;Q6QHG2 Q6QHG3 Q6QHG4 Q6QHG5 Q6QHG6 Q86WP9 Q8N555 Q8NCX3,Peroxisomal N(1)-acetyl-spermine/spermidine oxidase,Polyamine oxidase;, PF01593;, GO:0005829;GO:0005782;GO:0052899;GO:0052904;GO:0052903;GO:0016491;GO:0046592;GO:0052902;GO:0052901;GO:0006596;GO:0006598;GO:1901307;GO:0008104;GO:0009446;GO:0009447;GO:0046203;GO:0046208;GO:0006805;, C:cytosol; C:peroxisomal matrix;, F:N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:oxidoreductase activity; F:polyamine oxidase activity; F:spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity; F:spermine:oxygen oxidoreductase (spermidine-forming) activity;, P:polyamine biosynthetic process; P:polyamine catabolic process; P:positive regulation of spermidine biosynthetic process; P:protein localization; P:putrescine biosynthetic process; P:putrescine catabolic process; P:spermidine catabolic process; P:spermine catabolic process; P:xenobiotic metabolic process;|Q6QHG2 Q6QHG3 Q6QHG4 Q6QHG5 Q6QHG6 Q86WP9 Q8N555 Q8NCX3,Peroxisomal N(1)-acetyl-spermine/spermidine oxidase,Polyamine oxidase;, PF01593;, GO:0005829;GO:0005782;GO:0052899;GO:0052904;GO:0052903;GO:0016491;GO:0046592;GO:0052902;GO:0052901;GO:0006596;GO:0006598;GO:1901307;GO:0008104;GO:0009446;GO:0009447;GO:0046203;GO:0046208;GO:0006805;, C:cytosol; C:peroxisomal matrix;, F:N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:oxidoreductase activity; F:polyamine oxidase activity; F:spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity; F:spermine:oxygen oxidoreductase (spermidine-forming) activity;, P:polyamine biosynthetic process; P:polyamine catabolic process; P:positive regulation of spermidine biosynthetic process; P:protein localization; P:putrescine biosynthetic process; P:putrescine catabolic process; P:spermidine catabolic process; P:spermine catabolic process; P:xenobiotic metabolic process; scaffold311 indexed_genome mRNA 23473 27872 . - . ID=transcript_16556;Q6QHG2 Q6QHG3 Q6QHG4 Q6QHG5 Q6QHG6 Q86WP9 Q8N555 Q8NCX3,Peroxisomal N(1)-acetyl-spermine/spermidine oxidase,Polyamine oxidase;, PF01593;, GO:0005829;GO:0005782;GO:0052899;GO:0052904;GO:0052903;GO:0016491;GO:0046592;GO:0052902;GO:0052901;GO:0006596;GO:0006598;GO:1901307;GO:0008104;GO:0009446;GO:0009447;GO:0046203;GO:0046208;GO:0006805;, C:cytosol; C:peroxisomal matrix;, F:N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:oxidoreductase activity; F:polyamine oxidase activity; F:spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity; F:spermine:oxygen oxidoreductase (spermidine-forming) activity;, P:polyamine biosynthetic process; P:polyamine catabolic process; P:positive regulation of spermidine biosynthetic process; P:protein localization; P:putrescine biosynthetic process; P:putrescine catabolic process; P:spermidine catabolic process; P:spermine catabolic process; P:xenobiotic metabolic process;|Q6QHG2 Q6QHG3 Q6QHG4 Q6QHG5 Q6QHG6 Q86WP9 Q8N555 Q8NCX3,Peroxisomal N(1)-acetyl-spermine/spermidine oxidase,Polyamine oxidase;, PF01593;, GO:0005829;GO:0005782;GO:0052899;GO:0052904;GO:0052903;GO:0016491;GO:0046592;GO:0052902;GO:0052901;GO:0006596;GO:0006598;GO:1901307;GO:0008104;GO:0009446;GO:0009447;GO:0046203;GO:0046208;GO:0006805;, C:cytosol; C:peroxisomal matrix;, F:N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:oxidoreductase activity; F:polyamine oxidase activity; F:spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity; F:spermine:oxygen oxidoreductase (spermidine-forming) activity;, P:polyamine biosynthetic process; P:polyamine catabolic process; P:positive regulation of spermidine biosynthetic process; P:protein localization; P:putrescine biosynthetic process; P:putrescine catabolic process; P:spermidine catabolic process; P:spermine catabolic process; P:xenobiotic metabolic process;|Q6QHG2 Q6QHG3 Q6QHG4 Q6QHG5 Q6QHG6 Q86WP9 Q8N555 Q8NCX3,Peroxisomal N(1)-acetyl-spermine/spermidine oxidase,Polyamine oxidase;, PF01593;, GO:0005829;GO:0005782;GO:0052899;GO:0052904;GO:0052903;GO:0016491;GO:0046592;GO:0052902;GO:0052901;GO:0006596;GO:0006598;GO:1901307;GO:0008104;GO:0009446;GO:0009447;GO:0046203;GO:0046208;GO:0006805;, C:cytosol; C:peroxisomal matrix;, F:N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; F:oxidoreductase activity; F:polyamine oxidase activity; F:spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity; F:spermine:oxygen oxidoreductase (spermidine-forming) activity;, P:polyamine biosynthetic process; P:polyamine catabolic process; P:positive regulation of spermidine biosynthetic process; P:protein localization; P:putrescine biosynthetic process; P:putrescine catabolic process; P:spermidine catabolic process; P:spermine catabolic process; P:xenobiotic metabolic process; scaffold311 indexed_genome mRNA 40614 63036 . + . ID=transcript_16557;A2VDF0 A1L300 Q5VWY2 Q5VWY3 Q6ZPD2,Fucose mutarotase,, PF05025;, GO:0005829;GO:0042806;GO:0036373;GO:0016857;GO:0006004;GO:0036065;, C:cytosol;, F:fucose binding; F:L-fucose mutarotase activity; F:racemase and epimerase activity, acting on carbohydrates and derivatives;, P:fucose metabolic process; P:fucosylation;|P30084 O00739 Q5VWY1 Q96H54,Enoyl-CoA hydratase, mitochondrial {ECO:0000305},Enoyl-CoA hydratase 1;Short-chain enoyl-CoA hydratase;, PF00378;, GO:0005759;GO:0005739;GO:0043956;GO:0120092;GO:0004300;GO:0009083;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxypropionyl-CoA dehydratase activity; F:crotonyl-CoA hydratase activity; F:enoyl-CoA hydratase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation;|P30084 O00739 Q5VWY1 Q96H54,Enoyl-CoA hydratase, mitochondrial {ECO:0000305},Enoyl-CoA hydratase 1;Short-chain enoyl-CoA hydratase;, PF00378;, GO:0005759;GO:0005739;GO:0043956;GO:0120092;GO:0004300;GO:0009083;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxypropionyl-CoA dehydratase activity; F:crotonyl-CoA hydratase activity; F:enoyl-CoA hydratase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation;|P30084 O00739 Q5VWY1 Q96H54,Enoyl-CoA hydratase, mitochondrial {ECO:0000305},Enoyl-CoA hydratase 1;Short-chain enoyl-CoA hydratase;, PF00378;, GO:0005759;GO:0005739;GO:0043956;GO:0120092;GO:0004300;GO:0009083;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxypropionyl-CoA dehydratase activity; F:crotonyl-CoA hydratase activity; F:enoyl-CoA hydratase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation;|P30084 O00739 Q5VWY1 Q96H54,Enoyl-CoA hydratase, mitochondrial {ECO:0000305},Enoyl-CoA hydratase 1;Short-chain enoyl-CoA hydratase;, PF00378;, GO:0005759;GO:0005739;GO:0043956;GO:0120092;GO:0004300;GO:0009083;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxypropionyl-CoA dehydratase activity; F:crotonyl-CoA hydratase activity; F:enoyl-CoA hydratase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation;|P30084 O00739 Q5VWY1 Q96H54,Enoyl-CoA hydratase, mitochondrial {ECO:0000305},Enoyl-CoA hydratase 1;Short-chain enoyl-CoA hydratase;, PF00378;, GO:0005759;GO:0005739;GO:0043956;GO:0120092;GO:0004300;GO:0009083;GO:0006635;, C:mitochondrial matrix; C:mitochondrion;, F:3-hydroxypropionyl-CoA dehydratase activity; F:crotonyl-CoA hydratase activity; F:enoyl-CoA hydratase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation; scaffold311 indexed_genome mRNA 63064 70047 . - . ID=transcript_16558;Q96NZ9 B7ZL57 B7ZL58 E9KL31 Q5VWY4 Q7Z4X5 Q8IWR3 Q8NCS2,Proline-rich acidic protein 1,Epididymis tissue protein Li 178;Uterine-specific proline-rich acidic protein;, PF15314;, GO:0005576;, C:extracellular region; scaffold311 indexed_genome mRNA 80094 89560 . + . ID=transcript_16559;Q9NYX4 Q5VWX3 Q5VWY5 Q5VWY6,Neuron-specific vesicular protein calcyon,, PF06387;, GO:1904115;GO:0031410;GO:0030659;GO:0005768;GO:0098978;GO:0016021;GO:0005887;GO:0098843;GO:0032051;GO:0044877;GO:0008089;GO:0048268;GO:0007212;GO:0016197;GO:1905445;GO:0045807;GO:2001019;GO:0098884;, C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:endosome; C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:postsynaptic endocytic zone;, F:clathrin light chain binding; F:protein-containing complex binding;, P:anterograde axonal transport; P:clathrin coat assembly; P:dopamine receptor signaling pathway; P:endosomal transport; P:positive regulation of clathrin coat assembly; P:positive regulation of endocytosis; P:positive regulation of retrograde axon cargo transport; P:postsynaptic neurotransmitter receptor internalization;|Q9NYX4 Q5VWX3 Q5VWY5 Q5VWY6,Neuron-specific vesicular protein calcyon,, PF06387;, GO:1904115;GO:0031410;GO:0030659;GO:0005768;GO:0098978;GO:0016021;GO:0005887;GO:0098843;GO:0032051;GO:0044877;GO:0008089;GO:0048268;GO:0007212;GO:0016197;GO:1905445;GO:0045807;GO:2001019;GO:0098884;, C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:endosome; C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:postsynaptic endocytic zone;, F:clathrin light chain binding; F:protein-containing complex binding;, P:anterograde axonal transport; P:clathrin coat assembly; P:dopamine receptor signaling pathway; P:endosomal transport; P:positive regulation of clathrin coat assembly; P:positive regulation of endocytosis; P:positive regulation of retrograde axon cargo transport; P:postsynaptic neurotransmitter receptor internalization;|Q9NYX4 Q5VWX3 Q5VWY5 Q5VWY6,Neuron-specific vesicular protein calcyon,, PF06387;, GO:1904115;GO:0031410;GO:0030659;GO:0005768;GO:0098978;GO:0016021;GO:0005887;GO:0098843;GO:0032051;GO:0044877;GO:0008089;GO:0048268;GO:0007212;GO:0016197;GO:1905445;GO:0045807;GO:2001019;GO:0098884;, C:axon cytoplasm; C:cytoplasmic vesicle; C:cytoplasmic vesicle membrane; C:endosome; C:glutamatergic synapse; C:integral component of membrane; C:integral component of plasma membrane; C:postsynaptic endocytic zone;, F:clathrin light chain binding; F:protein-containing complex binding;, P:anterograde axonal transport; P:clathrin coat assembly; P:dopamine receptor signaling pathway; P:endosomal transport; P:positive regulation of clathrin coat assembly; P:positive regulation of endocytosis; P:positive regulation of retrograde axon cargo transport; P:postsynaptic neurotransmitter receptor internalization; scaffold311 indexed_genome mRNA 95961 102498 . - . ID=transcript_16560;Q15399 D1CS39 D1CS41 O15452 Q32MK3 Q32MK4 Q9UG90,Toll-like receptor 1,Toll/interleukin-1 receptor-like protein;, PF13855;PF01463;PF01582;, GO:0005794;GO:0005887;GO:0016020;GO:0045121;GO:0030670;GO:0005886;GO:0035354;GO:0042802;GO:0071723;GO:0050135;GO:0061809;GO:0038023;GO:0035663;GO:0004888;GO:0001775;GO:0071221;GO:0071727;GO:0042495;GO:0006955;GO:0006954;GO:0045087;GO:0042116;GO:0001774;GO:0002755;GO:0032755;GO:0032757;GO:0034137;GO:0032760;GO:0007165;GO:0034130;GO:0002224;GO:0038123;, C:Golgi apparatus; C:integral component of plasma membrane; C:membrane; C:membrane raft; C:phagocytic vesicle membrane; C:plasma membrane; C:Toll-like receptor 1-Toll-like receptor 2 protein complex;, F:identical protein binding; F:lipopeptide binding; F:NAD(P)+ nucleosidase activity; F:NAD+ nucleotidase, cyclic ADP-ribose generating; F:signaling receptor activity; F:Toll-like receptor 2 binding; F:transmembrane signaling receptor activity;, P:cell activation; P:cellular response to bacterial lipopeptide; P:cellular response to triacyl bacterial lipopeptide; P:detection of triacyl bacterial lipopeptide; P:immune response; P:inflammatory response; P:innate immune response; P:macrophage activation; P:microglial cell activation; P:MyD88-dependent toll-like receptor signaling pathway; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of toll-like receptor 2 signaling pathway; P:positive regulation of tumor necrosis factor production; P:signal transduction; P:toll-like receptor 1 signaling pathway; P:toll-like receptor signaling pathway; P:toll-like receptor TLR1:TLR2 signaling pathway; scaffold311 indexed_genome mRNA 123856 151318 . + . ID=transcript_16561;Q8NB15 A8K8L5 Q8WUP1 Q96BV2,Zinc finger protein 511 {ECO:0000305},, , GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;|Q8NB15 A8K8L5 Q8WUP1 Q96BV2,Zinc finger protein 511 {ECO:0000305},, , GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046872;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding;|Q9BSJ2 B4DM18 B7ZKL8 F5H4E0 F5H4L0 O43632 Q5VWX7,Gamma-tubulin complex component 2,Gamma-ring complex protein 103 kDa;Spindle pole body protein Spc97 homolog;, PF04130;PF17681;, GO:0005813;GO:0005881;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005815;GO:0005654;GO:0000922;GO:0043015;GO:0007420;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0001764;GO:0065003;GO:0051225;, C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:microtubule organizing center; C:nucleoplasm; C:spindle pole;, F:gamma-tubulin binding;, P:brain development; P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:neuron migration; P:protein-containing complex assembly; P:spindle assembly;|Q9BSJ2 B4DM18 B7ZKL8 F5H4E0 F5H4L0 O43632 Q5VWX7,Gamma-tubulin complex component 2,Gamma-ring complex protein 103 kDa;Spindle pole body protein Spc97 homolog;, PF04130;PF17681;, GO:0005813;GO:0005881;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005815;GO:0005654;GO:0000922;GO:0043015;GO:0007420;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0001764;GO:0065003;GO:0051225;, C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:microtubule organizing center; C:nucleoplasm; C:spindle pole;, F:gamma-tubulin binding;, P:brain development; P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:neuron migration; P:protein-containing complex assembly; P:spindle assembly;|Q9BSJ2 B4DM18 B7ZKL8 F5H4E0 F5H4L0 O43632 Q5VWX7,Gamma-tubulin complex component 2,Gamma-ring complex protein 103 kDa;Spindle pole body protein Spc97 homolog;, PF04130;PF17681;, GO:0005813;GO:0005881;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005815;GO:0005654;GO:0000922;GO:0043015;GO:0007420;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0001764;GO:0065003;GO:0051225;, C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:microtubule organizing center; C:nucleoplasm; C:spindle pole;, F:gamma-tubulin binding;, P:brain development; P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:neuron migration; P:protein-containing complex assembly; P:spindle assembly;|Q9BSJ2 B4DM18 B7ZKL8 F5H4E0 F5H4L0 O43632 Q5VWX7,Gamma-tubulin complex component 2,Gamma-ring complex protein 103 kDa;Spindle pole body protein Spc97 homolog;, PF04130;PF17681;, GO:0005813;GO:0005881;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005815;GO:0005654;GO:0000922;GO:0043015;GO:0007420;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0001764;GO:0065003;GO:0051225;, C:centrosome; C:cytoplasmic microtubule; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:microtubule organizing center; C:nucleoplasm; C:spindle pole;, F:gamma-tubulin binding;, P:brain development; P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:neuron migration; P:protein-containing complex assembly; P:spindle assembly; scaffold311 indexed_genome mRNA 153311 161268 . + . ID=transcript_16562;P78325 B4DVM6 H0YL36 H0YLR0 H0YN39,Disintegrin and metalloproteinase domain-containing protein 8,Cell surface antigen MS2;, PF08516;PF00200;PF01562;PF01421;, GO:0071133;GO:0009986;GO:0005737;GO:0032127;GO:0101003;GO:0005887;GO:0032010;GO:0005886;GO:0002102;GO:0042581;GO:0035579;GO:0070820;GO:0070821;GO:0005509;GO:0050839;GO:0004222;GO:0008237;GO:0043621;GO:0008270;GO:0001525;GO:0000902;GO:0098609;GO:0071456;GO:0022617;GO:0006954;GO:0002523;GO:0048247;GO:0043524;GO:0043312;GO:0002675;GO:0045780;GO:0045785;GO:0002693;GO:2000418;GO:2000415;GO:0045089;GO:0043406;GO:0051044;GO:2000391;GO:0051092;GO:0051897;GO:0010954;GO:0050714;GO:0033089;GO:0070245;GO:2000309;GO:0022407;, C:alpha9-beta1 integrin-ADAM8 complex; C:cell surface; C:cytoplasm; C:dense core granule membrane; C:ficolin-1-rich granule membrane; C:integral component of plasma membrane; C:phagolysosome; C:plasma membrane; C:podosome; C:specific granule; C:specific granule membrane; C:tertiary granule; C:tertiary granule membrane;, F:calcium ion binding; F:cell adhesion molecule binding; F:metalloendopeptidase activity; F:metallopeptidase activity; F:protein self-association; F:zinc ion binding;, P:angiogenesis; P:cell morphogenesis; P:cell-cell adhesion; P:cellular response to hypoxia; P:extracellular matrix disassembly; P:inflammatory response; P:leukocyte migration involved in inflammatory response; P:lymphocyte chemotaxis; P:negative regulation of neuron apoptotic process; P:neutrophil degranulation; P:positive regulation of acute inflammatory response; P:positive regulation of bone resorption; P:positive regulation of cell adhesion; P:positive regulation of cellular extravasation; P:positive regulation of eosinophil migration; P:positive regulation of fibronectin-dependent thymocyte migration; P:positive regulation of innate immune response; P:positive regulation of MAP kinase activity; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of neutrophil extravasation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein kinase B signaling; P:positive regulation of protein processing; P:positive regulation of protein secretion; P:positive regulation of T cell differentiation in thymus; P:positive regulation of thymocyte apoptotic process; P:positive regulation of tumor necrosis factor (ligand) superfamily member 11 production; P:regulation of cell-cell adhesion; scaffold311 indexed_genome mRNA 168151 168877 . - . ID=transcript_16563;Q9Y4P9 A5YM71 D3DVY0 Q5JX78,Sperm flagellar protein 1,, PF06294;, GO:0097729;GO:0016324;GO:1990716;GO:0005930;GO:0016323;GO:0097542;GO:0005737;GO:0030175;GO:0030027;GO:0005874;GO:0005902;GO:0003779;GO:0008017;GO:1904158;GO:0016477;GO:0003341;GO:0046847;GO:0030032;GO:0001578;GO:0060548;GO:0007026;GO:0051493;GO:2000095;, C:9+2 motile cilium; C:apical plasma membrane; C:axonemal central apparatus; C:axoneme; C:basolateral plasma membrane; C:ciliary tip; C:cytoplasm; C:filopodium; C:lamellipodium; C:microtubule; C:microvillus;, F:actin binding; F:microtubule binding;, P:axonemal central apparatus assembly; P:cell migration; P:cilium movement; P:filopodium assembly; P:lamellipodium assembly; P:microtubule bundle formation; P:negative regulation of cell death; P:negative regulation of microtubule depolymerization; P:regulation of cytoskeleton organization; P:regulation of Wnt signaling pathway, planar cell polarity pathway; scaffold312 indexed_genome mRNA 78413 85418 . + . ID=transcript_16564;Q13459 O75314 Q9NUJ2 Q9UHN0,Unconventional myosin-IXb,Unconventional myosin-9b;, PF00612;PF00063;PF00788;PF00620;, GO:0015629;GO:0005884;GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0016459;GO:0048471;GO:0003779;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0005096;GO:0046872;GO:0000146;GO:0048495;GO:0031267;GO:0030048;GO:0035023;GO:0051056;GO:0007266;GO:0035385;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:myosin complex; C:perinuclear region of cytoplasm;, F:actin binding; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:GTPase activator activity; F:metal ion binding; F:microfilament motor activity; F:Roundabout binding; F:small GTPase binding;, P:actin filament-based movement; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway;|Q13459 O75314 Q9NUJ2 Q9UHN0,Unconventional myosin-IXb,Unconventional myosin-9b;, PF00612;PF00063;PF00788;PF00620;, GO:0015629;GO:0005884;GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0016459;GO:0048471;GO:0003779;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0005096;GO:0046872;GO:0000146;GO:0048495;GO:0031267;GO:0030048;GO:0035023;GO:0051056;GO:0007266;GO:0035385;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:myosin complex; C:perinuclear region of cytoplasm;, F:actin binding; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:GTPase activator activity; F:metal ion binding; F:microfilament motor activity; F:Roundabout binding; F:small GTPase binding;, P:actin filament-based movement; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway; scaffold312 indexed_genome mRNA 87490 108974 . + . ID=transcript_16565;Q13459 O75314 Q9NUJ2 Q9UHN0,Unconventional myosin-IXb,Unconventional myosin-9b;, PF00612;PF00063;PF00788;PF00620;, GO:0015629;GO:0005884;GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0016459;GO:0048471;GO:0003779;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0005096;GO:0046872;GO:0000146;GO:0048495;GO:0031267;GO:0030048;GO:0035023;GO:0051056;GO:0007266;GO:0035385;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:myosin complex; C:perinuclear region of cytoplasm;, F:actin binding; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:GTPase activator activity; F:metal ion binding; F:microfilament motor activity; F:Roundabout binding; F:small GTPase binding;, P:actin filament-based movement; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway;|Q13459 O75314 Q9NUJ2 Q9UHN0,Unconventional myosin-IXb,Unconventional myosin-9b;, PF00612;PF00063;PF00788;PF00620;, GO:0015629;GO:0005884;GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0016459;GO:0048471;GO:0003779;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0005096;GO:0046872;GO:0000146;GO:0048495;GO:0031267;GO:0030048;GO:0035023;GO:0051056;GO:0007266;GO:0035385;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:myosin complex; C:perinuclear region of cytoplasm;, F:actin binding; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:GTPase activator activity; F:metal ion binding; F:microfilament motor activity; F:Roundabout binding; F:small GTPase binding;, P:actin filament-based movement; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway;|Q13459 O75314 Q9NUJ2 Q9UHN0,Unconventional myosin-IXb,Unconventional myosin-9b;, PF00612;PF00063;PF00788;PF00620;, GO:0015629;GO:0005884;GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0016459;GO:0048471;GO:0003779;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0005096;GO:0046872;GO:0000146;GO:0048495;GO:0031267;GO:0030048;GO:0035023;GO:0051056;GO:0007266;GO:0035385;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:myosin complex; C:perinuclear region of cytoplasm;, F:actin binding; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:GTPase activator activity; F:metal ion binding; F:microfilament motor activity; F:Roundabout binding; F:small GTPase binding;, P:actin filament-based movement; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway;|Q13459 O75314 Q9NUJ2 Q9UHN0,Unconventional myosin-IXb,Unconventional myosin-9b;, PF00612;PF00063;PF00788;PF00620;, GO:0015629;GO:0005884;GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0016459;GO:0048471;GO:0003779;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0005096;GO:0046872;GO:0000146;GO:0048495;GO:0031267;GO:0030048;GO:0035023;GO:0051056;GO:0007266;GO:0035385;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:myosin complex; C:perinuclear region of cytoplasm;, F:actin binding; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:GTPase activator activity; F:metal ion binding; F:microfilament motor activity; F:Roundabout binding; F:small GTPase binding;, P:actin filament-based movement; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway;|Q13459 O75314 Q9NUJ2 Q9UHN0,Unconventional myosin-IXb,Unconventional myosin-9b;, PF00612;PF00063;PF00788;PF00620;, GO:0015629;GO:0005884;GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0016459;GO:0048471;GO:0003779;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0005096;GO:0046872;GO:0000146;GO:0048495;GO:0031267;GO:0030048;GO:0035023;GO:0051056;GO:0007266;GO:0035385;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:myosin complex; C:perinuclear region of cytoplasm;, F:actin binding; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:GTPase activator activity; F:metal ion binding; F:microfilament motor activity; F:Roundabout binding; F:small GTPase binding;, P:actin filament-based movement; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway;|Q13459 O75314 Q9NUJ2 Q9UHN0,Unconventional myosin-IXb,Unconventional myosin-9b;, PF00612;PF00063;PF00788;PF00620;, GO:0015629;GO:0005884;GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0016459;GO:0048471;GO:0003779;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0005096;GO:0046872;GO:0000146;GO:0048495;GO:0031267;GO:0030048;GO:0035023;GO:0051056;GO:0007266;GO:0035385;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:myosin complex; C:perinuclear region of cytoplasm;, F:actin binding; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:GTPase activator activity; F:metal ion binding; F:microfilament motor activity; F:Roundabout binding; F:small GTPase binding;, P:actin filament-based movement; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway;|Q13459 O75314 Q9NUJ2 Q9UHN0,Unconventional myosin-IXb,Unconventional myosin-9b;, PF00612;PF00063;PF00788;PF00620;, GO:0015629;GO:0005884;GO:0005938;GO:0005737;GO:0005829;GO:0016020;GO:0016459;GO:0048471;GO:0003779;GO:0043531;GO:0005524;GO:0016887;GO:0005516;GO:0005096;GO:0046872;GO:0000146;GO:0048495;GO:0031267;GO:0030048;GO:0035023;GO:0051056;GO:0007266;GO:0035385;, C:actin cytoskeleton; C:actin filament; C:cell cortex; C:cytoplasm; C:cytosol; C:membrane; C:myosin complex; C:perinuclear region of cytoplasm;, F:actin binding; F:ADP binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:GTPase activator activity; F:metal ion binding; F:microfilament motor activity; F:Roundabout binding; F:small GTPase binding;, P:actin filament-based movement; P:regulation of Rho protein signal transduction; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; P:Roundabout signaling pathway; scaffold312 indexed_genome mRNA 110563 113037 . + . ID=transcript_16566;Q9NZ43 Q8NCK1 Q9BRT4,Vesicle transport protein USE1,Putative MAPK-activating protein PM26;USE1-like protein;p31;, PF09753;, GO:0030137;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005886;GO:0031201;GO:0005484;GO:0007041;GO:0030163;GO:0015031;GO:0006890;GO:0032940;, C:COPI-coated vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:SNARE complex;, F:SNAP receptor activity;, P:lysosomal transport; P:protein catabolic process; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:secretion by cell;|Q9NZ43 Q8NCK1 Q9BRT4,Vesicle transport protein USE1,Putative MAPK-activating protein PM26;USE1-like protein;p31;, PF09753;, GO:0030137;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0005886;GO:0031201;GO:0005484;GO:0007041;GO:0030163;GO:0015031;GO:0006890;GO:0032940;, C:COPI-coated vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane; C:SNARE complex;, F:SNAP receptor activity;, P:lysosomal transport; P:protein catabolic process; P:protein transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:secretion by cell; scaffold312 indexed_genome mRNA 118546 119645 . + . ID=transcript_16567;Q9H607,Occludin/ELL domain-containing protein 1,, PF07303; scaffold312 indexed_genome mRNA 122070 123613 . - . ID=transcript_16568;P10588 B2RC68 Q5XGA0 Q6P586 Q9BUE8,Nuclear receptor subfamily 2 group F member 6,V-erbA-related protein 2;, PF00104;PF00105;, GO:0000785;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0004879;GO:0000978;GO:0043565;GO:1990837;GO:0008270;GO:0048856;GO:0030154;GO:0050965;GO:0043153;GO:0000122;GO:0048666;GO:0006357;GO:0006367;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:detection of temperature stimulus involved in sensory perception of pain; P:entrainment of circadian clock by photoperiod; P:negative regulation of transcription by RNA polymerase II; P:neuron development; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; scaffold312 indexed_genome mRNA 147354 150634 . - . ID=transcript_16569;A0A1B0GVG4,Coiled-coil domain-containing protein 194 {ECO:0000305} scaffold312 indexed_genome mRNA 163509 171734 . + . ID=transcript_16570;P61550 I7GPQ9,Endogenous retrovirus group S71 member 1 Env polyprotein,Envelope polyprotein;HERV-T Env protein;HERV-T_19q13.11 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold315 indexed_genome mRNA 82701 100105 . + . ID=transcript_16571;Q9HCB8,Protein phosphatase 1 regulatory subunit 12B,Myosin phosphatase-targeting subunit 2;, PF12796;PF15898;, GO:0031672;GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0030018;GO:0008047;GO:0004857;GO:0019208;GO:0019901;GO:0000086;GO:0006937;GO:0007165;, C:A band; C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:Z disc;, F:enzyme activator activity; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:G2/M transition of mitotic cell cycle; P:regulation of muscle contraction; P:signal transduction;|Q9HCB8,Protein phosphatase 1 regulatory subunit 12B,Myosin phosphatase-targeting subunit 2;, PF12796;PF15898;, GO:0031672;GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0030018;GO:0008047;GO:0004857;GO:0019208;GO:0019901;GO:0000086;GO:0006937;GO:0007165;, C:A band; C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:Z disc;, F:enzyme activator activity; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:G2/M transition of mitotic cell cycle; P:regulation of muscle contraction; P:signal transduction; scaffold315 indexed_genome mRNA 102539 107490 . - . ID=transcript_16572;Q8N9I0 Q496K5 Q8NBE5,Synaptotagmin-2 {ECO:0000305},Synaptotagmin II {ECO:0000312|HGNC:HGNC:11510};, PF00168;, GO:0030424;GO:0042584;GO:0030669;GO:0031045;GO:0070382;GO:0016021;GO:0005886;GO:0030672;GO:0005509;GO:0005544;GO:0030276;GO:0043533;GO:0001786;GO:0000149;GO:0019905;GO:0048791;GO:0017156;GO:0030154;GO:0071277;GO:0061024;GO:1903861;GO:0017158;GO:0014059;GO:0048488;GO:0016192;, C:axon; C:chromaffin granule membrane; C:clathrin-coated endocytic vesicle membrane; C:dense core granule; C:exocytic vesicle; C:integral component of membrane; C:plasma membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:inositol 1,3,4,5 tetrakisphosphate binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:membrane organization; P:positive regulation of dendrite extension; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:synaptic vesicle endocytosis; P:vesicle-mediated transport;|Q8N9I0 Q496K5 Q8NBE5,Synaptotagmin-2 {ECO:0000305},Synaptotagmin II {ECO:0000312|HGNC:HGNC:11510};, PF00168;, GO:0030424;GO:0042584;GO:0030669;GO:0031045;GO:0070382;GO:0016021;GO:0005886;GO:0030672;GO:0005509;GO:0005544;GO:0030276;GO:0043533;GO:0001786;GO:0000149;GO:0019905;GO:0048791;GO:0017156;GO:0030154;GO:0071277;GO:0061024;GO:1903861;GO:0017158;GO:0014059;GO:0048488;GO:0016192;, C:axon; C:chromaffin granule membrane; C:clathrin-coated endocytic vesicle membrane; C:dense core granule; C:exocytic vesicle; C:integral component of membrane; C:plasma membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:inositol 1,3,4,5 tetrakisphosphate binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:membrane organization; P:positive regulation of dendrite extension; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:synaptic vesicle endocytosis; P:vesicle-mediated transport;|Q8N9I0 Q496K5 Q8NBE5,Synaptotagmin-2 {ECO:0000305},Synaptotagmin II {ECO:0000312|HGNC:HGNC:11510};, PF00168;, GO:0030424;GO:0042584;GO:0030669;GO:0031045;GO:0070382;GO:0016021;GO:0005886;GO:0030672;GO:0005509;GO:0005544;GO:0030276;GO:0043533;GO:0001786;GO:0000149;GO:0019905;GO:0048791;GO:0017156;GO:0030154;GO:0071277;GO:0061024;GO:1903861;GO:0017158;GO:0014059;GO:0048488;GO:0016192;, C:axon; C:chromaffin granule membrane; C:clathrin-coated endocytic vesicle membrane; C:dense core granule; C:exocytic vesicle; C:integral component of membrane; C:plasma membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:inositol 1,3,4,5 tetrakisphosphate binding; F:phosphatidylserine binding; F:SNARE binding; F:syntaxin binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cell differentiation; P:cellular response to calcium ion; P:membrane organization; P:positive regulation of dendrite extension; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:synaptic vesicle endocytosis; P:vesicle-mediated transport; scaffold316 indexed_genome mRNA 28814 71835 . + . ID=transcript_16573;Q9NUQ3 Q2KQ75 Q5JNZ7 Q9P0X1,Gamma-taxilin,Environmental lipopolysaccharide-responding gene protein;Factor inhibiting ATF4-mediated transcription;Lipopolysaccharide-specific response protein 5;, PF09728;, GO:0005829;GO:0031965;GO:0033613;GO:0019905;GO:0008134;GO:0007049;GO:0030500;GO:0051726;GO:0010564;, C:cytosol; C:nuclear membrane;, F:activating transcription factor binding; F:syntaxin binding; F:transcription factor binding;, P:cell cycle; P:regulation of bone mineralization; P:regulation of cell cycle; P:regulation of cell cycle process;|Q9NUQ3 Q2KQ75 Q5JNZ7 Q9P0X1,Gamma-taxilin,Environmental lipopolysaccharide-responding gene protein;Factor inhibiting ATF4-mediated transcription;Lipopolysaccharide-specific response protein 5;, PF09728;, GO:0005829;GO:0031965;GO:0033613;GO:0019905;GO:0008134;GO:0007049;GO:0030500;GO:0051726;GO:0010564;, C:cytosol; C:nuclear membrane;, F:activating transcription factor binding; F:syntaxin binding; F:transcription factor binding;, P:cell cycle; P:regulation of bone mineralization; P:regulation of cell cycle; P:regulation of cell cycle process;|Q9NUQ3 Q2KQ75 Q5JNZ7 Q9P0X1,Gamma-taxilin,Environmental lipopolysaccharide-responding gene protein;Factor inhibiting ATF4-mediated transcription;Lipopolysaccharide-specific response protein 5;, PF09728;, GO:0005829;GO:0031965;GO:0033613;GO:0019905;GO:0008134;GO:0007049;GO:0030500;GO:0051726;GO:0010564;, C:cytosol; C:nuclear membrane;, F:activating transcription factor binding; F:syntaxin binding; F:transcription factor binding;, P:cell cycle; P:regulation of bone mineralization; P:regulation of cell cycle; P:regulation of cell cycle process;|Q9NUQ3 Q2KQ75 Q5JNZ7 Q9P0X1,Gamma-taxilin,Environmental lipopolysaccharide-responding gene protein;Factor inhibiting ATF4-mediated transcription;Lipopolysaccharide-specific response protein 5;, PF09728;, GO:0005829;GO:0031965;GO:0033613;GO:0019905;GO:0008134;GO:0007049;GO:0030500;GO:0051726;GO:0010564;, C:cytosol; C:nuclear membrane;, F:activating transcription factor binding; F:syntaxin binding; F:transcription factor binding;, P:cell cycle; P:regulation of bone mineralization; P:regulation of cell cycle; P:regulation of cell cycle process; scaffold316 indexed_genome mRNA 75441 76240 . + . ID=transcript_16574;Q16576 Q5JP00,Histone-binding protein RBBP7,Histone acetyltransferase type B subunit 2;Nucleosome-remodeling factor subunit RBAP46;Retinoblastoma-binding protein 7;Retinoblastoma-binding protein p46;, PF12265;PF00400;, GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0003723;GO:0070370;GO:0034080;GO:0006260;GO:0030308;GO:0070317;GO:0045814;GO:0000122;GO:0043687;GO:1901796;GO:0048545;GO:0019058;, C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:RNA binding;, P:cellular heat acclimation; P:CENP-A containing nucleosome assembly; P:DNA replication; P:negative regulation of cell growth; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:regulation of signal transduction by p53 class mediator; P:response to steroid hormone; P:viral life cycle; scaffold316 indexed_genome mRNA 76268 77294 . + . ID=transcript_16575;Q16576 Q5JP00,Histone-binding protein RBBP7,Histone acetyltransferase type B subunit 2;Nucleosome-remodeling factor subunit RBAP46;Retinoblastoma-binding protein 7;Retinoblastoma-binding protein p46;, PF12265;PF00400;, GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0003723;GO:0070370;GO:0034080;GO:0006260;GO:0030308;GO:0070317;GO:0045814;GO:0000122;GO:0043687;GO:1901796;GO:0048545;GO:0019058;, C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:RNA binding;, P:cellular heat acclimation; P:CENP-A containing nucleosome assembly; P:DNA replication; P:negative regulation of cell growth; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:regulation of signal transduction by p53 class mediator; P:response to steroid hormone; P:viral life cycle; scaffold316 indexed_genome mRNA 77317 79127 . - . ID=transcript_16576;Q16576 Q5JP00,Histone-binding protein RBBP7,Histone acetyltransferase type B subunit 2;Nucleosome-remodeling factor subunit RBAP46;Retinoblastoma-binding protein 7;Retinoblastoma-binding protein p46;, PF12265;PF00400;, GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0003723;GO:0070370;GO:0034080;GO:0006260;GO:0030308;GO:0070317;GO:0045814;GO:0000122;GO:0043687;GO:1901796;GO:0048545;GO:0019058;, C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:RNA binding;, P:cellular heat acclimation; P:CENP-A containing nucleosome assembly; P:DNA replication; P:negative regulation of cell growth; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:regulation of signal transduction by p53 class mediator; P:response to steroid hormone; P:viral life cycle; scaffold316 indexed_genome mRNA 79167 83867 . + . ID=transcript_16577;Q16576 Q5JP00,Histone-binding protein RBBP7,Histone acetyltransferase type B subunit 2;Nucleosome-remodeling factor subunit RBAP46;Retinoblastoma-binding protein 7;Retinoblastoma-binding protein p46;, PF12265;PF00400;, GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0003723;GO:0070370;GO:0034080;GO:0006260;GO:0030308;GO:0070317;GO:0045814;GO:0000122;GO:0043687;GO:1901796;GO:0048545;GO:0019058;, C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:RNA binding;, P:cellular heat acclimation; P:CENP-A containing nucleosome assembly; P:DNA replication; P:negative regulation of cell growth; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:regulation of signal transduction by p53 class mediator; P:response to steroid hormone; P:viral life cycle;|Q16576 Q5JP00,Histone-binding protein RBBP7,Histone acetyltransferase type B subunit 2;Nucleosome-remodeling factor subunit RBAP46;Retinoblastoma-binding protein 7;Retinoblastoma-binding protein p46;, PF12265;PF00400;, GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0003723;GO:0070370;GO:0034080;GO:0006260;GO:0030308;GO:0070317;GO:0045814;GO:0000122;GO:0043687;GO:1901796;GO:0048545;GO:0019058;, C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:RNA binding;, P:cellular heat acclimation; P:CENP-A containing nucleosome assembly; P:DNA replication; P:negative regulation of cell growth; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:regulation of signal transduction by p53 class mediator; P:response to steroid hormone; P:viral life cycle;|Q16576 Q5JP00,Histone-binding protein RBBP7,Histone acetyltransferase type B subunit 2;Nucleosome-remodeling factor subunit RBAP46;Retinoblastoma-binding protein 7;Retinoblastoma-binding protein p46;, PF12265;PF00400;, GO:0005829;GO:0035098;GO:0005654;GO:0005634;GO:0016581;GO:0003723;GO:0070370;GO:0034080;GO:0006260;GO:0030308;GO:0070317;GO:0045814;GO:0000122;GO:0043687;GO:1901796;GO:0048545;GO:0019058;, C:cytosol; C:ESC/E(Z) complex; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:RNA binding;, P:cellular heat acclimation; P:CENP-A containing nucleosome assembly; P:DNA replication; P:negative regulation of cell growth; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:regulation of signal transduction by p53 class mediator; P:response to steroid hormone; P:viral life cycle; scaffold317 indexed_genome mRNA 638 1248 . - . ID=transcript_16578;Q8N4Y2 D5LPR2 Q8NBW8,EF-hand calcium-binding domain-containing protein 4A,Calcium release-activated calcium channel regulator 2B;Calcium release-activated channel regulator 2B;, , GO:0005737;GO:0005509;GO:0034613;GO:2001256;GO:0002115;, C:cytoplasm;, F:calcium ion binding;, P:cellular protein localization; P:regulation of store-operated calcium entry; P:store-operated calcium entry; scaffold317 indexed_genome mRNA 5145 9047 . - . ID=transcript_16579;Q96AD5 O60643 Q5EFF5 Q6XYE5 Q96ET6 Q9NQ61 Q9NQ62,Patatin-like phospholipase domain-containing protein 2 {ECO:0000305},Adipose triglyceride lipase {ECO:0000303|PubMed:15550674};Calcium-independent phospholipase A2;Desnutrin;IPLA2-zeta;Pigment epithelium-derived factor;TTS2.2 {ECO:0000303|PubMed:17603008};Transport-secretion protein 2;, PF01734;, GO:0005737;GO:0005829;GO:0005788;GO:0005789;GO:0016021;GO:0005811;GO:0016020;GO:0005654;GO:0005886;GO:0050253;GO:0004806;GO:0036155;GO:0044267;GO:0006651;GO:0034389;GO:0055088;GO:0019915;GO:0010891;GO:0010898;GO:0043687;GO:0019433;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:nucleoplasm; C:plasma membrane;, F:retinyl-palmitate esterase activity; F:triglyceride lipase activity;, P:acylglycerol acyl-chain remodeling; P:cellular protein metabolic process; P:diacylglycerol biosynthetic process; P:lipid droplet organization; P:lipid homeostasis; P:lipid storage; P:negative regulation of sequestering of triglyceride; P:positive regulation of triglyceride catabolic process; P:post-translational protein modification; P:triglyceride catabolic process;|Q96AD5 O60643 Q5EFF5 Q6XYE5 Q96ET6 Q9NQ61 Q9NQ62,Patatin-like phospholipase domain-containing protein 2 {ECO:0000305},Adipose triglyceride lipase {ECO:0000303|PubMed:15550674};Calcium-independent phospholipase A2;Desnutrin;IPLA2-zeta;Pigment epithelium-derived factor;TTS2.2 {ECO:0000303|PubMed:17603008};Transport-secretion protein 2;, PF01734;, GO:0005737;GO:0005829;GO:0005788;GO:0005789;GO:0016021;GO:0005811;GO:0016020;GO:0005654;GO:0005886;GO:0050253;GO:0004806;GO:0036155;GO:0044267;GO:0006651;GO:0034389;GO:0055088;GO:0019915;GO:0010891;GO:0010898;GO:0043687;GO:0019433;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:nucleoplasm; C:plasma membrane;, F:retinyl-palmitate esterase activity; F:triglyceride lipase activity;, P:acylglycerol acyl-chain remodeling; P:cellular protein metabolic process; P:diacylglycerol biosynthetic process; P:lipid droplet organization; P:lipid homeostasis; P:lipid storage; P:negative regulation of sequestering of triglyceride; P:positive regulation of triglyceride catabolic process; P:post-translational protein modification; P:triglyceride catabolic process;|Q96AD5 O60643 Q5EFF5 Q6XYE5 Q96ET6 Q9NQ61 Q9NQ62,Patatin-like phospholipase domain-containing protein 2 {ECO:0000305},Adipose triglyceride lipase {ECO:0000303|PubMed:15550674};Calcium-independent phospholipase A2;Desnutrin;IPLA2-zeta;Pigment epithelium-derived factor;TTS2.2 {ECO:0000303|PubMed:17603008};Transport-secretion protein 2;, PF01734;, GO:0005737;GO:0005829;GO:0005788;GO:0005789;GO:0016021;GO:0005811;GO:0016020;GO:0005654;GO:0005886;GO:0050253;GO:0004806;GO:0036155;GO:0044267;GO:0006651;GO:0034389;GO:0055088;GO:0019915;GO:0010891;GO:0010898;GO:0043687;GO:0019433;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:nucleoplasm; C:plasma membrane;, F:retinyl-palmitate esterase activity; F:triglyceride lipase activity;, P:acylglycerol acyl-chain remodeling; P:cellular protein metabolic process; P:diacylglycerol biosynthetic process; P:lipid droplet organization; P:lipid homeostasis; P:lipid storage; P:negative regulation of sequestering of triglyceride; P:positive regulation of triglyceride catabolic process; P:post-translational protein modification; P:triglyceride catabolic process; scaffold317 indexed_genome mRNA 17332 19699 . + . ID=transcript_16580;Q9HB75 Q59FD1 Q59H10 Q59HC7 Q7Z4P8 Q8NC89 Q8NDL2 Q96C25 Q9NRE6,p53-induced death domain-containing protein 1 {ECO:0000305},Leucine-rich repeat and death domain-containing protein;, PF00531;PF13855;PF10461;PF00791;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0005123;GO:0004175;GO:0006919;GO:0006915;GO:0006974;GO:0006977;GO:0008625;GO:0043066;GO:0043065;GO:0051092;GO:0016540;GO:0042981;GO:0043122;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:death receptor binding; F:endopeptidase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to DNA damage stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoprocessing; P:regulation of apoptotic process; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction;|Q9HB75 Q59FD1 Q59H10 Q59HC7 Q7Z4P8 Q8NC89 Q8NDL2 Q96C25 Q9NRE6,p53-induced death domain-containing protein 1 {ECO:0000305},Leucine-rich repeat and death domain-containing protein;, PF00531;PF13855;PF10461;PF00791;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0005123;GO:0004175;GO:0006919;GO:0006915;GO:0006974;GO:0006977;GO:0008625;GO:0043066;GO:0043065;GO:0051092;GO:0016540;GO:0042981;GO:0043122;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:death receptor binding; F:endopeptidase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to DNA damage stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoprocessing; P:regulation of apoptotic process; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction;|Q9HB75 Q59FD1 Q59H10 Q59HC7 Q7Z4P8 Q8NC89 Q8NDL2 Q96C25 Q9NRE6,p53-induced death domain-containing protein 1 {ECO:0000305},Leucine-rich repeat and death domain-containing protein;, PF00531;PF13855;PF10461;PF00791;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0005123;GO:0004175;GO:0006919;GO:0006915;GO:0006974;GO:0006977;GO:0008625;GO:0043066;GO:0043065;GO:0051092;GO:0016540;GO:0042981;GO:0043122;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:death receptor binding; F:endopeptidase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to DNA damage stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoprocessing; P:regulation of apoptotic process; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction;|Q9HB75 Q59FD1 Q59H10 Q59HC7 Q7Z4P8 Q8NC89 Q8NDL2 Q96C25 Q9NRE6,p53-induced death domain-containing protein 1 {ECO:0000305},Leucine-rich repeat and death domain-containing protein;, PF00531;PF13855;PF10461;PF00791;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0005123;GO:0004175;GO:0006919;GO:0006915;GO:0006974;GO:0006977;GO:0008625;GO:0043066;GO:0043065;GO:0051092;GO:0016540;GO:0042981;GO:0043122;GO:0007165;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:death receptor binding; F:endopeptidase activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:cellular response to DNA damage stimulus; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of apoptotic process; P:positive regulation of apoptotic process; P:positive regulation of NF-kappaB transcription factor activity; P:protein autoprocessing; P:regulation of apoptotic process; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction; scaffold317 indexed_genome mRNA 25553 30427 . + . ID=transcript_16581;E9PR97 Q8TBU8,Mitochondrial glutamate carrier 1,Glutamate/H(+) symporter 1;Solute carrier family 25 member 22;, PF00153;, GO:0016021;GO:0005743;GO:0015183;GO:0005313;GO:0015293;GO:0022857;GO:0015810;GO:0006811;GO:0015813;GO:0043490;, C:integral component of membrane; C:mitochondrial inner membrane;, F:L-aspartate transmembrane transporter activity; F:L-glutamate transmembrane transporter activity; F:symporter activity; F:transmembrane transporter activity;, P:aspartate transmembrane transport; P:ion transport; P:L-glutamate transmembrane transport; P:malate-aspartate shuttle; scaffold317 indexed_genome mRNA 45603 50239 . + . ID=transcript_16582;Q8NB37 B7ZKW5 Q2NL76 Q6ZQY0 Q8NAE0,Glutamine amidotransferase-like class 1 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26616},Parkinson disease 7 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26616};, , GO:0070062;, C:extracellular exosome;|Q8NB37 B7ZKW5 Q2NL76 Q6ZQY0 Q8NAE0,Glutamine amidotransferase-like class 1 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26616},Parkinson disease 7 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26616};, , GO:0070062;, C:extracellular exosome;|Q8NB37 B7ZKW5 Q2NL76 Q6ZQY0 Q8NAE0,Glutamine amidotransferase-like class 1 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26616},Parkinson disease 7 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26616};, , GO:0070062;, C:extracellular exosome;|Q8NB37 B7ZKW5 Q2NL76 Q6ZQY0 Q8NAE0,Glutamine amidotransferase-like class 1 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26616},Parkinson disease 7 domain-containing protein 1 {ECO:0000312|HGNC:HGNC:26616};, , GO:0070062;, C:extracellular exosome; scaffold317 indexed_genome mRNA 51582 58543 . - . ID=transcript_16583;P37837 B2R8M2 O00751 Q8WV32 Q8WZ45,Transaldolase,, PF00923;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0048029;GO:0004801;GO:0005975;GO:0006002;GO:0019682;GO:0035722;GO:0006098;GO:0009052;GO:0005999;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:monosaccharide binding; F:sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity;, P:carbohydrate metabolic process; P:fructose 6-phosphate metabolic process; P:glyceraldehyde-3-phosphate metabolic process; P:interleukin-12-mediated signaling pathway; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:xylulose biosynthetic process;|P37837 B2R8M2 O00751 Q8WV32 Q8WZ45,Transaldolase,, PF00923;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0048029;GO:0004801;GO:0005975;GO:0006002;GO:0019682;GO:0035722;GO:0006098;GO:0009052;GO:0005999;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:monosaccharide binding; F:sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity;, P:carbohydrate metabolic process; P:fructose 6-phosphate metabolic process; P:glyceraldehyde-3-phosphate metabolic process; P:interleukin-12-mediated signaling pathway; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:xylulose biosynthetic process;|P37837 B2R8M2 O00751 Q8WV32 Q8WZ45,Transaldolase,, PF00923;, GO:0005737;GO:0005829;GO:0070062;GO:0005634;GO:0048029;GO:0004801;GO:0005975;GO:0006002;GO:0019682;GO:0035722;GO:0006098;GO:0009052;GO:0005999;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleus;, F:monosaccharide binding; F:sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity;, P:carbohydrate metabolic process; P:fructose 6-phosphate metabolic process; P:glyceraldehyde-3-phosphate metabolic process; P:interleukin-12-mediated signaling pathway; P:pentose-phosphate shunt; P:pentose-phosphate shunt, non-oxidative branch; P:xylulose biosynthetic process; scaffold317 indexed_genome mRNA 87035 93080 . - . ID=transcript_16584;Q9H6S3 B3KSX1 B7ZKL3 Q53GM8 Q8WYW7 Q96K06 Q9H6K9,Epidermal growth factor receptor kinase substrate 8-like protein 2,Epidermal growth factor receptor pathway substrate 8-related protein 2;, PF08416;PF18016;PF00018;, GO:0005829;GO:0070062;GO:0005886;GO:0032991;GO:0032587;GO:0032421;GO:0032426;GO:0031982;GO:0003779;GO:0045296;GO:1900029;GO:0050790;GO:0035023;GO:0007266;GO:0007605;, C:cytosol; C:extracellular exosome; C:plasma membrane; C:protein-containing complex; C:ruffle membrane; C:stereocilium bundle; C:stereocilium tip; C:vesicle;, F:actin binding; F:cadherin binding;, P:positive regulation of ruffle assembly; P:regulation of catalytic activity; P:regulation of Rho protein signal transduction; P:Rho protein signal transduction; P:sensory perception of sound; scaffold317 indexed_genome mRNA 99555 102326 . - . ID=transcript_16585;Q96HE8 A0A0A0MS80 A8MQ01 A8MXY8 B7WNU5,Transmembrane protein 80,, PF09799;, GO:0035869;GO:0016021;GO:1905515;, C:ciliary transition zone; C:integral component of membrane;, , P:non-motile cilium assembly;|Q96HE8 A0A0A0MS80 A8MQ01 A8MXY8 B7WNU5,Transmembrane protein 80,, PF09799;, GO:0035869;GO:0016021;GO:1905515;, C:ciliary transition zone; C:integral component of membrane;, , P:non-motile cilium assembly; scaffold317 indexed_genome mRNA 128851 131747 . + . ID=transcript_16586;Q9HBB8 C9J7X1 Q9H746 Q9HAU3 Q9HBB5 Q9HBB6 Q9HBB7 Q9NX86 Q9NXI9,Cadherin-related family member 5 {ECO:0000305},Mu-protocadherin {ECO:0000312|EMBL:AAG33495.1};Mucin and cadherin-like protein {ECO:0000303|PubMed:11031102};Mucin-like protocadherin {ECO:0000303|PubMed:24725409};, , GO:0016324;GO:0031526;GO:0005905;GO:0070062;GO:0005887;GO:0031528;GO:0044214;GO:0008013;GO:0005509;GO:0050839;GO:0007155;GO:0030154;GO:0007156;GO:0090675;GO:0032532;, C:apical plasma membrane; C:brush border membrane; C:clathrin-coated pit; C:extracellular exosome; C:integral component of plasma membrane; C:microvillus membrane; C:spanning component of plasma membrane;, F:beta-catenin binding; F:calcium ion binding; F:cell adhesion molecule binding;, P:cell adhesion; P:cell differentiation; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:intermicrovillar adhesion; P:regulation of microvillus length;|Q9HBB8 C9J7X1 Q9H746 Q9HAU3 Q9HBB5 Q9HBB6 Q9HBB7 Q9NX86 Q9NXI9,Cadherin-related family member 5 {ECO:0000305},Mu-protocadherin {ECO:0000312|EMBL:AAG33495.1};Mucin and cadherin-like protein {ECO:0000303|PubMed:11031102};Mucin-like protocadherin {ECO:0000303|PubMed:24725409};, , GO:0016324;GO:0031526;GO:0005905;GO:0070062;GO:0005887;GO:0031528;GO:0044214;GO:0008013;GO:0005509;GO:0050839;GO:0007155;GO:0030154;GO:0007156;GO:0090675;GO:0032532;, C:apical plasma membrane; C:brush border membrane; C:clathrin-coated pit; C:extracellular exosome; C:integral component of plasma membrane; C:microvillus membrane; C:spanning component of plasma membrane;, F:beta-catenin binding; F:calcium ion binding; F:cell adhesion molecule binding;, P:cell adhesion; P:cell differentiation; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:intermicrovillar adhesion; P:regulation of microvillus length; scaffold317 indexed_genome mRNA 132432 133583 . + . ID=transcript_16587;Q9HBB8 C9J7X1 Q9H746 Q9HAU3 Q9HBB5 Q9HBB6 Q9HBB7 Q9NX86 Q9NXI9,Cadherin-related family member 5 {ECO:0000305},Mu-protocadherin {ECO:0000312|EMBL:AAG33495.1};Mucin and cadherin-like protein {ECO:0000303|PubMed:11031102};Mucin-like protocadherin {ECO:0000303|PubMed:24725409};, , GO:0016324;GO:0031526;GO:0005905;GO:0070062;GO:0005887;GO:0031528;GO:0044214;GO:0008013;GO:0005509;GO:0050839;GO:0007155;GO:0030154;GO:0007156;GO:0090675;GO:0032532;, C:apical plasma membrane; C:brush border membrane; C:clathrin-coated pit; C:extracellular exosome; C:integral component of plasma membrane; C:microvillus membrane; C:spanning component of plasma membrane;, F:beta-catenin binding; F:calcium ion binding; F:cell adhesion molecule binding;, P:cell adhesion; P:cell differentiation; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:intermicrovillar adhesion; P:regulation of microvillus length; scaffold317 indexed_genome mRNA 133713 137528 . + . ID=transcript_16588;Q92985 B9EGL3 O00331 O00332 O00333 O75924 Q9UE79,Interferon regulatory factor 7,, PF00605;PF10401;, GO:0000785;GO:0005737;GO:0005829;GO:0010008;GO:0005654;GO:0005634;GO:0003677;GO:0000981;GO:0000978;GO:1990837;GO:0006974;GO:0051607;GO:0019043;GO:0002376;GO:0016064;GO:0045087;GO:0060333;GO:0039530;GO:2000110;GO:0000122;GO:0032727;GO:0032728;GO:0045944;GO:0045893;GO:0032481;GO:0060340;GO:0002819;GO:0050776;GO:0045655;GO:0034124;GO:0034127;GO:0006357;GO:0032479;GO:0009615;GO:0035666;GO:0060337;, C:chromatin; C:cytoplasm; C:cytosol; C:endosome membrane; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:cellular response to DNA damage stimulus; P:defense response to virus; P:establishment of viral latency; P:immune system process; P:immunoglobulin mediated immune response; P:innate immune response; P:interferon-gamma-mediated signaling pathway; P:MDA-5 signaling pathway; P:negative regulation of macrophage apoptotic process; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of interferon-alpha production; P:positive regulation of interferon-beta production; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of type I interferon production; P:positive regulation of type I interferon-mediated signaling pathway; P:regulation of adaptive immune response; P:regulation of immune response; P:regulation of monocyte differentiation; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:regulation of MyD88-independent toll-like receptor signaling pathway; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production; P:response to virus; P:TRIF-dependent toll-like receptor signaling pathway; P:type I interferon signaling pathway; scaffold317 indexed_genome mRNA 138232 152806 . - . ID=transcript_16589;Q9P1Y6 A6H8W1 B7ZM64 B9EGP0 C9JS82 Q6PJP2 Q8IVY2 Q8N2Y7 Q9BSM2,PHD and RING finger domain-containing protein 1,, PF00628;PF13639;, GO:0016020;GO:0046872;GO:0019904;GO:0070063;GO:0006397;GO:0006366;, C:membrane;, F:metal ion binding; F:protein domain specific binding; F:RNA polymerase binding;, P:mRNA processing; P:transcription by RNA polymerase II;|Q9P1Y6 A6H8W1 B7ZM64 B9EGP0 C9JS82 Q6PJP2 Q8IVY2 Q8N2Y7 Q9BSM2,PHD and RING finger domain-containing protein 1,, PF00628;PF13639;, GO:0016020;GO:0046872;GO:0019904;GO:0070063;GO:0006397;GO:0006366;, C:membrane;, F:metal ion binding; F:protein domain specific binding; F:RNA polymerase binding;, P:mRNA processing; P:transcription by RNA polymerase II;|Q9P1Y6 A6H8W1 B7ZM64 B9EGP0 C9JS82 Q6PJP2 Q8IVY2 Q8N2Y7 Q9BSM2,PHD and RING finger domain-containing protein 1,, PF00628;PF13639;, GO:0016020;GO:0046872;GO:0019904;GO:0070063;GO:0006397;GO:0006366;, C:membrane;, F:metal ion binding; F:protein domain specific binding; F:RNA polymerase binding;, P:mRNA processing; P:transcription by RNA polymerase II;|Q9P1Y6 A6H8W1 B7ZM64 B9EGP0 C9JS82 Q6PJP2 Q8IVY2 Q8N2Y7 Q9BSM2,PHD and RING finger domain-containing protein 1,, PF00628;PF13639;, GO:0016020;GO:0046872;GO:0019904;GO:0070063;GO:0006397;GO:0006366;, C:membrane;, F:metal ion binding; F:protein domain specific binding; F:RNA polymerase binding;, P:mRNA processing; P:transcription by RNA polymerase II;|Q9P1Y6 A6H8W1 B7ZM64 B9EGP0 C9JS82 Q6PJP2 Q8IVY2 Q8N2Y7 Q9BSM2,PHD and RING finger domain-containing protein 1,, PF00628;PF13639;, GO:0016020;GO:0046872;GO:0019904;GO:0070063;GO:0006397;GO:0006366;, C:membrane;, F:metal ion binding; F:protein domain specific binding; F:RNA polymerase binding;, P:mRNA processing; P:transcription by RNA polymerase II;|Q9P1Y6 A6H8W1 B7ZM64 B9EGP0 C9JS82 Q6PJP2 Q8IVY2 Q8N2Y7 Q9BSM2,PHD and RING finger domain-containing protein 1,, PF00628;PF13639;, GO:0016020;GO:0046872;GO:0019904;GO:0070063;GO:0006397;GO:0006366;, C:membrane;, F:metal ion binding; F:protein domain specific binding; F:RNA polymerase binding;, P:mRNA processing; P:transcription by RNA polymerase II; scaffold317 indexed_genome mRNA 153049 157248 . - . ID=transcript_16590;Q9P1Y6 A6H8W1 B7ZM64 B9EGP0 C9JS82 Q6PJP2 Q8IVY2 Q8N2Y7 Q9BSM2,PHD and RING finger domain-containing protein 1,, PF00628;PF13639;, GO:0016020;GO:0046872;GO:0019904;GO:0070063;GO:0006397;GO:0006366;, C:membrane;, F:metal ion binding; F:protein domain specific binding; F:RNA polymerase binding;, P:mRNA processing; P:transcription by RNA polymerase II; scaffold317 indexed_genome mRNA 168897 170781 . - . ID=transcript_16591;Q02833 G5E9N9 Q3KP41 Q3KP42,Ras association domain-containing protein 7,HRAS1-related cluster protein 1;, PF00788;, GO:0034451;GO:0005737;GO:0006915;GO:0070507;GO:0007165;, C:centriolar satellite; C:cytoplasm;, , P:apoptotic process; P:regulation of microtubule cytoskeleton organization; P:signal transduction; scaffold317 indexed_genome mRNA 176938 178176 . + . ID=transcript_16592;Q8IXW0,Lamin tail domain-containing protein 2 scaffold320 indexed_genome mRNA 40612 43382 . - . ID=transcript_16593;Q8NCA9,Zinc finger protein 784,, PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:1990837;GO:0002244;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:hematopoietic progenitor cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold320 indexed_genome mRNA 56781 59187 . + . ID=transcript_16594;Q96C55 Q6NW31 Q96IL7,Zinc finger protein 524,, PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold320 indexed_genome mRNA 92804 96582 . + . ID=transcript_16595;P0C264,Uncharacterized serine/threonine-protein kinase SBK3,SH3-binding domain kinase family member 3;Sugen kinase 110;, PF00069;, GO:0005524;GO:0106310;GO:0004674;GO:0106311;, , F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; scaffold320 indexed_genome mRNA 102920 103487 . + . ID=transcript_16596;P0C263,Serine/threonine-protein kinase SBK2,SH3-binding domain kinase family member 2;Sugen kinase 69;, PF00069;, GO:0005524;GO:0004708;GO:0106310;GO:0106311;GO:0000187;, , F:ATP binding; F:MAP kinase kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;, P:activation of MAPK activity; scaffold320 indexed_genome mRNA 112668 129188 . - . ID=transcript_16597;A1L4H1 B5MDQ5 C7S7T9 C7S7U0 K7EP70,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Soluble scavenger protein with 5 SRCR domains;, PF00530;, GO:0062023;GO:0005737;GO:0031012;GO:0005615;GO:0016020;GO:0050840;GO:0001968;GO:0043236;GO:0005044;GO:0006952;GO:0050829;GO:0050830;GO:0042494;GO:0045087;GO:0007275;GO:0032717;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular space; C:membrane;, F:extracellular matrix binding; F:fibronectin binding; F:laminin binding; F:scavenger receptor activity;, P:defense response; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:detection of bacterial lipoprotein; P:innate immune response; P:multicellular organism development; P:negative regulation of interleukin-8 production;|A1L4H1 B5MDQ5 C7S7T9 C7S7U0 K7EP70,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Soluble scavenger protein with 5 SRCR domains;, PF00530;, GO:0062023;GO:0005737;GO:0031012;GO:0005615;GO:0016020;GO:0050840;GO:0001968;GO:0043236;GO:0005044;GO:0006952;GO:0050829;GO:0050830;GO:0042494;GO:0045087;GO:0007275;GO:0032717;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular space; C:membrane;, F:extracellular matrix binding; F:fibronectin binding; F:laminin binding; F:scavenger receptor activity;, P:defense response; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; P:detection of bacterial lipoprotein; P:innate immune response; P:multicellular organism development; P:negative regulation of interleukin-8 production; scaffold320 indexed_genome mRNA 148702 149625 . - . ID=transcript_16598;Q3ZCU0 Q8N9C3,Protein GVQW3 {ECO:0000305},GVQW motif-containing protein 3 {ECO:0000305};, PF17906; scaffold320 indexed_genome mRNA 169573 175659 . + . ID=transcript_16599;Q96AB3 Q6ZN91 Q9H5G0,Isochorismatase domain-containing protein 2,, PF00857;, GO:0005737;GO:0005634;GO:0031648;, C:cytoplasm; C:nucleus;, , P:protein destabilization;|Q96AB3 Q6ZN91 Q9H5G0,Isochorismatase domain-containing protein 2,, PF00857;, GO:0005737;GO:0005634;GO:0031648;, C:cytoplasm; C:nucleus;, , P:protein destabilization; scaffold323 indexed_genome mRNA 5407 13226 . + . ID=transcript_16600;Q9P2S5 Q5T0D6 Q9BUH7 Q9NTK7 Q9NX56,WD repeat-containing protein WRAP73,WD repeat-containing protein 8;WD repeat-containing protein antisense to TP73 gene;, PF00400;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0005815;GO:0072686;GO:1990811;GO:0030030;GO:0000070;GO:0090307;GO:1902857;GO:1902440;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:microtubule organizing center; C:mitotic spindle; C:MWP complex;, , P:cell projection organization; P:mitotic sister chromatid segregation; P:mitotic spindle assembly; P:positive regulation of non-motile cilium assembly; P:protein localization to mitotic spindle pole body;|Q9P2S5 Q5T0D6 Q9BUH7 Q9NTK7 Q9NX56,WD repeat-containing protein WRAP73,WD repeat-containing protein 8;WD repeat-containing protein antisense to TP73 gene;, PF00400;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0005815;GO:0072686;GO:1990811;GO:0030030;GO:0000070;GO:0090307;GO:1902857;GO:1902440;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:microtubule organizing center; C:mitotic spindle; C:MWP complex;, , P:cell projection organization; P:mitotic sister chromatid segregation; P:mitotic spindle assembly; P:positive regulation of non-motile cilium assembly; P:protein localization to mitotic spindle pole body;|Q9P2S5 Q5T0D6 Q9BUH7 Q9NTK7 Q9NX56,WD repeat-containing protein WRAP73,WD repeat-containing protein 8;WD repeat-containing protein antisense to TP73 gene;, PF00400;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0005815;GO:0072686;GO:1990811;GO:0030030;GO:0000070;GO:0090307;GO:1902857;GO:1902440;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:microtubule organizing center; C:mitotic spindle; C:MWP complex;, , P:cell projection organization; P:mitotic sister chromatid segregation; P:mitotic spindle assembly; P:positive regulation of non-motile cilium assembly; P:protein localization to mitotic spindle pole body;|Q9P2S5 Q5T0D6 Q9BUH7 Q9NTK7 Q9NX56,WD repeat-containing protein WRAP73,WD repeat-containing protein 8;WD repeat-containing protein antisense to TP73 gene;, PF00400;, GO:0005814;GO:0005813;GO:0036064;GO:0005737;GO:0005815;GO:0072686;GO:1990811;GO:0030030;GO:0000070;GO:0090307;GO:1902857;GO:1902440;, C:centriole; C:centrosome; C:ciliary basal body; C:cytoplasm; C:microtubule organizing center; C:mitotic spindle; C:MWP complex;, , P:cell projection organization; P:mitotic sister chromatid segregation; P:mitotic spindle assembly; P:positive regulation of non-motile cilium assembly; P:protein localization to mitotic spindle pole body; scaffold323 indexed_genome mRNA 14298 17504 . - . ID=transcript_16601;Q5T0D9 A8K1K4 Q8WV04,Tumor protein p63-regulated gene 1-like protein {ECO:0000305},Mossy fiber terminal-associated vertebrate-specific presynaptic protein;Protein FAM79A;, PF12456;, GO:0044305;GO:0005737;GO:0070062;GO:0048786;GO:0008021;GO:0030672;GO:0042802;GO:0051966;, C:calyx of Held; C:cytoplasm; C:extracellular exosome; C:presynaptic active zone; C:synaptic vesicle; C:synaptic vesicle membrane;, F:identical protein binding;, P:regulation of synaptic transmission, glutamatergic;|Q5T0D9 A8K1K4 Q8WV04,Tumor protein p63-regulated gene 1-like protein {ECO:0000305},Mossy fiber terminal-associated vertebrate-specific presynaptic protein;Protein FAM79A;, PF12456;, GO:0044305;GO:0005737;GO:0070062;GO:0048786;GO:0008021;GO:0030672;GO:0042802;GO:0051966;, C:calyx of Held; C:cytoplasm; C:extracellular exosome; C:presynaptic active zone; C:synaptic vesicle; C:synaptic vesicle membrane;, F:identical protein binding;, P:regulation of synaptic transmission, glutamatergic; scaffold323 indexed_genome mRNA 101051 125586 . + . ID=transcript_16602;O75095 Q4AC86 Q5VV39,Multiple epidermal growth factor-like domains protein 6,Epidermal growth factor-like protein 3;, PF07645;PF12661;PF00053;, GO:0005576;GO:0005509;, C:extracellular region;, F:calcium ion binding;|O75095 Q4AC86 Q5VV39,Multiple epidermal growth factor-like domains protein 6,Epidermal growth factor-like protein 3;, PF07645;PF12661;PF00053;, GO:0005576;GO:0005509;, C:extracellular region;, F:calcium ion binding; scaffold323 indexed_genome mRNA 132844 138809 . - . ID=transcript_16603;O75095 Q4AC86 Q5VV39,Multiple epidermal growth factor-like domains protein 6,Epidermal growth factor-like protein 3;, PF07645;PF12661;PF00053;, GO:0005576;GO:0005509;, C:extracellular region;, F:calcium ion binding; scaffold323 indexed_genome mRNA 144854 148531 . - . ID=transcript_16604;Q5VV41 Q86TF0 Q99434,Rho guanine nucleotide exchange factor 16,Ephexin-4;, PF00169;PF00621;PF14604;, GO:0005829;GO:0045296;GO:0005085;GO:0030165;GO:0030971;GO:0031267;GO:0090630;GO:0060326;GO:0007186;GO:0043065;GO:1903078;GO:0051056;, C:cytosol;, F:cadherin binding; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:receptor tyrosine kinase binding; F:small GTPase binding;, P:activation of GTPase activity; P:cell chemotaxis; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of protein localization to plasma membrane; P:regulation of small GTPase mediated signal transduction; scaffold323 indexed_genome mRNA 152281 169120 . - . ID=transcript_16605;Q5VV41 Q86TF0 Q99434,Rho guanine nucleotide exchange factor 16,Ephexin-4;, PF00169;PF00621;PF14604;, GO:0005829;GO:0045296;GO:0005085;GO:0030165;GO:0030971;GO:0031267;GO:0090630;GO:0060326;GO:0007186;GO:0043065;GO:1903078;GO:0051056;, C:cytosol;, F:cadherin binding; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:receptor tyrosine kinase binding; F:small GTPase binding;, P:activation of GTPase activity; P:cell chemotaxis; P:G protein-coupled receptor signaling pathway; P:positive regulation of apoptotic process; P:positive regulation of protein localization to plasma membrane; P:regulation of small GTPase mediated signal transduction; scaffold326 indexed_genome mRNA 115974 122485 . - . ID=transcript_16606;Q8TF44 Q8N3H7,C2 calcium-dependent domain-containing protein 4C,Nuclear-localized factor 3;Protein FAM148C;, PF00168;, GO:0005829;, C:cytosol; scaffold326 indexed_genome mRNA 122926 125074 . + . ID=transcript_16607;Q8WX39 C9J5F0 Q6JVE7,Epididymal-specific lipocalin-9,MUP-like lipocalin;, PF00061;, GO:0005615;GO:0036094;, C:extracellular space;, F:small molecule binding; scaffold326 indexed_genome mRNA 150651 154164 . + . ID=transcript_16608;Q8WX39 C9J5F0 Q6JVE7,Epididymal-specific lipocalin-9,MUP-like lipocalin;, PF00061;, GO:0005615;GO:0036094;, C:extracellular space;, F:small molecule binding; scaffold327 indexed_genome mRNA 26238 29979 . + . ID=transcript_16609;P0CW00 H7BXJ3,Testis-specific Y-encoded protein 8,, PF00956;, GO:0000785;GO:0005634;GO:0003682;GO:0042393;GO:0030154;GO:0007506;GO:0006334;GO:0007283;, C:chromatin; C:nucleus;, F:chromatin binding; F:histone binding;, P:cell differentiation; P:gonadal mesoderm development; P:nucleosome assembly; P:spermatogenesis; scaffold328 indexed_genome mRNA 47596 98442 . + . ID=transcript_16610;P00352 O00768 Q5SYR1,Retinal dehydrogenase 1 {ECO:0000305},ALDH-E1;ALHDII;Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0005497;GO:0018479;GO:0005096;GO:0051287;GO:0001758;GO:0006081;GO:0006069;GO:0061624;GO:0120163;GO:0001523;GO:0042572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:androgen binding; F:benzaldehyde dehydrogenase (NAD+) activity; F:GTPase activator activity; F:NAD binding; F:retinal dehydrogenase activity;, P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:negative regulation of cold-induced thermogenesis; P:retinoid metabolic process; P:retinol metabolic process;|O00299 Q15089 Q502X1,Chloride intracellular channel protein 1,Chloride channel ABP;Nuclear chloride ion channel 27;Regulatory nuclear chloride ion channel protein;, PF13409;, GO:0072562;GO:0005903;GO:0034707;GO:0005737;GO:0070062;GO:0005615;GO:0016020;GO:0005739;GO:0005635;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:0031982;GO:0045296;GO:0005254;GO:0005244;GO:0006821;GO:0006749;GO:0070527;GO:0045669;GO:0051726;GO:0034765;GO:0051881;GO:0007165;, C:blood microparticle; C:brush border; C:chloride channel complex; C:cytoplasm; C:extracellular exosome; C:extracellular space; C:membrane; C:mitochondrion; C:nuclear envelope; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:vesicle;, F:cadherin binding; F:chloride channel activity; F:voltage-gated ion channel activity;, P:chloride transport; P:glutathione metabolic process; P:platelet aggregation; P:positive regulation of osteoblast differentiation; P:regulation of cell cycle; P:regulation of ion transmembrane transport; P:regulation of mitochondrial membrane potential; P:signal transduction;|P00352 O00768 Q5SYR1,Retinal dehydrogenase 1 {ECO:0000305},ALDH-E1;ALHDII;Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0005497;GO:0018479;GO:0005096;GO:0051287;GO:0001758;GO:0006081;GO:0006069;GO:0061624;GO:0120163;GO:0001523;GO:0042572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:androgen binding; F:benzaldehyde dehydrogenase (NAD+) activity; F:GTPase activator activity; F:NAD binding; F:retinal dehydrogenase activity;, P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:negative regulation of cold-induced thermogenesis; P:retinoid metabolic process; P:retinol metabolic process;|P00352 O00768 Q5SYR1,Retinal dehydrogenase 1 {ECO:0000305},ALDH-E1;ALHDII;Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0005497;GO:0018479;GO:0005096;GO:0051287;GO:0001758;GO:0006081;GO:0006069;GO:0061624;GO:0120163;GO:0001523;GO:0042572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:androgen binding; F:benzaldehyde dehydrogenase (NAD+) activity; F:GTPase activator activity; F:NAD binding; F:retinal dehydrogenase activity;, P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:negative regulation of cold-induced thermogenesis; P:retinoid metabolic process; P:retinol metabolic process;|P00352 O00768 Q5SYR1,Retinal dehydrogenase 1 {ECO:0000305},ALDH-E1;ALHDII;Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0005497;GO:0018479;GO:0005096;GO:0051287;GO:0001758;GO:0006081;GO:0006069;GO:0061624;GO:0120163;GO:0001523;GO:0042572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:androgen binding; F:benzaldehyde dehydrogenase (NAD+) activity; F:GTPase activator activity; F:NAD binding; F:retinal dehydrogenase activity;, P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:negative regulation of cold-induced thermogenesis; P:retinoid metabolic process; P:retinol metabolic process;|P00352 O00768 Q5SYR1,Retinal dehydrogenase 1 {ECO:0000305},ALDH-E1;ALHDII;Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0005497;GO:0018479;GO:0005096;GO:0051287;GO:0001758;GO:0006081;GO:0006069;GO:0061624;GO:0120163;GO:0001523;GO:0042572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:androgen binding; F:benzaldehyde dehydrogenase (NAD+) activity; F:GTPase activator activity; F:NAD binding; F:retinal dehydrogenase activity;, P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:negative regulation of cold-induced thermogenesis; P:retinoid metabolic process; P:retinol metabolic process; scaffold329 indexed_genome mRNA 47573 98423 . - . ID=transcript_16611;P00352 O00768 Q5SYR1,Retinal dehydrogenase 1 {ECO:0000305},ALDH-E1;ALHDII;Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0005497;GO:0018479;GO:0005096;GO:0051287;GO:0001758;GO:0006081;GO:0006069;GO:0061624;GO:0120163;GO:0001523;GO:0042572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:androgen binding; F:benzaldehyde dehydrogenase (NAD+) activity; F:GTPase activator activity; F:NAD binding; F:retinal dehydrogenase activity;, P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:negative regulation of cold-induced thermogenesis; P:retinoid metabolic process; P:retinol metabolic process;|P00352 O00768 Q5SYR1,Retinal dehydrogenase 1 {ECO:0000305},ALDH-E1;ALHDII;Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0005497;GO:0018479;GO:0005096;GO:0051287;GO:0001758;GO:0006081;GO:0006069;GO:0061624;GO:0120163;GO:0001523;GO:0042572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:androgen binding; F:benzaldehyde dehydrogenase (NAD+) activity; F:GTPase activator activity; F:NAD binding; F:retinal dehydrogenase activity;, P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:negative regulation of cold-induced thermogenesis; P:retinoid metabolic process; P:retinol metabolic process;|P00352 O00768 Q5SYR1,Retinal dehydrogenase 1 {ECO:0000305},ALDH-E1;ALHDII;Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0005497;GO:0018479;GO:0005096;GO:0051287;GO:0001758;GO:0006081;GO:0006069;GO:0061624;GO:0120163;GO:0001523;GO:0042572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:androgen binding; F:benzaldehyde dehydrogenase (NAD+) activity; F:GTPase activator activity; F:NAD binding; F:retinal dehydrogenase activity;, P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:negative regulation of cold-induced thermogenesis; P:retinoid metabolic process; P:retinol metabolic process;|P00352 O00768 Q5SYR1,Retinal dehydrogenase 1 {ECO:0000305},ALDH-E1;ALHDII;Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0005497;GO:0018479;GO:0005096;GO:0051287;GO:0001758;GO:0006081;GO:0006069;GO:0061624;GO:0120163;GO:0001523;GO:0042572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:androgen binding; F:benzaldehyde dehydrogenase (NAD+) activity; F:GTPase activator activity; F:NAD binding; F:retinal dehydrogenase activity;, P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:negative regulation of cold-induced thermogenesis; P:retinoid metabolic process; P:retinol metabolic process;|P00352 O00768 Q5SYR1,Retinal dehydrogenase 1 {ECO:0000305},ALDH-E1;ALHDII;Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};, PF00171;, GO:0005737;GO:0005829;GO:0070062;GO:0004029;GO:0005497;GO:0018479;GO:0005096;GO:0051287;GO:0001758;GO:0006081;GO:0006069;GO:0061624;GO:0120163;GO:0001523;GO:0042572;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:aldehyde dehydrogenase (NAD+) activity; F:androgen binding; F:benzaldehyde dehydrogenase (NAD+) activity; F:GTPase activator activity; F:NAD binding; F:retinal dehydrogenase activity;, P:cellular aldehyde metabolic process; P:ethanol oxidation; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; P:negative regulation of cold-induced thermogenesis; P:retinoid metabolic process; P:retinol metabolic process; scaffold330 indexed_genome mRNA 81065 137413 . + . ID=transcript_16612;Q8IYW2 B1AP44 B7WPK8 Q5JSF7 Q5SR76 Q5SR77 Q86ST2 Q8N777 Q9NTQ5,Cilia- and flagella-associated protein 46 {ECO:0000305},Tetratricopeptide repeat protein 40 {ECO:0000312|HGNC:HGNC:25247};, , GO:0005930;GO:0035082;GO:0060294;, C:axoneme;, , P:axoneme assembly; P:cilium movement involved in cell motility;|Q8IYW2 B1AP44 B7WPK8 Q5JSF7 Q5SR76 Q5SR77 Q86ST2 Q8N777 Q9NTQ5,Cilia- and flagella-associated protein 46 {ECO:0000305},Tetratricopeptide repeat protein 40 {ECO:0000312|HGNC:HGNC:25247};, , GO:0005930;GO:0035082;GO:0060294;, C:axoneme;, , P:axoneme assembly; P:cilium movement involved in cell motility;|Q8IYW2 B1AP44 B7WPK8 Q5JSF7 Q5SR76 Q5SR77 Q86ST2 Q8N777 Q9NTQ5,Cilia- and flagella-associated protein 46 {ECO:0000305},Tetratricopeptide repeat protein 40 {ECO:0000312|HGNC:HGNC:25247};, , GO:0005930;GO:0035082;GO:0060294;, C:axoneme;, , P:axoneme assembly; P:cilium movement involved in cell motility; scaffold330 indexed_genome mRNA 142626 155984 . + . ID=transcript_16613;Q8IYW2 B1AP44 B7WPK8 Q5JSF7 Q5SR76 Q5SR77 Q86ST2 Q8N777 Q9NTQ5,Cilia- and flagella-associated protein 46 {ECO:0000305},Tetratricopeptide repeat protein 40 {ECO:0000312|HGNC:HGNC:25247};, , GO:0005930;GO:0035082;GO:0060294;, C:axoneme;, , P:axoneme assembly; P:cilium movement involved in cell motility;|Q8IYW2 B1AP44 B7WPK8 Q5JSF7 Q5SR76 Q5SR77 Q86ST2 Q8N777 Q9NTQ5,Cilia- and flagella-associated protein 46 {ECO:0000305},Tetratricopeptide repeat protein 40 {ECO:0000312|HGNC:HGNC:25247};, , GO:0005930;GO:0035082;GO:0060294;, C:axoneme;, , P:axoneme assembly; P:cilium movement involved in cell motility;|Q8IYW2 B1AP44 B7WPK8 Q5JSF7 Q5SR76 Q5SR77 Q86ST2 Q8N777 Q9NTQ5,Cilia- and flagella-associated protein 46 {ECO:0000305},Tetratricopeptide repeat protein 40 {ECO:0000312|HGNC:HGNC:25247};, , GO:0005930;GO:0035082;GO:0060294;, C:axoneme;, , P:axoneme assembly; P:cilium movement involved in cell motility;|Q8IYW2 B1AP44 B7WPK8 Q5JSF7 Q5SR76 Q5SR77 Q86ST2 Q8N777 Q9NTQ5,Cilia- and flagella-associated protein 46 {ECO:0000305},Tetratricopeptide repeat protein 40 {ECO:0000312|HGNC:HGNC:25247};, , GO:0005930;GO:0035082;GO:0060294;, C:axoneme;, , P:axoneme assembly; P:cilium movement involved in cell motility; scaffold331 indexed_genome mRNA 66382 67834 . + . ID=transcript_16614;Q6NTF9 Q7L534 Q9H5W6 Q9HBK7 Q9UDT2,Rhomboid domain-containing protein 2,, PF01694;, GO:0005794;GO:0000139;GO:0000839;GO:0030176;GO:0005654;GO:0048471;GO:0051787;GO:0004252;GO:1990381;GO:0030968;GO:0030433;, C:Golgi apparatus; C:Golgi membrane; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:misfolded protein binding; F:serine-type endopeptidase activity; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:ubiquitin-dependent ERAD pathway; scaffold331 indexed_genome mRNA 67842 74641 . + . ID=transcript_16615;Q6NTF9 Q7L534 Q9H5W6 Q9HBK7 Q9UDT2,Rhomboid domain-containing protein 2,, PF01694;, GO:0005794;GO:0000139;GO:0000839;GO:0030176;GO:0005654;GO:0048471;GO:0051787;GO:0004252;GO:1990381;GO:0030968;GO:0030433;, C:Golgi apparatus; C:Golgi membrane; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:misfolded protein binding; F:serine-type endopeptidase activity; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:ubiquitin-dependent ERAD pathway;|Q6NTF9 Q7L534 Q9H5W6 Q9HBK7 Q9UDT2,Rhomboid domain-containing protein 2,, PF01694;, GO:0005794;GO:0000139;GO:0000839;GO:0030176;GO:0005654;GO:0048471;GO:0051787;GO:0004252;GO:1990381;GO:0030968;GO:0030433;, C:Golgi apparatus; C:Golgi membrane; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:misfolded protein binding; F:serine-type endopeptidase activity; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:ubiquitin-dependent ERAD pathway;|Q6NTF9 Q7L534 Q9H5W6 Q9HBK7 Q9UDT2,Rhomboid domain-containing protein 2,, PF01694;, GO:0005794;GO:0000139;GO:0000839;GO:0030176;GO:0005654;GO:0048471;GO:0051787;GO:0004252;GO:1990381;GO:0030968;GO:0030433;, C:Golgi apparatus; C:Golgi membrane; C:Hrd1p ubiquitin ligase ERAD-L complex; C:integral component of endoplasmic reticulum membrane; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:misfolded protein binding; F:serine-type endopeptidase activity; F:ubiquitin-specific protease binding;, P:endoplasmic reticulum unfolded protein response; P:ubiquitin-dependent ERAD pathway; scaffold331 indexed_genome mRNA 131669 155967 . + . ID=transcript_16616;P16435 Q16455 Q197M5 Q8N181 Q9H3M8 Q9UDT3,NADPH--cytochrome P450 reductase {ECO:0000255|HAMAP-Rule:MF_03212},, PF00667;PF00258;PF00175;, GO:0005829;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0050660;GO:0010181;GO:0050661;GO:0003958;GO:0016491;GO:0016709;GO:0090346;GO:0022900;GO:0032770;GO:0009725;GO:0006805;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:flavin adenine dinucleotide binding; F:FMN binding; F:NADP binding; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:cellular organofluorine metabolic process; P:electron transport chain; P:positive regulation of monooxygenase activity; P:response to hormone; P:xenobiotic metabolic process;|P16435 Q16455 Q197M5 Q8N181 Q9H3M8 Q9UDT3,NADPH--cytochrome P450 reductase {ECO:0000255|HAMAP-Rule:MF_03212},, PF00667;PF00258;PF00175;, GO:0005829;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0050660;GO:0010181;GO:0050661;GO:0003958;GO:0016491;GO:0016709;GO:0090346;GO:0022900;GO:0032770;GO:0009725;GO:0006805;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:flavin adenine dinucleotide binding; F:FMN binding; F:NADP binding; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:cellular organofluorine metabolic process; P:electron transport chain; P:positive regulation of monooxygenase activity; P:response to hormone; P:xenobiotic metabolic process;|P16435 Q16455 Q197M5 Q8N181 Q9H3M8 Q9UDT3,NADPH--cytochrome P450 reductase {ECO:0000255|HAMAP-Rule:MF_03212},, PF00667;PF00258;PF00175;, GO:0005829;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0050660;GO:0010181;GO:0050661;GO:0003958;GO:0016491;GO:0016709;GO:0090346;GO:0022900;GO:0032770;GO:0009725;GO:0006805;, C:cytosol; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:flavin adenine dinucleotide binding; F:FMN binding; F:NADP binding; F:NADPH-hemoprotein reductase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;, P:cellular organofluorine metabolic process; P:electron transport chain; P:positive regulation of monooxygenase activity; P:response to hormone; P:xenobiotic metabolic process; scaffold333 indexed_genome mRNA 43567 54823 . - . ID=transcript_16617;O95236 B1AHI4 B1AHI5 Q5U5N4 Q9BQ82 Q9BQA3,Apolipoprotein L3,Apolipoprotein L-III;TNF-inducible protein CG12-1;, PF05461;, GO:0005737;GO:0005576;GO:0016020;GO:0008289;GO:0005319;GO:0006954;GO:0042157;GO:0043123;, C:cytoplasm; C:extracellular region; C:membrane;, F:lipid binding; F:lipid transporter activity;, P:inflammatory response; P:lipoprotein metabolic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling;|Q9BPW4 Q9BQ37 Q9BXQ8,Apolipoprotein L4,Apolipoprotein L-IV;, PF05461;, GO:0005615;GO:0043231;GO:0008289;GO:0006629;GO:0006869;GO:0042157;, C:extracellular space; C:intracellular membrane-bounded organelle;, F:lipid binding;, P:lipid metabolic process; P:lipid transport; P:lipoprotein metabolic process; scaffold334 indexed_genome mRNA 21022 23960 . - . ID=transcript_16618;Q76NI1 B0QZC5 Q5T233 Q6ZNH8 Q8TEE5 Q96LV7 Q9C095,Kinase non-catalytic C-lobe domain-containing protein 1 {ECO:0000312|HGNC:HGNC:29374},Cerebral protein 9 {ECO:0000303|Ref.3};Protein very KIND {ECO:0000250|UniProtKB:Q0KK55};Ras-GEF domain-containing family member 2 {ECO:0000312|HGNC:HGNC:29374};, PF16474;PF00617;PF00618;, GO:0030425;GO:0032045;GO:0043025;GO:0043204;GO:0005085;GO:0021707;GO:0001934;GO:0050773;GO:0048814;GO:0007264;, C:dendrite; C:guanyl-nucleotide exchange factor complex; C:neuronal cell body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity;, P:cerebellar granule cell differentiation; P:positive regulation of protein phosphorylation; P:regulation of dendrite development; P:regulation of dendrite morphogenesis; P:small GTPase mediated signal transduction;|Q76NI1 B0QZC5 Q5T233 Q6ZNH8 Q8TEE5 Q96LV7 Q9C095,Kinase non-catalytic C-lobe domain-containing protein 1 {ECO:0000312|HGNC:HGNC:29374},Cerebral protein 9 {ECO:0000303|Ref.3};Protein very KIND {ECO:0000250|UniProtKB:Q0KK55};Ras-GEF domain-containing family member 2 {ECO:0000312|HGNC:HGNC:29374};, PF16474;PF00617;PF00618;, GO:0030425;GO:0032045;GO:0043025;GO:0043204;GO:0005085;GO:0021707;GO:0001934;GO:0050773;GO:0048814;GO:0007264;, C:dendrite; C:guanyl-nucleotide exchange factor complex; C:neuronal cell body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity;, P:cerebellar granule cell differentiation; P:positive regulation of protein phosphorylation; P:regulation of dendrite development; P:regulation of dendrite morphogenesis; P:small GTPase mediated signal transduction; scaffold334 indexed_genome mRNA 27215 35277 . + . ID=transcript_16619;Q76NI1 B0QZC5 Q5T233 Q6ZNH8 Q8TEE5 Q96LV7 Q9C095,Kinase non-catalytic C-lobe domain-containing protein 1 {ECO:0000312|HGNC:HGNC:29374},Cerebral protein 9 {ECO:0000303|Ref.3};Protein very KIND {ECO:0000250|UniProtKB:Q0KK55};Ras-GEF domain-containing family member 2 {ECO:0000312|HGNC:HGNC:29374};, PF16474;PF00617;PF00618;, GO:0030425;GO:0032045;GO:0043025;GO:0043204;GO:0005085;GO:0021707;GO:0001934;GO:0050773;GO:0048814;GO:0007264;, C:dendrite; C:guanyl-nucleotide exchange factor complex; C:neuronal cell body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity;, P:cerebellar granule cell differentiation; P:positive regulation of protein phosphorylation; P:regulation of dendrite development; P:regulation of dendrite morphogenesis; P:small GTPase mediated signal transduction;|Q76NI1 B0QZC5 Q5T233 Q6ZNH8 Q8TEE5 Q96LV7 Q9C095,Kinase non-catalytic C-lobe domain-containing protein 1 {ECO:0000312|HGNC:HGNC:29374},Cerebral protein 9 {ECO:0000303|Ref.3};Protein very KIND {ECO:0000250|UniProtKB:Q0KK55};Ras-GEF domain-containing family member 2 {ECO:0000312|HGNC:HGNC:29374};, PF16474;PF00617;PF00618;, GO:0030425;GO:0032045;GO:0043025;GO:0043204;GO:0005085;GO:0021707;GO:0001934;GO:0050773;GO:0048814;GO:0007264;, C:dendrite; C:guanyl-nucleotide exchange factor complex; C:neuronal cell body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity;, P:cerebellar granule cell differentiation; P:positive regulation of protein phosphorylation; P:regulation of dendrite development; P:regulation of dendrite morphogenesis; P:small GTPase mediated signal transduction; scaffold334 indexed_genome mRNA 35373 68893 . - . ID=transcript_16620;Q76NI1 B0QZC5 Q5T233 Q6ZNH8 Q8TEE5 Q96LV7 Q9C095,Kinase non-catalytic C-lobe domain-containing protein 1 {ECO:0000312|HGNC:HGNC:29374},Cerebral protein 9 {ECO:0000303|Ref.3};Protein very KIND {ECO:0000250|UniProtKB:Q0KK55};Ras-GEF domain-containing family member 2 {ECO:0000312|HGNC:HGNC:29374};, PF16474;PF00617;PF00618;, GO:0030425;GO:0032045;GO:0043025;GO:0043204;GO:0005085;GO:0021707;GO:0001934;GO:0050773;GO:0048814;GO:0007264;, C:dendrite; C:guanyl-nucleotide exchange factor complex; C:neuronal cell body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity;, P:cerebellar granule cell differentiation; P:positive regulation of protein phosphorylation; P:regulation of dendrite development; P:regulation of dendrite morphogenesis; P:small GTPase mediated signal transduction;|Q76NI1 B0QZC5 Q5T233 Q6ZNH8 Q8TEE5 Q96LV7 Q9C095,Kinase non-catalytic C-lobe domain-containing protein 1 {ECO:0000312|HGNC:HGNC:29374},Cerebral protein 9 {ECO:0000303|Ref.3};Protein very KIND {ECO:0000250|UniProtKB:Q0KK55};Ras-GEF domain-containing family member 2 {ECO:0000312|HGNC:HGNC:29374};, PF16474;PF00617;PF00618;, GO:0030425;GO:0032045;GO:0043025;GO:0043204;GO:0005085;GO:0021707;GO:0001934;GO:0050773;GO:0048814;GO:0007264;, C:dendrite; C:guanyl-nucleotide exchange factor complex; C:neuronal cell body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity;, P:cerebellar granule cell differentiation; P:positive regulation of protein phosphorylation; P:regulation of dendrite development; P:regulation of dendrite morphogenesis; P:small GTPase mediated signal transduction;|Q76NI1 B0QZC5 Q5T233 Q6ZNH8 Q8TEE5 Q96LV7 Q9C095,Kinase non-catalytic C-lobe domain-containing protein 1 {ECO:0000312|HGNC:HGNC:29374},Cerebral protein 9 {ECO:0000303|Ref.3};Protein very KIND {ECO:0000250|UniProtKB:Q0KK55};Ras-GEF domain-containing family member 2 {ECO:0000312|HGNC:HGNC:29374};, PF16474;PF00617;PF00618;, GO:0030425;GO:0032045;GO:0043025;GO:0043204;GO:0005085;GO:0021707;GO:0001934;GO:0050773;GO:0048814;GO:0007264;, C:dendrite; C:guanyl-nucleotide exchange factor complex; C:neuronal cell body; C:perikaryon;, F:guanyl-nucleotide exchange factor activity;, P:cerebellar granule cell differentiation; P:positive regulation of protein phosphorylation; P:regulation of dendrite development; P:regulation of dendrite morphogenesis; P:small GTPase mediated signal transduction; scaffold336 indexed_genome mRNA 2152 3999 . - . ID=transcript_16621;Q9Y330 B0UY00 Q5JQ98,Zinc finger and BTB domain-containing protein 12,Protein G10;, PF00651;PF00096;, GO:0005654;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II;|Q9Y330 B0UY00 Q5JQ98,Zinc finger and BTB domain-containing protein 12,Protein G10;, PF00651;PF00096;, GO:0005654;GO:0001227;GO:0046872;GO:0000978;GO:1990837;GO:0006357;, C:nucleoplasm;, F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold336 indexed_genome mRNA 91379 92868 . - . ID=transcript_16622;Q9UIP5,Complement C4-B,Basic complement C4;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3;, PF00207;PF07703;PF07677;PF01821;PF01835;PF17791;PF17789;PF01759;PF07678;, GO:0030424;GO:0072562;GO:0030425;GO:0070062;GO:0005576;GO:0005615;GO:0044216;GO:0005886;GO:0045202;GO:0030246;GO:0001848;GO:0004866;GO:0006956;GO:0006958;GO:0032490;GO:0006954;GO:0045087;GO:0008228;GO:2000427;GO:0030449;, C:axon; C:blood microparticle; C:dendrite; C:extracellular exosome; C:extracellular region; C:extracellular space; C:other organism cell; C:plasma membrane; C:synapse;, F:carbohydrate binding; F:complement binding; F:endopeptidase inhibitor activity;, P:complement activation; P:complement activation, classical pathway; P:detection of molecule of bacterial origin; P:inflammatory response; P:innate immune response; P:opsonization; P:positive regulation of apoptotic cell clearance; P:regulation of complement activation; scaffold336 indexed_genome mRNA 137602 142065 . - . ID=transcript_16623;Q7L8Q4 Q8N4R1 Q9NPK9 Q9UC10 Q9UC11 Q9UC12 Q9UC13 Q9UMG7,Tenascin-X {ECO:0000305},Hexabrachion-like protein;, PF07974;PF18720;PF00147;PF00041;, GO:0062023;GO:0070062;GO:0031012;GO:0005576;GO:0005615;GO:0098633;GO:0005201;GO:0008201;GO:0005178;GO:0030036;GO:0007155;GO:0030199;GO:0032963;GO:0048251;, C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:extracellular region; C:extracellular space;, F:collagen fibril binding; F:extracellular matrix structural constituent; F:heparin binding; F:integrin binding;, P:actin cytoskeleton organization; P:cell adhesion; P:collagen fibril organization; P:collagen metabolic process; P:elastic fiber assembly; scaffold339 indexed_genome mRNA 133174 137433 . + . ID=transcript_16624;Q2TAM9 A0PJ78 Q67GI3 Q86SS1 Q8TAH8,Tumor suppressor candidate gene 1 protein,TSG-9; scaffold341 indexed_genome mRNA 2144 3727 . - . ID=transcript_16625;Q8IVA1 M0R2R7 Q3KRG7,Purkinje cell protein 2 homolog,, PF02188;, GO:0043025;GO:0005085;, C:neuronal cell body;, F:guanyl-nucleotide exchange factor activity;|Q8IVA1 M0R2R7 Q3KRG7,Purkinje cell protein 2 homolog,, PF02188;, GO:0043025;GO:0005085;, C:neuronal cell body;, F:guanyl-nucleotide exchange factor activity; scaffold341 indexed_genome mRNA 8222 16585 . - . ID=transcript_16626;Q15833 B4E175 E7EQD5 Q9BU65,Syntaxin-binding protein 2,Protein unc-18 homolog 2;Protein unc-18 homolog B;, PF00995;, GO:0042582;GO:0044194;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0098793;GO:0030141;GO:0042581;GO:0070820;GO:0019905;GO:0017075;GO:0030348;GO:0006886;GO:0001909;GO:0007269;GO:0043312;GO:0002576;GO:0043304;GO:0006904;GO:0016192;, C:azurophil granule; C:cytolytic granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:presynapse; C:secretory granule; C:specific granule; C:tertiary granule;, F:syntaxin binding; F:syntaxin-1 binding; F:syntaxin-3 binding;, P:intracellular protein transport; P:leukocyte mediated cytotoxicity; P:neurotransmitter secretion; P:neutrophil degranulation; P:platelet degranulation; P:regulation of mast cell degranulation; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q15833 B4E175 E7EQD5 Q9BU65,Syntaxin-binding protein 2,Protein unc-18 homolog 2;Protein unc-18 homolog B;, PF00995;, GO:0042582;GO:0044194;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0098793;GO:0030141;GO:0042581;GO:0070820;GO:0019905;GO:0017075;GO:0030348;GO:0006886;GO:0001909;GO:0007269;GO:0043312;GO:0002576;GO:0043304;GO:0006904;GO:0016192;, C:azurophil granule; C:cytolytic granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:presynapse; C:secretory granule; C:specific granule; C:tertiary granule;, F:syntaxin binding; F:syntaxin-1 binding; F:syntaxin-3 binding;, P:intracellular protein transport; P:leukocyte mediated cytotoxicity; P:neurotransmitter secretion; P:neutrophil degranulation; P:platelet degranulation; P:regulation of mast cell degranulation; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q15833 B4E175 E7EQD5 Q9BU65,Syntaxin-binding protein 2,Protein unc-18 homolog 2;Protein unc-18 homolog B;, PF00995;, GO:0042582;GO:0044194;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0098793;GO:0030141;GO:0042581;GO:0070820;GO:0019905;GO:0017075;GO:0030348;GO:0006886;GO:0001909;GO:0007269;GO:0043312;GO:0002576;GO:0043304;GO:0006904;GO:0016192;, C:azurophil granule; C:cytolytic granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:presynapse; C:secretory granule; C:specific granule; C:tertiary granule;, F:syntaxin binding; F:syntaxin-1 binding; F:syntaxin-3 binding;, P:intracellular protein transport; P:leukocyte mediated cytotoxicity; P:neurotransmitter secretion; P:neutrophil degranulation; P:platelet degranulation; P:regulation of mast cell degranulation; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport;|Q15833 B4E175 E7EQD5 Q9BU65,Syntaxin-binding protein 2,Protein unc-18 homolog 2;Protein unc-18 homolog B;, PF00995;, GO:0042582;GO:0044194;GO:0005829;GO:0070062;GO:0005576;GO:0005886;GO:0098793;GO:0030141;GO:0042581;GO:0070820;GO:0019905;GO:0017075;GO:0030348;GO:0006886;GO:0001909;GO:0007269;GO:0043312;GO:0002576;GO:0043304;GO:0006904;GO:0016192;, C:azurophil granule; C:cytolytic granule; C:cytosol; C:extracellular exosome; C:extracellular region; C:plasma membrane; C:presynapse; C:secretory granule; C:specific granule; C:tertiary granule;, F:syntaxin binding; F:syntaxin-1 binding; F:syntaxin-3 binding;, P:intracellular protein transport; P:leukocyte mediated cytotoxicity; P:neurotransmitter secretion; P:neutrophil degranulation; P:platelet degranulation; P:regulation of mast cell degranulation; P:vesicle docking involved in exocytosis; P:vesicle-mediated transport; scaffold341 indexed_genome mRNA 48694 51000 . + . ID=transcript_16627;Q8IUR0 A8K7I6,Trafficking protein particle complex subunit 5,, PF04051;, GO:0005829;GO:0005783;GO:0030008;GO:1990070;GO:1990071;GO:1990072;GO:0048208;GO:0006888;, C:cytosol; C:endoplasmic reticulum; C:TRAPP complex; C:TRAPPI protein complex; C:TRAPPII protein complex; C:TRAPPIII protein complex;, , P:COPII vesicle coating; P:endoplasmic reticulum to Golgi vesicle-mediated transport; scaffold341 indexed_genome mRNA 86561 92570 . - . ID=transcript_16628;Q6UXB4,C-type lectin domain family 4 member G,Liver and lymph node sinusoidal endothelial cell C-type lectin {ECO:0000303|PubMed:14711836};, PF00059;, GO:0005887;GO:0005886;GO:0097367;GO:0070061;GO:0140081;GO:0005537;GO:0030247;GO:0120274;GO:0001618;GO:0002710;GO:0042130;GO:1903902;GO:0050776;GO:0046718;, C:integral component of plasma membrane; C:plasma membrane;, F:carbohydrate derivative binding; F:fructose binding; F:glycosylated region protein binding; F:mannose binding; F:polysaccharide binding; F:virus coreceptor activity; F:virus receptor activity;, P:negative regulation of T cell mediated immunity; P:negative regulation of T cell proliferation; P:positive regulation of viral life cycle; P:regulation of immune response; P:viral entry into host cell; scaffold341 indexed_genome mRNA 121273 124593 . + . ID=transcript_16629;Q96QQ1 Q96QQ2 Q96QQ3 Q96QQ4 Q96QQ5 Q96QQ6 Q96QQ7 Q96QQ8,CD209 antigen,C-type lectin domain family 4 member L;Dendritic cell-specific ICAM-3-grabbing non-integrin 1;, PF00059;, GO:0009986;GO:0005737;GO:0009897;GO:0005576;GO:0043657;GO:0016021;GO:0016020;GO:0005886;GO:0030246;GO:0005537;GO:0046872;GO:0042605;GO:0046790;GO:0001618;GO:0002250;GO:0019882;GO:0097323;GO:0009988;GO:0006897;GO:0007157;GO:0045087;GO:0035556;GO:0075733;GO:0007159;GO:0019048;GO:0046968;GO:0042102;GO:1903902;GO:0042129;GO:0002223;GO:0046718;GO:0019079;GO:0019062;, C:cell surface; C:cytoplasm; C:external side of plasma membrane; C:extracellular region; C:host cell; C:integral component of membrane; C:membrane; C:plasma membrane;, F:carbohydrate binding; F:mannose binding; F:metal ion binding; F:peptide antigen binding; F:virion binding; F:virus receptor activity;, P:adaptive immune response; P:antigen processing and presentation; P:B cell adhesion; P:cell-cell recognition; P:endocytosis; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:innate immune response; P:intracellular signal transduction; P:intracellular transport of virus; P:leukocyte cell-cell adhesion; P:modulation by virus of host process; P:peptide antigen transport; P:positive regulation of T cell proliferation; P:positive regulation of viral life cycle; P:regulation of T cell proliferation; P:stimulatory C-type lectin receptor signaling pathway; P:viral entry into host cell; P:viral genome replication; P:virion attachment to host cell; scaffold344 indexed_genome mRNA 107290 109091 . + . ID=transcript_16630;Q9BWU1 Q5JQZ7 Q5JR00 Q8TC78 Q9UPX2,Cyclin-dependent kinase 19,CDC2-related protein kinase 6;Cell division cycle 2-like protein kinase 6;Cell division protein kinase 19;Cyclin-dependent kinase 11;Death-preventing kinase;, PF00069;, GO:0005829;GO:0016592;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0008353;GO:0071222;GO:0043065;GO:0050729;GO:0006468;, C:cytosol; C:mediator complex; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:cellular response to lipopolysaccharide; P:positive regulation of apoptotic process; P:positive regulation of inflammatory response; P:protein phosphorylation; scaffold345 indexed_genome mRNA 5996 7531 . + . ID=transcript_16631;Q9H8G2 B4DWT4 D3DRK4 Q5VY32 Q6IPE6 Q96C59,Caspase activity and apoptosis inhibitor 1,Conserved anti-apoptotic protein;, PF15335;, GO:0006915;GO:2001268;, , , P:apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; scaffold345 indexed_genome mRNA 46263 48703 . - . ID=transcript_16632;Q9H8G2 B4DWT4 D3DRK4 Q5VY32 Q6IPE6 Q96C59,Caspase activity and apoptosis inhibitor 1,Conserved anti-apoptotic protein;, PF15335;, GO:0006915;GO:2001268;, , , P:apoptotic process; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; scaffold347 indexed_genome mRNA 93064 147265 . - . ID=transcript_16633;Q9BWU1 Q5JQZ7 Q5JR00 Q8TC78 Q9UPX2,Cyclin-dependent kinase 19,CDC2-related protein kinase 6;Cell division cycle 2-like protein kinase 6;Cell division protein kinase 19;Cyclin-dependent kinase 11;Death-preventing kinase;, PF00069;, GO:0005829;GO:0016592;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0008353;GO:0071222;GO:0043065;GO:0050729;GO:0006468;, C:cytosol; C:mediator complex; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:cellular response to lipopolysaccharide; P:positive regulation of apoptotic process; P:positive regulation of inflammatory response; P:protein phosphorylation;|Q9BWU1 Q5JQZ7 Q5JR00 Q8TC78 Q9UPX2,Cyclin-dependent kinase 19,CDC2-related protein kinase 6;Cell division cycle 2-like protein kinase 6;Cell division protein kinase 19;Cyclin-dependent kinase 11;Death-preventing kinase;, PF00069;, GO:0005829;GO:0016592;GO:0005634;GO:0005524;GO:0004693;GO:0106310;GO:0106311;GO:0008353;GO:0071222;GO:0043065;GO:0050729;GO:0006468;, C:cytosol; C:mediator complex; C:nucleus;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:cellular response to lipopolysaccharide; P:positive regulation of apoptotic process; P:positive regulation of inflammatory response; P:protein phosphorylation; scaffold350 indexed_genome mRNA 159 1182 . - . ID=transcript_16634;Q9UFB7 H7BXD3 Q6ZSY6 Q8WTY8 Q9ULN0,Zinc finger and BTB domain-containing protein 47,Zinc finger protein 651;, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold350 indexed_genome mRNA 2675 4213 . + . ID=transcript_16635;Q9UFB7 H7BXD3 Q6ZSY6 Q8WTY8 Q9ULN0,Zinc finger and BTB domain-containing protein 47,Zinc finger protein 651;, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold350 indexed_genome mRNA 4713 5657 . - . ID=transcript_16636;Q9UFB7 H7BXD3 Q6ZSY6 Q8WTY8 Q9ULN0,Zinc finger and BTB domain-containing protein 47,Zinc finger protein 651;, PF00651;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold350 indexed_genome mRNA 67068 90525 . + . ID=transcript_16637;Q9BRL7 O95152 Q68CX3 Q6UW18,Vesicle-trafficking protein SEC22c,SEC22 vesicle-trafficking protein homolog C;SEC22 vesicle-trafficking protein-like 3;, PF13774;, GO:0005783;GO:0005789;GO:0016021;GO:0006888;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport;|Q9BRL7 O95152 Q68CX3 Q6UW18,Vesicle-trafficking protein SEC22c,SEC22 vesicle-trafficking protein homolog C;SEC22 vesicle-trafficking protein-like 3;, PF13774;, GO:0005783;GO:0005789;GO:0016021;GO:0006888;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport;|Q9BRL7 O95152 Q68CX3 Q6UW18,Vesicle-trafficking protein SEC22c,SEC22 vesicle-trafficking protein homolog C;SEC22 vesicle-trafficking protein-like 3;, PF13774;, GO:0005783;GO:0005789;GO:0016021;GO:0006888;GO:0015031;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:protein transport; scaffold350 indexed_genome mRNA 99686 130976 . - . ID=transcript_16638;P32241 A5JUT9 B3KPV1 B4DEB5 B4DGI4 F5H1F5 G3V0I1 Q15871 Q6P2M6,Vasoactive intestinal polypeptide receptor 1,Pituitary adenylate cyclase-activating polypeptide type II receptor;VPAC1;, PF00002;PF02793;, GO:0005887;GO:0005886;GO:0043235;GO:0008528;GO:0017046;GO:0004999;GO:0007188;GO:0007166;GO:0007186;GO:0007187;GO:0002862;GO:0008284;, C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:G protein-coupled peptide receptor activity; F:peptide hormone binding; F:vasoactive intestinal polypeptide receptor activity;, P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of cell population proliferation; scaffold352 indexed_genome mRNA 104 15605 . + . ID=transcript_16639;Q8IZ69 D3DX25 Q32P57 Q96ME6 Q9H732,tRNA (uracil-5-)-methyltransferase homolog A,HpaII tiny fragments locus 9c protein;, PF05958;, GO:0003723;GO:0008173;GO:0006396;, , F:RNA binding; F:RNA methyltransferase activity;, P:RNA processing;|Q9NRW2,Microprocessor complex subunit DGCR8,DiGeorge syndrome critical region 8;, PF00035;, GO:0005737;GO:0005829;GO:0070877;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0003725;GO:0020037;GO:0042802;GO:0046872;GO:0070878;GO:0042803;GO:0140517;GO:0010586;GO:0031053;, C:cytoplasm; C:cytosol; C:microprocessor complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:protein-RNA adaptor activity;, P:miRNA metabolic process; P:primary miRNA processing;|Q9NRW2,Microprocessor complex subunit DGCR8,DiGeorge syndrome critical region 8;, PF00035;, GO:0005737;GO:0005829;GO:0070877;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0003725;GO:0020037;GO:0042802;GO:0046872;GO:0070878;GO:0042803;GO:0140517;GO:0010586;GO:0031053;, C:cytoplasm; C:cytosol; C:microprocessor complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:protein-RNA adaptor activity;, P:miRNA metabolic process; P:primary miRNA processing;|Q9NRW2,Microprocessor complex subunit DGCR8,DiGeorge syndrome critical region 8;, PF00035;, GO:0005737;GO:0005829;GO:0070877;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0003725;GO:0020037;GO:0042802;GO:0046872;GO:0070878;GO:0042803;GO:0140517;GO:0010586;GO:0031053;, C:cytoplasm; C:cytosol; C:microprocessor complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:protein-RNA adaptor activity;, P:miRNA metabolic process; P:primary miRNA processing;|Q6ZW26 Q8NA36,Collagen alpha-5(VI) chain,Collagen alpha-1(XXIX) chain;von Willebrand factor A domain-containing protein 4;, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005576;GO:0030020;GO:0007155;, C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular region;, F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; scaffold352 indexed_genome mRNA 25997 47049 . - . ID=transcript_16640;Q96M16,Transport and Golgi organization protein 2 homolog,, PF05742;, GO:0005794;GO:0007030;GO:0009306;, C:Golgi apparatus;, , P:Golgi organization; P:protein secretion;|Q8IZ69 D3DX25 Q32P57 Q96ME6 Q9H732,tRNA (uracil-5-)-methyltransferase homolog A,HpaII tiny fragments locus 9c protein;, PF05958;, GO:0003723;GO:0008173;GO:0006396;, , F:RNA binding; F:RNA methyltransferase activity;, P:RNA processing;|Q8IZ69 D3DX25 Q32P57 Q96ME6 Q9H732,tRNA (uracil-5-)-methyltransferase homolog A,HpaII tiny fragments locus 9c protein;, PF05958;, GO:0003723;GO:0008173;GO:0006396;, , F:RNA binding; F:RNA methyltransferase activity;, P:RNA processing;|Q8IZ69 D3DX25 Q32P57 Q96ME6 Q9H732,tRNA (uracil-5-)-methyltransferase homolog A,HpaII tiny fragments locus 9c protein;, PF05958;, GO:0003723;GO:0008173;GO:0006396;, , F:RNA binding; F:RNA methyltransferase activity;, P:RNA processing; scaffold352 indexed_genome mRNA 68769 71451 . + . ID=transcript_16641;O00192 B7WNV2,Armadillo repeat protein deleted in velo-cardio-facial syndrome,, PF00514;, GO:0005912;GO:0005737;GO:0005622;GO:0005634;GO:0005886;GO:0045296;GO:0016339;GO:0007155;GO:0098609;GO:0007043;GO:0007275;, C:adherens junction; C:cytoplasm; C:intracellular anatomical structure; C:nucleus; C:plasma membrane;, F:cadherin binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:cell-cell adhesion; P:cell-cell junction assembly; P:multicellular organism development; scaffold352 indexed_genome mRNA 74089 84554 . + . ID=transcript_16642;P21964 A8MPV9 Q6IB07 Q6ICE6 Q9BWC7,Catechol O-methyltransferase {ECO:0000305},, PF01596;, GO:0030424;GO:0005829;GO:0030425;GO:0070062;GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0016206;GO:0102084;GO:0000287;GO:0008171;GO:0102938;GO:0042424;GO:0032502;GO:0042417;GO:0032259;GO:0042135;, C:axon; C:cytosol; C:dendrite; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, F:catechol O-methyltransferase activity; F:L-dopa O-methyltransferase activity; F:magnesium ion binding; F:O-methyltransferase activity; F:orcinol O-methyltransferase activity;, P:catecholamine catabolic process; P:developmental process; P:dopamine metabolic process; P:methylation; P:neurotransmitter catabolic process;|O00192 B7WNV2,Armadillo repeat protein deleted in velo-cardio-facial syndrome,, PF00514;, GO:0005912;GO:0005737;GO:0005622;GO:0005634;GO:0005886;GO:0045296;GO:0016339;GO:0007155;GO:0098609;GO:0007043;GO:0007275;, C:adherens junction; C:cytoplasm; C:intracellular anatomical structure; C:nucleus; C:plasma membrane;, F:cadherin binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:cell-cell adhesion; P:cell-cell junction assembly; P:multicellular organism development;|P21964 A8MPV9 Q6IB07 Q6ICE6 Q9BWC7,Catechol O-methyltransferase {ECO:0000305},, PF01596;, GO:0030424;GO:0005829;GO:0030425;GO:0070062;GO:0016021;GO:0043231;GO:0016020;GO:0005886;GO:0016206;GO:0102084;GO:0000287;GO:0008171;GO:0102938;GO:0042424;GO:0032502;GO:0042417;GO:0032259;GO:0042135;, C:axon; C:cytosol; C:dendrite; C:extracellular exosome; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:plasma membrane;, F:catechol O-methyltransferase activity; F:L-dopa O-methyltransferase activity; F:magnesium ion binding; F:O-methyltransferase activity; F:orcinol O-methyltransferase activity;, P:catecholamine catabolic process; P:developmental process; P:dopamine metabolic process; P:methylation; P:neurotransmitter catabolic process; scaffold352 indexed_genome mRNA 97234 125151 . + . ID=transcript_16643;Q9NNW7 O95840 Q96IJ2 Q9H2Z5 Q9NZV3 Q9NZV4 Q9P2Y0 Q9P2Y1 Q9UQU8,Thioredoxin reductase 2, mitochondrial,Selenoprotein Z;TR-beta;Thioredoxin reductase TR3;, PF07992;PF02852;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0050660;GO:0004791;GO:0045454;GO:0034599;GO:0000305;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:thioredoxin-disulfide reductase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:response to oxygen radical;|Q9NNW7 O95840 Q96IJ2 Q9H2Z5 Q9NZV3 Q9NZV4 Q9P2Y0 Q9P2Y1 Q9UQU8,Thioredoxin reductase 2, mitochondrial,Selenoprotein Z;TR-beta;Thioredoxin reductase TR3;, PF07992;PF02852;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0050660;GO:0004791;GO:0045454;GO:0034599;GO:0000305;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:thioredoxin-disulfide reductase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:response to oxygen radical;|Q9NNW7 O95840 Q96IJ2 Q9H2Z5 Q9NZV3 Q9NZV4 Q9P2Y0 Q9P2Y1 Q9UQU8,Thioredoxin reductase 2, mitochondrial,Selenoprotein Z;TR-beta;Thioredoxin reductase TR3;, PF07992;PF02852;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0050660;GO:0004791;GO:0045454;GO:0034599;GO:0000305;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:thioredoxin-disulfide reductase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:response to oxygen radical;|Q9NNW7 O95840 Q96IJ2 Q9H2Z5 Q9NZV3 Q9NZV4 Q9P2Y0 Q9P2Y1 Q9UQU8,Thioredoxin reductase 2, mitochondrial,Selenoprotein Z;TR-beta;Thioredoxin reductase TR3;, PF07992;PF02852;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0050660;GO:0004791;GO:0045454;GO:0034599;GO:0000305;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:thioredoxin-disulfide reductase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:response to oxygen radical;|Q9NNW7 O95840 Q96IJ2 Q9H2Z5 Q9NZV3 Q9NZV4 Q9P2Y0 Q9P2Y1 Q9UQU8,Thioredoxin reductase 2, mitochondrial,Selenoprotein Z;TR-beta;Thioredoxin reductase TR3;, PF07992;PF02852;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0050660;GO:0004791;GO:0045454;GO:0034599;GO:0000305;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:thioredoxin-disulfide reductase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:response to oxygen radical;|Q9NNW7 O95840 Q96IJ2 Q9H2Z5 Q9NZV3 Q9NZV4 Q9P2Y0 Q9P2Y1 Q9UQU8,Thioredoxin reductase 2, mitochondrial,Selenoprotein Z;TR-beta;Thioredoxin reductase TR3;, PF07992;PF02852;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0050660;GO:0004791;GO:0045454;GO:0034599;GO:0000305;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:thioredoxin-disulfide reductase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:response to oxygen radical;|Q9NNW7 O95840 Q96IJ2 Q9H2Z5 Q9NZV3 Q9NZV4 Q9P2Y0 Q9P2Y1 Q9UQU8,Thioredoxin reductase 2, mitochondrial,Selenoprotein Z;TR-beta;Thioredoxin reductase TR3;, PF07992;PF02852;, GO:0005737;GO:0005829;GO:0043231;GO:0005759;GO:0005739;GO:0050660;GO:0004791;GO:0045454;GO:0034599;GO:0000305;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitochondrial matrix; C:mitochondrion;, F:flavin adenine dinucleotide binding; F:thioredoxin-disulfide reductase activity;, P:cell redox homeostasis; P:cellular response to oxidative stress; P:response to oxygen radical; scaffold353 indexed_genome mRNA 84188 117221 . + . ID=transcript_16644;P13861 Q16823 Q9BUB1,cAMP-dependent protein kinase type II-alpha regulatory subunit,, PF00027;PF02197;, GO:0005952;GO:0005813;GO:0097546;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0016020;GO:0031588;GO:0005886;GO:0044853;GO:0032991;GO:0030552;GO:0004862;GO:0008603;GO:0019904;GO:0034236;GO:0031625;GO:0034199;GO:0007596;GO:0071377;GO:0007268;GO:0035556;GO:2000480;GO:0002862;GO:0043949;GO:0010738;GO:0003091;, C:cAMP-dependent protein kinase complex; C:centrosome; C:ciliary base; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:membrane; C:nucleotide-activated protein kinase complex; C:plasma membrane; C:plasma membrane raft; C:protein-containing complex;, F:cAMP binding; F:cAMP-dependent protein kinase inhibitor activity; F:cAMP-dependent protein kinase regulator activity; F:protein domain specific binding; F:protein kinase A catalytic subunit binding; F:ubiquitin protein ligase binding;, P:activation of protein kinase A activity; P:blood coagulation; P:cellular response to glucagon stimulus; P:chemical synaptic transmission; P:intracellular signal transduction; P:negative regulation of cAMP-dependent protein kinase activity; P:negative regulation of inflammatory response to antigenic stimulus; P:regulation of cAMP-mediated signaling; P:regulation of protein kinase A signaling; P:renal water homeostasis; scaffold357 indexed_genome mRNA 16240 134411 . - . ID=transcript_16645;Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion; scaffold367 indexed_genome mRNA 34435 36784 . - . ID=transcript_16646;P48788 A6NIV8 A6NJU5,Troponin I, fast skeletal muscle,Troponin I, fast-twitch isoform;, PF00992;, GO:0005829;GO:0005634;GO:0005861;GO:0003779;GO:0031014;GO:0060048;GO:0006936;GO:0030049;GO:0045893;GO:0006937;GO:0003009;, C:cytosol; C:nucleus; C:troponin complex;, F:actin binding; F:troponin T binding;, P:cardiac muscle contraction; P:muscle contraction; P:muscle filament sliding; P:positive regulation of transcription, DNA-templated; P:regulation of muscle contraction; P:skeletal muscle contraction;|P48788 A6NIV8 A6NJU5,Troponin I, fast skeletal muscle,Troponin I, fast-twitch isoform;, PF00992;, GO:0005829;GO:0005634;GO:0005861;GO:0003779;GO:0031014;GO:0060048;GO:0006936;GO:0030049;GO:0045893;GO:0006937;GO:0003009;, C:cytosol; C:nucleus; C:troponin complex;, F:actin binding; F:troponin T binding;, P:cardiac muscle contraction; P:muscle contraction; P:muscle filament sliding; P:positive regulation of transcription, DNA-templated; P:regulation of muscle contraction; P:skeletal muscle contraction; scaffold367 indexed_genome mRNA 102360 111345 . + . ID=transcript_16647;P07339 Q6IB57,Cathepsin D,, PF07966;PF00026;, GO:0062023;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005765;GO:0005764;GO:0042470;GO:0045121;GO:0035580;GO:1904724;GO:0004190;GO:0070001;GO:0008233;GO:0019886;GO:0030574;GO:0042159;GO:0043312;GO:0043065;GO:0043280;GO:0006508;GO:0070201;, C:collagen-containing extracellular matrix; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane raft; C:specific granule lumen; C:tertiary granule lumen;, F:aspartic-type endopeptidase activity; F:aspartic-type peptidase activity; F:peptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:collagen catabolic process; P:lipoprotein catabolic process; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:proteolysis; P:regulation of establishment of protein localization;|P07339 Q6IB57,Cathepsin D,, PF07966;PF00026;, GO:0062023;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005765;GO:0005764;GO:0042470;GO:0045121;GO:0035580;GO:1904724;GO:0004190;GO:0070001;GO:0008233;GO:0019886;GO:0030574;GO:0042159;GO:0043312;GO:0043065;GO:0043280;GO:0006508;GO:0070201;, C:collagen-containing extracellular matrix; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane raft; C:specific granule lumen; C:tertiary granule lumen;, F:aspartic-type endopeptidase activity; F:aspartic-type peptidase activity; F:peptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:collagen catabolic process; P:lipoprotein catabolic process; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:proteolysis; P:regulation of establishment of protein localization;|P07339 Q6IB57,Cathepsin D,, PF07966;PF00026;, GO:0062023;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005765;GO:0005764;GO:0042470;GO:0045121;GO:0035580;GO:1904724;GO:0004190;GO:0070001;GO:0008233;GO:0019886;GO:0030574;GO:0042159;GO:0043312;GO:0043065;GO:0043280;GO:0006508;GO:0070201;, C:collagen-containing extracellular matrix; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane raft; C:specific granule lumen; C:tertiary granule lumen;, F:aspartic-type endopeptidase activity; F:aspartic-type peptidase activity; F:peptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:collagen catabolic process; P:lipoprotein catabolic process; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:proteolysis; P:regulation of establishment of protein localization;|P07339 Q6IB57,Cathepsin D,, PF07966;PF00026;, GO:0062023;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005765;GO:0005764;GO:0042470;GO:0045121;GO:0035580;GO:1904724;GO:0004190;GO:0070001;GO:0008233;GO:0019886;GO:0030574;GO:0042159;GO:0043312;GO:0043065;GO:0043280;GO:0006508;GO:0070201;, C:collagen-containing extracellular matrix; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane raft; C:specific granule lumen; C:tertiary granule lumen;, F:aspartic-type endopeptidase activity; F:aspartic-type peptidase activity; F:peptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:collagen catabolic process; P:lipoprotein catabolic process; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:proteolysis; P:regulation of establishment of protein localization;|P07339 Q6IB57,Cathepsin D,, PF07966;PF00026;, GO:0062023;GO:0010008;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043202;GO:0005765;GO:0005764;GO:0042470;GO:0045121;GO:0035580;GO:1904724;GO:0004190;GO:0070001;GO:0008233;GO:0019886;GO:0030574;GO:0042159;GO:0043312;GO:0043065;GO:0043280;GO:0006508;GO:0070201;, C:collagen-containing extracellular matrix; C:endosome membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:lysosomal lumen; C:lysosomal membrane; C:lysosome; C:melanosome; C:membrane raft; C:specific granule lumen; C:tertiary granule lumen;, F:aspartic-type endopeptidase activity; F:aspartic-type peptidase activity; F:peptidase activity;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:collagen catabolic process; P:lipoprotein catabolic process; P:neutrophil degranulation; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:proteolysis; P:regulation of establishment of protein localization; scaffold368 indexed_genome mRNA 188 764 . + . ID=transcript_16648;O00459 Q5EAT5 Q9UPH9,Phosphatidylinositol 3-kinase regulatory subunit beta,Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta;, PF16454;PF00620;PF00017;, GO:0005829;GO:0005634;GO:0005942;GO:0046935;GO:0001784;GO:0046982;GO:0019903;GO:0030971;GO:0001678;GO:0032869;GO:0038095;GO:0038096;GO:0008286;GO:0050900;GO:0000165;GO:0043409;GO:0014065;GO:0006661;GO:0046854;GO:0048015;GO:0042307;GO:0051897;GO:0045944;GO:0015031;GO:0010506;GO:0043551;GO:0051056;GO:0034976;GO:0050852;GO:0048010;, C:cytosol; C:nucleus; C:phosphatidylinositol 3-kinase complex;, F:1-phosphatidylinositol-3-kinase regulator activity; F:phosphotyrosine residue binding; F:protein heterodimerization activity; F:protein phosphatase binding; F:receptor tyrosine kinase binding;, P:cellular glucose homeostasis; P:cellular response to insulin stimulus; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:insulin receptor signaling pathway; P:leukocyte migration; P:MAPK cascade; P:negative regulation of MAPK cascade; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol phosphorylation; P:phosphatidylinositol-mediated signaling; P:positive regulation of protein import into nucleus; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:protein transport; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase activity; P:regulation of small GTPase mediated signal transduction; P:response to endoplasmic reticulum stress; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold368 indexed_genome mRNA 7155 10729 . + . ID=transcript_16649;P13284 Q76MF9 Q8NEI4 Q8WU77 Q9UL08,Gamma-interferon-inducible lysosomal thiol reductase,Gamma-interferon-inducible protein IP-30;Legumaturain;, PF03227;, GO:0030054;GO:0005829;GO:0005576;GO:0043231;GO:0043202;GO:0005764;GO:0016491;GO:0016667;GO:0042590;GO:0019886;GO:0060333;GO:0048147;GO:0050821;, C:cell junction; C:cytosol; C:extracellular region; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:interferon-gamma-mediated signaling pathway; P:negative regulation of fibroblast proliferation; P:protein stabilization;|P13284 Q76MF9 Q8NEI4 Q8WU77 Q9UL08,Gamma-interferon-inducible lysosomal thiol reductase,Gamma-interferon-inducible protein IP-30;Legumaturain;, PF03227;, GO:0030054;GO:0005829;GO:0005576;GO:0043231;GO:0043202;GO:0005764;GO:0016491;GO:0016667;GO:0042590;GO:0019886;GO:0060333;GO:0048147;GO:0050821;, C:cell junction; C:cytosol; C:extracellular region; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:interferon-gamma-mediated signaling pathway; P:negative regulation of fibroblast proliferation; P:protein stabilization;|P13284 Q76MF9 Q8NEI4 Q8WU77 Q9UL08,Gamma-interferon-inducible lysosomal thiol reductase,Gamma-interferon-inducible protein IP-30;Legumaturain;, PF03227;, GO:0030054;GO:0005829;GO:0005576;GO:0043231;GO:0043202;GO:0005764;GO:0016491;GO:0016667;GO:0042590;GO:0019886;GO:0060333;GO:0048147;GO:0050821;, C:cell junction; C:cytosol; C:extracellular region; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome;, F:oxidoreductase activity; F:oxidoreductase activity, acting on a sulfur group of donors;, P:antigen processing and presentation of exogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:interferon-gamma-mediated signaling pathway; P:negative regulation of fibroblast proliferation; P:protein stabilization; scaffold368 indexed_genome mRNA 40141 43121 . - . ID=transcript_16650;Q567V2 Q96P34 Q96QA0 Q9BSG4,Mpv17-like protein 2,, PF04117;, GO:0005737;GO:0016021;GO:0005743;GO:0005762;GO:0005739;GO:0061668;GO:0070131;, C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, , P:mitochondrial ribosome assembly; P:positive regulation of mitochondrial translation;|Q567V2 Q96P34 Q96QA0 Q9BSG4,Mpv17-like protein 2,, PF04117;, GO:0005737;GO:0016021;GO:0005743;GO:0005762;GO:0005739;GO:0061668;GO:0070131;, C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrion;, , P:mitochondrial ribosome assembly; P:positive regulation of mitochondrial translation; scaffold368 indexed_genome mRNA 51743 62919 . - . ID=transcript_16651;Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6,cAMP-specific 3',5'-cyclic phosphodiesterase 4C,DPDE1;PDE21;, PF18100;PF00233;, GO:0005929;GO:0005829;GO:0005615;GO:0005634;GO:0048471;GO:0004115;GO:0004114;GO:0046872;GO:0006198;GO:0007186;GO:0007165;, C:cilium; C:cytosol; C:extracellular space; C:nucleus; C:perinuclear region of cytoplasm;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:G protein-coupled receptor signaling pathway; P:signal transduction;|Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6,cAMP-specific 3',5'-cyclic phosphodiesterase 4C,DPDE1;PDE21;, PF18100;PF00233;, GO:0005929;GO:0005829;GO:0005615;GO:0005634;GO:0048471;GO:0004115;GO:0004114;GO:0046872;GO:0006198;GO:0007186;GO:0007165;, C:cilium; C:cytosol; C:extracellular space; C:nucleus; C:perinuclear region of cytoplasm;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:G protein-coupled receptor signaling pathway; P:signal transduction;|Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6,cAMP-specific 3',5'-cyclic phosphodiesterase 4C,DPDE1;PDE21;, PF18100;PF00233;, GO:0005929;GO:0005829;GO:0005615;GO:0005634;GO:0048471;GO:0004115;GO:0004114;GO:0046872;GO:0006198;GO:0007186;GO:0007165;, C:cilium; C:cytosol; C:extracellular space; C:nucleus; C:perinuclear region of cytoplasm;, F:3',5'-cyclic-AMP phosphodiesterase activity; F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:metal ion binding;, P:cAMP catabolic process; P:G protein-coupled receptor signaling pathway; P:signal transduction; scaffold368 indexed_genome mRNA 95579 96119 . - . ID=transcript_16652;Q9H0B3 B4DYH2 E9PDE0 E9PH54 Q2KHR5 Q8N4G8 Q96M14 Q9C0I0,IQ domain-containing protein N {ECO:0000312|HGNC:HGNC:29350},, PF00612;, GO:0005739;GO:0005634;, C:mitochondrion; C:nucleus; scaffold368 indexed_genome mRNA 96122 96967 . - . ID=transcript_16653;Q9H0B3 B4DYH2 E9PDE0 E9PH54 Q2KHR5 Q8N4G8 Q96M14 Q9C0I0,IQ domain-containing protein N {ECO:0000312|HGNC:HGNC:29350},, PF00612;, GO:0005739;GO:0005634;, C:mitochondrion; C:nucleus; scaffold368 indexed_genome mRNA 98482 100275 . - . ID=transcript_16654;Q9H0B3 B4DYH2 E9PDE0 E9PH54 Q2KHR5 Q8N4G8 Q96M14 Q9C0I0,IQ domain-containing protein N {ECO:0000312|HGNC:HGNC:29350},, PF00612;, GO:0005739;GO:0005634;, C:mitochondrion; C:nucleus; scaffold370 indexed_genome mRNA 25 1294 . + . ID=transcript_16655;Q9Y5E5 Q4V761,Protocadherin beta-4,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007399;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; P:synapse assembly; scaffold370 indexed_genome mRNA 36700 37613 . - . ID=transcript_16656;Q9Y5E3 B2R8R9,Protocadherin beta-6 {ECO:0000305},, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0042802;GO:0016339;GO:0007155;GO:0009988;GO:0007268;GO:0007156;GO:0007399;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding; F:identical protein binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:cell-cell recognition; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; P:synapse assembly; scaffold370 indexed_genome mRNA 62005 64443 . - . ID=transcript_16657;Q9Y5E2 A1L3Y8,Protocadherin beta-7,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold370 indexed_genome mRNA 64680 66350 . - . ID=transcript_16658;Q9Y5F0 A8K9V6,Protocadherin beta-13,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse assembly; scaffold370 indexed_genome mRNA 71429 77284 . + . ID=transcript_16659;Q9NRJ7 B3KPK5 Q8IYD5 Q96SE9 Q9HCF1,Protocadherin beta-16,Protocadherin-3X;, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse assembly;|Q9Y5E2 A1L3Y8,Protocadherin beta-7,, PF00028;PF08266;PF16492;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;|Q9Y5E1 Q2M2U8 Q496X9 Q9NRJ8,Protocadherin beta-9,Protocadherin-3H;, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:synapse assembly; scaffold370 indexed_genome mRNA 108502 110070 . - . ID=transcript_16660;Q9Y5F2 B4DSF7 Q2M223,Protocadherin beta-11,, PF00028;PF08266;PF16492;, GO:0016021;GO:0005887;GO:0045202;GO:0005509;GO:0016339;GO:0007155;GO:0007268;GO:0007156;GO:0007399;GO:0007416;, C:integral component of membrane; C:integral component of plasma membrane; C:synapse;, F:calcium ion binding;, P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell adhesion; P:chemical synaptic transmission; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; P:synapse assembly; scaffold370 indexed_genome mRNA 111259 112577 . - . ID=transcript_16661;Q9Y5E8 Q8IUX5,Protocadherin beta-15,, PF00028;PF08266;PF16492;, GO:0005887;GO:0032391;GO:0005509;GO:0007155;GO:0007156;GO:0007399;, C:integral component of plasma membrane; C:photoreceptor connecting cilium;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development; scaffold373 indexed_genome mRNA 6101 41321 . - . ID=transcript_16662;O94973 O75403 Q53ET1 Q96SI8,AP-2 complex subunit alpha-2,100 kDa coated vesicle protein C;Adaptor protein complex AP-2 subunit alpha-2;Adaptor-related protein complex 2 subunit alpha-2;Alpha-adaptin C;Alpha2-adaptin;Clathrin assembly protein complex 2 alpha-C large chain;Huntingtin yeast partner J;Huntingtin-interacting protein 9;Huntingtin-interacting protein J;Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0045334;GO:0030669;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0101003;GO:0005886;GO:0030667;GO:0140312;GO:0035615;GO:0097718;GO:0008289;GO:0019901;GO:0019886;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0043312;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:ficolin-1-rich granule membrane; C:plasma membrane; C:secretory granule membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:disordered domain specific binding; F:lipid binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O94973 O75403 Q53ET1 Q96SI8,AP-2 complex subunit alpha-2,100 kDa coated vesicle protein C;Adaptor protein complex AP-2 subunit alpha-2;Adaptor-related protein complex 2 subunit alpha-2;Alpha-adaptin C;Alpha2-adaptin;Clathrin assembly protein complex 2 alpha-C large chain;Huntingtin yeast partner J;Huntingtin-interacting protein 9;Huntingtin-interacting protein J;Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0045334;GO:0030669;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0101003;GO:0005886;GO:0030667;GO:0140312;GO:0035615;GO:0097718;GO:0008289;GO:0019901;GO:0019886;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0043312;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:ficolin-1-rich granule membrane; C:plasma membrane; C:secretory granule membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:disordered domain specific binding; F:lipid binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O94973 O75403 Q53ET1 Q96SI8,AP-2 complex subunit alpha-2,100 kDa coated vesicle protein C;Adaptor protein complex AP-2 subunit alpha-2;Adaptor-related protein complex 2 subunit alpha-2;Alpha-adaptin C;Alpha2-adaptin;Clathrin assembly protein complex 2 alpha-C large chain;Huntingtin yeast partner J;Huntingtin-interacting protein 9;Huntingtin-interacting protein J;Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0045334;GO:0030669;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0101003;GO:0005886;GO:0030667;GO:0140312;GO:0035615;GO:0097718;GO:0008289;GO:0019901;GO:0019886;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0043312;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:ficolin-1-rich granule membrane; C:plasma membrane; C:secretory granule membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:disordered domain specific binding; F:lipid binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O94973 O75403 Q53ET1 Q96SI8,AP-2 complex subunit alpha-2,100 kDa coated vesicle protein C;Adaptor protein complex AP-2 subunit alpha-2;Adaptor-related protein complex 2 subunit alpha-2;Alpha-adaptin C;Alpha2-adaptin;Clathrin assembly protein complex 2 alpha-C large chain;Huntingtin yeast partner J;Huntingtin-interacting protein 9;Huntingtin-interacting protein J;Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0045334;GO:0030669;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0101003;GO:0005886;GO:0030667;GO:0140312;GO:0035615;GO:0097718;GO:0008289;GO:0019901;GO:0019886;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0043312;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:ficolin-1-rich granule membrane; C:plasma membrane; C:secretory granule membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:disordered domain specific binding; F:lipid binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O94973 O75403 Q53ET1 Q96SI8,AP-2 complex subunit alpha-2,100 kDa coated vesicle protein C;Adaptor protein complex AP-2 subunit alpha-2;Adaptor-related protein complex 2 subunit alpha-2;Alpha-adaptin C;Alpha2-adaptin;Clathrin assembly protein complex 2 alpha-C large chain;Huntingtin yeast partner J;Huntingtin-interacting protein 9;Huntingtin-interacting protein J;Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0045334;GO:0030669;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0101003;GO:0005886;GO:0030667;GO:0140312;GO:0035615;GO:0097718;GO:0008289;GO:0019901;GO:0019886;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0043312;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:ficolin-1-rich granule membrane; C:plasma membrane; C:secretory granule membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:disordered domain specific binding; F:lipid binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O94973 O75403 Q53ET1 Q96SI8,AP-2 complex subunit alpha-2,100 kDa coated vesicle protein C;Adaptor protein complex AP-2 subunit alpha-2;Adaptor-related protein complex 2 subunit alpha-2;Alpha-adaptin C;Alpha2-adaptin;Clathrin assembly protein complex 2 alpha-C large chain;Huntingtin yeast partner J;Huntingtin-interacting protein 9;Huntingtin-interacting protein J;Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0045334;GO:0030669;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0101003;GO:0005886;GO:0030667;GO:0140312;GO:0035615;GO:0097718;GO:0008289;GO:0019901;GO:0019886;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0043312;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:ficolin-1-rich granule membrane; C:plasma membrane; C:secretory granule membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:disordered domain specific binding; F:lipid binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O94973 O75403 Q53ET1 Q96SI8,AP-2 complex subunit alpha-2,100 kDa coated vesicle protein C;Adaptor protein complex AP-2 subunit alpha-2;Adaptor-related protein complex 2 subunit alpha-2;Alpha-adaptin C;Alpha2-adaptin;Clathrin assembly protein complex 2 alpha-C large chain;Huntingtin yeast partner J;Huntingtin-interacting protein 9;Huntingtin-interacting protein J;Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0045334;GO:0030669;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0101003;GO:0005886;GO:0030667;GO:0140312;GO:0035615;GO:0097718;GO:0008289;GO:0019901;GO:0019886;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0043312;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:ficolin-1-rich granule membrane; C:plasma membrane; C:secretory granule membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:disordered domain specific binding; F:lipid binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O94973 O75403 Q53ET1 Q96SI8,AP-2 complex subunit alpha-2,100 kDa coated vesicle protein C;Adaptor protein complex AP-2 subunit alpha-2;Adaptor-related protein complex 2 subunit alpha-2;Alpha-adaptin C;Alpha2-adaptin;Clathrin assembly protein complex 2 alpha-C large chain;Huntingtin yeast partner J;Huntingtin-interacting protein 9;Huntingtin-interacting protein J;Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0045334;GO:0030669;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0101003;GO:0005886;GO:0030667;GO:0140312;GO:0035615;GO:0097718;GO:0008289;GO:0019901;GO:0019886;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0043312;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:ficolin-1-rich granule membrane; C:plasma membrane; C:secretory granule membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:disordered domain specific binding; F:lipid binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway;|O94973 O75403 Q53ET1 Q96SI8,AP-2 complex subunit alpha-2,100 kDa coated vesicle protein C;Adaptor protein complex AP-2 subunit alpha-2;Adaptor-related protein complex 2 subunit alpha-2;Alpha-adaptin C;Alpha2-adaptin;Clathrin assembly protein complex 2 alpha-C large chain;Huntingtin yeast partner J;Huntingtin-interacting protein 9;Huntingtin-interacting protein J;Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit;, PF01602;PF02296;PF02883;, GO:0030122;GO:0045334;GO:0030669;GO:0031410;GO:0005829;GO:0030666;GO:0036020;GO:0101003;GO:0005886;GO:0030667;GO:0140312;GO:0035615;GO:0097718;GO:0008289;GO:0019901;GO:0019886;GO:0072583;GO:0048013;GO:0006886;GO:0034383;GO:0032802;GO:0061024;GO:0043312;GO:0006898;GO:0050690;GO:0060071;, C:AP-2 adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:ficolin-1-rich granule membrane; C:plasma membrane; C:secretory granule membrane;, F:cargo adaptor activity; F:clathrin adaptor activity; F:disordered domain specific binding; F:lipid binding; F:protein kinase binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:clathrin-dependent endocytosis; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:neutrophil degranulation; P:receptor-mediated endocytosis; P:regulation of defense response to virus by virus; P:Wnt signaling pathway, planar cell polarity pathway; scaffold373 indexed_genome mRNA 83983 107619 . + . ID=transcript_16663;Q9BWS9 B3KWB0 Q8NBM9 Q96CZ3 Q96S93 Q96SK0 Q9BY52,Chitinase domain-containing protein 1,Stabilin-1-interacting chitinase-like protein;, PF00704;, GO:0070062;GO:0005576;GO:0005615;GO:0005770;GO:0043202;GO:0005764;GO:0016020;GO:0005634;GO:0005802;GO:0008061;GO:0070492;GO:0005975;GO:0045087;GO:1900016;GO:0002576;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:late endosome; C:lysosomal lumen; C:lysosome; C:membrane; C:nucleus; C:trans-Golgi network;, F:chitin binding; F:oligosaccharide binding;, P:carbohydrate metabolic process; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:platelet degranulation;|Q9BWS9 B3KWB0 Q8NBM9 Q96CZ3 Q96S93 Q96SK0 Q9BY52,Chitinase domain-containing protein 1,Stabilin-1-interacting chitinase-like protein;, PF00704;, GO:0070062;GO:0005576;GO:0005615;GO:0005770;GO:0043202;GO:0005764;GO:0016020;GO:0005634;GO:0005802;GO:0008061;GO:0070492;GO:0005975;GO:0045087;GO:1900016;GO:0002576;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:late endosome; C:lysosomal lumen; C:lysosome; C:membrane; C:nucleus; C:trans-Golgi network;, F:chitin binding; F:oligosaccharide binding;, P:carbohydrate metabolic process; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:platelet degranulation;|Q9BWS9 B3KWB0 Q8NBM9 Q96CZ3 Q96S93 Q96SK0 Q9BY52,Chitinase domain-containing protein 1,Stabilin-1-interacting chitinase-like protein;, PF00704;, GO:0070062;GO:0005576;GO:0005615;GO:0005770;GO:0043202;GO:0005764;GO:0016020;GO:0005634;GO:0005802;GO:0008061;GO:0070492;GO:0005975;GO:0045087;GO:1900016;GO:0002576;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:late endosome; C:lysosomal lumen; C:lysosome; C:membrane; C:nucleus; C:trans-Golgi network;, F:chitin binding; F:oligosaccharide binding;, P:carbohydrate metabolic process; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:platelet degranulation;|Q9BWS9 B3KWB0 Q8NBM9 Q96CZ3 Q96S93 Q96SK0 Q9BY52,Chitinase domain-containing protein 1,Stabilin-1-interacting chitinase-like protein;, PF00704;, GO:0070062;GO:0005576;GO:0005615;GO:0005770;GO:0043202;GO:0005764;GO:0016020;GO:0005634;GO:0005802;GO:0008061;GO:0070492;GO:0005975;GO:0045087;GO:1900016;GO:0002576;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:late endosome; C:lysosomal lumen; C:lysosome; C:membrane; C:nucleus; C:trans-Golgi network;, F:chitin binding; F:oligosaccharide binding;, P:carbohydrate metabolic process; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:platelet degranulation;|Q9BWS9 B3KWB0 Q8NBM9 Q96CZ3 Q96S93 Q96SK0 Q9BY52,Chitinase domain-containing protein 1,Stabilin-1-interacting chitinase-like protein;, PF00704;, GO:0070062;GO:0005576;GO:0005615;GO:0005770;GO:0043202;GO:0005764;GO:0016020;GO:0005634;GO:0005802;GO:0008061;GO:0070492;GO:0005975;GO:0045087;GO:1900016;GO:0002576;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:late endosome; C:lysosomal lumen; C:lysosome; C:membrane; C:nucleus; C:trans-Golgi network;, F:chitin binding; F:oligosaccharide binding;, P:carbohydrate metabolic process; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:platelet degranulation;|Q9BWS9 B3KWB0 Q8NBM9 Q96CZ3 Q96S93 Q96SK0 Q9BY52,Chitinase domain-containing protein 1,Stabilin-1-interacting chitinase-like protein;, PF00704;, GO:0070062;GO:0005576;GO:0005615;GO:0005770;GO:0043202;GO:0005764;GO:0016020;GO:0005634;GO:0005802;GO:0008061;GO:0070492;GO:0005975;GO:0045087;GO:1900016;GO:0002576;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:late endosome; C:lysosomal lumen; C:lysosome; C:membrane; C:nucleus; C:trans-Golgi network;, F:chitin binding; F:oligosaccharide binding;, P:carbohydrate metabolic process; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:platelet degranulation;|Q9BWS9 B3KWB0 Q8NBM9 Q96CZ3 Q96S93 Q96SK0 Q9BY52,Chitinase domain-containing protein 1,Stabilin-1-interacting chitinase-like protein;, PF00704;, GO:0070062;GO:0005576;GO:0005615;GO:0005770;GO:0043202;GO:0005764;GO:0016020;GO:0005634;GO:0005802;GO:0008061;GO:0070492;GO:0005975;GO:0045087;GO:1900016;GO:0002576;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:late endosome; C:lysosomal lumen; C:lysosome; C:membrane; C:nucleus; C:trans-Golgi network;, F:chitin binding; F:oligosaccharide binding;, P:carbohydrate metabolic process; P:innate immune response; P:negative regulation of cytokine production involved in inflammatory response; P:platelet degranulation;|O14817 Q6IAP6,Tetraspanin-4,Novel antigen 2;Transmembrane 4 superfamily member 7;, PF00335;, GO:0005925;GO:0005887;GO:0005886;GO:0031982;GO:0003823;GO:0005178;GO:0065003;, C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:vesicle;, F:antigen binding; F:integrin binding;, P:protein-containing complex assembly;|O14817 Q6IAP6,Tetraspanin-4,Novel antigen 2;Transmembrane 4 superfamily member 7;, PF00335;, GO:0005925;GO:0005887;GO:0005886;GO:0031982;GO:0003823;GO:0005178;GO:0065003;, C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:vesicle;, F:antigen binding; F:integrin binding;, P:protein-containing complex assembly;|O75954 D3DUQ7 Q53FV2 Q6FGJ8,Tetraspanin-9,Tetraspan NET-5;, PF00335;, GO:0005925;GO:0005887;GO:0005886;GO:0097197;, C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:tetraspanin-enriched microdomain; scaffold374 indexed_genome mRNA 54310 55632 . + . ID=transcript_16664;Q96A72,Protein mago nashi homolog 2,, PF02792;, GO:0071013;GO:0035145;GO:0043025;GO:0005654;GO:0005634;GO:0071006;GO:0071005;GO:0003723;GO:0031124;GO:0006406;GO:0000398;GO:0000184;GO:0006405;GO:0008380;, C:catalytic step 2 spliceosome; C:exon-exon junction complex; C:neuronal cell body; C:nucleoplasm; C:nucleus; C:U2-type catalytic step 1 spliceosome; C:U2-type precatalytic spliceosome;, F:RNA binding;, P:mRNA 3'-end processing; P:mRNA export from nucleus; P:mRNA splicing, via spliceosome; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:RNA export from nucleus; P:RNA splicing; scaffold377 indexed_genome mRNA 25802 27958 . + . ID=transcript_16665;Q6IQ02 Q96KX3 Q9HCW6 Q9HCW7 Q9HCW8,Transcription factor IIIB 90 kDa subunit,B-related factor 1;TAF3B2;TATA box-binding protein-associated factor, RNA polymerase III, subunit 2;, PF07741;PF08271;PF00382;, GO:0005654;GO:0005634;GO:0000126;GO:0097550;GO:0046872;GO:0000995;GO:0001006;GO:0017025;GO:0006352;GO:0045945;GO:0009303;GO:0006383;GO:0006384;GO:0070897;GO:0009304;, C:nucleoplasm; C:nucleus; C:transcription factor TFIIIB complex; C:transcription preinitiation complex;, F:metal ion binding; F:RNA polymerase III general transcription initiation factor activity; F:RNA polymerase III type 3 promoter sequence-specific DNA binding; F:TBP-class protein binding;, P:DNA-templated transcription, initiation; P:positive regulation of transcription by RNA polymerase III; P:rRNA transcription; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:transcription preinitiation complex assembly; P:tRNA transcription;|Q6IQ02 Q96KX3 Q9HCW6 Q9HCW7 Q9HCW8,Transcription factor IIIB 90 kDa subunit,B-related factor 1;TAF3B2;TATA box-binding protein-associated factor, RNA polymerase III, subunit 2;, PF07741;PF08271;PF00382;, GO:0005654;GO:0005634;GO:0000126;GO:0097550;GO:0046872;GO:0000995;GO:0001006;GO:0017025;GO:0006352;GO:0045945;GO:0009303;GO:0006383;GO:0006384;GO:0070897;GO:0009304;, C:nucleoplasm; C:nucleus; C:transcription factor TFIIIB complex; C:transcription preinitiation complex;, F:metal ion binding; F:RNA polymerase III general transcription initiation factor activity; F:RNA polymerase III type 3 promoter sequence-specific DNA binding; F:TBP-class protein binding;, P:DNA-templated transcription, initiation; P:positive regulation of transcription by RNA polymerase III; P:rRNA transcription; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:transcription preinitiation complex assembly; P:tRNA transcription; scaffold381 indexed_genome mRNA 11556 19641 . - . ID=transcript_16666;Q9NV57,1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase {ECO:0000255|HAMAP-Rule:MF_03154},Acireductone dioxygenase (Fe(2+)-requiring) {ECO:0000255|HAMAP-Rule:MF_03154};Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein 1 {ECO:0000255|HAMAP-Rule:MF_03154};Submergence-induced protein-like factor;, PF03079;, GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0010309;GO:0005506;GO:0016491;GO:0019509;GO:0006555;, C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;, F:acireductone dioxygenase [iron(II)-requiring] activity; F:iron ion binding; F:oxidoreductase activity;, P:L-methionine salvage from methylthioadenosine; P:methionine metabolic process;|Q9NV57,1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase {ECO:0000255|HAMAP-Rule:MF_03154},Acireductone dioxygenase (Fe(2+)-requiring) {ECO:0000255|HAMAP-Rule:MF_03154};Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein 1 {ECO:0000255|HAMAP-Rule:MF_03154};Submergence-induced protein-like factor;, PF03079;, GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0010309;GO:0005506;GO:0016491;GO:0019509;GO:0006555;, C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;, F:acireductone dioxygenase [iron(II)-requiring] activity; F:iron ion binding; F:oxidoreductase activity;, P:L-methionine salvage from methylthioadenosine; P:methionine metabolic process; scaffold381 indexed_genome mRNA 51278 61070 . - . ID=transcript_16667;O60930 B3KQU4 O60523 O60857 Q57Z93 Q5U0C1 Q6FHD4,Ribonuclease H1,Ribonuclease H type II;, PF01693;PF00075;, GO:0005737;GO:0000287;GO:0003676;GO:0004540;GO:0003723;GO:0004523;GO:0043137;GO:0006401;GO:0090502;, C:cytoplasm;, F:magnesium ion binding; F:nucleic acid binding; F:ribonuclease activity; F:RNA binding; F:RNA-DNA hybrid ribonuclease activity;, P:DNA replication, removal of RNA primer; P:RNA catabolic process; P:RNA phosphodiester bond hydrolysis, endonucleolytic;|O60930 B3KQU4 O60523 O60857 Q57Z93 Q5U0C1 Q6FHD4,Ribonuclease H1,Ribonuclease H type II;, PF01693;PF00075;, GO:0005737;GO:0000287;GO:0003676;GO:0004540;GO:0003723;GO:0004523;GO:0043137;GO:0006401;GO:0090502;, C:cytoplasm;, F:magnesium ion binding; F:nucleic acid binding; F:ribonuclease activity; F:RNA binding; F:RNA-DNA hybrid ribonuclease activity;, P:DNA replication, removal of RNA primer; P:RNA catabolic process; P:RNA phosphodiester bond hydrolysis, endonucleolytic; scaffold381 indexed_genome mRNA 71972 76667 . + . ID=transcript_16668;P62081 P23821 P24818 Q57Z92 Q6IPH1,40S ribosomal protein S7,Small ribosomal subunit protein eS7 {ECO:0000303|PubMed:24524803};, PF01251;, GO:0005829;GO:0022627;GO:0005925;GO:0016020;GO:0005815;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:1990904;GO:0005840;GO:0032040;GO:0045202;GO:0003730;GO:0048027;GO:0008266;GO:0019901;GO:0003723;GO:0003735;GO:1990948;GO:0030154;GO:1904667;GO:2000059;GO:0001843;GO:0000184;GO:0010628;GO:1902255;GO:0050821;GO:0042274;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic small ribosomal subunit; C:focal adhesion; C:membrane; C:microtubule organizing center; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:ribonucleoprotein complex; C:ribosome; C:small-subunit processome; C:synapse;, F:mRNA 3'-UTR binding; F:mRNA 5'-UTR binding; F:poly(U) RNA binding; F:protein kinase binding; F:RNA binding; F:structural constituent of ribosome; F:ubiquitin ligase inhibitor activity;, P:cell differentiation; P:negative regulation of ubiquitin protein ligase activity; P:negative regulation of ubiquitin-dependent protein catabolic process; P:neural tube closure; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:positive regulation of gene expression; P:positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; P:protein stabilization; P:ribosomal small subunit biogenesis; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold381 indexed_genome mRNA 80412 103900 . + . ID=transcript_16669;B4E1G0 J3KQY9 Q5CZ85 Q7Z6N1,Collectin-11,Collectin kidney protein 1;, PF01391;PF00059;, GO:0005581;GO:0005576;GO:0005615;GO:0005509;GO:0120153;GO:0003677;GO:0042806;GO:0005537;GO:0070492;GO:0019730;GO:0006956;GO:0001867;GO:0032502;GO:0097194;GO:0007275;GO:0006898;, C:collagen trimer; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:calcium-dependent carbohydrate binding; F:DNA binding; F:fucose binding; F:mannose binding; F:oligosaccharide binding;, P:antimicrobial humoral response; P:complement activation; P:complement activation, lectin pathway; P:developmental process; P:execution phase of apoptosis; P:multicellular organism development; P:receptor-mediated endocytosis;|B4E1G0 J3KQY9 Q5CZ85 Q7Z6N1,Collectin-11,Collectin kidney protein 1;, PF01391;PF00059;, GO:0005581;GO:0005576;GO:0005615;GO:0005509;GO:0120153;GO:0003677;GO:0042806;GO:0005537;GO:0070492;GO:0019730;GO:0006956;GO:0001867;GO:0032502;GO:0097194;GO:0007275;GO:0006898;, C:collagen trimer; C:extracellular region; C:extracellular space;, F:calcium ion binding; F:calcium-dependent carbohydrate binding; F:DNA binding; F:fucose binding; F:mannose binding; F:oligosaccharide binding;, P:antimicrobial humoral response; P:complement activation; P:complement activation, lectin pathway; P:developmental process; P:execution phase of apoptosis; P:multicellular organism development; P:receptor-mediated endocytosis; scaffold405 indexed_genome mRNA 32327 35088 . - . ID=transcript_16670;A4D2P6,Delphilin,Glutamate receptor, ionotropic, delta 2-interacting protein 1;, PF02181;PF00595;, GO:0045211;GO:0060292;, C:postsynaptic membrane;, , P:long-term synaptic depression; scaffold408 indexed_genome mRNA 26583 98963 . + . ID=transcript_16671;Q9UKA2 B2R7Q5 E1P530 O95919 Q5BJH0 Q9UJU0,F-box/LRR-repeat protein 4,F-box and leucine-rich repeat protein 4;F-box protein FBL4/FBL5;, PF00646;, GO:0005829;GO:0005758;GO:0016607;GO:0019005;GO:0000151;GO:0043687;GO:0000209;GO:0031146;GO:0006511;, C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9UKA2 B2R7Q5 E1P530 O95919 Q5BJH0 Q9UJU0,F-box/LRR-repeat protein 4,F-box and leucine-rich repeat protein 4;F-box protein FBL4/FBL5;, PF00646;, GO:0005829;GO:0005758;GO:0016607;GO:0019005;GO:0000151;GO:0043687;GO:0000209;GO:0031146;GO:0006511;, C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9UKA2 B2R7Q5 E1P530 O95919 Q5BJH0 Q9UJU0,F-box/LRR-repeat protein 4,F-box and leucine-rich repeat protein 4;F-box protein FBL4/FBL5;, PF00646;, GO:0005829;GO:0005758;GO:0016607;GO:0019005;GO:0000151;GO:0043687;GO:0000209;GO:0031146;GO:0006511;, C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9UKA2 B2R7Q5 E1P530 O95919 Q5BJH0 Q9UJU0,F-box/LRR-repeat protein 4,F-box and leucine-rich repeat protein 4;F-box protein FBL4/FBL5;, PF00646;, GO:0005829;GO:0005758;GO:0016607;GO:0019005;GO:0000151;GO:0043687;GO:0000209;GO:0031146;GO:0006511;, C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9UKA2 B2R7Q5 E1P530 O95919 Q5BJH0 Q9UJU0,F-box/LRR-repeat protein 4,F-box and leucine-rich repeat protein 4;F-box protein FBL4/FBL5;, PF00646;, GO:0005829;GO:0005758;GO:0016607;GO:0019005;GO:0000151;GO:0043687;GO:0000209;GO:0031146;GO:0006511;, C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process; scaffold409 indexed_genome mRNA 26577 98906 . + . ID=transcript_16672;Q9UKA2 B2R7Q5 E1P530 O95919 Q5BJH0 Q9UJU0,F-box/LRR-repeat protein 4,F-box and leucine-rich repeat protein 4;F-box protein FBL4/FBL5;, PF00646;, GO:0005829;GO:0005758;GO:0016607;GO:0019005;GO:0000151;GO:0043687;GO:0000209;GO:0031146;GO:0006511;, C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9UKA2 B2R7Q5 E1P530 O95919 Q5BJH0 Q9UJU0,F-box/LRR-repeat protein 4,F-box and leucine-rich repeat protein 4;F-box protein FBL4/FBL5;, PF00646;, GO:0005829;GO:0005758;GO:0016607;GO:0019005;GO:0000151;GO:0043687;GO:0000209;GO:0031146;GO:0006511;, C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9UKA2 B2R7Q5 E1P530 O95919 Q5BJH0 Q9UJU0,F-box/LRR-repeat protein 4,F-box and leucine-rich repeat protein 4;F-box protein FBL4/FBL5;, PF00646;, GO:0005829;GO:0005758;GO:0016607;GO:0019005;GO:0000151;GO:0043687;GO:0000209;GO:0031146;GO:0006511;, C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process;|Q9UKA2 B2R7Q5 E1P530 O95919 Q5BJH0 Q9UJU0,F-box/LRR-repeat protein 4,F-box and leucine-rich repeat protein 4;F-box protein FBL4/FBL5;, PF00646;, GO:0005829;GO:0005758;GO:0016607;GO:0019005;GO:0000151;GO:0043687;GO:0000209;GO:0031146;GO:0006511;, C:cytosol; C:mitochondrial intermembrane space; C:nuclear speck; C:SCF ubiquitin ligase complex; C:ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process; scaffold411 indexed_genome mRNA 93801 96648 . + . ID=transcript_16673;Q96LY2 Q6NW18,Coiled-coil domain-containing protein 74B,, PF14917;PF14916; scaffold412 indexed_genome mRNA 62021 71235 . + . ID=transcript_16674;O00303 A8K0S2 Q6IB45 Q8N978,Eukaryotic translation initiation factor 3 subunit F {ECO:0000255|HAMAP-Rule:MF_03005},Deubiquitinating enzyme eIF3f;Eukaryotic translation initiation factor 3 subunit 5 {ECO:0000255|HAMAP-Rule:MF_03005};eIF-3-epsilon {ECO:0000255|HAMAP-Rule:MF_03005};eIF3 p47 {ECO:0000255|HAMAP-Rule:MF_03005};, PF01398;PF13012;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0016020;GO:0008234;GO:0042802;GO:0070122;GO:0008237;GO:0004843;GO:0003743;GO:0031369;GO:0101005;GO:0001732;GO:0075522;GO:0016579;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane;, F:cysteine-type peptidase activity; F:identical protein binding; F:isopeptidase activity; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:translation initiation factor activity; F:translation initiation factor binding; F:ubiquitinyl hydrolase activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:protein deubiquitination; P:translational initiation;|O00303 A8K0S2 Q6IB45 Q8N978,Eukaryotic translation initiation factor 3 subunit F {ECO:0000255|HAMAP-Rule:MF_03005},Deubiquitinating enzyme eIF3f;Eukaryotic translation initiation factor 3 subunit 5 {ECO:0000255|HAMAP-Rule:MF_03005};eIF-3-epsilon {ECO:0000255|HAMAP-Rule:MF_03005};eIF3 p47 {ECO:0000255|HAMAP-Rule:MF_03005};, PF01398;PF13012;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0016020;GO:0008234;GO:0042802;GO:0070122;GO:0008237;GO:0004843;GO:0003743;GO:0031369;GO:0101005;GO:0001732;GO:0075522;GO:0016579;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane;, F:cysteine-type peptidase activity; F:identical protein binding; F:isopeptidase activity; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:translation initiation factor activity; F:translation initiation factor binding; F:ubiquitinyl hydrolase activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:protein deubiquitination; P:translational initiation;|O00303 A8K0S2 Q6IB45 Q8N978,Eukaryotic translation initiation factor 3 subunit F {ECO:0000255|HAMAP-Rule:MF_03005},Deubiquitinating enzyme eIF3f;Eukaryotic translation initiation factor 3 subunit 5 {ECO:0000255|HAMAP-Rule:MF_03005};eIF-3-epsilon {ECO:0000255|HAMAP-Rule:MF_03005};eIF3 p47 {ECO:0000255|HAMAP-Rule:MF_03005};, PF01398;PF13012;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0016020;GO:0008234;GO:0042802;GO:0070122;GO:0008237;GO:0004843;GO:0003743;GO:0031369;GO:0101005;GO:0001732;GO:0075522;GO:0016579;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane;, F:cysteine-type peptidase activity; F:identical protein binding; F:isopeptidase activity; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:translation initiation factor activity; F:translation initiation factor binding; F:ubiquitinyl hydrolase activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:protein deubiquitination; P:translational initiation;|O00303 A8K0S2 Q6IB45 Q8N978,Eukaryotic translation initiation factor 3 subunit F {ECO:0000255|HAMAP-Rule:MF_03005},Deubiquitinating enzyme eIF3f;Eukaryotic translation initiation factor 3 subunit 5 {ECO:0000255|HAMAP-Rule:MF_03005};eIF-3-epsilon {ECO:0000255|HAMAP-Rule:MF_03005};eIF3 p47 {ECO:0000255|HAMAP-Rule:MF_03005};, PF01398;PF13012;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0016020;GO:0008234;GO:0042802;GO:0070122;GO:0008237;GO:0004843;GO:0003743;GO:0031369;GO:0101005;GO:0001732;GO:0075522;GO:0016579;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane;, F:cysteine-type peptidase activity; F:identical protein binding; F:isopeptidase activity; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:translation initiation factor activity; F:translation initiation factor binding; F:ubiquitinyl hydrolase activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:protein deubiquitination; P:translational initiation; scaffold421 indexed_genome mRNA 66821 75789 . - . ID=transcript_16675;Q8IX01 C9JI71 O15071 O60369 Q5JPH7 Q8WUF7,SURP and G-patch domain-containing protein 2,Arginine/serine-rich-splicing factor 14;Splicing factor, arginine/serine-rich 14;, PF01585;PF01805;, GO:0016604;GO:0005654;GO:0003723;GO:0006397;GO:0008380;, C:nuclear body; C:nucleoplasm;, F:RNA binding;, P:mRNA processing; P:RNA splicing;|Q8IX01 C9JI71 O15071 O60369 Q5JPH7 Q8WUF7,SURP and G-patch domain-containing protein 2,Arginine/serine-rich-splicing factor 14;Splicing factor, arginine/serine-rich 14;, PF01585;PF01805;, GO:0016604;GO:0005654;GO:0003723;GO:0006397;GO:0008380;, C:nuclear body; C:nucleoplasm;, F:RNA binding;, P:mRNA processing; P:RNA splicing; scaffold421 indexed_genome mRNA 76798 77360 . - . ID=transcript_16676;Q71UM5 Q9BTJ1,40S ribosomal protein S27-like,Small ribosomal subunit protein eS27-like;, PF01667;, GO:0022627;GO:0005634;GO:0008656;GO:0046872;GO:0003723;GO:0003735;GO:0008494;GO:0006919;GO:0006978;GO:0042771;GO:0031571;GO:0045727;GO:0000028;GO:0006412;, C:cytosolic small ribosomal subunit; C:nucleus;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:metal ion binding; F:RNA binding; F:structural constituent of ribosome; F:translation activator activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic G1 DNA damage checkpoint; P:positive regulation of translation; P:ribosomal small subunit assembly; P:translation; scaffold424 indexed_genome mRNA 16237 77273 . - . ID=transcript_16677;Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion;|Q99569 Q86W91,Plakophilin-4,p0071;, PF00514;, GO:0005912;GO:0030054;GO:0005911;GO:0001533;GO:0005737;GO:0009898;GO:0005856;GO:0030057;GO:0030496;GO:0072686;GO:0005634;GO:0048471;GO:0005886;GO:0051233;GO:0000922;GO:0045296;GO:0098609;GO:0007043;GO:0007267;GO:0070268;GO:0031424;GO:0032467;GO:0043547;GO:0030155;, C:adherens junction; C:cell junction; C:cell-cell junction; C:cornified envelope; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytoskeleton; C:desmosome; C:midbody; C:mitotic spindle; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:spindle midzone; C:spindle pole;, F:cadherin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-cell signaling; P:cornification; P:keratinization; P:positive regulation of cytokinesis; P:positive regulation of GTPase activity; P:regulation of cell adhesion; scaffold425 indexed_genome mRNA 1833 5221 . + . ID=transcript_16678;Q5T7W7 A6NMJ4 A8K584 Q6ZQZ6 Q8IYM3 Q8WY73 Q96ML6 Q96MU1,Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2,Rhodanese domain-containing protein 2;, PF00581;PF12368;PF17773;|Q5T7W7 A6NMJ4 A8K584 Q6ZQZ6 Q8IYM3 Q8WY73 Q96ML6 Q96MU1,Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2,Rhodanese domain-containing protein 2;, PF00581;PF12368;PF17773; scaffold425 indexed_genome mRNA 8093 8771 . - . ID=transcript_16679;P28289 B2RB77 Q5T7W3 Q9BUF1,Tropomodulin-1,Erythrocyte tropomodulin;, PF03250;, GO:0005884;GO:0030863;GO:0005856;GO:0005829;GO:0016020;GO:0030016;GO:0030017;GO:0005865;GO:0003779;GO:0051015;GO:0005523;GO:0007015;GO:0008344;GO:0070307;GO:0006936;GO:0030049;GO:0030239;GO:0051694;, C:actin filament; C:cortical cytoskeleton; C:cytoskeleton; C:cytosol; C:membrane; C:myofibril; C:sarcomere; C:striated muscle thin filament;, F:actin binding; F:actin filament binding; F:tropomyosin binding;, P:actin filament organization; P:adult locomotory behavior; P:lens fiber cell development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:pointed-end actin filament capping; scaffold425 indexed_genome mRNA 12345 14518 . + . ID=transcript_16680;P28289 B2RB77 Q5T7W3 Q9BUF1,Tropomodulin-1,Erythrocyte tropomodulin;, PF03250;, GO:0005884;GO:0030863;GO:0005856;GO:0005829;GO:0016020;GO:0030016;GO:0030017;GO:0005865;GO:0003779;GO:0051015;GO:0005523;GO:0007015;GO:0008344;GO:0070307;GO:0006936;GO:0030049;GO:0030239;GO:0051694;, C:actin filament; C:cortical cytoskeleton; C:cytoskeleton; C:cytosol; C:membrane; C:myofibril; C:sarcomere; C:striated muscle thin filament;, F:actin binding; F:actin filament binding; F:tropomyosin binding;, P:actin filament organization; P:adult locomotory behavior; P:lens fiber cell development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:pointed-end actin filament capping; scaffold425 indexed_genome mRNA 33693 34308 . - . ID=transcript_16681;P28289 B2RB77 Q5T7W3 Q9BUF1,Tropomodulin-1,Erythrocyte tropomodulin;, PF03250;, GO:0005884;GO:0030863;GO:0005856;GO:0005829;GO:0016020;GO:0030016;GO:0030017;GO:0005865;GO:0003779;GO:0051015;GO:0005523;GO:0007015;GO:0008344;GO:0070307;GO:0006936;GO:0030049;GO:0030239;GO:0051694;, C:actin filament; C:cortical cytoskeleton; C:cytoskeleton; C:cytosol; C:membrane; C:myofibril; C:sarcomere; C:striated muscle thin filament;, F:actin binding; F:actin filament binding; F:tropomyosin binding;, P:actin filament organization; P:adult locomotory behavior; P:lens fiber cell development; P:muscle contraction; P:muscle filament sliding; P:myofibril assembly; P:pointed-end actin filament capping; scaffold429 indexed_genome mRNA 33294 42496 . - . ID=transcript_16682;Q494V2 D3DNA8 Q494V1 Q494V4 Q8N838,Cilia- and flagella-associated protein 100 {ECO:0000305},Coiled-coil domain-containing protein 37 {ECO:0000305};, PF13863;, GO:0097545;GO:0036064;GO:0031514;GO:0070840;GO:0003341;GO:0036159;GO:2000574;, C:axonemal outer doublet; C:ciliary basal body; C:motile cilium;, F:dynein complex binding;, P:cilium movement; P:inner dynein arm assembly; P:regulation of microtubule motor activity; scaffold429 indexed_genome mRNA 42729 58788 . - . ID=transcript_16683;Q494V2 D3DNA8 Q494V1 Q494V4 Q8N838,Cilia- and flagella-associated protein 100 {ECO:0000305},Coiled-coil domain-containing protein 37 {ECO:0000305};, PF13863;, GO:0097545;GO:0036064;GO:0031514;GO:0070840;GO:0003341;GO:0036159;GO:2000574;, C:axonemal outer doublet; C:ciliary basal body; C:motile cilium;, F:dynein complex binding;, P:cilium movement; P:inner dynein arm assembly; P:regulation of microtubule motor activity; scaffold429 indexed_genome mRNA 85812 89123 . - . ID=transcript_16684;Q9UIH9,Krueppel-like factor 15,Kidney-enriched krueppel-like factor;, PF00096;, GO:0000785;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0014898;GO:0001678;GO:1901653;GO:0010001;GO:0072112;GO:2000757;GO:0046326;GO:0045944;GO:0006357;GO:0030111;GO:0032868;, C:chromatin; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;, P:cardiac muscle hypertrophy in response to stress; P:cellular glucose homeostasis; P:cellular response to peptide; P:glial cell differentiation; P:glomerular visceral epithelial cell differentiation; P:negative regulation of peptidyl-lysine acetylation; P:positive regulation of glucose import; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of Wnt signaling pathway; P:response to insulin; scaffold430 indexed_genome mRNA 16678 36050 . - . ID=transcript_16685;Q9Y3F4 B2R5S5 B4DNJ6 Q5TZT4 Q9NTK0 Q9UQC8,Serine-threonine kinase receptor-associated protein,MAP activator with WD repeats;UNR-interacting protein;WD-40 repeat protein PT-WD;, PF00400;, GO:0005737;GO:0005829;GO:0005634;GO:0032797;GO:0034719;GO:0003723;GO:0005102;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0000122;GO:0030512;GO:0000387;, C:cytoplasm; C:cytosol; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:RNA binding; F:signaling receptor binding;, P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:spliceosomal snRNP assembly;|Q9Y3F4 B2R5S5 B4DNJ6 Q5TZT4 Q9NTK0 Q9UQC8,Serine-threonine kinase receptor-associated protein,MAP activator with WD repeats;UNR-interacting protein;WD-40 repeat protein PT-WD;, PF00400;, GO:0005737;GO:0005829;GO:0005634;GO:0032797;GO:0034719;GO:0003723;GO:0005102;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0000122;GO:0030512;GO:0000387;, C:cytoplasm; C:cytosol; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:RNA binding; F:signaling receptor binding;, P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:spliceosomal snRNP assembly;|Q9Y3F4 B2R5S5 B4DNJ6 Q5TZT4 Q9NTK0 Q9UQC8,Serine-threonine kinase receptor-associated protein,MAP activator with WD repeats;UNR-interacting protein;WD-40 repeat protein PT-WD;, PF00400;, GO:0005737;GO:0005829;GO:0005634;GO:0032797;GO:0034719;GO:0003723;GO:0005102;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0000122;GO:0030512;GO:0000387;, C:cytoplasm; C:cytosol; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:RNA binding; F:signaling receptor binding;, P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:spliceosomal snRNP assembly;|Q9Y3F4 B2R5S5 B4DNJ6 Q5TZT4 Q9NTK0 Q9UQC8,Serine-threonine kinase receptor-associated protein,MAP activator with WD repeats;UNR-interacting protein;WD-40 repeat protein PT-WD;, PF00400;, GO:0005737;GO:0005829;GO:0005634;GO:0032797;GO:0034719;GO:0003723;GO:0005102;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0000122;GO:0030512;GO:0000387;, C:cytoplasm; C:cytosol; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:RNA binding; F:signaling receptor binding;, P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:spliceosomal snRNP assembly;|P23434 Q9H1E9,Glycine cleavage system H protein, mitochondrial {ECO:0000303|PubMed:1671321},Lipoic acid-containing protein;, PF01597;, GO:0005737;GO:0005960;GO:0005759;GO:0005739;GO:0004047;GO:0006546;GO:0019464;GO:0009249;, C:cytoplasm; C:glycine cleavage complex; C:mitochondrial matrix; C:mitochondrion;, F:aminomethyltransferase activity;, P:glycine catabolic process; P:glycine decarboxylation via glycine cleavage system; P:protein lipoylation;|Q9Y3F4 B2R5S5 B4DNJ6 Q5TZT4 Q9NTK0 Q9UQC8,Serine-threonine kinase receptor-associated protein,MAP activator with WD repeats;UNR-interacting protein;WD-40 repeat protein PT-WD;, PF00400;, GO:0005737;GO:0005829;GO:0005634;GO:0032797;GO:0034719;GO:0003723;GO:0005102;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0000122;GO:0030512;GO:0000387;, C:cytoplasm; C:cytosol; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:RNA binding; F:signaling receptor binding;, P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:spliceosomal snRNP assembly;|Q9Y3F4 B2R5S5 B4DNJ6 Q5TZT4 Q9NTK0 Q9UQC8,Serine-threonine kinase receptor-associated protein,MAP activator with WD repeats;UNR-interacting protein;WD-40 repeat protein PT-WD;, PF00400;, GO:0005737;GO:0005829;GO:0005634;GO:0032797;GO:0034719;GO:0003723;GO:0005102;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0000122;GO:0030512;GO:0000387;, C:cytoplasm; C:cytosol; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:RNA binding; F:signaling receptor binding;, P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:spliceosomal snRNP assembly; scaffold432 indexed_genome mRNA 16738 36117 . - . ID=transcript_16686;Q9Y3F4 B2R5S5 B4DNJ6 Q5TZT4 Q9NTK0 Q9UQC8,Serine-threonine kinase receptor-associated protein,MAP activator with WD repeats;UNR-interacting protein;WD-40 repeat protein PT-WD;, PF00400;, GO:0005737;GO:0005829;GO:0005634;GO:0032797;GO:0034719;GO:0003723;GO:0005102;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0000122;GO:0030512;GO:0000387;, C:cytoplasm; C:cytosol; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:RNA binding; F:signaling receptor binding;, P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:spliceosomal snRNP assembly;|Q9Y3F4 B2R5S5 B4DNJ6 Q5TZT4 Q9NTK0 Q9UQC8,Serine-threonine kinase receptor-associated protein,MAP activator with WD repeats;UNR-interacting protein;WD-40 repeat protein PT-WD;, PF00400;, GO:0005737;GO:0005829;GO:0005634;GO:0032797;GO:0034719;GO:0003723;GO:0005102;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0000122;GO:0030512;GO:0000387;, C:cytoplasm; C:cytosol; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:RNA binding; F:signaling receptor binding;, P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:spliceosomal snRNP assembly;|Q9Y3F4 B2R5S5 B4DNJ6 Q5TZT4 Q9NTK0 Q9UQC8,Serine-threonine kinase receptor-associated protein,MAP activator with WD repeats;UNR-interacting protein;WD-40 repeat protein PT-WD;, PF00400;, GO:0005737;GO:0005829;GO:0005634;GO:0032797;GO:0034719;GO:0003723;GO:0005102;GO:0030277;GO:0010633;GO:0050680;GO:0010719;GO:0060394;GO:0000122;GO:0030512;GO:0000387;, C:cytoplasm; C:cytosol; C:nucleus; C:SMN complex; C:SMN-Sm protein complex;, F:RNA binding; F:signaling receptor binding;, P:maintenance of gastrointestinal epithelium; P:negative regulation of epithelial cell migration; P:negative regulation of epithelial cell proliferation; P:negative regulation of epithelial to mesenchymal transition; P:negative regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:spliceosomal snRNP assembly; scaffold434 indexed_genome mRNA 1304 3618 . - . ID=transcript_16687;P35236 B3KXE1 Q53XK4 Q5SXQ0 Q5SXQ1 Q9BV05,Tyrosine-protein phosphatase non-receptor type 7,Hematopoietic protein-tyrosine phosphatase;Protein-tyrosine phosphatase LC-PTP;, PF00102;, GO:0005737;GO:0009898;GO:0005829;GO:0015630;GO:0072686;GO:0005654;GO:0004725;GO:0071345;GO:0000165;GO:0006470;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:microtubule cytoskeleton; C:mitotic spindle; C:nucleoplasm;, F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:MAPK cascade; P:protein dephosphorylation;|P35236 B3KXE1 Q53XK4 Q5SXQ0 Q5SXQ1 Q9BV05,Tyrosine-protein phosphatase non-receptor type 7,Hematopoietic protein-tyrosine phosphatase;Protein-tyrosine phosphatase LC-PTP;, PF00102;, GO:0005737;GO:0009898;GO:0005829;GO:0015630;GO:0072686;GO:0005654;GO:0004725;GO:0071345;GO:0000165;GO:0006470;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:microtubule cytoskeleton; C:mitotic spindle; C:nucleoplasm;, F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:MAPK cascade; P:protein dephosphorylation; scaffold434 indexed_genome mRNA 5343 8880 . - . ID=transcript_16688;Q96BM9 B3KXD0,ADP-ribosylation factor-like protein 8A,ADP-ribosylation factor-like protein 10B;Novel small G protein indispensable for equal chromosome segregation 2;, PF00025;, GO:1904115;GO:0035577;GO:0005737;GO:0070062;GO:0101003;GO:0031902;GO:0005765;GO:0016020;GO:0030496;GO:0005886;GO:0051233;GO:0045202;GO:0005774;GO:0043014;GO:0048487;GO:0005525;GO:0003924;GO:0008089;GO:0007049;GO:0051301;GO:0007059;GO:0043312;GO:0015031;, C:axon cytoplasm; C:azurophil granule membrane; C:cytoplasm; C:extracellular exosome; C:ficolin-1-rich granule membrane; C:late endosome membrane; C:lysosomal membrane; C:membrane; C:midbody; C:plasma membrane; C:spindle midzone; C:synapse; C:vacuolar membrane;, F:alpha-tubulin binding; F:beta-tubulin binding; F:GTP binding; F:GTPase activity;, P:anterograde axonal transport; P:cell cycle; P:cell division; P:chromosome segregation; P:neutrophil degranulation; P:protein transport; scaffold434 indexed_genome mRNA 15697 16859 . - . ID=transcript_16689;O60883 B2R7M9 Q5SXP7 Q86VP7,G-protein coupled receptor 37-like 1,Endothelin B receptor-like protein 2;, PF00001;, GO:0060170;GO:0016021;GO:0005886;GO:0043235;GO:0008528;GO:0004930;GO:0042277;GO:0036505;GO:0007193;GO:0007186;GO:0048712;GO:1903206;GO:0045665;GO:0045879;GO:0003085;GO:0021940;GO:0043410;, C:ciliary membrane; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity; F:peptide binding; F:prosaposin receptor activity;, P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:negative regulation of astrocyte differentiation; P:negative regulation of hydrogen peroxide-induced cell death; P:negative regulation of neuron differentiation; P:negative regulation of smoothened signaling pathway; P:negative regulation of systemic arterial blood pressure; P:positive regulation of cerebellar granule cell precursor proliferation; P:positive regulation of MAPK cascade; scaffold434 indexed_genome mRNA 29968 30632 . - . ID=transcript_16690;Q9NV57,1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase {ECO:0000255|HAMAP-Rule:MF_03154},Acireductone dioxygenase (Fe(2+)-requiring) {ECO:0000255|HAMAP-Rule:MF_03154};Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein 1 {ECO:0000255|HAMAP-Rule:MF_03154};Submergence-induced protein-like factor;, PF03079;, GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0010309;GO:0005506;GO:0016491;GO:0019509;GO:0006555;, C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;, F:acireductone dioxygenase [iron(II)-requiring] activity; F:iron ion binding; F:oxidoreductase activity;, P:L-methionine salvage from methylthioadenosine; P:methionine metabolic process; scaffold434 indexed_genome mRNA 84793 89373 . + . ID=transcript_16691;P78545 B2R5Q6 Q6IAP8 Q7RU03 Q7Z3X2 Q8NFG2 Q99718,ETS-related transcription factor Elf-3,E74-like factor 3;Epithelial-restricted with serine box;Epithelium-restricted Ets protein ESX;Epithelium-specific Ets transcription factor 1;, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0001824;GO:0030154;GO:0030855;GO:0030198;GO:0006954;GO:0060056;GO:0045892;GO:0045747;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:blastocyst development; P:cell differentiation; P:epithelial cell differentiation; P:extracellular matrix organization; P:inflammatory response; P:mammary gland involution; P:negative regulation of transcription, DNA-templated; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|P78545 B2R5Q6 Q6IAP8 Q7RU03 Q7Z3X2 Q8NFG2 Q99718,ETS-related transcription factor Elf-3,E74-like factor 3;Epithelial-restricted with serine box;Epithelium-restricted Ets protein ESX;Epithelium-specific Ets transcription factor 1;, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0001824;GO:0030154;GO:0030855;GO:0030198;GO:0006954;GO:0060056;GO:0045892;GO:0045747;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:blastocyst development; P:cell differentiation; P:epithelial cell differentiation; P:extracellular matrix organization; P:inflammatory response; P:mammary gland involution; P:negative regulation of transcription, DNA-templated; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|P78545 B2R5Q6 Q6IAP8 Q7RU03 Q7Z3X2 Q8NFG2 Q99718,ETS-related transcription factor Elf-3,E74-like factor 3;Epithelial-restricted with serine box;Epithelium-restricted Ets protein ESX;Epithelium-specific Ets transcription factor 1;, PF00178;PF02198;, GO:0000785;GO:0005829;GO:0005794;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0001824;GO:0030154;GO:0030855;GO:0030198;GO:0006954;GO:0060056;GO:0045892;GO:0045747;GO:0045944;GO:0006357;GO:0006366;, C:chromatin; C:cytosol; C:Golgi apparatus; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:blastocyst development; P:cell differentiation; P:epithelial cell differentiation; P:extracellular matrix organization; P:inflammatory response; P:mammary gland involution; P:negative regulation of transcription, DNA-templated; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold436 indexed_genome mRNA 77917 78917 . - . ID=transcript_16692;Q3ZCU0 Q8N9C3,Protein GVQW3 {ECO:0000305},GVQW motif-containing protein 3 {ECO:0000305};, PF17906; scaffold437 indexed_genome mRNA 36096 54139 . - . ID=transcript_16693;Q99489 A8KAG4 Q5JXM4 Q5JXM5 Q5JXM6 Q8N552,D-aspartate oxidase,, PF01266;, GO:0005737;GO:0005829;GO:0005782;GO:0005777;GO:0003884;GO:0008445;GO:0071949;GO:0006533;GO:0019752;GO:0019478;GO:0007625;GO:0042445;GO:0007320;GO:0008104;, C:cytoplasm; C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:D-amino-acid oxidase activity; F:D-aspartate oxidase activity; F:FAD binding;, P:aspartate catabolic process; P:carboxylic acid metabolic process; P:D-amino acid catabolic process; P:grooming behavior; P:hormone metabolic process; P:insemination; P:protein localization;|Q99489 A8KAG4 Q5JXM4 Q5JXM5 Q5JXM6 Q8N552,D-aspartate oxidase,, PF01266;, GO:0005737;GO:0005829;GO:0005782;GO:0005777;GO:0003884;GO:0008445;GO:0071949;GO:0006533;GO:0019752;GO:0019478;GO:0007625;GO:0042445;GO:0007320;GO:0008104;, C:cytoplasm; C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:D-amino-acid oxidase activity; F:D-aspartate oxidase activity; F:FAD binding;, P:aspartate catabolic process; P:carboxylic acid metabolic process; P:D-amino acid catabolic process; P:grooming behavior; P:hormone metabolic process; P:insemination; P:protein localization; scaffold437 indexed_genome mRNA 60253 89365 . - . ID=transcript_16694;Q86VW1 O14567 Q5JXM1 Q8IUG8 Q8IZD5 Q96M90 Q96RU0,Solute carrier family 22 member 16,Carnitine transporter 2;Fly-like putative transporter 2;Organic cation transporter OKB1;Organic cation/carnitine transporter 6;, PF00083;, GO:0005829;GO:0016021;GO:0005886;GO:0005275;GO:0015226;GO:0015101;GO:0046717;GO:0015879;GO:0030154;GO:0030317;GO:0007275;GO:0015695;GO:0007338;GO:0007283;, C:cytosol; C:integral component of membrane; C:plasma membrane;, F:amine transmembrane transporter activity; F:carnitine transmembrane transporter activity; F:organic cation transmembrane transporter activity;, P:acid secretion; P:carnitine transport; P:cell differentiation; P:flagellated sperm motility; P:multicellular organism development; P:organic cation transport; P:single fertilization; P:spermatogenesis;|Q86VW1 O14567 Q5JXM1 Q8IUG8 Q8IZD5 Q96M90 Q96RU0,Solute carrier family 22 member 16,Carnitine transporter 2;Fly-like putative transporter 2;Organic cation transporter OKB1;Organic cation/carnitine transporter 6;, PF00083;, GO:0005829;GO:0016021;GO:0005886;GO:0005275;GO:0015226;GO:0015101;GO:0046717;GO:0015879;GO:0030154;GO:0030317;GO:0007275;GO:0015695;GO:0007338;GO:0007283;, C:cytosol; C:integral component of membrane; C:plasma membrane;, F:amine transmembrane transporter activity; F:carnitine transmembrane transporter activity; F:organic cation transmembrane transporter activity;, P:acid secretion; P:carnitine transport; P:cell differentiation; P:flagellated sperm motility; P:multicellular organism development; P:organic cation transport; P:single fertilization; P:spermatogenesis; scaffold438 indexed_genome mRNA 46322 47089 . + . ID=transcript_16695;Q99489 A8KAG4 Q5JXM4 Q5JXM5 Q5JXM6 Q8N552,D-aspartate oxidase,, PF01266;, GO:0005737;GO:0005829;GO:0005782;GO:0005777;GO:0003884;GO:0008445;GO:0071949;GO:0006533;GO:0019752;GO:0019478;GO:0007625;GO:0042445;GO:0007320;GO:0008104;, C:cytoplasm; C:cytosol; C:peroxisomal matrix; C:peroxisome;, F:D-amino-acid oxidase activity; F:D-aspartate oxidase activity; F:FAD binding;, P:aspartate catabolic process; P:carboxylic acid metabolic process; P:D-amino acid catabolic process; P:grooming behavior; P:hormone metabolic process; P:insemination; P:protein localization; scaffold438 indexed_genome mRNA 60247 89318 . - . ID=transcript_16696;Q86VW1 O14567 Q5JXM1 Q8IUG8 Q8IZD5 Q96M90 Q96RU0,Solute carrier family 22 member 16,Carnitine transporter 2;Fly-like putative transporter 2;Organic cation transporter OKB1;Organic cation/carnitine transporter 6;, PF00083;, GO:0005829;GO:0016021;GO:0005886;GO:0005275;GO:0015226;GO:0015101;GO:0046717;GO:0015879;GO:0030154;GO:0030317;GO:0007275;GO:0015695;GO:0007338;GO:0007283;, C:cytosol; C:integral component of membrane; C:plasma membrane;, F:amine transmembrane transporter activity; F:carnitine transmembrane transporter activity; F:organic cation transmembrane transporter activity;, P:acid secretion; P:carnitine transport; P:cell differentiation; P:flagellated sperm motility; P:multicellular organism development; P:organic cation transport; P:single fertilization; P:spermatogenesis;|Q86VW1 O14567 Q5JXM1 Q8IUG8 Q8IZD5 Q96M90 Q96RU0,Solute carrier family 22 member 16,Carnitine transporter 2;Fly-like putative transporter 2;Organic cation transporter OKB1;Organic cation/carnitine transporter 6;, PF00083;, GO:0005829;GO:0016021;GO:0005886;GO:0005275;GO:0015226;GO:0015101;GO:0046717;GO:0015879;GO:0030154;GO:0030317;GO:0007275;GO:0015695;GO:0007338;GO:0007283;, C:cytosol; C:integral component of membrane; C:plasma membrane;, F:amine transmembrane transporter activity; F:carnitine transmembrane transporter activity; F:organic cation transmembrane transporter activity;, P:acid secretion; P:carnitine transport; P:cell differentiation; P:flagellated sperm motility; P:multicellular organism development; P:organic cation transport; P:single fertilization; P:spermatogenesis; scaffold440 indexed_genome mRNA 14379 16885 . + . ID=transcript_16697;Q9H2T7 Q8IU74,Ran-binding protein 17,, PF03810;, GO:0005737;GO:0005643;GO:0005525;GO:0005049;GO:0031267;GO:0051028;GO:0006611;GO:0006606;, C:cytoplasm; C:nuclear pore;, F:GTP binding; F:nuclear export signal receptor activity; F:small GTPase binding;, P:mRNA transport; P:protein export from nucleus; P:protein import into nucleus;|Q9H2T7 Q8IU74,Ran-binding protein 17,, PF03810;, GO:0005737;GO:0005643;GO:0005525;GO:0005049;GO:0031267;GO:0051028;GO:0006611;GO:0006606;, C:cytoplasm; C:nuclear pore;, F:GTP binding; F:nuclear export signal receptor activity; F:small GTPase binding;, P:mRNA transport; P:protein export from nucleus; P:protein import into nucleus; scaffold440 indexed_genome mRNA 24783 27647 . - . ID=transcript_16698;O43711 Q96AD3,T-cell leukemia homeobox protein 3,Homeobox protein Hox-11L2;, PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0048513;GO:0007417;GO:0045665;GO:0048665;GO:0001764;GO:0002087;GO:0006357;GO:0007585;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ development; P:central nervous system development; P:negative regulation of neuron differentiation; P:neuron fate specification; P:neuron migration; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription by RNA polymerase II; P:respiratory gaseous exchange by respiratory system;|O43711 Q96AD3,T-cell leukemia homeobox protein 3,Homeobox protein Hox-11L2;, PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0048513;GO:0007417;GO:0045665;GO:0048665;GO:0001764;GO:0002087;GO:0006357;GO:0007585;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ development; P:central nervous system development; P:negative regulation of neuron differentiation; P:neuron fate specification; P:neuron migration; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription by RNA polymerase II; P:respiratory gaseous exchange by respiratory system;|O43711 Q96AD3,T-cell leukemia homeobox protein 3,Homeobox protein Hox-11L2;, PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0048513;GO:0007417;GO:0045665;GO:0048665;GO:0001764;GO:0002087;GO:0006357;GO:0007585;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ development; P:central nervous system development; P:negative regulation of neuron differentiation; P:neuron fate specification; P:neuron migration; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription by RNA polymerase II; P:respiratory gaseous exchange by respiratory system; scaffold440 indexed_genome mRNA 68561 80971 . + . ID=transcript_16699;Q96DC4 Q96EA5 Q9BYG9 Q9UDJ7,Nucleophosmin,Nucleolar phosphoprotein B23;Nucleolar protein NO38;Numatrin;, PF16276;PF03066;, GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:1990904;GO:0031616;GO:0033613;GO:0003682;GO:0001046;GO:0042393;GO:0051059;GO:0042803;GO:0019901;GO:0004860;GO:0043023;GO:0043024;GO:0003723;GO:0030957;GO:0003713;GO:0008134;GO:0051082;GO:0007569;GO:0034644;GO:0034080;GO:0007098;GO:0006338;GO:0006281;GO:0006886;GO:0043066;GO:0008285;GO:0010826;GO:0044387;GO:0006913;GO:0006334;GO:1902751;GO:0008284;GO:0051092;GO:0045944;GO:0045893;GO:0045727;GO:0008104;GO:0046599;GO:0010824;GO:0060735;GO:0032071;GO:0060699;GO:1902629;GO:0006357;GO:0042273;GO:0000055;GO:0042274;GO:0000056;GO:0042255;GO:0006407;GO:0007165;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:spindle pole centrosome;, F:activating transcription factor binding; F:chromatin binding; F:core promoter sequence-specific DNA binding; F:histone binding; F:NF-kappaB binding; F:protein homodimerization activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:ribosomal large subunit binding; F:ribosomal small subunit binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription factor binding; F:unfolded protein binding;, P:cell aging; P:cellular response to UV; P:CENP-A containing nucleosome assembly; P:centrosome cycle; P:chromatin remodeling; P:DNA repair; P:intracellular protein transport; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of centrosome duplication; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:nucleocytoplasmic transport; P:nucleosome assembly; P:positive regulation of cell cycle G2/M phase transition; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:protein localization; P:regulation of centriole replication; P:regulation of centrosome duplication; P:regulation of eIF2 alpha phosphorylation by dsRNA; P:regulation of endodeoxyribonuclease activity; P:regulation of endoribonuclease activity; P:regulation of mRNA stability involved in cellular response to UV; P:regulation of transcription by RNA polymerase II; P:ribosomal large subunit biogenesis; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus; P:ribosome assembly; P:rRNA export from nucleus; P:signal transduction; P:viral process;|Q96DC4 Q96EA5 Q9BYG9 Q9UDJ7,Nucleophosmin,Nucleolar phosphoprotein B23;Nucleolar protein NO38;Numatrin;, PF16276;PF03066;, GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:1990904;GO:0031616;GO:0033613;GO:0003682;GO:0001046;GO:0042393;GO:0051059;GO:0042803;GO:0019901;GO:0004860;GO:0043023;GO:0043024;GO:0003723;GO:0030957;GO:0003713;GO:0008134;GO:0051082;GO:0007569;GO:0034644;GO:0034080;GO:0007098;GO:0006338;GO:0006281;GO:0006886;GO:0043066;GO:0008285;GO:0010826;GO:0044387;GO:0006913;GO:0006334;GO:1902751;GO:0008284;GO:0051092;GO:0045944;GO:0045893;GO:0045727;GO:0008104;GO:0046599;GO:0010824;GO:0060735;GO:0032071;GO:0060699;GO:1902629;GO:0006357;GO:0042273;GO:0000055;GO:0042274;GO:0000056;GO:0042255;GO:0006407;GO:0007165;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:spindle pole centrosome;, F:activating transcription factor binding; F:chromatin binding; F:core promoter sequence-specific DNA binding; F:histone binding; F:NF-kappaB binding; F:protein homodimerization activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:ribosomal large subunit binding; F:ribosomal small subunit binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription factor binding; F:unfolded protein binding;, P:cell aging; P:cellular response to UV; P:CENP-A containing nucleosome assembly; P:centrosome cycle; P:chromatin remodeling; P:DNA repair; P:intracellular protein transport; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of centrosome duplication; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:nucleocytoplasmic transport; P:nucleosome assembly; P:positive regulation of cell cycle G2/M phase transition; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:protein localization; P:regulation of centriole replication; P:regulation of centrosome duplication; P:regulation of eIF2 alpha phosphorylation by dsRNA; P:regulation of endodeoxyribonuclease activity; P:regulation of endoribonuclease activity; P:regulation of mRNA stability involved in cellular response to UV; P:regulation of transcription by RNA polymerase II; P:ribosomal large subunit biogenesis; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus; P:ribosome assembly; P:rRNA export from nucleus; P:signal transduction; P:viral process;|Q96DC4 Q96EA5 Q9BYG9 Q9UDJ7,Nucleophosmin,Nucleolar phosphoprotein B23;Nucleolar protein NO38;Numatrin;, PF16276;PF03066;, GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:1990904;GO:0031616;GO:0033613;GO:0003682;GO:0001046;GO:0042393;GO:0051059;GO:0042803;GO:0019901;GO:0004860;GO:0043023;GO:0043024;GO:0003723;GO:0030957;GO:0003713;GO:0008134;GO:0051082;GO:0007569;GO:0034644;GO:0034080;GO:0007098;GO:0006338;GO:0006281;GO:0006886;GO:0043066;GO:0008285;GO:0010826;GO:0044387;GO:0006913;GO:0006334;GO:1902751;GO:0008284;GO:0051092;GO:0045944;GO:0045893;GO:0045727;GO:0008104;GO:0046599;GO:0010824;GO:0060735;GO:0032071;GO:0060699;GO:1902629;GO:0006357;GO:0042273;GO:0000055;GO:0042274;GO:0000056;GO:0042255;GO:0006407;GO:0007165;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:spindle pole centrosome;, F:activating transcription factor binding; F:chromatin binding; F:core promoter sequence-specific DNA binding; F:histone binding; F:NF-kappaB binding; F:protein homodimerization activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:ribosomal large subunit binding; F:ribosomal small subunit binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription factor binding; F:unfolded protein binding;, P:cell aging; P:cellular response to UV; P:CENP-A containing nucleosome assembly; P:centrosome cycle; P:chromatin remodeling; P:DNA repair; P:intracellular protein transport; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of centrosome duplication; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:nucleocytoplasmic transport; P:nucleosome assembly; P:positive regulation of cell cycle G2/M phase transition; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:protein localization; P:regulation of centriole replication; P:regulation of centrosome duplication; P:regulation of eIF2 alpha phosphorylation by dsRNA; P:regulation of endodeoxyribonuclease activity; P:regulation of endoribonuclease activity; P:regulation of mRNA stability involved in cellular response to UV; P:regulation of transcription by RNA polymerase II; P:ribosomal large subunit biogenesis; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus; P:ribosome assembly; P:rRNA export from nucleus; P:signal transduction; P:viral process; scaffold441 indexed_genome mRNA 12556 13232 . - . ID=transcript_16700;Q9H2T7 Q8IU74,Ran-binding protein 17,, PF03810;, GO:0005737;GO:0005643;GO:0005525;GO:0005049;GO:0031267;GO:0051028;GO:0006611;GO:0006606;, C:cytoplasm; C:nuclear pore;, F:GTP binding; F:nuclear export signal receptor activity; F:small GTPase binding;, P:mRNA transport; P:protein export from nucleus; P:protein import into nucleus; scaffold441 indexed_genome mRNA 14375 16881 . + . ID=transcript_16701;Q9H2T7 Q8IU74,Ran-binding protein 17,, PF03810;, GO:0005737;GO:0005643;GO:0005525;GO:0005049;GO:0031267;GO:0051028;GO:0006611;GO:0006606;, C:cytoplasm; C:nuclear pore;, F:GTP binding; F:nuclear export signal receptor activity; F:small GTPase binding;, P:mRNA transport; P:protein export from nucleus; P:protein import into nucleus;|Q9H2T7 Q8IU74,Ran-binding protein 17,, PF03810;, GO:0005737;GO:0005643;GO:0005525;GO:0005049;GO:0031267;GO:0051028;GO:0006611;GO:0006606;, C:cytoplasm; C:nuclear pore;, F:GTP binding; F:nuclear export signal receptor activity; F:small GTPase binding;, P:mRNA transport; P:protein export from nucleus; P:protein import into nucleus; scaffold441 indexed_genome mRNA 24778 27643 . + . ID=transcript_16702;O43711 Q96AD3,T-cell leukemia homeobox protein 3,Homeobox protein Hox-11L2;, PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0048513;GO:0007417;GO:0045665;GO:0048665;GO:0001764;GO:0002087;GO:0006357;GO:0007585;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ development; P:central nervous system development; P:negative regulation of neuron differentiation; P:neuron fate specification; P:neuron migration; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription by RNA polymerase II; P:respiratory gaseous exchange by respiratory system;|O43711 Q96AD3,T-cell leukemia homeobox protein 3,Homeobox protein Hox-11L2;, PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0048513;GO:0007417;GO:0045665;GO:0048665;GO:0001764;GO:0002087;GO:0006357;GO:0007585;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ development; P:central nervous system development; P:negative regulation of neuron differentiation; P:neuron fate specification; P:neuron migration; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription by RNA polymerase II; P:respiratory gaseous exchange by respiratory system;|O43711 Q96AD3,T-cell leukemia homeobox protein 3,Homeobox protein Hox-11L2;, PF00046;, GO:0000785;GO:0005654;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0048513;GO:0007417;GO:0045665;GO:0048665;GO:0001764;GO:0002087;GO:0006357;GO:0007585;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:animal organ development; P:central nervous system development; P:negative regulation of neuron differentiation; P:neuron fate specification; P:neuron migration; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of transcription by RNA polymerase II; P:respiratory gaseous exchange by respiratory system; scaffold441 indexed_genome mRNA 71029 72380 . + . ID=transcript_16703;Q96DC4 Q96EA5 Q9BYG9 Q9UDJ7,Nucleophosmin,Nucleolar phosphoprotein B23;Nucleolar protein NO38;Numatrin;, PF16276;PF03066;, GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:1990904;GO:0031616;GO:0033613;GO:0003682;GO:0001046;GO:0042393;GO:0051059;GO:0042803;GO:0019901;GO:0004860;GO:0043023;GO:0043024;GO:0003723;GO:0030957;GO:0003713;GO:0008134;GO:0051082;GO:0007569;GO:0034644;GO:0034080;GO:0007098;GO:0006338;GO:0006281;GO:0006886;GO:0043066;GO:0008285;GO:0010826;GO:0044387;GO:0006913;GO:0006334;GO:1902751;GO:0008284;GO:0051092;GO:0045944;GO:0045893;GO:0045727;GO:0008104;GO:0046599;GO:0010824;GO:0060735;GO:0032071;GO:0060699;GO:1902629;GO:0006357;GO:0042273;GO:0000055;GO:0042274;GO:0000056;GO:0042255;GO:0006407;GO:0007165;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:spindle pole centrosome;, F:activating transcription factor binding; F:chromatin binding; F:core promoter sequence-specific DNA binding; F:histone binding; F:NF-kappaB binding; F:protein homodimerization activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:ribosomal large subunit binding; F:ribosomal small subunit binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription factor binding; F:unfolded protein binding;, P:cell aging; P:cellular response to UV; P:CENP-A containing nucleosome assembly; P:centrosome cycle; P:chromatin remodeling; P:DNA repair; P:intracellular protein transport; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of centrosome duplication; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:nucleocytoplasmic transport; P:nucleosome assembly; P:positive regulation of cell cycle G2/M phase transition; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:protein localization; P:regulation of centriole replication; P:regulation of centrosome duplication; P:regulation of eIF2 alpha phosphorylation by dsRNA; P:regulation of endodeoxyribonuclease activity; P:regulation of endoribonuclease activity; P:regulation of mRNA stability involved in cellular response to UV; P:regulation of transcription by RNA polymerase II; P:ribosomal large subunit biogenesis; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus; P:ribosome assembly; P:rRNA export from nucleus; P:signal transduction; P:viral process; scaffold441 indexed_genome mRNA 77811 80531 . + . ID=transcript_16704;Q96DC4 Q96EA5 Q9BYG9 Q9UDJ7,Nucleophosmin,Nucleolar phosphoprotein B23;Nucleolar protein NO38;Numatrin;, PF16276;PF03066;, GO:0005813;GO:0005737;GO:0005829;GO:0005925;GO:0016020;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0032993;GO:1990904;GO:0031616;GO:0033613;GO:0003682;GO:0001046;GO:0042393;GO:0051059;GO:0042803;GO:0019901;GO:0004860;GO:0043023;GO:0043024;GO:0003723;GO:0030957;GO:0003713;GO:0008134;GO:0051082;GO:0007569;GO:0034644;GO:0034080;GO:0007098;GO:0006338;GO:0006281;GO:0006886;GO:0043066;GO:0008285;GO:0010826;GO:0044387;GO:0006913;GO:0006334;GO:1902751;GO:0008284;GO:0051092;GO:0045944;GO:0045893;GO:0045727;GO:0008104;GO:0046599;GO:0010824;GO:0060735;GO:0032071;GO:0060699;GO:1902629;GO:0006357;GO:0042273;GO:0000055;GO:0042274;GO:0000056;GO:0042255;GO:0006407;GO:0007165;GO:0016032;, C:centrosome; C:cytoplasm; C:cytosol; C:focal adhesion; C:membrane; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:protein-DNA complex; C:ribonucleoprotein complex; C:spindle pole centrosome;, F:activating transcription factor binding; F:chromatin binding; F:core promoter sequence-specific DNA binding; F:histone binding; F:NF-kappaB binding; F:protein homodimerization activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:ribosomal large subunit binding; F:ribosomal small subunit binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription factor binding; F:unfolded protein binding;, P:cell aging; P:cellular response to UV; P:CENP-A containing nucleosome assembly; P:centrosome cycle; P:chromatin remodeling; P:DNA repair; P:intracellular protein transport; P:negative regulation of apoptotic process; P:negative regulation of cell population proliferation; P:negative regulation of centrosome duplication; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; P:nucleocytoplasmic transport; P:nucleosome assembly; P:positive regulation of cell cycle G2/M phase transition; P:positive regulation of cell population proliferation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of translation; P:protein localization; P:regulation of centriole replication; P:regulation of centrosome duplication; P:regulation of eIF2 alpha phosphorylation by dsRNA; P:regulation of endodeoxyribonuclease activity; P:regulation of endoribonuclease activity; P:regulation of mRNA stability involved in cellular response to UV; P:regulation of transcription by RNA polymerase II; P:ribosomal large subunit biogenesis; P:ribosomal large subunit export from nucleus; P:ribosomal small subunit biogenesis; P:ribosomal small subunit export from nucleus; P:ribosome assembly; P:rRNA export from nucleus; P:signal transduction; P:viral process; scaffold443 indexed_genome mRNA 71997 76148 . + . ID=transcript_16705;Q9NPD8 Q2TU36,Ubiquitin-conjugating enzyme E2 T,Cell proliferation-inducing gene 50 protein;E2 ubiquitin-conjugating enzyme T;Ubiquitin carrier protein T;Ubiquitin-protein ligase T;, PF00179;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0061631;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0036297;GO:0051865;GO:0070979;GO:0044314;GO:0035519;GO:0070936;GO:0085020;GO:0070534;GO:0006513;GO:0000209;GO:0016567;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:interstrand cross-link repair; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K27-linked ubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9NPD8 Q2TU36,Ubiquitin-conjugating enzyme E2 T,Cell proliferation-inducing gene 50 protein;E2 ubiquitin-conjugating enzyme T;Ubiquitin carrier protein T;Ubiquitin-protein ligase T;, PF00179;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0061631;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0036297;GO:0051865;GO:0070979;GO:0044314;GO:0035519;GO:0070936;GO:0085020;GO:0070534;GO:0006513;GO:0000209;GO:0016567;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:interstrand cross-link repair; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K27-linked ubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination;|Q9NPD8 Q2TU36,Ubiquitin-conjugating enzyme E2 T,Cell proliferation-inducing gene 50 protein;E2 ubiquitin-conjugating enzyme T;Ubiquitin carrier protein T;Ubiquitin-protein ligase T;, PF00179;, GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003682;GO:0061631;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0036297;GO:0051865;GO:0070979;GO:0044314;GO:0035519;GO:0070936;GO:0085020;GO:0070534;GO:0006513;GO:0000209;GO:0016567;, C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:chromatin binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;, P:cellular response to DNA damage stimulus; P:DNA repair; P:interstrand cross-link repair; P:protein autoubiquitination; P:protein K11-linked ubiquitination; P:protein K27-linked ubiquitination; P:protein K29-linked ubiquitination; P:protein K48-linked ubiquitination; P:protein K6-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; scaffold445 indexed_genome mRNA 64998 81588 . + . ID=transcript_16706;P48059 B2RAJ4 B7Z483 B7Z7R3 B7Z907 Q53TE0 Q9BS44,LIM and senescent cell antigen-like-containing domain protein 1,Particularly interesting new Cys-His protein 1;Renal carcinoma antigen NY-REN-48;, PF00412;, GO:0005911;GO:0005737;GO:0005829;GO:0005925;GO:0048471;GO:0005886;GO:0032991;GO:0019901;GO:0044877;GO:0008270;GO:0007569;GO:0034329;GO:0098609;GO:0045216;GO:0071560;GO:0045184;GO:0045892;GO:0010811;GO:0051894;GO:0010628;GO:0043547;GO:2001046;GO:1901224;GO:1900026;GO:0033209;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:protein kinase binding; F:protein-containing complex binding; F:zinc ion binding;, P:cell aging; P:cell junction assembly; P:cell-cell adhesion; P:cell-cell junction organization; P:cellular response to transforming growth factor beta stimulus; P:establishment of protein localization; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell-substrate adhesion; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of substrate adhesion-dependent cell spreading; P:tumor necrosis factor-mediated signaling pathway;|P48059 B2RAJ4 B7Z483 B7Z7R3 B7Z907 Q53TE0 Q9BS44,LIM and senescent cell antigen-like-containing domain protein 1,Particularly interesting new Cys-His protein 1;Renal carcinoma antigen NY-REN-48;, PF00412;, GO:0005911;GO:0005737;GO:0005829;GO:0005925;GO:0048471;GO:0005886;GO:0032991;GO:0019901;GO:0044877;GO:0008270;GO:0007569;GO:0034329;GO:0098609;GO:0045216;GO:0071560;GO:0045184;GO:0045892;GO:0010811;GO:0051894;GO:0010628;GO:0043547;GO:2001046;GO:1901224;GO:1900026;GO:0033209;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:focal adhesion; C:perinuclear region of cytoplasm; C:plasma membrane; C:protein-containing complex;, F:protein kinase binding; F:protein-containing complex binding; F:zinc ion binding;, P:cell aging; P:cell junction assembly; P:cell-cell adhesion; P:cell-cell junction organization; P:cellular response to transforming growth factor beta stimulus; P:establishment of protein localization; P:negative regulation of transcription, DNA-templated; P:positive regulation of cell-substrate adhesion; P:positive regulation of focal adhesion assembly; P:positive regulation of gene expression; P:positive regulation of GTPase activity; P:positive regulation of integrin-mediated signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of substrate adhesion-dependent cell spreading; P:tumor necrosis factor-mediated signaling pathway; scaffold448 indexed_genome mRNA 36590 40406 . - . ID=transcript_16707;Q9BT75,Xaa-Pro dipeptidase,Imidodipeptidase;Peptidase D;Proline dipeptidase;, PF05195;PF00557;, GO:0070062;GO:0030145;GO:0070006;GO:0004181;GO:0008233;GO:0102009;GO:0006520;GO:0030574;GO:0006508;, C:extracellular exosome;, F:manganese ion binding; F:metalloaminopeptidase activity; F:metallocarboxypeptidase activity; F:peptidase activity; F:proline dipeptidase activity;, P:cellular amino acid metabolic process; P:collagen catabolic process; P:proteolysis;|Q9BT75,Xaa-Pro dipeptidase,Imidodipeptidase;Peptidase D;Proline dipeptidase;, PF05195;PF00557;, GO:0070062;GO:0030145;GO:0070006;GO:0004181;GO:0008233;GO:0102009;GO:0006520;GO:0030574;GO:0006508;, C:extracellular exosome;, F:manganese ion binding; F:metalloaminopeptidase activity; F:metallocarboxypeptidase activity; F:peptidase activity; F:proline dipeptidase activity;, P:cellular amino acid metabolic process; P:collagen catabolic process; P:proteolysis; scaffold448 indexed_genome mRNA 47610 52921 . + . ID=transcript_16708;P53567 B2R946 Q5U052,CCAAT/enhancer-binding protein gamma,, PF07716;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0042802;GO:0044877;GO:0000978;GO:0044377;GO:0043565;GO:1990837;GO:0008134;GO:0030183;GO:0043353;GO:0006955;GO:0001889;GO:0016071;GO:0042267;GO:0043433;GO:0043388;GO:0045739;GO:0051091;GO:0032729;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding, bending; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:B cell differentiation; P:enucleate erythrocyte differentiation; P:immune response; P:liver development; P:mRNA metabolic process; P:natural killer cell mediated cytotoxicity; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of DNA binding; P:positive regulation of DNA repair; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of interferon-gamma production; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold449 indexed_genome mRNA 36573 40389 . - . ID=transcript_16709;Q9BT75,Xaa-Pro dipeptidase,Imidodipeptidase;Peptidase D;Proline dipeptidase;, PF05195;PF00557;, GO:0070062;GO:0030145;GO:0070006;GO:0004181;GO:0008233;GO:0102009;GO:0006520;GO:0030574;GO:0006508;, C:extracellular exosome;, F:manganese ion binding; F:metalloaminopeptidase activity; F:metallocarboxypeptidase activity; F:peptidase activity; F:proline dipeptidase activity;, P:cellular amino acid metabolic process; P:collagen catabolic process; P:proteolysis;|Q9BT75,Xaa-Pro dipeptidase,Imidodipeptidase;Peptidase D;Proline dipeptidase;, PF05195;PF00557;, GO:0070062;GO:0030145;GO:0070006;GO:0004181;GO:0008233;GO:0102009;GO:0006520;GO:0030574;GO:0006508;, C:extracellular exosome;, F:manganese ion binding; F:metalloaminopeptidase activity; F:metallocarboxypeptidase activity; F:peptidase activity; F:proline dipeptidase activity;, P:cellular amino acid metabolic process; P:collagen catabolic process; P:proteolysis; scaffold449 indexed_genome mRNA 47589 52900 . + . ID=transcript_16710;P53567 B2R946 Q5U052,CCAAT/enhancer-binding protein gamma,, PF07716;, GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0001228;GO:0000981;GO:0042802;GO:0044877;GO:0000978;GO:0044377;GO:0043565;GO:1990837;GO:0008134;GO:0030183;GO:0043353;GO:0006955;GO:0001889;GO:0016071;GO:0042267;GO:0043433;GO:0043388;GO:0045739;GO:0051091;GO:0032729;GO:0045944;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein-containing complex binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding, bending; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;, P:B cell differentiation; P:enucleate erythrocyte differentiation; P:immune response; P:liver development; P:mRNA metabolic process; P:natural killer cell mediated cytotoxicity; P:negative regulation of DNA-binding transcription factor activity; P:positive regulation of DNA binding; P:positive regulation of DNA repair; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of interferon-gamma production; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold450 indexed_genome mRNA 655 12628 . - . ID=transcript_16711;P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process;|P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process;|P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process;|P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process;|P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process;|P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process; scaffold450 indexed_genome mRNA 18606 41337 . - . ID=transcript_16712;Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly; scaffold450 indexed_genome mRNA 47579 65692 . - . ID=transcript_16713;Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting;|Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting;|Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting;|Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting;|Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting;|Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting; scaffold450 indexed_genome mRNA 71478 76672 . - . ID=transcript_16714;Q9BUF0 Q9BUK2,Menin,, PF05053;, GO:0000785;GO:0000781;GO:0032154;GO:0005737;GO:0005829;GO:0005788;GO:0035097;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003690;GO:0000400;GO:0047485;GO:0030674;GO:0070412;GO:0000976;GO:0000403;GO:1904837;GO:0044267;GO:0006974;GO:0006281;GO:0034968;GO:0000165;GO:0045786;GO:0008285;GO:0045736;GO:0043433;GO:0046329;GO:0045668;GO:0001933;GO:0051974;GO:0000122;GO:0045892;GO:0002076;GO:0032092;GO:0045944;GO:0030511;GO:0043687;GO:0006357;GO:0010332;GO:0009411;, C:chromatin; C:chromosome, telomeric region; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:histone methyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:double-stranded DNA binding; F:four-way junction DNA binding; F:protein N-terminus binding; F:protein-macromolecule adaptor activity; F:R-SMAD binding; F:transcription regulatory region sequence-specific DNA binding; F:Y-form DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular protein metabolic process; P:cellular response to DNA damage stimulus; P:DNA repair; P:histone lysine methylation; P:MAPK cascade; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of JNK cascade; P:negative regulation of osteoblast differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoblast development; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:post-translational protein modification; P:regulation of transcription by RNA polymerase II; P:response to gamma radiation; P:response to UV;|Q9BUF0 Q9BUK2,Menin,, PF05053;, GO:0000785;GO:0000781;GO:0032154;GO:0005737;GO:0005829;GO:0005788;GO:0035097;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003690;GO:0000400;GO:0047485;GO:0030674;GO:0070412;GO:0000976;GO:0000403;GO:1904837;GO:0044267;GO:0006974;GO:0006281;GO:0034968;GO:0000165;GO:0045786;GO:0008285;GO:0045736;GO:0043433;GO:0046329;GO:0045668;GO:0001933;GO:0051974;GO:0000122;GO:0045892;GO:0002076;GO:0032092;GO:0045944;GO:0030511;GO:0043687;GO:0006357;GO:0010332;GO:0009411;, C:chromatin; C:chromosome, telomeric region; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:histone methyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:double-stranded DNA binding; F:four-way junction DNA binding; F:protein N-terminus binding; F:protein-macromolecule adaptor activity; F:R-SMAD binding; F:transcription regulatory region sequence-specific DNA binding; F:Y-form DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular protein metabolic process; P:cellular response to DNA damage stimulus; P:DNA repair; P:histone lysine methylation; P:MAPK cascade; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of JNK cascade; P:negative regulation of osteoblast differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoblast development; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:post-translational protein modification; P:regulation of transcription by RNA polymerase II; P:response to gamma radiation; P:response to UV;|Q9BUF0 Q9BUK2,Menin,, PF05053;, GO:0000785;GO:0000781;GO:0032154;GO:0005737;GO:0005829;GO:0005788;GO:0035097;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003690;GO:0000400;GO:0047485;GO:0030674;GO:0070412;GO:0000976;GO:0000403;GO:1904837;GO:0044267;GO:0006974;GO:0006281;GO:0034968;GO:0000165;GO:0045786;GO:0008285;GO:0045736;GO:0043433;GO:0046329;GO:0045668;GO:0001933;GO:0051974;GO:0000122;GO:0045892;GO:0002076;GO:0032092;GO:0045944;GO:0030511;GO:0043687;GO:0006357;GO:0010332;GO:0009411;, C:chromatin; C:chromosome, telomeric region; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:histone methyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:double-stranded DNA binding; F:four-way junction DNA binding; F:protein N-terminus binding; F:protein-macromolecule adaptor activity; F:R-SMAD binding; F:transcription regulatory region sequence-specific DNA binding; F:Y-form DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular protein metabolic process; P:cellular response to DNA damage stimulus; P:DNA repair; P:histone lysine methylation; P:MAPK cascade; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of JNK cascade; P:negative regulation of osteoblast differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoblast development; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:post-translational protein modification; P:regulation of transcription by RNA polymerase II; P:response to gamma radiation; P:response to UV; scaffold451 indexed_genome mRNA 1100 2182 . - . ID=transcript_16715;P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process; scaffold451 indexed_genome mRNA 3102 4710 . - . ID=transcript_16716;P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process; scaffold451 indexed_genome mRNA 5359 6565 . - . ID=transcript_16717;P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process;|P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process; scaffold451 indexed_genome mRNA 11038 11733 . + . ID=transcript_16718;P11217 A0AVK1 A6NDY6,Glycogen phosphorylase, muscle form,Myophosphorylase;, PF00343;, GO:0005737;GO:0005829;GO:0070062;GO:0008184;GO:0102250;GO:0000166;GO:0030170;GO:0102499;GO:0005980;GO:0005977;, C:cytoplasm; C:cytosol; C:extracellular exosome;, F:glycogen phosphorylase activity; F:linear malto-oligosaccharide phosphorylase activity; F:nucleotide binding; F:pyridoxal phosphate binding; F:SHG alpha-glucan phosphorylase activity;, P:glycogen catabolic process; P:glycogen metabolic process; scaffold451 indexed_genome mRNA 18602 41331 . - . ID=transcript_16719;Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly;|Q969H7 Q9BW01 Q9UEI0,Splicing factor 1,Mammalian branch point-binding protein;Transcription factor ZFM1;Zinc finger gene in MEN1 locus;Zinc finger protein 162;, PF00013;PF16275;PF00098;, GO:0005654;GO:0005634;GO:0005840;GO:0005681;GO:0042802;GO:0003729;GO:0045131;GO:0003723;GO:0003714;GO:0008270;GO:0000389;GO:0000398;GO:0048024;GO:0000245;, C:nucleoplasm; C:nucleus; C:ribosome; C:spliceosomal complex;, F:identical protein binding; F:mRNA binding; F:pre-mRNA branch point binding; F:RNA binding; F:transcription corepressor activity; F:zinc ion binding;, P:mRNA 3'-splice site recognition; P:mRNA splicing, via spliceosome; P:regulation of mRNA splicing, via spliceosome; P:spliceosomal complex assembly; scaffold451 indexed_genome mRNA 47573 65693 . - . ID=transcript_16720;Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting;|Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting;|Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting;|Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting;|Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting;|Q12851 Q86VU3,Mitogen-activated protein kinase kinase kinase kinase 2,B lymphocyte serine/threonine-protein kinase;Germinal center kinase;MAPK/ERK kinase kinase kinase 2;Rab8-interacting protein;, PF00780;PF00069;, GO:0016323;GO:0000139;GO:0005524;GO:0008349;GO:0031435;GO:0106310;GO:0004674;GO:0106311;GO:0007257;GO:0006955;GO:0045087;GO:0035556;GO:0007254;GO:0046330;GO:0006468;GO:0006903;, C:basolateral plasma membrane; C:Golgi membrane;, F:ATP binding; F:MAP kinase kinase kinase kinase activity; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:activation of JUN kinase activity; P:immune response; P:innate immune response; P:intracellular signal transduction; P:JNK cascade; P:positive regulation of JNK cascade; P:protein phosphorylation; P:vesicle targeting; scaffold451 indexed_genome mRNA 71479 76673 . - . ID=transcript_16721;Q9BUF0 Q9BUK2,Menin,, PF05053;, GO:0000785;GO:0000781;GO:0032154;GO:0005737;GO:0005829;GO:0005788;GO:0035097;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003690;GO:0000400;GO:0047485;GO:0030674;GO:0070412;GO:0000976;GO:0000403;GO:1904837;GO:0044267;GO:0006974;GO:0006281;GO:0034968;GO:0000165;GO:0045786;GO:0008285;GO:0045736;GO:0043433;GO:0046329;GO:0045668;GO:0001933;GO:0051974;GO:0000122;GO:0045892;GO:0002076;GO:0032092;GO:0045944;GO:0030511;GO:0043687;GO:0006357;GO:0010332;GO:0009411;, C:chromatin; C:chromosome, telomeric region; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:histone methyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:double-stranded DNA binding; F:four-way junction DNA binding; F:protein N-terminus binding; F:protein-macromolecule adaptor activity; F:R-SMAD binding; F:transcription regulatory region sequence-specific DNA binding; F:Y-form DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular protein metabolic process; P:cellular response to DNA damage stimulus; P:DNA repair; P:histone lysine methylation; P:MAPK cascade; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of JNK cascade; P:negative regulation of osteoblast differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoblast development; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:post-translational protein modification; P:regulation of transcription by RNA polymerase II; P:response to gamma radiation; P:response to UV;|Q9BUF0 Q9BUK2,Menin,, PF05053;, GO:0000785;GO:0000781;GO:0032154;GO:0005737;GO:0005829;GO:0005788;GO:0035097;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003690;GO:0000400;GO:0047485;GO:0030674;GO:0070412;GO:0000976;GO:0000403;GO:1904837;GO:0044267;GO:0006974;GO:0006281;GO:0034968;GO:0000165;GO:0045786;GO:0008285;GO:0045736;GO:0043433;GO:0046329;GO:0045668;GO:0001933;GO:0051974;GO:0000122;GO:0045892;GO:0002076;GO:0032092;GO:0045944;GO:0030511;GO:0043687;GO:0006357;GO:0010332;GO:0009411;, C:chromatin; C:chromosome, telomeric region; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:histone methyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:double-stranded DNA binding; F:four-way junction DNA binding; F:protein N-terminus binding; F:protein-macromolecule adaptor activity; F:R-SMAD binding; F:transcription regulatory region sequence-specific DNA binding; F:Y-form DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular protein metabolic process; P:cellular response to DNA damage stimulus; P:DNA repair; P:histone lysine methylation; P:MAPK cascade; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of JNK cascade; P:negative regulation of osteoblast differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoblast development; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:post-translational protein modification; P:regulation of transcription by RNA polymerase II; P:response to gamma radiation; P:response to UV;|Q9BUF0 Q9BUK2,Menin,, PF05053;, GO:0000785;GO:0000781;GO:0032154;GO:0005737;GO:0005829;GO:0005788;GO:0035097;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0003682;GO:0003690;GO:0000400;GO:0047485;GO:0030674;GO:0070412;GO:0000976;GO:0000403;GO:1904837;GO:0044267;GO:0006974;GO:0006281;GO:0034968;GO:0000165;GO:0045786;GO:0008285;GO:0045736;GO:0043433;GO:0046329;GO:0045668;GO:0001933;GO:0051974;GO:0000122;GO:0045892;GO:0002076;GO:0032092;GO:0045944;GO:0030511;GO:0043687;GO:0006357;GO:0010332;GO:0009411;, C:chromatin; C:chromosome, telomeric region; C:cleavage furrow; C:cytoplasm; C:cytosol; C:endoplasmic reticulum lumen; C:histone methyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:chromatin binding; F:double-stranded DNA binding; F:four-way junction DNA binding; F:protein N-terminus binding; F:protein-macromolecule adaptor activity; F:R-SMAD binding; F:transcription regulatory region sequence-specific DNA binding; F:Y-form DNA binding;, P:beta-catenin-TCF complex assembly; P:cellular protein metabolic process; P:cellular response to DNA damage stimulus; P:DNA repair; P:histone lysine methylation; P:MAPK cascade; P:negative regulation of cell cycle; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of JNK cascade; P:negative regulation of osteoblast differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of telomerase activity; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:osteoblast development; P:positive regulation of protein binding; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:post-translational protein modification; P:regulation of transcription by RNA polymerase II; P:response to gamma radiation; P:response to UV; scaffold452 indexed_genome mRNA 3078 6815 . - . ID=transcript_16722;Q96S55 B2RDB0 Q53EP6 Q59ET8 Q5W0E2 Q5W0E4 Q8WV26 Q9H681 Q9NRJ6,ATPase WRNIP1,Werner helicase-interacting protein 1;, PF00004;PF16193;PF12002;PF18279;, GO:0016020;GO:0005634;GO:0048471;GO:0005524;GO:0016887;GO:0003677;GO:0008047;GO:0042802;GO:0046872;GO:0017116;GO:0000731;GO:0006261;GO:0045087;GO:0006282;GO:0030174;, C:membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:DNA binding; F:enzyme activator activity; F:identical protein binding; F:metal ion binding; F:single-stranded DNA helicase activity;, P:DNA synthesis involved in DNA repair; P:DNA-dependent DNA replication; P:innate immune response; P:regulation of DNA repair; P:regulation of DNA-dependent DNA replication initiation; scaffold452 indexed_genome mRNA 6928 8001 . + . ID=transcript_16723;Q96S55 B2RDB0 Q53EP6 Q59ET8 Q5W0E2 Q5W0E4 Q8WV26 Q9H681 Q9NRJ6,ATPase WRNIP1,Werner helicase-interacting protein 1;, PF00004;PF16193;PF12002;PF18279;, GO:0016020;GO:0005634;GO:0048471;GO:0005524;GO:0016887;GO:0003677;GO:0008047;GO:0042802;GO:0046872;GO:0017116;GO:0000731;GO:0006261;GO:0045087;GO:0006282;GO:0030174;, C:membrane; C:nucleus; C:perinuclear region of cytoplasm;, F:ATP binding; F:ATPase activity; F:DNA binding; F:enzyme activator activity; F:identical protein binding; F:metal ion binding; F:single-stranded DNA helicase activity;, P:DNA synthesis involved in DNA repair; P:DNA-dependent DNA replication; P:innate immune response; P:regulation of DNA repair; P:regulation of DNA-dependent DNA replication initiation; scaffold453 indexed_genome mRNA 63613 64693 . - . ID=transcript_16724;Q9HA82 D6W665,Ceramide synthase 4 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 4 {ECO:0000250|UniProtKB:Q9D6J1};Sphingosine N-acyltransferase CERS4 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process; scaffold453 indexed_genome mRNA 68574 73241 . + . ID=transcript_16725;Q9HA82 D6W665,Ceramide synthase 4 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 4 {ECO:0000250|UniProtKB:Q9D6J1};Sphingosine N-acyltransferase CERS4 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process;|Q9HA82 D6W665,Ceramide synthase 4 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 4 {ECO:0000250|UniProtKB:Q9D6J1};Sphingosine N-acyltransferase CERS4 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process; scaffold454 indexed_genome mRNA 63605 64685 . - . ID=transcript_16726;Q9HA82 D6W665,Ceramide synthase 4 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 4 {ECO:0000250|UniProtKB:Q9D6J1};Sphingosine N-acyltransferase CERS4 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process; scaffold454 indexed_genome mRNA 70375 72437 . + . ID=transcript_16727;Q9HA82 D6W665,Ceramide synthase 4 {ECO:0000303|PubMed:17977534},LAG1 longevity assurance homolog 4 {ECO:0000250|UniProtKB:Q9D6J1};Sphingosine N-acyltransferase CERS4 {ECO:0000305};, PF00046;PF03798;, GO:0005783;GO:0005789;GO:0016021;GO:0003677;GO:0016410;GO:0050291;GO:0046513;GO:0030148;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:DNA binding; F:N-acyltransferase activity; F:sphingosine N-acyltransferase activity;, P:ceramide biosynthetic process; P:sphingolipid biosynthetic process; scaffold457 indexed_genome mRNA 2398 11833 . + . ID=transcript_16728;O00212,Rho-related GTP-binding protein RhoD,Rho-related protein HP1;, PF00071;, GO:0005938;GO:0042995;GO:0031410;GO:0005856;GO:0005829;GO:0005769;GO:0010008;GO:0043231;GO:0005886;GO:0005525;GO:0003924;GO:0019901;GO:0051017;GO:0007015;GO:0016477;GO:0030865;GO:0007163;GO:0048041;GO:0030032;GO:0045785;GO:0030335;GO:0032956;GO:0008360;GO:0051056;GO:0007266;, C:cell cortex; C:cell projection; C:cytoplasmic vesicle; C:cytoskeleton; C:cytosol; C:early endosome; C:endosome membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:GTP binding; F:GTPase activity; F:protein kinase binding;, P:actin filament bundle assembly; P:actin filament organization; P:cell migration; P:cortical cytoskeleton organization; P:establishment or maintenance of cell polarity; P:focal adhesion assembly; P:lamellipodium assembly; P:positive regulation of cell adhesion; P:positive regulation of cell migration; P:regulation of actin cytoskeleton organization; P:regulation of cell shape; P:regulation of small GTPase mediated signal transduction; P:Rho protein signal transduction; scaffold458 indexed_genome mRNA 3724 16482 . - . ID=transcript_16729;Q14493 B3KRJ5,Histone RNA hairpin-binding protein,Histone stem-loop-binding protein;, PF15247;, GO:0005737;GO:0005829;GO:0071204;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0071208;GO:0071207;GO:0042802;GO:0003729;GO:0003723;GO:0008334;GO:0006398;GO:0006406;GO:0051028;GO:0006369;, C:cytoplasm; C:cytosol; C:histone pre-mRNA 3'end processing complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:histone pre-mRNA DCP binding; F:histone pre-mRNA stem-loop binding; F:identical protein binding; F:mRNA binding; F:RNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA export from nucleus; P:mRNA transport; P:termination of RNA polymerase II transcription;|Q14493 B3KRJ5,Histone RNA hairpin-binding protein,Histone stem-loop-binding protein;, PF15247;, GO:0005737;GO:0005829;GO:0071204;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0071208;GO:0071207;GO:0042802;GO:0003729;GO:0003723;GO:0008334;GO:0006398;GO:0006406;GO:0051028;GO:0006369;, C:cytoplasm; C:cytosol; C:histone pre-mRNA 3'end processing complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:histone pre-mRNA DCP binding; F:histone pre-mRNA stem-loop binding; F:identical protein binding; F:mRNA binding; F:RNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA export from nucleus; P:mRNA transport; P:termination of RNA polymerase II transcription;|Q14493 B3KRJ5,Histone RNA hairpin-binding protein,Histone stem-loop-binding protein;, PF15247;, GO:0005737;GO:0005829;GO:0071204;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0071208;GO:0071207;GO:0042802;GO:0003729;GO:0003723;GO:0008334;GO:0006398;GO:0006406;GO:0051028;GO:0006369;, C:cytoplasm; C:cytosol; C:histone pre-mRNA 3'end processing complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:histone pre-mRNA DCP binding; F:histone pre-mRNA stem-loop binding; F:identical protein binding; F:mRNA binding; F:RNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA export from nucleus; P:mRNA transport; P:termination of RNA polymerase II transcription;|Q14493 B3KRJ5,Histone RNA hairpin-binding protein,Histone stem-loop-binding protein;, PF15247;, GO:0005737;GO:0005829;GO:0071204;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0071208;GO:0071207;GO:0042802;GO:0003729;GO:0003723;GO:0008334;GO:0006398;GO:0006406;GO:0051028;GO:0006369;, C:cytoplasm; C:cytosol; C:histone pre-mRNA 3'end processing complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:histone pre-mRNA DCP binding; F:histone pre-mRNA stem-loop binding; F:identical protein binding; F:mRNA binding; F:RNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA export from nucleus; P:mRNA transport; P:termination of RNA polymerase II transcription; scaffold458 indexed_genome mRNA 23002 27662 . + . ID=transcript_16730;A0AVI4 A6NH49 A6NI98 D3DVP8,E3 ubiquitin-protein ligase TM129,RING-type E3 ubiquitin transferase TM129 {ECO:0000305};, PF10272;, GO:0005783;GO:0005789;GO:0016021;GO:0046872;GO:0061630;GO:0000209;GO:0016567;GO:0006986;GO:0030970;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:protein ubiquitination; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; scaffold458 indexed_genome mRNA 28084 33301 . - . ID=transcript_16731;Q9Y6A5 Q2NKK4 Q3KQS5 Q9UMQ1,Transforming acidic coiled-coil-containing protein 3,ERIC-1;, PF05010;, GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0072686;GO:0000922;GO:0051301;GO:0008283;GO:0021987;GO:0007091;GO:0000226;GO:1902850;GO:0007052;GO:0060236;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:spindle pole;, , P:cell division; P:cell population proliferation; P:cerebral cortex development; P:metaphase/anaphase transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:microtubule cytoskeleton organization involved in mitosis; P:mitotic spindle organization; P:regulation of mitotic spindle organization; scaffold458 indexed_genome mRNA 33987 37745 . + . ID=transcript_16732;Q9Y6A5 Q2NKK4 Q3KQS5 Q9UMQ1,Transforming acidic coiled-coil-containing protein 3,ERIC-1;, PF05010;, GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0072686;GO:0000922;GO:0051301;GO:0008283;GO:0021987;GO:0007091;GO:0000226;GO:1902850;GO:0007052;GO:0060236;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:spindle pole;, , P:cell division; P:cell population proliferation; P:cerebral cortex development; P:metaphase/anaphase transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:microtubule cytoskeleton organization involved in mitosis; P:mitotic spindle organization; P:regulation of mitotic spindle organization;|Q9Y6A5 Q2NKK4 Q3KQS5 Q9UMQ1,Transforming acidic coiled-coil-containing protein 3,ERIC-1;, PF05010;, GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0072686;GO:0000922;GO:0051301;GO:0008283;GO:0021987;GO:0007091;GO:0000226;GO:1902850;GO:0007052;GO:0060236;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:spindle pole;, , P:cell division; P:cell population proliferation; P:cerebral cortex development; P:metaphase/anaphase transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:microtubule cytoskeleton organization involved in mitosis; P:mitotic spindle organization; P:regulation of mitotic spindle organization; scaffold459 indexed_genome mRNA 3724 16474 . - . ID=transcript_16733;Q14493 B3KRJ5,Histone RNA hairpin-binding protein,Histone stem-loop-binding protein;, PF15247;, GO:0005737;GO:0005829;GO:0071204;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0071208;GO:0071207;GO:0042802;GO:0003729;GO:0003723;GO:0008334;GO:0006398;GO:0006406;GO:0051028;GO:0006369;, C:cytoplasm; C:cytosol; C:histone pre-mRNA 3'end processing complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:histone pre-mRNA DCP binding; F:histone pre-mRNA stem-loop binding; F:identical protein binding; F:mRNA binding; F:RNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA export from nucleus; P:mRNA transport; P:termination of RNA polymerase II transcription;|Q14493 B3KRJ5,Histone RNA hairpin-binding protein,Histone stem-loop-binding protein;, PF15247;, GO:0005737;GO:0005829;GO:0071204;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0071208;GO:0071207;GO:0042802;GO:0003729;GO:0003723;GO:0008334;GO:0006398;GO:0006406;GO:0051028;GO:0006369;, C:cytoplasm; C:cytosol; C:histone pre-mRNA 3'end processing complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:histone pre-mRNA DCP binding; F:histone pre-mRNA stem-loop binding; F:identical protein binding; F:mRNA binding; F:RNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA export from nucleus; P:mRNA transport; P:termination of RNA polymerase II transcription;|Q14493 B3KRJ5,Histone RNA hairpin-binding protein,Histone stem-loop-binding protein;, PF15247;, GO:0005737;GO:0005829;GO:0071204;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0071208;GO:0071207;GO:0042802;GO:0003729;GO:0003723;GO:0008334;GO:0006398;GO:0006406;GO:0051028;GO:0006369;, C:cytoplasm; C:cytosol; C:histone pre-mRNA 3'end processing complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:histone pre-mRNA DCP binding; F:histone pre-mRNA stem-loop binding; F:identical protein binding; F:mRNA binding; F:RNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA export from nucleus; P:mRNA transport; P:termination of RNA polymerase II transcription;|Q14493 B3KRJ5,Histone RNA hairpin-binding protein,Histone stem-loop-binding protein;, PF15247;, GO:0005737;GO:0005829;GO:0071204;GO:0005730;GO:0005654;GO:0005634;GO:1990904;GO:0071208;GO:0071207;GO:0042802;GO:0003729;GO:0003723;GO:0008334;GO:0006398;GO:0006406;GO:0051028;GO:0006369;, C:cytoplasm; C:cytosol; C:histone pre-mRNA 3'end processing complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:ribonucleoprotein complex;, F:histone pre-mRNA DCP binding; F:histone pre-mRNA stem-loop binding; F:identical protein binding; F:mRNA binding; F:RNA binding;, P:histone mRNA metabolic process; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:mRNA export from nucleus; P:mRNA transport; P:termination of RNA polymerase II transcription; scaffold459 indexed_genome mRNA 22994 27654 . - . ID=transcript_16734;A0AVI4 A6NH49 A6NI98 D3DVP8,E3 ubiquitin-protein ligase TM129,RING-type E3 ubiquitin transferase TM129 {ECO:0000305};, PF10272;, GO:0005783;GO:0005789;GO:0016021;GO:0046872;GO:0061630;GO:0000209;GO:0016567;GO:0006986;GO:0030970;GO:0030433;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:protein ubiquitination; P:response to unfolded protein; P:retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway; scaffold459 indexed_genome mRNA 28076 33290 . + . ID=transcript_16735;Q9Y6A5 Q2NKK4 Q3KQS5 Q9UMQ1,Transforming acidic coiled-coil-containing protein 3,ERIC-1;, PF05010;, GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0072686;GO:0000922;GO:0051301;GO:0008283;GO:0021987;GO:0007091;GO:0000226;GO:1902850;GO:0007052;GO:0060236;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:spindle pole;, , P:cell division; P:cell population proliferation; P:cerebral cortex development; P:metaphase/anaphase transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:microtubule cytoskeleton organization involved in mitosis; P:mitotic spindle organization; P:regulation of mitotic spindle organization; scaffold459 indexed_genome mRNA 33974 37719 . + . ID=transcript_16736;Q9Y6A5 Q2NKK4 Q3KQS5 Q9UMQ1,Transforming acidic coiled-coil-containing protein 3,ERIC-1;, PF05010;, GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0072686;GO:0000922;GO:0051301;GO:0008283;GO:0021987;GO:0007091;GO:0000226;GO:1902850;GO:0007052;GO:0060236;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:spindle pole;, , P:cell division; P:cell population proliferation; P:cerebral cortex development; P:metaphase/anaphase transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:microtubule cytoskeleton organization involved in mitosis; P:mitotic spindle organization; P:regulation of mitotic spindle organization;|Q9Y6A5 Q2NKK4 Q3KQS5 Q9UMQ1,Transforming acidic coiled-coil-containing protein 3,ERIC-1;, PF05010;, GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0072686;GO:0000922;GO:0051301;GO:0008283;GO:0021987;GO:0007091;GO:0000226;GO:1902850;GO:0007052;GO:0060236;, C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:mitotic spindle; C:spindle pole;, , P:cell division; P:cell population proliferation; P:cerebral cortex development; P:metaphase/anaphase transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:microtubule cytoskeleton organization involved in mitosis; P:mitotic spindle organization; P:regulation of mitotic spindle organization; scaffold460 indexed_genome mRNA 1620 4113 . + . ID=transcript_16737;Q9NYQ8 O75091 Q9NSR7,Protocadherin Fat 2,Cadherin family member 8;Multiple epidermal growth factor-like domains protein 1;, PF00028;PF00008;PF02210;, GO:0005912;GO:0070062;GO:0005794;GO:0016021;GO:0005886;GO:0005509;GO:0098609;GO:0031589;GO:0010631;GO:0007156;, C:adherens junction; C:extracellular exosome; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;, F:calcium ion binding;, P:cell-cell adhesion; P:cell-substrate adhesion; P:epithelial cell migration; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold460 indexed_genome mRNA 18214 30714 . - . ID=transcript_16738;C9J3V5,Testis-expressed protein 22,, , GO:0001669;, C:acrosomal vesicle;|C9J3V5,Testis-expressed protein 22,, , GO:0001669;, C:acrosomal vesicle; scaffold460 indexed_genome mRNA 32741 44427 . - . ID=transcript_16739;Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process;|Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process; scaffold460 indexed_genome mRNA 78831 81078 . + . ID=transcript_16740;Q6IQ02 Q96KX3 Q9HCW6 Q9HCW7 Q9HCW8,Transcription factor IIIB 90 kDa subunit,B-related factor 1;TAF3B2;TATA box-binding protein-associated factor, RNA polymerase III, subunit 2;, PF07741;PF08271;PF00382;, GO:0005654;GO:0005634;GO:0000126;GO:0097550;GO:0046872;GO:0000995;GO:0001006;GO:0017025;GO:0006352;GO:0045945;GO:0009303;GO:0006383;GO:0006384;GO:0070897;GO:0009304;, C:nucleoplasm; C:nucleus; C:transcription factor TFIIIB complex; C:transcription preinitiation complex;, F:metal ion binding; F:RNA polymerase III general transcription initiation factor activity; F:RNA polymerase III type 3 promoter sequence-specific DNA binding; F:TBP-class protein binding;, P:DNA-templated transcription, initiation; P:positive regulation of transcription by RNA polymerase III; P:rRNA transcription; P:transcription by RNA polymerase III; P:transcription initiation from RNA polymerase III promoter; P:transcription preinitiation complex assembly; P:tRNA transcription; scaffold460 indexed_genome mRNA 81589 83973 . - . ID=transcript_16741;Q96KE9 Q8IVQ7 Q9BR94,BTB/POZ domain-containing protein 6,Lens BTB domain protein;, PF07707;PF00651;PF08005;, GO:0005829;GO:0022008;GO:0043687;, C:cytosol;, , P:neurogenesis; P:post-translational protein modification; scaffold462 indexed_genome mRNA 28 28484 . - . ID=transcript_16742;Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3,Ubiquitin carboxyl-terminal hydrolase 30,Deubiquitinating enzyme 30;Ubiquitin thioesterase 30;Ubiquitin-specific-processing protease 30;, PF00443;, GO:0005829;GO:0016021;GO:0005741;GO:0005739;GO:0005634;GO:0005778;GO:0004197;GO:0004843;GO:0000422;GO:0008053;GO:1901525;GO:0000425;GO:0016579;GO:0035871;GO:0044313;GO:0006511;, C:cytosol; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy of mitochondrion; P:mitochondrial fusion; P:negative regulation of mitophagy; P:pexophagy; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K6-linked deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3,Ubiquitin carboxyl-terminal hydrolase 30,Deubiquitinating enzyme 30;Ubiquitin thioesterase 30;Ubiquitin-specific-processing protease 30;, PF00443;, GO:0005829;GO:0016021;GO:0005741;GO:0005739;GO:0005634;GO:0005778;GO:0004197;GO:0004843;GO:0000422;GO:0008053;GO:1901525;GO:0000425;GO:0016579;GO:0035871;GO:0044313;GO:0006511;, C:cytosol; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy of mitochondrion; P:mitochondrial fusion; P:negative regulation of mitophagy; P:pexophagy; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K6-linked deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3,Ubiquitin carboxyl-terminal hydrolase 30,Deubiquitinating enzyme 30;Ubiquitin thioesterase 30;Ubiquitin-specific-processing protease 30;, PF00443;, GO:0005829;GO:0016021;GO:0005741;GO:0005739;GO:0005634;GO:0005778;GO:0004197;GO:0004843;GO:0000422;GO:0008053;GO:1901525;GO:0000425;GO:0016579;GO:0035871;GO:0044313;GO:0006511;, C:cytosol; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy of mitochondrion; P:mitochondrial fusion; P:negative regulation of mitophagy; P:pexophagy; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K6-linked deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3,Ubiquitin carboxyl-terminal hydrolase 30,Deubiquitinating enzyme 30;Ubiquitin thioesterase 30;Ubiquitin-specific-processing protease 30;, PF00443;, GO:0005829;GO:0016021;GO:0005741;GO:0005739;GO:0005634;GO:0005778;GO:0004197;GO:0004843;GO:0000422;GO:0008053;GO:1901525;GO:0000425;GO:0016579;GO:0035871;GO:0044313;GO:0006511;, C:cytosol; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy of mitochondrion; P:mitochondrial fusion; P:negative regulation of mitophagy; P:pexophagy; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K6-linked deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3,Ubiquitin carboxyl-terminal hydrolase 30,Deubiquitinating enzyme 30;Ubiquitin thioesterase 30;Ubiquitin-specific-processing protease 30;, PF00443;, GO:0005829;GO:0016021;GO:0005741;GO:0005739;GO:0005634;GO:0005778;GO:0004197;GO:0004843;GO:0000422;GO:0008053;GO:1901525;GO:0000425;GO:0016579;GO:0035871;GO:0044313;GO:0006511;, C:cytosol; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy of mitochondrion; P:mitochondrial fusion; P:negative regulation of mitophagy; P:pexophagy; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K6-linked deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3,Ubiquitin carboxyl-terminal hydrolase 30,Deubiquitinating enzyme 30;Ubiquitin thioesterase 30;Ubiquitin-specific-processing protease 30;, PF00443;, GO:0005829;GO:0016021;GO:0005741;GO:0005739;GO:0005634;GO:0005778;GO:0004197;GO:0004843;GO:0000422;GO:0008053;GO:1901525;GO:0000425;GO:0016579;GO:0035871;GO:0044313;GO:0006511;, C:cytosol; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy of mitochondrion; P:mitochondrial fusion; P:negative regulation of mitophagy; P:pexophagy; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K6-linked deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3,Ubiquitin carboxyl-terminal hydrolase 30,Deubiquitinating enzyme 30;Ubiquitin thioesterase 30;Ubiquitin-specific-processing protease 30;, PF00443;, GO:0005829;GO:0016021;GO:0005741;GO:0005739;GO:0005634;GO:0005778;GO:0004197;GO:0004843;GO:0000422;GO:0008053;GO:1901525;GO:0000425;GO:0016579;GO:0035871;GO:0044313;GO:0006511;, C:cytosol; C:integral component of membrane; C:mitochondrial outer membrane; C:mitochondrion; C:nucleus; C:peroxisomal membrane;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:autophagy of mitochondrion; P:mitochondrial fusion; P:negative regulation of mitophagy; P:pexophagy; P:protein deubiquitination; P:protein K11-linked deubiquitination; P:protein K6-linked deubiquitination; P:ubiquitin-dependent protein catabolic process;|Q6NS38 A4PET2 Q5XLE3,DNA oxidative demethylase ALKBH2,Alkylated DNA repair protein alkB homolog 2;Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2;Oxy DC1;, PF13532;, GO:0005654;GO:0103053;GO:0051747;GO:0043734;GO:0008198;GO:0006307;GO:0080111;GO:0070989;GO:0035511;, C:nucleoplasm;, F:1-ethyladenine demethylase activity; F:cytosine C-5 DNA demethylase activity; F:DNA-N1-methyladenine dioxygenase activity; F:ferrous iron binding;, P:DNA dealkylation involved in DNA repair; P:DNA demethylation; P:oxidative demethylation; P:oxidative DNA demethylation; scaffold462 indexed_genome mRNA 30651 43884 . + . ID=transcript_16743;P13051 A8K5M6 B2R8Y1 O00637 O00719 Q93028,Uracil-DNA glycosylase {ECO:0000255|HAMAP-Rule:MF_03166},, PF03167;, GO:0005739;GO:0005654;GO:0005634;GO:0003684;GO:0043024;GO:0004844;GO:0006284;GO:0097510;GO:0006287;GO:0045008;GO:0006281;GO:0045190;GO:0043066;GO:0016446;GO:0016032;, C:mitochondrion; C:nucleoplasm; C:nucleus;, F:damaged DNA binding; F:ribosomal small subunit binding; F:uracil DNA N-glycosylase activity;, P:base-excision repair; P:base-excision repair, AP site formation via deaminated base removal; P:base-excision repair, gap-filling; P:depyrimidination; P:DNA repair; P:isotype switching; P:negative regulation of apoptotic process; P:somatic hypermutation of immunoglobulin genes; P:viral process; scaffold465 indexed_genome mRNA 9570 37299 . - . ID=transcript_16744;Q96ME1 Q9BR90 Q9BTC7 Q9HAK7,F-box/LRR-repeat protein 18,F-box and leucine-rich repeat protein 18;, PF00646;, GO:0005829;GO:0019005;GO:0043687;GO:0000209;GO:0031146;, C:cytosol; C:SCF ubiquitin ligase complex;, , P:post-translational protein modification; P:protein polyubiquitination; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; scaffold472 indexed_genome mRNA 7405 9296 . + . ID=transcript_16745;Q8N201 A6NJ44 Q6NT70 Q6UX74 Q8WV40 Q96D36 Q9NTD1 Q9P2A8 Q9Y3W8,Integrator complex subunit 1,, PF12432;, GO:0016021;GO:0032039;GO:0016020;GO:0031965;GO:0005654;GO:0016180;GO:0042795;GO:0034474;, C:integral component of membrane; C:integrator complex; C:membrane; C:nuclear membrane; C:nucleoplasm;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II; P:U2 snRNA 3'-end processing; scaffold472 indexed_genome mRNA 57245 59894 . - . ID=transcript_16746;O60675 A4D214,Transcription factor MafK,Erythroid transcription factor NF-E2 p18 subunit;, PF03131;, GO:0000785;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0071535;GO:0000978;GO:0043565;GO:0001221;GO:0000976;GO:0007596;GO:0000122;GO:0007399;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RING-like zinc finger domain binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coregulator binding; F:transcription regulatory region sequence-specific DNA binding;, P:blood coagulation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:regulation of transcription by RNA polymerase II;|O60675 A4D214,Transcription factor MafK,Erythroid transcription factor NF-E2 p18 subunit;, PF03131;, GO:0000785;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0071535;GO:0000978;GO:0043565;GO:0001221;GO:0000976;GO:0007596;GO:0000122;GO:0007399;GO:0006357;, C:chromatin; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RING-like zinc finger domain binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:transcription coregulator binding; F:transcription regulatory region sequence-specific DNA binding;, P:blood coagulation; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:regulation of transcription by RNA polymerase II; scaffold472 indexed_genome mRNA 62701 64569 . + . ID=transcript_16747;Q6ZMB5 Q8TBQ6,Transmembrane protein 184A,, PF03619;, GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0030667;GO:0030658;GO:0008201;, C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:transport vesicle membrane;, F:heparin binding;|Q6ZMB5 Q8TBQ6,Transmembrane protein 184A,, PF03619;, GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0030667;GO:0030658;GO:0008201;, C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:transport vesicle membrane;, F:heparin binding; scaffold472 indexed_genome mRNA 64919 67664 . - . ID=transcript_16748;Q6ZMB5 Q8TBQ6,Transmembrane protein 184A,, PF03619;, GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0030667;GO:0030658;GO:0008201;, C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:transport vesicle membrane;, F:heparin binding;|Q6ZMB5 Q8TBQ6,Transmembrane protein 184A,, PF03619;, GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0030667;GO:0030658;GO:0008201;, C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:transport vesicle membrane;, F:heparin binding;|Q6ZMB5 Q8TBQ6,Transmembrane protein 184A,, PF03619;, GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0030667;GO:0030658;GO:0008201;, C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:transport vesicle membrane;, F:heparin binding;|Q6ZMB5 Q8TBQ6,Transmembrane protein 184A,, PF03619;, GO:0030659;GO:0031901;GO:0005768;GO:0016021;GO:0048471;GO:0005886;GO:0030667;GO:0030658;GO:0008201;, C:cytoplasmic vesicle membrane; C:early endosome membrane; C:endosome; C:integral component of membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:transport vesicle membrane;, F:heparin binding; scaffold472 indexed_genome mRNA 75579 78813 . - . ID=transcript_16749;Q9BT73 A4D216 A8MPW2,Proteasome assembly chaperone 3,, PF10178;, GO:0032991;GO:0060090;GO:0044877;GO:0051131;, C:protein-containing complex;, F:molecular adaptor activity; F:protein-containing complex binding;, P:chaperone-mediated protein complex assembly; scaffold474 indexed_genome mRNA 15222 16422 . - . ID=transcript_16750;Q9UDI6,Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial,Aldehyde dehydrogenase family 4 member A1;L-glutamate gamma-semialdehyde dehydrogenase;, PF00171;, GO:0005829;GO:0005759;GO:0005739;GO:0003842;GO:0004029;GO:0009055;GO:0042802;GO:0019470;GO:0046487;GO:0006562;GO:0010133;GO:0006560;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:1-pyrroline-5-carboxylate dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:electron transfer activity; F:identical protein binding;, P:4-hydroxyproline catabolic process; P:glyoxylate metabolic process; P:proline catabolic process; P:proline catabolic process to glutamate; P:proline metabolic process; scaffold474 indexed_genome mRNA 48548 60316 . - . ID=transcript_16751;Q5TF58 Q9H7K0,Intermediate filament family orphan 2,, PF00038;, GO:0005882;, C:intermediate filament;|Q5TF58 Q9H7K0,Intermediate filament family orphan 2,, PF00038;, GO:0005882;, C:intermediate filament;|Q5TF58 Q9H7K0,Intermediate filament family orphan 2,, PF00038;, GO:0005882;, C:intermediate filament;|Q5TF58 Q9H7K0,Intermediate filament family orphan 2,, PF00038;, GO:0005882;, C:intermediate filament; scaffold475 indexed_genome mRNA 675 24863 . - . ID=transcript_16752;Q9UDI6,Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial,Aldehyde dehydrogenase family 4 member A1;L-glutamate gamma-semialdehyde dehydrogenase;, PF00171;, GO:0005829;GO:0005759;GO:0005739;GO:0003842;GO:0004029;GO:0009055;GO:0042802;GO:0019470;GO:0046487;GO:0006562;GO:0010133;GO:0006560;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:1-pyrroline-5-carboxylate dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:electron transfer activity; F:identical protein binding;, P:4-hydroxyproline catabolic process; P:glyoxylate metabolic process; P:proline catabolic process; P:proline catabolic process to glutamate; P:proline metabolic process;|Q9UDI6,Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial,Aldehyde dehydrogenase family 4 member A1;L-glutamate gamma-semialdehyde dehydrogenase;, PF00171;, GO:0005829;GO:0005759;GO:0005739;GO:0003842;GO:0004029;GO:0009055;GO:0042802;GO:0019470;GO:0046487;GO:0006562;GO:0010133;GO:0006560;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:1-pyrroline-5-carboxylate dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:electron transfer activity; F:identical protein binding;, P:4-hydroxyproline catabolic process; P:glyoxylate metabolic process; P:proline catabolic process; P:proline catabolic process to glutamate; P:proline metabolic process;|Q9UDI6,Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial,Aldehyde dehydrogenase family 4 member A1;L-glutamate gamma-semialdehyde dehydrogenase;, PF00171;, GO:0005829;GO:0005759;GO:0005739;GO:0003842;GO:0004029;GO:0009055;GO:0042802;GO:0019470;GO:0046487;GO:0006562;GO:0010133;GO:0006560;, C:cytosol; C:mitochondrial matrix; C:mitochondrion;, F:1-pyrroline-5-carboxylate dehydrogenase activity; F:aldehyde dehydrogenase (NAD+) activity; F:electron transfer activity; F:identical protein binding;, P:4-hydroxyproline catabolic process; P:glyoxylate metabolic process; P:proline catabolic process; P:proline catabolic process to glutamate; P:proline metabolic process; scaffold475 indexed_genome mRNA 48527 60298 . + . ID=transcript_16753;Q5TF58 Q9H7K0,Intermediate filament family orphan 2,, PF00038;, GO:0005882;, C:intermediate filament;|Q5TF58 Q9H7K0,Intermediate filament family orphan 2,, PF00038;, GO:0005882;, C:intermediate filament;|Q5TF58 Q9H7K0,Intermediate filament family orphan 2,, PF00038;, GO:0005882;, C:intermediate filament;|Q5TF58 Q9H7K0,Intermediate filament family orphan 2,, PF00038;, GO:0005882;, C:intermediate filament; scaffold479 indexed_genome mRNA 21177 22022 . + . ID=transcript_16754;Q9UHP6,Radial spoke head 14 homolog,Rhabdoid tumor deletion region protein 1;, PF00514; scaffold479 indexed_genome mRNA 25299 25922 . - . ID=transcript_16755;Q9UHP6,Radial spoke head 14 homolog,Rhabdoid tumor deletion region protein 1;, PF00514; scaffold479 indexed_genome mRNA 30226 44488 . + . ID=transcript_16756;O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport;|O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport;|O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport;|O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport;|O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport;|O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport; scaffold480 indexed_genome mRNA 21176 22021 . + . ID=transcript_16757;Q9UHP6,Radial spoke head 14 homolog,Rhabdoid tumor deletion region protein 1;, PF00514; scaffold480 indexed_genome mRNA 25298 25922 . + . ID=transcript_16758;Q9UHP6,Radial spoke head 14 homolog,Rhabdoid tumor deletion region protein 1;, PF00514; scaffold480 indexed_genome mRNA 30226 44490 . + . ID=transcript_16759;O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport;|O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport;|O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport;|O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport;|O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport;|O95755 Q2M390 Q7Z4A9 Q9UHP5,Ras-related protein Rab-36,, PF00071;, GO:0005794;GO:0000139;GO:0005525;GO:0003924;GO:0015031;, C:Golgi apparatus; C:Golgi membrane;, F:GTP binding; F:GTPase activity;, P:protein transport; scaffold481 indexed_genome mRNA 970 4611 . + . ID=transcript_16760;Q96B67 A8K6T8 Q9P2H1,Arrestin domain-containing protein 3,TBP-2-like inducible membrane protein {ECO:0000303|PubMed:16269462};, PF02752;PF00339;, GO:0005737;GO:0005769;GO:0005768;GO:0005764;GO:0005886;GO:0031699;GO:0060613;GO:0071878;GO:0120163;GO:0031651;GO:0090327;GO:0051443;GO:0015031;GO:0043588;GO:0001659;, C:cytoplasm; C:early endosome; C:endosome; C:lysosome; C:plasma membrane;, F:beta-3 adrenergic receptor binding;, P:fat pad development; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; P:negative regulation of cold-induced thermogenesis; P:negative regulation of heat generation; P:negative regulation of locomotion involved in locomotory behavior; P:positive regulation of ubiquitin-protein transferase activity; P:protein transport; P:skin development; P:temperature homeostasis; scaffold481 indexed_genome mRNA 5559 7105 . + . ID=transcript_16761;Q96B67 A8K6T8 Q9P2H1,Arrestin domain-containing protein 3,TBP-2-like inducible membrane protein {ECO:0000303|PubMed:16269462};, PF02752;PF00339;, GO:0005737;GO:0005769;GO:0005768;GO:0005764;GO:0005886;GO:0031699;GO:0060613;GO:0071878;GO:0120163;GO:0031651;GO:0090327;GO:0051443;GO:0015031;GO:0043588;GO:0001659;, C:cytoplasm; C:early endosome; C:endosome; C:lysosome; C:plasma membrane;, F:beta-3 adrenergic receptor binding;, P:fat pad development; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; P:negative regulation of cold-induced thermogenesis; P:negative regulation of heat generation; P:negative regulation of locomotion involved in locomotory behavior; P:positive regulation of ubiquitin-protein transferase activity; P:protein transport; P:skin development; P:temperature homeostasis;|Q96B67 A8K6T8 Q9P2H1,Arrestin domain-containing protein 3,TBP-2-like inducible membrane protein {ECO:0000303|PubMed:16269462};, PF02752;PF00339;, GO:0005737;GO:0005769;GO:0005768;GO:0005764;GO:0005886;GO:0031699;GO:0060613;GO:0071878;GO:0120163;GO:0031651;GO:0090327;GO:0051443;GO:0015031;GO:0043588;GO:0001659;, C:cytoplasm; C:early endosome; C:endosome; C:lysosome; C:plasma membrane;, F:beta-3 adrenergic receptor binding;, P:fat pad development; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; P:negative regulation of cold-induced thermogenesis; P:negative regulation of heat generation; P:negative regulation of locomotion involved in locomotory behavior; P:positive regulation of ubiquitin-protein transferase activity; P:protein transport; P:skin development; P:temperature homeostasis; scaffold499 indexed_genome mRNA 193 1548 . + . ID=transcript_16762;P11717 Q7Z7G9 Q96PT5,Cation-independent mannose-6-phosphate receptor,300 kDa mannose 6-phosphate receptor;Insulin-like growth factor 2 receptor;Insulin-like growth factor II receptor;M6P/IGF2 receptor;, PF00878;PF00040;, GO:0009986;GO:0030118;GO:0030669;GO:0005769;GO:0030139;GO:0005768;GO:0010008;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0005770;GO:0016020;GO:0005641;GO:0048471;GO:0005886;GO:0030667;GO:0005802;GO:0032588;GO:0030140;GO:0030133;GO:0019899;GO:0001965;GO:0042802;GO:0005520;GO:0031995;GO:0005010;GO:0005537;GO:0051219;GO:0001972;GO:1905394;GO:0038023;GO:0031100;GO:0007186;GO:0001889;GO:0007041;GO:0061024;GO:0043312;GO:0044794;GO:0043065;GO:0009791;GO:0006898;GO:0032526;GO:1904772;GO:0007165;GO:0007283;, C:cell surface; C:clathrin coat; C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:membrane; C:nuclear envelope lumen; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:enzyme binding; F:G-protein alpha-subunit binding; F:identical protein binding; F:insulin-like growth factor binding; F:insulin-like growth factor II binding; F:insulin-like growth factor-activated receptor activity; F:mannose binding; F:phosphoprotein binding; F:retinoic acid binding; F:retromer complex binding; F:signaling receptor activity;, P:animal organ regeneration; P:G protein-coupled receptor signaling pathway; P:liver development; P:lysosomal transport; P:membrane organization; P:neutrophil degranulation; P:positive regulation by host of viral process; P:positive regulation of apoptotic process; P:post-embryonic development; P:receptor-mediated endocytosis; P:response to retinoic acid; P:response to tetrachloromethane; P:signal transduction; P:spermatogenesis; scaffold499 indexed_genome mRNA 2602 3248 . + . ID=transcript_16763;P11717 Q7Z7G9 Q96PT5,Cation-independent mannose-6-phosphate receptor,300 kDa mannose 6-phosphate receptor;Insulin-like growth factor 2 receptor;Insulin-like growth factor II receptor;M6P/IGF2 receptor;, PF00878;PF00040;, GO:0009986;GO:0030118;GO:0030669;GO:0005769;GO:0030139;GO:0005768;GO:0010008;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0005770;GO:0016020;GO:0005641;GO:0048471;GO:0005886;GO:0030667;GO:0005802;GO:0032588;GO:0030140;GO:0030133;GO:0019899;GO:0001965;GO:0042802;GO:0005520;GO:0031995;GO:0005010;GO:0005537;GO:0051219;GO:0001972;GO:1905394;GO:0038023;GO:0031100;GO:0007186;GO:0001889;GO:0007041;GO:0061024;GO:0043312;GO:0044794;GO:0043065;GO:0009791;GO:0006898;GO:0032526;GO:1904772;GO:0007165;GO:0007283;, C:cell surface; C:clathrin coat; C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:membrane; C:nuclear envelope lumen; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:enzyme binding; F:G-protein alpha-subunit binding; F:identical protein binding; F:insulin-like growth factor binding; F:insulin-like growth factor II binding; F:insulin-like growth factor-activated receptor activity; F:mannose binding; F:phosphoprotein binding; F:retinoic acid binding; F:retromer complex binding; F:signaling receptor activity;, P:animal organ regeneration; P:G protein-coupled receptor signaling pathway; P:liver development; P:lysosomal transport; P:membrane organization; P:neutrophil degranulation; P:positive regulation by host of viral process; P:positive regulation of apoptotic process; P:post-embryonic development; P:receptor-mediated endocytosis; P:response to retinoic acid; P:response to tetrachloromethane; P:signal transduction; P:spermatogenesis; scaffold499 indexed_genome mRNA 4622 6491 . - . ID=transcript_16764;P11717 Q7Z7G9 Q96PT5,Cation-independent mannose-6-phosphate receptor,300 kDa mannose 6-phosphate receptor;Insulin-like growth factor 2 receptor;Insulin-like growth factor II receptor;M6P/IGF2 receptor;, PF00878;PF00040;, GO:0009986;GO:0030118;GO:0030669;GO:0005769;GO:0030139;GO:0005768;GO:0010008;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0005770;GO:0016020;GO:0005641;GO:0048471;GO:0005886;GO:0030667;GO:0005802;GO:0032588;GO:0030140;GO:0030133;GO:0019899;GO:0001965;GO:0042802;GO:0005520;GO:0031995;GO:0005010;GO:0005537;GO:0051219;GO:0001972;GO:1905394;GO:0038023;GO:0031100;GO:0007186;GO:0001889;GO:0007041;GO:0061024;GO:0043312;GO:0044794;GO:0043065;GO:0009791;GO:0006898;GO:0032526;GO:1904772;GO:0007165;GO:0007283;, C:cell surface; C:clathrin coat; C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:membrane; C:nuclear envelope lumen; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:enzyme binding; F:G-protein alpha-subunit binding; F:identical protein binding; F:insulin-like growth factor binding; F:insulin-like growth factor II binding; F:insulin-like growth factor-activated receptor activity; F:mannose binding; F:phosphoprotein binding; F:retinoic acid binding; F:retromer complex binding; F:signaling receptor activity;, P:animal organ regeneration; P:G protein-coupled receptor signaling pathway; P:liver development; P:lysosomal transport; P:membrane organization; P:neutrophil degranulation; P:positive regulation by host of viral process; P:positive regulation of apoptotic process; P:post-embryonic development; P:receptor-mediated endocytosis; P:response to retinoic acid; P:response to tetrachloromethane; P:signal transduction; P:spermatogenesis; scaffold499 indexed_genome mRNA 6516 9919 . + . ID=transcript_16765;P11717 Q7Z7G9 Q96PT5,Cation-independent mannose-6-phosphate receptor,300 kDa mannose 6-phosphate receptor;Insulin-like growth factor 2 receptor;Insulin-like growth factor II receptor;M6P/IGF2 receptor;, PF00878;PF00040;, GO:0009986;GO:0030118;GO:0030669;GO:0005769;GO:0030139;GO:0005768;GO:0010008;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0005770;GO:0016020;GO:0005641;GO:0048471;GO:0005886;GO:0030667;GO:0005802;GO:0032588;GO:0030140;GO:0030133;GO:0019899;GO:0001965;GO:0042802;GO:0005520;GO:0031995;GO:0005010;GO:0005537;GO:0051219;GO:0001972;GO:1905394;GO:0038023;GO:0031100;GO:0007186;GO:0001889;GO:0007041;GO:0061024;GO:0043312;GO:0044794;GO:0043065;GO:0009791;GO:0006898;GO:0032526;GO:1904772;GO:0007165;GO:0007283;, C:cell surface; C:clathrin coat; C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:membrane; C:nuclear envelope lumen; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:enzyme binding; F:G-protein alpha-subunit binding; F:identical protein binding; F:insulin-like growth factor binding; F:insulin-like growth factor II binding; F:insulin-like growth factor-activated receptor activity; F:mannose binding; F:phosphoprotein binding; F:retinoic acid binding; F:retromer complex binding; F:signaling receptor activity;, P:animal organ regeneration; P:G protein-coupled receptor signaling pathway; P:liver development; P:lysosomal transport; P:membrane organization; P:neutrophil degranulation; P:positive regulation by host of viral process; P:positive regulation of apoptotic process; P:post-embryonic development; P:receptor-mediated endocytosis; P:response to retinoic acid; P:response to tetrachloromethane; P:signal transduction; P:spermatogenesis;|P11717 Q7Z7G9 Q96PT5,Cation-independent mannose-6-phosphate receptor,300 kDa mannose 6-phosphate receptor;Insulin-like growth factor 2 receptor;Insulin-like growth factor II receptor;M6P/IGF2 receptor;, PF00878;PF00040;, GO:0009986;GO:0030118;GO:0030669;GO:0005769;GO:0030139;GO:0005768;GO:0010008;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0005770;GO:0016020;GO:0005641;GO:0048471;GO:0005886;GO:0030667;GO:0005802;GO:0032588;GO:0030140;GO:0030133;GO:0019899;GO:0001965;GO:0042802;GO:0005520;GO:0031995;GO:0005010;GO:0005537;GO:0051219;GO:0001972;GO:1905394;GO:0038023;GO:0031100;GO:0007186;GO:0001889;GO:0007041;GO:0061024;GO:0043312;GO:0044794;GO:0043065;GO:0009791;GO:0006898;GO:0032526;GO:1904772;GO:0007165;GO:0007283;, C:cell surface; C:clathrin coat; C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:membrane; C:nuclear envelope lumen; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:enzyme binding; F:G-protein alpha-subunit binding; F:identical protein binding; F:insulin-like growth factor binding; F:insulin-like growth factor II binding; F:insulin-like growth factor-activated receptor activity; F:mannose binding; F:phosphoprotein binding; F:retinoic acid binding; F:retromer complex binding; F:signaling receptor activity;, P:animal organ regeneration; P:G protein-coupled receptor signaling pathway; P:liver development; P:lysosomal transport; P:membrane organization; P:neutrophil degranulation; P:positive regulation by host of viral process; P:positive regulation of apoptotic process; P:post-embryonic development; P:receptor-mediated endocytosis; P:response to retinoic acid; P:response to tetrachloromethane; P:signal transduction; P:spermatogenesis; scaffold499 indexed_genome mRNA 15542 17097 . + . ID=transcript_16766;P11717 Q7Z7G9 Q96PT5,Cation-independent mannose-6-phosphate receptor,300 kDa mannose 6-phosphate receptor;Insulin-like growth factor 2 receptor;Insulin-like growth factor II receptor;M6P/IGF2 receptor;, PF00878;PF00040;, GO:0009986;GO:0030118;GO:0030669;GO:0005769;GO:0030139;GO:0005768;GO:0010008;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0005770;GO:0016020;GO:0005641;GO:0048471;GO:0005886;GO:0030667;GO:0005802;GO:0032588;GO:0030140;GO:0030133;GO:0019899;GO:0001965;GO:0042802;GO:0005520;GO:0031995;GO:0005010;GO:0005537;GO:0051219;GO:0001972;GO:1905394;GO:0038023;GO:0031100;GO:0007186;GO:0001889;GO:0007041;GO:0061024;GO:0043312;GO:0044794;GO:0043065;GO:0009791;GO:0006898;GO:0032526;GO:1904772;GO:0007165;GO:0007283;, C:cell surface; C:clathrin coat; C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:membrane; C:nuclear envelope lumen; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:enzyme binding; F:G-protein alpha-subunit binding; F:identical protein binding; F:insulin-like growth factor binding; F:insulin-like growth factor II binding; F:insulin-like growth factor-activated receptor activity; F:mannose binding; F:phosphoprotein binding; F:retinoic acid binding; F:retromer complex binding; F:signaling receptor activity;, P:animal organ regeneration; P:G protein-coupled receptor signaling pathway; P:liver development; P:lysosomal transport; P:membrane organization; P:neutrophil degranulation; P:positive regulation by host of viral process; P:positive regulation of apoptotic process; P:post-embryonic development; P:receptor-mediated endocytosis; P:response to retinoic acid; P:response to tetrachloromethane; P:signal transduction; P:spermatogenesis;|P11717 Q7Z7G9 Q96PT5,Cation-independent mannose-6-phosphate receptor,300 kDa mannose 6-phosphate receptor;Insulin-like growth factor 2 receptor;Insulin-like growth factor II receptor;M6P/IGF2 receptor;, PF00878;PF00040;, GO:0009986;GO:0030118;GO:0030669;GO:0005769;GO:0030139;GO:0005768;GO:0010008;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0005770;GO:0016020;GO:0005641;GO:0048471;GO:0005886;GO:0030667;GO:0005802;GO:0032588;GO:0030140;GO:0030133;GO:0019899;GO:0001965;GO:0042802;GO:0005520;GO:0031995;GO:0005010;GO:0005537;GO:0051219;GO:0001972;GO:1905394;GO:0038023;GO:0031100;GO:0007186;GO:0001889;GO:0007041;GO:0061024;GO:0043312;GO:0044794;GO:0043065;GO:0009791;GO:0006898;GO:0032526;GO:1904772;GO:0007165;GO:0007283;, C:cell surface; C:clathrin coat; C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:membrane; C:nuclear envelope lumen; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:enzyme binding; F:G-protein alpha-subunit binding; F:identical protein binding; F:insulin-like growth factor binding; F:insulin-like growth factor II binding; F:insulin-like growth factor-activated receptor activity; F:mannose binding; F:phosphoprotein binding; F:retinoic acid binding; F:retromer complex binding; F:signaling receptor activity;, P:animal organ regeneration; P:G protein-coupled receptor signaling pathway; P:liver development; P:lysosomal transport; P:membrane organization; P:neutrophil degranulation; P:positive regulation by host of viral process; P:positive regulation of apoptotic process; P:post-embryonic development; P:receptor-mediated endocytosis; P:response to retinoic acid; P:response to tetrachloromethane; P:signal transduction; P:spermatogenesis; scaffold499 indexed_genome mRNA 18327 18926 . + . ID=transcript_16767;P11717 Q7Z7G9 Q96PT5,Cation-independent mannose-6-phosphate receptor,300 kDa mannose 6-phosphate receptor;Insulin-like growth factor 2 receptor;Insulin-like growth factor II receptor;M6P/IGF2 receptor;, PF00878;PF00040;, GO:0009986;GO:0030118;GO:0030669;GO:0005769;GO:0030139;GO:0005768;GO:0010008;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0005770;GO:0016020;GO:0005641;GO:0048471;GO:0005886;GO:0030667;GO:0005802;GO:0032588;GO:0030140;GO:0030133;GO:0019899;GO:0001965;GO:0042802;GO:0005520;GO:0031995;GO:0005010;GO:0005537;GO:0051219;GO:0001972;GO:1905394;GO:0038023;GO:0031100;GO:0007186;GO:0001889;GO:0007041;GO:0061024;GO:0043312;GO:0044794;GO:0043065;GO:0009791;GO:0006898;GO:0032526;GO:1904772;GO:0007165;GO:0007283;, C:cell surface; C:clathrin coat; C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:membrane; C:nuclear envelope lumen; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:enzyme binding; F:G-protein alpha-subunit binding; F:identical protein binding; F:insulin-like growth factor binding; F:insulin-like growth factor II binding; F:insulin-like growth factor-activated receptor activity; F:mannose binding; F:phosphoprotein binding; F:retinoic acid binding; F:retromer complex binding; F:signaling receptor activity;, P:animal organ regeneration; P:G protein-coupled receptor signaling pathway; P:liver development; P:lysosomal transport; P:membrane organization; P:neutrophil degranulation; P:positive regulation by host of viral process; P:positive regulation of apoptotic process; P:post-embryonic development; P:receptor-mediated endocytosis; P:response to retinoic acid; P:response to tetrachloromethane; P:signal transduction; P:spermatogenesis; scaffold499 indexed_genome mRNA 63031 63628 . + . ID=transcript_16768;P11717 Q7Z7G9 Q96PT5,Cation-independent mannose-6-phosphate receptor,300 kDa mannose 6-phosphate receptor;Insulin-like growth factor 2 receptor;Insulin-like growth factor II receptor;M6P/IGF2 receptor;, PF00878;PF00040;, GO:0009986;GO:0030118;GO:0030669;GO:0005769;GO:0030139;GO:0005768;GO:0010008;GO:0070062;GO:0005925;GO:0005794;GO:0005887;GO:0005770;GO:0016020;GO:0005641;GO:0048471;GO:0005886;GO:0030667;GO:0005802;GO:0032588;GO:0030140;GO:0030133;GO:0019899;GO:0001965;GO:0042802;GO:0005520;GO:0031995;GO:0005010;GO:0005537;GO:0051219;GO:0001972;GO:1905394;GO:0038023;GO:0031100;GO:0007186;GO:0001889;GO:0007041;GO:0061024;GO:0043312;GO:0044794;GO:0043065;GO:0009791;GO:0006898;GO:0032526;GO:1904772;GO:0007165;GO:0007283;, C:cell surface; C:clathrin coat; C:clathrin-coated endocytic vesicle membrane; C:early endosome; C:endocytic vesicle; C:endosome; C:endosome membrane; C:extracellular exosome; C:focal adhesion; C:Golgi apparatus; C:integral component of plasma membrane; C:late endosome; C:membrane; C:nuclear envelope lumen; C:perinuclear region of cytoplasm; C:plasma membrane; C:secretory granule membrane; C:trans-Golgi network; C:trans-Golgi network membrane; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:enzyme binding; F:G-protein alpha-subunit binding; F:identical protein binding; F:insulin-like growth factor binding; F:insulin-like growth factor II binding; F:insulin-like growth factor-activated receptor activity; F:mannose binding; F:phosphoprotein binding; F:retinoic acid binding; F:retromer complex binding; F:signaling receptor activity;, P:animal organ regeneration; P:G protein-coupled receptor signaling pathway; P:liver development; P:lysosomal transport; P:membrane organization; P:neutrophil degranulation; P:positive regulation by host of viral process; P:positive regulation of apoptotic process; P:post-embryonic development; P:receptor-mediated endocytosis; P:response to retinoic acid; P:response to tetrachloromethane; P:signal transduction; P:spermatogenesis; scaffold511 indexed_genome mRNA 21154 22606 . + . ID=transcript_16769;O75380,NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial,Complex I-13kD-A;NADH-ubiquinone oxidoreductase 13 kDa-A subunit;, PF10276;, GO:0005743;GO:0005747;GO:0009055;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:electron transfer activity; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold511 indexed_genome mRNA 24898 26282 . + . ID=transcript_16770;O75380,NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial,Complex I-13kD-A;NADH-ubiquinone oxidoreductase 13 kDa-A subunit;, PF10276;, GO:0005743;GO:0005747;GO:0009055;GO:0008137;GO:0006120;GO:0032981;, C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:electron transfer activity; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold513 indexed_genome mRNA 9716 15572 . + . ID=transcript_16771;Q5T5S1 B2RP89 C9JD38 Q6P2D9 Q8NAI4 Q8TF18,Coiled-coil domain-containing protein 183|Q5T5S1 B2RP89 C9JD38 Q6P2D9 Q8NAI4 Q8TF18,Coiled-coil domain-containing protein 183 scaffold513 indexed_genome mRNA 15678 39376 . + . ID=transcript_16772;Q8WU94 Q96SR8 Q9BU21 Q9H935,Rab-like protein 6,GTP-binding protein Parf;Partner of ARF;Rab-like protein 1;, , GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005525;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:GTP binding;|Q8WU94 Q96SR8 Q9BU21 Q9H935,Rab-like protein 6,GTP-binding protein Parf;Partner of ARF;Rab-like protein 1;, , GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005525;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:GTP binding;|Q8WU94 Q96SR8 Q9BU21 Q9H935,Rab-like protein 6,GTP-binding protein Parf;Partner of ARF;Rab-like protein 1;, , GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005525;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:GTP binding;|Q8WU94 Q96SR8 Q9BU21 Q9H935,Rab-like protein 6,GTP-binding protein Parf;Partner of ARF;Rab-like protein 1;, , GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005525;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:GTP binding;|Q8WU94 Q96SR8 Q9BU21 Q9H935,Rab-like protein 6,GTP-binding protein Parf;Partner of ARF;Rab-like protein 1;, , GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005525;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:GTP binding;|Q8WU94 Q96SR8 Q9BU21 Q9H935,Rab-like protein 6,GTP-binding protein Parf;Partner of ARF;Rab-like protein 1;, , GO:0005813;GO:0005737;GO:0005829;GO:0005634;GO:0005525;, C:centrosome; C:cytoplasm; C:cytosol; C:nucleus;, F:GTP binding; scaffold513 indexed_genome mRNA 48853 49504 . - . ID=transcript_16773;Q9NRX4 B1AMX0 B1AMX1 Q9H0Y3,14 kDa phosphohistidine phosphatase {ECO:0000303|PubMed:12383260},Phosphohistidine phosphatase 1 {ECO:0000303|PubMed:25574816};Protein histidine phosphatase {ECO:0000303|PubMed:19836471};Protein janus-A homolog;, PF05005;, GO:0005829;GO:0070062;GO:0016604;GO:0005654;GO:0005886;GO:0019855;GO:0044325;GO:0101006;GO:2000984;GO:0051350;GO:0050860;GO:0035971;GO:2000147;GO:0035774;GO:0006470;GO:2000249;, C:cytosol; C:extracellular exosome; C:nuclear body; C:nucleoplasm; C:plasma membrane;, F:calcium channel inhibitor activity; F:ion channel binding; F:protein histidine phosphatase activity;, P:negative regulation of ATP citrate synthase activity; P:negative regulation of lyase activity; P:negative regulation of T cell receptor signaling pathway; P:peptidyl-histidine dephosphorylation; P:positive regulation of cell motility; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:protein dephosphorylation; P:regulation of actin cytoskeleton reorganization; scaffold513 indexed_genome mRNA 55460 62782 . + . ID=transcript_16774;Q6UXC1 A2A3D4 B0QZ81 Q5T5S2 Q8NCX7,Apical endosomal glycoprotein,MAM domain-containing protein 4;, PF00057;PF00629;, GO:0016021;GO:0015031;, C:integral component of membrane;, , P:protein transport;|Q6UXC1 A2A3D4 B0QZ81 Q5T5S2 Q8NCX7,Apical endosomal glycoprotein,MAM domain-containing protein 4;, PF00057;PF00629;, GO:0016021;GO:0015031;, C:integral component of membrane;, , P:protein transport;|O60869 Q5T5T2 Q9UIM1,Endothelial differentiation-related factor 1,Multiprotein-bridging factor 1;, PF01381;PF08523;, GO:0005737;GO:0005829;GO:0005622;GO:0005730;GO:0005654;GO:0005634;GO:0005516;GO:0003677;GO:0003723;GO:0001094;GO:0003713;GO:0045446;GO:0007275;GO:0043388;GO:0045893;GO:0019216;GO:0006355;, C:cytoplasm; C:cytosol; C:intracellular anatomical structure; C:nucleolus; C:nucleoplasm; C:nucleus;, F:calmodulin binding; F:DNA binding; F:RNA binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator activity;, P:endothelial cell differentiation; P:multicellular organism development; P:positive regulation of DNA binding; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription, DNA-templated;|O60869 Q5T5T2 Q9UIM1,Endothelial differentiation-related factor 1,Multiprotein-bridging factor 1;, PF01381;PF08523;, GO:0005737;GO:0005829;GO:0005622;GO:0005730;GO:0005654;GO:0005634;GO:0005516;GO:0003677;GO:0003723;GO:0001094;GO:0003713;GO:0045446;GO:0007275;GO:0043388;GO:0045893;GO:0019216;GO:0006355;, C:cytoplasm; C:cytosol; C:intracellular anatomical structure; C:nucleolus; C:nucleoplasm; C:nucleus;, F:calmodulin binding; F:DNA binding; F:RNA binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator activity;, P:endothelial cell differentiation; P:multicellular organism development; P:positive regulation of DNA binding; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription, DNA-templated;|O60869 Q5T5T2 Q9UIM1,Endothelial differentiation-related factor 1,Multiprotein-bridging factor 1;, PF01381;PF08523;, GO:0005737;GO:0005829;GO:0005622;GO:0005730;GO:0005654;GO:0005634;GO:0005516;GO:0003677;GO:0003723;GO:0001094;GO:0003713;GO:0045446;GO:0007275;GO:0043388;GO:0045893;GO:0019216;GO:0006355;, C:cytoplasm; C:cytosol; C:intracellular anatomical structure; C:nucleolus; C:nucleoplasm; C:nucleus;, F:calmodulin binding; F:DNA binding; F:RNA binding; F:TFIID-class transcription factor complex binding; F:transcription coactivator activity;, P:endothelial cell differentiation; P:multicellular organism development; P:positive regulation of DNA binding; P:positive regulation of transcription, DNA-templated; P:regulation of lipid metabolic process; P:regulation of transcription, DNA-templated; scaffold514 indexed_genome mRNA 376 2000 . + . ID=transcript_16775;Q96AQ9 Q5T5Q5 Q8N3X3 Q8N9P9,Protein FAM131C,, PF15010;|Q96AQ9 Q5T5Q5 Q8N3X3 Q8N9P9,Protein FAM131C,, PF15010; scaffold514 indexed_genome mRNA 61671 69330 . - . ID=transcript_16776;P29317 B5A968 Q8N3Z2,Ephrin type-A receptor 2,Epithelial cell kinase;Tyrosine-protein kinase receptor ECK;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0009986;GO:0005925;GO:0005887;GO:0030027;GO:0031258;GO:0031256;GO:0043005;GO:0005886;GO:0043235;GO:0032587;GO:0070160;GO:0005524;GO:0045296;GO:0019838;GO:0004714;GO:0005005;GO:0001618;GO:0090630;GO:0048320;GO:0007411;GO:0002043;GO:0046849;GO:0060444;GO:0046058;GO:0007155;GO:0060326;GO:0016477;GO:0048870;GO:0050830;GO:0048013;GO:0006954;GO:0008630;GO:0030216;GO:0070309;GO:0033598;GO:0007275;GO:0016525;GO:0032682;GO:1901491;GO:0051898;GO:0021915;GO:0060035;GO:0014028;GO:0001649;GO:0030316;GO:1904238;GO:1903348;GO:0033674;GO:1903078;GO:0036342;GO:0043491;GO:0072659;GO:0045765;GO:0043535;GO:0033628;GO:0070372;GO:0010591;GO:0070848;GO:0001501;GO:0007169;GO:0001570;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:leading edge membrane; C:neuron projection; C:plasma membrane; C:receptor complex; C:ruffle membrane; C:tight junction;, F:ATP binding; F:cadherin binding; F:growth factor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity; F:virus receptor activity;, P:activation of GTPase activity; P:axial mesoderm formation; P:axon guidance; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:cAMP metabolic process; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell motility; P:defense response to Gram-positive bacterium; P:ephrin receptor signaling pathway; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:keratinocyte differentiation; P:lens fiber cell morphogenesis; P:mammary gland epithelial cell proliferation; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of chemokine production; P:negative regulation of lymphangiogenesis; P:negative regulation of protein kinase B signaling; P:neural tube development; P:notochord cell development; P:notochord formation; P:osteoblast differentiation; P:osteoclast differentiation; P:pericyte cell differentiation; P:positive regulation of bicellular tight junction assembly; P:positive regulation of kinase activity; P:positive regulation of protein localization to plasma membrane; P:post-anal tail morphogenesis; P:protein kinase B signaling; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of ERK1 and ERK2 cascade; P:regulation of lamellipodium assembly; P:response to growth factor; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P29317 B5A968 Q8N3Z2,Ephrin type-A receptor 2,Epithelial cell kinase;Tyrosine-protein kinase receptor ECK;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0009986;GO:0005925;GO:0005887;GO:0030027;GO:0031258;GO:0031256;GO:0043005;GO:0005886;GO:0043235;GO:0032587;GO:0070160;GO:0005524;GO:0045296;GO:0019838;GO:0004714;GO:0005005;GO:0001618;GO:0090630;GO:0048320;GO:0007411;GO:0002043;GO:0046849;GO:0060444;GO:0046058;GO:0007155;GO:0060326;GO:0016477;GO:0048870;GO:0050830;GO:0048013;GO:0006954;GO:0008630;GO:0030216;GO:0070309;GO:0033598;GO:0007275;GO:0016525;GO:0032682;GO:1901491;GO:0051898;GO:0021915;GO:0060035;GO:0014028;GO:0001649;GO:0030316;GO:1904238;GO:1903348;GO:0033674;GO:1903078;GO:0036342;GO:0043491;GO:0072659;GO:0045765;GO:0043535;GO:0033628;GO:0070372;GO:0010591;GO:0070848;GO:0001501;GO:0007169;GO:0001570;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:leading edge membrane; C:neuron projection; C:plasma membrane; C:receptor complex; C:ruffle membrane; C:tight junction;, F:ATP binding; F:cadherin binding; F:growth factor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity; F:virus receptor activity;, P:activation of GTPase activity; P:axial mesoderm formation; P:axon guidance; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:cAMP metabolic process; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell motility; P:defense response to Gram-positive bacterium; P:ephrin receptor signaling pathway; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:keratinocyte differentiation; P:lens fiber cell morphogenesis; P:mammary gland epithelial cell proliferation; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of chemokine production; P:negative regulation of lymphangiogenesis; P:negative regulation of protein kinase B signaling; P:neural tube development; P:notochord cell development; P:notochord formation; P:osteoblast differentiation; P:osteoclast differentiation; P:pericyte cell differentiation; P:positive regulation of bicellular tight junction assembly; P:positive regulation of kinase activity; P:positive regulation of protein localization to plasma membrane; P:post-anal tail morphogenesis; P:protein kinase B signaling; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of ERK1 and ERK2 cascade; P:regulation of lamellipodium assembly; P:response to growth factor; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P29317 B5A968 Q8N3Z2,Ephrin type-A receptor 2,Epithelial cell kinase;Tyrosine-protein kinase receptor ECK;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0009986;GO:0005925;GO:0005887;GO:0030027;GO:0031258;GO:0031256;GO:0043005;GO:0005886;GO:0043235;GO:0032587;GO:0070160;GO:0005524;GO:0045296;GO:0019838;GO:0004714;GO:0005005;GO:0001618;GO:0090630;GO:0048320;GO:0007411;GO:0002043;GO:0046849;GO:0060444;GO:0046058;GO:0007155;GO:0060326;GO:0016477;GO:0048870;GO:0050830;GO:0048013;GO:0006954;GO:0008630;GO:0030216;GO:0070309;GO:0033598;GO:0007275;GO:0016525;GO:0032682;GO:1901491;GO:0051898;GO:0021915;GO:0060035;GO:0014028;GO:0001649;GO:0030316;GO:1904238;GO:1903348;GO:0033674;GO:1903078;GO:0036342;GO:0043491;GO:0072659;GO:0045765;GO:0043535;GO:0033628;GO:0070372;GO:0010591;GO:0070848;GO:0001501;GO:0007169;GO:0001570;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:leading edge membrane; C:neuron projection; C:plasma membrane; C:receptor complex; C:ruffle membrane; C:tight junction;, F:ATP binding; F:cadherin binding; F:growth factor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity; F:virus receptor activity;, P:activation of GTPase activity; P:axial mesoderm formation; P:axon guidance; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:cAMP metabolic process; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell motility; P:defense response to Gram-positive bacterium; P:ephrin receptor signaling pathway; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:keratinocyte differentiation; P:lens fiber cell morphogenesis; P:mammary gland epithelial cell proliferation; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of chemokine production; P:negative regulation of lymphangiogenesis; P:negative regulation of protein kinase B signaling; P:neural tube development; P:notochord cell development; P:notochord formation; P:osteoblast differentiation; P:osteoclast differentiation; P:pericyte cell differentiation; P:positive regulation of bicellular tight junction assembly; P:positive regulation of kinase activity; P:positive regulation of protein localization to plasma membrane; P:post-anal tail morphogenesis; P:protein kinase B signaling; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of ERK1 and ERK2 cascade; P:regulation of lamellipodium assembly; P:response to growth factor; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis; scaffold516 indexed_genome mRNA 376 1996 . + . ID=transcript_16777;Q96AQ9 Q5T5Q5 Q8N3X3 Q8N9P9,Protein FAM131C,, PF15010;|Q96AQ9 Q5T5Q5 Q8N3X3 Q8N9P9,Protein FAM131C,, PF15010; scaffold516 indexed_genome mRNA 61654 69313 . - . ID=transcript_16778;P29317 B5A968 Q8N3Z2,Ephrin type-A receptor 2,Epithelial cell kinase;Tyrosine-protein kinase receptor ECK;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0009986;GO:0005925;GO:0005887;GO:0030027;GO:0031258;GO:0031256;GO:0043005;GO:0005886;GO:0043235;GO:0032587;GO:0070160;GO:0005524;GO:0045296;GO:0019838;GO:0004714;GO:0005005;GO:0001618;GO:0090630;GO:0048320;GO:0007411;GO:0002043;GO:0046849;GO:0060444;GO:0046058;GO:0007155;GO:0060326;GO:0016477;GO:0048870;GO:0050830;GO:0048013;GO:0006954;GO:0008630;GO:0030216;GO:0070309;GO:0033598;GO:0007275;GO:0016525;GO:0032682;GO:1901491;GO:0051898;GO:0021915;GO:0060035;GO:0014028;GO:0001649;GO:0030316;GO:1904238;GO:1903348;GO:0033674;GO:1903078;GO:0036342;GO:0043491;GO:0072659;GO:0045765;GO:0043535;GO:0033628;GO:0070372;GO:0010591;GO:0070848;GO:0001501;GO:0007169;GO:0001570;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:leading edge membrane; C:neuron projection; C:plasma membrane; C:receptor complex; C:ruffle membrane; C:tight junction;, F:ATP binding; F:cadherin binding; F:growth factor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity; F:virus receptor activity;, P:activation of GTPase activity; P:axial mesoderm formation; P:axon guidance; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:cAMP metabolic process; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell motility; P:defense response to Gram-positive bacterium; P:ephrin receptor signaling pathway; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:keratinocyte differentiation; P:lens fiber cell morphogenesis; P:mammary gland epithelial cell proliferation; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of chemokine production; P:negative regulation of lymphangiogenesis; P:negative regulation of protein kinase B signaling; P:neural tube development; P:notochord cell development; P:notochord formation; P:osteoblast differentiation; P:osteoclast differentiation; P:pericyte cell differentiation; P:positive regulation of bicellular tight junction assembly; P:positive regulation of kinase activity; P:positive regulation of protein localization to plasma membrane; P:post-anal tail morphogenesis; P:protein kinase B signaling; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of ERK1 and ERK2 cascade; P:regulation of lamellipodium assembly; P:response to growth factor; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P29317 B5A968 Q8N3Z2,Ephrin type-A receptor 2,Epithelial cell kinase;Tyrosine-protein kinase receptor ECK;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0009986;GO:0005925;GO:0005887;GO:0030027;GO:0031258;GO:0031256;GO:0043005;GO:0005886;GO:0043235;GO:0032587;GO:0070160;GO:0005524;GO:0045296;GO:0019838;GO:0004714;GO:0005005;GO:0001618;GO:0090630;GO:0048320;GO:0007411;GO:0002043;GO:0046849;GO:0060444;GO:0046058;GO:0007155;GO:0060326;GO:0016477;GO:0048870;GO:0050830;GO:0048013;GO:0006954;GO:0008630;GO:0030216;GO:0070309;GO:0033598;GO:0007275;GO:0016525;GO:0032682;GO:1901491;GO:0051898;GO:0021915;GO:0060035;GO:0014028;GO:0001649;GO:0030316;GO:1904238;GO:1903348;GO:0033674;GO:1903078;GO:0036342;GO:0043491;GO:0072659;GO:0045765;GO:0043535;GO:0033628;GO:0070372;GO:0010591;GO:0070848;GO:0001501;GO:0007169;GO:0001570;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:leading edge membrane; C:neuron projection; C:plasma membrane; C:receptor complex; C:ruffle membrane; C:tight junction;, F:ATP binding; F:cadherin binding; F:growth factor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity; F:virus receptor activity;, P:activation of GTPase activity; P:axial mesoderm formation; P:axon guidance; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:cAMP metabolic process; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell motility; P:defense response to Gram-positive bacterium; P:ephrin receptor signaling pathway; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:keratinocyte differentiation; P:lens fiber cell morphogenesis; P:mammary gland epithelial cell proliferation; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of chemokine production; P:negative regulation of lymphangiogenesis; P:negative regulation of protein kinase B signaling; P:neural tube development; P:notochord cell development; P:notochord formation; P:osteoblast differentiation; P:osteoclast differentiation; P:pericyte cell differentiation; P:positive regulation of bicellular tight junction assembly; P:positive regulation of kinase activity; P:positive regulation of protein localization to plasma membrane; P:post-anal tail morphogenesis; P:protein kinase B signaling; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of ERK1 and ERK2 cascade; P:regulation of lamellipodium assembly; P:response to growth factor; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis;|P29317 B5A968 Q8N3Z2,Ephrin type-A receptor 2,Epithelial cell kinase;Tyrosine-protein kinase receptor ECK;, PF14575;PF01404;PF00041;PF07714;PF00536;, GO:0009986;GO:0005925;GO:0005887;GO:0030027;GO:0031258;GO:0031256;GO:0043005;GO:0005886;GO:0043235;GO:0032587;GO:0070160;GO:0005524;GO:0045296;GO:0019838;GO:0004714;GO:0005005;GO:0001618;GO:0090630;GO:0048320;GO:0007411;GO:0002043;GO:0046849;GO:0060444;GO:0046058;GO:0007155;GO:0060326;GO:0016477;GO:0048870;GO:0050830;GO:0048013;GO:0006954;GO:0008630;GO:0030216;GO:0070309;GO:0033598;GO:0007275;GO:0016525;GO:0032682;GO:1901491;GO:0051898;GO:0021915;GO:0060035;GO:0014028;GO:0001649;GO:0030316;GO:1904238;GO:1903348;GO:0033674;GO:1903078;GO:0036342;GO:0043491;GO:0072659;GO:0045765;GO:0043535;GO:0033628;GO:0070372;GO:0010591;GO:0070848;GO:0001501;GO:0007169;GO:0001570;, C:cell surface; C:focal adhesion; C:integral component of plasma membrane; C:lamellipodium; C:lamellipodium membrane; C:leading edge membrane; C:neuron projection; C:plasma membrane; C:receptor complex; C:ruffle membrane; C:tight junction;, F:ATP binding; F:cadherin binding; F:growth factor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity; F:virus receptor activity;, P:activation of GTPase activity; P:axial mesoderm formation; P:axon guidance; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:bone remodeling; P:branching involved in mammary gland duct morphogenesis; P:cAMP metabolic process; P:cell adhesion; P:cell chemotaxis; P:cell migration; P:cell motility; P:defense response to Gram-positive bacterium; P:ephrin receptor signaling pathway; P:inflammatory response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:keratinocyte differentiation; P:lens fiber cell morphogenesis; P:mammary gland epithelial cell proliferation; P:multicellular organism development; P:negative regulation of angiogenesis; P:negative regulation of chemokine production; P:negative regulation of lymphangiogenesis; P:negative regulation of protein kinase B signaling; P:neural tube development; P:notochord cell development; P:notochord formation; P:osteoblast differentiation; P:osteoclast differentiation; P:pericyte cell differentiation; P:positive regulation of bicellular tight junction assembly; P:positive regulation of kinase activity; P:positive regulation of protein localization to plasma membrane; P:post-anal tail morphogenesis; P:protein kinase B signaling; P:protein localization to plasma membrane; P:regulation of angiogenesis; P:regulation of blood vessel endothelial cell migration; P:regulation of cell adhesion mediated by integrin; P:regulation of ERK1 and ERK2 cascade; P:regulation of lamellipodium assembly; P:response to growth factor; P:skeletal system development; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vasculogenesis; scaffold527 indexed_genome mRNA 829 25409 . + . ID=transcript_16779;Q6S382 Q6S383,Plectin,Hemidesmosomal protein 1;Plectin-1;, PF00307;PF00681;PF03501;PF17902;PF18373;, GO:0005903;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030056;GO:0045111;GO:0016020;GO:0048471;GO:0005886;GO:0042383;GO:0016528;GO:0003779;GO:0030506;GO:0045296;GO:0003723;GO:0005200;GO:0008307;GO:0005198;GO:0030199;GO:0031581;GO:0045104;GO:0042060;, C:brush border; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:intermediate filament cytoskeleton; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:sarcoplasm;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:structural molecule activity;, P:collagen fibril organization; P:hemidesmosome assembly; P:intermediate filament cytoskeleton organization; P:wound healing;|Q6S382 Q6S383,Plectin,Hemidesmosomal protein 1;Plectin-1;, PF00307;PF00681;PF03501;PF17902;PF18373;, GO:0005903;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030056;GO:0045111;GO:0016020;GO:0048471;GO:0005886;GO:0042383;GO:0016528;GO:0003779;GO:0030506;GO:0045296;GO:0003723;GO:0005200;GO:0008307;GO:0005198;GO:0030199;GO:0031581;GO:0045104;GO:0042060;, C:brush border; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:intermediate filament cytoskeleton; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:sarcoplasm;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:structural molecule activity;, P:collagen fibril organization; P:hemidesmosome assembly; P:intermediate filament cytoskeleton organization; P:wound healing;|Q6S382 Q6S383,Plectin,Hemidesmosomal protein 1;Plectin-1;, PF00307;PF00681;PF03501;PF17902;PF18373;, GO:0005903;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030056;GO:0045111;GO:0016020;GO:0048471;GO:0005886;GO:0042383;GO:0016528;GO:0003779;GO:0030506;GO:0045296;GO:0003723;GO:0005200;GO:0008307;GO:0005198;GO:0030199;GO:0031581;GO:0045104;GO:0042060;, C:brush border; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:intermediate filament cytoskeleton; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:sarcoplasm;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:structural molecule activity;, P:collagen fibril organization; P:hemidesmosome assembly; P:intermediate filament cytoskeleton organization; P:wound healing;|Q6S382 Q6S383,Plectin,Hemidesmosomal protein 1;Plectin-1;, PF00307;PF00681;PF03501;PF17902;PF18373;, GO:0005903;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030056;GO:0045111;GO:0016020;GO:0048471;GO:0005886;GO:0042383;GO:0016528;GO:0003779;GO:0030506;GO:0045296;GO:0003723;GO:0005200;GO:0008307;GO:0005198;GO:0030199;GO:0031581;GO:0045104;GO:0042060;, C:brush border; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:intermediate filament cytoskeleton; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:sarcoplasm;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:structural molecule activity;, P:collagen fibril organization; P:hemidesmosome assembly; P:intermediate filament cytoskeleton organization; P:wound healing;|Q6S382 Q6S383,Plectin,Hemidesmosomal protein 1;Plectin-1;, PF00307;PF00681;PF03501;PF17902;PF18373;, GO:0005903;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030056;GO:0045111;GO:0016020;GO:0048471;GO:0005886;GO:0042383;GO:0016528;GO:0003779;GO:0030506;GO:0045296;GO:0003723;GO:0005200;GO:0008307;GO:0005198;GO:0030199;GO:0031581;GO:0045104;GO:0042060;, C:brush border; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:intermediate filament cytoskeleton; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:sarcoplasm;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:structural molecule activity;, P:collagen fibril organization; P:hemidesmosome assembly; P:intermediate filament cytoskeleton organization; P:wound healing;|Q6S382 Q6S383,Plectin,Hemidesmosomal protein 1;Plectin-1;, PF00307;PF00681;PF03501;PF17902;PF18373;, GO:0005903;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030056;GO:0045111;GO:0016020;GO:0048471;GO:0005886;GO:0042383;GO:0016528;GO:0003779;GO:0030506;GO:0045296;GO:0003723;GO:0005200;GO:0008307;GO:0005198;GO:0030199;GO:0031581;GO:0045104;GO:0042060;, C:brush border; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:intermediate filament cytoskeleton; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:sarcoplasm;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:structural molecule activity;, P:collagen fibril organization; P:hemidesmosome assembly; P:intermediate filament cytoskeleton organization; P:wound healing;|Q6S382 Q6S383,Plectin,Hemidesmosomal protein 1;Plectin-1;, PF00307;PF00681;PF03501;PF17902;PF18373;, GO:0005903;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030056;GO:0045111;GO:0016020;GO:0048471;GO:0005886;GO:0042383;GO:0016528;GO:0003779;GO:0030506;GO:0045296;GO:0003723;GO:0005200;GO:0008307;GO:0005198;GO:0030199;GO:0031581;GO:0045104;GO:0042060;, C:brush border; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:intermediate filament cytoskeleton; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:sarcoplasm;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:structural molecule activity;, P:collagen fibril organization; P:hemidesmosome assembly; P:intermediate filament cytoskeleton organization; P:wound healing;|Q6S382 Q6S383,Plectin,Hemidesmosomal protein 1;Plectin-1;, PF00307;PF00681;PF03501;PF17902;PF18373;, GO:0005903;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030056;GO:0045111;GO:0016020;GO:0048471;GO:0005886;GO:0042383;GO:0016528;GO:0003779;GO:0030506;GO:0045296;GO:0003723;GO:0005200;GO:0008307;GO:0005198;GO:0030199;GO:0031581;GO:0045104;GO:0042060;, C:brush border; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:intermediate filament cytoskeleton; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:sarcoplasm;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:structural molecule activity;, P:collagen fibril organization; P:hemidesmosome assembly; P:intermediate filament cytoskeleton organization; P:wound healing;|Q6S382 Q6S383,Plectin,Hemidesmosomal protein 1;Plectin-1;, PF00307;PF00681;PF03501;PF17902;PF18373;, GO:0005903;GO:0043034;GO:0005737;GO:0005829;GO:0070062;GO:0005925;GO:0030056;GO:0045111;GO:0016020;GO:0048471;GO:0005886;GO:0042383;GO:0016528;GO:0003779;GO:0030506;GO:0045296;GO:0003723;GO:0005200;GO:0008307;GO:0005198;GO:0030199;GO:0031581;GO:0045104;GO:0042060;, C:brush border; C:costamere; C:cytoplasm; C:cytosol; C:extracellular exosome; C:focal adhesion; C:hemidesmosome; C:intermediate filament cytoskeleton; C:membrane; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcolemma; C:sarcoplasm;, F:actin binding; F:ankyrin binding; F:cadherin binding; F:RNA binding; F:structural constituent of cytoskeleton; F:structural constituent of muscle; F:structural molecule activity;, P:collagen fibril organization; P:hemidesmosome assembly; P:intermediate filament cytoskeleton organization; P:wound healing; scaffold532 indexed_genome mRNA 717 13247 . + . ID=transcript_16780;O75338 Q147X0 Q8WX95,Regulator of G-protein signaling 12,, PF02188;PF00595;PF02196;PF00615;, GO:0000794;GO:0005737;GO:0005829;GO:0030425;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0005096;GO:0030695;GO:0007186;GO:0009968;GO:0008277;, C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:GTPase activator activity; F:GTPase regulator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway;|O75338 Q147X0 Q8WX95,Regulator of G-protein signaling 12,, PF02188;PF00595;PF02196;PF00615;, GO:0000794;GO:0005737;GO:0005829;GO:0030425;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0005096;GO:0030695;GO:0007186;GO:0009968;GO:0008277;, C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:GTPase activator activity; F:GTPase regulator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway; scaffold532 indexed_genome mRNA 17460 19428 . - . ID=transcript_16781;O75338 Q147X0 Q8WX95,Regulator of G-protein signaling 12,, PF02188;PF00595;PF02196;PF00615;, GO:0000794;GO:0005737;GO:0005829;GO:0030425;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0005096;GO:0030695;GO:0007186;GO:0009968;GO:0008277;, C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:GTPase activator activity; F:GTPase regulator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway; scaffold532 indexed_genome mRNA 20599 25398 . + . ID=transcript_16782;Q04756 Q14726 Q2M1W7 Q53X47,Hepatocyte growth factor activator,, PF00008;PF00039;PF00040;PF00051;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005791;GO:0004252;GO:0008236;GO:0007596;GO:0006508;GO:0031638;, C:cytosol; C:extracellular region; C:extracellular space; C:rough endoplasmic reticulum;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:blood coagulation; P:proteolysis; P:zymogen activation;|Q04756 Q14726 Q2M1W7 Q53X47,Hepatocyte growth factor activator,, PF00008;PF00039;PF00040;PF00051;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005791;GO:0004252;GO:0008236;GO:0007596;GO:0006508;GO:0031638;, C:cytosol; C:extracellular region; C:extracellular space; C:rough endoplasmic reticulum;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:blood coagulation; P:proteolysis; P:zymogen activation; scaffold532 indexed_genome mRNA 30399 33430 . + . ID=transcript_16783;Q04756 Q14726 Q2M1W7 Q53X47,Hepatocyte growth factor activator,, PF00008;PF00039;PF00040;PF00051;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005791;GO:0004252;GO:0008236;GO:0007596;GO:0006508;GO:0031638;, C:cytosol; C:extracellular region; C:extracellular space; C:rough endoplasmic reticulum;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:blood coagulation; P:proteolysis; P:zymogen activation;|Q04756 Q14726 Q2M1W7 Q53X47,Hepatocyte growth factor activator,, PF00008;PF00039;PF00040;PF00051;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005791;GO:0004252;GO:0008236;GO:0007596;GO:0006508;GO:0031638;, C:cytosol; C:extracellular region; C:extracellular space; C:rough endoplasmic reticulum;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:blood coagulation; P:proteolysis; P:zymogen activation; scaffold533 indexed_genome mRNA 717 13210 . + . ID=transcript_16784;O75338 Q147X0 Q8WX95,Regulator of G-protein signaling 12,, PF02188;PF00595;PF02196;PF00615;, GO:0000794;GO:0005737;GO:0005829;GO:0030425;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0005096;GO:0030695;GO:0007186;GO:0009968;GO:0008277;, C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:GTPase activator activity; F:GTPase regulator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway;|O75338 Q147X0 Q8WX95,Regulator of G-protein signaling 12,, PF02188;PF00595;PF02196;PF00615;, GO:0000794;GO:0005737;GO:0005829;GO:0030425;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0005096;GO:0030695;GO:0007186;GO:0009968;GO:0008277;, C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:GTPase activator activity; F:GTPase regulator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway; scaffold533 indexed_genome mRNA 17422 19390 . - . ID=transcript_16785;O75338 Q147X0 Q8WX95,Regulator of G-protein signaling 12,, PF02188;PF00595;PF02196;PF00615;, GO:0000794;GO:0005737;GO:0005829;GO:0030425;GO:0016363;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0045202;GO:0005096;GO:0030695;GO:0007186;GO:0009968;GO:0008277;, C:condensed nuclear chromosome; C:cytoplasm; C:cytosol; C:dendrite; C:nuclear matrix; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:synapse;, F:GTPase activator activity; F:GTPase regulator activity;, P:G protein-coupled receptor signaling pathway; P:negative regulation of signal transduction; P:regulation of G protein-coupled receptor signaling pathway; scaffold533 indexed_genome mRNA 20561 25368 . - . ID=transcript_16786;Q04756 Q14726 Q2M1W7 Q53X47,Hepatocyte growth factor activator,, PF00008;PF00039;PF00040;PF00051;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005791;GO:0004252;GO:0008236;GO:0007596;GO:0006508;GO:0031638;, C:cytosol; C:extracellular region; C:extracellular space; C:rough endoplasmic reticulum;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:blood coagulation; P:proteolysis; P:zymogen activation;|Q04756 Q14726 Q2M1W7 Q53X47,Hepatocyte growth factor activator,, PF00008;PF00039;PF00040;PF00051;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005791;GO:0004252;GO:0008236;GO:0007596;GO:0006508;GO:0031638;, C:cytosol; C:extracellular region; C:extracellular space; C:rough endoplasmic reticulum;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:blood coagulation; P:proteolysis; P:zymogen activation; scaffold533 indexed_genome mRNA 30369 33400 . + . ID=transcript_16787;Q04756 Q14726 Q2M1W7 Q53X47,Hepatocyte growth factor activator,, PF00008;PF00039;PF00040;PF00051;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005791;GO:0004252;GO:0008236;GO:0007596;GO:0006508;GO:0031638;, C:cytosol; C:extracellular region; C:extracellular space; C:rough endoplasmic reticulum;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:blood coagulation; P:proteolysis; P:zymogen activation;|Q04756 Q14726 Q2M1W7 Q53X47,Hepatocyte growth factor activator,, PF00008;PF00039;PF00040;PF00051;PF00089;, GO:0005829;GO:0005576;GO:0005615;GO:0005791;GO:0004252;GO:0008236;GO:0007596;GO:0006508;GO:0031638;, C:cytosol; C:extracellular region; C:extracellular space; C:rough endoplasmic reticulum;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:blood coagulation; P:proteolysis; P:zymogen activation; scaffold534 indexed_genome mRNA 12233 14543 . + . ID=transcript_16788;A5PLL7,Plasmanylethanolamine desaturase {ECO:0000303|PubMed:31604315, ECO:0000303|PubMed:32209662},Plasmanylethanolamine desaturase 1 {ECO:0000312|HGNC:HGNC:16735};Transmembrane protein 189;, PF10520;, GO:0005783;GO:0005789;GO:0016021;GO:0016491;GO:0050207;GO:0008611;GO:0006631;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:oxidoreductase activity; F:plasmanylethanolamine desaturase activity;, P:ether lipid biosynthetic process; P:fatty acid metabolic process; scaffold534 indexed_genome mRNA 16341 19220 . + . ID=transcript_16789;A5PLL7,Plasmanylethanolamine desaturase {ECO:0000303|PubMed:31604315, ECO:0000303|PubMed:32209662},Plasmanylethanolamine desaturase 1 {ECO:0000312|HGNC:HGNC:16735};Transmembrane protein 189;, PF10520;, GO:0005783;GO:0005789;GO:0016021;GO:0016491;GO:0050207;GO:0008611;GO:0006631;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:oxidoreductase activity; F:plasmanylethanolamine desaturase activity;, P:ether lipid biosynthetic process; P:fatty acid metabolic process;|A5PLL7,Plasmanylethanolamine desaturase {ECO:0000303|PubMed:31604315, ECO:0000303|PubMed:32209662},Plasmanylethanolamine desaturase 1 {ECO:0000312|HGNC:HGNC:16735};Transmembrane protein 189;, PF10520;, GO:0005783;GO:0005789;GO:0016021;GO:0016491;GO:0050207;GO:0008611;GO:0006631;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:oxidoreductase activity; F:plasmanylethanolamine desaturase activity;, P:ether lipid biosynthetic process; P:fatty acid metabolic process; scaffold534 indexed_genome mRNA 64886 65549 . - . ID=transcript_16790;Q9H4J3 Q9H4J4 Q9UKL1 Q9UM48 Q9UM49 Q9UM50,Ubiquitin-conjugating enzyme E2 variant 1,CROC-1;TRAF6-regulated IKK activator 1 beta Uev1A;, PF00179;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0035370;GO:0031371;GO:0000151;GO:0000187;GO:0035973;GO:0030154;GO:0070498;GO:0007254;GO:0070423;GO:0043123;GO:0051092;GO:0045893;GO:0006301;GO:0070534;GO:0000209;GO:0006282;GO:0006355;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:UBC13-UEV1A complex; C:ubiquitin conjugating enzyme complex; C:ubiquitin ligase complex;, , P:activation of MAPK activity; P:aggrephagy; P:cell differentiation; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription, DNA-templated; P:postreplication repair; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of DNA repair; P:regulation of transcription, DNA-templated; scaffold535 indexed_genome mRNA 12238 14549 . + . ID=transcript_16791;A5PLL7,Plasmanylethanolamine desaturase {ECO:0000303|PubMed:31604315, ECO:0000303|PubMed:32209662},Plasmanylethanolamine desaturase 1 {ECO:0000312|HGNC:HGNC:16735};Transmembrane protein 189;, PF10520;, GO:0005783;GO:0005789;GO:0016021;GO:0016491;GO:0050207;GO:0008611;GO:0006631;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:oxidoreductase activity; F:plasmanylethanolamine desaturase activity;, P:ether lipid biosynthetic process; P:fatty acid metabolic process; scaffold535 indexed_genome mRNA 16347 19226 . + . ID=transcript_16792;A5PLL7,Plasmanylethanolamine desaturase {ECO:0000303|PubMed:31604315, ECO:0000303|PubMed:32209662},Plasmanylethanolamine desaturase 1 {ECO:0000312|HGNC:HGNC:16735};Transmembrane protein 189;, PF10520;, GO:0005783;GO:0005789;GO:0016021;GO:0016491;GO:0050207;GO:0008611;GO:0006631;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:oxidoreductase activity; F:plasmanylethanolamine desaturase activity;, P:ether lipid biosynthetic process; P:fatty acid metabolic process;|A5PLL7,Plasmanylethanolamine desaturase {ECO:0000303|PubMed:31604315, ECO:0000303|PubMed:32209662},Plasmanylethanolamine desaturase 1 {ECO:0000312|HGNC:HGNC:16735};Transmembrane protein 189;, PF10520;, GO:0005783;GO:0005789;GO:0016021;GO:0016491;GO:0050207;GO:0008611;GO:0006631;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;, F:oxidoreductase activity; F:plasmanylethanolamine desaturase activity;, P:ether lipid biosynthetic process; P:fatty acid metabolic process; scaffold535 indexed_genome mRNA 56915 58276 . - . ID=transcript_16793;Q15819,Ubiquitin-conjugating enzyme E2 variant 2,DDVit 1;Enterocyte differentiation-associated factor 1;Enterocyte differentiation-promoting factor 1;MMS2 homolog;Vitamin D3-inducible protein;, PF00179;, GO:0005737;GO:0070062;GO:0005654;GO:0005634;GO:0031372;GO:0000729;GO:0006302;GO:0006303;GO:0042275;GO:0043524;GO:0045739;GO:0010976;GO:0032436;GO:0051965;GO:0006301;GO:0070534;GO:0000209;GO:0016567;GO:0006282;, C:cytoplasm; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:UBC13-MMS2 complex;, , P:DNA double-strand break processing; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:error-free postreplication DNA repair; P:negative regulation of neuron apoptotic process; P:positive regulation of DNA repair; P:positive regulation of neuron projection development; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of synapse assembly; P:postreplication repair; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of DNA repair; scaffold535 indexed_genome mRNA 64858 65521 . - . ID=transcript_16794;Q9H4J3 Q9H4J4 Q9UKL1 Q9UM48 Q9UM49 Q9UM50,Ubiquitin-conjugating enzyme E2 variant 1,CROC-1;TRAF6-regulated IKK activator 1 beta Uev1A;, PF00179;, GO:0005737;GO:0005829;GO:0070062;GO:0005654;GO:0005634;GO:0032991;GO:0035370;GO:0031371;GO:0000151;GO:0000187;GO:0035973;GO:0030154;GO:0070498;GO:0007254;GO:0070423;GO:0043123;GO:0051092;GO:0045893;GO:0006301;GO:0070534;GO:0000209;GO:0006282;GO:0006355;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:UBC13-UEV1A complex; C:ubiquitin conjugating enzyme complex; C:ubiquitin ligase complex;, , P:activation of MAPK activity; P:aggrephagy; P:cell differentiation; P:interleukin-1-mediated signaling pathway; P:JNK cascade; P:nucleotide-binding oligomerization domain containing signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of transcription, DNA-templated; P:postreplication repair; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:regulation of DNA repair; P:regulation of transcription, DNA-templated; scaffold541 indexed_genome mRNA 13547 22158 . + . ID=transcript_16795;Q9BXL8 Q8TB18 Q9NWK7,Cell division cycle-associated protein 4,Hematopoietic progenitor protein;, PF06031;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0048096;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, , P:chromatin-mediated maintenance of transcription;|Q9BXL8 Q8TB18 Q9NWK7,Cell division cycle-associated protein 4,Hematopoietic progenitor protein;, PF06031;, GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0048096;, C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, , P:chromatin-mediated maintenance of transcription; scaffold541 indexed_genome mRNA 25600 30798 . - . ID=transcript_16796;Q96F83 B2RPK9 Q9BTP4,Uncharacterized protein CLBA1 {ECO:0000305},Clathrin-binding box of aftiphilin-containing protein 1 {ECO:0000312|HGNC:HGNC:20126};, PF15045;, GO:0030121;GO:0032588;GO:0030276;GO:0046907;, C:AP-1 adaptor complex; C:trans-Golgi network membrane;, F:clathrin binding;, P:intracellular transport;|Q96F83 B2RPK9 Q9BTP4,Uncharacterized protein CLBA1 {ECO:0000305},Clathrin-binding box of aftiphilin-containing protein 1 {ECO:0000312|HGNC:HGNC:20126};, PF15045;, GO:0030121;GO:0032588;GO:0030276;GO:0046907;, C:AP-1 adaptor complex; C:trans-Golgi network membrane;, F:clathrin binding;, P:intracellular transport;|Q96F83 B2RPK9 Q9BTP4,Uncharacterized protein CLBA1 {ECO:0000305},Clathrin-binding box of aftiphilin-containing protein 1 {ECO:0000312|HGNC:HGNC:20126};, PF15045;, GO:0030121;GO:0032588;GO:0030276;GO:0046907;, C:AP-1 adaptor complex; C:trans-Golgi network membrane;, F:clathrin binding;, P:intracellular transport;|Q96F83 B2RPK9 Q9BTP4,Uncharacterized protein CLBA1 {ECO:0000305},Clathrin-binding box of aftiphilin-containing protein 1 {ECO:0000312|HGNC:HGNC:20126};, PF15045;, GO:0030121;GO:0032588;GO:0030276;GO:0046907;, C:AP-1 adaptor complex; C:trans-Golgi network membrane;, F:clathrin binding;, P:intracellular transport; scaffold541 indexed_genome mRNA 56945 64988 . + . ID=transcript_16797;Q96EX9,Protein AHNAK2,, , GO:0043034;GO:0005737;GO:0030659;GO:0005829;GO:0005634;GO:0005886;GO:0042383;GO:0030315;GO:0030018;GO:0043484;, C:costamere; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:nucleus; C:plasma membrane; C:sarcolemma; C:T-tubule; C:Z disc;, , P:regulation of RNA splicing; scaffold542 indexed_genome mRNA 47031 61383 . - . ID=transcript_16798;P45379 A2TDB9 A8K3K6 O60214 Q99596 Q99597 Q9BUF6 Q9UM96,Troponin T, cardiac muscle,Cardiac muscle troponin T;, PF00992;, GO:0097512;GO:1990584;GO:0005829;GO:0030017;GO:0005865;GO:0005861;GO:0003779;GO:0042802;GO:0005523;GO:0030172;GO:0031013;GO:0060048;GO:0006936;GO:0030049;GO:0032780;GO:0032781;GO:0008016;GO:0006937;GO:0051592;GO:0045214;GO:0055010;, C:cardiac myofibril; C:cardiac Troponin complex; C:cytosol; C:sarcomere; C:striated muscle thin filament; C:troponin complex;, F:actin binding; F:identical protein binding; F:tropomyosin binding; F:troponin C binding; F:troponin I binding;, P:cardiac muscle contraction; P:muscle contraction; P:muscle filament sliding; P:negative regulation of ATPase activity; P:positive regulation of ATPase activity; P:regulation of heart contraction; P:regulation of muscle contraction; P:response to calcium ion; P:sarcomere organization; P:ventricular cardiac muscle tissue morphogenesis;|P45379 A2TDB9 A8K3K6 O60214 Q99596 Q99597 Q9BUF6 Q9UM96,Troponin T, cardiac muscle,Cardiac muscle troponin T;, PF00992;, GO:0097512;GO:1990584;GO:0005829;GO:0030017;GO:0005865;GO:0005861;GO:0003779;GO:0042802;GO:0005523;GO:0030172;GO:0031013;GO:0060048;GO:0006936;GO:0030049;GO:0032780;GO:0032781;GO:0008016;GO:0006937;GO:0051592;GO:0045214;GO:0055010;, C:cardiac myofibril; C:cardiac Troponin complex; C:cytosol; C:sarcomere; C:striated muscle thin filament; C:troponin complex;, F:actin binding; F:identical protein binding; F:tropomyosin binding; F:troponin C binding; F:troponin I binding;, P:cardiac muscle contraction; P:muscle contraction; P:muscle filament sliding; P:negative regulation of ATPase activity; P:positive regulation of ATPase activity; P:regulation of heart contraction; P:regulation of muscle contraction; P:response to calcium ion; P:sarcomere organization; P:ventricular cardiac muscle tissue morphogenesis;|P45379 A2TDB9 A8K3K6 O60214 Q99596 Q99597 Q9BUF6 Q9UM96,Troponin T, cardiac muscle,Cardiac muscle troponin T;, PF00992;, GO:0097512;GO:1990584;GO:0005829;GO:0030017;GO:0005865;GO:0005861;GO:0003779;GO:0042802;GO:0005523;GO:0030172;GO:0031013;GO:0060048;GO:0006936;GO:0030049;GO:0032780;GO:0032781;GO:0008016;GO:0006937;GO:0051592;GO:0045214;GO:0055010;, C:cardiac myofibril; C:cardiac Troponin complex; C:cytosol; C:sarcomere; C:striated muscle thin filament; C:troponin complex;, F:actin binding; F:identical protein binding; F:tropomyosin binding; F:troponin C binding; F:troponin I binding;, P:cardiac muscle contraction; P:muscle contraction; P:muscle filament sliding; P:negative regulation of ATPase activity; P:positive regulation of ATPase activity; P:regulation of heart contraction; P:regulation of muscle contraction; P:response to calcium ion; P:sarcomere organization; P:ventricular cardiac muscle tissue morphogenesis;|P45379 A2TDB9 A8K3K6 O60214 Q99596 Q99597 Q9BUF6 Q9UM96,Troponin T, cardiac muscle,Cardiac muscle troponin T;, PF00992;, GO:0097512;GO:1990584;GO:0005829;GO:0030017;GO:0005865;GO:0005861;GO:0003779;GO:0042802;GO:0005523;GO:0030172;GO:0031013;GO:0060048;GO:0006936;GO:0030049;GO:0032780;GO:0032781;GO:0008016;GO:0006937;GO:0051592;GO:0045214;GO:0055010;, C:cardiac myofibril; C:cardiac Troponin complex; C:cytosol; C:sarcomere; C:striated muscle thin filament; C:troponin complex;, F:actin binding; F:identical protein binding; F:tropomyosin binding; F:troponin C binding; F:troponin I binding;, P:cardiac muscle contraction; P:muscle contraction; P:muscle filament sliding; P:negative regulation of ATPase activity; P:positive regulation of ATPase activity; P:regulation of heart contraction; P:regulation of muscle contraction; P:response to calcium ion; P:sarcomere organization; P:ventricular cardiac muscle tissue morphogenesis; scaffold552 indexed_genome mRNA 353 1821 . - . ID=transcript_16799;Q96KA5 D3DTC1 Q658W6 Q7LG29 Q96AZ0 Q9H3N4,Cleft lip and palate transmembrane protein 1-like protein,Cisplatin resistance-related protein 9;, PF05602;, GO:0012505;GO:0016021;GO:0016020;GO:0006915;, C:endomembrane system; C:integral component of membrane; C:membrane;, , P:apoptotic process; scaffold552 indexed_genome mRNA 6525 10534 . + . ID=transcript_16800;Q96KA5 D3DTC1 Q658W6 Q7LG29 Q96AZ0 Q9H3N4,Cleft lip and palate transmembrane protein 1-like protein,Cisplatin resistance-related protein 9;, PF05602;, GO:0012505;GO:0016021;GO:0016020;GO:0006915;, C:endomembrane system; C:integral component of membrane; C:membrane;, , P:apoptotic process; scaffold552 indexed_genome mRNA 37133 41493 . + . ID=transcript_16801;O14746 O14783 Q2XS35 Q8N6C3 Q8NG38 Q8NG46,Telomerase reverse transcriptase,HEST2;Telomerase catalytic subunit;Telomerase-associated protein 2;, PF00078;PF12009;, GO:0000781;GO:0005829;GO:0042645;GO:0016607;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0031379;GO:0000333;GO:0005697;GO:1990572;GO:0051087;GO:0003677;GO:0042802;GO:0046872;GO:0008022;GO:0042803;GO:0047485;GO:0003723;GO:0003968;GO:0003964;GO:0003720;GO:0070034;GO:0003721;GO:0042162;GO:0098680;GO:0001223;GO:0000049;GO:1904837;GO:0071456;GO:0071897;GO:0022616;GO:0062103;GO:0070200;GO:0007005;GO:2000773;GO:2000352;GO:2001240;GO:0010629;GO:0043524;GO:1903799;GO:1903704;GO:0045766;GO:1900087;GO:0046326;GO:0042635;GO:0051000;GO:1902895;GO:0032092;GO:1904751;GO:2000648;GO:1903620;GO:1904754;GO:1904707;GO:0030177;GO:0030422;GO:0031647;GO:0090399;GO:0046686;GO:0006278;GO:0000723;GO:0007004;GO:0001172;, C:chromosome, telomeric region; C:cytosol; C:mitochondrial nucleoid; C:nuclear speck; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:RNA-directed RNA polymerase complex; C:telomerase catalytic core complex; C:telomerase holoenzyme complex; C:TERT-RMRP complex;, F:chaperone binding; F:DNA binding; F:identical protein binding; F:metal ion binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein N-terminus binding; F:RNA binding; F:RNA-directed 5'-3' RNA polymerase activity; F:RNA-directed DNA polymerase activity; F:telomerase activity; F:telomerase RNA binding; F:telomerase RNA reverse transcriptase activity; F:telomeric DNA binding; F:template-free RNA nucleotidyltransferase; F:transcription coactivator binding; F:tRNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to hypoxia; P:DNA biosynthetic process; P:DNA strand elongation; P:double-stranded RNA biosynthetic process; P:establishment of protein localization to telomere; P:mitochondrion organization; P:negative regulation of cellular senescence; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of production of siRNA involved in RNA interference; P:positive regulation of angiogenesis; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of glucose import; P:positive regulation of hair cycle; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein binding; P:positive regulation of protein localization to nucleolus; P:positive regulation of stem cell proliferation; P:positive regulation of transdifferentiation; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of Wnt signaling pathway; P:production of siRNA involved in RNA interference; P:regulation of protein stability; P:replicative senescence; P:response to cadmium ion; P:RNA-dependent DNA biosynthetic process; P:telomere maintenance; P:telomere maintenance via telomerase; P:transcription, RNA-templated; scaffold552 indexed_genome mRNA 41506 45391 . + . ID=transcript_16802;O14746 O14783 Q2XS35 Q8N6C3 Q8NG38 Q8NG46,Telomerase reverse transcriptase,HEST2;Telomerase catalytic subunit;Telomerase-associated protein 2;, PF00078;PF12009;, GO:0000781;GO:0005829;GO:0042645;GO:0016607;GO:0000783;GO:0005730;GO:0005654;GO:0005634;GO:0005886;GO:0016605;GO:0031379;GO:0000333;GO:0005697;GO:1990572;GO:0051087;GO:0003677;GO:0042802;GO:0046872;GO:0008022;GO:0042803;GO:0047485;GO:0003723;GO:0003968;GO:0003964;GO:0003720;GO:0070034;GO:0003721;GO:0042162;GO:0098680;GO:0001223;GO:0000049;GO:1904837;GO:0071456;GO:0071897;GO:0022616;GO:0062103;GO:0070200;GO:0007005;GO:2000773;GO:2000352;GO:2001240;GO:0010629;GO:0043524;GO:1903799;GO:1903704;GO:0045766;GO:1900087;GO:0046326;GO:0042635;GO:0051000;GO:1902895;GO:0032092;GO:1904751;GO:2000648;GO:1903620;GO:1904754;GO:1904707;GO:0030177;GO:0030422;GO:0031647;GO:0090399;GO:0046686;GO:0006278;GO:0000723;GO:0007004;GO:0001172;, C:chromosome, telomeric region; C:cytosol; C:mitochondrial nucleoid; C:nuclear speck; C:nuclear telomere cap complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:plasma membrane; C:PML body; C:RNA-directed RNA polymerase complex; C:telomerase catalytic core complex; C:telomerase holoenzyme complex; C:TERT-RMRP complex;, F:chaperone binding; F:DNA binding; F:identical protein binding; F:metal ion binding; F:protein C-terminus binding; F:protein homodimerization activity; F:protein N-terminus binding; F:RNA binding; F:RNA-directed 5'-3' RNA polymerase activity; F:RNA-directed DNA polymerase activity; F:telomerase activity; F:telomerase RNA binding; F:telomerase RNA reverse transcriptase activity; F:telomeric DNA binding; F:template-free RNA nucleotidyltransferase; F:transcription coactivator binding; F:tRNA binding;, P:beta-catenin-TCF complex assembly; P:cellular response to hypoxia; P:DNA biosynthetic process; P:DNA strand elongation; P:double-stranded RNA biosynthetic process; P:establishment of protein localization to telomere; P:mitochondrion organization; P:negative regulation of cellular senescence; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:negative regulation of production of siRNA involved in RNA interference; P:positive regulation of angiogenesis; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of glucose import; P:positive regulation of hair cycle; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of protein binding; P:positive regulation of protein localization to nucleolus; P:positive regulation of stem cell proliferation; P:positive regulation of transdifferentiation; P:positive regulation of vascular associated smooth muscle cell migration; P:positive regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of Wnt signaling pathway; P:production of siRNA involved in RNA interference; P:regulation of protein stability; P:replicative senescence; P:response to cadmium ion; P:RNA-dependent DNA biosynthetic process; P:telomere maintenance; P:telomere maintenance via telomerase; P:transcription, RNA-templated; scaffold553 indexed_genome mRNA 41786 44980 . + . ID=transcript_16803;Q9NQP4 Q5TD11 Q92779,Prefoldin subunit 4,Protein C-1;, PF01920;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0016272;GO:0001540;GO:0051087;GO:0051082;GO:1905907;GO:0006457;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:prefoldin complex;, F:amyloid-beta binding; F:chaperone binding; F:unfolded protein binding;, P:negative regulation of amyloid fibril formation; P:protein folding;|Q9NQP4 Q5TD11 Q92779,Prefoldin subunit 4,Protein C-1;, PF01920;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0016272;GO:0001540;GO:0051087;GO:0051082;GO:1905907;GO:0006457;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:prefoldin complex;, F:amyloid-beta binding; F:chaperone binding; F:unfolded protein binding;, P:negative regulation of amyloid fibril formation; P:protein folding;|Q9NQP4 Q5TD11 Q92779,Prefoldin subunit 4,Protein C-1;, PF01920;, GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0016272;GO:0001540;GO:0051087;GO:0051082;GO:1905907;GO:0006457;, C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:prefoldin complex;, F:amyloid-beta binding; F:chaperone binding; F:unfolded protein binding;, P:negative regulation of amyloid fibril formation; P:protein folding; scaffold571 indexed_genome mRNA 5798 9886 . - . ID=transcript_16804;Q15077 Q15754,P2Y purinoceptor 6,, PF00001;, GO:0005887;GO:0005886;GO:0001621;GO:0004930;GO:0045029;GO:0045030;GO:0007202;GO:0071415;GO:1905835;GO:0007186;GO:0006909;GO:0007200;GO:0070374;GO:0031587;GO:0032962;GO:1904707;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled ADP receptor activity; F:G protein-coupled receptor activity; F:G protein-coupled UDP receptor activity; F:G protein-coupled UTP receptor activity;, P:activation of phospholipase C activity; P:cellular response to purine-containing compound; P:cellular response to pyrimidine ribonucleotide; P:G protein-coupled receptor signaling pathway; P:phagocytosis; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of inositol trisphosphate biosynthetic process; P:positive regulation of vascular associated smooth muscle cell proliferation; scaffold582 indexed_genome mRNA 5868 6632 . - . ID=transcript_16805;Q8IZX2 Q8N406 Q8TEU0 Q9H6C9 Q9H6H9 Q9H6P3 Q9H8A9 Q9HCF4 Q9HCL8,E3 ubiquitin-protein ligase RNF213 {ECO:0000305},ALK lymphoma oligomerization partner on chromosome 17 {ECO:0000303|PubMed:12112524};Mysterin {ECO:0000303|PubMed:26126547};RING finger protein 213 {ECO:0000305};RING-type E3 ubiquitin transferase RNF213 {ECO:0000305};, PF00097;, GO:0005737;GO:0005829;GO:0016020;GO:0005730;GO:0016887;GO:0046872;GO:0004842;GO:0001525;GO:0033668;GO:2000051;GO:0051865;GO:0051260;GO:0000209;GO:0016567;GO:0002040;GO:0006511;, C:cytoplasm; C:cytosol; C:membrane; C:nucleolus;, F:ATPase activity; F:metal ion binding; F:ubiquitin-protein transferase activity;, P:angiogenesis; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of non-canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein homooligomerization; P:protein polyubiquitination; P:protein ubiquitination; P:sprouting angiogenesis; P:ubiquitin-dependent protein catabolic process; scaffold582 indexed_genome mRNA 43277 43939 . - . ID=transcript_16806;Q8IZX2 Q8N406 Q8TEU0 Q9H6C9 Q9H6H9 Q9H6P3 Q9H8A9 Q9HCF4 Q9HCL8,E3 ubiquitin-protein ligase RNF213 {ECO:0000305},ALK lymphoma oligomerization partner on chromosome 17 {ECO:0000303|PubMed:12112524};Mysterin {ECO:0000303|PubMed:26126547};RING finger protein 213 {ECO:0000305};RING-type E3 ubiquitin transferase RNF213 {ECO:0000305};, PF00097;, GO:0005737;GO:0005829;GO:0016020;GO:0005730;GO:0016887;GO:0046872;GO:0004842;GO:0001525;GO:0033668;GO:2000051;GO:0051865;GO:0051260;GO:0000209;GO:0016567;GO:0002040;GO:0006511;, C:cytoplasm; C:cytosol; C:membrane; C:nucleolus;, F:ATPase activity; F:metal ion binding; F:ubiquitin-protein transferase activity;, P:angiogenesis; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of non-canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein homooligomerization; P:protein polyubiquitination; P:protein ubiquitination; P:sprouting angiogenesis; P:ubiquitin-dependent protein catabolic process; scaffold583 indexed_genome mRNA 5773 6537 . - . ID=transcript_16807;Q8IZX2 Q8N406 Q8TEU0 Q9H6C9 Q9H6H9 Q9H6P3 Q9H8A9 Q9HCF4 Q9HCL8,E3 ubiquitin-protein ligase RNF213 {ECO:0000305},ALK lymphoma oligomerization partner on chromosome 17 {ECO:0000303|PubMed:12112524};Mysterin {ECO:0000303|PubMed:26126547};RING finger protein 213 {ECO:0000305};RING-type E3 ubiquitin transferase RNF213 {ECO:0000305};, PF00097;, GO:0005737;GO:0005829;GO:0016020;GO:0005730;GO:0016887;GO:0046872;GO:0004842;GO:0001525;GO:0033668;GO:2000051;GO:0051865;GO:0051260;GO:0000209;GO:0016567;GO:0002040;GO:0006511;, C:cytoplasm; C:cytosol; C:membrane; C:nucleolus;, F:ATPase activity; F:metal ion binding; F:ubiquitin-protein transferase activity;, P:angiogenesis; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of non-canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein homooligomerization; P:protein polyubiquitination; P:protein ubiquitination; P:sprouting angiogenesis; P:ubiquitin-dependent protein catabolic process; scaffold583 indexed_genome mRNA 31738 42282 . - . ID=transcript_16808;Q8IZX2 Q8N406 Q8TEU0 Q9H6C9 Q9H6H9 Q9H6P3 Q9H8A9 Q9HCF4 Q9HCL8,E3 ubiquitin-protein ligase RNF213 {ECO:0000305},ALK lymphoma oligomerization partner on chromosome 17 {ECO:0000303|PubMed:12112524};Mysterin {ECO:0000303|PubMed:26126547};RING finger protein 213 {ECO:0000305};RING-type E3 ubiquitin transferase RNF213 {ECO:0000305};, PF00097;, GO:0005737;GO:0005829;GO:0016020;GO:0005730;GO:0016887;GO:0046872;GO:0004842;GO:0001525;GO:0033668;GO:2000051;GO:0051865;GO:0051260;GO:0000209;GO:0016567;GO:0002040;GO:0006511;, C:cytoplasm; C:cytosol; C:membrane; C:nucleolus;, F:ATPase activity; F:metal ion binding; F:ubiquitin-protein transferase activity;, P:angiogenesis; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of non-canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein homooligomerization; P:protein polyubiquitination; P:protein ubiquitination; P:sprouting angiogenesis; P:ubiquitin-dependent protein catabolic process; scaffold583 indexed_genome mRNA 43184 43846 . - . ID=transcript_16809;Q8IZX2 Q8N406 Q8TEU0 Q9H6C9 Q9H6H9 Q9H6P3 Q9H8A9 Q9HCF4 Q9HCL8,E3 ubiquitin-protein ligase RNF213 {ECO:0000305},ALK lymphoma oligomerization partner on chromosome 17 {ECO:0000303|PubMed:12112524};Mysterin {ECO:0000303|PubMed:26126547};RING finger protein 213 {ECO:0000305};RING-type E3 ubiquitin transferase RNF213 {ECO:0000305};, PF00097;, GO:0005737;GO:0005829;GO:0016020;GO:0005730;GO:0016887;GO:0046872;GO:0004842;GO:0001525;GO:0033668;GO:2000051;GO:0051865;GO:0051260;GO:0000209;GO:0016567;GO:0002040;GO:0006511;, C:cytoplasm; C:cytosol; C:membrane; C:nucleolus;, F:ATPase activity; F:metal ion binding; F:ubiquitin-protein transferase activity;, P:angiogenesis; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of non-canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein homooligomerization; P:protein polyubiquitination; P:protein ubiquitination; P:sprouting angiogenesis; P:ubiquitin-dependent protein catabolic process; scaffold585 indexed_genome mRNA 22246 23176 . + . ID=transcript_16810;P61604 O95421 Q04984 Q53X54 Q9UDH0,10 kDa heat shock protein, mitochondrial,10 kDa chaperonin;Chaperonin 10;Early-pregnancy factor;, PF00166;, GO:0070062;GO:0016020;GO:0005759;GO:0005739;GO:0005524;GO:0016887;GO:0051087;GO:0046872;GO:0003723;GO:0051082;GO:0006919;GO:0051085;GO:0001649;GO:0006457;GO:0006986;, C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:chaperone binding; F:metal ion binding; F:RNA binding; F:unfolded protein binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:chaperone cofactor-dependent protein refolding; P:osteoblast differentiation; P:protein folding; P:response to unfolded protein; scaffold586 indexed_genome mRNA 4668 6557 . + . ID=transcript_16811;P63136,Endogenous retrovirus group K member 25 Pol protein,HERV-K_11q22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold591 indexed_genome mRNA 18398 23853 . - . ID=transcript_16812;Q8NHY3 Q8NHY4,GAS2-like protein 2,GAS2-related protein on chromosome 17;Growth arrest-specific protein 2-like 2;, PF00307;PF02187;, GO:0036064;GO:0005737;GO:0005886;GO:0051015;GO:0008093;GO:0001965;GO:0008017;GO:0051764;GO:0001578;GO:0000226;GO:0007026;GO:0045745;GO:1904825;GO:0060296;GO:0031110;, C:ciliary basal body; C:cytoplasm; C:plasma membrane;, F:actin filament binding; F:cytoskeletal anchor activity; F:G-protein alpha-subunit binding; F:microtubule binding;, P:actin crosslink formation; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:positive regulation of G protein-coupled receptor signaling pathway; P:protein localization to microtubule plus-end; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of microtubule polymerization or depolymerization;|Q8NHY3 Q8NHY4,GAS2-like protein 2,GAS2-related protein on chromosome 17;Growth arrest-specific protein 2-like 2;, PF00307;PF02187;, GO:0036064;GO:0005737;GO:0005886;GO:0051015;GO:0008093;GO:0001965;GO:0008017;GO:0051764;GO:0001578;GO:0000226;GO:0007026;GO:0045745;GO:1904825;GO:0060296;GO:0031110;, C:ciliary basal body; C:cytoplasm; C:plasma membrane;, F:actin filament binding; F:cytoskeletal anchor activity; F:G-protein alpha-subunit binding; F:microtubule binding;, P:actin crosslink formation; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:positive regulation of G protein-coupled receptor signaling pathway; P:protein localization to microtubule plus-end; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of microtubule polymerization or depolymerization;|Q8NHY3 Q8NHY4,GAS2-like protein 2,GAS2-related protein on chromosome 17;Growth arrest-specific protein 2-like 2;, PF00307;PF02187;, GO:0036064;GO:0005737;GO:0005886;GO:0051015;GO:0008093;GO:0001965;GO:0008017;GO:0051764;GO:0001578;GO:0000226;GO:0007026;GO:0045745;GO:1904825;GO:0060296;GO:0031110;, C:ciliary basal body; C:cytoplasm; C:plasma membrane;, F:actin filament binding; F:cytoskeletal anchor activity; F:G-protein alpha-subunit binding; F:microtubule binding;, P:actin crosslink formation; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:positive regulation of G protein-coupled receptor signaling pathway; P:protein localization to microtubule plus-end; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of microtubule polymerization or depolymerization; scaffold591 indexed_genome mRNA 38903 42566 . - . ID=transcript_16813;Q9H239 Q96F04 Q96TE2,Matrix metalloproteinase-28,Epilysin;, PF00045;PF00413;PF01471;, GO:0062023;GO:0005737;GO:0031012;GO:0005615;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0010760;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:negative regulation of macrophage chemotaxis; scaffold591 indexed_genome mRNA 43411 43919 . + . ID=transcript_16814;Q9H239 Q96F04 Q96TE2,Matrix metalloproteinase-28,Epilysin;, PF00045;PF00413;PF01471;, GO:0062023;GO:0005737;GO:0031012;GO:0005615;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0010760;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:negative regulation of macrophage chemotaxis; scaffold591 indexed_genome mRNA 45026 46275 . - . ID=transcript_16815;Q9H239 Q96F04 Q96TE2,Matrix metalloproteinase-28,Epilysin;, PF00045;PF00413;PF01471;, GO:0062023;GO:0005737;GO:0031012;GO:0005615;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0010760;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:negative regulation of macrophage chemotaxis; scaffold592 indexed_genome mRNA 18399 23855 . - . ID=transcript_16816;Q8NHY3 Q8NHY4,GAS2-like protein 2,GAS2-related protein on chromosome 17;Growth arrest-specific protein 2-like 2;, PF00307;PF02187;, GO:0036064;GO:0005737;GO:0005886;GO:0051015;GO:0008093;GO:0001965;GO:0008017;GO:0051764;GO:0001578;GO:0000226;GO:0007026;GO:0045745;GO:1904825;GO:0060296;GO:0031110;, C:ciliary basal body; C:cytoplasm; C:plasma membrane;, F:actin filament binding; F:cytoskeletal anchor activity; F:G-protein alpha-subunit binding; F:microtubule binding;, P:actin crosslink formation; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:positive regulation of G protein-coupled receptor signaling pathway; P:protein localization to microtubule plus-end; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of microtubule polymerization or depolymerization;|Q8NHY3 Q8NHY4,GAS2-like protein 2,GAS2-related protein on chromosome 17;Growth arrest-specific protein 2-like 2;, PF00307;PF02187;, GO:0036064;GO:0005737;GO:0005886;GO:0051015;GO:0008093;GO:0001965;GO:0008017;GO:0051764;GO:0001578;GO:0000226;GO:0007026;GO:0045745;GO:1904825;GO:0060296;GO:0031110;, C:ciliary basal body; C:cytoplasm; C:plasma membrane;, F:actin filament binding; F:cytoskeletal anchor activity; F:G-protein alpha-subunit binding; F:microtubule binding;, P:actin crosslink formation; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:positive regulation of G protein-coupled receptor signaling pathway; P:protein localization to microtubule plus-end; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of microtubule polymerization or depolymerization;|Q8NHY3 Q8NHY4,GAS2-like protein 2,GAS2-related protein on chromosome 17;Growth arrest-specific protein 2-like 2;, PF00307;PF02187;, GO:0036064;GO:0005737;GO:0005886;GO:0051015;GO:0008093;GO:0001965;GO:0008017;GO:0051764;GO:0001578;GO:0000226;GO:0007026;GO:0045745;GO:1904825;GO:0060296;GO:0031110;, C:ciliary basal body; C:cytoplasm; C:plasma membrane;, F:actin filament binding; F:cytoskeletal anchor activity; F:G-protein alpha-subunit binding; F:microtubule binding;, P:actin crosslink formation; P:microtubule bundle formation; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:positive regulation of G protein-coupled receptor signaling pathway; P:protein localization to microtubule plus-end; P:regulation of cilium beat frequency involved in ciliary motility; P:regulation of microtubule polymerization or depolymerization; scaffold592 indexed_genome mRNA 38906 42569 . - . ID=transcript_16817;Q9H239 Q96F04 Q96TE2,Matrix metalloproteinase-28,Epilysin;, PF00045;PF00413;PF01471;, GO:0062023;GO:0005737;GO:0031012;GO:0005615;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0010760;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:negative regulation of macrophage chemotaxis; scaffold592 indexed_genome mRNA 43414 43922 . + . ID=transcript_16818;Q9H239 Q96F04 Q96TE2,Matrix metalloproteinase-28,Epilysin;, PF00045;PF00413;PF01471;, GO:0062023;GO:0005737;GO:0031012;GO:0005615;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0010760;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:negative regulation of macrophage chemotaxis; scaffold592 indexed_genome mRNA 45029 46278 . - . ID=transcript_16819;Q9H239 Q96F04 Q96TE2,Matrix metalloproteinase-28,Epilysin;, PF00045;PF00413;PF01471;, GO:0062023;GO:0005737;GO:0031012;GO:0005615;GO:0004222;GO:0008270;GO:0030574;GO:0030198;GO:0010760;, C:collagen-containing extracellular matrix; C:cytoplasm; C:extracellular matrix; C:extracellular space;, F:metalloendopeptidase activity; F:zinc ion binding;, P:collagen catabolic process; P:extracellular matrix organization; P:negative regulation of macrophage chemotaxis; scaffold597 indexed_genome mRNA 5288 6457 . + . ID=transcript_16820;Q9UNW8 A8K7X7 B4E144 Q9BSU2,Probable G-protein coupled receptor 132,G2 accumulation protein;, PF00001;, GO:0016021;GO:0005886;GO:0004930;GO:0007186;GO:0000082;GO:0010972;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; P:G1/S transition of mitotic cell cycle; P:negative regulation of G2/M transition of mitotic cell cycle; scaffold598 indexed_genome mRNA 16457 21138 . - . ID=transcript_16821;P25208 A8K7B9 Q96IY8,Nuclear transcription factor Y subunit beta,CAAT box DNA-binding protein subunit B;Nuclear transcription factor Y subunit B;, PF00808;, GO:0016602;GO:0000785;GO:0005654;GO:0005634;GO:0032993;GO:0090575;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0046982;GO:0070491;GO:0000978;GO:0045944;GO:0019216;GO:0006357;GO:0006355;, C:CCAAT-binding factor complex; C:chromatin; C:nucleoplasm; C:nucleus; C:protein-DNA complex; C:RNA polymerase II transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:repressing transcription factor binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:positive regulation of transcription by RNA polymerase II; P:regulation of lipid metabolic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold598 indexed_genome mRNA 39716 42453 . + . ID=transcript_16822;Q9Y5Z7 B2R8Q5 C0H5X3,Host cell factor 2,C2 factor;, , GO:0005737;GO:0005829;GO:0035097;GO:0071339;GO:0016604;GO:0005654;GO:0005634;GO:0005886;GO:0003713;GO:0006338;GO:0000122;GO:0006357;GO:0006355;GO:0016032;, C:cytoplasm; C:cytosol; C:histone methyltransferase complex; C:MLL1 complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:transcription coactivator activity;, P:chromatin remodeling; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:viral process; scaffold599 indexed_genome mRNA 4453 5581 . - . ID=transcript_16823;O95721,Synaptosomal-associated protein 29 {ECO:0000312|HGNC:HGNC:11133},Soluble 29 kDa NSF attachment protein {ECO:0000312|HGNC:HGNC:11133};Vesicle-membrane fusion protein SNAP-29;, , GO:0005776;GO:0000421;GO:0035577;GO:0005813;GO:0020018;GO:0005737;GO:0005829;GO:0000139;GO:0005654;GO:0005886;GO:0098793;GO:0031201;GO:0005484;GO:0019905;GO:0097352;GO:0016240;GO:0060271;GO:0006887;GO:0061025;GO:0043312;GO:0015031;GO:0031629;GO:0016082;GO:0006906;GO:0006903;, C:autophagosome; C:autophagosome membrane; C:azurophil granule membrane; C:centrosome; C:ciliary pocket membrane; C:cytoplasm; C:cytosol; C:Golgi membrane; C:nucleoplasm; C:plasma membrane; C:presynapse; C:SNARE complex;, F:SNAP receptor activity; F:syntaxin binding;, P:autophagosome maturation; P:autophagosome membrane docking; P:cilium assembly; P:exocytosis; P:membrane fusion; P:neutrophil degranulation; P:protein transport; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle priming; P:vesicle fusion; P:vesicle targeting; scaffold599 indexed_genome mRNA 20506 40357 . - . ID=transcript_16824;P46109 A8KA44 D3DX35,Crk-like protein,, PF00017;PF00018;PF07653;, GO:0005829;GO:0098890;GO:0031594;GO:0005654;GO:0032991;GO:0045296;GO:0042802;GO:0001784;GO:0003723;GO:0095500;GO:0090630;GO:0000187;GO:0000186;GO:0009952;GO:0001783;GO:0001568;GO:0060326;GO:0035690;GO:0098761;GO:0071560;GO:0098749;GO:0021987;GO:1904888;GO:0019221;GO:0016358;GO:0086100;GO:0030010;GO:0008543;GO:0035685;GO:0021766;GO:0035556;GO:0007254;GO:0006629;GO:0008584;GO:0010629;GO:0001933;GO:0001764;GO:0003151;GO:0060017;GO:0060465;GO:0008284;GO:0070374;GO:1903977;GO:0001934;GO:0046579;GO:1900026;GO:0007265;GO:0038026;GO:0033628;GO:0001558;GO:0050773;GO:1904393;GO:2000404;GO:0048384;GO:0007338;GO:0007283;GO:0007416;GO:0050852;GO:0048538;GO:0001655;, C:cytosol; C:extrinsic component of postsynaptic membrane; C:neuromuscular junction; C:nucleoplasm; C:protein-containing complex;, F:cadherin binding; F:identical protein binding; F:phosphotyrosine residue binding; F:RNA binding;, P:acetylcholine receptor signaling pathway; P:activation of GTPase activity; P:activation of MAPK activity; P:activation of MAPKK activity; P:anterior/posterior pattern specification; P:B cell apoptotic process; P:blood vessel development; P:cell chemotaxis; P:cellular response to drug; P:cellular response to interleukin-7; P:cellular response to transforming growth factor beta stimulus; P:cerebellar neuron development; P:cerebral cortex development; P:cranial skeletal system development; P:cytokine-mediated signaling pathway; P:dendrite development; P:endothelin receptor signaling pathway; P:establishment of cell polarity; P:fibroblast growth factor receptor signaling pathway; P:helper T cell diapedesis; P:hippocampus development; P:intracellular signal transduction; P:JNK cascade; P:lipid metabolic process; P:male gonad development; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:neuron migration; P:outflow tract morphogenesis; P:parathyroid gland development; P:pharynx development; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glial cell migration; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:Ras protein signal transduction; P:reelin-mediated signaling pathway; P:regulation of cell adhesion mediated by integrin; P:regulation of cell growth; P:regulation of dendrite development; P:regulation of skeletal muscle acetylcholine-gated channel clustering; P:regulation of T cell migration; P:retinoic acid receptor signaling pathway; P:single fertilization; P:spermatogenesis; P:synapse assembly; P:T cell receptor signaling pathway; P:thymus development; P:urogenital system development;|P46109 A8KA44 D3DX35,Crk-like protein,, PF00017;PF00018;PF07653;, GO:0005829;GO:0098890;GO:0031594;GO:0005654;GO:0032991;GO:0045296;GO:0042802;GO:0001784;GO:0003723;GO:0095500;GO:0090630;GO:0000187;GO:0000186;GO:0009952;GO:0001783;GO:0001568;GO:0060326;GO:0035690;GO:0098761;GO:0071560;GO:0098749;GO:0021987;GO:1904888;GO:0019221;GO:0016358;GO:0086100;GO:0030010;GO:0008543;GO:0035685;GO:0021766;GO:0035556;GO:0007254;GO:0006629;GO:0008584;GO:0010629;GO:0001933;GO:0001764;GO:0003151;GO:0060017;GO:0060465;GO:0008284;GO:0070374;GO:1903977;GO:0001934;GO:0046579;GO:1900026;GO:0007265;GO:0038026;GO:0033628;GO:0001558;GO:0050773;GO:1904393;GO:2000404;GO:0048384;GO:0007338;GO:0007283;GO:0007416;GO:0050852;GO:0048538;GO:0001655;, C:cytosol; C:extrinsic component of postsynaptic membrane; C:neuromuscular junction; C:nucleoplasm; C:protein-containing complex;, F:cadherin binding; F:identical protein binding; F:phosphotyrosine residue binding; F:RNA binding;, P:acetylcholine receptor signaling pathway; P:activation of GTPase activity; P:activation of MAPK activity; P:activation of MAPKK activity; P:anterior/posterior pattern specification; P:B cell apoptotic process; P:blood vessel development; P:cell chemotaxis; P:cellular response to drug; P:cellular response to interleukin-7; P:cellular response to transforming growth factor beta stimulus; P:cerebellar neuron development; P:cerebral cortex development; P:cranial skeletal system development; P:cytokine-mediated signaling pathway; P:dendrite development; P:endothelin receptor signaling pathway; P:establishment of cell polarity; P:fibroblast growth factor receptor signaling pathway; P:helper T cell diapedesis; P:hippocampus development; P:intracellular signal transduction; P:JNK cascade; P:lipid metabolic process; P:male gonad development; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:neuron migration; P:outflow tract morphogenesis; P:parathyroid gland development; P:pharynx development; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glial cell migration; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:Ras protein signal transduction; P:reelin-mediated signaling pathway; P:regulation of cell adhesion mediated by integrin; P:regulation of cell growth; P:regulation of dendrite development; P:regulation of skeletal muscle acetylcholine-gated channel clustering; P:regulation of T cell migration; P:retinoic acid receptor signaling pathway; P:single fertilization; P:spermatogenesis; P:synapse assembly; P:T cell receptor signaling pathway; P:thymus development; P:urogenital system development; scaffold599 indexed_genome mRNA 50402 53919 . + . ID=transcript_16825;Q96NN9 B7WP37 D3DX37 D3DX38 Q6ZT44 Q8N1V3 Q8N5E0,Apoptosis-inducing factor 3,Apoptosis-inducing factor-like protein;, PF07992;PF14759;PF00355;, GO:0005829;GO:0005783;GO:0005743;GO:0005739;GO:0051537;GO:0050660;GO:0046872;GO:0016491;GO:0097194;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:flavin adenine dinucleotide binding; F:metal ion binding; F:oxidoreductase activity;, P:execution phase of apoptosis;|Q96NN9 B7WP37 D3DX37 D3DX38 Q6ZT44 Q8N1V3 Q8N5E0,Apoptosis-inducing factor 3,Apoptosis-inducing factor-like protein;, PF07992;PF14759;PF00355;, GO:0005829;GO:0005783;GO:0005743;GO:0005739;GO:0051537;GO:0050660;GO:0046872;GO:0016491;GO:0097194;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:flavin adenine dinucleotide binding; F:metal ion binding; F:oxidoreductase activity;, P:execution phase of apoptosis; scaffold600 indexed_genome mRNA 2299 8447 . + . ID=transcript_16826;O95721,Synaptosomal-associated protein 29 {ECO:0000312|HGNC:HGNC:11133},Soluble 29 kDa NSF attachment protein {ECO:0000312|HGNC:HGNC:11133};Vesicle-membrane fusion protein SNAP-29;, , GO:0005776;GO:0000421;GO:0035577;GO:0005813;GO:0020018;GO:0005737;GO:0005829;GO:0000139;GO:0005654;GO:0005886;GO:0098793;GO:0031201;GO:0005484;GO:0019905;GO:0097352;GO:0016240;GO:0060271;GO:0006887;GO:0061025;GO:0043312;GO:0015031;GO:0031629;GO:0016082;GO:0006906;GO:0006903;, C:autophagosome; C:autophagosome membrane; C:azurophil granule membrane; C:centrosome; C:ciliary pocket membrane; C:cytoplasm; C:cytosol; C:Golgi membrane; C:nucleoplasm; C:plasma membrane; C:presynapse; C:SNARE complex;, F:SNAP receptor activity; F:syntaxin binding;, P:autophagosome maturation; P:autophagosome membrane docking; P:cilium assembly; P:exocytosis; P:membrane fusion; P:neutrophil degranulation; P:protein transport; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle priming; P:vesicle fusion; P:vesicle targeting;|O95721,Synaptosomal-associated protein 29 {ECO:0000312|HGNC:HGNC:11133},Soluble 29 kDa NSF attachment protein {ECO:0000312|HGNC:HGNC:11133};Vesicle-membrane fusion protein SNAP-29;, , GO:0005776;GO:0000421;GO:0035577;GO:0005813;GO:0020018;GO:0005737;GO:0005829;GO:0000139;GO:0005654;GO:0005886;GO:0098793;GO:0031201;GO:0005484;GO:0019905;GO:0097352;GO:0016240;GO:0060271;GO:0006887;GO:0061025;GO:0043312;GO:0015031;GO:0031629;GO:0016082;GO:0006906;GO:0006903;, C:autophagosome; C:autophagosome membrane; C:azurophil granule membrane; C:centrosome; C:ciliary pocket membrane; C:cytoplasm; C:cytosol; C:Golgi membrane; C:nucleoplasm; C:plasma membrane; C:presynapse; C:SNARE complex;, F:SNAP receptor activity; F:syntaxin binding;, P:autophagosome maturation; P:autophagosome membrane docking; P:cilium assembly; P:exocytosis; P:membrane fusion; P:neutrophil degranulation; P:protein transport; P:synaptic vesicle fusion to presynaptic active zone membrane; P:synaptic vesicle priming; P:vesicle fusion; P:vesicle targeting; scaffold600 indexed_genome mRNA 20504 40354 . - . ID=transcript_16827;P46109 A8KA44 D3DX35,Crk-like protein,, PF00017;PF00018;PF07653;, GO:0005829;GO:0098890;GO:0031594;GO:0005654;GO:0032991;GO:0045296;GO:0042802;GO:0001784;GO:0003723;GO:0095500;GO:0090630;GO:0000187;GO:0000186;GO:0009952;GO:0001783;GO:0001568;GO:0060326;GO:0035690;GO:0098761;GO:0071560;GO:0098749;GO:0021987;GO:1904888;GO:0019221;GO:0016358;GO:0086100;GO:0030010;GO:0008543;GO:0035685;GO:0021766;GO:0035556;GO:0007254;GO:0006629;GO:0008584;GO:0010629;GO:0001933;GO:0001764;GO:0003151;GO:0060017;GO:0060465;GO:0008284;GO:0070374;GO:1903977;GO:0001934;GO:0046579;GO:1900026;GO:0007265;GO:0038026;GO:0033628;GO:0001558;GO:0050773;GO:1904393;GO:2000404;GO:0048384;GO:0007338;GO:0007283;GO:0007416;GO:0050852;GO:0048538;GO:0001655;, C:cytosol; C:extrinsic component of postsynaptic membrane; C:neuromuscular junction; C:nucleoplasm; C:protein-containing complex;, F:cadherin binding; F:identical protein binding; F:phosphotyrosine residue binding; F:RNA binding;, P:acetylcholine receptor signaling pathway; P:activation of GTPase activity; P:activation of MAPK activity; P:activation of MAPKK activity; P:anterior/posterior pattern specification; P:B cell apoptotic process; P:blood vessel development; P:cell chemotaxis; P:cellular response to drug; P:cellular response to interleukin-7; P:cellular response to transforming growth factor beta stimulus; P:cerebellar neuron development; P:cerebral cortex development; P:cranial skeletal system development; P:cytokine-mediated signaling pathway; P:dendrite development; P:endothelin receptor signaling pathway; P:establishment of cell polarity; P:fibroblast growth factor receptor signaling pathway; P:helper T cell diapedesis; P:hippocampus development; P:intracellular signal transduction; P:JNK cascade; P:lipid metabolic process; P:male gonad development; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:neuron migration; P:outflow tract morphogenesis; P:parathyroid gland development; P:pharynx development; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glial cell migration; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:Ras protein signal transduction; P:reelin-mediated signaling pathway; P:regulation of cell adhesion mediated by integrin; P:regulation of cell growth; P:regulation of dendrite development; P:regulation of skeletal muscle acetylcholine-gated channel clustering; P:regulation of T cell migration; P:retinoic acid receptor signaling pathway; P:single fertilization; P:spermatogenesis; P:synapse assembly; P:T cell receptor signaling pathway; P:thymus development; P:urogenital system development;|P46109 A8KA44 D3DX35,Crk-like protein,, PF00017;PF00018;PF07653;, GO:0005829;GO:0098890;GO:0031594;GO:0005654;GO:0032991;GO:0045296;GO:0042802;GO:0001784;GO:0003723;GO:0095500;GO:0090630;GO:0000187;GO:0000186;GO:0009952;GO:0001783;GO:0001568;GO:0060326;GO:0035690;GO:0098761;GO:0071560;GO:0098749;GO:0021987;GO:1904888;GO:0019221;GO:0016358;GO:0086100;GO:0030010;GO:0008543;GO:0035685;GO:0021766;GO:0035556;GO:0007254;GO:0006629;GO:0008584;GO:0010629;GO:0001933;GO:0001764;GO:0003151;GO:0060017;GO:0060465;GO:0008284;GO:0070374;GO:1903977;GO:0001934;GO:0046579;GO:1900026;GO:0007265;GO:0038026;GO:0033628;GO:0001558;GO:0050773;GO:1904393;GO:2000404;GO:0048384;GO:0007338;GO:0007283;GO:0007416;GO:0050852;GO:0048538;GO:0001655;, C:cytosol; C:extrinsic component of postsynaptic membrane; C:neuromuscular junction; C:nucleoplasm; C:protein-containing complex;, F:cadherin binding; F:identical protein binding; F:phosphotyrosine residue binding; F:RNA binding;, P:acetylcholine receptor signaling pathway; P:activation of GTPase activity; P:activation of MAPK activity; P:activation of MAPKK activity; P:anterior/posterior pattern specification; P:B cell apoptotic process; P:blood vessel development; P:cell chemotaxis; P:cellular response to drug; P:cellular response to interleukin-7; P:cellular response to transforming growth factor beta stimulus; P:cerebellar neuron development; P:cerebral cortex development; P:cranial skeletal system development; P:cytokine-mediated signaling pathway; P:dendrite development; P:endothelin receptor signaling pathway; P:establishment of cell polarity; P:fibroblast growth factor receptor signaling pathway; P:helper T cell diapedesis; P:hippocampus development; P:intracellular signal transduction; P:JNK cascade; P:lipid metabolic process; P:male gonad development; P:negative regulation of gene expression; P:negative regulation of protein phosphorylation; P:neuron migration; P:outflow tract morphogenesis; P:parathyroid gland development; P:pharynx development; P:positive regulation of cell population proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of glial cell migration; P:positive regulation of protein phosphorylation; P:positive regulation of Ras protein signal transduction; P:positive regulation of substrate adhesion-dependent cell spreading; P:Ras protein signal transduction; P:reelin-mediated signaling pathway; P:regulation of cell adhesion mediated by integrin; P:regulation of cell growth; P:regulation of dendrite development; P:regulation of skeletal muscle acetylcholine-gated channel clustering; P:regulation of T cell migration; P:retinoic acid receptor signaling pathway; P:single fertilization; P:spermatogenesis; P:synapse assembly; P:T cell receptor signaling pathway; P:thymus development; P:urogenital system development; scaffold600 indexed_genome mRNA 50398 53915 . + . ID=transcript_16828;Q96NN9 B7WP37 D3DX37 D3DX38 Q6ZT44 Q8N1V3 Q8N5E0,Apoptosis-inducing factor 3,Apoptosis-inducing factor-like protein;, PF07992;PF14759;PF00355;, GO:0005829;GO:0005783;GO:0005743;GO:0005739;GO:0051537;GO:0050660;GO:0046872;GO:0016491;GO:0097194;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:flavin adenine dinucleotide binding; F:metal ion binding; F:oxidoreductase activity;, P:execution phase of apoptosis;|Q96NN9 B7WP37 D3DX37 D3DX38 Q6ZT44 Q8N1V3 Q8N5E0,Apoptosis-inducing factor 3,Apoptosis-inducing factor-like protein;, PF07992;PF14759;PF00355;, GO:0005829;GO:0005783;GO:0005743;GO:0005739;GO:0051537;GO:0050660;GO:0046872;GO:0016491;GO:0097194;, C:cytosol; C:endoplasmic reticulum; C:mitochondrial inner membrane; C:mitochondrion;, F:2 iron, 2 sulfur cluster binding; F:flavin adenine dinucleotide binding; F:metal ion binding; F:oxidoreductase activity;, P:execution phase of apoptosis; scaffold601 indexed_genome mRNA 5288 6457 . + . ID=transcript_16829;Q9UNW8 A8K7X7 B4E144 Q9BSU2,Probable G-protein coupled receptor 132,G2 accumulation protein;, PF00001;, GO:0016021;GO:0005886;GO:0004930;GO:0007186;GO:0000082;GO:0010972;, C:integral component of membrane; C:plasma membrane;, F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; P:G1/S transition of mitotic cell cycle; P:negative regulation of G2/M transition of mitotic cell cycle; scaffold603 indexed_genome mRNA 27032 35998 . + . ID=transcript_16830;Q8IX01 C9JI71 O15071 O60369 Q5JPH7 Q8WUF7,SURP and G-patch domain-containing protein 2,Arginine/serine-rich-splicing factor 14;Splicing factor, arginine/serine-rich 14;, PF01585;PF01805;, GO:0016604;GO:0005654;GO:0003723;GO:0006397;GO:0008380;, C:nuclear body; C:nucleoplasm;, F:RNA binding;, P:mRNA processing; P:RNA splicing;|Q8IX01 C9JI71 O15071 O60369 Q5JPH7 Q8WUF7,SURP and G-patch domain-containing protein 2,Arginine/serine-rich-splicing factor 14;Splicing factor, arginine/serine-rich 14;, PF01585;PF01805;, GO:0016604;GO:0005654;GO:0003723;GO:0006397;GO:0008380;, C:nuclear body; C:nucleoplasm;, F:RNA binding;, P:mRNA processing; P:RNA splicing;|Q8IX01 C9JI71 O15071 O60369 Q5JPH7 Q8WUF7,SURP and G-patch domain-containing protein 2,Arginine/serine-rich-splicing factor 14;Splicing factor, arginine/serine-rich 14;, PF01585;PF01805;, GO:0016604;GO:0005654;GO:0003723;GO:0006397;GO:0008380;, C:nuclear body; C:nucleoplasm;, F:RNA binding;, P:mRNA processing; P:RNA splicing;|Q8IX01 C9JI71 O15071 O60369 Q5JPH7 Q8WUF7,SURP and G-patch domain-containing protein 2,Arginine/serine-rich-splicing factor 14;Splicing factor, arginine/serine-rich 14;, PF01585;PF01805;, GO:0016604;GO:0005654;GO:0003723;GO:0006397;GO:0008380;, C:nuclear body; C:nucleoplasm;, F:RNA binding;, P:mRNA processing; P:RNA splicing; scaffold603 indexed_genome mRNA 37009 37571 . - . ID=transcript_16831;Q71UM5 Q9BTJ1,40S ribosomal protein S27-like,Small ribosomal subunit protein eS27-like;, PF01667;, GO:0022627;GO:0005634;GO:0008656;GO:0046872;GO:0003723;GO:0003735;GO:0008494;GO:0006919;GO:0006978;GO:0042771;GO:0031571;GO:0045727;GO:0000028;GO:0006412;, C:cytosolic small ribosomal subunit; C:nucleus;, F:cysteine-type endopeptidase activator activity involved in apoptotic process; F:metal ion binding; F:RNA binding; F:structural constituent of ribosome; F:translation activator activity;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:mitotic G1 DNA damage checkpoint; P:positive regulation of translation; P:ribosomal small subunit assembly; P:translation; scaffold606 indexed_genome mRNA 3176 12224 . + . ID=transcript_16832;Q9H3T3 A5PKU4 F6IB19 Q9NRK9,Semaphorin-6B,Semaphorin-Z;, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007417;GO:0021766;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:central nervous system development; P:hippocampus development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9H3T3 A5PKU4 F6IB19 Q9NRK9,Semaphorin-6B,Semaphorin-Z;, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007417;GO:0021766;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:central nervous system development; P:hippocampus development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold606 indexed_genome mRNA 12470 13197 . + . ID=transcript_16833;Q9H3T3 A5PKU4 F6IB19 Q9NRK9,Semaphorin-6B,Semaphorin-Z;, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007417;GO:0021766;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:central nervous system development; P:hippocampus development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold606 indexed_genome mRNA 30984 33023 . - . ID=transcript_16834;P02750 Q8N4F5 Q96QZ4,Leucine-rich alpha-2-glycoprotein,, PF13855;, GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0016020;GO:0035580;GO:1904724;GO:0005160;GO:0050873;GO:0043312;GO:0045766;GO:0001938;GO:0030511;GO:0009617;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:membrane; C:specific granule lumen; C:tertiary granule lumen;, F:transforming growth factor beta receptor binding;, P:brown fat cell differentiation; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:response to bacterium; scaffold606 indexed_genome mRNA 34468 44999 . + . ID=transcript_16835;Q00G26 A2RRC1 Q6ZS68,Perilipin-5,Lipid storage droplet protein 5;, PF03036;, GO:0005737;GO:0005829;GO:0043231;GO:0005811;GO:0005739;GO:0042802;GO:0035473;GO:0034389;GO:0019915;GO:0051646;GO:0031999;GO:0060192;GO:0035359;GO:2000378;GO:0010897;GO:0032000;GO:0060193;GO:0010884;GO:0010890;GO:0010867;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion;, F:identical protein binding; F:lipase binding;, P:lipid droplet organization; P:lipid storage; P:mitochondrion localization; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of lipase activity; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of triglyceride catabolic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of lipase activity; P:positive regulation of lipid storage; P:positive regulation of sequestering of triglyceride; P:positive regulation of triglyceride biosynthetic process;|Q00G26 A2RRC1 Q6ZS68,Perilipin-5,Lipid storage droplet protein 5;, PF03036;, GO:0005737;GO:0005829;GO:0043231;GO:0005811;GO:0005739;GO:0042802;GO:0035473;GO:0034389;GO:0019915;GO:0051646;GO:0031999;GO:0060192;GO:0035359;GO:2000378;GO:0010897;GO:0032000;GO:0060193;GO:0010884;GO:0010890;GO:0010867;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion;, F:identical protein binding; F:lipase binding;, P:lipid droplet organization; P:lipid storage; P:mitochondrion localization; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of lipase activity; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of triglyceride catabolic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of lipase activity; P:positive regulation of lipid storage; P:positive regulation of sequestering of triglyceride; P:positive regulation of triglyceride biosynthetic process;|Q00G26 A2RRC1 Q6ZS68,Perilipin-5,Lipid storage droplet protein 5;, PF03036;, GO:0005737;GO:0005829;GO:0043231;GO:0005811;GO:0005739;GO:0042802;GO:0035473;GO:0034389;GO:0019915;GO:0051646;GO:0031999;GO:0060192;GO:0035359;GO:2000378;GO:0010897;GO:0032000;GO:0060193;GO:0010884;GO:0010890;GO:0010867;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion;, F:identical protein binding; F:lipase binding;, P:lipid droplet organization; P:lipid storage; P:mitochondrion localization; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of lipase activity; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of triglyceride catabolic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of lipase activity; P:positive regulation of lipid storage; P:positive regulation of sequestering of triglyceride; P:positive regulation of triglyceride biosynthetic process;|Q00G26 A2RRC1 Q6ZS68,Perilipin-5,Lipid storage droplet protein 5;, PF03036;, GO:0005737;GO:0005829;GO:0043231;GO:0005811;GO:0005739;GO:0042802;GO:0035473;GO:0034389;GO:0019915;GO:0051646;GO:0031999;GO:0060192;GO:0035359;GO:2000378;GO:0010897;GO:0032000;GO:0060193;GO:0010884;GO:0010890;GO:0010867;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion;, F:identical protein binding; F:lipase binding;, P:lipid droplet organization; P:lipid storage; P:mitochondrion localization; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of lipase activity; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of triglyceride catabolic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of lipase activity; P:positive regulation of lipid storage; P:positive regulation of sequestering of triglyceride; P:positive regulation of triglyceride biosynthetic process; scaffold608 indexed_genome mRNA 3166 12212 . + . ID=transcript_16836;Q9H3T3 A5PKU4 F6IB19 Q9NRK9,Semaphorin-6B,Semaphorin-Z;, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007417;GO:0021766;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:central nervous system development; P:hippocampus development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;|Q9H3T3 A5PKU4 F6IB19 Q9NRK9,Semaphorin-6B,Semaphorin-Z;, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007417;GO:0021766;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:central nervous system development; P:hippocampus development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold608 indexed_genome mRNA 12458 13185 . + . ID=transcript_16837;Q9H3T3 A5PKU4 F6IB19 Q9NRK9,Semaphorin-6B,Semaphorin-Z;, PF01437;PF01403;, GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007417;GO:0021766;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;, C:extracellular space; C:integral component of plasma membrane;, F:chemorepellent activity; F:semaphorin receptor binding;, P:axon guidance; P:central nervous system development; P:hippocampus development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway; scaffold608 indexed_genome mRNA 30957 32996 . + . ID=transcript_16838;P02750 Q8N4F5 Q96QZ4,Leucine-rich alpha-2-glycoprotein,, PF13855;, GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0043231;GO:0016020;GO:0035580;GO:1904724;GO:0005160;GO:0050873;GO:0043312;GO:0045766;GO:0001938;GO:0030511;GO:0009617;, C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:intracellular membrane-bounded organelle; C:membrane; C:specific granule lumen; C:tertiary granule lumen;, F:transforming growth factor beta receptor binding;, P:brown fat cell differentiation; P:neutrophil degranulation; P:positive regulation of angiogenesis; P:positive regulation of endothelial cell proliferation; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:response to bacterium; scaffold608 indexed_genome mRNA 34442 44984 . + . ID=transcript_16839;Q00G26 A2RRC1 Q6ZS68,Perilipin-5,Lipid storage droplet protein 5;, PF03036;, GO:0005737;GO:0005829;GO:0043231;GO:0005811;GO:0005739;GO:0042802;GO:0035473;GO:0034389;GO:0019915;GO:0051646;GO:0031999;GO:0060192;GO:0035359;GO:2000378;GO:0010897;GO:0032000;GO:0060193;GO:0010884;GO:0010890;GO:0010867;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion;, F:identical protein binding; F:lipase binding;, P:lipid droplet organization; P:lipid storage; P:mitochondrion localization; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of lipase activity; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of triglyceride catabolic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of lipase activity; P:positive regulation of lipid storage; P:positive regulation of sequestering of triglyceride; P:positive regulation of triglyceride biosynthetic process;|Q00G26 A2RRC1 Q6ZS68,Perilipin-5,Lipid storage droplet protein 5;, PF03036;, GO:0005737;GO:0005829;GO:0043231;GO:0005811;GO:0005739;GO:0042802;GO:0035473;GO:0034389;GO:0019915;GO:0051646;GO:0031999;GO:0060192;GO:0035359;GO:2000378;GO:0010897;GO:0032000;GO:0060193;GO:0010884;GO:0010890;GO:0010867;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion;, F:identical protein binding; F:lipase binding;, P:lipid droplet organization; P:lipid storage; P:mitochondrion localization; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of lipase activity; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of triglyceride catabolic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of lipase activity; P:positive regulation of lipid storage; P:positive regulation of sequestering of triglyceride; P:positive regulation of triglyceride biosynthetic process;|Q00G26 A2RRC1 Q6ZS68,Perilipin-5,Lipid storage droplet protein 5;, PF03036;, GO:0005737;GO:0005829;GO:0043231;GO:0005811;GO:0005739;GO:0042802;GO:0035473;GO:0034389;GO:0019915;GO:0051646;GO:0031999;GO:0060192;GO:0035359;GO:2000378;GO:0010897;GO:0032000;GO:0060193;GO:0010884;GO:0010890;GO:0010867;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion;, F:identical protein binding; F:lipase binding;, P:lipid droplet organization; P:lipid storage; P:mitochondrion localization; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of lipase activity; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of triglyceride catabolic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of lipase activity; P:positive regulation of lipid storage; P:positive regulation of sequestering of triglyceride; P:positive regulation of triglyceride biosynthetic process;|Q00G26 A2RRC1 Q6ZS68,Perilipin-5,Lipid storage droplet protein 5;, PF03036;, GO:0005737;GO:0005829;GO:0043231;GO:0005811;GO:0005739;GO:0042802;GO:0035473;GO:0034389;GO:0019915;GO:0051646;GO:0031999;GO:0060192;GO:0035359;GO:2000378;GO:0010897;GO:0032000;GO:0060193;GO:0010884;GO:0010890;GO:0010867;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:lipid droplet; C:mitochondrion;, F:identical protein binding; F:lipase binding;, P:lipid droplet organization; P:lipid storage; P:mitochondrion localization; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of lipase activity; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of triglyceride catabolic process; P:positive regulation of fatty acid beta-oxidation; P:positive regulation of lipase activity; P:positive regulation of lipid storage; P:positive regulation of sequestering of triglyceride; P:positive regulation of triglyceride biosynthetic process; scaffold611 indexed_genome mRNA 3213 12858 . - . ID=transcript_16840;O75074 B3KQD6 B4DKF2,Low-density lipoprotein receptor-related protein 3,105 kDa low-density lipoprotein receptor-related protein;, PF00431;PF00057;, GO:0005905;GO:0016021;GO:0045599;GO:0010629;GO:0010628;GO:0045669;GO:0006898;GO:0150104;, C:clathrin-coated pit; C:integral component of membrane;, , P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of osteoblast differentiation; P:receptor-mediated endocytosis; P:transport across blood-brain barrier;|O75074 B3KQD6 B4DKF2,Low-density lipoprotein receptor-related protein 3,105 kDa low-density lipoprotein receptor-related protein;, PF00431;PF00057;, GO:0005905;GO:0016021;GO:0045599;GO:0010629;GO:0010628;GO:0045669;GO:0006898;GO:0150104;, C:clathrin-coated pit; C:integral component of membrane;, , P:negative regulation of fat cell differentiation; P:negative regulation of gene expression; P:positive regulation of gene expression; P:positive regulation of osteoblast differentiation; P:receptor-mediated endocytosis; P:transport across blood-brain barrier; scaffold611 indexed_genome mRNA 12868 28381 . - . ID=transcript_16841;Q9NS82 B2RE84,Asc-type amino acid transporter 1,Solute carrier family 7 member 10;, PF13520;, GO:0005887;GO:0016020;GO:0005886;GO:0015179;GO:0015194;GO:0015175;GO:0006865;GO:0042941;GO:0042942;GO:0050900;GO:0015804;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:D-alanine transport; P:D-serine transport; P:leukocyte migration; P:neutral amino acid transport;|Q9UKQ8 Q9Y445,Large neutral amino acids transporter small subunit 2,L-type amino acid transporter 2;Solute carrier family 7 member 8;, PF13520;, GO:0016324;GO:0009925;GO:0016323;GO:0005737;GO:0005887;GO:0031528;GO:0005886;GO:0015171;GO:0015187;GO:0015180;GO:0015179;GO:0015190;GO:0015175;GO:0015101;GO:0042605;GO:0015349;GO:0019534;GO:0089718;GO:0006865;GO:0015816;GO:1904273;GO:1903801;GO:0098713;GO:0015820;GO:0050900;GO:0055065;GO:0015804;GO:0035524;GO:0009636;GO:0070327;GO:0150104;GO:0015827;GO:0015829;, C:apical plasma membrane; C:basal plasma membrane; C:basolateral plasma membrane; C:cytoplasm; C:integral component of plasma membrane; C:microvillus membrane; C:plasma membrane;, F:amino acid transmembrane transporter activity; F:glycine transmembrane transporter activity; F:L-alanine transmembrane transporter activity; F:L-amino acid transmembrane transporter activity; F:L-leucine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity; F:organic cation transmembrane transporter activity; F:peptide antigen binding; F:thyroid hormone transmembrane transporter activity; F:toxin transmembrane transporter activity;, P:amino acid import across plasma membrane; P:amino acid transport; P:glycine transport; P:L-alanine import across plasma membrane; P:L-leucine import across plasma membrane; P:leucine import across plasma membrane; P:leucine transport; P:leukocyte migration; P:metal ion homeostasis; P:neutral amino acid transport; P:proline transmembrane transport; P:response to toxic substance; P:thyroid hormone transport; P:transport across blood-brain barrier; P:tryptophan transport; P:valine transport;|Q9NS82 B2RE84,Asc-type amino acid transporter 1,Solute carrier family 7 member 10;, PF13520;, GO:0005887;GO:0016020;GO:0005886;GO:0015179;GO:0015194;GO:0015175;GO:0006865;GO:0042941;GO:0042942;GO:0050900;GO:0015804;, C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:L-amino acid transmembrane transporter activity; F:L-serine transmembrane transporter activity; F:neutral amino acid transmembrane transporter activity;, P:amino acid transport; P:D-alanine transport; P:D-serine transport; P:leukocyte migration; P:neutral amino acid transport; scaffold618 indexed_genome mRNA 6978 8852 . + . ID=transcript_16842;P50238 H3BPI2 Q13628 Q53XY7 Q96J34,Cysteine-rich protein 1,Cysteine-rich heart protein;Cysteine-rich intestinal protein;, PF00412;, GO:0005737;GO:0042277;GO:0008270;GO:0071236;GO:0071493;GO:0007507;GO:0006955;GO:0008630;GO:0060741;GO:0010468;GO:0010033;GO:0010043;, C:cytoplasm;, F:peptide binding; F:zinc ion binding;, P:cellular response to antibiotic; P:cellular response to UV-B; P:heart development; P:immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:prostate gland stromal morphogenesis; P:regulation of gene expression; P:response to organic substance; P:response to zinc ion;|P50238 H3BPI2 Q13628 Q53XY7 Q96J34,Cysteine-rich protein 1,Cysteine-rich heart protein;Cysteine-rich intestinal protein;, PF00412;, GO:0005737;GO:0042277;GO:0008270;GO:0071236;GO:0071493;GO:0007507;GO:0006955;GO:0008630;GO:0060741;GO:0010468;GO:0010033;GO:0010043;, C:cytoplasm;, F:peptide binding; F:zinc ion binding;, P:cellular response to antibiotic; P:cellular response to UV-B; P:heart development; P:immune response; P:intrinsic apoptotic signaling pathway in response to DNA damage; P:prostate gland stromal morphogenesis; P:regulation of gene expression; P:response to organic substance; P:response to zinc ion; scaffold618 indexed_genome mRNA 16525 20824 . + . ID=transcript_16843;Q86SX3 B5MDG3 E9PAQ4 Q86TT3 Q86TT4 Q86TT5 Q96B41 Q9H7H4,Tubulin epsilon and delta complex protein 1 {ECO:0000305},, PF14970;PF14971;, GO:0005814;GO:0005929;GO:0005737;GO:0045880;, C:centriole; C:cilium; C:cytoplasm;, , P:positive regulation of smoothened signaling pathway; scaffold619 indexed_genome mRNA 4457 18028 . + . ID=transcript_16844;Q9HCE9 A6NIJ0,Anoctamin-8,Transmembrane protein 16H;, PF04547;, GO:0005788;GO:0016021;GO:0005886;GO:0005229;GO:0044267;GO:0006821;GO:0034220;GO:0043687;GO:0055085;, C:endoplasmic reticulum lumen; C:integral component of membrane; C:plasma membrane;, F:intracellular calcium activated chloride channel activity;, P:cellular protein metabolic process; P:chloride transport; P:ion transmembrane transport; P:post-translational protein modification; P:transmembrane transport;|Q9BW61,DET1- and DDB1-associated protein 1 {ECO:0000303|PubMed:17452440},Placenta cross-immune reaction antigen 1 {ECO:0000303|Ref.2};, PF10172;, GO:0080008;GO:0005654;GO:0032436;GO:0043687;GO:0000209;, C:Cul4-RING E3 ubiquitin ligase complex; C:nucleoplasm;, , P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:protein polyubiquitination;|Q9HCE9 A6NIJ0,Anoctamin-8,Transmembrane protein 16H;, PF04547;, GO:0005788;GO:0016021;GO:0005886;GO:0005229;GO:0044267;GO:0006821;GO:0034220;GO:0043687;GO:0055085;, C:endoplasmic reticulum lumen; C:integral component of membrane; C:plasma membrane;, F:intracellular calcium activated chloride channel activity;, P:cellular protein metabolic process; P:chloride transport; P:ion transmembrane transport; P:post-translational protein modification; P:transmembrane transport; scaffold619 indexed_genome mRNA 18040 23403 . - . ID=transcript_16845;Q9HCE9 A6NIJ0,Anoctamin-8,Transmembrane protein 16H;, PF04547;, GO:0005788;GO:0016021;GO:0005886;GO:0005229;GO:0044267;GO:0006821;GO:0034220;GO:0043687;GO:0055085;, C:endoplasmic reticulum lumen; C:integral component of membrane; C:plasma membrane;, F:intracellular calcium activated chloride channel activity;, P:cellular protein metabolic process; P:chloride transport; P:ion transmembrane transport; P:post-translational protein modification; P:transmembrane transport;|Q9HCE9 A6NIJ0,Anoctamin-8,Transmembrane protein 16H;, PF04547;, GO:0005788;GO:0016021;GO:0005886;GO:0005229;GO:0044267;GO:0006821;GO:0034220;GO:0043687;GO:0055085;, C:endoplasmic reticulum lumen; C:integral component of membrane; C:plasma membrane;, F:intracellular calcium activated chloride channel activity;, P:cellular protein metabolic process; P:chloride transport; P:ion transmembrane transport; P:post-translational protein modification; P:transmembrane transport;|Q9HCE9 A6NIJ0,Anoctamin-8,Transmembrane protein 16H;, PF04547;, GO:0005788;GO:0016021;GO:0005886;GO:0005229;GO:0044267;GO:0006821;GO:0034220;GO:0043687;GO:0055085;, C:endoplasmic reticulum lumen; C:integral component of membrane; C:plasma membrane;, F:intracellular calcium activated chloride channel activity;, P:cellular protein metabolic process; P:chloride transport; P:ion transmembrane transport; P:post-translational protein modification; P:transmembrane transport; scaffold619 indexed_genome mRNA 29319 33293 . + . ID=transcript_16846;Q9BX61,tRNA modification GTPase GTPBP3, mitochondrial,GTP-binding protein 3;Mitochondrial GTP-binding protein 1;, PF01926;PF12631;PF10396;, GO:0005737;GO:0005739;GO:0005634;GO:0005525;GO:0003924;GO:0030488;GO:0002098;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:GTP binding; F:GTPase activity;, P:tRNA methylation; P:tRNA wobble uridine modification;|Q9BX61,tRNA modification GTPase GTPBP3, mitochondrial,GTP-binding protein 3;Mitochondrial GTP-binding protein 1;, PF01926;PF12631;PF10396;, GO:0005737;GO:0005739;GO:0005634;GO:0005525;GO:0003924;GO:0030488;GO:0002098;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:GTP binding; F:GTPase activity;, P:tRNA methylation; P:tRNA wobble uridine modification;|Q9BX61,tRNA modification GTPase GTPBP3, mitochondrial,GTP-binding protein 3;Mitochondrial GTP-binding protein 1;, PF01926;PF12631;PF10396;, GO:0005737;GO:0005739;GO:0005634;GO:0005525;GO:0003924;GO:0030488;GO:0002098;, C:cytoplasm; C:mitochondrion; C:nucleus;, F:GTP binding; F:GTPase activity;, P:tRNA methylation; P:tRNA wobble uridine modification; scaffold619 indexed_genome mRNA 38954 48555 . - . ID=transcript_16847;Q9BX97 Q86VP0 Q8N8Y0 Q8ND68 Q8TER8 Q9BZD5,Plasmalemma vesicle-associated protein,Fenestrated endothelial-linked structure protein;Plasmalemma vesicle protein 1;, PF06637;, GO:0005901;GO:0009986;GO:0070062;GO:0016021;GO:0048471;GO:0042802;GO:0032502;GO:0000165;GO:0002693;GO:0033209;, C:caveola; C:cell surface; C:extracellular exosome; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:identical protein binding;, P:developmental process; P:MAPK cascade; P:positive regulation of cellular extravasation; P:tumor necrosis factor-mediated signaling pathway; scaffold622 indexed_genome mRNA 12829 40183 . - . ID=transcript_16848;Q8IVV2 B7WNN3 B7WNT1 B7WPI9 H7BZ41 Q6ZRY7 Q86WW9 Q96DL7,Lipoxygenase homology domain-containing protein 1,, PF01477;, GO:0032420;GO:0004096;GO:0020037;GO:0007605;, C:stereocilium;, F:catalase activity; F:heme binding;, P:sensory perception of sound; scaffold629 indexed_genome mRNA 1 4645 . + . ID=transcript_16849;C9JLR9 A6NLS7 Q3C1V4,Uncharacterized protein C11orf95,, PF18658;, GO:0045892;, , , P:negative regulation of transcription, DNA-templated;|C9JLR9 A6NLS7 Q3C1V4,Uncharacterized protein C11orf95,, PF18658;, GO:0045892;, , , P:negative regulation of transcription, DNA-templated; scaffold630 indexed_genome mRNA 6644 21879 . + . ID=transcript_16850;Q96PE1 A6H8W3 D3DSW4 Q8N3R1 Q8TEM3 Q96KB2 Q9P1Z7 Q9UFY4,Adhesion G protein-coupled receptor A2 {ECO:0000305},G-protein coupled receptor 124 {ECO:0000303|PubMed:21421844};Tumor endothelial marker 5 {ECO:0000303|PubMed:11559528};, PF00002;PF01825;PF13855;, GO:0009986;GO:0030175;GO:0016021;GO:0005886;GO:1990909;GO:0004930;GO:0007166;GO:0007417;GO:0043542;GO:0007186;GO:1900747;GO:0090263;GO:0010595;GO:0045765;GO:0050920;GO:0090210;GO:0002040;GO:0016055;, C:cell surface; C:filopodium; C:integral component of membrane; C:plasma membrane; C:Wnt signalosome;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:central nervous system development; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endothelial cell migration; P:regulation of angiogenesis; P:regulation of chemotaxis; P:regulation of establishment of blood-brain barrier; P:sprouting angiogenesis; P:Wnt signaling pathway;|Q96PE1 A6H8W3 D3DSW4 Q8N3R1 Q8TEM3 Q96KB2 Q9P1Z7 Q9UFY4,Adhesion G protein-coupled receptor A2 {ECO:0000305},G-protein coupled receptor 124 {ECO:0000303|PubMed:21421844};Tumor endothelial marker 5 {ECO:0000303|PubMed:11559528};, PF00002;PF01825;PF13855;, GO:0009986;GO:0030175;GO:0016021;GO:0005886;GO:1990909;GO:0004930;GO:0007166;GO:0007417;GO:0043542;GO:0007186;GO:1900747;GO:0090263;GO:0010595;GO:0045765;GO:0050920;GO:0090210;GO:0002040;GO:0016055;, C:cell surface; C:filopodium; C:integral component of membrane; C:plasma membrane; C:Wnt signalosome;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:central nervous system development; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endothelial cell migration; P:regulation of angiogenesis; P:regulation of chemotaxis; P:regulation of establishment of blood-brain barrier; P:sprouting angiogenesis; P:Wnt signaling pathway;|Q96PE1 A6H8W3 D3DSW4 Q8N3R1 Q8TEM3 Q96KB2 Q9P1Z7 Q9UFY4,Adhesion G protein-coupled receptor A2 {ECO:0000305},G-protein coupled receptor 124 {ECO:0000303|PubMed:21421844};Tumor endothelial marker 5 {ECO:0000303|PubMed:11559528};, PF00002;PF01825;PF13855;, GO:0009986;GO:0030175;GO:0016021;GO:0005886;GO:1990909;GO:0004930;GO:0007166;GO:0007417;GO:0043542;GO:0007186;GO:1900747;GO:0090263;GO:0010595;GO:0045765;GO:0050920;GO:0090210;GO:0002040;GO:0016055;, C:cell surface; C:filopodium; C:integral component of membrane; C:plasma membrane; C:Wnt signalosome;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:central nervous system development; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endothelial cell migration; P:regulation of angiogenesis; P:regulation of chemotaxis; P:regulation of establishment of blood-brain barrier; P:sprouting angiogenesis; P:Wnt signaling pathway; scaffold631 indexed_genome mRNA 6645 21882 . + . ID=transcript_16851;Q96PE1 A6H8W3 D3DSW4 Q8N3R1 Q8TEM3 Q96KB2 Q9P1Z7 Q9UFY4,Adhesion G protein-coupled receptor A2 {ECO:0000305},G-protein coupled receptor 124 {ECO:0000303|PubMed:21421844};Tumor endothelial marker 5 {ECO:0000303|PubMed:11559528};, PF00002;PF01825;PF13855;, GO:0009986;GO:0030175;GO:0016021;GO:0005886;GO:1990909;GO:0004930;GO:0007166;GO:0007417;GO:0043542;GO:0007186;GO:1900747;GO:0090263;GO:0010595;GO:0045765;GO:0050920;GO:0090210;GO:0002040;GO:0016055;, C:cell surface; C:filopodium; C:integral component of membrane; C:plasma membrane; C:Wnt signalosome;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:central nervous system development; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endothelial cell migration; P:regulation of angiogenesis; P:regulation of chemotaxis; P:regulation of establishment of blood-brain barrier; P:sprouting angiogenesis; P:Wnt signaling pathway;|Q96PE1 A6H8W3 D3DSW4 Q8N3R1 Q8TEM3 Q96KB2 Q9P1Z7 Q9UFY4,Adhesion G protein-coupled receptor A2 {ECO:0000305},G-protein coupled receptor 124 {ECO:0000303|PubMed:21421844};Tumor endothelial marker 5 {ECO:0000303|PubMed:11559528};, PF00002;PF01825;PF13855;, GO:0009986;GO:0030175;GO:0016021;GO:0005886;GO:1990909;GO:0004930;GO:0007166;GO:0007417;GO:0043542;GO:0007186;GO:1900747;GO:0090263;GO:0010595;GO:0045765;GO:0050920;GO:0090210;GO:0002040;GO:0016055;, C:cell surface; C:filopodium; C:integral component of membrane; C:plasma membrane; C:Wnt signalosome;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:central nervous system development; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endothelial cell migration; P:regulation of angiogenesis; P:regulation of chemotaxis; P:regulation of establishment of blood-brain barrier; P:sprouting angiogenesis; P:Wnt signaling pathway;|Q96PE1 A6H8W3 D3DSW4 Q8N3R1 Q8TEM3 Q96KB2 Q9P1Z7 Q9UFY4,Adhesion G protein-coupled receptor A2 {ECO:0000305},G-protein coupled receptor 124 {ECO:0000303|PubMed:21421844};Tumor endothelial marker 5 {ECO:0000303|PubMed:11559528};, PF00002;PF01825;PF13855;, GO:0009986;GO:0030175;GO:0016021;GO:0005886;GO:1990909;GO:0004930;GO:0007166;GO:0007417;GO:0043542;GO:0007186;GO:1900747;GO:0090263;GO:0010595;GO:0045765;GO:0050920;GO:0090210;GO:0002040;GO:0016055;, C:cell surface; C:filopodium; C:integral component of membrane; C:plasma membrane; C:Wnt signalosome;, F:G protein-coupled receptor activity;, P:cell surface receptor signaling pathway; P:central nervous system development; P:endothelial cell migration; P:G protein-coupled receptor signaling pathway; P:negative regulation of vascular endothelial growth factor signaling pathway; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of endothelial cell migration; P:regulation of angiogenesis; P:regulation of chemotaxis; P:regulation of establishment of blood-brain barrier; P:sprouting angiogenesis; P:Wnt signaling pathway; scaffold631 indexed_genome mRNA 29047 46349 . - . ID=transcript_16852;Q6WKZ4 J3KNP0 Q307T1 Q6AZK4 Q6WKZ2 Q6WKZ6 Q86YV4 Q8TDL1 Q9H642,Rab11 family-interacting protein 1,Rab-coupling protein;, PF00168;PF09457;, GO:0005829;GO:0043231;GO:0030670;GO:0055037;GO:0031267;GO:0070164;GO:0015031;GO:0045055;, C:cytosol; C:intracellular membrane-bounded organelle; C:phagocytic vesicle membrane; C:recycling endosome;, F:small GTPase binding;, P:negative regulation of adiponectin secretion; P:protein transport; P:regulated exocytosis; scaffold636 indexed_genome mRNA 6048 8577 . - . ID=transcript_16853;Q8WWR8 A8K056 J3KNJ5 Q96D64,Sialidase-4,N-acetyl-alpha-neuraminidase 4;, PF13088;, GO:0005737;GO:0005789;GO:0043231;GO:0043202;GO:0005764;GO:0016020;GO:0005743;GO:0005741;GO:0043005;GO:0019866;GO:0005886;GO:0052794;GO:0052795;GO:0052796;GO:0004308;GO:0006689;GO:0006516;GO:0006687;GO:0010977;GO:0009313;, C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:lysosomal lumen; C:lysosome; C:membrane; C:mitochondrial inner membrane; C:mitochondrial outer membrane; C:neuron projection; C:organelle inner membrane; C:plasma membrane;, F:exo-alpha-(2->3)-sialidase activity; F:exo-alpha-(2->6)-sialidase activity; F:exo-alpha-(2->8)-sialidase activity; F:exo-alpha-sialidase activity;, P:ganglioside catabolic process; P:glycoprotein catabolic process; P:glycosphingolipid metabolic process; P:negative regulation of neuron projection development; P:oligosaccharide catabolic process; scaffold636 indexed_genome mRNA 48944 49465 . + . ID=transcript_16854;Q8N465 B4E3L6 E7ENP2 Q6IQ24 Q8N5Q8,D-2-hydroxyglutarate dehydrogenase, mitochondrial,, PF02913;PF01565;, GO:0005759;GO:0005739;GO:0051990;GO:0071949;GO:0006103;GO:0044267;GO:0032025;GO:0010042;GO:0010043;, C:mitochondrial matrix; C:mitochondrion;, F:(R)-2-hydroxyglutarate dehydrogenase activity; F:FAD binding;, P:2-oxoglutarate metabolic process; P:cellular protein metabolic process; P:response to cobalt ion; P:response to manganese ion; P:response to zinc ion; scaffold639 indexed_genome mRNA 2530 11366 . - . ID=transcript_16855;Q9UE45 Q9UE46 Q9UE47 Q9UE48 Q9UFQ6,U1 small nuclear ribonucleoprotein 70 kDa,, PF00076;PF12220;, GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005685;GO:0071004;GO:0003729;GO:0003723;GO:0017069;GO:0030619;GO:0000398;GO:1904715;GO:0061084;GO:0048026;GO:0043462;GO:0043484;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U1 snRNP; C:U2-type prespliceosome;, F:mRNA binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of chaperone-mediated autophagy; P:negative regulation of protein refolding; P:positive regulation of mRNA splicing, via spliceosome; P:regulation of ATPase activity; P:regulation of RNA splicing;|Q9UE45 Q9UE46 Q9UE47 Q9UE48 Q9UFQ6,U1 small nuclear ribonucleoprotein 70 kDa,, PF00076;PF12220;, GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005685;GO:0071004;GO:0003729;GO:0003723;GO:0017069;GO:0030619;GO:0000398;GO:1904715;GO:0061084;GO:0048026;GO:0043462;GO:0043484;, C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U1 snRNP; C:U2-type prespliceosome;, F:mRNA binding; F:RNA binding; F:snRNA binding; F:U1 snRNA binding;, P:mRNA splicing, via spliceosome; P:negative regulation of chaperone-mediated autophagy; P:negative regulation of protein refolding; P:positive regulation of mRNA splicing, via spliceosome; P:regulation of ATPase activity; P:regulation of RNA splicing; scaffold639 indexed_genome mRNA 38984 39998 . - . ID=transcript_16856;P34130 Q6FH56,Neurotrophin-4,Neurotrophin-5;Neutrophic factor 4;, PF00243;, GO:0030424;GO:0030425;GO:0005576;GO:0005615;GO:0008021;GO:0008083;GO:0005163;GO:0007202;GO:0008344;GO:0008544;GO:0007402;GO:0060384;GO:0007616;GO:0042490;GO:0007613;GO:0050804;GO:0043524;GO:0021675;GO:0038180;GO:0048812;GO:0048011;GO:0007422;GO:0033138;GO:0045664;GO:0008052;GO:0061193;GO:0007169;, C:axon; C:dendrite; C:extracellular region; C:extracellular space; C:synaptic vesicle;, F:growth factor activity; F:nerve growth factor receptor binding;, P:activation of phospholipase C activity; P:adult locomotory behavior; P:epidermis development; P:ganglion mother cell fate determination; P:innervation; P:long-term memory; P:mechanoreceptor differentiation; P:memory; P:modulation of chemical synaptic transmission; P:negative regulation of neuron apoptotic process; P:nerve development; P:nerve growth factor signaling pathway; P:neuron projection morphogenesis; P:neurotrophin TRK receptor signaling pathway; P:peripheral nervous system development; P:positive regulation of peptidyl-serine phosphorylation; P:regulation of neuron differentiation; P:sensory organ boundary specification; P:taste bud development; P:transmembrane receptor protein tyrosine kinase signaling pathway; scaffold639 indexed_genome mRNA 45182 45943 . + . ID=transcript_16857;P01229 Q9UDI0,Lutropin subunit beta,Luteinizing hormone subunit beta;, PF00007;, GO:0005737;GO:0005576;GO:0005615;GO:0005796;GO:0005179;GO:0005102;GO:0007267;GO:0007186;GO:0009755;GO:0008584;GO:0002862;GO:0016486;GO:0006701;GO:0007165;, C:cytoplasm; C:extracellular region; C:extracellular space; C:Golgi lumen;, F:hormone activity; F:signaling receptor binding;, P:cell-cell signaling; P:G protein-coupled receptor signaling pathway; P:hormone-mediated signaling pathway; P:male gonad development; P:negative regulation of inflammatory response to antigenic stimulus; P:peptide hormone processing; P:progesterone biosynthetic process; P:signal transduction; scaffold639 indexed_genome mRNA 48121 49632 . - . ID=transcript_16858;Q9Y230 B3KQ59 E7ETE5 Q6FIB9 Q6PK27 Q9Y361,RuvB-like 2,48 kDa TATA box-binding protein-interacting protein;51 kDa erythrocyte cytosolic protein;INO80 complex subunit J;Repressing pontin 52;TIP49b;TIP60-associated protein 54-beta;, PF06068;PF17856;, GO:0005813;GO:0005737;GO:0005829;GO:0000791;GO:0070062;GO:0031011;GO:0016020;GO:0071339;GO:0035267;GO:0016363;GO:0005654;GO:0005634;GO:0097255;GO:1990904;GO:0000812;GO:0043139;GO:0043531;GO:0005524;GO:0051117;GO:0008013;GO:0031490;GO:0003678;GO:0042802;GO:0042803;GO:0000978;GO:0000979;GO:0017025;GO:0001094;GO:0003714;GO:0051082;GO:0000492;GO:0071392;GO:0034644;GO:0006338;GO:0006310;GO:0006281;GO:0071169;GO:0016573;GO:0043968;GO:0043967;GO:0090090;GO:0071899;GO:0035066;GO:1904874;GO:0045944;GO:0006457;GO:0040008;GO:0006357;GO:0071733;, C:centrosome; C:cytoplasm; C:cytosol; C:euchromatin; C:extracellular exosome; C:Ino80 complex; C:membrane; C:MLL1 complex; C:NuA4 histone acetyltransferase complex; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:R2TP complex; C:ribonucleoprotein complex; C:Swr1 complex;, F:5'-3' DNA helicase activity; F:ADP binding; F:ATP binding; F:ATPase binding; F:beta-catenin binding; F:chromatin DNA binding; F:DNA helicase activity; F:identical protein binding; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II core promoter sequence-specific DNA binding; F:TBP-class protein binding; F:TFIID-class transcription factor complex binding; F:transcription corepressor activity; F:unfolded protein binding;, P:box C/D snoRNP assembly; P:cellular response to estradiol stimulus; P:cellular response to UV; P:chromatin remodeling; P:DNA recombination; P:DNA repair; P:establishment of protein localization to chromatin; P:histone acetylation; P:histone H2A acetylation; P:histone H4 acetylation; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of estrogen receptor binding; P:positive regulation of histone acetylation; P:positive regulation of telomerase RNA localization to Cajal body; P:positive regulation of transcription by RNA polymerase II; P:protein folding; P:regulation of growth; P:regulation of transcription by RNA polymerase II; P:transcriptional activation by promoter-enhancer looping; scaffold643 indexed_genome mRNA 600 1126 . + . ID=transcript_16859;Q01959 A2RUN4 Q14996,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3;, PF00209;, GO:0030424;GO:0009986;GO:0005737;GO:0098691;GO:0016600;GO:0016021;GO:0005887;GO:0099055;GO:0099056;GO:0045121;GO:0043005;GO:0043025;GO:0032809;GO:0005886;GO:0042734;GO:0035240;GO:0005330;GO:0008144;GO:0046872;GO:0008504;GO:0005326;GO:0005334;GO:0002020;GO:0047485;GO:0051721;GO:0044877;GO:0005102;GO:0021984;GO:0007568;GO:0042416;GO:0042420;GO:0015872;GO:0090494;GO:0051583;GO:1990384;GO:0007595;GO:0007626;GO:0015844;GO:0042136;GO:0006836;GO:0015874;GO:0040018;GO:0060134;GO:0042053;GO:0051591;GO:0042220;GO:0042493;GO:0045471;GO:0010039;GO:0035094;GO:0007608;GO:0035725;, C:axon; C:cell surface; C:cytoplasm; C:dopaminergic synapse; C:flotillin complex; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:membrane raft; C:neuron projection; C:neuronal cell body; C:neuronal cell body membrane; C:plasma membrane; C:presynaptic membrane;, F:dopamine binding; F:dopamine:sodium symporter activity; F:drug binding; F:metal ion binding; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:norepinephrine:sodium symporter activity; F:protease binding; F:protein N-terminus binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:signaling receptor binding;, P:adenohypophysis development; P:aging; P:dopamine biosynthetic process; P:dopamine catabolic process; P:dopamine transport; P:dopamine uptake; P:dopamine uptake involved in synaptic transmission; P:hyaloid vascular plexus regression; P:lactation; P:locomotory behavior; P:monoamine transport; P:neurotransmitter biosynthetic process; P:neurotransmitter transport; P:norepinephrine transport; P:positive regulation of multicellular organism growth; P:prepulse inhibition; P:regulation of dopamine metabolic process; P:response to cAMP; P:response to cocaine; P:response to drug; P:response to ethanol; P:response to iron ion; P:response to nicotine; P:sensory perception of smell; P:sodium ion transmembrane transport; scaffold643 indexed_genome mRNA 40118 46368 . - . ID=transcript_16860;Q8NF37 Q1HAQ1 Q7Z4G6 Q8N3U7 Q8WUL8 Q9GZW6,Lysophosphatidylcholine acyltransferase 1,1-acylglycerol-3-phosphate O-acyltransferase;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 2;Phosphonoformate immuno-associated protein 3;, PF01553;PF13833;, GO:0035577;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005811;GO:0016020;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0047191;GO:0005509;GO:0050200;GO:2001246;GO:0043312;GO:0006654;GO:0036151;GO:0006656;GO:0036148;GO:0008654;GO:0045732;GO:0060041;GO:0043129;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:1-alkylglycerophosphocholine O-acyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:negative regulation of phosphatidylcholine biosynthetic process; P:neutrophil degranulation; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine biosynthetic process; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of protein catabolic process; P:retina development in camera-type eye; P:surfactant homeostasis; scaffold643 indexed_genome mRNA 46466 49292 . - . ID=transcript_16861;Q8NF37 Q1HAQ1 Q7Z4G6 Q8N3U7 Q8WUL8 Q9GZW6,Lysophosphatidylcholine acyltransferase 1,1-acylglycerol-3-phosphate O-acyltransferase;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 2;Phosphonoformate immuno-associated protein 3;, PF01553;PF13833;, GO:0035577;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005811;GO:0016020;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0047191;GO:0005509;GO:0050200;GO:2001246;GO:0043312;GO:0006654;GO:0036151;GO:0006656;GO:0036148;GO:0008654;GO:0045732;GO:0060041;GO:0043129;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:1-alkylglycerophosphocholine O-acyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:negative regulation of phosphatidylcholine biosynthetic process; P:neutrophil degranulation; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine biosynthetic process; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of protein catabolic process; P:retina development in camera-type eye; P:surfactant homeostasis; scaffold644 indexed_genome mRNA 600 1126 . + . ID=transcript_16862;Q01959 A2RUN4 Q14996,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3;, PF00209;, GO:0030424;GO:0009986;GO:0005737;GO:0098691;GO:0016600;GO:0016021;GO:0005887;GO:0099055;GO:0099056;GO:0045121;GO:0043005;GO:0043025;GO:0032809;GO:0005886;GO:0042734;GO:0035240;GO:0005330;GO:0008144;GO:0046872;GO:0008504;GO:0005326;GO:0005334;GO:0002020;GO:0047485;GO:0051721;GO:0044877;GO:0005102;GO:0021984;GO:0007568;GO:0042416;GO:0042420;GO:0015872;GO:0090494;GO:0051583;GO:1990384;GO:0007595;GO:0007626;GO:0015844;GO:0042136;GO:0006836;GO:0015874;GO:0040018;GO:0060134;GO:0042053;GO:0051591;GO:0042220;GO:0042493;GO:0045471;GO:0010039;GO:0035094;GO:0007608;GO:0035725;, C:axon; C:cell surface; C:cytoplasm; C:dopaminergic synapse; C:flotillin complex; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:membrane raft; C:neuron projection; C:neuronal cell body; C:neuronal cell body membrane; C:plasma membrane; C:presynaptic membrane;, F:dopamine binding; F:dopamine:sodium symporter activity; F:drug binding; F:metal ion binding; F:monoamine transmembrane transporter activity; F:neurotransmitter transmembrane transporter activity; F:norepinephrine:sodium symporter activity; F:protease binding; F:protein N-terminus binding; F:protein phosphatase 2A binding; F:protein-containing complex binding; F:signaling receptor binding;, P:adenohypophysis development; P:aging; P:dopamine biosynthetic process; P:dopamine catabolic process; P:dopamine transport; P:dopamine uptake; P:dopamine uptake involved in synaptic transmission; P:hyaloid vascular plexus regression; P:lactation; P:locomotory behavior; P:monoamine transport; P:neurotransmitter biosynthetic process; P:neurotransmitter transport; P:norepinephrine transport; P:positive regulation of multicellular organism growth; P:prepulse inhibition; P:regulation of dopamine metabolic process; P:response to cAMP; P:response to cocaine; P:response to drug; P:response to ethanol; P:response to iron ion; P:response to nicotine; P:sensory perception of smell; P:sodium ion transmembrane transport; scaffold644 indexed_genome mRNA 40091 46340 . - . ID=transcript_16863;Q8NF37 Q1HAQ1 Q7Z4G6 Q8N3U7 Q8WUL8 Q9GZW6,Lysophosphatidylcholine acyltransferase 1,1-acylglycerol-3-phosphate O-acyltransferase;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 2;Phosphonoformate immuno-associated protein 3;, PF01553;PF13833;, GO:0035577;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005811;GO:0016020;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0047191;GO:0005509;GO:0050200;GO:2001246;GO:0043312;GO:0006654;GO:0036151;GO:0006656;GO:0036148;GO:0008654;GO:0045732;GO:0060041;GO:0043129;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:1-alkylglycerophosphocholine O-acyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:negative regulation of phosphatidylcholine biosynthetic process; P:neutrophil degranulation; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine biosynthetic process; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of protein catabolic process; P:retina development in camera-type eye; P:surfactant homeostasis; scaffold644 indexed_genome mRNA 46438 49264 . - . ID=transcript_16864;Q8NF37 Q1HAQ1 Q7Z4G6 Q8N3U7 Q8WUL8 Q9GZW6,Lysophosphatidylcholine acyltransferase 1,1-acylglycerol-3-phosphate O-acyltransferase;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 2;Phosphonoformate immuno-associated protein 3;, PF01553;PF13833;, GO:0035577;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005811;GO:0016020;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0047191;GO:0005509;GO:0050200;GO:2001246;GO:0043312;GO:0006654;GO:0036151;GO:0006656;GO:0036148;GO:0008654;GO:0045732;GO:0060041;GO:0043129;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:1-alkylglycerophosphocholine O-acyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:negative regulation of phosphatidylcholine biosynthetic process; P:neutrophil degranulation; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine biosynthetic process; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of protein catabolic process; P:retina development in camera-type eye; P:surfactant homeostasis; scaffold646 indexed_genome mRNA 24906 31681 . - . ID=transcript_16865;Q8N4S7 A8K5Q8 D3DUA2 D3DUA3 Q8NAS6 Q96NW1,Progestin and adipoQ receptor family member 4 {ECO:0000303|PubMed:16044242},Progestin and adipoQ receptor family member IV;, PF03006;, GO:0016021;GO:0038023;, C:integral component of membrane;, F:signaling receptor activity; scaffold647 indexed_genome mRNA 24904 31679 . - . ID=transcript_16866;Q8N4S7 A8K5Q8 D3DUA2 D3DUA3 Q8NAS6 Q96NW1,Progestin and adipoQ receptor family member 4 {ECO:0000303|PubMed:16044242},Progestin and adipoQ receptor family member IV;, PF03006;, GO:0016021;GO:0038023;, C:integral component of membrane;, F:signaling receptor activity; scaffold647 indexed_genome mRNA 44602 46958 . - . ID=transcript_16867;Q4VC44 D3DUA1 Q6ZSQ1 Q8WV62 Q9BQG6 Q9BUS5 Q9HCM0,FLYWCH-type zinc finger-containing protein 1,, PF04500;PF15423;, GO:0005829;GO:0016604;GO:0005654;GO:0003677;GO:0046872;, C:cytosol; C:nuclear body; C:nucleoplasm;, F:DNA binding; F:metal ion binding; scaffold649 indexed_genome mRNA 1678 6058 . + . ID=transcript_16868;P21854,B-cell differentiation antigen CD72,Lyb-2;, PF00059;, GO:0005887;GO:0005886;GO:0030246;GO:0005102;GO:0004888;GO:0007155;, C:integral component of plasma membrane; C:plasma membrane;, F:carbohydrate binding; F:signaling receptor binding; F:transmembrane signaling receptor activity;, P:cell adhesion; scaffold649 indexed_genome mRNA 28662 30221 . - . ID=transcript_16869;Q9Y3P8 B2RBP9,Signaling threshold-regulating transmembrane adapter 1,SHP2-interacting transmembrane adapter protein;Suppression-inducing transmembrane adapter 1;gp30/40;, , GO:0070062;GO:0005887;GO:0005886;GO:0019900;GO:0042169;GO:0002250;GO:0050863;GO:0007165;GO:0043029;, C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:kinase binding; F:SH2 domain binding;, P:adaptive immune response; P:regulation of T cell activation; P:signal transduction; P:T cell homeostasis; scaffold649 indexed_genome mRNA 34818 39225 . + . ID=transcript_16870;Q8WV48 A6XND6 Q5T4R5 Q5T4R8 Q5T4R9 Q86VB6 Q8N2E4,Coiled-coil domain-containing protein 107,, , GO:0016021;, C:integral component of membrane;|Q8WV48 A6XND6 Q5T4R5 Q5T4R8 Q5T4R9 Q86VB6 Q8N2E4,Coiled-coil domain-containing protein 107,, , GO:0016021;, C:integral component of membrane; scaffold649 indexed_genome mRNA 39301 41712 . + . ID=transcript_16871;Q8N4T4 Q49AG0 Q6TPQ2 Q96ST6,Rho guanine nucleotide exchange factor 39,, PF00621;, GO:0005886;GO:0005085;GO:0030335;, C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of cell migration;|Q8N4T4 Q49AG0 Q6TPQ2 Q96ST6,Rho guanine nucleotide exchange factor 39,, PF00621;, GO:0005886;GO:0005085;GO:0030335;, C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of cell migration; scaffold650 indexed_genome mRNA 1677 6057 . + . ID=transcript_16872;P21854,B-cell differentiation antigen CD72,Lyb-2;, PF00059;, GO:0005887;GO:0005886;GO:0030246;GO:0005102;GO:0004888;GO:0007155;, C:integral component of plasma membrane; C:plasma membrane;, F:carbohydrate binding; F:signaling receptor binding; F:transmembrane signaling receptor activity;, P:cell adhesion; scaffold650 indexed_genome mRNA 28665 30217 . - . ID=transcript_16873;Q9Y3P8 B2RBP9,Signaling threshold-regulating transmembrane adapter 1,SHP2-interacting transmembrane adapter protein;Suppression-inducing transmembrane adapter 1;gp30/40;, , GO:0070062;GO:0005887;GO:0005886;GO:0019900;GO:0042169;GO:0002250;GO:0050863;GO:0007165;GO:0043029;, C:extracellular exosome; C:integral component of plasma membrane; C:plasma membrane;, F:kinase binding; F:SH2 domain binding;, P:adaptive immune response; P:regulation of T cell activation; P:signal transduction; P:T cell homeostasis; scaffold650 indexed_genome mRNA 34814 39221 . - . ID=transcript_16874;Q8WV48 A6XND6 Q5T4R5 Q5T4R8 Q5T4R9 Q86VB6 Q8N2E4,Coiled-coil domain-containing protein 107,, , GO:0016021;, C:integral component of membrane;|Q8WV48 A6XND6 Q5T4R5 Q5T4R8 Q5T4R9 Q86VB6 Q8N2E4,Coiled-coil domain-containing protein 107,, , GO:0016021;, C:integral component of membrane; scaffold650 indexed_genome mRNA 39297 41704 . + . ID=transcript_16875;Q8N4T4 Q49AG0 Q6TPQ2 Q96ST6,Rho guanine nucleotide exchange factor 39,, PF00621;, GO:0005886;GO:0005085;GO:0030335;, C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of cell migration;|Q8N4T4 Q49AG0 Q6TPQ2 Q96ST6,Rho guanine nucleotide exchange factor 39,, PF00621;, GO:0005886;GO:0005085;GO:0030335;, C:plasma membrane;, F:guanyl-nucleotide exchange factor activity;, P:positive regulation of cell migration; scaffold651 indexed_genome mRNA 6295 6912 . - . ID=transcript_16876;Q8NEV1,Casein kinase II subunit alpha 3,Casein kinase II alpha 1 polypeptide pseudogene;, PF00069;, GO:0005829;GO:0005654;GO:0005634;GO:0005956;GO:0005524;GO:0106310;GO:0004674;GO:0106311;GO:0018105;GO:0018107;GO:0030307;GO:0008284;GO:0045732;GO:0006468;GO:0051726;, C:cytosol; C:nucleoplasm; C:nucleus; C:protein kinase CK2 complex;, F:ATP binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of protein catabolic process; P:protein phosphorylation; P:regulation of cell cycle; scaffold651 indexed_genome mRNA 7354 9818 . - . ID=transcript_16877;P68400 B4DYS6 D3DVV8 P19138 P20426 Q14013 Q5U065,Casein kinase II subunit alpha,, PF00069;, GO:0005829;GO:0005654;GO:0005634;GO:0016581;GO:0005886;GO:0005956;GO:0016580;GO:0005524;GO:0051879;GO:0042802;GO:0016301;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0061077;GO:0016236;GO:0007076;GO:2001234;GO:0043154;GO:2000059;GO:0018105;GO:0018107;GO:0006656;GO:0030307;GO:0008284;GO:0045732;GO:0030177;GO:0006457;GO:0006468;GO:0051726;GO:1905818;GO:1901796;GO:0048511;GO:0007165;GO:0016055;, C:cytosol; C:nucleoplasm; C:nucleus; C:NuRD complex; C:plasma membrane; C:protein kinase CK2 complex; C:Sin3 complex;, F:ATP binding; F:Hsp90 protein binding; F:identical protein binding; F:kinase activity; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:chaperone-mediated protein folding; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of protein catabolic process; P:positive regulation of Wnt signaling pathway; P:protein folding; P:protein phosphorylation; P:regulation of cell cycle; P:regulation of chromosome separation; P:regulation of signal transduction by p53 class mediator; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway;|P68400 B4DYS6 D3DVV8 P19138 P20426 Q14013 Q5U065,Casein kinase II subunit alpha,, PF00069;, GO:0005829;GO:0005654;GO:0005634;GO:0016581;GO:0005886;GO:0005956;GO:0016580;GO:0005524;GO:0051879;GO:0042802;GO:0016301;GO:0047485;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0061077;GO:0016236;GO:0007076;GO:2001234;GO:0043154;GO:2000059;GO:0018105;GO:0018107;GO:0006656;GO:0030307;GO:0008284;GO:0045732;GO:0030177;GO:0006457;GO:0006468;GO:0051726;GO:1905818;GO:1901796;GO:0048511;GO:0007165;GO:0016055;, C:cytosol; C:nucleoplasm; C:nucleus; C:NuRD complex; C:plasma membrane; C:protein kinase CK2 complex; C:Sin3 complex;, F:ATP binding; F:Hsp90 protein binding; F:identical protein binding; F:kinase activity; F:protein N-terminus binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:apoptotic process; P:chaperone-mediated protein folding; P:macroautophagy; P:mitotic chromosome condensation; P:negative regulation of apoptotic signaling pathway; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:phosphatidylcholine biosynthetic process; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of protein catabolic process; P:positive regulation of Wnt signaling pathway; P:protein folding; P:protein phosphorylation; P:regulation of cell cycle; P:regulation of chromosome separation; P:regulation of signal transduction by p53 class mediator; P:rhythmic process; P:signal transduction; P:Wnt signaling pathway; scaffold666 indexed_genome mRNA 473 1862 . - . ID=transcript_16878;P09211 O00460 Q15690 Q5TZY3,Glutathione S-transferase P {ECO:0000305},GST class-pi;GSTP1-1;, PF14497;PF02798;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005739;GO:0005634;GO:0005886;GO:0034774;GO:0097057;GO:0031982;GO:0035731;GO:0008144;GO:0005504;GO:0043295;GO:0004602;GO:0004364;GO:0008432;GO:0019207;GO:0070026;GO:0035730;GO:0031100;GO:0071460;GO:0071364;GO:0071385;GO:0032869;GO:0071222;GO:0034599;GO:0007417;GO:0035726;GO:1901687;GO:0006749;GO:0051122;GO:0043651;GO:0002674;GO:0043066;GO:0009890;GO:0070373;GO:2001237;GO:0048147;GO:0043124;GO:0032691;GO:0043508;GO:0070664;GO:0043407;GO:0043409;GO:0071638;GO:0051771;GO:0006469;GO:0071672;GO:0032873;GO:0032720;GO:0010804;GO:1904706;GO:0043312;GO:0035732;GO:0014003;GO:0032930;GO:0006693;GO:0070372;GO:0032872;GO:0043200;GO:0032355;GO:0045471;GO:0033591;GO:0000302;GO:0006805;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:mitochondrion; C:nucleus; C:plasma membrane; C:secretory granule lumen; C:TRAF2-GSTP1 complex; C:vesicle;, F:dinitrosyl-iron complex binding; F:drug binding; F:fatty acid binding; F:glutathione binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:JUN kinase binding; F:kinase regulator activity; F:nitric oxide binding; F:S-nitrosoglutathione binding;, P:animal organ regeneration; P:cellular response to cell-matrix adhesion; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucocorticoid stimulus; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:central nervous system development; P:common myeloid progenitor cell proliferation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:hepoxilin biosynthetic process; P:linoleic acid metabolic process; P:negative regulation of acute inflammatory response; P:negative regulation of apoptotic process; P:negative regulation of biosynthetic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-1 beta production; P:negative regulation of JUN kinase activity; P:negative regulation of leukocyte proliferation; P:negative regulation of MAP kinase activity; P:negative regulation of MAPK cascade; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of nitric-oxide synthase biosynthetic process; P:negative regulation of protein kinase activity; P:negative regulation of smooth muscle cell chemotaxis; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:negative regulation of vascular associated smooth muscle cell proliferation; P:neutrophil degranulation; P:nitric oxide storage; P:oligodendrocyte development; P:positive regulation of superoxide anion generation; P:prostaglandin metabolic process; P:regulation of ERK1 and ERK2 cascade; P:regulation of stress-activated MAPK cascade; P:response to amino acid; P:response to estradiol; P:response to ethanol; P:response to L-ascorbic acid; P:response to reactive oxygen species; P:xenobiotic metabolic process;|P09211 O00460 Q15690 Q5TZY3,Glutathione S-transferase P {ECO:0000305},GST class-pi;GSTP1-1;, PF14497;PF02798;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005739;GO:0005634;GO:0005886;GO:0034774;GO:0097057;GO:0031982;GO:0035731;GO:0008144;GO:0005504;GO:0043295;GO:0004602;GO:0004364;GO:0008432;GO:0019207;GO:0070026;GO:0035730;GO:0031100;GO:0071460;GO:0071364;GO:0071385;GO:0032869;GO:0071222;GO:0034599;GO:0007417;GO:0035726;GO:1901687;GO:0006749;GO:0051122;GO:0043651;GO:0002674;GO:0043066;GO:0009890;GO:0070373;GO:2001237;GO:0048147;GO:0043124;GO:0032691;GO:0043508;GO:0070664;GO:0043407;GO:0043409;GO:0071638;GO:0051771;GO:0006469;GO:0071672;GO:0032873;GO:0032720;GO:0010804;GO:1904706;GO:0043312;GO:0035732;GO:0014003;GO:0032930;GO:0006693;GO:0070372;GO:0032872;GO:0043200;GO:0032355;GO:0045471;GO:0033591;GO:0000302;GO:0006805;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:mitochondrion; C:nucleus; C:plasma membrane; C:secretory granule lumen; C:TRAF2-GSTP1 complex; C:vesicle;, F:dinitrosyl-iron complex binding; F:drug binding; F:fatty acid binding; F:glutathione binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:JUN kinase binding; F:kinase regulator activity; F:nitric oxide binding; F:S-nitrosoglutathione binding;, P:animal organ regeneration; P:cellular response to cell-matrix adhesion; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucocorticoid stimulus; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:central nervous system development; P:common myeloid progenitor cell proliferation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:hepoxilin biosynthetic process; P:linoleic acid metabolic process; P:negative regulation of acute inflammatory response; P:negative regulation of apoptotic process; P:negative regulation of biosynthetic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-1 beta production; P:negative regulation of JUN kinase activity; P:negative regulation of leukocyte proliferation; P:negative regulation of MAP kinase activity; P:negative regulation of MAPK cascade; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of nitric-oxide synthase biosynthetic process; P:negative regulation of protein kinase activity; P:negative regulation of smooth muscle cell chemotaxis; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:negative regulation of vascular associated smooth muscle cell proliferation; P:neutrophil degranulation; P:nitric oxide storage; P:oligodendrocyte development; P:positive regulation of superoxide anion generation; P:prostaglandin metabolic process; P:regulation of ERK1 and ERK2 cascade; P:regulation of stress-activated MAPK cascade; P:response to amino acid; P:response to estradiol; P:response to ethanol; P:response to L-ascorbic acid; P:response to reactive oxygen species; P:xenobiotic metabolic process; scaffold666 indexed_genome mRNA 19597 25303 . + . ID=transcript_16879;P49821 O60924 O60940 Q16104 Q6IBR3 Q96BF8 Q96HS7,NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial,Complex I-51kD;NADH dehydrogenase flavoprotein 1;NADH-ubiquinone oxidoreductase 51 kDa subunit;, PF01512;PF10589;PF10531;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0051539;GO:0010181;GO:0046872;GO:0051287;GO:0008137;GO:0042775;GO:0006120;GO:0032981;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:FMN binding; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|P49821 O60924 O60940 Q16104 Q6IBR3 Q96BF8 Q96HS7,NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial,Complex I-51kD;NADH dehydrogenase flavoprotein 1;NADH-ubiquinone oxidoreductase 51 kDa subunit;, PF01512;PF10589;PF10531;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0051539;GO:0010181;GO:0046872;GO:0051287;GO:0008137;GO:0042775;GO:0006120;GO:0032981;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:FMN binding; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|P49821 O60924 O60940 Q16104 Q6IBR3 Q96BF8 Q96HS7,NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial,Complex I-51kD;NADH dehydrogenase flavoprotein 1;NADH-ubiquinone oxidoreductase 51 kDa subunit;, PF01512;PF10589;PF10531;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0051539;GO:0010181;GO:0046872;GO:0051287;GO:0008137;GO:0042775;GO:0006120;GO:0032981;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:FMN binding; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|P49821 O60924 O60940 Q16104 Q6IBR3 Q96BF8 Q96HS7,NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial,Complex I-51kD;NADH dehydrogenase flavoprotein 1;NADH-ubiquinone oxidoreductase 51 kDa subunit;, PF01512;PF10589;PF10531;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0051539;GO:0010181;GO:0046872;GO:0051287;GO:0008137;GO:0042775;GO:0006120;GO:0032981;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:FMN binding; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold666 indexed_genome mRNA 25840 29980 . - . ID=transcript_16880;Q9Y2J0 B7Z3C3 Q96AE0,Rabphilin-3A,Exophilin-1;, PF00168;PF02318;, GO:0005829;GO:0043197;GO:0019898;GO:0043005;GO:0045211;GO:0032991;GO:0030141;GO:0045202;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0070679;GO:0042301;GO:1901981;GO:0005546;GO:0044877;GO:0008430;GO:0031267;GO:0008270;GO:0006886;GO:0061669;, C:cytosol; C:dendritic spine; C:extrinsic component of membrane; C:neuron projection; C:postsynaptic membrane; C:protein-containing complex; C:secretory granule; C:synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:inositol 1,4,5 trisphosphate binding; F:phosphate ion binding; F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-containing complex binding; F:selenium binding; F:small GTPase binding; F:zinc ion binding;, P:intracellular protein transport; P:spontaneous neurotransmitter secretion; scaffold666 indexed_genome mRNA 32933 35424 . - . ID=transcript_16881;Q8WV74 Q6ZW59,Nucleoside diphosphate-linked moiety X motif 8,, PF00293;, GO:0016787;GO:0046872;, , F:hydrolase activity; F:metal ion binding;|Q8WV74 Q6ZW59,Nucleoside diphosphate-linked moiety X motif 8,, PF00293;, GO:0016787;GO:0046872;, , F:hydrolase activity; F:metal ion binding; scaffold667 indexed_genome mRNA 1552 2836 . - . ID=transcript_16882;P01570 Q5VZ56 Q7M4S1,Interferon alpha-14,Interferon alpha-H;Interferon lambda-2-H;, PF00143;, GO:0005576;GO:0005615;GO:0005125;GO:0005126;GO:0005132;GO:0002250;GO:0030183;GO:0042100;GO:0007596;GO:0019221;GO:0051607;GO:0006959;GO:0002323;GO:0033141;GO:0043330;GO:0002286;GO:0060337;, C:extracellular region; C:extracellular space;, F:cytokine activity; F:cytokine receptor binding; F:type I interferon receptor binding;, P:adaptive immune response; P:B cell differentiation; P:B cell proliferation; P:blood coagulation; P:cytokine-mediated signaling pathway; P:defense response to virus; P:humoral immune response; P:natural killer cell activation involved in immune response; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; P:response to exogenous dsRNA; P:T cell activation involved in immune response; P:type I interferon signaling pathway; scaffold669 indexed_genome mRNA 1118 1862 . - . ID=transcript_16883;P09211 O00460 Q15690 Q5TZY3,Glutathione S-transferase P {ECO:0000305},GST class-pi;GSTP1-1;, PF14497;PF02798;, GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:1904813;GO:0005739;GO:0005634;GO:0005886;GO:0034774;GO:0097057;GO:0031982;GO:0035731;GO:0008144;GO:0005504;GO:0043295;GO:0004602;GO:0004364;GO:0008432;GO:0019207;GO:0070026;GO:0035730;GO:0031100;GO:0071460;GO:0071364;GO:0071385;GO:0032869;GO:0071222;GO:0034599;GO:0007417;GO:0035726;GO:1901687;GO:0006749;GO:0051122;GO:0043651;GO:0002674;GO:0043066;GO:0009890;GO:0070373;GO:2001237;GO:0048147;GO:0043124;GO:0032691;GO:0043508;GO:0070664;GO:0043407;GO:0043409;GO:0071638;GO:0051771;GO:0006469;GO:0071672;GO:0032873;GO:0032720;GO:0010804;GO:1904706;GO:0043312;GO:0035732;GO:0014003;GO:0032930;GO:0006693;GO:0070372;GO:0032872;GO:0043200;GO:0032355;GO:0045471;GO:0033591;GO:0000302;GO:0006805;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule lumen; C:mitochondrion; C:nucleus; C:plasma membrane; C:secretory granule lumen; C:TRAF2-GSTP1 complex; C:vesicle;, F:dinitrosyl-iron complex binding; F:drug binding; F:fatty acid binding; F:glutathione binding; F:glutathione peroxidase activity; F:glutathione transferase activity; F:JUN kinase binding; F:kinase regulator activity; F:nitric oxide binding; F:S-nitrosoglutathione binding;, P:animal organ regeneration; P:cellular response to cell-matrix adhesion; P:cellular response to epidermal growth factor stimulus; P:cellular response to glucocorticoid stimulus; P:cellular response to insulin stimulus; P:cellular response to lipopolysaccharide; P:cellular response to oxidative stress; P:central nervous system development; P:common myeloid progenitor cell proliferation; P:glutathione derivative biosynthetic process; P:glutathione metabolic process; P:hepoxilin biosynthetic process; P:linoleic acid metabolic process; P:negative regulation of acute inflammatory response; P:negative regulation of apoptotic process; P:negative regulation of biosynthetic process; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of interleukin-1 beta production; P:negative regulation of JUN kinase activity; P:negative regulation of leukocyte proliferation; P:negative regulation of MAP kinase activity; P:negative regulation of MAPK cascade; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of nitric-oxide synthase biosynthetic process; P:negative regulation of protein kinase activity; P:negative regulation of smooth muscle cell chemotaxis; P:negative regulation of stress-activated MAPK cascade; P:negative regulation of tumor necrosis factor production; P:negative regulation of tumor necrosis factor-mediated signaling pathway; P:negative regulation of vascular associated smooth muscle cell proliferation; P:neutrophil degranulation; P:nitric oxide storage; P:oligodendrocyte development; P:positive regulation of superoxide anion generation; P:prostaglandin metabolic process; P:regulation of ERK1 and ERK2 cascade; P:regulation of stress-activated MAPK cascade; P:response to amino acid; P:response to estradiol; P:response to ethanol; P:response to L-ascorbic acid; P:response to reactive oxygen species; P:xenobiotic metabolic process; scaffold669 indexed_genome mRNA 19588 25294 . + . ID=transcript_16884;P49821 O60924 O60940 Q16104 Q6IBR3 Q96BF8 Q96HS7,NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial,Complex I-51kD;NADH dehydrogenase flavoprotein 1;NADH-ubiquinone oxidoreductase 51 kDa subunit;, PF01512;PF10589;PF10531;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0051539;GO:0010181;GO:0046872;GO:0051287;GO:0008137;GO:0042775;GO:0006120;GO:0032981;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:FMN binding; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|P49821 O60924 O60940 Q16104 Q6IBR3 Q96BF8 Q96HS7,NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial,Complex I-51kD;NADH dehydrogenase flavoprotein 1;NADH-ubiquinone oxidoreductase 51 kDa subunit;, PF01512;PF10589;PF10531;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0051539;GO:0010181;GO:0046872;GO:0051287;GO:0008137;GO:0042775;GO:0006120;GO:0032981;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:FMN binding; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|P49821 O60924 O60940 Q16104 Q6IBR3 Q96BF8 Q96HS7,NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial,Complex I-51kD;NADH dehydrogenase flavoprotein 1;NADH-ubiquinone oxidoreductase 51 kDa subunit;, PF01512;PF10589;PF10531;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0051539;GO:0010181;GO:0046872;GO:0051287;GO:0008137;GO:0042775;GO:0006120;GO:0032981;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:FMN binding; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly;|P49821 O60924 O60940 Q16104 Q6IBR3 Q96BF8 Q96HS7,NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial,Complex I-51kD;NADH dehydrogenase flavoprotein 1;NADH-ubiquinone oxidoreductase 51 kDa subunit;, PF01512;PF10589;PF10531;, GO:0005829;GO:0005743;GO:0005747;GO:0005739;GO:0051539;GO:0010181;GO:0046872;GO:0051287;GO:0008137;GO:0042775;GO:0006120;GO:0032981;, C:cytosol; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;, F:4 iron, 4 sulfur cluster binding; F:FMN binding; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity;, P:mitochondrial ATP synthesis coupled electron transport; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; scaffold669 indexed_genome mRNA 25831 29928 . + . ID=transcript_16885;Q9Y2J0 B7Z3C3 Q96AE0,Rabphilin-3A,Exophilin-1;, PF00168;PF02318;, GO:0005829;GO:0043197;GO:0019898;GO:0043005;GO:0045211;GO:0032991;GO:0030141;GO:0045202;GO:0008021;GO:0030672;GO:0005509;GO:0005544;GO:0070679;GO:0042301;GO:1901981;GO:0005546;GO:0044877;GO:0008430;GO:0031267;GO:0008270;GO:0006886;GO:0061669;, C:cytosol; C:dendritic spine; C:extrinsic component of membrane; C:neuron projection; C:postsynaptic membrane; C:protein-containing complex; C:secretory granule; C:synapse; C:synaptic vesicle; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:inositol 1,4,5 trisphosphate binding; F:phosphate ion binding; F:phosphatidylinositol phosphate binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:protein-containing complex binding; F:selenium binding; F:small GTPase binding; F:zinc ion binding;, P:intracellular protein transport; P:spontaneous neurotransmitter secretion; scaffold669 indexed_genome mRNA 33986 35266 . - . ID=transcript_16886;Q8WV74 Q6ZW59,Nucleoside diphosphate-linked moiety X motif 8,, PF00293;, GO:0016787;GO:0046872;, , F:hydrolase activity; F:metal ion binding; scaffold671 indexed_genome mRNA 2132 4834 . - . ID=transcript_16887;P63128 Q9UKH4,Endogenous retrovirus group K member 9 Pol protein,HERV-K(C6) Gag-Pol protein;HERV-K109 Gag-Pol protein;HERV-K_6q14.1 provirus ancestral Gag-Pol polyprotein;, PF00692;PF01585;PF02337;PF00607;PF00077;PF00078;PF00098;, GO:0005886;GO:0004190;GO:0003887;GO:0003723;GO:0003964;GO:0004523;GO:0005198;GO:0008270;GO:0016032;, C:plasma membrane;, F:aspartic-type endopeptidase activity; F:DNA-directed DNA polymerase activity; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:structural molecule activity; F:zinc ion binding;, P:viral process; scaffold671 indexed_genome mRNA 23048 34832 . - . ID=transcript_16888;O43653 Q6UW92,Prostate stem cell antigen,, PF00021;, GO:0031225;GO:0070062;GO:0005576;GO:0005886;GO:0033130;GO:0070373;GO:0099601;, C:anchored component of membrane; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:acetylcholine receptor binding;, P:negative regulation of ERK1 and ERK2 cascade; P:regulation of neurotransmitter receptor activity; scaffold671 indexed_genome mRNA 35433 40954 . - . ID=transcript_16889;O75564 D3DWI5 O75565 Q86XJ5,Jerky protein homolog {ECO:0000305},, PF04218;PF03184;PF03221;, GO:0005737;GO:0005634;GO:1990904;GO:0003677;GO:0003729;GO:0090263;, C:cytoplasm; C:nucleus; C:ribonucleoprotein complex;, F:DNA binding; F:mRNA binding;, P:positive regulation of canonical Wnt signaling pathway; scaffold672 indexed_genome mRNA 2123 4822 . + . ID=transcript_16890;P63128 Q9UKH4,Endogenous retrovirus group K member 9 Pol protein,HERV-K(C6) Gag-Pol protein;HERV-K109 Gag-Pol protein;HERV-K_6q14.1 provirus ancestral Gag-Pol polyprotein;, PF00692;PF01585;PF02337;PF00607;PF00077;PF00078;PF00098;, GO:0005886;GO:0004190;GO:0003887;GO:0003723;GO:0003964;GO:0004523;GO:0005198;GO:0008270;GO:0016032;, C:plasma membrane;, F:aspartic-type endopeptidase activity; F:DNA-directed DNA polymerase activity; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:structural molecule activity; F:zinc ion binding;, P:viral process; scaffold672 indexed_genome mRNA 23027 34811 . + . ID=transcript_16891;O43653 Q6UW92,Prostate stem cell antigen,, PF00021;, GO:0031225;GO:0070062;GO:0005576;GO:0005886;GO:0033130;GO:0070373;GO:0099601;, C:anchored component of membrane; C:extracellular exosome; C:extracellular region; C:plasma membrane;, F:acetylcholine receptor binding;, P:negative regulation of ERK1 and ERK2 cascade; P:regulation of neurotransmitter receptor activity; scaffold677 indexed_genome mRNA 3235 4671 . - . ID=transcript_16892;Q8WV74 Q6ZW59,Nucleoside diphosphate-linked moiety X motif 8,, PF00293;, GO:0016787;GO:0046872;, , F:hydrolase activity; F:metal ion binding; scaffold677 indexed_genome mRNA 23077 31938 . - . ID=transcript_16893;Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; scaffold679 indexed_genome mRNA 23062 31923 . - . ID=transcript_16894;Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway;|Q9H1C4 O95764 Q569H6 Q710D4,Protein unc-93 homolog B1,, PF05978;, GO:0032009;GO:0005783;GO:0005789;GO:0005768;GO:0000139;GO:0016021;GO:0005764;GO:0035325;GO:0002250;GO:0051607;GO:0045087;GO:0006886;GO:0034138;GO:0034154;GO:0034162;GO:0002224;, C:early phagosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endosome; C:Golgi membrane; C:integral component of membrane; C:lysosome;, F:Toll-like receptor binding;, P:adaptive immune response; P:defense response to virus; P:innate immune response; P:intracellular protein transport; P:toll-like receptor 3 signaling pathway; P:toll-like receptor 7 signaling pathway; P:toll-like receptor 9 signaling pathway; P:toll-like receptor signaling pathway; scaffold685 indexed_genome mRNA 36965 38745 . + . ID=transcript_16895;O00303 A8K0S2 Q6IB45 Q8N978,Eukaryotic translation initiation factor 3 subunit F {ECO:0000255|HAMAP-Rule:MF_03005},Deubiquitinating enzyme eIF3f;Eukaryotic translation initiation factor 3 subunit 5 {ECO:0000255|HAMAP-Rule:MF_03005};eIF-3-epsilon {ECO:0000255|HAMAP-Rule:MF_03005};eIF3 p47 {ECO:0000255|HAMAP-Rule:MF_03005};, PF01398;PF13012;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0016020;GO:0008234;GO:0042802;GO:0070122;GO:0008237;GO:0004843;GO:0003743;GO:0031369;GO:0101005;GO:0001732;GO:0075522;GO:0016579;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane;, F:cysteine-type peptidase activity; F:identical protein binding; F:isopeptidase activity; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:translation initiation factor activity; F:translation initiation factor binding; F:ubiquitinyl hydrolase activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:protein deubiquitination; P:translational initiation;|O00303 A8K0S2 Q6IB45 Q8N978,Eukaryotic translation initiation factor 3 subunit F {ECO:0000255|HAMAP-Rule:MF_03005},Deubiquitinating enzyme eIF3f;Eukaryotic translation initiation factor 3 subunit 5 {ECO:0000255|HAMAP-Rule:MF_03005};eIF-3-epsilon {ECO:0000255|HAMAP-Rule:MF_03005};eIF3 p47 {ECO:0000255|HAMAP-Rule:MF_03005};, PF01398;PF13012;, GO:0005829;GO:0016282;GO:0033290;GO:0005852;GO:0071541;GO:0016020;GO:0008234;GO:0042802;GO:0070122;GO:0008237;GO:0004843;GO:0003743;GO:0031369;GO:0101005;GO:0001732;GO:0075522;GO:0016579;GO:0006413;, C:cytosol; C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex; C:eukaryotic translation initiation factor 3 complex, eIF3m; C:membrane;, F:cysteine-type peptidase activity; F:identical protein binding; F:isopeptidase activity; F:metallopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity; F:translation initiation factor activity; F:translation initiation factor binding; F:ubiquitinyl hydrolase activity;, P:formation of cytoplasmic translation initiation complex; P:IRES-dependent viral translational initiation; P:protein deubiquitination; P:translational initiation; scaffold688 indexed_genome mRNA 2171 2978 . + . ID=transcript_16896;P28906 A8K664 Q15970 Q15971 Q5JTA3 Q5JTA4 Q9UJB1,Hematopoietic progenitor cell antigen CD34,, PF06365;, GO:0016324;GO:0009925;GO:0005737;GO:0009897;GO:0036053;GO:0005887;GO:0045171;GO:0005764;GO:0048471;GO:0005886;GO:0030246;GO:0043199;GO:0008134;GO:0048870;GO:0098609;GO:0007160;GO:0001935;GO:0003158;GO:0071971;GO:0072011;GO:0003094;GO:0071425;GO:0030097;GO:0050900;GO:0035759;GO:0072254;GO:0030195;GO:1900035;GO:1900038;GO:0010629;GO:0032703;GO:1901215;GO:0045019;GO:0032720;GO:0038001;GO:0045766;GO:0010628;GO:1900168;GO:0071657;GO:0032733;GO:0042482;GO:0071636;GO:2001214;GO:0008217;GO:0050776;GO:0007165;GO:0072089;GO:0001894;GO:0060290;GO:0061042;, C:apical plasma membrane; C:basal plasma membrane; C:cytoplasm; C:external side of plasma membrane; C:glomerular endothelium fenestra; C:integral component of plasma membrane; C:intercellular bridge; C:lysosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:carbohydrate binding; F:sulfate binding; F:transcription factor binding;, P:cell motility; P:cell-cell adhesion; P:cell-matrix adhesion; P:endothelial cell proliferation; P:endothelium development; P:extracellular exosome assembly; P:glomerular endothelium development; P:glomerular filtration; P:hematopoietic stem cell proliferation; P:hemopoiesis; P:leukocyte migration; P:mesangial cell-matrix adhesion; P:metanephric glomerular mesangial cell differentiation; P:negative regulation of blood coagulation; P:negative regulation of cellular response to heat; P:negative regulation of cellular response to hypoxia; P:negative regulation of gene expression; P:negative regulation of interleukin-2 production; P:negative regulation of neuron death; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of tumor necrosis factor production; P:paracrine signaling; P:positive regulation of angiogenesis; P:positive regulation of gene expression; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of granulocyte colony-stimulating factor production; P:positive regulation of interleukin-10 production; P:positive regulation of odontogenesis; P:positive regulation of transforming growth factor beta production; P:positive regulation of vasculogenesis; P:regulation of blood pressure; P:regulation of immune response; P:signal transduction; P:stem cell proliferation; P:tissue homeostasis; P:transdifferentiation; P:vascular wound healing; scaffold689 indexed_genome mRNA 2171 2978 . + . ID=transcript_16897;P28906 A8K664 Q15970 Q15971 Q5JTA3 Q5JTA4 Q9UJB1,Hematopoietic progenitor cell antigen CD34,, PF06365;, GO:0016324;GO:0009925;GO:0005737;GO:0009897;GO:0036053;GO:0005887;GO:0045171;GO:0005764;GO:0048471;GO:0005886;GO:0030246;GO:0043199;GO:0008134;GO:0048870;GO:0098609;GO:0007160;GO:0001935;GO:0003158;GO:0071971;GO:0072011;GO:0003094;GO:0071425;GO:0030097;GO:0050900;GO:0035759;GO:0072254;GO:0030195;GO:1900035;GO:1900038;GO:0010629;GO:0032703;GO:1901215;GO:0045019;GO:0032720;GO:0038001;GO:0045766;GO:0010628;GO:1900168;GO:0071657;GO:0032733;GO:0042482;GO:0071636;GO:2001214;GO:0008217;GO:0050776;GO:0007165;GO:0072089;GO:0001894;GO:0060290;GO:0061042;, C:apical plasma membrane; C:basal plasma membrane; C:cytoplasm; C:external side of plasma membrane; C:glomerular endothelium fenestra; C:integral component of plasma membrane; C:intercellular bridge; C:lysosome; C:perinuclear region of cytoplasm; C:plasma membrane;, F:carbohydrate binding; F:sulfate binding; F:transcription factor binding;, P:cell motility; P:cell-cell adhesion; P:cell-matrix adhesion; P:endothelial cell proliferation; P:endothelium development; P:extracellular exosome assembly; P:glomerular endothelium development; P:glomerular filtration; P:hematopoietic stem cell proliferation; P:hemopoiesis; P:leukocyte migration; P:mesangial cell-matrix adhesion; P:metanephric glomerular mesangial cell differentiation; P:negative regulation of blood coagulation; P:negative regulation of cellular response to heat; P:negative regulation of cellular response to hypoxia; P:negative regulation of gene expression; P:negative regulation of interleukin-2 production; P:negative regulation of neuron death; P:negative regulation of nitric oxide biosynthetic process; P:negative regulation of tumor necrosis factor production; P:paracrine signaling; P:positive regulation of angiogenesis; P:positive regulation of gene expression; P:positive regulation of glial cell-derived neurotrophic factor production; P:positive regulation of granulocyte colony-stimulating factor production; P:positive regulation of interleukin-10 production; P:positive regulation of odontogenesis; P:positive regulation of transforming growth factor beta production; P:positive regulation of vasculogenesis; P:regulation of blood pressure; P:regulation of immune response; P:signal transduction; P:stem cell proliferation; P:tissue homeostasis; P:transdifferentiation; P:vascular wound healing; scaffold694 indexed_genome mRNA 39429 40317 . - . ID=transcript_16898;A6NNL5 B4DFB2,Uncharacterized protein C15orf61,, PF15031;, GO:0005576;, C:extracellular region; scaffold696 indexed_genome mRNA 3014 4906 . - . ID=transcript_16899;O15304 Q96P98 Q9UPD6,Apoptosis regulatory protein Siva,CD27-binding protein;, PF05458;, GO:0005737;GO:0005739;GO:0005654;GO:0005175;GO:0046872;GO:0005164;GO:0001618;GO:0008270;GO:0006924;GO:0097191;GO:0097193;GO:0032088;GO:1901030;, C:cytoplasm; C:mitochondrion; C:nucleoplasm;, F:CD27 receptor binding; F:metal ion binding; F:tumor necrosis factor receptor binding; F:virus receptor activity; F:zinc ion binding;, P:activation-induced cell death of T cells; P:extrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; scaffold696 indexed_genome mRNA 23393 26097 . - . ID=transcript_16900;Q8N142 Q86TT6 Q8N714,Adenylosuccinate synthetase isozyme 1 {ECO:0000255|HAMAP-Rule:MF_03126},Adenylosuccinate synthetase, basic isozyme {ECO:0000255|HAMAP-Rule:MF_03126};Adenylosuccinate synthetase, muscle isozyme {ECO:0000255|HAMAP-Rule:MF_03126};Adenylosuccinate synthetase-like 1 {ECO:0000303|PubMed:15786719};IMP--aspartate ligase 1 {ECO:0000255|HAMAP-Rule:MF_03126};, PF00709;, GO:0005737;GO:0005829;GO:0051015;GO:0004019;GO:0005525;GO:0003924;GO:0042802;GO:0000287;GO:0042301;GO:0044208;GO:0006167;GO:0006531;GO:0035690;GO:0071257;GO:0006541;GO:0002376;GO:0046040;GO:0009168;GO:0014850;GO:0042594;, C:cytoplasm; C:cytosol;, F:actin filament binding; F:adenylosuccinate synthase activity; F:GTP binding; F:GTPase activity; F:identical protein binding; F:magnesium ion binding; F:phosphate ion binding;, P:'de novo' AMP biosynthetic process; P:AMP biosynthetic process; P:aspartate metabolic process; P:cellular response to drug; P:cellular response to electrical stimulus; P:glutamine metabolic process; P:immune system process; P:IMP metabolic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to muscle activity; P:response to starvation; scaffold697 indexed_genome mRNA 2995 4887 . - . ID=transcript_16901;O15304 Q96P98 Q9UPD6,Apoptosis regulatory protein Siva,CD27-binding protein;, PF05458;, GO:0005737;GO:0005739;GO:0005654;GO:0005175;GO:0046872;GO:0005164;GO:0001618;GO:0008270;GO:0006924;GO:0097191;GO:0097193;GO:0032088;GO:1901030;, C:cytoplasm; C:mitochondrion; C:nucleoplasm;, F:CD27 receptor binding; F:metal ion binding; F:tumor necrosis factor receptor binding; F:virus receptor activity; F:zinc ion binding;, P:activation-induced cell death of T cells; P:extrinsic apoptotic signaling pathway; P:intrinsic apoptotic signaling pathway; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; scaffold697 indexed_genome mRNA 22703 34380 . - . ID=transcript_16902;Q8N142 Q86TT6 Q8N714,Adenylosuccinate synthetase isozyme 1 {ECO:0000255|HAMAP-Rule:MF_03126},Adenylosuccinate synthetase, basic isozyme {ECO:0000255|HAMAP-Rule:MF_03126};Adenylosuccinate synthetase, muscle isozyme {ECO:0000255|HAMAP-Rule:MF_03126};Adenylosuccinate synthetase-like 1 {ECO:0000303|PubMed:15786719};IMP--aspartate ligase 1 {ECO:0000255|HAMAP-Rule:MF_03126};, PF00709;, GO:0005737;GO:0005829;GO:0051015;GO:0004019;GO:0005525;GO:0003924;GO:0042802;GO:0000287;GO:0042301;GO:0044208;GO:0006167;GO:0006531;GO:0035690;GO:0071257;GO:0006541;GO:0002376;GO:0046040;GO:0009168;GO:0014850;GO:0042594;, C:cytoplasm; C:cytosol;, F:actin filament binding; F:adenylosuccinate synthase activity; F:GTP binding; F:GTPase activity; F:identical protein binding; F:magnesium ion binding; F:phosphate ion binding;, P:'de novo' AMP biosynthetic process; P:AMP biosynthetic process; P:aspartate metabolic process; P:cellular response to drug; P:cellular response to electrical stimulus; P:glutamine metabolic process; P:immune system process; P:IMP metabolic process; P:purine ribonucleoside monophosphate biosynthetic process; P:response to muscle activity; P:response to starvation; scaffold698 indexed_genome mRNA 4032 12754 . + . ID=transcript_16903;O75909 Q59FT6 Q86U16 Q96B63 Q9NNY9,Cyclin-K,, PF02984;PF00134;, GO:0002944;GO:0002945;GO:0008024;GO:0005654;GO:0005634;GO:0061575;GO:0004693;GO:0016538;GO:0019901;GO:0008353;GO:0007049;GO:0051301;GO:0006974;GO:0044828;GO:0032786;GO:2001165;GO:0045944;GO:0000079;GO:0006357;GO:0042795;GO:0006366;GO:0006368;, C:cyclin K-CDK12 complex; C:cyclin K-CDK13 complex; C:cyclin/CDK positive transcription elongation factor complex; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:cell cycle; P:cell division; P:cellular response to DNA damage stimulus; P:negative regulation by host of viral genome replication; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O75909 Q59FT6 Q86U16 Q96B63 Q9NNY9,Cyclin-K,, PF02984;PF00134;, GO:0002944;GO:0002945;GO:0008024;GO:0005654;GO:0005634;GO:0061575;GO:0004693;GO:0016538;GO:0019901;GO:0008353;GO:0007049;GO:0051301;GO:0006974;GO:0044828;GO:0032786;GO:2001165;GO:0045944;GO:0000079;GO:0006357;GO:0042795;GO:0006366;GO:0006368;, C:cyclin K-CDK12 complex; C:cyclin K-CDK13 complex; C:cyclin/CDK positive transcription elongation factor complex; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:cell cycle; P:cell division; P:cellular response to DNA damage stimulus; P:negative regulation by host of viral genome replication; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter;|O75909 Q59FT6 Q86U16 Q96B63 Q9NNY9,Cyclin-K,, PF02984;PF00134;, GO:0002944;GO:0002945;GO:0008024;GO:0005654;GO:0005634;GO:0061575;GO:0004693;GO:0016538;GO:0019901;GO:0008353;GO:0007049;GO:0051301;GO:0006974;GO:0044828;GO:0032786;GO:2001165;GO:0045944;GO:0000079;GO:0006357;GO:0042795;GO:0006366;GO:0006368;, C:cyclin K-CDK12 complex; C:cyclin K-CDK13 complex; C:cyclin/CDK positive transcription elongation factor complex; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:cell cycle; P:cell division; P:cellular response to DNA damage stimulus; P:negative regulation by host of viral genome replication; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold701 indexed_genome mRNA 6518 7926 . + . ID=transcript_16904;O75909 Q59FT6 Q86U16 Q96B63 Q9NNY9,Cyclin-K,, PF02984;PF00134;, GO:0002944;GO:0002945;GO:0008024;GO:0005654;GO:0005634;GO:0061575;GO:0004693;GO:0016538;GO:0019901;GO:0008353;GO:0007049;GO:0051301;GO:0006974;GO:0044828;GO:0032786;GO:2001165;GO:0045944;GO:0000079;GO:0006357;GO:0042795;GO:0006366;GO:0006368;, C:cyclin K-CDK12 complex; C:cyclin K-CDK13 complex; C:cyclin/CDK positive transcription elongation factor complex; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:cell cycle; P:cell division; P:cellular response to DNA damage stimulus; P:negative regulation by host of viral genome replication; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold701 indexed_genome mRNA 9462 12058 . + . ID=transcript_16905;O75909 Q59FT6 Q86U16 Q96B63 Q9NNY9,Cyclin-K,, PF02984;PF00134;, GO:0002944;GO:0002945;GO:0008024;GO:0005654;GO:0005634;GO:0061575;GO:0004693;GO:0016538;GO:0019901;GO:0008353;GO:0007049;GO:0051301;GO:0006974;GO:0044828;GO:0032786;GO:2001165;GO:0045944;GO:0000079;GO:0006357;GO:0042795;GO:0006366;GO:0006368;, C:cyclin K-CDK12 complex; C:cyclin K-CDK13 complex; C:cyclin/CDK positive transcription elongation factor complex; C:nucleoplasm; C:nucleus;, F:cyclin-dependent protein serine/threonine kinase activator activity; F:cyclin-dependent protein serine/threonine kinase activity; F:cyclin-dependent protein serine/threonine kinase regulator activity; F:protein kinase binding; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:cell cycle; P:cell division; P:cellular response to DNA damage stimulus; P:negative regulation by host of viral genome replication; P:positive regulation of DNA-templated transcription, elongation; P:positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues; P:positive regulation of transcription by RNA polymerase II; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:regulation of transcription by RNA polymerase II; P:snRNA transcription by RNA polymerase II; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; scaffold702 indexed_genome mRNA 29220 36303 . - . ID=transcript_16906;Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport; scaffold702 indexed_genome mRNA 37135 38212 . + . ID=transcript_16907;Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport; scaffold705 indexed_genome mRNA 29225 36267 . - . ID=transcript_16908;Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport;|Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport; scaffold705 indexed_genome mRNA 37099 38176 . - . ID=transcript_16909;Q59GH1 Q63Z40 Q6P1R9 Q7KZ57,Kinesin-like protein KIF1A,Axonal transporter of synaptic vesicles;Microtubule-based motor KIF1A;Unc-104- and KIF1A-related protein;, PF12473;PF00498;PF12423;PF00225;PF16183;PF00169;, GO:0030424;GO:1904115;GO:0005829;GO:0030425;GO:0098674;GO:0005871;GO:0005874;GO:0043025;GO:0098992;GO:0098794;GO:0008021;GO:0005524;GO:0008574;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0003774;GO:0008089;GO:1990048;GO:0030705;GO:0099519;GO:0022027;GO:0007018;GO:0098840;GO:0060998;GO:0061001;GO:1990049;GO:0016192;, C:axon; C:axon cytoplasm; C:cytosol; C:dendrite; C:extrinsic component of neuronal dense core vesicle membrane; C:kinesin complex; C:microtubule; C:neuronal cell body; C:neuronal dense core vesicle; C:postsynapse; C:synaptic vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal transport; P:anterograde neuronal dense core vesicle transport; P:cytoskeleton-dependent intracellular transport; P:dense core granule cytoskeletal transport; P:interkinetic nuclear migration; P:microtubule-based movement; P:protein transport along microtubule; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:retrograde neuronal dense core vesicle transport; P:vesicle-mediated transport; scaffold706 indexed_genome mRNA 38279 43012 . - . ID=transcript_16910;Q13158 Q14866 Q6IBR4,FAS-associated death domain protein,FAS-associating death domain-containing protein;Growth-inhibiting gene 3 protein;Mediator of receptor induced toxicity;Protein FADD;, PF00531;PF01335;, GO:0031265;GO:0044297;GO:0005737;GO:0005829;GO:0031264;GO:0045121;GO:0043005;GO:0005634;GO:0005886;GO:0097342;GO:0089720;GO:0035877;GO:0005123;GO:0042802;GO:0002020;GO:0044877;GO:0033612;GO:0005164;GO:0032813;GO:0097202;GO:0006919;GO:0006915;GO:0097190;GO:0048148;GO:0007166;GO:0071260;GO:0071550;GO:0051607;GO:0097191;GO:0097192;GO:0008625;GO:0045087;GO:0001822;GO:0048535;GO:0097049;GO:0097527;GO:0070236;GO:1902042;GO:0060546;GO:0042104;GO:0002821;GO:0043065;GO:2000454;GO:2001238;GO:0043123;GO:0032729;GO:0032757;GO:0045651;GO:0045862;GO:0001916;GO:0045944;GO:0032760;GO:0060340;GO:1902041;GO:0010803;GO:0043278;GO:0048536;GO:0033077;GO:0043029;GO:0048538;GO:0034138;GO:0036462;GO:0035666;GO:0016032;, C:CD95 death-inducing signaling complex; C:cell body; C:cytoplasm; C:cytosol; C:death-inducing signaling complex; C:membrane raft; C:neuron projection; C:nucleus; C:plasma membrane; C:ripoptosome;, F:caspase binding; F:death effector domain binding; F:death receptor binding; F:identical protein binding; F:protease binding; F:protein-containing complex binding; F:receptor serine/threonine kinase binding; F:tumor necrosis factor receptor binding; F:tumor necrosis factor receptor superfamily binding;, P:activation of cysteine-type endopeptidase activity; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:apoptotic process; P:apoptotic signaling pathway; P:behavioral response to cocaine; P:cell surface receptor signaling pathway; P:cellular response to mechanical stimulus; P:death-inducing signaling complex assembly; P:defense response to virus; P:extrinsic apoptotic signaling pathway; P:extrinsic apoptotic signaling pathway in absence of ligand; P:extrinsic apoptotic signaling pathway via death domain receptors; P:innate immune response; P:kidney development; P:lymph node development; P:motor neuron apoptotic process; P:necroptotic signaling pathway; P:negative regulation of activation-induced cell death of T cells; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of necroptotic process; P:positive regulation of activated T cell proliferation; P:positive regulation of adaptive immune response; P:positive regulation of apoptotic process; P:positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-8 production; P:positive regulation of macrophage differentiation; P:positive regulation of proteolysis; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I interferon-mediated signaling pathway; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to morphine; P:spleen development; P:T cell differentiation in thymus; P:T cell homeostasis; P:thymus development; P:toll-like receptor 3 signaling pathway; P:TRAIL-activated apoptotic signaling pathway; P:TRIF-dependent toll-like receptor signaling pathway; P:viral process; scaffold710 indexed_genome mRNA 20532 28839 . - . ID=transcript_16911;Q96H12 B2RC35 Q5T726 Q5T727 Q5T728,Myb/SANT-like DNA-binding domain-containing protein 3,, PF13873;, GO:0042802;, , F:identical protein binding; scaffold726 indexed_genome mRNA 8431 10344 . - . ID=transcript_16912;P07686,Beta-hexosaminidase subunit beta {ECO:0000305},Beta-N-acetylhexosaminidase subunit beta;Cervical cancer proto-oncogene 7 protein;N-acetyl-beta-glucosaminidase subunit beta;, PF00728;PF14845;, GO:0001669;GO:0042582;GO:0035578;GO:0060473;GO:0070062;GO:0005576;GO:0043202;GO:0016020;GO:0008375;GO:0004563;GO:0042802;GO:0102148;GO:0043615;GO:0006874;GO:0044267;GO:0030207;GO:0006689;GO:0006687;GO:0030214;GO:0042340;GO:0019915;GO:0007626;GO:0007040;GO:0008049;GO:0042552;GO:0050885;GO:0043312;GO:0009313;GO:0048477;GO:0007341;GO:0008654;GO:0045944;GO:0008360;GO:0007605;GO:0007338;GO:0001501;, C:acrosomal vesicle; C:azurophil granule; C:azurophil granule lumen; C:cortical granule; C:extracellular exosome; C:extracellular region; C:lysosomal lumen; C:membrane;, F:acetylglucosaminyltransferase activity; F:beta-N-acetylhexosaminidase activity; F:identical protein binding; F:N-acetyl-beta-D-galactosaminidase activity;, P:astrocyte cell migration; P:cellular calcium ion homeostasis; P:cellular protein metabolic process; P:chondroitin sulfate catabolic process; P:ganglioside catabolic process; P:glycosphingolipid metabolic process; P:hyaluronan catabolic process; P:keratan sulfate catabolic process; P:lipid storage; P:locomotory behavior; P:lysosome organization; P:male courtship behavior; P:myelination; P:neuromuscular process controlling balance; P:neutrophil degranulation; P:oligosaccharide catabolic process; P:oogenesis; P:penetration of zona pellucida; P:phospholipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell shape; P:sensory perception of sound; P:single fertilization; P:skeletal system development;|P07686,Beta-hexosaminidase subunit beta {ECO:0000305},Beta-N-acetylhexosaminidase subunit beta;Cervical cancer proto-oncogene 7 protein;N-acetyl-beta-glucosaminidase subunit beta;, PF00728;PF14845;, GO:0001669;GO:0042582;GO:0035578;GO:0060473;GO:0070062;GO:0005576;GO:0043202;GO:0016020;GO:0008375;GO:0004563;GO:0042802;GO:0102148;GO:0043615;GO:0006874;GO:0044267;GO:0030207;GO:0006689;GO:0006687;GO:0030214;GO:0042340;GO:0019915;GO:0007626;GO:0007040;GO:0008049;GO:0042552;GO:0050885;GO:0043312;GO:0009313;GO:0048477;GO:0007341;GO:0008654;GO:0045944;GO:0008360;GO:0007605;GO:0007338;GO:0001501;, C:acrosomal vesicle; C:azurophil granule; C:azurophil granule lumen; C:cortical granule; C:extracellular exosome; C:extracellular region; C:lysosomal lumen; C:membrane;, F:acetylglucosaminyltransferase activity; F:beta-N-acetylhexosaminidase activity; F:identical protein binding; F:N-acetyl-beta-D-galactosaminidase activity;, P:astrocyte cell migration; P:cellular calcium ion homeostasis; P:cellular protein metabolic process; P:chondroitin sulfate catabolic process; P:ganglioside catabolic process; P:glycosphingolipid metabolic process; P:hyaluronan catabolic process; P:keratan sulfate catabolic process; P:lipid storage; P:locomotory behavior; P:lysosome organization; P:male courtship behavior; P:myelination; P:neuromuscular process controlling balance; P:neutrophil degranulation; P:oligosaccharide catabolic process; P:oogenesis; P:penetration of zona pellucida; P:phospholipid biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell shape; P:sensory perception of sound; P:single fertilization; P:skeletal system development; scaffold727 indexed_genome mRNA 1540 2048 . + . ID=transcript_16913;Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling; scaffold727 indexed_genome mRNA 14767 40496 . + . ID=transcript_16914;Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling;|Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling;|Q96Q15 O43305 Q13284 Q8NFX2 Q96QV0 Q96RW3,Serine/threonine-protein kinase SMG1,61E3.4;Lambda/iota protein kinase C-interacting protein;, PF02260;PF00454;PF15785;PF17229;, GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0031931;GO:0031932;GO:0005524;GO:0046872;GO:0004672;GO:0004697;GO:0106310;GO:0004674;GO:0106311;GO:0003723;GO:0042162;GO:0006281;GO:0006406;GO:0016242;GO:0000184;GO:0018105;GO:0046854;GO:0046777;GO:2001020;GO:0032204;GO:0038202;, C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:TORC1 complex; C:TORC2 complex;, F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein kinase C activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA binding; F:telomeric DNA binding;, P:DNA repair; P:mRNA export from nucleus; P:negative regulation of macroautophagy; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:peptidyl-serine phosphorylation; P:phosphatidylinositol phosphorylation; P:protein autophosphorylation; P:regulation of response to DNA damage stimulus; P:regulation of telomere maintenance; P:TORC1 signaling; scaffold730 indexed_genome mRNA 29466 32075 . + . ID=transcript_16915;Q6ZUA9,Maestro heat-like repeat family member 5|Q6ZUA9,Maestro heat-like repeat family member 5 scaffold730 indexed_genome mRNA 36313 41111 . - . ID=transcript_16916;O75365 Q8IVN5 Q99849 Q9BTW5,Protein tyrosine phosphatase type IVA 3,PRL-R;Protein-tyrosine phosphatase 4a3;Protein-tyrosine phosphatase of regenerating liver 3;, , GO:0005737;GO:0005769;GO:0005634;GO:0005886;GO:0004727;GO:0004725;GO:0043542;GO:1904951;GO:1901224;GO:0006355;, C:cytoplasm; C:early endosome; C:nucleus; C:plasma membrane;, F:prenylated protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:endothelial cell migration; P:positive regulation of establishment of protein localization; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of transcription, DNA-templated; scaffold732 indexed_genome mRNA 29435 32041 . + . ID=transcript_16917;Q6ZUA9,Maestro heat-like repeat family member 5|Q6ZUA9,Maestro heat-like repeat family member 5 scaffold732 indexed_genome mRNA 36205 41910 . - . ID=transcript_16918;O75365 Q8IVN5 Q99849 Q9BTW5,Protein tyrosine phosphatase type IVA 3,PRL-R;Protein-tyrosine phosphatase 4a3;Protein-tyrosine phosphatase of regenerating liver 3;, , GO:0005737;GO:0005769;GO:0005634;GO:0005886;GO:0004727;GO:0004725;GO:0043542;GO:1904951;GO:1901224;GO:0006355;, C:cytoplasm; C:early endosome; C:nucleus; C:plasma membrane;, F:prenylated protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:endothelial cell migration; P:positive regulation of establishment of protein localization; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of transcription, DNA-templated;|O75365 Q8IVN5 Q99849 Q9BTW5,Protein tyrosine phosphatase type IVA 3,PRL-R;Protein-tyrosine phosphatase 4a3;Protein-tyrosine phosphatase of regenerating liver 3;, , GO:0005737;GO:0005769;GO:0005634;GO:0005886;GO:0004727;GO:0004725;GO:0043542;GO:1904951;GO:1901224;GO:0006355;, C:cytoplasm; C:early endosome; C:nucleus; C:plasma membrane;, F:prenylated protein tyrosine phosphatase activity; F:protein tyrosine phosphatase activity;, P:endothelial cell migration; P:positive regulation of establishment of protein localization; P:positive regulation of NIK/NF-kappaB signaling; P:regulation of transcription, DNA-templated; scaffold733 indexed_genome mRNA 28911 39830 . + . ID=transcript_16919;Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process;|Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process;|Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process; scaffold736 indexed_genome mRNA 28854 39773 . + . ID=transcript_16920;Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process;|Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process;|Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process; scaffold736 indexed_genome mRNA 40459 41301 . - . ID=transcript_16921;Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process; scaffold738 indexed_genome mRNA 13291 24172 . - . ID=transcript_16922;Q96FX7 A6NN78 Q8N7Q9,tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A,mRNA methyladenosine-N(1)-methyltransferase catalytic subunit TRMT61A {ECO:0000303|PubMed:29072297};tRNA(m1A58)-methyltransferase subunit TRMT61A;, PF08704;, GO:0005654;GO:0005634;GO:0031515;GO:0061953;GO:0016429;GO:0080009;GO:0030488;GO:0006400;, C:nucleoplasm; C:nucleus; C:tRNA (m1A) methyltransferase complex;, F:mRNA (adenine-N1-)-methyltransferase activity; F:tRNA (adenine-N1-)-methyltransferase activity;, P:mRNA methylation; P:tRNA methylation; P:tRNA modification;|Q96FX7 A6NN78 Q8N7Q9,tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A,mRNA methyladenosine-N(1)-methyltransferase catalytic subunit TRMT61A {ECO:0000303|PubMed:29072297};tRNA(m1A58)-methyltransferase subunit TRMT61A;, PF08704;, GO:0005654;GO:0005634;GO:0031515;GO:0061953;GO:0016429;GO:0080009;GO:0030488;GO:0006400;, C:nucleoplasm; C:nucleus; C:tRNA (m1A) methyltransferase complex;, F:mRNA (adenine-N1-)-methyltransferase activity; F:tRNA (adenine-N1-)-methyltransferase activity;, P:mRNA methylation; P:tRNA methylation; P:tRNA modification; scaffold738 indexed_genome mRNA 28606 31916 . + . ID=transcript_16923;P12277 A8K236 B2R5R4 Q2LE07 Q6FG40 Q9UC66,Creatine kinase B-type {ECO:0000305},Brain creatine kinase {ECO:0000303|PubMed:2828370};Creatine kinase B chain {ECO:0000303|PubMed:3692484};Creatine phosphokinase B-type;, PF00217;PF02807;, GO:0005829;GO:0030425;GO:0070062;GO:0005615;GO:0043025;GO:0005634;GO:0005524;GO:0004111;GO:0016301;GO:0031625;GO:0030644;GO:0021549;GO:0006600;GO:0046314;GO:0021762;, C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular space; C:neuronal cell body; C:nucleus;, F:ATP binding; F:creatine kinase activity; F:kinase activity; F:ubiquitin protein ligase binding;, P:cellular chloride ion homeostasis; P:cerebellum development; P:creatine metabolic process; P:phosphocreatine biosynthetic process; P:substantia nigra development;|P12277 A8K236 B2R5R4 Q2LE07 Q6FG40 Q9UC66,Creatine kinase B-type {ECO:0000305},Brain creatine kinase {ECO:0000303|PubMed:2828370};Creatine kinase B chain {ECO:0000303|PubMed:3692484};Creatine phosphokinase B-type;, PF00217;PF02807;, GO:0005829;GO:0030425;GO:0070062;GO:0005615;GO:0043025;GO:0005634;GO:0005524;GO:0004111;GO:0016301;GO:0031625;GO:0030644;GO:0021549;GO:0006600;GO:0046314;GO:0021762;, C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular space; C:neuronal cell body; C:nucleus;, F:ATP binding; F:creatine kinase activity; F:kinase activity; F:ubiquitin protein ligase binding;, P:cellular chloride ion homeostasis; P:cerebellum development; P:creatine metabolic process; P:phosphocreatine biosynthetic process; P:substantia nigra development;|P12277 A8K236 B2R5R4 Q2LE07 Q6FG40 Q9UC66,Creatine kinase B-type {ECO:0000305},Brain creatine kinase {ECO:0000303|PubMed:2828370};Creatine kinase B chain {ECO:0000303|PubMed:3692484};Creatine phosphokinase B-type;, PF00217;PF02807;, GO:0005829;GO:0030425;GO:0070062;GO:0005615;GO:0043025;GO:0005634;GO:0005524;GO:0004111;GO:0016301;GO:0031625;GO:0030644;GO:0021549;GO:0006600;GO:0046314;GO:0021762;, C:cytosol; C:dendrite; C:extracellular exosome; C:extracellular space; C:neuronal cell body; C:nucleus;, F:ATP binding; F:creatine kinase activity; F:kinase activity; F:ubiquitin protein ligase binding;, P:cellular chloride ion homeostasis; P:cerebellum development; P:creatine metabolic process; P:phosphocreatine biosynthetic process; P:substantia nigra development; scaffold741 indexed_genome mRNA 3622 5300 . + . ID=transcript_16924;Q96DN6 Q8N3M0 Q8NA81 Q96Q00,Methyl-CpG-binding domain protein 6,Methyl-CpG-binding protein MBD6;, , GO:0010369;GO:0005694;GO:0001650;GO:0005654;GO:0005634;GO:0003682;GO:0016579;, C:chromocenter; C:chromosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:protein deubiquitination;|Q96DN6 Q8N3M0 Q8NA81 Q96Q00,Methyl-CpG-binding domain protein 6,Methyl-CpG-binding protein MBD6;, , GO:0010369;GO:0005694;GO:0001650;GO:0005654;GO:0005634;GO:0003682;GO:0016579;, C:chromocenter; C:chromosome; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:chromatin binding;, P:protein deubiquitination; scaffold741 indexed_genome mRNA 5752 18966 . - . ID=transcript_16925;Q13561 B2RBK5 Q86YN2 Q9BW17,Dynactin subunit 2,50 kDa dynein-associated polypeptide;Dynactin complex 50 kDa subunit;p50 dynamitin;, PF04912;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0030286;GO:0070062;GO:0030426;GO:0000776;GO:0016020;GO:0005874;GO:0031982;GO:0042802;GO:0019901;GO:0030507;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0032402;GO:0007080;GO:0007052;GO:0071539;GO:0010389;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:dynein complex; C:extracellular exosome; C:growth cone; C:kinetochore; C:membrane; C:microtubule; C:vesicle;, F:identical protein binding; F:protein kinase binding; F:spectrin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q13561 B2RBK5 Q86YN2 Q9BW17,Dynactin subunit 2,50 kDa dynein-associated polypeptide;Dynactin complex 50 kDa subunit;p50 dynamitin;, PF04912;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0030286;GO:0070062;GO:0030426;GO:0000776;GO:0016020;GO:0005874;GO:0031982;GO:0042802;GO:0019901;GO:0030507;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0032402;GO:0007080;GO:0007052;GO:0071539;GO:0010389;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:dynein complex; C:extracellular exosome; C:growth cone; C:kinetochore; C:membrane; C:microtubule; C:vesicle;, F:identical protein binding; F:protein kinase binding; F:spectrin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q13561 B2RBK5 Q86YN2 Q9BW17,Dynactin subunit 2,50 kDa dynein-associated polypeptide;Dynactin complex 50 kDa subunit;p50 dynamitin;, PF04912;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0030286;GO:0070062;GO:0030426;GO:0000776;GO:0016020;GO:0005874;GO:0031982;GO:0042802;GO:0019901;GO:0030507;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0032402;GO:0007080;GO:0007052;GO:0071539;GO:0010389;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:dynein complex; C:extracellular exosome; C:growth cone; C:kinetochore; C:membrane; C:microtubule; C:vesicle;, F:identical protein binding; F:protein kinase binding; F:spectrin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q13561 B2RBK5 Q86YN2 Q9BW17,Dynactin subunit 2,50 kDa dynein-associated polypeptide;Dynactin complex 50 kDa subunit;p50 dynamitin;, PF04912;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0030286;GO:0070062;GO:0030426;GO:0000776;GO:0016020;GO:0005874;GO:0031982;GO:0042802;GO:0019901;GO:0030507;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0032402;GO:0007080;GO:0007052;GO:0071539;GO:0010389;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:dynein complex; C:extracellular exosome; C:growth cone; C:kinetochore; C:membrane; C:microtubule; C:vesicle;, F:identical protein binding; F:protein kinase binding; F:spectrin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle;|Q13561 B2RBK5 Q86YN2 Q9BW17,Dynactin subunit 2,50 kDa dynein-associated polypeptide;Dynactin complex 50 kDa subunit;p50 dynamitin;, PF04912;, GO:0005813;GO:0005737;GO:0005829;GO:0005869;GO:0030286;GO:0070062;GO:0030426;GO:0000776;GO:0016020;GO:0005874;GO:0031982;GO:0042802;GO:0019901;GO:0030507;GO:0019886;GO:0097711;GO:0006888;GO:0000086;GO:0032402;GO:0007080;GO:0007052;GO:0071539;GO:0010389;, C:centrosome; C:cytoplasm; C:cytosol; C:dynactin complex; C:dynein complex; C:extracellular exosome; C:growth cone; C:kinetochore; C:membrane; C:microtubule; C:vesicle;, F:identical protein binding; F:protein kinase binding; F:spectrin binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:ciliary basal body-plasma membrane docking; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:G2/M transition of mitotic cell cycle; P:melanosome transport; P:mitotic metaphase plate congression; P:mitotic spindle organization; P:protein localization to centrosome; P:regulation of G2/M transition of mitotic cell cycle; scaffold741 indexed_genome mRNA 21949 41203 . - . ID=transcript_16926;Q12840 A6H8M5 Q4LE26,Kinesin heavy chain isoform 5A,Kinesin heavy chain neuron-specific 1;Neuronal kinesin heavy chain;, PF00225;, GO:1904115;GO:0005829;GO:0032839;GO:0005871;GO:0016020;GO:0005874;GO:0043204;GO:0048471;GO:0045202;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0099641;GO:0098971;GO:0019886;GO:0007411;GO:0007268;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0048489;GO:0016192;, C:axon cytoplasm; C:cytosol; C:dendrite cytoplasm; C:kinesin complex; C:membrane; C:microtubule; C:perikaryon; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:chemical synaptic transmission; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:synaptic vesicle transport; P:vesicle-mediated transport; scaffold746 indexed_genome mRNA 7773 37373 . + . ID=transcript_16927;Q71RC2 A8K6T1 E9PDG5 G3XAA8 G5E976 Q5CZ97 Q6ZV14 Q96NF9,La-related protein 4,La ribonucleoprotein domain family member 4;, PF05383;, GO:0010494;GO:0005829;GO:0016020;GO:0003730;GO:0008143;GO:0003723;GO:0007010;GO:0045727;GO:0010608;GO:0022604;GO:0006412;, C:cytoplasmic stress granule; C:cytosol; C:membrane;, F:mRNA 3'-UTR binding; F:poly(A) binding; F:RNA binding;, P:cytoskeleton organization; P:positive regulation of translation; P:posttranscriptional regulation of gene expression; P:regulation of cell morphogenesis; P:translation; scaffold747 indexed_genome mRNA 10799 12017 . + . ID=transcript_16928;O15247 A8K9S0 O15174 Q5JT80 Q8TCE3,Chloride intracellular channel protein 2,XAP121;, PF13409;, GO:0034707;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005254;GO:0004602;GO:0005244;GO:0006749;GO:0060315;GO:0051099;GO:0010881;GO:0010880;GO:0007165;, C:chloride channel complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chloride channel activity; F:glutathione peroxidase activity; F:voltage-gated ion channel activity;, P:glutathione metabolic process; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of binding; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:signal transduction; scaffold748 indexed_genome mRNA 3396 15170 . - . ID=transcript_16929;O15247 A8K9S0 O15174 Q5JT80 Q8TCE3,Chloride intracellular channel protein 2,XAP121;, PF13409;, GO:0034707;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005254;GO:0004602;GO:0005244;GO:0006749;GO:0060315;GO:0051099;GO:0010881;GO:0010880;GO:0007165;, C:chloride channel complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chloride channel activity; F:glutathione peroxidase activity; F:voltage-gated ion channel activity;, P:glutathione metabolic process; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of binding; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:signal transduction;|O15247 A8K9S0 O15174 Q5JT80 Q8TCE3,Chloride intracellular channel protein 2,XAP121;, PF13409;, GO:0034707;GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005886;GO:0005254;GO:0004602;GO:0005244;GO:0006749;GO:0060315;GO:0051099;GO:0010881;GO:0010880;GO:0007165;, C:chloride channel complex; C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:plasma membrane;, F:chloride channel activity; F:glutathione peroxidase activity; F:voltage-gated ion channel activity;, P:glutathione metabolic process; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of binding; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:signal transduction; scaffold750 indexed_genome mRNA 14657 15385 . - . ID=transcript_16930;P08575 A0A0A0MT22 A8K7W6 Q16614 Q9H0Y6 X6R433,Receptor-type tyrosine-protein phosphatase C {ECO:0000305},Leukocyte common antigen;T200;, PF12567;PF00041;PF12453;PF00102;, GO:0032059;GO:0009986;GO:0009898;GO:0009897;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0016020;GO:0098857;GO:0045121;GO:0005886;GO:0030667;GO:0030506;GO:0043395;GO:0008201;GO:0019901;GO:0004725;GO:0005102;GO:0030507;GO:0005001;GO:0000187;GO:0030183;GO:0042100;GO:0050853;GO:0048539;GO:0035584;GO:0044770;GO:0007166;GO:0031668;GO:0051607;GO:0016311;GO:1904155;GO:0002244;GO:0034113;GO:0007159;GO:0001779;GO:0006933;GO:0001960;GO:0070373;GO:0032703;GO:1903979;GO:0031953;GO:0006469;GO:0061099;GO:0001915;GO:0045060;GO:0043312;GO:0044855;GO:0046641;GO:0050857;GO:0030890;GO:0070374;GO:2001238;GO:1905451;GO:0045588;GO:2000473;GO:0002925;GO:0002639;GO:0032743;GO:0048304;GO:0043410;GO:0050731;GO:0045860;GO:1903615;GO:2000648;GO:0001916;GO:0042102;GO:0032760;GO:0045059;GO:0006470;GO:0051726;GO:0010468;GO:0032677;GO:0050764;GO:0061097;GO:0046425;GO:0051209;GO:0010332;GO:0048864;GO:0042110;GO:0030217;GO:0042098;GO:0050852;GO:0016032;, C:bleb; C:cell surface; C:cytoplasmic side of plasma membrane; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:membrane microdomain; C:membrane raft; C:plasma membrane; C:secretory granule membrane;, F:ankyrin binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:spectrin binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:activation of MAPK activity; P:B cell differentiation; P:B cell proliferation; P:B cell receptor signaling pathway; P:bone marrow development; P:calcium-mediated signaling using intracellular calcium source; P:cell cycle phase transition; P:cell surface receptor signaling pathway; P:cellular response to extracellular stimulus; P:defense response to virus; P:dephosphorylation; P:DN2 thymocyte differentiation; P:hematopoietic progenitor cell differentiation; P:heterotypic cell-cell adhesion; P:leukocyte cell-cell adhesion; P:natural killer cell differentiation; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-2 production; P:negative regulation of microglial cell activation; P:negative regulation of protein autophosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of T cell mediated cytotoxicity; P:negative thymic T cell selection; P:neutrophil degranulation; P:plasma membrane raft distribution; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of antigen receptor-mediated signaling pathway; P:positive regulation of B cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of hematopoietic stem cell migration; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-2 production; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein tyrosine phosphatase activity; P:positive regulation of stem cell proliferation; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:positive thymic T cell selection; P:protein dephosphorylation; P:regulation of cell cycle; P:regulation of gene expression; P:regulation of interleukin-8 production; P:regulation of phagocytosis; P:regulation of protein tyrosine kinase activity; P:regulation of receptor signaling pathway via JAK-STAT; P:release of sequestered calcium ion into cytosol; P:response to gamma radiation; P:stem cell development; P:T cell activation; P:T cell differentiation; P:T cell proliferation; P:T cell receptor signaling pathway; P:viral process; scaffold750 indexed_genome mRNA 16392 19131 . - . ID=transcript_16931;Q9HD43 C9JCH2 Q15426 Q2NKN9 Q2NKP0,Receptor-type tyrosine-protein phosphatase H,Stomach cancer-associated protein tyrosine phosphatase 1;Transmembrane-type protein-tyrosine phosphatase type H;, PF00041;PF00102;, GO:0016324;GO:0005737;GO:0005887;GO:0031528;GO:0045296;GO:0004725;GO:0005001;GO:0006915;GO:0006470;, C:apical plasma membrane; C:cytoplasm; C:integral component of plasma membrane; C:microvillus membrane;, F:cadherin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:apoptotic process; P:protein dephosphorylation; scaffold750 indexed_genome mRNA 39822 40512 . - . ID=transcript_16932;P35236 B3KXE1 Q53XK4 Q5SXQ0 Q5SXQ1 Q9BV05,Tyrosine-protein phosphatase non-receptor type 7,Hematopoietic protein-tyrosine phosphatase;Protein-tyrosine phosphatase LC-PTP;, PF00102;, GO:0005737;GO:0009898;GO:0005829;GO:0015630;GO:0072686;GO:0005654;GO:0004725;GO:0071345;GO:0000165;GO:0006470;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:microtubule cytoskeleton; C:mitotic spindle; C:nucleoplasm;, F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:MAPK cascade; P:protein dephosphorylation; scaffold751 indexed_genome mRNA 14643 15371 . - . ID=transcript_16933;P08575 A0A0A0MT22 A8K7W6 Q16614 Q9H0Y6 X6R433,Receptor-type tyrosine-protein phosphatase C {ECO:0000305},Leukocyte common antigen;T200;, PF12567;PF00041;PF12453;PF00102;, GO:0032059;GO:0009986;GO:0009898;GO:0009897;GO:0070062;GO:0005925;GO:0016021;GO:0005887;GO:0016020;GO:0098857;GO:0045121;GO:0005886;GO:0030667;GO:0030506;GO:0043395;GO:0008201;GO:0019901;GO:0004725;GO:0005102;GO:0030507;GO:0005001;GO:0000187;GO:0030183;GO:0042100;GO:0050853;GO:0048539;GO:0035584;GO:0044770;GO:0007166;GO:0031668;GO:0051607;GO:0016311;GO:1904155;GO:0002244;GO:0034113;GO:0007159;GO:0001779;GO:0006933;GO:0001960;GO:0070373;GO:0032703;GO:1903979;GO:0031953;GO:0006469;GO:0061099;GO:0001915;GO:0045060;GO:0043312;GO:0044855;GO:0046641;GO:0050857;GO:0030890;GO:0070374;GO:2001238;GO:1905451;GO:0045588;GO:2000473;GO:0002925;GO:0002639;GO:0032743;GO:0048304;GO:0043410;GO:0050731;GO:0045860;GO:1903615;GO:2000648;GO:0001916;GO:0042102;GO:0032760;GO:0045059;GO:0006470;GO:0051726;GO:0010468;GO:0032677;GO:0050764;GO:0061097;GO:0046425;GO:0051209;GO:0010332;GO:0048864;GO:0042110;GO:0030217;GO:0042098;GO:0050852;GO:0016032;, C:bleb; C:cell surface; C:cytoplasmic side of plasma membrane; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:membrane microdomain; C:membrane raft; C:plasma membrane; C:secretory granule membrane;, F:ankyrin binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:protein kinase binding; F:protein tyrosine phosphatase activity; F:signaling receptor binding; F:spectrin binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:activation of MAPK activity; P:B cell differentiation; P:B cell proliferation; P:B cell receptor signaling pathway; P:bone marrow development; P:calcium-mediated signaling using intracellular calcium source; P:cell cycle phase transition; P:cell surface receptor signaling pathway; P:cellular response to extracellular stimulus; P:defense response to virus; P:dephosphorylation; P:DN2 thymocyte differentiation; P:hematopoietic progenitor cell differentiation; P:heterotypic cell-cell adhesion; P:leukocyte cell-cell adhesion; P:natural killer cell differentiation; P:negative regulation of cell adhesion involved in substrate-bound cell migration; P:negative regulation of cytokine-mediated signaling pathway; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of interleukin-2 production; P:negative regulation of microglial cell activation; P:negative regulation of protein autophosphorylation; P:negative regulation of protein kinase activity; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of T cell mediated cytotoxicity; P:negative thymic T cell selection; P:neutrophil degranulation; P:plasma membrane raft distribution; P:positive regulation of alpha-beta T cell proliferation; P:positive regulation of antigen receptor-mediated signaling pathway; P:positive regulation of B cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis; P:positive regulation of gamma-delta T cell differentiation; P:positive regulation of hematopoietic stem cell migration; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; P:positive regulation of immunoglobulin production; P:positive regulation of interleukin-2 production; P:positive regulation of isotype switching to IgG isotypes; P:positive regulation of MAPK cascade; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of protein kinase activity; P:positive regulation of protein tyrosine phosphatase activity; P:positive regulation of stem cell proliferation; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of T cell proliferation; P:positive regulation of tumor necrosis factor production; P:positive thymic T cell selection; P:protein dephosphorylation; P:regulation of cell cycle; P:regulation of gene expression; P:regulation of interleukin-8 production; P:regulation of phagocytosis; P:regulation of protein tyrosine kinase activity; P:regulation of receptor signaling pathway via JAK-STAT; P:release of sequestered calcium ion into cytosol; P:response to gamma radiation; P:stem cell development; P:T cell activation; P:T cell differentiation; P:T cell proliferation; P:T cell receptor signaling pathway; P:viral process; scaffold751 indexed_genome mRNA 16377 19117 . - . ID=transcript_16934;Q9HD43 C9JCH2 Q15426 Q2NKN9 Q2NKP0,Receptor-type tyrosine-protein phosphatase H,Stomach cancer-associated protein tyrosine phosphatase 1;Transmembrane-type protein-tyrosine phosphatase type H;, PF00041;PF00102;, GO:0016324;GO:0005737;GO:0005887;GO:0031528;GO:0045296;GO:0004725;GO:0005001;GO:0006915;GO:0006470;, C:apical plasma membrane; C:cytoplasm; C:integral component of plasma membrane; C:microvillus membrane;, F:cadherin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:apoptotic process; P:protein dephosphorylation; scaffold751 indexed_genome mRNA 19208 20540 . - . ID=transcript_16935;P23467 B7ZKS8 B7ZKT0 C9JX87 F5H3G6 Q14D85 Q3MIV7,Receptor-type tyrosine-protein phosphatase beta,Vascular endothelial protein tyrosine phosphatase;, PF00041;PF18861;PF00102;, GO:0005887;GO:0005886;GO:0043235;GO:0035579;GO:0070821;GO:0045296;GO:0005001;GO:0001525;GO:0016311;GO:0043312;GO:1990264;GO:0006796;GO:0006470;, C:integral component of plasma membrane; C:plasma membrane; C:receptor complex; C:specific granule membrane; C:tertiary granule membrane;, F:cadherin binding; F:transmembrane receptor protein tyrosine phosphatase activity;, P:angiogenesis; P:dephosphorylation; P:neutrophil degranulation; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; P:phosphate-containing compound metabolic process; P:protein dephosphorylation; scaffold751 indexed_genome mRNA 39813 40503 . - . ID=transcript_16936;P35236 B3KXE1 Q53XK4 Q5SXQ0 Q5SXQ1 Q9BV05,Tyrosine-protein phosphatase non-receptor type 7,Hematopoietic protein-tyrosine phosphatase;Protein-tyrosine phosphatase LC-PTP;, PF00102;, GO:0005737;GO:0009898;GO:0005829;GO:0015630;GO:0072686;GO:0005654;GO:0004725;GO:0071345;GO:0000165;GO:0006470;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:cytosol; C:microtubule cytoskeleton; C:mitotic spindle; C:nucleoplasm;, F:protein tyrosine phosphatase activity;, P:cellular response to cytokine stimulus; P:MAPK cascade; P:protein dephosphorylation; scaffold752 indexed_genome mRNA 38538 40553 . + . ID=transcript_16937;Q9UIA9 O94846 Q6PJK9 Q8NEK7,Exportin-7,Ran-binding protein 16;, PF03810;, GO:0005737;GO:0005643;GO:0005634;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus;|Q9UIA9 O94846 Q6PJK9 Q8NEK7,Exportin-7,Ran-binding protein 16;, PF03810;, GO:0005737;GO:0005643;GO:0005634;GO:0005049;GO:0031267;GO:0006611;, C:cytoplasm; C:nuclear pore; C:nucleus;, F:nuclear export signal receptor activity; F:small GTPase binding;, P:protein export from nucleus; scaffold756 indexed_genome mRNA 2967 31383 . - . ID=transcript_16938;Q96PV6 A0A087WTE7 B0VJY9 Q8IZ27 Q8NCX6,Leukocyte receptor cluster member 8,, PF03399;, GO:0005634;, C:nucleus;|Q96PV6 A0A087WTE7 B0VJY9 Q8IZ27 Q8NCX6,Leukocyte receptor cluster member 8,, PF03399;, GO:0005634;, C:nucleus;|Q8WUU2,Protein tweety homolog 1,, PF04906;, GO:0034707;GO:0031527;GO:0032433;GO:0016021;GO:0005886;GO:0030868;GO:0045202;GO:0005509;GO:0005229;GO:0005381;GO:0072320;GO:0098609;GO:0031589;GO:0006821;GO:0046847;GO:0034220;GO:0006826;GO:0000278;, C:chloride channel complex; C:filopodium membrane; C:filopodium tip; C:integral component of membrane; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:synapse;, F:calcium ion binding; F:intracellular calcium activated chloride channel activity; F:iron ion transmembrane transporter activity; F:volume-sensitive chloride channel activity;, P:cell-cell adhesion; P:cell-substrate adhesion; P:chloride transport; P:filopodium assembly; P:ion transmembrane transport; P:iron ion transport; P:mitotic cell cycle;|Q8WUU2,Protein tweety homolog 1,, PF04906;, GO:0034707;GO:0031527;GO:0032433;GO:0016021;GO:0005886;GO:0030868;GO:0045202;GO:0005509;GO:0005229;GO:0005381;GO:0072320;GO:0098609;GO:0031589;GO:0006821;GO:0046847;GO:0034220;GO:0006826;GO:0000278;, C:chloride channel complex; C:filopodium membrane; C:filopodium tip; C:integral component of membrane; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:synapse;, F:calcium ion binding; F:intracellular calcium activated chloride channel activity; F:iron ion transmembrane transporter activity; F:volume-sensitive chloride channel activity;, P:cell-cell adhesion; P:cell-substrate adhesion; P:chloride transport; P:filopodium assembly; P:ion transmembrane transport; P:iron ion transport; P:mitotic cell cycle;|Q8WUU2,Protein tweety homolog 1,, PF04906;, GO:0034707;GO:0031527;GO:0032433;GO:0016021;GO:0005886;GO:0030868;GO:0045202;GO:0005509;GO:0005229;GO:0005381;GO:0072320;GO:0098609;GO:0031589;GO:0006821;GO:0046847;GO:0034220;GO:0006826;GO:0000278;, C:chloride channel complex; C:filopodium membrane; C:filopodium tip; C:integral component of membrane; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:synapse;, F:calcium ion binding; F:intracellular calcium activated chloride channel activity; F:iron ion transmembrane transporter activity; F:volume-sensitive chloride channel activity;, P:cell-cell adhesion; P:cell-substrate adhesion; P:chloride transport; P:filopodium assembly; P:ion transmembrane transport; P:iron ion transport; P:mitotic cell cycle; scaffold757 indexed_genome mRNA 2966 18882 . - . ID=transcript_16939;Q96PV6 A0A087WTE7 B0VJY9 Q8IZ27 Q8NCX6,Leukocyte receptor cluster member 8,, PF03399;, GO:0005634;, C:nucleus;|Q96PV6 A0A087WTE7 B0VJY9 Q8IZ27 Q8NCX6,Leukocyte receptor cluster member 8,, PF03399;, GO:0005634;, C:nucleus; scaffold757 indexed_genome mRNA 25352 31383 . - . ID=transcript_16940;Q8WUU2,Protein tweety homolog 1,, PF04906;, GO:0034707;GO:0031527;GO:0032433;GO:0016021;GO:0005886;GO:0030868;GO:0045202;GO:0005509;GO:0005229;GO:0005381;GO:0072320;GO:0098609;GO:0031589;GO:0006821;GO:0046847;GO:0034220;GO:0006826;GO:0000278;, C:chloride channel complex; C:filopodium membrane; C:filopodium tip; C:integral component of membrane; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:synapse;, F:calcium ion binding; F:intracellular calcium activated chloride channel activity; F:iron ion transmembrane transporter activity; F:volume-sensitive chloride channel activity;, P:cell-cell adhesion; P:cell-substrate adhesion; P:chloride transport; P:filopodium assembly; P:ion transmembrane transport; P:iron ion transport; P:mitotic cell cycle;|Q8WUU2,Protein tweety homolog 1,, PF04906;, GO:0034707;GO:0031527;GO:0032433;GO:0016021;GO:0005886;GO:0030868;GO:0045202;GO:0005509;GO:0005229;GO:0005381;GO:0072320;GO:0098609;GO:0031589;GO:0006821;GO:0046847;GO:0034220;GO:0006826;GO:0000278;, C:chloride channel complex; C:filopodium membrane; C:filopodium tip; C:integral component of membrane; C:plasma membrane; C:smooth endoplasmic reticulum membrane; C:synapse;, F:calcium ion binding; F:intracellular calcium activated chloride channel activity; F:iron ion transmembrane transporter activity; F:volume-sensitive chloride channel activity;, P:cell-cell adhesion; P:cell-substrate adhesion; P:chloride transport; P:filopodium assembly; P:ion transmembrane transport; P:iron ion transport; P:mitotic cell cycle; scaffold765 indexed_genome mRNA 12691 27022 . - . ID=transcript_16941;Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway; scaffold766 indexed_genome mRNA 12682 27015 . - . ID=transcript_16942;Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway;|Q92503 A8K4E8 B4DDI5 D5G3K1 Q99780,SEC14-like protein 1 {ECO:0000305},, PF00650;PF03765;PF04707;, GO:0005737;GO:0005829;GO:0005794;GO:0005654;GO:0039552;GO:0015871;GO:0045087;GO:0039536;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleoplasm;, F:RIG-I binding;, P:choline transport; P:innate immune response; P:negative regulation of RIG-I signaling pathway; scaffold780 indexed_genome mRNA 22809 25580 . + . ID=transcript_16943;Q13363 Q4W5N3 Q7Z2Q5,C-terminal-binding protein 1,, PF00389;PF02826;, GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0042802;GO:0051287;GO:0016616;GO:0008022;GO:0019904;GO:0070491;GO:0001226;GO:0003714;GO:0008134;GO:0006342;GO:0008285;GO:0035067;GO:0090241;GO:0000122;GO:0045892;GO:0031065;GO:0006468;GO:0051726;GO:0019079;GO:0050872;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:identical protein binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein C-terminus binding; F:protein domain specific binding; F:repressing transcription factor binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:chromatin silencing; P:negative regulation of cell population proliferation; P:negative regulation of histone acetylation; P:negative regulation of histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone deacetylation; P:protein phosphorylation; P:regulation of cell cycle; P:viral genome replication; P:white fat cell differentiation;|Q13363 Q4W5N3 Q7Z2Q5,C-terminal-binding protein 1,, PF00389;PF02826;, GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0042802;GO:0051287;GO:0016616;GO:0008022;GO:0019904;GO:0070491;GO:0001226;GO:0003714;GO:0008134;GO:0006342;GO:0008285;GO:0035067;GO:0090241;GO:0000122;GO:0045892;GO:0031065;GO:0006468;GO:0051726;GO:0019079;GO:0050872;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:identical protein binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein C-terminus binding; F:protein domain specific binding; F:repressing transcription factor binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:chromatin silencing; P:negative regulation of cell population proliferation; P:negative regulation of histone acetylation; P:negative regulation of histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone deacetylation; P:protein phosphorylation; P:regulation of cell cycle; P:viral genome replication; P:white fat cell differentiation; scaffold780 indexed_genome mRNA 25582 31434 . - . ID=transcript_16944;Q13363 Q4W5N3 Q7Z2Q5,C-terminal-binding protein 1,, PF00389;PF02826;, GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0042802;GO:0051287;GO:0016616;GO:0008022;GO:0019904;GO:0070491;GO:0001226;GO:0003714;GO:0008134;GO:0006342;GO:0008285;GO:0035067;GO:0090241;GO:0000122;GO:0045892;GO:0031065;GO:0006468;GO:0051726;GO:0019079;GO:0050872;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:identical protein binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein C-terminus binding; F:protein domain specific binding; F:repressing transcription factor binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:chromatin silencing; P:negative regulation of cell population proliferation; P:negative regulation of histone acetylation; P:negative regulation of histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone deacetylation; P:protein phosphorylation; P:regulation of cell cycle; P:viral genome replication; P:white fat cell differentiation; scaffold780 indexed_genome mRNA 31437 37377 . - . ID=transcript_16945;Q13363 Q4W5N3 Q7Z2Q5,C-terminal-binding protein 1,, PF00389;PF02826;, GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0042802;GO:0051287;GO:0016616;GO:0008022;GO:0019904;GO:0070491;GO:0001226;GO:0003714;GO:0008134;GO:0006342;GO:0008285;GO:0035067;GO:0090241;GO:0000122;GO:0045892;GO:0031065;GO:0006468;GO:0051726;GO:0019079;GO:0050872;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:identical protein binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein C-terminus binding; F:protein domain specific binding; F:repressing transcription factor binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:chromatin silencing; P:negative regulation of cell population proliferation; P:negative regulation of histone acetylation; P:negative regulation of histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone deacetylation; P:protein phosphorylation; P:regulation of cell cycle; P:viral genome replication; P:white fat cell differentiation; scaffold781 indexed_genome mRNA 22810 25581 . + . ID=transcript_16946;Q13363 Q4W5N3 Q7Z2Q5,C-terminal-binding protein 1,, PF00389;PF02826;, GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0042802;GO:0051287;GO:0016616;GO:0008022;GO:0019904;GO:0070491;GO:0001226;GO:0003714;GO:0008134;GO:0006342;GO:0008285;GO:0035067;GO:0090241;GO:0000122;GO:0045892;GO:0031065;GO:0006468;GO:0051726;GO:0019079;GO:0050872;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:identical protein binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein C-terminus binding; F:protein domain specific binding; F:repressing transcription factor binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:chromatin silencing; P:negative regulation of cell population proliferation; P:negative regulation of histone acetylation; P:negative regulation of histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone deacetylation; P:protein phosphorylation; P:regulation of cell cycle; P:viral genome replication; P:white fat cell differentiation;|Q13363 Q4W5N3 Q7Z2Q5,C-terminal-binding protein 1,, PF00389;PF02826;, GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0042802;GO:0051287;GO:0016616;GO:0008022;GO:0019904;GO:0070491;GO:0001226;GO:0003714;GO:0008134;GO:0006342;GO:0008285;GO:0035067;GO:0090241;GO:0000122;GO:0045892;GO:0031065;GO:0006468;GO:0051726;GO:0019079;GO:0050872;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:identical protein binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein C-terminus binding; F:protein domain specific binding; F:repressing transcription factor binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:chromatin silencing; P:negative regulation of cell population proliferation; P:negative regulation of histone acetylation; P:negative regulation of histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone deacetylation; P:protein phosphorylation; P:regulation of cell cycle; P:viral genome replication; P:white fat cell differentiation; scaffold781 indexed_genome mRNA 25583 31415 . - . ID=transcript_16947;Q13363 Q4W5N3 Q7Z2Q5,C-terminal-binding protein 1,, PF00389;PF02826;, GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0042802;GO:0051287;GO:0016616;GO:0008022;GO:0019904;GO:0070491;GO:0001226;GO:0003714;GO:0008134;GO:0006342;GO:0008285;GO:0035067;GO:0090241;GO:0000122;GO:0045892;GO:0031065;GO:0006468;GO:0051726;GO:0019079;GO:0050872;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:identical protein binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein C-terminus binding; F:protein domain specific binding; F:repressing transcription factor binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:chromatin silencing; P:negative regulation of cell population proliferation; P:negative regulation of histone acetylation; P:negative regulation of histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone deacetylation; P:protein phosphorylation; P:regulation of cell cycle; P:viral genome replication; P:white fat cell differentiation; scaffold781 indexed_genome mRNA 31418 37358 . - . ID=transcript_16948;Q13363 Q4W5N3 Q7Z2Q5,C-terminal-binding protein 1,, PF00389;PF02826;, GO:0005737;GO:0005654;GO:0005634;GO:0017053;GO:0042802;GO:0051287;GO:0016616;GO:0008022;GO:0019904;GO:0070491;GO:0001226;GO:0003714;GO:0008134;GO:0006342;GO:0008285;GO:0035067;GO:0090241;GO:0000122;GO:0045892;GO:0031065;GO:0006468;GO:0051726;GO:0019079;GO:0050872;, C:cytoplasm; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:identical protein binding; F:NAD binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:protein C-terminus binding; F:protein domain specific binding; F:repressing transcription factor binding; F:RNA polymerase II transcription corepressor binding; F:transcription corepressor activity; F:transcription factor binding;, P:chromatin silencing; P:negative regulation of cell population proliferation; P:negative regulation of histone acetylation; P:negative regulation of histone H4 acetylation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:positive regulation of histone deacetylation; P:protein phosphorylation; P:regulation of cell cycle; P:viral genome replication; P:white fat cell differentiation; scaffold782 indexed_genome mRNA 4742 7894 . + . ID=transcript_16949;Q96PB1 B3KW13 O14574 Q3LIE2 Q6P4R4 Q9H6T9 Q9H770,N-acetylneuraminate 9-O-acetyltransferase {ECO:0000305},CAS1 domain-containing protein 1 {ECO:0000305};Sialate O-acetyltransferase {ECO:0000303|PubMed:20947662, ECO:0000303|PubMed:26169044};, PF07779;, GO:0030173;GO:0047186;GO:0005975;, C:integral component of Golgi membrane;, F:N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity;, P:carbohydrate metabolic process;|Q96PB1 B3KW13 O14574 Q3LIE2 Q6P4R4 Q9H6T9 Q9H770,N-acetylneuraminate 9-O-acetyltransferase {ECO:0000305},CAS1 domain-containing protein 1 {ECO:0000305};Sialate O-acetyltransferase {ECO:0000303|PubMed:20947662, ECO:0000303|PubMed:26169044};, PF07779;, GO:0030173;GO:0047186;GO:0005975;, C:integral component of Golgi membrane;, F:N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity;, P:carbohydrate metabolic process; scaffold782 indexed_genome mRNA 12805 13626 . - . ID=transcript_16950;Q96PB1 B3KW13 O14574 Q3LIE2 Q6P4R4 Q9H6T9 Q9H770,N-acetylneuraminate 9-O-acetyltransferase {ECO:0000305},CAS1 domain-containing protein 1 {ECO:0000305};Sialate O-acetyltransferase {ECO:0000303|PubMed:20947662, ECO:0000303|PubMed:26169044};, PF07779;, GO:0030173;GO:0047186;GO:0005975;, C:integral component of Golgi membrane;, F:N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity;, P:carbohydrate metabolic process; scaffold782 indexed_genome mRNA 23295 25531 . + . ID=transcript_16951;Q96PB1 B3KW13 O14574 Q3LIE2 Q6P4R4 Q9H6T9 Q9H770,N-acetylneuraminate 9-O-acetyltransferase {ECO:0000305},CAS1 domain-containing protein 1 {ECO:0000305};Sialate O-acetyltransferase {ECO:0000303|PubMed:20947662, ECO:0000303|PubMed:26169044};, PF07779;, GO:0030173;GO:0047186;GO:0005975;, C:integral component of Golgi membrane;, F:N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity;, P:carbohydrate metabolic process; scaffold789 indexed_genome mRNA 7618 8342 . + . ID=transcript_16952;Q9NW48 Q9ULJ5,Erbin {ECO:0000303|PubMed:10878805},Densin-180-like protein;Erbb2-interacting protein {ECO:0000303|PubMed:10878805};Protein LAP2;, PF13855;PF00595;, GO:0009925;GO:0005604;GO:0016323;GO:0030054;GO:0005737;GO:0098978;GO:0030056;GO:0031965;GO:0016607;GO:0005634;GO:0005886;GO:0098794;GO:0005176;GO:0005102;GO:0005200;GO:0045175;GO:0007155;GO:0071356;GO:0007173;GO:0038128;GO:0045197;GO:0007229;GO:0045104;GO:0071638;GO:0032088;GO:0070433;GO:0046579;GO:0006605;GO:0099072;GO:0032496;GO:0032495;GO:0007165;, C:basal plasma membrane; C:basement membrane; C:basolateral plasma membrane; C:cell junction; C:cytoplasm; C:glutamatergic synapse; C:hemidesmosome; C:nuclear membrane; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynapse;, F:ErbB-2 class receptor binding; F:signaling receptor binding; F:structural constituent of cytoskeleton;, P:basal protein localization; P:cell adhesion; P:cellular response to tumor necrosis factor; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:establishment or maintenance of epithelial cell apical/basal polarity; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of Ras protein signal transduction; P:protein targeting; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:response to lipopolysaccharide; P:response to muramyl dipeptide; P:signal transduction; scaffold789 indexed_genome mRNA 13061 16677 . - . ID=transcript_16953;Q9NW48 Q9ULJ5,Erbin {ECO:0000303|PubMed:10878805},Densin-180-like protein;Erbb2-interacting protein {ECO:0000303|PubMed:10878805};Protein LAP2;, PF13855;PF00595;, GO:0009925;GO:0005604;GO:0016323;GO:0030054;GO:0005737;GO:0098978;GO:0030056;GO:0031965;GO:0016607;GO:0005634;GO:0005886;GO:0098794;GO:0005176;GO:0005102;GO:0005200;GO:0045175;GO:0007155;GO:0071356;GO:0007173;GO:0038128;GO:0045197;GO:0007229;GO:0045104;GO:0071638;GO:0032088;GO:0070433;GO:0046579;GO:0006605;GO:0099072;GO:0032496;GO:0032495;GO:0007165;, C:basal plasma membrane; C:basement membrane; C:basolateral plasma membrane; C:cell junction; C:cytoplasm; C:glutamatergic synapse; C:hemidesmosome; C:nuclear membrane; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynapse;, F:ErbB-2 class receptor binding; F:signaling receptor binding; F:structural constituent of cytoskeleton;, P:basal protein localization; P:cell adhesion; P:cellular response to tumor necrosis factor; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:establishment or maintenance of epithelial cell apical/basal polarity; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of Ras protein signal transduction; P:protein targeting; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:response to lipopolysaccharide; P:response to muramyl dipeptide; P:signal transduction; scaffold789 indexed_genome mRNA 16885 18336 . - . ID=transcript_16954;Q9NW48 Q9ULJ5,Erbin {ECO:0000303|PubMed:10878805},Densin-180-like protein;Erbb2-interacting protein {ECO:0000303|PubMed:10878805};Protein LAP2;, PF13855;PF00595;, GO:0009925;GO:0005604;GO:0016323;GO:0030054;GO:0005737;GO:0098978;GO:0030056;GO:0031965;GO:0016607;GO:0005634;GO:0005886;GO:0098794;GO:0005176;GO:0005102;GO:0005200;GO:0045175;GO:0007155;GO:0071356;GO:0007173;GO:0038128;GO:0045197;GO:0007229;GO:0045104;GO:0071638;GO:0032088;GO:0070433;GO:0046579;GO:0006605;GO:0099072;GO:0032496;GO:0032495;GO:0007165;, C:basal plasma membrane; C:basement membrane; C:basolateral plasma membrane; C:cell junction; C:cytoplasm; C:glutamatergic synapse; C:hemidesmosome; C:nuclear membrane; C:nuclear speck; C:nucleus; C:plasma membrane; C:postsynapse;, F:ErbB-2 class receptor binding; F:signaling receptor binding; F:structural constituent of cytoskeleton;, P:basal protein localization; P:cell adhesion; P:cellular response to tumor necrosis factor; P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:establishment or maintenance of epithelial cell apical/basal polarity; P:integrin-mediated signaling pathway; P:intermediate filament cytoskeleton organization; P:negative regulation of monocyte chemotactic protein-1 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; P:positive regulation of Ras protein signal transduction; P:protein targeting; P:regulation of postsynaptic membrane neurotransmitter receptor levels; P:response to lipopolysaccharide; P:response to muramyl dipeptide; P:signal transduction; scaffold795 indexed_genome mRNA 24610 25429 . + . ID=transcript_16955;Q96NL0 B4DFD0 E9PBR4 Q8IWW5 Q8NB55 Q8TBG7,RUN domain-containing protein 3B,Rap2-binding protein 9;Rap2-interacting protein 9;, PF02759; scaffold796 indexed_genome mRNA 24604 25423 . - . ID=transcript_16956;Q96NL0 B4DFD0 E9PBR4 Q8IWW5 Q8NB55 Q8TBG7,RUN domain-containing protein 3B,Rap2-binding protein 9;Rap2-interacting protein 9;, PF02759; scaffold803 indexed_genome mRNA 9109 11508 . - . ID=transcript_16957;Q8N661,Lysoplasmalogenase,Transmembrane protein 86B;, PF07947;, GO:0005737;GO:0005789;GO:0016021;GO:0016020;GO:0047408;GO:0047409;GO:0042802;GO:0046485;GO:0036151;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:alkenylglycerophosphocholine hydrolase activity; F:alkenylglycerophosphoethanolamine hydrolase activity; F:identical protein binding;, P:ether lipid metabolic process; P:phosphatidylcholine acyl-chain remodeling; scaffold803 indexed_genome mRNA 12875 13617 . - . ID=transcript_16958;Q9UPN7 Q2M2H3 Q504V2 Q6NVJ6 Q9BU97,Serine/threonine-protein phosphatase 6 regulatory subunit 1,SAPS domain family member 1;, PF04499;, GO:0005829;GO:0005634;GO:0019903;GO:0019888;GO:0031267;GO:0048208;GO:0043666;, C:cytosol; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity; F:small GTPase binding;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; scaffold804 indexed_genome mRNA 33331 34244 . + . ID=transcript_16959;Q9H7B4 A8K0P0 B1AN38 Q86TL8 Q8N5Z6 Q96AI5,Histone-lysine N-methyltransferase SMYD3,SET and MYND domain-containing protein 3;Zinc finger MYND domain-containing protein 1;, PF00856;PF01753;, GO:0005829;GO:0005654;GO:0005634;GO:0018024;GO:0046872;GO:0000978;GO:0000993;GO:0001162;GO:0071549;GO:0045184;GO:0034968;GO:0014904;GO:0006469;GO:0006334;GO:0033138;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus;, F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding;, P:cellular response to dexamethasone stimulus; P:establishment of protein localization; P:histone lysine methylation; P:myotube cell development; P:negative regulation of protein kinase activity; P:nucleosome assembly; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; scaffold805 indexed_genome mRNA 33320 34233 . + . ID=transcript_16960;Q9H7B4 A8K0P0 B1AN38 Q86TL8 Q8N5Z6 Q96AI5,Histone-lysine N-methyltransferase SMYD3,SET and MYND domain-containing protein 3;Zinc finger MYND domain-containing protein 1;, PF00856;PF01753;, GO:0005829;GO:0005654;GO:0005634;GO:0018024;GO:0046872;GO:0000978;GO:0000993;GO:0001162;GO:0071549;GO:0045184;GO:0034968;GO:0014904;GO:0006469;GO:0006334;GO:0033138;GO:0045944;, C:cytosol; C:nucleoplasm; C:nucleus;, F:histone-lysine N-methyltransferase activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II complex binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding;, P:cellular response to dexamethasone stimulus; P:establishment of protein localization; P:histone lysine methylation; P:myotube cell development; P:negative regulation of protein kinase activity; P:nucleosome assembly; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of transcription by RNA polymerase II; scaffold806 indexed_genome mRNA 9112 11486 . - . ID=transcript_16961;Q8N661,Lysoplasmalogenase,Transmembrane protein 86B;, PF07947;, GO:0005737;GO:0005789;GO:0016021;GO:0016020;GO:0047408;GO:0047409;GO:0042802;GO:0046485;GO:0036151;, C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane;, F:alkenylglycerophosphocholine hydrolase activity; F:alkenylglycerophosphoethanolamine hydrolase activity; F:identical protein binding;, P:ether lipid metabolic process; P:phosphatidylcholine acyl-chain remodeling; scaffold806 indexed_genome mRNA 11522 26910 . + . ID=transcript_16962;Q9UPN7 Q2M2H3 Q504V2 Q6NVJ6 Q9BU97,Serine/threonine-protein phosphatase 6 regulatory subunit 1,SAPS domain family member 1;, PF04499;, GO:0005829;GO:0005634;GO:0019903;GO:0019888;GO:0031267;GO:0048208;GO:0043666;, C:cytosol; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity; F:small GTPase binding;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity;|Q9UPN7 Q2M2H3 Q504V2 Q6NVJ6 Q9BU97,Serine/threonine-protein phosphatase 6 regulatory subunit 1,SAPS domain family member 1;, PF04499;, GO:0005829;GO:0005634;GO:0019903;GO:0019888;GO:0031267;GO:0048208;GO:0043666;, C:cytosol; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity; F:small GTPase binding;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity;|Q9UPN7 Q2M2H3 Q504V2 Q6NVJ6 Q9BU97,Serine/threonine-protein phosphatase 6 regulatory subunit 1,SAPS domain family member 1;, PF04499;, GO:0005829;GO:0005634;GO:0019903;GO:0019888;GO:0031267;GO:0048208;GO:0043666;, C:cytosol; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity; F:small GTPase binding;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity;|Q9UPN7 Q2M2H3 Q504V2 Q6NVJ6 Q9BU97,Serine/threonine-protein phosphatase 6 regulatory subunit 1,SAPS domain family member 1;, PF04499;, GO:0005829;GO:0005634;GO:0019903;GO:0019888;GO:0031267;GO:0048208;GO:0043666;, C:cytosol; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity; F:small GTPase binding;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity;|Q9UPN7 Q2M2H3 Q504V2 Q6NVJ6 Q9BU97,Serine/threonine-protein phosphatase 6 regulatory subunit 1,SAPS domain family member 1;, PF04499;, GO:0005829;GO:0005634;GO:0019903;GO:0019888;GO:0031267;GO:0048208;GO:0043666;, C:cytosol; C:nucleus;, F:protein phosphatase binding; F:protein phosphatase regulator activity; F:small GTPase binding;, P:COPII vesicle coating; P:regulation of phosphoprotein phosphatase activity; scaffold810 indexed_genome mRNA 19802 25474 . - . ID=transcript_16963;Q96I15 B9A068 J3KN06 Q53SN1 Q53SN8 Q7L670 Q9NVT7 Q9NZR7,Selenocysteine lyase,, PF00266;, GO:0005829;GO:0005794;GO:0009000;GO:0016740;GO:0006520;GO:0001887;, C:cytosol; C:Golgi apparatus;, F:selenocysteine lyase activity; F:transferase activity;, P:cellular amino acid metabolic process; P:selenium compound metabolic process;|Q96I15 B9A068 J3KN06 Q53SN1 Q53SN8 Q7L670 Q9NVT7 Q9NZR7,Selenocysteine lyase,, PF00266;, GO:0005829;GO:0005794;GO:0009000;GO:0016740;GO:0006520;GO:0001887;, C:cytosol; C:Golgi apparatus;, F:selenocysteine lyase activity; F:transferase activity;, P:cellular amino acid metabolic process; P:selenium compound metabolic process; scaffold811 indexed_genome mRNA 19767 25439 . - . ID=transcript_16964;Q96I15 B9A068 J3KN06 Q53SN1 Q53SN8 Q7L670 Q9NVT7 Q9NZR7,Selenocysteine lyase,, PF00266;, GO:0005829;GO:0005794;GO:0009000;GO:0016740;GO:0006520;GO:0001887;, C:cytosol; C:Golgi apparatus;, F:selenocysteine lyase activity; F:transferase activity;, P:cellular amino acid metabolic process; P:selenium compound metabolic process;|Q96I15 B9A068 J3KN06 Q53SN1 Q53SN8 Q7L670 Q9NVT7 Q9NZR7,Selenocysteine lyase,, PF00266;, GO:0005829;GO:0005794;GO:0009000;GO:0016740;GO:0006520;GO:0001887;, C:cytosol; C:Golgi apparatus;, F:selenocysteine lyase activity; F:transferase activity;, P:cellular amino acid metabolic process; P:selenium compound metabolic process; scaffold820 indexed_genome mRNA 11 6654 . - . ID=transcript_16965;Q70IA6 B4DKP3 Q96M67,MOB kinase activator 2,HCCA2;Mob2 homolog;Mps one binder kinase activator-like 2;, PF03637;, GO:0005829;GO:0005730;GO:0005654;GO:0048471;GO:0046872;, C:cytosol; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:metal ion binding; scaffold820 indexed_genome mRNA 10166 11647 . - . ID=transcript_16966;Q70IA6 B4DKP3 Q96M67,MOB kinase activator 2,HCCA2;Mob2 homolog;Mps one binder kinase activator-like 2;, PF03637;, GO:0005829;GO:0005730;GO:0005654;GO:0048471;GO:0046872;, C:cytosol; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:metal ion binding; scaffold822 indexed_genome mRNA 10159 11640 . + . ID=transcript_16967;Q70IA6 B4DKP3 Q96M67,MOB kinase activator 2,HCCA2;Mob2 homolog;Mps one binder kinase activator-like 2;, PF03637;, GO:0005829;GO:0005730;GO:0005654;GO:0048471;GO:0046872;, C:cytosol; C:nucleolus; C:nucleoplasm; C:perinuclear region of cytoplasm;, F:metal ion binding; scaffold823 indexed_genome mRNA 17378 19423 . + . ID=transcript_16968;Q8WTR4 Q49AQ5 Q6UX76 Q7Z4S0 Q8N781 Q8NCB7 Q8TB77,Glycerophosphodiester phosphodiesterase domain-containing protein 5 {ECO:0000305},Glycerophosphocholine phosphodiesterase GDPD5 {ECO:0000250|UniProtKB:Q640M6};Glycerophosphodiester phosphodiesterase 2;Phosphoinositide phospholipase C GDPD5 {ECO:0000305};, PF03009;, GO:0012505;GO:0030426;GO:0016021;GO:0048471;GO:0047389;GO:0004435;GO:0006629;GO:0007399;, C:endomembrane system; C:growth cone; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:glycerophosphocholine phosphodiesterase activity; F:phosphatidylinositol phospholipase C activity;, P:lipid metabolic process; P:nervous system development; scaffold823 indexed_genome mRNA 23892 36882 . + . ID=transcript_16969;Q8WTR4 Q49AQ5 Q6UX76 Q7Z4S0 Q8N781 Q8NCB7 Q8TB77,Glycerophosphodiester phosphodiesterase domain-containing protein 5 {ECO:0000305},Glycerophosphocholine phosphodiesterase GDPD5 {ECO:0000250|UniProtKB:Q640M6};Glycerophosphodiester phosphodiesterase 2;Phosphoinositide phospholipase C GDPD5 {ECO:0000305};, PF03009;, GO:0012505;GO:0030426;GO:0016021;GO:0048471;GO:0047389;GO:0004435;GO:0006629;GO:0007399;, C:endomembrane system; C:growth cone; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:glycerophosphocholine phosphodiesterase activity; F:phosphatidylinositol phospholipase C activity;, P:lipid metabolic process; P:nervous system development;|Q8WTR4 Q49AQ5 Q6UX76 Q7Z4S0 Q8N781 Q8NCB7 Q8TB77,Glycerophosphodiester phosphodiesterase domain-containing protein 5 {ECO:0000305},Glycerophosphocholine phosphodiesterase GDPD5 {ECO:0000250|UniProtKB:Q640M6};Glycerophosphodiester phosphodiesterase 2;Phosphoinositide phospholipase C GDPD5 {ECO:0000305};, PF03009;, GO:0012505;GO:0030426;GO:0016021;GO:0048471;GO:0047389;GO:0004435;GO:0006629;GO:0007399;, C:endomembrane system; C:growth cone; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:glycerophosphocholine phosphodiesterase activity; F:phosphatidylinositol phospholipase C activity;, P:lipid metabolic process; P:nervous system development;|Q8WTR4 Q49AQ5 Q6UX76 Q7Z4S0 Q8N781 Q8NCB7 Q8TB77,Glycerophosphodiester phosphodiesterase domain-containing protein 5 {ECO:0000305},Glycerophosphocholine phosphodiesterase GDPD5 {ECO:0000250|UniProtKB:Q640M6};Glycerophosphodiester phosphodiesterase 2;Phosphoinositide phospholipase C GDPD5 {ECO:0000305};, PF03009;, GO:0012505;GO:0030426;GO:0016021;GO:0048471;GO:0047389;GO:0004435;GO:0006629;GO:0007399;, C:endomembrane system; C:growth cone; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:glycerophosphocholine phosphodiesterase activity; F:phosphatidylinositol phospholipase C activity;, P:lipid metabolic process; P:nervous system development; scaffold825 indexed_genome mRNA 17372 19417 . + . ID=transcript_16970;Q8WTR4 Q49AQ5 Q6UX76 Q7Z4S0 Q8N781 Q8NCB7 Q8TB77,Glycerophosphodiester phosphodiesterase domain-containing protein 5 {ECO:0000305},Glycerophosphocholine phosphodiesterase GDPD5 {ECO:0000250|UniProtKB:Q640M6};Glycerophosphodiester phosphodiesterase 2;Phosphoinositide phospholipase C GDPD5 {ECO:0000305};, PF03009;, GO:0012505;GO:0030426;GO:0016021;GO:0048471;GO:0047389;GO:0004435;GO:0006629;GO:0007399;, C:endomembrane system; C:growth cone; C:integral component of membrane; C:perinuclear region of cytoplasm;, F:glycerophosphocholine phosphodiesterase activity; F:phosphatidylinositol phospholipase C activity;, P:lipid metabolic process; P:nervous system development; scaffold828 indexed_genome mRNA 2670 15605 . - . ID=transcript_16971;Q9NRW2,Microprocessor complex subunit DGCR8,DiGeorge syndrome critical region 8;, PF00035;, GO:0005737;GO:0005829;GO:0070877;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0003725;GO:0020037;GO:0042802;GO:0046872;GO:0070878;GO:0042803;GO:0140517;GO:0010586;GO:0031053;, C:cytoplasm; C:cytosol; C:microprocessor complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:protein-RNA adaptor activity;, P:miRNA metabolic process; P:primary miRNA processing;|Q9NRW2,Microprocessor complex subunit DGCR8,DiGeorge syndrome critical region 8;, PF00035;, GO:0005737;GO:0005829;GO:0070877;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0003725;GO:0020037;GO:0042802;GO:0046872;GO:0070878;GO:0042803;GO:0140517;GO:0010586;GO:0031053;, C:cytoplasm; C:cytosol; C:microprocessor complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:protein-RNA adaptor activity;, P:miRNA metabolic process; P:primary miRNA processing;|Q9NRW2,Microprocessor complex subunit DGCR8,DiGeorge syndrome critical region 8;, PF00035;, GO:0005737;GO:0005829;GO:0070877;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0003725;GO:0020037;GO:0042802;GO:0046872;GO:0070878;GO:0042803;GO:0140517;GO:0010586;GO:0031053;, C:cytoplasm; C:cytosol; C:microprocessor complex; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;, F:double-stranded RNA binding; F:heme binding; F:identical protein binding; F:metal ion binding; F:primary miRNA binding; F:protein homodimerization activity; F:protein-RNA adaptor activity;, P:miRNA metabolic process; P:primary miRNA processing;|Q6ZW26 Q8NA36,Collagen alpha-5(VI) chain,Collagen alpha-1(XXIX) chain;von Willebrand factor A domain-containing protein 4;, PF01391;PF00092;, GO:0005581;GO:0062023;GO:0005576;GO:0030020;GO:0007155;, C:collagen trimer; C:collagen-containing extracellular matrix; C:extracellular region;, F:extracellular matrix structural constituent conferring tensile strength;, P:cell adhesion; scaffold829 indexed_genome mRNA 385 9520 . - . ID=transcript_16972;Q8N6Y0 A8K7L6 B2RCR9 Q8NBX7 Q96KH3 Q9BYI8,Usher syndrome type-1C protein-binding protein 1,AIE-75-binding protein;MCC-2;Mutated in colon cancer protein 2;, PF10506;, GO:0030165;, , F:PDZ domain binding;|Q8N6Y0 A8K7L6 B2RCR9 Q8NBX7 Q96KH3 Q9BYI8,Usher syndrome type-1C protein-binding protein 1,AIE-75-binding protein;MCC-2;Mutated in colon cancer protein 2;, PF10506;, GO:0030165;, , F:PDZ domain binding;|Q8N6Y0 A8K7L6 B2RCR9 Q8NBX7 Q96KH3 Q9BYI8,Usher syndrome type-1C protein-binding protein 1,AIE-75-binding protein;MCC-2;Mutated in colon cancer protein 2;, PF10506;, GO:0030165;, , F:PDZ domain binding; scaffold829 indexed_genome mRNA 12621 18573 . + . ID=transcript_16973;Q9NWV8 A8MQT0 B4DRY9 B4DVR1 Q6FIA0 Q9P018,BRISC and BRCA1-A complex member 1,Mediator of RAP80 interactions and targeting subunit of 40 kDa {ECO:0000303|PubMed:19261746};New component of the BRCA1-A complex {ECO:0000303|PubMed:19261749};, , GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051301;GO:0006325;GO:0006302;GO:0006303;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q9NWV8 A8MQT0 B4DRY9 B4DVR1 Q6FIA0 Q9P018,BRISC and BRCA1-A complex member 1,Mediator of RAP80 interactions and targeting subunit of 40 kDa {ECO:0000303|PubMed:19261746};New component of the BRCA1-A complex {ECO:0000303|PubMed:19261749};, , GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051301;GO:0006325;GO:0006302;GO:0006303;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q9NWV8 A8MQT0 B4DRY9 B4DVR1 Q6FIA0 Q9P018,BRISC and BRCA1-A complex member 1,Mediator of RAP80 interactions and targeting subunit of 40 kDa {ECO:0000303|PubMed:19261746};New component of the BRCA1-A complex {ECO:0000303|PubMed:19261749};, , GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051301;GO:0006325;GO:0006302;GO:0006303;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q9NWV8 A8MQT0 B4DRY9 B4DVR1 Q6FIA0 Q9P018,BRISC and BRCA1-A complex member 1,Mediator of RAP80 interactions and targeting subunit of 40 kDa {ECO:0000303|PubMed:19261746};New component of the BRCA1-A complex {ECO:0000303|PubMed:19261749};, , GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051301;GO:0006325;GO:0006302;GO:0006303;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q9NWV8 A8MQT0 B4DRY9 B4DVR1 Q6FIA0 Q9P018,BRISC and BRCA1-A complex member 1,Mediator of RAP80 interactions and targeting subunit of 40 kDa {ECO:0000303|PubMed:19261746};New component of the BRCA1-A complex {ECO:0000303|PubMed:19261749};, , GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051301;GO:0006325;GO:0006302;GO:0006303;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint; scaffold829 indexed_genome mRNA 19099 33518 . + . ID=transcript_16974;Q8NAG6 A8VU82 Q8N8J8,Ankyrin repeat and LEM domain-containing protein 1,Ankyrin repeat domain-containing protein 41;LEM-domain containing protein 3;, PF12796;PF03020;, GO:0005737;GO:0005829;GO:0005654;GO:0004519;GO:0006281;GO:0090305;GO:2001022;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:endonuclease activity;, P:DNA repair; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of response to DNA damage stimulus; P:protein export from nucleus;|Q96I13 Q9HAE9,Protein ABHD8 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 8 {ECO:0000305};, PF00561;, GO:0070062;GO:0005739;GO:0052689;GO:0042171;GO:0055088;GO:0006654;, C:extracellular exosome; C:mitochondrion;, F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity;, P:lipid homeostasis; P:phosphatidic acid biosynthetic process;|Q96I13 Q9HAE9,Protein ABHD8 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 8 {ECO:0000305};, PF00561;, GO:0070062;GO:0005739;GO:0052689;GO:0042171;GO:0055088;GO:0006654;, C:extracellular exosome; C:mitochondrion;, F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity;, P:lipid homeostasis; P:phosphatidic acid biosynthetic process; scaffold829 indexed_genome mRNA 35151 36544 . + . ID=transcript_16975;Q9BQ48,39S ribosomal protein L34, mitochondrial,Mitochondrial large ribosomal subunit protein bL34m {ECO:0000303|PubMed:25278503};, PF00468;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold830 indexed_genome mRNA 385 9523 . - . ID=transcript_16976;Q8N6Y0 A8K7L6 B2RCR9 Q8NBX7 Q96KH3 Q9BYI8,Usher syndrome type-1C protein-binding protein 1,AIE-75-binding protein;MCC-2;Mutated in colon cancer protein 2;, PF10506;, GO:0030165;, , F:PDZ domain binding;|Q8N6Y0 A8K7L6 B2RCR9 Q8NBX7 Q96KH3 Q9BYI8,Usher syndrome type-1C protein-binding protein 1,AIE-75-binding protein;MCC-2;Mutated in colon cancer protein 2;, PF10506;, GO:0030165;, , F:PDZ domain binding;|Q8N6Y0 A8K7L6 B2RCR9 Q8NBX7 Q96KH3 Q9BYI8,Usher syndrome type-1C protein-binding protein 1,AIE-75-binding protein;MCC-2;Mutated in colon cancer protein 2;, PF10506;, GO:0030165;, , F:PDZ domain binding; scaffold830 indexed_genome mRNA 12623 18575 . + . ID=transcript_16977;Q9NWV8 A8MQT0 B4DRY9 B4DVR1 Q6FIA0 Q9P018,BRISC and BRCA1-A complex member 1,Mediator of RAP80 interactions and targeting subunit of 40 kDa {ECO:0000303|PubMed:19261746};New component of the BRCA1-A complex {ECO:0000303|PubMed:19261749};, , GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051301;GO:0006325;GO:0006302;GO:0006303;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q9NWV8 A8MQT0 B4DRY9 B4DVR1 Q6FIA0 Q9P018,BRISC and BRCA1-A complex member 1,Mediator of RAP80 interactions and targeting subunit of 40 kDa {ECO:0000303|PubMed:19261746};New component of the BRCA1-A complex {ECO:0000303|PubMed:19261749};, , GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051301;GO:0006325;GO:0006302;GO:0006303;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q9NWV8 A8MQT0 B4DRY9 B4DVR1 Q6FIA0 Q9P018,BRISC and BRCA1-A complex member 1,Mediator of RAP80 interactions and targeting subunit of 40 kDa {ECO:0000303|PubMed:19261746};New component of the BRCA1-A complex {ECO:0000303|PubMed:19261749};, , GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051301;GO:0006325;GO:0006302;GO:0006303;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q9NWV8 A8MQT0 B4DRY9 B4DVR1 Q6FIA0 Q9P018,BRISC and BRCA1-A complex member 1,Mediator of RAP80 interactions and targeting subunit of 40 kDa {ECO:0000303|PubMed:19261746};New component of the BRCA1-A complex {ECO:0000303|PubMed:19261749};, , GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051301;GO:0006325;GO:0006302;GO:0006303;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint;|Q9NWV8 A8MQT0 B4DRY9 B4DVR1 Q6FIA0 Q9P018,BRISC and BRCA1-A complex member 1,Mediator of RAP80 interactions and targeting subunit of 40 kDa {ECO:0000303|PubMed:19261746};New component of the BRCA1-A complex {ECO:0000303|PubMed:19261749};, , GO:0070531;GO:0070552;GO:0005737;GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0007049;GO:0051301;GO:0006325;GO:0006302;GO:0006303;GO:0045739;GO:0016579;GO:0070536;GO:0010212;GO:0072425;, C:BRCA1-A complex; C:BRISC complex; C:cytoplasm; C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;, , P:cell cycle; P:cell division; P:chromatin organization; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:positive regulation of DNA repair; P:protein deubiquitination; P:protein K63-linked deubiquitination; P:response to ionizing radiation; P:signal transduction involved in G2 DNA damage checkpoint; scaffold830 indexed_genome mRNA 19101 33506 . + . ID=transcript_16978;Q8NAG6 A8VU82 Q8N8J8,Ankyrin repeat and LEM domain-containing protein 1,Ankyrin repeat domain-containing protein 41;LEM-domain containing protein 3;, PF12796;PF03020;, GO:0005737;GO:0005829;GO:0005654;GO:0004519;GO:0006281;GO:0090305;GO:2001022;GO:0006611;, C:cytoplasm; C:cytosol; C:nucleoplasm;, F:endonuclease activity;, P:DNA repair; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of response to DNA damage stimulus; P:protein export from nucleus;|Q96I13 Q9HAE9,Protein ABHD8 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 8 {ECO:0000305};, PF00561;, GO:0070062;GO:0005739;GO:0052689;GO:0042171;GO:0055088;GO:0006654;, C:extracellular exosome; C:mitochondrion;, F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity;, P:lipid homeostasis; P:phosphatidic acid biosynthetic process;|Q96I13 Q9HAE9,Protein ABHD8 {ECO:0000305},Alpha/beta hydrolase domain-containing protein 8 {ECO:0000305};, PF00561;, GO:0070062;GO:0005739;GO:0052689;GO:0042171;GO:0055088;GO:0006654;, C:extracellular exosome; C:mitochondrion;, F:carboxylic ester hydrolase activity; F:lysophosphatidic acid acyltransferase activity;, P:lipid homeostasis; P:phosphatidic acid biosynthetic process; scaffold830 indexed_genome mRNA 35139 36531 . + . ID=transcript_16979;Q9BQ48,39S ribosomal protein L34, mitochondrial,Mitochondrial large ribosomal subunit protein bL34m {ECO:0000303|PubMed:25278503};, PF00468;, GO:0005743;GO:0005762;GO:0005761;GO:0005739;GO:0003735;GO:0070125;GO:0070126;GO:0006412;, C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit; C:mitochondrial ribosome; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial translational elongation; P:mitochondrial translational termination; P:translation; scaffold833 indexed_genome mRNA 26244 26753 . + . ID=transcript_16980;Q05BQ5 Q6ZVU7 Q9NXU1,MBT domain-containing protein 1,, PF02820;, GO:0005634;GO:0003682;GO:0042393;GO:0035064;GO:0008270;GO:0006325;GO:0048706;GO:0045892;, C:nucleus;, F:chromatin binding; F:histone binding; F:methylated histone binding; F:zinc ion binding;, P:chromatin organization; P:embryonic skeletal system development; P:negative regulation of transcription, DNA-templated; scaffold836 indexed_genome mRNA 5797 9884 . - . ID=transcript_16981;Q15077 Q15754,P2Y purinoceptor 6,, PF00001;, GO:0005887;GO:0005886;GO:0001621;GO:0004930;GO:0045029;GO:0045030;GO:0007202;GO:0071415;GO:1905835;GO:0007186;GO:0006909;GO:0007200;GO:0070374;GO:0031587;GO:0032962;GO:1904707;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled ADP receptor activity; F:G protein-coupled receptor activity; F:G protein-coupled UDP receptor activity; F:G protein-coupled UTP receptor activity;, P:activation of phospholipase C activity; P:cellular response to purine-containing compound; P:cellular response to pyrimidine ribonucleotide; P:G protein-coupled receptor signaling pathway; P:phagocytosis; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; P:positive regulation of inositol trisphosphate biosynthetic process; P:positive regulation of vascular associated smooth muscle cell proliferation; scaffold839 indexed_genome mRNA 9163 17305 . + . ID=transcript_16982;Q9BQI9 A2RRE3 B4DV61,Nuclear receptor-interacting protein 2,, PF09668;, GO:0005737;GO:0005634;GO:0004190;, C:cytoplasm; C:nucleus;, F:aspartic-type endopeptidase activity;|Q9BQI9 A2RRE3 B4DV61,Nuclear receptor-interacting protein 2,, PF09668;, GO:0005737;GO:0005634;GO:0004190;, C:cytoplasm; C:nucleus;, F:aspartic-type endopeptidase activity; scaffold839 indexed_genome mRNA 17551 28753 . - . ID=transcript_16983;Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling; scaffold839 indexed_genome mRNA 33356 34433 . - . ID=transcript_16984;Q02790 D3DUQ1 Q9UCP1 Q9UCV7,Peptidyl-prolyl cis-trans isomerase FKBP4,51 kDa FK506-binding protein;52 kDa FK506-binding protein;59 kDa immunophilin;FK506-binding protein 4;FKBP59;HSP-binding immunophilin;Immunophilin FKBP52;Rotamase;, PF00254;PF00515;PF07719;, GO:0044295;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005739;GO:0043025;GO:0005654;GO:0048471;GO:0032991;GO:0032767;GO:0005528;GO:0031072;GO:0003755;GO:0030674;GO:0003723;GO:0048156;GO:0061077;GO:0006825;GO:0031115;GO:0031111;GO:0010977;GO:0006457;GO:0000413;GO:1900034;, C:axonal growth cone; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:copper-dependent protein binding; F:FK506 binding; F:heat shock protein binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein-macromolecule adaptor activity; F:RNA binding; F:tau protein binding;, P:chaperone-mediated protein folding; P:copper ion transport; P:negative regulation of microtubule polymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of neuron projection development; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of cellular response to heat; scaffold839 indexed_genome mRNA 34524 35427 . + . ID=transcript_16985;Q02790 D3DUQ1 Q9UCP1 Q9UCV7,Peptidyl-prolyl cis-trans isomerase FKBP4,51 kDa FK506-binding protein;52 kDa FK506-binding protein;59 kDa immunophilin;FK506-binding protein 4;FKBP59;HSP-binding immunophilin;Immunophilin FKBP52;Rotamase;, PF00254;PF00515;PF07719;, GO:0044295;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005739;GO:0043025;GO:0005654;GO:0048471;GO:0032991;GO:0032767;GO:0005528;GO:0031072;GO:0003755;GO:0030674;GO:0003723;GO:0048156;GO:0061077;GO:0006825;GO:0031115;GO:0031111;GO:0010977;GO:0006457;GO:0000413;GO:1900034;, C:axonal growth cone; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:copper-dependent protein binding; F:FK506 binding; F:heat shock protein binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein-macromolecule adaptor activity; F:RNA binding; F:tau protein binding;, P:chaperone-mediated protein folding; P:copper ion transport; P:negative regulation of microtubule polymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of neuron projection development; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of cellular response to heat; scaffold840 indexed_genome mRNA 9156 17305 . - . ID=transcript_16986;Q9BQI9 A2RRE3 B4DV61,Nuclear receptor-interacting protein 2,, PF09668;, GO:0005737;GO:0005634;GO:0004190;, C:cytoplasm; C:nucleus;, F:aspartic-type endopeptidase activity;|Q9BQI9 A2RRE3 B4DV61,Nuclear receptor-interacting protein 2,, PF09668;, GO:0005737;GO:0005634;GO:0004190;, C:cytoplasm; C:nucleus;, F:aspartic-type endopeptidase activity; scaffold840 indexed_genome mRNA 17551 28753 . - . ID=transcript_16987;Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;|Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6,KICSTOR complex protein ITFG2 {ECO:0000305},Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};, PF15907;, GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;, C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;, , P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling; scaffold840 indexed_genome mRNA 33355 34432 . - . ID=transcript_16988;Q02790 D3DUQ1 Q9UCP1 Q9UCV7,Peptidyl-prolyl cis-trans isomerase FKBP4,51 kDa FK506-binding protein;52 kDa FK506-binding protein;59 kDa immunophilin;FK506-binding protein 4;FKBP59;HSP-binding immunophilin;Immunophilin FKBP52;Rotamase;, PF00254;PF00515;PF07719;, GO:0044295;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005739;GO:0043025;GO:0005654;GO:0048471;GO:0032991;GO:0032767;GO:0005528;GO:0031072;GO:0003755;GO:0030674;GO:0003723;GO:0048156;GO:0061077;GO:0006825;GO:0031115;GO:0031111;GO:0010977;GO:0006457;GO:0000413;GO:1900034;, C:axonal growth cone; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:copper-dependent protein binding; F:FK506 binding; F:heat shock protein binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein-macromolecule adaptor activity; F:RNA binding; F:tau protein binding;, P:chaperone-mediated protein folding; P:copper ion transport; P:negative regulation of microtubule polymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of neuron projection development; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of cellular response to heat; scaffold840 indexed_genome mRNA 34523 35426 . + . ID=transcript_16989;Q02790 D3DUQ1 Q9UCP1 Q9UCV7,Peptidyl-prolyl cis-trans isomerase FKBP4,51 kDa FK506-binding protein;52 kDa FK506-binding protein;59 kDa immunophilin;FK506-binding protein 4;FKBP59;HSP-binding immunophilin;Immunophilin FKBP52;Rotamase;, PF00254;PF00515;PF07719;, GO:0044295;GO:0005737;GO:0005829;GO:0070062;GO:0005874;GO:0005739;GO:0043025;GO:0005654;GO:0048471;GO:0032991;GO:0032767;GO:0005528;GO:0031072;GO:0003755;GO:0030674;GO:0003723;GO:0048156;GO:0061077;GO:0006825;GO:0031115;GO:0031111;GO:0010977;GO:0006457;GO:0000413;GO:1900034;, C:axonal growth cone; C:cytoplasm; C:cytosol; C:extracellular exosome; C:microtubule; C:mitochondrion; C:neuronal cell body; C:nucleoplasm; C:perinuclear region of cytoplasm; C:protein-containing complex;, F:copper-dependent protein binding; F:FK506 binding; F:heat shock protein binding; F:peptidyl-prolyl cis-trans isomerase activity; F:protein-macromolecule adaptor activity; F:RNA binding; F:tau protein binding;, P:chaperone-mediated protein folding; P:copper ion transport; P:negative regulation of microtubule polymerization; P:negative regulation of microtubule polymerization or depolymerization; P:negative regulation of neuron projection development; P:protein folding; P:protein peptidyl-prolyl isomerization; P:regulation of cellular response to heat; scaffold843 indexed_genome mRNA 1 1982 . + . ID=transcript_16990;Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II; scaffold843 indexed_genome mRNA 26052 31397 . + . ID=transcript_16991;Q6UWJ1 Q5JSB1 Q6NUN1 Q8NG29 Q8TCI6 Q96EA6 Q9NWT2,Transmembrane and coiled-coil domain-containing protein 3,Putative LAG1-interacting protein;, PF00999;, GO:0016021;GO:0015299;, C:integral component of membrane;, F:solute:proton antiporter activity;|Q6UWJ1 Q5JSB1 Q6NUN1 Q8NG29 Q8TCI6 Q96EA6 Q9NWT2,Transmembrane and coiled-coil domain-containing protein 3,Putative LAG1-interacting protein;, PF00999;, GO:0016021;GO:0015299;, C:integral component of membrane;, F:solute:proton antiporter activity;|Q6UWJ1 Q5JSB1 Q6NUN1 Q8NG29 Q8TCI6 Q96EA6 Q9NWT2,Transmembrane and coiled-coil domain-containing protein 3,Putative LAG1-interacting protein;, PF00999;, GO:0016021;GO:0015299;, C:integral component of membrane;, F:solute:proton antiporter activity;|Q6UWJ1 Q5JSB1 Q6NUN1 Q8NG29 Q8TCI6 Q96EA6 Q9NWT2,Transmembrane and coiled-coil domain-containing protein 3,Putative LAG1-interacting protein;, PF00999;, GO:0016021;GO:0015299;, C:integral component of membrane;, F:solute:proton antiporter activity; scaffold846 indexed_genome mRNA 1 7053 . + . ID=transcript_16992;Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II;|Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II; scaffold846 indexed_genome mRNA 26008 31353 . + . ID=transcript_16993;Q6UWJ1 Q5JSB1 Q6NUN1 Q8NG29 Q8TCI6 Q96EA6 Q9NWT2,Transmembrane and coiled-coil domain-containing protein 3,Putative LAG1-interacting protein;, PF00999;, GO:0016021;GO:0015299;, C:integral component of membrane;, F:solute:proton antiporter activity;|Q6UWJ1 Q5JSB1 Q6NUN1 Q8NG29 Q8TCI6 Q96EA6 Q9NWT2,Transmembrane and coiled-coil domain-containing protein 3,Putative LAG1-interacting protein;, PF00999;, GO:0016021;GO:0015299;, C:integral component of membrane;, F:solute:proton antiporter activity;|Q6UWJ1 Q5JSB1 Q6NUN1 Q8NG29 Q8TCI6 Q96EA6 Q9NWT2,Transmembrane and coiled-coil domain-containing protein 3,Putative LAG1-interacting protein;, PF00999;, GO:0016021;GO:0015299;, C:integral component of membrane;, F:solute:proton antiporter activity;|Q6UWJ1 Q5JSB1 Q6NUN1 Q8NG29 Q8TCI6 Q96EA6 Q9NWT2,Transmembrane and coiled-coil domain-containing protein 3,Putative LAG1-interacting protein;, PF00999;, GO:0016021;GO:0015299;, C:integral component of membrane;, F:solute:proton antiporter activity; scaffold848 indexed_genome mRNA 23488 24052 . + . ID=transcript_16994;P63010 A6NJP3 P21851 Q7Z451 Q96J19,AP-2 complex subunit beta,AP105B;Adaptor protein complex AP-2 subunit beta;Adaptor-related protein complex 2 subunit beta;Beta-2-adaptin;Beta-adaptin;Clathrin assembly protein complex 2 beta large chain;Plasma membrane adaptor HA2/AP2 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030122;GO:0030131;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0098978;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0030276;GO:0044877;GO:0005048;GO:0019886;GO:0035904;GO:0048268;GO:0072583;GO:0060976;GO:0048013;GO:0006886;GO:0001822;GO:0034383;GO:0032802;GO:0061024;GO:1901215;GO:0045807;GO:1905477;GO:0098884;GO:0050690;GO:0048488;GO:0003281;GO:0016192;GO:0060071;, C:AP-2 adaptor complex; C:clathrin adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse;, F:clathrin binding; F:protein-containing complex binding; F:signal sequence binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:aorta development; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:coronary vasculature development; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:kidney development; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of neuron death; P:positive regulation of endocytosis; P:positive regulation of protein localization to membrane; P:postsynaptic neurotransmitter receptor internalization; P:regulation of defense response to virus by virus; P:synaptic vesicle endocytosis; P:ventricular septum development; P:vesicle-mediated transport; P:Wnt signaling pathway, planar cell polarity pathway; scaffold848 indexed_genome mRNA 26609 31158 . - . ID=transcript_16995;P63010 A6NJP3 P21851 Q7Z451 Q96J19,AP-2 complex subunit beta,AP105B;Adaptor protein complex AP-2 subunit beta;Adaptor-related protein complex 2 subunit beta;Beta-2-adaptin;Beta-adaptin;Clathrin assembly protein complex 2 beta large chain;Plasma membrane adaptor HA2/AP2 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030122;GO:0030131;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0098978;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0030276;GO:0044877;GO:0005048;GO:0019886;GO:0035904;GO:0048268;GO:0072583;GO:0060976;GO:0048013;GO:0006886;GO:0001822;GO:0034383;GO:0032802;GO:0061024;GO:1901215;GO:0045807;GO:1905477;GO:0098884;GO:0050690;GO:0048488;GO:0003281;GO:0016192;GO:0060071;, C:AP-2 adaptor complex; C:clathrin adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse;, F:clathrin binding; F:protein-containing complex binding; F:signal sequence binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:aorta development; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:coronary vasculature development; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:kidney development; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of neuron death; P:positive regulation of endocytosis; P:positive regulation of protein localization to membrane; P:postsynaptic neurotransmitter receptor internalization; P:regulation of defense response to virus by virus; P:synaptic vesicle endocytosis; P:ventricular septum development; P:vesicle-mediated transport; P:Wnt signaling pathway, planar cell polarity pathway; scaffold850 indexed_genome mRNA 23502 24066 . - . ID=transcript_16996;P63010 A6NJP3 P21851 Q7Z451 Q96J19,AP-2 complex subunit beta,AP105B;Adaptor protein complex AP-2 subunit beta;Adaptor-related protein complex 2 subunit beta;Beta-2-adaptin;Beta-adaptin;Clathrin assembly protein complex 2 beta large chain;Plasma membrane adaptor HA2/AP2 adaptin beta subunit;, PF01602;PF02883;PF09066;, GO:0030122;GO:0030131;GO:0045334;GO:0030669;GO:0005829;GO:0030666;GO:0036020;GO:0098978;GO:0016020;GO:0005886;GO:0098794;GO:0098793;GO:0030276;GO:0044877;GO:0005048;GO:0019886;GO:0035904;GO:0048268;GO:0072583;GO:0060976;GO:0048013;GO:0006886;GO:0001822;GO:0034383;GO:0032802;GO:0061024;GO:1901215;GO:0045807;GO:1905477;GO:0098884;GO:0050690;GO:0048488;GO:0003281;GO:0016192;GO:0060071;, C:AP-2 adaptor complex; C:clathrin adaptor complex; C:clathrin-coated endocytic vesicle; C:clathrin-coated endocytic vesicle membrane; C:cytosol; C:endocytic vesicle membrane; C:endolysosome membrane; C:glutamatergic synapse; C:membrane; C:plasma membrane; C:postsynapse; C:presynapse;, F:clathrin binding; F:protein-containing complex binding; F:signal sequence binding;, P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:aorta development; P:clathrin coat assembly; P:clathrin-dependent endocytosis; P:coronary vasculature development; P:ephrin receptor signaling pathway; P:intracellular protein transport; P:kidney development; P:low-density lipoprotein particle clearance; P:low-density lipoprotein particle receptor catabolic process; P:membrane organization; P:negative regulation of neuron death; P:positive regulation of endocytosis; P:positive regulation of protein localization to membrane; P:postsynaptic neurotransmitter receptor internalization; P:regulation of defense response to virus by virus; P:synaptic vesicle endocytosis; P:ventricular septum development; P:vesicle-mediated transport; P:Wnt signaling pathway, planar cell polarity pathway; scaffold871 indexed_genome mRNA 21158 23469 . + . ID=transcript_16997;Q9Y519 A8K9D7 Q63HM8 Q7Z421 Q8NBM5 Q9UGT8 Q9UGT9 Q9UGV5,Transmembrane protein 184B,Putative MAPK-activating protein FM08;, PF03619;, GO:0016021;, C:integral component of membrane; scaffold871 indexed_genome mRNA 28086 33725 . - . ID=transcript_16998;Q9Y519 A8K9D7 Q63HM8 Q7Z421 Q8NBM5 Q9UGT8 Q9UGT9 Q9UGV5,Transmembrane protein 184B,Putative MAPK-activating protein FM08;, PF03619;, GO:0016021;, C:integral component of membrane;|Q9Y519 A8K9D7 Q63HM8 Q7Z421 Q8NBM5 Q9UGT8 Q9UGT9 Q9UGV5,Transmembrane protein 184B,Putative MAPK-activating protein FM08;, PF03619;, GO:0016021;, C:integral component of membrane; scaffold873 indexed_genome mRNA 9342 33718 . + . ID=transcript_16999;Q9Y519 A8K9D7 Q63HM8 Q7Z421 Q8NBM5 Q9UGT8 Q9UGT9 Q9UGV5,Transmembrane protein 184B,Putative MAPK-activating protein FM08;, PF03619;, GO:0016021;, C:integral component of membrane;|Q9Y519 A8K9D7 Q63HM8 Q7Z421 Q8NBM5 Q9UGT8 Q9UGT9 Q9UGV5,Transmembrane protein 184B,Putative MAPK-activating protein FM08;, PF03619;, GO:0016021;, C:integral component of membrane;|Q9Y519 A8K9D7 Q63HM8 Q7Z421 Q8NBM5 Q9UGT8 Q9UGT9 Q9UGV5,Transmembrane protein 184B,Putative MAPK-activating protein FM08;, PF03619;, GO:0016021;, C:integral component of membrane;|Q9Y519 A8K9D7 Q63HM8 Q7Z421 Q8NBM5 Q9UGT8 Q9UGT9 Q9UGV5,Transmembrane protein 184B,Putative MAPK-activating protein FM08;, PF03619;, GO:0016021;, C:integral component of membrane; scaffold892 indexed_genome mRNA 23270 25927 . + . ID=transcript_17000;Q13765 A8MTN7 B2R4P8 F8VU71 Q3KQV4 Q53A18 Q53G46,Nascent polypeptide-associated complex subunit alpha,Alpha-NAC;, PF19026;PF01849;, GO:0005737;GO:0070062;GO:0005854;GO:0005634;GO:0003677;GO:0003713;GO:0003231;GO:0061384;GO:0010664;GO:1901227;GO:2000138;GO:0048633;GO:1901228;GO:0015031;GO:0048742;GO:0043403;GO:0006412;GO:0042060;, C:cytoplasm; C:extracellular exosome; C:nascent polypeptide-associated complex; C:nucleus;, F:DNA binding; F:transcription coactivator activity;, P:cardiac ventricle development; P:heart trabecula morphogenesis; P:negative regulation of striated muscle cell apoptotic process; P:negative regulation of transcription from RNA polymerase II promoter involved in heart development; P:positive regulation of cell proliferation involved in heart morphogenesis; P:positive regulation of skeletal muscle tissue growth; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; P:protein transport; P:regulation of skeletal muscle fiber development; P:skeletal muscle tissue regeneration; P:translation; P:wound healing; scaffold894 indexed_genome mRNA 7002 10866 . + . ID=transcript_17001;Q6DJT9 B4DLC2 Q59GH8 Q9Y4L2,Zinc finger protein PLAG1,Pleiomorphic adenoma gene 1 protein;, PF00096;, GO:0005813;GO:0005829;GO:0016607;GO:0005654;GO:0001228;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:0022612;GO:0035264;GO:0010629;GO:0060252;GO:0045944;GO:0060736;GO:0006355;GO:0006351;, C:centrosome; C:cytosol; C:nuclear speck; C:nucleoplasm;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:gland morphogenesis; P:multicellular organism growth; P:negative regulation of gene expression; P:positive regulation of glial cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:prostate gland growth; P:regulation of transcription, DNA-templated; P:transcription, DNA-templated; scaffold896 indexed_genome mRNA 5990 6499 . - . ID=transcript_17002;Q53H12 Q75KN1 Q96GC3 Q9NP48,Acylglycerol kinase, mitochondrial {ECO:0000303|PubMed:15939762},Multiple substrate lipid kinase {ECO:0000303|PubMed:16269826};, PF00781;, GO:0005737;GO:0005829;GO:0031305;GO:0043231;GO:0016020;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0042721;GO:0047620;GO:0005524;GO:0001729;GO:0017050;GO:0004143;GO:0102773;GO:0001727;GO:0003951;GO:0046513;GO:0046474;GO:0016310;GO:0045039;GO:0006665;GO:0046512;, C:cytoplasm; C:cytosol; C:integral component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:TIM22 mitochondrial import inner membrane insertion complex;, F:acylglycerol kinase activity; F:ATP binding; F:ceramide kinase activity; F:D-erythro-sphingosine kinase activity; F:diacylglycerol kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:NAD+ kinase activity;, P:ceramide biosynthetic process; P:glycerophospholipid biosynthetic process; P:phosphorylation; P:protein insertion into mitochondrial inner membrane; P:sphingolipid metabolic process; P:sphingosine biosynthetic process; scaffold896 indexed_genome mRNA 6565 7320 . + . ID=transcript_17003;Q53H12 Q75KN1 Q96GC3 Q9NP48,Acylglycerol kinase, mitochondrial {ECO:0000303|PubMed:15939762},Multiple substrate lipid kinase {ECO:0000303|PubMed:16269826};, PF00781;, GO:0005737;GO:0005829;GO:0031305;GO:0043231;GO:0016020;GO:0005743;GO:0005758;GO:0031966;GO:0005741;GO:0005739;GO:0042721;GO:0047620;GO:0005524;GO:0001729;GO:0017050;GO:0004143;GO:0102773;GO:0001727;GO:0003951;GO:0046513;GO:0046474;GO:0016310;GO:0045039;GO:0006665;GO:0046512;, C:cytoplasm; C:cytosol; C:integral component of mitochondrial inner membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrial inner membrane; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:TIM22 mitochondrial import inner membrane insertion complex;, F:acylglycerol kinase activity; F:ATP binding; F:ceramide kinase activity; F:D-erythro-sphingosine kinase activity; F:diacylglycerol kinase activity; F:dihydroceramide kinase activity; F:lipid kinase activity; F:NAD+ kinase activity;, P:ceramide biosynthetic process; P:glycerophospholipid biosynthetic process; P:phosphorylation; P:protein insertion into mitochondrial inner membrane; P:sphingolipid metabolic process; P:sphingosine biosynthetic process; scaffold901 indexed_genome mRNA 4225 17343 . + . ID=transcript_17004;P13866 B2R7E2 B7Z4Q9 B7ZA69,Sodium/glucose cotransporter 1,High affinity sodium-glucose cotransporter;Solute carrier family 5 member 1;, PF00474;, GO:0016324;GO:0031526;GO:0005911;GO:0005769;GO:0070062;GO:0016021;GO:0005887;GO:0043229;GO:0097708;GO:0048471;GO:0005886;GO:0015151;GO:0055056;GO:0015150;GO:0005354;GO:0005355;GO:0005412;GO:0005367;GO:0015146;GO:0005372;GO:0000017;GO:0015756;GO:0015757;GO:0098708;GO:1904659;GO:0106001;GO:0015798;GO:0015750;GO:0010035;GO:0098719;GO:0006814;GO:0035377;GO:0150104;, C:apical plasma membrane; C:brush border membrane; C:cell-cell junction; C:early endosome; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular organelle; C:intracellular vesicle; C:perinuclear region of cytoplasm; C:plasma membrane;, F:alpha-glucoside transmembrane transporter activity; F:D-glucose transmembrane transporter activity; F:fucose transmembrane transporter activity; F:galactose transmembrane transporter activity; F:glucose transmembrane transporter activity; F:glucose:sodium symporter activity; F:myo-inositol:sodium symporter activity; F:pentose transmembrane transporter activity; F:water transmembrane transporter activity;, P:alpha-glucoside transport; P:fucose transmembrane transport; P:galactose transmembrane transport; P:glucose import across plasma membrane; P:glucose transmembrane transport; P:intestinal hexose absorption; P:myo-inositol transport; P:pentose transmembrane transport; P:response to inorganic substance; P:sodium ion import across plasma membrane; P:sodium ion transport; P:transepithelial water transport; P:transport across blood-brain barrier; scaffold901 indexed_genome mRNA 28337 33647 . - . ID=transcript_17005;Q9UHP6,Radial spoke head 14 homolog,Rhabdoid tumor deletion region protein 1;, PF00514; scaffold902 indexed_genome mRNA 4223 17337 . + . ID=transcript_17006;P13866 B2R7E2 B7Z4Q9 B7ZA69,Sodium/glucose cotransporter 1,High affinity sodium-glucose cotransporter;Solute carrier family 5 member 1;, PF00474;, GO:0016324;GO:0031526;GO:0005911;GO:0005769;GO:0070062;GO:0016021;GO:0005887;GO:0043229;GO:0097708;GO:0048471;GO:0005886;GO:0015151;GO:0055056;GO:0015150;GO:0005354;GO:0005355;GO:0005412;GO:0005367;GO:0015146;GO:0005372;GO:0000017;GO:0015756;GO:0015757;GO:0098708;GO:1904659;GO:0106001;GO:0015798;GO:0015750;GO:0010035;GO:0098719;GO:0006814;GO:0035377;GO:0150104;, C:apical plasma membrane; C:brush border membrane; C:cell-cell junction; C:early endosome; C:extracellular exosome; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular organelle; C:intracellular vesicle; C:perinuclear region of cytoplasm; C:plasma membrane;, F:alpha-glucoside transmembrane transporter activity; F:D-glucose transmembrane transporter activity; F:fucose transmembrane transporter activity; F:galactose transmembrane transporter activity; F:glucose transmembrane transporter activity; F:glucose:sodium symporter activity; F:myo-inositol:sodium symporter activity; F:pentose transmembrane transporter activity; F:water transmembrane transporter activity;, P:alpha-glucoside transport; P:fucose transmembrane transport; P:galactose transmembrane transport; P:glucose import across plasma membrane; P:glucose transmembrane transport; P:intestinal hexose absorption; P:myo-inositol transport; P:pentose transmembrane transport; P:response to inorganic substance; P:sodium ion import across plasma membrane; P:sodium ion transport; P:transepithelial water transport; P:transport across blood-brain barrier; scaffold907 indexed_genome mRNA 514 1452 . - . ID=transcript_17007;O43426 O43425 O94984 Q4KMR1,Synaptojanin-1,Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;, PF08952;PF03372;PF02383;, GO:0030132;GO:0005829;GO:0030117;GO:0048471;GO:0098793;GO:0097060;GO:0043195;GO:0012506;GO:0034595;GO:0004438;GO:0004439;GO:0043812;GO:0003723;GO:0017124;GO:0007420;GO:0046855;GO:0043647;GO:0007612;GO:0061024;GO:0006836;GO:0006661;GO:0046856;GO:0046488;GO:1904980;GO:0048488;GO:0016082;GO:0048489;GO:0016191;, C:clathrin coat of coated pit; C:cytosol; C:membrane coat; C:perinuclear region of cytoplasm; C:presynapse; C:synaptic membrane; C:terminal bouton; C:vesicle membrane;, F:phosphatidylinositol phosphate 5-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4-phosphate phosphatase activity; F:RNA binding; F:SH3 domain binding;, P:brain development; P:inositol phosphate dephosphorylation; P:inositol phosphate metabolic process; P:learning; P:membrane organization; P:neurotransmitter transport; P:phosphatidylinositol biosynthetic process; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process; P:positive regulation of endosome organization; P:synaptic vesicle endocytosis; P:synaptic vesicle priming; P:synaptic vesicle transport; P:synaptic vesicle uncoating; scaffold908 indexed_genome mRNA 27143 28645 . + . ID=transcript_17008;O60667 A8K7J2 B7Z6Z0 D9MWM3,Fas apoptotic inhibitory molecule 3 {ECO:0000305},IgM Fc fragment receptor {ECO:0000312|HGNC:HGNC:14315};Regulator of Fas-induced apoptosis Toso {ECO:0000303|PubMed:9586636};, PF07686;, GO:0005576;GO:0016021;GO:0005886;GO:0004888;GO:0006968;GO:0002376;GO:0043066;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:transmembrane signaling receptor activity;, P:cellular defense response; P:immune system process; P:negative regulation of apoptotic process; scaffold909 indexed_genome mRNA 27137 28638 . - . ID=transcript_17009;O60667 A8K7J2 B7Z6Z0 D9MWM3,Fas apoptotic inhibitory molecule 3 {ECO:0000305},IgM Fc fragment receptor {ECO:0000312|HGNC:HGNC:14315};Regulator of Fas-induced apoptosis Toso {ECO:0000303|PubMed:9586636};, PF07686;, GO:0005576;GO:0016021;GO:0005886;GO:0004888;GO:0006968;GO:0002376;GO:0043066;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:transmembrane signaling receptor activity;, P:cellular defense response; P:immune system process; P:negative regulation of apoptotic process; scaffold929 indexed_genome mRNA 26108 26849 . - . ID=transcript_17010;Q86XZ4 A8K8G9 Q9H7D4 Q9H8Y7 Q9H8Z8,Spermatogenesis-associated serine-rich protein 2,Serine-rich spermatocytes and round spermatid 59 kDa protein;p59scr;, PF07139;, GO:0005737;GO:0005829;GO:0003723;, C:cytoplasm; C:cytosol;, F:RNA binding; scaffold929 indexed_genome mRNA 27423 28318 . - . ID=transcript_17011;Q86XZ4 A8K8G9 Q9H7D4 Q9H8Y7 Q9H8Z8,Spermatogenesis-associated serine-rich protein 2,Serine-rich spermatocytes and round spermatid 59 kDa protein;p59scr;, PF07139;, GO:0005737;GO:0005829;GO:0003723;, C:cytoplasm; C:cytosol;, F:RNA binding; scaffold930 indexed_genome mRNA 26104 26845 . - . ID=transcript_17012;Q86XZ4 A8K8G9 Q9H7D4 Q9H8Y7 Q9H8Z8,Spermatogenesis-associated serine-rich protein 2,Serine-rich spermatocytes and round spermatid 59 kDa protein;p59scr;, PF07139;, GO:0005737;GO:0005829;GO:0003723;, C:cytoplasm; C:cytosol;, F:RNA binding; scaffold930 indexed_genome mRNA 27419 28314 . - . ID=transcript_17013;Q86XZ4 A8K8G9 Q9H7D4 Q9H8Y7 Q9H8Z8,Spermatogenesis-associated serine-rich protein 2,Serine-rich spermatocytes and round spermatid 59 kDa protein;p59scr;, PF07139;, GO:0005737;GO:0005829;GO:0003723;, C:cytoplasm; C:cytosol;, F:RNA binding; scaffold932 indexed_genome mRNA 25389 27366 . + . ID=transcript_17014;Q9BYT8 Q9ULJ4,Neurolysin, mitochondrial,Angiotensin-binding protein;Microsomal endopeptidase;Mitochondrial oligopeptidase M;Neurotensin endopeptidase;, PF01432;, GO:0005576;GO:0005758;GO:0005886;GO:0046872;GO:0004222;GO:0042277;GO:0007186;GO:0006518;GO:0006508;GO:0006111;GO:1902809;, C:extracellular region; C:mitochondrial intermembrane space; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:peptide binding;, P:G protein-coupled receptor signaling pathway; P:peptide metabolic process; P:proteolysis; P:regulation of gluconeogenesis; P:regulation of skeletal muscle fiber differentiation; scaffold934 indexed_genome mRNA 25385 27362 . - . ID=transcript_17015;Q9BYT8 Q9ULJ4,Neurolysin, mitochondrial,Angiotensin-binding protein;Microsomal endopeptidase;Mitochondrial oligopeptidase M;Neurotensin endopeptidase;, PF01432;, GO:0005576;GO:0005758;GO:0005886;GO:0046872;GO:0004222;GO:0042277;GO:0007186;GO:0006518;GO:0006508;GO:0006111;GO:1902809;, C:extracellular region; C:mitochondrial intermembrane space; C:plasma membrane;, F:metal ion binding; F:metalloendopeptidase activity; F:peptide binding;, P:G protein-coupled receptor signaling pathway; P:peptide metabolic process; P:proteolysis; P:regulation of gluconeogenesis; P:regulation of skeletal muscle fiber differentiation; scaffold956 indexed_genome mRNA 6 1317 . - . ID=transcript_17016;Q8IX21 A8K950 B1AL17 Q5W0L8 Q6GMU6 Q9NPE8,SMC5-SMC6 complex localization factor protein 2 {ECO:0000312|HGNC:HGNC:17814},Smc5/6 localization factor 1 {ECO:0000303|PubMed:25931565};, PF14816;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0035861;GO:0044877;GO:0031625;GO:0006974;GO:0006281;GO:2000781;GO:0034184;GO:0031334;GO:1990166;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus; C:site of double-strand break;, F:protein-containing complex binding; F:ubiquitin protein ligase binding;, P:cellular response to DNA damage stimulus; P:DNA repair; P:positive regulation of double-strand break repair; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:positive regulation of protein-containing complex assembly; P:protein localization to site of double-strand break; scaffold957 indexed_genome mRNA 262 1465 . + . ID=transcript_17017;Q6ZRF8 A2VCM8 B4DFR6 Q5TGS6 Q6ZS63 Q96MP2,RING finger protein 207,, PF00643;PF00097;, GO:0048471;GO:0051087;GO:0030544;GO:0044325;GO:0008270;GO:0086019;GO:1902261;GO:0010628;GO:1903954;GO:1903762;GO:0055117;GO:1901207;, C:perinuclear region of cytoplasm;, F:chaperone binding; F:Hsp70 protein binding; F:ion channel binding; F:zinc ion binding;, P:cell-cell signaling involved in cardiac conduction; P:positive regulation of delayed rectifier potassium channel activity; P:positive regulation of gene expression; P:positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; P:positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; P:regulation of cardiac muscle contraction; P:regulation of heart looping; scaffold983 indexed_genome mRNA 4265 14422 . + . ID=transcript_17018;Q8IUD6 A0AVM5 B2R7G9 B6ZLM5 F5GX60 Q9BSE9,E3 ubiquitin-protein ligase RNF135 {ECO:0000305},RIG-I E3 ubiquitin ligase {ECO:0000303|PubMed:19484123};RING finger protein 135;RING finger protein leading to RIG-I activation {ECO:0000303|PubMed:19017631};RING-type E3 ubiquitin transferase RNF135 {ECO:0000305};, PF00622;, GO:0005737;GO:0010494;GO:0005829;GO:1990904;GO:0042802;GO:0046872;GO:0043021;GO:0039552;GO:0061630;GO:0004842;GO:0140374;GO:0010994;GO:0045087;GO:0032480;GO:0032728;GO:0051260;GO:0070534;GO:0000209;GO:0016567;GO:0045088;GO:0039529;, C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:ribonucleoprotein complex;, F:identical protein binding; F:metal ion binding; F:ribonucleoprotein complex binding; F:RIG-I binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:antiviral innate immune response; P:free ubiquitin chain polymerization; P:innate immune response; P:negative regulation of type I interferon production; P:positive regulation of interferon-beta production; P:protein homooligomerization; P:protein K63-linked ubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of innate immune response; P:RIG-I signaling pathway; scaffold995 indexed_genome mRNA 17727 31277 . - . ID=transcript_17019;P30291 B3KVE1 D3DQV0,Wee1-like protein kinase,Wee1A kinase;, PF00069;, GO:0005737;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0000287;GO:0004715;GO:0004672;GO:0004713;GO:0004714;GO:0051301;GO:0030010;GO:0000086;GO:0000226;GO:2000134;GO:0048812;, C:cytoplasm; C:nucleolus; C:nucleoplasm; C:nucleus;, F:ATP binding; F:magnesium ion binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity;, P:cell division; P:establishment of cell polarity; P:G2/M transition of mitotic cell cycle; P:microtubule cytoskeleton organization; P:negative regulation of G1/S transition of mitotic cell cycle; P:neuron projection morphogenesis; scaffold997 indexed_genome mRNA 3207 3851 . - . ID=transcript_17020;Q9NZM3 O95062 Q15812 Q9HAK4 Q9NXE6 Q9NYG0 Q9NZM2 Q9ULG4,Intersectin-2,SH3 domain-containing protein 1B;SH3P18;SH3P18-like WASP-associated protein;, PF00168;PF12763;PF16652;PF00621;PF00018;PF07653;PF14604;, GO:0005813;GO:0005905;GO:0005737;GO:0070062;GO:0098793;GO:0005509;GO:0005085;GO:0060090;GO:0030154;GO:0150007;GO:0006897;GO:0016197;GO:1903861;GO:0016032;, C:centrosome; C:clathrin-coated pit; C:cytoplasm; C:extracellular exosome; C:presynapse;, F:calcium ion binding; F:guanyl-nucleotide exchange factor activity; F:molecular adaptor activity;, P:cell differentiation; P:clathrin-dependent synaptic vesicle endocytosis; P:endocytosis; P:endosomal transport; P:positive regulation of dendrite extension; P:viral process; scaffold999 indexed_genome mRNA 23737 25930 . - . ID=transcript_17021;Q9Y5G6 B2RN87 Q9Y5D0,Protocadherin gamma-A7,, PF00028;PF08266;PF16492;PF15974;, GO:0005887;GO:0005509;GO:0007155;GO:0007156;, C:integral component of plasma membrane;, F:calcium ion binding;, P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; scaffold1006 indexed_genome mRNA 16810 30574 . + . ID=transcript_17022;P14784 B2R765,Interleukin-2 receptor subunit beta,High affinity IL-2 receptor subunit beta;Interleukin-15 receptor subunit beta {ECO:0000312|HGNC:HGNC:6009};p70-75;, PF18707;, GO:0009986;GO:0005829;GO:0005768;GO:0009897;GO:0005887;GO:0005893;GO:0016020;GO:0005886;GO:0042010;GO:0019976;GO:0004911;GO:0019221;GO:0035723;GO:0038110;GO:0000165;GO:0043066;GO:0050766;GO:0065003;GO:0007165;GO:0016032;, C:cell surface; C:cytosol; C:endosome; C:external side of plasma membrane; C:integral component of plasma membrane; C:interleukin-2 receptor complex; C:membrane; C:plasma membrane;, F:interleukin-15 receptor activity; F:interleukin-2 binding; F:interleukin-2 receptor activity;, P:cytokine-mediated signaling pathway; P:interleukin-15-mediated signaling pathway; P:interleukin-2-mediated signaling pathway; P:MAPK cascade; P:negative regulation of apoptotic process; P:positive regulation of phagocytosis; P:protein-containing complex assembly; P:signal transduction; P:viral process; scaffold1010 indexed_genome mRNA 8346 26958 . + . ID=transcript_17023;Q9NR09 Q9ULD1,Baculoviral IAP repeat-containing protein 6,BIR repeat-containing ubiquitin-conjugating enzyme;RING-type E3 ubiquitin transferase BIRC6 {ECO:0000305};Ubiquitin-conjugating BIR domain enzyme apollon;, PF00653;PF12356;PF00179;, GO:0005768;GO:0090543;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005802;GO:0004869;GO:0061631;GO:0004842;GO:0006915;GO:0007049;GO:0051301;GO:0060711;GO:0043066;GO:2001237;GO:0008284;GO:0006468;GO:0016567;GO:0042127;GO:0032465;GO:0060712;GO:0006511;, C:endosome; C:Flemming body; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole; C:trans-Golgi network;, F:cysteine-type endopeptidase inhibitor activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cell cycle; P:cell division; P:labyrinthine layer development; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:protein ubiquitination; P:regulation of cell population proliferation; P:regulation of cytokinesis; P:spongiotrophoblast layer development; P:ubiquitin-dependent protein catabolic process;|Q9NR09 Q9ULD1,Baculoviral IAP repeat-containing protein 6,BIR repeat-containing ubiquitin-conjugating enzyme;RING-type E3 ubiquitin transferase BIRC6 {ECO:0000305};Ubiquitin-conjugating BIR domain enzyme apollon;, PF00653;PF12356;PF00179;, GO:0005768;GO:0090543;GO:0016020;GO:0005815;GO:0030496;GO:0005634;GO:0000922;GO:0005802;GO:0004869;GO:0061631;GO:0004842;GO:0006915;GO:0007049;GO:0051301;GO:0060711;GO:0043066;GO:2001237;GO:0008284;GO:0006468;GO:0016567;GO:0042127;GO:0032465;GO:0060712;GO:0006511;, C:endosome; C:Flemming body; C:membrane; C:microtubule organizing center; C:midbody; C:nucleus; C:spindle pole; C:trans-Golgi network;, F:cysteine-type endopeptidase inhibitor activity; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;, P:apoptotic process; P:cell cycle; P:cell division; P:labyrinthine layer development; P:negative regulation of apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway; P:positive regulation of cell population proliferation; P:protein phosphorylation; P:protein ubiquitination; P:regulation of cell population proliferation; P:regulation of cytokinesis; P:spongiotrophoblast layer development; P:ubiquitin-dependent protein catabolic process; scaffold1022 indexed_genome mRNA 4789 5421 . + . ID=transcript_17024;Q9Y399 Q5T899 Q9BSQ4,28S ribosomal protein S2, mitochondrial,Mitochondrial small ribosomal subunit protein uS2m {ECO:0000303|PubMed:25838379};, PF00318;, GO:0005743;GO:0005763;GO:0005739;GO:0003735;GO:0061668;GO:0032543;GO:0070125;GO:0070126;, C:mitochondrial inner membrane; C:mitochondrial small ribosomal subunit; C:mitochondrion;, F:structural constituent of ribosome;, P:mitochondrial ribosome assembly; P:mitochondrial translation; P:mitochondrial translational elongation; P:mitochondrial translational termination; scaffold1023 indexed_genome mRNA 16299 20314 . + . ID=transcript_17025;Q15038 A8K254 B4DDT5 B4E1G3 C9JA96 C9JP84 E9PB45 F8VU62,DAZ-associated protein 2,Deleted in azoospermia-associated protein 2;, PF11029;, GO:0005737;GO:0016607;GO:0032991;GO:0042802;GO:0031435;GO:0043539;GO:0030971;GO:0050699;, C:cytoplasm; C:nuclear speck; C:protein-containing complex;, F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine/threonine kinase activator activity; F:receptor tyrosine kinase binding; F:WW domain binding; scaffold1023 indexed_genome mRNA 20531 22781 . - . ID=transcript_17026;Q0VAQ4 A6NIL5,Small cell adhesion glycoprotein,Small transmembrane and glycosylated protein;, , GO:0030054;GO:0030659;GO:0016021;GO:0005654;GO:0005886;, C:cell junction; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;|Q0VAQ4 A6NIL5,Small cell adhesion glycoprotein,Small transmembrane and glycosylated protein;, , GO:0030054;GO:0030659;GO:0016021;GO:0005654;GO:0005886;, C:cell junction; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:nucleoplasm; C:plasma membrane; scaffold1024 indexed_genome mRNA 6770 7524 . + . ID=transcript_17027;Q86Z20 Q86Z19,Coiled-coil domain-containing protein 125,Protein kenae;, , GO:0005737;GO:0042802;GO:0090630;GO:2000146;GO:0035024;, C:cytoplasm;, F:identical protein binding;, P:activation of GTPase activity; P:negative regulation of cell motility; P:negative regulation of Rho protein signal transduction; scaffold1024 indexed_genome mRNA 10411 11143 . + . ID=transcript_17028;Q86Z20 Q86Z19,Coiled-coil domain-containing protein 125,Protein kenae;, , GO:0005737;GO:0042802;GO:0090630;GO:2000146;GO:0035024;, C:cytoplasm;, F:identical protein binding;, P:activation of GTPase activity; P:negative regulation of cell motility; P:negative regulation of Rho protein signal transduction; scaffold1024 indexed_genome mRNA 15823 29845 . - . ID=transcript_17029;P50613 Q9BS60 Q9UE19,Cyclin-dependent kinase 7,39 kDa protein kinase;CDK-activating kinase 1;Cell division protein kinase 7;Serine/threonine-protein kinase 1;TFIIH basal transcription factor complex kinase subunit;, PF00069;, GO:0070516;GO:0019907;GO:0005737;GO:0005829;GO:0001650;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0000439;GO:0005675;GO:0070985;GO:0005524;GO:0004693;GO:0008094;GO:0008022;GO:0004672;GO:0106310;GO:0106311;GO:0008353;GO:0006370;GO:0007050;GO:0051301;GO:0000082;GO:0000086;GO:0006294;GO:0070816;GO:0045944;GO:0006468;GO:0050821;GO:0000079;GO:0042795;GO:0006363;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006283;, C:CAK-ERCC2 complex; C:cyclin-dependent protein kinase activating kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:transcription factor TFIIH core complex; C:transcription factor TFIIH holo complex; C:transcription factor TFIIK complex;, F:ATP binding; F:cyclin-dependent protein serine/threonine kinase activity; F:DNA-dependent ATPase activity; F:protein C-terminus binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity; F:RNA polymerase II CTD heptapeptide repeat kinase activity;, P:7-methylguanosine mRNA capping; P:cell cycle arrest; P:cell division; P:G1/S transition of mitotic cell cycle; P:G2/M transition of mitotic cell cycle; P:nucleotide-excision repair, preincision complex assembly; P:phosphorylation of RNA polymerase II C-terminal domain; P:positive regulation of transcription by RNA polymerase II; P:protein phosphorylation; P:protein stabilization; P:regulation of cyclin-dependent protein serine/threonine kinase activity; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription-coupled nucleotide-excision repair; scaffold1026 indexed_genome mRNA 6769 7523 . - . ID=transcript_17030;Q86Z20 Q86Z19,Coiled-coil domain-containing protein 125,Protein kenae;, , GO:0005737;GO:0042802;GO:0090630;GO:2000146;GO:0035024;, C:cytoplasm;, F:identical protein binding;, P:activation of GTPase activity; P:negative regulation of cell motility; P:negative regulation of Rho protein signal transduction; scaffold1026 indexed_genome mRNA 10410 12725 . + . ID=transcript_17031;Q86Z20 Q86Z19,Coiled-coil domain-containing protein 125,Protein kenae;, , GO:0005737;GO:0042802;GO:0090630;GO:2000146;GO:0035024;, C:cytoplasm;, F:identical protein binding;, P:activation of GTPase activity; P:negative regulation of cell motility; P:negative regulation of Rho protein signal transduction;|Q86Z20 Q86Z19,Coiled-coil domain-containing protein 125,Protein kenae;, , GO:0005737;GO:0042802;GO:0090630;GO:2000146;GO:0035024;, C:cytoplasm;, F:identical protein binding;, P:activation of GTPase activity; P:negative regulation of cell motility; P:negative regulation of Rho protein signal transduction; scaffold1029 indexed_genome mRNA 1892 28588 . - . ID=transcript_17032;Q9UKX2 A0AVL4 Q14322 Q16229 Q567P6 Q86T56,Myosin-2,Myosin heavy chain 2;Myosin heavy chain 2a;Myosin heavy chain IIa;Myosin heavy chain, skeletal muscle, adult 2;, PF00063;PF02736;PF01576;, GO:0005911;GO:0005829;GO:0005859;GO:0030016;GO:0032982;GO:0032991;GO:0030017;GO:0051015;GO:0005524;GO:0005516;GO:0000146;GO:0038096;GO:0006936;GO:0030049;, C:cell-cell junction; C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin filament; C:protein-containing complex; C:sarcomere;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:muscle contraction; P:muscle filament sliding;|Q9UKX2 A0AVL4 Q14322 Q16229 Q567P6 Q86T56,Myosin-2,Myosin heavy chain 2;Myosin heavy chain 2a;Myosin heavy chain IIa;Myosin heavy chain, skeletal muscle, adult 2;, PF00063;PF02736;PF01576;, GO:0005911;GO:0005829;GO:0005859;GO:0030016;GO:0032982;GO:0032991;GO:0030017;GO:0051015;GO:0005524;GO:0005516;GO:0000146;GO:0038096;GO:0006936;GO:0030049;, C:cell-cell junction; C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin filament; C:protein-containing complex; C:sarcomere;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:muscle contraction; P:muscle filament sliding;|Q9UKX2 A0AVL4 Q14322 Q16229 Q567P6 Q86T56,Myosin-2,Myosin heavy chain 2;Myosin heavy chain 2a;Myosin heavy chain IIa;Myosin heavy chain, skeletal muscle, adult 2;, PF00063;PF02736;PF01576;, GO:0005911;GO:0005829;GO:0005859;GO:0030016;GO:0032982;GO:0032991;GO:0030017;GO:0051015;GO:0005524;GO:0005516;GO:0000146;GO:0038096;GO:0006936;GO:0030049;, C:cell-cell junction; C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin filament; C:protein-containing complex; C:sarcomere;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:muscle contraction; P:muscle filament sliding;|P11055 Q15492,Myosin-3,Muscle embryonic myosin heavy chain;Myosin heavy chain 3;Myosin heavy chain, fast skeletal muscle, embryonic;SMHCE;, PF00063;PF02736;PF01576;, GO:0005829;GO:0070062;GO:0005859;GO:0032982;GO:0030017;GO:0051015;GO:0005524;GO:0016887;GO:0005516;GO:0000146;GO:0030048;GO:0046034;GO:0030326;GO:0060325;GO:0030049;GO:0007517;GO:0006470;GO:0045214;GO:0003009;, C:cytosol; C:extracellular exosome; C:muscle myosin complex; C:myosin filament; C:sarcomere;, F:actin filament binding; F:ATP binding; F:ATPase activity; F:calmodulin binding; F:microfilament motor activity;, P:actin filament-based movement; P:ATP metabolic process; P:embryonic limb morphogenesis; P:face morphogenesis; P:muscle filament sliding; P:muscle organ development; P:protein dephosphorylation; P:sarcomere organization; P:skeletal muscle contraction;|Q9UKX2 A0AVL4 Q14322 Q16229 Q567P6 Q86T56,Myosin-2,Myosin heavy chain 2;Myosin heavy chain 2a;Myosin heavy chain IIa;Myosin heavy chain, skeletal muscle, adult 2;, PF00063;PF02736;PF01576;, GO:0005911;GO:0005829;GO:0005859;GO:0030016;GO:0032982;GO:0032991;GO:0030017;GO:0051015;GO:0005524;GO:0005516;GO:0000146;GO:0038096;GO:0006936;GO:0030049;, C:cell-cell junction; C:cytosol; C:muscle myosin complex; C:myofibril; C:myosin filament; C:protein-containing complex; C:sarcomere;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:microfilament motor activity;, P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:muscle contraction; P:muscle filament sliding;|P12882 Q14CA4 Q9Y622,Myosin-1,Myosin heavy chain 1;Myosin heavy chain 2x;Myosin heavy chain IIx/d;Myosin heavy chain, skeletal muscle, adult 1;, PF00063;PF02736;PF01576;, GO:0031672;GO:0036464;GO:0014704;GO:0005859;GO:0032982;GO:0051015;GO:0005524;GO:0005516;GO:0003774;GO:0006936;, C:A band; C:cytoplasmic ribonucleoprotein granule; C:intercalated disc; C:muscle myosin complex; C:myosin filament;, F:actin filament binding; F:ATP binding; F:calmodulin binding; F:motor activity;, P:muscle contraction; scaffold1030 indexed_genome mRNA 640 17404 . - . ID=transcript_17033;Q9H3C7 B2RPK7 Q96T90 Q9GZR8 Q9H767,Gametogenetin-binding protein 2,Laryngeal carcinoma-related protein 1;Protein ZNF403;, , GO:0005737;GO:0031410;GO:0005634;GO:0030154;GO:0060716;GO:0008285;GO:0010629;GO:0033140;GO:0061099;GO:0042532;GO:0007283;, C:cytoplasm; C:cytoplasmic vesicle; C:nucleus;, , P:cell differentiation; P:labyrinthine layer blood vessel development; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of tyrosine phosphorylation of STAT protein; P:spermatogenesis;|Q9H3C7 B2RPK7 Q96T90 Q9GZR8 Q9H767,Gametogenetin-binding protein 2,Laryngeal carcinoma-related protein 1;Protein ZNF403;, , GO:0005737;GO:0031410;GO:0005634;GO:0030154;GO:0060716;GO:0008285;GO:0010629;GO:0033140;GO:0061099;GO:0042532;GO:0007283;, C:cytoplasm; C:cytoplasmic vesicle; C:nucleus;, , P:cell differentiation; P:labyrinthine layer blood vessel development; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of tyrosine phosphorylation of STAT protein; P:spermatogenesis;|Q9H3C7 B2RPK7 Q96T90 Q9GZR8 Q9H767,Gametogenetin-binding protein 2,Laryngeal carcinoma-related protein 1;Protein ZNF403;, , GO:0005737;GO:0031410;GO:0005634;GO:0030154;GO:0060716;GO:0008285;GO:0010629;GO:0033140;GO:0061099;GO:0042532;GO:0007283;, C:cytoplasm; C:cytoplasmic vesicle; C:nucleus;, , P:cell differentiation; P:labyrinthine layer blood vessel development; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of tyrosine phosphorylation of STAT protein; P:spermatogenesis; scaffold1031 indexed_genome mRNA 641 17403 . - . ID=transcript_17034;Q9H3C7 B2RPK7 Q96T90 Q9GZR8 Q9H767,Gametogenetin-binding protein 2,Laryngeal carcinoma-related protein 1;Protein ZNF403;, , GO:0005737;GO:0031410;GO:0005634;GO:0030154;GO:0060716;GO:0008285;GO:0010629;GO:0033140;GO:0061099;GO:0042532;GO:0007283;, C:cytoplasm; C:cytoplasmic vesicle; C:nucleus;, , P:cell differentiation; P:labyrinthine layer blood vessel development; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of tyrosine phosphorylation of STAT protein; P:spermatogenesis;|Q9H3C7 B2RPK7 Q96T90 Q9GZR8 Q9H767,Gametogenetin-binding protein 2,Laryngeal carcinoma-related protein 1;Protein ZNF403;, , GO:0005737;GO:0031410;GO:0005634;GO:0030154;GO:0060716;GO:0008285;GO:0010629;GO:0033140;GO:0061099;GO:0042532;GO:0007283;, C:cytoplasm; C:cytoplasmic vesicle; C:nucleus;, , P:cell differentiation; P:labyrinthine layer blood vessel development; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of tyrosine phosphorylation of STAT protein; P:spermatogenesis;|Q9H3C7 B2RPK7 Q96T90 Q9GZR8 Q9H767,Gametogenetin-binding protein 2,Laryngeal carcinoma-related protein 1;Protein ZNF403;, , GO:0005737;GO:0031410;GO:0005634;GO:0030154;GO:0060716;GO:0008285;GO:0010629;GO:0033140;GO:0061099;GO:0042532;GO:0007283;, C:cytoplasm; C:cytoplasmic vesicle; C:nucleus;, , P:cell differentiation; P:labyrinthine layer blood vessel development; P:negative regulation of cell population proliferation; P:negative regulation of gene expression; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; P:negative regulation of protein tyrosine kinase activity; P:negative regulation of tyrosine phosphorylation of STAT protein; P:spermatogenesis; scaffold1049 indexed_genome mRNA 3414 15431 . + . ID=transcript_17035;Q96BD0 Q9H4T7 Q9H4T8 Q9H8P2 Q9NWX8 Q9UI35 Q9UIG7,Solute carrier organic anion transporter family member 4A1,Colon organic anion transporter;Organic anion transporter polypeptide-related protein 1;Organic anion-transporting polypeptide E;Sodium-independent organic anion transporter E;Solute carrier family 21 member 12;, PF07648;PF03137;, GO:0005887;GO:0005886;GO:0015347;GO:0015349;GO:0043252;, C:integral component of plasma membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity; F:thyroid hormone transmembrane transporter activity;, P:sodium-independent organic anion transport; scaffold1050 indexed_genome mRNA 3417 15431 . + . ID=transcript_17036;Q96BD0 Q9H4T7 Q9H4T8 Q9H8P2 Q9NWX8 Q9UI35 Q9UIG7,Solute carrier organic anion transporter family member 4A1,Colon organic anion transporter;Organic anion transporter polypeptide-related protein 1;Organic anion-transporting polypeptide E;Sodium-independent organic anion transporter E;Solute carrier family 21 member 12;, PF07648;PF03137;, GO:0005887;GO:0005886;GO:0015347;GO:0015349;GO:0043252;, C:integral component of plasma membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity; F:thyroid hormone transmembrane transporter activity;, P:sodium-independent organic anion transport; scaffold1055 indexed_genome mRNA 19897 21840 . + . ID=transcript_17037;Q9UF02 A8K2A6 Q547R3 Q8WXS7 Q9UHM3,Voltage-dependent calcium channel gamma-5 subunit,Neuronal voltage-gated calcium channel gamma-5 subunit;Transmembrane AMPAR regulatory protein gamma-5;, PF00822;, GO:0032281;GO:0098978;GO:0099055;GO:0014069;GO:0098839;GO:0016247;GO:0015075;GO:0005245;GO:0099590;GO:0098943;GO:0051968;GO:0098970;GO:2000311;GO:0098962;GO:0019226;, C:AMPA glutamate receptor complex; C:glutamatergic synapse; C:integral component of postsynaptic membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:channel regulator activity; F:ion transmembrane transporter activity; F:voltage-gated calcium channel activity;, P:neurotransmitter receptor internalization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic neurotransmitter receptor diffusion trapping; P:regulation of AMPA receptor activity; P:regulation of postsynaptic neurotransmitter receptor activity; P:transmission of nerve impulse; scaffold1055 indexed_genome mRNA 26911 27494 . + . ID=transcript_17038;Q9UF02 A8K2A6 Q547R3 Q8WXS7 Q9UHM3,Voltage-dependent calcium channel gamma-5 subunit,Neuronal voltage-gated calcium channel gamma-5 subunit;Transmembrane AMPAR regulatory protein gamma-5;, PF00822;, GO:0032281;GO:0098978;GO:0099055;GO:0014069;GO:0098839;GO:0016247;GO:0015075;GO:0005245;GO:0099590;GO:0098943;GO:0051968;GO:0098970;GO:2000311;GO:0098962;GO:0019226;, C:AMPA glutamate receptor complex; C:glutamatergic synapse; C:integral component of postsynaptic membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:channel regulator activity; F:ion transmembrane transporter activity; F:voltage-gated calcium channel activity;, P:neurotransmitter receptor internalization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic neurotransmitter receptor diffusion trapping; P:regulation of AMPA receptor activity; P:regulation of postsynaptic neurotransmitter receptor activity; P:transmission of nerve impulse; scaffold1067 indexed_genome mRNA 1001 7054 . - . ID=transcript_17039;O14950 D3DUH6 Q13182 Q7Z5Z4,Myosin regulatory light chain 12B,MLC-2A;Myosin regulatory light chain 2-B, smooth muscle isoform;Myosin regulatory light chain 20 kDa;Myosin regulatory light chain MRLC2;SHUJUN-1;, PF08976;PF13405;, GO:0099738;GO:0005829;GO:0070062;GO:0016459;GO:0005509;GO:0006936;, C:cell cortex region; C:cytosol; C:extracellular exosome; C:myosin complex;, F:calcium ion binding;, P:muscle contraction; scaffold1067 indexed_genome mRNA 7094 8259 . - . ID=transcript_17040;P19105 Q53X45,Myosin regulatory light chain 12A,Epididymis secretory protein Li 24;MLC-2B;Myosin RLC;Myosin regulatory light chain 2, nonsarcomeric;Myosin regulatory light chain MRLC3;, PF08976;PF13405;, GO:0005829;GO:0070062;GO:0016459;GO:0005509;GO:0006936;GO:0070527;, C:cytosol; C:extracellular exosome; C:myosin complex;, F:calcium ion binding;, P:muscle contraction; P:platelet aggregation; scaffold1068 indexed_genome mRNA 4162 5140 . + . ID=transcript_17041;Q9Y6V0 A4D1A7 A6NNX9 O43373 O60305 Q08E72 Q9BVC8 Q9UIV2 Q9Y6U9,Protein piccolo,Aczonin;, PF00168;PF00595;PF05715;, GO:0030424;GO:0005856;GO:0048788;GO:0070062;GO:0098982;GO:0098978;GO:0014069;GO:0045202;GO:0005509;GO:0005544;GO:0005522;GO:0098882;GO:0019933;GO:0007010;GO:0030073;GO:0099526;GO:1904071;GO:0035418;GO:0017157;GO:0097091;GO:0016079;, C:axon; C:cytoskeleton; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:postsynaptic density; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:profilin binding; F:structural constituent of presynaptic active zone;, P:cAMP-mediated signaling; P:cytoskeleton organization; P:insulin secretion; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of exocytosis; P:synaptic vesicle clustering; P:synaptic vesicle exocytosis; scaffold1068 indexed_genome mRNA 9492 10333 . - . ID=transcript_17042;Q9Y6V0 A4D1A7 A6NNX9 O43373 O60305 Q08E72 Q9BVC8 Q9UIV2 Q9Y6U9,Protein piccolo,Aczonin;, PF00168;PF00595;PF05715;, GO:0030424;GO:0005856;GO:0048788;GO:0070062;GO:0098982;GO:0098978;GO:0014069;GO:0045202;GO:0005509;GO:0005544;GO:0005522;GO:0098882;GO:0019933;GO:0007010;GO:0030073;GO:0099526;GO:1904071;GO:0035418;GO:0017157;GO:0097091;GO:0016079;, C:axon; C:cytoskeleton; C:cytoskeleton of presynaptic active zone; C:extracellular exosome; C:GABA-ergic synapse; C:glutamatergic synapse; C:postsynaptic density; C:synapse;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:profilin binding; F:structural constituent of presynaptic active zone;, P:cAMP-mediated signaling; P:cytoskeleton organization; P:insulin secretion; P:presynapse to nucleus signaling pathway; P:presynaptic active zone assembly; P:protein localization to synapse; P:regulation of exocytosis; P:synaptic vesicle clustering; P:synaptic vesicle exocytosis; scaffold1073 indexed_genome mRNA 18354 25400 . - . ID=transcript_17043;Q53GL7 Q8N2I0 Q8WV05 Q96CH7 Q96K72,Protein mono-ADP-ribosyltransferase PARP10 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 10 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 10 {ECO:0000303|PubMed:20106667};, PF00644;, GO:0005737;GO:0005829;GO:0005794;GO:0005730;GO:0005634;GO:0070530;GO:0003950;GO:1990404;GO:0003714;GO:0034356;GO:0048147;GO:0010629;GO:0032088;GO:1900045;GO:0045071;GO:0006471;GO:0070213;GO:0140289;GO:0070212;GO:0010847;GO:0019985;GO:0019082;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:K63-linked polyubiquitin modification-dependent protein binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:transcription corepressor activity;, P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of fibroblast proliferation; P:negative regulation of gene expression; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein K63-linked ubiquitination; P:negative regulation of viral genome replication; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein poly-ADP-ribosylation; P:regulation of chromatin assembly; P:translesion synthesis; P:viral protein processing;|Q53GL7 Q8N2I0 Q8WV05 Q96CH7 Q96K72,Protein mono-ADP-ribosyltransferase PARP10 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 10 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 10 {ECO:0000303|PubMed:20106667};, PF00644;, GO:0005737;GO:0005829;GO:0005794;GO:0005730;GO:0005634;GO:0070530;GO:0003950;GO:1990404;GO:0003714;GO:0034356;GO:0048147;GO:0010629;GO:0032088;GO:1900045;GO:0045071;GO:0006471;GO:0070213;GO:0140289;GO:0070212;GO:0010847;GO:0019985;GO:0019082;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:K63-linked polyubiquitin modification-dependent protein binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:transcription corepressor activity;, P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of fibroblast proliferation; P:negative regulation of gene expression; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein K63-linked ubiquitination; P:negative regulation of viral genome replication; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein poly-ADP-ribosylation; P:regulation of chromatin assembly; P:translesion synthesis; P:viral protein processing;|Q53GL7 Q8N2I0 Q8WV05 Q96CH7 Q96K72,Protein mono-ADP-ribosyltransferase PARP10 {ECO:0000305},ADP-ribosyltransferase diphtheria toxin-like 10 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 10 {ECO:0000303|PubMed:20106667};, PF00644;, GO:0005737;GO:0005829;GO:0005794;GO:0005730;GO:0005634;GO:0070530;GO:0003950;GO:1990404;GO:0003714;GO:0034356;GO:0048147;GO:0010629;GO:0032088;GO:1900045;GO:0045071;GO:0006471;GO:0070213;GO:0140289;GO:0070212;GO:0010847;GO:0019985;GO:0019082;, C:cytoplasm; C:cytosol; C:Golgi apparatus; C:nucleolus; C:nucleus;, F:K63-linked polyubiquitin modification-dependent protein binding; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity; F:transcription corepressor activity;, P:NAD biosynthesis via nicotinamide riboside salvage pathway; P:negative regulation of fibroblast proliferation; P:negative regulation of gene expression; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of protein K63-linked ubiquitination; P:negative regulation of viral genome replication; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein mono-ADP-ribosylation; P:protein poly-ADP-ribosylation; P:regulation of chromatin assembly; P:translesion synthesis; P:viral protein processing; scaffold1098 indexed_genome mRNA 14105 22799 . + . ID=transcript_17044;Q7L5Y9 O95285 Q5JB54 Q6ZRD6 Q9BQ11 Q9H9V6 Q9H9Z4 Q9NW84,E3 ubiquitin-protein transferase MAEA,Cell proliferation-inducing gene 5 protein {ECO:0000303|Ref.1};Erythroblast macrophage protein {ECO:0000303|PubMed:9763581};Human lung cancer oncogene 10 protein;Macrophage erythroblast attacher;P44EMLP {ECO:0000303|PubMed:17467196};, PF10607;, GO:0005826;GO:0005737;GO:0005856;GO:0034657;GO:0005887;GO:0016363;GO:0005654;GO:0005634;GO:0005819;GO:0000151;GO:0003779;GO:0046872;GO:0061630;GO:0007155;GO:0007049;GO:0051301;GO:0043249;GO:0045721;GO:0033033;GO:0043161;GO:0007346;, C:actomyosin contractile ring; C:cytoplasm; C:cytoskeleton; C:GID complex; C:integral component of plasma membrane; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:spindle; C:ubiquitin ligase complex;, F:actin binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell adhesion; P:cell cycle; P:cell division; P:erythrocyte maturation; P:negative regulation of gluconeogenesis; P:negative regulation of myeloid cell apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of mitotic cell cycle;|Q7L5Y9 O95285 Q5JB54 Q6ZRD6 Q9BQ11 Q9H9V6 Q9H9Z4 Q9NW84,E3 ubiquitin-protein transferase MAEA,Cell proliferation-inducing gene 5 protein {ECO:0000303|Ref.1};Erythroblast macrophage protein {ECO:0000303|PubMed:9763581};Human lung cancer oncogene 10 protein;Macrophage erythroblast attacher;P44EMLP {ECO:0000303|PubMed:17467196};, PF10607;, GO:0005826;GO:0005737;GO:0005856;GO:0034657;GO:0005887;GO:0016363;GO:0005654;GO:0005634;GO:0005819;GO:0000151;GO:0003779;GO:0046872;GO:0061630;GO:0007155;GO:0007049;GO:0051301;GO:0043249;GO:0045721;GO:0033033;GO:0043161;GO:0007346;, C:actomyosin contractile ring; C:cytoplasm; C:cytoskeleton; C:GID complex; C:integral component of plasma membrane; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:spindle; C:ubiquitin ligase complex;, F:actin binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell adhesion; P:cell cycle; P:cell division; P:erythrocyte maturation; P:negative regulation of gluconeogenesis; P:negative regulation of myeloid cell apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of mitotic cell cycle;|Q7L5Y9 O95285 Q5JB54 Q6ZRD6 Q9BQ11 Q9H9V6 Q9H9Z4 Q9NW84,E3 ubiquitin-protein transferase MAEA,Cell proliferation-inducing gene 5 protein {ECO:0000303|Ref.1};Erythroblast macrophage protein {ECO:0000303|PubMed:9763581};Human lung cancer oncogene 10 protein;Macrophage erythroblast attacher;P44EMLP {ECO:0000303|PubMed:17467196};, PF10607;, GO:0005826;GO:0005737;GO:0005856;GO:0034657;GO:0005887;GO:0016363;GO:0005654;GO:0005634;GO:0005819;GO:0000151;GO:0003779;GO:0046872;GO:0061630;GO:0007155;GO:0007049;GO:0051301;GO:0043249;GO:0045721;GO:0033033;GO:0043161;GO:0007346;, C:actomyosin contractile ring; C:cytoplasm; C:cytoskeleton; C:GID complex; C:integral component of plasma membrane; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:spindle; C:ubiquitin ligase complex;, F:actin binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell adhesion; P:cell cycle; P:cell division; P:erythrocyte maturation; P:negative regulation of gluconeogenesis; P:negative regulation of myeloid cell apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of mitotic cell cycle; scaffold1099 indexed_genome mRNA 7395 12449 . + . ID=transcript_17045;Q7L5Y9 O95285 Q5JB54 Q6ZRD6 Q9BQ11 Q9H9V6 Q9H9Z4 Q9NW84,E3 ubiquitin-protein transferase MAEA,Cell proliferation-inducing gene 5 protein {ECO:0000303|Ref.1};Erythroblast macrophage protein {ECO:0000303|PubMed:9763581};Human lung cancer oncogene 10 protein;Macrophage erythroblast attacher;P44EMLP {ECO:0000303|PubMed:17467196};, PF10607;, GO:0005826;GO:0005737;GO:0005856;GO:0034657;GO:0005887;GO:0016363;GO:0005654;GO:0005634;GO:0005819;GO:0000151;GO:0003779;GO:0046872;GO:0061630;GO:0007155;GO:0007049;GO:0051301;GO:0043249;GO:0045721;GO:0033033;GO:0043161;GO:0007346;, C:actomyosin contractile ring; C:cytoplasm; C:cytoskeleton; C:GID complex; C:integral component of plasma membrane; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:spindle; C:ubiquitin ligase complex;, F:actin binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell adhesion; P:cell cycle; P:cell division; P:erythrocyte maturation; P:negative regulation of gluconeogenesis; P:negative regulation of myeloid cell apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of mitotic cell cycle; scaffold1099 indexed_genome mRNA 14099 22792 . + . ID=transcript_17046;Q7L5Y9 O95285 Q5JB54 Q6ZRD6 Q9BQ11 Q9H9V6 Q9H9Z4 Q9NW84,E3 ubiquitin-protein transferase MAEA,Cell proliferation-inducing gene 5 protein {ECO:0000303|Ref.1};Erythroblast macrophage protein {ECO:0000303|PubMed:9763581};Human lung cancer oncogene 10 protein;Macrophage erythroblast attacher;P44EMLP {ECO:0000303|PubMed:17467196};, PF10607;, GO:0005826;GO:0005737;GO:0005856;GO:0034657;GO:0005887;GO:0016363;GO:0005654;GO:0005634;GO:0005819;GO:0000151;GO:0003779;GO:0046872;GO:0061630;GO:0007155;GO:0007049;GO:0051301;GO:0043249;GO:0045721;GO:0033033;GO:0043161;GO:0007346;, C:actomyosin contractile ring; C:cytoplasm; C:cytoskeleton; C:GID complex; C:integral component of plasma membrane; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:spindle; C:ubiquitin ligase complex;, F:actin binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell adhesion; P:cell cycle; P:cell division; P:erythrocyte maturation; P:negative regulation of gluconeogenesis; P:negative regulation of myeloid cell apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of mitotic cell cycle;|Q7L5Y9 O95285 Q5JB54 Q6ZRD6 Q9BQ11 Q9H9V6 Q9H9Z4 Q9NW84,E3 ubiquitin-protein transferase MAEA,Cell proliferation-inducing gene 5 protein {ECO:0000303|Ref.1};Erythroblast macrophage protein {ECO:0000303|PubMed:9763581};Human lung cancer oncogene 10 protein;Macrophage erythroblast attacher;P44EMLP {ECO:0000303|PubMed:17467196};, PF10607;, GO:0005826;GO:0005737;GO:0005856;GO:0034657;GO:0005887;GO:0016363;GO:0005654;GO:0005634;GO:0005819;GO:0000151;GO:0003779;GO:0046872;GO:0061630;GO:0007155;GO:0007049;GO:0051301;GO:0043249;GO:0045721;GO:0033033;GO:0043161;GO:0007346;, C:actomyosin contractile ring; C:cytoplasm; C:cytoskeleton; C:GID complex; C:integral component of plasma membrane; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:spindle; C:ubiquitin ligase complex;, F:actin binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell adhesion; P:cell cycle; P:cell division; P:erythrocyte maturation; P:negative regulation of gluconeogenesis; P:negative regulation of myeloid cell apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of mitotic cell cycle;|Q7L5Y9 O95285 Q5JB54 Q6ZRD6 Q9BQ11 Q9H9V6 Q9H9Z4 Q9NW84,E3 ubiquitin-protein transferase MAEA,Cell proliferation-inducing gene 5 protein {ECO:0000303|Ref.1};Erythroblast macrophage protein {ECO:0000303|PubMed:9763581};Human lung cancer oncogene 10 protein;Macrophage erythroblast attacher;P44EMLP {ECO:0000303|PubMed:17467196};, PF10607;, GO:0005826;GO:0005737;GO:0005856;GO:0034657;GO:0005887;GO:0016363;GO:0005654;GO:0005634;GO:0005819;GO:0000151;GO:0003779;GO:0046872;GO:0061630;GO:0007155;GO:0007049;GO:0051301;GO:0043249;GO:0045721;GO:0033033;GO:0043161;GO:0007346;, C:actomyosin contractile ring; C:cytoplasm; C:cytoskeleton; C:GID complex; C:integral component of plasma membrane; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:spindle; C:ubiquitin ligase complex;, F:actin binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell adhesion; P:cell cycle; P:cell division; P:erythrocyte maturation; P:negative regulation of gluconeogenesis; P:negative regulation of myeloid cell apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of mitotic cell cycle;|Q7L5Y9 O95285 Q5JB54 Q6ZRD6 Q9BQ11 Q9H9V6 Q9H9Z4 Q9NW84,E3 ubiquitin-protein transferase MAEA,Cell proliferation-inducing gene 5 protein {ECO:0000303|Ref.1};Erythroblast macrophage protein {ECO:0000303|PubMed:9763581};Human lung cancer oncogene 10 protein;Macrophage erythroblast attacher;P44EMLP {ECO:0000303|PubMed:17467196};, PF10607;, GO:0005826;GO:0005737;GO:0005856;GO:0034657;GO:0005887;GO:0016363;GO:0005654;GO:0005634;GO:0005819;GO:0000151;GO:0003779;GO:0046872;GO:0061630;GO:0007155;GO:0007049;GO:0051301;GO:0043249;GO:0045721;GO:0033033;GO:0043161;GO:0007346;, C:actomyosin contractile ring; C:cytoplasm; C:cytoskeleton; C:GID complex; C:integral component of plasma membrane; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:spindle; C:ubiquitin ligase complex;, F:actin binding; F:metal ion binding; F:ubiquitin protein ligase activity;, P:cell adhesion; P:cell cycle; P:cell division; P:erythrocyte maturation; P:negative regulation of gluconeogenesis; P:negative regulation of myeloid cell apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of mitotic cell cycle; scaffold1102 indexed_genome mRNA 13024 14135 . + . ID=transcript_17047;Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; scaffold1102 indexed_genome mRNA 14198 25780 . - . ID=transcript_17048;Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; scaffold1102 indexed_genome mRNA 25918 27393 . + . ID=transcript_17049;Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; scaffold1113 indexed_genome mRNA 1 7409 . + . ID=transcript_17050;Q6UVM3 Q3SY59 Q5VTN1 Q6ZMT3,Potassium channel subfamily T member 2,Sequence like an intermediate conductance potassium channel subunit;Sodium and chloride-activated ATP-sensitive potassium channel Slo2.1;, PF03493;PF07885;, GO:0016021;GO:0005886;GO:0005524;GO:0070089;GO:0005228;GO:0015271;GO:0097623;, C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:chloride-activated potassium channel activity; F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity;, P:potassium ion export across plasma membrane;|Q5JUK3 B3KXF7 B7ZVY4 B9EGP2 G5E9V0 Q9P2C5,Potassium channel subfamily T member 1,KCa4.1;, PF03493;PF07885;, GO:0016021;GO:0005886;GO:0005228;GO:0015271;, C:integral component of membrane; C:plasma membrane;, F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity; scaffold1114 indexed_genome mRNA 1 7409 . + . ID=transcript_17051;Q6UVM3 Q3SY59 Q5VTN1 Q6ZMT3,Potassium channel subfamily T member 2,Sequence like an intermediate conductance potassium channel subunit;Sodium and chloride-activated ATP-sensitive potassium channel Slo2.1;, PF03493;PF07885;, GO:0016021;GO:0005886;GO:0005524;GO:0070089;GO:0005228;GO:0015271;GO:0097623;, C:integral component of membrane; C:plasma membrane;, F:ATP binding; F:chloride-activated potassium channel activity; F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity;, P:potassium ion export across plasma membrane;|Q5JUK3 B3KXF7 B7ZVY4 B9EGP2 G5E9V0 Q9P2C5,Potassium channel subfamily T member 1,KCa4.1;, PF03493;PF07885;, GO:0016021;GO:0005886;GO:0005228;GO:0015271;, C:integral component of membrane; C:plasma membrane;, F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity; scaffold1125 indexed_genome mRNA 2562 26619 . - . ID=transcript_17052;Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction; scaffold1126 indexed_genome mRNA 2563 26613 . - . ID=transcript_17053;Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction;|Q13972 F8VPA5 H0YKF2 J3KQP9 Q16027,Ras-specific guanine nucleotide-releasing factor 1,Guanine nucleotide-releasing protein;Ras-specific nucleotide exchange factor CDC25;, PF00169;PF00617;PF00618;PF00621;, GO:0005829;GO:0030426;GO:0043005;GO:0005886;GO:0035254;GO:0005085;GO:0090630;GO:0008283;GO:0007616;GO:0000165;GO:0031175;GO:0043547;GO:0046579;GO:0048168;GO:2000310;GO:0035020;GO:0046578;GO:0035023;GO:0048167;GO:0034976;GO:0007165;GO:0007264;, C:cytosol; C:growth cone; C:neuron projection; C:plasma membrane;, F:glutamate receptor binding; F:guanyl-nucleotide exchange factor activity;, P:activation of GTPase activity; P:cell population proliferation; P:long-term memory; P:MAPK cascade; P:neuron projection development; P:positive regulation of GTPase activity; P:positive regulation of Ras protein signal transduction; P:regulation of neuronal synaptic plasticity; P:regulation of NMDA receptor activity; P:regulation of Rac protein signal transduction; P:regulation of Ras protein signal transduction; P:regulation of Rho protein signal transduction; P:regulation of synaptic plasticity; P:response to endoplasmic reticulum stress; P:signal transduction; P:small GTPase mediated signal transduction; scaffold1130 indexed_genome mRNA 12861 13974 . + . ID=transcript_17054;P11234 B4E040 Q53T32 Q6ZS74,Ras-related protein Ral-B,, PF00071;, GO:0070062;GO:0030496;GO:0005886;GO:0051117;GO:0019003;GO:0005525;GO:0003924;GO:0031625;GO:0006915;GO:0007049;GO:0051301;GO:0071360;GO:0009267;GO:0032091;GO:2000786;GO:0032092;GO:0001934;GO:0071902;GO:0007265;GO:0001928;GO:0060178;GO:0007165;, C:extracellular exosome; C:midbody; C:plasma membrane;, F:ATPase binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell cycle; P:cell division; P:cellular response to exogenous dsRNA; P:cellular response to starvation; P:negative regulation of protein binding; P:positive regulation of autophagosome assembly; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:Ras protein signal transduction; P:regulation of exocyst assembly; P:regulation of exocyst localization; P:signal transduction; scaffold1130 indexed_genome mRNA 16569 21565 . + . ID=transcript_17055;P11234 B4E040 Q53T32 Q6ZS74,Ras-related protein Ral-B,, PF00071;, GO:0070062;GO:0030496;GO:0005886;GO:0051117;GO:0019003;GO:0005525;GO:0003924;GO:0031625;GO:0006915;GO:0007049;GO:0051301;GO:0071360;GO:0009267;GO:0032091;GO:2000786;GO:0032092;GO:0001934;GO:0071902;GO:0007265;GO:0001928;GO:0060178;GO:0007165;, C:extracellular exosome; C:midbody; C:plasma membrane;, F:ATPase binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell cycle; P:cell division; P:cellular response to exogenous dsRNA; P:cellular response to starvation; P:negative regulation of protein binding; P:positive regulation of autophagosome assembly; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:Ras protein signal transduction; P:regulation of exocyst assembly; P:regulation of exocyst localization; P:signal transduction; scaffold1135 indexed_genome mRNA 12831 13945 . + . ID=transcript_17056;P11234 B4E040 Q53T32 Q6ZS74,Ras-related protein Ral-B,, PF00071;, GO:0070062;GO:0030496;GO:0005886;GO:0051117;GO:0019003;GO:0005525;GO:0003924;GO:0031625;GO:0006915;GO:0007049;GO:0051301;GO:0071360;GO:0009267;GO:0032091;GO:2000786;GO:0032092;GO:0001934;GO:0071902;GO:0007265;GO:0001928;GO:0060178;GO:0007165;, C:extracellular exosome; C:midbody; C:plasma membrane;, F:ATPase binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell cycle; P:cell division; P:cellular response to exogenous dsRNA; P:cellular response to starvation; P:negative regulation of protein binding; P:positive regulation of autophagosome assembly; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:Ras protein signal transduction; P:regulation of exocyst assembly; P:regulation of exocyst localization; P:signal transduction; scaffold1135 indexed_genome mRNA 15108 21521 . + . ID=transcript_17057;P11234 B4E040 Q53T32 Q6ZS74,Ras-related protein Ral-B,, PF00071;, GO:0070062;GO:0030496;GO:0005886;GO:0051117;GO:0019003;GO:0005525;GO:0003924;GO:0031625;GO:0006915;GO:0007049;GO:0051301;GO:0071360;GO:0009267;GO:0032091;GO:2000786;GO:0032092;GO:0001934;GO:0071902;GO:0007265;GO:0001928;GO:0060178;GO:0007165;, C:extracellular exosome; C:midbody; C:plasma membrane;, F:ATPase binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell cycle; P:cell division; P:cellular response to exogenous dsRNA; P:cellular response to starvation; P:negative regulation of protein binding; P:positive regulation of autophagosome assembly; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:Ras protein signal transduction; P:regulation of exocyst assembly; P:regulation of exocyst localization; P:signal transduction;|P11234 B4E040 Q53T32 Q6ZS74,Ras-related protein Ral-B,, PF00071;, GO:0070062;GO:0030496;GO:0005886;GO:0051117;GO:0019003;GO:0005525;GO:0003924;GO:0031625;GO:0006915;GO:0007049;GO:0051301;GO:0071360;GO:0009267;GO:0032091;GO:2000786;GO:0032092;GO:0001934;GO:0071902;GO:0007265;GO:0001928;GO:0060178;GO:0007165;, C:extracellular exosome; C:midbody; C:plasma membrane;, F:ATPase binding; F:GDP binding; F:GTP binding; F:GTPase activity; F:ubiquitin protein ligase binding;, P:apoptotic process; P:cell cycle; P:cell division; P:cellular response to exogenous dsRNA; P:cellular response to starvation; P:negative regulation of protein binding; P:positive regulation of autophagosome assembly; P:positive regulation of protein binding; P:positive regulation of protein phosphorylation; P:positive regulation of protein serine/threonine kinase activity; P:Ras protein signal transduction; P:regulation of exocyst assembly; P:regulation of exocyst localization; P:signal transduction; scaffold1143 indexed_genome mRNA 9717 13736 . + . ID=transcript_17058;Q6ZS11 B4DPG5,Ras and Rab interactor-like protein,, PF02204;, GO:0015629;GO:0031410;GO:0001726;GO:0005096;GO:0005085;GO:0006897;GO:0015031;, C:actin cytoskeleton; C:cytoplasmic vesicle; C:ruffle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:endocytosis; P:protein transport; scaffold1143 indexed_genome mRNA 21134 25531 . - . ID=transcript_17059;Q8IXJ6 A8K3V1 B2RB45 O95889 Q924Y7 Q9P0G8 Q9UNT0 Q9Y6E9 U5TP13,NAD-dependent protein deacetylase sirtuin-2,Regulatory protein SIR2 homolog 2;SIR2-like protein 2;, PF02146;, GO:0005814;GO:0005813;GO:0005677;GO:0005694;GO:0000781;GO:0005737;GO:0005829;GO:0097386;GO:0030426;GO:0000792;GO:0044224;GO:0043219;GO:0072687;GO:0005874;GO:0030496;GO:0005739;GO:0072686;GO:0043209;GO:0005730;GO:0005634;GO:0033010;GO:0033270;GO:0043204;GO:0048471;GO:0005886;GO:0043220;GO:0005819;GO:0003682;GO:0035035;GO:0004407;GO:0042826;GO:0003950;GO:0070403;GO:0017136;GO:0046970;GO:0034979;GO:0033558;GO:0008134;GO:0042903;GO:0043130;GO:0008270;GO:0006914;GO:0051301;GO:0044242;GO:0061433;GO:0071872;GO:0035729;GO:0071456;GO:0071219;GO:0034599;GO:0006342;GO:0006348;GO:0048012;GO:0016575;GO:0070932;GO:0070933;GO:0045087;GO:0051321;GO:0007084;GO:0022011;GO:0010507;GO:0008285;GO:1900425;GO:0045599;GO:1900226;GO:0070446;GO:0010801;GO:0042177;GO:2000378;GO:0045843;GO:0000122;GO:0061428;GO:0045892;GO:0034983;GO:0014065;GO:0051987;GO:0051781;GO:0043388;GO:1900119;GO:0045836;GO:1900195;GO:0032436;GO:2000777;GO:0045944;GO:0043161;GO:0006471;GO:0006476;GO:0043491;GO:0000183;GO:0051726;GO:0007096;GO:0031641;GO:0042325;GO:0051775;GO:0021762;GO:0090042;, C:centriole; C:centrosome; C:chromatin silencing complex; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:glial cell projection; C:growth cone; C:heterochromatin; C:juxtaparanode region of axon; C:lateral loop; C:meiotic spindle; C:microtubule; C:midbody; C:mitochondrion; C:mitotic spindle; C:myelin sheath; C:nucleolus; C:nucleus; C:paranodal junction; C:paranode region of axon; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:Schmidt-Lanterman incisure; C:spindle;, F:chromatin binding; F:histone acetyltransferase binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H4-K16 specific); F:NAD-dependent protein deacetylase activity; F:protein deacetylase activity; F:transcription factor binding; F:tubulin deacetylase activity; F:ubiquitin binding; F:zinc ion binding;, P:autophagy; P:cell division; P:cellular lipid catabolic process; P:cellular response to caloric restriction; P:cellular response to epinephrine stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hypoxia; P:cellular response to molecule of bacterial origin; P:cellular response to oxidative stress; P:chromatin silencing; P:chromatin silencing at telomere; P:hepatocyte growth factor receptor signaling pathway; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:innate immune response; P:meiotic cell cycle; P:mitotic nuclear envelope reassembly; P:myelination in peripheral nervous system; P:negative regulation of autophagy; P:negative regulation of cell population proliferation; P:negative regulation of defense response to bacterium; P:negative regulation of fat cell differentiation; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of oligodendrocyte progenitor proliferation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein catabolic process; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of striated muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine deacetylation; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of cell division; P:positive regulation of DNA binding; P:positive regulation of execution phase of apoptosis; P:positive regulation of meiotic nuclear division; P:positive regulation of oocyte maturation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ADP-ribosylation; P:protein deacetylation; P:protein kinase B signaling; P:rDNA heterochromatin assembly; P:regulation of cell cycle; P:regulation of exit from mitosis; P:regulation of myelination; P:regulation of phosphorylation; P:response to redox state; P:substantia nigra development; P:tubulin deacetylation;|Q8IXJ6 A8K3V1 B2RB45 O95889 Q924Y7 Q9P0G8 Q9UNT0 Q9Y6E9 U5TP13,NAD-dependent protein deacetylase sirtuin-2,Regulatory protein SIR2 homolog 2;SIR2-like protein 2;, PF02146;, GO:0005814;GO:0005813;GO:0005677;GO:0005694;GO:0000781;GO:0005737;GO:0005829;GO:0097386;GO:0030426;GO:0000792;GO:0044224;GO:0043219;GO:0072687;GO:0005874;GO:0030496;GO:0005739;GO:0072686;GO:0043209;GO:0005730;GO:0005634;GO:0033010;GO:0033270;GO:0043204;GO:0048471;GO:0005886;GO:0043220;GO:0005819;GO:0003682;GO:0035035;GO:0004407;GO:0042826;GO:0003950;GO:0070403;GO:0017136;GO:0046970;GO:0034979;GO:0033558;GO:0008134;GO:0042903;GO:0043130;GO:0008270;GO:0006914;GO:0051301;GO:0044242;GO:0061433;GO:0071872;GO:0035729;GO:0071456;GO:0071219;GO:0034599;GO:0006342;GO:0006348;GO:0048012;GO:0016575;GO:0070932;GO:0070933;GO:0045087;GO:0051321;GO:0007084;GO:0022011;GO:0010507;GO:0008285;GO:1900425;GO:0045599;GO:1900226;GO:0070446;GO:0010801;GO:0042177;GO:2000378;GO:0045843;GO:0000122;GO:0061428;GO:0045892;GO:0034983;GO:0014065;GO:0051987;GO:0051781;GO:0043388;GO:1900119;GO:0045836;GO:1900195;GO:0032436;GO:2000777;GO:0045944;GO:0043161;GO:0006471;GO:0006476;GO:0043491;GO:0000183;GO:0051726;GO:0007096;GO:0031641;GO:0042325;GO:0051775;GO:0021762;GO:0090042;, C:centriole; C:centrosome; C:chromatin silencing complex; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:glial cell projection; C:growth cone; C:heterochromatin; C:juxtaparanode region of axon; C:lateral loop; C:meiotic spindle; C:microtubule; C:midbody; C:mitochondrion; C:mitotic spindle; C:myelin sheath; C:nucleolus; C:nucleus; C:paranodal junction; C:paranode region of axon; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:Schmidt-Lanterman incisure; C:spindle;, F:chromatin binding; F:histone acetyltransferase binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H4-K16 specific); F:NAD-dependent protein deacetylase activity; F:protein deacetylase activity; F:transcription factor binding; F:tubulin deacetylase activity; F:ubiquitin binding; F:zinc ion binding;, P:autophagy; P:cell division; P:cellular lipid catabolic process; P:cellular response to caloric restriction; P:cellular response to epinephrine stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hypoxia; P:cellular response to molecule of bacterial origin; P:cellular response to oxidative stress; P:chromatin silencing; P:chromatin silencing at telomere; P:hepatocyte growth factor receptor signaling pathway; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:innate immune response; P:meiotic cell cycle; P:mitotic nuclear envelope reassembly; P:myelination in peripheral nervous system; P:negative regulation of autophagy; P:negative regulation of cell population proliferation; P:negative regulation of defense response to bacterium; P:negative regulation of fat cell differentiation; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of oligodendrocyte progenitor proliferation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein catabolic process; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of striated muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine deacetylation; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of cell division; P:positive regulation of DNA binding; P:positive regulation of execution phase of apoptosis; P:positive regulation of meiotic nuclear division; P:positive regulation of oocyte maturation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ADP-ribosylation; P:protein deacetylation; P:protein kinase B signaling; P:rDNA heterochromatin assembly; P:regulation of cell cycle; P:regulation of exit from mitosis; P:regulation of myelination; P:regulation of phosphorylation; P:response to redox state; P:substantia nigra development; P:tubulin deacetylation;|Q8IXJ6 A8K3V1 B2RB45 O95889 Q924Y7 Q9P0G8 Q9UNT0 Q9Y6E9 U5TP13,NAD-dependent protein deacetylase sirtuin-2,Regulatory protein SIR2 homolog 2;SIR2-like protein 2;, PF02146;, GO:0005814;GO:0005813;GO:0005677;GO:0005694;GO:0000781;GO:0005737;GO:0005829;GO:0097386;GO:0030426;GO:0000792;GO:0044224;GO:0043219;GO:0072687;GO:0005874;GO:0030496;GO:0005739;GO:0072686;GO:0043209;GO:0005730;GO:0005634;GO:0033010;GO:0033270;GO:0043204;GO:0048471;GO:0005886;GO:0043220;GO:0005819;GO:0003682;GO:0035035;GO:0004407;GO:0042826;GO:0003950;GO:0070403;GO:0017136;GO:0046970;GO:0034979;GO:0033558;GO:0008134;GO:0042903;GO:0043130;GO:0008270;GO:0006914;GO:0051301;GO:0044242;GO:0061433;GO:0071872;GO:0035729;GO:0071456;GO:0071219;GO:0034599;GO:0006342;GO:0006348;GO:0048012;GO:0016575;GO:0070932;GO:0070933;GO:0045087;GO:0051321;GO:0007084;GO:0022011;GO:0010507;GO:0008285;GO:1900425;GO:0045599;GO:1900226;GO:0070446;GO:0010801;GO:0042177;GO:2000378;GO:0045843;GO:0000122;GO:0061428;GO:0045892;GO:0034983;GO:0014065;GO:0051987;GO:0051781;GO:0043388;GO:1900119;GO:0045836;GO:1900195;GO:0032436;GO:2000777;GO:0045944;GO:0043161;GO:0006471;GO:0006476;GO:0043491;GO:0000183;GO:0051726;GO:0007096;GO:0031641;GO:0042325;GO:0051775;GO:0021762;GO:0090042;, C:centriole; C:centrosome; C:chromatin silencing complex; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:glial cell projection; C:growth cone; C:heterochromatin; C:juxtaparanode region of axon; C:lateral loop; C:meiotic spindle; C:microtubule; C:midbody; C:mitochondrion; C:mitotic spindle; C:myelin sheath; C:nucleolus; C:nucleus; C:paranodal junction; C:paranode region of axon; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:Schmidt-Lanterman incisure; C:spindle;, F:chromatin binding; F:histone acetyltransferase binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H4-K16 specific); F:NAD-dependent protein deacetylase activity; F:protein deacetylase activity; F:transcription factor binding; F:tubulin deacetylase activity; F:ubiquitin binding; F:zinc ion binding;, P:autophagy; P:cell division; P:cellular lipid catabolic process; P:cellular response to caloric restriction; P:cellular response to epinephrine stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hypoxia; P:cellular response to molecule of bacterial origin; P:cellular response to oxidative stress; P:chromatin silencing; P:chromatin silencing at telomere; P:hepatocyte growth factor receptor signaling pathway; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:innate immune response; P:meiotic cell cycle; P:mitotic nuclear envelope reassembly; P:myelination in peripheral nervous system; P:negative regulation of autophagy; P:negative regulation of cell population proliferation; P:negative regulation of defense response to bacterium; P:negative regulation of fat cell differentiation; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of oligodendrocyte progenitor proliferation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein catabolic process; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of striated muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine deacetylation; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of cell division; P:positive regulation of DNA binding; P:positive regulation of execution phase of apoptosis; P:positive regulation of meiotic nuclear division; P:positive regulation of oocyte maturation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ADP-ribosylation; P:protein deacetylation; P:protein kinase B signaling; P:rDNA heterochromatin assembly; P:regulation of cell cycle; P:regulation of exit from mitosis; P:regulation of myelination; P:regulation of phosphorylation; P:response to redox state; P:substantia nigra development; P:tubulin deacetylation; scaffold1144 indexed_genome mRNA 9728 13735 . + . ID=transcript_17060;Q6ZS11 B4DPG5,Ras and Rab interactor-like protein,, PF02204;, GO:0015629;GO:0031410;GO:0001726;GO:0005096;GO:0005085;GO:0006897;GO:0015031;, C:actin cytoskeleton; C:cytoplasmic vesicle; C:ruffle;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity;, P:endocytosis; P:protein transport; scaffold1144 indexed_genome mRNA 21142 25530 . - . ID=transcript_17061;Q8IXJ6 A8K3V1 B2RB45 O95889 Q924Y7 Q9P0G8 Q9UNT0 Q9Y6E9 U5TP13,NAD-dependent protein deacetylase sirtuin-2,Regulatory protein SIR2 homolog 2;SIR2-like protein 2;, PF02146;, GO:0005814;GO:0005813;GO:0005677;GO:0005694;GO:0000781;GO:0005737;GO:0005829;GO:0097386;GO:0030426;GO:0000792;GO:0044224;GO:0043219;GO:0072687;GO:0005874;GO:0030496;GO:0005739;GO:0072686;GO:0043209;GO:0005730;GO:0005634;GO:0033010;GO:0033270;GO:0043204;GO:0048471;GO:0005886;GO:0043220;GO:0005819;GO:0003682;GO:0035035;GO:0004407;GO:0042826;GO:0003950;GO:0070403;GO:0017136;GO:0046970;GO:0034979;GO:0033558;GO:0008134;GO:0042903;GO:0043130;GO:0008270;GO:0006914;GO:0051301;GO:0044242;GO:0061433;GO:0071872;GO:0035729;GO:0071456;GO:0071219;GO:0034599;GO:0006342;GO:0006348;GO:0048012;GO:0016575;GO:0070932;GO:0070933;GO:0045087;GO:0051321;GO:0007084;GO:0022011;GO:0010507;GO:0008285;GO:1900425;GO:0045599;GO:1900226;GO:0070446;GO:0010801;GO:0042177;GO:2000378;GO:0045843;GO:0000122;GO:0061428;GO:0045892;GO:0034983;GO:0014065;GO:0051987;GO:0051781;GO:0043388;GO:1900119;GO:0045836;GO:1900195;GO:0032436;GO:2000777;GO:0045944;GO:0043161;GO:0006471;GO:0006476;GO:0043491;GO:0000183;GO:0051726;GO:0007096;GO:0031641;GO:0042325;GO:0051775;GO:0021762;GO:0090042;, C:centriole; C:centrosome; C:chromatin silencing complex; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:glial cell projection; C:growth cone; C:heterochromatin; C:juxtaparanode region of axon; C:lateral loop; C:meiotic spindle; C:microtubule; C:midbody; C:mitochondrion; C:mitotic spindle; C:myelin sheath; C:nucleolus; C:nucleus; C:paranodal junction; C:paranode region of axon; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:Schmidt-Lanterman incisure; C:spindle;, F:chromatin binding; F:histone acetyltransferase binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H4-K16 specific); F:NAD-dependent protein deacetylase activity; F:protein deacetylase activity; F:transcription factor binding; F:tubulin deacetylase activity; F:ubiquitin binding; F:zinc ion binding;, P:autophagy; P:cell division; P:cellular lipid catabolic process; P:cellular response to caloric restriction; P:cellular response to epinephrine stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hypoxia; P:cellular response to molecule of bacterial origin; P:cellular response to oxidative stress; P:chromatin silencing; P:chromatin silencing at telomere; P:hepatocyte growth factor receptor signaling pathway; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:innate immune response; P:meiotic cell cycle; P:mitotic nuclear envelope reassembly; P:myelination in peripheral nervous system; P:negative regulation of autophagy; P:negative regulation of cell population proliferation; P:negative regulation of defense response to bacterium; P:negative regulation of fat cell differentiation; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of oligodendrocyte progenitor proliferation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein catabolic process; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of striated muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine deacetylation; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of cell division; P:positive regulation of DNA binding; P:positive regulation of execution phase of apoptosis; P:positive regulation of meiotic nuclear division; P:positive regulation of oocyte maturation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ADP-ribosylation; P:protein deacetylation; P:protein kinase B signaling; P:rDNA heterochromatin assembly; P:regulation of cell cycle; P:regulation of exit from mitosis; P:regulation of myelination; P:regulation of phosphorylation; P:response to redox state; P:substantia nigra development; P:tubulin deacetylation;|Q8IXJ6 A8K3V1 B2RB45 O95889 Q924Y7 Q9P0G8 Q9UNT0 Q9Y6E9 U5TP13,NAD-dependent protein deacetylase sirtuin-2,Regulatory protein SIR2 homolog 2;SIR2-like protein 2;, PF02146;, GO:0005814;GO:0005813;GO:0005677;GO:0005694;GO:0000781;GO:0005737;GO:0005829;GO:0097386;GO:0030426;GO:0000792;GO:0044224;GO:0043219;GO:0072687;GO:0005874;GO:0030496;GO:0005739;GO:0072686;GO:0043209;GO:0005730;GO:0005634;GO:0033010;GO:0033270;GO:0043204;GO:0048471;GO:0005886;GO:0043220;GO:0005819;GO:0003682;GO:0035035;GO:0004407;GO:0042826;GO:0003950;GO:0070403;GO:0017136;GO:0046970;GO:0034979;GO:0033558;GO:0008134;GO:0042903;GO:0043130;GO:0008270;GO:0006914;GO:0051301;GO:0044242;GO:0061433;GO:0071872;GO:0035729;GO:0071456;GO:0071219;GO:0034599;GO:0006342;GO:0006348;GO:0048012;GO:0016575;GO:0070932;GO:0070933;GO:0045087;GO:0051321;GO:0007084;GO:0022011;GO:0010507;GO:0008285;GO:1900425;GO:0045599;GO:1900226;GO:0070446;GO:0010801;GO:0042177;GO:2000378;GO:0045843;GO:0000122;GO:0061428;GO:0045892;GO:0034983;GO:0014065;GO:0051987;GO:0051781;GO:0043388;GO:1900119;GO:0045836;GO:1900195;GO:0032436;GO:2000777;GO:0045944;GO:0043161;GO:0006471;GO:0006476;GO:0043491;GO:0000183;GO:0051726;GO:0007096;GO:0031641;GO:0042325;GO:0051775;GO:0021762;GO:0090042;, C:centriole; C:centrosome; C:chromatin silencing complex; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:glial cell projection; C:growth cone; C:heterochromatin; C:juxtaparanode region of axon; C:lateral loop; C:meiotic spindle; C:microtubule; C:midbody; C:mitochondrion; C:mitotic spindle; C:myelin sheath; C:nucleolus; C:nucleus; C:paranodal junction; C:paranode region of axon; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:Schmidt-Lanterman incisure; C:spindle;, F:chromatin binding; F:histone acetyltransferase binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H4-K16 specific); F:NAD-dependent protein deacetylase activity; F:protein deacetylase activity; F:transcription factor binding; F:tubulin deacetylase activity; F:ubiquitin binding; F:zinc ion binding;, P:autophagy; P:cell division; P:cellular lipid catabolic process; P:cellular response to caloric restriction; P:cellular response to epinephrine stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hypoxia; P:cellular response to molecule of bacterial origin; P:cellular response to oxidative stress; P:chromatin silencing; P:chromatin silencing at telomere; P:hepatocyte growth factor receptor signaling pathway; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:innate immune response; P:meiotic cell cycle; P:mitotic nuclear envelope reassembly; P:myelination in peripheral nervous system; P:negative regulation of autophagy; P:negative regulation of cell population proliferation; P:negative regulation of defense response to bacterium; P:negative regulation of fat cell differentiation; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of oligodendrocyte progenitor proliferation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein catabolic process; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of striated muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine deacetylation; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of cell division; P:positive regulation of DNA binding; P:positive regulation of execution phase of apoptosis; P:positive regulation of meiotic nuclear division; P:positive regulation of oocyte maturation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ADP-ribosylation; P:protein deacetylation; P:protein kinase B signaling; P:rDNA heterochromatin assembly; P:regulation of cell cycle; P:regulation of exit from mitosis; P:regulation of myelination; P:regulation of phosphorylation; P:response to redox state; P:substantia nigra development; P:tubulin deacetylation;|Q8IXJ6 A8K3V1 B2RB45 O95889 Q924Y7 Q9P0G8 Q9UNT0 Q9Y6E9 U5TP13,NAD-dependent protein deacetylase sirtuin-2,Regulatory protein SIR2 homolog 2;SIR2-like protein 2;, PF02146;, GO:0005814;GO:0005813;GO:0005677;GO:0005694;GO:0000781;GO:0005737;GO:0005829;GO:0097386;GO:0030426;GO:0000792;GO:0044224;GO:0043219;GO:0072687;GO:0005874;GO:0030496;GO:0005739;GO:0072686;GO:0043209;GO:0005730;GO:0005634;GO:0033010;GO:0033270;GO:0043204;GO:0048471;GO:0005886;GO:0043220;GO:0005819;GO:0003682;GO:0035035;GO:0004407;GO:0042826;GO:0003950;GO:0070403;GO:0017136;GO:0046970;GO:0034979;GO:0033558;GO:0008134;GO:0042903;GO:0043130;GO:0008270;GO:0006914;GO:0051301;GO:0044242;GO:0061433;GO:0071872;GO:0035729;GO:0071456;GO:0071219;GO:0034599;GO:0006342;GO:0006348;GO:0048012;GO:0016575;GO:0070932;GO:0070933;GO:0045087;GO:0051321;GO:0007084;GO:0022011;GO:0010507;GO:0008285;GO:1900425;GO:0045599;GO:1900226;GO:0070446;GO:0010801;GO:0042177;GO:2000378;GO:0045843;GO:0000122;GO:0061428;GO:0045892;GO:0034983;GO:0014065;GO:0051987;GO:0051781;GO:0043388;GO:1900119;GO:0045836;GO:1900195;GO:0032436;GO:2000777;GO:0045944;GO:0043161;GO:0006471;GO:0006476;GO:0043491;GO:0000183;GO:0051726;GO:0007096;GO:0031641;GO:0042325;GO:0051775;GO:0021762;GO:0090042;, C:centriole; C:centrosome; C:chromatin silencing complex; C:chromosome; C:chromosome, telomeric region; C:cytoplasm; C:cytosol; C:glial cell projection; C:growth cone; C:heterochromatin; C:juxtaparanode region of axon; C:lateral loop; C:meiotic spindle; C:microtubule; C:midbody; C:mitochondrion; C:mitotic spindle; C:myelin sheath; C:nucleolus; C:nucleus; C:paranodal junction; C:paranode region of axon; C:perikaryon; C:perinuclear region of cytoplasm; C:plasma membrane; C:Schmidt-Lanterman incisure; C:spindle;, F:chromatin binding; F:histone acetyltransferase binding; F:histone deacetylase activity; F:histone deacetylase binding; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H4-K16 specific); F:NAD-dependent protein deacetylase activity; F:protein deacetylase activity; F:transcription factor binding; F:tubulin deacetylase activity; F:ubiquitin binding; F:zinc ion binding;, P:autophagy; P:cell division; P:cellular lipid catabolic process; P:cellular response to caloric restriction; P:cellular response to epinephrine stimulus; P:cellular response to hepatocyte growth factor stimulus; P:cellular response to hypoxia; P:cellular response to molecule of bacterial origin; P:cellular response to oxidative stress; P:chromatin silencing; P:chromatin silencing at telomere; P:hepatocyte growth factor receptor signaling pathway; P:histone deacetylation; P:histone H3 deacetylation; P:histone H4 deacetylation; P:innate immune response; P:meiotic cell cycle; P:mitotic nuclear envelope reassembly; P:myelination in peripheral nervous system; P:negative regulation of autophagy; P:negative regulation of cell population proliferation; P:negative regulation of defense response to bacterium; P:negative regulation of fat cell differentiation; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of oligodendrocyte progenitor proliferation; P:negative regulation of peptidyl-threonine phosphorylation; P:negative regulation of protein catabolic process; P:negative regulation of reactive oxygen species metabolic process; P:negative regulation of striated muscle tissue development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine deacetylation; P:phosphatidylinositol 3-kinase signaling; P:positive regulation of attachment of spindle microtubules to kinetochore; P:positive regulation of cell division; P:positive regulation of DNA binding; P:positive regulation of execution phase of apoptosis; P:positive regulation of meiotic nuclear division; P:positive regulation of oocyte maturation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; P:positive regulation of transcription by RNA polymerase II; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein ADP-ribosylation; P:protein deacetylation; P:protein kinase B signaling; P:rDNA heterochromatin assembly; P:regulation of cell cycle; P:regulation of exit from mitosis; P:regulation of myelination; P:regulation of phosphorylation; P:response to redox state; P:substantia nigra development; P:tubulin deacetylation; scaffold1149 indexed_genome mRNA 1617 6986 . - . ID=transcript_17062;Q16790 Q5T4R1,Carbonic anhydrase 9,Carbonate dehydratase IX;Carbonic anhydrase IX;Membrane antigen MN;P54/58N;Renal cell carcinoma-associated antigen G250;pMW1;, PF00194;, GO:0016323;GO:0016021;GO:0031528;GO:0005730;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0002009;GO:0006730;GO:0061418;GO:0042493;GO:0033574;GO:0046903;, C:basolateral plasma membrane; C:integral component of membrane; C:microvillus membrane; C:nucleolus; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:morphogenesis of an epithelium; P:one-carbon metabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to drug; P:response to testosterone; P:secretion;|Q16790 Q5T4R1,Carbonic anhydrase 9,Carbonate dehydratase IX;Carbonic anhydrase IX;Membrane antigen MN;P54/58N;Renal cell carcinoma-associated antigen G250;pMW1;, PF00194;, GO:0016323;GO:0016021;GO:0031528;GO:0005730;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0002009;GO:0006730;GO:0061418;GO:0042493;GO:0033574;GO:0046903;, C:basolateral plasma membrane; C:integral component of membrane; C:microvillus membrane; C:nucleolus; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:morphogenesis of an epithelium; P:one-carbon metabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to drug; P:response to testosterone; P:secretion; scaffold1149 indexed_genome mRNA 7971 17451 . + . ID=transcript_17063;P07951 A6NM85 P06468 Q13894 Q53FM4 Q5TCU4 Q5TCU7 Q9UH67,Tropomyosin beta chain,Beta-tropomyosin;Tropomyosin-2;, PF00261;, GO:0015629;GO:0005884;GO:0005829;GO:0005862;GO:0003779;GO:0051015;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0043462;, C:actin cytoskeleton; C:actin filament; C:cytosol; C:muscle thin filament tropomyosin;, F:actin binding; F:actin filament binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of ATPase activity;|P07951 A6NM85 P06468 Q13894 Q53FM4 Q5TCU4 Q5TCU7 Q9UH67,Tropomyosin beta chain,Beta-tropomyosin;Tropomyosin-2;, PF00261;, GO:0015629;GO:0005884;GO:0005829;GO:0005862;GO:0003779;GO:0051015;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0043462;, C:actin cytoskeleton; C:actin filament; C:cytosol; C:muscle thin filament tropomyosin;, F:actin binding; F:actin filament binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of ATPase activity;|P07951 A6NM85 P06468 Q13894 Q53FM4 Q5TCU4 Q5TCU7 Q9UH67,Tropomyosin beta chain,Beta-tropomyosin;Tropomyosin-2;, PF00261;, GO:0015629;GO:0005884;GO:0005829;GO:0005862;GO:0003779;GO:0051015;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0043462;, C:actin cytoskeleton; C:actin filament; C:cytosol; C:muscle thin filament tropomyosin;, F:actin binding; F:actin filament binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of ATPase activity;|P07951 A6NM85 P06468 Q13894 Q53FM4 Q5TCU4 Q5TCU7 Q9UH67,Tropomyosin beta chain,Beta-tropomyosin;Tropomyosin-2;, PF00261;, GO:0015629;GO:0005884;GO:0005829;GO:0005862;GO:0003779;GO:0051015;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0043462;, C:actin cytoskeleton; C:actin filament; C:cytosol; C:muscle thin filament tropomyosin;, F:actin binding; F:actin filament binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of ATPase activity;|P07951 A6NM85 P06468 Q13894 Q53FM4 Q5TCU4 Q5TCU7 Q9UH67,Tropomyosin beta chain,Beta-tropomyosin;Tropomyosin-2;, PF00261;, GO:0015629;GO:0005884;GO:0005829;GO:0005862;GO:0003779;GO:0051015;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0043462;, C:actin cytoskeleton; C:actin filament; C:cytosol; C:muscle thin filament tropomyosin;, F:actin binding; F:actin filament binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of ATPase activity; scaffold1149 indexed_genome mRNA 22542 24002 . + . ID=transcript_17064;Q9Y490 A6NMY0 Q86YD0 Q9NZQ2 Q9UHH8 Q9UPX3,Talin-1,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0005912;GO:0009986;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0001726;GO:0032587;GO:0051015;GO:0045296;GO:0005178;GO:0030274;GO:0035091;GO:0001786;GO:0005200;GO:0017166;GO:0098609;GO:0007043;GO:0007044;GO:0030866;GO:0033622;GO:0007229;GO:0036498;GO:0006936;GO:0070527;GO:0002576;GO:0016032;, C:adherens junction; C:cell surface; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:actin filament binding; F:cadherin binding; F:integrin binding; F:LIM domain binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:structural constituent of cytoskeleton; F:vinculin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-substrate junction assembly; P:cortical actin cytoskeleton organization; P:integrin activation; P:integrin-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:muscle contraction; P:platelet aggregation; P:platelet degranulation; P:viral process; scaffold1150 indexed_genome mRNA 1617 6987 . - . ID=transcript_17065;Q16790 Q5T4R1,Carbonic anhydrase 9,Carbonate dehydratase IX;Carbonic anhydrase IX;Membrane antigen MN;P54/58N;Renal cell carcinoma-associated antigen G250;pMW1;, PF00194;, GO:0016323;GO:0016021;GO:0031528;GO:0005730;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0002009;GO:0006730;GO:0061418;GO:0042493;GO:0033574;GO:0046903;, C:basolateral plasma membrane; C:integral component of membrane; C:microvillus membrane; C:nucleolus; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:morphogenesis of an epithelium; P:one-carbon metabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to drug; P:response to testosterone; P:secretion;|Q16790 Q5T4R1,Carbonic anhydrase 9,Carbonate dehydratase IX;Carbonic anhydrase IX;Membrane antigen MN;P54/58N;Renal cell carcinoma-associated antigen G250;pMW1;, PF00194;, GO:0016323;GO:0016021;GO:0031528;GO:0005730;GO:0005886;GO:0004089;GO:0016836;GO:0008270;GO:0015701;GO:0002009;GO:0006730;GO:0061418;GO:0042493;GO:0033574;GO:0046903;, C:basolateral plasma membrane; C:integral component of membrane; C:microvillus membrane; C:nucleolus; C:plasma membrane;, F:carbonate dehydratase activity; F:hydro-lyase activity; F:zinc ion binding;, P:bicarbonate transport; P:morphogenesis of an epithelium; P:one-carbon metabolic process; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; P:response to drug; P:response to testosterone; P:secretion; scaffold1150 indexed_genome mRNA 7972 17449 . - . ID=transcript_17066;P07951 A6NM85 P06468 Q13894 Q53FM4 Q5TCU4 Q5TCU7 Q9UH67,Tropomyosin beta chain,Beta-tropomyosin;Tropomyosin-2;, PF00261;, GO:0015629;GO:0005884;GO:0005829;GO:0005862;GO:0003779;GO:0051015;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0043462;, C:actin cytoskeleton; C:actin filament; C:cytosol; C:muscle thin filament tropomyosin;, F:actin binding; F:actin filament binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of ATPase activity;|P07951 A6NM85 P06468 Q13894 Q53FM4 Q5TCU4 Q5TCU7 Q9UH67,Tropomyosin beta chain,Beta-tropomyosin;Tropomyosin-2;, PF00261;, GO:0015629;GO:0005884;GO:0005829;GO:0005862;GO:0003779;GO:0051015;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0043462;, C:actin cytoskeleton; C:actin filament; C:cytosol; C:muscle thin filament tropomyosin;, F:actin binding; F:actin filament binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of ATPase activity;|P07951 A6NM85 P06468 Q13894 Q53FM4 Q5TCU4 Q5TCU7 Q9UH67,Tropomyosin beta chain,Beta-tropomyosin;Tropomyosin-2;, PF00261;, GO:0015629;GO:0005884;GO:0005829;GO:0005862;GO:0003779;GO:0051015;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0043462;, C:actin cytoskeleton; C:actin filament; C:cytosol; C:muscle thin filament tropomyosin;, F:actin binding; F:actin filament binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of ATPase activity;|P07951 A6NM85 P06468 Q13894 Q53FM4 Q5TCU4 Q5TCU7 Q9UH67,Tropomyosin beta chain,Beta-tropomyosin;Tropomyosin-2;, PF00261;, GO:0015629;GO:0005884;GO:0005829;GO:0005862;GO:0003779;GO:0051015;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0043462;, C:actin cytoskeleton; C:actin filament; C:cytosol; C:muscle thin filament tropomyosin;, F:actin binding; F:actin filament binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of ATPase activity;|P07951 A6NM85 P06468 Q13894 Q53FM4 Q5TCU4 Q5TCU7 Q9UH67,Tropomyosin beta chain,Beta-tropomyosin;Tropomyosin-2;, PF00261;, GO:0015629;GO:0005884;GO:0005829;GO:0005862;GO:0003779;GO:0051015;GO:0042802;GO:0046982;GO:0042803;GO:0008307;GO:0007015;GO:0006936;GO:0030049;GO:0043462;, C:actin cytoskeleton; C:actin filament; C:cytosol; C:muscle thin filament tropomyosin;, F:actin binding; F:actin filament binding; F:identical protein binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:structural constituent of muscle;, P:actin filament organization; P:muscle contraction; P:muscle filament sliding; P:regulation of ATPase activity; scaffold1150 indexed_genome mRNA 22540 24000 . - . ID=transcript_17067;Q9Y490 A6NMY0 Q86YD0 Q9NZQ2 Q9UHH8 Q9UPX3,Talin-1,, PF16511;PF00373;PF01608;PF09141;PF08913;, GO:0005912;GO:0009986;GO:0005856;GO:0005829;GO:0070062;GO:0005576;GO:0005925;GO:0005886;GO:0001726;GO:0032587;GO:0051015;GO:0045296;GO:0005178;GO:0030274;GO:0035091;GO:0001786;GO:0005200;GO:0017166;GO:0098609;GO:0007043;GO:0007044;GO:0030866;GO:0033622;GO:0007229;GO:0036498;GO:0006936;GO:0070527;GO:0002576;GO:0016032;, C:adherens junction; C:cell surface; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:extracellular region; C:focal adhesion; C:plasma membrane; C:ruffle; C:ruffle membrane;, F:actin filament binding; F:cadherin binding; F:integrin binding; F:LIM domain binding; F:phosphatidylinositol binding; F:phosphatidylserine binding; F:structural constituent of cytoskeleton; F:vinculin binding;, P:cell-cell adhesion; P:cell-cell junction assembly; P:cell-substrate junction assembly; P:cortical actin cytoskeleton organization; P:integrin activation; P:integrin-mediated signaling pathway; P:IRE1-mediated unfolded protein response; P:muscle contraction; P:platelet aggregation; P:platelet degranulation; P:viral process; scaffold1151 indexed_genome mRNA 20631 21146 . + . ID=transcript_17068;Q14431 Q16564,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CDw116;, PF18611;PF09240;, GO:0009897;GO:0005576;GO:0005887;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0038023;GO:0044267;GO:0019221;GO:0000165;, C:external side of plasma membrane; C:extracellular region; C:integral component of plasma membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:signaling receptor activity;, P:cellular protein metabolic process; P:cytokine-mediated signaling pathway; P:MAPK cascade; scaffold1154 indexed_genome mRNA 9536 11474 . - . ID=transcript_17069;Q9NUJ7 A2BH51 A2BH52,PI-PLC X domain-containing protein 1,, PF00388;, GO:0005737;GO:0008081;GO:0006629;, C:cytoplasm;, F:phosphoric diester hydrolase activity;, P:lipid metabolic process; scaffold1154 indexed_genome mRNA 16633 17788 . - . ID=transcript_17070;Q9NUJ7 A2BH51 A2BH52,PI-PLC X domain-containing protein 1,, PF00388;, GO:0005737;GO:0008081;GO:0006629;, C:cytoplasm;, F:phosphoric diester hydrolase activity;, P:lipid metabolic process; scaffold1154 indexed_genome mRNA 22994 23866 . - . ID=transcript_17071;O43824 H0Y2S1 Q53F77 Q5HYX8,Putative GTP-binding protein 6,Pseudoautosomal GTP-binding protein-like;, PF16360;PF13167;PF01926;, GO:0005737;GO:0005525;GO:0046872;GO:0043022;, C:cytoplasm;, F:GTP binding; F:metal ion binding; F:ribosome binding; scaffold1156 indexed_genome mRNA 1014 21432 . - . ID=transcript_17072;Q96EP1 A6NEN5 B4DZ77 B4E2L6 Q96SL3 Q9NRT4 Q9NT32 Q9NVD5,E3 ubiquitin-protein ligase CHFR,Checkpoint with forkhead and RING finger domains protein;RING finger protein 196;RING-type E3 ubiquitin transferase CHFR {ECO:0000305};, PF00498;PF10283;PF17979;, GO:0005634;GO:0016605;GO:0046872;GO:0000166;GO:0061630;GO:0004842;GO:0051301;GO:0044779;GO:0007093;GO:0019941;GO:0032436;GO:0031398;GO:0031648;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:PML body;, F:metal ion binding; F:nucleotide binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell division; P:meiotic spindle checkpoint; P:mitotic cell cycle checkpoint; P:modification-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96EP1 A6NEN5 B4DZ77 B4E2L6 Q96SL3 Q9NRT4 Q9NT32 Q9NVD5,E3 ubiquitin-protein ligase CHFR,Checkpoint with forkhead and RING finger domains protein;RING finger protein 196;RING-type E3 ubiquitin transferase CHFR {ECO:0000305};, PF00498;PF10283;PF17979;, GO:0005634;GO:0016605;GO:0046872;GO:0000166;GO:0061630;GO:0004842;GO:0051301;GO:0044779;GO:0007093;GO:0019941;GO:0032436;GO:0031398;GO:0031648;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:PML body;, F:metal ion binding; F:nucleotide binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell division; P:meiotic spindle checkpoint; P:mitotic cell cycle checkpoint; P:modification-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96EP1 A6NEN5 B4DZ77 B4E2L6 Q96SL3 Q9NRT4 Q9NT32 Q9NVD5,E3 ubiquitin-protein ligase CHFR,Checkpoint with forkhead and RING finger domains protein;RING finger protein 196;RING-type E3 ubiquitin transferase CHFR {ECO:0000305};, PF00498;PF10283;PF17979;, GO:0005634;GO:0016605;GO:0046872;GO:0000166;GO:0061630;GO:0004842;GO:0051301;GO:0044779;GO:0007093;GO:0019941;GO:0032436;GO:0031398;GO:0031648;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:PML body;, F:metal ion binding; F:nucleotide binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell division; P:meiotic spindle checkpoint; P:mitotic cell cycle checkpoint; P:modification-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96EP1 A6NEN5 B4DZ77 B4E2L6 Q96SL3 Q9NRT4 Q9NT32 Q9NVD5,E3 ubiquitin-protein ligase CHFR,Checkpoint with forkhead and RING finger domains protein;RING finger protein 196;RING-type E3 ubiquitin transferase CHFR {ECO:0000305};, PF00498;PF10283;PF17979;, GO:0005634;GO:0016605;GO:0046872;GO:0000166;GO:0061630;GO:0004842;GO:0051301;GO:0044779;GO:0007093;GO:0019941;GO:0032436;GO:0031398;GO:0031648;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:PML body;, F:metal ion binding; F:nucleotide binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell division; P:meiotic spindle checkpoint; P:mitotic cell cycle checkpoint; P:modification-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96EP1 A6NEN5 B4DZ77 B4E2L6 Q96SL3 Q9NRT4 Q9NT32 Q9NVD5,E3 ubiquitin-protein ligase CHFR,Checkpoint with forkhead and RING finger domains protein;RING finger protein 196;RING-type E3 ubiquitin transferase CHFR {ECO:0000305};, PF00498;PF10283;PF17979;, GO:0005634;GO:0016605;GO:0046872;GO:0000166;GO:0061630;GO:0004842;GO:0051301;GO:0044779;GO:0007093;GO:0019941;GO:0032436;GO:0031398;GO:0031648;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:PML body;, F:metal ion binding; F:nucleotide binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell division; P:meiotic spindle checkpoint; P:mitotic cell cycle checkpoint; P:modification-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96EP1 A6NEN5 B4DZ77 B4E2L6 Q96SL3 Q9NRT4 Q9NT32 Q9NVD5,E3 ubiquitin-protein ligase CHFR,Checkpoint with forkhead and RING finger domains protein;RING finger protein 196;RING-type E3 ubiquitin transferase CHFR {ECO:0000305};, PF00498;PF10283;PF17979;, GO:0005634;GO:0016605;GO:0046872;GO:0000166;GO:0061630;GO:0004842;GO:0051301;GO:0044779;GO:0007093;GO:0019941;GO:0032436;GO:0031398;GO:0031648;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:PML body;, F:metal ion binding; F:nucleotide binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell division; P:meiotic spindle checkpoint; P:mitotic cell cycle checkpoint; P:modification-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96EP1 A6NEN5 B4DZ77 B4E2L6 Q96SL3 Q9NRT4 Q9NT32 Q9NVD5,E3 ubiquitin-protein ligase CHFR,Checkpoint with forkhead and RING finger domains protein;RING finger protein 196;RING-type E3 ubiquitin transferase CHFR {ECO:0000305};, PF00498;PF10283;PF17979;, GO:0005634;GO:0016605;GO:0046872;GO:0000166;GO:0061630;GO:0004842;GO:0051301;GO:0044779;GO:0007093;GO:0019941;GO:0032436;GO:0031398;GO:0031648;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:PML body;, F:metal ion binding; F:nucleotide binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell division; P:meiotic spindle checkpoint; P:mitotic cell cycle checkpoint; P:modification-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96EP1 A6NEN5 B4DZ77 B4E2L6 Q96SL3 Q9NRT4 Q9NT32 Q9NVD5,E3 ubiquitin-protein ligase CHFR,Checkpoint with forkhead and RING finger domains protein;RING finger protein 196;RING-type E3 ubiquitin transferase CHFR {ECO:0000305};, PF00498;PF10283;PF17979;, GO:0005634;GO:0016605;GO:0046872;GO:0000166;GO:0061630;GO:0004842;GO:0051301;GO:0044779;GO:0007093;GO:0019941;GO:0032436;GO:0031398;GO:0031648;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:PML body;, F:metal ion binding; F:nucleotide binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell division; P:meiotic spindle checkpoint; P:mitotic cell cycle checkpoint; P:modification-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;|Q96EP1 A6NEN5 B4DZ77 B4E2L6 Q96SL3 Q9NRT4 Q9NT32 Q9NVD5,E3 ubiquitin-protein ligase CHFR,Checkpoint with forkhead and RING finger domains protein;RING finger protein 196;RING-type E3 ubiquitin transferase CHFR {ECO:0000305};, PF00498;PF10283;PF17979;, GO:0005634;GO:0016605;GO:0046872;GO:0000166;GO:0061630;GO:0004842;GO:0051301;GO:0044779;GO:0007093;GO:0019941;GO:0032436;GO:0031398;GO:0031648;GO:0000209;GO:0016567;GO:0006511;, C:nucleus; C:PML body;, F:metal ion binding; F:nucleotide binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;, P:cell division; P:meiotic spindle checkpoint; P:mitotic cell cycle checkpoint; P:modification-dependent protein catabolic process; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein ubiquitination; P:protein destabilization; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold1157 indexed_genome mRNA 1980 8919 . - . ID=transcript_17073;P26951 A8K3F3 B9VI81 Q5HYQ7 Q5HYQ8 Q9UEH7,Interleukin-3 receptor subunit alpha,, PF18611;PF09240;, GO:0009897;GO:0016021;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0004912;GO:0019221;GO:0000165;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-3 receptor activity;, P:cytokine-mediated signaling pathway; P:MAPK cascade; scaffold1167 indexed_genome mRNA 12 8372 . - . ID=transcript_17074;Q9HC92 Q9HC93 Q9HC94 Q9HC95,Calpain-10,Calcium-activated neutral proteinase 10;, PF01067;PF00648;, GO:0005737;GO:0005829;GO:0005739;GO:0005886;GO:0004198;GO:0008092;GO:0000149;GO:0031532;GO:0006921;GO:0032869;GO:0046326;GO:0032024;GO:0032388;GO:2000676;GO:0006508;GO:0097050;, C:cytoplasm; C:cytosol; C:mitochondrion; C:plasma membrane;, F:calcium-dependent cysteine-type endopeptidase activity; F:cytoskeletal protein binding; F:SNARE binding;, P:actin cytoskeleton reorganization; P:cellular component disassembly involved in execution phase of apoptosis; P:cellular response to insulin stimulus; P:positive regulation of glucose import; P:positive regulation of insulin secretion; P:positive regulation of intracellular transport; P:positive regulation of type B pancreatic cell apoptotic process; P:proteolysis; P:type B pancreatic cell apoptotic process;|Q9HC92 Q9HC93 Q9HC94 Q9HC95,Calpain-10,Calcium-activated neutral proteinase 10;, PF01067;PF00648;, GO:0005737;GO:0005829;GO:0005739;GO:0005886;GO:0004198;GO:0008092;GO:0000149;GO:0031532;GO:0006921;GO:0032869;GO:0046326;GO:0032024;GO:0032388;GO:2000676;GO:0006508;GO:0097050;, C:cytoplasm; C:cytosol; C:mitochondrion; C:plasma membrane;, F:calcium-dependent cysteine-type endopeptidase activity; F:cytoskeletal protein binding; F:SNARE binding;, P:actin cytoskeleton reorganization; P:cellular component disassembly involved in execution phase of apoptosis; P:cellular response to insulin stimulus; P:positive regulation of glucose import; P:positive regulation of insulin secretion; P:positive regulation of intracellular transport; P:positive regulation of type B pancreatic cell apoptotic process; P:proteolysis; P:type B pancreatic cell apoptotic process;|Q9HC92 Q9HC93 Q9HC94 Q9HC95,Calpain-10,Calcium-activated neutral proteinase 10;, PF01067;PF00648;, GO:0005737;GO:0005829;GO:0005739;GO:0005886;GO:0004198;GO:0008092;GO:0000149;GO:0031532;GO:0006921;GO:0032869;GO:0046326;GO:0032024;GO:0032388;GO:2000676;GO:0006508;GO:0097050;, C:cytoplasm; C:cytosol; C:mitochondrion; C:plasma membrane;, F:calcium-dependent cysteine-type endopeptidase activity; F:cytoskeletal protein binding; F:SNARE binding;, P:actin cytoskeleton reorganization; P:cellular component disassembly involved in execution phase of apoptosis; P:cellular response to insulin stimulus; P:positive regulation of glucose import; P:positive regulation of insulin secretion; P:positive regulation of intracellular transport; P:positive regulation of type B pancreatic cell apoptotic process; P:proteolysis; P:type B pancreatic cell apoptotic process;|Q9HC92 Q9HC93 Q9HC94 Q9HC95,Calpain-10,Calcium-activated neutral proteinase 10;, PF01067;PF00648;, GO:0005737;GO:0005829;GO:0005739;GO:0005886;GO:0004198;GO:0008092;GO:0000149;GO:0031532;GO:0006921;GO:0032869;GO:0046326;GO:0032024;GO:0032388;GO:2000676;GO:0006508;GO:0097050;, C:cytoplasm; C:cytosol; C:mitochondrion; C:plasma membrane;, F:calcium-dependent cysteine-type endopeptidase activity; F:cytoskeletal protein binding; F:SNARE binding;, P:actin cytoskeleton reorganization; P:cellular component disassembly involved in execution phase of apoptosis; P:cellular response to insulin stimulus; P:positive regulation of glucose import; P:positive regulation of insulin secretion; P:positive regulation of intracellular transport; P:positive regulation of type B pancreatic cell apoptotic process; P:proteolysis; P:type B pancreatic cell apoptotic process;|Q9HC92 Q9HC93 Q9HC94 Q9HC95,Calpain-10,Calcium-activated neutral proteinase 10;, PF01067;PF00648;, GO:0005737;GO:0005829;GO:0005739;GO:0005886;GO:0004198;GO:0008092;GO:0000149;GO:0031532;GO:0006921;GO:0032869;GO:0046326;GO:0032024;GO:0032388;GO:2000676;GO:0006508;GO:0097050;, C:cytoplasm; C:cytosol; C:mitochondrion; C:plasma membrane;, F:calcium-dependent cysteine-type endopeptidase activity; F:cytoskeletal protein binding; F:SNARE binding;, P:actin cytoskeleton reorganization; P:cellular component disassembly involved in execution phase of apoptosis; P:cellular response to insulin stimulus; P:positive regulation of glucose import; P:positive regulation of insulin secretion; P:positive regulation of intracellular transport; P:positive regulation of type B pancreatic cell apoptotic process; P:proteolysis; P:type B pancreatic cell apoptotic process; scaffold1169 indexed_genome mRNA 3333 4029 . + . ID=transcript_17075;Q9HC92 Q9HC93 Q9HC94 Q9HC95,Calpain-10,Calcium-activated neutral proteinase 10;, PF01067;PF00648;, GO:0005737;GO:0005829;GO:0005739;GO:0005886;GO:0004198;GO:0008092;GO:0000149;GO:0031532;GO:0006921;GO:0032869;GO:0046326;GO:0032024;GO:0032388;GO:2000676;GO:0006508;GO:0097050;, C:cytoplasm; C:cytosol; C:mitochondrion; C:plasma membrane;, F:calcium-dependent cysteine-type endopeptidase activity; F:cytoskeletal protein binding; F:SNARE binding;, P:actin cytoskeleton reorganization; P:cellular component disassembly involved in execution phase of apoptosis; P:cellular response to insulin stimulus; P:positive regulation of glucose import; P:positive regulation of insulin secretion; P:positive regulation of intracellular transport; P:positive regulation of type B pancreatic cell apoptotic process; P:proteolysis; P:type B pancreatic cell apoptotic process; scaffold1169 indexed_genome mRNA 4884 5597 . + . ID=transcript_17076;Q9HC92 Q9HC93 Q9HC94 Q9HC95,Calpain-10,Calcium-activated neutral proteinase 10;, PF01067;PF00648;, GO:0005737;GO:0005829;GO:0005739;GO:0005886;GO:0004198;GO:0008092;GO:0000149;GO:0031532;GO:0006921;GO:0032869;GO:0046326;GO:0032024;GO:0032388;GO:2000676;GO:0006508;GO:0097050;, C:cytoplasm; C:cytosol; C:mitochondrion; C:plasma membrane;, F:calcium-dependent cysteine-type endopeptidase activity; F:cytoskeletal protein binding; F:SNARE binding;, P:actin cytoskeleton reorganization; P:cellular component disassembly involved in execution phase of apoptosis; P:cellular response to insulin stimulus; P:positive regulation of glucose import; P:positive regulation of insulin secretion; P:positive regulation of intracellular transport; P:positive regulation of type B pancreatic cell apoptotic process; P:proteolysis; P:type B pancreatic cell apoptotic process; scaffold1172 indexed_genome mRNA 4178 4756 . - . ID=transcript_17077;O75513 Q9UET1,Deformed epidermal autoregulatory factor 1 homolog,Nuclear DEAF-1-related transcriptional regulator;Suppressin;Zinc finger MYND domain-containing protein 5;, PF01342;PF01753;, GO:0000785;GO:0005737;GO:0005576;GO:0001650;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0009653;GO:0048706;GO:0007281;GO:0000122;GO:0045892;GO:0001843;GO:0045893;GO:0033599;GO:0006357;GO:0006366;, C:chromatin; C:cytoplasm; C:extracellular region; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:embryonic skeletal system development; P:germ cell development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold1172 indexed_genome mRNA 6438 6993 . - . ID=transcript_17078;O75513 Q9UET1,Deformed epidermal autoregulatory factor 1 homolog,Nuclear DEAF-1-related transcriptional regulator;Suppressin;Zinc finger MYND domain-containing protein 5;, PF01342;PF01753;, GO:0000785;GO:0005737;GO:0005576;GO:0001650;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0009653;GO:0048706;GO:0007281;GO:0000122;GO:0045892;GO:0001843;GO:0045893;GO:0033599;GO:0006357;GO:0006366;, C:chromatin; C:cytoplasm; C:extracellular region; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:embryonic skeletal system development; P:germ cell development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold1172 indexed_genome mRNA 16293 23825 . + . ID=transcript_17079;O75513 Q9UET1,Deformed epidermal autoregulatory factor 1 homolog,Nuclear DEAF-1-related transcriptional regulator;Suppressin;Zinc finger MYND domain-containing protein 5;, PF01342;PF01753;, GO:0000785;GO:0005737;GO:0005576;GO:0001650;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0009653;GO:0048706;GO:0007281;GO:0000122;GO:0045892;GO:0001843;GO:0045893;GO:0033599;GO:0006357;GO:0006366;, C:chromatin; C:cytoplasm; C:extracellular region; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:embryonic skeletal system development; P:germ cell development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75513 Q9UET1,Deformed epidermal autoregulatory factor 1 homolog,Nuclear DEAF-1-related transcriptional regulator;Suppressin;Zinc finger MYND domain-containing protein 5;, PF01342;PF01753;, GO:0000785;GO:0005737;GO:0005576;GO:0001650;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0009653;GO:0048706;GO:0007281;GO:0000122;GO:0045892;GO:0001843;GO:0045893;GO:0033599;GO:0006357;GO:0006366;, C:chromatin; C:cytoplasm; C:extracellular region; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:embryonic skeletal system development; P:germ cell development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold1173 indexed_genome mRNA 179 23784 . + . ID=transcript_17080;O75513 Q9UET1,Deformed epidermal autoregulatory factor 1 homolog,Nuclear DEAF-1-related transcriptional regulator;Suppressin;Zinc finger MYND domain-containing protein 5;, PF01342;PF01753;, GO:0000785;GO:0005737;GO:0005576;GO:0001650;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0009653;GO:0048706;GO:0007281;GO:0000122;GO:0045892;GO:0001843;GO:0045893;GO:0033599;GO:0006357;GO:0006366;, C:chromatin; C:cytoplasm; C:extracellular region; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:embryonic skeletal system development; P:germ cell development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75513 Q9UET1,Deformed epidermal autoregulatory factor 1 homolog,Nuclear DEAF-1-related transcriptional regulator;Suppressin;Zinc finger MYND domain-containing protein 5;, PF01342;PF01753;, GO:0000785;GO:0005737;GO:0005576;GO:0001650;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0009653;GO:0048706;GO:0007281;GO:0000122;GO:0045892;GO:0001843;GO:0045893;GO:0033599;GO:0006357;GO:0006366;, C:chromatin; C:cytoplasm; C:extracellular region; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:embryonic skeletal system development; P:germ cell development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75513 Q9UET1,Deformed epidermal autoregulatory factor 1 homolog,Nuclear DEAF-1-related transcriptional regulator;Suppressin;Zinc finger MYND domain-containing protein 5;, PF01342;PF01753;, GO:0000785;GO:0005737;GO:0005576;GO:0001650;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0009653;GO:0048706;GO:0007281;GO:0000122;GO:0045892;GO:0001843;GO:0045893;GO:0033599;GO:0006357;GO:0006366;, C:chromatin; C:cytoplasm; C:extracellular region; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:embryonic skeletal system development; P:germ cell development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75513 Q9UET1,Deformed epidermal autoregulatory factor 1 homolog,Nuclear DEAF-1-related transcriptional regulator;Suppressin;Zinc finger MYND domain-containing protein 5;, PF01342;PF01753;, GO:0000785;GO:0005737;GO:0005576;GO:0001650;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0009653;GO:0048706;GO:0007281;GO:0000122;GO:0045892;GO:0001843;GO:0045893;GO:0033599;GO:0006357;GO:0006366;, C:chromatin; C:cytoplasm; C:extracellular region; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:embryonic skeletal system development; P:germ cell development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;|O75513 Q9UET1,Deformed epidermal autoregulatory factor 1 homolog,Nuclear DEAF-1-related transcriptional regulator;Suppressin;Zinc finger MYND domain-containing protein 5;, PF01342;PF01753;, GO:0000785;GO:0005737;GO:0005576;GO:0001650;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0046872;GO:0000977;GO:0009653;GO:0048706;GO:0007281;GO:0000122;GO:0045892;GO:0001843;GO:0045893;GO:0033599;GO:0006357;GO:0006366;, C:chromatin; C:cytoplasm; C:extracellular region; C:fibrillar center; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:anatomical structure morphogenesis; P:embryonic skeletal system development; P:germ cell development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural tube closure; P:positive regulation of transcription, DNA-templated; P:regulation of mammary gland epithelial cell proliferation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II; scaffold1174 indexed_genome mRNA 16538 18481 . + . ID=transcript_17081;Q9UF02 A8K2A6 Q547R3 Q8WXS7 Q9UHM3,Voltage-dependent calcium channel gamma-5 subunit,Neuronal voltage-gated calcium channel gamma-5 subunit;Transmembrane AMPAR regulatory protein gamma-5;, PF00822;, GO:0032281;GO:0098978;GO:0099055;GO:0014069;GO:0098839;GO:0016247;GO:0015075;GO:0005245;GO:0099590;GO:0098943;GO:0051968;GO:0098970;GO:2000311;GO:0098962;GO:0019226;, C:AMPA glutamate receptor complex; C:glutamatergic synapse; C:integral component of postsynaptic membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:channel regulator activity; F:ion transmembrane transporter activity; F:voltage-gated calcium channel activity;, P:neurotransmitter receptor internalization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic neurotransmitter receptor diffusion trapping; P:regulation of AMPA receptor activity; P:regulation of postsynaptic neurotransmitter receptor activity; P:transmission of nerve impulse; scaffold1174 indexed_genome mRNA 23552 24135 . + . ID=transcript_17082;Q9UF02 A8K2A6 Q547R3 Q8WXS7 Q9UHM3,Voltage-dependent calcium channel gamma-5 subunit,Neuronal voltage-gated calcium channel gamma-5 subunit;Transmembrane AMPAR regulatory protein gamma-5;, PF00822;, GO:0032281;GO:0098978;GO:0099055;GO:0014069;GO:0098839;GO:0016247;GO:0015075;GO:0005245;GO:0099590;GO:0098943;GO:0051968;GO:0098970;GO:2000311;GO:0098962;GO:0019226;, C:AMPA glutamate receptor complex; C:glutamatergic synapse; C:integral component of postsynaptic membrane; C:postsynaptic density; C:postsynaptic density membrane;, F:channel regulator activity; F:ion transmembrane transporter activity; F:voltage-gated calcium channel activity;, P:neurotransmitter receptor internalization; P:neurotransmitter receptor transport, postsynaptic endosome to lysosome; P:positive regulation of synaptic transmission, glutamatergic; P:postsynaptic neurotransmitter receptor diffusion trapping; P:regulation of AMPA receptor activity; P:regulation of postsynaptic neurotransmitter receptor activity; P:transmission of nerve impulse; scaffold1181 indexed_genome mRNA 262 16238 . + . ID=transcript_17083;P47992 Q52MA8,Lymphotactin,ATAC;C motif chemokine 1;Cytokine SCM-1;Lymphotaxin;SCM-1-alpha;Small-inducible cytokine C1;XC chemokine ligand 1;, PF00048;, GO:0005576;GO:0005615;GO:0048020;GO:0008009;GO:0042379;GO:0042803;GO:0061844;GO:0007267;GO:0071346;GO:0071347;GO:0071353;GO:0071560;GO:0071356;GO:0070098;GO:0007186;GO:0006954;GO:0031640;GO:0048247;GO:0035782;GO:0002548;GO:2000562;GO:0043433;GO:0032689;GO:0032703;GO:0002725;GO:2000518;GO:0002826;GO:0045892;GO:0030593;GO:2000538;GO:2000563;GO:2000566;GO:0070374;GO:2000513;GO:0071663;GO:0043547;GO:2000558;GO:0032733;GO:0002690;GO:2000503;GO:0090023;GO:0051281;GO:0010820;GO:0002726;GO:0001916;GO:2000556;GO:2000553;GO:2000412;GO:0071636;GO:0050727;GO:0051209;GO:0009615;GO:0007165;, C:extracellular region; C:extracellular space;, F:CCR chemokine receptor binding; F:chemokine activity; F:chemokine receptor binding; F:protein homodimerization activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:cell-cell signaling; P:cellular response to interferon-gamma; P:cellular response to interleukin-1; P:cellular response to interleukin-4; P:cellular response to transforming growth factor beta stimulus; P:cellular response to tumor necrosis factor; P:chemokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:inflammatory response; P:killing of cells of other organism; P:lymphocyte chemotaxis; P:mature natural killer cell chemotaxis; P:monocyte chemotaxis; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-2 production; P:negative regulation of T cell cytokine production; P:negative regulation of T-helper 1 cell activation; P:negative regulation of T-helper 1 type immune response; P:negative regulation of transcription, DNA-templated; P:neutrophil chemotaxis; P:positive regulation of B cell chemotaxis; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; P:positive regulation of CD8-positive, alpha-beta T cell proliferation; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of granzyme A production; P:positive regulation of granzyme B production; P:positive regulation of GTPase activity; P:positive regulation of immunoglobulin production in mucosal tissue; P:positive regulation of interleukin-10 production; P:positive regulation of leukocyte chemotaxis; P:positive regulation of natural killer cell chemotaxis; P:positive regulation of neutrophil chemotaxis; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of T cell chemotaxis; P:positive regulation of T cell cytokine production; P:positive regulation of T cell mediated cytotoxicity; P:positive regulation of T-helper 1 cell cytokine production; P:positive regulation of T-helper 2 cell cytokine production; P:positive regulation of thymocyte migration; P:positive regulation of transforming growth factor beta production; P:regulation of inflammatory response; P:release of sequestered calcium ion into cytosol; P:response to virus; P:signal transduction; scaffold1187 indexed_genome mRNA 1055 2384 . - . ID=transcript_17084;Q9Y2A7 O60329 Q53QN5 Q53S94 Q53Y35,Nck-associated protein 1,Membrane-associated protein HEM-2;p125Nap1;, PF09735;, GO:0005829;GO:0070062;GO:0031941;GO:0005925;GO:0016021;GO:0030027;GO:0031258;GO:0001726;GO:0031209;GO:0006915;GO:0016477;GO:0000902;GO:0030031;GO:0007417;GO:0030866;GO:0038096;GO:0048812;GO:0030838;GO:2000601;GO:0010592;GO:0016601;GO:0048010;GO:0016032;, C:cytosol; C:extracellular exosome; C:filamentous actin; C:focal adhesion; C:integral component of membrane; C:lamellipodium; C:lamellipodium membrane; C:ruffle; C:SCAR complex;, , P:apoptotic process; P:cell migration; P:cell morphogenesis; P:cell projection assembly; P:central nervous system development; P:cortical actin cytoskeleton organization; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:neuron projection morphogenesis; P:positive regulation of actin filament polymerization; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of lamellipodium assembly; P:Rac protein signal transduction; P:vascular endothelial growth factor receptor signaling pathway; P:viral process; scaffold1192 indexed_genome mRNA 4813 24696 . + . ID=transcript_17085;Q15386 A4D235 A6NCP3 Q8TC15 Q96CR4 Q9UDU3,Ubiquitin-protein ligase E3C,HECT-type ubiquitin transferase E3C;HectH2;, PF00632;, GO:0005634;GO:0000502;GO:0061630;GO:0000209;GO:0006511;, C:nucleus; C:proteasome complex;, F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q15386 A4D235 A6NCP3 Q8TC15 Q96CR4 Q9UDU3,Ubiquitin-protein ligase E3C,HECT-type ubiquitin transferase E3C;HectH2;, PF00632;, GO:0005634;GO:0000502;GO:0061630;GO:0000209;GO:0006511;, C:nucleus; C:proteasome complex;, F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process;|Q15386 A4D235 A6NCP3 Q8TC15 Q96CR4 Q9UDU3,Ubiquitin-protein ligase E3C,HECT-type ubiquitin transferase E3C;HectH2;, PF00632;, GO:0005634;GO:0000502;GO:0061630;GO:0000209;GO:0006511;, C:nucleus; C:proteasome complex;, F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold1193 indexed_genome mRNA 10750 11999 . - . ID=transcript_17086;Q15386 A4D235 A6NCP3 Q8TC15 Q96CR4 Q9UDU3,Ubiquitin-protein ligase E3C,HECT-type ubiquitin transferase E3C;HectH2;, PF00632;, GO:0005634;GO:0000502;GO:0061630;GO:0000209;GO:0006511;, C:nucleus; C:proteasome complex;, F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold1193 indexed_genome mRNA 15614 17886 . + . ID=transcript_17087;Q15386 A4D235 A6NCP3 Q8TC15 Q96CR4 Q9UDU3,Ubiquitin-protein ligase E3C,HECT-type ubiquitin transferase E3C;HectH2;, PF00632;, GO:0005634;GO:0000502;GO:0061630;GO:0000209;GO:0006511;, C:nucleus; C:proteasome complex;, F:ubiquitin protein ligase activity;, P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold1194 indexed_genome mRNA 15549 16135 . + . ID=transcript_17088;Q8IYF3 A8K8V6 Q5JQQ8 Q96LZ4 Q96M47 Q9BXU6,Testis-expressed protein 11,Protein ZIP4 homolog {ECO:0000250|UniProtKB:Q14AT2};, PF08631;, GO:0000801;GO:0005694;GO:0051026;GO:0009566;GO:0008584;GO:0007060;GO:0006311;GO:0043066;GO:0007131;GO:0000712;GO:0007130;, C:central element; C:chromosome;, , P:chiasma assembly; P:fertilization; P:male gonad development; P:male meiosis chromosome segregation; P:meiotic gene conversion; P:negative regulation of apoptotic process; P:reciprocal meiotic recombination; P:resolution of meiotic recombination intermediates; P:synaptonemal complex assembly; scaffold1226 indexed_genome mRNA 5681 20617 . + . ID=transcript_17089;Q96NW4 Q71MF5 Q86UC3 Q8ND80 Q9H0I4,Ankyrin repeat domain-containing protein 27,VPS9 domain-containing protein;, PF00023;PF12796;PF02204;, GO:0030659;GO:0005829;GO:0005769;GO:0005770;GO:0005764;GO:0042470;GO:0016020;GO:0043005;GO:0005886;GO:0030133;GO:0097422;GO:0005096;GO:0005085;GO:0031267;GO:0000149;GO:0045022;GO:0035646;GO:0035544;GO:0048812;GO:0050775;GO:0010976;GO:0015031;GO:1990126;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:late endosome; C:lysosome; C:melanosome; C:membrane; C:neuron projection; C:plasma membrane; C:transport vesicle; C:tubular endosome;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:SNARE binding;, P:early endosome to late endosome transport; P:endosome to melanosome transport; P:negative regulation of SNARE complex assembly; P:neuron projection morphogenesis; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron projection development; P:protein transport; P:retrograde transport, endosome to plasma membrane;|Q96NW4 Q71MF5 Q86UC3 Q8ND80 Q9H0I4,Ankyrin repeat domain-containing protein 27,VPS9 domain-containing protein;, PF00023;PF12796;PF02204;, GO:0030659;GO:0005829;GO:0005769;GO:0005770;GO:0005764;GO:0042470;GO:0016020;GO:0043005;GO:0005886;GO:0030133;GO:0097422;GO:0005096;GO:0005085;GO:0031267;GO:0000149;GO:0045022;GO:0035646;GO:0035544;GO:0048812;GO:0050775;GO:0010976;GO:0015031;GO:1990126;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:late endosome; C:lysosome; C:melanosome; C:membrane; C:neuron projection; C:plasma membrane; C:transport vesicle; C:tubular endosome;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:SNARE binding;, P:early endosome to late endosome transport; P:endosome to melanosome transport; P:negative regulation of SNARE complex assembly; P:neuron projection morphogenesis; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron projection development; P:protein transport; P:retrograde transport, endosome to plasma membrane; scaffold1227 indexed_genome mRNA 12422 14053 . - . ID=transcript_17090;Q96NW4 Q71MF5 Q86UC3 Q8ND80 Q9H0I4,Ankyrin repeat domain-containing protein 27,VPS9 domain-containing protein;, PF00023;PF12796;PF02204;, GO:0030659;GO:0005829;GO:0005769;GO:0005770;GO:0005764;GO:0042470;GO:0016020;GO:0043005;GO:0005886;GO:0030133;GO:0097422;GO:0005096;GO:0005085;GO:0031267;GO:0000149;GO:0045022;GO:0035646;GO:0035544;GO:0048812;GO:0050775;GO:0010976;GO:0015031;GO:1990126;, C:cytoplasmic vesicle membrane; C:cytosol; C:early endosome; C:late endosome; C:lysosome; C:melanosome; C:membrane; C:neuron projection; C:plasma membrane; C:transport vesicle; C:tubular endosome;, F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:small GTPase binding; F:SNARE binding;, P:early endosome to late endosome transport; P:endosome to melanosome transport; P:negative regulation of SNARE complex assembly; P:neuron projection morphogenesis; P:positive regulation of dendrite morphogenesis; P:positive regulation of neuron projection development; P:protein transport; P:retrograde transport, endosome to plasma membrane; scaffold1234 indexed_genome mRNA 8774 9568 . + . ID=transcript_17091;Q8TDR0 Q6PCT1 Q7L8N9 Q9NRD6 Q9Y4Q1,TRAF3-interacting protein 1,Interleukin-13 receptor alpha 1-binding protein 1;Intraflagellar transport protein 54 homolog;Microtubule-interacting protein associated with TRAF3;, PF10243;PF17749;, GO:0005930;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0035869;GO:0005929;GO:0030992;GO:0008017;GO:0060271;GO:0042073;GO:0035735;GO:0001822;GO:0001738;GO:0050687;GO:0001933;GO:0031333;GO:0032480;GO:0070507;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:ciliary transition zone; C:cilium; C:intraciliary transport particle B;, F:microtubule binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:morphogenesis of a polarized epithelium; P:negative regulation of defense response to virus; P:negative regulation of protein phosphorylation; P:negative regulation of protein-containing complex assembly; P:negative regulation of type I interferon production; P:regulation of microtubule cytoskeleton organization; scaffold1237 indexed_genome mRNA 13635 16128 . - . ID=transcript_17092;Q9NVJ2 B4DI85,ADP-ribosylation factor-like protein 8B,ADP-ribosylation factor-like protein 10C;Novel small G protein indispensable for equal chromosome segregation 1;, PF00025;, GO:1904115;GO:0005737;GO:0070062;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0030496;GO:0051233;GO:0045202;GO:0005774;GO:0043014;GO:0048487;GO:0019003;GO:0005525;GO:0003924;GO:0008089;GO:0002747;GO:0002505;GO:0007049;GO:0051301;GO:0007059;GO:0016197;GO:0090117;GO:1902774;GO:0032418;GO:0090385;GO:0015031;GO:0046754;, C:axon cytoplasm; C:cytoplasm; C:extracellular exosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:midbody; C:spindle midzone; C:synapse; C:vacuolar membrane;, F:alpha-tubulin binding; F:beta-tubulin binding; F:GDP binding; F:GTP binding; F:GTPase activity;, P:anterograde axonal transport; P:antigen processing and presentation following phagocytosis; P:antigen processing and presentation of polysaccharide antigen via MHC class II; P:cell cycle; P:cell division; P:chromosome segregation; P:endosomal transport; P:endosome to lysosome transport of low-density lipoprotein particle; P:late endosome to lysosome transport; P:lysosome localization; P:phagosome-lysosome fusion; P:protein transport; P:viral exocytosis;|Q9NVJ2 B4DI85,ADP-ribosylation factor-like protein 8B,ADP-ribosylation factor-like protein 10C;Novel small G protein indispensable for equal chromosome segregation 1;, PF00025;, GO:1904115;GO:0005737;GO:0070062;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0030496;GO:0051233;GO:0045202;GO:0005774;GO:0043014;GO:0048487;GO:0019003;GO:0005525;GO:0003924;GO:0008089;GO:0002747;GO:0002505;GO:0007049;GO:0051301;GO:0007059;GO:0016197;GO:0090117;GO:1902774;GO:0032418;GO:0090385;GO:0015031;GO:0046754;, C:axon cytoplasm; C:cytoplasm; C:extracellular exosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:midbody; C:spindle midzone; C:synapse; C:vacuolar membrane;, F:alpha-tubulin binding; F:beta-tubulin binding; F:GDP binding; F:GTP binding; F:GTPase activity;, P:anterograde axonal transport; P:antigen processing and presentation following phagocytosis; P:antigen processing and presentation of polysaccharide antigen via MHC class II; P:cell cycle; P:cell division; P:chromosome segregation; P:endosomal transport; P:endosome to lysosome transport of low-density lipoprotein particle; P:late endosome to lysosome transport; P:lysosome localization; P:phagosome-lysosome fusion; P:protein transport; P:viral exocytosis; scaffold1238 indexed_genome mRNA 13637 15042 . - . ID=transcript_17093;Q9NVJ2 B4DI85,ADP-ribosylation factor-like protein 8B,ADP-ribosylation factor-like protein 10C;Novel small G protein indispensable for equal chromosome segregation 1;, PF00025;, GO:1904115;GO:0005737;GO:0070062;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0030496;GO:0051233;GO:0045202;GO:0005774;GO:0043014;GO:0048487;GO:0019003;GO:0005525;GO:0003924;GO:0008089;GO:0002747;GO:0002505;GO:0007049;GO:0051301;GO:0007059;GO:0016197;GO:0090117;GO:1902774;GO:0032418;GO:0090385;GO:0015031;GO:0046754;, C:axon cytoplasm; C:cytoplasm; C:extracellular exosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:midbody; C:spindle midzone; C:synapse; C:vacuolar membrane;, F:alpha-tubulin binding; F:beta-tubulin binding; F:GDP binding; F:GTP binding; F:GTPase activity;, P:anterograde axonal transport; P:antigen processing and presentation following phagocytosis; P:antigen processing and presentation of polysaccharide antigen via MHC class II; P:cell cycle; P:cell division; P:chromosome segregation; P:endosomal transport; P:endosome to lysosome transport of low-density lipoprotein particle; P:late endosome to lysosome transport; P:lysosome localization; P:phagosome-lysosome fusion; P:protein transport; P:viral exocytosis; scaffold1256 indexed_genome mRNA 14109 15270 . - . ID=transcript_17094;Q96NY9 Q9H7D9,Crossover junction endonuclease MUS81,, PF02732;, GO:0048476;GO:0005730;GO:0005654;GO:0005634;GO:0048257;GO:0003677;GO:0046872;GO:0000737;GO:0006281;GO:0000727;GO:0036297;GO:0031573;GO:0033687;GO:0000712;GO:0072429;, C:Holliday junction resolvase complex; C:nucleolus; C:nucleoplasm; C:nucleus;, F:3'-flap endonuclease activity; F:DNA binding; F:metal ion binding;, P:DNA catabolic process, endonucleolytic; P:DNA repair; P:double-strand break repair via break-induced replication; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:osteoblast proliferation; P:resolution of meiotic recombination intermediates; P:response to intra-S DNA damage checkpoint signaling; scaffold1257 indexed_genome mRNA 14074 19461 . - . ID=transcript_17095;Q96RK0 Q7LGI1 Q9UEG5 Q9Y6T1,Protein capicua homolog,, PF00505;, GO:0000785;GO:0043231;GO:0005654;GO:0005634;GO:0000981;GO:0000977;GO:0007420;GO:0007612;GO:0007613;GO:0045892;GO:0006357;GO:0035176;, C:chromatin; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;, P:brain development; P:learning; P:memory; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:social behavior; scaffold1265 indexed_genome mRNA 2028 22477 . + . ID=transcript_17096;Q13330 A5PLK4 Q86SW2 Q8NFI8 Q96GI8,Metastasis-associated protein MTA1,, PF01426;PF01448;PF00320;PF17226;PF00249;, GO:0005737;GO:0005829;GO:0043231;GO:0005874;GO:0005635;GO:0005654;GO:0005634;GO:0016581;GO:0003682;GO:0042826;GO:0000978;GO:0001103;GO:0003713;GO:0003714;GO:0008270;GO:0032922;GO:0006302;GO:0043153;GO:0016575;GO:0045475;GO:0000122;GO:1902499;GO:0043161;GO:0040029;GO:0010212;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:microtubule; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:chromatin binding; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:circadian regulation of gene expression; P:double-strand break repair; P:entrainment of circadian clock by photoperiod; P:histone deacetylation; P:locomotor rhythm; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein autoubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of gene expression, epigenetic; P:response to ionizing radiation; P:signal transduction;|Q13330 A5PLK4 Q86SW2 Q8NFI8 Q96GI8,Metastasis-associated protein MTA1,, PF01426;PF01448;PF00320;PF17226;PF00249;, GO:0005737;GO:0005829;GO:0043231;GO:0005874;GO:0005635;GO:0005654;GO:0005634;GO:0016581;GO:0003682;GO:0042826;GO:0000978;GO:0001103;GO:0003713;GO:0003714;GO:0008270;GO:0032922;GO:0006302;GO:0043153;GO:0016575;GO:0045475;GO:0000122;GO:1902499;GO:0043161;GO:0040029;GO:0010212;GO:0007165;, C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:microtubule; C:nuclear envelope; C:nucleoplasm; C:nucleus; C:NuRD complex;, F:chromatin binding; F:histone deacetylase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:transcription coactivator activity; F:transcription corepressor activity; F:zinc ion binding;, P:circadian regulation of gene expression; P:double-strand break repair; P:entrainment of circadian clock by photoperiod; P:histone deacetylation; P:locomotor rhythm; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of protein autoubiquitination; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:regulation of gene expression, epigenetic; P:response to ionizing radiation; P:signal transduction; scaffold1270 indexed_genome mRNA 3030 3739 . + . ID=transcript_17097;Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway; scaffold1270 indexed_genome mRNA 12227 16393 . + . ID=transcript_17098;Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway; scaffold1270 indexed_genome mRNA 19200 20046 . + . ID=transcript_17099;Q8TBW2 Q9UGA1,Ubiquitin carboxyl-terminal hydrolase 34,Deubiquitinating enzyme 34;Ubiquitin thioesterase 34;Ubiquitin-specific-processing protease 34;, PF12030;PF00443;, GO:0005829;GO:0005634;GO:0004197;GO:0004843;GO:0090263;GO:0016579;GO:0071108;GO:0006511;GO:0016055;, C:cytosol; C:nucleus;, F:cysteine-type endopeptidase activity; F:thiol-dependent ubiquitin-specific protease activity;, P:positive regulation of canonical Wnt signaling pathway; P:protein deubiquitination; P:protein K48-linked deubiquitination; P:ubiquitin-dependent protein catabolic process; P:Wnt signaling pathway; scaffold1278 indexed_genome mRNA 20143 21982 . + . ID=transcript_17100;P26440 B2RCV5 B3KVI7 J3KR54 Q53XZ9 Q96AF6,Isovaleryl-CoA dehydrogenase, mitochondrial {ECO:0000305},Butyryl-CoA dehydrogenase;, PF00441;PF02770;PF02771;, GO:0005759;GO:0031966;GO:0004085;GO:0050660;GO:0042802;GO:0008470;GO:0009083;GO:0033539;GO:0006552;, C:mitochondrial matrix; C:mitochondrial membrane;, F:butyryl-CoA dehydrogenase activity; F:flavin adenine dinucleotide binding; F:identical protein binding; F:isovaleryl-CoA dehydrogenase activity;, P:branched-chain amino acid catabolic process; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; P:leucine catabolic process; scaffold1286 indexed_genome mRNA 18592 21992 . - . ID=transcript_17101;Q14155 B1ALK6 B1ALK8 Q3LIA4 Q5W9H0 Q6P9G3 Q6PII2 Q86W63 Q8N3M1,Rho guanine nucleotide exchange factor 7,Beta-Pix;COOL-1;PAK-interacting exchange factor beta;p85;, PF00307;PF00169;PF00621;PF07653;, GO:0005938;GO:0005813;GO:0005829;GO:0005925;GO:0030027;GO:0097431;GO:0043005;GO:0043025;GO:0098794;GO:0032991;GO:0001726;GO:0043015;GO:0005085;GO:0019901;GO:0048013;GO:0048041;GO:0007186;GO:0007030;GO:0035556;GO:0030032;GO:0042059;GO:1905833;GO:0007399;GO:0043065;GO:0010763;GO:0043547;GO:2000394;GO:1900026;GO:1904424;GO:0051056;GO:0007165;, C:cell cortex; C:centrosome; C:cytosol; C:focal adhesion; C:lamellipodium; C:mitotic spindle pole; C:neuron projection; C:neuronal cell body; C:postsynapse; C:protein-containing complex; C:ruffle;, F:gamma-tubulin binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase binding;, P:ephrin receptor signaling pathway; P:focal adhesion assembly; P:G protein-coupled receptor signaling pathway; P:Golgi organization; P:intracellular signal transduction; P:lamellipodium assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of microtubule nucleation; P:nervous system development; P:positive regulation of apoptotic process; P:positive regulation of fibroblast migration; P:positive regulation of GTPase activity; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of GTP binding; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold1289 indexed_genome mRNA 240 4134 . - . ID=transcript_17102;Q96JL7,Actin-binding LIM protein 2,Actin-binding LIM protein family member 2;, PF16182;PF00412;PF02209;, GO:0015629;GO:0005737;GO:0051015;GO:0046872;GO:0030036;GO:0030032;GO:0006351;, C:actin cytoskeleton; C:cytoplasm;, F:actin filament binding; F:metal ion binding;, P:actin cytoskeleton organization; P:lamellipodium assembly; P:transcription, DNA-templated; scaffold1295 indexed_genome mRNA 115 7101 . + . ID=transcript_17103;Q96BZ4 Q6UWD2,5'-3' exonuclease PLD4 {ECO:0000305},Choline phosphatase 4;Phosphatidylcholine-hydrolyzing phospholipase D4;Phospholipase D family member 4 {ECO:0000312|HGNC:HGNC:23792};Phospholipase D4;, PF00614;PF13918;, GO:0005769;GO:0005783;GO:0005789;GO:0016021;GO:0005634;GO:0045335;GO:0032588;GO:0045145;GO:0002244;GO:0006954;GO:0045087;GO:0043647;GO:0006909;GO:1900015;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus; C:phagocytic vesicle; C:trans-Golgi network membrane;, F:single-stranded DNA 5'-3' exodeoxyribonuclease activity;, P:hematopoietic progenitor cell differentiation; P:inflammatory response; P:innate immune response; P:inositol phosphate metabolic process; P:phagocytosis; P:regulation of cytokine production involved in inflammatory response; scaffold1295 indexed_genome mRNA 19011 19765 . - . ID=transcript_17104;Q9Y4F5 Q2KHR7 Q86TI7,Centrosomal protein of 170 kDa protein B,Centrosomal protein 170B;, PF15308;PF00498;, GO:0005737;GO:0005874;, C:cytoplasm; C:microtubule; scaffold1295 indexed_genome mRNA 19798 20881 . + . ID=transcript_17105;Q9Y4F5 Q2KHR7 Q86TI7,Centrosomal protein of 170 kDa protein B,Centrosomal protein 170B;, PF15308;PF00498;, GO:0005737;GO:0005874;, C:cytoplasm; C:microtubule;|Q9Y4F5 Q2KHR7 Q86TI7,Centrosomal protein of 170 kDa protein B,Centrosomal protein 170B;, PF15308;PF00498;, GO:0005737;GO:0005874;, C:cytoplasm; C:microtubule; scaffold1296 indexed_genome mRNA 115 7100 . + . ID=transcript_17106;Q96BZ4 Q6UWD2,5'-3' exonuclease PLD4 {ECO:0000305},Choline phosphatase 4;Phosphatidylcholine-hydrolyzing phospholipase D4;Phospholipase D family member 4 {ECO:0000312|HGNC:HGNC:23792};Phospholipase D4;, PF00614;PF13918;, GO:0005769;GO:0005783;GO:0005789;GO:0016021;GO:0005634;GO:0045335;GO:0032588;GO:0045145;GO:0002244;GO:0006954;GO:0045087;GO:0043647;GO:0006909;GO:1900015;, C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus; C:phagocytic vesicle; C:trans-Golgi network membrane;, F:single-stranded DNA 5'-3' exodeoxyribonuclease activity;, P:hematopoietic progenitor cell differentiation; P:inflammatory response; P:innate immune response; P:inositol phosphate metabolic process; P:phagocytosis; P:regulation of cytokine production involved in inflammatory response; scaffold1296 indexed_genome mRNA 19009 19762 . - . ID=transcript_17107;Q9Y4F5 Q2KHR7 Q86TI7,Centrosomal protein of 170 kDa protein B,Centrosomal protein 170B;, PF15308;PF00498;, GO:0005737;GO:0005874;, C:cytoplasm; C:microtubule; scaffold1296 indexed_genome mRNA 19795 20880 . + . ID=transcript_17108;Q9Y4F5 Q2KHR7 Q86TI7,Centrosomal protein of 170 kDa protein B,Centrosomal protein 170B;, PF15308;PF00498;, GO:0005737;GO:0005874;, C:cytoplasm; C:microtubule;|Q9Y4F5 Q2KHR7 Q86TI7,Centrosomal protein of 170 kDa protein B,Centrosomal protein 170B;, PF15308;PF00498;, GO:0005737;GO:0005874;, C:cytoplasm; C:microtubule; scaffold1312 indexed_genome mRNA 3114 5820 . - . ID=transcript_17109;P19429,Troponin I, cardiac muscle,Cardiac troponin I;, PF00992;PF11636;, GO:0097512;GO:1990584;GO:0005829;GO:0030017;GO:0005861;GO:0003779;GO:0051015;GO:0019855;GO:0048306;GO:0046872;GO:0019904;GO:0019901;GO:0030172;GO:0031014;GO:0060048;GO:0006874;GO:0060047;GO:0007507;GO:0006936;GO:0030049;GO:0032780;GO:0010882;GO:0001980;GO:0003009;GO:0001570;GO:0055010;, C:cardiac myofibril; C:cardiac Troponin complex; C:cytosol; C:sarcomere; C:troponin complex;, F:actin binding; F:actin filament binding; F:calcium channel inhibitor activity; F:calcium-dependent protein binding; F:metal ion binding; F:protein domain specific binding; F:protein kinase binding; F:troponin C binding; F:troponin T binding;, P:cardiac muscle contraction; P:cellular calcium ion homeostasis; P:heart contraction; P:heart development; P:muscle contraction; P:muscle filament sliding; P:negative regulation of ATPase activity; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of systemic arterial blood pressure by ischemic conditions; P:skeletal muscle contraction; P:vasculogenesis; P:ventricular cardiac muscle tissue morphogenesis;|P19429,Troponin I, cardiac muscle,Cardiac troponin I;, PF00992;PF11636;, GO:0097512;GO:1990584;GO:0005829;GO:0030017;GO:0005861;GO:0003779;GO:0051015;GO:0019855;GO:0048306;GO:0046872;GO:0019904;GO:0019901;GO:0030172;GO:0031014;GO:0060048;GO:0006874;GO:0060047;GO:0007507;GO:0006936;GO:0030049;GO:0032780;GO:0010882;GO:0001980;GO:0003009;GO:0001570;GO:0055010;, C:cardiac myofibril; C:cardiac Troponin complex; C:cytosol; C:sarcomere; C:troponin complex;, F:actin binding; F:actin filament binding; F:calcium channel inhibitor activity; F:calcium-dependent protein binding; F:metal ion binding; F:protein domain specific binding; F:protein kinase binding; F:troponin C binding; F:troponin T binding;, P:cardiac muscle contraction; P:cellular calcium ion homeostasis; P:heart contraction; P:heart development; P:muscle contraction; P:muscle filament sliding; P:negative regulation of ATPase activity; P:regulation of cardiac muscle contraction by calcium ion signaling; P:regulation of systemic arterial blood pressure by ischemic conditions; P:skeletal muscle contraction; P:vasculogenesis; P:ventricular cardiac muscle tissue morphogenesis; scaffold1312 indexed_genome mRNA 6743 12690 . - . ID=transcript_17110;Q8N9W5 A8MUY0 E3W9A1 E9PAX5 Q6P4F6 Q8N9W0 Q96AR2,Dynein assembly factor 3, axonemal,, PF14737;PF14740;, GO:0005737;GO:0070286;GO:0044458;, C:cytoplasm;, , P:axonemal dynein complex assembly; P:motile cilium assembly;|Q8N9W5 A8MUY0 E3W9A1 E9PAX5 Q6P4F6 Q8N9W0 Q96AR2,Dynein assembly factor 3, axonemal,, PF14737;PF14740;, GO:0005737;GO:0070286;GO:0044458;, C:cytoplasm;, , P:axonemal dynein complex assembly; P:motile cilium assembly; scaffold1312 indexed_genome mRNA 14802 20074 . + . ID=transcript_17111;O00445 B3KWJ8 B7Z300 Q86X72,Synaptotagmin-5,Synaptotagmin V;, PF00168;, GO:0030424;GO:0031045;GO:0070382;GO:0099066;GO:0043025;GO:0048471;GO:0005886;GO:1990769;GO:0055038;GO:0030672;GO:0005509;GO:0005544;GO:0030276;GO:0005546;GO:0001786;GO:0046982;GO:0000149;GO:0019905;GO:0048791;GO:0017156;GO:0071277;GO:0007268;GO:0017158;GO:0014059;GO:0048488;GO:0016192;, C:axon; C:dense core granule; C:exocytic vesicle; C:integral component of neuronal dense core vesicle membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:proximal neuron projection; C:recycling endosome membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:protein heterodimerization activity; F:SNARE binding; F:syntaxin binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:chemical synaptic transmission; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:synaptic vesicle endocytosis; P:vesicle-mediated transport;|O00445 B3KWJ8 B7Z300 Q86X72,Synaptotagmin-5,Synaptotagmin V;, PF00168;, GO:0030424;GO:0031045;GO:0070382;GO:0099066;GO:0043025;GO:0048471;GO:0005886;GO:1990769;GO:0055038;GO:0030672;GO:0005509;GO:0005544;GO:0030276;GO:0005546;GO:0001786;GO:0046982;GO:0000149;GO:0019905;GO:0048791;GO:0017156;GO:0071277;GO:0007268;GO:0017158;GO:0014059;GO:0048488;GO:0016192;, C:axon; C:dense core granule; C:exocytic vesicle; C:integral component of neuronal dense core vesicle membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:plasma membrane; C:proximal neuron projection; C:recycling endosome membrane; C:synaptic vesicle membrane;, F:calcium ion binding; F:calcium-dependent phospholipid binding; F:clathrin binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:phosphatidylserine binding; F:protein heterodimerization activity; F:SNARE binding; F:syntaxin binding;, P:calcium ion-regulated exocytosis of neurotransmitter; P:calcium-ion regulated exocytosis; P:cellular response to calcium ion; P:chemical synaptic transmission; P:regulation of calcium ion-dependent exocytosis; P:regulation of dopamine secretion; P:synaptic vesicle endocytosis; P:vesicle-mediated transport; scaffold1325 indexed_genome mRNA 17223 18013 . + . ID=transcript_17112;Q9Y263 Q53EU5 Q5VY33 Q9NUL8 Q9NVE9 Q9UF53 Q9Y5L1,Phospholipase A-2-activating protein,, PF09070;PF08324;PF00400;, GO:0005737;GO:0070062;GO:0005634;GO:0045202;GO:0016005;GO:0043130;GO:0071222;GO:0006954;GO:0016236;GO:1900045;GO:0007399;GO:0006644;GO:1903861;GO:2001224;GO:0032430;GO:1903423;GO:0006693;GO:0043161;GO:0007165;GO:0010992;GO:0043162;, C:cytoplasm; C:extracellular exosome; C:nucleus; C:synapse;, F:phospholipase A2 activator activity; F:ubiquitin binding;, P:cellular response to lipopolysaccharide; P:inflammatory response; P:macroautophagy; P:negative regulation of protein K63-linked ubiquitination; P:nervous system development; P:phospholipid metabolic process; P:positive regulation of dendrite extension; P:positive regulation of neuron migration; P:positive regulation of phospholipase A2 activity; P:positive regulation of synaptic vesicle recycling; P:prostaglandin metabolic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:signal transduction; P:ubiquitin recycling; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; scaffold1328 indexed_genome mRNA 12666 13431 . + . ID=transcript_17113;Q6ZUB1 B2RPB1 Q5SQC9 Q8NA41 Q8ND27,Spermatogenesis-associated protein 31E1,Protein FAM75E1;, PF15371;PF14650;, GO:0016021;GO:0030154;GO:0007283;, C:integral component of membrane;, , P:cell differentiation; P:spermatogenesis; scaffold1332 indexed_genome mRNA 878 1492 . + . ID=transcript_17114;P36269 Q53XM9 Q6GMP0 Q96FC1 Q9UFM5,Glutathione hydrolase 5 proenzyme,Gamma-glutamyl transpeptidase-related enzyme {ECO:0000303|PubMed:1676842};Gamma-glutamyltransferase 5;Gamma-glutamyltransferase-like activity 1 {ECO:0000303|PubMed:1676842};Gamma-glutamyltranspeptidase 5;Leukotriene-C4 hydrolase;, , GO:0016021;GO:0031226;GO:0005886;GO:0036374;GO:0102953;GO:0103068;GO:0002951;GO:0000048;GO:0006520;GO:0006631;GO:0006750;GO:0006751;GO:0006954;GO:1901750;GO:0006691;GO:0002862;GO:0006508;GO:0032355;GO:0032496;GO:0034612;GO:0007283;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:glutathione hydrolase activity; F:hypoglycin A gamma-glutamyl transpeptidase activity; F:leukotriene C4 gamma-glutamyl transferase activity; F:leukotriene-C(4) hydrolase; F:peptidyltransferase activity;, P:cellular amino acid metabolic process; P:fatty acid metabolic process; P:glutathione biosynthetic process; P:glutathione catabolic process; P:inflammatory response; P:leukotriene D4 biosynthetic process; P:leukotriene metabolic process; P:negative regulation of inflammatory response to antigenic stimulus; P:proteolysis; P:response to estradiol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:spermatogenesis; scaffold1332 indexed_genome mRNA 11255 13591 . - . ID=transcript_17115;Q9UGT4 Q9H5Y6,Sushi domain-containing protein 2,, PF03782;PF01033;PF00084;PF00094;, GO:0070062;GO:0005615;GO:0016021;GO:0005886;GO:1902807;GO:0051782;, C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell division; scaffold1332 indexed_genome mRNA 13600 18450 . - . ID=transcript_17116;Q9UGT4 Q9H5Y6,Sushi domain-containing protein 2,, PF03782;PF01033;PF00084;PF00094;, GO:0070062;GO:0005615;GO:0016021;GO:0005886;GO:1902807;GO:0051782;, C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell division; scaffold1333 indexed_genome mRNA 877 1491 . + . ID=transcript_17117;P36269 Q53XM9 Q6GMP0 Q96FC1 Q9UFM5,Glutathione hydrolase 5 proenzyme,Gamma-glutamyl transpeptidase-related enzyme {ECO:0000303|PubMed:1676842};Gamma-glutamyltransferase 5;Gamma-glutamyltransferase-like activity 1 {ECO:0000303|PubMed:1676842};Gamma-glutamyltranspeptidase 5;Leukotriene-C4 hydrolase;, , GO:0016021;GO:0031226;GO:0005886;GO:0036374;GO:0102953;GO:0103068;GO:0002951;GO:0000048;GO:0006520;GO:0006631;GO:0006750;GO:0006751;GO:0006954;GO:1901750;GO:0006691;GO:0002862;GO:0006508;GO:0032355;GO:0032496;GO:0034612;GO:0007283;, C:integral component of membrane; C:intrinsic component of plasma membrane; C:plasma membrane;, F:glutathione hydrolase activity; F:hypoglycin A gamma-glutamyl transpeptidase activity; F:leukotriene C4 gamma-glutamyl transferase activity; F:leukotriene-C(4) hydrolase; F:peptidyltransferase activity;, P:cellular amino acid metabolic process; P:fatty acid metabolic process; P:glutathione biosynthetic process; P:glutathione catabolic process; P:inflammatory response; P:leukotriene D4 biosynthetic process; P:leukotriene metabolic process; P:negative regulation of inflammatory response to antigenic stimulus; P:proteolysis; P:response to estradiol; P:response to lipopolysaccharide; P:response to tumor necrosis factor; P:spermatogenesis; scaffold1333 indexed_genome mRNA 11253 13589 . - . ID=transcript_17118;Q9UGT4 Q9H5Y6,Sushi domain-containing protein 2,, PF03782;PF01033;PF00084;PF00094;, GO:0070062;GO:0005615;GO:0016021;GO:0005886;GO:1902807;GO:0051782;, C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell division; scaffold1333 indexed_genome mRNA 13598 18448 . - . ID=transcript_17119;Q9UGT4 Q9H5Y6,Sushi domain-containing protein 2,, PF03782;PF01033;PF00084;PF00094;, GO:0070062;GO:0005615;GO:0016021;GO:0005886;GO:1902807;GO:0051782;, C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:plasma membrane;, , P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell division; scaffold1393 indexed_genome mRNA 3370 15152 . - . ID=transcript_17120;Q5JUK3 B3KXF7 B7ZVY4 B9EGP2 G5E9V0 Q9P2C5,Potassium channel subfamily T member 1,KCa4.1;, PF03493;PF07885;, GO:0016021;GO:0005886;GO:0005228;GO:0015271;, C:integral component of membrane; C:plasma membrane;, F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity; scaffold1400 indexed_genome mRNA 10161 13983 . + . ID=transcript_17121;Q9Y6Q3 A0AVJ9 B4DVX4 G3V3L7 Q5T7Q4,Zinc finger protein 37 homolog,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000977;GO:0008270;GO:0000122;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold1401 indexed_genome mRNA 10158 13977 . + . ID=transcript_17122;Q9Y6Q3 A0AVJ9 B4DVX4 G3V3L7 Q5T7Q4,Zinc finger protein 37 homolog,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0000981;GO:0001227;GO:0000977;GO:0008270;GO:0000122;GO:0006357;GO:0006355;, C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold1403 indexed_genome mRNA 3538 4087 . - . ID=transcript_17123;Q96BM0,Interferon alpha-inducible protein 27-like protein 1 {ECO:0000305},Interferon-stimulated gene 12c protein {ECO:0000303|PubMed:14728724};, PF06140;, GO:0016021;GO:0005739;GO:0006915;GO:0097190;, C:integral component of membrane; C:mitochondrion;, , P:apoptotic process; P:apoptotic signaling pathway; scaffold1406 indexed_genome mRNA 3540 4090 . - . ID=transcript_17124;Q96BM0,Interferon alpha-inducible protein 27-like protein 1 {ECO:0000305},Interferon-stimulated gene 12c protein {ECO:0000303|PubMed:14728724};, PF06140;, GO:0016021;GO:0005739;GO:0006915;GO:0097190;, C:integral component of membrane; C:mitochondrion;, , P:apoptotic process; P:apoptotic signaling pathway; scaffold1407 indexed_genome mRNA 14790 15972 . - . ID=transcript_17125;P01859 A6NE66,Immunoglobulin heavy constant gamma 2 {ECO:0000303|PubMed:11340299, ECO:0000303|Ref.13},Ig gamma-2 chain C region {ECO:0000305};Ig gamma-2 chain C region DOT {ECO:0000305|PubMed:7737190};Ig gamma-2 chain C region TIL {ECO:0000305|PubMed:6774012};Ig gamma-2 chain C region ZIE {ECO:0000305|PubMed:113060, ECO:0000305|PubMed:118920};, PF07654;, GO:0072562;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0042571;GO:0003823;GO:0034987;GO:0050853;GO:0006956;GO:0006958;GO:0042742;GO:0038096;GO:0045087;GO:0002862;GO:0008228;GO:0018149;GO:0006911;GO:0006910;GO:0050871;GO:0030449;, C:blood microparticle; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:immunoglobulin complex, circulating;, F:antigen binding; F:immunoglobulin receptor binding;, P:B cell receptor signaling pathway; P:complement activation; P:complement activation, classical pathway; P:defense response to bacterium; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:innate immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:opsonization; P:peptide cross-linking; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; P:regulation of complement activation; scaffold1408 indexed_genome mRNA 14788 15971 . - . ID=transcript_17126;P01859 A6NE66,Immunoglobulin heavy constant gamma 2 {ECO:0000303|PubMed:11340299, ECO:0000303|Ref.13},Ig gamma-2 chain C region {ECO:0000305};Ig gamma-2 chain C region DOT {ECO:0000305|PubMed:7737190};Ig gamma-2 chain C region TIL {ECO:0000305|PubMed:6774012};Ig gamma-2 chain C region ZIE {ECO:0000305|PubMed:113060, ECO:0000305|PubMed:118920};, PF07654;, GO:0072562;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0042571;GO:0003823;GO:0034987;GO:0050853;GO:0006956;GO:0006958;GO:0042742;GO:0038096;GO:0045087;GO:0002862;GO:0008228;GO:0018149;GO:0006911;GO:0006910;GO:0050871;GO:0030449;, C:blood microparticle; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:immunoglobulin complex, circulating;, F:antigen binding; F:immunoglobulin receptor binding;, P:B cell receptor signaling pathway; P:complement activation; P:complement activation, classical pathway; P:defense response to bacterium; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:innate immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:opsonization; P:peptide cross-linking; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; P:regulation of complement activation;|P01861,Immunoglobulin heavy constant gamma 4 {ECO:0000303|PubMed:11340299, ECO:0000303|Ref.5},Ig gamma-4 chain C region {ECO:0000305};, PF07654;, GO:0072562;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0042571;GO:0003823;GO:0034987;GO:0050853;GO:0006956;GO:0006958;GO:0019221;GO:0042742;GO:0038096;GO:0045087;GO:0002862;GO:0008228;GO:0018149;GO:0006911;GO:0006910;GO:0050871;GO:0030449;, C:blood microparticle; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:immunoglobulin complex, circulating;, F:antigen binding; F:immunoglobulin receptor binding;, P:B cell receptor signaling pathway; P:complement activation; P:complement activation, classical pathway; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:innate immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:opsonization; P:peptide cross-linking; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; P:regulation of complement activation; scaffold1413 indexed_genome mRNA 2450 4608 . - . ID=transcript_17127;Q5MIZ7 Q6P9B0 Q86XB8 Q9BQJ0 Q9BRK2 Q9H913 Q9P2G0,Serine/threonine-protein phosphatase 4 regulatory subunit 3B,SMEK homolog 2;, PF04802;, GO:0005813;GO:0005737;GO:0016607;GO:0005654;GO:0030289;GO:0045722;GO:0006470;GO:0019216;, C:centrosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:protein phosphatase 4 complex;, , P:positive regulation of gluconeogenesis; P:protein dephosphorylation; P:regulation of lipid metabolic process;|Q5MIZ7 Q6P9B0 Q86XB8 Q9BQJ0 Q9BRK2 Q9H913 Q9P2G0,Serine/threonine-protein phosphatase 4 regulatory subunit 3B,SMEK homolog 2;, PF04802;, GO:0005813;GO:0005737;GO:0016607;GO:0005654;GO:0030289;GO:0045722;GO:0006470;GO:0019216;, C:centrosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:protein phosphatase 4 complex;, , P:positive regulation of gluconeogenesis; P:protein dephosphorylation; P:regulation of lipid metabolic process; scaffold1414 indexed_genome mRNA 14272 16430 . - . ID=transcript_17128;Q5MIZ7 Q6P9B0 Q86XB8 Q9BQJ0 Q9BRK2 Q9H913 Q9P2G0,Serine/threonine-protein phosphatase 4 regulatory subunit 3B,SMEK homolog 2;, PF04802;, GO:0005813;GO:0005737;GO:0016607;GO:0005654;GO:0030289;GO:0045722;GO:0006470;GO:0019216;, C:centrosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:protein phosphatase 4 complex;, , P:positive regulation of gluconeogenesis; P:protein dephosphorylation; P:regulation of lipid metabolic process;|Q5MIZ7 Q6P9B0 Q86XB8 Q9BQJ0 Q9BRK2 Q9H913 Q9P2G0,Serine/threonine-protein phosphatase 4 regulatory subunit 3B,SMEK homolog 2;, PF04802;, GO:0005813;GO:0005737;GO:0016607;GO:0005654;GO:0030289;GO:0045722;GO:0006470;GO:0019216;, C:centrosome; C:cytoplasm; C:nuclear speck; C:nucleoplasm; C:protein phosphatase 4 complex;, , P:positive regulation of gluconeogenesis; P:protein dephosphorylation; P:regulation of lipid metabolic process; scaffold1415 indexed_genome mRNA 810 9559 . + . ID=transcript_17129;Q4VC44 D3DUA1 Q6ZSQ1 Q8WV62 Q9BQG6 Q9BUS5 Q9HCM0,FLYWCH-type zinc finger-containing protein 1,, PF04500;PF15423;, GO:0005829;GO:0016604;GO:0005654;GO:0003677;GO:0046872;, C:cytosol; C:nuclear body; C:nucleoplasm;, F:DNA binding; F:metal ion binding;|Q4VC44 D3DUA1 Q6ZSQ1 Q8WV62 Q9BQG6 Q9BUS5 Q9HCM0,FLYWCH-type zinc finger-containing protein 1,, PF04500;PF15423;, GO:0005829;GO:0016604;GO:0005654;GO:0003677;GO:0046872;, C:cytosol; C:nuclear body; C:nucleoplasm;, F:DNA binding; F:metal ion binding; scaffold1417 indexed_genome mRNA 2624 12471 . + . ID=transcript_17130;O43866 A8K7M5 Q6UX63,CD5 antigen-like,Apoptosis inhibitor expressed by macrophages {ECO:0000303|PubMed:23236605};CT-2 {ECO:0000303|Ref.2};IgM-associated peptide {ECO:0000303|PubMed:8034987};SP-alpha {ECO:0000303|PubMed:9045627};, PF00530;, GO:0072562;GO:0009986;GO:0005737;GO:0005576;GO:0005615;GO:0005886;GO:0005044;GO:0004252;GO:0006915;GO:0006968;GO:0002376;GO:0006954;GO:1903661;GO:0030449;GO:0031638;, C:blood microparticle; C:cell surface; C:cytoplasm; C:extracellular region; C:extracellular space; C:plasma membrane;, F:scavenger receptor activity; F:serine-type endopeptidase activity;, P:apoptotic process; P:cellular defense response; P:immune system process; P:inflammatory response; P:positive regulation of complement-dependent cytotoxicity; P:regulation of complement activation; P:zymogen activation; scaffold1423 indexed_genome mRNA 5477 14313 . - . ID=transcript_17131;Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection;|Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection;|Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection;|Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection;|Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection;|Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection; scaffold1423 indexed_genome mRNA 14500 15143 . + . ID=transcript_17132;Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection; scaffold1424 indexed_genome mRNA 5477 14312 . - . ID=transcript_17133;Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection;|Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection;|Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection;|Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection;|Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection;|Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection; scaffold1424 indexed_genome mRNA 14499 15142 . + . ID=transcript_17134;Q9Y219 Q9UE17 Q9UE99 Q9UNK8 Q9Y6P9 Q9Y6Q0,Protein jagged-2,, PF01414;PF00008;PF07645;PF12661;PF07657;, GO:0005887;GO:0005886;GO:0005509;GO:0008083;GO:0005112;GO:0009912;GO:0030154;GO:1990134;GO:0042492;GO:0001701;GO:0016331;GO:0007219;GO:0042475;GO:0045747;GO:0030155;GO:0042127;GO:0003016;GO:0001501;GO:0007283;GO:0030217;GO:0045061;, C:integral component of plasma membrane; C:plasma membrane;, F:calcium ion binding; F:growth factor activity; F:Notch binding;, P:auditory receptor cell fate commitment; P:cell differentiation; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; P:gamma-delta T cell differentiation; P:in utero embryonic development; P:morphogenesis of embryonic epithelium; P:Notch signaling pathway; P:odontogenesis of dentin-containing tooth; P:positive regulation of Notch signaling pathway; P:regulation of cell adhesion; P:regulation of cell population proliferation; P:respiratory system process; P:skeletal system development; P:spermatogenesis; P:T cell differentiation; P:thymic T cell selection; scaffold1431 indexed_genome mRNA 2370 11566 . - . ID=transcript_17135;Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process; scaffold1433 indexed_genome mRNA 2369 7378 . + . ID=transcript_17136;Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process;|Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process; scaffold1437 indexed_genome mRNA 13276 15450 . + . ID=transcript_17137;Q8N5D6 A8K633 B2RA95 B7Z8S5 Q45F07 Q5T7U9 Q5T7V1 Q8N2K4 Q9UKI5,Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 {ECO:0000305},Forssman glycolipid synthase-like protein;, PF03414;, GO:0005794;GO:0000139;GO:0016021;GO:0031982;GO:0047277;GO:0046872;GO:0016757;GO:0005975;GO:0009247;GO:0030259;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:vesicle;, F:globoside alpha-N-acetylgalactosaminyltransferase activity; F:metal ion binding; F:transferase activity, transferring glycosyl groups;, P:carbohydrate metabolic process; P:glycolipid biosynthetic process; P:lipid glycosylation; P:protein glycosylation; scaffold1438 indexed_genome mRNA 13276 15450 . + . ID=transcript_17138;Q8N5D6 A8K633 B2RA95 B7Z8S5 Q45F07 Q5T7U9 Q5T7V1 Q8N2K4 Q9UKI5,Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 {ECO:0000305},Forssman glycolipid synthase-like protein;, PF03414;, GO:0005794;GO:0000139;GO:0016021;GO:0031982;GO:0047277;GO:0046872;GO:0016757;GO:0005975;GO:0009247;GO:0030259;GO:0006486;, C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:vesicle;, F:globoside alpha-N-acetylgalactosaminyltransferase activity; F:metal ion binding; F:transferase activity, transferring glycosyl groups;, P:carbohydrate metabolic process; P:glycolipid biosynthetic process; P:lipid glycosylation; P:protein glycosylation; scaffold1439 indexed_genome mRNA 4760 7741 . - . ID=transcript_17139;Q12888 F8VY86 Q2M1Z7 Q4LE46 Q5FWZ3 Q7Z3U4,TP53-binding protein 1 {ECO:0000305},, PF09038;, GO:0000781;GO:0000777;GO:0005737;GO:1990391;GO:0016604;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0042393;GO:0035064;GO:0002039;GO:0001102;GO:0042162;GO:0003712;GO:0061649;GO:0006974;GO:0071481;GO:0000077;GO:0006302;GO:0006303;GO:2000042;GO:0051091;GO:0045830;GO:0045944;GO:0045893;GO:0051260;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:cytoplasm; C:DNA repair complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:histone binding; F:methylated histone binding; F:p53 binding; F:RNA polymerase II activating transcription factor binding; F:telomeric DNA binding; F:transcription coregulator activity; F:ubiquitin modification-dependent histone binding;, P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:DNA damage checkpoint; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of isotype switching; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein homooligomerization; scaffold1440 indexed_genome mRNA 4760 7740 . - . ID=transcript_17140;Q12888 F8VY86 Q2M1Z7 Q4LE46 Q5FWZ3 Q7Z3U4,TP53-binding protein 1 {ECO:0000305},, PF09038;, GO:0000781;GO:0000777;GO:0005737;GO:1990391;GO:0016604;GO:0005654;GO:0005634;GO:0005657;GO:0035861;GO:0003684;GO:0042393;GO:0035064;GO:0002039;GO:0001102;GO:0042162;GO:0003712;GO:0061649;GO:0006974;GO:0071481;GO:0000077;GO:0006302;GO:0006303;GO:2000042;GO:0051091;GO:0045830;GO:0045944;GO:0045893;GO:0051260;, C:chromosome, telomeric region; C:condensed chromosome kinetochore; C:cytoplasm; C:DNA repair complex; C:nuclear body; C:nucleoplasm; C:nucleus; C:replication fork; C:site of double-strand break;, F:damaged DNA binding; F:histone binding; F:methylated histone binding; F:p53 binding; F:RNA polymerase II activating transcription factor binding; F:telomeric DNA binding; F:transcription coregulator activity; F:ubiquitin modification-dependent histone binding;, P:cellular response to DNA damage stimulus; P:cellular response to X-ray; P:DNA damage checkpoint; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:negative regulation of double-strand break repair via homologous recombination; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of isotype switching; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:protein homooligomerization; scaffold1451 indexed_genome mRNA 7068 13630 . + . ID=transcript_17141;Q92558 E1P5F2 Q5SZK7,Wiskott-Aldrich syndrome protein family member 1 {ECO:0000305},Protein WAVE-1;Verprolin homology domain-containing protein 1;, PF02205;, GO:0015629;GO:0005856;GO:0032839;GO:0005925;GO:0030027;GO:0005741;GO:0098794;GO:0032991;GO:0031209;GO:0003779;GO:0071933;GO:0051018;GO:0034237;GO:0030036;GO:0030041;GO:1990416;GO:0097484;GO:0098939;GO:0072673;GO:0070584;GO:0098885;GO:2000601;GO:0051388;GO:0065003;GO:0016601;GO:0006898;, C:actin cytoskeleton; C:cytoskeleton; C:dendrite cytoplasm; C:focal adhesion; C:lamellipodium; C:mitochondrial outer membrane; C:postsynapse; C:protein-containing complex; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dendritic transport of mitochondrion; P:lamellipodium morphogenesis; P:mitochondrion morphogenesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:protein-containing complex assembly; P:Rac protein signal transduction; P:receptor-mediated endocytosis; scaffold1453 indexed_genome mRNA 9767 14039 . - . ID=transcript_17142;Q96BD0 Q9H4T7 Q9H4T8 Q9H8P2 Q9NWX8 Q9UI35 Q9UIG7,Solute carrier organic anion transporter family member 4A1,Colon organic anion transporter;Organic anion transporter polypeptide-related protein 1;Organic anion-transporting polypeptide E;Sodium-independent organic anion transporter E;Solute carrier family 21 member 12;, PF07648;PF03137;, GO:0005887;GO:0005886;GO:0015347;GO:0015349;GO:0043252;, C:integral component of plasma membrane; C:plasma membrane;, F:sodium-independent organic anion transmembrane transporter activity; F:thyroid hormone transmembrane transporter activity;, P:sodium-independent organic anion transport; scaffold1464 indexed_genome mRNA 11761 12867 . + . ID=transcript_17143;Q96D59,E3 ubiquitin-protein ligase RNF183,, PF13639;, GO:0033106;GO:0005783;GO:0030176;GO:0005765;GO:0046872;GO:0061630;GO:0006915;GO:1902237;GO:0051865;GO:0000209;GO:0034976;, C:cis-Golgi network membrane; C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane; C:lysosomal membrane;, F:metal ion binding; F:ubiquitin protein ligase activity;, P:apoptotic process; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:protein autoubiquitination; P:protein polyubiquitination; P:response to endoplasmic reticulum stress; scaffold1473 indexed_genome mRNA 8091 8871 . + . ID=transcript_17144;Q9BVK6 Q14437 Q8WZ61,Transmembrane emp24 domain-containing protein 9,GMP25;Glycoprotein 25L2;p24 family protein alpha-2;p25;, PF01105;, GO:0030134;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0008021;GO:0030140;GO:0030133;GO:0019905;GO:0048205;GO:0006888;GO:0007030;GO:0006886;GO:0010638;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:synaptic vesicle; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:syntaxin binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:positive regulation of organelle organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold1474 indexed_genome mRNA 8089 8870 . - . ID=transcript_17145;Q9BVK6 Q14437 Q8WZ61,Transmembrane emp24 domain-containing protein 9,GMP25;Glycoprotein 25L2;p24 family protein alpha-2;p25;, PF01105;, GO:0030134;GO:0005829;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0070062;GO:0005794;GO:0000139;GO:0016021;GO:0008021;GO:0030140;GO:0030133;GO:0019905;GO:0048205;GO:0006888;GO:0007030;GO:0006886;GO:0010638;GO:0006890;, C:COPII-coated ER to Golgi transport vesicle; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:extracellular exosome; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:synaptic vesicle; C:trans-Golgi network transport vesicle; C:transport vesicle;, F:syntaxin binding;, P:COPI coating of Golgi vesicle; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport; P:positive regulation of organelle organization; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; scaffold1483 indexed_genome mRNA 2783 3345 . + . ID=transcript_17146;Q96Q06 A6NEI2,Perilipin-4,Adipocyte protein S3-12;, PF03036;, GO:0005829;GO:0005811;GO:0005886;, C:cytosol; C:lipid droplet; C:plasma membrane; scaffold1483 indexed_genome mRNA 5520 11764 . - . ID=transcript_17147;Q7Z4V5 I3L080 K7EQZ6 Q96GI5 Q9BW08,Hepatoma-derived growth factor-related protein 2,Hepatoma-derived growth factor 2;, PF11467;PF00855;, GO:0005634;GO:0003690;GO:0003712;GO:0030307;GO:0006357;, C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of cell growth; P:regulation of transcription by RNA polymerase II;|Q7Z4V5 I3L080 K7EQZ6 Q96GI5 Q9BW08,Hepatoma-derived growth factor-related protein 2,Hepatoma-derived growth factor 2;, PF11467;PF00855;, GO:0005634;GO:0003690;GO:0003712;GO:0030307;GO:0006357;, C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of cell growth; P:regulation of transcription by RNA polymerase II;|Q7Z4V5 I3L080 K7EQZ6 Q96GI5 Q9BW08,Hepatoma-derived growth factor-related protein 2,Hepatoma-derived growth factor 2;, PF11467;PF00855;, GO:0005634;GO:0003690;GO:0003712;GO:0030307;GO:0006357;, C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of cell growth; P:regulation of transcription by RNA polymerase II;|Q7Z4V5 I3L080 K7EQZ6 Q96GI5 Q9BW08,Hepatoma-derived growth factor-related protein 2,Hepatoma-derived growth factor 2;, PF11467;PF00855;, GO:0005634;GO:0003690;GO:0003712;GO:0030307;GO:0006357;, C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of cell growth; P:regulation of transcription by RNA polymerase II; scaffold1485 indexed_genome mRNA 2783 3345 . + . ID=transcript_17148;Q96Q06 A6NEI2,Perilipin-4,Adipocyte protein S3-12;, PF03036;, GO:0005829;GO:0005811;GO:0005886;, C:cytosol; C:lipid droplet; C:plasma membrane; scaffold1485 indexed_genome mRNA 5520 11764 . - . ID=transcript_17149;Q7Z4V5 I3L080 K7EQZ6 Q96GI5 Q9BW08,Hepatoma-derived growth factor-related protein 2,Hepatoma-derived growth factor 2;, PF11467;PF00855;, GO:0005634;GO:0003690;GO:0003712;GO:0030307;GO:0006357;, C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of cell growth; P:regulation of transcription by RNA polymerase II;|Q7Z4V5 I3L080 K7EQZ6 Q96GI5 Q9BW08,Hepatoma-derived growth factor-related protein 2,Hepatoma-derived growth factor 2;, PF11467;PF00855;, GO:0005634;GO:0003690;GO:0003712;GO:0030307;GO:0006357;, C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of cell growth; P:regulation of transcription by RNA polymerase II;|Q7Z4V5 I3L080 K7EQZ6 Q96GI5 Q9BW08,Hepatoma-derived growth factor-related protein 2,Hepatoma-derived growth factor 2;, PF11467;PF00855;, GO:0005634;GO:0003690;GO:0003712;GO:0030307;GO:0006357;, C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of cell growth; P:regulation of transcription by RNA polymerase II;|Q7Z4V5 I3L080 K7EQZ6 Q96GI5 Q9BW08,Hepatoma-derived growth factor-related protein 2,Hepatoma-derived growth factor 2;, PF11467;PF00855;, GO:0005634;GO:0003690;GO:0003712;GO:0030307;GO:0006357;, C:nucleus;, F:double-stranded DNA binding; F:transcription coregulator activity;, P:positive regulation of cell growth; P:regulation of transcription by RNA polymerase II; scaffold1494 indexed_genome mRNA 668 10389 . + . ID=transcript_17150;O95219 B3KMH0 B4DQV4 D3DNA3,Sorting nexin-4,, PF00787;, GO:0005737;GO:0005868;GO:0031901;GO:0016020;GO:0005886;GO:0032991;GO:0031201;GO:0005154;GO:0005158;GO:1990460;GO:0035091;GO:1990459;GO:0032456;GO:1903595;GO:0015031;, C:cytoplasm; C:cytoplasmic dynein complex; C:early endosome membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:SNARE complex;, F:epidermal growth factor receptor binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:transferrin receptor binding;, P:endocytic recycling; P:positive regulation of histamine secretion by mast cell; P:protein transport; scaffold1495 indexed_genome mRNA 4026 14644 . - . ID=transcript_17151;Q8N5G0 C9JYT8 Q9BRT5,Small integral membrane protein 20,Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 7 kDa {ECO:0000303|PubMed:26321642};, PF15061;, GO:0005576;GO:0016021;GO:0005743;GO:0033617;, C:extracellular region; C:integral component of membrane; C:mitochondrial inner membrane;, , P:mitochondrial cytochrome c oxidase assembly; scaffold1538 indexed_genome mRNA 4951 6597 . + . ID=transcript_17152;Q9UMX5 A1KYQ8 Q53FZ6 Q5TM90,Neudesin,Cell immortalization-related protein 2;Neuron-derived neurotrophic factor;Protein GIG47 {ECO:0000303|PubMed:22748190};Secreted protein of unknown function;, PF00173;, GO:0012505;GO:0005783;GO:0005615;GO:0016020;GO:0005739;GO:0008083;GO:0046872;GO:0032099;GO:1901215;GO:0043410;, C:endomembrane system; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:mitochondrion;, F:growth factor activity; F:metal ion binding;, P:negative regulation of appetite; P:negative regulation of neuron death; P:positive regulation of MAPK cascade;|Q9UMX5 A1KYQ8 Q53FZ6 Q5TM90,Neudesin,Cell immortalization-related protein 2;Neuron-derived neurotrophic factor;Protein GIG47 {ECO:0000303|PubMed:22748190};Secreted protein of unknown function;, PF00173;, GO:0012505;GO:0005783;GO:0005615;GO:0016020;GO:0005739;GO:0008083;GO:0046872;GO:0032099;GO:1901215;GO:0043410;, C:endomembrane system; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:mitochondrion;, F:growth factor activity; F:metal ion binding;, P:negative regulation of appetite; P:negative regulation of neuron death; P:positive regulation of MAPK cascade; scaffold1539 indexed_genome mRNA 4953 6599 . - . ID=transcript_17153;Q9UMX5 A1KYQ8 Q53FZ6 Q5TM90,Neudesin,Cell immortalization-related protein 2;Neuron-derived neurotrophic factor;Protein GIG47 {ECO:0000303|PubMed:22748190};Secreted protein of unknown function;, PF00173;, GO:0012505;GO:0005783;GO:0005615;GO:0016020;GO:0005739;GO:0008083;GO:0046872;GO:0032099;GO:1901215;GO:0043410;, C:endomembrane system; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:mitochondrion;, F:growth factor activity; F:metal ion binding;, P:negative regulation of appetite; P:negative regulation of neuron death; P:positive regulation of MAPK cascade;|Q9UMX5 A1KYQ8 Q53FZ6 Q5TM90,Neudesin,Cell immortalization-related protein 2;Neuron-derived neurotrophic factor;Protein GIG47 {ECO:0000303|PubMed:22748190};Secreted protein of unknown function;, PF00173;, GO:0012505;GO:0005783;GO:0005615;GO:0016020;GO:0005739;GO:0008083;GO:0046872;GO:0032099;GO:1901215;GO:0043410;, C:endomembrane system; C:endoplasmic reticulum; C:extracellular space; C:membrane; C:mitochondrion;, F:growth factor activity; F:metal ion binding;, P:negative regulation of appetite; P:negative regulation of neuron death; P:positive regulation of MAPK cascade; scaffold1550 indexed_genome mRNA 1741 2479 . - . ID=transcript_17154;Q9NR61 Q3KP23 Q9NQT9,Delta-like protein 4,Drosophila Delta homolog 4;, PF01414;PF00008;PF07657;, GO:0016021;GO:0005886;GO:0005509;GO:0005112;GO:0001525;GO:0003180;GO:0008015;GO:0072554;GO:0001974;GO:0001569;GO:0003209;GO:0003208;GO:0044344;GO:0035924;GO:0035912;GO:1903588;GO:0090051;GO:0008285;GO:0010596;GO:0010629;GO:0045746;GO:0000122;GO:0061314;GO:0007219;GO:0003344;GO:0010628;GO:2000179;GO:0045747;GO:0061074;GO:0050767;GO:0007165;GO:0030217;GO:0060579;GO:0003222;GO:0007601;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:Notch binding;, P:angiogenesis; P:aortic valve morphogenesis; P:blood circulation; P:blood vessel lumenization; P:blood vessel remodeling; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:dorsal aorta morphogenesis; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:pericardium morphogenesis; P:positive regulation of gene expression; P:positive regulation of neural precursor cell proliferation; P:positive regulation of Notch signaling pathway; P:regulation of neural retina development; P:regulation of neurogenesis; P:signal transduction; P:T cell differentiation; P:ventral spinal cord interneuron fate commitment; P:ventricular trabecula myocardium morphogenesis; P:visual perception; scaffold1551 indexed_genome mRNA 1741 2479 . - . ID=transcript_17155;Q9NR61 Q3KP23 Q9NQT9,Delta-like protein 4,Drosophila Delta homolog 4;, PF01414;PF00008;PF07657;, GO:0016021;GO:0005886;GO:0005509;GO:0005112;GO:0001525;GO:0003180;GO:0008015;GO:0072554;GO:0001974;GO:0001569;GO:0003209;GO:0003208;GO:0044344;GO:0035924;GO:0035912;GO:1903588;GO:0090051;GO:0008285;GO:0010596;GO:0010629;GO:0045746;GO:0000122;GO:0061314;GO:0007219;GO:0003344;GO:0010628;GO:2000179;GO:0045747;GO:0061074;GO:0050767;GO:0007165;GO:0030217;GO:0060579;GO:0003222;GO:0007601;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:Notch binding;, P:angiogenesis; P:aortic valve morphogenesis; P:blood circulation; P:blood vessel lumenization; P:blood vessel remodeling; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:dorsal aorta morphogenesis; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:pericardium morphogenesis; P:positive regulation of gene expression; P:positive regulation of neural precursor cell proliferation; P:positive regulation of Notch signaling pathway; P:regulation of neural retina development; P:regulation of neurogenesis; P:signal transduction; P:T cell differentiation; P:ventral spinal cord interneuron fate commitment; P:ventricular trabecula myocardium morphogenesis; P:visual perception; scaffold1564 indexed_genome mRNA 85 1731 . - . ID=transcript_17156;Q9Y4F5 Q2KHR7 Q86TI7,Centrosomal protein of 170 kDa protein B,Centrosomal protein 170B;, PF15308;PF00498;, GO:0005737;GO:0005874;, C:cytoplasm; C:microtubule; scaffold1566 indexed_genome mRNA 85 1730 . - . ID=transcript_17157;Q9Y4F5 Q2KHR7 Q86TI7,Centrosomal protein of 170 kDa protein B,Centrosomal protein 170B;, PF15308;PF00498;, GO:0005737;GO:0005874;, C:cytoplasm; C:microtubule; scaffold1586 indexed_genome mRNA 14155 15831 . - . ID=transcript_17158;P01854,Immunoglobulin heavy constant epsilon {ECO:0000303|PubMed:11340299, ECO:0000303|Ref.9},Ig epsilon chain C region {ECO:0000305};Ig epsilon chain C region ND {ECO:0000305|Ref.1};, PF07654;, GO:0009897;GO:0005576;GO:0042571;GO:0003823;GO:0034987;GO:0050853;GO:0006958;GO:0019221;GO:0042742;GO:0038095;GO:0006955;GO:0045087;GO:0006911;GO:0006910;GO:0050871;, C:external side of plasma membrane; C:extracellular region; C:immunoglobulin complex, circulating;, F:antigen binding; F:immunoglobulin receptor binding;, P:B cell receptor signaling pathway; P:complement activation, classical pathway; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:Fc-epsilon receptor signaling pathway; P:immune response; P:innate immune response; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; scaffold1587 indexed_genome mRNA 14155 15831 . - . ID=transcript_17159;P01854,Immunoglobulin heavy constant epsilon {ECO:0000303|PubMed:11340299, ECO:0000303|Ref.9},Ig epsilon chain C region {ECO:0000305};Ig epsilon chain C region ND {ECO:0000305|Ref.1};, PF07654;, GO:0009897;GO:0005576;GO:0042571;GO:0003823;GO:0034987;GO:0050853;GO:0006958;GO:0019221;GO:0042742;GO:0038095;GO:0006955;GO:0045087;GO:0006911;GO:0006910;GO:0050871;, C:external side of plasma membrane; C:extracellular region; C:immunoglobulin complex, circulating;, F:antigen binding; F:immunoglobulin receptor binding;, P:B cell receptor signaling pathway; P:complement activation, classical pathway; P:cytokine-mediated signaling pathway; P:defense response to bacterium; P:Fc-epsilon receptor signaling pathway; P:immune response; P:innate immune response; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; scaffold1594 indexed_genome mRNA 2402 4810 . + . ID=transcript_17160;P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation;|P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation;|P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation; scaffold1595 indexed_genome mRNA 5685 7910 . - . ID=transcript_17161;Q96FK6,WD repeat-containing protein 89,, PF00400; scaffold1596 indexed_genome mRNA 5676 7900 . + . ID=transcript_17162;Q96FK6,WD repeat-containing protein 89,, PF00400; scaffold1597 indexed_genome mRNA 10023 11094 . + . ID=transcript_17163;Q14157 B4E0U8 Q5VU75 Q5VU76 Q9BTU3 Q9UGL2 Q9UGL3 Q9UGL4 Q9UGL5,Ubiquitin-associated protein 2-like {ECO:0000305},Protein NICE-4;, PF12478;, GO:0005737;GO:0010494;GO:0005634;GO:0031519;GO:0003723;GO:0007339;GO:0061484;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleus; C:PcG protein complex;, F:RNA binding;, P:binding of sperm to zona pellucida; P:hematopoietic stem cell homeostasis; P:stress granule assembly; scaffold1597 indexed_genome mRNA 11582 15931 . - . ID=transcript_17164;Q14157 B4E0U8 Q5VU75 Q5VU76 Q9BTU3 Q9UGL2 Q9UGL3 Q9UGL4 Q9UGL5,Ubiquitin-associated protein 2-like {ECO:0000305},Protein NICE-4;, PF12478;, GO:0005737;GO:0010494;GO:0005634;GO:0031519;GO:0003723;GO:0007339;GO:0061484;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleus; C:PcG protein complex;, F:RNA binding;, P:binding of sperm to zona pellucida; P:hematopoietic stem cell homeostasis; P:stress granule assembly; scaffold1598 indexed_genome mRNA 10020 11091 . + . ID=transcript_17165;Q14157 B4E0U8 Q5VU75 Q5VU76 Q9BTU3 Q9UGL2 Q9UGL3 Q9UGL4 Q9UGL5,Ubiquitin-associated protein 2-like {ECO:0000305},Protein NICE-4;, PF12478;, GO:0005737;GO:0010494;GO:0005634;GO:0031519;GO:0003723;GO:0007339;GO:0061484;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleus; C:PcG protein complex;, F:RNA binding;, P:binding of sperm to zona pellucida; P:hematopoietic stem cell homeostasis; P:stress granule assembly; scaffold1598 indexed_genome mRNA 11579 15928 . + . ID=transcript_17166;Q14157 B4E0U8 Q5VU75 Q5VU76 Q9BTU3 Q9UGL2 Q9UGL3 Q9UGL4 Q9UGL5,Ubiquitin-associated protein 2-like {ECO:0000305},Protein NICE-4;, PF12478;, GO:0005737;GO:0010494;GO:0005634;GO:0031519;GO:0003723;GO:0007339;GO:0061484;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleus; C:PcG protein complex;, F:RNA binding;, P:binding of sperm to zona pellucida; P:hematopoietic stem cell homeostasis; P:stress granule assembly; scaffold1600 indexed_genome mRNA 335 15263 . - . ID=transcript_17167;Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation;|Q6DT37 O00565,Serine/threonine-protein kinase MRCK gamma,CDC42-binding protein kinase gamma;DMPK-like gamma;Myotonic dystrophy kinase-related CDC42-binding kinase gamma;Myotonic dystrophy protein kinase-like alpha;, PF00130;PF00780;PF08826;PF00069;, GO:0031252;GO:0034451;GO:0005737;GO:0005856;GO:0005829;GO:0005524;GO:0000287;GO:0106310;GO:0004674;GO:0106311;GO:0031532;GO:0031032;GO:0035556;GO:0018107;GO:0006468;, C:cell leading edge; C:centriolar satellite; C:cytoplasm; C:cytoskeleton; C:cytosol;, F:ATP binding; F:magnesium ion binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;, P:actin cytoskeleton reorganization; P:actomyosin structure organization; P:intracellular signal transduction; P:peptidyl-threonine phosphorylation; P:protein phosphorylation; scaffold1601 indexed_genome mRNA 4462 5435 . - . ID=transcript_17168;Q96L46 Q9BPV4,Calpain small subunit 2,Calcium-dependent protease small subunit 2;, PF13833;, GO:0005829;GO:0005886;GO:0005509;GO:0004198;GO:0022617;, C:cytosol; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity;, P:extracellular matrix disassembly; scaffold1602 indexed_genome mRNA 4460 5433 . - . ID=transcript_17169;Q96L46 Q9BPV4,Calpain small subunit 2,Calcium-dependent protease small subunit 2;, PF13833;, GO:0005829;GO:0005886;GO:0005509;GO:0004198;GO:0022617;, C:cytosol; C:plasma membrane;, F:calcium ion binding; F:calcium-dependent cysteine-type endopeptidase activity;, P:extracellular matrix disassembly; scaffold1619 indexed_genome mRNA 301 8693 . - . ID=transcript_17170;Q9NVJ2 B4DI85,ADP-ribosylation factor-like protein 8B,ADP-ribosylation factor-like protein 10C;Novel small G protein indispensable for equal chromosome segregation 1;, PF00025;, GO:1904115;GO:0005737;GO:0070062;GO:0031902;GO:0005765;GO:0005764;GO:0016020;GO:0030496;GO:0051233;GO:0045202;GO:0005774;GO:0043014;GO:0048487;GO:0019003;GO:0005525;GO:0003924;GO:0008089;GO:0002747;GO:0002505;GO:0007049;GO:0051301;GO:0007059;GO:0016197;GO:0090117;GO:1902774;GO:0032418;GO:0090385;GO:0015031;GO:0046754;, C:axon cytoplasm; C:cytoplasm; C:extracellular exosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome; C:membrane; C:midbody; C:spindle midzone; C:synapse; C:vacuolar membrane;, F:alpha-tubulin binding; F:beta-tubulin binding; F:GDP binding; F:GTP binding; F:GTPase activity;, P:anterograde axonal transport; P:antigen processing and presentation following phagocytosis; P:antigen processing and presentation of polysaccharide antigen via MHC class II; P:cell cycle; P:cell division; P:chromosome segregation; P:endosomal transport; P:endosome to lysosome transport of low-density lipoprotein particle; P:late endosome to lysosome transport; P:lysosome localization; P:phagosome-lysosome fusion; P:protein transport; P:viral exocytosis; scaffold1651 indexed_genome mRNA 5955 12786 . - . ID=transcript_17171;Q3SYA9,Putative POM121-like protein 1 scaffold1652 indexed_genome mRNA 520 2014 . + . ID=transcript_17172;Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process; scaffold1652 indexed_genome mRNA 2486 14172 . + . ID=transcript_17173;Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process;|Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7,Phosphofurin acidic cluster sorting protein 2,PACS1-like protein;, PF10254;, GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;, C:endoplasmic reticulum; C:mitochondrion;, F:ion channel binding;, P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process; scaffold1656 indexed_genome mRNA 7702 8207 . + . ID=transcript_17174;O95219 B3KMH0 B4DQV4 D3DNA3,Sorting nexin-4,, PF00787;, GO:0005737;GO:0005868;GO:0031901;GO:0016020;GO:0005886;GO:0032991;GO:0031201;GO:0005154;GO:0005158;GO:1990460;GO:0035091;GO:1990459;GO:0032456;GO:1903595;GO:0015031;, C:cytoplasm; C:cytoplasmic dynein complex; C:early endosome membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:SNARE complex;, F:epidermal growth factor receptor binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:transferrin receptor binding;, P:endocytic recycling; P:positive regulation of histamine secretion by mast cell; P:protein transport; scaffold1661 indexed_genome mRNA 391 5747 . + . ID=transcript_17175;P43363,Melanoma-associated antigen 10,Cancer/testis antigen 1.10;MAGE-10 antigen;, PF01454;PF12440;, GO:0005829;GO:0005654;, C:cytosol; C:nucleoplasm; scaffold1663 indexed_genome mRNA 3559 6204 . - . ID=transcript_17176;P62318 B4DJP7 B5BU13 P43331,Small nuclear ribonucleoprotein Sm D3,snRNP core protein D3;, PF01423;, GO:0071013;GO:0000243;GO:0005829;GO:0034709;GO:0016604;GO:0005654;GO:0005634;GO:0034715;GO:0071011;GO:0030532;GO:0034719;GO:0005681;GO:0097526;GO:0005697;GO:0005685;GO:0005689;GO:0005686;GO:0071007;GO:0071005;GO:0005687;GO:0046540;GO:0005682;GO:0005683;GO:0019899;GO:0071208;GO:0003723;GO:0070034;GO:0071209;GO:0008334;GO:0051170;GO:0000398;GO:0006479;GO:0008380;GO:0000387;GO:0006369;, C:catalytic step 2 spliceosome; C:commitment complex; C:cytosol; C:methylosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:precatalytic spliceosome; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal complex; C:spliceosomal tri-snRNP complex; C:telomerase holoenzyme complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:U7 snRNP;, F:enzyme binding; F:histone pre-mRNA DCP binding; F:RNA binding; F:telomerase RNA binding; F:U7 snRNA binding;, P:histone mRNA metabolic process; P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein methylation; P:RNA splicing; P:spliceosomal snRNP assembly; P:termination of RNA polymerase II transcription;|P62318 B4DJP7 B5BU13 P43331,Small nuclear ribonucleoprotein Sm D3,snRNP core protein D3;, PF01423;, GO:0071013;GO:0000243;GO:0005829;GO:0034709;GO:0016604;GO:0005654;GO:0005634;GO:0034715;GO:0071011;GO:0030532;GO:0034719;GO:0005681;GO:0097526;GO:0005697;GO:0005685;GO:0005689;GO:0005686;GO:0071007;GO:0071005;GO:0005687;GO:0046540;GO:0005682;GO:0005683;GO:0019899;GO:0071208;GO:0003723;GO:0070034;GO:0071209;GO:0008334;GO:0051170;GO:0000398;GO:0006479;GO:0008380;GO:0000387;GO:0006369;, C:catalytic step 2 spliceosome; C:commitment complex; C:cytosol; C:methylosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:precatalytic spliceosome; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal complex; C:spliceosomal tri-snRNP complex; C:telomerase holoenzyme complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:U7 snRNP;, F:enzyme binding; F:histone pre-mRNA DCP binding; F:RNA binding; F:telomerase RNA binding; F:U7 snRNA binding;, P:histone mRNA metabolic process; P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein methylation; P:RNA splicing; P:spliceosomal snRNP assembly; P:termination of RNA polymerase II transcription; scaffold1664 indexed_genome mRNA 3552 6197 . - . ID=transcript_17177;P62318 B4DJP7 B5BU13 P43331,Small nuclear ribonucleoprotein Sm D3,snRNP core protein D3;, PF01423;, GO:0071013;GO:0000243;GO:0005829;GO:0034709;GO:0016604;GO:0005654;GO:0005634;GO:0034715;GO:0071011;GO:0030532;GO:0034719;GO:0005681;GO:0097526;GO:0005697;GO:0005685;GO:0005689;GO:0005686;GO:0071007;GO:0071005;GO:0005687;GO:0046540;GO:0005682;GO:0005683;GO:0019899;GO:0071208;GO:0003723;GO:0070034;GO:0071209;GO:0008334;GO:0051170;GO:0000398;GO:0006479;GO:0008380;GO:0000387;GO:0006369;, C:catalytic step 2 spliceosome; C:commitment complex; C:cytosol; C:methylosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:precatalytic spliceosome; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal complex; C:spliceosomal tri-snRNP complex; C:telomerase holoenzyme complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:U7 snRNP;, F:enzyme binding; F:histone pre-mRNA DCP binding; F:RNA binding; F:telomerase RNA binding; F:U7 snRNA binding;, P:histone mRNA metabolic process; P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein methylation; P:RNA splicing; P:spliceosomal snRNP assembly; P:termination of RNA polymerase II transcription;|P62318 B4DJP7 B5BU13 P43331,Small nuclear ribonucleoprotein Sm D3,snRNP core protein D3;, PF01423;, GO:0071013;GO:0000243;GO:0005829;GO:0034709;GO:0016604;GO:0005654;GO:0005634;GO:0034715;GO:0071011;GO:0030532;GO:0034719;GO:0005681;GO:0097526;GO:0005697;GO:0005685;GO:0005689;GO:0005686;GO:0071007;GO:0071005;GO:0005687;GO:0046540;GO:0005682;GO:0005683;GO:0019899;GO:0071208;GO:0003723;GO:0070034;GO:0071209;GO:0008334;GO:0051170;GO:0000398;GO:0006479;GO:0008380;GO:0000387;GO:0006369;, C:catalytic step 2 spliceosome; C:commitment complex; C:cytosol; C:methylosome; C:nuclear body; C:nucleoplasm; C:nucleus; C:pICln-Sm protein complex; C:precatalytic spliceosome; C:small nuclear ribonucleoprotein complex; C:SMN-Sm protein complex; C:spliceosomal complex; C:spliceosomal tri-snRNP complex; C:telomerase holoenzyme complex; C:U1 snRNP; C:U12-type spliceosomal complex; C:U2 snRNP; C:U2-type catalytic step 2 spliceosome; C:U2-type precatalytic spliceosome; C:U4 snRNP; C:U4/U6 x U5 tri-snRNP complex; C:U5 snRNP; C:U7 snRNP;, F:enzyme binding; F:histone pre-mRNA DCP binding; F:RNA binding; F:telomerase RNA binding; F:U7 snRNA binding;, P:histone mRNA metabolic process; P:import into nucleus; P:mRNA splicing, via spliceosome; P:protein methylation; P:RNA splicing; P:spliceosomal snRNP assembly; P:termination of RNA polymerase II transcription; scaffold1668 indexed_genome mRNA 5052 6463 . - . ID=transcript_17178;Q92558 E1P5F2 Q5SZK7,Wiskott-Aldrich syndrome protein family member 1 {ECO:0000305},Protein WAVE-1;Verprolin homology domain-containing protein 1;, PF02205;, GO:0015629;GO:0005856;GO:0032839;GO:0005925;GO:0030027;GO:0005741;GO:0098794;GO:0032991;GO:0031209;GO:0003779;GO:0071933;GO:0051018;GO:0034237;GO:0030036;GO:0030041;GO:1990416;GO:0097484;GO:0098939;GO:0072673;GO:0070584;GO:0098885;GO:2000601;GO:0051388;GO:0065003;GO:0016601;GO:0006898;, C:actin cytoskeleton; C:cytoskeleton; C:dendrite cytoplasm; C:focal adhesion; C:lamellipodium; C:mitochondrial outer membrane; C:postsynapse; C:protein-containing complex; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dendritic transport of mitochondrion; P:lamellipodium morphogenesis; P:mitochondrion morphogenesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:protein-containing complex assembly; P:Rac protein signal transduction; P:receptor-mediated endocytosis; scaffold1668 indexed_genome mRNA 6819 8750 . + . ID=transcript_17179;Q92558 E1P5F2 Q5SZK7,Wiskott-Aldrich syndrome protein family member 1 {ECO:0000305},Protein WAVE-1;Verprolin homology domain-containing protein 1;, PF02205;, GO:0015629;GO:0005856;GO:0032839;GO:0005925;GO:0030027;GO:0005741;GO:0098794;GO:0032991;GO:0031209;GO:0003779;GO:0071933;GO:0051018;GO:0034237;GO:0030036;GO:0030041;GO:1990416;GO:0097484;GO:0098939;GO:0072673;GO:0070584;GO:0098885;GO:2000601;GO:0051388;GO:0065003;GO:0016601;GO:0006898;, C:actin cytoskeleton; C:cytoskeleton; C:dendrite cytoplasm; C:focal adhesion; C:lamellipodium; C:mitochondrial outer membrane; C:postsynapse; C:protein-containing complex; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dendritic transport of mitochondrion; P:lamellipodium morphogenesis; P:mitochondrion morphogenesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:protein-containing complex assembly; P:Rac protein signal transduction; P:receptor-mediated endocytosis;|Q92558 E1P5F2 Q5SZK7,Wiskott-Aldrich syndrome protein family member 1 {ECO:0000305},Protein WAVE-1;Verprolin homology domain-containing protein 1;, PF02205;, GO:0015629;GO:0005856;GO:0032839;GO:0005925;GO:0030027;GO:0005741;GO:0098794;GO:0032991;GO:0031209;GO:0003779;GO:0071933;GO:0051018;GO:0034237;GO:0030036;GO:0030041;GO:1990416;GO:0097484;GO:0098939;GO:0072673;GO:0070584;GO:0098885;GO:2000601;GO:0051388;GO:0065003;GO:0016601;GO:0006898;, C:actin cytoskeleton; C:cytoskeleton; C:dendrite cytoplasm; C:focal adhesion; C:lamellipodium; C:mitochondrial outer membrane; C:postsynapse; C:protein-containing complex; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dendritic transport of mitochondrion; P:lamellipodium morphogenesis; P:mitochondrion morphogenesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:protein-containing complex assembly; P:Rac protein signal transduction; P:receptor-mediated endocytosis; scaffold1669 indexed_genome mRNA 216 8750 . - . ID=transcript_17180;Q92558 E1P5F2 Q5SZK7,Wiskott-Aldrich syndrome protein family member 1 {ECO:0000305},Protein WAVE-1;Verprolin homology domain-containing protein 1;, PF02205;, GO:0015629;GO:0005856;GO:0032839;GO:0005925;GO:0030027;GO:0005741;GO:0098794;GO:0032991;GO:0031209;GO:0003779;GO:0071933;GO:0051018;GO:0034237;GO:0030036;GO:0030041;GO:1990416;GO:0097484;GO:0098939;GO:0072673;GO:0070584;GO:0098885;GO:2000601;GO:0051388;GO:0065003;GO:0016601;GO:0006898;, C:actin cytoskeleton; C:cytoskeleton; C:dendrite cytoplasm; C:focal adhesion; C:lamellipodium; C:mitochondrial outer membrane; C:postsynapse; C:protein-containing complex; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dendritic transport of mitochondrion; P:lamellipodium morphogenesis; P:mitochondrion morphogenesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:protein-containing complex assembly; P:Rac protein signal transduction; P:receptor-mediated endocytosis;|Q92558 E1P5F2 Q5SZK7,Wiskott-Aldrich syndrome protein family member 1 {ECO:0000305},Protein WAVE-1;Verprolin homology domain-containing protein 1;, PF02205;, GO:0015629;GO:0005856;GO:0032839;GO:0005925;GO:0030027;GO:0005741;GO:0098794;GO:0032991;GO:0031209;GO:0003779;GO:0071933;GO:0051018;GO:0034237;GO:0030036;GO:0030041;GO:1990416;GO:0097484;GO:0098939;GO:0072673;GO:0070584;GO:0098885;GO:2000601;GO:0051388;GO:0065003;GO:0016601;GO:0006898;, C:actin cytoskeleton; C:cytoskeleton; C:dendrite cytoplasm; C:focal adhesion; C:lamellipodium; C:mitochondrial outer membrane; C:postsynapse; C:protein-containing complex; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dendritic transport of mitochondrion; P:lamellipodium morphogenesis; P:mitochondrion morphogenesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:protein-containing complex assembly; P:Rac protein signal transduction; P:receptor-mediated endocytosis;|Q92558 E1P5F2 Q5SZK7,Wiskott-Aldrich syndrome protein family member 1 {ECO:0000305},Protein WAVE-1;Verprolin homology domain-containing protein 1;, PF02205;, GO:0015629;GO:0005856;GO:0032839;GO:0005925;GO:0030027;GO:0005741;GO:0098794;GO:0032991;GO:0031209;GO:0003779;GO:0071933;GO:0051018;GO:0034237;GO:0030036;GO:0030041;GO:1990416;GO:0097484;GO:0098939;GO:0072673;GO:0070584;GO:0098885;GO:2000601;GO:0051388;GO:0065003;GO:0016601;GO:0006898;, C:actin cytoskeleton; C:cytoskeleton; C:dendrite cytoplasm; C:focal adhesion; C:lamellipodium; C:mitochondrial outer membrane; C:postsynapse; C:protein-containing complex; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dendritic transport of mitochondrion; P:lamellipodium morphogenesis; P:mitochondrion morphogenesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:protein-containing complex assembly; P:Rac protein signal transduction; P:receptor-mediated endocytosis;|Q92558 E1P5F2 Q5SZK7,Wiskott-Aldrich syndrome protein family member 1 {ECO:0000305},Protein WAVE-1;Verprolin homology domain-containing protein 1;, PF02205;, GO:0015629;GO:0005856;GO:0032839;GO:0005925;GO:0030027;GO:0005741;GO:0098794;GO:0032991;GO:0031209;GO:0003779;GO:0071933;GO:0051018;GO:0034237;GO:0030036;GO:0030041;GO:1990416;GO:0097484;GO:0098939;GO:0072673;GO:0070584;GO:0098885;GO:2000601;GO:0051388;GO:0065003;GO:0016601;GO:0006898;, C:actin cytoskeleton; C:cytoskeleton; C:dendrite cytoplasm; C:focal adhesion; C:lamellipodium; C:mitochondrial outer membrane; C:postsynapse; C:protein-containing complex; C:SCAR complex;, F:actin binding; F:Arp2/3 complex binding; F:protein kinase A binding; F:protein kinase A regulatory subunit binding;, P:actin cytoskeleton organization; P:actin filament polymerization; P:cellular response to brain-derived neurotrophic factor stimulus; P:dendrite extension; P:dendritic transport of mitochondrion; P:lamellipodium morphogenesis; P:mitochondrion morphogenesis; P:modification of postsynaptic actin cytoskeleton; P:positive regulation of Arp2/3 complex-mediated actin nucleation; P:positive regulation of neurotrophin TRK receptor signaling pathway; P:protein-containing complex assembly; P:Rac protein signal transduction; P:receptor-mediated endocytosis; scaffold1670 indexed_genome mRNA 484 15063 . - . ID=transcript_17181;O95219 B3KMH0 B4DQV4 D3DNA3,Sorting nexin-4,, PF00787;, GO:0005737;GO:0005868;GO:0031901;GO:0016020;GO:0005886;GO:0032991;GO:0031201;GO:0005154;GO:0005158;GO:1990460;GO:0035091;GO:1990459;GO:0032456;GO:1903595;GO:0015031;, C:cytoplasm; C:cytoplasmic dynein complex; C:early endosome membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:SNARE complex;, F:epidermal growth factor receptor binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:transferrin receptor binding;, P:endocytic recycling; P:positive regulation of histamine secretion by mast cell; P:protein transport; scaffold1682 indexed_genome mRNA 4403 13247 . + . ID=transcript_17182;Q9Y448 B4DXA7 Q147U5 Q32Q57 Q5ISJ0 Q6P2S5 Q6PJM0 Q86XB4,Small kinetochore-associated protein {ECO:0000303|PubMed:19667759},Kinetochore-localized astrin-binding protein {ECO:0000303|PubMed:21402792};Kinetochore-localized astrin/SPAG5-binding protein;TRAF4-associated factor 1;, , GO:0034451;GO:0000777;GO:0005737;GO:0000776;GO:0035371;GO:0072686;GO:0005634;GO:0005886;GO:0001726;GO:0000922;GO:0051010;GO:0042803;GO:0051301;GO:0016477;GO:0071364;GO:0007059;GO:0000226;GO:0000070;GO:0051988;GO:0007051;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytoplasm; C:kinetochore; C:microtubule plus-end; C:mitotic spindle; C:nucleus; C:plasma membrane; C:ruffle; C:spindle pole;, F:microtubule plus-end binding; F:protein homodimerization activity;, P:cell division; P:cell migration; P:cellular response to epidermal growth factor stimulus; P:chromosome segregation; P:microtubule cytoskeleton organization; P:mitotic sister chromatid segregation; P:regulation of attachment of spindle microtubules to kinetochore; P:spindle organization; scaffold1683 indexed_genome mRNA 4397 13241 . + . ID=transcript_17183;Q9Y448 B4DXA7 Q147U5 Q32Q57 Q5ISJ0 Q6P2S5 Q6PJM0 Q86XB4,Small kinetochore-associated protein {ECO:0000303|PubMed:19667759},Kinetochore-localized astrin-binding protein {ECO:0000303|PubMed:21402792};Kinetochore-localized astrin/SPAG5-binding protein;TRAF4-associated factor 1;, , GO:0034451;GO:0000777;GO:0005737;GO:0000776;GO:0035371;GO:0072686;GO:0005634;GO:0005886;GO:0001726;GO:0000922;GO:0051010;GO:0042803;GO:0051301;GO:0016477;GO:0071364;GO:0007059;GO:0000226;GO:0000070;GO:0051988;GO:0007051;, C:centriolar satellite; C:condensed chromosome kinetochore; C:cytoplasm; C:kinetochore; C:microtubule plus-end; C:mitotic spindle; C:nucleus; C:plasma membrane; C:ruffle; C:spindle pole;, F:microtubule plus-end binding; F:protein homodimerization activity;, P:cell division; P:cell migration; P:cellular response to epidermal growth factor stimulus; P:chromosome segregation; P:microtubule cytoskeleton organization; P:mitotic sister chromatid segregation; P:regulation of attachment of spindle microtubules to kinetochore; P:spindle organization; scaffold1703 indexed_genome mRNA 26 4102 . - . ID=transcript_17184;Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; scaffold1704 indexed_genome mRNA 26 4101 . - . ID=transcript_17185;Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport;|Q9H0X9 A6NDP0 A6NJS8 B4DVB0 Q54A90 Q8N596 Q9BZB0 Q9P1Z4,Oxysterol-binding protein-related protein 5,Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};, PF01237;PF00169;, GO:0005829;GO:0005789;GO:0140268;GO:0016021;GO:0043231;GO:0016020;GO:0015485;GO:0008142;GO:0070273;GO:0001786;GO:0140343;GO:0032934;GO:0015248;GO:0008203;GO:0030301;GO:0006893;GO:0036150;GO:0015914;, C:cytosol; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-plasma membrane contact site; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane;, F:cholesterol binding; F:oxysterol binding; F:phosphatidylinositol-4-phosphate binding; F:phosphatidylserine binding; F:phosphatidylserine transfer activity; F:sterol binding; F:sterol transporter activity;, P:cholesterol metabolic process; P:cholesterol transport; P:Golgi to plasma membrane transport; P:phosphatidylserine acyl-chain remodeling; P:phospholipid transport; scaffold1726 indexed_genome mRNA 891 7855 . - . ID=transcript_17186;Q9UL68 A7E2C7 B2RP54 Q6IQ17 Q9UPP6,Myelin transcription factor 1-like protein {ECO:0000303|Ref.1},, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0007399;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:regulation of transcription by RNA polymerase II;|Q9UL68 A7E2C7 B2RP54 Q6IQ17 Q9UPP6,Myelin transcription factor 1-like protein {ECO:0000303|Ref.1},, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0007399;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:regulation of transcription by RNA polymerase II;|Q9UL68 A7E2C7 B2RP54 Q6IQ17 Q9UPP6,Myelin transcription factor 1-like protein {ECO:0000303|Ref.1},, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0007399;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:regulation of transcription by RNA polymerase II; scaffold1727 indexed_genome mRNA 890 7851 . + . ID=transcript_17187;Q9UL68 A7E2C7 B2RP54 Q6IQ17 Q9UPP6,Myelin transcription factor 1-like protein {ECO:0000303|Ref.1},, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0007399;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:regulation of transcription by RNA polymerase II;|Q9UL68 A7E2C7 B2RP54 Q6IQ17 Q9UPP6,Myelin transcription factor 1-like protein {ECO:0000303|Ref.1},, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0007399;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:regulation of transcription by RNA polymerase II;|Q9UL68 A7E2C7 B2RP54 Q6IQ17 Q9UPP6,Myelin transcription factor 1-like protein {ECO:0000303|Ref.1},, PF08474;PF01530;, GO:0000785;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0008270;GO:0000122;GO:0007399;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:zinc ion binding;, P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:regulation of transcription by RNA polymerase II; scaffold1740 indexed_genome mRNA 4205 6613 . + . ID=transcript_17188;P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation;|P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation;|P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation; scaffold1784 indexed_genome mRNA 9839 11366 . + . ID=transcript_17189;P61604 O95421 Q04984 Q53X54 Q9UDH0,10 kDa heat shock protein, mitochondrial,10 kDa chaperonin;Chaperonin 10;Early-pregnancy factor;, PF00166;, GO:0070062;GO:0016020;GO:0005759;GO:0005739;GO:0005524;GO:0016887;GO:0051087;GO:0046872;GO:0003723;GO:0051082;GO:0006919;GO:0051085;GO:0001649;GO:0006457;GO:0006986;, C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:chaperone binding; F:metal ion binding; F:RNA binding; F:unfolded protein binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:chaperone cofactor-dependent protein refolding; P:osteoblast differentiation; P:protein folding; P:response to unfolded protein; scaffold1785 indexed_genome mRNA 9835 11362 . - . ID=transcript_17190;P61604 O95421 Q04984 Q53X54 Q9UDH0,10 kDa heat shock protein, mitochondrial,10 kDa chaperonin;Chaperonin 10;Early-pregnancy factor;, PF00166;, GO:0070062;GO:0016020;GO:0005759;GO:0005739;GO:0005524;GO:0016887;GO:0051087;GO:0046872;GO:0003723;GO:0051082;GO:0006919;GO:0051085;GO:0001649;GO:0006457;GO:0006986;, C:extracellular exosome; C:membrane; C:mitochondrial matrix; C:mitochondrion;, F:ATP binding; F:ATPase activity; F:chaperone binding; F:metal ion binding; F:RNA binding; F:unfolded protein binding;, P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:chaperone cofactor-dependent protein refolding; P:osteoblast differentiation; P:protein folding; P:response to unfolded protein; scaffold1791 indexed_genome mRNA 3502 9956 . + . ID=transcript_17191;P13805 O95472 Q16061 Q5U0E1,Troponin T, slow skeletal muscle,Slow skeletal muscle troponin T;, PF00992;, GO:0005829;GO:0005861;GO:0005523;GO:0031014;GO:0006936;GO:0030049;GO:0045932;GO:0045214;GO:0003009;GO:0031444;GO:0014883;, C:cytosol; C:troponin complex;, F:tropomyosin binding; F:troponin T binding;, P:muscle contraction; P:muscle filament sliding; P:negative regulation of muscle contraction; P:sarcomere organization; P:skeletal muscle contraction; P:slow-twitch skeletal muscle fiber contraction; P:transition between fast and slow fiber;|P13805 O95472 Q16061 Q5U0E1,Troponin T, slow skeletal muscle,Slow skeletal muscle troponin T;, PF00992;, GO:0005829;GO:0005861;GO:0005523;GO:0031014;GO:0006936;GO:0030049;GO:0045932;GO:0045214;GO:0003009;GO:0031444;GO:0014883;, C:cytosol; C:troponin complex;, F:tropomyosin binding; F:troponin T binding;, P:muscle contraction; P:muscle filament sliding; P:negative regulation of muscle contraction; P:sarcomere organization; P:skeletal muscle contraction; P:slow-twitch skeletal muscle fiber contraction; P:transition between fast and slow fiber;|P13805 O95472 Q16061 Q5U0E1,Troponin T, slow skeletal muscle,Slow skeletal muscle troponin T;, PF00992;, GO:0005829;GO:0005861;GO:0005523;GO:0031014;GO:0006936;GO:0030049;GO:0045932;GO:0045214;GO:0003009;GO:0031444;GO:0014883;, C:cytosol; C:troponin complex;, F:tropomyosin binding; F:troponin T binding;, P:muscle contraction; P:muscle filament sliding; P:negative regulation of muscle contraction; P:sarcomere organization; P:skeletal muscle contraction; P:slow-twitch skeletal muscle fiber contraction; P:transition between fast and slow fiber; scaffold1800 indexed_genome mRNA 4569 10835 . + . ID=transcript_17192;Q96AA3 Q96J03,Protein RFT1 homolog,, PF04506;, GO:0005789;GO:0016021;GO:0008643;GO:0006488;GO:0034203;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:carbohydrate transport; P:dolichol-linked oligosaccharide biosynthetic process; P:glycolipid translocation; scaffold1801 indexed_genome mRNA 4569 10834 . + . ID=transcript_17193;Q96AA3 Q96J03,Protein RFT1 homolog,, PF04506;, GO:0005789;GO:0016021;GO:0008643;GO:0006488;GO:0034203;, C:endoplasmic reticulum membrane; C:integral component of membrane;, , P:carbohydrate transport; P:dolichol-linked oligosaccharide biosynthetic process; P:glycolipid translocation; scaffold1803 indexed_genome mRNA 1753 10371 . - . ID=transcript_17194;Q86VD7 D2T2J5 O14553 O43378,Mitochondrial coenzyme A transporter SLC25A42,Solute carrier family 25 member 42;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0043262;GO:0015217;GO:0080122;GO:0005347;GO:0015228;GO:0015866;GO:0080121;GO:0015867;GO:0035349;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:adenosine-diphosphatase activity; F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:coenzyme A transmembrane transporter activity;, P:ADP transport; P:AMP transport; P:ATP transport; P:coenzyme A transmembrane transport;|Q86VD7 D2T2J5 O14553 O43378,Mitochondrial coenzyme A transporter SLC25A42,Solute carrier family 25 member 42;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0043262;GO:0015217;GO:0080122;GO:0005347;GO:0015228;GO:0015866;GO:0080121;GO:0015867;GO:0035349;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:adenosine-diphosphatase activity; F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:coenzyme A transmembrane transporter activity;, P:ADP transport; P:AMP transport; P:ATP transport; P:coenzyme A transmembrane transport;|Q86VD7 D2T2J5 O14553 O43378,Mitochondrial coenzyme A transporter SLC25A42,Solute carrier family 25 member 42;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0043262;GO:0015217;GO:0080122;GO:0005347;GO:0015228;GO:0015866;GO:0080121;GO:0015867;GO:0035349;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:adenosine-diphosphatase activity; F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:coenzyme A transmembrane transporter activity;, P:ADP transport; P:AMP transport; P:ATP transport; P:coenzyme A transmembrane transport;|Q86VD7 D2T2J5 O14553 O43378,Mitochondrial coenzyme A transporter SLC25A42,Solute carrier family 25 member 42;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0043262;GO:0015217;GO:0080122;GO:0005347;GO:0015228;GO:0015866;GO:0080121;GO:0015867;GO:0035349;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:adenosine-diphosphatase activity; F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:coenzyme A transmembrane transporter activity;, P:ADP transport; P:AMP transport; P:ATP transport; P:coenzyme A transmembrane transport; scaffold1803 indexed_genome mRNA 10512 11705 . - . ID=transcript_17195;Q86VD7 D2T2J5 O14553 O43378,Mitochondrial coenzyme A transporter SLC25A42,Solute carrier family 25 member 42;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0043262;GO:0015217;GO:0080122;GO:0005347;GO:0015228;GO:0015866;GO:0080121;GO:0015867;GO:0035349;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:adenosine-diphosphatase activity; F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:coenzyme A transmembrane transporter activity;, P:ADP transport; P:AMP transport; P:ATP transport; P:coenzyme A transmembrane transport; scaffold1806 indexed_genome mRNA 1715 10333 . + . ID=transcript_17196;Q86VD7 D2T2J5 O14553 O43378,Mitochondrial coenzyme A transporter SLC25A42,Solute carrier family 25 member 42;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0043262;GO:0015217;GO:0080122;GO:0005347;GO:0015228;GO:0015866;GO:0080121;GO:0015867;GO:0035349;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:adenosine-diphosphatase activity; F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:coenzyme A transmembrane transporter activity;, P:ADP transport; P:AMP transport; P:ATP transport; P:coenzyme A transmembrane transport;|Q86VD7 D2T2J5 O14553 O43378,Mitochondrial coenzyme A transporter SLC25A42,Solute carrier family 25 member 42;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0043262;GO:0015217;GO:0080122;GO:0005347;GO:0015228;GO:0015866;GO:0080121;GO:0015867;GO:0035349;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:adenosine-diphosphatase activity; F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:coenzyme A transmembrane transporter activity;, P:ADP transport; P:AMP transport; P:ATP transport; P:coenzyme A transmembrane transport;|Q86VD7 D2T2J5 O14553 O43378,Mitochondrial coenzyme A transporter SLC25A42,Solute carrier family 25 member 42;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0043262;GO:0015217;GO:0080122;GO:0005347;GO:0015228;GO:0015866;GO:0080121;GO:0015867;GO:0035349;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:adenosine-diphosphatase activity; F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:coenzyme A transmembrane transporter activity;, P:ADP transport; P:AMP transport; P:ATP transport; P:coenzyme A transmembrane transport;|Q86VD7 D2T2J5 O14553 O43378,Mitochondrial coenzyme A transporter SLC25A42,Solute carrier family 25 member 42;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0043262;GO:0015217;GO:0080122;GO:0005347;GO:0015228;GO:0015866;GO:0080121;GO:0015867;GO:0035349;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:adenosine-diphosphatase activity; F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:coenzyme A transmembrane transporter activity;, P:ADP transport; P:AMP transport; P:ATP transport; P:coenzyme A transmembrane transport; scaffold1806 indexed_genome mRNA 10474 11667 . - . ID=transcript_17197;Q86VD7 D2T2J5 O14553 O43378,Mitochondrial coenzyme A transporter SLC25A42,Solute carrier family 25 member 42;, PF00153;, GO:0016021;GO:0005743;GO:0005739;GO:0005634;GO:0043262;GO:0015217;GO:0080122;GO:0005347;GO:0015228;GO:0015866;GO:0080121;GO:0015867;GO:0035349;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion; C:nucleus;, F:adenosine-diphosphatase activity; F:ADP transmembrane transporter activity; F:AMP transmembrane transporter activity; F:ATP transmembrane transporter activity; F:coenzyme A transmembrane transporter activity;, P:ADP transport; P:AMP transport; P:ATP transport; P:coenzyme A transmembrane transport; scaffold1816 indexed_genome mRNA 3091 6437 . - . ID=transcript_17198;Q13443 B7ZLN7 Q10718 Q8NFM6,Disintegrin and metalloproteinase domain-containing protein 9,Cellular disintegrin-related protein;Meltrin-gamma;Metalloprotease/disintegrin/cysteine-rich protein 9;Myeloma cell metalloproteinase;, PF08516;PF00200;PF01562;PF01421;, GO:0009986;GO:0070062;GO:0005615;GO:0005925;GO:0016021;GO:0031233;GO:0005518;GO:0005178;GO:0043236;GO:0046872;GO:0004222;GO:1902945;GO:0008237;GO:0005080;GO:0017124;GO:0000186;GO:0042987;GO:0007155;GO:0033627;GO:0016477;GO:0033631;GO:0007160;GO:0071222;GO:0007229;GO:0030216;GO:0006509;GO:0031293;GO:0042117;GO:0033630;GO:0030335;GO:0051549;GO:0034241;GO:0051044;GO:0050714;GO:0016485;GO:0051592;GO:0051384;GO:0042542;GO:0010042;GO:0034612;GO:0007179;, C:cell surface; C:extracellular exosome; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:intrinsic component of external side of plasma membrane;, F:collagen binding; F:integrin binding; F:laminin binding; F:metal ion binding; F:metalloendopeptidase activity; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; F:metallopeptidase activity; F:protein kinase C binding; F:SH3 domain binding;, P:activation of MAPKK activity; P:amyloid precursor protein catabolic process; P:cell adhesion; P:cell adhesion mediated by integrin; P:cell migration; P:cell-cell adhesion mediated by integrin; P:cell-matrix adhesion; P:cellular response to lipopolysaccharide; P:integrin-mediated signaling pathway; P:keratinocyte differentiation; P:membrane protein ectodomain proteolysis; P:membrane protein intracellular domain proteolysis; P:monocyte activation; P:positive regulation of cell adhesion mediated by integrin; P:positive regulation of cell migration; P:positive regulation of keratinocyte migration; P:positive regulation of macrophage fusion; P:positive regulation of membrane protein ectodomain proteolysis; P:positive regulation of protein secretion; P:protein processing; P:response to calcium ion; P:response to glucocorticoid; P:response to hydrogen peroxide; P:response to manganese ion; P:response to tumor necrosis factor; P:transforming growth factor beta receptor signaling pathway; scaffold1826 indexed_genome mRNA 8710 11098 . + . ID=transcript_17199;P16333 B7Z751 D3DNE3,Cytoplasmic protein NCK1,NCK adaptor protein 1;SH2/SH3 adaptor protein NCK-alpha;, PF00017;PF00018;PF14604;, GO:0005911;GO:0005737;GO:0005829;GO:0005783;GO:0005634;GO:0005886;GO:0000164;GO:0005840;GO:0012506;GO:0045296;GO:0008093;GO:0046875;GO:0071074;GO:0019904;GO:0004860;GO:0030674;GO:0030971;GO:0035591;GO:0005102;GO:0030159;GO:0007015;GO:0048013;GO:0038096;GO:0030032;GO:0060548;GO:1903912;GO:0046627;GO:0033137;GO:1903898;GO:1990441;GO:0070262;GO:0030838;GO:1903676;GO:1903679;GO:1902237;GO:0010976;GO:0042102;GO:0045944;GO:0036493;GO:0030334;GO:0051707;GO:0007172;GO:0006930;GO:0042110;GO:0050852;GO:0048010;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleus; C:plasma membrane; C:protein phosphatase type 1 complex; C:ribosome; C:vesicle membrane;, F:cadherin binding; F:cytoskeletal anchor activity; F:ephrin receptor binding; F:eukaryotic initiation factor eIF2 binding; F:protein domain specific binding; F:protein kinase inhibitor activity; F:protein-macromolecule adaptor activity; F:receptor tyrosine kinase binding; F:signaling adaptor activity; F:signaling receptor binding; F:signaling receptor complex adaptor activity;, P:actin filament organization; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium assembly; P:negative regulation of cell death; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:peptidyl-serine dephosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cap-dependent translational initiation; P:positive regulation of cap-independent translational initiation; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of neuron projection development; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cell migration; P:response to other organism; P:signal complex assembly; P:substrate-dependent cell migration, cell extension; P:T cell activation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold1830 indexed_genome mRNA 1 11093 . + . ID=transcript_17200;P16333 B7Z751 D3DNE3,Cytoplasmic protein NCK1,NCK adaptor protein 1;SH2/SH3 adaptor protein NCK-alpha;, PF00017;PF00018;PF14604;, GO:0005911;GO:0005737;GO:0005829;GO:0005783;GO:0005634;GO:0005886;GO:0000164;GO:0005840;GO:0012506;GO:0045296;GO:0008093;GO:0046875;GO:0071074;GO:0019904;GO:0004860;GO:0030674;GO:0030971;GO:0035591;GO:0005102;GO:0030159;GO:0007015;GO:0048013;GO:0038096;GO:0030032;GO:0060548;GO:1903912;GO:0046627;GO:0033137;GO:1903898;GO:1990441;GO:0070262;GO:0030838;GO:1903676;GO:1903679;GO:1902237;GO:0010976;GO:0042102;GO:0045944;GO:0036493;GO:0030334;GO:0051707;GO:0007172;GO:0006930;GO:0042110;GO:0050852;GO:0048010;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleus; C:plasma membrane; C:protein phosphatase type 1 complex; C:ribosome; C:vesicle membrane;, F:cadherin binding; F:cytoskeletal anchor activity; F:ephrin receptor binding; F:eukaryotic initiation factor eIF2 binding; F:protein domain specific binding; F:protein kinase inhibitor activity; F:protein-macromolecule adaptor activity; F:receptor tyrosine kinase binding; F:signaling adaptor activity; F:signaling receptor binding; F:signaling receptor complex adaptor activity;, P:actin filament organization; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium assembly; P:negative regulation of cell death; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:peptidyl-serine dephosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cap-dependent translational initiation; P:positive regulation of cap-independent translational initiation; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of neuron projection development; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cell migration; P:response to other organism; P:signal complex assembly; P:substrate-dependent cell migration, cell extension; P:T cell activation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;|P16333 B7Z751 D3DNE3,Cytoplasmic protein NCK1,NCK adaptor protein 1;SH2/SH3 adaptor protein NCK-alpha;, PF00017;PF00018;PF14604;, GO:0005911;GO:0005737;GO:0005829;GO:0005783;GO:0005634;GO:0005886;GO:0000164;GO:0005840;GO:0012506;GO:0045296;GO:0008093;GO:0046875;GO:0071074;GO:0019904;GO:0004860;GO:0030674;GO:0030971;GO:0035591;GO:0005102;GO:0030159;GO:0007015;GO:0048013;GO:0038096;GO:0030032;GO:0060548;GO:1903912;GO:0046627;GO:0033137;GO:1903898;GO:1990441;GO:0070262;GO:0030838;GO:1903676;GO:1903679;GO:1902237;GO:0010976;GO:0042102;GO:0045944;GO:0036493;GO:0030334;GO:0051707;GO:0007172;GO:0006930;GO:0042110;GO:0050852;GO:0048010;, C:cell-cell junction; C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:nucleus; C:plasma membrane; C:protein phosphatase type 1 complex; C:ribosome; C:vesicle membrane;, F:cadherin binding; F:cytoskeletal anchor activity; F:ephrin receptor binding; F:eukaryotic initiation factor eIF2 binding; F:protein domain specific binding; F:protein kinase inhibitor activity; F:protein-macromolecule adaptor activity; F:receptor tyrosine kinase binding; F:signaling adaptor activity; F:signaling receptor binding; F:signaling receptor complex adaptor activity;, P:actin filament organization; P:ephrin receptor signaling pathway; P:Fc-gamma receptor signaling pathway involved in phagocytosis; P:lamellipodium assembly; P:negative regulation of cell death; P:negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; P:negative regulation of insulin receptor signaling pathway; P:negative regulation of peptidyl-serine phosphorylation; P:negative regulation of PERK-mediated unfolded protein response; P:negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:peptidyl-serine dephosphorylation; P:positive regulation of actin filament polymerization; P:positive regulation of cap-dependent translational initiation; P:positive regulation of cap-independent translational initiation; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of neuron projection development; P:positive regulation of T cell proliferation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of translation in response to endoplasmic reticulum stress; P:regulation of cell migration; P:response to other organism; P:signal complex assembly; P:substrate-dependent cell migration, cell extension; P:T cell activation; P:T cell receptor signaling pathway; P:vascular endothelial growth factor receptor signaling pathway; scaffold1849 indexed_genome mRNA 7222 10263 . + . ID=transcript_17201;O95219 B3KMH0 B4DQV4 D3DNA3,Sorting nexin-4,, PF00787;, GO:0005737;GO:0005868;GO:0031901;GO:0016020;GO:0005886;GO:0032991;GO:0031201;GO:0005154;GO:0005158;GO:1990460;GO:0035091;GO:1990459;GO:0032456;GO:1903595;GO:0015031;, C:cytoplasm; C:cytoplasmic dynein complex; C:early endosome membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:SNARE complex;, F:epidermal growth factor receptor binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:transferrin receptor binding;, P:endocytic recycling; P:positive regulation of histamine secretion by mast cell; P:protein transport; scaffold1855 indexed_genome mRNA 1119 11217 . - . ID=transcript_17202;Q9C0C2 A7E2F8 Q6PJ35 Q6ZV74,182 kDa tankyrase-1-binding protein,, PF15327;, GO:0015629;GO:0005912;GO:0030014;GO:0005737;GO:0005829;GO:0000792;GO:0005634;GO:0005886;GO:0071532;GO:0045296;GO:0019899;GO:0044877;GO:0071479;GO:0006977;GO:0006302;GO:0000289;GO:0033138;GO:0010800;GO:0031954;GO:0007004;, C:actin cytoskeleton; C:adherens junction; C:CCR4-NOT complex; C:cytoplasm; C:cytosol; C:heterochromatin; C:nucleus; C:plasma membrane;, F:ankyrin repeat binding; F:cadherin binding; F:enzyme binding; F:protein-containing complex binding;, P:cellular response to ionizing radiation; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:double-strand break repair; P:nuclear-transcribed mRNA poly(A) tail shortening; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of protein autophosphorylation; P:telomere maintenance via telomerase; scaffold1859 indexed_genome mRNA 11 2345 . - . ID=transcript_17203;Q9P0U4 B2RC03 Q8N2W4 Q96BC8 Q9P2V7,CXXC-type zinc finger protein 1,CpG-binding protein;PHD finger and CXXC domain-containing protein 1;, PF00628;PF12269;PF02008;, GO:0005829;GO:0035097;GO:0016363;GO:0016607;GO:0005654;GO:0005634;GO:0048188;GO:0000987;GO:0035064;GO:0045322;GO:0008270;GO:0051568;GO:0036498;GO:0045893;GO:0006355;, C:cytosol; C:histone methyltransferase complex; C:nuclear matrix; C:nuclear speck; C:nucleoplasm; C:nucleus; C:Set1C/COMPASS complex;, F:cis-regulatory region sequence-specific DNA binding; F:methylated histone binding; F:unmethylated CpG binding; F:zinc ion binding;, P:histone H3-K4 methylation; P:IRE1-mediated unfolded protein response; P:positive regulation of transcription, DNA-templated; P:regulation of transcription, DNA-templated; scaffold1883 indexed_genome mRNA 2809 4041 . - . ID=transcript_17204;P16152 B2RBZ7 B4DFK7 Q3LHW8,Carbonyl reductase [NADPH] 1 {ECO:0000305},15-hydroxyprostaglandin dehydrogenase [NADP(+)];20-beta-hydroxysteroid dehydrogenase;NADPH-dependent carbonyl reductase 1;Prostaglandin 9-ketoreductase {ECO:0000303|PubMed:1597188};Prostaglandin-E(2) 9-reductase {ECO:0000250|UniProtKB:Q28960};Short chain dehydrogenase/reductase family 21C member 1;, PF00106;, GO:0005829;GO:0070062;GO:1903561;GO:0047021;GO:0047020;GO:0004090;GO:0016655;GO:0050221;GO:0019371;GO:0017144;GO:0030855;GO:0042373;, C:cytosol; C:extracellular exosome; C:extracellular vesicle;, F:15-hydroxyprostaglandin dehydrogenase (NADP+) activity; F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:carbonyl reductase (NADPH) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:prostaglandin-E2 9-reductase activity;, P:cyclooxygenase pathway; P:drug metabolic process; P:epithelial cell differentiation; P:vitamin K metabolic process; scaffold1893 indexed_genome mRNA 5943 8712 . + . ID=transcript_17205;P31749 B2RAM5 B7Z5R1 Q9BWB6,RAC-alpha serine/threonine-protein kinase,Protein kinase B;Protein kinase B alpha;Proto-oncogene c-Akt;RAC-PK-alpha;, PF00169;PF00069;PF00433;, GO:0005911;GO:0036064;GO:0005737;GO:0005829;GO:0031234;GO:0030027;GO:0015630;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0098794;GO:0032991;GO:0005819;GO:0031982;GO:0071889;GO:0005524;GO:0005516;GO:0019899;GO:0032794;GO:0042802;GO:0016301;GO:0030235;GO:0005547;GO:0043325;GO:0042803;GO:0004672;GO:0005080;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0032148;GO:0006924;GO:0007568;GO:0043276;GO:0008637;GO:0008643;GO:0030154;GO:0002042;GO:0008283;GO:0030030;GO:0071276;GO:0006974;GO:0071364;GO:0097011;GO:0071456;GO:0032869;GO:0071260;GO:1990090;GO:0071407;GO:0140052;GO:0071380;GO:0034614;GO:0071356;GO:0035924;GO:0019221;GO:0007173;GO:0072655;GO:0060079;GO:0097194;GO:0010761;GO:0007186;GO:0007281;GO:0042593;GO:0006006;GO:0005978;GO:0060709;GO:0030212;GO:0007249;GO:0006954;GO:0008286;GO:0048009;GO:0035655;GO:0035556;GO:0060716;GO:0031663;GO:0072656;GO:0060644;GO:0001893;GO:0043066;GO:0010507;GO:0045792;GO:0043154;GO:0010951;GO:2001240;GO:0031999;GO:0010629;GO:0046329;GO:1903038;GO:0010748;GO:2000402;GO:0016242;GO:1901215;GO:0045746;GO:1902176;GO:0032091;GO:0006469;GO:0100002;GO:0051898;GO:0071901;GO:0031397;GO:0045861;GO:0090201;GO:0038061;GO:0006809;GO:0001649;GO:0018105;GO:0018107;GO:0032287;GO:0014065;GO:0016310;GO:0043065;GO:0043536;GO:0030307;GO:0008284;GO:0032270;GO:0045737;GO:0051091;GO:0032079;GO:0010595;GO:0001938;GO:0045742;GO:0045600;GO:0010763;GO:1900087;GO:0010628;GO:0046326;GO:0010907;GO:0045725;GO:1903721;GO:0046889;GO:0010918;GO:0045429;GO:0051000;GO:0046622;GO:0033138;GO:0032436;GO:2000010;GO:1900182;GO:1903078;GO:0001934;GO:0048661;GO:0010765;GO:0045944;GO:0045893;GO:0045907;GO:0046777;GO:0030163;GO:0006606;GO:0043491;GO:0006468;GO:0016567;GO:0042981;GO:0030334;GO:0005979;GO:0043488;GO:0031641;GO:0010975;GO:0050999;GO:1901796;GO:0006417;GO:2000074;GO:0034405;GO:0032094;GO:0060416;GO:0009408;GO:1990418;GO:0006979;GO:0070141;GO:0007165;GO:0003376;GO:0021510;GO:0051146;GO:0031295;GO:0046146;GO:0031929;GO:0006412;, C:cell-cell junction; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:lamellipodium; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynapse; C:protein-containing complex; C:spindle; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calmodulin binding; F:enzyme binding; F:GTPase activating protein binding; F:identical protein binding; F:kinase activity; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase C binding; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase B activity; P:activation-induced cell death of T cells; P:aging; P:anoikis; P:apoptotic mitochondrial changes; P:carbohydrate transport; P:cell differentiation; P:cell migration involved in sprouting angiogenesis; P:cell population proliferation; P:cell projection organization; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to organic cyclic compound; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization to mitochondrion; P:excitatory postsynaptic potential; P:execution phase of apoptosis; P:fibroblast migration; P:G protein-coupled receptor signaling pathway; P:germ cell development; P:glucose homeostasis; P:glucose metabolic process; P:glycogen biosynthetic process; P:glycogen cell differentiation involved in embryonic placenta development; P:hyaluronan metabolic process; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:interleukin-18-mediated signaling pathway; P:intracellular signal transduction; P:labyrinthine layer blood vessel development; P:lipopolysaccharide-mediated signaling pathway; P:maintenance of protein location in mitochondrion; P:mammary gland epithelial cell differentiation; P:maternal placenta development; P:negative regulation of apoptotic process; P:negative regulation of autophagy; P:negative regulation of cell size; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of endopeptidase activity; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:negative regulation of JNK cascade; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of lymphocyte migration; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of Notch signaling pathway; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase activity by protein phosphorylation; P:negative regulation of protein kinase B signaling; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of protein ubiquitination; P:negative regulation of proteolysis; P:negative regulation of release of cytochrome c from mitochondria; P:NIK/NF-kappaB signaling; P:nitric oxide biosynthetic process; P:osteoblast differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peripheral nervous system myelin maintenance; P:phosphatidylinositol 3-kinase signaling; P:phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein metabolic process; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of fat cell differentiation; P:positive regulation of fibroblast migration; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of lipid biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of organ growth; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to nucleus; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vasoconstriction; P:protein autophosphorylation; P:protein catabolic process; P:protein import into nucleus; P:protein kinase B signaling; P:protein phosphorylation; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of glycogen biosynthetic process; P:regulation of mRNA stability; P:regulation of myelination; P:regulation of neuron projection development; P:regulation of nitric-oxide synthase activity; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:regulation of type B pancreatic cell development; P:response to fluid shear stress; P:response to food; P:response to growth hormone; P:response to heat; P:response to insulin-like growth factor stimulus; P:response to oxidative stress; P:response to UV-A; P:signal transduction; P:sphingosine-1-phosphate receptor signaling pathway; P:spinal cord development; P:striated muscle cell differentiation; P:T cell costimulation; P:tetrahydrobiopterin metabolic process; P:TOR signaling; P:translation; scaffold1893 indexed_genome mRNA 9177 9984 . - . ID=transcript_17206;P31749 B2RAM5 B7Z5R1 Q9BWB6,RAC-alpha serine/threonine-protein kinase,Protein kinase B;Protein kinase B alpha;Proto-oncogene c-Akt;RAC-PK-alpha;, PF00169;PF00069;PF00433;, GO:0005911;GO:0036064;GO:0005737;GO:0005829;GO:0031234;GO:0030027;GO:0015630;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0098794;GO:0032991;GO:0005819;GO:0031982;GO:0071889;GO:0005524;GO:0005516;GO:0019899;GO:0032794;GO:0042802;GO:0016301;GO:0030235;GO:0005547;GO:0043325;GO:0042803;GO:0004672;GO:0005080;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0032148;GO:0006924;GO:0007568;GO:0043276;GO:0008637;GO:0008643;GO:0030154;GO:0002042;GO:0008283;GO:0030030;GO:0071276;GO:0006974;GO:0071364;GO:0097011;GO:0071456;GO:0032869;GO:0071260;GO:1990090;GO:0071407;GO:0140052;GO:0071380;GO:0034614;GO:0071356;GO:0035924;GO:0019221;GO:0007173;GO:0072655;GO:0060079;GO:0097194;GO:0010761;GO:0007186;GO:0007281;GO:0042593;GO:0006006;GO:0005978;GO:0060709;GO:0030212;GO:0007249;GO:0006954;GO:0008286;GO:0048009;GO:0035655;GO:0035556;GO:0060716;GO:0031663;GO:0072656;GO:0060644;GO:0001893;GO:0043066;GO:0010507;GO:0045792;GO:0043154;GO:0010951;GO:2001240;GO:0031999;GO:0010629;GO:0046329;GO:1903038;GO:0010748;GO:2000402;GO:0016242;GO:1901215;GO:0045746;GO:1902176;GO:0032091;GO:0006469;GO:0100002;GO:0051898;GO:0071901;GO:0031397;GO:0045861;GO:0090201;GO:0038061;GO:0006809;GO:0001649;GO:0018105;GO:0018107;GO:0032287;GO:0014065;GO:0016310;GO:0043065;GO:0043536;GO:0030307;GO:0008284;GO:0032270;GO:0045737;GO:0051091;GO:0032079;GO:0010595;GO:0001938;GO:0045742;GO:0045600;GO:0010763;GO:1900087;GO:0010628;GO:0046326;GO:0010907;GO:0045725;GO:1903721;GO:0046889;GO:0010918;GO:0045429;GO:0051000;GO:0046622;GO:0033138;GO:0032436;GO:2000010;GO:1900182;GO:1903078;GO:0001934;GO:0048661;GO:0010765;GO:0045944;GO:0045893;GO:0045907;GO:0046777;GO:0030163;GO:0006606;GO:0043491;GO:0006468;GO:0016567;GO:0042981;GO:0030334;GO:0005979;GO:0043488;GO:0031641;GO:0010975;GO:0050999;GO:1901796;GO:0006417;GO:2000074;GO:0034405;GO:0032094;GO:0060416;GO:0009408;GO:1990418;GO:0006979;GO:0070141;GO:0007165;GO:0003376;GO:0021510;GO:0051146;GO:0031295;GO:0046146;GO:0031929;GO:0006412;, C:cell-cell junction; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:lamellipodium; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynapse; C:protein-containing complex; C:spindle; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calmodulin binding; F:enzyme binding; F:GTPase activating protein binding; F:identical protein binding; F:kinase activity; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase C binding; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase B activity; P:activation-induced cell death of T cells; P:aging; P:anoikis; P:apoptotic mitochondrial changes; P:carbohydrate transport; P:cell differentiation; P:cell migration involved in sprouting angiogenesis; P:cell population proliferation; P:cell projection organization; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to organic cyclic compound; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization to mitochondrion; P:excitatory postsynaptic potential; P:execution phase of apoptosis; P:fibroblast migration; P:G protein-coupled receptor signaling pathway; P:germ cell development; P:glucose homeostasis; P:glucose metabolic process; P:glycogen biosynthetic process; P:glycogen cell differentiation involved in embryonic placenta development; P:hyaluronan metabolic process; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:interleukin-18-mediated signaling pathway; P:intracellular signal transduction; P:labyrinthine layer blood vessel development; P:lipopolysaccharide-mediated signaling pathway; P:maintenance of protein location in mitochondrion; P:mammary gland epithelial cell differentiation; P:maternal placenta development; P:negative regulation of apoptotic process; P:negative regulation of autophagy; P:negative regulation of cell size; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of endopeptidase activity; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:negative regulation of JNK cascade; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of lymphocyte migration; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of Notch signaling pathway; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase activity by protein phosphorylation; P:negative regulation of protein kinase B signaling; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of protein ubiquitination; P:negative regulation of proteolysis; P:negative regulation of release of cytochrome c from mitochondria; P:NIK/NF-kappaB signaling; P:nitric oxide biosynthetic process; P:osteoblast differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peripheral nervous system myelin maintenance; P:phosphatidylinositol 3-kinase signaling; P:phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein metabolic process; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of fat cell differentiation; P:positive regulation of fibroblast migration; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of lipid biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of organ growth; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to nucleus; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vasoconstriction; P:protein autophosphorylation; P:protein catabolic process; P:protein import into nucleus; P:protein kinase B signaling; P:protein phosphorylation; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of glycogen biosynthetic process; P:regulation of mRNA stability; P:regulation of myelination; P:regulation of neuron projection development; P:regulation of nitric-oxide synthase activity; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:regulation of type B pancreatic cell development; P:response to fluid shear stress; P:response to food; P:response to growth hormone; P:response to heat; P:response to insulin-like growth factor stimulus; P:response to oxidative stress; P:response to UV-A; P:signal transduction; P:sphingosine-1-phosphate receptor signaling pathway; P:spinal cord development; P:striated muscle cell differentiation; P:T cell costimulation; P:tetrahydrobiopterin metabolic process; P:TOR signaling; P:translation; scaffold1894 indexed_genome mRNA 1154 8712 . + . ID=transcript_17207;P31749 B2RAM5 B7Z5R1 Q9BWB6,RAC-alpha serine/threonine-protein kinase,Protein kinase B;Protein kinase B alpha;Proto-oncogene c-Akt;RAC-PK-alpha;, PF00169;PF00069;PF00433;, GO:0005911;GO:0036064;GO:0005737;GO:0005829;GO:0031234;GO:0030027;GO:0015630;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0098794;GO:0032991;GO:0005819;GO:0031982;GO:0071889;GO:0005524;GO:0005516;GO:0019899;GO:0032794;GO:0042802;GO:0016301;GO:0030235;GO:0005547;GO:0043325;GO:0042803;GO:0004672;GO:0005080;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0032148;GO:0006924;GO:0007568;GO:0043276;GO:0008637;GO:0008643;GO:0030154;GO:0002042;GO:0008283;GO:0030030;GO:0071276;GO:0006974;GO:0071364;GO:0097011;GO:0071456;GO:0032869;GO:0071260;GO:1990090;GO:0071407;GO:0140052;GO:0071380;GO:0034614;GO:0071356;GO:0035924;GO:0019221;GO:0007173;GO:0072655;GO:0060079;GO:0097194;GO:0010761;GO:0007186;GO:0007281;GO:0042593;GO:0006006;GO:0005978;GO:0060709;GO:0030212;GO:0007249;GO:0006954;GO:0008286;GO:0048009;GO:0035655;GO:0035556;GO:0060716;GO:0031663;GO:0072656;GO:0060644;GO:0001893;GO:0043066;GO:0010507;GO:0045792;GO:0043154;GO:0010951;GO:2001240;GO:0031999;GO:0010629;GO:0046329;GO:1903038;GO:0010748;GO:2000402;GO:0016242;GO:1901215;GO:0045746;GO:1902176;GO:0032091;GO:0006469;GO:0100002;GO:0051898;GO:0071901;GO:0031397;GO:0045861;GO:0090201;GO:0038061;GO:0006809;GO:0001649;GO:0018105;GO:0018107;GO:0032287;GO:0014065;GO:0016310;GO:0043065;GO:0043536;GO:0030307;GO:0008284;GO:0032270;GO:0045737;GO:0051091;GO:0032079;GO:0010595;GO:0001938;GO:0045742;GO:0045600;GO:0010763;GO:1900087;GO:0010628;GO:0046326;GO:0010907;GO:0045725;GO:1903721;GO:0046889;GO:0010918;GO:0045429;GO:0051000;GO:0046622;GO:0033138;GO:0032436;GO:2000010;GO:1900182;GO:1903078;GO:0001934;GO:0048661;GO:0010765;GO:0045944;GO:0045893;GO:0045907;GO:0046777;GO:0030163;GO:0006606;GO:0043491;GO:0006468;GO:0016567;GO:0042981;GO:0030334;GO:0005979;GO:0043488;GO:0031641;GO:0010975;GO:0050999;GO:1901796;GO:0006417;GO:2000074;GO:0034405;GO:0032094;GO:0060416;GO:0009408;GO:1990418;GO:0006979;GO:0070141;GO:0007165;GO:0003376;GO:0021510;GO:0051146;GO:0031295;GO:0046146;GO:0031929;GO:0006412;, C:cell-cell junction; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:lamellipodium; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynapse; C:protein-containing complex; C:spindle; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calmodulin binding; F:enzyme binding; F:GTPase activating protein binding; F:identical protein binding; F:kinase activity; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase C binding; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase B activity; P:activation-induced cell death of T cells; P:aging; P:anoikis; P:apoptotic mitochondrial changes; P:carbohydrate transport; P:cell differentiation; P:cell migration involved in sprouting angiogenesis; P:cell population proliferation; P:cell projection organization; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to organic cyclic compound; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization to mitochondrion; P:excitatory postsynaptic potential; P:execution phase of apoptosis; P:fibroblast migration; P:G protein-coupled receptor signaling pathway; P:germ cell development; P:glucose homeostasis; P:glucose metabolic process; P:glycogen biosynthetic process; P:glycogen cell differentiation involved in embryonic placenta development; P:hyaluronan metabolic process; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:interleukin-18-mediated signaling pathway; P:intracellular signal transduction; P:labyrinthine layer blood vessel development; P:lipopolysaccharide-mediated signaling pathway; P:maintenance of protein location in mitochondrion; P:mammary gland epithelial cell differentiation; P:maternal placenta development; P:negative regulation of apoptotic process; P:negative regulation of autophagy; P:negative regulation of cell size; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of endopeptidase activity; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:negative regulation of JNK cascade; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of lymphocyte migration; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of Notch signaling pathway; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase activity by protein phosphorylation; P:negative regulation of protein kinase B signaling; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of protein ubiquitination; P:negative regulation of proteolysis; P:negative regulation of release of cytochrome c from mitochondria; P:NIK/NF-kappaB signaling; P:nitric oxide biosynthetic process; P:osteoblast differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peripheral nervous system myelin maintenance; P:phosphatidylinositol 3-kinase signaling; P:phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein metabolic process; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of fat cell differentiation; P:positive regulation of fibroblast migration; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of lipid biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of organ growth; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to nucleus; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vasoconstriction; P:protein autophosphorylation; P:protein catabolic process; P:protein import into nucleus; P:protein kinase B signaling; P:protein phosphorylation; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of glycogen biosynthetic process; P:regulation of mRNA stability; P:regulation of myelination; P:regulation of neuron projection development; P:regulation of nitric-oxide synthase activity; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:regulation of type B pancreatic cell development; P:response to fluid shear stress; P:response to food; P:response to growth hormone; P:response to heat; P:response to insulin-like growth factor stimulus; P:response to oxidative stress; P:response to UV-A; P:signal transduction; P:sphingosine-1-phosphate receptor signaling pathway; P:spinal cord development; P:striated muscle cell differentiation; P:T cell costimulation; P:tetrahydrobiopterin metabolic process; P:TOR signaling; P:translation;|P31749 B2RAM5 B7Z5R1 Q9BWB6,RAC-alpha serine/threonine-protein kinase,Protein kinase B;Protein kinase B alpha;Proto-oncogene c-Akt;RAC-PK-alpha;, PF00169;PF00069;PF00433;, GO:0005911;GO:0036064;GO:0005737;GO:0005829;GO:0031234;GO:0030027;GO:0015630;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0098794;GO:0032991;GO:0005819;GO:0031982;GO:0071889;GO:0005524;GO:0005516;GO:0019899;GO:0032794;GO:0042802;GO:0016301;GO:0030235;GO:0005547;GO:0043325;GO:0042803;GO:0004672;GO:0005080;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0032148;GO:0006924;GO:0007568;GO:0043276;GO:0008637;GO:0008643;GO:0030154;GO:0002042;GO:0008283;GO:0030030;GO:0071276;GO:0006974;GO:0071364;GO:0097011;GO:0071456;GO:0032869;GO:0071260;GO:1990090;GO:0071407;GO:0140052;GO:0071380;GO:0034614;GO:0071356;GO:0035924;GO:0019221;GO:0007173;GO:0072655;GO:0060079;GO:0097194;GO:0010761;GO:0007186;GO:0007281;GO:0042593;GO:0006006;GO:0005978;GO:0060709;GO:0030212;GO:0007249;GO:0006954;GO:0008286;GO:0048009;GO:0035655;GO:0035556;GO:0060716;GO:0031663;GO:0072656;GO:0060644;GO:0001893;GO:0043066;GO:0010507;GO:0045792;GO:0043154;GO:0010951;GO:2001240;GO:0031999;GO:0010629;GO:0046329;GO:1903038;GO:0010748;GO:2000402;GO:0016242;GO:1901215;GO:0045746;GO:1902176;GO:0032091;GO:0006469;GO:0100002;GO:0051898;GO:0071901;GO:0031397;GO:0045861;GO:0090201;GO:0038061;GO:0006809;GO:0001649;GO:0018105;GO:0018107;GO:0032287;GO:0014065;GO:0016310;GO:0043065;GO:0043536;GO:0030307;GO:0008284;GO:0032270;GO:0045737;GO:0051091;GO:0032079;GO:0010595;GO:0001938;GO:0045742;GO:0045600;GO:0010763;GO:1900087;GO:0010628;GO:0046326;GO:0010907;GO:0045725;GO:1903721;GO:0046889;GO:0010918;GO:0045429;GO:0051000;GO:0046622;GO:0033138;GO:0032436;GO:2000010;GO:1900182;GO:1903078;GO:0001934;GO:0048661;GO:0010765;GO:0045944;GO:0045893;GO:0045907;GO:0046777;GO:0030163;GO:0006606;GO:0043491;GO:0006468;GO:0016567;GO:0042981;GO:0030334;GO:0005979;GO:0043488;GO:0031641;GO:0010975;GO:0050999;GO:1901796;GO:0006417;GO:2000074;GO:0034405;GO:0032094;GO:0060416;GO:0009408;GO:1990418;GO:0006979;GO:0070141;GO:0007165;GO:0003376;GO:0021510;GO:0051146;GO:0031295;GO:0046146;GO:0031929;GO:0006412;, C:cell-cell junction; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:lamellipodium; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynapse; C:protein-containing complex; C:spindle; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calmodulin binding; F:enzyme binding; F:GTPase activating protein binding; F:identical protein binding; F:kinase activity; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase C binding; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase B activity; P:activation-induced cell death of T cells; P:aging; P:anoikis; P:apoptotic mitochondrial changes; P:carbohydrate transport; P:cell differentiation; P:cell migration involved in sprouting angiogenesis; P:cell population proliferation; P:cell projection organization; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to organic cyclic compound; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization to mitochondrion; P:excitatory postsynaptic potential; P:execution phase of apoptosis; P:fibroblast migration; P:G protein-coupled receptor signaling pathway; P:germ cell development; P:glucose homeostasis; P:glucose metabolic process; P:glycogen biosynthetic process; P:glycogen cell differentiation involved in embryonic placenta development; P:hyaluronan metabolic process; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:interleukin-18-mediated signaling pathway; P:intracellular signal transduction; P:labyrinthine layer blood vessel development; P:lipopolysaccharide-mediated signaling pathway; P:maintenance of protein location in mitochondrion; P:mammary gland epithelial cell differentiation; P:maternal placenta development; P:negative regulation of apoptotic process; P:negative regulation of autophagy; P:negative regulation of cell size; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of endopeptidase activity; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:negative regulation of JNK cascade; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of lymphocyte migration; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of Notch signaling pathway; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase activity by protein phosphorylation; P:negative regulation of protein kinase B signaling; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of protein ubiquitination; P:negative regulation of proteolysis; P:negative regulation of release of cytochrome c from mitochondria; P:NIK/NF-kappaB signaling; P:nitric oxide biosynthetic process; P:osteoblast differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peripheral nervous system myelin maintenance; P:phosphatidylinositol 3-kinase signaling; P:phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein metabolic process; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of fat cell differentiation; P:positive regulation of fibroblast migration; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of lipid biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of organ growth; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to nucleus; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vasoconstriction; P:protein autophosphorylation; P:protein catabolic process; P:protein import into nucleus; P:protein kinase B signaling; P:protein phosphorylation; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of glycogen biosynthetic process; P:regulation of mRNA stability; P:regulation of myelination; P:regulation of neuron projection development; P:regulation of nitric-oxide synthase activity; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:regulation of type B pancreatic cell development; P:response to fluid shear stress; P:response to food; P:response to growth hormone; P:response to heat; P:response to insulin-like growth factor stimulus; P:response to oxidative stress; P:response to UV-A; P:signal transduction; P:sphingosine-1-phosphate receptor signaling pathway; P:spinal cord development; P:striated muscle cell differentiation; P:T cell costimulation; P:tetrahydrobiopterin metabolic process; P:TOR signaling; P:translation; scaffold1894 indexed_genome mRNA 9177 9984 . - . ID=transcript_17208;P31749 B2RAM5 B7Z5R1 Q9BWB6,RAC-alpha serine/threonine-protein kinase,Protein kinase B;Protein kinase B alpha;Proto-oncogene c-Akt;RAC-PK-alpha;, PF00169;PF00069;PF00433;, GO:0005911;GO:0036064;GO:0005737;GO:0005829;GO:0031234;GO:0030027;GO:0015630;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0098794;GO:0032991;GO:0005819;GO:0031982;GO:0071889;GO:0005524;GO:0005516;GO:0019899;GO:0032794;GO:0042802;GO:0016301;GO:0030235;GO:0005547;GO:0043325;GO:0042803;GO:0004672;GO:0005080;GO:0051721;GO:0106310;GO:0004674;GO:0004712;GO:0106311;GO:0032148;GO:0006924;GO:0007568;GO:0043276;GO:0008637;GO:0008643;GO:0030154;GO:0002042;GO:0008283;GO:0030030;GO:0071276;GO:0006974;GO:0071364;GO:0097011;GO:0071456;GO:0032869;GO:0071260;GO:1990090;GO:0071407;GO:0140052;GO:0071380;GO:0034614;GO:0071356;GO:0035924;GO:0019221;GO:0007173;GO:0072655;GO:0060079;GO:0097194;GO:0010761;GO:0007186;GO:0007281;GO:0042593;GO:0006006;GO:0005978;GO:0060709;GO:0030212;GO:0007249;GO:0006954;GO:0008286;GO:0048009;GO:0035655;GO:0035556;GO:0060716;GO:0031663;GO:0072656;GO:0060644;GO:0001893;GO:0043066;GO:0010507;GO:0045792;GO:0043154;GO:0010951;GO:2001240;GO:0031999;GO:0010629;GO:0046329;GO:1903038;GO:0010748;GO:2000402;GO:0016242;GO:1901215;GO:0045746;GO:1902176;GO:0032091;GO:0006469;GO:0100002;GO:0051898;GO:0071901;GO:0031397;GO:0045861;GO:0090201;GO:0038061;GO:0006809;GO:0001649;GO:0018105;GO:0018107;GO:0032287;GO:0014065;GO:0016310;GO:0043065;GO:0043536;GO:0030307;GO:0008284;GO:0032270;GO:0045737;GO:0051091;GO:0032079;GO:0010595;GO:0001938;GO:0045742;GO:0045600;GO:0010763;GO:1900087;GO:0010628;GO:0046326;GO:0010907;GO:0045725;GO:1903721;GO:0046889;GO:0010918;GO:0045429;GO:0051000;GO:0046622;GO:0033138;GO:0032436;GO:2000010;GO:1900182;GO:1903078;GO:0001934;GO:0048661;GO:0010765;GO:0045944;GO:0045893;GO:0045907;GO:0046777;GO:0030163;GO:0006606;GO:0043491;GO:0006468;GO:0016567;GO:0042981;GO:0030334;GO:0005979;GO:0043488;GO:0031641;GO:0010975;GO:0050999;GO:1901796;GO:0006417;GO:2000074;GO:0034405;GO:0032094;GO:0060416;GO:0009408;GO:1990418;GO:0006979;GO:0070141;GO:0007165;GO:0003376;GO:0021510;GO:0051146;GO:0031295;GO:0046146;GO:0031929;GO:0006412;, C:cell-cell junction; C:ciliary basal body; C:cytoplasm; C:cytosol; C:extrinsic component of cytoplasmic side of plasma membrane; C:lamellipodium; C:microtubule cytoskeleton; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane; C:postsynapse; C:protein-containing complex; C:spindle; C:vesicle;, F:14-3-3 protein binding; F:ATP binding; F:calmodulin binding; F:enzyme binding; F:GTPase activating protein binding; F:identical protein binding; F:kinase activity; F:nitric-oxide synthase regulator activity; F:phosphatidylinositol-3,4,5-trisphosphate binding; F:phosphatidylinositol-3,4-bisphosphate binding; F:protein homodimerization activity; F:protein kinase activity; F:protein kinase C binding; F:protein phosphatase 2A binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein serine/threonine/tyrosine kinase activity; F:protein threonine kinase activity;, P:activation of protein kinase B activity; P:activation-induced cell death of T cells; P:aging; P:anoikis; P:apoptotic mitochondrial changes; P:carbohydrate transport; P:cell differentiation; P:cell migration involved in sprouting angiogenesis; P:cell population proliferation; P:cell projection organization; P:cellular response to cadmium ion; P:cellular response to DNA damage stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; P:cellular response to hypoxia; P:cellular response to insulin stimulus; P:cellular response to mechanical stimulus; P:cellular response to nerve growth factor stimulus; P:cellular response to organic cyclic compound; P:cellular response to oxidised low-density lipoprotein particle stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to reactive oxygen species; P:cellular response to tumor necrosis factor; P:cellular response to vascular endothelial growth factor stimulus; P:cytokine-mediated signaling pathway; P:epidermal growth factor receptor signaling pathway; P:establishment of protein localization to mitochondrion; P:excitatory postsynaptic potential; P:execution phase of apoptosis; P:fibroblast migration; P:G protein-coupled receptor signaling pathway; P:germ cell development; P:glucose homeostasis; P:glucose metabolic process; P:glycogen biosynthetic process; P:glycogen cell differentiation involved in embryonic placenta development; P:hyaluronan metabolic process; P:I-kappaB kinase/NF-kappaB signaling; P:inflammatory response; P:insulin receptor signaling pathway; P:insulin-like growth factor receptor signaling pathway; P:interleukin-18-mediated signaling pathway; P:intracellular signal transduction; P:labyrinthine layer blood vessel development; P:lipopolysaccharide-mediated signaling pathway; P:maintenance of protein location in mitochondrion; P:mammary gland epithelial cell differentiation; P:maternal placenta development; P:negative regulation of apoptotic process; P:negative regulation of autophagy; P:negative regulation of cell size; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of endopeptidase activity; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of fatty acid beta-oxidation; P:negative regulation of gene expression; P:negative regulation of JNK cascade; P:negative regulation of leukocyte cell-cell adhesion; P:negative regulation of long-chain fatty acid import across plasma membrane; P:negative regulation of lymphocyte migration; P:negative regulation of macroautophagy; P:negative regulation of neuron death; P:negative regulation of Notch signaling pathway; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of protein binding; P:negative regulation of protein kinase activity; P:negative regulation of protein kinase activity by protein phosphorylation; P:negative regulation of protein kinase B signaling; P:negative regulation of protein serine/threonine kinase activity; P:negative regulation of protein ubiquitination; P:negative regulation of proteolysis; P:negative regulation of release of cytochrome c from mitochondria; P:NIK/NF-kappaB signaling; P:nitric oxide biosynthetic process; P:osteoblast differentiation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peripheral nervous system myelin maintenance; P:phosphatidylinositol 3-kinase signaling; P:phosphorylation; P:positive regulation of apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of cellular protein metabolic process; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of endodeoxyribonuclease activity; P:positive regulation of endothelial cell migration; P:positive regulation of endothelial cell proliferation; P:positive regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of fat cell differentiation; P:positive regulation of fibroblast migration; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of gene expression; P:positive regulation of glucose import; P:positive regulation of glucose metabolic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of lipid biosynthetic process; P:positive regulation of mitochondrial membrane potential; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of organ growth; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein localization to cell surface; P:positive regulation of protein localization to nucleus; P:positive regulation of protein localization to plasma membrane; P:positive regulation of protein phosphorylation; P:positive regulation of smooth muscle cell proliferation; P:positive regulation of sodium ion transport; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:positive regulation of vasoconstriction; P:protein autophosphorylation; P:protein catabolic process; P:protein import into nucleus; P:protein kinase B signaling; P:protein phosphorylation; P:protein ubiquitination; P:regulation of apoptotic process; P:regulation of cell migration; P:regulation of glycogen biosynthetic process; P:regulation of mRNA stability; P:regulation of myelination; P:regulation of neuron projection development; P:regulation of nitric-oxide synthase activity; P:regulation of signal transduction by p53 class mediator; P:regulation of translation; P:regulation of type B pancreatic cell development; P:response to fluid shear stress; P:response to food; P:response to growth hormone; P:response to heat; P:response to insulin-like growth factor stimulus; P:response to oxidative stress; P:response to UV-A; P:signal transduction; P:sphingosine-1-phosphate receptor signaling pathway; P:spinal cord development; P:striated muscle cell differentiation; P:T cell costimulation; P:tetrahydrobiopterin metabolic process; P:TOR signaling; P:translation; scaffold1896 indexed_genome mRNA 2760 3993 . + . ID=transcript_17209;P16152 B2RBZ7 B4DFK7 Q3LHW8,Carbonyl reductase [NADPH] 1 {ECO:0000305},15-hydroxyprostaglandin dehydrogenase [NADP(+)];20-beta-hydroxysteroid dehydrogenase;NADPH-dependent carbonyl reductase 1;Prostaglandin 9-ketoreductase {ECO:0000303|PubMed:1597188};Prostaglandin-E(2) 9-reductase {ECO:0000250|UniProtKB:Q28960};Short chain dehydrogenase/reductase family 21C member 1;, PF00106;, GO:0005829;GO:0070062;GO:1903561;GO:0047021;GO:0047020;GO:0004090;GO:0016655;GO:0050221;GO:0019371;GO:0017144;GO:0030855;GO:0042373;, C:cytosol; C:extracellular exosome; C:extracellular vesicle;, F:15-hydroxyprostaglandin dehydrogenase (NADP+) activity; F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; F:carbonyl reductase (NADPH) activity; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; F:prostaglandin-E2 9-reductase activity;, P:cyclooxygenase pathway; P:drug metabolic process; P:epithelial cell differentiation; P:vitamin K metabolic process; scaffold1897 indexed_genome mRNA 9881 10908 . - . ID=transcript_17210;Q9H254 E9PGQ5 Q9H1K7 Q9H1K8 Q9H1K9 Q9H253 Q9H3G8 Q9HCD0,Spectrin beta chain, non-erythrocytic 4,Beta-IV spectrin;Spectrin, non-erythroid beta chain 3;, PF00307;PF15410;PF00435;, GO:0005884;GO:0043203;GO:0043194;GO:0070852;GO:0005737;GO:0005829;GO:0070062;GO:0014704;GO:0016020;GO:0043025;GO:0033268;GO:0016363;GO:0033270;GO:0005886;GO:0016605;GO:0008091;GO:0003779;GO:0030506;GO:0106006;GO:0019902;GO:0005543;GO:0030507;GO:0005200;GO:0051693;GO:0007628;GO:0007411;GO:0007409;GO:0061337;GO:0021952;GO:0045162;GO:0006888;GO:0009566;GO:0000165;GO:0010459;GO:0040018;GO:0072659;GO:0033135;GO:0002028;GO:0007605;GO:0019226;GO:0016192;, C:actin filament; C:axon hillock; C:axon initial segment; C:cell body fiber; C:cytoplasm; C:cytosol; C:extracellular exosome; C:intercalated disc; C:membrane; C:neuronal cell body; C:node of Ranvier; C:nuclear matrix; C:paranode region of axon; C:plasma membrane; C:PML body; C:spectrin;, F:actin binding; F:ankyrin binding; F:cytoskeletal protein-membrane anchor activity; F:phosphatase binding; F:phospholipid binding; F:spectrin binding; F:structural constituent of cytoskeleton;, P:actin filament capping; P:adult walking behavior; P:axon guidance; P:axonogenesis; P:cardiac conduction; P:central nervous system projection neuron axonogenesis; P:clustering of voltage-gated sodium channels; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:fertilization; P:MAPK cascade; P:negative regulation of heart rate; P:positive regulation of multicellular organism growth; P:protein localization to plasma membrane; P:regulation of peptidyl-serine phosphorylation; P:regulation of sodium ion transport; P:sensory perception of sound; P:transmission of nerve impulse; P:vesicle-mediated transport; scaffold1901 indexed_genome mRNA 31 1231 . - . ID=transcript_17211;Q6PF04 Q96SS9,Zinc finger protein 613,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold1901 indexed_genome mRNA 7160 9072 . + . ID=transcript_17212;Q9GZX5 Q96G73 Q9HAQ4,Zinc finger protein 350,KRAB zinc finger protein ZFQR;Zinc finger and BRCA1-interacting protein with a KRAB domain 1;Zinc finger protein ZBRK1;, PF01352;PF00096;, GO:0016604;GO:0016363;GO:0005654;GO:0005634;GO:0017053;GO:0003677;GO:0003700;GO:0001227;GO:0046872;GO:0000978;GO:0001162;GO:0000122;GO:0045892;GO:0006357;GO:0006355;, C:nuclear body; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:transcription repressor complex;, F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; scaffold1902 indexed_genome mRNA 31 1231 . - . ID=transcript_17213;Q6PF04 Q96SS9,Zinc finger protein 613,, PF01352;PF00096;, GO:0005634;GO:0003700;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold1912 indexed_genome mRNA 1983 2945 . + . ID=transcript_17214;Q8NDY3 Q5JUG2 Q96GD1,[Protein ADP-ribosylarginine] hydrolase-like protein 1,ADP-ribosylhydrolase 2;, PF03747;, GO:0003875;GO:0000287;GO:0051725;, , F:ADP-ribosylarginine hydrolase activity; F:magnesium ion binding;, P:protein de-ADP-ribosylation; scaffold1912 indexed_genome mRNA 6503 11265 . + . ID=transcript_17215;Q6PH85 Q5JSA5 Q5JSA6 Q5JSA7 Q9NVJ1 Q9NXR6,DCN1-like protein 2 {ECO:0000305},DCUN1 domain-containing protein 2;Defective in cullin neddylation protein 1-like protein 2;, PF03556;, GO:0005737;GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;GO:2000434;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation; P:regulation of protein neddylation; scaffold1912 indexed_genome mRNA 11275 12087 . - . ID=transcript_17216;Q6PH85 Q5JSA5 Q5JSA6 Q5JSA7 Q9NVJ1 Q9NXR6,DCN1-like protein 2 {ECO:0000305},DCUN1 domain-containing protein 2;Defective in cullin neddylation protein 1-like protein 2;, PF03556;, GO:0005737;GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;GO:2000434;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation; P:regulation of protein neddylation; scaffold1913 indexed_genome mRNA 1983 2945 . + . ID=transcript_17217;Q8NDY3 Q5JUG2 Q96GD1,[Protein ADP-ribosylarginine] hydrolase-like protein 1,ADP-ribosylhydrolase 2;, PF03747;, GO:0003875;GO:0000287;GO:0051725;, , F:ADP-ribosylarginine hydrolase activity; F:magnesium ion binding;, P:protein de-ADP-ribosylation; scaffold1913 indexed_genome mRNA 6503 11264 . + . ID=transcript_17218;Q6PH85 Q5JSA5 Q5JSA6 Q5JSA7 Q9NVJ1 Q9NXR6,DCN1-like protein 2 {ECO:0000305},DCUN1 domain-containing protein 2;Defective in cullin neddylation protein 1-like protein 2;, PF03556;, GO:0005737;GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;GO:2000434;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation; P:regulation of protein neddylation; scaffold1926 indexed_genome mRNA 6558 11107 . - . ID=transcript_17219;Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport;|Q9P260,RAB11-binding protein RELCH {ECO:0000305},LisH domain and HEAT repeat-containing protein KIAA1468;RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing {ECO:0000312|HGNC:HGNC:29289};RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats {ECO:0000303|PubMed:29514919};, , GO:0055037;GO:0005802;GO:0032367;, C:recycling endosome; C:trans-Golgi network;, , P:intracellular cholesterol transport; scaffold1960 indexed_genome mRNA 3267 8087 . - . ID=transcript_17220;Q9BVL4 Q2TAL2 Q5JZ81 Q8WUI0,Protein adenylyltransferase SelO, mitochondrial {ECO:0000305},Selenoprotein O {ECO:0000303|PubMed:27645994};, PF02696;, GO:0005694;GO:0005739;GO:0005524;GO:0046872;GO:0070733;GO:0018117;, C:chromosome; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:protein adenylyltransferase activity;, P:protein adenylylation;|Q9BVL4 Q2TAL2 Q5JZ81 Q8WUI0,Protein adenylyltransferase SelO, mitochondrial {ECO:0000305},Selenoprotein O {ECO:0000303|PubMed:27645994};, PF02696;, GO:0005694;GO:0005739;GO:0005524;GO:0046872;GO:0070733;GO:0018117;, C:chromosome; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:protein adenylyltransferase activity;, P:protein adenylylation;|Q9BVL4 Q2TAL2 Q5JZ81 Q8WUI0,Protein adenylyltransferase SelO, mitochondrial {ECO:0000305},Selenoprotein O {ECO:0000303|PubMed:27645994};, PF02696;, GO:0005694;GO:0005739;GO:0005524;GO:0046872;GO:0070733;GO:0018117;, C:chromosome; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:protein adenylyltransferase activity;, P:protein adenylylation;|Q9BVL4 Q2TAL2 Q5JZ81 Q8WUI0,Protein adenylyltransferase SelO, mitochondrial {ECO:0000305},Selenoprotein O {ECO:0000303|PubMed:27645994};, PF02696;, GO:0005694;GO:0005739;GO:0005524;GO:0046872;GO:0070733;GO:0018117;, C:chromosome; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:protein adenylyltransferase activity;, P:protein adenylylation; scaffold1961 indexed_genome mRNA 3267 8087 . - . ID=transcript_17221;Q9BVL4 Q2TAL2 Q5JZ81 Q8WUI0,Protein adenylyltransferase SelO, mitochondrial {ECO:0000305},Selenoprotein O {ECO:0000303|PubMed:27645994};, PF02696;, GO:0005694;GO:0005739;GO:0005524;GO:0046872;GO:0070733;GO:0018117;, C:chromosome; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:protein adenylyltransferase activity;, P:protein adenylylation;|Q9BVL4 Q2TAL2 Q5JZ81 Q8WUI0,Protein adenylyltransferase SelO, mitochondrial {ECO:0000305},Selenoprotein O {ECO:0000303|PubMed:27645994};, PF02696;, GO:0005694;GO:0005739;GO:0005524;GO:0046872;GO:0070733;GO:0018117;, C:chromosome; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:protein adenylyltransferase activity;, P:protein adenylylation;|Q9BVL4 Q2TAL2 Q5JZ81 Q8WUI0,Protein adenylyltransferase SelO, mitochondrial {ECO:0000305},Selenoprotein O {ECO:0000303|PubMed:27645994};, PF02696;, GO:0005694;GO:0005739;GO:0005524;GO:0046872;GO:0070733;GO:0018117;, C:chromosome; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:protein adenylyltransferase activity;, P:protein adenylylation;|Q9BVL4 Q2TAL2 Q5JZ81 Q8WUI0,Protein adenylyltransferase SelO, mitochondrial {ECO:0000305},Selenoprotein O {ECO:0000303|PubMed:27645994};, PF02696;, GO:0005694;GO:0005739;GO:0005524;GO:0046872;GO:0070733;GO:0018117;, C:chromosome; C:mitochondrion;, F:ATP binding; F:metal ion binding; F:protein adenylyltransferase activity;, P:protein adenylylation; scaffold1972 indexed_genome mRNA 6154 9604 . - . ID=transcript_17222;P04406 E7EUT4 P00354 Q53X65,Glyceraldehyde-3-phosphate dehydrogenase,Peptidyl-cysteine S-nitrosylase GAPDH;, PF02800;PF00044;, GO:0005737;GO:0005829;GO:0070062;GO:0097452;GO:0043231;GO:0005811;GO:0016020;GO:0015630;GO:0031965;GO:0005634;GO:0048471;GO:0005886;GO:1990904;GO:0031982;GO:0019828;GO:0097718;GO:0004365;GO:0042802;GO:0008017;GO:0051287;GO:0050661;GO:0035605;GO:0061844;GO:0061621;GO:0071346;GO:0050832;GO:0006094;GO:0006096;GO:0051873;GO:0031640;GO:0000226;GO:0010951;GO:0017148;GO:0051402;GO:0035606;GO:0001819;GO:0050821;GO:0016241;, C:cytoplasm; C:cytosol; C:extracellular exosome; C:GAIT complex; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane; C:microtubule cytoskeleton; C:nuclear membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ribonucleoprotein complex; C:vesicle;, F:aspartic-type endopeptidase inhibitor activity; F:disordered domain specific binding; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; F:identical protein binding; F:microtubule binding; F:NAD binding; F:NADP binding; F:peptidyl-cysteine S-nitrosylase activity;, P:antimicrobial humoral immune response mediated by antimicrobial peptide; P:canonical glycolysis; P:cellular response to interferon-gamma; P:defense response to fungus; P:gluconeogenesis; P:glycolytic process; P:killing by host of symbiont cells; P:killing of cells of other organism; P:microtubule cytoskeleton organization; P:negative regulation of endopeptidase activity; P:negative regulation of translation; P:neuron apoptotic process; P:peptidyl-cysteine S-trans-nitrosylation; P:positive regulation of cytokine production; P:protein stabilization; P:regulation of macroautophagy; scaffold1981 indexed_genome mRNA 405 4365 . + . ID=transcript_17223;Q14157 B4E0U8 Q5VU75 Q5VU76 Q9BTU3 Q9UGL2 Q9UGL3 Q9UGL4 Q9UGL5,Ubiquitin-associated protein 2-like {ECO:0000305},Protein NICE-4;, PF12478;, GO:0005737;GO:0010494;GO:0005634;GO:0031519;GO:0003723;GO:0007339;GO:0061484;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleus; C:PcG protein complex;, F:RNA binding;, P:binding of sperm to zona pellucida; P:hematopoietic stem cell homeostasis; P:stress granule assembly;|Q14157 B4E0U8 Q5VU75 Q5VU76 Q9BTU3 Q9UGL2 Q9UGL3 Q9UGL4 Q9UGL5,Ubiquitin-associated protein 2-like {ECO:0000305},Protein NICE-4;, PF12478;, GO:0005737;GO:0010494;GO:0005634;GO:0031519;GO:0003723;GO:0007339;GO:0061484;GO:0034063;, C:cytoplasm; C:cytoplasmic stress granule; C:nucleus; C:PcG protein complex;, F:RNA binding;, P:binding of sperm to zona pellucida; P:hematopoietic stem cell homeostasis; P:stress granule assembly; scaffold1981 indexed_genome mRNA 5999 8075 . - . ID=transcript_17224;O00165 A8W4W9 A8W4X0 B4DUJ7 Q5VYD5 Q5VYD7 Q96AU4 Q9BS80,HCLS1-associated protein X-1,HS1-associating protein X-1;HS1-binding protein 1;, , GO:0015629;GO:0016324;GO:0005938;GO:0030136;GO:0005783;GO:0030027;GO:0005758;GO:0005741;GO:0005739;GO:0005635;GO:0031965;GO:0000932;GO:0016529;GO:0005667;GO:0019966;GO:0047485;GO:0071345;GO:0043066;GO:2000251;GO:0030854;GO:0033138;GO:0050731;GO:0014068;GO:0051897;GO:0045944;GO:0030833;GO:0042981;GO:1903146;GO:1903214;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:clathrin-coated vesicle; C:endoplasmic reticulum; C:lamellipodium; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope; C:nuclear membrane; C:P-body; C:sarcoplasmic reticulum; C:transcription regulator complex;, F:interleukin-1 binding; F:protein N-terminus binding;, P:cellular response to cytokine stimulus; P:negative regulation of apoptotic process; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of granulocyte differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of actin filament polymerization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein targeting to mitochondrion;|O00165 A8W4W9 A8W4X0 B4DUJ7 Q5VYD5 Q5VYD7 Q96AU4 Q9BS80,HCLS1-associated protein X-1,HS1-associating protein X-1;HS1-binding protein 1;, , GO:0015629;GO:0016324;GO:0005938;GO:0030136;GO:0005783;GO:0030027;GO:0005758;GO:0005741;GO:0005739;GO:0005635;GO:0031965;GO:0000932;GO:0016529;GO:0005667;GO:0019966;GO:0047485;GO:0071345;GO:0043066;GO:2000251;GO:0030854;GO:0033138;GO:0050731;GO:0014068;GO:0051897;GO:0045944;GO:0030833;GO:0042981;GO:1903146;GO:1903214;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:clathrin-coated vesicle; C:endoplasmic reticulum; C:lamellipodium; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope; C:nuclear membrane; C:P-body; C:sarcoplasmic reticulum; C:transcription regulator complex;, F:interleukin-1 binding; F:protein N-terminus binding;, P:cellular response to cytokine stimulus; P:negative regulation of apoptotic process; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of granulocyte differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of actin filament polymerization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein targeting to mitochondrion;|O00165 A8W4W9 A8W4X0 B4DUJ7 Q5VYD5 Q5VYD7 Q96AU4 Q9BS80,HCLS1-associated protein X-1,HS1-associating protein X-1;HS1-binding protein 1;, , GO:0015629;GO:0016324;GO:0005938;GO:0030136;GO:0005783;GO:0030027;GO:0005758;GO:0005741;GO:0005739;GO:0005635;GO:0031965;GO:0000932;GO:0016529;GO:0005667;GO:0019966;GO:0047485;GO:0071345;GO:0043066;GO:2000251;GO:0030854;GO:0033138;GO:0050731;GO:0014068;GO:0051897;GO:0045944;GO:0030833;GO:0042981;GO:1903146;GO:1903214;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:clathrin-coated vesicle; C:endoplasmic reticulum; C:lamellipodium; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope; C:nuclear membrane; C:P-body; C:sarcoplasmic reticulum; C:transcription regulator complex;, F:interleukin-1 binding; F:protein N-terminus binding;, P:cellular response to cytokine stimulus; P:negative regulation of apoptotic process; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of granulocyte differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of actin filament polymerization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein targeting to mitochondrion; scaffold1982 indexed_genome mRNA 5996 8072 . + . ID=transcript_17225;O00165 A8W4W9 A8W4X0 B4DUJ7 Q5VYD5 Q5VYD7 Q96AU4 Q9BS80,HCLS1-associated protein X-1,HS1-associating protein X-1;HS1-binding protein 1;, , GO:0015629;GO:0016324;GO:0005938;GO:0030136;GO:0005783;GO:0030027;GO:0005758;GO:0005741;GO:0005739;GO:0005635;GO:0031965;GO:0000932;GO:0016529;GO:0005667;GO:0019966;GO:0047485;GO:0071345;GO:0043066;GO:2000251;GO:0030854;GO:0033138;GO:0050731;GO:0014068;GO:0051897;GO:0045944;GO:0030833;GO:0042981;GO:1903146;GO:1903214;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:clathrin-coated vesicle; C:endoplasmic reticulum; C:lamellipodium; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope; C:nuclear membrane; C:P-body; C:sarcoplasmic reticulum; C:transcription regulator complex;, F:interleukin-1 binding; F:protein N-terminus binding;, P:cellular response to cytokine stimulus; P:negative regulation of apoptotic process; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of granulocyte differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of actin filament polymerization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein targeting to mitochondrion;|O00165 A8W4W9 A8W4X0 B4DUJ7 Q5VYD5 Q5VYD7 Q96AU4 Q9BS80,HCLS1-associated protein X-1,HS1-associating protein X-1;HS1-binding protein 1;, , GO:0015629;GO:0016324;GO:0005938;GO:0030136;GO:0005783;GO:0030027;GO:0005758;GO:0005741;GO:0005739;GO:0005635;GO:0031965;GO:0000932;GO:0016529;GO:0005667;GO:0019966;GO:0047485;GO:0071345;GO:0043066;GO:2000251;GO:0030854;GO:0033138;GO:0050731;GO:0014068;GO:0051897;GO:0045944;GO:0030833;GO:0042981;GO:1903146;GO:1903214;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:clathrin-coated vesicle; C:endoplasmic reticulum; C:lamellipodium; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope; C:nuclear membrane; C:P-body; C:sarcoplasmic reticulum; C:transcription regulator complex;, F:interleukin-1 binding; F:protein N-terminus binding;, P:cellular response to cytokine stimulus; P:negative regulation of apoptotic process; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of granulocyte differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of actin filament polymerization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein targeting to mitochondrion;|O00165 A8W4W9 A8W4X0 B4DUJ7 Q5VYD5 Q5VYD7 Q96AU4 Q9BS80,HCLS1-associated protein X-1,HS1-associating protein X-1;HS1-binding protein 1;, , GO:0015629;GO:0016324;GO:0005938;GO:0030136;GO:0005783;GO:0030027;GO:0005758;GO:0005741;GO:0005739;GO:0005635;GO:0031965;GO:0000932;GO:0016529;GO:0005667;GO:0019966;GO:0047485;GO:0071345;GO:0043066;GO:2000251;GO:0030854;GO:0033138;GO:0050731;GO:0014068;GO:0051897;GO:0045944;GO:0030833;GO:0042981;GO:1903146;GO:1903214;, C:actin cytoskeleton; C:apical plasma membrane; C:cell cortex; C:clathrin-coated vesicle; C:endoplasmic reticulum; C:lamellipodium; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrion; C:nuclear envelope; C:nuclear membrane; C:P-body; C:sarcoplasmic reticulum; C:transcription regulator complex;, F:interleukin-1 binding; F:protein N-terminus binding;, P:cellular response to cytokine stimulus; P:negative regulation of apoptotic process; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of granulocyte differentiation; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein kinase B signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of actin filament polymerization; P:regulation of apoptotic process; P:regulation of autophagy of mitochondrion; P:regulation of protein targeting to mitochondrion; scaffold1988 indexed_genome mRNA 4946 6234 . - . ID=transcript_17226;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold1993 indexed_genome mRNA 4911 6199 . - . ID=transcript_17227;Q53H47 B4DY74 E7EN68 Q13579 Q1G668 Q96F41,Histone-lysine N-methyltransferase SETMAR {ECO:0000305},SET domain and mariner transposase fusion protein {ECO:0000305};, PF17906;PF05033;PF00856;PF01359;, GO:0005730;GO:0005634;GO:0035861;GO:0003677;GO:0044547;GO:0003690;GO:0004519;GO:0046975;GO:0042800;GO:0042803;GO:0003697;GO:0000014;GO:0008270;GO:0008283;GO:0000737;GO:0000729;GO:0015074;GO:0006303;GO:0097676;GO:0010452;GO:0051568;GO:0044774;GO:0071157;GO:2001251;GO:0090305;GO:2000373;GO:2001034;GO:0031297;, C:nucleolus; C:nucleus; C:site of double-strand break;, F:DNA binding; F:DNA topoisomerase binding; F:double-stranded DNA binding; F:endonuclease activity; F:histone methyltransferase activity (H3-K36 specific); F:histone methyltransferase activity (H3-K4 specific); F:protein homodimerization activity; F:single-stranded DNA binding; F:single-stranded DNA endodeoxyribonuclease activity; F:zinc ion binding;, P:cell population proliferation; P:DNA catabolic process, endonucleolytic; P:DNA double-strand break processing; P:DNA integration; P:double-strand break repair via nonhomologous end joining; P:histone H3-K36 dimethylation; P:histone H3-K36 methylation; P:histone H3-K4 methylation; P:mitotic DNA integrity checkpoint; P:negative regulation of cell cycle arrest; P:negative regulation of chromosome organization; P:nucleic acid phosphodiester bond hydrolysis; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; P:positive regulation of double-strand break repair via nonhomologous end joining; P:replication fork processing; scaffold2011 indexed_genome mRNA 3011 9824 . - . ID=transcript_17228;Q9Y2G9 A8K8P2 B3KWJ1 O75257 Q3KQX0 Q8TEM0,Protein strawberry notch homolog 2,, PF13872;PF13871;, GO:0005634;GO:0031490;GO:0042393;GO:0030282;GO:0061430;GO:0071348;GO:0071354;GO:1990830;GO:0071222;GO:0002281;GO:0045892;GO:0030316;GO:0072675;GO:0045944;GO:0050727;GO:0006355;, C:nucleus;, F:chromatin DNA binding; F:histone binding;, P:bone mineralization; P:bone trabecula morphogenesis; P:cellular response to interleukin-11; P:cellular response to interleukin-6; P:cellular response to leukemia inhibitory factor; P:cellular response to lipopolysaccharide; P:macrophage activation involved in immune response; P:negative regulation of transcription, DNA-templated; P:osteoclast differentiation; P:osteoclast fusion; P:positive regulation of transcription by RNA polymerase II; P:regulation of inflammatory response; P:regulation of transcription, DNA-templated; scaffold2046 indexed_genome mRNA 43 9266 . + . ID=transcript_17229;Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly;|Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly;|Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly;|Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly; scaffold2050 indexed_genome mRNA 43 3418 . + . ID=transcript_17230;Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly; scaffold2050 indexed_genome mRNA 3447 9268 . + . ID=transcript_17231;Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly;|Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly; scaffold2059 indexed_genome mRNA 1725 4173 . - . ID=transcript_17232;Q9BUD6 D3DVN9 Q4W5N4 Q9ULW1,Spondin-2,Differentially expressed in cancerous and non-cancerous lung cells 1;Mindin;, PF06468;PF19028;, GO:0070062;GO:0031012;GO:0046872;GO:0007155;GO:0045087;, C:extracellular exosome; C:extracellular matrix;, F:metal ion binding;, P:cell adhesion; P:innate immune response; scaffold2060 indexed_genome mRNA 1726 4171 . - . ID=transcript_17233;Q9BUD6 D3DVN9 Q4W5N4 Q9ULW1,Spondin-2,Differentially expressed in cancerous and non-cancerous lung cells 1;Mindin;, PF06468;PF19028;, GO:0070062;GO:0031012;GO:0046872;GO:0007155;GO:0045087;, C:extracellular exosome; C:extracellular matrix;, F:metal ion binding;, P:cell adhesion; P:innate immune response; scaffold2097 indexed_genome mRNA 1 1821 . + . ID=transcript_17234;Q86VE0,Myb-related transcription factor, partner of profilin,Myb-related protein p42POP;Partner of profilin;, PF13873;, GO:0005634;GO:0000981;GO:0001227;GO:0042802;GO:0000978;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold2097 indexed_genome mRNA 6876 7981 . + . ID=transcript_17235;Q86VE0,Myb-related transcription factor, partner of profilin,Myb-related protein p42POP;Partner of profilin;, PF13873;, GO:0005634;GO:0000981;GO:0001227;GO:0042802;GO:0000978;GO:0000122;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; scaffold2098 indexed_genome mRNA 3659 6619 . - . ID=transcript_17236;O95848 Q86SJ8,Uridine diphosphate glucose pyrophosphatase NUDT14,Nucleoside diphosphate-linked moiety X motif 14;, PF00293;, GO:0005829;GO:0047631;GO:0042802;GO:0046872;GO:0008768;GO:0006753;GO:0018279;GO:0019693;, C:cytosol;, F:ADP-ribose diphosphatase activity; F:identical protein binding; F:metal ion binding; F:UDP-sugar diphosphatase activity;, P:nucleoside phosphate metabolic process; P:protein N-linked glycosylation via asparagine; P:ribose phosphate metabolic process;|O95848 Q86SJ8,Uridine diphosphate glucose pyrophosphatase NUDT14,Nucleoside diphosphate-linked moiety X motif 14;, PF00293;, GO:0005829;GO:0047631;GO:0042802;GO:0046872;GO:0008768;GO:0006753;GO:0018279;GO:0019693;, C:cytosol;, F:ADP-ribose diphosphatase activity; F:identical protein binding; F:metal ion binding; F:UDP-sugar diphosphatase activity;, P:nucleoside phosphate metabolic process; P:protein N-linked glycosylation via asparagine; P:ribose phosphate metabolic process; scaffold2125 indexed_genome mRNA 920 3368 . - . ID=transcript_17237;Q9HD43 C9JCH2 Q15426 Q2NKN9 Q2NKP0,Receptor-type tyrosine-protein phosphatase H,Stomach cancer-associated protein tyrosine phosphatase 1;Transmembrane-type protein-tyrosine phosphatase type H;, PF00041;PF00102;, GO:0016324;GO:0005737;GO:0005887;GO:0031528;GO:0045296;GO:0004725;GO:0005001;GO:0006915;GO:0006470;, C:apical plasma membrane; C:cytoplasm; C:integral component of plasma membrane; C:microvillus membrane;, F:cadherin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:apoptotic process; P:protein dephosphorylation; scaffold2130 indexed_genome mRNA 894 3343 . - . ID=transcript_17238;Q9HD43 C9JCH2 Q15426 Q2NKN9 Q2NKP0,Receptor-type tyrosine-protein phosphatase H,Stomach cancer-associated protein tyrosine phosphatase 1;Transmembrane-type protein-tyrosine phosphatase type H;, PF00041;PF00102;, GO:0016324;GO:0005737;GO:0005887;GO:0031528;GO:0045296;GO:0004725;GO:0005001;GO:0006915;GO:0006470;, C:apical plasma membrane; C:cytoplasm; C:integral component of plasma membrane; C:microvillus membrane;, F:cadherin binding; F:protein tyrosine phosphatase activity; F:transmembrane receptor protein tyrosine phosphatase activity;, P:apoptotic process; P:protein dephosphorylation; scaffold2142 indexed_genome mRNA 54 8635 . - . ID=transcript_17239;Q12840 A6H8M5 Q4LE26,Kinesin heavy chain isoform 5A,Kinesin heavy chain neuron-specific 1;Neuronal kinesin heavy chain;, PF00225;, GO:1904115;GO:0005829;GO:0032839;GO:0005871;GO:0016020;GO:0005874;GO:0043204;GO:0048471;GO:0045202;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0099641;GO:0098971;GO:0019886;GO:0007411;GO:0007268;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0048489;GO:0016192;, C:axon cytoplasm; C:cytosol; C:dendrite cytoplasm; C:kinesin complex; C:membrane; C:microtubule; C:perikaryon; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:chemical synaptic transmission; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:synaptic vesicle transport; P:vesicle-mediated transport;|Q12840 A6H8M5 Q4LE26,Kinesin heavy chain isoform 5A,Kinesin heavy chain neuron-specific 1;Neuronal kinesin heavy chain;, PF00225;, GO:1904115;GO:0005829;GO:0032839;GO:0005871;GO:0016020;GO:0005874;GO:0043204;GO:0048471;GO:0045202;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0099641;GO:0098971;GO:0019886;GO:0007411;GO:0007268;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0048489;GO:0016192;, C:axon cytoplasm; C:cytosol; C:dendrite cytoplasm; C:kinesin complex; C:membrane; C:microtubule; C:perikaryon; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:chemical synaptic transmission; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:synaptic vesicle transport; P:vesicle-mediated transport;|Q12840 A6H8M5 Q4LE26,Kinesin heavy chain isoform 5A,Kinesin heavy chain neuron-specific 1;Neuronal kinesin heavy chain;, PF00225;, GO:1904115;GO:0005829;GO:0032839;GO:0005871;GO:0016020;GO:0005874;GO:0043204;GO:0048471;GO:0045202;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0099641;GO:0098971;GO:0019886;GO:0007411;GO:0007268;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0048489;GO:0016192;, C:axon cytoplasm; C:cytosol; C:dendrite cytoplasm; C:kinesin complex; C:membrane; C:microtubule; C:perikaryon; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:chemical synaptic transmission; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:synaptic vesicle transport; P:vesicle-mediated transport; scaffold2144 indexed_genome mRNA 379 8633 . + . ID=transcript_17240;Q12840 A6H8M5 Q4LE26,Kinesin heavy chain isoform 5A,Kinesin heavy chain neuron-specific 1;Neuronal kinesin heavy chain;, PF00225;, GO:1904115;GO:0005829;GO:0032839;GO:0005871;GO:0016020;GO:0005874;GO:0043204;GO:0048471;GO:0045202;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0099641;GO:0098971;GO:0019886;GO:0007411;GO:0007268;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0048489;GO:0016192;, C:axon cytoplasm; C:cytosol; C:dendrite cytoplasm; C:kinesin complex; C:membrane; C:microtubule; C:perikaryon; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:chemical synaptic transmission; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:synaptic vesicle transport; P:vesicle-mediated transport;|Q12840 A6H8M5 Q4LE26,Kinesin heavy chain isoform 5A,Kinesin heavy chain neuron-specific 1;Neuronal kinesin heavy chain;, PF00225;, GO:1904115;GO:0005829;GO:0032839;GO:0005871;GO:0016020;GO:0005874;GO:0043204;GO:0048471;GO:0045202;GO:0005524;GO:0008574;GO:0016887;GO:0008017;GO:0003777;GO:0003774;GO:0099641;GO:0098971;GO:0019886;GO:0007411;GO:0007268;GO:0030705;GO:0007018;GO:1990049;GO:0006890;GO:0048489;GO:0016192;, C:axon cytoplasm; C:cytosol; C:dendrite cytoplasm; C:kinesin complex; C:membrane; C:microtubule; C:perikaryon; C:perinuclear region of cytoplasm; C:synapse;, F:ATP binding; F:ATP-dependent microtubule motor activity, plus-end-directed; F:ATPase activity; F:microtubule binding; F:microtubule motor activity; F:motor activity;, P:anterograde axonal protein transport; P:anterograde dendritic transport of neurotransmitter receptor complex; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:axon guidance; P:chemical synaptic transmission; P:cytoskeleton-dependent intracellular transport; P:microtubule-based movement; P:retrograde neuronal dense core vesicle transport; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:synaptic vesicle transport; P:vesicle-mediated transport; scaffold2152 indexed_genome mRNA 679 6792 . - . ID=transcript_17241;P26951 A8K3F3 B9VI81 Q5HYQ7 Q5HYQ8 Q9UEH7,Interleukin-3 receptor subunit alpha,, PF18611;PF09240;, GO:0009897;GO:0016021;GO:0005886;GO:0043235;GO:0019955;GO:0004896;GO:0004912;GO:0019221;GO:0000165;, C:external side of plasma membrane; C:integral component of membrane; C:plasma membrane; C:receptor complex;, F:cytokine binding; F:cytokine receptor activity; F:interleukin-3 receptor activity;, P:cytokine-mediated signaling pathway; P:MAPK cascade; scaffold2188 indexed_genome mRNA 2815 9424 . - . ID=transcript_17242;Q96RT7 Q5JZ80 Q6PJ40 Q86YE9 Q9BY91 Q9UGX3 Q9UGX4,Gamma-tubulin complex component 6,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0008275;GO:0016020;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:gamma-tubulin small complex; C:membrane; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT7 Q5JZ80 Q6PJ40 Q86YE9 Q9BY91 Q9UGX3 Q9UGX4,Gamma-tubulin complex component 6,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0008275;GO:0016020;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:gamma-tubulin small complex; C:membrane; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT7 Q5JZ80 Q6PJ40 Q86YE9 Q9BY91 Q9UGX3 Q9UGX4,Gamma-tubulin complex component 6,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0008275;GO:0016020;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:gamma-tubulin small complex; C:membrane; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT7 Q5JZ80 Q6PJ40 Q86YE9 Q9BY91 Q9UGX3 Q9UGX4,Gamma-tubulin complex component 6,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0008275;GO:0016020;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:gamma-tubulin small complex; C:membrane; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly; scaffold2189 indexed_genome mRNA 2815 9422 . - . ID=transcript_17243;Q96RT7 Q5JZ80 Q6PJ40 Q86YE9 Q9BY91 Q9UGX3 Q9UGX4,Gamma-tubulin complex component 6,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0008275;GO:0016020;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:gamma-tubulin small complex; C:membrane; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT7 Q5JZ80 Q6PJ40 Q86YE9 Q9BY91 Q9UGX3 Q9UGX4,Gamma-tubulin complex component 6,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0008275;GO:0016020;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:gamma-tubulin small complex; C:membrane; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT7 Q5JZ80 Q6PJ40 Q86YE9 Q9BY91 Q9UGX3 Q9UGX4,Gamma-tubulin complex component 6,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0008275;GO:0016020;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:gamma-tubulin small complex; C:membrane; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;|Q96RT7 Q5JZ80 Q6PJ40 Q86YE9 Q9BY91 Q9UGX3 Q9UGX4,Gamma-tubulin complex component 6,, PF04130;PF17681;, GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0008275;GO:0016020;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;, C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:gamma-tubulin small complex; C:membrane; C:microtubule; C:spindle pole;, F:gamma-tubulin binding; F:microtubule binding;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly; scaffold2193 indexed_genome mRNA 5891 6876 . - . ID=transcript_17244;Q96C90 Q504S7 Q7KZD7,Protein phosphatase 1 regulatory subunit 14B,Phospholipase C-beta-3 neighbouring gene protein;, PF05361;, GO:0005737;GO:0004865;GO:0045087;GO:0042325;, C:cytoplasm;, F:protein serine/threonine phosphatase inhibitor activity;, P:innate immune response; P:regulation of phosphorylation; scaffold2193 indexed_genome mRNA 7517 8921 . + . ID=transcript_17245;P26885 Q5BJH9 Q9BTS7,Peptidyl-prolyl cis-trans isomerase FKBP2,13 kDa FK506-binding protein;FK506-binding protein 2;Immunophilin FKBP13;Rotamase;, PF00254;, GO:0005783;GO:0005789;GO:0005528;GO:0003755;, C:endoplasmic reticulum; C:endoplasmic reticulum membrane;, F:FK506 binding; F:peptidyl-prolyl cis-trans isomerase activity; scaffold2223 indexed_genome mRNA 292 987 . + . ID=transcript_17246;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold2226 indexed_genome mRNA 881 4115 . + . ID=transcript_17247;Q27J81 Q27J83 Q69YL8 Q6P1X7 Q6PK22 Q86TR7 Q9BRM1 Q9H6N1,Inverted formin-2,HBEBP2-binding protein C;, PF06367;PF06371;PF02181;PF02205;, GO:0048471;GO:0003779;GO:0031267;GO:0030036;GO:0090140;, C:perinuclear region of cytoplasm;, F:actin binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:regulation of mitochondrial fission; scaffold2230 indexed_genome mRNA 880 4095 . + . ID=transcript_17248;Q27J81 Q27J83 Q69YL8 Q6P1X7 Q6PK22 Q86TR7 Q9BRM1 Q9H6N1,Inverted formin-2,HBEBP2-binding protein C;, PF06367;PF06371;PF02181;PF02205;, GO:0048471;GO:0003779;GO:0031267;GO:0030036;GO:0090140;, C:perinuclear region of cytoplasm;, F:actin binding; F:small GTPase binding;, P:actin cytoskeleton organization; P:regulation of mitochondrial fission; scaffold2242 indexed_genome mRNA 6184 9338 . - . ID=transcript_17249;O95070 A6NM00 Q96G83 Q9BVD0,Protein YIF1A,54TMp;YIP1-interacting factor homolog A;, PF03878;, GO:0030134;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0030173;GO:0043231;GO:0006888;GO:0036498;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein transport;|O95070 A6NM00 Q96G83 Q9BVD0,Protein YIF1A,54TMp;YIP1-interacting factor homolog A;, PF03878;, GO:0030134;GO:0005789;GO:0005793;GO:0033116;GO:0005794;GO:0030173;GO:0043231;GO:0006888;GO:0036498;GO:0015031;, C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:Golgi apparatus; C:integral component of Golgi membrane; C:intracellular membrane-bounded organelle;, , P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:IRE1-mediated unfolded protein response; P:protein transport; scaffold2327 indexed_genome mRNA 1469 9117 . - . ID=transcript_17250;Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II;|Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II;|Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II;|Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II; scaffold2328 indexed_genome mRNA 1469 9117 . - . ID=transcript_17251;Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II;|Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II;|Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II;|Q14186 B4DLQ9 Q5JSB4 Q8IZL5,Transcription factor Dp-1,DRTF1-polypeptide 1;E2F dimerization partner 1;, PF08781;PF02319;, GO:0000785;GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0090575;GO:0000987;GO:0003700;GO:0000981;GO:0019904;GO:0008134;GO:0043276;GO:0006977;GO:0008544;GO:0070345;GO:0070317;GO:0051091;GO:1900087;GO:1900740;GO:0045944;GO:2000278;GO:0006357;GO:0000083;GO:0006366;, C:chromatin; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:RNA polymerase II transcription regulator complex;, F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein domain specific binding; F:transcription factor binding;, P:anoikis; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:epidermis development; P:negative regulation of fat cell proliferation; P:negative regulation of G0 to G1 transition; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:regulation of DNA biosynthetic process; P:regulation of transcription by RNA polymerase II; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:transcription by RNA polymerase II; scaffold2335 indexed_genome mRNA 1776 3835 . + . ID=transcript_17252;P78411 H0YMS7 P78416 Q7Z2E1,Iroquois-class homeodomain protein IRX-5,Homeodomain protein IRX-2A;Homeodomain protein IRXB2;Iroquois homeobox protein 5;, PF05920;, GO:0000785;GO:0005634;GO:0000981;GO:0000978;GO:1990837;GO:0005499;GO:0048468;GO:0048701;GO:0008406;GO:0030182;GO:0006357;GO:0050896;GO:0007601;, C:chromatin; C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:vitamin D binding;, P:cell development; P:embryonic cranial skeleton morphogenesis; P:gonad development; P:neuron differentiation; P:regulation of transcription by RNA polymerase II; P:response to stimulus; P:visual perception; scaffold2337 indexed_genome mRNA 1015 3778 . + . ID=transcript_17253;Q9NXH2,Transmembrane protein 214,, PF10151;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0006915;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:apoptotic process;|Q9NXH2,Transmembrane protein 214,, PF10151;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0006915;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:apoptotic process;|Q9NXH2,Transmembrane protein 214,, PF10151;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0006915;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:apoptotic process;|Q9NXH2,Transmembrane protein 214,, PF10151;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0006915;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:apoptotic process; scaffold2338 indexed_genome mRNA 1015 3778 . + . ID=transcript_17254;Q9NXH2,Transmembrane protein 214,, PF10151;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0006915;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:apoptotic process;|Q9NXH2,Transmembrane protein 214,, PF10151;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0006915;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:apoptotic process;|Q9NXH2,Transmembrane protein 214,, PF10151;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0006915;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:apoptotic process;|Q9NXH2,Transmembrane protein 214,, PF10151;, GO:0005881;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0016021;GO:0006915;, C:cytoplasmic microtubule; C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:integral component of membrane;, , P:apoptotic process; scaffold2343 indexed_genome mRNA 84 9161 . + . ID=transcript_17255;Q8TBX8 B2RDL3 B4DM11 B4DY44 Q9H6N2,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma {ECO:0000305},Phosphatidylinositol 5-phosphate 4-kinase type II gamma;, PF01504;, GO:0005776;GO:0005829;GO:0005783;GO:0070062;GO:0043229;GO:0005654;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0042802;GO:1902635;GO:0090217;GO:0046627;GO:0006661;GO:2000786;GO:0010506;GO:0014066;, C:autophagosome; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular organelle; C:nucleoplasm; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:identical protein binding;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling;|Q8TBX8 B2RDL3 B4DM11 B4DY44 Q9H6N2,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma {ECO:0000305},Phosphatidylinositol 5-phosphate 4-kinase type II gamma;, PF01504;, GO:0005776;GO:0005829;GO:0005783;GO:0070062;GO:0043229;GO:0005654;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0042802;GO:1902635;GO:0090217;GO:0046627;GO:0006661;GO:2000786;GO:0010506;GO:0014066;, C:autophagosome; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular organelle; C:nucleoplasm; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:identical protein binding;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling;|Q8TBX8 B2RDL3 B4DM11 B4DY44 Q9H6N2,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma {ECO:0000305},Phosphatidylinositol 5-phosphate 4-kinase type II gamma;, PF01504;, GO:0005776;GO:0005829;GO:0005783;GO:0070062;GO:0043229;GO:0005654;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0042802;GO:1902635;GO:0090217;GO:0046627;GO:0006661;GO:2000786;GO:0010506;GO:0014066;, C:autophagosome; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular organelle; C:nucleoplasm; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:identical protein binding;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling;|Q8TBX8 B2RDL3 B4DM11 B4DY44 Q9H6N2,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma {ECO:0000305},Phosphatidylinositol 5-phosphate 4-kinase type II gamma;, PF01504;, GO:0005776;GO:0005829;GO:0005783;GO:0070062;GO:0043229;GO:0005654;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0042802;GO:1902635;GO:0090217;GO:0046627;GO:0006661;GO:2000786;GO:0010506;GO:0014066;, C:autophagosome; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular organelle; C:nucleoplasm; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:identical protein binding;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling;|Q8TBX8 B2RDL3 B4DM11 B4DY44 Q9H6N2,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma {ECO:0000305},Phosphatidylinositol 5-phosphate 4-kinase type II gamma;, PF01504;, GO:0005776;GO:0005829;GO:0005783;GO:0070062;GO:0043229;GO:0005654;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0042802;GO:1902635;GO:0090217;GO:0046627;GO:0006661;GO:2000786;GO:0010506;GO:0014066;, C:autophagosome; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular organelle; C:nucleoplasm; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:identical protein binding;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling;|Q8TBX8 B2RDL3 B4DM11 B4DY44 Q9H6N2,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma {ECO:0000305},Phosphatidylinositol 5-phosphate 4-kinase type II gamma;, PF01504;, GO:0005776;GO:0005829;GO:0005783;GO:0070062;GO:0043229;GO:0005654;GO:0005886;GO:0016308;GO:0016309;GO:0005524;GO:0042802;GO:1902635;GO:0090217;GO:0046627;GO:0006661;GO:2000786;GO:0010506;GO:0014066;, C:autophagosome; C:cytosol; C:endoplasmic reticulum; C:extracellular exosome; C:intracellular organelle; C:nucleoplasm; C:plasma membrane;, F:1-phosphatidylinositol-4-phosphate 5-kinase activity; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; F:ATP binding; F:identical protein binding;, P:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; P:negative regulation of insulin receptor signaling pathway; P:phosphatidylinositol biosynthetic process; P:positive regulation of autophagosome assembly; P:regulation of autophagy; P:regulation of phosphatidylinositol 3-kinase signaling; scaffold2384 indexed_genome mRNA 4206 6298 . + . ID=transcript_17256;O43150 D6W4Y8,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2,Development and differentiation-enhancing factor 2;Paxillin-associated protein with ARF GAP activity 3;Pyk2 C-terminus-associated protein;, PF12796;PF01412;PF00169;PF14604;, GO:0032580;GO:0005886;GO:0005096;GO:0046872;, C:Golgi cisterna membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;|O43150 D6W4Y8,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2,Development and differentiation-enhancing factor 2;Paxillin-associated protein with ARF GAP activity 3;Pyk2 C-terminus-associated protein;, PF12796;PF01412;PF00169;PF14604;, GO:0032580;GO:0005886;GO:0005096;GO:0046872;, C:Golgi cisterna membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding; scaffold2388 indexed_genome mRNA 3304 6297 . + . ID=transcript_17257;O43150 D6W4Y8,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2,Development and differentiation-enhancing factor 2;Paxillin-associated protein with ARF GAP activity 3;Pyk2 C-terminus-associated protein;, PF12796;PF01412;PF00169;PF14604;, GO:0032580;GO:0005886;GO:0005096;GO:0046872;, C:Golgi cisterna membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;|O43150 D6W4Y8,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2,Development and differentiation-enhancing factor 2;Paxillin-associated protein with ARF GAP activity 3;Pyk2 C-terminus-associated protein;, PF12796;PF01412;PF00169;PF14604;, GO:0032580;GO:0005886;GO:0005096;GO:0046872;, C:Golgi cisterna membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding;|O43150 D6W4Y8,Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2,Development and differentiation-enhancing factor 2;Paxillin-associated protein with ARF GAP activity 3;Pyk2 C-terminus-associated protein;, PF12796;PF01412;PF00169;PF14604;, GO:0032580;GO:0005886;GO:0005096;GO:0046872;, C:Golgi cisterna membrane; C:plasma membrane;, F:GTPase activator activity; F:metal ion binding; scaffold2399 indexed_genome mRNA 5276 7823 . + . ID=transcript_17258;Q6PH85 Q5JSA5 Q5JSA6 Q5JSA7 Q9NVJ1 Q9NXR6,DCN1-like protein 2 {ECO:0000305},DCUN1 domain-containing protein 2;Defective in cullin neddylation protein 1-like protein 2;, PF03556;, GO:0005737;GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;GO:2000434;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation; P:regulation of protein neddylation; scaffold2400 indexed_genome mRNA 10 3508 . - . ID=transcript_17259;Q6PH85 Q5JSA5 Q5JSA6 Q5JSA7 Q9NVJ1 Q9NXR6,DCN1-like protein 2 {ECO:0000305},DCUN1 domain-containing protein 2;Defective in cullin neddylation protein 1-like protein 2;, PF03556;, GO:0005737;GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;GO:2000434;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation; P:regulation of protein neddylation; scaffold2400 indexed_genome mRNA 5275 7822 . - . ID=transcript_17260;Q6PH85 Q5JSA5 Q5JSA6 Q5JSA7 Q9NVJ1 Q9NXR6,DCN1-like protein 2 {ECO:0000305},DCUN1 domain-containing protein 2;Defective in cullin neddylation protein 1-like protein 2;, PF03556;, GO:0005737;GO:0005634;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:2000436;GO:0051443;GO:0045116;GO:2000434;, C:cytoplasm; C:nucleus; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:protein neddylation; P:regulation of protein neddylation; scaffold2461 indexed_genome mRNA 3204 5205 . + . ID=transcript_17261;E7EW91 F8VUH2 G3XA88 O00579 Q6IBL2 Q8IZ58 Q9BW99,Protein OS-9,Amplified in osteosarcoma 9;, PF07915;, GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0000836;GO:0030246;GO:0002020;GO:1904380;GO:1904153;GO:0006621;GO:0006605;GO:0016567;GO:0034976;GO:0030970;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex;, F:carbohydrate binding; F:protease binding;, P:endoplasmic reticulum mannose trimming; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein retention in ER lumen; P:protein targeting; P:protein ubiquitination; P:response to endoplasmic reticulum stress; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|E7EW91 F8VUH2 G3XA88 O00579 Q6IBL2 Q8IZ58 Q9BW99,Protein OS-9,Amplified in osteosarcoma 9;, PF07915;, GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0000836;GO:0030246;GO:0002020;GO:1904380;GO:1904153;GO:0006621;GO:0006605;GO:0016567;GO:0034976;GO:0030970;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex;, F:carbohydrate binding; F:protease binding;, P:endoplasmic reticulum mannose trimming; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein retention in ER lumen; P:protein targeting; P:protein ubiquitination; P:response to endoplasmic reticulum stress; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold2461 indexed_genome mRNA 6709 8227 . + . ID=transcript_17262;E7EW91 F8VUH2 G3XA88 O00579 Q6IBL2 Q8IZ58 Q9BW99,Protein OS-9,Amplified in osteosarcoma 9;, PF07915;, GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0000836;GO:0030246;GO:0002020;GO:1904380;GO:1904153;GO:0006621;GO:0006605;GO:0016567;GO:0034976;GO:0030970;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex;, F:carbohydrate binding; F:protease binding;, P:endoplasmic reticulum mannose trimming; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein retention in ER lumen; P:protein targeting; P:protein ubiquitination; P:response to endoplasmic reticulum stress; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|E7EW91 F8VUH2 G3XA88 O00579 Q6IBL2 Q8IZ58 Q9BW99,Protein OS-9,Amplified in osteosarcoma 9;, PF07915;, GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0000836;GO:0030246;GO:0002020;GO:1904380;GO:1904153;GO:0006621;GO:0006605;GO:0016567;GO:0034976;GO:0030970;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex;, F:carbohydrate binding; F:protease binding;, P:endoplasmic reticulum mannose trimming; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein retention in ER lumen; P:protein targeting; P:protein ubiquitination; P:response to endoplasmic reticulum stress; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold2462 indexed_genome mRNA 3204 5204 . + . ID=transcript_17263;E7EW91 F8VUH2 G3XA88 O00579 Q6IBL2 Q8IZ58 Q9BW99,Protein OS-9,Amplified in osteosarcoma 9;, PF07915;, GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0000836;GO:0030246;GO:0002020;GO:1904380;GO:1904153;GO:0006621;GO:0006605;GO:0016567;GO:0034976;GO:0030970;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex;, F:carbohydrate binding; F:protease binding;, P:endoplasmic reticulum mannose trimming; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein retention in ER lumen; P:protein targeting; P:protein ubiquitination; P:response to endoplasmic reticulum stress; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|E7EW91 F8VUH2 G3XA88 O00579 Q6IBL2 Q8IZ58 Q9BW99,Protein OS-9,Amplified in osteosarcoma 9;, PF07915;, GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0000836;GO:0030246;GO:0002020;GO:1904380;GO:1904153;GO:0006621;GO:0006605;GO:0016567;GO:0034976;GO:0030970;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex;, F:carbohydrate binding; F:protease binding;, P:endoplasmic reticulum mannose trimming; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein retention in ER lumen; P:protein targeting; P:protein ubiquitination; P:response to endoplasmic reticulum stress; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold2462 indexed_genome mRNA 6708 8224 . + . ID=transcript_17264;E7EW91 F8VUH2 G3XA88 O00579 Q6IBL2 Q8IZ58 Q9BW99,Protein OS-9,Amplified in osteosarcoma 9;, PF07915;, GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0000836;GO:0030246;GO:0002020;GO:1904380;GO:1904153;GO:0006621;GO:0006605;GO:0016567;GO:0034976;GO:0030970;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex;, F:carbohydrate binding; F:protease binding;, P:endoplasmic reticulum mannose trimming; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein retention in ER lumen; P:protein targeting; P:protein ubiquitination; P:response to endoplasmic reticulum stress; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process;|E7EW91 F8VUH2 G3XA88 O00579 Q6IBL2 Q8IZ58 Q9BW99,Protein OS-9,Amplified in osteosarcoma 9;, PF07915;, GO:0005783;GO:0005788;GO:0005789;GO:0044322;GO:0000836;GO:0030246;GO:0002020;GO:1904380;GO:1904153;GO:0006621;GO:0006605;GO:0016567;GO:0034976;GO:0030970;GO:0055085;GO:0030433;GO:0006511;, C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:Hrd1p ubiquitin ligase complex;, F:carbohydrate binding; F:protease binding;, P:endoplasmic reticulum mannose trimming; P:negative regulation of retrograde protein transport, ER to cytosol; P:protein retention in ER lumen; P:protein targeting; P:protein ubiquitination; P:response to endoplasmic reticulum stress; P:retrograde protein transport, ER to cytosol; P:transmembrane transport; P:ubiquitin-dependent ERAD pathway; P:ubiquitin-dependent protein catabolic process; scaffold2533 indexed_genome mRNA 179 1639 . + . ID=transcript_17265;Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process; scaffold2533 indexed_genome mRNA 3361 6943 . + . ID=transcript_17266;Q6IB77 H1AE11 O14833 Q96QK7,Glycine N-acyltransferase {ECO:0000303|PubMed:10630424},Acyl-CoA:glycine N-acyltransferase;Aralkyl acyl-CoA N-acyltransferase;Aralkyl acyl-CoA:amino acid N-acyltransferase;Benzoyl-coenzyme A:glycine N-acyltransferase;Glycine N-benzoyltransferase;HRP-1(CLP);, PF08444;PF06021;, GO:0005759;GO:0005739;GO:0047961;GO:0047962;GO:0016410;GO:0016746;GO:0006637;GO:1901787;GO:0006544;GO:0032787;GO:0009636;GO:0006805;, C:mitochondrial matrix; C:mitochondrion;, F:glycine N-acyltransferase activity; F:glycine N-benzoyltransferase activity; F:N-acyltransferase activity; F:transferase activity, transferring acyl groups;, P:acyl-CoA metabolic process; P:benzoyl-CoA metabolic process; P:glycine metabolic process; P:monocarboxylic acid metabolic process; P:response to toxic substance; P:xenobiotic metabolic process; scaffold2545 indexed_genome mRNA 1 2201 . + . ID=transcript_17267;P20265 Q14960 Q86V54 Q9UJL0,POU domain, class 3, transcription factor 2,Brain-specific homeobox/POU domain protein 2;Nervous system-specific octamer-binding transcription factor N-Oct-3;Octamer-binding protein 7;Octamer-binding transcription factor 7;, PF00046;PF00157;, GO:0000785;GO:0005654;GO:0005667;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0000978;GO:1990837;GO:0014002;GO:0071310;GO:0021799;GO:0008544;GO:0021869;GO:0021979;GO:0022011;GO:0010629;GO:0007399;GO:0021985;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0008284;GO:0040018;GO:0045944;GO:0050770;GO:0045595;GO:0006357;, C:chromatin; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:astrocyte development; P:cellular response to organic substance; P:cerebral cortex radially oriented cell migration; P:epidermis development; P:forebrain ventricular zone progenitor cell division; P:hypothalamus cell differentiation; P:myelination in peripheral nervous system; P:negative regulation of gene expression; P:nervous system development; P:neurohypophysis development; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:positive regulation of cell population proliferation; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of axonogenesis; P:regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold2548 indexed_genome mRNA 1 2194 . + . ID=transcript_17268;P20265 Q14960 Q86V54 Q9UJL0,POU domain, class 3, transcription factor 2,Brain-specific homeobox/POU domain protein 2;Nervous system-specific octamer-binding transcription factor N-Oct-3;Octamer-binding protein 7;Octamer-binding transcription factor 7;, PF00046;PF00157;, GO:0000785;GO:0005654;GO:0005667;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0042802;GO:0000978;GO:1990837;GO:0014002;GO:0071310;GO:0021799;GO:0008544;GO:0021869;GO:0021979;GO:0022011;GO:0010629;GO:0007399;GO:0021985;GO:0048666;GO:0030182;GO:0048663;GO:0048665;GO:0008284;GO:0040018;GO:0045944;GO:0050770;GO:0045595;GO:0006357;, C:chromatin; C:nucleoplasm; C:transcription regulator complex;, F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:astrocyte development; P:cellular response to organic substance; P:cerebral cortex radially oriented cell migration; P:epidermis development; P:forebrain ventricular zone progenitor cell division; P:hypothalamus cell differentiation; P:myelination in peripheral nervous system; P:negative regulation of gene expression; P:nervous system development; P:neurohypophysis development; P:neuron development; P:neuron differentiation; P:neuron fate commitment; P:neuron fate specification; P:positive regulation of cell population proliferation; P:positive regulation of multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:regulation of axonogenesis; P:regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; scaffold2622 indexed_genome mRNA 5184 6346 . + . ID=transcript_17269;Q9BXR3 Q6KH04 Q9BXR4 Q9UKH5 Q9UP31 Q9WIK9 Q9WJR4,Endogenous retrovirus group K member 6 Pol protein,HERV-K(C7) Pol protein;HERV-K(HML-2.HOM) Pol protein;HERV-K108 Pol protein;HERV-K_7p22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold2624 indexed_genome mRNA 6019 7986 . + . ID=transcript_17270;O75037 B2RP62 B7ZMI0 Q5T4J3,Kinesin-like protein KIF21B,, PF00225;PF00400;, GO:0031410;GO:0030425;GO:0030426;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007018;, C:cytoplasmic vesicle; C:dendrite; C:growth cone; C:kinesin complex; C:microtubule;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;, P:microtubule-based movement; scaffold2640 indexed_genome mRNA 5783 6944 . - . ID=transcript_17271;Q96EH8,E3 ubiquitin-protein ligase NEURL3,Lung-inducible neuralized-related C3CH4 RING domain protein;Neuralized-like protein 3;RING-type E3 ubiquitin transferase NEURL3 {ECO:0000305};, PF07177;, GO:0046872;GO:0061630;, , F:metal ion binding; F:ubiquitin protein ligase activity; scaffold2647 indexed_genome mRNA 6939 7509 . + . ID=transcript_17272;Q96FS4 O14518 O60484 O60618 Q2YD83,Signal-induced proliferation-associated protein 1,GTPase-activating protein Spa-1;p130 SPA-1;, PF00595;PF02145;, GO:0005737;GO:0005829;GO:0016020;GO:0005634;GO:0048471;GO:0032991;GO:0030133;GO:0005096;GO:0008022;GO:0090630;GO:0002250;GO:0042631;GO:0007010;GO:0035556;GO:0007162;GO:0045786;GO:0030308;GO:0051056;GO:0007165;, C:cytoplasm; C:cytosol; C:membrane; C:nucleus; C:perinuclear region of cytoplasm; C:protein-containing complex; C:transport vesicle;, F:GTPase activator activity; F:protein C-terminus binding;, P:activation of GTPase activity; P:adaptive immune response; P:cellular response to water deprivation; P:cytoskeleton organization; P:intracellular signal transduction; P:negative regulation of cell adhesion; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold2658 indexed_genome mRNA 573 2551 . + . ID=transcript_17273;P25311 D6W5T8 O60386 Q5XKQ4 Q8N4N0,Zinc-alpha-2-glycoprotein,, PF07654;PF00129;, GO:0062023;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0008320;GO:0004540;GO:0002476;GO:0007155;GO:0001580;GO:0008285;GO:0001895;GO:0055085;, C:collagen-containing extracellular matrix; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus;, F:protein transmembrane transporter activity; F:ribonuclease activity;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:cell adhesion; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:negative regulation of cell population proliferation; P:retina homeostasis; P:transmembrane transport; scaffold2658 indexed_genome mRNA 3675 6052 . + . ID=transcript_17274;P25311 D6W5T8 O60386 Q5XKQ4 Q8N4N0,Zinc-alpha-2-glycoprotein,, PF07654;PF00129;, GO:0062023;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0008320;GO:0004540;GO:0002476;GO:0007155;GO:0001580;GO:0008285;GO:0001895;GO:0055085;, C:collagen-containing extracellular matrix; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus;, F:protein transmembrane transporter activity; F:ribonuclease activity;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:cell adhesion; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:negative regulation of cell population proliferation; P:retina homeostasis; P:transmembrane transport;|P25311 D6W5T8 O60386 Q5XKQ4 Q8N4N0,Zinc-alpha-2-glycoprotein,, PF07654;PF00129;, GO:0062023;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0008320;GO:0004540;GO:0002476;GO:0007155;GO:0001580;GO:0008285;GO:0001895;GO:0055085;, C:collagen-containing extracellular matrix; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus;, F:protein transmembrane transporter activity; F:ribonuclease activity;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:cell adhesion; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:negative regulation of cell population proliferation; P:retina homeostasis; P:transmembrane transport; scaffold2659 indexed_genome mRNA 1864 7341 . + . ID=transcript_17275;P25311 D6W5T8 O60386 Q5XKQ4 Q8N4N0,Zinc-alpha-2-glycoprotein,, PF07654;PF00129;, GO:0062023;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0008320;GO:0004540;GO:0002476;GO:0007155;GO:0001580;GO:0008285;GO:0001895;GO:0055085;, C:collagen-containing extracellular matrix; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus;, F:protein transmembrane transporter activity; F:ribonuclease activity;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:cell adhesion; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:negative regulation of cell population proliferation; P:retina homeostasis; P:transmembrane transport;|P25311 D6W5T8 O60386 Q5XKQ4 Q8N4N0,Zinc-alpha-2-glycoprotein,, PF07654;PF00129;, GO:0062023;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0008320;GO:0004540;GO:0002476;GO:0007155;GO:0001580;GO:0008285;GO:0001895;GO:0055085;, C:collagen-containing extracellular matrix; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus;, F:protein transmembrane transporter activity; F:ribonuclease activity;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:cell adhesion; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:negative regulation of cell population proliferation; P:retina homeostasis; P:transmembrane transport;|P25311 D6W5T8 O60386 Q5XKQ4 Q8N4N0,Zinc-alpha-2-glycoprotein,, PF07654;PF00129;, GO:0062023;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0008320;GO:0004540;GO:0002476;GO:0007155;GO:0001580;GO:0008285;GO:0001895;GO:0055085;, C:collagen-containing extracellular matrix; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus;, F:protein transmembrane transporter activity; F:ribonuclease activity;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:cell adhesion; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:negative regulation of cell population proliferation; P:retina homeostasis; P:transmembrane transport;|P25311 D6W5T8 O60386 Q5XKQ4 Q8N4N0,Zinc-alpha-2-glycoprotein,, PF07654;PF00129;, GO:0062023;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0005634;GO:0008320;GO:0004540;GO:0002476;GO:0007155;GO:0001580;GO:0008285;GO:0001895;GO:0055085;, C:collagen-containing extracellular matrix; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:nucleus;, F:protein transmembrane transporter activity; F:ribonuclease activity;, P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; P:cell adhesion; P:detection of chemical stimulus involved in sensory perception of bitter taste; P:negative regulation of cell population proliferation; P:retina homeostasis; P:transmembrane transport; scaffold2662 indexed_genome mRNA 1262 3889 . + . ID=transcript_17276;Q9NVY5,Endosome-associated-trafficking regulator 1 {ECO:0000305},Antigen NY-CO-3 {ECO:0000303|PubMed:9610721};Serologically defined colon cancer antigen 3 {ECO:0000303|PubMed:23108400};, , GO:0005813;GO:0036064;GO:0005769;GO:0005768;GO:0030496;GO:0055037;GO:0007049;GO:0051301;GO:0030030;GO:0045724;GO:1903566;GO:0015031;GO:0032465;GO:1990126;, C:centrosome; C:ciliary basal body; C:early endosome; C:endosome; C:midbody; C:recycling endosome;, , P:cell cycle; P:cell division; P:cell projection organization; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein transport; P:regulation of cytokinesis; P:retrograde transport, endosome to plasma membrane;|Q9NVY5,Endosome-associated-trafficking regulator 1 {ECO:0000305},Antigen NY-CO-3 {ECO:0000303|PubMed:9610721};Serologically defined colon cancer antigen 3 {ECO:0000303|PubMed:23108400};, , GO:0005813;GO:0036064;GO:0005769;GO:0005768;GO:0030496;GO:0055037;GO:0007049;GO:0051301;GO:0030030;GO:0045724;GO:1903566;GO:0015031;GO:0032465;GO:1990126;, C:centrosome; C:ciliary basal body; C:early endosome; C:endosome; C:midbody; C:recycling endosome;, , P:cell cycle; P:cell division; P:cell projection organization; P:positive regulation of cilium assembly; P:positive regulation of protein localization to cilium; P:protein transport; P:regulation of cytokinesis; P:retrograde transport, endosome to plasma membrane; scaffold2704 indexed_genome mRNA 3007 4474 . + . ID=transcript_17277;Q5R3F8 Q96PY3,Protein phosphatase 1 regulatory subunit 29,Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2;Leucine-rich repeat and fibronectin type-III domain-containing protein 6;Leucine-rich repeat-containing protein 62;, PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0004864;GO:0010923;, C:extracellular matrix; C:extracellular space; C:integral component of membrane;, F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity;|Q5R3F8 Q96PY3,Protein phosphatase 1 regulatory subunit 29,Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2;Leucine-rich repeat and fibronectin type-III domain-containing protein 6;Leucine-rich repeat-containing protein 62;, PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0004864;GO:0010923;, C:extracellular matrix; C:extracellular space; C:integral component of membrane;, F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity; scaffold2704 indexed_genome mRNA 5394 5962 . - . ID=transcript_17278;Q5R3F8 Q96PY3,Protein phosphatase 1 regulatory subunit 29,Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2;Leucine-rich repeat and fibronectin type-III domain-containing protein 6;Leucine-rich repeat-containing protein 62;, PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0004864;GO:0010923;, C:extracellular matrix; C:extracellular space; C:integral component of membrane;, F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity; scaffold2705 indexed_genome mRNA 3007 4474 . + . ID=transcript_17279;Q5R3F8 Q96PY3,Protein phosphatase 1 regulatory subunit 29,Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2;Leucine-rich repeat and fibronectin type-III domain-containing protein 6;Leucine-rich repeat-containing protein 62;, PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0004864;GO:0010923;, C:extracellular matrix; C:extracellular space; C:integral component of membrane;, F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity;|Q5R3F8 Q96PY3,Protein phosphatase 1 regulatory subunit 29,Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2;Leucine-rich repeat and fibronectin type-III domain-containing protein 6;Leucine-rich repeat-containing protein 62;, PF13855;, GO:0031012;GO:0005615;GO:0016021;GO:0004864;GO:0010923;, C:extracellular matrix; C:extracellular space; C:integral component of membrane;, F:protein phosphatase inhibitor activity;, P:negative regulation of phosphatase activity; scaffold2710 indexed_genome mRNA 3607 5136 . + . ID=transcript_17280;Q96NA8 B7ZLB0 Q14D03,t-SNARE domain-containing protein 1,, PF13873;PF05739;PF14523;, GO:0012505;GO:0016021;GO:0031201;GO:0005484;GO:0000149;GO:0006886;GO:0048278;GO:0006906;, C:endomembrane system; C:integral component of membrane; C:SNARE complex;, F:SNAP receptor activity; F:SNARE binding;, P:intracellular protein transport; P:vesicle docking; P:vesicle fusion; scaffold2711 indexed_genome mRNA 3607 5136 . + . ID=transcript_17281;Q96NA8 B7ZLB0 Q14D03,t-SNARE domain-containing protein 1,, PF13873;PF05739;PF14523;, GO:0012505;GO:0016021;GO:0031201;GO:0005484;GO:0000149;GO:0006886;GO:0048278;GO:0006906;, C:endomembrane system; C:integral component of membrane; C:SNARE complex;, F:SNAP receptor activity; F:SNARE binding;, P:intracellular protein transport; P:vesicle docking; P:vesicle fusion; scaffold2747 indexed_genome mRNA 4205 6613 . + . ID=transcript_17282;P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation;|P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation;|P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation; scaffold2757 indexed_genome mRNA 80 4727 . - . ID=transcript_17283;Q8NE39 Q9H0V5 Q9H538 Q9UEU2,Zinc finger MYM-type protein 2,Fused in myeloproliferative disorders protein;Rearranged in atypical myeloproliferative disorder protein;Zinc finger protein 198;, PF12012;PF06467;, GO:0005829;GO:0016605;GO:0031624;GO:0008270;, C:cytosol; C:PML body;, F:ubiquitin conjugating enzyme binding; F:zinc ion binding; scaffold2761 indexed_genome mRNA 345 3346 . + . ID=transcript_17284;Q8IW92 A6NCE6 Q6UX60 Q8NC62 Q8NCB3 Q8NCJ1 Q96HP3,Beta-galactosidase-1-like protein 2,, PF01301;, GO:0005576;GO:0005773;GO:0004565;GO:0005975;, C:extracellular region; C:vacuole;, F:beta-galactosidase activity;, P:carbohydrate metabolic process; scaffold2763 indexed_genome mRNA 345 3346 . + . ID=transcript_17285;Q8IW92 A6NCE6 Q6UX60 Q8NC62 Q8NCB3 Q8NCJ1 Q96HP3,Beta-galactosidase-1-like protein 2,, PF01301;, GO:0005576;GO:0005773;GO:0004565;GO:0005975;, C:extracellular region; C:vacuole;, F:beta-galactosidase activity;, P:carbohydrate metabolic process; scaffold2763 indexed_genome mRNA 5074 6811 . - . ID=transcript_17286;Q9P2W7 B7Z5Z8 Q96FS7,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 {ECO:0000305},Beta-1,3-glucuronyltransferase 1;Glucuronosyltransferase P;UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase;, PF03360;, GO:0005789;GO:0005576;GO:0000139;GO:0016021;GO:0043231;GO:0015018;GO:0046872;GO:0005975;GO:0071456;GO:0050650;GO:0030203;GO:0006486;, C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:cellular response to hypoxia; P:chondroitin sulfate proteoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:protein glycosylation; scaffold2766 indexed_genome mRNA 2134 6687 . - . ID=transcript_17287;Q96AQ9 Q5T5Q5 Q8N3X3 Q8N9P9,Protein FAM131C,, PF15010;|Q96AQ9 Q5T5Q5 Q8N3X3 Q8N9P9,Protein FAM131C,, PF15010;|Q96AQ9 Q5T5Q5 Q8N3X3 Q8N9P9,Protein FAM131C,, PF15010; scaffold2769 indexed_genome mRNA 2137 6407 . - . ID=transcript_17288;Q96AQ9 Q5T5Q5 Q8N3X3 Q8N9P9,Protein FAM131C,, PF15010;|Q96AQ9 Q5T5Q5 Q8N3X3 Q8N9P9,Protein FAM131C,, PF15010; scaffold2796 indexed_genome mRNA 4423 5930 . - . ID=transcript_17289;Q8TDR0 Q6PCT1 Q7L8N9 Q9NRD6 Q9Y4Q1,TRAF3-interacting protein 1,Interleukin-13 receptor alpha 1-binding protein 1;Intraflagellar transport protein 54 homolog;Microtubule-interacting protein associated with TRAF3;, PF10243;PF17749;, GO:0005930;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0035869;GO:0005929;GO:0030992;GO:0008017;GO:0060271;GO:0042073;GO:0035735;GO:0001822;GO:0001738;GO:0050687;GO:0001933;GO:0031333;GO:0032480;GO:0070507;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:ciliary transition zone; C:cilium; C:intraciliary transport particle B;, F:microtubule binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:morphogenesis of a polarized epithelium; P:negative regulation of defense response to virus; P:negative regulation of protein phosphorylation; P:negative regulation of protein-containing complex assembly; P:negative regulation of type I interferon production; P:regulation of microtubule cytoskeleton organization; scaffold2797 indexed_genome mRNA 4423 7259 . - . ID=transcript_17290;Q8TDR0 Q6PCT1 Q7L8N9 Q9NRD6 Q9Y4Q1,TRAF3-interacting protein 1,Interleukin-13 receptor alpha 1-binding protein 1;Intraflagellar transport protein 54 homolog;Microtubule-interacting protein associated with TRAF3;, PF10243;PF17749;, GO:0005930;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0035869;GO:0005929;GO:0030992;GO:0008017;GO:0060271;GO:0042073;GO:0035735;GO:0001822;GO:0001738;GO:0050687;GO:0001933;GO:0031333;GO:0032480;GO:0070507;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:ciliary transition zone; C:cilium; C:intraciliary transport particle B;, F:microtubule binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:morphogenesis of a polarized epithelium; P:negative regulation of defense response to virus; P:negative regulation of protein phosphorylation; P:negative regulation of protein-containing complex assembly; P:negative regulation of type I interferon production; P:regulation of microtubule cytoskeleton organization;|Q8TDR0 Q6PCT1 Q7L8N9 Q9NRD6 Q9Y4Q1,TRAF3-interacting protein 1,Interleukin-13 receptor alpha 1-binding protein 1;Intraflagellar transport protein 54 homolog;Microtubule-interacting protein associated with TRAF3;, PF10243;PF17749;, GO:0005930;GO:0005813;GO:0036064;GO:0097546;GO:0097542;GO:0035869;GO:0005929;GO:0030992;GO:0008017;GO:0060271;GO:0042073;GO:0035735;GO:0001822;GO:0001738;GO:0050687;GO:0001933;GO:0031333;GO:0032480;GO:0070507;, C:axoneme; C:centrosome; C:ciliary basal body; C:ciliary base; C:ciliary tip; C:ciliary transition zone; C:cilium; C:intraciliary transport particle B;, F:microtubule binding;, P:cilium assembly; P:intraciliary transport; P:intraciliary transport involved in cilium assembly; P:kidney development; P:morphogenesis of a polarized epithelium; P:negative regulation of defense response to virus; P:negative regulation of protein phosphorylation; P:negative regulation of protein-containing complex assembly; P:negative regulation of type I interferon production; P:regulation of microtubule cytoskeleton organization; scaffold2916 indexed_genome mRNA 96 6671 . - . ID=transcript_17291;Q9HAQ2 Q86Z28 Q9H8A4,Kinesin-like protein KIF9,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0002102;GO:0031982;GO:0005524;GO:1990939;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0022617;GO:0007018;GO:1903008;GO:0071801;, C:cytoplasm; C:kinesin complex; C:microtubule; C:podosome; C:vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:extracellular matrix disassembly; P:microtubule-based movement; P:organelle disassembly; P:regulation of podosome assembly;|Q9HAQ2 Q86Z28 Q9H8A4,Kinesin-like protein KIF9,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0002102;GO:0031982;GO:0005524;GO:1990939;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0022617;GO:0007018;GO:1903008;GO:0071801;, C:cytoplasm; C:kinesin complex; C:microtubule; C:podosome; C:vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:extracellular matrix disassembly; P:microtubule-based movement; P:organelle disassembly; P:regulation of podosome assembly;|Q9HAQ2 Q86Z28 Q9H8A4,Kinesin-like protein KIF9,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0002102;GO:0031982;GO:0005524;GO:1990939;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0022617;GO:0007018;GO:1903008;GO:0071801;, C:cytoplasm; C:kinesin complex; C:microtubule; C:podosome; C:vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:extracellular matrix disassembly; P:microtubule-based movement; P:organelle disassembly; P:regulation of podosome assembly;|Q9HAQ2 Q86Z28 Q9H8A4,Kinesin-like protein KIF9,, PF00225;, GO:0005737;GO:0005871;GO:0005874;GO:0002102;GO:0031982;GO:0005524;GO:1990939;GO:0016887;GO:0042802;GO:0008017;GO:0003777;GO:0022617;GO:0007018;GO:1903008;GO:0071801;, C:cytoplasm; C:kinesin complex; C:microtubule; C:podosome; C:vesicle;, F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:identical protein binding; F:microtubule binding; F:microtubule motor activity;, P:extracellular matrix disassembly; P:microtubule-based movement; P:organelle disassembly; P:regulation of podosome assembly; scaffold3027 indexed_genome mRNA 3003 6263 . + . ID=transcript_17292;Q9GZU7 C9IYG0 Q7Z5Q3 Q7Z5Q4,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,Nuclear LIM interactor-interacting factor 3;Small C-terminal domain phosphatase 1;, PF03031;, GO:0070062;GO:0005654;GO:0005634;GO:0046872;GO:0004721;GO:0106306;GO:0106307;GO:0008420;GO:0006470;GO:0006357;, C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:protein dephosphorylation; P:regulation of transcription by RNA polymerase II;|Q9GZU7 C9IYG0 Q7Z5Q3 Q7Z5Q4,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,Nuclear LIM interactor-interacting factor 3;Small C-terminal domain phosphatase 1;, PF03031;, GO:0070062;GO:0005654;GO:0005634;GO:0046872;GO:0004721;GO:0106306;GO:0106307;GO:0008420;GO:0006470;GO:0006357;, C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:protein dephosphorylation; P:regulation of transcription by RNA polymerase II;|Q9GZU7 C9IYG0 Q7Z5Q3 Q7Z5Q4,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,Nuclear LIM interactor-interacting factor 3;Small C-terminal domain phosphatase 1;, PF03031;, GO:0070062;GO:0005654;GO:0005634;GO:0046872;GO:0004721;GO:0106306;GO:0106307;GO:0008420;GO:0006470;GO:0006357;, C:extracellular exosome; C:nucleoplasm; C:nucleus;, F:metal ion binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:RNA polymerase II CTD heptapeptide repeat phosphatase activity;, P:protein dephosphorylation; P:regulation of transcription by RNA polymerase II; scaffold3032 indexed_genome mRNA 2064 2964 . - . ID=transcript_17293;Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization; scaffold3032 indexed_genome mRNA 3769 4673 . - . ID=transcript_17294;Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization; scaffold3033 indexed_genome mRNA 2064 2964 . - . ID=transcript_17295;Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization; scaffold3033 indexed_genome mRNA 3768 4671 . + . ID=transcript_17296;Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization; scaffold3055 indexed_genome mRNA 1784 6157 . - . ID=transcript_17297;Q6UWJ1 Q5JSB1 Q6NUN1 Q8NG29 Q8TCI6 Q96EA6 Q9NWT2,Transmembrane and coiled-coil domain-containing protein 3,Putative LAG1-interacting protein;, PF00999;, GO:0016021;GO:0015299;, C:integral component of membrane;, F:solute:proton antiporter activity; scaffold3090 indexed_genome mRNA 663 2500 . - . ID=transcript_17298;Q9H9L7 B4DZU6 Q0VDB3 Q53FK8,Akirin-1 {ECO:0000305},, , GO:0000785;GO:0031965;GO:0005654;GO:0005634;GO:0003712;GO:0014839;GO:1902725;GO:1902723;GO:0010592;GO:0010759;GO:0045663;GO:0045944;, C:chromatin; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity;, P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of macrophage chemotaxis; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; scaffold3090 indexed_genome mRNA 2607 5279 . - . ID=transcript_17299;Q9H9L7 B4DZU6 Q0VDB3 Q53FK8,Akirin-1 {ECO:0000305},, , GO:0000785;GO:0031965;GO:0005654;GO:0005634;GO:0003712;GO:0014839;GO:1902725;GO:1902723;GO:0010592;GO:0010759;GO:0045663;GO:0045944;, C:chromatin; C:nuclear membrane; C:nucleoplasm; C:nucleus;, F:transcription coregulator activity;, P:myoblast migration involved in skeletal muscle regeneration; P:negative regulation of satellite cell differentiation; P:negative regulation of skeletal muscle satellite cell proliferation; P:positive regulation of lamellipodium assembly; P:positive regulation of macrophage chemotaxis; P:positive regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; scaffold3151 indexed_genome mRNA 1269 1810 . + . ID=transcript_17300;Q6ZR62 B2RPG1,Retrotransposon Gag-like protein 4 {ECO:0000312|HGNC:HGNC:25214},Mammalian retrotransposon-derived protein 4 {ECO:0000250|UniProtKB:Q3URY0};Zinc finger CCHC domain-containing protein 16;, , GO:0003676;GO:0008270;GO:0050890;GO:0042415;, , F:nucleic acid binding; F:zinc ion binding;, P:cognition; P:norepinephrine metabolic process; scaffold3207 indexed_genome mRNA 1687 3894 . - . ID=transcript_17301;P01877 A0A075B6N7,Immunoglobulin heavy constant alpha 2 {ECO:0000303|PubMed:11340299, ECO:0000303|Ref.7},Ig alpha-2 chain C region {ECO:0000305};Ig alpha-2 chain C region BUT {ECO:0000305|PubMed:416441};Ig alpha-2 chain C region LAN {ECO:0000305|PubMed:286295};, PF07654;PF00047;, GO:0072562;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0042571;GO:0071748;GO:0071752;GO:0071751;GO:0003823;GO:0019731;GO:0050853;GO:0006958;GO:0042742;GO:0003094;GO:0006955;GO:0045087;GO:0050900;GO:0006911;GO:0006910;GO:0050871;GO:0060267;GO:0006898;GO:0001895;, C:blood microparticle; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:immunoglobulin complex, circulating; C:monomeric IgA immunoglobulin complex; C:secretory dimeric IgA immunoglobulin complex; C:secretory IgA immunoglobulin complex;, F:antigen binding;, P:antibacterial humoral response; P:B cell receptor signaling pathway; P:complement activation, classical pathway; P:defense response to bacterium; P:glomerular filtration; P:immune response; P:innate immune response; P:leukocyte migration; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; P:positive regulation of respiratory burst; P:receptor-mediated endocytosis; P:retina homeostasis;|P01876,Immunoglobulin heavy constant alpha 1 {ECO:0000303|PubMed:11340299, ECO:0000303|Ref.12},Ig alpha-1 chain C region {ECO:0000305};Ig alpha-1 chain C region BUR {ECO:0000305|PubMed:107164};Ig alpha-1 chain C region TRO {ECO:0000305|PubMed:809331};, PF07654;, GO:0072562;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0042571;GO:0071748;GO:0071752;GO:0071751;GO:0003823;GO:0019731;GO:0050853;GO:0006958;GO:0042742;GO:0003094;GO:0006955;GO:0045087;GO:0050900;GO:0006911;GO:0006910;GO:0050871;GO:0060267;GO:0018298;GO:0006898;GO:0001895;, C:blood microparticle; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:immunoglobulin complex, circulating; C:monomeric IgA immunoglobulin complex; C:secretory dimeric IgA immunoglobulin complex; C:secretory IgA immunoglobulin complex;, F:antigen binding;, P:antibacterial humoral response; P:B cell receptor signaling pathway; P:complement activation, classical pathway; P:defense response to bacterium; P:glomerular filtration; P:immune response; P:innate immune response; P:leukocyte migration; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; P:positive regulation of respiratory burst; P:protein-chromophore linkage; P:receptor-mediated endocytosis; P:retina homeostasis; scaffold3214 indexed_genome mRNA 1687 3893 . - . ID=transcript_17302;P01877 A0A075B6N7,Immunoglobulin heavy constant alpha 2 {ECO:0000303|PubMed:11340299, ECO:0000303|Ref.7},Ig alpha-2 chain C region {ECO:0000305};Ig alpha-2 chain C region BUT {ECO:0000305|PubMed:416441};Ig alpha-2 chain C region LAN {ECO:0000305|PubMed:286295};, PF07654;PF00047;, GO:0072562;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0042571;GO:0071748;GO:0071752;GO:0071751;GO:0003823;GO:0019731;GO:0050853;GO:0006958;GO:0042742;GO:0003094;GO:0006955;GO:0045087;GO:0050900;GO:0006911;GO:0006910;GO:0050871;GO:0060267;GO:0006898;GO:0001895;, C:blood microparticle; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:immunoglobulin complex, circulating; C:monomeric IgA immunoglobulin complex; C:secretory dimeric IgA immunoglobulin complex; C:secretory IgA immunoglobulin complex;, F:antigen binding;, P:antibacterial humoral response; P:B cell receptor signaling pathway; P:complement activation, classical pathway; P:defense response to bacterium; P:glomerular filtration; P:immune response; P:innate immune response; P:leukocyte migration; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; P:positive regulation of respiratory burst; P:receptor-mediated endocytosis; P:retina homeostasis;|P01876,Immunoglobulin heavy constant alpha 1 {ECO:0000303|PubMed:11340299, ECO:0000303|Ref.12},Ig alpha-1 chain C region {ECO:0000305};Ig alpha-1 chain C region BUR {ECO:0000305|PubMed:107164};Ig alpha-1 chain C region TRO {ECO:0000305|PubMed:809331};, PF07654;, GO:0072562;GO:0009897;GO:0070062;GO:0005576;GO:0005615;GO:0042571;GO:0071748;GO:0071752;GO:0071751;GO:0003823;GO:0019731;GO:0050853;GO:0006958;GO:0042742;GO:0003094;GO:0006955;GO:0045087;GO:0050900;GO:0006911;GO:0006910;GO:0050871;GO:0060267;GO:0018298;GO:0006898;GO:0001895;, C:blood microparticle; C:external side of plasma membrane; C:extracellular exosome; C:extracellular region; C:extracellular space; C:immunoglobulin complex, circulating; C:monomeric IgA immunoglobulin complex; C:secretory dimeric IgA immunoglobulin complex; C:secretory IgA immunoglobulin complex;, F:antigen binding;, P:antibacterial humoral response; P:B cell receptor signaling pathway; P:complement activation, classical pathway; P:defense response to bacterium; P:glomerular filtration; P:immune response; P:innate immune response; P:leukocyte migration; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; P:positive regulation of respiratory burst; P:protein-chromophore linkage; P:receptor-mediated endocytosis; P:retina homeostasis; scaffold3241 indexed_genome mRNA 2574 3390 . - . ID=transcript_17303;P18621 B2R4H3 B4E3C2 B5ME31 J3QL51 Q3KQW2 Q6NZ54 Q7M4M5,60S ribosomal protein L17,60S ribosomal protein L23;Large ribosomal subunit protein uL22 {ECO:0000303|PubMed:24524803};PD-1;, PF00237;, GO:0005829;GO:0022625;GO:0005634;GO:0003723;GO:0003735;GO:0002181;GO:0000184;GO:0006364;GO:0006614;GO:0006412;GO:0006413;GO:0019083;, C:cytosol; C:cytosolic large ribosomal subunit; C:nucleus;, F:RNA binding; F:structural constituent of ribosome;, P:cytoplasmic translation; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:rRNA processing; P:SRP-dependent cotranslational protein targeting to membrane; P:translation; P:translational initiation; P:viral transcription; scaffold3252 indexed_genome mRNA 2485 5153 . + . ID=transcript_17304;Q9BXR3 Q6KH04 Q9BXR4 Q9UKH5 Q9UP31 Q9WIK9 Q9WJR4,Endogenous retrovirus group K member 6 Pol protein,HERV-K(C7) Pol protein;HERV-K(HML-2.HOM) Pol protein;HERV-K108 Pol protein;HERV-K_7p22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold3311 indexed_genome mRNA 2907 5359 . + . ID=transcript_17305;O75578 B2RAM4 B2RTV5 Q6UXJ6 Q9UHZ8,Integrin alpha-10,, PF01839;PF08441;PF00092;, GO:0034680;GO:0008305;GO:0005886;GO:0005518;GO:0098639;GO:0046872;GO:0007160;GO:0030198;GO:0007229;, C:integrin alpha10-beta1 complex; C:integrin complex; C:plasma membrane;, F:collagen binding; F:collagen binding involved in cell-matrix adhesion; F:metal ion binding;, P:cell-matrix adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; scaffold3312 indexed_genome mRNA 2907 5358 . + . ID=transcript_17306;O75578 B2RAM4 B2RTV5 Q6UXJ6 Q9UHZ8,Integrin alpha-10,, PF01839;PF08441;PF00092;, GO:0034680;GO:0008305;GO:0005886;GO:0005518;GO:0098639;GO:0046872;GO:0007160;GO:0030198;GO:0007229;, C:integrin alpha10-beta1 complex; C:integrin complex; C:plasma membrane;, F:collagen binding; F:collagen binding involved in cell-matrix adhesion; F:metal ion binding;, P:cell-matrix adhesion; P:extracellular matrix organization; P:integrin-mediated signaling pathway; scaffold3314 indexed_genome mRNA 1647 6104 . - . ID=transcript_17307;Q92622 Q96CK5,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein {ECO:0000312|HGNC:HGNC:28991},Beclin-1 associated RUN domain containing protein;, PF02759;PF13901;, GO:0005829;GO:0005769;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:1901981;GO:0006914;GO:0006897;GO:0002376;GO:0071985;GO:1901097;GO:0010507;GO:0045806;GO:0043553;GO:0006909;, C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm;, F:phosphatidylinositol phosphate binding;, P:autophagy; P:endocytosis; P:immune system process; P:multivesicular body sorting pathway; P:negative regulation of autophagosome maturation; P:negative regulation of autophagy; P:negative regulation of endocytosis; P:negative regulation of phosphatidylinositol 3-kinase activity; P:phagocytosis;|Q92622 Q96CK5,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein {ECO:0000312|HGNC:HGNC:28991},Beclin-1 associated RUN domain containing protein;, PF02759;PF13901;, GO:0005829;GO:0005769;GO:0043231;GO:0005770;GO:0005764;GO:0005654;GO:1901981;GO:0006914;GO:0006897;GO:0002376;GO:0071985;GO:1901097;GO:0010507;GO:0045806;GO:0043553;GO:0006909;, C:cytosol; C:early endosome; C:intracellular membrane-bounded organelle; C:late endosome; C:lysosome; C:nucleoplasm;, F:phosphatidylinositol phosphate binding;, P:autophagy; P:endocytosis; P:immune system process; P:multivesicular body sorting pathway; P:negative regulation of autophagosome maturation; P:negative regulation of autophagy; P:negative regulation of endocytosis; P:negative regulation of phosphatidylinositol 3-kinase activity; P:phagocytosis; scaffold3342 indexed_genome mRNA 590 2744 . - . ID=transcript_17308;Q8NF37 Q1HAQ1 Q7Z4G6 Q8N3U7 Q8WUL8 Q9GZW6,Lysophosphatidylcholine acyltransferase 1,1-acylglycerol-3-phosphate O-acyltransferase;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 2;Phosphonoformate immuno-associated protein 3;, PF01553;PF13833;, GO:0035577;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005811;GO:0016020;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0047191;GO:0005509;GO:0050200;GO:2001246;GO:0043312;GO:0006654;GO:0036151;GO:0006656;GO:0036148;GO:0008654;GO:0045732;GO:0060041;GO:0043129;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:1-alkylglycerophosphocholine O-acyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:negative regulation of phosphatidylcholine biosynthetic process; P:neutrophil degranulation; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine biosynthetic process; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of protein catabolic process; P:retina development in camera-type eye; P:surfactant homeostasis;|Q8NF37 Q1HAQ1 Q7Z4G6 Q8N3U7 Q8WUL8 Q9GZW6,Lysophosphatidylcholine acyltransferase 1,1-acylglycerol-3-phosphate O-acyltransferase;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 2;Phosphonoformate immuno-associated protein 3;, PF01553;PF13833;, GO:0035577;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005811;GO:0016020;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0047191;GO:0005509;GO:0050200;GO:2001246;GO:0043312;GO:0006654;GO:0036151;GO:0006656;GO:0036148;GO:0008654;GO:0045732;GO:0060041;GO:0043129;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:1-alkylglycerophosphocholine O-acyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:negative regulation of phosphatidylcholine biosynthetic process; P:neutrophil degranulation; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine biosynthetic process; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of protein catabolic process; P:retina development in camera-type eye; P:surfactant homeostasis; scaffold3343 indexed_genome mRNA 590 2744 . - . ID=transcript_17309;Q8NF37 Q1HAQ1 Q7Z4G6 Q8N3U7 Q8WUL8 Q9GZW6,Lysophosphatidylcholine acyltransferase 1,1-acylglycerol-3-phosphate O-acyltransferase;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 2;Phosphonoformate immuno-associated protein 3;, PF01553;PF13833;, GO:0035577;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005811;GO:0016020;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0047191;GO:0005509;GO:0050200;GO:2001246;GO:0043312;GO:0006654;GO:0036151;GO:0006656;GO:0036148;GO:0008654;GO:0045732;GO:0060041;GO:0043129;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:1-alkylglycerophosphocholine O-acyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:negative regulation of phosphatidylcholine biosynthetic process; P:neutrophil degranulation; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine biosynthetic process; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of protein catabolic process; P:retina development in camera-type eye; P:surfactant homeostasis;|Q8NF37 Q1HAQ1 Q7Z4G6 Q8N3U7 Q8WUL8 Q9GZW6,Lysophosphatidylcholine acyltransferase 1,1-acylglycerol-3-phosphate O-acyltransferase;1-acylglycerophosphocholine O-acyltransferase;1-alkenylglycerophosphocholine O-acyltransferase;1-alkylglycerophosphocholine O-acetyltransferase;Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;Acyltransferase-like 2;Phosphonoformate immuno-associated protein 3;, PF01553;PF13833;, GO:0035577;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0016021;GO:0005811;GO:0016020;GO:0005886;GO:0003841;GO:0047184;GO:0047159;GO:0047192;GO:0047191;GO:0005509;GO:0050200;GO:2001246;GO:0043312;GO:0006654;GO:0036151;GO:0006656;GO:0036148;GO:0008654;GO:0045732;GO:0060041;GO:0043129;, C:azurophil granule membrane; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of membrane; C:lipid droplet; C:membrane; C:plasma membrane;, F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:1-acylglycerophosphocholine O-acyltransferase activity; F:1-alkenylglycerophosphocholine O-acyltransferase activity; F:1-alkylglycerophosphocholine O-acetyltransferase activity; F:1-alkylglycerophosphocholine O-acyltransferase activity; F:calcium ion binding; F:plasmalogen synthase activity;, P:negative regulation of phosphatidylcholine biosynthetic process; P:neutrophil degranulation; P:phosphatidic acid biosynthetic process; P:phosphatidylcholine acyl-chain remodeling; P:phosphatidylcholine biosynthetic process; P:phosphatidylglycerol acyl-chain remodeling; P:phospholipid biosynthetic process; P:positive regulation of protein catabolic process; P:retina development in camera-type eye; P:surfactant homeostasis; scaffold3379 indexed_genome mRNA 1219 2031 . - . ID=transcript_17310;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold3428 indexed_genome mRNA 706 1246 . - . ID=transcript_17311;Q6ZR62 B2RPG1,Retrotransposon Gag-like protein 4 {ECO:0000312|HGNC:HGNC:25214},Mammalian retrotransposon-derived protein 4 {ECO:0000250|UniProtKB:Q3URY0};Zinc finger CCHC domain-containing protein 16;, , GO:0003676;GO:0008270;GO:0050890;GO:0042415;, , F:nucleic acid binding; F:zinc ion binding;, P:cognition; P:norepinephrine metabolic process; scaffold3480 indexed_genome mRNA 1993 2540 . + . ID=transcript_17312;Q02928 Q06766 Q16865 Q16866 Q5VSP8 Q86SU6 Q8IWY5,Cytochrome P450 4A11 {ECO:0000303|PubMed:10553002},20-hydroxyeicosatetraenoic acid synthase {ECO:0000305|PubMed:10660572, ECO:0000305|PubMed:15611369};CYP4AII;CYPIVA11;Cytochrome P-450HK-omega;Cytochrome P450HL-omega;Fatty acid omega-hydroxylase;Lauric acid omega-hydroxylase {ECO:0000303|PubMed:8914854};Long-chain fatty acid omega-monooxygenase;, PF00067;, GO:0016324;GO:0005737;GO:0005789;GO:0043231;GO:0018685;GO:0008392;GO:0008391;GO:0070330;GO:0020037;GO:0005506;GO:0050051;GO:0102033;GO:0019369;GO:0019373;GO:0006631;GO:0046456;GO:0001822;GO:0048252;GO:0006691;GO:0043651;GO:0001676;GO:0097267;GO:0031408;GO:0032305;GO:0003095;GO:0019222;GO:0003091;GO:0055078;, C:apical plasma membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:alkane 1-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:arachidonic acid monooxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:leukotriene-B4 20-monooxygenase activity; F:long-chain fatty acid omega-hydroxylase activity;, P:arachidonic acid metabolic process; P:epoxygenase P450 pathway; P:fatty acid metabolic process; P:icosanoid biosynthetic process; P:kidney development; P:lauric acid metabolic process; P:leukotriene metabolic process; P:linoleic acid metabolic process; P:long-chain fatty acid metabolic process; P:omega-hydroxylase P450 pathway; P:oxylipin biosynthetic process; P:positive regulation of icosanoid secretion; P:pressure natriuresis; P:regulation of metabolic process; P:renal water homeostasis; P:sodium ion homeostasis; scaffold3550 indexed_genome mRNA 3214 4706 . + . ID=transcript_17313;Q13136 A6NLE3 Q13135 Q14567 Q8N4I2,Liprin-alpha-1,LAR-interacting protein 1;Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1;, PF00536;PF07647;, GO:0005737;GO:0005829;GO:0005925;GO:0048786;GO:0007160;GO:1903077;GO:0051497;GO:0006836;GO:0007165;GO:0050808;, C:cytoplasm; C:cytosol; C:focal adhesion; C:presynaptic active zone;, , P:cell-matrix adhesion; P:negative regulation of protein localization to plasma membrane; P:negative regulation of stress fiber assembly; P:neurotransmitter transport; P:signal transduction; P:synapse organization; scaffold3613 indexed_genome mRNA 4686 5367 . - . ID=transcript_17314;Q9Y3C4 D6W5H6 Q8IWR6 Q8IWR7 Q9H3K4,EKC/KEOPS complex subunit TPRKB {ECO:0000305},PRPK-binding protein {ECO:0000303|PubMed:12659830};TP53RK-binding protein {ECO:0000303|PubMed:12659830};, PF08617;, GO:0005737;GO:0005829;GO:0000408;GO:0005634;GO:0019901;GO:0000722;GO:0002949;, C:cytoplasm; C:cytosol; C:EKC/KEOPS complex; C:nucleus;, F:protein kinase binding;, P:telomere maintenance via recombination; P:tRNA threonylcarbamoyladenosine modification; scaffold3773 indexed_genome mRNA 4827 5332 . + . ID=transcript_17315;O95219 B3KMH0 B4DQV4 D3DNA3,Sorting nexin-4,, PF00787;, GO:0005737;GO:0005868;GO:0031901;GO:0016020;GO:0005886;GO:0032991;GO:0031201;GO:0005154;GO:0005158;GO:1990460;GO:0035091;GO:1990459;GO:0032456;GO:1903595;GO:0015031;, C:cytoplasm; C:cytoplasmic dynein complex; C:early endosome membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:SNARE complex;, F:epidermal growth factor receptor binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:transferrin receptor binding;, P:endocytic recycling; P:positive regulation of histamine secretion by mast cell; P:protein transport; scaffold3813 indexed_genome mRNA 2020 3449 . - . ID=transcript_17316;Q16515 E9PBX2 Q13553 Q6DJU1 Q8N3E2,Acid-sensing ion channel 2 {ECO:0000303|PubMed:10842183},Amiloride-sensitive brain sodium channel;Amiloride-sensitive cation channel 1, neuronal;Amiloride-sensitive cation channel neuronal 1;Brain sodium channel 1 {ECO:0000303|PubMed:9037075};Mammalian degenerin homolog {ECO:0000303|PubMed:8631835};, PF00858;, GO:0043197;GO:0005887;GO:0043025;GO:0005886;GO:0022839;GO:0015280;GO:0007417;GO:0007268;GO:0050974;GO:0098662;GO:0034220;GO:0043066;GO:0007422;GO:0007602;GO:0051965;GO:0035418;GO:0034765;GO:0042391;GO:0003026;GO:0019229;GO:0010447;GO:0007605;GO:0050915;GO:0035725;, C:dendritic spine; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane;, F:ion gated channel activity; F:ligand-gated sodium channel activity;, P:central nervous system development; P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception; P:inorganic cation transmembrane transport; P:ion transmembrane transport; P:negative regulation of apoptotic process; P:peripheral nervous system development; P:phototransduction; P:positive regulation of synapse assembly; P:protein localization to synapse; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback; P:regulation of vasoconstriction; P:response to acidic pH; P:sensory perception of sound; P:sensory perception of sour taste; P:sodium ion transmembrane transport; scaffold3813 indexed_genome mRNA 3459 4747 . + . ID=transcript_17317;Q16515 E9PBX2 Q13553 Q6DJU1 Q8N3E2,Acid-sensing ion channel 2 {ECO:0000303|PubMed:10842183},Amiloride-sensitive brain sodium channel;Amiloride-sensitive cation channel 1, neuronal;Amiloride-sensitive cation channel neuronal 1;Brain sodium channel 1 {ECO:0000303|PubMed:9037075};Mammalian degenerin homolog {ECO:0000303|PubMed:8631835};, PF00858;, GO:0043197;GO:0005887;GO:0043025;GO:0005886;GO:0022839;GO:0015280;GO:0007417;GO:0007268;GO:0050974;GO:0098662;GO:0034220;GO:0043066;GO:0007422;GO:0007602;GO:0051965;GO:0035418;GO:0034765;GO:0042391;GO:0003026;GO:0019229;GO:0010447;GO:0007605;GO:0050915;GO:0035725;, C:dendritic spine; C:integral component of plasma membrane; C:neuronal cell body; C:plasma membrane;, F:ion gated channel activity; F:ligand-gated sodium channel activity;, P:central nervous system development; P:chemical synaptic transmission; P:detection of mechanical stimulus involved in sensory perception; P:inorganic cation transmembrane transport; P:ion transmembrane transport; P:negative regulation of apoptotic process; P:peripheral nervous system development; P:phototransduction; P:positive regulation of synapse assembly; P:protein localization to synapse; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback; P:regulation of vasoconstriction; P:response to acidic pH; P:sensory perception of sound; P:sensory perception of sour taste; P:sodium ion transmembrane transport; scaffold3909 indexed_genome mRNA 1669 4093 . - . ID=transcript_17318;Q8IZX2 Q8N406 Q8TEU0 Q9H6C9 Q9H6H9 Q9H6P3 Q9H8A9 Q9HCF4 Q9HCL8,E3 ubiquitin-protein ligase RNF213 {ECO:0000305},ALK lymphoma oligomerization partner on chromosome 17 {ECO:0000303|PubMed:12112524};Mysterin {ECO:0000303|PubMed:26126547};RING finger protein 213 {ECO:0000305};RING-type E3 ubiquitin transferase RNF213 {ECO:0000305};, PF00097;, GO:0005737;GO:0005829;GO:0016020;GO:0005730;GO:0016887;GO:0046872;GO:0004842;GO:0001525;GO:0033668;GO:2000051;GO:0051865;GO:0051260;GO:0000209;GO:0016567;GO:0002040;GO:0006511;, C:cytoplasm; C:cytosol; C:membrane; C:nucleolus;, F:ATPase activity; F:metal ion binding; F:ubiquitin-protein transferase activity;, P:angiogenesis; P:negative regulation by symbiont of host apoptotic process; P:negative regulation of non-canonical Wnt signaling pathway; P:protein autoubiquitination; P:protein homooligomerization; P:protein polyubiquitination; P:protein ubiquitination; P:sprouting angiogenesis; P:ubiquitin-dependent protein catabolic process; scaffold3940 indexed_genome mRNA 2323 4990 . + . ID=transcript_17319;Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly;|Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly; scaffold3947 indexed_genome mRNA 1 4987 . + . ID=transcript_17320;Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly;|Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly;|Q96CW5 O43631 O60852 O60853 Q5T8L2 Q7Z4K1 Q96I79,Gamma-tubulin complex component 3,Gamma-ring complex protein 104 kDa;Spindle pole body protein Spc98 homolog;, PF04130;PF17681;, GO:0005814;GO:0005813;GO:0005737;GO:0005829;GO:0000923;GO:0000930;GO:0008275;GO:0016020;GO:0005827;GO:0005819;GO:0043015;GO:0005200;GO:0005198;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0007338;GO:0051225;, C:centriole; C:centrosome; C:cytoplasm; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin small complex; C:membrane; C:polar microtubule; C:spindle;, F:gamma-tubulin binding; F:structural constituent of cytoskeleton; F:structural molecule activity;, P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:single fertilization; P:spindle assembly; scaffold3959 indexed_genome mRNA 1413 3024 . - . ID=transcript_17321;Q9H6Y7 D3DTK8 Q6XYE0 Q8NDC1 Q9Y3V1,E3 ubiquitin-protein ligase RNF167,RING finger protein 167;RING-type E3 ubiquitin transferase RNF167 {ECO:0000305};RING105;, PF02225;PF13639;, GO:0005737;GO:0012505;GO:0016021;GO:0061630;GO:0004842;GO:0008270;GO:0045786;GO:0000209;GO:0006511;, C:cytoplasm; C:endomembrane system; C:integral component of membrane;, F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;, P:negative regulation of cell cycle; P:protein polyubiquitination; P:ubiquitin-dependent protein catabolic process; scaffold4120 indexed_genome mRNA 1259 1992 . + . ID=transcript_17322;Q9NR61 Q3KP23 Q9NQT9,Delta-like protein 4,Drosophila Delta homolog 4;, PF01414;PF00008;PF07657;, GO:0016021;GO:0005886;GO:0005509;GO:0005112;GO:0001525;GO:0003180;GO:0008015;GO:0072554;GO:0001974;GO:0001569;GO:0003209;GO:0003208;GO:0044344;GO:0035924;GO:0035912;GO:1903588;GO:0090051;GO:0008285;GO:0010596;GO:0010629;GO:0045746;GO:0000122;GO:0061314;GO:0007219;GO:0003344;GO:0010628;GO:2000179;GO:0045747;GO:0061074;GO:0050767;GO:0007165;GO:0030217;GO:0060579;GO:0003222;GO:0007601;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:Notch binding;, P:angiogenesis; P:aortic valve morphogenesis; P:blood circulation; P:blood vessel lumenization; P:blood vessel remodeling; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:dorsal aorta morphogenesis; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:pericardium morphogenesis; P:positive regulation of gene expression; P:positive regulation of neural precursor cell proliferation; P:positive regulation of Notch signaling pathway; P:regulation of neural retina development; P:regulation of neurogenesis; P:signal transduction; P:T cell differentiation; P:ventral spinal cord interneuron fate commitment; P:ventricular trabecula myocardium morphogenesis; P:visual perception; scaffold4120 indexed_genome mRNA 2450 3859 . - . ID=transcript_17323;Q9NR61 Q3KP23 Q9NQT9,Delta-like protein 4,Drosophila Delta homolog 4;, PF01414;PF00008;PF07657;, GO:0016021;GO:0005886;GO:0005509;GO:0005112;GO:0001525;GO:0003180;GO:0008015;GO:0072554;GO:0001974;GO:0001569;GO:0003209;GO:0003208;GO:0044344;GO:0035924;GO:0035912;GO:1903588;GO:0090051;GO:0008285;GO:0010596;GO:0010629;GO:0045746;GO:0000122;GO:0061314;GO:0007219;GO:0003344;GO:0010628;GO:2000179;GO:0045747;GO:0061074;GO:0050767;GO:0007165;GO:0030217;GO:0060579;GO:0003222;GO:0007601;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:Notch binding;, P:angiogenesis; P:aortic valve morphogenesis; P:blood circulation; P:blood vessel lumenization; P:blood vessel remodeling; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:dorsal aorta morphogenesis; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:pericardium morphogenesis; P:positive regulation of gene expression; P:positive regulation of neural precursor cell proliferation; P:positive regulation of Notch signaling pathway; P:regulation of neural retina development; P:regulation of neurogenesis; P:signal transduction; P:T cell differentiation; P:ventral spinal cord interneuron fate commitment; P:ventricular trabecula myocardium morphogenesis; P:visual perception; scaffold4121 indexed_genome mRNA 18 3859 . - . ID=transcript_17324;Q9NR61 Q3KP23 Q9NQT9,Delta-like protein 4,Drosophila Delta homolog 4;, PF01414;PF00008;PF07657;, GO:0016021;GO:0005886;GO:0005509;GO:0005112;GO:0001525;GO:0003180;GO:0008015;GO:0072554;GO:0001974;GO:0001569;GO:0003209;GO:0003208;GO:0044344;GO:0035924;GO:0035912;GO:1903588;GO:0090051;GO:0008285;GO:0010596;GO:0010629;GO:0045746;GO:0000122;GO:0061314;GO:0007219;GO:0003344;GO:0010628;GO:2000179;GO:0045747;GO:0061074;GO:0050767;GO:0007165;GO:0030217;GO:0060579;GO:0003222;GO:0007601;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:Notch binding;, P:angiogenesis; P:aortic valve morphogenesis; P:blood circulation; P:blood vessel lumenization; P:blood vessel remodeling; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:dorsal aorta morphogenesis; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:pericardium morphogenesis; P:positive regulation of gene expression; P:positive regulation of neural precursor cell proliferation; P:positive regulation of Notch signaling pathway; P:regulation of neural retina development; P:regulation of neurogenesis; P:signal transduction; P:T cell differentiation; P:ventral spinal cord interneuron fate commitment; P:ventricular trabecula myocardium morphogenesis; P:visual perception;|Q9NR61 Q3KP23 Q9NQT9,Delta-like protein 4,Drosophila Delta homolog 4;, PF01414;PF00008;PF07657;, GO:0016021;GO:0005886;GO:0005509;GO:0005112;GO:0001525;GO:0003180;GO:0008015;GO:0072554;GO:0001974;GO:0001569;GO:0003209;GO:0003208;GO:0044344;GO:0035924;GO:0035912;GO:1903588;GO:0090051;GO:0008285;GO:0010596;GO:0010629;GO:0045746;GO:0000122;GO:0061314;GO:0007219;GO:0003344;GO:0010628;GO:2000179;GO:0045747;GO:0061074;GO:0050767;GO:0007165;GO:0030217;GO:0060579;GO:0003222;GO:0007601;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:Notch binding;, P:angiogenesis; P:aortic valve morphogenesis; P:blood circulation; P:blood vessel lumenization; P:blood vessel remodeling; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:dorsal aorta morphogenesis; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:pericardium morphogenesis; P:positive regulation of gene expression; P:positive regulation of neural precursor cell proliferation; P:positive regulation of Notch signaling pathway; P:regulation of neural retina development; P:regulation of neurogenesis; P:signal transduction; P:T cell differentiation; P:ventral spinal cord interneuron fate commitment; P:ventricular trabecula myocardium morphogenesis; P:visual perception;|Q9NR61 Q3KP23 Q9NQT9,Delta-like protein 4,Drosophila Delta homolog 4;, PF01414;PF00008;PF07657;, GO:0016021;GO:0005886;GO:0005509;GO:0005112;GO:0001525;GO:0003180;GO:0008015;GO:0072554;GO:0001974;GO:0001569;GO:0003209;GO:0003208;GO:0044344;GO:0035924;GO:0035912;GO:1903588;GO:0090051;GO:0008285;GO:0010596;GO:0010629;GO:0045746;GO:0000122;GO:0061314;GO:0007219;GO:0003344;GO:0010628;GO:2000179;GO:0045747;GO:0061074;GO:0050767;GO:0007165;GO:0030217;GO:0060579;GO:0003222;GO:0007601;, C:integral component of membrane; C:plasma membrane;, F:calcium ion binding; F:Notch binding;, P:angiogenesis; P:aortic valve morphogenesis; P:blood circulation; P:blood vessel lumenization; P:blood vessel remodeling; P:branching involved in blood vessel morphogenesis; P:cardiac atrium morphogenesis; P:cardiac ventricle morphogenesis; P:cellular response to fibroblast growth factor stimulus; P:cellular response to vascular endothelial growth factor stimulus; P:dorsal aorta morphogenesis; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:negative regulation of cell migration involved in sprouting angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of Notch signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:pericardium morphogenesis; P:positive regulation of gene expression; P:positive regulation of neural precursor cell proliferation; P:positive regulation of Notch signaling pathway; P:regulation of neural retina development; P:regulation of neurogenesis; P:signal transduction; P:T cell differentiation; P:ventral spinal cord interneuron fate commitment; P:ventricular trabecula myocardium morphogenesis; P:visual perception; scaffold4204 indexed_genome mRNA 73 4672 . + . ID=transcript_17325;Q5TC63 B9A6K2 Q2M232 Q5TC64 Q66K26 Q6P659 Q8N528 Q9H695,Growth hormone-regulated TBC protein 1,TBC1 domain family member 6;, PF00566;, GO:0005096;GO:0090630;GO:0006886;, , F:GTPase activator activity;, P:activation of GTPase activity; P:intracellular protein transport; scaffold4236 indexed_genome mRNA 713 1413 . + . ID=transcript_17326;Q6P4F7 B4DZN9 Q6PI96 Q9Y3S6,Rho GTPase-activating protein 11A {ECO:0000305},Rho-type GTPase-activating protein 11A {ECO:0000305};, PF00620;, GO:0005829;GO:0005634;GO:0005096;GO:0043547;GO:0051056;GO:0007165;, C:cytosol; C:nucleus;, F:GTPase activator activity;, P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold4299 indexed_genome mRNA 1893 2793 . - . ID=transcript_17327;Q99719 O15251 Q96MY5,Septin-5,Cell division control-related protein 1;Peanut-like protein 1;, PF00735;, GO:0032153;GO:0015630;GO:0005886;GO:0031105;GO:0005940;GO:0008021;GO:0005525;GO:0003924;GO:0042802;GO:0060090;GO:0005198;GO:0030534;GO:0034613;GO:0061640;GO:0017157;GO:2000300;GO:0035176;GO:0016080;, C:cell division site; C:microtubule cytoskeleton; C:plasma membrane; C:septin complex; C:septin ring; C:synaptic vesicle;, F:GTP binding; F:GTPase activity; F:identical protein binding; F:molecular adaptor activity; F:structural molecule activity;, P:adult behavior; P:cellular protein localization; P:cytoskeleton-dependent cytokinesis; P:regulation of exocytosis; P:regulation of synaptic vesicle exocytosis; P:social behavior; P:synaptic vesicle targeting; scaffold4307 indexed_genome mRNA 3426 4441 . + . ID=transcript_17328;Q02928 Q06766 Q16865 Q16866 Q5VSP8 Q86SU6 Q8IWY5,Cytochrome P450 4A11 {ECO:0000303|PubMed:10553002},20-hydroxyeicosatetraenoic acid synthase {ECO:0000305|PubMed:10660572, ECO:0000305|PubMed:15611369};CYP4AII;CYPIVA11;Cytochrome P-450HK-omega;Cytochrome P450HL-omega;Fatty acid omega-hydroxylase;Lauric acid omega-hydroxylase {ECO:0000303|PubMed:8914854};Long-chain fatty acid omega-monooxygenase;, PF00067;, GO:0016324;GO:0005737;GO:0005789;GO:0043231;GO:0018685;GO:0008392;GO:0008391;GO:0070330;GO:0020037;GO:0005506;GO:0050051;GO:0102033;GO:0019369;GO:0019373;GO:0006631;GO:0046456;GO:0001822;GO:0048252;GO:0006691;GO:0043651;GO:0001676;GO:0097267;GO:0031408;GO:0032305;GO:0003095;GO:0019222;GO:0003091;GO:0055078;, C:apical plasma membrane; C:cytoplasm; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle;, F:alkane 1-monooxygenase activity; F:arachidonic acid epoxygenase activity; F:arachidonic acid monooxygenase activity; F:aromatase activity; F:heme binding; F:iron ion binding; F:leukotriene-B4 20-monooxygenase activity; F:long-chain fatty acid omega-hydroxylase activity;, P:arachidonic acid metabolic process; P:epoxygenase P450 pathway; P:fatty acid metabolic process; P:icosanoid biosynthetic process; P:kidney development; P:lauric acid metabolic process; P:leukotriene metabolic process; P:linoleic acid metabolic process; P:long-chain fatty acid metabolic process; P:omega-hydroxylase P450 pathway; P:oxylipin biosynthetic process; P:positive regulation of icosanoid secretion; P:pressure natriuresis; P:regulation of metabolic process; P:renal water homeostasis; P:sodium ion homeostasis; scaffold4319 indexed_genome mRNA 278 3292 . + . ID=transcript_17329;P86397,Hydroxyacyl-thioester dehydratase type 2, mitochondrial {ECO:0000303|PubMed:17898086},3-hydroxyacyl-[acyl-carrier-protein] dehydratase {ECO:0000250|UniProtKB:P38790};, PF01575;, GO:0005759;GO:0005739;GO:0005730;GO:0008659;GO:0008693;GO:0047451;GO:0004317;GO:0006631;GO:0046949;, C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity; F:3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity; F:3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity; F:3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity;, P:fatty acid metabolic process; P:fatty-acyl-CoA biosynthetic process; scaffold4371 indexed_genome mRNA 231 2109 . - . ID=transcript_17330;Q9NYT6 Q8WWE6 Q96TE6 Q9NS44,Zinc finger protein 226,, PF01352;PF00096;, GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold4409 indexed_genome mRNA 3 4439 . + . ID=transcript_17331;Q9HCB8,Protein phosphatase 1 regulatory subunit 12B,Myosin phosphatase-targeting subunit 2;, PF12796;PF15898;, GO:0031672;GO:0005737;GO:0005856;GO:0005829;GO:0005654;GO:0030018;GO:0008047;GO:0004857;GO:0019208;GO:0019901;GO:0000086;GO:0006937;GO:0007165;, C:A band; C:cytoplasm; C:cytoskeleton; C:cytosol; C:nucleoplasm; C:Z disc;, F:enzyme activator activity; F:enzyme inhibitor activity; F:phosphatase regulator activity; F:protein kinase binding;, P:G2/M transition of mitotic cell cycle; P:regulation of muscle contraction; P:signal transduction; scaffold4416 indexed_genome mRNA 1588 2948 . - . ID=transcript_17332;Q8IWE4 B3KVY4,DCN1-like protein 3,DCUN1 domain-containing protein 3;Defective in cullin neddylation protein 1-like protein 3;Squamous cell carcinoma-related oncogene 3 {ECO:0000303|PubMed:25349211};, PF03556;, GO:0005737;GO:0005634;GO:0048471;GO:0005886;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:0030308;GO:2000134;GO:2000435;GO:0043065;GO:2000436;GO:0051443;GO:0043687;GO:0045116;GO:0010564;GO:2000434;GO:0010332;GO:0010225;, C:cytoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein neddylation; P:positive regulation of apoptotic process; P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:protein neddylation; P:regulation of cell cycle process; P:regulation of protein neddylation; P:response to gamma radiation; P:response to UV-C;|Q8IWE4 B3KVY4,DCN1-like protein 3,DCUN1 domain-containing protein 3;Defective in cullin neddylation protein 1-like protein 3;Squamous cell carcinoma-related oncogene 3 {ECO:0000303|PubMed:25349211};, PF03556;, GO:0005737;GO:0005634;GO:0048471;GO:0005886;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:0030308;GO:2000134;GO:2000435;GO:0043065;GO:2000436;GO:0051443;GO:0043687;GO:0045116;GO:0010564;GO:2000434;GO:0010332;GO:0010225;, C:cytoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein neddylation; P:positive regulation of apoptotic process; P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:protein neddylation; P:regulation of cell cycle process; P:regulation of protein neddylation; P:response to gamma radiation; P:response to UV-C; scaffold4416 indexed_genome mRNA 3109 3791 . - . ID=transcript_17333;Q8IWE4 B3KVY4,DCN1-like protein 3,DCUN1 domain-containing protein 3;Defective in cullin neddylation protein 1-like protein 3;Squamous cell carcinoma-related oncogene 3 {ECO:0000303|PubMed:25349211};, PF03556;, GO:0005737;GO:0005634;GO:0048471;GO:0005886;GO:0000151;GO:0097602;GO:0031624;GO:0032182;GO:0030308;GO:2000134;GO:2000435;GO:0043065;GO:2000436;GO:0051443;GO:0043687;GO:0045116;GO:0010564;GO:2000434;GO:0010332;GO:0010225;, C:cytoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:ubiquitin ligase complex;, F:cullin family protein binding; F:ubiquitin conjugating enzyme binding; F:ubiquitin-like protein binding;, P:negative regulation of cell growth; P:negative regulation of G1/S transition of mitotic cell cycle; P:negative regulation of protein neddylation; P:positive regulation of apoptotic process; P:positive regulation of protein neddylation; P:positive regulation of ubiquitin-protein transferase activity; P:post-translational protein modification; P:protein neddylation; P:regulation of cell cycle process; P:regulation of protein neddylation; P:response to gamma radiation; P:response to UV-C; scaffold4434 indexed_genome mRNA 269 1986 . + . ID=transcript_17334;Q93096 B2R6C8 O00648 Q49A54,Protein tyrosine phosphatase type IVA 1,PTP(CAAXI);Protein-tyrosine phosphatase 4a1;Protein-tyrosine phosphatase of regenerating liver 1;, , GO:0005737;GO:0009898;GO:0005769;GO:0005783;GO:0005634;GO:0005819;GO:0004725;GO:0007049;GO:0007275;GO:0030335;, C:cytoplasm; C:cytoplasmic side of plasma membrane; C:early endosome; C:endoplasmic reticulum; C:nucleus; C:spindle;, F:protein tyrosine phosphatase activity;, P:cell cycle; P:multicellular organism development; P:positive regulation of cell migration; scaffold4570 indexed_genome mRNA 1199 3587 . + . ID=transcript_17335;O14929 Q49A44 Q53QF0 Q53SU4 Q6P594 Q8WWB9,Histone acetyltransferase type B catalytic subunit,Histone acetyltransferase 1;, PF10394;, GO:0000785;GO:0000781;GO:0005737;GO:0016363;GO:0005654;GO:0005634;GO:0032991;GO:0010485;GO:0004402;GO:0042393;GO:0006348;GO:0006323;GO:0006335;GO:0006336;GO:0043967;GO:0006475;GO:0007584;, C:chromatin; C:chromosome, telomeric region; C:cytoplasm; C:nuclear matrix; C:nucleoplasm; C:nucleus; C:protein-containing complex;, F:H4 histone acetyltransferase activity; F:histone acetyltransferase activity; F:histone binding;, P:chromatin silencing at telomere; P:DNA packaging; P:DNA replication-dependent nucleosome assembly; P:DNA replication-independent nucleosome assembly; P:histone H4 acetylation; P:internal protein amino acid acetylation; P:response to nutrient; scaffold4577 indexed_genome mRNA 653 2584 . - . ID=transcript_17336;Q9H6S3 B3KSX1 B7ZKL3 Q53GM8 Q8WYW7 Q96K06 Q9H6K9,Epidermal growth factor receptor kinase substrate 8-like protein 2,Epidermal growth factor receptor pathway substrate 8-related protein 2;, PF08416;PF18016;PF00018;, GO:0005829;GO:0070062;GO:0005886;GO:0032991;GO:0032587;GO:0032421;GO:0032426;GO:0031982;GO:0003779;GO:0045296;GO:1900029;GO:0050790;GO:0035023;GO:0007266;GO:0007605;, C:cytosol; C:extracellular exosome; C:plasma membrane; C:protein-containing complex; C:ruffle membrane; C:stereocilium bundle; C:stereocilium tip; C:vesicle;, F:actin binding; F:cadherin binding;, P:positive regulation of ruffle assembly; P:regulation of catalytic activity; P:regulation of Rho protein signal transduction; P:Rho protein signal transduction; P:sensory perception of sound; scaffold4577 indexed_genome mRNA 3174 4055 . + . ID=transcript_17337;Q9H6S3 B3KSX1 B7ZKL3 Q53GM8 Q8WYW7 Q96K06 Q9H6K9,Epidermal growth factor receptor kinase substrate 8-like protein 2,Epidermal growth factor receptor pathway substrate 8-related protein 2;, PF08416;PF18016;PF00018;, GO:0005829;GO:0070062;GO:0005886;GO:0032991;GO:0032587;GO:0032421;GO:0032426;GO:0031982;GO:0003779;GO:0045296;GO:1900029;GO:0050790;GO:0035023;GO:0007266;GO:0007605;, C:cytosol; C:extracellular exosome; C:plasma membrane; C:protein-containing complex; C:ruffle membrane; C:stereocilium bundle; C:stereocilium tip; C:vesicle;, F:actin binding; F:cadherin binding;, P:positive regulation of ruffle assembly; P:regulation of catalytic activity; P:regulation of Rho protein signal transduction; P:Rho protein signal transduction; P:sensory perception of sound; scaffold4632 indexed_genome mRNA 262 4259 . + . ID=transcript_17338;O95219 B3KMH0 B4DQV4 D3DNA3,Sorting nexin-4,, PF00787;, GO:0005737;GO:0005868;GO:0031901;GO:0016020;GO:0005886;GO:0032991;GO:0031201;GO:0005154;GO:0005158;GO:1990460;GO:0035091;GO:1990459;GO:0032456;GO:1903595;GO:0015031;, C:cytoplasm; C:cytoplasmic dynein complex; C:early endosome membrane; C:membrane; C:plasma membrane; C:protein-containing complex; C:SNARE complex;, F:epidermal growth factor receptor binding; F:insulin receptor binding; F:leptin receptor binding; F:phosphatidylinositol binding; F:transferrin receptor binding;, P:endocytic recycling; P:positive regulation of histamine secretion by mast cell; P:protein transport; scaffold4721 indexed_genome mRNA 630 2469 . + . ID=transcript_17339;O00398 D3DTE5 Q4VBN7 Q86V16,Putative P2Y purinoceptor 10,P2Y-like receptor;, PF00001;, GO:0005887;GO:0005886;GO:0045028;GO:0004930;GO:0007186;GO:0051482;GO:0035025;, C:integral component of plasma membrane; C:plasma membrane;, F:G protein-coupled purinergic nucleotide receptor activity; F:G protein-coupled receptor activity;, P:G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of Rho protein signal transduction; scaffold4740 indexed_genome mRNA 1 1721 . + . ID=transcript_17340;Q9H6K5 A0A087WZ52 Q9H3X1,Proline-rich protein 36 {ECO:0000312|HGNC:HGNC:26172},, PF15363;|Q9H6K5 A0A087WZ52 Q9H3X1,Proline-rich protein 36 {ECO:0000312|HGNC:HGNC:26172},, PF15363; scaffold4812 indexed_genome mRNA 2058 3971 . + . ID=transcript_17341;Q9BVA1 A8K068,Tubulin beta-2B chain,, PF00091;PF03953;, GO:0005737;GO:0005874;GO:0015630;GO:0005634;GO:0098685;GO:0005525;GO:0003924;GO:0046982;GO:0005200;GO:1990403;GO:0000226;GO:0007017;GO:0000278;GO:0050804;GO:0001764;GO:1902669;, C:cytoplasm; C:microtubule; C:microtubule cytoskeleton; C:nucleus; C:Schaffer collateral - CA1 synapse;, F:GTP binding; F:GTPase activity; F:protein heterodimerization activity; F:structural constituent of cytoskeleton;, P:embryonic brain development; P:microtubule cytoskeleton organization; P:microtubule-based process; P:mitotic cell cycle; P:modulation of chemical synaptic transmission; P:neuron migration; P:positive regulation of axon guidance; scaffold4960 indexed_genome mRNA 246 3759 . - . ID=transcript_17342;A6NKL6,Transmembrane protein 200C,Transmembrane protein TTMA;Two transmembrane domain-containing family member A;, PF10177;, GO:0016021;, C:integral component of membrane; scaffold5070 indexed_genome mRNA 140 912 . - . ID=transcript_17343;O43435 C6G493 C6G494 O43436 Q96RJ2,T-box transcription factor TBX1,Testis-specific T-box protein;, PF00907;, GO:0000785;GO:0005634;GO:0003677;GO:0000981;GO:0046983;GO:0042803;GO:0000978;GO:0043565;GO:1990837;GO:0001525;GO:0009952;GO:0035909;GO:0048844;GO:0001568;GO:0048514;GO:0001708;GO:0008283;GO:0044344;GO:0071300;GO:0090103;GO:0060982;GO:0007368;GO:0042471;GO:0048701;GO:0048703;GO:0070166;GO:0030855;GO:0060325;GO:0007507;GO:0003007;GO:0042472;GO:0001945;GO:0097152;GO:0007498;GO:0042474;GO:0042693;GO:0007517;GO:0048644;GO:0060415;GO:0045596;GO:2001054;GO:0001755;GO:0042475;GO:0042473;GO:0003151;GO:0003148;GO:0060017;GO:0007389;GO:0060037;GO:0008284;GO:0050679;GO:0043410;GO:0002053;GO:0001934;GO:2001037;GO:0045944;GO:0045893;GO:2000027;GO:0006357;GO:0048384;GO:0048752;GO:0007605;GO:0035176;GO:0060023;GO:0048538;GO:0030878;GO:0043587;GO:0021644;, C:chromatin; C:nucleus;, F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:angiogenesis; P:anterior/posterior pattern specification; P:aorta morphogenesis; P:artery morphogenesis; P:blood vessel development; P:blood vessel morphogenesis; P:cell fate specification; P:cell population proliferation; P:cellular response to fibroblast growth factor stimulus; P:cellular response to retinoic acid; P:cochlea morphogenesis; P:coronary artery morphogenesis; P:determination of left/right symmetry; P:ear morphogenesis; P:embryonic cranial skeleton morphogenesis; P:embryonic viscerocranium morphogenesis; P:enamel mineralization; P:epithelial cell differentiation; P:face morphogenesis; P:heart development; P:heart morphogenesis; P:inner ear morphogenesis; P:lymph vessel development; P:mesenchymal cell apoptotic process; P:mesoderm development; P:middle ear morphogenesis; P:muscle cell fate commitment; P:muscle organ development; P:muscle organ morphogenesis; P:muscle tissue morphogenesis; P:negative regulation of cell differentiation; P:negative regulation of mesenchymal cell apoptotic process; P:neural crest cell migration; P:odontogenesis of dentin-containing tooth; P:outer ear morphogenesis; P:outflow tract morphogenesis; P:outflow tract septum morphogenesis; P:parathyroid gland development; P:pattern specification process; P:pharyngeal system development; P:positive regulation of cell population proliferation; P:positive regulation of epithelial cell proliferation; P:positive regulation of MAPK cascade; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of protein phosphorylation; P:positive regulation of tongue muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of animal organ morphogenesis; P:regulation of transcription by RNA polymerase II; P:retinoic acid receptor signaling pathway; P:semicircular canal morphogenesis; P:sensory perception of sound; P:social behavior; P:soft palate development; P:thymus development; P:thyroid gland development; P:tongue morphogenesis; P:vagus nerve morphogenesis; scaffold5100 indexed_genome mRNA 2511 3772 . + . ID=transcript_17344;P62875 P52436 Q6FHX3,DNA-directed RNA polymerases I, II, and III subunit RPABC5,DNA-directed RNA polymerase III subunit L;RNA polymerase II 7.6 kDa subunit;RPB10 homolog;, PF01194;, GO:0005829;GO:0005654;GO:0005634;GO:0005736;GO:0005665;GO:0005666;GO:0003677;GO:0003899;GO:0008270;GO:0006370;GO:0008543;GO:0000398;GO:0048239;GO:0045815;GO:0032481;GO:0050434;GO:0060964;GO:0006356;GO:0016070;GO:0042795;GO:0006363;GO:0006360;GO:0006366;GO:0006368;GO:0006361;GO:0006367;GO:0006351;GO:0006283;GO:0042797;, C:cytosol; C:nucleoplasm; C:nucleus; C:RNA polymerase I complex; C:RNA polymerase II, core complex; C:RNA polymerase III complex;, F:DNA binding; F:DNA-directed 5'-3' RNA polymerase activity; F:zinc ion binding;, P:7-methylguanosine mRNA capping; P:fibroblast growth factor receptor signaling pathway; P:mRNA splicing, via spliceosome; P:negative regulation of DNA recombination at telomere; P:positive regulation of gene expression, epigenetic; P:positive regulation of type I interferon production; P:positive regulation of viral transcription; P:regulation of gene silencing by miRNA; P:regulation of transcription by RNA polymerase I; P:RNA metabolic process; P:snRNA transcription by RNA polymerase II; P:termination of RNA polymerase I transcription; P:transcription by RNA polymerase I; P:transcription by RNA polymerase II; P:transcription elongation from RNA polymerase II promoter; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:transcription, DNA-templated; P:transcription-coupled nucleotide-excision repair; P:tRNA transcription by RNA polymerase III; scaffold5101 indexed_genome mRNA 221 2008 . + . ID=transcript_17345;Q14155 B1ALK6 B1ALK8 Q3LIA4 Q5W9H0 Q6P9G3 Q6PII2 Q86W63 Q8N3M1,Rho guanine nucleotide exchange factor 7,Beta-Pix;COOL-1;PAK-interacting exchange factor beta;p85;, PF00307;PF00169;PF00621;PF07653;, GO:0005938;GO:0005813;GO:0005829;GO:0005925;GO:0030027;GO:0097431;GO:0043005;GO:0043025;GO:0098794;GO:0032991;GO:0001726;GO:0043015;GO:0005085;GO:0019901;GO:0048013;GO:0048041;GO:0007186;GO:0007030;GO:0035556;GO:0030032;GO:0042059;GO:1905833;GO:0007399;GO:0043065;GO:0010763;GO:0043547;GO:2000394;GO:1900026;GO:1904424;GO:0051056;GO:0007165;, C:cell cortex; C:centrosome; C:cytosol; C:focal adhesion; C:lamellipodium; C:mitotic spindle pole; C:neuron projection; C:neuronal cell body; C:postsynapse; C:protein-containing complex; C:ruffle;, F:gamma-tubulin binding; F:guanyl-nucleotide exchange factor activity; F:protein kinase binding;, P:ephrin receptor signaling pathway; P:focal adhesion assembly; P:G protein-coupled receptor signaling pathway; P:Golgi organization; P:intracellular signal transduction; P:lamellipodium assembly; P:negative regulation of epidermal growth factor receptor signaling pathway; P:negative regulation of microtubule nucleation; P:nervous system development; P:positive regulation of apoptotic process; P:positive regulation of fibroblast migration; P:positive regulation of GTPase activity; P:positive regulation of lamellipodium morphogenesis; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of GTP binding; P:regulation of small GTPase mediated signal transduction; P:signal transduction; scaffold5125 indexed_genome mRNA 177 3516 . - . ID=transcript_17346;Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation; scaffold5194 indexed_genome mRNA 47 710 . - . ID=transcript_17347;P86397,Hydroxyacyl-thioester dehydratase type 2, mitochondrial {ECO:0000303|PubMed:17898086},3-hydroxyacyl-[acyl-carrier-protein] dehydratase {ECO:0000250|UniProtKB:P38790};, PF01575;, GO:0005759;GO:0005739;GO:0005730;GO:0008659;GO:0008693;GO:0047451;GO:0004317;GO:0006631;GO:0046949;, C:mitochondrial matrix; C:mitochondrion; C:nucleolus;, F:(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity; F:3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity; F:3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity; F:3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity;, P:fatty acid metabolic process; P:fatty-acyl-CoA biosynthetic process; scaffold5220 indexed_genome mRNA 335 914 . - . ID=transcript_17348;Q96JJ4,Maestro heat-like repeat-containing protein family member 1,HEAT repeat-containing protein 7A;, PF02985; scaffold5296 indexed_genome mRNA 1269 3072 . + . ID=transcript_17349;Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization; scaffold5303 indexed_genome mRNA 1268 3070 . - . ID=transcript_17350;Q08AD1 B1APG6 Q08AD2 Q6PGN8 Q96FB3 Q9UG20 Q9UPS4,Calmodulin-regulated spectrin-associated protein 2 {ECO:0000305},Calmodulin-regulated spectrin-associated protein 1-like protein 1;, PF17095;PF11971;PF08683;, GO:0036064;GO:0005829;GO:0005794;GO:1990752;GO:0005516;GO:0051011;GO:0030507;GO:0061564;GO:0031122;GO:0000226;GO:0007026;GO:0050773;GO:1903358;GO:0031113;GO:0033043;, C:ciliary basal body; C:cytosol; C:Golgi apparatus; C:microtubule end;, F:calmodulin binding; F:microtubule minus-end binding; F:spectrin binding;, P:axon development; P:cytoplasmic microtubule organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:regulation of dendrite development; P:regulation of Golgi organization; P:regulation of microtubule polymerization; P:regulation of organelle organization; scaffold5529 indexed_genome mRNA 467 3495 . + . ID=transcript_17351;Q96EX9,Protein AHNAK2,, , GO:0043034;GO:0005737;GO:0030659;GO:0005829;GO:0005634;GO:0005886;GO:0042383;GO:0030315;GO:0030018;GO:0043484;, C:costamere; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:nucleus; C:plasma membrane; C:sarcolemma; C:T-tubule; C:Z disc;, , P:regulation of RNA splicing; scaffold5563 indexed_genome mRNA 1 3014 . + . ID=transcript_17352;P52943 A1A4U1 B7Z6C0 E9PD13,Cysteine-rich protein 2,Protein ESP1;, PF00412;, GO:0005938;GO:0008270;GO:0030097;GO:0008284;, C:cell cortex;, F:zinc ion binding;, P:hemopoiesis; P:positive regulation of cell population proliferation; scaffold5573 indexed_genome mRNA 427 2206 . + . ID=transcript_17353;Q8TAV3,Cytochrome P450 2W1 {ECO:0000303|PubMed:22591743},CYPIIW1;, PF00067;, GO:0009986;GO:0005737;GO:0005788;GO:0005789;GO:0043231;GO:0005886;GO:0005503;GO:1904768;GO:0020037;GO:0005506;GO:0016712;GO:0008401;GO:0001972;GO:0008395;GO:0046222;GO:0042738;GO:0006082;GO:0006644;GO:0034653;GO:0006805;, C:cell surface; C:cytoplasm; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:intracellular membrane-bounded organelle; C:plasma membrane;, F:all-trans retinal binding; F:all-trans-retinol binding; F:heme binding; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; F:retinoic acid 4-hydroxylase activity; F:retinoic acid binding; F:steroid hydroxylase activity;, P:aflatoxin metabolic process; P:exogenous drug catabolic process; P:organic acid metabolic process; P:phospholipid metabolic process; P:retinoic acid catabolic process; P:xenobiotic metabolic process; scaffold5740 indexed_genome mRNA 2214 2906 . - . ID=transcript_17354;P10589,COUP transcription factor 1,COUP transcription factor I;Nuclear receptor subfamily 2 group F member 1;V-erbA-related protein 3;, PF00104;PF00105;, GO:0005829;GO:0005654;GO:0005634;GO:0003700;GO:0001227;GO:0004879;GO:0044323;GO:0000978;GO:0043565;GO:1990837;GO:0008270;GO:0048856;GO:0030154;GO:0010977;GO:0000122;GO:0007399;GO:0045944;GO:0006357;GO:0007165;GO:0006367;, C:cytosol; C:nucleoplasm; C:nucleus;, F:DNA-binding transcription factor activity; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:nuclear receptor activity; F:retinoic acid-responsive element binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:zinc ion binding;, P:anatomical structure development; P:cell differentiation; P:negative regulation of neuron projection development; P:negative regulation of transcription by RNA polymerase II; P:nervous system development; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:signal transduction; P:transcription initiation from RNA polymerase II promoter; scaffold5819 indexed_genome mRNA 1 1634 . + . ID=transcript_17355;Q9BXJ3 Q8IV25,Complement C1q tumor necrosis factor-related protein 4,C1q/TNF-related protein 4 {ECO:0000303|PubMed:24366864};, PF00386;, GO:0005615;GO:0005125;GO:0032755;GO:0070105;GO:1901224;GO:0032760;, C:extracellular space;, F:cytokine activity;, P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-6-mediated signaling pathway; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of tumor necrosis factor production; scaffold5906 indexed_genome mRNA 136 1694 . + . ID=transcript_17356;P33241 B3KPP1 B3KRR6 E9PBV6 E9PFP3 Q16096 Q53H48 Q6FHM3 Q9BUY8,Lymphocyte-specific protein 1,47 kDa actin-binding protein;52 kDa phosphoprotein;Lymphocyte-specific antigen WP34;, PF02029;, GO:0015629;GO:0070062;GO:0016020;GO:0005886;GO:0003779;GO:0006968;GO:0007165;, C:actin cytoskeleton; C:extracellular exosome; C:membrane; C:plasma membrane;, F:actin binding;, P:cellular defense response; P:signal transduction; scaffold5932 indexed_genome mRNA 662 1282 . + . ID=transcript_17357;P48509 A8KAK8 E9PI15 Q14826 Q86U54 Q96TE3,CD151 antigen,GP27;Membrane glycoprotein SFA-1;Platelet-endothelial tetraspan antigen 3;Tetraspanin-24;, PF00335;, GO:0005604;GO:0009986;GO:0005829;GO:0005925;GO:0005887;GO:0016020;GO:0005886;GO:0005178;GO:0007155;GO:0016477;GO:0030199;GO:0031581;GO:0030335;GO:0045807;GO:0042098;GO:0016032;GO:0044319;, C:basement membrane; C:cell surface; C:cytosol; C:focal adhesion; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:integrin binding;, P:cell adhesion; P:cell migration; P:collagen fibril organization; P:hemidesmosome assembly; P:positive regulation of cell migration; P:positive regulation of endocytosis; P:T cell proliferation; P:viral process; P:wound healing, spreading of cells; scaffold5932 indexed_genome mRNA 1303 2687 . - . ID=transcript_17358;P48509 A8KAK8 E9PI15 Q14826 Q86U54 Q96TE3,CD151 antigen,GP27;Membrane glycoprotein SFA-1;Platelet-endothelial tetraspan antigen 3;Tetraspanin-24;, PF00335;, GO:0005604;GO:0009986;GO:0005829;GO:0005925;GO:0005887;GO:0016020;GO:0005886;GO:0005178;GO:0007155;GO:0016477;GO:0030199;GO:0031581;GO:0030335;GO:0045807;GO:0042098;GO:0016032;GO:0044319;, C:basement membrane; C:cell surface; C:cytosol; C:focal adhesion; C:integral component of plasma membrane; C:membrane; C:plasma membrane;, F:integrin binding;, P:cell adhesion; P:cell migration; P:collagen fibril organization; P:hemidesmosome assembly; P:positive regulation of cell migration; P:positive regulation of endocytosis; P:T cell proliferation; P:viral process; P:wound healing, spreading of cells; scaffold5947 indexed_genome mRNA 29 1448 . - . ID=transcript_17359;P35247 Q5T0M3 Q6FH08 Q86YK9 Q8TCD8 Q9UCJ2 Q9UCJ3,Pulmonary surfactant-associated protein D,Collectin-7;Lung surfactant protein D;, PF01391;PF00059;PF09006;, GO:0045334;GO:0005581;GO:0030139;GO:0005789;GO:0005576;GO:0005615;GO:0005764;GO:0005771;GO:0005791;GO:0030246;GO:0044267;GO:0042742;GO:0043152;GO:0045087;GO:0048286;GO:0048246;GO:0052405;GO:0032703;GO:0042130;GO:0050766;GO:0072593;GO:0006898;GO:1905226;GO:0001817;GO:0050776;GO:0007585;GO:0043129;GO:0002224;, C:clathrin-coated endocytic vesicle; C:collagen trimer; C:endocytic vesicle; C:endoplasmic reticulum membrane; C:extracellular region; C:extracellular space; C:lysosome; C:multivesicular body; C:rough endoplasmic reticulum;, F:carbohydrate binding;, P:cellular protein metabolic process; P:defense response to bacterium; P:induction of bacterial agglutination; P:innate immune response; P:lung alveolus development; P:macrophage chemotaxis; P:negative regulation by host of symbiont molecular function; P:negative regulation of interleukin-2 production; P:negative regulation of T cell proliferation; P:positive regulation of phagocytosis; P:reactive oxygen species metabolic process; P:receptor-mediated endocytosis; P:regulation of adhesion of symbiont to host epithelial cell; P:regulation of cytokine production; P:regulation of immune response; P:respiratory gaseous exchange by respiratory system; P:surfactant homeostasis; P:toll-like receptor signaling pathway; scaffold6066 indexed_genome mRNA 947 1843 . - . ID=transcript_17360;Q8N201 A6NJ44 Q6NT70 Q6UX74 Q8WV40 Q96D36 Q9NTD1 Q9P2A8 Q9Y3W8,Integrator complex subunit 1,, PF12432;, GO:0016021;GO:0032039;GO:0016020;GO:0031965;GO:0005654;GO:0016180;GO:0042795;GO:0034474;, C:integral component of membrane; C:integrator complex; C:membrane; C:nuclear membrane; C:nucleoplasm;, , P:snRNA processing; P:snRNA transcription by RNA polymerase II; P:U2 snRNA 3'-end processing; scaffold6223 indexed_genome mRNA 1609 2268 . - . ID=transcript_17361;B4DYI2,Putative spermatogenesis-associated protein 31C2,Protein FAM75C2;, PF15371;PF14650;, GO:0016021;GO:0030154;GO:0007283;, C:integral component of membrane;, , P:cell differentiation; P:spermatogenesis; scaffold6254 indexed_genome mRNA 604 1201 . - . ID=transcript_17362;Q9BXR3 Q6KH04 Q9BXR4 Q9UKH5 Q9UP31 Q9WIK9 Q9WJR4,Endogenous retrovirus group K member 6 Pol protein,HERV-K(C7) Pol protein;HERV-K(HML-2.HOM) Pol protein;HERV-K108 Pol protein;HERV-K_7p22.1 provirus ancestral Pol protein;, PF00552;PF02022;PF00075;PF00665;PF00078;PF06817;, GO:0003677;GO:0035613;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;, , F:DNA binding; F:RNA stem-loop binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;, P:DNA integration; P:DNA recombination; scaffold6254 indexed_genome mRNA 1508 2773 . - . ID=transcript_17363;P61570,Endogenous retrovirus group K member 25 Env polyprotein,Envelope polyprotein;HERV-K_11q22.1 provirus ancestral Env polyprotein;, PF00517;PF13804;, GO:0016021;GO:0005886;GO:0005198;, C:integral component of membrane; C:plasma membrane;, F:structural molecule activity; scaffold6465 indexed_genome mRNA 408 1463 . + . ID=transcript_17364;Q9P2W7 B7Z5Z8 Q96FS7,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 {ECO:0000305},Beta-1,3-glucuronyltransferase 1;Glucuronosyltransferase P;UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase;, PF03360;, GO:0005789;GO:0005576;GO:0000139;GO:0016021;GO:0043231;GO:0015018;GO:0046872;GO:0005975;GO:0071456;GO:0050650;GO:0030203;GO:0006486;, C:endoplasmic reticulum membrane; C:extracellular region; C:Golgi membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle;, F:galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; F:metal ion binding;, P:carbohydrate metabolic process; P:cellular response to hypoxia; P:chondroitin sulfate proteoglycan biosynthetic process; P:glycosaminoglycan metabolic process; P:protein glycosylation; scaffold6527 indexed_genome mRNA 1 2281 . + . ID=transcript_17365;Q9NZV1 Q2M2G4 Q59GH0 Q7LCQ5 Q9H318,Cysteine-rich motor neuron 1 protein,Cysteine-rich repeat-containing protein S52;, PF02822;PF00219;PF00093;, GO:0005576;GO:0016021;GO:0005886;GO:0005520;GO:0005010;GO:0030165;GO:0004867;GO:0030514;GO:0045668;GO:0007399;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:insulin-like growth factor binding; F:insulin-like growth factor-activated receptor activity; F:PDZ domain binding; F:serine-type endopeptidase inhibitor activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of osteoblast differentiation; P:nervous system development; scaffold6541 indexed_genome mRNA 1 2278 . + . ID=transcript_17366;Q9NZV1 Q2M2G4 Q59GH0 Q7LCQ5 Q9H318,Cysteine-rich motor neuron 1 protein,Cysteine-rich repeat-containing protein S52;, PF02822;PF00219;PF00093;, GO:0005576;GO:0016021;GO:0005886;GO:0005520;GO:0005010;GO:0030165;GO:0004867;GO:0030514;GO:0045668;GO:0007399;, C:extracellular region; C:integral component of membrane; C:plasma membrane;, F:insulin-like growth factor binding; F:insulin-like growth factor-activated receptor activity; F:PDZ domain binding; F:serine-type endopeptidase inhibitor activity;, P:negative regulation of BMP signaling pathway; P:negative regulation of osteoblast differentiation; P:nervous system development; scaffold6556 indexed_genome mRNA 123 1306 . + . ID=transcript_17367;Q13395 Q9H581,Probable methyltransferase TARBP1,TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;, PF00588;, GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;, C:nucleus;, F:RNA binding; F:tRNA (guanine) methyltransferase activity;, P:regulation of transcription by RNA polymerase II; P:tRNA methylation; scaffold6607 indexed_genome mRNA 605 2753 . + . ID=transcript_17368;Q8WX39 C9J5F0 Q6JVE7,Epididymal-specific lipocalin-9,MUP-like lipocalin;, PF00061;, GO:0005615;GO:0036094;, C:extracellular space;, F:small molecule binding; scaffold6615 indexed_genome mRNA 496 1366 . - . ID=transcript_17369;P03905 Q6RL39 Q6RQN9 Q8HNR8,NADH-ubiquinone oxidoreductase chain 4,NADH dehydrogenase subunit 4;, PF01059;PF00361;, GO:0016021;GO:0005743;GO:0005747;GO:0008137;GO:0048039;GO:0009060;GO:0007568;GO:0021549;GO:0015990;GO:0001701;GO:0006120;GO:0032981;GO:0045471;GO:0001666;GO:0035094;, C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I;, F:NADH dehydrogenase (ubiquinone) activity; F:ubiquinone binding;, P:aerobic respiration; P:aging; P:cerebellum development; P:electron transport coupled proton transport; P:in utero embryonic development; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:response to ethanol; P:response to hypoxia; P:response to nicotine; scaffold6647 indexed_genome mRNA 486 1932 . + . ID=transcript_17370;P98196 Q5VXT2,Phospholipid-transporting ATPase IH,ATPase IS;ATPase class VI type 11A;P4-ATPase flippase complex alpha subunit ATP11A;, PF16212;PF16209;, GO:0005769;GO:0005783;GO:0005887;GO:0043231;GO:0005765;GO:0016020;GO:1990531;GO:0005886;GO:0055037;GO:0035579;GO:0070821;GO:0005802;GO:0005524;GO:0140326;GO:0000287;GO:0090555;GO:0140346;GO:0043312;GO:0045332;GO:0010831;, C:early endosome; C:endoplasmic reticulum; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:lysosomal membrane; C:membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane; C:recycling endosome; C:specific granule membrane; C:tertiary granule membrane; C:trans-Golgi network;, F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:magnesium ion binding; F:phosphatidylethanolamine flippase activity; F:phosphatidylserine flippase activity;, P:neutrophil degranulation; P:phospholipid translocation; P:positive regulation of myotube differentiation; scaffold6753 indexed_genome mRNA 918 2372 . - . ID=transcript_17371;P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation;|P50402 Q6FI02,Emerin,, PF03020;, GO:0005737;GO:0005829;GO:0005783;GO:0016021;GO:0016020;GO:0005874;GO:0005635;GO:0005637;GO:0031965;GO:0005640;GO:0005654;GO:0005819;GO:0003779;GO:0048487;GO:0045296;GO:0071363;GO:0007084;GO:0006936;GO:0007517;GO:0090090;GO:0048147;GO:0071763;GO:0046827;GO:0045048;GO:0060828;GO:0035914;, C:cytoplasm; C:cytosol; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:microtubule; C:nuclear envelope; C:nuclear inner membrane; C:nuclear membrane; C:nuclear outer membrane; C:nucleoplasm; C:spindle;, F:actin binding; F:beta-tubulin binding; F:cadherin binding;, P:cellular response to growth factor stimulus; P:mitotic nuclear envelope reassembly; P:muscle contraction; P:muscle organ development; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of fibroblast proliferation; P:nuclear membrane organization; P:positive regulation of protein export from nucleus; P:protein insertion into ER membrane; P:regulation of canonical Wnt signaling pathway; P:skeletal muscle cell differentiation; scaffold6848 indexed_genome mRNA 820 1570 . + . ID=transcript_17372;Q9Y696 Q9UFW9 Q9UQJ6,Chloride intracellular channel protein 4,Intracellular chloride ion channel protein p64H1;, , GO:0015629;GO:0045177;GO:0009986;GO:0005911;GO:0005813;GO:0034707;GO:0005737;GO:0030659;GO:0005829;GO:0070062;GO:0005902;GO:0030496;GO:0005739;GO:0016363;GO:0005634;GO:0048471;GO:0005886;GO:0005254;GO:0005244;GO:0001525;GO:0048754;GO:0030154;GO:0071277;GO:0006821;GO:0001886;GO:0035088;GO:0009566;GO:0030216;GO:0035264;GO:0030336;GO:0051493;GO:0034765;GO:0061299;GO:0007035;, C:actin cytoskeleton; C:apical part of cell; C:cell surface; C:cell-cell junction; C:centrosome; C:chloride channel complex; C:cytoplasm; C:cytoplasmic vesicle membrane; C:cytosol; C:extracellular exosome; C:microvillus; C:midbody; C:mitochondrion; C:nuclear matrix; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane;, F:chloride channel activity; F:voltage-gated ion channel activity;, P:angiogenesis; P:branching morphogenesis of an epithelial tube; P:cell differentiation; P:cellular response to calcium ion; P:chloride transport; P:endothelial cell morphogenesis; P:establishment or maintenance of apical/basal cell polarity; P:fertilization; P:keratinocyte differentiation; P:multicellular organism growth; P:negative regulation of cell migration; P:regulation of cytoskeleton organization; P:regulation of ion transmembrane transport; P:retina vasculature morphogenesis in camera-type eye; P:vacuolar acidification; scaffold7327 indexed_genome mRNA 119 1052 . + . ID=transcript_17373;Q99590 A6NEU9 A6NLW5 Q8IW59,Protein SCAF11,CTD-associated SR protein 11;Renal carcinoma antigen NY-REN-40;SC35-interacting protein 1;SR-related and CTD-associated factor 11;SRSF2-interacting protein;Serine/arginine-rich splicing factor 2-interacting protein;Splicing factor, arginine/serine-rich 2-interacting protein;Splicing regulatory protein 129;, PF13639;, GO:0016604;GO:0005730;GO:0005654;GO:0046872;GO:0003723;GO:0006397;GO:0008380;GO:0000375;GO:0000245;, C:nuclear body; C:nucleolus; C:nucleoplasm;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; scaffold7361 indexed_genome mRNA 1407 2340 . - . ID=transcript_17374;Q99590 A6NEU9 A6NLW5 Q8IW59,Protein SCAF11,CTD-associated SR protein 11;Renal carcinoma antigen NY-REN-40;SC35-interacting protein 1;SR-related and CTD-associated factor 11;SRSF2-interacting protein;Serine/arginine-rich splicing factor 2-interacting protein;Splicing factor, arginine/serine-rich 2-interacting protein;Splicing regulatory protein 129;, PF13639;, GO:0016604;GO:0005730;GO:0005654;GO:0046872;GO:0003723;GO:0006397;GO:0008380;GO:0000375;GO:0000245;, C:nuclear body; C:nucleolus; C:nucleoplasm;, F:metal ion binding; F:RNA binding;, P:mRNA processing; P:RNA splicing; P:RNA splicing, via transesterification reactions; P:spliceosomal complex assembly; scaffold7393 indexed_genome mRNA 4 1978 . - . ID=transcript_17375;P01871 A0A075B6N9 A0A0G2JQL4 P04220 P20769,Immunoglobulin heavy constant mu {ECO:0000303|PubMed:11340299, ECO:0000303|Ref.13},Ig mu chain C region {ECO:0000305};Ig mu chain C region BOT {ECO:0000305|PubMed:6425189};Ig mu chain C region GAL {ECO:0000305|PubMed:4803843};Ig mu chain C region OU {ECO:0000305|PubMed:4742735};, PF07654;, GO:0072562;GO:0009986;GO:0009897;GO:0070062;GO:0005615;GO:0071757;GO:0042571;GO:0016021;GO:0071756;GO:0005886;GO:0003823;GO:0002250;GO:0019731;GO:0050853;GO:0006958;GO:0042742;GO:0050829;GO:0045087;GO:0050900;GO:0006911;GO:0006910;GO:0050871;, C:blood microparticle; C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:extracellular space; C:hexameric IgM immunoglobulin complex; C:immunoglobulin complex, circulating; C:integral component of membrane; C:pentameric IgM immunoglobulin complex; C:plasma membrane;, F:antigen binding;, P:adaptive immune response; P:antibacterial humoral response; P:B cell receptor signaling pathway; P:complement activation, classical pathway; P:defense response to bacterium; P:defense response to Gram-negative bacterium; P:innate immune response; P:leukocyte migration; P:phagocytosis, engulfment; P:phagocytosis, recognition; P:positive regulation of B cell activation; scaffold7787 indexed_genome mRNA 408 1498 . + . ID=transcript_17376;Q14746 Q86U99,Conserved oligomeric Golgi complex subunit 2,Component of oligomeric Golgi complex 2;Low density lipoprotein receptor defect C-complementing protein;, PF06148;PF12022;, GO:0005829;GO:0000139;GO:0005795;GO:0017119;GO:0032588;GO:0044877;GO:0006888;GO:0007030;GO:0006891;GO:0015031;, C:cytosol; C:Golgi membrane; C:Golgi stack; C:Golgi transport complex; C:trans-Golgi network membrane;, F:protein-containing complex binding;, P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intra-Golgi vesicle-mediated transport; P:protein transport; scaffold7801 indexed_genome mRNA 492 1057 . - . ID=transcript_17377;P35226 Q16030 Q5T8Z3 Q96F37,Polycomb complex protein BMI-1,Polycomb group RING finger protein 4;RING finger protein 51;, PF16207;, GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0031519;GO:0035102;GO:0000151;GO:1990841;GO:0071535;GO:0008270;GO:0006342;GO:0030097;GO:0036353;GO:0070317;GO:0045814;GO:0000122;GO:0048146;GO:0051443;GO:0010468;GO:0007379;, C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus; C:PcG protein complex; C:PRC1 complex; C:ubiquitin ligase complex;, F:promoter-specific chromatin binding; F:RING-like zinc finger domain binding; F:zinc ion binding;, P:chromatin silencing; P:hemopoiesis; P:histone H2A-K119 monoubiquitination; P:negative regulation of G0 to G1 transition; P:negative regulation of gene expression, epigenetic; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of fibroblast proliferation; P:positive regulation of ubiquitin-protein transferase activity; P:regulation of gene expression; P:segment specification; scaffold7862 indexed_genome mRNA 256 1002 . - . ID=transcript_17378;Q8NDY3 Q5JUG2 Q96GD1,[Protein ADP-ribosylarginine] hydrolase-like protein 1,ADP-ribosylhydrolase 2;, PF03747;, GO:0003875;GO:0000287;GO:0051725;, , F:ADP-ribosylarginine hydrolase activity; F:magnesium ion binding;, P:protein de-ADP-ribosylation; scaffold7864 indexed_genome mRNA 256 1000 . - . ID=transcript_17379;Q8NDY3 Q5JUG2 Q96GD1,[Protein ADP-ribosylarginine] hydrolase-like protein 1,ADP-ribosylhydrolase 2;, PF03747;, GO:0003875;GO:0000287;GO:0051725;, , F:ADP-ribosylarginine hydrolase activity; F:magnesium ion binding;, P:protein de-ADP-ribosylation; scaffold7929 indexed_genome mRNA 341 1070 . - . ID=transcript_17380;Q96SL8 A2RU72 Q6ZMJ7,Flt3-interacting zinc finger protein 1,Zinc finger protein 798;, PF00096;, GO:0000785;GO:0005737;GO:0005634;GO:0046872;GO:0030971;GO:0001102;GO:0003713;GO:0001934;GO:0045944;, C:chromatin; C:cytoplasm; C:nucleus;, F:metal ion binding; F:receptor tyrosine kinase binding; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity;, P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; scaffold7929 indexed_genome mRNA 1421 2150 . - . ID=transcript_17381;Q96SL8 A2RU72 Q6ZMJ7,Flt3-interacting zinc finger protein 1,Zinc finger protein 798;, PF00096;, GO:0000785;GO:0005737;GO:0005634;GO:0046872;GO:0030971;GO:0001102;GO:0003713;GO:0001934;GO:0045944;, C:chromatin; C:cytoplasm; C:nucleus;, F:metal ion binding; F:receptor tyrosine kinase binding; F:RNA polymerase II activating transcription factor binding; F:transcription coactivator activity;, P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; scaffold7939 indexed_genome mRNA 1 1335 . + . ID=transcript_17382;O14514,Adhesion G protein-coupled receptor B1 {ECO:0000312|HGNC:HGNC:943},Brain-specific angiogenesis inhibitor 1 {ECO:0000303|PubMed:9393972};, PF00002;PF19188;PF16489;PF01825;PF02793;PF00090;, GO:0005911;GO:0030425;GO:0043197;GO:0005615;GO:0005925;GO:0016021;GO:0005887;GO:0048471;GO:0001891;GO:0005886;GO:0014069;GO:0004930;GO:0001530;GO:0030165;GO:0001786;GO:0007189;GO:0043277;GO:0007409;GO:0007155;GO:0007166;GO:0050829;GO:0043652;GO:0007186;GO:0045087;GO:0007517;GO:0016525;GO:0008285;GO:0010596;GO:0042177;GO:0031397;GO:0007422;GO:0006910;GO:1901741;GO:1903428;GO:0051965;GO:0048167;GO:0007165;, C:cell-cell junction; C:dendrite; C:dendritic spine; C:extracellular space; C:focal adhesion; C:integral component of membrane; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:phagocytic cup; C:plasma membrane; C:postsynaptic density;, F:G protein-coupled receptor activity; F:lipopolysaccharide binding; F:PDZ domain binding; F:phosphatidylserine binding;, P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:apoptotic cell clearance; P:axonogenesis; P:cell adhesion; P:cell surface receptor signaling pathway; P:defense response to Gram-negative bacterium; P:engulfment of apoptotic cell; P:G protein-coupled receptor signaling pathway; P:innate immune response; P:muscle organ development; P:negative regulation of angiogenesis; P:negative regulation of cell population proliferation; P:negative regulation of endothelial cell migration; P:negative regulation of protein catabolic process; P:negative regulation of protein ubiquitination; P:peripheral nervous system development; P:phagocytosis, recognition; P:positive regulation of myoblast fusion; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of synapse assembly; P:regulation of synaptic plasticity; P:signal transduction; scaffold8254 indexed_genome mRNA 92 1917 . + . ID=transcript_17383;Q15661 D2E6R9 D2E6S1 P15157 Q15663 Q6B052 Q9H2Y4 Q9H2Y5 Q9UQI1,Tryptase alpha/beta-1,Tryptase I;Tryptase alpha-1;, PF00089;, GO:0005576;GO:0005615;GO:0042802;GO:0004252;GO:0008236;GO:0006952;GO:0022617;GO:0006508;, C:extracellular region; C:extracellular space;, F:identical protein binding; F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:defense response; P:extracellular matrix disassembly; P:proteolysis;|Q9BZJ3 O95824 Q8TDI6 Q96L36 Q96RZ5 Q9H2Y6 Q9UQI8,Tryptase delta,Delta-tryptase;HmMCP-3-like tryptase III;Mast cell mMCP-7-like;Tryptase-3;, PF00089;, GO:0005615;GO:0004252;GO:0008236;GO:0006508;, C:extracellular space;, F:serine-type endopeptidase activity; F:serine-type peptidase activity;, P:proteolysis; scaffold8788 indexed_genome mRNA 585 1466 . + . ID=transcript_17384;P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein,Endogenous retrovirus group PABLB member 1;Envelope polyprotein;HERV-R(b) Env protein;HERV-R(b)_3p24.3 provirus ancestral Env polyprotein;, PF00429;, GO:0016021;GO:0005886;, C:integral component of membrane; C:plasma membrane; scaffold9081 indexed_genome mRNA 820 1477 . + . ID=transcript_17385;Q9C0H2 A4D201 B7WP98 Q6L749 Q6ZVG3 Q8TEG6,Protein tweety homolog 3,, PF04906;, GO:0034707;GO:0070062;GO:0005886;GO:0005254;GO:0005229;GO:0072320;GO:0006821;GO:0034220;, C:chloride channel complex; C:extracellular exosome; C:plasma membrane;, F:chloride channel activity; F:intracellular calcium activated chloride channel activity; F:volume-sensitive chloride channel activity;, P:chloride transport; P:ion transmembrane transport; scaffold9503 indexed_genome mRNA 505 1629 . - . ID=transcript_17386;Q9H7R5 A8K5T8,Zinc finger protein 665,Zinc finger protein 160-like;, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold10447 indexed_genome mRNA 574 1431 . + . ID=transcript_17387;Q96NI8 A1L472 B4DMP1,Zinc finger protein 570,, PF01352;PF00096;, GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;, C:nucleus;, F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;, P:regulation of transcription by RNA polymerase II; scaffold11025 indexed_genome mRNA 1 1347 . + . ID=transcript_17388;Q96S95,Calcium/calmodulin-dependent protein kinase II inhibitor 2,CaM-KII inhibitory protein;, PF15170;, GO:0005813;GO:0005829;GO:0005654;GO:0008427;GO:0019901;GO:0006469;, C:centrosome; C:cytosol; C:nucleoplasm;, F:calcium-dependent protein kinase inhibitor activity; F:protein kinase binding;, P:negative regulation of protein kinase activity;|Q96S95,Calcium/calmodulin-dependent protein kinase II inhibitor 2,CaM-KII inhibitory protein;, PF15170;, GO:0005813;GO:0005829;GO:0005654;GO:0008427;GO:0019901;GO:0006469;, C:centrosome; C:cytosol; C:nucleoplasm;, F:calcium-dependent protein kinase inhibitor activity; F:protein kinase binding;, P:negative regulation of protein kinase activity; scaffold11704 indexed_genome mRNA 261 777 . + . ID=transcript_17389;Q9BQ24 A8K3A4 Q86T05 Q96LT1,Zinc finger FYVE domain-containing protein 21,, PF01363;PF16696;, GO:0005768;GO:0005925;GO:0046872;, C:endosome; C:focal adhesion;, F:metal ion binding; scaffold11897 indexed_genome mRNA 130 667 . + . ID=transcript_17390;P35237 B2RBA8 Q59F97 Q5TD06 Q7Z2Y7 Q96J44 Q9UDI7,Serpin B6,Cytoplasmic antiproteinase;Peptidase inhibitor 6;Placental thrombin inhibitor;, PF00079;, GO:0062023;GO:0005737;GO:0005829;GO:0070062;GO:0005576;GO:0005615;GO:0101003;GO:0005886;GO:0030667;GO:0097180;GO:0070821;GO:0002020;GO:0004867;GO:0071470;GO:0010951;GO:0043312;GO:0007605;, C:collagen-containing extracellular matrix; C:cytoplasm; C:cytosol; C:extracellular exosome; C:extracellular region; C:extracellular space; C:ficolin-1-rich granule membrane; C:plasma membrane; C:secretory granule membrane; C:serine protease inhibitor complex; C:tertiary granule membrane;, F:protease binding; F:serine-type endopeptidase inhibitor activity;, P:cellular response to osmotic stress; P:negative regulation of endopeptidase activity; P:neutrophil degranulation; P:sensory perception of sound; scaffold12117 indexed_genome mRNA 129 1176 . + . ID=transcript_17391;Q9UKM7 Q5VSG3 Q9BRS9 Q9Y5K7,Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase,ER alpha-1,2-mannosidase;ER mannosidase 1;Man9GlcNAc2-specific-processing alpha-mannosidase;Mannosidase alpha class 1B member 1;, PF01532;, GO:0031410;GO:0005783;GO:0005789;GO:0044322;GO:1903561;GO:0005794;GO:0016021;GO:0016020;GO:0005509;GO:0004571;GO:1904380;GO:1904382;GO:0006491;GO:0009311;GO:0036508;GO:0006486;GO:0036511;GO:0036512;GO:0036509;GO:0036510;GO:0030433;GO:0019082;, C:cytoplasmic vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum quality control compartment; C:extracellular vesicle; C:Golgi apparatus; C:integral component of membrane; C:membrane;, F:calcium ion binding; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;, P:endoplasmic reticulum mannose trimming; P:mannose trimming involved in glycoprotein ERAD pathway; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein alpha-1,2-demannosylation; P:protein glycosylation; P:trimming of first mannose on A branch; P:trimming of second mannose on A branch; P:trimming of terminal mannose on B branch; P:trimming of terminal mannose on C branch; P:ubiquitin-dependent ERAD pathway; P:viral protein processing; scaffold12345 indexed_genome mRNA 260 840 . - . ID=transcript_17392;P48436 Q53Y80,Transcription factor SOX-9 {ECO:0000305},, PF00505;PF12444;, GO:0000785;GO:0005654;GO:0005634;GO:0032991;GO:0005667;GO:0008013;GO:0043425;GO:0003682;GO:0000987;GO:0001228;GO:0003700;GO:0000981;GO:0097157;GO:0034236;GO:0000978;GO:0043565;GO:1990837;GO:0097065;GO:0003180;GO:0060018;GO:0001658;GO:0060532;GO:0019933;GO:0001502;GO:0051216;GO:0001708;GO:0098609;GO:0071773;GO:0071364;GO:0071504;GO:0071347;GO:0071260;GO:0071300;GO:0071560;GO:0002062;GO:0003413;GO:0003415;GO:0006338;GO:0090103;GO:0007010;GO:0003203;GO:0031018;GO:0007173;GO:0060517;GO:0001837;GO:0060441;GO:0070371;GO:0030198;GO:0003430;GO:0001942;GO:0070384;GO:0007507;GO:0003170;GO:0003188;GO:0003179;GO:0060729;GO:0035622;GO:0032808;GO:0060174;GO:0060487;GO:0061145;GO:0019100;GO:0008584;GO:0030879;GO:0072289;GO:0061138;GO:0002009;GO:0043066;GO:1904864;GO:0070168;GO:0030502;GO:0090090;GO:0032331;GO:0030857;GO:0050680;GO:0046322;GO:0002683;GO:2001054;GO:0045662;GO:0030279;GO:0045668;GO:0046533;GO:1902894;GO:0000122;GO:0045892;GO:0014032;GO:0014036;GO:0007219;GO:0030903;GO:0006334;GO:0048709;GO:0001503;GO:0030916;GO:0090190;GO:0061036;GO:0008284;GO:2000138;GO:0032332;GO:1902732;GO:0030858;GO:0010634;GO:0050679;GO:1901203;GO:0010628;GO:0090184;GO:2000020;GO:0002053;GO:2000741;GO:0014068;GO:0045732;GO:0001934;GO:0045944;GO:0045893;GO:0030850;GO:0043491;GO:0034504;GO:0065003;GO:0042981;GO:0061046;GO:0030155;GO:0010564;GO:0042127;GO:0060784;GO:2000794;GO:0006357;GO:0060260;GO:0072034;GO:0070542;GO:0060041;GO:0060221;GO:0060009;GO:0060008;GO:0007165;GO:0001501;GO:0035019;GO:0007283;GO:0001894;GO:0060534;GO:0072197;GO:0072193;GO:0072190;, C:chromatin; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:transcription regulator complex;, F:beta-catenin binding; F:bHLH transcription factor binding; F:chromatin binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:pre-mRNA intronic binding; F:protein kinase A catalytic subunit binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:anterior head development; P:aortic valve morphogenesis; P:astrocyte fate commitment; P:branching involved in ureteric bud morphogenesis; P:bronchus cartilage development; P:cAMP-mediated signaling; P:cartilage condensation; P:cartilage development; P:cell fate specification; P:cell-cell adhesion; P:cellular response to BMP stimulus; P:cellular response to epidermal growth factor stimulus; P:cellular response to heparin; P:cellular response to interleukin-1; P:cellular response to mechanical stimulus; P:cellular response to retinoic acid; P:cellular response to transforming growth factor beta stimulus; P:chondrocyte differentiation; P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:chondrocyte hypertrophy; P:chromatin remodeling; P:cochlea morphogenesis; P:cytoskeleton organization; P:endocardial cushion morphogenesis; P:endocrine pancreas development; P:epidermal growth factor receptor signaling pathway; P:epithelial cell proliferation involved in prostatic bud elongation; P:epithelial to mesenchymal transition; P:epithelial tube branching involved in lung morphogenesis; P:ERK1 and ERK2 cascade; P:extracellular matrix organization; P:growth plate cartilage chondrocyte growth; P:hair follicle development; P:Harderian gland development; P:heart development; P:heart valve development; P:heart valve formation; P:heart valve morphogenesis; P:intestinal epithelial structure maintenance; P:intrahepatic bile duct development; P:lacrimal gland development; P:limb bud formation; P:lung epithelial cell differentiation; P:lung smooth muscle development; P:male germ-line sex determination; P:male gonad development; P:mammary gland development; P:metanephric nephron tubule formation; P:morphogenesis of a branching epithelium; P:morphogenesis of an epithelium; P:negative regulation of apoptotic process; P:negative regulation of beta-catenin-TCF complex assembly; P:negative regulation of biomineral tissue development; P:negative regulation of bone mineralization; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of chondrocyte differentiation; P:negative regulation of epithelial cell differentiation; P:negative regulation of epithelial cell proliferation; P:negative regulation of fatty acid oxidation; P:negative regulation of immune system process; P:negative regulation of mesenchymal cell apoptotic process; P:negative regulation of myoblast differentiation; P:negative regulation of ossification; P:negative regulation of osteoblast differentiation; P:negative regulation of photoreceptor cell differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:neural crest cell development; P:neural crest cell fate specification; P:Notch signaling pathway; P:notochord development; P:nucleosome assembly; P:oligodendrocyte differentiation; P:ossification; P:otic vesicle formation; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of cartilage development; P:positive regulation of cell population proliferation; P:positive regulation of cell proliferation involved in heart morphogenesis; P:positive regulation of chondrocyte differentiation; P:positive regulation of chondrocyte proliferation; P:positive regulation of epithelial cell differentiation; P:positive regulation of epithelial cell migration; P:positive regulation of epithelial cell proliferation; P:positive regulation of extracellular matrix assembly; P:positive regulation of gene expression; P:positive regulation of kidney development; P:positive regulation of male gonad development; P:positive regulation of mesenchymal cell proliferation; P:positive regulation of mesenchymal stem cell differentiation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein catabolic process; P:positive regulation of protein phosphorylation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:prostate gland development; P:protein kinase B signaling; P:protein localization to nucleus; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of branching involved in lung morphogenesis; P:regulation of cell adhesion; P:regulation of cell cycle process; P:regulation of cell population proliferation; P:regulation of cell proliferation involved in tissue homeostasis; P:regulation of epithelial cell proliferation involved in lung morphogenesis; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter; P:renal vesicle induction; P:response to fatty acid; P:retina development in camera-type eye; P:retinal rod cell differentiation; P:Sertoli cell development; P:Sertoli cell differentiation; P:signal transduction; P:skeletal system development; P:somatic stem cell population maintenance; P:spermatogenesis; P:tissue homeostasis; P:trachea cartilage development; P:ureter morphogenesis; P:ureter smooth muscle cell differentiation; P:ureter urothelium development; scaffold12838 indexed_genome mRNA 174 1107 . - . ID=transcript_17393;Q9H4K7 A6NDR3 B4DR85 Q96I17 Q9NVG9 Q9UFR4,Mitochondrial ribosome-associated GTPase 2,GTP-binding protein 5;Protein obg homolog 1;, PF01018;PF01926;, GO:0005743;GO:0005759;GO:0005761;GO:0005739;GO:0005525;GO:0003924;GO:0000287;GO:0070129;GO:0044065;GO:0042254;, C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrial ribosome; C:mitochondrion;, F:GTP binding; F:GTPase activity; F:magnesium ion binding;, P:regulation of mitochondrial translation; P:regulation of respiratory system process; P:ribosome biogenesis; scaffold13978 indexed_genome mRNA 1 910 . + . ID=transcript_17394;Q7RTS1 A4D271 Q14DE4,Class A basic helix-loop-helix protein 15,Class B basic helix-loop-helix protein 8;Muscle, intestine and stomach expression 1;, PF00010;, GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0046983;GO:0000978;GO:1990837;GO:0019722;GO:0048469;GO:0007267;GO:0042149;GO:0030968;GO:0007186;GO:0042593;GO:0007030;GO:0048312;GO:0006851;GO:0010832;GO:0030182;GO:0006357;, C:chromatin; C:nucleus;, F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;, P:calcium-mediated signaling; P:cell maturation; P:cell-cell signaling; P:cellular response to glucose starvation; P:endoplasmic reticulum unfolded protein response; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:Golgi organization; P:intracellular distribution of mitochondria; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of myotube differentiation; P:neuron differentiation; P:regulation of transcription by RNA polymerase II;